,Word,T,P
0,Comparison,0,0
1,of,0,0
2,budesonide,1,1
3,Turbuhaler,1,1
4,with,1,0
5,budesonide,1,1
6,aqua,1,0
7,in,0,0
8,the,0,0
9,treatment,0,0
10,of,0,0
11,seasonal,0,0
12,allergic,0,0
13,rhinitis,0,0
14,.,0,0
15,Rhinocort,0,0
16,Study,0,0
17,Group,0,0
18,.,0,0
19,OBJECTIVE,0,0
20,To,0,0
21,compare,0,0
22,the,0,0
23,effect,0,0
24,of,0,0
25,budesonide,1,1
26,Turbuhaler,1,1
27,400,0,0
28,microg/day,0,0
29,with,0,0
30,budesonide,1,1
31,aqua,1,1
32,256,0,0
33,microg/day,0,0
34,in,0,0
35,the,0,0
36,treatment,0,0
37,of,0,0
38,seasonal,0,0
39,allergic,0,0
40,rhinitis,0,0
41,(,0,0
42,SAR,0,0
43,),0,0
44,.,0,0
45,Secondarily,0,0
46,to,0,0
47,ascertain,0,0
48,patients,0,0
49,',0,0
50,preferences,0,0
51,for,0,0
52,the,0,0
53,two,0,0
54,nasal,0,0
55,devices,0,0
56,and,0,0
57,to,0,0
58,assess,0,0
59,quality,0,0
60,of,0,0
61,life,0,0
62,.,0,0
63,DESIGN,0,0
64,Randomized,0,0
65,",",0,0
66,multicentre,0,0
67,",",0,0
68,double-blind,0,0
69,",",0,0
70,double-,0,1
71,dummy,0,0
72,",",0,0
73,parallel,0,0
74,groups,0,0
75,study,0,0
76,.,0,0
77,SETTING,0,0
78,Private,0,0
79,practices,0,1
80,and,0,0
81,hospital,0,0
82,clinics,0,0
83,in,0,0
84,Ontario,0,0
85,",",0,0
86,Quebec,0,0
87,and,0,0
88,Manitoba,0,0
89,.,0,0
90,POPULATION,0,0
91,Two,0,0
92,hundred,0,0
93,and,0,0
94,eighty-four,0,0
95,out-patients,0,0
96,with,0,0
97,SAR,0,0
98,",",0,0
99,who,0,0
100,were,0,0
101,symptomatic,0,0
102,during,0,0
103,the,0,0
104,ragweed,0,1
105,season,0,0
106,",",0,0
107,volunteered,0,0
108,for,0,0
109,enrolment,0,0
110,(,0,0
111,243,0,0
112,randomized,0,0
113,),0,0
114,.,0,0
115,RESULTS,0,0
116,Mean,0,0
117,daily,0,1
118,nasal,0,0
119,symptom,0,0
120,scores,0,0
121,were,0,0
122,significantly,0,0
123,reduced,0,0
124,with,0,0
125,treatment,0,0
126,.,0,0
127,There,0,0
128,were,0,0
129,no,0,0
130,statistically,0,0
131,significant,0,0
132,changes,0,0
133,from,0,0
134,baseline,0,0
135,for,0,0
136,eye,0,0
137,symptoms,0,0
138,.,0,0
139,Most,0,0
140,patients,0,0
141,(,0,0
142,more,0,0
143,than,0,0
144,80,0,0
145,%,0,0
146,),0,0
147,achieved,0,0
148,substantial,0,0
149,control,0,0
150,of,0,0
151,their,0,0
152,symptoms,0,0
153,with,0,0
154,budesonide,1,1
155,.,1,0
156,The,0,0
157,most,0,0
158,common,0,0
159,nasal,0,0
160,and,0,0
161,non-nasal,0,0
162,adverse,0,0
163,events,0,0
164,for,0,0
165,both,0,0
166,groups,0,0
167,were,0,0
168,epistaxis,0,0
169,and,0,0
170,headache,0,0
171,.,0,0
172,Turbuhaler,1,0
173,was,0,0
174,easier,0,0
175,to,0,0
176,use,0,0
177,and,0,0
178,more,0,0
179,convenient,0,0
180,to,0,0
181,carry,0,0
182,",",0,0
183,had,0,0
184,less,0,0
185,of,0,0
186,an,0,0
187,unpleasant,0,0
188,taste,0,0
189,",",0,0
190,and,0,0
191,caused,0,0
192,less,0,0
193,nasal,0,0
194,irritation,0,0
195,than,0,0
196,the,0,0
197,aqua,1,0
198,spray,1,1
199,.,1,0
200,More,0,0
201,than,0,0
202,twice,0,0
203,as,0,0
204,many,0,0
205,patients,0,0
206,preferred,0,0
207,Turbuhaler,1,1
208,to,0,0
209,the,0,0
210,aqua,1,1
211,spray,1,1
212,(,0,0
213,69,0,0
214,%,0,0
215,versus,0,0
216,31,0,0
217,%,0,0
218,),0,0
219,.,0,0
220,Improvement,0,0
221,in,0,0
222,quality,0,0
223,of,0,0
224,life,0,0
225,from,0,0
226,baseline,0,0
227,to,0,0
228,clinic,0,0
229,visits,0,0
230,was,0,0
231,statistically,0,0
232,significant,0,0
233,in,0,0
234,both,0,0
235,groups,0,0
236,.,0,0
237,CONCLUSION,0,0
238,Once,0,0
239,daily,0,0
240,use,0,0
241,of,0,0
242,256,0,0
243,mg,0,0
244,of,0,0
245,budesonide,1,1
246,aqua,1,1
247,and,0,0
248,400,0,0
249,mg,0,1
250,of,0,0
251,budesonide,1,1
252,Turbuhaler,1,1
253,are,0,0
254,equally,0,0
255,safe,0,0
256,and,0,0
257,efficacious,0,0
258,in,0,0
259,the,0,0
260,treatment,0,0
261,of,0,0
262,SAR,0,0
263,.,0,0
264,Patients,0,0
265,preferred,0,0
266,the,0,0
267,budesonide,1,1
268,powder,1,1
269,formulation,1,0
270,delivered,0,0
271,via,0,0
272,Turbuhaler,1,1
273,two,0,0
274,to,0,0
275,one,0,0
276,over,0,0
277,the,0,0
278,aqua,1,0
279,formulation,1,0
280,.,1,0
281,Effects,0,0
282,of,0,0
283,insufficient,1,0
284,sleep,1,0
285,on,0,0
286,blood,0,0
287,pressure,0,0
288,in,0,0
289,hypertensive,0,0
290,patients,0,0
291,:,0,0
292,a,0,0
293,24-h,0,0
294,study,0,0
295,.,0,0
296,The,0,0
297,influence,0,0
298,of,0,0
299,acute,0,0
300,sleep,0,0
301,deprivation,0,0
302,during,0,0
303,the,0,0
304,first,0,0
305,part,0,0
306,of,0,0
307,the,0,0
308,night,0,0
309,on,0,0
310,24-h,1,1
311,blood,1,0
312,pressure,1,0
313,monitoring,1,1
314,(,0,0
315,ABPM,0,1
316,),0,0
317,was,0,0
318,studied,0,0
319,in,0,0
320,36,0,0
321,never-treated,0,0
322,mild,0,0
323,to,0,0
324,moderate,0,0
325,hypertensive,0,0
326,patients,0,0
327,.,0,0
328,According,0,0
329,to,0,0
330,a,0,0
331,crossover,0,0
332,design,0,0
333,",",0,0
334,they,0,0
335,were,0,0
336,randomized,0,0
337,to,0,0
338,have,0,0
339,either,0,0
340,sleep,1,0
341,deprivation,1,0
342,or,0,1
343,a,0,0
344,full,1,0
345,night,1,0
346,'s,1,0
347,sleep,1,0
348,1,0,0
349,week,0,0
350,apart,0,0
351,",",0,0
352,during,0,0
353,which,0,0
354,they,0,0
355,were,0,0
356,monitored,0,0
357,with,0,0
358,ABPM,0,0
359,.,0,0
360,Urine,0,1
361,samples,0,0
362,for,0,0
363,analysis,0,0
364,of,0,0
365,nocturnal,0,0
366,urinary,0,0
367,excretion,0,0
368,of,0,0
369,norepinephrine,0,0
370,were,0,0
371,collected,0,0
372,.,0,0
373,During,0,0
374,the,0,0
375,sleep-deprivation,1,0
376,day,0,0
377,",",0,0
378,both,0,0
379,mean,0,0
380,24-h,0,1
381,blood,0,0
382,pressure,0,0
383,and,0,0
384,mean,0,0
385,24-h,0,1
386,heart,0,0
387,rate,0,0
388,were,0,0
389,higher,0,0
390,in,0,0
391,comparison,0,0
392,with,0,0
393,those,0,0
394,recorded,0,0
395,during,0,0
396,the,0,0
397,routine,0,0
398,workday,0,0
399,",",0,0
400,the,0,0
401,difference,0,0
402,being,0,0
403,more,0,0
404,pronounced,0,0
405,during,0,0
406,the,0,0
407,nighttime,0,0
408,(,0,0
409,P,0,0
410,<,0,0
411,.01,0,0
412,),0,0
413,.,0,0
414,Urinary,0,0
415,excretion,0,0
416,of,0,0
417,norepinephrine,0,0
418,showed,0,0
419,a,0,0
420,significant,0,0
421,increase,0,0
422,at,0,0
423,night,0,0
424,during,0,0
425,sleep,1,0
426,deprivation,1,1
427,(,0,0
428,P,0,0
429,<,0,0
430,.05,0,0
431,),0,0
432,.,0,0
433,Blood,0,0
434,pressure,0,0
435,and,0,0
436,heart,0,0
437,rate,0,0
438,significantly,0,0
439,increased,0,0
440,in,0,0
441,the,0,0
442,morning,0,0
443,after,0,0
444,a,0,0
445,sleep-insufficient,1,0
446,night,0,0
447,(,0,0
448,P,0,0
449,<,0,0
450,.05,0,0
451,),0,0
452,.,0,0
453,These,0,0
454,data,0,0
455,suggest,0,0
456,that,0,0
457,lack,0,0
458,of,0,0
459,sleep,0,0
460,in,0,0
461,hypertensive,0,0
462,patients,0,0
463,may,0,0
464,increase,0,0
465,sympathetic,0,0
466,nervous,0,0
467,activity,0,0
468,during,0,0
469,the,0,0
470,night,0,0
471,and,0,0
472,the,0,0
473,following,0,0
474,morning,0,0
475,",",0,0
476,leading,0,0
477,to,0,0
478,increased,0,0
479,blood,0,0
480,pressure,0,0
481,and,0,0
482,heart,0,0
483,rate,0,0
484,.,0,0
485,This,0,0
486,situation,0,0
487,might,0,0
488,represent,0,0
489,an,0,0
490,increased,0,0
491,risk,0,0
492,for,0,0
493,both,0,0
494,target,0,0
495,organ,0,0
496,damage,0,0
497,and,0,0
498,acute,0,0
499,cardiovascular,0,0
500,diseases,0,0
501,.,0,0
502,Switching,0,0
503,patients,0,0
504,with,0,0
505,asthma,0,0
506,from,0,0
507,chlorofluorocarbon,0,1
508,(,0,0
509,CFC,0,0
510,),0,0
511,albuterol,0,1
512,to,0,0
513,hydrofluoroalkane-134a,1,1
514,(,1,0
515,HFA,1,1
516,),1,0
517,albuterol,1,1
518,.,1,0
519,Chlorofluorocarbon,0,1
520,(,0,0
521,CFC,0,0
522,),0,1
523,propellants,0,1
524,deplete,0,1
525,stratospheric,0,0
526,ozone,0,1
527,.,0,0
528,Production,0,0
529,and,0,0
530,use,0,0
531,of,0,0
532,CFCs,0,1
533,",",0,0
534,except,0,0
535,for,0,0
536,certain,0,0
537,critical,0,0
538,exemptions,0,0
539,",",0,0
540,has,0,0
541,been,0,0
542,prohibited,0,0
543,by,0,0
544,the,0,0
545,Montreal,0,0
546,Protocol,0,0
547,.,0,0
548,Use,0,0
549,of,0,0
550,CFCs,0,1
551,as,0,0
552,propellants,0,1
553,in,0,0
554,metered-dose,0,1
555,inhalers,0,1
556,(,0,0
557,MDIs,0,0
558,),0,1
559,is,0,0
560,still,0,0
561,allowed,0,0
562,",",0,0
563,but,0,0
564,the,0,0
565,U.S.,0,1
566,Food,0,0
567,and,0,0
568,Drug,0,1
569,Administration,0,1
570,is,0,0
571,planning,0,0
572,the,0,0
573,transition,0,0
574,to,0,0
575,alternative,0,0
576,propellants,0,1
577,for,0,0
578,use,0,0
579,in,0,0
580,MDIs,0,0
581,.,0,0
582,Hydrofluoroalkane-134a,1,1
583,(,1,0
584,HFA,1,0
585,),1,0
586,",",0,0
587,a,0,0
588,non-ozone-depleting,0,1
589,propellant,0,1
590,",",0,0
591,has,0,0
592,been,0,0
593,used,0,0
594,to,0,0
595,reformulate,0,0
596,albuterol,0,1
597,(,0,0
598,HFA,0,1
599,albuterol,0,1
600,),0,0
601,.,0,0
602,This,0,0
603,study,0,0
604,evaluates,0,0
605,whether,0,0
606,comparable,0,0
607,safety,0,0
608,and,0,0
609,efficacy,0,0
610,continues,0,0
611,for,0,0
612,12,0,0
613,weeks,0,0
614,after,0,0
615,patients,0,0
616,with,0,0
617,asthma,0,0
618,are,0,0
619,switched,1,0
620,from,1,0
621,CFC,1,0
622,albuterol,1,1
623,to,1,0
624,HFA,1,0
625,albuterol,1,1
626,.,1,0
627,Patients,0,0
628,with,0,0
629,asthma,0,0
630,stabilized,0,0
631,on,0,0
632,CFC,0,0
633,albuterol,0,1
634,during,0,0
635,a,0,0
636,12-week,0,0
637,safety,0,0
638,and,0,0
639,efficacy,0,0
640,trial,0,0
641,were,0,0
642,randomized,0,0
643,to,0,0
644,either,1,0
645,continue,1,0
646,receiving,1,0
647,CFC,1,1
648,albuterol,1,1
649,or,1,0
650,to,1,0
651,be,1,0
652,switched,1,0
653,to,1,0
654,receive,1,0
655,HFA,1,0
656,albuterol,1,1
657,in,1,0
658,a,1,0
659,yearlong,1,0
660,safety,1,0
661,and,1,0
662,efficacy,1,0
663,trial,1,0
664,.,1,0
665,Safety,0,0
666,and,0,0
667,efficacy,0,0
668,were,0,0
669,compared,0,0
670,over,0,0
671,the,0,0
672,first,0,0
673,12,0,0
674,weeks,0,0
675,of,0,0
676,the,0,0
677,yearlong,0,0
678,trial,0,0
679,between,0,0
680,patients,0,0
681,who,0,0
682,had,0,0
683,remained,0,0
684,on,0,0
685,CFC,0,0
686,albuterol,0,1
687,and,0,0
688,those,0,0
689,who,0,0
690,had,0,0
691,been,0,0
692,switched,0,0
693,to,0,0
694,HFA,0,0
695,albuterol,0,1
696,.,0,0
697,Bronchodilator,0,1
698,efficacy,0,0
699,was,0,0
700,evaluated,0,0
701,by,0,0
702,serial,0,0
703,spirometry,0,0
704,for,0,0
705,6,0,0
706,hr,0,0
707,after,0,0
708,the,0,0
709,patients,0,0
710,self-administered,0,0
711,the,0,0
712,study,0,0
713,drug,0,0
714,in,0,0
715,the,0,0
716,clinic,0,0
717,.,0,0
718,Safety,0,0
719,was,0,0
720,assessed,0,0
721,by,0,0
722,measuring,0,0
723,changes,0,0
724,in,0,0
725,pulse,0,1
726,rate,0,0
727,",",0,0
728,blood,0,0
729,pressure,0,0
730,",",0,0
731,and,0,0
732,electrocardiogram,0,0
733,(,0,1
734,ECG,0,1
735,),0,0
736,intervals,0,0
737,after,0,0
738,dosing,0,0
739,with,0,0
740,study,0,0
741,drug,0,0
742,",",0,0
743,monitoring,0,0
744,adverse,0,0
745,events,0,0
746,",",0,0
747,and,0,0
748,performing,0,0
749,prestudy,0,0
750,and,0,0
751,poststudy,0,0
752,laboratory,0,0
753,testing,0,0
754,and,0,0
755,physical,0,0
756,examinations,0,0
757,.,0,0
758,No,0,0
759,significant,0,0
760,differences,0,0
761,in,0,0
762,bronchodilator,0,1
763,efficacy,0,0
764,between,0,0
765,the,0,0
766,patients,0,0
767,continuing,0,0
768,to,0,0
769,receive,0,1
770,CFC,0,0
771,albuterol,0,1
772,and,0,0
773,those,0,0
774,switched,0,0
775,to,0,0
776,HFA,1,0
777,albuterol,1,1
778,were,0,0
779,found,0,0
780,in,0,0
781,the,0,0
782,12,0,0
783,weeks,0,0
784,after,0,0
785,the,0,0
786,switch,0,0
787,.,0,0
788,No,0,0
789,differences,0,0
790,between,0,0
791,the,0,0
792,two,0,0
793,products,0,0
794,were,0,0
795,found,0,0
796,for,0,0
797,changes,0,0
798,in,0,0
799,pulse,0,1
800,rate,0,0
801,",",0,0
802,blood,0,0
803,pressure,0,0
804,",",0,0
805,and,0,0
806,ECG,0,0
807,intervals,0,0
808,.,0,0
809,Adverse,0,0
810,event,0,0
811,profiles,0,0
812,were,0,0
813,similar,0,0
814,for,0,0
815,the,0,0
816,two,0,0
817,products,0,0
818,",",0,0
819,except,0,0
820,the,0,0
821,patients,0,0
822,remaining,0,0
823,on,0,0
824,CFC,0,0
825,albuterol,0,1
826,reported,0,0
827,increased,0,0
828,asthma,0,0
829,symptoms,0,0
830,and,0,0
831,rhinitis,0,0
832,significantly,0,0
833,more,0,0
834,often,0,0
835,than,0,0
836,the,0,0
837,patients,0,0
838,switched,0,0
839,to,0,0
840,HFA,0,0
841,albuterol,0,1
842,.,0,0
843,No,0,0
844,clinically,0,0
845,meaningful,0,0
846,changes,0,0
847,in,0,0
848,laboratory,0,0
849,tests,0,0
850,or,0,0
851,physical,0,0
852,examinations,0,0
853,were,0,0
854,found,0,0
855,in,0,0
856,either,0,0
857,treatment,0,0
858,group,0,0
859,.,0,0
860,Patients,0,0
861,with,0,0
862,asthma,0,0
863,switched,0,0
864,from,0,0
865,CFC,0,0
866,albuterol,0,1
867,to,0,0
868,HFA,1,0
869,albuterol,1,1
870,receive,0,1
871,comparable,0,0
872,bronchodilation,0,0
873,with,0,0
874,a,0,0
875,similar,0,0
876,safety,0,0
877,profile,0,0
878,as,0,0
879,those,0,0
880,continuing,0,0
881,to,0,0
882,receive,0,1
883,CFC,0,0
884,albuterol,0,1
885,.,0,0
886,Epinephrine-induced,0,0
887,panic,0,0
888,attacks,0,0
889,and,0,0
890,hyperventilation,0,0
891,.,0,0
892,To,0,0
893,assess,0,0
894,the,0,0
895,effects,0,0
896,of,0,0
897,epinephrine,1,1
898,on,0,0
899,ventilation,0,1
900,in,0,0
901,patients,0,0
902,with,0,0
903,panic,0,0
904,disorder,0,0
905,and,0,0
906,in,0,0
907,social,0,0
908,phobics,0,0
909,",",0,0
910,analyses,0,0
911,were,0,0
912,performed,0,0
913,on,0,0
914,pooled,0,0
915,data,0,0
916,from,0,0
917,two,0,0
918,previous,0,0
919,infusion,0,0
920,studies,0,0
921,.,0,0
922,Throughout,0,0
923,the,0,0
924,infusion,0,0
925,",",0,0
926,changes,0,0
927,in,0,0
928,transcutaneous,0,1
929,PCO2,0,1
930,(,0,0
931,tcPCO2,0,1
932,),0,0
933,",",0,0
934,subjective,0,0
935,anxiety,0,0
936,",",0,0
937,heart,0,0
938,rate,0,0
939,and,0,0
940,blood,0,0
941,pressure,0,0
942,were,0,0
943,recorded,0,0
944,continuously,0,0
945,.,0,0
946,Twenty-nine,0,0
947,patients,0,0
948,received,0,0
949,epinephrine,1,1
950,",",0,0
951,ten,0,0
952,patients,0,0
953,received,0,0
954,placebo,1,1
955,.,1,0
956,Thirteen,0,0
957,patients,0,0
958,(,0,0
959,45,0,0
960,%,0,0
961,),0,0
962,had,0,0
963,a,0,0
964,panic,0,0
965,attack,0,0
966,during,0,0
967,epinephrine,1,1
968,.,1,0
969,The,0,0
970,fall,0,0
971,in,0,0
972,tcPCO2,0,1
973,and,0,0
974,the,0,0
975,cardiovascular,0,0
976,response,0,0
977,was,0,0
978,greater,0,0
979,in,0,0
980,panicking,0,0
981,patients,0,0
982,than,0,0
983,patients,0,0
984,who,0,0
985,did,0,0
986,not,0,0
987,panic,0,0
988,.,0,0
989,Although,0,0
990,the,0,0
991,fall,0,0
992,in,0,0
993,tcPCO2,0,1
994,associated,0,0
995,with,0,0
996,panic,0,0
997,was,0,0
998,not,0,0
999,substantial,0,0
1000,and,0,0
1001,did,0,0
1002,not,0,0
1003,indicate,0,0
1004,clinically,0,0
1005,significant,0,0
1006,acute,0,0
1007,hyperventilation,0,0
1008,",",0,0
1009,it,0,0
1010,appears,0,0
1011,to,0,0
1012,be,0,0
1013,a,0,0
1014,sensitive,0,0
1015,index,0,0
1016,for,0,0
1017,epinephrine-induced,0,0
1018,panic,0,0
1019,.,0,0
1020,The,0,0
1021,fall,0,0
1022,in,0,0
1023,tcPCO2,0,1
1024,was,0,0
1025,predicted,0,0
1026,rather,0,0
1027,by,0,0
1028,the,0,0
1029,frequency,0,0
1030,of,0,0
1031,occurrence,0,0
1032,of,0,0
1033,anxiety-related,0,0
1034,somatic,0,0
1035,symptoms,0,0
1036,than,0,0
1037,by,0,0
1038,the,0,0
1039,fear,0,0
1040,of,0,0
1041,these,0,0
1042,symptoms,0,0
1043,.,0,0
1044,These,0,0
1045,findings,0,0
1046,further,0,0
1047,reduce,0,0
1048,a,0,0
1049,role,0,0
1050,for,0,0
1051,fear,0,0
1052,of,0,0
1053,bodily,0,0
1054,sensations,0,0
1055,in,0,0
1056,epinephrine-induced,1,0
1057,panic,0,0
1058,attacks,0,0
1059,and,0,0
1060,favor,0,0
1061,a,0,0
1062,biological,0,0
1063,sensitivity,0,0
1064,to,0,0
1065,sympathetic,0,0
1066,stimulation,0,0
1067,.,0,0
1068,Comparison,0,0
1069,of,0,0
1070,patient-controlled,1,1
1071,and,1,0
1072,nurse-administered,1,0
1073,analgesia,1,0
1074,using,0,0
1075,intravenous,0,1
1076,fentanyl,0,1
1077,during,0,0
1078,labor,0,0
1079,.,0,0
1080,Preliminary,0,0
1081,observations,0,0
1082,have,0,0
1083,shown,0,0
1084,that,0,0
1085,fentanyl,1,1
1086,citrate,1,1
1087,",",0,0
1088,a,0,0
1089,potent,0,0
1090,narcotic,0,0
1091,",",0,0
1092,is,0,0
1093,helpful,0,0
1094,during,0,0
1095,labor,0,0
1096,without,0,0
1097,undue,0,0
1098,side,0,0
1099,effects,0,0
1100,.,0,0
1101,This,0,0
1102,randomized,0,0
1103,prospective,0,0
1104,investigation,0,0
1105,compared,0,0
1106,the,0,0
1107,patient-controlled,1,1
1108,administration,1,0
1109,of,1,0
1110,fentanyl,1,1
1111,with,0,0
1112,that,0,0
1113,of,0,0
1114,administration,1,0
1115,by,1,0
1116,nurses,1,0
1117,on,1,0
1118,request,1,0
1119,.,1,0
1120,Eighty,0,0
1121,healthy,0,0
1122,women,0,0
1123,beginning,0,0
1124,active,0,1
1125,labor,0,1
1126,(,0,0
1127,cervical,0,0
1128,dilation,0,0
1129,4,0,0
1130,cm,0,0
1131,),0,0
1132,at,0,0
1133,term,0,0
1134,were,0,0
1135,assigned,0,0
1136,to,0,0
1137,receive,0,0
1138,fentanyl,1,1
1139,intravenously,1,1
1140,by,1,0
1141,either,1,0
1142,patient-controlled,1,1
1143,administration,1,0
1144,(,1,0
1145,n=37,1,0
1146,),1,0
1147,or,1,1
1148,nurse,1,1
1149,administration,1,0
1150,on,1,0
1151,demand,1,0
1152,(,0,0
1153,n=43,0,0
1154,),0,0
1155,.,0,0
1156,Pain,0,0
1157,intensity,0,0
1158,measurements,0,0
1159,during,0,0
1160,early,0,0
1161,and,0,0
1162,late,0,0
1163,labor,0,0
1164,revealed,0,0
1165,the,0,0
1166,degree,0,0
1167,of,0,0
1168,analgesia,0,0
1169,to,0,0
1170,be,0,0
1171,the,0,0
1172,same,0,0
1173,in,0,0
1174,both,0,0
1175,groups,0,0
1176,.,0,0
1177,The,0,0
1178,delay,0,0
1179,in,0,0
1180,setting,0,0
1181,up,0,0
1182,the,0,0
1183,infusion,0,1
1184,system,0,0
1185,and,0,0
1186,the,0,0
1187,short,0,0
1188,time,0,0
1189,between,0,0
1190,requesting,0,0
1191,analgesia,0,0
1192,and,0,0
1193,vaginal,0,0
1194,delivery,0,0
1195,were,0,0
1196,limitations,0,0
1197,with,0,0
1198,self-administration,0,1
1199,.,0,0
1200,Maternal,0,0
1201,oversedation,0,0
1202,and,0,0
1203,vomiting,0,0
1204,did,0,0
1205,not,0,0
1206,occur,0,0
1207,.,0,0
1208,Neonatal,0,0
1209,naloxone,0,1
1210,therapy,0,1
1211,was,0,0
1212,used,0,0
1213,infrequently,0,0
1214,",",0,0
1215,umbilical,0,0
1216,serum,0,0
1217,levels,0,0
1218,of,0,0
1219,fentanyl,0,1
1220,were,0,0
1221,the,0,0
1222,same,0,0
1223,in,0,0
1224,both,0,0
1225,groups,0,0
1226,",",0,0
1227,and,0,0
1228,postnatal,0,0
1229,neuroadaptive,0,0
1230,testing,0,0
1231,revealed,0,0
1232,comparable,0,0
1233,results,0,0
1234,in,0,0
1235,both,0,0
1236,groups,0,0
1237,.,0,0
1238,Despite,0,0
1239,the,0,0
1240,usefulness,0,0
1241,of,0,0
1242,fentanyl,0,1
1243,during,0,0
1244,labor,0,0
1245,",",0,0
1246,administration,1,0
1247,by,1,0
1248,the,1,0
1249,patient,1,0
1250,had,0,0
1251,no,0,0
1252,advantages,0,0
1253,over,0,0
1254,administration,1,0
1255,by,1,0
1256,the,1,0
1257,nurses,1,0
1258,in,0,0
1259,significantly,0,0
1260,reducing,0,0
1261,drug,0,0
1262,use,0,0
1263,",",0,0
1264,improving,0,0
1265,pain,0,0
1266,relief,0,0
1267,",",0,0
1268,or,0,1
1269,avoiding,0,0
1270,drowsiness,0,0
1271,.,0,0
1272,High-pressure,1,1
1273,",",1,0
1274,rapid-inflation,1,1
1275,pneumatic,1,1
1276,compression,1,1
1277,improves,0,0
1278,venous,0,0
1279,hemodynamics,0,0
1280,in,0,0
1281,healthy,0,0
1282,volunteers,0,0
1283,and,0,0
1284,patients,0,0
1285,who,0,0
1286,are,0,0
1287,post-thrombotic,0,0
1288,.,0,0
1289,PURPOSE,0,0
1290,Deep,0,1
1291,vein,0,0
1292,thrombosis,0,0
1293,(,0,0
1294,DVT,0,0
1295,),0,1
1296,is,0,0
1297,a,0,0
1298,preventable,0,0
1299,cause,0,0
1300,of,0,0
1301,morbidity,0,0
1302,and,0,0
1303,mortality,0,0
1304,in,0,0
1305,patients,0,0
1306,who,0,0
1307,are,0,0
1308,hospitalized,0,0
1309,.,0,0
1310,An,0,0
1311,important,0,0
1312,part,0,0
1313,of,0,0
1314,the,0,0
1315,mechanism,0,0
1316,of,0,0
1317,DVT,0,0
1318,prophylaxis,0,0
1319,with,0,0
1320,intermittent,0,1
1321,pneumatic,0,1
1322,compression,0,1
1323,(,0,0
1324,IPC,0,0
1325,),0,1
1326,is,0,0
1327,reduced,0,0
1328,venous,0,0
1329,stasis,0,0
1330,with,0,0
1331,increased,0,0
1332,velocity,0,0
1333,of,0,0
1334,venous,0,0
1335,return,0,0
1336,.,0,0
1337,The,0,0
1338,conventional,0,1
1339,methods,0,0
1340,of,0,0
1341,IPC,0,0
1342,use,0,0
1343,low,0,0
1344,pressure,0,0
1345,and,0,0
1346,slow,0,0
1347,inflation,0,0
1348,of,0,0
1349,the,0,0
1350,air,0,1
1351,bladder,0,0
1352,on,0,0
1353,the,0,0
1354,leg,0,0
1355,to,0,0
1356,augment,0,0
1357,venous,0,0
1358,return,0,0
1359,.,0,0
1360,Recently,0,0
1361,",",0,0
1362,compression,0,1
1363,devices,0,0
1364,have,0,0
1365,been,0,0
1366,designed,0,0
1367,that,0,0
1368,produce,0,0
1369,high,0,0
1370,pressure,0,0
1371,and,0,0
1372,rapid,0,0
1373,inflation,0,0
1374,of,0,0
1375,air,0,1
1376,cuffs,0,1
1377,on,0,0
1378,the,0,0
1379,plantar,0,0
1380,plexus,0,0
1381,of,0,0
1382,the,0,0
1383,foot,0,0
1384,and,0,0
1385,the,0,0
1386,calf,0,1
1387,.,0,0
1388,The,0,0
1389,purpose,0,0
1390,of,0,0
1391,this,0,0
1392,study,0,0
1393,is,0,0
1394,to,0,0
1395,evaluate,0,0
1396,the,0,0
1397,venous,0,0
1398,velocity,0,0
1399,response,0,0
1400,to,0,0
1401,high-pressure,0,1
1402,",",0,0
1403,rapid-inflation,0,1
1404,compression,0,1
1405,devices,0,1
1406,versus,0,0
1407,standard,0,0
1408,",",0,0
1409,low-pressure,0,1
1410,",",0,0
1411,slow-inflation,0,1
1412,compression,0,1
1413,devices,0,1
1414,in,0,0
1415,healthy,0,0
1416,volunteers,0,0
1417,and,0,0
1418,patients,0,0
1419,with,0,0
1420,severe,0,0
1421,post-thrombotic,0,0
1422,venous,0,0
1423,disease,0,0
1424,.,0,0
1425,METHOD,0,0
1426,Twenty-two,0,0
1427,lower,0,0
1428,extremities,0,0
1429,from,0,0
1430,healthy,0,0
1431,volunteers,0,0
1432,and,0,0
1433,11,0,0
1434,lower,0,0
1435,extremities,0,0
1436,from,0,0
1437,patients,0,0
1438,with,0,0
1439,class,0,0
1440,4,0,0
1441,to,0,0
1442,class,0,0
1443,6,0,0
1444,post-thrombotic,0,0
1445,chronic,0,0
1446,venous,0,0
1447,insufficiency,0,0
1448,were,0,0
1449,studied,0,0
1450,.,0,0
1451,With,0,0
1452,duplex,1,1
1453,ultrasound,1,1
1454,scanning,1,1
1455,(,0,0
1456,ATL-Ultramark,0,1
1457,9,0,0
1458,",",0,0
1459,Advanced,0,0
1460,Tech,0,0
1461,Laboratory,0,0
1462,",",0,0
1463,Bothell,0,1
1464,",",0,0
1465,Wash,0,0
1466,),0,0
1467,",",0,0
1468,acute,0,0
1469,DVT,0,0
1470,was,0,0
1471,excluded,0,0
1472,before,0,0
1473,subject,0,0
1474,evaluation,0,0
1475,.,0,0
1476,Venous,0,0
1477,velocities,0,0
1478,were,0,0
1479,monitored,0,0
1480,after,0,0
1481,the,0,0
1482,application,0,0
1483,of,0,0
1484,each,0,0
1485,of,0,0
1486,five,0,0
1487,IPC,0,0
1488,devices,0,0
1489,",",0,0
1490,with,0,0
1491,all,0,0
1492,the,0,0
1493,patients,0,0
1494,in,0,0
1495,the,0,0
1496,supine,0,0
1497,position,0,0
1498,.,0,0
1499,Three,1,0
1500,high-pressure,1,1
1501,",",1,0
1502,rapid-compression,1,1
1503,devices,1,1
1504,and,1,0
1505,two,1,0
1506,standard,1,0
1507,",",1,0
1508,low-pressure,1,1
1509,",",1,0
1510,slow-inflation,1,1
1511,compression,1,1
1512,devices,1,1
1513,were,0,0
1514,applied,0,0
1515,in,0,0
1516,a,0,0
1517,random,0,0
1518,sequence,0,0
1519,.,0,0
1520,Maximal,0,0
1521,venous,0,0
1522,velocities,0,0
1523,were,0,0
1524,obtained,0,0
1525,at,0,0
1526,the,0,0
1527,common,0,0
1528,femoral,0,1
1529,vein,0,0
1530,and,0,0
1531,the,0,0
1532,popliteal,0,0
1533,vein,0,0
1534,for,0,0
1535,all,0,0
1536,the,0,0
1537,devices,0,0
1538,and,0,0
1539,were,0,0
1540,recorded,0,0
1541,as,0,0
1542,the,0,0
1543,mean,0,0
1544,peak,0,0
1545,velocity,0,0
1546,of,0,0
1547,three,0,0
1548,compression,0,1
1549,cycles,0,0
1550,and,0,0
1551,compared,0,0
1552,with,0,0
1553,baseline,0,0
1554,velocities,0,0
1555,.,0,0
1556,RESULTS,0,0
1557,The,0,0
1558,baseline,0,0
1559,venous,0,0
1560,velocities,0,0
1561,were,0,0
1562,higher,0,0
1563,in,0,0
1564,the,0,0
1565,femoral,0,0
1566,veins,0,0
1567,than,0,0
1568,in,0,0
1569,the,0,0
1570,popliteal,0,0
1571,veins,0,0
1572,in,0,0
1573,both,0,0
1574,the,0,0
1575,volunteers,0,0
1576,and,0,0
1577,the,0,0
1578,post-thrombotic,0,0
1579,subjects,0,0
1580,.,0,0
1581,Standard,0,1
1582,and,0,0
1583,high-pressure,0,1
1584,",",0,0
1585,rapid-inflation,0,1
1586,compression,0,1
1587,significantly,0,0
1588,increased,0,0
1589,the,0,0
1590,popliteal,0,0
1591,and,0,0
1592,femoral,0,1
1593,vein,0,0
1594,velocities,0,0
1595,in,0,0
1596,healthy,0,0
1597,and,0,0
1598,post-thrombotic,0,0
1599,subjects,0,0
1600,.,0,0
1601,High-pressure,0,0
1602,",",0,0
1603,rapid-inflation,0,1
1604,compression,0,1
1605,produced,0,0
1606,significantly,0,0
1607,higher,0,0
1608,maximal,0,0
1609,venous,0,0
1610,velocities,0,0
1611,in,0,0
1612,the,0,0
1613,popliteal,0,0
1614,and,0,0
1615,femoral,0,0
1616,veins,0,0
1617,in,0,0
1618,both,0,0
1619,healthy,0,0
1620,volunteers,0,0
1621,and,0,0
1622,patients,0,0
1623,who,0,0
1624,were,0,0
1625,post-thrombotic,0,0
1626,as,0,0
1627,compared,0,0
1628,with,0,0
1629,standard,0,1
1630,compression,0,1
1631,.,0,0
1632,Compared,0,0
1633,with,0,0
1634,the,0,0
1635,healthy,0,0
1636,volunteers,0,0
1637,",",0,0
1638,the,0,0
1639,patients,0,0
1640,who,0,0
1641,were,0,0
1642,post-thrombotic,0,0
1643,had,0,0
1644,a,0,0
1645,significantly,0,0
1646,attenuated,0,0
1647,velocity,0,0
1648,response,0,0
1649,at,0,0
1650,both,0,0
1651,the,0,0
1652,popliteal,0,0
1653,and,0,0
1654,the,0,0
1655,femoral,0,1
1656,vein,0,0
1657,levels,0,0
1658,.,0,0
1659,CONCLUSION,0,0
1660,High-pressure,0,1
1661,",",0,0
1662,rapid-inflation,0,1
1663,pneumatic,0,1
1664,compression,0,1
1665,increases,0,0
1666,popliteal,0,0
1667,and,0,0
1668,femoral,0,1
1669,vein,0,0
1670,velocity,0,0
1671,as,0,0
1672,compared,0,0
1673,with,0,0
1674,standard,0,0
1675,",",0,0
1676,low-pressure,0,1
1677,",",0,0
1678,slow-inflation,0,1
1679,pneumatic,0,1
1680,compression,0,1
1681,.,0,0
1682,Patients,0,0
1683,with,0,0
1684,post-thrombotic,0,0
1685,venous,0,0
1686,disease,0,0
1687,have,0,0
1688,a,0,0
1689,compromised,0,0
1690,hemodynamic,0,0
1691,response,0,0
1692,to,0,0
1693,all,0,0
1694,IPC,0,0
1695,devices,0,0
1696,.,0,0
1697,However,0,0
1698,",",0,0
1699,an,0,0
1700,increased,0,0
1701,velocity,0,0
1702,response,0,0
1703,to,0,0
1704,the,0,0
1705,high-pressure,0,1
1706,",",0,0
1707,rapid-inflation,0,1
1708,compression,0,1
1709,device,0,1
1710,is,0,0
1711,preserved,0,0
1712,.,0,0
1713,High-pressure,0,0
1714,",",0,0
1715,rapid-inflation,0,1
1716,pneumatic,0,1
1717,compression,0,1
1718,may,0,0
1719,offer,0,0
1720,additional,0,0
1721,protection,0,0
1722,from,0,0
1723,thrombotic,0,0
1724,complications,0,0
1725,on,0,0
1726,the,0,0
1727,basis,0,0
1728,of,0,0
1729,an,0,0
1730,improved,0,0
1731,hemodynamic,0,0
1732,response,0,0
1733,",",0,0
1734,both,0,0
1735,in,0,0
1736,healthy,0,0
1737,volunteers,0,0
1738,and,0,0
1739,in,0,0
1740,patients,0,0
1741,who,0,0
1742,were,0,0
1743,post-thrombotic,0,0
1744,.,0,0
1745,Predictors,0,0
1746,of,0,0
1747,survival,0,0
1748,and,0,0
1749,eradication,0,0
1750,of,0,0
1751,Mycobacterium,0,0
1752,avium,0,0
1753,complex,0,0
1754,bacteremia,0,0
1755,(,0,0
1756,MAC,0,1
1757,),0,0
1758,in,0,0
1759,AIDS,0,0
1760,patients,0,0
1761,in,0,0
1762,the,0,0
1763,Canadian,0,0
1764,randomized,0,0
1765,MAC,0,1
1766,treatment,0,0
1767,trial,0,0
1768,.,0,0
1769,Canadian,0,0
1770,HIV,0,0
1771,Trials,0,1
1772,Network,0,0
1773,Protocol,0,0
1774,010,0,0
1775,Study,0,0
1776,Group,0,0
1777,.,0,0
1778,OBJECTIVE,0,0
1779,To,0,0
1780,assess,0,0
1781,the,0,0
1782,importance,0,0
1783,of,0,0
1784,baseline,0,0
1785,characteristics,0,0
1786,including,0,0
1787,medical,0,0
1788,history,0,0
1789,",",0,0
1790,indicators,0,0
1791,of,0,0
1792,current,0,0
1793,disease,0,0
1794,status,0,0
1795,",",0,0
1796,therapeutic,0,0
1797,drug,0,0
1798,use,0,0
1799,",",0,0
1800,in,0,0
1801,vitro,0,0
1802,drug,0,0
1803,susceptibility,0,0
1804,",",0,0
1805,immune,0,0
1806,status,0,0
1807,and,0,0
1808,mycobacterial,0,0
1809,load,0,0
1810,on,0,0
1811,bacteriologic,0,0
1812,response,0,0
1813,and,0,0
1814,survival,0,0
1815,in,0,0
1816,HIV-positive,0,0
1817,patients,0,0
1818,with,0,0
1819,Mycobacterium,0,0
1820,avium,0,1
1821,complex,0,0
1822,(,0,0
1823,MAC,0,1
1824,),0,0
1825,bacteremia,0,0
1826,.,0,0
1827,DESIGN,0,0
1828,An,0,0
1829,observational,0,0
1830,substudy,0,0
1831,of,0,0
1832,an,0,0
1833,open-label,0,0
1834,randomized,0,0
1835,controlled,0,0
1836,trial,0,0
1837,of,0,0
1838,two,1,0
1839,alternative,1,0
1840,therapeutic,1,0
1841,regimens,1,0
1842,for,1,0
1843,MAC,1,0
1844,.,1,0
1845,SETTING,0,0
1846,Twenty-four,0,0
1847,hospital-based,0,0
1848,HIV,0,0
1849,clinics,0,0
1850,in,0,0
1851,16,0,0
1852,Canadian,0,0
1853,cities,0,0
1854,.,0,0
1855,MAIN,0,0
1856,OUTCOME,0,0
1857,MEASURES,0,0
1858,The,0,0
1859,main,0,0
1860,outcome,0,0
1861,measures,0,0
1862,were,0,0
1863,survival,0,0
1864,and,0,0
1865,bacteriologic,0,0
1866,response,0,0
1867,",",0,0
1868,defined,0,0
1869,by,0,0
1870,consecutive,0,0
1871,negative,0,0
1872,blood,0,0
1873,cultures,0,0
1874,for,0,0
1875,MAC,0,0
1876,at,0,0
1877,least,0,0
1878,2,0,0
1879,weeks,0,0
1880,apart,0,0
1881,within,0,0
1882,16,0,0
1883,weeks,0,0
1884,of,0,0
1885,study,0,0
1886,entry,0,0
1887,.,0,0
1888,RESULTS,0,0
1889,Prior,0,0
1890,AIDS,0,0
1891,diagnosis,0,0
1892,",",0,0
1893,low,0,0
1894,Karnofsky,0,0
1895,score,0,0
1896,",",0,0
1897,active,0,0
1898,unstable,0,0
1899,AIDS-related,0,0
1900,conditions,0,0
1901,",",0,0
1902,absence,0,0
1903,of,0,0
1904,antiretroviral,0,1
1905,therapy,0,1
1906,and,0,0
1907,absence,0,0
1908,of,0,0
1909,Pneumocystis,0,0
1910,carinii,0,0
1911,pneumonia,0,0
1912,prophylaxis,0,0
1913,were,0,0
1914,associated,0,0
1915,with,0,0
1916,shorter,0,0
1917,survival,0,0
1918,by,0,0
1919,univariate,0,0
1920,regression,0,0
1921,using,0,0
1922,the,0,0
1923,proportional,0,0
1924,hazards,0,0
1925,model,0,0
1926,.,0,0
1927,On,0,0
1928,multivariate,0,0
1929,analysis,0,0
1930,",",0,0
1931,antiretroviral,0,1
1932,therapy,0,1
1933,was,0,0
1934,not,0,0
1935,an,0,0
1936,independent,0,0
1937,predictor,0,0
1938,of,0,0
1939,mortality,0,0
1940,",",0,0
1941,and,0,0
1942,previous,0,0
1943,rifabutin,0,1
1944,prophylaxis,0,0
1945,was,0,0
1946,independently,0,0
1947,associated,0,0
1948,with,0,0
1949,poor,0,0
1950,survival,0,0
1951,outcomes,0,0
1952,",",0,0
1953,a,0,0
1954,result,0,0
1955,consistent,0,0
1956,across,0,0
1957,study,0,0
1958,treatment,0,0
1959,.,0,0
1960,Using,0,0
1961,a,0,0
1962,logistic,0,0
1963,regression,0,0
1964,model,0,0
1965,",",0,0
1966,baseline,0,0
1967,quantitative,0,0
1968,mycobacterial,0,0
1969,load,0,0
1970,[,0,0
1971,relative,0,0
1972,odds,0,0
1973,of,0,0
1974,clearing,0,0
1975,",",0,0
1976,1.97,0,0
1977,for,0,0
1978,a,0,0
1979,decrease,0,0
1980,of,0,0
1981,1,0,0
1982,log10,0,0
1983,colony,0,0
1984,forming,0,0
1985,count,0,0
1986,;,0,0
1987,95,0,0
1988,%,0,0
1989,confidence,0,0
1990,interval,0,0
1991,(,0,0
1992,CI,0,0
1993,),0,0
1994,",",0,0
1995,1.36-2.87,0,0
1996,;,0,0
1997,P,0,0
1998,<,0,0
1999,0.001,0,0
2000,],0,0
2001,and,0,0
2002,Karnofsky,0,0
2003,score,0,0
2004,were,0,0
2005,the,0,0
2006,only,0,0
2007,statistically,0,0
2008,significant,0,0
2009,univariate,0,0
2010,predictors,0,0
2011,of,0,0
2012,clearance,0,0
2013,",",0,0
2014,although,0,0
2015,previous,0,0
2016,prophylaxis,0,0
2017,with,0,0
2018,rifabutin,0,1
2019,was,0,0
2020,also,0,0
2021,a,0,0
2022,significant,0,0
2023,predictor,0,0
2024,in,0,0
2025,a,0,0
2026,multivariate,0,0
2027,model,0,0
2028,(,0,0
2029,relative,0,0
2030,odds,0,0
2031,of,0,0
2032,clearing,0,0
2033,",",0,0
2034,0.39,0,0
2035,;,0,0
2036,95,0,0
2037,%,0,0
2038,CI,0,0
2039,",",0,0
2040,0.17-0.88,0,0
2041,;,0,0
2042,P,0,0
2043,<,0,0
2044,0.05,0,0
2045,),0,0
2046,.,0,0
2047,CONCLUSIONS,0,0
2048,This,0,0
2049,study,0,0
2050,indicates,0,0
2051,that,0,0
2052,although,0,0
2053,the,0,0
2054,level,0,0
2055,of,0,0
2056,MAC,0,0
2057,bacteremia,0,0
2058,is,0,0
2059,an,0,0
2060,important,0,0
2061,predictor,0,0
2062,of,0,0
2063,clearance,0,0
2064,",",0,0
2065,it,0,0
2066,is,0,0
2067,not,0,0
2068,associated,0,0
2069,with,0,0
2070,survival,0,0
2071,.,0,0
2072,Long,0,0
2073,term,0,0
2074,response,0,0
2075,to,0,0
2076,therapy,0,1
2077,of,0,0
2078,chronic,0,0
2079,anti-HBe-positive,0,0
2080,hepatitis,0,0
2081,B,0,0
2082,is,0,0
2083,poor,0,0
2084,independent,0,0
2085,of,0,0
2086,type,0,0
2087,and,0,0
2088,schedule,0,1
2089,of,0,0
2090,interferon,0,1
2091,.,0,0
2092,OBJECTIVE,0,0
2093,The,0,0
2094,response,0,0
2095,rate,0,0
2096,to,0,0
2097,alpha,1,1
2098,interferon,1,1
2099,(,1,0
2100,IFN,1,0
2101,),1,0
2102,of,0,0
2103,chronic,0,0
2104,anti-HBe-positive,0,0
2105,hepatitis,0,0
2106,B,0,0
2107,is,0,0
2108,variable,0,0
2109,.,0,0
2110,We,0,0
2111,studied,0,0
2112,whether,0,0
2113,type,0,0
2114,",",0,0
2115,dose,0,0
2116,",",0,0
2117,and,0,0
2118,schedule,0,0
2119,of,0,0
2120,IFN,1,0
2121,",",0,0
2122,and,0,0
2123,type,0,0
2124,and,0,0
2125,frequency,0,0
2126,of,0,0
2127,posttreatment,0,0
2128,monitoring,0,0
2129,",",0,0
2130,influence,0,0
2131,the,0,0
2132,response,0,0
2133,rate,0,0
2134,.,0,0
2135,METHODS,0,0
2136,Seventy-two,0,0
2137,consecutive,0,0
2138,anti-HBe-positive,0,0
2139,chronic,0,0
2140,hepatitis,0,0
2141,B,0,0
2142,patients,0,0
2143,(,0,0
2144,59,0,0
2145,male,0,0
2146,and,0,0
2147,13,0,0
2148,female,0,0
2149,",",0,0
2150,median,0,0
2151,age,0,0
2152,41,0,0
2153,yr,0,0
2154,),0,0
2155,stratified,0,0
2156,by,0,0
2157,sex,0,0
2158,and,0,0
2159,histology,0,0
2160,were,0,0
2161,randomly,0,0
2162,allocated,0,0
2163,to,0,0
2164,three,0,0
2165,treatment,0,0
2166,arms,0,0
2167,.,0,0
2168,Twenty-seven,0,0
2169,patients,0,0
2170,(,0,0
2171,A,0,0
2172,),0,0
2173,received,0,0
2174,10,0,0
2175,million,0,0
2176,units,0,0
2177,alpha-N1,1,1
2178,IFN,1,0
2179,i.m,1,1
2180,.,1,0
2181,t.w,0,1
2182,.,0,0
2183,for,0,0
2184,24,0,0
2185,wk,0,0
2186,(,0,0
2187,total,0,0
2188,dose,0,0
2189,:,0,0
2190,720,0,0
2191,million,0,0
2192,units,0,0
2193,),0,0
2194,;,0,0
2195,21,0,0
2196,(,0,0
2197,B,0,0
2198,),0,0
2199,received,0,0
2200,9,0,0
2201,million,0,0
2202,units,0,0
2203,alpha-2a,1,1
2204,IFN,1,0
2205,i.m,1,1
2206,.,1,0
2207,t.w,0,1
2208,.,0,0
2209,for,0,0
2210,4,0,0
2211,wk,0,0
2212,",",0,0
2213,followed,0,0
2214,by,0,0
2215,18,0,0
2216,million,0,0
2217,units,0,0
2218,for,0,0
2219,12,0,0
2220,wk,0,0
2221,and,0,0
2222,9,0,0
2223,million,0,0
2224,units,0,0
2225,for,0,0
2226,8,0,0
2227,wk,0,0
2228,(,0,0
2229,972,0,0
2230,million,0,0
2231,units,0,0
2232,),0,0
2233,;,0,0
2234,24,0,0
2235,(,0,0
2236,C,0,0
2237,),0,0
2238,received,0,0
2239,2,1,0
2240,alpha-2a,1,1
2241,IFN,1,0
2242,courses,1,1
2243,(,0,0
2244,9,0,0
2245,million,0,0
2246,units,0,0
2247,i.m,0,1
2248,.,0,0
2249,t.w,0,1
2250,.,0,0
2251,for,0,0
2252,16,0,0
2253,and,0,0
2254,12,0,0
2255,wk,0,0
2256,separated,0,0
2257,by,0,0
2258,a,0,0
2259,6-month,0,0
2260,interval,0,0
2261,[,0,0
2262,756,0,0
2263,million,0,0
2264,units,0,0
2265,],0,0
2266,),0,0
2267,.,0,0
2268,Primary,0,0
2269,response,0,0
2270,was,0,0
2271,defined,0,0
2272,by,0,0
2273,normal,0,0
2274,ALT,0,1
2275,and,0,0
2276,serum,0,0
2277,HBV-DNA,0,0
2278,levels,0,0
2279,below,0,0
2280,10,0,0
2281,pg/ml,0,0
2282,at,0,0
2283,the,0,0
2284,end,0,0
2285,of,0,0
2286,therapy,0,1
2287,and,0,0
2288,sustained,0,0
2289,response,0,0
2290,by,0,0
2291,normal,0,0
2292,ALT,0,1
2293,(,0,0
2294,tested,0,0
2295,monthly,0,0
2296,),0,0
2297,",",0,0
2298,undetectable,0,0
2299,HBV-DNA,0,0
2300,and,0,0
2301,IgM,0,1
2302,anti-HBc,0,1
2303,(,0,0
2304,<,0,0
2305,7,0,0
2306,I.U,0,0
2307,.,0,0
2308,Paul,0,0
2309,Ehrlich,0,0
2310,Institute,0,0
2311,),0,0
2312,(,0,0
2313,tested,0,0
2314,every,0,0
2315,3,0,0
2316,months,0,0
2317,),0,0
2318,during,0,0
2319,the,0,0
2320,posttreatment,0,0
2321,follow-up,0,0
2322,.,0,0
2323,RESULTS,0,0
2324,At,0,0
2325,the,0,0
2326,end,0,0
2327,of,0,0
2328,treatment,0,0
2329,",",0,0
2330,12,0,0
2331,",",0,0
2332,8,0,0
2333,",",0,0
2334,and,0,0
2335,13,0,0
2336,patients,0,0
2337,from,0,0
2338,groups,0,0
2339,A,0,0
2340,",",0,0
2341,B,0,0
2342,",",0,0
2343,and,0,0
2344,C,0,0
2345,",",0,0
2346,respectively,0,0
2347,",",0,0
2348,were,0,0
2349,responders,0,0
2350,.,0,0
2351,At,0,0
2352,the,0,0
2353,18-month,0,0
2354,follow-up,0,0
2355,",",0,0
2356,two,0,0
2357,patients,0,0
2358,in,0,0
2359,group,0,0
2360,A,0,0
2361,and,0,0
2362,only,0,0
2363,one,0,0
2364,in,0,0
2365,groups,0,0
2366,B,0,0
2367,and,0,0
2368,C,0,0
2369,maintained,0,0
2370,the,0,0
2371,response,0,0
2372,.,0,0
2373,Overall,0,0
2374,",",0,0
2375,after,0,0
2376,34,0,0
2377,months,0,0
2378,(,0,0
2379,median,0,0
2380,posttreatment,0,0
2381,follow-up,0,0
2382,),0,0
2383,",",0,0
2384,three,0,0
2385,patients,0,0
2386,were,0,0
2387,long,0,0
2388,term,0,0
2389,responders,0,0
2390,",",0,0
2391,whereas,0,0
2392,three,0,0
2393,showed,0,0
2394,a,0,0
2395,sustained,0,0
2396,remission,0,0
2397,after,0,0
2398,relapse,0,0
2399,.,0,0
2400,CONCLUSIONS,0,0
2401,The,0,0
2402,rate,0,0
2403,of,0,0
2404,long,0,0
2405,term,0,0
2406,response,0,0
2407,to,0,0
2408,interferon,0,1
2409,of,0,0
2410,anti-HBe-positive,0,0
2411,chronic,0,0
2412,hepatitis,0,0
2413,B,0,0
2414,is,0,0
2415,poor,0,0
2416,",",0,0
2417,independent,0,0
2418,of,0,0
2419,IFN,0,0
2420,type,0,0
2421,",",0,0
2422,dose,0,0
2423,",",0,0
2424,or,0,0
2425,schedule,0,0
2426,;,0,0
2427,the,0,0
2428,more,0,0
2429,stringent,0,0
2430,the,0,0
2431,monitoring,0,0
2432,",",0,0
2433,the,0,0
2434,higher,0,0
2435,the,0,0
2436,relapse,0,0
2437,rate,0,0
2438,.,0,0
2439,Problem-solving,1,1
2440,counseling,1,1
2441,for,0,0
2442,caregivers,0,0
2443,of,0,0
2444,the,0,0
2445,cognitively,0,0
2446,impaired,0,0
2447,:,0,0
2448,effective,0,0
2449,for,0,0
2450,whom,0,0
2451,?,0,0
2452,BACKGROUND,0,0
2453,Individualized,0,0
2454,problem-solving,1,1
2455,counseling,1,1
2456,for,0,0
2457,caregivers,0,0
2458,of,0,0
2459,cognitively,0,0
2460,impaired,0,0
2461,relatives,0,0
2462,is,0,0
2463,thought,0,0
2464,to,0,0
2465,help,0,0
2466,caregivers,0,0
2467,cope,0,0
2468,with,0,0
2469,the,0,0
2470,stress,0,0
2471,and,0,0
2472,burden,0,0
2473,of,0,0
2474,caregiving,0,0
2475,.,0,0
2476,Few,0,0
2477,studies,0,0
2478,have,0,0
2479,shown,0,0
2480,the,0,0
2481,effectiveness,0,0
2482,of,0,0
2483,counseling,0,1
2484,for,0,0
2485,these,0,0
2486,caregivers,0,0
2487,.,0,0
2488,OBJECTIVES,0,0
2489,To,0,0
2490,determine,0,0
2491,the,0,0
2492,effectiveness,0,0
2493,of,0,0
2494,individualized,1,0
2495,problem-solving,1,1
2496,counseling,1,1
2497,by,1,0
2498,nurses,1,0
2499,for,0,0
2500,caregivers,0,0
2501,and,0,0
2502,the,0,0
2503,expenditures,0,0
2504,of,0,0
2505,health,0,0
2506,care,0,1
2507,utilization,0,0
2508,.,0,0
2509,METHOD,0,0
2510,Caregivers,0,0
2511,(,0,0
2512,n,0,0
2513,=,0,0
2514,77,0,0
2515,),0,0
2516,of,0,0
2517,the,0,0
2518,cognitively,0,0
2519,impaired,0,0
2520,living,0,0
2521,at,0,0
2522,home,0,0
2523,were,0,0
2524,randomized,0,0
2525,to,0,0
2526,receive,0,0
2527,nurse,1,1
2528,counseling,1,1
2529,or,1,0
2530,not,1,0
2531,.,1,0
2532,Psychosocial,0,0
2533,adjustment,0,0
2534,to,0,0
2535,their,0,0
2536,relative,0,0
2537,'s,0,0
2538,illness,0,0
2539,",",0,0
2540,psychological,0,0
2541,distress,0,0
2542,",",0,0
2543,burden,0,0
2544,",",0,0
2545,coping,0,0
2546,skills,0,0
2547,",",0,0
2548,and,0,0
2549,expenditures,0,0
2550,were,0,0
2551,measured,0,0
2552,after,0,0
2553,6,0,0
2554,months,0,0
2555,and,0,0
2556,1,0,0
2557,year,0,0
2558,.,0,0
2559,RESULTS,0,0
2560,Although,0,0
2561,on,0,0
2562,average,0,0
2563,",",0,0
2564,all,0,0
2565,caregivers,0,0
2566,receiving,0,0
2567,nurse,1,1
2568,counseling,1,1
2569,indicated,0,0
2570,no,0,0
2571,improvement,0,0
2572,in,0,0
2573,psychosocial,0,0
2574,adjustment,0,0
2575,to,0,0
2576,their,0,0
2577,relative,0,0
2578,'s,0,0
2579,illness,0,0
2580,",",0,0
2581,psychological,0,0
2582,distress,0,0
2583,",",0,0
2584,or,0,0
2585,caregiver,0,1
2586,burden,0,0
2587,",",0,0
2588,they,0,0
2589,found,0,0
2590,counseling,0,1
2591,very,0,0
2592,helpful,0,0
2593,and,0,0
2594,it,0,0
2595,was,0,0
2596,effective,0,0
2597,for,0,0
2598,a,0,0
2599,subgroup,0,0
2600,of,0,0
2601,caregivers,0,0
2602,.,0,0
2603,Those,0,0
2604,with,0,0
2605,poor,0,0
2606,logical,0,0
2607,analysis,0,0
2608,coping,0,0
2609,skills,0,0
2610,at,0,0
2611,baseline,0,0
2612,had,0,0
2613,decreased,0,0
2614,psychological,0,0
2615,distress,0,0
2616,(,0,1
2617,F,0,0
2618,(,0,0
2619,"1,53",0,0
2620,),0,0
2621,=,0,0
2622,9.7,0,0
2623,",",0,0
2624,p,0,0
2625,=,0,0
2626,.003,0,0
2627,),0,0
2628,and,0,0
2629,improved,0,0
2630,psychosocial,0,1
2631,adjustment,0,0
2632,(,0,1
2633,F,0,0
2634,(,0,0
2635,"1,53",0,0
2636,),0,0
2637,=,0,0
2638,4.7,0,0
2639,",",0,0
2640,p,0,0
2641,=,0,0
2642,.035,0,0
2643,),0,0
2644,after,0,0
2645,1,0,0
2646,year,0,0
2647,.,0,0
2648,Caregivers,0,0
2649,in,0,0
2650,control,1,0
2651,and,0,0
2652,counseling,1,1
2653,groups,0,0
2654,whose,0,0
2655,relatives,0,0
2656,entered,0,0
2657,a,0,0
2658,nursing,0,1
2659,home,0,0
2660,improved,0,0
2661,their,0,0
2662,psychosocial,0,0
2663,adjustment,0,0
2664,23,0,0
2665,%,0,0
2666,on,0,0
2667,average,0,0
2668,whereas,0,0
2669,those,0,0
2670,continuing,0,0
2671,to,0,0
2672,live,0,0
2673,in,0,0
2674,the,0,0
2675,community,0,0
2676,decreased,0,0
2677,by,0,0
2678,8,0,0
2679,%,0,0
2680,.,0,0
2681,Almost,0,0
2682,half,0,0
2683,as,0,0
2684,many,0,0
2685,relatives,0,0
2686,entered,0,0
2687,nursing,0,0
2688,homes,0,1
2689,in,0,0
2690,the,0,0
2691,counseling,1,1
2692,group,0,0
2693,(,0,0
2694,n,0,0
2695,=,0,0
2696,9,0,0
2697,vs.,0,0
2698,n,0,0
2699,=,0,0
2700,5,0,0
2701,),0,0
2702,but,0,0
2703,these,0,0
2704,compared,0,0
2705,to,0,0
2706,control,1,0
2707,group,0,0
2708,relatives,0,0
2709,had,0,0
2710,greater,0,0
2711,annualized,0,0
2712,per,0,0
2713,person,0,0
2714,expenditures,0,0
2715,for,0,0
2716,health,0,0
2717,and,0,0
2718,social,0,1
2719,services,0,1
2720,(,0,0
2721,Cdn,0,0
2722,$,0,0
2723,"23,437",0,0
2724,vs.,0,0
2725,Cdn,0,0
2726,$,0,0
2727,"15,151",0,0
2728,),0,0
2729,.,0,0
2730,CONCLUSIONS,0,0
2731,Caregivers,0,0
2732,found,0,0
2733,nurse,1,1
2734,counseling,1,1
2735,most,0,0
2736,helpful,0,0
2737,.,0,0
2738,Those,0,0
2739,indicating,0,0
2740,infrequent,0,0
2741,use,0,0
2742,of,0,0
2743,logical,0,0
2744,analysis,0,0
2745,coping,0,0
2746,skills,0,0
2747,showed,0,0
2748,benefits,0,0
2749,.,0,0
2750,Oral,0,1
2751,and,0,0
2752,parenteral,0,1
2753,glutamine,1,1
2754,in,0,0
2755,bone,0,0
2756,marrow,0,0
2757,transplantation,0,0
2758,:,0,0
2759,a,0,0
2760,randomized,0,0
2761,",",0,0
2762,double-blind,0,0
2763,study,0,0
2764,.,0,0
2765,BACKGROUND,0,0
2766,Total,1,0
2767,parenteral,1,1
2768,nutrition,1,1
2769,(,1,0
2770,TPN,1,0
2771,),1,0
2772,supplemented,1,1
2773,with,1,0
2774,glutamine,1,1
2775,(,1,0
2776,GLN,1,0
2777,),1,1
2778,has,0,0
2779,been,0,0
2780,reported,0,0
2781,to,0,0
2782,be,0,0
2783,effective,0,0
2784,for,0,0
2785,patients,0,0
2786,with,0,0
2787,bone,0,0
2788,marrow,0,0
2789,transplantation,0,1
2790,(,0,0
2791,BMT,0,0
2792,),0,0
2793,.,0,0
2794,Our,0,0
2795,aim,0,0
2796,was,0,0
2797,to,0,0
2798,evaluate,0,0
2799,enteral,0,1
2800,and,0,0
2801,parenteral,0,1
2802,glutamine,0,1
2803,in,0,0
2804,patients,0,0
2805,undergoing,0,0
2806,BMT,0,0
2807,.,0,0
2808,METHODS,0,0
2809,For,0,0
2810,evaluation,0,0
2811,of,0,0
2812,GLN,0,0
2813,in,0,0
2814,BMT,0,0
2815,",",0,0
2816,66,0,0
2817,patients,0,0
2818,with,0,0
2819,43,0,0
2820,hematologic,0,0
2821,and,0,0
2822,23,0,0
2823,solid,0,0
2824,malignancies,0,0
2825,(,0,0
2826,21,0,0
2827,breast,0,0
2828,carcinomas,0,0
2829,),0,0
2830,",",0,0
2831,were,0,0
2832,randomized,0,0
2833,",",0,0
2834,double-blinded,0,0
2835,",",0,0
2836,to,0,0
2837,either,0,0
2838,oral,1,1
2839,GLN,1,0
2840,(,0,0
2841,n,0,0
2842,=,0,0
2843,35,0,0
2844,),0,0
2845,or,0,1
2846,glycine-control,1,1
2847,(,0,1
2848,GLY,0,0
2849,),0,1
2850,(,0,0
2851,n,0,0
2852,=,0,0
2853,31,0,0
2854,),0,0
2855,",",0,0
2856,10,0,0
2857,g,0,0
2858,three,0,0
2859,times,0,0
2860,daily,0,0
2861,.,0,0
2862,When,0,0
2863,TPN,1,0
2864,became,0,0
2865,necessary,0,0
2866,",",0,0
2867,patients,0,0
2868,who,0,0
2869,received,0,0
2870,GLN,1,0
2871,orally,0,1
2872,were,0,0
2873,given,0,0
2874,TPN,1,0
2875,with,1,0
2876,GLN,1,0
2877,(,0,0
2878,0.57,0,0
2879,g/kg,0,0
2880,),0,0
2881,.,0,0
2882,Those,0,0
2883,who,0,0
2884,received,0,0
2885,GLY,0,0
2886,received,0,0
2887,standard,0,1
2888,TPN,1,0
2889,",",0,0
2890,isocaloric,0,1
2891,and,0,0
2892,isonitrogenous,0,1
2893,.,0,0
2894,Patients,0,0
2895,with,0,0
2896,hematologic,0,0
2897,malignancies,0,0
2898,received,0,0
2899,high-dose,1,1
2900,chemotherapy,1,1
2901,",",1,0
2902,total,1,0
2903,body,1,0
2904,irradiation,1,1
2905,",",1,0
2906,and,1,0
2907,either,1,1
2908,allogeneic,1,1
2909,(,1,0
2910,ALLO,1,1
2911,),1,1
2912,BMT,1,0
2913,(,0,0
2914,n,0,0
2915,=,0,0
2916,18,0,0
2917,),0,0
2918,or,0,1
2919,autologous,1,1
2920,(,1,0
2921,AUTO,1,0
2922,),1,1
2923,stem,1,1
2924,cell,1,0
2925,transplantation,1,1
2926,(,0,0
2927,n,0,0
2928,=,0,0
2929,25,0,0
2930,),0,0
2931,.,0,0
2932,Patients,0,0
2933,with,0,0
2934,solid,0,0
2935,malignancies,0,0
2936,(,0,0
2937,n,0,0
2938,=,0,0
2939,23,0,0
2940,),0,0
2941,received,0,0
2942,AUTO,1,0
2943,.,1,0
2944,RESULTS,0,0
2945,There,0,0
2946,were,0,0
2947,14,0,0
2948,in-hospital,0,0
2949,deaths,0,0
2950,without,0,0
2951,relationship,0,0
2952,to,0,0
2953,GLN,0,0
2954,administration,0,0
2955,.,0,0
2956,For,0,0
2957,respective,0,0
2958,comparisons,0,0
2959,of,0,0
2960,ALLO,0,1
2961,and,0,0
2962,AUTO,0,0
2963,transplants,0,0
2964,in,0,0
2965,the,0,0
2966,GLN,0,0
2967,and,0,0
2968,GLY,0,0
2969,hematologic,0,0
2970,groups,0,0
2971,and,0,0
2972,AUTO,0,0
2973,in,0,0
2974,the,0,0
2975,solid,0,0
2976,tumor,0,0
2977,groups,0,0
2978,",",0,0
2979,there,0,0
2980,were,0,0
2981,no,0,0
2982,significant,0,0
2983,differences,0,0
2984,in,0,0
2985,hospital,0,0
2986,stay,0,0
2987,",",0,0
2988,duration,0,0
2989,of,0,0
2990,stay,0,0
2991,after,0,0
2992,BMT,0,0
2993,",",0,0
2994,TPN,0,0
2995,days,0,0
2996,",",0,0
2997,neutrophil,0,0
2998,recovery,0,0
2999,>,0,0
3000,500/mm3,0,0
3001,",",0,0
3002,incidence,0,0
3003,of,0,0
3004,positive,0,0
3005,blood,0,0
3006,cultures,0,0
3007,",",0,0
3008,sepsis,0,0
3009,",",0,0
3010,mucositis,0,0
3011,",",0,0
3012,and,0,0
3013,diarrhea,0,0
3014,.,0,0
3015,Acute,0,0
3016,graft,0,0
3017,us,0,0
3018,host,0,0
3019,disease,0,0
3020,occurred,0,0
3021,in,0,0
3022,1,0,0
3023,of,0,0
3024,10,0,0
3025,hematologic,0,0
3026,patients,0,0
3027,receiving,0,0
3028,GLN,0,0
3029,and,0,0
3030,in,0,0
3031,3,0,0
3032,of,0,0
3033,8,0,0
3034,patients,0,0
3035,receiving,0,0
3036,GLY,0,0
3037,placebo,0,1
3038,(,0,0
3039,p,0,0
3040,>,0,0
3041,.05,0,0
3042,),0,0
3043,.,0,0
3044,Possible,0,0
3045,reduction,0,0
3046,in,0,0
3047,need,0,0
3048,for,0,0
3049,TPN,0,0
3050,and,0,0
3051,a,0,0
3052,suggestion,0,0
3053,of,0,0
3054,improved,0,0
3055,long-term,0,0
3056,survival,0,0
3057,were,0,0
3058,associated,0,0
3059,with,0,0
3060,GLN,0,0
3061,.,0,0
3062,CONCLUSIONS,0,0
3063,Oral,0,0
3064,and,0,0
3065,parenteral,0,1
3066,GLN,1,0
3067,seemed,0,0
3068,to,0,0
3069,be,0,0
3070,of,0,0
3071,limited,0,0
3072,benefit,0,0
3073,for,0,0
3074,patients,0,0
3075,having,0,0
3076,AUTO,0,0
3077,or,0,1
3078,ALLO,0,1
3079,BMT,0,0
3080,for,0,0
3081,hematologic,0,0
3082,or,0,0
3083,solid,0,0
3084,malignancies,0,0
3085,.,0,0
3086,Further,0,0
3087,study,0,0
3088,of,0,0
3089,long-term,0,0
3090,effects,0,0
3091,of,0,0
3092,GLN,0,0
3093,in,0,0
3094,BMT,0,0
3095,seems,0,0
3096,warranted,0,0
3097,.,0,0
3098,A,0,0
3099,randomized,0,0
3100,phase,0,0
3101,II,0,0
3102,trial,0,0
3103,of,0,0
3104,5-fluorouracil,1,1
3105,",",0,0
3106,with,0,0
3107,or,0,0
3108,without,0,0
3109,human,1,0
3110,interferon-beta,1,1
3111,",",0,0
3112,for,0,0
3113,advanced,0,0
3114,colorectal,0,0
3115,cancer,0,0
3116,.,0,0
3117,This,0,0
3118,study,0,0
3119,compared,0,0
3120,the,0,0
3121,efficacy,0,0
3122,and,0,0
3123,safety,0,0
3124,of,0,0
3125,5-fluorouracil,1,1
3126,(,1,0
3127,5-FU,1,1
3128,),1,0
3129,monotherapy,1,1
3130,to,0,0
3131,that,0,0
3132,of,0,0
3133,5-FU,1,0
3134,combined,1,0
3135,with,1,0
3136,natural,1,0
3137,human,1,1
3138,interferon-beta,1,1
3139,(,1,0
3140,IFN-beta,1,1
3141,),1,0
3142,in,0,0
3143,patients,0,0
3144,with,0,0
3145,unresectable,0,0
3146,",",0,0
3147,advanced,0,0
3148,colorectal,0,0
3149,carcinoma,0,0
3150,.,0,0
3151,Forty-nine,0,0
3152,chemotherapy-naive,0,0
3153,patients,0,0
3154,were,0,0
3155,randomized,0,0
3156,to,0,0
3157,5-FU,0,0
3158,alone,0,1
3159,or,0,0
3160,to,0,0
3161,the,0,0
3162,combination,0,1
3163,.,0,0
3164,All,0,0
3165,patients,0,0
3166,received,0,0
3167,750,0,0
3168,mg,0,1
3169,m,0,0
3170,(,0,0
3171,-2,0,0
3172,),0,1
3173,day,0,1
3174,(,0,0
3175,-1,0,0
3176,),0,0
3177,5-FU,0,0
3178,for,0,0
3179,5,0,0
3180,days,0,0
3181,by,0,0
3182,continuous,0,1
3183,intravenous,0,1
3184,(,0,0
3185,i.v,0,1
3186,.,0,0
3187,),0,0
3188,infusion,0,0
3189,",",0,0
3190,followed,0,0
3191,after,0,0
3192,day,0,0
3193,15,0,0
3194,by,0,0
3195,a,0,0
3196,weekly,0,1
3197,i.v,0,1
3198,.,0,0
3199,bolus,0,0
3200,of,0,0
3201,750,0,1
3202,mg,0,1
3203,m,0,0
3204,(,0,0
3205,-2,0,0
3206,),0,0
3207,.,0,0
3208,IFN-beta,1,0
3209,was,0,0
3210,injected,0,1
3211,intramuscularly,0,1
3212,three,0,0
3213,times,0,0
3214,weekly,0,0
3215,at,0,0
3216,9,0,0
3217,M,0,0
3218,IU,0,1
3219,.,0,0
3220,Treatment,0,0
3221,continued,0,0
3222,for,0,0
3223,52,0,0
3224,weeks,0,0
3225,",",0,0
3226,or,0,0
3227,until,0,0
3228,disease,0,0
3229,progression,0,0
3230,or,0,1
3231,intolerable,0,0
3232,toxicity,0,0
3233,.,0,0
3234,Clinical,0,0
3235,endpoints,0,0
3236,were,0,0
3237,tumor,0,0
3238,response,0,0
3239,",",0,0
3240,time,0,0
3241,to,0,0
3242,progression,0,0
3243,",",0,0
3244,survival,0,0
3245,and,0,0
3246,toxicity,0,0
3247,.,0,0
3248,The,0,0
3249,addition,0,0
3250,of,0,0
3251,IFN-3,1,0
3252,to,1,0
3253,5-FU,1,0
3254,significantly,0,0
3255,improved,0,0
3256,response,0,0
3257,rate,0,0
3258,(,0,0
3259,33.3,0,0
3260,%,0,0
3261,vs,0,0
3262,4.5,0,0
3263,%,0,0
3264,for,0,0
3265,evaluable,0,0
3266,patients,0,0
3267,;,0,0
3268,P,0,0
3269,=,0,0
3270,0.021,0,0
3271,),0,0
3272,",",0,0
3273,time,0,0
3274,to,0,0
3275,progression,0,0
3276,(,0,0
3277,median,0,0
3278,7.2,0,0
3279,vs,0,0
3280,4.2,0,0
3281,months,0,0
3282,;,0,0
3283,P,0,0
3284,=,0,0
3285,0.0435,0,0
3286,),0,0
3287,",",0,0
3288,and,0,0
3289,survival,0,0
3290,time,0,0
3291,(,0,0
3292,median,0,0
3293,15.9,0,0
3294,vs,0,0
3295,7.2,0,0
3296,months,0,0
3297,;,0,0
3298,P,0,0
3299,=,0,0
3300,0.038,0,0
3301,),0,0
3302,without,0,0
3303,significantly,0,0
3304,increasing,0,0
3305,toxicity,0,0
3306,compared,0,0
3307,to,0,0
3308,5-FU,0,0
3309,alone,0,1
3310,.,0,0
3311,Cumulative,0,0
3312,5-FU,1,0
3313,dose,0,0
3314,was,0,0
3315,higher,0,0
3316,with,0,0
3317,combined,0,0
3318,therapy,0,1
3319,(,0,0
3320,P,0,0
3321,<,0,0
3322,0.001,0,0
3323,),0,0
3324,:,0,0
3325,more,0,0
3326,patients,0,0
3327,receiving,0,0
3328,monotherapy,0,1
3329,discontinued,0,0
3330,treatment,0,0
3331,because,0,0
3332,of,0,0
3333,disease,0,0
3334,progression,0,0
3335,.,0,0
3336,Fever,0,0
3337,was,0,0
3338,more,0,0
3339,frequent,0,0
3340,with,0,0
3341,combined,0,1
3342,therapy,0,1
3343,(,0,0
3344,P,0,0
3345,=,0,0
3346,0.008,0,0
3347,),0,0
3348,;,0,0
3349,there,0,0
3350,were,0,0
3351,no,0,0
3352,other,0,0
3353,differences,0,0
3354,in,0,0
3355,toxicity,0,0
3356,.,0,0
3357,The,0,0
3358,only,0,0
3359,grade,0,0
3360,IV,0,0
3361,toxicity,0,0
3362,observed,0,0
3363,was,0,0
3364,neutropenia,0,0
3365,(,0,0
3366,two,0,0
3367,patients,0,0
3368,per,0,0
3369,group,0,0
3370,),0,0
3371,.,0,0
3372,A,0,0
3373,randomized,0,0
3374,phase,0,0
3375,III,0,0
3376,trial,0,0
3377,has,0,0
3378,been,0,0
3379,initiated,0,0
3380,to,0,0
3381,confirm,0,0
3382,the,0,0
3383,synergy,0,0
3384,between,0,0
3385,5-FU,1,0
3386,and,0,0
3387,IFN-beta,1,0
3388,.,1,0
3389,Inflammatory,0,0
3390,response,0,0
3391,in,0,0
3392,humans,0,0
3393,exposed,0,0
3394,to,0,0
3395,2.0,0,0
3396,ppm,0,1
3397,nitrogen,1,0
3398,dioxide,1,1
3399,.,1,0
3400,Nitrogen,1,0
3401,dioxide,1,1
3402,(,1,0
3403,NO2,1,1
3404,),1,1
3405,is,0,0
3406,a,0,0
3407,common,0,0
3408,indoor,0,1
3409,air,0,1
3410,pollutant,0,0
3411,",",0,0
3412,especially,0,0
3413,in,0,0
3414,homes,0,0
3415,with,0,0
3416,unvented,0,0
3417,combustion,0,1
3418,appliances,0,1
3419,.,0,0
3420,Epidemiological,0,0
3421,studies,0,0
3422,suggest,0,0
3423,that,0,0
3424,children,0,0
3425,living,0,0
3426,in,0,0
3427,homes,0,1
3428,with,0,0
3429,unvented,0,0
3430,heating,0,1
3431,sources,0,0
3432,are,0,0
3433,more,0,0
3434,prone,0,0
3435,to,0,0
3436,respiratory,0,0
3437,infections,0,0
3438,than,0,0
3439,children,0,0
3440,living,0,0
3441,in,0,0
3442,homes,0,0
3443,with,0,0
3444,lower,0,0
3445,levels,0,0
3446,of,0,0
3447,NO2,1,0
3448,.,1,0
3449,However,0,0
3450,",",0,0
3451,experimental,0,0
3452,studies,0,0
3453,in,0,0
3454,which,0,0
3455,human,0,0
3456,volunteers,0,0
3457,were,0,0
3458,exposed,0,0
3459,acutely,0,0
3460,to,0,0
3461,moderate,0,0
3462,levels,0,0
3463,of,0,0
3464,NO2,1,1
3465,(,0,0
3466,0.5-2.0,0,0
3467,ppm,0,1
3468,),0,0
3469,have,0,0
3470,shown,0,0
3471,little,0,0
3472,evidence,0,0
3473,of,0,0
3474,lung,0,0
3475,inflammation,0,0
3476,or,0,1
3477,decreased,0,0
3478,host,0,0
3479,resistance,0,0
3480,capacity,0,0
3481,.,0,0
3482,In,0,0
3483,the,0,0
3484,study,0,0
3485,reported,0,0
3486,here,0,0
3487,",",0,0
3488,8,0,0
3489,healthy,0,0
3490,volunteers,0,0
3491,were,0,0
3492,exposed,0,0
3493,to,0,0
3494,2.0,0,0
3495,ppm,0,1
3496,NO2,1,1
3497,and,0,0
3498,to,0,0
3499,filtered,1,1
3500,air,1,1
3501,for,0,0
3502,4,0,0
3503,h,0,0
3504,while,0,0
3505,undergoing,1,0
3506,intermittent,1,1
3507,moderate,1,0
3508,exercise,1,1
3509,.,1,0
3510,Bronchoalveolar,1,0
3511,lavage,1,0
3512,was,0,0
3513,performed,0,0
3514,the,0,0
3515,following,0,0
3516,morning,0,0
3517,.,0,0
3518,The,0,0
3519,lavage,0,0
3520,was,0,0
3521,divided,0,0
3522,into,0,0
3523,a,0,0
3524,predominantly,0,0
3525,bronchial,0,0
3526,washing,0,1
3527,(,0,0
3528,first,0,0
3529,20,0,1
3530,ml,0,0
3531,of,0,0
3532,lavage,0,0
3533,;,0,0
3534,BL,0,1
3535,),0,0
3536,and,0,0
3537,a,0,0
3538,predominantly,0,0
3539,alveolar,0,0
3540,washing,0,1
3541,(,0,0
3542,BAL,0,0
3543,),0,0
3544,.,0,0
3545,In,0,0
3546,the,0,0
3547,BL,0,0
3548,",",0,0
3549,NO2,1,1
3550,exposure,0,0
3551,caused,0,0
3552,increases,0,0
3553,in,0,0
3554,polymorphonuclear,0,0
3555,neutrophils,0,0
3556,(,0,0
3557,PMNs,0,0
3558,),0,0
3559,",",0,0
3560,interleukin,0,1
3561,6,0,0
3562,(,0,0
3563,IL-6,0,0
3564,),0,0
3565,",",0,0
3566,IL-8,0,0
3567,",",0,0
3568,alpha1-antitrypsin,0,1
3569,",",0,0
3570,and,0,0
3571,tissue,0,0
3572,plasminogen,0,1
3573,activator,0,0
3574,",",0,0
3575,and,0,0
3576,decreases,0,0
3577,in,0,0
3578,epithelial,0,0
3579,cells,0,0
3580,.,0,0
3581,In,0,0
3582,the,0,0
3583,BAL,0,0
3584,",",0,0
3585,there,0,0
3586,were,0,0
3587,no,0,0
3588,NO2-induced,0,0
3589,changes,0,0
3590,in,0,0
3591,either,0,0
3592,cell,0,0
3593,numbers,0,0
3594,or,0,0
3595,soluble,0,0
3596,mediators,0,0
3597,.,0,0
3598,On,0,0
3599,the,0,0
3600,other,0,0
3601,hand,0,0
3602,",",0,0
3603,alveolar,0,0
3604,macrophages,0,0
3605,from,0,0
3606,BAL,0,0
3607,showed,0,0
3608,a,0,0
3609,decrease,0,0
3610,in,0,0
3611,the,0,0
3612,ability,0,0
3613,to,0,0
3614,phagocytose,0,0
3615,unopsonized,0,0
3616,Candida,0,0
3617,albicans,0,0
3618,and,0,0
3619,a,0,0
3620,decrease,0,0
3621,in,0,0
3622,superoxide,0,0
3623,production,0,0
3624,.,0,0
3625,No,0,0
3626,difference,0,0
3627,in,0,0
3628,susceptibility,0,0
3629,to,0,0
3630,virus,0,0
3631,infection,0,0
3632,was,0,0
3633,found,0,0
3634,between,0,0
3635,the,0,0
3636,NO2-,1,0
3637,and,0,0
3638,air-exposed,0,0
3639,macrophages,0,0
3640,.,0,0
3641,No,0,0
3642,changes,0,0
3643,in,0,0
3644,lung,0,0
3645,function,0,0
3646,were,0,0
3647,observed,0,0
3648,",",0,0
3649,but,0,0
3650,the,0,0
3651,aerosol,0,1
3652,bolus,0,1
3653,recovery,0,0
3654,technique,0,1
3655,revealed,0,0
3656,a,0,0
3657,statistically,0,0
3658,significant,0,0
3659,(,0,0
3660,p,0,0
3661,<,0,0
3662,.05,0,0
3663,),0,0
3664,decrease,0,0
3665,in,0,0
3666,the,0,0
3667,fraction,0,0
3668,of,0,0
3669,aerosol,0,1
3670,recovered,0,0
3671,following,0,0
3672,nitrogen,1,0
3673,dioxide,1,1
3674,exposure,0,0
3675,",",0,0
3676,which,0,0
3677,is,0,0
3678,suggestive,0,0
3679,of,0,0
3680,small,0,0
3681,obstructive,0,0
3682,changes,0,0
3683,induced,0,0
3684,by,0,0
3685,NO2,1,0
3686,.,1,0
3687,Cycle,0,0
3688,control,0,0
3689,with,0,0
3690,oral,1,1
3691,contraceptives,1,1
3692,containing,1,0
3693,20,1,0
3694,micrograms,1,1
3695,of,1,0
3696,ethinyl,1,1
3697,estradiol,1,1
3698,.,1,0
3699,A,0,0
3700,multicenter,0,0
3701,",",0,0
3702,randomized,0,0
3703,comparison,0,0
3704,of,0,0
3705,levonorgestrel/ethinyl,1,1
3706,estradiol,1,1
3707,(,0,0
3708,100,0,0
3709,micrograms/20,0,0
3710,micrograms,0,1
3711,),0,0
3712,and,0,0
3713,norethindrone/ethinyl,1,1
3714,estradiol,1,1
3715,(,0,0
3716,1000,0,0
3717,micrograms/20,0,0
3718,micrograms,0,1
3719,),0,0
3720,.,0,0
3721,A,0,0
3722,randomized,0,0
3723,",",0,0
3724,open-label,0,0
3725,",",0,0
3726,multicenter,0,0
3727,study,0,0
3728,was,0,0
3729,undertaken,0,0
3730,to,0,0
3731,compare,0,0
3732,the,0,0
3733,effects,0,0
3734,of,0,0
3735,oral,1,1
3736,contraceptives,1,1
3737,(,1,0
3738,OC,1,0
3739,),1,0
3740,containing,1,1
3741,100,1,0
3742,micrograms,1,1
3743,levonorgestrel,1,1
3744,(,1,0
3745,LNG,1,1
3746,),1,0
3747,/20,1,0
3748,micrograms,1,1
3749,ethinyl,1,1
3750,estradiol,1,1
3751,(,1,0
3752,EE,1,1
3753,),1,1
3754,(,1,0
3755,Aless/Loette,1,1
3756,),1,0
3757,and,0,0
3758,1000,1,0
3759,micrograms,1,1
3760,norethindrone,1,1
3761,acetate,1,1
3762,(,1,0
3763,NETA,1,0
3764,),1,0
3765,/20,1,0
3766,micrograms,1,1
3767,EE,1,0
3768,(,1,0
3769,Loestrin,1,1
3770,Fe,1,1
3771,1/20,1,1
3772,),1,0
3773,on,0,0
3774,menstrual,0,0
3775,cycle,0,0
3776,control,0,0
3777,over,0,0
3778,four,0,0
3779,cycles,0,0
3780,of,0,0
3781,use,0,0
3782,.,0,0
3783,A,0,0
3784,total,0,0
3785,of,0,0
3786,84,0,0
3787,evaluable,0,0
3788,women,0,0
3789,provided,0,0
3790,274,0,0
3791,cycles,0,0
3792,of,0,0
3793,exposure,0,0
3794,in,0,0
3795,the,0,0
3796,LNG/EE,0,0
3797,group,0,0
3798,",",0,0
3799,and,0,0
3800,89,0,0
3801,women,0,0
3802,provided,0,0
3803,289,0,0
3804,cycles,0,0
3805,of,0,0
3806,exposure,0,0
3807,in,0,0
3808,the,0,0
3809,NETA/EE,0,0
3810,group,0,0
3811,.,0,0
3812,Overall,0,0
3813,",",0,0
3814,the,0,0
3815,LNG/EE,0,0
3816,group,0,0
3817,achieved,0,0
3818,a,0,0
3819,consistently,0,0
3820,higher,0,0
3821,percentage,0,0
3822,of,0,0
3823,normal,0,0
3824,menstrual,0,0
3825,cycles,0,0
3826,as,0,0
3827,well,0,0
3828,as,0,0
3829,a,0,0
3830,lower,0,0
3831,rate,0,0
3832,of,0,0
3833,intermenstrual,0,0
3834,bleeding,0,0
3835,and,0,0
3836,amenorrhea,0,0
3837,than,0,0
3838,the,0,0
3839,NETA/EE,0,0
3840,group,0,0
3841,.,0,0
3842,In,0,0
3843,cycle,0,0
3844,4,0,0
3845,",",0,0
3846,63.8,0,0
3847,%,0,0
3848,of,0,0
3849,cycles,0,0
3850,were,0,0
3851,normal,0,0
3852,in,0,0
3853,the,0,0
3854,LNG/EE,0,0
3855,group,0,0
3856,compared,0,0
3857,with,0,0
3858,41.9,0,0
3859,%,0,0
3860,in,0,0
3861,the,0,0
3862,NETA/EE,0,1
3863,group,0,0
3864,(,0,0
3865,p,0,0
3866,<,0,0
3867,0.005,0,0
3868,),0,0
3869,.,0,0
3870,Of,0,0
3871,the,0,0
3872,total,0,0
3873,cycles,0,0
3874,in,0,0
3875,the,0,0
3876,NETA/EE,0,1
3877,group,0,0
3878,",",0,0
3879,10,0,0
3880,%,0,0
3881,were,0,0
3882,amenorrheic,0,0
3883,",",0,0
3884,compared,0,0
3885,with,0,0
3886,1.1,0,0
3887,%,0,0
3888,in,0,0
3889,the,0,0
3890,LNG/EE,0,0
3891,group,0,0
3892,.,0,0
3893,The,0,0
3894,occurrence,0,0
3895,of,0,0
3896,bleeding,0,0
3897,and/or,0,0
3898,spotting,0,1
3899,was,0,0
3900,significantly,0,0
3901,lower,0,0
3902,in,0,0
3903,cycles,0,0
3904,2,0,0
3905,and,0,0
3906,3,0,0
3907,in,0,0
3908,the,0,0
3909,LNG/EE,0,0
3910,group,0,0
3911,(,0,0
3912,41.7,0,0
3913,%,0,0
3914,and,0,0
3915,34.8,0,0
3916,%,0,0
3917,",",0,0
3918,respectively,0,0
3919,),0,0
3920,compared,0,0
3921,with,0,0
3922,the,0,0
3923,NETA/EE,0,1
3924,group,0,0
3925,(,0,0
3926,62.3,0,0
3927,%,0,0
3928,and,0,0
3929,56.3,0,0
3930,%,0,0
3931,;,0,0
3932,p,0,0
3933,<,0,0
3934,0.05,0,0
3935,),0,0
3936,.,0,0
3937,Other,0,0
3938,cycle,0,0
3939,variables,0,0
3940,were,0,0
3941,generally,0,0
3942,similar,0,0
3943,between,0,0
3944,groups,0,0
3945,",",0,0
3946,as,0,0
3947,was,0,0
3948,the,0,0
3949,incidence,0,0
3950,of,0,0
3951,adverse,0,0
3952,events,0,0
3953,.,0,0
3954,These,0,0
3955,results,0,0
3956,demonstrate,0,0
3957,that,0,0
3958,good,0,0
3959,cycle,0,0
3960,control,0,0
3961,was,0,0
3962,achieved,0,0
3963,with,0,0
3964,an,0,0
3965,OC,0,0
3966,containing,0,1
3967,20,0,0
3968,micrograms,0,1
3969,EE,1,0
3970,and,0,0
3971,that,0,0
3972,100,0,0
3973,micrograms,0,0
3974,LNG/20,1,0
3975,micrograms,0,1
3976,EE,1,0
3977,produces,0,0
3978,better,0,0
3979,cycle,0,0
3980,control,0,0
3981,than,0,0
3982,1000,0,0
3983,micrograms,0,0
3984,NETA/20,1,0
3985,micrograms,0,1
3986,EE,1,0
3987,.,1,0
3988,Sleep,0,1
3989,patterns,0,0
3990,in,0,0
3991,autistic,0,0
3992,children,0,0
3993,.,0,0
3994,Sleep,0,0
3995,disturbances,0,0
3996,are,0,0
3997,regarded,0,0
3998,as,0,0
3999,a,0,0
4000,common,0,0
4001,clinical,0,0
4002,feature,0,0
4003,in,0,0
4004,autistic,0,0
4005,children,0,0
4006,.,0,0
4007,This,0,0
4008,concept,0,0
4009,is,0,0
4010,based,0,0
4011,primarily,0,0
4012,on,0,0
4013,informal,0,1
4014,observations,0,0
4015,or,0,0
4016,studies,0,0
4017,conducted,0,0
4018,with,0,0
4019,questionnaires,1,0
4020,.,1,0
4021,In,0,0
4022,this,0,0
4023,study,0,0
4024,we,0,0
4025,compared,0,0
4026,data,0,0
4027,obtained,0,0
4028,by,0,0
4029,questionnaires,1,0
4030,to,0,0
4031,that,0,0
4032,obtained,0,0
4033,with,0,0
4034,actigraphy,1,0
4035,.,1,0
4036,Among,0,0
4037,22,0,0
4038,autistic,0,0
4039,children,0,0
4040,",",0,0
4041,12,0,0
4042,were,0,0
4043,reported,0,0
4044,as,0,0
4045,having,0,0
4046,sleep,0,0
4047,problems,0,0
4048,and,0,0
4049,8,0,0
4050,patients,0,0
4051,completed,0,0
4052,72,1,0
4053,hours,1,0
4054,actigraphy,1,0
4055,.,1,0
4056,While,0,0
4057,the,0,0
4058,employment,0,0
4059,of,0,0
4060,questionnaires,1,1
4061,disclosed,0,0
4062,that,0,0
4063,autistic,0,0
4064,children,0,0
4065,had,0,0
4066,an,0,0
4067,earlier,0,0
4068,morning,0,0
4069,awakening,0,0
4070,time,0,0
4071,and,0,0
4072,multiple,0,0
4073,and,0,0
4074,early,0,0
4075,night,0,0
4076,arousals,0,0
4077,",",0,0
4078,actigraphic,1,0
4079,monitoring,0,0
4080,showed,0,0
4081,that,0,0
4082,with,0,0
4083,the,0,0
4084,exception,0,0
4085,of,0,0
4086,an,0,0
4087,earlier,0,0
4088,morning,0,0
4089,arousal,0,0
4090,time,0,0
4091,(,0,0
4092,p,0,0
4093,=,0,0
4094,.045,0,0
4095,),0,0
4096,",",0,0
4097,sleep,0,0
4098,patterns,0,0
4099,of,0,0
4100,autistic,0,0
4101,children,0,0
4102,were,0,0
4103,similar,0,0
4104,to,0,0
4105,that,0,0
4106,of,0,0
4107,normal,0,0
4108,children,0,0
4109,.,0,0
4110,Parental,0,0
4111,oversensitivity,0,0
4112,to,0,0
4113,sleep,0,0
4114,disturbances,0,0
4115,of,0,0
4116,the,0,0
4117,autistic,0,0
4118,children,0,0
4119,may,0,0
4120,explain,0,0
4121,this,0,0
4122,phenomenon,0,0
4123,.,0,0
4124,Calcitriol,1,1
4125,for,0,0
4126,bone,0,0
4127,disease,0,0
4128,in,0,0
4129,patients,0,0
4130,with,0,0
4131,cirrhosis,0,0
4132,of,0,0
4133,the,0,0
4134,liver,0,0
4135,.,0,0
4136,BACKGROUND,0,0
4137,Osteoporosis,0,0
4138,is,0,0
4139,associated,0,0
4140,with,0,0
4141,cirrhosis,0,0
4142,of,0,0
4143,the,0,0
4144,liver,0,0
4145,",",0,0
4146,but,0,0
4147,the,0,0
4148,effects,0,0
4149,of,0,0
4150,therapy,0,1
4151,for,0,0
4152,osteoporosis,0,0
4153,associated,0,0
4154,with,0,0
4155,cirrhosis,0,0
4156,are,0,0
4157,still,0,0
4158,controversial,0,0
4159,.,0,0
4160,METHODS,0,0
4161,We,0,0
4162,evaluated,0,0
4163,the,0,0
4164,effects,0,0
4165,of,0,0
4166,calcitriol,1,1
4167,(,1,0
4168,"1alpha,25-dihydroxyvitamin",1,1
4169,D3,1,1
4170,),1,0
4171,on,0,0
4172,bone,0,0
4173,mineral,0,0
4174,density,0,0
4175,(,0,0
4176,BMD,0,0
4177,),0,0
4178,in,0,0
4179,76,0,0
4180,patients,0,0
4181,(,0,0
4182,26,0,0
4183,men,0,0
4184,and,0,0
4185,50,0,0
4186,women,0,0
4187,),0,0
4188,with,0,0
4189,cirrhosis,0,0
4190,who,0,0
4191,were,0,0
4192,assigned,0,0
4193,randomly,1,0
4194,to,1,0
4195,receive,1,1
4196,calcitriol,1,1
4197,(,1,0
4198,0.5,1,0
4199,mg,1,1
4200,twice,1,0
4201,per,1,0
4202,day,1,0
4203,),1,0
4204,or,1,0
4205,not,1,0
4206,.,1,0
4207,The,0,0
4208,BMD,0,0
4209,of,0,0
4210,the,0,0
4211,lumbar,0,1
4212,vertebrae,0,0
4213,was,0,0
4214,measured,1,0
4215,by,1,0
4216,dual-energy,1,0
4217,X-ray,1,0
4218,absorptiometry,1,0
4219,at,1,0
4220,least,1,0
4221,twice,1,0
4222,",",1,0
4223,12-57,1,0
4224,months,1,0
4225,apart,1,0
4226,.,1,0
4227,RESULTS,0,0
4228,For,0,0
4229,men,0,0
4230,",",0,0
4231,the,0,0
4232,mean,0,0
4233,annual,0,0
4234,change,0,0
4235,in,0,0
4236,BMD,0,0
4237,was,0,0
4238,1.1,0,0
4239,%,0,0
4240,in,0,0
4241,the,0,0
4242,treated,0,0
4243,group,0,0
4244,and,0,0
4245,-0.4,0,0
4246,%,0,0
4247,in,0,0
4248,the,0,0
4249,control,0,0
4250,group,0,0
4251,.,0,0
4252,The,0,0
4253,median,0,0
4254,(,0,0
4255,25th,0,0
4256,and,0,0
4257,75th,0,0
4258,percentiles,0,0
4259,),0,0
4260,annual,0,0
4261,change,0,0
4262,in,0,0
4263,BMD,0,0
4264,was,0,0
4265,0.6,0,0
4266,(,0,0
4267,-0.1,0,0
4268,",",0,0
4269,2.1,0,0
4270,%,0,0
4271,),0,0
4272,in,0,0
4273,the,0,0
4274,treated,0,0
4275,group,0,0
4276,and,0,0
4277,-1.4,0,0
4278,(,0,0
4279,-1.9,0,0
4280,",",0,0
4281,1.6,0,0
4282,%,0,0
4283,),0,0
4284,in,0,0
4285,the,0,0
4286,control,0,0
4287,group,0,0
4288,.,0,0
4289,The,0,0
4290,difference,0,0
4291,in,0,0
4292,the,0,0
4293,median,0,0
4294,annual,0,0
4295,change,0,0
4296,between,0,0
4297,the,0,0
4298,two,0,0
4299,groups,0,0
4300,was,0,0
4301,significant,0,0
4302,(,0,0
4303,P,0,0
4304,=,0,0
4305,0.013,0,0
4306,),0,0
4307,.,0,0
4308,For,0,0
4309,women,0,0
4310,",",0,0
4311,the,0,0
4312,mean,0,0
4313,annual,0,0
4314,change,0,0
4315,in,0,0
4316,BMD,0,0
4317,was,0,0
4318,-0.5,0,0
4319,%,0,0
4320,in,0,0
4321,the,0,0
4322,treated,0,0
4323,group,0,0
4324,and,0,0
4325,-2.3,0,0
4326,%,0,0
4327,in,0,0
4328,the,0,0
4329,control,0,0
4330,group,0,0
4331,.,0,0
4332,The,0,0
4333,median,0,0
4334,(,0,0
4335,25th,0,0
4336,and,0,0
4337,75th,0,0
4338,percentiles,0,0
4339,),0,0
4340,annual,0,0
4341,change,0,0
4342,in,0,0
4343,BMD,0,0
4344,was,0,0
4345,-0.5,0,0
4346,(,0,0
4347,-1.8,0,0
4348,",",0,0
4349,1.3,0,0
4350,%,0,0
4351,),0,0
4352,in,0,0
4353,the,0,0
4354,treated,0,0
4355,group,0,0
4356,and,0,0
4357,-1.5,0,0
4358,(,0,0
4359,-3.8,0,0
4360,",",0,0
4361,-0.7,0,0
4362,%,0,0
4363,),0,0
4364,in,0,0
4365,the,0,0
4366,control,0,0
4367,group,0,0
4368,.,0,0
4369,This,0,0
4370,difference,0,0
4371,was,0,0
4372,significant,0,0
4373,(,0,0
4374,P,0,0
4375,=,0,0
4376,0.011,0,0
4377,),0,0
4378,.,0,0
4379,CONCLUSIONS,0,0
4380,Our,0,0
4381,results,0,0
4382,suggest,0,0
4383,that,0,0
4384,calcitriol,0,0
4385,can,0,0
4386,prevent,0,0
4387,bone,0,0
4388,loss,0,0
4389,and,0,0
4390,",",0,0
4391,therefore,0,0
4392,",",0,0
4393,may,0,0
4394,be,0,0
4395,useful,0,0
4396,for,0,0
4397,the,0,0
4398,treatment,0,0
4399,of,0,0
4400,bone,0,0
4401,disease,0,0
4402,in,0,0
4403,patients,0,0
4404,with,0,0
4405,cirrhosis,0,0
4406,of,0,0
4407,the,0,0
4408,liver,0,0
4409,.,0,0
4410,Moderate-intensity,1,1
4411,exercise,1,1
4412,training,1,1
4413,with,0,0
4414,elements,0,0
4415,of,0,0
4416,step,0,0
4417,aerobics,0,1
4418,in,0,0
4419,patients,0,0
4420,with,0,0
4421,severe,0,0
4422,chronic,0,0
4423,heart,0,0
4424,failure,0,0
4425,.,0,0
4426,OBJECTIVE,0,0
4427,To,0,0
4428,evaluate,0,0
4429,whether,0,0
4430,a,0,0
4431,specific,0,0
4432,program,0,1
4433,of,0,0
4434,moderate-intensity,1,0
4435,step,1,0
4436,aerobics,1,1
4437,training,1,1
4438,may,0,0
4439,be,0,0
4440,sufficient,0,0
4441,to,0,0
4442,improve,0,0
4443,the,0,0
4444,exercise,0,1
4445,tolerance,0,0
4446,of,0,0
4447,patients,0,0
4448,with,0,0
4449,severe,0,0
4450,chronic,0,0
4451,heart,0,0
4452,failure,0,0
4453,.,0,0
4454,PATIENTS,0,0
4455,Twenty-six,0,0
4456,patients,0,0
4457,(,0,0
4458,22,0,0
4459,men,0,0
4460,",",0,0
4461,4,0,0
4462,women,0,0
4463,;,0,0
4464,mean,0,0
4465,+/-,0,0
4466,SD,0,0
4467,age,0,0
4468,",",0,0
4469,54,0,0
4470,+/-,0,0
4471,9yrs,0,0
4472,),0,0
4473,with,0,0
4474,a,0,0
4475,history,0,0
4476,of,0,0
4477,severe,0,0
4478,chronic,0,0
4479,heart,0,0
4480,failure,0,0
4481,(,0,0
4482,left,0,0
4483,ventricular,0,0
4484,ejection,0,0
4485,fraction,0,0
4486,of,0,0
4487,18,0,0
4488,%,0,0
4489,+/-,0,0
4490,8,0,0
4491,%,0,0
4492,),0,0
4493,.,0,0
4494,STUDY,0,0
4495,DESIGN,0,0
4496,Prospective,0,0
4497,",",0,0
4498,randomized,0,0
4499,",",0,0
4500,controlled,0,0
4501,trial,0,0
4502,.,0,0
4503,Patients,0,0
4504,were,0,0
4505,randomized,0,0
4506,into,0,0
4507,exercise,0,1
4508,and,0,0
4509,control,0,0
4510,groups,0,0
4511,.,0,0
4512,All,0,0
4513,patients,0,0
4514,underwent,0,0
4515,a,0,0
4516,clinical,0,0
4517,examination,0,0
4518,and,0,0
4519,a,0,0
4520,ramp,0,0
4521,pattern,0,0
4522,cycle,0,0
4523,exercise,0,1
4524,test,0,0
4525,before,0,0
4526,and,0,0
4527,after,0,0
4528,the,0,0
4529,observation,0,0
4530,period,0,0
4531,.,0,0
4532,The,0,0
4533,exercise,0,1
4534,group,0,0
4535,underwent,0,0
4536,a,0,0
4537,moderate-intensity,1,1
4538,(,1,0
4539,50,1,0
4540,%,1,0
4541,of,1,0
4542,peak,1,0
4543,oxygen,1,1
4544,uptake,1,0
4545,),1,0
4546,12-week,1,1
4547,training,1,1
4548,program,1,1
4549,",",1,0
4550,progressing,1,0
4551,to,1,0
4552,100,1,0
4553,minutes,1,0
4554,per,1,0
4555,week,1,0
4556,of,1,0
4557,step,1,0
4558,aerobics,1,1
4559,and,1,0
4560,50,1,0
4561,minutes,1,0
4562,per,1,0
4563,week,1,0
4564,of,1,0
4565,cycling,1,0
4566,.,1,0
4567,The,0,0
4568,control,0,0
4569,group,0,0
4570,did,0,0
4571,not,0,0
4572,perform,1,0
4573,a,1,0
4574,training,1,1
4575,program,1,1
4576,.,1,0
4577,MAIN,0,0
4578,OUTCOME,0,0
4579,MEASURES,0,0
4580,Peak,0,0
4581,oxygen,0,1
4582,uptake,0,0
4583,",",0,0
4584,peak,0,0
4585,workload,0,0
4586,",",0,0
4587,percent,0,0
4588,of,0,0
4589,predicted,0,0
4590,power,0,0
4591,ability,0,0
4592,.,0,0
4593,RESULTS,0,0
4594,Significant,0,0
4595,increases,0,0
4596,in,0,0
4597,peak,0,0
4598,oxygen,0,1
4599,uptake,0,0
4600,(,0,0
4601,15,0,0
4602,+/-,0,0
4603,3.4,0,0
4604,to,0,0
4605,18.5,0,0
4606,+/-,0,0
4607,2.9mL/kg/min,0,0
4608,;,0,0
4609,p,0,0
4610,=,0,0
4611,.001,0,0
4612,),0,0
4613,",",0,0
4614,peak,0,0
4615,workload,0,0
4616,(,0,0
4617,77,0,0
4618,+/-,0,0
4619,26,0,0
4620,to,0,0
4621,99,0,0
4622,+/-,0,0
4623,31,0,0
4624,watts,0,0
4625,;,0,0
4626,p,0,0
4627,=,0,0
4628,.000,0,0
4629,),0,0
4630,",",0,0
4631,and,0,0
4632,percent,0,0
4633,of,0,0
4634,predicted,0,0
4635,power,0,0
4636,ability,0,0
4637,(,0,0
4638,43,0,0
4639,%,0,0
4640,+/-,0,0
4641,10,0,0
4642,%,0,0
4643,to,0,0
4644,56,0,0
4645,%,0,0
4646,+/-,0,0
4647,13,0,0
4648,%,0,0
4649,;,0,0
4650,p,0,0
4651,=,0,0
4652,.000,0,0
4653,),0,0
4654,were,0,0
4655,observed,0,0
4656,in,0,0
4657,the,0,0
4658,exercise,0,1
4659,group,0,0
4660,.,0,0
4661,No,0,0
4662,significant,0,0
4663,changes,0,0
4664,in,0,0
4665,baseline,0,0
4666,parameters,0,0
4667,occurred,0,0
4668,in,0,0
4669,the,0,0
4670,control,0,0
4671,group,0,0
4672,.,0,0
4673,There,0,0
4674,were,0,0
4675,no,0,0
4676,critical,0,0
4677,changes,0,0
4678,in,0,0
4679,heart,0,0
4680,rate,0,0
4681,or,0,1
4682,blood,0,0
4683,pressure,0,0
4684,in,0,0
4685,either,0,0
4686,group,0,0
4687,.,0,0
4688,CONCLUSION,0,0
4689,Moderate-intensity,0,1
4690,step,0,0
4691,aerobics,0,1
4692,training,0,1
4693,significantly,0,0
4694,increases,0,0
4695,peak,0,0
4696,oxygen,0,1
4697,uptake,0,0
4698,and,0,0
4699,peak,0,0
4700,workloads,0,0
4701,in,0,0
4702,patients,0,0
4703,with,0,0
4704,severe,0,0
4705,chronic,0,0
4706,heart,0,0
4707,failure,0,0
4708,.,0,0
4709,The,0,0
4710,role,0,0
4711,of,0,0
4712,somatostatin,1,1
4713,(,1,0
4714,octreotide,1,1
4715,),1,0
4716,in,0,0
4717,the,0,0
4718,regulation,0,0
4719,of,0,0
4720,melatonin,0,1
4721,secretion,0,0
4722,in,0,0
4723,healthy,0,0
4724,volunteers,0,0
4725,and,0,0
4726,in,0,0
4727,patients,0,0
4728,with,0,0
4729,primary,0,0
4730,hypothyroidism,0,0
4731,.,0,0
4732,Somatostatin,1,1
4733,has,0,0
4734,been,0,0
4735,found,0,0
4736,in,0,0
4737,the,0,0
4738,pineal,0,0
4739,gland,0,0
4740,of,0,0
4741,several,0,0
4742,animal,0,0
4743,species,0,0
4744,",",0,0
4745,which,0,0
4746,suggests,0,0
4747,that,0,0
4748,it,0,0
4749,may,0,0
4750,be,0,0
4751,involved,0,0
4752,in,0,0
4753,the,0,0
4754,regulation,0,0
4755,of,0,0
4756,melatonin,0,1
4757,secretion,0,0
4758,.,0,0
4759,Whether,0,0
4760,somatostatin,1,1
4761,has,0,0
4762,regulatory,0,0
4763,influence,0,0
4764,on,0,0
4765,melatonin,0,1
4766,secretion,0,0
4767,in,0,0
4768,man,0,0
4769,has,0,0
4770,never,0,0
4771,been,0,0
4772,unequivocally,0,0
4773,shown,0,0
4774,.,0,0
4775,We,0,0
4776,studied,0,0
4777,the,0,0
4778,nocturnal,0,0
4779,melatonin,0,1
4780,secretion,0,0
4781,in,0,0
4782,8,0,0
4783,healthy,0,0
4784,volunteers,0,0
4785,",",0,0
4786,and,0,0
4787,6,0,0
4788,women,0,0
4789,with,0,0
4790,untreated,0,0
4791,primary,0,0
4792,hypothyroidism,0,0
4793,",",0,0
4794,a,0,0
4795,disease,0,0
4796,state,0,0
4797,that,0,0
4798,is,0,0
4799,associated,0,0
4800,with,0,0
4801,increased,0,0
4802,nocturnal,0,0
4803,secretion,0,0
4804,of,0,0
4805,melatonin,0,1
4806,.,0,0
4807,The,0,0
4808,participants,0,0
4809,were,0,0
4810,given,0,0
4811,subcutaneous,0,0
4812,injections,0,1
4813,at,0,0
4814,18:00,0,0
4815,h,0,0
4816,and,0,0
4817,23:00,0,0
4818,h,0,0
4819,of,0,0
4820,either,0,0
4821,saline,1,1
4822,or,1,1
4823,octreotide,1,1
4824,(,1,0
4825,Sandostatin,1,1
4826,;,1,0
4827,each,0,0
4828,injection,0,1
4829,50,0,0
4830,microg,0,0
4831,),0,0
4832,.,0,0
4833,During,0,0
4834,the,0,0
4835,nights,0,0
4836,when,0,0
4837,the,0,0
4838,healthy,0,0
4839,volunteers,0,0
4840,were,0,0
4841,given,0,0
4842,octreotide,1,1
4843,",",0,0
4844,melatonin,0,1
4845,secretion,0,0
4846,was,0,0
4847,similar,0,0
4848,to,0,0
4849,that,0,0
4850,recorded,0,0
4851,during,0,0
4852,administration,0,0
4853,of,0,0
4854,saline,1,1
4855,.,1,0
4856,Also,0,0
4857,the,0,0
4858,urinary,0,0
4859,excretion,0,0
4860,of,0,0
4861,melatonin,0,1
4862,was,0,0
4863,of,0,0
4864,similar,0,0
4865,magnitude,0,0
4866,at,0,0
4867,these,0,0
4868,two,0,0
4869,occasions,0,0
4870,.,0,0
4871,By,0,0
4872,contrast,0,0
4873,",",0,0
4874,the,0,0
4875,GH,0,1
4876,secretion,0,0
4877,was,0,0
4878,significantly,0,0
4879,lower,0,0
4880,the,0,0
4881,nights,0,0
4882,the,0,0
4883,healthy,0,0
4884,controls,0,0
4885,were,0,0
4886,given,0,0
4887,octreotide,1,1
4888,(,0,0
4889,GH,0,1
4890,AUC,0,0
4891,22.6+/-5.4,0,0
4892,mU/l,0,0
4893,x,0,0
4894,h,0,0
4895,during,0,0
4896,octreotide,1,1
4897,and,0,0
4898,126.6+/-21.9,0,0
4899,mU/l,0,0
4900,x,0,0
4901,h,0,1
4902,during,0,0
4903,saline,1,1
4904,;,1,0
4905,p,0,0
4906,<,0,0
4907,0.01,0,0
4908,),0,0
4909,.,0,0
4910,The,0,0
4911,patients,0,0
4912,with,0,0
4913,hypothyroidism,0,0
4914,also,0,0
4915,showed,0,0
4916,similar,0,0
4917,nocturnal,0,0
4918,melatonin,0,1
4919,secretion,0,0
4920,during,0,0
4921,octreotide,1,1
4922,and,0,0
4923,saline,1,1
4924,.,1,0
4925,Urinary,0,0
4926,excretion,0,0
4927,of,0,0
4928,melatonin,0,1
4929,also,0,0
4930,remained,0,0
4931,unchanged,0,0
4932,",",0,0
4933,as,0,0
4934,did,0,0
4935,GH,0,1
4936,secretion,0,0
4937,.,0,0
4938,The,0,0
4939,total,0,0
4940,nocturnal,0,0
4941,secretion,0,0
4942,of,0,0
4943,TSH,0,0
4944,was,0,0
4945,",",0,0
4946,however,0,0
4947,",",0,0
4948,significantly,0,0
4949,reduced,0,0
4950,by,0,0
4951,octreotide,1,1
4952,(,0,0
4953,TSH,0,0
4954,AUC,0,0
4955,562+/-136,0,0
4956,mU/l,0,0
4957,x,0,0
4958,h,0,0
4959,during,0,0
4960,octreotide,1,1
4961,and,0,0
4962,851+/-185,0,0
4963,mU/l,0,0
4964,x,0,0
4965,h,0,1
4966,during,0,0
4967,saline,1,1
4968,;,1,0
4969,p,0,0
4970,<,0,0
4971,0.05,0,0
4972,),0,0
4973,",",0,0
4974,thus,0,0
4975,suggesting,0,0
4976,that,0,0
4977,100,0,0
4978,microg,0,0
4979,of,0,0
4980,octreotide,1,1
4981,should,0,0
4982,be,0,0
4983,sufficient,0,0
4984,to,0,0
4985,inhibit,0,0
4986,also,0,0
4987,the,0,0
4988,pinealocytes,0,0
4989,if,0,0
4990,their,0,0
4991,function,0,0
4992,were,0,0
4993,regulated,0,0
4994,by,0,0
4995,somatostatin,1,1
4996,.,1,0
4997,Since,0,0
4998,exogenous,0,0
4999,somatostatin,1,1
5000,--,1,0
5001,in,1,0
5002,the,0,0
5003,form,0,0
5004,of,0,0
5005,octreotide,1,1
5006,--,1,0
5007,fails,1,0
5008,to,0,0
5009,influence,0,0
5010,nocturnal,0,0
5011,secretion,0,0
5012,and,0,0
5013,urinary,0,0
5014,excretion,0,0
5015,of,0,0
5016,melatonin,0,1
5017,in,0,0
5018,normal,0,0
5019,subjects,0,0
5020,and,0,0
5021,in,0,0
5022,patients,0,0
5023,with,0,0
5024,primary,0,0
5025,hypothyroidism,0,0
5026,",",0,0
5027,it,0,0
5028,is,0,0
5029,reasonable,0,0
5030,to,0,0
5031,assume,0,0
5032,that,0,0
5033,endogenous,0,0
5034,somatostatin,1,1
5035,may,0,0
5036,not,0,0
5037,be,0,0
5038,an,0,0
5039,important,0,0
5040,regulator,0,0
5041,of,0,0
5042,melatonin,0,1
5043,secretion,0,0
5044,in,0,0
5045,man,0,0
5046,.,0,0
5047,Chemotherapy,1,1
5048,for,0,0
5049,operable,0,0
5050,gastric,0,0
5051,cancer,0,0
5052,:,0,0
5053,results,0,0
5054,of,0,0
5055,the,0,0
5056,Dutch,0,1
5057,randomised,0,0
5058,FAMTX,0,0
5059,trial,0,0
5060,.,0,0
5061,The,0,0
5062,Dutch,0,0
5063,Gastric,0,0
5064,Cancer,0,1
5065,Group,0,0
5066,(,0,0
5067,DGCG,0,1
5068,),0,0
5069,.,0,0
5070,The,0,0
5071,aim,0,0
5072,of,0,0
5073,this,0,0
5074,trial,0,0
5075,was,0,0
5076,to,0,0
5077,investigate,0,0
5078,whether,0,0
5079,pre-operative,0,0
5080,chemotherapy,1,1
5081,leads,0,0
5082,to,0,0
5083,a,0,0
5084,15,0,0
5085,%,0,0
5086,higher,0,0
5087,curative,0,0
5088,resectability,0,0
5089,rate,0,0
5090,in,0,0
5091,patients,0,0
5092,with,0,0
5093,operable,0,0
5094,gastric,0,0
5095,cancer,0,0
5096,.,0,0
5097,In,0,0
5098,this,0,0
5099,randomised,0,0
5100,trial,0,0
5101,",",0,0
5102,patients,0,0
5103,were,0,0
5104,allocated,0,0
5105,to,0,0
5106,receive,0,0
5107,either,0,0
5108,four,0,0
5109,courses,0,0
5110,of,0,0
5111,chemotherapy,1,1
5112,using,1,0
5113,5-fluorouracil,1,1
5114,",",1,0
5115,doxorubicin,1,1
5116,and,1,0
5117,methotrexate,1,1
5118,(,1,1
5119,FAMTX,1,0
5120,),1,0
5121,prior,1,0
5122,to,1,0
5123,surgery,1,0
5124,or,1,0
5125,to,1,0
5126,undergo,1,0
5127,surgery,1,0
5128,only,1,0
5129,.,1,0
5130,Patients,0,0
5131,younger,0,0
5132,than,0,0
5133,75,0,0
5134,years,0,0
5135,of,0,0
5136,age,0,0
5137,with,0,0
5138,a,0,0
5139,good,0,0
5140,physical,0,0
5141,and,0,0
5142,mental,0,0
5143,condition,0,0
5144,and,0,0
5145,a,0,0
5146,histologically,0,0
5147,proven,0,0
5148,adenocarcinoma,0,0
5149,of,0,0
5150,the,0,0
5151,stomach,0,0
5152,without,0,0
5153,clinical,0,0
5154,or,0,1
5155,radiographic,0,0
5156,(,0,0
5157,computed,0,1
5158,tomography,0,1
5159,scan,0,1
5160,),0,0
5161,evidence,0,0
5162,of,0,0
5163,distant,0,0
5164,metastases,0,0
5165,were,0,0
5166,eligible,0,0
5167,for,0,0
5168,this,0,0
5169,trial,0,0
5170,.,0,0
5171,Early,0,0
5172,gastric,0,0
5173,cancer,0,0
5174,or,0,1
5175,cardia,0,0
5176,carcinoma,0,0
5177,were,0,0
5178,excluded,0,0
5179,.,0,0
5180,The,1,0
5181,response,1,0
5182,to,1,0
5183,chemotherapy,1,1
5184,was,1,0
5185,evaluated,1,0
5186,after,1,0
5187,two,1,0
5188,and,1,0
5189,four,1,0
5190,courses,1,0
5191,.,1,0
5192,In,0,0
5193,case,0,0
5194,of,0,0
5195,progressive,0,1
5196,disease,0,0
5197,(,0,0
5198,PD,0,0
5199,),0,0
5200,after,0,0
5201,two,0,0
5202,courses,0,0
5203,",",0,0
5204,patients,0,0
5205,were,0,0
5206,operated,0,0
5207,upon,0,0
5208,as,0,0
5209,soon,0,0
5210,as,0,0
5211,possible,0,0
5212,.,0,0
5213,Otherwise,0,0
5214,complete,0,0
5215,response,0,0
5216,(,0,0
5217,CR,0,1
5218,),0,0
5219,partial,0,0
5220,response,0,0
5221,(,0,0
5222,PR,0,1
5223,),0,1
5224,or,0,1
5225,stable,0,0
5226,disease,0,0
5227,(,0,0
5228,SD,0,0
5229,),0,0
5230,",",0,0
5231,two,0,0
5232,more,0,0
5233,courses,0,0
5234,were,0,0
5235,scheduled,0,0
5236,.,0,0
5237,The,0,0
5238,standard,0,0
5239,surgical,0,0
5240,procedure,0,0
5241,was,0,0
5242,a,0,0
5243,limited,0,0
5244,lymphadenectomy,0,1
5245,(,0,0
5246,D1,0,1
5247,),0,0
5248,with,0,0
5249,staging,0,0
5250,biopsy,0,1
5251,of,0,0
5252,the,0,0
5253,para-aortic,0,0
5254,lymph,0,0
5255,nodes,0,0
5256,.,0,0
5257,Between,0,0
5258,September,0,0
5259,1993,0,0
5260,and,0,0
5261,February,0,0
5262,1996,0,0
5263,",",0,0
5264,56,0,0
5265,eligible,0,0
5266,and,0,0
5267,evaluable,0,0
5268,patients,0,0
5269,were,0,0
5270,entered,0,0
5271,:,0,0
5272,27,0,0
5273,were,0,0
5274,randomised,0,0
5275,to,0,0
5276,receive,0,0
5277,FAMTX,0,0
5278,before,0,0
5279,surgery,0,0
5280,and,0,0
5281,29,0,0
5282,to,0,0
5283,undergo,0,0
5284,surgery,0,0
5285,only,0,0
5286,.,0,0
5287,In,0,0
5288,the,0,0
5289,FAMTX,0,0
5290,+,0,1
5291,surgery,0,1
5292,treatment,0,0
5293,group,0,0
5294,",",0,0
5295,15/27,0,0
5296,(,0,0
5297,56,0,0
5298,%,0,0
5299,),0,0
5300,had,0,0
5301,curative,0,0
5302,resections,0,0
5303,versus,0,0
5304,18/29,0,0
5305,(,0,0
5306,62,0,0
5307,%,0,0
5308,),0,0
5309,in,0,0
5310,the,0,0
5311,surgery,0,0
5312,only,0,0
5313,arm,0,0
5314,.,0,0
5315,There,0,0
5316,was,0,0
5317,no,0,0
5318,difference,0,0
5319,in,0,0
5320,the,0,0
5321,frequency,0,0
5322,of,0,0
5323,TNM,0,0
5324,stages,0,0
5325,I,0,0
5326,+,0,0
5327,II,0,0
5328,in,0,0
5329,both,0,0
5330,treatment,0,0
5331,arms,0,0
5332,:,0,0
5333,15/27,0,0
5334,versus,0,0
5335,15/29,0,0
5336,.,0,0
5337,Due,0,1
5338,to,0,0
5339,PD,0,0
5340,and/or,0,0
5341,toxicity,0,0
5342,",",0,0
5343,12,0,0
5344,patients,0,0
5345,(,0,0
5346,44,0,0
5347,%,0,0
5348,),0,0
5349,could,0,0
5350,not,0,0
5351,complete,0,0
5352,the,0,0
5353,planned,0,0
5354,four,0,0
5355,courses,0,0
5356,of,0,0
5357,FAMTX,0,0
5358,.,0,0
5359,Response,0,0
5360,evaluation,0,0
5361,after,0,0
5362,chemotherapy,0,1
5363,was,0,0
5364,possible,0,0
5365,in,0,0
5366,25,0,0
5367,patients,0,0
5368,:,0,0
5369,2,0,0
5370,CR,0,1
5371,",",0,0
5372,6,0,0
5373,PR,0,0
5374,",",0,0
5375,8,0,0
5376,SD,0,0
5377,and,0,0
5378,9,0,0
5379,PD,0,0
5380,.,0,0
5381,The,0,0
5382,difference,0,0
5383,in,0,0
5384,curative,0,0
5385,resectability,0,0
5386,rate,0,0
5387,was,0,0
5388,6.5,0,0
5389,%,0,0
5390,(,0,0
5391,95,0,0
5392,%,0,0
5393,confidence,0,0
5394,interval,0,0
5395,-32,0,0
5396,to,0,0
5397,+19,0,0
5398,%,0,0
5399,),0,0
5400,in,0,0
5401,favour,0,0
5402,of,0,0
5403,surgery,0,0
5404,only,0,0
5405,.,0,0
5406,Downstaging,0,0
5407,for,0,0
5408,stages,0,0
5409,I,0,0
5410,+,0,0
5411,II,0,0
5412,did,0,0
5413,not,0,0
5414,occur,0,0
5415,.,0,0
5416,PD,0,0
5417,was,0,0
5418,more,0,0
5419,often,0,0
5420,the,0,0
5421,reason,0,0
5422,for,0,0
5423,not,0,0
5424,completing,0,0
5425,the,0,0
5426,planned,0,0
5427,four,0,0
5428,courses,0,0
5429,than,0,0
5430,toxicity,0,0
5431,.,0,0
5432,More,0,0
5433,active,0,0
5434,regimens,0,0
5435,than,0,0
5436,FAMTX,1,0
5437,are,0,0
5438,required,0,0
5439,for,0,0
5440,future,0,0
5441,randomised,0,0
5442,trials,0,0
5443,.,0,0
5444,Barriers,0,0
5445,to,0,0
5446,hypertension,0,0
5447,care,0,1
5448,and,0,0
5449,control,0,0
5450,in,0,0
5451,young,0,0
5452,urban,0,0
5453,black,0,0
5454,men,0,0
5455,.,0,0
5456,Barriers,0,0
5457,to,0,0
5458,high,0,0
5459,blood,0,0
5460,pressure,0,0
5461,(,0,0
5462,HBP,0,0
5463,),0,1
5464,care,0,1
5465,and,0,0
5466,control,0,0
5467,have,0,0
5468,been,0,0
5469,reported,0,0
5470,in,0,0
5471,the,0,0
5472,literature,0,0
5473,for,0,0
5474,>,0,0
5475,30,0,0
5476,years,0,0
5477,.,0,0
5478,Few,0,0
5479,reports,0,0
5480,on,0,0
5481,barriers,0,0
5482,",",0,0
5483,however,0,0
5484,",",0,0
5485,have,0,0
5486,focused,0,0
5487,on,0,0
5488,the,0,0
5489,young,0,0
5490,black,0,0
5491,man,0,0
5492,with,0,0
5493,HBP,0,0
5494,",",0,0
5495,the,0,0
5496,age/sex/race,0,0
5497,group,0,0
5498,with,0,0
5499,the,0,0
5500,highest,0,0
5501,rates,0,0
5502,of,0,0
5503,early,0,0
5504,severe,0,0
5505,and,0,0
5506,complicated,0,0
5507,HBP,0,0
5508,and,0,0
5509,the,0,0
5510,lowest,0,0
5511,rates,0,0
5512,of,0,0
5513,awareness,0,0
5514,",",0,0
5515,treatment,0,0
5516,",",0,0
5517,and,0,0
5518,control,0,0
5519,.,0,0
5520,In,0,0
5521,a,0,0
5522,randomized,0,0
5523,clinical,0,0
5524,trial,0,0
5525,of,0,0
5526,comprehensive,0,0
5527,care,0,0
5528,for,0,0
5529,hypertensive,0,0
5530,young,0,0
5531,urban,0,0
5532,black,0,0
5533,men,0,0
5534,",",0,0
5535,factors,0,0
5536,potentially,0,0
5537,associated,0,0
5538,with,0,0
5539,care,0,1
5540,and,0,0
5541,control,0,0
5542,were,0,0
5543,assessed,0,0
5544,at,0,0
5545,baseline,0,0
5546,for,0,0
5547,the,0,0
5548,309,0,0
5549,enrolled,0,0
5550,men,0,0
5551,.,0,0
5552,A,0,0
5553,majority,0,0
5554,of,0,0
5555,the,0,0
5556,men,0,0
5557,encountered,0,0
5558,a,0,0
5559,variety,0,0
5560,of,0,0
5561,barriers,0,0
5562,including,0,0
5563,economic,0,0
5564,",",0,0
5565,social,0,0
5566,",",0,0
5567,and,0,0
5568,lifestyle,0,1
5569,obstacles,0,0
5570,to,0,0
5571,adequate,0,0
5572,BP,0,0
5573,care,0,1
5574,and,0,0
5575,control,0,1
5576,",",0,0
5577,including,0,0
5578,no,0,0
5579,current,0,0
5580,HBP,0,0
5581,care,0,1
5582,(,0,0
5583,49,0,0
5584,%,0,0
5585,),0,0
5586,",",0,0
5587,risk,0,0
5588,of,0,0
5589,alcoholism,0,0
5590,(,0,0
5591,62,0,0
5592,%,0,0
5593,),0,0
5594,",",0,0
5595,use,0,0
5596,of,0,0
5597,illicit,0,0
5598,drugs,0,1
5599,(,0,0
5600,45,0,0
5601,%,0,0
5602,),0,0
5603,",",0,0
5604,social,0,1
5605,isolation,0,0
5606,(,0,0
5607,47,0,0
5608,%,0,0
5609,),0,0
5610,",",0,0
5611,unemployment,0,0
5612,(,0,0
5613,40,0,0
5614,%,0,0
5615,),0,0
5616,",",0,0
5617,and,0,0
5618,lack,0,0
5619,of,0,0
5620,health,0,0
5621,insurance,0,0
5622,(,0,0
5623,51,0,0
5624,%,0,0
5625,),0,0
5626,.,0,0
5627,Having,0,0
5628,health,0,0
5629,insurance,0,1
5630,(,0,0
5631,odds,0,0
5632,ratio,0,0
5633,=,0,0
5634,7.20,0,0
5635,",",0,0
5636,P,0,0
5637,=,0,0
5638,.00,0,0
5639,),0,0
5640,and,0,0
5641,a,0,0
5642,negative,0,0
5643,urine,0,0
5644,drug,0,1
5645,screen,0,0
5646,(,0,0
5647,odds,0,0
5648,ratio,0,0
5649,=,0,0
5650,.56,0,0
5651,",",0,0
5652,P,0,0
5653,=,0,0
5654,.04,0,0
5655,),0,0
5656,were,0,0
5657,significant,0,0
5658,predictors,0,0
5659,of,0,0
5660,being,0,0
5661,in,0,0
5662,HBP,0,0
5663,care,0,0
5664,.,0,0
5665,Low,0,0
5666,alcoholism,0,0
5667,risk,0,0
5668,and,0,0
5669,employment,0,0
5670,were,0,0
5671,identified,0,0
5672,as,0,0
5673,significant,0,0
5674,predictors,0,0
5675,of,0,0
5676,compliance,0,0
5677,with,0,0
5678,HBP,0,0
5679,medication-taking,0,1
5680,behavior,0,0
5681,.,0,0
5682,Men,0,0
5683,currently,0,0
5684,using,0,0
5685,illicit,0,0
5686,drugs,0,1
5687,were,0,0
5688,2.64,0,0
5689,times,0,0
5690,less,0,0
5691,likely,0,0
5692,to,0,0
5693,have,0,0
5694,controlled,0,0
5695,BP,0,0
5696,compared,0,0
5697,with,0,0
5698,their,0,0
5699,counterparts,0,0
5700,who,0,0
5701,did,0,0
5702,not,0,0
5703,use,0,0
5704,illicit,0,0
5705,drugs,0,0
5706,",",0,0
5707,and,0,0
5708,men,0,0
5709,currently,0,0
5710,taking,0,0
5711,HBP,0,0
5712,medication,0,0
5713,were,0,0
5714,63,0,0
5715,times,0,0
5716,more,0,0
5717,likely,0,0
5718,have,0,0
5719,controlled,0,0
5720,BP,0,0
5721,compared,0,0
5722,with,0,0
5723,men,0,0
5724,not,0,0
5725,taking,0,0
5726,HBP,0,0
5727,medication,0,1
5728,.,0,0
5729,Comprehensive,1,0
5730,interventions,1,0
5731,are,0,0
5732,needed,0,0
5733,to,0,0
5734,address,0,0
5735,socioeconomic,0,0
5736,and,0,0
5737,lifestyle,0,1
5738,issues,0,0
5739,as,0,0
5740,well,0,0
5741,as,0,0
5742,other,0,0
5743,barriers,0,0
5744,to,0,0
5745,care,0,0
5746,and,0,0
5747,treatment,0,0
5748,",",0,0
5749,if,0,0
5750,HBP,0,0
5751,care,0,1
5752,is,0,0
5753,to,0,0
5754,be,0,0
5755,salient,0,0
5756,and,0,0
5757,effective,0,0
5758,in,0,0
5759,this,0,0
5760,high,0,0
5761,risk,0,0
5762,group,0,0
5763,.,0,0
5764,Clinical,0,0
5765,effects,0,0
5766,of,0,0
5767,root,0,0
5768,instrumentation,0,0
5769,using,0,0
5770,conventional,0,1
5771,steel,0,1
5772,or,0,1
5773,non-tooth,0,1
5774,substance,0,0
5775,removing,0,1
5776,plastic,0,1
5777,curettes,0,1
5778,during,0,0
5779,supportive,0,0
5780,periodontal,0,0
5781,therapy,0,1
5782,(,0,0
5783,SPT,0,0
5784,),0,0
5785,.,0,0
5786,Although,0,0
5787,root,0,0
5788,instrumentation,0,0
5789,has,0,0
5790,been,0,0
5791,accepted,0,0
5792,as,0,0
5793,the,0,0
5794,most,0,0
5795,important,0,0
5796,cause-related,0,0
5797,treatment,0,0
5798,of,0,0
5799,periodontal,0,0
5800,diseases,0,0
5801,",",0,0
5802,repeated,0,0
5803,scaling,0,0
5804,and,0,0
5805,root,0,0
5806,planing,0,1
5807,may,0,0
5808,over,0,0
5809,time,0,0
5810,result,0,0
5811,in,0,0
5812,substantive,0,0
5813,loss,0,0
5814,of,0,0
5815,tooth,0,0
5816,substance,0,0
5817,and,0,0
5818,increased,0,0
5819,sensitivity,0,0
5820,of,0,0
5821,the,0,0
5822,teeth,0,0
5823,.,0,0
5824,In,0,0
5825,an,0,0
5826,effort,0,0
5827,to,0,0
5828,minimize,0,0
5829,these,0,0
5830,side,0,0
5831,effects,0,0
5832,of,0,0
5833,therapy,0,1
5834,",",0,0
5835,non-root,0,0
5836,substance,0,0
5837,removing,0,0
5838,curettes,0,1
5839,have,0,0
5840,been,0,0
5841,developed,0,0
5842,.,0,0
5843,However,0,0
5844,",",0,0
5845,the,0,0
5846,clinical,0,0
5847,effects,0,0
5848,of,0,0
5849,such,0,0
5850,plastic,0,1
5851,curettes,0,1
5852,with,0,0
5853,regard,0,0
5854,to,0,0
5855,the,0,0
5856,control,0,0
5857,of,0,0
5858,the,0,0
5859,periodontal,0,0
5860,infection,0,0
5861,has,0,0
5862,not,0,0
5863,yet,0,0
5864,been,0,0
5865,established,0,0
5866,.,0,0
5867,The,0,0
5868,aims,0,0
5869,of,0,0
5870,this,0,0
5871,study,0,0
5872,were,0,0
5873,",",0,0
5874,therefore,0,0
5875,",",0,0
5876,to,0,0
5877,compare,0,0
5878,the,0,0
5879,effects,0,0
5880,of,0,0
5881,root,0,0
5882,instrumentation,0,0
5883,using,0,0
5884,plastic,1,1
5885,curettes,1,1
5886,(,0,0
5887,Universal,0,0
5888,Perio,0,1
5889,Soft,0,1
5890,Scaler,0,1
5891,",",0,0
5892,Hawe-Neos,0,0
5893,Dental,0,0
5894,",",0,0
5895,Bioggio,0,0
5896,",",0,0
5897,TI,0,0
5898,",",0,0
5899,Switzerland,0,0
5900,),0,0
5901,versus,0,0
5902,conventional,1,1
5903,steel,1,1
5904,curettes,1,1
5905,on,0,0
5906,the,0,0
5907,periodontal,0,0
5908,conditions,0,0
5909,during,0,0
5910,supportive,0,0
5911,periodontal,0,0
5912,therapy,0,1
5913,.,0,0
5914,40,0,0
5915,subjects,0,0
5916,participated,0,0
5917,in,0,0
5918,this,0,0
5919,parallel,0,0
5920,",",0,0
5921,randomized,0,0
5922,",",0,0
5923,double,0,0
5924,blind,0,0
5925,",",0,0
5926,prospective,0,0
5927,longitudinal,0,0
5928,clinical,0,0
5929,study,0,0
5930,following,0,0
5931,active,0,0
5932,peridontal,0,0
5933,therapy,0,1
5934,.,0,0
5935,20,0,0
5936,subjects,0,0
5937,served,0,0
5938,as,0,0
5939,a,0,0
5940,control,1,1
5941,group,1,0
5942,and,0,0
5943,were,0,0
5944,treated,1,0
5945,with,1,0
5946,conventional,1,1
5947,steel,1,1
5948,curettes,1,1
5949,during,0,0
5950,a,0,0
5951,supportive,0,1
5952,periodontal,0,0
5953,care,0,1
5954,visit,0,0
5955,(,0,0
5956,SPT,0,0
5957,),0,0
5958,.,0,0
5959,The,0,0
5960,other,0,0
5961,20,0,0
5962,subjects,0,0
5963,",",0,0
5964,the,0,0
5965,experimental,0,0
5966,group,0,0
5967,",",0,0
5968,were,0,0
5969,treated,0,0
5970,using,0,0
5971,plastic,1,1
5972,curettes,1,1
5973,during,0,0
5974,a,0,0
5975,similar,0,0
5976,SPT,0,0
5977,visit,0,0
5978,.,0,0
5979,Clinical,0,0
5980,parameters,0,0
5981,",",0,0
5982,such,0,0
5983,as,0,0
5984,bleeding,0,0
5985,on,0,0
5986,probing,0,0
5987,(,0,0
5988,BOP,0,1
5989,),0,1
5990,and,0,0
5991,probing,0,0
5992,pocket,0,0
5993,depth,0,1
5994,(,0,0
5995,PPD,0,1
5996,),0,0
5997,",",0,0
5998,were,0,0
5999,assessed,0,0
6000,at,0,0
6001,baseline,0,0
6002,and,0,0
6003,3-6,0,0
6004,months,0,0
6005,later,0,0
6006,at,0,0
6007,the,0,0
6008,next,0,0
6009,regular,0,1
6010,SPT,0,0
6011,visit,0,0
6012,.,0,0
6013,In,0,0
6014,addition,0,0
6015,",",0,0
6016,the,0,0
6017,BOP,0,0
6018,percentage,0,0
6019,was,0,0
6020,determined,0,0
6021,10,0,0
6022,days,0,0
6023,following,0,0
6024,baseline,0,0
6025,.,0,0
6026,The,0,0
6027,results,0,0
6028,showed,0,0
6029,that,0,0
6030,there,0,0
6031,were,0,0
6032,no,0,0
6033,statistically,0,0
6034,significant,0,0
6035,differences,0,0
6036,between,0,0
6037,the,0,0
6038,2,0,0
6039,treatment,0,0
6040,modalities,0,0
6041,regarding,0,0
6042,BOP,0,0
6043,and,0,0
6044,PPD,0,1
6045,at,0,0
6046,any,0,0
6047,observation,0,0
6048,time,0,0
6049,.,0,0
6050,Both,0,0
6051,treatments,0,0
6052,were,0,0
6053,effective,0,0
6054,in,0,0
6055,reducing,0,0
6056,the,0,0
6057,BOP,0,0
6058,percentage,0,0
6059,which,0,0
6060,ranged,0,0
6061,from,0,0
6062,17-42,0,0
6063,%,0,0
6064,at,0,0
6065,baseline,0,0
6066,by,0,0
6067,about,0,0
6068,40,0,0
6069,%,0,0
6070,after,0,0
6071,10,0,0
6072,days,0,0
6073,(,0,0
6074,mean,0,0
6075,BOP,0,0
6076,baseline,0,0
6077,:,0,0
6078,26,0,0
6079,%,0,0
6080,",",0,0
6081,mean,0,0
6082,BOP,0,0
6083,after,0,0
6084,10,0,0
6085,days,0,0
6086,:,0,0
6087,16,0,0
6088,%,0,0
6089,),0,0
6090,.,0,0
6091,This,0,0
6092,clinical,0,0
6093,study,0,0
6094,suggests,0,0
6095,that,0,0
6096,non-root,1,0
6097,substance,1,0
6098,removing,1,0
6099,curettes,1,1
6100,may,0,0
6101,be,0,0
6102,valuable,0,0
6103,instruments,0,0
6104,for,0,0
6105,periodontally,0,0
6106,treated,0,0
6107,patients,0,0
6108,during,0,0
6109,maintenance,0,0
6110,care,0,0
6111,",",0,0
6112,thus,0,0
6113,minimizing,0,0
6114,trauma,0,0
6115,on,0,0
6116,the,0,0
6117,hard,0,0
6118,structures,0,0
6119,of,0,0
6120,the,0,0
6121,teeth,0,0
6122,.,0,0
6123,Early,0,1
6124,immunisation,0,1
6125,with,0,0
6126,hepatitis,1,0
6127,B,1,0
6128,vaccine,1,1
6129,:,1,0
6130,a,0,0
6131,five-year,0,0
6132,study,0,0
6133,.,0,0
6134,We,0,0
6135,evaluated,0,0
6136,the,0,0
6137,response,0,0
6138,to,0,0
6139,the,0,0
6140,recombinant,1,1
6141,Hepatitis,1,0
6142,B,1,0
6143,vaccine,1,1
6144,using,0,0
6145,an,0,0
6146,accelerated,0,1
6147,schedule,0,0
6148,versus,0,0
6149,the,0,0
6150,traditional,0,1
6151,schedule,0,0
6152,by,0,0
6153,studying,0,0
6154,the,0,0
6155,immunologic,0,0
6156,memory,0,0
6157,induced,0,0
6158,in,0,0
6159,200,0,0
6160,children,0,0
6161,with,0,0
6162,HBs-Ag,0,1
6163,negative,0,0
6164,mothers,0,0
6165,.,0,0
6166,At,0,0
6167,seroconversion,0,0
6168,",",0,0
6169,the,0,0
6170,traditional,0,1
6171,schedule,0,0
6172,presented,0,0
6173,a,0,0
6174,higher,0,0
6175,percentage,0,0
6176,of,0,0
6177,children,0,0
6178,with,0,0
6179,serum,0,0
6180,HBs-Ag,0,1
6181,concentrations,0,0
6182,over,0,0
6183,100,0,0
6184,mIU/ml,0,0
6185,than,0,0
6186,the,0,0
6187,accelerated,0,0
6188,schedule,0,0
6189,.,0,0
6190,After,0,0
6191,five,0,0
6192,years,0,0
6193,this,0,0
6194,difference,0,0
6195,was,0,0
6196,no,0,0
6197,longer,0,0
6198,statistically,0,0
6199,significant,0,0
6200,and,0,0
6201,children,0,0
6202,who,0,0
6203,presented,0,0
6204,anti-HBsAg,0,0
6205,concentrations,0,0
6206,below,0,0
6207,10,0,0
6208,mUI/ml,0,0
6209,received,0,0
6210,an,0,0
6211,additional,0,0
6212,booster,0,0
6213,dose,0,0
6214,which,0,0
6215,stimulated,0,0
6216,the,0,0
6217,antibody,0,0
6218,concentration,0,0
6219,to,0,0
6220,exceed,0,0
6221,100,0,0
6222,mIU/ml,0,0
6223,in,0,0
6224,all,0,0
6225,cases,0,0
6226,.,0,0
6227,Recombinant,1,0
6228,HBV,1,1
6229,vaccine,1,1
6230,induced,0,0
6231,better,0,0
6232,long,0,0
6233,term,0,0
6234,immunologic,0,0
6235,memory,0,0
6236,when,0,0
6237,it,0,0
6238,was,0,0
6239,administered,0,0
6240,earlier,0,0
6241,.,0,0
6242,Prediction,0,0
6243,of,0,0
6244,metabolic,0,0
6245,and,0,0
6246,cardiopulmonary,0,1
6247,responses,0,0
6248,to,0,0
6249,maximum,1,0
6250,cycle,1,0
6251,ergometry,1,1
6252,:,1,0
6253,a,0,0
6254,randomised,0,0
6255,study,0,0
6256,.,0,0
6257,All,0,0
6258,of,0,0
6259,the,0,0
6260,most,0,0
6261,widely-cited,0,0
6262,studies,0,0
6263,for,0,0
6264,the,0,0
6265,prediction,0,0
6266,of,0,0
6267,maximum,0,0
6268,exercise,0,1
6269,responses,0,0
6270,have,0,0
6271,utilized,0,0
6272,either,0,0
6273,volunteers,0,0
6274,or,0,0
6275,referred,0,0
6276,subjects,0,0
6277,.,0,0
6278,Therefore,0,0
6279,",",0,0
6280,selection,0,0
6281,bias,0,0
6282,",",0,0
6283,with,0,0
6284,overestimation,0,0
6285,of,0,0
6286,the,0,0
6287,reference,0,0
6288,values,0,0
6289,",",0,0
6290,is,0,0
6291,a,0,0
6292,likely,0,0
6293,consequence,0,0
6294,.,0,0
6295,In,0,0
6296,order,0,0
6297,to,0,0
6298,establish,0,0
6299,a,0,0
6300,set,0,0
6301,of,0,0
6302,predictive,0,0
6303,equations,0,0
6304,for,0,0
6305,the,0,0
6306,gas,0,1
6307,exchange,0,1
6308,",",0,0
6309,ventilatory,0,0
6310,and,0,0
6311,cardiovascular,0,0
6312,responses,0,0
6313,to,0,0
6314,maximum,1,0
6315,ramp-incremental,1,0
6316,cycle,1,0
6317,ergometry,1,1
6318,",",0,0
6319,this,0,0
6320,study,0,0
6321,prospectively,0,0
6322,evaluated,0,0
6323,120,0,0
6324,sedentary,0,0
6325,individuals,0,0
6326,(,0,0
6327,60,0,0
6328,males,0,0
6329,",",0,0
6330,60,0,0
6331,females,0,0
6332,",",0,0
6333,aged,0,0
6334,20-80,0,0
6335,),0,0
6336,",",0,0
6337,randomly-selected,0,0
6338,from,0,0
6339,>,0,0
6340,"8,000",0,0
6341,subjects,0,0
6342,.,0,0
6343,Regular,0,0
6344,physical,0,0
6345,activity,0,0
6346,pattern,0,0
6347,by,0,0
6348,questionnaire,0,0
6349,",",0,0
6350,body,0,0
6351,composition,0,0
6352,by,0,0
6353,anthropometry,0,0
6354,and,0,0
6355,dual,1,0
6356,energy,1,0
6357,X-ray,1,0
6358,absorptiometry,1,0
6359,(,0,0
6360,n,0,0
6361,=,0,0
6362,75,0,0
6363,),0,0
6364,and,0,0
6365,knee,0,0
6366,strength,0,0
6367,by,0,0
6368,isokinetic,0,0
6369,dynamometry,0,0
6370,were,0,0
6371,also,0,0
6372,assessed,0,0
6373,.,0,0
6374,Previously,0,0
6375,reported,0,0
6376,equations,0,0
6377,typically,0,0
6378,overestimated,0,0
6379,the,0,0
6380,subjects,0,0
6381,',0,0
6382,peak,0,0
6383,oxygen,0,1
6384,uptake,0,0
6385,(,0,0
6386,p,0,0
6387,<,0,0
6388,0.05,0,0
6389,),0,0
6390,.,0,0
6391,Prediction,0,0
6392,linear,0,0
6393,equations,0,0
6394,for,0,0
6395,the,0,0
6396,main,0,0
6397,variables,0,0
6398,of,0,0
6399,clinical,0,0
6400,interest,0,0
6401,were,0,0
6402,established,0,0
6403,by,0,0
6404,backward,0,0
6405,stepwise,0,0
6406,regression,0,0
6407,analysis,0,0
6408,including,0,0
6409,:,0,0
6410,sex,0,0
6411,",",0,0
6412,age,0,0
6413,",",0,0
6414,knee,0,0
6415,extensor,0,1
6416,peak,0,0
6417,torque,0,0
6418,",",0,0
6419,bone-free,0,0
6420,lean,0,0
6421,leg,0,0
6422,mass,0,0
6423,",",0,0
6424,total,0,0
6425,and,0,0
6426,lean,0,0
6427,body,0,0
6428,mass,0,0
6429,",",0,0
6430,height,0,0
6431,",",0,0
6432,and,0,0
6433,physical,0,1
6434,activity,0,0
6435,scores,0,0
6436,.,0,0
6437,Reference,0,0
6438,intervals,0,0
6439,(,0,0
6440,95,0,0
6441,%,0,0
6442,confidence,0,0
6443,limits,0,0
6444,),0,0
6445,were,0,0
6446,calculated,0,0
6447,:,0,0
6448,some,0,0
6449,of,0,0
6450,these,0,0
6451,values,0,0
6452,differed,0,0
6453,markedly,0,0
6454,from,0,0
6455,those,0,0
6456,formerly,0,0
6457,recommended,0,0
6458,.,0,0
6459,The,0,0
6460,results,0,0
6461,therefore,0,0
6462,might,0,0
6463,provide,0,0
6464,a,0,0
6465,more,0,0
6466,appropriate,0,0
6467,frame,0,0
6468,of,0,0
6469,reference,0,0
6470,for,0,0
6471,interpretation,0,0
6472,of,0,0
6473,the,0,0
6474,responses,0,0
6475,to,0,0
6476,symptom-limited,0,0
6477,ramp,1,0
6478,incremental,1,0
6479,cycle,1,0
6480,ergometry,1,1
6481,in,0,0
6482,sedentary,0,0
6483,subjects,0,0
6484,;,0,0
6485,i.e,0,0
6486,.,0,0
6487,those,0,0
6488,usually,0,0
6489,referred,0,0
6490,for,0,0
6491,clinical,0,0
6492,cardiopulmonary,0,1
6493,exercise,0,1
6494,tests,0,0
6495,.,0,0
6496,The,0,0
6497,effect,0,0
6498,of,0,0
6499,body,0,0
6500,weight,0,0
6501,changes,0,0
6502,and,0,0
6503,endurance,0,0
6504,training,0,1
6505,on,0,0
6506,24h,0,0
6507,substrate,0,0
6508,oxidation,0,0
6509,.,0,0
6510,OBJECTIVE,0,0
6511,To,0,0
6512,investigate,0,0
6513,the,0,0
6514,effect,0,0
6515,of,0,0
6516,exercise,1,1
6517,training,1,1
6518,and,1,0
6519,dietary,1,1
6520,macronutrient,1,1
6521,composition,1,0
6522,on,0,0
6523,24,0,0
6524,h,0,0
6525,substrate,0,1
6526,oxidation,0,1
6527,in,0,0
6528,male,0,0
6529,",",0,0
6530,obese,0,0
6531,subjects,0,0
6532,.,0,0
6533,DESIGN,0,0
6534,A,0,0
6535,16,0,0
6536,month,0,0
6537,exercise,1,1
6538,intervention,1,1
6539,study,0,0
6540,was,0,0
6541,executed,0,0
6542,",",0,0
6543,including,0,0
6544,a,0,0
6545,weight,0,0
6546,loss,0,0
6547,period,0,0
6548,with,0,0
6549,a,0,0
6550,very,1,0
6551,low,1,0
6552,energy,1,0
6553,diet,1,1
6554,(,1,0
6555,VLED,1,1
6556,),1,0
6557,for,0,0
6558,2,0,0
6559,months,0,0
6560,at,0,0
6561,the,0,0
6562,start,0,0
6563,of,0,0
6564,the,0,0
6565,study,0,0
6566,.,0,0
6567,SUBJECTS,0,0
6568,Twelve,0,0
6569,male,0,0
6570,",",0,0
6571,obese,0,0
6572,subjects,0,0
6573,(,0,0
6574,age,0,0
6575,36.3+/-5.1,0,0
6576,y,0,0
6577,;,0,0
6578,body,0,0
6579,weight,0,0
6580,94.6+/-13.9,0,0
6581,kg,0,0
6582,;,0,0
6583,body,0,0
6584,mass,0,0
6585,index,0,0
6586,",",0,0
6587,BMI,0,0
6588,30.8+/-3.0,0,0
6589,kg/m2,0,0
6590,),0,0
6591,and,0,0
6592,in,0,0
6593,an,0,0
6594,additional,0,0
6595,study,0,0
6596,15,0,0
6597,lean,0,0
6598,",",0,0
6599,well-trained,0,1
6600,subjects,0,0
6601,(,0,0
6602,age,0,0
6603,36.2+/-7.2,0,0
6604,y,0,0
6605,;,0,0
6606,body,0,0
6607,weight,0,0
6608,72.2+/-5.9,0,0
6609,kg,0,0
6610,;,0,0
6611,BMI,0,0
6612,22.3+/-1.7,0,0
6613,kg/m2,0,0
6614,),0,0
6615,participated,0,0
6616,.,0,0
6617,MEASUREMENTS,0,0
6618,Substrate,0,0
6619,oxidation,0,0
6620,was,0,0
6621,measured,0,0
6622,during,0,0
6623,a,0,0
6624,standardized,0,0
6625,36,0,0
6626,h,0,0
6627,stay,0,0
6628,in,0,0
6629,the,0,0
6630,respiration,0,0
6631,chamber,0,0
6632,at,0,0
6633,the,0,0
6634,start,0,0
6635,of,0,0
6636,the,0,0
6637,study,0,0
6638,(,0,0
6639,0,0,0
6640,months,0,0
6641,),0,0
6642,",",0,0
6643,and,0,0
6644,at,0,0
6645,4,0,0
6646,",",0,0
6647,10,0,0
6648,and,0,0
6649,16,0,0
6650,months,0,0
6651,.,0,0
6652,In,0,0
6653,the,0,0
6654,respiration,0,0
6655,chamber,0,0
6656,subjects,0,0
6657,were,0,0
6658,randomly,0,0
6659,assigned,0,0
6660,to,0,0
6661,a,0,0
6662,high-fat,1,1
6663,(,1,0
6664,Hi.F,1,1
6665,),1,1
6666,diet,1,1
6667,(,1,0
6668,60,1,0
6669,%,1,0
6670,of,1,0
6671,energy,1,0
6672,(,1,0
6673,En,1,0
6674,%,1,0
6675,),1,1
6676,fat,1,0
6677,),1,0
6678,or,1,0
6679,a,1,0
6680,reduced-fat,1,1
6681,(,1,0
6682,Red.F,1,0
6683,),1,1
6684,diet,1,1
6685,(,1,0
6686,30,1,0
6687,En,1,0
6688,%,1,0
6689,fat,1,0
6690,),1,0
6691,.,1,0
6692,The,0,0
6693,well-trained,0,0
6694,group,0,0
6695,was,0,0
6696,measured,0,0
6697,once,0,0
6698,in,0,0
6699,the,0,0
6700,respiration,0,0
6701,chamber,0,0
6702,for,0,0
6703,36,0,0
6704,h,0,0
6705,according,0,0
6706,to,0,0
6707,the,0,0
6708,same,0,0
6709,protocol,0,0
6710,.,0,0
6711,RESULTS,0,0
6712,At,0,0
6713,any,0,0
6714,time,0,0
6715,point,0,0
6716,",",0,0
6717,independent,0,0
6718,of,0,0
6719,the,0,0
6720,diet,0,1
6721,consumed,0,0
6722,",",0,0
6723,the,0,0
6724,24,0,0
6725,h,0,0
6726,carbohydrate,0,1
6727,(,0,0
6728,CHO,0,1
6729,),0,0
6730,balances,0,0
6731,in,0,0
6732,the,0,0
6733,chamber,0,0
6734,were,0,0
6735,mostly,0,0
6736,negative,0,0
6737,(,0,0
6738,means,0,0
6739,ranging,0,0
6740,from,0,0
6741,+31,0,0
6742,to,0,0
6743,-98,0,0
6744,g/d,0,1
6745,),0,0
6746,and,0,0
6747,the,0,0
6748,fat,0,0
6749,balances,0,0
6750,mostly,0,0
6751,positive,0,0
6752,(,0,0
6753,means,0,0
6754,ranging,0,0
6755,from,0,0
6756,-26,0,0
6757,to,0,0
6758,+38,0,0
6759,g/d,0,1
6760,),0,0
6761,for,0,0
6762,the,0,0
6763,obese,0,0
6764,a,0,0
6765,well,0,0
6766,as,0,0
6767,for,0,0
6768,the,0,0
6769,lean,0,0
6770,",",0,0
6771,well-trained,0,1
6772,group,0,0
6773,.,0,0
6774,For,0,0
6775,both,0,0
6776,diets,0,1
6777,an,0,0
6778,increased,0,0
6779,shortage,0,0
6780,of,0,0
6781,70,0,0
6782,g,0,0
6783,of,0,0
6784,CHO,0,0
6785,was,0,0
6786,found,0,0
6787,at,0,0
6788,16,0,0
6789,months,0,0
6790,compared,0,0
6791,with,0,0
6792,4,0,0
6793,months,0,0
6794,",",0,0
6795,and,0,0
6796,an,0,0
6797,increase,0,0
6798,in,0,0
6799,fat,0,0
6800,balance,0,0
6801,of,0,0
6802,33,0,0
6803,g,0,0
6804,during,0,0
6805,the,0,0
6806,same,0,0
6807,time,0,0
6808,period,0,0
6809,in,0,0
6810,the,0,0
6811,obese,0,0
6812,subjects,0,0
6813,",",0,0
6814,indicating,0,0
6815,that,0,0
6816,CHO,0,1
6817,oxidation,0,0
6818,had,0,0
6819,increased,0,0
6820,with,0,0
6821,12,0,0
6822,months,0,0
6823,endurance,0,0
6824,training,0,1
6825,.,0,0
6826,In,0,0
6827,the,0,0
6828,well-trained,0,1
6829,group,0,0
6830,the,0,0
6831,24h,0,0
6832,CHO,0,0
6833,balance,0,0
6834,was,0,0
6835,even,0,0
6836,more,0,0
6837,negative,0,0
6838,for,0,0
6839,both,0,0
6840,types,0,0
6841,of,0,0
6842,diet,0,1
6843,(,0,0
6844,-103,0,0
6845,to,0,0
6846,-185,0,1
6847,g/d,0,1
6848,for,0,0
6849,the,0,0
6850,Red.F,0,0
6851,and,0,0
6852,Hi.F,0,1
6853,diet,0,1
6854,",",0,0
6855,respectively,0,0
6856,),0,0
6857,under,0,0
6858,similar,0,0
6859,conditions,0,0
6860,compared,0,0
6861,with,0,0
6862,the,0,0
6863,trained,0,1
6864,obese,0,0
6865,group,0,0
6866,.,0,0
6867,CONCLUSION,0,0
6868,The,0,0
6869,changes,0,0
6870,in,0,0
6871,24,0,0
6872,h,0,0
6873,substrate,0,1
6874,utilization,0,0
6875,in,0,0
6876,the,0,0
6877,obese,0,0
6878,",",0,0
6879,as,0,0
6880,well,0,0
6881,as,0,0
6882,in,0,0
6883,the,0,0
6884,well-trained,0,1
6885,group,0,0
6886,",",0,0
6887,suggest,0,0
6888,that,0,0
6889,endurance,0,0
6890,training,0,1
6891,increased,0,0
6892,the,0,0
6893,reliance,0,0
6894,on,0,0
6895,carbohydrate,0,1
6896,oxidation,0,1
6897,and,0,0
6898,therefore,0,0
6899,did,0,0
6900,not,0,0
6901,increase,0,0
6902,24,0,0
6903,fat,0,0
6904,oxidation,0,0
6905,.,0,0
6906,Bronchodilatory,0,1
6907,responses,0,0
6908,to,0,0
6909,formoterol,1,1
6910,",",1,0
6911,ipratropium,1,1
6912,",",1,0
6913,and,1,0
6914,their,1,0
6915,combination,1,1
6916,in,0,0
6917,patients,0,0
6918,with,0,0
6919,stable,0,0
6920,COPD,0,0
6921,.,0,0
6922,We,0,0
6923,studied,0,0
6924,27,0,0
6925,patients,0,0
6926,with,0,0
6927,stable,0,0
6928,chronic,0,0
6929,obstuctive,0,0
6930,pulmonary,0,0
6931,disease,0,0
6932,(,0,0
6933,COPD,0,0
6934,),0,0
6935,in,0,0
6936,a,0,0
6937,randomised,0,0
6938,",",0,0
6939,single-blind,0,0
6940,",",0,0
6941,within-patient,0,0
6942,",",0,0
6943,placebo-controlled,1,1
6944,clinical,0,0
6945,study,0,0
6946,.,0,0
6947,Each,0,0
6948,patient,0,0
6949,was,0,0
6950,assigned,0,0
6951,on,0,0
6952,six,0,0
6953,separate,0,0
6954,days,0,0
6955,to,0,0
6956,receive,0,0
6957,one,0,0
6958,of,0,0
6959,the,0,0
6960,following,0,0
6961,drug,0,0
6962,regimens,0,0
6963,in,0,0
6964,random,0,0
6965,order,0,0
6966,:,0,0
6967,A,0,0
6968,.,0,0
6969,40,0,0
6970,micrograms,0,0
6971,ipratropium,1,1
6972,bromide,1,1
6973,(,1,0
6974,Atrovent,1,1
6975,MDI,1,0
6976,",",1,0
6977,20,1,0
6978,micrograms/puff,1,0
6979,),1,0
6980,plus,1,1
6981,2,1,0
6982,puffs,1,1
6983,placebo,1,1
6984,;,1,0
6985,B,0,0
6986,.,0,0
6987,12,0,0
6988,micrograms,0,0
6989,formoterol,1,1
6990,fumarate,1,1
6991,(,1,0
6992,Foradil,1,1
6993,MDI,1,0
6994,",",1,0
6995,12,1,0
6996,micrograms/puff,1,0
6997,),1,0
6998,plus,1,1
6999,3,1,0
7000,puffs,1,1
7001,placebo,1,1
7002,;,1,0
7003,C.,0,0
7004,80,1,0
7005,micrograms,1,1
7006,ipratropium,1,1
7007,;,1,0
7008,D.,1,0
7009,24,1,0
7010,micrograms,1,1
7011,formoterol,1,1
7012,plus,1,1
7013,2,1,0
7014,puffs,1,1
7015,placebo,1,1
7016,;,1,0
7017,E.,1,0
7018,12,1,0
7019,micrograms,1,1
7020,formoterol,1,1
7021,plus,1,1
7022,40,1,0
7023,micrograms,1,1
7024,ipratropium,1,1
7025,plus,1,1
7026,1,1,0
7027,puff,1,1
7028,placebo,1,1
7029,;,1,0
7030,F.,0,0
7031,4,1,0
7032,puffs,1,1
7033,placebo,1,1
7034,.,1,0
7035,On,0,0
7036,each,0,0
7037,study,0,0
7038,day,0,0
7039,",",0,0
7040,spirometric,0,0
7041,indices,0,0
7042,and,0,0
7043,vital,0,0
7044,signs,0,0
7045,were,0,0
7046,measured,0,0
7047,at,0,0
7048,5,0,0
7049,",",0,0
7050,10,0,0
7051,",",0,0
7052,15,0,0
7053,and,0,0
7054,60,0,0
7055,minutes,0,0
7056,",",0,0
7057,and,0,0
7058,hourly,0,0
7059,thereafter,0,0
7060,up,0,0
7061,to,0,0
7062,and,0,0
7063,including,0,0
7064,12,0,0
7065,hours,0,0
7066,after,0,0
7067,study,0,0
7068,drug,0,0
7069,administration,0,0
7070,.,0,0
7071,Mean,0,0
7072,peak,0,0
7073,FEV1,0,0
7074,change,0,0
7075,(,0,0
7076,primary,0,0
7077,endpoint,0,0
7078,),0,0
7079,was,0,0
7080,maximum,0,0
7081,with,0,0
7082,the,0,0
7083,administration,0,0
7084,of,0,0
7085,the,0,0
7086,combination,0,1
7087,of,0,0
7088,ipratropium,1,1
7089,and,1,0
7090,formoterol,1,1
7091,(,0,0
7092,335.2,0,0
7093,ml,0,0
7094,",",0,0
7095,SE,0,1
7096,24.6,0,0
7097,),0,0
7098,",",0,0
7099,and,0,0
7100,it,0,0
7101,differed,0,0
7102,significantly,0,0
7103,from,0,0
7104,the,0,0
7105,observed,0,0
7106,peak,0,0
7107,changes,0,0
7108,following,0,0
7109,single,0,0
7110,administration,0,0
7111,of,0,0
7112,the,0,0
7113,two,0,0
7114,tested,0,0
7115,doses,0,0
7116,of,0,0
7117,ipratropium,1,1
7118,(,0,0
7119,p,0,0
7120,<,0,0
7121,0.05,0,0
7122,and,0,0
7123,p,0,0
7124,<,0,0
7125,0.05,0,0
7126,respectively,0,0
7127,),0,0
7128,.,0,0
7129,Safety,0,0
7130,and,0,0
7131,tolerability,0,0
7132,were,0,0
7133,satisfactory,0,0
7134,throughout,0,0
7135,the,0,0
7136,study,0,0
7137,.,0,0
7138,Differential,0,0
7139,effects,0,0
7140,of,0,0
7141,amino,0,1
7142,acid,0,1
7143,and,0,0
7144,ketoacid,0,1
7145,on,0,0
7146,protein,0,0
7147,metabolism,0,0
7148,in,0,0
7149,humans,0,0
7150,.,0,0
7151,We,0,0
7152,examined,0,0
7153,the,0,0
7154,effects,0,0
7155,of,0,0
7156,insulin,0,0
7157,",",0,0
7158,amino,0,1
7159,acid,0,1
7160,(,0,0
7161,AA,0,1
7162,),0,0
7163,",",0,0
7164,and,0,0
7165,branched-chain,0,0
7166,ketoacid,0,1
7167,(,0,0
7168,KA,0,1
7169,),0,0
7170,availability,0,0
7171,on,0,0
7172,leucine,0,1
7173,kinetics,0,0
7174,in,0,0
7175,eight,0,0
7176,healthy,0,0
7177,volunteers,0,0
7178,(,0,0
7179,age,0,0
7180,=,0,0
7181,22,0,0
7182,+/-,0,0
7183,2,0,0
7184,y,0,0
7185,",",0,0
7186,body,0,0
7187,mass,0,0
7188,index,0,0
7189,=,0,0
7190,24,0,0
7191,+/-,0,0
7192,1,0,0
7193,kg,0,0
7194,),0,0
7195,by,0,0
7196,using,0,0
7197,the,0,0
7198,euglycemic,1,0
7199,insulin,1,1
7200,clamp,1,1
7201,and,1,0
7202,[,1,0
7203,1-14C,1,0
7204,],1,0
7205,leucine,1,1
7206,turnover,1,0
7207,techniques,1,1
7208,.,1,0
7209,Four,0,0
7210,experimental,0,0
7211,conditions,0,0
7212,were,0,0
7213,studied,0,0
7214,:,0,0
7215,study,0,0
7216,I,0,0
7217,",",0,0
7218,hyperinsulinemia,0,0
7219,;,0,0
7220,study,0,0
7221,II,0,0
7222,",",0,0
7223,hyperinsulinemia,0,0
7224,with,0,0
7225,maintenance,0,0
7226,of,0,0
7227,basal,0,0
7228,plasma,0,0
7229,AA,0,1
7230,and,0,0
7231,branched-chain,0,0
7232,KA,0,0
7233,concentrations,0,0
7234,;,0,0
7235,study,0,0
7236,III,0,0
7237,",",0,0
7238,hyperinsulinemia,0,0
7239,with,0,0
7240,hyperaminoacidemia,0,1
7241,and,0,0
7242,basal,0,0
7243,plasma,0,0
7244,branched-chain,0,0
7245,KA,0,0
7246,concentrations,0,0
7247,;,0,0
7248,and,0,0
7249,study,0,0
7250,IV,0,0
7251,",",0,0
7252,hyperinsulinemia,0,0
7253,plus,0,1
7254,basal,0,0
7255,plasma,0,0
7256,AA,0,0
7257,concentrations,0,0
7258,and,0,0
7259,elevated,0,0
7260,branched-chain,0,0
7261,KA,0,0
7262,levels,0,0
7263,.,0,0
7264,Basal,0,0
7265,endogenous,0,0
7266,leucine,0,1
7267,flux,0,1
7268,(,0,0
7269,ELF,0,0
7270,),0,0
7271,averaged,0,0
7272,1.20,0,0
7273,+/-,0,0
7274,0.05,0,0
7275,(,0,0
7276,mumol.kg-1.min-1,0,0
7277,",",0,0
7278,mean,0,0
7279,+/-,0,0
7280,SE,0,1
7281,),0,0
7282,;,0,0
7283,basal,0,0
7284,leucine,0,1
7285,oxidation,0,1
7286,(,0,0
7287,LOX,0,0
7288,),0,0
7289,was,0,0
7290,0.25,0,0
7291,+/-,0,0
7292,0.01,0,0
7293,;,0,0
7294,and,0,0
7295,basal,0,0
7296,non-oxidative,0,0
7297,leucine,0,1
7298,disposal,0,0
7299,(,0,0
7300,NOLD,0,0
7301,),0,0
7302,was,0,0
7303,0.95,0,0
7304,+/-,0,0
7305,0.04,0,0
7306,.,0,0
7307,ELF,0,0
7308,significantly,0,0
7309,decreased,0,0
7310,in,0,0
7311,study,0,0
7312,I,0,0
7313,(,0,0
7314,0.77,0,0
7315,+/-,0,0
7316,0.06,0,0
7317,mumol.kg-1.min-1,0,0
7318,",",0,0
7319,P,0,0
7320,<,0,0
7321,0.01,0,0
7322,versus,0,0
7323,basal,0,0
7324,),0,0
7325,.,0,0
7326,When,0,0
7327,plasma,0,0
7328,AA,0,1
7329,and,0,0
7330,branched-chain,0,0
7331,KA,0,0
7332,were,0,0
7333,either,0,0
7334,maintained,0,0
7335,at,0,0
7336,their,0,0
7337,basal,0,0
7338,levels,0,0
7339,(,0,0
7340,study,0,0
7341,II,0,0
7342,),0,0
7343,or,0,1
7344,increased,0,0
7345,above,0,0
7346,baseline,0,0
7347,values,0,0
7348,(,0,0
7349,studies,0,0
7350,III,0,0
7351,and,0,0
7352,IV,0,0
7353,),0,0
7354,",",0,0
7355,ELF,0,0
7356,declined,0,0
7357,further,0,0
7358,(,0,0
7359,0.64,0,0
7360,+/-,0,0
7361,0.05,0,0
7362,",",0,0
7363,0.66,0,0
7364,+/-,0,0
7365,0.02,0,0
7366,",",0,0
7367,and,0,0
7368,0.66,0,0
7369,+/-,0,0
7370,0.03,0,0
7371,mumol.kg-1.min-1,0,0
7372,",",0,0
7373,respectively,0,0
7374,;,0,0
7375,all,0,0
7376,Ps,0,1
7377,<,0,0
7378,0.01,0,0
7379,versus,0,0
7380,basal,0,0
7381,and,0,0
7382,P,0,0
7383,<,0,0
7384,0.01,0,0
7385,versus,0,0
7386,study,0,0
7387,I,0,0
7388,),0,0
7389,.,0,0
7390,LOX,0,0
7391,declined,0,0
7392,in,0,0
7393,study,0,0
7394,I,0,0
7395,(,0,0
7396,0.12,0,0
7397,+/-,0,0
7398,0.02,0,0
7399,mumol.kg-1.min-1,0,0
7400,",",0,0
7401,P,0,0
7402,<,0,0
7403,0.01,0,0
7404,versus,0,0
7405,basal,0,0
7406,),0,0
7407,but,0,0
7408,increased,0,0
7409,significantly,0,0
7410,in,0,0
7411,studies,0,0
7412,II,0,0
7413,",",0,0
7414,III,0,0
7415,",",0,0
7416,and,0,0
7417,IV,0,0
7418,(,0,0
7419,0.31,0,0
7420,+/-,0,0
7421,0.04,0,0
7422,",",0,0
7423,0.37,0,0
7424,+/-,0,0
7425,0.03,0,0
7426,",",0,0
7427,and,0,0
7428,0.40,0,0
7429,+/-,0,0
7430,0.03,0,0
7431,mumol.kg-1.min-1,0,0
7432,",",0,0
7433,respectively,0,0
7434,",",0,0
7435,all,0,0
7436,Ps,0,1
7437,<,0,0
7438,0.01,0,0
7439,versus,0,0
7440,basal,0,0
7441,",",0,0
7442,P,0,0
7443,<,0,0
7444,0.05,0,0
7445,study,0,0
7446,IV,0,0
7447,versus,0,0
7448,study,0,0
7449,II,0,0
7450,",",0,0
7451,and,0,0
7452,P,0,0
7453,<,0,0
7454,0.05,0,0
7455,study,0,0
7456,III,0,0
7457,versus,0,0
7458,study,0,0
7459,II,0,0
7460,),0,0
7461,.,0,0
7462,NOLD,0,0
7463,declined,0,0
7464,in,0,0
7465,study,0,0
7466,I,0,0
7467,(,0,0
7468,0.65,0,0
7469,+/-,0,0
7470,0.05,0,0
7471,mumol/kg.min,0,0
7472,",",0,0
7473,P,0,0
7474,<,0,0
7475,0.01,0,0
7476,versus,0,0
7477,basal,0,0
7478,),0,0
7479,",",0,0
7480,whereas,0,0
7481,neither,0,0
7482,the,0,0
7483,maintenance,0,0
7484,of,0,0
7485,basal,0,0
7486,plasma,0,0
7487,AA/branched-chain,0,0
7488,KA,0,0
7489,levels,0,0
7490,(,0,0
7491,study,0,0
7492,II,0,0
7493,;,0,0
7494,0.89,0,0
7495,+/-,0,0
7496,0.2,0,0
7497,mumol.kg-1.min-1,0,0
7498,),0,0
7499,nor,0,0
7500,the,0,0
7501,elevation,0,0
7502,of,0,0
7503,plasma,0,0
7504,branched-chain,0,0
7505,KA,0,1
7506,concentration,0,0
7507,(,0,0
7508,study,0,0
7509,IV,0,0
7510,;,0,0
7511,0.96,0,0
7512,+/-,0,0
7513,0.1,0,0
7514,mumol.kg-1.min-1,0,0
7515,),0,0
7516,increased,0,0
7517,NOLD,0,0
7518,above,0,0
7519,baseline,0,0
7520,level,0,0
7521,.,0,0
7522,A,0,0
7523,stimulation,0,0
7524,of,0,0
7525,NOLD,0,0
7526,was,0,0
7527,observed,0,0
7528,only,0,0
7529,when,0,0
7530,plasma,0,0
7531,AA,0,0
7532,levels,0,0
7533,were,0,0
7534,increased,0,0
7535,(,0,0
7536,study,0,0
7537,III,0,0
7538,;,0,0
7539,1.23,0,0
7540,+/-,0,0
7541,0.03,0,0
7542,mumol/kg.min,0,0
7543,",",0,0
7544,P,0,0
7545,<,0,0
7546,0.01,0,0
7547,versus,0,0
7548,basal,0,0
7549,),0,0
7550,.,0,0
7551,In,0,0
7552,conclusion,0,0
7553,",",0,0
7554,the,0,0
7555,present,0,0
7556,data,0,0
7557,do,0,0
7558,not,0,0
7559,support,0,0
7560,the,0,0
7561,concept,0,0
7562,of,0,0
7563,a,0,0
7564,direct,0,0
7565,anabolic,0,0
7566,action,0,0
7567,of,0,0
7568,ketoanalogs,0,1
7569,but,0,0
7570,do,0,0
7571,provide,0,0
7572,additional,0,0
7573,evidence,0,0
7574,for,0,0
7575,the,0,0
7576,pivotal,0,0
7577,role,0,0
7578,of,0,0
7579,AA,0,0
7580,availability,0,0
7581,in,0,0
7582,the,0,0
7583,stimulation,0,0
7584,of,0,0
7585,whole-body,0,1
7586,protein,0,0
7587,synthesis,0,0
7588,.,0,0
7589,Efficacy,0,0
7590,of,0,0
7591,primaquine,1,1
7592,regimens,1,0
7593,for,0,0
7594,primaquine-resistant,0,0
7595,Plasmodium,0,1
7596,vivax,0,1
7597,malaria,0,1
7598,in,0,0
7599,Thailand,0,0
7600,.,0,0
7601,To,0,0
7602,define,0,0
7603,the,0,0
7604,current,0,0
7605,efficacy,0,0
7606,of,0,0
7607,Fansidar,1,1
7608,(,1,0
7609,F.,1,0
7610,Hoffmann-La,1,0
7611,Roche,1,0
7612,Ltd.,1,0
7613,",",0,0
7614,Basel,1,1
7615,Switzerland,1,0
7616,),1,1
7617,(,1,0
7618,pyrimethamine,1,1
7619,and,1,0
7620,sulfadoxine,1,1
7621,),1,0
7622,",",1,0
7623,primaquine,1,1
7624,in,0,0
7625,a,0,0
7626,high,0,0
7627,dose,0,0
7628,",",0,0
7629,and,0,0
7630,artesunate,1,1
7631,for,0,0
7632,treating,0,0
7633,acute,0,0
7634,Plasmodium,0,1
7635,vivax,0,1
7636,malaria,0,1
7637,",",0,0
7638,we,0,0
7639,conducted,0,0
7640,a,0,0
7641,comparative,0,0
7642,clinical,0,0
7643,trial,0,0
7644,of,0,0
7645,these,0,0
7646,3,0,0
7647,drugs,0,0
7648,in,0,0
7649,an,0,0
7650,open-label,0,0
7651,study,0,0
7652,.,0,0
7653,Patients,0,0
7654,(,0,0
7655,15-65,0,0
7656,years,0,0
7657,old,0,0
7658,),0,0
7659,were,0,0
7660,assigned,0,0
7661,to,0,0
7662,1,0,0
7663,of,0,0
7664,4,0,0
7665,treatments,0,0
7666,regimens,0,0
7667,in,0,0
7668,a,0,0
7669,serial,0,0
7670,order,0,0
7671,.,0,0
7672,Ninety,0,0
7673,percent,0,0
7674,of,0,0
7675,the,0,0
7676,patients,0,0
7677,were,0,0
7678,infected,0,0
7679,at,0,0
7680,Thailand-Myanmar,0,0
7681,border,0,0
7682,.,0,0
7683,Patients,0,0
7684,in,0,0
7685,group,0,0
7686,I,0,0
7687,(,0,0
7688,n,0,0
7689,=,0,0
7690,23,0,0
7691,),0,0
7692,received,0,0
7693,Fansidar,1,1
7694,(,0,0
7695,3,0,0
7696,tablets,0,1
7697,",",0,0
7698,75,0,0
7699,mg,0,0
7700,of,0,0
7701,pyrimethamine,1,1
7702,and,1,0
7703,"1,500",1,1
7704,mg,1,1
7705,of,1,0
7706,sulfadoxine,1,1
7707,",",0,0
7708,a,0,0
7709,single,0,0
7710,dose,0,0
7711,on,0,0
7712,the,0,0
7713,first,0,0
7714,day,0,0
7715,),0,0
7716,",",0,0
7717,group,0,0
7718,II,0,0
7719,(,0,0
7720,n,0,0
7721,=,0,0
7722,23,0,0
7723,),0,0
7724,received,0,0
7725,Fansidar,1,1
7726,(,1,0
7727,3,1,0
7728,tablets,1,1
7729,",",1,0
7730,75,1,0
7731,mg,1,0
7732,of,1,0
7733,pyrimethamine,1,1
7734,and,1,0
7735,"1,500",1,1
7736,mg,1,1
7737,of,1,0
7738,sulfadoxine,1,1
7739,",",0,0
7740,a,0,0
7741,single,0,0
7742,dose,0,0
7743,on,0,0
7744,the,0,0
7745,first,0,0
7746,day,0,0
7747,),0,0
7748,and,0,0
7749,then,0,0
7750,received,0,1
7751,primaquine,1,1
7752,(,1,0
7753,30,1,0
7754,mg,1,1
7755,a,1,0
7756,day,1,0
7757,for,1,0
7758,14,1,0
7759,days,1,0
7760,),1,0
7761,",",0,0
7762,group,0,0
7763,III,0,0
7764,(,0,0
7765,n,0,0
7766,=,0,0
7767,23,0,0
7768,),0,0
7769,received,1,0
7770,primaquine,1,1
7771,(,1,0
7772,30,1,0
7773,mg,1,1
7774,a,1,0
7775,day,1,0
7776,for,1,0
7777,14,1,0
7778,days,1,0
7779,),1,0
7780,",",0,0
7781,and,0,0
7782,group,0,0
7783,IV,0,0
7784,(,0,0
7785,n,0,0
7786,=,0,0
7787,23,0,0
7788,),0,0
7789,received,1,0
7790,artesunate,1,1
7791,(,0,0
7792,200,0,1
7793,mg,0,1
7794,once,0,0
7795,a,0,0
7796,day,0,0
7797,for,0,0
7798,3,0,0
7799,days,0,0
7800,),0,0
7801,and,0,0
7802,then,0,0
7803,primaquine,1,1
7804,(,0,0
7805,30,0,0
7806,mg,0,1
7807,a,0,0
7808,day,0,0
7809,for,0,0
7810,14,0,0
7811,days,0,0
7812,),0,0
7813,.,0,0
7814,Cure,0,0
7815,rates,0,0
7816,on,0,0
7817,day,0,0
7818,28,0,0
7819,of,0,0
7820,follow-up,0,0
7821,were,0,0
7822,40,0,0
7823,%,0,0
7824,",",0,0
7825,100,0,0
7826,%,0,0
7827,",",0,0
7828,100,0,0
7829,%,0,0
7830,",",0,0
7831,and,0,0
7832,100,0,0
7833,%,0,0
7834,in,0,0
7835,groups,0,0
7836,I,0,0
7837,",",0,0
7838,II,0,0
7839,",",0,0
7840,II,0,0
7841,",",0,0
7842,and,0,0
7843,IV,0,0
7844,",",0,0
7845,respectively,0,0
7846,.,0,0
7847,There,0,0
7848,were,0,0
7849,4,0,0
7850,and,0,0
7851,5,0,0
7852,patients,0,0
7853,in,0,0
7854,group,0,0
7855,I,0,0
7856,showing,0,0
7857,post-treatment,0,0
7858,reappearance,0,0
7859,of,0,0
7860,parasitemia,0,0
7861,at,0,0
7862,<,0,0
7863,or,0,0
7864,=,0,0
7865,16,0,0
7866,days,0,0
7867,and,0,0
7868,between,0,0
7869,17,0,0
7870,and,0,0
7871,28,0,0
7872,days,0,0
7873,",",0,0
7874,respectively,0,0
7875,.,0,0
7876,Patients,0,0
7877,in,0,0
7878,the,0,0
7879,other,0,0
7880,3,0,0
7881,groups,0,0
7882,showed,0,0
7883,negative,0,0
7884,parasitemias,0,0
7885,within,0,0
7886,7,0,0
7887,days,0,0
7888,after,0,0
7889,treatment,0,0
7890,.,0,0
7891,Artesunate,0,1
7892,plus,0,1
7893,primaquine,0,1
7894,(,0,0
7895,group,0,0
7896,IV,0,0
7897,),0,0
7898,cleared,0,0
7899,parasitemia,0,0
7900,faster,0,0
7901,than,0,0
7902,the,0,0
7903,other,0,0
7904,3,0,0
7905,regimens,0,0
7906,.,0,0
7907,There,0,0
7908,is,0,0
7909,a,0,0
7910,high,0,0
7911,proportion,0,0
7912,of,0,0
7913,ineffectiveness,0,0
7914,of,0,0
7915,Fansidar,0,1
7916,for,0,0
7917,treatment,0,0
7918,of,0,0
7919,P.,0,1
7920,vivax,0,1
7921,malaria,0,1
7922,and,0,0
7923,it,0,0
7924,should,0,0
7925,be,0,0
7926,no,0,0
7927,longer,0,0
7928,used,0,0
7929,for,0,0
7930,treatment,0,0
7931,of,0,0
7932,P.,0,1
7933,vivax,0,1
7934,malaria,0,0
7935,acquired,0,0
7936,at,0,0
7937,the,0,0
7938,Thailand-Myanmar,0,0
7939,border,0,0
7940,.,0,0
7941,A,0,0
7942,high,0,0
7943,dose,0,0
7944,of,0,0
7945,primaquine,0,1
7946,is,0,0
7947,safe,0,0
7948,and,0,0
7949,effective,0,0
7950,in,0,0
7951,the,0,0
7952,treatment,0,0
7953,of,0,0
7954,P.,0,1
7955,vivax,0,1
7956,malaria,0,0
7957,during,0,0
7958,the,0,0
7959,28-day,0,0
7960,follow-up,0,0
7961,period,0,0
7962,.,0,0
7963,Effect,0,0
7964,of,0,0
7965,sensory,1,0
7966,stimulation,1,1
7967,(,1,0
7968,acupuncture,1,1
7969,),1,0
7970,on,0,0
7971,sympathetic,0,0
7972,and,0,0
7973,parasympathetic,0,0
7974,activities,0,0
7975,in,0,0
7976,healthy,0,0
7977,subjects,0,0
7978,.,0,0
7979,UNLABELLED,0,0
7980,It,0,0
7981,has,0,0
7982,been,0,0
7983,postulated,0,0
7984,that,0,0
7985,sensory,1,0
7986,stimulation,1,1
7987,(,1,0
7988,acupuncture,1,1
7989,),1,1
7990,affects,0,0
7991,the,0,0
7992,cardiovascular,0,0
7993,system,0,0
7994,via,0,0
7995,the,0,0
7996,autonomic,0,0
7997,nervous,0,0
7998,system,0,0
7999,.,0,0
8000,Previously,0,0
8001,",",0,0
8002,skin,0,0
8003,temperature,0,0
8004,",",0,0
8005,thermography,0,0
8006,",",0,0
8007,plethysmography,0,1
8008,and,0,0
8009,blood,0,0
8010,pressure,0,0
8011,changes,0,0
8012,have,0,0
8013,been,0,0
8014,used,0,0
8015,in,0,0
8016,evaluation,0,0
8017,of,0,0
8018,sympathetic,0,0
8019,nerve,0,0
8020,activity,0,0
8021,following,0,0
8022,acupuncture,0,1
8023,.,0,0
8024,By,0,0
8025,using,0,0
8026,power,0,0
8027,spectral,0,0
8028,analysis,0,0
8029,",",0,0
8030,the,0,0
8031,low,0,0
8032,frequency,0,0
8033,and,0,0
8034,high,0,0
8035,frequency,0,0
8036,components,0,0
8037,of,0,0
8038,heart,0,0
8039,rate,0,0
8040,variability,0,0
8041,can,0,0
8042,be,0,0
8043,calculated,0,0
8044,reflecting,0,0
8045,the,0,0
8046,sympathetic,0,0
8047,and,0,0
8048,parasympathetic,0,0
8049,activity,0,0
8050,.,0,0
8051,The,0,0
8052,purpose,0,0
8053,of,0,0
8054,this,0,0
8055,study,0,0
8056,was,0,0
8057,to,0,0
8058,investigate,0,0
8059,to,0,0
8060,what,0,0
8061,extent,0,0
8062,acupuncture,0,1
8063,applied,0,0
8064,into,0,0
8065,the,0,0
8066,thenar,0,1
8067,muscle,0,0
8068,and,0,0
8069,into,0,0
8070,the,0,0
8071,cavum,0,0
8072,concha,0,0
8073,of,0,0
8074,the,0,0
8075,ear,0,0
8076,induced,0,0
8077,changes,0,0
8078,in,0,0
8079,the,0,0
8080,sympathetic,0,0
8081,and/or,0,0
8082,parasympathetic,0,0
8083,nervous,0,0
8084,system,0,0
8085,in,0,0
8086,healthy,0,0
8087,subjects,0,0
8088,.,0,0
8089,MATERIALS,0,0
8090,AND,0,0
8091,METHODS,0,0
8092,Twelve,0,0
8093,healthy,0,0
8094,volunteers,0,0
8095,",",0,0
8096,six,0,0
8097,men,0,0
8098,and,0,0
8099,six,0,0
8100,women,0,0
8101,",",0,0
8102,mean,0,0
8103,age,0,0
8104,34.4,0,0
8105,(,0,0
8106,range,0,0
8107,23-48,0,0
8108,),0,0
8109,participated,0,0
8110,in,0,0
8111,three,0,0
8112,balanced,0,0
8113,",",0,0
8114,randomly,0,0
8115,distributed,0,0
8116,sessions,0,1
8117,.,0,0
8118,At,0,0
8119,an,0,0
8120,individual,0,0
8121,initial,0,0
8122,visit,0,0
8123,the,0,0
8124,12,0,0
8125,volunteers,0,0
8126,were,0,0
8127,introduced,0,0
8128,to,0,0
8129,the,0,0
8130,needle,1,1
8131,sensation,1,0
8132,by,0,0
8133,having,0,0
8134,a,0,0
8135,needle,0,1
8136,inserted,0,1
8137,into,0,0
8138,the,0,0
8139,point,0,0
8140,LI,0,1
8141,11,0,0
8142,.,0,0
8143,The,0,0
8144,needle,0,0
8145,sensation,0,0
8146,was,0,0
8147,evoked,0,0
8148,and,0,0
8149,the,0,0
8150,subject,0,0
8151,was,0,0
8152,trained,0,1
8153,to,0,0
8154,identify,0,0
8155,the,0,0
8156,characteristic,0,0
8157,needle,0,1
8158,sensation,0,0
8159,.,0,0
8160,The,0,0
8161,introduction,0,0
8162,was,0,0
8163,followed,0,0
8164,by,0,0
8165,three,0,0
8166,test,0,0
8167,sessions,0,1
8168,.,0,0
8169,SESSION,0,0
8170,A,0,0
8171,A,0,0
8172,short,1,0
8173,acupuncture,1,1
8174,needle,1,1
8175,",",0,0
8176,(,0,0
8177,Seirin,0,1
8178,no,0,0
8179,3,0,0
8180,",",0,0
8181,&,0,0
8182,emptyv,0,0
8183,;,0,0
8184,0.20x15,0,0
8185,mm,0,0
8186,),0,0
8187,was,0,0
8188,inserted,0,1
8189,perpendicular,0,0
8190,into,0,0
8191,the,0,0
8192,earpoint,0,0
8193,",",0,0
8194,Lu,0,0
8195,1,0,0
8196,",",0,0
8197,in,0,0
8198,the,0,0
8199,left,0,0
8200,inferior,0,0
8201,hemi-conchae,0,0
8202,.,0,0
8203,SESSION,0,0
8204,B,0,0
8205,An,0,0
8206,acupuncture,1,1
8207,needle,1,1
8208,(,0,0
8209,Hwato,0,0
8210,",",0,0
8211,&,0,0
8212,emptyv,0,0
8213,;,0,0
8214,0.30x30,0,0
8215,mm,0,0
8216,),0,0
8217,was,0,0
8218,inserted,0,1
8219,perpendicular,0,0
8220,into,0,0
8221,the,0,0
8222,Hegu,0,0
8223,point,0,0
8224,(,0,0
8225,LI,0,1
8226,4,0,0
8227,),0,0
8228,in,0,0
8229,the,0,0
8230,middle,0,0
8231,of,0,0
8232,the,0,0
8233,right,0,0
8234,dorsal,0,0
8235,thenar,0,1
8236,muscle,0,0
8237,.,0,0
8238,SESSION,0,0
8239,C,0,0
8240,An,0,0
8241,acupuncture,1,1
8242,needle,1,1
8243,(,0,0
8244,Hwato,0,0
8245,",",0,0
8246,&,0,0
8247,emptyv,0,0
8248,;,0,0
8249,0.30x30,0,0
8250,mm,0,0
8251,),0,0
8252,was,0,0
8253,inserted,0,1
8254,perpendicular,0,0
8255,superficially,0,0
8256,into,0,0
8257,the,0,0
8258,skin,0,0
8259,overlying,0,0
8260,the,0,0
8261,Hegu,0,0
8262,point,0,0
8263,on,0,0
8264,the,0,0
8265,left,0,0
8266,hand,0,0
8267,.,0,0
8268,Results,0,0
8269,.,0,0
8270,Stimulation,0,0
8271,of,0,0
8272,the,0,0
8273,ear,0,0
8274,induced,0,0
8275,a,0,0
8276,significant,0,0
8277,increase,0,0
8278,in,0,0
8279,the,0,0
8280,parasympathetic,0,0
8281,activity,0,0
8282,during,0,0
8283,the,0,0
8284,stimulation,0,1
8285,period,0,0
8286,of,0,0
8287,25,0,0
8288,min,0,0
8289,(,0,0
8290,P,0,0
8291,<,0,0
8292,0.05,0,0
8293,),0,0
8294,and,0,0
8295,during,0,0
8296,the,0,0
8297,post-stimulation,0,0
8298,period,0,0
8299,of,0,0
8300,60,0,0
8301,min,0,0
8302,(,0,0
8303,P,0,0
8304,<,0,0
8305,0.05,0,0
8306,),0,0
8307,.,0,0
8308,No,0,0
8309,significant,0,0
8310,changes,0,0
8311,were,0,0
8312,observed,0,0
8313,in,0,0
8314,either,0,0
8315,the,0,0
8316,sympathetic,0,0
8317,activity,0,0
8318,",",0,0
8319,blood,0,0
8320,pressure,0,0
8321,or,0,1
8322,heart,0,0
8323,rate,0,0
8324,.,0,0
8325,Stimulation,0,0
8326,of,0,0
8327,the,0,0
8328,thenar,0,1
8329,muscle,0,0
8330,resulted,0,0
8331,in,0,0
8332,a,0,0
8333,significant,0,0
8334,increase,0,0
8335,in,0,0
8336,the,0,0
8337,sympathetic,0,0
8338,and,0,0
8339,the,0,0
8340,parasympathetic,0,0
8341,activity,0,0
8342,during,0,0
8343,the,0,0
8344,stimulation,0,1
8345,period,0,0
8346,(,0,0
8347,P,0,0
8348,<,0,0
8349,0.01,0,0
8350,),0,0
8351,and,0,0
8352,during,0,0
8353,the,0,0
8354,post-stimulation,0,0
8355,period,0,0
8356,(,0,0
8357,P,0,0
8358,<,0,0
8359,0.01,0,0
8360,and,0,0
8361,P,0,0
8362,<,0,0
8363,0.001,0,0
8364,",",0,0
8365,respectively,0,0
8366,),0,0
8367,.,0,0
8368,A,0,0
8369,significant,0,0
8370,decrease,0,0
8371,in,0,0
8372,the,0,0
8373,heart,0,0
8374,rate,0,0
8375,frequency,0,0
8376,(,0,0
8377,P,0,0
8378,<,0,0
8379,0.05,0,0
8380,),0,0
8381,at,0,0
8382,the,0,0
8383,end,0,0
8384,of,0,0
8385,the,0,0
8386,post-stimulation,0,0
8387,period,0,0
8388,was,0,0
8389,also,0,0
8390,demonstrated,0,0
8391,.,0,0
8392,The,0,0
8393,superficial,0,0
8394,needle,0,1
8395,insertion,0,1
8396,into,0,0
8397,the,0,0
8398,skin,0,0
8399,overlaying,0,0
8400,the,0,0
8401,right,0,0
8402,thenar,0,1
8403,muscle,0,0
8404,caused,0,0
8405,a,0,0
8406,pronounced,0,0
8407,balanced,0,0
8408,increase,0,0
8409,in,0,0
8410,both,0,0
8411,the,0,0
8412,sympathetic,0,0
8413,and,0,0
8414,parasympathetic,0,0
8415,activity,0,0
8416,during,0,0
8417,the,0,0
8418,post,0,0
8419,stimulation,0,1
8420,period,0,0
8421,of,0,0
8422,60,0,0
8423,min,0,0
8424,(,0,0
8425,P,0,0
8426,<,0,0
8427,0.01,0,0
8428,),0,0
8429,while,0,0
8430,no,0,0
8431,changes,0,0
8432,were,0,0
8433,observed,0,0
8434,during,0,0
8435,the,0,0
8436,stimulation,0,0
8437,period,0,0
8438,.,0,0
8439,CONCLUSION,0,0
8440,It,0,0
8441,is,0,0
8442,indicated,0,0
8443,that,0,0
8444,sensory,1,0
8445,stimulation,1,1
8446,(,1,0
8447,acupunctura,1,1
8448,),1,0
8449,in,0,0
8450,healthy,0,0
8451,persons,0,0
8452,is,0,0
8453,associated,0,0
8454,with,0,0
8455,changed,0,0
8456,activity,0,0
8457,in,0,0
8458,the,0,0
8459,sympathetic,0,0
8460,and,0,0
8461,parasympathetic,0,0
8462,nervous,0,0
8463,system,0,0
8464,depending,0,0
8465,on,0,0
8466,site,0,0
8467,of,0,0
8468,stimulation,0,1
8469,and,0,0
8470,period,0,0
8471,of,0,0
8472,observation,0,0
8473,.,0,0
8474,Hip,1,1
8475,protectors,1,0
8476,improve,0,0
8477,falls,0,0
8478,self-efficacy,0,0
8479,.,0,0
8480,OBJECTIVES,0,0
8481,To,0,0
8482,investigate,0,0
8483,the,0,0
8484,effect,0,0
8485,of,0,0
8486,use,0,0
8487,of,0,0
8488,external,1,1
8489,hip,1,0
8490,protectors,1,0
8491,on,0,0
8492,subjects,0,0
8493,',0,0
8494,fear,0,0
8495,of,0,0
8496,falling,0,0
8497,and,0,0
8498,falls,0,0
8499,self-efficacy,0,0
8500,(,0,0
8501,belief,0,0
8502,in,0,0
8503,their,0,0
8504,own,0,0
8505,ability,0,0
8506,to,0,0
8507,avoid,0,0
8508,falling,0,0
8509,),0,0
8510,.,0,0
8511,DESIGN,0,0
8512,Randomized,0,0
8513,controlled,0,0
8514,trial,0,0
8515,.,0,0
8516,SETTING,0,0
8517,Aged-care,0,1
8518,health,0,0
8519,services,0,0
8520,in,0,0
8521,Sydney,0,0
8522,",",0,0
8523,Australia,0,0
8524,.,0,0
8525,PARTICIPANTS,0,0
8526,131,0,0
8527,women,0,0
8528,aged,0,0
8529,75,0,0
8530,years,0,0
8531,or,0,0
8532,older,0,0
8533,",",0,0
8534,who,0,0
8535,had,0,0
8536,two,0,0
8537,or,0,0
8538,more,0,0
8539,falls,0,0
8540,or,0,0
8541,one,0,0
8542,fall,0,0
8543,requiring,0,0
8544,hospital,0,0
8545,admission,0,0
8546,in,0,0
8547,the,0,0
8548,previous,0,0
8549,year,0,0
8550,and,0,0
8551,who,0,0
8552,live,0,0
8553,at,0,0
8554,home,0,0
8555,.,0,0
8556,Sixty-one,0,0
8557,subjects,0,0
8558,were,0,0
8559,in,0,0
8560,the,0,0
8561,intervention,0,1
8562,group,0,0
8563,and,0,0
8564,70,0,0
8565,in,0,0
8566,the,0,0
8567,control,1,0
8568,group,0,0
8569,.,0,0
8570,INTERVENTION,0,0
8571,Use,0,0
8572,of,0,0
8573,external,1,1
8574,hip,1,0
8575,protectors,1,1
8576,and,1,0
8577,encouragement,1,0
8578,to,1,0
8579,use,1,0
8580,the,1,0
8581,protectors,1,0
8582,by,1,0
8583,an,1,0
8584,adherence,1,0
8585,nurse,1,1
8586,.,1,0
8587,MEASUREMENTS,0,0
8588,At,0,0
8589,the,0,0
8590,time,0,0
8591,of,0,0
8592,enrolment,0,0
8593,into,0,0
8594,a,0,0
8595,wider,0,0
8596,study,0,0
8597,examining,0,0
8598,the,0,0
8599,effect,0,0
8600,of,0,0
8601,hip,1,0
8602,protectors,1,0
8603,on,0,0
8604,hip,0,0
8605,fractures,0,0
8606,",",0,0
8607,participants,0,0
8608,recruited,0,0
8609,at,0,0
8610,home,0,0
8611,completed,0,0
8612,an,0,0
8613,assessment,0,0
8614,of,0,0
8615,fear,0,0
8616,of,0,0
8617,falling,0,0
8618,and,0,0
8619,falls,0,0
8620,efficacy,0,0
8621,as,0,0
8622,measured,0,0
8623,by,0,0
8624,the,0,0
8625,Falls,0,0
8626,Efficacy,0,0
8627,Scale,0,0
8628,and,0,0
8629,the,0,0
8630,Modified,0,0
8631,Falls,0,1
8632,Efficacy,0,0
8633,Scale,0,0
8634,.,0,0
8635,At,0,0
8636,4-month,0,0
8637,follow-up,0,0
8638,",",0,0
8639,these,0,0
8640,scales,0,0
8641,were,0,0
8642,readministered,0,0
8643,by,0,0
8644,an,0,0
8645,observer,0,0
8646,who,0,0
8647,was,0,0
8648,not,0,0
8649,aware,0,0
8650,of,0,0
8651,the,0,0
8652,allocation,0,0
8653,of,0,0
8654,the,0,0
8655,participant,0,0
8656,to,0,0
8657,intervention,0,1
8658,or,0,1
8659,control,0,0
8660,groups,0,0
8661,.,0,0
8662,RESULTS,0,0
8663,Fear,0,0
8664,of,0,0
8665,falling,0,0
8666,and,0,0
8667,falls,0,0
8668,self-efficacy,0,0
8669,",",0,0
8670,as,0,0
8671,measured,0,0
8672,by,0,0
8673,the,0,0
8674,Falls,0,1
8675,Efficacy,0,0
8676,and,0,0
8677,Modified,0,1
8678,Falls,0,1
8679,Efficacy,0,0
8680,Scales,0,0
8681,",",0,0
8682,were,0,0
8683,similar,0,0
8684,at,0,0
8685,baseline,0,0
8686,in,0,0
8687,both,0,0
8688,groups,0,0
8689,.,0,0
8690,Fear,0,0
8691,of,0,0
8692,falling,0,0
8693,was,0,0
8694,present,0,0
8695,at,0,0
8696,follow-up,0,0
8697,in,0,0
8698,43,0,0
8699,%,0,0
8700,of,0,0
8701,subjects,0,0
8702,using,0,0
8703,hip,0,0
8704,protectors,0,0
8705,and,0,0
8706,57,0,0
8707,%,0,0
8708,of,0,0
8709,the,0,0
8710,control,0,1
8711,group,0,0
8712,(,0,0
8713,chi2,0,0
8714,=,0,0
8715,2.58,0,0
8716,",",0,0
8717,P,0,0
8718,=,0,0
8719,0.11,0,0
8720,),0,0
8721,.,0,0
8722,Hip,1,0
8723,protector,1,0
8724,users,0,0
8725,had,0,0
8726,greater,0,0
8727,improvement,0,0
8728,in,0,0
8729,falls,0,0
8730,self-efficacy,0,0
8731,at,0,0
8732,follow-up,0,0
8733,as,0,0
8734,measured,0,0
8735,by,0,0
8736,the,0,0
8737,Falls,0,0
8738,Efficacy,0,0
8739,Scale,0,1
8740,(,0,0
8741,t,0,0
8742,=,0,0
8743,2.44,0,0
8744,",",0,0
8745,P,0,0
8746,=,0,0
8747,0.016,0,0
8748,),0,0
8749,and,0,0
8750,the,0,0
8751,Modified,0,0
8752,Falls,0,1
8753,Efficacy,0,0
8754,Scale,0,1
8755,(,0,0
8756,t,0,0
8757,=,0,0
8758,2.08,0,0
8759,",",0,0
8760,P,0,0
8761,=,0,0
8762,0.039,0,0
8763,),0,0
8764,.,0,0
8765,CONCLUSION,0,0
8766,Hip,1,0
8767,protectors,1,0
8768,improve,0,0
8769,falls,0,0
8770,self-efficacy,0,0
8771,.,0,0
8772,As,0,0
8773,users,0,0
8774,of,0,0
8775,hip,1,0
8776,protectors,1,0
8777,feel,0,0
8778,more,0,0
8779,confident,0,0
8780,that,0,0
8781,they,0,0
8782,can,0,0
8783,complete,0,0
8784,tasks,0,0
8785,safely,0,0
8786,",",0,0
8787,they,0,0
8788,may,0,0
8789,become,0,0
8790,more,0,0
8791,physically,0,0
8792,active,0,0
8793,and,0,0
8794,require,0,0
8795,less,0,0
8796,assistance,0,0
8797,with,0,0
8798,activities,0,0
8799,of,0,0
8800,daily,0,0
8801,living,0,0
8802,.,0,0
8803,Treatment,0,0
8804,with,0,0
8805,metformin,1,1
8806,of,0,0
8807,non-diabetic,0,0
8808,men,0,0
8809,with,0,0
8810,hypertension,0,0
8811,",",0,0
8812,hypertriglyceridaemia,0,0
8813,and,0,0
8814,central,0,0
8815,fat,0,0
8816,distribution,0,0
8817,:,0,0
8818,the,0,0
8819,BIGPRO,0,0
8820,1.2,0,0
8821,trial,0,0
8822,.,0,0
8823,BACKGROUND,0,0
8824,In,0,0
8825,the,0,0
8826,BIGPRO,0,0
8827,1,0,0
8828,trial,0,0
8829,",",0,0
8830,one,0,0
8831,year,0,0
8832,of,0,0
8833,treatment,0,0
8834,with,0,0
8835,metformin,1,1
8836,in,0,0
8837,non-diabetic,0,0
8838,obese,0,0
8839,subjects,0,0
8840,with,0,0
8841,a,0,0
8842,central,0,0
8843,fat,0,0
8844,distribution,0,0
8845,had,0,0
8846,no,0,0
8847,significant,0,0
8848,effect,0,0
8849,on,0,0
8850,fasting,0,0
8851,plasma,0,0
8852,triglyceride,0,1
8853,concentration,0,0
8854,or,0,1
8855,on,0,0
8856,blood,0,0
8857,pressure,0,0
8858,despite,0,0
8859,a,0,0
8860,decrease,0,0
8861,in,0,0
8862,weight,0,0
8863,",",0,0
8864,fasting,0,0
8865,plasma,0,0
8866,insulin,0,1
8867,and,0,0
8868,glucose,0,0
8869,concentrations,0,0
8870,.,0,0
8871,To,0,0
8872,re-evaluate,0,0
8873,the,0,0
8874,effect,0,0
8875,of,0,0
8876,metformin,1,1
8877,on,0,0
8878,fasting,0,0
8879,triglyceride,0,0
8880,concentration,0,0
8881,and,0,0
8882,on,0,0
8883,blood,0,0
8884,pressure,0,0
8885,",",0,0
8886,the,0,0
8887,BIGPRO,0,0
8888,1.2,0,0
8889,trial,0,0
8890,included,0,0
8891,non-diabetic,0,0
8892,men,0,0
8893,(,0,0
8894,n=168,0,0
8895,),0,0
8896,with,0,0
8897,a,0,0
8898,fasting,0,0
8899,plasma,0,0
8900,triglyceride,0,1
8901,concentration,0,0
8902,>,0,0
8903,or,0,1
8904,=1.7,0,0
8905,and,0,0
8906,<,0,0
8907,or,0,1
8908,=6.5,0,0
8909,mmol/l,0,0
8910,",",0,0
8911,high,0,0
8912,blood,0,0
8913,pressure,0,0
8914,(,0,0
8915,systolic,0,0
8916,>,0,0
8917,or,0,1
8918,=140,0,0
8919,and,0,0
8920,<,0,0
8921,or,0,1
8922,=180,0,0
8923,and/or,0,0
8924,diastolic,0,0
8925,>,0,0
8926,or,0,1
8927,=90,0,0
8928,and,0,0
8929,<,0,0
8930,or,0,1
8931,=105,0,0
8932,mmHg,0,0
8933,",",0,0
8934,or,0,0
8935,treatment,0,0
8936,for,0,0
8937,hypertension,0,0
8938,),0,0
8939,and,0,0
8940,a,0,0
8941,waist-to-hip,0,0
8942,ratio,0,0
8943,>,0,0
8944,or,0,1
8945,=0.95,0,0
8946,.,0,0
8947,METHODS,0,0
8948,A,0,0
8949,randomised,0,0
8950,double-blind,0,0
8951,trial,0,0
8952,comparing,0,0
8953,metformin,1,1
8954,treatment,1,1
8955,(,1,0
8956,850,1,0
8957,mg,1,1
8958,bid,1,1
8959,),1,0
8960,with,1,0
8961,placebo,1,1
8962,.,1,0
8963,RESULTS,0,0
8964,Metformin,1,1
8965,had,0,0
8966,no,0,0
8967,significant,0,0
8968,effect,0,0
8969,either,0,0
8970,on,0,0
8971,blood,0,0
8972,pressure,0,0
8973,or,0,1
8974,plasma,0,0
8975,triglyceride,0,0
8976,concentration,0,0
8977,.,0,0
8978,In,0,0
8979,comparison,0,0
8980,with,0,0
8981,the,0,0
8982,placebo,1,1
8983,group,0,0
8984,",",0,0
8985,fasting,0,0
8986,plasma,0,0
8987,insulin,0,1
8988,(,0,0
8989,p,0,0
8990,<,0,0
8991,0.04,0,0
8992,),0,0
8993,",",0,0
8994,total,0,0
8995,cholesterol,0,0
8996,(,0,0
8997,p,0,0
8998,<,0,0
8999,0.05,0,0
9000,),0,0
9001,and,0,0
9002,Apo,0,1
9003,B,0,1
9004,(,0,0
9005,p,0,0
9006,<,0,0
9007,0.008,0,0
9008,),0,0
9009,concentrations,0,0
9010,decreased,0,0
9011,more,0,0
9012,in,0,0
9013,the,0,0
9014,metformin,0,1
9015,group,0,0
9016,in,0,0
9017,the,0,0
9018,BIGPRO,0,0
9019,1,0,0
9020,.,0,0
9021,2,0,0
9022,trial,0,0
9023,",",0,0
9024,confirming,0,0
9025,most,0,0
9026,of,0,0
9027,the,0,0
9028,previous,0,0
9029,results,0,0
9030,of,0,0
9031,the,0,0
9032,BIGPRO,0,0
9033,1,0,0
9034,trial,0,0
9035,.,0,0
9036,Tissue,0,0
9037,plasminogen,0,0
9038,activator,0,0
9039,antigen,0,0
9040,concentration,0,0
9041,decreased,0,0
9042,significantly,0,0
9043,(,0,0
9044,p,0,0
9045,<,0,0
9046,0.01,0,0
9047,),0,0
9048,only,0,0
9049,in,0,0
9050,the,0,0
9051,metformin,1,1
9052,group,0,0
9053,",",0,0
9054,but,0,0
9055,this,0,0
9056,was,0,0
9057,not,0,0
9058,significantly,0,0
9059,different,0,0
9060,from,0,0
9061,the,0,0
9062,placebo,1,1
9063,group,0,0
9064,(,0,0
9065,p,0,0
9066,<,0,0
9067,0.12,0,0
9068,),0,0
9069,;,0,0
9070,further,0,0
9071,",",0,0
9072,there,0,0
9073,were,0,0
9074,no,0,0
9075,significant,0,0
9076,differences,0,0
9077,in,0,0
9078,the,0,0
9079,change,0,0
9080,in,0,0
9081,plasminogen,0,0
9082,activator,0,0
9083,inhibitor,0,1
9084,1,0,0
9085,.,0,0
9086,CONCLUSIONS,0,0
9087,The,0,0
9088,consistency,0,0
9089,of,0,0
9090,the,0,0
9091,two,0,0
9092,BIGPRO,0,0
9093,trials,0,0
9094,supports,0,0
9095,the,0,0
9096,conclusion,0,0
9097,that,0,0
9098,metformin,1,1
9099,affects,0,0
9100,several,0,0
9101,cardiovascular,0,0
9102,risk,0,0
9103,factors,0,0
9104,favourably,0,0
9105,in,0,0
9106,non-diabetic,0,0
9107,subjects,0,0
9108,with,0,0
9109,a,0,0
9110,central,0,0
9111,fat,0,0
9112,distribution,0,0
9113,.,0,0
9114,Ropivacaine-clonidine,1,1
9115,combination,1,1
9116,for,0,0
9117,caudal,0,0
9118,blockade,0,0
9119,in,0,0
9120,children,0,0
9121,.,0,0
9122,BACKGROUND,0,0
9123,Adding,0,0
9124,clonidine,1,1
9125,to,0,0
9126,weak,1,0
9127,ropivacaine,1,1
9128,solutions,1,1
9129,(,0,0
9130,<,0,0
9131,0.2,0,1
9132,%,0,0
9133,),0,0
9134,could,0,0
9135,potentially,0,0
9136,enhance,0,0
9137,analgesia,0,0
9138,as,0,0
9139,well,0,0
9140,as,0,0
9141,further,0,0
9142,reduce,0,0
9143,the,0,0
9144,risk,0,0
9145,for,0,0
9146,unwanted,0,0
9147,motor,0,0
9148,blockade,0,0
9149,.,0,0
9150,The,0,0
9151,aim,0,0
9152,of,0,0
9153,the,0,0
9154,present,0,0
9155,study,0,0
9156,was,0,0
9157,to,0,0
9158,compare,0,0
9159,the,0,0
9160,postoperative,0,0
9161,pain-relieving,0,0
9162,quality,0,0
9163,of,0,0
9164,a,0,0
9165,ropivacaine,1,1
9166,0.1,1,0
9167,%,1,0
9168,-clonidine,1,1
9169,mixture,1,1
9170,to,0,0
9171,that,0,0
9172,of,0,0
9173,plain,1,0
9174,ropivacaine,1,1
9175,0.2,0,0
9176,%,0,0
9177,following,0,0
9178,caudal,0,0
9179,administration,0,0
9180,in,0,0
9181,children,0,0
9182,.,0,0
9183,METHODS,0,0
9184,In,0,0
9185,a,0,0
9186,prospective,0,0
9187,",",0,0
9188,observer-blinded,0,0
9189,fashion,0,0
9190,",",0,0
9191,40,0,0
9192,ASA,0,0
9193,1,0,0
9194,paediatric,0,0
9195,patients,0,0
9196,undergoing,0,0
9197,subumbilical,0,0
9198,surgery,0,0
9199,were,0,0
9200,randomly,1,0
9201,allocated,1,0
9202,to,1,0
9203,receive,1,0
9204,a,1,0
9205,caudal,1,0
9206,injection,1,0
9207,of,1,0
9208,either,1,0
9209,plain,1,1
9210,ropivacaine,1,1
9211,0.2,1,0
9212,%,1,0
9213,(,1,0
9214,1,1,0
9215,ml/kg,1,0
9216,),1,0
9217,(,1,0
9218,R0.2,1,1
9219,),1,0
9220,or,1,1
9221,a,1,0
9222,mixture,1,1
9223,of,1,0
9224,ropivacaine,1,1
9225,0.1,1,0
9226,%,1,0
9227,with,1,0
9228,clonidine,1,1
9229,2,1,0
9230,microg/kg,1,1
9231,(,1,0
9232,1,1,0
9233,ml/kg,1,0
9234,),1,0
9235,(,1,0
9236,R0.1C,1,0
9237,),1,0
9238,.,0,0
9239,Objective,1,0
9240,pain,1,0
9241,scale,1,0
9242,score,1,0
9243,and,1,0
9244,need,1,0
9245,for,1,0
9246,supplemental,1,0
9247,analgesia,1,0
9248,were,1,0
9249,used,1,0
9250,to,1,0
9251,evaluate,1,0
9252,analgesia,1,0
9253,during,1,0
9254,the,1,0
9255,first,1,0
9256,24,1,0
9257,h,1,0
9258,postoperatively,1,0
9259,.,1,0
9260,Residual,1,0
9261,postoperative,1,0
9262,sedation,1,0
9263,was,1,0
9264,also,1,0
9265,assessed,1,0
9266,.,1,0
9267,RESULTS,0,0
9268,A,0,0
9269,significantly,0,0
9270,higher,0,0
9271,number,0,0
9272,of,0,0
9273,patients,0,0
9274,in,0,0
9275,the,0,0
9276,R0.1C,0,0
9277,group,0,0
9278,(,0,0
9279,18/20,0,0
9280,),0,0
9281,could,0,0
9282,be,0,0
9283,managed,0,0
9284,without,0,0
9285,supplemental,0,0
9286,analgesia,0,0
9287,during,0,0
9288,the,0,0
9289,first,0,0
9290,24,0,0
9291,h,0,0
9292,postoperatively,0,0
9293,compared,0,0
9294,to,0,0
9295,the,0,0
9296,R0.2,0,1
9297,group,0,0
9298,(,0,0
9299,11/20,0,0
9300,),0,0
9301,(,0,0
9302,P=0.034,0,0
9303,),0,0
9304,.,0,0
9305,Both,0,0
9306,the,0,0
9307,degree,0,0
9308,and,0,0
9309,the,0,0
9310,duration,0,0
9311,of,0,0
9312,postoperative,0,0
9313,sedation,0,0
9314,was,0,0
9315,similar,0,0
9316,in,0,0
9317,both,0,0
9318,groups,0,0
9319,.,0,0
9320,No,0,0
9321,signs,0,0
9322,of,0,0
9323,postoperative,0,0
9324,motor,0,0
9325,blockade,0,0
9326,were,0,0
9327,observed,0,0
9328,.,0,0
9329,CONCLUSIONS,0,0
9330,The,0,0
9331,combination,0,1
9332,of,0,0
9333,clonidine,1,1
9334,(,1,0
9335,2,1,0
9336,microg/kg,1,1
9337,),1,0
9338,and,1,0
9339,ropivacaine,1,1
9340,0.1,1,0
9341,%,1,0
9342,is,0,0
9343,associated,0,0
9344,with,0,0
9345,an,0,0
9346,improved,0,0
9347,quality,0,0
9348,of,0,0
9349,postoperative,0,0
9350,analgesia,0,0
9351,compared,0,0
9352,to,0,0
9353,plain,1,1
9354,0.2,1,0
9355,%,1,0
9356,ropivacaine,1,1
9357,.,1,0
9358,The,0,0
9359,improved,0,0
9360,analgesic,0,0
9361,quality,0,0
9362,of,0,0
9363,the,0,0
9364,clonidine-ropivacaine,0,1
9365,mixture,0,1
9366,is,0,0
9367,achieved,0,0
9368,without,0,0
9369,causing,0,0
9370,any,0,0
9371,significant,0,0
9372,degree,0,0
9373,of,0,0
9374,postoperative,0,0
9375,sedation,0,0
9376,.,0,0
9377,Secretin,0,1
9378,and,0,0
9379,autism,0,0
9380,:,0,0
9381,a,0,0
9382,two-part,0,0
9383,clinical,0,0
9384,investigation,0,0
9385,.,0,0
9386,Recent,0,0
9387,anecdotal,0,0
9388,reports,0,0
9389,have,0,0
9390,touted,0,0
9391,the,0,0
9392,gastrointestinal,0,0
9393,(,0,0
9394,GI,0,0
9395,),0,1
9396,hormone,0,1
9397,secretin,1,1
9398,as,0,0
9399,a,0,0
9400,treatment,0,0
9401,modality,0,0
9402,for,0,0
9403,autism,0,0
9404,",",0,0
9405,though,0,0
9406,there,0,0
9407,is,0,0
9408,little,0,0
9409,clinical,0,0
9410,evidence,0,0
9411,or,0,1
9412,literature,0,0
9413,to,0,0
9414,support,0,0
9415,its,0,0
9416,viability,0,0
9417,.,0,0
9418,We,0,0
9419,undertook,0,0
9420,a,0,0
9421,two-part,0,0
9422,clinical,0,0
9423,trial,0,0
9424,to,0,0
9425,investigate,0,0
9426,these,0,0
9427,claims,0,0
9428,.,0,0
9429,Fifty-six,0,0
9430,patients,0,0
9431,(,0,0
9432,49,0,0
9433,boys,0,0
9434,",",0,0
9435,7,0,0
9436,girls,0,0
9437,",",0,0
9438,mean,0,0
9439,age,0,0
9440,=,0,0
9441,6.4,0,0
9442,years,0,0
9443,",",0,0
9444,SD,0,0
9445,=,0,0
9446,2.7,0,0
9447,),0,0
9448,enrolled,0,0
9449,in,0,0
9450,an,0,0
9451,open-label,0,0
9452,trial,0,0
9453,of,0,0
9454,secretin,1,1
9455,",",0,0
9456,during,0,0
9457,which,0,0
9458,they,0,0
9459,received,0,0
9460,one,0,0
9461,injection,0,0
9462,of,0,0
9463,the,0,0
9464,hormone,0,1
9465,(,0,0
9466,2,0,0
9467,IU/kg,0,0
9468,),0,0
9469,.,0,0
9470,All,0,0
9471,subjects,0,0
9472,were,0,0
9473,evaluated,0,0
9474,by,0,0
9475,their,0,0
9476,parents,0,0
9477,at,0,0
9478,baseline,0,0
9479,and,0,0
9480,follow-up,0,0
9481,visits,0,0
9482,(,0,0
9483,3-6,0,0
9484,weeks,0,0
9485,later,0,0
9486,",",0,0
9487,M,0,0
9488,=,0,0
9489,3.7,0,0
9490,",",0,0
9491,SD,0,0
9492,=,0,0
9493,1.4,0,0
9494,weeks,0,0
9495,),0,0
9496,with,0,0
9497,Childhood,0,0
9498,Autism,0,0
9499,Rating,0,0
9500,Scales,0,0
9501,(,0,0
9502,CARS,0,0
9503,),0,0
9504,.,0,0
9505,Thirty-four,0,0
9506,patients,0,0
9507,were,0,0
9508,labeled,0,0
9509,with,0,0
9510,Pervasive,0,0
9511,Developmental,0,0
9512,Disorder,0,0
9513,Not,0,1
9514,Otherwise,0,0
9515,Specified,0,0
9516,",",0,0
9517,and,0,0
9518,22,0,0
9519,met,0,0
9520,diagnostic,0,0
9521,criteria,0,0
9522,for,0,0
9523,Autistic,0,0
9524,Disorder,0,0
9525,.,0,0
9526,Forty-five,0,0
9527,patients,0,0
9528,were,0,0
9529,concurrently,0,0
9530,on,0,0
9531,other,0,0
9532,drug,0,0
9533,treatments,0,0
9534,.,0,0
9535,At,0,0
9536,follow-up,0,0
9537,",",0,0
9538,some,0,0
9539,reported,0,0
9540,minimal,0,0
9541,but,0,0
9542,potentially,0,0
9543,significant,0,0
9544,improvements,0,0
9545,including,0,0
9546,changes,0,0
9547,in,0,0
9548,GI,0,0
9549,symptoms,0,0
9550,",",0,0
9551,expressive,0,0
9552,and/or,0,0
9553,receptive,0,0
9554,language,0,0
9555,function,0,0
9556,",",0,0
9557,and,0,0
9558,improved,0,0
9559,awareness,0,0
9560,and,0,0
9561,social,0,0
9562,interactions,0,0
9563,.,0,0
9564,No,0,0
9565,adverse,0,0
9566,effects,0,0
9567,were,0,0
9568,reported,0,0
9569,or,0,0
9570,observed,0,0
9571,.,0,0
9572,Subsequently,0,0
9573,",",0,0
9574,17,0,0
9575,of,0,0
9576,the,0,0
9577,most,0,0
9578,responsive,0,0
9579,patients,0,0
9580,from,0,0
9581,Study,0,0
9582,1,0,0
9583,began,0,0
9584,a,0,0
9585,double-blind,0,0
9586,trial,0,0
9587,that,0,0
9588,also,0,0
9589,included,0,0
9590,8,0,0
9591,newly,0,0
9592,enrolled,0,0
9593,patients,0,0
9594,.,0,0
9595,Patients,0,0
9596,in,0,0
9597,this,0,0
9598,second,0,0
9599,study,0,0
9600,were,0,0
9601,alternatively,0,0
9602,entered,0,0
9603,into,0,0
9604,one,0,0
9605,of,0,0
9606,two,0,0
9607,groups,0,0
9608,and,0,0
9609,received,0,0
9610,injections,0,1
9611,of,0,0
9612,secretin,1,1
9613,or,1,1
9614,placebo,1,1
9615,with,0,0
9616,crossover,0,0
9617,at,0,0
9618,4,0,0
9619,weeks,0,0
9620,.,0,0
9621,Patients,0,0
9622,from,0,0
9623,Study,0,0
9624,1,0,0
9625,entered,0,0
9626,into,0,0
9627,Study,0,0
9628,2,0,0
9629,at,0,0
9630,an,0,0
9631,average,0,0
9632,of,0,0
9633,6.5,0,0
9634,(,0,0
9635,SD,0,0
9636,=,0,0
9637,0.8,0,0
9638,),0,0
9639,weeks,0,0
9640,after,0,0
9641,beginning,0,0
9642,Study,0,0
9643,1,0,0
9644,.,0,0
9645,Results,0,0
9646,of,0,0
9647,both,0,0
9648,inquiries,0,0
9649,indicate,0,0
9650,that,0,0
9651,although,0,0
9652,treatment,0,0
9653,with,0,0
9654,secretin,1,1
9655,was,0,0
9656,reported,0,0
9657,to,0,0
9658,cause,0,0
9659,transient,0,0
9660,changes,0,0
9661,in,0,0
9662,speech,0,1
9663,and,0,0
9664,behavior,0,0
9665,in,0,0
9666,some,0,0
9667,children,0,0
9668,",",0,0
9669,overall,0,0
9670,it,0,0
9671,produced,0,0
9672,few,0,0
9673,clinically,0,0
9674,meaningful,0,0
9675,changes,0,0
9676,when,0,0
9677,compared,0,0
9678,to,0,0
9679,children,0,0
9680,given,0,0
9681,placebo,1,1
9682,injections,0,1
9683,.,0,0
9684,Assessment,0,0
9685,in,0,0
9686,multisite,0,0
9687,randomized,0,0
9688,clinical,0,0
9689,trials,0,0
9690,of,0,0
9691,patients,0,0
9692,with,0,0
9693,autistic,0,0
9694,disorder,0,0
9695,:,0,0
9696,the,0,0
9697,Autism,0,0
9698,RUPP,0,0
9699,Network,0,0
9700,.,0,0
9701,Research,0,0
9702,Units,0,0
9703,on,0,0
9704,Pediatric,0,0
9705,Psychopharmacology,0,0
9706,.,0,0
9707,Assessment,0,0
9708,of,0,0
9709,autistic,0,0
9710,disorder,0,0
9711,(,0,0
9712,autism,0,0
9713,),0,0
9714,symptoms,0,0
9715,",",0,0
9716,primary,0,0
9717,and,0,0
9718,secondary,0,0
9719,",",0,0
9720,poses,0,0
9721,more,0,0
9722,challenging,0,0
9723,problems,0,0
9724,than,0,0
9725,ordinarily,0,0
9726,found,0,0
9727,in,0,0
9728,multisite,0,0
9729,randomized,0,0
9730,clinical,0,0
9731,trial,0,0
9732,(,0,0
9733,RCT,0,0
9734,),0,0
9735,assessments,0,0
9736,.,0,0
9737,For,0,0
9738,example,0,0
9739,",",0,0
9740,subjects,0,0
9741,may,0,0
9742,be,0,0
9743,uncommunicative,0,0
9744,and,0,0
9745,extremely,0,0
9746,heterogeneous,0,0
9747,in,0,0
9748,problem,0,0
9749,presentation,0,0
9750,",",0,0
9751,and,0,0
9752,current,0,0
9753,pharmacological,0,0
9754,treatments,0,0
9755,are,0,0
9756,not,0,0
9757,likely,0,0
9758,to,0,0
9759,alter,0,0
9760,most,0,0
9761,core,0,0
9762,features,0,0
9763,of,0,0
9764,autism,0,0
9765,.,0,0
9766,The,0,0
9767,Autism,0,0
9768,Research,0,0
9769,Units,0,0
9770,on,0,0
9771,Pediatric,0,1
9772,Psychopharmacology,0,0
9773,(,0,0
9774,RUPP,0,1
9775,Autism,0,0
9776,Network,0,1
9777,),0,0
9778,resolved,0,0
9779,some,0,0
9780,of,0,0
9781,these,0,0
9782,problems,0,0
9783,during,0,0
9784,the,0,0
9785,design,0,0
9786,of,0,0
9787,a,0,0
9788,risperidone,1,1
9789,RCT,1,0
9790,in,0,0
9791,children/adolescents,0,0
9792,.,0,0
9793,The,0,0
9794,inappropriateness,0,0
9795,of,0,0
9796,the,0,0
9797,usual,0,0
9798,anchors,0,0
9799,for,0,0
9800,a,0,0
9801,Clinical,0,0
9802,Global,0,0
9803,Impression,0,0
9804,of,0,0
9805,Severity,0,0
9806,(,0,0
9807,CGI-S,0,1
9808,),0,0
9809,was,0,0
9810,resolved,0,0
9811,by,0,0
9812,defining,0,0
9813,uncomplicated,0,0
9814,autism,0,0
9815,without,0,0
9816,secondary,0,0
9817,symptoms,0,0
9818,as,0,0
9819,a,0,0
9820,CGI-S,0,0
9821,of,0,0
9822,3,0,0
9823,",",0,0
9824,mildly,0,0
9825,ill,0,0
9826,.,0,0
9827,The,0,0
9828,communication,0,0
9829,problems,0,0
9830,",",0,0
9831,compromising,0,0
9832,use,0,0
9833,of,0,0
9834,the,0,0
9835,patient,0,0
9836,as,0,0
9837,an,0,0
9838,informant,0,0
9839,",",0,0
9840,were,0,0
9841,addressed,0,0
9842,by,0,0
9843,several,0,0
9844,strategies,0,0
9845,",",0,0
9846,including,0,0
9847,careful,1,0
9848,questioning,1,0
9849,of,1,0
9850,care,1,0
9851,providers,1,0
9852,",",1,0
9853,rating,1,0
9854,scales,1,0
9855,",",1,0
9856,laboratory,1,0
9857,tests,1,0
9858,",",1,0
9859,and,1,0
9860,physical,1,0
9861,exams,1,0
9862,.,1,0
9863,The,0,0
9864,broad,0,0
9865,subject,0,0
9866,heterogeneity,0,0
9867,requires,0,0
9868,outcome,0,0
9869,measures,0,0
9870,sensitive,0,0
9871,to,0,0
9872,individual,0,0
9873,change,0,0
9874,over,0,0
9875,a,0,0
9876,wide,0,0
9877,spectrum,0,0
9878,of,0,0
9879,treatment,0,0
9880,response,0,0
9881,and,0,0
9882,side,0,0
9883,effects,0,0
9884,.,0,0
9885,The,0,0
9886,problems,0,0
9887,of,0,0
9888,neuropsychologically,0,0
9889,testing,0,0
9890,nonverbal,0,0
9891,",",0,0
9892,lower,0,0
9893,functioning,0,0
9894,",",0,0
9895,sometimes,0,0
9896,noncompliant,0,0
9897,subjects,0,0
9898,requires,0,0
9899,careful,0,0
9900,instrument,0,0
9901,selection/adaptation,0,0
9902,and,0,0
9903,flexible,0,1
9904,administration,0,0
9905,techniques,0,1
9906,.,0,0
9907,The,0,0
9908,problems,0,0
9909,of,0,0
9910,assessing,0,0
9911,low-end,0,1
9912,IQs,0,0
9913,",",0,0
9914,neglected,0,0
9915,by,0,0
9916,most,0,0
9917,standardized,0,0
9918,test,0,0
9919,developers,0,0
9920,",",0,0
9921,was,0,0
9922,resolved,0,0
9923,by,0,0
9924,an,0,0
9925,algorithm,0,0
9926,of,0,0
9927,test,0,0
9928,hierarchy,0,0
9929,.,0,0
9930,Scarcity,0,0
9931,of,0,0
9932,other,0,0
9933,autism-adapted,0,0
9934,cognitive,0,0
9935,and,0,0
9936,neuropsychological,0,0
9937,tests,0,0
9938,and,0,0
9939,lack,0,0
9940,of,0,0
9941,standardization,0,0
9942,required,0,0
9943,development,0,0
9944,of,0,0
9945,a,0,0
9946,new,0,0
9947,",",0,0
9948,specially,0,0
9949,adapted,0,0
9950,battery,0,1
9951,.,0,0
9952,Reliability,0,0
9953,on,0,0
9954,the,0,0
9955,Autism,0,0
9956,Diagnostic,0,0
9957,Interview,0,1
9958,(,0,0
9959,currently,0,0
9960,the,0,0
9961,most,0,0
9962,valid,0,0
9963,diagnostic,0,0
9964,instrument,0,0
9965,),0,0
9966,and,0,0
9967,other,0,0
9968,clinician,0,0
9969,instruments,0,0
9970,required,0,0
9971,extensive,0,0
9972,cross-site,0,0
9973,training,0,1
9974,(,0,0
9975,in-person,0,1
9976,",",0,0
9977,videotape,0,1
9978,",",0,0
9979,and,0,0
9980,teleconference,0,1
9981,sessions,0,1
9982,),0,0
9983,.,0,0
9984,Definition,0,0
9985,of,0,0
9986,a,0,0
9987,treatment,0,0
9988,responder,0,0
9989,required,0,0
9990,focus,0,0
9991,on,0,0
9992,individually,0,0
9993,relevant,0,0
9994,target,0,0
9995,symptoms,0,0
9996,",",0,0
9997,synthesis,0,0
9998,of,0,0
9999,possible,0,0
10000,modest,0,0
10001,improvements,0,0
10002,in,0,0
10003,many,0,0
10004,domains,0,0
10005,",",0,0
10006,and,0,0
10007,acceptance,0,0
10008,of,0,0
10009,attainable,0,0
10010,though,0,0
10011,imperfect,0,0
10012,goals,0,0
10013,.,0,0
10014,The,0,0
10015,assessment,1,0
10016,strategy,1,0
10017,developed,0,0
10018,is,0,0
10019,implemented,0,0
10020,in,0,0
10021,a,0,0
10022,RCT,0,0
10023,of,0,0
10024,risperidone,1,1
10025,(,0,0
10026,McDougle,0,0
10027,et,0,0
10028,al.,0,0
10029,",",0,0
10030,2000,0,0
10031,),0,0
10032,for,0,0
10033,which,0,0
10034,the,0,0
10035,design,0,0
10036,and,0,0
10037,other,0,0
10038,methodological,0,0
10039,challenges,0,0
10040,are,0,0
10041,described,0,0
10042,elsewhere,0,0
10043,(,0,0
10044,Scahill,0,0
10045,et,0,0
10046,al.,0,0
10047,",",0,0
10048,2000,0,0
10049,),0,0
10050,.,0,0
10051,Some,0,0
10052,of,0,0
10053,these,0,0
10054,problems,0,0
10055,and,0,0
10056,solutions,0,0
10057,are,0,0
10058,partially,0,0
10059,shared,0,0
10060,with,0,0
10061,RCTs,0,0
10062,of,0,0
10063,other,0,0
10064,treatments,0,0
10065,and,0,0
10066,other,0,0
10067,disorders,0,0
10068,.,0,0
10069,Plasma,0,0
10070,antioxidant,0,1
10071,status,0,0
10072,after,0,0
10073,high-dose,1,1
10074,chemotherapy,1,1
10075,:,1,0
10076,a,0,0
10077,randomized,0,0
10078,trial,0,0
10079,of,0,0
10080,parenteral,0,1
10081,nutrition,0,1
10082,in,0,0
10083,bone,0,0
10084,marrow,0,0
10085,transplantation,0,0
10086,patients,0,0
10087,.,0,0
10088,BACKGROUND,0,0
10089,Chemotherapy,1,1
10090,and,1,0
10091,radiation,1,1
10092,therapy,1,1
10093,result,0,0
10094,in,0,0
10095,increased,0,0
10096,free,0,0
10097,radical,0,1
10098,formation,0,0
10099,and,0,0
10100,depletion,0,0
10101,of,0,0
10102,tissue,0,0
10103,antioxidants,0,1
10104,.,0,0
10105,It,0,0
10106,is,0,0
10107,not,0,0
10108,known,0,0
10109,whether,0,0
10110,parenteral,1,1
10111,nutrition,1,1
10112,(,1,0
10113,PN,1,1
10114,),1,0
10115,administered,0,0
10116,during,0,0
10117,bone,1,0
10118,marrow,1,0
10119,transplantation,1,1
10120,(,1,0
10121,BMT,1,0
10122,),1,1
10123,supports,0,0
10124,systemic,0,0
10125,antioxidant,0,0
10126,status,0,0
10127,.,0,0
10128,OBJECTIVE,0,0
10129,The,0,0
10130,aims,0,0
10131,of,0,0
10132,the,0,0
10133,study,0,0
10134,were,0,0
10135,to,0,0
10136,determine,0,0
10137,1,0,0
10138,),0,0
10139,whether,0,0
10140,high-dose,1,1
10141,chemotherapy,1,1
10142,decreases,0,0
10143,concentrations,0,0
10144,of,0,0
10145,major,0,0
10146,circulating,0,0
10147,antioxidants,0,1
10148,in,0,0
10149,patients,0,0
10150,undergoing,0,0
10151,BMT,1,0
10152,and,0,0
10153,2,0,0
10154,),0,0
10155,whether,0,0
10156,administration,0,0
10157,of,0,0
10158,standard,0,1
10159,PN,1,1
10160,maintains,0,0
10161,systemic,0,0
10162,antioxidant,0,0
10163,concentrations,0,0
10164,compared,0,0
10165,with,0,0
10166,PN,1,1
10167,containing,0,1
10168,micronutrients,0,0
10169,and,0,0
10170,minimal,0,0
10171,lipids,0,0
10172,alone,0,0
10173,.,0,0
10174,DESIGN,0,0
10175,Twenty-four,0,0
10176,BMT,1,0
10177,patients,0,0
10178,were,0,0
10179,randomly,0,0
10180,assigned,0,0
10181,to,0,0
10182,receive,0,0
10183,either,0,0
10184,standard,1,1
10185,PN,1,1
10186,containing,1,1
10187,conventional,1,1
10188,amounts,1,0
10189,of,1,0
10190,dextrose,1,1
10191,",",1,0
10192,amino,1,1
10193,acids,1,1
10194,",",1,0
10195,micronutrients,1,0
10196,",",1,0
10197,and,1,0
10198,lipid,1,0
10199,(,0,0
10200,120,0,0
10201,kJ/d,0,0
10202,),0,0
10203,or,0,1
10204,a,0,0
10205,solution,1,1
10206,containing,1,1
10207,only,1,0
10208,micronutrients,1,1
10209,(,0,0
10210,identical,0,0
10211,to,0,0
10212,those,0,0
10213,in,0,0
10214,standard,0,1
10215,PN,0,1
10216,),0,0
10217,and,0,0
10218,a,0,0
10219,small,0,0
10220,amount,0,0
10221,of,0,0
10222,lipid,0,0
10223,(,0,0
10224,12,0,0
10225,kJ/d,0,0
10226,),0,0
10227,.,0,0
10228,Plasma,0,0
10229,antioxidant,0,1
10230,status,0,0
10231,was,0,0
10232,measured,0,0
10233,before,0,0
10234,conditioning,0,1
10235,therapy,0,1
10236,and,0,0
10237,serially,0,0
10238,at,0,0
10239,days,0,0
10240,1,0,0
10241,",",0,0
10242,3,0,0
10243,",",0,0
10244,7,0,0
10245,",",0,0
10246,10,0,0
10247,",",0,0
10248,and,0,0
10249,14,0,0
10250,after,0,0
10251,BMT,0,0
10252,.,0,0
10253,RESULTS,0,0
10254,Plasma,0,0
10255,glutathione,0,1
10256,(,0,0
10257,GSH,0,1
10258,),0,1
10259,and,0,0
10260,alpha-,0,1
10261,and,0,0
10262,gamma-tocopherol,0,1
10263,concentrations,0,0
10264,decreased,0,0
10265,and,0,0
10266,the,0,0
10267,GSH,0,1
10268,redox,0,0
10269,state,0,0
10270,became,0,0
10271,more,0,0
10272,oxidized,0,0
10273,after,0,0
10274,conditioning,0,1
10275,chemotherapy,0,1
10276,.,0,0
10277,Plasma,0,0
10278,cysteine,0,1
10279,concentrations,0,0
10280,were,0,0
10281,unchanged,0,0
10282,",",0,0
10283,whereas,0,0
10284,cystine,0,0
10285,concentrations,0,0
10286,increased,0,0
10287,.,0,0
10288,Plasma,0,0
10289,vitamin,0,1
10290,C,0,1
10291,and,0,0
10292,zinc,0,1
10293,concentrations,0,0
10294,and,0,0
10295,GSH,0,1
10296,peroxidase,0,1
10297,activity,0,0
10298,increased,0,0
10299,over,0,0
10300,time,0,0
10301,.,0,0
10302,Plasma,0,0
10303,alpha-tocopherol,0,1
10304,concentrations,0,0
10305,were,0,0
10306,lower,0,0
10307,in,0,0
10308,patients,0,0
10309,given,0,0
10310,standard,0,0
10311,PN,0,1
10312,.,0,0
10313,There,0,0
10314,were,0,0
10315,no,0,0
10316,differences,0,0
10317,in,0,0
10318,other,0,0
10319,plasma,0,0
10320,antioxidants,0,1
10321,between,0,0
10322,groups,0,0
10323,.,0,0
10324,CONCLUSIONS,0,0
10325,A,0,0
10326,significant,0,0
10327,decline,0,0
10328,in,0,0
10329,GSH-glutathione,0,0
10330,disulfide,0,1
10331,",",0,0
10332,cysteine-cystine,0,1
10333,",",0,0
10334,and,0,0
10335,vitamin,0,1
10336,E,0,1
10337,status,0,0
10338,occurs,0,0
10339,after,0,0
10340,chemotherapy,1,1
10341,and,1,0
10342,BMT,1,0
10343,.,1,0
10344,Standard,0,1
10345,PN,0,1
10346,does,0,0
10347,not,0,0
10348,improve,0,0
10349,antioxidant,0,1
10350,status,0,0
10351,compared,0,0
10352,with,0,0
10353,administration,0,0
10354,of,0,0
10355,micronutrients,0,0
10356,alone,0,0
10357,.,0,0
10358,Further,0,0
10359,evaluation,0,0
10360,of,0,0
10361,PN,0,1
10362,formulations,0,0
10363,to,0,0
10364,support,0,0
10365,patients,0,0
10366,undergoing,0,0
10367,high-dose,1,1
10368,chemotherapy,1,1
10369,and,0,0
10370,BMT,1,0
10371,are,0,0
10372,needed,0,0
10373,.,0,0
10374,The,0,0
10375,Finnish,0,0
10376,Diabetes,0,0
10377,Prevention,0,1
10378,Study,0,0
10379,.,0,0
10380,The,0,0
10381,aim,0,0
10382,of,0,0
10383,the,0,0
10384,Finnish,0,0
10385,Diabetes,0,0
10386,Prevention,0,1
10387,Study,0,0
10388,is,0,0
10389,to,0,0
10390,assess,0,0
10391,the,0,0
10392,efficacy,0,0
10393,of,0,0
10394,an,0,0
10395,intensive,1,1
10396,diet-exercise,1,1
10397,programme,1,1
10398,in,0,0
10399,preventing,0,0
10400,or,0,1
10401,delaying,0,0
10402,type,0,0
10403,2,0,0
10404,diabetes,0,0
10405,in,0,0
10406,individuals,0,0
10407,with,0,0
10408,impaired,0,0
10409,glucose,0,0
10410,tolerance,0,0
10411,(,0,0
10412,IGT,0,1
10413,),0,0
10414,and,0,0
10415,to,0,0
10416,evaluate,0,0
10417,the,0,0
10418,effect,0,0
10419,of,0,0
10420,the,0,0
10421,programme,0,1
10422,on,0,0
10423,the,0,0
10424,risk,0,0
10425,factors,0,0
10426,of,0,0
10427,atherosclerotic,0,0
10428,vascular,0,0
10429,diseases,0,0
10430,and,0,0
10431,the,0,0
10432,incidence,0,0
10433,of,0,0
10434,cardiovascular,0,0
10435,events,0,0
10436,.,0,0
10437,In,0,0
10438,this,0,0
10439,ongoing,0,0
10440,study,0,0
10441,",",0,0
10442,a,0,0
10443,total,0,0
10444,of,0,0
10445,523,0,0
10446,overweight,0,0
10447,subjects,0,0
10448,with,0,0
10449,IGT,0,0
10450,based,0,0
10451,on,0,0
10452,two,0,0
10453,oral,0,0
10454,glucose,0,0
10455,tolerance,0,0
10456,tests,0,0
10457,were,0,0
10458,randomized,0,0
10459,to,0,0
10460,either,0,0
10461,an,0,0
10462,intervention,0,1
10463,group,0,0
10464,or,0,1
10465,a,0,0
10466,control,0,0
10467,group,0,0
10468,.,0,0
10469,The,0,0
10470,main,0,0
10471,measure,0,0
10472,in,0,0
10473,the,0,0
10474,intervention,0,1
10475,group,0,0
10476,is,0,0
10477,individual,1,0
10478,dietary,1,0
10479,advice,1,1
10480,aimed,0,0
10481,at,0,0
10482,reducing,1,0
10483,weight,1,0
10484,and,1,0
10485,intake,1,0
10486,of,1,0
10487,saturated,1,0
10488,fat,1,0
10489,and,1,0
10490,increasing,1,0
10491,intake,1,0
10492,of,1,0
10493,dietary,1,0
10494,fibre,1,1
10495,.,1,0
10496,The,0,0
10497,intervention,0,0
10498,subjects,0,0
10499,are,0,0
10500,individually,0,0
10501,guided,0,1
10502,to,0,0
10503,increase,1,0
10504,their,1,0
10505,level,1,0
10506,of,1,0
10507,physical,1,0
10508,activity,1,0
10509,.,1,0
10510,The,0,0
10511,control,1,0
10512,group,1,0
10513,receives,1,0
10514,general,1,0
10515,information,1,0
10516,about,1,0
10517,the,1,0
10518,benefits,1,0
10519,of,1,0
10520,weight,1,0
10521,reduction,1,0
10522,",",1,0
10523,physical,1,1
10524,activity,1,0
10525,and,1,0
10526,healthy,1,0
10527,diet,1,1
10528,in,1,0
10529,the,1,0
10530,prevention,1,0
10531,of,1,0
10532,diabetes,1,0
10533,.,1,0
10534,A,0,0
10535,pilot,0,0
10536,study,0,0
10537,began,0,0
10538,in,0,0
10539,1993,0,0
10540,",",0,0
10541,and,0,0
10542,recruitment,0,0
10543,ended,0,0
10544,in,0,0
10545,1998,0,0
10546,.,0,0
10547,By,0,0
10548,the,0,0
10549,end,0,0
10550,of,0,0
10551,April,0,1
10552,1999,0,0
10553,there,0,0
10554,were,0,0
10555,65,0,0
10556,new,0,0
10557,cases,0,0
10558,of,0,0
10559,diabetes,0,0
10560,",",0,0
10561,34,0,0
10562,drop-outs,0,0
10563,and,0,0
10564,one,0,0
10565,death,0,0
10566,.,0,0
10567,The,0,0
10568,weight,0,0
10569,reduction,0,0
10570,was,0,0
10571,greater,0,0
10572,(,0,0
10573,-4.6,0,0
10574,kg,0,1
10575,),0,0
10576,at,0,0
10577,1,0,0
10578,year,0,0
10579,in,0,0
10580,the,0,0
10581,intervention,0,1
10582,group,0,0
10583,(,0,0
10584,n,0,0
10585,=,0,0
10586,152,0,0
10587,),0,0
10588,than,0,0
10589,in,0,0
10590,the,0,0
10591,control,0,1
10592,group,0,0
10593,(,0,0
10594,n,0,0
10595,=,0,0
10596,143,0,0
10597,",",0,0
10598,-0.9,0,0
10599,kg,0,0
10600,",",0,0
10601,P,0,0
10602,<,0,0
10603,0.0001,0,0
10604,),0,0
10605,",",0,0
10606,and,0,0
10607,this,0,0
10608,difference,0,0
10609,was,0,0
10610,sustained,0,0
10611,in,0,0
10612,the,0,0
10613,second,0,0
10614,year,0,0
10615,of,0,0
10616,follow-up,0,0
10617,.,0,0
10618,At,0,0
10619,1,0,0
10620,year,0,0
10621,43.4,0,0
10622,%,0,0
10623,and,0,0
10624,at,0,0
10625,2,0,0
10626,years,0,0
10627,41.8,0,0
10628,%,0,0
10629,of,0,0
10630,the,0,0
10631,intervention,0,1
10632,subjects,0,0
10633,had,0,0
10634,achieved,0,0
10635,a,0,0
10636,weight,0,0
10637,reduction,0,0
10638,of,0,0
10639,at,0,0
10640,least,0,0
10641,5,0,0
10642,kg,0,0
10643,",",0,0
10644,while,0,0
10645,the,0,0
10646,corresponding,0,0
10647,figures,0,0
10648,for,0,0
10649,the,0,0
10650,control,0,0
10651,subjects,0,0
10652,were,0,0
10653,14.0,0,0
10654,and,0,0
10655,12.0,0,0
10656,%,0,0
10657,(,0,0
10658,P,0,0
10659,<,0,0
10660,0.001,0,0
10661,between,0,0
10662,the,0,0
10663,groups,0,0
10664,),0,0
10665,.,0,0
10666,At,0,0
10667,1,0,0
10668,year,0,0
10669,the,0,0
10670,intervention,0,1
10671,group,0,0
10672,showed,0,0
10673,significantly,0,0
10674,greater,0,0
10675,reductions,0,0
10676,in,0,0
10677,2,0,0
10678,h,0,0
10679,glucose,0,0
10680,",",0,0
10681,fasting,0,0
10682,and,0,0
10683,2,0,0
10684,h,0,0
10685,insulin,0,1
10686,",",0,0
10687,systolic,0,0
10688,and,0,0
10689,diastolic,0,0
10690,blood,0,0
10691,pressure,0,0
10692,",",0,0
10693,and,0,0
10694,serum,0,0
10695,triglycerides,0,0
10696,.,0,0
10697,Most,0,0
10698,of,0,0
10699,the,0,0
10700,beneficial,0,0
10701,changes,0,0
10702,in,0,0
10703,cardiovascular,0,0
10704,risk,0,0
10705,factors,0,0
10706,were,0,0
10707,sustained,0,0
10708,for,0,0
10709,2,0,0
10710,years,0,0
10711,.,0,0
10712,These,0,0
10713,interim,0,0
10714,results,0,0
10715,of,0,0
10716,the,0,0
10717,ongoing,0,0
10718,Finnish,0,0
10719,Diabetes,0,0
10720,Prevention,0,1
10721,Study,0,0
10722,demonstrate,0,0
10723,the,0,0
10724,efficacy,0,0
10725,and,0,0
10726,feasibility,0,0
10727,of,0,0
10728,the,0,0
10729,lifestyle,0,1
10730,intervention,0,1
10731,programme,0,1
10732,.,0,0
10733,5-fluorouracil,1,1
10734,plus,1,1
10735,folinic,1,1
10736,acid,1,1
10737,with,0,0
10738,or,0,0
10739,without,0,0
10740,ifosfamide,1,1
10741,in,0,0
10742,advanced,0,0
10743,colorectal,0,0
10744,cancer,0,0
10745,:,0,0
10746,a,0,0
10747,phase,0,0
10748,II,0,0
10749,randomized,0,0
10750,trial,0,0
10751,.,0,0
10752,AIM,0,0
10753,This,0,0
10754,phase,0,0
10755,II,0,0
10756,trial,0,0
10757,evaluated,0,0
10758,the,0,0
10759,biomodulation,0,0
10760,of,0,0
10761,5-fluorouracil,1,1
10762,(,1,0
10763,5-FU,1,1
10764,),1,0
10765,plus,1,1
10766,folinic,1,1
10767,acid,1,1
10768,(,1,0
10769,FA,1,0
10770,),1,0
10771,with,1,0
10772,or,1,0
10773,without,1,0
10774,ifosfamide,1,1
10775,(,1,0
10776,IFO,1,0
10777,),1,0
10778,in,0,0
10779,chemotherapy-naive,0,0
10780,patients,0,0
10781,with,0,0
10782,colorectal,0,0
10783,cancer,0,0
10784,.,0,0
10785,PATIENTS,0,0
10786,AND,0,0
10787,METHODS,0,0
10788,Forty-eight,0,0
10789,patients,0,0
10790,were,0,0
10791,randomized,0,0
10792,to,0,0
10793,receive,0,0
10794,:,0,0
10795,FA,1,0
10796,(,0,0
10797,25,0,0
10798,mg/m2,0,1
10799,iv,0,0
10800,bolus,0,1
10801,days,0,0
10802,1,0,0
10803,to,0,0
10804,3,0,0
10805,),0,0
10806,",",0,0
10807,followed,0,0
10808,by,0,0
10809,5-FU,1,1
10810,(,0,0
10811,750,0,1
10812,mg/m2,0,1
10813,iv,0,0
10814,bolus,0,1
10815,days,0,0
10816,1,0,0
10817,to,0,0
10818,3,0,0
10819,),0,0
10820,",",0,0
10821,arm,0,0
10822,A,0,0
10823,;,0,0
10824,or,0,1
10825,FA,1,0
10826,(,0,0
10827,25,0,0
10828,mg/m2,0,1
10829,iv,0,0
10830,bolus,0,1
10831,days,0,0
10832,1,0,0
10833,to,0,0
10834,3,0,0
10835,),0,0
10836,",",0,0
10837,followed,0,0
10838,by,0,0
10839,5-FU,1,1
10840,(,0,0
10841,750,0,1
10842,mg/m2,0,1
10843,iv,0,0
10844,bolus,0,1
10845,days,0,0
10846,1,0,0
10847,to,0,0
10848,3,0,0
10849,),0,0
10850,plus,0,1
10851,IFO,1,1
10852,(,0,0
10853,"2,000",0,0
10854,mg/m2,0,1
10855,in,0,0
10856,1000,0,0
10857,mL,0,0
10858,5,0,0
10859,%,0,0
10860,dextrose,0,1
10861,in,0,0
10862,a,0,0
10863,2-hr,0,0
10864,infusion,0,1
10865,",",0,0
10866,days,0,0
10867,1,0,0
10868,to,0,0
10869,3,0,0
10870,),0,0
10871,",",0,0
10872,arm,0,0
10873,B.,0,1
10874,Mesna,0,1
10875,was,0,0
10876,added,0,0
10877,during,0,0
10878,and,0,0
10879,after,0,0
10880,IFO,0,0
10881,to,0,0
10882,prevent,0,0
10883,hemorrhagic,0,0
10884,cystitis,0,0
10885,.,0,0
10886,Treatment,0,0
10887,was,0,0
10888,repeated,0,0
10889,every,0,0
10890,21,0,0
10891,days,0,0
10892,in,0,0
10893,both,0,0
10894,arms,0,0
10895,.,0,0
10896,RESULTS,0,0
10897,Forty-five,0,0
10898,patients,0,0
10899,were,0,0
10900,assessable,0,0
10901,for,0,0
10902,response,0,0
10903,:,0,0
10904,in,0,0
10905,arm,0,0
10906,A,0,0
10907,",",0,0
10908,5,0,0
10909,patients,0,0
10910,achieved,0,0
10911,a,0,0
10912,partial,0,0
10913,response,0,0
10914,(,0,0
10915,overall,0,0
10916,response,0,0
10917,",",0,0
10918,25,0,0
10919,%,0,0
10920,),0,0
10921,",",0,0
10922,and,0,0
10923,in,0,0
10924,arm,0,0
10925,B,0,0
10926,",",0,0
10927,2,0,0
10928,patients,0,0
10929,achieved,0,0
10930,a,0,0
10931,complete,0,0
10932,and,0,0
10933,1,0,0
10934,a,0,0
10935,partial,0,0
10936,response,0,0
10937,(,0,0
10938,overall,0,0
10939,response,0,0
10940,",",0,0
10941,12,0,0
10942,%,0,0
10943,),0,0
10944,.,0,0
10945,Time,0,0
10946,to,0,0
10947,failure,0,0
10948,was,0,0
10949,3.5,0,0
10950,months,0,0
10951,(,0,0
10952,range,0,0
10953,",",0,0
10954,1-38,0,0
10955,),0,0
10956,in,0,0
10957,patients,0,0
10958,treated,0,0
10959,with,0,0
10960,5-FU,0,0
10961,plus,0,1
10962,FA,0,0
10963,",",0,0
10964,and,0,0
10965,3,0,0
10966,months,0,0
10967,(,0,0
10968,range,0,0
10969,",",0,0
10970,1-21,0,0
10971,),0,0
10972,in,0,0
10973,patients,0,0
10974,treated,0,0
10975,with,0,0
10976,the,0,0
10977,IFO,0,0
10978,combination,0,1
10979,.,0,0
10980,The,0,0
10981,median,0,0
10982,survival,0,0
10983,time,0,0
10984,was,0,0
10985,13.5,0,0
10986,months,0,0
10987,(,0,0
10988,range,0,0
10989,",",0,0
10990,1-49,0,0
10991,months,0,0
10992,),0,0
10993,in,0,0
10994,arm,0,0
10995,A,0,0
10996,and,0,0
10997,16,0,0
10998,months,0,0
10999,(,0,0
11000,range,0,0
11001,",",0,0
11002,1-43,0,0
11003,months,0,0
11004,),0,0
11005,in,0,0
11006,arm,0,0
11007,B,0,0
11008,.,0,0
11009,Diarrhea,0,0
11010,",",0,0
11011,stomatitis,0,0
11012,and,0,0
11013,vomiting,0,0
11014,were,0,0
11015,the,0,0
11016,most,0,0
11017,common,0,0
11018,nonhematologic,0,0
11019,toxicities,0,0
11020,in,0,0
11021,both,0,0
11022,arms,0,0
11023,.,0,0
11024,The,0,0
11025,most,0,0
11026,notable,0,0
11027,hematologic,0,0
11028,toxicity,0,0
11029,was,0,0
11030,leukopenia,0,0
11031,;,0,0
11032,15,0,0
11033,%,0,0
11034,and,0,0
11035,20,0,0
11036,%,0,0
11037,of,0,0
11038,patients,0,0
11039,experienced,0,0
11040,grade,0,0
11041,4,0,0
11042,in,0,0
11043,arm,0,0
11044,A,0,0
11045,and,0,0
11046,arm,0,0
11047,B,0,0
11048,",",0,0
11049,respectively,0,0
11050,.,0,0
11051,CONCLUSIONS,0,0
11052,IFO,0,0
11053,does,0,0
11054,not,0,0
11055,increase,0,0
11056,the,0,0
11057,activity,0,0
11058,of,0,0
11059,the,0,0
11060,5-FU,0,0
11061,plus,0,1
11062,FA,0,0
11063,combination,0,1
11064,in,0,0
11065,advanced,0,0
11066,colorectal,0,0
11067,cancer,0,0
11068,.,0,0
11069,The,0,0
11070,effect,0,0
11071,of,0,0
11072,case,1,0
11073,management,1,0
11074,on,0,0
11075,the,0,0
11076,costs,0,0
11077,of,0,0
11078,health,0,0
11079,care,0,0
11080,for,0,0
11081,enrollees,0,0
11082,in,0,0
11083,Medicare,0,1
11084,Plus,0,0
11085,Choice,0,0
11086,plans,0,0
11087,:,0,0
11088,a,0,0
11089,randomized,0,0
11090,trial,0,0
11091,.,0,0
11092,OBJECTIVE,0,0
11093,To,0,0
11094,measure,0,0
11095,the,0,0
11096,effects,0,0
11097,of,0,0
11098,case,0,0
11099,management,0,0
11100,on,0,0
11101,an,0,0
11102,older,0,0
11103,population,0,0
11104,'s,0,0
11105,costs,0,0
11106,of,0,0
11107,health,0,0
11108,care,0,0
11109,.,0,0
11110,DESIGN,0,0
11111,A,0,0
11112,1-year,0,0
11113,randomized,0,0
11114,controlled,0,0
11115,trial,0,0
11116,.,0,0
11117,SETTING,0,0
11118,Multiple,0,0
11119,sites,0,0
11120,of,0,0
11121,care,0,0
11122,in,0,0
11123,San,0,1
11124,Francisco,0,0
11125,",",0,0
11126,California,0,0
11127,.,0,0
11128,PARTICIPANTS,0,0
11129,Patients,0,0
11130,aged,0,0
11131,65,0,0
11132,or,0,0
11133,older,0,0
11134,of,0,0
11135,primary,0,0
11136,care,0,0
11137,physicians,0,0
11138,in,0,0
11139,a,0,0
11140,large,0,0
11141,provider,0,1
11142,organization,0,0
11143,bearing,0,0
11144,financial,0,0
11145,risk,0,0
11146,for,0,0
11147,their,0,0
11148,care,0,1
11149,(,0,0
11150,n,0,0
11151,=,0,0
11152,6409,0,0
11153,),0,0
11154,.,0,0
11155,INTERVENTION,0,0
11156,Screening,1,0
11157,for,1,0
11158,high,1,0
11159,risk,1,0
11160,and,1,0
11161,provision,1,1
11162,of,1,0
11163,social,1,0
11164,work-based,1,1
11165,case,1,0
11166,management,1,0
11167,.,1,0
11168,OUTCOME,0,0
11169,MEASURES,0,0
11170,Volume,0,1
11171,and,0,0
11172,cost,0,0
11173,of,0,0
11174,hospital,0,0
11175,",",0,0
11176,physician,0,0
11177,",",0,0
11178,case,0,0
11179,management,0,0
11180,",",0,0
11181,and,0,0
11182,other,0,0
11183,health-related,0,0
11184,services,0,0
11185,.,0,0
11186,RESULTS,0,0
11187,The,0,0
11188,experimental,0,0
11189,group,0,0
11190,used,0,0
11191,more,0,0
11192,case,0,0
11193,management,0,0
11194,services,0,0
11195,than,0,0
11196,the,0,0
11197,control,0,1
11198,group,0,0
11199,(,0,0
11200,0.09,0,0
11201,vs.,0,0
11202,0.02,0,0
11203,months,0,0
11204,per,0,0
11205,person,0,0
11206,",",0,0
11207,P,0,0
11208,<,0,0
11209,.001,0,0
11210,),0,0
11211,.,0,0
11212,The,0,0
11213,experimental,0,0
11214,group,0,0
11215,'s,0,0
11216,average,0,0
11217,total,0,0
11218,payments,0,0
11219,for,0,0
11220,health,0,0
11221,care,0,0
11222,were,0,0
11223,slightly,0,0
11224,lower,0,0
11225,(,0,0
11226,$,0,0
11227,3148,0,0
11228,vs,0,0
11229,$,0,0
11230,3277,0,0
11231,",",0,0
11232,P,0,0
11233,=,0,0
11234,.40,0,0
11235,),0,0
11236,.,0,0
11237,CONCLUSIONS,0,0
11238,This,0,0
11239,study,0,0
11240,provides,0,0
11241,no,0,0
11242,statistically,0,0
11243,significant,0,0
11244,evidence,0,0
11245,that,0,0
11246,social,0,0
11247,work-oriented,0,1
11248,case,0,0
11249,management,0,0
11250,reduces,0,0
11251,the,0,0
11252,use,0,0
11253,or,0,0
11254,the,0,0
11255,cost,0,0
11256,of,0,0
11257,health,0,0
11258,care,0,0
11259,for,0,0
11260,high-risk,0,0
11261,older,0,0
11262,people,0,0
11263,.,0,0
11264,Other,0,0
11265,potentially,0,0
11266,favorable,0,0
11267,effects,0,0
11268,of,0,0
11269,this,0,0
11270,type,0,0
11271,of,0,0
11272,case,0,0
11273,management,0,0
11274,need,0,0
11275,to,0,0
11276,be,0,0
11277,evaluated,0,0
11278,",",0,0
11279,as,0,0
11280,do,0,0
11281,the,0,0
11282,effects,0,0
11283,of,0,0
11284,other,0,0
11285,types,0,0
11286,of,0,0
11287,case,0,0
11288,management,0,0
11289,.,0,0
11290,Onset/offset,0,0
11291,characteristics,0,0
11292,and,0,0
11293,intubating,0,0
11294,conditions,0,0
11295,of,0,0
11296,rapacuronium,0,1
11297,:,0,0
11298,a,0,0
11299,comparison,0,0
11300,with,0,0
11301,rocuronium,0,1
11302,.,0,0
11303,We,0,0
11304,compared,0,0
11305,onset,0,0
11306,and,0,0
11307,offset,0,0
11308,of,0,0
11309,action,0,0
11310,and,0,0
11311,tracheal,0,0
11312,intubating,0,0
11313,conditions,0,0
11314,after,0,0
11315,rapacuronium,1,1
11316,and,1,0
11317,rocuronium,1,1
11318,in,0,0
11319,60,0,0
11320,patients,0,0
11321,in,0,0
11322,a,0,0
11323,randomized,0,0
11324,",",0,0
11325,assessor-blinded,0,0
11326,study,0,0
11327,.,0,0
11328,Following,0,0
11329,induction,0,0
11330,of,0,0
11331,anaesthesia,1,1
11332,with,1,0
11333,propofol,1,1
11334,2.5,1,0
11335,mg,1,1
11336,kg-1,1,0
11337,",",1,0
11338,either,1,0
11339,rapacuronium,1,1
11340,1.5,1,0
11341,mg,1,1
11342,kg-1,1,1
11343,(,1,0
11344,n,1,0
11345,=,1,0
11346,30,1,0
11347,),1,0
11348,or,1,0
11349,rocuronium,1,1
11350,0.6,1,0
11351,mg,1,1
11352,kg-1,1,1
11353,(,1,0
11354,n,1,0
11355,=,1,0
11356,30,1,0
11357,),1,0
11358,was,1,0
11359,administered,1,0
11360,to,1,0
11361,facilitate,1,0
11362,tracheal,1,0
11363,intubation,1,0
11364,.,1,0
11365,Anaesthesia,1,0
11366,was,1,0
11367,maintained,1,0
11368,with,1,0
11369,either,1,0
11370,a,1,0
11371,propofol,1,1
11372,infusion,1,1
11373,(,1,0
11374,100,1,0
11375,micrograms,1,1
11376,kg-1,1,0
11377,min-1,1,0
11378,),1,0
11379,or,1,1
11380,sevoflurane,1,1
11381,(,1,0
11382,1,1,0
11383,%,1,0
11384,end-tidal,1,0
11385,),1,0
11386,with,1,0
11387,66,1,0
11388,%,1,0
11389,nitrous,1,1
11390,oxide,1,1
11391,(,1,0
11392,N2O,1,1
11393,),1,0
11394,",",1,0
11395,n,1,0
11396,=,1,0
11397,15,1,0
11398,in,1,0
11399,each,1,0
11400,subgroup,1,0
11401,.,1,0
11402,Neuromuscular,1,0
11403,monitoring,1,0
11404,was,1,0
11405,performed,1,0
11406,using,1,0
11407,an,1,0
11408,electromyographic,1,0
11409,(,1,0
11410,EMG,1,0
11411,),1,1
11412,device,1,1
11413,(,1,0
11414,Datex,1,1
11415,Relaxograph,1,1
11416,),1,0
11417,.,1,0
11418,The,0,0
11419,lag,0,0
11420,times,0,0
11421,(,0,0
11422,mean,0,0
11423,42,0,0
11424,(,0,0
11425,SD,0,0
11426,11,0,0
11427,),0,0
11428,s,0,0
11429,and,0,0
11430,44,0,0
11431,(,0,0
11432,16,0,0
11433,),0,0
11434,s,0,0
11435,),0,0
11436,",",0,0
11437,maximum,0,0
11438,block,0,0
11439,(,0,0
11440,99,0,0
11441,(,0,0
11442,2,0,0
11443,),0,0
11444,%,0,0
11445,and,0,0
11446,98,0,0
11447,(,0,0
11448,3,0,0
11449,),0,0
11450,%,0,0
11451,),0,0
11452,and,0,0
11453,intubating,0,0
11454,conditions,0,0
11455,at,0,0
11456,60,0,0
11457,s,0,0
11458,(,0,0
11459,good-to-excellent,0,0
11460,in,0,0
11461,86,0,0
11462,%,0,0
11463,and,0,0
11464,84,0,0
11465,%,0,0
11466,of,0,0
11467,patients,0,0
11468,),0,0
11469,were,0,0
11470,similar,0,0
11471,for,0,0
11472,rapacuronium,0,1
11473,and,0,0
11474,rocuronium,0,1
11475,",",0,0
11476,respectively,0,0
11477,.,0,0
11478,The,0,0
11479,onset,0,0
11480,time,0,0
11481,of,0,0
11482,rapacuronium,0,0
11483,was,0,0
11484,shorter,0,0
11485,than,0,0
11486,rocuronium,0,1
11487,(,0,0
11488,87,0,0
11489,(,0,0
11490,20,0,0
11491,),0,0
11492,vs,0,0
11493,141,0,0
11494,(,0,0
11495,65,0,0
11496,),0,0
11497,s,0,0
11498,",",0,0
11499,P,0,0
11500,<,0,0
11501,0.001,0,0
11502,),0,0
11503,",",0,0
11504,and,0,0
11505,the,0,0
11506,degree,0,0
11507,of,0,0
11508,block,0,0
11509,at,0,0
11510,60,0,0
11511,s,0,0
11512,was,0,0
11513,greater,0,0
11514,(,0,0
11515,69,0,0
11516,(,0,0
11517,26,0,0
11518,),0,0
11519,vs,0,0
11520,50,0,1
11521,(,0,0
11522,27,0,0
11523,),0,0
11524,%,0,0
11525,",",0,0
11526,P,0,0
11527,<,0,0
11528,0.05,0,0
11529,),0,0
11530,.,0,0
11531,Twenty-five,0,0
11532,per,0,0
11533,cent,0,0
11534,recovery,0,0
11535,was,0,0
11536,shorter,0,0
11537,with,0,0
11538,rapacuronium,0,1
11539,than,0,0
11540,rocuronium,0,1
11541,during,0,0
11542,propofol,0,1
11543,(,0,0
11544,15.0,0,0
11545,(,0,0
11546,3.2,0,0
11547,),0,0
11548,vs,0,0
11549,39.1,0,0
11550,(,0,0
11551,14.2,0,0
11552,),0,0
11553,min,0,0
11554,",",0,0
11555,P,0,0
11556,<,0,0
11557,0.001,0,0
11558,),0,0
11559,and,0,0
11560,sevoflurane,0,1
11561,(,0,0
11562,15.1,0,0
11563,(,0,0
11564,4.2,0,0
11565,),0,0
11566,vs,0,0
11567,47.8,0,0
11568,(,0,0
11569,19.0,0,0
11570,),0,0
11571,min,0,0
11572,",",0,0
11573,P,0,0
11574,<,0,0
11575,0.001,0,0
11576,),0,0
11577,anaesthesia,0,1
11578,.,0,0
11579,We,0,0
11580,conclude,0,0
11581,that,0,0
11582,rapacuronium,0,1
11583,1.5,0,0
11584,mg,0,1
11585,kg-1,0,0
11586,had,0,0
11587,a,0,0
11588,more,0,0
11589,rapid,0,0
11590,onset,0,0
11591,",",0,0
11592,similar,0,0
11593,intubating,0,0
11594,conditions,0,0
11595,",",0,0
11596,and,0,0
11597,shorter,0,0
11598,recovery,0,0
11599,times,0,0
11600,than,0,0
11601,rocuronium,0,1
11602,0.6,0,0
11603,mg,0,0
11604,kg-1,0,0
11605,.,0,0
11606,Effect,0,0
11607,of,0,0
11608,systemic,0,0
11609,nitric,1,0
11610,oxide,1,1
11611,synthase,1,0
11612,inhibition,0,0
11613,on,0,0
11614,postexercise,0,0
11615,hypotension,0,0
11616,in,0,0
11617,humans,0,0
11618,.,0,0
11619,An,0,0
11620,acute,0,0
11621,bout,0,0
11622,of,0,0
11623,aerobic,0,1
11624,exercise,0,1
11625,results,0,0
11626,in,0,0
11627,a,0,0
11628,reduced,0,0
11629,blood,0,0
11630,pressure,0,0
11631,that,0,0
11632,lasts,0,0
11633,several,0,0
11634,hours,0,0
11635,.,0,0
11636,Animal,0,0
11637,studies,0,0
11638,suggest,0,0
11639,this,0,0
11640,response,0,0
11641,is,0,0
11642,mediated,0,0
11643,by,0,0
11644,increased,0,0
11645,production,0,0
11646,of,0,0
11647,nitric,0,0
11648,oxide,0,0
11649,.,0,0
11650,We,0,0
11651,tested,0,0
11652,the,0,0
11653,extent,0,0
11654,to,0,0
11655,which,0,0
11656,systemic,0,0
11657,nitric,0,0
11658,oxide,0,1
11659,synthase,0,0
11660,inhibition,0,0
11661,[,0,0
11662,N,0,0
11663,(,0,0
11664,G,0,0
11665,),0,1
11666,-monomethyl-L-arginine,0,1
11667,(,0,1
11668,L-NMMA,0,0
11669,),0,0
11670,],0,0
11671,can,0,0
11672,reverse,0,0
11673,the,0,0
11674,drop,0,0
11675,in,0,0
11676,blood,0,0
11677,pressure,0,0
11678,that,0,0
11679,occurs,0,0
11680,after,0,0
11681,exercise,0,0
11682,in,0,0
11683,humans,0,0
11684,.,0,0
11685,Eight,0,0
11686,healthy,0,0
11687,subjects,0,0
11688,underwent,0,0
11689,parallel,0,0
11690,experiments,0,0
11691,on,0,0
11692,2,0,0
11693,separate,0,0
11694,days,0,0
11695,.,0,0
11696,The,0,0
11697,order,0,0
11698,of,0,0
11699,the,0,0
11700,experiments,0,0
11701,was,0,0
11702,randomized,0,0
11703,between,0,0
11704,sham,0,1
11705,(,1,0
11706,60,1,0
11707,min,1,0
11708,of,1,0
11709,seated,1,0
11710,upright,1,1
11711,rest,1,0
11712,),1,0
11713,and,0,0
11714,exercise,0,1
11715,(,1,0
11716,60,1,0
11717,min,1,0
11718,of,1,0
11719,upright,1,1
11720,cycling,1,0
11721,at,1,0
11722,60,1,0
11723,%,1,0
11724,peak,1,0
11725,aerobic,1,1
11726,capacity,1,0
11727,),1,0
11728,.,0,0
11729,After,0,0
11730,both,0,0
11731,sham,0,1
11732,and,0,0
11733,exercise,0,1
11734,",",0,0
11735,subjects,0,0
11736,received,0,0
11737,",",0,0
11738,in,0,0
11739,sequence,0,0
11740,",",0,0
11741,systemic,0,0
11742,alpha-adrenergic,0,1
11743,blockade,0,1
11744,(,0,0
11745,phentolamine,0,1
11746,),0,0
11747,and,0,0
11748,L-NMMA,0,0
11749,.,0,0
11750,Phentolamine,0,1
11751,was,0,0
11752,given,0,0
11753,first,0,0
11754,to,0,0
11755,isolate,0,0
11756,the,0,0
11757,contribution,0,0
11758,of,0,0
11759,nitric,0,1
11760,oxide,0,0
11761,to,0,0
11762,postexercise,0,0
11763,hypotension,0,0
11764,by,0,0
11765,preventing,0,0
11766,reflex,0,0
11767,changes,0,0
11768,in,0,0
11769,sympathetic,0,0
11770,tone,0,1
11771,that,0,0
11772,result,0,0
11773,from,0,0
11774,systemic,0,0
11775,nitric,0,0
11776,oxide,0,1
11777,synthase,0,0
11778,inhibition,0,0
11779,and,0,0
11780,to,0,0
11781,control,0,0
11782,for,0,0
11783,alterations,0,0
11784,in,0,0
11785,resting,0,0
11786,sympathetic,0,0
11787,activity,0,0
11788,after,0,0
11789,exercise,0,1
11790,.,0,0
11791,During,0,0
11792,each,0,0
11793,condition,0,0
11794,",",0,0
11795,systemic,0,0
11796,and,0,0
11797,regional,0,0
11798,hemodynamics,0,0
11799,were,0,0
11800,measured,0,0
11801,.,0,0
11802,Throughout,0,0
11803,the,0,0
11804,study,0,0
11805,",",0,0
11806,arterial,0,0
11807,pressure,0,0
11808,and,0,0
11809,vascular,0,0
11810,resistances,0,0
11811,remained,0,0
11812,lower,0,0
11813,postexercise,0,0
11814,vs.,0,0
11815,postsham,0,0
11816,despite,0,0
11817,nitric,0,1
11818,oxide,0,1
11819,synthase,0,0
11820,inhibition,0,1
11821,(,0,0
11822,e.g.,0,0
11823,",",0,0
11824,mean,0,0
11825,arterial,0,0
11826,pressure,0,0
11827,after,0,0
11828,L-NMMA,0,0
11829,was,0,0
11830,108.0+/-2.4,0,0
11831,mmHg,0,0
11832,postsham,0,0
11833,vs.,0,0
11834,102.1+/-3.3,0,0
11835,mmHg,0,0
11836,postexercise,0,0
11837,;,0,0
11838,P,0,0
11839,<,0,0
11840,0.05,0,0
11841,),0,0
11842,.,0,0
11843,Thus,0,0
11844,it,0,0
11845,does,0,0
11846,not,0,0
11847,appear,0,0
11848,that,0,0
11849,postexercise,0,0
11850,hypotension,0,0
11851,is,0,0
11852,dependent,0,0
11853,on,0,0
11854,increased,0,0
11855,production,0,0
11856,of,0,0
11857,nitric,0,1
11858,oxide,0,0
11859,in,0,0
11860,humans,0,0
11861,.,0,0
11862,Efficacy,0,0
11863,and,0,0
11864,safety,0,0
11865,of,0,0
11866,recombinant,1,1
11867,human,1,1
11868,nerve,1,0
11869,growth,1,0
11870,factor,1,0
11871,in,0,0
11872,patients,0,0
11873,with,0,0
11874,diabetic,0,0
11875,polyneuropathy,0,0
11876,:,0,0
11877,A,0,0
11878,randomized,0,0
11879,controlled,0,0
11880,trial,0,0
11881,.,0,0
11882,rhNGF,0,0
11883,Clinical,0,0
11884,Investigator,0,0
11885,Group,0,0
11886,.,0,0
11887,CONTEXT,0,0
11888,Nerve,0,0
11889,growth,0,0
11890,factor,0,0
11891,is,0,0
11892,a,0,0
11893,neurotrophic,0,0
11894,factor,0,0
11895,that,0,0
11896,promotes,0,0
11897,the,0,0
11898,survival,0,0
11899,of,0,0
11900,small,0,0
11901,fiber,0,1
11902,sensory,0,0
11903,neurons,0,0
11904,and,0,0
11905,sympathetic,0,0
11906,neurons,0,0
11907,in,0,0
11908,the,0,0
11909,peripheral,0,0
11910,nervous,0,0
11911,system,0,0
11912,.,0,0
11913,Recombinant,1,0
11914,human,1,0
11915,nerve,1,0
11916,growth,1,1
11917,factor,1,1
11918,(,1,0
11919,rhNGF,1,1
11920,),1,1
11921,has,0,0
11922,demonstrated,0,0
11923,efficacy,0,0
11924,as,0,0
11925,treatment,0,0
11926,for,0,0
11927,peripheral,0,0
11928,neuropathy,0,0
11929,in,0,0
11930,experimental,0,0
11931,models,0,0
11932,and,0,0
11933,phase,0,0
11934,2,0,0
11935,clinical,0,0
11936,trials,0,0
11937,.,0,0
11938,OBJECTIVE,0,0
11939,To,0,0
11940,evaluate,0,0
11941,the,0,0
11942,efficacy,0,0
11943,and,0,0
11944,safety,0,0
11945,of,0,0
11946,a,0,0
11947,12-month,0,0
11948,regimen,0,0
11949,of,0,0
11950,rhNGF,0,0
11951,in,0,0
11952,patients,0,0
11953,with,0,0
11954,diabetic,0,0
11955,polyneuropathy,0,0
11956,.,0,0
11957,DESIGN,0,0
11958,Randomized,0,0
11959,",",0,0
11960,double-blind,0,0
11961,",",0,0
11962,placebo-controlled,1,1
11963,phase,0,0
11964,3,0,0
11965,trial,0,0
11966,conducted,0,0
11967,from,0,0
11968,July,0,0
11969,1997,0,0
11970,through,0,0
11971,May,0,0
11972,1999,0,0
11973,.,0,0
11974,SETTING,0,0
11975,Eighty-four,0,0
11976,outpatient,0,0
11977,centers,0,0
11978,throughout,0,0
11979,the,0,0
11980,United,0,0
11981,States,0,0
11982,.,0,0
11983,PATIENTS,0,0
11984,A,0,0
11985,total,0,0
11986,of,0,0
11987,1019,0,0
11988,men,0,0
11989,and,0,0
11990,women,0,0
11991,aged,0,0
11992,18,0,0
11993,to,0,0
11994,74,0,0
11995,years,0,0
11996,with,0,0
11997,either,0,0
11998,type,0,0
11999,1,0,0
12000,or,0,0
12001,type,0,0
12002,2,0,0
12003,diabetes,0,0
12004,and,0,0
12005,a,0,0
12006,sensory,0,0
12007,polyneuropathy,0,0
12008,attributable,0,0
12009,to,0,0
12010,diabetes,0,0
12011,.,0,0
12012,INTERVENTIONS,0,0
12013,Patients,0,0
12014,were,0,0
12015,randomly,0,0
12016,assigned,0,0
12017,to,0,0
12018,receive,0,0
12019,either,0,0
12020,rhNGF,1,0
12021,",",0,0
12022,0.1,0,0
12023,microg/kg,0,1
12024,(,0,0
12025,n,0,0
12026,=,0,0
12027,504,0,0
12028,),0,0
12029,",",0,0
12030,or,0,1
12031,placebo,1,1
12032,(,0,0
12033,n,0,0
12034,=,0,0
12035,515,0,0
12036,),0,0
12037,by,0,0
12038,subcutaneous,0,0
12039,injection,0,0
12040,3,0,0
12041,times,0,0
12042,per,0,0
12043,week,0,0
12044,for,0,0
12045,48,0,0
12046,weeks,0,0
12047,.,0,0
12048,Patients,0,0
12049,were,0,0
12050,assessed,0,0
12051,at,0,0
12052,baseline,0,0
12053,",",0,0
12054,12,0,0
12055,weeks,0,0
12056,",",0,0
12057,24,0,0
12058,weeks,0,0
12059,",",0,0
12060,and,0,0
12061,48,0,0
12062,weeks,0,0
12063,.,0,0
12064,MAIN,0,0
12065,OUTCOME,0,0
12066,MEASURES,0,0
12067,The,0,0
12068,primary,0,0
12069,outcome,0,0
12070,measure,0,0
12071,was,0,0
12072,a,0,0
12073,change,0,0
12074,in,0,0
12075,neuropathy,0,0
12076,between,0,0
12077,baseline,0,0
12078,and,0,0
12079,week,0,0
12080,48,0,0
12081,",",0,0
12082,demonstrated,0,0
12083,by,0,0
12084,the,0,0
12085,Neuropathy,0,0
12086,Impairment,0,0
12087,Score,0,0
12088,for,0,0
12089,the,0,0
12090,Lower,0,0
12091,Limbs,0,0
12092,",",0,0
12093,compared,0,0
12094,between,0,0
12095,the,0,0
12096,2,0,0
12097,groups,0,0
12098,.,0,0
12099,Secondary,0,0
12100,outcome,0,0
12101,measures,0,0
12102,included,0,0
12103,quantitative,0,0
12104,sensory,0,0
12105,tests,0,0
12106,using,0,0
12107,the,0,0
12108,CASE,0,1
12109,IV,0,0
12110,System,0,0
12111,",",0,0
12112,the,0,0
12113,Neuropathy,0,0
12114,Symptom,0,0
12115,and,0,0
12116,Change,0,1
12117,questionnaire,0,0
12118,",",0,0
12119,the,0,0
12120,Patient,0,0
12121,Benefit,0,0
12122,Questionnaire,0,1
12123,(,0,0
12124,PBQ,0,0
12125,),0,0
12126,",",0,0
12127,and,0,0
12128,a,0,0
12129,global,0,0
12130,symptom,0,0
12131,assessment,0,0
12132,",",0,0
12133,as,0,0
12134,well,0,0
12135,as,0,0
12136,nerve,0,0
12137,conduction,0,0
12138,studies,0,0
12139,and,0,0
12140,occurrence,0,0
12141,of,0,0
12142,new,0,0
12143,plantar,0,0
12144,foot,0,0
12145,ulcers,0,0
12146,.,0,0
12147,Patients,0,0
12148,also,0,0
12149,were,0,0
12150,evaluated,0,0
12151,for,0,0
12152,presence,0,0
12153,of,0,0
12154,adverse,0,0
12155,events,0,0
12156,.,0,0
12157,RESULTS,0,0
12158,Among,0,0
12159,patients,0,0
12160,who,0,0
12161,received,0,0
12162,rhNGF,1,0
12163,",",0,0
12164,418,0,0
12165,(,0,0
12166,83,0,0
12167,%,0,0
12168,),0,0
12169,completed,0,0
12170,the,0,0
12171,regimen,0,0
12172,compared,0,0
12173,with,0,0
12174,461,0,0
12175,(,0,0
12176,90,0,0
12177,%,0,0
12178,),0,0
12179,who,0,0
12180,received,0,0
12181,placebo,1,1
12182,.,1,0
12183,Administration,0,0
12184,of,0,0
12185,rhNGF,1,0
12186,was,0,0
12187,safe,0,0
12188,",",0,0
12189,with,0,0
12190,few,0,0
12191,adverse,0,0
12192,events,0,0
12193,attributed,0,0
12194,to,0,0
12195,treatment,0,0
12196,apart,0,0
12197,from,0,0
12198,injection,0,1
12199,site,0,0
12200,pain/hyperalgesia,0,0
12201,and,0,0
12202,other,0,0
12203,pain,0,0
12204,syndromes,0,0
12205,.,0,0
12206,However,0,0
12207,",",0,0
12208,neither,0,0
12209,the,0,0
12210,primary,0,0
12211,end,0,0
12212,point,0,0
12213,(,0,0
12214,P,0,0
12215,=.25,0,0
12216,),0,0
12217,nor,0,0
12218,most,0,0
12219,of,0,0
12220,the,0,0
12221,secondary,0,0
12222,end,0,0
12223,points,0,0
12224,demonstrated,0,0
12225,a,0,0
12226,significant,0,0
12227,benefit,0,0
12228,of,0,0
12229,rhNGF,1,0
12230,.,1,0
12231,Exceptions,0,0
12232,were,0,0
12233,the,0,0
12234,global,0,0
12235,symptom,0,0
12236,assessment,0,0
12237,(,0,0
12238,P,0,0
12239,=.03,0,0
12240,),0,0
12241,and,0,0
12242,2,0,0
12243,of,0,0
12244,32,0,0
12245,comparisons,0,0
12246,within,0,0
12247,the,0,0
12248,PBQ,0,0
12249,",",0,0
12250,which,0,0
12251,showed,0,0
12252,a,0,0
12253,modest,0,0
12254,but,0,0
12255,significant,0,0
12256,benefit,0,0
12257,of,0,0
12258,rhNGF,1,1
12259,(,0,0
12260,P,0,0
12261,=.05,0,0
12262,for,0,0
12263,severity,0,0
12264,of,0,0
12265,pain,0,0
12266,in,0,0
12267,the,0,0
12268,legs,0,0
12269,and,0,0
12270,P,0,0
12271,=.003,0,0
12272,for,0,0
12273,6-month,0,0
12274,symptoms,0,0
12275,in,0,0
12276,the,0,0
12277,feet,0,0
12278,and,0,0
12279,legs,0,0
12280,),0,0
12281,.,0,0
12282,CONCLUSION,0,0
12283,Unlike,0,0
12284,previous,0,0
12285,phase,0,0
12286,2,0,0
12287,trials,0,0
12288,",",0,0
12289,this,0,0
12290,phase,0,0
12291,3,0,0
12292,clinical,0,0
12293,trial,0,0
12294,failed,0,0
12295,to,0,0
12296,demonstrate,0,0
12297,a,0,0
12298,significant,0,0
12299,beneficial,0,0
12300,effect,0,0
12301,of,0,0
12302,rhNGF,0,0
12303,on,0,0
12304,diabetic,0,0
12305,polyneuropathy,0,0
12306,.,0,0
12307,JAMA,0,0
12308,.,0,0
12309,2000,0,0
12310,;,0,0
12311,284:2215-2221,0,0
12312,.,0,0
12313,Effect,0,0
12314,of,0,0
12315,systemic,1,0
12316,penicillin,1,1
12317,on,0,0
12318,pain,0,0
12319,in,0,0
12320,untreated,0,0
12321,irreversible,0,0
12322,pulpitis,0,0
12323,.,0,0
12324,OBJECTIVE,0,0
12325,The,0,0
12326,purpose,0,0
12327,of,0,0
12328,this,0,0
12329,prospective,0,0
12330,",",0,0
12331,randomized,0,0
12332,",",0,0
12333,double-blind,0,0
12334,study,0,0
12335,was,0,0
12336,to,0,0
12337,determine,0,0
12338,the,0,0
12339,effect,0,0
12340,of,0,0
12341,penicillin,1,1
12342,on,0,0
12343,pain,0,0
12344,in,0,0
12345,untreated,0,0
12346,teeth,0,0
12347,diagnosed,0,0
12348,with,0,0
12349,irreversible,0,0
12350,pulpitis,0,0
12351,.,0,0
12352,STUDY,0,0
12353,DESIGN,0,0
12354,Forty,0,0
12355,emergency,0,0
12356,patients,0,0
12357,participated,0,0
12358,",",0,0
12359,and,0,0
12360,each,0,0
12361,had,0,0
12362,a,0,0
12363,clinical,0,0
12364,diagnosis,0,0
12365,of,0,0
12366,an,0,0
12367,irreversible,0,0
12368,pulpitis,0,0
12369,.,0,0
12370,Patients,0,0
12371,randomly,0,0
12372,received,1,0
12373,a,1,0
12374,7-day,1,0
12375,oral,1,1
12376,dose,1,0
12377,(,1,0
12378,28,1,0
12379,capsules,1,1
12380,",",1,0
12381,500,1,0
12382,mg,1,0
12383,each,1,0
12384,",",1,0
12385,to,1,0
12386,be,1,0
12387,taken,1,0
12388,every,1,0
12389,6,1,0
12390,hours,1,0
12391,),1,0
12392,of,1,0
12393,either,1,0
12394,penicillin,1,1
12395,or,1,0
12396,a,1,0
12397,placebo,1,1
12398,control,1,0
12399,in,1,0
12400,a,1,0
12401,double-blind,1,0
12402,manner,1,0
12403,.,1,0
12404,No,0,0
12405,endodontic,0,1
12406,treatment,0,0
12407,was,0,0
12408,performed,0,0
12409,.,0,0
12410,Each,0,0
12411,patient,0,0
12412,also,0,0
12413,received,0,0
12414,ibuprofen,1,1
12415,;,1,0
12416,acetaminophen,1,1
12417,with,1,0
12418,codeine,1,1
12419,(,1,0
12420,30,1,0
12421,mg,1,1
12422,),1,0
12423,;,1,0
12424,and,1,0
12425,a,1,0
12426,7-day,1,0
12427,diary,1,1
12428,to,1,0
12429,record,1,0
12430,pain,1,0
12431,",",0,0
12432,percussion,0,1
12433,pain,0,0
12434,",",0,0
12435,and,0,0
12436,number,0,0
12437,and,0,0
12438,type,0,0
12439,of,0,0
12440,pain,0,0
12441,medication,0,0
12442,taken,0,0
12443,.,0,0
12444,RESULTS,0,0
12445,The,0,0
12446,administration,0,0
12447,of,0,0
12448,penicillin,1,1
12449,did,0,0
12450,not,0,0
12451,significantly,0,0
12452,(,0,0
12453,P,0,0
12454,>,0,0
12455,.05,0,0
12456,),0,0
12457,reduce,0,0
12458,pain,0,0
12459,",",0,0
12460,percussion,0,1
12461,pain,0,0
12462,",",0,0
12463,or,0,0
12464,the,0,0
12465,number,0,0
12466,of,0,0
12467,analgesic,0,0
12468,medications,0,1
12469,taken,0,0
12470,by,0,0
12471,patients,0,0
12472,with,0,0
12473,untreated,0,0
12474,irreversible,0,0
12475,pulpitis,0,0
12476,.,0,0
12477,The,0,0
12478,majority,0,0
12479,of,0,0
12480,patients,0,0
12481,with,0,0
12482,untreated,0,0
12483,irreversible,0,0
12484,pulpitis,0,0
12485,had,0,0
12486,significant,0,0
12487,pain,0,0
12488,and,0,0
12489,required,0,0
12490,analgesics,0,0
12491,to,0,0
12492,manage,0,0
12493,this,0,0
12494,pain,0,0
12495,.,0,0
12496,CONCLUSION,0,0
12497,Penicillin,0,1
12498,should,0,0
12499,not,0,0
12500,be,0,0
12501,prescribed,0,0
12502,for,0,0
12503,untreated,0,0
12504,irreversible,0,0
12505,pulpitis,0,0
12506,because,0,0
12507,penicillin,0,1
12508,is,0,0
12509,ineffective,0,0
12510,for,0,0
12511,pain,0,0
12512,relief,0,0
12513,.,0,0
12514,Oral,1,1
12515,ciprofloxacin,1,1
12516,vs.,1,0
12517,intramuscular,1,1
12518,ceftriaxone,1,1
12519,as,0,0
12520,empiric,0,0
12521,treatment,0,0
12522,of,0,0
12523,acute,0,0
12524,invasive,0,0
12525,diarrhea,0,0
12526,in,0,0
12527,children,0,0
12528,.,0,0
12529,BACKGROUND,0,0
12530,Acute,0,0
12531,invasive,0,0
12532,diarrhea,0,0
12533,is,0,0
12534,a,0,0
12535,potentially,0,0
12536,serious,0,0
12537,condition,0,0
12538,in,0,0
12539,children,0,0
12540,.,0,0
12541,Because,0,0
12542,of,0,0
12543,the,0,0
12544,increasing,0,0
12545,resistance,0,0
12546,of,0,0
12547,enteric,0,0
12548,pathogens,0,0
12549,to,0,0
12550,commonly,0,0
12551,used,0,0
12552,oral,0,1
12553,antibiotics,1,1
12554,",",1,0
12555,intramuscular,1,1
12556,ceftriaxone,1,1
12557,has,0,0
12558,become,0,0
12559,the,0,0
12560,routine,0,0
12561,drug,0,0
12562,in,0,0
12563,the,0,0
12564,treatment,0,0
12565,of,0,0
12566,acute,0,0
12567,invasive,0,0
12568,diarrhea,0,0
12569,requiring,0,0
12570,an,0,0
12571,emergency,0,0
12572,visit,0,0
12573,in,0,0
12574,southern,0,0
12575,Israel,0,1
12576,.,0,0
12577,The,0,0
12578,inconvenience,0,0
12579,of,0,0
12580,this,0,0
12581,parenteral,0,1
12582,regimen,0,0
12583,created,0,0
12584,an,0,0
12585,increased,0,0
12586,need,0,0
12587,for,0,0
12588,oral,0,1
12589,pediatric,0,0
12590,formulations,0,0
12591,for,0,0
12592,the,0,0
12593,treatment,0,0
12594,of,0,0
12595,invasive,0,0
12596,diarrhea,0,0
12597,.,0,0
12598,OBJECTIVES,0,0
12599,To,0,0
12600,evaluate,0,0
12601,the,0,0
12602,efficacy,0,0
12603,and,0,0
12604,safety,0,0
12605,of,0,0
12606,a,0,0
12607,suspension,0,1
12608,formulation,0,0
12609,of,0,0
12610,ciprofloxacin,1,1
12611,in,0,0
12612,the,0,0
12613,treatment,0,0
12614,of,0,0
12615,acute,0,0
12616,invasive,0,0
12617,diarrhea,0,0
12618,in,0,0
12619,infants,0,0
12620,and,0,0
12621,children,0,0
12622,.,0,0
12623,PATIENTS,0,0
12624,AND,0,0
12625,METHODS,0,0
12626,From,0,0
12627,July,0,0
12628,1996,0,0
12629,through,0,0
12630,December,0,0
12631,1997,0,0
12632,",",0,0
12633,201,0,0
12634,evaluable,0,0
12635,children,0,0
12636,ages,0,0
12637,6,0,0
12638,months,0,0
12639,to,0,0
12640,10,0,0
12641,years,0,0
12642,(,0,0
12643,35,0,0
12644,%,0,0
12645,<,0,0
12646,1,0,0
12647,year,0,0
12648,;,0,0
12649,70,0,0
12650,%,0,0
12651,<,0,0
12652,3,0,0
12653,years,0,0
12654,),0,0
12655,presenting,0,0
12656,with,0,0
12657,acute,0,0
12658,invasive,0,0
12659,diarrhea,0,0
12660,at,0,0
12661,the,0,0
12662,Pediatric,0,1
12663,Emergency,0,1
12664,Room,0,0
12665,were,0,0
12666,randomized,0,0
12667,to,0,0
12668,receive,0,0
12669,either,0,0
12670,ciprofloxacin,1,1
12671,suspension,1,1
12672,(,0,0
12673,10,0,0
12674,mg/kg,0,0
12675,twice,0,0
12676,a,0,0
12677,day,0,0
12678,+,0,1
12679,im,0,1
12680,placebo,1,1
12681,;,1,0
12682,n,0,0
12683,=,0,0
12684,95,0,0
12685,),0,0
12686,or,0,0
12687,im,1,1
12688,ceftriaxone,1,1
12689,(,0,0
12690,50,0,0
12691,mg/kg/day,0,1
12692,+,0,1
12693,placebo,1,1
12694,suspension,1,1
12695,;,1,0
12696,n,0,0
12697,=,0,0
12698,106,0,0
12699,),0,0
12700,for,0,0
12701,3,0,0
12702,days,0,0
12703,in,0,0
12704,a,0,0
12705,double,0,0
12706,blind,0,0
12707,manner,0,0
12708,.,0,0
12709,Stool,0,1
12710,cultures,0,0
12711,for,0,0
12712,Shigella,0,0
12713,",",0,0
12714,Salmonella,0,0
12715,",",0,0
12716,Campylobacter,0,0
12717,spp,0,0
12718,.,0,0
12719,and,0,0
12720,diarrheagenic,0,0
12721,Escherichia,0,0
12722,coli,0,0
12723,were,0,0
12724,obtained,0,0
12725,on,0,0
12726,Days,0,0
12727,1,0,0
12728,",",0,0
12729,3,0,0
12730,",",0,0
12731,4,0,0
12732,to,0,0
12733,5,0,0
12734,and,0,0
12735,21,0,0
12736,+/-,0,0
12737,5,0,0
12738,.,0,0
12739,Clinical,0,0
12740,response,0,0
12741,and,0,0
12742,safety,0,0
12743,were,0,0
12744,assessed,0,0
12745,on,0,0
12746,Days,0,0
12747,1,0,0
12748,",",0,0
12749,2,0,0
12750,",",0,0
12751,3,0,0
12752,",",0,0
12753,4,0,0
12754,to,0,0
12755,5,0,0
12756,and,0,0
12757,21,0,0
12758,+/-,0,0
12759,5,0,0
12760,.,0,0
12761,RESULTS,0,0
12762,We,0,0
12763,isolated,0,0
12764,127,0,0
12765,pathogens,0,0
12766,from,0,0
12767,121,0,0
12768,(,0,0
12769,60,0,0
12770,%,0,0
12771,),0,0
12772,patients,0,0
12773,:,0,0
12774,73,0,0
12775,(,0,0
12776,57,0,0
12777,%,0,0
12778,),0,0
12779,Shigella,0,0
12780,;,0,0
12781,23,0,0
12782,(,0,0
12783,18,0,0
12784,%,0,0
12785,),0,0
12786,Salmonella,0,0
12787,;,0,0
12788,18,0,0
12789,(,0,0
12790,14,0,0
12791,%,0,0
12792,),0,0
12793,E.,0,0
12794,coli,0,0
12795,;,0,0
12796,and,0,0
12797,13,0,0
12798,(,0,0
12799,10,0,0
12800,%,0,0
12801,),0,0
12802,Campylobacter,0,0
12803,.,0,0
12804,Overall,0,0
12805,bacteriologic,0,0
12806,eradication,0,0
12807,on,0,0
12808,Day,0,0
12809,4,0,0
12810,to,0,0
12811,5,0,0
12812,was,0,0
12813,99,0,0
12814,%,0,0
12815,for,0,0
12816,Shigella,0,0
12817,",",0,0
12818,77,0,0
12819,%,0,0
12820,for,0,0
12821,Salmonella,0,0
12822,and,0,0
12823,77,0,0
12824,%,0,0
12825,for,0,0
12826,Campylobacter,0,0
12827,",",0,0
12828,with,0,0
12829,no,0,0
12830,difference,0,0
12831,between,0,0
12832,the,0,0
12833,2,0,0
12834,groups,0,0
12835,.,0,0
12836,Clinical,0,0
12837,cure,0,0
12838,or,0,1
12839,improvement,0,0
12840,was,0,0
12841,observed,0,0
12842,in,0,0
12843,100,0,0
12844,and,0,0
12845,99,0,0
12846,%,0,0
12847,of,0,0
12848,the,0,0
12849,ciprofloxacin,1,1
12850,and,0,0
12851,ceftriaxone,1,1
12852,groups,0,0
12853,",",0,0
12854,respectively,0,0
12855,.,0,0
12856,Serum,0,0
12857,ciprofloxacin,1,1
12858,values,0,0
12859,determined,0,0
12860,on,0,0
12861,Day,0,0
12862,3,0,0
12863,of,0,0
12864,the,0,0
12865,treatment,0,0
12866,were,0,0
12867,higher,0,0
12868,in,0,0
12869,the,0,0
12870,majority,0,0
12871,of,0,0
12872,patients,0,0
12873,than,0,0
12874,were,0,0
12875,the,0,0
12876,MIC50,0,0
12877,and,0,0
12878,MIC90,0,0
12879,values,0,0
12880,for,0,0
12881,the,0,0
12882,Shigella,0,0
12883,and,0,0
12884,Salmonella,0,0
12885,spp,0,0
12886,.,0,0
12887,isolated,0,0
12888,.,0,0
12889,Possible,0,0
12890,drug-related,0,0
12891,adverse,0,0
12892,events,0,0
12893,occurred,0,0
12894,in,0,0
12895,13,0,0
12896,patients,0,0
12897,[,1,0
12898,ciprofloxacin,1,1
12899,",",0,0
12900,8,0,0
12901,(,0,0
12902,8,0,0
12903,%,0,0
12904,),0,0
12905,;,0,0
12906,ceftriaxone,1,1
12907,",",0,0
12908,5,0,0
12909,(,0,0
12910,4.7,0,0
12911,%,0,0
12912,),0,0
12913,],0,0
12914,and,0,0
12915,were,0,0
12916,mild,0,0
12917,and,0,0
12918,transient,0,0
12919,.,0,0
12920,Joint,0,0
12921,examination,0,0
12922,was,0,0
12923,normal,0,0
12924,during,0,0
12925,and,0,0
12926,after,0,0
12927,completion,0,0
12928,of,0,0
12929,therapy,0,1
12930,in,0,0
12931,all,0,0
12932,patients,0,0
12933,.,0,0
12934,CONCLUSION,0,0
12935,Oral,1,0
12936,ciprofloxacin,1,1
12937,was,0,0
12938,as,0,0
12939,safe,0,0
12940,and,0,0
12941,effective,0,0
12942,as,0,0
12943,intramuscular,1,1
12944,ceftriaxone,1,1
12945,for,0,0
12946,the,0,0
12947,empiric,0,0
12948,treatment,0,0
12949,of,0,0
12950,acute,0,0
12951,invasive,0,0
12952,diarrhea,0,0
12953,in,0,0
12954,ambulatory,0,0
12955,pediatric,0,0
12956,patients,0,0
12957,requiring,0,0
12958,an,0,0
12959,emergency,0,1
12960,room,0,0
12961,visit,0,0
12962,.,0,0
12963,Measurement,0,0
12964,of,0,0
12965,peptidase,0,0
12966,activity,0,0
12967,and,0,0
12968,evaluation,0,0
12969,of,0,0
12970,effectiveness,0,0
12971,of,0,0
12972,administration,0,0
12973,of,0,0
12974,minocycline,1,1
12975,for,0,0
12976,treatment,0,0
12977,of,0,0
12978,dogs,0,0
12979,with,0,0
12980,periodontitis,0,0
12981,.,0,0
12982,OBJECTIVE,0,0
12983,To,0,0
12984,determine,0,0
12985,clinical,0,0
12986,",",0,0
12987,enzymatic,0,0
12988,",",0,0
12989,and,0,0
12990,microbiologic,0,0
12991,effects,0,0
12992,of,0,0
12993,controlled-release,0,1
12994,localized,0,0
12995,administration,0,0
12996,of,0,0
12997,minocycline,1,1
12998,on,0,0
12999,dogs,0,0
13000,with,0,0
13001,periodontitis,0,0
13002,.,0,0
13003,ANIMALS,0,0
13004,Five,0,0
13005,adult,0,0
13006,Beagles,0,1
13007,with,0,0
13008,periodontitis,0,0
13009,.,0,0
13010,PROCEDURE,0,0
13011,After,0,0
13012,tooth,0,0
13013,scaling,0,0
13014,and,0,0
13015,root,0,0
13016,planing,0,1
13017,",",0,0
13018,2,0,0
13019,treatment,0,0
13020,",",0,0
13021,1,0,0
13022,placebo,0,1
13023,",",0,0
13024,and,0,0
13025,1,0,0
13026,control,0,0
13027,site,0,0
13028,were,0,0
13029,selected,0,0
13030,for,0,0
13031,each,0,0
13032,dog,0,0
13033,.,0,0
13034,Treatment,0,0
13035,sites,0,0
13036,(,0,0
13037,n,0,0
13038,=,0,0
13039,10,0,0
13040,),0,0
13041,received,0,0
13042,a,0,0
13043,periodontal,1,0
13044,formulation,1,0
13045,of,1,0
13046,minocycline,1,1
13047,hydrochloride,1,1
13048,",",1,0
13049,placebo,1,1
13050,sites,0,0
13051,(,0,0
13052,5,0,0
13053,),0,0
13054,received,1,0
13055,ointment,1,1
13056,without,1,0
13057,minocycline,1,1
13058,",",1,0
13059,and,1,0
13060,control,1,1
13061,sites,1,0
13062,(,1,0
13063,5,1,0
13064,),1,0
13065,did,1,0
13066,not,1,0
13067,receive,1,0
13068,ointment,1,1
13069,.,1,0
13070,Treatments,0,0
13071,were,0,0
13072,administered,0,0
13073,4,0,0
13074,times,0,0
13075,at,0,0
13076,weekly,0,0
13077,intervals,0,0
13078,.,0,0
13079,Peptidase,0,0
13080,activity,0,0
13081,and,0,0
13082,clinical,0,0
13083,and,0,0
13084,microbiologic,0,0
13085,effects,0,0
13086,were,0,0
13087,evaluated,0,0
13088,and,0,0
13089,compared,0,0
13090,among,0,0
13091,sites,0,0
13092,for,0,0
13093,17,0,0
13094,weeks,0,0
13095,.,0,0
13096,RESULTS,0,0
13097,Bleeding,0,0
13098,of,0,0
13099,the,0,0
13100,gums,0,1
13101,on,0,0
13102,probing,0,0
13103,(,0,0
13104,BOP,0,1
13105,),0,1
13106,and,0,0
13107,pocket,0,0
13108,depth,0,1
13109,(,0,0
13110,PD,0,0
13111,),0,0
13112,improved,0,0
13113,at,0,0
13114,the,0,0
13115,treatment,0,0
13116,site,0,0
13117,and,0,0
13118,were,0,0
13119,maintained,0,0
13120,for,0,0
13121,13,0,0
13122,weeks,0,0
13123,after,0,0
13124,treatment,0,0
13125,.,0,0
13126,However,0,0
13127,",",0,0
13128,BOP,0,0
13129,and,0,0
13130,PD,0,0
13131,in,0,0
13132,placebo,0,1
13133,and,0,0
13134,control,0,0
13135,sites,0,0
13136,increased,0,0
13137,from,0,0
13138,weeks,0,0
13139,9,0,0
13140,to,0,0
13141,17,0,0
13142,Peptidase,0,0
13143,activity,0,0
13144,in,0,0
13145,the,0,0
13146,periodontal,0,0
13147,pocket,0,0
13148,decreased,0,0
13149,noticeably,0,0
13150,from,0,0
13151,week,0,0
13152,1,0,0
13153,to,0,0
13154,17,0,0
13155,",",0,0
13156,compared,0,0
13157,with,0,0
13158,baseline,0,0
13159,values,0,0
13160,for,0,0
13161,the,0,0
13162,treatment,0,0
13163,site,0,0
13164,.,0,0
13165,However,0,0
13166,",",0,0
13167,peptidase,0,0
13168,activity,0,0
13169,for,0,0
13170,placebo,0,1
13171,and,0,0
13172,control,0,0
13173,sites,0,0
13174,increased,0,0
13175,and,0,0
13176,were,0,0
13177,above,0,0
13178,baseline,0,0
13179,values,0,0
13180,on,0,0
13181,week,0,0
13182,9,0,0
13183,and,0,0
13184,week,0,0
13185,13,0,0
13186,",",0,0
13187,respectively,0,0
13188,.,0,0
13189,Total,0,0
13190,bacterial,0,0
13191,counts,0,0
13192,decreased,0,0
13193,by,0,0
13194,90,0,0
13195,%,0,0
13196,for,0,0
13197,treatment,0,0
13198,sites,0,0
13199,and,0,0
13200,remained,0,0
13201,at,0,0
13202,that,0,0
13203,value,0,0
13204,for,0,0
13205,13,0,0
13206,weeks,0,0
13207,.,0,0
13208,However,0,0
13209,",",0,0
13210,for,0,0
13211,placebo,0,1
13212,and,0,0
13213,control,0,0
13214,sites,0,0
13215,",",0,0
13216,bacterial,0,0
13217,counts,0,0
13218,increased,0,0
13219,and,0,0
13220,reached,0,0
13221,the,0,0
13222,baseline,0,0
13223,value,0,0
13224,on,0,0
13225,week,0,0
13226,17,0,0
13227,.,0,0
13228,CONCLUSIONS,0,0
13229,AND,0,0
13230,CLINICAL,0,0
13231,RELEVANCE,0,0
13232,Increased,0,0
13233,peptidase,0,0
13234,activity,0,0
13235,is,0,0
13236,correlated,0,0
13237,with,0,0
13238,the,0,0
13239,progression,0,0
13240,of,0,0
13241,periodontitis,0,0
13242,in,0,0
13243,dogs,0,0
13244,.,0,0
13245,Treatment,0,0
13246,with,0,0
13247,minocycline,1,1
13248,",",0,0
13249,using,0,0
13250,a,0,0
13251,localized,0,0
13252,delivery,0,0
13253,system,0,0
13254,",",0,0
13255,was,0,0
13256,effective,0,0
13257,in,0,0
13258,dogs,0,0
13259,for,0,0
13260,at,0,0
13261,least,0,0
13262,13,0,0
13263,weeks,0,0
13264,after,0,0
13265,cessation,0,1
13266,of,0,0
13267,drug,0,0
13268,administration,0,0
13269,.,0,0
13270,Cardiovascular,0,0
13271,effects,0,0
13272,of,0,0
13273,tamoxifen,1,1
13274,in,0,0
13275,women,0,0
13276,with,0,0
13277,and,0,0
13278,without,0,0
13279,heart,0,0
13280,disease,0,0
13281,:,0,0
13282,breast,0,0
13283,cancer,0,0
13284,prevention,0,0
13285,trial,0,0
13286,.,0,0
13287,National,0,0
13288,Surgical,0,0
13289,Adjuvant,0,1
13290,Breast,0,0
13291,and,0,0
13292,Bowel,0,1
13293,Project,0,0
13294,Breast,0,0
13295,Cancer,0,0
13296,Prevention,0,1
13297,Trial,0,0
13298,Investigators,0,0
13299,.,0,0
13300,BACKGROUND,0,0
13301,The,0,0
13302,overall,0,0
13303,effect,0,0
13304,of,0,0
13305,prophylactic,0,1
13306,tamoxifen,0,1
13307,in,0,0
13308,women,0,0
13309,depends,0,0
13310,on,0,0
13311,the,0,0
13312,balance,0,0
13313,between,0,0
13314,the,0,0
13315,effects,0,0
13316,of,0,0
13317,the,0,0
13318,drug,0,0
13319,",",0,0
13320,which,0,0
13321,include,0,0
13322,preventing,0,0
13323,breast,0,0
13324,cancer,0,0
13325,and,0,0
13326,altering,0,0
13327,cardiovascular,0,0
13328,risk,0,0
13329,.,0,0
13330,In,0,0
13331,a,0,0
13332,recent,0,0
13333,clinical,0,0
13334,trial,0,0
13335,",",0,0
13336,postmenopausal,0,0
13337,estrogen-progestin,0,1
13338,therapy,0,1
13339,was,0,0
13340,shown,0,0
13341,to,0,0
13342,increase,0,0
13343,the,0,0
13344,risk,0,0
13345,of,0,0
13346,early,0,0
13347,cardiovascular,0,0
13348,events,0,0
13349,among,0,0
13350,women,0,0
13351,with,0,0
13352,a,0,0
13353,history,0,0
13354,of,0,0
13355,coronary,0,0
13356,heart,0,0
13357,disease,0,0
13358,(,0,0
13359,CHD,0,1
13360,),0,0
13361,.,0,0
13362,The,0,0
13363,cardiovascular,0,0
13364,effects,0,0
13365,of,0,0
13366,tamoxifen,0,1
13367,in,0,0
13368,women,0,0
13369,with,0,0
13370,and,0,0
13371,without,0,0
13372,CHD,0,1
13373,are,0,0
13374,not,0,0
13375,known,0,0
13376,.,0,0
13377,The,0,0
13378,National,0,0
13379,Surgical,0,0
13380,Adjuvant,0,1
13381,Breast,0,0
13382,and,0,0
13383,Bowel,0,1
13384,Project,0,0
13385,Breast,0,0
13386,Cancer,0,0
13387,Prevention,0,1
13388,Trial,0,1
13389,(,0,0
13390,BCPT,0,0
13391,),0,1
13392,is,0,0
13393,the,0,0
13394,only,0,0
13395,clinical,0,0
13396,trial,0,0
13397,that,0,0
13398,provides,0,0
13399,data,0,0
13400,to,0,0
13401,assess,0,0
13402,the,0,0
13403,cardiovascular,0,0
13404,effects,0,0
13405,of,0,0
13406,tamoxifen,0,1
13407,in,0,0
13408,women,0,0
13409,with,0,0
13410,and,0,0
13411,without,0,0
13412,CHD,0,1
13413,.,0,0
13414,METHODS,0,0
13415,A,0,0
13416,total,0,0
13417,of,0,0
13418,13,0,0
13419,388,0,0
13420,women,0,0
13421,at,0,0
13422,increased,0,0
13423,risk,0,0
13424,for,0,0
13425,breast,0,0
13426,cancer,0,0
13427,were,0,0
13428,randomly,0,0
13429,assigned,0,0
13430,in,0,0
13431,the,0,0
13432,BCPT,0,0
13433,to,0,0
13434,receive,0,0
13435,either,0,1
13436,tamoxifen,1,1
13437,(,1,0
13438,20,1,1
13439,mg/day,1,1
13440,),1,0
13441,or,1,0
13442,placebo,1,1
13443,.,1,0
13444,Cardiovascular,0,0
13445,follow-up,0,0
13446,was,0,0
13447,available,0,0
13448,for,0,0
13449,13,0,0
13450,194,0,0
13451,women,0,0
13452,",",0,0
13453,1048,0,0
13454,of,0,0
13455,whom,0,0
13456,had,0,0
13457,prior,0,0
13458,clinical,0,0
13459,CHD,0,1
13460,.,0,0
13461,Fatal,0,0
13462,and,0,0
13463,nonfatal,0,0
13464,myocardial,0,0
13465,infarction,0,0
13466,",",0,0
13467,unstable,0,0
13468,angina,0,0
13469,",",0,0
13470,and,0,0
13471,severe,0,0
13472,angina,0,0
13473,were,0,0
13474,tabulated,0,0
13475,(,0,0
13476,mean,0,0
13477,follow-up,0,0
13478,:,0,0
13479,49,0,0
13480,months,0,0
13481,),0,0
13482,.,0,0
13483,All,0,0
13484,statistical,0,0
13485,tests,0,0
13486,were,0,0
13487,two-sided,0,0
13488,.,0,0
13489,RESULTS,0,0
13490,Cardiovascular,0,0
13491,event,0,0
13492,rates,0,0
13493,were,0,0
13494,not,0,0
13495,statistically,0,0
13496,significantly,0,0
13497,different,0,0
13498,between,0,0
13499,women,0,0
13500,assigned,0,0
13501,to,0,0
13502,receive,0,1
13503,tamoxifen,0,1
13504,and,0,0
13505,those,0,0
13506,assigned,0,0
13507,to,0,0
13508,receive,0,0
13509,placebo,0,1
13510,",",0,0
13511,independent,0,0
13512,of,0,0
13513,pre-existing,0,0
13514,CHD,0,1
13515,.,0,0
13516,Among,0,0
13517,women,0,0
13518,without,0,0
13519,CHD,0,1
13520,(,0,0
13521,6074,0,0
13522,on,0,0
13523,tamoxifen,0,1
13524,versus,0,0
13525,6072,0,0
13526,on,0,0
13527,placebo,0,1
13528,),0,0
13529,",",0,0
13530,risk,0,0
13531,ratios,0,0
13532,(,0,0
13533,95,0,0
13534,%,0,0
13535,confidence,0,0
13536,intervals,0,0
13537,[,0,0
13538,CIs,0,0
13539,],0,0
13540,),0,0
13541,for,0,0
13542,tamoxifen,0,1
13543,users,0,0
13544,were,0,0
13545,1.75,0,0
13546,(,0,0
13547,0.44,0,0
13548,to,0,0
13549,8.13,0,0
13550,),0,0
13551,for,0,0
13552,fatal,0,0
13553,myocardial,0,0
13554,infarction,0,0
13555,",",0,0
13556,1.11,0,0
13557,(,0,0
13558,0.55,0,0
13559,to,0,0
13560,2.28,0,0
13561,),0,0
13562,for,0,0
13563,nonfatal,0,0
13564,myocardial,0,0
13565,infarction,0,0
13566,",",0,0
13567,0.69,0,0
13568,(,0,0
13569,0.29,0,0
13570,to,0,0
13571,1.57,0,0
13572,),0,0
13573,for,0,0
13574,unstable,0,0
13575,angina,0,0
13576,",",0,0
13577,and,0,0
13578,0.83,0,0
13579,(,0,0
13580,0.32,0,0
13581,to,0,0
13582,2.10,0,0
13583,),0,0
13584,for,0,0
13585,severe,0,0
13586,angina,0,0
13587,.,0,0
13588,In,0,0
13589,women,0,0
13590,with,0,0
13591,CHD,0,1
13592,(,0,0
13593,516,0,0
13594,on,0,0
13595,tamoxifen,0,1
13596,versus,0,0
13597,532,0,0
13598,on,0,0
13599,placebo,0,1
13600,),0,0
13601,",",0,0
13602,risk,0,0
13603,ratios,0,0
13604,(,0,0
13605,95,0,0
13606,%,0,0
13607,CIs,0,0
13608,),0,0
13609,for,0,0
13610,tamoxifen,0,1
13611,users,0,0
13612,were,0,0
13613,0.00,0,0
13614,(,0,0
13615,0,0,0
13616,to,0,0
13617,1.58,0,0
13618,),0,0
13619,for,0,0
13620,fatal,0,0
13621,myocardial,0,0
13622,infarction,0,0
13623,",",0,0
13624,1.25,0,0
13625,(,0,0
13626,0.32,0,0
13627,to,0,0
13628,5.18,0,0
13629,),0,0
13630,for,0,0
13631,nonfatal,0,0
13632,myocardial,0,0
13633,infarction,0,0
13634,",",0,0
13635,2.26,0,0
13636,(,0,0
13637,0.87,0,0
13638,to,0,0
13639,6.55,0,0
13640,),0,0
13641,for,0,0
13642,unstable,0,0
13643,angina,0,0
13644,",",0,0
13645,and,0,0
13646,1.39,0,0
13647,(,0,0
13648,0.23,0,0
13649,to,0,0
13650,9.47,0,0
13651,),0,0
13652,for,0,0
13653,severe,0,0
13654,angina,0,0
13655,.,0,0
13656,There,0,0
13657,was,0,0
13658,no,0,0
13659,evidence,0,0
13660,that,0,0
13661,the,0,0
13662,lack,0,0
13663,of,0,0
13664,association,0,0
13665,between,0,0
13666,tamoxifen,0,1
13667,and,0,0
13668,cardiovascular,0,0
13669,events,0,0
13670,was,0,0
13671,related,0,0
13672,to,0,0
13673,an,0,0
13674,early,0,0
13675,increase,0,0
13676,in,0,0
13677,risk,0,0
13678,that,0,0
13679,may,0,0
13680,have,0,0
13681,been,0,0
13682,offset,0,0
13683,by,0,0
13684,a,0,0
13685,late,0,0
13686,decrease,0,0
13687,in,0,0
13688,risk,0,0
13689,.,0,0
13690,CONCLUSION,0,0
13691,When,0,0
13692,used,0,0
13693,for,0,0
13694,breast,0,0
13695,cancer,0,0
13696,prevention,0,0
13697,in,0,0
13698,women,0,0
13699,with,0,0
13700,or,0,0
13701,without,0,0
13702,heart,0,0
13703,disease,0,0
13704,",",0,0
13705,tamoxifen,0,1
13706,is,0,0
13707,not,0,0
13708,associated,0,0
13709,with,0,0
13710,beneficial,0,0
13711,or,0,0
13712,adverse,0,0
13713,cardiovascular,0,0
13714,effects,0,0
13715,.,0,0
13716,The,0,0
13717,effects,0,0
13718,of,0,0
13719,treatment,0,0
13720,with,0,0
13721,interleukin-1,1,1
13722,receptor,1,0
13723,antagonist,1,1
13724,on,0,0
13725,the,0,0
13726,inflamed,0,0
13727,synovial,0,0
13728,membrane,0,0
13729,in,0,0
13730,rheumatoid,0,0
13731,arthritis,0,0
13732,.,0,0
13733,OBJECTIVE,0,0
13734,To,0,0
13735,evaluate,0,0
13736,the,0,0
13737,effects,0,0
13738,of,0,0
13739,treatment,0,0
13740,with,0,0
13741,interleukin-1,1,1
13742,receptor,1,0
13743,antagonist,1,1
13744,(,1,0
13745,IL-1Ra,1,1
13746,),1,0
13747,on,0,0
13748,synovial,0,0
13749,tissue,0,0
13750,in,0,0
13751,rheumatoid,0,0
13752,arthritis,0,0
13753,(,0,0
13754,RA,0,0
13755,),0,0
13756,.,0,0
13757,METHODS,0,0
13758,Twelve,0,0
13759,patients,0,0
13760,with,0,0
13761,RA,0,0
13762,entering,0,0
13763,a,0,0
13764,randomized,0,0
13765,clinical,0,0
13766,trial,0,0
13767,of,0,0
13768,human,1,0
13769,recombinant,1,1
13770,IL-1Ra,1,1
13771,underwent,0,0
13772,synovial,1,0
13773,biopsies,1,0
13774,before,0,0
13775,and,0,0
13776,after,0,0
13777,treatment,0,0
13778,.,0,0
13779,Cellular,0,0
13780,infiltration,0,0
13781,and,0,0
13782,adhesion,0,0
13783,molecule,0,0
13784,expression,0,0
13785,were,0,0
13786,evaluated,0,0
13787,after,0,0
13788,immunohistochemical,0,0
13789,staining,0,0
13790,.,0,0
13791,RESULTS,0,0
13792,There,0,0
13793,was,0,0
13794,a,0,0
13795,notable,0,0
13796,reduction,0,0
13797,in,0,0
13798,intimal,0,0
13799,layer,0,1
13800,macrophages,0,0
13801,and,0,0
13802,subintimal,0,1
13803,macrophages,0,0
13804,and,0,0
13805,lymphocytes,0,0
13806,after,0,0
13807,treatment,0,0
13808,with,0,0
13809,IL-1Ra,1,1
13810,at,0,0
13811,150,0,0
13812,mg/day,0,0
13813,(,0,0
13814,n=3,0,0
13815,),0,0
13816,.,0,0
13817,Increased,0,0
13818,cellular,0,0
13819,infiltration,0,0
13820,was,0,0
13821,observed,0,0
13822,in,0,0
13823,all,0,0
13824,patients,0,0
13825,receiving,0,0
13826,placebo,1,1
13827,(,0,0
13828,n=3,0,0
13829,),0,0
13830,;,0,0
13831,variable,0,0
13832,changes,0,0
13833,were,0,0
13834,observed,0,0
13835,after,0,0
13836,IL-1Ra,1,1
13837,30,0,0
13838,mg/day,0,0
13839,(,0,0
13840,n=6,0,0
13841,),0,0
13842,.,0,0
13843,In,0,0
13844,a,0,0
13845,limited,0,0
13846,study,0,0
13847,of,0,0
13848,adhesion,0,0
13849,molecule,0,0
13850,expression,0,0
13851,",",0,0
13852,down-regulation,0,0
13853,of,0,0
13854,E-selectin,0,1
13855,and,0,0
13856,vascular,0,0
13857,cell,0,0
13858,adhesion,0,0
13859,molecule-1,0,0
13860,was,0,0
13861,observed,0,0
13862,after,0,0
13863,treatment,0,0
13864,with,0,0
13865,IL-1Ra,1,1
13866,150,0,0
13867,mg/day,0,0
13868,",",0,0
13869,but,0,0
13870,not,0,0
13871,after,0,0
13872,IL-1Ra,1,1
13873,30,0,0
13874,mg/day,0,0
13875,or,0,0
13876,placebo,1,1
13877,.,1,0
13878,The,0,0
13879,apparent,0,0
13880,arrest,0,0
13881,of,0,0
13882,progressive,0,0
13883,joint,0,0
13884,damage,0,0
13885,seen,0,0
13886,in,0,0
13887,four,0,0
13888,patients,0,0
13889,after,0,0
13890,treatment,0,0
13891,with,0,0
13892,IL-1Ra,1,1
13893,was,0,0
13894,associated,0,0
13895,with,0,0
13896,reduced,0,0
13897,intimal,0,0
13898,layer,0,1
13899,macrophage,0,0
13900,accumulation,0,0
13901,in,0,0
13902,all,0,0
13903,patients,0,0
13904,.,0,0
13905,CONCLUSION,0,0
13906,Treatment,0,0
13907,of,0,0
13908,RA,0,0
13909,with,0,0
13910,IL-1Ra,1,1
13911,resulted,0,0
13912,in,0,0
13913,reduced,0,0
13914,mononuclear,0,0
13915,cell,0,0
13916,infiltration,0,0
13917,of,0,0
13918,synovial,0,0
13919,membrane,0,0
13920,",",0,0
13921,which,0,0
13922,may,0,0
13923,represent,0,0
13924,the,0,0
13925,in,0,0
13926,vivo,0,0
13927,inhibition,0,0
13928,of,0,0
13929,biologically,0,0
13930,relevant,0,0
13931,IL-1ss-mediated,0,0
13932,pathogenic,0,0
13933,effects,0,0
13934,.,0,0
13935,The,0,0
13936,injured,0,0
13937,colon,0,0
13938,:,0,0
13939,therapeutic,0,0
13940,considerations,0,0
13941,.,0,0
13942,A,0,0
13943,prospective,0,0
13944,randomized,0,0
13945,study,0,0
13946,was,0,0
13947,carried,0,0
13948,out,0,0
13949,at,0,0
13950,the,0,0
13951,Detroit,0,0
13952,General,0,1
13953,Hospital,0,0
13954,over,0,0
13955,a,0,0
13956,two,0,0
13957,year,0,0
13958,period,0,0
13959,to,0,0
13960,evaluate,0,0
13961,methods,0,0
13962,of,0,0
13963,management,0,0
13964,in,0,0
13965,165,0,0
13966,patients,0,0
13967,with,0,0
13968,colonic,1,0
13969,injuries,1,0
13970,.,1,0
13971,Results,0,0
13972,of,0,0
13973,the,0,0
13974,study,0,0
13975,show,0,0
13976,that,0,0
13977,primary,1,0
13978,closure,1,0
13979,is,0,0
13980,a,0,0
13981,safe,0,0
13982,and,0,0
13983,reiable,0,0
13984,method,0,0
13985,of,0,0
13986,management,0,0
13987,when,0,0
13988,rigid,0,1
13989,criteria,0,0
13990,are,0,0
13991,incorporated,0,0
13992,in,0,0
13993,an,0,0
13994,ongoing,0,0
13995,protocol,0,0
13996,.,0,0
13997,Moreover,0,0
13998,",",0,0
13999,the,0,0
14000,technic,0,0
14001,of,0,0
14002,exteriorization,1,0
14003,is,0,0
14004,a,0,0
14005,safe,0,0
14006,adjunct,0,0
14007,to,0,0
14008,management,0,0
14009,and,0,0
14010,is,0,0
14011,recommended,0,0
14012,in,0,0
14013,any,0,0
14014,patient,0,0
14015,with,0,0
14016,a,0,0
14017,colonic,0,0
14018,injury,0,0
14019,above,0,0
14020,18,0,0
14021,cm,0,0
14022,in,0,0
14023,which,0,0
14024,one,0,0
14025,suture,0,0
14026,line,0,0
14027,is,0,0
14028,required,0,0
14029,and,0,0
14030,in,0,0
14031,which,0,0
14032,the,0,0
14033,additional,0,0
14034,operating,0,0
14035,time,0,0
14036,of,0,0
14037,twenty,0,0
14038,minutes,0,0
14039,will,0,0
14040,not,0,0
14041,compromise,0,0
14042,the,0,0
14043,management,0,0
14044,of,0,0
14045,secondary,0,0
14046,injuries,0,0
14047,.,0,0
14048,Patients,0,0
14049,not,0,0
14050,fulfilling,0,0
14051,these,0,0
14052,criteria,0,0
14053,should,0,0
14054,have,0,0
14055,primary,1,0
14056,colostomy,1,0
14057,.,1,0
14058,These,0,0
14059,principles,0,0
14060,make,0,0
14061,it,0,0
14062,possible,0,0
14063,to,0,0
14064,reduce,0,0
14065,the,0,0
14066,need,0,0
14067,for,0,0
14068,primary,1,0
14069,colostomy,1,0
14070,to,0,0
14071,approximately,0,0
14072,50,0,0
14073,per,0,0
14074,cent,0,0
14075,in,0,0
14076,a,0,0
14077,large,0,0
14078,ongoing,0,0
14079,group,0,0
14080,of,0,0
14081,patients,0,0
14082,with,0,0
14083,colonic,0,0
14084,injury,0,0
14085,.,0,0
14086,The,0,0
14087,effect,0,0
14088,of,0,0
14089,aging,0,0
14090,on,0,0
14091,circulating,0,0
14092,levels,0,0
14093,of,0,0
14094,proinflammatory,0,0
14095,cytokines,0,0
14096,during,0,0
14097,septic,0,0
14098,shock,0,0
14099,.,0,0
14100,Norasept,1,1
14101,II,1,0
14102,Study,0,0
14103,Investigators,0,0
14104,.,0,0
14105,BACKGROUND,0,0
14106,As,0,0
14107,the,0,0
14108,proportion,0,0
14109,of,0,0
14110,the,0,0
14111,population,0,0
14112,that,0,0
14113,is,0,0
14114,older,0,0
14115,continues,0,0
14116,to,0,0
14117,rise,0,0
14118,",",0,0
14119,infection,0,0
14120,in,0,0
14121,older,0,0
14122,people,0,0
14123,has,0,0
14124,become,0,0
14125,an,0,0
14126,important,0,0
14127,healthcare,0,0
14128,problem,0,0
14129,.,0,0
14130,Although,0,0
14131,aging,0,0
14132,is,0,0
14133,associated,0,0
14134,with,0,0
14135,multiple,0,0
14136,abnormalities,0,0
14137,in,0,0
14138,immune,0,0
14139,function,0,0
14140,",",0,0
14141,the,0,0
14142,effect,0,0
14143,of,0,0
14144,aging,0,0
14145,on,0,0
14146,the,0,0
14147,production,0,0
14148,of,0,0
14149,proinflammatory,0,0
14150,cytokines,0,0
14151,has,0,0
14152,not,0,0
14153,been,0,0
14154,well,0,0
14155,studied,0,0
14156,under,0,0
14157,conditions,0,0
14158,of,0,0
14159,clinical,0,0
14160,stress,0,0
14161,.,0,0
14162,OBJECTIVES,0,0
14163,The,0,0
14164,aim,0,0
14165,of,0,0
14166,this,0,0
14167,study,0,0
14168,was,0,0
14169,to,0,0
14170,examine,0,0
14171,the,0,0
14172,effect,0,0
14173,of,0,0
14174,aging,0,0
14175,on,0,0
14176,circulating,0,0
14177,levels,0,0
14178,of,0,0
14179,the,0,0
14180,proinflammatory,0,0
14181,cytokines,0,0
14182,in,0,0
14183,a,0,0
14184,large,0,0
14185,cohort,0,0
14186,of,0,0
14187,septic,0,0
14188,shock,0,0
14189,patients,0,0
14190,.,0,0
14191,We,0,0
14192,hypothesized,0,0
14193,that,0,0
14194,aging,0,0
14195,would,0,0
14196,be,0,0
14197,associated,0,0
14198,with,0,0
14199,a,0,0
14200,diminished,0,0
14201,proinflammatory,0,0
14202,cytokine,0,0
14203,response,0,0
14204,to,0,0
14205,sepsis,0,0
14206,.,0,0
14207,DESIGN,0,0
14208,Patients,0,0
14209,with,0,0
14210,septic,0,0
14211,shock,0,0
14212,who,0,0
14213,were,0,0
14214,enrolled,0,0
14215,in,0,0
14216,the,0,0
14217,placebo,1,1
14218,limb,0,0
14219,of,0,0
14220,the,0,0
14221,North,1,0
14222,American,1,0
14223,Sepsis,1,0
14224,Trial,1,1
14225,(,1,0
14226,NORASEPT,1,0
14227,II,1,0
14228,),1,0
14229,study,0,0
14230,were,0,0
14231,analyzed,0,0
14232,.,0,0
14233,SETTING,0,0
14234,The,0,0
14235,intensive,0,1
14236,care,0,0
14237,units,0,1
14238,of,0,0
14239,105,0,0
14240,hospitals,0,0
14241,in,0,0
14242,the,0,0
14243,United,0,0
14244,States,0,0
14245,and,0,0
14246,Canada,0,0
14247,.,0,0
14248,PARTICIPANTS,0,0
14249,Nine,0,1
14250,hundred,0,0
14251,and,0,0
14252,thirty,0,0
14253,patients,0,0
14254,presenting,0,0
14255,to,0,0
14256,hospital,0,0
14257,within,0,0
14258,12,0,0
14259,hours,0,0
14260,of,0,0
14261,the,0,0
14262,onset,0,0
14263,of,0,0
14264,septic,0,0
14265,shock,0,0
14266,.,0,0
14267,MEASUREMENTS,0,0
14268,Interleukin-6,0,0
14269,(,0,0
14270,IL-6,0,0
14271,),0,0
14272,",",0,0
14273,tumor,0,0
14274,necrosis,0,0
14275,factor-alpha,0,0
14276,(,0,0
14277,TNF-alpha,0,1
14278,),0,0
14279,",",0,0
14280,soluble,0,1
14281,tumor,0,0
14282,necrosis,0,0
14283,factor-receptor-55,0,1
14284,(,0,0
14285,sTNF-R55,0,0
14286,),0,0
14287,",",0,0
14288,and,0,0
14289,soluble,0,1
14290,tumor,0,0
14291,necrosis,0,0
14292,factor-receptor-75,0,1
14293,(,0,0
14294,sTNF-R75,0,0
14295,),0,0
14296,concentrations,0,0
14297,were,0,0
14298,measured,0,0
14299,at,0,0
14300,enrollment,0,0
14301,.,0,0
14302,The,0,0
14303,study,0,0
14304,population,0,0
14305,was,0,0
14306,broken,0,0
14307,down,0,0
14308,into,0,0
14309,five,0,0
14310,age,0,0
14311,groups,0,0
14312,as,0,0
14313,follows,0,0
14314,:,0,0
14315,less,0,0
14316,than,0,0
14317,50,0,0
14318,years,0,0
14319,(,0,0
14320,group,0,0
14321,one,0,0
14322,),0,0
14323,",",0,0
14324,50,0,0
14325,to,0,0
14326,64,0,0
14327,years,0,0
14328,(,0,0
14329,group,0,0
14330,two,0,0
14331,),0,0
14332,",",0,0
14333,65,0,0
14334,to,0,0
14335,74,0,0
14336,years,0,0
14337,(,0,0
14338,group,0,0
14339,three,0,0
14340,),0,0
14341,",",0,0
14342,75,0,0
14343,to,0,0
14344,84,0,0
14345,years,0,0
14346,(,0,0
14347,group,0,0
14348,four,0,0
14349,),0,0
14350,",",0,0
14351,and,0,0
14352,85,0,0
14353,or,0,0
14354,older,0,0
14355,(,0,0
14356,group,0,0
14357,five,0,0
14358,),0,0
14359,.,0,0
14360,Clinical,0,0
14361,",",0,0
14362,demographic,0,0
14363,",",0,0
14364,and,0,0
14365,cytokine,0,0
14366,data,0,0
14367,were,0,0
14368,extracted,0,0
14369,to,0,0
14370,describe,0,0
14371,each,0,0
14372,age,0,0
14373,group,0,0
14374,.,0,0
14375,RESULTS,0,0
14376,Data,0,0
14377,were,0,0
14378,available,0,0
14379,for,0,0
14380,930,0,0
14381,patients,0,0
14382,.,0,0
14383,The,0,0
14384,patients,0,0
14385,',0,0
14386,mean,0,0
14387,age,0,0
14388,(,0,0
14389,+/-,0,0
14390,SD,0,0
14391,),0,0
14392,was,0,0
14393,59,0,0
14394,+/-,0,0
14395,17,0,0
14396,years,0,0
14397,(,0,0
14398,range,0,0
14399,",",0,0
14400,18,0,0
14401,to,0,0
14402,102,0,0
14403,),0,0
14404,.,0,0
14405,There,0,0
14406,were,0,0
14407,280,0,0
14408,patients,0,0
14409,in,0,0
14410,group,0,0
14411,one,0,0
14412,",",0,0
14413,242,0,0
14414,in,0,0
14415,group,0,0
14416,two,0,0
14417,",",0,0
14418,210,0,0
14419,in,0,0
14420,group,0,0
14421,three,0,0
14422,",",0,0
14423,150,0,0
14424,in,0,0
14425,group,0,0
14426,four,0,0
14427,",",0,0
14428,and,0,0
14429,48,0,0
14430,in,0,0
14431,group,0,0
14432,five,0,0
14433,.,0,0
14434,The,0,0
14435,primary,0,0
14436,diagnoses,0,0
14437,;,0,0
14438,clinical,0,0
14439,characteristics,0,0
14440,;,0,0
14441,and,0,0
14442,IL-6,0,0
14443,",",0,0
14444,sTNF-R55,0,0
14445,",",0,0
14446,and,0,0
14447,sTNF-R75,0,0
14448,levels,0,0
14449,were,0,0
14450,similar,0,0
14451,among,0,0
14452,the,0,0
14453,five,0,0
14454,age,0,0
14455,groups,0,0
14456,.,0,0
14457,The,0,0
14458,TNF-alpha,0,0
14459,levels,0,0
14460,were,0,0
14461,significantly,0,0
14462,higher,0,0
14463,",",0,0
14464,however,0,0
14465,",",0,0
14466,in,0,0
14467,the,0,0
14468,oldest,0,0
14469,group,0,0
14470,of,0,0
14471,patients,0,0
14472,(,0,0
14473,group,0,0
14474,five,0,0
14475,),0,0
14476,.,0,0
14477,The,0,0
14478,28-day,0,0
14479,survival,0,0
14480,was,0,0
14481,49,0,0
14482,%,0,0
14483,in,0,0
14484,patients,0,0
14485,over,0,0
14486,the,0,0
14487,age,0,0
14488,of,0,0
14489,75,0,0
14490,and,0,0
14491,58,0,0
14492,%,0,0
14493,in,0,0
14494,those,0,0
14495,under,0,0
14496,75,0,0
14497,years,0,0
14498,(,0,0
14499,P,0,0
14500,=,0,0
14501,.03,0,0
14502,),0,0
14503,.,0,0
14504,There,0,0
14505,was,0,0
14506,no,0,0
14507,gender,0,0
14508,difference,0,0
14509,in,0,0
14510,survival,0,0
14511,or,0,1
14512,cytokine,0,0
14513,levels,0,0
14514,.,0,0
14515,CONCLUSIONS,0,0
14516,Contrary,0,0
14517,to,0,0
14518,our,0,0
14519,expectations,0,0
14520,",",0,0
14521,we,0,0
14522,found,0,0
14523,that,0,0
14524,aging,0,0
14525,was,0,0
14526,not,0,0
14527,associated,0,0
14528,with,0,0
14529,a,0,0
14530,decline,0,0
14531,in,0,0
14532,the,0,0
14533,circulating,0,0
14534,levels,0,0
14535,of,0,0
14536,proinflammatory,0,0
14537,cytokines,0,0
14538,.,0,0
14539,Beneficial,0,0
14540,effects,0,0
14541,of,0,0
14542,a,0,0
14543,soy-based,1,1
14544,dietary,1,0
14545,supplement,1,1
14546,on,0,0
14547,lipid,0,0
14548,levels,0,0
14549,and,0,0
14550,cardiovascular,0,0
14551,risk,0,0
14552,markers,0,0
14553,in,0,0
14554,type,0,0
14555,2,0,0
14556,diabetic,0,0
14557,subjects,0,0
14558,.,0,0
14559,OBJECTIVE,0,0
14560,Consumption,0,0
14561,of,0,0
14562,soy,0,1
14563,protein,0,1
14564,has,0,0
14565,recently,0,0
14566,been,0,0
14567,shown,0,0
14568,to,0,0
14569,improve,0,0
14570,the,0,0
14571,blood,0,0
14572,lipid,0,0
14573,levels,0,0
14574,in,0,0
14575,nondiabetic,0,0
14576,subjects,0,0
14577,.,0,0
14578,The,0,0
14579,purpose,0,0
14580,of,0,0
14581,this,0,0
14582,study,0,0
14583,was,0,0
14584,to,0,0
14585,evaluate,0,0
14586,if,0,0
14587,a,0,0
14588,dietary,0,0
14589,supplement,0,1
14590,of,0,0
14591,soy,1,1
14592,protein,1,0
14593,",",1,0
14594,isoflavones,1,1
14595,",",1,0
14596,and,1,0
14597,cotyledon,1,1
14598,fiber,1,1
14599,(,1,0
14600,Abalon,1,1
14601,),1,1
14602,affects,0,0
14603,cardiovascular,0,0
14604,risk,0,0
14605,markers,0,0
14606,",",0,0
14607,blood,0,0
14608,glucose,0,0
14609,",",0,0
14610,and,0,0
14611,insulin,0,1
14612,levels,0,0
14613,in,0,0
14614,type,0,0
14615,2,0,0
14616,diabetic,0,0
14617,subjects,0,0
14618,.,0,0
14619,RESEARCH,0,0
14620,DESIGN,0,0
14621,AND,0,0
14622,METHODS,0,0
14623,Twenty,0,1
14624,type,0,0
14625,2,0,0
14626,diabetic,0,0
14627,subjects,0,0
14628,participated,0,0
14629,in,0,0
14630,a,0,0
14631,crossover,0,0
14632,trial,0,0
14633,.,0,0
14634,They,0,0
14635,were,0,0
14636,randomized,0,0
14637,to,0,0
14638,double-blind,0,0
14639,supplementation,0,1
14640,for,0,0
14641,6,1,0
14642,weeks,1,0
14643,with,1,0
14644,Abalon,1,1
14645,(,1,0
14646,soy,1,1
14647,protein,1,1
14648,[,0,0
14649,50,0,0
14650,g/day,0,0
14651,],0,0
14652,with,0,0
14653,high,0,0
14654,levels,0,0
14655,of,0,0
14656,isoflavones,1,1
14657,[,0,0
14658,minimum,0,0
14659,165,0,0
14660,mg/day,0,0
14661,],0,0
14662,and,0,0
14663,cotyledon,1,1
14664,fiber,1,1
14665,[,0,0
14666,20,0,0
14667,g/day,0,0
14668,],0,0
14669,),0,0
14670,or,0,1
14671,placebo,1,1
14672,(,0,0
14673,casein,0,1
14674,[,0,0
14675,50,0,0
14676,g/day,0,0
14677,],0,0
14678,and,0,0
14679,cellulose,0,1
14680,[,0,0
14681,20,0,0
14682,g/day,0,0
14683,],0,0
14684,),0,0
14685,",",0,0
14686,separated,0,0
14687,by,0,0
14688,a,0,0
14689,3-week,0,0
14690,wash-out,0,1
14691,period,0,0
14692,.,0,0
14693,RESULTS,0,0
14694,The,0,0
14695,results,0,0
14696,are,0,0
14697,expressed,0,0
14698,as,0,0
14699,means,0,0
14700,+/-,0,0
14701,SD,0,0
14702,.,0,0
14703,The,0,0
14704,percentage,0,0
14705,mean,0,0
14706,treatment,0,0
14707,difference,0,0
14708,between,0,0
14709,Abalon,1,1
14710,and,0,0
14711,placebo,1,1
14712,demonstrated,0,0
14713,significantly,0,0
14714,lower,0,0
14715,mean,0,0
14716,values,0,0
14717,after,0,0
14718,Abalon,1,0
14719,for,0,0
14720,LDL,0,0
14721,cholesterol,0,0
14722,(,0,0
14723,10,0,0
14724,+/-,0,0
14725,15,0,0
14726,%,0,0
14727,",",0,0
14728,P,0,0
14729,<,0,0
14730,0.05,0,0
14731,),0,0
14732,",",0,0
14733,LDL/UHDL,0,1
14734,ratio,0,0
14735,(,0,0
14736,12,0,0
14737,+/-,0,0
14738,18,0,0
14739,%,0,0
14740,",",0,0
14741,P,0,0
14742,<,0,0
14743,0.05,0,0
14744,),0,0
14745,",",0,0
14746,apolipoprotein,0,1
14747,(,0,0
14748,apo,0,0
14749,),0,1
14750,B100,0,1
14751,(,0,0
14752,30,0,0
14753,+/-,0,0
14754,38,0,0
14755,%,0,0
14756,",",0,0
14757,P,0,0
14758,<,0,0
14759,0.01,0,0
14760,),0,0
14761,",",0,0
14762,triglycerides,0,0
14763,(,0,0
14764,22,0,0
14765,+/-,0,0
14766,10,0,0
14767,%,0,0
14768,",",0,0
14769,P,0,0
14770,<,0,0
14771,0.05,0,0
14772,),0,0
14773,",",0,0
14774,and,0,0
14775,homocysteine,0,0
14776,(,0,0
14777,14,0,0
14778,+/-,0,0
14779,21,0,0
14780,%,0,0
14781,",",0,0
14782,P,0,0
14783,<,0,0
14784,0.01,0,0
14785,),0,0
14786,",",0,0
14787,whereas,0,0
14788,the,0,0
14789,total,0,0
14790,cholesterol,0,0
14791,value,0,0
14792,tended,0,0
14793,to,0,0
14794,be,0,0
14795,less,0,0
14796,significant,0,0
14797,but,0,0
14798,still,0,0
14799,lower,0,0
14800,(,0,0
14801,8,0,0
14802,+/-,0,0
14803,15,0,0
14804,%,0,0
14805,",",0,0
14806,P,0,0
14807,<,0,0
14808,0.08,0,0
14809,),0,0
14810,.,0,0
14811,No,0,0
14812,change,0,0
14813,occurred,0,0
14814,in,0,0
14815,HDL,0,1
14816,cholesterol,0,0
14817,",",0,0
14818,apo,0,0
14819,B100/apo,0,1
14820,A1,0,1
14821,ratio,0,0
14822,",",0,0
14823,plasminogen,0,0
14824,activator,0,0
14825,inhibitor,0,1
14826,1,0,0
14827,",",0,0
14828,factor,0,0
14829,VIIc,0,1
14830,",",0,0
14831,von,0,0
14832,Willebrand,0,0
14833,factor,0,0
14834,",",0,0
14835,fibrinogen,0,0
14836,",",0,0
14837,lipoprotein,0,0
14838,(,0,0
14839,a,0,0
14840,),0,0
14841,",",0,0
14842,glucose,0,0
14843,",",0,0
14844,HbA1c,0,1
14845,",",0,0
14846,or,0,0
14847,24-h,0,1
14848,blood,0,0
14849,pressure,0,0
14850,.,0,0
14851,CONCLUSIONS,0,0
14852,These,0,0
14853,results,0,0
14854,indicate,0,0
14855,beneficial,0,0
14856,effects,0,0
14857,of,0,0
14858,dietary,0,0
14859,supplementation,0,1
14860,with,0,0
14861,Abalon,1,1
14862,on,0,0
14863,cardiovascular,0,0
14864,risk,0,0
14865,markers,0,0
14866,in,0,0
14867,type,0,0
14868,2,0,0
14869,diabetic,0,0
14870,subjects,0,0
14871,.,0,0
14872,This,0,0
14873,improvement,0,0
14874,is,0,0
14875,seen,0,0
14876,even,0,0
14877,in,0,0
14878,individuals,0,0
14879,with,0,0
14880,near-normal,0,0
14881,lipid,0,0
14882,values,0,0
14883,.,0,0
14884,Comparison,0,0
14885,of,0,0
14886,provocative,0,0
14887,tests,0,0
14888,for,0,0
14889,unexplained,0,0
14890,syncope,0,0
14891,:,0,0
14892,isoprenaline,1,1
14893,and,1,0
14894,glyceryl,1,1
14895,trinitrate,1,1
14896,for,0,0
14897,diagnosing,0,0
14898,vasovagal,0,0
14899,syncope,0,0
14900,.,0,0
14901,AIMS,0,0
14902,To,0,0
14903,compare,0,0
14904,the,0,0
14905,sensitivity,0,0
14906,",",0,0
14907,specificity,0,0
14908,and,0,0
14909,adverse,0,0
14910,event,0,0
14911,profile,0,0
14912,of,0,0
14913,glyceryl,1,1
14914,trinitrate,1,1
14915,head-up,0,1
14916,tilt,0,0
14917,with,0,0
14918,isoprenaline,1,1
14919,head-up,0,1
14920,tilt,0,0
14921,in,0,0
14922,the,0,0
14923,diagnosis,0,0
14924,of,0,0
14925,vasovagal,0,0
14926,syncope,0,0
14927,in,0,0
14928,patients,0,0
14929,with,0,0
14930,unexplained,0,0
14931,syncope,0,0
14932,and,0,0
14933,healthy,0,0
14934,controls,0,0
14935,.,0,0
14936,METHODS,0,0
14937,AND,0,0
14938,RESULTS,0,0
14939,Forty-eight,0,0
14940,patients,0,0
14941,with,0,0
14942,unexplained,0,0
14943,syncope,0,0
14944,and,0,0
14945,negative,0,0
14946,passive,0,1
14947,head-up,0,1
14948,tilt,0,0
14949,at,0,0
14950,70,0,0
14951,degrees,0,0
14952,for,0,0
14953,40,0,0
14954,min,0,0
14955,",",0,0
14956,and,0,0
14957,14,0,0
14958,healthy,0,0
14959,controls,0,0
14960,underwent,0,0
14961,glyceryl,1,1
14962,trinitrate,1,1
14963,head-up,1,1
14964,tilt,1,1
14965,and,1,0
14966,isoprenaline,1,1
14967,head-up,1,1
14968,tilt,1,1
14969,(,0,0
14970,maximum,0,0
14971,dose,0,0
14972,5,0,0
14973,microg,0,0
14974,x,0,0
14975,min,0,1
14976,(,0,0
14977,-1,0,0
14978,),0,1
14979,),0,0
14980,one,0,0
14981,week,0,0
14982,apart,0,0
14983,in,0,0
14984,random,0,0
14985,order,0,0
14986,.,0,0
14987,Outcome,0,0
14988,measures,0,0
14989,were,0,0
14990,production,0,0
14991,of,0,0
14992,symptoms,0,0
14993,(,0,0
14994,syncope,0,0
14995,",",0,0
14996,pre-syncope,0,0
14997,),0,0
14998,with,0,0
14999,development,0,0
15000,of,0,0
15001,hypotension,0,0
15002,.,0,0
15003,In,0,0
15004,those,0,0
15005,with,0,0
15006,negative,0,0
15007,passive,0,1
15008,head-up,0,1
15009,tilt,0,0
15010,",",0,0
15011,the,0,0
15012,sensitivity,0,0
15013,of,0,0
15014,glyceryl,1,1
15015,trinitrate,1,1
15016,for,0,0
15017,diagnosing,0,0
15018,vasovagal,0,0
15019,syncope,0,0
15020,was,0,0
15021,48,0,0
15022,%,0,0
15023,and,0,0
15024,the,0,0
15025,specificity,0,0
15026,was,0,0
15027,71,0,0
15028,%,0,0
15029,.,0,0
15030,Glyceryl,0,1
15031,trinitrate,0,1
15032,was,0,0
15033,well,0,0
15034,tolerated,0,0
15035,.,0,0
15036,Isoprenaline,1,1
15037,sensitivity,0,0
15038,was,0,0
15039,21,0,0
15040,%,0,0
15041,with,0,0
15042,specificity,0,0
15043,64,0,0
15044,%,0,0
15045,.,0,0
15046,Side-effects,0,0
15047,prevented,0,0
15048,completion,0,0
15049,of,0,0
15050,the,0,0
15051,test,0,0
15052,in,0,0
15053,68,0,0
15054,%,0,0
15055,.,0,0
15056,Commonest,0,0
15057,adverse,0,0
15058,events,0,0
15059,were,0,0
15060,the,0,0
15061,development,0,0
15062,of,0,0
15063,hypertension,0,0
15064,or,0,1
15065,tachycardia,0,0
15066,and,0,0
15067,intolerable,0,0
15068,flushing,0,1
15069,or,0,1
15070,nausea,0,0
15071,.,0,0
15072,CONCLUSIONS,0,0
15073,Glyceryl,1,1
15074,trinitrate,1,1
15075,head-up,1,1
15076,tilt,1,0
15077,is,0,0
15078,as,0,0
15079,effective,0,0
15080,as,0,0
15081,isoprenaline,1,1
15082,head-up,1,1
15083,tilt,1,0
15084,as,0,0
15085,a,0,0
15086,provocative,0,0
15087,agent,0,0
15088,for,0,0
15089,vasovagal,0,0
15090,syncope,0,0
15091,and,0,0
15092,has,0,0
15093,a,0,0
15094,lower,0,0
15095,incidence,0,0
15096,of,0,0
15097,adverse,0,0
15098,events,0,0
15099,.,0,0
15100,Effect,0,0
15101,of,0,0
15102,the,0,0
15103,essential,1,0
15104,oils,1,1
15105,of,1,0
15106,garlic,1,1
15107,and,1,0
15108,onion,1,1
15109,on,0,0
15110,alimentary,0,0
15111,hyperlipemia,0,0
15112,.,0,0
15113,SUMMARY,0,0
15114,The,0,0
15115,effect,0,0
15116,of,0,0
15117,garlic,1,1
15118,and,1,0
15119,onion,1,1
15120,on,0,0
15121,alimentary,0,0
15122,hyperlipemia,0,0
15123,",",0,0
15124,induced,0,0
15125,by,0,0
15126,feeding,0,0
15127,100,0,0
15128,g,0,1
15129,butter,1,1
15130,",",0,0
15131,has,0,0
15132,been,0,0
15133,studied,0,0
15134,in,0,0
15135,10,0,0
15136,healthy,0,0
15137,subjects,0,0
15138,.,0,0
15139,The,0,0
15140,freshly,1,0
15141,extracted,1,0
15142,juice,1,1
15143,of,0,0
15144,50,1,0
15145,g,1,0
15146,of,1,0
15147,garlic,1,1
15148,or,1,1
15149,onion,1,1
15150,",",0,0
15151,as,0,0
15152,well,0,0
15153,as,0,0
15154,an,0,0
15155,equivalent,0,0
15156,amount,0,0
15157,of,0,0
15158,their,0,0
15159,ether-extracted,1,1
15160,essential,1,0
15161,oils,1,1
15162,",",0,0
15163,was,0,0
15164,administered,0,0
15165,randomly,0,0
15166,on,0,0
15167,four,0,0
15168,different,0,0
15169,days,0,0
15170,during,0,0
15171,a,0,0
15172,one-week,0,0
15173,period,0,0
15174,.,0,0
15175,Garlic,1,1
15176,and,1,0
15177,onion,1,1
15178,have,0,0
15179,a,0,0
15180,significant,0,0
15181,protective,0,0
15182,action,0,0
15183,against,0,0
15184,fat-induced,0,0
15185,increases,0,0
15186,in,0,0
15187,serum,0,0
15188,cholesterol,0,0
15189,and,0,0
15190,plasma,0,0
15191,fibrinogen,0,0
15192,and,0,0
15193,decreases,0,0
15194,in,0,0
15195,coagulation,0,0
15196,time,0,0
15197,and,0,0
15198,fibrinolytic,0,0
15199,activity,0,0
15200,.,0,0
15201,The,0,0
15202,essential,0,0
15203,oil,0,1
15204,fraction,0,0
15205,",",0,0
15206,which,0,0
15207,contains,0,0
15208,all,0,0
15209,the,0,0
15210,taste,0,0
15211,and,0,0
15212,odour,0,0
15213,",",0,0
15214,exactly,0,0
15215,duplicated,0,0
15216,the,0,0
15217,beneficial,0,0
15218,effects,0,0
15219,of,0,0
15220,whole,0,0
15221,garlic,1,1
15222,and,1,0
15223,onion,1,1
15224,.,1,0
15225,It,0,0
15226,is,0,0
15227,",",0,0
15228,therefore,0,0
15229,",",0,0
15230,concluded,0,0
15231,that,0,0
15232,the,0,0
15233,active,0,0
15234,principle,0,0
15235,of,0,0
15236,garlic,1,1
15237,and,1,0
15238,onion,1,1
15239,is,0,0
15240,the,0,0
15241,essential,0,0
15242,oil,0,1
15243,",",0,0
15244,which,0,0
15245,chemically,0,0
15246,is,0,0
15247,a,0,0
15248,combination,0,0
15249,of,0,0
15250,sulphur-containing,0,1
15251,compounds,0,1
15252,",",0,0
15253,mainly,0,0
15254,allyl,0,1
15255,propyl,0,1
15256,disulphide,0,1
15257,and,0,0
15258,diallyl,0,1
15259,disulphide,0,1
15260,.,0,0
15261,Repeated,0,0
15262,doses,0,0
15263,of,0,0
15264,porcine,1,1
15265,secretin,1,1
15266,in,0,0
15267,the,0,0
15268,treatment,0,0
15269,of,0,0
15270,autism,0,0
15271,:,0,0
15272,a,0,0
15273,randomized,0,0
15274,",",0,0
15275,placebo-controlled,0,1
15276,trial,0,0
15277,.,0,0
15278,BACKGROUND,0,0
15279,AND,0,0
15280,OBJECTIVES,0,1
15281,Anecdotal,0,0
15282,reports,0,0
15283,on,0,0
15284,the,0,0
15285,efficacy,0,0
15286,of,0,0
15287,secretin,1,1
15288,in,0,0
15289,autism,0,0
15290,raised,0,0
15291,great,0,0
15292,hopes,0,0
15293,for,0,0
15294,the,0,0
15295,treatment,0,0
15296,of,0,0
15297,children,0,0
15298,with,0,0
15299,this,0,0
15300,disorder,0,0
15301,.,0,0
15302,Initial,0,0
15303,single-dose,0,0
15304,",",0,0
15305,randomized,0,0
15306,",",0,0
15307,controlled,0,0
15308,trials,0,0
15309,failed,0,0
15310,to,0,0
15311,demonstrate,0,0
15312,any,0,0
15313,therapeutic,0,0
15314,effects,0,0
15315,of,0,0
15316,secretin,1,1
15317,.,1,0
15318,The,0,0
15319,present,0,0
15320,study,0,0
15321,is,0,0
15322,the,0,0
15323,first,0,0
15324,to,0,0
15325,test,0,0
15326,the,0,0
15327,outcome,0,0
15328,of,0,0
15329,repeated,0,0
15330,doses,0,0
15331,and,0,0
15332,to,0,0
15333,examine,0,0
15334,whether,0,0
15335,there,0,0
15336,is,0,0
15337,a,0,0
15338,subgroup,0,0
15339,of,0,0
15340,children,0,0
15341,who,0,0
15342,are,0,0
15343,more,0,0
15344,likely,0,0
15345,to,0,0
15346,achieve,0,0
15347,positive,0,0
15348,effects,0,0
15349,.,0,0
15350,METHOD,0,0
15351,Sixty-four,0,0
15352,children,0,0
15353,with,0,0
15354,autism,0,0
15355,(,0,0
15356,ages,0,0
15357,2-7,0,0
15358,years,0,0
15359,;,0,0
15360,55,0,0
15361,boys,0,0
15362,and,0,0
15363,9,0,0
15364,girls,0,0
15365,),0,0
15366,with,0,0
15367,a,0,0
15368,range,0,0
15369,of,0,0
15370,intelligence,0,0
15371,quotient,0,0
15372,and,0,0
15373,verbal,0,1
15374,ability,0,0
15375,were,0,0
15376,randomly,0,0
15377,assigned,0,0
15378,",",0,0
15379,in,0,0
15380,a,0,0
15381,double-blind,0,0
15382,manner,0,0
15383,",",0,0
15384,to,0,0
15385,secretin,1,1
15386,or,1,0
15387,placebo,1,1
15388,groups,0,0
15389,.,0,0
15390,Children,0,0
15391,received,0,0
15392,2,0,0
15393,doses,0,0
15394,of,0,0
15395,placebo,1,1
15396,or,1,1
15397,porcine,1,1
15398,secretin,1,1
15399,",",0,0
15400,6,0,0
15401,weeks,0,0
15402,apart,0,0
15403,.,0,0
15404,Assessments,0,0
15405,were,0,0
15406,performed,0,0
15407,at,0,0
15408,baseline,0,0
15409,and,0,0
15410,3,0,0
15411,weeks,0,0
15412,after,0,0
15413,each,0,0
15414,injection,0,1
15415,using,0,0
15416,several,0,0
15417,outcome,0,0
15418,measures,0,0
15419,.,0,0
15420,RESULTS,0,0
15421,There,0,0
15422,were,0,0
15423,no,0,0
15424,group,0,0
15425,differences,0,0
15426,on,0,0
15427,formal,0,0
15428,measures,0,0
15429,of,0,0
15430,language,0,0
15431,",",0,0
15432,cognition,0,0
15433,",",0,0
15434,or,0,0
15435,autistic,0,0
15436,symptomatology,0,0
15437,.,0,0
15438,Subgroupings,0,0
15439,based,0,0
15440,on,0,0
15441,cognitive,0,0
15442,level,0,0
15443,",",0,0
15444,the,0,0
15445,presence,0,0
15446,or,0,1
15447,absence,0,0
15448,of,0,0
15449,diarrhea,0,0
15450,",",0,0
15451,or,0,0
15452,a,0,0
15453,history,0,0
15454,of,0,0
15455,regression,0,0
15456,failed,0,0
15457,to,0,0
15458,show,0,0
15459,any,0,0
15460,significant,0,0
15461,therapeutic,0,0
15462,effects,0,0
15463,of,0,0
15464,secretin,1,1
15465,.,1,0
15466,CONCLUSION,0,0
15467,No,0,0
15468,evidence,0,0
15469,is,0,0
15470,provided,0,0
15471,for,0,0
15472,the,0,0
15473,efficacy,0,0
15474,of,0,0
15475,repeated,0,0
15476,doses,0,0
15477,of,0,0
15478,porcine,1,1
15479,secretin,1,1
15480,in,0,0
15481,the,0,0
15482,treatment,0,0
15483,of,0,0
15484,children,0,0
15485,with,0,0
15486,autism,0,0
15487,.,0,0
15488,The,0,0
15489,possible,0,0
15490,relationship,0,0
15491,between,0,0
15492,relief,0,0
15493,of,0,0
15494,biological,0,0
15495,symptoms,0,0
15496,and,0,0
15497,enhanced,0,0
15498,skill,0,1
15499,performance,0,0
15500,is,0,0
15501,discussed,0,0
15502,.,0,0
15503,A,0,0
15504,randomized,0,0
15505,",",0,0
15506,double-blind,0,0
15507,",",0,0
15508,placebo-controlled,0,1
15509,trial,0,0
15510,of,0,0
15511,single-dose,0,1
15512,intravenous,0,1
15513,secretin,1,1
15514,as,0,0
15515,treatment,0,0
15516,for,0,0
15517,children,0,0
15518,with,0,0
15519,autism,0,0
15520,.,0,0
15521,OBJECTIVE,0,0
15522,To,0,0
15523,determine,0,0
15524,whether,0,0
15525,a,0,0
15526,single,0,0
15527,injection,0,0
15528,of,0,0
15529,intravenous,0,1
15530,secretin,1,1
15531,results,0,0
15532,in,0,0
15533,measurable,0,0
15534,improvements,0,0
15535,in,0,0
15536,socialization,0,0
15537,and/or,0,0
15538,communication,0,0
15539,skills,0,0
15540,in,0,0
15541,children,0,0
15542,with,0,0
15543,autism,0,0
15544,.,0,0
15545,STUDY,0,0
15546,DESIGN,0,0
15547,Sixty,0,0
15548,subjects,0,0
15549,with,0,0
15550,autism,0,0
15551,were,0,0
15552,randomly,0,0
15553,selected,0,0
15554,and,0,0
15555,assigned,0,0
15556,to,0,0
15557,either,0,0
15558,treatment,0,0
15559,or,0,1
15560,placebo,1,1
15561,group,0,0
15562,.,0,0
15563,Subjects,0,0
15564,in,0,0
15565,the,0,0
15566,treatment,0,0
15567,group,0,0
15568,received,0,0
15569,2.0,1,0
15570,clinical,1,0
15571,units,1,0
15572,of,1,0
15573,secretin,1,1
15574,per,1,0
15575,kilogram,1,1
15576,of,1,0
15577,body,1,0
15578,weight,1,0
15579,as,0,0
15580,a,0,0
15581,single,0,0
15582,intravenous,0,1
15583,dose,0,0
15584,.,0,0
15585,Subjects,0,0
15586,in,0,0
15587,the,0,0
15588,placebo,1,1
15589,group,0,0
15590,received,0,0
15591,normal,1,0
15592,saline,1,1
15593,solution,1,1
15594,.,1,0
15595,Neurodevelopmental,0,0
15596,and,0,0
15597,behavioral,0,0
15598,assessments,0,0
15599,were,0,0
15600,performed,0,0
15601,for,0,0
15602,all,0,0
15603,subjects,0,0
15604,before,0,0
15605,injection,0,0
15606,and,0,0
15607,at,0,0
15608,3,0,0
15609,and,0,0
15610,6,0,0
15611,weeks,0,0
15612,after,0,0
15613,injection,0,0
15614,.,0,0
15615,RESULTS,0,0
15616,Assessment,0,0
15617,of,0,0
15618,language,0,0
15619,skills,0,0
15620,and,0,0
15621,parents,0,0
15622,',0,0
15623,behavioral,0,0
15624,assessments,0,0
15625,revealed,0,0
15626,no,0,0
15627,significant,0,0
15628,differences,0,0
15629,between,0,0
15630,the,0,0
15631,treatment,0,0
15632,and,0,0
15633,placebo,0,1
15634,groups,0,0
15635,.,0,0
15636,Raters,0,0
15637,',0,0
15638,assessments,0,0
15639,of,0,0
15640,severity,0,0
15641,of,0,0
15642,autistic,0,0
15643,symptoms,0,0
15644,did,0,0
15645,not,0,0
15646,differ,0,0
15647,for,0,0
15648,the,0,0
15649,2,0,0
15650,groups,0,0
15651,at,0,0
15652,6,0,0
15653,weeks,0,0
15654,after,0,0
15655,injection,0,0
15656,.,0,0
15657,A,0,0
15658,marginally,0,0
15659,statistically,0,0
15660,significant,0,0
15661,improvement,0,0
15662,in,0,0
15663,autistic,0,0
15664,behaviors,0,0
15665,was,0,0
15666,seen,0,0
15667,in,0,0
15668,the,0,0
15669,treatment,0,0
15670,group,0,0
15671,at,0,0
15672,3,0,0
15673,weeks,0,0
15674,after,0,0
15675,injection,0,1
15676,(,0,0
15677,P,0,0
15678,=.051,0,0
15679,),0,0
15680,.,0,0
15681,CONCLUSIONS,0,0
15682,A,0,0
15683,single,0,0
15684,dose,0,0
15685,of,0,0
15686,intravenous,0,1
15687,secretin,1,1
15688,does,0,0
15689,not,0,0
15690,appear,0,0
15691,to,0,0
15692,have,0,0
15693,significant,0,0
15694,effects,0,0
15695,on,0,0
15696,either,0,0
15697,parents,0,0
15698,',0,0
15699,perception,0,0
15700,of,0,0
15701,autistic,0,0
15702,behaviors,0,0
15703,or,0,0
15704,language,0,0
15705,skills,0,0
15706,at,0,0
15707,6,0,0
15708,weeks,0,0
15709,after,0,0
15710,injection,0,0
15711,.,0,0
15712,Transient,0,0
15713,",",0,0
15714,marginally,0,0
15715,significant,0,0
15716,improvements,0,0
15717,in,0,0
15718,autistic,0,0
15719,behaviors,0,0
15720,may,0,0
15721,occur,0,0
15722,in,0,0
15723,some,0,0
15724,children,0,0
15725,.,0,0
15726,Clinical,0,0
15727,description,0,0
15728,of,0,0
15729,encephalopathic,0,0
15730,syndromes,0,0
15731,and,0,0
15732,risk,0,0
15733,factors,0,0
15734,for,0,0
15735,their,0,0
15736,occurrence,0,0
15737,and,0,0
15738,outcome,0,0
15739,during,0,0
15740,melarsoprol,1,1
15741,treatment,0,0
15742,of,0,0
15743,human,0,0
15744,African,0,0
15745,trypanosomiasis,0,1
15746,.,0,0
15747,Encephalopathies,0,0
15748,are,0,0
15749,the,0,0
15750,most,0,0
15751,feared,0,0
15752,complications,0,0
15753,of,0,0
15754,sleeping,0,0
15755,sickness,0,0
15756,treatment,0,0
15757,with,0,0
15758,melarsoprol,1,1
15759,.,1,0
15760,To,0,0
15761,investigate,0,0
15762,the,0,0
15763,existence,0,0
15764,of,0,0
15765,risk,0,0
15766,factors,0,0
15767,",",0,0
15768,the,0,0
15769,incidence,0,0
15770,of,0,0
15771,encephalopathic,0,0
15772,syndromes,0,0
15773,and,0,0
15774,the,0,0
15775,relationship,0,0
15776,between,0,0
15777,the,0,0
15778,development,0,0
15779,of,0,0
15780,different,0,0
15781,types,0,0
15782,of,0,0
15783,encephalopathies,0,0
15784,and,0,0
15785,the,0,0
15786,clinical,0,0
15787,outcome,0,0
15788,was,0,0
15789,studied,0,0
15790,in,0,0
15791,a,0,0
15792,clinical,0,0
15793,trial,0,0
15794,with,0,0
15795,588,0,0
15796,patients,0,0
15797,under,0,0
15798,treatment,0,0
15799,with,0,0
15800,melarsoprol,1,1
15801,.,1,0
15802,The,0,0
15803,38,0,0
15804,encephalopathy,0,0
15805,cases,0,0
15806,were,0,0
15807,classified,0,0
15808,into,0,0
15809,three,0,0
15810,types,0,0
15811,according,0,0
15812,to,0,0
15813,the,0,0
15814,leading,0,0
15815,clinical,0,0
15816,picture,0,0
15817,:,0,0
15818,coma,0,0
15819,type,0,0
15820,",",0,0
15821,convulsion,0,0
15822,type,0,0
15823,and,0,0
15824,psychotic,0,0
15825,reactions,0,0
15826,.,0,0
15827,Nine,0,1
15828,patients,0,0
15829,were,0,0
15830,attributed,0,0
15831,to,0,0
15832,the,0,0
15833,convulsion,0,0
15834,type,0,0
15835,",",0,0
15836,defined,0,0
15837,as,0,0
15838,a,0,0
15839,transient,0,0
15840,event,0,0
15841,of,0,0
15842,short,0,0
15843,duration,0,0
15844,with,0,0
15845,convulsions,0,0
15846,followed,0,0
15847,by,0,0
15848,a,0,0
15849,post-ictal,0,0
15850,phase,0,0
15851,",",0,0
15852,without,0,0
15853,signs,0,0
15854,of,0,0
15855,a,0,0
15856,generalized,0,0
15857,disease,0,0
15858,.,0,0
15859,None,0,0
15860,of,0,0
15861,these,0,0
15862,patients,0,0
15863,died,0,0
15864,from,0,0
15865,the,0,0
15866,reaction,0,0
15867,.,0,0
15868,Febrile,0,0
15869,reactions,0,0
15870,in,0,0
15871,the,0,0
15872,48,0,0
15873,h,0,0
15874,preceding,0,0
15875,the,0,0
15876,reaction,0,0
15877,were,0,0
15878,generally,0,0
15879,not,0,0
15880,observed,0,0
15881,in,0,0
15882,this,0,0
15883,group,0,0
15884,.,0,0
15885,Twenty-five,0,0
15886,patients,0,0
15887,were,0,0
15888,attributed,0,0
15889,to,0,0
15890,the,0,0
15891,coma,0,0
15892,type,0,0
15893,",",0,0
15894,which,0,0
15895,is,0,0
15896,a,0,0
15897,progredient,0,0
15898,coma,0,0
15899,lasting,0,0
15900,several,0,0
15901,days,0,0
15902,.,0,0
15903,Those,0,0
15904,patients,0,0
15905,often,0,0
15906,had,0,0
15907,signs,0,0
15908,of,0,0
15909,a,0,0
15910,generalized,0,0
15911,disease,0,0
15912,such,0,0
15913,as,0,0
15914,fever,0,0
15915,(,0,0
15916,84,0,0
15917,%,0,0
15918,),0,0
15919,",",0,0
15920,headache,0,0
15921,(,0,0
15922,72,0,0
15923,%,0,0
15924,),0,0
15925,or,0,1
15926,bullous,0,0
15927,skin,0,0
15928,(,0,0
15929,8,0,0
15930,%,0,0
15931,),0,0
15932,reactions,0,0
15933,.,0,0
15934,The,0,0
15935,risk,0,0
15936,of,0,0
15937,mortality,0,0
15938,was,0,0
15939,high,0,0
15940,in,0,0
15941,this,0,0
15942,group,0,0
15943,(,0,0
15944,52,0,0
15945,%,0,0
15946,),0,0
15947,.,0,0
15948,About,0,0
15949,14/16,0,0
15950,patients,0,0
15951,with,0,0
15952,encephalopathic,0,0
15953,syndrome,0,0
15954,of,0,0
15955,the,0,0
15956,coma,0,0
15957,type,0,0
15958,were,0,0
15959,infected,0,0
15960,with,0,0
15961,malaria,0,0
15962,.,0,0
15963,Patients,0,0
15964,with,0,0
15965,psychotic,0,0
15966,reactions,0,0
15967,or,0,0
15968,abnormal,0,0
15969,psychiatric,0,0
15970,behaviour,0,0
15971,(,0,0
15972,3/38,0,0
15973,),0,0
15974,and,0,0
15975,one,0,0
15976,patient,0,0
15977,who,0,0
15978,died,0,0
15979,after,0,0
15980,alcohol,0,0
15981,intake,0,0
15982,were,0,0
15983,excluded,0,0
15984,from,0,0
15985,the,0,0
15986,analysis,0,0
15987,.,0,0
15988,The,0,0
15989,overall,0,0
15990,rate,0,0
15991,of,0,0
15992,encephalopathic,0,0
15993,syndromes,0,0
15994,in,0,0
15995,the,0,0
15996,cases,0,0
15997,analysed,0,0
15998,(,0,0
15999,n=34,0,0
16000,),0,0
16001,was,0,0
16002,5.8,0,0
16003,%,0,0
16004,",",0,0
16005,of,0,0
16006,which,0,0
16007,38.2,0,0
16008,%,0,0
16009,died,0,0
16010,.,0,0
16011,We,0,0
16012,did,0,0
16013,not,0,0
16014,find,0,0
16015,any,0,0
16016,parameters,0,0
16017,of,0,0
16018,predictive,0,0
16019,value,0,0
16020,for,0,0
16021,the,0,0
16022,risk,0,0
16023,of,0,0
16024,developing,0,0
16025,an,0,0
16026,encephalopathic,0,0
16027,syndrome,0,0
16028,based,0,0
16029,on,0,0
16030,the,0,0
16031,symptoms,0,0
16032,and,0,0
16033,signs,0,0
16034,before,0,0
16035,treatment,0,0
16036,initiation,0,0
16037,.,0,0
16038,The,0,0
16039,appearance,0,0
16040,during,0,0
16041,treatment,0,0
16042,of,0,0
16043,febrile,0,0
16044,reactions,0,0
16045,(,0,0
16046,RR,0,0
16047,11.5,0,0
16048,),0,0
16049,",",0,0
16050,headache,0,0
16051,(,0,0
16052,RR,0,0
16053,2.5,0,0
16054,),0,0
16055,",",0,0
16056,bullous,0,0
16057,eruptions,0,0
16058,(,0,0
16059,RR,0,0
16060,4.5,0,0
16061,),0,0
16062,and,0,0
16063,systolic,0,0
16064,hypotension,0,0
16065,(,0,0
16066,RR,0,0
16067,2.6,0,0
16068,),0,0
16069,were,0,0
16070,associated,0,0
16071,with,0,0
16072,an,0,0
16073,increased,0,0
16074,risk,0,0
16075,for,0,0
16076,the,0,0
16077,occurrence,0,0
16078,of,0,0
16079,encephalopathic,0,0
16080,syndromes,0,0
16081,especially,0,0
16082,of,0,0
16083,the,0,0
16084,coma,0,0
16085,type,0,0
16086,.,0,0
16087,Clinical,0,0
16088,and,0,0
16089,microbial,0,0
16090,evaluation,0,0
16091,of,0,0
16092,a,0,0
16093,histatin-containing,1,1
16094,mouthrinse,1,1
16095,in,0,0
16096,humans,0,0
16097,with,0,0
16098,experimental,0,0
16099,gingivitis,0,0
16100,.,0,0
16101,OBJECTIVE,0,0
16102,P-113,1,1
16103,",",1,0
16104,a,1,0
16105,12,1,0
16106,amino,1,1
16107,acid,1,1
16108,histatin-based,1,1
16109,peptide,1,0
16110,",",0,0
16111,was,0,0
16112,evaluated,0,0
16113,in,0,0
16114,a,0,0
16115,mouthrinse,1,1
16116,formulation,1,0
16117,for,0,0
16118,safety,0,0
16119,",",0,0
16120,prevention,0,0
16121,of,0,0
16122,the,0,0
16123,development,0,0
16124,of,0,0
16125,experimental,0,0
16126,gingivitis,0,0
16127,",",0,0
16128,and,0,0
16129,for,0,0
16130,its,0,0
16131,effects,0,0
16132,on,0,0
16133,periodontal,0,0
16134,flora,0,0
16135,.,0,0
16136,METHOD,0,0
16137,159,0,0
16138,periodontally,0,0
16139,healthy,0,0
16140,subjects,0,0
16141,abstained,0,0
16142,from,0,0
16143,oral,0,1
16144,hygiene,0,1
16145,procedures,0,0
16146,and,0,0
16147,self-administered,1,0
16148,either,1,0
16149,0.005,1,0
16150,%,1,0
16151,",",1,0
16152,0.01,1,0
16153,%,1,0
16154,",",1,0
16155,0.05,1,0
16156,%,1,0
16157,P-113,1,1
16158,or,1,1
16159,placebo,1,1
16160,mouthrinse,1,1
16161,formulations,1,0
16162,twice,1,0
16163,daily,1,0
16164,over,1,0
16165,a,1,0
16166,four,1,0
16167,week,1,0
16168,treatment,1,0
16169,period,1,0
16170,.,1,0
16171,During,0,0
16172,this,0,0
16173,time,0,0
16174,",",0,0
16175,the,0,0
16176,safety,0,0
16177,",",0,0
16178,anti-plaque,0,1
16179,",",0,0
16180,and,0,0
16181,anti-gingivitis,0,1
16182,effects,0,0
16183,of,0,0
16184,P-113,0,1
16185,were,0,0
16186,evaluated,0,0
16187,.,0,0
16188,RESULTS,0,0
16189,There,0,0
16190,was,0,0
16191,a,0,0
16192,significant,0,0
16193,reduction,0,0
16194,in,0,0
16195,plaque,0,0
16196,(,0,0
16197,p=0.046,0,0
16198,),0,0
16199,and,0,0
16200,a,0,0
16201,reduction,0,0
16202,in,0,0
16203,gingivitis,0,0
16204,(,0,0
16205,p=0.086,0,0
16206,),0,0
16207,for,0,0
16208,subjects,0,0
16209,using,0,0
16210,0.01,0,0
16211,%,0,0
16212,P-113,1,1
16213,mouthrinse,1,1
16214,.,1,0
16215,Significantly,0,0
16216,more,0,0
16217,subjects,0,0
16218,in,0,0
16219,the,0,0
16220,0.01,0,0
16221,%,0,0
16222,and,0,0
16223,0.05,0,0
16224,%,0,0
16225,treatment,0,0
16226,groups,0,0
16227,showed,0,0
16228,a,0,0
16229,small,0,0
16230,increase,0,0
16231,in,0,0
16232,plaque,0,0
16233,index,0,0
16234,of,0,0
16235,<,0,0
16236,0.25,0,0
16237,as,0,0
16238,compared,0,0
16239,to,0,0
16240,the,0,0
16241,placebo,0,1
16242,group,0,0
16243,(,0,0
16244,p,0,0
16245,<,0,0
16246,0.05,0,0
16247,),0,0
16248,.,0,0
16249,Similar,0,0
16250,trends,0,0
16251,were,0,0
16252,noted,0,0
16253,for,0,0
16254,changes,0,0
16255,in,0,0
16256,the,0,0
16257,%,0,0
16258,of,0,0
16259,sites,0,0
16260,with,0,0
16261,bleeding,0,0
16262,on,0,0
16263,probing,0,0
16264,in,0,0
16265,the,0,0
16266,0.01,0,0
16267,%,0,0
16268,P-113,1,1
16269,group,0,0
16270,.,0,0
16271,There,0,0
16272,were,0,0
16273,no,0,0
16274,treatment-related,0,0
16275,adverse,0,0
16276,events,0,0
16277,",",0,0
16278,and,0,0
16279,there,0,0
16280,were,0,0
16281,no,0,0
16282,adverse,0,0
16283,shifts,0,0
16284,in,0,0
16285,supragingival,0,0
16286,microflora,0,0
16287,during,0,0
16288,the,0,0
16289,study,0,0
16290,.,0,0
16291,CONCLUSION,0,0
16292,These,0,0
16293,data,0,0
16294,suggest,0,0
16295,that,0,0
16296,P-113,1,1
16297,mouthrinse,1,1
16298,is,0,0
16299,safe,0,0
16300,and,0,0
16301,reduces,0,0
16302,plaque,0,0
16303,",",0,0
16304,gingivitis,0,0
16305,and,0,0
16306,gingival,0,0
16307,bleeding,0,0
16308,in,0,0
16309,the,0,0
16310,human,0,0
16311,experimental,0,0
16312,gingivitis,0,0
16313,model,0,0
16314,.,0,0
16315,Rehabilitation,0,1
16316,outcomes,0,0
16317,following,0,0
16318,percutaneous,0,1
16319,coronary,0,0
16320,interventions,0,1
16321,(,0,0
16322,PCI,0,0
16323,),0,0
16324,.,0,0
16325,This,0,0
16326,prospective,0,0
16327,study,0,0
16328,evaluated,0,0
16329,the,0,0
16330,effect,0,0
16331,of,0,0
16332,an,0,0
16333,individualized,0,0
16334,",",0,0
16335,comprehensive,0,0
16336,",",0,0
16337,home-based,0,1
16338,cardiac,0,0
16339,rehabilitation,0,1
16340,program,0,1
16341,combining,0,1
16342,exercise,0,1
16343,training,0,1
16344,with,0,0
16345,risk,0,0
16346,factor,0,0
16347,modification,0,0
16348,and,0,0
16349,psychosocial,0,0
16350,counseling,0,1
16351,on,0,0
16352,risk,0,0
16353,factors,0,0
16354,",",0,0
16355,psychological,0,0
16356,well-being,0,0
16357,",",0,0
16358,functional,0,0
16359,capacity,0,0
16360,",",0,0
16361,and,0,0
16362,work,0,0
16363,resumption,0,0
16364,in,0,0
16365,99,0,0
16366,post-percutaneous,1,0
16367,coronary,1,0
16368,interventions,1,1
16369,(,1,0
16370,PCI,1,0
16371,),1,0
16372,patients,0,0
16373,randomized,0,0
16374,to,0,0
16375,control,1,1
16376,(,1,0
16377,standard,1,1
16378,care,1,1
16379,plus,1,1
16380,telephone,1,1
16381,follow-up,1,0
16382,",",0,0
16383,n=49,0,0
16384,),0,0
16385,or,1,1
16386,intervention,1,1
16387,(,0,0
16388,individualized,0,0
16389,",",0,0
16390,comprehensive,0,0
16391,",",0,0
16392,home-based,0,1
16393,cardiac,0,0
16394,rehabilitation,0,1
16395,",",0,0
16396,n=50,0,1
16397,),0,0
16398,groups,0,0
16399,.,0,0
16400,Data,0,0
16401,were,0,0
16402,collected,0,0
16403,at,0,0
16404,time,0,0
16405,1,0,0
16406,(,0,0
16407,T,0,0
16408,(,0,0
16409,1,0,0
16410,),0,0
16411,),0,0
16412,during,0,0
16413,hospital,0,0
16414,admission,0,0
16415,",",0,0
16416,time,0,0
16417,2,0,0
16418,(,0,0
16419,T,0,0
16420,(,0,0
16421,2,0,0
16422,),0,0
16423,),0,0
16424,approximately,0,0
16425,2,0,0
16426,months,0,0
16427,post-PCI,1,0
16428,",",0,0
16429,and,0,0
16430,time,0,0
16431,3,0,0
16432,(,0,0
16433,T,0,0
16434,(,0,0
16435,3,0,0
16436,),0,0
16437,),0,0
16438,approximately,0,0
16439,12,0,0
16440,months,0,0
16441,post-PCI,0,0
16442,.,0,0
16443,Results,0,0
16444,suggest,0,0
16445,that,0,0
16446,the,0,0
16447,allocation,0,0
16448,to,0,0
16449,an,0,0
16450,individualized,0,0
16451,",",0,0
16452,comprehensive,0,0
16453,",",0,0
16454,home-based,0,1
16455,cardiac,0,0
16456,rehabilitation,0,1
16457,program,0,1
16458,provided,0,0
16459,more,0,0
16460,advantageous,0,0
16461,outcomes,0,0
16462,.,0,0
16463,At,0,0
16464,both,0,0
16465,follow-ups,0,0
16466,",",0,0
16467,the,0,0
16468,intervention,0,1
16469,group,0,0
16470,showed,0,0
16471,within-group,0,0
16472,improvement,0,0
16473,in,0,0
16474,serum,0,0
16475,cholesterol,0,0
16476,levels,0,0
16477,(,0,0
16478,P,0,0
16479,<,0,0
16480,0.02,0,0
16481,;,0,0
16482,P,0,0
16483,<,0,0
16484,0.01,0,0
16485,),0,0
16486,and,0,0
16487,exercise,0,1
16488,participation,0,1
16489,(,0,0
16490,P,0,0
16491,<,0,0
16492,0.001,0,0
16493,;,0,0
16494,P,0,0
16495,<,0,0
16496,0.001,0,0
16497,),0,0
16498,with,0,0
16499,differences,0,0
16500,in,0,0
16501,exercise,0,1
16502,participation,0,0
16503,favoring,0,0
16504,the,0,0
16505,intervention,0,1
16506,group,0,0
16507,(,0,0
16508,P,0,0
16509,<,0,0
16510,0.01,0,0
16511,),0,0
16512,at,0,0
16513,T,0,0
16514,(,0,0
16515,2,0,0
16516,),0,0
16517,.,0,0
16518,Repeated,0,0
16519,measures,0,0
16520,ANOVA,0,0
16521,showed,0,0
16522,significant,0,0
16523,improvements,0,0
16524,over,0,0
16525,time,0,0
16526,in,0,0
16527,body,0,0
16528,mass,0,0
16529,index,0,0
16530,(,0,0
16531,BMI,0,1
16532,),0,1
16533,(,0,0
16534,P,0,0
16535,<,0,0
16536,0.01,0,0
16537,),0,0
16538,",",0,0
16539,psychological,0,0
16540,well-being,0,0
16541,(,0,0
16542,P,0,0
16543,<,0,0
16544,0.001,0,0
16545,),0,0
16546,",",0,0
16547,and,0,0
16548,functional,0,0
16549,capacity,0,0
16550,(,0,0
16551,P,0,0
16552,<,0,0
16553,0.001,0,0
16554,),0,0
16555,for,0,0
16556,both,0,0
16557,groups,0,0
16558,.,0,0
16559,More,0,0
16560,patients,0,0
16561,in,0,0
16562,the,0,0
16563,intervention,0,1
16564,group,0,0
16565,had,0,0
16566,returned,0,0
16567,to,0,0
16568,work,0,0
16569,at,0,0
16570,T,0,0
16571,(,0,0
16572,2,0,0
16573,),0,0
16574,(,0,0
16575,P,0,0
16576,<,0,0
16577,0.001,0,0
16578,),0,0
16579,and,0,0
16580,did,0,0
16581,so,0,0
16582,more,0,0
16583,quickly,0,0
16584,(,0,0
16585,P,0,0
16586,<,0,0
16587,0.01,0,0
16588,),0,0
16589,.,0,0
16590,These,0,0
16591,findings,0,0
16592,suggest,0,0
16593,that,0,0
16594,an,0,0
16595,individualized,0,0
16596,",",0,0
16597,comprehensive,0,0
16598,",",0,0
16599,home-based,0,1
16600,cardiac,0,0
16601,rehabilitation,0,1
16602,program,0,1
16603,improves,0,0
16604,risk,0,0
16605,factor,0,0
16606,profiles,0,0
16607,and,0,0
16608,work,0,0
16609,resumption,0,0
16610,patterns,0,0
16611,for,0,0
16612,patients,0,0
16613,following,0,0
16614,PCI,0,0
16615,.,0,0
16616,In,0,0
16617,vivo,0,0
16618,effect,0,0
16619,of,0,0
16620,clarithromycin,1,1
16621,on,0,0
16622,multiple,0,0
16623,cytochrome,0,0
16624,P450s,0,0
16625,.,0,0
16626,The,0,0
16627,in,0,0
16628,vivo,0,0
16629,effects,0,0
16630,of,0,0
16631,oral,0,1
16632,clarithromycin,1,1
16633,administration,0,0
16634,on,0,0
16635,the,0,0
16636,in,0,0
16637,vivo,0,0
16638,activity,0,0
16639,of,0,0
16640,cytochrome,0,0
16641,P450,0,0
16642,1A2,0,0
16643,",",0,0
16644,2C9,0,0
16645,",",0,0
16646,and,0,0
16647,2D6,0,0
16648,were,0,0
16649,determined,0,0
16650,.,0,0
16651,The,0,0
16652,cytochrome,0,0
16653,P450,0,0
16654,probes,0,1
16655,caffeine,1,1
16656,(,0,0
16657,CYP1A2,0,0
16658,),0,0
16659,",",0,0
16660,tolbutamide,1,1
16661,(,0,0
16662,CYP2C9,0,0
16663,),0,0
16664,",",0,0
16665,and,0,0
16666,dextromethorphan,1,1
16667,(,0,1
16668,CYP2D6,0,1
16669,),0,0
16670,were,0,0
16671,administered,0,0
16672,as,0,0
16673,an,0,0
16674,oral,0,1
16675,cocktail,0,1
16676,prior,0,0
16677,to,0,0
16678,and,0,0
16679,7,0,0
16680,days,0,0
16681,after,0,0
16682,oral,0,1
16683,clarithromycin,1,1
16684,(,0,0
16685,500,0,0
16686,mg,0,1
16687,twice,0,0
16688,daily,0,1
16689,),0,0
16690,administration,0,0
16691,to,0,0
16692,12,0,0
16693,healthy,0,0
16694,male,0,0
16695,subjects,0,0
16696,.,0,0
16697,Blood,0,0
16698,and,0,0
16699,urine,0,0
16700,samples,0,0
16701,were,0,0
16702,collected,0,0
16703,and,0,0
16704,assayed,0,0
16705,for,0,0
16706,each,0,0
16707,of,0,0
16708,the,0,0
16709,compounds,0,1
16710,and,0,0
16711,their,0,0
16712,metabolites,0,0
16713,using,0,0
16714,high-performance,0,0
16715,liquid,0,1
16716,chromatography,0,1
16717,.,0,0
16718,The,0,0
16719,CYP1A2,0,0
16720,indices,0,0
16721,",",0,0
16722,oral,0,1
16723,caffeine,0,1
16724,clearance,0,0
16725,(,0,0
16726,6.2,0,0
16727,+/-,0,0
16728,3.3,0,0
16729,l/h,0,0
16730,before,0,0
16731,and,0,0
16732,5.7,0,0
16733,+/-,0,0
16734,4.2,0,0
16735,l/h,0,0
16736,after,0,0
16737,",",0,0
16738,p,0,0
16739,>,0,0
16740,0.05,0,0
16741,),0,0
16742,and,0,0
16743,the,0,0
16744,6-h,0,0
16745,paraxanthine,0,1
16746,to,0,0
16747,caffeine,0,1
16748,serum,0,0
16749,concentration,0,0
16750,ratio,0,0
16751,(,0,0
16752,0.49,0,0
16753,+/-,0,0
16754,0.3,0,0
16755,before,0,0
16756,and,0,0
16757,0.44,0,0
16758,+/-,0,0
16759,0.3,0,0
16760,after,0,0
16761,",",0,0
16762,p,0,0
16763,>,0,0
16764,0.05,0,0
16765,),0,0
16766,",",0,0
16767,were,0,0
16768,unchanged,0,0
16769,following,0,0
16770,clarithromycin,0,1
16771,dosing,0,0
16772,.,0,0
16773,Neither,0,0
16774,the,0,0
16775,tolbutamide,1,1
16776,oral,0,1
16777,clearance,0,0
16778,(,0,0
16779,0.77,0,0
16780,+/-,0,0
16781,0.28,0,0
16782,l/h,0,0
16783,before,0,0
16784,and,0,0
16785,0.72,0,0
16786,+/-0.24,0,0
16787,l/h,0,0
16788,after,0,0
16789,",",0,0
16790,p,0,0
16791,>,0,0
16792,0.05,0,0
16793,),0,0
16794,nor,0,0
16795,the,0,0
16796,tolbutamide,1,1
16797,urinary,0,0
16798,metabolic,0,0
16799,ratio,0,0
16800,(,0,0
16801,779,0,0
16802,+/-,0,0
16803,294,0,0
16804,before,0,0
16805,and,0,0
16806,681,0,0
16807,+/-,0,0
16808,416,0,0
16809,after,0,0
16810,",",0,0
16811,p,0,0
16812,>,0,0
16813,0.05,0,0
16814,),0,0
16815,indices,0,0
16816,of,0,0
16817,CYP2C9,0,0
16818,were,0,0
16819,altered,0,0
16820,by,0,0
16821,clarithromycin,1,1
16822,administration,0,0
16823,.,0,0
16824,In,0,0
16825,the,0,0
16826,case,0,0
16827,of,0,0
16828,CYP2D6,0,0
16829,",",0,0
16830,the,0,0
16831,dextromethorphan,1,1
16832,to,0,0
16833,dextrorphan,0,1
16834,urinary,0,0
16835,ratio,0,0
16836,was,0,0
16837,not,0,0
16838,significantly,0,0
16839,different,0,0
16840,before,0,0
16841,(,0,0
16842,0.021,0,0
16843,+/-,0,0
16844,0.04,0,0
16845,),0,0
16846,and,0,0
16847,after,0,0
16848,(,0,0
16849,0.024,0,0
16850,+/-,0,0
16851,0.06,0,0
16852,),0,0
16853,clarithromycin,1,1
16854,dosing,0,0
16855,.,0,0
16856,In,0,0
16857,conclusion,0,0
16858,",",0,0
16859,clarithromycin,1,1
16860,does,0,0
16861,not,0,0
16862,appear,0,0
16863,to,0,0
16864,alter,0,0
16865,the,0,0
16866,in,0,0
16867,vivo,0,0
16868,catalytic,0,0
16869,activity,0,0
16870,of,0,0
16871,CYP1A2,0,0
16872,",",0,0
16873,CYP2C9,0,0
16874,",",0,0
16875,and,0,0
16876,CYP2D6,0,0
16877,in,0,0
16878,healthy,0,0
16879,individuals,0,0
16880,as,0,0
16881,assessed,0,0
16882,by,0,0
16883,caffeine,0,1
16884,",",0,0
16885,tolbutamide,0,1
16886,",",0,0
16887,and,0,0
16888,dextromethorphan,0,1
16889,",",0,0
16890,respectively,0,0
16891,.,0,0
16892,Gabapentin,0,1
16893,but,0,0
16894,not,0,0
16895,vigabatrin,0,1
16896,is,0,0
16897,effective,0,0
16898,in,0,0
16899,the,0,0
16900,treatment,0,0
16901,of,0,0
16902,acquired,0,0
16903,nystagmus,0,0
16904,in,0,0
16905,multiple,0,0
16906,sclerosis,0,0
16907,:,0,0
16908,How,0,0
16909,valid,0,0
16910,is,0,0
16911,the,0,0
16912,GABAergic,0,0
16913,hypothesis,0,0
16914,?,0,0
16915,Acquired,0,0
16916,nystagmus,0,0
16917,occurs,0,0
16918,frequently,0,0
16919,in,0,0
16920,patients,0,0
16921,with,0,0
16922,multiple,0,0
16923,sclerosis,0,0
16924,and,0,0
16925,is,0,0
16926,often,0,0
16927,the,0,0
16928,cause,0,0
16929,of,0,0
16930,illusory,0,0
16931,motion,0,0
16932,of,0,0
16933,the,0,0
16934,environment,0,0
16935,(,0,0
16936,oscillopsia,0,0
16937,),0,0
16938,",",0,0
16939,and,0,0
16940,blurring,0,0
16941,of,0,0
16942,vision,0,0
16943,.,0,0
16944,Based,0,0
16945,primarily,0,0
16946,on,0,0
16947,the,0,0
16948,beneficial,0,0
16949,effect,0,0
16950,of,0,0
16951,gabapentin,0,1
16952,on,0,0
16953,acquired,0,0
16954,pendular,0,1
16955,nystagmus,0,0
16956,(,0,0
16957,APN,0,1
16958,),0,0
16959,",",0,0
16960,a,0,0
16961,GABAergic,0,0
16962,mechanism,0,0
16963,in,0,0
16964,controlling,0,0
16965,nystagmus,0,0
16966,has,0,0
16967,been,0,0
16968,hypothesised,0,0
16969,.,0,0
16970,If,0,0
16971,increasing,0,0
16972,GABA,0,0
16973,concentrations,0,0
16974,in,0,0
16975,the,0,0
16976,CNS,0,0
16977,are,0,0
16978,critical,0,0
16979,for,0,0
16980,the,0,0
16981,treatment,0,0
16982,of,0,0
16983,nystagmus,0,0
16984,",",0,0
16985,then,0,0
16986,a,0,0
16987,selective,0,0
16988,GABAergic,0,0
16989,drug,0,0
16990,should,0,0
16991,be,0,0
16992,highly,0,0
16993,successful,0,0
16994,.,0,0
16995,However,0,0
16996,",",0,0
16997,as,0,0
16998,gabapentin,0,1
16999,is,0,0
17000,not,0,0
17001,a,0,0
17002,selective,0,0
17003,GABAergic,0,0
17004,agent,0,0
17005,",",0,0
17006,vigabatrin,0,1
17007,",",0,0
17008,a,0,0
17009,pure,0,0
17010,GABAergic,0,0
17011,medication,0,1
17012,",",0,0
17013,and,0,0
17014,gabapentin,0,1
17015,",",0,0
17016,were,0,0
17017,compared,0,0
17018,in,0,0
17019,a,0,0
17020,single,0,0
17021,blind,0,0
17022,cross,0,0
17023,over,0,0
17024,trial,0,0
17025,in,0,0
17026,eight,0,0
17027,patients,0,0
17028,with,0,0
17029,definite,0,0
17030,multiple,0,0
17031,sclerosis,0,0
17032,.,0,0
17033,Patients,0,0
17034,were,0,0
17035,randomly,0,0
17036,assigned,0,0
17037,to,0,0
17038,begin,0,0
17039,with,0,0
17040,gabapentin,1,1
17041,(,1,0
17042,1200,1,1
17043,mg,1,1
17044,daily,1,1
17045,),1,0
17046,or,1,1
17047,vigabatrin,1,1
17048,(,1,0
17049,2000,1,0
17050,mg,1,1
17051,daily,1,0
17052,),1,0
17053,.,0,0
17054,Neuro-ophthalmological,0,0
17055,and,0,0
17056,electro-oculographic,0,1
17057,(,0,0
17058,EOG,0,1
17059,),0,0
17060,evaluations,0,0
17061,were,0,0
17062,performed,0,0
17063,four,0,0
17064,and,0,0
17065,three,0,0
17066,times,0,0
17067,",",0,0
17068,respectively,0,0
17069,.,0,0
17070,Treatment,0,0
17071,efficacy,0,0
17072,was,0,0
17073,based,0,0
17074,on,0,0
17075,improving,0,0
17076,visual,0,0
17077,acuity,0,0
17078,and,0,0
17079,EOG,0,1
17080,indices,0,0
17081,(,0,0
17082,amplitude,0,0
17083,or,0,1
17084,frequency,0,0
17085,of,0,0
17086,nystagmus,0,0
17087,",",0,0
17088,or,0,0
17089,both,0,0
17090,),0,0
17091,by,0,0
17092,at,0,0
17093,least,0,0
17094,50,0,0
17095,%,0,0
17096,of,0,0
17097,pretreatment,0,0
17098,values,0,0
17099,.,0,0
17100,Three,0,0
17101,out,0,0
17102,of,0,0
17103,eight,0,0
17104,patients,0,0
17105,dropped,0,0
17106,out,0,0
17107,due,0,0
17108,to,0,0
17109,adverse,0,0
17110,effects,0,0
17111,.,0,0
17112,In,0,0
17113,the,0,0
17114,remaining,0,0
17115,five,0,0
17116,patients,0,0
17117,gabapentin,0,1
17118,improved,0,0
17119,symptomatic,0,0
17120,pendular,0,1
17121,or,0,1
17122,gaze,0,0
17123,evoked,0,0
17124,jerk,0,0
17125,nystagmus,0,0
17126,in,0,0
17127,four,0,0
17128,.,0,0
17129,Three,0,0
17130,patients,0,0
17131,decided,0,0
17132,to,0,0
17133,continue,0,0
17134,gabapentin,0,1
17135,therapy,0,1
17136,.,0,0
17137,Importantly,0,0
17138,",",0,0
17139,vigabatrin,0,1
17140,proved,0,0
17141,useful,0,0
17142,in,0,0
17143,only,0,0
17144,one,0,0
17145,out,0,0
17146,of,0,0
17147,five,0,0
17148,patients,0,0
17149,",",0,0
17150,suggesting,0,0
17151,that,0,0
17152,gabapentin,0,1
17153,effectiveness,0,0
17154,may,0,0
17155,be,0,0
17156,related,0,0
17157,to,0,0
17158,additional,0,0
17159,non-GABAergic,0,0
17160,mechanisms,0,0
17161,of,0,0
17162,action,0,0
17163,.,0,0
17164,Interaction,0,0
17165,with,0,0
17166,cerebral,0,0
17167,glutamate,0,1
17168,transmission,0,0
17169,by,0,0
17170,inhibition,0,0
17171,of,0,0
17172,NMDA,0,0
17173,receptor,0,0
17174,might,0,0
17175,be,0,0
17176,an,0,0
17177,alternative,0,0
17178,hypothesis,0,0
17179,for,0,0
17180,the,0,0
17181,therapeutic,0,0
17182,action,0,0
17183,of,0,0
17184,gabapentin,0,1
17185,.,0,0
17186,Patient,0,1
17187,positioning,0,0
17188,influences,0,0
17189,oxygen,0,1
17190,saturation,0,0
17191,in,0,0
17192,the,0,0
17193,acute,0,0
17194,phase,0,0
17195,of,0,0
17196,stroke,0,0
17197,.,0,0
17198,We,0,0
17199,evaluated,0,0
17200,arterial,0,0
17201,oxygen,0,1
17202,saturation,0,0
17203,(,0,1
17204,SaO,0,1
17205,(,0,0
17206,2,0,0
17207,),0,0
17208,),0,0
17209,and,0,0
17210,heart,0,0
17211,rate,0,0
17212,in,0,0
17213,acute,0,0
17214,stroke,0,0
17215,patients,0,0
17216,to,0,0
17217,determine,0,0
17218,whether,0,0
17219,routine,0,0
17220,positioning,0,0
17221,affected,0,0
17222,these,0,0
17223,physiological,0,0
17224,parameters,0,0
17225,.,0,0
17226,Measurements,0,0
17227,were,0,0
17228,recorded,0,0
17229,at,0,0
17230,the,0,0
17231,bedside,0,0
17232,non-invasively,0,0
17233,in,0,0
17234,five,1,0
17235,different,1,0
17236,positions,1,0
17237,assigned,0,0
17238,in,0,0
17239,random,0,0
17240,order,0,0
17241,each,0,0
17242,maintained,0,0
17243,for,0,0
17244,10,0,0
17245,min,0,0
17246,.,0,0
17247,One,0,0
17248,hundred,0,0
17249,and,0,0
17250,twenty-nine,0,0
17251,patients,0,0
17252,examined,0,0
17253,within,0,0
17254,a,0,0
17255,median,1,0
17256,of,0,0
17257,72,0,0
17258,h,0,0
17259,",",0,0
17260,lying,1,0
17261,on,1,0
17262,the,1,0
17263,left,1,0
17264,side,1,0
17265,resulted,0,0
17266,in,0,0
17267,slightly,0,0
17268,lower,0,0
17269,SaO,0,1
17270,(,0,0
17271,2,0,0
17272,),0,0
17273,than,0,0
17274,lying,1,0
17275,on,1,0
17276,the,1,0
17277,right,1,0
17278,side,1,0
17279,",",0,0
17280,which,0,0
17281,was,0,0
17282,statistically,0,0
17283,significant,0,0
17284,in,0,0
17285,the,0,0
17286,patients,0,0
17287,with,0,0
17288,a,0,0
17289,right,0,0
17290,(,0,0
17291,n,0,0
17292,=,0,0
17293,66,0,0
17294,),0,0
17295,",",0,0
17296,but,0,0
17297,not,0,0
17298,left,0,0
17299,",",0,0
17300,hemiparesis,0,0
17301,.,0,0
17302,Patients,0,0
17303,able,0,0
17304,to,0,0
17305,sit,1,0
17306,in,1,0
17307,a,1,0
17308,chair,1,1
17309,(,0,0
17310,n,0,0
17311,=,0,0
17312,65,0,0
17313,),0,0
17314,",",0,0
17315,who,0,0
17316,mostly,0,0
17317,had,0,0
17318,less,0,0
17319,severe,0,0
17320,strokes,0,0
17321,",",0,0
17322,had,0,0
17323,a,0,0
17324,significantly,0,0
17325,higher,0,0
17326,mean,0,0
17327,SaO,0,1
17328,(,0,0
17329,2,0,0
17330,),0,0
17331,and,0,0
17332,heart,0,0
17333,rate,0,0
17334,when,0,0
17335,sitting,0,0
17336,in,0,0
17337,the,0,0
17338,chair,0,0
17339,than,0,0
17340,when,0,0
17341,placed,0,0
17342,in,0,0
17343,any,0,0
17344,other,0,0
17345,position,0,0
17346,.,0,0
17347,About,0,0
17348,10,0,0
17349,%,0,0
17350,of,0,0
17351,patients,0,0
17352,",",0,0
17353,especially,0,0
17354,those,0,0
17355,with,0,0
17356,a,0,0
17357,severe,0,0
17358,stroke,0,0
17359,",",0,0
17360,with,0,0
17361,right,0,0
17362,hemiparesis,0,0
17363,and,0,0
17364,concomitant,0,0
17365,chest,0,1
17366,disease,0,0
17367,",",0,0
17368,experienced,0,0
17369,falls,0,0
17370,in,0,0
17371,SaO,0,1
17372,(,0,0
17373,2,0,0
17374,),0,0
17375,to,0,0
17376,90,0,0
17377,%,0,0
17378,or,0,0
17379,less,0,0
17380,for,0,0
17381,>,0,0
17382,/=2,0,0
17383,min,0,0
17384,in,0,0
17385,certain,0,0
17386,positions,0,0
17387,;,0,0
17388,the,0,0
17389,hypoxia,0,0
17390,was,0,0
17391,more,0,0
17392,likely,0,0
17393,when,0,0
17394,they,0,0
17395,were,0,0
17396,lying,1,0
17397,on,1,0
17398,their,1,0
17399,left,1,0
17400,side,1,0
17401,.,1,0
17402,These,0,0
17403,results,0,0
17404,may,0,0
17405,have,0,0
17406,implications,0,0
17407,for,0,0
17408,current,0,0
17409,practice,0,0
17410,and,0,0
17411,for,0,0
17412,future,0,0
17413,patient,0,0
17414,positioning,0,0
17415,strategies,0,0
17416,to,0,0
17417,improve,0,0
17418,outcome,0,0
17419,after,0,0
17420,stroke,0,0
17421,.,0,0
17422,Risk,0,1
17423,factors,0,0
17424,for,0,0
17425,malnutrition,0,0
17426,in,0,0
17427,patients,0,0
17428,undergoing,0,0
17429,gastroenterological,1,0
17430,and,1,0
17431,hernia,1,1
17432,surgery,1,0
17433,:,1,0
17434,an,0,0
17435,analysis,0,0
17436,of,0,0
17437,374,0,0
17438,patients,0,0
17439,.,0,0
17440,OBJECTIVE,0,0
17441,The,0,0
17442,aim,0,0
17443,of,0,0
17444,this,0,0
17445,study,0,0
17446,was,0,0
17447,to,0,0
17448,assess,0,0
17449,the,0,0
17450,nutritional,0,1
17451,status,0,0
17452,of,0,0
17453,374,0,0
17454,surgical,0,0
17455,patients,0,0
17456,with,0,0
17457,gastrointestinal,0,0
17458,disease,0,0
17459,and,0,0
17460,hernias,0,0
17461,of,0,0
17462,the,0,0
17463,abdominal,0,0
17464,wall,0,0
17465,;,0,0
17466,to,0,0
17467,identify,0,0
17468,risk,0,0
17469,factors,0,0
17470,associated,0,0
17471,with,0,0
17472,a,0,0
17473,poorer,0,0
17474,nutritional,0,0
17475,status,0,0
17476,in,0,0
17477,this,0,0
17478,group,0,0
17479,of,0,0
17480,patients,0,0
17481,and,0,0
17482,to,0,0
17483,assess,0,0
17484,awareness,0,0
17485,of,0,0
17486,the,0,0
17487,patient,0,0
17488,'s,0,0
17489,nutritional,0,1
17490,status,0,0
17491,by,0,0
17492,medical,0,0
17493,teams,0,0
17494,.,0,0
17495,SUMMARY,0,0
17496,BACKGROUND,0,0
17497,DATA,0,1
17498,Malnutrition,0,1
17499,is,0,0
17500,prevalent,0,0
17501,among,0,0
17502,surgical,0,0
17503,patients,0,0
17504,and,0,0
17505,is,0,0
17506,associated,0,0
17507,with,0,0
17508,higher,0,0
17509,surgical,0,0
17510,complication,0,0
17511,rates,0,0
17512,and,0,0
17513,mortality,0,0
17514,.,0,0
17515,The,0,0
17516,major,0,0
17517,causes,0,0
17518,of,0,0
17519,poor,0,0
17520,nutritional,0,1
17521,status,0,0
17522,are,0,0
17523,related,0,0
17524,to,0,0
17525,the,0,0
17526,underlying,0,0
17527,disease,0,0
17528,",",0,0
17529,socio-economic,0,0
17530,factors,0,0
17531,",",0,0
17532,age,0,0
17533,",",0,0
17534,and,0,0
17535,length,0,0
17536,of,0,0
17537,hospitalization,0,0
17538,.,0,0
17539,Despite,0,0
17540,its,0,0
17541,high,0,0
17542,prevalence,0,0
17543,",",0,0
17544,medical,0,0
17545,teams,0,0
17546,often,0,0
17547,overlook,0,0
17548,malnutrition,0,0
17549,",",0,0
17550,and,0,0
17551,screening,0,0
17552,of,0,0
17553,these,0,0
17554,patients,0,0
17555,is,0,0
17556,not,0,0
17557,routine,0,0
17558,.,0,0
17559,It,0,0
17560,is,0,0
17561,of,0,0
17562,utmost,0,0
17563,importance,0,0
17564,to,0,0
17565,identify,0,0
17566,patients,0,0
17567,at,0,0
17568,risk,0,0
17569,for,0,0
17570,malnutrition,0,0
17571,in,0,0
17572,order,0,0
17573,to,0,0
17574,prevent,0,0
17575,related,0,0
17576,complications,0,0
17577,.,0,0
17578,METHODS,0,0
17579,The,0,0
17580,374,0,0
17581,patients,0,0
17582,evaluated,0,0
17583,in,0,0
17584,this,0,0
17585,study,0,0
17586,were,0,0
17587,a,0,0
17588,subgroup,0,0
17589,of,0,0
17590,a,0,0
17591,larger,0,0
17592,multicenter,0,0
17593,",",0,0
17594,cross-sectional,0,0
17595,",",0,0
17596,randomized,0,0
17597,study,0,0
17598,that,0,0
17599,was,0,0
17600,carried,0,0
17601,out,0,0
17602,in,0,0
17603,1996,0,0
17604,.,0,0
17605,Nutritional,1,0
17606,status,1,0
17607,was,0,0
17608,assessed,0,0
17609,by,0,0
17610,using,0,0
17611,Subjective,1,0
17612,Global,1,0
17613,Assessment,1,0
17614,.,1,0
17615,RESULTS,0,0
17616,Malnutrition,0,0
17617,was,0,0
17618,present,0,0
17619,in,0,0
17620,55,0,0
17621,%,0,0
17622,of,0,0
17623,the,0,0
17624,patients,0,0
17625,",",0,0
17626,with,0,0
17627,19,0,0
17628,%,0,0
17629,of,0,0
17630,the,0,0
17631,patients,0,0
17632,severely,0,0
17633,malnourished,0,0
17634,.,0,0
17635,The,0,0
17636,presence,0,0
17637,of,0,0
17638,cancer,0,0
17639,",",0,0
17640,infection,0,0
17641,",",0,0
17642,age,0,0
17643,over,0,0
17644,60,0,0
17645,years,0,0
17646,",",0,0
17647,upper,0,0
17648,gastrointestinal,0,0
17649,disease,0,0
17650,",",0,0
17651,and,0,0
17652,longer,0,0
17653,length,0,0
17654,of,0,0
17655,hospital,0,0
17656,stay,0,0
17657,all,0,0
17658,negatively,0,0
17659,influenced,0,0
17660,nutritional,0,1
17661,status,0,0
17662,.,0,0
17663,Despite,0,0
17664,the,0,0
17665,high,0,0
17666,prevalence,0,0
17667,of,0,0
17668,malnutrition,0,0
17669,",",0,0
17670,the,0,0
17671,medical,0,0
17672,teams,0,0
17673,only,0,0
17674,assessed,0,0
17675,the,0,0
17676,nutritional,0,1
17677,status,0,0
17678,of,0,0
17679,a,0,0
17680,few,0,0
17681,patients,0,0
17682,.,0,0
17683,CONCLUSION,0,0
17684,Malnutrition,0,0
17685,was,0,0
17686,highly,0,0
17687,prevalent,0,0
17688,in,0,0
17689,this,0,0
17690,setting,0,0
17691,of,0,0
17692,patients,0,0
17693,.,0,0
17694,Therefore,0,0
17695,",",0,0
17696,patients,0,0
17697,with,0,0
17698,the,0,0
17699,risk,0,0
17700,factors,0,0
17701,above,0,0
17702,presented,0,0
17703,should,0,0
17704,routinely,0,0
17705,undergo,0,0
17706,nutritional,0,1
17707,screening,0,0
17708,and/or,0,0
17709,assessment,0,0
17710,in,0,0
17711,order,0,0
17712,to,0,0
17713,be,0,0
17714,able,0,0
17715,to,0,0
17716,early,0,0
17717,diagnose,0,0
17718,or,0,1
17719,prevent,0,0
17720,malnutrition,0,0
17721,and,0,0
17722,its,0,0
17723,correlated,0,0
17724,morbidity,0,0
17725,and,0,0
17726,mortality,0,0
17727,.,0,0
17728,Clomipramine,1,1
17729,versus,1,0
17730,haloperidol,1,1
17731,in,0,0
17732,the,0,0
17733,treatment,0,0
17734,of,0,0
17735,autistic,0,0
17736,disorder,0,0
17737,:,0,0
17738,a,0,0
17739,double-blind,0,0
17740,",",0,0
17741,placebo-controlled,1,1
17742,",",0,0
17743,crossover,0,0
17744,study,0,0
17745,.,0,0
17746,Clomipramine,1,1
17747,",",1,0
17748,haloperidol,1,1
17749,",",1,0
17750,and,1,0
17751,placebo,1,1
17752,were,0,0
17753,compared,0,0
17754,with,0,0
17755,baseline,0,0
17756,in,0,0
17757,the,0,0
17758,treatment,0,0
17759,of,0,0
17760,autism,0,0
17761,",",0,0
17762,and,0,0
17763,overall,0,0
17764,outcome,0,0
17765,",",0,0
17766,specific,0,0
17767,symptoms,0,0
17768,",",0,0
17769,and,0,0
17770,side,0,0
17771,effects,0,0
17772,were,0,0
17773,examined,0,0
17774,.,0,0
17775,It,0,0
17776,was,0,0
17777,hypothesized,0,0
17778,that,0,0
17779,clomipramine,1,1
17780,would,0,0
17781,be,0,0
17782,better,0,0
17783,tolerated,0,0
17784,than,0,0
17785,haloperidol,1,1
17786,and,0,0
17787,prove,0,0
17788,superior,0,0
17789,on,0,0
17790,a,0,0
17791,measure,0,0
17792,of,0,0
17793,stereotypy,0,0
17794,.,0,0
17795,Individuals,0,0
17796,with,0,0
17797,a,0,0
17798,DSM-IV,0,0
17799,diagnosis,0,0
17800,of,0,0
17801,autistic,0,0
17802,disorder,0,0
17803,(,0,0
17804,mean,0,0
17805,age,0,0
17806,",",0,0
17807,16.3,0,0
17808,years,0,0
17809,;,0,0
17810,range,0,0
17811,",",0,0
17812,10-36,0,0
17813,years,0,0
17814,),0,0
17815,were,0,0
17816,randomly,0,0
17817,assigned,0,0
17818,",",0,0
17819,by,0,0
17820,using,0,0
17821,a,0,0
17822,Latin,0,1
17823,square,0,0
17824,design,0,0
17825,",",0,0
17826,to,0,0
17827,the,0,0
17828,following,0,0
17829,7-week,0,0
17830,trials,0,0
17831,:,0,0
17832,placebo,1,1
17833,",",1,0
17834,clomipramine,1,1
17835,(,0,0
17836,mean,0,0
17837,daily,0,1
17838,dose,0,0
17839,",",0,0
17840,128.4,0,0
17841,mg,0,0
17842,;,0,0
17843,range,0,0
17844,",",0,0
17845,100-150,0,1
17846,mg,0,1
17847,),0,0
17848,",",0,0
17849,or,0,1
17850,haloperidol,1,1
17851,(,0,0
17852,mean,0,0
17853,daily,0,1
17854,dose,0,0
17855,",",0,0
17856,1.3,0,0
17857,mg,0,0
17858,;,0,0
17859,range,0,0
17860,",",0,0
17861,1-1.5,0,0
17862,mg,0,1
17863,),0,0
17864,.,0,0
17865,Data,0,0
17866,on,0,0
17867,36,0,0
17868,subjects,0,0
17869,were,0,0
17870,analyzed,0,0
17871,and,0,0
17872,taken,0,0
17873,together,0,0
17874,;,0,0
17875,the,0,0
17876,results,0,0
17877,favored,0,0
17878,haloperidol,1,1
17879,.,1,0
17880,In,0,0
17881,those,0,0
17882,patients,0,0
17883,who,0,0
17884,were,0,0
17885,able,0,0
17886,to,0,0
17887,complete,0,0
17888,a,0,0
17889,full,0,0
17890,therapeutic,0,0
17891,trial,0,0
17892,",",0,0
17893,clomipramine,1,1
17894,proved,0,0
17895,comparable,0,0
17896,to,0,0
17897,haloperidol,1,1
17898,in,0,0
17899,terms,0,0
17900,of,0,0
17901,improvement,0,0
17902,compared,0,0
17903,with,0,0
17904,baseline,0,0
17905,.,0,0
17906,However,0,0
17907,",",0,0
17908,significantly,0,0
17909,fewer,0,0
17910,individuals,0,0
17911,receiving,0,0
17912,clomipramine,1,1
17913,versus,0,1
17914,haloperidol,1,1
17915,were,0,0
17916,able,0,0
17917,to,0,0
17918,complete,0,0
17919,the,0,0
17920,trial,0,0
17921,(,0,0
17922,37.5,0,0
17923,%,0,0
17924,vs.,0,0
17925,69.7,0,0
17926,%,0,0
17927,",",0,0
17928,respectively,0,0
17929,),0,0
17930,for,0,0
17931,reasons,0,0
17932,related,0,0
17933,to,0,0
17934,both,0,0
17935,side,0,0
17936,effects,0,0
17937,and,0,0
17938,efficacy,0,0
17939,or,0,1
17940,behavior,0,0
17941,problems,0,0
17942,.,0,0
17943,In,0,0
17944,the,0,0
17945,intent-to-treat,0,0
17946,sample,0,0
17947,",",0,0
17948,which,0,0
17949,is,0,0
17950,perhaps,0,0
17951,more,0,0
17952,clinically,0,0
17953,relevant,0,0
17954,",",0,0
17955,only,0,0
17956,haloperidol,1,1
17957,proved,0,0
17958,superior,0,0
17959,to,0,0
17960,baseline,0,0
17961,on,0,0
17962,a,0,0
17963,global,0,0
17964,measure,0,0
17965,of,0,0
17966,autistic,0,0
17967,symptom,0,0
17968,severity,0,0
17969,",",0,0
17970,as,0,0
17971,well,0,0
17972,as,0,0
17973,specific,0,0
17974,measures,0,0
17975,for,0,0
17976,irritability,0,0
17977,and,0,0
17978,hyperactivity,0,0
17979,.,0,0
17980,Clomipramine,1,1
17981,did,0,0
17982,not,0,0
17983,seem,0,0
17984,more,0,0
17985,effective,0,0
17986,on,0,0
17987,a,0,0
17988,measure,0,0
17989,of,0,0
17990,stereotypy,0,0
17991,",",0,0
17992,nor,0,0
17993,was,0,0
17994,it,0,0
17995,better,0,0
17996,tolerated,0,0
17997,.,0,0
17998,A,0,0
17999,randomized,0,0
18000,effectiveness,0,0
18001,trial,0,0
18002,of,0,0
18003,collaborative,1,0
18004,care,1,0
18005,for,0,0
18006,patients,0,0
18007,with,0,0
18008,panic,0,0
18009,disorder,0,0
18010,in,0,0
18011,primary,0,0
18012,care,0,0
18013,.,0,0
18014,BACKGROUND,0,0
18015,Effectiveness,0,0
18016,studies,0,0
18017,have,0,0
18018,tested,0,0
18019,interventions,0,0
18020,to,0,0
18021,improve,0,0
18022,quality,0,0
18023,of,0,0
18024,care,0,0
18025,for,0,0
18026,depression,0,0
18027,in,0,0
18028,primary,0,0
18029,care,0,1
18030,",",0,0
18031,but,0,0
18032,none,0,0
18033,",",0,0
18034,to,0,0
18035,our,0,0
18036,knowledge,0,0
18037,",",0,0
18038,have,0,0
18039,been,0,0
18040,completed,0,0
18041,for,0,0
18042,panic,0,0
18043,disorder,0,0
18044,(,0,0
18045,PD,0,0
18046,),0,0
18047,in,0,0
18048,this,0,0
18049,setting,0,0
18050,.,0,0
18051,This,0,0
18052,study,0,0
18053,sought,0,0
18054,to,0,0
18055,test,0,0
18056,the,0,0
18057,clinical,0,0
18058,effectiveness,0,0
18059,of,0,0
18060,PD,1,0
18061,pharmacotherapy,1,1
18062,embedded,1,0
18063,in,1,0
18064,a,1,0
18065,disease,1,0
18066,management,1,0
18067,framework,1,0
18068,of,1,0
18069,collaborative,1,0
18070,care,1,1
18071,(,1,0
18072,CC,1,0
18073,),1,0
18074,.,1,0
18075,METHODS,0,0
18076,One,0,0
18077,hundred,0,0
18078,fifteen,0,0
18079,patients,0,0
18080,with,0,0
18081,PD,0,0
18082,from,0,0
18083,3,0,0
18084,primary,0,0
18085,care,0,0
18086,clinics,0,0
18087,were,0,0
18088,randomized,0,0
18089,to,0,0
18090,CC,1,0
18091,or,0,1
18092,usual,1,1
18093,care,1,1
18094,(,1,0
18095,UC,1,1
18096,),1,0
18097,.,1,0
18098,Patients,0,0
18099,in,0,0
18100,CC,0,0
18101,(,0,0
18102,n,0,0
18103,=,0,0
18104,57,0,0
18105,),0,0
18106,received,0,0
18107,educational,1,1
18108,videotapes,1,1
18109,and,1,0
18110,pamphlets,1,1
18111,;,1,0
18112,pharmacotherapy,1,1
18113,with,1,0
18114,the,1,0
18115,selective,1,0
18116,serotonin,1,1
18117,reuptake,1,1
18118,inhibitor,1,1
18119,paroxetine,1,1
18120,;,1,0
18121,2,1,0
18122,psychiatrist,1,0
18123,visits,1,0
18124,and,1,0
18125,2,1,0
18126,telephone,1,1
18127,calls,1,0
18128,in,0,0
18129,the,0,0
18130,first,0,0
18131,8,0,0
18132,weeks,0,0
18133,;,0,0
18134,and,0,0
18135,up,0,0
18136,to,0,0
18137,5,0,0
18138,telephone,1,1
18139,calls,1,0
18140,between,0,0
18141,3,0,0
18142,and,0,0
18143,12,0,0
18144,months,0,0
18145,',0,0
18146,follow-up,0,0
18147,.,0,0
18148,Usual,0,0
18149,care,0,0
18150,patients,0,0
18151,(,0,0
18152,n,0,0
18153,=,0,0
18154,58,0,0
18155,),0,0
18156,were,0,0
18157,treated,0,0
18158,by,0,0
18159,their,0,0
18160,primary,0,0
18161,care,0,0
18162,physician,0,0
18163,.,0,0
18164,Telephone,0,0
18165,assessments,0,0
18166,of,0,0
18167,panic,0,0
18168,",",0,0
18169,anxiety,0,0
18170,sensitivity,0,0
18171,",",0,0
18172,depression,0,0
18173,",",0,0
18174,and,0,0
18175,disability,0,0
18176,variables,0,0
18177,were,0,0
18178,performed,0,0
18179,at,0,0
18180,3,0,0
18181,",",0,0
18182,6,0,0
18183,",",0,0
18184,9,0,0
18185,",",0,0
18186,and,0,0
18187,12,0,0
18188,months,0,0
18189,',0,0
18190,follow-up,0,0
18191,.,0,0
18192,Adequacy,0,0
18193,of,0,0
18194,pharmacotherapy,0,1
18195,was,0,0
18196,assessed,0,0
18197,with,0,0
18198,an,0,0
18199,algorithm,0,0
18200,based,0,0
18201,on,0,0
18202,a,0,0
18203,review,0,0
18204,of,0,0
18205,efficacy,0,0
18206,studies,0,0
18207,.,0,0
18208,RESULTS,0,0
18209,Patients,0,0
18210,in,0,0
18211,CC,0,0
18212,were,0,0
18213,more,0,0
18214,likely,0,0
18215,to,0,0
18216,receive,0,1
18217,adequate,0,0
18218,(,0,0
18219,type,0,0
18220,",",0,0
18221,dose,0,0
18222,",",0,0
18223,duration,0,0
18224,),0,0
18225,medication,0,0
18226,and,0,0
18227,more,0,0
18228,likely,0,0
18229,to,0,0
18230,adhere,0,0
18231,to,0,0
18232,this,0,0
18233,medication,0,0
18234,at,0,0
18235,3,0,0
18236,and,0,0
18237,6,0,0
18238,months,0,0
18239,.,0,0
18240,Random,0,0
18241,regression,0,0
18242,analyses,0,0
18243,showed,0,0
18244,that,0,0
18245,CC,0,0
18246,patients,0,0
18247,improved,0,0
18248,significantly,0,0
18249,more,0,0
18250,over,0,0
18251,time,0,0
18252,compared,0,0
18253,with,0,0
18254,UC,0,0
18255,patients,0,0
18256,on,0,0
18257,anxiety,0,0
18258,",",0,0
18259,depression,0,0
18260,",",0,0
18261,and,0,0
18262,disability,0,0
18263,measures,0,0
18264,",",0,0
18265,with,0,0
18266,the,0,0
18267,greatest,0,0
18268,effects,0,0
18269,at,0,0
18270,3,0,0
18271,and,0,0
18272,6,0,0
18273,months,0,0
18274,.,0,0
18275,CONCLUSIONS,0,0
18276,Compared,0,0
18277,with,0,0
18278,UC,0,0
18279,",",0,0
18280,CC,0,0
18281,interventions,0,0
18282,significantly,0,0
18283,improved,0,0
18284,both,0,0
18285,quality,0,0
18286,of,0,0
18287,care,0,1
18288,and,0,0
18289,clinical,0,0
18290,and,0,0
18291,functional,0,0
18292,outcomes,0,0
18293,in,0,0
18294,primary,0,0
18295,care,0,1
18296,PD,0,0
18297,patients,0,0
18298,.,0,0
18299,Clinical,0,0
18300,differences,0,0
18301,were,0,0
18302,greatest,0,0
18303,in,0,0
18304,the,0,0
18305,first,0,0
18306,6,0,0
18307,months,0,0
18308,",",0,0
18309,corresponding,0,0
18310,to,0,0
18311,the,0,0
18312,greater,0,0
18313,quality,0,0
18314,of,0,0
18315,care,0,1
18316,and,0,0
18317,the,0,0
18318,greater,0,0
18319,intensity,0,0
18320,of,0,0
18321,intervention,0,1
18322,.,0,0
18323,Matched-pair,0,0
18324,analysis,1,0
18325,of,0,0
18326,all-polyethylene,1,1
18327,versus,1,0
18328,metal-backed,1,0
18329,tibial,1,1
18330,components,1,0
18331,.,1,0
18332,Forty-eight,0,0
18333,matched,0,0
18334,pairs,0,0
18335,of,0,0
18336,osteoarthritic,0,0
18337,knees,0,0
18338,from,0,0
18339,patients,0,0
18340,who,0,0
18341,underwent,0,0
18342,primary,0,0
18343,total,0,0
18344,knee,0,0
18345,arthroplasty,0,0
18346,with,0,0
18347,a,0,0
18348,round-on-round,0,0
18349,",",0,0
18350,Apollo,0,0
18351,Knee,0,0
18352,System,0,0
18353,were,0,0
18354,studied,0,0
18355,to,0,0
18356,evaluate,0,0
18357,the,0,0
18358,outcome,0,0
18359,between,0,0
18360,all-polyethylene,1,1
18361,and,1,0
18362,metal-backed,1,0
18363,tibial,1,1
18364,components,1,0
18365,.,1,0
18366,Patients,0,0
18367,were,0,0
18368,matched,0,0
18369,for,0,0
18370,patient,0,0
18371,factors,0,0
18372,",",0,0
18373,preoperative,0,0
18374,deformities,0,0
18375,",",0,0
18376,cruciate,0,1
18377,salvage,0,0
18378,or,0,1
18379,sacrifice,0,0
18380,",",0,0
18381,and,0,0
18382,surgical,0,0
18383,technique,0,1
18384,.,0,0
18385,At,0,0
18386,the,0,0
18387,last,0,0
18388,follow-up,0,0
18389,(,0,0
18390,average,0,0
18391,",",0,0
18392,38.4,0,0
18393,months,0,0
18394,),0,0
18395,",",0,0
18396,there,0,0
18397,was,0,0
18398,no,0,0
18399,statistically,0,0
18400,significant,0,0
18401,difference,0,0
18402,in,0,0
18403,terms,0,0
18404,of,0,0
18405,knee,0,0
18406,scores,0,0
18407,",",0,0
18408,patient,0,0
18409,self-assessment,0,0
18410,",",0,0
18411,and,0,0
18412,radiographic,0,0
18413,outcomes,0,0
18414,.,0,0
18415,No,0,0
18416,component,0,0
18417,required,0,0
18418,revision,0,0
18419,",",0,0
18420,and,0,0
18421,no,0,0
18422,revisions,0,0
18423,were,0,0
18424,pending,0,0
18425,.,0,0
18426,Maintenance,0,0
18427,of,0,0
18428,these,0,0
18429,results,0,0
18430,over,0,0
18431,time,0,0
18432,would,0,0
18433,project,0,0
18434,into,0,0
18435,better,0,0
18436,long-term,0,0
18437,success,0,0
18438,for,0,0
18439,all-polyethylene,1,1
18440,tibial,1,1
18441,components,1,0
18442,because,0,0
18443,of,0,0
18444,the,0,0
18445,amount,0,0
18446,of,0,0
18447,wear,0,0
18448,and,0,0
18449,osteolysis,0,0
18450,with,0,0
18451,current,0,0
18452,modular,0,1
18453,metal-backed,1,0
18454,tibial,1,1
18455,components,1,0
18456,.,1,0
18457,We,0,0
18458,advocate,0,0
18459,the,0,0
18460,use,0,0
18461,of,0,0
18462,a,0,0
18463,more,0,0
18464,cost-effective,0,0
18465,all-polyethylene,1,1
18466,tibial,1,1
18467,component,1,0
18468,in,0,0
18469,elderly,0,0
18470,patients,0,0
18471,(,0,0
18472,>,0,0
18473,70,0,0
18474,years,0,0
18475,old,0,0
18476,),0,0
18477,who,0,0
18478,are,0,0
18479,not,0,0
18480,likely,0,0
18481,to,0,0
18482,need,0,0
18483,the,0,0
18484,versatility,0,0
18485,of,0,0
18486,exchange,0,1
18487,of,0,0
18488,a,0,0
18489,modular,0,1
18490,polyethylene,0,1
18491,insert,0,1
18492,because,0,0
18493,of,0,0
18494,wear,0,0
18495,.,0,0
18496,The,0,0
18497,role,0,0
18498,of,0,0
18499,radiography,1,1
18500,in,0,0
18501,primary,0,0
18502,care,0,0
18503,patients,0,0
18504,with,0,0
18505,low,0,0
18506,back,0,0
18507,pain,0,0
18508,of,0,0
18509,at,0,0
18510,least,0,0
18511,6,0,0
18512,weeks,0,0
18513,duration,0,0
18514,:,0,0
18515,a,0,0
18516,randomised,0,0
18517,(,0,0
18518,unblinded,0,0
18519,),0,0
18520,controlled,0,0
18521,trial,0,0
18522,.,0,0
18523,OBJECTIVES,0,0
18524,To,0,0
18525,test,0,0
18526,the,0,0
18527,hypotheses,0,0
18528,that,0,0
18529,:,0,0
18530,(,0,0
18531,1,0,0
18532,),0,0
18533,Lumbar,0,1
18534,spine,0,1
18535,radiography,0,1
18536,in,0,0
18537,primary,0,0
18538,care,0,0
18539,patients,0,0
18540,with,0,0
18541,low,0,0
18542,back,0,0
18543,pain,0,0
18544,is,0,0
18545,not,0,0
18546,associated,0,0
18547,with,0,0
18548,improved,0,0
18549,patient,0,0
18550,outcomes,0,0
18551,",",0,0
18552,including,0,0
18553,pain,0,0
18554,",",0,0
18555,disability,0,0
18556,",",0,0
18557,health,0,0
18558,status,0,0
18559,",",0,0
18560,sickness,0,0
18561,absence,0,0
18562,",",0,0
18563,reassurance,0,0
18564,",",0,0
18565,and,0,0
18566,patient,0,0
18567,satisfaction,0,0
18568,or,0,1
18569,belief,0,0
18570,in,0,0
18571,the,0,0
18572,value,0,0
18573,of,0,0
18574,radiography,0,1
18575,.,0,0
18576,(,0,0
18577,2,0,0
18578,),0,0
18579,Lumbar,1,1
18580,spine,1,1
18581,radiography,1,1
18582,in,0,0
18583,primary,0,0
18584,care,0,0
18585,patients,0,0
18586,with,0,0
18587,low,0,0
18588,back,0,0
18589,pain,0,0
18590,is,0,0
18591,not,0,0
18592,associated,0,0
18593,with,0,0
18594,changes,0,0
18595,in,0,0
18596,patient,0,0
18597,management,0,0
18598,",",0,0
18599,including,0,0
18600,medication,0,0
18601,use,0,0
18602,",",0,0
18603,and,0,0
18604,the,0,0
18605,use,0,0
18606,of,0,0
18607,primary,0,0
18608,and,0,0
18609,secondary,0,0
18610,care,0,1
18611,services,0,0
18612,",",0,0
18613,physical,0,0
18614,therapies,0,0
18615,and,0,0
18616,complementary,0,1
18617,therapies,0,1
18618,.,0,0
18619,(,0,0
18620,3,0,0
18621,),0,0
18622,Participants,0,0
18623,choosing,0,0
18624,their,0,0
18625,treatment,0,0
18626,group,0,0
18627,(,0,0
18628,i.e,0,0
18629,.,0,1
18630,radiography,1,0
18631,or,0,0
18632,no,1,0
18633,radiography,1,1
18634,),1,0
18635,do,0,0
18636,not,0,0
18637,have,0,0
18638,better,0,0
18639,outcomes,0,0
18640,than,0,0
18641,those,0,0
18642,randomised,0,0
18643,to,0,0
18644,a,0,0
18645,treatment,0,0
18646,group,0,0
18647,.,0,0
18648,(,0,0
18649,4,0,0
18650,),0,0
18651,Lumbar,0,1
18652,spine,0,1
18653,radiography,0,1
18654,is,0,0
18655,not,0,0
18656,cost-effective,0,0
18657,compared,0,0
18658,with,0,0
18659,usual,0,1
18660,care,0,1
18661,without,0,0
18662,lumbar,0,1
18663,spine,0,0
18664,radiography,0,1
18665,.,0,0
18666,DESIGN,0,0
18667,A,0,0
18668,randomised,0,0
18669,unblinded,0,0
18670,controlled,0,0
18671,trial,0,0
18672,.,0,0
18673,SETTING,0,0
18674,Seventy-three,0,0
18675,general,0,0
18676,practices,0,0
18677,in,0,0
18678,Nottingham,0,0
18679,",",0,0
18680,North,0,0
18681,Nottinghamshire,0,0
18682,",",0,0
18683,Southern,0,0
18684,Derbyshire,0,0
18685,",",0,0
18686,North,0,0
18687,Lincolnshire,0,1
18688,and,0,0
18689,North,0,0
18690,Leicestershire,0,0
18691,.,0,0
18692,Fifty-two,0,0
18693,practices,0,0
18694,recruited,0,0
18695,participants,0,0
18696,to,0,0
18697,the,0,0
18698,trial,0,0
18699,.,0,0
18700,SUBJECTS,0,0
18701,Randomised,0,0
18702,arm,0,0
18703,:,0,0
18704,421,0,0
18705,participants,0,0
18706,with,0,0
18707,low,0,0
18708,back,0,0
18709,pain,0,0
18710,",",0,0
18711,with,0,0
18712,median,0,0
18713,duration,0,0
18714,of,0,0
18715,10,0,0
18716,weeks,0,0
18717,.,0,0
18718,Patient,0,0
18719,preference,0,0
18720,arm,0,0
18721,:,0,0
18722,55,0,0
18723,participants,0,0
18724,with,0,0
18725,low,0,0
18726,back,0,0
18727,pain,0,0
18728,",",0,0
18729,with,0,0
18730,median,0,0
18731,duration,0,0
18732,of,0,0
18733,11,0,0
18734,weeks,0,0
18735,.,0,0
18736,INTERVENTION,0,0
18737,Lumbar,1,1
18738,spine,1,1
18739,radiography,1,1
18740,and,1,0
18741,usual,1,1
18742,care,1,1
18743,versus,1,0
18744,usual,1,1
18745,care,1,1
18746,without,1,0
18747,radiography,1,1
18748,.,1,0
18749,MAIN,0,0
18750,OUTCOME,0,0
18751,MEASURES,0,0
18752,Roland,0,0
18753,adaptation,0,0
18754,of,0,0
18755,the,0,0
18756,Sickness,0,0
18757,Impact,0,0
18758,Profile,0,0
18759,",",0,0
18760,visual,0,0
18761,analogue,0,0
18762,pain,0,0
18763,scale,0,0
18764,",",0,0
18765,health,0,0
18766,status,0,0
18767,scale,0,0
18768,",",0,0
18769,EuroQol,0,0
18770,",",0,0
18771,use,0,0
18772,of,0,0
18773,primary,0,0
18774,and,0,0
18775,secondary,0,0
18776,care,0,1
18777,services,0,0
18778,",",0,0
18779,and,0,0
18780,physical,0,1
18781,and,0,0
18782,complementary,0,1
18783,therapies,0,0
18784,",",0,0
18785,sickness,0,0
18786,absence,0,0
18787,",",0,0
18788,medication,0,0
18789,use,0,0
18790,",",0,0
18791,patient,0,0
18792,satisfaction,0,0
18793,",",0,0
18794,reassurance,0,1
18795,and,0,0
18796,belief,0,0
18797,in,0,0
18798,value,0,0
18799,of,0,0
18800,radiography,0,1
18801,at,0,0
18802,3,0,0
18803,and,0,0
18804,9,0,0
18805,months,0,0
18806,post-randomisation,0,0
18807,.,0,0
18808,RESULTS,0,0
18809,Participants,0,0
18810,randomised,0,0
18811,to,0,0
18812,receive,0,0
18813,an,0,0
18814,X-ray,0,0
18815,were,0,0
18816,more,0,0
18817,likely,0,0
18818,to,0,0
18819,report,0,0
18820,low,0,0
18821,back,0,0
18822,pain,0,0
18823,at,0,0
18824,3,0,0
18825,months,0,0
18826,(,0,0
18827,odds,0,0
18828,ratio,0,0
18829,(,0,0
18830,OR,0,0
18831,),0,1
18832,=,0,0
18833,1.56,0,0
18834,;,0,0
18835,95,0,0
18836,%,0,0
18837,confidence,0,0
18838,interval,0,0
18839,(,0,0
18840,CI,0,0
18841,),0,0
18842,",",0,0
18843,1.02,0,0
18844,to,0,0
18845,2.40,0,0
18846,),0,0
18847,and,0,0
18848,had,0,0
18849,a,0,0
18850,lower,0,0
18851,overall,0,0
18852,health,0,0
18853,status,0,0
18854,score,0,0
18855,(,0,0
18856,p,0,0
18857,=,0,0
18858,0.02,0,0
18859,),0,0
18860,.,0,0
18861,There,0,0
18862,were,0,0
18863,no,0,0
18864,differences,0,0
18865,in,0,0
18866,health,0,0
18867,or,0,1
18868,functional,0,0
18869,status,0,0
18870,at,0,0
18871,9,0,0
18872,months,0,0
18873,.,0,0
18874,A,0,0
18875,higher,0,0
18876,proportion,0,0
18877,of,0,0
18878,participants,0,0
18879,consulted,0,0
18880,the,0,0
18881,general,0,0
18882,practitioner,0,1
18883,(,0,0
18884,GP,0,0
18885,),0,0
18886,in,0,0
18887,the,0,0
18888,3,0,0
18889,months,0,0
18890,following,0,0
18891,an,0,0
18892,X-ray,0,0
18893,(,0,0
18894,OR,0,0
18895,=,0,0
18896,2.72,0,0
18897,;,0,0
18898,95,0,0
18899,%,0,0
18900,CI,0,0
18901,",",0,0
18902,1.80,0,0
18903,to,0,0
18904,4.10,0,0
18905,),0,0
18906,.,0,0
18907,There,0,0
18908,were,0,0
18909,no,0,0
18910,differences,0,0
18911,in,0,0
18912,use,0,0
18913,of,0,0
18914,any,0,0
18915,other,0,0
18916,services,0,0
18917,",",0,0
18918,medication,0,0
18919,use,0,0
18920,or,0,1
18921,sickness,0,0
18922,absence,0,0
18923,at,0,0
18924,3,0,0
18925,or,0,0
18926,9,0,0
18927,months,0,0
18928,.,0,0
18929,No,0,0
18930,serious,0,0
18931,spinal,0,0
18932,pathology,0,0
18933,was,0,0
18934,identified,0,0
18935,in,0,0
18936,either,0,0
18937,group,0,0
18938,.,0,0
18939,The,0,0
18940,commonest,0,0
18941,X-ray,0,0
18942,reports,0,0
18943,were,0,0
18944,of,0,0
18945,discovertebral,0,0
18946,degeneration,0,0
18947,and,0,0
18948,normal,0,0
18949,findings,0,0
18950,.,0,0
18951,Many,0,0
18952,patients,0,0
18953,did,0,0
18954,not,0,0
18955,perceive,0,0
18956,their,0,0
18957,information,0,0
18958,needs,0,0
18959,were,0,0
18960,met,0,0
18961,within,0,0
18962,the,0,0
18963,consultation,0,0
18964,.,0,0
18965,Satisfaction,0,0
18966,with,0,0
18967,care,0,0
18968,was,0,0
18969,greater,0,0
18970,in,0,0
18971,the,0,0
18972,group,0,0
18973,receiving,0,0
18974,radiography,0,1
18975,at,0,0
18976,9,0,0
18977,months,0,0
18978,.,0,0
18979,Participants,0,0
18980,randomised,0,0
18981,to,0,0
18982,receive,0,0
18983,an,0,0
18984,X-ray,1,0
18985,were,0,0
18986,not,0,0
18987,less,0,0
18988,worried,0,0
18989,",",0,0
18990,or,0,0
18991,more,0,0
18992,reassured,0,0
18993,about,0,0
18994,serious,0,0
18995,disease,0,0
18996,causing,0,0
18997,their,0,0
18998,low,0,0
18999,back,0,0
19000,pain,0,0
19001,.,0,0
19002,Satisfaction,0,0
19003,was,0,0
19004,associated,0,0
19005,with,0,0
19006,meeting,0,0
19007,participants,0,0
19008,',0,0
19009,information,0,0
19010,needs,0,0
19011,and,0,0
19012,reduced,0,0
19013,belief,0,0
19014,in,0,0
19015,the,0,0
19016,necessity,0,0
19017,for,0,0
19018,investigations,0,0
19019,for,0,0
19020,low,0,0
19021,back,0,0
19022,pain,0,0
19023,",",0,0
19024,including,0,0
19025,X-rays,0,1
19026,and,0,0
19027,blood,0,0
19028,tests,0,0
19029,.,0,0
19030,In,0,0
19031,both,0,0
19032,groups,0,0
19033,",",0,0
19034,at,0,0
19035,3,0,0
19036,and,0,0
19037,9,0,0
19038,months,0,0
19039,80,0,0
19040,%,0,0
19041,of,0,0
19042,participants,0,0
19043,would,0,0
19044,choose,0,0
19045,to,0,0
19046,have,0,0
19047,an,0,0
19048,X-ray,0,0
19049,if,0,0
19050,the,0,0
19051,choice,0,0
19052,was,0,0
19053,available,0,0
19054,.,0,0
19055,Participants,0,0
19056,in,0,0
19057,the,0,0
19058,patient,0,0
19059,preference,0,0
19060,group,0,0
19061,achieved,0,0
19062,marginally,0,0
19063,better,0,0
19064,outcomes,0,0
19065,than,0,0
19066,those,0,0
19067,randomised,0,0
19068,to,0,0
19069,a,0,0
19070,treatment,0,0
19071,group,0,0
19072,",",0,0
19073,but,0,0
19074,the,0,0
19075,clinical,0,0
19076,significance,0,0
19077,of,0,0
19078,these,0,0
19079,differences,0,0
19080,is,0,0
19081,unclear,0,0
19082,.,0,0
19083,Lumbar,0,1
19084,spine,0,0
19085,radiography,0,1
19086,was,0,0
19087,associated,0,0
19088,with,0,0
19089,a,0,0
19090,net,0,0
19091,economic,0,0
19092,loss,0,0
19093,at,0,0
19094,3,0,0
19095,and,0,0
19096,9,0,0
19097,months,0,0
19098,.,0,0
19099,CONCLUSIONS,0,0
19100,Lumbar,0,1
19101,spine,0,1
19102,radiography,0,1
19103,in,0,0
19104,primary,0,0
19105,care,0,0
19106,patients,0,0
19107,with,0,0
19108,low,0,0
19109,back,0,0
19110,pain,0,0
19111,of,0,0
19112,at,0,0
19113,least,0,0
19114,6,0,0
19115,weeks,0,0
19116,duration,0,0
19117,is,0,0
19118,not,0,0
19119,associated,0,0
19120,with,0,0
19121,improved,0,0
19122,functioning,0,0
19123,",",0,0
19124,severity,0,0
19125,of,0,0
19126,pain,0,0
19127,or,0,1
19128,overall,0,0
19129,health,0,0
19130,status,0,0
19131,",",0,0
19132,and,0,0
19133,is,0,0
19134,associated,0,0
19135,with,0,0
19136,an,0,0
19137,increase,0,0
19138,in,0,0
19139,GP,0,0
19140,workload,0,0
19141,.,0,0
19142,Participants,0,0
19143,receiving,0,0
19144,X-rays,0,1
19145,are,0,0
19146,more,0,0
19147,satisfied,0,0
19148,with,0,0
19149,their,0,0
19150,care,0,0
19151,",",0,0
19152,but,0,0
19153,are,0,0
19154,not,0,0
19155,less,0,0
19156,worried,0,0
19157,or,0,0
19158,more,0,0
19159,reassured,0,0
19160,about,0,0
19161,serious,0,0
19162,disease,0,0
19163,causing,0,0
19164,their,0,0
19165,low,0,0
19166,back,0,0
19167,pain,0,0
19168,.,0,0
19169,CONCLUSIONS,0,0
19170,-,0,0
19171,RECOMMENDATIONS,0,0
19172,FOR,0,1
19173,FURTHER,0,0
19174,RESEARCH,0,0
19175,:,0,0
19176,Further,0,0
19177,work,0,0
19178,is,0,0
19179,required,0,0
19180,to,0,0
19181,develop,0,0
19182,and,0,0
19183,test,0,0
19184,an,0,0
19185,educational,0,1
19186,package,0,1
19187,that,0,0
19188,educates,0,0
19189,patients,0,0
19190,and,0,0
19191,GPs,0,0
19192,about,0,0
19193,the,0,0
19194,utility,0,0
19195,of,0,0
19196,radiography,0,1
19197,and,0,0
19198,provides,0,0
19199,strategies,0,0
19200,for,0,0
19201,identifying,0,0
19202,and,0,0
19203,meeting,0,0
19204,the,0,0
19205,information,0,0
19206,needs,0,0
19207,of,0,0
19208,patients,0,0
19209,",",0,0
19210,and,0,0
19211,the,0,0
19212,needs,0,0
19213,of,0,0
19214,patients,0,0
19215,and,0,0
19216,GPs,0,0
19217,to,0,0
19218,be,0,0
19219,reassured,0,0
19220,about,0,0
19221,missing,0,0
19222,serious,0,0
19223,disease,0,0
19224,.,0,0
19225,Guidelines,0,0
19226,on,0,0
19227,the,0,0
19228,management,0,0
19229,of,0,0
19230,low,0,0
19231,back,0,0
19232,pain,0,0
19233,in,0,0
19234,primary,0,0
19235,care,0,0
19236,should,0,0
19237,be,0,0
19238,consistent,0,0
19239,about,0,0
19240,not,0,0
19241,recommending,0,0
19242,lumbar,1,1
19243,spine,1,1
19244,radiography,1,1
19245,in,0,0
19246,patients,0,0
19247,with,0,0
19248,low,0,0
19249,back,0,0
19250,pain,0,0
19251,in,0,0
19252,the,0,0
19253,absence,0,0
19254,of,0,0
19255,red,0,0
19256,flags,0,0
19257,for,0,0
19258,serious,0,0
19259,spinal,0,0
19260,pathology,0,0
19261,",",0,0
19262,even,0,0
19263,if,0,0
19264,the,0,0
19265,pain,0,0
19266,has,0,0
19267,persisted,0,0
19268,for,0,0
19269,at,0,0
19270,least,0,0
19271,6,0,0
19272,weeks,0,0
19273,.,0,0
19274,Pharmacokinetic,0,0
19275,study,0,0
19276,of,0,0
19277,human,0,0
19278,immunodeficiency,0,0
19279,virus,0,1
19280,protease,1,1
19281,inhibitors,1,1
19282,used,1,0
19283,in,1,0
19284,combination,1,1
19285,with,1,0
19286,amprenavir,1,1
19287,.,1,0
19288,In,0,0
19289,an,0,0
19290,open-label,0,0
19291,",",0,0
19292,randomized,0,0
19293,",",0,0
19294,multicenter,0,0
19295,",",0,0
19296,multiple-dose,0,1
19297,pharmacokinetic,0,0
19298,study,0,0
19299,",",0,0
19300,we,0,0
19301,determined,0,0
19302,the,0,0
19303,steady-state,0,0
19304,pharmacokinetics,0,0
19305,of,0,0
19306,amprenavir,1,1
19307,with,1,0
19308,and,1,0
19309,without,1,0
19310,coadministration,1,1
19311,of,1,0
19312,indinavir,1,1
19313,",",1,0
19314,nelfinavir,1,1
19315,",",1,0
19316,or,1,0
19317,saquinavir,1,1
19318,soft,1,1
19319,gel,1,1
19320,formulation,1,0
19321,in,0,0
19322,31,0,0
19323,human,0,0
19324,immunodeficiency,0,0
19325,virus,0,1
19326,type,0,0
19327,1-infected,0,0
19328,subjects,0,0
19329,.,0,0
19330,The,0,0
19331,results,0,0
19332,indicated,0,0
19333,that,0,0
19334,amprenavir,1,1
19335,plasma,0,0
19336,concentrations,0,0
19337,were,0,0
19338,decreased,0,0
19339,by,0,0
19340,saquinavir,1,1
19341,soft,0,1
19342,gel,0,1
19343,capsule,0,1
19344,(,0,0
19345,by,0,0
19346,32,0,0
19347,%,0,0
19348,for,0,0
19349,area,0,0
19350,under,0,0
19351,the,0,0
19352,concentration-time,0,0
19353,curve,0,0
19354,at,0,0
19355,steady,0,0
19356,state,0,0
19357,[,0,0
19358,AUC,0,0
19359,(,0,0
19360,ss,0,0
19361,),0,1
19362,],0,0
19363,and,0,0
19364,37,0,0
19365,%,0,0
19366,for,0,0
19367,peak,0,0
19368,plasma,0,0
19369,concentration,0,0
19370,at,0,0
19371,steady,0,0
19372,state,0,0
19373,[,0,0
19374,C,0,1
19375,(,0,0
19376,max,0,0
19377,",",0,0
19378,ss,0,0
19379,),0,0
19380,],0,0
19381,),0,0
19382,and,0,0
19383,increased,0,0
19384,by,0,0
19385,indinavir,1,1
19386,(,0,0
19387,33,0,0
19388,%,0,0
19389,for,0,0
19390,AUC,0,0
19391,(,0,0
19392,ss,0,0
19393,),0,0
19394,),0,0
19395,.,0,0
19396,Nelfinavir,1,1
19397,significantly,0,0
19398,increased,0,0
19399,amprenavir,0,1
19400,minimum,0,0
19401,drug,0,0
19402,concentration,0,0
19403,at,0,0
19404,steady,0,0
19405,state,0,0
19406,(,0,0
19407,by,0,0
19408,189,0,0
19409,%,0,0
19410,),0,0
19411,but,0,0
19412,did,0,0
19413,not,0,0
19414,affect,0,0
19415,amprenavir,1,1
19416,AUC,0,0
19417,(,0,0
19418,ss,0,0
19419,),0,0
19420,or,0,1
19421,C,0,1
19422,(,0,0
19423,max,0,0
19424,",",0,0
19425,ss,0,0
19426,),0,0
19427,.,0,0
19428,Nelfinavir,1,1
19429,and,0,0
19430,saquinavir,1,1
19431,steady-state,0,0
19432,pharmacokinetics,0,0
19433,were,0,0
19434,unchanged,0,0
19435,by,0,0
19436,coadministration,0,1
19437,with,0,0
19438,amprenavir,1,1
19439,compared,0,0
19440,with,0,0
19441,the,0,0
19442,historical,0,0
19443,monotherapy,0,1
19444,data,0,0
19445,.,0,0
19446,Concentrations,0,0
19447,of,0,0
19448,indinavir,1,1
19449,",",0,0
19450,coadministered,0,1
19451,with,0,0
19452,amprenavir,1,1
19453,",",0,0
19454,in,0,0
19455,plasma,0,0
19456,decreased,0,0
19457,in,0,0
19458,both,0,0
19459,single-dose,0,0
19460,and,0,0
19461,steady-state,0,0
19462,evaluations,0,0
19463,.,0,0
19464,The,0,0
19465,changes,0,0
19466,in,0,0
19467,amprenavir,1,1
19468,steady-state,0,0
19469,pharmacokinetic,0,0
19470,parameters,0,0
19471,",",0,0
19472,relative,0,0
19473,to,0,0
19474,those,0,0
19475,for,0,0
19476,amprenavir,1,1
19477,alone,0,0
19478,",",0,0
19479,were,0,0
19480,not,0,0
19481,consistent,0,0
19482,among,0,0
19483,protease,0,1
19484,inhibitors,0,1
19485,",",0,0
19486,nor,0,0
19487,were,0,0
19488,the,0,0
19489,changes,0,0
19490,consistent,0,0
19491,with,0,0
19492,potential,0,0
19493,interactions,0,0
19494,in,0,0
19495,CYP3A4,0,1
19496,metabolism,0,0
19497,or,0,1
19498,P-glycoprotein,0,0
19499,transport,0,0
19500,.,0,0
19501,No,0,0
19502,dose,0,0
19503,adjustment,0,0
19504,of,0,0
19505,either,0,0
19506,protease,0,1
19507,inhibitor,0,1
19508,in,0,0
19509,any,0,0
19510,of,0,0
19511,the,0,0
19512,combinations,0,0
19513,studied,0,0
19514,is,0,0
19515,needed,0,0
19516,.,0,0
19517,Relationship,0,0
19518,between,0,0
19519,endogenous,1,0
19520,estrogen,1,1
19521,concentrations,1,0
19522,and,0,0
19523,serum,1,0
19524,cholesteryl,1,1
19525,ester,1,1
19526,transfer,0,1
19527,protein,0,0
19528,concentrations,0,0
19529,in,0,0
19530,Chinese,0,0
19531,women,0,0
19532,.,0,0
19533,BACKGROUND,0,0
19534,CETP,0,1
19535,plays,0,0
19536,an,0,0
19537,important,0,0
19538,role,0,0
19539,in,0,0
19540,HDL,0,1
19541,metabolism,0,0
19542,and,0,0
19543,in,0,0
19544,the,0,0
19545,reverse,0,0
19546,cholesterol,0,0
19547,transport,0,0
19548,pathway,0,0
19549,.,0,0
19550,METHODS,0,0
19551,The,0,0
19552,relationship,0,0
19553,between,0,0
19554,the,0,0
19555,changes,0,0
19556,of,0,0
19557,endogenous,0,0
19558,estrogen,0,1
19559,and,0,0
19560,the,0,0
19561,concentration,0,0
19562,of,0,0
19563,cholesteryl,0,1
19564,ester,0,1
19565,transfer,0,1
19566,protein,0,1
19567,(,0,0
19568,CETP,0,1
19569,),0,0
19570,in,0,0
19571,the,0,0
19572,serum,0,0
19573,of,0,0
19574,Chinese,0,0
19575,women,0,0
19576,was,0,0
19577,investigated,0,0
19578,.,0,0
19579,Serum,1,0
19580,concentrations,1,0
19581,of,1,0
19582,estradiol,1,1
19583,(,1,0
19584,E,1,1
19585,(,1,0
19586,2,1,0
19587,),1,0
19588,),1,0
19589,",",1,0
19590,follicle-stimulating,1,1
19591,hormone,1,1
19592,(,1,0
19593,FSH,1,0
19594,),1,0
19595,",",1,0
19596,CETP,1,1
19597,and,1,0
19598,lipid,1,0
19599,profile,1,0
19600,were,1,0
19601,determined,1,0
19602,in,1,0
19603,196,1,0
19604,Chinese,1,0
19605,women,1,0
19606,(,1,0
19607,52,1,0
19608,premenopausal,1,0
19609,with,1,0
19610,ages,1,0
19611,ranging,1,0
19612,from,1,0
19613,18,1,0
19614,to,1,0
19615,40,1,0
19616,years,1,0
19617,",",1,0
19618,57,1,0
19619,perimenopausal,1,0
19620,from,1,0
19621,41,1,0
19622,to,1,0
19623,60,1,0
19624,years,1,0
19625,",",1,0
19626,and,1,0
19627,87,1,0
19628,postmenopausal,1,0
19629,from,1,0
19630,61,1,0
19631,to,1,0
19632,81,1,0
19633,years,1,0
19634,),1,0
19635,.,1,0
19636,RESULTS,0,0
19637,Serum,0,0
19638,CETP,0,1
19639,concentration,0,0
19640,was,0,0
19641,significantly,0,0
19642,lower,0,0
19643,in,0,0
19644,postmenopausal,0,0
19645,women,0,0
19646,compared,0,0
19647,with,0,0
19648,those,0,0
19649,in,0,0
19650,perimenopausal,0,0
19651,and,0,0
19652,premenopausal,0,1
19653,women,0,0
19654,(,0,0
19655,1.39+/-1.06,0,0
19656,",",0,0
19657,2.36+/-1.50,0,0
19658,and,0,0
19659,2.31+/-1.25,0,0
19660,mg/l,0,0
19661,",",0,0
19662,respectively,0,0
19663,",",0,0
19664,P,0,0
19665,<,0,0
19666,0.0001,0,0
19667,),0,0
19668,.,0,0
19669,Even,0,0
19670,in,0,0
19671,the,0,0
19672,women,0,0
19673,around,0,0
19674,the,0,0
19675,menopausal,0,0
19676,",",0,0
19677,CETP,0,1
19678,concentration,0,0
19679,in,0,0
19680,postmenopause,0,0
19681,was,0,0
19682,significantly,0,0
19683,lower,0,0
19684,than,0,0
19685,that,0,0
19686,in,0,0
19687,premenopause,0,0
19688,(,0,0
19689,1.93+/-1.33,0,0
19690,vs.,0,0
19691,3.42+/-1.35,0,0
19692,mg/l,0,0
19693,",",0,0
19694,P,0,0
19695,<,0,0
19696,0.01,0,0
19697,),0,0
19698,.,0,0
19699,In,0,0
19700,addition,0,0
19701,",",0,0
19702,CETP,0,1
19703,concentration,0,0
19704,had,0,0
19705,a,0,0
19706,highly,0,0
19707,positive,0,0
19708,correlation,0,0
19709,with,0,0
19710,serum,0,0
19711,concentration,0,0
19712,of,0,0
19713,E,0,1
19714,(,0,0
19715,2,0,0
19716,),0,0
19717,(,0,0
19718,r=0.243,0,0
19719,",",0,0
19720,P,0,0
19721,<,0,0
19722,0.001,0,0
19723,),0,0
19724,",",0,0
19725,while,0,0
19726,negative,0,0
19727,correlation,0,0
19728,of,0,0
19729,CETP,0,1
19730,concentration,0,0
19731,with,0,0
19732,serum,0,0
19733,concentration,0,0
19734,of,0,0
19735,FSH,0,0
19736,was,0,0
19737,found,0,0
19738,(,0,0
19739,r=-0.273,0,0
19740,",",0,0
19741,P,0,0
19742,<,0,0
19743,0.001,0,0
19744,),0,0
19745,.,0,0
19746,CONCLUSIONS,0,0
19747,Estrogen,0,0
19748,may,0,0
19749,affect,0,0
19750,the,0,0
19751,concentration,0,0
19752,of,0,0
19753,CETP,0,0
19754,.,0,0
19755,Prognostic,0,0
19756,significance,0,0
19757,of,0,0
19758,the,0,0
19759,dobutamine,0,1
19760,echocardiography,0,0
19761,test,0,0
19762,in,0,0
19763,idiopathic,0,0
19764,dilated,0,0
19765,cardiomyopathy,0,0
19766,.,0,0
19767,Dobutamine,1,1
19768,stress,1,0
19769,echo,1,1
19770,provides,0,0
19771,potentially,0,0
19772,useful,0,0
19773,information,0,0
19774,on,0,0
19775,idiopathic,1,0
19776,dilated,1,0
19777,cardiomyopathy,1,0
19778,(,0,0
19779,IDC,0,0
19780,),0,0
19781,.,0,0
19782,From,0,0
19783,February,0,0
19784,1,0,0
19785,",",0,0
19786,1997,0,0
19787,",",0,0
19788,to,0,0
19789,October,0,0
19790,1,0,0
19791,",",0,0
19792,1999,0,0
19793,",",0,0
19794,186,0,0
19795,patients,0,0
19796,(,0,0
19797,131,0,0
19798,men,0,0
19799,and,0,0
19800,55,0,0
19801,women,0,0
19802,",",0,0
19803,mean,0,0
19804,age,0,0
19805,56,0,0
19806,+/-,0,0
19807,12,0,0
19808,years,0,0
19809,),0,0
19810,with,0,0
19811,IDC,0,0
19812,",",0,0
19813,ejection,0,0
19814,fraction,0,0
19815,<,0,0
19816,35,0,0
19817,%,0,0
19818,",",0,0
19819,and,0,0
19820,angiographically,0,0
19821,normal,0,0
19822,coronary,0,0
19823,arteries,0,0
19824,were,0,0
19825,studied,0,0
19826,by,0,0
19827,high-dose,1,1
19828,(,0,0
19829,up,0,0
19830,to,0,0
19831,40,0,0
19832,micro/kg/min,0,1
19833,),0,0
19834,dobutamine,1,1
19835,echo,1,0
19836,in,0,0
19837,6,0,0
19838,centers,0,0
19839,",",0,0
19840,all,0,0
19841,quality,0,0
19842,controlled,0,0
19843,for,0,0
19844,stress,0,0
19845,echo,0,0
19846,reading,0,1
19847,.,0,0
19848,In,0,0
19849,all,0,0
19850,patients,0,0
19851,",",0,0
19852,wall,0,0
19853,motion,0,0
19854,score,0,0
19855,index,0,0
19856,(,0,0
19857,WMSI,0,1
19858,),0,1
19859,(,0,0
19860,from,0,0
19861,1,0,0
19862,=,0,0
19863,normal,0,0
19864,to,0,0
19865,4,0,0
19866,=,0,0
19867,dyskinetic,0,0
19868,in,0,0
19869,a,0,0
19870,16-,0,0
19871,segment,0,0
19872,model,0,0
19873,of,0,0
19874,the,0,0
19875,left,0,0
19876,ventricle,0,0
19877,),0,0
19878,was,0,0
19879,evaluated,0,0
19880,by,0,0
19881,echo,0,0
19882,at,0,0
19883,baseline,0,0
19884,and,0,0
19885,peak,0,0
19886,dobutamine,0,1
19887,.,0,0
19888,One,0,0
19889,hundred,0,0
19890,eighty-four,0,0
19891,patients,0,0
19892,were,0,0
19893,followed,0,0
19894,up,0,0
19895,(,0,0
19896,mean,0,0
19897,15,0,0
19898,+/-,0,0
19899,13,0,0
19900,months,0,0
19901,),0,0
19902,and,0,0
19903,only,0,0
19904,cardiac,0,0
19905,death,0,0
19906,was,0,0
19907,considered,0,0
19908,as,0,0
19909,an,0,0
19910,end,0,0
19911,point,0,0
19912,.,0,0
19913,There,0,0
19914,were,0,0
19915,29,0,0
19916,cardiac,0,0
19917,deaths,0,0
19918,.,0,0
19919,Significant,0,0
19920,parameters,0,0
19921,for,0,0
19922,survival,0,0
19923,prediction,0,0
19924,at,0,0
19925,univariate,0,0
19926,analysis,0,0
19927,are,0,0
19928,:,0,0
19929,DeltaWMSI,0,0
19930,(,0,0
19931,chi-square,0,0
19932,20.1,0,0
19933,;,0,0
19934,p,0,0
19935,<,0,0
19936,0.0000,0,0
19937,),0,0
19938,",",0,0
19939,New,0,0
19940,York,0,0
19941,Heart,0,1
19942,Association,0,0
19943,(,0,0
19944,NYHA,0,0
19945,),0,1
19946,class,0,0
19947,(,0,0
19948,chi-square,0,0
19949,17.57,0,0
19950,;,0,0
19951,p,0,0
19952,<,0,0
19953,0.0000,0,0
19954,),0,0
19955,",",0,0
19956,rest,0,0
19957,ejection,0,0
19958,fraction,0,0
19959,(,0,0
19960,chi-square,0,0
19961,10.41,0,0
19962,;,0,0
19963,p,0,0
19964,=,0,0
19965,0.0013,0,0
19966,),0,0
19967,",",0,0
19968,angiotensin-converting,0,1
19969,enzyme,0,0
19970,inhibitors,0,1
19971,(,0,0
19972,chi-square,0,0
19973,8.23,0,0
19974,;,0,0
19975,p,0,0
19976,=,0,0
19977,0.0041,0,0
19978,),0,0
19979,",",0,0
19980,and,0,0
19981,hypertension,0,0
19982,(,0,0
19983,chi-square,0,0
19984,8.08,0,0
19985,",",0,0
19986,p,0,0
19987,=,0,0
19988,0.0045,0,0
19989,),0,0
19990,.,0,0
19991,In,0,0
19992,the,0,0
19993,multivariate,0,0
19994,stepwise,0,0
19995,analysis,0,0
19996,only,0,0
19997,DeltaWMSI,0,0
19998,and,0,0
19999,NYHA,0,0
20000,were,0,0
20001,independent,0,0
20002,predictors,0,0
20003,of,0,0
20004,outcome,0,0
20005,(,0,0
20006,DeltaWMSI,0,0
20007,=,0,0
20008,hazard,0,0
20009,ratio,0,0
20010,0.02,0,0
20011,",",0,0
20012,p,0,0
20013,<,0,0
20014,0.0000,0,0
20015,;,0,0
20016,NYHA,0,0
20017,class,0,0
20018,=,0,0
20019,hazard,0,0
20020,ratio,0,0
20021,3.83,0,0
20022,",",0,0
20023,p,0,0
20024,<,0,0
20025,0.0000,0,0
20026,),0,0
20027,.,0,0
20028,Kaplan-Meier,0,0
20029,survival,0,0
20030,estimates,0,0
20031,showed,0,0
20032,a,0,0
20033,better,0,0
20034,outcome,0,0
20035,for,0,0
20036,patients,0,0
20037,with,0,0
20038,a,0,0
20039,large,0,0
20040,inotropic,0,1
20041,response,0,0
20042,(,0,0
20043,DeltaWMSI,0,0
20044,>,0,0
20045,or,0,1
20046,=0.44,0,0
20047,",",0,0
20048,a,0,0
20049,cutoff,0,0
20050,identified,0,0
20051,by,0,0
20052,receiver-operating,0,0
20053,characteristic,0,0
20054,curves,0,0
20055,analysis,0,0
20056,),0,0
20057,than,0,0
20058,for,0,0
20059,those,0,0
20060,with,0,0
20061,a,0,0
20062,small,0,0
20063,or,0,0
20064,no,0,0
20065,myocardial,0,0
20066,inotropic,0,1
20067,response,0,0
20068,to,0,0
20069,dobutamine,0,1
20070,(,0,0
20071,93.6,0,0
20072,%,0,0
20073,vs,0,0
20074,69.4,0,0
20075,%,0,0
20076,",",0,0
20077,p,0,0
20078,=,0,0
20079,0.00033,0,0
20080,),0,0
20081,.,0,0
20082,Thus,0,0
20083,",",0,0
20084,in,0,0
20085,patients,0,0
20086,with,0,0
20087,IDC,0,0
20088,",",0,0
20089,an,0,0
20090,extensive,0,0
20091,contractile,0,0
20092,reserve,0,0
20093,identified,0,0
20094,by,0,0
20095,high-dose,0,1
20096,dobutamine,0,1
20097,stress,0,0
20098,echocardiography,0,0
20099,is,0,0
20100,associated,0,0
20101,with,0,0
20102,a,0,0
20103,better,0,0
20104,survival,0,0
20105,.,0,0
20106,Controlled,0,0
20107,prospective,0,0
20108,trial,0,0
20109,of,0,0
20110,prednisolone,1,1
20111,and,1,0
20112,cytotoxics,1,1
20113,in,0,0
20114,progressive,0,0
20115,IgA,0,0
20116,nephropathy,0,0
20117,.,0,0
20118,In,0,0
20119,a,0,0
20120,single-center,0,0
20121,",",0,0
20122,multiple-referral,0,0
20123,source,0,0
20124,study,0,0
20125,",",0,0
20126,38,0,0
20127,patients,0,0
20128,with,0,0
20129,progressive,0,0
20130,IgA,0,0
20131,nephropathy,0,0
20132,and,0,0
20133,controlled,0,0
20134,hypertension,0,0
20135,were,0,0
20136,randomized,0,0
20137,to,0,0
20138,treatment,0,0
20139,with,0,0
20140,prednisolone,1,1
20141,and,1,0
20142,cytotoxic,1,0
20143,agents,1,0
20144,",",0,0
20145,to,0,0
20146,therapy,0,1
20147,with,0,0
20148,low-dose,1,1
20149,cyclophosphamide,1,1
20150,then,1,0
20151,azathioprine,1,1
20152,",",1,0
20153,and,1,0
20154,to,1,0
20155,control,1,0
20156,groups,1,0
20157,.,1,0
20158,The,0,0
20159,follow-up,0,0
20160,period,0,0
20161,lasted,0,0
20162,2,0,0
20163,to,0,0
20164,6,0,0
20165,yr.,0,0
20166,Renal,0,0
20167,survival,0,0
20168,",",0,0
20169,as,0,0
20170,assessed,0,0
20171,by,0,0
20172,Kaplan-Meier,0,0
20173,analysis,0,0
20174,annually,0,0
20175,to,0,0
20176,5,0,0
20177,yr,0,0
20178,",",0,0
20179,showed,0,0
20180,significant,0,0
20181,preservation,0,0
20182,of,0,0
20183,function,0,0
20184,from,0,0
20185,3,0,0
20186,yr,0,0
20187,in,0,0
20188,the,0,0
20189,treatment,0,0
20190,group,0,0
20191,and,0,0
20192,82,0,0
20193,",",0,0
20194,82,0,0
20195,",",0,0
20196,72,0,0
20197,",",0,0
20198,and,0,0
20199,72,0,0
20200,%,0,0
20201,for,0,0
20202,2,0,0
20203,",",0,0
20204,3,0,0
20205,",",0,0
20206,4,0,0
20207,",",0,0
20208,and,0,0
20209,5,0,0
20210,yr,0,0
20211,",",0,0
20212,respectively,0,0
20213,",",0,0
20214,compared,0,0
20215,with,0,0
20216,68,0,0
20217,",",0,0
20218,47,0,0
20219,",",0,0
20220,26,0,0
20221,",",0,0
20222,and,0,0
20223,6,0,0
20224,%,0,0
20225,in,0,0
20226,controls,0,0
20227,.,0,0
20228,Rate,0,0
20229,of,0,0
20230,loss,0,0
20231,of,0,0
20232,renal,0,0
20233,function,0,0
20234,",",0,0
20235,evaluated,0,0
20236,objectively,0,0
20237,by,0,0
20238,least-squares,0,0
20239,analyses,0,0
20240,of,0,0
20241,reciprocal,0,0
20242,serum,0,0
20243,creatinine,0,0
20244,",",0,0
20245,was,0,0
20246,reduced-and,0,0
20247,in,0,0
20248,one-third,0,0
20249,of,0,0
20250,the,0,0
20251,patients,0,0
20252,",",0,0
20253,arrested-during,0,0
20254,immunosuppressive,0,1
20255,treatment,0,0
20256,.,0,0
20257,Proteinuria,0,0
20258,",",0,0
20259,present,0,0
20260,in,0,0
20261,all,0,0
20262,patients,0,0
20263,at,0,0
20264,the,0,0
20265,time,0,0
20266,of,0,0
20267,entry,0,0
20268,into,0,0
20269,the,0,0
20270,trial,0,0
20271,",",0,0
20272,was,0,0
20273,reduced,0,0
20274,by,0,0
20275,treatment,0,0
20276,from,0,0
20277,12,0,0
20278,mo,0,0
20279,",",0,0
20280,compared,0,0
20281,with,0,0
20282,pretreatment,0,0
20283,levels,0,0
20284,or,0,0
20285,controls,0,0
20286,;,0,0
20287,erythrocyturia,0,0
20288,was,0,0
20289,reduced,0,0
20290,from,0,0
20291,6,0,0
20292,mo,0,0
20293,.,0,0
20294,Histologic,0,0
20295,activity,0,0
20296,and,0,0
20297,chronicity,0,0
20298,indexes,0,0
20299,were,0,0
20300,determined,0,0
20301,in,0,0
20302,renal,0,0
20303,biopsies,0,0
20304,performed,0,0
20305,at,0,0
20306,trial,0,0
20307,entry,0,0
20308,.,0,0
20309,Multivariate,0,0
20310,analysis,0,0
20311,demonstrated,0,0
20312,that,0,0
20313,mesangial,0,0
20314,cell,0,0
20315,proliferation,0,0
20316,and,0,0
20317,matrix,0,1
20318,scores,0,0
20319,were,0,0
20320,highest,0,0
20321,in,0,0
20322,those,0,0
20323,patients,0,0
20324,with,0,0
20325,more,0,0
20326,rapidly,0,0
20327,progressive,0,0
20328,disease,0,0
20329,.,0,0
20330,No,0,0
20331,morphologic,0,0
20332,variable,0,0
20333,or,0,1
20334,residual,0,0
20335,renal,0,0
20336,function,0,0
20337,predicted,0,0
20338,response,0,0
20339,to,0,0
20340,immunosuppressive,0,1
20341,therapy,0,1
20342,at,0,0
20343,entry,0,0
20344,.,0,0
20345,Mean,0,0
20346,arterial,0,0
20347,pressures,0,0
20348,did,0,0
20349,not,0,0
20350,differ,0,0
20351,significantly,0,0
20352,between,0,0
20353,treatment,0,0
20354,and,0,0
20355,control,0,0
20356,groups,0,0
20357,.,0,0
20358,There,0,0
20359,was,0,0
20360,thus,0,0
20361,no,0,0
20362,explanation,0,0
20363,other,0,0
20364,than,0,0
20365,treatment,0,0
20366,for,0,0
20367,the,0,0
20368,improved,0,0
20369,outcome,0,0
20370,in,0,0
20371,patients,0,0
20372,who,0,0
20373,received,0,0
20374,immunosuppressive,0,1
20375,therapy,0,1
20376,.,0,0
20377,Morbidity,0,0
20378,attributable,0,0
20379,to,0,0
20380,treatment,0,0
20381,or,0,1
20382,to,0,0
20383,renal,0,0
20384,failure,0,0
20385,occurred,0,0
20386,in,0,0
20387,both,0,0
20388,groups,0,0
20389,;,0,0
20390,an,0,0
20391,audit,0,0
20392,showed,0,0
20393,that,0,0
20394,benefits,0,0
20395,of,0,0
20396,therapy,0,1
20397,outweighed,0,0
20398,expected,0,0
20399,or,0,0
20400,minor,0,0
20401,side,0,0
20402,effects,0,0
20403,of,0,0
20404,drugs,0,0
20405,in,0,0
20406,this,0,0
20407,population,0,0
20408,at,0,0
20409,risk,0,0
20410,of,0,0
20411,end-stage,0,0
20412,renal,0,0
20413,failure,0,0
20414,.,0,0
20415,Patients,0,0
20416,selected,0,0
20417,for,0,0
20418,moderately,0,0
20419,progressive,0,0
20420,IgA,0,0
20421,nephropathy,0,0
20422,benefit,0,0
20423,from,0,0
20424,treatment,0,0
20425,with,0,0
20426,prednisolone,1,1
20427,and,0,0
20428,cytotoxic,1,0
20429,agents,1,0
20430,;,1,0
20431,results,0,0
20432,are,0,0
20433,consistent,0,0
20434,with,0,0
20435,modulation,0,0
20436,of,0,0
20437,systemic,0,0
20438,immune,0,0
20439,response,0,0
20440,or,0,1
20441,nephritic,0,0
20442,injury,0,0
20443,",",0,0
20444,thus,0,0
20445,explaining,0,0
20446,improved,0,0
20447,outcome,0,0
20448,",",0,0
20449,and,0,0
20450,indicate,0,0
20451,that,0,0
20452,this,0,0
20453,therapy,0,1
20454,has,0,0
20455,an,0,0
20456,acceptably,0,0
20457,low,0,0
20458,risk,0,0
20459,of,0,0
20460,side,0,0
20461,effects,0,0
20462,.,0,0
20463,[,0,0
20464,Clinical,0,0
20465,study,0,0
20466,on,0,0
20467,retarding,0,0
20468,aging,0,0
20469,effect,0,0
20470,of,0,0
20471,tongbu,0,1
20472,recipe,0,1
20473,to,0,0
20474,traditional,0,1
20475,Chinese,0,1
20476,medicine,0,0
20477,],0,0
20478,.,0,0
20479,OBJECTIVE,0,0
20480,To,0,0
20481,study,0,0
20482,the,0,0
20483,mechanism,0,0
20484,of,0,0
20485,Tongbu,1,0
20486,No,1,0
20487,.,1,0
20488,1,1,0
20489,(,1,0
20490,TB1,1,0
20491,",",1,0
20492,a,1,0
20493,prescription,1,0
20494,for,1,0
20495,reinforcing,1,0
20496,Kidney,1,0
20497,and,1,0
20498,Spleen,1,0
20499,",",1,0
20500,clearing,1,0
20501,up,1,0
20502,the,1,0
20503,bowel,1,0
20504,viscera,1,0
20505,to,1,0
20506,send,1,0
20507,Turbid,1,1
20508,downward,1,0
20509,and,1,0
20510,regulating,1,0
20511,Qi,1,1
20512,and,1,0
20513,blood,1,0
20514,),1,0
20515,in,1,0
20516,retarding,0,0
20517,aging,0,0
20518,.,0,0
20519,METHODS,0,0
20520,A,0,0
20521,controlled,0,0
20522,",",0,0
20523,multiple,0,0
20524,indexes,0,0
20525,study,0,0
20526,was,0,0
20527,conducted,0,0
20528,in,0,0
20529,56,0,0
20530,old,0,0
20531,subjects,0,0
20532,randomized,0,0
20533,into,0,0
20534,3,0,0
20535,groups,0,0
20536,.,0,0
20537,RESULTS,0,0
20538,TB1,0,0
20539,(,0,0
20540,containing,0,1
20541,ginseng,0,1
20542,leaf,0,0
20543,",",0,0
20544,cistanche,0,1
20545,",",0,0
20546,fleeceflower,0,1
20547,root,0,0
20548,",",0,0
20549,immature,0,0
20550,bitter,0,1
20551,orange,0,1
20552,",",0,0
20553,rhubarb,0,1
20554,",",0,0
20555,etc,0,0
20556,),0,0
20557,could,0,0
20558,improve,0,0
20559,various,0,0
20560,symptoms,0,0
20561,of,0,0
20562,aging,0,0
20563,",",0,0
20564,and,0,0
20565,had,0,0
20566,the,0,0
20567,effect,0,0
20568,in,0,0
20569,regulating,0,0
20570,immune,0,0
20571,and,0,0
20572,endocrinal,0,0
20573,function,0,0
20574,",",0,0
20575,scavenging,0,1
20576,free,0,0
20577,radicals,0,1
20578,and,0,0
20579,adjusting,0,0
20580,coli,0,0
20581,flora,0,0
20582,.,0,0
20583,The,0,0
20584,effects,0,0
20585,of,0,0
20586,TB1,0,0
20587,and,0,0
20588,TB2,0,1
20589,(,0,0
20590,containing,0,1
20591,ginseng,0,1
20592,leaf,0,0
20593,",",0,0
20594,cistanche,0,1
20595,and,0,0
20596,fleeceflower,0,1
20597,root,0,0
20598,),0,0
20599,were,0,0
20600,different,0,0
20601,significantly,0,0
20602,(,0,0
20603,P,0,0
20604,<,0,0
20605,0.05,0,0
20606,",",0,0
20607,P,0,0
20608,<,0,0
20609,0.01,0,0
20610,),0,0
20611,.,0,0
20612,CONCLUSION,0,0
20613,TB1,0,0
20614,has,0,0
20615,a,0,0
20616,good,0,0
20617,comprehensive,0,0
20618,effect,0,0
20619,in,0,0
20620,retarding,0,0
20621,aging,0,0
20622,.,0,0
20623,Dronabinol,1,1
20624,versus,1,0
20625,megestrol,1,1
20626,acetate,1,1
20627,versus,1,0
20628,combination,1,1
20629,therapy,1,1
20630,for,0,0
20631,cancer-associated,0,0
20632,anorexia,0,0
20633,:,0,0
20634,a,0,0
20635,North,0,0
20636,Central,0,0
20637,Cancer,0,0
20638,Treatment,0,1
20639,Group,0,0
20640,study,0,0
20641,.,0,0
20642,PURPOSE,0,0
20643,To,0,0
20644,determine,0,0
20645,whether,0,0
20646,dronabinol,1,1
20647,administered,0,0
20648,alone,0,1
20649,or,0,0
20650,with,0,0
20651,megestrol,1,1
20652,acetate,1,1
20653,was,0,0
20654,more,0,0
20655,",",0,0
20656,less,0,0
20657,",",0,0
20658,or,0,0
20659,equal,0,0
20660,in,0,0
20661,efficacy,0,0
20662,to,0,0
20663,single-agent,0,0
20664,megestrol,1,1
20665,acetate,1,1
20666,for,0,0
20667,palliating,0,0
20668,cancer-associated,0,0
20669,anorexia,0,0
20670,.,0,0
20671,PATIENTS,0,0
20672,AND,0,0
20673,METHODS,0,0
20674,Four,0,0
20675,hundred,0,0
20676,sixty-nine,0,0
20677,assessable,0,0
20678,advanced,0,0
20679,cancer,0,0
20680,patients,0,0
20681,were,0,0
20682,randomized,0,0
20683,to,0,0
20684,(,0,0
20685,1,0,0
20686,),0,0
20687,oral,0,1
20688,megestrol,1,1
20689,acetate,1,1
20690,800,0,0
20691,mg/d,0,0
20692,liquid,1,1
20693,suspension,1,1
20694,plus,1,1
20695,placebo,1,1
20696,",",0,0
20697,(,0,0
20698,2,0,0
20699,),0,0
20700,oral,0,0
20701,dronabinol,1,1
20702,2.5,0,0
20703,mg,0,0
20704,twice,0,0
20705,a,0,0
20706,day,0,0
20707,plus,0,1
20708,placebo,1,1
20709,",",0,0
20710,or,0,1
20711,(,0,0
20712,3,0,0
20713,),0,0
20714,both,1,0
20715,agents,1,0
20716,.,1,0
20717,Eligible,0,0
20718,patients,0,0
20719,acknowledged,0,0
20720,that,0,0
20721,loss,0,0
20722,of,0,0
20723,appetite,0,0
20724,or,0,1
20725,weight,0,0
20726,was,0,0
20727,a,0,0
20728,problem,0,0
20729,and,0,0
20730,reported,0,0
20731,the,0,0
20732,loss,0,0
20733,of,0,0
20734,5,0,0
20735,pounds,0,0
20736,or,0,0
20737,more,0,0
20738,during,0,0
20739,2,0,0
20740,months,0,0
20741,and/or,0,0
20742,a,0,0
20743,daily,0,0
20744,intake,0,0
20745,of,0,0
20746,less,0,0
20747,than,0,0
20748,20,0,0
20749,calories/kg,0,0
20750,of,0,0
20751,body,0,0
20752,weight,0,0
20753,.,0,0
20754,RESULTS,0,0
20755,Groups,0,0
20756,were,0,0
20757,comparable,0,0
20758,at,0,0
20759,baseline,0,0
20760,in,0,0
20761,age,0,0
20762,",",0,0
20763,sex,0,0
20764,",",0,0
20765,tumor,0,0
20766,type,0,0
20767,",",0,0
20768,weight,0,0
20769,loss,0,0
20770,",",0,0
20771,and,0,0
20772,performance,0,0
20773,status,0,0
20774,.,0,0
20775,A,0,0
20776,greater,0,0
20777,percentage,0,0
20778,of,0,0
20779,megestrol,1,1
20780,acetate-treated,1,0
20781,patients,0,0
20782,reported,0,0
20783,appetite,0,0
20784,improvement,0,0
20785,and,0,0
20786,weight,0,0
20787,gain,0,0
20788,compared,0,0
20789,with,0,0
20790,dronabinol-treated,1,0
20791,patients,0,0
20792,:,0,0
20793,75,0,0
20794,%,0,0
20795,versus,0,0
20796,49,0,0
20797,%,0,0
20798,(,0,0
20799,P,0,0
20800,=.0001,0,0
20801,),0,0
20802,for,0,0
20803,appetite,0,0
20804,and,0,0
20805,11,0,0
20806,%,0,0
20807,versus,0,0
20808,3,0,0
20809,%,0,0
20810,(,0,0
20811,P,0,0
20812,=.02,0,0
20813,),0,0
20814,for,0,0
20815,>,0,0
20816,or,0,0
20817,=,0,0
20818,10,0,0
20819,%,0,0
20820,baseline,0,0
20821,weight,0,0
20822,gain,0,0
20823,.,0,0
20824,Combination,0,0
20825,treatment,0,0
20826,resulted,0,0
20827,in,0,0
20828,no,0,0
20829,significant,0,0
20830,differences,0,0
20831,in,0,0
20832,appetite,0,0
20833,or,0,1
20834,weight,0,0
20835,compared,0,0
20836,with,0,0
20837,megestrol,1,1
20838,acetate,1,1
20839,alone,0,1
20840,.,0,0
20841,The,0,0
20842,Functional,0,0
20843,Assessment,0,0
20844,of,0,0
20845,Anorexia/Cachexia,0,0
20846,Therapy,0,1
20847,questionnaire,0,0
20848,",",0,0
20849,which,0,0
20850,emphasizes,0,0
20851,anorexia-related,0,0
20852,questions,0,0
20853,",",0,0
20854,demonstrated,0,0
20855,an,0,0
20856,improvement,0,0
20857,in,0,0
20858,quality,0,0
20859,of,0,0
20860,life,0,0
20861,(,0,0
20862,QOL,0,1
20863,),0,0
20864,among,0,0
20865,megestrol,1,1
20866,acetate-treated,1,1
20867,and,0,0
20868,combination-treated,0,0
20869,patients,0,0
20870,.,0,0
20871,The,0,0
20872,single-item,0,0
20873,Uniscale,0,0
20874,",",0,0
20875,a,0,0
20876,global,0,0
20877,QOL,0,0
20878,instrument,0,0
20879,",",0,0
20880,found,0,0
20881,comparable,0,0
20882,scores,0,0
20883,.,0,0
20884,Toxicity,0,0
20885,was,0,0
20886,also,0,0
20887,comparable,0,0
20888,",",0,0
20889,with,0,0
20890,the,0,0
20891,exception,0,0
20892,of,0,0
20893,an,0,0
20894,increased,0,0
20895,incidence,0,0
20896,of,0,0
20897,impotence,0,0
20898,among,0,0
20899,men,0,0
20900,who,0,0
20901,received,0,0
20902,megestrol,1,1
20903,acetate,1,1
20904,.,1,0
20905,CONCLUSION,0,0
20906,In,0,0
20907,the,0,0
20908,doses,0,0
20909,and,0,0
20910,schedules,0,0
20911,we,0,0
20912,studied,0,0
20913,",",0,0
20914,megestrol,1,1
20915,acetate,1,1
20916,provided,0,0
20917,superior,0,0
20918,anorexia,0,0
20919,palliation,0,0
20920,among,0,0
20921,advanced,0,0
20922,cancer,0,0
20923,patients,0,0
20924,compared,0,0
20925,with,0,0
20926,dronabinol,1,1
20927,alone,0,0
20928,.,0,0
20929,Combination,0,0
20930,therapy,0,1
20931,did,0,0
20932,not,0,0
20933,appear,0,0
20934,to,0,0
20935,confer,0,0
20936,additional,0,0
20937,benefit,0,0
20938,.,0,0
20939,Marginal,0,0
20940,biotin,0,1
20941,deficiency,0,0
20942,during,0,0
20943,normal,0,0
20944,pregnancy,0,0
20945,.,0,0
20946,BACKGROUND,0,0
20947,Biotin,0,1
20948,deficiency,0,0
20949,is,0,0
20950,teratogenic,0,0
20951,in,0,0
20952,several,0,0
20953,mammalian,0,0
20954,species,0,0
20955,.,0,0
20956,Approximately,0,0
20957,50,0,0
20958,%,0,0
20959,of,0,0
20960,pregnant,0,0
20961,women,0,0
20962,have,0,0
20963,an,0,0
20964,abnormally,0,0
20965,increased,0,0
20966,urinary,0,0
20967,excretion,0,0
20968,of,0,0
20969,3-hydroxyisovaleric,0,0
20970,acid,0,1
20971,(,0,0
20972,3-HIA,0,0
20973,),0,0
20974,",",0,0
20975,which,0,0
20976,probably,0,0
20977,reflects,0,0
20978,decreased,0,0
20979,activity,0,0
20980,of,0,0
20981,the,0,0
20982,biotin-dependent,0,0
20983,enzyme,0,0
20984,methylcrotonyl-CoA,0,0
20985,carboxylase,0,0
20986,.,0,0
20987,However,0,0
20988,",",0,0
20989,increased,0,0
20990,3-HIA,0,0
20991,excretion,0,0
20992,could,0,0
20993,result,0,0
20994,from,0,0
20995,pregnancy,0,0
20996,per,0,0
20997,se,0,0
20998,(,0,0
20999,eg,0,0
21000,",",0,0
21001,from,0,0
21002,an,0,0
21003,effect,0,0
21004,of,0,0
21005,pregnancy,0,0
21006,on,0,0
21007,renal,0,0
21008,handling,0,0
21009,of,0,0
21010,organic,0,1
21011,acids,0,1
21012,),0,0
21013,.,0,0
21014,OBJECTIVE,0,0
21015,We,0,0
21016,tested,0,0
21017,the,0,0
21018,hypothesis,0,0
21019,that,0,0
21020,biotin,0,1
21021,supplementation,0,0
21022,significantly,0,0
21023,decreases,0,0
21024,3-HIA,0,0
21025,excretion,0,0
21026,in,0,0
21027,pregnant,0,0
21028,women,0,0
21029,with,0,0
21030,abnormally,0,0
21031,increased,0,0
21032,3-HIA,0,0
21033,excretion,0,0
21034,.,0,0
21035,DESIGN,0,0
21036,Twenty-six,0,0
21037,pregnant,0,0
21038,women,0,0
21039,with,0,0
21040,increased,0,0
21041,3-HIA,0,0
21042,excretion,0,0
21043,were,0,0
21044,studied,0,0
21045,in,0,0
21046,a,0,0
21047,randomized,0,0
21048,",",0,0
21049,placebo-controlled,1,1
21050,trial,0,0
21051,;,0,0
21052,10,0,0
21053,women,0,0
21054,were,0,0
21055,studied,0,0
21056,during,0,0
21057,early,0,0
21058,pregnancy,0,0
21059,(,0,0
21060,6-17,0,0
21061,wk,0,0
21062,gestation,0,0
21063,),0,0
21064,and,0,0
21065,16,0,0
21066,women,0,0
21067,during,0,0
21068,late,0,0
21069,pregnancy,0,0
21070,(,0,0
21071,21-37,0,0
21072,wk,0,0
21073,gestation,0,0
21074,),0,0
21075,.,0,0
21076,Urine,0,1
21077,samples,0,0
21078,were,0,0
21079,collected,0,0
21080,before,0,0
21081,and,0,0
21082,after,0,0
21083,14,0,0
21084,d,0,0
21085,of,0,0
21086,supplementation,0,1
21087,with,0,0
21088,300,1,1
21089,microg,1,0
21090,(,1,0
21091,1.2,1,0
21092,micromol,1,0
21093,),1,0
21094,biotin/d,1,1
21095,or,1,1
21096,placebo,1,1
21097,.,1,0
21098,RESULTS,0,0
21099,In,0,0
21100,the,0,0
21101,early-pregnancy,0,0
21102,group,0,0
21103,",",0,0
21104,3-HIA,0,0
21105,excretion,0,0
21106,decreased,0,0
21107,(,0,0
21108,P,0,0
21109,<,0,0
21110,0.006,0,0
21111,),0,0
21112,by,0,0
21113,11.7,0,0
21114,+/-,0,0
21115,3.6,0,0
21116,mmol/mol,0,0
21117,creatinine,0,0
21118,(,0,0
21119,mean,0,0
21120,+/-,0,0
21121,SEM,0,1
21122,),0,0
21123,in,0,0
21124,the,0,0
21125,5,0,0
21126,women,0,0
21127,who,0,0
21128,received,0,0
21129,biotin,0,1
21130,supplements,0,1
21131,",",0,0
21132,whereas,0,0
21133,3-HIA,0,0
21134,excretion,0,0
21135,increased,0,0
21136,by,0,0
21137,1.6,0,0
21138,+/-,0,0
21139,0.6,0,0
21140,mmol/mol,0,0
21141,creatinine,0,0
21142,in,0,0
21143,the,0,0
21144,5,0,0
21145,women,0,0
21146,who,0,0
21147,received,0,0
21148,placebo,0,1
21149,.,0,0
21150,In,0,0
21151,the,0,0
21152,late-pregnancy,0,0
21153,group,0,0
21154,",",0,0
21155,3-HIA,0,0
21156,excretion,0,0
21157,decreased,0,0
21158,(,0,0
21159,P,0,0
21160,<,0,0
21161,0.002,0,0
21162,),0,0
21163,by,0,0
21164,7.1,0,0
21165,+/-,0,0
21166,1.2,0,0
21167,mmol/mol,0,0
21168,creatinine,0,0
21169,in,0,0
21170,the,0,0
21171,8,0,0
21172,women,0,0
21173,who,0,0
21174,received,0,0
21175,biotin,0,1
21176,supplements,0,1
21177,",",0,0
21178,whereas,0,0
21179,3-HIA,0,0
21180,excretion,0,0
21181,increased,0,0
21182,by,0,0
21183,0.9,0,0
21184,+/-,0,0
21185,1.8,0,0
21186,mmol/mol,0,0
21187,creatinine,0,0
21188,in,0,0
21189,the,0,0
21190,8,0,0
21191,women,0,0
21192,who,0,0
21193,received,0,0
21194,placebo,0,1
21195,.,0,0
21196,CONCLUSIONS,0,0
21197,This,0,0
21198,study,0,0
21199,provides,0,0
21200,evidence,0,0
21201,that,0,0
21202,the,0,0
21203,increased,0,0
21204,excretion,0,0
21205,of,0,0
21206,3-HIA,0,0
21207,seen,0,0
21208,frequently,0,0
21209,in,0,0
21210,normal,0,0
21211,pregnancy,0,0
21212,reflects,0,0
21213,reduced,0,0
21214,biotin,0,1
21215,status,0,0
21216,.,0,0
21217,The,0,0
21218,conclusion,0,0
21219,that,0,0
21220,marginal,0,0
21221,biotin,0,1
21222,deficiency,0,0
21223,occurs,0,0
21224,frequently,0,0
21225,in,0,0
21226,the,0,0
21227,first,0,0
21228,trimester,0,0
21229,further,0,0
21230,raises,0,0
21231,concern,0,0
21232,about,0,0
21233,potential,0,0
21234,human,0,0
21235,teratogenicity,0,0
21236,.,0,0
21237,[,0,0
21238,Intravesical,0,1
21239,instillation,0,0
21240,of,0,0
21241,doxorubicin,1,1
21242,or,0,1
21243,epirubicin,1,1
21244,for,0,0
21245,chemoprophylaxis,0,1
21246,of,0,0
21247,superficial,0,0
21248,bladder,0,0
21249,cancer,0,0
21250,--,0,0
21251,the,0,0
21252,fifth,0,0
21253,study,0,0
21254,of,0,0
21255,the,0,0
21256,Japanese,0,0
21257,Urological,0,0
21258,Cancer,0,0
21259,Research,0,0
21260,Group,0,0
21261,for,0,0
21262,Adriamycin/Farumorubicin,0,1
21263,],0,0
21264,.,0,0
21265,A,0,0
21266,total,0,0
21267,of,0,0
21268,465,0,0
21269,patients,0,0
21270,with,0,0
21271,primary,0,0
21272,and,0,0
21273,multiple,0,0
21274,or,0,1
21275,recurrent,0,0
21276,",",0,0
21277,stages,0,0
21278,Ta,0,0
21279,and,0,0
21280,T1,0,1
21281,superficial,0,0
21282,bladder,0,1
21283,cancer,0,0
21284,were,0,0
21285,included,0,0
21286,in,0,0
21287,this,0,0
21288,randomized,0,0
21289,multicenter,0,0
21290,trial,0,0
21291,to,0,0
21292,compare,0,0
21293,the,0,0
21294,prophylactic,0,1
21295,effect,0,0
21296,by,0,0
21297,17,0,0
21298,times,0,0
21299,instillation,0,0
21300,of,0,0
21301,40,1,0
21302,mg,1,0
21303,doxorubicin,1,1
21304,or,1,0
21305,40,1,0
21306,mg,1,0
21307,epirubicin,1,1
21308,with,1,0
21309,no,1,0
21310,instillation,1,0
21311,after,1,0
21312,transurethral,1,1
21313,resection,1,1
21314,of,1,0
21315,tumor,1,0
21316,(,1,0
21317,s,1,0
21318,),1,0
21319,.,0,0
21320,The,0,0
21321,primary,0,0
21322,endpoint,0,0
21323,was,0,0
21324,first,0,0
21325,recurrence,0,0
21326,after,0,0
21327,transurethral,0,1
21328,resection,0,1
21329,.,0,0
21330,Endoscopic,0,1
21331,examination,0,0
21332,as,0,0
21333,well,0,0
21334,as,0,0
21335,urinary,0,0
21336,cytology,0,0
21337,was,0,0
21338,performed,0,0
21339,in,0,0
21340,each,0,0
21341,case,0,0
21342,every,0,0
21343,three,0,0
21344,months,0,0
21345,.,0,0
21346,It,0,0
21347,became,0,0
21348,evident,0,0
21349,that,0,0
21350,the,0,0
21351,recurrence,0,0
21352,rate,0,0
21353,in,0,0
21354,the,0,0
21355,doxorubicin,1,1
21356,or,0,1
21357,epirubicin,1,1
21358,instillation,0,0
21359,arm,0,0
21360,was,0,0
21361,lower,0,0
21362,that,0,0
21363,in,0,0
21364,the,0,0
21365,no,0,0
21366,instillation,0,0
21367,arm,0,0
21368,.,0,0
21369,Toxicity,0,0
21370,was,0,0
21371,mainly,0,0
21372,restricted,0,0
21373,to,0,0
21374,bladder,0,0
21375,irritation,0,0
21376,in,0,0
21377,about,0,0
21378,10,0,0
21379,%,0,0
21380,of,0,0
21381,patients,0,0
21382,in,0,0
21383,each,0,0
21384,instillation,0,0
21385,arm,0,0
21386,.,0,0
21387,A,0,0
21388,double-blind,0,0
21389,",",0,0
21390,placebo-controlled,1,1
21391,crossover,0,0
21392,study,0,0
21393,investigating,0,0
21394,the,0,0
21395,effect,0,0
21396,of,0,0
21397,porcine,1,1
21398,secretin,1,1
21399,in,0,0
21400,children,0,0
21401,with,0,0
21402,autism,0,0
21403,.,0,0
21404,OBJECTIVES,0,0
21405,A,0,0
21406,recent,0,0
21407,patient,0,0
21408,series,0,0
21409,reported,0,0
21410,the,0,0
21411,incidental,0,0
21412,findings,0,0
21413,of,0,0
21414,improved,0,0
21415,social,0,0
21416,and,0,0
21417,language,0,0
21418,skills,0,0
21419,in,0,0
21420,3,0,0
21421,children,0,0
21422,with,0,0
21423,autistic,0,0
21424,spectrum,0,0
21425,disorders,0,0
21426,after,0,0
21427,the,0,0
21428,administration,0,0
21429,of,0,0
21430,secretin,1,1
21431,",",0,0
21432,a,0,0
21433,peptide,0,0
21434,hormone,0,0
21435,.,0,0
21436,However,0,0
21437,",",0,0
21438,a,0,0
21439,subsequent,0,0
21440,study,0,0
21441,did,0,0
21442,not,0,0
21443,find,0,0
21444,evidence,0,0
21445,for,0,0
21446,a,0,0
21447,drug,0,0
21448,effect,0,0
21449,.,0,0
21450,Parents,0,0
21451,are,0,0
21452,seeking,0,0
21453,treatment,0,0
21454,with,0,0
21455,secretin,1,1
21456,despite,0,0
21457,the,0,0
21458,absence,0,0
21459,of,0,0
21460,empirical,0,0
21461,investigations,0,0
21462,demonstrating,0,0
21463,amelioration,0,0
21464,in,0,0
21465,autism,0,0
21466,symptomology,0,0
21467,.,0,0
21468,In,0,0
21469,order,0,0
21470,to,0,0
21471,more,0,0
21472,precisely,0,0
21473,measure,0,0
21474,the,0,0
21475,effects,0,0
21476,of,0,0
21477,secretin,1,1
21478,",",0,0
21479,this,0,0
21480,study,0,0
21481,investigated,0,0
21482,the,0,0
21483,effect,0,0
21484,of,0,0
21485,a,0,0
21486,single,0,0
21487,intravenous,1,1
21488,dose,1,0
21489,of,1,0
21490,porcine,1,1
21491,secretin,1,1
21492,on,0,0
21493,12,0,0
21494,autistic,0,0
21495,children,0,0
21496,through,0,0
21497,a,0,0
21498,randomized,0,0
21499,",",0,0
21500,double-blind,0,0
21501,",",0,0
21502,placebo-controlled,1,1
21503,",",0,0
21504,crossover,0,0
21505,study,0,0
21506,.,0,0
21507,Children,0,0
21508,were,0,0
21509,assessed,0,0
21510,on,0,0
21511,objective,0,0
21512,language,0,0
21513,and,0,0
21514,on,0,0
21515,social,0,0
21516,",",0,0
21517,neuropsychological,0,0
21518,",",0,0
21519,and,0,0
21520,gastrointestinal,0,0
21521,measures,0,0
21522,to,0,0
21523,evaluate,0,0
21524,drug,0,0
21525,effects,0,0
21526,.,0,0
21527,The,0,0
21528,study,0,0
21529,was,0,0
21530,conducted,0,0
21531,over,0,0
21532,a,0,0
21533,16-week,0,0
21534,trial,0,0
21535,.,0,0
21536,The,0,0
21537,results,0,0
21538,indicated,0,0
21539,that,0,0
21540,significant,0,0
21541,differences,0,0
21542,were,0,0
21543,not,0,0
21544,observed,0,0
21545,on,0,0
21546,the,0,0
21547,majority,0,0
21548,of,0,0
21549,the,0,0
21550,dependent,0,0
21551,variables,0,0
21552,.,0,0
21553,Statistically,0,0
21554,significant,0,0
21555,differences,0,0
21556,were,0,0
21557,observed,0,0
21558,on,0,0
21559,measures,0,0
21560,of,0,0
21561,positive,0,0
21562,affect,0,0
21563,and,0,0
21564,activity,0,0
21565,level,0,0
21566,following,0,0
21567,secretin,1,1
21568,infusion,0,1
21569,.,0,0
21570,In,0,0
21571,general,0,0
21572,",",0,0
21573,the,0,0
21574,autistic,0,0
21575,children,0,0
21576,did,0,0
21577,not,0,0
21578,demonstrate,0,0
21579,the,0,0
21580,improvements,0,0
21581,described,0,0
21582,in,0,0
21583,the,0,0
21584,initial,0,0
21585,retrospective,0,0
21586,report,0,0
21587,.,0,0
21588,Changes,0,0
21589,in,0,0
21590,selected,0,0
21591,fitness,0,0
21592,parameters,0,0
21593,following,0,0
21594,six,0,0
21595,weeks,0,0
21596,of,0,0
21597,snowshoe,1,0
21598,training,1,1
21599,.,1,0
21600,BACKGROUND,0,0
21601,Recently,0,0
21602,",",0,0
21603,there,0,0
21604,has,0,0
21605,been,0,0
21606,an,0,0
21607,increase,0,0
21608,in,0,0
21609,popularity,0,0
21610,and,0,0
21611,participation,0,0
21612,in,0,0
21613,the,0,0
21614,sport,0,1
21615,of,0,0
21616,snowshoeing,1,0
21617,.,1,0
21618,While,0,0
21619,the,0,0
21620,sport,0,1
21621,has,0,0
21622,gained,0,0
21623,considerable,0,0
21624,recognition,0,0
21625,",",0,0
21626,to,0,0
21627,date,0,0
21628,there,0,0
21629,is,0,0
21630,little,0,0
21631,or,0,0
21632,no,0,0
21633,scientific,0,0
21634,research,0,0
21635,regarding,0,0
21636,training,0,1
21637,responses,0,0
21638,to,0,0
21639,snowshoeing,0,0
21640,as,0,0
21641,a,0,0
21642,form,0,0
21643,of,0,0
21644,exercise,0,1
21645,.,0,0
21646,Therefore,0,0
21647,",",0,0
21648,the,0,0
21649,purpose,0,0
21650,of,0,0
21651,this,0,0
21652,study,0,0
21653,was,0,0
21654,to,0,0
21655,determine,0,0
21656,whether,0,0
21657,snowshoe,0,0
21658,training,0,1
21659,could,0,0
21660,improve,0,0
21661,fitness,0,0
21662,measures,0,0
21663,.,0,0
21664,A,0,0
21665,further,0,0
21666,purpose,0,0
21667,was,0,0
21668,to,0,0
21669,compare,0,0
21670,responses,0,0
21671,from,0,0
21672,a,0,0
21673,snowshoe,1,0
21674,training,1,1
21675,program,1,1
21676,to,0,0
21677,a,0,0
21678,similarly,0,0
21679,designed,0,0
21680,run,1,0
21681,training,1,1
21682,program,1,1
21683,.,1,0
21684,METHODS,0,0
21685,This,0,0
21686,prospective,0,0
21687,",",0,0
21688,comparative,0,0
21689,study,0,0
21690,was,0,0
21691,conducted,0,0
21692,with,0,0
21693,healthy,0,0
21694,males,0,0
21695,and,0,0
21696,females,0,0
21697,between,0,0
21698,the,0,0
21699,ages,0,0
21700,of,0,0
21701,19,0,0
21702,and,0,0
21703,24,0,0
21704,.,0,0
21705,These,0,0
21706,subjects,0,0
21707,were,0,0
21708,recruited,0,0
21709,from,0,0
21710,the,0,0
21711,University,0,0
21712,of,0,0
21713,Vermont,0,0
21714,population,0,0
21715,and,0,0
21716,surrounding,0,0
21717,community,0,1
21718,.,0,0
21719,Following,0,0
21720,baseline,0,0
21721,measurements,0,0
21722,in,0,0
21723,VO2max,0,0
21724,",",0,0
21725,running,0,0
21726,time,0,0
21727,to,0,0
21728,exhaustion,0,0
21729,(,0,0
21730,RTE,0,1
21731,),0,0
21732,",",0,0
21733,and,0,0
21734,anthropometry,0,0
21735,",",0,0
21736,17,0,0
21737,subjects,0,0
21738,(,0,0
21739,10,0,0
21740,snowshoers,0,0
21741,and,0,0
21742,7,0,0
21743,runners,0,0
21744,),0,0
21745,participated,0,0
21746,in,0,0
21747,a,0,0
21748,six,0,0
21749,week,0,0
21750,conditioning,0,1
21751,program,0,1
21752,.,0,0
21753,Both,0,0
21754,groups,0,0
21755,exercised,0,0
21756,for,0,0
21757,30,0,0
21758,min,0,0
21759,at,0,0
21760,75-85,0,0
21761,%,0,0
21762,age,0,0
21763,predicted,0,0
21764,maximum,0,0
21765,heart,0,0
21766,rate,0,0
21767,",",0,0
21768,3-4,0,0
21769,times,0,0
21770,per,0,0
21771,week,0,0
21772,",",0,0
21773,for,0,0
21774,a,0,0
21775,total,0,0
21776,of,0,0
21777,18,0,0
21778,sessions,0,0
21779,.,0,0
21780,RESULTS,0,0
21781,VO2max,0,0
21782,improved,0,0
21783,significantly,0,0
21784,in,0,0
21785,both,0,0
21786,running,0,0
21787,and,0,0
21788,snowshoeing,0,0
21789,groups,0,0
21790,",",0,0
21791,6.3,0,0
21792,and,0,0
21793,8.5,0,0
21794,%,0,0
21795,",",0,0
21796,respectively,0,0
21797,.,0,0
21798,Run,0,0
21799,time,0,0
21800,to,0,0
21801,exhaustion,0,0
21802,also,0,0
21803,improved,0,0
21804,significantly,0,0
21805,in,0,0
21806,both,0,0
21807,groups,0,0
21808,",",0,0
21809,23.3,0,0
21810,and,0,0
21811,33.5,0,0
21812,%,0,0
21813,",",0,0
21814,respectively,0,0
21815,.,0,0
21816,There,0,0
21817,were,0,0
21818,no,0,0
21819,changes,0,0
21820,in,0,0
21821,anthropometry,0,0
21822,for,0,0
21823,either,0,0
21824,group,0,0
21825,.,0,0
21826,With,0,0
21827,the,0,0
21828,exception,0,0
21829,of,0,0
21830,RTE,0,0
21831,",",0,0
21832,there,0,0
21833,were,0,0
21834,no,0,0
21835,statistically,0,0
21836,significant,0,0
21837,differences,0,0
21838,between,0,0
21839,groups,0,0
21840,in,0,0
21841,any,0,0
21842,other,0,0
21843,measurements,0,0
21844,at,0,0
21845,baseline,0,0
21846,.,0,0
21847,CONCLUSIONS,0,0
21848,These,0,0
21849,results,0,0
21850,support,0,0
21851,the,0,0
21852,acceptability,0,0
21853,of,0,0
21854,snowshoeing,0,0
21855,as,0,0
21856,a,0,0
21857,valid,0,0
21858,means,0,0
21859,to,0,0
21860,improve,0,0
21861,or,0,0
21862,maintain,0,0
21863,cardiovascular,0,0
21864,endurance,0,0
21865,.,0,0
21866,Effects,0,0
21867,of,0,0
21868,glucagon-like,1,1
21869,peptide-1,1,1
21870,(,1,0
21871,7-36,1,1
21872,),1,0
21873,amide,1,1
21874,on,0,0
21875,motility,0,0
21876,and,0,0
21877,sensation,0,0
21878,of,0,0
21879,the,0,0
21880,proximal,0,0
21881,stomach,0,0
21882,in,0,0
21883,humans,0,0
21884,.,0,0
21885,BACKGROUND,0,0
21886,Glucagon-like,1,1
21887,peptide-1,1,1
21888,(,1,0
21889,7-36,1,1
21890,),1,1
21891,amide,1,1
21892,(,1,1
21893,GLP-1,1,1
21894,),1,0
21895,retards,0,0
21896,gastric,0,0
21897,emptying,0,0
21898,",",0,0
21899,reduces,0,0
21900,food,0,0
21901,intake,0,0
21902,",",0,0
21903,and,0,0
21904,inhibits,0,0
21905,antroduodenal,0,0
21906,and,0,0
21907,stimulates,0,0
21908,pyloric,0,0
21909,motility,0,0
21910,.,0,0
21911,AIMS,0,0
21912,To,0,0
21913,assess,0,0
21914,the,0,0
21915,effects,0,0
21916,of,0,0
21917,synthetic,1,0
21918,GLP-1,1,1
21919,on,0,0
21920,fundus,0,0
21921,tone,0,1
21922,and,0,0
21923,volume,0,0
21924,waves,0,0
21925,",",0,0
21926,gastric,0,0
21927,compliance,0,0
21928,",",0,0
21929,and,0,0
21930,perception,0,0
21931,of,0,0
21932,gastric,0,0
21933,distension,0,0
21934,.,0,0
21935,SUBJECTS,0,0
21936,Eleven,0,1
21937,healthy,0,0
21938,male,0,0
21939,volunteers,0,0
21940,.,0,0
21941,METHODS,0,0
21942,Background,0,0
21943,infusions,0,1
21944,were,0,0
21945,saline,1,1
21946,",",1,0
21947,or,1,0
21948,GLP-1,1,0
21949,at,0,0
21950,0.3,0,0
21951,or,0,0
21952,0.9,0,0
21953,pmol/,0,0
21954,kg/min,0,0
21955,on,0,0
21956,separate,0,0
21957,days,0,0
21958,in,0,0
21959,random,0,0
21960,order,0,0
21961,.,0,0
21962,Interdigestive,0,0
21963,fundus,0,0
21964,motility,0,0
21965,was,0,0
21966,recorded,0,0
21967,by,0,0
21968,barostat,0,1
21969,(,0,0
21970,maximum,0,0
21971,capacity,0,0
21972,of,0,0
21973,intragastric,0,1
21974,bag,0,1
21975,1200,0,1
21976,ml,0,0
21977,),0,0
21978,during,0,0
21979,basal,0,0
21980,and,0,0
21981,peptide,0,0
21982,periods,0,0
21983,of,0,0
21984,60,0,0
21985,minutes,0,0
21986,each,0,0
21987,.,0,0
21988,Thereafter,0,0
21989,stepwise,0,0
21990,isobaric,0,1
21991,distensions,0,0
21992,were,0,0
21993,performed,0,0
21994,with,0,0
21995,ongoing,0,0
21996,peptide,0,0
21997,infusion,0,1
21998,",",0,0
21999,and,0,0
22000,gastric,0,0
22001,sensation,0,0
22002,was,0,0
22003,scored,0,0
22004,.,0,0
22005,RESULTS,0,0
22006,Low,0,0
22007,and,0,0
22008,high,0,0
22009,loads,0,0
22010,of,0,0
22011,GLP-1,1,0
22012,induced,0,0
22013,physiological,0,0
22014,and,0,0
22015,supraphysiological,0,0
22016,plasma,0,0
22017,immunoreactivities,0,0
22018,",",0,0
22019,respectively,0,0
22020,.,0,0
22021,GLP-1,1,0
22022,dose,0,0
22023,dependently,0,0
22024,diminished,0,0
22025,fundus,0,0
22026,tone,0,1
22027,(,0,0
22028,162.9,0,0
22029,(,0,0
22030,15.0,0,0
22031,),0,0
22032,and,0,0
22033,259.5,0,0
22034,(,0,0
22035,17.2,0,0
22036,),0,0
22037,v,0,0
22038,121.1,0,0
22039,(,0,0
22040,6.0,0,0
22041,),0,0
22042,ml,0,0
22043,with,0,0
22044,saline,0,1
22045,;,0,0
22046,p,0,0
22047,<,0,0
22048,0.0001,0,0
22049,),0,0
22050,.,0,0
22051,It,0,0
22052,greatly,0,0
22053,reduced,0,0
22054,volume,0,0
22055,waves,0,0
22056,and,0,0
22057,total,0,0
22058,volume,0,0
22059,displaced,0,0
22060,by,0,0
22061,these,0,0
22062,events,0,0
22063,(,0,0
22064,p,0,0
22065,<,0,0
22066,0.0001,0,0
22067,),0,0
22068,.,0,0
22069,Gastric,0,0
22070,compliance,0,0
22071,derived,0,0
22072,from,0,0
22073,isobaric,0,1
22074,distension,0,0
22075,rose,0,0
22076,in,0,0
22077,a,0,0
22078,dose,0,0
22079,related,0,0
22080,manner,0,1
22081,(,0,0
22082,42.6,0,0
22083,(,0,0
22084,5.5,0,0
22085,),0,0
22086,and,0,0
22087,63.6,0,0
22088,(,0,0
22089,7.7,0,0
22090,),0,0
22091,v,0,0
22092,27.0,0,0
22093,(,0,0
22094,3.5,0,0
22095,),0,0
22096,ml/mm,0,0
22097,Hg,0,0
22098,;,0,0
22099,p=0.0004,0,0
22100,),0,0
22101,with,0,0
22102,a,0,0
22103,concomitant,0,0
22104,reduction,0,0
22105,of,0,0
22106,the,0,0
22107,pressure,0,0
22108,at,0,0
22109,half,0,0
22110,maximum,0,0
22111,bag,0,1
22112,volume,0,0
22113,(,0,0
22114,6.4,0,0
22115,(,0,0
22116,0.4,0,0
22117,),0,0
22118,and,0,0
22119,5.5,0,0
22120,(,0,0
22121,0.4,0,0
22122,),0,0
22123,v,0,0
22124,7.2,0,0
22125,(,0,0
22126,0.1,0,0
22127,),0,0
22128,mm,0,0
22129,Hg,0,0
22130,;,0,0
22131,p,0,0
22132,<,0,0
22133,0.0001,0,0
22134,),0,0
22135,.,0,0
22136,GLP-1,1,0
22137,did,0,0
22138,not,0,0
22139,change,0,0
22140,perception,0,0
22141,of,0,0
22142,isobaric,0,1
22143,distension,0,0
22144,but,0,0
22145,reduced,0,0
22146,the,0,0
22147,perception,0,0
22148,score,0,0
22149,related,0,0
22150,to,0,0
22151,corresponding,0,0
22152,bag,0,1
22153,volume,0,0
22154,(,0,0
22155,p,0,0
22156,<,0,0
22157,0.0001,0,0
22158,),0,0
22159,.,0,0
22160,CONCLUSIONS,0,0
22161,GLP-1,1,0
22162,is,0,0
22163,a,0,0
22164,candidate,0,0
22165,physiological,0,0
22166,inhibitory,0,0
22167,regulator,0,0
22168,of,0,0
22169,fundus,0,0
22170,motility,0,0
22171,.,0,0
22172,It,0,0
22173,allows,0,0
22174,the,0,0
22175,stomach,0,0
22176,to,0,0
22177,afford,0,0
22178,a,0,0
22179,larger,0,0
22180,volume,0,0
22181,without,0,0
22182,increase,0,0
22183,in,0,0
22184,sensation,0,0
22185,.,0,0
22186,Laparoscopically,1,0
22187,assisted,1,0
22188,vaginal,1,0
22189,hysterectomy,1,1
22190,versus,0,0
22191,abdominal,1,0
22192,hysterectomy,1,1
22193,in,0,0
22194,stage,0,0
22195,I,0,0
22196,endometrial,0,0
22197,cancer,0,0
22198,.,0,0
22199,The,0,0
22200,purpose,0,0
22201,of,0,0
22202,this,0,0
22203,study,0,0
22204,was,0,0
22205,to,0,0
22206,evaluate,0,0
22207,and,0,0
22208,compare,0,0
22209,laparoscopic,1,1
22210,treatment,1,0
22211,for,0,0
22212,stage,0,0
22213,I,0,0
22214,endometrial,0,0
22215,cancer,0,0
22216,with,0,0
22217,the,0,0
22218,traditional,1,1
22219,transabdominal,1,1
22220,approach,1,1
22221,.,0,0
22222,From,0,0
22223,July,0,0
22224,1996,0,0
22225,to,0,0
22226,July,0,0
22227,1998,0,0
22228,",",0,0
22229,61,0,0
22230,patients,0,0
22231,with,0,0
22232,clinical,0,0
22233,stage,0,0
22234,I,0,0
22235,endometrial,0,0
22236,cancer,0,0
22237,were,0,0
22238,treated,0,0
22239,at,0,0
22240,the,0,0
22241,Gynaecology,0,0
22242,Oncology,0,0
22243,Unit,0,0
22244,at,0,0
22245,the,0,0
22246,Royal,0,1
22247,North,0,0
22248,Shore,0,0
22249,of,0,0
22250,Sydney,0,0
22251,",",0,0
22252,Australia,0,0
22253,.,0,0
22254,Twenty-nine,0,0
22255,patients,0,0
22256,were,0,0
22257,treated,0,0
22258,with,0,0
22259,laparoscopic,1,1
22260,assisted,1,1
22261,vaginal,1,1
22262,hysterectomy,1,1
22263,(,1,0
22264,LAVH,1,1
22265,),1,1
22266,and,1,0
22267,bilateral,1,1
22268,salpingo-oophrectomy,1,1
22269,(,1,0
22270,BSO,1,1
22271,),1,1
22272,plus,1,1
22273,minus,1,1
22274,laparoscopic,1,1
22275,pelvic,1,1
22276,lymphadenectomy,1,1
22277,(,1,0
22278,LPLA,1,1
22279,),1,0
22280,",",0,0
22281,while,0,0
22282,32,0,0
22283,patients,0,0
22284,were,0,0
22285,treated,0,0
22286,with,0,0
22287,the,0,0
22288,traditional,0,1
22289,laparotomy,1,1
22290,and,0,0
22291,underwent,0,0
22292,total,1,0
22293,abdominal,1,0
22294,hysterectomy,1,1
22295,(,1,0
22296,TAH,1,0
22297,),1,0
22298,and,0,0
22299,BSO,0,1
22300,plus,0,1
22301,minus,0,1
22302,pelvic,1,1
22303,lymphadenectomy,1,1
22304,(,0,0
22305,PLA,0,0
22306,),0,0
22307,.,0,0
22308,The,0,0
22309,main,0,0
22310,outcomes,0,0
22311,studied,0,0
22312,were,0,0
22313,operative,0,0
22314,time,0,0
22315,",",0,0
22316,blood,0,0
22317,loss,0,0
22318,",",0,0
22319,blood,0,0
22320,transfusion,0,0
22321,",",0,0
22322,intraoperative,0,1
22323,complications,0,0
22324,",",0,0
22325,postoperative,0,0
22326,complications,0,0
22327,",",0,0
22328,duration,0,0
22329,of,0,0
22330,hospital,0,0
22331,stay,0,0
22332,",",0,0
22333,and,0,0
22334,number,0,0
22335,of,0,0
22336,lymph,0,0
22337,nodes,0,0
22338,obtained,0,0
22339,.,0,0
22340,In,0,0
22341,conclusion,0,0
22342,",",0,0
22343,laparoscopic,1,1
22344,treatment,1,0
22345,of,0,0
22346,endometrial,0,0
22347,cancer,0,0
22348,is,0,0
22349,safe,0,0
22350,in,0,0
22351,the,0,0
22352,hands,0,0
22353,of,0,0
22354,experienced,0,0
22355,operators,0,0
22356,with,0,0
22357,minimal,0,0
22358,intraoperative,0,1
22359,and,0,0
22360,postoperative,0,0
22361,complications,0,0
22362,.,0,0
22363,This,0,0
22364,procedure,0,0
22365,is,0,0
22366,associated,0,0
22367,with,0,0
22368,significantly,0,0
22369,less,0,0
22370,blood,0,0
22371,loss,0,0
22372,and,0,0
22373,shorter,0,0
22374,hospitalization,0,0
22375,;,0,0
22376,however,0,0
22377,",",0,0
22378,it,0,0
22379,is,0,0
22380,associated,0,0
22381,with,0,0
22382,significantly,0,0
22383,longer,0,0
22384,operating,0,0
22385,time,0,0
22386,.,0,0
22387,Proper,0,1
22388,selection,0,0
22389,of,0,0
22390,patients,0,0
22391,for,0,0
22392,the,0,0
22393,laparoscopic,1,1
22394,procedure,1,0
22395,is,0,0
22396,the,0,0
22397,vital,0,0
22398,step,0,0
22399,in,0,0
22400,achieving,0,0
22401,the,0,0
22402,major,0,0
22403,goals,0,0
22404,of,0,0
22405,this,0,0
22406,approach,0,0
22407,.,0,0
22408,Effect,0,0
22409,of,0,0
22410,oxolamine,1,1
22411,on,0,0
22412,cough,0,0
22413,sensitivity,0,0
22414,in,0,0
22415,COPD,0,0
22416,patients,0,0
22417,.,0,0
22418,Effectiveness,0,0
22419,of,0,0
22420,two,0,0
22421,quadruple,0,1
22422,",",0,0
22423,tetracycline-,1,1
22424,or,0,0
22425,clarithromycin-containing,1,1
22426,",",0,0
22427,second-line,0,0
22428,",",0,0
22429,Helicobacter,1,0
22430,pylori,1,0
22431,eradication,1,0
22432,therapies,1,0
22433,.,1,0
22434,BACKGROUND,0,0
22435,There,0,0
22436,are,0,0
22437,no,0,0
22438,guidelines,0,0
22439,on,0,0
22440,second-line,0,0
22441,therapies,0,0
22442,for,0,0
22443,Helicobacter,0,0
22444,pylori,0,0
22445,eradication,0,0
22446,failures,0,0
22447,of,0,0
22448,omeprazole-clarithromycin-amoxicillin,0,1
22449,triple,0,0
22450,therapy,0,1
22451,.,0,0
22452,AIM,0,0
22453,To,0,0
22454,compare,0,0
22455,the,0,0
22456,efficacy,0,0
22457,of,0,0
22458,two,0,0
22459,second-line,0,0
22460,therapies,0,0
22461,for,0,0
22462,persistent,0,0
22463,H.,0,0
22464,pylori,0,0
22465,infection,0,0
22466,.,0,0
22467,METHODS,0,0
22468,Over,0,0
22469,a,0,0
22470,6-year,0,0
22471,period,0,0
22472,",",0,0
22473,patients,0,0
22474,with,0,0
22475,persistent,0,0
22476,H.,0,0
22477,pylori,0,0
22478,infection,0,0
22479,following,0,0
22480,omeprazole-clarithromycin-amoxicillin,1,1
22481,eradication,0,0
22482,therapy,0,1
22483,were,0,0
22484,randomized,0,0
22485,to,0,0
22486,receive,0,0
22487,omeprazole,1,1
22488,",",1,0
22489,20,1,0
22490,mg,1,0
22491,twice,1,0
22492,daily,1,0
22493,",",1,0
22494,bismuth,1,1
22495,",",1,0
22496,120,1,0
22497,mg,1,0
22498,four,1,0
22499,times,1,0
22500,daily,1,0
22501,",",1,0
22502,metronidazole,1,1
22503,",",1,0
22504,500,1,0
22505,mg,1,0
22506,twice,1,0
22507,daily,1,0
22508,",",1,0
22509,and,1,0
22510,either,1,0
22511,tetracycline,1,1
22512,",",1,0
22513,500,1,0
22514,mg,1,0
22515,four,1,0
22516,times,1,0
22517,daily,1,0
22518,",",1,0
22519,or,1,0
22520,clarithromycin,1,1
22521,",",1,0
22522,500,1,0
22523,mg,1,0
22524,twice,1,0
22525,daily,1,0
22526,",",0,0
22527,given,0,0
22528,for,0,0
22529,7,0,0
22530,days,0,0
22531,.,0,0
22532,Before,0,0
22533,therapy,0,0
22534,",",0,0
22535,patients,0,0
22536,underwent,0,0
22537,endoscopy,0,0
22538,with,0,0
22539,biopsies,0,0
22540,for,0,0
22541,histology,0,0
22542,",",0,0
22543,culture,0,0
22544,and,0,0
22545,antibiotic,0,1
22546,susceptibility,0,0
22547,tests,0,0
22548,.,0,0
22549,H.,0,0
22550,pylori,0,0
22551,infection,0,0
22552,was,0,0
22553,confirmed,0,0
22554,by,0,0
22555,histology,0,0
22556,.,0,0
22557,RESULTS,0,0
22558,Of,0,0
22559,the,0,0
22560,95,0,0
22561,randomized,0,0
22562,patients,0,0
22563,",",0,0
22564,88,0,0
22565,(,0,0
22566,93,0,0
22567,%,0,0
22568,),0,0
22569,completed,0,0
22570,the,0,0
22571,study,0,0
22572,.,0,0
22573,Age,0,0
22574,",",0,0
22575,sex,0,0
22576,",",0,0
22577,smoking,0,0
22578,",",0,0
22579,ulcer/non-ulcer,0,0
22580,dyspepsia,0,0
22581,ratio,0,0
22582,and,0,0
22583,antibiotic,0,1
22584,resistance,0,0
22585,were,0,0
22586,not,0,0
22587,significantly,0,0
22588,different,0,0
22589,between,0,0
22590,the,0,0
22591,treatment,0,0
22592,groups,0,0
22593,.,0,0
22594,On,0,0
22595,intention-to-treat,0,0
22596,analysis,0,0
22597,",",0,0
22598,eradication,0,0
22599,was,0,0
22600,achieved,0,0
22601,in,0,0
22602,41,0,0
22603,of,0,0
22604,the,0,0
22605,49,0,0
22606,patients,0,0
22607,(,0,0
22608,84,0,0
22609,%,0,0
22610,;,0,0
22611,95,0,0
22612,%,0,0
22613,confidence,0,0
22614,interval,0,0
22615,",",0,0
22616,70.4-92.7,0,1
22617,%,0,0
22618,),0,0
22619,and,0,0
22620,27,0,0
22621,of,0,0
22622,the,0,0
22623,46,0,0
22624,patients,0,0
22625,(,0,0
22626,59,0,0
22627,%,0,0
22628,;,0,0
22629,95,0,0
22630,%,0,0
22631,confidence,0,0
22632,interval,0,0
22633,",",0,0
22634,43.3-73.0,0,0
22635,%,0,0
22636,),0,0
22637,of,0,0
22638,the,0,0
22639,tetracycline-,0,1
22640,and,0,0
22641,clarithromycin-containing,0,1
22642,groups,0,0
22643,",",0,0
22644,respectively,0,0
22645,(,0,0
22646,P=0.007,0,0
22647,),0,0
22648,.,0,0
22649,On,0,0
22650,multivariate,0,0
22651,regression,0,0
22652,analysis,0,0
22653,",",0,0
22654,the,0,0
22655,sensitivity,0,0
22656,of,0,0
22657,H.,0,0
22658,pylori,0,0
22659,to,0,0
22660,metronidazole,0,1
22661,had,0,0
22662,a,0,0
22663,likelihood,0,0
22664,ratio,0,0
22665,of,0,0
22666,5.2,0,0
22667,(,0,0
22668,P=0.022,0,0
22669,),0,0
22670,",",0,0
22671,followed,0,0
22672,by,0,0
22673,the,0,0
22674,type,0,0
22675,of,0,0
22676,quadruple,0,1
22677,therapy,0,1
22678,(,0,0
22679,likelihood,0,0
22680,ratio,0,0
22681,",",0,0
22682,4.4,0,0
22683,;,0,0
22684,P=0.036,0,0
22685,),0,0
22686,.,0,0
22687,CONCLUSIONS,0,0
22688,Tetracycline-containing,1,1
22689,quadruple,1,1
22690,rescue,1,0
22691,therapy,1,1
22692,is,0,0
22693,highly,0,0
22694,effective,0,0
22695,in,0,0
22696,treating,0,0
22697,H.,0,0
22698,pylori,0,0
22699,eradication,0,0
22700,failures,0,0
22701,of,0,0
22702,the,0,0
22703,omeprazole-amoxicillin-clarithromycin,0,1
22704,regimen,0,0
22705,.,0,0
22706,[,0,0
22707,Clinical,0,0
22708,application,0,0
22709,of,0,0
22710,irradiated,0,0
22711,drug-containing,1,1
22712,porcine-cornea,1,0
22713,to,0,0
22714,patients,0,0
22715,with,0,0
22716,ocular,0,0
22717,burns,0,0
22718,],0,0
22719,.,0,0
22720,OBJECTIVE,0,0
22721,To,0,0
22722,explore,0,0
22723,a,0,0
22724,new,0,0
22725,method,0,0
22726,for,0,0
22727,the,0,0
22728,management,0,0
22729,of,0,0
22730,patients,0,0
22731,with,0,0
22732,ocular,0,0
22733,burns,0,0
22734,.,0,0
22735,METHODS,0,0
22736,Fifty-five,0,0
22737,cases,0,0
22738,of,0,0
22739,patients,0,0
22740,with,0,0
22741,ocular,0,0
22742,burns,0,0
22743,(,0,0
22744,in,0,0
22745,88,0,0
22746,eyes,0,0
22747,),0,0
22748,were,0,0
22749,randomly,0,0
22750,divided,0,0
22751,into,0,0
22752,treatment,0,0
22753,and,0,0
22754,control,0,0
22755,groups,0,0
22756,.,0,0
22757,Thirty,0,0
22758,cases,0,0
22759,in,0,0
22760,treatment,0,0
22761,group,0,0
22762,with,0,0
22763,49,0,0
22764,eyes,0,0
22765,were,0,0
22766,transplanted,0,0
22767,with,0,0
22768,irradiated,1,1
22769,drug-containing,1,1
22770,(,1,0
22771,ofloxacin,1,1
22772,",",1,0
22773,acetyl,1,1
22774,cysteine,1,1
22775,and,1,0
22776,reduced,1,0
22777,glutathione,1,1
22778,),1,0
22779,porcine-cornea,1,0
22780,.,1,0
22781,25,0,0
22782,cases,0,0
22783,in,0,0
22784,control,0,0
22785,group,0,0
22786,with,0,0
22787,39,0,0
22788,eyes,0,0
22789,were,0,0
22790,treated,0,0
22791,with,0,0
22792,routine,0,0
22793,program,0,1
22794,.,0,0
22795,RESULTS,0,0
22796,Thirty-two,0,0
22797,eyes,0,0
22798,were,0,0
22799,rescued,0,0
22800,in,0,0
22801,treatment,0,0
22802,group,0,0
22803,with,0,0
22804,the,0,0
22805,cure,0,0
22806,rate,0,0
22807,of,0,0
22808,65.3,0,0
22809,%,0,0
22810,.,0,0
22811,But,0,0
22812,only,0,0
22813,17,0,0
22814,eyes,0,0
22815,were,0,0
22816,saved,0,0
22817,in,0,0
22818,control,0,0
22819,group,0,0
22820,with,0,0
22821,the,0,0
22822,cure,0,0
22823,rate,0,0
22824,of,0,0
22825,43.59,0,0
22826,%,0,0
22827,",",0,0
22828,indicating,0,0
22829,significant,0,0
22830,difference,0,0
22831,of,0,0
22832,the,0,0
22833,cure,0,0
22834,rate,0,0
22835,between,0,0
22836,the,0,0
22837,two,0,0
22838,groups,0,0
22839,(,0,0
22840,P,0,0
22841,<,0,0
22842,0.05,0,0
22843,),0,0
22844,.,0,0
22845,CONCLUSION,0,0
22846,Irradiated,0,0
22847,drug-containing,0,1
22848,porcine-cornea,1,0
22849,might,0,0
22850,well,0,0
22851,be,0,0
22852,an,0,0
22853,ideal,0,0
22854,therapeutic,0,0
22855,material,0,0
22856,for,0,0
22857,the,0,0
22858,management,0,0
22859,of,0,0
22860,patients,0,0
22861,with,0,0
22862,ocular,0,0
22863,burns,0,0
22864,.,0,0
22865,The,0,0
22866,interaction,0,0
22867,between,0,0
22868,propofol,1,1
22869,and,1,0
22870,clonidine,1,1
22871,for,0,0
22872,loss,0,0
22873,of,0,0
22874,consciousness,0,0
22875,.,0,0
22876,UNLABELLED,0,0
22877,Clonidine,1,1
22878,premedication,0,0
22879,reduces,0,0
22880,the,0,0
22881,intraoperative,0,0
22882,requirement,0,0
22883,for,0,0
22884,opioids,0,1
22885,and,0,0
22886,volatile,0,0
22887,anesthetics,0,1
22888,.,0,0
22889,Clonidine,1,1
22890,also,0,0
22891,reduces,0,0
22892,the,0,0
22893,induction,0,0
22894,dose,0,0
22895,of,0,0
22896,IV,0,0
22897,anesthetics,0,1
22898,.,0,0
22899,There,0,0
22900,is,0,0
22901,no,0,0
22902,information,0,0
22903,",",0,0
22904,however,0,0
22905,",",0,0
22906,regarding,0,0
22907,the,0,0
22908,effect,0,0
22909,of,0,0
22910,oral,0,1
22911,clonidine,1,1
22912,premedication,0,0
22913,on,0,0
22914,the,0,0
22915,propofol,1,1
22916,blood,0,0
22917,concentrations,0,0
22918,required,0,0
22919,for,0,0
22920,loss,0,0
22921,of,0,0
22922,consciousness,0,0
22923,",",0,0
22924,and,0,0
22925,the,0,0
22926,interaction,0,0
22927,between,0,0
22928,propofol,1,1
22929,and,1,0
22930,clonidine,1,1
22931,.,1,0
22932,We,0,0
22933,randomly,0,0
22934,administered,0,0
22935,target,0,0
22936,effect-site,0,0
22937,concentrations,0,0
22938,of,0,0
22939,propofol,1,1
22940,ranging,0,0
22941,from,0,0
22942,0.5,0,0
22943,to,0,0
22944,5,0,0
22945,.,0,0
22946,0,0,0
22947,microg/mL,0,0
22948,by,0,0
22949,using,0,0
22950,computer-assisted,0,1
22951,target-controlled,0,1
22952,infusion,0,1
22953,to,0,0
22954,3,0,0
22955,groups,0,0
22956,of,0,0
22957,healthy,0,0
22958,male,0,0
22959,patients,0,0
22960,:,0,0
22961,Control,1,1
22962,(,1,0
22963,n,1,0
22964,=,1,0
22965,35,1,0
22966,),1,0
22967,",",1,0
22968,2.5,1,0
22969,microg/kg,1,1
22970,Clonidine,1,1
22971,(,1,0
22972,n,1,0
22973,=,1,0
22974,36,1,0
22975,),1,0
22976,",",1,0
22977,and,1,0
22978,5.0,1,0
22979,microg/kg,1,1
22980,Clonidine,1,1
22981,(,1,0
22982,n,1,0
22983,=,1,0
22984,36,1,0
22985,),1,0
22986,groups,1,0
22987,.,1,0
22988,Nothing,1,0
22989,was,1,0
22990,administered,1,0
22991,to,1,0
22992,the,1,0
22993,Control,1,1
22994,group,1,0
22995,.,1,0
22996,Clonidine,1,1
22997,(,0,0
22998,2.5,0,0
22999,or,0,0
23000,5.0,0,0
23001,microg/kg,0,1
23002,),0,0
23003,was,0,0
23004,administered,0,0
23005,orally,0,1
23006,90,0,0
23007,min,0,0
23008,before,0,0
23009,the,0,0
23010,induction,0,0
23011,of,0,0
23012,anesthesia,0,1
23013,in,0,0
23014,the,0,0
23015,Clonidine,1,1
23016,groups,0,0
23017,.,0,0
23018,After,0,0
23019,equilibration,0,0
23020,between,0,0
23021,the,0,0
23022,blood,0,0
23023,and,0,0
23024,effect-site,0,0
23025,for,0,0
23026,15,0,0
23027,min,0,0
23028,",",0,0
23029,a,0,0
23030,verbal,0,1
23031,command,0,0
23032,to,0,0
23033,open,0,0
23034,their,0,0
23035,eyes,0,0
23036,was,0,0
23037,given,0,0
23038,two,0,0
23039,times,0,0
23040,to,0,0
23041,the,0,0
23042,patients,0,0
23043,.,0,0
23044,Arterial,0,0
23045,blood,0,0
23046,samples,0,0
23047,for,0,0
23048,analysis,0,0
23049,of,0,0
23050,the,0,0
23051,serum,0,0
23052,propofol,1,1
23053,and,1,0
23054,clonidine,1,1
23055,concentrations,0,0
23056,were,0,0
23057,taken,0,0
23058,immediately,0,0
23059,before,0,0
23060,verbal,0,0
23061,commands,0,0
23062,were,0,0
23063,given,0,0
23064,.,0,0
23065,Measured,0,0
23066,serum,0,0
23067,propofol,1,1
23068,concentrations,0,0
23069,in,0,0
23070,equilibrium,0,0
23071,with,0,0
23072,the,0,0
23073,effect-site,0,0
23074,at,0,0
23075,which,0,0
23076,50,0,0
23077,%,0,0
23078,of,0,0
23079,the,0,0
23080,patients,0,0
23081,did,0,0
23082,not,0,0
23083,respond,0,0
23084,to,0,0
23085,verbal,0,1
23086,commands,0,1
23087,(,0,0
23088,EC50,0,0
23089,for,0,0
23090,loss,0,0
23091,of,0,0
23092,consciousness,0,0
23093,),0,0
23094,were,0,0
23095,determined,0,0
23096,by,0,0
23097,logistic,0,0
23098,regression,0,0
23099,.,0,0
23100,The,0,0
23101,EC50,0,0
23102,+/-,0,0
23103,SE,0,1
23104,values,0,0
23105,in,0,0
23106,the,0,0
23107,Control,0,1
23108,",",0,0
23109,2.5,0,0
23110,microg/kg,0,0
23111,Clonidine,1,1
23112,",",0,0
23113,and,0,0
23114,5.0,0,0
23115,microg/kg,0,1
23116,Clonidine,1,1
23117,groups,0,0
23118,were,0,0
23119,2.67,0,0
23120,+/-,0,0
23121,0.18,0,0
23122,",",0,0
23123,1.31,0,0
23124,+/-,0,0
23125,0.12,0,0
23126,",",0,0
23127,and,0,0
23128,0.91,0,0
23129,+/-,0,0
23130,0.13,0,0
23131,microg/mL,0,0
23132,",",0,0
23133,respectively,0,0
23134,.,0,0
23135,The,0,0
23136,EC50,0,0
23137,in,0,0
23138,the,0,0
23139,2.5,0,0
23140,and,0,0
23141,5.0,0,0
23142,microg/kg,0,1
23143,clonidine,0,1
23144,groups,0,0
23145,was,0,0
23146,significantly,0,0
23147,smaller,0,0
23148,than,0,0
23149,that,0,0
23150,in,0,0
23151,the,0,0
23152,Control,0,1
23153,group,0,0
23154,(,0,0
23155,P,0,0
23156,<,0,0
23157,0.001,0,0
23158,),0,0
23159,.,0,0
23160,The,0,0
23161,use,0,0
23162,of,0,0
23163,a,0,0
23164,response,0,0
23165,surface,0,0
23166,modeling,0,0
23167,analysis,0,0
23168,indicated,0,0
23169,that,0,0
23170,there,0,0
23171,was,0,0
23172,an,0,0
23173,additive,0,0
23174,interaction,0,0
23175,between,0,0
23176,measured,0,0
23177,arterial,0,0
23178,propofol,1,1
23179,and,1,0
23180,clonidine,1,1
23181,concentrations,0,0
23182,in,0,0
23183,relation,0,0
23184,to,0,0
23185,loss,0,0
23186,of,0,0
23187,consciousness,0,0
23188,.,0,0
23189,These,0,0
23190,results,0,0
23191,indicate,0,0
23192,that,0,0
23193,propofol,0,1
23194,and,0,0
23195,clonidine,0,1
23196,act,0,0
23197,additively,0,0
23198,for,0,0
23199,loss,0,0
23200,of,0,0
23201,consciousness,0,0
23202,.,0,0
23203,IMPLICATIONS,0,0
23204,Oral,0,0
23205,clonidine,1,1
23206,2.5,0,0
23207,and,0,0
23208,5.0,0,0
23209,microg/kg,0,1
23210,premedication,0,0
23211,decreases,0,0
23212,the,0,0
23213,propofol,1,1
23214,concentration,0,0
23215,required,0,0
23216,for,0,0
23217,loss,0,0
23218,of,0,0
23219,consciousness,0,0
23220,.,0,0
23221,A,0,0
23222,role,0,0
23223,for,0,0
23224,error,1,0
23225,training,1,1
23226,in,0,0
23227,surgical,1,0
23228,technical,1,0
23229,skill,1,1
23230,instruction,1,1
23231,and,1,0
23232,evaluation,1,0
23233,.,1,0
23234,BACKGROUND,0,0
23235,During,0,0
23236,the,0,0
23237,evaluation,0,0
23238,of,0,0
23239,many,0,0
23240,instances,0,0
23241,of,0,0
23242,the,0,0
23243,same,0,0
23244,basic,0,1
23245,surgical,0,0
23246,skill,0,0
23247,",",0,0
23248,we,0,0
23249,observed,0,0
23250,that,0,0
23251,there,0,0
23252,were,0,0
23253,several,0,0
23254,errors,0,0
23255,that,0,0
23256,occurred,0,0
23257,frequently,0,0
23258,.,0,0
23259,Two,0,0
23260,studies,0,0
23261,were,0,0
23262,undertaken,0,0
23263,to,0,0
23264,examine,0,0
23265,the,0,0
23266,use,0,0
23267,of,0,0
23268,these,0,0
23269,errors,0,0
23270,for,0,0
23271,improving,0,0
23272,the,0,0
23273,instruction,0,1
23274,and,0,0
23275,evaluation,0,0
23276,of,0,0
23277,the,0,0
23278,skill,0,0
23279,.,0,0
23280,MATERIALS,0,0
23281,AND,0,0
23282,METHODS,0,0
23283,For,0,0
23284,both,0,0
23285,studies,0,0
23286,",",0,0
23287,two,1,0
23288,types,1,0
23289,of,1,0
23290,rater,1,0
23291,training,1,1
23292,videotapes,1,1
23293,were,0,0
23294,developed,0,0
23295,.,0,0
23296,One,0,0
23297,involved,0,0
23298,the,0,0
23299,use,0,0
23300,of,0,0
23301,examples,1,0
23302,of,1,0
23303,common,1,0
23304,errors,1,0
23305,(,1,0
23306,error,1,0
23307,),1,0
23308,and,0,0
23309,the,0,0
23310,other,0,0
23311,demonstrated,0,0
23312,the,0,0
23313,skill,1,0
23314,being,1,0
23315,performed,1,0
23316,correctly,1,0
23317,(,1,0
23318,correct,1,0
23319,),1,0
23320,.,0,0
23321,A,0,0
23322,testing,0,0
23323,videotape,0,1
23324,was,0,0
23325,created,0,0
23326,consisting,0,0
23327,of,0,0
23328,24,0,0
23329,performances,0,0
23330,of,0,0
23331,the,0,0
23332,skill,0,0
23333,that,0,0
23334,ranged,0,0
23335,in,0,0
23336,quality,0,0
23337,of,0,0
23338,the,0,0
23339,performance,0,0
23340,.,0,0
23341,The,0,0
23342,first,0,0
23343,study,0,0
23344,was,0,0
23345,designed,0,0
23346,to,0,0
23347,assess,0,0
23348,the,0,0
23349,impact,0,0
23350,of,0,0
23351,error,1,0
23352,instruction,1,1
23353,on,0,0
23354,skill,0,0
23355,acquisition,0,0
23356,.,0,0
23357,In,0,0
23358,this,0,0
23359,study,0,0
23360,",",0,0
23361,a,0,0
23362,group,0,0
23363,of,0,0
23364,30,0,0
23365,senior,0,0
23366,medical,0,0
23367,students,0,0
23368,were,0,0
23369,randomly,0,0
23370,assigned,0,0
23371,to,0,0
23372,one,0,0
23373,of,0,0
23374,four,0,0
23375,different,0,0
23376,training,0,1
23377,groups,0,0
23378,:,0,0
23379,none,1,0
23380,",",1,0
23381,error,1,0
23382,only,1,0
23383,",",1,0
23384,correct,1,0
23385,only,1,0
23386,",",1,0
23387,and,1,0
23388,error+correct,1,1
23389,.,1,0
23390,Subjects,0,0
23391,were,0,0
23392,videotaped,0,1
23393,performing,0,0
23394,the,0,0
23395,skill,0,1
23396,before,0,0
23397,and,0,0
23398,after,0,0
23399,the,0,0
23400,training,0,1
23401,and,0,0
23402,three,0,0
23403,experts,0,0
23404,evaluated,0,0
23405,these,0,0
23406,performances,0,0
23407,independently,0,0
23408,using,0,0
23409,a,0,0
23410,7-point,0,0
23411,rating,0,0
23412,scale,0,0
23413,.,0,0
23414,The,0,0
23415,second,0,0
23416,study,0,0
23417,was,0,0
23418,designed,0,0
23419,to,0,0
23420,assess,0,0
23421,the,0,0
23422,impact,0,0
23423,of,0,0
23424,error,1,0
23425,training,1,1
23426,on,0,0
23427,skill,0,1
23428,evaluation,0,0
23429,and,0,0
23430,was,0,0
23431,done,0,0
23432,using,0,0
23433,both,0,0
23434,novice,0,0
23435,and,0,0
23436,expert,0,0
23437,raters,0,0
23438,.,0,0
23439,The,0,0
23440,same,0,0
23441,group,0,0
23442,of,0,0
23443,30,0,0
23444,senior,0,0
23445,medical,0,0
23446,students,0,0
23447,used,0,0
23448,in,0,0
23449,the,0,0
23450,first,0,0
23451,study,0,0
23452,was,0,0
23453,used,0,0
23454,as,0,0
23455,novice,0,0
23456,raters,0,0
23457,.,0,0
23458,Following,0,0
23459,training,0,1
23460,in,0,0
23461,one,0,0
23462,of,0,0
23463,the,0,0
23464,four,0,0
23465,training,0,1
23466,groups,0,0
23467,",",0,0
23468,each,0,0
23469,subject,0,0
23470,rated,0,0
23471,the,0,0
23472,24,0,0
23473,performances,0,0
23474,on,0,0
23475,the,0,0
23476,testing,1,0
23477,videotape,1,1
23478,and,1,0
23479,interrater,1,0
23480,reliability,1,0
23481,was,0,0
23482,assessed,0,0
23483,for,0,0
23484,each,0,0
23485,group,0,0
23486,.,0,0
23487,Surgical,0,0
23488,faculty,0,0
23489,served,0,0
23490,as,0,0
23491,expert,0,0
23492,raters,0,0
23493,in,0,0
23494,this,0,0
23495,study,0,0
23496,and,0,0
23497,were,0,0
23498,randomly,0,0
23499,assigned,0,0
23500,to,0,0
23501,receive,0,0
23502,either,0,0
23503,error,1,0
23504,training,1,1
23505,or,0,1
23506,no,1,0
23507,training,1,1
23508,.,1,0
23509,Each,0,0
23510,subject,0,0
23511,viewed,0,0
23512,the,0,0
23513,testing,0,0
23514,videotape,0,1
23515,",",0,0
23516,rating,0,0
23517,the,0,0
23518,performances,0,0
23519,and,0,0
23520,giving,0,0
23521,feedback,0,1
23522,commentary,0,0
23523,.,0,0
23524,Interrater,0,0
23525,reliability,0,0
23526,was,0,0
23527,calculated,0,0
23528,for,0,0
23529,the,0,0
23530,two,0,0
23531,groups,0,0
23532,and,0,0
23533,the,0,0
23534,precision,0,0
23535,of,0,0
23536,the,0,0
23537,feedback,0,1
23538,was,0,0
23539,assessed,0,0
23540,.,0,0
23541,RESULTS,0,0
23542,Significant,0,0
23543,improvement,0,0
23544,in,0,0
23545,posttest,0,0
23546,performance,0,0
23547,scores,0,0
23548,was,0,0
23549,seen,0,0
23550,only,0,0
23551,in,0,0
23552,the,0,0
23553,error+correct,1,1
23554,training,0,1
23555,group,0,0
23556,.,0,0
23557,Interrater,0,0
23558,reliability,0,0
23559,was,0,0
23560,somewhat,0,0
23561,lower,0,0
23562,for,0,0
23563,the,0,0
23564,correct,1,0
23565,only,1,0
23566,and,0,0
23567,error,1,0
23568,only,1,0
23569,training,0,1
23570,groups,0,0
23571,in,0,0
23572,both,0,0
23573,the,0,0
23574,student,0,0
23575,and,0,0
23576,faculty,0,0
23577,studies,0,0
23578,.,0,0
23579,Faculty,0,0
23580,raters,0,0
23581,receiving,0,0
23582,error,0,0
23583,training,0,1
23584,had,0,0
23585,a,0,0
23586,higher,0,0
23587,proportion,0,0
23588,of,0,0
23589,specific,0,0
23590,comments,0,0
23591,than,0,0
23592,the,0,0
23593,group,0,0
23594,that,0,0
23595,received,0,0
23596,no,0,0
23597,training,0,1
23598,although,0,0
23599,this,0,0
23600,difference,0,0
23601,was,0,0
23602,not,0,0
23603,statistically,0,0
23604,significant,0,0
23605,.,0,0
23606,CONCLUSIONS,0,0
23607,Instruction,0,0
23608,about,0,0
23609,common,1,0
23610,errors,1,0
23611,",",0,0
23612,when,0,0
23613,combined,0,0
23614,with,0,0
23615,instruction,0,1
23616,about,0,0
23617,the,0,0
23618,correct,0,0
23619,performance,0,0
23620,enhanced,0,0
23621,the,0,0
23622,acquisition,0,0
23623,of,0,0
23624,this,0,0
23625,surgical,0,0
23626,skill,0,0
23627,.,0,0
23628,This,0,0
23629,suggests,0,0
23630,a,0,0
23631,role,0,0
23632,for,0,0
23633,the,0,0
23634,use,0,0
23635,of,0,0
23636,errors,0,0
23637,in,0,0
23638,surgical,1,0
23639,technical,1,0
23640,skill,1,1
23641,instruction,1,1
23642,.,1,0
23643,Our,0,0
23644,study,0,0
23645,provides,0,0
23646,no,0,0
23647,support,0,0
23648,for,0,0
23649,a,0,0
23650,role,0,0
23651,for,0,0
23652,error,1,0
23653,training,1,1
23654,in,0,0
23655,improving,0,0
23656,skill,0,0
23657,evaluation,0,0
23658,.,0,0
23659,Diet,1,1
23660,and,0,0
23661,tobacco,0,1
23662,use,0,0
23663,:,0,0
23664,analysis,0,0
23665,of,0,0
23666,data,0,0
23667,from,0,0
23668,the,0,0
23669,diabetic,0,0
23670,control,0,0
23671,and,0,0
23672,complications,0,0
23673,trial,0,0
23674,",",0,0
23675,a,0,0
23676,randomized,0,0
23677,study,0,0
23678,.,0,0
23679,CONTEXT,0,0
23680,The,0,0
23681,Diabetic,0,0
23682,Control,0,1
23683,and,0,0
23684,Complications,0,0
23685,Trial,0,1
23686,(,0,0
23687,DCCT,0,1
23688,),0,0
23689,researchers,0,0
23690,kept,0,0
23691,careful,0,0
23692,records,0,0
23693,of,0,0
23694,the,0,0
23695,food,0,0
23696,consumption,0,0
23697,and,0,0
23698,tobacco,0,1
23699,using,0,0
23700,habits,0,0
23701,of,0,0
23702,type,0,0
23703,1,0,0
23704,diabetic,0,0
23705,subjects,0,0
23706,.,0,0
23707,However,0,0
23708,",",0,0
23709,they,0,0
23710,did,0,0
23711,not,0,0
23712,report,0,0
23713,the,0,0
23714,relationship,0,0
23715,of,0,0
23716,tobacco,0,1
23717,using,0,0
23718,habits,0,0
23719,with,0,0
23720,dietary,0,0
23721,intake,0,0
23722,.,0,0
23723,OBJECTIVE,0,0
23724,Analyze,0,0
23725,the,0,0
23726,relationship,0,0
23727,between,0,0
23728,tobacco,0,1
23729,smoking,0,1
23730,and,0,0
23731,intake,1,0
23732,of,1,0
23733,macro,1,0
23734,and,1,0
23735,micronutrients,1,0
23736,.,1,0
23737,DESIGN,0,0
23738,Randomized,0,0
23739,controlled,0,0
23740,trial,0,0
23741,.,0,0
23742,SETTING,0,0
23743,Referral,0,0
23744,clinics,0,0
23745,in,0,0
23746,27,0,0
23747,academic,0,0
23748,centers,0,0
23749,.,0,0
23750,PATIENTS,0,0
23751,Type,0,0
23752,1,0,0
23753,diabetics,0,0
23754,.,0,0
23755,INTERVENTION,0,0
23756,Using,0,0
23757,the,0,0
23758,data,1,0
23759,sets,1,0
23760,of,1,0
23761,the,1,0
23762,DCCT,1,0
23763,",",0,0
23764,this,0,0
23765,study,0,0
23766,analyzed,0,0
23767,the,0,0
23768,strengths,0,0
23769,of,0,0
23770,the,0,0
23771,associations,0,0
23772,between,0,0
23773,smoking,0,0
23774,and,0,0
23775,macronutrient,1,1
23776,consumption,1,0
23777,",",0,0
23778,hemoglobin,0,0
23779,A1c,0,1
23780,(,0,0
23781,HbA1c,0,1
23782,),0,0
23783,",",0,0
23784,body,0,0
23785,mass,0,0
23786,index,0,0
23787,(,0,0
23788,BMI,0,0
23789,),0,0
23790,",",0,0
23791,and,0,0
23792,serum,0,0
23793,lipid,0,0
23794,levels,0,0
23795,at,0,0
23796,the,0,0
23797,study,0,0
23798,baseline,0,0
23799,",",0,0
23800,2,0,0
23801,years,0,0
23802,",",0,0
23803,and,0,0
23804,4,0,0
23805,years,0,0
23806,.,0,0
23807,MAIN,0,0
23808,OUTCOME,0,0
23809,MEASURES,0,0
23810,Statistically,0,0
23811,significant,0,0
23812,correlations,0,0
23813,between,0,0
23814,smoking,0,0
23815,and,0,0
23816,nutrient,0,1
23817,intake,0,0
23818,",",0,0
23819,HbA1c,0,1
23820,",",0,0
23821,and,0,0
23822,serum,0,0
23823,lipid,0,0
23824,levels,0,0
23825,.,0,0
23826,RESULTS,0,0
23827,Cigarette,0,1
23828,",",0,0
23829,cigar,0,1
23830,",",0,0
23831,or,0,1
23832,pipe,0,1
23833,use,0,0
23834,at,0,0
23835,each,0,0
23836,time,0,0
23837,interval,0,0
23838,correlated,0,0
23839,with,0,0
23840,significantly,0,0
23841,increased,0,0
23842,caloric,0,1
23843,intake,0,0
23844,in,0,0
23845,males,0,0
23846,but,0,0
23847,not,0,0
23848,in,0,0
23849,females,0,0
23850,.,0,0
23851,In,0,0
23852,both,0,0
23853,males,0,0
23854,and,0,0
23855,females,0,0
23856,",",0,0
23857,tobacco,0,1
23858,users,0,0
23859,consumed,0,0
23860,more,0,0
23861,fat,0,0
23862,",",0,0
23863,cholesterol,0,0
23864,",",0,0
23865,and,0,0
23866,alcohol,0,0
23867,.,0,0
23868,Female,0,0
23869,smokers,0,0
23870,had,0,0
23871,higher,0,0
23872,serum,0,0
23873,low-density,0,0
23874,lipoprotein,0,0
23875,(,0,0
23876,LDL,0,0
23877,),0,1
23878,/high-density,0,0
23879,lipoprotein,0,0
23880,(,0,0
23881,HDL,0,1
23882,),0,0
23883,ratios,0,0
23884,and,0,0
23885,triglycerides,0,0
23886,.,0,0
23887,Serum,0,0
23888,cholesterols,0,0
23889,",",0,0
23890,LDL/HDL,0,0
23891,ratios,0,0
23892,",",0,0
23893,LDL,0,0
23894,cholesterols,0,0
23895,",",0,0
23896,and,0,0
23897,triglyceride,0,0
23898,determinations,0,0
23899,in,0,0
23900,male,0,0
23901,tobacco,0,1
23902,users,0,0
23903,significantly,0,0
23904,exceeded,0,0
23905,those,0,0
23906,in,0,0
23907,nonsmoking,0,0
23908,males,0,0
23909,.,0,0
23910,HDL,0,0
23911,cholesterols,0,0
23912,were,0,0
23913,lower,0,0
23914,in,0,0
23915,both,0,0
23916,female,0,0
23917,and,0,0
23918,male,0,0
23919,tobacco,0,1
23920,users,0,0
23921,.,0,0
23922,Nutrient,0,0
23923,intake,0,0
23924,of,0,0
23925,former,0,0
23926,tobacco,0,1
23927,users,0,0
23928,resembled,0,0
23929,that,0,0
23930,of,0,0
23931,nonusers,0,0
23932,rather,0,0
23933,than,0,0
23934,current,0,0
23935,users,0,0
23936,.,0,0
23937,CONCLUSIONS,0,0
23938,A,0,0
23939,significant,0,0
23940,association,0,0
23941,exists,0,0
23942,between,0,0
23943,smoking,0,0
23944,and,0,0
23945,a,0,0
23946,diet,0,1
23947,with,0,0
23948,higher,0,0
23949,risks,0,0
23950,of,0,0
23951,atherosclerosis,0,0
23952,",",0,0
23953,cancer,0,0
23954,",",0,0
23955,and,0,0
23956,other,0,0
23957,degenerative,0,0
23958,diseases,0,0
23959,.,0,0
23960,The,0,0
23961,strong,0,0
23962,association,0,0
23963,of,0,0
23964,tobacco,0,1
23965,with,0,0
23966,heart,0,0
23967,disease,0,0
23968,",",0,0
23969,stroke,0,0
23970,",",0,0
23971,vasculopathies,0,0
23972,",",0,0
23973,and,0,0
23974,various,0,0
23975,malignancies,0,0
23976,may,0,0
23977,be,0,0
23978,in,0,0
23979,part,0,0
23980,due,0,0
23981,to,0,0
23982,its,0,0
23983,association,0,0
23984,with,0,0
23985,a,0,0
23986,higher,0,0
23987,fat,0,0
23988,diet,0,1
23989,.,0,0
23990,The,0,0
23991,higher,0,0
23992,fat,0,0
23993,diet,0,1
23994,of,0,0
23995,tobacco,0,1
23996,users,0,0
23997,probably,0,0
23998,accounts,0,0
23999,in,0,0
24000,part,0,0
24001,for,0,0
24002,their,0,0
24003,higher,0,0
24004,risk,0,0
24005,of,0,0
24006,developing,0,0
24007,type,0,0
24008,2,0,0
24009,diabetes,0,0
24010,and,0,0
24011,hyperlipidemia,0,0
24012,.,0,0
24013,Tobacco,0,0
24014,users,0,0
24015,should,0,0
24016,be,0,0
24017,informed,0,0
24018,about,0,0
24019,the,0,0
24020,diet,0,1
24021,and,0,0
24022,tobacco,0,1
24023,use,0,0
24024,association,0,0
24025,.,0,0
24026,Metformin,1,1
24027,does,0,0
24028,not,0,0
24029,enhance,0,0
24030,ovulation,0,0
24031,induction,0,0
24032,in,0,0
24033,clomiphene,0,1
24034,resistant,0,0
24035,polycystic,0,0
24036,ovary,0,0
24037,syndrome,0,0
24038,in,0,0
24039,clinical,0,0
24040,practice,0,0
24041,.,0,0
24042,AIMS,0,0
24043,To,0,0
24044,determine,0,0
24045,whether,0,0
24046,metformin,1,1
24047,pretreatment,1,0
24048,has,0,0
24049,beneficial,0,0
24050,effects,0,0
24051,in,0,0
24052,clomiphene,0,1
24053,resistant,0,0
24054,infertile,0,0
24055,women,0,0
24056,with,0,0
24057,polycystic,0,0
24058,ovary,0,0
24059,syndrome,0,0
24060,(,0,0
24061,PCOS,0,0
24062,),0,0
24063,in,0,0
24064,an,0,0
24065,infertility,0,0
24066,clinic,0,0
24067,.,0,0
24068,METHODS,0,0
24069,This,0,0
24070,was,0,0
24071,a,0,0
24072,randomized,0,0
24073,placebo,0,1
24074,controlled,0,0
24075,double-blind,0,0
24076,crossover,0,0
24077,study,0,0
24078,of,0,0
24079,3,0,0
24080,months,0,0
24081,metformin,1,1
24082,(,0,0
24083,1500,0,0
24084,mg,0,1
24085,day-1,1,0
24086,),1,0
24087,/placebo,1,0
24088,",",0,0
24089,followed,0,0
24090,by,0,0
24091,3,0,0
24092,months,0,0
24093,metformin/placebo,1,1
24094,together,1,0
24095,with,1,0
24096,clomiphene,1,1
24097,(,0,0
24098,50-100,0,0
24099,mg,0,1
24100,for,0,0
24101,5,0,0
24102,days,0,0
24103,),0,0
24104,for,0,0
24105,three,0,0
24106,cycles,0,0
24107,in,0,0
24108,clomiphene,0,1
24109,resistant,0,0
24110,women,0,0
24111,with,0,0
24112,PCOS,0,0
24113,.,0,0
24114,The,0,0
24115,primary,0,0
24116,outcomes,0,0
24117,were,0,0
24118,restoration,0,0
24119,of,0,0
24120,spontaneous,0,0
24121,menses,0,0
24122,",",0,0
24123,ovulation,0,0
24124,induction,0,1
24125,(,0,0
24126,spontaneous,0,0
24127,or,0,1
24128,clomiphene,0,1
24129,induced,0,0
24130,),0,0
24131,and,0,0
24132,pregnancy,0,0
24133,.,0,0
24134,Secondary,0,0
24135,endpoints,0,0
24136,were,0,0
24137,changes,0,0
24138,in,0,0
24139,biochemical,0,0
24140,parameters,0,0
24141,related,0,0
24142,to,0,0
24143,androgens,0,0
24144,and,0,0
24145,insulin,0,0
24146,.,0,0
24147,RESULTS,0,0
24148,Twelve,0,0
24149,women,0,0
24150,completed,0,0
24151,the,0,0
24152,metformin,1,1
24153,arm,0,0
24154,and,0,0
24155,14,0,0
24156,the,0,0
24157,placebo,1,1
24158,arm,0,0
24159,.,0,0
24160,Spontaneous,0,0
24161,menstruation,0,0
24162,resumed,0,0
24163,in,0,0
24164,five,0,0
24165,metformin,1,1
24166,treated,0,0
24167,patients,0,0
24168,and,0,0
24169,in,0,0
24170,six,0,0
24171,placebo,1,1
24172,treated,0,0
24173,women,0,0
24174,",",0,0
24175,P=0.63,0,0
24176,.,0,0
24177,No,0,0
24178,women,0,0
24179,given,0,0
24180,metformin,0,1
24181,spontaneously,0,0
24182,ovulated,0,0
24183,",",0,0
24184,although,0,0
24185,one,0,0
24186,patient,0,0
24187,given,0,0
24188,placebo,1,1
24189,did,0,0
24190,",",0,0
24191,P=0.30,0,0
24192,.,0,0
24193,There,0,0
24194,was,0,0
24195,no,0,0
24196,difference,0,0
24197,in,0,0
24198,the,0,0
24199,efficacy,0,0
24200,of,0,0
24201,clomiphene,0,1
24202,between,0,0
24203,the,0,0
24204,two,0,0
24205,groups,0,0
24206,with,0,0
24207,ovulation,0,0
24208,being,0,0
24209,induced,0,0
24210,in,0,0
24211,five,0,0
24212,(,0,0
24213,out,0,0
24214,of,0,0
24215,12,0,0
24216,),0,0
24217,metformin,1,1
24218,treated,0,0
24219,women,0,0
24220,and,0,0
24221,four,0,0
24222,(,0,0
24223,out,0,0
24224,of,0,0
24225,14,0,0
24226,),0,0
24227,placebo,1,1
24228,treated,0,0
24229,women,0,0
24230,",",0,0
24231,P=0.63,0,0
24232,.,0,0
24233,Pregnancy,0,0
24234,occurred,0,0
24235,in,0,0
24236,three,0,0
24237,(,0,0
24238,out,0,0
24239,of,0,0
24240,12,0,0
24241,),0,0
24242,women,0,0
24243,given,0,0
24244,metformin,1,1
24245,and,0,0
24246,two,0,0
24247,(,0,0
24248,out,0,0
24249,of,0,0
24250,14,0,0
24251,),0,0
24252,women,0,0
24253,given,0,0
24254,placebo,1,1
24255,",",0,0
24256,P=0.59,0,0
24257,.,0,0
24258,CONCLUSIONS,0,0
24259,Metformin,1,1
24260,is,0,0
24261,not,0,0
24262,always,0,0
24263,beneficial,0,0
24264,when,0,0
24265,given,0,0
24266,to,0,0
24267,clomiphene,0,1
24268,resistant,0,0
24269,infertile,0,0
24270,women,0,0
24271,with,0,0
24272,PCOS,0,0
24273,in,0,0
24274,clinical,0,0
24275,practice,0,0
24276,.,0,0
24277,The,0,0
24278,influence,0,0
24279,of,0,0
24280,placebo,0,1
24281,awareness,0,0
24282,on,0,0
24283,stimulant,0,1
24284,drug,0,0
24285,response,0,0
24286,in,0,0
24287,a,0,0
24288,double-blind,0,0
24289,trial,0,0
24290,.,0,0
24291,RATIONALE,0,0
24292,Critics,0,0
24293,have,0,0
24294,called,0,0
24295,into,0,0
24296,question,0,0
24297,findings,0,0
24298,from,0,0
24299,double-blind,0,0
24300,placebo-controlled,0,1
24301,studies,0,0
24302,because,0,0
24303,subjects,0,0
24304,are,0,0
24305,given,0,0
24306,drug,0,0
24307,administration,0,0
24308,instructions,0,1
24309,informing,0,0
24310,them,0,0
24311,of,0,0
24312,a,0,0
24313,placebo,0,1
24314,condition,0,0
24315,.,0,0
24316,The,0,0
24317,assertion,0,0
24318,that,0,0
24319,these,0,0
24320,drug,0,0
24321,administration,0,0
24322,instructions,0,1
24323,bias,0,0
24324,estimates,0,0
24325,of,0,0
24326,effectiveness,0,0
24327,has,0,0
24328,undergone,0,0
24329,surprisingly,0,0
24330,little,0,0
24331,empirical,0,0
24332,investigation,0,0
24333,.,0,0
24334,OBJECTIVES,0,0
24335,The,0,0
24336,primary,0,0
24337,objective,0,0
24338,of,0,0
24339,this,0,0
24340,study,0,0
24341,was,0,0
24342,to,0,0
24343,determine,0,0
24344,whether,0,0
24345,drug,0,0
24346,administration,0,0
24347,instructions,0,1
24348,informing,0,0
24349,subjects,0,0
24350,of,0,0
24351,a,0,0
24352,placebo,1,1
24353,condition,0,0
24354,affect,0,0
24355,the,0,0
24356,drug,0,0
24357,response,0,0
24358,and,0,0
24359,affect,0,0
24360,the,0,0
24361,saliva,0,0
24362,concentration,0,0
24363,of,0,0
24364,the,0,0
24365,stimulant,0,0
24366,.,0,0
24367,METHODS,0,0
24368,We,0,0
24369,assessed,0,0
24370,caffeine,0,1
24371,responses,0,0
24372,and,0,0
24373,levels,0,0
24374,of,0,0
24375,saliva,0,0
24376,concentration,0,0
24377,of,0,0
24378,caffeine,0,1
24379,in,0,0
24380,52,0,0
24381,subjects,0,0
24382,who,0,0
24383,were,0,0
24384,randomly,0,0
24385,assigned,0,0
24386,to,0,0
24387,receive,0,0
24388,one,0,0
24389,of,0,0
24390,two,0,0
24391,drug,0,0
24392,administration,0,0
24393,instructions,0,1
24394,:,0,0
24395,(,0,0
24396,a,0,0
24397,),0,0
24398,placebo-informed,1,0
24399,instructions,1,1
24400,(,0,0
24401,i.e.,0,0
24402,",",0,0
24403,individuals,1,0
24404,informed,1,0
24405,of,1,0
24406,the,1,0
24407,placebo,1,1
24408,),1,0
24409,analogous,0,0
24410,to,0,0
24411,those,0,0
24412,used,0,0
24413,in,0,0
24414,double-blind,0,0
24415,studies,0,0
24416,and,0,0
24417,(,0,0
24418,b,0,0
24419,),0,0
24420,placebo-uninformed,1,0
24421,instructions,1,1
24422,(,0,0
24423,i.e.,0,0
24424,",",0,0
24425,individuals,1,0
24426,informed,1,0
24427,they,1,0
24428,are,1,0
24429,taking,1,0
24430,an,1,0
24431,active,1,1
24432,stimulant,1,0
24433,),1,0
24434,.,0,0
24435,RESULTS,0,0
24436,On,0,0
24437,most,0,0
24438,measures,0,0
24439,(,0,0
24440,systolic,0,0
24441,blood,0,0
24442,pressure,0,0
24443,",",0,0
24444,heart,0,0
24445,rate,0,0
24446,",",0,0
24447,hand,0,1
24448,steadiness,0,0
24449,",",0,0
24450,reaction,0,0
24451,time,0,0
24452,",",0,0
24453,fatigue,0,0
24454,",",0,0
24455,and,0,0
24456,tension,0,0
24457,),0,0
24458,",",0,0
24459,drug,0,0
24460,administration,0,0
24461,instructions,0,1
24462,did,0,0
24463,not,0,0
24464,significantly,0,0
24465,influence,0,0
24466,caffeine,0,1
24467,response,0,0
24468,.,0,0
24469,Instructions,0,0
24470,also,0,0
24471,had,0,0
24472,no,0,0
24473,significant,0,0
24474,effect,0,0
24475,on,0,0
24476,saliva,0,0
24477,concentration,0,0
24478,of,0,0
24479,caffeine,0,1
24480,.,0,0
24481,However,0,0
24482,",",0,0
24483,only,0,0
24484,individuals,0,0
24485,who,0,0
24486,were,0,0
24487,uninformed,0,0
24488,of,0,0
24489,the,0,0
24490,placebo,0,1
24491,condition,0,0
24492,showed,0,0
24493,significant,0,0
24494,diastolic,0,0
24495,blood,0,0
24496,pressure,0,0
24497,and,0,0
24498,vigor,0,0
24499,increases,0,0
24500,with,0,0
24501,125,0,0
24502,mg,0,0
24503,caffeine,1,1
24504,",",0,0
24505,and,0,0
24506,significant,0,0
24507,hand,0,1
24508,steadiness,0,0
24509,impairment,0,0
24510,and,0,0
24511,vigor,0,0
24512,increases,0,0
24513,with,0,0
24514,325,0,0
24515,mg,0,0
24516,caffeine,1,1
24517,compared,0,0
24518,to,0,0
24519,placebo,0,1
24520,.,0,0
24521,CONCLUSIONS,0,0
24522,These,0,0
24523,overall,0,0
24524,findings,0,0
24525,suggest,0,0
24526,that,0,0
24527,a,0,0
24528,limited,0,0
24529,bias,0,0
24530,is,0,0
24531,introduced,0,0
24532,by,0,0
24533,drug,0,0
24534,administration,0,0
24535,instructions,0,1
24536,.,0,0
24537,The,0,0
24538,results,0,0
24539,do,0,0
24540,not,0,0
24541,support,0,0
24542,any,0,0
24543,suggestion,0,0
24544,that,0,0
24545,information,0,0
24546,about,0,0
24547,the,0,0
24548,existence,0,0
24549,of,0,0
24550,a,0,0
24551,placebo,0,1
24552,condition,0,0
24553,dramatically,0,0
24554,influences,0,0
24555,conclusions,0,0
24556,drawn,0,0
24557,about,0,0
24558,drug,0,0
24559,responses,0,0
24560,in,0,0
24561,placebo-controlled,0,1
24562,trials,0,0
24563,.,0,0
24564,Thiabendazole,1,1
24565,for,0,0
24566,the,0,0
24567,prophylaxis,0,0
24568,of,0,0
24569,strongyloidiasis,0,0
24570,in,0,0
24571,immunosuppressed,0,0
24572,patients,0,0
24573,with,0,0
24574,hematological,0,0
24575,diseases,0,0
24576,:,0,0
24577,a,0,0
24578,randomized,0,0
24579,double-blind,0,0
24580,placebo-controlled,1,1
24581,study,0,0
24582,.,0,0
24583,Do,0,0
24584,colonic,0,0
24585,short-chain,0,0
24586,fatty,0,1
24587,acids,0,1
24588,contribute,0,0
24589,to,0,0
24590,the,0,0
24591,long-term,0,0
24592,adaptation,0,0
24593,of,0,0
24594,blood,0,0
24595,lipids,0,0
24596,in,0,0
24597,subjects,0,0
24598,with,0,0
24599,type,0,0
24600,2,0,0
24601,diabetes,0,0
24602,consuming,0,0
24603,a,0,0
24604,high-fiber,1,1
24605,diet,1,1
24606,?,0,0
24607,BACKGROUND,0,0
24608,We,0,0
24609,recently,0,0
24610,obtained,0,0
24611,evidence,0,0
24612,of,0,0
24613,long-term,0,0
24614,adaptation,0,0
24615,of,0,0
24616,blood,0,0
24617,lipids,0,0
24618,to,0,0
24619,changes,0,0
24620,in,0,0
24621,intakes,0,0
24622,of,0,0
24623,carbohydrate,1,1
24624,and,1,0
24625,fiber,1,1
24626,in,0,0
24627,subjects,0,0
24628,with,0,0
24629,type,0,0
24630,2,0,0
24631,diabetes,0,0
24632,.,0,0
24633,OBJECTIVE,0,0
24634,We,0,0
24635,determined,0,0
24636,the,0,0
24637,effect,0,0
24638,of,0,0
24639,increased,1,0
24640,carbohydrate,1,1
24641,and,1,0
24642,fiber,1,1
24643,intakes,1,0
24644,on,0,0
24645,serum,0,0
24646,short-chain,0,0
24647,fatty,0,1
24648,acids,0,1
24649,(,0,0
24650,SCFAs,0,0
24651,),0,0
24652,and,0,0
24653,the,0,0
24654,relation,0,0
24655,between,0,0
24656,changes,0,0
24657,in,0,0
24658,serum,0,0
24659,acetate,0,1
24660,and,0,0
24661,changes,0,0
24662,in,0,0
24663,blood,0,0
24664,lipids,0,0
24665,.,0,0
24666,DESIGN,0,0
24667,Subjects,0,0
24668,with,0,0
24669,type,0,0
24670,2,0,0
24671,diabetes,0,0
24672,(,0,0
24673,n,0,0
24674,=,0,0
24675,62,0,0
24676,),0,0
24677,were,0,0
24678,randomly,0,0
24679,assigned,0,0
24680,to,0,0
24681,receive,0,0
24682,approximately,0,0
24683,10,0,0
24684,%,0,0
24685,of,0,0
24686,energy,1,0
24687,from,1,0
24688,low-fiber,1,1
24689,breakfast,1,1
24690,cereal,1,1
24691,(,1,0
24692,LF,1,0
24693,diet,1,1
24694,),1,0
24695,",",1,0
24696,high-fiber,1,1
24697,breakfast,1,1
24698,cereal,1,1
24699,(,1,0
24700,HF,1,0
24701,diet,1,1
24702,),1,0
24703,",",1,0
24704,or,1,1
24705,monounsaturated,1,1
24706,fatty,1,1
24707,acids,1,1
24708,(,1,0
24709,MUFA,1,1
24710,diet,1,1
24711,),1,0
24712,for,0,0
24713,6,0,0
24714,mo,0,0
24715,.,0,0
24716,RESULTS,0,0
24717,Carbohydrate,0,1
24718,intakes,0,0
24719,were,0,0
24720,higher,0,0
24721,in,0,0
24722,the,0,0
24723,LF,0,0
24724,and,0,0
24725,HF,0,0
24726,groups,0,0
24727,than,0,0
24728,in,0,0
24729,the,0,0
24730,MUFA,0,1
24731,group,0,0
24732,(,0,0
24733,54,0,0
24734,%,0,0
24735,compared,0,0
24736,with,0,0
24737,43,0,0
24738,%,0,0
24739,),0,0
24740,",",0,0
24741,and,0,0
24742,more,0,0
24743,fiber,0,1
24744,was,0,0
24745,consumed,0,0
24746,by,0,0
24747,the,0,0
24748,HF,0,0
24749,group,0,0
24750,(,0,0
24751,approximately,0,0
24752,50,0,0
24753,g/d,0,1
24754,),0,0
24755,than,0,0
24756,by,0,0
24757,the,0,0
24758,LF,0,0
24759,or,0,1
24760,MUFA,0,1
24761,group,0,0
24762,(,0,0
24763,approximately,0,0
24764,23,0,0
24765,g/d,0,1
24766,),0,0
24767,.,0,0
24768,Fasting,0,0
24769,serum,0,0
24770,SCFAs,0,0
24771,did,0,0
24772,not,0,0
24773,change,0,0
24774,significantly,0,0
24775,over,0,0
24776,the,0,0
24777,first,0,0
24778,3,0,0
24779,mo,0,0
24780,.,0,0
24781,Between,0,0
24782,3,0,0
24783,and,0,0
24784,6,0,0
24785,mo,0,0
24786,",",0,0
24787,serum,0,0
24788,acetate,0,1
24789,tended,0,0
24790,(,0,0
24791,NS,0,0
24792,),0,0
24793,to,0,0
24794,decrease,0,0
24795,in,0,0
24796,the,0,0
24797,LF,0,0
24798,group,0,0
24799,(,0,0
24800,from,0,0
24801,69,0,0
24802,+/-,0,0
24803,4,0,0
24804,to,0,0
24805,59,0,0
24806,+/-,0,0
24807,5,0,0
24808,micromol/L,0,0
24809,),0,0
24810,and,0,0
24811,increase,0,0
24812,in,0,0
24813,the,0,0
24814,HF,0,0
24815,group,0,0
24816,(,0,0
24817,from,0,0
24818,100,0,0
24819,+/-,0,0
24820,18,0,0
24821,to,0,0
24822,107,0,0
24823,+/-,0,0
24824,17,0,0
24825,micromol/L,0,0
24826,),0,0
24827,",",0,0
24828,with,0,0
24829,no,0,0
24830,significant,0,0
24831,change,0,0
24832,in,0,0
24833,the,0,0
24834,MUFA,0,0
24835,group,0,0
24836,.,0,0
24837,Serum,0,0
24838,butyrate,0,1
24839,did,0,0
24840,not,0,0
24841,change,0,0
24842,significantly,0,0
24843,in,0,0
24844,the,0,0
24845,LF,0,0
24846,or,0,1
24847,MUFA,0,1
24848,group,0,0
24849,but,0,0
24850,increased,0,0
24851,in,0,0
24852,the,0,0
24853,HF,0,0
24854,group,0,0
24855,(,0,0
24856,from,0,0
24857,2.5,0,0
24858,+/-,0,0
24859,0.5,0,0
24860,to,0,0
24861,3.1,0,0
24862,+/-,0,0
24863,0.6,0,0
24864,micromol/L,0,0
24865,;,0,0
24866,P,0,0
24867,<,0,0
24868,0.001,0,0
24869,),0,0
24870,.,0,0
24871,Changes,0,0
24872,in,0,0
24873,serum,0,0
24874,acetate,0,1
24875,from,0,0
24876,0,0,0
24877,to,0,0
24878,3,0,0
24879,mo,0,0
24880,were,0,0
24881,not,0,0
24882,related,0,0
24883,to,0,0
24884,changes,0,0
24885,in,0,0
24886,lipids,0,0
24887,.,0,0
24888,However,0,0
24889,",",0,0
24890,changes,0,0
24891,in,0,0
24892,serum,0,0
24893,acetate,0,1
24894,from,0,0
24895,3,0,0
24896,to,0,0
24897,6,0,0
24898,mo,0,0
24899,were,0,0
24900,positively,0,0
24901,related,0,0
24902,to,0,0
24903,changes,0,0
24904,in,0,0
24905,the,0,0
24906,ratio,0,0
24907,of,0,0
24908,total,0,0
24909,to,0,0
24910,HDL,0,1
24911,cholesterol,0,0
24912,(,0,0
24913,P,0,0
24914,=,0,0
24915,0.041,0,0
24916,),0,0
24917,and,0,0
24918,in,0,0
24919,fasting,0,0
24920,(,0,0
24921,P,0,0
24922,=,0,0
24923,0.013,0,0
24924,),0,0
24925,and,0,0
24926,postprandial,0,0
24927,(,0,0
24928,P,0,0
24929,=,0,0
24930,0.016,0,0
24931,),0,0
24932,triacylglycerols,0,0
24933,.,0,0
24934,CONCLUSIONS,0,0
24935,In,0,0
24936,subjects,0,0
24937,with,0,0
24938,type,0,0
24939,2,0,0
24940,diabetes,0,0
24941,",",0,0
24942,changes,0,0
24943,in,0,0
24944,serum,0,0
24945,SCFAs,0,0
24946,in,0,0
24947,response,0,0
24948,to,0,0
24949,changes,0,0
24950,in,0,0
24951,carbohydrate,0,1
24952,and,0,0
24953,fiber,0,1
24954,intakes,0,0
24955,took,0,0
24956,many,0,0
24957,months,0,0
24958,to,0,0
24959,occur,0,0
24960,",",0,0
24961,and,0,0
24962,the,0,0
24963,changes,0,0
24964,in,0,0
24965,serum,0,0
24966,acetate,0,1
24967,were,0,0
24968,significantly,0,0
24969,related,0,0
24970,to,0,0
24971,the,0,0
24972,long-term,0,0
24973,adaptive,0,0
24974,changes,0,0
24975,in,0,0
24976,blood,0,0
24977,lipids,0,0
24978,.,0,0
24979,Prospective,0,0
24980,study,0,0
24981,of,0,0
24982,C-reactive,0,0
24983,protein,0,0
24984,",",0,0
24985,homocysteine,0,0
24986,",",0,0
24987,and,0,0
24988,plasma,0,0
24989,lipid,0,0
24990,levels,0,0
24991,as,0,0
24992,predictors,0,0
24993,of,0,0
24994,sudden,0,0
24995,cardiac,0,0
24996,death,0,0
24997,.,0,0
24998,BACKGROUND,0,0
24999,Sudden,0,0
25000,cardiac,0,0
25001,death,0,0
25002,(,0,0
25003,SCD,0,0
25004,),0,1
25005,is,0,0
25006,an,0,0
25007,important,0,0
25008,cause,0,0
25009,of,0,0
25010,mortality,0,0
25011,even,0,0
25012,among,0,0
25013,apparently,0,0
25014,healthy,0,0
25015,populations,0,0
25016,.,0,0
25017,However,0,0
25018,",",0,0
25019,our,0,0
25020,ability,0,0
25021,to,0,0
25022,identify,0,0
25023,those,0,0
25024,at,0,0
25025,risk,0,0
25026,for,0,0
25027,SCD,0,0
25028,in,0,0
25029,the,0,0
25030,general,0,0
25031,population,0,0
25032,is,0,0
25033,poor,0,0
25034,",",0,0
25035,and,0,0
25036,more,0,0
25037,specific,0,0
25038,markers,0,0
25039,are,0,0
25040,needed,0,0
25041,.,0,0
25042,METHODS,0,0
25043,AND,0,0
25044,RESULTS,0,0
25045,To,0,0
25046,compare,0,0
25047,and,0,0
25048,contrast,0,0
25049,the,0,0
25050,relative,0,0
25051,importance,0,0
25052,of,0,0
25053,C-reactive,1,0
25054,protein,1,1
25055,(,1,0
25056,CRP,1,1
25057,),1,0
25058,",",1,0
25059,homocysteine,1,0
25060,",",0,0
25061,and,0,0
25062,lipids,1,0
25063,as,0,0
25064,long-term,0,0
25065,predictors,0,0
25066,of,0,0
25067,SCD,0,0
25068,",",0,0
25069,we,0,0
25070,performed,0,0
25071,a,0,0
25072,prospective,0,0
25073,",",0,0
25074,nested,0,0
25075,",",0,0
25076,case-control,0,0
25077,analysis,0,0
25078,involving,0,0
25079,97,0,0
25080,cases,0,0
25081,of,0,0
25082,SCD,0,0
25083,among,0,0
25084,apparently,0,0
25085,healthy,0,0
25086,men,0,0
25087,enrolled,0,0
25088,in,0,0
25089,the,0,0
25090,Physician,0,0
25091,'s,0,0
25092,Health,0,0
25093,Study,0,0
25094,.,0,0
25095,Of,0,0
25096,these,0,0
25097,plasma,0,0
25098,markers,0,0
25099,measured,0,0
25100,",",0,0
25101,only,0,0
25102,baseline,0,0
25103,CRP,0,1
25104,levels,0,0
25105,were,0,0
25106,significantly,0,0
25107,associated,0,0
25108,with,0,0
25109,the,0,0
25110,risk,0,0
25111,of,0,0
25112,SCD,0,0
25113,over,0,0
25114,the,0,0
25115,ensuing,0,0
25116,17,0,0
25117,years,0,0
25118,of,0,0
25119,follow-up,0,0
25120,(,0,0
25121,P,0,0
25122,for,0,0
25123,trend=0.001,0,0
25124,),0,0
25125,.,0,0
25126,The,0,0
25127,increase,0,0
25128,in,0,0
25129,risk,0,0
25130,associated,0,0
25131,with,0,0
25132,CRP,1,1
25133,levels,0,0
25134,was,0,0
25135,primarily,0,0
25136,seen,0,0
25137,among,0,0
25138,men,0,0
25139,in,0,0
25140,the,0,0
25141,highest,0,0
25142,quartile,0,0
25143,",",0,0
25144,who,0,0
25145,were,0,0
25146,at,0,0
25147,a,0,0
25148,2.78-fold,0,0
25149,increased,0,0
25150,risk,0,0
25151,of,0,0
25152,SCD,0,0
25153,(,0,0
25154,95,0,0
25155,%,0,0
25156,CI,0,0
25157,1.35,0,0
25158,to,0,0
25159,5.72,0,0
25160,),0,0
25161,compared,0,0
25162,with,0,0
25163,men,0,0
25164,in,0,0
25165,the,0,0
25166,lowest,0,0
25167,quartile,0,0
25168,.,0,0
25169,These,0,0
25170,results,0,0
25171,were,0,0
25172,not,0,0
25173,significantly,0,0
25174,altered,0,0
25175,in,0,0
25176,analyses,0,0
25177,that,0,0
25178,(,0,0
25179,in,0,0
25180,addition,0,0
25181,to,0,0
25182,the,0,0
25183,matching,0,0
25184,variables,0,0
25185,of,0,0
25186,age,0,0
25187,and,0,0
25188,smoking,0,1
25189,status,0,0
25190,),0,0
25191,controlled,0,0
25192,for,0,0
25193,lipid,0,0
25194,parameters,0,0
25195,",",0,0
25196,homocysteine,0,0
25197,",",0,0
25198,and,0,0
25199,multiple,0,0
25200,cardiac,0,0
25201,risk,0,0
25202,factors,0,0
25203,(,0,0
25204,relative,0,0
25205,risk,0,0
25206,for,0,0
25207,highest,0,0
25208,versus,0,0
25209,lowest,0,0
25210,quartile,0,0
25211,2.65,0,0
25212,",",0,0
25213,95,0,0
25214,%,0,0
25215,CI,0,0
25216,0.79,0,0
25217,to,0,0
25218,8.83,0,0
25219,;,0,0
25220,P,0,0
25221,for,0,0
25222,trend=0.03,0,0
25223,),0,0
25224,.,0,0
25225,In,0,0
25226,contrast,0,0
25227,to,0,0
25228,the,0,0
25229,positive,0,0
25230,relationship,0,0
25231,observed,0,0
25232,for,0,0
25233,CRP,1,1
25234,",",0,0
25235,neither,0,0
25236,homocysteine,0,0
25237,nor,0,0
25238,lipid,0,0
25239,levels,0,0
25240,were,0,0
25241,significantly,0,0
25242,associated,0,0
25243,with,0,0
25244,risk,0,0
25245,of,0,0
25246,SCD,0,0
25247,.,0,0
25248,CONCLUSIONS,0,0
25249,These,0,0
25250,prospective,0,0
25251,data,0,0
25252,suggest,0,0
25253,that,0,0
25254,CRP,0,1
25255,levels,0,0
25256,may,0,0
25257,be,0,0
25258,useful,0,0
25259,in,0,0
25260,identifying,0,0
25261,apparently,0,0
25262,healthy,0,0
25263,men,0,0
25264,who,0,0
25265,are,0,0
25266,at,0,0
25267,an,0,0
25268,increased,0,0
25269,long-term,0,0
25270,risk,0,0
25271,of,0,0
25272,SCD,0,0
25273,.,0,0
25274,[,0,0
25275,Effect,0,0
25276,of,0,0
25277,valociclovir,1,1
25278,hydrochloride,1,1
25279,on,0,0
25280,patients,0,0
25281,with,0,0
25282,herpes,0,0
25283,zoster,0,0
25284,],0,0
25285,.,0,0
25286,Pain,0,0
25287,and,0,0
25288,fatigue,0,0
25289,management,0,0
25290,:,0,0
25291,results,0,0
25292,of,0,0
25293,a,0,0
25294,nursing,0,1
25295,randomized,0,0
25296,clinical,0,0
25297,trial,0,0
25298,.,0,0
25299,PURPOSE/OBJECTIVES,0,0
25300,Through,0,0
25301,a,0,0
25302,randomized,0,0
25303,clinical,0,0
25304,trial,0,0
25305,",",0,0
25306,to,0,0
25307,compare,0,0
25308,patients,0,0
25309,undergoing,0,0
25310,an,0,0
25311,initial,0,0
25312,course,0,0
25313,of,0,0
25314,chemotherapy,1,1
25315,who,0,0
25316,report,0,0
25317,pain,0,0
25318,and,0,0
25319,fatigue,0,0
25320,at,0,0
25321,baseline,0,0
25322,and,0,0
25323,who,0,0
25324,are,0,0
25325,receiving,0,0
25326,conventional,1,1
25327,care,1,1
25328,alone,1,1
25329,with,0,0
25330,those,0,0
25331,receiving,0,0
25332,conventional,1,1
25333,care,1,1
25334,plus,1,1
25335,a,1,0
25336,nursing,1,1
25337,intervention,1,1
25338,on,0,0
25339,outcomes,0,0
25340,reported,0,0
25341,at,0,0
25342,20,0,0
25343,weeks,0,0
25344,.,0,0
25345,SETTING,0,0
25346,Chemotherapy,0,1
25347,clinics,0,0
25348,of,0,0
25349,two,0,0
25350,comprehensive,0,0
25351,and,0,0
25352,two,0,0
25353,community,0,0
25354,cancer,0,0
25355,centers,0,0
25356,.,0,0
25357,METHODS,0,0
25358,Interviews,0,1
25359,were,0,0
25360,conducted,0,0
25361,at,0,0
25362,baseline,0,0
25363,and,0,0
25364,10,0,0
25365,and,0,0
25366,20,0,0
25367,weeks,0,0
25368,.,0,0
25369,An,0,0
25370,18-week,0,0
25371,",",0,0
25372,10-contact,0,1
25373,nursing,1,1
25374,intervention,1,1
25375,utilizing,1,0
25376,problem-solving,1,1
25377,approaches,1,0
25378,to,1,0
25379,symptom,1,0
25380,management,1,0
25381,and,1,0
25382,improving,1,0
25383,physical,1,1
25384,functioning,1,0
25385,and,1,0
25386,emotional,1,0
25387,health,1,0
25388,was,0,0
25389,implemented,0,0
25390,.,0,0
25391,SAMPLE,0,0
25392,The,0,0
25393,sample,0,0
25394,consisted,0,0
25395,of,0,0
25396,53,0,0
25397,patients,0,0
25398,in,0,0
25399,the,0,0
25400,experimental,0,0
25401,arm,0,0
25402,and,0,0
25403,60,0,0
25404,in,0,0
25405,the,0,0
25406,control,0,0
25407,arm,0,0
25408,who,0,0
25409,reported,0,0
25410,pain,0,0
25411,and,0,0
25412,fatigue,0,0
25413,at,0,0
25414,baseline,0,0
25415,.,0,0
25416,VARIABLES,0,0
25417,Pain,0,0
25418,and,0,0
25419,fatigue,0,0
25420,",",0,0
25421,numbers,0,0
25422,of,0,0
25423,other,0,0
25424,symptoms,0,0
25425,",",0,0
25426,and,0,0
25427,physical,0,1
25428,role,0,0
25429,impact,0,0
25430,and,0,0
25431,social-functioning,0,0
25432,subscales,0,0
25433,from,0,0
25434,the,0,0
25435,Medical,0,1
25436,Outcomes,0,0
25437,Study,0,0
25438,36,0,0
25439,Short,0,0
25440,Form,0,0
25441,.,0,0
25442,FINDINGS,0,0
25443,Patients,0,0
25444,who,0,0
25445,received,0,0
25446,the,0,0
25447,intervention,1,1
25448,reported,0,0
25449,a,0,0
25450,significant,0,0
25451,reduction,0,0
25452,in,0,0
25453,the,0,0
25454,number,0,0
25455,of,0,0
25456,symptoms,0,0
25457,experienced,0,0
25458,and,0,0
25459,improved,0,0
25460,physical,0,1
25461,and,0,0
25462,social,0,0
25463,functioning,0,0
25464,.,0,0
25465,Fewer,0,0
25466,patients,0,0
25467,in,0,0
25468,the,0,0
25469,experimental,0,0
25470,arm,0,0
25471,reported,0,0
25472,both,0,0
25473,pain,0,0
25474,and,0,0
25475,fatigue,0,0
25476,at,0,0
25477,20,0,0
25478,weeks,0,0
25479,.,0,0
25480,CONCLUSIONS,0,0
25481,Behavioral,1,0
25482,interventions,1,0
25483,targeted,0,0
25484,to,0,0
25485,patients,0,0
25486,with,0,0
25487,pain,0,0
25488,and,0,0
25489,fatigue,0,0
25490,can,0,0
25491,reduce,0,0
25492,symptom,0,0
25493,burden,0,0
25494,",",0,0
25495,improve,0,0
25496,the,0,0
25497,quality,0,0
25498,of,0,0
25499,the,0,0
25500,daily,0,0
25501,life,0,0
25502,of,0,0
25503,patients,0,0
25504,",",0,0
25505,and,0,0
25506,demonstrate,0,0
25507,the,0,0
25508,value-added,0,0
25509,role,0,0
25510,of,0,0
25511,nursing,1,1
25512,care,1,0
25513,for,0,0
25514,patients,0,0
25515,undergoing,0,0
25516,chemotherapy,0,1
25517,.,0,0
25518,IMPLICATIONS,0,0
25519,FOR,0,1
25520,NURSING,0,0
25521,These,0,0
25522,data,0,0
25523,support,0,0
25524,the,0,0
25525,value-added,0,0
25526,role,0,0
25527,of,0,0
25528,nursing,1,0
25529,interventions,1,0
25530,for,0,0
25531,symptom,0,0
25532,management,0,0
25533,and,0,0
25534,improved,0,0
25535,quality,0,0
25536,of,0,0
25537,life,0,0
25538,during,0,0
25539,the,0,0
25540,course,0,0
25541,of,0,0
25542,cancer,0,0
25543,treatment,0,0
25544,.,0,0
25545,Efficacy,0,0
25546,of,0,0
25547,porcine,1,1
25548,secretin,1,1
25549,in,0,0
25550,children,0,0
25551,with,0,0
25552,autism,0,0
25553,and,0,0
25554,pervasive,0,0
25555,developmental,0,0
25556,disorder,0,0
25557,.,0,0
25558,Secretin,1,0
25559,",",0,0
25560,a,0,0
25561,gastrointestinal,0,0
25562,(,0,0
25563,GI,0,0
25564,),0,0
25565,hormone,0,0
25566,",",0,0
25567,was,0,0
25568,reported,0,0
25569,in,0,0
25570,a,0,0
25571,preliminary,0,0
25572,study,0,0
25573,to,0,0
25574,improve,0,0
25575,language,0,0
25576,and,0,0
25577,behavior,0,0
25578,in,0,0
25579,children,0,0
25580,with,0,0
25581,autism/pervasive,0,0
25582,developmental,0,0
25583,disorder,0,0
25584,(,0,0
25585,PDD,0,0
25586,),0,1
25587,and,0,0
25588,chronic,0,0
25589,diarrhea,0,0
25590,.,0,0
25591,To,0,0
25592,determine,0,0
25593,the,0,0
25594,efficacy,0,0
25595,of,0,0
25596,secretin,1,1
25597,",",0,0
25598,we,0,0
25599,completed,0,0
25600,a,0,0
25601,double-blind,0,0
25602,",",0,0
25603,placebo-controlled,1,1
25604,",",0,0
25605,crossover,0,0
25606,(,0,0
25607,3,0,0
25608,weeks,0,0
25609,),0,0
25610,study,0,0
25611,in,0,0
25612,children,0,0
25613,with,0,0
25614,autism/PDD,0,0
25615,and,0,0
25616,various,0,0
25617,GI,0,0
25618,conditions,0,0
25619,using,0,0
25620,a,0,0
25621,single,0,0
25622,dose,0,0
25623,of,0,0
25624,intravenous,1,1
25625,porcine,1,1
25626,secretin,1,1
25627,.,1,0
25628,Children,0,0
25629,with,0,0
25630,chronic,0,0
25631,",",0,0
25632,active,0,0
25633,diarrhea,0,0
25634,showed,0,0
25635,a,0,0
25636,reduction,0,0
25637,in,0,0
25638,aberrant,0,0
25639,behaviors,0,0
25640,when,0,0
25641,treated,0,0
25642,with,0,0
25643,the,0,0
25644,secretin,1,1
25645,but,0,0
25646,not,0,0
25647,when,0,0
25648,treated,0,0
25649,with,0,0
25650,the,0,0
25651,placebo,1,1
25652,.,1,0
25653,Children,0,0
25654,with,0,0
25655,no,0,0
25656,GI,0,0
25657,problems,0,0
25658,are,0,0
25659,unaffected,0,0
25660,by,0,0
25661,either,0,0
25662,secretin,1,1
25663,or,1,0
25664,placebo,1,1
25665,.,1,0
25666,The,0,0
25667,improvement,0,0
25668,seen,0,0
25669,with,0,0
25670,secretin,1,1
25671,in,0,0
25672,children,0,0
25673,with,0,0
25674,autism/PDD,0,0
25675,and,0,0
25676,chronic,0,0
25677,diarrhea,0,0
25678,suggests,0,0
25679,that,0,0
25680,there,0,0
25681,may,0,0
25682,be,0,0
25683,a,0,0
25684,subtype,0,0
25685,of,0,0
25686,children,0,0
25687,with,0,0
25688,autism/PDD,0,0
25689,who,0,0
25690,respond,0,0
25691,to,0,0
25692,secretin,1,0
25693,.,1,0
25694,Use,0,0
25695,of,0,0
25696,high-dose,0,1
25697,cytarabine,1,1
25698,to,0,0
25699,enhance,0,0
25700,cisplatin,1,1
25701,cytotoxicity-effects,0,0
25702,on,0,0
25703,the,0,0
25704,response,0,0
25705,and,0,0
25706,overall,0,0
25707,survival,0,0
25708,rates,0,0
25709,of,0,0
25710,advanced,0,0
25711,head,0,0
25712,and,0,0
25713,neck,0,0
25714,cancer,0,0
25715,patients,0,0
25716,.,0,0
25717,UNLABELLED,0,0
25718,It,0,0
25719,has,0,0
25720,been,0,0
25721,reported,0,0
25722,that,0,0
25723,cytarabine,1,1
25724,",",0,0
25725,acting,0,0
25726,by,0,0
25727,at,0,0
25728,least,0,0
25729,two,0,0
25730,different,0,0
25731,mechanisms,0,0
25732,",",0,0
25733,enhances,0,0
25734,the,0,0
25735,cytotoxic,0,0
25736,effect,0,0
25737,of,0,0
25738,cisplatin,1,1
25739,in,0,0
25740,in,0,0
25741,vitro,0,0
25742,systems,0,0
25743,.,0,0
25744,The,0,0
25745,aim,0,0
25746,of,0,0
25747,this,0,0
25748,open,0,0
25749,",",0,0
25750,prospective,0,0
25751,",",0,0
25752,randomised,0,0
25753,study,0,0
25754,was,0,0
25755,to,0,0
25756,estimate,0,0
25757,the,0,0
25758,eventual,0,0
25759,benefits,0,0
25760,from,0,0
25761,the,0,0
25762,inclusion,0,0
25763,of,0,0
25764,high-dose,0,1
25765,cytarabine,1,1
25766,in,0,0
25767,the,0,0
25768,cisplatin-5-fluorouracil,1,1
25769,(,1,0
25770,5-FU,1,1
25771,),1,0
25772,regimen,0,1
25773,as,0,0
25774,first-line,0,0
25775,treatment,0,0
25776,of,0,0
25777,patients,0,0
25778,with,0,0
25779,advanced,0,0
25780,head,0,0
25781,and,0,0
25782,neck,0,0
25783,cancer,0,0
25784,.,0,0
25785,The,0,0
25786,study,0,0
25787,recruited,0,0
25788,successive,0,0
25789,patients,0,0
25790,with,0,0
25791,unresectable,0,0
25792,grade,0,0
25793,I/II,0,1
25794,head,0,0
25795,and,0,0
25796,neck,0,0
25797,cancer,0,0
25798,who,0,0
25799,were,0,0
25800,not,0,0
25801,suitable,0,0
25802,for,0,0
25803,irradiation,1,1
25804,treatment,1,0
25805,(,0,0
25806,T,0,0
25807,any,0,0
25808,N3,0,0
25809,or,0,0
25810,T4,0,0
25811,N2C,0,1
25812,),0,0
25813,",",0,0
25814,metastatic,0,0
25815,or,0,0
25816,previously,0,0
25817,irradiated,0,0
25818,.,0,0
25819,All,0,0
25820,patients,0,0
25821,gave,0,0
25822,their,0,0
25823,informed,0,0
25824,consent,0,0
25825,.,0,0
25826,A,0,0
25827,joint,0,0
25828,ear,0,0
25829,",",0,0
25830,nose,0,0
25831,and,0,0
25832,throat,0,0
25833,(,0,1
25834,ENT,0,1
25835,),0,0
25836,oncological,0,0
25837,committee,0,0
25838,performed,0,0
25839,the,0,0
25840,selection,0,0
25841,.,0,0
25842,A,0,0
25843,total,0,0
25844,of,0,0
25845,170,0,0
25846,patients,0,0
25847,were,0,0
25848,included,0,0
25849,in,0,0
25850,the,0,0
25851,study,0,0
25852,.,0,0
25853,Patients,0,0
25854,randomised,0,0
25855,to,0,0
25856,arm,0,0
25857,A,0,0
25858,were,0,0
25859,given,0,0
25860,1000,1,0
25861,mg/m,1,1
25862,(,1,0
25863,2,1,0
25864,),1,0
25865,cytarabine,1,1
25866,on,0,0
25867,day,0,0
25868,1,0,0
25869,preceding,0,0
25870,for,0,0
25871,6,0,0
25872,h,0,0
25873,cisplatin,1,1
25874,infusion,1,1
25875,",",0,0
25876,30,0,0
25877,mg/m,0,1
25878,(,0,0
25879,2,0,0
25880,),0,0
25881,/24,0,0
25882,h,0,1
25883,cisplatin,1,1
25884,intravenous,0,1
25885,(,0,0
25886,i.v,0,1
25887,.,0,0
25888,),0,0
25889,bolus,0,0
25890,days,0,0
25891,1-4,0,0
25892,and,0,0
25893,1000,0,0
25894,mg/m,0,1
25895,(,0,0
25896,2,0,0
25897,),0,0
25898,/24,0,0
25899,h,0,1
25900,5-FU,0,0
25901,in,0,0
25902,a,0,0
25903,4-h,0,0
25904,infusion,0,1
25905,on,0,0
25906,days,0,0
25907,1-4,0,0
25908,.,0,0
25909,Patients,0,0
25910,in,0,0
25911,arm,0,0
25912,B,0,0
25913,were,0,0
25914,given,0,0
25915,cisplatin,1,1
25916,and,1,0
25917,5-FU,1,0
25918,in,0,0
25919,the,0,0
25920,same,0,0
25921,dosage,0,0
25922,and,0,0
25923,schedule,0,1
25924,as,0,0
25925,in,0,0
25926,arm,0,0
25927,A,0,0
25928,.,0,0
25929,Additional,0,0
25930,irradiation+/-surgery,1,1
25931,was,0,0
25932,performed,0,0
25933,if,0,0
25934,and,0,0
25935,when,0,0
25936,feasible,0,0
25937,.,0,0
25938,Patients,0,0
25939,in,0,0
25940,both,0,0
25941,arms,0,0
25942,were,0,0
25943,well,0,0
25944,balanced,0,0
25945,with,0,0
25946,regard,0,0
25947,to,0,0
25948,clinical,0,0
25949,variables,0,0
25950,.,0,0
25951,The,0,0
25952,following,0,0
25953,results,0,0
25954,were,0,0
25955,obtained,0,0
25956,:,0,0
25957,Arm,0,0
25958,A,0,0
25959,:,0,0
25960,84,0,0
25961,patients,0,0
25962,were,0,0
25963,included,0,0
25964,",",0,0
25965,74,0,0
25966,were,0,0
25967,evaluable,0,0
25968,for,0,0
25969,activity,0,0
25970,;,0,0
25971,RESPONSE,0,1
25972,complete,0,0
25973,response,0,0
25974,(,0,0
25975,CR,0,1
25976,),0,1
25977,8,0,0
25978,(,0,0
25979,11,0,0
25980,%,0,0
25981,),0,0
25982,",",0,0
25983,partial,0,0
25984,response,0,0
25985,(,0,0
25986,PR,0,1
25987,),0,1
25988,40,0,0
25989,(,0,0
25990,54,0,0
25991,%,0,0
25992,),0,0
25993,",",0,0
25994,stable,0,0
25995,disease,0,0
25996,(,0,0
25997,SD,0,0
25998,),0,1
25999,11,0,0
26000,(,0,0
26001,15,0,0
26002,%,0,0
26003,),0,0
26004,",",0,0
26005,progressive,0,1
26006,disease,0,0
26007,(,0,0
26008,PD,0,0
26009,),0,1
26010,15,0,0
26011,(,0,0
26012,20,0,0
26013,%,0,0
26014,),0,0
26015,.,0,0
26016,The,0,0
26017,overall,0,0
26018,response,0,0
26019,rate,0,0
26020,(,0,0
26021,RR,0,0
26022,),0,0
26023,based,0,0
26024,on,0,0
26025,the,0,0
26026,evaluable,0,0
26027,patients,0,0
26028,was,0,0
26029,48/74,0,0
26030,(,0,0
26031,65,0,0
26032,%,0,0
26033,",",0,0
26034,95,0,0
26035,%,0,0
26036,confidence,0,0
26037,interval,0,0
26038,(,0,0
26039,CI,0,0
26040,),0,0
26041,54-75,0,0
26042,%,0,0
26043,),0,0
26044,;,0,0
26045,The,0,0
26046,RR,0,0
26047,based,0,0
26048,on,0,0
26049,an,0,0
26050,intent-to-treat,0,0
26051,analysis,0,0
26052,was,0,0
26053,57,0,0
26054,%,0,0
26055,",",0,0
26056,95,0,0
26057,%,0,0
26058,CI,0,0
26059,47-67,0,0
26060,%,0,0
26061,;,0,0
26062,Median,0,0
26063,survival,0,0
26064,was,0,0
26065,13,0,0
26066,months,0,0
26067,;,0,0
26068,There,0,0
26069,were,0,0
26070,50,0,0
26071,episodes,0,0
26072,of,0,0
26073,granulocytopenia,0,0
26074,grade,0,0
26075,IV,0,0
26076,and,0,0
26077,15,0,0
26078,of,0,0
26079,febrile,0,0
26080,neutropenia,0,0
26081,per,0,0
26082,316,0,0
26083,cycles,0,0
26084,.,0,0
26085,Arm,0,0
26086,B,0,0
26087,:,0,0
26088,86,0,0
26089,patients,0,0
26090,were,0,0
26091,included,0,0
26092,",",0,0
26093,80,0,0
26094,were,0,0
26095,evaluable,0,0
26096,for,0,0
26097,activity,0,0
26098,;,0,0
26099,RESPONSE,0,0
26100,CR,0,1
26101,7,0,0
26102,(,0,0
26103,9,0,0
26104,%,0,0
26105,),0,0
26106,",",0,0
26107,PR,0,1
26108,29,0,0
26109,(,0,0
26110,36,0,0
26111,%,0,0
26112,),0,0
26113,",",0,0
26114,SD,0,0
26115,10,0,0
26116,(,0,0
26117,12.5,0,0
26118,%,0,0
26119,),0,0
26120,",",0,0
26121,PD,0,0
26122,34,0,0
26123,(,0,0
26124,42.5,0,0
26125,%,0,0
26126,),0,0
26127,;,0,0
26128,The,0,0
26129,overall,0,0
26130,RR,0,0
26131,based,0,0
26132,on,0,0
26133,the,0,0
26134,evaluable,0,0
26135,patients,0,0
26136,was,0,0
26137,36/80,0,0
26138,(,0,0
26139,45,0,0
26140,%,0,0
26141,",",0,0
26142,95,0,0
26143,%,0,0
26144,CI,0,0
26145,35-56,0,0
26146,%,0,0
26147,),0,0
26148,;,0,0
26149,The,0,0
26150,RR,0,0
26151,based,0,0
26152,on,0,0
26153,an,0,0
26154,intent-to-treat,0,0
26155,analysis,0,0
26156,was,0,0
26157,42,0,0
26158,%,0,0
26159,",",0,0
26160,95,0,0
26161,%,0,0
26162,CI,0,0
26163,32-52,0,0
26164,%,0,0
26165,;,0,0
26166,Median,0,0
26167,survival,0,0
26168,was,0,0
26169,8,0,0
26170,months,0,0
26171,;,0,0
26172,There,0,0
26173,were,0,0
26174,14,0,0
26175,episodes,0,0
26176,of,0,0
26177,granulocytopenia,0,0
26178,grade,0,0
26179,IV,0,0
26180,and,0,0
26181,7,0,0
26182,febrile,0,0
26183,neutropenias,0,0
26184,per,0,0
26185,324,0,0
26186,cycles,0,0
26187,.,0,0
26188,The,0,0
26189,RR,0,0
26190,was,0,0
26191,significantly,0,0
26192,higher,0,0
26193,in,0,0
26194,arm,0,0
26195,A,0,0
26196,(,0,0
26197,P=0.013,0,0
26198,),0,0
26199,",",0,0
26200,power,0,0
26201,(,0,0
26202,one-sided,0,0
26203,),0,0
26204,80,0,0
26205,%,0,0
26206,.,0,0
26207,The,0,0
26208,proportion,0,0
26209,of,0,0
26210,patients,0,0
26211,from,0,0
26212,the,0,0
26213,appropriate,0,0
26214,subset,0,0
26215,who,0,0
26216,achieved,0,0
26217,a,0,0
26218,clinical,0,0
26219,response,0,0
26220,making,0,0
26221,additional,0,0
26222,treatment,0,0
26223,feasible,0,0
26224,was,0,0
26225,higher,0,0
26226,in,0,0
26227,arm,0,0
26228,A,0,0
26229,(,0,0
26230,P=0.00015,0,0
26231,),0,0
26232,",",0,0
26233,as,0,0
26234,well,0,0
26235,as,0,0
26236,the,0,0
26237,proportion,0,0
26238,of,0,0
26239,patients,0,0
26240,with,0,0
26241,a,0,0
26242,performance,0,0
26243,status,0,0
26244,2+3,0,1
26245,achieving,0,0
26246,a,0,0
26247,response,0,0
26248,(,0,0
26249,P,0,0
26250,<,0,0
26251,0.0001,0,0
26252,),0,0
26253,.,0,0
26254,Using,0,0
26255,the,0,0
26256,Log-rank,0,0
26257,test,0,0
26258,",",0,0
26259,patients,0,0
26260,from,0,0
26261,arm,0,0
26262,A,0,0
26263,achieved,0,0
26264,a,0,0
26265,significantly,0,0
26266,longer,0,0
26267,survival,0,0
26268,(,0,0
26269,P=0.009,0,0
26270,),0,0
26271,",",0,0
26272,with,0,0
26273,the,0,0
26274,probability,0,0
26275,of,0,0
26276,survival,0,0
26277,at,0,0
26278,12,0,0
26279,months,0,0
26280,of,0,0
26281,0.58,0,0
26282,for,0,0
26283,patients,0,0
26284,in,0,0
26285,arm,0,0
26286,A,0,0
26287,and,0,0
26288,0.28,0,0
26289,for,0,0
26290,patients,0,0
26291,in,0,0
26292,arm,0,0
26293,B.,0,1
26294,Grade,0,1
26295,IV,0,0
26296,granulocytopenia,0,0
26297,and,0,0
26298,thrombocytopenia,0,0
26299,were,0,0
26300,more,0,0
26301,frequent,0,0
26302,in,0,0
26303,arm,0,0
26304,A,0,0
26305,.,0,0
26306,Due,0,1
26307,to,0,0
26308,its,0,0
26309,haematological,0,0
26310,side-effects,0,0
26311,",",0,0
26312,cytarabine,1,1
26313,might,0,0
26314,not,0,0
26315,be,0,0
26316,the,0,0
26317,ideal,0,0
26318,drug,0,0
26319,to,0,0
26320,modulate,0,0
26321,the,0,0
26322,cytotoxicity,0,0
26323,of,0,0
26324,cisplatin,1,1
26325,.,1,0
26326,However,0,0
26327,",",0,0
26328,other,0,0
26329,modulators,0,0
26330,of,0,0
26331,its,0,0
26332,activity,0,0
26333,could,0,0
26334,be,0,0
26335,of,0,0
26336,interest,0,0
26337,for,0,0
26338,further,0,0
26339,studies,0,0
26340,in,0,0
26341,head,0,0
26342,and,0,0
26343,neck,0,0
26344,cancer,0,0
26345,patients,0,0
26346,.,0,0
26347,Multiple,0,0
26348,doses,0,0
26349,of,0,0
26350,secretin,1,1
26351,in,0,0
26352,the,0,0
26353,treatment,0,0
26354,of,0,0
26355,autism,0,0
26356,:,0,0
26357,a,0,0
26358,controlled,0,0
26359,study,0,0
26360,.,0,0
26361,UNLABELLED,0,0
26362,Dramatic,0,0
26363,effects,0,0
26364,on,0,0
26365,autistic,0,0
26366,behaviour,0,0
26367,after,0,0
26368,repeated,0,0
26369,injections,0,1
26370,of,0,0
26371,the,0,0
26372,gastrointestinal,0,0
26373,hormone,0,0
26374,secretin,1,1
26375,have,0,0
26376,been,0,0
26377,referred,0,0
26378,in,0,0
26379,a,0,0
26380,number,0,0
26381,of,0,0
26382,case,0,0
26383,reports,0,0
26384,.,0,0
26385,In,0,0
26386,the,0,0
26387,absence,0,0
26388,of,0,0
26389,curative,0,0
26390,and,0,0
26391,effective,0,0
26392,treatments,0,0
26393,for,0,0
26394,this,0,0
26395,disabling,0,0
26396,condition,0,0
26397,",",0,0
26398,this,0,0
26399,information,0,0
26400,has,0,0
26401,created,0,0
26402,new,0,0
26403,hope,0,0
26404,among,0,0
26405,parents,0,0
26406,.,0,0
26407,Although,0,0
26408,controlled,0,0
26409,studies,0,0
26410,on,0,0
26411,the,0,0
26412,effect,0,0
26413,of,0,0
26414,mainly,0,0
26415,one,0,0
26416,single,0,0
26417,dose,0,0
26418,have,0,0
26419,not,0,0
26420,documented,0,0
26421,any,0,0
26422,effect,0,0
26423,",",0,0
26424,many,0,0
26425,children,0,0
26426,still,0,0
26427,continue,0,0
26428,to,0,0
26429,receive,0,0
26430,secretin,1,1
26431,.,1,0
26432,Six,0,0
26433,children,0,0
26434,enrolled,0,0
26435,in,0,0
26436,a,0,0
26437,double-blind,0,0
26438,",",0,0
26439,placebo-controlled,0,1
26440,crossover,0,0
26441,study,0,0
26442,in,0,0
26443,which,0,0
26444,each,0,0
26445,child,0,0
26446,was,0,0
26447,its,0,0
26448,own,0,0
26449,control,0,0
26450,.,0,0
26451,Human,1,0
26452,synthetic,1,0
26453,secretin,1,1
26454,",",1,0
26455,mean,1,0
26456,dose,1,0
26457,3.4,1,0
26458,clinical,1,0
26459,units,1,0
26460,",",1,0
26461,and,1,0
26462,placebo,1,1
26463,were,1,0
26464,administered,1,0
26465,intravenously,1,0
26466,in,1,0
26467,randomized,1,0
26468,order,1,0
26469,every,1,1
26470,4th,1,0
26471,wk,1,0
26472,",",1,0
26473,on,1,0
26474,three,1,0
26475,occasions,1,0
26476,each,1,0
26477,.,1,0
26478,The,0,0
26479,measurement,0,0
26480,instruments,0,0
26481,were,0,0
26482,the,0,0
26483,visual,0,0
26484,analogue,0,0
26485,scale,0,0
26486,(,0,0
26487,VAS,0,1
26488,),0,0
26489,and,0,0
26490,the,0,0
26491,aberrant,0,0
26492,behaviour,0,0
26493,checklist,0,1
26494,(,0,0
26495,ABC,0,0
26496,),0,0
26497,.,0,0
26498,Statistically,0,0
26499,significant,0,0
26500,differences,0,0
26501,were,0,0
26502,found,0,0
26503,for,0,0
26504,placebo,0,1
26505,in,0,0
26506,3,0,0
26507,out,0,0
26508,of,0,0
26509,6,0,0
26510,children,0,0
26511,and,0,0
26512,for,0,0
26513,secretin,1,1
26514,in,0,0
26515,one,0,0
26516,child,0,0
26517,",",0,0
26518,using,0,0
26519,parental,0,0
26520,ratings,0,0
26521,only,0,0
26522,(,0,0
26523,VAS,0,1
26524,scores,0,0
26525,),0,0
26526,.,0,0
26527,Differences,0,0
26528,were,0,0
26529,small,0,0
26530,and,0,0
26531,lacked,0,0
26532,clinical,0,0
26533,significance,0,0
26534,",",0,0
26535,which,0,0
26536,was,0,0
26537,in,0,0
26538,accordance,0,0
26539,with,0,0
26540,the,0,0
26541,overall,0,0
26542,impression,0,0
26543,of,0,0
26544,the,0,0
26545,parents,0,0
26546,and,0,0
26547,teachers,0,0
26548,and,0,0
26549,visual,0,0
26550,inspection,0,0
26551,of,0,0
26552,graphs,0,1
26553,.,0,0
26554,CONCLUSION,0,0
26555,In,0,0
26556,this,0,0
26557,placebo-controlled,0,1
26558,study,0,0
26559,",",0,0
26560,multiple,0,0
26561,doses,0,0
26562,of,0,0
26563,secretin,0,1
26564,did,0,0
26565,not,0,0
26566,produce,0,0
26567,any,0,0
26568,symptomatic,0,0
26569,improvement,0,0
26570,.,0,0
26571,Walking,0,1
26572,trials,0,0
26573,in,0,0
26574,postmenopausal,0,0
26575,women,0,0
26576,:,0,0
26577,effect,0,0
26578,of,0,0
26579,one,0,0
26580,vs,0,0
26581,two,0,0
26582,daily,0,0
26583,bouts,0,0
26584,on,0,0
26585,aerobic,0,0
26586,fitness,0,0
26587,.,0,0
26588,We,0,0
26589,compared,0,0
26590,the,0,0
26591,effects,0,0
26592,of,0,0
26593,one,1,0
26594,vs,1,0
26595,two,1,0
26596,daily,1,0
26597,bouts,1,0
26598,of,1,0
26599,walking,1,0
26600,on,0,0
26601,aerobic,0,1
26602,fitness,0,0
26603,and,0,0
26604,body,0,0
26605,composition,0,0
26606,in,0,0
26607,postmenopausal,0,0
26608,women,0,0
26609,.,0,0
26610,One,0,0
26611,hundred,0,0
26612,and,0,0
26613,thirty-four,0,0
26614,subjects,0,0
26615,were,0,0
26616,randomized,0,0
26617,into,0,0
26618,exercise,0,1
26619,groups,0,0
26620,or,0,0
26621,a,0,0
26622,control,0,1
26623,group,0,0
26624,and,0,0
26625,130,0,0
26626,completed,0,0
26627,the,0,0
26628,study,0,0
26629,.,0,0
26630,The,0,0
26631,subjects,0,0
26632,walked,1,0
26633,5,1,0
26634,d/week,1,0
26635,for,1,0
26636,15,1,0
26637,weeks,1,0
26638,at,1,0
26639,65,1,0
26640,%,1,0
26641,of,1,0
26642,their,1,0
26643,maximal,1,0
26644,aerobic,1,1
26645,power,1,0
26646,expending,1,0
26647,300,1,1
26648,kcal,1,0
26649,(,1,0
26650,1255,1,0
26651,kJ,1,1
26652,),1,0
26653,in,1,0
26654,exercise,1,1
26655,in,1,0
26656,one,1,0
26657,(,1,0
26658,Group,1,0
26659,S1,1,1
26660,),1,0
26661,or,1,0
26662,two,1,0
26663,daily,1,0
26664,sessions,1,1
26665,(,1,0
26666,Group,1,0
26667,S2,1,1
26668,),1,0
26669,.,1,0
26670,VO,1,0
26671,(,1,0
26672,2max,1,0
26673,),1,0
26674,was,1,0
26675,measured,1,0
26676,in,1,0
26677,a,1,0
26678,direct,1,1
26679,maximal,1,0
26680,treadmill,1,1
26681,test,1,0
26682,.,1,0
26683,Body,1,1
26684,mass,1,0
26685,index,1,0
26686,(,1,0
26687,BMI,1,0
26688,),1,0
26689,was,1,0
26690,calculated,1,0
26691,and,1,0
26692,the,1,0
26693,percentage,1,0
26694,of,1,0
26695,body,1,0
26696,fat,1,0
26697,(,1,0
26698,fat,1,0
26699,%,1,0
26700,),1,0
26701,estimated,1,0
26702,using,1,0
26703,skinfold,1,0
26704,measurements,1,0
26705,.,1,0
26706,The,0,0
26707,net,0,0
26708,change,0,0
26709,in,0,0
26710,the,0,0
26711,VO,0,0
26712,(,0,0
26713,2max,0,0
26714,),0,0
26715,was,0,0
26716,2.5,0,0
26717,mL,0,0
26718,min/kg,0,0
26719,(,0,0
26720,95,0,0
26721,%,0,0
26722,CI,0,0
26723,1.5,0,0
26724,",",0,0
26725,3.5,0,0
26726,),0,0
26727,(,0,0
26728,8.7,0,0
26729,%,0,0
26730,),0,0
26731,in,0,0
26732,Group,0,0
26733,S1,0,0
26734,and,0,0
26735,2.5,0,0
26736,mL,0,1
26737,min/kg,0,0
26738,(,0,0
26739,95,0,0
26740,%,0,0
26741,CI,0,0
26742,1.5,0,0
26743,",",0,0
26744,3.5,0,0
26745,),0,0
26746,(,0,0
26747,8.8,0,0
26748,%,0,0
26749,),0,0
26750,in,0,0
26751,Group,0,0
26752,S2,0,1
26753,.,0,0
26754,The,0,0
26755,net,0,0
26756,change,0,0
26757,in,0,0
26758,body,0,0
26759,mass,0,0
26760,was,0,0
26761,-1.2,0,0
26762,kg,0,1
26763,(,0,0
26764,95,0,0
26765,%,0,0
26766,CI-1.9,0,0
26767,",",0,0
26768,-0.5,0,0
26769,),0,0
26770,in,0,0
26771,Group,0,0
26772,S1,0,0
26773,and,0,0
26774,-1.1,0,0
26775,kg,0,1
26776,(,0,0
26777,95,0,0
26778,%,0,0
26779,CI,0,0
26780,-1.8,0,0
26781,",",0,0
26782,-0.4,0,0
26783,),0,0
26784,in,0,0
26785,Group,0,0
26786,S2,0,1
26787,.,0,0
26788,The,0,0
26789,net,0,0
26790,fat,0,0
26791,%,0,0
26792,change,0,0
26793,was,0,0
26794,-2.1,0,0
26795,%,0,0
26796,(,0,0
26797,95,0,0
26798,%,0,0
26799,CI-2.7,0,0
26800,",",0,0
26801,-1.4,0,0
26802,),0,0
26803,in,0,0
26804,Group,0,0
26805,S1,0,0
26806,and,0,0
26807,-1.7,0,0
26808,%,0,0
26809,(,0,0
26810,95,0,0
26811,%,0,0
26812,CI-2.3,0,0
26813,",",0,0
26814,-1.0,0,0
26815,),0,0
26816,in,0,0
26817,Group,0,0
26818,S2,0,1
26819,.,0,0
26820,Exercise,0,0
26821,improved,0,0
26822,the,0,0
26823,maximal,0,0
26824,aerobic,0,1
26825,power,0,0
26826,and,0,0
26827,body,0,0
26828,composition,0,0
26829,equally,0,0
26830,when,0,0
26831,walking,1,0
26832,was,0,0
26833,performed,0,0
26834,in,0,0
26835,one,0,0
26836,or,0,0
26837,two,0,0
26838,daily,0,0
26839,bouts,0,0
26840,.,0,0
26841,Home,1,1
26842,based,1,0
26843,management,1,0
26844,in,0,0
26845,multiple,0,0
26846,sclerosis,0,0
26847,:,0,0
26848,results,0,0
26849,of,0,0
26850,a,0,0
26851,randomised,0,0
26852,controlled,0,0
26853,trial,0,0
26854,.,0,0
26855,BACKGROUND,0,0
26856,Home,1,0
26857,based,1,0
26858,medical,1,0
26859,care,1,1
26860,is,0,0
26861,a,0,0
26862,popular,0,0
26863,alternative,0,0
26864,to,0,0
26865,standard,0,1
26866,hospital,0,0
26867,care,0,1
26868,but,0,0
26869,there,0,0
26870,is,0,0
26871,uncertainty,0,0
26872,about,0,0
26873,its,0,0
26874,cost-effectiveness,0,0
26875,.,0,0
26876,OBJECTIVES,0,0
26877,To,0,0
26878,compare,0,0
26879,the,0,0
26880,effectiveness,0,0
26881,and,0,0
26882,the,0,0
26883,costs,0,0
26884,of,0,0
26885,multidisciplinary,1,0
26886,home,1,1
26887,based,1,0
26888,care,1,0
26889,in,0,0
26890,multiple,0,0
26891,sclerosis,0,0
26892,with,0,0
26893,hospital,0,0
26894,care,0,0
26895,in,0,0
26896,a,0,0
26897,prospective,0,0
26898,randomised,0,0
26899,controlled,0,0
26900,trial,0,0
26901,with,0,0
26902,a,0,0
26903,one,0,0
26904,year,0,0
26905,follow,0,0
26906,up,0,0
26907,.,0,0
26908,METHODS,0,0
26909,201,0,0
26910,patients,0,0
26911,with,0,0
26912,clinically,0,0
26913,definite,0,0
26914,multiple,0,0
26915,sclerosis,0,0
26916,were,0,0
26917,studied,0,0
26918,.,0,0
26919,They,0,0
26920,were,0,0
26921,randomised,0,0
26922,in,0,0
26923,a,0,0
26924,ratio,0,0
26925,2:1,0,0
26926,to,0,0
26927,an,0,0
26928,intervention,0,1
26929,group,0,0
26930,(,0,0
26931,133,0,0
26932,),0,0
26933,or,0,0
26934,a,0,0
26935,control,0,1
26936,group,0,0
26937,(,0,0
26938,68,0,0
26939,),0,0
26940,.,0,0
26941,They,0,0
26942,were,0,0
26943,assessed,0,0
26944,at,0,0
26945,baseline,0,0
26946,and,0,0
26947,one,0,0
26948,year,0,0
26949,after,0,0
26950,randomisation,0,0
26951,with,0,0
26952,validated,0,0
26953,measures,0,0
26954,of,0,0
26955,physical,0,0
26956,and,0,0
26957,psychological,0,0
26958,impairment,0,0
26959,and,0,0
26960,quality,0,0
26961,of,0,0
26962,life,0,0
26963,(,0,0
26964,SF-36,0,1
26965,health,0,0
26966,survey,0,0
26967,),0,0
26968,.,0,0
26969,The,0,0
26970,costs,0,0
26971,to,0,0
26972,the,0,0
26973,National,0,0
26974,Health,0,0
26975,Service,0,0
26976,over,0,0
26977,the,0,0
26978,one,0,0
26979,year,0,0
26980,follow,0,0
26981,up,0,0
26982,were,0,0
26983,calculated,0,0
26984,by,0,0
26985,a,0,0
26986,cost,0,0
26987,minimisation,0,0
26988,analysis,0,0
26989,.,0,0
26990,RESULTS,0,0
26991,There,0,0
26992,were,0,0
26993,no,0,0
26994,differences,0,0
26995,in,0,0
26996,functional,0,0
26997,status,0,0
26998,between,0,0
26999,the,0,0
27000,home,0,1
27001,based,0,0
27002,care,0,1
27003,group,0,0
27004,and,0,0
27005,the,0,0
27006,hospital,0,0
27007,group,0,0
27008,.,0,0
27009,There,0,0
27010,was,0,0
27011,a,0,0
27012,significant,0,0
27013,difference,0,0
27014,between,0,0
27015,the,0,0
27016,two,0,0
27017,groups,0,0
27018,favouring,0,0
27019,home,0,1
27020,based,0,0
27021,management,0,0
27022,in,0,0
27023,four,0,0
27024,SF-36,0,0
27025,health,0,0
27026,dimensions-general,0,0
27027,health,0,0
27028,",",0,0
27029,bodily,0,0
27030,pain,0,0
27031,",",0,0
27032,role-emotional,0,0
27033,",",0,0
27034,and,0,0
27035,social,0,1
27036,functioning,0,0
27037,(,0,0
27038,all,0,0
27039,p,0,0
27040,<,0,0
27041,or,0,0
27042,=,0,0
27043,0.001,0,0
27044,),0,0
27045,.,0,0
27046,The,0,0
27047,cost,0,0
27048,of,0,0
27049,home,0,1
27050,based,0,0
27051,care,0,0
27052,was,0,0
27053,slightly,0,0
27054,less,0,0
27055,(,0,0
27056,822,0,0
27057,euros/patient/year,0,0
27058,),0,0
27059,than,0,0
27060,hospital,0,0
27061,care,0,0
27062,",",0,0
27063,mainly,0,0
27064,as,0,0
27065,a,0,0
27066,result,0,0
27067,of,0,0
27068,a,0,0
27069,reduction,0,0
27070,in,0,0
27071,hospital,0,0
27072,admissions,0,0
27073,.,0,0
27074,CONCLUSIONS,0,0
27075,Comprehensive,1,0
27076,planning,1,0
27077,of,1,0
27078,home,1,1
27079,based,1,0
27080,intervention,1,1
27081,implemented,0,0
27082,by,0,0
27083,an,0,0
27084,interdisciplinary,0,0
27085,team,0,0
27086,and,0,0
27087,designed,0,0
27088,specifically,0,0
27089,for,0,0
27090,people,0,0
27091,with,0,0
27092,multiple,0,0
27093,sclerosis,0,0
27094,may,0,0
27095,provide,0,0
27096,a,0,0
27097,cost-effective,0,0
27098,approach,0,1
27099,to,0,0
27100,management,0,0
27101,and,0,0
27102,improve,0,0
27103,the,0,0
27104,quality,0,0
27105,of,0,0
27106,life,0,0
27107,.,0,0
27108,Hysteroscopic,1,1
27109,transcervical,1,1
27110,endometrial,1,0
27111,resection,1,1
27112,versus,0,0
27113,thermal,1,0
27114,destruction,1,0
27115,for,0,0
27116,menorrhagia,0,0
27117,:,0,0
27118,a,0,0
27119,prospective,0,0
27120,randomized,0,0
27121,trial,0,0
27122,on,0,0
27123,satisfaction,0,0
27124,rate,0,0
27125,.,0,0
27126,OBJECTIVE,0,0
27127,The,0,0
27128,purpose,0,0
27129,of,0,0
27130,this,0,0
27131,study,0,0
27132,was,0,0
27133,to,0,0
27134,compare,0,0
27135,the,0,0
27136,satisfaction,0,0
27137,rate,0,0
27138,and,0,0
27139,the,0,0
27140,effectiveness,0,0
27141,of,0,0
27142,transcervical,1,1
27143,hysteroscopic,1,1
27144,endometrial,1,0
27145,resection,1,1
27146,and,0,0
27147,thermal,1,1
27148,destruction,1,0
27149,of,0,0
27150,the,0,0
27151,endometrium,0,0
27152,in,0,0
27153,the,0,0
27154,treatment,0,0
27155,of,0,0
27156,menorrhagia,0,0
27157,.,0,0
27158,STUDY,0,0
27159,DESIGN,0,0
27160,A,0,0
27161,prospective,0,0
27162,randomized,0,0
27163,trial,0,0
27164,with,0,0
27165,2,0,0
27166,years,0,0
27167,of,0,0
27168,follow-up,0,0
27169,was,0,0
27170,carried,0,0
27171,out,0,0
27172,in,0,0
27173,the,0,0
27174,Department,0,0
27175,of,0,0
27176,Gynecology,0,0
27177,of,0,0
27178,the,0,0
27179,University,0,0
27180,of,0,0
27181,Naples,0,0
27182,.,0,0
27183,Eighty-two,0,0
27184,patients,0,0
27185,who,0,0
27186,were,0,0
27187,affected,0,0
27188,by,0,0
27189,menorrhagia,0,0
27190,that,0,0
27191,was,0,0
27192,unresponsive,0,0
27193,to,0,0
27194,medical,0,0
27195,treatment,0,0
27196,were,0,0
27197,respectively,0,0
27198,randomized,0,0
27199,to,0,0
27200,transcervical,1,1
27201,hysteroscopic,1,1
27202,endometrial,1,0
27203,resection,1,1
27204,or,1,1
27205,to,1,0
27206,thermal,1,1
27207,destruction,1,0
27208,of,1,0
27209,the,1,0
27210,endometrium,1,0
27211,.,1,0
27212,Satisfaction,0,0
27213,rate,0,0
27214,",",0,0
27215,operative,0,0
27216,time,0,0
27217,",",0,0
27218,discharge,0,0
27219,time,0,0
27220,",",0,0
27221,complication,0,0
27222,rate,0,0
27223,",",0,0
27224,reintervention,0,0
27225,rate,0,0
27226,",",0,0
27227,and,0,0
27228,resumption,0,0
27229,of,0,0
27230,normal,0,0
27231,activity,0,0
27232,were,0,0
27233,evaluated,0,0
27234,in,0,0
27235,each,0,0
27236,group,0,0
27237,.,0,0
27238,RESULTS,0,0
27239,The,0,0
27240,satisfaction,0,0
27241,rate,0,0
27242,was,0,0
27243,significantly,0,0
27244,higher,0,0
27245,in,0,0
27246,the,0,0
27247,thermal,1,1
27248,destruction,1,0
27249,group,0,0
27250,.,0,0
27251,Operative,0,0
27252,time,0,0
27253,was,0,0
27254,significantly,0,0
27255,shorter,0,0
27256,in,0,0
27257,the,0,0
27258,thermal,0,1
27259,destruction,0,0
27260,group,0,0
27261,(,0,0
27262,24,0,0
27263,+/-,0,0
27264,4,0,0
27265,minutes,0,0
27266,vs,0,0
27267,37,0,0
27268,+/-,0,0
27269,6,0,0
27270,minutes,0,0
27271,),0,0
27272,.,0,0
27273,Intraoperative,0,0
27274,blood,0,0
27275,loss,0,0
27276,was,0,0
27277,significantly,0,0
27278,lower,0,0
27279,in,0,0
27280,the,0,0
27281,thermal,0,1
27282,destruction,0,0
27283,group,0,0
27284,(,0,0
27285,7.2,0,0
27286,+/-,0,0
27287,2.8,0,0
27288,mL,0,0
27289,vs,0,0
27290,89,0,0
27291,+/-,0,0
27292,38,0,0
27293,mL,0,0
27294,),0,0
27295,.,0,0
27296,Reintervention,0,0
27297,rates,0,0
27298,were,0,0
27299,higher,0,0
27300,in,0,0
27301,the,0,0
27302,transcervical,1,1
27303,hysteroscopic,1,1
27304,endometrial,1,0
27305,resection,1,1
27306,group,0,0
27307,",",0,0
27308,although,0,0
27309,postoperative,0,0
27310,pain,0,0
27311,was,0,0
27312,not,0,0
27313,significantly,0,0
27314,different,0,0
27315,between,0,0
27316,the,0,0
27317,two,0,0
27318,groups,0,0
27319,.,0,0
27320,Discharge,0,0
27321,time,0,0
27322,",",0,0
27323,complication,0,0
27324,rate,0,0
27325,",",0,0
27326,and,0,0
27327,resumption,0,0
27328,of,0,0
27329,normal,0,0
27330,activity,0,0
27331,were,0,0
27332,not,0,0
27333,significantly,0,0
27334,different,0,0
27335,between,0,0
27336,the,0,0
27337,two,0,0
27338,groups,0,0
27339,.,0,0
27340,CONCLUSION,0,0
27341,Thermal,1,0
27342,destruction,1,0
27343,of,1,0
27344,the,1,0
27345,endometrium,1,0
27346,for,0,0
27347,the,0,0
27348,treatment,0,0
27349,of,0,0
27350,menorrhagia,0,0
27351,should,0,0
27352,be,0,0
27353,considered,0,0
27354,an,0,0
27355,effective,0,0
27356,therapeutic,0,0
27357,option,0,0
27358,because,0,0
27359,of,0,0
27360,its,0,0
27361,acceptability,0,0
27362,among,0,0
27363,patients,0,0
27364,",",0,0
27365,shorter,0,0
27366,operative,0,0
27367,time,0,0
27368,",",0,0
27369,and,0,0
27370,lower,0,0
27371,blood,0,0
27372,loss,0,0
27373,.,0,0
27374,Treatment,0,0
27375,of,0,0
27376,canine,0,0
27377,parvoviral,0,0
27378,enteritis,0,0
27379,with,0,0
27380,interferon-omega,1,1
27381,in,0,0
27382,a,0,0
27383,placebo-controlled,0,1
27384,challenge,0,0
27385,trial,0,0
27386,.,0,0
27387,Canine,0,0
27388,parvoviral,0,0
27389,enteritis,0,0
27390,continues,0,0
27391,to,0,0
27392,cause,0,0
27393,significant,0,0
27394,morbidity,0,0
27395,and,0,0
27396,mortality,0,0
27397,in,0,0
27398,dogs,0,0
27399,worldwide,0,0
27400,",",0,0
27401,and,0,0
27402,efficacious,0,0
27403,antiviral,1,0
27404,therapies,1,0
27405,are,0,0
27406,lacking,0,0
27407,.,0,0
27408,The,0,0
27409,present,0,0
27410,trial,0,0
27411,was,0,0
27412,aimed,0,0
27413,at,0,0
27414,evaluating,0,0
27415,the,0,0
27416,therapeutic,0,0
27417,efficacy,0,0
27418,of,0,0
27419,a,0,0
27420,recombinant,1,1
27421,feline,1,0
27422,interferon,1,1
27423,(,1,0
27424,type,1,0
27425,omega,1,1
27426,),1,0
27427,preparation,0,1
27428,in,0,0
27429,the,0,0
27430,treatment,0,0
27431,of,0,0
27432,parvoviral,0,0
27433,enteritis,0,0
27434,in,0,0
27435,dogs,0,0
27436,.,0,0
27437,A,0,0
27438,double-blind,0,0
27439,",",0,0
27440,placebo-controlled,0,1
27441,challenge,0,0
27442,trial,0,0
27443,was,0,0
27444,performed,0,0
27445,in,0,0
27446,beagle,0,0
27447,pups,0,0
27448,(,0,0
27449,8-9,0,0
27450,weeks,0,1
27451,),0,0
27452,;,0,0
27453,clinical,0,0
27454,signs,0,0
27455,",",0,0
27456,body,0,0
27457,weight,0,0
27458,",",0,0
27459,hematologic,0,0
27460,parameters,0,0
27461,",",0,0
27462,and,0,0
27463,mortality,0,0
27464,were,0,0
27465,monitored,0,0
27466,for,0,0
27467,a,0,0
27468,period,0,0
27469,of,0,0
27470,14,0,0
27471,days,0,0
27472,after,0,0
27473,challenge,0,0
27474,.,0,0
27475,Fourteen,0,0
27476,animals,0,0
27477,were,0,0
27478,inoculated,1,0
27479,with,1,0
27480,virulent,1,0
27481,canine,1,0
27482,parvovirus,1,0
27483,;,1,0
27484,10,0,0
27485,animals,0,0
27486,that,0,0
27487,developed,0,0
27488,clinical,0,0
27489,signs,0,0
27490,thereby,0,0
27491,meeting,0,0
27492,the,0,0
27493,inclusion,0,0
27494,criteria,0,0
27495,were,0,0
27496,admitted,0,0
27497,to,0,0
27498,the,0,0
27499,treatment,0,0
27500,phase,0,0
27501,in,0,0
27502,two,0,0
27503,randomly,0,0
27504,selected,0,0
27505,groups,0,0
27506,(,1,0
27507,placebo,1,1
27508,and,0,0
27509,IFN,1,0
27510,),1,0
27511,of,0,0
27512,equal,0,0
27513,size,0,0
27514,.,0,0
27515,The,0,0
27516,IFN,0,0
27517,group,0,0
27518,received,0,0
27519,daily,0,0
27520,intravenous,0,0
27521,injections,0,1
27522,of,0,0
27523,rFeIFN-omega,1,1
27524,(,0,0
27525,2.5,0,0
27526,MU/kg,0,1
27527,),0,0
27528,for,0,0
27529,three,0,0
27530,consecutive,0,0
27531,days,0,0
27532,.,0,0
27533,The,0,0
27534,placebo,1,1
27535,group,0,0
27536,received,0,0
27537,daily,0,0
27538,injections,0,1
27539,of,0,0
27540,saline,1,1
27541,without,0,0
27542,IFN,0,0
27543,.,0,0
27544,Both,0,0
27545,groups,0,0
27546,of,0,0
27547,animals,0,0
27548,received,0,0
27549,individual,0,0
27550,supportive,0,1
27551,treatment,0,0
27552,consisting,0,0
27553,of,0,0
27554,adjusted,0,0
27555,diet,0,1
27556,and,0,0
27557,electrolyte,0,0
27558,solution,0,1
27559,.,0,0
27560,All,0,0
27561,five,0,0
27562,dogs,0,0
27563,in,0,0
27564,the,0,0
27565,placebo,0,1
27566,group,0,0
27567,developed,0,0
27568,fulminating,0,0
27569,enteritis,0,0
27570,with,0,0
27571,typical,0,0
27572,clinical,0,0
27573,signs,0,0
27574,and,0,0
27575,died,0,0
27576,within,0,0
27577,10,0,0
27578,days,0,0
27579,post-inoculation,0,0
27580,(,0,0
27581,or,0,0
27582,6,0,0
27583,days,0,0
27584,post-treatment,0,0
27585,),0,0
27586,.,0,0
27587,In,0,0
27588,the,0,0
27589,IFN-treated,0,0
27590,group,0,0
27591,",",0,0
27592,one,0,0
27593,animal,0,0
27594,died,0,0
27595,on,0,0
27596,day,0,0
27597,2,0,0
27598,after,0,0
27599,the,0,0
27600,treatment,0,0
27601,was,0,0
27602,started,0,0
27603,",",0,0
27604,whereas,0,0
27605,the,0,0
27606,other,0,0
27607,four,0,0
27608,dogs,0,0
27609,survived,0,0
27610,the,0,0
27611,challenge,0,0
27612,and,0,0
27613,gradually,0,0
27614,recovered,0,0
27615,.,0,0
27616,Our,0,0
27617,data,0,0
27618,confirm,0,0
27619,that,0,0
27620,the,0,0
27621,rFeIFN-omega,1,0
27622,can,0,0
27623,exert,0,0
27624,a,0,0
27625,significant,0,0
27626,therapeutic,0,0
27627,effect,0,0
27628,on,0,0
27629,dogs,0,0
27630,with,0,0
27631,parvoviral,0,0
27632,enteritis,0,0
27633,by,0,0
27634,improving,0,0
27635,clinical,0,0
27636,signs,0,0
27637,and,0,0
27638,reducing,0,0
27639,mortality,0,0
27640,.,0,0
27641,Effect,0,0
27642,of,0,0
27643,macronutrient,1,1
27644,composition,0,0
27645,of,0,0
27646,the,0,0
27647,diet,0,1
27648,on,0,0
27649,the,0,0
27650,regulation,0,0
27651,of,0,0
27652,lipolysis,0,0
27653,in,0,0
27654,adipose,0,0
27655,tissue,0,0
27656,at,0,0
27657,rest,0,0
27658,and,0,0
27659,during,0,0
27660,exercise,0,1
27661,:,0,0
27662,microdialysis,0,1
27663,study,0,0
27664,.,0,0
27665,The,0,0
27666,aim,0,0
27667,of,0,0
27668,the,0,0
27669,present,0,0
27670,study,0,0
27671,was,0,0
27672,to,0,0
27673,elucidate,0,0
27674,",",0,0
27675,using,0,0
27676,a,0,0
27677,microdialysis,0,1
27678,technique,0,1
27679,",",0,0
27680,whether,0,0
27681,modifications,0,0
27682,in,0,0
27683,the,0,0
27684,proportion,0,0
27685,of,0,0
27686,fat,1,0
27687,in,1,0
27688,the,1,0
27689,diet,1,1
27690,influence,0,0
27691,lipid,0,0
27692,mobilization,0,0
27693,from,0,0
27694,adipose,0,0
27695,tissue,0,0
27696,in,0,0
27697,situ,0,0
27698,.,0,0
27699,Nine,0,1
27700,healthy,0,0
27701,volunteers,0,0
27702,(,0,0
27703,age,0,0
27704,",",0,0
27705,23.4,0,0
27706,+/-,0,0
27707,0.2,0,0
27708,years,0,0
27709,;,0,0
27710,body,0,0
27711,mas,0,0
27712,index,0,0
27713,[,0,0
27714,BMI,0,0
27715,],0,0
27716,",",0,0
27717,23.5,0,0
27718,+/-,0,0
27719,1.6,0,0
27720,kg/m,0,0
27721,(,0,0
27722,2,0,0
27723,),0,0
27724,),0,0
27725,were,0,0
27726,fed,0,0
27727,",",0,0
27728,in,0,0
27729,random,0,0
27730,order,0,0
27731,",",0,0
27732,with,0,0
27733,a,0,0
27734,high-fat,1,1
27735,diet,1,1
27736,(,1,0
27737,HFD,1,1
27738,),1,1
27739,(,1,0
27740,65,1,0
27741,%,1,0
27742,of,1,0
27743,energy,1,0
27744,content,1,0
27745,fat,1,0
27746,",",1,0
27747,15,1,0
27748,%,1,0
27749,protein,1,0
27750,",",1,0
27751,20,1,0
27752,%,1,0
27753,carbohydrate,1,1
27754,),1,0
27755,or,1,0
27756,a,1,0
27757,high-carbohydrate,1,1
27758,diet,1,1
27759,(,1,0
27760,HCD,1,1
27761,),1,1
27762,(,1,0
27763,70,1,0
27764,%,1,0
27765,carbohydrate,1,1
27766,",",1,0
27767,15,1,0
27768,%,1,0
27769,protein,1,0
27770,",",1,0
27771,15,1,0
27772,%,1,0
27773,fat,1,0
27774,),1,0
27775,for,1,0
27776,5,1,0
27777,days,1,0
27778,",",1,0
27779,with,1,0
27780,a,1,0
27781,washout,1,0
27782,period,1,0
27783,of,1,0
27784,10,1,0
27785,days,1,0
27786,between,1,0
27787,the,1,0
27788,diets,1,1
27789,.,1,0
27790,Subjects,0,0
27791,were,0,0
27792,studied,0,0
27793,in,0,0
27794,the,0,0
27795,fasting,0,0
27796,state,0,0
27797,on,0,0
27798,the,0,0
27799,morning,0,0
27800,following,0,0
27801,days,0,0
27802,4,0,0
27803,and,0,0
27804,5,0,0
27805,of,0,0
27806,each,0,0
27807,diet,0,1
27808,.,0,0
27809,We,0,0
27810,measured,0,0
27811,the,0,0
27812,concentration,0,0
27813,of,0,0
27814,extracellular,0,0
27815,glycerol,0,1
27816,(,0,0
27817,EGC,0,0
27818,),0,0
27819,in,0,0
27820,adipose,0,0
27821,tissue,0,0
27822,in,0,0
27823,response,0,0
27824,to,0,0
27825,(,0,0
27826,1,0,0
27827,),0,0
27828,pharmacologic,0,0
27829,stimulation,0,1
27830,with,0,0
27831,isoprenaline,1,1
27832,(,0,0
27833,1,0,0
27834,and,0,0
27835,10,0,0
27836,micromol/L,0,0
27837,),0,0
27838,in,0,0
27839,situ,0,0
27840,",",0,0
27841,(,0,0
27842,2,0,0
27843,),0,0
27844,stimulation,0,0
27845,with,0,0
27846,intravenous,0,1
27847,infusion,0,1
27848,of,0,0
27849,epinephrine,1,1
27850,(,0,0
27851,0.0375,0,0
27852,microg/min/kg,0,0
27853,body,0,0
27854,weight,0,0
27855,),0,0
27856,",",0,0
27857,and,0,0
27858,(,0,0
27859,3,0,0
27860,),0,0
27861,submaximal,0,0
27862,aerobic,1,1
27863,exercise,1,1
27864,(,0,0
27865,50,0,0
27866,%,0,0
27867,V*O2max,0,0
27868,",",0,0
27869,60-minute,0,1
27870,duration,0,0
27871,),0,0
27872,.,0,0
27873,No,0,0
27874,effect,0,0
27875,of,0,0
27876,the,0,0
27877,diet,0,1
27878,composition,0,0
27879,was,0,0
27880,found,0,0
27881,in,0,0
27882,the,0,0
27883,increases,0,0
27884,of,0,0
27885,EGC,0,0
27886,in,0,0
27887,response,0,0
27888,to,0,0
27889,isoprenaline,0,1
27890,(,0,0
27891,area,0,0
27892,under,0,0
27893,the,0,0
27894,curve,0,0
27895,[,0,0
27896,AUC,0,0
27897,],0,0
27898,:,0,0
27899,HFD,0,0
27900,",",0,0
27901,"1,534",0,0
27902,+/-,0,0
27903,370,0,0
27904,micromol/90,0,0
27905,min,0,0
27906,;,0,0
27907,HCD,0,1
27908,",",0,0
27909,"1,108",0,0
27910,+/-,0,0
27911,465,0,0
27912,micromol/90,0,0
27913,min,0,0
27914,;,0,0
27915,not,0,0
27916,significant,0,0
27917,[,0,0
27918,NS,0,0
27919,],0,0
27920,),0,0
27921,or,0,0
27922,epinephrine,0,1
27923,stimulations,0,1
27924,(,0,0
27925,AUC,0,0
27926,:,0,0
27927,HFD,0,0
27928,",",0,0
27929,190,0,0
27930,+/-,0,0
27931,92,0,0
27932,micromol/30,0,0
27933,min,0,0
27934,;,0,0
27935,HCD,0,1
27936,",",0,0
27937,251,0,0
27938,+/-,0,0
27939,298,0,0
27940,micromol/30,0,0
27941,min,0,0
27942,;,0,0
27943,NS,0,0
27944,),0,0
27945,.,0,0
27946,The,0,0
27947,exercise-induced,0,0
27948,increase,0,0
27949,in,0,0
27950,EGC,0,0
27951,was,0,0
27952,higher,0,0
27953,during,0,0
27954,the,0,0
27955,HFD,0,1
27956,(,0,0
27957,AUC,0,0
27958,:,0,0
27959,HFD,0,0
27960,",",0,0
27961,"1,641",0,0
27962,+/-,0,0
27963,181,0,0
27964,micromol/60,0,0
27965,min,0,0
27966,;,0,0
27967,HCD,0,1
27968,",",0,0
27969,963,0,0
27970,+/-,0,0
27971,156,0,0
27972,micromol/60,0,0
27973,min,0,0
27974,;,0,0
27975,P,0,0
27976,<,0,0
27977,.05,0,0
27978,),0,0
27979,and,0,0
27980,was,0,0
27981,associated,0,0
27982,with,0,0
27983,a,0,0
27984,higher,0,0
27985,exercise-induced,0,0
27986,response,0,0
27987,of,0,0
27988,norepinephrine,0,0
27989,(,0,0
27990,P,0,0
27991,<,0,0
27992,.05,0,0
27993,),0,0
27994,and,0,0
27995,epinephrine,0,1
27996,(,0,0
27997,P,0,0
27998,=.056,0,0
27999,),0,0
28000,and,0,0
28001,lower,0,0
28002,insulinemia,0,0
28003,during,0,0
28004,exercise,0,1
28005,.,0,0
28006,The,0,0
28007,results,0,0
28008,suggest,0,0
28009,that,0,0
28010,macronutrient,0,1
28011,composition,0,0
28012,of,0,0
28013,diet,0,1
28014,does,0,0
28015,not,0,0
28016,affect,0,0
28017,the,0,0
28018,beta-adrenergic,0,1
28019,responsiveness,0,0
28020,of,0,0
28021,adipose,0,0
28022,tissue,0,0
28023,to,0,0
28024,catecholamine,0,0
28025,action,0,0
28026,at,0,0
28027,rest,0,0
28028,.,0,0
28029,During,0,0
28030,exercise,0,0
28031,",",0,0
28032,the,0,0
28033,HFD,1,0
28034,promotes,0,0
28035,higher,0,0
28036,lipolysis,0,0
28037,in,0,0
28038,adipose,0,0
28039,tissue,0,0
28040,and,0,0
28041,this,0,0
28042,is,0,0
28043,associated,0,0
28044,with,0,0
28045,a,0,0
28046,higher,0,0
28047,catecholamine,0,0
28048,response,0,0
28049,and,0,0
28050,lower,0,0
28051,insulinemia,0,0
28052,.,0,0
28053,The,0,0
28054,effects,0,0
28055,of,0,0
28056,chloroquine,1,1
28057,",",1,0
28058,amodiaquine,1,1
28059,and,0,0
28060,chloroquine,1,1
28061,plus,1,1
28062,chlorpheniramine,1,1
28063,on,0,0
28064,the,0,0
28065,disposition,0,0
28066,kinetics,0,0
28067,of,0,0
28068,the,0,0
28069,hepatomegaly,0,0
28070,associated,0,0
28071,with,0,0
28072,acute,0,0
28073,",",0,0
28074,uncomplicated,0,0
28075,",",0,0
28076,Plasmodium,0,0
28077,falciparum,0,0
28078,malaria,0,1
28079,in,0,0
28080,children,0,0
28081,.,0,0
28082,The,0,0
28083,effects,0,0
28084,of,0,0
28085,chloroquine,1,1
28086,(,1,0
28087,CQ,1,1
28088,),1,0
28089,",",1,0
28090,amodiaquine,1,1
28091,(,1,0
28092,AQ,1,0
28093,),1,0
28094,and,0,0
28095,CQ,1,1
28096,plus,1,1
28097,chlorpheniramine,1,1
28098,(,0,0
28099,a,0,0
28100,histamine,0,1
28101,H,0,1
28102,(,0,0
28103,1,0,0
28104,),0,0
28105,antagonist,0,1
28106,that,0,0
28107,reverses,0,0
28108,CQ,0,0
28109,resistance,0,0
28110,in,0,0
28111,vitro,0,0
28112,and,0,0
28113,in,0,0
28114,vivo,0,0
28115,),0,0
28116,on,0,0
28117,the,0,0
28118,disposition,0,0
28119,of,0,0
28120,the,0,0
28121,enlarged,0,0
28122,liver,0,0
28123,associated,0,0
28124,with,0,0
28125,acute,0,0
28126,",",0,0
28127,symptomatic,0,0
28128,",",0,0
28129,uncomplicated,0,0
28130,",",0,0
28131,Plasmodium,0,0
28132,falciparum,0,0
28133,malaria,0,1
28134,were,0,0
28135,evaluated,0,0
28136,.,0,0
28137,The,0,0
28138,subjects,0,0
28139,",",0,0
28140,131,0,0
28141,children,0,0
28142,aged,0,0
28143,0.6-12,0,0
28144,years,0,0
28145,who,0,0
28146,lived,0,0
28147,in,0,0
28148,an,0,0
28149,endemic,0,0
28150,area,0,0
28151,of,0,0
28152,Nigeria,0,0
28153,",",0,0
28154,were,0,0
28155,randomly,0,0
28156,allotted,0,0
28157,to,0,0
28158,the,0,0
28159,three,0,0
28160,treatment,0,0
28161,groups,0,0
28162,.,0,0
28163,The,0,0
28164,cumulative,0,0
28165,proportions,0,0
28166,of,0,0
28167,the,0,0
28168,children,0,0
28169,with,0,0
28170,complete,0,0
28171,resolution,0,0
28172,of,0,0
28173,their,0,0
28174,enlarged,0,0
28175,livers,0,0
28176,at,0,0
28177,48,0,0
28178,",",0,0
28179,96,0,0
28180,",",0,0
28181,168,0,0
28182,or,0,0
28183,336,0,0
28184,and,0,0
28185,504,0,0
28186,h,0,0
28187,after,0,0
28188,commencement,0,0
28189,of,0,0
28190,treatment,0,0
28191,were,0,0
28192,significantly,0,0
28193,higher,0,0
28194,in,0,0
28195,those,0,0
28196,treated,0,0
28197,with,0,0
28198,CQ,1,1
28199,plus,1,1
28200,chlorpheniramine,1,1
28201,(,1,1
28202,CQCP,1,0
28203,),1,0
28204,than,0,0
28205,in,0,0
28206,the,0,0
28207,other,0,0
28208,two,0,0
28209,treatment,0,0
28210,groups,0,0
28211,(,0,0
28212,with,0,0
28213,P-values,0,0
28214,of,0,0
28215,0.02,0,0
28216,",",0,0
28217,0.001,0,0
28218,",",0,0
28219,0.00000,0,0
28220,and,0,0
28221,0.00002,0,0
28222,",",0,0
28223,respectively,0,0
28224,),0,0
28225,.,0,0
28226,Among,0,0
28227,those,0,0
28228,with,0,0
28229,complete,0,0
28230,resolution,0,0
28231,",",0,0
28232,however,0,0
28233,",",0,0
28234,the,0,0
28235,times,0,0
28236,to,0,0
28237,resolution,0,0
28238,of,0,0
28239,50,0,0
28240,%,0,0
28241,(,0,0
28242,HR50,0,1
28243,),0,0
28244,or,0,1
28245,90,0,0
28246,%,0,0
28247,(,0,0
28248,HR90,0,0
28249,),0,0
28250,of,0,0
28251,the,0,0
28252,liver,0,0
28253,enlargement,0,0
28254,were,0,0
28255,similar,0,0
28256,in,0,0
28257,all,0,0
28258,the,0,0
28259,treatment,0,0
28260,groups,0,0
28261,.,0,0
28262,Complete,0,0
28263,resolution,0,0
28264,of,0,0
28265,the,0,0
28266,enlarged,0,0
28267,liver,0,0
28268,within,0,0
28269,168,0,0
28270,h,0,0
28271,was,0,0
28272,associated,0,0
28273,with,0,0
28274,a,0,0
28275,sensitive,0,0
28276,response,0,0
28277,to,0,0
28278,each,0,0
28279,treatment,0,0
28280,.,0,0
28281,Overall,0,0
28282,",",0,0
28283,in,0,0
28284,children,0,0
28285,with,0,0
28286,complete,0,0
28287,or,0,1
28288,partial,0,0
28289,resolution,0,0
28290,of,0,0
28291,their,0,0
28292,enlarged,0,0
28293,livers,0,0
28294,",",0,0
28295,the,0,0
28296,area,0,0
28297,produced,0,0
28298,by,0,0
28299,plotting,0,0
28300,liver,0,0
28301,size,0,0
28302,against,0,0
28303,time,0,0
28304,(,0,0
28305,i.e,0,0
28306,.,0,0
28307,the,0,0
28308,area,0,0
28309,under,0,0
28310,the,0,0
28311,curve,0,0
28312,of,0,0
28313,hepatomegaly,0,0
28314,v.,0,0
28315,time,0,0
28316,",",0,0
28317,or,0,1
28318,AUC,0,0
28319,(,0,1
28320,hp,0,1
28321,),0,1
28322,),0,0
28323,and,0,0
28324,the,0,0
28325,half-life,0,0
28326,of,0,0
28327,the,0,0
28328,hepatomegaly,0,0
28329,(,0,0
28330,t,0,0
28331,(,0,0
28332,1/2hp,0,1
28333,),0,0
28334,),0,0
28335,were,0,0
28336,significantly,0,0
28337,lower,0,0
28338,in,0,0
28339,the,0,0
28340,CQCP,1,0
28341,group,0,0
28342,than,0,0
28343,in,0,0
28344,the,0,0
28345,other,0,0
28346,two,0,0
28347,groups,0,0
28348,.,0,0
28349,The,0,0
28350,volume,0,0
28351,of,0,0
28352,blood,0,0
28353,completely,0,0
28354,cleared,0,0
28355,of,0,0
28356,the,0,0
28357,'hepatic,0,0
28358,pathological,0,0
28359,processes,0,0
28360,',0,0
28361,which,0,0
28362,led,0,0
28363,to,0,0
28364,the,0,0
28365,hepatomegaly,0,0
28366,(,0,0
28367,CL,0,1
28368,(,0,1
28369,Bhp,0,1
28370,),0,1
28371,),0,0
28372,and,0,0
28373,the,0,0
28374,fractional,0,0
28375,reduction,0,0
28376,of,0,0
28377,AUC,0,0
28378,(,0,0
28379,hp,0,1
28380,),0,0
28381,at,0,0
28382,48,0,0
28383,and,0,0
28384,96,0,0
28385,h,0,1
28386,(,0,0
28387,i.e,0,0
28388,.,0,1
28389,AUC,0,0
28390,(,0,0
28391,hpFr148,0,0
28392,),0,0
28393,and,0,0
28394,AUC,0,1
28395,(,0,1
28396,hpFr96,0,1
28397,),0,1
28398,),0,0
28399,were,0,0
28400,significantly,0,0
28401,higher,0,0
28402,in,0,0
28403,the,0,0
28404,CQCP,1,0
28405,group,0,0
28406,than,0,0
28407,in,0,0
28408,the,0,0
28409,other,0,0
28410,treatment,0,0
28411,groups,0,0
28412,.,0,0
28413,When,0,0
28414,the,0,0
28415,children,0,0
28416,with,0,0
28417,complete,0,0
28418,resolution,0,0
28419,of,0,0
28420,their,0,0
28421,liver,0,0
28422,enlargement,0,0
28423,were,0,0
28424,considered,0,0
28425,separately,0,0
28426,",",0,0
28427,t,0,0
28428,(,0,0
28429,1/2hp,0,1
28430,),0,0
28431,(,0,0
28432,P=0.0008,0,0
28433,),0,0
28434,but,0,0
28435,not,0,0
28436,AUC,0,0
28437,(,0,0
28438,hp,0,1
28439,),0,0
28440,was,0,0
28441,found,0,0
28442,to,0,0
28443,be,0,0
28444,significantly,0,0
28445,lower,0,0
28446,",",0,0
28447,and,0,0
28448,AUC,0,0
28449,(,0,1
28450,hpFr196,0,0
28451,),0,1
28452,(,0,0
28453,P=0.01,0,0
28454,),0,0
28455,and,0,0
28456,CL,0,1
28457,(,0,1
28458,Bhl,0,0
28459,),0,1
28460,(,0,0
28461,P=0.002,0,0
28462,),0,0
28463,were,0,0
28464,found,0,0
28465,to,0,0
28466,be,0,0
28467,significantly,0,0
28468,higher,0,0
28469,in,0,0
28470,the,0,0
28471,CQCP,1,0
28472,group,0,0
28473,than,0,0
28474,in,0,0
28475,the,0,0
28476,other,0,0
28477,groups,0,0
28478,.,0,0
28479,Among,0,0
28480,the,0,0
28481,children,0,0
28482,with,0,0
28483,only,0,0
28484,partial,0,0
28485,resolution,0,0
28486,of,0,0
28487,their,0,0
28488,enlarged,0,0
28489,livers,0,0
28490,",",0,0
28491,the,0,0
28492,indices,0,0
28493,of,0,0
28494,resolution,0,0
28495,and,0,0
28496,the,0,0
28497,kinetic,0,0
28498,parameters,0,0
28499,of,0,0
28500,disposition,0,0
28501,were,0,0
28502,similar,0,0
28503,in,0,0
28504,all,0,0
28505,three,0,0
28506,groups,0,0
28507,.,0,0
28508,The,0,0
28509,data,0,0
28510,indicate,0,0
28511,that,0,0
28512,the,0,0
28513,addition,0,0
28514,of,0,0
28515,chlorpheniramine,1,1
28516,to,0,0
28517,chloroquine,1,1
28518,had,0,0
28519,a,0,0
28520,beneficial,0,0
28521,effect,0,0
28522,on,0,0
28523,both,0,0
28524,the,0,0
28525,early,0,0
28526,and,0,0
28527,late,0,0
28528,stages,0,0
28529,of,0,0
28530,the,0,0
28531,resolution,0,0
28532,of,0,0
28533,the,0,0
28534,liver,0,0
28535,enlargement,0,0
28536,associated,0,0
28537,with,0,0
28538,acute,0,0
28539,",",0,0
28540,symptomatic,0,0
28541,",",0,0
28542,uncomplicated,0,0
28543,",",0,0
28544,P.,0,1
28545,falciparum,0,0
28546,malaria,0,0
28547,.,0,0
28548,Lamivudine,1,1
28549,300,0,0
28550,mg,0,1
28551,QD,0,1
28552,versus,0,0
28553,continued,0,0
28554,lamivudine,1,1
28555,150,0,0
28556,mg,0,0
28557,BID,0,0
28558,with,0,0
28559,stavudine,1,1
28560,and,0,0
28561,a,0,0
28562,protease,1,1
28563,inhibitor,1,1
28564,in,0,0
28565,suppressed,0,0
28566,patients,0,0
28567,.,0,0
28568,PURPOSE,0,0
28569,To,0,0
28570,compare,0,0
28571,the,0,0
28572,efficacy,0,0
28573,(,0,0
28574,sustained,0,0
28575,virologic,0,0
28576,suppression,0,0
28577,),0,0
28578,and,0,0
28579,safety/tolerability,0,0
28580,of,0,0
28581,a,0,0
28582,switch,0,0
28583,to,0,0
28584,lamivudine,1,1
28585,300,0,0
28586,mg,0,0
28587,once,0,0
28588,daily,0,1
28589,(,0,0
28590,QD,0,1
28591,),0,0
28592,versus,0,0
28593,continued,0,0
28594,lamivudine,1,1
28595,150,0,0
28596,mg,0,0
28597,twice,0,0
28598,daily,0,1
28599,(,0,0
28600,BID,0,1
28601,),0,0
28602,in,0,0
28603,virologically,0,0
28604,suppressed,0,0
28605,patients,0,0
28606,(,0,0
28607,HIV-1,0,1
28608,RNA,0,1
28609,<,0,0
28610,400,0,0
28611,copies/mL,0,0
28612,for,0,0
28613,>,0,0
28614,or,0,0
28615,=3,0,0
28616,months,0,0
28617,),0,0
28618,on,0,0
28619,stable,0,0
28620,(,0,0
28621,>,0,0
28622,or,0,1
28623,=6,0,0
28624,months,0,0
28625,),0,0
28626,therapy,0,1
28627,with,0,0
28628,lamivudine,1,1
28629,150,1,0
28630,mg,1,1
28631,BID,1,1
28632,plus,1,1
28633,stavudine,1,1
28634,and,1,0
28635,either,1,1
28636,indinavir,1,1
28637,or,1,0
28638,nelfinavir,1,1
28639,.,1,0
28640,METHOD,0,0
28641,Eighty-nine,0,0
28642,suppressed,0,0
28643,patients,0,0
28644,>,0,0
28645,or,0,0
28646,=18,0,0
28647,years,0,0
28648,old,0,0
28649,with,0,0
28650,CD4,0,0
28651,counts,0,0
28652,>,0,0
28653,50,0,0
28654,cells/mm,0,0
28655,(,0,0
28656,3,0,0
28657,),0,0
28658,were,0,0
28659,enrolled,0,0
28660,in,0,0
28661,this,0,0
28662,phase,0,0
28663,II,0,0
28664,",",0,0
28665,open-label,0,0
28666,",",0,0
28667,multicenter,0,0
28668,",",0,0
28669,randomized,0,0
28670,",",0,0
28671,stratified,0,0
28672,(,0,0
28673,by,0,0
28674,pretrial,1,1
28675,protease,1,1
28676,inhibitor,1,1
28677,[,0,0
28678,PI,0,1
28679,],0,0
28680,),0,0
28681,",",0,0
28682,parallel-group,0,0
28683,clinical,0,0
28684,trial,0,0
28685,.,0,0
28686,Eighty-one,0,0
28687,patients,0,0
28688,received,0,0
28689,either,0,0
28690,lamivudine,1,1
28691,300,0,1
28692,mg,0,1
28693,QD,0,1
28694,(,0,0
28695,n,0,0
28696,=,0,0
28697,39,0,0
28698,),0,0
28699,or,0,0
28700,150,0,0
28701,mg,0,1
28702,BID,0,1
28703,(,0,0
28704,n,0,0
28705,=,0,0
28706,42,0,0
28707,),0,0
28708,with,0,0
28709,their,0,0
28710,pretrial,1,0
28711,stavudine/PI,1,1
28712,regimens,1,0
28713,for,0,0
28714,24,0,0
28715,weeks,0,0
28716,.,0,0
28717,RESULTS,0,0
28718,A,0,0
28719,high,0,0
28720,rate,0,0
28721,of,0,0
28722,virologic,0,0
28723,suppression,0,0
28724,was,0,0
28725,sustained,0,0
28726,with,0,0
28727,both,0,0
28728,regimens,0,0
28729,throughout,0,0
28730,the,0,0
28731,trial,0,0
28732,.,0,0
28733,At,0,0
28734,week,0,0
28735,24,0,0
28736,",",0,0
28737,intent-to-treat,0,0
28738,:,0,0
28739,exposed,0,0
28740,(,0,0
28741,missing,0,0
28742,=,0,0
28743,failure,0,0
28744,),0,0
28745,analyses,0,0
28746,showed,0,0
28747,no,0,0
28748,statistically,0,0
28749,significant,0,0
28750,differences,0,0
28751,in,0,0
28752,the,0,0
28753,percentage,0,0
28754,of,0,0
28755,patients,0,0
28756,with,0,0
28757,HIV-1,0,0
28758,RNA,0,0
28759,<,0,0
28760,400,0,1
28761,copies/mL,0,0
28762,(,0,0
28763,95,0,0
28764,%,0,0
28765,[,0,0
28766,QD,0,1
28767,],0,0
28768,vs.,0,0
28769,90,0,0
28770,%,0,0
28771,[,0,0
28772,BID,0,1
28773,],0,0
28774,),0,0
28775,or,0,0
28776,<,0,0
28777,50,0,0
28778,copies/mL,0,0
28779,(,0,0
28780,82,0,0
28781,%,0,0
28782,[,0,0
28783,QD,0,1
28784,],0,0
28785,vs.,0,0
28786,81,0,0
28787,%,0,0
28788,[,0,0
28789,BID,0,1
28790,],0,0
28791,),0,0
28792,or,0,0
28793,in,0,0
28794,the,0,0
28795,median,0,0
28796,change,0,0
28797,from,0,0
28798,baseline,0,0
28799,in,0,0
28800,CD4,0,0
28801,counts,0,0
28802,(,0,0
28803,+42,0,0
28804,cells/mm,0,0
28805,(,0,0
28806,3,0,0
28807,),0,0
28808,[,0,0
28809,QD,0,1
28810,],0,0
28811,vs.,0,0
28812,+22,0,1
28813,cells/mm,0,0
28814,(,0,0
28815,3,0,0
28816,),0,0
28817,[,0,0
28818,BID,0,1
28819,],0,0
28820,),0,0
28821,.,0,0
28822,Both,0,0
28823,regimens,0,0
28824,were,0,0
28825,well,0,0
28826,tolerated,0,0
28827,.,0,0
28828,No,0,0
28829,patient,0,0
28830,experienced,0,0
28831,virologic,0,0
28832,failure,0,0
28833,",",0,0
28834,clinical,0,0
28835,disease,0,0
28836,progression,0,0
28837,",",0,0
28838,or,0,0
28839,a,0,0
28840,drug-related,0,0
28841,serious,0,0
28842,adverse,0,0
28843,event,0,0
28844,during,0,0
28845,the,0,0
28846,trial,0,0
28847,.,0,0
28848,Self-reported,0,0
28849,medication,0,0
28850,adherence,0,0
28851,was,0,0
28852,high,0,0
28853,in,0,0
28854,both,0,0
28855,groups,0,0
28856,.,0,0
28857,CONCLUSION,0,0
28858,Patients,0,0
28859,who,0,0
28860,experience,0,0
28861,virologic,0,0
28862,suppression,0,0
28863,with,0,0
28864,a,0,0
28865,regimen,0,0
28866,of,0,0
28867,lamivudine,1,1
28868,150,0,0
28869,mg,0,0
28870,BID,0,1
28871,in,0,0
28872,combination,1,1
28873,with,1,0
28874,stavudine/PI,1,1
28875,can,0,0
28876,maintain,0,0
28877,that,0,0
28878,suppression,0,0
28879,by,0,0
28880,continuing,0,0
28881,their,0,0
28882,regimen,0,1
28883,or,0,0
28884,switching,0,0
28885,to,0,0
28886,lamivudine,1,1
28887,300,0,1
28888,mg,0,1
28889,QD,0,1
28890,and,0,0
28891,continuing,0,0
28892,the,0,0
28893,other,0,0
28894,components,0,0
28895,.,0,0
28896,Adverse,0,0
28897,event,0,0
28898,profiles,0,0
28899,were,0,0
28900,comparable,0,0
28901,among,0,0
28902,treatment,0,0
28903,regimens,0,0
28904,",",0,0
28905,and,0,0
28906,no,0,0
28907,new,0,0
28908,safety,0,0
28909,concerns,0,0
28910,were,0,0
28911,raised,0,0
28912,.,0,0
28913,Comparison,0,0
28914,of,0,0
28915,acustimulation,0,0
28916,and,0,0
28917,ondansetron,0,1
28918,for,0,0
28919,the,0,0
28920,treatment,0,0
28921,of,0,0
28922,established,0,0
28923,postoperative,0,0
28924,nausea,0,0
28925,and,0,0
28926,vomiting,0,0
28927,.,0,0
28928,BACKGROUND,0,0
28929,This,0,0
28930,study,0,0
28931,was,0,0
28932,designed,0,0
28933,to,0,0
28934,evaluate,0,0
28935,transcutaneous,0,1
28936,electrical,0,1
28937,acupoint,0,1
28938,stimulation,0,1
28939,(,0,0
28940,acustimulation,0,0
28941,),0,0
28942,using,0,0
28943,the,0,0
28944,ReliefBand,0,0
28945,compared,0,0
28946,with,0,0
28947,ondansetron,0,1
28948,for,0,0
28949,the,0,0
28950,treatment,0,0
28951,of,0,0
28952,established,0,0
28953,postoperative,0,0
28954,nausea,0,0
28955,and,0,0
28956,vomiting,0,0
28957,(,0,1
28958,PONV,0,0
28959,),0,0
28960,after,0,0
28961,outpatient,0,0
28962,laparoscopic,0,1
28963,surgery,0,0
28964,.,0,0
28965,METHODS,0,0
28966,After,0,0
28967,the,0,0
28968,authors,0,0
28969,obtained,0,0
28970,institutional,0,0
28971,review,0,0
28972,board,0,1
28973,approval,0,0
28974,and,0,0
28975,written,0,1
28976,informed,0,0
28977,consent,0,0
28978,",",0,0
28979,268,0,0
28980,outpatients,0,0
28981,were,0,0
28982,enrolled,0,0
28983,in,0,0
28984,this,0,0
28985,randomized,0,0
28986,",",0,0
28987,double-blind,0,0
28988,",",0,0
28989,placebo-,0,1
28990,and,0,0
28991,sham-controlled,0,1
28992,study,0,0
28993,.,0,0
28994,All,0,0
28995,patients,0,0
28996,received,0,0
28997,antiemetic,0,0
28998,prophylaxis,0,0
28999,with,0,0
29000,metoclopramide,0,1
29001,",",0,0
29002,10,0,0
29003,mg,0,0
29004,intravenously,0,0
29005,",",0,0
29006,or,0,0
29007,droperidol,0,1
29008,",",0,0
29009,0.625,0,1
29010,mg,0,0
29011,intravenously,0,0
29012,",",0,0
29013,after,0,0
29014,induction,0,0
29015,of,0,0
29016,anesthesia,0,1
29017,.,0,0
29018,A,0,0
29019,total,0,0
29020,of,0,0
29021,90,0,0
29022,patients,0,0
29023,developed,0,0
29024,PONV,0,0
29025,in,0,0
29026,the,0,0
29027,recovery,0,0
29028,units,0,1
29029,and,0,0
29030,were,0,0
29031,randomized,0,0
29032,to,0,0
29033,one,1,0
29034,of,1,0
29035,three,1,0
29036,treatment,1,0
29037,groups,1,0
29038,:,1,0
29039,(,1,0
29040,1,1,0
29041,),1,0
29042,the,1,0
29043,ondansetron,1,1
29044,group,1,0
29045,received,1,0
29046,4,1,0
29047,mg,1,0
29048,intravenous,1,1
29049,ondansetron,1,1
29050,and,1,0
29051,a,1,0
29052,sham,1,1
29053,ReliefBand,1,0
29054,;,1,0
29055,(,1,0
29056,2,1,0
29057,),1,0
29058,the,1,0
29059,acustimulation,1,0
29060,group,1,0
29061,received,1,0
29062,2,1,0
29063,ml,1,0
29064,intravenous,1,1
29065,saline,1,1
29066,and,1,0
29067,a,1,0
29068,ReliefBand,1,0
29069,;,1,0
29070,and,1,0
29071,(,1,0
29072,3,1,0
29073,),1,0
29074,the,1,0
29075,combination,1,1
29076,group,1,0
29077,received,1,0
29078,4,1,0
29079,mg,1,0
29080,intravenous,1,1
29081,ondansetron,1,1
29082,and,1,0
29083,a,1,0
29084,ReliefBand,1,0
29085,.,1,0
29086,A,1,0
29087,rescue,1,0
29088,antiemetic,1,1
29089,(,1,0
29090,10,1,0
29091,mg,1,1
29092,intravenous,1,1
29093,metoclopramide,1,1
29094,),1,0
29095,was,1,0
29096,administered,1,0
29097,only,1,0
29098,if,1,0
29099,the,1,0
29100,PONV,1,0
29101,symptoms,1,0
29102,persisted,1,0
29103,for,1,0
29104,15,1,0
29105,min,1,0
29106,or,1,0
29107,longer,1,0
29108,after,1,0
29109,initiating,1,0
29110,the,1,0
29111,treatment,1,0
29112,.,1,0
29113,A,0,0
29114,blinded,0,0
29115,observer,0,0
29116,recorded,0,0
29117,the,0,0
29118,recovery,0,0
29119,times,0,0
29120,",",0,0
29121,emetic,0,0
29122,symptoms,0,0
29123,",",0,0
29124,rescue,0,0
29125,antiemetics,0,0
29126,",",0,0
29127,maximum,0,0
29128,nausea,0,0
29129,scores,0,0
29130,",",0,0
29131,complete,0,0
29132,response,0,0
29133,to,0,0
29134,study,0,0
29135,treatment,0,0
29136,",",0,0
29137,and,0,0
29138,time,0,0
29139,to,0,0
29140,achieve,0,0
29141,discharge,0,0
29142,criteria,0,0
29143,.,0,0
29144,Postdischarge,0,0
29145,side,0,0
29146,effects,0,0
29147,",",0,0
29148,as,0,0
29149,well,0,0
29150,as,0,0
29151,patient,0,0
29152,satisfaction,0,0
29153,and,0,0
29154,quality,0,0
29155,of,0,0
29156,recovery,0,0
29157,scores,0,0
29158,",",0,0
29159,were,0,0
29160,assessed,0,0
29161,at,0,0
29162,24,0,0
29163,and,0,0
29164,72,0,0
29165,h,0,0
29166,after,0,0
29167,surgery,0,0
29168,.,0,0
29169,RESULTS,0,0
29170,The,0,0
29171,combination,0,1
29172,group,0,0
29173,had,0,0
29174,a,0,0
29175,significantly,0,0
29176,higher,0,0
29177,complete,0,0
29178,response,0,0
29179,rate,0,0
29180,than,0,0
29181,the,0,0
29182,acustimulation,0,0
29183,group,0,0
29184,(,0,0
29185,73,0,0
29186,%,0,0
29187,vs.40,0,0
29188,%,0,0
29189,",",0,0
29190,P,0,0
29191,<,0,0
29192,0.01,0,0
29193,),0,0
29194,.,0,0
29195,In,0,0
29196,addition,0,0
29197,",",0,0
29198,fewer,0,0
29199,patients,0,0
29200,(,0,0
29201,8,0,0
29202,vs.,0,0
29203,18,0,0
29204,),0,0
29205,in,0,0
29206,the,0,0
29207,combination,0,1
29208,(,0,0
29209,vs.,0,0
29210,acustimulation,0,0
29211,),0,0
29212,group,0,0
29213,experienced,0,0
29214,subsequent,0,0
29215,emetic,0,0
29216,events,0,0
29217,(,0,0
29218,P,0,0
29219,<,0,0
29220,0.03,0,0
29221,),0,0
29222,.,0,0
29223,However,0,0
29224,",",0,0
29225,there,0,0
29226,were,0,0
29227,no,0,0
29228,significant,0,0
29229,differences,0,0
29230,between,0,0
29231,the,0,0
29232,three,0,0
29233,groups,0,0
29234,with,0,0
29235,respect,0,0
29236,to,0,0
29237,patient,0,0
29238,satisfaction,0,0
29239,and,0,0
29240,quality,0,0
29241,of,0,0
29242,recovery,0,0
29243,scores,0,0
29244,.,0,0
29245,CONCLUSIONS,0,0
29246,Acustimulation,0,0
29247,with,0,0
29248,the,0,0
29249,ReliefBand,0,0
29250,can,0,0
29251,be,0,0
29252,used,0,0
29253,as,0,0
29254,an,0,0
29255,alternative,0,0
29256,to,0,0
29257,ondansetron,0,1
29258,for,0,0
29259,the,0,0
29260,treatment,0,0
29261,of,0,0
29262,established,0,0
29263,PONV,0,0
29264,.,0,0
29265,However,0,0
29266,",",0,0
29267,the,0,0
29268,use,0,0
29269,of,0,0
29270,ondansetron,0,1
29271,(,0,0
29272,4,0,0
29273,mg,0,1
29274,intravenously,0,0
29275,),0,0
29276,in,0,0
29277,combination,0,1
29278,with,0,0
29279,the,0,0
29280,ReliefBand,0,0
29281,device,0,0
29282,improved,0,0
29283,the,0,0
29284,complete,0,0
29285,response,0,0
29286,rate,0,0
29287,to,0,0
29288,the,0,0
29289,acustimulation,0,0
29290,therapy,0,1
29291,.,0,0
29292,Pharmacokinetic,0,0
29293,and,0,0
29294,safety,0,0
29295,assessments,0,0
29296,of,0,0
29297,galantamine,1,1
29298,and,1,0
29299,risperidone,1,1
29300,after,0,0
29301,the,0,0
29302,two,0,0
29303,drugs,0,0
29304,are,0,0
29305,administered,0,0
29306,alone,0,0
29307,and,0,0
29308,together,0,0
29309,.,0,0
29310,To,0,0
29311,explore,0,0
29312,the,0,0
29313,steady-state,0,0
29314,pharmacokinetic,0,0
29315,profile,0,0
29316,after,0,0
29317,coadministration,0,1
29318,of,0,0
29319,galantamine,1,1
29320,and,1,0
29321,risperidone,1,1
29322,",",0,0
29323,an,0,0
29324,open-label,0,0
29325,",",0,0
29326,randomized,0,0
29327,",",0,0
29328,single-center,0,0
29329,",",0,0
29330,two-way,0,0
29331,crossover,0,0
29332,drug-drug,0,0
29333,interaction,0,0
29334,study,0,0
29335,was,0,0
29336,conducted,0,0
29337,in,0,0
29338,16,0,0
29339,healthy,0,0
29340,elderly,0,0
29341,subjects,0,0
29342,",",0,0
29343,ages,0,0
29344,60,0,0
29345,years,0,0
29346,and,0,0
29347,older,0,0
29348,.,0,0
29349,The,0,0
29350,results,0,0
29351,showed,0,0
29352,that,0,0
29353,risperidone,1,1
29354,",",0,0
29355,when,0,0
29356,administered,0,0
29357,with,0,0
29358,galantamine,1,1
29359,",",0,0
29360,did,0,0
29361,not,0,0
29362,change,0,0
29363,the,0,0
29364,bioavailability,0,0
29365,of,0,0
29366,galantamine,1,1
29367,at,0,0
29368,steady,0,0
29369,state,0,0
29370,.,0,0
29371,In,0,0
29372,addition,0,0
29373,",",0,0
29374,systemic,0,0
29375,exposure,0,0
29376,of,0,0
29377,risperidone,1,1
29378,active,0,1
29379,moiety,0,1
29380,(,1,0
29381,risperidone,1,1
29382,plus,1,1
29383,9-hydroxyrisperidone,1,0
29384,),1,0
29385,",",0,0
29386,the,0,0
29387,most,0,0
29388,clinically,0,0
29389,relevant,0,0
29390,component,0,0
29391,of,0,0
29392,risperidone,1,1
29393,treatment,0,0
29394,",",0,0
29395,was,0,0
29396,not,0,0
29397,affected,0,0
29398,by,0,0
29399,galantamine,1,1
29400,coadministration,0,1
29401,",",0,0
29402,while,0,0
29403,systemic,0,0
29404,exposure,0,0
29405,was,0,0
29406,increased,0,0
29407,by,0,0
29408,approximately,0,0
29409,10,0,0
29410,%,0,0
29411,for,0,0
29412,risperidone,1,1
29413,and,0,0
29414,decreased,0,0
29415,by,0,0
29416,about,0,0
29417,10,0,0
29418,%,0,0
29419,for,0,0
29420,9-hydroxyrisperidone,1,0
29421,(,0,0
29422,active,0,0
29423,metabolite,0,0
29424,of,0,0
29425,risperidone,1,1
29426,),1,0
29427,.,0,0
29428,Galantamine,1,1
29429,and,1,0
29430,risperidone,1,1
29431,were,0,0
29432,both,0,0
29433,safe,0,0
29434,and,0,0
29435,well,0,0
29436,tolerated,0,0
29437,administered,0,0
29438,either,0,0
29439,alone,0,1
29440,or,0,0
29441,together,0,0
29442,.,0,0
29443,Thus,0,0
29444,",",0,0
29445,no,0,0
29446,dose,0,0
29447,adjustment,0,0
29448,for,0,0
29449,either,0,0
29450,risperidone,1,1
29451,orgalantamine,1,1
29452,is,0,0
29453,necessary,0,0
29454,when,0,0
29455,these,0,0
29456,two,0,0
29457,drugs,0,0
29458,are,0,0
29459,administered,0,0
29460,together,0,0
29461,in,0,0
29462,the,0,0
29463,dose,0,0
29464,range,0,0
29465,evaluated,0,0
29466,.,0,0
29467,Clinical,0,0
29468,performance,0,0
29469,of,0,0
29470,the,0,0
29471,Reichert,1,0
29472,AT550,1,0
29473,:,1,0
29474,a,0,0
29475,new,0,0
29476,non-contact,1,0
29477,tonometer,1,1
29478,.,1,0
29479,The,0,0
29480,aim,0,0
29481,of,0,0
29482,the,0,0
29483,present,0,0
29484,study,0,0
29485,was,0,0
29486,to,0,0
29487,assess,0,0
29488,the,0,0
29489,level,0,0
29490,of,0,0
29491,accuracy,0,0
29492,for,0,0
29493,measurements,0,0
29494,of,0,0
29495,intra-ocular,0,1
29496,pressure,0,0
29497,(,0,0
29498,IOP,0,0
29499,),0,0
29500,obtained,0,0
29501,with,0,0
29502,a,0,0
29503,new,0,0
29504,non-contact,1,1
29505,tonometer,1,1
29506,(,1,0
29507,NCT,1,0
29508,),1,0
29509,the,1,0
29510,Reichert,1,0
29511,AT550,1,0
29512,.,1,0
29513,Measurements,0,0
29514,were,0,0
29515,compared,0,0
29516,against,0,0
29517,those,0,0
29518,obtained,0,0
29519,with,0,0
29520,the,0,0
29521,Reichert,1,0
29522,Xpert,1,0
29523,Plus,1,0
29524,",",1,0
29525,Goldmann,1,1
29526,applanation,1,1
29527,tonometer,1,1
29528,and,1,0
29529,Perkins,1,1
29530,tonometer,1,1
29531,.,1,0
29532,Thirty-five,0,0
29533,university,0,0
29534,students,0,0
29535,were,0,0
29536,assessed,0,0
29537,with,0,0
29538,the,0,0
29539,four,0,0
29540,tonometers,0,0
29541,in,0,0
29542,a,0,0
29543,randomised,0,0
29544,order,0,0
29545,",",0,0
29546,with,0,0
29547,non-contact,0,0
29548,tonometry,0,0
29549,performed,0,0
29550,first,0,0
29551,.,0,0
29552,Each,0,0
29553,of,0,0
29554,the,0,0
29555,four,0,0
29556,measurement,0,0
29557,devices,0,0
29558,had,0,0
29559,its,0,0
29560,own,0,0
29561,trained,0,1
29562,clinical,0,0
29563,observer,0,0
29564,.,0,0
29565,Plots,0,0
29566,of,0,0
29567,differences,0,0
29568,of,0,0
29569,IOP,0,0
29570,as,0,0
29571,a,0,0
29572,function,0,0
29573,of,0,0
29574,the,0,0
29575,mean,0,0
29576,for,0,0
29577,each,0,0
29578,pair,0,0
29579,of,0,0
29580,instruments,0,0
29581,were,0,0
29582,obtained,0,0
29583,.,0,0
29584,No,0,0
29585,statistically,0,0
29586,significant,0,0
29587,differences,0,0
29588,were,0,0
29589,found,0,0
29590,when,0,0
29591,comparing,0,0
29592,the,0,0
29593,AT550,1,0
29594,NCT,1,0
29595,with,0,0
29596,contact,1,0
29597,applanation,1,1
29598,tonometry,1,1
29599,(,1,0
29600,AT,1,1
29601,),1,1
29602,(,0,0
29603,p,0,0
29604,>,0,0
29605,0.05,0,0
29606,),0,0
29607,",",0,0
29608,displaying,0,0
29609,the,0,0
29610,closest,0,0
29611,level,0,0
29612,of,0,0
29613,agreement,0,0
29614,(,0,0
29615,as,0,0
29616,represented,0,0
29617,by,0,0
29618,the,0,0
29619,lowest,0,0
29620,mean,0,0
29621,difference,0,0
29622,and,0,0
29623,the,0,0
29624,narrowest,0,0
29625,confidence,0,0
29626,interval,0,0
29627,),0,0
29628,with,0,0
29629,the,0,0
29630,Goldmann,1,1
29631,tonometer,1,1
29632,(,0,0
29633,limits,0,0
29634,of,0,0
29635,agreement,0,0
29636,",",0,0
29637,0.12+/-2.17,0,0
29638,),0,0
29639,.,0,0
29640,In,0,0
29641,conclusion,0,0
29642,",",0,0
29643,readings,0,0
29644,of,0,0
29645,IOP,0,0
29646,with,0,0
29647,the,0,0
29648,AT550,1,0
29649,NCT,1,0
29650,are,0,0
29651,clinically,0,0
29652,comparable,0,0
29653,with,0,0
29654,those,0,0
29655,obtained,0,0
29656,with,0,0
29657,Goldmann,1,0
29658,tonometry,1,0
29659,in,0,0
29660,a,0,0
29661,population,0,0
29662,with,0,0
29663,IOP,0,0
29664,within,0,0
29665,the,0,0
29666,normal,0,0
29667,range,0,0
29668,.,0,0
29669,Increased,0,0
29670,concentration,0,0
29671,of,0,0
29672,corticosteroid-binding,0,0
29673,globulin,0,1
29674,due,0,0
29675,to,0,0
29676,antidepressant,0,1
29677,treatment,0,0
29678,with,0,0
29679,amitritpyline,1,1
29680,",",0,0
29681,but,0,0
29682,not,0,0
29683,paroxetine,1,1
29684,.,1,0
29685,Utilization,0,0
29686,of,0,0
29687,health,1,0
29688,care,1,0
29689,services,1,0
29690,by,0,0
29691,patients,0,0
29692,with,0,0
29693,chronic,0,0
29694,obstructive,0,0
29695,pulmonary,0,0
29696,disease,0,0
29697,.,0,0
29698,In,0,0
29699,order,0,0
29700,to,0,0
29701,identify,0,0
29702,healthcare,1,0
29703,resource,1,0
29704,use,0,0
29705,patterns,0,0
29706,associated,0,0
29707,with,0,0
29708,chronic,0,0
29709,obstructive,0,0
29710,pulmonary,0,0
29711,disease,0,0
29712,(,0,0
29713,COPD,0,0
29714,),0,0
29715,",",0,0
29716,resource,0,0
29717,utilization,0,0
29718,(,0,0
29719,RU,0,0
29720,),0,0
29721,data,0,0
29722,collection,0,0
29723,was,0,0
29724,integrated,0,0
29725,into,0,0
29726,a,0,0
29727,randomized,0,0
29728,",",0,0
29729,double-blind,0,0
29730,placebo-controlled,1,1
29731,study,0,0
29732,of,0,0
29733,Viozan,0,1
29734,(,0,0
29735,sibenadet,0,1
29736,HCl,0,1
29737,),0,0
29738,.,0,0
29739,This,0,0
29740,study,0,0
29741,enrolled,0,0
29742,patients,0,0
29743,with,0,0
29744,symptomatic,0,0
29745,",",0,0
29746,smoking-related,0,0
29747,COPD,0,0
29748,",",0,0
29749,randomized,0,0
29750,to,0,0
29751,receive,0,1
29752,sibenadet,1,1
29753,or,1,1
29754,placebo,1,1
29755,for,0,0
29756,a,0,0
29757,52-week,0,0
29758,treatment,0,0
29759,period,0,0
29760,.,0,0
29761,A,0,0
29762,questionnaire,0,0
29763,establishing,0,0
29764,typical,0,0
29765,pre-trial,0,0
29766,",",0,0
29767,COPD-related,0,0
29768,RU,0,0
29769,was,0,0
29770,completed,0,0
29771,by,0,0
29772,each,0,0
29773,patient,0,0
29774,.,0,0
29775,Subsequent,0,0
29776,data,0,0
29777,were,0,0
29778,collected,0,0
29779,by,0,0
29780,means,0,0
29781,of,0,0
29782,an,0,0
29783,Interactive,1,0
29784,Voice,1,0
29785,Response,1,0
29786,System,1,0
29787,(,0,0
29788,IVRS,0,1
29789,),0,0
29790,at,0,0
29791,30-day,0,0
29792,intervals,0,0
29793,(,0,0
29794,14,0,0
29795,time,0,0
29796,points,0,0
29797,),0,0
29798,during,0,0
29799,the,0,0
29800,study,0,0
29801,and,0,0
29802,in,0,0
29803,the,0,0
29804,follow-up,0,0
29805,period,0,0
29806,.,0,0
29807,The,0,0
29808,IVRS,0,0
29809,system,0,0
29810,facilitated,0,0
29811,data,0,0
29812,collection,0,0
29813,and,0,0
29814,minimized,0,0
29815,inconvenience,0,0
29816,to,0,0
29817,the,0,0
29818,patient,0,0
29819,.,0,0
29820,Compliance,0,0
29821,with,0,0
29822,the,0,0
29823,requirement,0,0
29824,to,0,0
29825,record,0,0
29826,details,0,0
29827,of,0,0
29828,the,0,0
29829,healthcare,0,0
29830,services,0,0
29831,during,0,0
29832,the,0,0
29833,year-long,0,0
29834,study,0,0
29835,was,0,0
29836,high,0,0
29837,.,0,0
29838,No,0,0
29839,overall,0,0
29840,trend,0,0
29841,for,0,0
29842,lower,0,0
29843,RU,0,0
29844,was,0,0
29845,associated,0,0
29846,with,0,0
29847,sibenadet,0,1
29848,therapy,0,1
29849,",",0,0
29850,which,0,0
29851,correlates,0,0
29852,with,0,0
29853,the,0,0
29854,lack,0,0
29855,of,0,0
29856,sustained,0,0
29857,clinical,0,0
29858,effect,0,0
29859,seen,0,0
29860,in,0,0
29861,studies,0,0
29862,conducted,0,0
29863,concurrently,0,0
29864,.,0,0
29865,These,0,0
29866,data,0,0
29867,do,0,0
29868,",",0,0
29869,however,0,0
29870,",",0,0
29871,provide,0,0
29872,valuable,0,0
29873,information,0,0
29874,on,0,0
29875,RU,0,0
29876,associated,0,0
29877,with,0,0
29878,COPD,0,0
29879,and,0,0
29880,insights,0,0
29881,into,0,0
29882,adjustments,0,0
29883,associated,0,0
29884,with,0,0
29885,changes,0,0
29886,in,0,0
29887,disease,0,0
29888,course,0,0
29889,.,0,0
29890,Physicians,0,0
29891,were,0,0
29892,seen,0,0
29893,to,0,0
29894,be,0,0
29895,the,0,0
29896,most,0,0
29897,common,0,0
29898,source,0,0
29899,of,0,0
29900,care,0,0
29901,for,0,0
29902,patients,0,0
29903,with,0,0
29904,COPD,0,0
29905,and,0,0
29906,more,0,0
29907,of,0,0
29908,the,0,0
29909,patients,0,0
29910,with,0,0
29911,severe,0,0
29912,COPD,0,1
29913,(,0,0
29914,stage,0,0
29915,III,0,0
29916,),0,0
29917,than,0,0
29918,mild,0,0
29919,(,0,0
29920,stage,0,0
29921,I,0,0
29922,),0,0
29923,were,0,0
29924,seen,0,0
29925,to,0,0
29926,utilize,0,0
29927,the,0,0
29928,most,0,0
29929,expensive,0,0
29930,resources,0,0
29931,(,0,0
29932,e.g,0,0
29933,.,0,0
29934,inpatient,0,0
29935,hospital,0,0
29936,care,0,1
29937,),0,0
29938,.,0,0
29939,For,0,0
29940,those,0,0
29941,patients,0,0
29942,who,0,0
29943,experienced,0,0
29944,an,0,0
29945,exacerbation,0,0
29946,during,0,0
29947,the,0,0
29948,trial,0,0
29949,(,0,0
29950,irrespective,0,0
29951,of,0,0
29952,treatment,0,0
29953,group,0,0
29954,),0,0
29955,",",0,0
29956,resource,0,0
29957,use,0,0
29958,was,0,0
29959,increased,0,0
29960,during,0,0
29961,the,0,0
29962,periods,0,0
29963,when,0,0
29964,an,0,0
29965,exacerbation,0,0
29966,was,0,0
29967,reported,0,0
29968,when,0,0
29969,compared,0,0
29970,with,0,0
29971,the,0,0
29972,periods,0,0
29973,before,0,0
29974,or,0,0
29975,after,0,0
29976,an,0,0
29977,exacerbation,0,0
29978,.,0,0
29979,The,0,0
29980,proportion,0,0
29981,of,0,0
29982,cases,0,0
29983,attending,0,0
29984,the,0,0
29985,physician,0,0
29986,doubled,0,0
29987,and,0,0
29988,with,0,0
29989,a,0,0
29990,trip,0,0
29991,to,0,0
29992,the,0,0
29993,Emergency,0,1
29994,Room,0,1
29995,(,0,0
29996,ER,0,1
29997,),0,0
29998,increased,0,0
29999,approximately,0,0
30000,ninefold,0,0
30001,during,0,0
30002,the,0,0
30003,reporting,0,0
30004,period,0,0
30005,in,0,0
30006,which,0,0
30007,the,0,0
30008,exacerbation,0,0
30009,occurred,0,0
30010,compared,0,0
30011,with,0,0
30012,the,0,0
30013,previous,0,0
30014,month,0,0
30015,.,0,0
30016,This,0,0
30017,study,0,0
30018,has,0,0
30019,shown,0,0
30020,that,0,0
30021,use,0,0
30022,of,0,0
30023,an,0,0
30024,IVRS,0,0
30025,",",0,0
30026,even,0,0
30027,in,0,0
30028,elderly,0,0
30029,patients,0,0
30030,",",0,0
30031,is,0,0
30032,an,0,0
30033,effective,0,0
30034,means,0,0
30035,of,0,0
30036,gathering,0,0
30037,RU,0,0
30038,data,0,0
30039,over,0,0
30040,long,0,0
30041,periods,0,0
30042,.,0,0
30043,The,0,0
30044,study,0,0
30045,findings,0,0
30046,suggest,0,0
30047,that,0,0
30048,the,0,0
30049,advent,0,0
30050,of,0,0
30051,effective,0,0
30052,therapeutic,0,0
30053,interventions,0,0
30054,",",0,0
30055,particularly,0,0
30056,any,0,0
30057,with,0,0
30058,the,0,0
30059,ability,0,0
30060,to,0,0
30061,minimize,0,0
30062,exacerbations,0,0
30063,and,0,0
30064,limit,0,0
30065,disease,0,0
30066,progression,0,0
30067,",",0,0
30068,could,0,0
30069,impact,0,0
30070,on,0,0
30071,the,0,0
30072,health,0,0
30073,care,0,0
30074,services,0,1
30075,used,0,0
30076,and,0,0
30077,potentially,0,0
30078,reduce,0,0
30079,associated,0,0
30080,costs,0,0
30081,.,0,0
30082,Double-blind,0,0
30083,",",0,0
30084,placebo-controlled,1,1
30085,study,0,0
30086,of,0,0
30087,L-carnosine,1,1
30088,supplementation,1,1
30089,in,0,0
30090,children,0,0
30091,with,0,0
30092,autistic,0,0
30093,spectrum,0,0
30094,disorders,0,0
30095,.,0,0
30096,L-Carnosine,1,0
30097,",",1,0
30098,a,1,0
30099,dipeptide,1,0
30100,",",0,0
30101,can,0,0
30102,enhance,0,0
30103,frontal,0,0
30104,lobe,0,0
30105,function,0,0
30106,or,0,1
30107,be,0,0
30108,neuroprotective,0,0
30109,.,0,0
30110,It,0,0
30111,can,0,0
30112,also,0,0
30113,correlate,0,0
30114,with,0,0
30115,gamma-aminobutyric,0,0
30116,acid,0,1
30117,(,0,0
30118,GABA,0,1
30119,),0,1
30120,-homocarnosine,0,1
30121,interaction,0,0
30122,",",0,0
30123,with,0,0
30124,possible,0,0
30125,anticonvulsive,0,1
30126,effects,0,0
30127,.,0,0
30128,We,0,0
30129,investigated,0,0
30130,31,0,0
30131,children,0,0
30132,with,0,0
30133,autistic,0,0
30134,spectrum,0,0
30135,disorders,0,0
30136,in,0,0
30137,an,0,0
30138,8-week,0,0
30139,",",0,0
30140,double-blinded,0,0
30141,study,0,0
30142,to,0,0
30143,determine,0,0
30144,if,0,0
30145,800,0,0
30146,mg,0,0
30147,L-carnosine,1,1
30148,daily,0,0
30149,would,0,0
30150,result,0,0
30151,in,0,0
30152,observable,0,0
30153,changes,0,0
30154,versus,0,0
30155,placebo,1,1
30156,.,1,0
30157,Outcome,0,0
30158,measures,0,0
30159,were,0,0
30160,the,0,0
30161,Childhood,0,0
30162,Autism,0,0
30163,Rating,0,0
30164,Scale,0,0
30165,",",0,0
30166,the,0,0
30167,Gilliam,0,0
30168,Autism,0,0
30169,Rating,0,0
30170,Scale,0,0
30171,",",0,0
30172,the,0,0
30173,Expressive,0,0
30174,and,0,0
30175,Receptive,0,1
30176,One-Word,0,1
30177,Picture,0,1
30178,Vocabulary,0,1
30179,tests,0,0
30180,",",0,0
30181,and,0,0
30182,Clinical,0,0
30183,Global,0,0
30184,Impressions,0,1
30185,of,0,0
30186,Change,0,0
30187,.,0,0
30188,Children,0,0
30189,on,0,0
30190,placebo,1,1
30191,did,0,0
30192,not,0,0
30193,show,0,0
30194,statistically,0,0
30195,significant,0,0
30196,changes,0,0
30197,.,0,0
30198,After,0,0
30199,8,0,0
30200,weeks,0,0
30201,on,0,0
30202,L-carnosine,1,1
30203,",",0,0
30204,children,0,0
30205,showed,0,0
30206,statistically,0,0
30207,significant,0,0
30208,improvements,0,0
30209,on,0,0
30210,the,0,0
30211,Gilliam,0,0
30212,Autism,0,0
30213,Rating,0,0
30214,Scale,0,1
30215,(,0,0
30216,total,0,0
30217,score,0,0
30218,and,0,0
30219,the,0,0
30220,Behavior,0,0
30221,",",0,0
30222,Socialization,0,0
30223,",",0,0
30224,and,0,0
30225,Communication,0,1
30226,subscales,0,0
30227,),0,0
30228,and,0,0
30229,the,0,0
30230,Receptive,0,0
30231,One-Word,0,0
30232,Picture,0,1
30233,Vocabulary,0,1
30234,test,0,0
30235,(,0,0
30236,all,0,0
30237,P,0,0
30238,<,0,0
30239,.05,0,0
30240,),0,0
30241,.,0,0
30242,Improved,0,0
30243,trends,0,0
30244,were,0,0
30245,noted,0,0
30246,on,0,0
30247,other,0,0
30248,outcome,0,0
30249,measures,0,0
30250,.,0,0
30251,Although,0,0
30252,the,0,0
30253,mechanism,0,0
30254,of,0,0
30255,action,0,0
30256,of,0,0
30257,L-carnosine,1,1
30258,is,0,0
30259,not,0,0
30260,well,0,0
30261,understood,0,0
30262,",",0,0
30263,it,0,0
30264,may,0,0
30265,enhance,0,0
30266,neurologic,0,0
30267,function,0,0
30268,",",0,0
30269,perhaps,0,0
30270,in,0,0
30271,the,0,0
30272,enterorhinal,0,0
30273,or,0,0
30274,temporal,0,0
30275,cortex,0,0
30276,.,0,0
30277,Gastrointestinal,0,0
30278,safety,0,0
30279,of,0,0
30280,NO-aspirin,1,1
30281,(,1,0
30282,NCX-4016,1,1
30283,),1,0
30284,in,0,0
30285,healthy,0,0
30286,human,0,0
30287,volunteers,0,0
30288,:,0,0
30289,a,0,0
30290,proof,0,0
30291,of,0,0
30292,concept,0,0
30293,endoscopic,0,1
30294,study,0,0
30295,.,0,0
30296,BACKGROUND,0,0
30297,AND,0,0
30298,AIMS,0,0
30299,NCX-4016,1,1
30300,is,0,0
30301,a,0,0
30302,nitric,0,0
30303,oxide-releasing,0,1
30304,derivative,0,1
30305,of,0,0
30306,aspirin,0,1
30307,with,0,0
30308,antiplatelet,0,1
30309,activity,0,0
30310,.,0,0
30311,The,0,0
30312,aim,0,0
30313,of,0,0
30314,this,0,0
30315,study,0,0
30316,was,0,0
30317,to,0,0
30318,investigate,0,0
30319,the,0,0
30320,effect,0,0
30321,of,0,0
30322,NCX-4016,1,0
30323,on,0,0
30324,gastrointestinal,0,0
30325,mucosa,0,0
30326,and,0,0
30327,platelet,0,0
30328,functions,0,0
30329,in,0,0
30330,healthy,0,0
30331,human,0,0
30332,volunteers,0,0
30333,.,0,0
30334,METHODS,0,0
30335,This,0,0
30336,was,0,0
30337,a,0,0
30338,parallel-group,0,0
30339,",",0,0
30340,double-blind,0,0
30341,",",0,0
30342,placebo-controlled,0,1
30343,study,0,0
30344,.,0,0
30345,Forty,0,0
30346,healthy,0,0
30347,subjects,0,0
30348,were,0,0
30349,randomly,0,0
30350,allocated,0,0
30351,to,0,0
30352,receive,0,0
30353,7,0,0
30354,days,0,0
30355,of,0,0
30356,treatment,0,0
30357,with,0,0
30358,NCX-4016,1,1
30359,(,1,0
30360,400,1,0
30361,and,1,0
30362,800,1,0
30363,mg,1,0
30364,twice,1,0
30365,daily,1,1
30366,),1,0
30367,",",1,0
30368,equimolar,1,0
30369,doses,1,0
30370,of,1,0
30371,aspirin,1,1
30372,(,1,0
30373,200,1,1
30374,and,1,0
30375,420,1,0
30376,mg,1,0
30377,twice,1,0
30378,daily,1,1
30379,),1,0
30380,",",1,0
30381,or,1,0
30382,placebo,1,1
30383,.,1,0
30384,Upper,0,0
30385,endoscopies,0,0
30386,were,0,0
30387,performed,0,0
30388,before,0,0
30389,and,0,0
30390,at,0,0
30391,the,0,0
30392,end,0,0
30393,of,0,0
30394,the,0,0
30395,treatment,0,0
30396,period,0,0
30397,",",0,0
30398,and,0,0
30399,gastroduodenal,0,0
30400,lesions,0,0
30401,were,0,0
30402,graded,0,0
30403,using,0,0
30404,a,0,0
30405,predefined,0,0
30406,scoring,0,0
30407,system,0,0
30408,.,0,0
30409,Basal,0,0
30410,and,0,0
30411,posttreatment,0,0
30412,platelet,0,0
30413,aggregation,0,0
30414,in,0,0
30415,response,0,0
30416,to,0,0
30417,arachidonic,0,1
30418,acid,0,1
30419,(,0,0
30420,AA,0,1
30421,),0,1
30422,and,0,0
30423,serum,0,0
30424,thromboxane,0,0
30425,(,0,0
30426,TX,0,0
30427,),0,1
30428,B,0,0
30429,(,0,0
30430,2,0,0
30431,),0,0
30432,and,0,0
30433,AA-stimulated,0,0
30434,platelet,0,0
30435,TXB,0,1
30436,(,0,0
30437,2,0,0
30438,),0,0
30439,production,0,0
30440,were,0,0
30441,investigated,0,0
30442,.,0,0
30443,RESULTS,0,0
30444,Mucosal,0,0
30445,endoscopic,0,1
30446,injury,0,0
30447,score,0,0
30448,on,0,0
30449,day,0,0
30450,7,0,0
30451,was,0,0
30452,0.63,0,0
30453,+/-,0,0
30454,0.16,0,0
30455,in,0,0
30456,the,0,0
30457,placebo,0,1
30458,group,0,0
30459,and,0,0
30460,11.0,0,0
30461,+/-,0,0
30462,3.0,0,0
30463,and,0,0
30464,16.1,0,0
30465,+/-,0,0
30466,1.6,0,0
30467,in,0,0
30468,healthy,0,0
30469,volunteers,0,0
30470,treated,0,0
30471,with,0,0
30472,200,0,0
30473,and,0,0
30474,420,0,0
30475,mg,0,1
30476,aspirin,0,1
30477,twice,0,0
30478,daily,0,1
30479,(,0,0
30480,P,0,0
30481,<,0,0
30482,0.0001,0,0
30483,vs.,0,0
30484,placebo,0,1
30485,),0,0
30486,.,0,0
30487,NCX-4016,0,0
30488,was,0,0
30489,virtually,0,0
30490,devoid,0,0
30491,of,0,0
30492,gastric,0,0
30493,and,0,0
30494,duodenal,0,0
30495,toxicity,0,0
30496,",",0,0
30497,resulting,0,0
30498,in,0,0
30499,a,0,0
30500,total,0,0
30501,gastric,0,0
30502,and,0,0
30503,duodenal,0,0
30504,endoscopic,0,1
30505,score,0,0
30506,of,0,0
30507,1.38,0,0
30508,+/-,0,0
30509,0.3,0,0
30510,and,0,0
30511,1.25,0,0
30512,+/-,0,0
30513,0.5,0,1
30514,(,0,0
30515,P,0,0
30516,<,0,0
30517,0.0001,0,0
30518,vs.,0,0
30519,aspirin,0,1
30520,",",0,0
30521,not,0,0
30522,significant,0,0
30523,vs.,0,0
30524,placebo,0,1
30525,),0,0
30526,.,0,0
30527,NCX-4016,0,0
30528,inhibited,0,0
30529,AA-induced,0,0
30530,platelet,0,0
30531,aggregation,0,0
30532,as,0,0
30533,well,0,0
30534,as,0,0
30535,serum,0,0
30536,TXB,0,1
30537,(,0,0
30538,2,0,0
30539,),0,0
30540,and,0,0
30541,platelet,0,0
30542,TXB,0,1
30543,(,0,0
30544,2,0,0
30545,),0,0
30546,generation,0,0
30547,induced,0,0
30548,by,0,0
30549,AA,0,0
30550,to,0,0
30551,the,0,0
30552,same,0,0
30553,extent,0,0
30554,as,0,0
30555,aspirin,1,1
30556,(,0,0
30557,not,0,0
30558,significant,0,0
30559,vs.,0,0
30560,aspirin,0,1
30561,),0,0
30562,.,0,0
30563,CONCLUSIONS,0,0
30564,In,0,0
30565,this,0,0
30566,study,0,0
30567,",",0,0
30568,we,0,0
30569,have,0,0
30570,proven,0,0
30571,the,0,0
30572,concept,0,0
30573,that,0,0
30574,addition,0,0
30575,of,0,0
30576,an,0,0
30577,NO-donating,0,0
30578,moiety,0,1
30579,to,0,0
30580,aspirin,0,1
30581,results,0,0
30582,in,0,0
30583,a,0,0
30584,new,0,0
30585,chemical,0,0
30586,entity,0,0
30587,that,0,0
30588,maintains,0,0
30589,cyclooxygenase-1,0,0
30590,and,0,0
30591,platelet,0,0
30592,inhibitory,0,0
30593,activity,0,0
30594,while,0,0
30595,nearly,0,0
30596,avoiding,0,0
30597,gastrointestinal,0,0
30598,damage,0,0
30599,.,0,0
30600,Optimal,0,0
30601,therapy,0,1
30602,for,0,0
30603,advanced,0,0
30604,chronic,0,0
30605,venous,0,0
30606,insufficiency,0,0
30607,.,0,0
30608,INTRODUCTION,0,0
30609,While,0,0
30610,definitive,0,0
30611,therapy,0,1
30612,awaits,0,0
30613,level,0,0
30614,I,0,0
30615,evidence,0,0
30616,",",0,0
30617,controversy,0,0
30618,persists,0,0
30619,regarding,0,0
30620,the,0,0
30621,optimal,0,0
30622,operation,0,0
30623,for,0,0
30624,treatment,0,0
30625,of,0,0
30626,advanced,0,0
30627,chronic,0,0
30628,venous,0,0
30629,insufficiency,0,0
30630,(,0,0
30631,CVI,0,0
30632,),0,0
30633,.,0,0
30634,We,0,0
30635,propose,0,0
30636,a,0,0
30637,pragmatic,0,0
30638,approach,0,1
30639,to,0,0
30640,the,0,0
30641,correction,0,0
30642,or,0,1
30643,amelioration,0,0
30644,of,0,0
30645,venous,0,0
30646,hypertension,0,0
30647,resulting,0,0
30648,from,0,0
30649,hydrodynamic,0,1
30650,and,0,0
30651,hydrostatic,0,1
30652,venous,0,0
30653,reflux,0,0
30654,.,0,0
30655,We,0,0
30656,evaluated,0,0
30657,a,0,0
30658,strategy,0,0
30659,of,0,0
30660,balloon,0,1
30661,dissection,0,0
30662,",",0,0
30663,subfascial,0,1
30664,endoscopic,0,1
30665,perforating,0,0
30666,vein,0,0
30667,surgery,0,1
30668,(,0,0
30669,SEPS,0,0
30670,),0,0
30671,with,0,0
30672,routine,0,0
30673,posterior,0,1
30674,deep,0,1
30675,compartment,0,0
30676,fasciotomy,0,0
30677,",",0,0
30678,including,0,0
30679,ligation,0,1
30680,and,0,0
30681,stripping,0,0
30682,of,0,0
30683,the,0,0
30684,superficial,0,0
30685,system,0,0
30686,",",0,0
30687,for,0,0
30688,use,0,0
30689,when,0,0
30690,reflux,0,0
30691,is,0,0
30692,documented,0,0
30693,at,0,0
30694,duplex,0,1
30695,ultrasound,0,1
30696,(,0,0
30697,US,0,1
30698,),0,0
30699,scanning,0,1
30700,.,0,0
30701,METHODS,0,0
30702,This,0,0
30703,is,0,0
30704,a,0,0
30705,cooperative,0,0
30706,",",0,0
30707,multicenter,0,0
30708,",",0,0
30709,retrospective,0,0
30710,review,0,0
30711,of,0,0
30712,832,0,0
30713,patients,0,0
30714,stratified,0,0
30715,by,0,0
30716,CEAP,0,1
30717,classification,0,0
30718,.,0,0
30719,The,0,0
30720,series,0,0
30721,consisted,0,0
30722,of,0,0
30723,300,0,0
30724,patients,0,0
30725,with,0,0
30726,C4,0,0
30727,CVI,0,0
30728,",",0,0
30729,119,0,0
30730,patients,0,0
30731,with,0,0
30732,C5,0,0
30733,CVI,0,1
30734,",",0,0
30735,and,0,0
30736,413,0,0
30737,patients,0,0
30738,with,0,0
30739,C6,0,0
30740,CVI,0,0
30741,.,0,0
30742,A,0,0
30743,subset,0,0
30744,of,0,0
30745,92,0,0
30746,patients,0,0
30747,with,0,0
30748,C4,0,0
30749,disease,0,0
30750,were,0,0
30751,prospectively,0,0
30752,randomized,0,0
30753,",",0,0
30754,and,0,0
30755,ambulatory,0,0
30756,venous,0,0
30757,pressure,0,0
30758,(,0,0
30759,AVP,0,0
30760,),0,0
30761,was,0,0
30762,determined,0,0
30763,preoperatively,0,0
30764,and,0,0
30765,postoperatively,0,0
30766,.,0,0
30767,All,0,0
30768,patients,0,0
30769,underwent,0,0
30770,duplex,1,1
30771,US,1,1
30772,scanning,1,1
30773,to,0,0
30774,document,0,0
30775,reflux,0,0
30776,in,0,0
30777,the,0,0
30778,deep,0,1
30779,",",0,0
30780,superficial,0,0
30781,",",0,0
30782,and,0,0
30783,perforating,0,0
30784,venous,0,0
30785,systems,0,0
30786,.,0,0
30787,Efficacy,0,0
30788,",",0,0
30789,safety,0,0
30790,",",0,0
30791,and,0,0
30792,durability,0,0
30793,were,0,0
30794,evaluated,0,0
30795,over,0,0
30796,follow-up,0,0
30797,of,0,0
30798,1,0,0
30799,to,0,0
30800,9,0,0
30801,years,0,0
30802,(,0,0
30803,mean,0,0
30804,",",0,0
30805,31/2,0,0
30806,years,0,0
30807,),0,0
30808,.,0,0
30809,Uniformity,0,0
30810,was,0,0
30811,attempted,0,0
30812,by,0,0
30813,adoption,0,0
30814,of,0,0
30815,the,0,0
30816,senior,0,0
30817,author,0,0
30818,'s,0,0
30819,protocol,0,0
30820,and,0,0
30821,technique,0,1
30822,through,0,0
30823,on-site,0,1
30824,preceptorship,0,1
30825,in,0,0
30826,each,0,0
30827,surgeon,0,0
30828,'s,0,0
30829,operative,0,0
30830,theater,0,1
30831,.,0,0
30832,RESULTS,0,0
30833,This,0,0
30834,technique,0,1
30835,interrupted,0,0
30836,3,0,0
30837,to,0,0
30838,14,0,0
30839,(,0,0
30840,mean,0,0
30841,",",0,0
30842,7,0,0
30843,),0,0
30844,incompetent,0,0
30845,perforating,0,0
30846,veins,0,0
30847,per,0,0
30848,patient,0,0
30849,.,0,0
30850,Of,0,0
30851,the,0,0
30852,832,0,0
30853,patients,0,0
30854,undergoing,0,0
30855,SEPS,1,0
30856,",",0,0
30857,460,0,0
30858,(,0,0
30859,55,0,0
30860,%,0,0
30861,),0,0
30862,underwent,0,0
30863,saphenous,1,1
30864,vein,1,0
30865,ligation,1,1
30866,and,1,0
30867,stripping,1,0
30868,at,0,0
30869,the,0,0
30870,same,0,0
30871,operation,0,0
30872,.,0,0
30873,In,0,0
30874,92,0,0
30875,%,0,0
30876,ulcers,0,0
30877,healed,0,0
30878,or,0,0
30879,were,0,0
30880,significantly,0,0
30881,improved,0,0
30882,within,0,0
30883,4,0,0
30884,to,0,0
30885,14,0,0
30886,weeks,0,0
30887,.,0,0
30888,In,0,0
30889,64,0,0
30890,(,0,0
30891,8,0,0
30892,%,0,0
30893,),0,0
30894,patients,0,0
30895,",",0,0
30896,ulcers,0,0
30897,failed,0,0
30898,to,0,0
30899,heal,0,0
30900,or,0,0
30901,there,0,0
30902,was,0,0
30903,no,0,0
30904,benefit,0,0
30905,from,0,0
30906,the,0,0
30907,operation,0,0
30908,.,0,0
30909,Thirty-two,0,0
30910,patients,0,0
30911,(,0,0
30912,4,0,0
30913,%,0,0
30914,),0,0
30915,experienced,0,0
30916,recurrent,0,0
30917,ulceration,0,0
30918,or,0,1
30919,skin,0,0
30920,deterioration,0,0
30921,at,0,0
30922,6,0,0
30923,months-2,0,0
30924,years,0,0
30925,(,0,0
30926,mean,0,0
30927,",",0,0
30928,15,0,0
30929,mo,0,0
30930,),0,0
30931,.,0,0
30932,Repeat,0,0
30933,SEPS,0,0
30934,was,0,0
30935,successful,0,0
30936,in,0,0
30937,25,0,0
30938,of,0,0
30939,these,0,0
30940,96,0,0
30941,patients,0,0
30942,",",0,0
30943,and,0,0
30944,deep,0,1
30945,valve,0,1
30946,repair,0,1
30947,was,0,0
30948,successful,0,0
30949,in,0,0
30950,4,0,0
30951,patients,0,0
30952,.,0,0
30953,In,0,0
30954,the,0,0
30955,92,0,0
30956,randomized,0,0
30957,patients,0,0
30958,with,0,0
30959,C4,0,0
30960,disease,0,0
30961,",",0,0
30962,41,0,0
30963,refused,0,0
30964,postoperative,0,0
30965,AVP,0,0
30966,",",0,0
30967,leaving,0,0
30968,51,0,0
30969,compliant,0,0
30970,patients,0,0
30971,.,0,0
30972,The,0,0
30973,SEPS,0,0
30974,group,0,0
30975,(,0,0
30976,n,0,0
30977,=,0,0
30978,25,0,0
30979,),0,0
30980,had,0,0
30981,significantly,0,0
30982,reduced,0,0
30983,AVP,0,0
30984,(,0,0
30985,P,0,0
30986,<,0,0
30987,.01,0,0
30988,),0,0
30989,compared,0,0
30990,with,0,0
30991,the,0,0
30992,control,0,1
30993,group,0,0
30994,(,0,0
30995,n,0,0
30996,=,0,0
30997,26,0,0
30998,),0,0
30999,.,0,0
31000,Complications,0,0
31001,in,0,0
31002,825,0,0
31003,patients,0,0
31004,were,0,0
31005,less,0,0
31006,than,0,0
31007,3,0,0
31008,%,0,0
31009,and,0,0
31010,consisted,0,0
31011,mostly,0,0
31012,of,0,0
31013,transient,0,0
31014,neurologic,0,0
31015,disorders,0,0
31016,(,0,0
31017,eg,0,0
31018,",",0,0
31019,paradysthesia,0,0
31020,),0,0
31021,",",0,0
31022,but,0,0
31023,deep,0,1
31024,venous,0,0
31025,thrombosis,0,0
31026,occurred,0,0
31027,in,0,0
31028,2,0,0
31029,patients,0,0
31030,",",0,0
31031,with,0,0
31032,pulmonary,0,0
31033,embolus,0,0
31034,in,0,0
31035,1,0,0
31036,.,0,0
31037,No,0,0
31038,operative,0,0
31039,deaths,0,0
31040,occurred,0,0
31041,.,0,0
31042,Follow-up,0,0
31043,for,0,0
31044,1,0,0
31045,to,0,0
31046,9,0,0
31047,years,0,0
31048,(,0,0
31049,mean,0,0
31050,",",0,0
31051,31/2,0,0
31052,years,0,0
31053,),0,0
31054,demonstrated,0,0
31055,durability,0,0
31056,.,0,0
31057,CONCLUSION,0,0
31058,The,0,0
31059,efficacy,0,0
31060,",",0,0
31061,safety,0,0
31062,",",0,0
31063,and,0,0
31064,durability,0,0
31065,of,0,0
31066,this,0,0
31067,operative,0,0
31068,protocol,0,0
31069,proved,0,0
31070,beneficial,0,0
31071,in,0,0
31072,our,0,0
31073,clinical,0,0
31074,experience,0,0
31075,with,0,0
31076,832,0,0
31077,patients,0,0
31078,during,0,0
31079,9,0,0
31080,years,0,0
31081,of,0,0
31082,follow-up,0,0
31083,.,0,0
31084,The,0,0
31085,SEPS,0,0
31086,subset,0,0
31087,of,0,0
31088,randomized,0,0
31089,patients,0,0
31090,with,0,0
31091,C4,0,0
31092,disease,0,0
31093,experienced,0,0
31094,significant,0,0
31095,decrease,0,0
31096,in,0,0
31097,AVP,0,0
31098,",",0,0
31099,objectively,0,0
31100,supporting,0,0
31101,the,0,0
31102,effectiveness,0,0
31103,of,0,0
31104,reflux,0,0
31105,surgery,0,0
31106,in,0,0
31107,advanced,0,0
31108,CVI,0,0
31109,.,0,0
31110,Until,0,0
31111,definitive,0,0
31112,level,0,0
31113,I,0,0
31114,evidence,0,0
31115,is,0,0
31116,available,0,0
31117,",",0,0
31118,this,0,0
31119,operative,0,0
31120,technique,0,1
31121,is,0,0
31122,advocated,0,0
31123,as,0,0
31124,optimal,0,0
31125,therapy,0,1
31126,for,0,0
31127,CVI,0,0
31128,.,0,0
31129,Evaluation,0,0
31130,of,0,0
31131,25-gauge,1,1
31132,Quincke,1,0
31133,and,1,0
31134,24-gauge,1,1
31135,Gertie,1,1
31136,Marx,1,1
31137,needles,0,1
31138,for,0,0
31139,spinal,0,0
31140,anaesthesia,0,1
31141,for,0,0
31142,caesarean,0,0
31143,section,0,0
31144,.,0,0
31145,OBJECTIVE,0,0
31146,To,0,0
31147,compare,0,0
31148,the,0,0
31149,insertion,0,0
31150,characteristics,0,0
31151,and,0,0
31152,rate,0,0
31153,of,0,0
31154,complications,0,0
31155,between,0,0
31156,25-gauge,1,1
31157,Quincke,1,0
31158,and,1,0
31159,24-gauge,1,1
31160,Gertie,1,1
31161,Marx,1,1
31162,needles,1,1
31163,.,0,0
31164,DESIGN,0,0
31165,Prospective,0,0
31166,",",0,0
31167,randomized,0,0
31168,study,0,0
31169,.,0,0
31170,SETTING,0,0
31171,University,0,0
31172,of,0,0
31173,Benin,0,1
31174,Teaching,0,0
31175,Hospital,0,0
31176,;,0,0
31177,a,0,0
31178,university-affiliated,0,0
31179,tertiary,0,0
31180,centre,0,0
31181,.,0,0
31182,SUBJECTS,0,0
31183,Parturients,0,0
31184,(,0,0
31185,ASA,0,1
31186,1,0,0
31187,and,0,0
31188,2,0,0
31189,),0,0
31190,scheduled,0,0
31191,for,0,0
31192,elective,0,0
31193,caesarean,0,0
31194,section,0,0
31195,.,0,0
31196,They,0,0
31197,were,0,0
31198,randomly,0,0
31199,assigned,0,0
31200,to,0,0
31201,receive,0,0
31202,spinal,1,0
31203,anaesthesia,1,1
31204,with,1,0
31205,either,1,0
31206,25-gauge,1,1
31207,Quincke,1,0
31208,needle,1,1
31209,or,1,1
31210,24-gauge,1,1
31211,Gertie,1,1
31212,Marx,1,1
31213,needle,1,1
31214,.,1,0
31215,The,0,0
31216,patients,0,0
31217,with,0,0
31218,abnormal,0,0
31219,spaces,0,0
31220,",",0,0
31221,coagulopathy,0,0
31222,",",0,0
31223,infection,0,0
31224,",",0,0
31225,pre-eclampsia/eclampsia,0,0
31226,or,0,1
31227,obesity,0,0
31228,were,0,0
31229,excluded,0,0
31230,.,0,0
31231,MAIN,0,0
31232,OUTCOME,0,0
31233,MEASURES,0,0
31234,The,0,0
31235,number,0,0
31236,of,0,0
31237,attempts,0,0
31238,at,0,0
31239,successful,0,0
31240,identification,0,0
31241,of,0,0
31242,the,0,0
31243,spinal,0,0
31244,space,0,0
31245,",",0,0
31246,intraoperative,0,1
31247,complications,0,0
31248,",",0,0
31249,incidence,0,0
31250,of,0,0
31251,postdural,0,0
31252,puncture,0,1
31253,headache,0,0
31254,(,0,0
31255,PDPH,0,1
31256,),0,0
31257,",",0,0
31258,non-postdural,0,0
31259,puncture,0,1
31260,headache,0,0
31261,(,0,0
31262,NPDPH,0,1
31263,),0,1
31264,and,0,0
31265,backache,0,0
31266,.,0,0
31267,RESULTS,0,0
31268,Sixty,0,0
31269,women,0,0
31270,were,0,0
31271,studied,0,0
31272,.,0,0
31273,The,0,0
31274,24-gauge,0,1
31275,Gertie,0,0
31276,Marx,0,1
31277,needle,0,1
31278,resulted,0,0
31279,in,0,0
31280,more,0,0
31281,successful,0,0
31282,location,0,0
31283,of,0,0
31284,the,0,0
31285,spinal,0,0
31286,space,0,0
31287,on,0,0
31288,the,0,0
31289,second,0,0
31290,attempt,0,0
31291,(,0,0
31292,P,0,0
31293,<,0,0
31294,0.05,0,0
31295,),0,0
31296,.,0,0
31297,Non-postdural,0,0
31298,puncture,0,0
31299,headache,0,0
31300,was,0,0
31301,seen,0,0
31302,in,0,0
31303,43,0,0
31304,%,0,0
31305,of,0,0
31306,the,0,0
31307,study,0,0
31308,population,0,0
31309,.,0,0
31310,PDPH,0,0
31311,was,0,0
31312,seen,0,0
31313,in,0,0
31314,10,0,0
31315,%,0,0
31316,of,0,0
31317,the,0,0
31318,Quincke,0,0
31319,group,0,0
31320,and,0,0
31321,none,0,0
31322,in,0,0
31323,the,0,0
31324,Gertie,0,1
31325,Marx,0,1
31326,group,0,0
31327,.,0,0
31328,There,0,0
31329,was,0,0
31330,no,0,0
31331,difference,0,0
31332,in,0,0
31333,the,0,0
31334,incidence,0,0
31335,of,0,0
31336,backache,0,0
31337,in,0,0
31338,both,0,0
31339,groups,0,0
31340,.,0,0
31341,CONCLUSION,0,0
31342,The,0,0
31343,ease,0,0
31344,of,0,0
31345,insertion,0,1
31346,and,0,0
31347,low,0,0
31348,incidence,0,0
31349,of,0,0
31350,PDPH,0,0
31351,with,0,0
31352,the,0,0
31353,Gertie,0,1
31354,Marx,0,1
31355,needle,0,1
31356,may,0,0
31357,encourage,0,0
31358,trainee,0,0
31359,anaesthetists,0,0
31360,to,0,0
31361,use,0,0
31362,this,0,0
31363,needle,0,1
31364,for,0,0
31365,caesarean,0,0
31366,section,0,0
31367,.,0,0
31368,Clonidine,1,1
31369,premedication,0,0
31370,improves,0,0
31371,metabolic,0,0
31372,control,0,0
31373,in,0,0
31374,type,0,0
31375,2,0,0
31376,diabetic,0,0
31377,patients,0,0
31378,during,0,0
31379,ophthalmic,0,0
31380,surgery,0,0
31381,.,0,0
31382,BACKGROUND,0,0
31383,In,0,0
31384,stressful,0,0
31385,conditions,0,0
31386,",",0,0
31387,increasing,0,0
31388,blood,0,0
31389,glucose,0,0
31390,concentrations,0,0
31391,are,0,0
31392,closely,0,0
31393,related,0,0
31394,to,0,0
31395,an,0,0
31396,increase,0,0
31397,in,0,0
31398,catecholamines,0,0
31399,and,0,0
31400,cortisol,0,0
31401,release,0,0
31402,.,0,0
31403,Clonidine,0,1
31404,",",0,0
31405,a,0,0
31406,centrally,0,0
31407,acting,0,0
31408,alpha,0,1
31409,(,0,0
31410,2,0,0
31411,),0,0
31412,-adrenoceptor,0,1
31413,agonist,0,1
31414,",",0,0
31415,has,0,0
31416,neuroendocrine,0,0
31417,effects,0,0
31418,",",0,0
31419,including,0,0
31420,inhibition,0,0
31421,of,0,0
31422,sympathoadrenal,0,0
31423,activity,0,0
31424,.,0,0
31425,We,0,0
31426,therefore,0,0
31427,evaluated,0,0
31428,the,0,0
31429,effect,0,0
31430,of,0,0
31431,clonidine,1,1
31432,on,0,0
31433,blood,0,0
31434,glucose,0,0
31435,control,0,1
31436,and,0,0
31437,insulin,0,1
31438,requirements,0,0
31439,during,0,0
31440,ophthalmic,0,0
31441,surgery,0,0
31442,when,0,0
31443,given,0,0
31444,as,0,0
31445,premedication,0,0
31446,in,0,0
31447,type,0,0
31448,2,0,0
31449,diabetic,0,0
31450,patients,0,0
31451,.,0,0
31452,METHODS,0,0
31453,After,0,0
31454,randomization,0,0
31455,",",0,0
31456,patients,0,0
31457,were,0,0
31458,premedicated,0,0
31459,with,0,0
31460,clonidine,1,1
31461,or,1,1
31462,flunitrazepam,1,1
31463,(,0,1
31464,control,0,0
31465,),0,0
31466,.,0,0
31467,Patients,0,0
31468,were,0,0
31469,given,0,0
31470,insulin,1,0
31471,by,0,0
31472,continuous,0,1
31473,i.v,0,1
31474,.,0,0
31475,infusion,0,0
31476,to,0,0
31477,maintain,0,0
31478,blood,0,0
31479,glucose,0,0
31480,in,0,0
31481,the,0,0
31482,range,0,0
31483,5.5-11.1,0,0
31484,mmol,0,1
31485,litre,0,1
31486,(,0,0
31487,-1,0,0
31488,),0,0
31489,.,0,0
31490,Blood,0,0
31491,glucose,0,0
31492,concentrations,0,0
31493,were,0,0
31494,measured,0,0
31495,every,0,0
31496,15,0,0
31497,min,0,0
31498,during,0,0
31499,surgery,0,0
31500,",",0,0
31501,and,0,0
31502,hourly,0,0
31503,for,0,0
31504,6,0,0
31505,h,0,0
31506,after,0,0
31507,surgery,0,0
31508,.,0,0
31509,Plasma,0,0
31510,C-peptide,0,0
31511,and,0,0
31512,counter-regulatory,0,0
31513,hormones,0,0
31514,were,0,0
31515,also,0,0
31516,measured,0,0
31517,.,0,0
31518,RESULTS,0,0
31519,Glycaemia,0,0
31520,was,0,0
31521,significantly,0,0
31522,lower,0,0
31523,in,0,0
31524,the,0,0
31525,clonidine,0,1
31526,group,0,0
31527,(,0,0
31528,P,0,0
31529,<,0,0
31530,0.01,0,0
31531,),0,0
31532,and,0,0
31533,the,0,0
31534,median,0,0
31535,amount,0,0
31536,of,0,0
31537,insulin,0,1
31538,administered,0,0
31539,was,0,0
31540,significantly,0,0
31541,reduced,0,0
31542,:,0,0
31543,clonidine,0,1
31544,group,0,0
31545,9.0,0,0
31546,(,0,0
31547,interquartile,0,0
31548,range,0,0
31549,5.1,0,0
31550,),0,0
31551,units,0,0
31552,;,0,0
31553,control,0,0
31554,18.6,0,0
31555,(,0,0
31556,10.2,0,0
31557,),0,0
31558,units,0,0
31559,;,0,0
31560,P,0,0
31561,<,0,0
31562,0.01,0,0
31563,),0,0
31564,.,0,0
31565,Plasma,0,0
31566,catecholamine,0,0
31567,concentrations,0,0
31568,were,0,0
31569,lower,0,0
31570,in,0,0
31571,patients,0,0
31572,given,0,0
31573,clonidine,1,1
31574,(,0,0
31575,P,0,0
31576,<,0,0
31577,0.05,0,0
31578,),0,0
31579,but,0,0
31580,there,0,0
31581,was,0,0
31582,no,0,0
31583,difference,0,0
31584,in,0,0
31585,cortisol,0,0
31586,concentrations,0,0
31587,.,0,0
31588,CONCLUSION,0,0
31589,Premedication,0,0
31590,of,0,0
31591,type,0,0
31592,2,0,0
31593,diabetic,0,0
31594,patients,0,0
31595,with,0,0
31596,clonidine,1,1
31597,90,0,0
31598,min,0,0
31599,before,0,0
31600,surgery,0,1
31601,improves,0,0
31602,blood,0,0
31603,glucose,0,0
31604,control,0,0
31605,and,0,0
31606,decreases,0,0
31607,insulin,0,0
31608,requirements,0,0
31609,during,0,0
31610,ophthalmic,0,0
31611,surgery,0,0
31612,.,0,0
31613,Multiple,1,1
31614,risk,1,0
31615,factor,1,0
31616,intervention,1,1
31617,reduces,0,0
31618,cardiovascular,0,0
31619,risk,0,0
31620,in,0,0
31621,hypertensive,0,0
31622,patients,0,0
31623,with,0,0
31624,echolucent,0,0
31625,plaques,0,0
31626,in,0,0
31627,the,0,0
31628,carotid,0,0
31629,artery,0,0
31630,.,0,0
31631,OBJECTIVE,0,0
31632,In,0,0
31633,a,0,0
31634,previously,0,0
31635,published,0,0
31636,randomized,0,0
31637,6-year,0,0
31638,study,0,0
31639,we,0,0
31640,observed,0,0
31641,that,0,0
31642,multiple,1,0
31643,risk,1,0
31644,factor,1,0
31645,intervention,1,1
31646,reduced,0,0
31647,cardiovascular,0,0
31648,risk,0,0
31649,in,0,0
31650,high-risk,0,0
31651,hypertensive,0,0
31652,men,0,0
31653,",",0,0
31654,and,0,0
31655,that,0,0
31656,this,0,0
31657,effect,0,0
31658,was,0,0
31659,confined,0,0
31660,to,0,0
31661,patients,0,0
31662,with,0,0
31663,carotid,0,0
31664,artery,0,0
31665,plaques,0,0
31666,.,0,0
31667,Hypothetically,0,0
31668,",",0,0
31669,the,0,0
31670,underlying,0,0
31671,mechanism,0,0
31672,might,0,0
31673,have,0,0
31674,been,0,0
31675,a,0,0
31676,stabilization,0,0
31677,of,0,0
31678,echolucent,0,0
31679,",",0,0
31680,instable,0,0
31681,",",0,0
31682,rupture-prone,0,0
31683,plaques,0,0
31684,.,0,0
31685,The,0,0
31686,aim,0,0
31687,of,0,0
31688,the,0,0
31689,present,0,0
31690,study,0,0
31691,was,0,0
31692,to,0,0
31693,examine,0,0
31694,plaque,0,0
31695,characteristics,0,0
31696,by,0,0
31697,B-mode,1,1
31698,ultrasound,1,1
31699,in,0,0
31700,the,0,0
31701,previous,0,0
31702,intervention,0,1
31703,study,0,0
31704,",",0,0
31705,and,0,0
31706,also,0,0
31707,to,0,0
31708,investigate,0,0
31709,the,0,0
31710,relationship,0,0
31711,between,0,0
31712,plaque,0,0
31713,characteristics,0,0
31714,at,0,0
31715,baseline,0,0
31716,and,0,0
31717,cardiovascular,0,0
31718,events,0,0
31719,during,0,0
31720,the,0,0
31721,6-year,0,0
31722,follow-up,0,0
31723,in,0,0
31724,the,0,0
31725,two,0,0
31726,randomization,0,0
31727,groups,0,0
31728,.,0,0
31729,METHODS,0,0
31730,High,1,0
31731,resolution,1,0
31732,B-mode,1,1
31733,ultrasound,1,1
31734,was,0,0
31735,used,0,0
31736,to,0,0
31737,characterize,0,0
31738,plaque,0,0
31739,echogenicity,0,0
31740,in,0,0
31741,four,0,0
31742,subgroups,0,0
31743,-,0,0
31744,dominantly,0,0
31745,echolucent,0,0
31746,",",0,0
31747,substantially,0,0
31748,echolucent,0,0
31749,",",0,0
31750,dominantly,0,0
31751,echogenic,0,0
31752,",",0,0
31753,and,0,0
31754,uniformly,0,0
31755,echogenic,0,0
31756,.,0,0
31757,RESULTS,0,0
31758,In,0,0
31759,the,0,0
31760,usual,1,1
31761,care,1,1
31762,group,1,0
31763,17,0,0
31764,of,0,0
31765,32,0,0
31766,(,0,0
31767,53,0,0
31768,%,0,0
31769,),0,0
31770,patients,0,0
31771,with,0,0
31772,echolucent,0,0
31773,plaques,0,0
31774,at,0,0
31775,baseline,0,0
31776,suffered,0,0
31777,from,0,0
31778,a,0,0
31779,combined,0,1
31780,end-point,0,0
31781,(,0,0
31782,any,0,0
31783,death,0,0
31784,or,0,0
31785,nonfatal,0,0
31786,myocardial,0,0
31787,infarction,0,0
31788,or,0,1
31789,nonfatal,0,0
31790,stroke,0,0
31791,),0,0
31792,during,0,0
31793,follow-up,0,0
31794,compared,0,0
31795,with,0,0
31796,seven,0,0
31797,of,0,0
31798,28,0,0
31799,(,0,0
31800,25,0,0
31801,%,0,0
31802,),0,0
31803,patients,0,0
31804,in,0,0
31805,the,0,0
31806,intervention,1,1
31807,group,1,0
31808,(,0,0
31809,P,0,0
31810,=,0,0
31811,0.036,0,0
31812,),0,0
31813,.,0,0
31814,The,0,0
31815,corresponding,0,0
31816,numbers,0,0
31817,in,0,0
31818,patients,0,0
31819,with,0,0
31820,echogenic,0,0
31821,plaques,0,0
31822,were,0,0
31823,n,0,0
31824,=,0,0
31825,4/13,0,0
31826,(,0,0
31827,31,0,0
31828,%,0,0
31829,),0,0
31830,and,0,0
31831,n,0,0
31832,=,0,0
31833,4/17,0,0
31834,(,0,0
31835,24,0,0
31836,%,0,0
31837,),0,0
31838,",",0,0
31839,respectively,0,0
31840,(,0,0
31841,NS,0,0
31842,),0,0
31843,.,0,0
31844,In,0,0
31845,the,0,0
31846,usual,1,1
31847,care,1,1
31848,group,1,0
31849,11,0,0
31850,of,0,0
31851,33,0,0
31852,(,0,0
31853,33,0,0
31854,%,0,0
31855,),0,0
31856,patients,0,0
31857,with,0,0
31858,no,0,0
31859,plaques,0,0
31860,suffered,0,0
31861,from,0,0
31862,a,0,0
31863,combined,0,0
31864,end-point,0,0
31865,during,0,0
31866,follow-up,0,0
31867,compared,0,0
31868,with,0,0
31869,11,0,0
31870,of,0,0
31871,30,0,0
31872,(,0,0
31873,37,0,0
31874,%,0,0
31875,),0,0
31876,in,0,0
31877,the,0,0
31878,intervention,1,1
31879,group,1,0
31880,.,1,0
31881,CONCLUSION,0,0
31882,Our,0,0
31883,data,0,0
31884,indicate,0,0
31885,that,0,0
31886,the,0,0
31887,beneficial,0,0
31888,effect,0,0
31889,of,0,0
31890,the,0,0
31891,multiple,1,0
31892,risk,1,0
31893,intervention,1,1
31894,programme,1,1
31895,was,0,0
31896,confined,0,0
31897,to,0,0
31898,those,0,0
31899,patients,0,0
31900,with,0,0
31901,echolucent,0,0
31902,plaques,0,0
31903,.,0,0
31904,The,0,0
31905,data,0,0
31906,have,0,0
31907,to,0,0
31908,be,0,0
31909,confirmed,0,0
31910,with,0,0
31911,a,0,0
31912,large-scale,0,0
31913,trial,0,0
31914,.,0,0
31915,Effect,0,0
31916,of,0,0
31917,a,0,0
31918,high-protein,1,1
31919,",",1,0
31920,energy-restricted,1,1
31921,diet,1,1
31922,on,0,0
31923,weight,0,0
31924,loss,0,0
31925,and,0,0
31926,energy,0,0
31927,expenditure,0,0
31928,after,0,0
31929,weight,0,0
31930,stabilization,0,0
31931,in,0,0
31932,hyperinsulinemic,0,0
31933,subjects,0,0
31934,.,0,0
31935,OBJECTIVE,0,0
31936,To,0,0
31937,determine,0,0
31938,the,0,0
31939,effect,0,0
31940,of,0,0
31941,replacing,0,0
31942,some,0,0
31943,dietary,0,1
31944,carbohydrate,0,1
31945,with,0,0
31946,protein,0,0
31947,",",0,0
31948,during,0,0
31949,energy,0,0
31950,restriction,0,0
31951,",",0,0
31952,on,0,0
31953,weight,0,0
31954,loss,0,0
31955,",",0,0
31956,total,0,0
31957,energy,0,0
31958,expenditure,0,0
31959,(,0,0
31960,TEE,0,1
31961,),0,0
31962,",",0,0
31963,resting,0,0
31964,energy,0,0
31965,expenditure,0,0
31966,(,0,0
31967,REE,0,1
31968,),0,0
31969,",",0,0
31970,respiratory,0,0
31971,quotient,0,0
31972,(,0,0
31973,RQ,0,1
31974,),0,0
31975,",",0,0
31976,and,0,0
31977,the,0,0
31978,thermic,0,0
31979,effect,0,0
31980,of,0,0
31981,feeding,0,0
31982,(,0,0
31983,TEF,0,1
31984,),0,0
31985,in,0,0
31986,subjects,0,0
31987,with,0,0
31988,hyperinsulinemia,0,0
31989,.,0,0
31990,DESIGN,0,0
31991,Parallel,0,0
31992,",",0,0
31993,clinical,0,0
31994,intervention,0,1
31995,study,0,0
31996,of,0,0
31997,12,0,0
31998,weeks,0,0
31999,energy,1,0
32000,restriction,1,1
32001,(,0,0
32002,6.5,0,0
32003,MJ/day,0,1
32004,),0,0
32005,and,0,0
32006,4,0,0
32007,weeks,0,0
32008,energy,1,0
32009,balance,1,0
32010,(,0,0
32011,8.2,0,0
32012,MJ/day,0,1
32013,),0,0
32014,in,0,0
32015,two,0,0
32016,groups,0,0
32017,of,0,0
32018,subjects,0,0
32019,randomly,0,0
32020,assigned,0,0
32021,to,0,0
32022,either,0,0
32023,a,0,0
32024,high-protein,1,1
32025,(,1,0
32026,HP,1,1
32027,),1,1
32028,diet,1,1
32029,(,0,0
32030,27,0,0
32031,%,0,0
32032,of,0,0
32033,energy,0,0
32034,(,0,0
32035,%,0,0
32036,E,0,1
32037,),0,0
32038,as,0,0
32039,protein,0,0
32040,",",0,0
32041,45,0,0
32042,%,0,0
32043,E,0,1
32044,as,0,0
32045,carbohydrate,0,1
32046,),0,0
32047,or,0,0
32048,a,0,0
32049,lower-protein,1,1
32050,(,1,0
32051,LP,1,1
32052,),1,1
32053,diet,1,1
32054,(,0,0
32055,16,0,0
32056,%,0,0
32057,E,0,1
32058,as,0,0
32059,protein,0,0
32060,",",0,0
32061,57,0,0
32062,%,0,0
32063,E,0,1
32064,as,0,0
32065,carbohydrate,0,1
32066,),0,0
32067,.,0,0
32068,SUBJECTS,0,0
32069,A,0,0
32070,total,0,0
32071,of,0,0
32072,36,0,0
32073,obese,0,0
32074,nondiabetic,0,0
32075,volunteers,0,0
32076,with,0,0
32077,hyperinsulinemia,0,0
32078,(,0,0
32079,10,0,0
32080,males/26,0,0
32081,females,0,0
32082,",",0,0
32083,aged,0,0
32084,34-65,0,0
32085,y,0,0
32086,",",0,0
32087,BMI,0,0
32088,28-43,0,0
32089,kg/m,0,0
32090,(,0,0
32091,2,0,0
32092,),0,0
32093,",",0,0
32094,fasting,0,0
32095,insulin,0,1
32096,12-45,0,0
32097,mU/l,0,0
32098,),0,0
32099,.,0,0
32100,MEASUREMENTS,0,0
32101,Body,0,1
32102,weight,0,0
32103,and,0,0
32104,composition,0,0
32105,",",0,0
32106,TEE,0,0
32107,",",0,0
32108,REE,0,1
32109,",",0,0
32110,and,0,0
32111,RQ,0,1
32112,were,0,0
32113,measured,0,0
32114,at,0,0
32115,baseline,0,0
32116,and,0,0
32117,at,0,0
32118,week,0,0
32119,16,0,0
32120,.,0,0
32121,In,0,0
32122,addition,0,0
32123,",",0,0
32124,the,0,0
32125,TEF,0,0
32126,to,0,0
32127,an,0,0
32128,HP,1,0
32129,or,0,1
32130,LP,1,1
32131,meal,0,1
32132,was,0,0
32133,determined,0,0
32134,for,0,0
32135,3,0,0
32136,h,0,0
32137,",",0,0
32138,at,0,0
32139,baseline,0,0
32140,and,0,0
32141,at,0,0
32142,week,0,0
32143,16,0,0
32144,.,0,0
32145,RESULTS,0,0
32146,After,0,0
32147,16,0,0
32148,weeks,0,0
32149,",",0,0
32150,weight,0,0
32151,loss,0,0
32152,was,0,0
32153,similar,0,0
32154,in,0,0
32155,response,0,0
32156,to,0,0
32157,each,0,0
32158,diet,0,1
32159,;,0,0
32160,the,0,0
32161,overall,0,0
32162,decrease,0,0
32163,was,0,0
32164,7.9+/-0.6,0,0
32165,kg,0,1
32166,(,0,0
32167,P,0,0
32168,<,0,0
32169,0.001,0,0
32170,),0,0
32171,",",0,0
32172,of,0,0
32173,which,0,0
32174,6.8+/-0.5,0,0
32175,kg,0,0
32176,was,0,0
32177,fat,0,0
32178,(,0,0
32179,P,0,0
32180,<,0,0
32181,0.001,0,0
32182,),0,0
32183,.,0,0
32184,REE,0,0
32185,fell,0,0
32186,similarly,0,0
32187,with,0,0
32188,each,0,0
32189,diet,0,1
32190,;,0,0
32191,the,0,0
32192,overall,0,0
32193,decrease,0,0
32194,was,0,0
32195,719+/-106,0,0
32196,kJ/day,0,1
32197,(,0,0
32198,P,0,0
32199,<,0,0
32200,0.001,0,0
32201,),0,0
32202,.,0,0
32203,The,0,0
32204,TEF,0,0
32205,was,0,0
32206,2,0,0
32207,%,0,0
32208,greater,0,0
32209,after,0,0
32210,the,0,0
32211,HP,1,0
32212,than,0,0
32213,after,0,0
32214,the,0,0
32215,LP,1,1
32216,meal,0,0
32217,at,0,0
32218,baseline,0,0
32219,(,0,0
32220,P,0,0
32221,<,0,0
32222,0.01,0,0
32223,),0,0
32224,and,0,0
32225,0.8,0,0
32226,%,0,0
32227,greater,0,0
32228,at,0,0
32229,week,0,0
32230,16,0,0
32231,(,0,0
32232,P=0.35,0,0
32233,),0,0
32234,.,0,0
32235,After,0,0
32236,16,0,0
32237,weeks,0,0
32238,",",0,0
32239,the,0,0
32240,TEF,0,0
32241,was,0,0
32242,not,0,0
32243,reduced,0,0
32244,in,0,0
32245,either,0,0
32246,dietary,0,0
32247,group,0,0
32248,.,0,0
32249,There,0,0
32250,was,0,0
32251,no,0,0
32252,change,0,0
32253,in,0,0
32254,TEE,0,0
32255,after,0,0
32256,16,0,0
32257,weeks,0,0
32258,.,0,0
32259,CONCLUSION,0,0
32260,In,0,0
32261,subjects,0,0
32262,with,0,0
32263,hyperinsulinemia,0,0
32264,an,0,0
32265,energy-restrictive,0,1
32266,diet,0,1
32267,containing,0,1
32268,an,0,0
32269,increased,0,0
32270,protein-to-carbohydrate,0,0
32271,ratio,0,0
32272,does,0,0
32273,not,0,0
32274,enhance,0,0
32275,weight,0,0
32276,loss,0,0
32277,or,0,1
32278,significantly,0,0
32279,affect,0,0
32280,energy,0,0
32281,expenditure,0,0
32282,.,0,0
32283,Caloric,0,1
32284,restriction,0,0
32285,",",0,0
32286,rather,0,0
32287,than,0,0
32288,the,0,0
32289,macronutrient,0,1
32290,composition,0,0
32291,of,0,0
32292,the,0,0
32293,diet,0,1
32294,",",0,0
32295,is,0,0
32296,the,0,0
32297,most,0,0
32298,important,0,0
32299,determinant,0,0
32300,of,0,0
32301,weight,0,0
32302,loss,0,0
32303,.,0,0
32304,The,0,0
32305,utility,0,0
32306,of,0,0
32307,laparoscopy,0,1
32308,in,0,0
32309,the,0,0
32310,diagnosis,0,0
32311,of,0,0
32312,acute,0,0
32313,appendicitis,0,0
32314,in,0,0
32315,women,0,0
32316,of,0,0
32317,reproductive,0,0
32318,age,0,0
32319,.,0,0
32320,AIM,0,0
32321,To,0,0
32322,see,0,0
32323,whether,0,0
32324,laparoscopy,1,1
32325,improves,0,0
32326,the,0,0
32327,accuracy,0,0
32328,of,0,0
32329,a,0,0
32330,clinical,0,0
32331,diagnosis,0,0
32332,of,0,0
32333,acute,0,0
32334,appendicitis,0,0
32335,in,0,0
32336,women,0,0
32337,of,0,0
32338,reproductive,0,0
32339,age,0,0
32340,",",0,0
32341,and,0,0
32342,to,0,0
32343,determine,0,0
32344,what,0,0
32345,the,0,0
32346,long-term,0,0
32347,sequelae,0,0
32348,are,0,0
32349,of,0,0
32350,not,0,0
32351,removing,0,0
32352,an,0,0
32353,appendix,0,0
32354,deemed,0,0
32355,at,0,0
32356,laparoscopy,0,1
32357,to,0,0
32358,be,0,0
32359,normal,0,0
32360,.,0,0
32361,METHOD,0,0
32362,The,0,0
32363,initial,0,0
32364,part,0,0
32365,of,0,0
32366,the,0,0
32367,study,0,0
32368,was,0,0
32369,undertaken,0,0
32370,during,0,0
32371,1991-1992,0,0
32372,.,0,0
32373,Female,0,0
32374,patients,0,0
32375,between,0,0
32376,16,0,0
32377,and,0,0
32378,45,0,0
32379,years,0,0
32380,were,0,0
32381,eligible,0,0
32382,for,0,0
32383,inclusion,0,0
32384,once,0,0
32385,a,0,0
32386,clinical,0,0
32387,decision,0,0
32388,had,0,0
32389,been,0,0
32390,made,0,0
32391,to,0,0
32392,perform,0,0
32393,an,0,0
32394,appendicectomy,0,1
32395,for,0,0
32396,suspected,0,0
32397,acute,0,0
32398,appendicitis,0,0
32399,.,0,0
32400,Following,0,0
32401,consent,0,0
32402,",",0,0
32403,patients,0,0
32404,were,0,0
32405,randomized,0,0
32406,into,0,0
32407,two,0,0
32408,groups,0,0
32409,.,0,0
32410,One,0,0
32411,group,0,0
32412,had,0,0
32413,open,1,0
32414,appendicectomy,1,1
32415,",",0,0
32416,as,0,0
32417,planned,0,0
32418,.,0,0
32419,The,0,0
32420,other,0,0
32421,group,0,0
32422,had,0,0
32423,laparoscopy,1,1
32424,",",1,0
32425,followed,1,0
32426,by,1,0
32427,open,1,0
32428,appendicectomy,1,1
32429,only,0,0
32430,if,0,0
32431,the,0,0
32432,appendix,0,0
32433,was,0,0
32434,seen,0,0
32435,to,0,0
32436,be,0,0
32437,inflamed,0,0
32438,or,0,0
32439,was,0,0
32440,not,0,0
32441,visualized,0,0
32442,.,0,0
32443,The,0,0
32444,end,0,0
32445,points,0,0
32446,for,0,0
32447,the,0,0
32448,study,0,0
32449,were,0,0
32450,the,0,0
32451,clinical,0,0
32452,outcomes,0,0
32453,of,0,0
32454,all,0,0
32455,patients,0,0
32456,",",0,0
32457,and,0,0
32458,the,0,0
32459,results,0,0
32460,of,0,0
32461,histology,0,0
32462,",",0,0
32463,where,0,0
32464,appropriate,0,0
32465,.,0,0
32466,An,0,0
32467,attempt,0,0
32468,was,0,0
32469,made,0,0
32470,to,0,0
32471,contact,0,0
32472,all,0,0
32473,patients,0,0
32474,at,0,0
32475,10,0,0
32476,years,0,0
32477,to,0,0
32478,determine,0,0
32479,whether,0,0
32480,they,0,0
32481,had,0,0
32482,had,0,0
32483,a,0,0
32484,subsequent,0,0
32485,appendicectomy,0,1
32486,",",0,0
32487,or,0,0
32488,had,0,0
32489,been,0,0
32490,diagnosed,0,0
32491,with,0,0
32492,another,0,0
32493,abdominal,0,0
32494,condition,0,0
32495,that,0,0
32496,might,0,0
32497,be,0,0
32498,relevant,0,0
32499,to,0,0
32500,the,0,0
32501,initial,0,0
32502,presentation,0,0
32503,in,0,0
32504,1991-1992,0,0
32505,.,0,0
32506,RESULTS,0,0
32507,Laparoscopic,0,1
32508,assessment,0,0
32509,was,0,0
32510,correct,0,0
32511,in,0,0
32512,all,0,0
32513,cases,0,0
32514,in,0,0
32515,which,0,0
32516,the,0,0
32517,appendix,0,0
32518,was,0,0
32519,visualized,0,0
32520,.,0,0
32521,Diagnostic,0,0
32522,accuracy,0,0
32523,was,0,0
32524,improved,0,0
32525,from,0,0
32526,75,0,0
32527,%,0,0
32528,to,0,0
32529,97,0,0
32530,%,0,0
32531,.,0,0
32532,Laparoscopy,0,1
32533,was,0,0
32534,associated,0,0
32535,with,0,0
32536,no,0,0
32537,added,0,0
32538,complications,0,0
32539,",",0,0
32540,no,0,0
32541,increase,0,0
32542,in,0,0
32543,hospital,0,0
32544,stay,0,0
32545,in,0,0
32546,patients,0,0
32547,who,0,0
32548,went,0,0
32549,on,0,0
32550,to,0,0
32551,appendicectomy,0,1
32552,",",0,0
32553,and,0,0
32554,a,0,0
32555,reduction,0,0
32556,in,0,0
32557,hospital,0,0
32558,stay,0,0
32559,for,0,0
32560,those,0,0
32561,who,0,0
32562,underwent,0,0
32563,laparoscopy,0,1
32564,alone,0,1
32565,.,0,0
32566,No,0,0
32567,patients,0,0
32568,developed,0,0
32569,a,0,0
32570,problem,0,0
32571,over,0,0
32572,the,0,0
32573,10-year,0,0
32574,follow-up,0,0
32575,period,0,0
32576,from,0,0
32577,having,0,0
32578,a,0,0
32579,normal-looking,0,0
32580,appendix,0,0
32581,not,0,0
32582,removed,0,0
32583,at,0,0
32584,laparoscopy,0,1
32585,.,0,0
32586,CONCLUSION,0,0
32587,Laparoscopic,0,1
32588,assessment,0,0
32589,of,0,0
32590,the,0,0
32591,appendix,0,0
32592,is,0,0
32593,reliable,0,0
32594,",",0,0
32595,and,0,0
32596,to,0,0
32597,leave,0,0
32598,a,0,0
32599,normal-looking,0,0
32600,appendix,0,0
32601,at,0,0
32602,laparoscopy,0,1
32603,does,0,0
32604,not,0,0
32605,appear,0,0
32606,to,0,0
32607,cause,0,0
32608,any,0,0
32609,long-term,0,0
32610,problems,0,0
32611,.,0,0
32612,Recombinant,1,1
32613,human,1,0
32614,thrombopoietin,1,1
32615,augments,0,0
32616,mobilization,0,0
32617,of,0,0
32618,peripheral,0,0
32619,blood,0,0
32620,progenitor,0,0
32621,cells,0,0
32622,for,0,0
32623,autologous,0,1
32624,transplantation,0,0
32625,.,0,0
32626,This,0,0
32627,study,0,0
32628,assessed,0,0
32629,the,0,0
32630,ability,0,0
32631,of,0,0
32632,various,0,0
32633,schedules,0,0
32634,of,0,0
32635,recombinant,1,1
32636,human,1,1
32637,thrombopoietin,1,1
32638,(,1,0
32639,rhTPO,1,1
32640,),1,0
32641,to,0,0
32642,enhance,0,0
32643,mobilization,0,0
32644,of,0,0
32645,peripheral,0,0
32646,blood,0,0
32647,progenitor,0,0
32648,cells,0,0
32649,(,0,0
32650,PBPCs,0,0
32651,),0,0
32652,in,0,0
32653,134,0,0
32654,patients,0,0
32655,with,0,0
32656,cancer,0,0
32657,undergoing,0,0
32658,high-dose,0,1
32659,chemotherapy,0,1
32660,and,0,0
32661,autologous,0,1
32662,PBPC,0,1
32663,transplantation,0,0
32664,.,0,0
32665,Patients,0,0
32666,received,0,0
32667,the,0,0
32668,study,0,0
32669,drug,0,0
32670,on,0,0
32671,days,0,0
32672,1,0,0
32673,",",0,0
32674,3,0,0
32675,",",0,0
32676,and,0,0
32677,5,0,0
32678,before,0,0
32679,initiation,0,0
32680,of,0,0
32681,granulocyte,0,0
32682,colony-stimulating,0,1
32683,factor,0,0
32684,(,0,0
32685,G-CSF,0,1
32686,),0,0
32687,10,0,0
32688,microg/kg/day,0,0
32689,on,0,0
32690,day,0,0
32691,5,0,0
32692,and,0,0
32693,pheresis,0,0
32694,starting,0,0
32695,on,0,0
32696,day,0,0
32697,9,0,0
32698,.,0,0
32699,Randomly,0,0
32700,assigned,0,0
32701,treatments,0,0
32702,on,0,0
32703,days,0,0
32704,1,0,0
32705,",",0,0
32706,3,0,0
32707,",",0,0
32708,and,0,0
32709,5,0,0
32710,were,0,0
32711,:,0,0
32712,group,0,0
32713,1,0,0
32714,(,0,0
32715,n=27,0,0
32716,),0,1
32717,placebo,1,1
32718,",",1,0
32719,placebo,1,1
32720,",",1,0
32721,rhTPO,1,1
32722,1.5,0,0
32723,microg/kg,0,0
32724,;,0,0
32725,group,0,0
32726,2,0,0
32727,(,0,0
32728,n=27,0,0
32729,),0,1
32730,rhTPO,0,1
32731,1.5,0,0
32732,microg/kg,0,0
32733,",",0,0
32734,placebo,0,1
32735,",",0,0
32736,placebo,0,1
32737,;,0,0
32738,groups,0,0
32739,3,0,0
32740,(,0,0
32741,n=28,0,0
32742,),0,0
32743,and,0,0
32744,4,0,1
32745,(,0,0
32746,n=22,0,0
32747,),0,1
32748,rhTPO,0,1
32749,0.5,0,0
32750,microg/kg,0,0
32751,on,0,0
32752,all,0,0
32753,3,0,0
32754,treatment,0,0
32755,days,0,0
32756,;,0,0
32757,and,0,0
32758,group,0,0
32759,5,0,1
32760,(,0,0
32761,n=30,0,0
32762,),0,1
32763,placebo,0,1
32764,on,0,0
32765,all,0,0
32766,3,0,0
32767,treatment,0,0
32768,days,0,0
32769,.,0,0
32770,After,0,0
32771,high-dose,1,1
32772,chemotherapy,1,1
32773,and,1,0
32774,PBPC,1,1
32775,transplantation,1,0
32776,",",0,0
32777,groups,0,0
32778,1,0,0
32779,through,0,0
32780,4,0,0
32781,received,0,0
32782,rhTPO,0,0
32783,1.5,0,0
32784,microg/kg,0,0
32785,days,0,0
32786,0,0,0
32787,",",0,0
32788,+2,0,0
32789,",",0,0
32790,+4,0,0
32791,",",0,0
32792,and,0,0
32793,+6,0,0
32794,with,0,0
32795,either,0,0
32796,G-CSF,0,1
32797,5,0,0
32798,microg/kg/day,0,1
32799,(,0,0
32800,groups,0,0
32801,1-3,0,0
32802,),0,0
32803,or,0,0
32804,granulocyte-macrophage,0,1
32805,colony-stimulating,0,1
32806,factor,0,0
32807,250,0,1
32808,microg/m,0,0
32809,(,0,0
32810,2,0,0
32811,),0,0
32812,/day,0,1
32813,(,0,0
32814,group,0,0
32815,4,0,0
32816,),0,0
32817,.,0,0
32818,Group,0,0
32819,5,0,0
32820,received,0,0
32821,placebo,1,1
32822,plus,0,1
32823,G-CSF,0,1
32824,5,0,0
32825,microg/kg/day,0,0
32826,.,0,0
32827,The,0,0
32828,addition,0,0
32829,of,0,0
32830,rhTPO,1,0
32831,to,0,0
32832,G-CSF,0,1
32833,increased,0,0
32834,median,0,0
32835,CD34+,0,0
32836,cell,0,0
32837,yield/pheresis,0,1
32838,in,0,0
32839,cohorts,0,0
32840,in,0,0
32841,which,0,0
32842,rhTPO,1,0
32843,was,0,0
32844,started,0,0
32845,before,0,0
32846,day,0,0
32847,5,0,0
32848,",",0,0
32849,with,0,0
32850,higher,0,0
32851,yields,0,0
32852,in,0,0
32853,groups,0,0
32854,2,0,0
32855,(,0,0
32856,2.67,0,0
32857,x,0,0
32858,10,0,0
32859,(,0,0
32860,6,0,0
32861,),0,0
32862,/kg,0,0
32863,),0,0
32864,and,0,0
32865,groups,0,0
32866,3,0,0
32867,and,0,0
32868,4,0,0
32869,(,0,0
32870,3.10,0,0
32871,x,0,0
32872,10,0,0
32873,(,0,0
32874,6,0,0
32875,),0,0
32876,/kg,0,0
32877,),0,0
32878,than,0,0
32879,in,0,0
32880,group,0,0
32881,1,0,0
32882,(,0,0
32883,1.86,0,0
32884,x,0,0
32885,10,0,0
32886,(,0,0
32887,6,0,0
32888,),0,0
32889,/kg,0,0
32890,),0,1
32891,or,0,1
32892,group,0,0
32893,5,0,1
32894,(,0,0
32895,1.65,0,0
32896,x,0,0
32897,10,0,0
32898,(,0,0
32899,6,0,0
32900,),0,0
32901,/kg,0,0
32902,),0,1
32903,(,0,0
32904,P=.006,0,0
32905,across,0,0
32906,groups,0,0
32907,),0,0
32908,.,0,0
32909,Comparing,0,0
32910,rhTPO,1,0
32911,to,0,0
32912,placebo,1,1
32913,",",0,0
32914,higher,0,0
32915,percentages,0,0
32916,of,0,0
32917,patients,0,0
32918,achieved,0,0
32919,the,0,0
32920,minimum,0,0
32921,yield,0,0
32922,of,0,0
32923,CD34+,0,0
32924,>,0,0
32925,or,0,1
32926,=2,0,0
32927,x,0,0
32928,10,0,0
32929,(,0,0
32930,6,0,0
32931,),0,0
32932,/kg,0,0
32933,(,0,0
32934,92,0,0
32935,%,0,0
32936,v,0,0
32937,75,0,0
32938,%,0,0
32939,;,0,0
32940,P=.050,0,0
32941,),0,0
32942,as,0,0
32943,well,0,0
32944,as,0,0
32945,the,0,0
32946,target,0,0
32947,yield,0,0
32948,of,0,0
32949,CD34+,0,0
32950,>,0,0
32951,or,0,1
32952,=5,0,0
32953,x,0,0
32954,10,0,0
32955,(,0,0
32956,6,0,0
32957,),0,0
32958,/kg,0,0
32959,(,0,0
32960,73,0,0
32961,%,0,0
32962,v,0,0
32963,46,0,0
32964,%,0,0
32965,;,0,0
32966,P=,0,1
32967,.041,0,0
32968,),0,0
32969,.,0,0
32970,rhTPO-treated,1,0
32971,patients,0,0
32972,required,0,0
32973,fewer,0,0
32974,phereses,0,0
32975,to,0,0
32976,achieve,0,0
32977,minimum,0,0
32978,(,0,0
32979,P=,0,1
32980,.011,0,0
32981,),0,0
32982,and,0,0
32983,target,0,0
32984,(,0,0
32985,P=,0,1
32986,.015,0,0
32987,),0,0
32988,CD34+,0,0
32989,cell,0,0
32990,values,0,0
32991,.,0,0
32992,rhTPO,1,0
32993,given,0,0
32994,after,0,0
32995,transplantation,0,0
32996,did,0,0
32997,not,0,0
32998,speed,0,0
32999,platelet,0,0
33000,recovery,0,0
33001,.,0,0
33002,No,0,0
33003,neutralizing,0,0
33004,antibodies,0,0
33005,were,0,0
33006,observed,0,0
33007,.,0,0
33008,We,0,0
33009,conclude,0,0
33010,that,0,0
33011,rhTPO,1,0
33012,can,0,0
33013,safely,0,0
33014,enhance,0,0
33015,mobilization,0,0
33016,of,0,0
33017,PBPC,0,0
33018,",",0,0
33019,reduce,0,0
33020,the,0,0
33021,number,0,0
33022,of,0,0
33023,leukapheresis,0,1
33024,",",0,0
33025,and,0,0
33026,allow,0,0
33027,more,0,0
33028,patients,0,0
33029,to,0,0
33030,meet,0,0
33031,minimal,0,0
33032,cell,0,0
33033,yield,0,0
33034,requirements,0,0
33035,to,0,0
33036,receive,0,0
33037,high-dose,0,1
33038,chemotherapy,1,1
33039,with,0,0
33040,PBPC,1,0
33041,transplantation,1,0
33042,.,1,0
33043,A,0,0
33044,randomized,0,0
33045,clinical,0,0
33046,trial,0,0
33047,of,0,0
33048,treatment,0,0
33049,of,0,0
33050,clomiphene,0,1
33051,citrate-resistant,0,1
33052,anovulation,0,0
33053,with,0,0
33054,the,0,0
33055,use,0,0
33056,of,0,0
33057,oral,0,1
33058,contraceptive,0,1
33059,pill,0,1
33060,suppression,0,0
33061,and,0,0
33062,repeat,0,1
33063,clomiphene,0,1
33064,citrate,0,1
33065,treatment,0,0
33066,.,0,0
33067,OBJECTIVE,0,0
33068,The,0,0
33069,purpose,0,0
33070,of,0,0
33071,this,0,0
33072,study,0,0
33073,was,0,0
33074,to,0,0
33075,evaluate,0,0
33076,the,0,0
33077,effectiveness,0,0
33078,and,0,0
33079,endocrine,0,0
33080,response,0,0
33081,of,0,0
33082,oral,1,1
33083,contraceptive,1,1
33084,ovarian,0,0
33085,suppression,0,0
33086,followed,0,0
33087,by,0,0
33088,clomiphene,1,1
33089,citrate,1,1
33090,in,0,0
33091,patients,0,0
33092,who,0,0
33093,previously,0,0
33094,were,0,0
33095,clomiphene,0,1
33096,citrate,0,1
33097,resistant,0,0
33098,.,0,0
33099,STUDY,0,0
33100,DESIGN,0,0
33101,Forty-eight,0,0
33102,patients,0,0
33103,from,0,0
33104,a,0,0
33105,private,0,0
33106,tertiary,0,0
33107,infertility,0,0
33108,clinic,0,0
33109,were,0,0
33110,assigned,0,0
33111,randomly,0,0
33112,prospectively,1,0
33113,to,1,0
33114,either,1,0
33115,group,1,0
33116,1,1,0
33117,(,1,0
33118,oral,1,1
33119,contraceptive/clomiphene,1,1
33120,citrate,1,1
33121,),1,0
33122,",",1,0
33123,which,1,0
33124,received,1,0
33125,continuous,1,0
33126,oral,1,1
33127,contraceptives,1,1
33128,followed,1,0
33129,by,1,0
33130,clomiphene,1,1
33131,citrate,1,1
33132,",",1,0
33133,or,1,0
33134,to,1,0
33135,group,1,0
33136,2,1,0
33137,(,1,0
33138,control,1,0
33139,),1,0
33140,received,1,0
33141,no,1,0
33142,treatment,1,0
33143,in,1,0
33144,the,1,0
33145,cycle,1,0
33146,before,1,0
33147,clomiphene,1,1
33148,citrate,1,1
33149,treatment,1,0
33150,.,1,0
33151,On,1,0
33152,day,1,0
33153,3,1,0
33154,",",1,0
33155,17,1,0
33156,beta-estradiol,1,0
33157,",",1,0
33158,follicle-stimulating,1,0
33159,hormone,1,0
33160,",",1,0
33161,luteinizing,1,0
33162,hormone,1,0
33163,",",1,0
33164,and,1,0
33165,androgens,1,0
33166,were,1,0
33167,assayed,1,0
33168,before,1,0
33169,and,1,0
33170,after,1,0
33171,treatment,1,0
33172,.,1,0
33173,Follicle,0,0
33174,growth,0,0
33175,",",0,0
33176,ovulation,0,0
33177,",",0,0
33178,and,0,0
33179,pregnancy,0,0
33180,were,0,0
33181,evaluated,0,0
33182,.,0,0
33183,The,0,0
33184,Student,0,0
33185,t,0,0
33186,test,0,0
33187,and,0,0
33188,analysis,0,0
33189,of,0,0
33190,variance,0,0
33191,were,0,0
33192,used,0,0
33193,for,0,0
33194,statistical,0,0
33195,significance,0,0
33196,.,0,0
33197,RESULTS,0,0
33198,The,0,0
33199,oral,0,1
33200,contraceptive/clomiphene,0,1
33201,citrate,0,1
33202,group,0,0
33203,had,0,0
33204,a,0,0
33205,significantly,0,0
33206,higher,0,0
33207,percentage,0,0
33208,of,0,0
33209,patients,0,0
33210,who,0,0
33211,ovulated,0,0
33212,and,0,0
33213,of,0,0
33214,ovulatory,0,0
33215,cycles,0,0
33216,and,0,0
33217,pregnancies,0,0
33218,.,0,0
33219,Significantly,0,0
33220,lower,0,0
33221,levels,0,0
33222,of,0,0
33223,17,0,0
33224,beta-estradiol,0,0
33225,",",0,0
33226,luteinizing,0,0
33227,hormone,0,0
33228,",",0,0
33229,and,0,0
33230,androgen,0,0
33231,levels,0,0
33232,were,0,0
33233,seen,0,0
33234,in,0,0
33235,the,0,0
33236,oral,0,1
33237,contraceptive/clomiphene,0,1
33238,citrate,0,1
33239,group,0,0
33240,",",0,0
33241,with,0,0
33242,no,0,0
33243,significant,0,0
33244,changes,0,0
33245,in,0,0
33246,group,0,0
33247,2,0,0
33248,.,0,0
33249,CONCLUSION,0,0
33250,Suppression,0,0
33251,of,0,0
33252,the,0,0
33253,ovary,0,0
33254,with,0,0
33255,oral,0,0
33256,contraceptives,0,1
33257,results,0,0
33258,in,0,0
33259,excellent,0,0
33260,rates,0,0
33261,of,0,0
33262,ovulation,0,0
33263,and,0,0
33264,pregnancy,0,0
33265,in,0,0
33266,patients,0,0
33267,who,0,0
33268,previously,0,0
33269,were,0,0
33270,resistant,0,0
33271,to,0,0
33272,clomiphene,1,1
33273,citrate,1,1
33274,.,1,0
33275,The,0,0
33276,decreases,0,0
33277,in,0,0
33278,ovarian,0,0
33279,androgens,0,0
33280,",",0,0
33281,luteinizing,0,0
33282,hormone,0,0
33283,",",0,0
33284,and,0,0
33285,17,0,0
33286,beta-estradiol,0,0
33287,may,0,0
33288,be,0,0
33289,responsible,0,0
33290,for,0,0
33291,the,0,0
33292,improved,0,0
33293,response,0,0
33294,.,0,0
33295,A,0,0
33296,comparative,0,0
33297,study,0,0
33298,of,0,0
33299,a,0,0
33300,new,0,0
33301,food,0,0
33302,supplement,0,1
33303,",",0,0
33304,ViviScal,1,0
33305,",",1,0
33306,with,1,0
33307,fish,1,1
33308,extract,1,1
33309,for,0,0
33310,the,0,0
33311,treatment,0,0
33312,of,0,0
33313,hereditary,0,0
33314,androgenic,0,0
33315,alopecia,0,0
33316,in,0,0
33317,young,0,0
33318,males,0,0
33319,.,0,0
33320,A,0,0
33321,controlled,0,0
33322,",",0,0
33323,randomized,0,0
33324,",",0,0
33325,double-blind,0,0
33326,",",0,0
33327,parallel-group,0,0
33328,study,0,0
33329,compared,0,0
33330,the,0,0
33331,effects,0,0
33332,of,0,0
33333,ViviScal,1,0
33334,(,1,0
33335,a,1,0
33336,new,1,0
33337,food,1,0
33338,supplement,1,1
33339,incorporating,1,0
33340,special,1,0
33341,marine,1,0
33342,extracts,1,1
33343,and,1,0
33344,a,1,0
33345,silica,1,1
33346,compound,1,1
33347,),1,0
33348,with,1,0
33349,those,1,0
33350,of,1,0
33351,a,1,0
33352,fish,1,1
33353,extract,1,1
33354,in,0,0
33355,the,0,0
33356,treatment,0,0
33357,of,0,0
33358,young,0,0
33359,males,0,0
33360,with,0,0
33361,hereditary,0,0
33362,androgenic,0,0
33363,alopecia,0,0
33364,.,0,0
33365,The,0,0
33366,pretreatment,0,0
33367,histological,0,0
33368,diagnosis,0,0
33369,was,0,0
33370,alopecia,0,0
33371,with,0,0
33372,a,0,0
33373,mild,0,0
33374,to,0,0
33375,moderate,0,0
33376,perifollicular,0,0
33377,inflammation,0,0
33378,zone,0,0
33379,.,0,0
33380,The,0,0
33381,study,0,0
33382,consisted,0,0
33383,of,0,0
33384,20,0,0
33385,subjects,0,0
33386,who,0,0
33387,received,0,0
33388,two,1,0
33389,tablets,1,1
33390,of,1,0
33391,ViviScal,1,0
33392,once,1,0
33393,daily,1,0
33394,and,1,0
33395,20,1,0
33396,who,1,0
33397,received,1,0
33398,two,1,0
33399,tablets,1,1
33400,of,1,0
33401,fish,1,0
33402,extract,1,1
33403,once,1,0
33404,daily,1,0
33405,for,1,0
33406,6,1,0
33407,months,1,0
33408,.,1,0
33409,The,0,0
33410,mean,0,0
33411,patient,0,0
33412,age,0,0
33413,and,0,0
33414,mean,0,0
33415,duration,0,0
33416,and,0,0
33417,severity,0,0
33418,of,0,0
33419,baldness,0,0
33420,compared,0,0
33421,well,0,0
33422,between,0,0
33423,the,0,0
33424,two,0,0
33425,groups,0,0
33426,.,0,0
33427,Most,0,0
33428,patients,0,0
33429,had,0,0
33430,been,0,0
33431,treated,0,0
33432,with,0,0
33433,long-term,0,0
33434,topical,0,1
33435,2,0,0
33436,%,0,0
33437,minoxidil,1,1
33438,for,0,0
33439,1,0,0
33440,year,0,0
33441,or,0,0
33442,more,0,0
33443,prior,0,0
33444,to,0,0
33445,the,0,0
33446,study,0,0
33447,.,0,0
33448,At,0,0
33449,baseline,0,0
33450,and,0,0
33451,after,0,0
33452,6,0,0
33453,months,0,0
33454,',0,0
33455,treatment,0,0
33456,",",0,0
33457,a,0,0
33458,biopsy,0,0
33459,was,0,0
33460,taken,0,0
33461,for,0,0
33462,histological,0,0
33463,examination,0,0
33464,.,0,0
33465,A,0,0
33466,non-vellus,0,0
33467,hair,0,0
33468,count,0,0
33469,was,0,0
33470,performed,0,0
33471,at,0,0
33472,baseline,0,0
33473,and,0,0
33474,after,0,0
33475,2,0,0
33476,",",0,0
33477,4,0,0
33478,and,0,0
33479,6,0,0
33480,months,0,0
33481,.,0,0
33482,In,0,0
33483,the,0,0
33484,fish,1,1
33485,extract,1,1
33486,treatment,0,0
33487,group,0,0
33488,three,0,0
33489,patients,0,0
33490,withdrew,0,0
33491,from,0,0
33492,the,0,0
33493,study,0,0
33494,before,0,0
33495,the,0,0
33496,fourth,0,0
33497,month,0,0
33498,due,0,0
33499,to,0,0
33500,lack,0,0
33501,of,0,0
33502,therapeutic,0,0
33503,effect,0,0
33504,.,0,0
33505,After,0,0
33506,6,0,0
33507,months,0,0
33508,',0,0
33509,treatment,0,0
33510,",",0,0
33511,patients,0,0
33512,receiving,0,0
33513,ViviScal,1,0
33514,showed,0,0
33515,a,0,0
33516,mean,0,0
33517,increase,0,0
33518,in,0,0
33519,non-vellus,0,0
33520,hair,0,0
33521,of,0,0
33522,38,0,0
33523,%,0,0
33524,compared,0,0
33525,with,0,0
33526,a,0,0
33527,2,0,0
33528,%,0,0
33529,increase,0,0
33530,in,0,0
33531,the,0,0
33532,fish,1,1
33533,extract,1,1
33534,treatment,0,1
33535,group,0,0
33536,(,0,0
33537,P,0,0
33538,<,0,0
33539,0.0001,0,0
33540,),0,0
33541,.,0,0
33542,In,0,0
33543,the,0,0
33544,ViviScal,1,0
33545,group,0,0
33546,",",0,0
33547,19,0,0
33548,(,0,0
33549,95,0,0
33550,%,0,0
33551,),0,0
33552,subjects,0,0
33553,showed,0,0
33554,both,0,0
33555,clinical,0,0
33556,and,0,0
33557,histological,0,0
33558,cure,0,0
33559,",",0,0
33560,whereas,0,0
33561,none,0,0
33562,treated,0,0
33563,with,0,0
33564,fish,0,1
33565,extract,0,1
33566,showed,0,0
33567,any,0,0
33568,clinical,0,0
33569,or,0,0
33570,histological,0,0
33571,difference,0,0
33572,after,0,0
33573,6,0,0
33574,months,0,0
33575,',0,0
33576,treatment,0,0
33577,(,0,0
33578,P,0,0
33579,<,0,0
33580,0.0001,0,0
33581,),0,0
33582,.,0,0
33583,In,0,0
33584,both,0,0
33585,groups,0,0
33586,",",0,0
33587,a,0,0
33588,minimal,0,0
33589,decrease,0,0
33590,in,0,0
33591,the,0,0
33592,erythemal,0,0
33593,index,0,0
33594,was,0,0
33595,observed,0,0
33596,.,0,0
33597,In,0,0
33598,conclusion,0,0
33599,",",0,0
33600,ViviScal,1,0
33601,appears,0,0
33602,to,0,0
33603,be,0,0
33604,the,0,0
33605,first,0,0
33606,highly,0,0
33607,active,0,0
33608,treatment,0,0
33609,for,0,0
33610,androgenic,0,0
33611,alopecia,0,0
33612,in,0,0
33613,young,0,0
33614,males,0,0
33615,.,0,0
33616,Outcome,0,0
33617,of,0,0
33618,children,0,0
33619,with,0,0
33620,centrally,0,0
33621,reviewed,0,0
33622,low-grade,0,0
33623,gliomas,0,0
33624,treated,0,0
33625,with,0,0
33626,chemotherapy,1,1
33627,with,1,0
33628,or,1,0
33629,without,1,0
33630,radiotherapy,1,1
33631,on,0,0
33632,Children,0,0
33633,'s,0,0
33634,Cancer,0,0
33635,Group,0,0
33636,high-grade,0,0
33637,glioma,0,0
33638,study,0,0
33639,CCG-945,0,1
33640,.,0,0
33641,BACKGROUND,0,0
33642,The,0,0
33643,objectives,0,0
33644,of,0,0
33645,the,0,0
33646,current,0,0
33647,study,0,0
33648,were,0,0
33649,to,0,0
33650,determine,0,0
33651,the,0,0
33652,outcome,0,0
33653,of,0,0
33654,children,0,0
33655,who,0,0
33656,were,0,0
33657,treated,0,0
33658,with,0,0
33659,chemotherapy,1,1
33660,and,1,0
33661,radiotherapy,1,1
33662,on,0,0
33663,the,0,0
33664,Children,0,0
33665,'s,0,0
33666,Cancer,0,1
33667,Group,0,0
33668,(,0,0
33669,CCG,0,1
33670,),0,1
33671,high-grade,0,0
33672,glioma,0,1
33673,protocol,0,1
33674,(,0,0
33675,CCG-945,0,1
33676,),0,0
33677,who,0,0
33678,were,0,0
33679,diagnosed,0,0
33680,with,0,0
33681,low-grade,0,0
33682,gliomas,0,0
33683,on,0,0
33684,post,0,0
33685,hoc,0,0
33686,central,0,0
33687,pathologic,0,0
33688,review,0,0
33689,and,0,0
33690,to,0,0
33691,identify,0,0
33692,clinical,0,0
33693,and,0,0
33694,biologic,0,0
33695,features,0,0
33696,associated,0,0
33697,with,0,0
33698,prognosis,0,0
33699,.,0,0
33700,METHODS,0,0
33701,Between,0,0
33702,1985,0,0
33703,and,0,0
33704,1991,0,0
33705,",",0,0
33706,250,0,0
33707,children,0,0
33708,with,0,0
33709,institutionally,0,0
33710,classified,0,0
33711,high-grade,0,0
33712,gliomas,0,0
33713,were,0,0
33714,enrolled,0,0
33715,on,0,0
33716,CCG-945,0,1
33717,.,0,0
33718,Patients,0,0
33719,older,0,0
33720,than,0,0
33721,24,0,0
33722,months,0,0
33723,with,0,0
33724,intracranial,0,0
33725,lesions,0,0
33726,were,0,0
33727,assigned,0,0
33728,randomly,0,0
33729,to,0,0
33730,receive,0,0
33731,either,0,0
33732,lomustine,1,1
33733,",",1,0
33734,vincristine,1,1
33735,",",1,0
33736,and,1,0
33737,prednisone,1,1
33738,(,1,0
33739,control,1,1
33740,regimen,1,1
33741,),1,0
33742,or,1,0
33743,the,1,0
33744,8-drugs-in-1-day,1,1
33745,regimen,1,1
33746,(,1,0
33747,experimental,1,0
33748,regimen,1,1
33749,),1,0
33750,;,1,0
33751,younger,0,0
33752,patients,0,0
33753,and,0,0
33754,those,0,0
33755,with,0,0
33756,primary,0,0
33757,spinal,0,0
33758,cord,0,0
33759,tumors,0,0
33760,were,0,0
33761,assigned,0,0
33762,nonrandomly,0,0
33763,to,0,0
33764,the,0,0
33765,experimental,0,0
33766,regimen,0,0
33767,.,0,0
33768,Central,0,0
33769,independent,0,0
33770,review,0,0
33771,by,0,0
33772,5,0,0
33773,neuropathologists,0,0
33774,led,0,0
33775,to,0,0
33776,a,0,0
33777,reclassification,0,0
33778,of,0,0
33779,low-grade,0,0
33780,glioma,0,0
33781,in,0,0
33782,70,0,0
33783,patients,0,0
33784,",",0,0
33785,who,0,0
33786,were,0,0
33787,the,0,0
33788,focus,0,0
33789,of,0,0
33790,the,0,0
33791,current,0,0
33792,study,0,0
33793,.,0,0
33794,RESULTS,0,0
33795,The,0,0
33796,study,0,0
33797,involved,0,0
33798,42,0,0
33799,males,0,0
33800,and,0,0
33801,28,0,0
33802,females,0,0
33803,(,0,0
33804,median,0,0
33805,age,0,0
33806,",",0,0
33807,7.7,0,0
33808,years,0,0
33809,),0,0
33810,with,0,0
33811,a,0,0
33812,median,0,0
33813,follow-up,0,0
33814,of,0,0
33815,10.4,0,0
33816,years,0,0
33817,.,0,0
33818,At,0,0
33819,5,0,0
33820,years,0,0
33821,",",0,0
33822,the,0,0
33823,progression-free,0,0
33824,survival,0,0
33825,(,0,0
33826,PFS,0,0
33827,),0,0
33828,rate,0,0
33829,was,0,0
33830,63,0,0
33831,%,0,0
33832,+/-,0,0
33833,6,0,0
33834,%,0,0
33835,",",0,0
33836,and,0,0
33837,the,0,0
33838,overall,0,0
33839,survival,0,0
33840,(,0,0
33841,OS,0,0
33842,),0,0
33843,rate,0,0
33844,was,0,0
33845,79,0,0
33846,%,0,0
33847,+/-,0,0
33848,5,0,0
33849,%,0,0
33850,",",0,0
33851,compared,0,0
33852,with,0,0
33853,a,0,0
33854,PFS,0,0
33855,rate,0,0
33856,of,0,0
33857,19,0,0
33858,%,0,0
33859,+/-,0,0
33860,3,0,0
33861,%,0,0
33862,(,0,0
33863,P,0,0
33864,<,0,0
33865,0.0001,0,0
33866,),0,0
33867,and,0,0
33868,an,0,0
33869,OS,0,0
33870,rate,0,0
33871,of,0,0
33872,22,0,0
33873,%,0,0
33874,+/-,0,0
33875,3,0,0
33876,%,0,0
33877,(,0,0
33878,P,0,0
33879,<,0,0
33880,0.0001,0,0
33881,),0,0
33882,in,0,0
33883,the,0,0
33884,remainder,0,0
33885,of,0,0
33886,the,0,0
33887,cohort,0,0
33888,.,0,0
33889,Significantly,0,0
33890,poorer,0,0
33891,5-year,0,0
33892,PFS,0,0
33893,was,0,0
33894,seen,0,0
33895,in,0,0
33896,children,0,0
33897,younger,0,0
33898,than,0,0
33899,24,0,0
33900,months,0,0
33901,",",0,0
33902,those,0,0
33903,with,0,0
33904,fibrillary,0,0
33905,astrocytoma,0,0
33906,",",0,0
33907,and,0,0
33908,those,0,0
33909,with,0,0
33910,posterior,0,1
33911,fossa,0,0
33912,tumors,0,0
33913,.,0,0
33914,Patients,0,0
33915,demonstrated,0,0
33916,a,0,0
33917,modest,0,0
33918,improvement,0,0
33919,in,0,0
33920,PFS,0,0
33921,but,0,0
33922,no,0,0
33923,improvement,0,0
33924,in,0,0
33925,OS,0,0
33926,compared,0,0
33927,with,0,0
33928,children,0,0
33929,with,0,0
33930,low-grade,0,0
33931,gliomas,0,0
33932,who,0,0
33933,were,0,0
33934,treated,0,0
33935,with,0,0
33936,contemporary,0,0
33937,chemotherapy-alone,0,0
33938,approaches,0,0
33939,.,0,0
33940,CONCLUSIONS,0,0
33941,The,0,0
33942,current,0,0
33943,report,0,0
33944,calls,0,0
33945,attention,0,0
33946,to,0,0
33947,the,0,0
33948,importance,0,0
33949,of,0,0
33950,central,0,0
33951,pathologic,0,0
33952,review,0,0
33953,in,0,0
33954,large,0,0
33955,multiinstitutional,0,0
33956,trials,0,0
33957,of,0,0
33958,children,0,0
33959,with,0,0
33960,gliomas,0,0
33961,and,0,0
33962,suggests,0,0
33963,that,0,0
33964,aggressive,0,0
33965,front-line,0,0
33966,combined,0,1
33967,chemoradiotherapy,0,1
33968,does,0,0
33969,not,0,0
33970,confer,0,0
33971,a,0,0
33972,survival,0,0
33973,advantage,0,0
33974,in,0,0
33975,this,0,0
33976,highly,0,0
33977,selected,0,0
33978,population,0,0
33979,of,0,0
33980,patients,0,0
33981,.,0,0
33982,T,0,0
33983,lymphocyte,0,0
33984,subsets,0,0
33985,and,0,0
33986,NK,0,0
33987,cell,0,0
33988,cytotoxicity,0,0
33989,in,0,0
33990,chronic,0,0
33991,hemodialysis,0,0
33992,patients,0,0
33993,.,0,0
33994,The,0,0
33995,effect,0,0
33996,of,0,0
33997,recombinant,1,1
33998,human,1,1
33999,erythropoietin,1,1
34000,(,1,0
34001,rHu-EPO,1,1
34002,),1,0
34003,treatment,1,0
34004,.,1,0
34005,We,0,0
34006,investigated,0,0
34007,subpopulations,0,0
34008,of,0,0
34009,T,0,0
34010,lymphocytes,0,0
34011,",",0,0
34012,NK,0,0
34013,cell,0,0
34014,number,0,0
34015,and,0,0
34016,cytotoxic,0,1
34017,activity,0,0
34018,in,0,0
34019,14,0,0
34020,chronic,0,0
34021,uremic,0,0
34022,patients,0,0
34023,on,0,0
34024,regular,1,1
34025,hemodialysis,1,0
34026,treatment,1,0
34027,.,1,0
34028,We,0,0
34029,observed,0,0
34030,a,0,0
34031,significantly,0,0
34032,decreased,0,0
34033,absolute,0,0
34034,lymphocyte,0,0
34035,number,0,0
34036,and,0,0
34037,percentage,0,0
34038,of,0,0
34039,CD3,0,1
34040,cells,0,0
34041,.,0,0
34042,Relative,0,0
34043,numbers,0,0
34044,of,0,0
34045,CD16,0,0
34046,cells,0,0
34047,were,0,0
34048,significantly,0,0
34049,elevated,0,0
34050,",",0,0
34051,but,0,0
34052,NK,0,0
34053,cell,0,0
34054,cytotoxic,0,0
34055,activity,0,0
34056,was,0,0
34057,within,0,0
34058,a,0,0
34059,normal,0,0
34060,range,0,0
34061,.,0,0
34062,Nine,0,1
34063,patients,0,0
34064,with,0,0
34065,chronic,0,0
34066,renal,0,0
34067,anemia,0,0
34068,on,0,0
34069,maintenance,0,0
34070,hemodialysis,0,0
34071,were,0,0
34072,enrolled,0,0
34073,in,0,0
34074,rHu-EPO,1,1
34075,treatment,0,0
34076,trial,0,0
34077,.,0,0
34078,The,0,0
34079,treatment,0,0
34080,was,0,0
34081,continued,0,0
34082,till,0,0
34083,the,0,0
34084,hematocrit,0,0
34085,level,0,0
34086,reached,0,0
34087,30,0,0
34088,%,0,0
34089,.,0,0
34090,Each,0,0
34091,of,0,0
34092,the,0,0
34093,patients,0,0
34094,had,0,0
34095,corrected,0,0
34096,anemia,0,0
34097,and,0,0
34098,well-being,0,0
34099,.,0,0
34100,After,0,0
34101,12,0,0
34102,weeks,0,0
34103,of,0,0
34104,the,0,0
34105,treatment,0,0
34106,we,0,0
34107,observed,0,0
34108,in,0,0
34109,these,0,0
34110,patients,0,0
34111,decreases,0,0
34112,in,0,0
34113,CD3,0,1
34114,",",0,0
34115,CD4,0,0
34116,",",0,0
34117,CD8,0,0
34118,and,0,0
34119,CD16,0,1
34120,cell,0,0
34121,numbers,0,0
34122,and,0,0
34123,elevation,0,0
34124,of,0,0
34125,CD4/CD8,0,0
34126,ratio,0,0
34127,.,0,0
34128,Cytotoxic,0,0
34129,activity,0,0
34130,of,0,0
34131,NK,0,0
34132,cells,0,0
34133,did,0,0
34134,not,0,0
34135,change,0,0
34136,significantly,0,0
34137,.,0,0
34138,Presented,0,0
34139,results,0,0
34140,indicate,0,0
34141,that,0,0
34142,chronic,0,0
34143,hemodialysis,0,0
34144,patients,0,0
34145,have,0,0
34146,significantly,0,0
34147,diminished,0,0
34148,lymphocyte,0,0
34149,number,0,0
34150,.,0,0
34151,rHu,1,0
34152,EPO,1,1
34153,treatment,0,0
34154,affects,0,0
34155,the,0,0
34156,T,0,0
34157,lymphocyte,0,0
34158,subsets,0,0
34159,inducing,0,0
34160,a,0,0
34161,deep,0,1
34162,decrease,0,0
34163,of,0,0
34164,CD8,0,0
34165,and,0,0
34166,CD16,0,1
34167,cell,0,0
34168,percentage,0,0
34169,leading,0,0
34170,to,0,0
34171,normalisation,0,0
34172,of,0,0
34173,the,0,0
34174,CD4/CD8,0,0
34175,ratio,0,0
34176,.,0,0
34177,[,0,0
34178,Myocardial,0,0
34179,ischemia,0,0
34180,with,0,0
34181,stable,0,0
34182,angina,0,0
34183,pectoris,0,0
34184,:,0,0
34185,clinico-ergometric,0,0
34186,evaluation,0,0
34187,after,0,0
34188,the,0,0
34189,use,0,0
34190,of,0,0
34191,diltiazem,1,1
34192,],1,0
34193,.,0,0
34194,PURPOSE,0,0
34195,To,0,0
34196,evaluate,0,0
34197,the,0,0
34198,efficacy,0,0
34199,of,0,0
34200,diltiazem,1,1
34201,versus,0,0
34202,placebo,1,1
34203,in,0,0
34204,patients,0,0
34205,with,0,0
34206,stable,0,0
34207,angina,0,0
34208,.,0,0
34209,METHODS,0,0
34210,Eight-seven,0,0
34211,angina,0,0
34212,pectoris,0,0
34213,patients,0,0
34214,",",0,0
34215,mean,0,0
34216,age,0,0
34217,of,0,0
34218,57,0,0
34219,+/-,0,0
34220,9,0,0
34221,",",0,0
34222,82,0,0
34223,white,0,0
34224,and,0,0
34225,79,0,0
34226,male,0,0
34227,were,0,0
34228,evaluated,0,0
34229,in,0,0
34230,a,0,0
34231,randomized,0,0
34232,",",0,0
34233,double-blind,0,0
34234,trial,0,0
34235,of,0,0
34236,two,0,0
34237,groups,0,0
34238,of,0,0
34239,patients,0,0
34240,diltiazem,1,1
34241,and,1,0
34242,placebo,1,1
34243,",",0,0
34244,3,0,0
34245,to,0,0
34246,4,0,0
34247,tablets,0,1
34248,a,0,0
34249,day,0,0
34250,(,1,0
34251,diltiazem,1,1
34252,180,0,0
34253,to,0,0
34254,240,0,0
34255,mg,0,1
34256,daily,0,0
34257,),0,0
34258,.,0,0
34259,The,0,0
34260,patients,0,0
34261,were,0,0
34262,evaluated,0,0
34263,after,0,0
34264,laboratory,0,0
34265,tests,0,0
34266,and,0,0
34267,clinical-ergometric,0,0
34268,examinations,0,0
34269,.,0,0
34270,A,0,0
34271,coronary,0,0
34272,arteriography,0,1
34273,was,0,0
34274,performed,0,0
34275,on,0,0
34276,study,0,0
34277,entry,0,0
34278,.,0,0
34279,RESULTS,0,0
34280,The,0,0
34281,average,0,0
34282,of,0,0
34283,anginal,0,0
34284,attacks,0,0
34285,",",0,0
34286,number,0,0
34287,of,0,0
34288,weekly,0,1
34289,sublingual,0,1
34290,nitrate,0,1
34291,",",0,0
34292,heart,0,0
34293,rate,0,0
34294,",",0,0
34295,systolic,0,0
34296,and,0,0
34297,diastolic,0,0
34298,pressure,0,0
34299,at,0,0
34300,rest,0,0
34301,and,0,0
34302,at,0,0
34303,the,0,0
34304,end,0,0
34305,of,0,0
34306,diltiazem,1,1
34307,period,0,0
34308,were,0,0
34309,significantly,0,0
34310,lower,0,0
34311,(,0,0
34312,p,0,0
34313,<,0,0
34314,0.05,0,0
34315,),0,0
34316,regarding,0,0
34317,same,0,0
34318,periods,0,0
34319,on,0,0
34320,placebo,1,1
34321,.,1,0
34322,The,0,0
34323,percentage,0,0
34324,of,0,0
34325,depression,0,0
34326,for,0,0
34327,ST-segment,0,0
34328,was,0,0
34329,lower,0,0
34330,for,0,0
34331,diltiazem,1,1
34332,when,0,0
34333,compared,0,0
34334,with,0,0
34335,placebo,1,1
34336,(,0,0
34337,p,0,0
34338,<,0,0
34339,0.05,0,0
34340,),0,0
34341,and,0,0
34342,the,0,0
34343,percentage,0,0
34344,of,0,0
34345,patients,0,0
34346,that,0,0
34347,reach,0,0
34348,higher,0,0
34349,stages,0,0
34350,in,0,0
34351,the,0,0
34352,ergometric,0,0
34353,test,0,0
34354,was,0,0
34355,significantly,0,0
34356,better,0,0
34357,for,0,0
34358,diltiazem,1,1
34359,.,1,0
34360,Heart,0,0
34361,rate,0,0
34362,and,0,0
34363,systolic,0,0
34364,plus,0,1
34365,diastolic,0,0
34366,pressures,0,0
34367,after,0,0
34368,exercise,0,1
34369,did,0,0
34370,not,0,0
34371,differ,0,0
34372,in,0,0
34373,both,0,0
34374,groups,0,0
34375,.,0,0
34376,CONCLUSION,0,0
34377,Diltiazem,1,1
34378,reduced,0,0
34379,the,0,0
34380,clinical,0,0
34381,and,0,0
34382,electrocardiographical,0,0
34383,aspects,0,0
34384,and,0,0
34385,raises,0,0
34386,the,0,0
34387,effort,0,0
34388,tolerance,0,0
34389,during,0,0
34390,the,0,0
34391,ergometric,0,0
34392,test,0,0
34393,in,0,0
34394,patients,0,0
34395,with,0,0
34396,stable,0,0
34397,angina,0,0
34398,.,0,0
34399,A,0,0
34400,controlled,0,0
34401,clinical,0,0
34402,trial,0,0
34403,of,0,0
34404,a,0,0
34405,muscle,1,0
34406,relaxant,1,1
34407,analgesic,1,0
34408,combination,1,1
34409,in,0,0
34410,the,0,0
34411,treatment,0,0
34412,of,0,0
34413,acute,0,0
34414,lumbago,0,0
34415,.,0,0
34416,Randomized,0,0
34417,phase,0,0
34418,II,0,0
34419,trial,0,0
34420,of,0,0
34421,high-dose,0,1
34422,4'-epi-doxorubicin,1,1
34423,+,0,1
34424,cyclophosphamide,1,1
34425,versus,0,0
34426,high-dose,0,1
34427,4'-epi-doxorubicin,1,1
34428,+,1,1
34429,cisplatin,1,1
34430,in,0,0
34431,previously,0,0
34432,untreated,0,0
34433,patients,0,0
34434,with,0,0
34435,extensive,0,0
34436,small,0,0
34437,cell,0,0
34438,lung,0,0
34439,cancer,0,0
34440,.,0,0
34441,One,0,0
34442,hundred,0,0
34443,and,0,0
34444,eleven,0,0
34445,previously,0,0
34446,untreated,0,0
34447,patients,0,0
34448,with,0,0
34449,extensive,0,0
34450,small,0,0
34451,cell,0,0
34452,lung,0,0
34453,cancer,0,0
34454,were,0,0
34455,included,0,0
34456,in,0,0
34457,a,0,0
34458,prospective,0,0
34459,randomized,0,0
34460,study,0,0
34461,with,0,0
34462,the,0,0
34463,aim,0,0
34464,to,0,0
34465,assess,0,0
34466,the,0,0
34467,efficacy,0,0
34468,and,0,0
34469,tolerance,0,0
34470,of,0,0
34471,high-dose,1,1
34472,epirubicin,1,1
34473,(,0,0
34474,120,0,0
34475,mg/m2,0,1
34476,),0,0
34477,in,0,0
34478,combination,0,1
34479,with,0,0
34480,either,0,0
34481,cyclophosphamide,1,1
34482,(,0,0
34483,800,0,0
34484,mg/m2,0,1
34485,;,0,0
34486,arm,0,0
34487,1,0,0
34488,),0,0
34489,or,0,1
34490,cisplatin,1,1
34491,(,0,0
34492,60,0,0
34493,mg/m2,0,1
34494,;,0,0
34495,arm,0,0
34496,2,0,0
34497,),0,0
34498,.,0,0
34499,Ninety-six,0,0
34500,patients,0,0
34501,were,0,0
34502,evaluable,0,0
34503,for,0,0
34504,response,0,0
34505,and,0,0
34506,toxicity,0,0
34507,and,0,0
34508,additional,0,0
34509,12,0,0
34510,patients,0,0
34511,for,0,0
34512,toxicity,0,0
34513,only,0,0
34514,.,0,0
34515,The,0,0
34516,overall,0,0
34517,response,0,0
34518,rate,0,0
34519,(,0,0
34520,CR+PR,0,1
34521,),0,0
34522,in,0,0
34523,arm,0,0
34524,1,0,0
34525,and,0,0
34526,2,0,0
34527,were,0,0
34528,61.4,0,0
34529,(,0,0
34530,27/44,0,0
34531,),0,0
34532,and,0,0
34533,67.3,0,0
34534,%,0,0
34535,(,0,0
34536,35/52,0,0
34537,),0,0
34538,",",0,0
34539,respectively,0,0
34540,.,0,0
34541,The,0,0
34542,mean,0,0
34543,duration,0,0
34544,of,0,0
34545,remission,0,0
34546,was,0,0
34547,4.4,0,0
34548,months,0,0
34549,(,0,0
34550,arm,0,0
34551,1,0,0
34552,),0,0
34553,and,0,0
34554,4.9,0,0
34555,months,0,0
34556,(,0,0
34557,arm,0,0
34558,2,0,0
34559,),0,0
34560,.,0,0
34561,The,0,0
34562,mean,0,0
34563,survival,0,0
34564,time,0,0
34565,was,0,0
34566,6.6,0,0
34567,months,0,0
34568,in,0,0
34569,arm,0,0
34570,1,0,0
34571,and,0,0
34572,7.7,0,0
34573,months,0,0
34574,in,0,0
34575,arm,0,0
34576,2.,0,0
34577,WHO,0,0
34578,grade,0,0
34579,4,0,0
34580,toxicity,0,0
34581,was,0,0
34582,encountered,0,0
34583,in,0,0
34584,25.5,0,0
34585,and,0,0
34586,15.8,0,0
34587,%,0,0
34588,of,0,0
34589,patients,0,0
34590,in,0,0
34591,arm,0,0
34592,1,0,0
34593,and,0,0
34594,2,0,0
34595,",",0,0
34596,respectively,0,0
34597,.,0,0
34598,One,0,0
34599,case,0,0
34600,of,0,0
34601,cardiotoxicity,0,0
34602,resulting,0,0
34603,in,0,0
34604,the,0,0
34605,patient,0,0
34606,'s,0,0
34607,death,0,0
34608,was,0,0
34609,observed,0,0
34610,in,0,0
34611,arm,0,0
34612,1,0,0
34613,.,0,0
34614,Both,0,0
34615,combinations,0,0
34616,showed,0,0
34617,considerable,0,0
34618,antitumor,0,0
34619,activity,0,0
34620,.,0,0
34621,Toxicity,0,0
34622,was,0,0
34623,acceptable,0,0
34624,.,0,0
34625,Induction,1,1
34626,chemotherapy,1,1
34627,in,0,0
34628,head,0,0
34629,and,0,0
34630,neck,0,0
34631,cancer,0,0
34632,:,0,0
34633,results,0,0
34634,of,0,0
34635,a,0,0
34636,phase,0,0
34637,III,0,0
34638,trial,0,0
34639,.,0,0
34640,Between,0,0
34641,December,0,0
34642,1982,0,0
34643,and,0,0
34644,October,0,0
34645,1986,0,0
34646,",",0,0
34647,131,0,0
34648,patients,0,0
34649,with,0,0
34650,stage,0,0
34651,II-III-IV,0,0
34652,squamous,0,0
34653,cell,0,0
34654,carcinoma,0,0
34655,of,0,0
34656,the,0,0
34657,oropharynx,0,0
34658,or,0,1
34659,oral,0,1
34660,cavity,0,1
34661,were,0,0
34662,randomized,0,0
34663,to,0,0
34664,induction,1,0
34665,chemotherapy,1,1
34666,",",1,0
34667,consisting,1,0
34668,of,1,0
34669,bleomycin,1,1
34670,(,1,0
34671,10,1,0
34672,mg/m2/day,1,1
34673,in,1,0
34674,continuous,1,1
34675,infusion,1,1
34676,from,1,0
34677,day,1,0
34678,1,1,0
34679,to,1,0
34680,day,1,0
34681,5,1,0
34682,),1,0
34683,",",1,0
34684,methotrexate,1,1
34685,(,1,0
34686,120,1,0
34687,mg/m2,1,1
34688,on,1,0
34689,day,1,0
34690,2,1,0
34691,),1,0
34692,followed,1,0
34693,by,1,0
34694,folinic,1,1
34695,acid,1,1
34696,",",1,0
34697,5-fluorouracil,1,1
34698,(,1,0
34699,5,1,0
34700,FU,1,1
34701,),1,0
34702,(,1,0
34703,600,1,1
34704,mg/m2,1,1
34705,on,1,0
34706,day,1,0
34707,2,1,0
34708,),1,0
34709,",",1,0
34710,and,1,0
34711,cisplatin,1,1
34712,(,1,0
34713,120,1,0
34714,mg/m2,1,1
34715,on,1,0
34716,day,1,0
34717,4,1,0
34718,),1,0
34719,every,1,0
34720,4,1,0
34721,weeks,1,0
34722,for,1,0
34723,a,1,0
34724,total,1,0
34725,of,1,0
34726,three,1,0
34727,cycles,1,0
34728,followed,1,0
34729,by,1,0
34730,definitive,1,0
34731,locoregional,1,0
34732,treatment,1,0
34733,versus,1,0
34734,locoregional,1,0
34735,treatment,1,0
34736,alone,1,1
34737,.,1,0
34738,The,0,0
34739,modalities,0,0
34740,of,0,0
34741,definitive,0,0
34742,treatment,0,0
34743,(,1,0
34744,radiotherapy,1,1
34745,+/-,1,0
34746,surgery,1,1
34747,),1,0
34748,were,0,0
34749,chosen,0,0
34750,prior,0,0
34751,to,0,0
34752,randomization,0,0
34753,.,0,0
34754,A,0,0
34755,total,0,0
34756,of,0,0
34757,116,0,0
34758,patients,0,0
34759,were,0,0
34760,evaluable,0,0
34761,.,0,0
34762,Of,0,0
34763,55,0,0
34764,patients,0,0
34765,in,0,0
34766,the,0,0
34767,chemotherapy,1,1
34768,arm,0,0
34769,",",0,0
34770,four,0,0
34771,(,0,0
34772,7,0,0
34773,%,0,0
34774,),0,0
34775,had,0,0
34776,a,0,0
34777,complete,0,0
34778,response,0,0
34779,(,0,0
34780,CR,0,1
34781,),0,0
34782,and,0,0
34783,23,0,0
34784,(,0,0
34785,42,0,0
34786,%,0,0
34787,),0,0
34788,a,0,0
34789,partial,0,0
34790,response,0,0
34791,(,0,0
34792,PR,0,1
34793,),0,0
34794,following,0,0
34795,the,0,0
34796,induction,0,0
34797,regimen,0,0
34798,.,0,0
34799,At,0,0
34800,the,0,0
34801,completion,0,0
34802,of,0,0
34803,locoregional,0,0
34804,treatment,0,0
34805,",",0,0
34806,76,0,0
34807,%,0,0
34808,(,0,0
34809,42,0,0
34810,of,0,0
34811,55,0,0
34812,),0,0
34813,of,0,0
34814,patients,0,0
34815,in,0,0
34816,the,0,0
34817,experimental,0,0
34818,group,0,0
34819,were,0,0
34820,in,0,0
34821,CR,0,1
34822,compared,0,0
34823,to,0,0
34824,89,0,0
34825,%,0,0
34826,(,0,0
34827,54,0,0
34828,of,0,0
34829,61,0,0
34830,),0,0
34831,in,0,0
34832,the,0,0
34833,control,0,0
34834,group,0,0
34835,.,0,0
34836,There,0,0
34837,was,0,0
34838,no,0,0
34839,difference,0,0
34840,in,0,0
34841,survival,0,0
34842,",",0,0
34843,cause-specific,0,0
34844,survival,0,0
34845,",",0,0
34846,and,0,0
34847,pattern,0,0
34848,of,0,0
34849,relapse,0,0
34850,between,0,0
34851,both,0,0
34852,groups,0,0
34853,.,0,0
34854,The,0,0
34855,median,0,0
34856,survival,0,0
34857,was,0,0
34858,22,0,0
34859,months,0,0
34860,in,0,0
34861,the,0,0
34862,chemotherapy,0,1
34863,group,0,0
34864,and,0,0
34865,29,0,0
34866,months,0,0
34867,in,0,0
34868,the,0,0
34869,control,0,0
34870,group,0,0
34871,.,0,0
34872,Responders,0,0
34873,to,0,0
34874,chemotherapy,0,1
34875,did,0,0
34876,not,0,0
34877,fare,0,0
34878,better,0,0
34879,than,0,0
34880,nonresponders,0,0
34881,.,0,0
34882,Chemotherapy-related,0,0
34883,toxicities,0,0
34884,were,0,0
34885,few,0,0
34886,and,0,0
34887,most,0,0
34888,of,0,0
34889,them,0,0
34890,related,0,0
34891,to,0,0
34892,cisplatin,0,1
34893,which,0,0
34894,was,0,0
34895,reduced,0,0
34896,to,0,0
34897,100,0,0
34898,mg/m2,0,0
34899,for,0,0
34900,35,0,0
34901,patients,0,0
34902,.,0,0
34903,There,0,0
34904,were,0,0
34905,no,0,0
34906,treatment-related,0,0
34907,deaths,0,0
34908,and,0,0
34909,",",0,0
34910,in,0,0
34911,the,0,0
34912,experimental,0,0
34913,arm,0,0
34914,of,0,0
34915,the,0,0
34916,trial,0,0
34917,",",0,0
34918,no,0,0
34919,increased,0,0
34920,morbidity,0,0
34921,from,0,0
34922,locoregional,0,0
34923,treatment,0,0
34924,.,0,0
34925,This,0,0
34926,induction,0,0
34927,regimen,0,1
34928,does,0,0
34929,not,0,0
34930,offer,0,0
34931,any,0,0
34932,advantages,0,0
34933,over,0,0
34934,standard,0,0
34935,treatment,0,0
34936,.,0,0
34937,Iloprost,1,1
34938,in,0,0
34939,cardiopulmonary,0,1
34940,bypass,0,0
34941,procedures,0,0
34942,.,0,0
34943,The,0,0
34944,inhibition,0,0
34945,of,0,0
34946,platelet,0,0
34947,aggregation,0,0
34948,during,0,0
34949,cardiopulmonary,0,1
34950,bypass,0,1
34951,and,0,0
34952,effects,0,0
34953,on,0,0
34954,post-operative,0,0
34955,placebo-controlled,1,1
34956,study,0,0
34957,of,0,0
34958,145,0,0
34959,patients,0,0
34960,.,0,0
34961,Significant,0,0
34962,preservation,0,0
34963,of,0,0
34964,platelet,0,0
34965,numbers,0,0
34966,and,0,0
34967,function,0,0
34968,were,0,0
34969,shown,0,0
34970,without,0,0
34971,significant,0,0
34972,haemodynamic,0,0
34973,problems,0,0
34974,",",0,0
34975,but,0,0
34976,no,0,0
34977,effect,0,0
34978,on,0,0
34979,cerebral,0,0
34980,deficits,0,0
34981,could,0,0
34982,be,0,0
34983,found,0,0
34984,.,0,0
34985,The,0,0
34986,use,0,0
34987,of,0,0
34988,iloprost,1,1
34989,in,0,0
34990,patients,0,0
34991,with,0,0
34992,severe,0,0
34993,thrombocytopenia,0,0
34994,seems,0,0
34995,justified,0,0
34996,",",0,0
34997,but,0,0
34998,the,0,0
34999,clinical,0,0
35000,benefits,0,0
35001,from,0,0
35002,its,0,0
35003,use,0,0
35004,in,0,0
35005,routine,0,0
35006,cardiopulmonary,0,1
35007,bypass,0,1
35008,remain,0,0
35009,to,0,0
35010,be,0,0
35011,shown,0,0
35012,.,0,0
35013,A,0,0
35014,randomized,0,0
35015,trial,0,0
35016,of,0,0
35017,a,0,0
35018,health,1,0
35019,care,1,1
35020,program,1,1
35021,for,1,0
35022,first-time,1,0
35023,adolescent,1,0
35024,mothers,1,0
35025,and,1,0
35026,their,1,0
35027,infants,1,0
35028,.,1,0
35029,To,0,0
35030,test,0,0
35031,the,0,0
35032,effectiveness,0,0
35033,of,0,0
35034,a,0,0
35035,special,1,0
35036,health,1,0
35037,care,1,1
35038,program,1,1
35039,for,0,0
35040,adolescent,0,0
35041,mothers,0,0
35042,(,0,0
35043,17,0,0
35044,years,0,0
35045,old,0,0
35046,or,0,0
35047,younger,0,0
35048,),0,0
35049,and,0,0
35050,their,0,0
35051,infants,0,0
35052,",",0,0
35053,243,0,0
35054,mother-infant,0,0
35055,pairs,0,0
35056,were,0,0
35057,randomly,0,0
35058,assigned,0,0
35059,to,0,0
35060,one,0,0
35061,of,0,0
35062,two,0,0
35063,groups,0,0
35064,.,0,0
35065,All,0,0
35066,of,0,0
35067,the,0,0
35068,mothers,0,0
35069,were,0,0
35070,unwed,0,0
35071,",",0,0
35072,on,0,0
35073,Medicaid,0,1
35074,",",0,0
35075,and,0,0
35076,black,0,0
35077,.,0,0
35078,The,0,0
35079,control,1,0
35080,group,1,0
35081,received,1,0
35082,routine,1,0
35083,well-baby,1,1
35084,care,1,1
35085,.,1,0
35086,The,0,0
35087,experimental,0,0
35088,group,0,0
35089,received,0,0
35090,routine,1,0
35091,care,1,1
35092,and,1,0
35093,services,1,0
35094,that,1,0
35095,included,1,0
35096,rigorous,1,0
35097,follow-up,1,0
35098,",",1,0
35099,discussions,1,0
35100,with,1,0
35101,the,1,0
35102,mother,1,0
35103,about,1,0
35104,her,1,0
35105,plans,1,0
35106,for,1,0
35107,return,1,0
35108,to,1,0
35109,school,1,0
35110,and,1,0
35111,use,1,0
35112,of,1,0
35113,family,1,0
35114,planning,1,0
35115,methods,1,0
35116,",",1,0
35117,and,1,0
35118,extra,1,0
35119,health,1,0
35120,teaching,1,1
35121,.,1,0
35122,The,0,0
35123,dropout,0,0
35124,rate,0,0
35125,in,0,0
35126,the,0,0
35127,experimental,0,0
35128,group,0,0
35129,(,0,0
35130,60,0,0
35131,%,0,0
35132,),0,0
35133,was,0,0
35134,significantly,0,0
35135,less,0,0
35136,after,0,0
35137,18,0,0
35138,months,0,0
35139,than,0,0
35140,the,0,0
35141,control,0,1
35142,group,0,0
35143,(,0,0
35144,82,0,0
35145,%,0,0
35146,),0,0
35147,.,0,0
35148,In,0,0
35149,spite,0,0
35150,of,0,0
35151,the,0,0
35152,high,0,0
35153,dropout,0,0
35154,rate,0,0
35155,",",0,0
35156,91,0,0
35157,%,0,0
35158,of,0,0
35159,the,0,0
35160,mothers,0,0
35161,were,0,0
35162,located,0,0
35163,for,0,0
35164,the,0,0
35165,18,0,0
35166,month,0,0
35167,follow-up,0,0
35168,interview,0,0
35169,.,0,0
35170,The,0,0
35171,repeat,0,0
35172,pregnancy,0,0
35173,rate,0,0
35174,in,0,0
35175,the,0,0
35176,experimental,0,0
35177,group,0,0
35178,was,0,0
35179,12,0,0
35180,%,0,0
35181,after,0,0
35182,18,0,0
35183,months,0,0
35184,",",0,0
35185,and,0,0
35186,28,0,0
35187,%,0,0
35188,in,0,0
35189,the,0,0
35190,control,0,0
35191,group,0,0
35192,.,0,0
35193,There,0,0
35194,was,0,0
35195,no,0,0
35196,significant,0,0
35197,difference,0,0
35198,in,0,0
35199,the,0,0
35200,percentage,0,0
35201,returning,0,0
35202,to,0,0
35203,school,0,0
35204,.,0,0
35205,After,0,0
35206,12,0,0
35207,months,0,0
35208,",",0,0
35209,the,0,0
35210,infants,0,0
35211,in,0,0
35212,the,0,0
35213,experimental,0,0
35214,group,0,0
35215,were,0,0
35216,more,0,0
35217,likely,0,0
35218,to,0,0
35219,be,0,0
35220,fully,0,0
35221,immunized,0,1
35222,(,0,0
35223,33,0,0
35224,%,0,0
35225,),0,0
35226,than,0,0
35227,the,0,0
35228,infants,0,0
35229,in,0,0
35230,the,0,0
35231,control,0,1
35232,group,0,0
35233,(,0,0
35234,18,0,0
35235,%,0,0
35236,),0,0
35237,.,0,0
35238,Mothers,0,0
35239,in,0,0
35240,the,0,0
35241,special,1,0
35242,care,1,1
35243,program,1,1
35244,who,0,0
35245,continued,0,0
35246,to,0,0
35247,attend,0,0
35248,clinic,0,0
35249,used,0,0
35250,the,0,0
35251,emergency,0,0
35252,room,0,0
35253,less,0,0
35254,than,0,0
35255,the,0,0
35256,mothers,0,0
35257,who,0,0
35258,continued,0,0
35259,to,0,0
35260,attend,0,0
35261,in,0,0
35262,the,0,0
35263,control,0,0
35264,group,0,0
35265,.,0,0
35266,These,0,0
35267,results,0,0
35268,suggest,0,0
35269,that,0,0
35270,a,0,0
35271,comprehensive,1,0
35272,health,1,0
35273,care,1,1
35274,program,1,1
35275,is,0,0
35276,one,0,0
35277,way,0,0
35278,to,0,0
35279,bring,0,0
35280,about,0,0
35281,better,0,0
35282,outcomes,0,0
35283,for,0,0
35284,both,0,0
35285,adolescent,0,0
35286,mothers,0,0
35287,and,0,0
35288,their,0,0
35289,infants,0,0
35290,.,0,0
35291,Safety,0,0
35292,of,0,0
35293,injectable,1,1
35294,opioid,1,1
35295,maintenance,1,0
35296,treatment,1,0
35297,for,0,0
35298,heroin,0,1
35299,dependence,0,0
35300,.,0,0
35301,BACKGROUND,0,0
35302,There,0,0
35303,is,0,0
35304,a,0,0
35305,growing,0,0
35306,debate,0,0
35307,about,0,0
35308,injectable,1,1
35309,opioid,1,1
35310,treatment,1,0
35311,programs,1,1
35312,in,0,0
35313,many,0,0
35314,Western,0,0
35315,countries,0,0
35316,.,0,0
35317,This,0,0
35318,is,0,0
35319,the,0,0
35320,first,0,0
35321,placebo-controlled,1,1
35322,study,0,0
35323,of,0,0
35324,the,0,0
35325,safety,0,0
35326,of,0,0
35327,injectable,1,1
35328,opioids,1,1
35329,in,0,0
35330,a,0,0
35331,controlled,0,0
35332,treatment,0,0
35333,setting,0,0
35334,.,0,0
35335,METHODS,0,0
35336,Twenty-five,0,0
35337,opioid-dependent,0,0
35338,patients,0,0
35339,on,0,0
35340,intravenous,1,1
35341,(,1,0
35342,IV,1,0
35343,),1,1
35344,heroin,1,1
35345,or,1,1
35346,IV,1,0
35347,methadone,1,1
35348,maintenance,1,0
35349,treatment,1,0
35350,were,0,0
35351,randomly,0,0
35352,assigned,0,0
35353,to,0,0
35354,either,0,0
35355,their,0,0
35356,individual,1,0
35357,prescribed,1,0
35358,IV,1,0
35359,maintenance,1,0
35360,dose,1,0
35361,or,1,1
35362,placebo,1,1
35363,.,1,0
35364,Acute,0,0
35365,drug,0,0
35366,effects,0,0
35367,were,0,0
35368,recorded,0,0
35369,",",0,0
35370,focusing,0,0
35371,on,0,0
35372,electrocardiography,0,0
35373,",",0,0
35374,respiratory,0,0
35375,movements,0,0
35376,",",0,0
35377,arterial,0,0
35378,blood,0,0
35379,oxygen,0,1
35380,saturation,0,0
35381,",",0,0
35382,and,0,0
35383,electroencephalography,0,1
35384,(,0,1
35385,EEG,0,0
35386,),0,0
35387,.,0,0
35388,RESULTS,0,0
35389,After,0,0
35390,heroin,1,1
35391,injection,1,0
35392,",",0,0
35393,marked,0,0
35394,respiratory,0,0
35395,depression,0,0
35396,progressing,0,0
35397,to,0,0
35398,a,0,0
35399,Cheyne-Stokes,0,1
35400,pattern,0,0
35401,occurred,0,0
35402,.,0,0
35403,Peripheral,0,0
35404,arterial,0,0
35405,blood,0,0
35406,oxygenation,0,0
35407,decreased,0,0
35408,to,0,0
35409,78.9,0,0
35410,+/-,0,0
35411,8.7,0,0
35412,%,0,0
35413,(,0,0
35414,mean,0,0
35415,+/-,0,0
35416,SD,0,0
35417,),0,0
35418,ranging,0,0
35419,from,0,0
35420,52,0,0
35421,%,0,0
35422,-90,0,0
35423,%,0,0
35424,.,0,0
35425,During,0,0
35426,hypoxia,0,0
35427,",",0,0
35428,7,0,0
35429,of,0,0
35430,the,0,0
35431,16,0,0
35432,subjects,0,0
35433,experienced,0,0
35434,intermittent,0,1
35435,and,0,0
35436,somewhat,0,0
35437,severe,0,0
35438,bradycardia,0,0
35439,.,0,0
35440,Five,0,0
35441,subjects,0,0
35442,exhibited,0,0
35443,paroxysmal,0,0
35444,EEG,0,0
35445,patterns,0,0
35446,.,0,0
35447,After,0,0
35448,methadone,1,1
35449,injection,1,1
35450,",",0,0
35451,respiratory,0,0
35452,depression,0,0
35453,was,0,0
35454,less,0,0
35455,pronounced,0,0
35456,than,0,0
35457,after,0,0
35458,heroin,1,0
35459,injection,1,0
35460,.,1,0
35461,No,0,0
35462,relevant,0,0
35463,bradycardia,0,0
35464,was,0,0
35465,noted,0,0
35466,.,0,0
35467,CONCLUSIONS,0,0
35468,Opioid,1,1
35469,doses,0,0
35470,commonly,0,0
35471,prescribed,0,0
35472,in,0,0
35473,IV,1,0
35474,opioid,1,1
35475,treatment,1,0
35476,induce,0,0
35477,marked,0,0
35478,respiratory,0,0
35479,and,0,0
35480,circulatory,0,0
35481,depression,0,0
35482,",",0,0
35483,as,0,0
35484,well,0,0
35485,as,0,0
35486,occasionally,0,0
35487,irregular,0,0
35488,paroxysmal,0,0
35489,EEG,0,1
35490,activity,0,0
35491,.,0,0
35492,Further,0,0
35493,studies,0,0
35494,are,0,0
35495,needed,0,0
35496,to,0,0
35497,optimize,0,0
35498,the,0,0
35499,clinical,0,0
35500,practice,0,0
35501,of,0,0
35502,IV,1,0
35503,opioid,1,1
35504,treatment,1,0
35505,to,0,0
35506,prevent,0,0
35507,serious,0,0
35508,complications,0,0
35509,.,0,0
35510,Moreover,0,0
35511,",",0,0
35512,the,0,0
35513,extent,0,0
35514,of,0,0
35515,the,0,0
35516,observed,0,0
35517,effects,0,0
35518,raises,0,0
35519,questions,0,0
35520,about,0,0
35521,the,0,0
35522,appropriateness,0,0
35523,of,0,0
35524,IV,1,0
35525,opioid,1,1
35526,treatment,1,0
35527,in,0,0
35528,the,0,0
35529,present,0,0
35530,form,0,0
35531,.,0,0
35532,Evaluation,0,0
35533,of,0,0
35534,umbilical,1,0
35535,cord,1,0
35536,serum,1,0
35537,therapy,1,1
35538,for,0,0
35539,persistent,0,0
35540,corneal,0,0
35541,epithelial,0,0
35542,defects,0,0
35543,.,0,0
35544,AIMS,0,0
35545,To,0,0
35546,evaluate,0,0
35547,umbilical,1,0
35548,cord,1,0
35549,serum,1,0
35550,therapy,1,1
35551,as,0,0
35552,a,0,0
35553,means,0,0
35554,of,0,0
35555,promoting,0,0
35556,the,0,0
35557,healing,0,0
35558,of,0,0
35559,persistent,0,0
35560,corneal,0,0
35561,epithelial,0,0
35562,defects,0,0
35563,.,0,0
35564,METHODS,0,0
35565,Umbilical,1,1
35566,cord,1,0
35567,serum,1,0
35568,or,1,1
35569,autologous,1,1
35570,serum,1,0
35571,drops,1,1
35572,were,0,0
35573,used,0,0
35574,to,0,0
35575,promote,0,0
35576,the,0,0
35577,healing,0,0
35578,of,0,0
35579,persistent,0,0
35580,epithelial,0,0
35581,defects,0,0
35582,.,0,0
35583,The,0,0
35584,study,0,0
35585,design,0,0
35586,was,0,0
35587,a,0,0
35588,prospective,0,0
35589,randomised,0,0
35590,controlled,0,0
35591,clinical,0,0
35592,trial,0,0
35593,.,0,0
35594,60,0,0
35595,eyes,0,0
35596,of,0,0
35597,59,0,0
35598,patients,0,0
35599,were,0,0
35600,divided,0,0
35601,into,0,0
35602,two,0,0
35603,groups,0,0
35604,",",0,0
35605,31,0,0
35606,in,0,0
35607,the,0,0
35608,cord,1,0
35609,serum,1,0
35610,group,0,0
35611,and,0,0
35612,29,0,0
35613,in,0,0
35614,the,0,0
35615,autologous,1,1
35616,serum,1,0
35617,control,1,0
35618,group,1,0
35619,.,1,0
35620,Epithelial,0,0
35621,defects,0,0
35622,measuring,0,0
35623,at,0,0
35624,least,0,0
35625,2,0,0
35626,mm,0,0
35627,in,0,0
35628,linear,0,0
35629,dimension,0,0
35630,resistant,0,0
35631,to,0,0
35632,conventional,0,1
35633,medical,0,1
35634,management,0,0
35635,were,0,0
35636,included,0,0
35637,.,0,0
35638,Serial,0,0
35639,measurements,0,0
35640,of,0,0
35641,the,0,0
35642,size,0,0
35643,of,0,0
35644,the,0,0
35645,epithelial,0,0
35646,defects-namely,0,0
35647,",",0,0
35648,two,0,0
35649,maximum,0,0
35650,linear,0,0
35651,dimensions,0,0
35652,perpendicular,0,0
35653,to,0,0
35654,each,0,0
35655,other,0,0
35656,",",0,0
35657,and,0,0
35658,the,0,0
35659,area,0,0
35660,and,0,0
35661,perimeter,0,0
35662,was,0,0
35663,done,0,0
35664,at,0,0
35665,start,0,0
35666,of,0,0
35667,therapy,0,1
35668,and,0,0
35669,follow,0,0
35670,up,0,0
35671,days,0,0
35672,3,0,0
35673,",",0,0
35674,7,0,0
35675,",",0,0
35676,14,0,0
35677,",",0,0
35678,21,0,0
35679,.,0,0
35680,Rate,0,0
35681,of,0,0
35682,healing,0,0
35683,of,0,0
35684,the,0,0
35685,epithelial,0,0
35686,defects,0,0
35687,were,0,0
35688,measured,0,0
35689,as,0,0
35690,percentage,0,0
35691,decrease,0,0
35692,from,0,0
35693,the,0,0
35694,baseline,0,0
35695,parameter,0,0
35696,at,0,0
35697,each,0,0
35698,subsequent,0,0
35699,follow,0,0
35700,up,0,0
35701,.,0,0
35702,The,0,0
35703,data,0,0
35704,were,0,0
35705,analysed,0,0
35706,by,0,0
35707,the,0,0
35708,non-parametric,0,0
35709,Wilcoxon,0,0
35710,rank,0,0
35711,sum,0,0
35712,test,0,0
35713,using,0,0
35714,STATA,0,0
35715,7.0,0,0
35716,.,0,0
35717,RESULTS,0,0
35718,The,0,0
35719,median,0,0
35720,percentage,0,0
35721,decrease,0,0
35722,in,0,0
35723,the,0,0
35724,size,0,0
35725,of,0,0
35726,the,0,0
35727,epithelial,0,0
35728,defect,0,0
35729,was,0,0
35730,significantly,0,0
35731,greater,0,0
35732,in,0,0
35733,the,0,0
35734,cord,1,0
35735,serum,1,0
35736,group,0,0
35737,at,0,0
35738,days,0,0
35739,7,0,0
35740,",",0,0
35741,14,0,0
35742,and,0,0
35743,21,0,0
35744,(,0,0
35745,p,0,0
35746,<,0,0
35747,0.05,0,0
35748,),0,0
35749,when,0,0
35750,measured,0,0
35751,in,0,0
35752,terms,0,0
35753,of,0,0
35754,the,0,0
35755,area,0,0
35756,and,0,0
35757,perimeter,0,0
35758,.,0,0
35759,A,0,0
35760,greater,0,0
35761,number,0,0
35762,of,0,0
35763,patients,0,0
35764,showed,0,0
35765,complete,0,0
35766,re-epithelialisation,0,0
35767,with,0,0
35768,umbilical,0,0
35769,cord,1,0
35770,serum,1,0
35771,(,0,0
35772,n,0,0
35773,=,0,0
35774,18,0,0
35775,),0,0
35776,than,0,0
35777,with,0,0
35778,autologous,0,1
35779,serum,0,0
35780,(,0,0
35781,n,0,0
35782,=,0,0
35783,11,0,0
35784,),0,0
35785,(,0,0
35786,Pearson,0,0
35787,chi,0,0
35788,=,0,0
35789,0.19,0,0
35790,),0,0
35791,.,0,0
35792,None,0,0
35793,of,0,0
35794,the,0,0
35795,patients,0,0
35796,reported,0,0
35797,any,0,0
35798,side,0,0
35799,effects,0,0
35800,or,0,0
35801,discomfort,0,0
35802,with,0,0
35803,either,0,0
35804,treatment,0,0
35805,.,0,0
35806,CONCLUSIONS,0,0
35807,Umbilical,1,1
35808,cord,1,0
35809,serum,1,0
35810,leads,0,0
35811,to,0,0
35812,faster,0,0
35813,healing,0,0
35814,of,0,0
35815,the,0,0
35816,persistent,0,0
35817,corneal,0,0
35818,epithelial,0,0
35819,defects,0,0
35820,refractory,0,0
35821,to,0,0
35822,all,0,0
35823,medical,0,0
35824,management,0,0
35825,compared,0,0
35826,to,0,0
35827,autologous,1,1
35828,serum,1,0
35829,.,1,0
35830,Esomeprazole,1,1
35831,resolves,0,0
35832,chronic,0,0
35833,heartburn,0,0
35834,in,0,0
35835,patients,0,0
35836,without,0,0
35837,erosive,0,0
35838,oesophagitis,0,0
35839,.,0,0
35840,BACKGROUND,0,0
35841,Patients,0,0
35842,with,0,0
35843,chronic,0,0
35844,heartburn,0,0
35845,but,0,0
35846,with,0,0
35847,no,0,0
35848,endoscopic,0,1
35849,evidence,0,0
35850,of,0,0
35851,erosive,0,0
35852,oesophagitis,0,0
35853,require,0,0
35854,gastric,0,0
35855,acid,0,1
35856,suppression,0,0
35857,to,0,0
35858,relieve,0,0
35859,symptoms,0,0
35860,.,0,0
35861,AIM,0,0
35862,To,0,0
35863,assess,0,0
35864,the,0,0
35865,efficacy,0,0
35866,and,0,0
35867,safety,0,0
35868,of,0,0
35869,esomeprazole,1,1
35870,in,0,0
35871,patients,0,0
35872,with,0,0
35873,frequent,0,0
35874,heartburn,0,0
35875,for,0,0
35876,>,0,0
35877,or,0,0
35878,=,0,0
35879,6,0,0
35880,months,0,0
35881,and,0,0
35882,no,0,0
35883,evidence,0,0
35884,of,0,0
35885,erosive,0,0
35886,oesophagitis,0,0
35887,on,0,0
35888,endoscopy,0,0
35889,.,0,0
35890,METHODS,0,0
35891,Two,0,0
35892,randomized,0,0
35893,",",0,0
35894,double-blind,0,0
35895,",",0,0
35896,4-week,0,1
35897,",",0,0
35898,multi-centre,0,0
35899,trials,0,0
35900,with,0,0
35901,identical,0,0
35902,methodology,0,0
35903,compared,0,0
35904,once-daily,0,1
35905,esomeprazole,1,1
35906,",",0,0
35907,40,0,0
35908,mg,0,1
35909,(,0,0
35910,n,0,0
35911,=,0,0
35912,241,0,0
35913,),0,0
35914,or,0,0
35915,20,0,1
35916,mg,0,1
35917,(,0,0
35918,n,0,0
35919,=,0,0
35920,234,0,0
35921,),0,0
35922,",",0,0
35923,with,0,0
35924,placebo,1,1
35925,(,0,0
35926,n,0,0
35927,=,0,0
35928,242,0,0
35929,),0,0
35930,for,0,0
35931,the,0,0
35932,rigorous,0,0
35933,end-point,0,0
35934,of,0,0
35935,complete,0,0
35936,resolution,0,0
35937,of,0,0
35938,heartburn,0,0
35939,.,0,0
35940,Secondary,0,0
35941,end-points,0,0
35942,included,0,0
35943,the,0,0
35944,percentage,0,0
35945,of,0,0
35946,heartburn-free,0,0
35947,days,0,0
35948,and,0,0
35949,the,0,0
35950,time,0,0
35951,to,0,0
35952,first,0,0
35953,and,0,0
35954,sustained,0,0
35955,resolution,0,0
35956,of,0,0
35957,heartburn,0,0
35958,.,0,0
35959,RESULTS,0,0
35960,Patients,0,0
35961,treated,0,0
35962,with,0,0
35963,either,0,0
35964,dose,0,0
35965,of,0,0
35966,esomeprazole,1,1
35967,were,0,0
35968,two,0,0
35969,to,0,0
35970,three,0,0
35971,times,0,0
35972,more,0,0
35973,likely,0,0
35974,to,0,0
35975,achieve,0,0
35976,complete,0,0
35977,resolution,0,0
35978,of,0,0
35979,heartburn,0,0
35980,than,0,0
35981,patients,0,0
35982,treated,0,0
35983,with,0,0
35984,placebo,1,1
35985,(,0,0
35986,P,0,0
35987,<,0,0
35988,0.001,0,0
35989,),0,0
35990,.,0,0
35991,The,0,0
35992,percentage,0,0
35993,of,0,0
35994,heartburn-free,0,0
35995,days,0,0
35996,was,0,0
35997,significantly,0,0
35998,higher,0,0
35999,with,0,0
36000,esomeprazole,1,1
36001,40,0,0
36002,mg,0,1
36003,(,0,0
36004,63,0,0
36005,%,0,0
36006,",",0,0
36007,66,0,0
36008,%,0,0
36009,),0,0
36010,or,0,1
36011,20,0,1
36012,mg,0,1
36013,(,0,0
36014,63,0,0
36015,%,0,0
36016,",",0,0
36017,68,0,0
36018,%,0,0
36019,),0,0
36020,than,0,0
36021,with,0,0
36022,placebo,1,1
36023,(,0,0
36024,46,0,0
36025,%,0,0
36026,",",0,0
36027,36,0,0
36028,%,0,0
36029,;,0,0
36030,P,0,0
36031,<,0,0
36032,or,0,0
36033,=,0,0
36034,0.001,0,0
36035,),0,0
36036,in,0,0
36037,each,0,0
36038,of,0,0
36039,the,0,0
36040,two,0,0
36041,studies,0,0
36042,.,0,0
36043,Esomeprazole,1,1
36044,was,0,0
36045,associated,0,0
36046,with,0,0
36047,a,0,0
36048,significantly,0,0
36049,shorter,0,0
36050,mean,0,0
36051,time,0,0
36052,to,0,0
36053,first,0,0
36054,(,0,0
36055,6-7,0,0
36056,days,0,0
36057,),0,0
36058,and,0,0
36059,sustained,0,0
36060,(,0,0
36061,12-17,0,0
36062,days,0,0
36063,),0,0
36064,resolution,0,0
36065,of,0,0
36066,heartburn,0,0
36067,compared,0,0
36068,with,0,0
36069,placebo,1,1
36070,(,0,0
36071,first,0,0
36072,",",0,0
36073,10-12,0,0
36074,days,0,0
36075,;,0,0
36076,sustained,0,0
36077,",",0,0
36078,21-22,0,0
36079,days,0,0
36080,;,0,0
36081,P,0,0
36082,<,0,0
36083,or,0,0
36084,=,0,0
36085,0.008,0,0
36086,),0,0
36087,.,0,0
36088,The,0,0
36089,spectrum,0,0
36090,and,0,0
36091,frequency,0,0
36092,of,0,0
36093,adverse,0,0
36094,events,0,0
36095,with,0,0
36096,esomeprazole,1,1
36097,were,0,0
36098,similar,0,0
36099,to,0,0
36100,those,0,0
36101,with,0,0
36102,placebo,1,1
36103,.,1,0
36104,CONCLUSIONS,0,0
36105,Esomeprazole,1,1
36106,",",0,0
36107,at,0,0
36108,daily,0,0
36109,doses,0,0
36110,of,0,0
36111,40,0,0
36112,mg,0,0
36113,or,0,0
36114,20,0,0
36115,mg,0,0
36116,",",0,0
36117,is,0,0
36118,effective,0,0
36119,and,0,0
36120,safe,0,0
36121,for,0,0
36122,the,0,0
36123,treatment,0,0
36124,of,0,0
36125,chronic,0,0
36126,heartburn,0,0
36127,in,0,0
36128,patients,0,0
36129,without,0,0
36130,erosive,0,0
36131,oesophagitis,0,0
36132,.,0,0
36133,Efficacy,0,0
36134,of,0,0
36135,azithromycin,1,1
36136,for,0,0
36137,the,0,0
36138,treatment,0,0
36139,of,0,0
36140,feline,0,0
36141,chlamydophilosis,0,0
36142,.,0,0
36143,The,0,0
36144,current,0,0
36145,recommended,0,0
36146,treatment,0,0
36147,for,0,0
36148,feline,0,0
36149,chlamydophilosis,0,0
36150,involves,0,0
36151,daily,0,0
36152,oral,0,0
36153,administration,0,0
36154,of,0,0
36155,antimicrobials,1,1
36156,to,0,0
36157,all,0,0
36158,cats,0,0
36159,within,0,0
36160,an,0,0
36161,affected,0,0
36162,group,0,0
36163,for,0,0
36164,a,0,0
36165,prolonged,0,0
36166,period,0,0
36167,of,0,0
36168,time,0,0
36169,(,0,0
36170,4-6,0,0
36171,weeks,0,0
36172,),0,0
36173,.,0,0
36174,Not,0,0
36175,surprisingly,0,0
36176,",",0,0
36177,owner,0,0
36178,compliance,0,0
36179,can,0,0
36180,be,0,0
36181,poor,0,0
36182,resulting,0,0
36183,in,0,0
36184,apparent,0,0
36185,treatment,0,0
36186,failure,0,0
36187,.,0,0
36188,Recent,0,0
36189,anecdotal,0,0
36190,evidence,0,0
36191,",",0,0
36192,supported,0,0
36193,by,0,0
36194,its,0,0
36195,efficacy,0,0
36196,in,0,0
36197,the,0,0
36198,treatment,0,0
36199,of,0,0
36200,Chlamydia,0,0
36201,trachomatis,0,0
36202,infection,0,0
36203,in,0,0
36204,humans,0,0
36205,",",0,0
36206,has,0,0
36207,suggested,0,0
36208,that,0,0
36209,azithromycin,1,1
36210,may,0,0
36211,offer,0,0
36212,an,0,0
36213,alternative,0,0
36214,by,0,0
36215,allowing,0,0
36216,less,0,0
36217,frequent,0,0
36218,dosing,0,0
36219,for,0,0
36220,a,0,0
36221,shorter,0,0
36222,duration,0,0
36223,.,0,0
36224,A,0,0
36225,clinical,0,0
36226,trial,0,0
36227,was,0,0
36228,designed,0,0
36229,to,0,0
36230,evaluate,0,0
36231,the,0,0
36232,efficacy,0,0
36233,of,0,0
36234,azithromycin,1,1
36235,for,0,0
36236,the,0,0
36237,treatment,0,0
36238,of,0,0
36239,chlamydia,0,0
36240,(,0,0
36241,Chlamydophila,0,0
36242,felis,0,1
36243,),0,0
36244,infection,0,0
36245,in,0,0
36246,cats,0,0
36247,.,0,0
36248,Whilst,0,0
36249,azithromycin,1,1
36250,",",0,0
36251,given,0,0
36252,at,0,0
36253,10-15,0,0
36254,mg/kg,0,1
36255,daily,0,0
36256,for,0,0
36257,3,0,0
36258,days,0,0
36259,and,0,0
36260,then,0,0
36261,twice,0,0
36262,weekly,0,1
36263,",",0,0
36264,provided,0,0
36265,a,0,0
36266,similar,0,0
36267,",",0,0
36268,rapid,0,0
36269,resolution,0,0
36270,of,0,0
36271,clinical,0,0
36272,signs,0,0
36273,and,0,0
36274,negative,0,0
36275,isolation,0,0
36276,scores,0,0
36277,as,0,0
36278,doxycycline,1,1
36279,",",0,0
36280,C,0,0
36281,felis,0,0
36282,was,0,0
36283,re-isolated,0,0
36284,in,0,0
36285,four,0,0
36286,out,0,0
36287,of,0,0
36288,the,0,0
36289,five,0,0
36290,cats,0,0
36291,treated,0,0
36292,.,0,0
36293,Furthermore,0,0
36294,",",0,0
36295,even,0,0
36296,daily,0,0
36297,administration,0,0
36298,of,0,0
36299,azithromycin,1,1
36300,to,0,0
36301,chronically,0,0
36302,infected,0,0
36303,cats,0,0
36304,was,0,0
36305,ineffective,0,0
36306,in,0,0
36307,clearing,0,0
36308,infection,0,0
36309,.,0,0
36310,The,0,0
36311,azithromycin,0,1
36312,protocols,0,0
36313,used,0,0
36314,here,0,0
36315,were,0,0
36316,therefore,0,0
36317,found,0,0
36318,to,0,0
36319,be,0,0
36320,unsuccessful,0,0
36321,in,0,0
36322,eliminating,0,0
36323,the,0,0
36324,carriage,0,0
36325,of,0,0
36326,this,0,0
36327,strain,0,0
36328,of,0,0
36329,C,0,0
36330,felis,0,0
36331,.,0,0
36332,Prophylactic,0,1
36333,effect,0,0
36334,of,0,0
36335,phenytoin,1,1
36336,in,0,0
36337,bipolar,0,0
36338,disorder,0,0
36339,:,0,0
36340,a,0,0
36341,controlled,0,0
36342,study,0,0
36343,.,0,0
36344,OBJECTIVE,0,0
36345,Phenytoin,1,1
36346,is,0,0
36347,an,0,0
36348,effective,0,0
36349,anticonvulsant,0,0
36350,that,0,0
36351,has,0,0
36352,not,0,0
36353,previously,0,0
36354,been,0,0
36355,studied,0,0
36356,prophylactically,0,0
36357,in,0,0
36358,bipolar,0,0
36359,(,0,0
36360,BP,0,0
36361,),0,0
36362,patients,0,0
36363,.,0,0
36364,Thus,0,0
36365,a,0,0
36366,study,0,0
36367,of,0,0
36368,phenytoin,1,1
36369,prophylaxis,0,0
36370,was,0,0
36371,undertaken,0,0
36372,and,0,0
36373,is,0,0
36374,herein,0,0
36375,reported,0,0
36376,.,0,0
36377,METHOD,0,0
36378,Bipolar,0,0
36379,patients,0,0
36380,were,0,0
36381,studied,0,0
36382,who,0,0
36383,had,0,0
36384,at,0,0
36385,least,0,0
36386,one,0,0
36387,episode,0,0
36388,per,0,0
36389,year,0,0
36390,in,0,0
36391,the,0,0
36392,previous,0,0
36393,2,0,0
36394,years,0,0
36395,despite,0,0
36396,ongoing,0,0
36397,prophylaxis,0,0
36398,.,0,0
36399,Patients,0,0
36400,were,0,0
36401,stable,0,0
36402,for,0,0
36403,a,0,0
36404,mean,0,0
36405,of,0,0
36406,4,0,0
36407,months,0,0
36408,(,0,0
36409,range,0,0
36410,1-13,0,0
36411,),0,0
36412,before,0,0
36413,entering,0,0
36414,the,0,0
36415,study,0,0
36416,.,0,0
36417,Phenytoin,1,1
36418,or,1,0
36419,placebo,1,1
36420,was,0,0
36421,added,0,0
36422,to,0,0
36423,their,0,0
36424,current,0,0
36425,therapy,0,1
36426,in,0,0
36427,a,0,0
36428,double-blind,0,0
36429,cross-over,0,0
36430,design,0,0
36431,for,0,0
36432,6,0,0
36433,months,0,0
36434,in,0,0
36435,each,0,0
36436,phase,0,0
36437,.,0,0
36438,Thirty,0,0
36439,observation,0,0
36440,periods,0,0
36441,of,0,0
36442,6,0,0
36443,months,0,0
36444,each,0,0
36445,were,0,0
36446,studied,0,0
36447,for,0,0
36448,23,0,0
36449,patients,0,0
36450,.,0,0
36451,RESULTS,0,0
36452,Three,0,0
36453,patients,0,0
36454,had,0,0
36455,relapse,0,0
36456,on,0,0
36457,phenytoin,1,1
36458,and,0,0
36459,nine,0,0
36460,had,0,0
36461,relapse,0,0
36462,on,0,0
36463,placebo,0,1
36464,.,0,0
36465,There,0,0
36466,was,0,0
36467,a,0,0
36468,significant,0,0
36469,prophylactic,0,1
36470,effect,0,0
36471,of,0,0
36472,phenytoin,1,1
36473,in,0,0
36474,BP,0,0
36475,disorder,0,0
36476,[,0,0
36477,Cox,0,1
36478,'s,0,0
36479,F-test,0,0
36480,for,0,0
36481,comparing,0,0
36482,survival,0,0
36483,in,0,0
36484,two,0,0
36485,groups,0,0
36486,:,0,0
36487,F,0,0
36488,(,0,0
36489,6,0,0
36490,",",0,0
36491,18,0,0
36492,),0,0
36493,=,0,0
36494,3.44,0,0
36495,",",0,0
36496,p,0,0
36497,=,0,0
36498,0.02,0,0
36499,],0,0
36500,.,0,0
36501,CONCLUSIONS,0,0
36502,This,0,0
36503,study,0,0
36504,suggests,0,0
36505,prophylactic,0,0
36506,effects,0,0
36507,of,0,0
36508,add-on,0,1
36509,phenytoin,1,1
36510,in,0,0
36511,BP,0,0
36512,illness,0,0
36513,.,0,0
36514,However,0,0
36515,",",0,0
36516,the,0,0
36517,number,0,0
36518,of,0,0
36519,patients,0,0
36520,was,0,0
36521,small,0,0
36522,and,0,0
36523,confirmation,0,0
36524,is,0,0
36525,necessary,0,0
36526,.,0,0
36527,Can,0,0
36528,acupuncture,1,0
36529,ease,0,0
36530,the,0,0
36531,symptoms,0,0
36532,of,0,0
36533,menopause,0,0
36534,?,0,0
36535,In,0,0
36536,a,0,0
36537,randomized,0,0
36538,",",0,0
36539,2-group,0,0
36540,clinical,0,0
36541,study,0,0
36542,",",0,0
36543,acupuncture,1,1
36544,was,0,0
36545,used,0,0
36546,for,0,0
36547,the,0,0
36548,relief,0,0
36549,of,0,0
36550,menopausal,0,0
36551,hot,0,0
36552,flushes,0,0
36553,",",0,0
36554,sleep,0,0
36555,disturbances,0,0
36556,",",0,0
36557,and,0,0
36558,mood,0,0
36559,changes,0,0
36560,.,0,0
36561,The,0,0
36562,experimental,0,0
36563,acupuncture,1,1
36564,treatment,0,0
36565,consisted,0,0
36566,of,0,0
36567,specific,0,0
36568,acupuncture,1,1
36569,body,0,0
36570,points,0,0
36571,related,0,0
36572,to,0,0
36573,menopausal,0,0
36574,symptoms,0,0
36575,.,0,0
36576,The,0,0
36577,comparison,0,0
36578,acupuncture,1,1
36579,treatment,0,0
36580,consisted,0,0
36581,of,0,0
36582,a,0,0
36583,treatment,0,0
36584,designated,0,0
36585,as,0,0
36586,a,0,0
36587,general,0,0
36588,tonic,0,0
36589,specifically,0,0
36590,designed,0,0
36591,to,0,0
36592,benefit,0,0
36593,the,0,0
36594,flow,0,0
36595,of,0,0
36596,Ch'i,0,0
36597,(,0,0
36598,energy,0,0
36599,),0,0
36600,.,0,0
36601,Results,0,0
36602,from,0,0
36603,the,0,0
36604,experimental,0,0
36605,acupuncture,1,1
36606,treatment,0,0
36607,group,0,0
36608,showed,0,0
36609,a,0,0
36610,decrease,0,0
36611,in,0,0
36612,mean,0,0
36613,monthly,0,0
36614,hot,0,0
36615,flush,0,1
36616,severity,0,0
36617,for,0,0
36618,site-specific,0,0
36619,acupuncture,0,1
36620,.,0,0
36621,The,0,0
36622,comparison,0,0
36623,acupuncture,1,1
36624,treatment,0,0
36625,group,0,0
36626,had,0,0
36627,no,0,0
36628,significant,0,0
36629,change,0,0
36630,in,0,0
36631,severity,0,0
36632,from,0,0
36633,baseline,0,0
36634,over,0,0
36635,the,0,0
36636,treatment,0,0
36637,phase,0,0
36638,.,0,0
36639,Sleep,0,0
36640,disturbances,0,0
36641,in,0,0
36642,the,0,0
36643,experimental,0,0
36644,acupuncture,1,1
36645,treatment,0,0
36646,group,0,0
36647,declined,0,0
36648,over,0,0
36649,the,0,0
36650,study,0,0
36651,.,0,0
36652,Mood,0,0
36653,changes,0,0
36654,in,0,0
36655,both,0,0
36656,the,0,0
36657,experimental,0,0
36658,acupuncture,1,1
36659,treatment,0,0
36660,group,0,0
36661,and,0,0
36662,the,0,0
36663,comparison,0,0
36664,acupuncture,0,1
36665,treatment,0,0
36666,group,0,0
36667,showed,0,0
36668,a,0,0
36669,significant,0,0
36670,difference,0,0
36671,between,0,0
36672,the,0,0
36673,baseline,0,0
36674,and,0,0
36675,the,0,0
36676,third,0,0
36677,month,0,0
36678,of,0,0
36679,the,0,0
36680,study,0,0
36681,.,0,0
36682,Acupuncture,1,0
36683,using,0,0
36684,menopausal-specific,0,0
36685,sites,0,0
36686,holds,0,0
36687,promise,0,0
36688,for,0,0
36689,nonhormonal,0,1
36690,relief,0,0
36691,of,0,0
36692,hot,0,0
36693,flushes,0,0
36694,and,0,0
36695,sleep,0,0
36696,disturbances,0,0
36697,.,0,0
36698,Extracorporeal,1,1
36699,shock,1,0
36700,wave,1,1
36701,therapy,1,1
36702,(,1,0
36703,ESWT,1,1
36704,),1,0
36705,in,0,0
36706,patients,0,0
36707,with,0,0
36708,chronic,0,0
36709,proximal,0,0
36710,plantar,0,0
36711,fasciitis,0,0
36712,:,0,0
36713,a,0,0
36714,2-year,0,0
36715,follow-up,0,0
36716,.,0,0
36717,The,0,0
36718,aim,0,0
36719,of,0,0
36720,this,0,0
36721,study,0,0
36722,was,0,0
36723,to,0,0
36724,compare,0,0
36725,the,0,0
36726,effect,0,0
36727,of,0,0
36728,extracorporeal,1,1
36729,shock,1,0
36730,wave,1,1
36731,therapy,1,1
36732,(,0,0
36733,ESWT,0,1
36734,),0,0
36735,in,0,0
36736,patients,0,0
36737,with,0,0
36738,chronically,0,0
36739,painful,0,0
36740,proximal,0,0
36741,plantar,0,0
36742,fasciitis,0,0
36743,with,0,0
36744,a,0,0
36745,further,0,0
36746,conventional,0,1
36747,conservative,0,1
36748,treatment,0,0
36749,.,0,0
36750,Forty-seven,0,0
36751,patients,0,0
36752,(,0,0
36753,49,0,0
36754,feet,0,0
36755,),0,0
36756,with,0,0
36757,a,0,0
36758,previously,0,0
36759,unsuccessful,0,0
36760,nonsurgical,0,1
36761,treatment,0,0
36762,of,0,0
36763,at,0,0
36764,least,0,0
36765,6,0,0
36766,months,0,0
36767,were,0,0
36768,randomized,0,0
36769,to,0,0
36770,two,0,0
36771,groups,0,0
36772,.,0,0
36773,Heel,1,0
36774,cups,1,0
36775,had,0,0
36776,to,0,0
36777,be,0,0
36778,worn,0,0
36779,throughout,0,0
36780,the,0,0
36781,study,0,0
36782,.,0,0
36783,Group,0,0
36784,1,0,0
36785,(,0,0
36786,25,0,0
36787,heels,0,0
36788,),0,0
36789,was,0,0
36790,treated,0,0
36791,immediately,0,0
36792,with,0,0
36793,three,0,0
36794,sessions,0,0
36795,of,0,0
36796,ESWT,1,0
36797,(,1,0
36798,3000,1,1
36799,shock,1,0
36800,waves/session,1,0
36801,of,1,0
36802,0.2,1,0
36803,mJ/mm2,1,0
36804,),1,0
36805,at,1,0
36806,weekly,1,1
36807,intervals,1,0
36808,.,1,0
36809,The,0,0
36810,patients,0,0
36811,of,0,0
36812,group,0,0
36813,2,0,0
36814,(,0,0
36815,24,0,0
36816,heels,0,0
36817,),0,0
36818,continued,0,0
36819,nonsurgical,1,1
36820,treatment,1,0
36821,(,1,0
36822,iontophoresis,1,1
36823,with,1,0
36824,diclofenac,1,1
36825,and,1,0
36826,an,1,0
36827,oral,1,1
36828,nonsteroidal,1,1
36829,anti-inflammatory,1,1
36830,drug,1,0
36831,),1,0
36832,for,0,0
36833,12,0,0
36834,weeks,0,0
36835,.,0,0
36836,After,0,0
36837,this,0,0
36838,period,0,0
36839,they,0,0
36840,were,0,0
36841,treated,0,0
36842,using,0,0
36843,the,0,0
36844,protocol,0,0
36845,of,0,0
36846,group,0,0
36847,1,0,0
36848,.,0,0
36849,No,0,0
36850,significant,0,0
36851,difference,0,0
36852,of,0,0
36853,pain,0,0
36854,and,0,0
36855,walking,0,1
36856,time,0,0
36857,after,0,0
36858,further,0,0
36859,nonsurgical,0,1
36860,treatment,0,0
36861,(,0,0
36862,3,0,0
36863,months,0,0
36864,),0,0
36865,was,0,0
36866,seen,0,0
36867,in,0,0
36868,group,0,0
36869,2,0,0
36870,.,0,0
36871,At,0,0
36872,12,0,0
36873,weeks,0,0
36874,after,0,0
36875,ESWT,0,0
36876,",",0,0
36877,the,0,0
36878,pain,0,0
36879,estimation,0,0
36880,on,0,0
36881,the,0,0
36882,visual,0,0
36883,analogue,0,0
36884,scale,0,0
36885,(,0,0
36886,VAS,0,1
36887,),0,0
36888,for,0,0
36889,activities,0,0
36890,of,0,0
36891,daily,0,0
36892,living,0,0
36893,diminished,0,0
36894,significantly,0,0
36895,by,0,0
36896,62.9,0,0
36897,%,0,0
36898,in,0,0
36899,group,0,0
36900,1,0,0
36901,and,0,0
36902,by,0,0
36903,63.0,0,0
36904,%,0,0
36905,in,0,0
36906,group,0,0
36907,2,0,0
36908,.,0,0
36909,The,0,0
36910,comfortable,0,0
36911,walking,0,0
36912,time,0,0
36913,had,0,0
36914,increased,0,0
36915,significantly,0,0
36916,in,0,0
36917,both,0,0
36918,groups,0,0
36919,.,0,0
36920,Two,0,0
36921,years,0,0
36922,after,0,0
36923,ESWT,0,0
36924,",",0,0
36925,pain,0,0
36926,during,0,0
36927,activities,0,0
36928,of,0,0
36929,daily,0,0
36930,living,0,0
36931,decreased,0,0
36932,by,0,0
36933,94,0,0
36934,%,0,0
36935,in,0,0
36936,group,0,0
36937,1,0,0
36938,and,0,0
36939,by,0,0
36940,90,0,0
36941,%,0,0
36942,in,0,0
36943,group,0,0
36944,2,0,0
36945,on,0,0
36946,the,0,0
36947,VAS,0,0
36948,and,0,0
36949,the,0,0
36950,comfortable,0,0
36951,walking,0,0
36952,time,0,0
36953,had,0,0
36954,increased,0,0
36955,significantly,0,0
36956,in,0,0
36957,both,0,0
36958,groups,0,0
36959,.,0,0
36960,Intraperitoneal,1,1
36961,cisplatin,1,1
36962,versus,0,0
36963,no,0,0
36964,further,0,0
36965,treatment,0,0
36966,:,0,0
36967,8-year,0,0
36968,results,0,0
36969,of,0,0
36970,EORTC,0,0
36971,55875,0,0
36972,",",0,0
36973,a,0,0
36974,randomized,0,0
36975,phase,0,0
36976,III,0,0
36977,study,0,0
36978,in,0,0
36979,ovarian,0,0
36980,cancer,0,0
36981,patients,0,0
36982,with,0,0
36983,a,0,0
36984,pathologically,0,0
36985,complete,0,0
36986,remission,0,0
36987,after,0,0
36988,platinum-based,1,1
36989,intravenous,1,1
36990,chemotherapy,1,1
36991,.,1,0
36992,First-line,1,1
36993,intravenous,1,1
36994,chemotherapy,1,1
36995,(,0,0
36996,CT,0,0
36997,),0,1
36998,following,0,0
36999,debulking,0,1
37000,surgery,0,1
37001,is,0,0
37002,associated,0,0
37003,with,0,0
37004,prolonged,0,0
37005,survival,0,0
37006,",",0,0
37007,in,0,0
37008,particular,0,0
37009,in,0,0
37010,patients,0,0
37011,who,0,0
37012,achieve,0,0
37013,a,0,0
37014,pathological,0,0
37015,complete,0,0
37016,remission,0,0
37017,(,0,0
37018,pCR,0,0
37019,),0,0
37020,at,0,0
37021,second-look,0,1
37022,surgery,0,0
37023,but,0,0
37024,in,0,0
37025,whom,0,0
37026,a,0,0
37027,high,0,0
37028,rate,0,0
37029,of,0,0
37030,relapses,0,0
37031,still,0,0
37032,occurs,0,0
37033,.,0,0
37034,Between,0,0
37035,1988,0,0
37036,and,0,0
37037,1997,0,0
37038,",",0,0
37039,153,0,0
37040,patients,0,0
37041,in,0,0
37042,pCR,0,0
37043,following,0,0
37044,platinum-based,1,1
37045,intravenous,1,1
37046,CT,1,0
37047,were,0,0
37048,randomized,0,0
37049,between,0,0
37050,four,1,0
37051,courses,1,0
37052,of,1,0
37053,intraperitoneal,1,1
37054,cisplatin,1,1
37055,(,1,0
37056,P,1,0
37057,),1,1
37058,(,1,0
37059,90,1,0
37060,mg/m2,1,1
37061,every,1,0
37062,3,1,0
37063,weeks,1,0
37064,),1,0
37065,or,1,0
37066,observation,1,0
37067,.,1,0
37068,Overall,0,0
37069,survival,0,0
37070,(,0,0
37071,OS,0,0
37072,),0,0
37073,was,0,0
37074,the,0,0
37075,primary,0,0
37076,endpoint,0,0
37077,",",0,0
37078,while,0,0
37079,progression-free,0,0
37080,survival,0,0
37081,(,0,0
37082,PFS,0,0
37083,),0,0
37084,was,0,0
37085,a,0,0
37086,secondary,0,0
37087,endpoint,0,0
37088,.,0,0
37089,This,0,0
37090,intent-to-treat,0,0
37091,analysis,0,0
37092,includes,0,0
37093,16,0,0
37094,patients,0,0
37095,who,0,0
37096,were,0,0
37097,not,0,0
37098,eligible,0,0
37099,and,0,0
37100,17,0,0
37101,patients,0,0
37102,who,0,0
37103,had,0,0
37104,protocol,0,0
37105,violations,0,0
37106,.,0,0
37107,The,0,0
37108,two,0,0
37109,groups,0,0
37110,were,0,0
37111,well,0,0
37112,balanced,0,0
37113,in,0,0
37114,terms,0,0
37115,of,0,0
37116,age,0,0
37117,(,0,0
37118,median,0,0
37119,=,0,0
37120,55,0,0
37121,years,0,0
37122,),0,0
37123,",",0,0
37124,performance,0,0
37125,status,0,0
37126,(,0,0
37127,78,0,0
37128,%,0,0
37129,P.S,0,0
37130,.,0,0
37131,O,0,0
37132,),0,0
37133,",",0,0
37134,FIGO,0,0
37135,stage,0,0
37136,(,0,0
37137,96,0,0
37138,%,0,0
37139,stage,0,0
37140,III,0,0
37141,),0,0
37142,",",0,0
37143,histology,0,0
37144,(,0,0
37145,serous,0,0
37146,in,0,0
37147,66,0,0
37148,%,0,0
37149,),0,0
37150,",",0,0
37151,grade,0,0
37152,(,0,0
37153,2,0,0
37154,or,0,0
37155,3,0,0
37156,in,0,0
37157,80,0,0
37158,%,0,0
37159,),0,0
37160,",",0,0
37161,and,0,0
37162,residuum,0,0
37163,before,0,0
37164,intravenous,0,1
37165,CT,0,0
37166,(,0,0
37167,>,0,0
37168,1,0,0
37169,cm,0,0
37170,in,0,0
37171,40,0,0
37172,%,0,0
37173,),0,0
37174,.,0,0
37175,Intraperitoneal,1,0
37176,CT,1,0
37177,was,0,0
37178,delivered,0,0
37179,mainly,0,0
37180,through,0,0
37181,intraperitoneal,0,1
37182,catheters,0,1
37183,(,0,0
37184,Port-a-Cath,0,0
37185,61,0,0
37186,%,0,0
37187,and,0,0
37188,Tenckhoff,0,1
37189,25,0,1
37190,%,0,0
37191,),0,0
37192,.,0,0
37193,Side,0,0
37194,effects,0,0
37195,of,0,0
37196,intraperitoneal,1,1
37197,cisplatin,1,1
37198,included,0,0
37199,vomiting,0,0
37200,[,0,0
37201,>,0,0
37202,or,0,0
37203,=grade,0,0
37204,2,0,0
37205,(,0,0
37206,82,0,0
37207,%,0,0
37208,),0,0
37209,],0,0
37210,",",0,0
37211,rise,0,0
37212,in,0,0
37213,serum,0,0
37214,creatinine,0,0
37215,[,0,0
37216,>,0,0
37217,or,0,0
37218,=grade,0,0
37219,2,0,0
37220,(,0,0
37221,14,0,0
37222,%,0,0
37223,),0,0
37224,],0,0
37225,",",0,0
37226,abdominal,0,0
37227,pain,0,0
37228,[,0,0
37229,grade,0,0
37230,1-2,0,0
37231,(,0,0
37232,38,0,0
37233,%,0,0
37234,),0,0
37235,],0,0
37236,",",0,0
37237,and,0,0
37238,neurotoxicity,0,0
37239,[,0,0
37240,grade,0,0
37241,2-3,0,0
37242,(,0,0
37243,15,0,0
37244,%,0,0
37245,),0,0
37246,],0,0
37247,.,0,0
37248,After,0,0
37249,a,0,0
37250,median,0,0
37251,follow-up,0,0
37252,of,0,0
37253,8,0,0
37254,years,0,0
37255,",",0,0
37256,80,0,0
37257,patients,0,0
37258,(,0,0
37259,52,0,0
37260,%,0,0
37261,),0,0
37262,have,0,0
37263,progressed,0,0
37264,with,0,0
37265,no,0,0
37266,difference,0,0
37267,in,0,0
37268,the,0,0
37269,pattern,0,0
37270,of,0,0
37271,relapse,0,0
37272,between,0,0
37273,the,0,0
37274,two,0,0
37275,groups,0,0
37276,and,0,0
37277,75,0,0
37278,patients,0,0
37279,(,0,0
37280,49,0,0
37281,%,0,0
37282,),0,0
37283,have,0,0
37284,died,0,0
37285,;,0,0
37286,the,0,0
37287,respective,0,0
37288,hazard,0,0
37289,ratios,0,0
37290,for,0,0
37291,PFS,0,0
37292,and,0,0
37293,OS,0,0
37294,with,0,0
37295,95,0,0
37296,%,0,0
37297,CI,0,0
37298,are,0,0
37299,0.89,0,0
37300,(,0,0
37301,0.59-1.33,0,0
37302,),0,0
37303,and,0,0
37304,0.82,0,0
37305,(,0,0
37306,0.52-1.29,0,0
37307,),0,0
37308,.,0,0
37309,These,0,0
37310,results,0,0
37311,are,0,0
37312,suggestive,0,0
37313,of,0,0
37314,a,0,0
37315,treatment,0,0
37316,benefit,0,0
37317,but,0,0
37318,do,0,0
37319,not,0,0
37320,support,0,0
37321,a,0,0
37322,change,0,0
37323,in,0,0
37324,clinical,0,0
37325,practice,0,0
37326,.,0,0
37327,Other,0,0
37328,randomized,0,0
37329,clinical,0,0
37330,trials,0,0
37331,of,0,0
37332,intraperitoneal,1,0
37333,CT,1,0
37334,are,0,0
37335,reviewed,0,0
37336,and,0,0
37337,briefly,0,0
37338,discussed,0,0
37339,.,0,0
37340,Bupropion,1,1
37341,SR,1,1
37342,and,1,0
37343,counseling,1,1
37344,for,1,0
37345,smoking,1,0
37346,cessation,0,1
37347,in,0,0
37348,actual,0,0
37349,practice,0,0
37350,:,0,0
37351,predictors,0,0
37352,of,0,0
37353,outcome,0,0
37354,.,0,0
37355,To,0,0
37356,date,0,0
37357,",",0,0
37358,only,0,0
37359,one,0,0
37360,study,0,0
37361,has,0,0
37362,been,0,0
37363,published,0,0
37364,on,0,0
37365,individual,0,0
37366,characteristics,0,0
37367,associated,0,0
37368,with,0,0
37369,outcome,0,0
37370,following,0,0
37371,standard,1,1
37372,treatment,1,0
37373,with,1,0
37374,bupropion,1,1
37375,SR,1,1
37376,for,0,0
37377,smoking,0,0
37378,cessation,0,1
37379,.,0,0
37380,To,0,0
37381,investigate,0,0
37382,treatment,0,0
37383,outcome,0,0
37384,beyond,0,0
37385,the,0,0
37386,6-week,0,0
37387,end-of-treatment,0,0
37388,point,0,0
37389,",",0,0
37390,the,0,0
37391,present,0,0
37392,study,0,0
37393,examined,0,0
37394,characteristics,0,0
37395,associated,0,0
37396,with,0,0
37397,more,0,0
37398,clinically,0,0
37399,relevant,0,0
37400,smoking,0,0
37401,endpoints,0,0
37402,following,0,0
37403,treatment,0,0
37404,with,0,0
37405,bupropion,1,1
37406,SR,1,1
37407,in,0,0
37408,a,0,0
37409,large,0,0
37410,health,0,0
37411,care,0,1
37412,system,0,0
37413,.,0,0
37414,A,0,0
37415,total,0,0
37416,of,0,0
37417,"1,524",0,0
37418,smokers,0,0
37419,(,0,0
37420,649,0,0
37421,men,0,0
37422,and,0,0
37423,875,0,0
37424,women,0,0
37425,),0,0
37426,of,0,0
37427,average,0,0
37428,age,0,0
37429,45.1,0,0
37430,years,0,0
37431,were,0,0
37432,randomized,0,0
37433,to,0,0
37434,receive,0,0
37435,one,0,0
37436,of,0,0
37437,four,0,0
37438,combinations,0,0
37439,of,0,0
37440,bupropion,1,1
37441,SR,1,1
37442,(,0,0
37443,150,0,0
37444,or,0,0
37445,300,0,1
37446,mg,0,1
37447,),0,0
37448,and,0,0
37449,behavioral,1,1
37450,counseling,1,1
37451,(,1,0
37452,tailored,1,1
37453,mailings,1,1
37454,or,1,0
37455,proactive,1,0
37456,telephone,1,1
37457,counseling,1,1
37458,),1,0
37459,and,0,0
37460,assessed,0,0
37461,for,0,0
37462,point-prevalent,0,0
37463,smoking,0,0
37464,status,0,0
37465,at,0,0
37466,3,0,0
37467,and,0,0
37468,12,0,0
37469,months,0,0
37470,.,0,0
37471,Multiple,0,0
37472,logistic,0,0
37473,regression,0,0
37474,analyses,0,0
37475,of,0,0
37476,potential,0,0
37477,risk,0,0
37478,factors,0,0
37479,for,0,0
37480,12-month,0,0
37481,point-prevalent,0,0
37482,smoking,0,0
37483,and,0,0
37484,for,0,0
37485,persistent,0,0
37486,smoking,0,1
37487,(,0,0
37488,point-prevalent,0,0
37489,smoking,0,0
37490,at,0,0
37491,both,0,0
37492,follow-ups,0,0
37493,),0,0
37494,following,0,0
37495,treatment,0,0
37496,were,0,0
37497,conducted,0,0
37498,for,0,0
37499,men,0,0
37500,and,0,0
37501,women,0,0
37502,combined,0,0
37503,and,0,0
37504,separately,0,0
37505,.,0,0
37506,Risk,0,0
37507,factors,0,0
37508,for,0,0
37509,smoking,0,0
37510,at,0,0
37511,both,0,0
37512,endpoints,0,0
37513,in,0,0
37514,the,0,0
37515,combined,0,0
37516,sample,0,0
37517,included,0,0
37518,treatment,0,0
37519,with,0,0
37520,tailored,0,1
37521,mailings,0,1
37522,",",0,0
37523,female,0,0
37524,gender,0,0
37525,",",0,0
37526,younger,0,0
37527,age,0,0
37528,",",0,0
37529,higher,0,0
37530,levels,0,0
37531,of,0,0
37532,tobacco,0,1
37533,dependence,0,0
37534,",",0,0
37535,shorter,0,0
37536,previous,0,0
37537,quit,0,0
37538,attempts,0,0
37539,",",0,0
37540,previous,0,0
37541,use,0,0
37542,of,0,0
37543,nicotine,0,1
37544,replacement,0,1
37545,therapy,0,1
37546,",",0,0
37547,and,0,0
37548,report,0,0
37549,of,0,0
37550,current,0,0
37551,depressive,0,0
37552,symptoms,0,0
37553,or,0,0
37554,lifetime,0,0
37555,depression,0,0
37556,.,0,0
37557,Risk,0,0
37558,factors,0,0
37559,for,0,0
37560,smoking,0,0
37561,following,0,0
37562,treatment,0,0
37563,identified,0,0
37564,in,0,0
37565,women,0,0
37566,only,0,0
37567,included,0,0
37568,treatment,0,0
37569,with,0,0
37570,the,0,0
37571,lower,0,0
37572,dose,0,0
37573,of,0,0
37574,bupropion,1,1
37575,SR,1,0
37576,",",0,0
37577,younger,0,0
37578,age,0,0
37579,",",0,0
37580,and,0,0
37581,higher,0,0
37582,perceived,0,0
37583,stress,0,0
37584,",",0,0
37585,whereas,0,0
37586,those,0,0
37587,that,0,0
37588,were,0,0
37589,unique,0,0
37590,to,0,0
37591,men,0,0
37592,included,0,0
37593,the,0,0
37594,presence,0,0
37595,of,0,0
37596,lifetime,0,0
37597,depression,0,0
37598,.,0,0
37599,The,0,0
37600,results,0,0
37601,are,0,0
37602,discussed,0,0
37603,in,0,0
37604,terms,0,0
37605,of,0,0
37606,their,0,0
37607,implications,0,0
37608,for,0,0
37609,the,0,0
37610,need,0,0
37611,for,0,0
37612,more,0,0
37613,effective,0,0
37614,treatments,0,0
37615,in,0,0
37616,general,0,0
37617,",",0,0
37618,and,0,0
37619,the,0,0
37620,role,0,0
37621,of,0,0
37622,individual,0,0
37623,differences,0,0
37624,in,0,0
37625,the,0,0
37626,likelihood,0,0
37627,of,0,0
37628,returning,0,0
37629,to,0,0
37630,smoking,0,1
37631,following,0,0
37632,treatment,0,0
37633,for,0,0
37634,quitting,0,0
37635,.,0,0
37636,Randomized,0,0
37637,Phase,0,0
37638,II,0,0
37639,trial,0,0
37640,assessing,0,0
37641,estramustine,1,1
37642,and,1,0
37643,vinblastine,1,1
37644,combination,1,1
37645,chemotherapy,1,1
37646,vs,1,0
37647,estramustine,1,1
37648,alone,1,1
37649,in,0,0
37650,patients,0,0
37651,with,0,0
37652,progressive,0,0
37653,hormone-escaped,0,1
37654,metastatic,0,0
37655,prostate,0,0
37656,cancer,0,0
37657,.,0,0
37658,Based,0,0
37659,on,0,0
37660,the,0,0
37661,results,0,0
37662,of,0,0
37663,combined,0,0
37664,data,0,0
37665,from,0,0
37666,three,0,0
37667,North,0,0
37668,American,0,0
37669,Phase,0,0
37670,II,0,0
37671,studies,0,0
37672,",",0,0
37673,a,0,0
37674,randomised,0,0
37675,Phase,0,0
37676,II,0,0
37677,study,0,0
37678,in,0,0
37679,the,0,0
37680,same,0,0
37681,patient,0,0
37682,population,0,0
37683,was,0,0
37684,performed,0,0
37685,",",0,0
37686,using,0,0
37687,combination,0,1
37688,chemotherapy,1,1
37689,with,1,0
37690,estramustine,1,1
37691,phosphate,1,1
37692,(,1,0
37693,EMP,1,1
37694,),1,1
37695,and,1,0
37696,vinblastine,1,1
37697,(,1,1
37698,VBL,1,0
37699,),1,0
37700,in,0,0
37701,hormone,0,1
37702,refractory,0,0
37703,prostate,0,0
37704,cancer,0,0
37705,patients,0,0
37706,.,0,0
37707,In,0,0
37708,all,0,0
37709,",",0,0
37710,92,0,0
37711,patients,0,0
37712,were,0,0
37713,randomised,0,0
37714,into,0,0
37715,a,0,0
37716,Phase,0,0
37717,II,0,0
37718,study,0,0
37719,of,0,0
37720,oral,1,1
37721,EMP,1,1
37722,(,1,0
37723,10,1,0
37724,mg,1,1
37725,kg,1,0
37726,day,1,0
37727,continuously,1,0
37728,),1,0
37729,or,1,0
37730,oral,1,1
37731,EMP,1,1
37732,in,1,0
37733,combination,1,1
37734,with,1,0
37735,intravenous,1,1
37736,VBL,1,0
37737,(,0,0
37738,4,0,0
37739,mg,0,1
37740,m,0,0
37741,(,0,0
37742,2,0,0
37743,),0,0
37744,week,0,0
37745,for,0,0
37746,6,0,0
37747,weeks,0,0
37748,",",0,0
37749,followed,0,0
37750,by,0,0
37751,2,0,0
37752,weeks,0,0
37753,rest,0,0
37754,),0,0
37755,.,0,0
37756,The,0,0
37757,end,0,0
37758,points,0,0
37759,were,0,0
37760,toxicity,0,0
37761,and,0,0
37762,PSA,0,0
37763,response,0,0
37764,in,0,0
37765,both,0,0
37766,groups,0,0
37767,",",0,0
37768,with,0,0
37769,the,0,0
37770,option,0,0
37771,to,0,0
37772,continue,0,0
37773,the,0,0
37774,trial,0,0
37775,as,0,0
37776,a,0,0
37777,Phase,0,0
37778,III,0,0
37779,study,0,0
37780,with,0,0
37781,time,0,0
37782,to,0,0
37783,progression,0,0
37784,and,0,0
37785,survival,0,0
37786,as,0,0
37787,end,0,0
37788,points,0,0
37789,",",0,0
37790,if,0,0
37791,sufficient,0,0
37792,responses,0,0
37793,were,0,0
37794,observed,0,0
37795,.,0,0
37796,Toxicity,0,0
37797,was,0,0
37798,unexpectedly,0,0
37799,high,0,0
37800,in,0,0
37801,both,0,0
37802,treatment,0,0
37803,arms,0,0
37804,and,0,0
37805,led,0,0
37806,to,0,0
37807,treatment,0,0
37808,withdrawal,0,1
37809,or,0,1
37810,refusal,0,0
37811,in,0,0
37812,49,0,0
37813,%,0,0
37814,of,0,0
37815,all,0,0
37816,patients,0,0
37817,",",0,0
37818,predominantly,0,0
37819,already,0,0
37820,during,0,0
37821,the,0,0
37822,first,0,0
37823,treatment,0,0
37824,cycle,0,0
37825,.,0,0
37826,The,0,0
37827,mean,0,0
37828,treatment,0,0
37829,duration,0,0
37830,was,0,0
37831,10,0,0
37832,and,0,0
37833,14,0,0
37834,weeks,0,0
37835,",",0,0
37836,median,0,0
37837,time,0,0
37838,to,0,0
37839,PSA,0,0
37840,progression,0,0
37841,was,0,0
37842,27.2,0,0
37843,and,0,0
37844,30.8,0,0
37845,weeks,0,0
37846,",",0,0
37847,median,0,0
37848,survival,0,0
37849,time,0,0
37850,was,0,0
37851,44,0,0
37852,and,0,0
37853,50.9,0,0
37854,weeks,0,0
37855,",",0,0
37856,and,0,0
37857,PSA,0,1
37858,response,0,0
37859,rate,0,0
37860,was,0,0
37861,only,0,0
37862,24.6,0,0
37863,and,0,0
37864,28.9,0,0
37865,%,0,0
37866,in,0,0
37867,the,0,0
37868,EMP/VBL,1,0
37869,and,0,0
37870,EMP,1,1
37871,arms,0,0
37872,",",0,0
37873,respectively,0,0
37874,.,0,0
37875,There,0,0
37876,was,0,0
37877,no,0,0
37878,correlation,0,0
37879,between,0,0
37880,PSA,0,0
37881,response,0,0
37882,and,0,0
37883,survival,0,0
37884,.,0,0
37885,While,0,0
37886,the,0,0
37887,PSA,0,0
37888,response,0,0
37889,in,0,0
37890,the,0,0
37891,patients,0,0
37892,tested,0,0
37893,was,0,0
37894,less,0,0
37895,than,0,0
37896,half,0,0
37897,that,0,0
37898,recorded,0,0
37899,in,0,0
37900,the,0,0
37901,North,0,0
37902,American,0,0
37903,studies,0,0
37904,",",0,0
37905,the,0,0
37906,toxicity,0,0
37907,of,0,0
37908,EMP,1,1
37909,monotherapy,0,1
37910,or,0,1
37911,in,0,0
37912,combination,0,1
37913,with,0,0
37914,VBL,1,0
37915,was,0,0
37916,much,0,0
37917,higher,0,0
37918,than,0,0
37919,expected,0,0
37920,.,0,0
37921,Further,0,0
37922,research,0,0
37923,on,0,0
37924,more,0,0
37925,effective,0,0
37926,and,0,0
37927,less,0,0
37928,toxic,0,0
37929,treatment,0,0
37930,strategies,0,0
37931,for,0,0
37932,hormone,0,0
37933,refractory,0,0
37934,prostate,0,0
37935,cancer,0,0
37936,is,0,0
37937,mandatory,0,0
37938,.,0,0
37939,Raising,0,0
37940,high-density,0,0
37941,lipoprotein,0,0
37942,in,0,0
37943,humans,0,0
37944,through,0,0
37945,inhibition,1,0
37946,of,1,0
37947,cholesteryl,1,1
37948,ester,1,1
37949,transfer,1,1
37950,protein,1,0
37951,:,1,0
37952,an,0,0
37953,initial,0,0
37954,multidose,0,1
37955,study,0,0
37956,of,0,0
37957,torcetrapib,1,1
37958,.,1,0
37959,OBJECTIVE,0,0
37960,The,0,0
37961,ability,0,0
37962,of,0,0
37963,the,0,0
37964,potent,0,0
37965,cholesteryl,1,1
37966,ester,1,1
37967,transfer,1,1
37968,protein,1,1
37969,(,1,0
37970,CETP,1,1
37971,),1,1
37972,inhibitor,1,1
37973,torcetrapib,1,1
37974,(,0,0
37975,"CP-529,414",0,0
37976,),0,0
37977,to,0,0
37978,raise,0,0
37979,high-density,0,0
37980,lipoprotein,0,0
37981,cholesterol,0,0
37982,(,0,0
37983,HDL-C,0,1
37984,),0,0
37985,levels,0,0
37986,in,0,0
37987,healthy,0,0
37988,young,0,0
37989,subjects,0,0
37990,was,0,0
37991,tested,0,0
37992,in,0,0
37993,this,0,0
37994,initial,0,0
37995,phase,0,0
37996,1,0,0
37997,multidose,0,1
37998,study,0,0
37999,.,0,0
38000,METHODS,0,0
38001,AND,0,0
38002,RESULTS,0,0
38003,Five,0,0
38004,groups,0,0
38005,of,0,0
38006,8,0,0
38007,subjects,0,0
38008,each,0,0
38009,were,0,0
38010,randomized,0,0
38011,to,0,0
38012,placebo,1,1
38013,(,0,0
38014,n=2,0,0
38015,),0,1
38016,or,0,1
38017,torcetrapib,1,1
38018,(,0,0
38019,n=6,0,1
38020,),0,0
38021,at,0,0
38022,10,0,0
38023,",",0,0
38024,30,0,0
38025,",",0,0
38026,60,0,0
38027,",",0,0
38028,and,0,0
38029,120,0,0
38030,mg,0,1
38031,daily,0,0
38032,and,0,0
38033,120,0,0
38034,mg,0,0
38035,twice,0,0
38036,daily,0,0
38037,for,0,0
38038,14,0,0
38039,days,0,0
38040,.,0,0
38041,Torcetrapib,1,0
38042,was,0,0
38043,well,0,0
38044,tolerated,0,0
38045,",",0,0
38046,with,0,0
38047,all,0,0
38048,treated,0,0
38049,subjects,0,0
38050,completing,0,0
38051,the,0,0
38052,study,0,0
38053,.,0,0
38054,The,0,0
38055,correlation,0,0
38056,of,0,0
38057,plasma,0,0
38058,drug,0,0
38059,levels,0,0
38060,with,0,0
38061,inhibition,0,0
38062,(,0,0
38063,EC50=43,0,0
38064,nM,0,1
38065,),0,0
38066,was,0,0
38067,as,0,0
38068,expected,0,0
38069,based,0,0
38070,on,0,0
38071,in,0,0
38072,vitro,0,0
38073,potency,0,0
38074,(,0,0
38075,IC50,0,0
38076,approximately,0,0
38077,50,0,0
38078,nM,0,1
38079,),0,0
38080,",",0,0
38081,and,0,0
38082,increases,0,0
38083,in,0,0
38084,CETP,0,0
38085,mass,0,0
38086,were,0,0
38087,consistent,0,0
38088,with,0,0
38089,the,0,0
38090,proposed,0,0
38091,mechanism,0,0
38092,of,0,0
38093,inhibition,0,0
38094,.,0,0
38095,CETP,1,0
38096,inhibition,1,0
38097,increased,0,0
38098,with,0,0
38099,escalating,0,0
38100,dose,0,0
38101,",",0,0
38102,leading,0,0
38103,to,0,0
38104,elevations,0,0
38105,of,0,0
38106,HDL-C,0,0
38107,of,0,0
38108,16,0,0
38109,%,0,0
38110,to,0,0
38111,91,0,0
38112,%,0,0
38113,.,0,0
38114,Total,0,0
38115,plasma,0,0
38116,cholesterol,0,0
38117,did,0,0
38118,not,0,0
38119,change,0,0
38120,significantly,0,0
38121,because,0,0
38122,of,0,0
38123,a,0,0
38124,reduction,0,0
38125,in,0,0
38126,nonHDL-C,0,0
38127,",",0,0
38128,including,0,0
38129,a,0,0
38130,21,0,0
38131,%,0,0
38132,to,0,0
38133,42,0,0
38134,%,0,0
38135,lowering,0,0
38136,of,0,0
38137,low-density,0,0
38138,lipoprotein,0,0
38139,cholesterol,0,0
38140,at,0,0
38141,the,0,0
38142,higher,0,0
38143,doses,0,0
38144,.,0,0
38145,Apolipoprotein,0,0
38146,A-I,0,0
38147,and,0,0
38148,E,0,1
38149,were,0,0
38150,elevated,0,0
38151,27,0,0
38152,%,0,0
38153,and,0,0
38154,66,0,0
38155,%,0,0
38156,",",0,0
38157,respectively,0,0
38158,",",0,0
38159,and,0,0
38160,apoB,0,0
38161,was,0,0
38162,reduced,0,0
38163,26,0,0
38164,%,0,0
38165,with,0,0
38166,120,0,0
38167,mg,0,0
38168,twice,0,0
38169,daily,0,0
38170,.,0,0
38171,Cholesteryl,0,0
38172,ester,0,1
38173,content,0,0
38174,decreased,0,0
38175,and,0,0
38176,triglyceride,0,0
38177,increased,0,0
38178,in,0,0
38179,the,0,0
38180,nonHDL,0,0
38181,plasma,0,0
38182,fraction,0,0
38183,",",0,0
38184,with,0,0
38185,contrasting,0,0
38186,changes,0,0
38187,occurring,0,0
38188,in,0,0
38189,HDL,0,1
38190,.,0,0
38191,CONCLUSIONS,0,0
38192,These,0,0
38193,effects,0,0
38194,of,0,0
38195,CETP,1,1
38196,inhibition,1,0
38197,resemble,0,0
38198,those,0,0
38199,observed,0,0
38200,in,0,0
38201,partial,0,0
38202,CETP,0,1
38203,deficiency,0,0
38204,.,0,0
38205,This,0,0
38206,work,0,0
38207,serves,0,0
38208,as,0,0
38209,a,0,0
38210,prelude,0,0
38211,to,0,0
38212,further,0,0
38213,studies,0,0
38214,in,0,0
38215,subjects,0,0
38216,with,0,0
38217,low,0,0
38218,HDL,0,1
38219,",",0,0
38220,or,0,0
38221,combinations,0,0
38222,of,0,0
38223,dyslipidemia,0,0
38224,",",0,0
38225,in,0,0
38226,assessing,0,0
38227,the,0,0
38228,role,0,0
38229,of,0,0
38230,CETP,0,1
38231,in,0,0
38232,atherosclerosis,0,0
38233,.,0,0
38234,The,0,0
38235,long-term,0,0
38236,effect,0,0
38237,of,0,0
38238,oxandrolone,1,1
38239,on,0,0
38240,hepatic,0,0
38241,acute,0,0
38242,phase,0,0
38243,proteins,0,0
38244,in,0,0
38245,severely,0,0
38246,burned,0,0
38247,children,0,0
38248,.,0,0
38249,BACKGROUND,0,0
38250,Acute,0,0
38251,phase,0,0
38252,protein,0,1
38253,production,0,0
38254,is,0,0
38255,a,0,0
38256,hallmark,0,0
38257,of,0,0
38258,severe,0,0
38259,burns,0,0
38260,.,0,0
38261,We,0,0
38262,wondered,0,0
38263,whether,0,0
38264,anabolic,1,0
38265,treatment,1,0
38266,with,0,0
38267,oxandrolone,0,1
38268,would,0,0
38269,affect,0,0
38270,these,0,0
38271,proteins,0,0
38272,.,0,0
38273,METHODS,0,0
38274,Thirty-five,0,0
38275,children,0,0
38276,with,0,0
38277,>,0,0
38278,or,0,1
38279,=40,0,0
38280,%,0,0
38281,total,0,0
38282,body,0,0
38283,surface,0,0
38284,area,0,0
38285,burns,0,0
38286,were,0,0
38287,randomized,0,0
38288,to,0,0
38289,receive,0,0
38290,either,0,0
38291,placebo,1,1
38292,or,1,1
38293,oxandrolone,1,1
38294,(,0,0
38295,0.1,0,0
38296,mg/kg,0,1
38297,by,0,0
38298,mouth,0,0
38299,twice,0,0
38300,daily,0,1
38301,),0,0
38302,from,0,0
38303,postoperative,0,0
38304,day,0,0
38305,5,0,0
38306,to,0,0
38307,1,0,0
38308,year,0,0
38309,postburn,0,0
38310,.,0,0
38311,Levels,0,0
38312,of,0,0
38313,constitutive,0,0
38314,proteins,0,0
38315,and,0,0
38316,acute,0,0
38317,phase,0,0
38318,proteins,0,0
38319,were,0,0
38320,measured,0,0
38321,at,0,0
38322,admission,0,0
38323,;,0,0
38324,at,0,0
38325,discharge,0,0
38326,;,0,0
38327,and,0,0
38328,at,0,0
38329,6,0,0
38330,",",0,0
38331,9,0,0
38332,",",0,0
38333,and,0,0
38334,12,0,0
38335,months,0,0
38336,after,0,0
38337,burn,0,0
38338,.,0,0
38339,Total,0,0
38340,albumin,0,1
38341,supplementation,0,1
38342,and,0,0
38343,hepatic,0,0
38344,transaminases,0,0
38345,were,0,0
38346,also,0,0
38347,assessed,0,0
38348,.,0,0
38349,RESULTS,0,0
38350,Constitutive,0,0
38351,proteins,0,0
38352,such,0,0
38353,as,0,0
38354,albumin,0,1
38355,",",0,0
38356,prealbumin,0,0
38357,",",0,0
38358,and,0,0
38359,retinol-binding,0,0
38360,protein,0,0
38361,levels,0,0
38362,increased,0,0
38363,(,0,0
38364,p,0,0
38365,<,0,0
38366,0.05,0,0
38367,),0,0
38368,",",0,0
38369,and,0,0
38370,acute,0,0
38371,phase,0,0
38372,proteins,0,0
38373,such,0,0
38374,as,0,0
38375,alpha,0,1
38376,1-acid,0,0
38377,glycoprotein,0,0
38378,",",0,0
38379,C3,0,0
38380,complement,0,0
38381,",",0,0
38382,alpha,0,1
38383,2-macroglobulin,0,1
38384,",",0,0
38385,and,0,0
38386,fibrinogen,0,0
38387,levels,0,0
38388,significantly,0,0
38389,decreased,0,0
38390,in,0,0
38391,the,0,0
38392,oxandrolone,0,1
38393,group,0,0
38394,compared,0,0
38395,with,0,0
38396,placebo,0,1
38397,(,0,0
38398,p,0,0
38399,<,0,0
38400,0.05,0,0
38401,),0,0
38402,.,0,0
38403,Albumin,0,0
38404,supplementation,0,1
38405,during,0,0
38406,the,0,0
38407,acute,0,0
38408,hospitalization,0,0
38409,was,0,0
38410,reduced,0,0
38411,in,0,0
38412,the,0,0
38413,oxandrolone,0,1
38414,group,0,0
38415,.,0,0
38416,Hepatic,0,0
38417,transaminases,0,0
38418,remained,0,0
38419,within,0,0
38420,normal,0,0
38421,levels,0,0
38422,.,0,0
38423,CONCLUSION,0,0
38424,Treatment,0,0
38425,with,0,0
38426,oxandrolone,0,1
38427,in,0,0
38428,severe,0,0
38429,burns,0,0
38430,significantly,0,0
38431,increases,0,0
38432,constitutive,0,0
38433,protein,0,0
38434,and,0,0
38435,reduces,0,0
38436,acute,0,0
38437,phase,0,0
38438,protein,0,0
38439,levels,0,0
38440,.,0,0
38441,A,0,0
38442,selective,1,0
38443,angiotensin,1,1
38444,receptor,1,0
38445,antagonist,1,1
38446,",",1,0
38447,Valsartan,1,1
38448,",",0,0
38449,produced,0,0
38450,regression,0,0
38451,of,0,0
38452,left,0,0
38453,ventricular,0,0
38454,hypertrophy,0,0
38455,associated,0,0
38456,with,0,0
38457,a,0,0
38458,reduction,0,0
38459,of,0,0
38460,arterial,0,0
38461,stiffness,0,0
38462,.,0,0
38463,We,0,0
38464,investigated,0,0
38465,whether,0,0
38466,a,0,0
38467,selective,1,0
38468,angiotensin,1,1
38469,II,1,0
38470,receptor,1,0
38471,blocker,1,1
38472,(,1,0
38473,ARB,1,1
38474,),1,0
38475,would,0,0
38476,have,0,0
38477,a,0,0
38478,regressive,0,0
38479,effect,0,0
38480,on,0,0
38481,left,0,0
38482,ventricular,0,0
38483,hypertrophy,0,0
38484,(,0,0
38485,LVH,0,1
38486,),0,0
38487,in,0,0
38488,patients,0,0
38489,on,0,0
38490,continuous,0,0
38491,ambulatory,0,0
38492,peritoneal,0,1
38493,dialysis,0,1
38494,(,0,0
38495,CAPD,0,0
38496,),0,0
38497,.,0,0
38498,In,0,0
38499,a,0,0
38500,double-blind,0,0
38501,study,0,0
38502,",",0,0
38503,24,0,0
38504,CAPD,0,0
38505,patients,0,0
38506,with,0,0
38507,LVH,0,0
38508,[,0,0
38509,left,0,0
38510,ventricular,0,0
38511,mass,0,0
38512,index,0,0
38513,(,0,0
38514,LVMi,0,0
38515,),0,0
38516,>,0,0
38517,110,0,0
38518,g/m2,0,0
38519,for,0,0
38520,women,0,0
38521,and,0,0
38522,LVMi,0,0
38523,>,0,0
38524,137,0,0
38525,g/m2,0,0
38526,for,0,0
38527,men,0,0
38528,],0,0
38529,were,0,0
38530,randomized,0,0
38531,to,0,0
38532,12,0,0
38533,months,0,0
38534,',0,0
38535,administration,0,0
38536,of,0,0
38537,either,0,0
38538,the,0,0
38539,ARB,1,1
38540,valsartan,1,1
38541,(,0,0
38542,n,0,0
38543,=,0,0
38544,14,0,0
38545,),0,0
38546,or,1,0
38547,a,1,0
38548,placebo,1,1
38549,(,0,0
38550,n,0,0
38551,=,0,0
38552,10,0,0
38553,),0,0
38554,.,0,0
38555,The,0,0
38556,target,0,0
38557,blood,0,0
38558,pressure,0,0
38559,(,0,0
38560,BP,0,0
38561,),0,0
38562,was,0,0
38563,140/90,0,0
38564,mmHg,0,0
38565,or,0,0
38566,lower,0,0
38567,in,0,0
38568,both,0,0
38569,groups,0,0
38570,.,0,0
38571,The,0,0
38572,following,0,0
38573,parameters,0,0
38574,were,0,0
38575,measured,0,0
38576,before,0,0
38577,and,0,0
38578,at,0,0
38579,the,0,0
38580,end,0,0
38581,of,0,0
38582,the,0,0
38583,study,0,0
38584,:,0,0
38585,aortic,0,0
38586,and,0,0
38587,large-artery,0,1
38588,compliance,0,0
38589,and,0,0
38590,arterial,0,0
38591,wave,0,1
38592,reflections,0,0
38593,[,0,0
38594,pulse,0,0
38595,wave,0,1
38596,velocity,0,0
38597,(,0,0
38598,PWV,0,1
38599,),0,1
38600,and,0,0
38601,augmentation,0,1
38602,index,0,0
38603,(,0,0
38604,AI,0,1
38605,),0,1
38606,application,0,1
38607,tonometry,0,1
38608,],0,0
38609,and,0,0
38610,cardiac,0,0
38611,echocardiography,0,0
38612,.,0,0
38613,Periodically,0,0
38614,recorded,0,0
38615,were,0,0
38616,body,0,0
38617,weight,0,0
38618,",",0,0
38619,BP,0,0
38620,(,0,0
38621,mercury,0,1
38622,sphygmomanometer,0,1
38623,),0,0
38624,",",0,0
38625,serum,0,0
38626,creatinine,0,0
38627,",",0,0
38628,electrolytes,0,0
38629,",",0,0
38630,complete,0,0
38631,blood,0,0
38632,cell,0,0
38633,counts,0,0
38634,",",0,0
38635,urine,0,0
38636,volume,0,0
38637,",",0,0
38638,drainage,0,1
38639,volume,0,0
38640,",",0,0
38641,and,0,0
38642,weekly,0,1
38643,creatinine,0,0
38644,clearance,0,0
38645,.,0,0
38646,Two-way,0,0
38647,analysis,0,0
38648,of,0,0
38649,variance,0,0
38650,for,0,0
38651,repeated,0,0
38652,measurements,0,0
38653,was,0,0
38654,used,0,0
38655,for,0,0
38656,statistical,0,0
38657,analysis,0,0
38658,.,0,0
38659,Systolic,0,0
38660,and,0,0
38661,diastolic,0,0
38662,BP,0,0
38663,were,0,0
38664,both,0,0
38665,reduced,0,0
38666,in,0,0
38667,patients,0,0
38668,treated,0,0
38669,with,0,0
38670,ARB,1,0
38671,.,1,0
38672,The,0,0
38673,LVMi,0,0
38674,was,0,0
38675,significantly,0,0
38676,reduced,0,0
38677,in,0,0
38678,patients,0,0
38679,treated,0,0
38680,with,0,0
38681,ARB,1,1
38682,(,0,0
38683,to,0,0
38684,121,0,0
38685,+/-,0,0
38686,4,0,0
38687,from,0,0
38688,145,0,0
38689,+/-,0,0
38690,5,0,0
38691,),0,0
38692,but,0,0
38693,not,0,0
38694,in,0,0
38695,those,0,0
38696,receiving,0,0
38697,placebo,1,1
38698,(,0,0
38699,to,0,0
38700,137,0,0
38701,+/-,0,0
38702,3,0,0
38703,from,0,0
38704,152,0,0
38705,+/-,0,0
38706,3,0,0
38707,",",0,0
38708,p,0,0
38709,<,0,0
38710,0.05,0,0
38711,),0,0
38712,.,0,0
38713,The,0,0
38714,decrease,0,0
38715,in,0,0
38716,LVMi,0,0
38717,was,0,0
38718,associated,0,0
38719,with,0,0
38720,a,0,0
38721,reduction,0,0
38722,in,0,0
38723,PWV,0,1
38724,and,0,0
38725,AI,0,0
38726,.,0,0
38727,In,0,0
38728,CAPD,0,0
38729,patients,0,0
38730,with,0,0
38731,LVH,0,0
38732,",",0,0
38733,ARB,1,0
38734,reduced,0,0
38735,LVMi,0,0
38736,in,0,0
38737,association,0,0
38738,with,0,0
38739,alterations,0,0
38740,in,0,0
38741,arterial,0,0
38742,hemodynamics,0,0
38743,.,0,0
38744,Effects,0,0
38745,of,0,0
38746,a,0,0
38747,combination,0,1
38748,of,0,0
38749,evening,1,0
38750,primrose,1,1
38751,oil,1,1
38752,(,1,0
38753,gamma,1,1
38754,linolenic,1,1
38755,acid,1,1
38756,),1,0
38757,and,1,0
38758,fish,1,1
38759,oil,1,1
38760,(,1,0
38761,eicosapentaenoic,1,1
38762,+,1,1
38763,docahexaenoic,1,1
38764,acid,1,1
38765,),1,0
38766,versus,1,0
38767,magnesium,1,1
38768,",",1,0
38769,and,1,0
38770,versus,1,0
38771,placebo,1,1
38772,in,0,0
38773,preventing,0,0
38774,pre-eclampsia,0,0
38775,.,0,0
38776,In,0,0
38777,a,0,0
38778,placebo,1,1
38779,controlled,0,0
38780,",",0,0
38781,partially,0,0
38782,double-blinded,0,0
38783,",",0,0
38784,clinical,0,0
38785,trial,0,0
38786,",",0,0
38787,a,0,0
38788,combination,1,1
38789,of,1,0
38790,evening,1,0
38791,primrose,1,1
38792,oil,1,1
38793,and,1,0
38794,fish,1,1
38795,oil,1,1
38796,was,1,0
38797,compared,1,0
38798,to,1,0
38799,Magnesium,1,1
38800,Oxide,1,1
38801,",",1,0
38802,and,1,0
38803,to,1,0
38804,a,1,0
38805,Placebo,1,1
38806,in,0,0
38807,preventing,0,0
38808,Pre-Eclampsia,0,0
38809,of,0,0
38810,Pregnancy,0,0
38811,.,0,0
38812,All,0,0
38813,were,0,0
38814,given,0,0
38815,as,0,0
38816,nutritional,0,1
38817,supplements,0,1
38818,for,0,0
38819,six,0,0
38820,months,0,0
38821,to,0,0
38822,a,0,0
38823,group,0,0
38824,of,0,0
38825,primiparous,0,0
38826,and,0,0
38827,multiparous,0,0
38828,pregnant,0,0
38829,women,0,0
38830,.,0,0
38831,Some,0,0
38832,of,0,0
38833,these,0,0
38834,women,0,0
38835,had,0,0
38836,personal,0,1
38837,or,0,1
38838,family,0,0
38839,histories,0,0
38840,of,0,0
38841,hypertension,0,0
38842,(,0,0
38843,21,0,0
38844,%,0,0
38845,),0,0
38846,.,0,0
38847,Only,0,0
38848,those,0,0
38849,patients,0,0
38850,who,0,0
38851,received,0,0
38852,prenatal,0,0
38853,care,0,0
38854,at,0,0
38855,the,0,0
38856,Central,0,0
38857,Maternity,0,0
38858,Hospital,0,0
38859,for,0,0
38860,Luanda,0,0
38861,were,0,0
38862,included,0,0
38863,in,0,0
38864,the,0,0
38865,study,0,0
38866,.,0,0
38867,Compared,0,0
38868,to,0,0
38869,the,0,0
38870,Placebo,1,1
38871,group,0,0
38872,(,0,0
38873,29,0,0
38874,%,0,0
38875,),0,0
38876,",",0,0
38877,the,0,0
38878,group,0,0
38879,receiving,0,0
38880,the,0,0
38881,mixture,0,1
38882,of,0,0
38883,evening,1,0
38884,primrose,1,1
38885,oil,1,1
38886,and,0,0
38887,fish,1,1
38888,oil,1,1
38889,containing,0,1
38890,Gamma-linolenic,1,1
38891,acid,1,1
38892,(,1,0
38893,GLA,1,0
38894,),1,0
38895,",",1,0
38896,Eicosapentaenoic,1,1
38897,acid,1,1
38898,(,1,0
38899,EPA,1,0
38900,),1,0
38901,",",0,0
38902,and,0,0
38903,Docosahexaenoic,1,1
38904,acid,1,1
38905,(,1,0
38906,DHA,1,0
38907,),1,0
38908,had,0,0
38909,a,0,0
38910,significantly,0,0
38911,lower,0,0
38912,incidence,0,0
38913,of,0,0
38914,edema,0,0
38915,(,0,0
38916,13,0,0
38917,%,0,0
38918,",",0,0
38919,p,0,0
38920,=,0,0
38921,0.004,0,0
38922,),0,0
38923,.,0,0
38924,The,0,0
38925,group,0,0
38926,receiving,0,0
38927,Magnesium,1,1
38928,Oxide,1,1
38929,had,0,0
38930,statistically,0,0
38931,significant,0,0
38932,fewer,0,0
38933,subjects,0,0
38934,who,0,0
38935,developed,0,0
38936,hypertension,0,0
38937,of,0,0
38938,pregnancy,0,0
38939,.,0,0
38940,There,0,0
38941,were,0,0
38942,3,0,0
38943,cases,0,0
38944,of,0,0
38945,eclampsia,0,0
38946,",",0,0
38947,all,0,0
38948,in,0,0
38949,the,0,0
38950,Placebo,1,1
38951,group,0,0
38952,.,0,0
38953,Rapid-sequence,1,0
38954,intubation,1,1
38955,of,0,0
38956,head,0,0
38957,trauma,0,0
38958,patients,0,0
38959,:,0,0
38960,prevention,0,0
38961,of,0,0
38962,fasciculations,0,0
38963,with,0,0
38964,pancuronium,1,1
38965,versus,0,0
38966,minidose,1,1
38967,succinylcholine,1,1
38968,.,1,0
38969,INTRODUCTION,0,0
38970,Fasciculations,0,0
38971,during,0,0
38972,rapid-sequence,0,0
38973,intubation,0,0
38974,may,0,0
38975,lead,0,0
38976,to,0,0
38977,increased,0,0
38978,intracranial,0,0
38979,pressure,0,0
38980,and,0,0
38981,emesis,0,0
38982,with,0,0
38983,aspiration,0,0
38984,.,0,0
38985,Standard,0,1
38986,rapid-sequence,0,0
38987,intubation,0,1
38988,requires,0,0
38989,a,0,0
38990,nondepolarizing,0,1
38991,blocking,0,0
38992,agent,0,0
38993,before,0,0
38994,succinylcholine,1,1
38995,administration,1,0
38996,.,1,0
38997,HYPOTHESIS,0,0
38998,Prevention,0,0
38999,of,0,0
39000,fasciculations,0,0
39001,during,0,0
39002,rapid-sequence,0,0
39003,intubation,0,1
39004,of,0,0
39005,head,0,0
39006,trauma,0,0
39007,patients,0,0
39008,can,0,0
39009,be,0,0
39010,accomplished,0,0
39011,as,0,0
39012,safely,0,0
39013,and,0,0
39014,effectively,0,0
39015,with,0,0
39016,minidose,0,1
39017,succinylcholine,1,1
39018,as,0,0
39019,with,0,0
39020,a,0,0
39021,defasciculating,0,0
39022,dose,0,0
39023,of,0,0
39024,pancuronium,0,1
39025,.,0,0
39026,DESIGN,0,0
39027,A,0,0
39028,prospective,0,0
39029,",",0,0
39030,randomized,0,0
39031,",",0,0
39032,double-blind,0,0
39033,study,0,0
39034,.,0,0
39035,SETTING,0,0
39036,An,0,0
39037,inner-city,0,0
39038,county,0,0
39039,trauma,0,0
39040,center,0,0
39041,with,0,0
39042,"70,000",0,0
39043,patient,0,0
39044,visits,0,0
39045,per,0,0
39046,year,0,0
39047,.,0,0
39048,PARTICIPANTS,0,0
39049,Sequential,0,0
39050,adult,0,0
39051,head,0,0
39052,trauma,0,0
39053,patients,0,0
39054,requiring,0,0
39055,rapid-sequence,0,0
39056,intubation,0,1
39057,who,0,0
39058,had,0,0
39059,no,0,0
39060,contraindications,0,0
39061,to,0,0
39062,succinylcholine,1,1
39063,or,0,0
39064,pancuronium,1,1
39065,.,1,0
39066,INTERVENTIONS,0,0
39067,Each,0,0
39068,head,0,0
39069,trauma,0,0
39070,patient,0,0
39071,requiring,0,0
39072,rapid-sequence,0,0
39073,intubation,0,1
39074,who,0,0
39075,met,0,0
39076,the,0,0
39077,inclusion,0,0
39078,criteria,0,0
39079,received,0,0
39080,standard,0,1
39081,rapid-sequence,1,0
39082,intubation,1,1
39083,maneuvers,1,1
39084,and,0,0
39085,lidocaine,1,1
39086,(,0,0
39087,1,0,0
39088,mg/kg,0,1
39089,),0,0
39090,IV,0,0
39091,.,0,0
39092,Patients,0,0
39093,were,0,0
39094,randomized,0,0
39095,to,0,0
39096,receive,0,0
39097,either,0,0
39098,minidose,1,1
39099,succinylcholine,1,1
39100,(,1,0
39101,0.1,1,1
39102,mg/kg,1,1
39103,),1,0
39104,or,1,1
39105,pancuronium,1,1
39106,(,0,0
39107,0.03,0,0
39108,mg/kg,0,1
39109,),0,0
39110,IV,0,0
39111,one,0,0
39112,minute,0,0
39113,prior,0,0
39114,to,0,0
39115,the,0,0
39116,full,1,0
39117,paralytic,1,0
39118,dose,1,0
39119,of,1,0
39120,succinylcholine,1,1
39121,(,0,0
39122,1.5,0,0
39123,mg/kg,0,1
39124,),0,0
39125,IV,0,0
39126,.,0,0
39127,Fasciculations,0,0
39128,were,0,0
39129,recorded,0,0
39130,using,0,0
39131,a,0,0
39132,graded,0,0
39133,visual,0,0
39134,scale,0,0
39135,.,0,0
39136,RESULTS,0,0
39137,Of,0,0
39138,46,0,0
39139,patients,0,0
39140,",",0,0
39141,eight,0,0
39142,of,0,0
39143,19,0,0
39144,(,0,0
39145,42,0,0
39146,%,0,0
39147,),0,0
39148,in,0,0
39149,the,0,0
39150,pancuronium,1,1
39151,group,0,0
39152,and,0,0
39153,six,0,0
39154,of,0,0
39155,27,0,0
39156,(,0,0
39157,22,0,0
39158,%,0,0
39159,),0,0
39160,in,0,0
39161,the,0,0
39162,succinylcholine,1,1
39163,group,0,0
39164,experienced,0,0
39165,fasciculations,0,0
39166,.,0,0
39167,No,0,0
39168,statistically,0,0
39169,significant,0,0
39170,difference,0,0
39171,in,0,0
39172,fasciculations,0,0
39173,was,0,0
39174,detected,0,0
39175,between,0,0
39176,the,0,0
39177,two,0,0
39178,groups,0,0
39179,using,0,0
39180,chi,0,0
39181,2,0,0
39182,analysis,0,0
39183,.,0,0
39184,Complete,0,0
39185,relaxation,0,1
39186,of,0,0
39187,the,0,0
39188,cords,0,0
39189,was,0,0
39190,present,0,0
39191,in,0,0
39192,all,0,0
39193,but,0,0
39194,two,0,0
39195,patients,0,0
39196,",",0,0
39197,one,0,0
39198,in,0,0
39199,each,0,0
39200,group,0,0
39201,.,0,0
39202,No,0,0
39203,patient,0,0
39204,in,0,0
39205,either,0,0
39206,group,0,0
39207,experienced,0,0
39208,emesis,0,0
39209,or,0,1
39210,significant,0,0
39211,dysrhythmias,0,0
39212,.,0,0
39213,CONCLUSION,0,0
39214,Pretreatment,0,1
39215,with,0,0
39216,minidose,0,1
39217,succinylcholine,1,1
39218,causes,0,0
39219,no,0,0
39220,greater,0,0
39221,incidence,0,0
39222,of,0,0
39223,fasciculations,0,0
39224,than,0,0
39225,pancuronium,1,1
39226,in,0,0
39227,rapid-sequence,0,0
39228,intubation,0,1
39229,of,0,0
39230,head,0,0
39231,trauma,0,0
39232,patients,0,0
39233,in,0,0
39234,an,0,0
39235,ED,0,1
39236,setting,0,0
39237,.,0,0
39238,Thus,0,0
39239,succinylcholine,1,1
39240,may,0,0
39241,be,0,0
39242,used,0,0
39243,as,0,0
39244,the,0,0
39245,sole,0,0
39246,paralytic,0,0
39247,agent,0,0
39248,in,0,0
39249,rapid-sequence,0,0
39250,intubation,0,1
39251,of,0,0
39252,head,0,0
39253,trauma,0,0
39254,patients,0,0
39255,.,0,0
39256,Body,1,1
39257,asymmetry,1,0
39258,affects,0,0
39259,conjugate,0,0
39260,lateral,0,0
39261,eye,0,1
39262,movement,0,0
39263,.,0,0
39264,A.,0,0
39265,H.,0,0
39266,Baker,0,1
39267,(,0,0
39268,1989,0,0
39269,),0,0
39270,and,0,0
39271,A.,0,0
39272,H.,0,0
39273,Baker,0,1
39274,and,0,0
39275,A.,0,0
39276,I.,0,1
39277,Ledner,0,0
39278,(,0,0
39279,1990,0,0
39280,),0,0
39281,reported,0,0
39282,that,0,0
39283,asymmetrical,0,0
39284,visual,0,0
39285,stimulation,0,1
39286,affects,0,0
39287,conjugate,0,0
39288,lateral,0,0
39289,eye,0,1
39290,movement,0,0
39291,(,0,0
39292,CLEM,0,0
39293,),0,0
39294,.,0,0
39295,In,0,0
39296,the,0,0
39297,present,0,0
39298,article,0,0
39299,",",0,0
39300,the,0,0
39301,authors,0,0
39302,explored,0,0
39303,whether,0,0
39304,asymmetrical,0,0
39305,body,0,0
39306,position,0,0
39307,similarly,0,0
39308,affects,0,0
39309,CLEM,0,0
39310,.,0,0
39311,The,0,0
39312,authors,0,0
39313,assessed,0,0
39314,CLEMs,0,0
39315,twice,0,0
39316,in,0,0
39317,a,0,0
39318,counterbalanced,0,0
39319,design,0,0
39320,.,0,0
39321,In,0,0
39322,the,0,0
39323,control,0,1
39324,(,0,0
39325,symmetric,0,0
39326,),0,0
39327,condition,0,0
39328,",",0,0
39329,each,0,0
39330,participant,0,0
39331,sat,0,0
39332,in,0,0
39333,a,0,0
39334,completely,1,0
39335,symmetrical,1,0
39336,position,1,0
39337,facing,0,0
39338,a,0,0
39339,wall,0,0
39340,devoid,0,0
39341,of,0,0
39342,any,0,0
39343,asymmetrical,0,0
39344,features,0,0
39345,.,0,0
39346,In,0,0
39347,the,0,0
39348,experimental,0,0
39349,(,0,0
39350,asymmetrical,0,0
39351,),0,0
39352,condition,0,0
39353,",",0,0
39354,half,0,0
39355,the,0,0
39356,participants,0,0
39357,rotated,1,0
39358,their,1,0
39359,heads,1,0
39360,68,1,0
39361,degrees,1,0
39362,clockwise,1,0
39363,relative,1,0
39364,to,1,0
39365,their,1,0
39366,bodies,1,0
39367,to,1,0
39368,face,1,0
39369,the,1,0
39370,experimenter,1,0
39371,",",1,0
39372,and,1,0
39373,the,1,0
39374,other,1,0
39375,half,1,0
39376,rotated,1,1
39377,their,1,0
39378,heads,1,0
39379,68,1,0
39380,degrees,1,0
39381,counterclockwise,1,0
39382,",",0,0
39383,also,0,0
39384,to,0,0
39385,face,0,0
39386,the,0,0
39387,experimenter,0,0
39388,.,0,0
39389,CLEM,0,0
39390,was,0,0
39391,predominantly,0,0
39392,toward,0,0
39393,the,0,0
39394,body,0,0
39395,'s,0,0
39396,position,0,0
39397,in,0,0
39398,the,0,0
39399,asymmetrical,0,0
39400,condition,0,0
39401,rather,0,0
39402,than,0,0
39403,toward,0,0
39404,the,0,0
39405,body,0,0
39406,'s,0,0
39407,position,0,0
39408,in,0,0
39409,the,0,0
39410,symmetrical,0,0
39411,condition,0,0
39412,.,0,0
39413,Clinical,0,0
39414,effects,0,0
39415,of,0,0
39416,naltrexone,1,1
39417,on,0,0
39418,autistic,0,0
39419,behavior,0,0
39420,.,0,0
39421,Eight,0,0
39422,young,0,0
39423,adults,0,0
39424,who,0,0
39425,were,0,0
39426,diagnosed,0,0
39427,with,0,0
39428,autism,0,0
39429,were,0,0
39430,given,0,0
39431,the,0,0
39432,opiate,1,1
39433,antagonist,1,1
39434,naltrexone,1,1
39435,to,0,0
39436,control,0,0
39437,self-injurious,0,0
39438,behavior,0,0
39439,and,0,0
39440,maladaptive,0,0
39441,idiosyncratic,0,0
39442,mannerisms,0,0
39443,.,0,0
39444,The,0,0
39445,drug,0,0
39446,and,0,0
39447,placebo,1,1
39448,were,0,0
39449,administered,0,0
39450,in,0,0
39451,a,0,0
39452,double-blind,0,0
39453,crossover,0,0
39454,design,0,0
39455,over,0,0
39456,17,0,0
39457,weeks,0,0
39458,.,0,0
39459,Although,0,0
39460,one,0,0
39461,subject,0,0
39462,appeared,0,0
39463,to,0,0
39464,have,0,0
39465,partial,0,0
39466,decreases,0,0
39467,in,0,0
39468,maladaptive,0,0
39469,behaviors,0,0
39470,associated,0,0
39471,with,0,0
39472,naltrexone,1,1
39473,use,0,0
39474,",",0,0
39475,the,0,0
39476,drugs,0,0
39477,",",0,0
39478,as,0,0
39479,administered,0,0
39480,in,0,0
39481,this,0,0
39482,study,0,0
39483,",",0,0
39484,did,0,0
39485,not,0,0
39486,reduce,0,0
39487,the,0,0
39488,self-injurious,0,0
39489,and,0,0
39490,other,0,0
39491,maladaptive,0,0
39492,behaviors,0,0
39493,of,0,0
39494,the,0,0
39495,subjects,0,0
39496,.,0,0
39497,Plasma,0,0
39498,kinetics,0,0
39499,of,0,0
39500,zeaxanthin,1,1
39501,and,0,0
39502,3'-dehydro-lutein,0,1
39503,after,0,0
39504,multiple,0,0
39505,oral,0,1
39506,doses,0,0
39507,of,0,0
39508,synthetic,1,0
39509,zeaxanthin,1,1
39510,.,1,0
39511,BACKGROUND,0,0
39512,Zeaxanthin,1,1
39513,is,0,0
39514,hypothesized,0,0
39515,to,0,0
39516,reduce,0,0
39517,the,0,0
39518,risk,0,0
39519,of,0,0
39520,age-related,0,0
39521,macular,0,0
39522,degeneration,0,0
39523,;,0,0
39524,however,0,0
39525,",",0,0
39526,kinetic,0,0
39527,information,0,0
39528,is,0,0
39529,limited,0,0
39530,.,0,0
39531,OBJECTIVES,0,0
39532,The,0,0
39533,objective,0,0
39534,was,0,0
39535,to,0,0
39536,investigate,0,0
39537,the,0,0
39538,plasma,0,0
39539,kinetics,0,0
39540,of,0,0
39541,synthetic,0,0
39542,zeaxanthin,1,1
39543,after,0,0
39544,repeated,0,0
39545,oral,0,1
39546,doses,0,0
39547,and,0,0
39548,to,0,0
39549,assess,0,0
39550,the,0,0
39551,possible,0,0
39552,influence,0,0
39553,of,0,0
39554,other,0,0
39555,carotenoids,0,1
39556,on,0,0
39557,plasma,0,0
39558,zeaxanthin,1,1
39559,concentrations,0,0
39560,.,0,0
39561,DESIGN,0,0
39562,After,0,0
39563,a,0,0
39564,run-in,0,0
39565,of,0,0
39566,3,0,0
39567,d,0,0
39568,",",0,0
39569,20,0,0
39570,healthy,0,0
39571,volunteers,0,0
39572,assigned,0,0
39573,to,0,0
39574,2,0,0
39575,parallel,0,0
39576,dose,0,0
39577,groups,0,0
39578,received,0,0
39579,once,0,0
39580,daily,0,0
39581,oral,0,1
39582,doses,0,0
39583,of,0,0
39584,either,0,0
39585,1,0,0
39586,mg,0,1
39587,(,0,0
39588,1.76,0,0
39589,micro,0,1
39590,mol,0,0
39591,),0,0
39592,or,0,1
39593,10,0,1
39594,mg,0,1
39595,(,0,0
39596,17.6,0,0
39597,micro,0,1
39598,mol,0,0
39599,),0,0
39600,zeaxanthin,1,1
39601,for,0,0
39602,42,0,0
39603,d.,0,0
39604,Plasma,0,0
39605,concentration-time,0,0
39606,profiles,0,0
39607,on,0,0
39608,days,0,0
39609,1,0,0
39610,and,0,0
39611,42,0,0
39612,",",0,0
39613,concentrations,0,0
39614,immediately,0,0
39615,before,0,0
39616,zeaxanthin,1,1
39617,intake,0,0
39618,during,0,0
39619,the,0,0
39620,dosing,0,0
39621,period,0,0
39622,",",0,0
39623,and,0,0
39624,concentrations,0,0
39625,after,0,0
39626,the,0,0
39627,last,0,0
39628,dose,0,0
39629,until,0,0
39630,day,0,0
39631,76,0,0
39632,were,0,0
39633,monitored,0,0
39634,.,0,0
39635,RESULTS,0,0
39636,all-E-Zeaxanthin,1,1
39637,concentrations,0,0
39638,increased,0,0
39639,from,0,0
39640,0.048,0,0
39641,+/-,0,0
39642,0.026,0,0
39643,micro,0,0
39644,mol/L,0,0
39645,at,0,0
39646,baseline,0,0
39647,to,0,0
39648,0.20,0,0
39649,+/-,0,0
39650,0.07,0,0
39651,and,0,0
39652,0.92,0,0
39653,+/-,0,0
39654,0.28,0,0
39655,micro,0,0
39656,mol/L,0,0
39657,with,0,0
39658,1,0,0
39659,and,0,0
39660,10,0,0
39661,mg,0,1
39662,zeaxanthin,1,1
39663,",",0,0
39664,respectively,0,0
39665,.,0,0
39666,The,0,0
39667,dose-normalized,0,0
39668,bioavailability,0,0
39669,of,0,0
39670,all-E-zeaxanthin,0,1
39671,after,0,0
39672,the10-mg,0,0
39673,dose,0,0
39674,was,0,0
39675,40,0,0
39676,%,0,0
39677,lower,0,0
39678,(,0,0
39679,P,0,0
39680,<,0,0
39681,0.001,0,0
39682,),0,0
39683,than,0,0
39684,after,0,0
39685,the,0,0
39686,1-mg,0,1
39687,dose,0,0
39688,.,0,0
39689,Other,0,0
39690,kinetic,0,0
39691,parameters,0,0
39692,did,0,0
39693,not,0,0
39694,differ,0,0
39695,significantly,0,0
39696,between,0,0
39697,groups,0,0
39698,.,0,0
39699,After,0,0
39700,17,0,0
39701,d,0,0
39702,of,0,0
39703,dosing,0,0
39704,",",0,0
39705,>,0,0
39706,90,0,0
39707,%,0,0
39708,of,0,0
39709,steady,0,0
39710,state,0,0
39711,concentrations,0,0
39712,were,0,0
39713,reached,0,0
39714,",",0,0
39715,which,0,0
39716,was,0,0
39717,compatible,0,0
39718,with,0,0
39719,an,0,0
39720,effective,0,0
39721,half-life,0,0
39722,for,0,0
39723,accumulation,0,0
39724,of,0,0
39725,5,0,0
39726,d.,0,0
39727,The,0,0
39728,terminal,0,0
39729,elimination,0,0
39730,half-life,0,0
39731,was,0,0
39732,12,0,0
39733,+/-,0,0
39734,7,0,0
39735,d,0,0
39736,(,0,0
39737,n,0,0
39738,=,0,0
39739,20,0,0
39740,),0,0
39741,.,0,0
39742,The,0,0
39743,time,0,0
39744,course,0,0
39745,of,0,0
39746,plasma,0,0
39747,all-E-3-'dehydro-lutein,0,0
39748,concentrations,0,0
39749,resembled,0,0
39750,that,0,0
39751,of,0,0
39752,all-E-zeaxanthin,1,1
39753,.,1,0
39754,The,0,0
39755,data,0,0
39756,provided,0,0
39757,evidence,0,0
39758,that,0,0
39759,all-E-3-'dehydro-lutein,0,0
39760,was,0,0
39761,derived,0,0
39762,from,0,0
39763,all-E-zeaxanthin,1,1
39764,.,1,0
39765,Concentrations,0,0
39766,of,0,0
39767,other,0,0
39768,carotenoids,0,1
39769,were,0,0
39770,not,0,0
39771,affected,0,0
39772,.,0,0
39773,Zeaxanthin,1,1
39774,was,0,0
39775,well,0,0
39776,tolerated,0,0
39777,.,0,0
39778,CONCLUSION,0,0
39779,Long-term,0,0
39780,oral,0,1
39781,intake,0,0
39782,of,0,0
39783,1,0,0
39784,and,0,0
39785,10,0,0
39786,mg,0,1
39787,zeaxanthin,1,1
39788,as,0,0
39789,beadlets,0,1
39790,increases,0,0
39791,plasma,0,0
39792,zeaxanthin,0,1
39793,concentrations,0,0
39794,approximately,0,0
39795,4-,0,1
39796,and,0,0
39797,20-fold,0,0
39798,",",0,0
39799,respectively,0,0
39800,.,0,0
39801,Evidence,0,0
39802,that,0,0
39803,all-E-3-dehydro-lutein,0,1
39804,is,0,0
39805,formed,0,0
39806,from,0,0
39807,zeaxanthin,1,1
39808,was,0,0
39809,strong,0,0
39810,.,0,0
39811,Skin,0,0
39812,concentrations,0,0
39813,of,0,0
39814,thromboxane,0,0
39815,synthetase,0,1
39816,inhibitor,0,1
39817,after,0,0
39818,topical,0,1
39819,application,0,0
39820,with,0,0
39821,bioelastic,0,1
39822,membrane,0,0
39823,.,0,0
39824,Elevated,0,0
39825,thromboxane,0,0
39826,levels,0,0
39827,are,0,0
39828,associated,0,0
39829,with,0,0
39830,a,0,0
39831,number,0,0
39832,of,0,0
39833,disease,0,0
39834,states,0,0
39835,",",0,0
39836,including,0,0
39837,dermal,0,1
39838,pressure,0,0
39839,ulcers,0,0
39840,.,0,0
39841,When,0,0
39842,dazmegrel,1,0
39843,was,1,0
39844,orally,1,1
39845,administered,1,0
39846,to,1,0
39847,greyhound,1,0
39848,dogs,1,0
39849,wearing,1,0
39850,leg,1,0
39851,casts,1,1
39852,",",0,0
39853,it,0,0
39854,resulted,0,0
39855,in,0,0
39856,a,0,0
39857,sparring,0,0
39858,effect,0,0
39859,on,0,0
39860,the,0,0
39861,skin,0,0
39862,areas,0,0
39863,of,0,0
39864,potential,0,0
39865,pressure,0,0
39866,ulcer,0,0
39867,development,0,0
39868,.,0,0
39869,The,0,0
39870,objective,0,0
39871,of,0,0
39872,this,0,0
39873,research,0,0
39874,was,0,0
39875,to,0,0
39876,determine,0,0
39877,if,0,0
39878,bioelastic,0,1
39879,matrices,0,1
39880,could,0,0
39881,provide,0,0
39882,controlled,0,0
39883,release,0,0
39884,of,0,0
39885,thromboxane,0,0
39886,A2,0,0
39887,synthetase,0,1
39888,inhibitor,0,1
39889,(,0,0
39890,dazmegrel,0,1
39891,),0,0
39892,at,0,0
39893,tissue,0,0
39894,concentrations,0,0
39895,sufficient,0,0
39896,for,0,0
39897,inhibition,0,0
39898,of,0,0
39899,thromboxane,0,0
39900,synthesis,0,0
39901,.,0,0
39902,The,0,0
39903,animal,0,0
39904,used,0,0
39905,for,0,0
39906,these,0,0
39907,studies,0,0
39908,was,0,0
39909,the,0,0
39910,greyhound,0,0
39911,",",0,0
39912,which,0,0
39913,has,0,0
39914,thin,0,0
39915,skin,0,0
39916,",",0,0
39917,angular,0,0
39918,conformation,0,0
39919,",",0,0
39920,limited,0,0
39921,body,0,0
39922,fat,0,0
39923,and,0,0
39924,is,0,0
39925,predisposed,0,0
39926,to,0,0
39927,pressure,0,0
39928,ulcers,0,0
39929,similar,0,0
39930,to,0,0
39931,those,0,0
39932,occurring,0,0
39933,in,0,0
39934,humans,0,0
39935,.,0,0
39936,In,0,0
39937,vivo,0,0
39938,skin,0,0
39939,penetration,0,0
39940,studies,0,0
39941,showed,0,0
39942,that,0,0
39943,epidermal,0,0
39944,exposure,0,0
39945,to,0,0
39946,bioelastic,0,1
39947,thromboxane,0,0
39948,synthetase,0,1
39949,inhibitor,0,1
39950,(,0,0
39951,TSI,0,1
39952,),0,0
39953,matrix,0,1
39954,resulted,0,0
39955,in,0,0
39956,local,0,0
39957,tissue,0,0
39958,concentrations,0,0
39959,of,0,0
39960,TSI,0,1
39961,sufficient,0,0
39962,for,0,0
39963,thromboxane,0,0
39964,synthetase,0,0
39965,inhibition,0,0
39966,.,0,0
39967,There,0,0
39968,were,0,0
39969,no,0,0
39970,significant,0,0
39971,differences,0,0
39972,between,0,0
39973,dazmegrel,0,1
39974,in,0,0
39975,the,0,0
39976,skin,0,0
39977,layers,0,1
39978,(,0,0
39979,epidermis,0,0
39980,",",0,0
39981,dermis,0,0
39982,and,0,0
39983,subcutaneous,0,0
39984,layers,0,1
39985,),0,0
39986,on,0,0
39987,1,0,0
39988,",",0,0
39989,7,0,0
39990,and,0,0
39991,14-day,0,0
39992,exposures,0,0
39993,.,0,0
39994,Reduced,0,0
39995,cardiotoxicity,0,0
39996,and,0,0
39997,comparable,0,0
39998,efficacy,0,0
39999,in,0,0
40000,a,0,0
40001,phase,0,0
40002,III,0,0
40003,trial,0,0
40004,of,0,0
40005,pegylated,1,1
40006,liposomal,1,1
40007,doxorubicin,1,1
40008,HCl,1,1
40009,(,1,0
40010,CAELYX/Doxil,1,0
40011,),1,0
40012,versus,0,0
40013,conventional,1,1
40014,doxorubicin,1,1
40015,for,0,0
40016,first-line,0,0
40017,treatment,0,0
40018,of,0,0
40019,metastatic,0,0
40020,breast,0,0
40021,cancer,0,0
40022,.,0,0
40023,BACKGROUND,0,0
40024,This,0,0
40025,study,0,0
40026,was,0,0
40027,designed,0,0
40028,to,0,0
40029,demonstrate,0,0
40030,that,0,0
40031,efficacy,0,0
40032,[,0,0
40033,progression-free,0,0
40034,survival,0,0
40035,(,0,0
40036,PFS,0,0
40037,),0,0
40038,],0,0
40039,of,0,0
40040,CAELYX,1,0
40041,[,1,0
40042,pegylated,1,1
40043,liposomal,1,1
40044,doxorubicin,1,1
40045,HCl,1,1
40046,(,1,0
40047,PLD,1,1
40048,),1,0
40049,],1,0
40050,is,0,0
40051,non-inferior,0,0
40052,to,0,0
40053,doxorubicin,1,1
40054,with,0,0
40055,significantly,0,0
40056,less,0,0
40057,cardiotoxicity,0,0
40058,in,0,0
40059,first-line,0,0
40060,treatment,0,0
40061,of,0,0
40062,women,0,0
40063,with,0,0
40064,metastatic,0,0
40065,breast,0,0
40066,cancer,0,0
40067,(,0,0
40068,MBC,0,0
40069,),0,0
40070,.,0,0
40071,PATIENTS,0,0
40072,AND,0,0
40073,METHODS,0,0
40074,Women,0,0
40075,(,0,0
40076,n=509,0,0
40077,),0,0
40078,with,0,0
40079,MBC,0,0
40080,and,0,0
40081,normal,0,0
40082,cardiac,0,0
40083,function,0,0
40084,were,0,0
40085,randomized,0,0
40086,to,0,0
40087,receive,0,0
40088,either,0,0
40089,PLD,1,1
40090,50,0,0
40091,mg/m2,0,1
40092,(,0,0
40093,every,0,0
40094,4,0,0
40095,weeks,0,0
40096,),0,0
40097,or,0,0
40098,doxorubicin,1,1
40099,60,1,0
40100,mg/m2,1,1
40101,(,0,0
40102,every,0,0
40103,3,0,0
40104,weeks,0,0
40105,),0,0
40106,.,0,0
40107,Cardiac,0,0
40108,event,0,0
40109,rates,0,0
40110,were,0,0
40111,based,0,0
40112,on,0,0
40113,reductions,0,0
40114,in,0,0
40115,left,0,0
40116,ventricular,0,0
40117,ejection,0,0
40118,fraction,0,0
40119,as,0,0
40120,a,0,0
40121,function,0,0
40122,of,0,0
40123,cumulative,0,0
40124,anthracycline,1,1
40125,dose,0,0
40126,.,0,0
40127,RESULTS,0,0
40128,PLD,1,1
40129,and,0,0
40130,doxorubicin,1,1
40131,were,0,0
40132,comparable,0,0
40133,with,0,0
40134,respect,0,0
40135,to,0,0
40136,PFS,0,0
40137,[,0,0
40138,6.9,0,0
40139,versus,0,0
40140,7.8,0,0
40141,months,0,0
40142,",",0,0
40143,respectively,0,0
40144,;,0,0
40145,hazard,0,0
40146,ratio,0,0
40147,(,0,0
40148,HR,0,0
40149,),0,0
40150,=1.00,0,0
40151,;,0,0
40152,95,0,0
40153,%,0,0
40154,confidence,0,0
40155,interval,0,0
40156,(,0,0
40157,CI,0,0
40158,),0,0
40159,0.82-1.22,0,0
40160,],0,0
40161,.,0,0
40162,Subgroup,0,0
40163,results,0,0
40164,were,0,0
40165,consistent,0,0
40166,.,0,0
40167,Overall,0,0
40168,risk,0,0
40169,of,0,0
40170,cardiotoxicity,0,0
40171,was,0,0
40172,significantly,0,0
40173,higher,0,0
40174,with,0,0
40175,doxorubicin,1,1
40176,than,0,0
40177,PLD,1,1
40178,(,0,0
40179,HR=3.16,0,0
40180,;,0,0
40181,95,0,0
40182,%,0,0
40183,CI,0,0
40184,1.58-6.31,0,0
40185,;,0,0
40186,P,0,0
40187,<,0,0
40188,0.001,0,0
40189,),0,0
40190,.,0,0
40191,Overall,0,0
40192,survival,0,0
40193,was,0,0
40194,similar,0,0
40195,(,0,0
40196,21,0,0
40197,and,0,0
40198,22,0,0
40199,months,0,0
40200,for,0,0
40201,PLD,1,1
40202,and,0,0
40203,doxorubicin,1,1
40204,",",0,0
40205,respectively,0,0
40206,;,0,0
40207,HR=0.94,0,0
40208,;,0,0
40209,95,0,0
40210,%,0,0
40211,CI,0,0
40212,0.74-1.19,0,0
40213,),0,0
40214,.,0,0
40215,Alopecia,0,0
40216,(,0,0
40217,overall,0,0
40218,",",0,0
40219,66,0,0
40220,%,0,0
40221,versus,0,0
40222,20,0,0
40223,%,0,0
40224,;,0,0
40225,pronounced,0,0
40226,",",0,0
40227,54,0,0
40228,%,0,0
40229,versus,0,0
40230,7,0,0
40231,%,0,0
40232,),0,0
40233,",",0,0
40234,nausea,0,0
40235,(,0,0
40236,53,0,0
40237,%,0,0
40238,versus,0,0
40239,37,0,0
40240,%,0,0
40241,),0,0
40242,",",0,0
40243,vomiting,0,0
40244,(,0,0
40245,31,0,0
40246,%,0,0
40247,versus,0,0
40248,19,0,0
40249,%,0,0
40250,),0,0
40251,and,0,0
40252,neutropenia,0,0
40253,(,0,0
40254,10,0,0
40255,%,0,0
40256,versus,0,0
40257,4,0,0
40258,%,0,0
40259,),0,0
40260,were,0,0
40261,more,0,0
40262,often,0,0
40263,associated,0,0
40264,with,0,0
40265,doxorubicin,1,1
40266,than,0,0
40267,PLD,1,1
40268,.,1,0
40269,Palmar-plantar,0,0
40270,erythrodysesthesia,0,1
40271,(,0,0
40272,48,0,0
40273,%,0,0
40274,versus,0,0
40275,2,0,0
40276,%,0,0
40277,),0,0
40278,",",0,0
40279,stomatitis,0,0
40280,(,0,0
40281,22,0,0
40282,%,0,0
40283,versus,0,0
40284,15,0,0
40285,%,0,0
40286,),0,0
40287,and,0,0
40288,mucositis,0,0
40289,(,0,0
40290,23,0,0
40291,%,0,0
40292,versus,0,0
40293,13,0,0
40294,%,0,0
40295,),0,0
40296,were,0,0
40297,more,0,0
40298,often,0,0
40299,associated,0,0
40300,with,0,0
40301,PLD,1,1
40302,than,0,0
40303,doxorubicin,1,1
40304,.,1,0
40305,CONCLUSIONS,0,0
40306,In,0,0
40307,first-line,0,0
40308,therapy,0,1
40309,for,0,0
40310,MBC,0,0
40311,",",0,0
40312,PLD,1,1
40313,provides,0,0
40314,comparable,0,0
40315,efficacy,0,0
40316,to,0,0
40317,doxorubicin,1,1
40318,",",0,0
40319,with,0,0
40320,significantly,0,0
40321,reduced,0,0
40322,cardiotoxicity,0,0
40323,",",0,0
40324,myelosuppression,0,0
40325,",",0,0
40326,vomiting,0,0
40327,and,0,0
40328,alopecia,0,0
40329,.,0,0
40330,A,0,0
40331,randomised,0,0
40332,controlled,0,0
40333,trial,0,0
40334,comparing,0,0
40335,Drawtex,1,0
40336,with,1,0
40337,standard,1,1
40338,dressings,1,1
40339,for,0,0
40340,exuding,0,0
40341,wounds,0,0
40342,.,0,0
40343,OBJECTIVE,0,0
40344,This,0,0
40345,randomised,0,0
40346,controlled,0,0
40347,clinical,0,0
40348,trial,0,0
40349,compared,0,0
40350,a,0,0
40351,capillary,1,0
40352,dressing,1,1
40353,(,1,0
40354,Drawtex,1,0
40355,",",1,0
40356,now,1,0
40357,rebranded,1,0
40358,as,1,0
40359,Vibriant,1,0
40360,RCD,1,1
40361,[,1,0
40362,Vibriant,1,0
40363,Technology,1,0
40364,Services,1,1
40365,],1,0
40366,),1,0
40367,with,1,0
40368,routine,1,0
40369,practice,1,0
40370,for,1,0
40371,exuding,1,0
40372,wounds,1,0
40373,greater,0,0
40374,than,0,0
40375,2.5,0,0
40376,x,0,0
40377,2.5,0,0
40378,cm,0,0
40379,.,0,0
40380,METHOD,0,0
40381,The,0,0
40382,target,0,0
40383,population,0,0
40384,was,0,0
40385,300,0,1
40386,control,0,0
40387,and,0,0
40388,300,0,1
40389,test,0,0
40390,subjects,0,0
40391,across,0,0
40392,three,0,0
40393,sites,0,0
40394,in,0,0
40395,the,0,0
40396,UK,0,0
40397,",",0,0
40398,but,0,0
40399,recruitment,0,0
40400,difficulties,0,0
40401,resulted,0,0
40402,in,0,0
40403,only,0,0
40404,125,0,0
40405,patients,0,0
40406,being,0,0
40407,evaluable,0,0
40408,.,0,0
40409,Wound,0,0
40410,progress,0,0
40411,was,0,0
40412,recorded,0,0
40413,by,0,0
40414,nurses,0,0
40415,',0,0
40416,perception,0,0
40417,of,0,0
40418,the,0,0
40419,progress,0,0
40420,of,0,0
40421,wound,0,0
40422,healing,0,0
40423,and,0,0
40424,by,0,0
40425,objective,0,0
40426,digital,0,1
40427,imaging,0,0
40428,.,0,0
40429,In,0,0
40430,the,0,0
40431,final,0,0
40432,analysis,0,0
40433,digital,0,1
40434,images,0,0
40435,were,0,0
40436,randomised,0,0
40437,(,0,0
40438,in,0,0
40439,time,0,0
40440,order,0,0
40441,),0,0
40442,and,0,0
40443,a,0,0
40444,panel,0,0
40445,of,0,0
40446,nurses,0,0
40447,who,0,0
40448,were,0,0
40449,not,0,0
40450,otherwise,0,0
40451,involved,0,0
40452,in,0,0
40453,the,0,0
40454,research,0,0
40455,project,0,0
40456,graded,0,0
40457,the,0,0
40458,wound,0,0
40459,'s,0,0
40460,progress,0,0
40461,.,0,0
40462,RESULTS,0,0
40463,After,0,0
40464,deconvolution,0,0
40465,of,0,0
40466,the,0,0
40467,data,0,0
40468,",",0,0
40469,the,0,0
40470,subjective,0,0
40471,(,0,0
40472,nurse,0,1
40473,perception,0,0
40474,),0,0
40475,method,0,0
40476,of,0,0
40477,evaluation,0,0
40478,determined,0,0
40479,that,0,0
40480,the,0,0
40481,new,0,0
40482,dressing,0,1
40483,resulted,0,0
40484,in,0,0
40485,wound,0,0
40486,improvement,0,0
40487,in,0,0
40488,12.7,0,0
40489,%,0,0
40490,more,0,0
40491,patients,0,0
40492,than,0,0
40493,did,0,0
40494,routine,0,0
40495,practice,0,0
40496,",",0,0
40497,but,0,0
40498,the,0,0
40499,blinded,0,0
40500,assessment,0,0
40501,method,0,1
40502,(,0,0
40503,based,0,0
40504,on,0,0
40505,the,0,0
40506,digital,0,1
40507,images,0,0
40508,),0,0
40509,showed,0,0
40510,that,0,0
40511,routine,0,0
40512,practice,0,0
40513,was,0,0
40514,better,0,0
40515,by,0,0
40516,6.6,0,0
40517,%,0,0
40518,.,0,0
40519,CONCLUSION,0,0
40520,Evaluation,0,0
40521,of,0,0
40522,wound,0,0
40523,progress,0,0
40524,is,0,0
40525,clearly,0,0
40526,difficult,0,0
40527,.,0,0
40528,Human,0,0
40529,nature,0,0
40530,makes,0,0
40531,us,0,0
40532,favour,0,0
40533,novelty,0,0
40534,if,0,0
40535,we,0,0
40536,believe,0,0
40537,it,0,0
40538,is,0,0
40539,going,0,0
40540,to,0,0
40541,be,0,0
40542,better,0,0
40543,.,0,0
40544,Making,0,0
40545,interpretation,0,0
40546,more,0,0
40547,objective,0,0
40548,removed,0,0
40549,that,0,0
40550,bias,0,0
40551,and,0,0
40552,did,0,0
40553,not,0,0
40554,demonstrate,0,0
40555,a,0,0
40556,significant,0,0
40557,advantage,0,0
40558,for,0,0
40559,the,0,0
40560,test,0,0
40561,dressing,0,1
40562,.,0,0
40563,The,0,0
40564,findings,0,0
40565,suggest,0,0
40566,that,0,0
40567,unblinded,0,0
40568,assessment,0,0
40569,by,0,0
40570,trial,0,0
40571,nurses,0,0
40572,is,0,0
40573,unacceptable,0,0
40574,on,0,0
40575,its,0,0
40576,own,0,0
40577,.,0,0
40578,Blinded,0,0
40579,assessments,0,0
40580,may,0,0
40581,miss,0,0
40582,finer,0,0
40583,nuances,0,0
40584,of,0,0
40585,wound,0,0
40586,progression,0,0
40587,",",0,0
40588,but,0,0
40589,are,0,0
40590,likely,0,0
40591,to,0,0
40592,be,0,0
40593,more,0,0
40594,accurate,0,0
40595,.,0,0
40596,The,0,0
40597,authors,0,0
40598,suggest,0,0
40599,that,0,0
40600,the,0,0
40601,true,0,0
40602,result,0,0
40603,lies,0,0
40604,somewhere,0,0
40605,in,0,0
40606,the,0,0
40607,middle,0,0
40608,",",0,0
40609,with,0,0
40610,the,0,0
40611,trial,0,0
40612,dressing,0,1
40613,likely,0,0
40614,to,0,0
40615,be,0,0
40616,as,0,0
40617,effective,0,0
40618,as,0,0
40619,",",0,0
40620,but,0,0
40621,not,0,0
40622,more,0,0
40623,effective,0,0
40624,than,0,0
40625,",",0,0
40626,a,0,0
40627,standard,0,1
40628,dressing,0,0
40629,.,0,0
40630,Does,0,1
40631,aerobic,1,1
40632,training,1,1
40633,lead,0,0
40634,to,0,0
40635,a,0,0
40636,more,0,0
40637,active,0,0
40638,lifestyle,0,1
40639,and,0,0
40640,improved,0,0
40641,quality,0,0
40642,of,0,0
40643,life,0,0
40644,in,0,0
40645,patients,0,0
40646,with,0,0
40647,chronic,0,0
40648,heart,0,0
40649,failure,0,0
40650,?,0,0
40651,BACKGROUND,0,0
40652,Due,0,1
40653,to,0,0
40654,dyspnea,0,0
40655,and,0,0
40656,fatigue,0,0
40657,",",0,0
40658,patients,0,0
40659,with,0,0
40660,chronic,0,0
40661,heart,0,0
40662,failure,0,0
40663,(,0,0
40664,CHF,0,0
40665,),0,0
40666,are,0,0
40667,often,0,0
40668,restricted,0,0
40669,in,0,0
40670,the,0,0
40671,performance,0,0
40672,of,0,0
40673,everyday,0,0
40674,activities,0,0
40675,",",0,0
40676,which,0,0
40677,gradually,0,0
40678,may,0,0
40679,lead,0,0
40680,to,0,0
40681,hypoactivity,0,0
40682,.,0,0
40683,AIMS,0,0
40684,To,0,0
40685,assess,0,0
40686,whether,0,0
40687,aerobic,1,0
40688,training,1,1
40689,leads,0,0
40690,to,0,0
40691,a,0,0
40692,more,0,0
40693,active,0,0
40694,lifestyle,0,1
40695,and,0,0
40696,improved,0,0
40697,quality,0,0
40698,of,0,0
40699,life,0,0
40700,(,0,0
40701,QoL,0,0
40702,),0,0
40703,in,0,0
40704,patients,0,0
40705,with,0,0
40706,CHF,0,0
40707,.,0,0
40708,METHODS,0,0
40709,Patients,0,0
40710,with,0,0
40711,stable,0,0
40712,CHF,0,0
40713,(,0,0
40714,NYHA,0,0
40715,II/III,0,0
40716,;,0,0
40717,59,0,0
40718,(,0,0
40719,11,0,0
40720,),0,0
40721,years,0,0
40722,),0,0
40723,were,0,0
40724,randomly,0,0
40725,assigned,0,0
40726,to,0,0
40727,a,0,0
40728,training,1,1
40729,group,0,0
40730,(,0,0
40731,n=18,0,0
40732,;,0,0
40733,3-month,0,0
40734,aerobic,1,1
40735,program,1,1
40736,above,1,0
40737,standard,1,1
40738,treatment,1,0
40739,),1,0
40740,or,0,1
40741,control,1,1
40742,group,1,0
40743,(,0,0
40744,n=16,0,0
40745,;,0,0
40746,standard,1,1
40747,treatment,1,0
40748,without,1,0
40749,special,1,0
40750,advice,1,1
40751,for,1,0
40752,exercise,1,1
40753,),1,0
40754,.,0,0
40755,Measurements,0,0
40756,were,0,0
40757,performed,0,0
40758,on,0,0
40759,level,0,0
40760,of,0,0
40761,everyday,0,0
40762,physical,0,1
40763,activity,0,0
40764,(,0,0
40765,PA,0,1
40766,",",0,0
40767,novel,0,0
40768,accelerometry-based,0,1
40769,activity,0,0
40770,monitor,0,1
40771,),0,0
40772,and,0,0
40773,QoL,0,0
40774,",",0,0
40775,and,0,0
40776,on,0,0
40777,several,0,0
40778,related,0,0
40779,parameters,0,0
40780,.,0,0
40781,RESULTS,0,0
40782,Training,0,0
40783,did,0,0
40784,not,0,0
40785,result,0,0
40786,in,0,0
40787,a,0,0
40788,more,0,0
40789,active,0,0
40790,lifestyle,0,1
40791,or,0,1
40792,improved,0,0
40793,QoL,0,0
40794,",",0,0
40795,but,0,0
40796,improved,0,0
40797,(,0,0
40798,P,0,0
40799,<,0,0
40800,0.05,0,0
40801,),0,0
40802,peak,0,0
40803,power,0,0
40804,(,0,0
40805,17,0,0
40806,%,0,0
40807,),0,0
40808,",",0,0
40809,6-min,0,0
40810,walk,0,1
40811,distance,0,0
40812,(,0,0
40813,10,0,0
40814,%,0,0
40815,),0,0
40816,",",0,0
40817,muscle,0,0
40818,strength,0,0
40819,(,0,0
40820,13-15,0,0
40821,%,0,0
40822,),0,0
40823,and,0,0
40824,depression,0,0
40825,(,0,0
40826,-1.3,0,0
40827,unit,0,0
40828,),0,0
40829,.,0,0
40830,Changes,0,0
40831,in,0,0
40832,level,0,0
40833,of,0,0
40834,everyday,0,0
40835,PA,0,1
40836,were,0,0
40837,related,0,0
40838,to,0,0
40839,changes,0,0
40840,in,0,0
40841,peak,0,0
40842,Vo,0,1
40843,(,0,0
40844,2,0,0
40845,),0,0
40846,(,0,0
40847,r=0.58,0,0
40848,",",0,0
40849,P=0.01,0,0
40850,),0,0
40851,and,0,0
40852,knee,0,0
40853,extension,0,0
40854,strength,0,0
40855,(,0,0
40856,r=0.48,0,0
40857,",",0,0
40858,P=0.05,0,0
40859,),0,0
40860,.,0,0
40861,CONCLUSIONS,0,0
40862,At,0,0
40863,group,0,0
40864,level,0,0
40865,training,0,1
40866,did,0,0
40867,not,0,0
40868,result,0,0
40869,in,0,0
40870,a,0,0
40871,more,0,0
40872,active,0,0
40873,lifestyle,0,1
40874,or,0,1
40875,improved,0,0
40876,QoL,0,0
40877,.,0,0
40878,However,0,0
40879,",",0,0
40880,correlations,0,0
40881,between,0,0
40882,training-related,0,0
40883,changes,0,0
40884,in,0,0
40885,parameters,0,0
40886,suggest,0,0
40887,that,0,0
40888,aerobic,0,1
40889,training,0,1
40890,has,0,0
40891,the,0,0
40892,potential,0,0
40893,to,0,0
40894,increase,0,0
40895,levels,0,0
40896,of,0,0
40897,everyday,0,0
40898,PA,0,1
40899,in,0,0
40900,CHF,0,0
40901,.,0,0
40902,The,0,0
40903,influence,0,0
40904,of,0,0
40905,pre-,1,0
40906,and,1,0
40907,intraoperative,1,1
40908,positioning,1,0
40909,of,1,0
40910,the,1,0
40911,condyle,1,0
40912,in,0,0
40913,the,0,0
40914,centre,0,0
40915,of,0,0
40916,the,0,0
40917,articular,0,0
40918,fossa,0,0
40919,on,0,0
40920,the,0,0
40921,position,0,0
40922,of,0,0
40923,the,0,0
40924,disc,0,0
40925,in,0,0
40926,orthognathic,1,0
40927,surgery,1,0
40928,.,1,0
40929,A,0,0
40930,magnetic,0,1
40931,resonance,0,1
40932,study,0,0
40933,.,0,0
40934,OBJECTIVE,0,0
40935,We,0,0
40936,investigated,0,0
40937,the,0,0
40938,changes,0,0
40939,in,0,0
40940,the,0,0
40941,temporomandibular,0,0
40942,joint,0,0
40943,(,0,0
40944,TMJ,0,1
40945,),0,0
40946,after,0,0
40947,bilateral,1,1
40948,sagittal,1,0
40949,split,1,1
40950,osteotomy,1,1
40951,of,1,0
40952,the,1,0
40953,mandible,1,0
40954,for,0,0
40955,orthognathic,0,1
40956,surgery,0,0
40957,and,0,0
40958,the,0,0
40959,influence,0,0
40960,of,0,0
40961,positioning,1,0
40962,of,1,0
40963,the,1,0
40964,condylar,1,0
40965,process,1,0
40966,in,0,0
40967,the,0,0
40968,centre,0,0
40969,of,0,0
40970,the,0,0
40971,articular,0,0
40972,fossa,0,0
40973,before,0,0
40974,and,0,0
40975,during,0,0
40976,the,0,0
40977,operation,0,0
40978,for,0,0
40979,preventing,0,0
40980,changes,0,0
40981,in,0,0
40982,the,0,0
40983,TMJ,0,0
40984,postoperatively,0,0
40985,.,0,0
40986,STUDY,0,0
40987,DESIGN,0,0
40988,A,0,0
40989,total,0,0
40990,of,0,0
40991,28,0,0
40992,patients,0,0
40993,with,0,0
40994,mandibular,0,0
40995,retrognathism,0,0
40996,had,0,0
40997,bilateral,1,1
40998,sagittal,1,0
40999,split,1,1
41000,osteotomies,1,1
41001,for,1,0
41002,mandibular,1,0
41003,advancement,1,0
41004,.,1,0
41005,In,0,0
41006,one,0,0
41007,group,0,0
41008,of,0,0
41009,14,0,0
41010,patients,0,0
41011,(,0,0
41012,28,0,0
41013,TMJ,0,1
41014,),0,0
41015,",",0,0
41016,the,0,0
41017,condyles,1,0
41018,were,1,0
41019,placed,1,0
41020,in,1,0
41021,the,1,0
41022,centre,1,0
41023,of,1,0
41024,the,1,0
41025,articular,1,0
41026,fossa,1,0
41027,before,1,0
41028,and,1,0
41029,during,1,0
41030,the,1,0
41031,operation,1,0
41032,",",1,0
41033,and,1,0
41034,in,1,0
41035,the,1,0
41036,other,1,0
41037,group,1,0
41038,they,1,0
41039,were,1,0
41040,not,1,0
41041,.,1,0
41042,Differences,0,0
41043,on,0,0
41044,magnetic,1,1
41045,resonance,1,1
41046,imaging,1,1
41047,(,1,0
41048,MRI,1,1
41049,),1,0
41050,were,0,0
41051,calculated,0,0
41052,and,0,0
41053,the,0,0
41054,results,0,0
41055,were,0,0
41056,evaluated,0,0
41057,.,0,0
41058,RESULTS,0,0
41059,The,0,0
41060,main,0,0
41061,differences,0,0
41062,were,0,0
41063,found,0,0
41064,at,0,0
41065,maximal,0,0
41066,mouth,0,0
41067,opening,0,0
41068,.,0,0
41069,15/28,0,0
41070,TMJs,0,0
41071,(,0,0
41072,54,0,0
41073,%,0,0
41074,),0,0
41075,that,0,0
41076,had,0,0
41077,not,0,0
41078,been,0,0
41079,positioned,0,1
41080,changed,0,0
41081,the,0,0
41082,position,0,0
41083,of,0,0
41084,the,0,0
41085,disc,0,0
41086,from,0,0
41087,physiological,0,0
41088,to,0,0
41089,anterior,0,0
41090,disc,0,0
41091,derangement,0,0
41092,with,0,0
41093,and,0,0
41094,without,0,0
41095,reduction,0,0
41096,postoperatively,0,0
41097,.,0,0
41098,In,0,0
41099,the,0,0
41100,28,0,0
41101,that,0,0
41102,had,0,0
41103,been,0,0
41104,positioned,0,1
41105,",",0,0
41106,changes,0,0
41107,were,0,0
41108,found,0,0
41109,in,0,0
41110,only,0,0
41111,3,0,0
41112,TMJs,0,0
41113,(,0,0
41114,11,0,0
41115,%,0,0
41116,),0,0
41117,postoperatively,0,0
41118,.,0,0
41119,CONCLUSIONS,0,0
41120,Fixing,1,0
41121,the,1,0
41122,condylar,1,0
41123,process,1,0
41124,in,1,0
41125,the,1,0
41126,centre,1,0
41127,of,1,0
41128,the,1,0
41129,articular,1,0
41130,fossa,1,0
41131,intraoperatively,1,0
41132,before,0,0
41133,bilateral,0,1
41134,sagittal,0,0
41135,split,0,1
41136,osteotomy,0,1
41137,is,0,0
41138,a,0,0
41139,factor,0,0
41140,in,0,0
41141,preventing,0,0
41142,postoperative,0,0
41143,structural,0,0
41144,changes,0,0
41145,in,0,0
41146,the,0,0
41147,temporomandibular,0,0
41148,joint,0,0
41149,.,0,0
41150,Metoprolol,1,1
41151,CR/XL,1,0
41152,improves,0,0
41153,systolic,0,0
41154,and,0,0
41155,diastolic,0,0
41156,left,0,0
41157,ventricular,0,0
41158,function,0,0
41159,in,0,0
41160,patients,0,0
41161,with,0,0
41162,chronic,0,0
41163,heart,0,0
41164,failure,0,0
41165,.,0,0
41166,AIMS,0,0
41167,To,0,0
41168,investigate,0,0
41169,whether,0,0
41170,metoprolol,1,1
41171,controlled,1,0
41172,release/extended,1,1
41173,release,1,0
41174,(,1,0
41175,CR/XL,1,0
41176,),1,0
41177,once,0,0
41178,daily,0,0
41179,would,0,0
41180,improve,0,0
41181,diastolic,0,0
41182,and,0,0
41183,systolic,0,0
41184,left,0,0
41185,ventricular,0,0
41186,function,0,0
41187,in,0,0
41188,patients,0,0
41189,with,0,0
41190,chronic,0,0
41191,heart,0,0
41192,failure,0,0
41193,and,0,0
41194,decreased,0,0
41195,ejection,0,0
41196,fraction,0,0
41197,.,0,0
41198,METHODS,0,0
41199,In,0,0
41200,an,0,0
41201,echocardiographic,0,0
41202,substudy,0,0
41203,to,0,0
41204,the,0,0
41205,Metoprolol,1,1
41206,CR/XL,1,0
41207,Randomized,0,0
41208,Intervention,0,1
41209,Trial,0,0
41210,in,0,0
41211,Heart,0,1
41212,Failure,0,1
41213,(,0,0
41214,MERIT-HF,0,1
41215,),0,0
41216,",",0,0
41217,66,0,0
41218,patients,0,0
41219,were,0,0
41220,examined,0,0
41221,three,0,0
41222,times,0,0
41223,during,0,0
41224,a,0,0
41225,12-month,0,0
41226,period,0,0
41227,blinded,0,0
41228,to,0,0
41229,treatment,0,0
41230,group,0,0
41231,",",0,0
41232,assessing,0,0
41233,left,0,0
41234,ventricular,0,0
41235,dimensions,0,0
41236,and,0,0
41237,ejection,0,0
41238,fraction,0,0
41239,",",0,0
41240,and,0,0
41241,Doppler,0,1
41242,mitral,0,0
41243,inflow,0,0
41244,parameters,0,0
41245,",",0,0
41246,all,0,0
41247,measured,0,0
41248,in,0,0
41249,a,0,0
41250,core,0,0
41251,laboratory,0,0
41252,.,0,0
41253,RESULTS,0,0
41254,In,0,0
41255,the,0,0
41256,metoprolol,1,1
41257,CR/XL,1,0
41258,group,0,0
41259,left,0,0
41260,ventricular,0,0
41261,ejection,0,0
41262,fraction,0,0
41263,increased,0,0
41264,from,0,0
41265,0.26,0,0
41266,to,0,0
41267,0.31,0,0
41268,(,0,0
41269,P,0,0
41270,=,0,0
41271,0.009,0,0
41272,),0,0
41273,after,0,0
41274,a,0,0
41275,mean,0,0
41276,observation,0,0
41277,period,0,0
41278,of,0,0
41279,10.6,0,0
41280,months,0,0
41281,",",0,0
41282,and,0,0
41283,deceleration,0,0
41284,time,0,0
41285,of,0,0
41286,the,0,0
41287,early,0,0
41288,mitral,0,0
41289,filling,0,1
41290,wave,0,1
41291,(,0,0
41292,E,0,1
41293,),0,0
41294,increased,0,0
41295,from,0,0
41296,189,0,0
41297,to,0,0
41298,246,0,0
41299,ms,0,0
41300,(,0,0
41301,P,0,0
41302,=,0,0
41303,0.0012,0,0
41304,),0,0
41305,",",0,0
41306,time,0,0
41307,velocity,0,0
41308,integral,0,0
41309,of,0,0
41310,E-wave,0,1
41311,increased,0,0
41312,from,0,0
41313,8.7,0,0
41314,to,0,0
41315,11.2,0,0
41316,cm,0,0
41317,(,0,0
41318,P,0,0
41319,=,0,0
41320,0.018,0,0
41321,),0,0
41322,",",0,0
41323,and,0,0
41324,the,0,0
41325,duration,0,0
41326,of,0,0
41327,the,0,0
41328,late,0,0
41329,mitral,0,0
41330,filling,0,1
41331,wave,0,1
41332,(,0,0
41333,A,0,0
41334,),0,0
41335,increased,0,0
41336,from,0,0
41337,122,0,0
41338,to,0,0
41339,145,0,0
41340,ms,0,0
41341,(,0,0
41342,P,0,0
41343,=,0,0
41344,0.014,0,0
41345,),0,0
41346,.,0,0
41347,No,0,0
41348,significant,0,0
41349,changes,0,0
41350,were,0,0
41351,seen,0,0
41352,in,0,0
41353,the,0,0
41354,placebo,1,1
41355,group,0,0
41356,regarding,0,0
41357,any,0,0
41358,of,0,0
41359,these,0,0
41360,variables,0,0
41361,.,0,0
41362,CONCLUSION,0,0
41363,Metoprolol,1,1
41364,CR/XL,1,0
41365,once,0,0
41366,daily,0,0
41367,in,0,0
41368,addition,0,0
41369,to,0,0
41370,standard,0,1
41371,therapy,0,1
41372,improved,0,0
41373,both,0,0
41374,diastolic,0,0
41375,and,0,0
41376,systolic,0,0
41377,function,0,0
41378,in,0,0
41379,patients,0,0
41380,with,0,0
41381,chronic,0,0
41382,heart,0,0
41383,failure,0,0
41384,and,0,0
41385,decreased,0,0
41386,ejection,0,0
41387,fraction,0,0
41388,.,0,0
41389,Perispinal,0,1
41390,analgesia,0,0
41391,for,0,0
41392,labour,0,0
41393,followed,0,0
41394,by,0,0
41395,patient-controlled,0,1
41396,infusion,0,1
41397,with,0,0
41398,bupivacaine,1,1
41399,and,0,0
41400,sufentanil,1,1
41401,:,1,0
41402,combined,1,0
41403,spinal-epidural,1,1
41404,vs.,1,0
41405,epidural,1,1
41406,analgesia,0,0
41407,alone,0,1
41408,.,0,0
41409,BACKGROUND,0,0
41410,AND,0,0
41411,OBJECTIVE,0,0
41412,Combined,0,1
41413,spinal-epidural,0,1
41414,is,0,0
41415,an,0,0
41416,alternative,0,0
41417,technique,0,1
41418,to,0,0
41419,epidural,0,1
41420,analgesia,0,0
41421,for,0,0
41422,labour,0,0
41423,",",0,0
41424,but,0,0
41425,its,0,0
41426,benefits,0,0
41427,are,0,0
41428,not,0,0
41429,clearly,0,0
41430,identified,0,0
41431,.,0,0
41432,METHODS,0,0
41433,A,0,0
41434,prospective,0,0
41435,",",0,0
41436,blinded,0,0
41437,",",0,0
41438,randomized,0,0
41439,study,0,0
41440,was,0,0
41441,undertaken,0,0
41442,involving,0,0
41443,113,0,0
41444,women,0,0
41445,attending,0,0
41446,a,0,0
41447,university,0,0
41448,hospital,0,0
41449,obstetric,0,0
41450,department,0,0
41451,.,0,0
41452,Analgesia,0,0
41453,was,0,0
41454,initiated,1,0
41455,with,1,0
41456,intrathecal,1,1
41457,bupivacaine,1,1
41458,0.25,1,1
41459,%,1,0
41460,1,1,0
41461,mL,1,0
41462,+,1,0
41463,sufentanil,1,1
41464,5,1,0
41465,microg,1,0
41466,in,1,0
41467,the,1,0
41468,combined,1,0
41469,spinal-epidural,1,1
41470,group,1,0
41471,(,1,0
41472,n,1,0
41473,=,1,0
41474,54,1,0
41475,),1,0
41476,",",1,0
41477,and,1,0
41478,with,1,0
41479,bupivacaine,1,1
41480,0.125,1,1
41481,%,1,0
41482,+,1,1
41483,epinephrine,1,1
41484,2.5,1,0
41485,microg,1,1
41486,mL,1,1
41487,(,1,0
41488,-1,1,0
41489,),1,0
41490,+,1,0
41491,sufentanil,1,1
41492,7.5,1,0
41493,microg,1,0
41494,in,1,0
41495,the,1,0
41496,epidural,1,1
41497,group,1,0
41498,(,1,0
41499,n,1,0
41500,=,1,0
41501,59,1,0
41502,),1,0
41503,.,1,0
41504,In,1,0
41505,both,1,0
41506,cases,1,0
41507,this,1,0
41508,was,1,0
41509,followed,1,0
41510,by,1,0
41511,patient-controlled,1,1
41512,epidural,1,1
41513,analgesia,1,0
41514,with,1,0
41515,bupivacaine,1,1
41516,0.125,1,1
41517,%,1,0
41518,(,1,0
41519,+,1,1
41520,sufentanil,1,1
41521,0.25,1,1
41522,microg,1,1
41523,mL,1,1
41524,(,1,0
41525,-1,1,0
41526,),1,0
41527,),1,0
41528,.,1,0
41529,Duration,0,0
41530,of,0,0
41531,labour,0,0
41532,",",0,0
41533,quality,0,0
41534,of,0,0
41535,analgesia,0,0
41536,and,0,0
41537,side-effects,0,0
41538,were,0,0
41539,compared,0,0
41540,between,0,0
41541,groups,0,0
41542,.,0,0
41543,RESULTS,0,0
41544,In,0,0
41545,the,0,0
41546,combined,0,0
41547,spinal-epidural,0,1
41548,group,0,0
41549,",",0,0
41550,the,0,0
41551,onset,0,0
41552,of,0,0
41553,analgesia,0,0
41554,was,0,0
41555,faster,0,0
41556,(,0,0
41557,5,0,0
41558,vs.,0,0
41559,15,0,0
41560,min,0,0
41561,",",0,0
41562,P,0,0
41563,<,0,0
41564,0.001,0,0
41565,),0,0
41566,",",0,0
41567,the,0,0
41568,consumption,0,0
41569,of,0,0
41570,bupivacaine,1,1
41571,was,0,0
41572,lower,0,0
41573,(,0,0
41574,7.5,0,0
41575,vs.,0,0
41576,11.3,0,0
41577,mg,0,1
41578,h,0,1
41579,(,0,0
41580,-1,0,0
41581,),0,0
41582,",",0,0
41583,P,0,0
41584,=,0,0
41585,0.003,0,0
41586,),0,0
41587,and,0,0
41588,there,0,0
41589,was,0,0
41590,less,0,0
41591,unilateral,0,0
41592,analgesia,0,0
41593,(,0,0
41594,14.8,0,0
41595,%,0,0
41596,vs.,0,0
41597,40.7,0,0
41598,%,0,0
41599,",",0,0
41600,P,0,0
41601,=,0,0
41602,0.002,0,0
41603,),0,0
41604,than,0,0
41605,in,0,0
41606,the,0,0
41607,epidural,0,1
41608,group,0,0
41609,.,0,0
41610,The,0,0
41611,characteristics,0,0
41612,of,0,0
41613,labour,0,0
41614,were,0,0
41615,similar,0,0
41616,in,0,0
41617,both,0,0
41618,groups,0,0
41619,.,0,0
41620,However,0,0
41621,",",0,0
41622,in,0,0
41623,the,0,0
41624,combined,0,0
41625,spinal-epidural,0,1
41626,group,0,0
41627,",",0,0
41628,there,0,0
41629,was,0,0
41630,a,0,0
41631,higher,0,0
41632,incidence,0,0
41633,of,0,0
41634,posterior,0,1
41635,presentation,0,0
41636,(,0,0
41637,25.9,0,0
41638,%,0,0
41639,vs.,0,0
41640,10,0,0
41641,%,0,0
41642,",",0,0
41643,P,0,0
41644,=,0,0
41645,0.03,0,0
41646,),0,0
41647,",",0,0
41648,pruritus,0,0
41649,(,0,0
41650,P,0,0
41651,<,0,0
41652,0.001,0,0
41653,),0,0
41654,",",0,0
41655,hypotension,0,0
41656,(,0,0
41657,P,0,0
41658,=,0,0
41659,0.002,0,0
41660,),0,0
41661,",",0,0
41662,somnolence,0,0
41663,(,0,0
41664,P,0,0
41665,=,0,0
41666,0.01,0,0
41667,),0,0
41668,",",0,0
41669,nausea,0,0
41670,(,0,0
41671,P,0,0
41672,=,0,0
41673,0.02,0,0
41674,),0,0
41675,and,0,0
41676,one,0,0
41677,case,0,0
41678,of,0,0
41679,meningitis,0,0
41680,.,0,0
41681,CONCLUSIONS,0,0
41682,The,0,0
41683,combined,0,0
41684,spinal-epidural,0,1
41685,technique,0,1
41686,provided,0,0
41687,more,0,0
41688,effective,0,0
41689,analgesia,0,0
41690,during,0,0
41691,labour,0,0
41692,than,0,0
41693,epidural,0,1
41694,analgesia,0,0
41695,alone,0,1
41696,but,0,0
41697,offered,0,0
41698,no,0,0
41699,other,0,0
41700,advantage,0,0
41701,.,0,0
41702,It,0,0
41703,induced,0,0
41704,more,0,0
41705,adverse,0,0
41706,effects,0,0
41707,and,0,0
41708,this,0,0
41709,should,0,0
41710,be,0,0
41711,considered,0,0
41712,before,0,0
41713,routinely,0,0
41714,using,0,0
41715,the,0,0
41716,combined,0,1
41717,spinal-epidural,0,1
41718,technique,0,1
41719,.,0,0
41720,A,0,0
41721,randomized,0,0
41722,comparison,0,0
41723,of,0,0
41724,alternative,0,0
41725,techniques,0,1
41726,to,0,0
41727,achieve,0,0
41728,coronary,0,0
41729,sinus,0,0
41730,cannulation,0,0
41731,during,0,0
41732,biventricular,0,1
41733,implantation,0,0
41734,procedures,0,0
41735,.,0,0
41736,INTRODUCTION,0,0
41737,Biventricular,1,0
41738,pacing,0,1
41739,system,0,1
41740,implantation,0,1
41741,is,0,0
41742,a,0,0
41743,time-consuming,0,0
41744,and,0,0
41745,challenging,0,0
41746,procedure,0,0
41747,.,0,0
41748,A,0,0
41749,critical,0,0
41750,step,0,0
41751,in,0,0
41752,biventricular,0,1
41753,pacemaker,0,1
41754,implantation,0,1
41755,is,0,0
41756,coronary,0,0
41757,sinus,0,0
41758,(,0,0
41759,CS,0,1
41760,),0,0
41761,cannulation,0,0
41762,.,0,0
41763,CS,0,0
41764,cannulation,0,0
41765,can,0,0
41766,be,0,0
41767,achieved,0,0
41768,either,0,0
41769,using,0,0
41770,dedicated,1,0
41771,guiding,1,1
41772,catheters,1,1
41773,(,1,0
41774,guiding,1,0
41775,catheter,1,1
41776,alone,1,1
41777,positioning,1,0
41778,strategy,1,0
41779,",",1,0
41780,GCA,1,0
41781,),1,0
41782,or,0,0
41783,with,0,0
41784,the,0,0
41785,aid,0,0
41786,of,0,0
41787,an,0,0
41788,electrophysiology,1,0
41789,catheter,1,1
41790,advanced,1,0
41791,inside,1,0
41792,the,1,0
41793,guiding,1,1
41794,catheter,1,1
41795,(,1,0
41796,electrophysiology,1,0
41797,catheter,1,1
41798,aided,1,0
41799,positioning,1,0
41800,strategy,1,0
41801,",",1,0
41802,EPA,1,0
41803,),1,0
41804,.,1,0
41805,AIM,0,0
41806,OF,0,0
41807,THE,0,1
41808,STUDY,0,0
41809,To,0,0
41810,evaluate,0,0
41811,whether,0,0
41812,the,0,0
41813,EPA,1,0
41814,technique,1,1
41815,is,0,0
41816,useful,0,0
41817,for,0,0
41818,reducing,0,0
41819,CS,0,1
41820,cannulation,0,0
41821,time,0,0
41822,compared,0,0
41823,to,0,0
41824,a,0,0
41825,conventional,0,1
41826,GCA,1,0
41827,technique,1,1
41828,.,1,0
41829,METHODS,0,0
41830,Thirty-four,0,0
41831,consecutive,0,0
41832,patients,0,0
41833,were,0,0
41834,randomly,0,0
41835,assigned,0,0
41836,to,0,0
41837,the,0,0
41838,GCA,1,0
41839,(,0,0
41840,18,0,0
41841,patients,0,0
41842,),0,0
41843,or,0,1
41844,EPA,1,1
41845,(,0,0
41846,16,0,0
41847,patients,0,0
41848,),0,0
41849,CS,1,1
41850,cannulation,1,0
41851,strategy,1,0
41852,.,0,0
41853,RESULTS,0,0
41854,Time,0,0
41855,to,0,0
41856,successful,0,0
41857,catheterization,0,0
41858,of,0,0
41859,CS,0,1
41860,was,0,0
41861,5.0,0,0
41862,+/-,0,0
41863,2.4,0,0
41864,min,0,0
41865,in,0,0
41866,the,0,0
41867,EPA,1,0
41868,group,0,0
41869,versus,0,0
41870,10.1,0,0
41871,+/-,0,0
41872,5.4,0,0
41873,min,0,0
41874,in,0,0
41875,the,0,0
41876,GCA,1,0
41877,group,0,0
41878,p,0,0
41879,=,0,0
41880,0.004,0,0
41881,.,0,0
41882,Fluoroscopy,0,1
41883,time,0,0
41884,was,0,0
41885,4.6,0,0
41886,+/-,0,0
41887,2.3,0,0
41888,min,0,0
41889,in,0,0
41890,the,0,0
41891,EPA,1,0
41892,group,0,0
41893,versus,0,0
41894,9.2,0,0
41895,+/-,0,0
41896,4.9,0,0
41897,min,0,0
41898,in,0,0
41899,the,0,0
41900,GCA,1,0
41901,group,0,0
41902,p,0,0
41903,=,0,0
41904,0.004,0,0
41905,.,0,0
41906,Total,0,0
41907,contrast,0,0
41908,dye,0,1
41909,volume,0,0
41910,to,0,0
41911,search,0,0
41912,and,0,0
41913,engage,0,0
41914,the,0,0
41915,CS,0,1
41916,ostium,0,0
41917,was,0,0
41918,0.0,0,0
41919,ml,0,0
41920,in,0,0
41921,the,0,0
41922,EPA,1,0
41923,group,0,0
41924,versus,0,0
41925,14.3,0,0
41926,+/-,0,0
41927,3.4,0,0
41928,ml,0,0
41929,in,0,0
41930,the,0,0
41931,GCA,1,0
41932,group,0,0
41933,p,0,0
41934,<,0,0
41935,0.001,0,0
41936,.,0,0
41937,CONCLUSIONS,0,0
41938,Cannulation,0,0
41939,of,0,0
41940,CS,0,1
41941,with,0,0
41942,the,0,0
41943,adjunct,0,0
41944,of,0,0
41945,an,0,0
41946,electrophysiology,1,0
41947,catheter,1,1
41948,to,0,0
41949,dedicated,0,0
41950,delivery,0,0
41951,systems,0,0
41952,significantly,0,0
41953,reduces,0,0
41954,procedural,0,0
41955,time,0,0
41956,",",0,0
41957,fluoroscopy,0,1
41958,time,0,0
41959,and,0,0
41960,contrast,0,0
41961,dye,0,1
41962,volume,0,0
41963,compared,0,0
41964,to,0,0
41965,a,0,0
41966,conventional,0,1
41967,strategy,0,0
41968,.,0,0
41969,A,0,0
41970,comparison,0,0
41971,of,0,0
41972,laparoscopically,1,1
41973,assisted,1,0
41974,and,1,0
41975,open,1,1
41976,colectomy,1,0
41977,for,0,0
41978,colon,0,0
41979,cancer,0,0
41980,.,0,0
41981,BACKGROUND,0,0
41982,Minimally,0,0
41983,invasive,0,0
41984,",",0,0
41985,laparoscopically,1,1
41986,assisted,1,0
41987,surgery,1,0
41988,was,0,0
41989,first,0,0
41990,considered,0,0
41991,in,0,0
41992,1990,0,0
41993,for,0,0
41994,patients,0,0
41995,undergoing,0,0
41996,colectomy,0,0
41997,for,0,0
41998,cancer,0,0
41999,.,0,0
42000,Concern,0,0
42001,that,0,0
42002,this,0,0
42003,approach,0,1
42004,would,0,0
42005,compromise,0,0
42006,survival,0,0
42007,by,0,0
42008,failing,0,0
42009,to,0,0
42010,achieve,0,0
42011,a,0,0
42012,proper,0,0
42013,oncologic,0,0
42014,resection,0,1
42015,or,0,1
42016,adequate,0,0
42017,staging,0,0
42018,or,0,1
42019,by,0,0
42020,altering,0,0
42021,patterns,0,0
42022,of,0,0
42023,recurrence,0,0
42024,(,0,0
42025,based,0,0
42026,on,0,0
42027,frequent,0,0
42028,reports,0,0
42029,of,0,0
42030,tumor,0,0
42031,recurrences,0,0
42032,within,0,0
42033,surgical,0,0
42034,wounds,0,0
42035,),0,0
42036,prompted,0,0
42037,a,0,0
42038,controlled,0,0
42039,trial,0,0
42040,evaluation,0,0
42041,.,0,0
42042,METHODS,0,0
42043,We,0,0
42044,conducted,0,0
42045,a,0,0
42046,noninferiority,0,0
42047,trial,0,0
42048,at,0,0
42049,48,0,0
42050,institutions,0,0
42051,and,0,0
42052,randomly,0,0
42053,assigned,0,0
42054,872,0,0
42055,patients,0,0
42056,with,0,0
42057,adenocarcinoma,0,0
42058,of,0,0
42059,the,0,0
42060,colon,0,0
42061,to,0,0
42062,undergo,0,0
42063,open,1,0
42064,or,1,0
42065,laparoscopically,1,1
42066,assisted,1,1
42067,colectomy,1,0
42068,performed,0,0
42069,by,0,0
42070,credentialed,0,0
42071,surgeons,0,0
42072,.,0,0
42073,The,0,0
42074,median,0,0
42075,follow-up,0,0
42076,was,0,0
42077,4.4,0,0
42078,years,0,0
42079,.,0,0
42080,The,0,0
42081,primary,0,0
42082,end,0,0
42083,point,0,0
42084,was,0,0
42085,the,0,0
42086,time,0,0
42087,to,0,0
42088,tumor,0,0
42089,recurrence,0,0
42090,.,0,0
42091,RESULTS,0,0
42092,At,0,0
42093,three,0,0
42094,years,0,0
42095,",",0,0
42096,the,0,0
42097,rates,0,0
42098,of,0,0
42099,recurrence,0,0
42100,were,0,0
42101,similar,0,0
42102,in,0,0
42103,the,0,0
42104,two,0,0
42105,groups,0,0
42106,--,0,0
42107,16,0,0
42108,percent,0,0
42109,among,0,0
42110,patients,0,0
42111,in,0,0
42112,the,0,0
42113,group,0,0
42114,that,0,0
42115,underwent,0,0
42116,laparoscopically,0,1
42117,assisted,0,1
42118,surgery,0,0
42119,and,0,0
42120,18,0,0
42121,percent,0,0
42122,among,0,0
42123,patients,0,0
42124,in,0,0
42125,the,0,0
42126,open-colectomy,0,1
42127,group,0,0
42128,(,0,0
42129,two-sided,0,0
42130,P=0.32,0,0
42131,;,0,0
42132,hazard,0,0
42133,ratio,0,0
42134,for,0,0
42135,recurrence,0,0
42136,",",0,0
42137,0.86,0,0
42138,;,0,0
42139,95,0,0
42140,percent,0,0
42141,confidence,0,0
42142,interval,0,0
42143,",",0,0
42144,0.63,0,0
42145,to,0,0
42146,1.17,0,0
42147,),0,0
42148,.,0,0
42149,Recurrence,0,0
42150,rates,0,0
42151,in,0,0
42152,surgical,0,0
42153,wounds,0,0
42154,were,0,0
42155,less,0,0
42156,than,0,0
42157,1,0,0
42158,percent,0,0
42159,in,0,0
42160,both,0,0
42161,groups,0,0
42162,(,0,0
42163,P=0.50,0,0
42164,),0,0
42165,.,0,0
42166,The,0,0
42167,overall,0,0
42168,survival,0,0
42169,rate,0,0
42170,at,0,0
42171,three,0,0
42172,years,0,0
42173,was,0,0
42174,also,0,0
42175,very,0,0
42176,similar,0,0
42177,in,0,0
42178,the,0,0
42179,two,0,0
42180,groups,0,0
42181,(,0,0
42182,86,0,0
42183,percent,0,0
42184,in,0,0
42185,the,0,0
42186,laparoscopic-surgery,0,1
42187,group,0,0
42188,and,0,0
42189,85,0,0
42190,percent,0,0
42191,in,0,0
42192,the,0,0
42193,open-colectomy,0,1
42194,group,0,0
42195,;,0,0
42196,P=0.51,0,0
42197,;,0,0
42198,hazard,0,0
42199,ratio,0,0
42200,for,0,0
42201,death,0,0
42202,in,0,0
42203,the,0,0
42204,laparoscopic-surgery,0,1
42205,group,0,0
42206,",",0,0
42207,0.91,0,0
42208,;,0,0
42209,95,0,0
42210,percent,0,0
42211,confidence,0,0
42212,interval,0,0
42213,",",0,0
42214,0.68,0,0
42215,to,0,0
42216,1.21,0,0
42217,),0,0
42218,",",0,0
42219,with,0,0
42220,no,0,0
42221,significant,0,0
42222,difference,0,0
42223,between,0,0
42224,groups,0,0
42225,in,0,0
42226,the,0,0
42227,time,0,0
42228,to,0,0
42229,recurrence,0,0
42230,or,0,1
42231,overall,0,0
42232,survival,0,0
42233,for,0,0
42234,patients,0,0
42235,with,0,0
42236,any,0,0
42237,stage,0,0
42238,of,0,0
42239,cancer,0,0
42240,.,0,0
42241,Perioperative,0,0
42242,recovery,0,0
42243,was,0,0
42244,faster,0,0
42245,in,0,0
42246,the,0,0
42247,laparoscopic-surgery,0,1
42248,group,0,0
42249,than,0,0
42250,in,0,0
42251,the,0,0
42252,open-colectomy,0,1
42253,group,0,0
42254,",",0,0
42255,as,0,0
42256,reflected,0,0
42257,by,0,0
42258,a,0,0
42259,shorter,0,0
42260,median,0,0
42261,hospital,0,0
42262,stay,0,0
42263,(,0,0
42264,five,0,0
42265,days,0,0
42266,vs.,0,0
42267,six,0,0
42268,days,0,0
42269,",",0,0
42270,P,0,0
42271,<,0,0
42272,0.001,0,0
42273,),0,0
42274,and,0,0
42275,briefer,0,1
42276,use,0,0
42277,of,0,0
42278,parenteral,0,1
42279,narcotics,0,1
42280,(,0,0
42281,three,0,0
42282,days,0,0
42283,vs.,0,0
42284,four,0,0
42285,days,0,0
42286,",",0,0
42287,P,0,0
42288,<,0,0
42289,0.001,0,0
42290,),0,0
42291,and,0,0
42292,oral,0,1
42293,analgesics,0,0
42294,(,0,0
42295,one,0,0
42296,day,0,0
42297,vs.,0,0
42298,two,0,0
42299,days,0,0
42300,",",0,0
42301,P=0.02,0,0
42302,),0,0
42303,.,0,0
42304,The,0,0
42305,rates,0,0
42306,of,0,0
42307,intraoperative,0,0
42308,complications,0,0
42309,",",0,0
42310,30-day,0,0
42311,postoperative,0,0
42312,mortality,0,0
42313,",",0,0
42314,complications,0,0
42315,at,0,0
42316,discharge,0,0
42317,and,0,0
42318,60,0,0
42319,days,0,0
42320,",",0,0
42321,hospital,0,0
42322,readmission,0,0
42323,",",0,0
42324,and,0,0
42325,reoperation,0,0
42326,were,0,0
42327,very,0,0
42328,similar,0,0
42329,between,0,0
42330,groups,0,0
42331,.,0,0
42332,CONCLUSIONS,0,0
42333,In,0,0
42334,this,0,0
42335,multi-institutional,0,0
42336,study,0,0
42337,",",0,0
42338,the,0,0
42339,rates,0,0
42340,of,0,0
42341,recurrent,0,0
42342,cancer,0,0
42343,were,0,0
42344,similar,0,0
42345,after,0,0
42346,laparoscopically,1,1
42347,assisted,1,1
42348,colectomy,1,0
42349,and,0,0
42350,open,1,1
42351,colectomy,1,0
42352,",",0,0
42353,suggesting,0,0
42354,that,0,0
42355,the,0,0
42356,laparoscopic,0,1
42357,approach,0,1
42358,is,0,0
42359,an,0,0
42360,acceptable,0,0
42361,alternative,0,0
42362,to,0,0
42363,open,0,0
42364,surgery,0,0
42365,for,0,0
42366,colon,0,0
42367,cancer,0,0
42368,.,0,0
42369,ROMEO,0,0
42370,:,0,0
42371,rethink,0,0
42372,organization,0,0
42373,to,0,0
42374,improve,0,0
42375,education,0,1
42376,and,0,0
42377,outcomes,0,0
42378,.,0,0
42379,AIMS,0,0
42380,Scarcity,0,0
42381,of,0,0
42382,resources,0,0
42383,",",0,0
42384,expertise,0,0
42385,and,0,0
42386,evidence-based,0,1
42387,models,0,0
42388,have,0,0
42389,so,0,0
42390,far,0,0
42391,limited,0,0
42392,delivery,0,0
42393,of,0,0
42394,patient-centred,0,1
42395,diabetes,0,0
42396,education,0,0
42397,.,0,0
42398,We,0,0
42399,have,0,0
42400,developed,0,0
42401,and,0,0
42402,validated,0,0
42403,a,0,0
42404,group,0,0
42405,care,0,1
42406,approach,0,1
42407,that,0,0
42408,is,0,0
42409,applicable,0,0
42410,to,0,0
42411,everyday,0,0
42412,clinical,0,0
42413,practice,0,0
42414,and,0,0
42415,cost-effective,0,0
42416,in,0,0
42417,improving,0,0
42418,metabolic,0,0
42419,control,0,1
42420,",",0,0
42421,knowledge,0,0
42422,of,0,0
42423,diabetes,0,0
42424,",",0,0
42425,health,0,0
42426,behaviours,0,0
42427,",",0,0
42428,and,0,0
42429,quality,0,0
42430,of,0,0
42431,life,0,0
42432,in,0,0
42433,Type,0,1
42434,2,0,0
42435,diabetes,0,0
42436,.,0,0
42437,A,0,0
42438,clinical,0,0
42439,trial,0,0
42440,(,0,0
42441,ROMEO,0,0
42442,),0,0
42443,was,0,0
42444,planned,0,0
42445,to,0,0
42446,evaluate,0,0
42447,applicability,0,0
42448,and,0,0
42449,reproducibility,0,0
42450,of,0,0
42451,group,0,0
42452,care,0,0
42453,in,0,0
42454,other,0,0
42455,outpatients,0,0
42456,facilities,0,0
42457,and,0,0
42458,assess,0,0
42459,its,0,0
42460,impact,0,0
42461,on,0,0
42462,a,0,0
42463,larger,0,0
42464,patient,0,0
42465,population,0,0
42466,.,0,0
42467,METHODS,0,0
42468,Multicentre,0,0
42469,",",0,0
42470,randomized,0,0
42471,",",0,0
42472,controlled,0,0
42473,clinical,0,0
42474,trial,0,0
42475,of,0,0
42476,group,1,0
42477,vs.,1,0
42478,individual,1,0
42479,care,1,0
42480,in,0,0
42481,the,0,0
42482,routine,0,0
42483,management,0,0
42484,of,0,0
42485,Type,0,1
42486,2,0,0
42487,diabetes,0,0
42488,.,0,0
42489,Nine,0,1
42490,hundred,0,0
42491,patient,0,0
42492,aged,0,0
42493,<,0,0
42494,80,0,0
42495,",",0,0
42496,with,0,0
42497,diabetes,0,0
42498,of,0,0
42499,>,0,0
42500,or,0,1
42501,=1,0,0
42502,year,0,0
42503,known,0,0
42504,duration,0,0
42505,",",0,0
42506,treated,0,0
42507,by,0,0
42508,either,0,0
42509,diet,1,1
42510,alone,1,1
42511,or,1,1
42512,diet,1,1
42513,and,1,0
42514,oral,1,1
42515,agents,1,0
42516,",",0,0
42517,will,0,0
42518,be,0,0
42519,recruited,0,0
42520,in,0,0
42521,15,0,0
42522,centres,0,0
42523,and,0,0
42524,followed,0,0
42525,for,0,0
42526,4,0,0
42527,years,0,0
42528,.,0,0
42529,Training,1,0
42530,of,1,0
42531,physicians,1,0
42532,",",1,0
42533,nurses,1,0
42534,and,1,0
42535,dietitians,1,0
42536,included,1,0
42537,preparation,1,1
42538,of,1,0
42539,operating,1,0
42540,manual,1,0
42541,and,1,0
42542,videos,1,1
42543,",",1,0
42544,interactive,1,0
42545,sessions,1,1
42546,",",1,0
42547,and,1,0
42548,evaluation,1,0
42549,of,1,0
42550,local,1,0
42551,facilities,1,0
42552,and,1,0
42553,resources,1,0
42554,.,1,0
42555,RESULTS,0,0
42556,PRIMARY,0,0
42557,MEASUREMENTS,0,0
42558,3-monthly,0,1
42559,HbA1c,0,1
42560,",",0,0
42561,fasting,0,0
42562,blood,0,0
42563,glucose,0,0
42564,",",0,0
42565,body,0,0
42566,weight,0,0
42567,",",0,0
42568,waist-hip,0,0
42569,ratio,0,0
42570,",",0,0
42571,yearly,0,0
42572,blood,0,0
42573,lipids,0,0
42574,",",0,0
42575,and,0,0
42576,bi-yearly,0,0
42577,assessment,0,0
42578,of,0,0
42579,knowledge,0,0
42580,of,0,0
42581,diabetes,0,0
42582,",",0,0
42583,health,0,0
42584,behaviours,0,0
42585,and,0,0
42586,quality,0,0
42587,of,0,0
42588,life,0,0
42589,.,0,0
42590,SECONDARY,0,0
42591,OUTCOMES,0,0
42592,systolic,0,0
42593,and,0,0
42594,diastolic,0,0
42595,blood,0,0
42596,pressure,0,0
42597,",",0,0
42598,evaluation,0,0
42599,of,0,0
42600,ECG,0,0
42601,for,0,0
42602,ischaemia,0,0
42603,and,0,0
42604,QT,0,0
42605,interval,0,0
42606,",",0,0
42607,hypoglycaemic,0,0
42608,and,0,0
42609,anti-hypertensive,0,1
42610,medication,0,1
42611,and,0,0
42612,cardiovascular,0,0
42613,events,0,0
42614,.,0,0
42615,Analysis,0,0
42616,will,0,0
42617,be,0,0
42618,by,0,0
42619,intention-to-treat,0,0
42620,.,0,0
42621,DISCUSSION,0,0
42622,If,0,0
42623,ROMEO,0,0
42624,confirms,0,0
42625,that,0,0
42626,group,0,0
42627,care,0,0
42628,can,0,0
42629,be,0,0
42630,successfully,0,0
42631,implemented,0,0
42632,in,0,0
42633,different,0,0
42634,clinics,0,0
42635,",",0,0
42636,a,0,0
42637,novel,0,0
42638,clinico-pedagogic,0,0
42639,tool,0,0
42640,will,0,0
42641,have,0,0
42642,been,0,0
42643,acquired,0,0
42644,to,0,0
42645,support,0,0
42646,patient-centred,0,1
42647,education,0,1
42648,",",0,0
42649,improve,0,0
42650,lifestyle,0,1
42651,and,0,0
42652,outcomes,0,0
42653,",",0,0
42654,support,0,0
42655,team,0,0
42656,work,0,0
42657,",",0,0
42658,enhance,0,0
42659,providers,0,0
42660,',0,0
42661,attitudes,0,0
42662,and,0,0
42663,competencies,0,0
42664,and,0,0
42665,ameliorate,0,0
42666,diabetes,0,0
42667,care,0,0
42668,organization,0,0
42669,.,0,0
42670,Bevacizumab,1,1
42671,plus,1,1
42672,irinotecan,1,1
42673,",",1,0
42674,fluorouracil,1,1
42675,",",1,0
42676,and,1,0
42677,leucovorin,1,1
42678,for,0,0
42679,metastatic,0,0
42680,colorectal,0,0
42681,cancer,0,0
42682,.,0,0
42683,BACKGROUND,0,0
42684,Bevacizumab,1,1
42685,",",0,0
42686,a,0,0
42687,monoclonal,0,1
42688,antibody,0,0
42689,against,0,0
42690,vascular,0,0
42691,endothelial,0,0
42692,growth,0,0
42693,factor,0,0
42694,",",0,0
42695,has,0,0
42696,shown,0,0
42697,promising,0,0
42698,preclinical,0,0
42699,and,0,0
42700,clinical,0,0
42701,activity,0,0
42702,against,0,0
42703,metastatic,0,0
42704,colorectal,0,0
42705,cancer,0,0
42706,",",0,0
42707,particularly,0,0
42708,in,0,0
42709,combination,0,1
42710,with,0,0
42711,chemotherapy,0,1
42712,.,0,0
42713,METHODS,0,0
42714,Of,0,0
42715,813,0,0
42716,patients,0,0
42717,with,0,0
42718,previously,0,0
42719,untreated,0,0
42720,metastatic,0,0
42721,colorectal,0,0
42722,cancer,0,0
42723,",",0,0
42724,we,0,0
42725,randomly,0,0
42726,assigned,0,0
42727,402,0,0
42728,to,0,0
42729,receive,0,0
42730,irinotecan,1,1
42731,",",1,0
42732,bolus,1,1
42733,fluorouracil,1,1
42734,",",1,0
42735,and,1,0
42736,leucovorin,1,1
42737,(,1,1
42738,IFL,1,1
42739,),1,1
42740,plus,1,1
42741,bevacizumab,1,1
42742,(,0,0
42743,5,0,0
42744,mg,0,1
42745,per,0,0
42746,kilogram,0,1
42747,of,0,0
42748,body,0,0
42749,weight,0,0
42750,every,0,0
42751,two,0,0
42752,weeks,0,0
42753,),0,0
42754,and,0,0
42755,411,0,0
42756,to,0,0
42757,receive,0,0
42758,IFL,1,1
42759,plus,1,1
42760,placebo,1,1
42761,.,1,0
42762,The,0,0
42763,primary,0,0
42764,end,0,0
42765,point,0,0
42766,was,0,0
42767,overall,0,0
42768,survival,0,0
42769,.,0,0
42770,Secondary,0,0
42771,end,0,0
42772,points,0,0
42773,were,0,0
42774,progression-free,0,0
42775,survival,0,0
42776,",",0,0
42777,the,0,0
42778,response,0,0
42779,rate,0,0
42780,",",0,0
42781,the,0,0
42782,duration,0,0
42783,of,0,0
42784,the,0,0
42785,response,0,0
42786,",",0,0
42787,safety,0,0
42788,",",0,0
42789,and,0,0
42790,the,0,0
42791,quality,0,0
42792,of,0,0
42793,life,0,0
42794,.,0,0
42795,RESULTS,0,0
42796,The,0,0
42797,median,0,0
42798,duration,0,0
42799,of,0,0
42800,survival,0,0
42801,was,0,0
42802,20.3,0,0
42803,months,0,0
42804,in,0,0
42805,the,0,0
42806,group,0,0
42807,given,0,0
42808,IFL,1,1
42809,plus,1,1
42810,bevacizumab,1,1
42811,",",0,0
42812,as,0,0
42813,compared,0,0
42814,with,0,0
42815,15.6,0,0
42816,months,0,0
42817,in,0,0
42818,the,0,0
42819,group,0,0
42820,given,0,0
42821,IFL,1,1
42822,plus,1,1
42823,placebo,1,1
42824,",",0,0
42825,corresponding,0,0
42826,to,0,0
42827,a,0,0
42828,hazard,0,0
42829,ratio,0,0
42830,for,0,0
42831,death,0,0
42832,of,0,0
42833,0.66,0,0
42834,(,0,0
42835,P,0,0
42836,<,0,0
42837,0.001,0,0
42838,),0,0
42839,.,0,0
42840,The,0,0
42841,median,0,0
42842,duration,0,0
42843,of,0,0
42844,progression-free,0,0
42845,survival,0,0
42846,was,0,0
42847,10.6,0,0
42848,months,0,0
42849,in,0,0
42850,the,0,0
42851,group,0,0
42852,given,0,0
42853,IFL,1,1
42854,plus,1,1
42855,bevacizumab,1,1
42856,",",0,0
42857,as,0,0
42858,compared,0,0
42859,with,0,0
42860,6.2,0,0
42861,months,0,0
42862,in,0,0
42863,the,0,0
42864,group,0,0
42865,given,0,0
42866,IFL,1,1
42867,plus,1,1
42868,placebo,1,1
42869,(,0,0
42870,hazard,0,0
42871,ratio,0,0
42872,for,0,0
42873,disease,0,0
42874,progression,0,0
42875,",",0,0
42876,0.54,0,0
42877,;,0,0
42878,P,0,0
42879,<,0,0
42880,0.001,0,0
42881,),0,0
42882,;,0,0
42883,the,0,0
42884,corresponding,0,0
42885,rates,0,0
42886,of,0,0
42887,response,0,0
42888,were,0,0
42889,44.8,0,0
42890,percent,0,0
42891,and,0,0
42892,34.8,0,0
42893,percent,0,0
42894,(,0,0
42895,P=0.004,0,0
42896,),0,0
42897,.,0,0
42898,The,0,0
42899,median,0,0
42900,duration,0,0
42901,of,0,0
42902,the,0,0
42903,response,0,0
42904,was,0,0
42905,10.4,0,0
42906,months,0,0
42907,in,0,0
42908,the,0,0
42909,group,0,0
42910,given,0,0
42911,IFL,1,1
42912,plus,1,1
42913,bevacizumab,1,1
42914,",",0,0
42915,as,0,0
42916,compared,0,0
42917,with,0,0
42918,7.1,0,0
42919,months,0,0
42920,in,0,0
42921,the,0,0
42922,group,0,0
42923,given,0,0
42924,IFL,1,1
42925,plus,1,1
42926,placebo,1,1
42927,(,0,0
42928,hazard,0,0
42929,ratio,0,0
42930,for,0,0
42931,progression,0,0
42932,",",0,0
42933,0.62,0,0
42934,;,0,0
42935,P=0.001,0,0
42936,),0,0
42937,.,0,0
42938,Grade,0,0
42939,3,0,0
42940,hypertension,0,0
42941,was,0,0
42942,more,0,0
42943,common,0,0
42944,during,0,0
42945,treatment,0,0
42946,with,0,0
42947,IFL,1,1
42948,plus,1,1
42949,bevacizumab,1,1
42950,than,0,0
42951,with,0,0
42952,IFL,1,1
42953,plus,1,1
42954,placebo,1,1
42955,(,0,0
42956,11.0,0,0
42957,percent,0,0
42958,vs.,0,0
42959,2.3,0,0
42960,percent,0,0
42961,),0,0
42962,but,0,0
42963,was,0,0
42964,easily,0,0
42965,managed,0,0
42966,.,0,0
42967,CONCLUSIONS,0,0
42968,The,0,0
42969,addition,0,0
42970,of,0,0
42971,bevacizumab,1,1
42972,to,0,0
42973,fluorouracil-based,1,1
42974,combination,1,1
42975,chemotherapy,1,1
42976,results,0,0
42977,in,0,0
42978,statistically,0,0
42979,significant,0,0
42980,and,0,0
42981,clinically,0,0
42982,meaningful,0,0
42983,improvement,0,0
42984,in,0,0
42985,survival,0,0
42986,among,0,0
42987,patients,0,0
42988,with,0,0
42989,metastatic,0,0
42990,colorectal,0,0
42991,cancer,0,0
42992,.,0,0
42993,Clarithromycin,1,1
42994,reduces,0,0
42995,the,0,0
42996,severity,0,0
42997,of,0,0
42998,bronchial,0,0
42999,hyperresponsiveness,0,0
43000,in,0,0
43001,patients,0,0
43002,with,0,0
43003,asthma,0,0
43004,.,0,0
43005,A,0,0
43006,randomised,0,0
43007,double-blind,0,0
43008,placebo-controlled,1,1
43009,study,0,0
43010,was,0,0
43011,designed,0,0
43012,to,0,0
43013,evaluate,0,0
43014,the,0,0
43015,effects,0,0
43016,of,0,0
43017,a,0,0
43018,semisynthetic,1,1
43019,macrolide,1,1
43020,antibiotic,1,1
43021,",",1,0
43022,clarithromycin,1,1
43023,",",0,0
43024,on,0,0
43025,bronchial,1,0
43026,hyperresponsiveness,1,0
43027,to,0,0
43028,methacholine,1,0
43029,in,0,0
43030,patients,0,0
43031,with,0,0
43032,a,0,0
43033,diagnosis,0,0
43034,of,0,0
43035,asthma,0,0
43036,.,0,0
43037,Adult,0,0
43038,asthma,0,0
43039,patients,0,0
43040,undergoing,0,0
43041,treatment,0,0
43042,with,0,0
43043,budesonide,1,1
43044,400,0,0
43045,microg,0,0
43046,b.i.d,0,1
43047,.,0,0
43048,and,0,0
43049,salbutamol,1,1
43050,200,0,1
43051,microg,0,0
43052,p.r.n,0,0
43053,.,0,0
43054,less,0,0
43055,than,0,0
43056,twice,0,0
43057,weekly,0,1
43058,were,0,0
43059,studied,0,0
43060,.,0,0
43061,Arm,0,0
43062,A,0,0
43063,(,0,0
43064,16,0,0
43065,males/six,0,0
43066,females,0,0
43067,",",0,0
43068,aged,0,0
43069,48,0,0
43070,+/-,0,0
43071,16,0,0
43072,yrs,0,0
43073,),0,0
43074,received,0,0
43075,clarithromycin,1,1
43076,250,0,1
43077,mg,0,0
43078,b.i.d,0,1
43079,.,0,0
43080,for,0,0
43081,8,0,0
43082,weeks,0,0
43083,",",0,0
43084,arm,0,0
43085,B,0,0
43086,(,0,0
43087,eight,0,0
43088,males/12,0,0
43089,females,0,0
43090,",",0,0
43091,aged,0,0
43092,42,0,0
43093,+/-,0,0
43094,12,0,0
43095,yrs,0,0
43096,),0,0
43097,clarithromycin,1,1
43098,250,0,0
43099,mg,0,0
43100,t.id,0,1
43101,.,0,0
43102,and,0,0
43103,arm,0,0
43104,C,0,1
43105,(,0,0
43106,six,0,0
43107,males/15,0,0
43108,females,0,0
43109,",",0,0
43110,aged,0,0
43111,41,0,0
43112,+/-,0,0
43113,16,0,0
43114,yrs,0,0
43115,),0,0
43116,placebo,1,1
43117,dextrose,1,1
43118,tablets,0,1
43119,.,0,0
43120,Bronchial,0,0
43121,hyperresponsiveness,0,0
43122,was,0,0
43123,quantified,0,0
43124,by,0,0
43125,measurement,0,0
43126,of,0,0
43127,the,0,0
43128,provocative,0,0
43129,dose,0,0
43130,of,0,0
43131,methacholine,1,0
43132,causing,0,0
43133,a,0,0
43134,20,0,0
43135,%,0,0
43136,fall,0,0
43137,in,0,0
43138,forced,0,0
43139,expiratory,0,0
43140,volume,0,0
43141,in,0,0
43142,one,0,0
43143,second,0,0
43144,(,0,0
43145,PD20,0,1
43146,),0,0
43147,.,0,0
43148,Median,0,0
43149,(,0,0
43150,interquartile,0,0
43151,range,0,0
43152,),0,0
43153,PD20,0,1
43154,in,0,0
43155,the,0,0
43156,three,0,0
43157,groups,0,0
43158,before,0,0
43159,and,0,0
43160,after,0,0
43161,treatment,0,0
43162,with,0,0
43163,clarithromycin,1,1
43164,were,0,0
43165,:,0,0
43166,arm,0,0
43167,A,0,0
43168,:,0,0
43169,0.3,0,0
43170,(,0,0
43171,0.1-1,0,0
43172,),0,0
43173,and,0,0
43174,1.3,0,0
43175,(,0,0
43176,0.6-2,0,0
43177,),0,1
43178,mg,0,1
43179,;,0,0
43180,arm,0,0
43181,B,0,0
43182,:,0,0
43183,0.4,0,0
43184,(,0,0
43185,0.1-0.9,0,0
43186,),0,0
43187,and,0,0
43188,2,0,0
43189,(,0,0
43190,2-2,0,0
43191,),0,0
43192,mg,0,1
43193,;,0,0
43194,and,0,0
43195,arm,0,0
43196,C,0,0
43197,:,0,0
43198,0.4,0,0
43199,(,0,0
43200,0.1-0.9,0,0
43201,),0,0
43202,and,0,0
43203,0.3,0,0
43204,(,0,0
43205,0.1-0.6,0,0
43206,),0,1
43207,mg,0,1
43208,",",0,0
43209,respectively,0,0
43210,.,0,0
43211,Serum,0,0
43212,free,0,0
43213,cortisol,0,0
43214,levels,0,0
43215,were,0,0
43216,determined,0,0
43217,and,0,0
43218,remained,0,0
43219,unchanged,0,0
43220,from,0,0
43221,baseline,0,0
43222,in,0,0
43223,the,0,0
43224,clarithromycin-treated,1,0
43225,patients,0,0
43226,.,0,0
43227,It,0,0
43228,is,0,0
43229,concluded,0,0
43230,that,0,0
43231,clarithromycin,1,1
43232,reduces,0,0
43233,the,0,0
43234,degree,0,0
43235,of,0,0
43236,bronchial,0,0
43237,hyperresponsiveness,0,0
43238,in,0,0
43239,patients,0,0
43240,with,0,0
43241,asthma,0,0
43242,.,0,0
43243,[,0,0
43244,Cardiac,0,0
43245,protection,0,0
43246,is,0,0
43247,a,0,0
43248,clinical,0,0
43249,evidence,0,0
43250,],0,0
43251,.,0,0
43252,AIM,0,0
43253,Anaesthetics,0,1
43254,may,0,0
43255,have,0,0
43256,protective,0,0
43257,effect,0,0
43258,against,0,0
43259,myocardial,0,0
43260,ischemia,0,0
43261,.,0,0
43262,We,0,0
43263,aimed,0,0
43264,to,0,0
43265,investigate,0,0
43266,if,0,0
43267,sevoflurane,0,1
43268,administration,0,0
43269,could,0,0
43270,exert,0,0
43271,myocardial,0,0
43272,protection,0,0
43273,during,0,0
43274,following,0,0
43275,coronary,0,0
43276,occlusion,0,0
43277,in,0,0
43278,patients,0,0
43279,with,0,0
43280,coronary,0,0
43281,artery,0,0
43282,disease,0,0
43283,.,0,0
43284,METHODS,0,0
43285,a,0,0
43286,),0,0
43287,.,0,0
43288,EXPERIMENTAL,0,0
43289,DESIGN,0,0
43290,prospective,0,0
43291,",",0,0
43292,randomized,0,0
43293,study,0,0
43294,.,0,0
43295,b,0,0
43296,),0,0
43297,.,0,0
43298,SETTING,0,0
43299,University,0,0
43300,Hospital,0,0
43301,",",0,0
43302,cardiac,0,0
43303,surgical,0,0
43304,operative,0,0
43305,theatre,0,1
43306,.,0,0
43307,c,0,0
43308,),0,0
43309,.,0,0
43310,PATIENTS,0,0
43311,42,0,0
43312,patients,0,0
43313,with,0,0
43314,coronary,0,0
43315,artery,0,0
43316,disease,0,0
43317,",",0,0
43318,scheduled,0,0
43319,to,0,0
43320,undergo,0,0
43321,coronary,0,0
43322,surgery,0,0
43323,.,0,0
43324,INCLUSION,0,0
43325,CRITERIA,0,0
43326,severe,0,0
43327,coronary,0,0
43328,stenosis,0,0
43329,of,0,0
43330,anterior,0,0
43331,descending,0,0
43332,coronary,0,0
43333,artery,0,0
43334,;,0,0
43335,no,0,0
43336,collateral,0,0
43337,flow,0,0
43338,on,0,0
43339,angiography,0,1
43340,;,0,0
43341,at,0,0
43342,least,0,0
43343,two,0,0
43344,normokinetic,0,0
43345,segments,0,0
43346,in,0,0
43347,the,0,0
43348,myocardial,0,0
43349,region,0,0
43350,supplied,0,0
43351,by,0,0
43352,the,0,0
43353,vessel,0,0
43354,being,0,0
43355,bypassed,0,0
43356,.,0,0
43357,PATIENTS,0,0
43358,were,0,0
43359,randomized,0,0
43360,to,1,0
43361,receive,1,1
43362,(,1,0
43363,group,1,0
43364,S,1,1
43365,),1,0
43366,or,1,1
43367,not,1,0
43368,(,1,0
43369,group,1,0
43370,C,1,1
43371,),1,0
43372,sevoflurane,1,1
43373,administration,0,0
43374,for,0,0
43375,15,0,0
43376,min,0,0
43377,just,0,0
43378,before,0,0
43379,coronary,0,0
43380,occlusion,0,0
43381,.,0,0
43382,d,0,0
43383,),0,0
43384,.,0,0
43385,INTERVENTIONS,0,0
43386,Transoesophageal,1,0
43387,Tissue,1,0
43388,Doppler,1,1
43389,echocardiographic,1,0
43390,examination,1,0
43391,of,1,0
43392,myocardial,1,0
43393,systolic,1,0
43394,and,1,0
43395,early,1,0
43396,diastolic,1,0
43397,velocities,1,0
43398,in,1,0
43399,both,1,0
43400,groups,1,0
43401,basally,1,0
43402,and,1,0
43403,60,1,0
43404,s,1,0
43405,after,1,0
43406,coronary,1,0
43407,occlusion,1,0
43408,by,1,0
43409,the,1,0
43410,surgeon,1,0
43411,.,1,0
43412,e,0,0
43413,),0,0
43414,.,0,0
43415,MEASURES,0,0
43416,systolic,0,0
43417,and,0,0
43418,early,0,0
43419,diastolic,0,0
43420,velocities,0,0
43421,were,0,0
43422,registered,0,0
43423,by,0,0
43424,Tissue,0,0
43425,Doppler,0,0
43426,from,0,0
43427,a,0,0
43428,long-axis,0,0
43429,view,0,0
43430,of,0,0
43431,the,0,0
43432,interventricular,0,0
43433,septum,0,1
43434,or,0,1
43435,the,0,0
43436,anterior,0,0
43437,wall,0,0
43438,of,0,0
43439,the,0,0
43440,left,0,0
43441,ventricle,0,0
43442,.,0,0
43443,RESULTS,0,0
43444,In,0,0
43445,group,0,0
43446,C,0,0
43447,a,0,0
43448,significant,0,0
43449,reduction,0,0
43450,of,0,0
43451,systolic,0,0
43452,and,0,0
43453,diastolic,0,0
43454,intramyocardial,0,1
43455,velocities,0,0
43456,was,0,0
43457,found,0,0
43458,during,0,0
43459,myocardial,0,0
43460,ischemia,0,0
43461,due,0,0
43462,to,0,0
43463,coronary,0,0
43464,occlusion,0,0
43465,.,0,0
43466,CONCLUSION,0,0
43467,Treatment,0,0
43468,with,0,0
43469,sevoflurane,0,1
43470,before,0,0
43471,coronary,0,0
43472,occlusion,0,0
43473,seem,0,0
43474,effective,0,0
43475,in,0,0
43476,reducing,0,0
43477,functional,0,0
43478,myocardial,0,0
43479,impairment,0,0
43480,due,0,0
43481,to,0,0
43482,ischemia,0,0
43483,.,0,0
43484,Untreated,0,0
43485,silicone,0,1
43486,breast,0,0
43487,implant,0,1
43488,rupture,0,0
43489,.,0,0
43490,Implant,0,0
43491,rupture,0,0
43492,is,0,0
43493,a,0,0
43494,well-known,0,0
43495,complication,0,0
43496,of,0,0
43497,breast,0,0
43498,implant,0,1
43499,surgery,0,0
43500,that,0,0
43501,can,0,0
43502,pass,0,0
43503,unnoticed,0,0
43504,by,0,0
43505,both,0,0
43506,patient,0,0
43507,and,0,0
43508,physician,0,0
43509,.,0,0
43510,To,0,0
43511,date,0,0
43512,",",0,0
43513,no,0,0
43514,prospective,0,0
43515,study,0,0
43516,has,0,0
43517,addressed,0,0
43518,the,0,0
43519,possible,0,0
43520,health,0,0
43521,implications,0,0
43522,of,0,0
43523,silicone,0,1
43524,breast,0,0
43525,implant,0,1
43526,rupture,0,0
43527,.,0,0
43528,The,0,0
43529,aim,0,0
43530,of,0,0
43531,the,0,0
43532,present,0,0
43533,study,0,0
43534,was,0,0
43535,to,0,0
43536,evaluate,0,0
43537,whether,0,0
43538,untreated,0,0
43539,ruptures,0,0
43540,are,0,0
43541,associated,0,0
43542,with,0,0
43543,changes,0,0
43544,over,0,0
43545,time,0,0
43546,in,0,0
43547,magnetic,0,1
43548,resonance,0,1
43549,imaging,0,0
43550,findings,0,0
43551,",",0,0
43552,serologic,0,0
43553,markers,0,0
43554,",",0,0
43555,or,0,0
43556,self-reported,0,0
43557,breast,0,0
43558,symptoms,0,0
43559,.,0,0
43560,A,0,0
43561,baseline,0,0
43562,magnetic,0,1
43563,resonance,0,1
43564,imaging,0,1
43565,examination,0,0
43566,was,0,0
43567,performed,0,0
43568,in,0,0
43569,1999,0,0
43570,on,0,0
43571,271,0,0
43572,women,0,0
43573,who,0,0
43574,were,0,0
43575,randomly,0,0
43576,chosen,0,0
43577,from,0,0
43578,a,0,0
43579,larger,0,0
43580,cohort,0,0
43581,of,0,0
43582,women,0,0
43583,having,0,0
43584,cosmetic,0,0
43585,breast,0,0
43586,implants,0,1
43587,for,0,0
43588,a,0,0
43589,median,0,0
43590,period,0,0
43591,of,0,0
43592,12,0,0
43593,years,0,0
43594,(,0,0
43595,range,0,0
43596,",",0,0
43597,3,0,0
43598,to,0,0
43599,25,0,0
43600,years,0,0
43601,),0,0
43602,.,0,0
43603,A,0,0
43604,follow-up,0,0
43605,magnetic,0,1
43606,resonance,0,1
43607,imaging,0,1
43608,examination,0,0
43609,was,0,0
43610,carried,0,0
43611,out,0,0
43612,in,0,0
43613,2001,0,0
43614,",",0,0
43615,excluding,0,0
43616,women,0,0
43617,who,0,0
43618,underwent,0,0
43619,explantation,0,0
43620,in,0,0
43621,the,0,0
43622,period,0,0
43623,between,0,0
43624,the,0,0
43625,two,0,0
43626,magnetic,0,1
43627,resonance,0,1
43628,imaging,0,1
43629,examinations,0,1
43630,(,0,0
43631,n,0,0
43632,=,0,0
43633,44,0,0
43634,),0,0
43635,.,0,0
43636,On,0,0
43637,the,0,0
43638,basis,0,0
43639,of,0,0
43640,these,0,0
43641,examinations,0,0
43642,",",0,0
43643,the,0,0
43644,authors,0,0
43645,identified,0,0
43646,64,0,0
43647,women,0,0
43648,who,0,0
43649,had,0,0
43650,at,0,0
43651,least,0,0
43652,one,0,0
43653,ruptured,0,0
43654,implant,0,0
43655,at,0,0
43656,the,0,0
43657,first,0,0
43658,magnetic,0,1
43659,resonance,0,1
43660,imaging,0,1
43661,examination,0,0
43662,and,0,0
43663,",",0,0
43664,for,0,0
43665,comparison,0,0
43666,",",0,0
43667,all,0,0
43668,women,0,0
43669,who,0,0
43670,had,0,0
43671,intact,0,0
43672,implants,0,1
43673,at,0,0
43674,both,0,0
43675,examinations,0,0
43676,(,0,0
43677,n,0,0
43678,=,0,0
43679,98,0,0
43680,),0,0
43681,.,0,0
43682,Magnetic,0,0
43683,resonance,0,0
43684,images,0,0
43685,from,0,0
43686,the,0,0
43687,two,0,0
43688,examinations,0,0
43689,were,0,0
43690,compared,0,0
43691,and,0,0
43692,changes,0,0
43693,in,0,0
43694,rupture,0,0
43695,configuration,0,0
43696,were,0,0
43697,evaluated,0,0
43698,.,0,0
43699,Comparisons,0,0
43700,were,0,0
43701,also,0,0
43702,made,0,0
43703,for,0,0
43704,self-reported,0,0
43705,breast,0,0
43706,symptoms,0,0
43707,occurring,0,0
43708,during,0,0
43709,the,0,0
43710,study,0,0
43711,period,0,0
43712,and,0,0
43713,for,0,0
43714,changes,0,0
43715,in,0,0
43716,serum,0,0
43717,values,0,0
43718,of,0,0
43719,antinuclear,0,0
43720,antibodies,0,0
43721,",",0,0
43722,rheumatoid,0,0
43723,factor,0,0
43724,",",0,0
43725,and,0,0
43726,cardiolipin,0,0
43727,antibodies,0,0
43728,immunoglobulin,0,1
43729,G,0,0
43730,and,0,0
43731,immunoglobulin,0,1
43732,M.,0,0
43733,The,0,0
43734,majority,0,0
43735,of,0,0
43736,the,0,0
43737,women,0,0
43738,with,0,0
43739,implant,0,1
43740,rupture,0,0
43741,had,0,0
43742,no,0,0
43743,visible,0,0
43744,magnetic,0,1
43745,resonance,0,1
43746,imaging,0,0
43747,changes,0,0
43748,of,0,0
43749,their,0,0
43750,ruptured,0,0
43751,implants,0,1
43752,.,0,0
43753,For,0,0
43754,11,0,0
43755,implants,0,1
43756,(,0,0
43757,11,0,0
43758,percent,0,0
43759,),0,0
43760,in,0,0
43761,10,0,0
43762,women,0,0
43763,",",0,0
43764,the,0,0
43765,authors,0,0
43766,observed,0,0
43767,progression,0,0
43768,of,0,0
43769,silicone,0,1
43770,seepage,0,0
43771,",",0,0
43772,either,0,0
43773,as,0,0
43774,a,0,0
43775,conversion,0,0
43776,from,0,0
43777,intracapsular,0,1
43778,into,0,0
43779,extracapsular,0,1
43780,rupture,0,0
43781,(,0,0
43782,n,0,0
43783,=,0,0
43784,7,0,0
43785,),0,0
43786,",",0,0
43787,as,0,0
43788,progression,0,0
43789,of,0,0
43790,extra-capsular,0,0
43791,silicone,0,1
43792,(,0,0
43793,n,0,0
43794,=,0,0
43795,3,0,0
43796,),0,0
43797,",",0,0
43798,or,0,0
43799,as,0,0
43800,increasing,0,0
43801,herniation,0,0
43802,of,0,0
43803,the,0,0
43804,silicone,0,1
43805,within,0,0
43806,the,0,0
43807,fibrous,0,0
43808,capsule,0,1
43809,(,0,0
43810,n,0,0
43811,=,0,0
43812,1,0,0
43813,),0,0
43814,;,0,0
43815,however,0,0
43816,",",0,0
43817,in,0,0
43818,most,0,0
43819,cases,0,0
43820,",",0,0
43821,these,0,0
43822,changes,0,0
43823,were,0,0
43824,minor,0,0
43825,.,0,0
43826,Some,0,0
43827,changes,0,0
43828,could,0,0
43829,be,0,0
43830,ascribed,0,0
43831,to,0,0
43832,trauma,0,0
43833,",",0,0
43834,but,0,0
43835,others,0,0
43836,seemed,0,0
43837,spontaneous,0,0
43838,.,0,0
43839,There,0,0
43840,was,0,0
43841,no,0,0
43842,increase,0,0
43843,in,0,0
43844,levels,0,0
43845,of,0,0
43846,autoantibodies,0,0
43847,during,0,0
43848,the,0,0
43849,study,0,0
43850,period,0,0
43851,in,0,0
43852,either,0,0
43853,study,0,0
43854,group,0,0
43855,.,0,0
43856,Women,0,0
43857,with,0,0
43858,untreated,0,0
43859,implant,1,1
43860,ruptures,1,0
43861,reported,0,0
43862,a,0,0
43863,significant,0,0
43864,increase,0,0
43865,in,0,0
43866,nonspecific,0,0
43867,breast,0,0
43868,changes,0,0
43869,(,0,0
43870,odds,0,0
43871,ratio,0,0
43872,",",0,0
43873,2.1,0,0
43874,;,0,0
43875,95,0,0
43876,percent,0,0
43877,confidence,0,0
43878,interval,0,0
43879,",",0,0
43880,1.2,0,0
43881,to,0,0
43882,3.8,0,0
43883,),0,0
43884,compared,0,0
43885,with,0,0
43886,women,0,0
43887,without,0,0
43888,ruptures,0,0
43889,.,0,0
43890,On,0,0
43891,the,0,0
43892,basis,0,0
43893,of,0,0
43894,this,0,0
43895,first,0,0
43896,study,0,0
43897,of,0,0
43898,women,0,0
43899,with,0,0
43900,untreated,0,0
43901,silicone,0,1
43902,breast,0,0
43903,implant,0,1
43904,rupture,0,0
43905,",",0,0
43906,the,0,0
43907,authors,0,0
43908,conclude,0,0
43909,that,0,0
43910,implant,0,1
43911,rupture,0,0
43912,is,0,0
43913,a,0,0
43914,relatively,0,0
43915,harmless,0,0
43916,condition,0,0
43917,",",0,0
43918,which,0,0
43919,only,0,0
43920,rarely,0,0
43921,progresses,0,0
43922,and,0,0
43923,gives,0,0
43924,rise,0,0
43925,to,0,0
43926,notable,0,0
43927,symptoms,0,0
43928,.,0,0
43929,Even,0,0
43930,so,0,0
43931,",",0,0
43932,because,0,0
43933,of,0,0
43934,a,0,0
43935,small,0,0
43936,risk,0,0
43937,of,0,0
43938,silicone,0,1
43939,spread,0,0
43940,",",0,0
43941,the,0,0
43942,authors,0,0
43943,suggest,0,0
43944,that,0,0
43945,women,0,0
43946,with,0,0
43947,implant,0,0
43948,ruptures,0,0
43949,be,0,0
43950,followed,0,0
43951,clinically,0,0
43952,",",0,0
43953,if,0,0
43954,not,0,0
43955,operated,0,0
43956,on,0,0
43957,.,0,0
43958,Because,0,0
43959,implant,0,0
43960,ruptures,0,0
43961,often,0,0
43962,occur,0,0
43963,asymptomatically,0,0
43964,",",0,0
43965,any,0,0
43966,woman,0,0
43967,with,0,0
43968,silicone,0,1
43969,implants,0,1
43970,",",0,0
43971,regardless,0,0
43972,of,0,0
43973,rupture,0,0
43974,status,0,0
43975,",",0,0
43976,should,0,0
43977,be,0,0
43978,evaluated,0,0
43979,at,0,0
43980,regular,0,0
43981,intervals,0,0
43982,.,0,0
43983,Evaluation,0,0
43984,of,0,0
43985,an,0,0
43986,aquatics,1,0
43987,programme,1,1
43988,on,0,0
43989,fitness,0,0
43990,parameters,0,0
43991,of,0,0
43992,individuals,0,0
43993,with,0,0
43994,a,0,0
43995,brain,0,0
43996,injury,0,0
43997,.,0,0
43998,The,0,0
43999,primary,0,0
44000,objective,0,0
44001,was,0,0
44002,to,0,0
44003,determine,0,0
44004,the,0,0
44005,effect,0,0
44006,of,0,0
44007,an,0,0
44008,aquatic,1,0
44009,exercise,1,1
44010,programme,1,1
44011,on,0,0
44012,the,0,0
44013,physical,0,0
44014,fitness,0,0
44015,of,0,0
44016,people,0,0
44017,with,0,0
44018,a,0,0
44019,brain,0,0
44020,injury,0,0
44021,.,0,0
44022,A,0,0
44023,pre-test-post-test,0,0
44024,randomized-groups,0,0
44025,design,0,0
44026,was,0,0
44027,conducted,0,0
44028,.,0,0
44029,Sixteen,0,0
44030,outpatients,0,0
44031,with,0,0
44032,a,0,0
44033,brain,0,0
44034,injury,0,0
44035,were,0,0
44036,included,0,0
44037,in,0,0
44038,the,0,0
44039,study,0,0
44040,.,0,0
44041,Eight,0,0
44042,participants,0,0
44043,were,0,0
44044,assigned,0,0
44045,to,0,0
44046,an,0,0
44047,aquatic,1,0
44048,exercise,1,1
44049,group,1,0
44050,and,1,0
44051,eight,1,0
44052,to,1,0
44053,a,1,0
44054,control,1,0
44055,group,1,0
44056,.,1,0
44057,The,0,0
44058,components,0,0
44059,of,0,0
44060,physical,0,0
44061,fitness,0,0
44062,measured,0,0
44063,included,0,0
44064,cardiovascular,0,0
44065,endurance,0,0
44066,",",0,0
44067,body,0,0
44068,composition,0,0
44069,",",0,0
44070,muscular,0,0
44071,strength,0,0
44072,and,0,0
44073,endurance,0,1
44074,and,0,0
44075,flexibility,0,0
44076,.,0,0
44077,Measurements,0,0
44078,were,0,0
44079,taken,0,0
44080,pre-,0,0
44081,and,0,0
44082,post-programme,0,1
44083,.,0,0
44084,Results,0,0
44085,indicated,0,0
44086,an,0,0
44087,increase,0,0
44088,in,0,0
44089,components,0,0
44090,of,0,0
44091,physical,0,0
44092,fitness,0,0
44093,for,0,0
44094,the,0,0
44095,experimental,0,0
44096,group,0,0
44097,but,0,0
44098,not,0,0
44099,the,0,0
44100,control,0,0
44101,group,0,0
44102,.,0,0
44103,Increases,0,0
44104,in,0,0
44105,fitness,0,0
44106,were,0,0
44107,reported,0,0
44108,as,0,0
44109,having,0,0
44110,a,0,0
44111,positive,0,0
44112,impact,0,0
44113,on,0,0
44114,the,0,0
44115,functional,0,0
44116,capacity,0,0
44117,of,0,0
44118,individuals,0,0
44119,in,0,0
44120,the,0,0
44121,exercise,0,1
44122,group,0,0
44123,as,0,0
44124,well,0,0
44125,as,0,0
44126,enhancing,0,0
44127,the,0,0
44128,individual,0,0
44129,'s,0,0
44130,ability,0,0
44131,to,0,0
44132,complete,0,0
44133,activities,0,0
44134,of,0,0
44135,daily,0,0
44136,living,0,0
44137,successfully,0,0
44138,.,0,0
44139,Results,0,0
44140,indicate,0,0
44141,that,0,0
44142,aquatic,0,0
44143,exercise,0,1
44144,may,0,0
44145,positively,0,0
44146,impact,0,0
44147,the,0,0
44148,primary,0,0
44149,and,0,0
44150,secondary,0,0
44151,physical,0,0
44152,injuries,0,0
44153,caused,0,0
44154,by,0,0
44155,a,0,0
44156,brain,0,0
44157,injury,0,0
44158,.,0,0
44159,Registration,0,0
44160,accuracy,0,0
44161,of,0,0
44162,153Gd,0,0
44163,transmission,0,0
44164,images,0,0
44165,of,0,0
44166,the,0,0
44167,brain,0,0
44168,.,0,0
44169,PURPOSE,0,0
44170,The,0,0
44171,aim,0,0
44172,of,0,0
44173,the,0,0
44174,study,0,0
44175,was,0,0
44176,to,0,0
44177,determine,0,0
44178,the,0,0
44179,accuracy,0,0
44180,of,0,0
44181,non-rigid,0,0
44182,nine-parameter,0,1
44183,image,0,1
44184,registrations,0,0
44185,based,0,0
44186,on,0,0
44187,153Gd,1,0
44188,transmission,1,0
44189,computed,1,1
44190,tomography,1,1
44191,(,0,0
44192,TCT,0,0
44193,),0,1
44194,images,0,0
44195,as,0,0
44196,compared,0,0
44197,with,0,0
44198,those,0,0
44199,based,0,0
44200,on,0,0
44201,99mTc-ethyl,1,1
44202,cysteinate,1,1
44203,dimer,1,0
44204,(,1,0
44205,ECD,1,1
44206,),1,0
44207,images,1,0
44208,and,0,0
44209,to,0,0
44210,assess,0,0
44211,whether,0,0
44212,normalised,0,0
44213,mutual,0,0
44214,information,0,0
44215,(,0,0
44216,NMI,0,1
44217,),0,1
44218,or,0,1
44219,count,0,0
44220,difference,0,0
44221,(,0,0
44222,CD,0,0
44223,),0,0
44224,should,0,0
44225,be,0,0
44226,used,0,0
44227,.,0,0
44228,METHODS,0,0
44229,TCT,0,0
44230,and,0,0
44231,ECD,0,1
44232,data,0,0
44233,were,0,0
44234,acquired,0,0
44235,in,0,0
44236,25,0,0
44237,randomly,0,0
44238,selected,0,0
44239,patients,0,0
44240,.,0,0
44241,Emission,0,0
44242,images,0,0
44243,were,0,0
44244,registered,0,0
44245,to,0,0
44246,an,0,0
44247,ECD,1,1
44248,template,0,0
44249,with,0,0
44250,a,0,0
44251,CD,0,0
44252,cost,0,0
44253,function,0,0
44254,.,0,0
44255,The,0,0
44256,same,0,0
44257,registration,0,0
44258,parameters,0,0
44259,were,0,0
44260,applied,0,0
44261,to,0,0
44262,the,0,0
44263,transmission,0,0
44264,images,0,0
44265,to,0,0
44266,create,0,0
44267,a,0,0
44268,TCT,0,0
44269,template,0,0
44270,.,0,0
44271,All,0,0
44272,TCT,0,0
44273,images,0,0
44274,were,0,0
44275,registered,0,0
44276,to,0,0
44277,the,0,0
44278,TCT,1,0
44279,template,0,0
44280,and,0,0
44281,the,0,0
44282,same,0,0
44283,registration,0,0
44284,parameters,0,0
44285,were,0,0
44286,applied,0,0
44287,to,0,0
44288,the,0,0
44289,ECD,1,0
44290,images,0,0
44291,.,0,0
44292,The,0,0
44293,procedure,0,0
44294,was,0,0
44295,repeated,0,0
44296,with,0,0
44297,NMI,0,0
44298,as,0,0
44299,cost,0,0
44300,function,0,0
44301,.,0,0
44302,Accuracy,0,0
44303,of,0,0
44304,both,0,0
44305,ECD-based,1,1
44306,and,0,0
44307,TCT-based,1,1
44308,registrations,0,0
44309,was,0,0
44310,assessed,0,0
44311,by,0,0
44312,comparing,0,0
44313,the,0,0
44314,normalisation,0,0
44315,parameter,0,0
44316,values,0,0
44317,and,0,0
44318,regional,0,0
44319,activities,0,0
44320,in,0,0
44321,the,0,0
44322,spatially,0,0
44323,normalised,0,0
44324,ECD,0,1
44325,images,0,0
44326,",",0,0
44327,using,0,0
44328,a,0,0
44329,mixed-model,0,1
44330,analysis,0,0
44331,of,0,0
44332,variance,0,0
44333,(,0,0
44334,ANOVA,0,1
44335,),0,0
44336,.,0,0
44337,Scheffe,0,0
44338,post,0,0
44339,hoc,0,0
44340,tests,0,0
44341,were,0,0
44342,performed,0,0
44343,.,0,0
44344,RESULTS,0,0
44345,No,0,0
44346,significant,0,0
44347,differences,0,0
44348,were,0,0
44349,found,0,0
44350,between,0,0
44351,ECD/CD,1,0
44352,",",1,0
44353,ECD/NMI,1,0
44354,and,0,0
44355,TCT/CD,1,0
44356,",",0,0
44357,suggesting,0,0
44358,that,0,0
44359,ECD,0,1
44360,registration,0,0
44361,can,0,0
44362,be,0,0
44363,done,0,0
44364,with,0,0
44365,either,0,0
44366,CD,0,0
44367,or,0,0
44368,NMI,0,0
44369,",",0,0
44370,and,0,0
44371,that,0,0
44372,TCT,0,0
44373,registration,0,0
44374,using,0,0
44375,CD,0,1
44376,is,0,0
44377,equally,0,0
44378,as,0,0
44379,accurate,0,0
44380,as,0,0
44381,ECD,0,1
44382,registration,0,0
44383,.,0,0
44384,The,0,0
44385,accuracy,0,0
44386,of,0,0
44387,TCT,0,0
44388,registration,0,0
44389,with,0,0
44390,NMI,0,0
44391,was,0,0
44392,lower,0,0
44393,",",0,0
44394,with,0,0
44395,discrepancies,0,0
44396,occurring,0,0
44397,in,0,0
44398,the,0,0
44399,frontal,0,0
44400,inferior,0,0
44401,region,0,0
44402,and,0,0
44403,the,0,0
44404,cerebellum,0,0
44405,.,0,0
44406,The,0,0
44407,analysis,0,0
44408,of,0,0
44409,normalisation,0,0
44410,parameters,0,0
44411,indicated,0,0
44412,that,0,0
44413,z-scaling,0,0
44414,is,0,0
44415,underestimated,0,0
44416,and,0,0
44417,yz-rotation,0,1
44418,overestimated,0,0
44419,with,0,0
44420,TCT/NMI,0,0
44421,registration,0,0
44422,.,0,0
44423,CONCLUSION,0,0
44424,We,0,0
44425,conclude,0,0
44426,that,0,0
44427,ECD,1,1
44428,registrations,0,0
44429,with,0,0
44430,CD,1,0
44431,or,0,1
44432,NMI,1,0
44433,are,0,0
44434,as,0,0
44435,accurate,0,0
44436,as,0,0
44437,TCT,1,0
44438,registrations,0,0
44439,with,0,0
44440,CD,0,0
44441,and,0,0
44442,that,0,0
44443,TCT,1,0
44444,registrations,0,0
44445,with,0,0
44446,NMI,0,0
44447,should,0,0
44448,be,0,0
44449,avoided,0,0
44450,.,0,0
44451,Long-term,0,0
44452,quality,0,0
44453,of,0,0
44454,life,0,0
44455,measures,0,0
44456,after,0,0
44457,functional,0,0
44458,endoscopic,0,1
44459,sinus,0,0
44460,surgery,0,0
44461,.,0,0
44462,BACKGROUND,0,0
44463,Chronic,0,0
44464,rhinosinusitis,0,0
44465,(,0,0
44466,CRS,0,1
44467,),0,1
44468,is,0,0
44469,a,0,0
44470,common,0,0
44471,disease,0,0
44472,that,0,0
44473,has,0,0
44474,a,0,0
44475,significant,0,0
44476,impact,0,0
44477,on,0,0
44478,quality,0,0
44479,of,0,0
44480,life,0,0
44481,(,0,0
44482,QOL,0,0
44483,),0,0
44484,.,0,0
44485,The,0,0
44486,aim,0,0
44487,of,0,0
44488,this,0,0
44489,study,0,0
44490,was,0,0
44491,to,0,0
44492,evaluate,0,0
44493,the,0,0
44494,longer-term,0,0
44495,effects,0,0
44496,of,0,0
44497,combined,0,0
44498,medical,0,0
44499,and,0,0
44500,surgical,1,0
44501,therapy,1,1
44502,for,1,0
44503,CRS,1,1
44504,on,0,0
44505,overall,0,0
44506,health,0,0
44507,status,0,0
44508,and,0,0
44509,QOL,0,0
44510,.,0,0
44511,METHODS,0,0
44512,We,0,0
44513,used,0,0
44514,a,0,0
44515,prospective,0,0
44516,study,0,0
44517,that,0,0
44518,utilized,0,0
44519,the,0,0
44520,Short-Form,1,0
44521,36,1,0
44522,Survey,1,0
44523,at,0,0
44524,baseline,1,0
44525,presentation,1,0
44526,and,0,0
44527,at,0,0
44528,a,0,0
44529,mean,1,0
44530,time,1,0
44531,of,1,0
44532,3,1,0
44533,years,1,0
44534,post-functional,1,0
44535,endoscopic,1,1
44536,sinus,1,0
44537,surgery,1,0
44538,to,0,0
44539,assess,0,0
44540,the,0,0
44541,general,0,0
44542,health,0,0
44543,status,0,0
44544,of,0,0
44545,patients,0,0
44546,who,0,0
44547,presented,0,0
44548,for,0,0
44549,their,0,0
44550,initial,0,0
44551,visitfrom,0,0
44552,1996,0,0
44553,to,0,0
44554,1998,0,0
44555,.,0,0
44556,Of,0,0
44557,the,0,0
44558,200,0,0
44559,randomly,0,0
44560,selected,0,0
44561,patients,0,0
44562,",",0,0
44563,150,0,0
44564,respondents,0,0
44565,completed,0,0
44566,follow-up,0,0
44567,surveys,0,0
44568,(,0,0
44569,a,0,0
44570,75,0,0
44571,%,0,0
44572,response,0,0
44573,rate,0,0
44574,),0,0
44575,.,0,0
44576,RESULTS,0,0
44577,Eighty-nine,0,0
44578,(,0,0
44579,59.3,0,0
44580,%,0,0
44581,),0,0
44582,women,0,0
44583,and,0,0
44584,61,0,0
44585,(,0,0
44586,40.7,0,0
44587,%,0,0
44588,),0,0
44589,men,0,0
44590,were,0,0
44591,included,0,0
44592,in,0,0
44593,the,0,0
44594,study,0,0
44595,.,0,0
44596,Baseline,0,0
44597,QOL,0,0
44598,scores,0,0
44599,indicated,0,0
44600,significant,0,0
44601,differences,0,0
44602,between,0,0
44603,patients,0,0
44604,with,0,0
44605,CRS,0,1
44606,and,0,0
44607,published,0,0
44608,norms,0,0
44609,in,0,0
44610,6/8,0,0
44611,subscale,0,0
44612,parameters,0,0
44613,(,0,0
44614,role,0,0
44615,physical,0,1
44616,",",0,0
44617,bodily,0,0
44618,pain,0,0
44619,",",0,0
44620,general,0,0
44621,health,0,0
44622,",",0,0
44623,social,0,0
44624,function,0,0
44625,",",0,0
44626,vitality,0,0
44627,",",0,0
44628,and,0,0
44629,mental,0,0
44630,health,0,0
44631,),0,0
44632,.,0,0
44633,Significant,0,0
44634,improvement,0,0
44635,in,0,0
44636,all,0,0
44637,six,0,0
44638,categories,0,0
44639,was,0,0
44640,maintained,0,0
44641,at,0,0
44642,the,0,0
44643,end,0,0
44644,of,0,0
44645,the,0,0
44646,study,0,0
44647,period,0,0
44648,(,0,0
44649,p,0,0
44650,<,0,0
44651,0.05,0,0
44652,),0,0
44653,with,0,0
44654,QOL,0,0
44655,scores,0,0
44656,within,0,0
44657,limits,0,0
44658,of,0,0
44659,published,0,0
44660,norms,0,0
44661,for,0,0
44662,the,0,0
44663,general,0,0
44664,population,0,0
44665,.,0,0
44666,CONCLUSION,0,0
44667,Our,0,0
44668,data,0,0
44669,indicate,0,0
44670,that,0,0
44671,functional,1,0
44672,endoscopic,1,1
44673,sinus,1,0
44674,surgery,1,0
44675,",",0,0
44676,combined,0,0
44677,with,0,0
44678,appropriate,0,0
44679,postoperative,0,0
44680,care,0,0
44681,",",0,0
44682,is,0,0
44683,effective,0,0
44684,at,0,0
44685,maintaining,0,0
44686,a,0,0
44687,significant,0,0
44688,improvement,0,0
44689,in,0,0
44690,the,0,0
44691,overall,0,0
44692,general,0,0
44693,health,0,0
44694,status,0,0
44695,of,0,0
44696,patients,0,0
44697,for,0,0
44698,at,0,0
44699,least,0,0
44700,3,0,0
44701,years,0,0
44702,after,0,0
44703,surgical,0,0
44704,intervention,0,1
44705,and,0,0
44706,that,0,0
44707,the,0,0
44708,overall,0,0
44709,scores,0,0
44710,return,0,0
44711,to,0,0
44712,a,0,0
44713,range,0,0
44714,of,0,0
44715,normative,0,0
44716,values,0,0
44717,for,0,0
44718,the,0,0
44719,general,0,0
44720,population,0,0
44721,.,0,0
44722,Rye,1,1
44723,bran,1,1
44724,bread,1,1
44725,intake,1,0
44726,elevates,0,0
44727,urinary,0,0
44728,excretion,0,0
44729,of,0,0
44730,ferulic,0,1
44731,acid,0,1
44732,in,0,0
44733,humans,0,0
44734,",",0,0
44735,but,0,0
44736,does,0,0
44737,not,0,0
44738,affect,0,0
44739,the,0,0
44740,susceptibility,0,0
44741,of,0,0
44742,LDL,0,0
44743,to,0,0
44744,oxidation,0,0
44745,ex,0,0
44746,vivo,0,0
44747,.,0,0
44748,BACKGROUND,0,0
44749,Rye,1,1
44750,bread,1,1
44751,contributes,0,0
44752,an,0,0
44753,important,0,0
44754,part,0,0
44755,of,0,0
44756,the,0,0
44757,whole,0,0
44758,grain,0,0
44759,intake,0,0
44760,in,0,0
44761,the,0,0
44762,Scandinavian,0,0
44763,diet,0,1
44764,.,0,0
44765,Ferulic,0,0
44766,acid,0,1
44767,is,0,0
44768,the,0,0
44769,major,0,0
44770,phenolic,0,1
44771,compound,0,1
44772,in,0,0
44773,rye,0,1
44774,bran,0,1
44775,and,0,0
44776,is,0,0
44777,an,0,0
44778,antioxidant,0,0
44779,in,0,0
44780,vitro,0,0
44781,and,0,0
44782,may,0,0
44783,",",0,0
44784,therefore,0,0
44785,",",0,0
44786,contribute,0,0
44787,to,0,0
44788,cardioprotective,0,0
44789,effects,0,0
44790,of,0,0
44791,whole,0,0
44792,grain,0,0
44793,consumption,0,0
44794,.,0,0
44795,AIM,0,0
44796,OF,0,0
44797,THE,0,1
44798,STUDY,0,0
44799,Firstly,0,0
44800,",",0,0
44801,to,0,0
44802,evaluate,0,0
44803,the,0,0
44804,bioavailability,0,0
44805,and,0,0
44806,potential,0,0
44807,antioxidative,0,0
44808,effects,0,0
44809,in,0,0
44810,humans,0,0
44811,of,0,0
44812,ferulic,0,1
44813,acid,0,1
44814,from,0,0
44815,rye,0,1
44816,.,0,0
44817,Secondly,0,0
44818,",",0,0
44819,to,0,0
44820,evaluate,0,0
44821,urine,0,0
44822,levels,0,0
44823,of,0,0
44824,ferulic,0,1
44825,acid,0,1
44826,as,0,0
44827,a,0,0
44828,possible,0,0
44829,biomarker,0,0
44830,of,0,0
44831,the,0,0
44832,ordinary,0,1
44833,dietary,0,0
44834,intake,0,0
44835,of,0,0
44836,ferulic,0,1
44837,acid,0,1
44838,.,0,0
44839,METHODS,0,0
44840,We,0,0
44841,determined,0,0
44842,the,0,0
44843,urinary,0,0
44844,excretion,0,0
44845,of,0,0
44846,ferulic,0,1
44847,acid,0,1
44848,in,0,0
44849,18,0,0
44850,postmenopausal,0,0
44851,women,0,0
44852,after,0,0
44853,a,0,0
44854,dietary,1,0
44855,intake,1,0
44856,of,1,0
44857,rye,1,1
44858,bran,1,1
44859,or,1,1
44860,an,1,0
44861,inert,1,1
44862,wheat,1,1
44863,bran,1,1
44864,(,1,0
44865,control,1,1
44866,),1,0
44867,in,0,0
44868,a,0,0
44869,crossover,0,0
44870,study,0,0
44871,(,0,0
44872,2,0,0
44873,x,0,0
44874,6,0,0
44875,weeks,0,0
44876,with,0,0
44877,4,0,0
44878,weeks,0,0
44879,washout,0,0
44880,),0,0
44881,.,0,0
44882,The,0,0
44883,potential,0,0
44884,antioxidative,0,0
44885,effect,0,0
44886,of,0,0
44887,the,0,0
44888,rye,0,1
44889,bran,0,1
44890,intervention,0,1
44891,was,0,0
44892,investigated,0,0
44893,by,0,0
44894,measuring,0,0
44895,low-density,0,0
44896,lipoprotein,0,0
44897,(,0,0
44898,LDL,0,0
44899,),0,0
44900,susceptibility,0,0
44901,to,0,0
44902,copper,0,0
44903,oxidation,0,0
44904,ex,0,0
44905,vivo,0,0
44906,.,0,0
44907,The,0,0
44908,subjects,0,0
44909,ingested,0,0
44910,rye,0,1
44911,bran,0,1
44912,enriched,0,1
44913,breads,0,1
44914,equivalent,0,0
44915,to,0,0
44916,approximately,0,0
44917,10.2,0,0
44918,mg,0,0
44919,ferulic,0,1
44920,acid,0,1
44921,per,0,0
44922,day,0,0
44923,.,0,0
44924,RESULTS,0,0
44925,The,0,0
44926,urinary,0,0
44927,excretion,0,0
44928,of,0,0
44929,ferulic,0,1
44930,acid,0,1
44931,averaged,0,0
44932,approximately,0,0
44933,4.8,0,0
44934,mg,0,0
44935,per,0,0
44936,day,0,0
44937,during,0,0
44938,intervention,0,1
44939,with,0,0
44940,rye,1,1
44941,bran,1,1
44942,breads,1,1
44943,and,0,0
44944,approximately,0,0
44945,1.9,0,0
44946,mg,0,0
44947,per,0,0
44948,day,0,0
44949,on,0,0
44950,the,0,0
44951,control,1,1
44952,breads,1,1
44953,(,0,0
44954,P,0,0
44955,=,0,0
44956,0.002,0,0
44957,),0,0
44958,.,0,0
44959,Rye,1,1
44960,bran,1,1
44961,intervention,1,1
44962,had,0,0
44963,no,0,0
44964,influence,0,0
44965,on,0,0
44966,lag,0,0
44967,time,0,0
44968,or,0,1
44969,propagation,0,0
44970,rate,0,0
44971,of,0,0
44972,the,0,0
44973,LDL,0,0
44974,oxidation,0,1
44975,ex,0,0
44976,vivo,0,0
44977,.,0,0
44978,CONCLUSIONS,0,0
44979,The,0,0
44980,present,0,0
44981,study,0,0
44982,demonstrated,0,0
44983,that,0,0
44984,ferulic,0,1
44985,acid,0,1
44986,from,0,0
44987,rye,0,1
44988,bran,0,1
44989,is,0,0
44990,bioavailable,0,0
44991,and,0,0
44992,that,0,0
44993,the,0,0
44994,urinary,0,0
44995,concentration,0,0
44996,of,0,0
44997,ferulic,0,1
44998,acid,0,1
44999,reflects,0,0
45000,the,0,0
45001,dietary,0,0
45002,intake,0,0
45003,of,0,0
45004,this,0,0
45005,hydroxycinnamic,0,1
45006,acid,0,1
45007,.,0,0
45008,Within,0,0
45009,the,0,0
45010,period,0,0
45011,of,0,0
45012,intervention,0,1
45013,",",0,0
45014,the,0,0
45015,elevated,0,0
45016,ferulic,0,1
45017,acid,0,1
45018,did,0,0
45019,not,0,0
45020,produce,0,0
45021,a,0,0
45022,measurable,0,0
45023,antioxidative,0,0
45024,effect,0,0
45025,on,0,0
45026,the,0,0
45027,subjects,0,0
45028,',0,0
45029,LDL,0,0
45030,.,0,0
45031,It,0,0
45032,is,0,0
45033,suggested,0,0
45034,that,0,0
45035,the,0,0
45036,determination,0,0
45037,of,0,0
45038,ferulic,0,1
45039,acid,0,1
45040,in,0,0
45041,urine,0,0
45042,is,0,0
45043,a,0,0
45044,useful,0,0
45045,biomarker,0,0
45046,to,0,0
45047,assess,0,0
45048,the,0,0
45049,intake,0,0
45050,of,0,0
45051,ferulic,0,1
45052,acid,0,1
45053,from,0,0
45054,a,0,0
45055,regular,0,1
45056,diet,0,1
45057,.,0,0
45058,Low-dose,1,1
45059,oral,1,1
45060,etoposide-based,1,1
45061,induction,0,0
45062,regimen,0,1
45063,for,0,0
45064,children,0,0
45065,with,0,0
45066,acute,0,0
45067,lymphoblastic,0,0
45068,leukemia,0,0
45069,in,0,0
45070,first,0,0
45071,bone,0,0
45072,marrow,0,0
45073,relapse,0,0
45074,.,0,0
45075,We,0,0
45076,evaluated,0,0
45077,the,0,0
45078,clinical,0,0
45079,response,0,0
45080,to,0,0
45081,low-dose,1,1
45082,etoposide,1,1
45083,in,0,0
45084,relapsed,0,0
45085,acute,0,0
45086,lymphoblastic,0,0
45087,leukemia,0,0
45088,(,0,0
45089,ALL,0,0
45090,),0,0
45091,.,0,0
45092,Of,0,0
45093,the,0,0
45094,45,0,0
45095,patients,0,0
45096,with,0,0
45097,ALL,0,0
45098,in,0,0
45099,first,0,0
45100,bone,0,0
45101,marrow,0,0
45102,relapse,0,0
45103,enrolled,0,0
45104,on,0,0
45105,the,0,0
45106,ALL,0,0
45107,R15,0,1
45108,protocol,0,0
45109,",",0,0
45110,44,0,0
45111,had,0,0
45112,received,0,0
45113,epipodophyllotoxins,1,1
45114,during,1,0
45115,frontline,1,0
45116,therapy,1,1
45117,.,1,0
45118,In,0,0
45119,the,0,0
45120,first,0,0
45121,week,0,0
45122,of,0,0
45123,remission,0,0
45124,induction,0,0
45125,therapy,0,1
45126,",",0,0
45127,patients,1,0
45128,received,1,0
45129,etoposide,1,1
45130,(,1,0
45131,50,1,0
45132,mg/m,1,1
45133,(,1,0
45134,2,1,0
45135,),1,0
45136,per,1,0
45137,day,1,0
45138,),1,0
45139,administered,1,0
45140,orally,1,1
45141,as,1,0
45142,a,1,0
45143,single,1,0
45144,agent,1,0
45145,once,1,1
45146,or,1,0
45147,twice,1,0
45148,daily,1,0
45149,.,1,0
45150,On,0,0
45151,Day,0,0
45152,8,0,0
45153,",",0,0
45154,patients,0,0
45155,started,0,0
45156,to,0,0
45157,receive,0,0
45158,dexamethasone,1,1
45159,",",1,0
45160,vincristine,1,1
45161,",",1,0
45162,and,1,0
45163,L-asparaginase,1,1
45164,.,1,0
45165,Etoposide,1,1
45166,was,1,0
45167,administered,1,0
45168,until,1,0
45169,Day,1,0
45170,22,1,0
45171,.,1,0
45172,Two,1,0
45173,courses,1,0
45174,of,1,0
45175,consolidation,1,0
45176,therapy,1,1
45177,were,1,0
45178,followed,1,0
45179,by,1,0
45180,continuation,1,0
45181,therapy,1,1
45182,or,1,1
45183,hematopoietic,1,1
45184,stem,1,1
45185,cell,1,0
45186,transplantation,1,0
45187,.,1,0
45188,After,0,0
45189,7,0,0
45190,days,0,0
45191,of,0,0
45192,single-agent,0,0
45193,etoposide,0,1
45194,treatment,0,0
45195,",",0,0
45196,peripheral,0,0
45197,blast,0,0
45198,cell,0,0
45199,counts,0,0
45200,(,0,0
45201,P=0.013,0,0
45202,),0,0
45203,and,0,0
45204,percentages,0,0
45205,of,0,0
45206,bone,0,0
45207,marrow,0,0
45208,blasts,0,0
45209,(,0,0
45210,P=0.016,0,0
45211,),0,0
45212,were,0,0
45213,significantly,0,0
45214,reduced,0,0
45215,.,0,0
45216,In,0,0
45217,all,0,0
45218,",",0,0
45219,38,0,0
45220,(,0,0
45221,84.4,0,0
45222,%,0,0
45223,),0,0
45224,attained,0,0
45225,second,0,0
45226,remission,0,0
45227,.,0,0
45228,Only,0,0
45229,time,0,0
45230,to,0,0
45231,relapse,0,0
45232,was,0,0
45233,significantly,0,0
45234,associated,0,0
45235,with,0,0
45236,outcome,0,0
45237,(,0,0
45238,P=0.025,0,0
45239,),0,0
45240,:,0,0
45241,the,0,0
45242,5-year,0,0
45243,event-free,0,0
45244,survival,0,0
45245,estimates,0,0
45246,(,0,0
45247,+/-se,0,0
45248,),0,0
45249,were,0,0
45250,52.0+/-9.6,0,0
45251,%,0,0
45252,for,0,0
45253,those,0,0
45254,with,0,0
45255,late,0,0
45256,relapse,0,0
45257,and,0,0
45258,20.0+/-8.0,0,0
45259,%,0,0
45260,for,0,0
45261,those,0,0
45262,with,0,0
45263,early,0,0
45264,relapse,0,0
45265,.,0,0
45266,We,0,0
45267,conclude,0,0
45268,that,0,0
45269,low-dose,1,1
45270,etoposide,1,1
45271,administered,0,0
45272,orally,0,1
45273,has,0,0
45274,a,0,0
45275,cytoreductive,0,0
45276,effect,0,0
45277,in,0,0
45278,relapsed,0,0
45279,ALL,0,0
45280,.,0,0
45281,Absorption,0,0
45282,of,0,0
45283,intramuscular,0,1
45284,phenobarbitone,0,1
45285,in,0,0
45286,children,0,0
45287,with,0,0
45288,severe,0,0
45289,falciparum,0,0
45290,malaria,0,1
45291,.,0,0
45292,The,0,0
45293,absorption,0,0
45294,of,0,0
45295,intramuscular,1,1
45296,phenobarbitone,1,1
45297,7,1,0
45298,mg.kg-1,1,0
45299,was,0,0
45300,studied,0,0
45301,in,0,0
45302,11,0,0
45303,Karen,0,0
45304,children,0,0
45305,aged,0,0
45306,between,0,0
45307,1.7,0,0
45308,and,0,0
45309,11,0,0
45310,y,0,0
45311,with,0,0
45312,severe,0,0
45313,falciparum,0,0
45314,malaria,0,1
45315,.,0,0
45316,Eight,0,0
45317,of,0,0
45318,the,0,0
45319,children,0,0
45320,were,0,0
45321,comatose,0,0
45322,.,0,0
45323,Clinical,0,0
45324,findings,0,0
45325,were,0,0
45326,compared,0,0
45327,with,0,0
45328,those,0,0
45329,in,0,0
45330,9,0,0
45331,further,0,0
45332,children,0,0
45333,with,0,0
45334,severe,0,0
45335,malaria,0,1
45336,of,0,0
45337,similar,0,0
45338,age,0,0
45339,range,0,0
45340,(,0,0
45341,four,0,0
45342,of,0,0
45343,whom,0,0
45344,were,0,0
45345,unconscious,0,0
45346,),0,0
45347,",",0,0
45348,who,0,0
45349,received,0,0
45350,an,0,0
45351,identical,1,0
45352,placebo,1,1
45353,.,1,0
45354,One,0,0
45355,child,0,0
45356,",",0,0
45357,who,0,0
45358,had,0,0
45359,received,0,0
45360,placebo,0,1
45361,",",0,0
45362,had,0,0
45363,repeated,0,0
45364,convulsions,0,0
45365,and,0,0
45366,died,0,0
45367,1,0,0
45368,h,0,0
45369,after,0,0
45370,admission,0,0
45371,to,0,0
45372,hospital,0,0
45373,.,0,0
45374,The,0,0
45375,remainder,0,0
45376,made,0,0
45377,an,0,0
45378,uncomplicated,0,0
45379,recovery,0,0
45380,.,0,0
45381,There,0,0
45382,were,0,0
45383,no,0,0
45384,convulsions,0,0
45385,subsequent,0,0
45386,to,0,0
45387,treatment,0,0
45388,",",0,0
45389,although,0,0
45390,the,0,0
45391,study,0,0
45392,was,0,0
45393,too,0,0
45394,small,0,0
45395,to,0,0
45396,assess,0,0
45397,anticonvulsant,0,1
45398,efficacy,0,0
45399,.,0,0
45400,There,0,0
45401,was,0,0
45402,no,0,0
45403,observable,0,0
45404,toxicity,0,0
45405,",",0,0
45406,but,0,0
45407,phenobarbitone,0,1
45408,recipients,0,0
45409,had,0,0
45410,a,0,0
45411,significant,0,0
45412,tendency,0,0
45413,to,0,0
45414,deepen,0,0
45415,in,0,0
45416,their,0,0
45417,level,0,0
45418,of,0,0
45419,coma,0,0
45420,or,0,0
45421,to,0,0
45422,become,0,0
45423,sleepy,0,0
45424,within,0,0
45425,the,0,0
45426,4,0,0
45427,h,0,0
45428,after,0,0
45429,drug,0,0
45430,administration,0,0
45431,.,0,0
45432,Phenobarbitone,0,1
45433,was,0,0
45434,rapidly,0,0
45435,absorbed,0,0
45436,",",0,0
45437,reaching,0,0
45438,a,0,0
45439,mean,0,0
45440,(,0,0
45441,range,0,0
45442,),0,1
45443,peak,0,0
45444,concentration,0,0
45445,of,0,0
45446,34.2,0,0
45447,[,0,0
45448,29.3-42.6,0,0
45449,],0,0
45450,mumol.l-1,0,0
45451,in,0,0
45452,a,0,0
45453,median,0,0
45454,(,0,0
45455,range,0,0
45456,),0,0
45457,of,0,0
45458,4,0,0
45459,(,0,0
45460,2.5-12,0,0
45461,),0,0
45462,h.,0,0
45463,These,0,0
45464,values,0,0
45465,are,0,0
45466,comparable,0,0
45467,to,0,0
45468,those,0,0
45469,previously,0,0
45470,reported,0,0
45471,in,0,0
45472,healthy,0,0
45473,children,0,0
45474,and,0,0
45475,in,0,0
45476,children,0,0
45477,with,0,0
45478,febrile,0,0
45479,convulsions,0,0
45480,.,0,0
45481,Intramuscular,0,1
45482,phenobarbitone,0,1
45483,is,0,0
45484,well,0,0
45485,absorbed,0,0
45486,in,0,0
45487,children,0,0
45488,with,0,0
45489,severe,0,0
45490,malaria,0,0
45491,;,0,0
45492,the,0,0
45493,optimum,0,0
45494,prophylactic,0,1
45495,anticonvulsant,0,1
45496,dose,0,0
45497,remains,0,0
45498,to,0,0
45499,be,0,0
45500,determined,0,0
45501,.,0,0
45502,Faulty,0,0
45503,Japanese,0,0
45504,sentences,0,0
45505,are,0,0
45506,judged,0,0
45507,more,0,0
45508,grammatical,1,0
45509,when,0,0
45510,punctuation,0,0
45511,is,0,0
45512,used,0,0
45513,:,0,0
45514,negative,0,0
45515,implications,0,0
45516,for,0,0
45517,Chomsky,1,0
45518,'s,1,0
45519,principle,1,0
45520,of,1,0
45521,Full,1,0
45522,Interpretation,1,0
45523,.,1,0
45524,88,0,0
45525,adult,0,0
45526,Japanese,0,0
45527,speakers,0,1
45528,judged,0,0
45529,the,0,0
45530,grammaticality,0,0
45531,of,0,0
45532,isolated,0,0
45533,simple,0,0
45534,bitransitive,0,0
45535,sentences,0,1
45536,involving,0,0
45537,an,0,0
45538,uninterpretable,1,0
45539,extra,1,0
45540,argument,1,0
45541,in,0,0
45542,addition,0,0
45543,to,0,0
45544,three,0,0
45545,legitimate,1,0
45546,arguments,1,0
45547,.,1,0
45548,The,0,0
45549,sentences,0,0
45550,thus,0,0
45551,violated,0,0
45552,Chomsky,0,0
45553,'s,0,0
45554,principle,0,0
45555,of,0,0
45556,Full,0,1
45557,Interpretation,0,0
45558,which,0,0
45559,prohibits,0,0
45560,the,0,0
45561,structure,0,0
45562,building,0,0
45563,of,0,0
45564,a,0,0
45565,sentence,0,0
45566,including,0,0
45567,uninterpretable,0,0
45568,elements,0,1
45569,.,0,0
45570,The,0,0
45571,primary,0,0
45572,variable,0,0
45573,of,0,0
45574,interest,0,0
45575,was,0,0
45576,the,0,0
45577,presence,0,0
45578,or,0,1
45579,absence,0,0
45580,of,0,0
45581,punctuation,0,0
45582,",",0,0
45583,i.e.,0,0
45584,",",0,0
45585,commas,0,0
45586,",",0,0
45587,which,0,0
45588,enclosed,0,0
45589,the,0,0
45590,extra,0,0
45591,argument,0,0
45592,.,0,0
45593,Findings,0,0
45594,showed,0,0
45595,that,0,0
45596,sentences,0,0
45597,with,0,0
45598,punctuation,0,0
45599,were,0,0
45600,judged,0,0
45601,more,0,0
45602,grammatical,1,0
45603,than,0,0
45604,the,0,0
45605,ones,0,0
45606,without,0,0
45607,punctuation,0,0
45608,",",0,0
45609,with,0,0
45610,an,0,0
45611,average,0,0
45612,score,0,0
45613,of,0,0
45614,judged,0,0
45615,grammaticality,0,0
45616,exceeding,0,0
45617,3,0,0
45618,on,0,0
45619,a,0,0
45620,7-point,0,0
45621,scale,0,0
45622,(,0,0
45623,1,0,0
45624,=least,0,0
45625,grammatical,0,0
45626,;,0,0
45627,7=most,0,0
45628,grammatical,0,0
45629,),0,0
45630,.,0,0
45631,This,0,0
45632,score,0,0
45633,would,0,0
45634,not,0,0
45635,be,0,0
45636,expected,0,0
45637,if,0,0
45638,the,0,0
45639,speakers,0,1
45640,possess,0,0
45641,and,0,0
45642,judge,0,0
45643,the,0,0
45644,sentences,0,0
45645,in,0,0
45646,conformity,0,0
45647,with,0,0
45648,the,0,0
45649,principle,0,0
45650,of,0,0
45651,Full,0,0
45652,Interpretation,0,0
45653,.,0,0
45654,Effect,0,0
45655,of,0,0
45656,ibuprofen,1,1
45657,on,0,0
45658,cyclooxygenase,0,1
45659,and,0,0
45660,nitric,0,1
45661,oxide,0,1
45662,synthase,0,0
45663,of,0,0
45664,gastric,0,0
45665,mucosa,0,0
45666,:,0,0
45667,correlation,0,0
45668,with,0,0
45669,endoscopic,0,1
45670,lesions,0,0
45671,and,0,0
45672,adverse,0,0
45673,reactions,0,0
45674,.,0,0
45675,The,0,0
45676,aim,0,0
45677,of,0,0
45678,this,0,0
45679,study,0,0
45680,was,0,0
45681,to,0,0
45682,evaluate,0,0
45683,the,0,0
45684,effect,0,0
45685,of,0,0
45686,ibuprofen,1,1
45687,on,0,0
45688,gastric,0,0
45689,mucosa,0,0
45690,and,0,0
45691,enzymes,0,0
45692,involved,0,0
45693,in,0,0
45694,gastroprotection,0,0
45695,in,0,0
45696,healthy,0,0
45697,volunteers,0,0
45698,.,0,0
45699,Twenty-four,0,0
45700,Helicobacter,0,0
45701,pylori-negative,0,0
45702,subjects,0,0
45703,were,0,0
45704,randomized,0,0
45705,to,0,0
45706,treatment,0,0
45707,with,0,0
45708,ibuprofen,1,1
45709,or,1,1
45710,ibuprofen-arginate,1,1
45711,(,0,0
45712,each,0,0
45713,600,0,1
45714,mg/6,0,1
45715,hr,0,0
45716,during,0,0
45717,3,0,0
45718,days,0,0
45719,),0,0
45720,.,0,0
45721,Endoscopies,1,0
45722,were,0,0
45723,performed,0,0
45724,1,0,0
45725,week,0,0
45726,before,0,0
45727,and,0,0
45728,after,0,0
45729,treatment,0,0
45730,.,0,0
45731,Biopsies,0,0
45732,were,0,0
45733,taken,0,0
45734,from,0,0
45735,the,0,0
45736,gastric,0,0
45737,antrum,0,0
45738,and,0,0
45739,corpus,0,0
45740,for,0,0
45741,determination,0,0
45742,of,0,0
45743,prostaglandin,0,1
45744,E2,0,0
45745,(,0,0
45746,PGE2,0,0
45747,),0,0
45748,by,0,0
45749,ELISA,1,0
45750,and,0,0
45751,cyclooxygenase,0,1
45752,(,0,0
45753,COX-1,0,0
45754,and,0,0
45755,COX-2,0,0
45756,),0,0
45757,and,0,0
45758,nitric,0,1
45759,oxide,0,1
45760,synthase,0,0
45761,(,0,0
45762,eNOS,0,1
45763,and,0,0
45764,iNOS,0,0
45765,),0,0
45766,by,0,0
45767,western,0,0
45768,blot,0,0
45769,.,0,0
45770,All,0,0
45771,subjects,0,0
45772,had,0,0
45773,at,0,0
45774,least,0,0
45775,one,0,0
45776,gastric,0,0
45777,lesion,0,0
45778,except,0,0
45779,for,0,0
45780,two,0,0
45781,individuals,0,0
45782,taking,0,0
45783,ibuprofen-arginate,0,1
45784,.,0,0
45785,Ibuprofen-arginate,0,1
45786,caused,0,0
45787,a,0,0
45788,lower,0,0
45789,rate,0,0
45790,of,0,0
45791,clinical,0,0
45792,adverse,0,0
45793,reactions,0,0
45794,than,0,0
45795,ibuprofen,0,1
45796,.,0,0
45797,Subjects,0,0
45798,with,0,0
45799,gastric,0,0
45800,lesions,0,0
45801,or,0,0
45802,adverse,0,0
45803,reactions,0,0
45804,had,0,0
45805,lower,0,0
45806,PGE2,0,0
45807,levels,0,0
45808,.,0,0
45809,COX-1,0,0
45810,",",0,0
45811,COX-2,0,0
45812,",",0,0
45813,eNOS,0,0
45814,",",0,0
45815,and,0,0
45816,iNOS,0,0
45817,were,0,0
45818,detectable,0,0
45819,in,0,0
45820,all,0,0
45821,subjects,0,0
45822,.,0,0
45823,The,0,0
45824,constitutive,0,0
45825,enzymes,0,0
45826,(,0,0
45827,COX-1,0,0
45828,and,0,0
45829,eNOS,0,1
45830,),0,0
45831,did,0,0
45832,not,0,0
45833,change,0,0
45834,after,0,0
45835,treatment,0,0
45836,.,0,0
45837,COX-2,0,0
45838,was,0,0
45839,higher,0,0
45840,in,0,0
45841,corpus,0,0
45842,than,0,0
45843,antrum,0,0
45844,and,0,0
45845,it,0,0
45846,increased,0,0
45847,after,0,0
45848,ibuprofen,0,1
45849,treatment,0,0
45850,.,0,0
45851,iNOS,0,0
45852,tended,0,0
45853,to,0,0
45854,increase,0,0
45855,mildly,0,0
45856,in,0,0
45857,the,0,0
45858,corpus,0,0
45859,in,0,0
45860,subjects,0,0
45861,with,0,0
45862,adverse,0,0
45863,reactions,0,0
45864,or,0,0
45865,endoscopic,0,1
45866,lesions,0,0
45867,.,0,0
45868,There,0,0
45869,were,0,0
45870,no,0,0
45871,significant,0,0
45872,differences,0,0
45873,between,0,0
45874,ibuprofen,0,1
45875,and,0,0
45876,ibuprofen-arginate,0,1
45877,in,0,0
45878,PGE2,0,0
45879,",",0,0
45880,or,0,0
45881,enzymes,0,0
45882,.,0,0
45883,Transitions,0,0
45884,during,0,0
45885,effective,0,0
45886,treatment,0,0
45887,for,0,0
45888,cocaine-abusing,0,0
45889,homeless,0,0
45890,persons,0,0
45891,:,0,0
45892,establishing,0,0
45893,abstinence,0,0
45894,",",0,0
45895,lapse,0,0
45896,",",0,0
45897,and,0,0
45898,relapse,0,0
45899,",",0,0
45900,and,0,0
45901,reestablishing,0,0
45902,abstinence,0,0
45903,.,0,0
45904,Data,0,0
45905,are,0,0
45906,reported,0,0
45907,on,0,0
45908,drug,0,0
45909,use,0,0
45910,among,0,0
45911,cocaine-dependent,0,0
45912,homeless,0,0
45913,persons,0,0
45914,who,0,0
45915,participated,0,0
45916,in,0,0
45917,a,0,0
45918,clinical,0,0
45919,trial,0,0
45920,that,0,0
45921,compared,0,0
45922,day,1,0
45923,treatment,1,0
45924,only,1,0
45925,(,0,0
45926,DT,0,0
45927,",",0,0
45928,n,0,0
45929,=,0,0
45930,69,0,0
45931,),0,0
45932,with,0,0
45933,day,1,1
45934,treatment,1,0
45935,plus,1,1
45936,abstinent-contingent,1,1
45937,housing,1,1
45938,and,1,0
45939,work,1,0
45940,(,0,0
45941,DT+,0,0
45942,",",0,0
45943,n,0,0
45944,=,0,0
45945,72,0,0
45946,),0,0
45947,.,0,0
45948,Drug,0,0
45949,use,0,0
45950,was,0,0
45951,measured,0,0
45952,with,0,0
45953,multiple,0,0
45954,weekly,0,1
45955,urine,0,0
45956,toxicologies,0,0
45957,.,0,0
45958,Compared,0,0
45959,with,0,0
45960,DT,0,0
45961,participants,0,0
45962,",",0,0
45963,more,0,0
45964,DT+,0,0
45965,participants,0,0
45966,established,0,0
45967,abstinence,1,0
45968,",",0,0
45969,maintained,0,0
45970,abstinence,0,0
45971,for,0,0
45972,longer,0,0
45973,durations,0,0
45974,",",0,0
45975,were,0,0
45976,marginally,0,0
45977,significantly,0,0
45978,more,0,0
45979,likely,0,0
45980,to,0,0
45981,lapse,0,0
45982,",",0,0
45983,and,0,0
45984,significantly,0,0
45985,less,0,0
45986,likely,0,0
45987,to,0,0
45988,relapse,0,0
45989,.,0,0
45990,Of,0,0
45991,all,0,0
45992,participants,0,0
45993,who,0,0
45994,established,0,0
45995,abstinence,0,0
45996,and,0,0
45997,then,0,0
45998,relapsed,0,0
45999,",",0,0
46000,DT+,0,0
46001,participants,0,0
46002,relapsed,0,0
46003,later,0,0
46004,and,0,0
46005,were,0,0
46006,more,0,0
46007,likely,0,0
46008,to,0,0
46009,reestablish,0,0
46010,abstinence,0,0
46011,.,0,0
46012,These,0,0
46013,analyses,0,0
46014,yield,0,0
46015,information,0,0
46016,on,0,0
46017,the,0,0
46018,processes,0,0
46019,involved,0,0
46020,in,0,0
46021,the,0,0
46022,manner,0,0
46023,in,0,0
46024,which,0,0
46025,drug,0,0
46026,use,0,0
46027,changes,0,0
46028,as,0,0
46029,a,0,0
46030,result,0,0
46031,of,0,0
46032,abstinent-contingent,1,1
46033,housing,1,1
46034,and,1,0
46035,work,1,0
46036,.,1,0
46037,A,0,0
46038,double-blind,0,0
46039,",",0,0
46040,placebo-controlled,1,1
46041,study,0,0
46042,of,0,0
46043,the,0,0
46044,efficacy,0,0
46045,of,0,0
46046,transdermal,1,1
46047,clonidine,1,1
46048,in,0,0
46049,autism,0,0
46050,.,0,0
46051,BACKGROUND,0,0
46052,Autistic,0,0
46053,individuals,0,0
46054,often,0,0
46055,exhibit,0,0
46056,hyperarousal,0,0
46057,behaviors,0,0
46058,(,0,0
46059,e.g.,0,0
46060,",",0,0
46061,stereotyped,0,0
46062,body,0,0
46063,movements,0,0
46064,",",0,0
46065,self-stimulation,0,0
46066,",",0,0
46067,hypervigilance,0,0
46068,",",0,0
46069,and,0,0
46070,hyperactivity,0,0
46071,),0,0
46072,.,0,0
46073,Clonidine,1,1
46074,",",0,0
46075,an,0,0
46076,alpha,0,1
46077,2-adrenergic,0,1
46078,receptor,0,0
46079,agonist,0,1
46080,",",0,0
46081,has,0,0
46082,been,0,0
46083,shown,0,0
46084,to,0,0
46085,be,0,0
46086,effective,0,0
46087,in,0,0
46088,reducing,0,0
46089,impulsivity,0,0
46090,",",0,0
46091,inattention,0,0
46092,",",0,0
46093,and,0,0
46094,hyperactivity,0,0
46095,associated,0,0
46096,with,0,0
46097,attention,0,0
46098,deficit,0,0
46099,disorder,0,0
46100,with,0,0
46101,hyperactivity,0,0
46102,.,0,0
46103,This,0,0
46104,study,0,0
46105,investigated,0,0
46106,the,0,0
46107,efficacy,0,0
46108,and,0,0
46109,safety,0,0
46110,of,0,0
46111,transdermal,0,1
46112,clonidine,1,1
46113,in,0,0
46114,reducing,0,0
46115,hyperarousal,0,0
46116,behaviors,0,0
46117,associated,0,0
46118,with,0,0
46119,autism,0,0
46120,.,0,0
46121,METHOD,0,0
46122,A,0,0
46123,double-blind,0,0
46124,",",0,0
46125,placebo-crossover,1,0
46126,study,0,0
46127,with,0,0
46128,transdermal,0,1
46129,clonidine,1,1
46130,was,0,0
46131,performed,0,0
46132,in,0,0
46133,nine,0,0
46134,autistic,0,0
46135,males,0,0
46136,(,0,0
46137,aged,0,0
46138,5,0,0
46139,to,0,0
46140,33,0,0
46141,years,0,0
46142,),0,0
46143,.,0,0
46144,Subjects,0,0
46145,received,0,0
46146,either,0,0
46147,clonidine,1,1
46148,(,0,0
46149,approximately,0,0
46150,0.005,0,0
46151,mg/kg/day,0,0
46152,),0,0
46153,or,0,1
46154,placebo,1,1
46155,by,0,0
46156,a,0,0
46157,weekly,0,1
46158,transdermal,0,1
46159,patch,0,1
46160,.,0,0
46161,Each,0,0
46162,trial,0,0
46163,lasted,0,0
46164,4,0,0
46165,weeks,0,0
46166,with,0,0
46167,a,0,0
46168,2-week,0,0
46169,washout,0,0
46170,period,0,0
46171,between,0,0
46172,treatment,0,0
46173,phases,0,0
46174,.,0,0
46175,Subjects,0,0
46176,were,0,0
46177,evaluated,0,0
46178,every,0,0
46179,2,0,0
46180,weeks,0,0
46181,by,0,0
46182,clinician,0,0
46183,raters,0,0
46184,and,0,0
46185,weekly,0,1
46186,by,0,0
46187,parents,0,0
46188,.,0,0
46189,RESULTS,0,0
46190,The,0,0
46191,clonidine,1,1
46192,treatment,0,0
46193,showed,0,0
46194,a,0,0
46195,significant,0,0
46196,difference,0,0
46197,from,0,0
46198,placebo,1,1
46199,treatment,0,0
46200,on,0,0
46201,three,0,0
46202,subscales,0,0
46203,of,0,0
46204,the,0,0
46205,Ritvo-Freeman,0,0
46206,Real,0,0
46207,Life,0,0
46208,Rating,0,0
46209,Scale,0,1
46210,(,0,0
46211,i.e.,0,0
46212,",",0,0
46213,social,0,0
46214,relationship,0,0
46215,to,0,0
46216,people,0,0
46217,",",0,0
46218,affectual,0,0
46219,responses,0,0
46220,",",0,0
46221,and,0,0
46222,sensory,0,0
46223,responses,0,0
46224,),0,0
46225,.,0,0
46226,The,0,0
46227,Clinical,0,0
46228,Global,0,0
46229,Impressions,0,1
46230,scale,0,0
46231,indicated,0,0
46232,that,0,0
46233,clonidine,1,1
46234,produced,0,0
46235,a,0,0
46236,significant,0,0
46237,improvement,0,0
46238,on,0,0
46239,severity,0,0
46240,of,0,0
46241,illness,0,0
46242,",",0,0
46243,global,0,0
46244,improvement,0,0
46245,",",0,0
46246,and,0,0
46247,efficacy,0,0
46248,index,0,0
46249,for,0,0
46250,therapeutic,0,0
46251,effect,0,0
46252,of,0,0
46253,the,0,0
46254,drug,0,0
46255,.,0,0
46256,A,0,0
46257,patient,0,0
46258,global,0,0
46259,rating,0,0
46260,scale,0,0
46261,showed,0,0
46262,clonidine,1,1
46263,treatment,0,0
46264,resulted,0,0
46265,in,0,0
46266,significant,0,0
46267,improvement,0,0
46268,in,0,0
46269,comparison,0,0
46270,with,0,0
46271,placebo,1,1
46272,.,1,0
46273,Adverse,0,0
46274,effects,0,0
46275,included,0,0
46276,sedation,0,0
46277,and,0,0
46278,fatigue,0,0
46279,during,0,0
46280,the,0,0
46281,first,0,0
46282,2,0,0
46283,weeks,0,0
46284,of,0,0
46285,clonidine,1,1
46286,treatment,0,0
46287,.,0,0
46288,CONCLUSION,0,0
46289,Results,0,0
46290,from,0,0
46291,this,0,0
46292,preliminary,0,0
46293,study,0,0
46294,show,0,0
46295,that,0,0
46296,clonidine,1,1
46297,was,0,0
46298,effective,0,0
46299,in,0,0
46300,reducing,0,0
46301,several,0,0
46302,hyperarousal,0,0
46303,behaviors,0,0
46304,and,0,0
46305,improved,0,0
46306,social,0,0
46307,relationships,0,0
46308,in,0,0
46309,some,0,0
46310,autistic,0,0
46311,subjects,0,0
46312,.,0,0
46313,Further,0,0
46314,studies,0,0
46315,are,0,0
46316,needed,0,0
46317,in,0,0
46318,a,0,0
46319,larger,0,0
46320,autistic,0,0
46321,population,0,0
46322,to,0,0
46323,determine,0,0
46324,the,0,0
46325,dose-response,0,0
46326,relationship,0,0
46327,of,0,0
46328,clonidine,1,1
46329,.,1,0
46330,Risperidone,1,1
46331,in,0,0
46332,the,0,0
46333,treatment,0,0
46334,of,0,0
46335,disruptive,0,0
46336,behavioral,0,0
46337,symptoms,0,0
46338,in,0,0
46339,children,0,0
46340,with,0,0
46341,autistic,0,0
46342,and,0,0
46343,other,0,0
46344,pervasive,0,0
46345,developmental,0,0
46346,disorders,0,0
46347,.,0,0
46348,OBJECTIVE,0,0
46349,To,0,0
46350,investigate,0,0
46351,the,0,0
46352,efficacy,0,0
46353,and,0,0
46354,safety,0,0
46355,of,0,0
46356,risperidone,1,1
46357,for,0,0
46358,the,0,0
46359,treatment,0,0
46360,of,0,0
46361,disruptive,0,0
46362,behavioral,0,0
46363,symptoms,0,0
46364,in,0,0
46365,children,0,0
46366,with,0,0
46367,autism,0,0
46368,and,0,0
46369,other,0,0
46370,pervasive,0,0
46371,developmental,0,0
46372,disorders,0,0
46373,(,0,0
46374,PDD,0,0
46375,),0,0
46376,.,0,0
46377,METHODS,0,0
46378,In,0,0
46379,this,0,0
46380,8-week,0,0
46381,",",0,0
46382,randomized,0,0
46383,",",0,0
46384,double-blind,0,0
46385,",",0,0
46386,placebo-controlled,0,1
46387,trial,0,0
46388,",",0,0
46389,risperidone/placebo,1,1
46390,solution,1,1
46391,(,0,0
46392,0.01-0.06,0,0
46393,mg/kg/day,0,1
46394,),0,0
46395,was,0,0
46396,administered,0,0
46397,to,0,0
46398,79,0,0
46399,children,0,0
46400,who,0,0
46401,were,0,0
46402,aged,0,0
46403,5,0,0
46404,to,0,0
46405,12,0,0
46406,years,0,0
46407,and,0,0
46408,had,0,0
46409,PDD,0,0
46410,.,0,0
46411,Behavioral,0,0
46412,symptoms,0,0
46413,were,0,0
46414,assessed,0,0
46415,using,0,0
46416,the,0,0
46417,Aberrant,0,0
46418,Behavior,0,0
46419,Checklist,0,1
46420,(,0,0
46421,ABC,0,1
46422,),0,0
46423,",",0,0
46424,Nisonger,0,1
46425,Child,0,0
46426,Behavior,0,0
46427,Rating,0,0
46428,Form,0,1
46429,",",0,0
46430,and,0,0
46431,Clinical,0,0
46432,Global,0,0
46433,Impression-Change,0,1
46434,.,0,0
46435,Safety,0,0
46436,assessments,0,0
46437,included,0,0
46438,vital,0,0
46439,signs,0,0
46440,",",0,0
46441,electrocardiogram,0,0
46442,",",0,0
46443,extrapyramidal,0,0
46444,symptoms,0,0
46445,",",0,0
46446,adverse,0,0
46447,events,0,0
46448,",",0,0
46449,and,0,0
46450,laboratory,0,0
46451,tests,0,0
46452,.,0,0
46453,RESULTS,0,0
46454,Subjects,0,0
46455,who,0,0
46456,were,0,0
46457,taking,0,0
46458,risperidone,1,1
46459,(,0,0
46460,mean,0,0
46461,dosage,0,0
46462,:,0,0
46463,0.04,0,0
46464,mg/kg/day,0,0
46465,;,0,0
46466,1.17,0,0
46467,mg/day,0,0
46468,),0,0
46469,experienced,0,0
46470,a,0,0
46471,significantly,0,0
46472,greater,0,0
46473,mean,0,0
46474,decrease,0,0
46475,on,0,0
46476,the,0,0
46477,irritability,0,0
46478,subscale,0,0
46479,of,0,0
46480,the,0,0
46481,ABC,0,1
46482,(,0,0
46483,primary,0,0
46484,endpoint,0,0
46485,),0,0
46486,compared,0,0
46487,with,0,0
46488,those,0,0
46489,who,0,0
46490,were,0,0
46491,taking,0,0
46492,placebo,0,1
46493,.,0,0
46494,By,0,0
46495,study,0,0
46496,endpoint,0,0
46497,",",0,0
46498,risperidone-treated,1,0
46499,subjects,0,0
46500,exhibited,0,0
46501,a,0,0
46502,64,0,0
46503,%,0,0
46504,improvement,0,0
46505,over,0,0
46506,baseline,0,0
46507,in,0,0
46508,the,0,0
46509,irritability,0,0
46510,score,0,0
46511,almost,0,0
46512,double,0,0
46513,that,0,0
46514,of,0,0
46515,placebo-treated,1,0
46516,subjects,0,0
46517,(,0,0
46518,31,0,0
46519,%,0,0
46520,),0,0
46521,.,0,0
46522,Risperidone-treated,1,0
46523,subjects,0,0
46524,also,0,0
46525,exhibited,0,0
46526,significantly,0,0
46527,greater,0,0
46528,decreases,0,0
46529,on,0,0
46530,the,0,0
46531,other,0,0
46532,4,0,0
46533,subscales,0,0
46534,of,0,0
46535,the,0,0
46536,ABC,0,0
46537,;,0,0
46538,on,0,0
46539,the,0,0
46540,conduct,0,0
46541,problem,0,0
46542,",",0,0
46543,insecure/anxious,0,0
46544,",",0,0
46545,hyperactive,0,0
46546,",",0,0
46547,and,0,0
46548,overly,0,0
46549,sensitive,0,0
46550,subscales,0,0
46551,of,0,0
46552,the,0,0
46553,Nisonger,0,1
46554,Child,0,0
46555,Behavior,0,0
46556,Rating,0,0
46557,Form,0,1
46558,(,0,0
46559,parent,0,1
46560,version,0,0
46561,),0,0
46562,;,0,0
46563,and,0,0
46564,on,0,0
46565,the,0,0
46566,Visual,0,0
46567,Analog,0,1
46568,Scale,0,0
46569,of,0,0
46570,the,0,0
46571,most,0,0
46572,troublesome,0,0
46573,symptom,0,0
46574,.,0,0
46575,More,0,0
46576,risperidone-treated,1,0
46577,subjects,0,0
46578,(,0,0
46579,87,0,0
46580,%,0,0
46581,),0,0
46582,showed,0,0
46583,global,0,0
46584,improvement,0,0
46585,in,0,0
46586,their,0,0
46587,condition,0,0
46588,compared,0,0
46589,with,0,0
46590,the,0,0
46591,placebo,1,1
46592,group,0,0
46593,(,0,0
46594,40,0,0
46595,%,0,0
46596,),0,0
46597,.,0,0
46598,Somnolence,0,0
46599,",",0,0
46600,the,0,0
46601,most,0,0
46602,frequently,0,0
46603,reported,0,0
46604,adverse,0,0
46605,event,0,0
46606,",",0,0
46607,was,0,0
46608,noted,0,0
46609,in,0,0
46610,72.5,0,0
46611,%,0,0
46612,versus,0,0
46613,7.7,0,0
46614,%,0,0
46615,of,0,0
46616,subjects,0,0
46617,(,1,0
46618,risperidone,1,1
46619,vs,1,0
46620,placebo,1,1
46621,),1,0
46622,and,0,0
46623,seemed,0,0
46624,manageable,0,0
46625,with,0,0
46626,dose/dose-schedule,0,0
46627,modification,0,0
46628,.,0,0
46629,Risperidone-treated,1,0
46630,subjects,0,0
46631,experienced,0,0
46632,statistically,0,0
46633,significantly,0,0
46634,greater,0,0
46635,increases,0,0
46636,in,0,0
46637,weight,0,0
46638,(,0,0
46639,2.7,0,0
46640,vs,0,0
46641,1.0,0,0
46642,kg,0,0
46643,),0,0
46644,",",0,0
46645,pulse,0,1
46646,rate,0,0
46647,",",0,0
46648,and,0,0
46649,systolic,0,0
46650,blood,0,0
46651,pressure,0,0
46652,.,0,0
46653,Extrapyramidal,0,0
46654,symptoms,0,0
46655,scores,0,0
46656,were,0,0
46657,comparable,0,0
46658,between,0,0
46659,groups,0,0
46660,.,0,0
46661,CONCLUSIONS,0,0
46662,Risperidone,1,1
46663,was,0,0
46664,well,0,0
46665,tolerated,0,0
46666,and,0,0
46667,efficacious,0,0
46668,in,0,0
46669,treating,0,0
46670,behavioral,0,0
46671,symptoms,0,0
46672,associated,0,0
46673,with,0,0
46674,PDD,0,0
46675,in,0,0
46676,children,0,0
46677,.,0,0
46678,Total,0,0
46679,anthelmintic,0,1
46680,failure,0,0
46681,to,0,0
46682,control,0,0
46683,nematode,0,0
46684,parasites,0,0
46685,of,0,0
46686,small,0,0
46687,ruminants,0,0
46688,on,0,0
46689,government,0,0
46690,breeding,0,0
46691,farms,0,0
46692,in,0,0
46693,Sabah,0,0
46694,",",0,0
46695,East,0,1
46696,Malaysia,0,0
46697,.,0,0
46698,Government-owned,0,0
46699,small-ruminant,0,0
46700,breeding,0,0
46701,farms,0,0
46702,in,0,0
46703,Malaysia,0,0
46704,provide,0,0
46705,the,0,0
46706,source,0,0
46707,of,0,0
46708,sheep,0,1
46709,and,0,0
46710,goats,0,1
46711,to,0,0
46712,smallholder,0,0
46713,farmers,0,0
46714,in,0,0
46715,the,0,0
46716,country,0,0
46717,.,0,0
46718,In,0,0
46719,the,0,0
46720,eastern,0,0
46721,Malaysian,0,0
46722,state,0,0
46723,of,0,0
46724,Sabah,0,0
46725,",",0,0
46726,high-level,0,0
46727,stock,0,0
46728,losses,0,0
46729,have,0,0
46730,been,0,0
46731,recorded,0,0
46732,on,0,0
46733,these,0,0
46734,farms,0,0
46735,for,0,0
46736,several,0,0
46737,years,0,0
46738,",",0,0
46739,frequently,0,0
46740,accompanied,0,0
46741,by,0,0
46742,clinical,0,0
46743,signs,0,0
46744,indicating,0,0
46745,pathogenic,0,0
46746,levels,0,0
46747,of,0,0
46748,infections,0,0
46749,with,0,0
46750,the,0,0
46751,nematode,0,0
46752,parasite,0,0
46753,Haemonchus,0,0
46754,contortus,0,0
46755,.,0,0
46756,This,0,0
46757,suggests,0,0
46758,that,0,0
46759,their,0,0
46760,dependence,0,0
46761,on,0,0
46762,chemotherapy,1,1
46763,to,0,0
46764,control,0,0
46765,parasite,0,0
46766,infections,0,0
46767,had,0,0
46768,failed,0,0
46769,.,0,0
46770,Accordingly,0,0
46771,",",0,0
46772,tests,0,0
46773,for,0,0
46774,anthelmintic,0,1
46775,efficacy,0,0
46776,using,0,0
46777,the,0,0
46778,faecal,1,0
46779,egg,1,1
46780,count,1,0
46781,reduction,1,0
46782,test,1,0
46783,(,0,0
46784,FECRT,0,0
46785,),0,0
46786,on,0,0
46787,the,0,0
46788,range,0,0
46789,of,0,0
46790,drugs,0,0
46791,used,0,0
46792,to,0,0
46793,control,0,0
46794,nematode,0,0
46795,parasites,0,0
46796,were,0,0
46797,carried,0,0
46798,out,0,0
46799,on,0,0
46800,the,0,0
46801,five,0,0
46802,government,0,0
46803,small-ruminant,0,0
46804,breeding,0,0
46805,farms,0,0
46806,in,0,0
46807,Sabah,0,0
46808,.,0,0
46809,These,0,0
46810,tests,0,0
46811,showed,0,0
46812,a,0,0
46813,total,0,0
46814,failure,0,0
46815,of,0,0
46816,the,0,0
46817,benzimidazole,1,1
46818,",",1,0
46819,imidothiazole,1,1
46820,",",1,0
46821,macrocyclic,1,1
46822,lactone,1,1
46823,and,0,0
46824,salicylanilide,1,1
46825,groups,0,0
46826,of,0,0
46827,anthelmintics,0,1
46828,to,0,0
46829,control,0,0
46830,H.,0,0
46831,contortus,0,0
46832,infections,0,0
46833,of,0,0
46834,sheep,0,1
46835,and,0,0
46836,goats,0,1
46837,on,0,0
46838,all,0,0
46839,farms,0,0
46840,.,0,0
46841,Drastic,0,0
46842,changes,0,0
46843,in,0,0
46844,animal,0,0
46845,management,0,0
46846,need,0,0
46847,to,0,0
46848,be,0,0
46849,made,0,0
46850,in,0,0
46851,an,0,0
46852,attempt,0,0
46853,to,0,0
46854,deal,0,0
46855,with,0,0
46856,this,0,0
46857,situation,0,0
46858,",",0,0
46859,for,0,0
46860,which,0,0
46861,suggestions,0,0
46862,are,0,0
46863,made,0,0
46864,.,0,0
46865,Sustained,0,0
46866,oral,0,1
46867,health,0,0
46868,improvement,0,0
46869,and,0,0
46870,use,0,0
46871,of,0,0
46872,toothbrushes,1,1
46873,and,1,0
46874,dentifrice,1,1
46875,by,0,0
46876,previous,0,0
46877,users,0,0
46878,of,0,0
46879,traditional,0,0
46880,materials,0,0
46881,in,0,0
46882,a,0,0
46883,rural,0,0
46884,population,0,0
46885,in,0,0
46886,Andhra,0,0
46887,Pradesh,0,0
46888,",",0,0
46889,India,0,0
46890,.,0,0
46891,AIM,0,0
46892,To,0,0
46893,follow-up,0,0
46894,",",0,0
46895,one,0,0
46896,year,0,0
46897,later,0,0
46898,",",0,0
46899,a,0,0
46900,double-blind,0,0
46901,",",0,0
46902,randomised,0,0
46903,study,0,0
46904,",",0,0
46905,which,0,0
46906,investigated,0,0
46907,the,0,0
46908,effect,0,0
46909,of,0,0
46910,regular,1,1
46911,brushing,1,1
46912,with,1,0
46913,dentifrices,1,1
46914,on,0,0
46915,the,0,0
46916,oral,0,1
46917,health,0,0
46918,of,0,0
46919,an,0,0
46920,economically,0,0
46921,disadvantaged,0,0
46922,rural,0,0
46923,population,0,0
46924,in,0,0
46925,Andhra,0,0
46926,Pradesh,0,0
46927,",",0,0
46928,India,0,0
46929,who,0,0
46930,were,0,0
46931,primarily,0,0
46932,users,0,0
46933,of,0,0
46934,traditional,0,0
46935,materials,0,0
46936,.,0,0
46937,SUBJECTS,0,0
46938,150,0,0
46939,of,0,0
46940,the,0,0
46941,original,0,0
46942,study,0,0
46943,population,0,0
46944,.,0,0
46945,METHOD,0,0
46946,Examination,0,0
46947,to,0,0
46948,determine,0,0
46949,whether,0,0
46950,the,0,0
46951,improvements,0,0
46952,in,0,0
46953,oral,0,1
46954,health,0,0
46955,status,0,0
46956,and,0,0
46957,oral,0,1
46958,health,0,0
46959,behaviour,0,0
46960,(,0,0
46961,use,0,0
46962,of,0,0
46963,toothbrush,1,1
46964,and,1,0
46965,dentifrice,1,1
46966,),1,0
46967,",",0,0
46968,being,0,0
46969,unsupported,0,0
46970,",",0,0
46971,had,0,0
46972,been,0,0
46973,sustained,0,0
46974,since,0,0
46975,completion,0,0
46976,of,0,0
46977,the,0,0
46978,original,0,0
46979,study,0,0
46980,.,0,0
46981,RESULTS,0,0
46982,Data,0,0
46983,analysis,0,0
46984,showed,0,0
46985,sustained,0,0
46986,",",0,0
46987,statistically,0,0
46988,significant,0,0
46989,improvements,0,0
46990,in,0,0
46991,gingival,0,0
46992,health,0,0
46993,as,0,0
46994,measured,0,0
46995,by,0,0
46996,gingival,0,0
46997,bleeding,0,0
46998,and,0,0
46999,plaque,0,0
47000,indices,0,0
47001,(,0,0
47002,GBI,0,1
47003,and,0,0
47004,PI,0,1
47005,),0,0
47006,comparing,0,0
47007,users,0,0
47008,and,0,0
47009,non-users,0,0
47010,of,0,0
47011,toothbrushes,0,1
47012,and,0,0
47013,dentifrice,0,1
47014,in,0,0
47015,the,0,0
47016,original,0,0
47017,study,0,0
47018,(,0,0
47019,PI,0,1
47020,:,0,0
47021,p,0,0
47022,=,0,0
47023,0.04,0,0
47024,;,0,0
47025,GBI,0,0
47026,:,0,0
47027,p,0,0
47028,=,0,0
47029,0.03,0,0
47030,),0,0
47031,and,0,0
47032,sustained,0,0
47033,use,0,0
47034,of,0,0
47035,toothbrushes,0,1
47036,and,0,0
47037,dentifrice,0,1
47038,by,0,0
47039,60,0,0
47040,%,0,0
47041,of,0,0
47042,the,0,0
47043,subjects,0,0
47044,at,0,0
47045,follow-up,0,0
47046,one,0,0
47047,year,0,0
47048,later,0,0
47049,.,0,0
47050,CONCLUSIONS,0,0
47051,This,0,0
47052,study,0,0
47053,shows,0,0
47054,a,0,0
47055,beneficial,0,0
47056,effect,0,0
47057,on,0,0
47058,oral,0,1
47059,hygiene,0,1
47060,indices,0,0
47061,following,0,0
47062,the,0,0
47063,introduction,1,0
47064,of,1,0
47065,toothbrushes,1,1
47066,and,1,0
47067,dentifrices,1,1
47068,to,0,0
47069,a,0,0
47070,community,0,0
47071,using,0,0
47072,traditional,0,1
47073,oral,0,1
47074,hygiene,0,1
47075,materials,0,1
47076,and,0,0
47077,sustainability,0,0
47078,of,0,0
47079,use,0,0
47080,of,0,0
47081,these,0,0
47082,materials,0,0
47083,with,0,0
47084,motivation,0,0
47085,and,0,0
47086,support,0,0
47087,.,0,0
47088,It,0,0
47089,may,0,0
47090,therefore,0,0
47091,be,0,0
47092,concluded,0,0
47093,that,0,0
47094,it,0,0
47095,is,0,0
47096,feasible,0,0
47097,to,0,0
47098,achieve,0,0
47099,significant,0,0
47100,use,0,0
47101,of,0,0
47102,conventional,0,1
47103,toothbrushes,0,1
47104,and,0,0
47105,toothpastes,0,1
47106,",",0,0
47107,with,0,0
47108,consequent,0,0
47109,major,0,0
47110,and,0,0
47111,sustained,0,0
47112,improvements,0,0
47113,in,0,0
47114,plaque,0,0
47115,control,0,1
47116,and,0,0
47117,gingival,0,0
47118,health,0,0
47119,in,0,0
47120,a,0,0
47121,disadvantaged,0,0
47122,population,0,0
47123,hitherto,0,0
47124,often,0,0
47125,considered,0,0
47126,as,0,0
47127,not,0,0
47128,amenable,0,0
47129,to,0,0
47130,conventional,0,1
47131,oral,0,1
47132,hygiene,0,1
47133,for,0,0
47134,cultural,0,0
47135,or,0,0
47136,economic,0,0
47137,reasons,0,0
47138,.,0,0
47139,Abstinence,0,0
47140,incentive,0,1
47141,effects,0,0
47142,in,0,0
47143,a,0,0
47144,short-term,0,0
47145,outpatient,0,0
47146,detoxification,0,0
47147,program,0,1
47148,.,0,0
47149,Despite,0,0
47150,being,0,0
47151,widely,0,0
47152,available,0,0
47153,",",0,0
47154,outpatient,0,0
47155,detoxification,0,0
47156,has,0,0
47157,limited,0,0
47158,efficacy,0,0
47159,as,0,0
47160,a,0,0
47161,stand-alone,0,1
47162,treatment,0,0
47163,.,0,0
47164,This,0,0
47165,study,0,0
47166,examined,0,0
47167,whether,0,0
47168,abstinence-contingent,1,1
47169,incentives,1,0
47170,would,0,0
47171,improve,0,0
47172,outcomes,0,0
47173,for,0,0
47174,patients,0,0
47175,entering,0,0
47176,outpatient,0,0
47177,opiate,0,1
47178,detoxification,0,0
47179,.,0,0
47180,Participants,0,0
47181,(,0,0
47182,N,0,0
47183,=,0,0
47184,211,0,0
47185,),0,0
47186,received,0,0
47187,a,0,0
47188,100,0,0
47189,US,0,1
47190,dollars,0,0
47191,voucher,0,1
47192,on,0,0
47193,the,0,0
47194,last,0,0
47195,day,0,0
47196,of,0,0
47197,detoxification,1,0
47198,either,0,0
47199,contingent,0,1
47200,on,0,0
47201,opiate,0,1
47202,and,0,0
47203,cocaine,0,1
47204,abstinence,0,0
47205,or,0,0
47206,noncontingently,0,1
47207,.,0,0
47208,Urine,0,1
47209,samples,0,0
47210,were,0,0
47211,collected,0,0
47212,at,0,0
47213,intake,0,0
47214,",",0,0
47215,on,0,0
47216,Wednesday,0,0
47217,",",0,0
47218,Friday,0,0
47219,(,0,0
47220,the,0,0
47221,last,0,0
47222,day,0,0
47223,of,0,0
47224,detoxification,0,0
47225,),0,0
47226,",",0,0
47227,and,0,0
47228,the,0,0
47229,following,0,0
47230,Monday,0,0
47231,.,0,0
47232,Among,0,0
47233,contingent-voucher,1,0
47234,participants,0,0
47235,",",0,0
47236,31,0,0
47237,%,0,0
47238,were,0,0
47239,drug-free,0,1
47240,on,0,0
47241,Friday,0,0
47242,compared,0,0
47243,with,0,0
47244,18,0,0
47245,%,0,0
47246,of,0,0
47247,noncontingent,0,1
47248,controls,0,0
47249,(,0,0
47250,Z,0,1
47251,=,0,0
47252,2.4,0,0
47253,",",0,0
47254,p,0,0
47255,<,0,0
47256,.05,0,0
47257,),0,0
47258,.,0,0
47259,Few,0,0
47260,(,0,0
47261,12-13,0,0
47262,%,0,0
47263,),0,0
47264,participants,0,0
47265,tested,0,0
47266,negative,0,0
47267,on,0,0
47268,Monday,0,0
47269,.,0,0
47270,Results,0,0
47271,support,0,0
47272,the,0,0
47273,ability,0,0
47274,of,0,0
47275,vouchers,0,1
47276,to,0,0
47277,produce,0,0
47278,modest,0,0
47279,improvements,0,0
47280,in,0,0
47281,abstinence,0,0
47282,initiation,0,0
47283,rates,0,0
47284,during,0,0
47285,brief,0,1
47286,detoxification,0,0
47287,but,0,0
47288,suggest,0,0
47289,that,0,0
47290,additional,0,0
47291,interventions,0,0
47292,are,0,0
47293,needed,0,0
47294,to,0,0
47295,sustain,0,0
47296,improvements,0,0
47297,.,0,0
47298,Genetic,0,0
47299,polymorphisms,0,0
47300,of,0,0
47301,human,0,0
47302,flavin,0,1
47303,monooxygenase,0,0
47304,3,0,0
47305,in,0,0
47306,sulindac-mediated,1,1
47307,primary,0,0
47308,chemoprevention,0,1
47309,of,0,0
47310,familial,0,0
47311,adenomatous,0,0
47312,polyposis,0,0
47313,.,0,0
47314,PURPOSE,0,0
47315,Sulindac,1,1
47316,is,0,0
47317,a,0,0
47318,nonsteroidal,0,0
47319,anti-inflammatory,0,1
47320,drug,0,1
47321,(,0,0
47322,NSAID,0,0
47323,),0,0
47324,effective,0,0
47325,in,0,0
47326,regressing,0,0
47327,adenomas,0,0
47328,in,0,0
47329,patients,0,0
47330,with,0,0
47331,familial,0,0
47332,adenomatous,0,0
47333,polyposis,0,0
47334,(,0,0
47335,FAP,0,0
47336,),0,0
47337,.,0,0
47338,However,0,0
47339,",",0,0
47340,a,0,0
47341,recent,0,0
47342,randomized,0,0
47343,trial,0,0
47344,showed,0,0
47345,that,0,0
47346,sulindac,1,1
47347,",",0,0
47348,when,0,0
47349,compared,0,0
47350,with,0,0
47351,placebo,1,1
47352,",",0,0
47353,failed,0,0
47354,to,0,0
47355,prevent,0,0
47356,the,0,0
47357,development,0,0
47358,of,0,0
47359,adenomatous,0,0
47360,polyps,0,0
47361,in,0,0
47362,genotypically,0,0
47363,positive,0,0
47364,but,0,0
47365,phenotypically,0,0
47366,negative,0,0
47367,FAP,0,0
47368,patients,0,0
47369,.,0,0
47370,The,0,0
47371,present,0,0
47372,study,0,0
47373,determined,0,0
47374,whether,0,0
47375,polymorphisms,0,0
47376,in,0,0
47377,the,0,0
47378,gene,0,0
47379,encoding,0,1
47380,flavin,0,1
47381,monooxygenase,0,0
47382,3,0,0
47383,(,0,0
47384,FMO3,0,1
47385,),0,0
47386,",",0,0
47387,a,0,0
47388,hepatic,0,0
47389,microsomal,0,0
47390,enzyme,0,0
47391,that,0,0
47392,inactivates,0,0
47393,sulindac,1,1
47394,",",0,0
47395,played,0,0
47396,a,0,0
47397,role,0,0
47398,in,0,0
47399,determining,0,0
47400,the,0,0
47401,efficacy,0,0
47402,of,0,0
47403,sulindac,1,1
47404,in,0,0
47405,preventing,0,0
47406,polyposis,0,0
47407,in,0,0
47408,this,0,0
47409,cohort,0,0
47410,of,0,0
47411,FAP,0,0
47412,patients,0,0
47413,.,0,0
47414,EXPERIMENTAL,0,0
47415,DESIGN,0,0
47416,Genotyping,0,0
47417,was,0,0
47418,performed,0,0
47419,on,0,0
47420,seven,0,0
47421,established,0,0
47422,FMO3,0,0
47423,polymorphisms,0,0
47424,previously,0,0
47425,shown,0,0
47426,to,0,0
47427,have,0,0
47428,functional,0,0
47429,relevance-M66I,0,0
47430,",",0,0
47431,P153L,0,0
47432,",",0,0
47433,E158K,0,0
47434,",",0,0
47435,V257M,0,1
47436,",",0,0
47437,E305X,0,0
47438,",",0,0
47439,E308G,0,0
47440,",",0,0
47441,and,0,0
47442,R492W-in,0,0
47443,21,0,0
47444,and,0,0
47445,20,0,0
47446,FAP,0,0
47447,patients,0,0
47448,",",0,0
47449,who,0,0
47450,received,0,0
47451,sulindac,1,1
47452,and,1,0
47453,placebo,1,1
47454,",",0,0
47455,respectively,0,0
47456,.,0,0
47457,RESULTS,0,0
47458,None,0,0
47459,of,0,0
47460,the,0,0
47461,41,0,0
47462,patients,0,0
47463,exhibited,0,0
47464,heterozygous,0,0
47465,or,0,0
47466,homozygous,0,0
47467,M66I,0,0
47468,and,0,0
47469,R492W,0,1
47470,variant,0,0
47471,alleles,0,0
47472,",",0,0
47473,or,0,0
47474,homozygous,0,0
47475,P153L,0,0
47476,",",0,0
47477,V257M,0,1
47478,",",0,0
47479,and,0,0
47480,E305X,0,0
47481,variant,0,0
47482,alleles,0,0
47483,.,0,0
47484,Among,0,0
47485,sulindac-treated,1,0
47486,patients,0,0
47487,who,0,0
47488,did,0,0
47489,not,0,0
47490,develop,0,0
47491,adenomas,0,0
47492,(,0,0
47493,responders,0,0
47494,),0,0
47495,",",0,0
47496,4,0,0
47497,(,0,0
47498,33,0,0
47499,%,0,0
47500,),0,0
47501,were,0,0
47502,homozygous,0,0
47503,for,0,0
47504,E158K,0,0
47505,and,0,0
47506,2,0,0
47507,(,0,0
47508,17,0,0
47509,%,0,0
47510,),0,0
47511,were,0,0
47512,homozygous,0,0
47513,for,0,0
47514,E308G,0,0
47515,variant,0,0
47516,alleles,0,0
47517,.,0,0
47518,In,0,0
47519,contrast,0,0
47520,",",0,0
47521,none,0,0
47522,of,0,0
47523,the,0,0
47524,patients,0,0
47525,on,0,0
47526,sulindac,0,1
47527,who,0,0
47528,developed,0,0
47529,adenomas,0,0
47530,(,0,0
47531,nonresponders,0,0
47532,),0,0
47533,exhibited,0,0
47534,homozygosity,0,0
47535,for,0,0
47536,either,0,0
47537,of,0,0
47538,the,0,0
47539,two,0,0
47540,variant,0,0
47541,alleles,0,0
47542,.,0,0
47543,In,0,0
47544,addition,0,0
47545,",",0,0
47546,polymorphisms,0,0
47547,in,0,0
47548,the,0,0
47549,E158K,0,0
47550,or,0,0
47551,E308G,0,0
47552,allele,0,0
47553,were,0,0
47554,associated,0,0
47555,with,0,0
47556,a,0,0
47557,significant,0,0
47558,reduction,0,0
47559,in,0,0
47560,mucosal,0,0
47561,prostanoid,0,1
47562,levels,0,0
47563,in,0,0
47564,patients,0,0
47565,treated,0,0
47566,with,0,0
47567,sulindac,1,1
47568,.,1,0
47569,CONCLUSIONS,0,0
47570,Polymorphisms,0,0
47571,in,0,0
47572,FMO3,0,0
47573,",",0,0
47574,particularly,0,0
47575,at,0,0
47576,the,0,0
47577,E158K,0,0
47578,and,0,0
47579,E308G,0,0
47580,loci,0,0
47581,",",0,0
47582,may,0,0
47583,reduce,0,0
47584,activity,0,0
47585,in,0,0
47586,catabolizing,0,0
47587,sulindac,1,1
47588,and,0,0
47589,result,0,0
47590,in,0,0
47591,an,0,0
47592,increased,0,0
47593,efficacy,0,0
47594,to,0,0
47595,prevent,0,0
47596,polyposis,0,0
47597,in,0,0
47598,FAP,0,0
47599,.,0,0
47600,Group-based,0,1
47601,HIV,1,0
47602,risk,1,0
47603,reduction,1,0
47604,intervention,1,1
47605,for,0,0
47606,adolescent,0,0
47607,girls,0,0
47608,:,0,0
47609,evidence,0,0
47610,of,0,0
47611,feasibility,0,0
47612,and,0,0
47613,efficacy,0,0
47614,.,0,0
47615,The,0,0
47616,purposes,0,0
47617,of,0,0
47618,this,0,0
47619,pilot,0,0
47620,study,0,0
47621,were,0,0
47622,(,0,0
47623,a,0,0
47624,),0,0
47625,to,0,0
47626,assess,0,0
47627,the,0,0
47628,feasibility,0,0
47629,of,0,0
47630,a,0,0
47631,community-based,1,0
47632,",",1,0
47633,small,1,0
47634,group,1,0
47635,HIV,1,0
47636,risk,1,0
47637,reduction,1,0
47638,intervention,1,1
47639,with,0,0
47640,adolescent,0,0
47641,girls,0,0
47642,",",0,0
47643,and,0,0
47644,(,0,0
47645,b,0,0
47646,),0,0
47647,to,0,0
47648,obtain,0,0
47649,preliminary,0,0
47650,evidence,0,0
47651,of,0,0
47652,the,0,0
47653,efficacy,0,0
47654,of,0,0
47655,this,0,0
47656,theoretically-guided,1,1
47657,intervention,1,1
47658,using,0,0
47659,a,0,0
47660,controlled,0,0
47661,design,0,0
47662,.,0,0
47663,The,0,0
47664,feasibility,0,0
47665,of,0,0
47666,the,0,0
47667,intervention,0,1
47668,was,0,0
47669,demonstrated,0,0
47670,by,0,0
47671,successfully,0,0
47672,implementing,0,0
47673,it,0,0
47674,with,0,0
47675,33,0,0
47676,sexually-active,0,0
47677,",",0,0
47678,single,0,0
47679,girls,0,0
47680,.,0,0
47681,Preliminary,0,0
47682,evidence,0,0
47683,of,0,0
47684,the,0,0
47685,efficacy,0,0
47686,of,0,0
47687,the,0,0
47688,intervention,0,1
47689,was,0,0
47690,obtained,0,0
47691,using,0,0
47692,a,0,0
47693,randomized,0,0
47694,trial,0,0
47695,with,0,0
47696,62,0,0
47697,sexually-active,0,0
47698,",",0,0
47699,single,0,0
47700,girls,0,0
47701,.,0,0
47702,Data,0,0
47703,obtained,0,0
47704,at,0,0
47705,a,0,0
47706,3-month,0,0
47707,follow-up,0,0
47708,assessment,0,0
47709,showed,0,0
47710,that,0,0
47711,girls,0,0
47712,who,0,0
47713,received,0,0
47714,the,0,0
47715,HIV-related,1,0
47716,intervention,1,1
47717,improved,0,0
47718,their,0,0
47719,HIV-related,0,0
47720,knowledge,0,0
47721,and,0,0
47722,enhanced,0,0
47723,their,0,0
47724,motivation,0,0
47725,for,0,0
47726,risk,0,0
47727,reduction,0,0
47728,compared,0,0
47729,to,0,0
47730,girls,0,0
47731,who,0,0
47732,received,0,0
47733,a,0,0
47734,control,1,1
47735,(,1,0
47736,health,1,0
47737,promotion,1,1
47738,),1,0
47739,intervention,1,1
47740,.,1,0
47741,Effect,0,0
47742,sizes,0,0
47743,suggest,0,0
47744,that,0,0
47745,the,0,0
47746,HIV,1,0
47747,intervention,1,1
47748,also,0,0
47749,reduced,0,0
47750,several,0,0
47751,risk,0,0
47752,behaviors,0,0
47753,(,0,0
47754,e.g.,0,0
47755,",",0,0
47756,vaginal,0,0
47757,sex,0,0
47758,without,0,0
47759,a,0,0
47760,condom,0,0
47761,",",0,0
47762,giving,0,0
47763,oral,0,1
47764,sex,0,0
47765,",",0,0
47766,and,0,0
47767,alcohol,0,1
47768,and,0,0
47769,drug,0,0
47770,use,0,0
47771,before,0,0
47772,sex,0,0
47773,),0,0
47774,.,0,0
47775,Challenges,0,0
47776,to,0,0
47777,implementation,0,0
47778,and,0,0
47779,suggestions,0,0
47780,for,0,0
47781,intervention,0,1
47782,enhancement,0,0
47783,are,0,0
47784,discussed,0,0
47785,.,0,0
47786,Effects,0,0
47787,of,0,0
47788,an,0,0
47789,antimicrobial,1,1
47790,additive,1,0
47791,to,0,0
47792,toothbrushes,0,1
47793,on,0,0
47794,residual,0,0
47795,periodontal,0,0
47796,pathogens,0,0
47797,.,0,0
47798,OBJECTIVE,0,0
47799,Previous,0,0
47800,studies,0,0
47801,have,0,0
47802,reported,0,0
47803,the,0,0
47804,link,0,0
47805,between,0,0
47806,residual,0,0
47807,microbial,0,0
47808,contamination,0,0
47809,of,0,0
47810,toothbrushes,0,1
47811,and,0,0
47812,periodontal,0,0
47813,diseases,0,0
47814,.,0,0
47815,The,0,0
47816,goal,0,0
47817,of,0,0
47818,this,0,0
47819,pilot,0,0
47820,study,0,0
47821,was,0,0
47822,to,0,0
47823,evaluate,0,0
47824,the,0,0
47825,effects,0,0
47826,of,0,0
47827,an,1,0
47828,antimicrobial,1,1
47829,additive,1,1
47830,(,1,0
47831,Microban,1,1
47832,),1,0
47833,to,0,0
47834,toothbrushes,0,1
47835,on,0,0
47836,residual,0,0
47837,retention,0,0
47838,of,0,0
47839,periodontal,0,0
47840,pathogens,0,0
47841,.,0,0
47842,METHODOLOGY,0,0
47843,Twenty,0,0
47844,patients,0,0
47845,had,0,0
47846,one,0,0
47847,side,0,0
47848,of,0,0
47849,their,0,0
47850,mouths,0,0
47851,brushed,0,0
47852,with,0,0
47853,a,0,0
47854,toothbrush,1,1
47855,containing,1,1
47856,the,1,0
47857,antimicrobial,1,1
47858,agent,1,0
47859,(,0,0
47860,experimental,0,0
47861,side,0,0
47862,),0,0
47863,",",0,0
47864,and,0,0
47865,the,0,0
47866,other,0,0
47867,side,0,0
47868,with,0,0
47869,a,0,0
47870,toothbrush,1,1
47871,containing,1,1
47872,no,1,0
47873,agent,1,0
47874,(,0,0
47875,control,0,0
47876,),0,0
47877,.,0,0
47878,Toothbrushes,0,1
47879,were,0,0
47880,air-dried,0,1
47881,(,0,0
47882,25,0,0
47883,degrees,0,0
47884,C,0,0
47885,),0,0
47886,for,0,0
47887,four,0,0
47888,or,0,0
47889,24,0,0
47890,hours,0,0
47891,.,0,0
47892,Toothbrush,0,1
47893,heads,0,0
47894,were,0,0
47895,vortexed,0,0
47896,and,0,0
47897,cultured,0,0
47898,for,0,0
47899,Prevotella,0,0
47900,species,0,0
47901,(,0,0
47902,Ps,0,1
47903,),0,0
47904,",",0,0
47905,Porphyromonas,0,0
47906,gingivalis,0,0
47907,(,0,0
47908,Pg,0,0
47909,),0,0
47910,",",0,0
47911,Actinobacillus,0,0
47912,actinomycetemcomitans,0,0
47913,(,0,0
47914,Aa,0,1
47915,),0,0
47916,",",0,0
47917,and,0,0
47918,non-specific,0,0
47919,colony-forming,0,0
47920,units,0,1
47921,(,0,0
47922,NS,0,0
47923,),0,0
47924,.,0,0
47925,The,0,0
47926,plates,0,0
47927,were,0,0
47928,incubated,0,0
47929,and,0,0
47930,counted,0,0
47931,.,0,0
47932,Means,0,0
47933,and,0,0
47934,standard,0,1
47935,deviations,0,0
47936,were,0,0
47937,calculated,0,0
47938,",",0,0
47939,and,0,0
47940,data,0,0
47941,were,0,0
47942,analyzed,0,0
47943,using,0,0
47944,a,0,0
47945,series,0,0
47946,of,0,0
47947,t-tests,0,0
47948,(,0,0
47949,paired,0,0
47950,and,0,0
47951,unpaired,0,0
47952,),0,0
47953,and,0,0
47954,Wilcoxon,0,0
47955,matched-pairs,0,0
47956,signed-rank,0,0
47957,test,0,0
47958,.,0,0
47959,RESULTS,0,0
47960,No,0,0
47961,significant,0,0
47962,inter-,0,0
47963,or,0,0
47964,intra-group,0,0
47965,differences,0,0
47966,in,0,0
47967,mean,0,0
47968,counts,0,0
47969,were,0,0
47970,found,0,0
47971,;,0,0
47972,however,0,0
47973,",",0,0
47974,when,0,0
47975,four-hour,0,0
47976,and,0,0
47977,24-hour,0,0
47978,data,0,0
47979,for,0,0
47980,Aa,0,1
47981,",",0,0
47982,Pg,0,0
47983,",",0,0
47984,or,0,0
47985,NS,0,0
47986,were,0,0
47987,combined,0,0
47988,",",0,0
47989,experimental,0,0
47990,counts,0,0
47991,were,0,0
47992,lower,0,0
47993,than,0,0
47994,controls,0,0
47995,in,0,0
47996,39/50,0,0
47997,(,0,0
47998,78,0,0
47999,%,0,0
48000,),0,0
48001,of,0,0
48002,the,0,0
48003,matched,0,0
48004,pairs,0,0
48005,(,0,0
48006,Wilcoxon,0,0
48007,signed-rank,0,0
48008,test,0,0
48009,p,0,0
48010,=,0,0
48011,0.01,0,0
48012,),0,0
48013,.,0,0
48014,CONCLUSION,0,0
48015,Toothbrushes,0,1
48016,containing,0,1
48017,the,0,0
48018,antimicrobial,1,1
48019,additive,1,0
48020,showed,0,0
48021,lower,0,0
48022,microbial,0,0
48023,counts,0,0
48024,than,0,0
48025,those,0,0
48026,without,0,0
48027,",",0,0
48028,but,0,0
48029,between-group,0,0
48030,means,0,0
48031,were,0,0
48032,not,0,0
48033,statistically,0,0
48034,significant,0,0
48035,.,0,0
48036,Randomized,0,0
48037,controlled,0,0
48038,trial,0,0
48039,to,0,0
48040,compare,0,0
48041,the,0,0
48042,early,0,0
48043,and,0,0
48044,mid-term,0,0
48045,results,0,0
48046,of,0,0
48047,stapled,1,1
48048,versus,1,0
48049,open,1,0
48050,hemorrhoidectomy,1,1
48051,.,1,0
48052,BACKGROUND,0,0
48053,The,0,0
48054,new,0,0
48055,technique,0,1
48056,of,0,0
48057,circular,0,0
48058,stapler,0,1
48059,for,0,0
48060,the,0,0
48061,treatment,0,0
48062,of,0,0
48063,hemorrhoids,0,0
48064,has,0,0
48065,shown,0,0
48066,early,0,0
48067,promise,0,0
48068,in,0,0
48069,terms,0,0
48070,of,0,0
48071,minimal,0,0
48072,or,0,0
48073,no,0,0
48074,postoperative,0,0
48075,pain,0,0
48076,",",0,0
48077,early,0,0
48078,discharge,0,0
48079,from,0,0
48080,hospital,0,0
48081,",",0,0
48082,and,0,0
48083,quick,0,1
48084,return,0,0
48085,to,0,0
48086,work,0,0
48087,.,0,0
48088,This,0,0
48089,study,0,0
48090,was,0,0
48091,designed,0,0
48092,to,0,0
48093,compare,0,0
48094,stapled,1,1
48095,technique,1,1
48096,with,1,0
48097,the,1,0
48098,well-accepted,1,0
48099,conventional,1,1
48100,Milligan,1,1
48101,Morgan,1,0
48102,hemorrhoidectomy,1,1
48103,.,1,0
48104,METHODS,0,0
48105,After,0,0
48106,fulfilling,0,0
48107,the,0,0
48108,selection,0,0
48109,criteria,0,0
48110,",",0,0
48111,84,0,0
48112,patients,0,0
48113,were,0,0
48114,randomly,0,0
48115,allocated,0,0
48116,to,0,0
48117,the,0,0
48118,stapled,1,1
48119,(,0,0
48120,n,0,0
48121,=,0,0
48122,42,0,0
48123,),0,0
48124,or,0,0
48125,open,1,1
48126,group,0,1
48127,(,0,0
48128,n,0,0
48129,=,0,0
48130,42,0,0
48131,),0,0
48132,.,0,0
48133,All,0,0
48134,patients,0,0
48135,were,0,0
48136,operated,0,0
48137,on,0,0
48138,under,0,0
48139,spinal,1,0
48140,anesthesia,1,1
48141,.,1,0
48142,The,0,0
48143,2,0,0
48144,techniques,0,0
48145,were,0,0
48146,evaluated,0,0
48147,with,0,0
48148,respect,0,0
48149,to,0,0
48150,the,0,0
48151,operative,0,0
48152,time,0,0
48153,",",0,0
48154,pain,0,0
48155,scores,0,0
48156,",",0,0
48157,complications,0,0
48158,",",0,0
48159,day,0,0
48160,of,0,0
48161,discharge,0,0
48162,",",0,0
48163,return,0,0
48164,to,0,0
48165,work,0,0
48166,",",0,0
48167,and,0,0
48168,level,0,0
48169,of,0,0
48170,satisfaction,0,0
48171,.,0,0
48172,RESULTS,0,0
48173,The,0,0
48174,mean,0,0
48175,age,0,0
48176,of,0,0
48177,patients,0,0
48178,was,0,0
48179,46.02,0,0
48180,years,0,0
48181,(,0,0
48182,SD,0,0
48183,",",0,0
48184,12.33,0,0
48185,),0,0
48186,in,0,0
48187,the,0,0
48188,stapled,0,1
48189,group,0,0
48190,and,0,0
48191,48.64,0,0
48192,years,0,0
48193,(,0,0
48194,14.57,0,0
48195,),0,0
48196,in,0,0
48197,the,0,0
48198,open,0,0
48199,group,0,0
48200,.,0,0
48201,Grade,0,0
48202,III,0,0
48203,or,0,1
48204,IV,0,0
48205,hemorrhoids,0,0
48206,were,0,0
48207,more,0,0
48208,common,0,0
48209,in,0,0
48210,men,0,0
48211,(,0,0
48212,ie,0,0
48213,",",0,0
48214,80.9,0,0
48215,%,0,0
48216,and,0,0
48217,85.7,0,0
48218,%,0,0
48219,in,0,0
48220,the,0,0
48221,stapled,0,1
48222,and,0,0
48223,open,0,1
48224,group,0,0
48225,",",0,0
48226,respectively,0,0
48227,),0,0
48228,.,0,0
48229,The,0,0
48230,mean,0,0
48231,operative,0,0
48232,time,0,0
48233,was,0,0
48234,shorter,0,0
48235,in,0,0
48236,the,0,0
48237,stapled,0,1
48238,group,0,0
48239,24.28,0,0
48240,minutes,0,0
48241,(,0,0
48242,4.25,0,0
48243,),0,0
48244,versus,0,0
48245,45.21,0,0
48246,minutes,0,0
48247,(,0,0
48248,5.36,0,0
48249,),0,0
48250,in,0,0
48251,the,0,0
48252,Milligan-Morgan,0,0
48253,group,0,0
48254,(,0,0
48255,P,0,0
48256,<,0,0
48257,.001,0,0
48258,),0,0
48259,.,0,0
48260,The,0,0
48261,blood,0,0
48262,loss,0,0
48263,",",0,0
48264,pain,0,0
48265,scores,0,0
48266,and,0,0
48267,requirement,0,0
48268,of,0,0
48269,analgesics,0,0
48270,was,0,0
48271,significantly,0,0
48272,less,0,0
48273,in,0,0
48274,the,0,0
48275,stapled,0,1
48276,group,0,0
48277,.,0,0
48278,Mean,0,0
48279,hospital,0,0
48280,stay,0,0
48281,was,0,0
48282,1.24,0,0
48283,days,0,0
48284,(,0,0
48285,0.62,0,0
48286,),0,0
48287,and,0,0
48288,2.76,0,0
48289,days,0,0
48290,(,0,0
48291,1.01,0,0
48292,),0,0
48293,(,0,0
48294,P,0,0
48295,<,0,0
48296,.001,0,0
48297,),0,0
48298,in,0,0
48299,the,0,0
48300,stapled,0,1
48301,and,0,0
48302,open,0,1
48303,group,0,0
48304,",",0,0
48305,respectively,0,0
48306,.,0,0
48307,The,0,0
48308,patients,0,0
48309,in,0,0
48310,the,0,0
48311,stapled,0,1
48312,group,0,0
48313,returned,0,0
48314,to,0,0
48315,work,0,0
48316,or,0,0
48317,routine,0,0
48318,activities,0,0
48319,earlier,0,0
48320,(,0,0
48321,ie,0,0
48322,",",0,0
48323,within,0,0
48324,8.12,0,0
48325,days,0,0
48326,[,0,0
48327,2.48,0,0
48328,],0,0
48329,),0,0
48330,as,0,0
48331,compared,0,0
48332,with,0,0
48333,17.62,0,0
48334,(,0,0
48335,5.59,0,0
48336,),0,0
48337,in,0,0
48338,the,0,0
48339,open,0,0
48340,group,0,0
48341,.,0,0
48342,Only,0,0
48343,88.1,0,0
48344,%,0,0
48345,of,0,0
48346,patients,0,0
48347,were,0,0
48348,satisfied,0,0
48349,by,0,0
48350,the,0,0
48351,open,0,0
48352,method,0,0
48353,compared,0,0
48354,with,0,0
48355,97.6,0,0
48356,%,0,0
48357,after,0,0
48358,the,0,0
48359,stapled,0,1
48360,technique,0,1
48361,.,0,0
48362,The,0,0
48363,median,0,0
48364,follow-up,0,0
48365,period,0,0
48366,was,0,0
48367,11,0,0
48368,months,0,0
48369,with,0,0
48370,a,0,0
48371,maximum,0,0
48372,follow-up,0,0
48373,of,0,0
48374,19,0,0
48375,months,0,0
48376,(,0,0
48377,range,0,0
48378,2-19,0,0
48379,months,0,0
48380,),0,0
48381,.,0,0
48382,CONCLUSIONS,0,0
48383,Stapled,1,0
48384,hemorrhoidectomy,1,1
48385,is,0,0
48386,a,0,0
48387,safe,0,0
48388,and,0,0
48389,effective,0,0
48390,day-care,0,1
48391,procedure,0,0
48392,for,0,0
48393,the,0,0
48394,treatment,0,0
48395,of,0,0
48396,grade,0,0
48397,III,0,0
48398,and,0,0
48399,grade,0,0
48400,IV,0,0
48401,hemorrhoids,0,0
48402,.,0,0
48403,It,0,0
48404,ensures,0,0
48405,lesser,0,0
48406,postoperative,0,0
48407,pain,0,0
48408,",",0,0
48409,early,0,0
48410,discharge,0,0
48411,",",0,0
48412,less,0,0
48413,time,0,0
48414,off,0,0
48415,work,0,0
48416,",",0,0
48417,complications,0,0
48418,similar,0,0
48419,to,0,0
48420,the,0,0
48421,open,0,0
48422,technique,0,1
48423,",",0,0
48424,and,0,0
48425,in,0,0
48426,the,0,0
48427,end,0,0
48428,a,0,0
48429,more,0,0
48430,satisfied,0,0
48431,patient,0,0
48432,with,0,0
48433,no,0,0
48434,perianal,0,0
48435,wound,0,0
48436,.,0,0
48437,However,0,0
48438,",",0,0
48439,more,0,0
48440,such,0,0
48441,randomized,0,0
48442,trials,0,0
48443,are,0,0
48444,essential,0,0
48445,to,0,0
48446,deny,0,0
48447,any,0,0
48448,long-term,0,0
48449,complication,0,0
48450,.,0,0
48451,Is,0,0
48452,successful,0,0
48453,rehabilitation,0,1
48454,of,0,0
48455,complex,0,0
48456,regional,0,0
48457,pain,0,0
48458,syndrome,0,0
48459,due,0,0
48460,to,0,0
48461,sustained,0,0
48462,attention,0,0
48463,to,0,0
48464,the,0,0
48465,affected,0,0
48466,limb,0,0
48467,?,0,0
48468,A,0,0
48469,randomised,0,0
48470,clinical,0,0
48471,trial,0,0
48472,.,0,0
48473,In,0,0
48474,complex,0,0
48475,regional,0,0
48476,pain,0,0
48477,syndrome,0,0
48478,(,0,0
48479,CRPS1,0,1
48480,),0,0
48481,initiated,0,0
48482,by,0,0
48483,wrist,0,1
48484,fracture,0,0
48485,",",0,0
48486,a,0,0
48487,motor,1,0
48488,imagery,1,1
48489,program,1,1
48490,(,0,0
48491,MIP,0,1
48492,),0,0
48493,",",0,0
48494,consisting,0,0
48495,of,0,0
48496,hand,0,1
48497,laterality,0,0
48498,recognition,0,0
48499,followed,0,0
48500,by,0,0
48501,imagined,1,0
48502,movements,1,0
48503,and,0,0
48504,then,0,0
48505,mirror,1,1
48506,movements,1,0
48507,",",0,0
48508,reduces,0,0
48509,pain,0,0
48510,and,0,0
48511,disability,0,0
48512,",",0,0
48513,but,0,0
48514,the,0,0
48515,mechanism,0,0
48516,of,0,0
48517,effect,0,0
48518,is,0,0
48519,unclear,0,0
48520,.,0,0
48521,Possibilities,0,0
48522,include,0,0
48523,sustained,0,0
48524,attention,0,0
48525,to,0,0
48526,the,0,0
48527,affected,0,0
48528,limb,0,0
48529,",",0,0
48530,in,0,0
48531,which,0,0
48532,case,0,0
48533,the,0,0
48534,order,0,0
48535,of,0,0
48536,MIP,0,0
48537,components,0,0
48538,would,0,0
48539,not,0,0
48540,alter,0,0
48541,the,0,0
48542,effect,0,0
48543,",",0,0
48544,and,0,0
48545,sequential,0,0
48546,activation,0,0
48547,of,0,0
48548,cortical,0,0
48549,motor,0,0
48550,networks,0,0
48551,",",0,0
48552,in,0,0
48553,which,0,0
48554,case,0,0
48555,it,0,0
48556,would,0,0
48557,.,0,0
48558,Twenty,0,0
48559,subjects,0,0
48560,with,0,0
48561,chronic,0,0
48562,CRPS1,0,1
48563,initiated,0,0
48564,by,0,0
48565,wrist,0,1
48566,fracture,0,0
48567,and,0,0
48568,who,0,0
48569,satisfied,0,0
48570,stringent,0,0
48571,inclusion,0,0
48572,criteria,0,0
48573,",",0,0
48574,were,0,0
48575,randomly,0,0
48576,allocated,0,0
48577,to,0,0
48578,one,0,0
48579,of,0,0
48580,three,0,0
48581,groups,0,0
48582,:,0,0
48583,hand,1,1
48584,laterality,1,0
48585,recognition,1,0
48586,",",1,0
48587,imagined,1,0
48588,movements,1,0
48589,",",1,0
48590,mirror,1,1
48591,movements,1,0
48592,(,1,0
48593,RecImMir,1,0
48594,",",1,0
48595,MIP,1,0
48596,),1,0
48597,;,1,0
48598,imagined,1,0
48599,movements,1,0
48600,",",1,0
48601,recognition,1,0
48602,",",1,0
48603,imagined,1,1
48604,movements,1,0
48605,(,1,0
48606,ImRecIm,1,0
48607,),1,0
48608,;,1,0
48609,recognition,1,0
48610,",",1,0
48611,mirror,1,0
48612,movements,1,0
48613,",",1,0
48614,recognition,1,0
48615,(,1,0
48616,RecMirRec,1,0
48617,),1,0
48618,.,1,0
48619,At,0,0
48620,6,0,0
48621,and,0,0
48622,18,0,0
48623,weeks,0,0
48624,",",0,0
48625,reduced,0,0
48626,pain,0,0
48627,and,0,0
48628,disability,0,0
48629,were,0,0
48630,greater,0,0
48631,for,0,0
48632,the,0,0
48633,RecImMir,0,0
48634,group,0,0
48635,than,0,0
48636,for,0,0
48637,the,0,0
48638,other,0,0
48639,groups,0,0
48640,(,0,0
48641,P,0,0
48642,<,0,0
48643,0.05,0,0
48644,),0,0
48645,.,0,0
48646,Hand,0,0
48647,laterality,0,0
48648,recognition,0,0
48649,imparted,0,0
48650,a,0,0
48651,consistent,0,0
48652,reduction,0,0
48653,in,0,0
48654,pain,0,0
48655,and,0,0
48656,disability,0,0
48657,across,0,0
48658,groups,0,0
48659,",",0,0
48660,however,0,0
48661,",",0,0
48662,this,0,0
48663,effect,0,0
48664,was,0,0
48665,limited,0,0
48666,in,0,0
48667,magnitude,0,0
48668,.,0,0
48669,Imagined,0,0
48670,movements,0,0
48671,imparted,0,0
48672,a,0,0
48673,further,0,0
48674,reduction,0,0
48675,in,0,0
48676,pain,0,0
48677,and,0,0
48678,disability,0,0
48679,",",0,0
48680,but,0,0
48681,only,0,0
48682,if,0,0
48683,they,0,0
48684,followed,0,0
48685,hand,0,1
48686,laterality,0,0
48687,recognition,0,0
48688,.,0,0
48689,Mirror,0,1
48690,movements,0,0
48691,also,0,0
48692,imparted,0,0
48693,a,0,0
48694,reduction,0,0
48695,in,0,0
48696,pain,0,0
48697,and,0,0
48698,disability,0,0
48699,",",0,0
48700,but,0,0
48701,only,0,0
48702,when,0,0
48703,they,0,0
48704,followed,0,0
48705,imagined,0,0
48706,movements,0,0
48707,.,0,0
48708,The,0,0
48709,effect,0,0
48710,of,0,0
48711,the,0,0
48712,MIP,0,0
48713,seems,0,0
48714,to,0,0
48715,be,0,0
48716,dependent,0,0
48717,on,0,0
48718,the,0,0
48719,order,0,0
48720,of,0,0
48721,components,0,0
48722,",",0,0
48723,which,0,0
48724,suggests,0,0
48725,that,0,0
48726,it,0,0
48727,is,0,0
48728,not,0,0
48729,due,0,0
48730,to,0,0
48731,sustained,0,0
48732,attention,0,0
48733,to,0,0
48734,the,0,0
48735,affected,0,0
48736,limb,0,0
48737,",",0,0
48738,but,0,0
48739,is,0,0
48740,consistent,0,0
48741,with,0,0
48742,sequential,0,0
48743,activation,0,0
48744,of,0,0
48745,cortical,0,0
48746,motor,0,0
48747,networks,0,0
48748,.,0,0
48749,Comparison,0,0
48750,of,0,0
48751,intravenous,0,1
48752,and,0,0
48753,intra-arterial,0,1
48754,urokinase,0,1
48755,thrombolysis,0,1
48756,for,0,0
48757,acute,0,0
48758,ischaemic,0,0
48759,stroke,0,0
48760,.,0,0
48761,Intravenous,1,0
48762,fibrinolysis,1,0
48763,(,1,0
48764,IVF,1,0
48765,),1,0
48766,with,1,0
48767,rt-PA,1,1
48768,(,1,0
48769,alteplase,1,1
48770,),1,1
48771,provides,0,0
48772,significant,0,0
48773,benefits,0,0
48774,in,0,0
48775,acute,0,0
48776,ischaemic,0,0
48777,stroke,0,0
48778,when,0,0
48779,it,0,0
48780,is,0,0
48781,given,0,0
48782,within,0,0
48783,the,0,0
48784,first,0,0
48785,three,0,0
48786,hours,0,0
48787,following,0,0
48788,stroke,0,0
48789,onset,0,0
48790,.,0,0
48791,Intra-arterial,1,1
48792,fibrinolysis,1,0
48793,(,1,0
48794,IAF,1,0
48795,),1,0
48796,with,1,0
48797,pro-urokinase,1,1
48798,in,0,0
48799,PROACT,0,0
48800,II,0,0
48801,study,0,0
48802,provides,0,0
48803,quite,0,0
48804,the,0,0
48805,same,0,0
48806,benefit,0,0
48807,in,0,0
48808,the,0,0
48809,first,0,0
48810,6,0,0
48811,hours,0,0
48812,.,0,0
48813,IVF,1,0
48814,and,0,0
48815,IAF,1,0
48816,have,0,0
48817,never,0,0
48818,been,0,0
48819,compared,0,0
48820,.,0,0
48821,To,0,0
48822,compare,0,0
48823,the,0,0
48824,efficacy,0,0
48825,and,0,0
48826,safety,0,0
48827,of,0,0
48828,IVF,1,0
48829,and,0,0
48830,IAF,1,0
48831,with,0,0
48832,urokinase,0,1
48833,given,0,0
48834,within,0,0
48835,the,0,0
48836,first,0,0
48837,6,0,0
48838,hours,0,0
48839,of,0,0
48840,acute,0,0
48841,ischaemic,0,0
48842,stroke,0,0
48843,.,0,0
48844,Patients,0,0
48845,fulfilling,0,0
48846,the,0,0
48847,selection,0,0
48848,criteria,0,0
48849,were,0,0
48850,randomly,0,0
48851,assigned,0,0
48852,to,0,0
48853,receive,0,0
48854,urokinase,1,1
48855,"900,000",0,0
48856,units,0,0
48857,via,0,0
48858,intravenous,0,1
48859,or,0,0
48860,intra-arterial,0,1
48861,routes,0,0
48862,.,0,0
48863,This,0,0
48864,randomised,0,0
48865,monocentre,0,0
48866,study,0,0
48867,was,0,0
48868,done,0,0
48869,between,0,0
48870,December,0,0
48871,1995,0,0
48872,and,0,0
48873,August,0,0
48874,1997,0,0
48875,.,0,0
48876,The,0,0
48877,primary,0,0
48878,outcome,0,0
48879,was,0,0
48880,defined,0,0
48881,as,0,0
48882,the,0,0
48883,number,0,0
48884,of,0,0
48885,patients,0,0
48886,with,0,0
48887,a,0,0
48888,modified,0,0
48889,Rankin,0,0
48890,score,0,0
48891,of,0,0
48892,2,0,0
48893,or,0,0
48894,less,0,0
48895,.,0,0
48896,Secondary,0,0
48897,outcomes,0,0
48898,included,0,0
48899,mortality,0,0
48900,",",0,0
48901,frequency,0,0
48902,of,0,0
48903,symptomatic,0,0
48904,intracranial,0,0
48905,haemorrhage,0,0
48906,(,0,0
48907,SIH,0,0
48908,),0,0
48909,",",0,0
48910,neurological,0,0
48911,and,0,0
48912,functional,0,0
48913,scores,0,0
48914,.,0,0
48915,Fourteen,0,0
48916,patients,0,0
48917,were,0,0
48918,given,0,0
48919,IVF,1,0
48920,and,0,0
48921,13,0,0
48922,IAF,1,0
48923,.,1,0
48924,The,0,0
48925,study,0,0
48926,was,0,0
48927,terminated,0,0
48928,by,0,0
48929,the,0,0
48930,National,0,0
48931,Health,0,0
48932,Authorities,0,0
48933,when,0,0
48934,27,0,0
48935,patients,0,0
48936,had,0,0
48937,been,0,0
48938,included,0,0
48939,because,0,0
48940,of,0,0
48941,the,0,0
48942,mortality,0,0
48943,rate,0,0
48944,.,0,0
48945,Seven,0,0
48946,patients,0,0
48947,(,0,0
48948,26,0,0
48949,%,0,0
48950,),0,0
48951,died,0,0
48952,",",0,0
48953,4,0,0
48954,in,0,0
48955,the,0,0
48956,IV,0,0
48957,group,0,0
48958,(,0,0
48959,oedematous,0,1
48960,infarct,0,0
48961,in,0,0
48962,3,0,0
48963,and,0,0
48964,recurrence,0,0
48965,in,0,0
48966,1,0,0
48967,),0,0
48968,",",0,0
48969,3,0,0
48970,in,0,0
48971,the,0,0
48972,IA,0,0
48973,group,0,0
48974,(,0,0
48975,SIH,0,0
48976,in,0,0
48977,2,0,0
48978,",",0,0
48979,and,0,0
48980,oedematous,0,1
48981,infarct,0,0
48982,in,0,0
48983,1,0,0
48984,),0,0
48985,.,0,0
48986,Patients,0,0
48987,given,0,0
48988,IVF,1,0
48989,were,0,0
48990,treated,0,0
48991,significantly,0,0
48992,earlier,0,0
48993,(,0,0
48994,4:16,0,0
48995,h,0,0
48996,vs,0,0
48997,5:24,0,0
48998,h,0,0
48999,;,0,0
49000,p=.007,0,0
49001,),0,0
49002,.,0,0
49003,Although,0,0
49004,IA,0,0
49005,patients,0,0
49006,showed,0,0
49007,greater,0,0
49008,and,0,0
49009,earlier,0,0
49010,improvement,0,0
49011,there,0,0
49012,was,0,0
49013,no,0,0
49014,significant,0,0
49015,difference,0,0
49016,in,0,0
49017,primary,0,0
49018,and,0,0
49019,secondary,0,0
49020,outcomes,0,0
49021,.,0,0
49022,Because,0,0
49023,of,0,0
49024,premature,0,0
49025,termination,0,0
49026,",",0,0
49027,the,0,0
49028,trial,0,0
49029,was,0,0
49030,too,0,0
49031,small,0,0
49032,to,0,0
49033,provide,0,0
49034,any,0,0
49035,reliable,0,0
49036,and,0,0
49037,conclusive,0,0
49038,results,0,0
49039,.,0,0
49040,Intra-arterial,0,0
49041,fibrinolysis,0,0
49042,began,0,0
49043,significantly,0,0
49044,later,0,0
49045,than,0,0
49046,IV,0,0
49047,fibrinolysis,0,0
49048,but,0,0
49049,it,0,0
49050,gave,0,0
49051,non-significantly,0,0
49052,better,0,0
49053,results,0,0
49054,in,0,0
49055,this,0,0
49056,prematurely,0,0
49057,terminated,0,0
49058,study,0,0
49059,.,0,0
49060,Treatment,0,1
49061,outcome,0,0
49062,of,0,0
49063,appliance,1,1
49064,therapy,1,1
49065,in,0,0
49066,temporomandibular,0,0
49067,disorder,0,0
49068,patients,0,0
49069,with,0,0
49070,myofascial,0,1
49071,pain,0,0
49072,after,0,0
49073,6,0,0
49074,and,0,0
49075,12,0,0
49076,months,0,0
49077,.,0,0
49078,AIM,0,0
49079,To,0,0
49080,compare,0,0
49081,the,0,0
49082,long-term,0,0
49083,effect,0,0
49084,of,0,0
49085,treatment,0,0
49086,with,0,0
49087,a,0,0
49088,stabilization,1,0
49089,appliance,1,1
49090,(,0,0
49091,group,0,0
49092,T,0,0
49093,),0,0
49094,and,0,0
49095,treatment,0,0
49096,with,0,0
49097,a,0,0
49098,control,1,1
49099,appliance,1,1
49100,(,0,0
49101,group,0,0
49102,C,0,1
49103,),0,0
49104,in,0,0
49105,temporomandibular,0,0
49106,disorder,0,0
49107,(,0,0
49108,TMD,0,1
49109,),0,0
49110,patients,0,0
49111,with,0,0
49112,myofascial,0,0
49113,pain,0,0
49114,.,0,0
49115,METHODS,0,0
49116,In,0,0
49117,this,0,0
49118,controlled,0,0
49119,trial,0,0
49120,",",0,0
49121,60,0,0
49122,patients,0,0
49123,(,0,0
49124,mean,0,0
49125,age,0,0
49126,29,0,0
49127,years,0,0
49128,),0,0
49129,with,0,0
49130,myofascial,0,1
49131,pain,0,0
49132,were,0,0
49133,evaluated,0,0
49134,after,0,0
49135,10,0,0
49136,weeks,0,0
49137,of,0,0
49138,treatment,0,0
49139,with,0,0
49140,either,0,0
49141,a,0,0
49142,stabilization,1,0
49143,appliance,1,1
49144,or,0,1
49145,a,0,0
49146,control,1,0
49147,appliance,1,1
49148,.,1,0
49149,All,0,0
49150,60,0,0
49151,patients,0,0
49152,were,0,0
49153,then,0,0
49154,assigned,0,0
49155,to,0,0
49156,1,0,0
49157,of,0,0
49158,3,0,0
49159,groups,0,0
49160,according,0,0
49161,to,0,0
49162,demand,0,0
49163,for,0,0
49164,treatment,0,0
49165,.,0,0
49166,Seventeen,0,0
49167,patients,0,0
49168,from,0,0
49169,group,0,0
49170,C,0,0
49171,requested,0,0
49172,another,0,0
49173,appliance,0,1
49174,and,0,0
49175,were,0,0
49176,given,0,0
49177,a,0,0
49178,stabilization,1,0
49179,appliance,1,1
49180,",",0,0
49181,thus,0,0
49182,creating,0,0
49183,a,0,0
49184,mixed,0,1
49185,group,0,0
49186,(,0,0
49187,group,0,0
49188,M,0,0
49189,),0,0
49190,.,0,0
49191,RESULTS,0,0
49192,A,0,0
49193,significant,0,0
49194,difference,0,0
49195,in,0,0
49196,improvement,0,0
49197,of,0,0
49198,overall,0,0
49199,subjective,0,0
49200,symptoms,0,0
49201,in,0,0
49202,an,0,0
49203,intent-to-treat,0,0
49204,analysis,0,0
49205,between,0,0
49206,groups,0,0
49207,T,0,0
49208,and,0,0
49209,C,0,0
49210,was,0,0
49211,found,0,0
49212,at,0,0
49213,the,0,0
49214,follow-ups,0,0
49215,.,0,0
49216,In,0,0
49217,a,0,0
49218,survival,0,0
49219,analysis,0,0
49220,of,0,0
49221,treatment,0,0
49222,compliance,0,0
49223,",",0,0
49224,a,0,0
49225,significant,0,0
49226,difference,0,0
49227,was,0,0
49228,found,0,0
49229,between,0,0
49230,groups,0,0
49231,T,0,0
49232,and,0,0
49233,C.,0,0
49234,At,0,0
49235,the,0,0
49236,6-,0,1
49237,and,0,0
49238,12-month,0,0
49239,follow-ups,0,0
49240,",",0,0
49241,a,0,0
49242,significant,0,0
49243,reduction,0,0
49244,in,0,0
49245,myofascial,0,1
49246,pain,0,0
49247,",",0,0
49248,as,0,0
49249,measured,0,0
49250,on,0,0
49251,a,0,0
49252,visual,0,0
49253,analog,0,0
49254,scale,0,0
49255,",",0,0
49256,was,0,0
49257,found,0,0
49258,in,0,0
49259,all,0,0
49260,three,0,0
49261,groups,0,0
49262,.,0,0
49263,A,0,0
49264,significant,0,0
49265,decrease,0,0
49266,in,0,0
49267,frequency,0,0
49268,and,0,0
49269,intensity,0,0
49270,of,0,0
49271,myofascial,0,1
49272,pain,0,0
49273,was,0,0
49274,found,0,0
49275,in,0,0
49276,group,0,0
49277,T,0,0
49278,at,0,0
49279,the,0,0
49280,follow-ups,0,0
49281,.,0,0
49282,A,0,0
49283,significant,0,0
49284,decrease,0,0
49285,in,0,0
49286,number,0,0
49287,of,0,0
49288,tender,0,0
49289,sites,0,0
49290,on,0,0
49291,the,0,0
49292,masticatory,0,0
49293,muscles,0,0
49294,was,0,0
49295,found,0,0
49296,in,0,0
49297,group,0,0
49298,T,0,0
49299,at,0,0
49300,the,0,0
49301,follow-ups,0,0
49302,.,0,0
49303,CONCLUSION,0,0
49304,The,0,0
49305,results,0,0
49306,support,0,0
49307,the,0,0
49308,conclusion,0,0
49309,that,0,0
49310,the,0,0
49311,positive,0,0
49312,treatment,0,0
49313,outcome,0,0
49314,obtained,0,0
49315,by,0,0
49316,use,0,0
49317,of,0,0
49318,a,0,0
49319,stabilization,1,0
49320,appliance,1,1
49321,to,0,0
49322,alleviate,0,0
49323,the,0,0
49324,signs,0,0
49325,and,0,0
49326,symptoms,0,0
49327,in,0,0
49328,patients,0,0
49329,with,0,0
49330,myofascial,0,1
49331,pain,0,0
49332,persisted,0,0
49333,after,0,0
49334,6,0,0
49335,and,0,0
49336,12,0,0
49337,months,0,0
49338,.,0,0
49339,Most,0,0
49340,patients,0,0
49341,in,0,0
49342,groups,0,0
49343,T,0,0
49344,and,0,0
49345,M,0,0
49346,reported,0,0
49347,positive,0,0
49348,changes,0,0
49349,in,0,0
49350,overall,0,0
49351,subjective,0,0
49352,symptoms,0,0
49353,in,0,0
49354,this,0,0
49355,trial,0,0
49356,.,0,0
49357,We,0,0
49358,therefore,0,0
49359,recommend,0,0
49360,use,0,0
49361,of,0,0
49362,the,0,0
49363,stabilization,1,0
49364,appliance,1,1
49365,in,0,0
49366,the,0,0
49367,treatment,0,0
49368,of,0,0
49369,TMD,0,0
49370,patients,0,0
49371,with,0,0
49372,myofascial,0,0
49373,pain,0,0
49374,.,0,0
49375,Effects,0,0
49376,of,0,0
49377,Saccharomyces,1,0
49378,boulardii,1,1
49379,in,0,0
49380,children,0,0
49381,with,0,0
49382,acute,0,0
49383,diarrhoea,0,0
49384,.,0,0
49385,AIM,0,0
49386,Certain,0,0
49387,probiotic,0,1
49388,agents,0,0
49389,",",0,0
49390,e.g,0,0
49391,.,0,0
49392,Lactobacillus,0,0
49393,GG,0,1
49394,",",0,0
49395,have,0,0
49396,shown,0,0
49397,efficacy,0,0
49398,in,0,0
49399,clinical,0,0
49400,trials,0,0
49401,for,0,0
49402,the,0,0
49403,treatment,0,0
49404,of,0,0
49405,acute,0,0
49406,childhood,0,0
49407,diarrhoea,0,0
49408,",",0,0
49409,but,0,0
49410,few,0,0
49411,studies,0,0
49412,have,0,0
49413,examined,0,0
49414,the,0,0
49415,effect,0,0
49416,of,0,0
49417,Saccharomyces,1,0
49418,boulardii,1,1
49419,.,1,0
49420,We,0,0
49421,evaluated,0,0
49422,the,0,0
49423,effect,0,0
49424,of,0,0
49425,S.,1,1
49426,boulardii,1,1
49427,in,0,0
49428,children,0,0
49429,with,0,0
49430,acute,0,0
49431,diarrhoea,0,0
49432,.,0,0
49433,METHODS,0,0
49434,Two,0,0
49435,hundred,0,0
49436,children,0,0
49437,were,0,0
49438,randomized,0,0
49439,to,0,0
49440,receive,0,0
49441,S.,1,1
49442,boulardii,1,1
49443,in,0,0
49444,a,0,0
49445,granulated,0,1
49446,form,0,0
49447,in,0,0
49448,a,0,0
49449,daily,0,0
49450,dose,0,0
49451,of,0,0
49452,250,0,1
49453,mg,0,1
49454,(,1,0
49455,S.,1,1
49456,boulardii,1,1
49457,group,0,0
49458,),0,0
49459,or,0,1
49460,placebo,1,1
49461,(,1,0
49462,placebo,1,1
49463,group,0,0
49464,),0,0
49465,for,0,0
49466,5,0,0
49467,d.,0,0
49468,Clinical,0,0
49469,and,0,0
49470,demographic,0,0
49471,characteristics,0,0
49472,on,0,0
49473,admission,0,0
49474,were,0,0
49475,similar,0,0
49476,between,0,0
49477,the,0,0
49478,study,0,0
49479,groups,0,0
49480,.,0,0
49481,RESULTS,0,0
49482,The,0,0
49483,medians,0,0
49484,of,0,0
49485,the,0,0
49486,average,0,0
49487,stool,0,0
49488,frequency,0,0
49489,after,0,0
49490,the,0,0
49491,second,0,0
49492,day,0,0
49493,of,0,0
49494,the,0,0
49495,treatment,0,0
49496,were,0,0
49497,significantly,0,0
49498,lower,0,0
49499,in,0,0
49500,the,0,0
49501,S.,1,1
49502,boulardii,1,1
49503,group,0,0
49504,than,0,0
49505,in,0,0
49506,the,0,0
49507,placebo,1,1
49508,group,0,0
49509,(,0,0
49510,p,0,0
49511,=,0,0
49512,0.003,0,0
49513,),0,0
49514,.,0,0
49515,The,0,0
49516,duration,0,0
49517,of,0,0
49518,diarrhoea,0,0
49519,significantly,0,0
49520,reduced,0,0
49521,in,0,0
49522,the,0,0
49523,S.,1,1
49524,boulardii,1,1
49525,group,0,0
49526,compared,0,0
49527,with,0,0
49528,the,0,0
49529,placebo,1,1
49530,group,0,0
49531,(,0,0
49532,4.7,0,0
49533,vs,0,0
49534,5.5,0,0
49535,d,0,0
49536,",",0,0
49537,p,0,0
49538,=,0,0
49539,0.03,0,0
49540,),0,0
49541,.,0,0
49542,The,0,0
49543,effect,0,0
49544,of,0,0
49545,S.,1,1
49546,boulardii,1,1
49547,on,0,0
49548,watery,0,0
49549,diarrhoea,0,0
49550,became,0,0
49551,apparent,0,0
49552,after,0,0
49553,the,0,0
49554,second,0,0
49555,day,0,0
49556,of,0,0
49557,the,0,0
49558,treatment,0,0
49559,.,0,0
49560,The,0,0
49561,duration,0,0
49562,of,0,0
49563,hospital,0,0
49564,stay,0,0
49565,was,0,0
49566,shorter,0,0
49567,in,0,0
49568,the,0,0
49569,S.,1,1
49570,boulardii,1,1
49571,group,0,0
49572,than,0,0
49573,in,0,0
49574,the,0,0
49575,placebo,1,1
49576,group,0,0
49577,(,0,0
49578,2.9,0,0
49579,vs,0,0
49580,3.9,0,0
49581,d,0,0
49582,",",0,0
49583,p,0,0
49584,<,0,0
49585,0.001,0,0
49586,),0,0
49587,.,0,0
49588,Four,0,0
49589,children,0,0
49590,from,0,0
49591,the,0,0
49592,placebo,1,1
49593,group,0,0
49594,versus,0,0
49595,only,0,0
49596,one,0,0
49597,child,0,0
49598,from,0,0
49599,the,0,0
49600,S.,1,1
49601,boulardii,1,1
49602,group,0,0
49603,had,0,0
49604,persisting,0,0
49605,diarrhoea,0,0
49606,.,0,0
49607,CONCLUSION,0,0
49608,The,0,0
49609,placebo-controlled,1,1
49610,study,0,0
49611,suggested,0,0
49612,that,0,0
49613,S.,1,0
49614,boulardii,1,1
49615,significantly,0,0
49616,reduced,0,0
49617,the,0,0
49618,duration,0,0
49619,of,0,0
49620,acute,0,0
49621,diarrhoea,0,0
49622,and,0,0
49623,the,0,0
49624,duration,0,0
49625,of,0,0
49626,hospital,0,0
49627,stay,0,0
49628,.,0,0
49629,S.,1,0
49630,boulardii,1,1
49631,seems,0,0
49632,to,0,0
49633,be,0,0
49634,a,0,0
49635,promising,0,0
49636,agent,0,0
49637,for,0,0
49638,the,0,0
49639,amelioration,0,0
49640,of,0,0
49641,the,0,0
49642,course,0,0
49643,of,0,0
49644,acute,0,0
49645,diarrhoea,0,0
49646,in,0,0
49647,children,0,0
49648,when,0,0
49649,used,0,0
49650,therapeutically,0,0
49651,.,0,0
49652,Comparative,0,0
49653,study,0,0
49654,of,0,0
49655,the,0,0
49656,efficacy,0,0
49657,of,0,0
49658,eprinomectin,1,1
49659,versus,1,0
49660,ivermectin,1,1
49661,",",0,0
49662,and,0,0
49663,field,0,0
49664,efficacy,0,0
49665,of,0,0
49666,eprinomectin,1,1
49667,only,0,0
49668,",",0,0
49669,for,0,0
49670,the,0,0
49671,treatment,0,0
49672,of,0,0
49673,chorioptic,0,0
49674,mange,0,0
49675,in,0,0
49676,alpacas,0,0
49677,.,0,0
49678,The,0,0
49679,efficacy,0,0
49680,of,0,0
49681,eprinomectin,1,1
49682,versus,0,1
49683,ivermectin,1,1
49684,(,0,0
49685,Study,0,0
49686,1,0,0
49687,:,0,0
49688,a,0,0
49689,single-centre,0,0
49690,",",0,0
49691,randomised,0,0
49692,",",0,0
49693,treatment-controlled,0,0
49694,",",0,0
49695,blinded,0,0
49696,field,0,0
49697,trial,0,0
49698,),0,0
49699,",",0,0
49700,and,0,0
49701,the,0,0
49702,field,0,0
49703,efficacy,0,0
49704,of,0,0
49705,eprinomectin,1,1
49706,(,0,0
49707,Study,0,0
49708,2,0,0
49709,:,0,0
49710,a,0,0
49711,single-centre,0,0
49712,",",0,0
49713,open,0,0
49714,",",0,0
49715,un-controlled,0,0
49716,field,0,0
49717,trial,0,0
49718,),0,0
49719,for,0,0
49720,the,0,0
49721,treatment,0,0
49722,of,0,0
49723,chorioptic,0,0
49724,infestation,0,0
49725,in,0,0
49726,naturally,0,0
49727,infested,0,0
49728,alpacas,0,0
49729,were,0,0
49730,assessed,0,0
49731,in,0,0
49732,two,0,0
49733,studies,0,0
49734,.,0,0
49735,Thirty,0,0
49736,alpacas,0,0
49737,",",0,0
49738,all,0,0
49739,positive,0,0
49740,for,0,0
49741,Chorioptes,0,0
49742,sp,0,0
49743,.,0,0
49744,mite,0,0
49745,",",0,0
49746,were,0,0
49747,randomly,0,0
49748,allocated,0,0
49749,to,0,0
49750,two,0,0
49751,treatment,0,0
49752,groups,0,0
49753,in,0,0
49754,Study,0,0
49755,1,0,0
49756,.,0,0
49757,Group,0,0
49758,A,0,0
49759,received,0,0
49760,a,0,0
49761,single,0,0
49762,topical,0,1
49763,administration,0,0
49764,of,0,0
49765,a,0,0
49766,0.5,0,0
49767,%,0,0
49768,formulation,0,0
49769,of,0,0
49770,eprinomectin,1,1
49771,at,0,0
49772,the,0,0
49773,dose,0,0
49774,rate,0,0
49775,of,0,0
49776,500mug/kg,0,1
49777,.,0,0
49778,Group,0,0
49779,B,0,0
49780,received,0,0
49781,three,0,0
49782,subcutaneous,0,0
49783,administrations,0,0
49784,at,0,0
49785,14,0,0
49786,days,0,0
49787,interval,0,0
49788,of,0,0
49789,a,0,0
49790,1,0,0
49791,%,0,0
49792,formulation,0,0
49793,of,0,0
49794,ivermectin,1,1
49795,at,0,0
49796,the,0,0
49797,dose,0,0
49798,rate,0,0
49799,of,0,0
49800,400mug/kg,0,0
49801,.,0,0
49802,Response,0,0
49803,to,0,0
49804,treatment,0,0
49805,was,0,0
49806,assessed,0,0
49807,by,0,0
49808,periodic,0,1
49809,mite,0,0
49810,count,0,0
49811,",",0,0
49812,and,0,0
49813,skin,0,0
49814,lesions,0,0
49815,scored,0,0
49816,.,0,0
49817,In,0,0
49818,Study,0,0
49819,2,0,0
49820,",",0,0
49821,one,0,0
49822,group,0,0
49823,of,0,0
49824,19,0,0
49825,alpacas,0,0
49826,received,0,0
49827,four,0,0
49828,administrations,0,0
49829,at,0,0
49830,weekly,0,1
49831,interval,0,0
49832,of,0,0
49833,topical,0,1
49834,eprinomectin,1,1
49835,at,0,0
49836,the,0,0
49837,dose,0,0
49838,rate,0,0
49839,of,0,0
49840,500mug/kg,0,1
49841,",",0,0
49842,and,0,0
49843,response,0,0
49844,to,0,0
49845,treatment,0,0
49846,was,0,0
49847,monitored,0,0
49848,by,0,0
49849,mite,0,0
49850,counts,0,0
49851,.,0,0
49852,No,0,0
49853,localised,0,0
49854,or,0,0
49855,systemic,0,0
49856,side,0,0
49857,effects,0,0
49858,were,0,0
49859,observed,0,0
49860,in,0,0
49861,either,0,0
49862,trial,0,0
49863,.,0,0
49864,There,0,0
49865,was,0,0
49866,a,0,0
49867,statistically,0,0
49868,significant,0,0
49869,decrease,0,0
49870,in,0,0
49871,mite,0,0
49872,counts,0,0
49873,on,0,0
49874,day,0,0
49875,7,0,0
49876,(,0,0
49877,P,0,0
49878,<,0,0
49879,0.001,0,0
49880,),0,0
49881,within,0,0
49882,treatment,0,0
49883,Groups,0,0
49884,A,0,0
49885,and,0,0
49886,B,0,0
49887,of,0,0
49888,Study,0,0
49889,1,0,0
49890,",",0,0
49891,but,0,0
49892,mite,0,0
49893,counts,0,0
49894,increased,0,0
49895,again,0,0
49896,on,0,0
49897,day,0,0
49898,14,0,0
49899,and,0,0
49900,remained,0,0
49901,high,0,0
49902,for,0,0
49903,the,0,0
49904,duration,0,0
49905,of,0,0
49906,the,0,0
49907,trial,0,0
49908,in,0,0
49909,both,0,0
49910,treatment,0,0
49911,groups,0,0
49912,.,0,0
49913,On,0,0
49914,day,0,0
49915,14,0,0
49916,of,0,0
49917,Study,0,0
49918,2,0,0
49919,",",0,0
49920,there,0,0
49921,was,0,0
49922,a,0,0
49923,statistically,0,0
49924,significant,0,0
49925,reduction,0,0
49926,in,0,0
49927,mite,0,0
49928,counts,0,0
49929,(,0,0
49930,P,0,0
49931,<,0,0
49932,0.008,0,0
49933,),0,0
49934,and,0,0
49935,the,0,0
49936,mite,0,0
49937,counts,0,0
49938,remained,0,0
49939,very,0,0
49940,low,0,0
49941,throughout,0,0
49942,the,0,0
49943,remainder,0,0
49944,of,0,0
49945,the,0,0
49946,study,0,0
49947,.,0,0
49948,The,0,0
49949,eprinomectin,1,1
49950,protocol,0,0
49951,employed,0,0
49952,in,0,0
49953,Study,0,0
49954,2,0,0
49955,",",0,0
49956,consisting,0,0
49957,of,0,0
49958,four,0,0
49959,weekly,0,0
49960,topical,0,1
49961,administrations,0,0
49962,at,0,0
49963,the,0,0
49964,dose,0,0
49965,rate,0,0
49966,of,0,0
49967,500mug/kg,0,1
49968,of,0,0
49969,body,0,0
49970,weight,0,0
49971,",",0,0
49972,proved,0,0
49973,highly,0,0
49974,effective,0,0
49975,at,0,0
49976,reducing,0,0
49977,the,0,0
49978,Chorioptes,0,0
49979,mite,0,0
49980,burden,0,0
49981,in,0,0
49982,alpacas,0,0
49983,.,0,0
49984,Effects,0,0
49985,of,0,0
49986,congestive,0,0
49987,heart,0,0
49988,failure,0,0
49989,on,0,0
49990,plasma,0,0
49991,von,0,0
49992,Willebrand,0,0
49993,factor,0,0
49994,and,0,0
49995,soluble,0,1
49996,P-selectin,0,0
49997,concentrations,0,0
49998,in,0,0
49999,patients,0,0
50000,with,0,0
50001,non-valvar,0,0
50002,atrial,0,0
50003,fibrillation,0,0
50004,.,0,0
50005,OBJECTIVE,0,0
50006,To,0,0
50007,examine,0,0
50008,further,0,0
50009,the,0,0
50010,relations,0,0
50011,of,0,0
50012,plasma,0,0
50013,von,0,0
50014,Willebrand,1,0
50015,factor,1,1
50016,(,0,0
50017,vWf,0,0
50018,",",0,0
50019,an,0,0
50020,index,0,0
50021,of,0,0
50022,endothelial,0,0
50023,damage,0,0
50024,and,0,0
50025,dysfunction,0,0
50026,),0,0
50027,and,0,0
50028,soluble,0,1
50029,P-selectin,1,1
50030,(,0,0
50031,sP-sel,0,0
50032,",",0,0
50033,an,0,0
50034,index,0,0
50035,of,0,0
50036,platelet,0,0
50037,activation,0,0
50038,),0,0
50039,concentrations,0,0
50040,to,0,0
50041,the,0,0
50042,presence,0,0
50043,and,0,0
50044,onset,0,0
50045,of,0,0
50046,clinical,0,0
50047,congestive,0,0
50048,heart,0,0
50049,failure,0,0
50050,(,0,0
50051,CHF,0,0
50052,),0,0
50053,and,0,0
50054,the,0,0
50055,degree,0,0
50056,of,0,0
50057,left,0,0
50058,ventricular,0,0
50059,(,0,0
50060,LV,0,1
50061,),0,0
50062,dysfunction,0,0
50063,in,0,0
50064,patients,0,0
50065,taking,0,0
50066,part,0,0
50067,in,0,0
50068,the,0,0
50069,SPAF,0,0
50070,(,0,0
50071,stroke,0,0
50072,prevention,0,0
50073,in,0,0
50074,atrial,0,0
50075,fibrillation,0,0
50076,),0,0
50077,study,0,0
50078,.,0,0
50079,METHODS,0,0
50080,Plasma,0,0
50081,concentrations,0,0
50082,of,0,0
50083,vWf,1,0
50084,and,1,0
50085,sP-sel,1,0
50086,were,0,0
50087,measured,0,0
50088,by,0,0
50089,enzyme,0,0
50090,linked,0,0
50091,immunosorbent,0,0
50092,assay,0,0
50093,(,0,0
50094,ELISA,0,0
50095,),0,0
50096,in,0,0
50097,1321,0,0
50098,participants,0,0
50099,in,0,0
50100,the,0,0
50101,SPAF,0,0
50102,III,0,0
50103,study,0,0
50104,and,0,0
50105,related,0,0
50106,to,0,0
50107,the,0,0
50108,presence,0,0
50109,and,0,0
50110,onset,0,0
50111,of,0,0
50112,clinical,0,0
50113,CHF,0,0
50114,",",0,0
50115,as,0,0
50116,well,0,0
50117,as,0,0
50118,echocardiographic,0,0
50119,findings,0,0
50120,.,0,0
50121,Of,0,0
50122,the,0,0
50123,1321,0,0
50124,patients,0,0
50125,with,0,0
50126,atrial,0,0
50127,fibrillation,0,0
50128,(,0,0
50129,AF,0,1
50130,),0,0
50131,",",0,0
50132,331,0,0
50133,(,0,0
50134,25,0,0
50135,%,0,0
50136,),0,0
50137,had,0,0
50138,a,0,0
50139,documented,0,0
50140,history,0,0
50141,of,0,0
50142,clinical,0,0
50143,heart,0,0
50144,failure,0,0
50145,",",0,0
50146,of,0,0
50147,which,0,0
50148,168,0,0
50149,cases,0,0
50150,were,0,0
50151,related,0,0
50152,to,0,0
50153,a,0,0
50154,new,0,0
50155,or,0,0
50156,recurrent,0,0
50157,episode,0,0
50158,of,0,0
50159,acute,0,0
50160,decompensated,0,0
50161,heart,0,0
50162,failure,0,0
50163,occurring,0,0
50164,within,0,0
50165,the,0,0
50166,preceding,0,0
50167,three,0,0
50168,months,0,0
50169,.,0,0
50170,RESULTS,0,0
50171,Mean,0,0
50172,plasma,0,0
50173,vWf,0,0
50174,was,0,0
50175,higher,0,0
50176,among,0,0
50177,patients,0,0
50178,with,0,0
50179,AF,0,0
50180,and,0,0
50181,CHF,0,0
50182,(,0,0
50183,154,0,0
50184,(,0,0
50185,29,0,0
50186,),0,0
50187,v,0,0
50188,144,0,0
50189,(,0,0
50190,31,0,0
50191,),0,0
50192,IU/dl,0,0
50193,",",0,0
50194,p,0,0
50195,<,0,0
50196,0.001,0,0
50197,),0,0
50198,",",0,0
50199,particularly,0,0
50200,those,0,0
50201,with,0,0
50202,acute,0,0
50203,or,0,0
50204,recent,0,0
50205,decompensated,0,0
50206,symptoms,0,0
50207,.,0,0
50208,Patients,0,0
50209,with,0,0
50210,severe,0,0
50211,LV,0,1
50212,dysfunction,0,0
50213,on,0,0
50214,two,0,0
50215,dimensional,0,0
50216,echocardiography,0,0
50217,and,0,0
50218,low,0,0
50219,fractional,0,0
50220,shortening,0,0
50221,also,0,0
50222,had,0,0
50223,significantly,0,0
50224,higher,0,0
50225,vWf,0,0
50226,concentrations,0,0
50227,than,0,0
50228,those,0,0
50229,with,0,0
50230,no,0,0
50231,LV,0,0
50232,dysfunction,0,0
50233,.,0,0
50234,CHF,0,0
50235,patients,0,0
50236,with,0,0
50237,clinical,0,0
50238,features,0,0
50239,--,0,0
50240,with,0,0
50241,(,0,0
50242,156,0,0
50243,(,0,0
50244,28,0,0
50245,),0,0
50246,IU/dl,0,0
50247,),0,0
50248,and,0,0
50249,without,0,1
50250,(,0,0
50251,152,0,0
50252,(,0,0
50253,31,0,0
50254,),0,0
50255,IU/dl,0,0
50256,),0,0
50257,LV,0,1
50258,dysfunction,0,0
50259,--,0,0
50260,also,0,0
50261,had,0,0
50262,higher,0,0
50263,mean,0,0
50264,vWf,0,0
50265,concentrations,0,0
50266,than,0,0
50267,patients,0,0
50268,with,0,0
50269,asymptomatic,0,0
50270,LV,0,1
50271,dysfunction,0,0
50272,(,0,0
50273,146,0,0
50274,(,0,0
50275,31,0,0
50276,),0,0
50277,IU/dl,0,0
50278,",",0,0
50279,p,0,0
50280,<,0,0
50281,0.001,0,0
50282,),0,0
50283,.,0,0
50284,The,0,0
50285,presence,0,0
50286,of,0,0
50287,mitral,0,0
50288,regurgitation,0,0
50289,in,0,0
50290,CHF,0,0
50291,was,0,0
50292,associated,0,0
50293,with,0,0
50294,lower,0,0
50295,vWf,0,0
50296,concentrations,0,0
50297,.,0,0
50298,Plasma,0,0
50299,sP-sel,0,0
50300,concentrations,0,0
50301,were,0,0
50302,not,0,0
50303,affected,0,0
50304,by,0,0
50305,presence,0,0
50306,",",0,0
50307,onset,0,0
50308,",",0,0
50309,or,0,0
50310,severity,0,0
50311,of,0,0
50312,heart,0,0
50313,failure,0,0
50314,.,0,0
50315,CONCLUSIONS,0,0
50316,CHF,0,0
50317,may,0,0
50318,contribute,0,0
50319,to,0,0
50320,hypercoagulability,0,0
50321,and,0,0
50322,thrombotic,0,0
50323,risk,0,0
50324,in,0,0
50325,AF,0,0
50326,through,0,0
50327,increased,0,0
50328,endothelial,0,0
50329,damage,0,0
50330,and,0,0
50331,dysfunction,0,0
50332,.,0,0
50333,Patients,0,0
50334,with,0,0
50335,acute,0,0
50336,or,0,0
50337,recent,0,0
50338,decompensated,0,0
50339,features,0,0
50340,have,0,0
50341,the,0,0
50342,highest,0,0
50343,degree,0,0
50344,of,0,0
50345,endothelial,0,0
50346,damage,0,0
50347,and,0,0
50348,dysfunction,0,0
50349,.,0,0
50350,The,0,0
50351,presence,0,0
50352,of,0,0
50353,CHF,0,0
50354,clinical,0,0
50355,features,0,0
50356,was,0,0
50357,an,0,0
50358,important,0,0
50359,determinant,0,0
50360,of,0,0
50361,plasma,0,0
50362,vWf,0,0
50363,concentrations,0,0
50364,.,0,0
50365,A,0,0
50366,short-term,1,0
50367,cognitive,1,0
50368,group,1,0
50369,treatment,1,0
50370,program,1,1
50371,gives,0,0
50372,substantial,0,0
50373,weight,0,0
50374,reduction,0,0
50375,up,0,0
50376,to,0,0
50377,18,0,0
50378,months,0,0
50379,from,0,0
50380,the,0,0
50381,end,0,0
50382,of,0,0
50383,treatment,0,0
50384,.,0,0
50385,A,0,0
50386,randomized,0,0
50387,controlled,0,0
50388,trial,0,0
50389,.,0,0
50390,OBJECTIVE,0,0
50391,To,0,0
50392,describe,0,0
50393,and,0,0
50394,evaluate,0,0
50395,long-term,0,0
50396,efficacy,0,0
50397,(,0,0
50398,18,0,0
50399,months,0,0
50400,from,0,0
50401,the,0,0
50402,end,0,0
50403,of,0,0
50404,treatment,0,0
50405,),0,0
50406,of,0,0
50407,a,0,0
50408,new,0,0
50409,cognitive,1,0
50410,short-term,1,0
50411,weight,1,0
50412,reducing,1,0
50413,treatment,1,0
50414,program,1,1
50415,for,0,0
50416,obese,0,0
50417,patients,0,0
50418,.,0,0
50419,SUBJECTS,0,0
50420,One,0,0
50421,hundred,0,0
50422,and,0,0
50423,five,0,0
50424,obese,0,0
50425,[,0,0
50426,Body,0,1
50427,Mass,0,0
50428,Index,0,1
50429,(,0,0
50430,BMI,0,0
50431,),0,0
50432,>,0,0
50433,or,0,0
50434,=,0,0
50435,30,0,0
50436,],0,0
50437,patients,0,0
50438,participated,0,0
50439,in,0,0
50440,the,0,0
50441,study,0,0
50442,.,0,0
50443,Of,0,0
50444,these,0,0
50445,",",0,0
50446,62,0,0
50447,took,0,0
50448,part,0,0
50449,in,0,0
50450,the,0,0
50451,treatment,0,0
50452,program,0,1
50453,and,0,0
50454,43,0,0
50455,served,0,0
50456,as,0,0
50457,controls,0,0
50458,.,0,0
50459,METHOD,0,0
50460,From,0,0
50461,an,0,0
50462,obesity,0,0
50463,unit,0,0
50464,'s,0,0
50465,waiting,0,0
50466,list,0,0
50467,",",0,0
50468,the,0,0
50469,patients,0,0
50470,were,0,0
50471,randomly,0,0
50472,assigned,0,0
50473,to,0,0
50474,either,0,0
50475,a,0,0
50476,treatment,0,0
50477,group,0,0
50478,or,0,1
50479,remained,0,0
50480,in,0,0
50481,the,0,0
50482,waiting,0,0
50483,list,0,0
50484,to,0,0
50485,serve,0,0
50486,as,0,0
50487,a,0,0
50488,control,1,0
50489,group,0,0
50490,.,0,0
50491,The,0,0
50492,treatment,0,0
50493,group,0,0
50494,participated,0,0
50495,in,0,0
50496,a,0,0
50497,10-week,1,1
50498,(,1,0
50499,30,1,0
50500,hours,1,0
50501,),1,0
50502,cognitive,1,0
50503,group,1,0
50504,treatment,1,0
50505,program,1,1
50506,.,1,0
50507,All,0,0
50508,participants,0,0
50509,were,0,0
50510,weighed,0,0
50511,at,0,0
50512,the,0,0
50513,outset,0,0
50514,of,0,0
50515,the,0,0
50516,study,0,0
50517,",",0,0
50518,directly,0,0
50519,after,0,0
50520,treatment,0,0
50521,and,0,0
50522,at,0,0
50523,a,0,0
50524,6-,0,0
50525,",",0,0
50526,12-,0,0
50527,and,0,0
50528,18-month,0,0
50529,post-treatment,1,0
50530,follow-up,0,0
50531,without,0,0
50532,any,0,0
50533,booster,0,0
50534,treatment,1,0
50535,after,0,0
50536,the,0,0
50537,10-week,0,1
50538,program,0,1
50539,.,0,0
50540,RESULTS,0,0
50541,Fifty-seven,0,0
50542,(,0,0
50543,92,0,0
50544,%,0,0
50545,),0,0
50546,patients,0,0
50547,completed,0,0
50548,treatment,1,0
50549,.,1,0
50550,For,0,0
50551,the,0,0
50552,34,0,0
50553,(,0,0
50554,60,0,0
50555,%,0,0
50556,),0,0
50557,patients,0,0
50558,who,0,0
50559,participated,0,0
50560,in,0,0
50561,the,0,0
50562,study,0,0
50563,18,0,0
50564,months,0,0
50565,after,0,0
50566,treatment,0,0
50567,was,0,0
50568,terminated,0,0
50569,",",0,0
50570,the,0,0
50571,mean,0,0
50572,weight,0,0
50573,loss,0,0
50574,at,0,0
50575,treatment,0,0
50576,'s,0,0
50577,end,0,0
50578,was,0,0
50579,8.5,0,0
50580,kg,0,0
50581,(,0,0
50582,SD=16.1,0,0
50583,),0,0
50584,.,0,0
50585,Eighteen,0,0
50586,months,0,0
50587,later,0,0
50588,their,0,0
50589,mean,0,0
50590,weight,0,0
50591,loss,0,0
50592,was,0,0
50593,10.4,0,0
50594,kg,0,0
50595,(,0,0
50596,SD=10.8,0,0
50597,),0,0
50598,.,0,0
50599,The,0,0
50600,control,0,0
50601,patients,0,0
50602,(,0,0
50603,n=31.72,0,0
50604,%,0,0
50605,),0,0
50606,that,0,0
50607,participated,0,0
50608,in,0,0
50609,the,0,0
50610,study,0,0
50611,during,0,0
50612,the,0,0
50613,same,0,0
50614,period,0,0
50615,increased,0,0
50616,in,0,0
50617,weight,0,0
50618,by,0,0
50619,2.3,0,0
50620,kg,0,0
50621,(,0,0
50622,SD=7.0,0,0
50623,),0,0
50624,.,0,0
50625,The,0,0
50626,weight,0,0
50627,difference,0,0
50628,between,0,0
50629,the,0,0
50630,treatment,0,0
50631,and,0,0
50632,control,0,1
50633,group,0,0
50634,at,0,0
50635,the,0,0
50636,18-month,0,0
50637,follow-up,0,0
50638,was,0,0
50639,highly,0,0
50640,significant,0,0
50641,(,0,0
50642,p,0,0
50643,<,0,0
50644,0.001,0,0
50645,),0,0
50646,.,0,0
50647,CONCLUSION,0,0
50648,The,0,0
50649,cognitive,1,0
50650,group,1,0
50651,treatment,1,0
50652,program,1,1
50653,was,0,0
50654,highly,0,0
50655,acceptable,0,0
50656,among,0,0
50657,the,0,0
50658,participants,0,0
50659,and,0,0
50660,was,0,0
50661,completed,0,0
50662,by,0,0
50663,nearly,0,0
50664,all,0,0
50665,the,0,0
50666,patients,0,0
50667,.,0,0
50668,The,0,0
50669,10-week,0,1
50670,treatment,0,0
50671,program,0,1
50672,resulted,0,0
50673,in,0,0
50674,satisfactory,0,0
50675,weight,0,0
50676,loss,0,0
50677,.,0,0
50678,The,0,0
50679,weight,0,0
50680,difference,0,0
50681,between,0,0
50682,the,0,0
50683,treatment,1,0
50684,group,0,0
50685,and,0,0
50686,controls,1,0
50687,was,0,0
50688,nearly,0,0
50689,the,0,0
50690,same,0,0
50691,at,0,0
50692,18,0,0
50693,months,0,0
50694,after,0,0
50695,end,0,0
50696,of,0,0
50697,treatment,0,0
50698,as,0,0
50699,at,0,0
50700,six,0,0
50701,months,0,0
50702,.,0,0
50703,The,0,0
50704,study,0,0
50705,",",0,0
50706,therefore,0,0
50707,",",0,0
50708,does,0,0
50709,not,0,0
50710,provide,0,0
50711,support,0,0
50712,for,0,0
50713,the,0,0
50714,contention,0,0
50715,that,0,0
50716,a,0,0
50717,lengthy,0,0
50718,therapy,0,1
50719,for,0,0
50720,obesity,0,0
50721,is,0,0
50722,necessary,0,0
50723,if,0,0
50724,treatment,0,0
50725,results,0,0
50726,are,0,0
50727,lasting,0,0
50728,.,0,0
50729,Acute,0,0
50730,pressor,0,1
50731,and,0,0
50732,hormonal,0,0
50733,effects,0,0
50734,of,0,0
50735,beta-endorphin,1,0
50736,at,0,0
50737,high,0,0
50738,doses,0,0
50739,in,0,0
50740,healthy,0,0
50741,and,0,0
50742,hypertensive,0,0
50743,subjects,0,0
50744,:,0,0
50745,role,0,0
50746,of,0,0
50747,opioid,0,1
50748,receptor,0,0
50749,agonism,0,0
50750,.,0,0
50751,CONTEXT,0,0
50752,The,0,0
50753,opioid,0,1
50754,system,0,0
50755,is,0,0
50756,involved,0,0
50757,in,0,0
50758,blood,0,0
50759,pressure,0,0
50760,regulation,0,0
50761,in,0,0
50762,both,0,0
50763,normal,0,0
50764,humans,0,0
50765,and,0,0
50766,patients,0,0
50767,with,0,0
50768,essential,0,0
50769,hypertension,0,0
50770,.,0,0
50771,OBJECTIVE,0,0
50772,The,0,0
50773,objective,0,0
50774,of,0,0
50775,the,0,0
50776,study,0,0
50777,was,0,0
50778,to,0,0
50779,investigate,0,0
50780,the,0,0
50781,effects,0,0
50782,of,0,0
50783,a,0,0
50784,high-dose,0,1
50785,infusion,0,1
50786,of,0,0
50787,beta-endorphin,1,0
50788,",",0,0
50789,an,0,0
50790,opioid,0,1
50791,peptide,0,0
50792,",",0,0
50793,on,0,0
50794,blood,0,0
50795,pressure,0,0
50796,and,0,0
50797,on,0,0
50798,the,0,0
50799,hormonal,0,0
50800,profile,0,0
50801,in,0,0
50802,healthy,0,0
50803,subjects,0,0
50804,and,0,0
50805,in,0,0
50806,hypertensive,0,0
50807,patients,0,0
50808,and,0,0
50809,the,0,0
50810,mediation,0,0
50811,played,0,0
50812,by,0,0
50813,opioid,0,1
50814,receptor,0,0
50815,agonism,0,0
50816,.,0,0
50817,DESIGN,0,0
50818,",",0,0
50819,SETTING,0,0
50820,",",0,0
50821,AND,0,0
50822,PARTICIPANTS,0,0
50823,According,0,0
50824,to,0,0
50825,a,0,0
50826,randomized,0,0
50827,double-blind,0,0
50828,design,0,0
50829,",",0,0
50830,11,0,0
50831,healthy,0,0
50832,subjects,0,0
50833,(,0,0
50834,controls,0,0
50835,),0,0
50836,and,0,0
50837,12,0,0
50838,hypertensive,0,0
50839,inpatients,0,0
50840,(,0,0
50841,mean,0,0
50842,age,0,0
50843,",",0,0
50844,38.9,0,0
50845,and,0,0
50846,40.4,0,0
50847,yr,0,0
50848,",",0,0
50849,respectively,0,0
50850,),0,0
50851,received,0,0
50852,1-h,1,0
50853,iv,1,0
50854,infusion,1,1
50855,of,1,0
50856,beta-endorphin,1,0
50857,(,1,0
50858,250,1,1
50859,mug/h,1,0
50860,),1,0
50861,and,1,0
50862,",",1,0
50863,on,1,0
50864,another,1,0
50865,occasion,1,0
50866,",",1,0
50867,the,1,0
50868,same,1,0
50869,infusion,1,1
50870,protocol,1,0
50871,preceded,1,0
50872,by,1,0
50873,the,1,0
50874,opioid,1,1
50875,antagonist,1,1
50876,naloxone,1,1
50877,(,1,0
50878,8,1,0
50879,mg,1,1
50880,),1,0
50881,.,1,0
50882,MAIN,0,0
50883,OUTCOME,0,0
50884,MEASURES,0,0
50885,Hemodynamic,0,0
50886,and,0,0
50887,hormonal,0,0
50888,measurements,0,0
50889,were,0,0
50890,performed,0,0
50891,at,0,0
50892,established,0,0
50893,times,0,0
50894,during,0,0
50895,the,0,0
50896,infusion,0,0
50897,protocols,0,0
50898,.,0,0
50899,RESULTS,0,0
50900,At,0,0
50901,baseline,0,0
50902,",",0,0
50903,circulating,0,0
50904,beta-endorphin,0,0
50905,",",0,0
50906,norepinephrine,0,0
50907,",",0,0
50908,and,0,0
50909,endothelin-1,0,0
50910,in,0,0
50911,hypertensive,0,0
50912,patients,0,0
50913,were,0,0
50914,significantly,0,0
50915,(,0,0
50916,P,0,0
50917,<,0,0
50918,0.05,0,0
50919,),0,0
50920,higher,0,0
50921,than,0,0
50922,in,0,0
50923,controls,0,0
50924,.,0,0
50925,In,0,0
50926,controls,0,0
50927,",",0,0
50928,beta-endorphin,0,0
50929,reduced,0,0
50930,blood,0,0
50931,pressure,0,0
50932,(,0,0
50933,P,0,0
50934,<,0,0
50935,0.01,0,0
50936,),0,0
50937,and,0,0
50938,circulating,0,0
50939,norepinephrine,0,1
50940,(,0,0
50941,P,0,0
50942,<,0,0
50943,0.02,0,0
50944,),0,0
50945,and,0,0
50946,increased,0,0
50947,plasma,0,0
50948,atrial,0,0
50949,natriuretic,0,1
50950,factor,0,0
50951,(,0,0
50952,P,0,0
50953,<,0,0
50954,0.003,0,0
50955,),0,0
50956,and,0,0
50957,GH,0,1
50958,(,0,0
50959,P,0,0
50960,<,0,0
50961,0.0001,0,0
50962,),0,0
50963,.,0,0
50964,In,0,0
50965,hypertensive,0,0
50966,patients,0,0
50967,",",0,0
50968,beta-endorphin,1,0
50969,decreased,0,0
50970,systemic,0,0
50971,vascular,0,0
50972,resistance,0,0
50973,(,0,0
50974,P,0,0
50975,<,0,0
50976,0.0001,0,0
50977,),0,0
50978,",",0,0
50979,blood,0,0
50980,pressure,0,0
50981,(,0,0
50982,P,0,0
50983,<,0,0
50984,0.0001,0,0
50985,),0,0
50986,",",0,0
50987,and,0,0
50988,plasma,0,0
50989,norepinephrine,0,1
50990,(,0,0
50991,P,0,0
50992,<,0,0
50993,0.0001,0,0
50994,),0,0
50995,and,0,0
50996,endothelin-1,0,1
50997,(,0,0
50998,P,0,0
50999,<,0,0
51000,0.0001,0,0
51001,),0,0
51002,and,0,0
51003,raised,0,0
51004,circulating,0,0
51005,atrial,0,0
51006,natriuretic,0,1
51007,factor,0,0
51008,(,0,0
51009,P,0,0
51010,<,0,0
51011,0.0001,0,0
51012,),0,0
51013,",",0,0
51014,GH,0,1
51015,(,0,0
51016,P,0,0
51017,<,0,0
51018,0.0001,0,0
51019,),0,0
51020,",",0,0
51021,and,0,0
51022,IGF-I,0,1
51023,(,0,0
51024,P,0,0
51025,<,0,0
51026,0.0001,0,0
51027,),0,0
51028,.,0,0
51029,These,0,0
51030,hemodynamic,0,0
51031,and,0,0
51032,hormonal,0,0
51033,responses,0,0
51034,to,0,0
51035,beta-endorphin,0,0
51036,in,0,0
51037,hypertensive,0,0
51038,patients,0,0
51039,were,0,0
51040,significantly,0,0
51041,(,0,0
51042,P,0,0
51043,<,0,0
51044,0.0001,0,0
51045,),0,0
51046,greater,0,0
51047,than,0,0
51048,in,0,0
51049,controls,0,0
51050,but,0,0
51051,were,0,0
51052,annulled,0,0
51053,in,0,0
51054,all,0,0
51055,individuals,0,0
51056,when,0,0
51057,naloxone,0,1
51058,preceded,0,0
51059,beta-endorphin,0,0
51060,infusion,0,1
51061,.,0,0
51062,CONCLUSIONS,0,0
51063,High,0,0
51064,doses,0,0
51065,of,0,0
51066,beta-endorphin,1,0
51067,induce,0,0
51068,hypotensive,0,0
51069,and,0,0
51070,beneficial,0,0
51071,hormonal,0,0
51072,effects,0,0
51073,in,0,0
51074,humans,0,0
51075,",",0,0
51076,which,0,0
51077,are,0,0
51078,enhanced,0,0
51079,in,0,0
51080,essential,0,0
51081,hypertension,0,0
51082,and,0,0
51083,are,0,0
51084,mediated,0,0
51085,by,0,0
51086,opioid,0,0
51087,receptors,0,0
51088,.,0,0
51089,Safety,0,0
51090,",",0,0
51091,tolerability,0,0
51092,",",0,0
51093,and,0,0
51094,changes,0,0
51095,in,0,0
51096,amyloid,0,0
51097,beta,0,1
51098,concentrations,0,0
51099,after,0,0
51100,administration,0,0
51101,of,0,0
51102,a,0,0
51103,gamma-secretase,1,1
51104,inhibitor,1,1
51105,in,0,0
51106,volunteers,0,0
51107,.,0,0
51108,Amyloid,0,0
51109,beta,0,1
51110,(,0,0
51111,Abeta,0,1
51112,),0,0
51113,may,0,0
51114,play,0,0
51115,a,0,0
51116,central,0,0
51117,role,0,0
51118,in,0,0
51119,the,0,0
51120,pathogenesis,0,0
51121,of,0,0
51122,Alzheimer,0,0
51123,disease,0,0
51124,.,0,0
51125,A,0,0
51126,functional,0,0
51127,gamma-secretase,0,1
51128,inhibitor,0,1
51129,",",0,0
51130,LY450139,1,0
51131,",",0,0
51132,was,0,0
51133,developed,0,0
51134,that,0,0
51135,inhibits,0,0
51136,Abeta,0,1
51137,formation,0,0
51138,in,0,0
51139,whole,0,0
51140,cell,0,0
51141,assays,0,0
51142,",",0,0
51143,transgenic,0,0
51144,mice,0,0
51145,",",0,0
51146,and,0,0
51147,beagle,0,0
51148,dogs,0,0
51149,.,0,0
51150,The,0,0
51151,authors,0,0
51152,wished,0,0
51153,to,0,0
51154,determine,0,0
51155,the,0,0
51156,safety,0,0
51157,and,0,0
51158,tolerability,0,0
51159,of,0,0
51160,this,0,0
51161,drug,0,0
51162,",",0,0
51163,and,0,0
51164,the,0,0
51165,reduction,0,0
51166,of,0,0
51167,Abeta,0,1
51168,in,0,0
51169,plasma,0,0
51170,and,0,0
51171,cerebrospinal,0,0
51172,fluid,0,1
51173,(,0,0
51174,CSF,0,0
51175,),0,0
51176,after,0,0
51177,multiple,0,0
51178,doses,0,0
51179,.,0,0
51180,Volunteer,0,0
51181,subjects,0,0
51182,(,0,0
51183,N,0,0
51184,=,0,0
51185,37,0,0
51186,),0,0
51187,were,0,0
51188,studied,0,0
51189,using,1,0
51190,doses,1,0
51191,from,1,0
51192,5,1,0
51193,to,1,0
51194,50,1,0
51195,mg/day,1,0
51196,given,1,0
51197,for,1,0
51198,14,1,0
51199,days,1,0
51200,.,1,0
51201,Plasma,1,0
51202,and,1,0
51203,CSF,1,0
51204,concentrations,1,0
51205,of,1,0
51206,LY450139,1,0
51207,",",1,0
51208,Abeta,1,1
51209,(,1,0
51210,1-40,1,0
51211,),1,0
51212,and,1,0
51213,Abeta,1,1
51214,(,1,0
51215,1-X,1,0
51216,),1,1
51217,(,1,0
51218,Abeta,1,1
51219,(,1,1
51220,total,1,0
51221,),1,0
51222,),1,0
51223,were,0,0
51224,determined,0,0
51225,",",0,0
51226,and,0,0
51227,safety,0,0
51228,and,0,0
51229,tolerability,0,0
51230,were,0,0
51231,assessed,0,0
51232,.,0,0
51233,The,0,0
51234,plasma,0,0
51235,half-life,0,0
51236,of,0,0
51237,LY450139,0,0
51238,was,0,0
51239,approximately,0,0
51240,2.5,0,0
51241,hours,0,0
51242,.,0,0
51243,Pharmacokinetic,0,0
51244,analyses,0,0
51245,showed,0,0
51246,a,0,0
51247,linear,0,0
51248,relationship,0,0
51249,between,0,0
51250,dose,0,0
51251,and,0,0
51252,plasma,0,0
51253,concentrations,0,0
51254,",",0,0
51255,with,0,0
51256,a,0,0
51257,Cmax,0,0
51258,of,0,0
51259,828,0,0
51260,+/-,0,0
51261,19.2,0,0
51262,ng/mL,0,0
51263,after,0,0
51264,a,0,0
51265,50-mg,0,1
51266,dose,0,0
51267,.,0,0
51268,Plasma,0,0
51269,Abeta,0,0
51270,concentrations,0,0
51271,decreased,0,0
51272,in,0,0
51273,a,0,0
51274,dose-dependent,0,0
51275,manner,0,0
51276,over,0,0
51277,a,0,0
51278,6-hour,0,0
51279,interval,0,0
51280,following,0,0
51281,drug,0,0
51282,administration,0,0
51283,",",0,0
51284,with,0,0
51285,a,0,0
51286,maximum,0,0
51287,decrease,0,0
51288,of,0,0
51289,approximately,0,0
51290,40,0,0
51291,%,0,0
51292,relative,0,0
51293,to,0,0
51294,baseline,0,0
51295,.,0,0
51296,After,0,0
51297,returning,0,0
51298,to,0,0
51299,baseline,0,0
51300,",",0,0
51301,Abeta,0,1
51302,concentrations,0,0
51303,were,0,0
51304,transiently,0,0
51305,increased,0,0
51306,.,0,0
51307,CSF,0,0
51308,Abeta,0,0
51309,concentrations,0,0
51310,were,0,0
51311,unchanged,0,0
51312,.,0,0
51313,Adverse,0,0
51314,events,0,0
51315,reported,0,0
51316,by,0,0
51317,subjects,0,0
51318,taking,0,0
51319,5-mg,0,1
51320,",",0,0
51321,20-mg,0,1
51322,",",0,0
51323,or,0,0
51324,40-mg,0,1
51325,doses,0,0
51326,were,0,0
51327,similar,0,0
51328,to,0,0
51329,those,0,0
51330,reported,0,0
51331,by,0,0
51332,subjects,0,0
51333,taking,0,0
51334,placebo,0,1
51335,.,0,0
51336,Two,0,0
51337,of,0,0
51338,7,0,0
51339,subjects,0,0
51340,taking,0,0
51341,50,0,0
51342,mg/day,0,0
51343,experienced,0,0
51344,adverse,0,0
51345,events,0,0
51346,that,0,0
51347,may,0,0
51348,have,0,0
51349,been,0,0
51350,drug,0,0
51351,related,0,0
51352,.,0,0
51353,In,0,0
51354,this,0,0
51355,phase,0,0
51356,1,0,0
51357,volunteer,0,0
51358,study,0,0
51359,",",0,0
51360,reported,0,0
51361,adverse,0,0
51362,events,0,0
51363,after,0,0
51364,taking,0,0
51365,LY450139,1,0
51366,were,0,0
51367,manageable,0,0
51368,.,0,0
51369,A,0,0
51370,dose-dependent,0,0
51371,reduction,0,0
51372,in,0,0
51373,plasma,0,0
51374,Abeta,0,1
51375,was,0,0
51376,demonstrated,0,0
51377,",",0,0
51378,and,0,0
51379,changes,0,0
51380,in,0,0
51381,plasma,0,0
51382,Abeta,0,1
51383,concentrations,0,0
51384,were,0,0
51385,temporally,0,0
51386,related,0,0
51387,to,0,0
51388,the,0,0
51389,pharmacokinetic,0,0
51390,characteristics,0,0
51391,of,0,0
51392,LY450139,0,0
51393,.,0,0
51394,Anti-Xa,0,1
51395,effect,0,0
51396,of,0,0
51397,a,0,0
51398,low,0,0
51399,molecular,0,0
51400,weight,0,0
51401,heparin,1,1
51402,(,1,0
51403,dalteparin,1,1
51404,),1,1
51405,does,0,0
51406,not,0,0
51407,accumulate,0,0
51408,in,0,0
51409,extended,0,1
51410,duration,0,0
51411,therapy,0,1
51412,for,0,0
51413,venous,0,0
51414,thromboembolism,0,0
51415,in,0,0
51416,cancer,0,0
51417,patients,0,0
51418,.,0,0
51419,Many,0,0
51420,patients,0,0
51421,with,0,0
51422,venous,0,0
51423,thromboembolism,0,0
51424,are,0,0
51425,being,0,0
51426,treated,0,0
51427,with,0,0
51428,low,0,0
51429,molecular,0,0
51430,weight,0,0
51431,heparin,0,1
51432,for,0,0
51433,extended,0,0
51434,periods,0,0
51435,of,0,0
51436,time,0,0
51437,.,0,0
51438,It,0,0
51439,is,0,0
51440,not,0,0
51441,certain,0,0
51442,if,0,0
51443,it,0,0
51444,is,0,0
51445,necessary,0,0
51446,to,0,0
51447,assess,0,0
51448,anti-Xa,0,0
51449,levels,0,0
51450,for,0,0
51451,extended,0,0
51452,treatment,0,0
51453,periods,0,0
51454,.,0,0
51455,This,0,0
51456,study,0,0
51457,is,0,0
51458,a,0,0
51459,prospective,0,0
51460,assessment,0,0
51461,of,0,0
51462,anti-Xa,0,0
51463,levels,0,0
51464,in,0,0
51465,patients,0,0
51466,on,0,0
51467,long-term,0,0
51468,therapy,0,1
51469,for,0,0
51470,acute,0,0
51471,venous,0,0
51472,thromboembolism,0,0
51473,who,0,0
51474,have,0,0
51475,active,0,0
51476,cancer,0,0
51477,.,0,0
51478,Consecutive,0,0
51479,consenting,0,0
51480,patients,0,0
51481,from,0,0
51482,one,0,0
51483,center,0,0
51484,in,0,0
51485,a,0,0
51486,multicenter,0,0
51487,trial,0,0
51488,that,0,0
51489,compared,0,0
51490,6,0,0
51491,months,0,0
51492,of,0,0
51493,low,0,0
51494,molecular,0,0
51495,weight,0,0
51496,heparin,0,1
51497,with,0,0
51498,oral,1,1
51499,anticoagulant,1,1
51500,therapy,1,1
51501,were,0,0
51502,treated,0,0
51503,with,0,0
51504,therapeutic,0,0
51505,doses,0,0
51506,of,0,0
51507,dalteparin,0,1
51508,(,0,0
51509,200,0,1
51510,IU,0,1
51511,per,0,0
51512,kilogram,0,1
51513,),0,0
51514,subcutaneously,0,0
51515,daily,0,0
51516,.,0,0
51517,Anti-Xa,0,0
51518,levels,0,0
51519,were,0,0
51520,assessed,0,0
51521,at,0,0
51522,the,0,0
51523,end,0,0
51524,of,0,0
51525,weeks,0,0
51526,1,0,0
51527,and,0,0
51528,"4,4-6",0,0
51529,hours,0,0
51530,after,0,0
51531,injection,0,0
51532,of,0,0
51533,dalteparin,0,1
51534,.,0,0
51535,Patients,0,0
51536,were,0,0
51537,followed,0,0
51538,for,0,0
51539,bleeding,0,0
51540,and,0,0
51541,recurrent,0,0
51542,venous,0,0
51543,thromboembolism,0,0
51544,.,0,0
51545,There,0,0
51546,were,0,0
51547,24,0,0
51548,patients,0,0
51549,who,0,0
51550,had,0,0
51551,anti-Xa,0,0
51552,levels,0,0
51553,measured,0,0
51554,at,0,0
51555,weeks,0,0
51556,1,0,0
51557,and,0,0
51558,4,0,0
51559,.,0,0
51560,Two,0,0
51561,other,0,0
51562,patients,0,0
51563,had,0,0
51564,week,0,0
51565,1,0,0
51566,measurements,0,0
51567,performed,0,0
51568,but,0,0
51569,died,0,0
51570,before,0,0
51571,the,0,0
51572,week,0,0
51573,4,0,0
51574,sample,0,0
51575,was,0,0
51576,collected,0,0
51577,due,0,0
51578,to,0,0
51579,their,0,0
51580,underlying,0,0
51581,cancer,0,0
51582,.,0,0
51583,The,0,0
51584,mean,0,0
51585,anti-Xa,0,0
51586,levels,0,0
51587,at,0,0
51588,weeks,0,0
51589,1,0,0
51590,and,0,0
51591,4,0,0
51592,were,0,0
51593,1.11,0,0
51594,and,0,0
51595,1.03,0,0
51596,anti-Xa,0,0
51597,units/ml,0,0
51598,respectively,0,0
51599,(,0,0
51600,P=0.13,0,0
51601,),0,0
51602,.,0,0
51603,These,0,0
51604,results,0,0
51605,suggest,0,0
51606,that,0,0
51607,for,0,0
51608,patients,0,0
51609,with,0,0
51610,active,1,0
51611,cancer,1,0
51612,receiving,1,0
51613,extended,1,1
51614,duration,1,0
51615,therapy,1,1
51616,with,0,0
51617,low,0,0
51618,molecular,0,0
51619,weight,0,0
51620,heparin,1,1
51621,(,1,0
51622,dalteparin,1,1
51623,),1,0
51624,there,0,0
51625,is,0,0
51626,no,0,0
51627,accumulation,0,0
51628,of,0,0
51629,anti-Xa,0,0
51630,effect,0,0
51631,over,0,0
51632,the,0,0
51633,first,0,0
51634,month,0,0
51635,of,0,0
51636,therapy,0,1
51637,.,0,0
51638,Monitoring,0,0
51639,of,0,0
51640,anti-Xa,0,0
51641,levels,0,0
51642,in,0,0
51643,this,0,0
51644,situation,0,0
51645,is,0,0
51646,usually,0,0
51647,not,0,0
51648,required,0,0
51649,.,0,0
51650,Long,0,0
51651,term,0,0
51652,follow,0,0
51653,up,0,0
51654,of,0,0
51655,patients,0,0
51656,treated,0,0
51657,for,0,0
51658,Helicobacter,0,0
51659,pylori,0,0
51660,infection,0,0
51661,.,0,0
51662,BACKGROUND,0,0
51663,Helicobacter,0,0
51664,pylori,0,0
51665,infection,0,0
51666,induces,0,0
51667,progressive,0,0
51668,inflammatory,0,0
51669,changes,0,0
51670,in,0,0
51671,the,0,0
51672,gastric,0,0
51673,mucosa,0,0
51674,that,0,0
51675,may,0,0
51676,lead,0,0
51677,to,0,0
51678,gastric,0,0
51679,cancer,0,0
51680,.,0,0
51681,Understanding,0,0
51682,long,0,0
51683,term,0,0
51684,effects,0,0
51685,resulting,0,0
51686,from,0,0
51687,the,0,0
51688,cure,0,0
51689,of,0,0
51690,this,0,0
51691,infection,0,0
51692,is,0,0
51693,needed,0,0
51694,to,0,0
51695,design,0,0
51696,cancer,0,0
51697,prevention,0,0
51698,strategies,0,0
51699,.,0,0
51700,METHODS,0,0
51701,A,0,0
51702,cohort,0,0
51703,of,0,0
51704,795,0,0
51705,adults,0,0
51706,with,0,0
51707,preneoplastic,0,0
51708,gastric,0,0
51709,lesions,0,0
51710,was,0,0
51711,randomised,0,0
51712,to,0,0
51713,receive,1,0
51714,anti-H,1,1
51715,pylori,1,0
51716,treatment,1,0
51717,and/or,1,0
51718,antioxidants,1,1
51719,.,1,0
51720,At,0,0
51721,the,0,0
51722,end,0,0
51723,of,0,0
51724,six,0,0
51725,years,0,0
51726,of,0,0
51727,intervention,0,1
51728,",",0,0
51729,those,0,0
51730,who,0,0
51731,did,0,0
51732,not,0,0
51733,receive,0,0
51734,anti-H,0,1
51735,pylori,0,0
51736,treatment,0,0
51737,were,0,0
51738,offered,0,0
51739,it,0,0
51740,.,0,0
51741,Gastric,0,0
51742,biopsies,0,0
51743,were,0,0
51744,obtained,0,0
51745,at,0,0
51746,baseline,0,0
51747,",",0,0
51748,and,0,0
51749,at,0,0
51750,3,0,0
51751,",",0,0
51752,6,0,0
51753,",",0,0
51754,and,0,0
51755,12,0,0
51756,years,0,0
51757,.,0,0
51758,A,0,0
51759,histopathology,0,0
51760,score,0,0
51761,was,0,0
51762,utilised,0,0
51763,to,0,0
51764,document,0,0
51765,changes,0,0
51766,in,0,0
51767,gastric,0,0
51768,lesions,0,0
51769,.,0,0
51770,Non-linear,0,0
51771,mixed,0,0
51772,models,0,0
51773,were,0,0
51774,used,0,0
51775,to,0,0
51776,estimate,0,0
51777,the,0,0
51778,cumulative,0,0
51779,effect,0,0
51780,of,0,0
51781,H,0,0
51782,pylori,0,0
51783,clearance,0,0
51784,on,0,0
51785,histopathology,0,0
51786,scores,0,0
51787,adjusted,0,0
51788,for,0,0
51789,follow,0,0
51790,up,0,0
51791,time,0,0
51792,",",0,0
51793,interventions,0,0
51794,",",0,0
51795,and,0,0
51796,confounders,0,0
51797,.,0,0
51798,RESULTS,0,0
51799,Ninety,0,0
51800,seven,0,0
51801,per,0,0
51802,cent,0,0
51803,of,0,0
51804,subjects,0,0
51805,were,0,0
51806,H,0,0
51807,pylori,0,0
51808,positive,0,0
51809,at,0,0
51810,baseline,0,0
51811,",",0,0
51812,and,0,0
51813,53,0,0
51814,%,0,0
51815,were,0,0
51816,positive,0,0
51817,at,0,0
51818,12,0,0
51819,years,0,0
51820,.,0,0
51821,Subjects,0,0
51822,accumulated,0,0
51823,1703,0,0
51824,person,0,0
51825,years,0,0
51826,free,0,0
51827,of,0,0
51828,infection,0,0
51829,.,0,0
51830,A,0,0
51831,multivariate,0,0
51832,model,0,0
51833,showed,0,0
51834,a,0,0
51835,significant,0,0
51836,regression,0,0
51837,in,0,0
51838,histopathology,0,0
51839,score,0,0
51840,as,0,0
51841,a,0,0
51842,function,0,0
51843,of,0,0
51844,the,0,0
51845,square,0,0
51846,of,0,0
51847,H,0,0
51848,pylori,0,0
51849,negative,0,0
51850,time,0,0
51851,.,0,0
51852,Subjects,0,0
51853,who,0,0
51854,were,0,0
51855,H,0,0
51856,pylori,0,0
51857,negative,0,0
51858,had,0,0
51859,14.8,0,0
51860,%,0,0
51861,more,0,0
51862,regression,0,0
51863,and,0,0
51864,13.7,0,0
51865,%,0,0
51866,less,0,0
51867,progression,0,0
51868,than,0,0
51869,patients,0,0
51870,who,0,0
51871,were,0,0
51872,positive,0,0
51873,at,0,0
51874,12,0,0
51875,years,0,0
51876,(,0,0
51877,p,0,0
51878,=,0,0
51879,0.001,0,0
51880,),0,0
51881,.,0,0
51882,The,0,0
51883,rate,0,0
51884,of,0,0
51885,healing,0,0
51886,of,0,0
51887,gastric,0,0
51888,lesions,0,0
51889,occurred,0,0
51890,more,0,0
51891,rapidly,0,0
51892,as,0,0
51893,years,0,0
51894,free,0,0
51895,of,0,0
51896,infection,0,0
51897,accumulated,0,0
51898,",",0,0
51899,and,0,0
51900,was,0,0
51901,more,0,0
51902,pronounced,0,0
51903,in,0,0
51904,less,0,0
51905,advanced,0,0
51906,lesions,0,0
51907,.,0,0
51908,CONCLUSIONS,0,0
51909,Preneoplastic,0,0
51910,gastric,0,0
51911,lesions,0,0
51912,regress,0,0
51913,at,0,0
51914,a,0,0
51915,rate,0,0
51916,equal,0,0
51917,to,0,0
51918,the,0,0
51919,square,0,0
51920,of,0,0
51921,time,0,0
51922,in,0,0
51923,patients,0,0
51924,rendered,0,0
51925,free,0,0
51926,of,0,0
51927,H,0,0
51928,pylori,0,0
51929,infection,0,0
51930,.,0,0
51931,Our,0,0
51932,findings,0,0
51933,suggest,0,0
51934,that,0,0
51935,patients,0,0
51936,with,0,0
51937,preneoplastic,0,0
51938,gastric,0,0
51939,lesions,0,0
51940,should,0,0
51941,be,0,0
51942,treated,0,0
51943,and,0,0
51944,cured,0,0
51945,of,0,0
51946,their,0,0
51947,H,0,1
51948,pylori,0,0
51949,infection,0,0
51950,.,0,0
51951,Administrative,0,0
51952,Data,0,0
51953,Feedback,0,1
51954,for,0,0
51955,Effective,1,0
51956,Cardiac,1,0
51957,Treatment,1,0
51958,:,1,0
51959,AFFECT,0,0
51960,",",0,0
51961,a,0,0
51962,cluster,0,0
51963,randomized,0,0
51964,trial,0,0
51965,.,0,0
51966,CONTEXT,0,0
51967,Hospital,0,0
51968,report,0,0
51969,cards,0,0
51970,are,0,0
51971,increasingly,0,0
51972,being,0,0
51973,implemented,0,0
51974,for,0,0
51975,quality,0,0
51976,improvement,0,0
51977,despite,0,0
51978,lack,0,0
51979,of,0,0
51980,strong,0,0
51981,evidence,0,0
51982,to,0,0
51983,support,0,0
51984,their,0,0
51985,use,0,0
51986,.,0,0
51987,OBJECTIVE,0,0
51988,To,0,0
51989,determine,0,0
51990,whether,0,0
51991,hospital,1,0
51992,report,1,0
51993,cards,1,1
51994,constructed,1,0
51995,using,1,0
51996,linked,1,0
51997,hospital,1,0
51998,and,1,0
51999,prescription,1,0
52000,administrative,1,0
52001,databases,1,0
52002,are,0,0
52003,effective,0,0
52004,for,0,0
52005,improving,0,0
52006,quality,0,0
52007,of,0,0
52008,care,0,0
52009,for,0,0
52010,acute,0,0
52011,myocardial,0,0
52012,infarction,0,0
52013,(,0,0
52014,AMI,0,1
52015,),0,0
52016,.,0,0
52017,DESIGN,0,0
52018,The,0,0
52019,Administrative,1,0
52020,Data,1,0
52021,Feedback,1,1
52022,for,1,0
52023,Effective,1,0
52024,Cardiac,1,1
52025,Treatment,1,1
52026,(,0,0
52027,AFFECT,0,0
52028,),0,0
52029,study,0,0
52030,",",0,0
52031,a,0,0
52032,cluster,0,0
52033,randomized,0,0
52034,trial,0,0
52035,.,0,0
52036,SETTING,0,0
52037,AND,0,0
52038,PATIENTS,0,0
52039,Patients,0,0
52040,with,0,0
52041,AMI,0,0
52042,who,0,0
52043,were,0,0
52044,admitted,0,0
52045,to,0,0
52046,76,0,0
52047,acute,0,0
52048,care,0,0
52049,hospitals,0,0
52050,in,0,0
52051,Quebec,0,0
52052,that,0,0
52053,treated,0,0
52054,at,0,0
52055,least,0,0
52056,30,0,0
52057,AMI,0,0
52058,patients,0,0
52059,per,0,0
52060,year,0,0
52061,between,0,0
52062,April,0,1
52063,1,0,0
52064,",",0,0
52065,1999,0,0
52066,",",0,0
52067,and,0,0
52068,March,0,0
52069,31,0,0
52070,",",0,0
52071,2003,0,0
52072,.,0,0
52073,INTERVENTION,0,0
52074,Hospitals,0,0
52075,were,0,0
52076,randomly,0,0
52077,assigned,0,0
52078,to,0,0
52079,receive,0,1
52080,rapid,1,0
52081,(,0,0
52082,immediate,0,0
52083,;,0,0
52084,n,0,0
52085,=,0,0
52086,38,0,0
52087,hospitals,0,0
52088,and,0,0
52089,2533,0,0
52090,patients,0,0
52091,),0,0
52092,or,0,1
52093,delayed,1,0
52094,(,0,0
52095,14,0,0
52096,months,0,0
52097,;,0,0
52098,n,0,0
52099,=,0,0
52100,38,0,0
52101,hospitals,0,0
52102,and,0,0
52103,3142,0,0
52104,patients,0,0
52105,),0,0
52106,confidential,1,0
52107,feedback,1,1
52108,on,1,0
52109,quality,1,0
52110,indicators,1,0
52111,constructed,1,0
52112,using,1,0
52113,administrative,1,0
52114,data,1,0
52115,.,1,0
52116,MAIN,0,0
52117,OUTCOME,0,0
52118,MEASURES,0,0
52119,Quality,0,0
52120,indicators,0,0
52121,pertaining,0,0
52122,to,0,0
52123,processes,0,0
52124,of,0,0
52125,care,0,0
52126,and,0,0
52127,outcomes,0,0
52128,of,0,0
52129,patients,0,0
52130,admitted,0,0
52131,between,0,0
52132,4,0,0
52133,and,0,0
52134,10,0,0
52135,months,0,0
52136,after,0,0
52137,randomization,0,0
52138,.,0,0
52139,The,0,0
52140,primary,0,0
52141,indicator,0,0
52142,was,0,0
52143,the,0,0
52144,proportion,0,0
52145,of,0,0
52146,elderly,0,0
52147,survivors,0,0
52148,of,0,0
52149,AMI,0,0
52150,at,0,0
52151,each,0,0
52152,study,0,0
52153,hospital,0,0
52154,who,0,0
52155,filled,0,0
52156,a,0,0
52157,prescription,0,0
52158,for,0,0
52159,a,0,0
52160,beta-blocker,0,1
52161,within,0,0
52162,30,0,0
52163,days,0,0
52164,after,0,0
52165,discharge,0,0
52166,.,0,0
52167,RESULTS,0,0
52168,At,0,0
52169,follow-up,0,0
52170,",",0,0
52171,adjusted,0,0
52172,prescription,0,0
52173,rates,0,0
52174,within,0,0
52175,30,0,0
52176,days,0,0
52177,after,0,0
52178,discharge,0,0
52179,were,0,0
52180,similar,0,0
52181,in,0,0
52182,the,0,0
52183,early,0,0
52184,vs,0,0
52185,late,0,0
52186,groups,0,0
52187,(,0,0
52188,for,0,0
52189,beta-blockers,0,1
52190,",",0,0
52191,odds,0,0
52192,ratio,0,0
52193,[,0,0
52194,OR,0,0
52195,],0,0
52196,",",0,0
52197,1.06,0,0
52198,;,0,0
52199,95,0,0
52200,%,0,0
52201,confidence,0,0
52202,interval,0,0
52203,[,0,0
52204,CI,0,0
52205,],0,0
52206,",",0,0
52207,0.82-1.37,0,0
52208,;,0,0
52209,for,0,0
52210,angiotensin-converting,0,1
52211,enzyme,0,0
52212,inhibitors,0,1
52213,",",0,0
52214,OR,0,0
52215,",",0,0
52216,1.17,0,0
52217,;,0,0
52218,95,0,0
52219,%,0,0
52220,CI,0,0
52221,",",0,0
52222,0.90-1.52,0,0
52223,;,0,0
52224,for,0,0
52225,lipid-lowering,0,1
52226,drugs,0,0
52227,",",0,0
52228,OR,0,0
52229,",",0,0
52230,1.14,0,0
52231,;,0,0
52232,95,0,0
52233,%,0,0
52234,CI,0,0
52235,",",0,0
52236,0.86-1.50,0,0
52237,;,0,0
52238,and,0,0
52239,for,0,0
52240,aspirin,0,1
52241,",",0,0
52242,OR,0,0
52243,",",0,0
52244,1.05,0,0
52245,;,0,0
52246,95,0,0
52247,%,0,0
52248,CI,0,0
52249,",",0,0
52250,0.84-1.33,0,0
52251,),0,0
52252,.,0,0
52253,In,0,0
52254,addition,0,0
52255,",",0,0
52256,adjusted,0,0
52257,mortality,0,0
52258,was,0,0
52259,similar,0,0
52260,in,0,0
52261,both,0,0
52262,groups,0,0
52263,",",0,0
52264,as,0,0
52265,were,0,0
52266,length,0,0
52267,of,0,0
52268,in-hospital,0,0
52269,stay,0,0
52270,",",0,0
52271,physician,0,0
52272,visits,0,0
52273,after,0,0
52274,discharge,0,0
52275,",",0,0
52276,waiting,0,0
52277,times,0,0
52278,for,0,0
52279,invasive,0,0
52280,cardiac,0,0
52281,procedures,0,0
52282,",",0,0
52283,and,0,0
52284,readmissions,0,0
52285,for,0,0
52286,cardiac,0,0
52287,complications,0,0
52288,.,0,0
52289,CONCLUSIONS,0,0
52290,Feedback,0,1
52291,based,0,0
52292,on,0,0
52293,one-time,0,0
52294,",",0,0
52295,confidential,0,0
52296,report,0,0
52297,cards,0,1
52298,constructed,0,0
52299,using,0,0
52300,administrative,0,0
52301,data,0,0
52302,is,0,0
52303,not,0,0
52304,an,0,0
52305,effective,0,0
52306,strategy,0,0
52307,for,0,0
52308,quality,0,0
52309,improvement,0,0
52310,regarding,0,0
52311,care,0,0
52312,of,0,0
52313,patients,0,0
52314,with,0,0
52315,AMI,0,0
52316,.,0,0
52317,A,0,0
52318,need,0,0
52319,exists,0,0
52320,for,0,0
52321,further,0,0
52322,studies,0,0
52323,to,0,0
52324,rigorously,0,0
52325,evaluate,0,0
52326,the,0,0
52327,effectiveness,0,0
52328,of,0,0
52329,more,0,0
52330,intensive,0,1
52331,report,1,0
52332,card,1,1
52333,interventions,1,0
52334,.,1,0
52335,Superior,0,0
52336,efficacy,0,0
52337,of,0,0
52338,clopidogrel,1,1
52339,plus,1,1
52340,acetylsalicylic,1,1
52341,acid,1,1
52342,compared,0,0
52343,with,0,0
52344,extended-release,1,1
52345,dipyridamole,1,1
52346,plus,1,1
52347,acetylsalicylic,1,1
52348,acid,1,1
52349,in,0,0
52350,preventing,0,0
52351,arterial,0,0
52352,thrombogenesis,0,0
52353,in,0,0
52354,healthy,0,0
52355,volunteers,0,0
52356,.,0,0
52357,INTRODUCTION,0,0
52358,Recent,0,0
52359,ex,0,0
52360,vivo,0,0
52361,platelet,0,0
52362,aggregometry,0,0
52363,data,0,0
52364,indicate,0,0
52365,that,0,0
52366,clopidogrel,1,1
52367,75,0,0
52368,mg/day,0,0
52369,plus,1,1
52370,acetylsalicylic,1,1
52371,acid,1,1
52372,(,1,0
52373,ASA,1,1
52374,),1,0
52375,75,0,0
52376,mg/day,0,0
52377,is,0,0
52378,a,0,0
52379,more,0,0
52380,potent,0,0
52381,antiplatelet,0,1
52382,regimen,0,1
52383,than,0,0
52384,the,0,0
52385,marketed,0,0
52386,combination,0,1
52387,of,0,0
52388,dipyridamole+ASA,1,1
52389,.,1,0
52390,The,0,0
52391,present,0,0
52392,study,0,0
52393,was,0,0
52394,designed,0,0
52395,to,0,0
52396,assess,0,0
52397,the,0,0
52398,antithrombotic,0,1
52399,effect,0,0
52400,of,0,0
52401,both,0,0
52402,dual,1,0
52403,antiplatelet,1,1
52404,regimens,1,1
52405,using,0,0
52406,a,0,0
52407,human,0,1
52408,ex,0,0
52409,vivo,0,0
52410,model,0,0
52411,of,0,0
52412,arterial,0,0
52413,thrombosis,0,0
52414,.,0,0
52415,MATERIALS,0,0
52416,AND,0,0
52417,METHODS,0,0
52418,This,0,0
52419,was,0,0
52420,a,0,0
52421,randomized,0,0
52422,",",0,0
52423,double-blind,0,0
52424,",",0,0
52425,placebo-controlled,0,1
52426,",",0,0
52427,crossover,0,0
52428,study,0,0
52429,.,0,0
52430,During,0,0
52431,two,0,0
52432,10-day,0,0
52433,treatment,0,0
52434,periods,0,0
52435,separated,0,0
52436,by,0,0
52437,a,0,0
52438,14-day,0,0
52439,washout,0,0
52440,period,0,0
52441,",",0,0
52442,23,0,0
52443,healthy,0,0
52444,male,0,0
52445,volunteers,0,0
52446,received,0,0
52447,once-daily,0,1
52448,clopidogrel,1,1
52449,75,1,0
52450,mg,1,1
52451,plus,1,1
52452,acetylsalicylic,1,1
52453,acid,1,1
52454,75,0,0
52455,mg,0,0
52456,",",0,0
52457,or,0,0
52458,twice-daily,0,1
52459,extended-release,1,1
52460,dipyridamole,1,1
52461,200,1,1
52462,mg,1,1
52463,plus,1,1
52464,acetylsalicylic,1,1
52465,acid,1,1
52466,25,0,0
52467,mg,0,0
52468,.,0,0
52469,Assessments,0,0
52470,were,0,0
52471,made,0,0
52472,at,0,0
52473,baseline,0,0
52474,and,0,0
52475,on,0,0
52476,Day,0,0
52477,10,0,0
52478,of,0,0
52479,each,0,0
52480,period,0,0
52481,.,0,0
52482,Arterial,0,0
52483,thrombus,0,0
52484,formation,0,0
52485,was,0,0
52486,induced,0,0
52487,ex,0,0
52488,vivo,0,0
52489,by,0,0
52490,exposing,0,0
52491,a,0,0
52492,collagen-coated,0,1
52493,surface,0,0
52494,in,0,0
52495,a,0,0
52496,parallel-plate,0,1
52497,perfusion,0,0
52498,chamber,0,1
52499,to,0,0
52500,native,0,0
52501,blood,0,0
52502,for,0,0
52503,3,0,0
52504,min,0,0
52505,(,0,0
52506,arterial,0,0
52507,wall,0,0
52508,shear,0,0
52509,rate,0,0
52510,2600,0,1
52511,s,0,0
52512,(,0,0
52513,-1,0,0
52514,),0,0
52515,),0,0
52516,.,0,0
52517,Total,0,0
52518,platelet,0,0
52519,and,0,0
52520,fibrin,0,1
52521,deposition,0,0
52522,was,0,0
52523,determined,0,0
52524,by,0,0
52525,immunoenzymatic,0,0
52526,methods,0,0
52527,.,0,0
52528,RESULTS,0,0
52529,Compared,0,0
52530,with,0,0
52531,baseline,0,0
52532,values,0,0
52533,",",0,0
52534,the,0,0
52535,mean,0,0
52536,inhibition,0,0
52537,of,0,0
52538,total,0,0
52539,platelet,0,0
52540,deposition,0,0
52541,was,0,0
52542,63.9+/-5.9,0,0
52543,%,0,0
52544,with,0,0
52545,clopidogrel,1,1
52546,plus,1,1
52547,acetylsalicylic,1,1
52548,acid,1,1
52549,",",0,0
52550,compared,0,0
52551,with,0,0
52552,18.4+/-5.6,0,0
52553,%,0,0
52554,for,0,0
52555,extended-release,1,1
52556,dipyridamole,1,1
52557,plus,1,1
52558,acetylsalicylic,1,1
52559,acid,1,1
52560,(,0,0
52561,67,0,0
52562,%,0,0
52563,reduction,0,0
52564,;,0,0
52565,95,0,0
52566,%,0,0
52567,CI,0,0
52568,",",0,0
52569,49-79,0,0
52570,%,0,0
52571,;,0,0
52572,p,0,0
52573,<,0,0
52574,0.0001,0,0
52575,),0,0
52576,.,0,0
52577,Corresponding,0,0
52578,figures,0,0
52579,for,0,0
52580,fibrin,0,1
52581,deposition,0,0
52582,were,0,0
52583,64.9+/-4.8,0,0
52584,%,0,0
52585,and,0,0
52586,18.3+/-9.7,0,0
52587,%,0,0
52588,",",0,0
52589,respectively,0,0
52590,(,0,0
52591,58,0,0
52592,%,0,0
52593,reduction,0,0
52594,;,0,0
52595,95,0,0
52596,%,0,0
52597,CI,0,0
52598,",",0,0
52599,45-67,0,0
52600,%,0,0
52601,;,0,0
52602,p,0,0
52603,<,0,0
52604,0.0001,0,0
52605,),0,0
52606,.,0,0
52607,Both,0,0
52608,treatments,0,0
52609,were,0,0
52610,well,0,0
52611,tolerated,0,0
52612,.,0,0
52613,CONCLUSIONS,0,0
52614,Clopidogrel,1,1
52615,plus,1,1
52616,acetylsalicylic,1,1
52617,acid,1,1
52618,showed,0,0
52619,significantly,0,0
52620,superior,0,0
52621,antithrombotic,0,1
52622,efficacy,0,0
52623,compared,0,0
52624,with,0,0
52625,extended-release,1,1
52626,dipyridamole,1,1
52627,plus,1,1
52628,acetylsalicylic,1,1
52629,acid,1,1
52630,in,0,0
52631,preventing,0,0
52632,arterial,0,0
52633,thrombogenesis,0,0
52634,in,0,0
52635,humans,0,0
52636,.,0,0
52637,Interventions,0,0
52638,in,0,0
52639,the,0,0
52640,initial,0,0
52641,prodromal,0,0
52642,states,0,0
52643,of,0,0
52644,psychosis,0,0
52645,in,0,0
52646,Germany,0,0
52647,:,0,0
52648,concept,0,0
52649,and,0,0
52650,recruitment,0,0
52651,.,0,0
52652,BACKGROUND,0,0
52653,The,0,0
52654,Early,0,1
52655,Detection,0,0
52656,and,0,0
52657,Intervention,0,1
52658,Programme,0,1
52659,of,0,0
52660,the,0,0
52661,German,0,1
52662,Research,0,0
52663,Network,0,0
52664,on,0,0
52665,Schizophrenia,0,0
52666,(,0,0
52667,GRNS,0,0
52668,),0,1
52669,investigates,0,0
52670,the,0,0
52671,initial,0,0
52672,prodromal,0,0
52673,phase,0,0
52674,of,0,0
52675,psychosis,0,0
52676,in,0,0
52677,a,0,0
52678,multidimensional,0,0
52679,approach,0,1
52680,.,0,0
52681,Two,0,0
52682,intervention,0,0
52683,strategies,0,0
52684,are,0,0
52685,being,0,0
52686,studied,0,0
52687,by,0,0
52688,two,0,0
52689,large-scale,0,0
52690,multicentre,0,0
52691,projects,0,0
52692,.,0,0
52693,AIMS,0,0
52694,To,0,0
52695,present,0,0
52696,the,0,0
52697,concept,0,0
52698,of,0,0
52699,the,0,0
52700,intervention,0,1
52701,studies,0,0
52702,",",0,0
52703,and,0,0
52704,to,0,0
52705,provide,0,0
52706,an,0,0
52707,interim,0,0
52708,report,0,0
52709,of,0,0
52710,the,0,0
52711,recruitment,0,0
52712,procedure,0,0
52713,.,0,0
52714,METHOD,0,0
52715,Comprehensive,1,0
52716,cognitive-behavioural,1,1
52717,therapy,1,1
52718,has,0,0
52719,been,0,0
52720,developed,0,0
52721,for,0,0
52722,patients,0,0
52723,in,0,0
52724,the,0,0
52725,early,0,0
52726,initial,0,0
52727,prodromal,0,0
52728,state,0,0
52729,.,0,0
52730,For,0,0
52731,patients,0,0
52732,in,0,0
52733,the,0,0
52734,late,0,0
52735,initial,0,0
52736,prodromal,0,0
52737,state,0,0
52738,the,0,0
52739,atypical,1,0
52740,neuroleptic,1,0
52741,amisulpride,1,1
52742,is,0,0
52743,explored,0,0
52744,.,0,0
52745,Both,0,0
52746,interventions,0,0
52747,are,0,0
52748,evaluated,0,0
52749,in,0,0
52750,randomised,0,0
52751,controlled,0,0
52752,trials,0,0
52753,using,0,0
52754,clinical,0,0
52755,management,0,0
52756,as,0,0
52757,the,0,0
52758,control,0,0
52759,condition,0,0
52760,.,0,0
52761,RESULTS,0,0
52762,Between,0,0
52763,January,0,0
52764,2001,0,0
52765,and,0,0
52766,March,0,0
52767,2003,0,0
52768,",",0,0
52769,1212,0,0
52770,individuals,0,0
52771,seeking,0,0
52772,help,0,0
52773,for,0,0
52774,mental,0,0
52775,health,0,0
52776,problems,0,0
52777,were,0,0
52778,screened,0,0
52779,for,0,0
52780,putative,0,0
52781,prodromal,0,0
52782,symptoms,0,0
52783,at,0,0
52784,four,0,0
52785,university,0,0
52786,centres,0,0
52787,.,0,0
52788,More,0,0
52789,than,0,0
52790,388,0,0
52791,individuals,0,0
52792,fulfilled,0,0
52793,criteria,0,0
52794,for,0,0
52795,both,0,0
52796,interventions,0,0
52797,and,0,0
52798,188,0,0
52799,(,0,0
52800,48.5,0,0
52801,%,0,0
52802,),0,0
52803,gave,0,0
52804,informed,0,0
52805,consent,0,0
52806,to,0,0
52807,participate,0,0
52808,in,0,0
52809,the,0,0
52810,trials,0,0
52811,.,0,0
52812,CONCLUSIONS,0,0
52813,The,0,0
52814,screening,0,0
52815,procedure,0,0
52816,appears,0,0
52817,to,0,0
52818,be,0,0
52819,feasible,0,0
52820,and,0,0
52821,trial,0,0
52822,participation,0,1
52823,seems,0,0
52824,to,0,0
52825,be,0,0
52826,acceptable,0,0
52827,to,0,0
52828,a,0,0
52829,relevant,0,0
52830,proportion,0,0
52831,of,0,0
52832,people,0,0
52833,at,0,0
52834,increased,0,0
52835,risk,0,0
52836,of,0,0
52837,developing,0,0
52838,psychosis,0,0
52839,.,0,0
52840,Effect,0,0
52841,of,0,0
52842,mild,1,0
52843,endurance,1,1
52844,exercise,1,1
52845,training,1,1
52846,and,0,0
52847,pravastatin,1,1
52848,on,0,0
52849,peripheral,0,0
52850,vasodilatation,0,0
52851,of,0,0
52852,forearm,0,1
52853,resistance,0,0
52854,vessels,0,0
52855,in,0,0
52856,patients,0,0
52857,with,0,0
52858,coronary,0,0
52859,artery,0,0
52860,disease,0,0
52861,.,0,0
52862,BACKGROUND,0,0
52863,Improved,0,0
52864,endothelial,0,0
52865,function,0,0
52866,may,0,0
52867,contribute,0,0
52868,to,0,0
52869,the,0,0
52870,beneficial,0,0
52871,effects,0,0
52872,of,0,0
52873,cholesterol,0,0
52874,lowering,0,0
52875,therapy,0,1
52876,in,0,0
52877,patients,0,0
52878,with,0,0
52879,coronary,0,0
52880,artery,0,0
52881,disease,0,0
52882,(,0,0
52883,CAD,0,0
52884,),0,0
52885,",",0,0
52886,but,0,0
52887,results,0,0
52888,of,0,0
52889,the,0,0
52890,effect,0,0
52891,of,0,0
52892,statin,0,1
52893,therapy,0,1
52894,on,0,0
52895,endothelial,0,0
52896,function,0,0
52897,are,0,0
52898,disparate,0,0
52899,in,0,0
52900,these,0,0
52901,patients,0,0
52902,.,0,0
52903,Exercise,1,1
52904,training,1,1
52905,has,0,0
52906,been,0,0
52907,reported,0,0
52908,to,0,0
52909,improve,0,0
52910,endothelial,0,0
52911,function,0,0
52912,of,0,0
52913,patients,0,0
52914,at,0,0
52915,risk,0,0
52916,of,0,0
52917,or,0,0
52918,with,0,0
52919,established,0,0
52920,CAD,0,0
52921,.,0,0
52922,The,0,0
52923,goal,0,0
52924,of,0,0
52925,the,0,0
52926,study,0,0
52927,was,0,0
52928,to,0,0
52929,compare,0,0
52930,the,0,0
52931,effect,0,0
52932,of,0,0
52933,mild,1,0
52934,exercise,1,1
52935,training,1,1
52936,or,0,1
52937,statin,1,1
52938,therapy,1,1
52939,on,0,0
52940,forearm,0,1
52941,endothelial,0,0
52942,function,0,0
52943,in,0,0
52944,CAD,0,0
52945,patients,0,0
52946,with,0,0
52947,average,0,0
52948,cholesterol,0,0
52949,levels,0,0
52950,.,0,0
52951,DESIGN,0,0
52952,AND,0,0
52953,METHODS,0,0
52954,Twenty-eight,0,0
52955,sedentary,0,1
52956,male,0,0
52957,patients,0,0
52958,with,0,0
52959,angiographically,0,0
52960,documented,0,0
52961,CAD,0,0
52962,and,0,0
52963,average,0,0
52964,pretreatment,0,0
52965,total,0,0
52966,plasma,0,0
52967,cholesterol,0,0
52968,levels,0,0
52969,(,0,0
52970,5.1+/-0.9,0,0
52971,mmol/l,0,0
52972,),0,0
52973,aged,0,0
52974,42-75,0,0
52975,years,0,0
52976,were,0,0
52977,included,0,0
52978,.,0,0
52979,They,0,0
52980,were,0,0
52981,randomly,0,0
52982,assigned,0,0
52983,in,0,0
52984,a,0,0
52985,2,0,0
52986,:,0,0
52987,1,0,0
52988,order,0,0
52989,to,0,0
52990,either,0,0
52991,statin,1,1
52992,therapy,1,1
52993,(,1,0
52994,pravastatin,1,1
52995,",",0,0
52996,40,0,0
52997,mg,0,0
52998,daily,0,1
52999,),0,0
53000,or,0,1
53001,exercise,1,1
53002,training,1,1
53003,therapy,1,1
53004,(,1,0
53005,mild,1,0
53006,endurance,1,1
53007,exercise,1,1
53008,three,1,0
53009,or,1,0
53010,more,1,0
53011,times,1,0
53012,a,1,0
53013,week,1,0
53014,),1,0
53015,.,0,0
53016,The,0,0
53017,effects,0,0
53018,of,0,0
53019,10,0,0
53020,weeks,0,0
53021,of,0,0
53022,either,0,0
53023,treatment,0,0
53024,on,0,0
53025,endothelium-dependent,0,0
53026,and,0,0
53027,independent,0,0
53028,vasodilation,0,0
53029,of,0,0
53030,forearm,0,1
53031,resistance,0,0
53032,vessels,0,0
53033,was,0,0
53034,assessed,0,0
53035,by,0,0
53036,plethysmography,0,1
53037,.,0,0
53038,Cardiopulmonary,1,1
53039,exercise,1,1
53040,testing,0,0
53041,was,0,0
53042,performed,0,0
53043,at,0,0
53044,baseline,0,0
53045,and,0,0
53046,after,0,0
53047,10,0,0
53048,weeks,0,0
53049,.,0,0
53050,RESULTS,0,0
53051,Ten,0,0
53052,weeks,0,0
53053,of,0,0
53054,pravastatin,1,1
53055,therapy,1,1
53056,significantly,0,0
53057,reduced,0,0
53058,low-density,0,0
53059,lipoprotein,0,0
53060,cholesterol,0,0
53061,(,0,0
53062,from,0,0
53063,3.8+/-0.6,0,0
53064,to,0,0
53065,3.1+/-0.6,0,0
53066,mmol/l,0,0
53067,at,0,0
53068,study,0,0
53069,end,0,0
53070,",",0,0
53071,P=0.04,0,0
53072,),0,0
53073,and,0,0
53074,the,0,0
53075,ratio,0,0
53076,of,0,0
53077,total,0,0
53078,to,0,0
53079,high-density,0,0
53080,lipoprotein,0,0
53081,cholesterol,0,0
53082,(,0,0
53083,from,0,0
53084,4.9+/-0.8,0,0
53085,to,0,0
53086,3.7+/-0.7,0,0
53087,mmol/l,0,0
53088,",",0,0
53089,P=0.002,0,0
53090,),0,0
53091,.,0,0
53092,Exercise,1,1
53093,training,1,1
53094,did,0,0
53095,not,0,0
53096,significantly,0,0
53097,modify,0,0
53098,the,0,0
53099,lipid,0,0
53100,profile,0,0
53101,.,0,0
53102,Peak,0,0
53103,oxygen,0,0
53104,consumption,0,0
53105,",",0,0
53106,maximal,0,0
53107,achieved,0,0
53108,workload,0,0
53109,and,0,0
53110,exercise,0,1
53111,duration,0,0
53112,tended,0,0
53113,to,0,0
53114,improve,0,0
53115,in,0,0
53116,the,0,0
53117,exercise,0,1
53118,training,0,1
53119,group,0,0
53120,but,0,0
53121,remained,0,0
53122,unchanged,0,0
53123,in,0,0
53124,the,0,0
53125,pravastatin-treated,1,1
53126,group,0,0
53127,.,0,0
53128,Neither,0,0
53129,10,0,0
53130,weeks,0,0
53131,of,0,0
53132,pravastatin,1,1
53133,nor,0,0
53134,mild,1,0
53135,endurance,1,1
53136,exercise,1,1
53137,training,1,1
53138,improved,0,0
53139,endothelium-dependent,0,0
53140,or,0,1
53141,independent,0,0
53142,vasomotor,0,0
53143,function,0,0
53144,in,0,0
53145,forearm,0,1
53146,resistance,0,0
53147,vessels,0,0
53148,.,0,0
53149,CONCLUSIONS,0,0
53150,In,0,0
53151,patients,0,0
53152,with,0,0
53153,CAD,0,0
53154,and,0,0
53155,average,0,0
53156,cholesterol,0,0
53157,levels,0,0
53158,",",0,0
53159,10,0,0
53160,weeks,0,0
53161,of,0,0
53162,treatment,0,0
53163,with,0,0
53164,mild,1,0
53165,endurance,1,1
53166,exercise,1,1
53167,training,1,1
53168,or,0,1
53169,with,0,0
53170,pravastatin,1,1
53171,failed,0,0
53172,to,0,0
53173,improve,0,0
53174,endothelium-dependent,0,0
53175,or,0,1
53176,independent,0,0
53177,vasomotor,0,0
53178,function,0,0
53179,in,0,0
53180,forearm,0,1
53181,resistance,0,0
53182,vessels,0,0
53183,.,0,0
53184,Hydrogen,1,1
53185,peroxide,1,1
53186,mouth,1,0
53187,rinse,1,1
53188,:,1,0
53189,an,0,0
53190,analgesic,0,0
53191,post-tonsillectomy,0,0
53192,.,0,0
53193,OBJECTIVE,0,0
53194,To,0,0
53195,compare,0,0
53196,the,0,0
53197,analgesic,0,0
53198,efficacy,0,0
53199,of,0,0
53200,hydrogen,1,1
53201,peroxide,1,1
53202,(,1,0
53203,H2O2,1,1
53204,),1,1
53205,mouth,1,0
53206,rinse,1,1
53207,with,0,0
53208,control,1,0
53209,for,0,0
53210,post-tonsillectomy,0,1
53211,pain,0,0
53212,management,0,0
53213,.,0,0
53214,DESIGN,0,0
53215,Double-blinded,0,0
53216,",",0,0
53217,prospective,0,0
53218,",",0,0
53219,randomized,0,0
53220,",",0,0
53221,controlled,0,0
53222,clinical,0,0
53223,trial,0,0
53224,.,0,0
53225,PATIENTS,0,0
53226,AND,0,0
53227,METHODS,0,0
53228,Thirty-seven,0,0
53229,patients,0,0
53230,from,0,0
53231,5,0,0
53232,to,0,0
53233,14,0,0
53234,years,0,0
53235,old,0,0
53236,undergoing,0,0
53237,electrocautery,1,1
53238,tonsillectomy,1,1
53239,were,0,0
53240,randomized,0,0
53241,to,0,0
53242,either,0,0
53243,the,0,0
53244,H2O2,1,1
53245,mouth,1,1
53246,rinse,1,1
53247,or,1,1
53248,the,1,0
53249,water,1,1
53250,rinse,1,1
53251,(,1,0
53252,control,1,1
53253,),1,0
53254,group,1,0
53255,.,1,0
53256,For,0,0
53257,14,0,0
53258,days,0,0
53259,",",0,0
53260,patients,0,0
53261,recorded,0,0
53262,pain,0,0
53263,levels,0,0
53264,twice,0,0
53265,daily,0,0
53266,using,0,0
53267,a,0,0
53268,visual,0,0
53269,analogue,0,0
53270,scale,0,0
53271,.,0,0
53272,Analgesic,0,0
53273,uses,0,0
53274,",",0,0
53275,as,0,0
53276,well,0,0
53277,as,0,0
53278,any,0,0
53279,complications,0,0
53280,",",0,0
53281,were,0,0
53282,also,0,0
53283,noted,0,0
53284,by,0,0
53285,the,0,0
53286,patients,0,0
53287,.,0,0
53288,RESULTS,0,0
53289,Thirty-seven,0,0
53290,patients,0,0
53291,completed,0,0
53292,the,0,0
53293,study,0,0
53294,",",0,0
53295,21,0,0
53296,in,0,0
53297,the,0,0
53298,treatment,0,0
53299,group,0,0
53300,and,0,0
53301,16,0,0
53302,in,0,0
53303,the,0,0
53304,control,0,0
53305,group,0,0
53306,.,0,0
53307,Mean,0,0
53308,postoperative,0,0
53309,days,0,0
53310,of,0,0
53311,pain,0,0
53312,were,0,0
53313,10.3,0,0
53314,and,0,0
53315,8.3,0,0
53316,",",0,0
53317,respectively,0,0
53318,",",0,0
53319,and,0,0
53320,differed,0,0
53321,significantly,0,0
53322,(,0,0
53323,p,0,0
53324,=,0,0
53325,.008,0,0
53326,),0,0
53327,.,0,0
53328,Mean,0,0
53329,postoperative,0,0
53330,days,0,0
53331,of,0,0
53332,analgesic,0,0
53333,use,0,0
53334,were,0,0
53335,9.0,0,0
53336,and,0,0
53337,6.7,0,0
53338,",",0,0
53339,respectively,0,0
53340,",",0,0
53341,and,0,0
53342,differed,0,0
53343,significantly,0,0
53344,(,0,0
53345,p,0,0
53346,=,0,0
53347,.005,0,0
53348,),0,0
53349,.,0,0
53350,Only,0,0
53351,one,0,0
53352,incidence,0,0
53353,of,0,0
53354,postoperative,0,0
53355,hemorrhage,0,0
53356,occurred,0,0
53357,in,0,0
53358,the,0,0
53359,study,0,0
53360,group,0,0
53361,.,0,0
53362,CONCLUSION,0,0
53363,In,0,0
53364,our,0,0
53365,study,0,0
53366,",",0,0
53367,the,0,0
53368,H2O2,1,1
53369,mouth,1,0
53370,rinse,1,1
53371,does,0,0
53372,not,0,0
53373,provide,0,0
53374,a,0,0
53375,better,0,0
53376,analgesic,0,0
53377,effect,0,0
53378,than,0,0
53379,the,0,0
53380,water,0,1
53381,rinse,0,1
53382,for,0,0
53383,post-tonsillectomy,0,1
53384,pain,0,0
53385,relief,0,0
53386,.,0,0
53387,Analgesic,0,0
53388,efficacy,0,0
53389,of,0,0
53390,caudal,1,0
53391,block,1,0
53392,versus,0,1
53393,diclofenac,1,1
53394,suppository,1,1
53395,and,0,0
53396,local,0,0
53397,anesthetic,0,1
53398,infiltration,0,0
53399,following,0,0
53400,pediatric,0,0
53401,laparoscopy,0,1
53402,.,0,0
53403,AIM,0,0
53404,To,0,0
53405,compare,0,0
53406,the,0,0
53407,analgesic,0,0
53408,efficacy,0,0
53409,of,0,0
53410,caudal,1,0
53411,block,1,0
53412,with,0,0
53413,diclofenac,1,1
53414,suppository,1,1
53415,and,1,0
53416,local,1,0
53417,anesthetic,1,1
53418,infiltration,1,0
53419,in,0,0
53420,children,0,0
53421,undergoing,0,0
53422,laparoscopy,0,1
53423,.,0,0
53424,METHODS,0,0
53425,We,0,0
53426,studied,0,0
53427,50,0,0
53428,children,0,0
53429,undergoing,0,0
53430,laparoscopy,0,1
53431,for,0,0
53432,diagnostic,0,0
53433,and,0,0
53434,therapeutic,0,0
53435,purposes,0,0
53436,.,0,0
53437,Their,0,0
53438,ages,0,0
53439,ranged,0,0
53440,from,0,0
53441,3,0,0
53442,to,0,0
53443,13,0,0
53444,years,0,0
53445,",",0,0
53446,and,0,0
53447,all,0,0
53448,belonged,0,0
53449,to,0,0
53450,American,0,0
53451,Society,0,0
53452,of,0,0
53453,Anesthesiologists,0,0
53454,(,0,0
53455,ASA,0,1
53456,),0,0
53457,class,0,0
53458,I,0,0
53459,or,0,0
53460,II,0,0
53461,.,0,0
53462,Anesthesia,1,0
53463,was,1,0
53464,carried,1,0
53465,out,1,0
53466,using,1,0
53467,the,1,0
53468,standard,1,1
53469,procedure,1,0
53470,.,1,0
53471,Patients,0,0
53472,were,0,0
53473,randomly,0,0
53474,assigned,0,0
53475,to,0,0
53476,one,0,0
53477,of,0,0
53478,two,0,0
53479,groups,0,0
53480,.,0,0
53481,Group,0,0
53482,1,0,0
53483,received,0,0
53484,caudal,1,0
53485,block,1,0
53486,with,1,0
53487,bupivacaine,1,1
53488,1,1,0
53489,mL/kg,1,0
53490,after,1,0
53491,anesthetic,1,0
53492,induction,1,0
53493,.,1,0
53494,Group,0,0
53495,2,0,0
53496,received,0,0
53497,diclofenac,1,1
53498,suppository,1,1
53499,3,1,0
53500,mg/kg,1,1
53501,postinduction,1,0
53502,and,1,0
53503,local,1,0
53504,anesthetic,1,1
53505,infiltration,1,0
53506,at,1,0
53507,the,1,0
53508,port,1,1
53509,sites,1,0
53510,at,0,0
53511,the,0,0
53512,end,0,0
53513,of,0,0
53514,the,0,0
53515,procedure,0,0
53516,.,0,0
53517,Pain,0,0
53518,was,0,0
53519,assessed,0,0
53520,using,0,0
53521,the,0,0
53522,Hannallah,0,0
53523,objective,0,0
53524,pain,0,0
53525,scale,0,0
53526,at,0,0
53527,15,0,0
53528,",",0,0
53529,30,0,0
53530,",",0,0
53531,60,0,0
53532,",",0,0
53533,120,0,0
53534,",",0,0
53535,and,0,0
53536,360,0,0
53537,minutes,0,0
53538,postextubation,0,0
53539,.,0,0
53540,RESULTS,0,0
53541,The,0,0
53542,pain,0,0
53543,scores,0,0
53544,were,0,0
53545,comparable,0,0
53546,in,0,0
53547,both,0,0
53548,groups,0,0
53549,at,0,0
53550,all,0,0
53551,times,0,0
53552,.,0,0
53553,Twelve,0,0
53554,percent,0,0
53555,of,0,0
53556,caudal,0,0
53557,block,0,0
53558,patients,0,0
53559,and,0,0
53560,20,0,0
53561,%,0,0
53562,of,0,0
53563,diclofenac,0,1
53564,patients,0,0
53565,needed,0,0
53566,rescue,0,0
53567,analgesic,0,0
53568,",",0,0
53569,a,0,0
53570,statistically,0,0
53571,insignificant,0,0
53572,difference,0,0
53573,.,0,0
53574,In,0,0
53575,2,0,0
53576,patients,0,0
53577,",",0,0
53578,caudal,0,0
53579,block,0,0
53580,was,0,0
53581,technically,0,0
53582,difficult,0,0
53583,and,0,0
53584,they,0,0
53585,were,0,0
53586,excluded,0,0
53587,from,0,0
53588,the,0,0
53589,study,0,0
53590,.,0,0
53591,The,0,0
53592,incidence,0,0
53593,of,0,0
53594,side,0,0
53595,effects,0,0
53596,was,0,0
53597,low,0,0
53598,in,0,0
53599,our,0,0
53600,study,0,0
53601,.,0,0
53602,CONCLUSION,0,0
53603,We,0,0
53604,find,0,0
53605,the,0,0
53606,analgesic,0,0
53607,efficacy,0,0
53608,of,0,0
53609,diclofenac,1,1
53610,suppository,1,1
53611,combined,0,1
53612,with,0,0
53613,local,0,0
53614,anesthetic,1,1
53615,infiltration,1,0
53616,at,0,0
53617,port,0,1
53618,sites,0,0
53619,comparable,0,0
53620,to,0,0
53621,caudal,0,0
53622,block,0,0
53623,.,0,0
53624,Given,0,0
53625,the,0,0
53626,necessarily,0,0
53627,invasive,0,0
53628,nature,0,0
53629,of,0,0
53630,caudal,0,0
53631,block,0,0
53632,",",0,0
53633,we,0,0
53634,suggest,0,0
53635,the,0,0
53636,combined,0,0
53637,use,0,0
53638,of,0,0
53639,diclofenac,1,1
53640,suppository,1,1
53641,with,0,0
53642,local,0,0
53643,anesthetic,1,1
53644,infiltration,1,0
53645,at,0,0
53646,port,0,0
53647,sites,0,0
53648,as,0,0
53649,a,0,0
53650,useful,0,0
53651,and,0,0
53652,more,0,0
53653,economical,0,0
53654,alternative,0,0
53655,for,0,0
53656,analgesia,0,0
53657,following,0,0
53658,pediatric,0,0
53659,laparoscopy,0,1
53660,.,0,0
53661,Topiramate,1,1
53662,improves,0,0
53663,health-related,0,0
53664,quality,0,0
53665,of,0,0
53666,life,0,0
53667,when,0,0
53668,used,0,0
53669,to,0,0
53670,prevent,0,0
53671,migraine,0,0
53672,.,0,0
53673,OBJECTIVE,0,0
53674,To,0,0
53675,assess,0,0
53676,changes,0,0
53677,in,0,0
53678,health-related,0,0
53679,quality,0,0
53680,of,0,0
53681,life,0,0
53682,(,0,0
53683,HRQoL,0,1
53684,),0,1
53685,measures,0,0
53686,among,0,0
53687,patients,0,0
53688,receiving,0,0
53689,topiramate,1,1
53690,(,1,1
53691,TPM,1,1
53692,),1,0
53693,100,0,0
53694,mg/d,0,0
53695,in,0,0
53696,two,0,0
53697,divided,0,0
53698,doses,0,0
53699,for,0,0
53700,migraine,0,0
53701,prevention,0,0
53702,in,0,0
53703,three,0,0
53704,randomized,0,0
53705,",",0,0
53706,double-blind,0,0
53707,",",0,0
53708,placebo-controlled,0,1
53709,",",0,0
53710,26-week,0,0
53711,trials,0,0
53712,with,0,0
53713,similar,0,0
53714,protocols,0,1
53715,and,0,0
53716,study,0,0
53717,populations,0,0
53718,.,0,0
53719,BACKGROUND,0,0
53720,Migraine,0,0
53721,substantially,0,0
53722,impairs,0,0
53723,HRQoL,0,1
53724,and,0,0
53725,work,0,0
53726,productivity,0,0
53727,before,0,0
53728,",",0,0
53729,during,0,0
53730,",",0,0
53731,and,0,0
53732,after,0,0
53733,attacks,0,0
53734,.,0,0
53735,Approximately,0,0
53736,50,0,0
53737,%,0,0
53738,of,0,0
53739,patients,0,0
53740,with,0,0
53741,migraine,0,0
53742,could,0,0
53743,be,0,0
53744,recommended,0,0
53745,for,0,0
53746,preventive,0,0
53747,therapies,0,0
53748,",",0,0
53749,yet,0,0
53750,only,0,0
53751,3,0,0
53752,%,0,0
53753,to,0,0
53754,5,0,0
53755,%,0,0
53756,of,0,0
53757,patients,0,0
53758,receive,0,0
53759,them,0,0
53760,.,0,0
53761,TPM,1,0
53762,is,0,0
53763,an,0,0
53764,effective,0,0
53765,and,0,0
53766,generally,0,0
53767,well-tolerated,0,0
53768,migraine,0,0
53769,prophylactic,0,1
53770,(,0,0
53771,preventive,0,0
53772,),0,0
53773,therapy,0,1
53774,for,0,0
53775,adults,0,0
53776,",",0,0
53777,as,0,0
53778,demonstrated,0,0
53779,in,0,0
53780,several,0,0
53781,randomized,0,0
53782,",",0,0
53783,double-blind,0,0
53784,",",0,0
53785,placebo-controlled,0,1
53786,trials,0,0
53787,.,0,0
53788,The,0,0
53789,most,0,0
53790,common,0,0
53791,adverse,0,0
53792,events,0,0
53793,in,0,0
53794,double-blind,0,0
53795,",",0,0
53796,placebo-controlled,0,1
53797,studies,0,0
53798,of,0,0
53799,TPM,1,1
53800,in,0,0
53801,migraine,0,0
53802,prevention,0,0
53803,are,0,0
53804,paresthesia,0,0
53805,",",0,0
53806,fatigue,0,0
53807,",",0,0
53808,anorexia,0,0
53809,",",0,0
53810,nausea,0,0
53811,",",0,0
53812,taste,0,0
53813,alteration,0,0
53814,",",0,0
53815,and,0,0
53816,diarrhea,0,0
53817,.,0,0
53818,DESIGN,0,0
53819,AND,0,0
53820,METHODS,0,0
53821,The,0,0
53822,Migraine-Specific,0,0
53823,Questionnaire,0,0
53824,(,0,0
53825,MSQ,0,0
53826,",",0,0
53827,version,0,0
53828,2.1,0,0
53829,),0,0
53830,was,0,0
53831,used,0,0
53832,to,0,0
53833,assess,0,0
53834,the,0,0
53835,effect,0,0
53836,of,0,0
53837,TPM,1,1
53838,100,0,0
53839,mg/d,0,0
53840,on,0,0
53841,the,0,0
53842,functionality,0,0
53843,and,0,0
53844,HRQoL,0,1
53845,of,0,0
53846,randomized,0,0
53847,intent-to-treat,0,0
53848,(,0,0
53849,ITT,0,1
53850,),0,1
53851,and,0,0
53852,study-completer,0,0
53853,populations,0,0
53854,pooled,0,0
53855,from,0,0
53856,three,0,0
53857,randomized,0,0
53858,",",0,0
53859,double-blind,0,0
53860,",",0,0
53861,placebo-controlled,0,1
53862,trials,0,0
53863,.,0,0
53864,MSQ,0,0
53865,scores,0,0
53866,(,0,0
53867,0,0,0
53868,to,0,0
53869,100,0,0
53870,",",0,0
53871,higher,0,0
53872,score,0,0
53873,indicates,0,0
53874,better,0,0
53875,functioning,0,0
53876,),0,0
53877,were,0,0
53878,assessed,0,0
53879,for,0,0
53880,the,0,0
53881,following,0,0
53882,three,0,0
53883,domains,0,0
53884,:,0,0
53885,role,0,0
53886,restriction,0,1
53887,(,0,0
53888,examines,0,0
53889,the,0,0
53890,degree,0,0
53891,to,0,0
53892,which,0,0
53893,performance,0,0
53894,of,0,0
53895,daily,0,0
53896,activities,0,0
53897,is,0,0
53898,limited,0,0
53899,by,0,0
53900,migraine,0,0
53901,),0,0
53902,",",0,0
53903,role,0,0
53904,prevention,0,0
53905,(,0,0
53906,examines,0,0
53907,the,0,0
53908,degree,0,0
53909,to,0,0
53910,which,0,0
53911,performance,0,0
53912,of,0,0
53913,daily,0,0
53914,activities,0,0
53915,is,0,0
53916,interrupted,0,0
53917,by,0,0
53918,migraine,0,0
53919,),0,0
53920,",",0,0
53921,and,0,0
53922,emotional,0,0
53923,function,0,0
53924,(,0,0
53925,examines,0,0
53926,feelings,0,0
53927,of,0,0
53928,frustration,0,0
53929,and,0,0
53930,helplessness,0,0
53931,due,0,0
53932,to,0,0
53933,migraine,0,0
53934,),0,0
53935,.,0,0
53936,Between-group,0,0
53937,differences,0,0
53938,from,0,0
53939,baseline,0,0
53940,in,0,0
53941,mean,0,0
53942,MSQ,0,0
53943,domain,0,0
53944,scores,0,0
53945,for,0,0
53946,TPM,1,1
53947,100,0,1
53948,mg/d,0,0
53949,and,0,0
53950,placebo,1,1
53951,were,0,0
53952,compared,0,0
53953,using,0,0
53954,a,0,0
53955,mixed-effects,0,0
53956,model,0,0
53957,with,0,0
53958,piecewise,0,0
53959,linear,0,0
53960,regression,0,0
53961,.,0,0
53962,Effect,0,0
53963,sizes,0,0
53964,were,0,0
53965,calculated,0,0
53966,to,0,0
53967,estimate,0,0
53968,the,0,0
53969,magnitude,0,0
53970,of,0,0
53971,change,0,0
53972,in,0,0
53973,HRQoL,0,1
53974,that,0,0
53975,can,0,0
53976,be,0,0
53977,associated,0,0
53978,with,0,0
53979,TPM,1,1
53980,therapy,1,1
53981,.,1,0
53982,RESULTS,0,0
53983,TPM,1,1
53984,100,0,0
53985,mg/d,0,0
53986,significantly,0,0
53987,improved,0,0
53988,all,0,0
53989,three,0,0
53990,MSQ,0,0
53991,domains,0,0
53992,compared,0,0
53993,with,0,0
53994,placebo,1,1
53995,for,0,0
53996,both,0,0
53997,the,0,0
53998,ITT,0,0
53999,(,1,0
54000,TPM,1,1
54001,",",0,0
54002,n,0,0
54003,=,0,0
54004,372,0,0
54005,;,0,0
54006,placebo,1,1
54007,",",0,0
54008,n,0,0
54009,=,0,0
54010,362,0,0
54011,),0,0
54012,and,0,0
54013,study-completer,0,0
54014,(,0,0
54015,TPM,0,1
54016,",",0,0
54017,n,0,0
54018,=,0,0
54019,220,0,0
54020,;,0,0
54021,placebo,0,1
54022,",",0,0
54023,n,0,0
54024,=,0,0
54025,216,0,0
54026,),0,0
54027,populations,0,0
54028,(,0,0
54029,P,0,0
54030,<,0,0
54031,.001,0,0
54032,for,0,0
54033,all,0,0
54034,three,0,0
54035,domains,0,0
54036,",",0,0
54037,both,0,0
54038,populations,0,0
54039,),0,0
54040,.,0,0
54041,Effect,0,0
54042,sizes,0,0
54043,for,0,0
54044,TPM,1,1
54045,100,0,0
54046,mg/d,0,0
54047,varied,0,0
54048,from,0,0
54049,0.40,0,0
54050,to,0,0
54051,0.78,0,0
54052,",",0,0
54053,indicating,0,0
54054,that,0,0
54055,the,0,0
54056,changes,0,0
54057,in,0,0
54058,MSQ,0,0
54059,scores,0,0
54060,for,0,0
54061,TPM,1,1
54062,100,0,0
54063,mg/d,0,0
54064,were,0,0
54065,moderate,0,0
54066,and,0,0
54067,may,0,0
54068,be,0,0
54069,clinically,0,0
54070,significant,0,0
54071,.,0,0
54072,CONCLUSION,0,0
54073,TPM,1,1
54074,100,0,0
54075,mg/d,0,0
54076,has,0,0
54077,been,0,0
54078,shown,0,0
54079,to,0,0
54080,be,0,0
54081,effective,0,0
54082,in,0,0
54083,the,0,0
54084,prevention,0,0
54085,of,0,0
54086,migraine,0,0
54087,headache,0,0
54088,in,0,0
54089,adults,0,0
54090,.,0,0
54091,As,0,0
54092,the,0,0
54093,MSQ,0,0
54094,results,0,0
54095,from,0,0
54096,the,0,0
54097,three,0,0
54098,randomized,0,0
54099,",",0,0
54100,placebo-controlled,0,1
54101,trials,0,0
54102,indicate,0,0
54103,",",0,0
54104,HRQoL,0,1
54105,is,0,0
54106,significantly,0,0
54107,improved,0,0
54108,for,0,0
54109,up,0,0
54110,to,0,0
54111,6,0,0
54112,months,0,0
54113,following,0,0
54114,initiation,0,0
54115,of,0,0
54116,treatment,0,0
54117,.,0,0
54118,Atomoxetine,1,1
54119,alone,0,0
54120,or,0,0
54121,combined,0,1
54122,with,0,0
54123,fluoxetine,1,1
54124,for,0,0
54125,treating,0,0
54126,ADHD,0,1
54127,with,0,0
54128,comorbid,0,0
54129,depressive,0,0
54130,or,0,1
54131,anxiety,0,0
54132,symptoms,0,0
54133,.,0,0
54134,OBJECTIVE,0,0
54135,Symptoms,0,0
54136,of,0,0
54137,depression,0,0
54138,and,0,0
54139,anxiety,0,0
54140,are,0,0
54141,commonly,0,0
54142,comorbid,0,0
54143,with,0,0
54144,attention-deficit/hyperactivity,0,0
54145,disorder,0,0
54146,(,0,0
54147,ADHD,0,1
54148,),0,0
54149,.,0,0
54150,The,0,0
54151,authors,0,0
54152,assessed,0,0
54153,the,0,0
54154,safety,0,0
54155,and,0,0
54156,effectiveness,0,0
54157,of,0,0
54158,atomoxetine,1,1
54159,monotherapy,0,1
54160,compared,0,0
54161,with,0,0
54162,combined,0,1
54163,atomoxetine/fluoxetine,1,1
54164,therapy,1,1
54165,in,0,0
54166,a,0,0
54167,population,0,0
54168,of,0,0
54169,children,0,0
54170,and,0,0
54171,adolescents,0,0
54172,with,0,0
54173,ADHD,0,1
54174,and,0,0
54175,concurrent,0,1
54176,symptoms,0,0
54177,of,0,0
54178,depression,0,0
54179,or,0,0
54180,anxiety,0,0
54181,.,0,0
54182,METHOD,0,0
54183,Patients,0,0
54184,were,0,0
54185,randomized,0,0
54186,to,0,0
54187,treatment,0,0
54188,with,0,0
54189,fluoxetine,1,1
54190,(,1,0
54191,n,1,0
54192,=,1,0
54193,127,1,0
54194,),1,0
54195,or,1,1
54196,placebo,1,1
54197,(,0,0
54198,n,0,0
54199,=,0,0
54200,46,0,0
54201,),0,0
54202,under,0,0
54203,double-blind,0,0
54204,conditions,0,0
54205,for,0,0
54206,8,0,0
54207,weeks,0,0
54208,",",0,0
54209,with,0,0
54210,concomitant,1,0
54211,atomoxetine,1,1
54212,use,1,0
54213,the,1,0
54214,last,1,0
54215,5,1,0
54216,weeks,1,0
54217,.,1,0
54218,RESULTS,0,0
54219,At,0,0
54220,end,0,0
54221,point,0,0
54222,",",0,0
54223,reductions,0,0
54224,in,0,0
54225,ADHD,0,0
54226,",",0,0
54227,depressive,0,0
54228,",",0,0
54229,and,0,0
54230,anxiety,0,0
54231,symptoms,0,0
54232,were,0,0
54233,marked,0,0
54234,for,0,0
54235,both,0,0
54236,treatment,0,0
54237,groups,0,0
54238,(,0,0
54239,p,0,0
54240,<,0,0
54241,.001,0,0
54242,for,0,0
54243,the,0,0
54244,relevant,0,0
54245,scale,0,0
54246,in,0,0
54247,each,0,0
54248,symptom,0,0
54249,cluster,0,0
54250,),0,0
54251,.,0,0
54252,Some,0,0
54253,differences,0,0
54254,between,0,0
54255,treatment,0,0
54256,groups,0,0
54257,for,0,0
54258,depressive,0,0
54259,symptoms,0,0
54260,were,0,0
54261,significant,0,0
54262,",",0,0
54263,but,0,0
54264,the,0,0
54265,magnitudes,0,0
54266,of,0,0
54267,the,0,0
54268,differences,0,0
54269,were,0,0
54270,small,0,0
54271,and,0,0
54272,likely,0,0
54273,of,0,0
54274,limited,0,0
54275,clinical,0,0
54276,importance,0,0
54277,.,0,0
54278,Completion,0,0
54279,rates,0,0
54280,for,0,0
54281,the,0,0
54282,two,0,0
54283,groups,0,0
54284,were,0,0
54285,similar,0,0
54286,",",0,0
54287,as,0,0
54288,were,0,0
54289,discontinuation,0,0
54290,rates,0,0
54291,for,0,0
54292,adverse,0,0
54293,events,0,0
54294,.,0,0
54295,The,0,0
54296,combination,0,0
54297,group,0,0
54298,had,0,0
54299,greater,0,0
54300,increases,0,0
54301,in,0,0
54302,blood,0,0
54303,pressure,0,0
54304,and,0,0
54305,pulse,0,1
54306,than,0,0
54307,did,0,0
54308,the,0,0
54309,monotherapy,0,1
54310,group,0,0
54311,.,0,0
54312,CONCLUSIONS,0,0
54313,In,0,0
54314,pediatric,0,0
54315,patients,0,0
54316,with,0,0
54317,ADHD,0,1
54318,and,0,0
54319,comorbid,0,0
54320,symptoms,0,0
54321,of,0,0
54322,depression,0,0
54323,or,0,1
54324,anxiety,0,0
54325,",",0,0
54326,atomoxetine,1,1
54327,monotherapy,1,1
54328,appears,0,0
54329,to,0,0
54330,be,0,0
54331,effective,0,0
54332,for,0,0
54333,treating,0,0
54334,ADHD,0,1
54335,.,0,0
54336,Anxiety,0,0
54337,and,0,0
54338,depressive,0,0
54339,symptoms,0,0
54340,also,0,0
54341,improved,0,0
54342,",",0,0
54343,but,0,0
54344,the,0,0
54345,absence,0,0
54346,of,0,0
54347,a,0,0
54348,placebo-only,0,0
54349,arm,0,0
54350,does,0,0
54351,not,0,0
54352,allow,0,0
54353,us,0,0
54354,to,0,0
54355,conclude,0,0
54356,that,0,0
54357,these,0,0
54358,effects,0,0
54359,are,0,0
54360,specifically,0,0
54361,the,0,0
54362,result,0,0
54363,of,0,0
54364,treatment,0,0
54365,with,0,0
54366,atomoxetine,1,1
54367,.,1,0
54368,Combined,1,0
54369,atomoxetine/fluoxetine,1,1
54370,therapy,0,1
54371,was,0,0
54372,well,0,0
54373,tolerated,0,0
54374,.,0,0
54375,[,0,0
54376,A,0,0
54377,randomized,0,0
54378,study,0,0
54379,of,0,0
54380,prophylactic,0,1
54381,intravesical,0,1
54382,instillation,0,0
54383,of,0,0
54384,pirarubicin,1,1
54385,(,1,0
54386,THP,1,0
54387,),1,0
54388,prior,0,0
54389,to,0,0
54390,transurethral,0,1
54391,resection,0,1
54392,of,0,0
54393,superficial,0,0
54394,bladder,0,0
54395,cancer,0,0
54396,],0,0
54397,.,0,0
54398,A,0,0
54399,prospective,0,0
54400,randomized,0,0
54401,study,0,0
54402,was,0,0
54403,conducted,0,0
54404,to,0,0
54405,evaluate,0,0
54406,the,0,0
54407,efficacy,0,0
54408,of,0,0
54409,prophylactic,0,1
54410,intravesical,1,1
54411,instillation,1,0
54412,of,1,0
54413,pirarubicin,1,1
54414,(,1,0
54415,THP,1,0
54416,),1,0
54417,prior,0,0
54418,to,0,0
54419,transurethral,1,1
54420,resection,1,1
54421,(,0,0
54422,TUR,0,0
54423,),0,0
54424,of,0,0
54425,superficial,0,0
54426,bladder,0,0
54427,cancer,0,0
54428,.,0,0
54429,A,0,0
54430,total,0,0
54431,of,0,0
54432,63,0,0
54433,patients,0,0
54434,were,0,0
54435,randomized,0,0
54436,into,0,0
54437,two,0,0
54438,groups,0,0
54439,",",0,0
54440,the,0,0
54441,THP,1,0
54442,group,0,0
54443,and,0,0
54444,the,0,0
54445,control,0,0
54446,group,0,0
54447,.,0,0
54448,In,0,0
54449,the,0,0
54450,THP,0,0
54451,group,0,0
54452,",",0,0
54453,30,0,0
54454,mg,0,0
54455,of,0,0
54456,THP,0,0
54457,dissolved,0,1
54458,in,0,0
54459,50,1,0
54460,ml,1,0
54461,saline,1,1
54462,was,0,0
54463,administered,0,0
54464,4,0,0
54465,times,0,0
54466,intravesically,0,0
54467,for,0,0
54468,4,0,0
54469,consecutive,0,0
54470,days,0,0
54471,before,0,0
54472,TUR,0,0
54473,.,0,0
54474,In,0,0
54475,the,0,0
54476,control,0,0
54477,group,0,0
54478,",",0,0
54479,no,1,0
54480,instillation,1,0
54481,was,1,0
54482,performed,1,0
54483,before,1,0
54484,TUR,1,0
54485,.,1,0
54486,The,0,0
54487,patients,0,0
54488,were,0,0
54489,followed,0,0
54490,by,0,0
54491,cystoscopy,0,1
54492,and,0,0
54493,urinary,0,0
54494,cytology,0,0
54495,every,0,0
54496,3,0,0
54497,months,0,0
54498,.,0,0
54499,The,0,0
54500,non-recurrence,0,0
54501,rates,0,0
54502,in,0,0
54503,the,0,0
54504,THP,0,0
54505,group,0,0
54506,and,0,0
54507,control,0,1
54508,group,0,0
54509,were,0,0
54510,54.1,0,0
54511,%,0,0
54512,versus,0,0
54513,37.6,0,0
54514,%,0,0
54515,at,0,0
54516,1,0,0
54517,year,0,0
54518,and,0,0
54519,40.4,0,0
54520,%,0,0
54521,versus,0,0
54522,26.8,0,0
54523,%,0,0
54524,at,0,0
54525,2,0,0
54526,years,0,0
54527,",",0,0
54528,respectively,0,0
54529,(,0,0
54530,P,0,0
54531,=,0,0
54532,0.086,0,0
54533,),0,0
54534,.,0,0
54535,Time,0,0
54536,to,0,0
54537,recurrence,0,0
54538,for,0,0
54539,tumors,0,0
54540,larger,0,0
54541,than,0,0
54542,1,0,0
54543,cm,0,0
54544,was,0,0
54545,significantly,0,0
54546,longer,0,0
54547,in,0,0
54548,the,0,0
54549,THP,0,1
54550,group,0,0
54551,(,0,0
54552,P,0,0
54553,=,0,0
54554,0.0137,0,0
54555,),0,0
54556,.,0,0
54557,Time,0,0
54558,to,0,0
54559,recurrence,0,0
54560,for,0,0
54561,single,0,0
54562,and,0,0
54563,grade,0,0
54564,1+2,0,0
54565,tumors,0,0
54566,tended,0,0
54567,to,0,0
54568,be,0,0
54569,longer,0,0
54570,in,0,0
54571,the,0,0
54572,THP,0,1
54573,group,0,0
54574,(,0,0
54575,P,0,0
54576,=,0,0
54577,0.09,0,0
54578,",",0,0
54579,P,0,0
54580,=,0,0
54581,0.079,0,0
54582,),0,0
54583,.,0,0
54584,No,0,0
54585,significant,0,0
54586,adverse,0,0
54587,effects,0,0
54588,were,0,0
54589,observed,0,0
54590,in,0,0
54591,any,0,0
54592,patient,0,0
54593,.,0,0
54594,Our,0,0
54595,findings,0,0
54596,suggest,0,0
54597,that,0,0
54598,intravesical,0,1
54599,THP,0,0
54600,instillation,0,0
54601,prior,0,0
54602,to,0,0
54603,TUR,0,0
54604,would,0,0
54605,be,0,0
54606,effective,0,0
54607,for,0,0
54608,patients,0,0
54609,with,0,0
54610,single,0,0
54611,",",0,0
54612,low,0,0
54613,grade,0,0
54614,lesions,0,0
54615,larger,0,0
54616,than,0,0
54617,1,0,0
54618,cm,0,0
54619,of,0,0
54620,superficial,0,0
54621,bladder,0,0
54622,cancer,0,0
54623,.,0,0
54624,Effect,0,0
54625,of,0,0
54626,esomeprazole,1,1
54627,on,0,0
54628,nighttime,0,0
54629,heartburn,0,0
54630,and,0,0
54631,sleep,0,0
54632,quality,0,0
54633,in,0,0
54634,patients,0,0
54635,with,0,0
54636,GERD,0,0
54637,:,0,0
54638,a,0,0
54639,randomized,0,0
54640,",",0,0
54641,placebo-controlled,0,1
54642,trial,0,0
54643,.,0,0
54644,OBJECTIVES,0,0
54645,Sleep,0,0
54646,disturbances,0,0
54647,are,0,0
54648,common,0,0
54649,in,0,0
54650,patients,0,0
54651,with,0,0
54652,gastroesophageal,0,0
54653,reflux,0,0
54654,disease,0,0
54655,(,0,0
54656,GERD,0,1
54657,),0,0
54658,.,0,0
54659,This,0,0
54660,study,0,0
54661,examined,0,0
54662,the,0,0
54663,effects,0,0
54664,of,0,0
54665,esomeprazole,0,1
54666,on,0,0
54667,nighttime,0,0
54668,heartburn,0,0
54669,",",0,0
54670,GERD-related,0,0
54671,sleep,0,0
54672,disturbances,0,0
54673,",",0,0
54674,sleep,0,0
54675,quality,0,0
54676,",",0,0
54677,work,0,0
54678,productivity,0,0
54679,",",0,0
54680,and,0,0
54681,regular,0,0
54682,activities,0,0
54683,.,0,0
54684,METHODS,0,0
54685,This,0,0
54686,multicenter,0,0
54687,",",0,0
54688,randomized,0,0
54689,",",0,0
54690,double-blind,0,0
54691,",",0,0
54692,placebo-controlled,1,1
54693,trial,0,0
54694,included,0,0
54695,adults,0,0
54696,with,0,0
54697,GERD-associated,0,0
54698,sleep,0,0
54699,disturbances,0,0
54700,and,0,0
54701,moderate-to-severe,0,0
54702,nighttime,0,1
54703,heartburn,0,0
54704,(,0,0
54705,recorded,0,0
54706,by,0,0
54707,patient,0,0
54708,diary,0,1
54709,during,0,0
54710,screening,0,0
54711,),0,0
54712,.,0,0
54713,Patients,0,0
54714,received,0,0
54715,oral,1,0
54716,esomeprazole,1,1
54717,40,1,0
54718,mg,1,1
54719,(,1,0
54720,n,1,0
54721,=,1,0
54722,220,1,0
54723,),1,0
54724,or,1,0
54725,20,1,1
54726,mg,1,1
54727,(,1,0
54728,n,1,0
54729,=,1,0
54730,226,1,0
54731,),1,0
54732,or,1,1
54733,placebo,1,1
54734,(,1,0
54735,n,1,0
54736,=,1,0
54737,229,1,0
54738,),1,0
54739,once,1,0
54740,daily,1,0
54741,for,1,0
54742,4,1,0
54743,wk,1,0
54744,.,1,0
54745,The,0,0
54746,primary,0,0
54747,outcome,0,0
54748,was,0,0
54749,relief,0,0
54750,of,0,0
54751,nighttime,0,0
54752,heartburn,0,0
54753,.,0,0
54754,Secondary,0,0
54755,outcomes,0,0
54756,included,0,0
54757,resolution,0,0
54758,of,0,0
54759,sleep,0,0
54760,disturbances,0,0
54761,",",0,0
54762,sleep,0,0
54763,quality,0,0
54764,measured,0,0
54765,by,0,0
54766,the,0,0
54767,Pittsburgh,0,0
54768,Sleep,0,1
54769,Quality,0,0
54770,Index,0,1
54771,(,0,0
54772,PSQI,0,1
54773,),0,0
54774,questionnaire,0,0
54775,",",0,0
54776,and,0,0
54777,work,0,0
54778,productivity,0,0
54779,measured,0,0
54780,by,0,0
54781,the,0,0
54782,Work,0,1
54783,Productivity,0,0
54784,and,0,0
54785,Activity,0,0
54786,Impairment,0,0
54787,Questionnaire,0,0
54788,.,0,0
54789,RESULTS,0,0
54790,Nighttime,0,0
54791,heartburn,0,0
54792,was,0,0
54793,relieved,0,0
54794,in,0,0
54795,53.1,0,0
54796,%,0,0
54797,(,0,0
54798,111/209,0,0
54799,),0,0
54800,",",0,0
54801,50.5,0,0
54802,%,0,0
54803,(,0,0
54804,111/220,0,0
54805,),0,0
54806,",",0,0
54807,and,0,0
54808,12.7,0,0
54809,%,0,0
54810,(,0,0
54811,28/221,0,0
54812,),0,0
54813,of,0,0
54814,patients,0,0
54815,who,0,0
54816,received,0,0
54817,esomeprazole,0,1
54818,40,0,0
54819,mg,0,0
54820,",",0,0
54821,esomeprazole,0,1
54822,20,0,0
54823,mg,0,0
54824,",",0,0
54825,and,0,0
54826,placebo,0,1
54827,",",0,0
54828,respectively,0,0
54829,.,0,0
54830,Differences,0,0
54831,(,0,0
54832,95,0,0
54833,%,0,0
54834,CI,0,0
54835,),0,0
54836,versus,0,0
54837,placebo,0,1
54838,were,0,0
54839,40.5,0,0
54840,%,0,0
54841,(,0,0
54842,32.4,0,0
54843,%,0,0
54844,",",0,0
54845,48.5,0,0
54846,%,0,0
54847,),0,0
54848,and,0,0
54849,37.8,0,0
54850,%,0,0
54851,(,0,0
54852,29.9,0,0
54853,%,0,0
54854,",",0,0
54855,45.7,0,0
54856,%,0,0
54857,),0,0
54858,and,0,0
54859,were,0,0
54860,highly,0,0
54861,significant,0,0
54862,(,0,0
54863,p,0,0
54864,<,0,0
54865,0.0001,0,0
54866,),0,0
54867,.,0,0
54868,GERD-related,0,0
54869,sleep,0,0
54870,disturbances,0,0
54871,resolved,0,0
54872,in,0,0
54873,significantly,0,0
54874,more,0,0
54875,(,0,0
54876,p,0,0
54877,<,0,0
54878,0.0001,0,0
54879,),0,0
54880,patients,0,0
54881,who,0,0
54882,received,0,0
54883,esomeprazole,0,1
54884,40,0,0
54885,(,0,0
54886,73.7,0,0
54887,%,0,0
54888,),0,0
54889,or,0,1
54890,20,0,1
54891,mg,0,1
54892,(,0,0
54893,73.2,0,0
54894,%,0,0
54895,),0,0
54896,than,0,0
54897,in,0,0
54898,those,0,0
54899,who,0,0
54900,received,0,0
54901,placebo,0,1
54902,(,0,0
54903,41.2,0,0
54904,%,0,0
54905,),0,0
54906,.,0,0
54907,Both,0,0
54908,esomeprazole,0,1
54909,groups,0,0
54910,had,0,0
54911,greater,0,0
54912,PSQI,0,0
54913,global,0,0
54914,score,0,0
54915,changes,0,0
54916,from,0,0
54917,baseline,0,0
54918,(,0,0
54919,p,0,0
54920,<,0,0
54921,0.0001,0,0
54922,vs,0,0
54923,placebo,0,1
54924,),0,0
54925,and,0,0
54926,more,0,0
54927,(,0,0
54928,p,0,0
54929,<,0,0
54930,0.0001,0,0
54931,vs,0,0
54932,placebo,0,1
54933,),0,0
54934,work,0,0
54935,hours,0,0
54936,saved,0,0
54937,per,0,0
54938,week,0,0
54939,per,0,0
54940,patient,0,0
54941,compared,0,0
54942,with,0,0
54943,baseline,0,0
54944,(,0,0
54945,esomeprazole,0,1
54946,40,0,0
54947,mg,0,0
54948,",",0,0
54949,11.6,0,0
54950,h,0,0
54951,;,0,0
54952,esomeprazole,0,1
54953,20,0,0
54954,mg,0,0
54955,",",0,0
54956,12.3,0,0
54957,h,0,0
54958,;,0,0
54959,placebo,0,1
54960,",",0,0
54961,6.2,0,0
54962,h,0,0
54963,),0,0
54964,.,0,0
54965,CONCLUSIONS,0,0
54966,Esomeprazole,0,1
54967,reduced,0,0
54968,nighttime,0,0
54969,heartburn,0,0
54970,and,0,0
54971,GERD-related,0,0
54972,sleep,0,0
54973,disturbances,0,0
54974,and,0,0
54975,improved,0,0
54976,sleep,0,0
54977,quality,0,0
54978,and,0,0
54979,work,0,0
54980,productivity,0,0
54981,.,0,0
54982,Comparison,0,0
54983,of,0,0
54984,the,0,0
54985,effectiveness,0,0
54986,of,0,0
54987,oral,0,1
54988,diazepam,1,1
54989,and,1,0
54990,midazolam,1,1
54991,for,0,0
54992,the,0,0
54993,sedation,0,0
54994,of,0,0
54995,autistic,0,0
54996,patients,0,0
54997,during,0,0
54998,dental,0,0
54999,treatment,0,0
55000,.,0,0
55001,PURPOSE,0,0
55002,This,0,0
55003,study,0,0
55004,was,0,0
55005,undertaken,0,0
55006,to,0,0
55007,compare,0,0
55008,the,0,0
55009,effectiveness,0,0
55010,of,0,0
55011,oral,0,1
55012,diazepam,1,1
55013,and,1,0
55014,midazolam,1,1
55015,in,0,0
55016,sedating,0,0
55017,autistic,0,0
55018,patients,0,0
55019,during,0,0
55020,dental,0,0
55021,treatment,0,0
55022,.,0,0
55023,METHODS,0,0
55024,The,0,0
55025,treatment,0,0
55026,regimen,0,0
55027,consisted,0,0
55028,of,0,0
55029,nitrous,1,1
55030,oxide/oxygen,1,1
55031,inhalation,1,1
55032,in,0,0
55033,conjunction,0,1
55034,with,0,0
55035,oral,1,1
55036,administration,1,0
55037,of,1,0
55038,either,1,0
55039,diazepam,1,1
55040,0.3,1,0
55041,mg/kg,1,0
55042,or,1,0
55043,midazolam,1,1
55044,0.5,1,0
55045,mg/kg,1,0
55046,in,0,0
55047,a,0,0
55048,cross-over,0,0
55049,design,0,0
55050,study,0,0
55051,of,0,0
55052,13,0,0
55053,subjects,0,0
55054,aged,0,0
55055,5.8,0,0
55056,to,0,0
55057,14.7,0,0
55058,years,0,0
55059,.,0,0
55060,A,0,0
55061,drug,0,0
55062,was,0,0
55063,classified,0,0
55064,as,0,0
55065,being,0,0
55066,effective,0,0
55067,when,0,0
55068,over,0,0
55069,70,0,0
55070,%,0,0
55071,of,0,0
55072,the,0,0
55073,patients,0,0
55074,taking,0,0
55075,the,0,0
55076,drug,0,0
55077,were,0,0
55078,judged,0,0
55079,as,0,0
55080,success,0,0
55081,in,0,0
55082,all,0,0
55083,3,0,0
55084,behavioral,0,0
55085,criteria,0,0
55086,:,0,0
55087,(,0,0
55088,1,0,0
55089,),0,0
55090,sleeping,0,0
55091,;,0,0
55092,(,0,0
55093,2,0,0
55094,),0,0
55095,body,0,0
55096,movement,0,0
55097,;,0,0
55098,and,0,0
55099,(,0,0
55100,3,0,0
55101,),0,0
55102,crying,0,0
55103,behaviors,0,0
55104,.,0,0
55105,The,0,0
55106,study,0,0
55107,was,0,0
55108,observed,0,0
55109,by,0,0
55110,an,0,0
55111,independent,0,0
55112,clinician,0,0
55113,with,0,0
55114,an,0,0
55115,intraexaminer,0,0
55116,reliability,0,0
55117,of,0,0
55118,88,0,0
55119,%,0,0
55120,.,0,0
55121,RESULTS,0,0
55122,For,0,0
55123,sleeping,0,0
55124,behavior,0,0
55125,",",0,0
55126,midazolam,0,1
55127,was,0,0
55128,found,0,0
55129,to,0,0
55130,be,0,0
55131,significantly,0,0
55132,more,0,0
55133,effective,0,0
55134,than,0,0
55135,diazepam,0,1
55136,as,0,0
55137,the,0,0
55138,duration,0,0
55139,of,0,0
55140,stimulation,0,1
55141,increased,0,0
55142,(,0,0
55143,P,0,0
55144,<,0,0
55145,.05,0,0
55146,),0,0
55147,.,0,0
55148,For,0,0
55149,the,0,0
55150,movement,0,0
55151,and,0,0
55152,crying,0,0
55153,behaviors,0,0
55154,",",0,0
55155,midazolam,0,1
55156,also,0,0
55157,proved,0,0
55158,to,0,0
55159,be,0,0
55160,significantly,0,0
55161,more,0,0
55162,effective,0,0
55163,from,0,0
55164,the,0,0
55165,start,0,0
55166,of,0,0
55167,treatment,0,0
55168,through,0,0
55169,the,0,0
55170,35-,0,0
55171,and,0,0
55172,40-min,0,1
55173,markers,0,0
55174,",",0,0
55175,respectively,0,0
55176,(,0,0
55177,P,0,0
55178,<,0,0
55179,.05,0,0
55180,),0,0
55181,.,0,0
55182,For,0,0
55183,the,0,0
55184,remainder,0,0
55185,of,0,0
55186,treatment,0,0
55187,",",0,0
55188,however,0,0
55189,",",0,0
55190,there,0,0
55191,was,0,0
55192,no,0,0
55193,statistically,0,0
55194,significant,0,0
55195,difference,0,0
55196,in,0,0
55197,these,0,0
55198,behaviors,0,0
55199,between,0,0
55200,the,0,0
55201,trials,0,0
55202,(,0,0
55203,P,0,0
55204,>,0,0
55205,.05,0,0
55206,),0,0
55207,.,0,0
55208,Diazepam,0,1
55209,and,0,0
55210,midazolam,0,1
55211,were,0,0
55212,rated,0,0
55213,as,0,0
55214,77,0,0
55215,%,0,0
55216,and,0,0
55217,100,0,1
55218,%,0,0
55219,successful,0,0
55220,",",0,0
55221,according,0,0
55222,to,0,0
55223,the,0,0
55224,overall,0,0
55225,behavior,0,0
55226,evaluation,0,0
55227,criteria,0,0
55228,(,0,0
55229,P=.02,0,0
55230,),0,0
55231,.,0,0
55232,CONCLUSIONS,0,0
55233,Both,0,1
55234,diazepam,0,1
55235,and,0,0
55236,midazolam,0,1
55237,were,0,0
55238,shown,0,0
55239,to,0,0
55240,be,0,0
55241,effective,0,0
55242,sedative,0,1
55243,agents,0,0
55244,",",0,0
55245,successfully,0,0
55246,and,0,0
55247,safely,0,0
55248,used,0,0
55249,to,0,0
55250,sedate,0,0
55251,autistic,0,0
55252,patients,0,0
55253,for,0,0
55254,dental,0,0
55255,treatment,0,0
55256,.,0,0
55257,Midazolam,0,1
55258,was,0,0
55259,significantly,0,0
55260,more,0,0
55261,effective,0,0
55262,than,0,0
55263,diazepam,0,1
55264,in,0,0
55265,those,0,0
55266,portions,0,0
55267,of,0,0
55268,the,0,0
55269,procedure,0,0
55270,with,0,0
55271,increased,0,0
55272,stimulation,0,0
55273,.,0,0
55274,A,0,0
55275,double-blind,0,0
55276,",",0,0
55277,placebo-controlled,1,1
55278,study,0,0
55279,of,0,0
55280,valproate,1,1
55281,for,0,0
55282,aggression,0,0
55283,in,0,0
55284,youth,0,0
55285,with,0,0
55286,pervasive,0,0
55287,developmental,0,0
55288,disorders,0,0
55289,.,0,0
55290,OBJECTIVE,0,0
55291,The,0,0
55292,aim,0,0
55293,of,0,0
55294,this,0,0
55295,study,0,0
55296,was,0,0
55297,to,0,0
55298,study,0,0
55299,valproate,1,1
55300,efficacy,0,0
55301,and,0,0
55302,safety,0,0
55303,for,0,0
55304,aggression,0,0
55305,in,0,0
55306,children,0,0
55307,and,0,0
55308,adolescents,0,0
55309,with,0,0
55310,pervasive,0,0
55311,developmental,0,0
55312,disorders,0,0
55313,(,0,0
55314,PDD,0,0
55315,),0,0
55316,.,0,0
55317,METHODS,0,0
55318,In,0,0
55319,this,0,0
55320,prospective,0,0
55321,double-blind,0,0
55322,",",0,0
55323,placebo-controlled,1,1
55324,study,0,0
55325,",",0,0
55326,30,0,0
55327,subjects,0,0
55328,(,0,0
55329,20,0,0
55330,boys,0,0
55331,",",0,0
55332,10,0,0
55333,girls,0,0
55334,),0,0
55335,6-20,0,0
55336,years,0,0
55337,of,0,0
55338,age,0,0
55339,with,0,0
55340,PDD,0,0
55341,and,0,0
55342,significant,0,0
55343,aggression,0,0
55344,were,0,0
55345,randomized,0,0
55346,and,0,0
55347,received,0,0
55348,treatment,0,0
55349,with,0,0
55350,valproate,1,1
55351,(,1,0
55352,VPA,1,0
55353,),1,1
55354,or,0,1
55355,placebo,1,1
55356,(,1,1
55357,PBO,1,0
55358,),1,0
55359,for,0,0
55360,8,0,0
55361,weeks,0,0
55362,as,0,0
55363,outpatients,0,0
55364,.,0,0
55365,Mean,0,0
55366,VPA,0,0
55367,trough,0,0
55368,blood,0,0
55369,levels,0,0
55370,were,0,0
55371,75.5,0,0
55372,mcg/mL,0,0
55373,at,0,0
55374,week,0,0
55375,4,0,0
55376,and,0,0
55377,77.8,0,0
55378,mcg/mL,0,0
55379,at,0,0
55380,week,0,0
55381,8,0,0
55382,.,0,0
55383,RESULTS,0,0
55384,No,0,0
55385,treatment,0,0
55386,difference,0,0
55387,was,0,0
55388,observed,0,0
55389,statistically,0,0
55390,between,0,0
55391,VPA,1,0
55392,and,0,0
55393,PBO,1,0
55394,groups,0,0
55395,.,0,0
55396,The,0,0
55397,Aberrant,0,0
55398,Behavior,0,0
55399,Checklist,0,0
55400,--,0,0
55401,Community,0,1
55402,Scale,0,1
55403,(,0,0
55404,ABC-C,0,1
55405,),0,1
55406,Irritability,0,0
55407,subscale,0,0
55408,was,0,0
55409,the,0,0
55410,primary,0,0
55411,outcome,0,0
55412,measure,0,0
55413,(,0,0
55414,p,0,0
55415,=,0,0
55416,0.65,0,0
55417,),0,0
55418,",",0,0
55419,and,0,0
55420,CGI,0,0
55421,--,0,1
55422,Improvement,0,0
55423,(,0,0
55424,p,0,0
55425,=,0,0
55426,0.16,0,0
55427,),0,0
55428,and,0,0
55429,OAS,0,1
55430,(,0,0
55431,p,0,0
55432,=,0,0
55433,0.96,0,0
55434,),0,0
55435,were,0,0
55436,secondary,0,0
55437,outcome,0,0
55438,measures,0,0
55439,.,0,0
55440,Increased,0,0
55441,appetite,0,0
55442,and,0,0
55443,skin,0,0
55444,rash,0,0
55445,were,0,0
55446,significant,0,0
55447,side,0,0
55448,effects,0,0
55449,.,0,0
55450,Only,0,0
55451,1,0,0
55452,subject,0,0
55453,was,0,0
55454,dropped,0,0
55455,from,0,0
55456,the,0,0
55457,study,0,0
55458,owing,0,0
55459,to,0,0
55460,side,0,0
55461,effects,0,0
55462,",",0,0
55463,notably,0,0
55464,a,0,0
55465,spreading,0,0
55466,skin,0,0
55467,rash,0,0
55468,",",0,0
55469,which,0,0
55470,then,0,0
55471,resolved,0,0
55472,spontaneously,0,0
55473,.,0,0
55474,Two,0,0
55475,subjects,0,0
55476,receiving,0,0
55477,VPA,1,0
55478,developed,0,0
55479,increased,0,0
55480,serum,0,0
55481,ammonia,0,0
55482,levels,0,0
55483,",",0,0
55484,one,0,0
55485,with,0,0
55486,an,0,0
55487,associated,0,0
55488,parent,0,1
55489,report,0,0
55490,of,0,0
55491,slurred,0,0
55492,speech,0,1
55493,and,0,0
55494,mild,0,0
55495,cognitive,0,0
55496,slowing,0,0
55497,.,0,0
55498,Poststudy,0,0
55499,",",0,0
55500,of,0,0
55501,16,0,0
55502,VPA,1,0
55503,and,0,0
55504,PBO,1,0
55505,subjects,0,0
55506,receiving,0,0
55507,VPA,1,0
55508,",",0,0
55509,10,0,0
55510,subjects,0,0
55511,demonstrated,0,0
55512,sustained,0,0
55513,response,0,0
55514,",",0,0
55515,4,0,0
55516,of,0,0
55517,whom,0,0
55518,later,0,0
55519,attempted,0,0
55520,taper,0,0
55521,",",0,0
55522,with,0,0
55523,significant,0,0
55524,relapse,0,0
55525,of,0,0
55526,aggression,0,0
55527,.,0,0
55528,CONCLUSION,0,0
55529,The,0,0
55530,present,0,0
55531,negative,0,0
55532,findings,0,0
55533,can,0,0
55534,not,0,0
55535,be,0,0
55536,viewed,0,0
55537,as,0,0
55538,conclusive,0,0
55539,",",0,0
55540,partly,0,0
55541,owing,0,0
55542,to,0,0
55543,the,0,0
55544,large,0,0
55545,placebo,1,1
55546,response,0,0
55547,",",0,0
55548,subject,0,0
55549,heterogeneity,0,0
55550,",",0,0
55551,and,0,0
55552,size,0,0
55553,of,0,0
55554,the,0,0
55555,groups,0,0
55556,.,0,0
55557,Larger,0,0
55558,studies,0,0
55559,are,0,0
55560,needed,0,0
55561,to,0,0
55562,expand,0,0
55563,upon,0,0
55564,these,0,0
55565,findings,0,0
55566,.,0,0
55567,[,0,0
55568,The,0,0
55569,comparison,0,0
55570,of,0,0
55571,the,0,0
55572,effect,0,0
55573,of,0,0
55574,enalapril,1,1
55575,and,1,0
55576,indapamide,1,1
55577,on,0,0
55578,the,0,0
55579,peripheral,0,0
55580,blood,0,0
55581,pressure,0,0
55582,and,0,0
55583,central,0,0
55584,blood,0,0
55585,pressure,0,0
55586,through,0,0
55587,pulse,0,1
55588,wave,0,1
55589,analysis,0,0
55590,],0,0
55591,.,0,0
55592,OBJECTIVES,0,0
55593,The,0,0
55594,purpose,0,0
55595,of,0,0
55596,this,0,0
55597,study,0,0
55598,was,0,0
55599,to,0,0
55600,evaluate,0,0
55601,the,0,0
55602,effects,0,0
55603,of,0,0
55604,the,0,0
55605,angiotensin-converting,1,1
55606,enzyme,1,0
55607,(,1,0
55608,ACE,1,0
55609,),1,1
55610,inhibitor,1,1
55611,enalapril,1,1
55612,and,1,0
55613,diuretic,1,1
55614,indapamide,1,1
55615,on,0,0
55616,the,0,0
55617,peripheral,0,0
55618,blood,0,0
55619,pressure,0,0
55620,and,0,0
55621,the,0,0
55622,central,0,0
55623,blood,0,0
55624,pressure,0,0
55625,in,0,0
55626,Chinese,0,0
55627,patients,0,0
55628,with,0,0
55629,essential,0,0
55630,hypertension,0,0
55631,.,0,0
55632,METHODS,0,0
55633,This,0,0
55634,study,0,0
55635,was,0,0
55636,a,0,0
55637,double,0,0
55638,blind,0,0
55639,",",0,0
55640,randomized,0,0
55641,study,0,0
55642,.,0,0
55643,Informed,0,0
55644,consent,0,0
55645,were,0,0
55646,given,0,0
55647,by,0,0
55648,all,0,0
55649,patients,0,0
55650,.,0,0
55651,After,0,0
55652,2,0,0
55653,weeks,0,0
55654,of,0,0
55655,placebo,1,1
55656,run-in,0,0
55657,period,0,0
55658,",",0,0
55659,105,0,0
55660,patients,0,0
55661,with,0,0
55662,mild,0,0
55663,or,0,0
55664,moderate,0,0
55665,essential,0,0
55666,hypertension,0,0
55667,were,0,0
55668,randomized,0,0
55669,to,0,0
55670,receive,0,0
55671,either,0,1
55672,enalapril,1,1
55673,(,0,0
55674,10,0,0
55675,mg,0,1
55676,per,0,0
55677,day,0,0
55678,),0,0
55679,or,1,1
55680,indapamide,1,1
55681,(,0,0
55682,2.5,0,0
55683,mg,0,1
55684,per,0,0
55685,day,0,0
55686,),0,0
55687,for,0,0
55688,8,0,0
55689,weeks,0,0
55690,.,0,0
55691,Radial,0,0
55692,pulse,0,0
55693,wave,0,1
55694,recordings,0,0
55695,were,0,0
55696,performed,0,0
55697,in,0,0
55698,all,0,0
55699,the,0,0
55700,patients,0,0
55701,before,0,0
55702,the,0,0
55703,active,0,0
55704,treatments,0,0
55705,were,0,0
55706,given,0,0
55707,and,0,0
55708,at,0,0
55709,the,0,0
55710,end,0,0
55711,of,0,0
55712,the,0,0
55713,study,0,0
55714,.,0,0
55715,Only,0,0
55716,those,0,0
55717,patients,0,0
55718,who,0,0
55719,have,0,0
55720,finished,0,0
55721,8,0,0
55722,weeks,0,0
55723,of,0,0
55724,active,0,0
55725,treatment,0,0
55726,in,0,0
55727,both,0,0
55728,groups,0,0
55729,were,0,0
55730,included,0,0
55731,into,0,0
55732,the,0,0
55733,final,0,0
55734,analysis,0,0
55735,.,0,0
55736,RESULTS,0,0
55737,One,0,0
55738,hundred,0,0
55739,one,0,0
55740,patients,0,0
55741,(,0,0
55742,51,0,0
55743,in,0,0
55744,enalapril,1,1
55745,group,0,0
55746,and,0,0
55747,50,0,0
55748,in,0,0
55749,indapamide,1,1
55750,group,0,0
55751,),0,0
55752,completed,0,0
55753,the,0,0
55754,study,0,0
55755,.,0,0
55756,No,0,0
55757,significant,0,0
55758,difference,0,0
55759,(,0,0
55760,all,0,0
55761,P,0,0
55762,values,0,0
55763,>,0,0
55764,0.05,0,0
55765,),0,0
55766,was,0,0
55767,found,0,0
55768,in,0,0
55769,baseline,0,0
55770,data,0,0
55771,between,0,0
55772,the,0,0
55773,two,0,0
55774,groups,0,0
55775,.,0,0
55776,After,0,0
55777,8,0,0
55778,weeks,0,0
55779,of,0,0
55780,treatment,0,0
55781,",",0,0
55782,all,0,0
55783,the,0,0
55784,parameters,0,0
55785,of,0,0
55786,pulse,0,1
55787,wave,0,1
55788,(,0,0
55789,except,0,0
55790,heart,0,0
55791,rates,0,0
55792,in,0,0
55793,both,0,0
55794,groups,0,0
55795,and,0,0
55796,augmentation,0,0
55797,index,0,0
55798,in,0,0
55799,indapamide,1,1
55800,group,0,0
55801,),0,0
55802,decreased,0,0
55803,significantly,0,0
55804,.,0,0
55805,Comparison,0,0
55806,of,0,0
55807,the,0,0
55808,2,0,0
55809,groups,0,0
55810,showed,0,0
55811,that,0,0
55812,there,0,0
55813,were,0,0
55814,no,0,0
55815,significant,0,0
55816,differences,0,0
55817,(,0,0
55818,all,0,0
55819,P,0,0
55820,values,0,0
55821,>,0,0
55822,0.05,0,0
55823,),0,0
55824,in,0,0
55825,all,0,0
55826,the,0,0
55827,parameters,0,0
55828,of,0,0
55829,pulse,0,1
55830,wave,0,0
55831,except,0,0
55832,that,0,0
55833,the,0,0
55834,central,0,0
55835,systolic,0,0
55836,blood,0,0
55837,pressure,0,0
55838,",",0,0
55839,augmentation,0,0
55840,and,0,0
55841,augmentation,0,0
55842,index,0,0
55843,were,0,0
55844,significantly,0,0
55845,lower,0,0
55846,in,0,0
55847,enalapril,1,1
55848,group,0,0
55849,than,0,0
55850,in,0,0
55851,indapamide,1,1
55852,group,0,0
55853,.,0,0
55854,In,0,0
55855,enalapril,1,1
55856,group,0,0
55857,",",0,0
55858,the,0,0
55859,reduced,0,0
55860,values,0,0
55861,of,0,0
55862,systolic,0,0
55863,blood,0,0
55864,pressure,0,0
55865,and,0,0
55866,pulse,0,1
55867,pressure,0,0
55868,in,0,0
55869,central,0,0
55870,aorta,0,0
55871,were,0,0
55872,significantly,0,0
55873,larger,0,0
55874,than,0,0
55875,those,0,0
55876,in,0,0
55877,brachial,0,0
55878,artery,0,0
55879,.,0,0
55880,However,0,0
55881,",",0,0
55882,the,0,0
55883,difference,0,0
55884,was,0,0
55885,not,0,0
55886,observed,0,0
55887,in,0,0
55888,indapamide,1,1
55889,group,0,0
55890,.,0,0
55891,CONCLUSIONS,0,0
55892,Enalapril,1,1
55893,and,1,0
55894,indapamide,1,1
55895,are,0,0
55896,both,0,0
55897,similarly,0,0
55898,effective,0,0
55899,in,0,0
55900,reducing,0,0
55901,peripheral,0,0
55902,arterial,0,0
55903,blood,0,0
55904,pressure,0,0
55905,.,0,0
55906,Moreover,0,0
55907,",",0,0
55908,enalapril,1,1
55909,is,0,0
55910,more,0,0
55911,effective,0,0
55912,in,0,0
55913,reducing,0,0
55914,central,0,0
55915,systolic,0,0
55916,pressure,0,0
55917,and,0,0
55918,augmentation,0,0
55919,index,0,0
55920,than,0,0
55921,indapamide,1,1
55922,.,1,0
55923,The,0,0
55924,difference,0,0
55925,is,0,0
55926,probably,0,0
55927,due,0,0
55928,to,0,0
55929,the,0,0
55930,reduction,0,0
55931,of,0,0
55932,wave,0,1
55933,reflection,0,0
55934,caused,0,0
55935,by,0,0
55936,enalapril,1,1
55937,.,1,0
55938,Efficacy,0,0
55939,of,0,0
55940,nebulized,1,1
55941,flunisolide,1,1
55942,combined,1,1
55943,with,1,0
55944,salbutamol,1,1
55945,and,1,0
55946,ipratropium,1,1
55947,bromide,1,1
55948,in,0,0
55949,stable,0,0
55950,patients,0,0
55951,with,0,0
55952,moderate-to-severe,0,0
55953,chronic,0,0
55954,obstructive,0,0
55955,pulmonary,0,0
55956,disease,0,0
55957,.,0,0
55958,BACKGROUND,0,0
55959,The,0,0
55960,efficacy,0,0
55961,of,0,0
55962,nebulized,0,1
55963,corticosteroids,1,1
55964,in,0,0
55965,the,0,0
55966,prevention,0,0
55967,of,0,0
55968,exacerbation,0,0
55969,of,0,0
55970,chronic,0,0
55971,obstructive,0,0
55972,pulmonary,0,0
55973,disease,0,0
55974,(,0,0
55975,COPD,0,0
55976,),0,1
55977,has,0,0
55978,been,0,0
55979,poorly,0,0
55980,studied,0,0
55981,.,0,0
55982,OBJECTIVE,0,0
55983,To,0,0
55984,evaluate,0,0
55985,the,0,0
55986,efficacy,0,0
55987,and,0,0
55988,tolerability,0,0
55989,of,0,0
55990,nebulized,1,1
55991,flunisolide,1,1
55992,(,0,0
55993,1,0,0
55994,mg,0,1
55995,),0,0
55996,+,1,1
55997,salbutamol/ipratropium,1,1
55998,bromide,1,1
55999,(,0,0
56000,"1,875/375",0,0
56001,microg,0,1
56002,),0,0
56003,b.i.d,0,1
56004,.,0,0
56005,in,0,0
56006,comparison,0,0
56007,with,0,0
56008,placebo,1,1
56009,+,1,1
56010,salbutamol/ipratropium,1,1
56011,bromide,1,1
56012,.,1,0
56013,METHODS,0,0
56014,This,0,0
56015,was,0,0
56016,a,0,0
56017,randomized,0,0
56018,",",0,0
56019,parallel-group,0,0
56020,",",0,0
56021,double-blind,0,0
56022,study,0,0
56023,on,0,0
56024,114,0,0
56025,patients,0,0
56026,with,0,0
56027,COPD,0,0
56028,of,0,0
56029,moderate-to-severe,0,0
56030,degree,0,0
56031,.,0,0
56032,The,0,0
56033,main,0,0
56034,outcome,0,0
56035,was,0,0
56036,the,0,0
56037,frequency,0,0
56038,of,0,0
56039,severe,0,0
56040,exacerbations,0,0
56041,over,0,0
56042,a,0,0
56043,6-month,0,0
56044,period,0,0
56045,.,0,0
56046,Before,0,0
56047,and,0,0
56048,after,0,0
56049,treatment,0,0
56050,",",0,0
56051,respiratory,0,0
56052,symptoms,0,0
56053,",",0,0
56054,forced,0,0
56055,expiratory,0,0
56056,volume,0,0
56057,in,0,0
56058,1,0,0
56059,s,0,0
56060,(,0,0
56061,FEV,0,1
56062,(,0,0
56063,1,0,0
56064,),0,0
56065,),0,0
56066,",",0,0
56067,shuttle,0,0
56068,walking,0,1
56069,test,0,0
56070,distance,0,0
56071,and,0,0
56072,St.,0,1
56073,George,0,0
56074,'s,0,0
56075,Respiratory,0,0
56076,Questionnaire,0,0
56077,scores,0,0
56078,were,0,0
56079,evaluated,0,0
56080,.,0,0
56081,RESULTS,0,0
56082,The,0,0
56083,total,0,0
56084,number,0,0
56085,of,0,0
56086,exacerbations,0,0
56087,was,0,0
56088,slightly,0,0
56089,lower,0,0
56090,in,0,0
56091,the,0,0
56092,flunisolide,1,1
56093,group,0,0
56094,compared,0,0
56095,to,0,0
56096,the,0,0
56097,placebo,1,1
56098,group,0,0
56099,(,0,0
56100,19,0,0
56101,vs.,0,0
56102,34,0,0
56103,",",0,0
56104,p,0,0
56105,=,0,0
56106,0.054,0,0
56107,),0,0
56108,;,0,0
56109,the,0,0
56110,number,0,0
56111,of,0,0
56112,patients,0,0
56113,experiencing,0,0
56114,at,0,0
56115,least,0,0
56116,one,0,0
56117,exacerbation,0,0
56118,during,0,0
56119,the,0,0
56120,study,0,0
56121,was,0,0
56122,also,0,0
56123,decreased,0,0
56124,(,0,0
56125,16,0,0
56126,vs.,0,0
56127,26,0,0
56128,",",0,0
56129,p,0,0
56130,=,0,0
56131,0.059,0,0
56132,),0,0
56133,.,0,0
56134,In,0,0
56135,particular,0,0
56136,",",0,0
56137,type,0,0
56138,3,0,0
56139,Anthonisens,0,0
56140,'s,0,0
56141,exacerbations,0,0
56142,were,0,0
56143,significantly,0,0
56144,reduced,0,0
56145,by,0,0
56146,flunisolide,1,1
56147,(,0,0
56148,p,0,0
56149,=,0,0
56150,0.044,0,0
56151,),0,0
56152,.,0,0
56153,In,0,0
56154,the,0,0
56155,placebo,1,1
56156,group,0,0
56157,",",0,0
56158,scores,0,0
56159,were,0,0
56160,higher,0,0
56161,than,0,0
56162,in,0,0
56163,the,0,0
56164,flunisolide,1,1
56165,group,0,0
56166,but,0,0
56167,nonsignificant,0,0
56168,for,0,0
56169,dyspnea,0,0
56170,",",0,0
56171,cough,0,0
56172,",",0,0
56173,sputum,0,0
56174,amount,0,0
56175,and,0,0
56176,purulence,0,0
56177,.,0,1
56178,FEV,0,1
56179,(,0,0
56180,1,0,0
56181,),0,0
56182,was,0,0
56183,significantly,0,0
56184,increased,0,0
56185,compared,0,0
56186,to,0,0
56187,baseline,0,0
56188,in,0,0
56189,both,0,0
56190,groups,0,0
56191,",",0,0
56192,and,0,0
56193,the,0,0
56194,area,0,0
56195,under,0,0
56196,the,0,0
56197,FEV,0,1
56198,(,0,0
56199,1,0,0
56200,),0,0
56201,-time,0,0
56202,curve,0,0
56203,during,0,0
56204,the,0,0
56205,6-month,0,0
56206,period,0,0
56207,was,0,0
56208,significantly,0,0
56209,greater,0,0
56210,in,0,0
56211,the,0,0
56212,flunisolide,1,1
56213,group,0,0
56214,(,0,0
56215,5.2,0,0
56216,+/-,0,0
56217,10.6,0,0
56218,vs.,0,0
56219,2.1,0,0
56220,+/-,0,0
56221,5.0,0,0
56222,",",0,0
56223,flunisolide,1,1
56224,vs.,0,0
56225,placebo,1,1
56226,",",0,0
56227,respectively,0,0
56228,;,0,0
56229,p,0,0
56230,=,0,0
56231,0.047,0,0
56232,),0,0
56233,.,0,0
56234,For,0,0
56235,shuttle,0,0
56236,walking,0,1
56237,test,0,0
56238,distance,0,0
56239,and,0,0
56240,scores,0,0
56241,of,0,0
56242,the,0,0
56243,St.,0,1
56244,George,0,0
56245,'s,0,0
56246,Respiratory,0,0
56247,Questionnaire,0,0
56248,",",0,0
56249,no,0,0
56250,significant,0,0
56251,difference,0,0
56252,between,0,0
56253,the,0,0
56254,baseline,0,0
56255,evaluation,0,0
56256,and,0,0
56257,the,0,0
56258,end,0,0
56259,of,0,0
56260,the,0,0
56261,study,0,0
56262,was,0,0
56263,observed,0,0
56264,in,0,0
56265,both,0,0
56266,groups,0,0
56267,.,0,0
56268,CONCLUSIONS,0,0
56269,Nebulized,1,0
56270,flunisolide,1,1
56271,is,0,0
56272,a,0,0
56273,good,0,0
56274,alternative,0,0
56275,to,0,0
56276,other,0,0
56277,inhaled,0,1
56278,corticosteroids,0,1
56279,when,0,0
56280,added,0,0
56281,to,0,0
56282,nebulized,1,1
56283,salbutamol/ipratropium,1,1
56284,bromide,1,1
56285,in,0,0
56286,the,0,0
56287,long-term,0,0
56288,treatment,0,0
56289,of,0,0
56290,moderate-to-severe,0,0
56291,COPD,0,0
56292,patients,0,0
56293,.,0,0
56294,Biochemical,0,0
56295,and,0,0
56296,functional,0,0
56297,effects,0,0
56298,of,0,0
56299,creatine,1,0
56300,phosphate,1,1
56301,in,0,0
56302,cardioplegic,0,1
56303,solution,0,1
56304,during,0,0
56305,aortic,0,0
56306,valve,0,0
56307,surgery,0,0
56308,--,0,0
56309,a,0,0
56310,clinical,0,0
56311,study,0,0
56312,.,0,0
56313,During,0,0
56314,myocardial,0,0
56315,ischemia,0,0
56316,there,0,0
56317,is,0,0
56318,a,0,0
56319,drop,0,0
56320,in,0,0
56321,high-energy,0,1
56322,phosphates,0,0
56323,in,0,0
56324,the,0,0
56325,myocardium,0,0
56326,.,0,0
56327,Cold,0,0
56328,potassium,0,1
56329,cardioplegia,0,1
56330,decreases,0,0
56331,but,0,0
56332,does,0,0
56333,not,0,0
56334,altogether,0,0
56335,prevent,0,0
56336,this,0,0
56337,reduction,0,0
56338,.,0,0
56339,Supplementation,0,0
56340,of,0,0
56341,cardioplegic,0,1
56342,solutions,0,0
56343,with,0,0
56344,the,0,0
56345,high-energy,0,1
56346,compound,0,1
56347,creatine,1,1
56348,phosphate,1,1
56349,(,0,0
56350,10,0,0
56351,mmol/L,0,0
56352,),0,0
56353,compared,0,0
56354,to,0,0
56355,plain,1,1
56356,cardioplegic,1,1
56357,solutions,1,0
56358,was,0,0
56359,investigated,0,0
56360,in,0,0
56361,this,0,0
56362,study,0,0
56363,.,0,0
56364,Thirty,0,0
56365,patients,0,0
56366,scheduled,0,0
56367,for,0,0
56368,aortic,0,0
56369,valve,0,0
56370,replacement,0,0
56371,were,0,0
56372,included,0,0
56373,.,0,0
56374,The,0,0
56375,patients,0,0
56376,were,0,0
56377,randomized,0,0
56378,to,0,0
56379,group,0,0
56380,I,0,0
56381,(,1,0
56382,creatine,1,1
56383,phosphate,1,1
56384,),1,0
56385,or,0,1
56386,group,0,1
56387,II,0,1
56388,(,1,0
56389,control,1,0
56390,),1,0
56391,.,0,0
56392,Postoperative,0,0
56393,hemodynamic,0,0
56394,evaluation,0,0
56395,revealed,0,0
56396,no,0,0
56397,significant,0,0
56398,differences,0,0
56399,between,0,0
56400,the,0,0
56401,groups,0,0
56402,.,0,0
56403,However,0,0
56404,",",0,0
56405,group,0,0
56406,I,0,0
56407,exhibited,0,0
56408,a,0,0
56409,tendency,0,0
56410,toward,0,0
56411,a,0,0
56412,better,0,0
56413,stroke-work,0,0
56414,index,0,0
56415,(,0,0
56416,135,0,0
56417,+/-,0,0
56418,18,0,0
56419,%,0,0
56420,vs.,0,0
56421,102,0,0
56422,+/-,0,0
56423,5,0,0
56424,%,0,0
56425,recovery,0,0
56426,15,0,0
56427,minutes,0,0
56428,after,0,0
56429,bypass,0,0
56430,and,0,0
56431,145,0,0
56432,+/-,0,0
56433,16,0,0
56434,%,0,0
56435,vs.,0,0
56436,119,0,0
56437,+/-,0,0
56438,11,0,0
56439,%,0,0
56440,recovery,0,0
56441,105,0,0
56442,min,0,0
56443,after,0,0
56444,bypass,0,0
56445,),0,0
56446,.,0,0
56447,There,0,0
56448,were,0,0
56449,fewer,0,0
56450,patients,0,0
56451,in,0,0
56452,group,0,0
56453,I,0,0
56454,(,0,0
56455,5/15,0,0
56456,),0,0
56457,needing,0,0
56458,inotropic,0,1
56459,support,0,0
56460,compared,0,0
56461,to,0,0
56462,group,0,0
56463,II,0,0
56464,(,0,0
56465,9/14,0,0
56466,),0,0
56467,.,0,0
56468,The,0,0
56469,myocardial,0,0
56470,content,0,0
56471,of,0,0
56472,ATP,0,1
56473,and,0,0
56474,creatine,1,1
56475,phosphate,1,1
56476,showed,0,0
56477,no,0,0
56478,significant,0,0
56479,differences,0,0
56480,during,0,0
56481,ischemia,0,0
56482,and,0,0
56483,reperfusion,0,1
56484,.,0,0
56485,It,0,0
56486,is,0,0
56487,concluded,0,0
56488,that,0,0
56489,the,0,0
56490,myocardial,0,0
56491,protection,0,0
56492,during,0,0
56493,ischemia,0,0
56494,was,0,0
56495,sufficient,0,0
56496,to,0,0
56497,prevent,0,0
56498,significant,0,0
56499,reductions,0,0
56500,of,0,0
56501,myocardial,0,0
56502,ATP,0,1
56503,and,0,0
56504,creatine,0,1
56505,phosphate,0,1
56506,irrespective,0,0
56507,of,0,0
56508,supplementation,0,1
56509,with,0,0
56510,CP,0,1
56511,.,0,0
56512,Safety,0,0
56513,and,0,0
56514,immunogenicity,0,0
56515,of,0,0
56516,IMVAMUNE,1,0
56517,",",0,0
56518,a,0,0
56519,promising,0,0
56520,candidate,0,0
56521,as,0,0
56522,a,0,0
56523,third,0,0
56524,generation,0,0
56525,smallpox,0,0
56526,vaccine,0,1
56527,.,0,0
56528,A,0,0
56529,Phase,0,0
56530,I,0,0
56531,trial,0,0
56532,was,0,0
56533,performed,0,0
56534,to,0,0
56535,investigate,0,0
56536,the,0,0
56537,safety,0,0
56538,and,0,0
56539,immunogenicity,0,0
56540,of,0,0
56541,the,0,0
56542,third,1,0
56543,generation,1,0
56544,smallpox,1,0
56545,vaccine,1,1
56546,MVA-BN,1,0
56547,(,1,0
56548,IMVAMUNE,1,0
56549,),1,0
56550,",",0,0
56551,a,0,0
56552,highly,0,0
56553,attenuated,0,0
56554,clone,0,0
56555,derived,0,0
56556,from,0,0
56557,the,0,0
56558,Modified,0,0
56559,Vaccinia,0,1
56560,Virus,0,0
56561,Ankara,0,0
56562,strain,0,0
56563,571,0,0
56564,",",0,0
56565,in,0,0
56566,naive,0,0
56567,and,0,0
56568,pre-immunized,0,0
56569,subjects,0,0
56570,.,0,0
56571,A,0,0
56572,total,0,0
56573,of,0,0
56574,86,0,0
56575,healthy,0,0
56576,subjects,0,0
56577,received,0,0
56578,the,0,0
56579,vaccine,1,1
56580,in,0,0
56581,five,0,0
56582,groups,0,0
56583,using,0,0
56584,different,0,0
56585,doses,0,0
56586,and,0,0
56587,routes,0,0
56588,of,0,0
56589,administration,0,0
56590,.,0,0
56591,All,0,0
56592,38,0,0
56593,subjects,0,0
56594,seroconverted,0,0
56595,in,0,0
56596,the,0,0
56597,groups,0,0
56598,receiving,0,0
56599,the,0,0
56600,highest,0,0
56601,dose,0,0
56602,(,0,0
56603,10,0,0
56604,(,0,0
56605,8,0,0
56606,),0,0
56607,TCID50,0,0
56608,),0,0
56609,.,0,0
56610,All,0,0
56611,vaccinations,0,0
56612,were,0,0
56613,well,0,0
56614,tolerated,0,0
56615,with,0,0
56616,mainly,0,0
56617,mild,0,0
56618,or,0,1
56619,moderate,0,0
56620,pain,0,0
56621,at,0,0
56622,the,0,0
56623,injection,0,1
56624,site,0,0
56625,being,0,0
56626,the,0,0
56627,most,0,0
56628,frequent,0,0
56629,symptom,0,0
56630,.,0,0
56631,The,0,0
56632,results,0,0
56633,indicate,0,0
56634,that,0,0
56635,MVA-BN,0,0
56636,has,0,0
56637,the,0,0
56638,potential,0,0
56639,to,0,0
56640,be,0,0
56641,developed,0,0
56642,as,0,0
56643,an,0,0
56644,efficient,0,0
56645,and,0,0
56646,safe,0,0
56647,alternative,0,0
56648,to,0,0
56649,the,0,0
56650,conventional,0,1
56651,smallpox,0,0
56652,vaccines,0,1
56653,such,0,0
56654,as,0,0
56655,Lister-Elstree,1,0
56656,or,1,0
56657,Dryvax,1,1
56658,.,1,0
56659,Unique,0,0
56660,attributes,0,0
56661,render,0,0
56662,it,0,0
56663,a,0,0
56664,promising,0,0
56665,candidate,0,0
56666,for,0,0
56667,prophylactic,0,1
56668,mass,0,0
56669,immunization,0,1
56670,",",0,0
56671,even,0,0
56672,in,0,0
56673,subjects,0,0
56674,for,0,0
56675,whom,0,0
56676,conventional,0,1
56677,smallpox,0,0
56678,vaccines,0,1
56679,are,0,0
56680,contraindicated,0,0
56681,.,0,0
56682,Pre-treatment,0,1
56683,proliferation,0,0
56684,and,0,0
56685,the,0,0
56686,outcome,0,0
56687,of,0,0
56688,conventional,1,1
56689,and,1,0
56690,accelerated,1,1
56691,radiotherapy,1,1
56692,.,1,0
56693,This,0,0
56694,study,0,0
56695,investigated,0,0
56696,the,0,0
56697,influence,0,0
56698,of,0,0
56699,pre-treatment,0,0
56700,proliferation,0,0
56701,characteristics,0,0
56702,",",0,0
56703,assessed,1,0
56704,by,1,0
56705,Ki-67,1,0
56706,staining,1,0
56707,",",0,0
56708,in,0,0
56709,patients,0,0
56710,treated,0,0
56711,in,0,0
56712,the,0,0
56713,CHART,0,0
56714,trial,0,0
56715,of,0,0
56716,accelerated,1,1
56717,radiotherapy,1,1
56718,in,0,0
56719,head,0,0
56720,and,0,0
56721,neck,0,0
56722,cancer,0,0
56723,.,0,0
56724,Histological,0,0
56725,material,0,0
56726,from,0,0
56727,402,0,0
56728,patients,0,0
56729,was,0,0
56730,collected,0,0
56731,and,0,0
56732,stained,0,1
56733,for,0,0
56734,the,0,0
56735,presence,0,0
56736,and,0,0
56737,pattern,0,0
56738,of,0,0
56739,Ki-67,0,0
56740,staining,0,0
56741,.,0,0
56742,Locoregional,0,0
56743,control,0,0
56744,and,0,0
56745,overall,0,0
56746,survival,0,0
56747,were,0,0
56748,the,0,0
56749,main,0,0
56750,clinical,0,0
56751,endpoints,0,0
56752,.,0,0
56753,Increasing,0,0
56754,Ki-67,0,0
56755,positivity,0,0
56756,was,0,0
56757,associated,0,0
56758,with,0,0
56759,decreasing,0,0
56760,differentiation,0,1
56761,(,0,0
56762,P,0,0
56763,<,0,0
56764,0.001,0,0
56765,),0,0
56766,and,0,0
56767,increasing,0,0
56768,N-stage,0,0
56769,(,0,0
56770,P,0,0
56771,<,0,0
56772,0.004,0,0
56773,),0,0
56774,.,0,0
56775,Increasing,0,0
56776,N-stage,0,0
56777,was,0,0
56778,also,0,0
56779,associated,0,0
56780,with,0,0
56781,the,0,0
56782,progression,0,0
56783,of,0,0
56784,proliferation,0,0
56785,pattern,0,0
56786,from,0,0
56787,marginal,0,0
56788,to,0,0
56789,random,0,0
56790,(,0,0
56791,P,0,0
56792,<,0,0
56793,0.001,0,0
56794,),0,0
56795,.,0,0
56796,Using,0,0
56797,a,0,0
56798,multivariate,0,0
56799,model,0,0
56800,",",0,0
56801,a,0,0
56802,trend,0,0
56803,was,0,0
56804,seen,0,0
56805,towards,0,0
56806,a,0,0
56807,greater,0,0
56808,benefit,0,0
56809,from,0,0
56810,CHART,0,0
56811,in,0,0
56812,the,0,0
56813,lower,0,0
56814,Ki-67,0,0
56815,tumours,0,0
56816,(,0,0
56817,P,0,0
56818,=,0,0
56819,0.08,0,0
56820,),0,0
56821,;,0,0
56822,this,0,0
56823,became,0,0
56824,significant,0,0
56825,by,0,0
56826,pooling,0,0
56827,the,0,0
56828,low,0,0
56829,and,0,0
56830,intermediate,0,0
56831,Ki-67,0,0
56832,groups,0,0
56833,in,0,0
56834,comparison,0,0
56835,with,0,0
56836,the,0,0
56837,high,0,0
56838,Ki-67,0,1
56839,group,0,0
56840,(,0,0
56841,P,0,0
56842,=,0,0
56843,0.032,0,0
56844,),0,0
56845,.,0,0
56846,Tumours,0,0
56847,with,0,0
56848,marginal,0,0
56849,proliferation,0,0
56850,pattern,0,0
56851,showed,0,0
56852,a,0,0
56853,lower,0,0
56854,hazard,0,0
56855,ratio,0,0
56856,with,0,0
56857,CHART,0,0
56858,versus,0,0
56859,conventional,0,1
56860,for,0,0
56861,locoregional,0,0
56862,control,0,1
56863,(,0,0
56864,P,0,0
56865,=,0,0
56866,0.005,0,0
56867,),0,0
56868,.,0,0
56869,The,0,0
56870,data,0,0
56871,presented,0,0
56872,in,0,0
56873,this,0,0
56874,study,0,0
56875,do,0,0
56876,not,0,0
56877,support,0,0
56878,that,0,0
56879,a,0,0
56880,high,0,0
56881,pre-treatment,0,0
56882,Ki-67,0,0
56883,is,0,0
56884,associated,0,0
56885,with,0,0
56886,a,0,0
56887,therapeutic,0,0
56888,benefit,0,0
56889,from,0,0
56890,accelerated,1,1
56891,radiotherapy,1,1
56892,.,1,0
56893,The,0,0
56894,impact,0,0
56895,of,0,0
56896,emotional,1,0
56897,distress,1,0
56898,on,0,0
56899,HIV,0,0
56900,risk,0,0
56901,reduction,0,0
56902,among,0,0
56903,women,0,0
56904,.,0,0
56905,This,0,0
56906,study,0,0
56907,evaluated,0,0
56908,whether,0,0
56909,333,0,0
56910,seronegative,0,0
56911,African,0,0
56912,American,0,0
56913,female,0,0
56914,drug,0,0
56915,users,0,0
56916,(,0,0
56917,aged,0,0
56918,18-59,0,0
56919,years,0,0
56920,),0,0
56921,participating,0,0
56922,in,0,0
56923,an,0,0
56924,HIV,1,0
56925,intervention,1,1
56926,and,0,0
56927,with,0,0
56928,higher,0,0
56929,levels,0,0
56930,of,0,0
56931,emotional,0,0
56932,distress,0,0
56933,",",0,0
56934,specifically,0,0
56935,symptoms,0,0
56936,of,0,0
56937,depression,0,0
56938,and,0,0
56939,anxiety,0,0
56940,",",0,0
56941,reduced,0,0
56942,HIV,0,0
56943,risk,0,0
56944,behaviors,0,0
56945,to,0,0
56946,a,0,0
56947,lesser,0,0
56948,extent,0,0
56949,than,0,0
56950,those,0,0
56951,with,0,0
56952,lower,0,0
56953,levels,0,0
56954,of,0,0
56955,emotional,0,0
56956,distress,0,0
56957,.,0,0
56958,Participants,0,0
56959,were,0,0
56960,recruited,0,0
56961,between,0,0
56962,June,0,0
56963,1998,0,0
56964,and,0,0
56965,January,0,0
56966,2001,0,0
56967,from,0,0
56968,inner-city,0,0
56969,Atlanta,0,0
56970,(,0,0
56971,Georgia,0,0
56972,",",0,0
56973,U.S.,0,1
56974,),0,0
56975,neighborhoods,0,0
56976,and,0,0
56977,were,0,0
56978,randomly,0,0
56979,assigned,0,0
56980,to,0,0
56981,one,0,0
56982,of,0,0
56983,two,0,0
56984,enhanced,1,0
56985,gender-specific,1,0
56986,and,1,0
56987,culturally,1,1
56988,specific,1,0
56989,HIV,1,0
56990,intervention,1,1
56991,conditions,0,0
56992,or,0,0
56993,to,0,0
56994,the,0,0
56995,NIDA,0,1
56996,standard,0,1
56997,condition,0,0
56998,.,0,0
56999,Participants,0,0
57000,were,0,0
57001,interviewed,0,0
57002,at,0,0
57003,baseline,0,0
57004,",",0,0
57005,post-intervention,0,0
57006,and,0,0
57007,at,0,0
57008,6-month,0,0
57009,follow-up,0,0
57010,with,0,0
57011,a,0,0
57012,structured,1,1
57013,questionnaire,1,0
57014,including,0,0
57015,information,0,0
57016,on,0,0
57017,sociodemographics,0,0
57018,",",0,0
57019,sexual,0,0
57020,and,0,0
57021,drug-using,0,0
57022,behavior,0,0
57023,",",0,0
57024,and,0,0
57025,psychosocial,0,0
57026,characteristics,0,0
57027,.,0,0
57028,Despite,0,0
57029,a,0,0
57030,significant,0,0
57031,decline,0,0
57032,in,0,0
57033,symptoms,0,0
57034,of,0,0
57035,emotional,0,0
57036,distress,0,0
57037,during,0,0
57038,the,0,0
57039,study,0,0
57040,period,0,0
57041,",",0,0
57042,the,0,0
57043,women,0,0
57044,in,0,0
57045,this,0,0
57046,sample,0,0
57047,reported,0,0
57048,high,0,0
57049,levels,0,0
57050,of,0,0
57051,depressive,0,0
57052,and,0,0
57053,anxiety,0,0
57054,symptoms,0,0
57055,at,0,0
57056,baseline,0,0
57057,and,0,0
57058,6-month,0,0
57059,follow-up,0,0
57060,.,0,0
57061,Higher,0,0
57062,levels,0,0
57063,of,0,0
57064,emotional,0,0
57065,distress,0,0
57066,were,0,0
57067,positively,0,0
57068,associated,0,0
57069,with,0,0
57070,post-intervention,0,0
57071,sexual,0,0
57072,and,0,0
57073,drug-taking,0,0
57074,risk,0,0
57075,.,0,0
57076,Women,0,0
57077,in,0,0
57078,both,0,0
57079,enhanced,1,0
57080,intervention,1,1
57081,conditions,1,0
57082,reduced,0,0
57083,their,0,0
57084,sexual,0,0
57085,and,0,0
57086,drug-taking,0,0
57087,risks,0,0
57088,more,0,0
57089,than,0,0
57090,women,0,0
57091,in,0,0
57092,the,0,0
57093,standard,1,1
57094,intervention,1,1
57095,.,1,0
57096,Those,0,0
57097,in,0,0
57098,the,0,0
57099,motivation,1,0
57100,intervention,1,1
57101,arm,0,0
57102,experienced,0,0
57103,a,0,0
57104,greater,0,0
57105,reduction,0,0
57106,in,0,0
57107,depressive,0,0
57108,symptoms,0,0
57109,",",0,0
57110,accompanied,0,0
57111,by,0,0
57112,a,0,0
57113,greater,0,0
57114,reduction,0,0
57115,in,0,0
57116,sexual,0,0
57117,risk,0,0
57118,behavior,0,0
57119,.,0,0
57120,Findings,0,0
57121,suggest,0,0
57122,the,0,0
57123,need,0,0
57124,for,0,0
57125,effective,0,0
57126,interventions,0,0
57127,and,0,0
57128,mental,0,0
57129,health,0,0
57130,resources,0,0
57131,among,0,0
57132,subgroups,0,0
57133,of,0,0
57134,high-risk,0,0
57135,women,0,0
57136,who,0,0
57137,may,0,0
57138,be,0,0
57139,most,0,0
57140,resistant,0,0
57141,to,0,0
57142,behavioral,0,0
57143,change,0,0
57144,.,0,0
57145,Similar,0,0
57146,compliance,0,0
57147,and,0,0
57148,effect,0,0
57149,of,0,0
57150,treatment,0,0
57151,in,0,0
57152,chronic,0,0
57153,hepatitis,0,0
57154,C,0,1
57155,resulting,0,0
57156,from,0,0
57157,intravenous,1,1
57158,drug,1,0
57159,use,1,0
57160,in,0,0
57161,comparison,0,0
57162,with,0,0
57163,other,0,0
57164,infection,0,0
57165,causes,0,0
57166,.,0,0
57167,OBJECTIVES,0,0
57168,There,0,0
57169,is,0,0
57170,some,0,0
57171,reluctance,0,0
57172,to,0,0
57173,treat,0,0
57174,intravenous,0,1
57175,drug,0,0
57176,users,0,0
57177,(,0,0
57178,IVDUs,0,0
57179,),0,0
57180,with,0,0
57181,chronic,0,0
57182,hepatitis,0,1
57183,C,0,1
57184,(,0,0
57185,CHC,0,1
57186,),0,0
57187,because,0,0
57188,of,0,0
57189,presumed,0,0
57190,lower,0,0
57191,compliance,0,0
57192,and,0,0
57193,response,0,0
57194,to,0,0
57195,antiviral,1,0
57196,therapy,1,1
57197,.,1,0
57198,We,0,0
57199,intended,0,0
57200,to,0,0
57201,evaluate,0,0
57202,the,0,0
57203,compliance,0,0
57204,and,0,0
57205,response,0,0
57206,to,0,0
57207,antiviral,1,0
57208,treatment,1,0
57209,for,1,0
57210,CHC,1,1
57211,in,0,0
57212,IVDUs,0,0
57213,compared,0,0
57214,with,0,0
57215,non-IVDUs,0,0
57216,.,0,0
57217,METHODS,0,0
57218,A,0,0
57219,retrospective,0,0
57220,cohort,0,0
57221,study,0,0
57222,--,0,0
57223,secondary,0,0
57224,analysis,0,0
57225,of,0,0
57226,the,0,0
57227,results,0,0
57228,of,0,0
57229,a,0,0
57230,treatment,0,0
57231,trial,0,0
57232,--,0,0
57233,was,0,0
57234,performed,0,0
57235,in,0,0
57236,Belgium,0,0
57237,and,0,0
57238,The,0,0
57239,Netherlands,0,0
57240,.,0,0
57241,A,0,0
57242,total,0,0
57243,of,0,0
57244,406,0,0
57245,previously,0,0
57246,untreated,0,0
57247,CHC,0,1
57248,patients,0,0
57249,",",0,0
57250,including,0,0
57251,98,0,0
57252,(,0,0
57253,24,0,0
57254,%,0,0
57255,),0,0
57256,IVDUs,0,0
57257,",",0,0
57258,were,0,0
57259,studied,0,0
57260,for,0,0
57261,compliance,0,0
57262,(,0,0
57263,presentation,0,0
57264,at,0,0
57265,the,0,0
57266,end,0,0
57267,of,0,0
57268,treatment,0,0
57269,),0,0
57270,",",0,0
57271,complete,0,0
57272,response,0,0
57273,(,0,0
57274,alanine,0,0
57275,aminotransferase,0,0
57276,within,0,0
57277,normal,0,0
57278,limits,0,0
57279,and,0,0
57280,serum,0,0
57281,hepatitis,0,1
57282,C,0,1
57283,virus,0,1
57284,polymerase,0,0
57285,chain,0,1
57286,reaction,0,1
57287,negative,0,0
57288,),0,0
57289,at,0,0
57290,the,0,0
57291,end,0,0
57292,of,0,0
57293,therapy,0,1
57294,and,0,0
57295,sustained,0,0
57296,virological,0,0
57297,response,0,0
57298,(,0,0
57299,SVR,0,1
57300,),0,0
57301,.,0,0
57302,RESULTS,0,0
57303,Non-compliance,0,0
57304,(,0,0
57305,8.2,0,0
57306,%,0,0
57307,),0,0
57308,in,0,0
57309,IVDUs,0,0
57310,was,0,0
57311,not,0,0
57312,different,0,0
57313,from,0,0
57314,non-IVDUs,0,0
57315,(,0,0
57316,6.8,0,0
57317,%,0,0
57318,),0,0
57319,(,0,0
57320,relative,0,0
57321,risk=1.20,0,0
57322,;,0,0
57323,95,0,0
57324,%,0,0
57325,confidence,0,0
57326,interval=0.55-2.62,0,0
57327,),0,0
57328,.,0,0
57329,Complete,0,0
57330,response,0,0
57331,after,0,0
57332,controlling,0,0
57333,for,0,0
57334,hepatitis,0,0
57335,C,0,1
57336,virus,0,0
57337,was,0,0
57338,similar,0,0
57339,(,0,0
57340,relative,0,0
57341,risk=1.19,0,0
57342,;,0,0
57343,95,0,0
57344,%,0,0
57345,confidence,0,0
57346,interval=0.89-1.60,0,0
57347,),0,0
57348,.,0,0
57349,Controlling,0,0
57350,for,0,0
57351,treatment,0,0
57352,arm,0,0
57353,",",0,0
57354,age,0,0
57355,",",0,0
57356,sex,0,0
57357,",",0,0
57358,presence,0,0
57359,of,0,0
57360,cirrhosis,0,0
57361,or,0,1
57362,hepatitis,0,1
57363,C,0,1
57364,virus,0,1
57365,viral,0,0
57366,load,0,0
57367,before,0,0
57368,treatment,0,0
57369,did,0,0
57370,not,0,0
57371,change,0,0
57372,these,0,0
57373,results,0,0
57374,.,0,0
57375,There,0,0
57376,was,0,0
57377,a,0,0
57378,marginally,0,0
57379,significant,0,0
57380,difference,0,0
57381,in,0,0
57382,the,0,0
57383,sustained,0,0
57384,virological,0,0
57385,response,0,0
57386,between,0,0
57387,IVDUs,0,1
57388,(,0,0
57389,46.6,0,0
57390,%,0,0
57391,),0,0
57392,and,0,0
57393,non-IVDUs,0,0
57394,(,0,0
57395,34.6,0,0
57396,%,0,0
57397,),0,0
57398,(,0,0
57399,relative,0,0
57400,risk=1.35,0,0
57401,;,0,0
57402,95,0,0
57403,%,0,0
57404,confidence,0,0
57405,interval=1.00-1.81,0,0
57406,),0,0
57407,",",0,0
57408,also,0,0
57409,disappearing,0,0
57410,after,0,0
57411,adjusting,0,0
57412,for,0,0
57413,genotype,0,0
57414,.,0,0
57415,No,0,0
57416,difference,0,0
57417,in,0,0
57418,compliance,0,0
57419,or,0,1
57420,sustained,0,0
57421,virological,0,0
57422,response,0,0
57423,was,0,0
57424,found,0,0
57425,between,0,0
57426,active,0,0
57427,and,0,0
57428,non-active,0,1
57429,IVDUs,0,1
57430,or,0,0
57431,between,0,0
57432,IVDU,0,0
57433,patients,0,0
57434,in,0,0
57435,or,0,0
57436,without,0,0
57437,a,0,0
57438,methadone,0,1
57439,maintenance,0,0
57440,program,0,1
57441,.,0,0
57442,CONCLUSIONS,0,0
57443,In,0,0
57444,this,0,0
57445,group,0,0
57446,of,0,0
57447,Benelux,0,0
57448,patients,0,0
57449,",",0,0
57450,IVDUs,0,0
57451,showed,0,0
57452,similar,0,0
57453,compliance,0,0
57454,and,0,0
57455,response,0,0
57456,to,0,0
57457,treatment,0,0
57458,with,0,0
57459,interferon,0,1
57460,and,0,0
57461,ribavirin,0,1
57462,compared,0,0
57463,with,0,0
57464,other,0,0
57465,patients,0,0
57466,with,0,0
57467,CHC,0,0
57468,infection,0,0
57469,.,0,0
57470,Therefore,0,0
57471,",",0,0
57472,it,0,0
57473,is,0,0
57474,no,0,0
57475,longer,0,0
57476,justifiable,0,0
57477,to,0,0
57478,withhold,0,0
57479,treatment,0,0
57480,to,0,0
57481,chronic,0,0
57482,hepatitis,0,0
57483,C,0,0
57484,patients,0,0
57485,who,0,0
57486,use,0,0
57487,intravenous,0,0
57488,drugs,0,0
57489,.,0,0
57490,Effect,0,0
57491,of,0,0
57492,micronutrient,1,1
57493,supplement,1,1
57494,on,0,0
57495,health,0,0
57496,and,0,0
57497,nutritional,0,1
57498,status,0,0
57499,of,0,0
57500,schoolchildren,0,0
57501,:,0,0
57502,study,0,0
57503,design,0,0
57504,.,0,0
57505,OBJECTIVE,0,0
57506,We,0,0
57507,tested,0,0
57508,the,0,0
57509,hypothesis,0,0
57510,that,0,0
57511,supplementation,1,1
57512,with,1,0
57513,a,1,0
57514,micronutrient-fortified,1,1
57515,beverage,1,1
57516,improves,0,0
57517,micronutrient,0,1
57518,status,0,0
57519,and,0,0
57520,physical,0,1
57521,and,0,0
57522,mental,0,0
57523,development,0,0
57524,in,0,0
57525,apparently,0,0
57526,healthy,0,0
57527,schoolchildren,0,0
57528,.,0,0
57529,METHODS,0,0
57530,The,0,0
57531,study,0,0
57532,was,0,0
57533,carried,0,0
57534,out,0,0
57535,in,0,0
57536,middle-income,0,0
57537,students,0,0
57538,in,0,0
57539,two,0,0
57540,residential,0,0
57541,schools,0,0
57542,that,0,0
57543,catered,0,0
57544,to,0,0
57545,children,0,0
57546,from,0,0
57547,a,0,0
57548,semi-urban,0,0
57549,population,0,0
57550,near,0,0
57551,Hyderabad,0,0
57552,",",0,0
57553,India,0,0
57554,.,0,0
57555,Included,0,0
57556,were,0,0
57557,869,0,0
57558,children,0,0
57559,who,0,0
57560,were,0,0
57561,6,0,0
57562,to,0,0
57563,16,0,0
57564,y,0,0
57565,of,0,0
57566,age,0,0
57567,in,0,0
57568,grades,0,0
57569,1,0,0
57570,to,0,0
57571,10,0,0
57572,.,0,0
57573,Because,0,0
57574,children,0,0
57575,at,0,0
57576,each,0,0
57577,grade,0,0
57578,were,0,0
57579,distributed,0,0
57580,across,0,0
57581,two,0,0
57582,classrooms,0,0
57583,(,0,0
57584,clusters,0,0
57585,),0,0
57586,and,0,0
57587,were,0,0
57588,homogeneous,0,0
57589,",",0,0
57590,each,0,0
57591,grade,0,0
57592,was,0,0
57593,considered,0,0
57594,to,0,0
57595,consist,0,0
57596,of,0,0
57597,a,0,0
57598,matched,0,0
57599,pair,0,0
57600,.,0,0
57601,There,0,0
57602,were,0,0
57603,thus,0,0
57604,10,0,0
57605,pairs,0,0
57606,available,0,0
57607,for,0,0
57608,the,0,0
57609,study,0,0
57610,.,0,0
57611,Classes,0,0
57612,in,0,0
57613,each,0,0
57614,grade,0,0
57615,were,0,0
57616,randomized,0,0
57617,to,0,0
57618,receive,0,0
57619,a,0,0
57620,micronutrient-enriched,1,1
57621,beverage,1,1
57622,or,1,1
57623,a,1,0
57624,placebo,1,1
57625,without,1,0
57626,added,1,0
57627,micronutrients,1,0
57628,.,1,0
57629,The,0,0
57630,study,0,0
57631,was,0,0
57632,double,0,0
57633,blinded,0,0
57634,and,0,0
57635,the,0,0
57636,duration,0,0
57637,was,0,0
57638,14,0,0
57639,mo,0,0
57640,",",0,0
57641,with,0,0
57642,supervised,0,1
57643,feeding,0,0
57644,of,0,0
57645,the,0,0
57646,micronutrient-enriched,1,1
57647,beverage,1,1
57648,.,1,0
57649,The,0,0
57650,effect,0,0
57651,of,0,0
57652,the,0,0
57653,micronutrients,1,0
57654,on,0,0
57655,the,0,0
57656,outcome,0,0
57657,variables,0,0
57658,growth,0,0
57659,",",0,0
57660,biochemical,0,0
57661,status,0,0
57662,",",0,0
57663,mental,0,0
57664,function,0,0
57665,",",0,0
57666,and,0,0
57667,bone,0,0
57668,health,0,0
57669,were,0,0
57670,assessed,0,0
57671,.,0,0
57672,RESULTS,0,0
57673,The,0,0
57674,number,0,0
57675,of,0,0
57676,matched,0,0
57677,pairs,0,0
57678,varied,0,0
57679,between,0,0
57680,seven,0,0
57681,and,0,0
57682,eight,0,0
57683,",",0,0
57684,and,0,0
57685,the,0,0
57686,required,0,0
57687,number,0,0
57688,of,0,0
57689,children,0,0
57690,per,0,0
57691,treatment,0,0
57692,group,0,0
57693,ranged,0,0
57694,from,0,0
57695,32,0,0
57696,in,0,0
57697,the,0,0
57698,case,0,0
57699,of,0,0
57700,bone,0,0
57701,heath,0,0
57702,to,0,0
57703,177,0,0
57704,for,0,0
57705,body,0,0
57706,weight,0,0
57707,.,0,0
57708,The,0,0
57709,power,0,0
57710,of,0,0
57711,the,0,0
57712,outcome,0,0
57713,variables,0,0
57714,ranged,0,0
57715,from,0,0
57716,74,0,0
57717,%,0,0
57718,to,0,0
57719,100,0,0
57720,%,0,0
57721,and,0,0
57722,was,0,0
57723,adequate,0,0
57724,for,0,0
57725,successful,0,0
57726,pairing,0,0
57727,.,0,0
57728,The,0,0
57729,effect,0,0
57730,assessed,0,0
57731,at,0,0
57732,the,0,0
57733,end,0,0
57734,of,0,0
57735,supplementation,1,1
57736,showed,0,0
57737,that,0,0
57738,the,0,0
57739,intervention,0,1
57740,was,0,0
57741,beneficial,0,0
57742,.,0,0
57743,CONCLUSIONS,0,0
57744,Designing,0,0
57745,an,0,0
57746,intervention,0,1
57747,",",0,0
57748,choosing,0,0
57749,outcome,0,0
57750,variables,0,0
57751,",",0,0
57752,and,0,0
57753,implementing,0,0
57754,the,0,0
57755,protocol,0,0
57756,in,0,0
57757,a,0,0
57758,typical,0,0
57759,Indian,0,0
57760,school,0,0
57761,setting,0,0
57762,were,0,0
57763,achieved,0,0
57764,.,0,0
57765,Effects,0,0
57766,of,0,0
57767,cooking,1,1
57768,plant,1,0
57769,oils,1,1
57770,on,0,0
57771,recurrent,0,0
57772,aphthous,0,0
57773,stomatitis,0,0
57774,:,0,0
57775,a,0,0
57776,randomized,0,0
57777,",",0,0
57778,placebo-controlled,0,1
57779,",",0,0
57780,double-blind,0,0
57781,trial,0,0
57782,.,0,0
57783,OBJECTIVE,0,0
57784,One-third,0,0
57785,of,0,0
57786,the,0,0
57787,total,0,0
57788,population,0,0
57789,seems,0,0
57790,to,0,0
57791,develop,0,0
57792,minor,0,0
57793,recurrent,0,0
57794,aphthous,0,0
57795,stomatitis,0,0
57796,(,0,0
57797,RAS,0,0
57798,),0,0
57799,during,0,0
57800,their,0,0
57801,lifetime,0,0
57802,.,0,0
57803,However,0,0
57804,",",0,0
57805,well-controlled,0,0
57806,dietary,0,1
57807,intervention,0,1
57808,studies,0,0
57809,to,0,0
57810,prevent,0,0
57811,minor,0,0
57812,RAS,0,0
57813,are,0,0
57814,very,0,0
57815,rare,0,0
57816,.,0,0
57817,The,0,0
57818,objective,0,0
57819,of,0,0
57820,the,0,0
57821,present,0,0
57822,study,0,0
57823,was,0,0
57824,to,0,0
57825,investigate,0,0
57826,whether,0,0
57827,the,0,0
57828,prevalence,0,0
57829,of,0,0
57830,RAS,0,0
57831,decreased,0,0
57832,with,0,0
57833,perilla,1,1
57834,oil,1,1
57835,(,0,0
57836,rich,0,1
57837,in,0,0
57838,alpha-linolenic,0,1
57839,acid,0,1
57840,),0,0
57841,.,0,0
57842,METHODS,0,0
57843,Thirty,0,0
57844,subjects,0,0
57845,(,0,0
57846,8,0,0
57847,men,0,0
57848,and,0,0
57849,22,0,0
57850,women,0,0
57851,),0,0
57852,who,0,0
57853,had,0,0
57854,minor,0,0
57855,RAS,0,0
57856,at,0,0
57857,least,0,0
57858,once,0,0
57859,a,0,0
57860,month,0,0
57861,were,0,0
57862,randomly,0,0
57863,allocated,0,0
57864,to,0,0
57865,a,0,0
57866,soybean,1,1
57867,oil,1,1
57868,group,1,0
57869,or,1,1
57870,a,1,0
57871,perilla,1,1
57872,oil,1,1
57873,group,1,0
57874,in,1,0
57875,a,1,0
57876,double-blind,1,0
57877,manner,1,0
57878,(,1,0
57879,experimental,1,0
57880,phase,1,0
57881,),1,0
57882,after,1,0
57883,a,1,0
57884,run-in,1,0
57885,phase,1,0
57886,of,1,0
57887,4,1,0
57888,mo,1,0
57889,during,1,0
57890,which,1,0
57891,subjects,1,0
57892,used,1,0
57893,a,1,0
57894,reference,1,0
57895,oil,1,1
57896,",",1,0
57897,the,1,0
57898,most,1,0
57899,popular,1,0
57900,cooking,1,1
57901,oil,1,1
57902,in,1,0
57903,Japan,1,1
57904,",",1,0
57905,or,1,0
57906,a,1,0
57907,50/50,1,1
57908,mixture,1,0
57909,of,1,0
57910,soybean,1,1
57911,oil,1,1
57912,and,1,0
57913,rapeseed,1,1
57914,oil,1,1
57915,.,1,0
57916,During,0,0
57917,the,0,0
57918,experimental,0,0
57919,phase,0,0
57920,",",0,0
57921,subjects,0,0
57922,were,0,0
57923,asked,0,0
57924,to,0,0
57925,use,0,0
57926,soybean,0,1
57927,oil,0,1
57928,or,0,1
57929,perilla,0,1
57930,oil,0,1
57931,as,0,0
57932,the,0,0
57933,sole,0,0
57934,cooking,0,1
57935,oil,0,1
57936,for,0,0
57937,8,0,0
57938,mo,0,0
57939,.,0,0
57940,Blood,0,0
57941,samples,0,0
57942,were,0,0
57943,collected,0,0
57944,at,0,0
57945,the,0,0
57946,start,0,0
57947,and,0,0
57948,end,0,0
57949,of,0,0
57950,the,0,0
57951,experimental,0,0
57952,phase,0,0
57953,for,0,0
57954,fatty,0,1
57955,acid,0,1
57956,analysis,0,0
57957,of,0,0
57958,total,0,0
57959,plasma,0,0
57960,phospholipid,0,0
57961,fraction,0,0
57962,.,0,0
57963,Occurrence,0,0
57964,and,0,0
57965,needed,0,0
57966,days,0,0
57967,for,0,0
57968,healing,0,0
57969,of,0,0
57970,minor,0,0
57971,RAS,0,0
57972,were,0,0
57973,recorded,0,0
57974,during,0,0
57975,the,0,0
57976,two,0,0
57977,phases,0,0
57978,and,0,0
57979,compared,0,0
57980,.,0,0
57981,RESULTS,0,0
57982,alpha-Linolenic,0,1
57983,acid,0,1
57984,concentrations,0,0
57985,in,0,0
57986,the,0,0
57987,plasma,0,0
57988,phospholipid,0,0
57989,fraction,0,0
57990,increased,0,0
57991,significantly,0,0
57992,in,0,0
57993,both,0,0
57994,groups,0,0
57995,during,0,0
57996,the,0,0
57997,experimental,0,0
57998,phase,0,0
57999,to,0,0
58000,a,0,0
58001,similar,0,0
58002,extent,0,0
58003,.,0,0
58004,The,0,0
58005,prevalence,0,0
58006,of,0,0
58007,minor,0,0
58008,RAS,0,0
58009,in,0,0
58010,the,0,0
58011,experimental,0,0
58012,phase,0,0
58013,decreased,0,0
58014,significantly,0,0
58015,in,0,0
58016,both,0,0
58017,groups,0,0
58018,compared,0,0
58019,with,0,0
58020,the,0,0
58021,run-in,0,0
58022,phase,0,0
58023,to,0,0
58024,a,0,0
58025,similar,0,0
58026,extent,0,0
58027,",",0,0
58028,without,0,0
58029,intergroup,0,0
58030,differences,0,0
58031,.,0,0
58032,CONCLUSION,0,0
58033,Perilla,0,1
58034,oil,0,1
58035,",",0,0
58036,which,0,0
58037,is,0,0
58038,rich,0,0
58039,in,0,0
58040,alpha-linolenic,0,1
58041,acid,0,1
58042,",",0,0
58043,was,0,0
58044,not,0,0
58045,superior,0,0
58046,to,0,0
58047,soybean,0,1
58048,oil,0,1
58049,in,0,0
58050,preventing,0,0
58051,minor,0,0
58052,RAS,0,0
58053,.,0,0
58054,There,0,0
58055,was,0,0
58056,a,0,0
58057,possibility,0,0
58058,that,0,0
58059,avoiding,0,0
58060,rapeseed,0,1
58061,oil,0,1
58062,might,0,0
58063,be,0,0
58064,beneficial,0,0
58065,for,0,0
58066,prevention,0,0
58067,of,0,0
58068,minor,0,0
58069,RAS,0,0
58070,.,0,0
58071,CDP571,1,1
58072,",",0,0
58073,a,0,0
58074,humanized,0,0
58075,monoclonal,0,1
58076,antibody,0,0
58077,to,0,0
58078,tumour,0,0
58079,necrosis,0,0
58080,factor-alpha,0,0
58081,",",0,0
58082,for,0,0
58083,steroid-dependent,0,0
58084,Crohn,0,0
58085,'s,0,0
58086,disease,0,0
58087,:,0,0
58088,a,0,0
58089,randomized,0,0
58090,",",0,0
58091,double-blind,0,0
58092,",",0,0
58093,placebo-controlled,1,1
58094,trial,0,0
58095,.,0,0
58096,BACKGROUND,0,0
58097,More,0,0
58098,than,0,0
58099,50,0,0
58100,%,0,0
58101,of,0,0
58102,patients,0,0
58103,with,0,0
58104,Crohn,0,0
58105,'s,0,0
58106,disease,0,0
58107,become,0,0
58108,either,0,0
58109,steroid,0,1
58110,resistant,0,0
58111,or,0,1
58112,dependent,0,0
58113,.,0,0
58114,Accordingly,0,0
58115,",",0,0
58116,development,0,0
58117,of,0,0
58118,new,0,0
58119,treatments,0,0
58120,for,0,0
58121,steroid-dependent,0,0
58122,Crohn,0,0
58123,'s,0,0
58124,disease,0,0
58125,is,0,0
58126,a,0,0
58127,research,0,0
58128,priority,0,0
58129,.,0,0
58130,AIM,0,0
58131,To,0,0
58132,evaluate,0,0
58133,CDP571,1,1
58134,",",0,0
58135,a,0,0
58136,humanized,0,0
58137,antibody,0,0
58138,to,0,0
58139,tumour,0,0
58140,necrosis,0,0
58141,factor-alpha,0,0
58142,",",0,0
58143,for,0,0
58144,the,0,0
58145,treatment,0,0
58146,of,0,0
58147,steroid-dependent,0,0
58148,Crohn,0,0
58149,'s,0,0
58150,disease,0,0
58151,.,0,0
58152,METHODS,0,0
58153,Patients,0,0
58154,with,0,0
58155,steroid-dependent,0,0
58156,Crohn,0,0
58157,'s,0,0
58158,disease,0,0
58159,(,0,0
58160,n,0,0
58161,=,0,0
58162,271,0,0
58163,),0,0
58164,were,0,0
58165,enrolled,0,0
58166,in,0,0
58167,a,0,0
58168,36-week,0,0
58169,",",0,0
58170,double-blind,0,0
58171,",",0,0
58172,placebo-controlled,1,1
58173,trial,0,0
58174,.,0,0
58175,Steroid,0,0
58176,dependence,0,0
58177,was,0,0
58178,defined,0,0
58179,as,0,0
58180,use,0,0
58181,of,0,0
58182,prednisolone,0,1
58183,or,0,1
58184,prednisone,1,1
58185,(,0,0
58186,15-40,0,0
58187,mg/day,0,1
58188,),0,0
58189,or,0,1
58190,budesonide,0,1
58191,(,0,0
58192,9,0,0
58193,mg/day,0,0
58194,),0,0
58195,for,0,0
58196,>,0,0
58197,or,0,0
58198,=8,0,0
58199,weeks,0,0
58200,",",0,0
58201,a,0,0
58202,previous,0,0
58203,failed,0,0
58204,attempt,0,0
58205,to,0,0
58206,decrease,0,0
58207,or,0,0
58208,discontinue,0,0
58209,steroids,0,1
58210,within,0,0
58211,8,0,0
58212,weeks,0,0
58213,of,0,0
58214,screening,0,0
58215,",",0,0
58216,and,0,0
58217,a,0,0
58218,Crohn,0,0
58219,'s,0,0
58220,Disease,0,0
58221,Activity,0,0
58222,Index,0,1
58223,score,0,0
58224,of,0,0
58225,<,0,0
58226,or,0,0
58227,=150,0,0
58228,points,0,0
58229,.,0,0
58230,Patients,0,0
58231,were,0,0
58232,randomized,0,0
58233,to,0,0
58234,receive,0,0
58235,intravenous,1,1
58236,CDP571,1,1
58237,10,1,0
58238,mg/kg,1,1
58239,or,1,1
58240,placebo,1,1
58241,8-weekly,0,1
58242,through,0,0
58243,to,0,0
58244,week,0,0
58245,32,0,0
58246,.,0,0
58247,Steroids,0,0
58248,were,0,0
58249,then,0,0
58250,tapered,0,1
58251,using,0,0
58252,a,0,0
58253,defined,0,0
58254,schedule,0,0
58255,.,0,0
58256,The,0,0
58257,primary,0,0
58258,efficacy,0,0
58259,endpoint,0,0
58260,was,0,0
58261,the,0,0
58262,percentage,0,0
58263,of,0,0
58264,patients,0,0
58265,with,0,0
58266,steroid,0,1
58267,sparing,0,0
58268,",",0,0
58269,defined,0,0
58270,as,0,0
58271,discontinuation,0,0
58272,of,0,0
58273,steroid,0,1
58274,therapy,1,1
58275,without,0,0
58276,a,0,0
58277,disease,0,0
58278,flare,0,0
58279,(,0,0
58280,Crohn,0,0
58281,'s,0,0
58282,Disease,0,0
58283,Activity,0,0
58284,Index,0,1
58285,score,0,0
58286,>,0,0
58287,or,0,1
58288,=220,0,0
58289,points,0,0
58290,),0,0
58291,at,0,0
58292,week,0,0
58293,36,0,0
58294,.,0,0
58295,RESULTS,0,0
58296,Steroid,0,0
58297,sparing,0,0
58298,occurred,0,0
58299,in,0,0
58300,53,0,0
58301,of,0,0
58302,181,0,0
58303,(,0,0
58304,29.3,0,0
58305,%,0,0
58306,),0,0
58307,CDP571,1,1
58308,patients,0,0
58309,and,0,0
58310,33,0,0
58311,of,0,0
58312,90,0,0
58313,(,0,0
58314,36.7,0,0
58315,%,0,0
58316,),0,0
58317,placebo,1,1
58318,patients,0,0
58319,(,0,0
58320,P,0,0
58321,=,0,0
58322,0.24,0,0
58323,),0,0
58324,.,0,0
58325,Adverse,0,0
58326,events,0,0
58327,occurred,0,0
58328,at,0,0
58329,similar,0,0
58330,frequencies,0,0
58331,in,0,0
58332,both,0,0
58333,treatment,0,0
58334,groups,0,0
58335,.,0,0
58336,CONCLUSIONS,0,0
58337,CDP571,1,1
58338,was,0,0
58339,ineffective,0,0
58340,for,0,0
58341,sparing,0,0
58342,steroids,0,1
58343,in,0,0
58344,patients,0,0
58345,with,0,0
58346,steroid-dependent,0,0
58347,Crohn,0,0
58348,'s,0,0
58349,disease,0,0
58350,.,0,0
58351,CDP571,1,0
58352,was,0,0
58353,well,0,0
58354,tolerated,0,0
58355,.,0,0
58356,Longitudinal,0,0
58357,quality,0,0
58358,of,0,0
58359,life,0,0
58360,study,0,0
58361,in,0,0
58362,patients,0,0
58363,with,0,0
58364,metastatic,0,0
58365,gastric,0,0
58366,cancer,0,0
58367,.,0,0
58368,Analysis,0,0
58369,modalities,0,0
58370,and,0,0
58371,clinical,0,0
58372,applicability,0,0
58373,of,0,0
58374,QoL,0,0
58375,in,0,0
58376,randomized,0,0
58377,phase,0,0
58378,II,0,0
58379,trial,0,0
58380,in,0,0
58381,a,0,0
58382,digestive,0,0
58383,oncology,0,0
58384,.,0,0
58385,OBJECTIVES,0,0
58386,The,0,0
58387,aim,0,0
58388,of,0,0
58389,this,0,0
58390,study,0,0
58391,was,0,0
58392,to,0,0
58393,compare,0,0
58394,the,0,0
58395,longitudinal,0,0
58396,quality,0,0
58397,of,0,0
58398,life,0,0
58399,(,0,0
58400,QoL,0,0
58401,),0,0
58402,between,0,0
58403,LV5FU2-irinotecan,1,1
58404,and,1,0
58405,LV5FU2,1,1
58406,alone,1,1
58407,or,1,0
58408,LV5FU2-cisplatin,1,1
58409,in,0,0
58410,a,0,0
58411,randomized,0,0
58412,Phase,0,0
58413,II,0,0
58414,trial,0,0
58415,in,0,0
58416,patients,0,0
58417,with,0,0
58418,metastatic,0,0
58419,gastric,0,0
58420,adenocarcinoma,0,0
58421,.,0,0
58422,METHODS,0,0
58423,Among,0,0
58424,134,0,0
58425,eligible,0,0
58426,patients,0,0
58427,",",0,0
58428,QLQ-C30,0,0
58429,scores,0,0
58430,were,0,0
58431,collected,0,0
58432,and,0,0
58433,described,0,0
58434,at,0,0
58435,each,0,0
58436,2,0,0
58437,monthly,0,0
58438,follow-up,0,0
58439,visit,0,0
58440,during,0,0
58441,6,0,0
58442,months,0,0
58443,.,0,0
58444,The,0,0
58445,frequencies,0,0
58446,of,0,0
58447,QLQ-C30,0,0
58448,score,0,0
58449,improvement,0,0
58450,were,0,0
58451,calculated,0,0
58452,and,0,0
58453,mixed,0,0
58454,models,0,0
58455,for,0,0
58456,repeated,0,0
58457,measurements,0,0
58458,were,0,0
58459,applied,0,0
58460,with,0,0
58461,or,0,0
58462,without,0,0
58463,extreme,0,0
58464,poorest,0,0
58465,imputation,0,0
58466,for,0,0
58467,missing,0,0
58468,scores,0,0
58469,.,0,0
58470,The,0,0
58471,survival,0,0
58472,until,0,0
58473,definitive,0,0
58474,global,0,0
58475,health,0,0
58476,score,0,0
58477,(,0,0
58478,GHS,0,1
58479,),0,0
58480,deterioration,0,0
58481,was,0,0
58482,estimated,0,0
58483,.,0,0
58484,RESULTS,0,0
58485,At,0,0
58486,the,0,0
58487,3rd,0,0
58488,follow-up,0,0
58489,",",0,0
58490,patients,0,0
58491,with,0,0
58492,a,0,0
58493,stable,0,0
58494,or,0,0
58495,improved,0,0
58496,global,0,0
58497,health,0,0
58498,ranged,0,0
58499,from,0,0
58500,11,0,0
58501,%,0,0
58502,in,0,0
58503,the,0,0
58504,LV5FU2-cisplatin,1,1
58505,arm,0,0
58506,to,0,0
58507,18,0,0
58508,%,0,0
58509,in,0,0
58510,the,0,0
58511,LV5FU2-irinotecan,1,1
58512,arm,0,0
58513,.,0,0
58514,The,0,0
58515,irinotecan-based-therapy,0,1
58516,presented,0,0
58517,14,0,0
58518,to,0,0
58519,15,0,0
58520,scores,0,0
58521,with,0,0
58522,a,0,0
58523,better,0,0
58524,QoL,0,0
58525,.,0,0
58526,The,0,0
58527,time,0,0
58528,until,0,0
58529,definitive,0,0
58530,GHS,0,1
58531,deterioration,0,0
58532,was,0,0
58533,globally,0,0
58534,similar,0,0
58535,between,0,0
58536,treatment,0,0
58537,arms,0,0
58538,.,0,0
58539,CONCLUSION,0,0
58540,This,0,0
58541,study,0,0
58542,highlights,0,0
58543,a,0,0
58544,better,0,0
58545,impact,0,0
58546,of,0,0
58547,LV5FU2-irinotecan,1,1
58548,and,0,0
58549,the,0,0
58550,interest,0,0
58551,of,0,0
58552,QoL,0,0
58553,assessment,0,0
58554,in,0,0
58555,phase,0,0
58556,II,0,0
58557,trials,0,0
58558,to,0,0
58559,complement,0,0
58560,the,0,0
58561,risk-benefit,0,0
58562,judgement,0,0
58563,.,0,0
58564,A,0,0
58565,crossover,0,0
58566,study,0,0
58567,of,0,0
58568,risperidone,1,1
58569,in,0,0
58570,children,0,0
58571,",",0,0
58572,adolescents,0,0
58573,and,0,0
58574,adults,0,0
58575,with,0,0
58576,mental,0,0
58577,retardation,0,0
58578,.,0,0
58579,Risperidone,1,1
58580,has,0,0
58581,shown,0,0
58582,safety,0,0
58583,and,0,0
58584,efficacy,0,0
58585,for,0,0
58586,aggressive,0,0
58587,and,0,0
58588,destructive,0,0
58589,behaviors,0,0
58590,in,0,0
58591,short-term,0,0
58592,studies,0,0
58593,.,0,0
58594,This,0,0
58595,longer-duration,0,0
58596,study,0,0
58597,includes,0,0
58598,a,0,0
58599,broad,0,0
58600,sample,0,0
58601,.,0,0
58602,Forty,0,0
58603,subjects,0,0
58604,",",0,0
58605,aged,0,0
58606,8-56,0,0
58607,years,0,0
58608,(,0,0
58609,mean=22,0,0
58610,),0,0
58611,",",0,0
58612,all,0,0
58613,with,0,0
58614,mental,0,0
58615,retardation,0,0
58616,and,0,0
58617,36,0,0
58618,with,0,0
58619,autism,0,0
58620,spectrum,0,0
58621,disorders,0,0
58622,participated,0,0
58623,in,0,0
58624,this,0,0
58625,22-week,0,0
58626,crossover,0,0
58627,study,0,0
58628,",",0,0
58629,with,0,0
58630,24,0,0
58631,weeks,0,0
58632,of,0,0
58633,open,0,0
58634,maintenance,0,0
58635,thereafter,0,0
58636,.,0,0
58637,Of,0,0
58638,40,0,0
58639,subjects,0,0
58640,",",0,0
58641,23,0,0
58642,(,0,0
58643,57.5,0,0
58644,%,0,0
58645,),0,0
58646,responded,0,0
58647,fully,0,0
58648,(,0,0
58649,50,0,0
58650,%,0,0
58651,decrease,0,0
58652,in,0,0
58653,Aberrant,0,0
58654,Behavior,0,0
58655,Checklist-Community,0,0
58656,Irritability,0,0
58657,subscale,0,0
58658,score,0,0
58659,),0,0
58660,",",0,0
58661,while,0,0
58662,35,0,0
58663,subjects,0,0
58664,(,0,0
58665,87.5,0,0
58666,%,0,0
58667,),0,0
58668,showed,0,0
58669,a,0,0
58670,25,0,0
58671,%,0,0
58672,decrease,0,0
58673,.,0,0
58674,Gender,0,0
58675,",",0,0
58676,mood,0,0
58677,disorder,0,0
58678,",",0,0
58679,and,0,0
58680,antiseizure,0,0
58681,medications,0,1
58682,did,0,0
58683,not,0,0
58684,alter,0,0
58685,response,0,0
58686,.,0,0
58687,Increased,0,0
58688,appetite,0,0
58689,and,0,0
58690,weight,0,0
58691,gain,0,0
58692,were,0,0
58693,common,0,0
58694,.,0,0
58695,Low,0,0
58696,dose,0,0
58697,risperidone,0,1
58698,was,0,0
58699,effective,0,0
58700,for,0,0
58701,aggressive,0,0
58702,behavior,0,0
58703,in,0,0
58704,persons,0,0
58705,with,0,0
58706,MR.,0,0
58707,More,0,0
58708,long-term,0,0
58709,studies,0,0
58710,are,0,0
58711,needed,0,0
58712,",",0,0
58713,incorporating,0,0
58714,weight,0,0
58715,control,0,0
58716,interventions,0,0
58717,.,0,0
58718,Evaluation,0,0
58719,of,0,0
58720,a,0,0
58721,novel,1,0
58722,technique,1,1
58723,for,0,0
58724,wound,1,0
58725,closure,1,0
58726,using,1,0
58727,a,1,0
58728,barbed,1,1
58729,suture,1,0
58730,.,1,0
58731,BACKGROUND,0,0
58732,Suture,0,0
58733,knots,0,0
58734,present,0,0
58735,several,0,0
58736,disadvantages,0,0
58737,in,0,0
58738,wound,0,0
58739,closure,0,0
58740,",",0,0
58741,because,0,0
58742,they,0,0
58743,are,0,0
58744,tedious,0,0
58745,to,0,0
58746,tie,0,1
58747,and,0,0
58748,place,0,0
58749,ischemic,0,0
58750,demands,0,0
58751,on,0,0
58752,tissue,0,0
58753,.,0,0
58754,Bulky,0,0
58755,knots,0,0
58756,may,0,0
58757,be,0,0
58758,a,0,0
58759,nidus,0,0
58760,for,0,0
58761,infection,0,0
58762,",",0,0
58763,and,0,0
58764,they,0,0
58765,may,0,0
58766,extrude,0,0
58767,through,0,0
58768,skin,0,0
58769,weeks,0,0
58770,after,0,0
58771,surgery,0,0
58772,.,0,0
58773,Needle,0,0
58774,manipulations,0,0
58775,during,0,0
58776,knot-tying,0,1
58777,predispose,0,0
58778,the,0,0
58779,surgeon,0,0
58780,to,0,0
58781,glove,0,1
58782,perforation,0,0
58783,.,0,0
58784,A,0,0
58785,barbed,1,1
58786,suture,1,0
58787,was,0,0
58788,developed,0,0
58789,that,0,0
58790,is,0,0
58791,self-anchoring,0,0
58792,",",0,0
58793,requiring,0,0
58794,no,0,0
58795,knots,0,0
58796,or,0,0
58797,slack,0,0
58798,management,0,0
58799,for,0,0
58800,wound,0,0
58801,closure,0,0
58802,.,0,0
58803,The,0,0
58804,elimination,0,0
58805,of,0,0
58806,knot,0,1
58807,tying,0,0
58808,may,0,0
58809,have,0,0
58810,advantages,0,0
58811,over,0,0
58812,conventional,0,1
58813,wound,0,0
58814,closure,0,0
58815,methods,0,0
58816,.,0,0
58817,METHODS,0,0
58818,This,0,0
58819,prospective,0,0
58820,",",0,0
58821,randomized,0,0
58822,",",0,0
58823,controlled,0,0
58824,trial,0,0
58825,was,0,0
58826,designed,0,0
58827,to,0,0
58828,show,0,0
58829,that,0,0
58830,the,0,0
58831,use,0,0
58832,of,0,0
58833,barbed,1,1
58834,suture,1,0
58835,in,0,0
58836,dermal,0,1
58837,closure,0,0
58838,of,0,0
58839,the,0,0
58840,Pfannenstiel,0,1
58841,incision,0,1
58842,during,0,0
58843,nonemergent,0,0
58844,cesarean,0,0
58845,delivery,0,0
58846,surgery,0,0
58847,produces,0,0
58848,scar,0,0
58849,cosmesis,0,0
58850,at,0,0
58851,5,0,0
58852,weeks,0,0
58853,that,0,0
58854,is,0,0
58855,no,0,0
58856,worse,0,0
58857,than,0,0
58858,that,0,0
58859,observed,0,0
58860,with,0,0
58861,conventional,1,1
58862,closure,1,0
58863,using,0,0
58864,3-0,1,1
58865,polydioxanone,1,1
58866,suture,1,1
58867,.,1,0
58868,Cosmesis,0,0
58869,was,0,0
58870,assessed,0,0
58871,by,0,0
58872,review,0,0
58873,of,0,0
58874,postoperative,0,0
58875,photographs,0,0
58876,by,0,0
58877,a,0,0
58878,blinded,0,0
58879,",",0,0
58880,independent,0,0
58881,plastic,0,1
58882,surgeon,0,0
58883,using,0,0
58884,the,0,0
58885,modified,0,0
58886,Hollander,0,0
58887,cosmesis,0,0
58888,score,0,0
58889,.,0,0
58890,Secondary,0,0
58891,endpoints,0,0
58892,included,0,0
58893,infection,0,0
58894,",",0,0
58895,dehiscence,0,0
58896,",",0,0
58897,pain,0,0
58898,",",0,0
58899,closure,0,0
58900,time,0,0
58901,",",0,0
58902,and,0,0
58903,other,0,0
58904,adverse,0,0
58905,events,0,0
58906,.,0,0
58907,RESULTS,0,0
58908,The,0,0
58909,study,0,0
58910,enrolled,0,0
58911,195,0,0
58912,patients,0,0
58913,",",0,0
58914,of,0,0
58915,whom,0,0
58916,188,0,0
58917,were,0,0
58918,eligible,0,0
58919,for,0,0
58920,analysis,0,0
58921,.,0,0
58922,Cosmesis,0,0
58923,scores,0,0
58924,did,0,0
58925,not,0,0
58926,significantly,0,0
58927,differ,0,0
58928,between,0,0
58929,the,0,0
58930,barbed,0,1
58931,suture,0,1
58932,group,0,0
58933,and,0,0
58934,the,0,0
58935,control,0,0
58936,group,0,0
58937,.,0,0
58938,Rates,0,0
58939,of,0,0
58940,infection,0,0
58941,",",0,0
58942,dehiscence,0,0
58943,",",0,0
58944,and,0,0
58945,other,0,0
58946,adverse,0,0
58947,events,0,0
58948,did,0,0
58949,not,0,0
58950,significantly,0,0
58951,differ,0,0
58952,between,0,0
58953,the,0,0
58954,two,0,0
58955,groups,0,0
58956,.,0,0
58957,Closure,0,0
58958,time,0,0
58959,and,0,0
58960,pain,0,0
58961,scores,0,0
58962,were,0,0
58963,comparable,0,0
58964,between,0,0
58965,the,0,0
58966,groups,0,0
58967,.,0,0
58968,CONCLUSIONS,0,0
58969,The,0,0
58970,barbed,0,1
58971,suture,0,1
58972,represents,0,0
58973,an,0,0
58974,innovative,0,0
58975,option,0,0
58976,for,0,0
58977,wound,0,0
58978,closure,0,0
58979,.,0,0
58980,With,0,0
58981,a,0,0
58982,cosmesis,0,0
58983,and,0,0
58984,safety,0,0
58985,profile,0,0
58986,that,0,0
58987,is,0,0
58988,similar,0,0
58989,to,0,0
58990,that,0,0
58991,of,0,0
58992,conventional,1,1
58993,suture,1,1
58994,technique,0,1
58995,",",0,0
58996,it,0,0
58997,avoids,0,0
58998,the,0,0
58999,drawbacks,0,0
59000,inherent,0,0
59001,to,0,0
59002,suture,0,0
59003,knots,0,0
59004,.,0,0
59005,Evaluation,0,0
59006,of,0,0
59007,prostaglandin,1,0
59008,E1,1,1
59009,for,0,0
59010,prevention,0,0
59011,of,0,0
59012,respiratory,0,0
59013,failure,0,0
59014,in,0,0
59015,high,0,0
59016,risk,0,0
59017,trauma,0,0
59018,patients,0,0
59019,:,0,0
59020,a,0,0
59021,prospective,0,0
59022,clinical,0,0
59023,trial,0,0
59024,and,0,0
59025,correlation,0,0
59026,with,0,0
59027,plasma,0,0
59028,suppressive,0,0
59029,factors,0,0
59030,for,0,0
59031,neutrophil,0,0
59032,activation,0,0
59033,.,0,0
59034,A,0,0
59035,group,0,0
59036,of,0,0
59037,48,0,0
59038,critically,0,0
59039,injured,0,0
59040,patients,0,0
59041,were,0,0
59042,entered,0,0
59043,into,0,0
59044,a,0,0
59045,prospective,0,0
59046,",",0,0
59047,double-blind,0,0
59048,",",0,0
59049,placebo-controlled,1,1
59050,trial,0,0
59051,to,0,0
59052,evaluate,0,0
59053,the,0,0
59054,efficacy,0,0
59055,of,0,0
59056,early,1,0
59057,infusion,1,1
59058,of,1,0
59059,PGE1,1,0
59060,for,0,0
59061,reducing,0,0
59062,the,0,0
59063,incidence,0,0
59064,of,0,0
59065,severe,0,0
59066,respiratory,0,0
59067,failure,0,0
59068,and,0,0
59069,mortality,0,0
59070,.,0,0
59071,Secondary,0,0
59072,assessments,0,0
59073,examined,0,0
59074,the,0,0
59075,effects,0,0
59076,of,0,0
59077,the,0,0
59078,PGE1,0,0
59079,infusion,0,1
59080,on,0,0
59081,plasma,0,0
59082,mediated,0,0
59083,suppression,0,0
59084,of,0,0
59085,PMN,0,1
59086,superoxide,0,0
59087,production,0,0
59088,and,0,0
59089,loss,0,0
59090,of,0,0
59091,PMN,0,1
59092,granule,0,1
59093,enzyme,0,0
59094,content,0,0
59095,.,0,0
59096,The,0,0
59097,incidence,0,0
59098,of,0,0
59099,severe,0,0
59100,respiratory,0,0
59101,failure,0,0
59102,was,0,0
59103,lower,0,0
59104,in,0,0
59105,the,0,0
59106,PGE1,0,0
59107,group,0,0
59108,--,0,0
59109,13,0,0
59110,%,0,0
59111,versus,0,0
59112,32,0,0
59113,%,0,0
59114,",",0,0
59115,but,0,0
59116,this,0,0
59117,did,0,0
59118,not,0,0
59119,reach,0,0
59120,significance,0,0
59121,.,0,0
59122,The,0,0
59123,overall,0,0
59124,morality,0,0
59125,was,0,0
59126,equivalent,0,0
59127,between,0,0
59128,the,0,0
59129,two,0,0
59130,groups,0,0
59131,--,0,0
59132,26,0,0
59133,%,0,0
59134,(,1,0
59135,PGE1,1,0
59136,),1,0
59137,versus,0,0
59138,28,0,0
59139,%,0,0
59140,(,1,0
59141,placebo,1,1
59142,),1,0
59143,.,0,0
59144,The,0,0
59145,suppressive,0,0
59146,activity,0,0
59147,of,0,0
59148,the,0,0
59149,patient,0,0
59150,plasma,0,0
59151,was,0,0
59152,assayed,0,0
59153,by,0,0
59154,measurement,0,0
59155,of,0,0
59156,normal,0,0
59157,PMN,0,1
59158,superoxide,0,0
59159,production,0,0
59160,relative,0,0
59161,to,0,0
59162,normal,0,0
59163,control,0,1
59164,plasma,0,0
59165,(,0,0
59166,ratio,0,0
59167,P,0,0
59168,:,0,0
59169,C,0,0
59170,),0,0
59171,.,0,0
59172,The,0,0
59173,baseline,0,0
59174,ratio,0,0
59175,P,0,0
59176,:,0,0
59177,C,0,0
59178,was,0,0
59179,62,0,0
59180,+/-,0,0
59181,5,0,0
59182,%,0,0
59183,in,0,0
59184,the,0,0
59185,PGE1,0,0
59186,group,0,0
59187,versus,0,0
59188,60,0,0
59189,+/-,0,0
59190,5,0,0
59191,%,0,0
59192,in,0,0
59193,the,0,0
59194,placebo,0,1
59195,group,0,0
59196,.,0,0
59197,The,0,0
59198,day,0,0
59199,1,0,0
59200,plasma,0,0
59201,samples,0,0
59202,showed,0,0
59203,significant,0,0
59204,reversal,0,0
59205,of,0,0
59206,plasma,0,0
59207,suppressive,0,0
59208,activity,0,0
59209,in,0,0
59210,the,0,0
59211,PGE1,0,0
59212,group,0,0
59213,--,0,0
59214,ratio,0,0
59215,P,0,0
59216,:,0,0
59217,C,0,0
59218,88,0,0
59219,+/-,0,0
59220,5,0,0
59221,%,0,0
59222,versus,0,0
59223,67,0,0
59224,+/-,0,0
59225,5,0,0
59226,%,0,0
59227,in,0,0
59228,the,0,0
59229,placebo,0,1
59230,group,0,0
59231,(,0,0
59232,P,0,0
59233,less,0,0
59234,than,0,0
59235,0.02,0,0
59236,),0,0
59237,.,0,0
59238,In,0,0
59239,patients,0,0
59240,who,0,0
59241,received,0,0
59242,the,0,0
59243,full,0,0
59244,7,0,0
59245,days,0,0
59246,of,0,0
59247,infusion,0,0
59248,",",0,0
59249,the,0,0
59250,plasma,0,0
59251,suppressive,0,0
59252,activity,0,0
59253,remained,0,0
59254,significantly,0,0
59255,diminished,0,0
59256,in,0,0
59257,the,0,0
59258,PGE1,0,0
59259,group,0,0
59260,--,0,0
59261,ratio,0,0
59262,P,0,0
59263,:,0,0
59264,C,0,0
59265,77,0,0
59266,+/-,0,0
59267,4,0,0
59268,%,0,0
59269,versus,0,0
59270,61,0,0
59271,+/-,0,0
59272,5,0,0
59273,%,0,0
59274,(,0,0
59275,P,0,0
59276,less,0,0
59277,than,0,0
59278,0.04,0,0
59279,),0,0
59280,.,0,0
59281,The,0,0
59282,baseline,0,0
59283,lysozyme,0,0
59284,content,0,0
59285,of,0,0
59286,patient,0,0
59287,PMN,0,1
59288,'s,0,0
59289,relative,0,0
59290,to,0,0
59291,that,0,0
59292,of,0,0
59293,normal,0,0
59294,control,0,1
59295,PMNs,0,1
59296,(,0,0
59297,ratio,0,0
59298,P,0,0
59299,:,0,0
59300,C,0,0
59301,),0,0
59302,was,0,0
59303,119,0,0
59304,+/-,0,0
59305,14,0,0
59306,%,0,0
59307,in,0,0
59308,the,0,0
59309,PGE1,0,0
59310,group,0,0
59311,.,0,0
59312,A,0,0
59313,significant,0,0
59314,loss,0,0
59315,of,0,0
59316,lysozyme,0,0
59317,content,0,0
59318,was,0,0
59319,observed,0,0
59320,in,0,0
59321,the,0,0
59322,PGE1,0,0
59323,group,0,0
59324,on,0,0
59325,day,0,0
59326,1,0,0
59327,of,0,0
59328,the,0,0
59329,infusion,0,1
59330,--,0,0
59331,ratio,0,0
59332,P,0,0
59333,:,0,0
59334,C,0,0
59335,79,0,0
59336,+/-,0,0
59337,8,0,0
59338,%,0,0
59339,(,0,0
59340,P,0,0
59341,less,0,0
59342,than,0,0
59343,0.03,0,0
59344,),0,0
59345,",",0,0
59346,and,0,0
59347,was,0,0
59348,associated,0,0
59349,with,0,0
59350,a,0,0
59351,reduction,0,0
59352,in,0,0
59353,the,0,0
59354,plasma,0,0
59355,suppressive,0,0
59356,activity,0,0
59357,.,0,0
59358,(,0,0
59359,ABSTRACT,0,0
59360,TRUNCATED,0,1
59361,AT,0,1
59362,250,0,1
59363,WORDS,0,0
59364,),0,0
59365,Effect,0,0
59366,of,0,0
59367,step,1,0
59368,aerobics,1,1
59369,training,1,1
59370,on,0,0
59371,anaerobic,0,1
59372,performance,0,0
59373,of,0,0
59374,men,0,0
59375,and,0,0
59376,women,0,0
59377,.,0,0
59378,The,0,0
59379,purpose,0,0
59380,of,0,0
59381,this,0,0
59382,study,0,0
59383,was,0,0
59384,to,0,0
59385,investigate,0,0
59386,the,0,0
59387,effects,0,0
59388,of,0,0
59389,10,0,0
59390,weeks,0,0
59391,of,0,0
59392,step,1,0
59393,aerobics,1,1
59394,training,1,1
59395,on,0,0
59396,anaerobic,0,1
59397,performance,0,0
59398,of,0,0
59399,men,0,0
59400,and,0,0
59401,women,0,0
59402,.,0,0
59403,College-age,0,0
59404,volunteers,0,0
59405,(,0,0
59406,64,0,0
59407,women,0,0
59408,and,0,0
59409,54,0,0
59410,men,0,0
59411,),0,0
59412,were,0,0
59413,divided,0,0
59414,into,0,0
59415,step,1,0
59416,aerobics,1,1
59417,(,0,0
59418,33,0,0
59419,women,0,0
59420,",",0,0
59421,27,0,0
59422,men,0,0
59423,),0,0
59424,and,0,0
59425,control,1,1
59426,(,0,0
59427,31,0,0
59428,women,0,0
59429,",",0,0
59430,27,0,0
59431,men,0,0
59432,),0,0
59433,groups,0,0
59434,.,0,0
59435,Before,0,0
59436,and,0,0
59437,after,0,0
59438,the,0,0
59439,10-week,0,1
59440,period,0,0
59441,",",0,0
59442,the,0,0
59443,subjects,0,0
59444,',0,0
59445,body,0,0
59446,composition,0,0
59447,",",0,0
59448,muscular,0,0
59449,strength,0,0
59450,",",0,0
59451,Wingate,0,1
59452,anaerobic,0,1
59453,performance,0,0
59454,",",0,0
59455,and,0,0
59456,vertical,0,0
59457,jump,0,0
59458,anaerobic,0,1
59459,performance,0,0
59460,were,0,0
59461,determined,0,0
59462,.,0,0
59463,The,0,0
59464,step,1,0
59465,aerobics,1,1
59466,group,0,0
59467,participated,0,0
59468,in,0,0
59469,step,1,0
59470,aerobics,1,1
59471,sessions,0,1
59472,of,0,0
59473,50,0,0
59474,minutes,0,0
59475,per,0,0
59476,day,0,0
59477,",",0,0
59478,3,0,0
59479,days,0,0
59480,per,0,0
59481,week,0,0
59482,for,0,0
59483,10,0,0
59484,weeks,0,0
59485,",",0,0
59486,at,0,0
59487,60-80,0,0
59488,%,0,0
59489,of,0,0
59490,their,0,0
59491,heart,0,0
59492,rate,0,0
59493,reserve,0,0
59494,.,0,0
59495,Results,0,0
59496,of,0,0
59497,2,0,0
59498,x,0,0
59499,2,0,0
59500,analysis,0,0
59501,of,0,0
59502,covariance,0,0
59503,with,0,0
59504,repeated,0,0
59505,measures,0,0
59506,indicated,0,0
59507,significant,0,0
59508,sex,0,0
59509,differences,0,0
59510,in,0,0
59511,percentage,0,0
59512,body,0,0
59513,fat,0,0
59514,",",0,0
59515,lean,0,0
59516,body,0,0
59517,mass,0,0
59518,",",0,0
59519,muscular,0,0
59520,strength,0,0
59521,",",0,0
59522,and,0,0
59523,in,0,0
59524,all,0,0
59525,of,0,0
59526,the,0,0
59527,measured,0,0
59528,indices,0,0
59529,of,0,0
59530,the,0,0
59531,Wingate,0,1
59532,Anaerobic,0,1
59533,Test,0,0
59534,.,0,0
59535,The,0,0
59536,step,0,0
59537,aerobics,1,1
59538,group,0,0
59539,showed,0,0
59540,significant,0,0
59541,improvement,0,0
59542,only,0,0
59543,in,0,0
59544,mean,0,0
59545,power,0,0
59546,relative,0,0
59547,to,0,0
59548,body,0,0
59549,weight,0,0
59550,compared,0,0
59551,with,0,0
59552,the,0,0
59553,control,0,1
59554,group,0,0
59555,and,0,0
59556,women,0,0
59557,showed,0,0
59558,significant,0,0
59559,improvement,0,0
59560,only,0,0
59561,in,0,0
59562,anaerobic,0,0
59563,power,0,0
59564,of,0,0
59565,vertical,0,0
59566,jump,0,0
59567,when,0,0
59568,compared,0,0
59569,with,0,0
59570,men,0,0
59571,.,0,0
59572,It,0,0
59573,can,0,0
59574,be,0,0
59575,concluded,0,0
59576,that,0,0
59577,10,0,0
59578,weeks,0,0
59579,of,0,0
59580,step,0,0
59581,aerobics,0,1
59582,was,0,0
59583,not,0,0
59584,effective,0,0
59585,in,0,0
59586,improving,0,0
59587,all,0,0
59588,of,0,0
59589,the,0,0
59590,measured,0,0
59591,anaerobic,0,0
59592,indices,0,0
59593,in,0,0
59594,men,0,0
59595,and,0,0
59596,women,0,0
59597,.,0,0
59598,Joint,0,0
59599,attention,0,0
59600,and,0,0
59601,symbolic,0,1
59602,play,0,0
59603,in,0,0
59604,young,0,0
59605,children,0,0
59606,with,0,0
59607,autism,0,0
59608,:,0,0
59609,a,0,0
59610,randomized,0,0
59611,controlled,0,0
59612,intervention,0,1
59613,study,0,0
59614,.,0,0
59615,BACKGROUND,0,0
59616,Delays,0,0
59617,and,0,0
59618,deficits,0,0
59619,in,0,0
59620,joint,0,0
59621,attention,0,0
59622,and,0,0
59623,symbolic,0,1
59624,play,0,0
59625,constitute,0,0
59626,two,0,0
59627,important,0,0
59628,developmental,0,0
59629,problems,0,0
59630,in,0,0
59631,young,0,0
59632,children,0,0
59633,with,0,0
59634,autism,0,0
59635,.,0,0
59636,These,0,0
59637,areas,0,0
59638,of,0,0
59639,deficit,0,0
59640,have,0,0
59641,been,0,0
59642,well,0,0
59643,studied,0,0
59644,in,0,0
59645,autism,0,0
59646,but,0,0
59647,have,0,0
59648,rarely,0,0
59649,been,0,0
59650,the,0,0
59651,focus,0,0
59652,of,0,0
59653,treatment,0,0
59654,efforts,0,0
59655,(,0,0
59656,see,0,0
59657,Kasari,0,1
59658,",",0,0
59659,Freeman,0,0
59660,",",0,0
59661,&,0,0
59662,Paparella,0,0
59663,",",0,0
59664,2001,0,0
59665,),0,0
59666,.,0,0
59667,In,0,0
59668,this,0,0
59669,study,0,0
59670,",",0,0
59671,we,0,0
59672,examine,0,0
59673,the,0,0
59674,efficacy,0,0
59675,of,0,0
59676,targeted,0,0
59677,interventions,0,0
59678,of,0,0
59679,joint,1,0
59680,attention,1,0
59681,and,1,0
59682,symbolic,1,1
59683,play,1,0
59684,.,1,0
59685,METHODS,0,0
59686,Participants,0,0
59687,were,0,0
59688,58,0,0
59689,children,0,0
59690,with,0,0
59691,autism,0,0
59692,aged,0,0
59693,3,0,0
59694,and,0,0
59695,4,0,0
59696,years,0,0
59697,(,0,0
59698,46,0,0
59699,boys,0,0
59700,),0,0
59701,.,0,0
59702,Children,0,0
59703,were,0,0
59704,randomized,0,0
59705,to,0,0
59706,a,0,0
59707,joint,1,0
59708,attention,1,0
59709,intervention,1,1
59710,",",1,0
59711,a,1,0
59712,symbolic,1,1
59713,play,1,0
59714,intervention,1,1
59715,",",1,0
59716,or,1,1
59717,control,1,0
59718,group,1,0
59719,.,1,0
59720,Interventions,0,0
59721,were,0,0
59722,conducted,0,0
59723,30,0,0
59724,minutes,0,0
59725,daily,0,0
59726,for,0,0
59727,5-6,0,0
59728,weeks,0,0
59729,.,0,0
59730,Both,0,0
59731,structured,0,0
59732,assessments,0,0
59733,of,0,0
59734,joint,0,0
59735,attention,0,0
59736,and,0,0
59737,play,0,0
59738,skills,0,1
59739,and,0,0
59740,mother-child,0,0
59741,interactions,0,0
59742,were,0,0
59743,collected,0,0
59744,pre,0,0
59745,and,0,0
59746,post,0,0
59747,intervention,0,1
59748,by,0,0
59749,independent,0,0
59750,assessors,0,0
59751,.,0,0
59752,RESULTS,0,0
59753,Results,0,0
59754,indicate,0,0
59755,that,0,0
59756,both,0,0
59757,intervention,0,1
59758,groups,0,0
59759,improved,0,0
59760,significantly,0,0
59761,over,0,0
59762,the,0,0
59763,control,0,0
59764,group,0,0
59765,on,0,0
59766,certain,0,0
59767,behaviors,0,0
59768,.,0,0
59769,Children,0,0
59770,in,0,0
59771,the,0,0
59772,joint,0,0
59773,attention,0,0
59774,intervention,0,1
59775,initiated,0,0
59776,significantly,0,0
59777,more,0,0
59778,showing,0,0
59779,and,0,0
59780,responsiveness,0,0
59781,to,0,0
59782,joint,0,0
59783,attention,0,0
59784,on,0,0
59785,the,0,0
59786,structured,0,0
59787,joint,0,0
59788,attention,0,0
59789,assessment,0,0
59790,and,0,0
59791,more,0,0
59792,child-initiated,0,0
59793,joint,0,0
59794,attention,0,0
59795,in,0,0
59796,the,0,0
59797,mother-child,0,0
59798,interaction,0,0
59799,.,0,0
59800,The,0,0
59801,children,0,0
59802,in,0,0
59803,the,0,0
59804,play,0,0
59805,group,0,0
59806,showed,0,0
59807,more,0,0
59808,diverse,0,0
59809,types,0,0
59810,of,0,0
59811,symbolic,0,0
59812,play,0,0
59813,in,0,0
59814,interaction,0,0
59815,with,0,0
59816,their,0,0
59817,mothers,0,0
59818,and,0,0
59819,higher,0,0
59820,play,0,0
59821,levels,0,0
59822,on,0,0
59823,both,0,0
59824,the,0,0
59825,play,0,0
59826,assessment,0,0
59827,and,0,0
59828,in,0,0
59829,interaction,0,0
59830,with,0,0
59831,their,0,0
59832,mothers,0,0
59833,.,0,0
59834,CONCLUSIONS,0,0
59835,This,0,0
59836,randomized,0,0
59837,controlled,0,0
59838,trial,0,0
59839,provides,0,0
59840,promising,0,0
59841,data,0,0
59842,on,0,0
59843,the,0,0
59844,specificity,0,0
59845,and,0,0
59846,generalizability,0,0
59847,of,0,0
59848,joint,0,0
59849,attention,0,0
59850,and,0,0
59851,play,0,0
59852,interventions,0,1
59853,for,0,0
59854,young,0,0
59855,children,0,0
59856,with,0,0
59857,autism,0,0
59858,.,0,0
59859,Future,0,0
59860,studies,0,0
59861,need,0,0
59862,to,0,0
59863,examine,0,0
59864,the,0,0
59865,long-term,0,0
59866,effects,0,0
59867,of,0,0
59868,these,0,0
59869,early,0,0
59870,interventions,0,0
59871,on,0,0
59872,children,0,0
59873,'s,0,0
59874,development,0,0
59875,.,0,0
59876,Nitroglycerin,1,1
59877,",",1,0
59878,nitroprusside,1,1
59879,",",0,0
59880,or,0,0
59881,both,0,0
59882,",",0,0
59883,in,0,0
59884,preventing,0,0
59885,radial,0,1
59886,artery,0,0
59887,spasm,0,0
59888,during,0,0
59889,transradial,0,1
59890,artery,0,0
59891,catheterization,0,0
59892,.,0,0
59893,OBJECTIVE,0,0
59894,Radial,0,0
59895,artery,0,0
59896,spasm,0,0
59897,remains,0,0
59898,a,0,0
59899,major,0,0
59900,complication,0,0
59901,of,0,0
59902,transradial,0,1
59903,coronary,0,0
59904,interventions,0,0
59905,.,0,0
59906,The,0,0
59907,aim,0,0
59908,of,0,0
59909,this,0,0
59910,study,0,0
59911,was,0,0
59912,to,0,0
59913,compare,0,0
59914,the,0,0
59915,efficacy,0,0
59916,of,0,0
59917,three,0,0
59918,different,0,0
59919,intra-arterial,0,1
59920,vasodilating,1,0
59921,cocktails,1,1
59922,in,0,0
59923,reducing,0,0
59924,the,0,0
59925,incidence,0,0
59926,of,0,0
59927,radial,0,1
59928,artery,0,0
59929,spasm,0,0
59930,in,0,0
59931,patients,0,0
59932,undergoing,0,0
59933,transradial,0,1
59934,coronary,0,0
59935,angiography,0,1
59936,.,0,0
59937,The,0,0
59938,secondary,0,0
59939,goal,0,0
59940,was,0,0
59941,to,0,0
59942,assess,0,0
59943,the,0,0
59944,predictors,0,0
59945,of,0,0
59946,arterial,0,0
59947,spasm,0,0
59948,in,0,0
59949,this,0,0
59950,large,0,0
59951,group,0,0
59952,of,0,0
59953,patients,0,0
59954,.,0,0
59955,METHODS,0,0
59956,A,0,0
59957,total,0,0
59958,of,0,0
59959,379,0,0
59960,patients,0,0
59961,undergoing,0,0
59962,the,0,0
59963,procedure,0,0
59964,were,0,0
59965,randomly,0,0
59966,enrolled,0,0
59967,in,0,0
59968,1,0,0
59969,of,0,0
59970,3,0,0
59971,groups,0,0
59972,.,0,0
59973,Every,0,0
59974,patient,0,0
59975,in,0,0
59976,each,0,0
59977,of,0,0
59978,the,0,0
59979,3,0,0
59980,groups,0,0
59981,received,0,0
59982,intra-arterial,0,1
59983,heparin,1,1
59984,",",1,0
59985,lidocaine,1,1
59986,and,0,0
59987,diltiazem,1,1
59988,.,1,0
59989,Along,0,0
59990,with,0,0
59991,that,0,0
59992,",",0,0
59993,patients,0,0
59994,in,0,0
59995,Group,0,0
59996,A,0,0
59997,received,0,0
59998,nitroglycerin,1,1
59999,;,1,0
60000,patients,0,0
60001,in,0,0
60002,Group,0,0
60003,B,0,0
60004,received,0,0
60005,nitroprusside,1,1
60006,instead,0,0
60007,of,0,0
60008,nitroglycerin,1,1
60009,;,1,0
60010,and,0,0
60011,patients,0,0
60012,in,0,0
60013,Group,0,0
60014,C,0,0
60015,received,0,0
60016,both,0,0
60017,nitroglycerin,1,1
60018,and,1,0
60019,nitroprusside,1,1
60020,.,1,0
60021,A,0,0
60022,single,0,0
60023,experienced,0,0
60024,operator,0,0
60025,",",0,0
60026,blinded,0,0
60027,to,0,0
60028,the,0,0
60029,study,0,0
60030,drug,0,0
60031,",",0,0
60032,subjectively,0,0
60033,determined,0,0
60034,the,0,0
60035,presence,0,0
60036,of,0,0
60037,spasm,0,0
60038,.,0,0
60039,RESULTS,0,0
60040,Of,0,0
60041,379,0,0
60042,patients,0,0
60043,",",0,0
60044,a,0,0
60045,total,0,0
60046,of,0,0
60047,44,0,0
60048,patients,0,0
60049,(,0,0
60050,11.6,0,0
60051,%,0,0
60052,),0,0
60053,experienced,0,0
60054,spasm,0,0
60055,.,0,0
60056,The,0,0
60057,occurrence,0,0
60058,of,0,0
60059,spasm,0,0
60060,was,0,0
60061,similar,0,0
60062,",",0,0
60063,independent,0,0
60064,of,0,0
60065,the,0,0
60066,vasodilator,0,0
60067,cocktail,0,1
60068,used,0,0
60069,(,0,0
60070,Group,0,0
60071,A,0,0
60072,:,0,0
60073,12.2,0,0
60074,%,0,0
60075,",",0,0
60076,Group,0,0
60077,B,0,0
60078,:,0,0
60079,13.4,0,0
60080,%,0,0
60081,",",0,0
60082,Group,0,0
60083,C,0,0
60084,:,0,0
60085,9.5,0,0
60086,%,0,0
60087,;,0,0
60088,p,0,0
60089,=,0,0
60090,0.597,0,0
60091,),0,0
60092,.,0,0
60093,After,0,0
60094,multivariate,0,0
60095,analysis,0,0
60096,",",0,0
60097,the,0,0
60098,following,0,0
60099,variables,0,0
60100,were,0,0
60101,found,0,0
60102,to,0,0
60103,be,0,0
60104,independent,0,0
60105,predictors,0,0
60106,of,0,0
60107,spasm,0,0
60108,:,0,0
60109,radial,0,1
60110,artery,0,0
60111,diameter,0,0
60112,(,0,0
60113,RD,0,1
60114,),0,0
60115,/height,0,0
60116,index,0,0
60117,(,0,0
60118,p,0,0
60119,=,0,0
60120,0.005,0,0
60121,),0,0
60122,",",0,0
60123,RD/BSA,0,0
60124,index,0,0
60125,(,0,0
60126,p,0,0
60127,=,0,0
60128,0.012,0,0
60129,),0,0
60130,",",0,0
60131,and,0,0
60132,sheath,0,1
60133,outer,0,0
60134,diameter,0,0
60135,(,0,0
60136,OD,0,1
60137,),0,1
60138,/RD,0,1
60139,index,0,0
60140,(,0,0
60141,p,0,0
60142,=,0,0
60143,0.024,0,0
60144,),0,0
60145,.,0,0
60146,CONCLUSION,0,0
60147,In,0,0
60148,this,0,0
60149,prospective,0,0
60150,",",0,0
60151,randomized,0,0
60152,trial,0,0
60153,",",0,0
60154,the,0,0
60155,addition,0,0
60156,of,0,0
60157,a,0,0
60158,direct,1,0
60159,nitric,1,1
60160,oxide,1,1
60161,donor,1,0
60162,to,0,0
60163,nitroglycerin,1,1
60164,in,0,0
60165,an,0,0
60166,antispastic,0,1
60167,cocktail,0,1
60168,did,0,0
60169,not,0,0
60170,reduce,0,0
60171,the,0,0
60172,risk,0,0
60173,of,0,0
60174,spasm,0,0
60175,",",0,0
60176,and,0,0
60177,the,0,0
60178,use,0,0
60179,of,0,0
60180,nitroglycerin,1,1
60181,was,0,0
60182,found,0,0
60183,to,0,0
60184,be,0,0
60185,as,0,0
60186,effective,0,0
60187,as,0,0
60188,nitroprusside,1,1
60189,.,1,0
60190,Also,0,0
60191,",",0,0
60192,morphometric,0,0
60193,and,0,0
60194,mechanical,0,0
60195,factors,0,0
60196,play,0,0
60197,a,0,0
60198,significant,0,0
60199,role,0,0
60200,in,0,0
60201,predicting,0,0
60202,the,0,0
60203,occurrence,0,0
60204,of,0,0
60205,radial,0,0
60206,spasm,0,0
60207,.,0,0
60208,The,0,0
60209,sex,0,0
60210,of,0,0
60211,the,0,0
60212,patient,0,0
60213,",",0,0
60214,presence,0,0
60215,of,0,0
60216,diabetes,0,0
60217,",",0,0
60218,body,0,0
60219,surface,0,0
60220,area,0,0
60221,and,0,0
60222,smoking,0,1
60223,history,0,0
60224,appeared,0,0
60225,to,0,0
60226,play,0,0
60227,no,0,0
60228,role,0,0
60229,in,0,0
60230,predicting,0,0
60231,the,0,0
60232,occurrence,0,0
60233,of,0,0
60234,radial,0,0
60235,spasm,0,0
60236,.,0,0
60237,[,0,0
60238,Rapidity,0,0
60239,of,0,0
60240,pain,0,0
60241,relief,0,0
60242,",",0,0
60243,medication,0,1
60244,requirement,0,0
60245,and,0,0
60246,patient,0,0
60247,satisfaction,0,0
60248,with,0,0
60249,reflux,0,0
60250,treatment,0,0
60251,in,0,0
60252,the,0,0
60253,physician,0,0
60254,'s,0,0
60255,office,0,0
60256,],0,0
60257,.,0,0
60258,Treatment,0,0
60259,of,0,0
60260,gastroesophageal,0,0
60261,reflux,0,0
60262,disease,0,0
60263,(,0,0
60264,GERD,0,1
60265,),0,0
60266,with,0,0
60267,proton,1,1
60268,pump,1,1
60269,inhibitors,1,1
60270,was,0,0
60271,investigated,0,0
60272,in,0,0
60273,three,0,0
60274,controlled,0,0
60275,prospective,0,0
60276,",",0,0
60277,randomized,0,0
60278,open,0,0
60279,studies,0,0
60280,.,0,0
60281,Lansoprazole,1,1
60282,",",1,0
60283,omeprazole,1,1
60284,MUPS,1,1
60285,and,1,0
60286,esomeprazole,1,1
60287,were,0,0
60288,compared,0,0
60289,under,0,0
60290,doctor,0,0
60291,'s,0,0
60292,office,0,0
60293,conditions,0,0
60294,.,0,0
60295,The,0,0
60296,outcomes,0,0
60297,of,0,0
60298,interest,0,0
60299,were,0,0
60300,the,0,0
60301,rapidity,0,0
60302,of,0,0
60303,pain,0,0
60304,relief,0,0
60305,achieved,0,0
60306,with,0,0
60307,a,0,0
60308,single,0,0
60309,dose,0,0
60310,",",0,0
60311,effectiveness,0,0
60312,and,0,0
60313,patient,0,0
60314,satisfaction,0,0
60315,with,0,0
60316,on,0,0
60317,demand,0,0
60318,therapy,0,1
60319,.,0,0
60320,In,0,0
60321,the,0,0
60322,first,0,0
60323,study,0,0
60324,",",0,0
60325,180,0,0
60326,patients,0,0
60327,with,0,0
60328,chronic,0,0
60329,and,0,0
60330,prolonged,0,0
60331,episodes,0,0
60332,of,0,0
60333,reflux,0,0
60334,were,0,0
60335,investigated,0,0
60336,.,0,0
60337,Time,0,0
60338,to,0,0
60339,pain,0,0
60340,relief,0,0
60341,following,0,0
60342,a,0,0
60343,single,0,0
60344,dose,0,0
60345,was,0,0
60346,1.1,0,0
60347,+/-,0,0
60348,0.8,0,0
60349,hours,0,0
60350,with,0,0
60351,30,0,0
60352,mg,0,0
60353,lansoprazole,1,1
60354,",",0,0
60355,3.0,0,0
60356,+/-,0,0
60357,2.5,0,0
60358,hours,0,0
60359,with,0,0
60360,20,0,0
60361,mgomeprazole,1,1
60362,MUPS,0,0
60363,and,0,0
60364,2.1,0,0
60365,+/-,0,0
60366,1.2,0,0
60367,hours,0,0
60368,with,0,0
60369,40,0,0
60370,mg,0,0
60371,esomeprazole,1,1
60372,.,1,0
60373,Studies,0,0
60374,2,0,0
60375,and,0,0
60376,3,0,0
60377,were,0,0
60378,designed,0,0
60379,as,0,0
60380,cross-over,0,0
60381,studies,0,0
60382,intended,0,0
60383,to,0,0
60384,investigate,0,0
60385,drug,0,0
60386,consumption,0,0
60387,.,0,0
60388,In,0,0
60389,study,0,0
60390,2,0,0
60391,",",0,0
60392,the,0,0
60393,amount,0,0
60394,of,0,0
60395,lansoprazole,1,1
60396,consumed,0,0
60397,was,0,0
60398,approximately,0,0
60399,50,0,0
60400,%,0,0
60401,less,0,0
60402,than,0,0
60403,that,0,0
60404,of,0,0
60405,omeprazole,1,1
60406,",",0,0
60407,and,0,0
60408,this,0,0
60409,translated,0,0
60410,to,0,0
60411,81,0,0
60412,%,0,0
60413,patient,0,0
60414,satisfaction,0,0
60415,with,0,0
60416,lansoprazole,1,1
60417,compared,0,0
60418,with,0,0
60419,only,0,0
60420,9.5,0,0
60421,%,0,0
60422,for,0,0
60423,omeprazole,1,1
60424,.,1,0
60425,In,0,0
60426,study,0,0
60427,3,0,0
60428,comparing,0,0
60429,lansoprazole,0,1
60430,and,0,0
60431,esomeprazole,1,1
60432,",",0,0
60433,consumption,0,0
60434,of,0,0
60435,the,0,0
60436,former,0,0
60437,was,0,0
60438,85,0,0
60439,%,0,0
60440,that,0,0
60441,of,0,0
60442,the,0,0
60443,latter,0,0
60444,.,0,0
60445,58,0,0
60446,%,0,0
60447,of,0,0
60448,the,0,0
60449,patients,0,0
60450,opted,0,0
60451,to,0,0
60452,continuetreatment,0,0
60453,with,0,0
60454,lansoprazole,1,1
60455,",",0,0
60456,compared,0,0
60457,with,0,0
60458,only,0,0
60459,25,0,0
60460,%,0,0
60461,in,0,0
60462,the,0,0
60463,case,0,0
60464,of,0,0
60465,esomeprazole,1,1
60466,.,0,0
60467,The,0,0
60468,appreciably,0,0
60469,greater,0,0
60470,patient,0,0
60471,satisfaction,0,0
60472,with,0,0
60473,lansoprazole,1,1
60474,was,0,0
60475,due,0,0
60476,tothe,0,0
60477,faster,0,0
60478,pain,0,0
60479,relief,0,0
60480,achieved,0,0
60481,with,0,0
60482,this,0,0
60483,drug,0,0
60484,.,0,0
60485,Clinical,0,0
60486,evaluation,0,0
60487,of,0,0
60488,the,0,0
60489,intraoral,1,1
60490,fluoride,1,1
60491,releasing,1,1
60492,system,1,0
60493,in,0,0
60494,radiation-induced,0,0
60495,xerostomic,0,0
60496,subjects,0,0
60497,.,0,0
60498,Part,0,0
60499,2,0,0
60500,:,0,0
60501,Phase,0,0
60502,I,0,0
60503,study,0,0
60504,.,0,0
60505,Radiation-induced,0,0
60506,xerostomia,0,0
60507,can,0,0
60508,result,0,0
60509,in,0,0
60510,the,0,0
60511,rapid,0,0
60512,onset,0,0
60513,and,0,0
60514,progression,0,0
60515,of,0,0
60516,dental,0,0
60517,caries,0,0
60518,in,0,0
60519,head,0,0
60520,and,0,0
60521,neck,0,0
60522,cancer,0,0
60523,patients,0,0
60524,.,0,0
60525,Topically,0,0
60526,applied,0,0
60527,fluorides,0,1
60528,have,0,0
60529,been,0,0
60530,successfully,0,0
60531,used,0,0
60532,to,0,0
60533,inhibit,0,0
60534,the,0,0
60535,formation,0,0
60536,of,0,0
60537,dental,0,0
60538,caries,0,0
60539,in,0,0
60540,this,0,0
60541,population,0,0
60542,.,0,0
60543,However,0,0
60544,",",0,0
60545,because,0,0
60546,intensive,0,1
60547,daily,0,1
60548,self-application,0,1
60549,is,0,0
60550,required,0,0
60551,",",0,0
60552,compliance,0,0
60553,is,0,0
60554,an,0,0
60555,issue,0,0
60556,.,0,0
60557,The,0,0
60558,intraoral,1,0
60559,fluoride-releasing,1,1
60560,system,1,1
60561,(,1,0
60562,IFRS,1,1
60563,),1,0
60564,containing,1,1
60565,a,1,0
60566,sodium,1,1
60567,fluoride,1,1
60568,core,1,0
60569,is,0,0
60570,a,0,0
60571,newly,0,0
60572,developed,0,0
60573,",",0,0
60574,sustained-release,0,1
60575,",",0,0
60576,passive,0,1
60577,drug,0,0
60578,delivery,0,0
60579,system,0,0
60580,that,0,0
60581,does,0,0
60582,not,0,0
60583,require,0,0
60584,patient,0,0
60585,involvement,0,0
60586,except,0,0
60587,for,0,0
60588,periodic,0,1
60589,replacement,0,1
60590,",",0,0
60591,thus,0,0
60592,reducing,0,0
60593,the,0,0
60594,effect,0,0
60595,of,0,0
60596,patient,0,0
60597,compliance,0,0
60598,on,0,0
60599,its,0,0
60600,effectiveness,0,0
60601,in,0,0
60602,dental,0,0
60603,caries,0,0
60604,prevention,0,0
60605,.,0,0
60606,Twenty-two,0,0
60607,head,0,0
60608,and,0,0
60609,neck,0,0
60610,cancer,0,0
60611,patients,0,0
60612,from,0,0
60613,U.,0,0
60614,T.,0,0
60615,M.,0,0
60616,D.,0,0
60617,Anderson,0,0
60618,Cancer,0,0
60619,Center,0,0
60620,",",0,0
60621,with,0,0
60622,radiation-induced,0,0
60623,xerostomia,0,0
60624,",",0,0
60625,were,0,0
60626,entered,0,0
60627,into,0,0
60628,a,0,0
60629,pilot,0,0
60630,study,0,0
60631,to,0,0
60632,contrast,0,0
60633,the,0,0
60634,daily,0,1
60635,home,0,1
60636,use,0,0
60637,of,0,0
60638,a,0,0
60639,0.4,0,0
60640,%,0,0
60641,stannous,0,1
60642,fluoride-gel-containing,1,1
60643,tray,1,1
60644,(,0,0
60645,control,0,1
60646,group,0,0
60647,),0,0
60648,to,0,0
60649,IFRS,1,1
60650,(,0,0
60651,study,0,0
60652,group,0,0
60653,),0,0
60654,with,0,0
60655,respect,0,0
60656,to,0,0
60657,tolerability,0,0
60658,and,0,0
60659,adherence,0,0
60660,",",0,0
60661,and,0,0
60662,to,0,0
60663,obtain,0,0
60664,information,0,0
60665,on,0,0
60666,relative,0,0
60667,caries,0,0
60668,preventive,0,0
60669,efficacy,0,0
60670,.,0,0
60671,Participants,0,0
60672,were,0,0
60673,stratified,0,0
60674,on,0,0
60675,the,0,0
60676,basis,0,0
60677,of,0,0
60678,radiation,0,1
60679,exposure,0,0
60680,and,0,0
60681,randomly,0,0
60682,assigned,0,0
60683,to,0,0
60684,treatment,0,0
60685,with,0,0
60686,either,0,0
60687,IFRS,0,1
60688,or,0,0
60689,stannous,0,1
60690,fluoride,0,1
60691,gel,0,1
60692,.,0,0
60693,Patients,0,0
60694,in,0,0
60695,both,0,0
60696,groups,0,0
60697,were,0,0
60698,fitted,0,0
60699,with,0,0
60700,two,0,0
60701,IFRS,1,0
60702,retainers,1,1
60703,and,0,0
60704,also,0,0
60705,were,0,0
60706,instructed,0,0
60707,to,0,0
60708,use,0,0
60709,a,0,0
60710,1100-ppm,1,0
60711,fluoride,1,1
60712,conventional,1,1
60713,sodium,1,1
60714,fluoride,1,1
60715,dentifrice,1,1
60716,twice,1,0
60717,daily,1,0
60718,.,1,0
60719,The,0,0
60720,study,0,0
60721,was,0,0
60722,conducted,0,0
60723,as,0,0
60724,a,0,0
60725,single-blinded,0,0
60726,",",0,0
60727,parallel-cell,0,0
60728,trial,0,0
60729,.,0,0
60730,Pre-existing,0,0
60731,carious,0,0
60732,lesions,0,0
60733,were,0,0
60734,restored,0,0
60735,prior,0,0
60736,to,0,0
60737,the,0,0
60738,beginning,0,0
60739,of,0,0
60740,the,0,0
60741,study,0,0
60742,.,0,0
60743,The,0,0
60744,efficacy,0,0
60745,variable,0,0
60746,was,0,0
60747,determined,0,0
60748,by,0,0
60749,the,0,0
60750,mean,0,0
60751,number,0,0
60752,of,0,0
60753,new,0,0
60754,or,0,0
60755,recurrent,0,0
60756,decayed,0,0
60757,surfaces,0,0
60758,.,0,0
60759,Patients,0,0
60760,were,0,0
60761,examined,0,0
60762,for,0,0
60763,caries,0,0
60764,4,0,0
60765,",",0,0
60766,8,0,0
60767,",",0,0
60768,12,0,0
60769,",",0,0
60770,24,0,0
60771,",",0,0
60772,36,0,0
60773,",",0,0
60774,and,0,0
60775,48,0,0
60776,weeks,0,0
60777,after,0,0
60778,initiation,0,0
60779,of,0,0
60780,treatment,0,0
60781,.,0,0
60782,Reports,0,0
60783,of,0,0
60784,adverse,0,0
60785,reactions,0,0
60786,were,0,0
60787,based,0,0
60788,on,0,0
60789,information,0,0
60790,volunteered,0,0
60791,by,0,0
60792,patients,0,0
60793,and,0,0
60794,that,0,0
60795,were,0,0
60796,elicited,0,0
60797,during,0,0
60798,interviews,0,0
60799,.,0,0
60800,At,0,0
60801,baseline,0,0
60802,",",0,0
60803,the,0,0
60804,resting,0,0
60805,and,0,0
60806,stimulated,0,0
60807,salivary,0,0
60808,flow,0,0
60809,rates,0,0
60810,(,0,0
60811,g/5min,0,1
60812,),0,0
60813,were,0,0
60814,significantly,0,0
60815,greater,0,0
60816,in,0,0
60817,the,0,0
60818,control,0,0
60819,group,0,0
60820,than,0,0
60821,in,0,0
60822,the,0,0
60823,study,0,0
60824,group,0,0
60825,(,0,0
60826,p,0,0
60827,<,0,0
60828,0.05,0,0
60829,),0,0
60830,.,0,0
60831,Patients,0,0
60832,in,0,0
60833,the,0,0
60834,control,0,0
60835,group,0,0
60836,had,0,0
60837,received,0,0
60838,significantly,0,0
60839,more,0,0
60840,radiation,0,0
60841,than,0,0
60842,those,0,0
60843,in,0,0
60844,the,0,0
60845,test,0,0
60846,group,0,0
60847,(,0,0
60848,68Gy,0,0
60849,vs.,0,0
60850,60Gy,0,0
60851,;,0,0
60852,p=0.047,0,0
60853,),0,0
60854,.,0,0
60855,No,0,0
60856,marked,0,0
60857,differences,0,0
60858,in,0,0
60859,follow-up,0,0
60860,new,0,0
60861,and,0,0
60862,recurrent,0,0
60863,caries,0,0
60864,were,0,0
60865,found,0,0
60866,between,0,0
60867,the,0,0
60868,stannous,0,1
60869,fluoride,0,1
60870,gel,0,1
60871,control,0,1
60872,and,0,0
60873,IFRS,0,1
60874,groups,0,0
60875,during,0,0
60876,the,0,0
60877,study,0,0
60878,period,0,0
60879,.,0,0
60880,The,0,0
60881,rate,0,0
60882,of,0,0
60883,new,0,0
60884,or,0,0
60885,recurrent,0,0
60886,carious,0,0
60887,lesions,0,0
60888,in,0,0
60889,the,0,0
60890,group,0,0
60891,treated,0,0
60892,with,0,0
60893,the,0,0
60894,fluoride,0,1
60895,gel,0,1
60896,was,0,0
60897,slightly,0,0
60898,lower,0,0
60899,than,0,0
60900,in,0,0
60901,the,0,0
60902,IFRS,0,1
60903,group,0,0
60904,",",0,0
60905,based,0,0
60906,on,0,0
60907,carious,0,0
60908,lesions,0,0
60909,at,0,0
60910,the,0,0
60911,baseline,0,0
60912,examination,0,0
60913,(,0,0
60914,Poisson,0,0
60915,mean,0,0
60916,number,0,0
60917,of,0,0
60918,new,0,0
60919,or,0,0
60920,recurrent,0,0
60921,carious,0,0
60922,lesions,0,0
60923,for,0,0
60924,the,0,0
60925,control,0,0
60926,group=0.55,0,0
60927,per,0,0
60928,year,0,0
60929,vs.,0,0
60930,0.83,0,0
60931,per,0,0
60932,year,0,0
60933,for,0,0
60934,the,0,0
60935,study,0,0
60936,group,0,0
60937,",",0,0
60938,p=0.705,0,0
60939,;,0,0
60940,odds,0,0
60941,ratio,0,0
60942,of,0,0
60943,the,0,0
60944,occurrence,0,0
60945,of,0,0
60946,any,0,0
60947,new,0,0
60948,or,0,0
60949,recurrent,0,0
60950,caries,0,0
60951,during,0,0
60952,follow-up,0,0
60953,for,0,0
60954,control,0,0
60955,group,0,0
60956,vs.,0,0
60957,the,0,0
60958,study,0,0
60959,group=0.80,0,0
60960,;,0,0
60961,p=0.781,0,0
60962,),0,0
60963,.,0,0
60964,This,0,0
60965,pilot,0,0
60966,study,0,0
60967,revealed,0,0
60968,that,0,0
60969,the,0,0
60970,IFRS,0,0
60971,was,0,0
60972,well-tolerated,0,0
60973,and,0,0
60974,safe,0,0
60975,in,0,0
60976,this,0,0
60977,study,0,0
60978,population,0,0
60979,associated,0,0
60980,with,0,0
60981,minimal,0,0
60982,complications,0,0
60983,during,0,0
60984,the,0,0
60985,duration,0,0
60986,of,0,0
60987,this,0,0
60988,study,0,0
60989,and,0,0
60990,was,0,0
60991,comparable,0,0
60992,in,0,0
60993,efficacy,0,0
60994,to,0,0
60995,a,0,0
60996,SnF,0,0
60997,(,0,0
60998,2,0,0
60999,),0,0
61000,gel,0,1
61001,in,0,0
61002,preventing,0,0
61003,caries,0,0
61004,development,0,0
61005,.,0,0
61006,The,0,0
61007,IFRS,0,0
61008,provided,0,0
61009,similar,0,0
61010,rates,0,0
61011,of,0,0
61012,control,0,0
61013,for,0,0
61014,caries,0,0
61015,formation,0,0
61016,to,0,0
61017,a,0,0
61018,fluoride-gel-containing,0,1
61019,tray,0,1
61020,.,0,0
61021,The,0,0
61022,IFRS,0,0
61023,is,0,0
61024,designed,0,0
61025,to,0,0
61026,release,0,0
61027,a,0,0
61028,daily,0,0
61029,dose,0,0
61030,of,0,0
61031,0.12mg,0,0
61032,of,0,0
61033,sodium,1,1
61034,fluoride,1,1
61035,",",0,0
61036,which,0,0
61037,can,0,0
61038,be,0,0
61039,evenly,0,0
61040,distributed,0,0
61041,throughout,0,0
61042,the,0,0
61043,oral,0,1
61044,cavity,0,0
61045,for,0,0
61046,a,0,0
61047,single,0,0
61048,application,0,0
61049,of,0,0
61050,4,0,0
61051,months,0,0
61052,.,0,0
61053,It,0,0
61054,would,0,0
61055,be,0,0
61056,more,0,0
61057,convenient,0,0
61058,than,0,0
61059,the,0,0
61060,daily,0,1
61061,home,0,1
61062,application,0,0
61063,of,0,0
61064,a,0,0
61065,tray,0,1
61066,of,0,0
61067,0.4,0,0
61068,%,0,0
61069,stannous,0,1
61070,fluoride,0,1
61071,or,0,1
61072,1.1,0,0
61073,%,0,0
61074,sodium,0,1
61075,fluoride,0,1
61076,gel,0,1
61077,",",0,0
61078,and,0,0
61079,avoids,0,0
61080,the,0,0
61081,problem,0,0
61082,of,0,0
61083,variable,0,0
61084,patient,0,0
61085,compliance,0,0
61086,.,0,0
61087,Dexamethasone,1,1
61088,effectively,0,0
61089,reduces,0,0
61090,postoperative,0,0
61091,nausea,0,0
61092,and,0,0
61093,vomiting,0,0
61094,in,0,0
61095,a,0,0
61096,general,0,0
61097,surgical,0,0
61098,adult,0,0
61099,patient,0,0
61100,population,0,0
61101,.,0,0
61102,BACKGROUND,0,0
61103,Postoperative,0,0
61104,nausea,0,0
61105,and,0,0
61106,vomiting,0,0
61107,(,0,1
61108,PONV,0,0
61109,),0,1
61110,is,0,0
61111,still,0,0
61112,a,0,0
61113,common,0,0
61114,and,0,0
61115,major,0,0
61116,complication,0,0
61117,for,0,0
61118,surgical,0,0
61119,patients,0,0
61120,",",0,0
61121,which,0,0
61122,may,0,0
61123,delay,0,0
61124,post-anesthetic,0,0
61125,care,0,1
61126,unit,0,0
61127,discharge,0,0
61128,",",0,0
61129,prolong,0,0
61130,hospital,0,0
61131,stay,0,0
61132,and,0,0
61133,thus,0,0
61134,increase,0,0
61135,the,0,0
61136,cost,0,0
61137,of,0,0
61138,hospitalization,0,0
61139,.,0,0
61140,It,0,0
61141,is,0,0
61142,understood,0,0
61143,that,0,0
61144,PONV,0,0
61145,is,0,0
61146,a,0,0
61147,multi-factorial,0,0
61148,outcome,0,0
61149,and,0,0
61150,occurs,0,0
61151,more,0,0
61152,often,0,0
61153,with,0,0
61154,general,0,0
61155,anesthesia,0,1
61156,than,0,0
61157,with,0,0
61158,other,0,0
61159,anesthetic,0,0
61160,methods,0,0
61161,.,0,0
61162,Prophylactic,0,0
61163,administration,0,0
61164,of,0,0
61165,antihistamines,0,1
61166,",",0,0
61167,antidopaminergics,0,1
61168,",",0,0
61169,anticholinergics,0,1
61170,",",0,0
61171,phenothiazines,0,1
61172,",",0,0
61173,serotonin,0,1
61174,antagonist,0,1
61175,",",0,0
61176,steroids,0,1
61177,and,0,0
61178,even,0,0
61179,acupuncture,0,1
61180,has,0,0
61181,been,0,0
61182,shown,0,0
61183,to,0,0
61184,be,0,0
61185,effective,0,0
61186,.,0,0
61187,However,0,0
61188,",",0,0
61189,expenses,0,0
61190,and,0,0
61191,side,0,0
61192,effects,0,0
61193,of,0,0
61194,these,0,0
61195,agents,0,0
61196,have,0,0
61197,also,0,0
61198,been,0,0
61199,a,0,0
61200,concern,0,0
61201,for,0,0
61202,clinical,0,0
61203,doctors,0,0
61204,.,0,0
61205,The,0,0
61206,aim,0,0
61207,for,0,0
61208,this,0,0
61209,prospective,0,0
61210,study,0,0
61211,was,0,0
61212,to,0,0
61213,find,0,0
61214,an,0,0
61215,agent,0,0
61216,that,0,0
61217,is,0,0
61218,cost,0,0
61219,effective,0,0
61220,and,0,0
61221,side,0,0
61222,effect,0,0
61223,free,0,0
61224,(,0,0
61225,or,0,0
61226,at,0,0
61227,least,0,0
61228,with,0,0
61229,a,0,0
61230,low,0,0
61231,incidence,0,0
61232,of,0,0
61233,side,0,0
61234,effects,0,0
61235,),0,0
61236,for,0,0
61237,the,0,0
61238,prevention,0,0
61239,of,0,0
61240,PONV,0,0
61241,.,0,0
61242,METHODS,0,0
61243,A,0,0
61244,total,0,0
61245,of,0,0
61246,700,0,0
61247,adult,0,0
61248,surgical,0,0
61249,patients,0,0
61250,who,0,0
61251,planned,0,0
61252,to,0,0
61253,have,0,0
61254,surgery,0,0
61255,under,0,0
61256,general,0,0
61257,anesthesia,0,1
61258,were,0,0
61259,enrolled,0,0
61260,in,0,0
61261,this,0,0
61262,double-blinded,0,0
61263,",",0,0
61264,randomized,0,0
61265,and,0,0
61266,placebo-controlled,1,1
61267,study,0,0
61268,.,0,0
61269,Group,0,0
61270,P,0,0
61271,received,0,0
61272,the,0,0
61273,placebo,1,1
61274,(,0,0
61275,0.9,0,0
61276,%,0,0
61277,normal,1,0
61278,saline,1,1
61279,2,0,0
61280,ml,0,0
61281,),0,0
61282,and,0,0
61283,Group,0,0
61284,D,0,1
61285,received,0,0
61286,10,0,0
61287,mg,0,0
61288,dexamethasone,1,1
61289,intravenously,0,0
61290,right,0,0
61291,before,0,0
61292,the,0,0
61293,induction,0,0
61294,of,0,0
61295,anesthesia,0,1
61296,.,0,0
61297,RESULTS,0,0
61298,We,0,0
61299,found,0,0
61300,that,0,0
61301,during,0,0
61302,the,0,0
61303,postoperative,0,0
61304,period,0,0
61305,of,0,0
61306,1-8,0,0
61307,h,0,0
61308,",",0,0
61309,patients,0,0
61310,in,0,0
61311,Group,0,0
61312,D,0,0
61313,reported,0,0
61314,a,0,0
61315,lower,0,0
61316,incidence,0,0
61317,of,0,0
61318,PONV,0,0
61319,(,0,0
61320,24,0,0
61321,%,0,0
61322,),0,0
61323,than,0,0
61324,those,0,0
61325,in,0,0
61326,Group,0,0
61327,P,0,0
61328,(,0,0
61329,39,0,0
61330,%,0,0
61331,",",0,0
61332,p,0,0
61333,<,0,0
61334,0.001,0,0
61335,),0,0
61336,.,0,0
61337,Patients,0,0
61338,in,0,0
61339,Group,0,0
61340,D,0,0
61341,also,0,0
61342,requested,0,0
61343,less,0,0
61344,rescue,0,0
61345,anti-emetic,0,1
61346,(,0,0
61347,17,0,0
61348,%,0,0
61349,),0,0
61350,than,0,0
61351,those,0,0
61352,in,0,0
61353,Group,0,0
61354,P,0,0
61355,(,0,0
61356,30,0,0
61357,%,0,0
61358,",",0,0
61359,p,0,0
61360,<,0,0
61361,0.05,0,0
61362,),0,0
61363,.,0,0
61364,The,0,0
61365,same,0,0
61366,phenomenon,0,0
61367,was,0,0
61368,also,0,0
61369,noted,0,0
61370,in,0,0
61371,the,0,0
61372,8-to-24-hour,0,0
61373,interval,0,0
61374,(,0,0
61375,PONV,0,0
61376,4,0,0
61377,%,0,0
61378,vs.,0,0
61379,12,0,0
61380,%,0,0
61381,",",0,0
61382,p,0,0
61383,<,0,0
61384,0.05,0,0
61385,and,0,0
61386,rescue,0,0
61387,anti-emetic,0,1
61388,3,0,0
61389,%,0,0
61390,vs.,0,0
61391,9,0,0
61392,%,0,0
61393,",",0,0
61394,p,0,0
61395,<,0,0
61396,0.05,0,0
61397,in,0,0
61398,Group,0,0
61399,D,0,0
61400,vs.,0,0
61401,Group,0,0
61402,P,0,0
61403,",",0,0
61404,respectively,0,0
61405,.,0,0
61406,),0,0
61407,CONCLUSIONS,0,0
61408,We,0,0
61409,conclude,0,0
61410,that,0,0
61411,the,0,0
61412,prophylactic,0,1
61413,intravenous,0,1
61414,administration,0,0
61415,of,0,0
61416,10,0,0
61417,mg,0,0
61418,dexamethasone,0,1
61419,immediately,0,0
61420,before,0,0
61421,the,0,0
61422,induction,0,0
61423,of,0,0
61424,anesthesia,0,1
61425,is,0,0
61426,effective,0,0
61427,in,0,0
61428,preventing,0,0
61429,PONV,0,0
61430,in,0,0
61431,the,0,0
61432,general,0,0
61433,surgical,0,0
61434,adult,0,0
61435,patient,0,0
61436,population,0,0
61437,.,0,0
61438,Intermittent,1,0
61439,recombinant,1,1
61440,growth,1,0
61441,hormone,1,1
61442,treatment,1,0
61443,in,0,0
61444,short,0,0
61445,children,0,0
61446,born,0,0
61447,small,0,0
61448,for,0,0
61449,gestational,0,0
61450,age,0,0
61451,:,0,0
61452,four-year,0,0
61453,results,0,0
61454,of,0,0
61455,a,0,0
61456,randomized,0,0
61457,trial,0,0
61458,of,0,0
61459,two,0,0
61460,different,0,0
61461,treatment,0,0
61462,regimens,0,0
61463,.,0,0
61464,BACKGROUND,0,0
61465,Treatment,0,0
61466,of,0,0
61467,short,0,0
61468,children,0,0
61469,born,0,0
61470,small,0,0
61471,for,0,0
61472,gestational,0,0
61473,age,0,0
61474,SGA,0,0
61475,with,0,0
61476,recombinant,1,1
61477,human,1,0
61478,growth,1,0
61479,hormone,1,1
61480,r-hGH,1,0
61481,increases,0,0
61482,growth,0,0
61483,velocity,0,0
61484,during,0,0
61485,childhood,0,0
61486,.,0,0
61487,As,0,0
61488,in,0,0
61489,other,0,0
61490,indications,0,0
61491,",",0,0
61492,the,0,0
61493,growth,0,0
61494,velocity,0,0
61495,in,0,0
61496,these,0,0
61497,patients,0,0
61498,is,0,0
61499,more,0,0
61500,marked,0,0
61501,during,0,0
61502,the,0,0
61503,first,0,0
61504,year,0,0
61505,of,0,0
61506,treatment,0,0
61507,and,0,0
61508,then,0,0
61509,decreases,0,0
61510,.,0,0
61511,This,0,0
61512,study,0,0
61513,was,0,0
61514,undertaken,0,0
61515,to,0,0
61516,evaluate,0,0
61517,the,0,0
61518,efficacy,0,0
61519,of,0,0
61520,different,0,0
61521,r-hGH,1,0
61522,treatment,1,0
61523,schedules,0,1
61524,(,0,0
61525,67,0,0
61526,microg/kg/day,0,0
61527,in,0,0
61528,a,0,0
61529,discontinuous,0,0
61530,or,0,0
61531,continuous,0,1
61532,regimen,0,1
61533,),0,0
61534,during,0,0
61535,the,0,0
61536,second,0,0
61537,year,0,0
61538,of,0,0
61539,r-hGH,0,0
61540,treatment,0,0
61541,by,0,0
61542,comparing,0,0
61543,height,0,0
61544,velocity,0,0
61545,changes,0,0
61546,and,0,0
61547,total,0,0
61548,gain,0,0
61549,of,0,0
61550,height,0,0
61551,over,0,0
61552,a,0,0
61553,4-year,0,0
61554,period,0,0
61555,.,0,0
61556,METHODS,0,0
61557,58,0,0
61558,growth-retarded,0,0
61559,SGA,0,0
61560,children,0,0
61561,aged,0,0
61562,2-5,0,0
61563,years,0,0
61564,were,0,0
61565,randomized,0,0
61566,to,0,0
61567,a,0,0
61568,TOTO,1,1
61569,regimen,1,1
61570,(,0,0
61571,4,0,0
61572,years,0,0
61573,alternating,0,1
61574,treatment,0,0
61575,(,0,1
61576,T,0,0
61577,),0,1
61578,and,0,0
61579,observation,0,1
61580,(,0,1
61581,O,0,0
61582,),0,0
61583,",",0,0
61584,n,0,0
61585,=,0,0
61586,30,0,0
61587,),0,0
61588,or,0,0
61589,a,0,0
61590,TTOO,0,0
61591,regimen,0,1
61592,(,0,0
61593,2,0,0
61594,years,0,0
61595,',0,0
61596,treatment,0,0
61597,",",0,0
61598,followed,0,0
61599,by,0,0
61600,2,0,0
61601,years,0,0
61602,',0,0
61603,observation,0,0
61604,",",0,0
61605,n,0,0
61606,=,0,0
61607,28,0,0
61608,),0,0
61609,.,0,0
61610,Height,0,0
61611,velocity,0,0
61612,HV,0,0
61613,and,0,0
61614,total,0,0
61615,height,0,0
61616,gain,0,0
61617,were,0,0
61618,assessed,0,0
61619,during,0,0
61620,the,0,0
61621,4-year,0,0
61622,study,0,0
61623,.,0,0
61624,RESULTS,0,0
61625,In,0,0
61626,both,0,0
61627,groups,0,0
61628,",",0,0
61629,HV,0,0
61630,and,0,0
61631,HV,0,0
61632,standard,0,1
61633,deviation,0,0
61634,score,0,0
61635,HV-SDSCA,0,1
61636,increased,0,0
61637,during,0,0
61638,treatment,0,0
61639,and,0,0
61640,decreased,0,0
61641,during,0,0
61642,observation,0,0
61643,periods,0,0
61644,.,0,0
61645,Interruption,0,0
61646,of,0,0
61647,treatment,0,0
61648,in,0,0
61649,the,0,0
61650,TOTO,0,1
61651,group,0,0
61652,did,0,0
61653,not,0,0
61654,result,0,0
61655,in,0,0
61656,a,0,0
61657,better,0,0
61658,gain,0,0
61659,in,0,0
61660,height,0,0
61661,standard,0,1
61662,deviation,0,0
61663,score,0,0
61664,H-SDSCA,0,0
61665,when,0,0
61666,compared,0,0
61667,with,0,0
61668,the,0,0
61669,TTOO,0,0
61670,group,0,0
61671,.,0,0
61672,After,0,0
61673,4,0,0
61674,years,0,0
61675,of,0,0
61676,study,0,0
61677,",",0,0
61678,the,0,0
61679,gain,0,0
61680,in,0,0
61681,H-SDSCA,0,0
61682,was,0,0
61683,1.4,0,0
61684,+,0,0
61685,or,0,0
61686,-,0,0
61687,01,0,0
61688,in,0,0
61689,the,0,0
61690,TOTO,0,1
61691,group,0,0
61692,and,0,0
61693,1.6,0,0
61694,+,0,0
61695,or,0,0
61696,-,0,0
61697,0.2,0,0
61698,in,0,0
61699,the,0,0
61700,TTOO,0,0
61701,group,0,0
61702,leading,0,0
61703,to,0,0
61704,a,0,0
61705,mean,0,0
61706,height,0,0
61707,of,0,0
61708,-2.0,0,0
61709,+,0,1
61710,or,0,0
61711,-,0,0
61712,1.0,0,0
61713,SDS,0,0
61714,and,0,0
61715,-2.0,0,1
61716,+,0,1
61717,or,0,0
61718,-,0,0
61719,0.8,0,0
61720,SDS,0,0
61721,",",0,0
61722,respectively,0,0
61723,.,0,0
61724,The,0,0
61725,rate,0,0
61726,of,0,0
61727,bone,0,0
61728,maturation,0,0
61729,was,0,0
61730,similar,0,0
61731,in,0,0
61732,the,0,0
61733,two,0,0
61734,groups,0,0
61735,.,0,0
61736,CONCLUSIONS,0,0
61737,In,0,0
61738,short,0,0
61739,SGA,0,0
61740,children,0,0
61741,",",0,0
61742,TOTO,1,1
61743,and,0,0
61744,TTOO,1,0
61745,regimens,0,1
61746,produced,0,0
61747,significant,0,0
61748,improvements,0,0
61749,in,0,0
61750,growth,0,0
61751,during,0,0
61752,r-hGH,1,0
61753,treatment,1,0
61754,.,0,0
61755,However,0,0
61756,",",0,0
61757,treatment,0,0
61758,interruption,0,0
61759,after,0,0
61760,1,0,0
61761,year,0,0
61762,did,0,0
61763,not,0,0
61764,influence,0,0
61765,the,0,0
61766,overall,0,0
61767,gain,0,0
61768,in,0,0
61769,height,0,0
61770,SDS,0,0
61771,when,0,0
61772,compared,0,0
61773,with,0,0
61774,2,0,0
61775,years,0,0
61776,',0,0
61777,continuous,0,0
61778,treatment,0,0
61779,.,0,0
61780,Paraesthesia,0,0
61781,during,0,0
61782,the,0,0
61783,needle-through-needle,1,1
61784,and,0,0
61785,the,0,0
61786,double,1,1
61787,segment,1,0
61788,technique,1,1
61789,for,0,0
61790,combined,0,0
61791,spinal,0,0
61792,epidural,0,1
61793,anaesthesia,0,1
61794,.,0,0
61795,Paraesthesia,0,0
61796,during,0,0
61797,regional,0,0
61798,anaesthesia,0,1
61799,is,0,0
61800,an,0,0
61801,unpleasant,0,0
61802,sensation,0,0
61803,for,0,0
61804,patients,0,0
61805,and,0,0
61806,",",0,0
61807,more,0,0
61808,importantly,0,0
61809,",",0,0
61810,in,0,0
61811,some,0,0
61812,cases,0,0
61813,it,0,0
61814,is,0,0
61815,related,0,0
61816,to,0,0
61817,neurological,0,0
61818,injury,0,0
61819,.,0,0
61820,Relatively,0,0
61821,few,0,0
61822,studies,0,0
61823,have,0,0
61824,been,0,0
61825,conducted,0,0
61826,on,0,0
61827,the,0,0
61828,frequency,0,0
61829,of,0,0
61830,paraesthesia,0,0
61831,during,0,0
61832,combined,0,0
61833,spinal,0,0
61834,epidural,0,1
61835,anaesthesia,0,1
61836,.,0,0
61837,We,0,0
61838,compared,0,0
61839,two,0,0
61840,combined,0,0
61841,spinal,1,0
61842,epidural,1,1
61843,anaesthesia,1,1
61844,techniques,0,1
61845,:,0,0
61846,the,1,0
61847,needle-through-needle,1,1
61848,technique,1,1
61849,and,1,0
61850,the,1,0
61851,double,1,1
61852,segment,1,0
61853,technique,1,1
61854,in,0,0
61855,this,0,0
61856,respect,0,0
61857,.,0,0
61858,We,0,0
61859,randomly,0,0
61860,allocated,0,0
61861,116,0,0
61862,parturients,0,0
61863,undergoing,0,0
61864,elective,0,0
61865,Caesarean,0,0
61866,section,0,0
61867,to,0,0
61868,receive,0,1
61869,anaesthesia,1,1
61870,using,0,0
61871,one,0,0
61872,of,0,0
61873,these,0,0
61874,techniques,0,1
61875,.,0,0
61876,Both,0,0
61877,techniques,0,0
61878,were,0,0
61879,performed,0,0
61880,using,0,0
61881,a,0,0
61882,27G,1,0
61883,pencil,1,1
61884,point,1,0
61885,needle,1,1
61886,",",1,0
61887,an,1,0
61888,18G,1,0
61889,Tuohy,1,0
61890,needle,1,1
61891,",",1,0
61892,and,1,0
61893,a,1,0
61894,20G,1,0
61895,multiport,1,1
61896,epidural,1,1
61897,catheter,1,1
61898,from,0,0
61899,the,0,0
61900,same,0,0
61901,manufacturer,0,0
61902,.,0,0
61903,The,0,0
61904,overall,0,0
61905,frequency,0,0
61906,of,0,0
61907,paraesthesia,0,0
61908,was,0,0
61909,higher,0,0
61910,in,0,0
61911,the,0,0
61912,needle-through-needle,1,1
61913,technique,1,1
61914,group,0,0
61915,(,0,0
61916,56.9,0,0
61917,%,0,0
61918,vs.,0,0
61919,31.6,0,0
61920,%,0,0
61921,",",0,0
61922,p,0,0
61923,=,0,0
61924,0.011,0,0
61925,),0,0
61926,.,0,0
61927,The,0,0
61928,frequency,0,0
61929,of,0,0
61930,paraesthesia,0,0
61931,at,0,0
61932,spinal,0,0
61933,needle,0,1
61934,insertion,0,1
61935,was,0,0
61936,20.7,0,0
61937,%,0,0
61938,in,0,0
61939,the,0,0
61940,needle-through-needle,1,1
61941,technique,0,1
61942,group,0,0
61943,and,0,0
61944,8.8,0,0
61945,%,0,0
61946,in,0,0
61947,the,0,0
61948,double,1,0
61949,segment,1,0
61950,technique,0,1
61951,group,0,0
61952,;,0,0
61953,whereas,0,0
61954,the,0,0
61955,frequency,0,0
61956,of,0,0
61957,paraesthesia,0,0
61958,at,0,0
61959,epidural,0,1
61960,catheter,0,1
61961,insertion,0,1
61962,was,0,0
61963,46.6,0,0
61964,%,0,0
61965,in,0,0
61966,the,0,0
61967,needle-through-needle,1,1
61968,technique,1,1
61969,group,0,0
61970,and,0,0
61971,24.6,0,0
61972,%,0,0
61973,in,0,0
61974,the,0,0
61975,double,1,0
61976,segment,1,0
61977,technique,0,1
61978,group,0,0
61979,.,0,0
61980,Factors,0,0
61981,that,0,0
61982,influence,0,0
61983,cancer,0,0
61984,patients,0,0
61985,',0,0
61986,anxiety,0,0
61987,following,0,0
61988,a,0,0
61989,medical,0,0
61990,consultation,0,0
61991,:,0,0
61992,impact,0,0
61993,of,0,0
61994,a,0,0
61995,communication,1,0
61996,skills,1,1
61997,training,1,1
61998,programme,1,0
61999,for,0,0
62000,physicians,0,0
62001,.,0,0
62002,BACKGROUND,0,0
62003,No,0,0
62004,study,0,0
62005,has,0,0
62006,yet,0,0
62007,assessed,0,0
62008,the,0,0
62009,impact,0,0
62010,of,0,0
62011,physicians,0,0
62012,',0,0
62013,skills,0,0
62014,acquisition,0,0
62015,after,0,0
62016,a,0,0
62017,communication,1,0
62018,skills,1,1
62019,training,1,1
62020,programme,1,0
62021,on,0,0
62022,the,0,0
62023,evolution,0,0
62024,of,0,0
62025,patients,0,0
62026,',0,0
62027,anxiety,0,0
62028,following,0,0
62029,a,0,0
62030,medical,0,0
62031,consultation,0,0
62032,.,0,0
62033,This,0,0
62034,study,0,0
62035,aimed,0,0
62036,to,0,0
62037,compare,0,0
62038,the,0,0
62039,impact,0,0
62040,",",0,0
62041,on,0,0
62042,patients,0,0
62043,',0,0
62044,anxiety,0,0
62045,",",0,0
62046,of,0,0
62047,a,0,0
62048,basic,1,1
62049,communication,1,0
62050,skills,1,1
62051,training,1,1
62052,programme,1,1
62053,(,1,1
62054,BT,1,1
62055,),1,0
62056,and,0,0
62057,the,0,0
62058,same,0,0
62059,programme,0,1
62060,consolidated,0,0
62061,by,0,0
62062,consolidation,1,0
62063,workshops,1,1
62064,(,0,0
62065,CW,0,1
62066,),0,0
62067,",",0,0
62068,and,0,0
62069,to,0,0
62070,investigate,0,0
62071,physicians,0,0
62072,',0,0
62073,communication,0,0
62074,variables,0,0
62075,associated,0,0
62076,with,0,0
62077,patients,0,0
62078,',0,0
62079,anxiety,0,0
62080,.,0,0
62081,PATIENTS,0,0
62082,AND,0,0
62083,METHODS,0,0
62084,Physicians,0,1
62085,",",0,0
62086,after,0,0
62087,attending,0,0
62088,the,0,0
62089,BT,1,1
62090,",",0,0
62091,were,0,0
62092,randomly,0,0
62093,assigned,0,0
62094,to,0,0
62095,CW,1,1
62096,or,0,0
62097,to,0,0
62098,a,0,0
62099,waiting,1,0
62100,list,1,0
62101,.,1,0
62102,The,0,0
62103,control,0,0
62104,group,0,0
62105,was,0,0
62106,not,0,0
62107,a,0,0
62108,non-intervention,0,0
62109,group,0,0
62110,.,0,0
62111,Consultations,0,0
62112,with,0,0
62113,a,0,0
62114,cancer,0,0
62115,patient,0,0
62116,were,0,0
62117,recorded,0,0
62118,.,0,0
62119,Patients,0,0
62120,',0,0
62121,anxiety,0,0
62122,was,0,0
62123,assessed,0,0
62124,with,0,0
62125,the,0,0
62126,State,0,1
62127,Trait,0,0
62128,Anxiety,0,0
62129,Inventory,0,0
62130,before,0,0
62131,and,0,0
62132,after,0,0
62133,a,0,0
62134,consultation,0,0
62135,.,0,0
62136,Communication,0,0
62137,skills,0,0
62138,were,0,0
62139,analysed,0,0
62140,according,0,0
62141,to,0,0
62142,the,0,0
62143,Cancer,0,0
62144,Research,0,0
62145,Campaign,0,0
62146,Workshop,0,1
62147,Evaluation,0,0
62148,Manual,0,0
62149,.,0,0
62150,RESULTS,0,0
62151,No,0,0
62152,statistically,0,0
62153,significant,0,0
62154,change,0,0
62155,over,0,0
62156,time,0,0
62157,and,0,0
62158,between,0,0
62159,groups,0,0
62160,was,0,0
62161,observed,0,0
62162,.,0,0
62163,Mixed-effects,0,0
62164,modelling,0,0
62165,showed,0,0
62166,that,0,0
62167,a,0,0
62168,decrease,0,0
62169,in,0,0
62170,patients,0,0
62171,',0,0
62172,anxiety,0,0
62173,was,0,0
62174,linked,0,0
62175,with,0,0
62176,screening,0,0
62177,questions,0,0
62178,(,0,0
62179,P,0,0
62180,=,0,0
62181,0.045,0,0
62182,),0,0
62183,",",0,0
62184,physicians,0,0
62185,',0,0
62186,satisfaction,0,0
62187,about,0,0
62188,support,0,1
62189,given,0,0
62190,(,0,0
62191,P,0,0
62192,=,0,0
62193,0.004,0,0
62194,),0,0
62195,and,0,0
62196,with,0,0
62197,patients,0,0
62198,',0,0
62199,distress,0,0
62200,(,0,0
62201,P,0,0
62202,<,0,0
62203,0.001,0,0
62204,),0,0
62205,.,0,0
62206,An,0,0
62207,increase,0,0
62208,in,0,0
62209,anxiety,0,0
62210,was,0,0
62211,linked,0,0
62212,with,0,0
62213,breaking,0,0
62214,bad,0,1
62215,news,0,0
62216,(,0,0
62217,P,0,0
62218,=,0,0
62219,0.050,0,0
62220,),0,0
62221,and,0,0
62222,with,0,0
62223,supportive,0,1
62224,skills,0,1
62225,(,0,0
62226,P,0,0
62227,=,0,0
62228,0.013,0,0
62229,),0,0
62230,.,0,0
62231,No,0,0
62232,impact,0,0
62233,of,0,0
62234,the,0,0
62235,training,0,1
62236,programme,0,1
62237,was,0,0
62238,observed,0,0
62239,.,0,0
62240,CONCLUSIONS,0,0
62241,This,0,0
62242,study,0,0
62243,shows,0,0
62244,the,0,0
62245,influence,0,0
62246,of,0,0
62247,some,0,0
62248,communication,0,0
62249,skills,0,0
62250,on,0,0
62251,the,0,0
62252,evolution,0,0
62253,of,0,0
62254,patients,0,0
62255,',0,0
62256,anxiety,0,0
62257,.,0,0
62258,Physicians,0,0
62259,should,0,0
62260,be,0,0
62261,aware,0,0
62262,of,0,0
62263,these,0,0
62264,influences,0,0
62265,.,0,0
62266,Randomized,0,0
62267,comparison,0,0
62268,of,0,0
62269,two,1,0
62270,communication,1,0
62271,interventions,1,0
62272,for,0,0
62273,preschoolers,0,0
62274,with,0,0
62275,autism,0,0
62276,spectrum,0,0
62277,disorders,0,0
62278,.,0,0
62279,This,0,0
62280,randomized,0,0
62281,group,0,0
62282,experiment,0,0
62283,compared,0,0
62284,the,0,0
62285,efficacy,0,0
62286,of,0,0
62287,2,1,0
62288,communication,1,0
62289,interventions,1,1
62290,(,1,0
62291,Responsive,1,1
62292,Education,1,1
62293,and,1,0
62294,Prelinguistic,1,1
62295,Milieu,1,1
62296,Teaching,1,0
62297,[,1,0
62298,RPMT,1,0
62299,],1,0
62300,and,1,0
62301,the,1,0
62302,Picture,1,0
62303,Exchange,1,1
62304,Communication,1,1
62305,System,1,0
62306,[,1,0
62307,PECS,1,0
62308,],1,0
62309,),1,0
62310,in,0,0
62311,36,0,0
62312,preschoolers,0,0
62313,with,0,0
62314,autism,0,0
62315,spectrum,0,0
62316,disorders,0,0
62317,.,0,0
62318,Each,0,0
62319,treatment,0,0
62320,was,0,0
62321,delivered,0,0
62322,3,0,0
62323,times,0,0
62324,per,0,0
62325,week,0,0
62326,",",0,0
62327,in,0,0
62328,20-min,0,1
62329,sessions,0,1
62330,",",0,0
62331,for,0,0
62332,6,0,0
62333,months,0,0
62334,.,0,0
62335,The,0,0
62336,results,0,0
62337,revealed,0,0
62338,that,0,0
62339,the,0,0
62340,RPMT,1,0
62341,facilitated,0,0
62342,the,0,0
62343,frequency,0,0
62344,of,0,0
62345,generalized,0,0
62346,turn,0,0
62347,taking,0,0
62348,and,0,0
62349,generalized,0,0
62350,initiating,0,0
62351,joint,0,0
62352,attention,0,0
62353,more,0,0
62354,than,0,0
62355,did,0,0
62356,the,0,0
62357,PECS,0,0
62358,.,0,0
62359,The,0,0
62360,latter,0,0
62361,effect,0,0
62362,occurred,0,0
62363,only,0,0
62364,for,0,0
62365,children,0,0
62366,who,0,0
62367,began,0,0
62368,treatment,0,0
62369,with,0,0
62370,at,0,0
62371,least,0,0
62372,some,0,0
62373,initiating,0,0
62374,joint,0,0
62375,attention,0,0
62376,.,0,0
62377,In,0,0
62378,contrast,0,0
62379,",",0,0
62380,the,0,0
62381,PECS,1,0
62382,facilitated,0,0
62383,generalized,0,0
62384,requests,0,0
62385,more,0,0
62386,than,0,0
62387,the,0,0
62388,RPMT,0,0
62389,in,0,0
62390,children,0,0
62391,with,0,0
62392,very,0,0
62393,little,0,0
62394,initiating,0,0
62395,joint,0,0
62396,attention,0,0
62397,prior,0,0
62398,to,0,0
62399,treatment,0,0
62400,.,0,0
62401,These,0,0
62402,effect,0,0
62403,sizes,0,0
62404,were,0,0
62405,large,0,0
62406,.,0,0
62407,Effects,0,0
62408,of,0,0
62409,single,0,0
62410,doses,0,0
62411,of,0,0
62412,rabeprazole,1,1
62413,20,0,0
62414,mg,0,1
62415,and,0,0
62416,esomeprazole,1,1
62417,40,0,0
62418,mg,0,0
62419,on,0,0
62420,24-h,0,1
62421,intragastric,0,1
62422,pH,0,0
62423,in,0,0
62424,healthy,0,0
62425,subjects,0,0
62426,.,0,0
62427,OBJECTIVE,0,0
62428,To,0,0
62429,compare,0,0
62430,antisecretory,0,0
62431,effects,0,0
62432,of,0,0
62433,single,0,0
62434,doses,0,0
62435,of,0,0
62436,rabeprazole,1,1
62437,and,0,0
62438,esomeprazole,1,1
62439,.,1,0
62440,METHODS,0,0
62441,Open,0,0
62442,",",0,0
62443,randomised,0,0
62444,",",0,0
62445,2-way,0,0
62446,crossover,0,0
62447,",",0,0
62448,clinical,0,0
62449,pharmacology,0,0
62450,study,0,0
62451,.,0,0
62452,24,0,0
62453,healthy,0,0
62454,subjects,0,0
62455,(,0,0
62456,10,0,0
62457,men,0,0
62458,;,0,0
62459,mean,0,0
62460,age,0,0
62461,26.2,0,0
62462,y,0,0
62463,),0,0
62464,received,0,0
62465,a,0,0
62466,single,0,0
62467,dose,0,0
62468,of,0,0
62469,rabeprazole,1,1
62470,20,1,0
62471,mg,1,1
62472,or,1,0
62473,esomeprazole,1,1
62474,40,1,0
62475,mg,1,0
62476,",",0,0
62477,with,0,0
62478,a,0,0
62479,14-day,0,0
62480,'washout,0,1
62481,',0,0
62482,.,0,0
62483,Intragastric,0,0
62484,pH,0,0
62485,was,0,0
62486,recorded,0,0
62487,continuously,0,0
62488,from,0,0
62489,24,0,0
62490,h,0,0
62491,before,0,0
62492,to,0,0
62493,24,0,0
62494,h,0,0
62495,after,0,0
62496,dosing,0,0
62497,.,0,0
62498,RESULTS,0,0
62499,Mean,0,0
62500,intragastric,0,1
62501,pH,0,0
62502,was,0,0
62503,higher,0,0
62504,after,0,0
62505,esomeprazole,1,1
62506,than,0,0
62507,rabeprazole,1,1
62508,during,0,0
62509,0-5,0,0
62510,h,0,0
62511,after,0,0
62512,dosing,0,0
62513,(,0,0
62514,P=0.0001,0,0
62515,),0,0
62516,;,0,0
62517,the,0,0
62518,reverse,0,0
62519,was,0,0
62520,true,0,0
62521,from,0,0
62522,14-24,0,0
62523,h,0,1
62524,(,0,0
62525,P=0.0002,0,0
62526,),0,0
62527,.,0,0
62528,Mean,0,0
62529,%,0,0
62530,time,0,0
62531,pH,0,0
62532,>,0,0
62533,3,0,0
62534,and,0,0
62535,>,0,0
62536,4,0,0
62537,was,0,0
62538,greater,0,0
62539,after,0,0
62540,esomeprazole,1,1
62541,than,0,0
62542,rabeprazole,1,1
62543,during,0,0
62544,0-14,0,0
62545,h,0,1
62546,(,0,0
62547,P=0.041,0,0
62548,and,0,0
62549,0.044,0,0
62550,),0,0
62551,",",0,0
62552,but,0,0
62553,the,0,0
62554,reverse,0,0
62555,was,0,0
62556,true,0,0
62557,during,0,0
62558,14-24,0,0
62559,h,0,1
62560,(,0,0
62561,P=0.0005,0,0
62562,and,0,0
62563,0.001,0,0
62564,),0,0
62565,.,0,0
62566,In,0,0
62567,the,0,0
62568,0-24,0,0
62569,h,0,0
62570,interval,0,0
62571,as,0,0
62572,a,0,0
62573,whole,0,0
62574,",",0,0
62575,there,0,0
62576,was,0,0
62577,no,0,0
62578,difference,0,0
62579,between,0,0
62580,treatments,0,0
62581,in,0,0
62582,mean,0,0
62583,pH,0,1
62584,or,0,1
62585,%,0,0
62586,time,0,0
62587,pH,0,0
62588,>,0,0
62589,3,0,0
62590,or,0,0
62591,>,0,0
62592,4,0,0
62593,.,0,0
62594,CONCLUSION,0,0
62595,Single-dose,0,0
62596,rabeprazole,1,1
62597,20,0,0
62598,mg,0,0
62599,was,0,0
62600,as,0,0
62601,effective,0,0
62602,as,0,0
62603,esomeprazole,1,1
62604,40,0,0
62605,mg,0,0
62606,in,0,0
62607,increasing,0,0
62608,intragastric,0,1
62609,pH,0,1
62610,and,0,0
62611,maintaining,0,0
62612,pH,0,0
62613,>,0,0
62614,3,0,0
62615,and,0,0
62616,>,0,0
62617,4,0,0
62618,",",0,0
62619,despite,0,0
62620,the,0,0
62621,2-fold,0,0
62622,difference,0,0
62623,in,0,0
62624,dose,0,0
62625,.,0,0
62626,Rotigotine,1,1
62627,transdermal,1,1
62628,patch,1,1
62629,enables,0,0
62630,rapid,0,0
62631,titration,0,0
62632,to,0,0
62633,effective,0,0
62634,doses,0,0
62635,in,0,0
62636,advanced-stage,0,0
62637,idiopathic,0,0
62638,Parkinson,0,0
62639,disease,0,0
62640,:,0,0
62641,subanalysis,0,0
62642,of,0,0
62643,a,0,0
62644,parallel,0,0
62645,group,0,0
62646,",",0,0
62647,open-label,0,0
62648,",",0,0
62649,dose-escalation,0,0
62650,study,0,0
62651,.,0,0
62652,OBJECTIVE,0,0
62653,Rotigotine,1,1
62654,(,1,0
62655,Neupro,1,1
62656,),1,1
62657,is,0,0
62658,formulated,0,0
62659,as,0,0
62660,a,0,0
62661,transdermal,0,1
62662,delivery,0,0
62663,system,0,1
62664,designed,0,0
62665,to,0,0
62666,provide,0,0
62667,a,0,0
62668,selective,0,0
62669,",",0,0
62670,non-ergot,0,0
62671,D3/D2/D1,0,1
62672,agonist,0,1
62673,to,0,0
62674,the,0,0
62675,systemic,0,0
62676,blood,0,0
62677,flow,0,0
62678,over,0,0
62679,a,0,0
62680,24-hour,0,0
62681,period,0,0
62682,.,0,0
62683,In,0,0
62684,clinical,0,0
62685,trials,0,0
62686,",",0,0
62687,patches,1,0
62688,were,1,0
62689,applied,1,0
62690,once,1,0
62691,daily,1,0
62692,and,1,0
62693,uptitrated,1,0
62694,to,1,0
62695,the,1,0
62696,individual,1,0
62697,effective,1,0
62698,dose,1,0
62699,in,1,0
62700,increments,1,0
62701,of,1,0
62702,2,1,0
62703,mg/24,1,0
62704,h,1,0
62705,every,1,0
62706,week,1,0
62707,.,1,0
62708,The,0,0
62709,aim,0,0
62710,of,0,0
62711,this,0,0
62712,analysis,0,0
62713,was,0,0
62714,to,0,0
62715,determine,0,0
62716,the,0,0
62717,safety,0,0
62718,of,0,0
62719,a,0,0
62720,more,0,0
62721,rapid,0,0
62722,titration,0,0
62723,of,0,0
62724,rotigotine,1,1
62725,by,0,0
62726,assessing,0,0
62727,the,0,0
62728,tolerability,0,0
62729,of,0,0
62730,escalating,0,0
62731,transdermal,0,1
62732,doses,0,0
62733,of,0,0
62734,rotigotine,1,1
62735,given,0,0
62736,in,0,0
62737,2,0,0
62738,different,0,0
62739,titration,0,0
62740,schemes,0,0
62741,.,0,0
62742,METHODS,0,0
62743,We,0,0
62744,analyzed,0,0
62745,the,0,0
62746,safety,0,0
62747,of,0,0
62748,rotigotine,1,1
62749,in,0,0
62750,2,0,0
62751,groups,0,0
62752,of,0,0
62753,patients,0,0
62754,with,0,0
62755,advanced,0,0
62756,stage,0,0
62757,Parkinson,0,0
62758,Disease,0,0
62759,.,0,0
62760,The,0,0
62761,starting,0,0
62762,dose,0,0
62763,of,0,0
62764,4,0,0
62765,mg/24,0,0
62766,h,0,0
62767,was,0,0
62768,increased,0,0
62769,every,0,0
62770,week,0,0
62771,by,0,0
62772,2,0,0
62773,mg/24,0,0
62774,h,0,0
62775,in,0,0
62776,the,0,0
62777,slow-titration,0,1
62778,group,0,0
62779,and,0,0
62780,4,0,0
62781,mg/24,0,0
62782,h,0,0
62783,in,0,0
62784,the,0,0
62785,fast-titration,0,0
62786,group,0,0
62787,.,0,0
62788,The,0,0
62789,primary,0,0
62790,focus,0,0
62791,of,0,0
62792,this,0,0
62793,subanalysis,0,0
62794,was,0,0
62795,the,0,0
62796,separate,0,0
62797,tolerability,0,0
62798,of,0,0
62799,rotigotine,1,1
62800,in,0,0
62801,each,0,0
62802,randomized,0,0
62803,treatment,0,0
62804,arm,0,0
62805,",",0,0
62806,during,0,0
62807,the,0,0
62808,dose-escalation,0,0
62809,period,0,0
62810,.,0,0
62811,However,0,0
62812,",",0,0
62813,the,0,0
62814,2,0,0
62815,titration,0,0
62816,schemes,0,0
62817,were,0,0
62818,also,0,0
62819,compared,0,0
62820,with,0,0
62821,each,0,0
62822,other,0,0
62823,.,0,0
62824,RESULTS,0,0
62825,The,0,0
62826,dose,0,0
62827,of,0,0
62828,first,0,0
62829,reported,0,0
62830,nausea,0,0
62831,and/or,0,0
62832,vomiting,0,0
62833,was,0,0
62834,8,0,0
62835,mg/24,0,0
62836,h,0,0
62837,for,0,0
62838,the,0,0
62839,fast-titration,0,0
62840,group,0,0
62841,and,0,0
62842,4,0,0
62843,mg/,0,1
62844,24,0,0
62845,h,0,0
62846,for,0,0
62847,the,0,0
62848,slow-titration,0,0
62849,group,0,0
62850,.,0,0
62851,There,0,0
62852,were,0,0
62853,no,0,0
62854,remarkable,0,0
62855,differences,0,0
62856,concerning,0,0
62857,the,0,0
62858,side-effect,0,0
62859,profile,0,0
62860,between,0,0
62861,the,0,0
62862,2,0,0
62863,different,0,0
62864,titration,0,0
62865,schemes,0,0
62866,.,0,0
62867,CONCLUSIONS,0,0
62868,The,0,0
62869,fast-titration,0,0
62870,regimen,0,0
62871,had,0,0
62872,a,0,0
62873,similar,0,0
62874,adverse,0,0
62875,event,0,0
62876,profile,0,0
62877,to,0,0
62878,slower,0,0
62879,titration,0,0
62880,",",0,0
62881,and,0,0
62882,allowed,0,0
62883,rotigotine,1,1
62884,to,0,0
62885,be,0,0
62886,introduced,0,0
62887,quickly,0,0
62888,.,0,0
62889,This,0,0
62890,subanalysis,0,0
62891,suggests,0,0
62892,that,0,0
62893,rotigotine,1,1
62894,may,0,0
62895,be,0,0
62896,uptitrated,0,0
62897,more,0,0
62898,rapidly,0,0
62899,.,0,0
62900,Divalproex,1,1
62901,versus,1,0
62902,placebo,1,1
62903,for,0,0
62904,the,0,0
62905,prevention,0,0
62906,of,0,0
62907,irritability,0,0
62908,associated,0,0
62909,with,0,0
62910,fluoxetine,1,1
62911,treatment,0,0
62912,in,0,0
62913,autism,0,0
62914,spectrum,0,0
62915,disorder,0,0
62916,.,0,0
62917,Efficacy,0,0
62918,and,0,0
62919,safety,0,0
62920,of,0,0
62921,zoledronic,1,1
62922,acid,1,1
62923,in,0,0
62924,patients,0,0
62925,with,0,0
62926,breast,0,0
62927,cancer,0,0
62928,metastatic,0,0
62929,to,0,0
62930,bone,0,0
62931,:,0,0
62932,a,0,0
62933,multicenter,0,0
62934,clinical,0,0
62935,trial,0,0
62936,.,0,0
62937,PURPOSE,0,0
62938,This,0,0
62939,study,0,0
62940,evaluated,0,0
62941,the,0,0
62942,efficacy,0,0
62943,and,0,0
62944,safety,0,0
62945,of,0,0
62946,zoledronic,1,1
62947,acid,1,1
62948,in,0,0
62949,breast,0,0
62950,cancer,0,0
62951,patients,0,0
62952,with,0,0
62953,newly,0,0
62954,diagnosed,0,0
62955,bone,0,0
62956,metastases,0,0
62957,.,0,0
62958,MATERIALS,0,0
62959,AND,0,0
62960,METHODS,0,0
62961,Patients,0,0
62962,diagnosed,0,0
62963,with,0,0
62964,bone,0,0
62965,metastases,0,0
62966,<,0,0
62967,or,0,0
62968,=,0,0
62969,6,0,0
62970,weeks,0,0
62971,prior,0,0
62972,to,0,0
62973,first,0,0
62974,visit,0,0
62975,were,0,0
62976,enrolled,0,0
62977,.,0,0
62978,Zoledronic,1,1
62979,acid,1,1
62980,(,0,0
62981,4,0,0
62982,mg,0,1
62983,),0,0
62984,was,0,0
62985,administered,0,0
62986,via,0,0
62987,a,0,0
62988,15-minute,0,1
62989,infusion,0,1
62990,every,0,1
62991,3,0,0
62992,or,0,0
62993,4,0,0
62994,weeks,0,0
62995,for,0,0
62996,12,0,0
62997,infusions,0,0
62998,.,0,0
62999,Skeletal-related,0,0
63000,events,0,0
63001,(,0,0
63002,SREs,0,0
63003,),0,0
63004,were,0,0
63005,defined,0,0
63006,as,0,0
63007,pathologic,0,0
63008,bone,0,0
63009,fractures,0,0
63010,",",0,0
63011,spinal,0,0
63012,cord,0,0
63013,compression,0,1
63014,",",0,0
63015,surgery,0,0
63016,to,0,0
63017,bone,0,0
63018,",",0,0
63019,radiation,0,1
63020,therapy,0,1
63021,to,0,0
63022,bone,0,0
63023,",",0,0
63024,and,0,0
63025,hypercalcemia,0,0
63026,of,0,0
63027,malignancy,0,0
63028,.,0,0
63029,Primary,0,0
63030,efficacy,0,0
63031,end,0,0
63032,points,0,0
63033,were,0,0
63034,the,0,0
63035,proportion,0,0
63036,of,0,0
63037,patients,0,0
63038,with,0,0
63039,at,0,0
63040,least,0,0
63041,one,0,0
63042,SRE,0,0
63043,and,0,0
63044,the,0,0
63045,time,0,0
63046,to,0,0
63047,first,0,0
63048,SRE,0,1
63049,.,0,0
63050,Secondary,0,0
63051,end,0,0
63052,points,0,0
63053,included,0,0
63054,pain,0,0
63055,",",0,0
63056,analgesic,0,0
63057,use,0,0
63058,",",0,0
63059,and,0,0
63060,quality,0,0
63061,of,0,0
63062,life,0,0
63063,.,0,0
63064,RESULTS,0,0
63065,Among,0,0
63066,312,0,0
63067,patients,0,0
63068,enrolled,0,0
63069,",",0,0
63070,30,0,0
63071,%,0,0
63072,experienced,0,0
63073,at,0,0
63074,least,0,0
63075,one,0,0
63076,SRE,0,0
63077,during,0,0
63078,the,0,0
63079,12-month,0,0
63080,study,0,0
63081,",",0,0
63082,and,0,0
63083,22,0,0
63084,%,0,0
63085,experienced,0,0
63086,only,0,0
63087,one,0,0
63088,SRE,0,0
63089,.,0,0
63090,The,0,0
63091,median,0,0
63092,time,0,0
63093,to,0,0
63094,first,0,0
63095,SRE,0,1
63096,was,0,0
63097,not,0,0
63098,reached,0,0
63099,in,0,0
63100,the,0,0
63101,intent-to-treat,0,0
63102,population,0,0
63103,.,0,0
63104,Mean,0,0
63105,pain,0,0
63106,and,0,0
63107,analgesic,0,0
63108,scores,0,0
63109,declined,0,0
63110,from,0,0
63111,baseline,0,0
63112,",",0,0
63113,and,0,0
63114,quality-of-life,0,0
63115,scores,0,0
63116,remained,0,0
63117,stable,0,0
63118,to,0,0
63119,study,0,0
63120,end,0,0
63121,.,0,0
63122,The,0,0
63123,most,0,0
63124,frequently,0,0
63125,reported,0,0
63126,adverse,0,0
63127,events,0,0
63128,",",0,0
63129,regardless,0,0
63130,of,0,0
63131,relationship,0,0
63132,to,0,0
63133,study,0,0
63134,drug,0,0
63135,",",0,0
63136,were,0,0
63137,pyrexia,0,0
63138,(,0,0
63139,22,0,0
63140,%,0,0
63141,),0,0
63142,and,0,0
63143,bone,0,1
63144,pain,0,0
63145,(,0,0
63146,10,0,0
63147,%,0,0
63148,),0,0
63149,.,0,0
63150,Serum,0,0
63151,creatinine,0,0
63152,levels,0,0
63153,did,0,0
63154,not,0,0
63155,significantly,0,0
63156,increase,0,0
63157,from,0,0
63158,baseline,0,0
63159,throughout,0,0
63160,the,0,0
63161,study,0,0
63162,.,0,0
63163,CONCLUSIONS,0,0
63164,Breast,0,0
63165,cancer,0,0
63166,patients,0,0
63167,with,0,0
63168,newly,0,0
63169,diagnosed,0,0
63170,bone,0,0
63171,metastases,0,0
63172,who,0,0
63173,were,0,0
63174,treated,0,0
63175,with,0,0
63176,zoledronic,1,1
63177,acid,1,1
63178,had,0,0
63179,a,0,0
63180,low,0,0
63181,incidence,0,0
63182,of,0,0
63183,SREs,0,0
63184,compared,0,0
63185,with,0,0
63186,patients,0,0
63187,who,0,0
63188,received,0,0
63189,placebo,1,1
63190,in,0,0
63191,randomized,0,0
63192,phase,0,0
63193,III,0,0
63194,trials,0,0
63195,",",0,0
63196,and,0,0
63197,pain,0,0
63198,was,0,0
63199,decreased,0,0
63200,from,0,0
63201,baseline,0,0
63202,.,0,0
63203,This,0,0
63204,study,0,0
63205,demonstrated,0,0
63206,the,0,0
63207,favorable,0,0
63208,risk,0,0
63209,:,0,0
63210,benefit,0,0
63211,ratio,0,0
63212,of,0,0
63213,zoledronic,1,1
63214,acid,1,1
63215,for,0,0
63216,the,0,0
63217,prevention,0,0
63218,of,0,0
63219,skeletal,0,0
63220,complications,0,0
63221,.,0,0
63222,Cardiac,0,0
63223,safety,0,0
63224,of,0,0
63225,formoterol,1,1
63226,12,0,0
63227,microg,0,0
63228,twice,0,0
63229,daily,0,0
63230,in,0,0
63231,patients,0,0
63232,with,0,0
63233,chronic,0,0
63234,obstructive,0,0
63235,pulmonary,0,0
63236,disease,0,0
63237,.,0,0
63238,BACKGROUND,0,0
63239,Some,0,0
63240,evidence,0,0
63241,suggests,0,0
63242,an,0,0
63243,increased,0,0
63244,risk,0,0
63245,of,0,0
63246,myocardial,0,0
63247,infarction,0,0
63248,and,0,0
63249,dysrhythmia,0,0
63250,events,0,0
63251,associated,0,0
63252,with,0,0
63253,beta,0,1
63254,(,0,0
63255,2,0,0
63256,),0,0
63257,-agonist,0,1
63258,use,0,0
63259,in,0,0
63260,patients,0,0
63261,with,0,0
63262,chronic,0,0
63263,obstructive,0,0
63264,pulmonary,0,0
63265,disease,0,0
63266,(,0,0
63267,COPD,0,0
63268,),0,0
63269,.,0,0
63270,This,0,0
63271,prospective,0,0
63272,",",0,0
63273,multicenter,0,0
63274,",",0,0
63275,randomized,0,0
63276,",",0,0
63277,double-blind,0,0
63278,",",0,0
63279,placebo-controlled,0,1
63280,study,0,0
63281,compared,0,0
63282,the,0,0
63283,cardiac,0,0
63284,safety,0,0
63285,of,0,0
63286,formoterol,1,1
63287,and,0,0
63288,placebo,1,1
63289,in,0,0
63290,patients,0,0
63291,with,0,0
63292,COPD,0,0
63293,.,0,0
63294,METHODS,0,0
63295,After,0,0
63296,a,0,0
63297,3-14-day,0,0
63298,run-in,0,0
63299,",",0,0
63300,204,0,0
63301,patients,0,0
63302,were,0,0
63303,randomized,0,0
63304,to,0,0
63305,receive,0,0
63306,formoterol,1,1
63307,12,1,0
63308,microg,1,0
63309,dry,1,0
63310,powder,1,1
63311,inhalation,1,1
63312,or,1,1
63313,matching,1,0
63314,placebo,1,1
63315,twice,1,0
63316,daily,1,0
63317,for,1,0
63318,8,1,0
63319,weeks,1,0
63320,.,1,0
63321,Twenty,1,0
63322,four-hour,1,0
63323,continuous,1,1
63324,electrocardiography,1,1
63325,(,1,0
63326,Holter,1,1
63327,monitoring,1,1
63328,),1,0
63329,was,0,0
63330,performed,0,0
63331,at,0,0
63332,screening,0,0
63333,and,0,0
63334,after,0,0
63335,2,0,0
63336,and,0,0
63337,8,0,0
63338,weeks,0,0
63339,of,0,0
63340,treatment,0,0
63341,.,0,0
63342,RESULTS,0,0
63343,Only,0,0
63344,a,0,0
63345,small,0,0
63346,number,0,0
63347,of,0,0
63348,patients,0,0
63349,met,0,0
63350,the,0,0
63351,predefined,0,0
63352,criteria,0,0
63353,for,0,0
63354,a,0,0
63355,proarrhythmic,0,0
63356,event,0,0
63357,(,0,0
63358,4,0,0
63359,formoterol,1,1
63360,and,0,0
63361,2,0,0
63362,placebo,1,1
63363,patients,0,0
63364,),0,0
63365,.,0,0
63366,No,0,0
63367,patients,0,0
63368,had,0,0
63369,sustained,0,0
63370,postbaseline,0,0
63371,ventricular,0,0
63372,tachycardia,0,0
63373,events,0,0
63374,",",0,0
63375,postbaseline,0,0
63376,run,0,0
63377,of,0,0
63378,ventricular,0,0
63379,ectopic,0,0
63380,beats,0,0
63381,associated,0,0
63382,with,0,0
63383,relevant,0,0
63384,symptoms,0,0
63385,(,0,0
63386,e.g,0,0
63387,.,0,0
63388,hypotension,0,0
63389,",",0,0
63390,syncope,0,0
63391,),0,0
63392,",",0,0
63393,or,0,0
63394,an,0,0
63395,episode,0,0
63396,of,0,0
63397,ventricular,0,0
63398,flutter,0,0
63399,or,0,1
63400,fibrillation,0,0
63401,.,0,0
63402,Holter,0,0
63403,monitoring,0,0
63404,data,0,0
63405,were,0,0
63406,variable,0,0
63407,but,0,0
63408,showed,0,0
63409,no,0,0
63410,clinically,0,0
63411,meaningful,0,0
63412,differences,0,0
63413,between,0,0
63414,the,0,0
63415,formoterol,0,1
63416,and,0,0
63417,placebo,0,1
63418,groups,0,0
63419,",",0,0
63420,respectively,0,0
63421,",",0,0
63422,for,0,0
63423,variables,0,0
63424,such,0,0
63425,as,0,0
63426,(,0,0
63427,mean+/-SD,0,0
63428,at,0,0
63429,end,0,0
63430,of,0,0
63431,treatment,0,0
63432,),0,0
63433,:,0,0
63434,heart,0,0
63435,rate,0,0
63436,(,0,0
63437,80+/-8.6,0,0
63438,vs.,0,0
63439,80+/-10.6,0,0
63440,bpm,0,0
63441,),0,0
63442,",",0,0
63443,number,0,0
63444,and,0,0
63445,rate,0,0
63446,of,0,0
63447,ventricular,0,0
63448,premature,0,0
63449,beats,0,1
63450,(,0,0
63451,total,0,0
63452,732+/-2685.4,0,0
63453,vs.,0,0
63454,650+/-2090.6,0,0
63455,;,0,0
63456,rate,0,0
63457,35+/-131.0,0,0
63458,vs.,0,0
63459,30+/-101.3,0,0
63460,per,0,0
63461,h,0,0
63462,),0,0
63463,",",0,0
63464,ventricular,0,0
63465,tachycardia,0,0
63466,events,0,0
63467,(,0,0
63468,total,0,0
63469,0.4+/-1.70,0,0
63470,vs.,0,0
63471,1.0+/-9.23,0,0
63472,;,0,0
63473,rate,0,0
63474,0.02+/-0.082,0,0
63475,vs.,0,0
63476,0.05+/-0.479,0,0
63477,per,0,0
63478,h,0,0
63479,),0,0
63480,",",0,0
63481,and,0,0
63482,supraventricular,0,0
63483,premature,0,0
63484,beats,0,1
63485,(,0,0
63486,total,0,0
63487,504+/-1844.1,0,0
63488,vs.,0,0
63489,823+/-2961.8,0,0
63490,;,0,0
63491,rate,0,0
63492,22+/-80.6,0,0
63493,vs.,0,0
63494,37+/-129.6,0,0
63495,per,0,0
63496,h,0,0
63497,),0,0
63498,.,0,0
63499,Vital,0,0
63500,signs,0,0
63501,and,0,0
63502,electrocardiogram,0,0
63503,data,0,0
63504,",",0,0
63505,including,0,0
63506,corrected,0,0
63507,QT,0,0
63508,intervals,0,0
63509,(,0,0
63510,Bazett,0,0
63511,and,0,0
63512,Fridericia,0,1
63513,),0,0
63514,",",0,0
63515,were,0,0
63516,similar,0,0
63517,across,0,0
63518,treatment,0,0
63519,groups,0,0
63520,.,0,0
63521,The,0,0
63522,overall,0,0
63523,adverse,0,0
63524,event,0,0
63525,experience,0,0
63526,was,0,0
63527,similar,0,0
63528,in,0,0
63529,the,0,0
63530,formoterol,0,1
63531,(,0,0
63532,n=26,0,0
63533,[,0,0
63534,27,0,0
63535,%,0,0
63536,],0,0
63537,),0,0
63538,and,0,0
63539,placebo,0,1
63540,(,0,0
63541,n=33,0,0
63542,[,0,0
63543,31,0,0
63544,%,0,0
63545,],0,0
63546,),0,0
63547,groups,0,0
63548,.,0,0
63549,The,0,0
63550,most,0,0
63551,common,0,0
63552,adverse,0,0
63553,events,0,0
63554,",",0,0
63555,infections,0,0
63556,and,0,0
63557,respiratory,0,0
63558,events,0,0
63559,",",0,0
63560,were,0,0
63561,expected,0,0
63562,for,0,0
63563,this,0,0
63564,patient,0,0
63565,population,0,0
63566,.,0,0
63567,The,0,0
63568,incidence,0,0
63569,of,0,0
63570,cardiac,0,0
63571,adverse,0,0
63572,events,0,0
63573,was,0,0
63574,low,0,0
63575,(,0,0
63576,1,0,0
63577,formoterol,0,1
63578,and,0,0
63579,4,0,0
63580,placebo,0,1
63581,patients,0,0
63582,),0,0
63583,.,0,0
63584,CONCLUSIONS,0,0
63585,The,0,0
63586,results,0,0
63587,of,0,0
63588,this,0,0
63589,study,0,0
63590,confirm,0,0
63591,the,0,0
63592,good,0,0
63593,cardiovascular,0,0
63594,safety,0,0
63595,profile,0,0
63596,of,0,0
63597,formoterol,0,1
63598,in,0,0
63599,patients,0,0
63600,with,0,0
63601,COPD,0,0
63602,.,0,0
63603,Virtual,1,1
63604,reality,1,1
63605,exposure,1,0
63606,therapy,1,1
63607,and,1,0
63608,standard,1,1
63609,(,1,0
63610,in,1,0
63611,vivo,1,0
63612,),1,0
63613,exposure,1,0
63614,therapy,1,1
63615,in,0,0
63616,the,0,0
63617,treatment,0,0
63618,of,0,0
63619,fear,0,0
63620,of,0,0
63621,flying,0,0
63622,.,0,0
63623,This,0,0
63624,controlled,0,0
63625,clinical,0,0
63626,trial,0,0
63627,tested,0,0
63628,virtual,1,1
63629,reality,1,1
63630,exposure,1,0
63631,(,1,0
63632,VRE,1,1
63633,),1,0
63634,therapy,1,1
63635,for,0,0
63636,the,0,0
63637,fear,0,0
63638,of,0,0
63639,flying,0,1
63640,(,0,0
63641,FOF,0,1
63642,),0,0
63643,",",0,0
63644,a,0,0
63645,relatively,0,0
63646,new,0,0
63647,and,0,0
63648,innovative,0,0
63649,way,0,0
63650,to,0,0
63651,do,0,0
63652,exposure,0,0
63653,therapy,0,1
63654,",",0,0
63655,and,0,0
63656,compared,0,0
63657,it,0,0
63658,to,0,0
63659,standard,1,1
63660,(,1,0
63661,in,1,0
63662,vivo,1,0
63663,),1,0
63664,exposure,1,0
63665,therapy,1,1
63666,(,1,0
63667,SE,1,1
63668,),1,0
63669,and,0,0
63670,a,0,0
63671,wait,0,1
63672,list,0,0
63673,(,0,0
63674,WL,0,1
63675,),0,0
63676,control,0,0
63677,with,0,0
63678,a,0,0
63679,6-,0,1
63680,and,0,0
63681,12-month,0,0
63682,follow-up,0,0
63683,.,0,0
63684,Eighty-three,0,0
63685,participants,0,0
63686,with,0,0
63687,FOF,0,1
63688,were,0,0
63689,randomly,0,0
63690,assigned,0,0
63691,to,0,0
63692,VRE,0,1
63693,",",0,0
63694,SE,0,1
63695,",",0,0
63696,or,0,0
63697,WL,0,0
63698,.,0,0
63699,Seventy-five,0,0
63700,participants,0,0
63701,",",0,0
63702,25,0,0
63703,per,0,0
63704,group,0,0
63705,",",0,0
63706,completed,0,0
63707,the,0,0
63708,study,0,0
63709,.,0,0
63710,Twenty-three,0,0
63711,WL,0,0
63712,participants,0,0
63713,completed,0,0
63714,randomly,0,0
63715,assigned,0,0
63716,treatment,0,0
63717,following,0,0
63718,the,0,0
63719,waiting,0,0
63720,period,0,0
63721,.,0,0
63722,Treatment,0,0
63723,consisted,0,0
63724,of,0,0
63725,4,1,0
63726,sessions,1,1
63727,of,1,0
63728,anxiety,1,0
63729,management,1,0
63730,training,1,1
63731,followed,1,0
63732,either,1,0
63733,by,1,0
63734,exposure,1,0
63735,to,1,0
63736,a,1,0
63737,virtual,1,1
63738,airplane,1,1
63739,(,1,0
63740,VRE,1,1
63741,),1,0
63742,or,1,0
63743,an,1,0
63744,actual,1,0
63745,airplane,1,0
63746,at,1,0
63747,the,1,0
63748,airport,1,0
63749,(,1,0
63750,SE,1,1
63751,),1,0
63752,conducted,0,0
63753,over,0,0
63754,6,0,0
63755,weeks,0,0
63756,.,0,0
63757,Results,0,0
63758,indicate,0,0
63759,that,0,0
63760,VRE,1,1
63761,was,0,0
63762,superior,0,0
63763,to,0,0
63764,WL,1,0
63765,on,0,0
63766,all,0,0
63767,measures,0,0
63768,",",0,0
63769,including,0,0
63770,willingness,0,0
63771,to,0,0
63772,fly,0,0
63773,on,0,0
63774,the,0,0
63775,posttreatment,0,0
63776,flight,0,1
63777,(,0,0
63778,76,0,0
63779,%,0,0
63780,for,0,0
63781,VRE,0,1
63782,and,0,0
63783,SE,0,1
63784,;,0,0
63785,20,0,0
63786,%,0,0
63787,for,0,0
63788,WL,0,0
63789,),0,0
63790,.,0,0
63791,VRE,1,0
63792,and,0,0
63793,SE,1,1
63794,were,0,0
63795,essentially,0,0
63796,equivalent,0,0
63797,on,0,0
63798,standardized,0,0
63799,questionnaires,0,1
63800,",",0,0
63801,willingness,0,0
63802,to,0,0
63803,fly,0,0
63804,",",0,0
63805,anxiety,0,0
63806,ratings,0,0
63807,during,0,0
63808,the,0,0
63809,flight,0,0
63810,",",0,0
63811,self-ratings,0,0
63812,of,0,0
63813,improvement,0,0
63814,",",0,0
63815,and,0,0
63816,patient,0,0
63817,satisfaction,0,0
63818,with,0,0
63819,treatment,0,0
63820,.,0,0
63821,Follow-up,0,0
63822,assessments,0,0
63823,at,0,0
63824,6,0,0
63825,and,0,0
63826,12,0,0
63827,months,0,0
63828,indicated,0,0
63829,that,0,0
63830,treatment,0,0
63831,gains,0,0
63832,were,0,0
63833,maintained,0,0
63834,",",0,0
63835,with,0,0
63836,more,0,0
63837,than,0,0
63838,70,0,0
63839,%,0,0
63840,of,0,0
63841,respondents,0,0
63842,from,0,0
63843,both,0,0
63844,groups,0,0
63845,reporting,0,0
63846,continued,0,0
63847,flying,0,1
63848,at,0,0
63849,follow-up,0,0
63850,.,0,0
63851,Based,0,0
63852,on,0,0
63853,these,0,0
63854,findings,0,0
63855,",",0,0
63856,the,0,0
63857,use,0,0
63858,of,0,0
63859,VRE,0,1
63860,in,0,0
63861,the,0,0
63862,treatment,0,0
63863,of,0,0
63864,FOF,0,1
63865,was,0,0
63866,supported,0,0
63867,in,0,0
63868,this,0,0
63869,controlled,0,0
63870,study,0,0
63871,",",0,0
63872,suggesting,0,0
63873,that,0,0
63874,experiences,0,0
63875,in,0,0
63876,the,0,0
63877,virtual,0,1
63878,world,0,0
63879,can,0,0
63880,change,0,0
63881,experiences,0,0
63882,in,0,0
63883,the,0,0
63884,real,0,0
63885,world,0,0
63886,.,0,0
63887,Risperidone,1,1
63888,in,0,0
63889,children,0,0
63890,with,0,0
63891,autism,0,0
63892,:,0,0
63893,randomized,0,0
63894,",",0,0
63895,placebo-controlled,0,1
63896,",",0,0
63897,double-blind,0,0
63898,study,0,0
63899,.,0,0
63900,Some,0,0
63901,open-label,0,0
63902,studies,0,0
63903,suggest,0,0
63904,that,0,0
63905,risperidone,1,1
63906,can,0,0
63907,be,0,0
63908,useful,0,0
63909,in,0,0
63910,the,0,0
63911,treatment,0,0
63912,of,0,0
63913,certain,0,0
63914,target,0,0
63915,symptoms,0,0
63916,in,0,0
63917,children,0,0
63918,with,0,0
63919,autism,0,0
63920,.,0,0
63921,We,0,0
63922,aimed,0,0
63923,to,0,0
63924,study,0,0
63925,whether,0,0
63926,the,0,0
63927,use,0,0
63928,of,0,0
63929,risperidone,1,1
63930,in,0,0
63931,comparison,0,0
63932,with,0,0
63933,placebo,1,1
63934,improved,0,0
63935,functioning,0,0
63936,in,0,0
63937,children,0,0
63938,with,0,0
63939,autism,0,0
63940,with,0,0
63941,regard,0,0
63942,to,0,0
63943,behavior,0,0
63944,(,0,0
63945,aggressiveness,0,0
63946,",",0,0
63947,hyperactivity,0,0
63948,",",0,0
63949,irritability,0,0
63950,),0,0
63951,",",0,0
63952,social,0,0
63953,and,0,0
63954,emotional,0,0
63955,responsiveness,0,0
63956,",",0,0
63957,and,0,0
63958,communication,0,0
63959,skills,0,0
63960,.,0,0
63961,We,0,0
63962,conducted,0,0
63963,a,0,0
63964,randomized,0,0
63965,",",0,0
63966,double-blind,0,0
63967,",",0,0
63968,placebo-controlled,1,1
63969,trial,0,0
63970,with,0,0
63971,40,0,0
63972,consecutive,0,0
63973,children,0,0
63974,with,0,0
63975,autism,0,0
63976,",",0,0
63977,whose,0,0
63978,ages,0,0
63979,ranged,0,0
63980,from,0,0
63981,2,0,0
63982,to,0,0
63983,9,0,0
63984,years,0,0
63985,",",0,0
63986,who,0,0
63987,were,0,0
63988,receiving,0,0
63989,either,0,0
63990,risperidone,1,1
63991,or,1,1
63992,placebo,1,1
63993,given,0,0
63994,orally,0,0
63995,at,0,0
63996,a,0,0
63997,dose,0,0
63998,of,0,0
63999,1,0,0
64000,mg/day,0,0
64001,for,0,0
64002,6,0,0
64003,months,0,0
64004,.,0,0
64005,Autism,0,0
64006,symptoms,0,0
64007,were,0,0
64008,monitored,0,0
64009,periodically,0,0
64010,.,0,0
64011,The,0,0
64012,outcome,0,0
64013,variables,0,0
64014,were,0,0
64015,total,0,0
64016,scores,0,0
64017,on,0,0
64018,the,0,0
64019,Childhood,0,0
64020,Autism,0,0
64021,Rating,0,0
64022,Scale,0,1
64023,(,0,0
64024,CARS,0,1
64025,),0,0
64026,and,0,0
64027,the,0,0
64028,Children,0,0
64029,'s,0,0
64030,Global,0,0
64031,Assessment,0,1
64032,Scale,0,1
64033,(,0,0
64034,CGAS,0,1
64035,),0,0
64036,after,0,0
64037,6,0,0
64038,months,0,0
64039,.,0,0
64040,Of,0,0
64041,the,0,0
64042,40,0,0
64043,children,0,0
64044,enrolled,0,0
64045,",",0,0
64046,39,0,0
64047,completed,0,0
64048,the,0,0
64049,trial,0,0
64050,over,0,0
64051,a,0,0
64052,period,0,0
64053,of,0,0
64054,18,0,0
64055,months,0,0
64056,;,0,0
64057,19,0,0
64058,received,0,0
64059,risperidone,1,1
64060,",",0,0
64061,and,0,0
64062,20,0,0
64063,received,0,0
64064,placebo,1,1
64065,.,1,0
64066,In,0,0
64067,the,0,0
64068,risperidone,1,1
64069,group,0,0
64070,",",0,0
64071,12,0,0
64072,of,0,0
64073,19,0,0
64074,children,0,0
64075,showed,0,0
64076,improvement,0,0
64077,in,0,0
64078,the,0,0
64079,total,0,0
64080,Childhood,0,0
64081,Autism,0,0
64082,Rating,0,0
64083,Scale,0,1
64084,score,0,0
64085,and,0,0
64086,17,0,0
64087,of,0,0
64088,19,0,0
64089,children,0,0
64090,in,0,0
64091,the,0,0
64092,Children,0,0
64093,'s,0,0
64094,Global,0,0
64095,Assessment,0,1
64096,Scale,0,0
64097,score,0,0
64098,compared,0,0
64099,with,0,0
64100,0,0,0
64101,of,0,0
64102,20,0,0
64103,children,0,0
64104,for,0,0
64105,the,0,0
64106,Childhood,0,0
64107,Autism,0,0
64108,Rating,0,0
64109,Scale,0,1
64110,score,0,0
64111,and,0,0
64112,2,0,0
64113,of,0,0
64114,20,0,0
64115,children,0,0
64116,for,0,0
64117,the,0,0
64118,Children,0,0
64119,'s,0,0
64120,Global,0,0
64121,Assessment,0,1
64122,Scale,0,0
64123,score,0,0
64124,in,0,0
64125,the,0,0
64126,placebo,1,1
64127,group,0,0
64128,(,0,0
64129,P,0,0
64130,<,0,0
64131,.001,0,0
64132,and,0,0
64133,P,0,0
64134,=,0,0
64135,.035,0,0
64136,",",0,0
64137,respectively,0,0
64138,),0,0
64139,.,0,0
64140,Risperidone,1,1
64141,also,0,0
64142,improved,0,0
64143,social,0,0
64144,responsiveness,0,0
64145,and,0,0
64146,nonverbal,0,0
64147,communication,0,0
64148,and,0,0
64149,reduced,0,0
64150,the,0,0
64151,symptoms,0,0
64152,of,0,0
64153,hyperactivity,0,0
64154,and,0,0
64155,aggression,0,0
64156,.,0,0
64157,Risperidone,1,1
64158,was,0,0
64159,associated,0,0
64160,with,0,0
64161,increased,0,0
64162,appetite,0,0
64163,and,0,0
64164,a,0,0
64165,mild,0,0
64166,weight,0,0
64167,gain,0,0
64168,",",0,0
64169,mild,0,0
64170,sedation,0,0
64171,in,0,0
64172,20,0,0
64173,%,0,0
64174,",",0,0
64175,and,0,0
64176,transient,0,0
64177,dyskinesias,0,0
64178,in,0,0
64179,three,0,0
64180,children,0,0
64181,.,0,0
64182,Risperidone,1,1
64183,improved,0,0
64184,global,0,0
64185,functioning,0,0
64186,and,0,0
64187,social,0,1
64188,responsiveness,0,0
64189,while,0,0
64190,reducing,0,0
64191,hyperactivity,0,0
64192,and,0,0
64193,aggression,0,0
64194,in,0,0
64195,children,0,0
64196,with,0,0
64197,autism,0,0
64198,and,0,0
64199,was,0,0
64200,well,0,0
64201,tolerated,0,0
64202,.,0,0
64203,Albumin-glutaraldehyde,1,1
64204,bioadhesive,1,1
64205,(,1,0
64206,Bioglue,1,1
64207,),1,0
64208,for,0,0
64209,prevention,0,0
64210,of,0,0
64211,postoperative,0,0
64212,complications,0,0
64213,after,0,0
64214,stapled,0,1
64215,hemorrhoidopexy,0,1
64216,:,0,0
64217,A,0,0
64218,randomized,0,0
64219,controlled,0,0
64220,trial,0,0
64221,.,0,0
64222,BACKGROUND,0,0
64223,Hemorrhoidopexy,0,1
64224,using,0,0
64225,the,0,0
64226,circumferential,0,0
64227,stapler,0,1
64228,is,0,0
64229,an,0,0
64230,established,0,0
64231,method,0,0
64232,for,0,0
64233,surgical,0,0
64234,treatment,0,0
64235,of,0,0
64236,patients,0,0
64237,with,0,0
64238,prolapsing,0,0
64239,hemorrhoids,0,0
64240,.,0,0
64241,Despite,0,0
64242,its,0,0
64243,advantages,0,0
64244,",",0,0
64245,complications,0,0
64246,such,0,0
64247,as,0,0
64248,anal,0,0
64249,canal,0,0
64250,stenosis,0,0
64251,",",0,0
64252,hemorrhage,0,0
64253,and,0,0
64254,anastomosis,0,0
64255,leak,0,0
64256,with,0,0
64257,eventual,0,0
64258,intrapelvic,0,0
64259,sepsis,0,0
64260,can,0,0
64261,cause,0,0
64262,serious,0,0
64263,postoperative,0,0
64264,problems,0,0
64265,.,0,0
64266,The,0,0
64267,aim,0,0
64268,of,0,0
64269,this,0,0
64270,study,0,0
64271,was,0,0
64272,to,0,0
64273,evaluate,0,0
64274,the,0,0
64275,utility,0,0
64276,of,0,0
64277,a,0,0
64278,surgical,0,0
64279,adhesive,0,1
64280,",",0,0
64281,the,0,0
64282,biological,1,0
64283,albumin-glutaraldehyde,1,1
64284,glue,1,1
64285,Bioglue,1,1
64286,",",0,0
64287,in,0,0
64288,reduction,0,0
64289,of,0,0
64290,these,0,0
64291,postoperative,0,0
64292,complications,0,0
64293,.,0,0
64294,PATIENTS,0,0
64295,AND,0,0
64296,METHODS,0,0
64297,Between,0,0
64298,January,0,0
64299,2002,0,0
64300,and,0,0
64301,November,0,0
64302,2004,0,0
64303,",",0,0
64304,200,0,0
64305,patients,0,0
64306,undergoing,0,0
64307,stapled,1,1
64308,hemorrhoidopexy,1,1
64309,were,0,0
64310,enrolled,0,0
64311,in,0,0
64312,a,0,0
64313,prospective,0,0
64314,",",0,0
64315,randomized,0,0
64316,clinical,0,0
64317,trial,0,0
64318,.,0,0
64319,One,0,0
64320,hundred,0,0
64321,patients,0,0
64322,were,0,0
64323,randomly,0,0
64324,assigned,0,0
64325,to,0,0
64326,the,0,0
64327,control,1,0
64328,group,1,0
64329,;,1,0
64330,the,0,0
64331,study,0,0
64332,group,0,0
64333,consisted,0,0
64334,of,0,0
64335,100,0,0
64336,patients,0,0
64337,who,0,0
64338,received,0,0
64339,Bioglue,1,1
64340,in,1,0
64341,the,1,0
64342,mucosa,1,0
64343,anastomosis,1,0
64344,area,1,0
64345,.,1,0
64346,All,0,0
64347,patients,0,0
64348,received,0,0
64349,standardized,1,0
64350,postoperative,1,0
64351,analgesic,1,0
64352,",",1,0
64353,laxative,1,1
64354,and,1,0
64355,antibiotic,1,1
64356,treatment,1,0
64357,.,1,0
64358,We,0,0
64359,then,0,0
64360,evaluated,0,0
64361,the,0,0
64362,two,0,0
64363,groups,0,0
64364,for,0,0
64365,postoperative,0,0
64366,complications,0,0
64367,(,0,0
64368,after,0,0
64369,surgery,0,1
64370,and,0,0
64371,6,0,0
64372,months,0,0
64373,postoperatively,0,0
64374,),0,0
64375,.,0,0
64376,RESULTS,0,0
64377,From,0,0
64378,the,0,0
64379,control,0,1
64380,group,0,0
64381,(,0,0
64382,no,0,0
64383,Bioglue,0,1
64384,application,0,1
64385,),0,0
64386,",",0,0
64387,two,0,0
64388,patients,0,0
64389,presented,0,0
64390,with,0,0
64391,anal,0,0
64392,stenosis,0,0
64393,",",0,0
64394,two,0,0
64395,with,0,0
64396,hemorrhage,0,0
64397,",",0,0
64398,three,0,0
64399,had,0,0
64400,anastomosis,0,0
64401,leak,0,0
64402,and,0,0
64403,one,0,0
64404,had,0,0
64405,thrombosis,0,0
64406,",",0,0
64407,whereas,0,0
64408,none,0,0
64409,of,0,0
64410,the,0,0
64411,patients,0,0
64412,from,0,0
64413,the,0,0
64414,Bioglue,0,1
64415,group,0,0
64416,had,0,0
64417,any,0,0
64418,of,0,0
64419,these,0,0
64420,complications,0,0
64421,.,0,0
64422,Both,0,0
64423,groups,0,0
64424,had,0,0
64425,patients,0,0
64426,with,0,0
64427,severe,0,0
64428,postoperative,0,0
64429,pain,0,0
64430,(,0,0
64431,3,0,0
64432,each,0,0
64433,),0,0
64434,and,0,0
64435,fecal,0,0
64436,incontinence,0,0
64437,(,0,0
64438,1,0,0
64439,patient,0,0
64440,each,0,0
64441,),0,0
64442,.,0,0
64443,The,0,0
64444,overall,0,0
64445,difference,0,0
64446,in,0,0
64447,the,0,0
64448,number,0,0
64449,of,0,0
64450,complications,0,0
64451,in,0,0
64452,the,0,0
64453,two,0,0
64454,groups,0,0
64455,was,0,0
64456,statistically,0,0
64457,significant,0,0
64458,(,0,0
64459,p,0,0
64460,<,0,0
64461,0.05,0,0
64462,),0,0
64463,.,0,0
64464,CONCLUSION,0,0
64465,In,0,0
64466,this,0,0
64467,first,0,0
64468,study,0,0
64469,using,0,0
64470,Bioglue,0,1
64471,in,0,0
64472,patients,0,0
64473,undergoing,0,0
64474,circumferential,0,0
64475,stapled,0,1
64476,hemorrhoidopexy,0,1
64477,we,0,0
64478,have,0,0
64479,shown,0,0
64480,that,0,0
64481,application,0,0
64482,of,0,0
64483,the,0,0
64484,glue,0,1
64485,is,0,0
64486,effective,0,0
64487,in,0,0
64488,reducing,0,0
64489,postoperative,0,0
64490,complications,0,0
64491,.,0,0
64492,Effectiveness,0,0
64493,of,0,0
64494,written,0,1
64495,guidelines,0,0
64496,on,0,0
64497,the,0,0
64498,appropriateness,0,0
64499,of,0,0
64500,thromboprophylaxis,1,1
64501,prescriptions,1,0
64502,for,0,0
64503,medical,0,0
64504,patients,0,0
64505,:,0,0
64506,a,0,0
64507,prospective,0,0
64508,randomized,0,0
64509,study,0,0
64510,.,0,0
64511,OBJECTIVE,0,0
64512,To,0,0
64513,assess,0,0
64514,the,0,0
64515,effectiveness,0,0
64516,of,0,0
64517,providing,0,0
64518,doctors,0,0
64519,with,0,0
64520,written,0,1
64521,thromboprophylaxis,1,1
64522,prescription,1,0
64523,aids,1,0
64524,based,0,0
64525,on,0,0
64526,current,0,0
64527,recommendations,0,0
64528,.,0,0
64529,DESIGN,0,0
64530,A,0,0
64531,prospective,0,0
64532,trial,0,0
64533,of,0,0
64534,specific,0,0
64535,anticoagulant,0,1
64536,prescription,0,0
64537,forms,0,0
64538,:,0,0
64539,a,0,0
64540,1-day,0,0
64541,survey,0,0
64542,before,0,0
64543,and,0,0
64544,after,0,0
64545,the,0,0
64546,intervention,0,1
64547,in,0,0
64548,each,0,0
64549,centre,0,0
64550,.,0,0
64551,SETTING,0,0
64552,30,0,0
64553,Internal,0,0
64554,Medicine,0,1
64555,departments,0,0
64556,of,0,0
64557,Assistance,0,0
64558,Publique-H?pitaux,0,1
64559,de,0,0
64560,Paris,0,0
64561,.,0,0
64562,SUBJECTS,0,0
64563,All,0,0
64564,inpatients,0,0
64565,were,0,0
64566,included,0,0
64567,",",0,0
64568,except,0,0
64569,those,0,0
64570,who,0,0
64571,were,0,0
64572,either,0,0
64573,admitted,0,0
64574,or,0,0
64575,discharged,0,0
64576,on,0,0
64577,the,0,0
64578,day,0,0
64579,of,0,0
64580,the,0,0
64581,survey,0,0
64582,",",0,0
64583,and,0,0
64584,those,0,0
64585,receiving,0,0
64586,curative,1,0
64587,anticoagulant,1,1
64588,treatment,0,0
64589,.,0,0
64590,INTERVENTIONS,0,0
64591,The,0,0
64592,study,0,0
64593,included,0,0
64594,three,0,0
64595,parts,0,0
64596,:,0,0
64597,(,0,0
64598,i,0,0
64599,),0,0
64600,a,0,0
64601,1-day,0,0
64602,baseline,0,0
64603,survey,0,0
64604,;,0,0
64605,(,0,0
64606,ii,0,0
64607,),0,0
64608,over,0,0
64609,the,0,0
64610,following,0,0
64611,3-month,0,0
64612,period,0,0
64613,",",0,0
64614,departments,0,0
64615,were,0,0
64616,randomized,0,0
64617,into,0,0
64618,two,0,0
64619,groups,0,0
64620,:,0,0
64621,all,0,0
64622,practitioners,0,0
64623,in,0,0
64624,wards,0,0
64625,allocated,0,0
64626,to,0,0
64627,the,0,0
64628,intervention,0,1
64629,group,0,0
64630,were,0,0
64631,required,0,0
64632,to,0,0
64633,systematically,0,0
64634,use,0,0
64635,specific,1,0
64636,anticoagulant,1,1
64637,prescription,0,0
64638,forms,0,0
64639,",",0,0
64640,whilst,0,0
64641,doctors,0,0
64642,in,0,0
64643,the,0,0
64644,control,0,0
64645,group,0,0
64646,continued,0,0
64647,prescribing,0,0
64648,according,0,0
64649,to,0,0
64650,their,1,0
64651,usual,1,1
64652,practices,1,1
64653,and,0,0
64654,(,0,0
64655,iii,0,0
64656,),0,0
64657,a,0,0
64658,1-day,0,0
64659,postintervention,0,0
64660,survey,0,0
64661,.,0,0
64662,MAIN,0,0
64663,OUTCOME,0,0
64664,MEASURE,0,0
64665,The,0,0
64666,proportion,0,0
64667,of,0,0
64668,prescriptions,0,0
64669,in,0,0
64670,accordance,0,0
64671,with,0,0
64672,the,0,0
64673,recommendations,0,0
64674,.,0,0
64675,RESULTS,0,0
64676,"1,469",0,0
64677,patients,0,0
64678,were,0,0
64679,included,0,0
64680,.,0,0
64681,The,0,0
64682,intervention,0,0
64683,produced,0,0
64684,a,0,0
64685,significant,0,0
64686,reduction,0,0
64687,in,0,0
64688,the,0,0
64689,frequency,0,0
64690,of,0,0
64691,over-prescriptions,0,0
64692,",",0,0
64693,from,0,0
64694,25,0,0
64695,%,0,0
64696,to,0,0
64697,14,0,0
64698,%,0,0
64699,of,0,0
64700,the,0,0
64701,patients,0,0
64702,who,0,0
64703,did,0,0
64704,not,0,0
64705,meet,0,0
64706,the,0,0
64707,guideline,0,0
64708,criteria,0,0
64709,(,0,0
64710,adjusted,0,0
64711,OR,0,0
64712,:,0,0
64713,0.3,0,0
64714,;,0,0
64715,95,0,0
64716,%,0,0
64717,CI,0,0
64718,:,0,0
64719,0.1-0.8,0,0
64720,),0,0
64721,.,0,0
64722,Using,0,0
64723,specific,0,0
64724,forms,0,0
64725,did,0,0
64726,not,0,0
64727,improve,0,0
64728,under-prescription,0,0
64729,of,1,0
64730,anticoagulants,1,1
64731,.,1,0
64732,A,0,0
64733,little,0,0
64734,over,0,0
64735,60,0,0
64736,%,0,0
64737,of,0,0
64738,the,0,0
64739,patients,0,0
64740,who,0,0
64741,met,0,0
64742,guideline,0,0
64743,criteria,0,0
64744,for,0,0
64745,thromboprophylaxis,0,1
64746,were,0,0
64747,prescribed,1,0
64748,anticoagulants,1,1
64749,in,0,0
64750,both,0,0
64751,intervention,0,1
64752,and,0,0
64753,control,0,0
64754,wards,0,0
64755,",",0,0
64756,either,0,0
64757,at,0,0
64758,baseline,0,0
64759,or,0,1
64760,after,0,0
64761,intervention,0,1
64762,.,0,0
64763,CONCLUSIONS,1,0
64764,Multitargeted,1,1
64765,interventions,1,0
64766,using,0,0
64767,a,0,0
64768,variety,0,0
64769,of,0,0
64770,means,0,0
64771,and,0,0
64772,strategies,0,0
64773,should,0,0
64774,still,0,0
64775,be,0,0
64776,considered,0,0
64777,to,0,0
64778,improve,0,0
64779,prescriptions,0,0
64780,that,0,0
64781,may,0,0
64782,have,0,0
64783,a,0,0
64784,significant,0,0
64785,impact,0,0
64786,on,0,0
64787,health,0,0
64788,expenses,0,0
64789,and,0,0
64790,",",0,0
64791,most,0,0
64792,importantly,0,0
64793,",",0,0
64794,on,0,0
64795,patients,0,0
64796,outcomes,0,0
64797,.,0,0
64798,Trials,0,0
64799,and,0,0
64800,tribulations,0,0
64801,in,0,0
64802,speech,1,1
64803,therapy,1,1
64804,.,1,0
64805,Thrombus,0,0
64806,aspiration,0,0
64807,reduces,0,0
64808,microvascular,0,0
64809,obstruction,0,0
64810,after,0,0
64811,primary,0,0
64812,coronary,0,0
64813,intervention,0,1
64814,:,0,0
64815,a,0,0
64816,myocardial,0,0
64817,contrast,0,0
64818,echocardiography,0,0
64819,substudy,0,0
64820,of,0,0
64821,the,0,0
64822,REMEDIA,0,0
64823,Trial,0,0
64824,.,0,0
64825,OBJECTIVES,0,0
64826,The,0,0
64827,aim,0,0
64828,of,0,0
64829,this,0,0
64830,study,0,0
64831,was,0,0
64832,to,0,0
64833,clarify,0,0
64834,the,0,0
64835,role,0,0
64836,of,0,0
64837,microembolization,0,0
64838,in,0,0
64839,the,0,0
64840,genesis,0,0
64841,of,0,0
64842,microvascular,0,0
64843,obstruction,0,0
64844,(,0,0
64845,MO,0,1
64846,),0,0
64847,after,0,0
64848,percutaneous,0,1
64849,coronary,0,0
64850,intervention,0,1
64851,(,0,0
64852,PCI,0,0
64853,),0,0
64854,.,0,0
64855,BACKGROUND,0,0
64856,Fifty,0,0
64857,consecutive,0,0
64858,patients,0,0
64859,entered,0,0
64860,the,0,0
64861,myocardial,0,0
64862,contrast,0,0
64863,echocardiography,0,1
64864,(,0,0
64865,MCE,0,0
64866,),0,0
64867,substudy,0,0
64868,of,0,0
64869,the,0,0
64870,REMEDIA,0,1
64871,(,0,0
64872,Randomized,0,0
64873,Evaluation,0,0
64874,of,0,0
64875,the,0,0
64876,Effect,0,0
64877,of,0,0
64878,Mechanical,0,1
64879,Reduction,0,0
64880,of,0,0
64881,Distal,0,0
64882,Embolization,0,0
64883,by,0,0
64884,Thrombus,0,0
64885,Aspiration,0,0
64886,in,0,0
64887,Primary,0,0
64888,and,0,0
64889,Rescue,0,1
64890,Angioplasty,0,1
64891,),0,0
64892,trial,0,0
64893,",",0,0
64894,which,0,0
64895,defined,0,0
64896,the,0,0
64897,role,0,0
64898,of,0,0
64899,a,0,0
64900,new,0,0
64901,thrombus-aspirating,0,0
64902,device,0,1
64903,in,0,0
64904,preventing,0,0
64905,distal,0,0
64906,microembolization,0,0
64907,after,0,0
64908,PCI,0,0
64909,.,0,0
64910,METHODS,0,0
64911,A,0,0
64912,total,0,0
64913,of,0,0
64914,25,0,0
64915,patients,0,0
64916,were,0,0
64917,randomized,0,0
64918,to,0,0
64919,be,0,0
64920,pretreated,0,0
64921,with,0,0
64922,thrombus,1,0
64923,aspiration,1,0
64924,before,1,0
64925,PCI,1,0
64926,of,1,0
64927,the,1,0
64928,culprit,1,0
64929,lesion,1,0
64930,and,1,0
64931,25,0,0
64932,received,0,0
64933,standard,1,1
64934,PCI,1,0
64935,.,1,0
64936,At,0,0
64937,24,0,0
64938,h,0,0
64939,",",0,0
64940,1,0,0
64941,week,0,0
64942,",",0,0
64943,and,0,0
64944,6,0,0
64945,months,0,0
64946,after,0,0
64947,PCI,0,0
64948,",",0,0
64949,MCE,0,0
64950,was,0,0
64951,performed,0,0
64952,by,0,0
64953,Sonovue,0,1
64954,",",0,0
64955,and,0,0
64956,real-time,0,1
64957,imaging,0,0
64958,was,0,0
64959,performed,0,0
64960,by,0,0
64961,contrast,0,0
64962,pulse,0,1
64963,sequencing,0,0
64964,technology,0,0
64965,.,0,0
64966,Regional,0,0
64967,wall,0,0
64968,motion,0,1
64969,score,0,0
64970,index,0,0
64971,(,0,0
64972,WMSI,0,1
64973,),0,0
64974,",",0,0
64975,contrast,0,0
64976,score,0,0
64977,index,0,0
64978,(,0,0
64979,CSI,0,1
64980,),0,0
64981,",",0,0
64982,endocardial,0,1
64983,length,0,0
64984,of,0,0
64985,wall,0,0
64986,motion,0,1
64987,abnormality,0,0
64988,(,0,0
64989,WML,0,1
64990,),0,1
64991,and,0,0
64992,contrast,0,1
64993,defect,0,0
64994,(,0,0
64995,CDL,0,0
64996,),0,0
64997,",",0,0
64998,end-diastolic,0,0
64999,and,0,0
65000,end-systolic,0,0
65001,left,0,0
65002,ventricular,0,0
65003,(,0,0
65004,LV,0,1
65005,),0,0
65006,volumes,0,0
65007,",",0,0
65008,and,0,0
65009,ejection,0,0
65010,fraction,0,0
65011,were,0,0
65012,calculated,0,0
65013,.,0,0
65014,RESULTS,0,0
65015,At,0,0
65016,each,0,0
65017,time,0,0
65018,point,0,0
65019,",",0,0
65020,in,0,0
65021,patients,0,0
65022,treated,0,0
65023,with,0,0
65024,a,0,0
65025,thrombus-aspiration,0,0
65026,filter,0,1
65027,device,0,1
65028,",",0,0
65029,WMSI,0,1
65030,",",0,0
65031,CSI,0,1
65032,",",0,0
65033,WML,0,1
65034,",",0,0
65035,and,0,0
65036,CDL,0,0
65037,were,0,0
65038,significantly,0,0
65039,lower,0,0
65040,and,0,0
65041,ejection,0,0
65042,fraction,0,0
65043,higher,0,0
65044,(,0,0
65045,p,0,0
65046,<,0,0
65047,0.05,0,0
65048,vs.,0,0
65049,control,0,0
65050,patients,0,0
65051,),0,0
65052,",",0,0
65053,whereas,0,0
65054,LV,0,0
65055,volumes,0,0
65056,were,0,0
65057,slightly,0,0
65058,but,0,0
65059,not,0,0
65060,significantly,0,0
65061,smaller,0,0
65062,compared,0,0
65063,with,0,0
65064,control,0,0
65065,patients,0,0
65066,.,0,0
65067,In,0,0
65068,the,0,0
65069,overall,0,0
65070,study,0,0
65071,population,0,0
65072,",",0,0
65073,the,0,0
65074,extent,0,0
65075,of,0,0
65076,MO,0,1
65077,significantly,0,0
65078,correlated,0,0
65079,with,0,0
65080,temporal,0,0
65081,changes,0,0
65082,in,0,0
65083,LV,0,0
65084,volumes,0,0
65085,.,0,0
65086,CONCLUSIONS,0,0
65087,Thrombus,0,0
65088,aspiration,0,1
65089,used,0,0
65090,at,0,0
65091,the,0,0
65092,time,0,0
65093,of,0,0
65094,PCI,0,0
65095,significantly,0,0
65096,reduces,0,0
65097,the,0,0
65098,extent,0,0
65099,of,0,0
65100,MO,0,1
65101,and,0,0
65102,myocardial,0,0
65103,dysfunction,0,0
65104,",",0,0
65105,although,0,0
65106,it,0,0
65107,does,0,0
65108,not,0,0
65109,have,0,0
65110,a,0,0
65111,significant,0,0
65112,favorable,0,0
65113,effect,0,0
65114,in,0,0
65115,preventing,0,0
65116,LV,0,0
65117,remodeling,0,0
65118,.,0,0
65119,Thus,0,0
65120,",",0,0
65121,the,0,0
65122,beneficial,0,0
65123,effect,0,0
65124,of,0,0
65125,thrombus,0,0
65126,aspiration,0,1
65127,occurs,0,0
65128,at,0,0
65129,the,0,0
65130,microvascular,0,0
65131,level,0,0
65132,",",0,0
65133,but,0,0
65134,additional,0,0
65135,mechanisms,0,0
65136,may,0,0
65137,play,0,0
65138,a,0,0
65139,role,0,0
65140,in,0,0
65141,influencing,0,0
65142,the,0,0
65143,final,0,0
65144,extent,0,0
65145,of,0,0
65146,MO,0,1
65147,",",0,0
65148,which,0,0
65149,strictly,0,0
65150,correlates,0,0
65151,with,0,0
65152,post-infarct,0,0
65153,LV,0,0
65154,remodeling,0,0
65155,.,0,0
65156,Nordic,1,1
65157,walking,1,1
65158,and,0,0
65159,chronic,0,0
65160,low,0,0
65161,back,0,0
65162,pain,0,0
65163,:,0,0
65164,design,0,0
65165,of,0,0
65166,a,0,0
65167,randomized,0,0
65168,clinical,0,0
65169,trial,0,0
65170,.,0,0
65171,BACKGROUND,0,0
65172,Low,0,0
65173,Back,0,0
65174,Pain,0,0
65175,is,0,0
65176,a,0,0
65177,major,0,0
65178,public,0,0
65179,health,0,0
65180,problem,0,0
65181,all,0,0
65182,over,0,0
65183,the,0,0
65184,western,0,0
65185,world,0,0
65186,.,0,0
65187,Active,0,0
65188,approaches,0,0
65189,including,0,0
65190,exercise,0,1
65191,in,0,0
65192,the,0,0
65193,treatment,0,0
65194,of,0,0
65195,low,0,0
65196,back,0,0
65197,pain,0,0
65198,results,0,0
65199,in,0,0
65200,better,0,0
65201,outcomes,0,0
65202,for,0,0
65203,patients,0,0
65204,",",0,0
65205,but,0,0
65206,it,0,0
65207,is,0,0
65208,not,0,0
65209,known,0,0
65210,exactly,0,0
65211,which,0,0
65212,types,0,0
65213,of,0,0
65214,back,0,0
65215,exercises,0,1
65216,are,0,0
65217,most,0,0
65218,beneficial,0,0
65219,or,0,0
65220,whether,0,0
65221,general,0,0
65222,physical,0,1
65223,activity,0,0
65224,provide,0,0
65225,similar,0,0
65226,benefits,0,0
65227,.,0,0
65228,Nordic,1,0
65229,Walking,1,0
65230,is,0,0
65231,a,0,0
65232,popular,0,0
65233,and,0,0
65234,fast,0,1
65235,growing,0,0
65236,type,0,0
65237,of,0,0
65238,exercise,0,1
65239,in,0,0
65240,Northern,0,0
65241,Europe,0,1
65242,.,0,0
65243,Initial,0,0
65244,studies,0,0
65245,have,0,0
65246,demonstrated,0,0
65247,that,0,0
65248,persons,0,0
65249,performing,0,0
65250,Nordic,1,0
65251,Walking,1,1
65252,are,0,0
65253,able,0,0
65254,to,0,0
65255,exercise,0,0
65256,longer,0,0
65257,and,0,0
65258,harder,0,0
65259,compared,0,0
65260,to,0,0
65261,normal,0,0
65262,walking,0,1
65263,thereby,0,0
65264,increasing,0,0
65265,their,0,0
65266,cardiovascular,0,0
65267,metabolism,0,0
65268,.,0,0
65269,Until,0,0
65270,now,0,0
65271,no,0,0
65272,studies,0,0
65273,have,0,0
65274,been,0,0
65275,performed,0,0
65276,to,0,0
65277,investigate,0,0
65278,whether,0,0
65279,Nordic,1,0
65280,Walking,1,1
65281,has,0,0
65282,beneficial,0,0
65283,effects,0,0
65284,in,0,0
65285,relation,0,0
65286,to,0,0
65287,low,0,0
65288,back,0,0
65289,pain,0,0
65290,.,0,0
65291,The,0,0
65292,primary,0,0
65293,aim,0,0
65294,of,0,0
65295,this,0,0
65296,study,0,0
65297,is,0,0
65298,to,0,0
65299,investigate,0,0
65300,whether,0,0
65301,supervised,1,1
65302,Nordic,1,0
65303,Walking,1,1
65304,can,0,0
65305,reduce,0,0
65306,pain,0,0
65307,and,0,0
65308,improve,0,0
65309,function,0,0
65310,in,0,0
65311,a,0,0
65312,population,0,0
65313,of,0,0
65314,chronic,0,0
65315,low,0,0
65316,back,0,0
65317,pain,0,0
65318,patients,0,0
65319,when,0,0
65320,compared,0,0
65321,to,0,0
65322,unsupervised,1,1
65323,Nordic,1,1
65324,Walking,1,1
65325,and,1,0
65326,advice,1,1
65327,to,1,0
65328,stay,1,0
65329,active,1,0
65330,.,1,0
65331,In,0,0
65332,addition,0,0
65333,we,0,0
65334,investigate,0,0
65335,whether,0,0
65336,there,0,0
65337,is,0,0
65338,an,0,0
65339,increase,0,0
65340,in,0,0
65341,the,0,0
65342,cardiovascular,0,0
65343,metabolism,0,0
65344,in,0,0
65345,persons,0,0
65346,performing,0,0
65347,supervised,1,1
65348,Nordic,1,0
65349,Walking,1,1
65350,compared,0,0
65351,to,0,0
65352,persons,0,0
65353,who,0,0
65354,are,0,0
65355,advised,1,0
65356,to,1,0
65357,stay,1,0
65358,active,1,0
65359,.,1,0
65360,Finally,0,0
65361,",",0,0
65362,we,0,0
65363,investigate,0,0
65364,whether,0,0
65365,there,0,0
65366,is,0,0
65367,a,0,0
65368,difference,0,0
65369,in,0,0
65370,compliance,0,0
65371,between,0,0
65372,persons,0,0
65373,receiving,0,0
65374,supervised,1,1
65375,Nordic,1,1
65376,Walking,1,1
65377,and,0,0
65378,persons,0,0
65379,doing,0,0
65380,unsupervised,1,1
65381,Nordic,1,0
65382,Walking,1,1
65383,.,1,0
65384,METHODS,0,0
65385,One,0,0
65386,hundred,0,0
65387,and,0,0
65388,fifty,0,0
65389,patients,0,0
65390,with,0,0
65391,low,0,0
65392,back,0,0
65393,pain,0,0
65394,for,0,0
65395,at,0,0
65396,least,0,0
65397,eight,0,0
65398,weeks,0,0
65399,and,0,0
65400,referred,0,0
65401,to,0,0
65402,a,0,0
65403,specialized,0,0
65404,secondary,0,0
65405,sector,0,0
65406,outpatient,0,0
65407,back,0,0
65408,pain,0,0
65409,clinic,0,0
65410,are,0,0
65411,included,0,0
65412,in,0,0
65413,the,0,0
65414,study,0,0
65415,.,0,0
65416,After,0,0
65417,completion,0,0
65418,of,0,0
65419,the,0,0
65420,standard,1,0
65421,back,1,0
65422,centre,1,0
65423,treatment,1,0
65424,patients,0,0
65425,are,0,0
65426,randomized,0,0
65427,into,0,0
65428,one,0,0
65429,of,0,0
65430,three,0,0
65431,groups,0,0
65432,:,0,0
65433,A,0,0
65434,),0,0
65435,Nordic,1,0
65436,Walking,1,1
65437,twice,1,0
65438,a,1,0
65439,week,1,0
65440,for,1,0
65441,eight,1,0
65442,weeks,1,0
65443,under,1,0
65444,supervision,1,0
65445,of,1,0
65446,a,1,0
65447,specially,1,0
65448,trained,1,1
65449,instructor,1,1
65450,;,1,0
65451,B,0,0
65452,),0,0
65453,Unsupervised,1,1
65454,Nordic,1,0
65455,Walking,1,1
65456,for,1,0
65457,eight,1,0
65458,weeks,1,0
65459,after,1,0
65460,one,1,0
65461,training,1,1
65462,session,1,1
65463,with,1,0
65464,an,1,0
65465,instructor,1,1
65466,;,1,0
65467,C,0,0
65468,),0,0
65469,A,1,0
65470,one,1,0
65471,hour,1,0
65472,motivational,1,1
65473,talk,1,0
65474,including,1,0
65475,advice,1,1
65476,to,1,0
65477,stay,1,0
65478,active,1,0
65479,.,1,0
65480,Outcome,0,0
65481,measures,0,0
65482,are,0,0
65483,pain,0,0
65484,",",0,0
65485,function,0,0
65486,",",0,0
65487,overall,0,0
65488,health,0,0
65489,",",0,0
65490,cardiovascular,0,0
65491,ability,0,0
65492,and,0,0
65493,activity,0,0
65494,level,0,0
65495,.,0,0
65496,RESULTS,0,0
65497,No,0,0
65498,results,0,0
65499,available,0,0
65500,at,0,0
65501,this,0,0
65502,point,0,0
65503,.,0,0
65504,DISCUSSION,0,0
65505,This,0,0
65506,study,0,0
65507,will,0,0
65508,investigate,0,0
65509,the,0,0
65510,effect,0,0
65511,of,0,0
65512,Nordic,1,0
65513,Walking,1,0
65514,on,0,0
65515,pain,0,0
65516,and,0,0
65517,function,0,0
65518,in,0,0
65519,a,0,0
65520,population,0,0
65521,of,0,0
65522,people,0,0
65523,with,0,0
65524,chronic,0,0
65525,LBP,0,0
65526,.,0,0
65527,Risperidone,1,1
65528,improves,0,0
65529,behavioral,0,0
65530,symptoms,0,0
65531,in,0,0
65532,children,0,0
65533,with,0,0
65534,autism,0,0
65535,in,0,0
65536,a,0,0
65537,randomized,0,0
65538,",",0,0
65539,double-blind,0,0
65540,",",0,0
65541,placebo-controlled,1,1
65542,trial,0,0
65543,.,0,0
65544,Subgroup,0,0
65545,analysis,0,0
65546,of,0,0
65547,children,0,0
65548,(,0,0
65549,5-12,0,0
65550,years,0,0
65551,),0,0
65552,with,0,0
65553,autism,0,0
65554,enrolled,0,0
65555,in,0,0
65556,an,0,0
65557,8-week,0,0
65558,",",0,0
65559,double-blind,0,0
65560,",",0,0
65561,placebo-controlled,1,1
65562,trial,0,0
65563,of,0,0
65564,risperidone,1,1
65565,for,0,0
65566,pervasive,0,0
65567,developmental,0,0
65568,disorders,0,0
65569,.,0,0
65570,The,0,0
65571,primary,0,0
65572,efficacy,0,0
65573,measure,0,0
65574,was,0,0
65575,the,0,0
65576,Aberrant,0,0
65577,Behavior,0,0
65578,Checklist-Irritability,0,0
65579,(,0,0
65580,ABC-I,0,1
65581,),0,0
65582,subscale,0,0
65583,.,0,0
65584,Data,0,0
65585,were,0,0
65586,available,0,0
65587,for,0,0
65588,55,0,0
65589,children,0,0
65590,given,0,0
65591,risperidone,1,1
65592,(,0,0
65593,n=27,0,0
65594,),0,1
65595,or,0,1
65596,placebo,1,1
65597,(,0,0
65598,n=28,0,0
65599,),0,0
65600,;,0,0
65601,mean,0,0
65602,baseline,0,0
65603,ABC-I,0,1
65604,(,0,0
65605,+/-,0,0
65606,SD,0,0
65607,),0,0
65608,was,0,0
65609,20.6,0,0
65610,(,0,0
65611,8.1,0,0
65612,),0,0
65613,and,0,0
65614,21.6,0,0
65615,(,0,0
65616,10.2,0,0
65617,),0,0
65618,.,0,0
65619,Risperidone,1,1
65620,[,0,0
65621,mean,0,0
65622,dose,0,0
65623,(,0,0
65624,+/-,0,0
65625,SD,0,0
65626,),0,0
65627,:,0,0
65628,1.37,0,0
65629,mg/day,0,0
65630,(,0,0
65631,0.7,0,0
65632,),0,0
65633,],0,0
65634,resulted,0,0
65635,in,0,0
65636,significantly,0,0
65637,greater,0,0
65638,reduction,0,0
65639,from,0,0
65640,baseline,0,0
65641,to,0,0
65642,endpoint,0,0
65643,in,0,0
65644,ABC-I,0,1
65645,versus,0,0
65646,placebo,1,1
65647,[,0,0
65648,mean,0,0
65649,change,0,0
65650,(,0,0
65651,+/-,0,0
65652,SD,0,0
65653,),0,0
65654,:,0,0
65655,-13.4,0,0
65656,(,0,0
65657,1.5,0,0
65658,),0,0
65659,vs.,0,0
65660,-7.2,0,0
65661,(,0,0
65662,1.4,0,0
65663,),0,0
65664,",",0,0
65665,P,0,0
65666,<,0,0
65667,0.05,0,0
65668,;,0,0
65669,ES=-0.7,0,0
65670,],0,0
65671,.,0,0
65672,The,0,0
65673,most,0,0
65674,common,0,0
65675,adverse,0,0
65676,effect,0,0
65677,with,0,0
65678,risperidone,1,1
65679,was,0,0
65680,somnolence,0,0
65681,(,0,0
65682,74,0,0
65683,%,0,0
65684,vs.,0,0
65685,7,0,0
65686,%,0,0
65687,with,0,0
65688,placebo,1,1
65689,),1,0
65690,.,0,0
65691,Risperidone,1,1
65692,treatment,0,0
65693,was,0,0
65694,well,0,0
65695,tolerated,0,0
65696,and,0,0
65697,significantly,0,0
65698,improved,0,0
65699,behavioral,0,0
65700,problems,0,0
65701,associated,0,0
65702,with,0,0
65703,autism,0,0
65704,.,0,0
65705,Enhanced,0,0
65706,baroreceptor,0,1
65707,control,0,0
65708,of,0,0
65709,the,0,0
65710,cardiovascular,0,0
65711,system,0,0
65712,by,0,0
65713,polyunsaturated,1,1
65714,Fatty,1,0
65715,acids,1,1
65716,in,0,0
65717,heart,0,0
65718,failure,0,0
65719,patients,0,0
65720,.,0,0
65721,OBJECTIVES,0,0
65722,The,0,0
65723,intention,0,0
65724,of,0,0
65725,this,0,0
65726,study,0,0
65727,was,0,0
65728,to,0,0
65729,test,0,0
65730,the,0,0
65731,hypothesis,0,0
65732,that,0,0
65733,",",0,0
65734,in,0,0
65735,heart,0,0
65736,failure,0,0
65737,patients,0,0
65738,",",0,0
65739,dietary,1,0
65740,supplementation,1,1
65741,of,1,0
65742,polyunsaturated,1,1
65743,fatty,1,1
65744,acids,1,1
65745,(,1,0
65746,PUFA,1,0
65747,),1,1
65748,enhances,0,0
65749,arterial,0,0
65750,baroreceptor,0,0
65751,control,0,0
65752,of,0,0
65753,the,0,0
65754,cardiovascular,0,0
65755,system,0,0
65756,.,0,0
65757,BACKGROUND,0,0
65758,Administration,0,0
65759,of,0,0
65760,PUFA,1,0
65761,reduces,0,0
65762,the,0,0
65763,risk,0,0
65764,of,0,0
65765,life-threatening,0,0
65766,arrhythmias,0,0
65767,in,0,0
65768,patients,0,0
65769,surviving,0,0
65770,myocardial,0,0
65771,infarction,0,0
65772,.,0,0
65773,This,0,0
65774,might,0,0
65775,result,0,0
65776,from,0,0
65777,potentiation,0,0
65778,of,0,0
65779,arterial,0,0
65780,baroreflexes,0,1
65781,",",0,0
65782,but,0,0
65783,whether,0,0
65784,or,0,0
65785,not,0,0
65786,PUFA,1,0
65787,enhance,0,0
65788,baroreflex,0,0
65789,function,0,0
65790,has,0,0
65791,never,0,0
65792,been,0,0
65793,studied,0,0
65794,in,0,0
65795,humans,0,0
65796,.,0,0
65797,METHODS,0,0
65798,Patients,0,0
65799,with,0,0
65800,post-myocardial,0,0
65801,infarction,0,0
65802,left,0,0
65803,ventricular,0,0
65804,dysfunction,0,0
65805,underwent,0,0
65806,beat-to-beat,0,1
65807,blood,0,0
65808,pressure,0,0
65809,(,0,0
65810,BP,0,0
65811,),0,1
65812,(,0,0
65813,Finapres,0,1
65814,",",0,0
65815,Ohmeda,0,0
65816,Inc.,0,0
65817,",",0,0
65818,Englewood,0,0
65819,",",0,0
65820,Colorado,0,0
65821,),0,0
65822,and,0,0
65823,R-R,0,0
65824,interval,0,0
65825,(,0,0
65826,electrocardiogram,0,0
65827,),0,1
65828,recording,0,0
65829,;,0,0
65830,baroreceptor,0,0
65831,reflexes,0,0
65832,were,0,0
65833,assessed,0,0
65834,from,0,0
65835,the,0,0
65836,bradycardic,0,0
65837,and,0,0
65838,depressor,0,0
65839,responses,0,0
65840,to,0,0
65841,graded,0,0
65842,neck,0,0
65843,suction,0,1
65844,(,0,0
65845,NS,0,0
65846,),0,0
65847,as,0,0
65848,well,0,0
65849,as,0,0
65850,by,0,0
65851,computation,0,0
65852,of,0,0
65853,the,0,0
65854,alpha,0,1
65855,spontaneous,0,0
65856,baroreflex,0,0
65857,sensitivity,0,0
65858,index,0,0
65859,.,0,0
65860,Assessments,0,0
65861,were,0,0
65862,repeated,0,0
65863,after,0,0
65864,prolonged,0,0
65865,treatment,0,0
65866,with,0,0
65867,PUFA,1,0
65868,(,0,0
65869,2,0,0
65870,g/die,0,1
65871,",",0,0
65872,n,0,0
65873,=,0,0
65874,15,0,0
65875,),0,0
65876,or,0,1
65877,placebo,1,1
65878,(,0,0
65879,n,0,0
65880,=,0,0
65881,10,0,0
65882,),0,0
65883,.,0,0
65884,RESULTS,0,0
65885,Baseline,0,0
65886,BP,0,0
65887,and,0,0
65888,R-R,0,0
65889,interval,0,0
65890,were,0,0
65891,unaffected,0,0
65892,by,0,0
65893,PUFA,1,0
65894,.,1,0
65895,Both,0,0
65896,reflex,0,0
65897,depressor,0,0
65898,and,0,0
65899,bradycardic,0,0
65900,responses,0,0
65901,to,0,0
65902,NS,0,0
65903,increased,0,0
65904,after,0,0
65905,PUFA,1,0
65906,(,0,0
65907,respectively,0,0
65908,from,0,0
65909,-0.09,0,0
65910,+/-,0,0
65911,0.01,0,0
65912,to,0,0
65913,-0.16,0,0
65914,+/-,0,0
65915,0.01,0,0
65916,mm,0,0
65917,Hg,0,0
65918,x,0,0
65919,mm,0,0
65920,Hg,0,0
65921,(,0,0
65922,-1,0,0
65923,),0,0
65924,",",0,0
65925,p,0,0
65926,<,0,0
65927,0.01,0,0
65928,",",0,0
65929,and,0,0
65930,from,0,0
65931,1.25,0,0
65932,+/-,0,0
65933,0.9,0,0
65934,to,0,0
65935,1.76,0,0
65936,+/-,0,0
65937,1.1,0,0
65938,ms,0,0
65939,x,0,0
65940,mm,0,0
65941,Hg,0,0
65942,(,0,0
65943,-1,0,0
65944,),0,0
65945,",",0,0
65946,p,0,0
65947,<,0,0
65948,0.04,0,0
65949,),0,0
65950,but,0,0
65951,not,0,0
65952,after,0,0
65953,placebo,1,1
65954,.,1,0
65955,The,0,0
65956,spontaneous,0,0
65957,baroreflex,0,0
65958,sensitivity,0,0
65959,increased,0,0
65960,in,0,0
65961,the,0,0
65962,PUFA,1,0
65963,(,0,0
65964,from,0,0
65965,8.99,0,0
65966,+/-,0,0
65967,1.4,0,0
65968,to,0,0
65969,12.2,0,0
65970,+/-,0,0
65971,1.2,0,0
65972,ms,0,0
65973,x,0,0
65974,mm,0,0
65975,Hg,0,0
65976,(,0,0
65977,-1,0,0
65978,),0,0
65979,",",0,0
65980,p,0,0
65981,<,0,0
65982,0.02,0,0
65983,),0,0
65984,but,0,0
65985,not,0,0
65986,in,0,0
65987,the,0,0
65988,placebo,1,1
65989,group,0,0
65990,.,0,0
65991,Polyunsaturated,1,1
65992,fatty,1,0
65993,acids,1,1
65994,(,0,0
65995,but,0,0
65996,not,0,0
65997,placebo,1,1
65998,),1,0
65999,treatment,0,0
66000,also,0,0
66001,significantly,0,0
66002,increased,0,0
66003,R-R,0,0
66004,interval,0,0
66005,total,0,0
66006,variance,0,0
66007,and,0,0
66008,low-frequency,0,1
66009,and,0,0
66010,high-frequency,0,1
66011,spectral,0,0
66012,powers,0,0
66013,.,0,0
66014,CONCLUSIONS,0,0
66015,Dietary,1,1
66016,PUFA,1,0
66017,supplementation,1,1
66018,markedly,0,0
66019,potentiates,0,0
66020,baroreflex,0,0
66021,function,0,0
66022,and,0,0
66023,enhances,0,0
66024,heart,0,0
66025,rate,0,0
66026,variability,0,0
66027,in,0,0
66028,patients,0,0
66029,with,0,0
66030,stable,0,0
66031,congestive,0,0
66032,heart,0,0
66033,failure,0,0
66034,.,0,0
66035,Polydioxanone,1,1
66036,sternal,1,1
66037,sutures,1,1
66038,for,0,0
66039,prevention,0,0
66040,of,0,0
66041,sternal,0,1
66042,dehiscence,0,0
66043,.,0,0
66044,BACKGROUND,0,0
66045,Sternal,0,1
66046,dehiscence,0,0
66047,and,0,0
66048,wound,0,0
66049,instability,0,0
66050,are,0,0
66051,troublesome,0,0
66052,complications,0,0
66053,following,0,0
66054,median,0,0
66055,sternotomy,0,1
66056,.,0,0
66057,Classic,0,0
66058,sternal,0,0
66059,approximation,0,0
66060,with,0,0
66061,stainless,0,1
66062,steel,0,1
66063,wires,0,1
66064,may,0,0
66065,not,0,0
66066,be,0,0
66067,the,0,0
66068,ideal,0,0
66069,approach,0,1
66070,in,0,0
66071,patients,0,0
66072,predisposed,0,0
66073,to,0,0
66074,these,0,0
66075,complications,0,0
66076,.,0,0
66077,We,0,0
66078,tested,0,0
66079,the,0,0
66080,efficacy,0,0
66081,of,0,0
66082,polydioxanone,1,1
66083,(,1,0
66084,PDS,1,1
66085,),1,0
66086,suture,1,1
66087,in,0,0
66088,sternal,0,1
66089,closure,0,0
66090,and,0,0
66091,in,0,0
66092,prevention,0,0
66093,of,0,0
66094,complications,0,0
66095,in,0,0
66096,comparison,0,0
66097,to,0,0
66098,steel,0,1
66099,wires,0,1
66100,in,0,0
66101,high-risk,0,0
66102,individuals,0,0
66103,.,0,0
66104,METHODS,0,0
66105,Three,0,0
66106,hundred,0,0
66107,sixty-six,0,0
66108,patients,0,0
66109,undergoing,0,0
66110,elective,0,0
66111,cardiac,0,0
66112,surgery,0,0
66113,with,0,0
66114,full,0,0
66115,median,0,0
66116,sternotomy,0,1
66117,and,0,0
66118,having,0,0
66119,body,0,0
66120,surface,0,1
66121,area,0,0
66122,(,0,0
66123,BSA,0,0
66124,),0,0
66125,less,0,0
66126,than,0,0
66127,1.5,0,0
66128,m,0,0
66129,(,0,0
66130,2,0,0
66131,),0,0
66132,were,0,0
66133,randomly,0,0
66134,assigned,0,0
66135,to,0,0
66136,receive,0,1
66137,PDS,1,1
66138,(,0,0
66139,n,0,0
66140,=,0,0
66141,181,0,0
66142,),0,0
66143,or,0,0
66144,stainless,1,1
66145,steel,1,1
66146,(,0,0
66147,SS,0,1
66148,",",0,0
66149,n,0,0
66150,=,0,0
66151,185,0,0
66152,),0,0
66153,sternal,0,1
66154,approximation,0,0
66155,.,0,0
66156,The,0,0
66157,study,0,0
66158,was,0,0
66159,focused,0,0
66160,on,0,0
66161,aseptic,0,0
66162,sternal,0,1
66163,complications,0,0
66164,",",0,0
66165,namely,0,0
66166,bone,0,0
66167,dehiscence,0,0
66168,and,0,0
66169,superficial,0,0
66170,wound,0,0
66171,instability,0,0
66172,.,0,0
66173,RESULTS,0,0
66174,Both,0,1
66175,bone,0,0
66176,dehiscence,0,0
66177,and,0,0
66178,superficial,0,0
66179,wound,0,0
66180,instability,0,0
66181,were,0,0
66182,less,0,0
66183,frequent,0,0
66184,in,0,0
66185,the,0,0
66186,PDS,1,1
66187,Group,0,0
66188,(,0,0
66189,4,0,0
66190,and,0,0
66191,3,0,0
66192,cases,0,0
66193,in,0,0
66194,the,0,0
66195,SS,0,1
66196,Group,0,0
66197,",",0,0
66198,respectively,0,0
66199,",",0,0
66200,vs.,0,0
66201,no,0,0
66202,cases,0,0
66203,in,0,0
66204,the,0,0
66205,PDS,0,1
66206,Group,0,0
66207,),0,0
66208,.,0,0
66209,Cox,0,0
66210,proportional,0,0
66211,hazards,0,0
66212,regression,0,0
66213,model,0,0
66214,in,0,0
66215,the,0,0
66216,whole,0,0
66217,study,0,0
66218,population,0,0
66219,identified,0,0
66220,female,0,0
66221,sex,0,0
66222,",",0,0
66223,chronic,0,0
66224,renal,0,0
66225,insufficiency,0,0
66226,",",0,0
66227,diabetes,0,0
66228,",",0,0
66229,advanced,0,0
66230,age,0,0
66231,",",0,0
66232,lower,0,0
66233,sternal,0,0
66234,thickness,0,0
66235,",",0,0
66236,osteoporosis,0,0
66237,",",0,0
66238,corticosteroid,0,1
66239,therapy,0,1
66240,",",0,0
66241,and,0,0
66242,prolonged,0,0
66243,CPB,0,1
66244,or,0,1
66245,ventilation,0,1
66246,times,0,0
66247,as,0,0
66248,predisposing,0,0
66249,factors,0,0
66250,to,0,0
66251,any,0,0
66252,of,0,0
66253,the,0,0
66254,two,0,0
66255,studied,0,0
66256,sternal,0,0
66257,complications,0,0
66258,.,0,0
66259,DISCUSSION,0,0
66260,Data,0,0
66261,suggest,0,0
66262,that,0,0
66263,PDS,1,1
66264,suture,0,0
66265,can,0,0
66266,protect,0,0
66267,against,0,0
66268,development,0,0
66269,of,0,0
66270,aseptic,0,0
66271,sternal,0,1
66272,complications,0,0
66273,following,0,0
66274,median,0,0
66275,sternotomy,0,1
66276,in,0,0
66277,high-risk,0,0
66278,patients,0,0
66279,with,0,0
66280,little,0,0
66281,body,0,0
66282,mass,0,0
66283,.,0,0
66284,The,0,0
66285,adoption,0,0
66286,of,0,0
66287,PDS,1,1
66288,in,0,0
66289,other,0,0
66290,subsets,0,0
66291,of,0,0
66292,patients,0,0
66293,",",0,0
66294,i.e.,0,0
66295,",",0,0
66296,obese,0,0
66297,individuals,0,0
66298,",",0,0
66299,is,0,0
66300,to,0,0
66301,be,0,0
66302,questioned,0,0
66303,.,0,0
66304,A,0,0
66305,randomized,0,0
66306,controlled,0,0
66307,trial,0,0
66308,of,0,0
66309,a,0,0
66310,cognitive,1,0
66311,behavioural,1,0
66312,intervention,1,1
66313,for,0,0
66314,anger,0,0
66315,management,0,0
66316,in,0,0
66317,children,0,0
66318,diagnosed,0,0
66319,with,0,0
66320,Asperger,0,0
66321,syndrome,0,0
66322,.,0,0
66323,The,0,0
66324,purpose,0,0
66325,of,0,0
66326,the,0,0
66327,study,0,0
66328,described,0,0
66329,was,0,0
66330,to,0,0
66331,evaluate,0,0
66332,the,0,0
66333,effectiveness,0,0
66334,of,0,0
66335,a,0,0
66336,cognitive,0,0
66337,behavioural,0,0
66338,intervention,0,1
66339,for,0,0
66340,anger,0,0
66341,management,0,0
66342,with,0,0
66343,children,0,0
66344,diagnosed,0,0
66345,with,0,0
66346,Asperger,0,0
66347,syndrome,0,0
66348,.,0,0
66349,Forty-five,0,0
66350,children,0,0
66351,and,0,0
66352,their,0,0
66353,parents,0,0
66354,were,0,0
66355,randomly,0,0
66356,assigned,0,0
66357,to,0,0
66358,either,0,0
66359,intervention,1,1
66360,or,0,1
66361,wait-list,1,1
66362,control,1,0
66363,conditions,1,0
66364,.,1,0
66365,Children,0,0
66366,in,0,0
66367,the,0,0
66368,intervention,0,1
66369,participated,0,0
66370,in,0,0
66371,six,1,0
66372,2-h,1,0
66373,weekly,1,1
66374,sessions,1,1
66375,while,0,0
66376,parents,0,0
66377,participated,0,0
66378,in,0,0
66379,a,0,0
66380,larger,0,0
66381,parent,0,0
66382,group,0,0
66383,.,0,0
66384,Parent,0,0
66385,reports,0,0
66386,indicated,0,0
66387,a,0,0
66388,significant,0,0
66389,decrease,0,0
66390,in,0,0
66391,episodes,0,0
66392,of,0,0
66393,anger,0,0
66394,following,0,0
66395,intervention,0,1
66396,and,0,0
66397,a,0,0
66398,significant,0,0
66399,increase,0,0
66400,in,0,0
66401,their,0,0
66402,own,0,0
66403,confidence,0,0
66404,in,0,0
66405,managing,0,0
66406,anger,0,0
66407,in,0,0
66408,their,0,0
66409,child,0,0
66410,.,0,0
66411,Qualitative,0,0
66412,information,0,0
66413,gathered,0,0
66414,from,0,0
66415,parents,0,0
66416,and,0,0
66417,teachers,0,0
66418,indicated,0,0
66419,some,0,0
66420,generalization,0,0
66421,of,0,0
66422,strategies,0,0
66423,learned,0,0
66424,in,0,0
66425,the,0,0
66426,clinic,0,0
66427,setting,0,0
66428,to,0,0
66429,both,0,0
66430,home,0,1
66431,and,0,0
66432,school,0,0
66433,settings,0,0
66434,.,0,0
66435,Limitations,0,0
66436,of,0,0
66437,the,0,0
66438,study,0,0
66439,and,0,0
66440,suggestions,0,0
66441,for,0,0
66442,future,0,0
66443,research,0,0
66444,are,0,0
66445,also,0,0
66446,discussed,0,0
66447,.,0,0
66448,New,0,0
66449,hope,0,0
66450,for,0,0
66451,children,0,0
66452,with,0,0
66453,Kawasaki,0,0
66454,disease,0,0
66455,.,0,0
66456,Kawasaki,0,0
66457,disease,0,0
66458,is,0,0
66459,now,0,0
66460,the,0,0
66461,most,0,0
66462,common,0,0
66463,cause,0,0
66464,of,0,0
66465,acquired,0,0
66466,heart,0,0
66467,disease,0,0
66468,in,0,0
66469,America,0,0
66470,'s,0,0
66471,children,0,0
66472,.,0,0
66473,It,0,0
66474,is,0,0
66475,an,0,0
66476,acute,0,0
66477,febrile,0,0
66478,illness,0,0
66479,that,0,0
66480,may,0,0
66481,cause,0,0
66482,coronary,0,0
66483,artery,0,0
66484,aneurysm,0,0
66485,formation,0,0
66486,in,0,0
66487,infected,0,0
66488,children,0,0
66489,.,0,0
66490,The,0,0
66491,results,0,0
66492,of,0,0
66493,a,0,0
66494,multicenter,0,0
66495,",",0,0
66496,randomized,0,0
66497,trial,0,0
66498,on,0,0
66499,the,0,0
66500,effect,0,0
66501,of,0,0
66502,intravenous,1,1
66503,administration,1,0
66504,of,1,0
66505,gamma,1,1
66506,globulin,1,1
66507,(,1,0
66508,IVGG,1,1
66509,),1,1
66510,plus,1,1
66511,aspirin,1,1
66512,versus,1,1
66513,aspirin,1,1
66514,alone,1,1
66515,upon,0,0
66516,coronary,0,0
66517,aneurysm,0,0
66518,formation,0,0
66519,show,0,0
66520,a,0,0
66521,decrease,0,0
66522,in,0,0
66523,coronary,0,0
66524,aneurysm,0,0
66525,formation,0,0
66526,from,0,0
66527,the,0,0
66528,usual,0,1
66529,20,0,0
66530,%,0,0
66531,-30,0,0
66532,%,0,0
66533,to,0,0
66534,3,0,0
66535,%,0,0
66536,.,0,0
66537,Administration,0,0
66538,of,0,0
66539,IVGG,1,1
66540,presents,0,0
66541,some,0,0
66542,unique,0,0
66543,challenges,0,0
66544,for,0,0
66545,nurses,0,0
66546,.,0,0
66547,Also,0,0
66548,",",0,0
66549,the,0,0
66550,pediatric,0,0
66551,nurse,0,1
66552,must,0,0
66553,educate,0,0
66554,parents,0,0
66555,and,0,0
66556,children,0,0
66557,about,0,0
66558,this,0,0
66559,disease,0,0
66560,to,0,0
66561,prepare,0,0
66562,them,0,0
66563,for,0,0
66564,discharge,0,0
66565,and,0,0
66566,long-term,0,0
66567,follow-up,0,0
66568,care,0,0
66569,.,0,0
66570,Cost-effectiveness,0,0
66571,of,0,0
66572,collaborative,1,0
66573,care,1,1
66574,including,1,0
66575,PST,1,0
66576,and,1,0
66577,an,1,0
66578,antidepressant,1,1
66579,treatment,1,0
66580,algorithm,1,0
66581,for,0,0
66582,the,0,0
66583,treatment,0,0
66584,of,0,0
66585,major,0,0
66586,depressive,0,0
66587,disorder,0,0
66588,in,0,0
66589,primary,0,0
66590,care,0,0
66591,;,0,0
66592,a,0,0
66593,randomised,0,0
66594,clinical,0,0
66595,trial,0,0
66596,.,0,0
66597,BACKGROUND,0,0
66598,Depressive,0,0
66599,disorder,0,0
66600,is,0,0
66601,currently,0,0
66602,one,0,0
66603,of,0,0
66604,the,0,0
66605,most,0,0
66606,burdensome,0,0
66607,disorders,0,0
66608,worldwide,0,0
66609,.,0,0
66610,Evidence-based,0,0
66611,treatments,0,0
66612,for,0,0
66613,depressive,0,0
66614,disorder,0,0
66615,are,0,0
66616,already,0,0
66617,available,0,0
66618,",",0,0
66619,but,0,0
66620,these,0,0
66621,are,0,0
66622,used,0,0
66623,insufficiently,0,0
66624,",",0,0
66625,and,0,0
66626,with,0,0
66627,less,0,0
66628,positive,0,0
66629,results,0,0
66630,than,0,0
66631,possible,0,0
66632,.,0,0
66633,Earlier,0,0
66634,research,0,0
66635,in,0,0
66636,the,0,0
66637,USA,0,0
66638,has,0,0
66639,shown,0,0
66640,good,0,0
66641,results,0,0
66642,in,0,0
66643,the,0,0
66644,treatment,0,0
66645,of,0,0
66646,depressive,0,0
66647,disorder,0,0
66648,based,0,0
66649,on,0,0
66650,a,0,0
66651,collaborative,1,0
66652,care,1,1
66653,approach,1,1
66654,with,1,0
66655,Problem,1,0
66656,Solving,1,0
66657,Treatment,1,1
66658,and,1,0
66659,an,1,0
66660,antidepressant,1,1
66661,treatment,1,0
66662,algorithm,1,0
66663,",",0,0
66664,and,0,0
66665,research,0,0
66666,in,0,0
66667,the,0,0
66668,UK,0,0
66669,has,0,0
66670,also,0,0
66671,shown,0,0
66672,good,0,0
66673,results,0,0
66674,with,0,0
66675,Problem,1,0
66676,Solving,1,0
66677,Treatment,1,0
66678,.,1,0
66679,These,0,0
66680,treatment,0,0
66681,strategies,0,0
66682,may,0,0
66683,also,0,0
66684,work,0,0
66685,very,0,0
66686,well,0,0
66687,in,0,0
66688,the,0,0
66689,Netherlands,0,0
66690,too,0,0
66691,",",0,0
66692,even,0,0
66693,though,0,0
66694,health,0,0
66695,care,0,0
66696,systems,0,0
66697,differ,0,0
66698,between,0,0
66699,countries,0,0
66700,.,0,0
66701,METHODS/DESIGN,0,0
66702,This,0,0
66703,study,0,0
66704,is,0,0
66705,a,0,0
66706,two-armed,0,0
66707,randomised,0,0
66708,clinical,0,0
66709,trial,0,0
66710,",",0,0
66711,with,0,0
66712,randomization,0,0
66713,on,0,0
66714,patient-level,0,0
66715,.,0,0
66716,The,0,0
66717,aim,0,0
66718,of,0,0
66719,the,0,0
66720,trial,0,0
66721,is,0,0
66722,to,0,0
66723,evaluate,0,0
66724,the,0,0
66725,treatment,0,0
66726,of,0,0
66727,depressive,0,0
66728,disorder,0,0
66729,in,0,0
66730,primary,0,0
66731,care,0,0
66732,in,0,0
66733,the,0,0
66734,Netherlands,0,0
66735,by,0,0
66736,means,0,0
66737,of,0,0
66738,an,0,0
66739,adapted,1,0
66740,collaborative,1,0
66741,care,1,1
66742,framework,1,0
66743,",",1,0
66744,including,1,0
66745,contracting,1,0
66746,and,1,0
66747,adherence-improving,1,1
66748,strategies,1,0
66749,",",1,0
66750,combined,1,0
66751,with,1,0
66752,Problem,1,0
66753,Solving,1,0
66754,Treatment,1,1
66755,and,1,0
66756,antidepressant,1,1
66757,medication,1,1
66758,according,1,0
66759,to,1,0
66760,a,1,0
66761,treatment,1,0
66762,algorithm,1,0
66763,.,1,0
66764,Forty,0,0
66765,general,0,0
66766,practices,0,0
66767,will,0,0
66768,be,0,0
66769,randomised,1,0
66770,to,1,0
66771,either,1,0
66772,the,1,0
66773,intervention,1,1
66774,group,1,0
66775,or,1,1
66776,the,1,0
66777,control,1,0
66778,group,1,0
66779,.,1,0
66780,Included,0,0
66781,will,0,0
66782,be,0,0
66783,patients,0,0
66784,who,0,0
66785,are,0,0
66786,diagnosed,0,0
66787,with,0,0
66788,moderate,0,0
66789,to,0,0
66790,severe,0,0
66791,depression,0,0
66792,",",0,0
66793,based,0,0
66794,on,0,0
66795,DSM-IV,0,0
66796,criteria,0,0
66797,",",0,0
66798,and,0,0
66799,stratified,0,0
66800,according,0,0
66801,to,0,0
66802,comorbid,0,0
66803,chronic,0,0
66804,physical,0,0
66805,illness,0,0
66806,.,0,0
66807,Patients,1,0
66808,in,1,0
66809,the,1,0
66810,intervention,1,1
66811,group,1,0
66812,will,1,0
66813,receive,1,0
66814,treatment,1,0
66815,based,1,0
66816,on,1,0
66817,the,1,0
66818,collaborative,1,0
66819,care,1,1
66820,approach,1,1
66821,",",1,0
66822,and,1,0
66823,patients,1,0
66824,in,1,0
66825,the,1,0
66826,control,1,0
66827,group,1,0
66828,will,1,0
66829,receive,1,0
66830,care,1,0
66831,as,1,0
66832,usual,1,1
66833,.,1,0
66834,Baseline,1,0
66835,measurements,1,0
66836,and,1,0
66837,follow,1,0
66838,up,1,0
66839,measures,1,0
66840,(,1,0
66841,3,1,0
66842,",",1,0
66843,6,1,0
66844,",",1,0
66845,9,1,0
66846,and,1,0
66847,12,1,0
66848,months,1,0
66849,),1,0
66850,are,1,0
66851,assessed,1,0
66852,using,1,0
66853,questionnaires,1,1
66854,and,1,0
66855,an,1,0
66856,interview,1,0
66857,.,1,0
66858,The,0,0
66859,primary,0,0
66860,outcome,0,0
66861,measure,0,0
66862,is,0,0
66863,severity,0,0
66864,of,0,0
66865,depressive,0,0
66866,symptoms,0,0
66867,",",0,0
66868,according,0,0
66869,to,0,0
66870,the,0,0
66871,PHQ9,0,0
66872,.,0,0
66873,Secondary,0,0
66874,outcome,0,0
66875,measures,0,0
66876,are,0,0
66877,remission,0,0
66878,as,0,0
66879,measured,0,0
66880,with,0,0
66881,the,0,0
66882,PHQ9,0,0
66883,and,0,0
66884,the,0,0
66885,IDS-SR,0,0
66886,",",0,0
66887,and,0,0
66888,cost-effectiveness,0,0
66889,measured,0,0
66890,with,0,0
66891,the,0,0
66892,TiC-P,0,0
66893,",",0,0
66894,the,0,0
66895,EQ-5D,0,0
66896,and,0,0
66897,the,0,0
66898,SF-36,0,1
66899,.,0,0
66900,DISCUSSION,0,0
66901,In,0,0
66902,this,0,0
66903,study,0,0
66904,",",0,0
66905,an,0,0
66906,American,0,0
66907,model,0,0
66908,to,0,0
66909,enhance,0,0
66910,care,0,0
66911,for,0,0
66912,patients,0,0
66913,with,0,0
66914,a,0,0
66915,depressive,0,0
66916,disorder,0,0
66917,",",0,0
66918,the,0,0
66919,collaborative,1,0
66920,care,1,1
66921,model,1,0
66922,",",0,0
66923,will,0,0
66924,be,0,0
66925,evaluated,0,0
66926,for,0,0
66927,effectiveness,0,0
66928,in,0,0
66929,the,0,0
66930,primary,0,0
66931,care,0,0
66932,setting,0,0
66933,.,0,0
66934,If,0,0
66935,effective,0,0
66936,across,0,0
66937,the,0,0
66938,Atlantic,0,0
66939,and,0,0
66940,across,0,0
66941,different,0,0
66942,health,0,0
66943,care,0,1
66944,systems,0,0
66945,",",0,0
66946,it,0,0
66947,is,0,0
66948,also,0,0
66949,likely,0,0
66950,to,0,0
66951,be,0,0
66952,an,0,0
66953,effective,0,0
66954,strategy,0,0
66955,to,0,0
66956,implement,0,0
66957,in,0,0
66958,the,0,0
66959,treatment,0,0
66960,of,0,0
66961,major,0,0
66962,depressive,0,0
66963,disorder,0,0
66964,in,0,0
66965,the,0,0
66966,Netherlands,0,0
66967,.,0,0
66968,Compliance,0,0
66969,with,0,0
66970,continuous,1,1
66971,passive,1,0
66972,movement,1,0
66973,is,0,0
66974,low,0,0
66975,after,0,0
66976,surgical,0,0
66977,treatment,0,0
66978,of,0,0
66979,idiopathic,0,0
66980,club,0,0
66981,foot,0,0
66982,in,0,0
66983,infants,0,0
66984,:,0,0
66985,a,0,0
66986,prospective,0,0
66987,",",0,0
66988,double-blinded,0,0
66989,clinical,0,0
66990,study,0,0
66991,.,0,0
66992,Treatment,0,0
66993,by,0,0
66994,continuous,1,1
66995,passive,1,0
66996,movement,1,0
66997,at,1,0
66998,home,1,1
66999,is,0,0
67000,an,0,0
67001,alternative,0,0
67002,to,0,0
67003,immobilisation,0,1
67004,in,0,0
67005,a,0,0
67006,cast,0,1
67007,after,0,0
67008,surgery,0,0
67009,for,0,0
67010,club,0,0
67011,foot,0,0
67012,.,0,0
67013,Compliance,0,0
67014,with,0,0
67015,the,0,0
67016,recommended,0,0
67017,treatment,0,0
67018,",",0,0
67019,of,0,0
67020,at,0,0
67021,least,0,0
67022,four,0,0
67023,hours,0,0
67024,daily,0,0
67025,",",0,0
67026,is,0,0
67027,unknown,0,0
67028,.,0,0
67029,The,0,0
67030,duration,0,0
67031,of,0,0
67032,treatment,0,0
67033,was,0,0
67034,measured,0,0
67035,in,0,0
67036,24,0,0
67037,of,0,0
67038,27,0,0
67039,consecutive,0,0
67040,children,0,0
67041,with,0,0
67042,a,0,0
67043,mean,0,0
67044,age,0,0
67045,of,0,0
67046,24,0,0
67047,months,0,0
67048,(,0,0
67049,5,0,0
67050,to,0,0
67051,75,0,0
67052,),0,0
67053,following,0,0
67054,posteromedial,0,1
67055,release,0,0
67056,for,0,0
67057,idiopathic,0,0
67058,club,0,0
67059,foot,0,0
67060,.,0,0
67061,Only,0,0
67062,21,0,0
67063,%,0,0
67064,(,0,0
67065,5,0,0
67066,),0,0
67067,of,0,0
67068,the,0,0
67069,children,0,0
67070,used,0,0
67071,the,0,0
67072,continuous,1,1
67073,passive,1,1
67074,movement,1,0
67075,machine,0,1
67076,as,0,0
67077,recommended,0,0
67078,.,0,0
67079,The,0,0
67080,mean,0,0
67081,duration,0,0
67082,of,0,0
67083,treatment,0,0
67084,at,0,0
67085,home,0,0
67086,each,0,0
67087,day,0,0
67088,was,0,0
67089,126,0,0
67090,minutes,0,0
67091,(,0,0
67092,11,0,0
67093,to,0,0
67094,496,0,0
67095,),0,0
67096,.,0,0
67097,The,0,0
67098,mean,0,0
67099,range,0,0
67100,of,0,0
67101,movement,0,0
67102,for,0,0
67103,plantar,0,0
67104,flexion,0,0
67105,improved,0,0
67106,from,0,0
67107,15.2,0,0
67108,degrees,0,0
67109,(,0,0
67110,10.0,0,0
67111,degrees,0,0
67112,to,0,0
67113,20.6,0,0
67114,degrees,0,0
67115,),0,0
67116,to,0,0
67117,18.7,0,0
67118,degrees,0,0
67119,(,0,0
67120,10.0,0,0
67121,degrees,0,0
67122,to,0,0
67123,33.0,0,0
67124,degrees,0,0
67125,),0,0
67126,and,0,0
67127,for,0,0
67128,dorsiflexion,0,0
67129,from,0,0
67130,12.3,0,0
67131,degrees,0,0
67132,(,0,0
67133,7.4,0,0
67134,degrees,0,0
67135,to,0,0
67136,19.4,0,0
67137,degrees,0,0
67138,),0,0
67139,to,0,0
67140,18.9,0,0
67141,degrees,0,0
67142,(,0,0
67143,10.0,0,0
67144,degrees,0,0
67145,to,0,0
67146,24.1,0,0
67147,degrees,0,0
67148,),0,0
67149,(,0,0
67150,both,0,0
67151,",",0,0
67152,p,0,0
67153,=,0,0
67154,0.0001,0,0
67155,),0,0
67156,when,0,0
67157,the,0,0
67158,first,0,0
67159,third,0,0
67160,of,0,0
67161,therapy,0,1
67162,was,0,0
67163,compared,0,0
67164,with,0,0
67165,the,0,0
67166,last,0,0
67167,third,0,0
67168,.,0,0
67169,A,0,0
67170,low,0,0
67171,level,0,0
67172,of,0,0
67173,patient,0,0
67174,compliance,0,0
67175,must,0,0
67176,be,0,0
67177,considered,0,0
67178,when,0,0
67179,the,0,0
67180,outcome,0,0
67181,after,0,0
67182,treatment,0,0
67183,at,0,0
67184,home,0,1
67185,is,0,0
67186,interpreted,0,0
67187,.,0,0
67188,Providing,0,0
67189,live,1,0
67190,supervision,1,1
67191,via,1,0
67192,teleconferencing,1,1
67193,improves,0,0
67194,acquisition,0,0
67195,of,0,0
67196,motivational,0,1
67197,interviewing,0,1
67198,skills,0,1
67199,after,0,0
67200,workshop,0,1
67201,attendance,0,0
67202,.,0,0
67203,Teleconferencing,1,0
67204,Supervision,1,1
67205,is,0,0
67206,a,0,0
67207,method,0,0
67208,for,0,0
67209,training,0,1
67210,community-based,0,1
67211,substance,0,0
67212,abuse,0,0
67213,clinicians,0,0
67214,in,0,0
67215,Motivational,1,0
67216,Interviewing,1,1
67217,(,1,0
67218,MI,1,1
67219,),1,0
67220,.,1,0
67221,Following,0,0
67222,a,0,0
67223,2-day,0,1
67224,workshop,0,1
67225,",",0,0
67226,13,0,0
67227,clinicians,0,0
67228,received,0,0
67229,live,1,0
67230,supervision,1,1
67231,via,1,0
67232,telephone,1,1
67233,during,0,0
67234,5,0,0
67235,counseling,0,0
67236,sessions,0,1
67237,conducted,0,0
67238,at,0,0
67239,their,0,0
67240,community,0,0
67241,treatment,0,0
67242,facilities,0,0
67243,.,0,0
67244,Clinicians,0,0
67245,were,0,0
67246,assessed,0,0
67247,for,0,0
67248,skill,0,0
67249,level,0,0
67250,at,0,0
67251,post-workshop,0,1
67252,",",0,0
67253,at,0,0
67254,post-training,0,1
67255,",",0,0
67256,and,0,0
67257,3,0,0
67258,months,0,0
67259,later,0,0
67260,;,0,0
67261,learning,0,0
67262,was,0,0
67263,assessed,0,0
67264,using,0,0
67265,the,0,0
67266,MI,0,1
67267,Treatment,0,1
67268,Integrity,0,0
67269,instrument,0,0
67270,.,0,0
67271,All,0,0
67272,summary,0,0
67273,scores,0,0
67274,and,0,0
67275,therapist,0,1
67276,behavior,0,0
67277,frequency,0,0
67278,counts,0,0
67279,improved,0,0
67280,by,0,0
67281,post-training,0,1
67282,or,0,0
67283,by,0,0
67284,the,0,0
67285,3,0,0
67286,month,0,0
67287,follow-up,0,0
67288,",",0,0
67289,although,0,0
67290,some,0,0
67291,gains,0,0
67292,were,0,0
67293,not,0,0
67294,statistically,0,0
67295,significant,0,0
67296,.,0,0
67297,Teleconferencing,1,0
67298,Supervision,1,0
67299,may,0,0
67300,help,0,0
67301,facilitate,0,0
67302,the,0,0
67303,proficient,0,0
67304,use,0,0
67305,of,0,0
67306,MI,0,1
67307,community,0,0
67308,clinicians,0,0
67309,following,0,0
67310,workshop,0,1
67311,instruction,0,1
67312,.,0,0
67313,Safety,0,0
67314,",",0,0
67315,pharmacokinetics,0,0
67316,and,0,0
67317,pharmocodynamics,0,0
67318,of,0,0
67319,recombinant,1,1
67320,human,1,1
67321,porphobilinogen,1,1
67322,deaminase,1,1
67323,in,0,0
67324,healthy,0,0
67325,subjects,0,0
67326,and,0,0
67327,asymptomatic,0,0
67328,carriers,0,0
67329,of,0,0
67330,the,0,0
67331,acute,0,0
67332,intermittent,0,1
67333,porphyria,0,0
67334,gene,0,0
67335,who,0,0
67336,have,0,0
67337,increased,0,0
67338,porphyrin,0,1
67339,precursor,0,0
67340,excretion,0,0
67341,.,0,0
67342,BACKGROUND,0,0
67343,AND,0,0
67344,OBJECTIVE,0,0
67345,Acute,0,0
67346,intermittent,0,1
67347,porphyria,0,0
67348,is,0,0
67349,an,0,0
67350,autosomal,0,0
67351,dominant,0,0
67352,disorder,0,0
67353,caused,0,0
67354,by,0,0
67355,deficient,0,0
67356,activity,0,0
67357,of,0,0
67358,the,0,0
67359,third,0,0
67360,enzyme,0,0
67361,in,0,0
67362,the,0,0
67363,haem,0,0
67364,biosynthetic,0,0
67365,pathway,0,0
67366,",",0,0
67367,porphobilinogen,0,0
67368,deaminase,0,1
67369,.,0,0
67370,It,0,0
67371,is,0,0
67372,characterised,0,0
67373,by,0,0
67374,acute,0,0
67375,",",0,0
67376,potentially,0,0
67377,life-threatening,0,0
67378,neurological,0,0
67379,attacks,0,0
67380,that,0,0
67381,are,0,0
67382,precipitated,0,0
67383,by,0,0
67384,various,0,0
67385,drugs,0,0
67386,",",0,0
67387,reproductive,0,0
67388,hormones,0,0
67389,and,0,0
67390,other,0,0
67391,factors,0,0
67392,.,0,0
67393,During,0,0
67394,acute,0,0
67395,attacks,0,0
67396,",",0,0
67397,the,0,0
67398,porphyrin,0,0
67399,precursors,0,0
67400,5-aminolevulinic,0,1
67401,acid,0,1
67402,and,0,0
67403,porphobilinogen,0,1
67404,accumulate,0,0
67405,and,0,0
67406,are,0,0
67407,excreted,0,0
67408,at,0,0
67409,high,0,0
67410,concentrations,0,0
67411,in,0,0
67412,the,0,0
67413,urine,0,0
67414,.,0,0
67415,Current,0,0
67416,treatment,0,0
67417,is,0,0
67418,based,0,0
67419,on,0,0
67420,glucose,0,0
67421,loading,0,1
67422,and,0,0
67423,parenteral,0,1
67424,haem,0,1
67425,replenishment,0,0
67426,",",0,0
67427,which,0,0
67428,reduce,0,0
67429,the,0,0
67430,accumulation,0,0
67431,of,0,0
67432,5-aminolevulinic,0,1
67433,acid,0,1
67434,and,0,0
67435,porphobilinogen,0,0
67436,.,0,0
67437,Recently,0,0
67438,",",0,0
67439,a,0,0
67440,new,0,0
67441,form,0,0
67442,of,0,0
67443,treatment,0,0
67444,based,0,0
67445,on,0,0
67446,porphobilinogen,1,0
67447,deaminase,1,1
67448,enzyme,1,1
67449,replacement,1,1
67450,therapy,1,1
67451,has,0,0
67452,been,0,0
67453,shown,0,0
67454,to,0,0
67455,be,0,0
67456,effective,0,0
67457,in,0,0
67458,an,0,0
67459,acute,0,0
67460,intermittent,0,1
67461,porphyria,0,0
67462,mouse,0,0
67463,model,0,0
67464,which,0,0
67465,",",0,0
67466,during,0,0
67467,phenobarbital,0,1
67468,(,0,0
67469,phenobarbitone,0,1
67470,),0,1
67471,induction,0,0
67472,of,0,0
67473,haem,0,0
67474,biosynthesis,0,0
67475,",",0,0
67476,mimics,0,0
67477,the,0,0
67478,biochemical,0,0
67479,pattern,0,0
67480,of,0,0
67481,acute,0,0
67482,porphyric,0,0
67483,attacks,0,0
67484,.,0,0
67485,The,0,0
67486,objective,0,0
67487,of,0,0
67488,the,0,0
67489,present,0,0
67490,study,0,0
67491,was,0,0
67492,to,0,0
67493,investigate,0,0
67494,the,0,0
67495,safety,0,0
67496,",",0,0
67497,pharmacokinetics,0,0
67498,and,0,0
67499,pharmacodynamics,0,0
67500,of,0,0
67501,recombinant,1,1
67502,human,1,1
67503,porphobilinogen,1,1
67504,deaminase,1,1
67505,(,1,0
67506,P,1,0
67507,9808,1,0
67508,),1,0
67509,",",0,0
67510,administered,0,0
67511,to,0,0
67512,healthy,0,0
67513,subjects,0,0
67514,and,0,0
67515,asymptomatic,0,0
67516,porphobilinogen,0,1
67517,deaminase-deficient,0,0
67518,subjects,0,0
67519,with,0,0
67520,high,0,0
67521,concentrations,0,0
67522,of,0,0
67523,porphobilinogen,0,0
67524,",",0,0
67525,the,0,0
67526,substrate,0,0
67527,of,0,0
67528,porphobilinogen,0,0
67529,deaminase,0,1
67530,.,0,0
67531,STUDY,0,0
67532,DESIGN,0,0
67533,Forty,0,0
67534,individuals,0,0
67535,participated,0,0
67536,in,0,0
67537,this,0,0
67538,two-part,0,0
67539,study,0,0
67540,:,0,0
67541,20,0,0
67542,asymptomatic,0,0
67543,porphobilinogen,0,0
67544,deaminase-deficient,0,0
67545,subjects,0,0
67546,(,0,0
67547,both,0,0
67548,male,0,0
67549,and,0,0
67550,female,0,0
67551,),0,0
67552,with,0,0
67553,>,0,0
67554,or,0,0
67555,=4,0,0
67556,times,0,0
67557,the,0,0
67558,upper,0,0
67559,reference,0,0
67560,urinary,0,0
67561,porphobilinogen,0,1
67562,level,0,0
67563,",",0,0
67564,and,0,0
67565,20,0,0
67566,healthy,0,0
67567,male,0,0
67568,subjects,0,0
67569,.,0,0
67570,Four,0,0
67571,different,0,0
67572,doses,0,0
67573,of,0,0
67574,recombinant,1,1
67575,human,1,1
67576,porphobilinogen,1,1
67577,deaminase,1,1
67578,were,0,0
67579,studied,0,0
67580,(,0,0
67581,0.5,0,0
67582,",",0,0
67583,1,0,0
67584,",",0,0
67585,2,0,0
67586,and,0,0
67587,4,0,0
67588,mg/kg,0,1
67589,bodyweight,0,0
67590,),0,0
67591,.,0,0
67592,Part,0,0
67593,A,0,0
67594,included,0,0
67595,12,0,0
67596,asymptomatic,0,0
67597,porphobilinogen,0,0
67598,deaminase-deficient,0,0
67599,subjects,0,0
67600,",",0,0
67601,and,0,0
67602,the,0,0
67603,enzyme,0,0
67604,was,0,0
67605,administered,0,0
67606,in,0,0
67607,an,0,0
67608,open-label,0,0
67609,",",0,0
67610,single-dose,0,0
67611,design,0,0
67612,.,0,0
67613,Part,0,0
67614,B,0,0
67615,included,0,0
67616,20,0,0
67617,asymptomatic,0,0
67618,porphobilinogen,0,0
67619,deaminase-deficient,0,0
67620,subjects,0,0
67621,and,0,0
67622,20,0,0
67623,healthy,0,0
67624,subjects,0,0
67625,.,0,0
67626,The,0,0
67627,same,0,0
67628,enzyme,0,0
67629,dosages,0,0
67630,were,0,0
67631,administered,0,0
67632,as,0,0
67633,divided,0,0
67634,doses,0,0
67635,every,0,0
67636,12,0,0
67637,hours,0,0
67638,for,0,0
67639,4,0,0
67640,consecutive,0,0
67641,days,0,0
67642,in,0,0
67643,a,0,0
67644,randomised,0,0
67645,",",0,0
67646,double-blinded,0,0
67647,",",0,0
67648,placebo-controlled,0,1
67649,design,0,0
67650,.,0,0
67651,The,0,0
67652,washout,0,0
67653,period,0,0
67654,between,0,0
67655,Parts,0,1
67656,A,0,0
67657,and,0,0
67658,B,0,0
67659,was,0,0
67660,2,0,0
67661,weeks,0,0
67662,.,0,0
67663,METHODS,0,0
67664,The,0,0
67665,concentrations,0,0
67666,of,0,0
67667,recombinant,0,1
67668,human,0,1
67669,porphobilinogen,1,1
67670,deaminase,1,1
67671,and,0,0
67672,titres,0,0
67673,of,0,0
67674,antibodies,0,0
67675,against,0,0
67676,recombinant,0,1
67677,human,0,1
67678,porphobilinogen,0,1
67679,deaminase,0,1
67680,were,0,0
67681,analysed,0,0
67682,by,0,0
67683,ELISA,0,0
67684,.,0,0
67685,Plasma,0,0
67686,porphobilinogen,0,0
67687,and,0,0
67688,5-aminolevulinic,0,1
67689,acid,0,1
67690,concentrations,0,0
67691,were,0,0
67692,analysed,0,0
67693,using,0,0
67694,a,0,0
67695,novel,0,0
67696,liquid,0,1
67697,chromatography-tandem,0,0
67698,mass,0,0
67699,spectrometry,0,1
67700,method,0,0
67701,.,0,0
67702,Urinary,0,0
67703,porphobilinogen,0,0
67704,",",0,0
67705,5-aminolevulinic,0,1
67706,acid,0,1
67707,and,0,0
67708,porphyrin,0,0
67709,concentrations,0,0
67710,",",0,0
67711,as,0,0
67712,well,0,0
67713,as,0,0
67714,plasma,0,0
67715,porphyrin,0,0
67716,concentrations,0,0
67717,",",0,0
67718,were,0,0
67719,analysed,0,0
67720,using,0,0
67721,standard,0,0
67722,methods,0,0
67723,.,0,0
67724,The,0,0
67725,pharmacodynamic,0,0
67726,effect,0,0
67727,of,0,0
67728,the,0,0
67729,enzyme,0,0
67730,was,0,0
67731,studied,0,0
67732,through,0,0
67733,changes,0,0
67734,in,0,0
67735,plasma,0,0
67736,porphobilinogen,0,0
67737,concentrations,0,0
67738,.,0,0
67739,RESULTS,0,0
67740,No,0,0
67741,serious,0,0
67742,adverse,0,0
67743,events,0,0
67744,were,0,0
67745,observed,0,0
67746,.,0,0
67747,Seven,0,0
67748,subjects,0,0
67749,(,0,0
67750,four,0,0
67751,healthy,0,0
67752,men,0,0
67753,and,0,0
67754,three,0,0
67755,asymptomatic,0,0
67756,porphobilinogen,0,0
67757,deaminase-deficient,0,0
67758,subjects,0,0
67759,),0,0
67760,developed,0,0
67761,antibodies,0,0
67762,against,0,0
67763,recombinant,0,1
67764,human,1,1
67765,porphobilinogen,1,1
67766,deaminase,1,1
67767,but,0,0
67768,did,0,0
67769,not,0,0
67770,experience,0,0
67771,allergic,0,0
67772,manifestations,0,0
67773,.,0,0
67774,The,0,0
67775,mean,0,0
67776,elimination,0,0
67777,half-lives,0,0
67778,of,0,0
67779,the,0,0
67780,highest,0,0
67781,doses,0,0
67782,of,0,0
67783,recombinant,0,1
67784,human,1,1
67785,porphobilinogen,1,1
67786,deaminase,1,1
67787,ranged,0,0
67788,between,0,0
67789,1.7,0,0
67790,and,0,0
67791,2.5,0,0
67792,hours,0,0
67793,for,0,0
67794,both,0,0
67795,healthy,0,0
67796,men,0,0
67797,and,0,0
67798,asymptomatic,0,0
67799,porphobilinogen,0,1
67800,deaminase-deficient,0,0
67801,subjects,0,0
67802,.,0,0
67803,The,0,0
67804,area,0,0
67805,under,0,0
67806,the,0,0
67807,plasma,0,0
67808,concentration-time,0,0
67809,curve,0,0
67810,was,0,0
67811,proportional,0,0
67812,to,0,0
67813,the,0,0
67814,respective,0,0
67815,dose,0,0
67816,.,0,0
67817,In,0,0
67818,asymptomatic,0,0
67819,porphobilinogen,0,0
67820,deaminase-deficient,0,0
67821,subjects,0,0
67822,",",0,0
67823,plasma,0,0
67824,porphobilinogen,0,0
67825,concentrations,0,0
67826,decreased,0,0
67827,below,0,0
67828,measurable,0,0
67829,levels,0,0
67830,almost,0,0
67831,instantaneously,0,0
67832,after,0,0
67833,administration,0,0
67834,of,0,0
67835,any,0,0
67836,dose,0,0
67837,of,0,0
67838,the,0,0
67839,enzyme,0,0
67840,.,0,0
67841,The,0,0
67842,effect,0,0
67843,lasted,0,0
67844,for,0,0
67845,approximately,0,0
67846,2,0,0
67847,hours,0,0
67848,",",0,0
67849,after,0,0
67850,which,0,0
67851,the,0,0
67852,plasma,0,0
67853,porphobilinogen,0,1
67854,concentration,0,0
67855,slowly,0,0
67856,increased,0,0
67857,",",0,0
67858,reaching,0,0
67859,about,0,0
67860,70,0,0
67861,%,0,0
67862,of,0,0
67863,the,0,0
67864,initial,0,0
67865,values,0,0
67866,12,0,0
67867,hours,0,0
67868,after,0,0
67869,administration,0,0
67870,.,0,0
67871,There,0,0
67872,was,0,0
67873,no,0,0
67874,effect,0,0
67875,on,0,0
67876,plasma,0,0
67877,5-aminolevulinic,0,1
67878,acid,0,1
67879,concentrations,0,0
67880,",",0,0
67881,and,0,0
67882,there,0,0
67883,was,0,0
67884,a,0,0
67885,transitory,0,0
67886,increment,0,0
67887,in,0,0
67888,porphyrin,0,0
67889,concentrations,0,0
67890,.,0,0
67891,The,0,0
67892,corresponding,0,0
67893,concentrations,0,0
67894,of,0,0
67895,metabolites,0,0
67896,in,0,0
67897,the,0,0
67898,urine,0,0
67899,reflected,0,0
67900,the,0,0
67901,pattern,0,0
67902,observed,0,0
67903,in,0,0
67904,the,0,0
67905,plasma,0,0
67906,.,0,0
67907,CONCLUSIONS,0,0
67908,The,0,0
67909,recombinant,1,1
67910,human,1,0
67911,porphobilinogen,1,1
67912,deaminase,1,1
67913,enzyme,1,0
67914,preparation,1,1
67915,was,0,0
67916,found,0,0
67917,to,0,0
67918,be,0,0
67919,safe,0,0
67920,to,0,0
67921,administer,0,0
67922,and,0,0
67923,effective,0,0
67924,for,0,0
67925,removal,0,0
67926,of,0,0
67927,the,0,0
67928,accumulated,0,0
67929,metabolite,0,0
67930,porphobilinogen,0,1
67931,from,0,0
67932,plasma,0,0
67933,and,0,0
67934,urine,0,0
67935,.,0,0
67936,The,0,0
67937,pharmacokinetic,0,0
67938,profile,0,0
67939,of,0,0
67940,recombinant,1,1
67941,human,1,1
67942,porphobilinogen,1,1
67943,deaminase,1,1
67944,showed,0,0
67945,dose,0,0
67946,proportionality,0,0
67947,",",0,0
67948,and,0,0
67949,the,0,0
67950,elimination,0,0
67951,half-life,0,0
67952,was,0,0
67953,about,0,0
67954,2.0,0,0
67955,hours,0,0
67956,for,0,0
67957,the,0,0
67958,two,0,0
67959,highest,0,0
67960,doses,0,0
67961,.,0,0
67962,Thus,0,0
67963,",",0,0
67964,clinical,0,0
67965,grounds,0,0
67966,were,0,0
67967,established,0,0
67968,for,0,0
67969,investigation,0,0
67970,of,0,0
67971,the,0,0
67972,therapeutic,0,0
67973,efficacy,0,0
67974,of,0,0
67975,the,0,0
67976,enzyme,0,0
67977,during,0,0
67978,periods,0,0
67979,of,0,0
67980,overt,0,0
67981,disease,0,0
67982,in,0,0
67983,patients,0,0
67984,with,0,0
67985,acute,0,0
67986,intermittent,0,1
67987,porphyria,0,0
67988,.,0,0
67989,A,0,0
67990,comparison,0,0
67991,of,0,0
67992,laser-assisted,1,1
67993,drug,1,0
67994,delivery,1,0
67995,at,0,0
67996,two,0,0
67997,output,0,0
67998,energies,0,0
67999,for,0,0
68000,enhancing,0,0
68001,the,0,0
68002,delivery,0,0
68003,of,0,0
68004,topically,1,1
68005,applied,1,0
68006,LMX-4,1,1
68007,cream,1,1
68008,prior,0,0
68009,to,0,0
68010,venipuncture,1,0
68011,.,1,0
68012,BACKGROUND,0,0
68013,Laser-assisted,1,1
68014,drug,1,1
68015,delivery,1,0
68016,(,1,0
68017,LAD,1,0
68018,),1,1
68019,has,0,0
68020,the,0,0
68021,potential,0,0
68022,for,0,0
68023,facilitating,0,0
68024,topical,0,1
68025,anesthesia,0,1
68026,with,0,0
68027,reduced,0,0
68028,onset,0,0
68029,time,0,0
68030,.,0,0
68031,METHODS,0,0
68032,In,0,0
68033,this,0,0
68034,randomized,0,0
68035,",",0,0
68036,double-blind,0,0
68037,",",0,0
68038,crossover,0,0
68039,study,0,0
68040,we,0,0
68041,compared,0,0
68042,the,0,0
68043,efficacy,0,0
68044,and,0,0
68045,adverse,0,0
68046,event,0,0
68047,profile,0,0
68048,of,0,0
68049,LAD,1,0
68050,for,1,0
68051,topical,1,1
68052,anesthesia,1,1
68053,before,0,0
68054,venipuncture,1,0
68055,using,0,0
68056,two,0,0
68057,output,0,0
68058,energies,0,0
68059,(,0,0
68060,2.0,0,0
68061,and,0,0
68062,3.5,0,0
68063,J/cm2,0,0
68064,),0,0
68065,.,0,0
68066,RESULTS,0,0
68067,Mean,0,0
68068,Visual,0,1
68069,Analog,0,1
68070,Scale,0,0
68071,pain,0,0
68072,scores,0,0
68073,were,0,0
68074,not,0,0
68075,statistically,0,0
68076,different,0,0
68077,(,0,0
68078,P,0,0
68079,=,0,0
68080,0.57,0,0
68081,),0,0
68082,between,0,0
68083,the,0,0
68084,low-energy,0,1
68085,(,0,0
68086,mean,0,0
68087,=,0,0
68088,6.7,0,0
68089,),0,0
68090,and,0,0
68091,high-energy,0,1
68092,(,0,0
68093,mean,0,0
68094,=,0,0
68095,8.1,0,0
68096,),0,0
68097,lasers,0,1
68098,.,0,0
68099,CONCLUSIONS,0,0
68100,LAD,1,0
68101,at,0,0
68102,an,0,0
68103,energy,0,0
68104,of,0,0
68105,2.0,0,0
68106,J/cm2,0,0
68107,(,0,0
68108,570,0,0
68109,mJ,0,0
68110,),0,0
68111,is,0,0
68112,as,0,0
68113,effective,0,0
68114,",",0,0
68115,with,0,0
68116,similar,0,0
68117,adverse,0,0
68118,events,0,0
68119,",",0,0
68120,as,0,0
68121,an,0,0
68122,energy,0,0
68123,of,0,0
68124,3.5,0,0
68125,J/cm2,0,0
68126,(,0,0
68127,1000,0,0
68128,mJ,0,0
68129,),0,0
68130,in,0,0
68131,facilitating,0,0
68132,topical,0,1
68133,anesthesia,0,1
68134,.,0,0
68135,Exercise,0,1
68136,capacity,0,0
68137,in,0,0
68138,atrial,0,0
68139,fibrillation,0,0
68140,:,0,0
68141,a,0,0
68142,substudy,0,0
68143,of,0,0
68144,the,0,0
68145,Sotalol-Amiodarone,0,1
68146,Atrial,0,0
68147,Fibrillation,0,1
68148,Efficacy,0,0
68149,Trial,0,1
68150,(,0,0
68151,SAFE-T,0,0
68152,),0,0
68153,.,0,0
68154,BACKGROUND,0,0
68155,Therapy,0,1
68156,for,0,0
68157,chronic,0,0
68158,atrial,0,0
68159,fibrillation,0,0
68160,(,0,0
68161,AF,0,1
68162,),0,1
68163,focuses,0,0
68164,on,0,0
68165,rate,0,0
68166,versus,0,1
68167,rhythm,0,1
68168,control,0,0
68169,",",0,0
68170,but,0,0
68171,little,0,0
68172,is,0,0
68173,known,0,0
68174,about,0,0
68175,the,0,0
68176,effects,0,0
68177,of,0,0
68178,common,0,0
68179,therapeutic,0,0
68180,interventions,0,0
68181,on,0,0
68182,exercise,0,1
68183,tolerance,0,0
68184,in,0,0
68185,AF,0,0
68186,.,0,0
68187,METHODS,0,0
68188,Six,0,0
68189,hundred,0,0
68190,fifty-five,0,0
68191,patients,0,0
68192,with,0,0
68193,chronic,0,0
68194,AF,0,1
68195,underwent,0,0
68196,maximal,1,0
68197,exercise,1,1
68198,testing,1,0
68199,at,0,0
68200,baseline,0,0
68201,and,0,0
68202,8,0,0
68203,weeks,0,0
68204,",",0,0
68205,6,0,0
68206,months,0,0
68207,",",0,0
68208,and,0,0
68209,1,0,0
68210,year,0,0
68211,after,0,0
68212,randomization,0,0
68213,to,0,0
68214,sotalol,1,1
68215,",",1,0
68216,amiodarone,1,1
68217,",",1,0
68218,or,1,1
68219,placebo,1,1
68220,therapy,0,1
68221,and,0,0
68222,attempted,1,0
68223,direct,1,1
68224,current,1,0
68225,cardioversion,1,1
68226,.,1,0
68227,Analyses,0,0
68228,of,0,0
68229,baseline,0,0
68230,determinants,0,0
68231,of,0,0
68232,exercise,0,1
68233,capacity,0,0
68234,",",0,0
68235,predictors,0,0
68236,of,0,0
68237,change,0,0
68238,in,0,0
68239,exercise,0,1
68240,capacity,0,0
68241,at,0,0
68242,6,0,0
68243,months,0,0
68244,and,0,0
68245,1,0,0
68246,year,0,0
68247,",",0,0
68248,and,0,0
68249,the,0,0
68250,short-,0,0
68251,and,0,0
68252,long-term,0,0
68253,effects,0,0
68254,of,0,0
68255,cardioversion,0,1
68256,on,0,0
68257,exercise,0,1
68258,capacity,0,0
68259,were,0,0
68260,made,0,0
68261,.,0,0
68262,RESULTS,0,0
68263,Age,0,0
68264,",",0,0
68265,obesity,0,0
68266,",",0,0
68267,and,0,0
68268,presence,0,0
68269,of,0,0
68270,symptoms,0,0
68271,accompanying,0,0
68272,AF,0,0
68273,were,0,0
68274,inversely,0,0
68275,associated,0,0
68276,with,0,0
68277,baseline,0,0
68278,exercise,0,1
68279,capacity,0,0
68280,",",0,0
68281,but,0,0
68282,these,0,0
68283,factors,0,0
68284,accounted,0,0
68285,for,0,0
68286,only,0,0
68287,10,0,0
68288,%,0,0
68289,of,0,0
68290,the,0,0
68291,variance,0,0
68292,in,0,0
68293,exercise,0,1
68294,capacity,0,0
68295,.,0,0
68296,Patients,0,0
68297,most,0,0
68298,likely,0,0
68299,to,0,0
68300,benefit,0,0
68301,from,0,0
68302,cardioversion,0,1
68303,were,0,0
68304,those,0,0
68305,most,0,0
68306,limited,0,0
68307,initially,0,0
68308,",",0,0
68309,younger,0,0
68310,",",0,0
68311,not,0,0
68312,obese,0,0
68313,or,0,0
68314,hypertensive,0,0
68315,",",0,0
68316,and,0,0
68317,with,0,0
68318,an,0,0
68319,uncontrolled,0,0
68320,ventricular,0,0
68321,rate,0,0
68322,at,0,0
68323,baseline,0,0
68324,.,0,0
68325,Conversion,0,0
68326,to,0,0
68327,sinus,0,0
68328,rhythm,0,1
68329,(,0,0
68330,SR,0,1
68331,),0,0
68332,resulted,0,0
68333,in,0,0
68334,significant,0,0
68335,reductions,0,0
68336,in,0,0
68337,resting,0,0
68338,(,0,0
68339,approximately,0,0
68340,25,0,0
68341,beat/min,0,0
68342,),0,0
68343,and,0,0
68344,peak,0,0
68345,exercise,0,1
68346,(,0,0
68347,approximately,0,0
68348,40,0,0
68349,beat/min,0,0
68350,),0,0
68351,heart,0,0
68352,rates,0,0
68353,at,0,0
68354,6,0,0
68355,months,0,0
68356,and,0,0
68357,1,0,0
68358,year,0,0
68359,(,0,0
68360,P,0,0
68361,<,0,0
68362,.001,0,0
68363,),0,0
68364,.,0,0
68365,Successful,0,0
68366,cardioversion,1,1
68367,improved,0,0
68368,exercise,0,1
68369,capacity,0,0
68370,by,0,0
68371,15,0,0
68372,%,0,0
68373,at,0,0
68374,8,0,0
68375,weeks,0,0
68376,",",0,0
68377,and,0,0
68378,these,0,0
68379,improvements,0,0
68380,were,0,0
68381,maintained,0,0
68382,throughout,0,0
68383,the,0,0
68384,year,0,0
68385,.,0,0
68386,This,0,0
68387,improvement,0,0
68388,was,0,0
68389,observed,0,0
68390,both,0,0
68391,among,0,0
68392,those,0,0
68393,who,0,0
68394,maintained,0,0
68395,SR,0,1
68396,and,0,0
68397,those,0,0
68398,with,0,0
68399,intermittent,0,0
68400,AF,0,0
68401,.,0,0
68402,CONCLUSION,0,0
68403,Cardioversion,1,0
68404,resulted,0,0
68405,in,0,0
68406,a,0,0
68407,sustained,0,0
68408,improvement,0,0
68409,in,0,0
68410,exercise,0,1
68411,capacity,0,0
68412,over,0,0
68413,the,0,0
68414,course,0,0
68415,of,0,0
68416,1,0,0
68417,year,0,0
68418,",",0,0
68419,and,0,0
68420,this,0,0
68421,improvement,0,0
68422,was,0,0
68423,similar,0,0
68424,between,0,0
68425,those,0,0
68426,in,0,0
68427,SR,0,0
68428,and,0,0
68429,those,0,0
68430,with,0,0
68431,SR,0,1
68432,and,0,0
68433,recurrent,0,0
68434,AF,0,0
68435,.,0,0
68436,Patients,0,0
68437,most,0,0
68438,likely,0,0
68439,to,0,0
68440,improve,0,0
68441,with,0,0
68442,treatment,0,0
68443,tended,0,0
68444,to,0,0
68445,be,0,0
68446,younger,0,0
68447,and,0,0
68448,nonobese,0,0
68449,and,0,0
68450,have,0,0
68451,the,0,0
68452,greatest,0,0
68453,limitations,0,0
68454,initially,0,0
68455,.,0,0
68456,Enhanced,0,0
68457,inotropic,0,1
68458,state,0,0
68459,of,0,0
68460,the,0,0
68461,failing,0,0
68462,left,0,0
68463,ventricle,0,0
68464,by,0,0
68465,cardiac,1,0
68466,contractility,1,0
68467,modulation,1,0
68468,electrical,1,1
68469,signals,1,0
68470,is,0,0
68471,not,0,0
68472,associated,0,0
68473,with,0,0
68474,increased,0,0
68475,myocardial,0,0
68476,oxygen,0,1
68477,consumption,0,0
68478,.,0,0
68479,BACKGROUND,0,0
68480,Previous,0,0
68481,studies,0,0
68482,in,0,0
68483,patients,0,0
68484,and,0,0
68485,in,0,0
68486,dogs,0,0
68487,with,0,0
68488,experimentally,0,0
68489,induced,0,0
68490,heart,0,0
68491,failure,0,0
68492,(,0,0
68493,HF,0,0
68494,),0,0
68495,showed,0,0
68496,that,0,0
68497,electrical,1,0
68498,signals,1,0
68499,applied,0,0
68500,to,0,0
68501,the,0,0
68502,failing,0,0
68503,myocardium,0,0
68504,during,0,0
68505,the,0,0
68506,absolute,0,0
68507,refractory,0,0
68508,period,0,0
68509,improved,0,0
68510,left,0,0
68511,ventricular,0,0
68512,(,0,0
68513,LV,0,1
68514,),0,0
68515,function,0,0
68516,.,0,0
68517,We,0,0
68518,examined,0,0
68519,the,0,0
68520,effects,0,0
68521,these,0,0
68522,same,0,0
68523,cardiac,1,0
68524,contractility,1,0
68525,modulating,1,0
68526,(,1,0
68527,CCM,1,1
68528,),1,0
68529,electrical,1,0
68530,signals,1,0
68531,on,0,0
68532,myocardial,0,0
68533,oxygen,0,1
68534,consumption,0,0
68535,(,0,1
68536,MVO,0,1
68537,(,0,0
68538,2,0,0
68539,),0,0
68540,),0,0
68541,in,0,0
68542,both,0,0
68543,patients,0,0
68544,and,0,0
68545,dogs,0,0
68546,with,0,0
68547,chronic,0,0
68548,HF,0,0
68549,.,0,0
68550,METHODS,0,0
68551,AND,0,0
68552,RESULTS,0,0
68553,Six,0,1
68554,dogs,0,0
68555,with,0,0
68556,microembolizations-induced,1,0
68557,HF,1,0
68558,and,0,0
68559,9,0,0
68560,HF,0,0
68561,patients,0,0
68562,underwent,0,0
68563,CCM,1,1
68564,leads,1,0
68565,and,1,0
68566,generator,1,1
68567,(,1,0
68568,OPTIMIZER,1,1
68569,II,1,0
68570,),1,0
68571,implantation,1,0
68572,.,1,0
68573,After,0,0
68574,baseline,0,0
68575,measurements,0,0
68576,",",0,0
68577,CCM,1,0
68578,signals,1,0
68579,were,0,0
68580,delivered,0,0
68581,continuously,0,0
68582,for,0,0
68583,2,0,0
68584,hours,0,0
68585,in,0,0
68586,dogs,0,0
68587,and,0,0
68588,for,0,0
68589,30,0,0
68590,minutes,0,0
68591,in,0,0
68592,patients,0,0
68593,.,0,0
68594,MVO,0,0
68595,(,0,0
68596,2,0,0
68597,),0,0
68598,was,0,0
68599,measured,0,0
68600,before,0,0
68601,and,0,0
68602,after,0,0
68603,CCM,1,1
68604,therapy,1,1
68605,.,1,0
68606,In,0,0
68607,dogs,0,0
68608,",",0,0
68609,CCM,1,0
68610,therapy,1,1
68611,increased,0,0
68612,LV,0,1
68613,ejection,0,0
68614,fraction,0,0
68615,at,0,0
68616,2,0,0
68617,hours,0,0
68618,(,0,0
68619,26,0,0
68620,+/-,0,0
68621,1,0,0
68622,versus,0,0
68623,31,0,0
68624,+/-,0,0
68625,2,0,0
68626,%,0,0
68627,",",0,0
68628,P,0,0
68629,=,0,0
68630,.001,0,0
68631,),0,0
68632,without,0,0
68633,increasing,0,0
68634,MVO,0,1
68635,(,0,0
68636,2,0,0
68637,),0,0
68638,(,0,0
68639,257,0,0
68640,+/-,0,0
68641,41,0,0
68642,versus,0,0
68643,180,0,0
68644,+/-,0,0
68645,34,0,0
68646,micromol/min,0,0
68647,),0,0
68648,.,0,0
68649,In,0,0
68650,patients,0,0
68651,",",0,0
68652,CCM,1,0
68653,therapy,1,1
68654,increased,0,0
68655,LV,0,1
68656,peak,0,0
68657,+dP/dt,0,0
68658,by,0,0
68659,10.1,0,0
68660,+/-,0,0
68661,1.5,0,0
68662,%,0,0
68663,.,0,0
68664,As,0,0
68665,with,0,0
68666,dogs,0,0
68667,",",0,0
68668,the,0,0
68669,increase,0,0
68670,in,0,0
68671,LV,0,1
68672,function,0,0
68673,after,0,0
68674,30,0,0
68675,minutes,0,0
68676,of,0,0
68677,CCM,1,0
68678,therapy,1,1
68679,was,0,0
68680,not,0,0
68681,associated,0,0
68682,with,0,0
68683,increased,0,0
68684,MVO,0,1
68685,(,0,0
68686,2,0,0
68687,),0,0
68688,(,0,0
68689,13.6,0,0
68690,+/-,0,0
68691,9.7,0,0
68692,versus,0,0
68693,12.5,0,0
68694,+/-,0,0
68695,7.2,0,0
68696,mL,0,0
68697,O,0,0
68698,(,0,0
68699,2,0,0
68700,),0,0
68701,/min,0,0
68702,),0,0
68703,.,0,0
68704,CONCLUSIONS,0,0
68705,The,0,0
68706,study,0,0
68707,results,0,0
68708,suggest,0,0
68709,that,0,0
68710,unlike,0,0
68711,cAMP-dependent,0,0
68712,positive,0,0
68713,inotropic,0,1
68714,drugs,0,0
68715,",",0,0
68716,the,0,0
68717,increase,0,0
68718,in,0,0
68719,LV,0,1
68720,function,0,0
68721,during,0,0
68722,CCM,1,1
68723,therapy,1,1
68724,is,0,0
68725,elicited,0,0
68726,without,0,0
68727,increasing,0,0
68728,MVO,0,1
68729,(,0,0
68730,2,0,0
68731,),0,0
68732,.,0,0
68733,Successful,0,0
68734,new,0,0
68735,method,0,0
68736,of,0,0
68737,extracorporeal,1,1
68738,percutaneous,1,1
68739,endoscopic,1,1
68740,gastrostomy,1,1
68741,(,1,0
68742,E-PEG,1,1
68743,),1,0
68744,.,1,0
68745,BACKGROUND,0,0
68746,Although,0,0
68747,percutaneous,1,1
68748,endoscopic,1,1
68749,gastrostomy,1,1
68750,(,1,0
68751,PEG,1,1
68752,),1,1
68753,has,0,0
68754,become,0,0
68755,popular,0,0
68756,for,0,0
68757,patients,0,0
68758,with,0,0
68759,swallowing,0,0
68760,disorders,0,0
68761,as,0,0
68762,a,0,0
68763,nutrition,0,1
68764,support,0,0
68765,or,0,1
68766,a,0,0
68767,decompressant,0,1
68768,of,0,0
68769,gastrointestine,0,0
68770,",",0,0
68771,perioperative,0,0
68772,complications,0,0
68773,associated,0,0
68774,with,0,0
68775,PEG,1,1
68776,have,0,0
68777,not,0,0
68778,decreased,0,0
68779,",",0,0
68780,especially,0,0
68781,peristomal,0,0
68782,infections,0,0
68783,.,0,0
68784,To,0,0
68785,reduce,0,0
68786,peristomal,0,0
68787,infections,0,0
68788,",",0,0
68789,we,0,0
68790,designed,0,0
68791,a,0,0
68792,new,0,0
68793,method,0,0
68794,of,0,0
68795,gastrostomy,0,1
68796,by,0,0
68797,extracorporeal,0,1
68798,approach,0,1
68799,under,0,0
68800,endoscopic,0,1
68801,observation,0,0
68802,",",0,0
68803,named,0,0
68804,as,0,0
68805,extra-corporeal,1,1
68806,PEG,1,1
68807,(,1,0
68808,E-PEG,1,1
68809,),1,0
68810,.,1,0
68811,METHODS,0,0
68812,Experimental,0,0
68813,studies,0,0
68814,for,0,0
68815,E-PEG,1,1
68816,were,0,0
68817,performed,0,0
68818,repeatedly,0,0
68819,using,0,0
68820,pigs,0,0
68821,under,0,0
68822,general,0,0
68823,anesthesia,1,1
68824,to,0,0
68825,confirm,0,0
68826,the,0,0
68827,safety,0,0
68828,of,0,0
68829,its,0,0
68830,procedure,0,0
68831,for,0,0
68832,human,0,0
68833,use,0,0
68834,.,0,0
68835,After,0,0
68836,approval,0,0
68837,of,0,0
68838,institutional,0,0
68839,ethics,0,0
68840,review,0,0
68841,board,0,0
68842,in,0,0
68843,our,0,0
68844,university,0,0
68845,",",0,0
68846,thirty,0,0
68847,patients,0,0
68848,with,0,0
68849,prior,0,0
68850,consent,0,0
68851,participated,0,0
68852,in,0,0
68853,this,0,0
68854,study,0,0
68855,.,0,0
68856,The,0,0
68857,operation,0,0
68858,time,0,0
68859,",",0,0
68860,the,0,0
68861,incidence,0,0
68862,rate,0,0
68863,of,0,0
68864,complications,0,0
68865,and,0,0
68866,the,0,0
68867,hospital,0,0
68868,stay,0,0
68869,were,0,0
68870,compared,0,0
68871,between,0,0
68872,E-PEG,1,1
68873,and,1,0
68874,ordinary,1,1
68875,pull-method,1,1
68876,PEG,1,1
68877,groups,1,0
68878,.,0,0
68879,RESULTS,0,0
68880,Two,0,0
68881,patients,0,0
68882,(,0,0
68883,6.7,0,0
68884,%,0,0
68885,),0,0
68886,in,0,0
68887,E-PEG,1,1
68888,group,0,0
68889,had,0,0
68890,postoperative,0,0
68891,complications,0,0
68892,",",0,0
68893,i.e.,0,0
68894,",",0,0
68895,aspiration,0,0
68896,pneumonia,0,0
68897,and,0,0
68898,surgical,0,1
68899,site,0,0
68900,infection,0,0
68901,.,0,0
68902,The,0,0
68903,operation,0,0
68904,time,0,0
68905,of,0,0
68906,E-PEG,1,1
68907,group,0,0
68908,was,0,0
68909,5-16,0,0
68910,(,0,0
68911,mean,0,0
68912,+/-,0,0
68913,SD,0,0
68914,:,0,0
68915,10.3,0,0
68916,+/-,0,0
68917,2.96,0,0
68918,),0,0
68919,min,0,0
68920,as,0,0
68921,compared,0,0
68922,to,0,0
68923,14-37,0,0
68924,(,0,0
68925,mean,0,0
68926,+/-,0,0
68927,SD,0,0
68928,:,0,0
68929,26.9,0,0
68930,+/-,0,0
68931,8.39,0,0
68932,),0,0
68933,min,0,0
68934,with,0,0
68935,pull-method,0,1
68936,PEG,1,1
68937,.,1,0
68938,The,0,0
68939,postoperative,0,0
68940,hospital,0,0
68941,day,0,0
68942,of,0,0
68943,E-PEG,1,1
68944,was,0,0
68945,within,0,0
68946,two,0,0
68947,days,0,0
68948,except,0,0
68949,for,0,0
68950,the,0,0
68951,two,0,0
68952,complicated,0,0
68953,cases,0,0
68954,.,0,0
68955,Significance,0,0
68956,differences,0,0
68957,of,0,0
68958,operation,0,0
68959,time,0,0
68960,",",0,0
68961,complication,0,0
68962,rate,0,0
68963,and,0,0
68964,postoperative,0,0
68965,hospital,0,0
68966,stay,0,0
68967,between,0,0
68968,those,0,0
68969,groups,0,0
68970,observed,0,0
68971,statistically,0,0
68972,.,0,0
68973,CONCLUSIONS,0,0
68974,These,0,0
68975,results,0,0
68976,indicate,0,0
68977,that,0,0
68978,E-PEG,1,1
68979,was,0,0
68980,safe,0,0
68981,",",0,0
68982,tolerable,0,0
68983,and,0,0
68984,speedy,0,0
68985,when,0,0
68986,compared,0,0
68987,ordinary,0,0
68988,pull-method,0,1
68989,PEG,1,1
68990,.,1,0
68991,Comparison,0,0
68992,of,0,0
68993,three,0,0
68994,methods,0,0
68995,to,0,0
68996,increase,0,0
68997,knowledge,0,0
68998,about,0,0
68999,breast,0,0
69000,cancer,0,0
69001,and,0,0
69002,breast,0,0
69003,cancer,0,0
69004,screening,0,0
69005,in,0,0
69006,screening,0,0
69007,mammography,0,0
69008,patients,0,0
69009,.,0,0
69010,RATIONALE,0,0
69011,AND,0,0
69012,OBJECTIVES,0,0
69013,The,0,0
69014,specific,0,0
69015,aim,0,0
69016,of,0,0
69017,the,0,0
69018,study,0,0
69019,was,0,0
69020,to,0,0
69021,determine,0,0
69022,which,0,0
69023,of,0,0
69024,several,0,0
69025,cost-effective,0,0
69026,interventions,0,1
69027,is,0,0
69028,best,0,0
69029,able,0,0
69030,to,0,0
69031,improve,0,0
69032,the,0,0
69033,breast,0,0
69034,cancer,0,0
69035,knowledge,0,0
69036,of,0,0
69037,women,0,0
69038,who,0,0
69039,present,0,0
69040,for,0,0
69041,screening,0,0
69042,mammography,0,0
69043,.,0,0
69044,MATERIALS,0,0
69045,AND,0,0
69046,METHODS,0,0
69047,A,0,0
69048,total,0,0
69049,of,0,0
69050,198,0,0
69051,English-speaking,0,0
69052,women,0,0
69053,",",0,0
69054,with,0,0
69055,no,0,0
69056,personal,0,1
69057,or,0,1
69058,family,0,0
69059,history,0,0
69060,of,0,0
69061,breast,0,0
69062,cancer,0,0
69063,",",0,0
69064,were,0,0
69065,recruited,0,0
69066,and,0,0
69067,randomized,0,0
69068,to,0,0
69069,four,0,0
69070,groups,0,0
69071,when,0,0
69072,they,0,0
69073,presented,0,0
69074,to,0,0
69075,the,0,0
69076,clinic,0,0
69077,for,0,0
69078,a,0,0
69079,screening,0,0
69080,mammogram,0,0
69081,.,0,0
69082,All,0,0
69083,women,0,0
69084,filled,0,0
69085,in,0,0
69086,a,0,0
69087,demographic,0,0
69088,data,0,0
69089,form,0,0
69090,and,0,0
69091,answered,0,0
69092,a,0,0
69093,questionnaire,0,0
69094,containing,0,1
69095,nine,0,0
69096,questions,0,0
69097,about,0,0
69098,breast,0,0
69099,cancer,0,0
69100,",",0,0
69101,risk,0,0
69102,",",0,0
69103,and,0,0
69104,screening,0,0
69105,to,0,0
69106,assess,0,0
69107,their,0,0
69108,knowledge,0,0
69109,and,0,0
69110,perception,0,0
69111,.,0,0
69112,Three,0,0
69113,educational,1,0
69114,interventions,1,0
69115,were,0,0
69116,tested,0,0
69117,in,0,0
69118,this,0,0
69119,study,0,0
69120,.,0,0
69121,The,0,0
69122,first,0,0
69123,consisted,0,0
69124,of,0,0
69125,a,0,0
69126,brochure,1,1
69127,",",1,0
69128,which,1,0
69129,provided,1,0
69130,answers,1,0
69131,to,1,0
69132,the,1,0
69133,questionnaire,1,0
69134,items,1,0
69135,and,1,0
69136,addressed,1,0
69137,the,1,0
69138,issues,1,0
69139,in,1,0
69140,more,1,0
69141,depth,1,0
69142,.,1,0
69143,The,0,0
69144,second,0,0
69145,intervention,0,1
69146,was,0,0
69147,an,0,0
69148,educational,1,1
69149,conversation,1,0
69150,with,1,0
69151,a,1,0
69152,specially,1,0
69153,trained,1,1
69154,mammography,1,0
69155,technologist,1,0
69156,.,1,0
69157,She,0,0
69158,reviewed,0,0
69159,the,0,0
69160,subject,0,0
69161,'s,0,0
69162,answers,0,0
69163,to,0,0
69164,the,0,0
69165,questionnaire,0,0
69166,items,0,1
69167,correcting,0,0
69168,and/or,0,0
69169,clarifying,0,0
69170,them,0,0
69171,.,0,0
69172,The,0,0
69173,third,0,0
69174,intervention,0,1
69175,consisted,0,0
69176,of,0,0
69177,the,0,0
69178,brochure,1,1
69179,together,1,0
69180,with,1,0
69181,the,1,0
69182,conversation,1,0
69183,with,1,0
69184,a,1,0
69185,trained,1,1
69186,technologist,1,0
69187,.,1,0
69188,There,0,0
69189,was,0,0
69190,also,0,0
69191,a,0,0
69192,control,0,0
69193,group,0,0
69194,that,0,0
69195,just,0,0
69196,filled,0,0
69197,in,0,0
69198,the,0,0
69199,study,0,0
69200,questionnaire,0,0
69201,but,1,0
69202,did,1,0
69203,not,1,0
69204,receive,1,0
69205,an,1,0
69206,educational,1,1
69207,intervention,1,1
69208,.,1,0
69209,The,0,0
69210,same,0,0
69211,questionnaire,0,0
69212,was,0,0
69213,administered,0,0
69214,by,0,0
69215,telephone,0,1
69216,4,0,0
69217,to,0,0
69218,6,0,0
69219,weeks,0,0
69220,after,0,0
69221,the,0,0
69222,screening,0,0
69223,experience,0,0
69224,to,0,0
69225,all,0,0
69226,study,0,0
69227,subjects,0,0
69228,.,0,0
69229,Changes,0,0
69230,in,0,0
69231,their,0,0
69232,knowledge,0,0
69233,and,0,0
69234,perceptions,0,0
69235,of,0,0
69236,breast,0,0
69237,cancer,0,0
69238,were,0,0
69239,measured,0,0
69240,and,0,0
69241,compared,0,0
69242,.,0,0
69243,RESULTS,0,0
69244,A,0,0
69245,statistically,0,0
69246,significant,0,0
69247,increase,0,0
69248,in,0,0
69249,knowledge,0,0
69250,was,0,0
69251,found,0,0
69252,in,0,0
69253,all,0,0
69254,of,0,0
69255,the,0,0
69256,three,0,0
69257,investigated,0,0
69258,groups,0,0
69259,compared,0,0
69260,to,0,0
69261,the,0,0
69262,control,0,0
69263,group,0,0
69264,.,0,0
69265,There,0,0
69266,were,0,0
69267,no,0,0
69268,statistically,0,0
69269,significant,0,0
69270,differences,0,0
69271,in,0,0
69272,the,0,0
69273,amount,0,0
69274,of,0,0
69275,increase,0,0
69276,between,0,0
69277,women,0,0
69278,who,0,0
69279,underwent,0,0
69280,different,0,0
69281,interventions,0,0
69282,.,0,0
69283,CONCLUSIONS,0,0
69284,All,0,0
69285,three,0,0
69286,interventions,0,0
69287,resulted,0,0
69288,in,0,0
69289,increased,0,0
69290,knowledge,0,0
69291,about,0,0
69292,breast,0,0
69293,cancer,0,0
69294,and,0,0
69295,screening,0,0
69296,.,0,0
69297,No,0,0
69298,differences,0,0
69299,in,0,0
69300,the,0,0
69301,amount,0,0
69302,of,0,0
69303,knowledge,0,0
69304,increase,0,0
69305,were,0,0
69306,found,0,0
69307,between,0,0
69308,three,0,0
69309,interventions,0,0
69310,tested,0,0
69311,.,0,0
69312,The,0,0
69313,educational,0,0
69314,brochure,0,1
69315,seems,0,0
69316,to,0,0
69317,represent,0,0
69318,the,0,0
69319,most,0,0
69320,convenient,0,0
69321,and,0,0
69322,least,0,0
69323,costly,0,0
69324,method,0,0
69325,to,0,0
69326,increase,0,0
69327,knowledge,0,0
69328,about,0,0
69329,breast,0,0
69330,cancer,0,0
69331,and,0,0
69332,screening,0,0
69333,among,0,0
69334,women,0,0
69335,who,0,0
69336,present,0,0
69337,for,0,0
69338,screening,0,0
69339,mammography,0,0
69340,.,0,0
69341,Women,0,0
69342,'s,0,0
69343,responses,0,0
69344,to,0,0
69345,information,0,0
69346,on,0,0
69347,mammographic,0,0
69348,breast,0,0
69349,density,0,0
69350,.,0,0
69351,The,0,0
69352,objective,0,0
69353,of,0,0
69354,this,0,0
69355,study,0,0
69356,was,0,0
69357,to,0,0
69358,determine,0,0
69359,the,0,0
69360,negative,0,0
69361,and,0,0
69362,positive,0,0
69363,outcomes,0,0
69364,of,0,0
69365,providing,0,0
69366,mammographic,0,0
69367,breast,0,0
69368,density,0,0
69369,(,0,0
69370,MBD,0,1
69371,),0,0
69372,information,0,0
69373,to,0,0
69374,participants,0,0
69375,of,0,0
69376,a,0,0
69377,screening,1,0
69378,program,1,1
69379,.,1,0
69380,A,0,0
69381,randomized,0,0
69382,experiment,0,0
69383,was,0,0
69384,conducted,0,0
69385,with,0,0
69386,a,0,0
69387,sample,0,0
69388,of,0,0
69389,618,0,0
69390,women,0,0
69391,50,0,0
69392,years,0,0
69393,or,0,0
69394,older,0,0
69395,with,0,0
69396,MBD,0,0
69397,greater,0,0
69398,than,0,0
69399,50,0,0
69400,%,0,0
69401,of,0,0
69402,breast,0,0
69403,volume,0,0
69404,.,0,0
69405,The,0,0
69406,intervention,0,0
69407,consisted,0,0
69408,of,0,0
69409,reporting,1,0
69410,the,1,0
69411,presence,1,0
69412,of,1,0
69413,MBD,1,0
69414,in,1,0
69415,the,1,0
69416,screening,1,0
69417,mammography,1,0
69418,results,1,0
69419,letter,1,0
69420,that,1,0
69421,was,1,0
69422,sent,1,0
69423,along,1,0
69424,with,1,0
69425,an,1,0
69426,information,1,0
69427,pamphlet,1,1
69428,.,1,0
69429,Compared,0,0
69430,to,0,0
69431,the,0,0
69432,controls,1,0
69433,",",0,0
69434,more,0,0
69435,women,0,0
69436,in,0,0
69437,the,0,0
69438,intervention,0,1
69439,group,0,0
69440,described,0,0
69441,the,0,0
69442,term,0,0
69443,breast,0,0
69444,density,0,0
69445,correctly,0,0
69446,and,0,0
69447,recognized,0,0
69448,it,0,0
69449,as,0,0
69450,a,0,0
69451,risk,0,0
69452,factor,0,0
69453,for,0,0
69454,breast,0,0
69455,cancer,0,0
69456,.,0,0
69457,Although,0,0
69458,at,0,0
69459,the,0,0
69460,4-week,0,1
69461,follow-up,0,0
69462,the,0,0
69463,intervention,0,1
69464,group,0,0
69465,indicated,0,0
69466,that,0,0
69467,they,0,0
69468,were,0,0
69469,very,0,0
69470,likely,0,0
69471,to,0,0
69472,have,0,0
69473,an,0,0
69474,annual,1,0
69475,clinical,1,0
69476,breast,1,0
69477,examination,1,0
69478,more,0,0
69479,frequently,0,0
69480,than,0,0
69481,controls,0,0
69482,",",0,0
69483,no,0,0
69484,differences,0,0
69485,were,0,0
69486,detected,0,0
69487,at,0,0
69488,6,0,0
69489,months,0,0
69490,.,0,0
69491,There,0,0
69492,were,0,0
69493,no,0,0
69494,significant,0,0
69495,differences,0,0
69496,on,0,0
69497,other,0,0
69498,behavioural,0,0
69499,or,0,0
69500,psychological,0,0
69501,measures,0,0
69502,",",0,0
69503,although,0,0
69504,at,0,0
69505,the,0,0
69506,4-week,0,0
69507,follow-up,0,0
69508,the,0,0
69509,control,0,0
69510,group,0,0
69511,perceived,0,0
69512,their,0,0
69513,risk,0,0
69514,for,0,0
69515,breast,0,0
69516,cancer,0,0
69517,",",0,0
69518,relative,0,0
69519,to,0,0
69520,other,0,0
69521,women,0,0
69522,their,0,0
69523,age,0,0
69524,",",0,0
69525,as,0,0
69526,a,0,0
69527,lot,0,0
69528,lower,0,0
69529,than,0,0
69530,did,0,0
69531,women,0,0
69532,in,0,0
69533,the,0,0
69534,intervention,0,1
69535,group,0,0
69536,.,0,0
69537,The,0,0
69538,results,0,0
69539,demonstrate,0,0
69540,a,0,0
69541,feasible,0,0
69542,and,0,0
69543,non-threatening,0,0
69544,way,0,0
69545,to,0,0
69546,provide,0,0
69547,women,0,0
69548,with,0,0
69549,important,0,0
69550,personalized,0,1
69551,information,0,0
69552,about,0,0
69553,breast,0,0
69554,cancer,0,0
69555,risk,0,0
69556,.,0,0
69557,Chemoradiation,0,1
69558,comparing,0,0
69559,cisplatin,1,1
69560,versus,0,1
69561,carboplatin,1,1
69562,in,0,0
69563,locally,0,0
69564,advanced,0,0
69565,nasopharyngeal,0,0
69566,cancer,0,0
69567,:,0,0
69568,randomised,0,0
69569,",",0,0
69570,non-inferiority,0,0
69571,",",0,0
69572,open,0,0
69573,trial,0,0
69574,.,0,0
69575,PURPOSE,0,0
69576,This,0,0
69577,single,0,0
69578,centre,0,0
69579,",",0,0
69580,open,0,0
69581,labelled,0,0
69582,",",0,0
69583,randomised,0,0
69584,non-inferiority,0,0
69585,trial,0,0
69586,compared,0,0
69587,concurrent,0,1
69588,chemoradiotherapy,1,1
69589,with,1,0
69590,carboplatin,1,1
69591,versus,0,0
69592,standard,1,1
69593,concurrent,1,1
69594,chemoradiotherapy,1,1
69595,with,1,0
69596,cisplatin,1,1
69597,in,0,0
69598,patients,0,0
69599,with,0,0
69600,locoregionally,0,0
69601,advanced,0,0
69602,nasopharyngeal,0,0
69603,cancer,0,0
69604,(,0,0
69605,NPC,0,1
69606,),0,0
69607,.,0,0
69608,PATIENTS,0,0
69609,AND,0,0
69610,METHODS,0,0
69611,From,0,0
69612,August,0,0
69613,1999,0,0
69614,to,0,0
69615,December,0,0
69616,2004,0,0
69617,",",0,0
69618,206,0,0
69619,patients,0,0
69620,with,0,0
69621,locally,0,0
69622,advanced,0,0
69623,NPC,0,0
69624,were,0,0
69625,randomised,0,0
69626,with,0,0
69627,101,1,0
69628,to,1,0
69629,cisplatin,1,1
69630,arm,1,0
69631,and,1,0
69632,105,1,0
69633,to,1,0
69634,carboplatin,1,1
69635,arm,0,0
69636,.,0,0
69637,Planned,1,0
69638,radiotherapy,1,1
69639,was,0,0
69640,the,0,0
69641,same,0,0
69642,in,0,0
69643,both,0,0
69644,groups,0,0
69645,.,0,0
69646,All,0,0
69647,the,0,0
69648,patients,0,0
69649,were,0,0
69650,evaluated,0,0
69651,for,0,0
69652,toxicity,0,0
69653,and,0,0
69654,survival,0,0
69655,according,0,0
69656,to,0,0
69657,the,0,0
69658,as-treated,0,0
69659,principle,0,0
69660,.,0,0
69661,RESULTS,0,0
69662,With,0,0
69663,a,0,0
69664,median,0,0
69665,follow-up,0,0
69666,of,0,0
69667,26.3,0,0
69668,months,0,0
69669,(,0,0
69670,range,0,0
69671,3-74.6,0,0
69672,months,0,0
69673,),0,0
69674,",",0,0
69675,59,0,0
69676,%,0,0
69677,of,0,0
69678,patients,0,0
69679,in,0,0
69680,the,0,0
69681,cisplatin,0,1
69682,arm,0,0
69683,completed,0,0
69684,the,0,0
69685,planned,0,0
69686,concurrent,0,1
69687,chemoradiation,0,1
69688,treatment,0,0
69689,",",0,0
69690,compared,0,0
69691,to,0,0
69692,73,0,0
69693,%,0,0
69694,in,0,0
69695,the,0,0
69696,carboplatin,0,1
69697,arm,0,0
69698,.,0,0
69699,Forty-two,0,0
69700,percent,0,0
69701,of,0,0
69702,cisplatin,0,1
69703,patients,0,0
69704,completed,0,0
69705,the,0,0
69706,3,0,0
69707,cycles,0,0
69708,of,0,0
69709,adjuvant,0,1
69710,therapy,0,1
69711,compared,0,0
69712,to,0,0
69713,70,0,0
69714,%,0,0
69715,in,0,0
69716,the,0,0
69717,carboplatin,0,1
69718,group,0,0
69719,.,0,0
69720,There,0,0
69721,were,0,0
69722,more,0,0
69723,renal,0,0
69724,toxicity,0,0
69725,",",0,0
69726,leucopenia,0,0
69727,",",0,0
69728,and,0,0
69729,anaemia,0,0
69730,in,0,0
69731,the,0,0
69732,cisplatin,0,1
69733,group,0,0
69734,",",0,0
69735,and,0,0
69736,more,0,0
69737,thrombocytopenia,0,0
69738,in,0,0
69739,the,0,0
69740,carboplatin,0,1
69741,arm,0,0
69742,.,0,0
69743,The,0,0
69744,3,0,0
69745,year,0,0
69746,disease,0,0
69747,free,0,0
69748,survival,0,0
69749,rates,0,0
69750,were,0,0
69751,63.4,0,0
69752,%,0,0
69753,for,0,0
69754,the,0,0
69755,cisplatin,0,1
69756,group,0,0
69757,and,0,0
69758,60.9,0,0
69759,%,0,0
69760,for,0,0
69761,the,0,0
69762,carboplatin,0,1
69763,group,0,0
69764,(,0,0
69765,p=0.9613,0,0
69766,),0,1
69767,(,0,0
69768,HR,0,0
69769,0.70,0,0
69770,",",0,0
69771,95,0,0
69772,%,0,0
69773,confidence,0,0
69774,interval,0,0
69775,(,0,0
69776,CI,0,0
69777,),0,0
69778,:,0,0
69779,0.50-0.98,0,0
69780,),0,0
69781,.,0,0
69782,The,0,0
69783,3,0,0
69784,year,0,0
69785,overall,0,0
69786,survival,0,0
69787,rates,0,0
69788,were,0,0
69789,77.7,0,0
69790,%,0,0
69791,and,0,0
69792,79.2,0,0
69793,%,0,0
69794,for,0,0
69795,cisplatin,0,1
69796,and,0,0
69797,carboplatin,0,1
69798,groups,0,0
69799,",",0,0
69800,respectively,0,0
69801,(,0,0
69802,p=0.9884,0,0
69803,),0,1
69804,(,0,0
69805,HR,0,0
69806,0.83,0,0
69807,",",0,0
69808,95,0,0
69809,%,0,0
69810,CI,0,0
69811,:,0,0
69812,0.63-1.010,0,0
69813,),0,0
69814,.,0,0
69815,CONCLUSION,0,0
69816,We,0,0
69817,concluded,0,0
69818,that,0,0
69819,the,0,0
69820,tolerability,0,0
69821,of,0,0
69822,carboplatin,1,1
69823,based,0,0
69824,regimen,0,0
69825,is,0,0
69826,better,0,0
69827,than,0,0
69828,that,0,0
69829,of,0,0
69830,the,0,0
69831,cisplatin,1,1
69832,regimen,0,0
69833,.,0,0
69834,Moreover,0,0
69835,",",0,0
69836,the,0,0
69837,treatment,0,0
69838,efficacy,0,0
69839,of,0,0
69840,carboplatin,0,1
69841,arm,0,0
69842,is,0,0
69843,not,0,0
69844,different,0,0
69845,from,0,0
69846,the,0,0
69847,standard,0,0
69848,regimen,0,0
69849,in,0,0
69850,the,0,0
69851,treatment,0,0
69852,of,0,0
69853,locoregional,0,0
69854,advanced,0,0
69855,stage,0,0
69856,NPC,0,0
69857,.,0,0
69858,Treatment,1,0
69859,of,1,0
69860,periodontal,1,0
69861,disease,1,0
69862,and,0,0
69863,the,0,0
69864,risk,0,0
69865,of,0,0
69866,preterm,0,0
69867,birth,0,0
69868,.,0,0
69869,Is,0,0
69870,Na+,1,0
69871,modeling,1,0
69872,necessary,0,0
69873,in,0,0
69874,high,0,0
69875,flux,0,0
69876,dialysis,0,1
69877,?,0,0
69878,One,0,0
69879,important,0,0
69880,pathogenic,0,0
69881,factor,0,0
69882,in,0,0
69883,dialysis,0,1
69884,hypotension,0,0
69885,is,0,0
69886,the,0,0
69887,drop,0,0
69888,in,0,0
69889,plasma,0,0
69890,osmolality,0,0
69891,.,0,0
69892,Increasing,0,0
69893,the,0,0
69894,dialysate,0,1
69895,Na+,1,0
69896,concentration,0,0
69897,decreases,0,0
69898,hypotensive,0,0
69899,episodes,0,0
69900,.,0,0
69901,The,0,0
69902,authors,0,0
69903,studied,0,0
69904,39,0,0
69905,patients,0,0
69906,being,0,0
69907,treated,0,0
69908,with,0,0
69909,high,1,0
69910,flux,1,0
69911,dialysis,1,1
69912,.,1,0
69913,During,0,0
69914,a,0,0
69915,9,0,0
69916,week,0,0
69917,period,0,0
69918,",",0,0
69919,the,0,0
69920,patients,0,0
69921,were,0,0
69922,on,0,0
69923,a,0,0
69924,standard,1,1
69925,Na+,1,0
69926,dialysate,1,1
69927,(,0,0
69928,Na+,0,0
69929,=,0,0
69930,140,0,0
69931,meq/L,0,0
69932,),0,0
69933,basal,0,0
69934,period,0,0
69935,(,0,0
69936,B,0,0
69937,),0,0
69938,;,0,0
69939,9,0,0
69940,%,0,0
69941,(,0,0
69942,Na+,0,0
69943,=,0,0
69944,149,0,0
69945,meq/L,0,0
69946,),0,0
69947,linear,1,0
69948,(,0,1
69949,L,0,1
69950,),0,0
69951,;,0,0
69952,step,0,1
69953,drop,0,0
69954,(,0,0
69955,S,0,0
69956,),0,0
69957,;,0,0
69958,and,0,0
69959,exponential,0,0
69960,drop,0,0
69961,(,0,0
69962,E,0,1
69963,),0,0
69964,.,0,0
69965,The,0,0
69966,Na+,1,0
69967,program,1,1
69968,was,0,0
69969,changed,0,0
69970,weekly,0,1
69971,at,0,0
69972,random,0,0
69973,.,0,0
69974,The,0,0
69975,results,0,0
69976,obtained,0,0
69977,with,0,0
69978,the,0,0
69979,three,0,0
69980,Na+,1,0
69981,modeling,1,0
69982,programs,0,0
69983,were,0,0
69984,similar,0,0
69985,.,0,0
69986,We,0,0
69987,compared,0,0
69988,the,0,0
69989,periods,0,0
69990,with,0,0
69991,and,0,0
69992,without,0,0
69993,Na+,1,0
69994,modeling,1,0
69995,:,1,0
69996,no,0,0
69997,differences,0,0
69998,were,0,0
69999,found,0,0
70000,in,0,0
70001,weight,0,0
70002,gained,0,0
70003,interdialysis,0,0
70004,",",0,0
70005,mean,0,0
70006,blood,0,0
70007,pressure,0,0
70008,predialysis,0,0
70009,and,0,0
70010,postdialysis,0,1
70011,",",0,0
70012,and,0,0
70013,hemoconcentration,0,0
70014,.,0,0
70015,Serum,0,0
70016,Na+,0,0
70017,levels,0,0
70018,were,0,0
70019,significantly,0,0
70020,higher,0,0
70021,predialysis,0,0
70022,and,0,0
70023,postdialysis,0,1
70024,for,0,0
70025,those,0,0
70026,patients,0,0
70027,on,0,0
70028,Na+,1,0
70029,modeling,1,0
70030,.,1,0
70031,Hypotensive,0,0
70032,episodes,0,0
70033,and,0,0
70034,cramps,0,0
70035,decreased,0,0
70036,50,0,0
70037,%,0,0
70038,with,0,0
70039,Na+,1,0
70040,modeling,1,0
70041,.,1,0
70042,The,0,0
70043,amount,0,0
70044,of,0,0
70045,hypertonic,0,1
70046,and,0,0
70047,normal,0,0
70048,saline,0,1
70049,given,0,0
70050,during,0,0
70051,dialysis,0,1
70052,was,0,0
70053,markedly,0,0
70054,reduced,0,0
70055,.,0,0
70056,Na+,1,0
70057,modeling,1,0
70058,should,0,0
70059,always,0,0
70060,be,0,0
70061,used,0,0
70062,in,0,0
70063,patients,0,0
70064,being,0,0
70065,maintained,0,0
70066,on,0,0
70067,high,1,0
70068,flux,1,0
70069,dialysis,1,1
70070,.,1,0
70071,Propofol,1,1
70072,and,1,0
70073,midazolam,1,1
70074,act,0,0
70075,synergistically,0,0
70076,in,0,0
70077,combination,0,0
70078,.,0,0
70079,We,0,0
70080,have,0,0
70081,studied,0,0
70082,interactions,0,0
70083,between,0,0
70084,i.v,1,0
70085,.,1,0
70086,propofol,1,1
70087,and,1,0
70088,midazolam,1,1
70089,for,0,0
70090,induction,0,0
70091,of,0,0
70092,anaesthesia,0,1
70093,in,0,0
70094,200,0,0
70095,unpremedicated,0,0
70096,female,0,0
70097,patients,0,0
70098,undergoing,0,0
70099,elective,0,0
70100,gynaecological,0,0
70101,surgery,0,0
70102,.,0,0
70103,Using,0,0
70104,end-points,0,0
70105,of,0,0
70106,hypnosis,0,1
70107,(,0,0
70108,loss,0,0
70109,of,0,0
70110,response,0,0
70111,to,0,0
70112,verbal,0,1
70113,command,0,1
70114,),0,0
70115,and,0,0
70116,anaesthesia,0,1
70117,(,0,0
70118,loss,0,0
70119,of,0,0
70120,response,0,0
70121,to,0,0
70122,a,0,0
70123,5-s,0,1
70124,transcutaneous,0,0
70125,tetanic,0,1
70126,stimulus,0,0
70127,),0,0
70128,",",0,0
70129,we,0,0
70130,determined,0,0
70131,dose-response,0,0
70132,curves,0,0
70133,for,0,0
70134,propofol,1,1
70135,and,1,0
70136,midazolam,1,1
70137,alone,1,1
70138,and,1,0
70139,in,1,0
70140,combination,1,1
70141,.,1,0
70142,For,0,0
70143,hypnosis,0,1
70144,",",0,0
70145,synergistic,0,0
70146,interaction,0,0
70147,was,0,0
70148,found,0,0
70149,(,0,0
70150,P,0,0
70151,less,0,0
70152,than,0,0
70153,0.01,0,0
70154,),0,0
70155,",",0,0
70156,the,0,0
70157,combination,0,1
70158,having,0,0
70159,1.44,0,0
70160,times,0,0
70161,the,0,0
70162,potency,0,0
70163,of,0,0
70164,the,0,0
70165,individual,0,0
70166,agents,0,0
70167,.,0,0
70168,Although,0,0
70169,midazolam,1,1
70170,failed,0,0
70171,to,0,0
70172,produce,0,0
70173,anaesthesia,0,1
70174,in,0,0
70175,the,0,0
70176,dose,0,0
70177,range,0,0
70178,used,0,0
70179,",",0,0
70180,the,0,0
70181,dose,0,0
70182,of,0,0
70183,propofol,1,1
70184,required,0,0
70185,to,0,0
70186,produce,0,0
70187,anaesthesia,0,1
70188,was,0,0
70189,reduced,0,0
70190,by,0,0
70191,52,0,0
70192,%,0,0
70193,in,0,0
70194,the,0,0
70195,presence,0,0
70196,of,0,0
70197,midazolam,1,1
70198,(,0,0
70199,P,0,0
70200,less,0,0
70201,than,0,0
70202,0.01,0,0
70203,),0,0
70204,.,0,0
70205,The,0,0
70206,reduction,0,0
70207,in,0,0
70208,arterial,0,0
70209,pressure,0,0
70210,at,0,0
70211,induction,0,0
70212,was,0,0
70213,the,0,0
70214,same,0,0
70215,for,0,0
70216,the,0,0
70217,combination,0,0
70218,as,0,0
70219,for,0,0
70220,the,0,0
70221,individual,0,0
70222,agents,0,0
70223,.,0,0
70224,The,0,0
70225,cause,0,0
70226,of,0,0
70227,the,0,0
70228,synergism,0,0
70229,was,0,0
70230,not,0,0
70231,clear,0,0
70232,",",0,0
70233,but,0,0
70234,may,0,0
70235,have,0,0
70236,been,0,0
70237,interaction,0,0
70238,at,0,0
70239,CNS,0,1
70240,GABAA,0,0
70241,receptors,0,0
70242,.,0,0
70243,Using,0,0
70244,the,0,0
70245,demand-control,1,0
70246,model,1,0
70247,of,1,0
70248,job,1,0
70249,strain,1,0
70250,to,0,0
70251,predict,0,0
70252,caregiver,0,1
70253,burden,0,0
70254,and,0,0
70255,caregiver,0,1
70256,satisfaction,0,0
70257,in,0,0
70258,the,0,0
70259,informal,0,1
70260,caregivers,0,0
70261,of,0,0
70262,heart,0,0
70263,failure,0,0
70264,patients,0,0
70265,.,0,0
70266,OBJECTIVES,0,0
70267,The,1,0
70268,demand-control,1,0
70269,(,1,0
70270,D-C,1,1
70271,),1,0
70272,model,1,0
70273,of,1,0
70274,job,1,0
70275,strain,1,0
70276,has,0,0
70277,generated,0,0
70278,a,0,0
70279,considerable,0,0
70280,body,0,0
70281,of,0,0
70282,empirical,0,0
70283,support,0,0
70284,in,0,0
70285,predicting,0,0
70286,psychological,0,0
70287,health,0,0
70288,outcomes,0,0
70289,in,0,0
70290,the,0,0
70291,context,0,0
70292,of,0,0
70293,work,0,0
70294,.,0,0
70295,This,0,0
70296,study,0,0
70297,aimed,0,0
70298,to,0,0
70299,extend,0,0
70300,previous,0,0
70301,work,0,0
70302,using,0,0
70303,the,0,0
70304,D-C,1,1
70305,model,1,0
70306,of,1,0
70307,job,1,0
70308,strain,1,0
70309,to,0,0
70310,predict,0,0
70311,caregiver,0,1
70312,burden,0,0
70313,and,0,0
70314,satisfaction,0,0
70315,in,0,0
70316,the,0,0
70317,informal,0,1
70318,caregivers,0,0
70319,of,0,0
70320,patients,0,0
70321,with,0,0
70322,heart,0,0
70323,failure,0,0
70324,.,0,0
70325,DESIGN,0,0
70326,AND,0,0
70327,METHOD,0,1
70328,Data,0,0
70329,were,0,0
70330,gathered,0,0
70331,from,0,0
70332,60,0,0
70333,caregiver/patient,0,0
70334,dyads,0,0
70335,in,0,0
70336,a,0,0
70337,cross-sectional,0,0
70338,design,0,0
70339,.,0,0
70340,Patients,0,0
70341,with,0,0
70342,chronic,0,0
70343,stable,0,0
70344,heart,0,0
70345,failure,0,0
70346,were,0,0
70347,recruited,0,0
70348,from,0,0
70349,out-patient,0,0
70350,clinics,0,0
70351,.,0,0
70352,The,0,0
70353,dependent,0,0
70354,variables,0,0
70355,were,0,0
70356,caregiver,1,1
70357,burden,1,0
70358,and,1,0
70359,satisfaction,1,0
70360,.,1,0
70361,Demand,0,0
70362,and,0,0
70363,control,0,0
70364,were,0,0
70365,measured,0,0
70366,using,0,0
70367,both,0,0
70368,patient-,0,1
70369,and,0,0
70370,caregiver-derived,0,0
70371,measures,0,0
70372,.,0,0
70373,RESULTS,0,0
70374,The,0,0
70375,D-C,1,1
70376,model,1,0
70377,accounted,0,0
70378,for,0,0
70379,15,0,0
70380,and,0,0
70381,19,0,0
70382,%,0,0
70383,of,0,0
70384,the,0,0
70385,variance,0,0
70386,in,0,0
70387,caregiver,0,1
70388,burden,0,0
70389,",",0,0
70390,after,0,0
70391,controlling,0,0
70392,for,0,0
70393,age,0,0
70394,",",0,0
70395,gender,0,0
70396,and,0,0
70397,relationship,0,0
70398,to,0,0
70399,the,0,0
70400,patient,0,0
70401,.,0,0
70402,Lower,0,0
70403,control,0,0
70404,was,0,0
70405,associated,0,0
70406,with,0,0
70407,higher,0,0
70408,burden,0,0
70409,.,0,0
70410,The,0,0
70411,D-C,1,0
70412,model,1,0
70413,did,0,0
70414,not,0,0
70415,predict,0,0
70416,caregiver,0,0
70417,satisfaction,0,0
70418,.,0,0
70419,CONCLUSION,0,0
70420,The,0,0
70421,D-C,1,1
70422,model,1,0
70423,was,0,0
70424,associated,0,0
70425,with,0,0
70426,caregiver,0,1
70427,burden,0,0
70428,",",0,0
70429,but,0,0
70430,not,0,0
70431,satisfaction,0,0
70432,in,0,0
70433,caregivers,0,0
70434,",",0,0
70435,with,0,0
70436,control,0,0
70437,being,0,0
70438,the,0,0
70439,dominant,0,0
70440,predictor,0,0
70441,.,0,0
70442,Research,0,0
70443,linking,0,0
70444,the,0,0
70445,theory,0,1
70446,and,0,0
70447,findings,0,0
70448,from,0,0
70449,job,0,0
70450,strain,0,0
70451,and,0,0
70452,informal,0,1
70453,caregiving,0,0
70454,studies,0,0
70455,may,0,0
70456,elucidate,0,0
70457,both,0,0
70458,fields,0,0
70459,of,0,0
70460,research,0,0
70461,.,0,0
70462,Using,0,0
70463,the,0,0
70464,demand-control,1,0
70465,model,1,0
70466,of,1,0
70467,job,1,0
70468,strain,1,0
70469,to,0,0
70470,predict,0,0
70471,caregiver,0,1
70472,burden,0,0
70473,and,0,0
70474,caregiver,0,1
70475,satisfaction,0,0
70476,in,0,0
70477,the,0,0
70478,informal,0,1
70479,caregivers,0,0
70480,of,0,0
70481,heart,0,0
70482,failure,0,0
70483,patients,0,0
70484,.,0,0
70485,Effect,0,0
70486,of,0,0
70487,low-intensity,1,0
70488,back,1,0
70489,exercise,1,1
70490,on,0,0
70491,quality,0,0
70492,of,0,0
70493,life,0,0
70494,and,0,0
70495,back,0,0
70496,extensor,0,1
70497,strength,0,0
70498,in,0,0
70499,patients,0,0
70500,with,0,0
70501,osteoporosis,0,0
70502,:,0,0
70503,a,0,0
70504,randomized,0,0
70505,controlled,0,0
70506,trial,0,0
70507,.,0,0
70508,UNLABELLED,0,0
70509,Randomized,0,0
70510,controlled,0,0
70511,study,0,0
70512,in,0,0
70513,80,0,0
70514,postmenopausal,0,0
70515,women,0,0
70516,with,0,0
70517,osteoporosis,0,0
70518,was,0,0
70519,conducted,0,0
70520,to,0,0
70521,investigate,0,0
70522,the,0,0
70523,effect,0,0
70524,of,0,0
70525,a,0,0
70526,home-based,1,1
70527,",",1,0
70528,simple,1,0
70529,",",1,0
70530,low-intensity,1,0
70531,exercise,1,1
70532,.,1,0
70533,Low-intensity,1,0
70534,back-strengthening,1,1
70535,exercise,1,1
70536,was,0,0
70537,effective,0,0
70538,in,0,0
70539,improving,0,0
70540,the,0,0
70541,quality,0,0
70542,of,0,0
70543,life,0,0
70544,and,0,0
70545,back,0,0
70546,extensor,0,0
70547,strength,0,0
70548,.,0,0
70549,INTRODUCTION,0,0
70550,AND,0,0
70551,HYPOTHESIS,0,1
70552,Back-strengthening,0,1
70553,exercise,0,1
70554,is,0,0
70555,effective,0,0
70556,in,0,0
70557,increasing,0,0
70558,back,0,0
70559,extensor,0,1
70560,strength,0,0
70561,and,0,0
70562,decreasing,0,0
70563,risk,0,0
70564,of,0,0
70565,vertebral,0,0
70566,fractures,0,0
70567,.,0,0
70568,We,0,0
70569,hypothesized,0,0
70570,that,0,0
70571,a,0,0
70572,home-based,0,1
70573,",",0,0
70574,simple,0,0
70575,",",0,0
70576,low-intensity,0,0
70577,exercise,0,1
70578,could,0,0
70579,enhance,0,0
70580,back,0,0
70581,extensor,0,1
70582,strength,0,0
70583,and,0,0
70584,improve,0,0
70585,the,0,0
70586,quality,0,0
70587,of,0,0
70588,life,0,0
70589,and/or,0,0
70590,spinal,0,0
70591,range,0,0
70592,of,0,0
70593,motion,0,0
70594,in,0,0
70595,postmenopausal,0,0
70596,women,0,0
70597,in,0,0
70598,a,0,0
70599,short-term,0,0
70600,follow-up,0,0
70601,.,0,0
70602,METHODS,0,0
70603,Eighty,0,0
70604,postmenopausal,0,0
70605,women,0,0
70606,with,0,0
70607,osteoporosis,0,0
70608,were,0,0
70609,randomly,0,0
70610,assigned,0,0
70611,to,0,0
70612,a,0,0
70613,control,1,1
70614,group,1,0
70615,(,0,0
70616,n,0,0
70617,=,0,0
70618,38,0,0
70619,),0,0
70620,or,0,0
70621,an,0,0
70622,exercise,1,1
70623,group,1,0
70624,(,0,0
70625,n,0,0
70626,=,0,0
70627,42,0,0
70628,),0,0
70629,.,0,0
70630,Subjects,0,0
70631,were,0,0
70632,instructed,0,0
70633,to,0,0
70634,lift,0,0
70635,their,0,0
70636,upper,0,0
70637,trunk,0,0
70638,from,0,0
70639,a,0,0
70640,prone,0,0
70641,position,0,0
70642,antigravity,0,1
70643,and,0,0
70644,maintain,0,0
70645,the,0,0
70646,neutral,0,1
70647,position,0,0
70648,.,0,0
70649,Isometric,0,0
70650,back,0,0
70651,extensor,0,0
70652,strength,0,0
70653,",",0,0
70654,spinal,0,0
70655,range,0,0
70656,of,0,0
70657,motion,0,0
70658,",",0,0
70659,and,0,0
70660,scores,0,0
70661,for,0,0
70662,quality,0,0
70663,of,0,0
70664,life,0,0
70665,were,0,0
70666,evaluated,0,0
70667,at,0,0
70668,baseline,0,0
70669,and,0,0
70670,4,0,0
70671,months,0,0
70672,.,0,0
70673,RESULTS,0,0
70674,Back,0,0
70675,extensor,0,1
70676,strength,0,0
70677,significantly,0,0
70678,increased,0,0
70679,both,0,0
70680,in,0,0
70681,the,0,0
70682,exercise,0,1
70683,group,0,0
70684,(,0,0
70685,26,0,0
70686,%,0,0
70687,),0,0
70688,and,0,0
70689,in,0,0
70690,the,0,0
70691,control,0,1
70692,group,0,0
70693,(,0,0
70694,11,0,0
70695,%,0,0
70696,),0,0
70697,.,0,0
70698,Scores,0,0
70699,for,0,0
70700,quality,0,0
70701,of,0,0
70702,life,0,0
70703,increased,0,0
70704,in,0,0
70705,the,0,0
70706,exercise,0,1
70707,group,0,0
70708,(,0,0
70709,7,0,0
70710,%,0,0
70711,),0,0
70712,",",0,0
70713,whereas,0,0
70714,it,0,0
70715,remained,0,0
70716,unchanged,0,0
70717,in,0,0
70718,the,0,0
70719,control,0,1
70720,group,0,0
70721,(,0,0
70722,0,0,0
70723,%,0,0
70724,),0,0
70725,.,0,0
70726,There,0,0
70727,was,0,0
70728,a,0,0
70729,significant,0,0
70730,difference,0,0
70731,in,0,0
70732,quality,0,0
70733,of,0,0
70734,life,0,0
70735,score,0,0
70736,between,0,0
70737,the,0,0
70738,groups,0,0
70739,(,0,0
70740,p,0,0
70741,=,0,0
70742,0.012,0,0
70743,),0,0
70744,.,0,0
70745,CONCLUSIONS,0,0
70746,Low-intensity,0,0
70747,back-strengthening,0,1
70748,exercise,0,1
70749,was,0,0
70750,effective,0,0
70751,in,0,0
70752,improving,0,0
70753,the,0,0
70754,quality,0,0
70755,of,0,0
70756,life,0,0
70757,and,0,0
70758,back,0,0
70759,extensor,0,1
70760,strength,0,0
70761,in,0,0
70762,patients,0,0
70763,with,0,0
70764,osteoporosis,0,0
70765,.,0,0
70766,The,0,0
70767,relationship,0,0
70768,between,0,0
70769,histology,0,0
70770,and,0,0
70771,outcome,0,0
70772,in,0,0
70773,advanced,0,0
70774,and,0,0
70775,recurrent,0,0
70776,endometrial,0,0
70777,cancer,0,0
70778,patients,0,0
70779,participating,0,0
70780,in,0,0
70781,first-line,0,1
70782,chemotherapy,1,1
70783,trials,0,0
70784,:,0,0
70785,a,0,0
70786,Gynecologic,0,0
70787,Oncology,0,0
70788,Group,0,0
70789,study,0,0
70790,.,0,0
70791,OBJECTIVES,0,0
70792,To,0,0
70793,explore,0,0
70794,associations,0,0
70795,between,0,0
70796,histology,0,0
70797,and,0,0
70798,outcome,0,0
70799,in,0,0
70800,advanced,0,0
70801,or,0,0
70802,recurrent,0,0
70803,endometrial,0,0
70804,cancer,0,0
70805,patients,0,0
70806,participating,0,0
70807,in,0,0
70808,Gynecologic,0,0
70809,Oncology,0,0
70810,Group,0,0
70811,chemotherapy,0,1
70812,trials,0,0
70813,.,0,0
70814,METHODS,0,0
70815,Age,0,0
70816,",",0,0
70817,race,0,0
70818,",",0,0
70819,performance,0,0
70820,status,0,0
70821,",",0,0
70822,histologic,0,0
70823,type,0,0
70824,(,0,0
70825,serous=S,0,0
70826,;,0,0
70827,clear,0,0
70828,cell=CC,0,0
70829,;,0,0
70830,endometrioid=E,0,0
70831,),0,0
70832,",",0,0
70833,disease,0,0
70834,stage,0,0
70835,",",0,0
70836,and,0,0
70837,prior,0,0
70838,radiation,0,1
70839,were,0,0
70840,evaluated,0,0
70841,using,0,0
70842,various,1,0
70843,analytic,1,0
70844,methods,1,0
70845,to,1,0
70846,evaluate,1,0
70847,the,1,0
70848,probability,1,0
70849,of,1,0
70850,response,1,0
70851,and,1,0
70852,identify,1,0
70853,independent,1,0
70854,predictors,1,0
70855,of,1,0
70856,progression-free,1,0
70857,survival,1,0
70858,(,1,0
70859,PFS,1,0
70860,),1,1
70861,and,1,0
70862,overall,1,0
70863,survival,1,0
70864,(,1,0
70865,OS,1,0
70866,),1,0
70867,.,1,0
70868,RESULTS,0,0
70869,Single,1,0
70870,agent,1,0
70871,or,0,1
70872,combination,1,1
70873,chemotherapy,1,1
70874,regimens,1,1
70875,including,0,0
70876,doxorubicin,1,1
70877,(,1,0
70878,A,1,0
70879,),1,0
70880,(,0,0
70881,12,0,0
70882,%,0,0
70883,),0,0
70884,",",0,0
70885,doxorubicin/cisplatin,1,1
70886,(,0,0
70887,AP,0,0
70888,),0,1
70889,(,0,0
70890,63,0,0
70891,%,0,0
70892,),0,0
70893,",",0,0
70894,doxorubicin/paclitaxel,1,1
70895,(,0,0
70896,AT,0,1
70897,),0,1
70898,(,0,0
70899,13,0,0
70900,%,0,0
70901,),0,0
70902,",",0,0
70903,and,0,0
70904,paclitaxel/doxorubicin/cisplatin,1,1
70905,(,0,1
70906,TAP,0,1
70907,),0,1
70908,(,0,0
70909,11,0,0
70910,%,0,0
70911,),0,0
70912,were,0,0
70913,used,0,0
70914,among,0,0
70915,1203,0,0
70916,patients,0,0
70917,treated,0,0
70918,on,0,0
70919,4,0,0
70920,randomized,0,0
70921,clinical,0,0
70922,trials,0,0
70923,.,0,0
70924,Breakdown,0,0
70925,of,0,0
70926,disease,0,0
70927,stage,0,0
70928,was,0,0
70929,7.8,0,0
70930,%,0,0
70931,stage,0,0
70932,III,0,0
70933,",",0,0
70934,22.8,0,0
70935,%,0,0
70936,stage,0,0
70937,IV,0,0
70938,",",0,0
70939,and,0,0
70940,69.4,0,0
70941,%,0,0
70942,recurrent,0,0
70943,disease,0,0
70944,.,0,0
70945,Histologic,0,0
70946,distribution,0,0
70947,was,0,0
70948,18,0,0
70949,%,0,0
70950,S,0,0
70951,",",0,0
70952,3.7,0,0
70953,%,0,0
70954,CC,0,0
70955,",",0,0
70956,8.5,0,0
70957,%,0,0
70958,mixed,0,0
70959,",",0,0
70960,51.7,0,0
70961,%,0,0
70962,E,0,1
70963,and,0,0
70964,18.1,0,0
70965,%,0,0
70966,other,0,0
70967,.,0,0
70968,More,0,0
70969,S/CC,0,0
70970,patients,0,0
70971,enrolled,0,0
70972,on,0,0
70973,trials,0,0
70974,with,0,0
70975,advanced,0,0
70976,stage,0,0
70977,(,0,0
70978,III-IV,0,1
70979,),0,1
70980,disease,0,0
70981,(,0,0
70982,as,0,0
70983,opposed,0,0
70984,to,0,0
70985,recurrent,0,0
70986,disease,0,0
70987,),0,0
70988,compared,0,0
70989,to,0,0
70990,E,0,0
70991,patients,0,0
70992,(,0,0
70993,45,0,0
70994,%,0,0
70995,vs.,0,0
70996,24,0,0
70997,%,0,0
70998,",",0,0
70999,p,0,0
71000,<,0,0
71001,0.05,0,0
71002,),0,0
71003,.,0,0
71004,Overall,0,0
71005,response,0,0
71006,rate,0,0
71007,was,0,0
71008,42,0,0
71009,%,0,0
71010,(,0,0
71011,E=44,0,0
71012,%,0,0
71013,",",0,0
71014,S=44,0,0
71015,%,0,0
71016,",",0,0
71017,CC=32,0,0
71018,%,0,0
71019,),0,0
71020,.,0,0
71021,Histologic,0,0
71022,type,0,0
71023,was,0,0
71024,not,0,0
71025,an,0,0
71026,independent,0,0
71027,predictor,0,0
71028,of,0,0
71029,response,0,0
71030,.,0,0
71031,Independent,0,0
71032,predictors,0,0
71033,of,0,0
71034,PFS,0,0
71035,included,0,0
71036,race,0,0
71037,",",0,0
71038,performance,0,0
71039,status,0,0
71040,",",0,0
71041,disease,0,0
71042,stage,0,0
71043,",",0,0
71044,and,0,0
71045,CC,0,0
71046,histology,0,0
71047,.,0,0
71048,Histology,0,0
71049,was,0,0
71050,also,0,0
71051,an,0,0
71052,independent,0,0
71053,predictor,0,0
71054,of,0,0
71055,OS,0,0
71056,;,0,0
71057,the,0,0
71058,relative,0,0
71059,hazard,0,0
71060,ratio,0,0
71061,for,0,0
71062,S,0,0
71063,histology,0,0
71064,was,0,0
71065,1.2,0,0
71066,(,0,0
71067,1.02-1.4,0,0
71068,;,0,0
71069,p=0.03,0,0
71070,),0,0
71071,",",0,0
71072,and,0,0
71073,for,0,0
71074,CC,0,0
71075,was,0,0
71076,1.51,0,0
71077,(,0,0
71078,1.1-2.07,0,0
71079,;,0,0
71080,p=0.01,0,0
71081,),0,0
71082,.,0,0
71083,CONCLUSION,0,0
71084,In,0,0
71085,patients,0,0
71086,with,0,0
71087,advanced/recurrent,0,0
71088,endometrial,0,0
71089,cancer,0,0
71090,treated,0,0
71091,with,0,0
71092,A,0,0
71093,",",0,0
71094,P,0,0
71095,and/or,0,0
71096,T,0,0
71097,",",0,0
71098,response,0,0
71099,was,0,0
71100,not,0,0
71101,associated,0,0
71102,with,0,0
71103,histology,0,0
71104,.,0,0
71105,This,0,0
71106,exploratory,0,0
71107,analysis,0,0
71108,does,0,0
71109,not,0,0
71110,support,0,0
71111,exclusion,0,0
71112,of,0,0
71113,S,0,0
71114,tumors,0,0
71115,in,0,0
71116,future,0,0
71117,trials,0,0
71118,.,0,0
71119,Poorer,0,0
71120,PFS,0,0
71121,and,0,0
71122,OS,0,0
71123,were,0,0
71124,observed,0,0
71125,in,0,0
71126,CC,0,0
71127,compared,0,0
71128,to,0,0
71129,other,0,0
71130,types,0,0
71131,",",0,0
71132,but,0,0
71133,a,0,0
71134,lack,0,0
71135,of,0,0
71136,benefit,0,0
71137,from,0,0
71138,chemotherapy,0,1
71139,was,0,0
71140,not,0,0
71141,shown,0,0
71142,",",0,0
71143,and,0,0
71144,as,0,0
71145,this,0,0
71146,histology,0,0
71147,represents,0,0
71148,such,0,0
71149,a,0,0
71150,small,0,0
71151,fraction,0,0
71152,",",0,0
71153,it,0,0
71154,does,0,0
71155,not,0,0
71156,seem,0,0
71157,feasible,0,0
71158,to,0,0
71159,have,0,0
71160,separate,0,0
71161,chemotherapy,0,1
71162,trials,0,0
71163,for,0,0
71164,CC,0,0
71165,.,0,0
71166,Long-term,0,0
71167,growth,0,0
71168,hormone,0,1
71169,treatment,0,0
71170,in,0,0
71171,growth,0,0
71172,hormone,0,1
71173,deficient,0,0
71174,adults,0,0
71175,.,0,0
71176,Growth,1,0
71177,hormone,1,0
71178,treatment,1,0
71179,in,0,0
71180,GH-deficient,0,1
71181,adults,0,0
71182,has,0,0
71183,proved,0,0
71184,beneficial,0,0
71185,in,0,0
71186,recent,0,0
71187,short-term,0,0
71188,trials,0,0
71189,",",0,0
71190,but,0,0
71191,long-term,0,0
71192,results,0,0
71193,have,0,0
71194,not,0,0
71195,yet,0,0
71196,been,0,0
71197,reported,0,0
71198,.,0,0
71199,Thirteen,0,0
71200,GH-deficient,0,1
71201,adults,0,0
71202,(,0,0
71203,4,0,0
71204,females,0,0
71205,",",0,0
71206,9,0,0
71207,males,0,0
71208,;,0,0
71209,mean,0,0
71210,(,0,0
71211,SEM,0,1
71212,),0,0
71213,age,0,0
71214,26.4,0,0
71215,(,0,0
71216,1.7,0,0
71217,),0,0
71218,years,0,0
71219,),0,0
71220,",",0,0
71221,who,0,0
71222,had,0,0
71223,completed,0,0
71224,4,0,0
71225,months,0,0
71226,of,0,0
71227,GH,1,1
71228,therapy,1,1
71229,in,0,0
71230,a,0,0
71231,double-blind,0,0
71232,placebo-controlled,1,1
71233,cross-over,0,0
71234,study,0,0
71235,were,0,0
71236,followed,0,0
71237,",",0,0
71238,for,0,0
71239,further,0,0
71240,16.1,0,0
71241,(,0,0
71242,0.8,0,0
71243,),0,0
71244,months,0,0
71245,of,0,0
71246,uninterrupted,0,0
71247,GH,1,1
71248,therapy,1,1
71249,in,0,0
71250,an,0,0
71251,open,0,0
71252,design,0,0
71253,.,0,0
71254,A,0,0
71255,significant,0,0
71256,mean,0,0
71257,increase,0,0
71258,of,0,0
71259,1.3,0,0
71260,cm,0,0
71261,in,0,0
71262,linear,0,0
71263,height,0,0
71264,was,0,0
71265,recorded,0,0
71266,",",0,0
71267,whereas,0,0
71268,body,0,0
71269,mass,0,0
71270,index,0,0
71271,remained,0,0
71272,unchanged,0,0
71273,.,0,0
71274,Mean,0,0
71275,muscle,0,0
71276,volume,0,0
71277,of,0,0
71278,the,0,0
71279,thigh,0,0
71280,",",0,0
71281,estimated,0,0
71282,by,0,0
71283,computerised,0,0
71284,tomography,0,1
71285,",",0,0
71286,increased,0,0
71287,significantly,0,0
71288,compared,0,0
71289,with,0,0
71290,that,0,0
71291,of,0,0
71292,the,0,0
71293,initial,0,0
71294,placebo,1,1
71295,period,0,0
71296,(,0,0
71297,p,0,0
71298,=,0,0
71299,0.01,0,0
71300,),0,0
71301,",",0,0
71302,and,0,0
71303,a,0,0
71304,slight,0,0
71305,decrease,0,0
71306,was,0,0
71307,recorded,0,0
71308,in,0,0
71309,adipose,0,0
71310,tissue,0,0
71311,volume,0,0
71312,of,0,0
71313,the,0,0
71314,thigh,0,1
71315,(,0,0
71316,p,0,0
71317,=,0,0
71318,0.10,0,0
71319,),0,0
71320,and,0,0
71321,subscapular,0,0
71322,skinfold,0,0
71323,thickness,0,0
71324,(,0,0
71325,p,0,0
71326,=,0,0
71327,0.10,0,0
71328,),0,0
71329,.,0,0
71330,Still,0,0
71331,",",0,0
71332,the,0,0
71333,muscle,0,0
71334,to,0,0
71335,fat,0,0
71336,ratio,0,0
71337,of,0,0
71338,the,0,0
71339,thigh,0,0
71340,was,0,0
71341,significantly,0,0
71342,lower,0,0
71343,compared,0,0
71344,with,0,0
71345,that,0,0
71346,of,0,0
71347,normal,0,0
71348,subjects,0,0
71349,(,0,0
71350,72.6/27.4,0,0
71351,vs,0,0
71352,77.9/22.1,0,0
71353,),0,0
71354,(,0,0
71355,p,0,0
71356,less,0,0
71357,than,0,0
71358,0.01,0,0
71359,),0,0
71360,.,0,0
71361,The,0,0
71362,mean,0,0
71363,isometric,0,0
71364,strength,0,0
71365,of,0,0
71366,the,0,0
71367,quadriceps,0,0
71368,muscles,0,0
71369,increased,0,0
71370,significantly,0,0
71371,during,0,0
71372,long-term,0,0
71373,GH,0,1
71374,therapy,0,1
71375,(,0,0
71376,p,0,0
71377,less,0,0
71378,than,0,0
71379,0.01,0,0
71380,),0,0
71381,",",0,0
71382,but,0,0
71383,remained,0,0
71384,lower,0,0
71385,compared,0,0
71386,with,0,0
71387,that,0,0
71388,of,0,0
71389,normal,0,0
71390,subjects,0,0
71391,(,0,0
71392,1.66,0,0
71393,(,0,0
71394,0.10,0,0
71395,),0,0
71396,vs,0,0
71397,2.13,0,0
71398,(,0,0
71399,0.11,0,0
71400,),0,0
71401,Nm/kg,0,1
71402,body,0,0
71403,weight,0,0
71404,),0,0
71405,.,0,0
71406,Exercise,0,1
71407,capacity,0,0
71408,performed,0,0
71409,on,0,0
71410,a,0,0
71411,bicycle,0,1
71412,ergometer,0,1
71413,increased,0,0
71414,significantly,0,0
71415,after,0,0
71416,long-term,0,0
71417,therapy,0,1
71418,(,0,0
71419,p,0,0
71420,less,0,0
71421,than,0,0
71422,0.05,0,0
71423,),0,0
71424,",",0,0
71425,but,0,0
71426,still,0,0
71427,did,0,0
71428,not,0,0
71429,reach,0,0
71430,the,0,0
71431,values,0,0
71432,seen,0,0
71433,in,0,0
71434,normal,0,0
71435,subjects,0,0
71436,(,0,0
71437,22.5,0,0
71438,(,0,0
71439,3.4,0,0
71440,),0,0
71441,vs,0,0
71442,37.4,0,0
71443,(,0,0
71444,4.2,0,0
71445,),0,0
71446,watt.min.kg-1,0,0
71447,.,0,0
71448,No,0,0
71449,adverse,0,0
71450,reactions,0,0
71451,were,0,0
71452,recorded,0,0
71453,during,0,0
71454,long-term,0,0
71455,therapy,0,1
71456,and,0,0
71457,hemoglobin,0,0
71458,A1c,0,1
71459,remained,0,0
71460,unchanged,0,0
71461,.,0,0
71462,These,0,0
71463,data,0,0
71464,suggest,0,0
71465,that,0,0
71466,long-term,0,0
71467,GH,0,1
71468,replacement,0,1
71469,therapy,0,1
71470,in,0,0
71471,GH-deficient,0,1
71472,adults,0,0
71473,has,0,0
71474,beneficial,0,0
71475,effects,0,0
71476,on,0,0
71477,several,0,0
71478,physiological,0,0
71479,features,0,0
71480,which,0,0
71481,are,0,0
71482,subnormal,0,0
71483,in,0,0
71484,these,0,0
71485,patients,0,0
71486,.,0,0
71487,Parenteral,1,1
71488,amino,1,1
71489,acid,1,1
71490,and,0,0
71491,metabolic,0,0
71492,acidosis,0,0
71493,in,0,0
71494,premature,0,0
71495,infants,0,0
71496,.,0,0
71497,BACKGROUND,0,0
71498,Aggressive,1,0
71499,parenteral,1,1
71500,nutrition,1,1
71501,(,1,0
71502,PN,1,1
71503,),1,0
71504,including,1,0
71505,amino,1,1
71506,acids,1,1
71507,is,0,0
71508,recommended,0,0
71509,for,0,0
71510,low-birth-weight,0,0
71511,infants,0,0
71512,to,0,0
71513,prevent,0,0
71514,energy,0,0
71515,and,0,0
71516,protein,0,0
71517,deficit,0,0
71518,.,0,0
71519,Their,0,0
71520,impact,0,0
71521,on,0,0
71522,acid-base,0,0
71523,homeostasis,0,0
71524,has,0,0
71525,not,0,0
71526,been,0,0
71527,examined,0,0
71528,.,0,0
71529,METHODS,0,0
71530,We,0,0
71531,investigated,0,0
71532,the,0,0
71533,impact,0,0
71534,of,0,0
71535,dose,0,0
71536,and,0,0
71537,duration,0,0
71538,of,0,0
71539,parenteral,1,1
71540,amino,1,1
71541,acids,1,1
71542,",",1,0
71543,with,1,0
71544,cysteine,1,1
71545,",",0,0
71546,on,0,0
71547,acid-base,0,0
71548,parameters,0,0
71549,in,0,0
71550,122,0,0
71551,low-birth-weight,0,0
71552,infants,0,0
71553,.,0,0
71554,Premature,0,0
71555,infants,0,0
71556,<,0,0
71557,or=32,0,0
71558,weeks,0,0
71559,",",0,0
71560,<,0,0
71561,or=1850,0,0
71562,g,0,1
71563,",",0,0
71564,and,0,0
71565,receiving,0,0
71566,parenteral,1,1
71567,amino,1,1
71568,acids,1,1
71569,at,0,0
71570,1.5,0,0
71571,g/kg/d,0,0
71572,for,0,0
71573,an,0,0
71574,extended,0,1
71575,period,0,0
71576,(,0,0
71577,>,0,0
71578,24,0,0
71579,hours,0,0
71580,),0,0
71581,",",0,0
71582,or,0,0
71583,3,0,0
71584,g/kg/d,0,0
71585,for,0,0
71586,a,0,0
71587,short,0,0
71588,(,0,0
71589,5,0,0
71590,hour,0,0
71591,),0,0
71592,",",0,0
71593,extended,0,1
71594,(,0,0
71595,24,0,0
71596,hour,0,0
71597,),0,0
71598,",",0,0
71599,or,0,1
71600,prolonged,0,0
71601,(,0,0
71602,3-5,0,0
71603,days,0,0
71604,),0,0
71605,duration,0,0
71606,were,0,0
71607,included,0,0
71608,in,0,0
71609,the,0,0
71610,study,0,0
71611,.,0,0
71612,Data,0,0
71613,were,0,0
71614,obtained,0,0
71615,at,0,0
71616,age,0,0
71617,0-3,0,0
71618,days,0,0
71619,(,0,0
71620,n,0,0
71621,=,0,0
71622,43,0,0
71623,),0,0
71624,or,0,0
71625,",",0,0
71626,when,0,0
71627,clinically,0,0
71628,stable,0,0
71629,",",0,0
71630,age,0,0
71631,3-5,0,0
71632,days,0,0
71633,(,0,0
71634,n,0,0
71635,=,0,0
71636,49,0,0
71637,),0,0
71638,.,0,0
71639,Data,0,0
71640,from,0,0
71641,30,0,0
71642,infants,0,0
71643,",",0,0
71644,matched,0,0
71645,for,0,0
71646,birth,0,0
71647,weight,0,0
71648,and,0,0
71649,gestational,0,0
71650,age,0,0
71651,",",0,0
71652,receiving,0,0
71653,PN,1,1
71654,during,0,0
71655,the,0,0
71656,first,0,0
71657,5,0,0
71658,days,0,0
71659,after,0,0
71660,birth,0,0
71661,were,0,0
71662,also,0,0
71663,obtained,0,0
71664,.,0,0
71665,Acidosis,0,0
71666,was,0,0
71667,defined,0,0
71668,as,0,0
71669,pH,0,0
71670,<,0,0
71671,7.25,0,0
71672,.,0,0
71673,RESULTS,0,0
71674,Acidosis,0,0
71675,was,0,0
71676,evident,0,0
71677,in,0,0
71678,all,0,0
71679,infants,0,0
71680,between,0,0
71681,2,0,0
71682,and,0,0
71683,5,0,0
71684,days,0,0
71685,after,0,0
71686,birth,0,0
71687,.,0,0
71688,Infants,0,0
71689,with,0,0
71690,large,0,0
71691,patent,0,0
71692,ductus,0,0
71693,arteriosus,0,0
71694,(,0,0
71695,PDA,0,1
71696,),0,0
71697,exhibited,0,0
71698,significantly,0,0
71699,(,0,0
71700,p,0,0
71701,<,0,0
71702,.05,0,0
71703,),0,0
71704,lower,0,0
71705,pH,0,0
71706,early,0,0
71707,",",0,0
71708,had,0,0
71709,higher,0,0
71710,blood,0,0
71711,urea,0,0
71712,nitrogen,0,0
71713,levels,0,0
71714,(,0,0
71715,26,0,0
71716,+/-,0,0
71717,9,0,0
71718,vs,0,0
71719,18,0,0
71720,+,0,0
71721,8,0,0
71722,mg/dL,0,0
71723,;,0,0
71724,p,0,0
71725,<,0,0
71726,.05,0,0
71727,),0,0
71728,",",0,0
71729,and,0,0
71730,had,0,0
71731,greater,0,0
71732,weight,0,0
71733,loss,0,0
71734,(,0,0
71735,approximately,0,0
71736,17,0,0
71737,%,0,0
71738,of,0,0
71739,birth,0,0
71740,weight,0,0
71741,),0,0
71742,when,0,0
71743,compared,0,0
71744,with,0,0
71745,infants,0,0
71746,without,0,0
71747,PDA,0,1
71748,.,0,0
71749,Gestational,0,0
71750,age,0,0
71751,",",0,0
71752,weight,0,0
71753,loss,0,0
71754,",",0,0
71755,and,0,0
71756,patent,0,0
71757,ductus,0,0
71758,arteriosus,0,0
71759,accounted,0,0
71760,for,0,0
71761,65,0,0
71762,%,0,0
71763,of,0,0
71764,variance,0,0
71765,in,0,0
71766,acidosis,0,0
71767,.,0,0
71768,CONCLUSIONS,0,0
71769,Low-birth-weight,0,0
71770,infants,0,0
71771,develop,0,0
71772,metabolic,0,0
71773,acidosis,0,0
71774,between,0,0
71775,2,0,0
71776,and,0,0
71777,5,0,0
71778,days,0,0
71779,after,0,0
71780,birth,0,0
71781,",",0,0
71782,irrespective,0,0
71783,of,0,0
71784,dose,0,0
71785,and,0,0
71786,duration,0,0
71787,of,0,0
71788,parenteral,1,1
71789,amino,1,1
71790,acid,1,1
71791,administration,1,0
71792,.,1,0
71793,Careful,0,0
71794,management,0,0
71795,of,0,0
71796,parenteral,1,1
71797,fluids,1,0
71798,and,0,0
71799,comorbidities,0,0
71800,may,0,0
71801,lower,0,0
71802,the,0,0
71803,incidence,0,0
71804,of,0,0
71805,acidosis,0,0
71806,and,0,0
71807,promote,0,1
71808,protein,0,1
71809,accretion,0,0
71810,.,0,0
71811,Improvement,0,0
71812,in,0,0
71813,sensory,0,0
71814,impairment,0,0
71815,and,0,0
71816,social,0,1
71817,interaction,0,0
71818,in,0,0
71819,young,0,0
71820,children,0,0
71821,with,0,0
71822,autism,0,0
71823,following,0,0
71824,treatment,0,0
71825,with,0,0
71826,an,0,0
71827,original,1,0
71828,Qigong,1,1
71829,massage,1,1
71830,methodology,1,0
71831,.,1,0
71832,In,0,0
71833,clinical,0,0
71834,research,0,0
71835,",",0,0
71836,sensory,0,0
71837,impairment,0,0
71838,is,0,0
71839,considered,0,0
71840,one,0,0
71841,of,0,0
71842,the,0,0
71843,core,0,0
71844,deficits,0,0
71845,in,0,0
71846,autism,0,0
71847,and,0,0
71848,is,0,0
71849,associated,0,0
71850,with,0,0
71851,impaired,0,0
71852,socialization,0,0
71853,",",0,0
71854,behavioral,0,0
71855,disturbances,0,0
71856,and,0,0
71857,bowel,0,0
71858,and,0,0
71859,sleep,0,0
71860,problems,0,0
71861,.,0,0
71862,The,0,0
71863,effectiveness,0,0
71864,of,0,0
71865,the,0,0
71866,Cignolini,1,1
71867,methodology,1,0
71868,",",1,0
71869,an,1,0
71870,original,1,0
71871,Qigong,1,1
71872,massage,1,1
71873,methodology,1,0
71874,",",0,0
71875,in,0,0
71876,treating,0,0
71877,sensory,0,0
71878,impairment,0,0
71879,in,0,0
71880,young,0,0
71881,children,0,0
71882,with,0,0
71883,autism,0,0
71884,was,0,0
71885,evaluated,0,0
71886,in,0,0
71887,a,0,0
71888,small,0,0
71889,",",0,0
71890,controlled,0,0
71891,study,0,0
71892,.,0,0
71893,Thirteen,0,0
71894,children,0,0
71895,with,0,0
71896,autism,0,0
71897,between,0,0
71898,the,0,0
71899,ages,0,0
71900,of,0,0
71901,three,0,0
71902,and,0,0
71903,six,0,0
71904,received,0,0
71905,daily,0,0
71906,treatment,0,0
71907,according,0,0
71908,to,0,0
71909,the,0,0
71910,methodology,0,0
71911,for,0,0
71912,5,0,0
71913,months,0,0
71914,.,0,0
71915,Compared,0,0
71916,with,0,0
71917,untreated,0,0
71918,children,0,0
71919,",",0,0
71920,treated,0,0
71921,children,0,0
71922,experienced,0,0
71923,significant,0,0
71924,improvement,0,0
71925,of,0,0
71926,their,0,0
71927,sensory,0,0
71928,impairment,0,0
71929,(,0,0
71930,p,0,0
71931,<,0,0
71932,0.01,0,0
71933,),0,0
71934,",",0,0
71935,and,0,0
71936,demonstrated,0,0
71937,increased,0,0
71938,social,0,0
71939,skills,0,1
71940,(,0,0
71941,p,0,0
71942,<,0,0
71943,0.04,0,0
71944,),0,0
71945,and,0,0
71946,basic,0,1
71947,living,0,0
71948,skills,0,1
71949,(,0,0
71950,p,0,0
71951,<,0,0
71952,0.02,0,0
71953,),0,0
71954,on,0,0
71955,standardized,0,0
71956,measures,0,0
71957,.,0,0
71958,In,0,0
71959,addition,0,0
71960,",",0,0
71961,all,0,0
71962,of,0,0
71963,the,0,0
71964,children,0,0
71965,with,0,0
71966,bowel,0,0
71967,and,0,0
71968,sleep,0,0
71969,abnormalities,0,0
71970,demonstrated,0,0
71971,improvement,0,0
71972,after,0,0
71973,treatment,0,0
71974,.,0,0
71975,Efficacy,0,0
71976,of,0,0
71977,amantadine,1,1
71978,on,0,0
71979,quality,0,0
71980,of,0,0
71981,life,0,0
71982,in,0,0
71983,patients,0,0
71984,with,0,0
71985,chronic,0,0
71986,hepatitis,0,0
71987,C,0,0
71988,treated,0,0
71989,with,0,0
71990,interferon-alpha,1,1
71991,and,1,0
71992,ribavirin,1,1
71993,:,1,0
71994,results,0,0
71995,from,0,0
71996,a,0,0
71997,randomized,0,0
71998,",",0,0
71999,placebo-controlled,1,1
72000,",",0,0
72001,double-blind,0,0
72002,trial,0,0
72003,.,0,0
72004,AIM,0,0
72005,The,0,0
72006,aim,0,0
72007,of,0,0
72008,this,0,0
72009,study,0,0
72010,was,0,0
72011,to,0,0
72012,investigate,0,0
72013,whether,0,0
72014,amantadine,0,1
72015,reduces,0,0
72016,deterioration,0,0
72017,of,0,0
72018,quality,0,0
72019,of,0,0
72020,life,0,0
72021,in,0,0
72022,patients,0,0
72023,with,0,0
72024,chronic,0,0
72025,hepatitis,0,0
72026,C,0,1
72027,during,0,0
72028,and,0,0
72029,after,0,0
72030,treatment,0,0
72031,with,0,0
72032,interferon-alpha,0,1
72033,(,0,0
72034,IFN-alpha,0,1
72035,),0,1
72036,and,0,0
72037,ribavirin,0,1
72038,.,0,0
72039,PATIENTS,0,0
72040,AND,0,0
72041,METHODS,0,0
72042,In,0,0
72043,this,0,0
72044,randomized,0,0
72045,",",0,0
72046,prospective,0,0
72047,",",0,0
72048,placebo-controlled,1,1
72049,",",0,0
72050,multicenter,0,0
72051,trial,0,0
72052,",",0,0
72053,previously,0,0
72054,untreated,0,0
72055,patients,0,0
72056,with,0,0
72057,chronic,0,0
72058,hepatitis,0,0
72059,C,0,0
72060,were,0,0
72061,treated,0,0
72062,with,0,0
72063,IFN-alpha,1,1
72064,plus,1,1
72065,ribavirin,1,1
72066,[,1,0
72067,17,1,0
72068,],1,0
72069,and,0,0
72070,randomized,0,0
72071,for,0,0
72072,treatment,0,0
72073,with,0,0
72074,amantadine,1,1
72075,(,0,0
72076,200,0,1
72077,mg/day,0,0
72078,",",0,0
72079,orally,0,1
72080,",",0,0
72081,n=136,0,0
72082,),0,0
72083,or,1,1
72084,placebo,1,1
72085,(,0,0
72086,n=131,0,0
72087,),0,0
72088,.,0,0
72089,Quality,0,0
72090,of,0,0
72091,life,0,0
72092,was,0,0
72093,assessed,0,0
72094,with,0,0
72095,the,0,0
72096,'Profile,0,0
72097,of,0,0
72098,Mood,0,0
72099,States,0,0
72100,',0,0
72101,scale,0,0
72102,and,0,0
72103,the,0,0
72104,'Everyday,0,0
72105,Life,0,0
72106,',0,0
72107,questionnaire,0,0
72108,at,0,0
72109,baseline,0,0
72110,",",0,0
72111,treatment,0,0
72112,week,0,0
72113,(,0,0
72114,TW,0,0
72115,),0,0
72116,8,0,0
72117,",",0,0
72118,TW24,0,0
72119,",",0,0
72120,TW48,0,0
72121,",",0,0
72122,and,0,0
72123,at,0,0
72124,follow-up,0,0
72125,.,0,0
72126,RESULTS,0,0
72127,Early,0,0
72128,during,0,0
72129,treatment,0,0
72130,at,0,0
72131,TW8,0,0
72132,",",0,0
72133,quality,0,0
72134,of,0,0
72135,life,0,0
72136,was,0,0
72137,not,0,0
72138,different,0,0
72139,between,0,0
72140,patients,0,0
72141,in,0,0
72142,the,0,0
72143,control,0,0
72144,and,0,0
72145,the,0,0
72146,amantadine,0,1
72147,group,0,0
72148,.,0,0
72149,At,0,0
72150,TW24,0,0
72151,",",0,0
72152,the,0,0
72153,control,0,1
72154,group,0,0
72155,but,0,0
72156,not,0,0
72157,the,0,0
72158,amantadine,1,1
72159,group,0,0
72160,",",0,0
72161,however,0,0
72162,",",0,0
72163,showed,0,0
72164,significant,0,0
72165,deterioration,0,0
72166,of,0,0
72167,the,0,0
72168,modalities,0,0
72169,depression,0,0
72170,",",0,0
72171,fatigue,0,0
72172,",",0,0
72173,and,0,0
72174,vigor,0,0
72175,compared,0,0
72176,with,0,0
72177,baseline,0,0
72178,.,0,0
72179,Especially,0,0
72180,",",0,0
72181,nonresponders,0,0
72182,in,0,0
72183,the,0,0
72184,amantadine,0,1
72185,group,0,0
72186,showed,0,0
72187,significantly,0,0
72188,lower,0,0
72189,deterioration,0,0
72190,of,0,0
72191,depression,0,0
72192,",",0,0
72193,anger,0,0
72194,",",0,0
72195,mind,0,0
72196,function,0,0
72197,",",0,0
72198,everyday,0,0
72199,life,0,0
72200,",",0,0
72201,and,0,0
72202,zest,0,0
72203,for,0,0
72204,life,0,0
72205,than,0,0
72206,those,0,0
72207,in,0,0
72208,the,0,0
72209,placebo,1,1
72210,group,0,0
72211,.,0,0
72212,After,0,0
72213,treatment,0,0
72214,",",0,0
72215,the,0,0
72216,beneficial,0,0
72217,effects,0,0
72218,of,0,0
72219,amantadine,0,1
72220,disappeared,0,0
72221,.,0,0
72222,CONCLUSION,0,0
72223,The,0,0
72224,addition,0,0
72225,of,0,0
72226,amantadine,1,1
72227,to,0,0
72228,IFN-alpha,1,1
72229,plus,1,1
72230,ribavirin,1,1
72231,combination,0,1
72232,therapy,0,1
72233,may,0,0
72234,reduce,0,0
72235,deterioration,0,0
72236,of,0,0
72237,depression,0,0
72238,",",0,0
72239,fatigue,0,0
72240,",",0,0
72241,and,0,0
72242,vigor,0,0
72243,during,0,0
72244,treatment,0,0
72245,but,0,0
72246,does,0,0
72247,not,0,0
72248,affect,0,0
72249,quality,0,0
72250,of,0,0
72251,life,0,0
72252,after,0,0
72253,treatment,0,0
72254,.,0,0
72255,Protein,1,1
72256,ingestion,1,0
72257,further,0,0
72258,augments,0,0
72259,S6K1,0,0
72260,phosphorylation,0,0
72261,in,0,0
72262,skeletal,0,0
72263,muscle,0,0
72264,following,0,0
72265,resistance,0,0
72266,type,0,0
72267,exercise,0,1
72268,in,0,0
72269,males,0,0
72270,.,0,0
72271,Our,0,0
72272,objective,0,0
72273,was,0,0
72274,to,0,0
72275,determine,0,0
72276,the,0,0
72277,impact,0,0
72278,of,0,0
72279,carbohydrate,1,1
72280,and/or,1,0
72281,protein,1,1
72282,ingestion,1,0
72283,before,0,0
72284,and,0,0
72285,after,0,0
72286,exercise,1,1
72287,on,0,0
72288,ribosomal,0,0
72289,protein,0,1
72290,S6,0,1
72291,kinase,0,0
72292,(,0,0
72293,S6K1,0,0
72294,),0,0
72295,and,0,0
72296,S6,0,1
72297,phosphorylation,0,0
72298,status,0,0
72299,in,0,0
72300,human,0,0
72301,skeletal,0,0
72302,muscle,0,0
72303,tissue,0,0
72304,.,0,0
72305,Seven,0,0
72306,healthy,0,0
72307,",",0,0
72308,untrained,0,1
72309,men,0,0
72310,(,0,0
72311,22.5,0,0
72312,+/-,0,0
72313,0.9,0,0
72314,y,0,0
72315,),0,0
72316,were,0,0
72317,randomly,0,0
72318,assigned,0,0
72319,to,0,0
72320,2,0,0
72321,cross-over,0,0
72322,experiments,0,0
72323,.,0,0
72324,Before,0,0
72325,",",0,0
72326,immediately,0,0
72327,after,0,0
72328,",",0,0
72329,and,0,0
72330,1,0,0
72331,h,0,0
72332,after,0,0
72333,a,0,0
72334,single,0,0
72335,bout,0,0
72336,of,0,0
72337,resistance,1,0
72338,exercise,1,1
72339,",",0,0
72340,subjects,0,0
72341,consumed,0,0
72342,0.3,0,0
72343,g,0,1
72344,x,0,0
72345,kg,0,1
72346,(,0,0
72347,-1,0,0
72348,),0,0
72349,carbohydrate,1,1
72350,with,1,0
72351,or,1,0
72352,without,1,0
72353,0.3,1,0
72354,g,1,1
72355,x,1,0
72356,kg,1,1
72357,(,1,0
72358,-1,1,0
72359,),1,1
72360,protein,1,1
72361,hydrolysate,1,1
72362,(,1,0
72363,CHO+PRO,1,1
72364,and,1,0
72365,CHO,1,0
72366,",",1,0
72367,respectively,1,0
72368,),1,0
72369,.,1,0
72370,Muscle,1,0
72371,biopsies,1,0
72372,were,0,0
72373,taken,0,0
72374,before,0,0
72375,and,0,0
72376,immediately,0,0
72377,after,0,0
72378,exercise,0,1
72379,and,0,0
72380,after,0,0
72381,1,0,0
72382,and,0,0
72383,4,0,0
72384,h,0,0
72385,of,0,0
72386,postexercise,0,0
72387,recovery,0,0
72388,to,0,0
72389,determine,0,0
72390,4E-BP1,0,0
72391,",",0,0
72392,S6K1,0,0
72393,(,0,0
72394,both,0,0
72395,T,0,0
72396,(,0,0
72397,421,0,0
72398,),0,0
72399,/S,0,0
72400,(,0,0
72401,424,0,0
72402,),0,0
72403,and,0,0
72404,T,0,0
72405,(,0,0
72406,389,0,0
72407,),0,0
72408,),0,0
72409,",",0,0
72410,and,0,0
72411,S6,0,1
72412,phosphorylation,0,0
72413,status,0,0
72414,.,0,0
72415,Following,0,0
72416,resistance,0,0
72417,exercise,0,1
72418,",",0,0
72419,4E-BP1,1,1
72420,phosphorylation,1,0
72421,was,0,0
72422,reduced,0,0
72423,to,0,0
72424,a,0,0
72425,greater,0,0
72426,extent,0,0
72427,in,0,0
72428,the,0,0
72429,CHO,1,1
72430,treatment,0,0
72431,(,0,0
72432,-48,0,0
72433,+/-,0,0
72434,7,0,0
72435,%,0,0
72436,),0,0
72437,than,0,0
72438,in,0,0
72439,the,0,0
72440,CHO+PRO,1,1
72441,treatment,0,0
72442,(,0,0
72443,-15,0,0
72444,+/-,0,0
72445,14,0,0
72446,%,0,0
72447,",",0,0
72448,P,0,0
72449,<,0,0
72450,0.01,0,0
72451,),0,0
72452,.,0,0
72453,During,0,0
72454,recovery,0,0
72455,",",0,0
72456,4E-BP1,0,1
72457,phosphorylation,0,0
72458,increased,0,0
72459,in,0,0
72460,both,0,0
72461,experiments,0,0
72462,(,0,0
72463,P,0,0
72464,<,0,0
72465,0.01,0,0
72466,),0,0
72467,",",0,0
72468,and,0,0
72469,tended,0,0
72470,to,0,0
72471,be,0,0
72472,higher,0,0
72473,in,0,0
72474,the,0,0
72475,CHO+PRO,0,1
72476,test,0,0
72477,(,0,0
72478,P,0,0
72479,=,0,0
72480,0.08,0,0
72481,),0,0
72482,.,0,0
72483,S6K1,0,0
72484,phosphorylation,0,0
72485,at,0,0
72486,T,0,0
72487,(,0,0
72488,421,0,0
72489,),0,0
72490,/S,0,0
72491,(,0,0
72492,424,0,0
72493,),0,0
72494,substantially,0,0
72495,increased,0,0
72496,following,0,0
72497,exercise,0,1
72498,and,0,0
72499,remained,0,0
72500,elevated,0,0
72501,during,0,0
72502,recovery,0,0
72503,with,0,0
72504,no,0,0
72505,differences,0,0
72506,between,0,0
72507,treatments,0,0
72508,.,0,0
72509,In,0,0
72510,contrast,0,0
72511,to,0,0
72512,the,0,0
72513,CHO,1,1
72514,treatment,1,0
72515,(,0,0
72516,-4,0,0
72517,+/-,0,0
72518,2,0,0
72519,%,0,0
72520,),0,0
72521,",",0,0
72522,S6K1,0,0
72523,phosphorylation,0,0
72524,at,0,0
72525,T,0,0
72526,(,0,0
72527,389,0,0
72528,),0,0
72529,was,0,0
72530,higher,0,0
72531,following,0,0
72532,exercise,0,0
72533,in,0,0
72534,the,0,0
72535,CHO+PRO,1,1
72536,treatment,0,0
72537,only,0,0
72538,(,0,0
72539,+78,0,0
72540,+/-,0,0
72541,2,0,0
72542,%,0,0
72543,",",0,0
72544,P,0,0
72545,<,0,0
72546,0.01,0,0
72547,),0,0
72548,.,0,0
72549,During,0,0
72550,recovery,0,0
72551,",",0,0
72552,S6K1,0,0
72553,phosphorylation,0,0
72554,at,0,0
72555,T,0,0
72556,(,0,0
72557,389,0,0
72558,),0,0
72559,remained,0,0
72560,higher,0,0
72561,in,0,0
72562,CHO+PRO,1,0
72563,than,0,0
72564,in,0,0
72565,CHO,1,1
72566,(,0,0
72567,P,0,0
72568,<,0,0
72569,0.05,0,0
72570,),0,0
72571,.,0,0
72572,S6,0,0
72573,phosphorylation,0,0
72574,was,0,0
72575,substantially,0,0
72576,higher,0,0
72577,following,0,0
72578,exercise,0,0
72579,in,0,0
72580,the,0,0
72581,CHO+PRO,1,1
72582,(,0,0
72583,1.69,0,0
72584,+/-,0,0
72585,0.35,0,0
72586,),0,0
72587,than,0,0
72588,in,0,0
72589,the,0,0
72590,CHO,1,1
72591,experiment,0,0
72592,(,0,0
72593,0.45,0,0
72594,+/-,0,0
72595,0.07,0,0
72596,",",0,0
72597,P,0,0
72598,<,0,0
72599,0.01,0,0
72600,),0,0
72601,and,0,0
72602,remained,0,0
72603,elevated,0,0
72604,during,0,0
72605,recovery,0,0
72606,(,0,0
72607,P,0,0
72608,<,0,0
72609,0.05,0,0
72610,),0,0
72611,.,0,0
72612,We,0,0
72613,conclude,0,0
72614,that,0,0
72615,the,0,0
72616,availability,0,0
72617,of,0,0
72618,dietary,0,0
72619,protein,0,0
72620,further,0,0
72621,enhances,0,0
72622,phosphorylation,0,0
72623,of,0,0
72624,S6K1,0,0
72625,during,0,0
72626,recovery,0,0
72627,from,0,0
72628,resistance,0,0
72629,type,0,0
72630,exercise,0,1
72631,.,0,0
72632,[,0,0
72633,Application,0,1
72634,of,0,0
72635,tacrolimus,1,1
72636,and,1,0
72637,cyclosporine,1,1
72638,A,1,0
72639,in,0,0
72640,HBV-carrying,0,0
72641,renal,0,0
72642,transplant,0,0
72643,recipients,0,0
72644,],0,0
72645,.,0,0
72646,OBJECTIVE,0,0
72647,To,0,0
72648,compare,0,0
72649,the,0,0
72650,long-term,0,0
72651,effect,0,0
72652,and,0,0
72653,safety,0,0
72654,of,0,0
72655,tacrolimus,1,1
72656,(,1,0
72657,FK506,1,1
72658,),1,1
72659,and,1,0
72660,cyclosporine,1,1
72661,(,1,1
72662,CsA,1,1
72663,),1,0
72664,in,0,0
72665,kidney,0,0
72666,transplant,0,1
72667,(,0,0
72668,KT,0,1
72669,),0,1
72670,recipients,0,0
72671,carrying,0,0
72672,hepatitis,0,0
72673,B,0,1
72674,Virus,0,0
72675,(,0,0
72676,HBV,0,1
72677,),0,0
72678,.,0,0
72679,METHODS,0,0
72680,A,0,0
72681,total,0,0
72682,of,0,0
72683,109,0,0
72684,patients,0,0
72685,with,0,0
72686,HBV,0,0
72687,were,0,0
72688,randomized,0,0
72689,into,0,0
72690,FK506,1,1
72691,group,0,0
72692,(,0,0
72693,52,0,0
72694,cases,0,0
72695,),0,0
72696,and,0,0
72697,CsA,1,1
72698,group,0,0
72699,(,0,0
72700,57,0,0
72701,cases,0,0
72702,),0,0
72703,after,0,0
72704,KT,0,1
72705,",",0,0
72706,and,0,0
72707,a,0,0
72708,2-year-long,0,0
72709,follow-up,0,0
72710,of,0,0
72711,the,0,0
72712,patients,0,0
72713,was,0,0
72714,conducted,0,0
72715,to,0,0
72716,record,0,0
72717,the,0,0
72718,patient,0,0
72719,and,0,0
72720,graft,0,0
72721,survival,0,0
72722,",",0,0
72723,incidence,0,0
72724,of,0,0
72725,acute,0,0
72726,graft,0,0
72727,rejection,0,0
72728,and,0,0
72729,postoperative,0,0
72730,liver,0,0
72731,function,0,0
72732,.,0,0
72733,RESULTS,0,0
72734,The,0,0
72735,2-year,0,0
72736,patient/graft,0,0
72737,survival,0,0
72738,was,0,0
72739,86.0,0,0
72740,%,0,0
72741,/73.7,0,0
72742,%,0,0
72743,and,0,0
72744,94.2,0,0
72745,%,0,0
72746,/90.3,0,0
72747,%,0,0
72748,in,0,0
72749,CsA,0,1
72750,and,0,0
72751,FK506,0,0
72752,groups,0,0
72753,",",0,0
72754,respectively,0,0
72755,(,0,0
72756,P,0,0
72757,<,0,0
72758,0.05,0,0
72759,),0,0
72760,",",0,0
72761,with,0,0
72762,incidence,0,0
72763,of,0,0
72764,acute,0,0
72765,rejection,0,0
72766,of,0,0
72767,10.5,0,0
72768,%,0,0
72769,and,0,0
72770,9.6,0,0
72771,%,0,0
72772,(,0,0
72773,P,0,0
72774,>,0,0
72775,0.05,0,0
72776,),0,0
72777,",",0,0
72778,and,0,0
72779,rate,0,0
72780,of,0,0
72781,abnormal,0,0
72782,liver,0,0
72783,function,0,0
72784,of,0,0
72785,26.3,0,0
72786,%,0,0
72787,and,0,0
72788,15.4,0,0
72789,%,0,0
72790,(,0,0
72791,P,0,0
72792,<,0,0
72793,0.05,0,0
72794,),0,0
72795,",",0,0
72796,respectively,0,0
72797,.,0,0
72798,Eight,0,0
72799,patients,0,0
72800,(,0,0
72801,14.4,0,0
72802,%,0,0
72803,),0,0
72804,in,0,0
72805,CsA,0,1
72806,group,0,0
72807,required,0,0
72808,a,0,0
72809,drug,0,0
72810,conversion,0,0
72811,but,0,0
72812,none,0,0
72813,in,0,0
72814,FK506,0,0
72815,group,0,0
72816,.,0,0
72817,The,0,0
72818,drug,0,0
72819,conversion,0,0
72820,resulted,0,0
72821,in,0,0
72822,significant,0,0
72823,reduction,0,0
72824,of,0,0
72825,ALT/AST,0,1
72826,level,0,0
72827,from,0,0
72828,255.13+/-31.38/201.88+/-21.25,0,0
72829,U/L,0,1
72830,to,0,0
72831,31.25+/-11.50/25.13+/-9.68,0,0
72832,U/L,0,1
72833,(,0,0
72834,P,0,0
72835,<,0,0
72836,0.01,0,0
72837,),0,0
72838,.,0,0
72839,CONCLUSION,0,0
72840,For,0,0
72841,HBV-carrying,0,0
72842,renal,0,0
72843,transplant,0,0
72844,recipients,0,0
72845,",",0,0
72846,FK506,1,0
72847,as,0,0
72848,the,0,0
72849,primary,0,0
72850,choice,0,0
72851,of,0,0
72852,immunosuppressant,0,1
72853,can,0,0
72854,be,0,0
72855,more,0,0
72856,effective,0,0
72857,and,0,0
72858,safer,0,0
72859,than,0,0
72860,CsA,0,0
72861,.,0,0
72862,Eight,1,0
72863,in-office,1,1
72864,tooth,1,0
72865,whitening,1,1
72866,systems,1,0
72867,evaluated,0,0
72868,in,0,0
72869,vivo,0,0
72870,:,0,0
72871,a,0,0
72872,pilot,0,0
72873,study,0,0
72874,.,0,0
72875,This,0,0
72876,in,0,0
72877,vivo,0,0
72878,pilot,0,0
72879,study,0,0
72880,evaluated,0,0
72881,eight,1,0
72882,products,1,0
72883,with,1,0
72884,hydrogen,1,1
72885,peroxide,1,1
72886,(,1,0
72887,HP,1,0
72888,),1,0
72889,concentrations,1,0
72890,ranging,1,0
72891,from,1,0
72892,15,1,0
72893,%,1,0
72894,to,1,0
72895,35,1,0
72896,%,1,0
72897,.,1,0
72898,The,0,0
72899,treatment,0,0
72900,contact,0,0
72901,time,0,0
72902,varied,0,0
72903,from,0,0
72904,15,0,0
72905,minutes,0,0
72906,to,0,0
72907,60,0,0
72908,minutes,0,0
72909,.,0,0
72910,Patients,0,0
72911,were,0,0
72912,evaluated,0,0
72913,for,0,0
72914,color,0,0
72915,at,0,0
72916,baseline,0,0
72917,",",0,0
72918,immediately,0,0
72919,after,0,0
72920,treatment,0,0
72921,and,0,0
72922,at,0,0
72923,one,0,0
72924,",",0,0
72925,two,0,0
72926,",",0,0
72927,four,0,0
72928,and,0,0
72929,six,0,0
72930,weeks,0,0
72931,after,0,0
72932,treatment,0,0
72933,using,0,0
72934,a,0,0
72935,colorimeter,1,0
72936,",",1,0
72937,shade,1,1
72938,guide,1,0
72939,and,1,0
72940,photos,1,0
72941,.,1,0
72942,All,0,0
72943,eight,0,0
72944,products,0,0
72945,were,0,0
72946,effective,0,0
72947,in,0,0
72948,bleaching,0,1
72949,teeth,0,0
72950,.,0,0
72951,Colorimeter,0,0
72952,data,0,0
72953,for,0,0
72954,deltaE,0,0
72955,immediately,0,0
72956,after,0,0
72957,treatment,0,0
72958,was,0,0
72959,6.77,0,0
72960,.,0,0
72961,At,0,0
72962,one,0,0
72963,and,0,0
72964,six,0,0
72965,weeks,0,0
72966,after,0,0
72967,bleaching,0,1
72968,",",0,0
72969,there,0,0
72970,were,0,0
72971,51,0,0
72972,%,0,0
72973,and,0,0
72974,65,0,0
72975,%,0,0
72976,reductions,0,0
72977,in,0,0
72978,deltaE,0,0
72979,",",0,0
72980,respectively,0,0
72981,.,0,0
72982,Predictors,0,0
72983,of,0,0
72984,incident,0,0
72985,depression,0,0
72986,after,0,0
72987,hip,0,0
72988,fracture,0,0
72989,surgery,0,0
72990,.,0,0
72991,OBJECTIVE,0,0
72992,Depression,0,0
72993,after,0,0
72994,hip,1,0
72995,fracture,1,0
72996,surgery,1,1
72997,is,0,0
72998,prevalent,0,0
72999,and,0,0
73000,associated,0,0
73001,with,0,0
73002,increased,0,0
73003,mortality,0,0
73004,rates,0,0
73005,and,0,0
73006,impaired,0,0
73007,functional,0,0
73008,recovery,0,0
73009,.,0,0
73010,The,0,0
73011,incidence,0,0
73012,of,0,0
73013,new-onset,0,0
73014,depressive,0,0
73015,symptoms,0,0
73016,in,0,0
73017,patients,0,0
73018,initially,0,0
73019,not,0,0
73020,depressed,0,0
73021,after,0,0
73022,hip,1,0
73023,fracture,1,0
73024,surgery,1,1
73025,and,0,0
73026,their,0,0
73027,relationship,0,0
73028,with,0,0
73029,functional,0,0
73030,recovery,0,0
73031,is,0,0
73032,unknown,0,0
73033,.,0,0
73034,METHODS,0,0
73035,A,0,0
73036,cohort,0,0
73037,of,0,0
73038,139,0,0
73039,nondepressed,0,0
73040,elderly,0,0
73041,patients,0,0
73042,(,0,0
73043,>,0,0
73044,60,0,0
73045,years,0,0
73046,),0,0
73047,hospitalized,0,0
73048,for,0,0
73049,hip,1,0
73050,fracture,1,0
73051,surgery,1,0
73052,were,0,0
73053,followed,0,0
73054,up,0,0
73055,for,0,0
73056,six,0,0
73057,months,0,0
73058,.,0,0
73059,Clinically,0,0
73060,significant,0,0
73061,depressive,0,0
73062,symptoms,0,0
73063,were,0,0
73064,defined,0,0
73065,as,0,0
73066,a,0,0
73067,score,0,0
73068,of,0,0
73069,7,0,0
73070,or,0,0
73071,more,0,0
73072,on,0,0
73073,the,0,0
73074,15-item,0,0
73075,Geriatric,0,0
73076,Depression,0,0
73077,Scale,0,0
73078,.,0,0
73079,RESULTS,0,0
73080,The,0,0
73081,authors,0,0
73082,found,0,0
73083,a,0,0
73084,cumulative,0,0
73085,incidence,0,0
73086,rate,0,0
73087,of,0,0
73088,20.5,0,0
73089,%,0,0
73090,adjusted,0,0
73091,for,0,0
73092,dropouts,0,0
73093,.,0,0
73094,Multiple,0,0
73095,Cox-regression,0,0
73096,analyses,0,0
73097,yielded,0,0
73098,the,0,0
73099,presence,0,0
73100,of,0,0
73101,subthreshold,0,0
73102,symptoms,0,0
73103,of,0,0
73104,depression,0,0
73105,",",0,0
73106,anxiety,0,0
73107,",",0,0
73108,pain,0,0
73109,",",0,0
73110,and,0,0
73111,cognitive,0,0
73112,impairment,0,0
73113,at,0,0
73114,baseline,0,0
73115,",",0,0
73116,the,0,0
73117,premorbid,0,0
73118,level,0,0
73119,of,0,0
73120,mobility,0,0
73121,",",0,0
73122,and,0,0
73123,a,0,0
73124,history,0,0
73125,of,0,0
73126,(,0,0
73127,treated,0,0
73128,),0,0
73129,depression,0,0
73130,as,0,0
73131,risk,0,0
73132,factors,0,0
73133,for,0,0
73134,incident,0,0
73135,depression,0,0
73136,(,0,0
73137,p,0,0
73138,<,0,0
73139,0.05,0,0
73140,),0,0
73141,.,0,0
73142,A,0,0
73143,forward,0,0
73144,",",0,0
73145,conditional,0,1
73146,procedure,0,0
73147,identified,0,0
73148,postoperative,0,0
73149,pain,0,0
73150,(,0,0
73151,hazard,0,0
73152,ratio,0,0
73153,[,0,0
73154,HR,0,0
73155,],0,0
73156,=,0,0
73157,1.32,0,0
73158,",",0,0
73159,95,0,0
73160,%,0,0
73161,confidence,0,0
73162,interval,0,0
73163,[,0,0
73164,CI,0,0
73165,],0,0
73166,:,0,0
73167,1.14-1.53,0,0
73168,",",0,0
73169,Wald,0,0
73170,chi,0,0
73171,(,0,0
73172,2,0,0
73173,),0,0
73174,=,0,0
73175,13.57,0,0
73176,",",0,0
73177,df,0,0
73178,=,0,0
73179,1,0,0
73180,",",0,0
73181,p,0,0
73182,<,0,0
73183,0.001,0,0
73184,),0,0
73185,and,0,0
73186,baseline,0,0
73187,anxiety,0,0
73188,(,0,0
73189,HR,0,0
73190,=,0,0
73191,1.25,0,0
73192,",",0,0
73193,95,0,0
73194,%,0,0
73195,CI,0,0
73196,:,0,0
73197,1.08-1.44,0,0
73198,",",0,0
73199,Wald,0,0
73200,chi,0,0
73201,(,0,0
73202,2,0,0
73203,),0,0
73204,=,0,0
73205,8.86,0,0
73206,",",0,0
73207,df,0,0
73208,=,0,0
73209,1,0,0
73210,",",0,0
73211,p,0,0
73212,=,0,0
73213,0.003,0,0
73214,),0,0
73215,as,0,0
73216,the,0,0
73217,strongest,0,0
73218,independent,0,0
73219,risk,0,0
73220,factors,0,0
73221,.,0,0
73222,Incident,0,0
73223,depression,0,0
73224,was,0,0
73225,associated,0,0
73226,with,0,0
73227,a,0,0
73228,less,0,0
73229,favorable,0,0
73230,outcome,0,0
73231,at,0,0
73232,3,0,0
73233,months,0,0
73234,follow-up,0,0
73235,.,0,0
73236,CONCLUSION,0,0
73237,This,0,0
73238,exploratory,0,0
73239,study,0,0
73240,identified,0,0
73241,two,0,0
73242,treatable,0,0
73243,baseline,0,0
73244,characteristics,0,0
73245,that,0,0
73246,predicted,0,0
73247,incident,0,0
73248,depression,0,0
73249,in,0,0
73250,nondepressed,0,0
73251,patients,0,0
73252,after,0,0
73253,hip-fracture,0,0
73254,surgery,0,0
73255,.,0,0
73256,Anti-inflammatory,0,0
73257,effects,0,0
73258,of,0,0
73259,inhaled,1,1
73260,carbon,1,1
73261,monoxide,1,1
73262,in,0,0
73263,patients,0,0
73264,with,0,0
73265,COPD,0,0
73266,:,0,0
73267,a,0,0
73268,pilot,0,0
73269,study,0,0
73270,.,0,0
73271,In,0,0
73272,vitro,0,0
73273,and,0,0
73274,in,0,0
73275,vivo,0,0
73276,studies,0,0
73277,have,0,0
73278,shown,0,0
73279,that,0,0
73280,carbon,1,1
73281,monoxide,1,1
73282,(,0,0
73283,CO,0,1
73284,),0,1
73285,has,0,0
73286,both,0,0
73287,anti-inflammatory,0,0
73288,and,0,0
73289,anti-oxidant,0,0
73290,capacities,0,0
73291,.,0,0
73292,Since,0,0
73293,chronic,0,0
73294,obstructive,0,0
73295,pulmonary,0,0
73296,disease,0,0
73297,(,0,0
73298,COPD,0,0
73299,),0,1
73300,is,0,0
73301,characterised,0,0
73302,by,0,0
73303,inflammation,0,0
73304,and,0,0
73305,oxidative,0,0
73306,stress,0,0
73307,",",0,0
73308,low-dose,1,1
73309,CO,1,1
73310,could,0,0
73311,be,0,0
73312,of,0,0
73313,therapeutic,0,0
73314,use,0,0
73315,.,0,0
73316,The,0,0
73317,aim,0,0
73318,of,0,0
73319,the,0,0
73320,present,0,0
73321,study,0,0
73322,was,0,0
73323,to,0,0
73324,investigate,0,0
73325,the,0,0
73326,feasibility,0,0
73327,and,0,0
73328,anti-inflammatory,0,1
73329,effects,0,0
73330,of,0,0
73331,100-125,0,0
73332,ppm,0,1
73333,CO,1,1
73334,inhalation,1,1
73335,in,0,0
73336,patients,0,0
73337,with,0,0
73338,stable,0,0
73339,COPD,0,0
73340,.,0,0
73341,In,0,0
73342,total,0,0
73343,",",0,0
73344,20,0,0
73345,ex-smoking,0,0
73346,COPD,0,0
73347,patients,0,0
73348,with,0,0
73349,post-bronchodilator,0,0
73350,forced,0,0
73351,expiratory,0,0
73352,volume,0,0
73353,in,0,0
73354,one,0,0
73355,second,0,0
73356,(,0,0
73357,FEV,0,1
73358,(,0,0
73359,1,0,0
73360,),0,0
73361,),0,0
73362,>,0,0
73363,1.20,0,0
73364,L,0,0
73365,and,0,0
73366,FEV,0,1
73367,(,0,0
73368,1,0,0
73369,),0,0
73370,/forced,0,0
73371,vital,0,0
73372,capacity,0,0
73373,<,0,0
73374,70,0,0
73375,%,0,0
73376,were,0,0
73377,enrolled,0,0
73378,in,0,0
73379,a,0,0
73380,randomised,0,0
73381,",",0,0
73382,placebo-controlled,1,1
73383,",",0,0
73384,crossover,0,0
73385,study,0,0
73386,.,0,0
73387,Effects,0,0
73388,on,0,0
73389,inflammation,0,0
73390,were,0,0
73391,measured,0,0
73392,in,0,0
73393,induced,0,0
73394,sputum,0,0
73395,and,0,0
73396,blood,0,0
73397,.,0,0
73398,CO,0,0
73399,inhalation,0,0
73400,was,0,0
73401,feasible,0,0
73402,and,0,0
73403,patients,0,0
73404,',0,0
73405,vital,0,0
73406,signs,0,0
73407,were,0,0
73408,unaffected,0,0
73409,;,0,0
73410,2,0,0
73411,h.day,0,0
73412,(,0,0
73413,-1,0,0
73414,),0,0
73415,inhalation,0,1
73416,of,0,0
73417,low-dose,0,1
73418,CO,0,1
73419,on,0,0
73420,4,0,0
73421,consecutive,0,0
73422,days,0,0
73423,led,0,0
73424,to,0,0
73425,a,0,0
73426,maximal,0,0
73427,individual,0,0
73428,carboxyhaemoglobin,0,0
73429,level,0,0
73430,of,0,0
73431,4.5,0,0
73432,%,0,0
73433,.,0,0
73434,Two,0,0
73435,exacerbations,0,0
73436,occurred,0,0
73437,in,0,0
73438,the,0,0
73439,CO,0,0
73440,period,0,0
73441,.,0,0
73442,CO,0,0
73443,inhalation,0,0
73444,led,0,0
73445,to,0,0
73446,trends,0,0
73447,in,0,0
73448,reduced,0,0
73449,sputum,0,0
73450,eosinophils,0,1
73451,(,0,0
73452,median,0,0
73453,reduction,0,0
73454,0.25,0,1
73455,%,0,0
73456,point,0,0
73457,),0,0
73458,and,0,0
73459,improved,0,0
73460,responsiveness,0,0
73461,to,0,0
73462,methacholine,0,1
73463,(,0,0
73464,median,0,0
73465,provocative,0,0
73466,concentration,0,0
73467,causing,0,0
73468,a,0,0
73469,20,0,0
73470,%,0,0
73471,fall,0,0
73472,in,0,0
73473,FEV,0,1
73474,(,0,0
73475,1,0,0
73476,),0,0
73477,0.85,0,0
73478,versus,0,0
73479,0.63,0,0
73480,mg.mL,0,1
73481,(,0,0
73482,-1,0,0
73483,),0,0
73484,),0,0
73485,.,0,0
73486,Inhalation,0,0
73487,of,0,0
73488,100-125,0,0
73489,ppm,0,1
73490,carbon,1,1
73491,monoxide,1,1
73492,by,0,0
73493,patients,0,0
73494,with,0,0
73495,chronic,0,0
73496,obstructive,0,0
73497,pulmonary,0,0
73498,disease,0,0
73499,in,0,0
73500,a,0,0
73501,stable,0,0
73502,phase,0,0
73503,was,0,0
73504,feasible,0,0
73505,and,0,0
73506,led,0,0
73507,to,0,0
73508,trends,0,0
73509,in,0,0
73510,reduction,0,0
73511,of,0,0
73512,sputum,0,0
73513,eosinophils,0,0
73514,and,0,0
73515,improvement,0,0
73516,of,0,0
73517,responsiveness,0,0
73518,to,0,0
73519,methacholine,0,0
73520,.,0,0
73521,Further,0,0
73522,studies,0,0
73523,need,0,0
73524,to,0,0
73525,confirm,0,0
73526,the,0,0
73527,safety,0,0
73528,and,0,0
73529,efficacy,0,0
73530,in,0,0
73531,inflammatory,0,0
73532,lung,0,0
73533,diseases,0,0
73534,.,0,0
73535,Sodium,1,1
73536,bicarbonate,1,1
73537,",",1,0
73538,N-acetylcysteine,1,1
73539,",",1,0
73540,and,1,0
73541,saline,1,1
73542,for,0,0
73543,prevention,0,0
73544,of,0,0
73545,radiocontrast-induced,0,0
73546,nephropathy,0,0
73547,.,0,0
73548,A,0,0
73549,comparison,0,0
73550,of,0,0
73551,3,0,0
73552,regimens,0,0
73553,for,0,0
73554,protecting,0,0
73555,contrast-induced,0,0
73556,nephropathy,0,0
73557,in,0,0
73558,patients,0,0
73559,undergoing,0,0
73560,coronary,1,0
73561,procedures,1,0
73562,.,1,0
73563,A,0,0
73564,single-center,0,0
73565,prospective,0,0
73566,controlled,0,0
73567,trial,0,0
73568,.,0,0
73569,BACKGROUND,0,0
73570,Several,0,0
73571,protective,0,0
73572,therapies,0,0
73573,have,0,0
73574,been,0,0
73575,developed,0,0
73576,to,0,0
73577,prevent,0,0
73578,contrast-induced,0,0
73579,nephropathy,0,0
73580,(,0,0
73581,CIN,0,1
73582,),0,0
73583,.,0,0
73584,We,0,0
73585,aimed,0,0
73586,to,0,0
73587,investigate,0,0
73588,the,0,0
73589,efficacy,0,0
73590,of,0,0
73591,sodium,1,1
73592,bicarbonate,1,1
73593,by,0,0
73594,comparing,0,0
73595,2,0,0
73596,other,0,0
73597,regimens,0,0
73598,",",0,0
73599,including,0,0
73600,combination,1,1
73601,of,1,0
73602,N-acetylcysteine,1,1
73603,(,1,0
73604,NAC,1,1
73605,),1,1
73606,plus,1,1
73607,sodium,1,1
73608,chloride,1,1
73609,and,1,0
73610,sodium,1,1
73611,chloride,1,1
73612,alone,1,1
73613,",",0,0
73614,to,0,0
73615,prevent,0,0
73616,CIN,0,1
73617,in,0,0
73618,patients,0,0
73619,undergoing,0,0
73620,cardiovascular,0,0
73621,procedures,0,0
73622,.,0,0
73623,METHODS,0,0
73624,We,0,0
73625,prospectively,0,0
73626,enrolled,0,0
73627,264,0,0
73628,patients,0,0
73629,who,0,0
73630,were,0,0
73631,scheduled,0,0
73632,for,0,0
73633,cardiovascular,0,0
73634,procedures,0,0
73635,and,0,0
73636,had,0,0
73637,a,0,0
73638,baseline,0,0
73639,creatinine,0,0
73640,level,0,0
73641,>,0,0
73642,1.2,0,0
73643,mg/dL,0,0
73644,.,0,0
73645,The,0,0
73646,patients,0,0
73647,were,0,0
73648,assigned,0,0
73649,1,0,0
73650,of,0,0
73651,3,0,0
73652,prophylactic,0,0
73653,regimens,0,0
73654,:,0,0
73655,infusion,1,1
73656,of,1,0
73657,sodium,1,1
73658,bicarbonate,1,1
73659,",",1,0
73660,sodium,1,1
73661,chloride,1,1
73662,",",1,0
73663,sodium,1,1
73664,chloride,1,1
73665,plus,1,1
73666,oral,1,1
73667,NAC,1,1
73668,(,0,0
73669,600,0,0
73670,mg,0,1
73671,bid,0,1
73672,),0,0
73673,.,0,0
73674,Contrast-induced,0,0
73675,nephropathy,0,0
73676,was,0,0
73677,defined,0,0
73678,as,0,0
73679,an,0,0
73680,increase,0,0
73681,in,0,0
73682,serum,0,0
73683,creatinine,0,0
73684,level,0,0
73685,>,0,0
73686,25,0,0
73687,%,0,0
73688,or,0,0
73689,0.5,0,0
73690,mg/dL,0,0
73691,after,0,0
73692,48,0,0
73693,hours,0,0
73694,.,0,0
73695,RESULTS,0,0
73696,There,0,0
73697,were,0,0
73698,no,0,0
73699,significant,0,0
73700,differences,0,0
73701,among,0,0
73702,groups,0,0
73703,regarding,0,0
73704,baseline,0,0
73705,demographic,0,0
73706,properties,0,0
73707,and,0,0
73708,nephropathy,0,0
73709,risk,0,0
73710,factors,0,0
73711,.,0,0
73712,The,0,0
73713,change,0,0
73714,in,0,0
73715,creatinine,0,0
73716,clearance,0,0
73717,was,0,0
73718,significantly,0,0
73719,better,0,0
73720,in,0,0
73721,the,0,0
73722,sodium,1,1
73723,bicarbonate,1,1
73724,group,0,0
73725,than,0,0
73726,other,0,0
73727,2,0,0
73728,groups,0,0
73729,(,0,0
73730,P,0,0
73731,=,0,0
73732,.007,0,0
73733,),0,0
73734,.,0,0
73735,The,0,0
73736,incidence,0,0
73737,of,0,0
73738,CIN,0,1
73739,was,0,0
73740,significantly,0,0
73741,lower,0,0
73742,in,0,0
73743,the,0,0
73744,sodium,1,1
73745,bicarbonate,1,1
73746,group,0,0
73747,(,0,0
73748,4.5,0,0
73749,%,0,0
73750,),0,0
73751,compared,0,0
73752,with,0,0
73753,sodium,1,1
73754,chloride,1,1
73755,alone,1,1
73756,(,0,0
73757,13.6,0,0
73758,%,0,0
73759,",",0,0
73760,P,0,0
73761,=,0,0
73762,.036,0,0
73763,),0,0
73764,and,0,0
73765,tended,0,0
73766,to,0,0
73767,be,0,0
73768,lower,0,0
73769,than,0,0
73770,in,0,0
73771,the,0,0
73772,combination,1,1
73773,group,0,0
73774,(,0,0
73775,12.5,0,0
73776,%,0,0
73777,",",0,0
73778,P,0,0
73779,=,0,0
73780,.059,0,0
73781,),0,0
73782,.,0,0
73783,After,0,0
73784,adjusting,0,0
73785,the,0,0
73786,Mehran,0,0
73787,nephropathy,0,0
73788,risk,0,0
73789,score,0,0
73790,",",0,0
73791,the,0,0
73792,risk,0,0
73793,of,0,0
73794,CIN,0,1
73795,significantly,0,0
73796,reduced,0,0
73797,with,0,0
73798,sodium,1,1
73799,bicarbonate,1,1
73800,compared,0,0
73801,with,0,0
73802,sodium,1,1
73803,chloride,1,1
73804,alone,0,1
73805,(,0,0
73806,adjusted,0,0
73807,risk,0,0
73808,ratio,0,0
73809,0.29,0,0
73810,",",0,0
73811,P,0,0
73812,=,0,0
73813,.043,0,0
73814,),0,0
73815,.,0,0
73816,CONCLUSIONS,0,0
73817,Hydration,0,0
73818,with,0,0
73819,sodium,1,1
73820,bicarbonate,1,1
73821,provides,0,0
73822,better,0,0
73823,protection,0,0
73824,against,0,0
73825,CIN,0,1
73826,than,0,0
73827,the,0,0
73828,sodium,1,1
73829,chloride,1,1
73830,infusion,1,1
73831,does,0,0
73832,alone,0,0
73833,.,0,0
73834,Combination,1,0
73835,therapy,1,1
73836,of,1,0
73837,NAC,1,1
73838,plus,1,1
73839,sodium,1,1
73840,chloride,1,1
73841,did,0,0
73842,not,0,0
73843,offer,0,0
73844,additional,0,0
73845,benefit,0,0
73846,over,0,0
73847,hydration,0,1
73848,with,0,0
73849,sodium,1,1
73850,chloride,1,1
73851,alone,1,0
73852,.,1,0
73853,[,0,0
73854,Effect,0,0
73855,of,0,0
73856,acupuncture,1,1
73857,on,0,0
73858,rehabilitation,0,1
73859,training,0,1
73860,of,0,0
73861,child,0,0
73862,'s,0,0
73863,autism,0,0
73864,],0,0
73865,.,0,0
73866,OBJECTIVE,0,0
73867,To,0,0
73868,observe,0,0
73869,the,0,0
73870,effect,0,0
73871,of,0,0
73872,acupuncture,1,1
73873,on,0,0
73874,rehabilitation,0,1
73875,training,0,1
73876,for,0,0
73877,children,0,0
73878,'s,0,0
73879,autism,0,0
73880,.,0,0
73881,METHODS,0,0
73882,Forty,0,0
73883,autistic,0,0
73884,children,0,0
73885,receiving,0,0
73886,rehabilitation,0,1
73887,training,0,1
73888,were,0,0
73889,divided,0,0
73890,into,0,0
73891,a,0,0
73892,control,0,1
73893,group,0,0
73894,and,0,0
73895,a,0,0
73896,treatment,0,0
73897,group,0,0
73898,",",0,0
73899,20,0,0
73900,cases,0,0
73901,in,0,0
73902,each,0,0
73903,group,0,0
73904,.,0,0
73905,The,0,0
73906,control,0,0
73907,group,0,0
73908,received,0,0
73909,rehabilitation,1,1
73910,training,1,1
73911,including,1,0
73912,ABA,1,1
73913,training,1,1
73914,",",1,0
73915,the,1,0
73916,Conductive,1,0
73917,Education,1,1
73918,Approach,1,1
73919,and,1,0
73920,the,1,0
73921,training,1,1
73922,of,1,0
73923,sensory,1,0
73924,integration,1,0
73925,",",0,0
73926,about,0,0
73927,90,0,0
73928,sessions,0,0
73929,for,0,0
73930,each,0,0
73931,training,0,1
73932,;,0,0
73933,the,0,0
73934,treatment,0,0
73935,group,0,0
73936,received,0,0
73937,acupuncture,1,1
73938,treatment,1,0
73939,for,0,0
73940,60-90,0,0
73941,sessions,0,1
73942,after,1,0
73943,the,1,0
73944,rehabilitation,1,1
73945,training,1,1
73946,.,1,0
73947,Their,0,0
73948,results,0,0
73949,were,0,0
73950,detected,0,0
73951,by,0,0
73952,the,0,0
73953,revised,0,0
73954,Chinese,0,0
73955,version,0,0
73956,of,0,0
73957,Psycho-Educational,0,1
73958,Profile,0,0
73959,for,0,0
73960,autistic,0,0
73961,and,0,0
73962,developmentally,0,0
73963,disabled,0,0
73964,children,0,0
73965,(,0,0
73966,C-PEP,0,1
73967,),0,0
73968,.,0,0
73969,RESULTS,0,0
73970,The,0,0
73971,markedly,0,0
73972,effective,0,0
73973,rate,0,0
73974,was,0,0
73975,55.0,0,0
73976,%,0,0
73977,in,0,0
73978,the,0,0
73979,treatment,0,0
73980,group,0,0
73981,and,0,0
73982,15.0,0,0
73983,%,0,0
73984,in,0,0
73985,the,0,0
73986,control,0,0
73987,group,0,0
73988,with,0,0
73989,a,0,0
73990,very,0,0
73991,significant,0,0
73992,difference,0,0
73993,between,0,0
73994,the,0,0
73995,two,0,0
73996,groups,0,0
73997,(,0,0
73998,P,0,0
73999,<,0,0
74000,0.01,0,0
74001,),0,0
74002,;,0,0
74003,the,0,0
74004,differences,0,0
74005,before,0,0
74006,and,0,0
74007,after,0,0
74008,training,0,1
74009,in,0,0
74010,some,0,0
74011,projects,0,0
74012,such,0,0
74013,as,0,0
74014,the,0,0
74015,total,0,0
74016,score,0,0
74017,of,0,0
74018,development,0,0
74019,",",0,0
74020,imitation,0,0
74021,",",0,0
74022,oral,0,1
74023,cognition,0,0
74024,in,0,0
74025,the,0,0
74026,treatment,0,0
74027,group,0,0
74028,were,0,0
74029,very,0,0
74030,significantly,0,0
74031,different,0,0
74032,from,0,0
74033,those,0,0
74034,in,0,0
74035,the,0,0
74036,control,0,1
74037,group,0,0
74038,(,0,0
74039,P,0,0
74040,<,0,0
74041,0.01,0,0
74042,),0,0
74043,.,0,0
74044,CONCLUSION,0,0
74045,Acupuncture,1,1
74046,combined,0,1
74047,with,0,0
74048,scientific,1,0
74049,and,1,0
74050,effective,1,0
74051,rehabilitation,1,1
74052,training,1,1
74053,has,0,0
74054,a,0,0
74055,better,0,0
74056,therapeutic,0,0
74057,effect,0,0
74058,than,0,0
74059,that,0,0
74060,of,0,0
74061,the,0,0
74062,simple,1,1
74063,rehabilitation,1,1
74064,training,1,1
74065,for,0,0
74066,child,0,0
74067,'s,0,0
74068,autism,0,0
74069,.,0,0
74070,Fondaparinux,1,1
74071,combined,1,1
74072,with,1,0
74073,intermittent,1,1
74074,pneumatic,1,1
74075,compression,1,1
74076,vs.,0,0
74077,intermittent,1,1
74078,pneumatic,1,1
74079,compression,1,1
74080,alone,1,1
74081,for,0,0
74082,prevention,0,0
74083,of,0,0
74084,venous,0,0
74085,thromboembolism,0,0
74086,after,0,0
74087,abdominal,0,0
74088,surgery,0,0
74089,:,0,0
74090,a,0,0
74091,randomized,0,0
74092,",",0,0
74093,double-blind,0,0
74094,comparison,0,0
74095,.,0,0
74096,BACKGROUND,0,0
74097,The,0,0
74098,benefit,0,0
74099,of,0,0
74100,combined,0,1
74101,mechanical,0,0
74102,and,0,0
74103,pharmacologic,0,0
74104,methods,0,0
74105,for,0,0
74106,venous,0,0
74107,thromboembolism,0,0
74108,prevention,0,0
74109,after,0,0
74110,abdominal,0,0
74111,surgery,0,0
74112,has,0,0
74113,not,0,0
74114,been,0,0
74115,clearly,0,0
74116,established,0,0
74117,.,0,0
74118,OBJECTIVES,0,0
74119,To,0,0
74120,compare,0,0
74121,the,0,0
74122,efficacy,0,0
74123,and,0,0
74124,safety,0,0
74125,of,0,0
74126,fondaparinux,1,1
74127,in,1,0
74128,conjunction,1,1
74129,with,1,0
74130,intermittent,1,1
74131,pneumatic,1,1
74132,compression,1,1
74133,vs.,0,0
74134,intermittent,1,1
74135,pneumatic,1,1
74136,compression,1,1
74137,alone,1,1
74138,in,0,0
74139,this,0,0
74140,context,0,0
74141,.,0,0
74142,PATIENTS,0,0
74143,AND,0,0
74144,METHODS,0,0
74145,This,0,0
74146,was,0,0
74147,a,0,0
74148,randomized,0,0
74149,",",0,0
74150,double-blind,0,0
74151,",",0,0
74152,placebo-controlled,1,1
74153,superiority,0,0
74154,trial,0,0
74155,.,0,0
74156,Patients,0,0
74157,aged,0,0
74158,at,0,0
74159,least,0,0
74160,40,0,0
74161,years,0,0
74162,undergoing,0,0
74163,abdominal,0,0
74164,surgery,0,0
74165,were,0,0
74166,randomized,0,0
74167,to,0,0
74168,receive,0,0
74169,either,0,0
74170,fondaparinux,1,1
74171,2.5,0,0
74172,mg,0,1
74173,or,0,1
74174,placebo,1,1
74175,s.c.,0,1
74176,for,0,0
74177,5-9,0,0
74178,days,0,0
74179,",",0,0
74180,starting,0,0
74181,6-8,0,0
74182,h,0,0
74183,postoperatively,0,0
74184,.,0,0
74185,All,0,0
74186,patients,0,0
74187,received,0,0
74188,intermittent,1,1
74189,pneumatic,1,1
74190,compression,1,1
74191,.,1,0
74192,The,0,0
74193,primary,0,0
74194,efficacy,0,0
74195,outcome,0,0
74196,was,0,0
74197,venous,0,0
74198,thromboembolism,0,0
74199,up,0,0
74200,to,0,0
74201,day,0,0
74202,10,0,0
74203,.,0,0
74204,The,0,0
74205,main,0,0
74206,safety,0,0
74207,outcomes,0,0
74208,were,0,0
74209,major,0,0
74210,bleeding,0,0
74211,and,0,0
74212,all-cause,0,0
74213,mortality,0,0
74214,.,0,0
74215,Follow-up,0,0
74216,lasted,0,0
74217,32,0,0
74218,days,0,0
74219,.,0,0
74220,RESULTS,0,0
74221,Of,0,0
74222,the,0,0
74223,1309,0,0
74224,patients,0,0
74225,randomized,0,0
74226,",",0,0
74227,842,0,0
74228,(,0,0
74229,64.3,0,0
74230,%,0,0
74231,),0,0
74232,were,0,0
74233,evaluable,0,0
74234,for,0,0
74235,efficacy,0,0
74236,.,0,0
74237,The,0,0
74238,venous,0,0
74239,thromboembolism,0,0
74240,rate,0,0
74241,was,0,0
74242,1.7,0,0
74243,%,0,0
74244,(,0,0
74245,7/424,0,0
74246,),0,0
74247,in,0,0
74248,the,0,0
74249,fondaparinux-treated,1,0
74250,patients,0,0
74251,and,0,0
74252,5.3,0,0
74253,%,0,0
74254,(,0,0
74255,22/418,0,0
74256,),0,0
74257,in,0,0
74258,the,0,0
74259,placebo-treated,1,0
74260,patients,0,0
74261,(,0,0
74262,odds,0,0
74263,ratio,0,0
74264,reduction,0,0
74265,69.8,0,0
74266,%,0,0
74267,;,0,0
74268,95,0,0
74269,%,0,0
74270,confidence,0,0
74271,interval,0,0
74272,27.9-87.3,0,0
74273,;,0,0
74274,P,0,0
74275,=,0,0
74276,0.004,0,0
74277,),0,0
74278,.,0,0
74279,Fondaparinux,1,1
74280,significantly,0,0
74281,reduced,0,0
74282,the,0,0
74283,proximal,0,0
74284,deep,0,1
74285,vein,0,0
74286,thrombosis,0,0
74287,rate,0,0
74288,from,0,0
74289,1.7,0,0
74290,%,0,0
74291,(,0,0
74292,7/417,0,0
74293,),0,0
74294,to,0,0
74295,0.2,0,1
74296,%,0,0
74297,(,0,0
74298,1/424,0,0
74299,;,0,0
74300,P,0,0
74301,=,0,0
74302,0.037,0,0
74303,),0,0
74304,.,0,0
74305,Major,0,0
74306,bleeds,0,0
74307,occurred,0,0
74308,in,0,0
74309,1.6,0,0
74310,%,0,0
74311,(,0,0
74312,10/635,0,1
74313,),0,0
74314,and,0,0
74315,0.2,0,1
74316,%,0,0
74317,(,0,0
74318,1/650,0,0
74319,),0,0
74320,of,0,0
74321,fondaparinux-treated,1,1
74322,and,0,0
74323,placebo-treated,1,0
74324,patients,0,0
74325,",",0,0
74326,respectively,0,0
74327,(,0,0
74328,P,0,0
74329,=,0,0
74330,0.006,0,0
74331,),0,0
74332,",",0,0
74333,none,0,0
74334,being,0,0
74335,fatal,0,0
74336,or,0,1
74337,involving,0,0
74338,a,0,0
74339,critical,0,0
74340,organ,0,0
74341,.,0,0
74342,By,0,0
74343,day,0,0
74344,32,0,0
74345,",",0,0
74346,eight,0,0
74347,patients,0,0
74348,(,0,0
74349,1.3,0,0
74350,%,0,0
74351,),0,0
74352,receiving,0,0
74353,fondaparinux,1,1
74354,and,0,0
74355,five,0,0
74356,(,0,0
74357,0.8,0,0
74358,%,0,0
74359,),0,0
74360,receiving,0,0
74361,placebo,1,1
74362,had,0,0
74363,died,0,0
74364,.,0,0
74365,CONCLUSIONS,0,0
74366,In,0,0
74367,patients,0,0
74368,undergoing,0,0
74369,abdominal,0,0
74370,surgery,0,1
74371,and,0,0
74372,receiving,0,0
74373,intermittent,1,1
74374,pneumatic,1,1
74375,compression,1,1
74376,",",1,0
74377,fondaparinux,1,1
74378,2.5,0,0
74379,mg,0,0
74380,reduced,0,0
74381,the,0,0
74382,venous,0,0
74383,thromboembolism,0,0
74384,rate,0,0
74385,by,0,0
74386,69.8,0,0
74387,%,0,0
74388,as,0,0
74389,compared,0,0
74390,to,0,0
74391,pneumatic,1,1
74392,compression,1,1
74393,alone,1,1
74394,",",0,0
74395,with,0,0
74396,a,0,0
74397,low,0,0
74398,bleeding,0,0
74399,risk,0,0
74400,as,0,0
74401,compared,0,0
74402,to,0,0
74403,placebo,1,1
74404,.,1,0
74405,How,0,0
74406,can,0,0
74407,we,0,0
74408,help,0,0
74409,witnesses,0,0
74410,to,0,0
74411,remember,0,0
74412,more,0,0
74413,?,0,0
74414,It,0,0
74415,'s,0,0
74416,an,0,0
74417,(,0,0
74418,eyes,0,0
74419,),0,0
74420,open,0,0
74421,and,0,0
74422,shut,0,0
74423,case,0,0
74424,.,0,0
74425,Five,0,0
74426,experiments,0,0
74427,tested,0,0
74428,the,0,0
74429,idea,0,0
74430,that,0,0
74431,instructing,0,0
74432,a,0,0
74433,witness,0,0
74434,to,0,0
74435,close,0,0
74436,their,0,0
74437,eyes,0,0
74438,during,0,0
74439,retrieval,0,1
74440,might,0,0
74441,increase,0,0
74442,retrieval,0,1
74443,success,0,0
74444,.,0,0
74445,In,0,0
74446,Experiment,0,0
74447,1,0,0
74448,participants,0,0
74449,watched,1,0
74450,a,1,0
74451,video,1,1
74452,",",0,0
74453,before,0,0
74454,a,0,0
74455,cued-recall,0,1
74456,test,0,0
74457,for,0,0
74458,which,0,0
74459,they,0,0
74460,were,0,0
74461,either,0,0
74462,instructed,0,0
74463,to,0,0
74464,close,0,0
74465,their,0,0
74466,eyes,0,0
74467,",",0,0
74468,or,0,0
74469,received,0,0
74470,no-instructions,1,1
74471,.,1,0
74472,Eye-closure,0,0
74473,led,0,0
74474,to,0,0
74475,an,0,0
74476,increase,0,0
74477,in,0,0
74478,correct,0,0
74479,cued-recall,0,1
74480,",",0,0
74481,with,0,0
74482,no,0,0
74483,increase,0,0
74484,in,0,0
74485,incorrect,0,0
74486,responses,0,0
74487,.,0,0
74488,Experiments,0,0
74489,2-5,0,0
74490,sought,0,0
74491,to,0,0
74492,test,0,0
74493,the,0,0
74494,generality,0,0
74495,of,0,0
74496,this,0,0
74497,effect,0,0
74498,over,0,0
74499,variations,0,0
74500,in,0,0
74501,study,0,0
74502,material,0,0
74503,(,1,0
74504,video,1,1
74505,or,1,1
74506,live,1,0
74507,interaction,1,0
74508,),1,0
74509,",",0,0
74510,test,0,1
74511,format,0,1
74512,(,1,0
74513,cued-,1,1
74514,or,1,1
74515,free-recall,1,1
74516,),1,0
74517,and,0,0
74518,information,0,0
74519,modality,0,0
74520,(,1,0
74521,visual,1,0
74522,or,1,1
74523,auditory,1,1
74524,details,1,0
74525,recalled,1,0
74526,),1,0
74527,.,0,0
74528,Overall,0,0
74529,",",0,0
74530,eye-closure,0,0
74531,increased,0,0
74532,recall,0,0
74533,of,0,0
74534,both,0,0
74535,visual,0,0
74536,detail,0,0
74537,and,0,0
74538,auditory,0,1
74539,details,0,0
74540,",",0,0
74541,with,0,0
74542,no,0,0
74543,accompanying,0,0
74544,increase,0,0
74545,in,0,0
74546,recall,0,0
74547,of,0,0
74548,false,0,0
74549,details,0,0
74550,.,0,0
74551,Collectively,0,0
74552,",",0,0
74553,these,0,0
74554,data,0,0
74555,convincingly,0,0
74556,demonstrate,0,0
74557,the,0,0
74558,benefits,0,0
74559,of,0,0
74560,eye-closure,0,0
74561,as,0,0
74562,an,0,0
74563,aid,0,0
74564,to,0,0
74565,retrieval,0,1
74566,",",0,0
74567,and,0,0
74568,offer,0,0
74569,insight,0,0
74570,into,0,0
74571,why,0,0
74572,hypnosis,0,1
74573,",",0,0
74574,which,0,0
74575,usually,0,0
74576,involves,0,0
74577,eye-closure,0,0
74578,",",0,0
74579,may,0,0
74580,facilitate,0,0
74581,eyewitness,0,0
74582,recall,0,0
74583,.,0,0
74584,A,0,0
74585,randomized,0,0
74586,parallel,0,0
74587,study,0,0
74588,to,0,0
74589,assess,0,0
74590,the,0,0
74591,safety,0,0
74592,and,0,0
74593,efficacy,0,0
74594,of,0,0
74595,two,0,0
74596,different,0,0
74597,dosing,0,0
74598,regimens,0,0
74599,of,0,0
74600,5,0,0
74601,%,0,0
74602,imiquimod,1,1
74603,in,0,0
74604,the,0,0
74605,treatment,0,0
74606,of,0,0
74607,superficial,0,0
74608,basal,0,0
74609,cell,0,0
74610,carcinoma,0,0
74611,.,0,0
74612,OBJECTIVES,0,0
74613,This,0,0
74614,study,0,0
74615,was,0,0
74616,designed,0,0
74617,to,0,0
74618,compare,0,0
74619,the,0,0
74620,safety,0,0
74621,and,0,0
74622,efficacy,0,0
74623,of,0,0
74624,two,0,0
74625,cycled,0,0
74626,dosing,0,0
74627,regimens,0,0
74628,of,0,0
74629,imiquimod,1,1
74630,5,0,0
74631,%,0,0
74632,cream,0,1
74633,for,0,0
74634,treatment,0,0
74635,of,0,0
74636,superficial,0,0
74637,basal,0,0
74638,cell,0,0
74639,carcinoma,0,0
74640,(,0,0
74641,sBCC,0,0
74642,),0,0
74643,.,0,0
74644,METHODS,0,0
74645,Patients,0,0
74646,(,0,0
74647,n,0,0
74648,=,0,0
74649,32,0,0
74650,),0,0
74651,were,0,0
74652,randomized,0,0
74653,to,0,0
74654,receive,0,0
74655,one,0,0
74656,of,0,0
74657,two,0,0
74658,treatment,0,0
74659,regimens,0,0
74660,:,0,0
74661,8,1,0
74662,weeks,1,0
74663,of,1,0
74664,treatment,1,0
74665,with,1,0
74666,once-daily,1,1
74667,dosing,1,0
74668,for,1,0
74669,alternate,1,1
74670,weeks,1,0
74671,(,1,0
74672,R1,1,1
74673,),1,0
74674,and,1,0
74675,5,1,0
74676,weeks,1,0
74677,of,1,0
74678,once-daily,1,1
74679,dosing,1,0
74680,with,1,0
74681,a,1,0
74682,1-week,1,0
74683,interval,1,0
74684,in,1,0
74685,the,1,0
74686,middle,1,0
74687,of,1,0
74688,the,1,0
74689,course,1,0
74690,(,0,0
74691,R2,0,0
74692,),0,0
74693,.,0,0
74694,Efficacy,0,0
74695,measures,0,0
74696,were,0,0
74697,tumour,0,0
74698,clearance,0,0
74699,at,0,0
74700,weeks,0,0
74701,19,0,0
74702,and,0,0
74703,52,0,0
74704,and,0,0
74705,measures,0,0
74706,of,0,0
74707,patients,0,0
74708,',0,0
74709,acceptability,0,0
74710,.,0,0
74711,RESULTS,0,0
74712,Data,0,0
74713,from,0,0
74714,30,0,0
74715,patients,0,0
74716,(,0,0
74717,13,0,0
74718,females,0,0
74719,),0,0
74720,",",0,0
74721,14,0,0
74722,on,0,0
74723,R1,0,1
74724,and,0,0
74725,16,0,0
74726,on,0,0
74727,R2,0,0
74728,",",0,0
74729,were,0,0
74730,analysed,0,0
74731,.,0,0
74732,The,0,0
74733,results,0,0
74734,revealed,0,0
74735,an,0,0
74736,initial,0,0
74737,clearance,0,0
74738,rate,0,0
74739,of,0,0
74740,64,0,0
74741,%,0,0
74742,at,0,0
74743,week,0,0
74744,19,0,0
74745,for,0,0
74746,R1,0,1
74747,and,0,0
74748,81,0,0
74749,%,0,0
74750,for,0,0
74751,R2,0,1
74752,(,0,0
74753,95,0,0
74754,%,0,0
74755,CI,0,0
74756,for,0,0
74757,difference,0,0
74758,:,0,0
74759,-14,0,0
74760,%,0,0
74761,to,0,0
74762,45,0,0
74763,%,0,0
74764,",",0,0
74765,p,0,0
74766,=,0,0
74767,0.21,0,0
74768,),0,0
74769,.,0,0
74770,However,0,0
74771,",",0,0
74772,clearance,0,0
74773,rates,0,0
74774,at,0,0
74775,week,0,0
74776,52,0,0
74777,were,0,0
74778,significantly,0,0
74779,different,0,0
74780,:,0,0
74781,43,0,0
74782,%,0,0
74783,for,0,0
74784,R1,0,1
74785,and,0,0
74786,88,0,0
74787,%,0,0
74788,for,0,0
74789,R2,0,1
74790,(,0,0
74791,95,0,0
74792,%,0,0
74793,CI,0,0
74794,for,0,0
74795,difference,0,0
74796,:,0,0
74797,11,0,0
74798,%,0,0
74799,to,0,0
74800,68,0,0
74801,%,0,0
74802,",",0,0
74803,p,0,0
74804,=,0,0
74805,0.02,0,0
74806,),0,0
74807,.,0,0
74808,There,0,0
74809,was,0,0
74810,no,0,0
74811,difference,0,0
74812,in,0,0
74813,acceptability,0,0
74814,of,0,0
74815,treatment,0,0
74816,as,0,0
74817,measured,0,0
74818,by,0,0
74819,composite,0,0
74820,median,0,0
74821,visual,0,0
74822,analogue,0,0
74823,scores,0,0
74824,at,0,0
74825,week,0,0
74826,8,0,0
74827,.,0,0
74828,CONCLUSION,0,0
74829,Five,0,0
74830,weeks,0,0
74831,of,0,0
74832,5,0,0
74833,%,0,0
74834,imiquimod,1,1
74835,cream,0,1
74836,once,0,0
74837,daily,0,0
74838,with,0,0
74839,a,0,0
74840,1-week,0,0
74841,interval,0,0
74842,was,0,0
74843,more,0,0
74844,effective,0,0
74845,but,0,0
74846,as,0,0
74847,well,0,0
74848,tolerated,0,0
74849,as,0,0
74850,the,0,0
74851,8-week,0,1
74852,alternate,0,1
74853,week,0,0
74854,regimen,0,1
74855,for,0,0
74856,sBCC,0,0
74857,.,0,0
74858,An,0,0
74859,exploratory,0,0
74860,",",0,0
74861,pragmatic,0,0
74862,",",0,0
74863,cluster,0,0
74864,randomised,0,0
74865,trial,0,0
74866,of,0,0
74867,practice,1,0
74868,nurse,1,1
74869,training,1,1
74870,in,0,0
74871,the,0,0
74872,use,0,0
74873,of,0,0
74874,asthma,0,0
74875,action,0,0
74876,plans,0,0
74877,.,0,0
74878,INTRODUCTION,0,0
74879,To,0,0
74880,investigate,0,0
74881,the,0,0
74882,feasibility,0,0
74883,of,0,0
74884,improving,0,0
74885,asthma,0,0
74886,management,0,0
74887,-,0,0
74888,in,0,0
74889,particular,0,0
74890,",",0,0
74891,the,0,0
74892,implementation,0,0
74893,of,0,0
74894,individualised,1,0
74895,asthma,1,0
74896,action,1,0
74897,plans,1,1
74898,(,1,0
74899,AAPs,1,0
74900,),1,0
74901,for,0,0
74902,poorly-controlled,0,0
74903,adult,0,0
74904,asthma,0,0
74905,patients,0,0
74906,-,0,0
74907,by,0,0
74908,providing,0,0
74909,training,0,1
74910,in,0,0
74911,asthma-focused,0,1
74912,clinical,0,0
74913,and,0,0
74914,communication,0,0
74915,skills,0,1
74916,for,0,0
74917,practice,0,0
74918,nurses,0,0
74919,who,0,0
74920,deliver,0,0
74921,asthma,0,0
74922,clinics,0,0
74923,.,0,0
74924,METHODS,0,0
74925,A,0,0
74926,pragmatic,0,0
74927,",",0,0
74928,cluster,0,0
74929,randomised,0,0
74930,trial,0,0
74931,with,0,0
74932,an,0,0
74933,intervention,0,1
74934,(,0,0
74935,an,0,0
74936,interactive,0,1
74937,seminar,0,1
74938,),0,0
74939,delivered,0,1
74940,at,0,0
74941,practice,0,0
74942,level,0,0
74943,(,0,0
74944,n=13,0,0
74945,practices,0,0
74946,;,0,0
74947,6=intervention,0,0
74948,",",0,0
74949,7=control,0,0
74950,),0,0
74951,.,0,0
74952,The,0,0
74953,impact,0,0
74954,of,0,0
74955,the,0,0
74956,intervention,0,1
74957,was,0,0
74958,assessed,0,0
74959,against,0,0
74960,patient,0,0
74961,outcomes,0,0
74962,:,0,0
74963,routinely,0,0
74964,available,0,0
74965,asthma,0,0
74966,outcome,0,0
74967,measures,0,0
74968,(,0,0
74969,beta2-agonist,0,1
74970,prescription,0,1
74971,rate,0,0
74972,and,0,0
74973,number,0,0
74974,of,0,0
74975,oral,0,1
74976,steroid,0,1
74977,courses,0,0
74978,),0,0
74979,for,0,0
74980,asthma,0,0
74981,patients,0,0
74982,identified,0,0
74983,as,0,0
74984,being,0,0
74985,poorly-controlled,0,0
74986,from,0,0
74987,practice,0,0
74988,records,0,0
74989,;,0,0
74990,and,0,0
74991,questionnaire,0,0
74992,data,0,0
74993,-,0,0
74994,Mini,0,0
74995,Asthma,0,0
74996,Quality,0,0
74997,of,0,0
74998,Life,0,0
74999,Questionnaire,0,0
75000,(,0,0
75001,AQLQ,0,1
75002,),0,0
75003,and,0,0
75004,the,0,0
75005,Asthma,0,0
75006,Control,0,1
75007,Questionnaire,0,1
75008,(,0,0
75009,ACQ,0,0
75010,),0,0
75011,-,0,0
75012,from,0,0
75013,a,0,0
75014,subset,0,0
75015,of,0,0
75016,consenting,0,0
75017,patients,0,0
75018,.,0,0
75019,Data,0,0
75020,was,0,0
75021,collected,0,0
75022,at,0,0
75023,baseline,0,0
75024,and,0,0
75025,at,0,0
75026,6-month,0,0
75027,follow-up,0,0
75028,.,0,0
75029,ANALYSISs,0,1
75030,:,0,0
75031,Routine,0,0
75032,data,0,0
75033,was,0,0
75034,analysed,0,0
75035,for,0,0
75036,629,0,0
75037,patients,0,0
75038,.,0,0
75039,236,0,0
75040,(,0,0
75041,37,0,0
75042,%,0,0
75043,),0,0
75044,of,0,0
75045,these,0,0
75046,patients,0,0
75047,consented,0,0
75048,to,0,0
75049,provide,0,0
75050,questionnaire,0,0
75051,data,0,0
75052,at,0,0
75053,baseline,0,0
75054,",",0,0
75055,with,0,0
75056,75,0,0
75057,%,0,0
75058,returning,0,0
75059,questionnaires,0,1
75060,at,0,0
75061,follow-up,0,0
75062,.,0,0
75063,After,0,0
75064,adjustment,0,0
75065,for,0,0
75066,baseline,0,0
75067,and,0,0
75068,practice,0,0
75069,",",0,0
75070,there,0,0
75071,was,0,0
75072,a,0,0
75073,significant,0,0
75074,difference,0,0
75075,at,0,0
75076,followup,0,0
75077,between,0,0
75078,intervention,0,1
75079,and,0,0
75080,control,0,0
75081,practices,0,0
75082,on,0,0
75083,the,0,0
75084,Mini,0,0
75085,AQLQ,0,0
75086,only,0,0
75087,(,0,0
75088,p=0.03,0,0
75089,),0,0
75090,.,0,0
75091,Estimates,0,0
75092,for,0,0
75093,subsequent,0,0
75094,sample,0,0
75095,sizes,0,0
75096,to,0,0
75097,inform,0,0
75098,future,0,0
75099,trials,0,0
75100,of,0,0
75101,asthma,0,0
75102,training,0,1
75103,were,0,0
75104,identified,0,0
75105,.,0,0
75106,CONCLUSION,0,0
75107,Training,0,0
75108,designed,0,0
75109,to,0,0
75110,support,0,0
75111,practice,0,0
75112,nurses,0,0
75113,in,0,0
75114,implementing,0,0
75115,individualised,0,0
75116,AAPs,0,0
75117,impacted,0,0
75118,on,0,0
75119,one,0,0
75120,patient,0,0
75121,outcome,0,0
75122,only,0,0
75123,.,0,0
75124,This,0,0
75125,disappointing,0,0
75126,outcome,0,0
75127,may,0,0
75128,have,0,0
75129,been,0,0
75130,due,0,0
75131,to,0,0
75132,many,0,0
75133,different,0,0
75134,factors,0,0
75135,such,0,0
75136,as,0,0
75137,outcome,0,0
75138,measure,0,0
75139,limitations,0,0
75140,",",0,0
75141,data,0,0
75142,collection,0,0
75143,problems,0,0
75144,",",0,0
75145,and,0,0
75146,underestimating,0,0
75147,the,0,0
75148,complexity,0,0
75149,of,0,0
75150,supporting,0,0
75151,practice,0,0
75152,nurses,0,0
75153,in,0,0
75154,behaviour,0,0
75155,change,0,0
75156,.,0,0
75157,Effects,0,0
75158,of,0,0
75159,vacuum-compression,1,1
75160,therapy,1,1
75161,on,0,0
75162,healing,0,0
75163,of,0,0
75164,diabetic,0,0
75165,foot,0,0
75166,ulcers,0,0
75167,:,0,0
75168,randomized,0,0
75169,controlled,0,0
75170,trial,0,0
75171,.,0,0
75172,A,0,0
75173,single-blind,0,0
75174,",",0,0
75175,randomized,0,0
75176,controlled,0,0
75177,trial,0,0
75178,was,0,0
75179,conducted,0,0
75180,to,0,0
75181,evaluate,0,0
75182,vacuum-compression,1,1
75183,therapy,1,1
75184,(,1,0
75185,VCT,1,0
75186,),1,0
75187,for,0,0
75188,the,0,0
75189,healing,0,0
75190,of,0,0
75191,diabetic,0,0
75192,foot,0,0
75193,ulcers,0,0
75194,.,0,0
75195,Eighteen,0,0
75196,diabetic,0,0
75197,patients,0,0
75198,with,0,0
75199,foot,0,0
75200,ulcers,0,0
75201,were,0,0
75202,recruited,0,0
75203,through,0,0
75204,simple,0,1
75205,nonprobability,0,0
75206,sampling,0,0
75207,.,0,0
75208,Subjects,0,0
75209,were,0,0
75210,randomly,0,0
75211,assigned,0,0
75212,to,0,0
75213,either,0,0
75214,an,0,0
75215,experimental,0,0
75216,or,0,0
75217,a,0,0
75218,control,1,0
75219,group,0,0
75220,.,0,0
75221,Before,0,0
75222,and,0,0
75223,after,0,0
75224,intervention,0,1
75225,",",0,0
75226,the,0,0
75227,foot,0,0
75228,ulcer,0,0
75229,surface,0,0
75230,area,0,0
75231,was,0,0
75232,estimated,0,0
75233,stereologically,0,0
75234,",",0,0
75235,based,0,0
75236,on,0,0
75237,Cavalieri,0,1
75238,'s,0,0
75239,principle,0,0
75240,.,0,0
75241,The,0,0
75242,experimental,0,0
75243,group,0,0
75244,was,0,0
75245,treated,0,0
75246,with,0,0
75247,VCT,1,0
75248,in,1,0
75249,addition,1,0
75250,to,1,0
75251,conventional,1,1
75252,therapy,1,1
75253,for,0,0
75254,10,0,0
75255,sessions,0,0
75256,.,0,0
75257,The,0,0
75258,control,0,0
75259,group,0,0
75260,received,0,0
75261,only,0,0
75262,conventional,1,1
75263,therapy,1,1
75264,",",1,0
75265,including,1,0
75266,debridement,1,1
75267,",",1,0
75268,blood,1,0
75269,glucose,1,0
75270,control,1,0
75271,agents,1,0
75272,",",1,0
75273,systemic,1,0
75274,antibiotics,1,1
75275,",",1,0
75276,wound,1,0
75277,cleaning,1,1
75278,with,1,0
75279,normal,1,0
75280,saline,1,1
75281,",",1,0
75282,offloading,1,1
75283,(,1,0
75284,pressure,1,0
75285,relief,1,0
75286,),1,0
75287,",",1,0
75288,and,1,0
75289,daily,1,0
75290,wound,1,0
75291,dressings,1,1
75292,.,1,0
75293,The,0,0
75294,mean,0,0
75295,foot,0,0
75296,ulcer,0,0
75297,surface,0,0
75298,area,0,0
75299,decreased,0,0
75300,from,0,0
75301,46.88,0,0
75302,+/-,0,0
75303,9.28,0,0
75304,mm,0,0
75305,(,0,0
75306,2,0,0
75307,),0,0
75308,to,0,0
75309,35.09,0,0
75310,+/-,0,0
75311,4.09,0,0
75312,mm,0,0
75313,(,0,0
75314,2,0,0
75315,),0,0
75316,in,0,0
75317,the,0,0
75318,experimental,0,0
75319,group,0,0
75320,(,0,0
75321,p,0,0
75322,=,0,0
75323,0.006,0,0
75324,),0,0
75325,and,0,0
75326,from,0,0
75327,46.62,0,0
75328,+/-,0,0
75329,10.03,0,0
75330,mm,0,0
75331,(,0,0
75332,2,0,0
75333,),0,0
75334,to,0,0
75335,42.89,0,0
75336,+/-,0,0
75337,8.1,0,0
75338,mm,0,0
75339,(,0,0
75340,2,0,0
75341,),0,0
75342,in,0,0
75343,the,0,0
75344,control,0,1
75345,group,0,0
75346,(,0,0
75347,p,0,0
75348,=,0,0
75349,0.01,0,0
75350,),0,0
75351,.,0,0
75352,After,0,0
75353,treatment,0,0
75354,",",0,0
75355,the,0,0
75356,experimental,0,0
75357,group,0,0
75358,significantly,0,0
75359,improved,0,0
75360,in,0,0
75361,measures,0,0
75362,of,0,0
75363,foot,0,0
75364,ulcer,0,0
75365,surface,0,0
75366,area,0,0
75367,compared,0,0
75368,with,0,0
75369,the,0,0
75370,control,0,1
75371,group,0,0
75372,(,0,0
75373,p,0,0
75374,=,0,0
75375,0.024,0,0
75376,),0,0
75377,.,0,0
75378,VCT,1,0
75379,enhances,0,0
75380,diabetic,0,0
75381,foot,0,0
75382,ulcer,0,0
75383,healing,0,0
75384,when,0,0
75385,combined,0,0
75386,with,0,0
75387,appropriate,0,0
75388,wound,0,0
75389,care,0,0
75390,.,0,0
75391,Comparison,0,0
75392,of,0,0
75393,menopausal,0,0
75394,symptoms,0,0
75395,during,0,0
75396,the,0,0
75397,first,0,0
75398,year,0,0
75399,of,0,0
75400,adjuvant,0,1
75401,therapy,0,1
75402,with,0,0
75403,either,0,0
75404,exemestane,1,1
75405,or,1,1
75406,tamoxifen,1,1
75407,in,0,0
75408,early,0,0
75409,breast,0,0
75410,cancer,0,0
75411,:,0,0
75412,report,0,0
75413,of,0,0
75414,a,0,0
75415,Tamoxifen,0,1
75416,Exemestane,0,1
75417,Adjuvant,0,1
75418,Multicenter,0,0
75419,trial,0,0
75420,substudy,0,0
75421,.,0,0
75422,PURPOSE,0,0
75423,Hormonal,0,1
75424,breast,0,0
75425,cancer,0,0
75426,treatment,0,0
75427,increases,0,0
75428,menopausal,0,0
75429,symptoms,0,0
75430,in,0,0
75431,women,0,0
75432,.,0,0
75433,This,0,0
75434,study,0,0
75435,investigated,0,0
75436,differences,0,0
75437,between,0,0
75438,the,0,0
75439,symptoms,0,0
75440,associated,0,0
75441,with,0,0
75442,either,0,0
75443,adjuvant,1,1
75444,tamoxifen,1,1
75445,or,1,1
75446,exemestane,1,1
75447,.,1,0
75448,PATIENTS,0,0
75449,AND,0,0
75450,METHODS,0,0
75451,Ten,0,1
75452,common,0,0
75453,symptoms,0,0
75454,were,0,0
75455,assessed,0,0
75456,by,0,0
75457,self-report,0,0
75458,questionnaire,0,0
75459,administered,0,0
75460,to,0,0
75461,"1,614",0,0
75462,consecutive,0,0
75463,patients,0,0
75464,at,0,0
75465,baseline,0,0
75466,and,0,0
75467,every,0,0
75468,3,0,0
75469,months,0,0
75470,during,0,0
75471,the,0,0
75472,first,0,0
75473,year,0,0
75474,of,0,0
75475,a,0,0
75476,double-blind,0,0
75477,",",0,0
75478,randomized,0,0
75479,trial,0,0
75480,of,0,0
75481,postmenopausal,0,0
75482,women,0,0
75483,with,0,0
75484,early,0,0
75485,hormone,0,0
75486,receptor-positive,0,0
75487,breast,0,0
75488,cancer,0,0
75489,.,0,0
75490,Symptoms,0,0
75491,were,0,0
75492,categorized,0,0
75493,as,0,0
75494,none,0,0
75495,",",0,0
75496,mild,0,0
75497,",",0,0
75498,moderate,0,0
75499,",",0,0
75500,or,0,0
75501,severe,0,0
75502,.,0,0
75503,A,0,0
75504,hot,0,0
75505,flash,0,1
75506,score,0,0
75507,was,0,0
75508,calculated,0,0
75509,at,0,0
75510,each,0,0
75511,time,0,0
75512,point,0,0
75513,.,0,0
75514,Symptoms,0,0
75515,were,0,0
75516,analyzed,0,0
75517,by,0,0
75518,repeated-measures,0,0
75519,analysis,0,0
75520,of,0,0
75521,variance,0,0
75522,.,0,0
75523,Each,0,0
75524,time,0,0
75525,period,0,0
75526,was,0,0
75527,tested,0,0
75528,repeatedly,0,0
75529,against,0,0
75530,the,0,0
75531,baseline,0,0
75532,;,0,0
75533,an,0,0
75534,overall,0,0
75535,P,0,0
75536,value,0,0
75537,was,0,0
75538,assigned,0,0
75539,for,0,0
75540,each,0,0
75541,reported,0,0
75542,symptom,0,0
75543,.,0,0
75544,RESULTS,0,0
75545,Compliance,0,0
75546,was,0,0
75547,excellent,0,0
75548,",",0,0
75549,with,0,0
75550,"7,286",0,0
75551,questionnaires,0,0
75552,analyzed,0,0
75553,.,0,0
75554,Baseline,0,0
75555,symptom,0,0
75556,prevalence,0,0
75557,ranged,0,0
75558,from,0,0
75559,2,0,0
75560,%,0,0
75561,(,0,0
75562,vaginal,0,1
75563,bleeding,0,0
75564,),0,0
75565,to,0,0
75566,60,0,0
75567,%,0,0
75568,to,0,0
75569,70,0,0
75570,%,0,0
75571,(,0,0
75572,bone/muscle,0,0
75573,aches,0,1
75574,and,0,0
75575,low,0,0
75576,energy,0,0
75577,),0,0
75578,.,0,0
75579,There,0,0
75580,were,0,0
75581,no,0,0
75582,significant,0,0
75583,differences,0,0
75584,in,0,0
75585,vaginal,0,0
75586,bleeding,0,0
75587,",",0,0
75588,mood,0,0
75589,alteration,0,0
75590,",",0,0
75591,or,0,0
75592,low,0,0
75593,energy,0,0
75594,.,0,0
75595,Patients,0,0
75596,receiving,0,0
75597,tamoxifen,0,1
75598,had,0,0
75599,significantly,0,0
75600,more,0,0
75601,vaginal,0,1
75602,discharge,0,0
75603,(,0,0
75604,P,0,0
75605,<,0,0
75606,.0001,0,0
75607,),0,0
75608,.,0,0
75609,Exemestane,0,1
75610,patients,0,0
75611,reported,0,0
75612,more,0,0
75613,bone/muscle,0,0
75614,aches,0,0
75615,(,0,0
75616,P,0,0
75617,<,0,0
75618,.0001,0,0
75619,),0,0
75620,",",0,0
75621,vaginal,0,1
75622,dryness,0,0
75623,(,0,0
75624,P,0,0
75625,=,0,0
75626,.0004,0,0
75627,),0,0
75628,",",0,0
75629,and,0,0
75630,difficulty,0,0
75631,sleeping,0,0
75632,(,0,0
75633,P,0,0
75634,=,0,0
75635,.03,0,0
75636,),0,0
75637,.,0,0
75638,In,0,0
75639,both,0,0
75640,groups,0,0
75641,",",0,0
75642,the,0,0
75643,hot,0,0
75644,flash,0,1
75645,score,0,0
75646,peaked,0,0
75647,at,0,0
75648,3,0,0
75649,months,0,0
75650,and,0,0
75651,decreased,0,0
75652,thereafter,0,0
75653,.,0,0
75654,At,0,0
75655,12,0,0
75656,months,0,0
75657,",",0,0
75658,patients,0,0
75659,receiving,0,0
75660,tamoxifen,0,1
75661,had,0,0
75662,a,0,0
75663,significantly,0,0
75664,higher,0,0
75665,mean,0,0
75666,hot,0,0
75667,flash,0,1
75668,score,0,0
75669,(,0,0
75670,P,0,0
75671,=,0,0
75672,.03,0,0
75673,),0,0
75674,",",0,0
75675,with,0,0
75676,daily,0,0
75677,hot,0,0
75678,flashes,0,0
75679,increasing,0,0
75680,from,0,0
75681,baseline,0,0
75682,by,0,0
75683,33,0,0
75684,%,0,0
75685,compared,0,0
75686,with,0,0
75687,a,0,0
75688,7,0,0
75689,%,0,0
75690,increase,0,0
75691,from,0,0
75692,baseline,0,0
75693,with,0,0
75694,exemestane,0,1
75695,.,0,0
75696,CONCLUSION,0,0
75697,At,0,0
75698,12,0,0
75699,months,0,0
75700,",",0,0
75701,exemestane,0,1
75702,was,0,0
75703,associated,0,0
75704,with,0,0
75705,fewer,0,0
75706,hot,0,0
75707,flashes,0,0
75708,and,0,0
75709,less,0,0
75710,vaginal,0,0
75711,discharge,0,0
75712,than,0,0
75713,tamoxifen,0,1
75714,",",0,0
75715,but,0,0
75716,with,0,0
75717,more,0,0
75718,vaginal,0,0
75719,dryness,0,0
75720,",",0,0
75721,bone/muscle,0,0
75722,aches,0,0
75723,",",0,0
75724,and,0,0
75725,difficulty,0,0
75726,sleeping,0,0
75727,.,0,0
75728,Symptoms,0,0
75729,were,0,0
75730,common,0,0
75731,in,0,0
75732,both,0,0
75733,groups,0,0
75734,.,0,0
75735,Covariation,0,0
75736,of,0,0
75737,adolescent,1,0
75738,physical,1,1
75739,activity,1,0
75740,and,1,0
75741,dietary,1,0
75742,behaviors,1,0
75743,over,0,0
75744,12,0,0
75745,months,0,0
75746,.,0,0
75747,PURPOSE,0,0
75748,This,0,0
75749,study,0,0
75750,examined,0,0
75751,covariation,0,0
75752,among,0,0
75753,changes,1,0
75754,in,1,0
75755,dietary,1,0
75756,",",1,0
75757,physical,1,0
75758,activity,1,0
75759,",",1,0
75760,and,1,0
75761,sedentary,1,0
75762,behaviors,1,0
75763,over,0,0
75764,12,0,0
75765,months,0,0
75766,among,0,0
75767,adolescents,0,0
75768,participating,0,0
75769,in,0,0
75770,a,0,0
75771,health,0,0
75772,behavior,0,0
75773,intervention,0,1
75774,.,0,0
75775,Evidence,0,0
75776,of,0,0
75777,covariation,0,0
75778,among,0,0
75779,behaviors,0,0
75780,would,0,0
75781,suggest,0,0
75782,multi-behavior,0,0
75783,interventions,0,0
75784,could,0,0
75785,have,0,0
75786,synergistic,0,0
75787,effects,0,0
75788,.,0,0
75789,METHODS,0,0
75790,Prospective,0,0
75791,analyses,0,0
75792,were,0,0
75793,conducted,0,0
75794,with,0,0
75795,baseline,0,0
75796,and,0,0
75797,12-month,0,0
75798,assessments,0,0
75799,from,0,0
75800,a,0,0
75801,randomized,0,0
75802,controlled,0,0
75803,trial,0,0
75804,to,0,0
75805,promote,0,0
75806,improved,0,0
75807,diet,0,1
75808,",",0,0
75809,physical,0,0
75810,activity,0,0
75811,",",0,0
75812,and,0,0
75813,sedentary,1,1
75814,behaviors,1,0
75815,(,1,0
75816,experimental,1,0
75817,condition,1,1
75818,),1,0
75819,or,1,1
75820,SUN,1,1
75821,protection,1,0
75822,behaviors,1,0
75823,(,0,0
75824,comparison,0,0
75825,condition,0,0
75826,),0,0
75827,.,0,0
75828,Participants,0,0
75829,were,0,0
75830,adolescent,0,0
75831,girls,0,0
75832,and,0,0
75833,boys,0,0
75834,(,0,0
75835,N,0,0
75836,=,0,0
75837,878,0,0
75838,),0,0
75839,aged,0,0
75840,11-15,0,0
75841,years,0,0
75842,on,0,0
75843,entry,0,0
75844,.,0,0
75845,The,0,0
75846,main,0,0
75847,outcomes,0,0
75848,were,0,0
75849,:,0,0
75850,diet,0,1
75851,",",0,0
75852,based,0,0
75853,on,0,0
75854,multiple,0,0
75855,24-hour,0,1
75856,recalls,0,1
75857,(,0,0
75858,total,0,0
75859,fat,0,0
75860,",",0,0
75861,grams,0,0
75862,of,0,0
75863,fiber,0,1
75864,",",0,0
75865,servings,0,0
75866,of,0,0
75867,fruit,0,0
75868,and,0,0
75869,vegetables,0,1
75870,",",0,0
75871,total,0,0
75872,calories,0,1
75873,),0,0
75874,;,0,0
75875,average,0,0
75876,daily,0,1
75877,energy,0,0
75878,expenditure,0,0
75879,(,0,0
75880,kcals/kg,0,0
75881,),0,0
75882,based,0,0
75883,on,0,0
75884,7-day,0,0
75885,physical,0,1
75886,activity,0,0
75887,recall,0,0
75888,interviews,0,0
75889,;,0,0
75890,daily,0,0
75891,minutes,0,0
75892,of,0,0
75893,moderate-vigorous,0,0
75894,physical,0,1
75895,activity,0,0
75896,minutes,0,0
75897,from,0,0
75898,accelerometery,0,0
75899,;,0,0
75900,and,0,0
75901,self-reported,0,0
75902,daily,0,1
75903,hours,0,0
75904,of,0,0
75905,sedentary,0,0
75906,behavior,0,0
75907,.,0,0
75908,RESULTS,0,0
75909,Covariation,0,0
75910,was,0,0
75911,found,0,0
75912,between,0,0
75913,fat,0,0
75914,and,0,0
75915,calories,0,1
75916,(,0,0
75917,r,0,0
75918,=,0,0
75919,.16,0,0
75920,),0,0
75921,",",0,0
75922,fiber,0,1
75923,and,0,0
75924,calories,0,1
75925,(,0,0
75926,r,0,0
75927,=,0,0
75928,.53,0,0
75929,),0,0
75930,",",0,0
75931,fiber,0,1
75932,and,0,0
75933,fruit/vegetables,0,1
75934,(,0,0
75935,r,0,0
75936,=,0,0
75937,.53,0,0
75938,),0,0
75939,",",0,0
75940,calories,0,1
75941,and,0,0
75942,fruit/vegetables,0,1
75943,(,0,0
75944,r,0,0
75945,=,0,0
75946,.34,0,0
75947,),0,0
75948,",",0,0
75949,and,0,0
75950,fruit,0,1
75951,and,0,0
75952,vegetables,0,1
75953,and,0,0
75954,sedentary,0,1
75955,behavior,0,0
75956,(,0,0
75957,r,0,0
75958,=,0,0
75959,-.12,0,0
75960,),0,0
75961,for,0,0
75962,the,0,0
75963,total,0,0
75964,sample,0,0
75965,(,0,0
75966,all,0,0
75967,p,0,0
75968,values,0,0
75969,<,0,0
75970,.01,0,0
75971,),0,0
75972,.,0,0
75973,The,0,0
75974,pattern,0,0
75975,of,0,0
75976,findings,0,0
75977,was,0,0
75978,similar,0,0
75979,for,0,0
75980,most,0,0
75981,subgroups,0,0
75982,defined,0,0
75983,by,0,0
75984,gender,0,0
75985,and,0,0
75986,study,0,0
75987,condition,0,0
75988,.,0,0
75989,CONCLUSIONS,0,0
75990,The,0,0
75991,strongest,0,0
75992,covariation,0,0
75993,was,0,0
75994,observed,0,0
75995,for,0,0
75996,diet,0,1
75997,variables,0,0
75998,that,0,0
75999,are,0,0
76000,inherently,0,0
76001,related,0,0
76002,(,0,0
76003,calories,0,1
76004,and,0,0
76005,fat,0,0
76006,",",0,0
76007,fiber,0,1
76008,",",0,0
76009,and,0,0
76010,fruit/vegetables,0,0
76011,),0,0
76012,.,0,0
76013,Little,0,0
76014,covariation,0,0
76015,was,0,0
76016,detected,0,0
76017,within,0,0
76018,or,0,0
76019,between,0,0
76020,other,0,0
76021,diet,0,1
76022,",",0,0
76023,physical,0,1
76024,activity,0,0
76025,and,0,0
76026,sedentary,0,1
76027,behavior,0,0
76028,domains,0,0
76029,suggesting,0,0
76030,that,0,0
76031,interventions,0,0
76032,to,0,0
76033,improve,0,0
76034,these,0,0
76035,behaviors,0,0
76036,in,0,0
76037,adolescents,0,0
76038,need,0,0
76039,to,0,0
76040,include,0,0
76041,specific,0,0
76042,program,0,1
76043,components,0,0
76044,for,0,0
76045,each,0,0
76046,target,0,0
76047,behavior,0,0
76048,of,0,0
76049,interest,0,0
76050,.,0,0
76051,How,0,0
76052,well,0,0
76053,do,0,0
76054,blood,1,0
76055,folate,1,0
76056,concentrations,0,0
76057,predict,0,0
76058,dietary,1,0
76059,folate,1,0
76060,intakes,1,0
76061,in,0,0
76062,a,0,0
76063,sample,0,0
76064,of,0,0
76065,Canadian,0,0
76066,lactating,0,0
76067,women,0,0
76068,exposed,0,0
76069,to,0,0
76070,high,0,0
76071,levels,0,0
76072,of,0,0
76073,folate,0,0
76074,?,0,0
76075,An,0,0
76076,observational,0,0
76077,study,0,0
76078,.,0,0
76079,BACKGROUND,0,0
76080,In,0,0
76081,1998,0,0
76082,",",0,0
76083,mandatory,0,0
76084,folic,0,1
76085,acid,0,1
76086,fortification,0,1
76087,of,0,0
76088,white,1,0
76089,flour,1,1
76090,and,1,0
76091,select,1,0
76092,cereal,1,1
76093,grain,1,0
76094,products,1,0
76095,was,0,0
76096,implemented,0,0
76097,in,0,0
76098,Canada,0,0
76099,with,0,0
76100,the,0,0
76101,intention,0,0
76102,to,0,0
76103,increase,0,0
76104,dietary,1,0
76105,folate,1,0
76106,intakes,1,0
76107,of,0,0
76108,reproducing,0,0
76109,women,0,0
76110,.,0,0
76111,Folic,0,0
76112,acid,0,1
76113,fortification,0,1
76114,has,0,0
76115,produced,0,0
76116,a,0,0
76117,dramatic,0,0
76118,increase,0,0
76119,in,0,0
76120,blood,0,0
76121,folate,0,0
76122,concentrations,0,0
76123,among,0,0
76124,reproductive,0,0
76125,age,0,0
76126,women,0,0
76127,",",0,0
76128,and,0,0
76129,a,0,0
76130,reduction,0,0
76131,in,0,0
76132,neural,0,0
76133,tube,0,1
76134,defect,0,0
76135,(,0,0
76136,NTD,0,1
76137,),0,0
76138,-affected,0,0
76139,pregnancies,0,0
76140,.,0,0
76141,In,0,0
76142,response,0,0
76143,to,0,0
76144,improved,0,0
76145,blood,0,0
76146,folate,0,0
76147,concentrations,0,0
76148,",",0,0
76149,many,0,0
76150,health,0,0
76151,care,0,1
76152,professionals,0,0
76153,are,0,0
76154,asking,0,0
76155,whether,0,0
76156,a,0,0
76157,folic,1,1
76158,acid,1,1
76159,supplement,1,1
76160,is,0,0
76161,necessary,0,0
76162,for,0,0
76163,NTD,0,1
76164,prevention,0,0
76165,among,0,0
76166,women,0,0
76167,with,0,0
76168,high,0,0
76169,blood,0,0
76170,folate,0,0
76171,values,0,0
76172,",",0,0
76173,and,0,0
76174,how,0,0
76175,reliably,0,0
76176,high,0,0
76177,RBC,0,0
76178,folate,0,0
76179,concentrations,0,0
76180,predict,0,0
76181,folate,0,0
76182,intakes,0,0
76183,shown,0,0
76184,in,0,0
76185,randomized,0,0
76186,controlled,0,0
76187,trials,0,0
76188,to,0,0
76189,be,0,0
76190,protective,0,0
76191,against,0,0
76192,NTDs,0,0
76193,.,0,0
76194,The,0,0
76195,objective,0,0
76196,of,0,0
76197,this,0,0
76198,study,0,0
76199,was,0,0
76200,to,0,0
76201,determine,0,0
76202,how,0,0
76203,predictive,0,0
76204,blood,1,0
76205,folate,1,1
76206,concentrations,0,0
76207,and,0,0
76208,folate,0,0
76209,intakes,0,0
76210,are,0,0
76211,of,0,0
76212,each,0,0
76213,other,0,0
76214,in,0,0
76215,a,0,0
76216,sample,0,0
76217,of,0,0
76218,well-educated,0,0
76219,lactating,0,0
76220,Canadian,0,0
76221,women,0,0
76222,exposed,0,0
76223,to,0,0
76224,high,0,0
76225,levels,0,0
76226,of,0,0
76227,synthetic,0,0
76228,folate,0,0
76229,.,0,0
76230,METHODS,0,0
76231,The,0,0
76232,relationship,0,0
76233,between,0,0
76234,blood,1,0
76235,folate,1,1
76236,concentrations,0,0
76237,and,0,0
76238,dietary,0,1
76239,folate,0,0
76240,intakes,0,0
76241,",",0,0
76242,determined,0,0
76243,by,0,0
76244,weighed,1,0
76245,food,1,0
76246,records,1,0
76247,",",0,0
76248,were,0,0
76249,assessed,0,0
76250,in,0,0
76251,a,0,0
76252,sample,0,0
76253,of,0,0
76254,predominantly,0,0
76255,university-educated,0,0
76256,lactating,0,0
76257,women,0,0
76258,(,0,0
76259,32,0,0
76260,+/-,0,0
76261,4,0,0
76262,yr,0,0
76263,),0,0
76264,at,0,0
76265,4-,0,1
76266,(,0,0
76267,n,0,0
76268,=,0,0
76269,53,0,0
76270,),0,0
76271,and,0,0
76272,16-wk,0,1
76273,postpartum,0,0
76274,(,0,0
76275,n,0,0
76276,=,0,0
76277,55,0,0
76278,),0,0
76279,.,0,0
76280,RESULTS,0,0
76281,Median,0,0
76282,blood,1,0
76283,folate,1,0
76284,concentrations,0,0
76285,of,0,0
76286,all,0,0
76287,participants,0,0
76288,were,0,0
76289,well,0,0
76290,above,0,0
76291,plasma,0,0
76292,and,0,0
76293,RBC,0,0
76294,folate,0,1
76295,cut-off,0,0
76296,levels,0,0
76297,indicative,0,0
76298,of,0,0
76299,deficiency,0,0
76300,(,0,0
76301,6.7,0,0
76302,and,0,0
76303,317,0,0
76304,nmol/L,0,0
76305,",",0,0
76306,respectively,0,0
76307,),0,0
76308,and,0,0
76309,all,0,0
76310,",",0,0
76311,except,0,0
76312,for,0,0
76313,2,0,0
76314,subjects,0,0
76315,",",0,0
76316,were,0,0
76317,above,0,0
76318,the,0,0
76319,cut-off,0,0
76320,for,0,0
76321,NTD-risk,0,0
76322,reduction,0,0
76323,(,0,0
76324,>,0,0
76325,906,0,0
76326,nmol/L,0,0
76327,),0,0
76328,.,0,0
76329,Only,0,0
76330,modest,0,0
76331,associations,0,0
76332,existed,0,0
76333,between,0,0
76334,total,1,0
76335,folate,1,0
76336,intakes,1,0
76337,and,0,0
76338,plasma,0,0
76339,(,0,0
76340,r,0,0
76341,=,0,0
76342,0.46,0,0
76343,",",0,0
76344,P,0,0
76345,<,0,0
76346,0.001,0,0
76347,),0,0
76348,and,0,0
76349,RBC,0,1
76350,(,0,0
76351,r,0,0
76352,=,0,0
76353,0.36,0,0
76354,",",0,0
76355,P,0,0
76356,<,0,0
76357,0.01,0,0
76358,),0,0
76359,folate,0,0
76360,concentrations,0,0
76361,at,0,0
76362,16-wk,0,1
76363,postpartum,0,0
76364,.,0,0
76365,Plasma,0,0
76366,and,0,0
76367,RBC,0,0
76368,folate,0,1
76369,values,0,0
76370,at,0,0
76371,16-wk,0,1
76372,postpartum,0,0
76373,correctly,0,0
76374,identified,0,0
76375,the,0,0
76376,quartile,0,0
76377,of,0,0
76378,folate,0,0
76379,intake,0,0
76380,of,0,0
76381,only,0,0
76382,26,0,0
76383,of,0,0
76384,55,0,0
76385,(,0,0
76386,47,0,0
76387,%,0,0
76388,),0,0
76389,and,0,0
76390,18,0,0
76391,of,0,0
76392,55,0,0
76393,(,0,0
76394,33,0,0
76395,%,0,0
76396,),0,0
76397,of,0,0
76398,subjects,0,0
76399,",",0,0
76400,respectively,0,0
76401,.,0,0
76402,The,0,0
76403,mean,0,0
76404,RBC,0,0
76405,folate,0,1
76406,concentration,0,0
76407,of,0,0
76408,women,0,0
76409,consuming,0,0
76410,151-410,0,0
76411,microg/d,0,1
76412,of,0,0
76413,synthetic,0,1
76414,folate,0,1
76415,(,0,0
76416,2nd,0,0
76417,quartile,0,0
76418,of,0,0
76419,intake,0,0
76420,),0,0
76421,did,0,0
76422,not,0,0
76423,differ,0,0
76424,from,0,0
76425,that,0,0
76426,of,0,0
76427,women,0,0
76428,consuming,0,0
76429,>,0,0
76430,410,0,0
76431,microg/d,0,1
76432,(,0,0
76433,3rd,0,0
76434,and,0,0
76435,4th,0,0
76436,quartile,0,0
76437,),0,0
76438,.,0,0
76439,CONCLUSION,0,0
76440,Folate,1,1
76441,intakes,1,0
76442,",",0,0
76443,estimated,0,0
76444,by,0,0
76445,food,0,0
76446,composition,0,0
76447,tables,0,0
76448,",",0,0
76449,and,0,0
76450,blood,0,0
76451,folate,0,1
76452,concentrations,0,0
76453,are,0,0
76454,not,0,0
76455,predictive,0,0
76456,of,0,0
76457,each,0,0
76458,other,0,0
76459,in,0,0
76460,Canadian,0,0
76461,lactating,0,0
76462,women,0,0
76463,exposed,0,0
76464,to,0,0
76465,high,0,0
76466,levels,0,0
76467,of,0,0
76468,folate,0,0
76469,.,0,0
76470,Synthetic,0,0
76471,intakes,0,0
76472,>,0,0
76473,151-410,0,0
76474,microg/d,0,1
76475,in,0,0
76476,these,0,0
76477,women,0,0
76478,produced,0,0
76479,little,0,0
76480,additional,0,0
76481,benefit,0,0
76482,in,0,0
76483,terms,0,0
76484,of,0,0
76485,maximizing,0,0
76486,RBC,0,0
76487,content,0,0
76488,.,0,0
76489,More,0,0
76490,studies,0,0
76491,are,0,0
76492,needed,0,0
76493,to,0,0
76494,examine,0,0
76495,the,0,0
76496,relationship,0,0
76497,between,0,0
76498,blood,1,0
76499,folate,1,1
76500,concentration,0,0
76501,and,0,0
76502,NTD,0,1
76503,risk,0,0
76504,.,0,0
76505,Until,0,0
76506,data,0,0
76507,from,0,0
76508,such,0,0
76509,studies,0,0
76510,are,0,0
76511,available,0,0
76512,",",0,0
76513,women,0,0
76514,planning,0,0
76515,a,0,0
76516,pregnancy,0,0
76517,should,0,0
76518,continue,0,0
76519,to,0,0
76520,consume,0,0
76521,a,0,0
76522,daily,0,0
76523,folic,1,1
76524,acid,1,1
76525,supplement,1,1
76526,of,0,0
76527,400,0,0
76528,microg,0,0
76529,.,0,0
76530,Robotic,1,0
76531,therapy,1,1
76532,:,1,0
76533,a,0,0
76534,novel,0,0
76535,approach,0,1
76536,in,0,0
76537,upper-limb,0,0
76538,neurorehabilitation,0,1
76539,after,0,0
76540,stroke,0,0
76541,.,0,0
76542,Sivelestat,1,1
76543,sodium,1,1
76544,hydrate,1,1
76545,improves,0,0
76546,septic,0,0
76547,acute,0,0
76548,lung,0,0
76549,injury,0,0
76550,by,0,0
76551,reducing,0,0
76552,alveolar,0,0
76553,dysfunction,0,0
76554,.,0,0
76555,Sivelestat,1,1
76556,sodium,1,1
76557,hydrate,1,1
76558,(,1,0
76559,sivelestat,1,1
76560,),1,1
76561,is,0,0
76562,a,0,0
76563,selective,0,0
76564,inhibitor,0,1
76565,of,0,0
76566,polymorphonuclear,0,0
76567,leukocyte,0,0
76568,elastase,0,1
76569,(,0,0
76570,PMN-E,0,0
76571,),0,0
76572,.,0,0
76573,We,0,0
76574,administered,0,0
76575,sivelestat,1,0
76576,to,0,0
76577,patients,0,0
76578,with,0,0
76579,septic,0,0
76580,acute,0,0
76581,lung,0,0
76582,injury,0,0
76583,(,0,0
76584,ALI,0,1
76585,),0,0
76586,to,0,0
76587,examine,0,0
76588,its,0,0
76589,usefulness,0,0
76590,.,0,0
76591,The,0,0
76592,primary,0,0
76593,endpoints,0,0
76594,in,0,0
76595,the,0,0
76596,study,0,0
76597,were,0,0
76598,the,0,0
76599,duration,0,0
76600,of,0,0
76601,artificial,0,0
76602,ventilation,0,1
76603,and,0,0
76604,pulmonary,0,0
76605,oxygenation,0,0
76606,ability,0,0
76607,",",0,0
76608,and,0,0
76609,the,0,0
76610,secondary,0,0
76611,endpoints,0,0
76612,were,0,0
76613,mortality,0,0
76614,and,0,0
76615,the,0,0
76616,concentrations,0,0
76617,of,0,0
76618,PMN-E,0,0
76619,",",0,0
76620,SP-D,0,0
76621,",",0,0
76622,TNF-alpha,0,1
76623,and,0,0
76624,IL-8,0,0
76625,in,0,0
76626,blood,0,0
76627,.,0,0
76628,In,0,0
76629,the,0,0
76630,sivelestat,1,1
76631,group,0,0
76632,",",0,0
76633,the,0,0
76634,duration,0,0
76635,of,0,0
76636,artificial,0,0
76637,ventilation,0,1
76638,",",0,0
76639,pulmonary,0,0
76640,oxygenation,0,0
76641,ability,0,0
76642,",",0,0
76643,and,0,0
76644,the,0,0
76645,blood,0,0
76646,PMN-E,0,0
76647,",",0,0
76648,SP-D,0,0
76649,",",0,0
76650,TNF-alpha,0,1
76651,and,0,0
76652,IL-8,0,0
76653,concentrations,0,0
76654,decreased,0,0
76655,significantly,0,0
76656,.,0,0
76657,Administration,0,0
76658,of,0,0
76659,sivelestat,1,0
76660,was,0,0
76661,found,0,0
76662,to,0,0
76663,reduce,0,0
76664,alveolar,0,0
76665,dysfunction,0,0
76666,and,0,0
76667,improve,0,0
76668,respiratory,0,0
76669,function,0,0
76670,",",0,0
76671,and,0,0
76672,it,0,0
76673,was,0,0
76674,suggested,0,0
76675,that,0,0
76676,early,0,0
76677,administration,0,0
76678,might,0,0
76679,be,0,0
76680,useful,0,0
76681,.,0,0
76682,Home,1,1
76683,blood,1,0
76684,pressure,1,0
76685,monitoring,1,0
76686,:,1,0
76687,advantages,0,0
76688,and,0,0
76689,limitations,0,0
76690,.,0,0
76691,Home,1,0
76692,blood,1,0
76693,pressure,1,0
76694,monitoring,1,0
76695,is,0,0
76696,a,0,0
76697,useful,0,0
76698,tool,0,0
76699,for,0,0
76700,clinical,0,0
76701,management,0,0
76702,of,0,0
76703,patients,0,0
76704,with,0,0
76705,hypertension,0,0
76706,.,0,0
76707,Its,0,0
76708,major,0,0
76709,advantages,0,0
76710,are,0,0
76711,the,0,0
76712,ease,0,0
76713,with,0,0
76714,which,0,0
76715,the,0,0
76716,techniques,0,1
76717,can,0,0
76718,be,0,0
76719,learned,0,0
76720,",",0,0
76721,reproducibility,0,0
76722,of,0,0
76723,values,0,0
76724,",",0,0
76725,sensitivity,0,0
76726,of,0,0
76727,measurement,0,0
76728,and,0,0
76729,availability,0,0
76730,of,0,0
76731,normotensive,0,0
76732,data,0,0
76733,.,0,0
76734,In,0,0
76735,spite,0,0
76736,of,0,0
76737,the,0,0
76738,ability,0,0
76739,to,0,0
76740,tell,0,0
76741,whether,0,0
76742,a,0,0
76743,subject,0,0
76744,has,0,0
76745,normal,0,0
76746,or,0,0
76747,abnormal,0,0
76748,values,0,0
76749,",",0,0
76750,because,0,0
76751,of,0,0
76752,the,0,0
76753,lack,0,0
76754,of,0,0
76755,prospective,0,0
76756,mortality/morbidity,0,0
76757,data,0,0
76758,",",0,0
76759,home,1,1
76760,blood,1,0
76761,pressure,1,0
76762,monitoring,1,0
76763,can,0,0
76764,not,0,0
76765,be,0,0
76766,used,0,0
76767,to,0,0
76768,decide,0,0
76769,whether,0,0
76770,treatment,0,0
76771,is,0,0
76772,indicated,0,0
76773,.,0,0
76774,The,0,0
76775,treatment,0,0
76776,decision,0,0
76777,must,0,0
76778,be,0,0
76779,based,0,0
76780,on,0,0
76781,repeated,0,0
76782,clinic,1,0
76783,blood,1,0
76784,pressure,1,0
76785,readings,0,0
76786,.,0,0
76787,After,0,0
76788,that,0,0
76789,the,0,0
76790,home,1,1
76791,blood,1,0
76792,pressure,1,0
76793,monitoring,1,0
76794,can,0,0
76795,be,0,0
76796,used,0,0
76797,to,0,0
76798,exclude,0,0
76799,individuals,0,0
76800,who,0,0
76801,are,0,0
76802,at,0,0
76803,risk,0,0
76804,for,0,0
76805,side,0,0
76806,effects,0,0
76807,due,0,0
76808,to,0,0
76809,low,0,0
76810,out-of-office,0,1
76811,blood,0,0
76812,pressure,0,0
76813,readings,0,0
76814,and,0,0
76815,to,0,0
76816,precisely,0,0
76817,monitor,0,0
76818,the,0,0
76819,blood,0,0
76820,pressure,0,0
76821,response,0,0
76822,to,0,0
76823,therapy,0,1
76824,.,0,0
76825,Home,1,0
76826,blood,1,0
76827,pressure,1,0
76828,monitoring,1,0
76829,is,0,0
76830,frequently,0,0
76831,used,0,0
76832,to,0,0
76833,find,0,0
76834,subjects,0,0
76835,with,0,0
76836,'white-coat,0,0
76837,',0,0
76838,hypertension,0,0
76839,.,0,0
76840,In,0,0
76841,our,0,0
76842,study,0,0
76843,of,0,0
76844,borderline,0,0
76845,hypertension,0,0
76846,in,0,0
76847,Tecumseh,0,0
76848,",",0,0
76849,white-coat,0,0
76850,hypertension,0,0
76851,is,0,0
76852,present,0,0
76853,in,0,0
76854,7.1,0,0
76855,%,0,0
76856,of,0,0
76857,the,0,0
76858,whole,0,1
76859,population,0,0
76860,and,0,0
76861,in,0,0
76862,58,0,0
76863,%,0,0
76864,of,0,0
76865,all,0,0
76866,subjects,0,0
76867,with,0,0
76868,elevated,0,0
76869,blood,0,0
76870,pressures,0,0
76871,in,0,0
76872,the,0,0
76873,clinic,0,0
76874,.,0,0
76875,Subjects,0,0
76876,with,0,0
76877,white-coat,0,0
76878,hypertension,0,0
76879,in,0,0
76880,Tecumseh,0,0
76881,appear,0,0
76882,to,0,0
76883,be,0,0
76884,at,0,0
76885,an,0,0
76886,increased,0,0
76887,risk,0,0
76888,for,0,0
76889,coronary,0,0
76890,heart,0,0
76891,disease,0,0
76892,:,0,0
76893,they,0,0
76894,show,0,0
76895,repeated,0,0
76896,elevated,0,0
76897,clinic,0,0
76898,readings,0,0
76899,throughout,0,0
76900,their,0,0
76901,life,0,0
76902,time,0,0
76903,",",0,0
76904,their,0,0
76905,parents,0,0
76906,have,0,0
76907,higher,0,0
76908,blood,0,0
76909,pressure,0,0
76910,",",0,0
76911,their,0,0
76912,high-density,0,0
76913,lipoprotein,0,0
76914,is,0,0
76915,decreased,0,0
76916,and,0,0
76917,insulin,0,1
76918,",",0,0
76919,cholesterol,0,0
76920,and,0,0
76921,triglycerides,0,0
76922,are,0,0
76923,elevated,0,0
76924,.,0,0
76925,Whereas,0,0
76926,subjects,0,0
76927,with,0,0
76928,white-coat,0,0
76929,hypertension,0,0
76930,should,0,0
76931,not,0,0
76932,be,0,0
76933,treated,0,0
76934,with,0,0
76935,antihypertensive,0,0
76936,agents,0,0
76937,",",0,0
76938,they,0,0
76939,must,0,0
76940,be,0,0
76941,followed,0,0
76942,and,0,0
76943,managed,0,0
76944,through,0,0
76945,non-pharmacologic,1,0
76946,means,1,0
76947,.,1,0
76948,Short-course,0,1
76949,nitrofurantoin,1,1
76950,for,0,0
76951,the,0,0
76952,treatment,0,0
76953,of,0,0
76954,acute,0,0
76955,uncomplicated,0,0
76956,cystitis,0,0
76957,in,0,0
76958,women,0,0
76959,.,0,0
76960,BACKGROUND,0,0
76961,There,0,0
76962,is,0,0
76963,a,0,0
76964,paucity,0,0
76965,of,0,0
76966,data,0,0
76967,on,0,0
76968,the,0,0
76969,efficacy,0,0
76970,of,0,0
76971,nitrofurantoin,1,1
76972,for,0,0
76973,the,0,0
76974,treatment,0,0
76975,of,0,0
76976,acute,0,0
76977,uncomplicated,0,0
76978,cystitis,0,0
76979,in,0,0
76980,regimens,0,0
76981,shorter,0,0
76982,than,0,0
76983,7,0,0
76984,days,0,0
76985,.,0,0
76986,Evidence-based,0,0
76987,use,0,0
76988,of,0,0
76989,this,0,0
76990,drug,0,0
76991,is,0,0
76992,increasingly,0,0
76993,important,0,0
76994,as,0,0
76995,trimethoprim-sulfamethoxazole,1,1
76996,resistance,0,0
76997,among,0,0
76998,uropathogens,0,0
76999,increases,0,0
77000,.,0,0
77001,METHODS,0,0
77002,To,0,0
77003,assess,0,0
77004,the,0,0
77005,efficacy,0,0
77006,of,0,0
77007,nitrofurantoin,1,1
77008,vs,0,0
77009,trimethoprim-sulfamethoxazole,1,1
77010,",",0,0
77011,338,0,0
77012,women,0,0
77013,aged,0,0
77014,18,0,0
77015,to,0,0
77016,45,0,0
77017,years,0,0
77018,with,0,0
77019,acute,0,0
77020,uncomplicated,0,0
77021,cystitis,0,0
77022,were,0,0
77023,randomized,0,0
77024,to,0,0
77025,open-label,0,0
77026,treatment,0,0
77027,with,0,0
77028,either,0,0
77029,trimethoprim-sulfamethoxazole,1,1
77030,",",1,0
77031,1,1,0
77032,double-strength,1,1
77033,tablet,1,1
77034,twice,1,0
77035,daily,1,0
77036,for,1,0
77037,3,1,0
77038,days,1,0
77039,",",1,0
77040,or,1,0
77041,nitrofurantoin,1,1
77042,",",1,0
77043,100,1,0
77044,mg,1,0
77045,twice,1,0
77046,daily,1,0
77047,for,1,0
77048,5,1,0
77049,days,1,0
77050,.,1,0
77051,Clinical,0,0
77052,cure,0,0
77053,30,0,0
77054,days,0,0
77055,after,0,0
77056,therapy,0,1
77057,was,0,0
77058,the,0,0
77059,main,0,0
77060,outcome,0,0
77061,measure,0,0
77062,.,0,0
77063,Secondary,0,0
77064,outcomes,0,0
77065,included,0,0
77066,clinical,0,0
77067,and,0,0
77068,microbiological,0,0
77069,cure,0,0
77070,rates,0,0
77071,5,0,0
77072,to,0,0
77073,9,0,0
77074,days,0,0
77075,after,0,0
77076,therapy,0,1
77077,and,0,0
77078,",",0,0
77079,for,0,0
77080,trimethoprim-sulfamethoxazole-treated,1,1
77081,women,0,0
77082,",",0,0
77083,clinical,0,0
77084,cure,0,0
77085,stratified,0,0
77086,by,0,0
77087,the,0,0
77088,trimethoprim-sulfamethoxazole,1,1
77089,susceptibility,0,0
77090,of,0,0
77091,the,0,0
77092,uropathogen,0,0
77093,.,0,0
77094,RESULTS,0,0
77095,Clinical,0,0
77096,cure,0,0
77097,was,0,0
77098,achieved,0,0
77099,in,0,0
77100,79,0,0
77101,%,0,0
77102,of,0,0
77103,the,0,0
77104,trimethoprim-sulfamethoxazole,0,1
77105,group,0,0
77106,and,0,0
77107,in,0,0
77108,84,0,0
77109,%,0,0
77110,of,0,0
77111,the,0,0
77112,nitrofurantoin,0,1
77113,group,0,0
77114,",",0,0
77115,for,0,0
77116,a,0,0
77117,difference,0,0
77118,of,0,0
77119,-5,0,0
77120,%,0,0
77121,(,0,0
77122,95,0,0
77123,%,0,0
77124,confidence,0,0
77125,interval,0,0
77126,",",0,0
77127,-13,0,0
77128,%,0,0
77129,to,0,0
77130,4,0,0
77131,%,0,0
77132,),0,0
77133,.,0,0
77134,Clinical,0,0
77135,and,0,0
77136,microbiological,0,0
77137,cure,0,0
77138,rates,0,0
77139,at,0,0
77140,the,0,0
77141,first,0,0
77142,follow-up,0,0
77143,visit,0,0
77144,were,0,0
77145,also,0,0
77146,equivalent,0,0
77147,between,0,0
77148,the,0,0
77149,2,0,0
77150,groups,0,0
77151,.,0,0
77152,In,0,0
77153,the,0,0
77154,trimethoprim-sulfamethoxazole,1,1
77155,arm,0,0
77156,",",0,0
77157,7,0,0
77158,of,0,0
77159,17,0,0
77160,women,0,0
77161,(,0,0
77162,41,0,0
77163,%,0,0
77164,),0,0
77165,with,0,0
77166,a,0,0
77167,trimethoprim-sulfamethoxazole-nonsusceptible,0,1
77168,isolate,0,0
77169,had,0,0
77170,a,0,0
77171,clinical,0,0
77172,cure,0,0
77173,compared,0,0
77174,with,0,0
77175,84,0,0
77176,%,0,0
77177,of,0,0
77178,women,0,0
77179,with,0,0
77180,a,0,0
77181,trimethoprim-sulfamethoxazole-susceptible,0,1
77182,isolate,0,0
77183,(,0,0
77184,P,0,0
77185,<,0,0
77186,.001,0,0
77187,),0,0
77188,.,0,0
77189,CONCLUSION,0,0
77190,A,0,0
77191,5-day,0,1
77192,course,0,0
77193,of,0,0
77194,nitrofurantoin,0,1
77195,is,0,0
77196,equivalent,0,0
77197,clinically,0,0
77198,and,0,0
77199,microbiologically,0,0
77200,to,0,0
77201,a,0,0
77202,3-day,0,0
77203,course,0,0
77204,of,0,0
77205,trimethoprim-sulfamethoxazole,0,1
77206,and,0,0
77207,should,0,0
77208,be,0,0
77209,considered,0,0
77210,an,0,0
77211,effective,0,0
77212,fluoroquinolone-sparing,0,0
77213,alternative,0,0
77214,for,0,0
77215,the,0,0
77216,treatment,0,0
77217,of,0,0
77218,acute,0,0
77219,cystitis,0,0
77220,in,0,0
77221,women,0,0
77222,.,0,0
77223,Several,0,0
77224,indicators,0,0
77225,of,0,0
77226,oxidative,0,0
77227,stress,0,0
77228,",",0,0
77229,immunity,0,0
77230,",",0,0
77231,and,0,0
77232,illness,0,0
77233,improved,0,0
77234,in,0,0
77235,trained,0,1
77236,men,0,0
77237,consuming,0,0
77238,an,0,0
77239,encapsulated,1,1
77240,juice,1,1
77241,powder,1,1
77242,concentrate,1,1
77243,for,0,0
77244,28,0,0
77245,weeks,0,0
77246,.,0,0
77247,Phytonutrients,1,0
77248,from,1,0
77249,plant,1,0
77250,foods,1,1
77251,provide,0,0
77252,numerous,0,0
77253,antioxidants,0,1
77254,.,0,0
77255,We,0,0
77256,hypothesized,0,0
77257,that,0,0
77258,supplementation,0,1
77259,for,0,0
77260,28,0,0
77261,wk,0,0
77262,with,0,0
77263,a,0,0
77264,commercially,1,0
77265,available,1,0
77266,encapsulated,1,1
77267,juice,1,1
77268,powder,1,1
77269,concentrate,1,1
77270,(,1,0
77271,JPC,1,0
77272,),1,0
77273,could,0,0
77274,influence,0,0
77275,indicators,0,0
77276,of,0,0
77277,oxidative,0,0
77278,stress,0,0
77279,",",0,0
77280,immunity,0,0
77281,",",0,0
77282,and,0,0
77283,illness,0,0
77284,.,0,0
77285,Trained,0,0
77286,men,0,0
77287,(,0,0
77288,n,0,0
77289,=,0,0
77290,41,0,0
77291,;,0,0
77292,34,0,0
77293,+/-,0,0
77294,5,0,0
77295,y,0,0
77296,;,0,0
77297,maximum,0,0
77298,oxygen,0,1
77299,uptake,0,0
77300,=,0,0
77301,55,0,0
77302,+/-,0,0
77303,7,0,0
77304,mL,0,0
77305,x,0,0
77306,kg,0,1
77307,(,0,0
77308,-1,0,0
77309,),0,0
77310,x,0,0
77311,min,0,1
77312,(,0,0
77313,-1,0,0
77314,),0,1
77315,),0,0
77316,from,0,0
77317,a,0,0
77318,homogenous,0,0
77319,police,0,0
77320,Special,0,0
77321,Forces,0,0
77322,unit,0,0
77323,were,0,0
77324,randomly,0,0
77325,assigned,0,0
77326,in,0,0
77327,a,0,0
77328,double,0,0
77329,blind,0,0
77330,manner,0,0
77331,to,0,0
77332,either,0,0
77333,JPC,1,1
77334,(,0,0
77335,n,0,0
77336,=,0,0
77337,21,0,0
77338,),0,0
77339,or,1,1
77340,placebo,1,1
77341,(,0,0
77342,n,0,0
77343,=,0,0
77344,20,0,0
77345,),0,0
77346,.,0,0
77347,We,0,0
77348,used,0,0
77349,multiple,0,0
77350,7-d,0,1
77351,food,0,0
77352,records,0,0
77353,to,0,0
77354,assess,0,0
77355,dietary,0,1
77356,intake,0,0
77357,and,0,0
77358,found,0,0
77359,inadequate,0,0
77360,mean,0,0
77361,daily,0,1
77362,fruit,0,1
77363,and,0,0
77364,vegetable,0,1
77365,consumption,0,0
77366,(,0,0
77367,3.2,0,0
77368,+/-,0,0
77369,1.2,0,0
77370,servings,0,0
77371,),0,0
77372,.,0,0
77373,The,0,0
77374,group,0,0
77375,physician,0,0
77376,documented,0,0
77377,all,0,0
77378,duty,0,0
77379,days,0,0
77380,lost,0,0
77381,due,0,0
77382,to,0,0
77383,illness,0,0
77384,.,0,0
77385,We,1,0
77386,collected,1,0
77387,plasma,1,0
77388,at,1,0
77389,baseline,1,0
77390,and,1,0
77391,study,1,0
77392,wk,1,0
77393,4,1,0
77394,",",1,0
77395,8,1,0
77396,",",1,0
77397,16,1,0
77398,",",1,0
77399,and,1,0
77400,28,1,0
77401,for,1,0
77402,analysis,1,0
77403,of,1,0
77404,carbonyl,1,0
77405,groups,1,0
77406,on,1,0
77407,protein,1,0
77408,(,1,0
77409,CP,1,1
77410,),1,0
77411,and,1,0
77412,TNFalpha,1,0
77413,.,1,0
77414,Over,0,0
77415,the,0,0
77416,28-wk,0,0
77417,investigation,0,0
77418,",",0,0
77419,CP,0,1
77420,was,0,0
77421,lower,0,0
77422,in,0,0
77423,the,0,0
77424,JPC,1,0
77425,group,0,0
77426,",",0,0
77427,with,0,0
77428,both,0,0
77429,a,0,0
77430,treatment,0,0
77431,and,0,0
77432,a,0,0
77433,time,0,0
77434,x,0,0
77435,treatment,0,1
77436,interaction,0,0
77437,(,0,0
77438,P,0,0
77439,<,0,0
77440,0.05,0,0
77441,),0,0
77442,.,0,0
77443,Concentrations,0,0
77444,of,0,0
77445,both,0,0
77446,CP,0,1
77447,and,0,0
77448,TNFalpha,0,0
77449,at,0,0
77450,16,0,0
77451,and,0,0
77452,28,0,0
77453,wk,0,0
77454,were,0,0
77455,lower,0,0
77456,in,0,0
77457,the,0,0
77458,JPC,1,0
77459,than,0,0
77460,in,0,0
77461,the,0,0
77462,placebo,1,1
77463,group,0,0
77464,(,0,0
77465,P,0,0
77466,<,0,0
77467,0.001,0,0
77468,),0,0
77469,.,0,0
77470,TNFalpha,0,0
77471,increased,0,0
77472,during,0,0
77473,the,0,0
77474,first,0,0
77475,8,0,0
77476,wk,0,0
77477,followed,0,0
77478,by,0,0
77479,a,0,0
77480,decrease,0,0
77481,in,0,0
77482,both,0,0
77483,groups,0,0
77484,for,0,0
77485,the,0,0
77486,following,0,0
77487,20,0,1
77488,wk,0,0
77489,(,0,0
77490,P,0,0
77491,<,0,0
77492,0.001,0,0
77493,),0,0
77494,.,0,0
77495,Over,0,0
77496,the,0,0
77497,final,0,0
77498,20,0,0
77499,wk,0,0
77500,of,0,0
77501,the,0,0
77502,study,0,0
77503,",",0,0
77504,the,0,0
77505,placebo,1,1
77506,group,0,0
77507,tended,0,0
77508,to,0,0
77509,have,0,0
77510,more,0,0
77511,days,0,0
77512,of,0,0
77513,illness,0,0
77514,than,0,0
77515,the,0,0
77516,JPC,1,0
77517,group,0,0
77518,(,0,0
77519,P,0,0
77520,=,0,0
77521,0.068,0,0
77522,),0,0
77523,.,0,0
77524,These,0,0
77525,data,0,0
77526,suggest,0,0
77527,beneficial,0,0
77528,JPC,1,0
77529,effects,0,0
77530,with,0,0
77531,regard,0,0
77532,to,0,0
77533,reduction,0,0
77534,of,0,0
77535,duty,0,0
77536,days,0,0
77537,lost,0,0
77538,due,0,0
77539,to,0,0
77540,illness,0,0
77541,and,0,0
77542,reduction,0,0
77543,of,0,0
77544,CP,0,1
77545,and,0,0
77546,TNFalpha,0,0
77547,concentrations,0,0
77548,in,0,0
77549,this,0,0
77550,group,0,0
77551,of,0,0
77552,trained,0,1
77553,men,0,0
77554,over,0,0
77555,28,0,0
77556,wk,0,0
77557,.,0,0
77558,Results,0,0
77559,of,0,0
77560,a,0,0
77561,phase,0,0
77562,III,0,0
77563,",",0,0
77564,8-week,0,0
77565,",",0,0
77566,multicenter,0,0
77567,",",0,0
77568,prospective,0,0
77569,",",0,0
77570,randomized,0,0
77571,",",0,0
77572,double-blind,0,0
77573,",",0,0
77574,parallel-group,0,0
77575,clinical,0,0
77576,trial,0,0
77577,to,0,0
77578,assess,0,0
77579,the,0,0
77580,effects,0,0
77581,of,0,0
77582,amlodipine,1,1
77583,camsylate,1,1
77584,versus,0,1
77585,amlodipine,1,1
77586,besylate,1,1
77587,in,0,0
77588,Korean,0,0
77589,adults,0,0
77590,with,0,0
77591,mild,0,0
77592,to,0,0
77593,moderate,0,0
77594,hypertension,0,0
77595,.,0,0
77596,BACKGROUND,0,0
77597,Amlodipine,1,1
77598,besylate,1,1
77599,has,0,0
77600,been,0,0
77601,used,0,0
77602,in,0,0
77603,Korea,0,0
77604,for,0,0
77605,the,0,0
77606,treatment,0,0
77607,of,0,0
77608,hypertension,0,0
77609,for,0,0
77610,>,0,0
77611,17,0,0
77612,years,0,0
77613,",",0,0
77614,with,0,0
77615,well-established,0,0
77616,efficacy,0,0
77617,and,0,0
77618,tolerability,0,0
77619,.,0,0
77620,Amlodipine,1,1
77621,camsylate,1,1
77622,is,0,0
77623,a,0,0
77624,newer,0,0
77625,formulation,0,0
77626,developed,0,0
77627,for,0,0
77628,generic,0,0
77629,use,0,0
77630,.,0,0
77631,It,0,0
77632,has,0,0
77633,been,0,0
77634,assessed,0,0
77635,in,0,0
77636,terms,0,0
77637,of,0,0
77638,physical,0,1
77639,stability,0,0
77640,and,0,0
77641,pharmacokinetic,0,0
77642,and,0,0
77643,pharmacodynamic,0,0
77644,properties,0,0
77645,and,0,0
77646,been,0,0
77647,found,0,0
77648,to,0,0
77649,be,0,0
77650,effective,0,0
77651,in,0,0
77652,lowering,0,0
77653,blood,0,0
77654,pressure,0,0
77655,in,0,0
77656,preclinical,0,0
77657,and,0,0
77658,Phase,0,0
77659,I,0,0
77660,and,0,0
77661,II,0,0
77662,trials,0,0
77663,.,0,0
77664,However,0,0
77665,",",0,0
77666,to,0,0
77667,date,0,0
77668,",",0,0
77669,no,0,0
77670,studies,0,0
77671,have,0,0
77672,compared,0,0
77673,the,0,0
77674,clinical,0,0
77675,effectiveness,0,0
77676,of,0,0
77677,amlodipine,1,1
77678,camsylate,1,1
77679,and,0,0
77680,amlodipine,1,1
77681,besylate,1,1
77682,in,0,0
77683,treating,0,0
77684,hypertension,0,0
77685,.,0,0
77686,OBJECTIVE,0,0
77687,This,0,0
77688,study,0,0
77689,was,0,0
77690,designed,0,0
77691,to,0,0
77692,determine,0,0
77693,the,0,0
77694,effectiveness,0,0
77695,and,0,0
77696,tolerability,0,0
77697,of,0,0
77698,amlodipine,1,1
77699,camsylate,1,1
77700,compared,0,0
77701,with,0,0
77702,amlodipine,1,1
77703,besylate,1,1
77704,in,0,0
77705,Korean,0,0
77706,patients,0,0
77707,with,0,0
77708,mild,0,0
77709,to,0,0
77710,moderate,0,0
77711,hypertension,0,0
77712,.,0,0
77713,METHODS,0,0
77714,This,0,0
77715,Phase,0,0
77716,III,0,0
77717,",",0,0
77718,8-week,0,0
77719,",",0,0
77720,prospective,0,0
77721,",",0,0
77722,randomized,0,0
77723,",",0,0
77724,double-blind,0,0
77725,",",0,0
77726,parallel-group,0,0
77727,study,0,0
77728,was,0,0
77729,conducted,0,0
77730,in,0,0
77731,13,0,0
77732,cardiology,0,0
77733,centers,0,0
77734,across,0,0
77735,the,0,0
77736,Republic,0,0
77737,of,0,0
77738,Korea,0,0
77739,.,0,0
77740,Male,0,0
77741,and,0,0
77742,female,0,0
77743,Korean,0,0
77744,patients,0,0
77745,aged,0,0
77746,18,0,0
77747,to,0,0
77748,75,0,0
77749,years,0,0
77750,having,0,0
77751,uncomplicated,0,0
77752,",",0,0
77753,mild,0,0
77754,to,0,0
77755,moderate,0,0
77756,",",0,0
77757,essential,0,0
77758,hypertension,0,0
77759,(,0,0
77760,sitting,0,1
77761,diastolic,0,0
77762,blood,0,0
77763,pressure,0,0
77764,[,0,0
77765,SiDBP,0,0
77766,],0,0
77767,90-,0,0
77768,<,0,0
77769,110,0,0
77770,mm,0,0
77771,Hg,0,0
77772,),0,0
77773,and,0,0
77774,receiving,0,0
77775,no,0,0
77776,antihypertensives,0,1
77777,in,0,0
77778,the,0,0
77779,2,0,0
77780,weeks,0,0
77781,before,0,0
77782,randomization,0,0
77783,were,0,0
77784,eligible,0,0
77785,.,0,0
77786,Patients,0,0
77787,were,0,0
77788,randomly,1,0
77789,assigned,1,0
77790,to,1,0
77791,receive,1,0
77792,oral,1,1
77793,treatment,1,0
77794,with,1,0
77795,amlodipine,1,1
77796,camsylate,1,1
77797,or,1,1
77798,amlodipine,1,1
77799,besylate,1,1
77800,.,1,0
77801,For,1,0
77802,the,1,0
77803,first,1,0
77804,4,1,0
77805,weeks,1,0
77806,",",1,0
77807,patients,1,0
77808,received,1,0
77809,amlodipine,1,1
77810,5,1,0
77811,mg,1,1
77812,QD,1,1
77813,(,1,0
77814,morning,1,0
77815,),1,0
77816,.,1,0
77817,After,1,0
77818,4,1,0
77819,weeks,1,0
77820,",",1,0
77821,if,1,0
77822,either,1,0
77823,blood,1,0
77824,pressure,1,0
77825,was,1,0
77826,>,1,0
77827,or,1,1
77828,=140/,1,0
77829,>,1,0
77830,or,1,1
77831,=90,1,0
77832,mm,1,0
77833,Hg,1,0
77834,or,1,1
77835,SiDBP,1,0
77836,had,1,0
77837,not,1,0
77838,decreased,1,0
77839,by,1,0
77840,>,1,0
77841,or,1,0
77842,=10,1,0
77843,mm,1,0
77844,Hg,1,0
77845,from,1,0
77846,baseline,1,0
77847,",",1,0
77848,the,1,0
77849,dose,1,0
77850,of,1,0
77851,amlodipine,1,1
77852,was,1,0
77853,increased,1,0
77854,to,1,0
77855,10,1,0
77856,mg,1,1
77857,QD,1,0
77858,for,1,0
77859,4,1,0
77860,weeks,1,0
77861,.,1,0
77862,Trough,1,0
77863,blood,1,0
77864,pressure,1,0
77865,and,1,0
77866,heart,1,0
77867,rate,1,0
77868,were,1,0
77869,measured,1,0
77870,in,1,0
77871,duplicate,1,0
77872,with,1,0
77873,the,1,0
77874,patient,1,0
77875,in,1,0
77876,the,1,0
77877,sitting,1,0
77878,position,1,0
77879,at,1,0
77880,each,1,0
77881,clinic,1,0
77882,visit,1,0
77883,(,1,0
77884,baseline,1,0
77885,[,1,0
77886,week,1,0
77887,0,1,0
77888,],1,0
77889,and,1,0
77890,weeks,1,0
77891,4,1,0
77892,and,1,0
77893,8,1,0
77894,of,1,0
77895,treatment,1,0
77896,),1,0
77897,;,1,0
77898,mean,1,0
77899,values,1,0
77900,were,1,0
77901,calculated,1,0
77902,and,1,0
77903,recorded,1,0
77904,.,1,0
77905,At,1,0
77906,weeks,1,0
77907,4,1,0
77908,and,1,0
77909,8,1,0
77910,",",1,0
77911,tolerability,1,0
77912,was,1,0
77913,assessed,1,0
77914,using,1,0
77915,history,1,0
77916,taking,1,0
77917,and,1,0
77918,laboratory,1,0
77919,analysis,1,0
77920,",",1,0
77921,and,1,0
77922,compliance,1,0
77923,was,1,0
77924,assessed,1,0
77925,using,1,0
77926,pill,1,1
77927,counts,1,0
77928,.,1,0
77929,The,0,0
77930,primary,0,0
77931,end,0,0
77932,point,0,0
77933,was,0,0
77934,change,0,0
77935,from,0,0
77936,baseline,0,0
77937,in,0,0
77938,SiDBP,0,0
77939,at,0,0
77940,week,0,0
77941,8,0,0
77942,.,0,0
77943,Secondary,0,0
77944,end,0,0
77945,points,0,0
77946,were,0,0
77947,change,0,0
77948,from,0,0
77949,baseline,0,0
77950,in,0,0
77951,sitting,0,0
77952,systolic,0,0
77953,blood,0,0
77954,pressure,0,0
77955,(,0,0
77956,SiSBP,0,0
77957,),0,0
77958,at,0,0
77959,week,0,0
77960,8,0,0
77961,in,0,0
77962,the,0,0
77963,total,0,0
77964,population,0,0
77965,and,0,0
77966,in,0,0
77967,the,0,0
77968,subgroup,0,0
77969,of,0,0
77970,patients,0,0
77971,who,0,0
77972,had,0,0
77973,previously,0,0
77974,received,0,0
77975,antihypertensive,0,1
77976,treatment,0,0
77977,versus,0,0
77978,those,0,0
77979,who,0,0
77980,had,0,0
77981,not,0,0
77982,.,0,0
77983,RESULTS,0,0
77984,A,0,0
77985,total,0,0
77986,of,0,0
77987,189,0,0
77988,patients,0,0
77989,were,0,0
77990,enrolled,0,0
77991,(,0,0
77992,mean,0,0
77993,age,0,0
77994,",",0,0
77995,53,0,0
77996,years,0,0
77997,;,0,0
77998,105,0,0
77999,women,0,0
78000,",",0,0
78001,84,0,0
78002,men,0,0
78003,;,0,0
78004,mean,0,0
78005,body,0,0
78006,weight,0,0
78007,",",0,0
78008,65.8,0,0
78009,kg,0,0
78010,),0,0
78011,.,0,0
78012,One,0,0
78013,patient,0,0
78014,in,0,0
78015,the,0,0
78016,amlodipine,1,1
78017,camsylate,1,1
78018,group,0,0
78019,dropped,0,0
78020,out,0,0
78021,of,0,0
78022,the,0,0
78023,study,0,0
78024,at,0,0
78025,week,0,0
78026,0,0,0
78027,of,0,0
78028,treatment,0,0
78029,(,0,0
78030,this,0,0
78031,patient,0,0
78032,did,0,0
78033,not,0,0
78034,use,0,0
78035,any,0,0
78036,study,0,0
78037,medication,0,1
78038,),0,0
78039,and,0,0
78040,was,0,0
78041,excluded,0,0
78042,from,0,0
78043,the,0,0
78044,modified,0,0
78045,intent-to-treat,0,0
78046,(,0,0
78047,ITT,0,1
78048,),0,0
78049,analysis,0,0
78050,.,0,0
78051,Thus,0,0
78052,",",0,0
78053,188,0,0
78054,patients,0,0
78055,were,0,0
78056,treated,0,0
78057,and,0,0
78058,included,0,0
78059,in,0,0
78060,the,0,0
78061,ITT,0,1
78062,analysis,0,0
78063,(,0,0
78064,94,0,0
78065,patients,0,0
78066,per,0,0
78067,treatment,0,0
78068,group,0,0
78069,;,0,0
78070,ITT,0,1
78071,analysis,0,0
78072,),0,0
78073,;,0,0
78074,161,0,0
78075,patients,0,0
78076,were,0,0
78077,included,0,0
78078,in,0,0
78079,the,0,0
78080,perprotocol,0,0
78081,(,0,0
78082,PP,0,0
78083,),0,1
78084,analysis,0,0
78085,(,0,0
78086,n,0,0
78087,=,0,0
78088,80,0,0
78089,for,0,0
78090,amlodipine,1,1
78091,camsylate,1,1
78092,",",0,0
78093,n,0,0
78094,=,0,0
78095,81,0,0
78096,for,0,0
78097,amlodipine,1,1
78098,besylate,1,1
78099,),1,1
78100,(,0,0
78101,14,0,0
78102,patients,0,0
78103,in,0,0
78104,the,0,0
78105,amlodipine,1,1
78106,camsylate,1,1
78107,group,0,0
78108,and,0,0
78109,13,0,0
78110,patients,0,0
78111,in,0,0
78112,the,0,0
78113,amlodipine,1,1
78114,besylate,1,1
78115,group,0,0
78116,were,0,0
78117,excluded,0,0
78118,from,0,0
78119,the,0,0
78120,PP,0,0
78121,analysis,0,0
78122,due,0,0
78123,to,0,0
78124,consistent,0,0
78125,withdrawal,0,1
78126,or,0,1
78127,protocol,0,1
78128,violation,0,0
78129,),0,0
78130,.,0,0
78131,Mean,0,0
78132,(,0,0
78133,SD,0,0
78134,),0,1
78135,SiSBP,0,0
78136,and,0,0
78137,SiDBP,0,0
78138,were,0,0
78139,significantly,0,0
78140,decreased,0,0
78141,from,0,0
78142,baseline,0,0
78143,in,0,0
78144,both,0,0
78145,groups,0,0
78146,(,1,0
78147,amlodipine,1,1
78148,camsylate,1,1
78149,",",0,0
78150,from,0,0
78151,146.7,0,0
78152,[,0,0
78153,12.3,0,0
78154,],0,0
78155,/96.6,0,0
78156,[,0,0
78157,5.4,0,0
78158,],0,0
78159,to,0,0
78160,127.9,0,0
78161,[,0,0
78162,14.8,0,0
78163,],0,0
78164,/83.4,0,0
78165,[,0,0
78166,7.7,0,0
78167,],0,0
78168,mm,0,0
78169,Hg,0,0
78170,[,0,0
78171,both,0,0
78172,",",0,0
78173,P,0,0
78174,<,0,0
78175,0.001,0,0
78176,],0,0
78177,;,0,0
78178,amlodipine,1,1
78179,besylate,1,1
78180,",",0,0
78181,from,0,0
78182,146.8,0,0
78183,[,0,0
78184,12.8,0,0
78185,],0,0
78186,/96.7,0,0
78187,[,0,0
78188,5.1,0,0
78189,],0,0
78190,to,0,0
78191,128.0,0,0
78192,[,0,0
78193,10.1,0,0
78194,],0,0
78195,/83.8,0,0
78196,[,0,0
78197,7.5,0,0
78198,],0,0
78199,mm,0,0
78200,Hg,0,0
78201,[,0,0
78202,both,0,0
78203,",",0,0
78204,P,0,0
78205,<,0,0
78206,0.001,0,0
78207,],0,0
78208,),0,0
78209,.,0,0
78210,The,0,0
78211,differences,0,0
78212,in,0,0
78213,SiSBP/SiDBP,0,0
78214,between,0,0
78215,the,0,0
78216,2,0,0
78217,groups,0,0
78218,at,0,0
78219,week,0,0
78220,8,0,0
78221,were,0,0
78222,not,0,0
78223,significant,0,0
78224,.,0,0
78225,The,0,0
78226,SiDBP,0,0
78227,response,0,0
78228,rates,0,0
78229,in,0,0
78230,the,0,0
78231,subgroups,0,0
78232,that,0,0
78233,had,0,0
78234,and,0,0
78235,had,0,0
78236,not,0,0
78237,been,0,0
78238,previously,0,0
78239,treated,0,0
78240,with,0,0
78241,antihypertensives,0,0
78242,were,0,0
78243,statistically,0,0
78244,similar,0,0
78245,(,0,0
78246,56/69,0,0
78247,[,0,0
78248,81.2,0,0
78249,%,0,0
78250,],0,0
78251,and,0,0
78252,83/92,0,0
78253,[,0,0
78254,90.2,0,0
78255,%,0,0
78256,],0,0
78257,",",0,0
78258,respectively,0,0
78259,),0,0
78260,.,0,0
78261,The,0,0
78262,prevalences,0,0
78263,of,0,0
78264,clinical,0,0
78265,adverse,0,0
78266,events,0,0
78267,(,0,0
78268,AEs,0,0
78269,),0,0
78270,were,0,0
78271,not,0,0
78272,significantly,0,0
78273,different,0,0
78274,between,0,0
78275,the,0,0
78276,2,0,0
78277,treatment,0,0
78278,groups,0,0
78279,(,1,0
78280,amlodipine,1,1
78281,camsylate,1,1
78282,",",0,0
78283,27.3,0,0
78284,%,0,0
78285,;,0,0
78286,amlodipine,1,1
78287,besylate,1,1
78288,",",0,0
78289,28.7,0,0
78290,%,0,0
78291,),0,0
78292,.,0,0
78293,The,0,0
78294,most,0,0
78295,common,0,0
78296,AEs,0,0
78297,were,0,0
78298,dizziness,0,0
78299,and,0,0
78300,dyspnea,0,0
78301,(,0,0
78302,both,0,0
78303,in,0,0
78304,3/94,0,0
78305,[,0,0
78306,3.2,0,0
78307,%,0,0
78308,],0,0
78309,and,0,0
78310,1/94,0,0
78311,[,0,0
78312,1.1,0,0
78313,%,0,0
78314,],0,0
78315,patients,0,0
78316,who,0,0
78317,received,0,0
78318,amlodipine,1,1
78319,camsylate,1,1
78320,and,0,0
78321,amlodipine,1,1
78322,besylate,1,1
78323,",",0,0
78324,respectively,0,0
78325,),0,0
78326,.,0,0
78327,CONCLUSION,0,0
78328,The,0,0
78329,effectiveness,0,0
78330,and,0,0
78331,tolerability,0,0
78332,of,0,0
78333,amlodipine,1,1
78334,camsylate,1,1
78335,were,0,0
78336,not,0,0
78337,significantly,0,0
78338,different,0,0
78339,from,0,0
78340,those,0,0
78341,of,0,0
78342,amlodipine,1,1
78343,besylate,1,1
78344,in,0,0
78345,these,0,0
78346,Korean,0,0
78347,adults,0,0
78348,with,0,0
78349,mild,0,0
78350,to,0,0
78351,moderate,0,0
78352,hypertension,0,0
78353,.,0,0
78354,Effect,0,0
78355,of,0,0
78356,a,0,0
78357,ferrule,1,1
78358,and,0,0
78359,increased,0,0
78360,clinical,0,0
78361,crown,0,0
78362,length,0,0
78363,on,0,0
78364,the,0,0
78365,in,0,0
78366,vitro,0,0
78367,fracture,0,0
78368,resistance,0,0
78369,of,0,0
78370,premolars,0,0
78371,restored,0,0
78372,using,0,0
78373,two,0,0
78374,dowel-and-core,0,0
78375,systems,0,0
78376,.,0,0
78377,This,0,0
78378,study,0,0
78379,investigated,0,0
78380,the,0,0
78381,effect,0,0
78382,of,0,0
78383,a,0,0
78384,crown-lengthening,1,0
78385,ferrule,1,1
78386,on,0,0
78387,the,0,0
78388,fracture,0,0
78389,resistance,0,0
78390,of,0,0
78391,endodontically-treated,0,0
78392,teeth,0,0
78393,restored,0,0
78394,with,0,0
78395,two,0,0
78396,dowel-core,0,0
78397,systems,0,0
78398,.,0,0
78399,Thirty-two,0,0
78400,extracted,0,0
78401,mandibular,0,0
78402,first,0,0
78403,premolars,0,0
78404,were,0,0
78405,sectioned,0,0
78406,perpendicular,0,0
78407,to,0,0
78408,the,0,0
78409,long,0,0
78410,axis,0,0
78411,at,0,0
78412,a,0,0
78413,point,0,0
78414,1.0,0,0
78415,mm,0,0
78416,occlusal,0,1
78417,to,0,0
78418,the,0,0
78419,buccal,0,1
78420,cementoenamel,0,0
78421,junction,0,0
78422,.,0,0
78423,Following,0,0
78424,endodontic,0,0
78425,treatment,0,0
78426,",",0,0
78427,the,0,0
78428,teeth,0,0
78429,were,0,0
78430,randomly,0,0
78431,assigned,0,0
78432,to,0,0
78433,four,0,0
78434,groups,0,0
78435,:,0,0
78436,cast,1,1
78437,Ni-Cr,1,0
78438,alloy,1,1
78439,dowel-core,1,1
78440,with,1,0
78441,no,1,0
78442,ferrule,1,1
78443,(,1,0
78444,Group,1,0
78445,A1,1,1
78446,),1,0
78447,",",1,0
78448,cast,1,1
78449,Ni-Cr,1,0
78450,alloy,1,1
78451,dowel-core,1,1
78452,with,1,0
78453,2.0,1,0
78454,mm,1,0
78455,ferrule,1,1
78456,(,1,0
78457,Group,1,0
78458,A2,1,1
78459,),1,0
78460,",",1,0
78461,prefabricated,1,1
78462,carbon,1,1
78463,fiber-reinforced,1,1
78464,dowel-resin,1,1
78465,core,1,0
78466,with,1,0
78467,no,1,0
78468,ferrule,1,1
78469,(,1,0
78470,Group,1,0
78471,B1,1,1
78472,),1,0
78473,and,0,0
78474,carbon,1,1
78475,fiber-reinforced,1,1
78476,dowel-resin,1,1
78477,core,1,0
78478,with,1,0
78479,2.0,1,0
78480,mm,1,0
78481,ferrule,1,1
78482,(,0,0
78483,Group,0,0
78484,B2,0,1
78485,),0,0
78486,.,0,0
78487,Each,0,0
78488,specimen,0,0
78489,was,0,0
78490,embedded,0,0
78491,in,0,0
78492,a,0,0
78493,self-cured,0,0
78494,acrylic,0,1
78495,resin,0,1
78496,block,0,0
78497,from,0,0
78498,2.0,0,0
78499,mm,0,0
78500,apical,0,0
78501,to,0,0
78502,the,0,0
78503,margins,0,0
78504,of,0,0
78505,a,0,0
78506,cast,0,1
78507,Ni-Cr,0,0
78508,alloy,0,1
78509,crown,0,0
78510,",",0,0
78511,then,0,0
78512,loaded,0,0
78513,at,0,0
78514,150,0,0
78515,degrees,0,0
78516,from,0,0
78517,the,0,0
78518,long,0,0
78519,axis,0,0
78520,in,0,0
78521,a,0,0
78522,universal,0,0
78523,testing,0,0
78524,machine,0,1
78525,at,0,0
78526,a,0,0
78527,crosshead,0,1
78528,speed,0,0
78529,of,0,0
78530,1.0,0,0
78531,mm/minute,0,0
78532,until,0,0
78533,fracture,0,0
78534,.,0,0
78535,The,0,0
78536,data,0,0
78537,were,0,0
78538,recorded,0,0
78539,and,0,0
78540,analyzed,0,0
78541,using,0,0
78542,ANOVA,0,1
78543,and,0,0
78544,Fisher,0,1
78545,'s,0,0
78546,exact,0,0
78547,tests,0,0
78548,",",0,0
78549,with,0,0
78550,alpha,0,0
78551,=,0,0
78552,0.05,0,0
78553,.,0,0
78554,Mean,0,0
78555,failure,0,0
78556,loads,0,0
78557,(,0,0
78558,kN,0,0
78559,),0,0
78560,for,0,0
78561,the,0,0
78562,A1,0,0
78563,",",0,0
78564,A2,0,0
78565,",",0,0
78566,B1,0,1
78567,and,0,0
78568,B2,0,1
78569,Groups,0,0
78570,were,0,0
78571,:,0,0
78572,1.46,0,0
78573,(,0,0
78574,S.D,0,0
78575,.,0,0
78576,0.45,0,0
78577,),0,0
78578,",",0,0
78579,1.07,0,0
78580,(,0,0
78581,0.21,0,0
78582,),0,0
78583,",",0,0
78584,1.13,0,0
78585,(,0,0
78586,0.30,0,0
78587,),0,0
78588,and,0,0
78589,1.02,0,0
78590,(,0,0
78591,0.27,0,0
78592,),0,0
78593,.,0,0
78594,The,0,0
78595,teeth,0,0
78596,restored,0,0
78597,with,0,0
78598,cast,1,0
78599,Ni-Cr,1,0
78600,dowel-cores,1,1
78601,and,1,0
78602,2.0,1,0
78603,mm,1,0
78604,ferrules,1,1
78605,demonstrated,0,0
78606,significantly,0,0
78607,lower,0,0
78608,fracture,0,0
78609,strengths,0,0
78610,",",0,0
78611,p,0,0
78612,=,0,0
78613,0.04,0,0
78614,.,0,0
78615,There,0,0
78616,were,0,0
78617,significant,0,0
78618,differences,0,0
78619,in,0,0
78620,the,0,0
78621,root,0,0
78622,fracture,0,0
78623,patterns,0,0
78624,between,0,0
78625,the,0,0
78626,two,0,0
78627,dowel,0,1
78628,systems,0,0
78629,",",0,0
78630,with,0,0
78631,the,0,0
78632,carbon,1,1
78633,fiber-reinforced,1,1
78634,dowel-resin,1,1
78635,core,1,0
78636,system,1,1
78637,",",0,0
78638,being,0,0
78639,the,0,0
78640,less,0,0
78641,severe,0,0
78642,p,0,0
78643,<,0,0
78644,0.05,0,0
78645,.,0,0
78646,Crown,1,0
78647,lengthening,1,0
78648,with,0,0
78649,a,0,0
78650,2.0,1,0
78651,mm,1,0
78652,apical,1,0
78653,extended,1,1
78654,ferrule,1,1
78655,resulted,0,0
78656,in,0,0
78657,reduced,0,0
78658,fracture,0,0
78659,strengths,0,0
78660,for,0,0
78661,endodontically-treated,0,0
78662,teeth,0,0
78663,restored,0,0
78664,using,0,0
78665,two,0,0
78666,dowel-core,0,1
78667,systems,0,0
78668,and,0,0
78669,cast,0,1
78670,metal,0,0
78671,crowns,0,1
78672,.,0,0
78673,The,0,0
78674,carbon,0,1
78675,fiber-reinforced,0,1
78676,dowel-resin,0,1
78677,core,0,0
78678,system,0,0
78679,reduced,0,0
78680,the,0,0
78681,severity,0,0
78682,of,0,0
78683,the,0,0
78684,root,0,0
78685,fractures,0,0
78686,.,0,0
78687,Comparison,0,0
78688,with,0,0
78689,computed,1,0
78690,tomography,1,1
78691,of,0,0
78692,two,0,0
78693,ultrasound,0,1
78694,devices,0,0
78695,for,0,0
78696,diagnosis,0,0
78697,of,0,0
78698,abdominal,0,0
78699,aortic,0,0
78700,aneurysm,0,0
78701,.,0,0
78702,Screening,0,0
78703,for,0,0
78704,abdominal,0,0
78705,aortic,0,0
78706,aneurysms,0,0
78707,(,0,0
78708,AAAs,0,1
78709,),0,0
78710,in,0,0
78711,patients,0,0
78712,at,0,0
78713,risk,0,0
78714,will,0,0
78715,become,0,0
78716,more,0,0
78717,cost,0,0
78718,effective,0,0
78719,if,0,0
78720,a,0,0
78721,simple,0,0
78722,",",0,0
78723,inexpensive,0,0
78724,",",0,0
78725,and,0,0
78726,reliable,0,0
78727,ultrasound,0,1
78728,device,0,1
78729,is,0,0
78730,available,0,0
78731,.,0,0
78732,The,0,0
78733,aim,0,0
78734,of,0,0
78735,this,0,0
78736,study,0,0
78737,was,0,0
78738,to,0,0
78739,compare,0,0
78740,a,0,0
78741,2-dimensional,0,0
78742,",",0,0
78743,handheld,1,1
78744,ultrasound,1,1
78745,device,1,1
78746,and,0,0
78747,a,0,0
78748,newly,0,0
78749,developed,0,0
78750,ultrasound,1,1
78751,volume,1,0
78752,scanner,1,1
78753,(,0,0
78754,based,0,0
78755,on,0,0
78756,bladder,0,0
78757,scan,0,1
78758,technology,0,1
78759,),0,0
78760,with,0,0
78761,computed,1,1
78762,tomography,1,1
78763,(,1,0
78764,CT,1,0
78765,),1,0
78766,for,0,0
78767,diagnosing,0,0
78768,AAA,0,1
78769,.,0,0
78770,A,0,0
78771,total,0,0
78772,of,0,0
78773,146,0,0
78774,patients,0,0
78775,(,0,0
78776,mean,0,0
78777,age,0,0
78778,69,0,0
78779,+/-,0,0
78780,10,0,0
78781,years,0,0
78782,;,0,0
78783,127,0,0
78784,men,0,0
78785,),0,0
78786,were,0,0
78787,screened,0,0
78788,for,0,0
78789,the,0,0
78790,presence,0,0
78791,of,0,0
78792,AAAs,0,1
78793,(,0,0
78794,diameter,0,0
78795,>,0,0
78796,3,0,0
78797,cm,0,0
78798,),0,0
78799,using,0,0
78800,CT.,0,1
78801,All,0,0
78802,patients,0,0
78803,were,0,0
78804,examined,0,0
78805,with,0,0
78806,the,0,0
78807,handheld,0,1
78808,ultrasound,0,1
78809,device,0,1
78810,and,0,0
78811,the,0,0
78812,volume,0,0
78813,scanner,0,1
78814,.,0,0
78815,Maximal,0,0
78816,diameters,0,0
78817,and,0,0
78818,volumes,0,0
78819,were,0,0
78820,used,0,0
78821,for,0,0
78822,the,0,0
78823,analyses,0,0
78824,.,0,0
78825,AAAs,0,0
78826,were,0,0
78827,diagnosed,0,0
78828,by,0,0
78829,CT,1,0
78830,in,0,0
78831,116,0,0
78832,patients,0,0
78833,(,0,0
78834,80,0,0
78835,%,0,0
78836,),0,0
78837,.,0,0
78838,The,0,0
78839,absolute,0,0
78840,difference,0,0
78841,of,0,0
78842,aortic,0,0
78843,diameter,0,0
78844,between,0,0
78845,ultrasound,1,1
78846,and,0,0
78847,CT,1,0
78848,was,0,0
78849,<,0,0
78850,5,0,0
78851,mm,0,0
78852,in,0,0
78853,88,0,0
78854,%,0,0
78855,of,0,0
78856,patients,0,0
78857,.,0,0
78858,Limits,0,0
78859,of,0,0
78860,agreement,0,0
78861,between,0,0
78862,ultrasound,0,1
78863,and,0,0
78864,CT,1,1
78865,(,0,0
78866,-6.6,0,0
78867,to,0,0
78868,9.4,0,0
78869,mm,0,0
78870,),0,0
78871,exceeded,0,0
78872,the,0,0
78873,limits,0,0
78874,of,0,0
78875,clinical,0,0
78876,acceptability,0,0
78877,(,0,0
78878,+/-5,0,0
78879,mm,0,0
78880,),0,0
78881,.,0,0
78882,An,0,0
78883,excellent,0,0
78884,correlation,0,0
78885,between,0,0
78886,ultrasound,1,1
78887,and,0,0
78888,CT,1,0
78889,was,0,0
78890,observed,0,0
78891,(,0,0
78892,r,0,0
78893,=,0,0
78894,0.98,0,0
78895,),0,0
78896,.,0,0
78897,The,0,0
78898,correlation,0,0
78899,coefficient,0,0
78900,between,0,0
78901,the,0,0
78902,volume,0,0
78903,scanner,0,1
78904,and,0,0
78905,CT,1,0
78906,was,0,0
78907,0.86,0,0
78908,",",0,0
78909,with,0,0
78910,agreement,0,0
78911,of,0,0
78912,90,0,0
78913,%,0,0
78914,and,0,0
78915,kappa,0,0
78916,value,0,0
78917,of,0,0
78918,0.73,0,0
78919,.,0,0
78920,Using,0,0
78921,an,0,0
78922,optimal,0,0
78923,cut-off,0,0
78924,value,0,0
78925,of,0,0
78926,>,0,0
78927,56,0,0
78928,ml,0,0
78929,",",0,0
78930,defined,0,0
78931,by,0,0
78932,receiver-operating,0,0
78933,characteristic,0,0
78934,curve,0,0
78935,analysis,0,0
78936,",",0,0
78937,sensitivity,0,0
78938,",",0,0
78939,specificity,0,0
78940,",",0,0
78941,and,0,0
78942,the,0,0
78943,positive,0,0
78944,and,0,0
78945,negative,0,0
78946,predictive,0,0
78947,values,0,0
78948,of,0,0
78949,the,0,0
78950,volume,0,0
78951,scanner,0,1
78952,for,0,0
78953,detecting,0,0
78954,AAA,0,1
78955,were,0,0
78956,90,0,0
78957,%,0,0
78958,",",0,0
78959,90,0,0
78960,%,0,0
78961,",",0,0
78962,97,0,0
78963,%,0,0
78964,",",0,0
78965,and,0,0
78966,71,0,0
78967,%,0,0
78968,",",0,0
78969,respectively,0,0
78970,.,0,0
78971,In,0,0
78972,conclusion,0,0
78973,",",0,0
78974,this,0,0
78975,study,0,0
78976,shows,0,0
78977,that,0,0
78978,a,0,0
78979,2-dimensional,0,0
78980,",",0,0
78981,handheld,0,1
78982,ultrasound,0,1
78983,device,0,1
78984,and,0,0
78985,a,0,0
78986,newly,0,0
78987,developed,0,0
78988,ultrasound,0,1
78989,volume,0,0
78990,scanner,0,1
78991,can,0,0
78992,effectively,0,0
78993,identify,0,0
78994,patients,0,0
78995,with,0,0
78996,AAAs,0,1
78997,confirmed,0,0
78998,by,0,0
78999,CT,0,0
79000,.,0,0
79001,The,0,0
79002,cost-effectiveness,0,0
79003,of,0,0
79004,parasitologic,0,0
79005,diagnosis,0,0
79006,for,0,0
79007,malaria-suspected,0,0
79008,patients,0,0
79009,in,0,0
79010,an,0,0
79011,era,0,0
79012,of,0,0
79013,combination,0,1
79014,therapy,0,1
79015,.,0,0
79016,The,0,0
79017,introduction,0,0
79018,of,0,0
79019,artemisinin-based,1,1
79020,combination,1,1
79021,therapy,1,1
79022,in,0,0
79023,sub-Saharan,0,0
79024,Africa,0,0
79025,has,0,0
79026,prompted,0,0
79027,calls,0,0
79028,for,0,0
79029,increased,0,0
79030,use,0,0
79031,of,0,0
79032,parasitologic,0,0
79033,diagnosis,0,0
79034,for,0,0
79035,malaria,0,0
79036,.,0,0
79037,We,0,0
79038,evaluated,0,0
79039,the,0,0
79040,cost-effectiveness,0,0
79041,of,0,0
79042,rapid,1,0
79043,diagnostic,1,0
79044,tests,1,0
79045,(,1,0
79046,RDTs,1,1
79047,),1,0
79048,in,0,0
79049,comparison,0,0
79050,to,0,0
79051,microscopy,1,1
79052,in,0,0
79053,guiding,0,0
79054,treatment,0,0
79055,of,0,0
79056,non-severe,0,0
79057,febrile,0,0
79058,illness,0,0
79059,at,0,0
79060,varying,0,0
79061,levels,0,0
79062,of,0,0
79063,malaria,0,1
79064,endemicity,0,0
79065,using,0,0
79066,data,0,0
79067,on,0,0
79068,test,0,0
79069,accuracy,0,0
79070,and,0,0
79071,costs,0,0
79072,collected,0,0
79073,as,0,0
79074,part,0,0
79075,of,0,0
79076,a,0,0
79077,Tanzanian,0,0
79078,trial,0,0
79079,.,0,0
79080,If,0,0
79081,prescribers,0,0
79082,complied,0,0
79083,with,0,0
79084,current,0,0
79085,guidelines,0,0
79086,",",0,0
79087,microscopy,0,0
79088,would,0,0
79089,give,0,0
79090,rise,0,0
79091,to,0,0
79092,lower,0,0
79093,average,0,0
79094,costs,0,0
79095,per,0,0
79096,patient,0,0
79097,correctly,0,0
79098,treated,0,0
79099,than,0,0
79100,RDTs,1,1
79101,in,0,0
79102,areas,0,0
79103,of,0,0
79104,both,0,0
79105,high,0,0
79106,and,0,0
79107,low,0,0
79108,transmission,0,0
79109,.,0,0
79110,RDT,0,0
79111,introduction,0,0
79112,would,0,0
79113,result,0,0
79114,in,0,0
79115,an,0,0
79116,additional,0,0
79117,2.3,0,0
79118,%,0,0
79119,and,0,0
79120,9.4,0,0
79121,%,0,0
79122,of,0,0
79123,patients,0,0
79124,correctly,0,0
79125,treated,0,0
79126,",",0,0
79127,at,0,0
79128,an,0,0
79129,incremental,0,0
79130,cost,0,0
79131,of,0,0
79132,$,0,0
79133,25,0,0
79134,and,0,0
79135,$,0,0
79136,7,0,0
79137,in,0,0
79138,the,0,0
79139,low,0,0
79140,and,0,0
79141,high,0,0
79142,transmission,0,0
79143,settings,0,0
79144,",",0,0
79145,respectively,0,0
79146,.,0,0
79147,Cost-effectiveness,0,0
79148,would,0,0
79149,be,0,0
79150,worse,0,0
79151,if,0,0
79152,prescribers,0,0
79153,do,0,0
79154,not,0,0
79155,comply,0,0
79156,with,0,0
79157,test,0,0
79158,results,0,0
79159,.,0,0
79160,The,0,0
79161,cost,0,0
79162,of,0,0
79163,this,0,0
79164,additional,0,0
79165,benefit,0,0
79166,may,0,0
79167,be,0,0
79168,higher,0,0
79169,than,0,0
79170,many,0,0
79171,countries,0,0
79172,can,0,0
79173,afford,0,0
79174,without,0,0
79175,external,0,1
79176,assistance,0,0
79177,or,0,0
79178,lower,0,0
79179,RDT,0,0
79180,prices,0,0
79181,.,0,0
79182,Impact,0,0
79183,of,0,0
79184,a,0,0
79185,controlled,1,0
79186,heated,1,1
79187,breathing,1,1
79188,tube,1,1
79189,humidifier,1,1
79190,on,0,0
79191,sleep,0,0
79192,quality,0,0
79193,during,0,0
79194,CPAP,1,1
79195,therapy,1,1
79196,in,0,0
79197,a,0,0
79198,cool,0,0
79199,sleeping,0,0
79200,environment,0,0
79201,.,0,0
79202,There,0,0
79203,are,0,0
79204,conflicting,0,0
79205,data,0,0
79206,on,0,0
79207,the,0,0
79208,effect,0,0
79209,of,0,0
79210,adding,0,0
79211,a,0,0
79212,heated,1,1
79213,humidifier,1,1
79214,to,0,0
79215,nasal,0,0
79216,continuous,1,1
79217,positive,1,0
79218,airway,1,0
79219,pressure,1,0
79220,(,1,0
79221,CPAP,1,1
79222,),1,0
79223,therapy,1,1
79224,for,0,0
79225,patients,0,0
79226,with,0,0
79227,obstructive,0,0
79228,sleep,0,0
79229,apnoea,0,1
79230,syndrome,0,0
79231,(,0,0
79232,OSAS,0,1
79233,),0,0
79234,.,0,0
79235,The,0,0
79236,effects,0,0
79237,of,0,0
79238,heated,0,1
79239,humidification,0,1
79240,on,0,0
79241,sleep,0,0
79242,quality,0,0
79243,and,0,0
79244,treatment,0,0
79245,side-effects,0,0
79246,for,0,0
79247,patients,0,0
79248,who,0,0
79249,prefer,0,0
79250,a,0,0
79251,cold,0,1
79252,bedroom,0,1
79253,environment,0,0
79254,have,0,0
79255,not,0,0
79256,been,0,0
79257,studied,0,0
79258,.,0,0
79259,A,0,0
79260,randomised,0,0
79261,",",0,0
79262,controlled,0,0
79263,crossover,0,0
79264,trial,0,0
79265,involving,0,0
79266,19,0,0
79267,patients,0,0
79268,with,0,0
79269,a,0,0
79270,first-ever,0,0
79271,diagnosis,0,0
79272,of,0,0
79273,OSAS,0,0
79274,measured,0,0
79275,the,0,0
79276,effect,0,0
79277,of,0,0
79278,conventional,1,1
79279,heated,1,1
79280,humidification,1,1
79281,added,1,0
79282,to,1,0
79283,CPAP,1,1
79284,compared,0,0
79285,with,0,0
79286,a,0,0
79287,controlled,1,0
79288,heated,1,1
79289,breathing,1,1
79290,tube,1,1
79291,humidifier,1,1
79292,(,1,1
79293,ThermoSmart,1,1
79294,(,1,1
79295,R,1,0
79296,),1,0
79297,;,1,0
79298,Fisher,0,1
79299,and,0,0
79300,Paykel,0,1
79301,Healthcare,0,0
79302,",",0,0
79303,Auckland,0,0
79304,",",0,0
79305,New,0,0
79306,Zealand,0,0
79307,),0,0
79308,on,0,0
79309,sleep,0,0
79310,quality,0,0
79311,.,0,0
79312,During,0,0
79313,the,0,0
79314,night,0,0
79315,in,0,0
79316,the,0,0
79317,sleep,0,0
79318,laboratory,0,0
79319,at,0,0
79320,a,0,0
79321,mean,0,0
79322,room,0,0
79323,temperature,0,0
79324,of,0,0
79325,14,0,0
79326,degrees,0,0
79327,C,0,0
79328,",",0,0
79329,less,0,0
79330,condensation,0,0
79331,formed,0,0
79332,with,0,0
79333,the,0,0
79334,controlled,1,0
79335,heated,1,1
79336,breathing,1,1
79337,tube,1,1
79338,humidifier,1,1
79339,(,0,0
79340,1.9,0,0
79341,mL,0,0
79342,versus,0,0
79343,35.3,0,0
79344,mL,0,0
79345,),0,0
79346,in,0,0
79347,the,0,0
79348,delivery,0,0
79349,system,0,0
79350,.,0,0
79351,In,0,0
79352,addition,0,0
79353,",",0,0
79354,the,0,0
79355,total,0,0
79356,sleep,0,0
79357,time,0,0
79358,",",0,0
79359,time,0,0
79360,spent,0,0
79361,in,0,0
79362,sleep,0,0
79363,stages,0,0
79364,3,0,0
79365,and,0,0
79366,4,0,0
79367,",",0,0
79368,and,0,0
79369,rapid,0,0
79370,eye,0,1
79371,movement,0,0
79372,sleep,0,0
79373,phases,0,0
79374,were,0,0
79375,significantly,0,0
79376,longer,0,0
79377,and,0,0
79378,the,0,0
79379,overall,0,0
79380,side-effect,0,0
79381,score,0,0
79382,was,0,0
79383,lower,0,0
79384,than,0,0
79385,with,0,0
79386,conventional,0,1
79387,heated,0,1
79388,humidification,0,1
79389,.,0,0
79390,Patients,0,0
79391,on,0,0
79392,nasal,0,0
79393,continuous,0,1
79394,positive,0,0
79395,airway,0,0
79396,pressure,0,0
79397,desiring,0,0
79398,a,0,0
79399,cool,0,1
79400,bedroom,0,1
79401,temperature,0,0
79402,could,0,0
79403,benefit,0,0
79404,from,0,0
79405,controlled,1,0
79406,heated,1,1
79407,breathing,1,0
79408,tube,1,1
79409,humidification,1,1
79410,technology,1,1
79411,(,0,0
79412,with,0,0
79413,inputs,0,0
79414,from,0,0
79415,ambient,0,1
79416,temperature,0,0
79417,",",0,0
79418,set,0,0
79419,pressure,0,0
79420,and,0,0
79421,flow,0,0
79422,),0,0
79423,.,0,0
79424,Randomized,0,0
79425,",",0,0
79426,comparative,0,0
79427,study,0,0
79428,of,0,0
79429,the,0,0
79430,efficacy,0,0
79431,and,0,0
79432,safety,0,0
79433,of,0,0
79434,artesunate,1,1
79435,plus,1,1
79436,amodiaquine,1,1
79437,",",0,0
79438,administered,0,0
79439,as,0,0
79440,a,0,0
79441,single,0,0
79442,daily,0,0
79443,intake,0,0
79444,versus,0,0
79445,two,0,0
79446,daily,0,0
79447,intakes,0,0
79448,in,0,0
79449,the,0,0
79450,treatment,0,0
79451,of,0,0
79452,uncomplicated,0,0
79453,falciparum,0,0
79454,malaria,0,1
79455,.,0,0
79456,BACKGROUND,0,0
79457,Artesunate,1,1
79458,plus,1,1
79459,amodiaquine,1,1
79460,is,0,0
79461,a,0,0
79462,coblistered,0,0
79463,ACT,0,0
79464,",",0,0
79465,given,0,0
79466,as,0,0
79467,a,0,0
79468,single,0,0
79469,daily,0,0
79470,intake,0,0
79471,.,0,0
79472,It,0,0
79473,has,0,0
79474,been,0,0
79475,suggested,0,0
79476,that,0,0
79477,",",0,0
79478,in,0,0
79479,view,0,0
79480,of,0,0
79481,the,0,0
79482,number,0,0
79483,of,0,0
79484,tablets,0,1
79485,to,0,0
79486,be,0,0
79487,taken,0,0
79488,(,0,0
79489,particularly,0,0
79490,in,0,0
79491,adults,0,0
79492,),0,0
79493,",",0,0
79494,it,0,0
79495,may,0,0
79496,be,0,0
79497,possible,0,0
79498,to,0,0
79499,improve,0,0
79500,compliance,0,0
79501,by,0,0
79502,allowing,0,0
79503,patients,0,0
79504,to,0,0
79505,divide,0,0
79506,the,0,0
79507,daily,0,0
79508,dose,0,0
79509,.,0,0
79510,The,0,0
79511,objectives,0,0
79512,of,0,0
79513,this,0,0
79514,randomized,0,0
79515,",",0,0
79516,comparative,0,0
79517,",",0,0
79518,open-label,0,0
79519,",",0,0
79520,multicentre,0,0
79521,study,0,0
79522,",",0,0
79523,conducted,0,0
79524,in,0,0
79525,Senegal,0,0
79526,and,0,0
79527,in,0,0
79528,Cameroon,0,1
79529,in,0,0
79530,2005,0,0
79531,",",0,0
79532,was,0,0
79533,to,0,0
79534,demonstrate,0,0
79535,the,0,0
79536,non-inferiority,0,0
79537,and,0,0
79538,to,0,0
79539,compare,0,0
79540,the,0,0
79541,safety,0,0
79542,of,0,0
79543,artesunate,1,1
79544,plus,1,1
79545,amodiaquine,1,1
79546,",",0,0
79547,as,0,0
79548,a,0,0
79549,single,0,0
79550,daily,0,0
79551,intake,0,0
79552,versus,0,0
79553,two,0,0
79554,daily,0,0
79555,intakes,0,0
79556,.,0,0
79557,METHODS,0,0
79558,A,0,0
79559,three-day,0,0
79560,treatment,0,0
79561,period,0,0
79562,and,0,0
79563,14-day,0,0
79564,follow-up,0,0
79565,period,0,0
79566,was,0,0
79567,performed,0,0
79568,in,0,0
79569,any,0,0
79570,subject,0,0
79571,weighting,0,0
79572,more,0,0
79573,than,0,0
79574,10,0,0
79575,kg,0,0
79576,",",0,0
79577,presenting,0,0
79578,with,0,0
79579,a,0,0
79580,malaria,0,1
79581,paroxysm,0,0
79582,confirmed,0,0
79583,by,0,0
79584,parasitaemia,0,0
79585,>,0,0
79586,or,0,0
79587,=,0,0
79588,"1,000/microl",0,0
79589,",",0,0
79590,after,0,0
79591,informed,0,0
79592,consent,0,0
79593,.,0,0
79594,Patients,0,0
79595,were,0,0
79596,randomly,0,0
79597,allocated,0,0
79598,into,0,0
79599,one,0,0
79600,of,0,0
79601,the,0,0
79602,two,0,0
79603,regimens,0,0
79604,",",0,0
79605,with,0,0
79606,dosage,0,0
79607,according,0,0
79608,to,0,0
79609,bodyweight,0,1
79610,range,0,0
79611,.,0,0
79612,All,0,0
79613,products,0,0
79614,were,0,0
79615,administered,0,0
79616,by,0,0
79617,an,0,0
79618,authorized,0,0
79619,person,0,0
79620,",",0,0
79621,blinded,0,0
79622,to,0,0
79623,both,0,0
79624,the,0,0
79625,investigating,0,0
79626,physician,0,0
79627,and,0,0
79628,the,0,0
79629,biologist,0,1
79630,.,0,0
79631,The,0,0
79632,primary,0,0
79633,endpoint,0,0
79634,was,0,0
79635,an,0,0
79636,adequate,0,0
79637,response,0,0
79638,to,0,0
79639,treatment,0,0
79640,on,0,0
79641,D14,0,1
79642,(,0,0
79643,WHO,0,1
79644,definition,0,0
79645,),0,0
79646,.,0,0
79647,The,0,0
79648,two-sided,0,0
79649,90,0,0
79650,%,0,0
79651,confidence,0,0
79652,interval,0,0
79653,of,0,0
79654,the,0,0
79655,difference,0,0
79656,was,0,0
79657,calculated,0,0
79658,on,0,0
79659,intent,0,0
79660,to,0,0
79661,treat,0,0
79662,(,0,0
79663,ITT,0,1
79664,),0,0
79665,population,0,0
79666,;,0,0
79667,the,0,0
79668,acceptance,0,0
79669,limit,0,0
79670,for,0,0
79671,non-inferiority,0,0
79672,was,0,0
79673,3,0,0
79674,%,0,0
79675,.,0,0
79676,The,0,0
79677,safety,0,0
79678,was,0,0
79679,evaluated,0,0
79680,by,0,0
79681,incidence,0,0
79682,of,0,0
79683,adverse,0,0
79684,events,0,0
79685,.,0,0
79686,RESULTS,0,0
79687,Three-hundred,0,0
79688,and,0,0
79689,sixteen,0,0
79690,patients,0,0
79691,were,0,0
79692,included,0,0
79693,in,0,0
79694,the,0,0
79695,study,0,0
79696,.,0,0
79697,The,0,0
79698,two,0,0
79699,patient,0,0
79700,groups,0,0
79701,were,0,0
79702,strictly,0,0
79703,comparable,0,0
79704,on,0,0
79705,D0,0,1
79706,.,0,0
79707,The,0,0
79708,adequate,0,0
79709,responses,0,0
79710,to,0,0
79711,treatment,0,0
79712,were,0,0
79713,similar,0,0
79714,for,0,0
79715,the,0,0
79716,two,0,0
79717,treatment,0,0
79718,regimens,0,0
79719,on,0,0
79720,D14,0,0
79721,",",0,0
79722,PCR-corrected,0,1
79723,(,0,0
79724,"99,4",0,0
79725,%,0,0
79726,in,0,0
79727,the,0,0
79728,one-daily,0,1
79729,intake,0,0
79730,group,0,0
79731,versus,0,0
79732,"99,3",0,0
79733,%,0,0
79734,in,0,0
79735,the,0,0
79736,comparative,0,0
79737,group,0,0
79738,),0,0
79739,.,0,0
79740,The,0,0
79741,statistical,0,0
79742,analyses,0,0
79743,demonstrated,0,0
79744,the,0,0
79745,non-inferiority,0,0
79746,of,0,0
79747,administering,0,0
79748,artesunate/amodiaquine,0,1
79749,as,0,0
79750,two,0,0
79751,intakes,0,0
79752,.,0,0
79753,The,0,0
79754,drug,0,0
79755,was,0,0
79756,well,0,0
79757,tolerated,0,0
79758,.,0,0
79759,The,0,0
79760,main,0,0
79761,adverse,0,0
79762,events,0,0
79763,were,0,0
79764,gastrointestinal,0,0
79765,disorders,0,0
79766,(,0,0
79767,2.5,0,0
79768,%,0,0
79769,),0,0
79770,and,0,0
79771,pruritus,0,0
79772,(,0,0
79773,2.5,0,0
79774,%,0,0
79775,),0,0
79776,;,0,0
79777,safety,0,0
79778,profiles,0,0
79779,were,0,0
79780,similar,0,0
79781,in,0,0
79782,the,0,0
79783,two,0,0
79784,groups,0,0
79785,.,0,0
79786,CONCLUSION,0,0
79787,This,0,0
79788,pilot,0,0
79789,study,0,0
79790,confirms,0,0
79791,the,0,0
79792,efficacy,0,0
79793,and,0,0
79794,good,0,0
79795,tolerability,0,0
79796,of,0,0
79797,artesunate,0,1
79798,plus,0,1
79799,amodiaquine,1,1
79800,",",0,0
79801,administrated,0,0
79802,either,0,0
79803,in,0,0
79804,one,0,0
79805,or,0,0
79806,in,0,0
79807,two,0,0
79808,daily,0,0
79809,intakes,0,0
79810,.,0,0
79811,Osteosarcoma,0,0
79812,:,0,0
79813,the,0,0
79814,addition,0,0
79815,of,0,0
79816,muramyl,1,0
79817,tripeptide,1,0
79818,to,0,0
79819,chemotherapy,0,1
79820,improves,0,0
79821,overall,0,0
79822,survival,0,0
79823,--,0,0
79824,a,0,0
79825,report,0,0
79826,from,0,0
79827,the,0,0
79828,Children,0,0
79829,'s,0,0
79830,Oncology,0,0
79831,Group,0,0
79832,.,0,0
79833,PURPOSE,0,0
79834,To,0,0
79835,compare,0,0
79836,three-drug,0,1
79837,chemotherapy,0,1
79838,with,0,0
79839,cisplatin,1,1
79840,",",1,0
79841,doxorubicin,1,1
79842,",",1,0
79843,and,1,0
79844,methotrexate,1,1
79845,with,0,0
79846,four-drug,1,1
79847,chemotherapy,1,1
79848,with,1,0
79849,cisplatin,1,1
79850,",",1,0
79851,doxorubicin,1,1
79852,",",1,0
79853,methotrexate,1,1
79854,",",1,0
79855,and,1,0
79856,ifosfamide,1,1
79857,for,0,0
79858,the,0,0
79859,treatment,0,0
79860,of,0,0
79861,osteosarcoma,0,0
79862,.,0,0
79863,To,0,0
79864,determine,0,0
79865,whether,0,0
79866,the,0,0
79867,addition,0,0
79868,of,0,0
79869,muramyl,1,1
79870,tripeptide,1,1
79871,(,1,0
79872,MTP,1,1
79873,),1,0
79874,to,0,0
79875,chemotherapy,0,1
79876,enhances,0,0
79877,event-free,0,0
79878,survival,0,0
79879,(,0,0
79880,EFS,0,0
79881,),0,1
79882,and,0,0
79883,overall,0,0
79884,survival,0,0
79885,in,0,0
79886,newly,0,0
79887,diagnosed,0,0
79888,patients,0,0
79889,with,0,0
79890,osteosarcoma,0,0
79891,.,0,0
79892,PATIENTS,0,0
79893,AND,0,0
79894,METHODS,0,0
79895,Six,0,1
79896,hundred,0,0
79897,sixty-two,0,0
79898,patients,0,0
79899,with,0,0
79900,osteosarcoma,0,0
79901,without,0,0
79902,clinically,0,0
79903,detectable,0,0
79904,metastatic,0,0
79905,disease,0,0
79906,and,0,0
79907,whose,0,0
79908,disease,0,0
79909,was,0,0
79910,considered,0,0
79911,resectable,0,0
79912,received,0,0
79913,one,0,0
79914,of,0,0
79915,four,0,0
79916,prospectively,0,0
79917,randomized,0,0
79918,treatments,0,0
79919,.,0,0
79920,All,0,0
79921,patients,0,0
79922,received,0,0
79923,identical,0,0
79924,cumulative,0,0
79925,doses,0,0
79926,of,0,0
79927,cisplatin,1,1
79928,",",1,0
79929,doxorubicin,1,1
79930,",",1,0
79931,and,1,0
79932,methotrexate,1,1
79933,and,0,0
79934,underwent,0,0
79935,definitive,0,0
79936,surgical,0,0
79937,resection,0,1
79938,of,0,0
79939,primary,0,0
79940,tumor,0,0
79941,.,0,0
79942,Patients,0,0
79943,were,0,0
79944,randomly,0,0
79945,assigned,0,0
79946,to,0,0
79947,receive,0,0
79948,or,0,0
79949,not,0,0
79950,to,0,0
79951,receive,1,0
79952,ifosfamide,1,1
79953,and/or,1,0
79954,MTP,1,1
79955,in,0,0
79956,a,0,0
79957,2,0,0
79958,x,0,0
79959,2,0,0
79960,factorial,0,0
79961,design,0,0
79962,.,0,0
79963,The,0,0
79964,primary,0,0
79965,end,0,0
79966,points,0,0
79967,for,0,0
79968,analysis,0,0
79969,were,0,0
79970,EFS,0,0
79971,and,0,0
79972,overall,0,0
79973,survival,0,0
79974,.,0,0
79975,RESULTS,0,0
79976,In,0,0
79977,the,0,0
79978,current,0,0
79979,analysis,0,0
79980,",",0,0
79981,there,0,0
79982,was,0,0
79983,no,0,0
79984,evidence,0,0
79985,of,0,0
79986,interaction,0,0
79987,",",0,0
79988,and,0,0
79989,we,0,0
79990,were,0,0
79991,able,0,0
79992,to,0,0
79993,examine,0,0
79994,each,0,0
79995,intervention,0,0
79996,separately,0,0
79997,.,0,0
79998,The,0,0
79999,chemotherapy,0,1
80000,regimens,0,0
80001,resulted,0,0
80002,in,0,0
80003,similar,0,0
80004,EFS,0,0
80005,and,0,0
80006,overall,0,0
80007,survival,0,0
80008,.,0,0
80009,There,0,0
80010,was,0,0
80011,a,0,0
80012,trend,0,0
80013,toward,0,0
80014,better,0,0
80015,EFS,0,0
80016,with,0,0
80017,the,0,0
80018,addition,0,0
80019,of,0,0
80020,MTP,0,1
80021,(,0,0
80022,P,0,0
80023,=,0,0
80024,.08,0,0
80025,),0,0
80026,.,0,0
80027,The,0,0
80028,addition,0,0
80029,of,0,0
80030,MTP,0,0
80031,to,0,0
80032,chemotherapy,0,1
80033,improved,0,0
80034,6-year,0,0
80035,overall,0,0
80036,survival,0,0
80037,from,0,0
80038,70,0,0
80039,%,0,0
80040,to,0,0
80041,78,0,0
80042,%,0,0
80043,(,0,0
80044,P,0,0
80045,=,0,0
80046,.03,0,0
80047,),0,0
80048,.,0,0
80049,The,0,0
80050,hazard,0,0
80051,ratio,0,0
80052,for,0,0
80053,overall,0,0
80054,survival,0,0
80055,with,0,0
80056,the,0,0
80057,addition,0,0
80058,of,0,0
80059,MTP,0,0
80060,was,0,0
80061,0.71,0,0
80062,(,0,0
80063,95,0,0
80064,%,0,0
80065,CI,0,0
80066,",",0,0
80067,0.52,0,0
80068,to,0,0
80069,0.96,0,0
80070,),0,0
80071,.,0,0
80072,CONCLUSION,0,0
80073,The,0,0
80074,addition,0,0
80075,of,0,0
80076,ifosfamide,0,1
80077,to,0,0
80078,cisplatin,0,1
80079,",",0,0
80080,doxorubicin,0,1
80081,",",0,0
80082,and,0,0
80083,methotrexate,0,1
80084,did,0,0
80085,not,0,0
80086,enhance,0,0
80087,EFS,0,0
80088,or,0,1
80089,overall,0,0
80090,survival,0,0
80091,for,0,0
80092,patients,0,0
80093,with,0,0
80094,osteosarcoma,0,0
80095,.,0,0
80096,The,0,0
80097,addition,0,0
80098,of,0,0
80099,MTP,0,0
80100,to,0,0
80101,chemotherapy,0,1
80102,resulted,0,0
80103,in,0,0
80104,a,0,0
80105,statistically,0,0
80106,significant,0,0
80107,improvement,0,0
80108,in,0,0
80109,overall,0,0
80110,survival,0,0
80111,and,0,0
80112,a,0,0
80113,trend,0,0
80114,toward,0,0
80115,better,0,0
80116,EFS,0,0
80117,.,0,0
80118,Prospective,0,0
80119,randomized,0,0
80120,controlled,0,0
80121,trial,0,0
80122,to,0,0
80123,evaluate,0,0
80124,fast-track,1,1
80125,elective,1,0
80126,open,1,1
80127,infrarenal,1,0
80128,aneurysm,1,0
80129,repair,1,1
80130,.,1,0
80131,BACKGROUND,0,0
80132,AND,0,0
80133,AIMS,0,0
80134,Fast-track,0,1
80135,programs,0,0
80136,have,0,0
80137,been,0,0
80138,introduced,0,0
80139,in,0,0
80140,many,0,0
80141,surgical,0,0
80142,fields,0,0
80143,to,0,0
80144,minimize,0,0
80145,postoperative,0,0
80146,morbidity,0,0
80147,and,0,0
80148,mortality,0,0
80149,.,0,0
80150,Morbidity,0,0
80151,after,0,0
80152,elective,0,0
80153,open,0,0
80154,infrarenal,0,0
80155,aneurysm,0,0
80156,repair,0,1
80157,is,0,0
80158,as,0,0
80159,high,0,0
80160,as,0,0
80161,30,0,0
80162,%,0,0
80163,;,0,0
80164,mortality,0,0
80165,ranges,0,0
80166,up,0,0
80167,to,0,0
80168,10,0,0
80169,%,0,0
80170,.,0,0
80171,In,0,0
80172,terms,0,0
80173,of,0,0
80174,open,0,0
80175,infrarenal,0,0
80176,aneurysm,0,0
80177,repair,0,1
80178,",",0,0
80179,no,0,0
80180,randomized,0,0
80181,controlled,0,0
80182,trials,0,0
80183,exist,0,0
80184,to,0,0
80185,introduce,0,0
80186,and,0,0
80187,evaluate,0,0
80188,such,0,0
80189,patient,0,0
80190,care,0,0
80191,programs,0,0
80192,.,0,0
80193,MATERIALS,0,0
80194,AND,0,0
80195,METHODS,0,0
80196,This,0,0
80197,study,0,0
80198,involved,0,0
80199,prospective,0,0
80200,randomization,0,0
80201,of,0,0
80202,82,0,0
80203,patients,0,0
80204,in,0,0
80205,a,0,0
80206,traditional,0,1
80207,and,0,0
80208,a,0,0
80209,fast-track,1,1
80210,treatment,0,0
80211,arm,0,0
80212,.,0,0
80213,Main,0,0
80214,differences,0,0
80215,consisted,0,0
80216,in,0,0
80217,preoperative,1,0
80218,bowel,1,0
80219,washout,1,1
80220,(,0,0
80221,none,0,0
80222,vs.,0,0
80223,3,0,0
80224,l,0,0
80225,cleaning,0,1
80226,solution,0,1
80227,),0,0
80228,and,0,0
80229,analgesia,0,1
80230,(,0,0
80231,patient,0,0
80232,controlled,0,0
80233,analgesia,0,0
80234,vs.,0,0
80235,patient,0,0
80236,controlled,0,0
80237,epidural,0,1
80238,analgesia,0,0
80239,),0,0
80240,.,0,0
80241,Study,0,0
80242,endpoints,0,0
80243,were,0,0
80244,morbidity,0,0
80245,and,0,0
80246,mortality,0,0
80247,",",0,0
80248,need,0,0
80249,for,0,0
80250,postoperative,0,0
80251,mechanical,0,0
80252,ventilation,0,1
80253,",",0,0
80254,and,0,0
80255,length,0,0
80256,of,0,0
80257,stay,0,0
80258,(,0,0
80259,LOS,0,1
80260,),0,0
80261,on,0,0
80262,intensive,0,1
80263,care,0,1
80264,unit,0,0
80265,(,0,0
80266,ICU,0,0
80267,),0,0
80268,.,0,0
80269,RESULTS,0,0
80270,The,0,0
80271,need,0,0
80272,for,0,0
80273,assisted,0,1
80274,postoperative,0,0
80275,ventilation,0,1
80276,was,0,0
80277,significantly,0,0
80278,higher,0,0
80279,in,0,0
80280,the,0,0
80281,traditional,0,1
80282,group,0,0
80283,(,0,0
80284,33.3,0,0
80285,%,0,0
80286,vs.,0,0
80287,5.4,0,0
80288,%,0,0
80289,;,0,0
80290,p,0,0
80291,=,0,0
80292,0.011,0,0
80293,),0,0
80294,.,0,0
80295,Median,0,0
80296,LOS,0,1
80297,on,0,0
80298,ICU,0,0
80299,was,0,0
80300,shorter,0,0
80301,in,0,0
80302,the,0,0
80303,fast-track,0,1
80304,group,0,0
80305,",",0,0
80306,41,0,0
80307,vs.,0,0
80308,20,0,0
80309,h.,0,0
80310,The,0,0
80311,rate,0,0
80312,of,0,0
80313,postoperative,0,0
80314,medical,0,0
80315,complications,0,0
80316,was,0,0
80317,significantly,0,0
80318,lower,0,0
80319,in,0,0
80320,the,0,0
80321,fast-track,0,1
80322,group,0,0
80323,",",0,0
80324,16.2,0,0
80325,%,0,0
80326,vs.,0,0
80327,35.7,0,0
80328,%,0,0
80329,(,0,0
80330,p,0,0
80331,=,0,0
80332,0.045,0,0
80333,),0,0
80334,.,0,0
80335,CONCLUSION,0,0
80336,We,0,0
80337,introduced,0,0
80338,and,0,0
80339,evaluated,0,0
80340,an,0,0
80341,optimized,0,0
80342,patient,1,0
80343,care,1,1
80344,program,1,1
80345,for,0,0
80346,patients,0,0
80347,undergoing,0,0
80348,open,0,0
80349,infrarenal,0,0
80350,aortic,0,0
80351,aneurysm,0,0
80352,repair,0,1
80353,which,0,0
80354,showed,0,0
80355,a,0,0
80356,significant,0,0
80357,advantage,0,0
80358,for,0,0
80359,fast-track,0,1
80360,patients,0,0
80361,in,0,0
80362,terms,0,0
80363,of,0,0
80364,postoperative,0,0
80365,morbidity,0,0
80366,.,0,0
80367,Chronology,0,0
80368,of,0,0
80369,panic,0,0
80370,and,0,0
80371,avoidance,0,0
80372,",",0,0
80373,age,0,0
80374,of,0,0
80375,onset,0,0
80376,in,0,0
80377,panic,0,0
80378,disorder,0,0
80379,",",0,0
80380,and,0,0
80381,prediction,0,0
80382,of,0,0
80383,treatment,0,0
80384,response,0,0
80385,.,0,0
80386,A,0,0
80387,report,0,0
80388,from,0,0
80389,the,0,0
80390,Cross-National,0,0
80391,Collaborative,0,0
80392,Panic,0,0
80393,Study,0,0
80394,.,0,0
80395,The,0,0
80396,relevance,0,0
80397,of,0,0
80398,the,0,0
80399,chronology,0,0
80400,between,0,0
80401,panic,0,0
80402,disorder,0,0
80403,and,0,0
80404,avoidance,0,0
80405,behavior,0,0
80406,and,0,0
80407,of,0,0
80408,an,0,0
80409,early,0,0
80410,",",0,0
80411,medium,0,1
80412,or,0,1
80413,late,0,0
80414,onset,0,0
80415,of,0,0
80416,panic,0,0
80417,disorder,0,0
80418,was,0,0
80419,tested,0,0
80420,.,0,0
80421,Groups,0,0
80422,from,0,0
80423,the,0,0
80424,sample,0,0
80425,of,0,0
80426,the,0,0
80427,cross-national,1,0
80428,collaborative,1,0
80429,panic,1,0
80430,study,1,0
80431,(,0,0
80432,CNCPS,0,0
80433,),0,0
80434,were,0,0
80435,compared,0,0
80436,for,0,0
80437,differences,0,0
80438,in,0,0
80439,basic,0,1
80440,characteristics,0,0
80441,and,0,0
80442,for,0,0
80443,the,0,0
80444,ability,0,0
80445,to,0,0
80446,predict,0,0
80447,treatment,0,0
80448,response,0,0
80449,.,0,0
80450,Patients,0,0
80451,who,0,0
80452,developed,0,0
80453,avoidance,0,0
80454,behavior,0,0
80455,before,0,0
80456,the,0,0
80457,full,0,0
80458,syndrome,0,0
80459,of,0,0
80460,panic,0,0
80461,disorder,0,0
80462,had,0,0
80463,less,0,0
80464,often,0,0
80465,a,0,0
80466,full,0,0
80467,agoraphobia,0,0
80468,but,0,0
80469,were,0,0
80470,not,0,0
80471,different,0,0
80472,in,0,0
80473,their,0,0
80474,response,0,0
80475,to,0,0
80476,treatment,1,0
80477,.,1,0
80478,Patients,0,0
80479,with,0,0
80480,an,0,0
80481,early,0,0
80482,onset,0,0
80483,of,0,0
80484,panic,0,0
80485,disorder,0,0
80486,suffered,0,0
80487,more,0,0
80488,often,0,0
80489,from,0,0
80490,agoraphobia,0,0
80491,.,0,0
80492,The,0,0
80493,treatment,1,0
80494,response,0,0
80495,was,0,0
80496,similar,0,0
80497,in,0,0
80498,the,0,0
80499,groups,0,0
80500,with,0,0
80501,early,0,0
80502,",",0,0
80503,medium,0,1
80504,or,0,1
80505,late,0,0
80506,onset,0,0
80507,of,0,0
80508,panic,0,0
80509,disorder,0,0
80510,.,0,0
80511,Neither,0,0
80512,the,0,0
80513,chronology,0,0
80514,between,0,0
80515,panic,0,0
80516,disorder,0,0
80517,and,0,0
80518,avoidance,0,0
80519,behavior,0,0
80520,nor,0,0
80521,the,0,0
80522,age,0,0
80523,of,0,0
80524,onset,0,0
80525,of,0,0
80526,panic,0,0
80527,disorder,0,0
80528,predicted,0,0
80529,outcome,0,0
80530,in,0,0
80531,short-term,1,0
80532,treatment,1,0
80533,with,1,0
80534,alprazolam,1,1
80535,or,1,0
80536,imipramine,1,1
80537,.,1,0
80538,Microtensile,0,1
80539,bond,0,0
80540,strength,0,0
80541,of,0,0
80542,a,0,0
80543,repair,0,1
80544,composite,0,0
80545,to,0,0
80546,leucite-reinforced,0,1
80547,feldspathic,0,1
80548,ceramic,0,1
80549,.,0,0
80550,The,0,0
80551,purpose,0,0
80552,of,0,0
80553,this,0,0
80554,study,0,0
80555,was,0,0
80556,to,0,0
80557,evaluate,0,0
80558,the,0,0
80559,microtensile,0,1
80560,bond,0,0
80561,strength,0,0
80562,of,0,0
80563,a,0,0
80564,repair,0,1
80565,composite,0,0
80566,resin,0,1
80567,to,0,0
80568,a,0,0
80569,leucite-reinforced,0,1
80570,feldspathic,0,1
80571,ceramic,0,1
80572,(,0,0
80573,Omega,0,1
80574,900,0,1
80575,",",0,0
80576,VITA,0,1
80577,),0,0
80578,submitted,0,0
80579,to,0,0
80580,two,0,0
80581,surface,0,0
80582,conditionings,0,0
80583,methods,0,0
80584,:,0,0
80585,1,0,0
80586,),0,0
80587,etching,1,1
80588,with,1,0
80589,hydrofluoric,1,1
80590,acid,1,1
80591,+,1,1
80592,silane,1,1
80593,application,1,1
80594,or,1,1
80595,2,1,0
80596,),1,0
80597,tribochemical,1,0
80598,silica,1,1
80599,coating,1,1
80600,.,1,0
80601,The,0,0
80602,null,0,0
80603,hypothesis,0,0
80604,is,0,0
80605,that,0,0
80606,both,0,0
80607,surface,0,0
80608,treatments,0,0
80609,can,0,0
80610,generate,0,0
80611,similar,0,0
80612,bond,0,0
80613,strengths,0,0
80614,.,0,0
80615,Ten,0,0
80616,ceramic,0,1
80617,blocks,0,1
80618,(,0,0
80619,6x6x6,0,0
80620,mm,0,0
80621,),0,0
80622,were,0,0
80623,fabricated,0,1
80624,and,0,0
80625,randomly,0,0
80626,assigned,0,0
80627,to,0,0
80628,2,0,0
80629,groups,0,0
80630,(,0,0
80631,n=5,0,0
80632,),0,0
80633,",",0,0
80634,according,0,0
80635,to,0,0
80636,the,0,0
80637,conditioning,0,1
80638,method,0,0
80639,:,0,0
80640,G1-,0,1
80641,10,0,0
80642,%,0,0
80643,hydrofluoric,1,1
80644,acid,1,1
80645,application,0,0
80646,for,0,0
80647,2,0,0
80648,min,0,0
80649,plus,0,1
80650,rinsing,0,1
80651,and,0,0
80652,drying,0,0
80653,",",0,0
80654,followed,0,0
80655,by,0,0
80656,silane,1,1
80657,application,0,0
80658,for,0,0
80659,30,0,0
80660,s,0,0
80661,;,0,0
80662,G2-,0,1
80663,airborne,0,0
80664,particle,0,0
80665,abrasion,0,1
80666,with,0,0
80667,30,0,0
80668,microm,0,0
80669,silica,0,1
80670,oxide,0,1
80671,particles,0,0
80672,(,0,0
80673,CoJet-Sand,0,1
80674,),0,0
80675,for,0,0
80676,20,0,0
80677,s,0,0
80678,using,0,0
80679,a,0,0
80680,chairside,0,1
80681,air-abrasion,0,1
80682,device,0,1
80683,(,0,0
80684,CoJet,0,1
80685,System,0,1
80686,),0,0
80687,",",0,0
80688,followed,0,0
80689,by,0,0
80690,silane,0,1
80691,application,0,0
80692,for,0,0
80693,5,0,0
80694,min,0,0
80695,.,0,0
80696,Single,0,0
80697,Bond,0,1
80698,adhesive,0,1
80699,system,0,0
80700,was,0,0
80701,applied,0,0
80702,to,0,0
80703,the,0,0
80704,surfaces,0,1
80705,and,0,0
80706,light,0,1
80707,cured,0,0
80708,(,0,0
80709,40,0,0
80710,s,0,0
80711,),0,0
80712,.,0,0
80713,Z-250,0,0
80714,composite,0,0
80715,resin,0,1
80716,was,0,0
80717,placed,0,0
80718,incrementally,0,0
80719,on,0,0
80720,the,0,0
80721,treated,0,0
80722,ceramic,0,1
80723,surface,0,0
80724,to,0,0
80725,build,0,0
80726,a,0,0
80727,6x6x6,0,0
80728,mm,0,0
80729,block,0,0
80730,.,0,0
80731,Bar,0,0
80732,specimens,0,0
80733,with,0,0
80734,an,0,0
80735,adhesive,0,1
80736,area,0,0
80737,of,0,0
80738,approximately,0,0
80739,1,0,0
80740,+/-,0,0
80741,0.1,0,0
80742,mm,0,0
80743,(,0,0
80744,2,0,0
80745,),0,0
80746,were,0,0
80747,obtained,0,0
80748,from,0,0
80749,the,0,0
80750,composite-ceramic,0,1
80751,blocks,0,1
80752,(,0,0
80753,6,0,0
80754,per,0,0
80755,block,0,0
80756,and,0,0
80757,30,0,0
80758,per,0,0
80759,group,0,0
80760,),0,0
80761,for,0,0
80762,microtensile,0,1
80763,testing,0,0
80764,.,0,0
80765,No,0,0
80766,statistically,0,0
80767,significant,0,0
80768,difference,0,0
80769,was,0,0
80770,observed,0,0
80771,between,0,0
80772,G1,0,0
80773,(,0,0
80774,10.19,0,0
80775,+/-,0,0
80776,3.1,0,0
80777,MPa,0,1
80778,),0,0
80779,and,0,0
80780,G2,0,1
80781,(,0,0
80782,10.17,0,0
80783,+/-,0,0
80784,3.1,0,0
80785,MPa,0,1
80786,),0,0
80787,(,0,0
80788,p=0.982,0,0
80789,),0,1
80790,(,0,0
80791,Student,0,1
80792,'s,0,0
80793,t,0,0
80794,test,0,0
80795,;,0,0
80796,?,0,0
80797,=,0,0
80798,0.05,0,0
80799,),0,0
80800,.,0,0
80801,The,0,0
80802,null,0,0
80803,hypothesis,0,0
80804,was,0,0
80805,",",0,0
80806,therefore,0,0
80807,",",0,0
80808,accepted,0,0
80809,.,0,0
80810,In,0,0
80811,conclusion,0,0
80812,",",0,0
80813,both,0,0
80814,surface,0,0
80815,conditioning,0,1
80816,methods,0,0
80817,provided,0,0
80818,similar,0,0
80819,microtensile,0,1
80820,bond,0,0
80821,strengths,0,0
80822,between,0,0
80823,the,0,0
80824,repair,0,1
80825,composite,0,1
80826,resin,0,1
80827,and,0,0
80828,the,0,0
80829,ceramic,0,1
80830,.,0,0
80831,Further,0,0
80832,studies,0,0
80833,using,0,0
80834,long-term,0,0
80835,aging,0,0
80836,procedures,0,0
80837,should,0,0
80838,be,0,0
80839,conducted,0,0
80840,.,0,0
80841,[,0,0
80842,4,0,0
80843,years,0,0
80844,',0,0
80845,experience,0,0
80846,with,0,0
80847,a,0,0
80848,balloon-expandable,1,1
80849,endoprosthesis,1,1
80850,.,1,0
80851,Experimental,0,0
80852,and,0,0
80853,clinical,0,0
80854,application,0,1
80855,],0,0
80856,.,0,0
80857,During,0,0
80858,a,0,0
80859,4-year,0,0
80860,period,0,0
80861,of,0,0
80862,clinical,0,0
80863,application,0,0
80864,of,0,0
80865,the,0,0
80866,balloon-expandable,1,1
80867,Palmaz,1,1
80868,stent,1,0
80869,",",0,0
80870,a,0,0
80871,randomized,0,0
80872,trial,0,0
80873,comparing,0,0
80874,stent,1,1
80875,implantation,1,1
80876,and,1,0
80877,traditional,1,1
80878,balloon,1,1
80879,angioplasty,1,1
80880,of,0,0
80881,iliac,0,0
80882,arteries,0,0
80883,in,0,0
80884,arterial,0,0
80885,occlusive,0,0
80886,disease,0,0
80887,was,0,0
80888,started,0,0
80889,.,0,0
80890,The,0,0
80891,first,0,0
80892,long-term,0,0
80893,results,0,0
80894,",",0,0
80895,recorded,0,0
80896,after,0,0
80897,2,0,0
80898,years,0,0
80899,",",0,0
80900,indicate,0,0
80901,statistically,0,0
80902,significant,0,0
80903,differences,0,0
80904,in,0,0
80905,the,0,0
80906,complication,0,0
80907,rate,0,0
80908,(,0,0
80909,after,0,0
80910,stenting,0,1
80911,2/62,0,0
80912,and,0,0
80913,after,0,0
80914,angioplasty,0,1
80915,5/69,0,0
80916,),0,0
80917,and,0,0
80918,patency,0,0
80919,(,0,0
80920,greater,0,0
80921,than,0,0
80922,or,0,0
80923,equal,0,0
80924,to,0,0
80925,70,0,0
80926,%,0,0
80927,of,0,0
80928,original,0,0
80929,lumen,0,0
80930,size,0,0
80931,upon,0,0
80932,stent,1,1
80933,implantation,1,1
80934,or,1,1
80935,balloon,1,1
80936,inflation,1,0
80937,:,1,0
80938,95,0,0
80939,%,0,0
80940,after,0,0
80941,stenting,0,1
80942,and,0,0
80943,72,0,0
80944,%,0,0
80945,after,0,0
80946,angioplasty,0,0
80947,),0,0
80948,.,0,0
80949,Clinical,0,0
80950,improvement,0,0
80951,after,0,0
80952,2,0,0
80953,years,0,0
80954,was,0,0
80955,89,0,0
80956,%,0,0
80957,after,0,0
80958,stenting,0,1
80959,and,0,0
80960,70,0,0
80961,%,0,0
80962,after,0,0
80963,angioplasty,0,0
80964,.,0,0
80965,Parallel,0,0
80966,to,0,0
80967,the,0,0
80968,clinical,0,0
80969,trials,0,0
80970,",",0,0
80971,experimental,0,0
80972,canine,0,0
80973,artery,0,0
80974,stenting,0,1
80975,was,0,0
80976,performed,0,0
80977,to,0,0
80978,evaluate,0,0
80979,differences,0,0
80980,in,0,0
80981,the,0,0
80982,long-term,0,0
80983,patency,0,0
80984,of,0,0
80985,stents,0,1
80986,exposed,0,0
80987,to,0,0
80988,restricted,0,0
80989,flow,0,0
80990,.,0,0
80991,Significant,0,0
80992,differences,0,0
80993,in,0,0
80994,neointimal,0,0
80995,healing,0,0
80996,were,0,0
80997,found,0,0
80998,between,0,0
80999,normally,0,0
81000,perfused,0,0
81001,stents,0,1
81002,and,0,0
81003,stents,0,1
81004,with,0,0
81005,artificially,0,0
81006,reduced,0,0
81007,flow,0,0
81008,:,0,0
81009,during,0,0
81010,the,0,0
81011,total,0,0
81012,observation,0,0
81013,period,0,0
81014,of,0,0
81015,6,0,0
81016,months,0,0
81017,the,0,0
81018,neointimal,0,0
81019,height,0,0
81020,was,0,0
81021,up,0,0
81022,to,0,0
81023,200,0,0
81024,%,0,0
81025,higher,0,0
81026,in,0,0
81027,flow-restricted,0,0
81028,stents,0,1
81029,",",0,0
81030,while,0,0
81031,the,0,0
81032,histological,0,0
81033,composition,0,0
81034,of,0,0
81035,the,0,0
81036,neointima,0,0
81037,was,0,0
81038,the,0,0
81039,same,0,0
81040,as,0,0
81041,with,0,0
81042,normally,0,0
81043,perfused,0,0
81044,stents,0,1
81045,.,0,0
81046,Safety,0,0
81047,and,0,0
81048,tolerability,0,0
81049,of,0,0
81050,cold-adapted,0,0
81051,influenza,1,1
81052,vaccine,1,1
81053,",",1,0
81054,trivalent,1,0
81055,",",0,0
81056,in,0,0
81057,infants,0,0
81058,younger,0,0
81059,than,0,0
81060,6,0,0
81061,months,0,0
81062,of,0,0
81063,age,0,0
81064,.,0,0
81065,OBJECTIVE,0,0
81066,Young,0,0
81067,children,0,0
81068,are,0,0
81069,at,0,0
81070,high,0,0
81071,risk,0,0
81072,for,0,0
81073,influenza-related,0,0
81074,complications,0,0
81075,.,0,0
81076,Vaccination,0,0
81077,of,0,0
81078,close,0,0
81079,household,0,0
81080,contacts,0,1
81081,is,0,0
81082,recommended,0,0
81083,to,0,0
81084,provide,0,0
81085,indirect,0,0
81086,protection,0,0
81087,to,0,0
81088,children,0,0
81089,<,0,0
81090,6,0,0
81091,months,0,0
81092,of,0,0
81093,age,0,0
81094,.,0,0
81095,Studies,0,0
81096,have,0,0
81097,shown,0,0
81098,that,0,0
81099,live,0,0
81100,",",0,0
81101,cold-adapted,0,0
81102,influenza,1,1
81103,vaccine,1,1
81104,",",0,0
81105,trivalent,0,0
81106,",",0,0
81107,is,0,0
81108,efficacious,0,0
81109,in,0,0
81110,children,0,0
81111,.,0,0
81112,To,0,0
81113,assess,0,0
81114,the,0,0
81115,risks,0,0
81116,associated,0,0
81117,with,0,0
81118,inadvertent,0,0
81119,exposure,0,0
81120,of,0,0
81121,infants,0,0
81122,to,0,0
81123,vaccine,0,1
81124,viruses,0,0
81125,from,0,0
81126,vaccinated,0,0
81127,contacts,0,0
81128,",",0,0
81129,this,0,0
81130,study,0,0
81131,was,0,0
81132,designed,0,0
81133,to,0,0
81134,evaluate,0,0
81135,the,0,0
81136,safety,0,0
81137,and,0,0
81138,tolerability,0,0
81139,of,0,0
81140,cold-adapted,0,0
81141,influenza,1,1
81142,vaccine,1,1
81143,",",0,0
81144,trivalent,0,0
81145,",",0,0
81146,administered,0,0
81147,intranasally,0,0
81148,to,0,0
81149,healthy,0,0
81150,children,0,0
81151,6,0,0
81152,to,0,0
81153,<,0,0
81154,24,0,0
81155,weeks,0,0
81156,of,0,0
81157,age,0,0
81158,.,0,0
81159,METHODS,0,0
81160,Healthy,0,0
81161,infants,0,0
81162,aged,0,0
81163,6,0,0
81164,to,0,0
81165,<,0,0
81166,16,0,0
81167,weeks,0,0
81168,and,0,0
81169,16,0,0
81170,to,0,0
81171,<,0,0
81172,24,0,0
81173,weeks,0,0
81174,",",0,0
81175,respectively,0,0
81176,",",0,0
81177,were,0,0
81178,randomly,0,0
81179,assigned,0,0
81180,to,0,0
81181,receive,0,0
81182,2,1,0
81183,doses,1,0
81184,of,1,0
81185,influenza,1,1
81186,vaccine,1,1
81187,",",1,0
81188,or,1,0
81189,placebo,1,1
81190,intranasally,0,0
81191,35,0,0
81192,+/-,0,0
81193,7,0,0
81194,days,0,0
81195,apart,0,0
81196,.,0,0
81197,Reactogenicity,0,0
81198,events,0,0
81199,were,0,0
81200,monitored,0,0
81201,for,0,0
81202,11,0,0
81203,days,0,0
81204,after,0,0
81205,each,0,0
81206,dose,0,0
81207,.,0,0
81208,Other,0,0
81209,adverse,0,0
81210,events,0,0
81211,were,0,0
81212,monitored,0,0
81213,through,0,0
81214,28,0,0
81215,to,0,0
81216,35,0,0
81217,days,0,0
81218,after,0,0
81219,dose,0,0
81220,2,0,0
81221,.,0,0
81222,RESULTS,0,0
81223,Of,0,0
81224,the,0,0
81225,infants,0,0
81226,aged,0,0
81227,6,0,0
81228,to,0,0
81229,<,0,0
81230,16,0,0
81231,weeks,0,0
81232,",",0,0
81233,31,0,0
81234,received,0,0
81235,influenza,1,1
81236,vaccine,1,1
81237,and,0,0
81238,28,0,0
81239,received,0,0
81240,placebo,1,1
81241,",",0,0
81242,and,0,0
81243,of,0,0
81244,those,0,0
81245,aged,0,0
81246,16,0,0
81247,to,0,0
81248,<,0,0
81249,24,0,0
81250,weeks,0,0
81251,",",0,0
81252,30,0,0
81253,received,0,0
81254,influenza,1,1
81255,vaccine,1,1
81256,and,0,0
81257,31,0,0
81258,received,0,0
81259,placebo,1,1
81260,.,1,0
81261,In,0,0
81262,the,0,0
81263,6-,0,0
81264,to,0,0
81265,<,0,0
81266,16-week,0,0
81267,cohort,0,0
81268,",",0,0
81269,more,0,0
81270,influenza,0,1
81271,vaccine,0,1
81272,",",0,0
81273,recipients,0,0
81274,experienced,0,0
81275,irritability,0,0
81276,(,0,0
81277,66.7,0,0
81278,%,0,0
81279,vs,0,0
81280,35.7,0,0
81281,%,0,0
81282,),0,0
81283,and,0,0
81284,runny,0,0
81285,nose,0,0
81286,or,0,1
81287,nasal,0,1
81288,congestion,0,0
81289,(,0,0
81290,63.3,0,0
81291,%,0,0
81292,vs,0,0
81293,33.3,0,0
81294,%,0,0
81295,),0,0
81296,after,0,0
81297,dose,0,0
81298,1,0,0
81299,but,0,0
81300,not,0,0
81301,dose,0,0
81302,2,0,0
81303,.,0,0
81304,There,0,0
81305,were,0,0
81306,no,0,0
81307,significant,0,0
81308,increases,0,0
81309,in,0,0
81310,any,0,0
81311,other,0,0
81312,reactogenicity,0,0
81313,events,0,0
81314,or,0,0
81315,adverse,0,0
81316,events,0,0
81317,in,0,0
81318,the,0,0
81319,vaccine,0,1
81320,recipients,0,0
81321,compared,0,0
81322,with,0,0
81323,the,0,0
81324,placebo,1,1
81325,group,0,0
81326,.,0,0
81327,CONCLUSIONS,0,0
81328,Although,0,0
81329,there,0,0
81330,was,0,0
81331,an,0,0
81332,increase,0,0
81333,in,0,0
81334,mild,0,0
81335,reactogenicity,0,0
81336,events,0,0
81337,in,0,0
81338,children,0,0
81339,6,0,0
81340,to,0,0
81341,<,0,0
81342,16,0,0
81343,weeks,0,0
81344,of,0,0
81345,age,0,0
81346,",",0,0
81347,cold-adapted,0,0
81348,influenza,1,1
81349,vaccine,1,1
81350,",",0,0
81351,trivalent,0,0
81352,",",0,0
81353,was,0,0
81354,generally,0,0
81355,well,0,0
81356,tolerated,0,0
81357,in,0,0
81358,infants,0,0
81359,6,0,0
81360,to,0,0
81361,<,0,0
81362,24,0,0
81363,weeks,0,0
81364,of,0,0
81365,age,0,0
81366,.,0,0
81367,These,0,0
81368,findings,0,0
81369,support,0,0
81370,further,0,0
81371,evaluation,0,0
81372,of,0,0
81373,cold-adapted,0,0
81374,influenza,1,1
81375,vaccine,1,1
81376,",",0,0
81377,trivalent,0,0
81378,",",0,0
81379,in,0,0
81380,infants,0,0
81381,<,0,0
81382,6,0,0
81383,months,0,0
81384,of,0,0
81385,age,0,0
81386,.,0,0
81387,Split-face,0,1
81388,comparison,0,0
81389,of,0,0
81390,the,0,0
81391,erbium,1,1
81392,micropeel,1,0
81393,with,1,0
81394,intense,1,0
81395,pulsed,1,1
81396,light,1,0
81397,.,1,0
81398,BACKGROUND,0,0
81399,A,0,0
81400,variety,0,0
81401,of,0,0
81402,photorejuvenative,0,1
81403,techniques,0,1
81404,have,0,0
81405,been,0,0
81406,utilized,0,0
81407,to,0,0
81408,reverse,0,0
81409,the,0,0
81410,signs,0,0
81411,of,0,0
81412,cutaneous,0,0
81413,photoaging,0,0
81414,",",0,0
81415,including,0,0
81416,ablative,0,1
81417,and,0,0
81418,nonablative,0,1
81419,laser,0,1
81420,resurfacing,0,0
81421,as,0,0
81422,well,0,0
81423,as,0,0
81424,light-based,0,0
81425,devices,0,0
81426,.,0,0
81427,OBJECTIVE,0,0
81428,The,0,0
81429,purpose,0,0
81430,of,0,0
81431,this,0,0
81432,split-face,0,1
81433,randomized,0,0
81434,prospective,0,0
81435,open-label,0,0
81436,trial,0,0
81437,was,0,0
81438,to,0,0
81439,determine,0,0
81440,the,0,0
81441,effectiveness,0,0
81442,of,0,0
81443,sequential,1,0
81444,erbium,1,1
81445,:,1,1
81446,yttrium-aluminum-garnet,1,1
81447,(,1,0
81448,Er,1,0
81449,:,1,1
81450,YAG,1,1
81451,),1,0
81452,laser,1,1
81453,versus,1,0
81454,intense,1,0
81455,pulsed,1,1
81456,light,1,1
81457,(,1,0
81458,IPL,1,1
81459,),1,0
81460,for,0,0
81461,the,0,0
81462,treatment,0,0
81463,of,0,0
81464,mild,0,0
81465,to,0,0
81466,moderate,0,0
81467,facial,0,0
81468,photodamage,0,0
81469,.,0,0
81470,MATERIALS,0,0
81471,AND,0,0
81472,METHODS,0,0
81473,Ten,0,1
81474,subjects,0,0
81475,(,0,0
81476,ages,0,0
81477,35-63,0,0
81478,),0,0
81479,with,0,0
81480,facial,0,0
81481,dyschromia,0,0
81482,and,0,0
81483,rhytides,0,0
81484,were,0,0
81485,enrolled,0,0
81486,.,0,0
81487,Study,0,0
81488,patients,0,0
81489,were,0,0
81490,randomized,0,0
81491,to,0,0
81492,the,0,0
81493,two,0,0
81494,treatment,0,0
81495,arms,0,0
81496,",",0,0
81497,Er,1,0
81498,:,1,0
81499,YAG,1,1
81500,(,0,0
81501,3.8,0,0
81502,J/cm,0,1
81503,(,0,0
81504,2,0,0
81505,),0,0
81506,",",0,0
81507,30,0,0
81508,%,0,0
81509,pattern,1,0
81510,overlap,1,0
81511,",",0,0
81512,0,0,0
81513,%,0,0
81514,interpulse,1,0
81515,overlap,1,0
81516,",",0,0
81517,15,0,0
81518,microm,0,0
81519,per,0,0
81520,pass,0,0
81521,with,0,0
81522,no,0,0
81523,coagulation,0,0
81524,),0,0
81525,and,0,0
81526,IPL,1,1
81527,(,0,0
81528,560-nm,0,1
81529,filter,0,1
81530,",",0,0
81531,30,0,0
81532,J/cm,0,1
81533,(,0,0
81534,2,0,0
81535,),0,0
81536,",",0,0
81537,2.4/4.0-ms,0,0
81538,pulse,0,1
81539,with,0,0
81540,10-ms,0,0
81541,delay,0,0
81542,),0,0
81543,",",0,0
81544,each,0,0
81545,receiving,0,0
81546,three,0,0
81547,sequential,0,0
81548,treatments,0,0
81549,spaced,0,1
81550,1,0,0
81551,month,0,0
81552,apart,0,0
81553,.,0,0
81554,Subjective,0,0
81555,and,0,0
81556,blinded,0,0
81557,physician,0,0
81558,evaluations,0,0
81559,were,0,0
81560,performed,0,0
81561,at,0,0
81562,baseline,0,0
81563,and,0,0
81564,4,0,0
81565,",",0,0
81566,8,0,0
81567,",",0,0
81568,and,0,0
81569,20,0,0
81570,weeks,0,0
81571,posttreatment,0,0
81572,using,0,0
81573,a,0,0
81574,nominal,0,0
81575,scale,0,0
81576,from,0,0
81577,1,0,0
81578,to,0,0
81579,4,0,0
81580,.,0,0
81581,Erythema,0,0
81582,and,0,0
81583,adverse,0,0
81584,events,0,0
81585,were,0,0
81586,assessed,0,0
81587,1,0,0
81588,week,0,0
81589,following,0,0
81590,each,0,0
81591,treatment,0,0
81592,.,0,0
81593,RESULTS,0,0
81594,Ten,0,0
81595,female,0,0
81596,subjects,0,0
81597,with,0,0
81598,mild,0,0
81599,to,0,0
81600,moderate,0,0
81601,facial,0,0
81602,photodamage,0,0
81603,were,0,0
81604,treated,0,0
81605,with,0,0
81606,one,0,0
81607,pass,0,0
81608,of,0,0
81609,either,0,0
81610,IPL,0,1
81611,or,0,0
81612,Er,0,1
81613,:,0,0
81614,YAG,0,0
81615,in,0,0
81616,a,0,0
81617,split-face,0,1
81618,fashion,0,0
81619,.,0,0
81620,Patients,0,0
81621,received,0,0
81622,three,0,0
81623,treatments,0,0
81624,each,0,0
81625,spaced,0,1
81626,1,0,0
81627,month,0,0
81628,apart,0,0
81629,.,0,0
81630,Nine,0,1
81631,of,0,0
81632,10,0,0
81633,patients,0,0
81634,completed,0,0
81635,the,0,0
81636,trial,0,0
81637,;,0,0
81638,1,0,0
81639,withdrew,0,0
81640,due,0,0
81641,to,0,0
81642,pain,0,0
81643,during,0,0
81644,the,0,0
81645,second,0,0
81646,Er,0,0
81647,:,0,0
81648,YAG,0,0
81649,treatment,0,0
81650,.,0,0
81651,Baseline,0,0
81652,subjective,0,0
81653,and,0,0
81654,blinded,0,0
81655,physician,0,0
81656,dyschromia,0,0
81657,and,0,0
81658,rhytid,0,0
81659,scores,0,0
81660,revealed,0,0
81661,no,0,0
81662,significant,0,0
81663,difference,0,0
81664,between,0,0
81665,the,0,0
81666,IPL,0,1
81667,and,0,0
81668,Er,0,0
81669,:,0,0
81670,YAG,0,0
81671,randomly,0,0
81672,assigned,0,0
81673,sides,0,0
81674,.,0,0
81675,Up,0,0
81676,to,0,0
81677,three,0,0
81678,IPL,0,1
81679,or,0,0
81680,Er,0,1
81681,:,0,0
81682,YAG,0,0
81683,treatments,0,0
81684,did,0,0
81685,not,0,0
81686,result,0,0
81687,in,0,0
81688,a,0,0
81689,significant,0,0
81690,improvement,0,0
81691,in,0,0
81692,rhytid,0,0
81693,scores,0,0
81694,.,0,0
81695,Subjective,0,0
81696,and,0,0
81697,blinded,0,0
81698,physician,0,0
81699,dyschromia,0,0
81700,scores,0,0
81701,improved,0,0
81702,26,0,0
81703,and,0,0
81704,38,0,0
81705,%,0,0
81706,",",0,0
81707,respectively,0,0
81708,",",0,0
81709,3,0,0
81710,months,0,0
81711,after,0,0
81712,the,0,0
81713,final,0,0
81714,IPL,0,1
81715,treatment,0,0
81716,",",0,0
81717,but,0,0
81718,only,0,0
81719,by,0,0
81720,7,0,0
81721,and,0,0
81722,29,0,0
81723,%,0,0
81724,",",0,0
81725,respectively,0,0
81726,",",0,0
81727,with,0,0
81728,Er,0,0
81729,:,0,0
81730,YAG,0,0
81731,.,0,0
81732,Subjective,0,0
81733,global,0,0
81734,facial,0,0
81735,appearance,0,0
81736,scores,0,0
81737,worsened,0,0
81738,by,0,0
81739,5,0,0
81740,%,0,0
81741,while,0,0
81742,blinded,0,0
81743,physician,0,0
81744,scores,0,0
81745,improved,0,0
81746,by,0,0
81747,16,0,0
81748,%,0,0
81749,3,0,0
81750,months,0,0
81751,after,0,0
81752,3,0,0
81753,Er,0,0
81754,:,0,0
81755,YAG,0,0
81756,treatments,0,0
81757,",",0,0
81758,but,0,0
81759,by,0,0
81760,28,0,0
81761,and,0,0
81762,20,0,0
81763,%,0,0
81764,for,0,0
81765,IPL,0,1
81766,",",0,0
81767,respectively,0,0
81768,.,0,0
81769,The,0,0
81770,overall,0,0
81771,incidence,0,0
81772,of,0,0
81773,adverse,0,0
81774,events,0,0
81775,and,0,0
81776,subsequent,0,0
81777,downtime,0,0
81778,was,0,0
81779,increased,0,0
81780,for,0,0
81781,Er,0,0
81782,:,0,0
81783,YAG,0,1
81784,(,0,0
81785,1/10,0,0
81786,patients,0,0
81787,experienced,0,0
81788,hyperpigmentation,0,0
81789,",",0,0
81790,3/10,0,0
81791,exfoliation,0,0
81792,",",0,0
81793,1/10,0,0
81794,blistering,0,0
81795,",",0,0
81796,and,0,0
81797,5/10,0,0
81798,discomfort,0,0
81799,),0,0
81800,compared,0,0
81801,to,0,0
81802,IPL,0,1
81803,(,0,0
81804,1/10,0,0
81805,exfoliation,0,0
81806,and,0,0
81807,1/10,0,0
81808,discomfort,0,0
81809,),0,0
81810,",",0,0
81811,although,0,0
81812,no,0,0
81813,permanent,0,0
81814,side,0,0
81815,effects,0,0
81816,were,0,0
81817,observed,0,0
81818,with,0,0
81819,either,0,0
81820,treatment,0,0
81821,arm,0,0
81822,.,0,0
81823,CONCLUSIONS,0,0
81824,While,0,0
81825,low-fluence,0,1
81826,erbium,0,1
81827,resurfacing,0,0
81828,has,0,0
81829,a,0,0
81830,modest,0,0
81831,effect,0,0
81832,on,0,0
81833,facial,0,0
81834,photodamage,0,0
81835,",",0,0
81836,patients,0,0
81837,preferred,0,0
81838,IPL,0,1
81839,because,0,0
81840,it,0,0
81841,resulted,0,0
81842,in,0,0
81843,less,0,0
81844,downtime,0,0
81845,.,0,0
81846,The,0,0
81847,authors,0,0
81848,have,0,0
81849,indicated,0,0
81850,no,0,0
81851,significant,0,0
81852,interest,0,0
81853,with,0,0
81854,commercial,0,0
81855,supporters,0,0
81856,.,0,0
81857,Influence,0,0
81858,of,0,0
81859,two,0,0
81860,different,0,0
81861,resection,0,1
81862,techniques,0,1
81863,(,1,0
81864,conventional,1,1
81865,liver,1,0
81866,resection,1,1
81867,versus,1,0
81868,anterior,1,0
81869,approach,1,1
81870,),1,0
81871,of,0,0
81872,liver,0,0
81873,metastases,0,0
81874,from,0,0
81875,colorectal,0,0
81876,cancer,0,0
81877,on,0,0
81878,hematogenous,0,0
81879,tumor,0,0
81880,cell,0,0
81881,dissemination,0,0
81882,-,0,0
81883,prospective,0,0
81884,randomized,0,0
81885,multicenter,0,0
81886,trial,0,0
81887,.,0,0
81888,BACKGROUND,0,0
81889,Surgical,1,0
81890,hepatic,1,0
81891,resection,1,1
81892,remains,0,0
81893,the,0,0
81894,treatment,0,0
81895,of,0,0
81896,choice,0,0
81897,for,0,0
81898,patients,0,0
81899,with,0,0
81900,liver,0,0
81901,metastases,0,0
81902,from,0,0
81903,colorectal,0,0
81904,cancer,0,0
81905,despite,0,0
81906,the,0,0
81907,use,0,0
81908,of,0,0
81909,alternative,0,0
81910,therapeutic,0,0
81911,strategies,0,0
81912,.,0,0
81913,Although,0,0
81914,this,0,0
81915,procedure,0,0
81916,provides,0,0
81917,long-term,0,0
81918,survival,0,0
81919,in,0,0
81920,a,0,0
81921,significant,0,0
81922,number,0,0
81923,of,0,0
81924,patients,0,0
81925,",",0,0
81926,50-75,0,0
81927,%,0,0
81928,of,0,0
81929,the,0,0
81930,patients,0,0
81931,develop,0,0
81932,intra-,0,0
81933,and/or,0,0
81934,extrahepatic,0,0
81935,recurrence,0,0
81936,.,0,0
81937,One,0,0
81938,possible,0,0
81939,reason,0,0
81940,for,0,0
81941,tumor,0,0
81942,recurrence,0,0
81943,may,0,0
81944,be,0,0
81945,intraoperative,0,0
81946,hematogenous,0,0
81947,tumor,0,0
81948,cell,0,0
81949,dissemination,0,0
81950,due,0,0
81951,to,0,0
81952,mechanical,0,0
81953,manipulation,0,0
81954,of,0,0
81955,the,0,0
81956,tumor,0,0
81957,during,0,0
81958,hepatic,0,0
81959,resection,0,1
81960,.,0,0
81961,Surgical,0,0
81962,technique,0,0
81963,may,0,0
81964,have,0,0
81965,an,0,0
81966,influence,0,0
81967,on,0,0
81968,hematogenous,0,0
81969,tumor,0,0
81970,cell,0,0
81971,spread,0,0
81972,.,0,0
81973,We,0,0
81974,hypothesize,0,0
81975,that,0,0
81976,hematogenous,0,0
81977,tumor,0,0
81978,cell,0,0
81979,dissemination,0,0
81980,may,0,0
81981,be,0,0
81982,reduced,0,0
81983,by,0,0
81984,using,0,0
81985,the,0,0
81986,anterior,0,0
81987,approach,0,1
81988,technique,0,1
81989,compared,0,0
81990,to,0,0
81991,conventional,0,1
81992,liver,0,0
81993,resection,0,1
81994,.,0,0
81995,METHODS/DESIGN,0,0
81996,This,0,0
81997,is,0,0
81998,a,0,0
81999,multi-centre,0,0
82000,prospective,0,0
82001,randomized,0,0
82002,controlled,0,0
82003,",",0,0
82004,superiority,0,0
82005,trial,0,0
82006,to,0,0
82007,compare,0,0
82008,two,0,0
82009,liver,1,0
82010,resection,1,0
82011,techniques,1,1
82012,of,1,0
82013,liver,1,0
82014,metastases,1,0
82015,from,0,0
82016,colorectal,0,0
82017,cancer,0,0
82018,.,0,0
82019,150,0,0
82020,patients,0,0
82021,will,0,0
82022,be,0,0
82023,included,0,0
82024,and,0,0
82025,randomized,0,0
82026,intraoperatively,0,0
82027,after,0,0
82028,surgical,0,0
82029,exploration,0,0
82030,just,0,0
82031,prior,0,0
82032,to,0,0
82033,resection,0,0
82034,.,0,0
82035,The,0,0
82036,primary,0,0
82037,objective,0,0
82038,is,0,0
82039,to,0,0
82040,compare,0,0
82041,the,0,0
82042,anterior,1,0
82043,approach,1,1
82044,with,0,0
82045,the,0,0
82046,conventional,1,1
82047,liver,1,0
82048,resection,1,1
82049,technique,1,1
82050,with,0,0
82051,regard,0,0
82052,to,0,0
82053,intraoperative,0,1
82054,haematogenous,0,0
82055,tumor,0,0
82056,cell,0,0
82057,dissemination,0,0
82058,.,0,0
82059,As,0,0
82060,secondary,0,0
82061,objectives,0,0
82062,we,0,0
82063,examine,0,0
82064,five,0,0
82065,year,0,0
82066,survival,0,0
82067,rates,0,0
82068,(,0,0
82069,OS,0,0
82070,and,0,0
82071,DFS,0,0
82072,),0,0
82073,",",0,0
82074,blood,0,0
82075,loss,0,0
82076,",",0,0
82077,duration,0,0
82078,of,0,0
82079,operation,0,0
82080,",",0,0
82081,requirement,0,0
82082,of,0,0
82083,blood,0,0
82084,transfusions,0,0
82085,",",0,0
82086,morbidity,0,0
82087,rate,0,0
82088,",",0,0
82089,prognostic,0,0
82090,relevance,0,0
82091,of,0,0
82092,tumor,0,0
82093,cell,0,0
82094,detection,0,0
82095,in,0,0
82096,blood,0,0
82097,and,0,0
82098,bone,0,0
82099,marrow,0,0
82100,and,0,0
82101,the,0,0
82102,comparison,0,0
82103,of,0,0
82104,tumor,0,0
82105,cell,0,0
82106,detection,0,0
82107,by,0,0
82108,different,0,0
82109,detection,0,0
82110,methods,0,0
82111,.,0,0
82112,CONCLUSION,0,0
82113,This,0,0
82114,trial,0,0
82115,will,0,0
82116,answer,0,0
82117,the,0,0
82118,question,0,0
82119,whether,0,0
82120,there,0,0
82121,is,0,0
82122,an,0,0
82123,advantage,0,0
82124,for,0,0
82125,the,0,0
82126,anterior,1,0
82127,approach,1,1
82128,technique,1,1
82129,compared,0,0
82130,to,0,0
82131,the,0,0
82132,conventional,1,1
82133,resection,1,1
82134,group,0,0
82135,with,0,0
82136,regard,0,0
82137,to,0,0
82138,tumor,0,0
82139,cell,0,0
82140,dissemination,0,0
82141,.,0,0
82142,It,0,0
82143,will,0,0
82144,also,0,0
82145,add,0,0
82146,further,0,0
82147,information,0,0
82148,about,0,0
82149,prognostic,0,0
82150,differences,0,0
82151,",",0,0
82152,safety,0,0
82153,",",0,0
82154,advantages,0,0
82155,and,0,0
82156,disadvantages,0,0
82157,of,0,0
82158,each,0,0
82159,technique,0,1
82160,.,0,0
82161,TRIAL,0,0
82162,REGISTRATION,0,0
82163,Current,0,0
82164,controlled,0,0
82165,trials,0,0
82166,-,0,0
82167,ISRCTN45066244,0,0
82168,.,0,0
82169,Desogestrel,0,1
82170,and,0,0
82171,gestodene,0,1
82172,in,0,0
82173,oral,0,0
82174,contraceptives,0,1
82175,:,0,0
82176,12,0,0
82177,months,0,0
82178,',0,0
82179,assessment,0,0
82180,of,0,0
82181,carbohydrate,0,1
82182,and,0,0
82183,lipoprotein,0,0
82184,metabolism,0,0
82185,.,0,0
82186,We,0,0
82187,examined,0,0
82188,the,0,0
82189,influence,0,0
82190,on,0,0
82191,carbohydrate,0,1
82192,and,0,0
82193,lipoprotein,0,0
82194,metabolism,0,0
82195,of,0,0
82196,oral,1,1
82197,contraceptives,1,1
82198,(,1,0
82199,OCs,1,1
82200,),1,0
82201,containing,0,1
82202,two,0,0
82203,new,0,0
82204,third-generation,0,0
82205,progestogens,1,1
82206,",",1,0
82207,desogestrel,1,1
82208,and,1,0
82209,gestodene,1,1
82210,.,0,0
82211,This,0,0
82212,was,0,0
82213,a,0,0
82214,prospective,0,0
82215,randomized,0,0
82216,study,0,0
82217,in,0,0
82218,which,0,0
82219,monophasic,0,0
82220,combinations,0,0
82221,of,0,0
82222,20,1,0
82223,micrograms,1,0
82224,ethinyl,1,1
82225,estradiol,1,1
82226,(,1,0
82227,E2,1,0
82228,),1,0
82229,and,0,0
82230,150,1,0
82231,micrograms,1,1
82232,desogestrel,1,1
82233,or,0,0
82234,30,0,0
82235,micrograms,0,0
82236,ethinyl,1,1
82237,E2,1,0
82238,plus,1,1
82239,75,1,0
82240,micrograms,1,0
82241,gestodene,1,0
82242,were,0,0
82243,administered,0,0
82244,to,0,0
82245,15,0,0
82246,and,0,0
82247,19,0,0
82248,healthy,0,0
82249,women,0,0
82250,",",0,0
82251,respectively,0,0
82252,.,0,0
82253,An,0,0
82254,oral,0,0
82255,glucose,0,0
82256,tolerance,0,0
82257,test,0,0
82258,including,0,0
82259,measurement,0,0
82260,of,0,0
82261,insulin,0,1
82262,response,0,0
82263,was,0,0
82264,performed,0,0
82265,before,0,0
82266,treatment,0,0
82267,and,0,0
82268,after,0,0
82269,3,0,0
82270,",",0,0
82271,6,0,0
82272,",",0,0
82273,and,0,0
82274,12,0,0
82275,months,0,0
82276,of,0,0
82277,treatment,0,0
82278,.,0,0
82279,We,0,0
82280,also,0,0
82281,determined,0,0
82282,fasting,0,0
82283,plasma,0,0
82284,concentrations,0,0
82285,of,0,0
82286,total,0,0
82287,cholesterol,0,0
82288,;,0,0
82289,high-density,0,0
82290,lipoprotein,0,0
82291,cholesterol,0,0
82292,",",0,0
82293,including,0,0
82294,the,0,0
82295,subfractions,0,1
82296,high-density,0,0
82297,lipoprotein2,0,0
82298,cholesterol,0,0
82299,and,0,0
82300,high-density,0,0
82301,lipoprotein3,0,0
82302,cholesterol,0,0
82303,;,0,0
82304,low-density,0,0
82305,lipoprotein,0,0
82306,cholesterol,0,0
82307,;,0,0
82308,very,0,0
82309,low-density,0,0
82310,lipoprotein,0,0
82311,cholesterol,0,0
82312,;,0,0
82313,and,0,0
82314,triglycerides,0,0
82315,.,0,0
82316,A,0,0
82317,transient,0,0
82318,deterioration,0,0
82319,of,0,0
82320,glucose,0,0
82321,tolerance,0,0
82322,was,0,0
82323,observed,0,0
82324,despite,0,0
82325,unchanged,0,0
82326,levels,0,0
82327,of,0,0
82328,insulin,0,0
82329,after,0,0
82330,treatment,0,0
82331,with,0,0
82332,both,0,0
82333,compounds,0,1
82334,for,0,0
82335,3,0,0
82336,months,0,0
82337,.,0,0
82338,In,0,0
82339,both,0,0
82340,groups,0,0
82341,plasma,0,0
82342,levels,0,0
82343,of,0,0
82344,triglycerides,0,0
82345,",",0,0
82346,very,0,0
82347,low-density,0,0
82348,lipoprotein,0,0
82349,cholesterol,0,0
82350,",",0,0
82351,and,0,0
82352,high-density,0,0
82353,lipoprotein,0,0
82354,cholesterol,0,0
82355,increased,0,0
82356,significantly,0,0
82357,after,0,0
82358,3,0,0
82359,months,0,0
82360,.,0,0
82361,After,0,0
82362,12,0,0
82363,months,0,0
82364,",",0,0
82365,a,0,0
82366,significant,0,0
82367,increase,0,0
82368,in,0,0
82369,the,0,0
82370,high-density,0,0
82371,lipoprotein,0,0
82372,cholesterol/total,0,0
82373,cholesterol,0,0
82374,ratio,0,0
82375,was,0,0
82376,observed,0,0
82377,in,0,0
82378,the,0,0
82379,ethinyl,0,1
82380,E2-desogestrel,0,1
82381,group,0,0
82382,",",0,0
82383,and,0,0
82384,no,0,0
82385,persistent,0,0
82386,changes,0,0
82387,in,0,0
82388,low-density,0,0
82389,lipoprotein,0,0
82390,cholesterol,0,0
82391,could,0,0
82392,be,0,0
82393,demonstrated,0,0
82394,in,0,0
82395,any,0,0
82396,of,0,0
82397,the,0,0
82398,groups,0,0
82399,.,0,0
82400,Our,0,0
82401,results,0,0
82402,indicate,0,0
82403,that,0,0
82404,treatment,0,0
82405,with,0,0
82406,either,0,0
82407,compound,0,1
82408,for,0,0
82409,12,0,0
82410,months,0,0
82411,has,0,0
82412,no,0,0
82413,effect,0,0
82414,on,0,0
82415,carbohydrate,0,1
82416,or,0,1
82417,lipoprotein,0,0
82418,metabolism,0,0
82419,known,0,0
82420,to,0,0
82421,increase,0,0
82422,the,0,0
82423,risk,0,0
82424,of,0,0
82425,cardiovascular,0,0
82426,disease,0,0
82427,.,0,0
82428,Resource,0,1
82429,utilization,0,0
82430,and,0,0
82431,economic,0,0
82432,costs,0,0
82433,of,0,0
82434,care,0,0
82435,based,0,0
82436,on,0,0
82437,a,0,0
82438,randomized,0,0
82439,trial,0,0
82440,of,0,0
82441,vacuum-assisted,1,1
82442,closure,1,0
82443,therapy,1,1
82444,in,0,0
82445,the,0,0
82446,treatment,0,0
82447,of,0,0
82448,diabetic,0,0
82449,foot,0,0
82450,wounds,0,0
82451,.,0,0
82452,BACKGROUND,0,0
82453,To,0,0
82454,evaluate,0,0
82455,resource,0,0
82456,utilization,0,0
82457,and,0,0
82458,direct,0,1
82459,economic,0,0
82460,costs,0,0
82461,of,0,0
82462,care,0,0
82463,for,0,0
82464,patients,0,0
82465,treated,0,0
82466,with,0,0
82467,negative-pressure,1,1
82468,wound,1,0
82469,therapy,1,1
82470,(,1,0
82471,NPWT,1,1
82472,),1,0
82473,",",0,0
82474,using,0,0
82475,the,1,0
82476,Vacuum-Assisted,1,1
82477,Closure,1,1
82478,(,1,0
82479,V.A.C,1,1
82480,.,1,0
82481,),1,0
82482,system,1,0
82483,",",0,0
82484,compared,0,0
82485,to,0,0
82486,standard,1,1
82487,moist,1,1
82488,wound,1,0
82489,therapy,1,1
82490,(,1,0
82491,MWT,1,1
82492,),1,0
82493,.,1,0
82494,METHODS,0,0
82495,A,0,0
82496,total,0,0
82497,of,0,0
82498,162,0,0
82499,diabetic,0,0
82500,patients,0,0
82501,with,0,0
82502,post-amputation,0,0
82503,wounds,0,0
82504,(,0,0
82505,up,0,0
82506,to,0,0
82507,the,0,0
82508,trans-metatarsal,0,0
82509,level,0,0
82510,),0,0
82511,entered,0,0
82512,a,0,0
82513,16-week,0,0
82514,",",0,0
82515,randomized,0,0
82516,clinical,0,0
82517,trial,0,0
82518,.,0,0
82519,Patients,0,0
82520,randomized,0,0
82521,to,0,0
82522,V.A.C,1,0
82523,.,1,0
82524,(,0,0
82525,n,0,0
82526,=,0,0
82527,77,0,0
82528,),0,0
82529,received,0,0
82530,therapy,1,1
82531,with,1,0
82532,dressing,1,1
82533,changes,1,0
82534,every,0,0
82535,48,0,0
82536,hours,0,0
82537,.,0,0
82538,Control,0,0
82539,patients,0,0
82540,(,0,0
82541,n,0,0
82542,=,0,0
82543,85,0,0
82544,),0,0
82545,received,0,0
82546,standard,0,1
82547,MWT,1,1
82548,.,1,0
82549,Resource,0,0
82550,utilization,0,0
82551,",",0,0
82552,procedures,0,0
82553,",",0,0
82554,and,0,0
82555,direct,0,0
82556,costs,0,0
82557,were,0,0
82558,calculated,0,0
82559,and,0,0
82560,analyzed,0,0
82561,in,0,0
82562,this,0,0
82563,post,0,0
82564,hoc,0,0
82565,retrospective,0,0
82566,study,0,0
82567,.,0,0
82568,RESULTS,0,0
82569,There,0,0
82570,was,0,0
82571,no,0,0
82572,difference,0,0
82573,between,0,0
82574,groups,0,0
82575,for,0,0
82576,in-patient,0,0
82577,hospital,0,0
82578,stay,0,0
82579,(,0,0
82580,number,0,0
82581,of,0,0
82582,admissions,0,0
82583,or,0,0
82584,length,0,0
82585,of,0,0
82586,stay,0,0
82587,),0,0
82588,.,0,0
82589,More,0,0
82590,surgical,0,0
82591,procedures,0,0
82592,(,0,0
82593,including,0,0
82594,debridement,0,1
82595,),0,0
82596,were,0,0
82597,required,0,0
82598,in,0,0
82599,the,0,0
82600,MWT,1,1
82601,group,0,0
82602,(,0,0
82603,120,0,0
82604,vs,0,0
82605,43,0,0
82606,NPWT,1,0
82607,",",0,0
82608,P,0,0
82609,<,0,0
82610,.001,0,0
82611,),0,0
82612,.,0,0
82613,The,0,0
82614,average,0,0
82615,number,0,0
82616,of,0,0
82617,dressing,0,1
82618,changes,0,0
82619,performed,0,0
82620,per,0,0
82621,patient,0,0
82622,was,0,0
82623,118.0,0,0
82624,(,0,0
82625,range,0,0
82626,12-226,0,0
82627,),0,0
82628,for,0,0
82629,MWT,1,1
82630,versus,0,0
82631,41,0,0
82632,(,0,0
82633,6-140,0,0
82634,),0,0
82635,for,0,0
82636,NPWT,1,1
82637,(,0,0
82638,P,0,0
82639,=,0,0
82640,.0001,0,0
82641,),0,0
82642,.,0,0
82643,The,0,0
82644,MWT,1,0
82645,group,0,0
82646,had,0,0
82647,11,0,0
82648,(,0,0
82649,range,0,0
82650,0-106,0,0
82651,),0,0
82652,outpatient,0,0
82653,treatment,0,0
82654,visits,0,0
82655,during,0,0
82656,the,0,0
82657,study,0,0
82658,versus,0,0
82659,4,0,0
82660,(,0,0
82661,range,0,0
82662,0-47,0,0
82663,),0,0
82664,in,0,0
82665,the,0,0
82666,NPWT,1,1
82667,group,0,0
82668,(,0,0
82669,P,0,0
82670,<,0,0
82671,.05,0,0
82672,),0,0
82673,.,0,0
82674,The,0,0
82675,average,0,0
82676,direct,0,0
82677,cost,0,0
82678,per,0,0
82679,patient,0,0
82680,treated,0,0
82681,for,0,0
82682,8,0,0
82683,weeks,0,0
82684,or,0,0
82685,longer,0,0
82686,(,0,0
82687,independent,0,0
82688,of,0,0
82689,clinical,0,0
82690,outcome,0,0
82691,),0,0
82692,was,0,0
82693,$,0,0
82694,"27,270",0,0
82695,and,0,0
82696,$,0,0
82697,"36,096",0,0
82698,in,0,0
82699,the,0,0
82700,NPWT,0,0
82701,and,0,0
82702,MWT,0,1
82703,groups,0,0
82704,",",0,0
82705,respectively,0,0
82706,.,0,0
82707,The,0,0
82708,average,0,0
82709,total,0,0
82710,cost,0,0
82711,to,0,0
82712,achieve,0,0
82713,healing,0,0
82714,was,0,0
82715,$,0,0
82716,"25,954",0,0
82717,for,0,0
82718,patients,0,0
82719,treated,0,0
82720,with,0,0
82721,NPWT,1,1
82722,(,0,0
82723,n,0,0
82724,=,0,0
82725,43,0,0
82726,),0,0
82727,compared,0,0
82728,with,0,0
82729,$,0,0
82730,"38,806",0,0
82731,for,0,0
82732,the,0,0
82733,MWT,1,1
82734,group,0,0
82735,(,0,0
82736,n,0,0
82737,=,0,0
82738,33,0,0
82739,),0,0
82740,.,0,0
82741,CONCLUSION,0,0
82742,Treatment,0,0
82743,of,0,0
82744,diabetic,0,0
82745,patients,0,0
82746,with,0,0
82747,post,0,0
82748,amputation,0,1
82749,wounds,0,0
82750,using,0,0
82751,NPWT,1,0
82752,resulted,0,0
82753,in,0,0
82754,lower,0,0
82755,resource,0,0
82756,utilization,0,0
82757,and,0,0
82758,a,0,0
82759,greater,0,0
82760,proportion,0,0
82761,of,0,0
82762,patients,0,0
82763,obtaining,0,0
82764,wound,0,0
82765,healing,0,0
82766,at,0,0
82767,a,0,0
82768,lower,0,0
82769,overall,0,0
82770,cost,0,0
82771,of,0,0
82772,care,0,0
82773,when,0,0
82774,compared,0,0
82775,to,0,0
82776,MWT,1,0
82777,.,1,0
82778,Effect,0,0
82779,of,0,0
82780,finasteride,1,1
82781,treatment,0,0
82782,on,0,0
82783,suburethral,0,1
82784,prostatic,0,0
82785,microvessel,0,0
82786,density,0,0
82787,in,0,0
82788,patients,0,0
82789,with,0,0
82790,hematuria,0,0
82791,related,0,0
82792,to,0,0
82793,benign,0,0
82794,prostate,0,0
82795,hyperplasia,0,0
82796,.,0,0
82797,INTRODUCTION,0,0
82798,In,0,0
82799,the,0,0
82800,present,0,0
82801,study,0,0
82802,we,0,0
82803,evaluated,0,0
82804,the,0,0
82805,effect,0,0
82806,of,0,0
82807,short-term,0,0
82808,finasteride,1,1
82809,treatment,0,0
82810,on,0,0
82811,microvessel,0,0
82812,density,0,0
82813,(,0,0
82814,MVD,0,1
82815,),0,0
82816,which,0,0
82817,is,0,0
82818,an,0,0
82819,indicator,0,0
82820,of,0,0
82821,prostatic,0,0
82822,angiogenesis,0,0
82823,in,0,0
82824,patients,0,0
82825,with,0,0
82826,hematuria,0,0
82827,secondary,0,0
82828,to,0,0
82829,benign,0,0
82830,prostatic,0,1
82831,hyperplasia,0,0
82832,(,0,0
82833,BPH,0,0
82834,),0,0
82835,.,0,0
82836,MATERIALS,0,0
82837,AND,0,0
82838,METHODS,0,0
82839,30,0,0
82840,patients,0,0
82841,who,0,0
82842,were,0,0
82843,candidates,0,0
82844,for,0,0
82845,BPH,0,0
82846,surgery,0,0
82847,were,0,0
82848,prospectively,0,0
82849,included,0,0
82850,in,0,0
82851,the,0,0
82852,study,0,0
82853,.,0,0
82854,All,0,0
82855,patients,0,0
82856,had,0,0
82857,history,0,0
82858,of,0,0
82859,gross,0,0
82860,hematuria,0,0
82861,and,0,0
82862,evaluated,0,0
82863,by,0,0
82864,ultrasonography,0,1
82865,and,0,0
82866,cystoscopy,0,1
82867,.,0,0
82868,The,0,0
82869,patients,0,0
82870,were,0,0
82871,randomized,0,0
82872,two,0,0
82873,groups,0,0
82874,before,0,0
82875,surgery,0,0
82876,.,0,0
82877,The,0,0
82878,treatment,0,0
82879,group,0,0
82880,consisted,0,0
82881,of,0,0
82882,13,0,0
82883,patients,0,0
82884,who,0,0
82885,were,0,0
82886,given,0,0
82887,5,1,0
82888,mg,1,0
82889,finasteride,1,1
82890,daily,1,0
82891,for,0,0
82892,4,0,0
82893,weeks,0,0
82894,before,0,0
82895,surgery,0,0
82896,.,0,0
82897,The,0,0
82898,control,0,0
82899,group,0,0
82900,consisted,0,0
82901,of,0,0
82902,17,0,0
82903,patients,0,0
82904,who,0,0
82905,did,1,0
82906,not,1,0
82907,receive,1,0
82908,finasteride,1,1
82909,before,0,0
82910,surgery,0,0
82911,.,0,0
82912,During,0,0
82913,surgery,0,0
82914,",",0,0
82915,resected,0,0
82916,suburethral,0,0
82917,and,0,0
82918,hyperplastic,0,0
82919,prostate,0,0
82920,specimens,0,0
82921,were,0,0
82922,sent,0,0
82923,for,0,0
82924,histopathologic,0,0
82925,MVD,0,1
82926,determination,0,0
82927,separately,0,0
82928,.,0,0
82929,RESULTS,0,0
82930,Mean,0,0
82931,MVD,0,0
82932,in,0,0
82933,the,0,0
82934,suburethral,0,0
82935,portion,0,0
82936,of,0,0
82937,prostate,0,0
82938,was,0,0
82939,significantly,0,0
82940,lower,0,0
82941,in,0,0
82942,patients,0,0
82943,treated,0,0
82944,with,0,0
82945,finasteride,0,1
82946,when,0,0
82947,compared,0,0
82948,with,0,0
82949,controls,0,0
82950,(,0,0
82951,9.08,0,0
82952,+/-,0,0
82953,5.6,0,0
82954,and,0,0
82955,13.94,0,0
82956,+/-,0,0
82957,5.90,0,0
82958,",",0,0
82959,respectively,0,0
82960,",",0,0
82961,p,0,0
82962,<,0,0
82963,0.05,0,0
82964,),0,0
82965,.,0,0
82966,Mean,0,0
82967,MVD,0,0
82968,for,0,0
82969,the,0,0
82970,hyperplastic,0,0
82971,portion,0,0
82972,of,0,0
82973,prostate,0,0
82974,was,0,0
82975,similar,0,0
82976,for,0,0
82977,the,0,0
82978,finasteride,0,1
82979,and,0,0
82980,control,0,1
82981,groups,0,0
82982,(,0,0
82983,14.21,0,0
82984,+/-,0,0
82985,7.10,0,0
82986,and,0,0
82987,19.75,0,0
82988,+/-,0,0
82989,9.73,0,0
82990,",",0,0
82991,respectively,0,0
82992,",",0,0
82993,p,0,0
82994,>,0,0
82995,0.05,0,0
82996,),0,0
82997,.,0,0
82998,CONCLUSION,0,0
82999,The,0,0
83000,potential,0,0
83001,role,0,0
83002,of,0,0
83003,finasteride,0,1
83004,on,0,0
83005,hematuria,0,0
83006,related,0,0
83007,to,0,0
83008,BPH,0,0
83009,may,0,0
83010,be,0,0
83011,the,0,0
83012,suppressive,0,0
83013,effect,0,0
83014,on,0,0
83015,MVD,0,0
83016,in,0,0
83017,the,0,0
83018,suburethral,0,0
83019,tissue,0,0
83020,of,0,0
83021,prostate,0,0
83022,.,0,0
83023,Post-laparoscopic,0,1
83024,cholecystectomy,0,1
83025,pain,0,0
83026,:,0,0
83027,effects,0,0
83028,of,0,0
83029,intraperitoneal,0,0
83030,local,0,0
83031,anesthetics,1,1
83032,on,0,0
83033,pain,0,0
83034,control,0,0
83035,--,0,0
83036,a,0,0
83037,randomized,0,0
83038,prospective,0,0
83039,double-blinded,0,0
83040,placebo-controlled,0,1
83041,trial,0,0
83042,.,0,0
83043,Postoperative,0,0
83044,pain,0,0
83045,after,0,0
83046,laparoscopic,0,1
83047,cholecystectomy,0,1
83048,(,0,0
83049,LC,0,1
83050,),0,1
83051,is,0,0
83052,generally,0,0
83053,less,0,0
83054,than,0,0
83055,open,0,0
83056,cholecystectomy,0,0
83057,;,0,0
83058,however,0,0
83059,",",0,0
83060,the,0,0
83061,postoperative,0,0
83062,shoulder,0,0
83063,and,0,0
83064,abdominal,0,0
83065,pain,0,0
83066,experienced,0,0
83067,by,0,0
83068,patients,0,0
83069,still,0,0
83070,causes,0,0
83071,preventable,0,0
83072,distress,0,0
83073,.,0,0
83074,Intraperitoneal,0,0
83075,irrigation,0,1
83076,of,0,0
83077,the,0,0
83078,diaphragmatic,0,0
83079,surface,0,0
83080,and,0,0
83081,gallbladder,0,0
83082,fossa,0,0
83083,using,0,0
83084,normal,0,0
83085,saline,1,1
83086,",",1,0
83087,bupivacaine,1,1
83088,",",0,0
83089,or,0,0
83090,lignocaine,1,1
83091,may,0,0
83092,effectively,0,0
83093,control,0,0
83094,visceral,0,0
83095,abdominal,0,0
83096,pain,0,0
83097,after,0,0
83098,an,0,0
83099,LC,0,0
83100,.,0,0
83101,Two,0,0
83102,hundred,0,0
83103,patients,0,0
83104,with,0,0
83105,similar,0,0
83106,demographics,0,0
83107,undergoing,0,0
83108,elective,0,0
83109,LC,0,0
83110,were,0,0
83111,randomized,0,0
83112,to,0,0
83113,one,0,0
83114,of,0,0
83115,four,0,0
83116,groups,0,0
83117,of,0,0
83118,50,0,0
83119,patients,0,0
83120,each,0,0
83121,",",0,0
83122,including,0,0
83123,Group,0,0
83124,A,0,0
83125,placebo,1,1
83126,control,0,0
83127,",",0,0
83128,Group,0,0
83129,B,0,0
83130,with,0,0
83131,isotonic,1,1
83132,saline,1,1
83133,irrigation,1,1
83134,",",0,0
83135,Group,0,0
83136,C,0,0
83137,with,0,0
83138,bupivacaine,1,1
83139,irrigation,1,1
83140,",",0,0
83141,and,0,0
83142,Group,0,0
83143,D,0,1
83144,with,0,0
83145,lignocaine,1,1
83146,irrigation,1,1
83147,.,1,0
83148,All,0,0
83149,patients,0,0
83150,received,0,0
83151,preperitoneal,0,0
83152,abdominal,0,0
83153,wall,0,0
83154,infiltration,0,0
83155,with,0,0
83156,0.25,0,0
83157,per,0,0
83158,cent,0,0
83159,bupivacaine,1,1
83160,to,0,0
83161,control,0,1
83162,parietal,0,0
83163,(,0,0
83164,somatic,0,0
83165,),0,0
83166,abdominal,0,0
83167,pain,0,0
83168,.,0,0
83169,The,0,0
83170,visual,0,0
83171,analogue,0,0
83172,and,0,0
83173,verbal,0,1
83174,rating,0,0
83175,pain,0,0
83176,scores,0,0
83177,at,0,0
83178,0,0,0
83179,",",0,0
83180,4,0,0
83181,",",0,0
83182,8,0,0
83183,",",0,0
83184,12,0,0
83185,and,0,0
83186,24,0,0
83187,hours,0,0
83188,for,0,0
83189,both,0,0
83190,shoulder,0,0
83191,and,0,0
83192,abdominal,0,0
83193,pain,0,0
83194,were,0,0
83195,recorded,0,0
83196,in,0,0
83197,a,0,0
83198,prospective,0,0
83199,double-blind,0,0
83200,fashion,0,0
83201,at,0,0
83202,four,0,0
83203,points,0,0
83204,during,0,0
83205,the,0,0
83206,first,0,0
83207,24,0,0
83208,postoperative,0,0
83209,hours,0,0
83210,.,0,0
83211,Analgesia,0,0
83212,requirements,0,0
83213,",",0,0
83214,vital,0,0
83215,signs,0,0
83216,",",0,0
83217,blood,0,0
83218,glucose,0,0
83219,",",0,0
83220,and,0,0
83221,incidence,0,0
83222,of,0,0
83223,nausea,0,0
83224,and,0,0
83225,vomiting,0,0
83226,were,0,0
83227,also,0,0
83228,recorded,0,0
83229,.,0,0
83230,Patients,0,0
83231,in,0,0
83232,each,0,0
83233,group,0,0
83234,demonstrated,0,0
83235,a,0,0
83236,significant,0,0
83237,difference,0,0
83238,in,0,0
83239,visual,0,0
83240,analogue,0,0
83241,and,0,0
83242,verbal,0,1
83243,rating,0,0
83244,pain,0,0
83245,scores,0,0
83246,and,0,0
83247,analgesic,0,0
83248,consumption,0,0
83249,when,0,0
83250,compared,0,0
83251,with,0,0
83252,controls,0,0
83253,.,0,0
83254,Lignocaine,1,1
83255,controlled,0,0
83256,pain,0,0
83257,significantly,0,0
83258,better,0,0
83259,than,0,0
83260,saline,1,1
83261,or,0,0
83262,bupivacaine,1,1
83263,.,1,0
83264,Bowel,0,1
83265,function,0,0
83266,recovery,0,0
83267,was,0,0
83268,similar,0,0
83269,in,0,0
83270,all,0,0
83271,patients,0,0
83272,",",0,0
83273,and,0,0
83274,there,0,0
83275,were,0,0
83276,no,0,0
83277,significant,0,0
83278,complications,0,0
83279,.,0,0
83280,We,0,0
83281,conclude,0,0
83282,that,0,0
83283,intraperitoneal,0,1
83284,irrigation,0,1
83285,with,0,0
83286,either,0,0
83287,saline,1,1
83288,",",1,0
83289,bupivacaine,1,1
83290,",",0,0
83291,or,0,0
83292,lignocaine,1,1
83293,can,0,0
83294,significantly,0,0
83295,reduce,0,0
83296,visceral,0,0
83297,abdominal,0,0
83298,pain,0,0
83299,after,0,0
83300,LC,0,0
83301,.,0,0
83302,Lignocaine,1,1
83303,was,0,0
83304,the,0,0
83305,most,0,0
83306,efficacious,0,0
83307,local,0,0
83308,anesthetic,0,1
83309,in,0,0
83310,this,0,0
83311,trial,0,0
83312,and,0,0
83313,has,0,0
83314,a,0,0
83315,high,0,0
83316,safety,0,0
83317,profile,0,0
83318,when,0,0
83319,used,0,0
83320,at,0,0
83321,recommended,0,0
83322,doses,0,0
83323,.,0,0
83324,Determinants,0,0
83325,of,0,0
83326,improvement,0,0
83327,in,0,0
83328,walking,0,0
83329,capacity,0,0
83330,among,0,0
83331,individuals,0,0
83332,with,0,0
83333,chronic,0,0
83334,stroke,0,0
83335,following,0,0
83336,a,0,0
83337,multi-dimensional,1,0
83338,exercise,1,1
83339,program,1,1
83340,.,1,0
83341,OBJECTIVE,0,0
83342,To,0,0
83343,identify,0,0
83344,the,0,0
83345,determinants,0,0
83346,of,0,0
83347,improvement,0,0
83348,in,0,0
83349,walking,0,1
83350,capacity,0,0
83351,following,0,0
83352,therapeutic,1,0
83353,exercise,1,1
83354,in,0,0
83355,chronic,0,0
83356,stroke,0,0
83357,survivors,0,0
83358,.,0,0
83359,DESIGN,0,0
83360,A,0,0
83361,secondary,0,0
83362,analysis,0,0
83363,of,0,0
83364,data,0,0
83365,obtained,0,0
83366,from,0,0
83367,a,0,0
83368,prospective,0,0
83369,",",0,0
83370,single-blind,0,0
83371,",",0,0
83372,randomized,0,0
83373,controlled,0,0
83374,intervention,0,1
83375,trial,0,0
83376,.,0,0
83377,SUBJECTS,0,0
83378,Sixty-three,0,0
83379,community-dwelling,0,0
83380,individuals,0,0
83381,(,0,0
83382,mean,0,0
83383,age,0,0
83384,=,0,0
83385,65,0,0
83386,years,0,0
83387,",",0,0
83388,age,0,0
83389,range,0,0
83390,=,0,0
83391,50-87,0,0
83392,years,0,0
83393,),0,0
83394,with,0,0
83395,a,0,0
83396,chronic,0,0
83397,stroke,0,0
83398,(,0,0
83399,post-stroke,0,0
83400,duration,0,0
83401,:,0,0
83402,mean,0,0
83403,=,0,0
83404,5.5,0,0
83405,years,0,0
83406,",",0,0
83407,range,0,0
83408,=,0,0
83409,1-28,0,0
83410,years,0,0
83411,),0,0
83412,.,0,0
83413,METHODS,0,0
83414,Subjects,0,0
83415,were,0,0
83416,randomized,0,0
83417,into,0,0
83418,a,0,0
83419,leg,1,0
83420,exercise,1,1
83421,group,0,0
83422,(,0,0
83423,n,0,0
83424,=,0,0
83425,32,0,0
83426,),0,0
83427,or,0,0
83428,an,0,0
83429,arm,1,0
83430,exercise,1,1
83431,group,0,0
83432,(,0,0
83433,n,0,0
83434,=,0,0
83435,31,0,0
83436,),0,0
83437,.,0,0
83438,Subjects,0,0
83439,in,0,0
83440,each,0,0
83441,group,0,0
83442,underwent,0,0
83443,3,0,0
83444,1-hour,0,0
83445,exercise,1,1
83446,sessions,1,1
83447,per,0,0
83448,week,0,0
83449,for,0,0
83450,19,0,0
83451,weeks,0,0
83452,.,0,0
83453,Walking,0,0
83454,capacity,0,0
83455,",",0,0
83456,cardiorespiratory,0,0
83457,fitness,0,0
83458,",",0,0
83459,isometric,0,1
83460,knee,0,0
83461,extensor,0,1
83462,muscle,0,0
83463,strength,0,0
83464,",",0,0
83465,balance,0,0
83466,ability,0,0
83467,",",0,0
83468,and,0,0
83469,balance,0,0
83470,confidence,0,0
83471,were,0,0
83472,evaluated,0,0
83473,before,0,0
83474,and,0,0
83475,after,0,0
83476,the,0,0
83477,interventions,0,0
83478,.,0,0
83479,Multiple,0,0
83480,regression,0,0
83481,analysis,0,0
83482,was,0,0
83483,performed,0,0
83484,to,0,0
83485,identify,0,0
83486,the,0,0
83487,determinants,0,0
83488,of,0,0
83489,improvement,0,0
83490,in,0,0
83491,walking,0,0
83492,capacity,0,0
83493,.,0,0
83494,RESULTS,0,0
83495,After,0,0
83496,controlling,0,0
83497,for,0,0
83498,age,0,0
83499,",",0,0
83500,gender,0,0
83501,",",0,0
83502,post-stroke,0,0
83503,duration,0,0
83504,",",0,0
83505,and,0,0
83506,baseline,0,0
83507,walking,0,1
83508,capacity,0,0
83509,",",0,0
83510,gain,0,0
83511,in,0,0
83512,paretic,0,0
83513,leg,0,0
83514,muscle,0,0
83515,strength,0,0
83516,and,0,0
83517,peak,0,0
83518,oxygen,0,1
83519,consumption,0,0
83520,remained,0,0
83521,independently,0,0
83522,associated,0,0
83523,with,0,0
83524,gain,0,0
83525,in,0,0
83526,walking,0,1
83527,capacity,0,0
83528,(,0,0
83529,R2,0,0
83530,=,0,0
83531,0.229,0,0
83532,),0,0
83533,.,0,0
83534,CONCLUSION,0,0
83535,Enhancement,0,0
83536,of,0,0
83537,cardiorespiratory,0,0
83538,fitness,0,0
83539,and,0,0
83540,paretic,0,0
83541,leg,0,0
83542,muscle,0,0
83543,strength,0,0
83544,are,0,0
83545,both,0,0
83546,significant,0,0
83547,determinants,0,0
83548,in,0,0
83549,improving,0,0
83550,walking,0,1
83551,capacity,0,0
83552,among,0,0
83553,chronic,0,0
83554,stroke,0,0
83555,survivors,0,0
83556,.,0,0
83557,However,0,0
83558,",",0,0
83559,the,0,0
83560,rather,0,0
83561,weak,0,0
83562,relationship,0,0
83563,(,0,0
83564,R2,0,0
83565,=,0,0
83566,0.229,0,0
83567,),0,0
83568,indicates,0,0
83569,that,0,0
83570,other,0,0
83571,factors,0,0
83572,not,0,0
83573,measured,0,0
83574,in,0,0
83575,this,0,0
83576,study,0,0
83577,may,0,0
83578,also,0,0
83579,contribute,0,0
83580,to,0,0
83581,the,0,0
83582,improvement,0,0
83583,in,0,0
83584,walking,0,0
83585,capacity,0,0
83586,.,0,0
83587,Genital,0,0
83588,responsiveness,0,0
83589,in,0,0
83590,healthy,0,0
83591,women,0,0
83592,with,0,0
83593,and,0,0
83594,without,0,0
83595,sexual,0,0
83596,arousal,0,0
83597,disorder,0,0
83598,.,0,0
83599,INTRODUCTION,0,0
83600,Most,0,0
83601,pharmacological,0,0
83602,treatments,0,0
83603,that,0,0
83604,are,0,0
83605,currently,0,0
83606,being,0,0
83607,developed,0,0
83608,for,0,0
83609,women,0,0
83610,with,0,0
83611,sexual,0,0
83612,arousal,0,0
83613,disorder,0,0
83614,are,0,0
83615,aimed,0,0
83616,at,0,0
83617,remedying,0,0
83618,a,0,0
83619,vasculogenic,0,0
83620,deficit,0,0
83621,.,0,0
83622,AIM,0,0
83623,This,0,0
83624,study,0,0
83625,investigated,0,0
83626,whether,0,0
83627,pre-,0,0
83628,and,0,0
83629,postmenopausal,0,0
83630,women,0,0
83631,with,0,0
83632,sexual,0,0
83633,arousal,0,0
83634,disorder,0,0
83635,are,0,0
83636,less,0,0
83637,genitally,0,0
83638,responsive,0,0
83639,to,0,0
83640,visual,0,0
83641,sexual,0,0
83642,stimuli,0,1
83643,than,0,0
83644,pre-,0,0
83645,and,0,0
83646,postmenopausal,0,0
83647,women,0,0
83648,without,0,0
83649,sexual,0,0
83650,problems,0,0
83651,.,0,0
83652,METHOD,0,0
83653,Twenty-nine,0,0
83654,medically,0,0
83655,healthy,0,0
83656,women,0,0
83657,with,0,0
83658,sexual,0,0
83659,arousal,0,0
83660,disorder,0,0
83661,(,0,0
83662,15,0,0
83663,premenopausal,0,0
83664,and,0,0
83665,14,0,0
83666,postmenopausal,0,0
83667,),0,0
83668,",",0,0
83669,diagnosed,0,0
83670,using,0,0
83671,the,0,0
83672,Diagnostic,0,0
83673,and,0,0
83674,Statistical,0,0
83675,Manual,0,0
83676,of,0,0
83677,Mental,0,0
83678,Disorders,0,0
83679,",",0,0
83680,4th,0,0
83681,Edition,0,0
83682,(,0,0
83683,DSM-IV,0,0
83684,),0,0
83685,criteria,0,0
83686,",",0,0
83687,and,0,0
83688,30,0,0
83689,age-matched,0,0
83690,women,0,0
83691,without,0,0
83692,sexual,0,0
83693,problems,0,0
83694,(,0,0
83695,16,0,0
83696,premenopausal,0,0
83697,and,0,0
83698,14,0,0
83699,postmenopausal,0,0
83700,),0,0
83701,were,0,0
83702,shown,0,0
83703,sexual,1,0
83704,stimuli,1,1
83705,depicting,1,0
83706,cunnilingus,1,0
83707,and,1,0
83708,intercourse,1,0
83709,.,1,0
83710,MAIN,0,0
83711,OUTCOME,0,0
83712,MEASURE,0,0
83713,Genital,0,0
83714,arousal,0,0
83715,was,0,0
83716,assessed,0,0
83717,as,0,0
83718,vaginal,0,0
83719,pulse,0,1
83720,amplitude,0,0
83721,(,0,0
83722,VPA,0,0
83723,),0,0
83724,using,0,0
83725,vaginal,1,0
83726,photoplethysmography,1,1
83727,.,1,0
83728,RESULTS,0,0
83729,Results,0,0
83730,showed,0,0
83731,no,0,0
83732,significant,0,0
83733,differences,0,0
83734,between,0,0
83735,the,0,0
83736,two,0,0
83737,groups,0,0
83738,in,0,0
83739,mean,0,0
83740,and,0,0
83741,maximum,0,0
83742,VPA,0,0
83743,",",0,0
83744,nor,0,0
83745,in,0,0
83746,latency,0,0
83747,of,0,0
83748,VPA,0,0
83749,response,0,0
83750,.,0,0
83751,CONCLUSION,0,0
83752,Women,0,0
83753,with,0,0
83754,sexual,0,0
83755,arousal,0,0
83756,disorder,0,0
83757,diagnosed,0,0
83758,according,0,0
83759,to,0,0
83760,DSM-IV,0,0
83761,criteria,0,0
83762,were,0,0
83763,not,0,0
83764,less,0,0
83765,genitally,0,0
83766,responsive,0,0
83767,to,0,0
83768,visual,0,0
83769,sexual,0,0
83770,stimuli,0,1
83771,than,0,0
83772,women,0,0
83773,without,0,0
83774,such,0,0
83775,problems,0,0
83776,.,0,0
83777,These,0,0
83778,findings,0,0
83779,are,0,0
83780,in,0,0
83781,line,0,0
83782,with,0,0
83783,previous,0,0
83784,studies,0,0
83785,.,0,0
83786,The,0,0
83787,sexual,0,0
83788,problems,0,0
83789,these,0,0
83790,women,0,0
83791,report,0,0
83792,are,0,0
83793,clearly,0,0
83794,not,0,0
83795,related,0,0
83796,to,0,0
83797,their,0,0
83798,potential,0,0
83799,to,0,0
83800,become,0,0
83801,genitally,0,0
83802,aroused,0,0
83803,.,0,0
83804,We,0,0
83805,argue,0,0
83806,that,0,0
83807,the,0,0
83808,DSM-IV,0,0
83809,criteria,0,0
83810,for,0,0
83811,sexual,0,0
83812,arousal,0,0
83813,disorder,0,0
83814,are,0,0
83815,in,0,0
83816,need,0,0
83817,of,0,0
83818,revision,0,0
83819,.,0,0
83820,In,0,0
83821,medically,0,0
83822,healthy,0,0
83823,women,0,0
83824,",",0,0
83825,impaired,0,0
83826,genital,0,0
83827,responsiveness,0,0
83828,is,0,0
83829,not,0,0
83830,a,0,0
83831,valid,0,0
83832,diagnostic,0,0
83833,criterion,0,0
83834,.,0,0
83835,Effect,0,0
83836,of,0,0
83837,prophylactic,1,1
83838,transluminal,1,1
83839,balloon,1,1
83840,angioplasty,1,1
83841,on,0,0
83842,cerebral,0,0
83843,vasospasm,0,0
83844,and,0,0
83845,outcome,0,0
83846,in,0,0
83847,patients,0,0
83848,with,0,0
83849,Fisher,0,1
83850,grade,0,0
83851,III,0,0
83852,subarachnoid,0,0
83853,hemorrhage,0,0
83854,:,0,0
83855,results,0,0
83856,of,0,0
83857,a,0,0
83858,phase,0,0
83859,II,0,0
83860,multicenter,0,0
83861,",",0,0
83862,randomized,0,0
83863,",",0,0
83864,clinical,0,0
83865,trial,0,0
83866,.,0,0
83867,BACKGROUND,0,0
83868,AND,0,0
83869,PURPOSE,0,1
83870,Cerebral,0,0
83871,vasospasm,0,0
83872,continues,0,0
83873,to,0,0
83874,be,0,0
83875,a,0,0
83876,major,0,0
83877,cause,0,0
83878,of,0,0
83879,poor,0,0
83880,outcome,0,0
83881,in,0,0
83882,patients,0,0
83883,with,0,0
83884,ruptured,0,0
83885,aneurysms,0,0
83886,.,0,0
83887,Prophylactic,1,0
83888,Transluminal,1,1
83889,Balloon,1,1
83890,Angioplasty,1,1
83891,(,1,0
83892,pTBA,1,0
83893,),1,0
83894,appeared,0,0
83895,to,0,0
83896,prevent,0,0
83897,delayed,0,0
83898,ischemic,0,0
83899,neurological,0,0
83900,deficit,0,0
83901,in,0,0
83902,a,0,0
83903,pilot,0,0
83904,study,0,0
83905,.,0,0
83906,A,0,0
83907,phase,0,0
83908,II,0,0
83909,multicenter,0,0
83910,randomized,0,0
83911,clinical,0,0
83912,trial,0,0
83913,was,0,0
83914,subsequently,0,0
83915,designed,0,0
83916,.,0,0
83917,METHODS,0,0
83918,One,0,0
83919,hundred,0,0
83920,and,0,0
83921,seventy,0,0
83922,patients,0,0
83923,with,0,0
83924,Fisher,0,1
83925,Grade,0,1
83926,III,0,0
83927,subarachnoid,0,0
83928,hemorrhage,0,0
83929,were,0,0
83930,enrolled,0,0
83931,in,0,0
83932,the,0,0
83933,study,0,0
83934,.,0,0
83935,Of,0,0
83936,these,0,0
83937,",",0,0
83938,85,0,0
83939,patients,0,0
83940,were,0,0
83941,randomized,0,0
83942,to,0,0
83943,the,0,0
83944,treatment,0,0
83945,group,0,0
83946,and,0,0
83947,underwent,0,0
83948,pTBA,1,0
83949,within,0,0
83950,96,0,0
83951,hours,0,0
83952,after,0,0
83953,subarachnoid,0,0
83954,hemorrhage,0,0
83955,.,0,0
83956,Main,0,0
83957,end,0,0
83958,points,0,0
83959,of,0,0
83960,the,0,0
83961,study,0,0
83962,included,0,0
83963,the,0,0
83964,3-month,0,0
83965,dichotomized,0,0
83966,Glasgow,0,0
83967,Outcome,0,0
83968,Score,0,1
83969,(,0,0
83970,GOS,0,1
83971,),0,0
83972,",",0,0
83973,development,0,0
83974,of,0,0
83975,delayed,0,0
83976,ischemic,0,0
83977,neurological,0,0
83978,deficit,0,0
83979,(,0,0
83980,DIND,0,1
83981,),0,0
83982,",",0,0
83983,occurrence,0,0
83984,of,0,0
83985,Transcranial,0,1
83986,Doppler,0,1
83987,(,0,0
83988,TCD,0,0
83989,),0,0
83990,vasospasm,0,0
83991,",",0,0
83992,and,0,0
83993,length,0,0
83994,of,0,0
83995,stay,0,0
83996,in,0,0
83997,the,0,0
83998,ICU,0,0
83999,and,0,0
84000,hospital,0,0
84001,.,0,0
84002,RESULTS,0,0
84003,The,0,0
84004,incidence,0,0
84005,of,0,0
84006,DIND,0,0
84007,was,0,0
84008,lower,0,0
84009,in,0,0
84010,the,0,0
84011,pTBA,1,0
84012,group,0,0
84013,(,0,0
84014,P=0.30,0,0
84015,),0,0
84016,and,0,0
84017,fewer,0,0
84018,patients,0,0
84019,required,0,0
84020,therapeutic,0,0
84021,angioplasty,1,0
84022,to,0,0
84023,treat,0,0
84024,DIND,0,1
84025,(,0,0
84026,P=0.03,0,0
84027,),0,0
84028,.,0,0
84029,Overall,0,0
84030,pTBA,1,0
84031,resulted,0,0
84032,in,0,0
84033,an,0,0
84034,absolute,0,0
84035,risk,0,0
84036,reduction,0,0
84037,of,0,0
84038,5.9,0,0
84039,%,0,0
84040,and,0,0
84041,a,0,0
84042,relative,0,0
84043,risk,0,0
84044,reduction,0,0
84045,of,0,0
84046,10.4,0,0
84047,%,0,0
84048,unfavorable,0,0
84049,outcome,0,0
84050,(,0,0
84051,P=0.54,0,0
84052,),0,0
84053,.,0,0
84054,Good,0,0
84055,grade,0,0
84056,patients,0,0
84057,had,0,0
84058,absolute,0,0
84059,and,0,0
84060,relative,0,0
84061,risk,0,0
84062,reductions,0,0
84063,of,0,0
84064,respectively,0,0
84065,9.5,0,0
84066,and,0,0
84067,29.4,0,0
84068,%,0,0
84069,(,0,0
84070,P=0.73,0,0
84071,),0,0
84072,.,0,0
84073,Length,0,0
84074,of,0,0
84075,stay,0,0
84076,in,0,0
84077,ICU,0,0
84078,and,0,0
84079,hospital,0,0
84080,was,0,0
84081,similar,0,0
84082,in,0,0
84083,both,0,0
84084,groups,0,0
84085,.,0,0
84086,Four,0,0
84087,patients,0,0
84088,had,0,0
84089,a,0,0
84090,procedure-related,0,0
84091,vessel,0,0
84092,perforation,0,0
84093,",",0,0
84094,of,0,0
84095,which,0,0
84096,three,0,0
84097,patients,0,0
84098,died,0,0
84099,.,0,0
84100,CONCLUSIONS,0,0
84101,While,0,0
84102,the,0,0
84103,trial,0,0
84104,is,0,0
84105,unsuccessful,0,0
84106,as,0,0
84107,defined,0,0
84108,by,0,0
84109,the,0,0
84110,primary,0,0
84111,end,0,0
84112,point,0,0
84113,(,0,0
84114,GOS,0,1
84115,),0,0
84116,",",0,0
84117,proof,0,0
84118,of,0,0
84119,concept,0,0
84120,is,0,0
84121,confirmed,0,0
84122,by,0,0
84123,these,0,0
84124,results,0,0
84125,.,0,0
84126,Fewer,0,0
84127,patients,0,0
84128,tend,0,0
84129,to,0,0
84130,develop,0,0
84131,vasospasm,0,0
84132,after,0,0
84133,treatment,0,0
84134,with,0,0
84135,pTBA,1,0
84136,and,0,0
84137,there,0,0
84138,is,0,0
84139,a,0,0
84140,statistically,0,0
84141,significantly,0,0
84142,decreased,0,0
84143,need,0,0
84144,for,0,0
84145,therapeutic,1,0
84146,angioplasty,1,0
84147,.,1,0
84148,pTBA,1,0
84149,does,0,0
84150,not,0,0
84151,improve,0,0
84152,the,0,0
84153,poor,0,0
84154,outcome,0,0
84155,of,0,0
84156,patients,0,0
84157,with,0,0
84158,Fisher,0,1
84159,grade,0,0
84160,III,0,0
84161,subarachnoid,0,0
84162,hemorrhage,0,0
84163,.,0,0
84164,Evaluation,0,0
84165,of,0,0
84166,a,0,0
84167,device,1,0
84168,to,1,0
84169,facilitate,1,0
84170,female,1,0
84171,urethral,1,1
84172,catheterization,1,0
84173,.,1,0
84174,Urethral,1,0
84175,catheterization,1,0
84176,is,1,0
84177,a,0,0
84178,skilled,0,0
84179,procedure,0,0
84180,that,0,0
84181,nurses,0,0
84182,in,0,0
84183,hospital,0,0
84184,settings,0,0
84185,perform,0,0
84186,routinely,0,0
84187,.,0,0
84188,The,0,0
84189,opening,0,0
84190,of,0,0
84191,the,0,0
84192,female,0,0
84193,urethra,0,1
84194,is,0,0
84195,located,0,0
84196,within,0,0
84197,the,0,0
84198,vulvar,0,0
84199,vestibule,0,0
84200,",",0,0
84201,making,0,0
84202,insertion,0,0
84203,of,0,0
84204,urinary,0,0
84205,catheters,0,1
84206,into,0,0
84207,females,0,0
84208,a,0,0
84209,greater,0,0
84210,technical,0,0
84211,challenge,0,0
84212,than,0,0
84213,in,0,0
84214,males,0,0
84215,.,0,0
84216,Researchers,0,0
84217,evaluated,0,0
84218,whether,0,0
84219,a,0,0
84220,new,0,0
84221,device,0,0
84222,might,0,0
84223,decrease,0,0
84224,the,0,0
84225,time,0,0
84226,required,0,0
84227,for,0,0
84228,catheter,0,1
84229,insertion,0,0
84230,",",0,0
84231,increase,0,0
84232,the,0,0
84233,likelihood,0,0
84234,of,0,0
84235,inserting,0,1
84236,the,0,0
84237,catheter,0,1
84238,on,0,0
84239,the,0,0
84240,first,0,0
84241,attempt,0,0
84242,(,0,0
84243,improved,0,0
84244,accuracy,0,0
84245,),0,0
84246,",",0,0
84247,and,0,0
84248,reduce,0,0
84249,patient,0,0
84250,discomfort,0,0
84251,.,0,0
84252,Comments,0,0
84253,about,0,0
84254,the,0,0
84255,device,0,0
84256,from,0,0
84257,both,0,0
84258,patients,0,0
84259,and,0,0
84260,nurses,0,0
84261,also,0,0
84262,are,0,0
84263,reported,0,0
84264,.,0,0
84265,Atypical,0,0
84266,recruitment,0,0
84267,of,0,0
84268,medial,0,0
84269,prefrontal,0,0
84270,cortex,0,0
84271,in,0,0
84272,autism,0,0
84273,spectrum,0,0
84274,disorders,0,0
84275,:,0,0
84276,an,0,0
84277,fMRI,1,0
84278,study,0,0
84279,of,0,0
84280,two,0,0
84281,executive,1,0
84282,function,1,0
84283,tasks,1,1
84284,.,1,0
84285,Recent,0,0
84286,studies,0,0
84287,have,0,0
84288,suggested,0,0
84289,an,0,0
84290,uneven,0,0
84291,profile,0,0
84292,of,0,0
84293,executive,0,0
84294,dysfunction,0,0
84295,in,0,0
84296,autism,0,0
84297,spectrum,0,0
84298,disorders,0,0
84299,(,0,0
84300,ASD,0,0
84301,),0,0
84302,.,0,0
84303,For,0,0
84304,example,0,0
84305,",",0,0
84306,some,0,0
84307,authors,0,0
84308,have,0,0
84309,reported,0,0
84310,deficits,0,0
84311,on,0,0
84312,newly,0,0
84313,developed,0,0
84314,tests,0,0
84315,of,0,0
84316,executive,0,0
84317,function,0,0
84318,sensitive,0,0
84319,to,0,0
84320,rostral,0,0
84321,prefrontal,0,0
84322,function,0,0
84323,",",0,0
84324,despite,0,0
84325,spared,0,0
84326,",",0,0
84327,or,0,0
84328,even,0,0
84329,superior,0,0
84330,",",0,0
84331,performance,0,0
84332,on,0,0
84333,other,0,0
84334,tests,0,0
84335,.,0,0
84336,We,0,0
84337,investigated,0,0
84338,the,0,0
84339,performance,0,0
84340,of,0,0
84341,a,0,0
84342,group,0,0
84343,of,0,0
84344,high-functioning,0,0
84345,participants,0,0
84346,with,0,0
84347,ASD,0,0
84348,(,0,0
84349,N=15,0,1
84350,),0,0
84351,and,0,0
84352,an,0,0
84353,age-,0,0
84354,and,0,0
84355,IQ-matched,0,0
84356,control,0,1
84357,group,0,0
84358,(,0,0
84359,N=18,0,0
84360,),0,0
84361,on,0,0
84362,two,1,0
84363,executive,1,0
84364,function,1,0
84365,tests,1,0
84366,",",0,0
84367,whilst,0,0
84368,undergoing,1,0
84369,functional,1,0
84370,magnetic,1,1
84371,resonance,1,1
84372,imaging,1,1
84373,(,1,0
84374,fMRI,1,0
84375,),1,0
84376,.,1,0
84377,Behaviourally,0,0
84378,",",0,0
84379,there,0,0
84380,were,0,0
84381,no,0,0
84382,significant,0,0
84383,differences,0,0
84384,between,0,0
84385,the,0,0
84386,two,0,0
84387,groups,0,0
84388,.,0,0
84389,In,0,0
84390,a,0,0
84391,classical,1,0
84392,test,1,0
84393,of,1,0
84394,executive,1,0
84395,function,1,0
84396,(,0,0
84397,random,0,0
84398,response,0,0
84399,generation,0,0
84400,),0,0
84401,",",0,0
84402,BOLD,0,0
84403,signal,0,0
84404,differed,0,0
84405,between,0,0
84406,the,0,0
84407,groups,0,0
84408,in,0,0
84409,the,0,0
84410,cerebellum,0,0
84411,but,0,0
84412,not,0,0
84413,in,0,0
84414,the,0,0
84415,frontal,0,0
84416,lobes,0,0
84417,.,0,0
84418,However,0,0
84419,",",0,0
84420,on,0,0
84421,a,0,0
84422,new,1,0
84423,test,1,0
84424,of,1,0
84425,executive,1,0
84426,function,1,0
84427,(,0,0
84428,selection,0,0
84429,between,0,0
84430,stimulus-oriented,0,1
84431,and,0,0
84432,stimulus-independent,0,0
84433,thought,0,0
84434,),0,0
84435,",",0,0
84436,the,0,0
84437,ASD,0,0
84438,group,0,0
84439,exhibited,0,0
84440,significantly,0,0
84441,greater,0,0
84442,signal-change,0,0
84443,in,0,0
84444,medial,0,0
84445,rostral,0,0
84446,prefrontal,0,1
84447,cortex,0,0
84448,(,0,0
84449,especially,0,0
84450,Brodmann,0,0
84451,Area,0,0
84452,10,0,0
84453,),0,0
84454,in,0,0
84455,the,0,0
84456,comparison,0,0
84457,of,0,0
84458,stimulus-oriented,0,1
84459,versus,0,0
84460,stimulus-independent,0,0
84461,attention,0,0
84462,.,0,0
84463,In,0,0
84464,addition,0,0
84465,",",0,0
84466,the,0,0
84467,new,0,0
84468,test,0,0
84469,(,0,0
84470,but,0,0
84471,not,0,0
84472,the,0,0
84473,classical,0,1
84474,test,0,0
84475,),0,0
84476,provided,0,0
84477,evidence,0,0
84478,for,0,0
84479,abnormal,0,0
84480,functional,0,0
84481,organisation,0,0
84482,of,0,0
84483,medial,0,0
84484,prefrontal,0,0
84485,cortex,0,0
84486,in,0,0
84487,ASD,0,0
84488,.,0,0
84489,These,0,0
84490,results,0,0
84491,underline,0,0
84492,the,0,0
84493,heterogeneity,0,0
84494,of,0,0
84495,different,0,0
84496,tests,0,0
84497,of,0,0
84498,executive,0,0
84499,function,0,0
84500,",",0,0
84501,and,0,0
84502,suggest,0,0
84503,that,0,0
84504,executive,0,0
84505,functioning,0,0
84506,in,0,0
84507,ASD,0,0
84508,is,0,0
84509,associated,0,0
84510,with,0,0
84511,task-specific,0,1
84512,functional,0,0
84513,change,0,0
84514,.,0,0
84515,Penetration,0,1
84516,and,0,0
84517,accumulation,0,0
84518,of,0,0
84519,moxifloxacin,1,1
84520,in,0,0
84521,uterine,0,0
84522,tissue,0,0
84523,.,0,0
84524,OBJECTIVE,0,0
84525,To,0,0
84526,determine,0,0
84527,whether,0,0
84528,moxifloxacin,1,1
84529,penetrates,0,0
84530,the,0,0
84531,uterine,0,0
84532,tissue,0,0
84533,and,0,0
84534,accumulates,0,0
84535,at,0,0
84536,levels,0,0
84537,sufficient,0,0
84538,to,0,0
84539,eradicate,0,0
84540,the,0,0
84541,major,0,0
84542,pathogens,0,0
84543,causing,0,0
84544,pelvic,0,0
84545,inflammatory,0,0
84546,disease,0,0
84547,(,0,0
84548,PID,0,1
84549,),0,0
84550,.,0,0
84551,METHOD,0,0
84552,In,0,0
84553,a,0,0
84554,prospective,0,0
84555,",",0,0
84556,multicenter,0,0
84557,",",0,0
84558,open-label,0,0
84559,",",0,0
84560,parallel-group,0,0
84561,study,0,0
84562,we,0,0
84563,determined,0,0
84564,the,0,0
84565,concentration,0,0
84566,of,0,0
84567,moxifloxacin,0,1
84568,in,0,0
84569,plasma,0,0
84570,and,0,0
84571,uterine,0,0
84572,tissue,0,0
84573,after,0,0
84574,a,0,0
84575,single,0,0
84576,",",0,0
84577,400-mg,1,1
84578,intravenous,1,1
84579,dose,1,0
84580,of,1,0
84581,moxifloxacin,1,1
84582,.,1,0
84583,Study,0,0
84584,participants,0,0
84585,were,0,0
84586,randomized,0,0
84587,for,0,0
84588,time,0,0
84589,of,0,0
84590,tissue,0,0
84591,sampling,0,0
84592,",",0,0
84593,which,0,0
84594,was,0,0
84595,performed,0,0
84596,1,0,0
84597,",",0,0
84598,2,0,0
84599,",",0,0
84600,4,0,0
84601,",",0,0
84602,7,0,0
84603,",",0,0
84604,or,0,0
84605,24,0,0
84606,hours,0,0
84607,following,0,0
84608,the,0,0
84609,moxifloxacin,1,1
84610,infusion,0,1
84611,.,0,0
84612,RESULTS,0,0
84613,Of,0,0
84614,43,0,0
84615,participants,0,0
84616,",",0,0
84617,40,0,0
84618,were,0,0
84619,randomized,0,0
84620,to,0,0
84621,tissue,0,0
84622,sampling,0,0
84623,.,0,0
84624,Moxifloxacin,0,1
84625,accumulated,0,0
84626,in,0,0
84627,uterine,0,0
84628,tissue,0,0
84629,and,0,0
84630,concentrations,0,0
84631,were,0,0
84632,highest,0,0
84633,1,0,0
84634,hour,0,0
84635,after,0,0
84636,infusion,0,1
84637,in,0,0
84638,both,0,0
84639,plasma,0,0
84640,and,0,0
84641,tissue,0,0
84642,.,0,0
84643,Tissue,0,0
84644,to,0,0
84645,plasma,0,0
84646,ratios,0,0
84647,remained,0,0
84648,between,0,0
84649,1.7,0,0
84650,and,0,0
84651,2.1,0,0
84652,for,0,0
84653,24,0,0
84654,hours,0,0
84655,.,0,0
84656,Moxifloxacin,0,1
84657,was,0,0
84658,found,0,0
84659,to,0,0
84660,be,0,0
84661,safe,0,0
84662,and,0,0
84663,well,0,0
84664,tolerated,0,0
84665,.,0,0
84666,CONCLUSION,0,0
84667,Based,0,0
84668,on,0,0
84669,known,0,0
84670,minimum,0,0
84671,inhibitory,0,0
84672,concentration,0,0
84673,data,0,0
84674,",",0,0
84675,the,0,0
84676,uterine,0,0
84677,tissue,0,0
84678,concentrations,0,0
84679,of,0,0
84680,moxifloxacin,0,1
84681,achieved,0,0
84682,over,0,0
84683,24,0,0
84684,hours,0,0
84685,would,0,0
84686,be,0,0
84687,sufficient,0,0
84688,to,0,0
84689,eradicate,0,0
84690,the,0,0
84691,range,0,0
84692,of,0,0
84693,bacterial,0,0
84694,pathogens,0,0
84695,responsible,0,0
84696,for,0,0
84697,PID,0,1
84698,.,0,0
84699,In,0,0
84700,school-aged,0,0
84701,children,0,0
84702,a,0,0
84703,combination,0,0
84704,of,0,0
84705,galacto-oligosaccharides,1,1
84706,and,1,0
84707,Lactobacillus,1,1
84708,GG,1,1
84709,increases,0,0
84710,bifidobacteria,0,0
84711,more,0,0
84712,than,0,0
84713,Lactobacillus,1,0
84714,GG,1,1
84715,on,0,0
84716,its,0,0
84717,own,0,0
84718,.,0,0
84719,The,0,0
84720,aim,0,0
84721,of,0,0
84722,this,0,0
84723,study,0,0
84724,was,0,0
84725,to,0,0
84726,compare,0,0
84727,a,0,0
84728,combination,0,0
84729,of,0,0
84730,Lactobacillus,1,1
84731,GG,1,1
84732,(,1,0
84733,LGG,1,1
84734,),1,0
84735,and,1,0
84736,galacto-oligosaccharides,1,1
84737,(,1,0
84738,GOS,1,0
84739,),1,0
84740,with,1,0
84741,LGG,1,0
84742,on,1,0
84743,its,1,0
84744,own,1,0
84745,",",0,0
84746,and,0,0
84747,their,0,0
84748,effects,0,0
84749,on,0,0
84750,the,0,0
84751,intestinal,0,0
84752,microbiota,0,0
84753,in,0,0
84754,school-aged,0,0
84755,children,0,0
84756,.,0,0
84757,The,0,0
84758,randomized,0,0
84759,",",0,0
84760,double-blinded,0,0
84761,",",0,0
84762,crossover,0,0
84763,study,0,0
84764,comprised,0,0
84765,30,0,0
84766,healthy,0,0
84767,children,0,0
84768,.,0,0
84769,There,0,0
84770,were,0,0
84771,two,0,0
84772,3-week,0,0
84773,study,0,0
84774,periods,0,0
84775,with,0,0
84776,a,0,0
84777,4-week,0,1
84778,wash-out,0,1
84779,period,0,0
84780,in,0,0
84781,between,0,0
84782,.,0,0
84783,The,0,0
84784,children,0,0
84785,ingested,0,0
84786,daily,0,0
84787,65,0,0
84788,ml,0,0
84789,of,0,0
84790,milk-based,1,1
84791,fruit,1,1
84792,juice,1,1
84793,containing,1,1
84794,either,1,0
84795,LGG,1,1
84796,alone,1,1
84797,(,0,0
84798,6.5,0,0
84799,x,0,0
84800,10,0,0
84801,(,0,0
84802,9,0,0
84803,),0,0
84804,CFU,0,0
84805,),0,0
84806,or,0,1
84807,LGG,1,1
84808,plus,1,1
84809,2,1,0
84810,g,1,0
84811,of,1,0
84812,GOS,1,0
84813,.,1,0
84814,Symptom,0,0
84815,diaries,0,0
84816,were,0,0
84817,filled,0,0
84818,during,0,0
84819,the,0,0
84820,study,0,0
84821,periods,0,0
84822,.,0,0
84823,Fecal,0,0
84824,samples,0,0
84825,were,0,0
84826,collected,0,0
84827,at,0,0
84828,the,0,0
84829,beginning,0,0
84830,and,0,0
84831,end,0,0
84832,of,0,0
84833,both,0,0
84834,study,0,0
84835,periods,0,0
84836,.,0,0
84837,At,0,0
84838,the,0,0
84839,end,0,0
84840,of,0,0
84841,both,0,0
84842,study,0,0
84843,periods,0,0
84844,",",0,0
84845,the,0,0
84846,amount,0,0
84847,of,0,0
84848,bifidobacteria,0,0
84849,was,0,0
84850,significantly,0,0
84851,greater,0,0
84852,after,0,0
84853,the,0,0
84854,ingestion,0,0
84855,of,0,0
84856,LGG,1,0
84857,+,1,1
84858,GOS,1,1
84859,compared,0,0
84860,with,0,0
84861,LGG,1,0
84862,alone,1,1
84863,(,0,0
84864,geometric,0,0
84865,mean,0,0
84866,9.33,0,0
84867,x,0,0
84868,10,0,0
84869,(,0,0
84870,9,0,0
84871,),0,0
84872,vs.,0,0
84873,4.28,0,0
84874,x,0,0
84875,10,0,0
84876,(,0,0
84877,9,0,0
84878,),0,0
84879,CFU/g,0,0
84880,",",0,0
84881,p,0,0
84882,<,0,0
84883,0.001,0,0
84884,),0,0
84885,.,0,0
84886,No,0,0
84887,significant,0,0
84888,differences,0,0
84889,were,0,0
84890,seen,0,0
84891,in,0,0
84892,the,0,0
84893,amount,0,0
84894,of,0,0
84895,lactobacilli,0,0
84896,or,0,1
84897,LGG,1,0
84898,",",0,0
84899,nor,0,0
84900,did,0,0
84901,gastrointestinal,0,0
84902,symptoms,0,0
84903,",",0,0
84904,defecation,0,0
84905,frequency,0,0
84906,",",0,0
84907,consistency,0,0
84908,of,0,0
84909,stools,0,0
84910,or,0,0
84911,ease,0,0
84912,of,0,0
84913,defecation,0,0
84914,differ,0,0
84915,between,0,0
84916,the,0,0
84917,two,0,0
84918,study,0,0
84919,periods,0,0
84920,.,0,0
84921,Ingestion,0,0
84922,of,0,0
84923,LGG,1,0
84924,combined,1,0
84925,with,1,0
84926,2,1,0
84927,g,1,0
84928,of,1,0
84929,GOS,1,0
84930,increased,0,0
84931,the,0,0
84932,bifidobacteria,0,0
84933,more,0,0
84934,than,0,0
84935,LGG,1,0
84936,on,1,0
84937,its,1,0
84938,own,1,0
84939,and,0,0
84940,thus,0,0
84941,GOS,1,0
84942,clearly,0,0
84943,has,0,0
84944,a,0,0
84945,prebiotic,0,1
84946,effect,0,0
84947,in,0,0
84948,children,0,0
84949,.,0,0
84950,The,0,0
84951,children,0,0
84952,tolerated,0,0
84953,well,0,0
84954,a,0,0
84955,daily,0,0
84956,intake,0,0
84957,of,0,0
84958,2,0,0
84959,g,0,0
84960,of,0,0
84961,GOS,1,0
84962,.,1,0
84963,Anxiety,0,0
84964,sensitivity,0,0
84965,as,0,0
84966,an,0,0
84967,incremental,0,0
84968,predictor,0,0
84969,of,0,0
84970,later,0,0
84971,anxiety,0,0
84972,symptoms,0,0
84973,and,0,0
84974,syndromes,0,0
84975,.,0,0
84976,Although,0,0
84977,anxiety,0,0
84978,sensitivity,0,0
84979,(,0,0
84980,AS,0,0
84981,),0,1
84982,has,0,0
84983,been,0,0
84984,shown,0,0
84985,to,0,0
84986,predict,0,0
84987,anxiety,0,0
84988,symptoms,0,0
84989,and,0,0
84990,panic,0,0
84991,",",0,0
84992,this,0,0
84993,literature,0,0
84994,is,0,0
84995,limited,0,0
84996,in,0,0
84997,regard,0,0
84998,to,0,0
84999,evaluating,0,0
85000,AS,0,0
85001,as,0,0
85002,an,0,0
85003,incremental,0,0
85004,predictor,0,0
85005,of,0,0
85006,anxiety,1,0
85007,psychopathology,1,0
85008,relative,0,0
85009,to,0,0
85010,other,0,0
85011,established,0,0
85012,risk,0,0
85013,factors,0,0
85014,including,0,0
85015,sex,0,0
85016,and,0,0
85017,negative,0,0
85018,affect,0,0
85019,.,0,0
85020,The,0,0
85021,present,0,0
85022,report,0,0
85023,prospectively,0,0
85024,evaluated,0,0
85025,whether,0,0
85026,AS,0,0
85027,was,0,0
85028,predictive,0,0
85029,of,0,0
85030,later,0,0
85031,changes,0,0
85032,in,0,0
85033,anxiety,0,0
85034,symptoms,0,0
85035,after,0,0
85036,controlling,1,0
85037,for,1,0
85038,potential,1,0
85039,confounding,1,0
85040,factors,1,0
85041,.,1,0
85042,Consistent,0,0
85043,with,0,0
85044,hypothesis,0,0
85045,",",0,0
85046,AS,0,0
85047,was,0,0
85048,found,0,0
85049,to,0,0
85050,be,0,0
85051,a,0,0
85052,significant,0,0
85053,",",0,0
85054,incremental,0,0
85055,predictor,0,0
85056,of,0,0
85057,anxiety,0,0
85058,symptoms,0,0
85059,over,0,0
85060,time,0,0
85061,",",0,0
85062,even,0,0
85063,after,0,0
85064,controlling,0,0
85065,for,0,0
85066,sex,0,0
85067,and,0,0
85068,negative,0,0
85069,affectivity,0,0
85070,.,0,0
85071,These,0,0
85072,data,0,0
85073,provide,0,0
85074,novel,0,0
85075,evidence,0,0
85076,for,0,0
85077,the,0,0
85078,unique,0,0
85079,association,0,0
85080,between,0,0
85081,AS,0,0
85082,of,0,0
85083,the,0,0
85084,development,0,0
85085,of,0,0
85086,anxiety,0,0
85087,symptoms,0,0
85088,.,0,0
85089,Best,0,0
85090,evidence,0,0
85091,in,0,0
85092,critical,0,0
85093,care,0,0
85094,medicine,0,0
85095,.,0,0
85096,Steroids,1,0
85097,to,0,0
85098,prevent,0,0
85099,post-extubation,0,0
85100,airway,0,0
85101,obstruction,0,0
85102,in,0,0
85103,adult,0,0
85104,critically,0,0
85105,ill,0,0
85106,patients,0,0
85107,.,0,0
85108,Cognitive,0,0
85109,effects,0,0
85110,of,0,0
85111,risperidone,1,1
85112,in,0,0
85113,children,0,0
85114,with,0,0
85115,autism,0,0
85116,and,0,0
85117,irritable,0,0
85118,behavior,0,0
85119,.,0,0
85120,OBJECTIVE,0,0
85121,The,0,0
85122,objective,0,0
85123,of,0,0
85124,this,0,0
85125,research,0,0
85126,was,0,0
85127,to,0,0
85128,explore,0,0
85129,the,0,0
85130,effects,0,0
85131,of,0,0
85132,risperidone,1,1
85133,on,0,0
85134,cognitive,0,0
85135,processes,0,0
85136,in,0,0
85137,children,0,0
85138,with,0,0
85139,autism,0,0
85140,and,0,0
85141,irritable,0,0
85142,behavior,0,0
85143,.,0,0
85144,METHOD,0,0
85145,Thirty-eight,0,0
85146,children,0,0
85147,",",0,0
85148,ages,0,0
85149,5-17,0,0
85150,years,0,0
85151,with,0,0
85152,autism,0,0
85153,and,0,0
85154,severe,0,0
85155,behavioral,0,1
85156,disturbance,0,0
85157,",",0,0
85158,were,0,0
85159,randomly,0,0
85160,assigned,0,0
85161,to,0,0
85162,risperidone,1,1
85163,(,0,0
85164,0.5,0,0
85165,to,0,0
85166,3.5,0,0
85167,mg/day,0,0
85168,),0,0
85169,or,1,1
85170,placebo,1,1
85171,for,0,0
85172,8,0,0
85173,weeks,0,0
85174,.,0,0
85175,This,0,0
85176,sample,0,0
85177,of,0,0
85178,38,0,0
85179,was,0,0
85180,a,0,0
85181,subset,0,0
85182,of,0,0
85183,101,0,0
85184,subjects,0,0
85185,who,0,0
85186,participated,0,0
85187,in,0,0
85188,the,0,0
85189,clinical,0,0
85190,trial,0,0
85191,;,0,0
85192,63,0,0
85193,were,0,0
85194,unable,0,0
85195,to,0,0
85196,perform,0,0
85197,the,0,0
85198,cognitive,0,0
85199,tasks,0,0
85200,.,0,0
85201,A,0,0
85202,double-blind,0,0
85203,placebo-controlled,0,1
85204,parallel,0,0
85205,groups,0,0
85206,design,0,0
85207,was,0,0
85208,used,0,0
85209,.,0,0
85210,Dependent,0,0
85211,measures,0,0
85212,included,0,0
85213,tests,0,0
85214,of,0,0
85215,sustained,0,0
85216,attention,0,0
85217,",",0,0
85218,verbal,0,1
85219,learning,0,0
85220,",",0,0
85221,hand-eye,0,0
85222,coordination,0,1
85223,",",0,0
85224,and,0,0
85225,spatial,0,0
85226,memory,0,0
85227,assessed,0,0
85228,before,0,0
85229,",",0,0
85230,during,0,0
85231,",",0,0
85232,and,0,0
85233,after,0,0
85234,the,0,0
85235,8-week,0,0
85236,treatment,0,0
85237,.,0,0
85238,Changes,0,0
85239,in,0,0
85240,performance,0,0
85241,were,0,0
85242,compared,0,0
85243,by,0,0
85244,repeated,0,0
85245,measures,0,0
85246,ANOVA,0,0
85247,.,0,0
85248,RESULTS,0,0
85249,Twenty-nine,0,0
85250,boys,0,0
85251,and,0,0
85252,9,0,0
85253,girls,0,0
85254,with,0,0
85255,autism,0,0
85256,and,0,0
85257,severe,0,0
85258,behavioral,0,1
85259,disturbance,0,0
85260,and,0,0
85261,a,0,0
85262,mental,0,0
85263,age,0,0
85264,>,0,0
85265,or=18,0,0
85266,months,0,0
85267,completed,0,0
85268,the,0,0
85269,cognitive,0,0
85270,part,0,0
85271,of,0,0
85272,the,0,0
85273,study,0,0
85274,.,0,0
85275,No,0,0
85276,decline,0,0
85277,in,0,0
85278,performance,0,0
85279,occurred,0,0
85280,with,0,0
85281,risperidone,0,1
85282,.,0,0
85283,Performance,0,0
85284,on,0,0
85285,a,0,0
85286,cancellation,0,0
85287,task,0,1
85288,(,0,0
85289,number,0,0
85290,of,0,0
85291,correct,0,0
85292,detections,0,0
85293,),0,0
85294,and,0,0
85295,a,0,0
85296,verbal,0,1
85297,learning,0,0
85298,task,0,1
85299,(,0,0
85300,word,0,1
85301,recognition,0,1
85302,),0,0
85303,was,0,0
85304,better,0,0
85305,on,0,0
85306,risperidone,1,1
85307,than,0,0
85308,on,0,0
85309,placebo,1,1
85310,(,0,0
85311,without,0,0
85312,correction,0,0
85313,for,0,0
85314,multiplicity,0,0
85315,),0,0
85316,.,0,0
85317,Equivocal,0,0
85318,improvement,0,0
85319,also,0,0
85320,occurred,0,0
85321,on,0,0
85322,a,0,0
85323,spatial,0,0
85324,memory,0,0
85325,task,0,1
85326,.,0,0
85327,There,0,0
85328,were,0,0
85329,no,0,0
85330,significant,0,0
85331,differences,0,0
85332,between,0,0
85333,treatment,0,0
85334,conditions,0,0
85335,on,0,0
85336,the,0,0
85337,Purdue,0,1
85338,Pegboard,0,1
85339,(,0,0
85340,hand-eye,0,1
85341,coordination,0,1
85342,),0,1
85343,task,0,1
85344,or,0,1
85345,the,0,0
85346,Analog,0,1
85347,Classroom,0,1
85348,Task,0,1
85349,(,0,0
85350,timed,0,0
85351,math,0,0
85352,test,0,0
85353,),0,0
85354,.,0,0
85355,CONCLUSION,0,0
85356,Risperidone,1,1
85357,given,0,0
85358,to,0,0
85359,children,0,0
85360,with,0,0
85361,autism,0,0
85362,at,0,0
85363,doses,0,0
85364,up,0,0
85365,to,0,0
85366,3.5,0,0
85367,mg,0,0
85368,for,0,0
85369,up,0,0
85370,to,0,0
85371,8,0,0
85372,weeks,0,0
85373,appears,0,0
85374,to,0,0
85375,have,0,0
85376,no,0,0
85377,detrimental,0,0
85378,effect,0,0
85379,on,0,0
85380,cognitive,0,0
85381,performance,0,0
85382,.,0,0
85383,Randomized,0,0
85384,trial,0,0
85385,of,0,0
85386,a,0,0
85387,decision,0,0
85388,aid,0,0
85389,for,0,0
85390,individuals,0,0
85391,considering,0,0
85392,genetic,0,0
85393,testing,0,0
85394,for,0,0
85395,hereditary,0,0
85396,nonpolyposis,0,0
85397,colorectal,0,0
85398,cancer,0,0
85399,risk,0,0
85400,.,0,0
85401,BACKGROUND,0,0
85402,Despite,0,0
85403,the,0,0
85404,potential,0,0
85405,benefits,0,0
85406,of,0,0
85407,genetic,0,0
85408,testing,0,0
85409,for,0,0
85410,hereditary,0,0
85411,nonpolyposis,0,0
85412,colorectal,0,0
85413,cancer,0,0
85414,(,0,0
85415,HNPCC,0,1
85416,),0,0
85417,risk,0,0
85418,",",0,0
85419,individuals,0,0
85420,can,0,0
85421,find,0,0
85422,the,0,0
85423,genetic,0,0
85424,testing,0,0
85425,decision-making,0,0
85426,process,0,0
85427,complicated,0,0
85428,and,0,0
85429,challenging,0,0
85430,.,0,0
85431,The,0,0
85432,goal,0,0
85433,of,0,0
85434,the,0,0
85435,current,0,0
85436,study,0,0
85437,was,0,0
85438,to,0,0
85439,measure,0,0
85440,the,0,0
85441,effectiveness,0,0
85442,of,0,0
85443,a,0,0
85444,tailored,0,1
85445,decision,0,0
85446,aid,0,0
85447,designed,0,0
85448,specifically,0,0
85449,to,0,0
85450,assist,0,0
85451,individuals,0,0
85452,to,0,0
85453,make,0,0
85454,informed,0,0
85455,decisions,0,0
85456,regarding,0,0
85457,genetic,0,0
85458,testing,0,0
85459,for,0,0
85460,HNPCC,0,0
85461,risk,0,0
85462,.,0,0
85463,METHODS,0,0
85464,In,0,0
85465,all,0,0
85466,",",0,0
85467,153,0,0
85468,individuals,0,0
85469,were,0,0
85470,randomized,0,0
85471,to,0,0
85472,receive,1,0
85473,the,1,0
85474,decision,1,0
85475,aid,1,0
85476,or,1,1
85477,a,1,0
85478,control,1,1
85479,pamphlet,1,1
85480,at,1,0
85481,the,1,0
85482,end,1,0
85483,of,1,0
85484,their,1,0
85485,first,1,0
85486,genetic,1,0
85487,counseling,1,1
85488,consultation,1,0
85489,.,1,0
85490,Of,0,0
85491,these,0,0
85492,",",0,0
85493,109,0,0
85494,(,0,0
85495,71.2,0,0
85496,%,0,0
85497,),0,0
85498,completed,0,0
85499,the,0,0
85500,first,0,0
85501,questionnaire,0,0
85502,1,0,0
85503,week,0,0
85504,after,0,0
85505,consultation,0,0
85506,",",0,0
85507,whereas,0,0
85508,95,0,0
85509,(,0,0
85510,62.1,0,0
85511,%,0,0
85512,),0,0
85513,completed,0,0
85514,the,0,0
85515,6-month,0,0
85516,follow-up,0,0
85517,questionnaire,0,0
85518,.,0,0
85519,RESULTS,0,0
85520,Although,0,0
85521,the,0,0
85522,decision,0,0
85523,aid,0,0
85524,had,0,0
85525,no,0,0
85526,significant,0,0
85527,effect,0,0
85528,on,0,0
85529,postdecisional,0,0
85530,regret,0,0
85531,or,0,1
85532,actual,0,0
85533,genetic,0,0
85534,testing,0,0
85535,decision,0,0
85536,",",0,0
85537,the,0,0
85538,trial,0,0
85539,results,0,0
85540,demonstrated,0,0
85541,that,0,0
85542,participants,0,0
85543,who,0,0
85544,received,0,0
85545,the,0,0
85546,decision,1,0
85547,aid,1,0
85548,had,0,0
85549,significantly,0,0
85550,lower,0,0
85551,levels,0,0
85552,of,0,0
85553,decisional,0,0
85554,conflict,0,0
85555,(,0,0
85556,ie,0,0
85557,",",0,0
85558,uncertainty,0,0
85559,),0,0
85560,regarding,0,0
85561,genetic,0,0
85562,testing,0,1
85563,(,0,0
85564,chi-square,0,0
85565,(,0,0
85566,1,0,0
85567,),0,0
85568,=,0,0
85569,8.97,0,0
85570,;,0,0
85571,P,0,0
85572,=,0,0
85573,.003,0,0
85574,),0,0
85575,and,0,0
85576,were,0,0
85577,more,0,0
85578,likely,0,0
85579,to,0,0
85580,be,0,0
85581,classified,0,0
85582,as,0,0
85583,having,0,0
85584,made,0,0
85585,an,0,0
85586,informed,0,0
85587,choice,0,0
85588,concerning,0,0
85589,genetic,0,0
85590,testing,0,1
85591,(,0,0
85592,chi-square,0,0
85593,(,0,0
85594,1,0,0
85595,),0,0
85596,=,0,0
85597,4.37,0,0
85598,;,0,0
85599,P,0,0
85600,=,0,0
85601,.037,0,0
85602,),0,0
85603,than,0,0
85604,participants,0,0
85605,who,0,0
85606,received,0,0
85607,a,0,0
85608,control,1,0
85609,pamphlet,1,1
85610,.,1,0
85611,Also,0,0
85612,",",0,0
85613,men,0,0
85614,who,0,0
85615,received,0,0
85616,the,0,0
85617,decision,1,0
85618,aid,1,0
85619,had,0,0
85620,significantly,0,0
85621,higher,0,0
85622,knowledge,0,0
85623,levels,0,0
85624,regarding,0,0
85625,genetic,0,0
85626,testing,0,0
85627,compared,0,0
85628,with,0,0
85629,men,0,0
85630,who,0,0
85631,received,0,0
85632,the,0,0
85633,control,1,0
85634,pamphlet,1,1
85635,",",0,0
85636,whereas,0,0
85637,no,0,0
85638,such,0,0
85639,differences,0,0
85640,were,0,0
85641,found,0,0
85642,for,0,0
85643,women,0,0
85644,(,0,0
85645,chi-square,0,0
85646,(,0,0
85647,2,0,0
85648,),0,0
85649,=,0,0
85650,6.76,0,0
85651,;,0,0
85652,P,0,0
85653,=,0,0
85654,.034,0,0
85655,),0,0
85656,.,0,0
85657,CONCLUSIONS,0,0
85658,A,0,0
85659,decision,1,0
85660,aid,1,0
85661,for,0,0
85662,individuals,0,0
85663,considering,0,0
85664,genetic,0,0
85665,testing,0,0
85666,for,0,0
85667,HNPCC,0,0
85668,is,0,0
85669,an,0,0
85670,effective,0,0
85671,intervention,0,1
85672,to,0,0
85673,reduce,0,0
85674,uncertainty,0,0
85675,and,0,0
85676,assist,0,0
85677,individuals,0,0
85678,to,0,0
85679,make,0,0
85680,an,0,0
85681,informed,0,0
85682,choice,0,0
85683,regarding,0,0
85684,genetic,0,0
85685,testing,0,0
85686,for,0,0
85687,HNPCC,0,0
85688,after,0,0
85689,genetic,0,0
85690,counseling,0,1
85691,.,0,0
85692,Placebo-controlled,1,0
85693,trial,0,0
85694,evaluating,0,0
85695,safety,0,0
85696,with,0,0
85697,12-months,0,0
85698,continuous,0,1
85699,use,0,0
85700,of,0,0
85701,6,1,0
85702,%,1,0
85703,hydrogen,1,1
85704,peroxide,1,1
85705,whitening,1,1
85706,strips,1,0
85707,.,1,0
85708,OBJECTIVE,0,0
85709,To,0,0
85710,assess,0,0
85711,the,0,0
85712,safety,0,0
85713,and,0,0
85714,tolerability,0,0
85715,of,0,0
85716,6,1,0
85717,%,1,0
85718,hydrogen,1,1
85719,peroxide,1,1
85720,whitening,1,1
85721,strips,1,0
85722,over,0,0
85723,12,0,0
85724,months,0,0
85725,.,0,0
85726,METHODS,0,0
85727,80,0,0
85728,adults,0,0
85729,were,0,0
85730,randomly,0,0
85731,assigned,0,0
85732,equally,0,0
85733,to,0,0
85734,one,0,0
85735,of,0,0
85736,two,0,0
85737,treatments,0,0
85738,:,0,0
85739,6,1,0
85740,%,1,0
85741,hydrogen,1,1
85742,peroxide,1,1
85743,strips,1,0
85744,or,1,0
85745,placebo,1,1
85746,strips,1,0
85747,.,1,0
85748,Strips,0,0
85749,were,0,0
85750,worn,0,0
85751,5,0,0
85752,min,0,0
85753,daily,0,0
85754,for,0,0
85755,12,0,0
85756,months,0,0
85757,.,0,0
85758,Safety,0,0
85759,and,0,0
85760,tolerability,0,0
85761,were,0,0
85762,assessed,0,0
85763,via,0,0
85764,oral,0,1
85765,status,0,0
85766,interviews,0,1
85767,and,0,0
85768,oral,0,1
85769,examinations,0,0
85770,at,0,0
85771,baseline,0,0
85772,and,0,0
85773,after,0,0
85774,1,0,0
85775,",",0,0
85776,2,0,0
85777,",",0,0
85778,3,0,0
85779,",",0,0
85780,6,0,0
85781,",",0,0
85782,9,0,0
85783,",",0,0
85784,and,0,0
85785,12,0,0
85786,months,0,0
85787,of,0,0
85788,use,0,0
85789,.,0,0
85790,RESULTS,0,0
85791,Tooth,0,1
85792,sensitivity,0,0
85793,and,0,0
85794,oral,0,1
85795,irritation,0,0
85796,were,0,0
85797,the,0,0
85798,two,0,0
85799,most,0,0
85800,common,0,0
85801,adverse,0,0
85802,events,0,0
85803,.,0,0
85804,After,0,0
85805,12,0,0
85806,months,0,0
85807,use,0,0
85808,",",0,0
85809,tooth,0,0
85810,sensitivity,0,0
85811,was,0,0
85812,reported,0,0
85813,by,0,0
85814,10,0,0
85815,%,0,0
85816,of,0,0
85817,subjects,0,0
85818,in,0,0
85819,the,0,0
85820,6,1,0
85821,%,1,0
85822,strip,1,1
85823,group,0,0
85824,with,0,0
85825,a,0,0
85826,95,0,0
85827,%,0,0
85828,confidence,0,0
85829,interval,0,0
85830,(,0,0
85831,CI,0,0
85832,),0,1
85833,of,0,0
85834,(,0,0
85835,2.8,0,0
85836,%,0,0
85837,",",0,0
85838,23.7,0,0
85839,%,0,0
85840,),0,0
85841,and,0,0
85842,5,0,0
85843,%,0,0
85844,of,0,0
85845,subjects,0,0
85846,in,0,0
85847,the,0,0
85848,placebo,1,1
85849,group,0,0
85850,with,0,0
85851,a,0,0
85852,95,0,0
85853,%,0,0
85854,CI,0,0
85855,of,0,0
85856,(,0,0
85857,0.6,0,0
85858,%,0,0
85859,",",0,0
85860,16.9,0,0
85861,%,0,0
85862,),0,0
85863,.,0,0
85864,The,0,0
85865,occurrence,0,0
85866,of,0,0
85867,reported,0,0
85868,oral,0,1
85869,irritation,0,0
85870,was,0,0
85871,0,0,0
85872,%,0,0
85873,in,0,0
85874,the,0,0
85875,6,1,0
85876,%,1,0
85877,strip,1,1
85878,group,0,0
85879,with,0,0
85880,a,0,0
85881,95,0,0
85882,%,0,0
85883,CI,0,0
85884,of,0,0
85885,(,0,0
85886,0,0,0
85887,%,0,0
85888,",",0,0
85889,8.8,0,0
85890,%,0,0
85891,),0,0
85892,and,0,0
85893,2.5,0,0
85894,%,0,0
85895,in,0,0
85896,the,0,0
85897,placebo,1,1
85898,strip,1,1
85899,group,0,0
85900,with,0,0
85901,a,0,0
85902,95,0,0
85903,%,0,0
85904,CI,0,0
85905,of,0,0
85906,(,0,0
85907,0.1,0,0
85908,%,0,0
85909,",",0,0
85910,13.2,0,0
85911,%,0,0
85912,),0,0
85913,.,0,0
85914,The,0,0
85915,occurrence,0,0
85916,of,0,0
85917,observed,0,0
85918,oral,0,1
85919,irritation,0,0
85920,was,0,0
85921,also,0,0
85922,similar,0,0
85923,between,0,0
85924,groups,0,0
85925,.,0,0
85926,The,0,0
85927,groups,0,0
85928,did,0,0
85929,not,0,0
85930,differ,0,0
85931,significantly,0,0
85932,(,0,0
85933,p,0,0
85934,>,0,0
85935,0.67,0,0
85936,),0,0
85937,for,0,0
85938,the,0,0
85939,percent,0,0
85940,of,0,0
85941,subjects,0,0
85942,with,0,0
85943,each,0,0
85944,type,0,0
85945,of,0,0
85946,adverse,0,0
85947,event,0,0
85948,.,0,0
85949,In,0,0
85950,the,0,0
85951,6,1,0
85952,%,1,0
85953,strip,1,1
85954,group,0,0
85955,",",0,0
85956,two,0,0
85957,subjects,0,0
85958,discontinued,0,0
85959,product,0,0
85960,use,0,0
85961,due,0,0
85962,to,0,0
85963,an,0,0
85964,adverse,0,0
85965,event,0,0
85966,(,0,0
85967,tooth,0,0
85968,sensitivity,0,0
85969,),0,0
85970,compared,0,0
85971,to,0,0
85972,no,0,0
85973,subjects,0,0
85974,in,0,0
85975,the,0,0
85976,placebo,1,1
85977,group,0,0
85978,.,0,0
85979,Groups,0,0
85980,did,0,0
85981,not,0,0
85982,differ,0,0
85983,significantly,0,0
85984,(,0,0
85985,p,0,0
85986,>,0,0
85987,0.49,0,0
85988,),0,0
85989,with,0,0
85990,respect,0,0
85991,to,0,0
85992,this,0,0
85993,outcome,0,0
85994,.,0,0
85995,CONCLUSION,0,0
85996,Use,0,0
85997,of,0,0
85998,6,1,0
85999,%,1,0
86000,hydrogen,1,1
86001,peroxide,1,1
86002,whitening,1,1
86003,strips,1,0
86004,over,0,0
86005,12,0,0
86006,months,0,0
86007,resulted,0,0
86008,in,0,0
86009,a,0,0
86010,safety,0,0
86011,profile,0,0
86012,similar,0,0
86013,to,0,0
86014,that,0,0
86015,seen,0,0
86016,with,0,0
86017,placebo,1,1
86018,strips,1,0
86019,.,1,0
86020,Combination,1,1
86021,chemotherapy,1,1
86022,and,0,0
86023,ALVAC-CEA/B7.1,1,1
86024,vaccine,1,1
86025,in,0,0
86026,patients,0,0
86027,with,0,0
86028,metastatic,0,0
86029,colorectal,0,0
86030,cancer,0,0
86031,.,0,0
86032,PURPOSE,0,0
86033,The,0,0
86034,combination,0,0
86035,of,0,0
86036,vaccines,1,1
86037,and,0,0
86038,chemotherapy,1,1
86039,holds,0,0
86040,promise,0,0
86041,for,0,0
86042,cancer,0,0
86043,therapy,0,1
86044,",",0,0
86045,but,0,0
86046,the,0,0
86047,effect,0,0
86048,of,0,0
86049,cytotoxic,0,0
86050,chemotherapy,0,1
86051,on,0,0
86052,vaccine-induced,0,0
86053,antitumor,0,0
86054,immunity,0,0
86055,is,0,0
86056,unknown,0,0
86057,.,0,0
86058,This,0,0
86059,study,0,0
86060,was,0,0
86061,conducted,0,0
86062,to,0,0
86063,assess,0,0
86064,the,0,0
86065,effects,0,0
86066,of,0,0
86067,systemic,0,0
86068,chemotherapy,0,1
86069,on,0,0
86070,ALVAC-CEA/B7.1-induced,0,0
86071,T-cell,0,0
86072,immunity,0,0
86073,in,0,0
86074,patients,0,0
86075,with,0,0
86076,metastatic,0,0
86077,colorectal,0,0
86078,cancer,0,0
86079,.,0,0
86080,EXPERIMENTAL,0,0
86081,DESIGN,0,0
86082,Patients,0,0
86083,with,0,0
86084,metastatic,0,0
86085,colorectal,0,0
86086,cancer,0,0
86087,were,0,0
86088,treated,0,0
86089,with,0,0
86090,fluorouracil,1,1
86091,",",1,0
86092,leucovorin,1,1
86093,",",1,0
86094,and,1,0
86095,irinotecan,1,1
86096,and,0,0
86097,were,0,0
86098,also,0,0
86099,given,0,0
86100,ALVAC-CEA/B7.1,1,1
86101,vaccine,1,1
86102,with,1,0
86103,or,1,0
86104,without,1,0
86105,tetanus,1,1
86106,toxoid,1,1
86107,adjuvant,1,1
86108,.,1,0
86109,Eligible,0,0
86110,patients,0,0
86111,were,0,0
86112,randomized,0,0
86113,to,0,0
86114,ALVAC,1,1
86115,followed,1,0
86116,by,1,0
86117,chemotherapy,1,1
86118,and,1,0
86119,booster,1,1
86120,vaccination,1,1
86121,(,1,0
86122,group,1,0
86123,1,1,0
86124,),1,0
86125,",",1,0
86126,ALVAC,1,1
86127,and,1,0
86128,tetanus,1,1
86129,toxoid,1,1
86130,followed,1,0
86131,by,1,0
86132,chemotherapy,1,1
86133,(,1,0
86134,group,1,0
86135,2,1,0
86136,),1,0
86137,",",1,0
86138,or,1,0
86139,chemotherapy,1,1
86140,alone,1,1
86141,followed,1,0
86142,by,1,0
86143,ALVAC,1,1
86144,in,1,0
86145,patients,1,0
86146,without,1,0
86147,disease,1,0
86148,progression,1,0
86149,(,1,0
86150,group,1,0
86151,3,0,0
86152,),0,0
86153,.,0,0
86154,Humoral,0,0
86155,immune,0,0
86156,responses,0,0
86157,were,0,0
86158,measured,0,0
86159,by,0,0
86160,standard,0,1
86161,ELISA,1,0
86162,assay,1,0
86163,",",0,0
86164,and,0,0
86165,carcinoembryonic,0,0
86166,antigen,0,0
86167,(,0,0
86168,CEA,0,0
86169,),0,0
86170,-specific,0,0
86171,T-cell,0,0
86172,responses,0,0
86173,were,0,0
86174,measured,0,0
86175,by,0,0
86176,IFN-gamma,1,1
86177,enzyme-linked,1,0
86178,immunospot,1,0
86179,assay,1,0
86180,.,1,0
86181,RESULTS,0,0
86182,One,0,0
86183,hundred,0,0
86184,eighteen,0,0
86185,patients,0,0
86186,were,0,0
86187,randomized,0,0
86188,to,0,0
86189,receive,0,0
86190,either,0,0
86191,ALVAC,1,1
86192,before,0,0
86193,and,0,0
86194,concomitantly,0,0
86195,with,0,0
86196,chemotherapy,1,1
86197,(,0,0
86198,n,0,0
86199,=,0,0
86200,39,0,0
86201,),0,0
86202,",",0,0
86203,ALVAC,1,1
86204,with,0,0
86205,tetanus,1,1
86206,adjuvant,1,1
86207,before,0,0
86208,and,0,0
86209,concomitantly,0,0
86210,with,0,0
86211,chemotherapy,1,1
86212,(,0,0
86213,n,0,0
86214,=,0,0
86215,40,0,0
86216,),0,0
86217,",",0,0
86218,or,0,1
86219,chemotherapy,1,1
86220,followed,0,0
86221,by,0,0
86222,ALVAC,1,1
86223,(,0,0
86224,n,0,0
86225,=,0,0
86226,39,0,0
86227,),0,0
86228,.,0,0
86229,Serious,0,0
86230,adverse,0,0
86231,events,0,0
86232,were,0,0
86233,largely,0,0
86234,gastrointestinal,0,0
86235,(,0,0
86236,n,0,0
86237,=,0,0
86238,30,0,0
86239,),0,0
86240,and,0,0
86241,hematologic,0,0
86242,(,0,0
86243,n,0,0
86244,=,0,0
86245,24,0,0
86246,),0,0
86247,.,0,0
86248,Overall,0,0
86249,",",0,0
86250,42,0,0
86251,patients,0,0
86252,(,0,0
86253,40.4,0,0
86254,%,0,0
86255,),0,0
86256,showed,0,0
86257,objective,0,0
86258,clinical,0,0
86259,responses,0,0
86260,.,0,0
86261,All,0,0
86262,patients,0,0
86263,developed,0,0
86264,antibody,0,0
86265,responses,0,0
86266,against,0,0
86267,ALVAC,0,1
86268,",",0,0
86269,but,0,0
86270,increased,0,0
86271,anti-CEA,0,0
86272,antibody,0,0
86273,titers,0,0
86274,were,0,0
86275,detected,0,0
86276,in,0,0
86277,only,0,0
86278,three,0,0
86279,patients,0,0
86280,.,0,0
86281,Increases,0,0
86282,in,0,0
86283,CEA-specific,0,0
86284,T,0,0
86285,cells,0,0
86286,were,0,0
86287,detected,0,0
86288,in,0,0
86289,50,0,0
86290,%,0,0
86291,",",0,0
86292,37,0,0
86293,%,0,0
86294,",",0,0
86295,and,0,0
86296,30,0,0
86297,%,0,0
86298,of,0,0
86299,patients,0,0
86300,in,0,0
86301,groups,0,0
86302,1,0,0
86303,",",0,0
86304,2,0,0
86305,",",0,0
86306,and,0,0
86307,3,0,0
86308,",",0,0
86309,respectively,0,0
86310,.,0,0
86311,There,0,0
86312,were,0,0
86313,no,0,0
86314,differences,0,0
86315,in,0,0
86316,clinical,0,0
86317,or,0,0
86318,immune,0,0
86319,responses,0,0
86320,between,0,0
86321,the,0,0
86322,treatment,0,0
86323,groups,0,0
86324,.,0,0
86325,CONCLUSION,0,0
86326,The,0,0
86327,combination,0,1
86328,of,0,0
86329,ALVAC-CEA/B7.1,1,1
86330,vaccine,1,1
86331,and,0,0
86332,systemic,0,0
86333,chemotherapy,1,1
86334,has,0,0
86335,an,0,0
86336,acceptable,0,0
86337,safety,0,0
86338,profile,0,0
86339,in,0,0
86340,patients,0,0
86341,with,0,0
86342,metastatic,0,0
86343,colorectal,0,0
86344,cancer,0,0
86345,.,0,0
86346,Systemic,0,0
86347,chemotherapy,0,1
86348,did,0,0
86349,not,0,0
86350,affect,0,0
86351,the,0,0
86352,generation,0,0
86353,of,0,0
86354,CEA-specific,0,1
86355,T-cell,0,0
86356,responses,0,0
86357,following,0,0
86358,vaccination,0,0
86359,.,0,0
86360,A,0,0
86361,controlled,0,0
86362,comparison,0,0
86363,between,0,0
86364,single,0,0
86365,doses,0,0
86366,of,0,0
86367,intravenous,1,1
86368,and,1,0
86369,intramuscular,1,1
86370,morphine,1,1
86371,with,0,0
86372,respect,0,0
86373,to,0,0
86374,analgesic,0,0
86375,effects,0,0
86376,and,0,0
86377,patient,0,0
86378,safety,0,0
86379,.,0,0
86380,UNLABELLED,0,0
86381,BACKGROUND,0,0
86382,AND,0,0
86383,AIM,0,0
86384,OF,0,1
86385,INVESTIGATION,0,1
86386,:,0,0
86387,Intramuscular,0,1
86388,(,0,0
86389,IM,0,1
86390,),0,0
86391,administration,0,0
86392,has,0,0
86393,been,0,0
86394,considered,0,0
86395,to,0,0
86396,be,0,0
86397,safer,0,0
86398,than,0,0
86399,intravenous,0,1
86400,(,0,0
86401,IV,0,0
86402,),0,0
86403,for,0,0
86404,opioids,1,1
86405,on,0,0
86406,wards,0,0
86407,",",0,0
86408,but,0,0
86409,a,0,0
86410,comparative,0,0
86411,knowledge,0,0
86412,of,0,0
86413,patient,0,0
86414,safety,0,0
86415,and,0,0
86416,analgesic,0,1
86417,potency,0,0
86418,following,0,0
86419,a,0,0
86420,single,0,0
86421,dose,0,0
86422,of,0,0
86423,IV,0,0
86424,and,0,0
86425,IM,0,1
86426,administration,0,0
86427,is,0,0
86428,lacking,0,0
86429,.,0,0
86430,This,0,0
86431,study,0,0
86432,was,0,0
86433,carried,0,0
86434,out,0,0
86435,to,0,0
86436,compare,0,0
86437,patient,0,0
86438,safety,0,0
86439,and,0,0
86440,analgesic,0,0
86441,efficacy,0,0
86442,of,0,0
86443,a,0,0
86444,single,0,0
86445,and,0,0
86446,high,0,0
86447,dose,0,0
86448,of,0,0
86449,morphine,1,1
86450,given,1,0
86451,IM,1,1
86452,or,1,1
86453,IV,1,0
86454,for,0,0
86455,post-operative,0,0
86456,pain,0,0
86457,management,0,0
86458,.,0,0
86459,MATERIALS,0,0
86460,AND,0,0
86461,METHODS,0,0
86462,Thirty-eight,0,0
86463,patients,0,0
86464,with,0,0
86465,post-operative,0,0
86466,pain,0,0
86467,following,0,0
86468,hip,1,0
86469,replacement,1,1
86470,surgery,1,0
86471,were,0,0
86472,given,0,0
86473,IM,1,1
86474,or,1,1
86475,IV,1,0
86476,morphine,1,1
86477,10,0,0
86478,mg,0,0
86479,at,0,0
86480,a,0,0
86481,specified,0,0
86482,pain,0,0
86483,level,0,0
86484,.,0,0
86485,The,0,0
86486,study,0,0
86487,was,0,0
86488,randomized,0,0
86489,and,0,0
86490,double,0,0
86491,blinded,0,0
86492,.,0,0
86493,Time,0,0
86494,to,0,0
86495,onset,0,0
86496,of,0,0
86497,analgesic,0,1
86498,effect,0,0
86499,(,0,0
86500,11-point,0,0
86501,numeric,0,0
86502,rating,0,0
86503,scale,0,0
86504,),0,0
86505,",",0,0
86506,respiratory,0,0
86507,function,0,0
86508,(,0,1
86509,p,0,0
86510,(,0,0
86511,a,0,0
86512,),0,0
86513,CO2,0,0
86514,",",0,0
86515,p,0,0
86516,(,0,0
86517,a,0,0
86518,),0,0
86519,O2,0,0
86520,",",0,0
86521,and,0,0
86522,respiratory,0,0
86523,rate,0,0
86524,),0,0
86525,",",0,0
86526,level,0,0
86527,of,0,0
86528,sedation,0,0
86529,(,0,0
86530,5-point,0,0
86531,verbal,0,1
86532,rating,0,0
86533,scale,0,0
86534,),0,0
86535,",",0,0
86536,and,0,0
86537,hemodynamic,0,0
86538,function,0,0
86539,were,0,0
86540,recorded,0,0
86541,.,0,0
86542,RESULTS,0,0
86543,In,0,0
86544,the,0,0
86545,IV,0,0
86546,group,0,0
86547,there,0,0
86548,was,0,0
86549,a,0,0
86550,slight,0,0
86551,but,0,0
86552,significant,0,0
86553,increase,0,0
86554,in,0,0
86555,p,0,0
86556,(,0,0
86557,a,0,0
86558,),0,0
86559,CO2,0,0
86560,after,0,0
86561,5,0,0
86562,",",0,0
86563,10,0,0
86564,",",0,0
86565,and,0,0
86566,15,0,0
86567,min,0,0
86568,compared,0,0
86569,with,0,0
86570,the,0,0
86571,IM,0,1
86572,group,0,0
86573,(,0,0
86574,5.2,0,0
86575,vs.,0,0
86576,4.8,0,0
86577,",",0,0
86578,5.4,0,0
86579,",",0,0
86580,vs.,0,0
86581,5.0,0,0
86582,and,0,0
86583,5.5,0,0
86584,vs.,0,0
86585,5.1,0,0
86586,kPa,0,0
86587,",",0,0
86588,respectively,0,0
86589,),0,0
86590,.,0,0
86591,The,0,0
86592,IV,0,0
86593,group,0,0
86594,had,0,0
86595,a,0,0
86596,significantly,0,0
86597,faster,0,0
86598,onset,0,0
86599,of,0,0
86600,analgesic,0,0
86601,effect,0,0
86602,than,0,0
86603,the,0,0
86604,IM,0,1
86605,group,0,0
86606,(,0,0
86607,5,0,0
86608,vs.,0,0
86609,20,0,0
86610,min,0,0
86611,),0,0
86612,.,0,0
86613,Between,0,0
86614,5,0,0
86615,and,0,0
86616,25,0,0
86617,min,0,0
86618,after,0,0
86619,morphine,1,1
86620,administration,0,0
86621,",",0,0
86622,pain,0,0
86623,status,0,0
86624,in,0,0
86625,the,0,0
86626,IV,0,0
86627,group,0,0
86628,was,0,0
86629,significantly,0,0
86630,improved,0,0
86631,compared,0,0
86632,with,0,0
86633,the,0,0
86634,IM,0,1
86635,group,0,0
86636,.,0,0
86637,Patients,0,0
86638,in,0,0
86639,the,0,0
86640,IV,0,0
86641,group,0,0
86642,were,0,0
86643,slightly,0,0
86644,more,0,0
86645,sedated,0,0
86646,than,0,0
86647,the,0,0
86648,IM,0,1
86649,group,0,0
86650,5,0,0
86651,and,0,0
86652,10,0,0
86653,min,0,0
86654,after,0,0
86655,morphine,0,1
86656,.,0,0
86657,CONCLUSION,0,0
86658,A,0,0
86659,10,0,0
86660,mg,0,1
86661,bolus,0,1
86662,dose,0,0
86663,of,0,0
86664,IV,0,0
86665,morphine,0,1
86666,given,0,0
86667,to,0,0
86668,patients,0,0
86669,with,0,0
86670,moderate,0,0
86671,pain,0,0
86672,after,0,0
86673,surgery,1,0
86674,does,0,0
86675,not,0,0
86676,cause,0,0
86677,severe,0,0
86678,respiratory,0,0
86679,depression,0,0
86680,",",0,0
86681,but,0,0
86682,provides,0,0
86683,more,0,0
86684,rapid,0,0
86685,and,0,0
86686,better,0,0
86687,initial,0,0
86688,analgesia,0,0
86689,than,0,0
86690,10,0,0
86691,mg,0,0
86692,given,0,0
86693,IM,0,0
86694,.,0,0
86695,IV,0,0
86696,morphine,1,1
86697,even,0,0
86698,at,0,0
86699,a,0,0
86700,dose,0,0
86701,as,0,0
86702,high,0,0
86703,as,0,0
86704,10,0,0
86705,mg,0,0
86706,IV,0,0
86707,is,0,0
86708,well,0,0
86709,tolerated,0,0
86710,if,0,0
86711,there,0,0
86712,is,0,0
86713,a,0,0
86714,certain,0,0
86715,level,0,0
86716,of,0,0
86717,pain,0,0
86718,at,0,0
86719,its,0,0
86720,administration,0,0
86721,.,0,0
86722,The,0,0
86723,safety,0,0
86724,of,0,0
86725,IV,0,0
86726,morphine,1,1
86727,on,0,0
86728,the,0,0
86729,general,0,0
86730,ward,0,0
86731,needs,0,0
86732,to,0,0
86733,be,0,0
86734,further,0,0
86735,explored,0,0
86736,in,0,0
86737,adequately,0,0
86738,controlled,0,0
86739,studies,0,0
86740,.,0,0
86741,Faux,1,0
86742,pas,1,1
86743,detection,1,0
86744,and,0,0
86745,intentional,0,0
86746,action,0,0
86747,in,0,0
86748,Asperger,0,0
86749,Syndrome,0,0
86750,.,0,0
86751,A,0,0
86752,replication,0,0
86753,on,0,0
86754,a,0,0
86755,French,0,0
86756,sample,0,0
86757,.,0,0
86758,In,0,0
86759,the,0,0
86760,present,0,0
86761,study,0,0
86762,",",0,0
86763,we,0,0
86764,investigated,0,0
86765,mind,0,0
86766,reading,0,1
86767,abilities,0,0
86768,in,0,0
86769,a,0,0
86770,group,0,0
86771,of,0,0
86772,adults,0,0
86773,with,0,0
86774,Asperger,0,0
86775,Syndrome,0,0
86776,(,0,0
86777,AS,0,0
86778,),0,0
86779,by,0,0
86780,using,0,0
86781,the,0,0
86782,faux,1,0
86783,pas,1,1
86784,task,1,1
86785,",",1,0
86786,an,1,0
86787,advanced,1,0
86788,test,1,0
86789,of,1,0
86790,theory,1,0
86791,of,1,0
86792,mind,1,0
86793,(,0,0
86794,Baron-Cohen,0,1
86795,et,0,0
86796,al,0,0
86797,.,0,0
86798,(,0,0
86799,1999,0,0
86800,),0,0
86801,.,0,0
86802,Journal,0,0
86803,of,0,0
86804,Autism,0,0
86805,and,0,0
86806,Developmental,0,0
86807,Disorders,0,0
86808,",",0,0
86809,29,0,0
86810,",",0,0
86811,407-418,0,0
86812,),0,0
86813,.,0,0
86814,The,0,0
86815,faux,1,0
86816,pas,1,1
86817,is,0,0
86818,a,0,0
86819,particular,0,0
86820,case,0,0
86821,of,0,0
86822,a,0,0
86823,non-intentional,0,0
86824,action,0,0
86825,reflecting,0,0
86826,an,0,0
86827,involuntary,0,0
86828,socially,0,0
86829,inappropriate,0,0
86830,behavior,0,0
86831,.,0,0
86832,Here,0,0
86833,",",0,0
86834,individuals,0,0
86835,with,0,0
86836,AS,0,0
86837,over-detected,0,0
86838,faux,1,0
86839,pas,1,1
86840,stories,0,1
86841,",",0,0
86842,failed,0,0
86843,to,0,0
86844,provide,0,0
86845,correct,0,0
86846,justifications,0,0
86847,of,0,0
86848,the,0,0
86849,speaker,0,0
86850,'s,0,0
86851,behavior,0,0
86852,and,0,0
86853,were,0,0
86854,unaware,0,0
86855,of,0,0
86856,the,0,0
86857,mistaken,0,0
86858,belief,0,0
86859,and,0,0
86860,of,0,0
86861,the,0,0
86862,resulting,0,0
86863,emotional,0,0
86864,impact,0,0
86865,",",0,0
86866,whereas,0,0
86867,they,0,0
86868,appeared,0,0
86869,to,0,0
86870,be,0,0
86871,responsive,0,0
86872,to,0,0
86873,social,0,0
86874,rule,0,0
86875,violations,0,0
86876,.,0,0
86877,We,0,0
86878,hypothesized,0,0
86879,that,0,0
86880,because,0,0
86881,of,0,0
86882,an,0,0
86883,impaired,0,0
86884,theory-of-mind,0,0
86885,",",0,0
86886,individuals,0,0
86887,with,0,0
86888,AS,0,0
86889,may,0,0
86890,develop,0,0
86891,compensatory,0,0
86892,cognitive,0,0
86893,strategies,0,0
86894,based,0,0
86895,on,0,0
86896,overlearned,0,0
86897,abstract,0,0
86898,knowledge,0,0
86899,about,0,0
86900,normative,0,0
86901,rules,0,0
86902,.,0,0
86903,Endobronchial,0,0
86904,ultrasonography-guided,0,1
86905,transbronchial,1,1
86906,needle,1,1
86907,aspiration,1,1
86908,increases,0,0
86909,the,0,0
86910,diagnostic,0,0
86911,yield,0,0
86912,of,0,0
86913,peripheral,0,0
86914,pulmonary,0,0
86915,lesions,0,0
86916,:,0,0
86917,a,0,0
86918,randomized,0,0
86919,trial,0,0
86920,.,0,0
86921,BACKGROUND,0,0
86922,The,0,0
86923,diagnostic,0,0
86924,yield,0,0
86925,of,0,0
86926,endobronchial,1,0
86927,ultrasonography,1,1
86928,(,1,0
86929,EBUS,1,0
86930,),1,0
86931,-guided,1,0
86932,transbronchial,1,1
86933,needle,1,1
86934,aspiration,1,1
86935,(,1,0
86936,TBNA,1,0
86937,),1,0
86938,for,0,0
86939,peripheral,0,0
86940,pulmonary,0,0
86941,lesions,0,0
86942,(,0,0
86943,PPLs,0,1
86944,),0,1
86945,has,0,0
86946,not,0,0
86947,been,0,0
86948,evaluated,0,0
86949,.,0,0
86950,The,0,0
86951,diagnostic,0,0
86952,impact,0,0
86953,of,0,0
86954,TBNA,0,0
86955,when,0,0
86956,the,0,0
86957,EBUS,0,0
86958,probe,0,1
86959,is,0,0
86960,adjacent,0,0
86961,to,0,0
86962,lesions,0,0
86963,remains,0,0
86964,to,0,0
86965,be,0,0
86966,determined,0,0
86967,.,0,0
86968,DESIGN,0,0
86969,A,0,0
86970,prospective,0,0
86971,",",0,0
86972,randomized,0,0
86973,trial,0,0
86974,.,0,0
86975,METHODS,0,0
86976,Two,0,0
86977,hundred,0,0
86978,two,0,0
86979,patients,0,0
86980,with,0,0
86981,PPLs,0,1
86982,and,0,0
86983,positive,0,0
86984,EBUS,0,0
86985,findings,0,0
86986,were,0,0
86987,enrolled,0,0
86988,.,0,0
86989,They,0,0
86990,were,0,0
86991,randomly,0,0
86992,classified,0,0
86993,into,0,0
86994,two,0,0
86995,groups,0,0
86996,.,0,0
86997,In,0,0
86998,the,0,0
86999,EBUS,0,0
87000,conventional,0,1
87001,diagnostic,0,0
87002,procedures,0,0
87003,(,0,0
87004,CDPs,0,1
87005,),0,1
87006,group,0,0
87007,(,0,0
87008,103,0,0
87009,patients,0,0
87010,),0,0
87011,",",0,0
87012,both,0,0
87013,transbronchial,1,1
87014,biopsy,1,1
87015,(,0,0
87016,TBB,0,1
87017,),0,1
87018,and,0,0
87019,bronchial,0,0
87020,washing,0,1
87021,(,0,0
87022,BW,0,1
87023,),0,0
87024,were,0,0
87025,performed,0,0
87026,.,0,0
87027,In,0,0
87028,the,0,0
87029,EBUS-TBNA,0,0
87030,plus,0,1
87031,CDPs,0,1
87032,group,0,0
87033,(,0,0
87034,99,0,0
87035,patients,0,0
87036,),0,0
87037,",",0,0
87038,TBNA,0,0
87039,",",0,0
87040,TBB,0,1
87041,",",0,0
87042,and,0,0
87043,BW,0,1
87044,were,0,0
87045,performed,0,0
87046,.,0,0
87047,The,0,0
87048,diagnostic,0,0
87049,yield,0,0
87050,in,0,0
87051,each,0,0
87052,group,0,0
87053,was,0,0
87054,compared,0,0
87055,.,0,0
87056,RESULTS,0,0
87057,A,0,0
87058,total,0,0
87059,of,0,0
87060,182,0,0
87061,patients,0,0
87062,(,0,0
87063,94,0,0
87064,in,0,0
87065,the,0,0
87066,EBUS,0,0
87067,CDPs,0,1
87068,group,0,0
87069,and,0,0
87070,88,0,0
87071,in,0,0
87072,the,0,0
87073,EBUS-TBNA,0,0
87074,plus,0,1
87075,CDPs,0,1
87076,group,0,0
87077,),0,0
87078,were,0,0
87079,analyzed,0,0
87080,.,0,0
87081,The,0,0
87082,yield,0,0
87083,in,0,0
87084,the,0,0
87085,EBUS-TBNA,0,0
87086,plus,0,1
87087,CDPs,0,1
87088,group,0,0
87089,(,0,0
87090,78.4,0,0
87091,%,0,0
87092,),0,0
87093,was,0,0
87094,significantly,0,0
87095,higher,0,0
87096,than,0,0
87097,the,0,0
87098,EBUS,0,0
87099,CDPs,0,1
87100,group,0,0
87101,(,0,0
87102,60.6,0,0
87103,%,0,0
87104,",",0,0
87105,p,0,0
87106,=,0,0
87107,0.015,0,0
87108,),0,0
87109,.,0,0
87110,Cases,0,0
87111,in,0,0
87112,which,0,0
87113,the,0,0
87114,EBUS,0,0
87115,probe,0,0
87116,was,0,0
87117,located,0,0
87118,within,0,0
87119,the,0,0
87120,lesions,0,0
87121,had,0,0
87122,a,0,0
87123,significantly,0,0
87124,higher,0,0
87125,diagnostic,0,0
87126,yield,0,0
87127,(,0,0
87128,78.3,0,0
87129,%,0,0
87130,),0,0
87131,than,0,0
87132,when,0,0
87133,the,0,0
87134,EBUS,0,0
87135,probe,0,1
87136,was,0,0
87137,adjacent,0,0
87138,to,0,0
87139,them,0,0
87140,(,0,0
87141,47.2,0,0
87142,%,0,0
87143,",",0,0
87144,p,0,0
87145,<,0,0
87146,0.001,0,0
87147,),0,0
87148,.,0,0
87149,Concerning,0,0
87150,the,0,0
87151,three,0,0
87152,different,0,0
87153,techniques,0,1
87154,",",0,0
87155,TBNA,0,0
87156,showed,0,0
87157,the,0,0
87158,highest,0,0
87159,diagnostic,0,0
87160,yield,0,0
87161,(,0,0
87162,62.5,0,0
87163,%,0,0
87164,),0,0
87165,in,0,0
87166,comparison,0,0
87167,to,0,0
87168,TBB,0,1
87169,(,0,0
87170,48.9,0,0
87171,%,0,0
87172,),0,0
87173,and,0,0
87174,to,0,0
87175,BW,0,1
87176,(,0,0
87177,19.8,0,0
87178,%,0,0
87179,),0,0
87180,.,0,0
87181,The,0,0
87182,diagnostic,0,0
87183,yield,0,0
87184,of,0,0
87185,TBNA,0,0
87186,remained,0,0
87187,unchanged,0,0
87188,even,0,0
87189,when,0,0
87190,the,0,0
87191,EBUS,0,0
87192,probe,0,1
87193,was,0,0
87194,adjacent,0,0
87195,to,0,0
87196,the,0,0
87197,lesions,0,0
87198,(,0,0
87199,p,0,0
87200,=,0,0
87201,0.89,0,0
87202,),0,0
87203,.,0,0
87204,No,0,0
87205,additional,0,0
87206,adverse,0,0
87207,effects,0,0
87208,were,0,0
87209,observed,0,0
87210,in,0,0
87211,the,0,0
87212,EBUS-TBNA,0,0
87213,plus,0,1
87214,CDPs,0,1
87215,group,0,0
87216,.,0,0
87217,CONCLUSIONS,0,0
87218,Applying,0,0
87219,TBNA,0,0
87220,to,0,0
87221,EBUS-guided,0,1
87222,CDPs,0,1
87223,further,0,0
87224,increased,0,0
87225,the,0,0
87226,diagnostic,0,0
87227,yield,0,0
87228,of,0,0
87229,PPLs,0,1
87230,without,0,0
87231,additional,0,0
87232,risk,0,0
87233,.,0,0
87234,The,0,0
87235,diagnostic,0,0
87236,advantage,0,0
87237,of,0,0
87238,TBNA,0,0
87239,became,0,0
87240,more,0,0
87241,obvious,0,0
87242,if,0,0
87243,the,0,0
87244,EBUS,0,0
87245,probe,0,1
87246,was,0,0
87247,adjacent,0,0
87248,to,0,0
87249,the,0,0
87250,lesions,0,0
87251,.,0,0
87252,TRIAL,0,0
87253,REGISTRATION,0,0
87254,Clinicaltrials.gov,0,0
87255,Identifier,0,0
87256,:,0,0
87257,NCT00626587,0,0
87258,.,0,0
87259,Safety,0,0
87260,and,0,0
87261,immunogenicity,0,0
87262,of,0,0
87263,a,0,0
87264,cluster,1,0
87265,specific,1,0
87266,immunotherapy,1,1
87267,in,0,0
87268,children,0,0
87269,with,0,0
87270,bronchial,0,0
87271,asthma,0,0
87272,and,0,0
87273,mite,0,0
87274,allergy,0,0
87275,.,0,0
87276,BACKGROUND,0,0
87277,Cluster,1,0
87278,specific,1,1
87279,immunotherapy,1,1
87280,(,1,0
87281,SIT,1,0
87282,),1,1
87283,is,0,0
87284,a,0,0
87285,modern,0,0
87286,form,0,0
87287,of,0,0
87288,allergen,0,1
87289,immunotherapy,0,1
87290,allowing,0,0
87291,safe,0,0
87292,administration,0,0
87293,of,0,0
87294,high,0,0
87295,allergen,0,0
87296,doses,0,0
87297,in,0,0
87298,a,0,0
87299,short,0,0
87300,time,0,0
87301,interval,0,0
87302,compared,0,0
87303,to,0,0
87304,classic,0,0
87305,SIT,0,0
87306,.,0,0
87307,In,0,0
87308,the,0,0
87309,current,0,0
87310,study,0,0
87311,",",0,0
87312,we,0,0
87313,investigated,0,0
87314,the,0,0
87315,safety,0,0
87316,profile,0,0
87317,and,0,0
87318,immunological,0,0
87319,effect,0,0
87320,of,0,0
87321,cluster,0,0
87322,SIT,0,0
87323,in,0,0
87324,children,0,0
87325,with,0,0
87326,allergic,0,0
87327,asthma,0,0
87328,due,0,0
87329,to,0,0
87330,house,0,1
87331,dust,0,1
87332,mite,0,0
87333,allergy,0,0
87334,.,0,0
87335,METHODS,0,0
87336,A,0,0
87337,total,0,0
87338,of,0,0
87339,34,0,0
87340,children,0,0
87341,(,0,0
87342,6-18,0,0
87343,years,0,0
87344,),0,0
87345,with,0,0
87346,allergic,0,0
87347,asthma,0,0
87348,were,0,0
87349,assigned,0,0
87350,to,0,0
87351,cluster,0,0
87352,(,0,0
87353,n,0,0
87354,=,0,0
87355,22,0,0
87356,),0,0
87357,or,0,0
87358,classic,0,1
87359,SIT,0,0
87360,(,0,0
87361,n,0,0
87362,=,0,0
87363,12,0,0
87364,),0,0
87365,.,0,0
87366,To,0,0
87367,achieve,0,0
87368,a,0,0
87369,maintenance,0,0
87370,dose,0,0
87371,of,0,0
87372,allergen,0,1
87373,extract,0,1
87374,",",0,0
87375,cluster,0,0
87376,patients,0,0
87377,received,0,0
87378,14,1,0
87379,injections,1,1
87380,of,1,0
87381,house,1,1
87382,dust,1,1
87383,mite,1,0
87384,allergen,1,1
87385,within,1,0
87386,6,1,0
87387,weeks,1,0
87388,",",0,0
87389,whereas,0,0
87390,the,0,0
87391,classic,1,0
87392,SIT,1,0
87393,group,1,0
87394,received,1,0
87395,14,1,0
87396,injections,1,0
87397,within,0,0
87398,14,0,0
87399,weeks,0,0
87400,.,0,0
87401,Safety,0,0
87402,was,0,0
87403,monitored,0,0
87404,by,0,0
87405,recording,0,0
87406,adverse,0,0
87407,events,0,0
87408,.,0,0
87409,Immunogenicity,0,0
87410,was,0,0
87411,measured,0,0
87412,by,0,0
87413,specific,0,0
87414,IgG,0,0
87415,(,0,0
87416,Mite,0,0
87417,),0,0
87418,and,0,0
87419,IgG4,0,1
87420,(,0,1
87421,Mite,0,0
87422,),0,0
87423,",",0,0
87424,by,0,0
87425,antibody-blocking,0,0
87426,properties,0,0
87427,on,0,0
87428,basophil,0,0
87429,activation,0,0
87430,",",0,0
87431,and,0,0
87432,by,0,0
87433,the,0,0
87434,T,0,0
87435,cell,0,0
87436,subset,0,0
87437,transcription,0,0
87438,factors,0,0
87439,Foxp3,0,1
87440,",",0,0
87441,T-bet,0,0
87442,",",0,0
87443,and,0,0
87444,GATA-3,0,0
87445,.,0,0
87446,RESULTS,0,0
87447,There,0,0
87448,were,0,0
87449,no,0,0
87450,significant,0,0
87451,differences,0,0
87452,in,0,0
87453,local,0,0
87454,and,0,0
87455,systemic,0,0
87456,side,0,0
87457,effects,0,0
87458,between,0,0
87459,the,0,0
87460,two,0,0
87461,groups,0,0
87462,.,0,0
87463,In,0,0
87464,the,0,0
87465,cluster,0,0
87466,group,0,0
87467,",",0,0
87468,serum,0,0
87469,levels,0,0
87470,of,0,0
87471,specific,0,0
87472,IgG,0,0
87473,(,0,0
87474,Mite,0,0
87475,),0,1
87476,(,0,0
87477,p,0,0
87478,<,0,0
87479,0.001,0,0
87480,),0,0
87481,and,0,0
87482,specific,0,1
87483,IgG4,0,1
87484,(,0,0
87485,Mite,0,0
87486,),0,1
87487,(,0,0
87488,p,0,0
87489,<,0,0
87490,0.001,0,0
87491,),0,0
87492,significantly,0,0
87493,increased,0,0
87494,after,0,0
87495,8,0,0
87496,weeks,0,0
87497,",",0,0
87498,while,0,0
87499,it,0,0
87500,took,0,0
87501,12,0,0
87502,weeks,0,0
87503,in,0,0
87504,the,0,0
87505,classic,0,0
87506,SIT,0,0
87507,group,0,0
87508,.,0,0
87509,These,0,0
87510,data,0,0
87511,were,0,0
87512,confirmed,0,0
87513,by,0,0
87514,blocking,0,0
87515,CD63,0,0
87516,expression,0,0
87517,as,0,0
87518,well,0,0
87519,as,0,0
87520,release,0,0
87521,of,0,0
87522,cysteinyl,0,0
87523,leukotrienes,0,0
87524,after,0,0
87525,in,0,0
87526,vitro,0,0
87527,basophil,0,0
87528,stimulation,0,1
87529,.,0,0
87530,No,0,0
87531,differences,0,0
87532,in,0,0
87533,transcription,0,0
87534,factor,0,0
87535,expression,0,0
87536,were,0,0
87537,found,0,0
87538,in,0,0
87539,the,0,0
87540,two,0,0
87541,groups,0,0
87542,.,0,0
87543,CONCLUSION,0,0
87544,Cluster,0,0
87545,SIT,0,0
87546,is,0,0
87547,safe,0,0
87548,in,0,0
87549,children,0,0
87550,.,0,0
87551,Additionally,0,0
87552,",",0,0
87553,our,0,0
87554,data,0,0
87555,demonstrated,0,0
87556,an,0,0
87557,even,0,0
87558,more,0,0
87559,rapid,0,0
87560,induction,0,0
87561,of,0,0
87562,specific,0,0
87563,immune,0,0
87564,tolerance,0,0
87565,.,0,0
87566,Cluster,0,0
87567,SIT,0,0
87568,is,0,0
87569,an,0,0
87570,attractive,0,0
87571,alternative,0,0
87572,to,0,0
87573,conventional,0,1
87574,up-dosing,0,1
87575,schedules,0,0
87576,with,0,0
87577,fewer,0,0
87578,consultations,0,0
87579,for,0,0
87580,the,0,0
87581,patients,0,0
87582,.,0,0
87583,Development,0,0
87584,of,0,0
87585,autistic,0,0
87586,children,0,0
87587,based,0,0
87588,on,0,0
87589,maternal,0,0
87590,responses,0,0
87591,to,0,0
87592,the,0,0
87593,Autism,0,0
87594,Behavior,0,0
87595,Checklist,0,0
87596,.,0,0
87597,BACKGROUND,0,0
87598,language,1,0
87599,and,1,0
87600,speech-language,1,0
87601,intervention,1,1
87602,.,1,0
87603,AIM,0,0
87604,to,0,0
87605,evaluate,0,0
87606,the,0,0
87607,development,0,0
87608,process,0,0
87609,of,0,0
87610,autistic,0,0
87611,children,0,0
87612,",",0,0
87613,in,0,0
87614,a,0,0
87615,direct,1,0
87616,and,1,0
87617,indirect,1,0
87618,intervention,1,1
87619,context,0,0
87620,based,0,0
87621,on,0,0
87622,the,0,0
87623,responses,0,0
87624,of,0,0
87625,mothers,0,0
87626,to,0,0
87627,the,0,0
87628,Autism,0,0
87629,Behavior,0,0
87630,Checklist,0,0
87631,.,0,0
87632,METHOD,0,0
87633,the,0,0
87634,research,0,0
87635,sample,0,0
87636,consisted,0,0
87637,of,0,0
87638,11,0,0
87639,mothers,0,0
87640,of,0,0
87641,children,0,0
87642,diagnosed,0,0
87643,",",0,0
87644,according,0,0
87645,to,0,0
87646,the,0,0
87647,criteria,0,0
87648,established,0,0
87649,by,0,0
87650,the,0,0
87651,DSM,0,0
87652,IVtr,0,0
87653,(,0,0
87654,APA,0,1
87655,",",0,0
87656,2002,0,0
87657,),0,0
87658,",",0,0
87659,with,0,0
87660,autism,0,0
87661,(,0,0
87662,six,0,0
87663,),0,0
87664,and,0,0
87665,with,0,0
87666,Asperger,0,0
87667,Syndrome,0,0
87668,(,0,0
87669,five,0,0
87670,),0,0
87671,and,0,0
87672,who,0,0
87673,were,0,0
87674,seen,0,0
87675,at,0,0
87676,the,0,0
87677,Investigation,0,0
87678,Laboratory,0,0
87679,of,0,0
87680,Global,0,0
87681,Developmental,0,0
87682,Disorders,0,0
87683,of,0,0
87684,the,0,0
87685,Federal,0,1
87686,University,0,0
87687,of,0,0
87688,S?o,0,0
87689,Paulo,0,0
87690,.,0,0
87691,These,0,0
87692,children,0,0
87693,were,0,0
87694,randomly,0,0
87695,divided,0,0
87696,into,0,0
87697,two,0,0
87698,groups,0,0
87699,:,0,0
87700,Six,0,0
87701,were,0,0
87702,receiving,1,0
87703,both,1,0
87704,direct,1,1
87705,and,1,0
87706,indirect,1,0
87707,intervention,1,1
87708,(,1,0
87709,TG,1,0
87710,),1,0
87711,",",1,0
87712,and,0,0
87713,five,0,0
87714,were,0,0
87715,receiving,1,0
87716,indirect,1,0
87717,intervention,1,1
87718,exclusively,1,0
87719,(,0,0
87720,OG,0,0
87721,),0,0
87722,.,0,0
87723,The,1,0
87724,Autism,1,0
87725,Behavior,1,0
87726,Checklist,1,1
87727,(,0,0
87728,Krug,0,1
87729,et,0,0
87730,al.,0,0
87731,",",0,0
87732,1993,0,0
87733,),0,0
87734,was,0,0
87735,used,0,0
87736,",",0,0
87737,adapted,0,0
87738,to,0,0
87739,the,0,0
87740,Portuguese,0,0
87741,language,0,0
87742,by,0,0
87743,Marteleto,0,1
87744,(,0,0
87745,2003,0,0
87746,),0,0
87747,.,0,0
87748,This,0,0
87749,behavior,0,0
87750,checklist,0,1
87751,(,0,0
87752,57,0,0
87753,items,0,0
87754,),0,0
87755,allows,0,0
87756,the,0,0
87757,detailed,0,0
87758,description,0,0
87759,of,0,0
87760,non-adaptable,0,0
87761,characteristics,0,0
87762,regarding,0,0
87763,the,0,0
87764,following,0,0
87765,areas,0,0
87766,:,0,0
87767,sensory,0,0
87768,",",0,0
87769,use,0,0
87770,of,0,0
87771,the,0,0
87772,body,0,0
87773,and,0,0
87774,object,0,0
87775,",",0,0
87776,Language,0,1
87777,",",0,0
87778,Psycho-social,0,1
87779,and,0,0
87780,Relational,0,0
87781,.,0,0
87782,The,0,0
87783,questionnaire,0,0
87784,was,0,0
87785,filled,0,0
87786,in,0,0
87787,during,0,0
87788,an,0,0
87789,interview,0,0
87790,on,0,0
87791,three,0,0
87792,occasions,0,0
87793,:,0,0
87794,at,0,0
87795,the,0,0
87796,beginning,0,0
87797,of,0,0
87798,intervention,0,1
87799,",",0,0
87800,after,0,0
87801,six,0,0
87802,months,0,0
87803,and,0,0
87804,at,0,0
87805,the,0,0
87806,end,0,0
87807,of,0,0
87808,12,0,0
87809,months,0,0
87810,.,0,0
87811,RESULTS,0,0
87812,after,0,0
87813,statistical,0,0
87814,analysis,0,0
87815,it,0,0
87816,was,0,0
87817,observed,0,0
87818,that,0,0
87819,there,0,0
87820,was,0,0
87821,a,0,0
87822,greater,0,0
87823,development,0,0
87824,in,0,0
87825,the,0,0
87826,total,0,0
87827,scores,0,0
87828,and,0,0
87829,in,0,0
87830,the,0,0
87831,areas,0,0
87832,of,0,0
87833,language,0,0
87834,",",0,0
87835,psycho-social,0,0
87836,and,0,0
87837,relational,0,0
87838,for,0,0
87839,the,0,0
87840,TG,0,0
87841,.,0,0
87842,This,0,0
87843,suggests,0,0
87844,a,0,0
87845,greater,0,0
87846,development,0,0
87847,pattern,0,0
87848,during,0,0
87849,the,0,0
87850,studied,0,0
87851,period,0,0
87852,for,0,0
87853,this,0,0
87854,group,0,0
87855,.,0,0
87856,CONCLUSION,0,0
87857,the,0,0
87858,mothers,0,0
87859,of,0,0
87860,both,0,0
87861,groups,0,0
87862,observed,0,0
87863,behavioral,0,0
87864,changes,0,0
87865,.,0,0
87866,The,0,0
87867,better,0,0
87868,scores,0,0
87869,observed,0,0
87870,for,0,0
87871,the,0,0
87872,TG,0,0
87873,is,0,0
87874,probably,0,0
87875,related,0,0
87876,to,0,0
87877,the,0,0
87878,effectiveness,0,0
87879,of,0,0
87880,direct,0,0
87881,intervention,0,1
87882,",",0,0
87883,and,0,0
87884,not,0,0
87885,to,0,0
87886,the,0,0
87887,lack,0,0
87888,of,0,0
87889,attention,0,0
87890,of,0,0
87891,parents,0,0
87892,in,0,0
87893,the,1,0
87894,OG,1,0
87895,in,0,0
87896,recognizing,0,0
87897,behavioral,0,0
87898,changes,0,0
87899,in,0,0
87900,their,0,0
87901,children,0,0
87902,.,0,0
87903,Direct,0,0
87904,and,0,0
87905,indirect,0,0
87906,effects,0,0
87907,of,0,0
87908,interdental,1,0
87909,hygiene,1,1
87910,in,0,0
87911,a,0,0
87912,clinical,0,0
87913,trial,0,0
87914,.,0,0
87915,Many,0,0
87916,randomized,0,0
87917,controlled,0,0
87918,trials,0,0
87919,(,0,0
87920,RCTs,0,1
87921,),0,0
87922,in,0,0
87923,dental,0,1
87924,research,0,0
87925,test,0,0
87926,the,0,0
87927,efficacy,0,0
87928,of,0,0
87929,interventions,0,0
87930,on,0,0
87931,more,0,0
87932,than,0,0
87933,one,0,0
87934,outcome,0,0
87935,variable,0,0
87936,.,0,0
87937,Univariate,0,0
87938,methods,0,0
87939,",",0,0
87940,such,0,0
87941,as,0,0
87942,the,0,0
87943,t,0,0
87944,test,0,0
87945,or,0,1
87946,analysis,0,0
87947,of,0,0
87948,covariance,0,0
87949,",",0,0
87950,can,0,0
87951,not,0,0
87952,evaluate,0,0
87953,the,0,0
87954,efficacy,0,0
87955,of,0,0
87956,interventions,0,0
87957,on,0,0
87958,multiple,0,0
87959,outcomes,0,0
87960,simultaneously,0,0
87961,.,0,0
87962,The,0,0
87963,aim,0,0
87964,of,0,0
87965,this,0,0
87966,study,0,0
87967,was,0,0
87968,to,0,0
87969,use,0,0
87970,structural,1,0
87971,equation,1,1
87972,modeling,1,1
87973,(,0,0
87974,SEM,0,1
87975,),0,0
87976,to,0,0
87977,re-analyze,0,0
87978,a,0,0
87979,RCT,0,0
87980,",",0,0
87981,comparing,0,0
87982,the,0,0
87983,effects,0,0
87984,of,0,0
87985,pre-curved,1,0
87986,interdental,1,1
87987,brushes,1,1
87988,and,1,0
87989,flossing,1,1
87990,on,0,0
87991,probing,0,0
87992,pocket,0,0
87993,depth,0,1
87994,(,0,0
87995,PPD,0,1
87996,),0,0
87997,",",0,0
87998,plaque,0,0
87999,indices,0,0
88000,",",0,0
88001,and,0,0
88002,bleeding,0,0
88003,on,0,0
88004,probing,0,0
88005,(,0,0
88006,BOP,0,0
88007,),0,0
88008,measured,0,0
88009,at,0,0
88010,baseline,0,0
88011,",",0,0
88012,intermediate,0,0
88013,",",0,0
88014,and,0,0
88015,final,0,0
88016,examinations,0,0
88017,.,0,0
88018,Results,0,0
88019,of,0,0
88020,SEM,0,1
88021,showed,0,0
88022,that,0,0
88023,the,0,0
88024,observed,0,0
88025,greater,0,0
88026,reduction,0,0
88027,in,0,0
88028,PPD,0,1
88029,and,0,0
88030,BOP,0,0
88031,in,0,0
88032,persons,0,0
88033,using,0,0
88034,interdental,0,1
88035,brushing,0,1
88036,than,0,0
88037,in,0,0
88038,those,0,0
88039,flossing,0,1
88040,is,0,0
88041,due,0,0
88042,mainly,0,0
88043,to,0,0
88044,the,0,0
88045,greater,0,0
88046,efficiency,0,0
88047,in,0,0
88048,plaque,0,0
88049,removal,0,0
88050,with,0,0
88051,the,0,0
88052,interdental,0,1
88053,brushes,0,1
88054,(,0,0
88055,indirect,0,0
88056,effect,0,0
88057,),0,0
88058,rather,0,0
88059,than,0,0
88060,to,0,0
88061,the,0,0
88062,compression,0,1
88063,of,0,0
88064,the,0,0
88065,interdental,0,1
88066,papillae,0,0
88067,(,0,0
88068,direct,0,1
88069,effect,0,0
88070,),0,0
88071,.,0,0
88072,In,0,0
88073,contrast,0,0
88074,",",0,0
88075,smokers,0,0
88076,showed,0,0
88077,less,0,0
88078,BOP,0,0
88079,at,0,0
88080,baseline,0,0
88081,but,0,0
88082,also,0,0
88083,less,0,0
88084,improvement,0,0
88085,in,0,0
88086,BOP,0,0
88087,through,0,0
88088,direct,0,0
88089,effects,0,0
88090,.,0,0
88091,Two,0,0
88092,large,0,0
88093,preoperative,0,0
88094,doses,0,0
88095,of,0,0
88096,erythropoietin,1,1
88097,do,0,0
88098,not,0,0
88099,reduce,0,0
88100,the,0,0
88101,systemic,0,0
88102,inflammatory,0,0
88103,response,0,0
88104,to,0,0
88105,cardiac,0,0
88106,surgery,0,0
88107,.,0,0
88108,OBJECTIVES,0,0
88109,Cardiac,0,0
88110,surgery,0,1
88111,and,0,0
88112,cardiopulmonary,0,1
88113,bypass,0,1
88114,(,0,0
88115,CPB,0,1
88116,),0,0
88117,induce,0,0
88118,an,0,0
88119,inflammatory,0,0
88120,reaction,0,0
88121,that,0,0
88122,may,0,0
88123,lead,0,0
88124,to,0,0
88125,tissue,0,0
88126,injury,0,0
88127,.,0,0
88128,Experimental,0,0
88129,studies,0,0
88130,suggest,0,0
88131,that,0,0
88132,recombinant,1,1
88133,human,1,1
88134,erythropoietin,1,1
88135,(,1,0
88136,EPO,1,1
88137,),1,0
88138,independent,0,0
88139,of,0,0
88140,its,0,0
88141,erythropoietic,0,0
88142,effect,0,0
88143,may,0,0
88144,be,0,0
88145,used,0,0
88146,clinically,0,0
88147,as,0,0
88148,an,0,0
88149,anti-inflammatory,0,0
88150,drug,0,0
88151,.,0,0
88152,This,0,0
88153,study,0,0
88154,tested,0,0
88155,the,0,0
88156,hypothesis,0,0
88157,that,0,0
88158,2,0,0
88159,large,0,0
88160,doses,0,0
88161,of,0,0
88162,EPO,1,1
88163,administered,0,0
88164,shortly,0,0
88165,before,0,0
88166,CPB,0,0
88167,ameliorate,0,0
88168,the,0,0
88169,systemic,0,0
88170,inflammatory,0,0
88171,response,0,0
88172,to,0,0
88173,CPB,0,0
88174,.,0,0
88175,DESIGN,0,0
88176,AND,0,0
88177,SETTING,0,1
88178,A,0,0
88179,prospective,0,0
88180,",",0,0
88181,double-blind,0,0
88182,",",0,0
88183,placebo-controlled,1,1
88184,and,0,0
88185,randomized,0,0
88186,study,0,0
88187,at,0,0
88188,a,0,0
88189,single,0,0
88190,tertiary,0,0
88191,care,0,1
88192,hospital,0,0
88193,.,0,0
88194,PARTICIPANTS,0,0
88195,Patients,0,0
88196,scheduled,0,0
88197,for,0,0
88198,coronary,0,0
88199,artery,0,0
88200,bypass,0,1
88201,graft,0,0
88202,surgery,0,0
88203,with,0,0
88204,CPB,0,0
88205,.,0,0
88206,INTERVENTIONS,0,0
88207,EPO,1,1
88208,(,1,0
88209,epoetin,1,1
88210,alfa,1,1
88211,",",0,0
88212,500,0,0
88213,IU/kg,0,0
88214,intravenously,0,0
88215,",",0,0
88216,n,0,0
88217,=,0,0
88218,22,0,0
88219,),0,0
88220,or,0,1
88221,placebo,1,1
88222,(,0,0
88223,n,0,0
88224,=,0,0
88225,21,0,0
88226,),0,0
88227,was,0,0
88228,administered,0,0
88229,12,0,0
88230,to,0,0
88231,18,0,0
88232,hours,0,0
88233,preoperatively,0,0
88234,and,0,0
88235,again,0,0
88236,at,0,0
88237,the,0,0
88238,induction,0,0
88239,of,0,0
88240,anesthesia,0,1
88241,.,0,0
88242,MEASUREMENTS,0,0
88243,AND,0,0
88244,MAIN,0,0
88245,RESULTS,0,0
88246,CPB,0,1
88247,in,0,0
88248,both,0,0
88249,groups,0,0
88250,greatly,0,0
88251,increased,0,0
88252,plasma,0,0
88253,concentrations,0,0
88254,of,0,0
88255,tumor,0,0
88256,necrosis,0,0
88257,factor,0,1
88258,alpha,0,1
88259,(,0,0
88260,TNF-alpha,0,1
88261,),0,0
88262,",",0,0
88263,interleukin,0,1
88264,(,0,0
88265,IL,0,1
88266,),0,0
88267,-1beta,0,0
88268,",",0,0
88269,IL-1beta,0,0
88270,receptor,0,0
88271,antagonist,0,1
88272,",",0,0
88273,IL-6,0,0
88274,",",0,0
88275,IL-10,0,0
88276,",",0,0
88277,and,0,0
88278,N-terminal,0,0
88279,probrain,0,0
88280,natriuretic,0,1
88281,peptide,0,1
88282,(,0,0
88283,NT-proBNP,0,0
88284,),0,0
88285,.,0,0
88286,Compared,0,0
88287,with,0,0
88288,placebo,1,1
88289,",",1,0
88290,EPO,1,1
88291,at,0,0
88292,day,0,0
88293,3,0,0
88294,after,0,0
88295,CPB,0,0
88296,augmented,0,0
88297,the,0,0
88298,TNF-alpha,0,1
88299,response,0,0
88300,(,0,0
88301,p,0,0
88302,<,0,0
88303,0.05,0,0
88304,),0,0
88305,and,0,0
88306,at,0,0
88307,2,0,0
88308,hours,0,0
88309,after,0,0
88310,CPB,0,0
88311,increased,0,0
88312,NT-proBNP,0,0
88313,(,0,0
88314,p,0,0
88315,<,0,0
88316,0.05,0,0
88317,),0,0
88318,.,0,0
88319,Also,0,0
88320,",",0,0
88321,EPO,1,1
88322,tended,0,0
88323,to,0,0
88324,enhance,0,0
88325,the,0,0
88326,CPB-induced,0,0
88327,increase,0,0
88328,in,0,0
88329,IL-1beta,0,0
88330,receptor,0,0
88331,antagonist,0,1
88332,(,0,0
88333,p,0,0
88334,=,0,0
88335,0.057,0,0
88336,),0,0
88337,.,0,0
88338,Otherwise,0,0
88339,",",0,0
88340,EPO,1,1
88341,had,0,0
88342,no,0,0
88343,effect,0,0
88344,on,0,0
88345,pro-,0,0
88346,and,0,0
88347,antiinflammatory,0,0
88348,mediators,0,0
88349,compared,0,0
88350,with,0,0
88351,placebo,0,1
88352,.,0,0
88353,CONCLUSIONS,0,0
88354,Two,0,0
88355,large,0,0
88356,doses,0,0
88357,of,0,0
88358,EPO,1,1
88359,given,0,0
88360,shortly,0,0
88361,before,0,0
88362,CPB,0,0
88363,do,0,0
88364,not,0,0
88365,reduce,0,0
88366,perioperative,0,0
88367,release,0,0
88368,of,0,0
88369,inflammatory,0,0
88370,cytokines,0,0
88371,.,0,0
88372,In,0,0
88373,contrast,0,0
88374,",",0,0
88375,EPO,1,1
88376,may,0,0
88377,augment,0,0
88378,the,0,0
88379,TNF-alpha,0,1
88380,and,0,0
88381,NT-proBNP,0,0
88382,response,0,0
88383,.,0,0
88384,Although,0,0
88385,the,0,0
88386,long-term,0,0
88387,clinical,0,0
88388,impact,0,0
88389,remains,0,0
88390,unknown,0,0
88391,",",0,0
88392,the,0,0
88393,findings,0,0
88394,do,0,0
88395,not,0,0
88396,support,0,0
88397,use,0,0
88398,of,0,0
88399,EPO,1,1
88400,as,0,0
88401,an,0,0
88402,anti-inflammatory,0,1
88403,drug,0,0
88404,in,0,0
88405,patients,0,0
88406,undergoing,0,0
88407,cardiac,0,0
88408,surgery,0,0
88409,.,0,0
88410,Bolus,0,1
88411,injection,0,1
88412,of,0,0
88413,contrast,1,0
88414,agents,1,0
88415,with,0,0
88416,various,0,0
88417,iodine,0,1
88418,concentrations,0,0
88419,and,0,0
88420,delivery,0,0
88421,rates,0,0
88422,for,0,0
88423,intracranial,0,0
88424,three-dimensional,0,1
88425,CT,0,0
88426,angiography,0,1
88427,:,0,0
88428,evaluation,0,0
88429,of,0,0
88430,intracranial,0,0
88431,arteriovenous,0,1
88432,contrast,0,0
88433,using,0,0
88434,a,0,0
88435,multidetector-row,0,0
88436,CT,0,0
88437,scanner,0,1
88438,.,0,0
88439,PURPOSE,0,0
88440,We,0,0
88441,evaluated,0,0
88442,the,0,0
88443,difference,0,0
88444,in,0,0
88445,computed,0,1
88446,tomography,0,1
88447,(,0,0
88448,CT,0,0
88449,),0,0
88450,attenuation,0,0
88451,values,0,0
88452,of,0,0
88453,the,0,0
88454,intracranial,0,0
88455,arterial,0,0
88456,and,0,0
88457,venous,0,0
88458,systems,0,0
88459,among,0,0
88460,the,0,0
88461,various,0,0
88462,contrast,0,0
88463,injection,0,1
88464,protocols,0,0
88465,(,1,0
88466,higher,1,0
88467,iodine,1,1
88468,delivery,0,0
88469,rate,0,0
88470,or,0,0
88471,higher,1,0
88472,concentration,1,0
88473,of,0,0
88474,the,0,0
88475,agent,0,0
88476,),0,0
88477,on,0,0
88478,the,0,0
88479,source,0,0
88480,images,0,0
88481,of,0,0
88482,intracranial,0,0
88483,three-dimensional,0,1
88484,CT,0,1
88485,angiography,0,1
88486,(,0,0
88487,3D-CTA,0,0
88488,),0,0
88489,using,0,0
88490,a,0,0
88491,multidetector-row,1,0
88492,CT,1,0
88493,(,1,0
88494,MDCT,1,0
88495,),1,0
88496,scanner,1,1
88497,.,1,0
88498,MATERIALS,0,0
88499,AND,0,0
88500,METHODS,0,0
88501,We,0,0
88502,used,0,0
88503,100,1,0
88504,ml,1,0
88505,of,1,0
88506,iopamidol,1,1
88507,300,1,0
88508,at,1,0
88509,an,1,0
88510,injection,1,1
88511,rate,1,0
88512,of,1,0
88513,3.0,1,0
88514,ml/s,1,0
88515,",",1,0
88516,100,1,0
88517,ml,1,0
88518,of,1,0
88519,iopamidol,1,1
88520,300,1,0
88521,at,1,0
88522,an,1,0
88523,injection,1,1
88524,rate,1,0
88525,of,1,0
88526,3.7,1,0
88527,ml/s,1,0
88528,",",1,0
88529,and,1,0
88530,80,1,0
88531,ml,1,0
88532,of,1,0
88533,iopamidol,1,1
88534,370,1,0
88535,at,0,0
88536,an,0,0
88537,injection,0,1
88538,rate,0,0
88539,of,0,0
88540,3.0,0,0
88541,ml/s,0,0
88542,.,0,0
88543,There,0,0
88544,were,0,0
88545,10,0,0
88546,patients,0,0
88547,in,0,0
88548,each,0,0
88549,group,0,0
88550,.,0,0
88551,Attenuation,0,0
88552,values,0,0
88553,of,0,0
88554,the,0,0
88555,bilateral,0,1
88556,internal,0,0
88557,carotid,0,0
88558,arteries,0,0
88559,(,0,0
88560,ICAs,0,1
88561,),0,0
88562,",",0,0
88563,basilar,0,1
88564,artery,0,0
88565,trunk,0,0
88566,",",0,0
88567,bilateral,0,0
88568,cavernous,0,0
88569,sinuses,0,1
88570,(,0,0
88571,CSs,0,0
88572,),0,0
88573,",",0,0
88574,and,0,0
88575,Galenic,0,0
88576,vein,0,0
88577,were,0,0
88578,measured,0,0
88579,quantitatively,0,0
88580,on,0,0
88581,the,0,0
88582,axial,0,0
88583,CT,0,0
88584,angiographic,0,1
88585,source,0,0
88586,images,0,0
88587,obtained,0,0
88588,by,0,0
88589,four-channel,0,1
88590,MDCT,0,0
88591,.,0,0
88592,RESULTS,0,0
88593,Injection,0,0
88594,of,0,0
88595,the,0,0
88596,high-concentration,1,0
88597,contrast,1,0
88598,with,0,0
88599,a,0,0
88600,higher,1,0
88601,iodine-delivery,1,0
88602,rate,0,0
88603,achieved,0,0
88604,good,0,0
88605,arteriovenous,0,1
88606,contrast,0,0
88607,at,0,0
88608,the,0,0
88609,cavernous,0,0
88610,portion,0,0
88611,.,0,0
88612,With,0,0
88613,the,0,0
88614,same,0,0
88615,rate,0,0
88616,of,0,0
88617,iodine,1,1
88618,delivery,0,0
88619,",",0,0
88620,injection,0,0
88621,of,0,0
88622,the,0,0
88623,intermediate,1,0
88624,concentrate,1,1
88625,agent,1,0
88626,increased,0,0
88627,the,0,0
88628,CT,0,0
88629,value,0,0
88630,of,0,0
88631,not,0,0
88632,only,0,0
88633,the,0,0
88634,ICAs,0,1
88635,but,0,0
88636,also,0,0
88637,the,0,0
88638,CSs,0,0
88639,.,0,0
88640,CONCLUSION,0,0
88641,High-concentration,1,0
88642,contrast,1,0
88643,could,0,0
88644,increase,0,0
88645,ICA,0,1
88646,attenuation,0,0
88647,without,0,0
88648,intracavernous,0,0
88649,attenuation,0,0
88650,gain,0,0
88651,during,0,0
88652,the,0,0
88653,first-pass,0,0
88654,phase,0,0
88655,.,0,0
88656,Comparison,0,0
88657,of,0,0
88658,40,0,0
88659,milliliters,0,0
88660,of,0,0
88661,0.25,0,0
88662,%,0,0
88663,intrapleural,0,1
88664,bupivacaine,1,1
88665,with,0,0
88666,epinephrine,1,1
88667,with,0,0
88668,20,0,0
88669,milliliters,0,0
88670,of,0,0
88671,0.5,0,0
88672,%,0,0
88673,intrapleural,0,1
88674,bupivacaine,0,1
88675,with,0,0
88676,epinephrine,0,1
88677,after,0,0
88678,cholecystectomy,0,0
88679,.,0,0
88680,To,0,0
88681,determine,0,0
88682,the,0,0
88683,influence,0,0
88684,of,0,0
88685,the,0,0
88686,volume,0,0
88687,of,0,0
88688,local,0,0
88689,anesthetic,0,1
88690,injected,0,1
88691,for,0,0
88692,intrapleural,0,1
88693,analgesia,0,0
88694,",",0,0
88695,40,0,0
88696,patients,0,0
88697,undergoing,0,0
88698,cholecystectomy,0,0
88699,were,0,0
88700,randomly,0,0
88701,allocated,0,0
88702,to,0,0
88703,two,0,0
88704,groups,0,0
88705,of,0,0
88706,20,0,0
88707,patients,0,0
88708,each,0,0
88709,.,0,0
88710,One,1,0
88711,group,1,0
88712,received,1,0
88713,40,1,0
88714,mL,1,0
88715,of,1,0
88716,0.25,1,1
88717,%,1,0
88718,bupivacaine,1,1
88719,with,1,0
88720,epinephrine,1,1
88721,injected,1,1
88722,intrapleurally,1,1
88723,postoperatively,1,0
88724,.,1,0
88725,The,1,0
88726,other,1,0
88727,group,1,0
88728,received,1,0
88729,20,1,0
88730,mL,1,0
88731,of,1,0
88732,0.5,1,1
88733,%,1,0
88734,bupivacaine,1,1
88735,with,1,0
88736,epinephrine,1,1
88737,.,1,0
88738,The,0,0
88739,onset,0,0
88740,time,0,0
88741,of,0,0
88742,analgesia,0,0
88743,was,0,0
88744,nearly,0,0
88745,the,0,0
88746,same,0,0
88747,in,0,0
88748,both,0,0
88749,groups,0,0
88750,and,0,0
88751,within,0,0
88752,25,0,0
88753,min,0,0
88754,all,0,0
88755,patients,0,0
88756,were,0,0
88757,nearly,0,0
88758,pain,0,0
88759,free,0,0
88760,.,0,0
88761,Our,0,0
88762,data,0,0
88763,demonstrate,0,0
88764,that,0,0
88765,100,0,0
88766,mg,0,0
88767,of,0,0
88768,bupivacaine,0,1
88769,with,0,0
88770,epinephrine,0,1
88771,elicits,0,0
88772,effective,0,0
88773,analgesia,0,0
88774,after,0,0
88775,cholecystectomy,0,0
88776,.,0,0
88777,There,0,0
88778,are,0,0
88779,only,0,0
88780,minor,0,0
88781,differences,0,0
88782,between,0,0
88783,20,0,0
88784,and,0,0
88785,40,0,0
88786,mL,0,0
88787,with,0,0
88788,regard,0,0
88789,to,0,0
88790,pain,0,0
88791,relief,0,0
88792,.,0,0
88793,The,0,0
88794,authors,0,0
88795,conclude,0,0
88796,that,0,0
88797,the,0,0
88798,volume,0,0
88799,of,0,0
88800,local,0,0
88801,anesthetic,0,0
88802,within,0,0
88803,the,0,0
88804,range,0,0
88805,of,0,0
88806,20-40,0,1
88807,mL,0,0
88808,in,0,0
88809,an,0,0
88810,adult,0,0
88811,has,0,0
88812,little,0,0
88813,influence,0,0
88814,on,0,0
88815,the,0,0
88816,extent,0,0
88817,or,0,1
88818,duration,0,0
88819,of,0,0
88820,intrapleural,0,1
88821,analgesia,0,0
88822,.,0,0
88823,Two-year,0,0
88824,prospective,0,0
88825,clinical,0,0
88826,comparison,0,0
88827,of,0,0
88828,immediate,1,0
88829,replacement,1,1
88830,vs.,1,0
88831,immediate,1,0
88832,restoration,1,0
88833,of,1,0
88834,single,1,0
88835,tooth,1,0
88836,in,0,0
88837,the,0,0
88838,esthetic,0,1
88839,zone,0,0
88840,.,0,0
88841,AIM,0,0
88842,To,0,0
88843,compare,0,0
88844,the,0,0
88845,immediate,0,0
88846,restoration,0,0
88847,of,0,0
88848,single,1,0
88849,implants,1,1
88850,in,0,0
88851,the,0,0
88852,esthetic,0,1
88853,zones,0,0
88854,performed,0,0
88855,on,0,0
88856,implants,0,1
88857,placed,0,0
88858,immediately,0,0
88859,after,0,0
88860,tooth,0,0
88861,extraction,0,1
88862,or,0,0
88863,8,0,0
88864,weeks,0,0
88865,later,0,0
88866,(,0,0
88867,immediate,0,0
88868,replacement,1,1
88869,vs.,0,0
88870,immediate,0,0
88871,restoration,1,0
88872,),1,0
88873,.,0,0
88874,METHODS,0,0
88875,Sixteen,0,0
88876,patients,0,0
88877,(,0,0
88878,10,0,0
88879,women,0,0
88880,and,0,0
88881,6,0,0
88882,men,0,0
88883,),0,0
88884,with,0,0
88885,a,0,0
88886,mean,0,0
88887,age,0,0
88888,of,0,0
88889,35,0,0
88890,years,0,0
88891,(,0,0
88892,ranging,0,0
88893,from,0,0
88894,21,0,0
88895,to,0,0
88896,49,0,0
88897,years,0,0
88898,old,0,0
88899,),0,0
88900,were,0,0
88901,treated,0,0
88902,from,0,0
88903,2004,0,0
88904,to,0,0
88905,2005,0,0
88906,for,0,0
88907,single-tooth,0,1
88908,replacement,0,1
88909,in,0,0
88910,the,0,0
88911,upper,0,0
88912,arch,0,0
88913,.,0,0
88914,The,0,0
88915,patients,0,0
88916,were,0,0
88917,randomly,0,0
88918,divided,0,0
88919,into,0,0
88920,two,0,0
88921,groups,0,0
88922,:,0,0
88923,in,0,0
88924,the,0,0
88925,test,0,0
88926,group,0,0
88927,patients,0,0
88928,received,0,0
88929,implants,1,1
88930,placed,1,0
88931,and,1,0
88932,restored,1,0
88933,(,0,0
88934,non-occlusal,0,0
88935,loading,0,1
88936,),0,0
88937,at,0,0
88938,the,0,0
88939,time,0,0
88940,of,0,0
88941,tooth,0,0
88942,extraction,0,1
88943,;,0,0
88944,in,0,0
88945,the,0,0
88946,control,0,0
88947,group,0,0
88948,implants,1,1
88949,were,1,0
88950,placed,1,0
88951,8,0,0
88952,weeks,0,0
88953,after,1,0
88954,tooth,1,0
88955,extraction,1,1
88956,and,1,0
88957,immediately,1,0
88958,restored,1,0
88959,.,1,0
88960,All,0,0
88961,the,0,0
88962,patients,0,0
88963,received,0,0
88964,tapered,1,1
88965,effect,1,0
88966,(,1,0
88967,TE,1,1
88968,),1,0
88969,implants,1,1
88970,from,0,0
88971,the,0,0
88972,Straumann,0,0
88973,Dental,0,0
88974,Implant,0,1
88975,System,0,0
88976,.,0,0
88977,The,0,0
88978,following,0,0
88979,parameters,0,0
88980,were,0,0
88981,evaluated,0,0
88982,at,0,0
88983,the,0,0
88984,moment,0,0
88985,of,0,0
88986,provisional,0,0
88987,restoration,0,0
88988,(,0,0
88989,within,0,0
88990,48,0,0
88991,h,0,0
88992,after,0,0
88993,implant,0,1
88994,placement,0,1
88995,),0,0
88996,and,0,0
88997,at,0,0
88998,the,0,0
88999,2,0,0
89000,years,0,0
89001,follow-up,0,0
89002,visit,0,0
89003,:,0,0
89004,marginal,0,0
89005,bone,0,0
89006,resorption,0,0
89007,",",0,0
89008,papilla,0,0
89009,index,0,0
89010,",",0,0
89011,position,0,0
89012,of,0,0
89013,the,0,0
89014,mucosal,0,0
89015,margin,0,0
89016,.,0,0
89017,The,0,0
89018,implant,0,1
89019,stability,0,0
89020,quotient,0,0
89021,was,0,0
89022,measured,0,0
89023,at,0,0
89024,the,0,0
89025,moment,0,0
89026,of,0,0
89027,implant,0,1
89028,placement,0,1
89029,and,0,0
89030,at,0,0
89031,the,0,0
89032,moment,0,0
89033,of,0,0
89034,the,0,0
89035,delivery,0,0
89036,of,0,0
89037,the,0,0
89038,definitive,0,0
89039,restoration,0,0
89040,.,0,0
89041,RESULTS,0,0
89042,No,0,0
89043,statistically,0,0
89044,significant,0,0
89045,differences,0,0
89046,were,0,0
89047,found,0,0
89048,in,0,0
89049,any,0,0
89050,of,0,0
89051,the,0,0
89052,studied,0,0
89053,parameters,0,0
89054,between,0,0
89055,the,0,0
89056,test,0,0
89057,and,0,0
89058,the,0,0
89059,control,0,1
89060,groups,0,0
89061,(,0,0
89062,P,0,0
89063,>,0,0
89064,0.05,0,0
89065,),0,0
89066,.,0,0
89067,The,0,0
89068,implant,0,1
89069,stability,0,0
89070,quotient,0,0
89071,values,0,0
89072,between,0,0
89073,the,0,0
89074,test,0,0
89075,and,0,0
89076,control,0,0
89077,groups,0,0
89078,were,0,0
89079,significant,0,0
89080,(,0,0
89081,P,0,0
89082,<,0,0
89083,0.05,0,0
89084,),0,0
89085,at,0,0
89086,the,0,0
89087,moment,0,0
89088,of,0,0
89089,implant,0,1
89090,placement,0,1
89091,but,0,0
89092,were,0,0
89093,no,0,0
89094,more,0,0
89095,significant,0,0
89096,at,0,0
89097,the,0,0
89098,loading,0,0
89099,of,0,0
89100,the,0,0
89101,definitive,0,0
89102,restoration,0,0
89103,(,0,0
89104,P,0,0
89105,>,0,0
89106,0.05,0,0
89107,),0,0
89108,.,0,0
89109,CONCLUSION,0,0
89110,The,0,0
89111,results,0,0
89112,of,0,0
89113,the,0,0
89114,present,0,0
89115,study,0,0
89116,suggest,0,0
89117,that,0,0
89118,immediate,0,0
89119,replacement,0,1
89120,without,0,0
89121,functional,0,0
89122,loading,0,0
89123,may,0,0
89124,be,0,0
89125,considered,0,0
89126,a,0,0
89127,valuable,0,0
89128,therapeutic,0,0
89129,option,0,0
89130,for,0,0
89131,selected,0,0
89132,cases,0,0
89133,of,0,0
89134,single-tooth,1,1
89135,replacement,1,1
89136,in,0,0
89137,the,0,0
89138,esthetic,0,1
89139,area,0,0
89140,when,0,0
89141,TE,0,1
89142,implants,0,1
89143,are,0,0
89144,used,0,0
89145,.,0,0
89146,Implant,0,0
89147,stability,0,0
89148,at,0,0
89149,the,0,0
89150,moment,0,0
89151,of,0,0
89152,implant,0,1
89153,placement,0,1
89154,is,0,0
89155,slightly,0,0
89156,inferior,0,0
89157,in,0,0
89158,the,0,0
89159,immediate,0,0
89160,replacement,0,1
89161,group,0,0
89162,",",0,0
89163,but,0,0
89164,it,0,0
89165,does,0,0
89166,not,0,0
89167,affect,0,0
89168,the,0,0
89169,treatment,0,0
89170,result,0,0
89171,.,0,0
89172,Effect,0,0
89173,of,0,0
89174,diltiazem,1,1
89175,on,0,0
89176,symptomatic,0,0
89177,and,0,0
89178,asymptomatic,0,0
89179,episodes,0,0
89180,of,0,0
89181,ST,0,0
89182,segment,0,0
89183,depression,0,0
89184,occurring,0,0
89185,during,0,0
89186,daily,0,1
89187,life,0,0
89188,and,0,0
89189,during,0,0
89190,exercise,0,1
89191,.,0,0
89192,BACKGROUND,0,0
89193,Silent,0,0
89194,myocardial,0,0
89195,ischemia,0,0
89196,is,0,0
89197,an,0,0
89198,adverse,0,0
89199,prognostic,0,0
89200,marker,0,0
89201,in,0,0
89202,patients,0,0
89203,with,0,0
89204,coronary,0,0
89205,disease,0,0
89206,;,0,0
89207,however,0,0
89208,",",0,0
89209,controlled,0,0
89210,data,0,0
89211,on,0,0
89212,the,0,0
89213,effect,0,0
89214,of,0,0
89215,treatment,0,0
89216,are,0,0
89217,sparse,0,1
89218,and,0,0
89219,contradictory,0,0
89220,",",0,0
89221,and,0,0
89222,the,0,0
89223,relations,0,0
89224,among,0,0
89225,the,0,0
89226,occurrence,0,0
89227,of,0,0
89228,ST,0,0
89229,segment,0,0
89230,depression,0,0
89231,",",0,0
89232,drug,0,0
89233,efficacy,0,0
89234,",",0,0
89235,and,0,0
89236,heart,0,0
89237,rate,0,0
89238,are,0,0
89239,unclear,0,0
89240,.,0,0
89241,METHODS,0,0
89242,AND,0,0
89243,RESULTS,0,0
89244,Sixty,0,0
89245,patients,0,0
89246,with,0,0
89247,stable,0,0
89248,coronary,0,0
89249,artery,0,0
89250,disease,0,0
89251,",",0,0
89252,a,0,0
89253,positive,0,0
89254,treadmill,0,1
89255,exercise,0,1
89256,test,0,0
89257,and,0,0
89258,asymptomatic,0,0
89259,ST,0,1
89260,segment,0,0
89261,depression,0,0
89262,on,0,0
89263,ambulatory,0,0
89264,electrocardiographic,0,0
89265,recording,0,0
89266,were,0,0
89267,assessed,0,0
89268,in,0,0
89269,a,0,0
89270,multicenter,0,0
89271,",",0,0
89272,double-blind,0,0
89273,",",0,0
89274,placebo-controlled,1,1
89275,",",0,0
89276,cross-over,0,0
89277,trial,0,0
89278,.,0,0
89279,Treadmill,1,1
89280,exercise,1,1
89281,tests,0,0
89282,and,0,0
89283,72-hour,0,0
89284,electrocardiographic,0,0
89285,recordings,0,0
89286,were,0,0
89287,obtained,0,0
89288,at,0,0
89289,the,0,0
89290,end,0,0
89291,of,0,0
89292,two,0,0
89293,2-week,0,0
89294,treatment,0,0
89295,periods,0,0
89296,with,0,0
89297,sustained-release,1,1
89298,diltiazem,1,1
89299,180,0,0
89300,mg,0,0
89301,b.i.d,0,1
89302,.,0,0
89303,or,0,0
89304,equivalent,0,0
89305,placebo,1,1
89306,.,1,0
89307,Episodes,0,0
89308,of,0,0
89309,asymptomatic,0,0
89310,ST,0,0
89311,depression,0,0
89312,decreased,0,0
89313,by,0,0
89314,50,0,0
89315,%,0,0
89316,or,0,0
89317,more,0,0
89318,in,0,0
89319,70,0,0
89320,%,0,0
89321,of,0,0
89322,the,0,0
89323,patients,0,0
89324,from,0,0
89325,a,0,0
89326,median,0,0
89327,number,0,0
89328,of,0,0
89329,4.5,0,0
89330,(,0,0
89331,range,0,0
89332,",",0,0
89333,0-19,0,0
89334,),0,0
89335,to,0,0
89336,1.5,0,0
89337,(,0,0
89338,range,0,0
89339,",",0,0
89340,0-13,0,0
89341,),0,0
89342,(,0,0
89343,p,0,0
89344,=,0,0
89345,0.0001,0,0
89346,),0,0
89347,;,0,0
89348,their,0,0
89349,cumulative,0,0
89350,duration,0,0
89351,also,0,0
89352,decreased,0,0
89353,from,0,0
89354,78.5,0,0
89355,(,0,0
89356,range,0,0
89357,",",0,0
89358,0-60,0,0
89359,),0,0
89360,to,0,0
89361,24.5,0,0
89362,(,0,0
89363,range,0,0
89364,",",0,0
89365,0-411,0,0
89366,),0,0
89367,minutes,0,0
89368,(,0,0
89369,p,0,0
89370,=,0,0
89371,0.001,0,0
89372,),0,0
89373,.,0,0
89374,No,0,0
89375,circadian,0,0
89376,variation,0,0
89377,was,0,0
89378,found,0,0
89379,in,0,0
89380,the,0,0
89381,efficacy,0,0
89382,of,0,0
89383,diltiazem,1,1
89384,.,1,0
89385,The,0,0
89386,occurrence,0,0
89387,of,0,0
89388,ischemic,0,0
89389,type,0,0
89390,ST,0,0
89391,segment,0,0
89392,depression,0,0
89393,was,0,0
89394,modulated,0,0
89395,by,0,0
89396,changes,0,0
89397,in,0,0
89398,heart,0,0
89399,rate,0,0
89400,rather,0,0
89401,than,0,0
89402,by,0,0
89403,absolute,0,0
89404,heart,0,0
89405,rate,0,0
89406,.,0,0
89407,Diltiazem,1,1
89408,also,0,0
89409,improved,0,0
89410,exercise,0,1
89411,test,0,0
89412,end,0,0
89413,points,0,0
89414,but,0,0
89415,to,0,0
89416,a,0,0
89417,lesser,0,0
89418,extent,0,0
89419,.,0,0
89420,Time,0,0
89421,to,0,0
89422,ST,0,0
89423,segment,0,0
89424,depression,0,0
89425,increased,0,0
89426,to,0,0
89427,341,0,0
89428,+/-,0,0
89429,148,0,0
89430,from,0,0
89431,296,0,0
89432,+/-,0,0
89433,154,0,0
89434,seconds,0,0
89435,(,0,0
89436,p,0,0
89437,=,0,0
89438,0.005,0,0
89439,),0,0
89440,.,0,0
89441,Although,0,0
89442,less,0,0
89443,frequent,0,0
89444,with,0,0
89445,diltiazem,1,1
89446,administration,0,0
89447,(,0,0
89448,45,0,0
89449,versus,0,0
89450,54,0,0
89451,patients,0,0
89452,",",0,0
89453,p,0,0
89454,less,0,0
89455,than,0,0
89456,0.03,0,0
89457,),0,0
89458,",",0,0
89459,exercise-induced,0,1
89460,ST,0,0
89461,depression,0,0
89462,was,0,0
89463,more,0,0
89464,often,0,0
89465,asymptomatic,0,0
89466,(,0,0
89467,98,0,0
89468,%,0,0
89469,versus,0,0
89470,72,0,0
89471,%,0,0
89472,of,0,0
89473,patients,0,0
89474,",",0,0
89475,p,0,0
89476,less,0,0
89477,than,0,0
89478,0.0001,0,0
89479,),0,0
89480,.,0,0
89481,CONCLUSIONS,0,0
89482,Diltiazem,1,1
89483,reduces,0,0
89484,the,0,0
89485,frequency,0,0
89486,and,0,0
89487,severity,0,0
89488,of,0,0
89489,ischemic,0,0
89490,type,0,0
89491,ST,0,0
89492,depression,0,0
89493,in,0,0
89494,patients,0,0
89495,with,0,0
89496,stable,0,0
89497,coronary,0,0
89498,artery,0,0
89499,disease,0,0
89500,.,0,0
89501,Three-year,0,0
89502,clinical,0,0
89503,outcome,0,0
89504,after,0,0
89505,primary,0,0
89506,stenting,0,1
89507,of,0,0
89508,totally,0,0
89509,occluded,0,0
89510,native,0,0
89511,coronary,0,0
89512,arteries,0,0
89513,:,0,0
89514,a,0,0
89515,randomized,0,0
89516,comparison,0,0
89517,of,0,0
89518,bare-metal,1,1
89519,stent,1,1
89520,implantation,1,0
89521,with,1,0
89522,sirolimus-eluting,1,0
89523,stent,1,1
89524,implantation,1,0
89525,for,0,0
89526,the,0,0
89527,treatment,0,0
89528,of,0,0
89529,total,0,0
89530,coronary,0,0
89531,occlusions,0,0
89532,(,0,0
89533,Primary,0,0
89534,Stenting,0,0
89535,of,0,0
89536,Totally,0,0
89537,Occluded,0,0
89538,Native,0,0
89539,Coronary,0,0
89540,Arteries,0,1
89541,[,0,0
89542,PRISON,0,1
89543,],0,0
89544,II,0,0
89545,study,0,0
89546,),0,0
89547,.,0,0
89548,BACKGROUND,0,0
89549,The,0,0
89550,purpose,0,0
89551,of,0,0
89552,this,0,0
89553,study,0,0
89554,was,0,0
89555,to,0,0
89556,examine,0,0
89557,the,0,0
89558,3-year,0,0
89559,clinical,0,0
89560,outcome,0,0
89561,in,0,0
89562,patients,0,0
89563,enrolled,0,0
89564,in,0,0
89565,the,0,0
89566,Primary,0,0
89567,Stenting,0,0
89568,of,0,0
89569,Totally,0,0
89570,Occluded,0,0
89571,Native,0,0
89572,Coronary,0,0
89573,Arteries,0,1
89574,II,0,0
89575,study,0,0
89576,.,0,0
89577,METHODS,0,0
89578,Patients,0,0
89579,with,0,0
89580,totally,0,0
89581,occluded,0,0
89582,coronary,0,0
89583,arteries,0,0
89584,randomized,0,0
89585,to,0,0
89586,either,0,0
89587,sirolimus-eluting,1,0
89588,Cypher,1,1
89589,stents,1,1
89590,(,1,0
89591,SESs,1,0
89592,),1,1
89593,(,0,0
89594,Cordis,0,0
89595,",",0,0
89596,a,0,0
89597,Johnson,0,0
89598,&,0,0
89599,Joshson,0,1
89600,Company,0,0
89601,",",0,0
89602,Miami,0,0
89603,Lakes,0,0
89604,",",0,0
89605,FL,0,1
89606,),0,0
89607,(,0,0
89608,100,0,1
89609,patients,0,0
89610,),0,0
89611,or,0,0
89612,bare-metal,1,1
89613,BxVelocity,1,0
89614,stents,1,1
89615,(,1,0
89616,BMSs,1,1
89617,),1,1
89618,(,0,0
89619,Cordis,0,0
89620,),0,1
89621,(,0,0
89622,100,0,1
89623,patients,0,0
89624,),0,0
89625,were,0,0
89626,followed,0,0
89627,clinically,0,0
89628,for,0,0
89629,3,0,0
89630,years,0,0
89631,.,0,0
89632,RESULTS,0,0
89633,Between,0,0
89634,1,0,0
89635,and,0,0
89636,3,0,0
89637,years,0,0
89638,",",0,0
89639,there,0,0
89640,were,0,0
89641,infrequent,0,0
89642,additional,0,0
89643,clinical,0,0
89644,events,0,0
89645,that,0,0
89646,were,0,0
89647,equally,0,0
89648,distributed,0,0
89649,between,0,0
89650,the,0,0
89651,SES,0,1
89652,and,0,0
89653,the,0,0
89654,BMS,0,1
89655,group,0,0
89656,.,0,0
89657,After,0,0
89658,3,0,0
89659,years,0,0
89660,",",0,0
89661,target,0,0
89662,lesion,0,0
89663,revascularization,0,0
89664,was,0,0
89665,7,0,0
89666,%,0,0
89667,in,0,0
89668,the,0,0
89669,SES,0,1
89670,group,0,0
89671,versus,0,0
89672,27,0,0
89673,%,0,0
89674,in,0,0
89675,the,0,0
89676,BMS,0,1
89677,group,0,0
89678,(,0,0
89679,P,0,0
89680,<,0,0
89681,.001,0,0
89682,),0,0
89683,;,0,0
89684,and,0,0
89685,target,0,0
89686,vessel,0,0
89687,revascularization,0,0
89688,was,0,0
89689,seen,0,0
89690,in,0,0
89691,11,0,0
89692,%,0,0
89693,in,0,0
89694,the,0,0
89695,SES,0,1
89696,group,0,0
89697,versus,0,0
89698,30,0,0
89699,%,0,0
89700,in,0,0
89701,the,0,0
89702,BMS,0,1
89703,group,0,0
89704,(,0,0
89705,P,0,0
89706,=,0,0
89707,.002,0,0
89708,),0,0
89709,.,0,0
89710,Major,0,0
89711,adverse,0,0
89712,cardiac,0,0
89713,events,0,0
89714,were,0,0
89715,noted,0,0
89716,in,0,0
89717,10,0,0
89718,%,0,0
89719,of,0,0
89720,the,0,0
89721,SES,0,1
89722,group,0,0
89723,versus,0,0
89724,34,0,0
89725,%,0,0
89726,in,0,0
89727,the,0,0
89728,BMS,0,1
89729,group,0,0
89730,(,0,0
89731,P,0,0
89732,<,0,0
89733,.001,0,0
89734,),0,0
89735,.,0,0
89736,There,0,0
89737,were,0,0
89738,no,0,0
89739,statistically,0,0
89740,significant,0,0
89741,differences,0,0
89742,in,0,0
89743,death,0,0
89744,",",0,0
89745,myocardial,0,0
89746,infarction,0,0
89747,",",0,0
89748,and,0,0
89749,stent,0,1
89750,thrombosis,0,0
89751,according,0,0
89752,to,0,0
89753,the,0,0
89754,Academic,0,0
89755,Research,0,0
89756,Consortium,0,0
89757,criteria,0,0
89758,between,0,0
89759,the,0,0
89760,2,0,0
89761,groups,0,0
89762,.,0,0
89763,CONCLUSIONS,0,0
89764,Clinical,0,0
89765,outcome,0,0
89766,up,0,0
89767,to,0,0
89768,3,0,0
89769,years,0,0
89770,after,0,0
89771,implantation,0,0
89772,of,0,0
89773,SESs,1,0
89774,for,0,0
89775,total,0,0
89776,coronary,0,0
89777,occlusions,0,0
89778,continues,0,0
89779,to,0,0
89780,demonstrate,0,0
89781,a,0,0
89782,significant,0,0
89783,reduction,0,0
89784,in,0,0
89785,adverse,0,0
89786,clinical,0,0
89787,events,0,0
89788,compared,0,0
89789,with,0,0
89790,BMSs,1,0
89791,without,0,0
89792,the,0,0
89793,evidence,0,0
89794,for,0,0
89795,either,0,0
89796,disproportionate,0,0
89797,late,0,0
89798,restenosis,0,0
89799,or,0,1
89800,late,0,0
89801,stent,0,1
89802,thrombosis,0,0
89803,.,0,0
89804,Recombinant,1,1
89805,human,1,1
89806,granulocyte-macrophage,1,1
89807,colony,1,1
89808,stimulating,1,0
89809,factor,1,1
89810,(,1,1
89811,rhGM-CSF,1,1
89812,),1,1
89813,reduces,0,0
89814,infection-related,0,0
89815,mortality,0,0
89816,after,0,0
89817,allogeneic,0,1
89818,T-cell,0,0
89819,depleted,0,0
89820,BMT,0,0
89821,.,0,0
89822,Effect,0,0
89823,of,0,0
89824,recombinant,1,1
89825,adenovirus-p53,1,1
89826,combined,1,1
89827,with,1,0
89828,radiotherapy,1,1
89829,on,0,0
89830,long-term,0,0
89831,prognosis,0,0
89832,of,0,0
89833,advanced,0,0
89834,nasopharyngeal,0,0
89835,carcinoma,0,0
89836,.,0,0
89837,PURPOSE,0,0
89838,To,0,0
89839,centrally,0,0
89840,assess,0,0
89841,the,0,0
89842,safety,0,0
89843,",",0,0
89844,efficacy,0,0
89845,",",0,0
89846,and,0,0
89847,6-year,0,0
89848,follow-up,0,0
89849,of,0,0
89850,recombinant,1,1
89851,adenovirus-p53,1,1
89852,(,1,0
89853,rAd-p53,1,1
89854,),1,0
89855,combined,1,1
89856,with,1,0
89857,radiotherapy,1,1
89858,(,1,0
89859,RT,1,1
89860,),1,0
89861,for,0,0
89862,patients,0,0
89863,with,0,0
89864,nasopharyngeal,0,0
89865,carcinoma,0,0
89866,(,0,0
89867,NPC,0,1
89868,),0,0
89869,.,0,0
89870,PATIENTS,0,0
89871,AND,0,0
89872,METHODS,0,0
89873,A,0,0
89874,randomized,0,0
89875,controlled,0,0
89876,clinical,0,0
89877,study,0,0
89878,on,0,0
89879,rAd-p53,1,1
89880,combined,1,0
89881,with,1,0
89882,RT,1,0
89883,in,0,0
89884,42,0,0
89885,patients,0,0
89886,with,0,0
89887,NPC,0,0
89888,was,0,0
89889,compared,0,0
89890,with,0,0
89891,a,0,0
89892,control,0,0
89893,group,0,0
89894,of,0,0
89895,40,0,0
89896,patients,0,0
89897,with,0,0
89898,NPC,0,0
89899,treated,0,0
89900,with,0,0
89901,RT,1,0
89902,alone,1,0
89903,.,1,0
89904,In,0,0
89905,the,0,0
89906,group,0,0
89907,receiving,0,0
89908,rAd-p53,1,1
89909,combined,1,1
89910,with,1,0
89911,RT,1,0
89912,",",1,0
89913,rAd-p53,1,1
89914,was,0,0
89915,intratumorally,0,0
89916,injected,0,1
89917,once,0,0
89918,a,0,0
89919,week,0,0
89920,for,0,0
89921,8,0,0
89922,weeks,0,0
89923,.,0,0
89924,Concurrent,0,0
89925,RT,0,0
89926,(,0,0
89927,70,0,0
89928,Gy,0,1
89929,in,0,0
89930,35,0,0
89931,fractions,0,0
89932,),0,0
89933,was,0,0
89934,given,0,0
89935,to,0,0
89936,the,0,0
89937,nasopharyngeal,0,0
89938,tumor,0,0
89939,and,0,0
89940,neck,0,0
89941,lymph,0,0
89942,node,0,0
89943,.,0,0
89944,Patients,0,0
89945,and,0,0
89946,tumors,0,0
89947,were,0,0
89948,monitored,0,0
89949,for,0,0
89950,adverse,0,0
89951,events,0,0
89952,and,0,0
89953,responses,0,0
89954,.,0,0
89955,RESULTS,0,0
89956,rAd-p53-specific,0,1
89957,p53,0,0
89958,mRNA,0,0
89959,was,0,0
89960,detected,0,0
89961,in,0,0
89962,postinjection,0,0
89963,of,0,0
89964,rAd-p53,0,1
89965,biopsies,0,0
89966,from,0,0
89967,16,0,0
89968,(,0,0
89969,94.1,0,0
89970,%,0,0
89971,),0,0
89972,of,0,0
89973,17,0,0
89974,patients,0,0
89975,.,0,0
89976,Upregulation,0,0
89977,of,0,0
89978,p21/WAF1,0,0
89979,and,0,0
89980,Bax,0,1
89981,and,0,0
89982,downregulation,0,0
89983,of,0,0
89984,vascular,0,0
89985,endothelial,0,0
89986,growth,0,0
89987,factor,0,0
89988,were,0,0
89989,observed,0,0
89990,in,0,0
89991,postinjection,0,0
89992,tumor,0,0
89993,biopsy,0,1
89994,.,0,0
89995,Complete,0,0
89996,response,0,0
89997,rate,0,0
89998,in,0,0
89999,the,0,0
90000,group,0,0
90001,receiving,0,0
90002,rAd-p53,1,1
90003,combined,1,1
90004,with,1,0
90005,RT,1,0
90006,was,0,0
90007,observed,0,0
90008,at,0,0
90009,2.73,0,0
90010,times,0,0
90011,that,0,0
90012,of,0,0
90013,the,0,0
90014,group,0,0
90015,receiving,0,0
90016,RT,1,1
90017,alone,1,1
90018,(,0,0
90019,66.7,0,0
90020,%,0,0
90021,v,0,0
90022,24.4,0,0
90023,%,0,0
90024,),0,0
90025,.,0,0
90026,Six-year,0,0
90027,follow-up,0,0
90028,data,0,0
90029,showed,0,0
90030,that,0,0
90031,rAd-p53,1,1
90032,significantly,0,0
90033,increased,0,0
90034,the,0,0
90035,5-year,0,0
90036,locoregional,0,0
90037,tumor,0,0
90038,control,0,1
90039,rate,0,0
90040,by,0,0
90041,25.3,0,0
90042,%,0,0
90043,for,0,0
90044,patients,0,0
90045,with,0,0
90046,NPC,0,0
90047,treated,0,0
90048,with,0,0
90049,irradiation,0,1
90050,(,0,0
90051,P,0,0
90052,=,0,0
90053,.002,0,0
90054,),0,0
90055,.,0,0
90056,The,0,0
90057,5-year,0,0
90058,overall,0,0
90059,survival,0,0
90060,rate,0,0
90061,and,0,0
90062,5-year,0,0
90063,disease-free,0,0
90064,survival,0,0
90065,rate,0,0
90066,of,0,0
90067,the,0,0
90068,group,0,0
90069,receiving,0,0
90070,rAd-p53,1,1
90071,combined,1,1
90072,with,1,0
90073,RT,1,0
90074,were,0,0
90075,7.5,0,0
90076,%,0,0
90077,(,0,0
90078,P,0,0
90079,=,0,0
90080,.34,0,0
90081,),0,0
90082,and,0,0
90083,11.7,0,0
90084,%,0,0
90085,(,0,0
90086,P,0,0
90087,=,0,0
90088,.21,0,0
90089,),0,0
90090,higher,0,0
90091,than,0,0
90092,those,0,0
90093,of,0,0
90094,the,0,0
90095,group,0,0
90096,receiving,0,0
90097,RT,1,0
90098,alone,1,1
90099,.,1,0
90100,No,0,0
90101,dose-limiting,0,0
90102,toxicity,0,0
90103,or,0,1
90104,adverse,0,0
90105,events,0,0
90106,appeared,0,0
90107,",",0,0
90108,except,0,0
90109,for,0,0
90110,transient,0,0
90111,fever,0,0
90112,after,0,0
90113,rAd-p53,1,1
90114,administration,0,0
90115,.,0,0
90116,CONCLUSION,0,0
90117,In,0,0
90118,patients,0,0
90119,with,0,0
90120,NPC,0,0
90121,",",0,0
90122,rAd-p53,1,1
90123,was,0,0
90124,safe,0,0
90125,and,0,0
90126,biologically,0,0
90127,active,0,0
90128,.,0,0
90129,Our,0,0
90130,results,0,0
90131,indicated,0,0
90132,that,0,0
90133,rAd-p53,1,1
90134,improves,0,0
90135,radiotherapeutic,0,1
90136,tumor,0,0
90137,control,0,1
90138,and,0,0
90139,survival,0,0
90140,rate,0,0
90141,in,0,0
90142,patients,0,0
90143,with,0,0
90144,NPC,0,0
90145,.,0,0
90146,Comparison,0,0
90147,of,0,0
90148,propofol,1,1
90149,",",1,0
90150,droperidol,1,1
90151,",",1,0
90152,and,1,0
90153,metoclopramide,1,1
90154,for,0,0
90155,prophylaxis,0,0
90156,of,0,0
90157,postoperative,0,0
90158,nausea,0,0
90159,and,0,0
90160,vomiting,0,0
90161,after,0,0
90162,breast,0,0
90163,cancer,0,0
90164,surgery,0,0
90165,:,0,0
90166,a,0,0
90167,prospective,0,0
90168,",",0,0
90169,randomized,0,0
90170,",",0,0
90171,double-blind,0,0
90172,",",0,0
90173,placebo-controlled,1,1
90174,study,0,0
90175,in,0,0
90176,Japanese,0,0
90177,patients,0,0
90178,.,0,0
90179,BACKGROUND,0,0
90180,Breast,0,0
90181,cancer,0,0
90182,surgery,0,1
90183,performed,0,0
90184,with,0,0
90185,the,0,0
90186,patient,0,0
90187,under,0,0
90188,general,0,0
90189,anesthesia,0,1
90190,has,0,0
90191,been,0,0
90192,associated,0,0
90193,with,0,0
90194,a,0,0
90195,relatively,0,0
90196,high,0,0
90197,incidence,0,0
90198,of,0,0
90199,postoperative,0,0
90200,nausea,0,0
90201,and,0,0
90202,vomiting,0,0
90203,(,0,1
90204,PONV,0,0
90205,),0,0
90206,.,0,0
90207,Between,0,0
90208,60,0,0
90209,%,0,0
90210,and,0,0
90211,80,0,0
90212,%,0,0
90213,of,0,0
90214,patients,0,0
90215,who,0,0
90216,undergo,0,0
90217,mastectomy,0,1
90218,(,0,0
90219,with,0,0
90220,axillary,0,0
90221,dissection,0,0
90222,),0,0
90223,experience,0,0
90224,PONV,0,0
90225,.,0,0
90226,We,0,0
90227,previously,0,0
90228,reported,0,0
90229,that,0,0
90230,propofol,1,1
90231,at,0,0
90232,a,0,0
90233,subhypnotic,0,1
90234,dose,0,0
90235,of,0,0
90236,0.5,0,0
90237,mg/kg,0,0
90238,was,0,0
90239,more,0,0
90240,effective,0,0
90241,than,0,0
90242,placebo,1,1
90243,in,0,0
90244,preventing,0,0
90245,PONV,0,0
90246,in,0,0
90247,women,0,0
90248,who,0,0
90249,undergo,0,0
90250,mastectomy,0,1
90251,.,0,0
90252,OBJECTIVE,0,0
90253,The,0,0
90254,purpose,0,0
90255,of,0,0
90256,this,0,0
90257,study,0,0
90258,was,0,0
90259,to,0,0
90260,compare,0,0
90261,the,0,0
90262,efficacy,0,0
90263,of,0,0
90264,a,0,0
90265,subhypnotic,0,1
90266,dose,0,0
90267,of,0,0
90268,propofol,1,1
90269,with,0,0
90270,the,0,0
90271,conventional,1,1
90272,antiemetics,1,0
90273,droperidol,1,1
90274,and,1,0
90275,metoclopramide,1,1
90276,for,0,0
90277,the,0,0
90278,prophylaxis,0,0
90279,of,0,0
90280,PONV,0,0
90281,after,0,0
90282,breast,0,0
90283,cancer,0,0
90284,surgery,0,0
90285,in,0,0
90286,Japanese,0,0
90287,patients,0,0
90288,.,0,0
90289,METHODS,0,0
90290,In,0,0
90291,this,0,0
90292,prospective,0,0
90293,",",0,0
90294,randomized,0,0
90295,",",0,0
90296,double-blind,0,0
90297,",",0,0
90298,placebo-controlled,1,1
90299,study,0,0
90300,",",0,0
90301,Japanese,0,0
90302,women,0,0
90303,were,0,0
90304,randomized,0,0
90305,to,0,0
90306,1,0,0
90307,of,0,0
90308,4,0,0
90309,groups,0,0
90310,to,0,0
90311,receive,0,0
90312,IV,0,0
90313,administration,0,0
90314,of,0,0
90315,propofol,1,1
90316,0.5,0,0
90317,mg/kg,0,0
90318,",",0,0
90319,droperidol,1,1
90320,20,0,0
90321,microg/kg,0,0
90322,",",0,0
90323,metoclopramide,1,1
90324,0.2,0,0
90325,mg/kg,0,0
90326,",",0,0
90327,or,0,1
90328,placebo,1,1
90329,(,1,0
90330,isotonic,1,1
90331,saline,1,1
90332,),1,0
90333,immediately,0,0
90334,after,0,0
90335,skin,0,0
90336,suture,0,0
90337,.,0,0
90338,A,0,0
90339,standard,0,0
90340,general,0,0
90341,anesthetic,0,1
90342,technique,0,1
90343,",",0,0
90344,including,0,0
90345,sevoflurane,0,1
90346,and,0,0
90347,air,0,1
90348,in,0,0
90349,oxygen,0,0
90350,",",0,0
90351,was,0,0
90352,used,0,0
90353,.,0,0
90354,All,0,0
90355,episodes,0,0
90356,of,0,0
90357,PONV,0,0
90358,during,0,0
90359,the,0,0
90360,first,0,0
90361,24,0,0
90362,hours,0,0
90363,after,0,0
90364,anesthesia,0,1
90365,administration,0,0
90366,were,0,0
90367,recorded,0,0
90368,by,0,0
90369,an,0,0
90370,investigator,0,0
90371,who,0,0
90372,was,0,0
90373,blinded,0,0
90374,to,0,0
90375,treatment,0,0
90376,assignment,0,0
90377,.,0,0
90378,The,0,0
90379,investigator,0,0
90380,questioned,0,0
90381,the,0,0
90382,patients,0,0
90383,as,0,0
90384,to,0,0
90385,whether,0,0
90386,they,0,0
90387,experienced,0,0
90388,extrapyramidal,0,0
90389,symptoms,0,0
90390,.,0,0
90391,To,0,0
90392,maintain,0,0
90393,the,0,0
90394,integrity,0,0
90395,of,0,0
90396,the,0,0
90397,study,0,0
90398,results,0,0
90399,",",0,0
90400,none,0,0
90401,of,0,0
90402,the,0,0
90403,patients,0,0
90404,received,0,0
90405,preanesthetic,0,0
90406,medication,0,0
90407,.,0,0
90408,RESULTS,0,0
90409,A,0,0
90410,total,0,0
90411,of,0,0
90412,100,0,0
90413,women,0,0
90414,(,0,0
90415,mean,0,0
90416,[,0,0
90417,SD,0,0
90418,],0,0
90419,age,0,0
90420,",",0,0
90421,52,0,0
90422,[,0,0
90423,7,0,0
90424,],0,0
90425,years,0,0
90426,;,0,0
90427,height,0,0
90428,",",0,0
90429,154,0,0
90430,[,0,0
90431,6,0,0
90432,],0,0
90433,cm,0,0
90434,;,0,0
90435,weight,0,0
90436,",",0,0
90437,54,0,0
90438,[,0,0
90439,7,0,0
90440,],0,0
90441,kg,0,0
90442,),0,0
90443,were,0,0
90444,included,0,0
90445,in,0,0
90446,the,0,0
90447,study,0,0
90448,.,0,0
90449,Each,0,0
90450,study,0,0
90451,group,0,0
90452,comprised,0,0
90453,25,0,0
90454,patients,0,0
90455,.,0,0
90456,There,0,0
90457,were,0,0
90458,no,0,0
90459,significant,0,0
90460,differences,0,0
90461,between,0,0
90462,treatment,0,0
90463,groups,0,0
90464,with,0,0
90465,regard,0,0
90466,to,0,0
90467,patient,0,0
90468,demographics,0,0
90469,",",0,0
90470,surgery,0,0
90471,type,0,0
90472,",",0,0
90473,or,0,1
90474,awakening,0,0
90475,time,0,0
90476,.,0,0
90477,The,0,0
90478,prevalences,0,0
90479,of,0,0
90480,PONV,0,0
90481,0,0,0
90482,to,0,0
90483,24,0,0
90484,hours,0,0
90485,after,0,0
90486,anesthesia,0,1
90487,were,0,0
90488,28,0,0
90489,%,0,0
90490,with,0,0
90491,propofol,1,1
90492,(,0,0
90493,P,0,0
90494,=,0,0
90495,0.005,0,0
90496,),0,0
90497,",",0,0
90498,32,0,0
90499,%,0,0
90500,with,0,0
90501,droperidol,1,1
90502,(,0,0
90503,P,0,0
90504,=,0,0
90505,0.011,0,0
90506,),0,0
90507,",",0,0
90508,and,0,0
90509,60,0,0
90510,%,0,0
90511,with,0,0
90512,metoclopramide,1,1
90513,(,0,0
90514,P,0,0
90515,=,0,0
90516,NS,0,0
90517,),0,0
90518,",",0,0
90519,compared,0,0
90520,with,0,0
90521,placebo,1,1
90522,(,0,0
90523,68,0,0
90524,%,0,0
90525,),0,0
90526,.,0,0
90527,No,0,0
90528,significant,0,0
90529,difference,0,0
90530,in,0,0
90531,the,0,0
90532,prevalence,0,0
90533,of,0,0
90534,PONV,0,0
90535,was,0,0
90536,found,0,0
90537,between,0,0
90538,patients,0,0
90539,receiving,0,0
90540,propofol,1,1
90541,and,0,0
90542,those,0,0
90543,receiving,0,0
90544,droperidol,1,1
90545,",",0,0
90546,and,0,0
90547,propofol,1,1
90548,and,0,0
90549,droperidol,1,1
90550,were,0,0
90551,associated,0,0
90552,with,0,0
90553,significantly,0,0
90554,lower,0,0
90555,prevalences,0,0
90556,of,0,0
90557,PONV,0,0
90558,compared,0,0
90559,with,0,0
90560,metoclopramide,1,1
90561,(,0,0
90562,P,0,0
90563,=,0,0
90564,0.022,0,0
90565,and,0,0
90566,P,0,0
90567,=,0,0
90568,0.043,0,0
90569,",",0,0
90570,respectively,0,0
90571,),0,0
90572,.,0,0
90573,Extrapyramidal,0,0
90574,symptoms,0,0
90575,were,0,0
90576,not,0,0
90577,reported,0,0
90578,in,0,0
90579,any,0,0
90580,of,0,0
90581,the,0,0
90582,groups,0,0
90583,.,0,0
90584,CONCLUSIONS,0,0
90585,The,0,0
90586,prevalences,0,0
90587,of,0,0
90588,PONV,0,0
90589,were,0,0
90590,not,0,0
90591,significantly,0,0
90592,different,0,0
90593,between,0,0
90594,propofol,1,1
90595,0.5,0,1
90596,mg/kg,0,1
90597,and,0,0
90598,droperidol,1,1
90599,20,0,1
90600,microg/kg,0,0
90601,0,0,0
90602,to,0,0
90603,24,0,0
90604,hours,0,0
90605,after,0,0
90606,anesthesia,0,1
90607,in,0,0
90608,this,0,0
90609,small,0,0
90610,",",0,0
90611,select,0,0
90612,group,0,0
90613,of,0,0
90614,Japanese,0,0
90615,women,0,0
90616,who,0,0
90617,underwent,0,0
90618,breast,0,0
90619,cancer,0,0
90620,surgery,0,0
90621,.,0,0
90622,The,0,0
90623,prevalences,0,0
90624,of,0,0
90625,PONV,0,0
90626,were,0,0
90627,significantly,0,0
90628,lower,0,0
90629,with,0,0
90630,propofol,1,1
90631,and,0,0
90632,droperidol,1,1
90633,compared,0,0
90634,with,0,0
90635,metoclopramide,1,1
90636,0.2,0,0
90637,mg/kg,0,1
90638,and,0,0
90639,placebo,1,1
90640,.,1,0
90641,Measuring,0,0
90642,social,0,1
90643,cognition,0,0
90644,in,0,0
90645,adolescents,0,0
90646,:,0,0
90647,implications,0,0
90648,for,0,0
90649,students,0,0
90650,with,0,0
90651,TBI,0,0
90652,returning,0,0
90653,to,0,0
90654,school,0,0
90655,.,0,0
90656,In,0,0
90657,everyday,0,0
90658,adolescent,1,0
90659,communication,1,0
90660,",",0,0
90661,the,0,0
90662,ability,0,0
90663,to,0,0
90664,empathise,1,0
90665,with,1,0
90666,the,1,0
90667,mental,1,0
90668,state,1,0
90669,of,1,0
90670,others,1,0
90671,",",0,0
90672,recognise,0,0
90673,or,0,1
90674,infer,1,0
90675,intentions,1,0
90676,",",0,0
90677,or,0,0
90678,make,1,0
90679,judgements,1,0
90680,about,1,0
90681,emotional,1,0
90682,state,1,0
90683,",",0,0
90684,is,0,0
90685,a,0,0
90686,non-conscious,0,0
90687,but,0,0
90688,vital,0,0
90689,prerequisite,0,0
90690,of,0,0
90691,relating,0,0
90692,.,0,0
90693,Execution,0,0
90694,of,0,0
90695,these,0,0
90696,skills,0,0
90697,in,0,0
90698,social,0,0
90699,interactions,0,0
90700,supports,0,0
90701,both,0,0
90702,the,0,0
90703,exchange,0,1
90704,of,0,0
90705,social,0,1
90706,knowledge,0,0
90707,and,0,0
90708,also,0,0
90709,the,0,0
90710,development,0,0
90711,and,0,0
90712,maintenance,0,0
90713,of,0,0
90714,personal,0,1
90715,relationships,0,0
90716,.,0,0
90717,Thus,0,0
90718,",",0,0
90719,adolescents,0,0
90720,with,0,0
90721,impairments,0,0
90722,in,0,0
90723,these,0,0
90724,skills,0,0
90725,are,0,0
90726,at,0,0
90727,risk,0,0
90728,for,0,0
90729,a,0,0
90730,variety,0,0
90731,of,0,0
90732,negative,0,0
90733,outcomes,0,0
90734,.,0,0
90735,In,0,0
90736,this,0,0
90737,paper,0,0
90738,",",0,0
90739,we,0,0
90740,present,0,0
90741,data,0,0
90742,to,0,0
90743,illustrate,0,0
90744,that,0,0
90745,adolescents,0,0
90746,with,0,0
90747,traumatic,0,0
90748,brain,0,0
90749,injury,0,0
90750,(,0,0
90751,TBI,0,0
90752,),0,0
90753,are,0,0
90754,likely,0,0
90755,to,0,0
90756,have,0,0
90757,impairments,0,0
90758,in,0,0
90759,processes,0,0
90760,such,0,0
90761,as,0,0
90762,emotion,0,0
90763,recognition,0,0
90764,and,0,0
90765,mental,0,0
90766,state,0,0
90767,attribution,0,0
90768,",",0,0
90769,and,0,0
90770,that,0,0
90771,these,0,0
90772,might,0,0
90773,not,0,0
90774,be,0,0
90775,identified,0,0
90776,on,0,0
90777,standardised,0,0
90778,tests,0,0
90779,.,0,0
90780,This,0,0
90781,is,0,0
90782,considered,0,0
90783,from,0,0
90784,the,0,0
90785,perspective,0,0
90786,of,0,0
90787,clinical,0,0
90788,assessment,0,0
90789,and,0,0
90790,intervention,0,1
90791,in,0,0
90792,school,0,0
90793,contexts,0,0
90794,.,0,0
90795,Ondansetron,1,1
90796,has,0,0
90797,similar,0,0
90798,clinical,0,0
90799,efficacy,0,0
90800,against,0,0
90801,both,0,0
90802,nausea,0,0
90803,and,0,0
90804,vomiting,0,0
90805,.,0,0
90806,Ondansetron,1,1
90807,is,0,0
90808,widely,0,0
90809,believed,0,0
90810,to,0,0
90811,prevent,0,0
90812,postoperative,0,0
90813,vomiting,0,0
90814,more,0,0
90815,effectively,0,0
90816,than,0,0
90817,nausea,0,0
90818,.,0,0
90819,We,0,0
90820,analysed,0,0
90821,data,0,0
90822,from,0,0
90823,5161,0,0
90824,patients,0,0
90825,undergoing,0,0
90826,general,0,0
90827,anaesthesia,1,1
90828,who,0,0
90829,were,0,0
90830,randomly,0,0
90831,stratified,0,0
90832,to,0,0
90833,receive,0,0
90834,a,0,0
90835,combination,0,0
90836,of,0,0
90837,six,0,0
90838,interventions,0,0
90839,",",0,0
90840,one,0,0
90841,of,0,0
90842,which,0,0
90843,was,0,0
90844,4,0,0
90845,mg,0,1
90846,ondansetron,1,1
90847,vs,1,0
90848,placebo,1,1
90849,.,1,0
90850,For,0,0
90851,the,0,0
90852,purpose,0,0
90853,of,0,0
90854,this,0,0
90855,study,0,0
90856,a,0,0
90857,20,0,0
90858,%,0,0
90859,difference,0,0
90860,in,0,0
90861,the,0,0
90862,relative,0,0
90863,risks,0,0
90864,for,0,0
90865,the,0,0
90866,two,0,0
90867,outcomes,0,0
90868,was,0,0
90869,considered,0,0
90870,clinically,0,0
90871,relevant,0,0
90872,.,0,0
90873,Nausea,0,0
90874,was,0,0
90875,reduced,0,0
90876,from,0,0
90877,38,0,0
90878,%,0,0
90879,(,0,0
90880,969/2585,0,0
90881,),0,0
90882,in,0,0
90883,the,0,0
90884,control,0,0
90885,to,0,0
90886,28,0,0
90887,%,0,0
90888,(,0,0
90889,715/2576,0,1
90890,),0,0
90891,in,0,0
90892,the,0,0
90893,ondansetron,1,1
90894,group,0,0
90895,",",0,0
90896,corresponding,0,0
90897,to,0,0
90898,a,0,0
90899,relative,0,0
90900,risk,0,0
90901,of,0,0
90902,0.74,0,0
90903,",",0,0
90904,or,0,0
90905,a,0,0
90906,relative,0,0
90907,risk,0,0
90908,reduction,0,0
90909,of,0,0
90910,26,0,0
90911,%,0,0
90912,.,0,0
90913,Vomiting,0,0
90914,was,0,0
90915,reduced,0,0
90916,from,0,0
90917,17,0,0
90918,%,0,0
90919,(,0,0
90920,441/2585,0,0
90921,),0,0
90922,to,0,0
90923,11,0,0
90924,%,0,0
90925,(,0,0
90926,293/2576,0,0
90927,),0,0
90928,",",0,0
90929,corresponding,0,0
90930,to,0,0
90931,a,0,0
90932,relative,0,0
90933,risk,0,0
90934,of,0,0
90935,0.67,0,0
90936,",",0,0
90937,or,0,0
90938,a,0,0
90939,relative,0,0
90940,risk,0,0
90941,reduction,0,0
90942,of,0,0
90943,33,0,0
90944,%,0,0
90945,.,0,0
90946,The,0,0
90947,relative,0,0
90948,risks,0,0
90949,of,0,0
90950,0.67,0,0
90951,and,0,0
90952,0.74,0,0
90953,were,0,0
90954,clinically,0,0
90955,similar,0,0
90956,and,0,0
90957,the,0,0
90958,difference,0,0
90959,between,0,0
90960,them,0,0
90961,did,0,0
90962,not,0,0
90963,reach,0,0
90964,statistical,0,0
90965,significance,0,0
90966,.,0,0
90967,We,0,0
90968,thus,0,0
90969,conclude,0,0
90970,that,0,0
90971,ondansetron,1,1
90972,prevents,0,0
90973,postoperative,0,0
90974,nausea,0,0
90975,and,0,0
90976,postoperative,0,0
90977,vomiting,0,0
90978,equally,0,0
90979,well,0,0
90980,.,0,0
90981,A,0,0
90982,double-blind,0,0
90983,",",0,0
90984,placebo-controlled,1,1
90985,trial,0,0
90986,of,0,0
90987,oral,1,1
90988,human,1,0
90989,immunoglobulin,1,1
90990,for,0,0
90991,gastrointestinal,0,0
90992,dysfunction,0,0
90993,in,0,0
90994,children,0,0
90995,with,0,0
90996,autistic,0,0
90997,disorder,0,0
90998,.,0,0
90999,Controversy,0,0
91000,exists,0,0
91001,regarding,0,0
91002,the,0,0
91003,extent,0,0
91004,and,0,0
91005,possible,0,0
91006,causal,0,0
91007,relationship,0,0
91008,between,0,0
91009,gastrointestinal,0,0
91010,symptoms,0,0
91011,and,0,0
91012,autism,0,0
91013,.,0,0
91014,A,0,0
91015,randomized,0,0
91016,",",0,0
91017,double-blind,0,0
91018,",",0,0
91019,placebo-controlled,1,1
91020,",",0,0
91021,parallel,0,0
91022,groups,0,0
91023,",",0,0
91024,dose-ranging,0,0
91025,study,0,0
91026,of,0,0
91027,oral,1,1
91028,",",1,0
91029,human,1,1
91030,immunoglobulin,1,1
91031,(,1,0
91032,IGOH,1,0
91033,140,0,0
91034,",",0,0
91035,420,0,0
91036,",",0,0
91037,or,0,0
91038,840,0,0
91039,mg/day,0,0
91040,),0,0
91041,was,0,0
91042,utilized,0,0
91043,with,0,0
91044,125,0,0
91045,children,0,0
91046,(,0,0
91047,ages,0,0
91048,2-17,0,0
91049,years,0,0
91050,),0,0
91051,with,0,0
91052,autism,0,0
91053,and,0,0
91054,persistent,0,0
91055,GI,0,0
91056,symptoms,0,0
91057,.,0,0
91058,Endpoint,0,0
91059,analysis,0,0
91060,revealed,0,0
91061,no,0,0
91062,significant,0,0
91063,differences,0,0
91064,across,0,0
91065,treatment,0,0
91066,groups,0,0
91067,on,0,0
91068,a,0,0
91069,modified,0,0
91070,global,0,0
91071,improvement,0,0
91072,scale,0,0
91073,(,0,0
91074,validated,0,0
91075,in,0,0
91076,irritable,0,0
91077,bowel,0,0
91078,syndrome,0,0
91079,studies,0,0
91080,),0,0
91081,",",0,0
91082,number,0,0
91083,of,0,0
91084,daily,0,0
91085,bowel,0,0
91086,movements,0,0
91087,",",0,0
91088,days,0,0
91089,of,0,0
91090,constipation,0,0
91091,",",0,0
91092,or,0,0
91093,severity,0,0
91094,of,0,0
91095,problem,0,0
91096,behaviors,0,0
91097,.,0,0
91098,IGOH,1,0
91099,was,0,0
91100,well-tolerated,0,0
91101,;,0,0
91102,there,0,0
91103,were,0,0
91104,no,0,0
91105,serious,0,0
91106,adverse,0,0
91107,events,0,0
91108,.,0,0
91109,This,0,0
91110,study,0,0
91111,demonstrates,0,0
91112,the,0,0
91113,importance,0,0
91114,of,0,0
91115,conducting,0,0
91116,rigorous,0,0
91117,trials,0,0
91118,in,0,0
91119,children,0,0
91120,with,0,0
91121,autism,0,0
91122,and,0,0
91123,casts,0,1
91124,doubt,0,0
91125,on,0,0
91126,one,0,0
91127,GI,0,0
91128,mechanism,0,0
91129,presumed,0,0
91130,to,0,0
91131,exert,0,0
91132,etiological,0,0
91133,and/or,0,0
91134,symptomatic,0,0
91135,effects,0,0
91136,in,0,0
91137,this,0,0
91138,population,0,0
91139,.,0,0
91140,Do,0,0
91141,catheter,1,1
91142,washouts,1,0
91143,extend,0,0
91144,patency,0,0
91145,time,0,0
91146,in,0,0
91147,long-term,0,0
91148,indwelling,0,1
91149,urethral,0,0
91150,catheters,0,1
91151,?,0,0
91152,A,0,0
91153,randomized,0,0
91154,controlled,0,0
91155,trial,0,0
91156,of,0,0
91157,acidic,1,1
91158,washout,1,0
91159,solution,1,1
91160,",",1,0
91161,normal,1,0
91162,saline,1,1
91163,washout,1,0
91164,",",0,0
91165,or,0,0
91166,standard,1,1
91167,care,1,1
91168,.,1,0
91169,PURPOSE,0,0
91170,Blockage,0,0
91171,of,0,0
91172,long-term,0,0
91173,indwelling,0,1
91174,catheters,0,1
91175,with,0,0
91176,mineral,0,0
91177,deposit,0,0
91178,is,0,0
91179,an,0,0
91180,ongoing,0,0
91181,management,0,0
91182,issue,0,0
91183,",",0,0
91184,but,0,0
91185,evidence,0,0
91186,on,0,0
91187,optimal,0,0
91188,management,0,0
91189,is,0,0
91190,lacking,0,0
91191,.,0,0
91192,Our,0,0
91193,purpose,0,0
91194,was,0,0
91195,to,0,0
91196,examine,0,0
91197,whether,0,0
91198,catheter,1,0
91199,washouts,1,0
91200,prevent,0,0
91201,or,0,0
91202,reduce,0,0
91203,catheter,0,1
91204,blockage,0,0
91205,.,0,0
91206,DESIGN,0,0
91207,A,0,0
91208,multisite,0,0
91209,randomized,0,0
91210,controlled,0,0
91211,trial,0,0
91212,.,0,0
91213,SUBJECTS,0,0
91214,AND,0,0
91215,SETTING,0,1
91216,Adults,0,0
91217,with,0,0
91218,long-term,0,0
91219,indwelling,0,1
91220,catheters,0,1
91221,that,0,0
91222,required,0,0
91223,changing,0,0
91224,every,0,0
91225,3,0,0
91226,weeks,0,0
91227,or,0,0
91228,less,0,0
91229,",",0,0
91230,living,0,0
91231,in,0,0
91232,the,0,0
91233,community,0,0
91234,",",0,0
91235,and,0,0
91236,requiring,0,0
91237,supportive,0,1
91238,or,0,1
91239,continuing,0,0
91240,care,0,1
91241,were,0,0
91242,recruited,0,0
91243,.,0,0
91244,Participants,0,0
91245,were,0,0
91246,randomly,0,0
91247,assigned,0,0
91248,to,0,0
91249,1,0,0
91250,of,0,0
91251,3,0,0
91252,groups,0,0
91253,:,0,0
91254,control,1,0
91255,(,1,0
91256,usual,1,1
91257,care,1,1
91258,",",1,0
91259,no,1,0
91260,washout,1,0
91261,),1,0
91262,",",1,0
91263,saline,1,1
91264,washout,1,0
91265,",",1,0
91266,or,1,0
91267,commercially,1,0
91268,available,1,0
91269,acidic,1,1
91270,washout,1,1
91271,solution,1,1
91272,(,1,0
91273,Contisol,1,1
91274,Maelor,0,1
91275,Pharmaceuticals,0,1
91276,Ltd,0,1
91277,",",0,0
91278,Wrexham,0,1
91279,",",0,0
91280,UK,0,0
91281,),0,0
91282,.,0,0
91283,METHODS,0,0
91284,At,0,0
91285,baseline,0,0
91286,visit,0,0
91287,",",0,0
91288,the,0,0
91289,catheter,0,0
91290,was,0,0
91291,changed,0,0
91292,and,0,0
91293,participants,0,0
91294,were,0,0
91295,followed,0,0
91296,weekly,0,1
91297,for,0,0
91298,8,0,0
91299,weeks,0,0
91300,",",0,0
91301,with,0,0
91302,checks,0,0
91303,for,0,0
91304,catheter,0,1
91305,patency,0,0
91306,and,0,0
91307,urine,0,0
91308,pH,0,0
91309,.,0,0
91310,Participants,0,0
91311,randomized,0,0
91312,to,0,0
91313,saline,1,1
91314,or,1,1
91315,commercial,1,1
91316,solution,1,1
91317,had,0,0
91318,a,0,0
91319,weekly,0,1
91320,washout,1,0
91321,with,0,0
91322,the,0,0
91323,appropriate,0,0
91324,solution,0,1
91325,.,0,0
91326,Endpoints,0,0
91327,were,0,0
91328,8,0,0
91329,weeks,0,0
91330,(,0,0
91331,completion,0,0
91332,data,0,0
91333,),0,0
91334,",",0,0
91335,3,0,0
91336,or,0,0
91337,more,0,0
91338,catheter,0,0
91339,changes,0,0
91340,in,0,0
91341,the,0,0
91342,8-week,0,0
91343,period,0,0
91344,",",0,0
91345,or,0,0
91346,symptomatic,0,0
91347,urinary,0,0
91348,tract,0,0
91349,infection,0,0
91350,(,0,0
91351,UTI,0,1
91352,),0,0
91353,requiring,0,0
91354,antibiotics,0,1
91355,.,0,0
91356,The,0,0
91357,study,0,0
91358,hypothesis,0,0
91359,was,0,0
91360,that,0,0
91361,catheter,0,1
91362,life,0,0
91363,would,0,0
91364,be,0,0
91365,extended,0,0
91366,by,0,0
91367,25,0,0
91368,%,0,0
91369,in,0,0
91370,the,0,0
91371,commercial,1,1
91372,solution,1,1
91373,group,0,0
91374,.,0,0
91375,It,0,0
91376,was,0,0
91377,not,0,0
91378,possible,0,0
91379,to,0,0
91380,blind,0,0
91381,participants,0,0
91382,or,0,0
91383,research,0,0
91384,nurses,0,0
91385,to,0,0
91386,washout,1,0
91387,versus,1,0
91388,no,1,0
91389,intervention,1,1
91390,",",0,0
91391,but,0,0
91392,participants,0,0
91393,in,0,0
91394,the,0,0
91395,saline,1,1
91396,and,1,0
91397,washout,1,0
91398,solution,1,1
91399,groups,0,0
91400,were,0,0
91401,blinded,0,0
91402,to,0,0
91403,solution,0,1
91404,type,0,0
91405,.,0,0
91406,RESULTS,0,0
91407,One,0,0
91408,hundred,0,0
91409,twelve,0,0
91410,potential,0,0
91411,participants,0,0
91412,were,0,0
91413,screened,0,0
91414,;,0,0
91415,73,0,0
91416,were,0,0
91417,enrolled,0,0
91418,",",0,0
91419,randomized,0,0
91420,",",0,0
91421,and,0,0
91422,included,0,0
91423,in,0,0
91424,the,0,0
91425,final,0,0
91426,analysis,0,0
91427,.,0,0
91428,Of,0,0
91429,these,0,0
91430,",",0,0
91431,53,0,0
91432,completed,0,0
91433,the,0,0
91434,full,0,0
91435,8,0,0
91436,weeks,0,0
91437,of,0,0
91438,data,0,0
91439,collection,0,0
91440,;,0,0
91441,16,0,0
91442,terminated,0,0
91443,early,0,0
91444,because,0,0
91445,of,0,0
91446,3,0,0
91447,catheter,0,0
91448,changes,0,0
91449,or,0,0
91450,self-reported,0,0
91451,'UTI,0,0
91452,',0,0
91453,.,0,0
91454,Other,0,0
91455,reasons,0,0
91456,for,0,0
91457,termination,0,0
91458,were,0,0
91459,hematuria,0,0
91460,",",0,0
91461,latex,0,0
91462,sensitivity,0,0
91463,",",0,0
91464,deceased/severe,0,0
91465,illness,0,0
91466,",",0,0
91467,or,0,0
91468,personal,0,1
91469,choice,0,0
91470,.,0,0
91471,Analysis,0,0
91472,of,0,0
91473,variance,0,0
91474,was,0,0
91475,used,0,0
91476,to,0,0
91477,analyze,0,0
91478,mean,0,0
91479,differences,0,0
91480,on,0,0
91481,demographic,0,0
91482,variables,0,0
91483,and,0,0
91484,mean,0,0
91485,number,0,0
91486,of,0,0
91487,weeks,0,0
91488,in,0,0
91489,study,0,0
91490,.,0,0
91491,Kaplan-Meier,0,0
91492,survival,0,0
91493,curve,0,0
91494,analysis,0,0
91495,showed,0,0
91496,no,0,0
91497,statistical,0,0
91498,difference,0,0
91499,between,0,0
91500,the,0,0
91501,groups,0,0
91502,in,0,0
91503,time,0,0
91504,to,0,0
91505,first,0,0
91506,catheter,0,1
91507,change,0,0
91508,.,0,0
91509,CONCLUSION,0,0
91510,At,0,0
91511,this,0,0
91512,time,0,0
91513,",",0,0
91514,the,0,0
91515,evidence,0,0
91516,is,0,0
91517,insufficient,0,0
91518,to,0,0
91519,state,0,0
91520,whether,0,0
91521,catheter,1,1
91522,washout,1,0
91523,with,1,0
91524,saline,1,1
91525,or,1,1
91526,Contisol,1,1
91527,is,0,0
91528,more,0,0
91529,effective,0,0
91530,than,0,0
91531,usual,1,1
91532,care,1,0
91533,with,1,0
91534,no,1,0
91535,washout,1,0
91536,in,0,0
91537,preventing,0,0
91538,blocking,0,0
91539,.,0,0
91540,No,0,0
91541,increased,0,0
91542,risk,0,0
91543,of,0,0
91544,UTI,0,1
91545,was,0,0
91546,associated,0,0
91547,with,0,0
91548,washout,1,0
91549,regimes,1,0
91550,.,1,0
91551,Pegfilgrastim,1,1
91552,for,0,0
91553,peripheral,0,0
91554,CD34+,0,0
91555,mobilization,0,0
91556,in,0,0
91557,patients,0,0
91558,with,0,0
91559,solid,0,0
91560,tumours,0,0
91561,.,0,0
91562,The,0,0
91563,efficacy,0,0
91564,of,0,0
91565,pegfilgrastim+/-chemotherapy,1,1
91566,for,0,0
91567,mobilizing,0,0
91568,stem,0,1
91569,cells,0,0
91570,in,0,0
91571,patients,0,0
91572,with,0,0
91573,solid,0,0
91574,tumours,0,0
91575,was,0,0
91576,assessed,0,0
91577,.,0,0
91578,In,0,0
91579,cycle,0,0
91580,0,0,0
91581,",",0,0
91582,a,0,0
91583,14-day,0,0
91584,prechemotherapy,0,0
91585,cycle,0,0
91586,",",0,0
91587,patients,0,0
91588,(,0,0
91589,N=61,0,0
91590,),0,0
91591,were,0,0
91592,randomized,0,0
91593,open-label,0,0
91594,to,0,0
91595,single,0,0
91596,doses,0,0
91597,of,0,0
91598,pegfilgrastim,1,1
91599,(,0,0
91600,6,0,0
91601,",",0,0
91602,12,0,0
91603,or,0,0
91604,18,0,0
91605,mg,0,1
91606,),0,0
91607,on,0,0
91608,day,0,0
91609,1,0,0
91610,",",0,0
91611,or,0,0
91612,daily,0,1
91613,filgrastim,1,1
91614,(,0,0
91615,10,0,0
91616,microg/kg,0,1
91617,),0,0
91618,for,0,0
91619,<,0,0
91620,or,0,0
91621,=7,0,0
91622,days,0,0
91623,.,0,0
91624,Mean,0,0
91625,peak,0,0
91626,peripheral,0,0
91627,CD34+,0,0
91628,cell,0,0
91629,counts,0,0
91630,increased,0,0
91631,with,0,0
91632,pegfilgrastim,1,1
91633,dose,0,0
91634,",",0,0
91635,but,0,0
91636,were,0,0
91637,significantly,0,0
91638,higher,0,0
91639,than,0,0
91640,filgrastim,1,1
91641,only,0,0
91642,at,0,0
91643,the,0,0
91644,18,0,0
91645,mg,0,1
91646,dose,0,0
91647,(,0,0
91648,10.17,0,0
91649,vs,0,0
91650,4.96,0,0
91651,x,0,0
91652,10,0,0
91653,(,0,0
91654,4,0,0
91655,),0,0
91656,/ml,0,0
91657,;,0,0
91658,P=0.014,0,0
91659,),0,0
91660,.,0,0
91661,In,0,0
91662,the,0,0
91663,clinically,0,0
91664,relevant,0,0
91665,period,0,0
91666,of,0,0
91667,days,0,0
91668,3-7,0,0
91669,",",0,0
91670,both,0,0
91671,12,0,0
91672,and,0,0
91673,18,0,0
91674,mg,0,1
91675,pegfilgrastim,1,1
91676,doses,0,0
91677,produced,0,0
91678,significantly,0,0
91679,higher,0,0
91680,peak,0,0
91681,CD34+,0,0
91682,counts,0,0
91683,(,0,0
91684,8.18,0,0
91685,and,0,0
91686,9.96,0,0
91687,vs,0,0
91688,4.51,0,0
91689,x,0,0
91690,10,0,0
91691,(,0,0
91692,4,0,0
91693,),0,0
91694,/ml,0,0
91695,for,0,0
91696,filgrastim,1,1
91697,;,1,0
91698,P=0.034,0,0
91699,and,0,0
91700,0.006,0,0
91701,),0,0
91702,.,0,0
91703,In,0,0
91704,cycle,0,0
91705,1,0,0
91706,",",0,0
91707,patients,0,0
91708,received,0,0
91709,carboplatin/paclitaxel,1,1
91710,on,0,0
91711,day,0,0
91712,1,0,0
91713,",",0,0
91714,followed,0,0
91715,from,0,0
91716,day,0,0
91717,2,0,0
91718,by,0,0
91719,pegfilgrastim,1,1
91720,6-18,0,0
91721,mg,0,1
91722,or,0,1
91723,daily,0,1
91724,filgrastim,1,1
91725,(,0,0
91726,5,0,0
91727,microg/kg/day,0,0
91728,for,0,0
91729,<,0,0
91730,or,0,1
91731,=14,0,0
91732,days,0,0
91733,),0,0
91734,as,0,0
91735,per,0,0
91736,randomization,0,0
91737,in,0,0
91738,cycle,0,0
91739,0,0,0
91740,.,0,0
91741,There,0,0
91742,were,0,0
91743,no,0,0
91744,significant,0,0
91745,differences,0,0
91746,in,0,0
91747,mean,0,0
91748,peak,0,0
91749,CD34+,0,0
91750,count,0,0
91751,between,0,0
91752,pegfilgrastim,1,1
91753,and,0,0
91754,filgrastim,1,1
91755,",",0,0
91756,but,0,0
91757,there,0,0
91758,was,0,0
91759,an,0,0
91760,advantage,0,0
91761,for,0,0
91762,pegfilgrastim,1,1
91763,18,0,0
91764,mg,0,0
91765,in,0,0
91766,the,0,0
91767,relevant,0,0
91768,period,0,0
91769,of,0,0
91770,days,0,0
91771,7-12,0,0
91772,(,0,0
91773,3.14,0,0
91774,vs,0,0
91775,1.19,0,0
91776,x,0,0
91777,10,0,0
91778,(,0,0
91779,4,0,0
91780,),0,0
91781,/ml,0,0
91782,;,0,0
91783,P=0.043,0,0
91784,),0,0
91785,.,0,0
91786,A,0,0
91787,single,0,0
91788,pegfilgrastim,1,1
91789,dose,0,0
91790,(,0,0
91791,>,0,0
91792,or,0,0
91793,=6,0,0
91794,mg,0,1
91795,),0,0
91796,could,0,0
91797,be,0,0
91798,substituted,0,0
91799,for,0,0
91800,daily,0,0
91801,filgrastim,1,1
91802,in,0,0
91803,cytokine-only,0,0
91804,peripheral,0,0
91805,CD34+,0,0
91806,cell,0,0
91807,mobilization,0,0
91808,.,0,0
91809,A,0,0
91810,dose-ranging,0,0
91811,study,0,0
91812,of,0,0
91813,pramipexole,1,1
91814,for,0,0
91815,the,0,0
91816,symptomatic,0,0
91817,treatment,0,0
91818,of,0,0
91819,restless,0,0
91820,legs,0,0
91821,syndrome,0,0
91822,:,0,0
91823,polysomnographic,0,0
91824,evaluation,0,0
91825,of,0,0
91826,periodic,0,1
91827,leg,0,0
91828,movements,0,0
91829,and,0,0
91830,sleep,0,0
91831,disturbance,0,0
91832,.,0,0
91833,OBJECTIVE,0,0
91834,To,0,0
91835,evaluate,0,0
91836,",",0,0
91837,both,0,0
91838,polysomnographically,0,0
91839,and,0,0
91840,by,0,0
91841,subjective,0,0
91842,scales,0,0
91843,",",0,0
91844,the,0,0
91845,efficacy,0,0
91846,and,0,0
91847,safety,0,0
91848,profile,0,0
91849,of,0,0
91850,pramipexole,1,1
91851,for,0,0
91852,restless,0,0
91853,legs,0,0
91854,syndrome,0,0
91855,(,0,0
91856,RLS,0,0
91857,),0,0
91858,via,0,0
91859,a,0,0
91860,3-week,0,0
91861,",",0,0
91862,double-blind,0,0
91863,",",0,0
91864,placebo-controlled,0,1
91865,",",0,0
91866,parallel-group,0,0
91867,",",0,0
91868,dose-ranging,0,0
91869,study,0,0
91870,.,0,0
91871,METHODS,0,0
91872,At,0,0
91873,baseline,0,0
91874,and,0,0
91875,after,0,0
91876,3,0,0
91877,weeks,0,0
91878,",",0,0
91879,periodic,0,1
91880,limb,0,0
91881,movements,0,0
91882,(,0,0
91883,PLM,0,0
91884,),0,1
91885,and,0,0
91886,sleep,0,0
91887,parameters,0,0
91888,were,0,0
91889,assessed,0,0
91890,by,0,0
91891,polysomnography,1,1
91892,",",1,0
91893,and,1,0
91894,patients,1,0
91895,self-assessed,1,0
91896,their,1,0
91897,sleep,1,0
91898,disturbance,1,0
91899,and,1,0
91900,overall,1,0
91901,RLS,1,0
91902,severity,1,0
91903,using,1,0
91904,the,1,0
91905,international,1,0
91906,RLS,1,0
91907,study,1,0
91908,group,1,0
91909,rating,1,0
91910,scale,1,0
91911,(,1,0
91912,IRLS,1,1
91913,),1,0
91914,.,0,0
91915,Four,1,0
91916,pramipexole,1,0
91917,doses,1,0
91918,were,1,0
91919,evaluated,1,0
91920,:,1,0
91921,0.125,1,0
91922,",",1,0
91923,0.25,1,0
91924,",",1,0
91925,0.50,1,0
91926,",",1,0
91927,and,1,0
91928,0.75mg/d,1,0
91929,.,1,0
91930,Data,0,0
91931,from,0,0
91932,107,0,0
91933,patients,0,0
91934,were,0,0
91935,included,0,0
91936,in,0,0
91937,the,0,0
91938,intent-to-treat,0,0
91939,(,0,0
91940,ITT,0,1
91941,),0,0
91942,analysis,0,0
91943,.,0,0
91944,RESULTS,0,0
91945,For,0,0
91946,pramipexole,1,1
91947,recipients,0,0
91948,",",0,0
91949,the,0,0
91950,primary,0,0
91951,outcome,0,0
91952,measure,0,0
91953,",",0,0
91954,PLM,0,0
91955,per,0,0
91956,hour,0,0
91957,in,0,0
91958,bed,0,0
91959,asleep,0,0
91960,or,0,1
91961,awake,0,1
91962,(,0,0
91963,the,0,0
91964,PLM,0,0
91965,index,0,0
91966,",",0,0
91967,or,0,1
91968,PLMI,0,0
91969,),0,0
91970,",",0,0
91971,decreased,0,0
91972,by,0,0
91973,a,0,0
91974,median,0,0
91975,of,0,0
91976,-26.55,0,0
91977,to,0,0
91978,-52.70,0,0
91979,depending,0,0
91980,on,0,0
91981,dosage,0,0
91982,group,0,0
91983,",",0,0
91984,vs.,0,0
91985,-3.00,0,0
91986,for,0,0
91987,placebo,1,1
91988,(,0,0
91989,p,0,0
91990,<,0,0
91991,0.01,0,0
91992,or,0,0
91993,0.001,0,0
91994,for,0,0
91995,each,0,0
91996,group,0,0
91997,vs.,0,0
91998,placebo,0,1
91999,;,0,0
92000,Wilcoxon-Mann-Whitney,0,1
92001,test,0,0
92002,),0,0
92003,.,0,0
92004,Improvements,0,0
92005,in,0,0
92006,the,0,0
92007,secondary,0,0
92008,endpoints,0,0
92009,of,0,0
92010,PLM,0,0
92011,while,0,0
92012,asleep,0,0
92013,and,0,0
92014,while,0,0
92015,awake,0,0
92016,were,0,0
92017,also,0,0
92018,significantly,0,0
92019,superior,0,0
92020,for,0,0
92021,pramipexole,0,1
92022,.,0,0
92023,At,0,0
92024,3,0,0
92025,weeks,0,0
92026,",",0,0
92027,all,0,0
92028,pramipexole,1,1
92029,doses,0,0
92030,reduced,0,0
92031,the,0,0
92032,median,0,0
92033,for,0,0
92034,PLM,0,0
92035,while,0,0
92036,asleep,0,0
92037,to,0,0
92038,levels,0,0
92039,considered,0,0
92040,normal,0,0
92041,(,0,0
92042,<,0,0
92043,5PLM/h,0,1
92044,),0,0
92045,.,0,0
92046,Except,0,0
92047,for,0,0
92048,delta-sleep,0,1
92049,time,0,0
92050,and,0,0
92051,awakenings/arousals,0,0
92052,",",0,0
92053,sleep,0,0
92054,parameters,0,0
92055,remained,0,0
92056,unchanged,0,0
92057,or,0,1
92058,favored,0,0
92059,pramipexole,1,1
92060,.,1,0
92061,Median,0,0
92062,sleep,0,0
92063,latency,0,0
92064,was,0,0
92065,reduced,0,0
92066,by,0,0
92067,-5.00,0,0
92068,to,0,0
92069,-11.75min,0,0
92070,in,0,0
92071,the,0,0
92072,pramipexole,0,1
92073,groups,0,0
92074,",",0,0
92075,vs.,0,0
92076,-2.00,0,0
92077,for,0,0
92078,placebo,1,1
92079,(,0,0
92080,p,0,0
92081,<,0,0
92082,0.05,0,0
92083,for,0,0
92084,all,0,0
92085,groups,0,0
92086,except,0,0
92087,0.25mg/d,0,1
92088,),0,0
92089,.,0,0
92090,Median,0,0
92091,total,0,0
92092,sleep,0,0
92093,time,0,0
92094,increased,0,0
92095,by,0,0
92096,25.75-66.75min,0,0
92097,",",0,0
92098,vs.,0,0
92099,25.50,0,0
92100,(,0,0
92101,p,0,0
92102,<,0,0
92103,0.05,0,0
92104,for,0,0
92105,0.50mg/d,0,0
92106,),0,0
92107,",",0,0
92108,and,0,0
92109,median,0,0
92110,time,0,0
92111,in,0,0
92112,stages,0,0
92113,2-4/rapid,0,0
92114,eye,0,1
92115,movement,0,0
92116,(,0,0
92117,REM,0,1
92118,),0,0
92119,sleep,0,0
92120,increased,0,0
92121,by,0,0
92122,37.00-68.00min,0,0
92123,",",0,0
92124,vs.,0,0
92125,26.75,0,0
92126,(,0,0
92127,p,0,0
92128,<,0,0
92129,0.05,0,0
92130,for,0,0
92131,0.50mg/d,0,0
92132,),0,0
92133,.,0,0
92134,By,0,0
92135,subjective,0,0
92136,IRLS,0,1
92137,ratings,0,0
92138,",",0,0
92139,all,0,0
92140,pramipexole,1,1
92141,doses,0,0
92142,were,0,0
92143,significantly,0,0
92144,superior,0,0
92145,to,0,0
92146,placebo,1,1
92147,.,1,0
92148,Safety,0,0
92149,analysis,0,0
92150,demonstrated,0,0
92151,no,0,0
92152,dose-dependent,0,0
92153,increase,0,0
92154,in,0,0
92155,adverse,0,0
92156,events,0,0
92157,",",0,0
92158,and,0,0
92159,no,0,0
92160,drug-related,0,0
92161,increase,0,0
92162,in,0,0
92163,daytime,0,0
92164,somnolence,0,0
92165,was,0,0
92166,observed,0,0
92167,.,0,0
92168,CONCLUSIONS,0,0
92169,Pramipexole,1,1
92170,is,0,0
92171,effective,0,0
92172,and,0,0
92173,well,0,0
92174,tolerated,0,0
92175,in,0,0
92176,RLS,0,0
92177,",",0,0
92178,most,0,0
92179,notably,0,0
92180,among,0,0
92181,objective,0,0
92182,measures,0,0
92183,",",0,0
92184,for,0,0
92185,reducing,0,0
92186,PLM,0,0
92187,and,0,0
92188,decreasing,0,0
92189,sleep,0,0
92190,latency,0,0
92191,.,0,0
92192,Although,0,0
92193,other,0,0
92194,sleep,0,0
92195,parameters,0,0
92196,showed,0,0
92197,lesser,0,0
92198,",",0,0
92199,usually,0,0
92200,insignificant,0,0
92201,change,0,0
92202,",",0,0
92203,patients,0,0
92204,',0,0
92205,subjective,0,0
92206,ratings,0,0
92207,of,0,0
92208,RLS,0,0
92209,severity,0,0
92210,and,0,0
92211,sleep,0,0
92212,disturbance,0,0
92213,were,0,0
92214,significantly,0,0
92215,improved,0,0
92216,(,0,0
92217,p0.0023,0,0
92218,),0,0
92219,.,0,0
92220,[,0,0
92221,Efficacy,0,0
92222,of,0,0
92223,immunomodulating,1,1
92224,treatment,1,0
92225,in,0,0
92226,patients,0,0
92227,with,0,0
92228,different,0,0
92229,degrees,0,0
92230,of,0,0
92231,immunosuppression,0,1
92232,],0,0
92233,.,0,0
92234,Immunodepression,0,0
92235,is,0,0
92236,a,0,0
92237,common,0,0
92238,condition,0,0
92239,in,0,0
92240,patients,0,0
92241,undergoing,0,0
92242,elective,0,0
92243,operations,0,0
92244,and,0,0
92245,it,0,0
92246,constitutes,0,0
92247,a,0,0
92248,high,0,0
92249,risk,0,0
92250,for,0,0
92251,the,0,0
92252,onset,0,0
92253,of,0,0
92254,postoperative,0,0
92255,infective,0,0
92256,complications,0,0
92257,.,0,0
92258,The,0,0
92259,use,0,0
92260,of,0,0
92261,immunomodulatory,1,0
92262,drugs,1,1
92263,has,0,0
92264,proved,0,0
92265,useful,0,0
92266,in,0,0
92267,the,0,0
92268,prophylaxis,0,0
92269,of,0,0
92270,these,0,0
92271,complications,0,0
92272,",",0,0
92273,although,0,0
92274,the,0,0
92275,precise,0,0
92276,indications,0,0
92277,for,0,0
92278,each,0,0
92279,drug,0,0
92280,have,0,0
92281,not,0,0
92282,yet,0,0
92283,been,0,0
92284,clearly,0,0
92285,codified,0,0
92286,.,0,0
92287,The,0,0
92288,present,0,0
92289,study,0,0
92290,aimed,0,0
92291,to,0,0
92292,assess,0,0
92293,the,0,0
92294,effects,0,0
92295,of,0,0
92296,thymostimulin,1,1
92297,in,0,0
92298,patients,0,0
92299,with,0,0
92300,different,0,0
92301,degrees,0,0
92302,of,0,0
92303,immunodepression,0,0
92304,",",0,0
92305,by,0,0
92306,evaluating,0,0
92307,both,0,0
92308,the,0,0
92309,incidence,0,0
92310,of,0,0
92311,postoperative,0,0
92312,infections,0,0
92313,and,0,0
92314,the,0,0
92315,changes,0,0
92316,induced,0,0
92317,in,0,0
92318,various,0,0
92319,immunological,0,0
92320,parameters,0,0
92321,.,0,0
92322,The,0,0
92323,results,0,0
92324,obtained,0,0
92325,indicated,0,0
92326,that,0,0
92327,those,0,0
92328,subjects,0,0
92329,with,0,0
92330,the,0,0
92331,highest,0,0
92332,degree,0,0
92333,of,0,0
92334,immunodepression,0,0
92335,(,0,0
92336,hypo-anergic,0,0
92337,),0,0
92338,benefited,0,0
92339,most,0,0
92340,from,0,0
92341,drug,1,0
92342,therapy,1,1
92343,in,0,0
92344,comparison,0,0
92345,to,0,0
92346,those,0,0
92347,with,0,0
92348,a,0,0
92349,lesser,0,0
92350,degree,0,0
92351,of,0,0
92352,immunodepression,0,0
92353,(,0,0
92354,relatively,0,0
92355,hypo-ergic,0,0
92356,),0,0
92357,.,0,0
92358,The,0,0
92359,advantages,0,0
92360,were,0,0
92361,evident,0,0
92362,in,0,0
92363,hypo-anergic,0,0
92364,subjects,0,0
92365,both,0,0
92366,with,0,0
92367,regard,0,0
92368,to,0,0
92369,the,0,0
92370,frequency,0,0
92371,of,0,0
92372,early,0,0
92373,postoperative,0,0
92374,infections,0,0
92375,",",0,0
92376,and,0,0
92377,with,0,0
92378,regard,0,0
92379,to,0,0
92380,immunological,0,0
92381,parameters,0,0
92382,.,0,0
92383,On,0,0
92384,the,0,0
92385,other,0,0
92386,hand,0,0
92387,",",0,0
92388,in,0,0
92389,relatively,0,0
92390,hypo-ergic,0,0
92391,subjects,0,0
92392,",",0,0
92393,benefits,0,0
92394,were,0,0
92395,limited,0,0
92396,to,0,0
92397,the,0,0
92398,improvement,0,0
92399,of,0,0
92400,some,0,0
92401,immunological,0,0
92402,parameters,0,0
92403,.,0,0
92404,In,0,0
92405,our,0,0
92406,opinion,0,0
92407,",",0,0
92408,the,0,0
92409,use,0,0
92410,of,0,0
92411,thymostimulin,1,1
92412,is,0,0
92413,of,0,0
92414,particular,0,0
92415,use,0,0
92416,only,0,0
92417,in,0,0
92418,those,0,0
92419,subjects,0,0
92420,with,0,0
92421,marked,0,0
92422,immunodepression,0,0
92423,since,0,0
92424,the,0,0
92425,incidence,0,0
92426,of,0,0
92427,post-operative,0,0
92428,sepsis,0,0
92429,is,0,0
92430,highest,0,0
92431,in,0,0
92432,this,0,0
92433,group,0,0
92434,.,0,0
92435,The,0,0
92436,effect,0,0
92437,of,0,0
92438,risedronate,1,1
92439,treatment,0,0
92440,on,0,0
92441,serum,0,0
92442,cytokines,0,0
92443,in,0,0
92444,postmenopausal,0,0
92445,osteoporosis,0,0
92446,:,0,0
92447,a,0,0
92448,6-month,0,0
92449,randomized,0,0
92450,and,0,0
92451,controlled,0,0
92452,study,0,0
92453,.,0,0
92454,There,0,0
92455,is,0,0
92456,much,0,0
92457,evidence,0,0
92458,suggesting,0,0
92459,that,0,0
92460,the,0,0
92461,decline,0,0
92462,in,0,0
92463,ovarian,0,0
92464,function,0,0
92465,after,0,0
92466,menopause,0,0
92467,is,0,0
92468,associated,0,0
92469,with,0,0
92470,spontaneous,0,0
92471,increases,0,0
92472,in,0,0
92473,proinflammatory,0,0
92474,cytokines,0,0
92475,.,0,0
92476,Treatment,0,0
92477,with,0,0
92478,risedronate,1,1
92479,is,0,0
92480,accompanied,0,0
92481,by,0,0
92482,significant,0,0
92483,changes,0,0
92484,in,0,0
92485,bone,0,0
92486,turnover,0,0
92487,and,0,0
92488,bone,0,0
92489,mineral,0,0
92490,density,0,0
92491,.,0,0
92492,The,0,0
92493,objective,0,0
92494,of,0,0
92495,this,0,0
92496,study,0,0
92497,was,0,0
92498,to,0,0
92499,determine,0,0
92500,the,0,0
92501,effects,0,0
92502,of,0,0
92503,risedronate,1,1
92504,treatment,0,0
92505,on,0,0
92506,the,0,0
92507,level,0,0
92508,of,0,0
92509,serum,0,0
92510,cytokines,0,0
92511,including,0,0
92512,receptor,0,0
92513,activator,0,0
92514,of,0,0
92515,nuclear,0,0
92516,factor-kappaB,0,0
92517,ligand,0,0
92518,(,0,0
92519,RANKL,0,1
92520,),0,0
92521,and,0,0
92522,osteoprotegerin,0,0
92523,among,0,0
92524,postmenopausal,0,0
92525,women,0,0
92526,with,0,0
92527,osteoporosis,0,0
92528,.,0,0
92529,The,0,0
92530,study,0,0
92531,group,0,0
92532,consisted,0,0
92533,of,0,0
92534,61,0,0
92535,postmenopausal,0,0
92536,women,0,0
92537,with,0,0
92538,osteoporosis,0,0
92539,.,0,0
92540,Patients,0,0
92541,were,0,0
92542,randomly,0,0
92543,divided,0,0
92544,in,0,0
92545,two,0,0
92546,groups,0,0
92547,:,0,0
92548,In,0,0
92549,group,0,0
92550,1,0,0
92551,(,0,0
92552,n,0,0
92553,=,0,0
92554,41,0,0
92555,),0,0
92556,postmenopausal,0,0
92557,women,0,0
92558,received,0,0
92559,oral,1,1
92560,risedronate,1,1
92561,(,0,0
92562,35,0,0
92563,mg/week,0,1
92564,),0,0
92565,",",0,0
92566,calcium,1,1
92567,(,0,0
92568,"1,000",0,1
92569,mg/day,0,0
92570,),0,0
92571,",",0,0
92572,and,0,0
92573,vitamin,1,1
92574,D,1,1
92575,(,0,0
92576,400,0,0
92577,IU/day,0,0
92578,),0,0
92579,for,0,0
92580,12,0,0
92581,months,0,0
92582,.,0,0
92583,In,0,0
92584,group,0,0
92585,2,0,0
92586,(,0,0
92587,control,0,0
92588,group,0,0
92589,;,0,0
92590,n,0,0
92591,=,0,0
92592,20,0,0
92593,),0,0
92594,patients,0,0
92595,received,0,0
92596,only,0,0
92597,oral,1,1
92598,calcium,1,1
92599,(,0,0
92600,"1,000",0,1
92601,mg/day,0,1
92602,),0,0
92603,and,0,0
92604,vitamin,1,1
92605,D,1,1
92606,(,0,0
92607,400,0,0
92608,IU/day,0,0
92609,),0,0
92610,.,0,0
92611,Bone,0,1
92612,mineral,0,0
92613,density,0,0
92614,(,0,0
92615,BMD,0,0
92616,),0,0
92617,of,0,0
92618,lumbar,0,1
92619,spine,0,1
92620,(,0,0
92621,L1-L4,0,1
92622,),0,1
92623,and,0,0
92624,proximal,0,0
92625,femur,0,0
92626,were,0,0
92627,determined,0,0
92628,using,0,0
92629,dual,0,0
92630,X-ray,0,0
92631,absorptiometry,0,0
92632,at,0,0
92633,baseline,0,0
92634,and,0,0
92635,after,0,0
92636,one,0,0
92637,year,0,0
92638,.,0,0
92639,Venous,0,0
92640,blood,0,0
92641,samples,0,0
92642,were,0,0
92643,obtained,0,0
92644,for,0,0
92645,determination,0,0
92646,of,0,0
92647,serum,0,0
92648,cytokines,0,0
92649,including,0,0
92650,interleukin-1beta,0,1
92651,(,0,0
92652,IL-1beta,0,0
92653,),0,0
92654,",",0,0
92655,tumor,0,0
92656,necrosis,0,0
92657,factor-alpha,0,0
92658,(,0,0
92659,TNF-alpha,0,1
92660,),0,0
92661,",",0,0
92662,RANKL,0,1
92663,",",0,0
92664,osteoprotegerin,0,0
92665,",",0,0
92666,and,0,0
92667,markers,0,0
92668,of,0,0
92669,bone,0,0
92670,formation,0,0
92671,and,0,0
92672,resorption,0,0
92673,.,0,0
92674,Levels,0,0
92675,of,0,0
92676,serum,0,0
92677,cytokines,0,0
92678,were,0,0
92679,measured,0,0
92680,before,0,0
92681,therapy,0,1
92682,and,0,0
92683,after,0,0
92684,three,0,0
92685,and,0,0
92686,6,0,0
92687,months,0,0
92688,.,0,0
92689,Markers,0,0
92690,of,0,0
92691,bone,0,0
92692,metabolism,0,0
92693,were,0,0
92694,studied,0,0
92695,before,0,0
92696,therapy,0,1
92697,and,0,0
92698,after,0,0
92699,6,0,0
92700,months,0,0
92701,.,0,0
92702,In,0,0
92703,group,0,0
92704,1,0,0
92705,(,0,0
92706,risedronate,0,1
92707,plus,0,1
92708,calcium/vitamin,0,1
92709,D-treated,0,0
92710,patients,0,0
92711,),0,0
92712,",",0,0
92713,serum,0,0
92714,levels,0,0
92715,of,0,0
92716,RANKL,0,0
92717,and,0,0
92718,IL-1beta,0,0
92719,significantly,0,0
92720,decreased,0,0
92721,and,0,0
92722,the,0,0
92723,level,0,0
92724,of,0,0
92725,osteoprotegerin,0,0
92726,significantly,0,0
92727,increased,0,0
92728,after,0,0
92729,three,0,0
92730,and,0,0
92731,6,0,0
92732,months,0,0
92733,",",0,0
92734,but,0,0
92735,no,0,0
92736,significant,0,0
92737,difference,0,0
92738,was,0,0
92739,found,0,0
92740,in,0,0
92741,TNF-alpha,0,0
92742,level,0,0
92743,.,0,0
92744,In,0,0
92745,group,0,0
92746,2,0,0
92747,",",0,0
92748,however,0,0
92749,",",0,0
92750,the,0,0
92751,level,0,0
92752,of,0,0
92753,serum,0,0
92754,cytokines,0,0
92755,did,0,0
92756,not,0,0
92757,change,0,0
92758,after,0,0
92759,three,0,0
92760,and,0,0
92761,6,0,0
92762,months,0,0
92763,.,0,0
92764,In,0,0
92765,cases,0,0
92766,of,0,0
92767,bone,0,0
92768,turnover,0,0
92769,",",0,0
92770,both,0,0
92771,markers,0,0
92772,of,0,0
92773,bone,0,0
92774,resorption,0,0
92775,and,0,0
92776,formation,0,0
92777,significantly,0,0
92778,decreased,0,0
92779,after,0,0
92780,6,0,0
92781,months,0,0
92782,in,0,0
92783,group,0,0
92784,1,0,0
92785,.,0,0
92786,In,0,0
92787,conclusion,0,0
92788,risedronate,0,1
92789,could,0,0
92790,improve,0,0
92791,osteoporosis,0,0
92792,by,0,0
92793,increasing,0,0
92794,osteoprotegerin,0,0
92795,and,0,0
92796,reducing,0,0
92797,RANKL,0,1
92798,and,0,0
92799,IL-1beta,0,0
92800,.,0,0
92801,Fixed-dose,0,1
92802,manidipine/delapril,1,1
92803,versus,0,0
92804,losartan/hydrochlorothiazide,1,1
92805,in,0,0
92806,hypertensive,0,0
92807,patients,0,0
92808,with,0,0
92809,type,0,0
92810,2,0,0
92811,diabetes,0,0
92812,and,0,0
92813,microalbuminuria,0,0
92814,.,0,0
92815,INTRODUCTION,0,0
92816,Patients,0,0
92817,with,0,0
92818,diabetes,0,0
92819,complicated,0,0
92820,by,0,0
92821,hypertension,0,0
92822,and,0,0
92823,microalbuminuria,0,0
92824,have,0,0
92825,elevated,0,0
92826,cardiovascular,0,0
92827,risk,0,0
92828,",",0,0
92829,and,0,0
92830,controlling,0,0
92831,blood,0,0
92832,pressure,0,0
92833,in,0,0
92834,these,0,0
92835,patients,0,0
92836,is,0,0
92837,an,0,0
92838,urgent,0,0
92839,clinical,0,0
92840,priority,0,0
92841,.,0,0
92842,The,0,0
92843,present,0,0
92844,study,0,0
92845,aimed,0,0
92846,to,0,0
92847,examine,0,0
92848,the,0,0
92849,effects,0,0
92850,of,0,0
92851,a,0,0
92852,fixed-dose,0,1
92853,combination,0,1
92854,of,0,0
92855,antihypertensives,0,1
92856,on,0,0
92857,blood,0,0
92858,pressure,0,0
92859,and,0,0
92860,microalbuminuria,0,0
92861,.,0,0
92862,METHODS,0,0
92863,Patients,0,0
92864,with,0,0
92865,type,0,0
92866,2,0,0
92867,diabetes,0,0
92868,",",0,0
92869,mild-to-moderate,0,0
92870,hypertension,0,0
92871,(,0,0
92872,diastolic,0,0
92873,blood,0,0
92874,pressure,0,0
92875,85-105,0,0
92876,mmHg,0,0
92877,",",0,0
92878,systolic,0,0
92879,blood,0,0
92880,pressure,0,0
92881,<,0,0
92882,160,0,0
92883,mmHg,0,0
92884,",",0,0
92885,and,0,0
92886,24-hour,0,0
92887,mean,0,0
92888,systolic,0,0
92889,blood,0,0
92890,pressure,0,0
92891,>,0,0
92892,130,0,0
92893,mmHg,0,0
92894,),0,0
92895,",",0,0
92896,and,0,0
92897,microalbuminuria,0,0
92898,were,0,0
92899,randomized,0,0
92900,to,0,0
92901,1,0,0
92902,year,0,0
92903,of,0,0
92904,doubleblind,0,0
92905,treatment,0,0
92906,with,0,0
92907,fixed-dose,1,1
92908,manidipine/delapril,1,1
92909,(,0,0
92910,n=54,0,0
92911,),0,0
92912,or,0,1
92913,losartan/hydrochlorothiazide,1,1
92914,(,1,0
92915,HCTZ,1,0
92916,),1,1
92917,(,0,0
92918,n=56,0,0
92919,),0,0
92920,.,0,0
92921,RESULTS,0,0
92922,Blood,0,0
92923,pressure,0,0
92924,was,0,0
92925,significantly,0,0
92926,reduced,0,0
92927,at,0,0
92928,1,0,0
92929,year,0,0
92930,in,0,0
92931,both,0,0
92932,groups,0,0
92933,(,0,0
92934,-22.2/-14.6,0,1
92935,mmHg,0,0
92936,and,0,0
92937,-19.5/-14.3,0,1
92938,mmHg,0,0
92939,",",0,0
92940,for,0,0
92941,systolic,0,0
92942,and,0,0
92943,diastolic,0,0
92944,blood,0,0
92945,pressure,0,0
92946,respectively,0,0
92947,",",0,0
92948,P,0,0
92949,<,0,0
92950,0.001,0,0
92951,for,0,0
92952,each,0,0
92953,),0,0
92954,",",0,0
92955,with,0,0
92956,no,0,0
92957,significant,0,0
92958,between-group,0,0
92959,difference,0,0
92960,.,0,0
92961,Reductions,0,0
92962,in,0,0
92963,microalbuminuria,0,0
92964,occurred,0,0
92965,in,0,0
92966,both,0,0
92967,groups,0,0
92968,",",0,0
92969,with,0,0
92970,mean,0,0
92971,changes,0,0
92972,at,0,0
92973,1,0,0
92974,year,0,0
92975,of,0,0
92976,-3.9,0,0
92977,mg/mmol,0,0
92978,creatinine,0,0
92979,(,0,0
92980,95,0,0
92981,%,0,0
92982,CI,0,0
92983,-5.3,0,0
92984,",",0,0
92985,-2.5,0,0
92986,),0,0
92987,for,0,0
92988,manidipine/delapril,1,1
92989,(,0,0
92990,P,0,0
92991,<,0,0
92992,0.001,0,0
92993,vs.,0,0
92994,baseline,0,0
92995,),0,0
92996,and,0,0
92997,-2.7,0,0
92998,mg/mmol,0,0
92999,creatinine,0,0
93000,(,0,0
93001,95,0,0
93002,%,0,0
93003,CI,0,0
93004,-4.0,0,0
93005,",",0,0
93006,-1.3,0,0
93007,),0,0
93008,for,0,0
93009,losartan/HCTZ,1,1
93010,(,0,0
93011,P,0,0
93012,<,0,0
93013,0.001,0,0
93014,vs.,0,0
93015,baseline,0,0
93016,and,0,0
93017,P=0.199,0,0
93018,between,0,0
93019,groups,0,0
93020,),0,0
93021,.,0,0
93022,Glycemia,0,0
93023,over,0,0
93024,the,0,0
93025,1-year,0,0
93026,study,0,0
93027,was,0,0
93028,largely,0,0
93029,unaffected,0,0
93030,;,0,0
93031,the,0,0
93032,blood,0,0
93033,glucose,0,0
93034,concentration,0,0
93035,was,0,0
93036,reduced,0,0
93037,from,0,0
93038,baseline,0,0
93039,with,0,0
93040,manidipine/delapril,1,1
93041,",",0,0
93042,although,0,0
93043,not,0,0
93044,statistically,0,0
93045,significant,0,0
93046,(,0,0
93047,mean,0,0
93048,change,0,0
93049,-0.2,0,0
93050,mmol/L,0,0
93051,",",0,0
93052,P=0.064,0,0
93053,),0,0
93054,.,0,0
93055,Both,0,0
93056,treatments,0,0
93057,were,0,0
93058,well,0,0
93059,tolerated,0,0
93060,",",0,0
93061,with,0,0
93062,discontinuation,0,0
93063,for,0,0
93064,adverse,0,0
93065,events,0,0
93066,for,0,0
93067,one,0,0
93068,(,0,0
93069,1.9,0,0
93070,%,0,0
93071,),0,0
93072,patient,0,0
93073,in,0,0
93074,the,0,0
93075,manidipine/delapril,1,1
93076,group,0,0
93077,and,0,0
93078,two,0,0
93079,(,0,0
93080,3.6,0,0
93081,%,0,0
93082,),0,0
93083,in,0,0
93084,the,0,0
93085,losartan/HCTZ,1,1
93086,group,0,0
93087,.,0,0
93088,CONCLUSIONS,0,0
93089,A,0,0
93090,fixed-dose,0,1
93091,manidipine/delapril,1,1
93092,combination,0,1
93093,represents,0,0
93094,a,0,0
93095,useful,0,0
93096,addition,0,0
93097,to,0,0
93098,the,0,0
93099,treatment,0,0
93100,options,0,0
93101,available,0,0
93102,to,0,0
93103,control,0,0
93104,hypertension,0,0
93105,complicated,0,0
93106,by,0,0
93107,diabetes,0,0
93108,and,0,0
93109,microalbuminuria,0,0
93110,.,0,0
93111,Bridge,1,1
93112,plate,1,1
93113,osteosynthesis,1,1
93114,using,1,0
93115,dynamic,1,0
93116,condylar,1,0
93117,screw,1,1
93118,(,1,0
93119,DCS,1,1
93120,),1,0
93121,or,1,1
93122,retrograde,1,1
93123,intramedullary,1,0
93124,supracondylar,1,1
93125,nail,1,1
93126,(,1,0
93127,RIMSN,1,0
93128,),1,0
93129,in,0,0
93130,the,0,0
93131,treatment,0,0
93132,of,0,0
93133,distal,0,0
93134,femoral,0,0
93135,fractures,0,0
93136,:,0,0
93137,comparison,0,0
93138,of,0,0
93139,two,0,0
93140,methods,0,0
93141,in,0,0
93142,a,0,0
93143,prospective,0,0
93144,randomized,0,0
93145,study,0,0
93146,.,0,0
93147,BACKGROUND,0,0
93148,The,0,0
93149,treatment,0,0
93150,of,0,0
93151,distal,0,0
93152,femoral,0,0
93153,fractures,0,0
93154,remains,0,0
93155,a,0,0
93156,significant,0,0
93157,surgical,0,0
93158,challenge,0,0
93159,.,0,0
93160,With,0,0
93161,the,0,0
93162,rigid,0,1
93163,fixation,0,0
93164,of,0,0
93165,the,0,0
93166,distal,0,0
93167,femoral,0,0
93168,fractures,0,0
93169,",",0,0
93170,bone,0,0
93171,grafting,0,1
93172,is,0,0
93173,frequently,0,0
93174,needed,0,0
93175,.,0,0
93176,Biological,0,0
93177,osteosynthesis,0,1
93178,using,0,0
93179,dynamic,0,0
93180,condylar,0,0
93181,screw,0,1
93182,(,0,0
93183,DCS,0,1
93184,),0,1
93185,and,0,0
93186,retrograde,0,1
93187,intramedullary,0,0
93188,supracondylar,0,1
93189,nail,0,1
93190,(,0,0
93191,RIMSN,0,0
93192,),0,0
93193,preserve,0,0
93194,the,0,0
93195,blood,0,0
93196,supply,0,0
93197,and,0,0
93198,limit,0,0
93199,the,0,0
93200,need,0,0
93201,for,0,0
93202,bone,0,0
93203,grafting,0,0
93204,.,0,0
93205,METHODS,0,0
93206,From,0,0
93207,September,0,0
93208,2002,0,0
93209,to,0,0
93210,December,0,0
93211,2004,0,0
93212,",",0,0
93213,68,0,0
93214,closed,0,0
93215,fractures,0,0
93216,of,0,0
93217,the,0,0
93218,distal,0,0
93219,femur,0,0
93220,were,0,0
93221,treated,0,0
93222,by,0,0
93223,bridge,1,0
93224,plate,1,0
93225,osteosynthesis,1,1
93226,using,1,0
93227,DCS,1,1
93228,in,1,0
93229,31,1,0
93230,and,1,0
93231,RIMSN,1,0
93232,in,1,0
93233,37,1,0
93234,.,1,0
93235,The,0,0
93236,patients,0,0
93237,were,0,0
93238,allocated,0,0
93239,to,0,0
93240,one,0,0
93241,of,0,0
93242,the,0,0
93243,two,0,0
93244,groups,0,0
93245,randomly,0,0
93246,and,0,0
93247,followed,0,0
93248,for,0,0
93249,24-36,0,0
93250,months,0,0
93251,(,0,0
93252,average,0,0
93253,:,0,0
93254,30,0,0
93255,months,0,0
93256,),0,0
93257,.,0,0
93258,RESULTS,0,0
93259,With,0,0
93260,respect,0,0
93261,to,0,0
93262,operation,0,0
93263,time,0,0
93264,",",0,0
93265,the,0,0
93266,DCS,0,1
93267,group,0,0
93268,presented,0,0
93269,significantly,0,0
93270,better,0,0
93271,results,0,0
93272,than,0,0
93273,the,0,0
93274,RIMSN,0,1
93275,group,0,0
93276,(,0,0
93277,p=0.000,0,0
93278,),0,0
93279,.,0,0
93280,However,0,0
93281,",",0,0
93282,the,0,0
93283,blood,0,0
93284,loss,0,0
93285,was,0,0
93286,significantly,0,0
93287,more,0,0
93288,in,0,0
93289,the,0,0
93290,DCS,0,1
93291,group,0,0
93292,(,0,0
93293,p=0.000,0,0
93294,),0,0
93295,.,0,0
93296,There,0,0
93297,were,0,0
93298,no,0,0
93299,significant,0,0
93300,differences,0,0
93301,in,0,0
93302,terms,0,0
93303,of,0,0
93304,cumulative,0,0
93305,rate,0,0
93306,of,0,0
93307,union,0,0
93308,(,0,0
93309,p=0.855,0,0
93310,),0,0
93311,",",0,0
93312,range,0,0
93313,of,0,0
93314,motion,0,0
93315,of,0,0
93316,the,0,0
93317,knee,0,0
93318,(,0,0
93319,p=0.727,0,0
93320,),0,0
93321,",",0,0
93322,overall,0,0
93323,results,0,0
93324,(,0,0
93325,p=0.925,0,0
93326,),0,0
93327,and,0,0
93328,complications,0,0
93329,(,0,0
93330,p=0.927,0,0
93331,),0,0
93332,between,0,0
93333,the,0,0
93334,two,0,0
93335,groups,0,0
93336,.,0,0
93337,CONCLUSION,0,0
93338,No,0,0
93339,implant,0,1
93340,or,0,1
93341,surgical,0,0
93342,technique,0,1
93343,is,0,0
93344,superior,0,0
93345,to,0,0
93346,any,0,0
93347,other,0,0
93348,under,0,0
93349,all,0,0
93350,circumstances,0,0
93351,for,0,0
93352,distal,0,0
93353,femoral,0,0
93354,fracture,0,0
93355,.,0,0
93356,RIMSN,0,0
93357,is,0,0
93358,standard,0,0
93359,care,0,0
93360,",",0,0
93361,yet,0,0
93362,the,0,0
93363,biological,0,0
93364,osteosynthesis,0,1
93365,using,0,0
93366,DCS,0,1
93367,is,0,0
93368,a,0,0
93369,very,0,0
93370,good,0,0
93371,alternative,0,0
93372,for,0,0
93373,the,0,0
93374,treatment,0,0
93375,of,0,0
93376,distal,0,0
93377,femoral,0,0
93378,fractures,0,0
93379,.,0,0
93380,Pulse,0,1
93381,oximeter,0,1
93382,perfusion,0,0
93383,index,0,0
93384,as,0,0
93385,an,0,0
93386,early,0,0
93387,indicator,0,0
93388,of,0,0
93389,sympathectomy,0,0
93390,after,0,0
93391,epidural,0,1
93392,anesthesia,0,1
93393,.,0,0
93394,BACKGROUND,0,0
93395,The,0,0
93396,pulse,0,1
93397,oximeter,0,1
93398,perfusion,0,1
93399,index,0,0
93400,(,0,0
93401,PI,0,1
93402,),0,1
93403,has,0,0
93404,been,0,0
93405,used,0,0
93406,to,0,0
93407,indicate,0,0
93408,sympathectomy-induced,0,0
93409,vasodilatation,0,0
93410,.,0,0
93411,We,0,0
93412,hypothesized,0,0
93413,that,0,0
93414,pulse,0,1
93415,oximeter,0,1
93416,PI,0,1
93417,provides,0,0
93418,an,0,0
93419,earlier,0,0
93420,and,0,0
93421,clearer,0,0
93422,indication,0,0
93423,of,0,0
93424,sympathectomy,0,0
93425,following,0,0
93426,epidural,0,1
93427,anesthesia,0,1
93428,than,0,0
93429,skin,0,0
93430,temperature,0,0
93431,and,0,0
93432,arterial,0,0
93433,pressure,0,0
93434,.,0,0
93435,METHODS,0,0
93436,Forty,0,0
93437,patients,0,0
93438,received,1,0
93439,lumbar,1,0
93440,epidural,1,1
93441,catheters,1,1
93442,.,1,0
93443,Patients,0,0
93444,were,0,0
93445,randomized,0,0
93446,to,0,0
93447,receive,1,0
93448,either,1,0
93449,10,1,0
93450,ml,1,0
93451,0.5,1,0
93452,%,1,0
93453,bupivacaine,1,1
93454,or,1,1
93455,10,1,0
93456,ml,1,0
93457,0.25,1,1
93458,%,1,0
93459,bupivacaine,1,1
93460,.,1,0
93461,PI,0,0
93462,in,0,0
93463,the,0,0
93464,toe,0,0
93465,",",0,0
93466,mean,1,0
93467,arterial,1,0
93468,pressure,1,0
93469,(,1,0
93470,MAP,1,1
93471,),1,1
93472,and,1,0
93473,toe,1,1
93474,temperature,1,0
93475,were,1,0
93476,all,1,0
93477,assessed,1,0
93478,at,1,0
93479,baseline,1,0
93480,and,1,0
93481,at,1,0
93482,5,1,0
93483,",",1,0
93484,10,1,0
93485,and,1,0
93486,20,1,0
93487,min,1,0
93488,following,1,0
93489,epidural,1,1
93490,anesthesia,1,1
93491,.,1,0
93492,The,0,0
93493,effect,0,0
93494,of,0,0
93495,epidural,1,1
93496,anesthesia,1,1
93497,over,0,0
93498,time,0,0
93499,was,0,0
93500,assessed,0,0
93501,by,0,0
93502,repeated,0,0
93503,measures,0,0
93504,analysis,0,0
93505,of,0,0
93506,variance,0,0
93507,.,0,0
93508,Additionally,0,0
93509,",",0,0
93510,we,0,0
93511,defined,0,0
93512,clinically,0,0
93513,evident,0,0
93514,sympathectomy,0,0
93515,criteria,0,0
93516,(,0,0
93517,a,0,0
93518,100,0,1
93519,%,0,0
93520,increase,0,0
93521,in,0,0
93522,the,0,0
93523,PI,0,0
93524,",",0,0
93525,a,0,0
93526,15,0,0
93527,%,0,0
93528,decrease,0,0
93529,in,0,0
93530,MAP,0,1
93531,and,0,0
93532,a,0,0
93533,1,0,0
93534,degrees,0,0
93535,C,0,0
93536,increase,0,0
93537,in,0,0
93538,toe,0,0
93539,temperature,0,0
93540,),0,0
93541,.,0,0
93542,The,0,0
93543,numbers,0,0
93544,of,0,0
93545,patients,0,0
93546,demonstrating,0,0
93547,these,0,0
93548,changes,0,0
93549,for,0,0
93550,each,0,0
93551,test,0,0
93552,were,0,0
93553,compared,0,0
93554,using,0,0
93555,the,0,0
93556,McNemar,0,0
93557,test,0,0
93558,for,0,0
93559,each,0,0
93560,time,0,0
93561,point,0,0
93562,.,0,0
93563,RESULTS,0,0
93564,Twenty-nine,0,0
93565,subjects,0,0
93566,had,0,0
93567,photoplethysmography,0,0
93568,signals,0,0
93569,that,0,0
93570,met,0,0
93571,a,0,0
93572,priori,0,0
93573,signal,0,0
93574,quality,0,0
93575,criteria,0,0
93576,for,0,0
93577,analysis,0,0
93578,.,0,0
93579,By,0,0
93580,20,0,0
93581,min,0,0
93582,",",0,0
93583,PI,0,0
93584,increased,0,0
93585,by,0,0
93586,326,0,0
93587,%,0,0
93588,",",0,0
93589,compared,0,0
93590,with,0,0
93591,a,0,0
93592,10,0,0
93593,%,0,0
93594,decrease,0,0
93595,and,0,0
93596,a,0,0
93597,3,0,0
93598,%,0,0
93599,increase,0,0
93600,in,0,0
93601,MAP,0,1
93602,and,0,0
93603,toe,0,0
93604,temperature,0,0
93605,",",0,0
93606,respectively,0,0
93607,.,0,0
93608,For,0,0
93609,PI,0,0
93610,15/29,0,0
93611,",",0,0
93612,26/29,0,0
93613,and,0,0
93614,29/29,0,0
93615,of,0,0
93616,the,0,0
93617,subjects,0,0
93618,met,0,0
93619,the,0,0
93620,sympathectomy,0,0
93621,criteria,0,0
93622,at,0,0
93623,5,0,0
93624,",",0,0
93625,10,0,0
93626,and,0,0
93627,20,0,0
93628,min,0,0
93629,",",0,0
93630,respectively,0,0
93631,",",0,0
93632,compared,0,0
93633,with,0,0
93634,4/29,0,0
93635,",",0,0
93636,6/29,0,0
93637,and,0,0
93638,18/29,0,0
93639,for,0,0
93640,MAP,0,1
93641,changes,0,0
93642,and,0,0
93643,3/29,0,0
93644,",",0,0
93645,8/29,0,0
93646,and,0,0
93647,14/29,0,0
93648,for,0,0
93649,toe,0,0
93650,temperature,0,0
93651,changes,0,0
93652,.,0,0
93653,CONCLUSIONS,0,0
93654,PI,0,0
93655,was,0,0
93656,an,0,0
93657,earlier,0,0
93658,",",0,0
93659,clearer,0,0
93660,and,0,0
93661,more,0,0
93662,sensitive,0,0
93663,indicator,0,0
93664,of,0,0
93665,the,0,0
93666,development,0,0
93667,of,0,0
93668,epidural-induced,0,0
93669,sympathectomy,0,0
93670,than,0,0
93671,either,0,0
93672,skin,0,0
93673,temperature,0,0
93674,or,0,0
93675,MAP,0,1
93676,.,0,0
93677,Perioperative,0,1
93678,fever,0,0
93679,and,0,0
93680,outcome,0,0
93681,in,0,0
93682,surgical,0,0
93683,patients,0,0
93684,with,0,0
93685,aneurysmal,0,0
93686,subarachnoid,0,0
93687,hemorrhage,0,0
93688,.,0,0
93689,OBJECTIVE,0,0
93690,We,0,0
93691,examined,0,0
93692,the,0,0
93693,incidence,0,0
93694,of,0,0
93695,perioperative,0,0
93696,fever,0,0
93697,and,0,0
93698,its,0,0
93699,relationship,0,0
93700,to,0,0
93701,outcome,0,0
93702,among,0,0
93703,patients,0,0
93704,enrolled,0,0
93705,in,0,0
93706,the,0,0
93707,Intraoperative,0,0
93708,Hypothermia,0,1
93709,for,0,0
93710,Aneurysm,0,0
93711,Surgery,0,1
93712,Trial,0,0
93713,.,0,0
93714,METHODS,0,0
93715,One,0,0
93716,thousand,0,0
93717,patients,0,0
93718,with,0,0
93719,initial,0,0
93720,World,0,0
93721,Federation,0,0
93722,of,0,0
93723,Neurological,0,0
93724,Surgeons,0,0
93725,grades,0,0
93726,of,0,0
93727,I,0,0
93728,to,0,0
93729,III,0,0
93730,undergoing,0,0
93731,clipping,0,1
93732,of,0,0
93733,intracranial,0,0
93734,aneurysms,0,0
93735,after,0,0
93736,subarachnoid,0,0
93737,hemorrhage,0,0
93738,were,0,0
93739,randomized,0,0
93740,to,0,0
93741,intraoperative,1,1
93742,normothermia,1,1
93743,(,0,0
93744,36,0,0
93745,degrees,0,0
93746,C-37,0,0
93747,degrees,0,0
93748,C,0,0
93749,),0,0
93750,or,0,1
93751,hypothermia,1,0
93752,(,0,0
93753,32.5,0,0
93754,degrees,0,0
93755,C-33.5,0,0
93756,degrees,0,0
93757,C,0,0
93758,),0,0
93759,.,0,0
93760,Fever,0,0
93761,(,0,0
93762,>,0,0
93763,or,0,0
93764,=38.5,0,0
93765,degrees,0,0
93766,C,0,0
93767,),0,0
93768,and,0,0
93769,other,0,0
93770,complications,0,0
93771,(,0,0
93772,including,0,0
93773,infections,0,0
93774,),0,0
93775,occurring,0,0
93776,between,0,0
93777,admission,0,0
93778,and,0,0
93779,discharge,0,1
93780,(,0,0
93781,or,0,1
93782,death,0,0
93783,),0,0
93784,were,0,0
93785,recorded,0,0
93786,.,0,0
93787,Functional,0,0
93788,and,0,0
93789,neuropsychologic,0,0
93790,outcomes,0,0
93791,were,0,0
93792,assessed,0,0
93793,3,0,0
93794,months,0,0
93795,postoperatively,0,0
93796,.,0,0
93797,The,0,0
93798,primary,0,0
93799,outcome,0,0
93800,variable,0,0
93801,for,0,0
93802,the,0,0
93803,trial,0,0
93804,was,0,0
93805,dichotomized,0,0
93806,Glasgow,0,0
93807,Outcome,0,0
93808,Scale,0,1
93809,(,0,0
93810,good,0,0
93811,outcome,0,0
93812,versus,0,0
93813,all,0,0
93814,others,0,0
93815,),0,0
93816,.,0,0
93817,RESULTS,0,0
93818,Fever,0,0
93819,was,0,0
93820,reported,0,0
93821,in,0,0
93822,41,0,0
93823,%,0,0
93824,of,0,0
93825,patients,0,0
93826,.,0,0
93827,In,0,0
93828,97,0,0
93829,%,0,0
93830,of,0,0
93831,these,0,0
93832,",",0,0
93833,fever,0,0
93834,occurred,0,0
93835,in,0,0
93836,the,0,0
93837,postoperative,0,0
93838,period,0,0
93839,.,0,0
93840,The,0,0
93841,median,0,0
93842,time,0,0
93843,from,0,0
93844,surgery,0,0
93845,to,0,0
93846,first,0,0
93847,fever,0,0
93848,was,0,0
93849,3,0,0
93850,days,0,0
93851,.,0,0
93852,All,0,0
93853,measures,0,0
93854,of,0,0
93855,outcome,0,0
93856,were,0,0
93857,worse,0,0
93858,in,0,0
93859,patients,0,0
93860,who,0,0
93861,developed,0,0
93862,fever,0,0
93863,",",0,0
93864,even,0,0
93865,in,0,0
93866,those,0,0
93867,without,0,0
93868,infections,0,0
93869,or,0,0
93870,who,0,0
93871,were,0,0
93872,World,0,0
93873,Federation,0,0
93874,of,0,0
93875,Neurological,0,0
93876,Surgeons,0,0
93877,grade,0,0
93878,I.,0,1
93879,Logistic,0,0
93880,regression,0,0
93881,analyses,0,0
93882,were,0,0
93883,performed,0,0
93884,to,0,0
93885,adjust,0,0
93886,for,0,0
93887,differences,0,0
93888,in,0,0
93889,preoperative,0,0
93890,factors,0,0
93891,(,0,0
93892,e.g.,0,0
93893,",",0,0
93894,age,0,0
93895,",",0,0
93896,Fisher,0,1
93897,grade,0,0
93898,",",0,0
93899,initial,0,0
93900,neurological,0,0
93901,status,0,0
93902,),0,0
93903,.,0,0
93904,This,0,0
93905,demonstrated,0,0
93906,that,0,0
93907,fever,0,0
93908,continued,0,0
93909,to,0,0
93910,be,0,0
93911,significantly,0,0
93912,associated,0,0
93913,with,0,0
93914,most,0,0
93915,outcome,0,0
93916,measures,0,0
93917,",",0,0
93918,even,0,0
93919,when,0,0
93920,infection,0,0
93921,was,0,0
93922,added,0,0
93923,to,0,0
93924,the,0,0
93925,model,0,0
93926,.,0,0
93927,An,0,0
93928,alternative,0,0
93929,stepwise,0,0
93930,model,0,0
93931,selection,0,0
93932,process,0,0
93933,including,0,0
93934,all,0,0
93935,fever-related,0,0
93936,measures,0,0
93937,from,0,0
93938,the,0,0
93939,preoperative,0,0
93940,and,0,0
93941,intraoperative,0,1
93942,period,0,0
93943,(,0,0
93944,e.g.,0,0
93945,",",0,0
93946,hydrocephalus,0,0
93947,",",0,0
93948,duration,0,0
93949,of,0,0
93950,surgery,0,0
93951,",",0,0
93952,intraoperative,0,1
93953,blood,0,0
93954,loss,0,0
93955,),0,0
93956,resulted,0,0
93957,in,0,0
93958,the,0,0
93959,loss,0,0
93960,of,0,0
93961,significance,0,0
93962,for,0,0
93963,dichotomized,0,0
93964,Glasgow,0,0
93965,Outcome,0,0
93966,Scale,0,0
93967,",",0,0
93968,but,0,0
93969,significant,0,0
93970,associations,0,0
93971,between,0,0
93972,fever,0,0
93973,and,0,0
93974,several,0,0
93975,other,0,0
93976,outcome,0,0
93977,measures,0,0
93978,remained,0,0
93979,.,0,0
93980,After,0,0
93981,adding,0,0
93982,postoperative,0,0
93983,delayed,0,0
93984,ischemic,0,0
93985,neurological,0,0
93986,deficits,0,0
93987,to,0,0
93988,the,0,0
93989,model,0,0
93990,",",0,0
93991,only,0,0
93992,worsened,0,0
93993,National,0,0
93994,Institutes,0,0
93995,of,0,0
93996,Health,0,0
93997,Stroke,0,1
93998,Scale,0,0
93999,score,0,0
94000,",",0,0
94001,Barthel,0,0
94002,Activities,0,0
94003,of,0,0
94004,Daily,0,0
94005,Living,0,0
94006,index,0,0
94007,",",0,0
94008,and,0,0
94009,discharge,0,1
94010,destination,0,0
94011,(,0,0
94012,home,0,0
94013,versus,0,1
94014,other,0,0
94015,),0,0
94016,remained,0,0
94017,independently,0,0
94018,associated,0,0
94019,with,0,0
94020,fever,0,0
94021,.,0,0
94022,CONCLUSION,0,0
94023,These,0,0
94024,findings,0,0
94025,suggest,0,0
94026,that,0,0
94027,fever,0,0
94028,is,0,0
94029,associated,0,0
94030,with,0,0
94031,worsened,0,0
94032,outcome,0,0
94033,in,0,0
94034,surgical,0,0
94035,subarachnoid,0,0
94036,hemorrhage,0,0
94037,patients,0,0
94038,",",0,0
94039,although,0,0
94040,",",0,0
94041,because,0,0
94042,the,0,0
94043,association,0,0
94044,between,0,0
94045,fever,0,0
94046,and,0,0
94047,the,0,0
94048,primary,0,0
94049,outcome,0,0
94050,measure,0,0
94051,for,0,0
94052,the,0,0
94053,trial,0,0
94054,is,0,0
94055,dependent,0,0
94056,on,0,0
94057,the,0,0
94058,covariates,0,0
94059,used,0,0
94060,in,0,0
94061,the,0,0
94062,analysis,0,0
94063,(,0,0
94064,particularly,0,0
94065,operative,0,0
94066,events,0,0
94067,and,0,0
94068,delayed,0,0
94069,ischemic,0,0
94070,neurological,0,0
94071,deficits,0,0
94072,),0,0
94073,",",0,0
94074,we,0,0
94075,can,0,0
94076,not,0,0
94077,rule,0,0
94078,out,0,0
94079,the,0,0
94080,possibility,0,0
94081,that,0,0
94082,fever,0,0
94083,is,0,0
94084,a,0,0
94085,marker,0,0
94086,for,0,0
94087,other,0,0
94088,events,0,0
94089,.,0,0
94090,Only,0,0
94091,a,0,0
94092,formal,0,1
94093,trial,0,0
94094,of,0,0
94095,fever,0,0
94096,treatment,0,0
94097,or,0,1
94098,prevention,0,0
94099,can,0,0
94100,address,0,0
94101,this,0,0
94102,issue,0,0
94103,.,0,0
94104,Pilot,0,0
94105,study,0,0
94106,of,0,0
94107,Panax,1,1
94108,quinquefolius,1,0
94109,(,1,0
94110,American,1,0
94111,ginseng,1,1
94112,),1,0
94113,to,0,0
94114,improve,0,0
94115,cancer-related,0,0
94116,fatigue,0,0
94117,:,0,0
94118,a,0,0
94119,randomized,0,0
94120,",",0,0
94121,double-blind,0,0
94122,",",0,0
94123,dose-finding,0,0
94124,evaluation,0,0
94125,:,0,0
94126,NCCTG,0,1
94127,trial,0,0
94128,N03CA,0,1
94129,.,0,0
94130,PURPOSE,0,0
94131,This,0,0
94132,pilot,0,0
94133,trial,0,0
94134,sought,0,0
94135,to,0,0
94136,investigate,0,0
94137,whether,0,0
94138,any,0,0
94139,of,0,0
94140,three,0,0
94141,doses,0,0
94142,of,0,0
94143,American,1,0
94144,ginseng,1,1
94145,(,1,0
94146,Panax,1,1
94147,quinquefolius,1,0
94148,),1,0
94149,might,0,0
94150,help,0,0
94151,cancer-related,0,0
94152,fatigue,0,0
94153,.,0,0
94154,A,0,0
94155,secondary,0,0
94156,aim,0,0
94157,was,0,0
94158,to,0,0
94159,evaluate,0,0
94160,toxicity,0,0
94161,.,0,0
94162,METHODS,0,0
94163,Eligible,0,0
94164,adults,0,0
94165,with,0,0
94166,cancer,0,0
94167,were,0,0
94168,randomized,0,0
94169,in,0,0
94170,a,0,0
94171,double-blind,0,0
94172,manner,0,0
94173,",",0,0
94174,to,0,0
94175,receive,0,0
94176,American,1,0
94177,ginseng,1,1
94178,in,0,0
94179,doses,0,0
94180,of,0,0
94181,750,0,0
94182,",",0,0
94183,"1,000",0,0
94184,",",0,0
94185,or,0,0
94186,"2,000",0,0
94187,mg/day,0,0
94188,or,0,0
94189,placebo,1,1
94190,given,0,0
94191,in,0,0
94192,twice,0,0
94193,daily,0,1
94194,dosing,0,0
94195,over,0,0
94196,8,0,0
94197,weeks,0,0
94198,.,0,0
94199,Outcome,0,0
94200,measures,0,0
94201,included,0,0
94202,the,0,0
94203,Brief,0,1
94204,Fatigue,0,0
94205,Inventory,0,0
94206,",",0,0
94207,vitality,0,0
94208,subscale,0,0
94209,of,0,0
94210,the,0,0
94211,Medical,0,1
94212,Outcome,0,0
94213,Scale,0,0
94214,Short,0,1
94215,Form-36,0,1
94216,(,0,0
94217,SF-36,0,1
94218,),0,0
94219,",",0,0
94220,and,0,0
94221,the,0,0
94222,Global,0,0
94223,Impression,0,0
94224,of,0,0
94225,Benefit,0,0
94226,Scale,0,0
94227,at,0,0
94228,4,0,0
94229,and,0,0
94230,8,0,0
94231,weeks,0,0
94232,.,0,0
94233,RESULTS,0,0
94234,Two,0,0
94235,hundred,0,0
94236,ninety,0,0
94237,patients,0,0
94238,were,0,0
94239,accrued,0,0
94240,to,0,0
94241,this,0,0
94242,trial,0,0
94243,.,0,0
94244,Nonsignificant,0,0
94245,trends,0,0
94246,for,0,0
94247,all,0,0
94248,outcomes,0,0
94249,were,0,0
94250,seen,0,0
94251,in,0,0
94252,favor,0,0
94253,of,0,0
94254,the,0,0
94255,"1,000-",0,0
94256,and,0,0
94257,"2,000-mg/day",0,1
94258,doses,0,0
94259,of,0,0
94260,American,1,0
94261,ginseng,1,1
94262,.,1,0
94263,Area,0,0
94264,under,0,0
94265,the,0,0
94266,curve,0,0
94267,analysis,0,0
94268,of,0,0
94269,activity,0,0
94270,interference,0,0
94271,from,0,0
94272,the,0,0
94273,Brief,0,1
94274,Fatigue,0,0
94275,Inventory,0,0
94276,was,0,0
94277,460-467,0,0
94278,in,0,0
94279,the,0,0
94280,placebo,1,1
94281,group,0,0
94282,and,0,0
94283,750,0,1
94284,mg/day,0,0
94285,group,0,0
94286,versus,0,0
94287,480-551,0,0
94288,in,0,0
94289,the,0,0
94290,"1,000-",0,0
94291,and,0,0
94292,"2,000-mg/day",0,1
94293,arms,0,0
94294,",",0,0
94295,respectively,0,0
94296,.,0,0
94297,Change,0,0
94298,from,0,0
94299,baseline,0,0
94300,in,0,0
94301,the,0,0
94302,vitality,0,0
94303,subscale,0,0
94304,of,0,0
94305,the,0,0
94306,SF-36,0,1
94307,was,0,0
94308,7.3-7.8,0,0
94309,in,0,0
94310,the,0,0
94311,placebo,1,1
94312,and,0,0
94313,the,0,0
94314,750-mg/day,0,1
94315,arm,0,0
94316,",",0,0
94317,versus,0,0
94318,10.5-14.6,0,0
94319,in,0,0
94320,the,0,0
94321,"1,000-",0,0
94322,and,0,0
94323,"2,000-mg/day",0,1
94324,arms,0,0
94325,.,0,0
94326,Over,0,0
94327,twice,0,0
94328,as,0,0
94329,many,0,0
94330,patients,0,0
94331,on,0,0
94332,ginseng,1,1
94333,perceived,0,0
94334,a,0,0
94335,benefit,0,0
94336,and,0,0
94337,were,0,0
94338,satisfied,0,0
94339,with,0,0
94340,treatment,0,0
94341,over,0,0
94342,those,0,0
94343,on,0,0
94344,placebo,1,1
94345,.,1,0
94346,There,0,0
94347,were,0,0
94348,no,0,0
94349,significant,0,0
94350,differences,0,0
94351,in,0,0
94352,any,0,0
94353,measured,0,0
94354,toxicities,0,0
94355,between,0,0
94356,any,0,0
94357,of,0,0
94358,the,0,0
94359,arms,0,0
94360,.,0,0
94361,CONCLUSION,0,0
94362,There,0,0
94363,appears,0,0
94364,to,0,0
94365,be,0,0
94366,some,0,0
94367,activity,0,0
94368,and,0,0
94369,tolerable,0,0
94370,toxicity,0,0
94371,at,0,0
94372,"1,000-2,000",0,0
94373,mg/day,0,0
94374,doses,0,0
94375,of,0,0
94376,American,1,0
94377,ginseng,1,1
94378,with,0,0
94379,regard,0,0
94380,to,0,0
94381,cancer-related,0,0
94382,fatigue,0,0
94383,.,0,0
94384,Thus,0,0
94385,",",0,0
94386,further,0,0
94387,study,0,0
94388,of,0,0
94389,American,1,0
94390,ginseng,1,1
94391,is,0,0
94392,warranted,0,0
94393,.,0,0
94394,Adjuvant,0,1
94395,therapy,0,1
94396,with,0,0
94397,pegylated,0,1
94398,interferon,0,1
94399,alfa-2b,0,1
94400,versus,0,0
94401,observation,0,0
94402,in,0,0
94403,resected,0,0
94404,stage,0,0
94405,III,0,0
94406,melanoma,0,0
94407,:,0,0
94408,a,0,0
94409,phase,0,0
94410,III,0,0
94411,randomized,0,0
94412,controlled,0,0
94413,trial,0,0
94414,of,0,0
94415,health-related,0,0
94416,quality,0,0
94417,of,0,0
94418,life,0,0
94419,and,0,0
94420,symptoms,0,0
94421,by,0,0
94422,the,0,0
94423,European,0,0
94424,Organisation,0,0
94425,for,0,0
94426,Research,0,0
94427,and,0,0
94428,Treatment,0,0
94429,of,0,0
94430,Cancer,0,0
94431,Melanoma,0,0
94432,Group,0,0
94433,.,0,0
94434,PURPOSE,0,0
94435,Interferon,0,1
94436,(,0,0
94437,IFN,0,0
94438,),0,0
94439,-based,0,1
94440,adjuvant,0,1
94441,therapy,0,1
94442,in,0,0
94443,melanoma,0,0
94444,is,0,0
94445,associated,0,0
94446,with,0,0
94447,significant,0,0
94448,side,0,0
94449,effects,0,0
94450,",",0,0
94451,which,0,0
94452,necessitates,0,0
94453,evaluation,0,0
94454,of,0,0
94455,health-related,0,0
94456,quality,0,0
94457,of,0,0
94458,life,0,0
94459,(,0,0
94460,HRQOL,0,0
94461,),0,0
94462,.,0,0
94463,Our,0,0
94464,trial,0,0
94465,examined,0,0
94466,the,0,0
94467,HRQOL,0,0
94468,effects,0,0
94469,of,0,0
94470,adjuvant,0,1
94471,pegylated,0,1
94472,IFN-alpha-2b,0,1
94473,(,0,0
94474,PEG-IFN-alpha-2b,0,1
94475,),0,1
94476,versus,0,0
94477,observation,0,0
94478,in,0,0
94479,patients,0,0
94480,with,0,0
94481,stage,0,0
94482,III,0,0
94483,melanoma,0,0
94484,.,0,0
94485,METHODS,0,0
94486,A,0,0
94487,total,0,0
94488,of,0,0
94489,"1,256",0,0
94490,patients,0,0
94491,with,0,0
94492,stage,0,0
94493,III,0,0
94494,melanoma,0,0
94495,were,0,0
94496,randomly,0,0
94497,assigned,0,0
94498,after,1,0
94499,full,1,0
94500,lymphadenectomy,1,0
94501,to,1,0
94502,receive,1,0
94503,either,1,1
94504,observation,1,0
94505,(,1,0
94506,n,1,0
94507,=,1,0
94508,629,1,0
94509,),1,0
94510,or,1,1
94511,PEG-IFN-alpha-2b,1,1
94512,(,1,0
94513,n,1,0
94514,=,1,0
94515,627,1,0
94516,),1,0
94517,:,1,0
94518,induction,1,0
94519,6,1,0
94520,micrograms/kg/wk,1,0
94521,[,1,0
94522,DOSAGE,1,0
94523,ERROR,1,1
94524,CORRECTED,1,0
94525,],1,0
94526,for,1,0
94527,8,1,0
94528,weeks,1,0
94529,then,1,0
94530,maintenance,1,0
94531,3,1,0
94532,micrograms/kg/wk,1,0
94533,[,1,0
94534,DOSAGE,1,0
94535,ERROR,1,1
94536,CORRECTED,1,0
94537,],1,0
94538,for,1,0
94539,an,1,0
94540,intended,1,0
94541,total,1,0
94542,duration,1,0
94543,of,1,0
94544,5,1,0
94545,years,1,0
94546,.,1,0
94547,The,0,0
94548,European,1,0
94549,Organisation,1,0
94550,for,1,0
94551,Research,1,0
94552,and,1,0
94553,Treatment,1,0
94554,of,1,0
94555,Cancer,1,0
94556,Quality,1,0
94557,of,1,0
94558,Life,1,0
94559,Questionnaire,1,0
94560,C30,1,0
94561,was,0,0
94562,used,0,0
94563,to,0,0
94564,assess,0,0
94565,HRQOL,0,0
94566,.,0,0
94567,RESULTS,0,0
94568,At,0,0
94569,3.8,0,0
94570,years,0,0
94571,of,0,0
94572,median,0,0
94573,follow-up,0,0
94574,",",0,0
94575,for,0,0
94576,the,0,0
94577,primary,0,0
94578,end,0,0
94579,point,0,0
94580,",",0,0
94581,recurrence-free,0,0
94582,survival,0,0
94583,(,0,0
94584,RFS,0,1
94585,),0,0
94586,",",0,0
94587,risk,0,0
94588,was,0,0
94589,reduced,0,0
94590,by,0,0
94591,18,0,0
94592,%,0,0
94593,(,0,0
94594,hazard,0,0
94595,rate,0,0
94596,=,0,0
94597,0.82,0,0
94598,;,0,0
94599,P,0,0
94600,=,0,0
94601,.01,0,0
94602,),0,0
94603,in,0,0
94604,the,0,0
94605,PEG-IFN-alpha-2b,0,1
94606,arm,0,0
94607,compared,0,0
94608,with,0,0
94609,observation,0,0
94610,.,0,0
94611,Significant,0,0
94612,and,0,0
94613,clinically,0,0
94614,meaningful,0,0
94615,differences,0,0
94616,occurred,0,0
94617,with,0,0
94618,the,0,0
94619,PEG-IFN-alpha-2b,0,1
94620,treatment,0,0
94621,arm,0,0
94622,compared,0,0
94623,with,0,0
94624,the,0,0
94625,observation,0,0
94626,group,0,0
94627,",",0,0
94628,showing,0,0
94629,decreased,0,0
94630,global,0,0
94631,HRQOL,0,0
94632,at,0,0
94633,month,0,0
94634,3,0,0
94635,(,0,0
94636,-11.6,0,0
94637,points,0,0
94638,;,0,0
94639,99,0,0
94640,%,0,0
94641,CI,0,0
94642,",",0,0
94643,-8.2,0,0
94644,to,0,0
94645,-15.0,0,0
94646,),0,0
94647,and,0,0
94648,year,0,0
94649,2,0,0
94650,(,0,0
94651,-10.5,0,0
94652,points,0,0
94653,;,0,0
94654,99,0,0
94655,%,0,0
94656,CI,0,0
94657,",",0,0
94658,-6.6,0,0
94659,to,0,0
94660,-14.4,0,0
94661,),0,0
94662,.,0,0
94663,Many,0,0
94664,of,0,0
94665,the,0,0
94666,other,0,0
94667,scales,0,0
94668,showed,0,0
94669,statistically,0,0
94670,significant,0,0
94671,differences,0,0
94672,between,0,0
94673,scores,0,0
94674,when,0,0
94675,comparing,0,0
94676,the,0,0
94677,two,0,0
94678,arms,0,0
94679,.,0,0
94680,From,0,0
94681,a,0,0
94682,clinical,0,0
94683,point,0,0
94684,of,0,0
94685,view,0,0
94686,",",0,0
94687,important,0,0
94688,differences,0,0
94689,were,0,0
94690,found,0,0
94691,for,0,0
94692,five,0,0
94693,scales,0,0
94694,:,0,0
94695,two,0,0
94696,functioning,0,0
94697,scales,0,0
94698,(,0,0
94699,social,0,0
94700,and,0,0
94701,role,0,0
94702,functioning,0,0
94703,),0,0
94704,and,0,0
94705,three,0,0
94706,symptom,0,0
94707,scales,0,0
94708,(,0,0
94709,appetite,0,0
94710,loss,0,0
94711,",",0,0
94712,fatigue,0,0
94713,",",0,0
94714,and,0,0
94715,dyspnea,0,0
94716,),0,0
94717,",",0,0
94718,with,0,0
94719,the,0,0
94720,PEG-IFN-alpha-2b,0,1
94721,arm,0,0
94722,being,0,0
94723,most,0,0
94724,impaired,0,0
94725,.,0,0
94726,CONCLUSION,0,0
94727,PEG-IFN-alpha-2b,0,1
94728,leads,0,0
94729,to,0,0
94730,a,0,0
94731,significant,0,0
94732,and,0,0
94733,sustained,0,0
94734,improvement,0,0
94735,in,0,0
94736,RFS,0,0
94737,.,0,0
94738,There,0,0
94739,is,0,0
94740,an,0,0
94741,expected,0,0
94742,negative,0,0
94743,effect,0,0
94744,on,0,0
94745,global,0,0
94746,HRQOL,0,0
94747,and,0,0
94748,selected,0,0
94749,symptoms,0,0
94750,when,0,0
94751,patients,0,0
94752,undergo,0,0
94753,PEG-IFN-alpha-2b,0,1
94754,treatment,0,0
94755,.,0,0
94756,The,0,0
94757,ADDITION-Cambridge,0,0
94758,trial,0,0
94759,protocol,0,0
94760,:,0,0
94761,a,0,0
94762,cluster,0,0
94763,--,0,0
94764,randomised,0,0
94765,controlled,0,0
94766,trial,0,0
94767,of,0,0
94768,screening,0,0
94769,for,0,0
94770,type,0,0
94771,2,0,0
94772,diabetes,0,0
94773,and,0,0
94774,intensive,0,1
94775,treatment,0,0
94776,for,0,0
94777,screen-detected,0,0
94778,patients,0,0
94779,.,0,0
94780,BACKGROUND,0,0
94781,The,0,0
94782,increasing,0,0
94783,prevalence,0,0
94784,of,0,0
94785,type,0,0
94786,2,0,0
94787,diabetes,0,0
94788,poses,0,0
94789,a,0,0
94790,major,0,0
94791,public,0,0
94792,health,0,0
94793,challenge,0,0
94794,.,0,0
94795,Population-based,0,0
94796,screening,0,0
94797,and,0,0
94798,early,0,0
94799,treatment,0,0
94800,for,0,0
94801,type,0,0
94802,2,0,0
94803,diabetes,0,0
94804,could,0,0
94805,reduce,0,0
94806,this,0,0
94807,growing,0,0
94808,burden,0,0
94809,.,0,0
94810,However,0,0
94811,",",0,0
94812,the,0,0
94813,benefits,0,0
94814,of,0,0
94815,such,0,0
94816,a,0,0
94817,strategy,0,0
94818,remain,0,0
94819,uncertain,0,0
94820,.,0,0
94821,METHODS,0,0
94822,AND,0,0
94823,DESIGN,0,0
94824,The,0,0
94825,ADDITION-Cambridge,0,0
94826,study,0,0
94827,aims,0,0
94828,to,0,0
94829,evaluate,0,0
94830,the,0,0
94831,effectiveness,0,0
94832,and,0,0
94833,cost-effectiveness,0,0
94834,of,0,0
94835,(,0,0
94836,i,0,0
94837,),0,0
94838,a,0,0
94839,stepwise,1,0
94840,screening,1,0
94841,strategy,1,0
94842,for,1,0
94843,type,1,0
94844,2,1,0
94845,diabetes,1,0
94846,;,1,0
94847,and,0,0
94848,(,0,0
94849,ii,0,0
94850,),0,0
94851,intensive,1,1
94852,multifactorial,1,0
94853,treatment,1,0
94854,for,1,0
94855,people,1,0
94856,with,1,0
94857,screen-detected,1,0
94858,diabetes,1,0
94859,in,1,0
94860,primary,1,0
94861,care,1,0
94862,.,1,0
94863,63,0,0
94864,practices,0,0
94865,in,0,0
94866,the,0,0
94867,East,0,1
94868,Anglia,0,0
94869,region,0,0
94870,participated,0,0
94871,.,0,0
94872,Three,0,0
94873,undertook,0,0
94874,the,0,0
94875,pilot,0,0
94876,study,0,0
94877,",",0,0
94878,33,0,0
94879,were,0,0
94880,allocated,0,0
94881,to,0,0
94882,three,0,0
94883,groups,0,0
94884,:,0,0
94885,no,1,0
94886,screening,1,0
94887,(,1,0
94888,control,1,1
94889,),1,0
94890,",",1,0
94891,screening,1,0
94892,followed,1,0
94893,by,1,0
94894,intensive,1,1
94895,treatment,1,0
94896,(,1,0
94897,IT,1,0
94898,),1,1
94899,and,1,0
94900,screening,1,1
94901,plus,1,1
94902,routine,1,1
94903,care,1,1
94904,(,0,0
94905,RC,0,1
94906,),0,0
94907,in,0,0
94908,an,0,0
94909,unbalanced,0,0
94910,(,0,0
94911,1:3:3,0,0
94912,),0,0
94913,randomisation,0,0
94914,.,0,0
94915,The,0,0
94916,remaining,0,0
94917,27,0,0
94918,practices,0,0
94919,were,0,0
94920,randomly,0,0
94921,allocated,0,0
94922,to,0,0
94923,IT,0,0
94924,and,0,0
94925,RC,0,1
94926,.,0,0
94927,A,0,0
94928,risk,0,0
94929,score,0,0
94930,incorporating,0,0
94931,routine,0,0
94932,practice,0,0
94933,data,0,0
94934,was,0,0
94935,used,0,0
94936,to,0,0
94937,identify,0,0
94938,people,0,0
94939,aged,0,0
94940,40-69,0,0
94941,years,0,0
94942,at,0,0
94943,high-risk,0,0
94944,of,0,0
94945,undiagnosed,0,0
94946,diabetes,0,0
94947,.,0,0
94948,In,0,0
94949,the,0,0
94950,screening,0,0
94951,practices,0,0
94952,",",0,0
94953,high-risk,0,0
94954,individuals,0,0
94955,were,0,0
94956,invited,0,0
94957,to,0,0
94958,take,0,0
94959,part,0,0
94960,in,0,0
94961,a,0,0
94962,stepwise,0,0
94963,screening,0,0
94964,programme,0,1
94965,.,0,0
94966,In,0,0
94967,the,0,0
94968,IT,0,0
94969,group,0,0
94970,",",0,0
94971,diabetes,0,0
94972,treatment,0,0
94973,is,0,0
94974,optimised,0,0
94975,through,0,0
94976,guidelines,0,0
94977,",",0,0
94978,target-led,0,0
94979,multifactorial,0,0
94980,treatment,0,0
94981,",",0,0
94982,audit,0,0
94983,",",0,0
94984,feedback,0,1
94985,",",0,0
94986,and,0,0
94987,academic,0,0
94988,detailing,0,0
94989,for,0,0
94990,practice,0,0
94991,teams,0,0
94992,",",0,0
94993,alongside,0,0
94994,provision,0,1
94995,of,0,0
94996,educational,0,1
94997,materials,0,0
94998,for,0,0
94999,newly,0,0
95000,diagnosed,0,0
95001,participants,0,0
95002,.,0,0
95003,Primary,0,0
95004,endpoints,0,0
95005,are,0,0
95006,modelled,0,0
95007,cardiovascular,0,0
95008,risk,0,0
95009,at,0,0
95010,one,0,0
95011,year,0,0
95012,",",0,0
95013,and,0,0
95014,cardiovascular,0,0
95015,mortality,0,0
95016,and,0,0
95017,morbidity,0,0
95018,at,0,0
95019,five,0,0
95020,years,0,0
95021,after,0,0
95022,diagnosis,0,0
95023,of,0,0
95024,diabetes,0,0
95025,.,0,0
95026,Secondary,0,0
95027,endpoints,0,0
95028,include,0,0
95029,all-cause,0,0
95030,mortality,0,0
95031,",",0,0
95032,development,0,0
95033,of,0,0
95034,renal,0,0
95035,and,0,0
95036,visual,0,0
95037,impairment,0,0
95038,",",0,0
95039,peripheral,0,0
95040,neuropathy,0,0
95041,",",0,0
95042,health,0,0
95043,service,0,0
95044,costs,0,0
95045,",",0,0
95046,self-reported,0,0
95047,quality,0,0
95048,of,0,0
95049,life,0,0
95050,",",0,0
95051,functional,0,0
95052,status,0,0
95053,and,0,0
95054,health,0,0
95055,utility,0,0
95056,.,0,0
95057,Impact,0,0
95058,of,0,0
95059,the,0,0
95060,screening,0,0
95061,programme,0,1
95062,at,0,0
95063,the,0,0
95064,population,0,0
95065,level,0,0
95066,is,0,0
95067,also,0,0
95068,assessed,0,0
95069,through,0,0
95070,measures,0,0
95071,of,0,0
95072,mortality,0,0
95073,",",0,0
95074,cardiovascular,0,0
95075,morbidity,0,0
95076,",",0,0
95077,health,0,0
95078,status,0,0
95079,and,0,0
95080,health,0,0
95081,service,0,0
95082,use,0,0
95083,among,0,0
95084,high-risk,0,0
95085,individuals,0,0
95086,.,0,0
95087,DISCUSSION,0,0
95088,ADDITION-Cambridge,0,0
95089,is,0,0
95090,conducted,0,0
95091,in,0,0
95092,a,0,0
95093,defined,0,0
95094,high-risk,0,0
95095,group,0,0
95096,accessible,0,0
95097,through,0,0
95098,primary,0,0
95099,care,0,0
95100,.,0,0
95101,It,0,0
95102,addresses,0,0
95103,the,0,0
95104,feasibility,0,0
95105,of,0,0
95106,population-based,0,0
95107,screening,0,0
95108,for,0,0
95109,diabetes,0,0
95110,",",0,0
95111,as,0,0
95112,well,0,0
95113,as,0,0
95114,the,0,0
95115,benefits,0,0
95116,and,0,0
95117,costs,0,0
95118,of,0,0
95119,screening,0,0
95120,and,0,0
95121,intensive,0,1
95122,multifactorial,0,0
95123,treatment,0,0
95124,early,0,0
95125,in,0,0
95126,the,0,0
95127,disease,0,0
95128,trajectory,0,0
95129,.,0,0
95130,The,0,0
95131,intensive,0,1
95132,treatment,0,0
95133,algorithm,0,0
95134,is,0,0
95135,based,0,0
95136,on,0,0
95137,evidence,0,0
95138,from,0,0
95139,studies,0,0
95140,including,0,0
95141,individuals,0,0
95142,with,0,0
95143,clinically,0,0
95144,diagnosed,0,0
95145,diabetes,0,0
95146,and,0,0
95147,the,0,0
95148,education,0,1
95149,materials,0,0
95150,are,0,0
95151,informed,0,0
95152,by,0,0
95153,psychological,0,0
95154,theory,0,0
95155,.,0,0
95156,ADDITION-Cambridge,0,0
95157,will,0,0
95158,provide,0,0
95159,timely,0,0
95160,evidence,0,0
95161,concerning,0,0
95162,the,0,0
95163,benefits,0,0
95164,of,0,0
95165,early,0,0
95166,intensive,0,1
95167,treatment,0,0
95168,and,0,0
95169,will,0,0
95170,inform,0,0
95171,policy,0,0
95172,decisions,0,0
95173,concerning,0,0
95174,screening,0,0
95175,for,0,0
95176,type,0,0
95177,2,0,0
95178,diabetes,0,0
95179,.,0,0
95180,TRIAL,0,0
95181,REGISTRATION,0,0
95182,Current,0,0
95183,Controlled,0,0
95184,trials,0,0
95185,ISRCTN86769081,0,0
95186,.,0,0
95187,Efficacy,0,0
95188,of,0,0
95189,chlorhexidine,1,1
95190,gluconate,1,1
95191,use,0,0
95192,in,0,0
95193,the,0,0
95194,prevention,0,0
95195,of,0,0
95196,perirectal,0,0
95197,infections,0,0
95198,in,0,0
95199,patients,0,0
95200,with,0,0
95201,acute,0,0
95202,leukemia,0,0
95203,.,0,0
95204,The,0,0
95205,frequency,0,0
95206,of,0,0
95207,rectal,0,0
95208,infections,0,0
95209,is,0,0
95210,increased,0,0
95211,in,0,0
95212,patients,0,0
95213,with,0,0
95214,acute,0,0
95215,leukemia,0,0
95216,.,0,0
95217,Complications,0,0
95218,associated,0,0
95219,with,0,0
95220,rectal,0,0
95221,lesions,0,0
95222,may,0,0
95223,be,0,0
95224,severe,0,0
95225,enough,0,0
95226,to,0,0
95227,cause,0,0
95228,life-threatening,0,0
95229,septicemia,0,0
95230,.,0,0
95231,Clinical,0,0
95232,research,0,0
95233,evaluating,0,0
95234,the,0,0
95235,effects,0,0
95236,of,0,0
95237,preventive,0,0
95238,perirectal,0,0
95239,skin,0,0
95240,care,0,1
95241,is,0,0
95242,scarce,0,0
95243,.,0,0
95244,This,0,0
95245,study,0,0
95246,'s,0,0
95247,purpose,0,0
95248,was,0,0
95249,to,0,0
95250,determine,0,0
95251,whether,0,0
95252,using,0,0
95253,chlorhexidine,1,1
95254,gluconate,1,1
95255,(,1,0
95256,CHG,1,0
95257,),1,0
95258,in,0,0
95259,a,0,0
95260,prophylactic,0,0
95261,perirectal,0,0
95262,skin-care,0,0
95263,regimen,0,1
95264,decreases,0,0
95265,perirectal,0,0
95266,infections,0,0
95267,and,0,0
95268,whether,0,0
95269,it,0,0
95270,produces,0,0
95271,more,0,0
95272,skin,0,0
95273,irritation,0,0
95274,than,0,0
95275,a,0,0
95276,nonmedicated,0,0
95277,skin,0,0
95278,cleanser,0,1
95279,.,0,0
95280,The,0,0
95281,sample,0,0
95282,consisted,0,0
95283,of,0,0
95284,40,0,0
95285,patients,0,0
95286,",",0,0
95287,16,0,0
95288,of,0,0
95289,whom,0,0
95290,were,0,0
95291,randomized,0,0
95292,to,0,0
95293,use,0,0
95294,chlorhexidine,1,1
95295,and,0,0
95296,24,0,0
95297,of,0,0
95298,whom,0,0
95299,were,0,0
95300,randomized,0,0
95301,to,0,0
95302,use,0,0
95303,nonmedicated,1,0
95304,skin,1,0
95305,cleanser,1,1
95306,.,1,0
95307,Chi-square,0,0
95308,and,0,0
95309,t-tests,0,0
95310,were,0,0
95311,used,0,0
95312,to,0,0
95313,analyze,0,0
95314,the,0,0
95315,incidence,0,0
95316,of,0,0
95317,skin,0,0
95318,breakdown,0,0
95319,and,0,0
95320,rectal,0,0
95321,infections,0,0
95322,;,0,0
95323,the,0,0
95324,correlation,0,0
95325,between,0,0
95326,the,0,0
95327,two,0,0
95328,factors,0,0
95329,;,0,0
95330,a,0,0
95331,positive,0,0
95332,history,0,0
95333,of,0,0
95334,rectal,0,0
95335,infections,0,0
95336,",",0,0
95337,fissures,0,0
95338,",",0,0
95339,or,0,0
95340,hemorrhoids,0,0
95341,;,0,0
95342,presence,0,0
95343,of,0,0
95344,hemorrhoids,0,0
95345,;,0,0
95346,severity,0,0
95347,of,0,0
95348,diarrhea,0,0
95349,;,0,0
95350,and,0,0
95351,duration,0,0
95352,and,0,0
95353,severity,0,0
95354,of,0,0
95355,granulocytopenia,0,0
95356,.,0,0
95357,A,0,0
95358,positive,0,0
95359,relationship,0,0
95360,was,0,0
95361,found,0,0
95362,between,0,0
95363,the,0,0
95364,severity,0,0
95365,of,0,0
95366,granulocytopenia,0,0
95367,and,0,0
95368,the,0,0
95369,incidence,0,0
95370,of,0,0
95371,rectal,0,0
95372,infections,0,0
95373,(,0,0
95374,p,0,0
95375,=,0,0
95376,0.02,0,0
95377,),0,0
95378,.,0,0
95379,No,0,0
95380,significant,0,0
95381,difference,0,0
95382,was,0,0
95383,seen,0,0
95384,in,0,0
95385,the,0,0
95386,occurrence,0,0
95387,of,0,0
95388,perirectal,0,0
95389,infections,0,0
95390,(,0,0
95391,p,0,0
95392,=,0,0
95393,0.35,0,0
95394,),0,0
95395,or,0,0
95396,skin,0,0
95397,breakdown,0,0
95398,(,0,0
95399,p,0,0
95400,=,0,0
95401,0.18,0,0
95402,),0,0
95403,between,0,0
95404,the,0,0
95405,two,0,0
95406,groups,0,0
95407,.,0,0
95408,The,0,0
95409,data,0,0
95410,suggest,0,0
95411,that,0,0
95412,CHG,0,0
95413,does,0,0
95414,not,0,0
95415,offer,0,0
95416,increased,0,0
95417,protection,0,0
95418,against,0,0
95419,perirectal,0,0
95420,infections,0,0
95421,in,0,0
95422,patients,0,0
95423,undergoing,0,0
95424,intensive,0,1
95425,chemotherapy,0,1
95426,",",0,0
95427,nor,0,0
95428,is,0,0
95429,it,0,0
95430,more,0,0
95431,irritating,0,0
95432,than,0,0
95433,a,0,0
95434,nonmedicated,0,0
95435,skin,0,0
95436,cleanser,0,1
95437,.,0,0
95438,Further,0,0
95439,studies,0,0
95440,are,0,0
95441,needed,0,0
95442,to,0,0
95443,examine,0,0
95444,the,0,0
95445,efficacy,0,0
95446,of,0,0
95447,hygienic,0,1
95448,measures,0,0
95449,such,0,0
95450,as,0,0
95451,using,0,0
95452,skin,0,0
95453,disinfectants,0,1
95454,to,0,0
95455,prevent,0,0
95456,infections,0,0
95457,in,0,0
95458,patients,0,0
95459,who,0,0
95460,are,0,0
95461,immunocompromised,0,0
95462,.,0,0
95463,Randomized,0,0
95464,clinical,0,0
95465,trial,0,0
95466,of,0,0
95467,balance-based,0,1
95468,torso,1,0
95469,weighting,1,1
95470,for,0,0
95471,improving,0,0
95472,upright,0,1
95473,mobility,0,0
95474,in,0,0
95475,people,0,0
95476,with,0,0
95477,multiple,0,0
95478,sclerosis,0,0
95479,.,0,0
95480,BACKGROUND,0,0
95481,Torso,0,0
95482,weighting,0,1
95483,has,0,0
95484,sometimes,0,0
95485,been,0,0
95486,effective,0,0
95487,for,0,0
95488,improving,0,0
95489,upright,0,1
95490,mobility,0,0
95491,in,0,0
95492,people,0,0
95493,with,0,0
95494,multiple,0,0
95495,sclerosis,0,0
95496,",",0,0
95497,but,0,0
95498,parameters,0,0
95499,for,0,0
95500,weighting,0,0
95501,have,0,0
95502,been,0,0
95503,inconsistent,0,0
95504,.,0,0
95505,OBJECTIVE,0,0
95506,To,0,0
95507,determine,0,0
95508,whether,0,0
95509,balance-based,1,1
95510,torso,1,1
95511,weighting,1,1
95512,(,1,0
95513,BBTW,1,1
95514,),1,1
95515,has,0,0
95516,immediate,0,0
95517,effects,0,0
95518,on,0,0
95519,upright,0,1
95520,mobility,0,0
95521,in,0,0
95522,people,0,0
95523,with,0,0
95524,multiple,0,0
95525,sclerosis,0,0
95526,.,0,0
95527,METHODS,0,0
95528,This,0,0
95529,was,0,0
95530,a,0,0
95531,2-phase,0,0
95532,randomized,0,0
95533,clinical,0,0
95534,trial,0,0
95535,.,0,0
95536,In,0,0
95537,phase,0,0
95538,1,0,0
95539,",",0,0
95540,36,0,0
95541,participants,0,0
95542,were,0,0
95543,randomly,0,0
95544,assigned,0,0
95545,to,0,0
95546,experimental,0,0
95547,and,0,0
95548,control,0,0
95549,groups,0,0
95550,.,0,0
95551,In,0,0
95552,phase,0,0
95553,2,0,0
95554,",",0,0
95555,the,0,0
95556,control,0,0
95557,group,0,0
95558,was,0,0
95559,subsequently,0,0
95560,randomized,0,0
95561,into,0,0
95562,2,0,0
95563,groups,0,0
95564,with,0,0
95565,alternate,0,0
95566,weight-placement,0,0
95567,.,0,0
95568,Tests,0,0
95569,of,0,0
95570,upright,0,1
95571,mobility,0,0
95572,included,0,0
95573,:,0,0
95574,timed,0,0
95575,up,0,0
95576,and,0,0
95577,go,0,1
95578,(,0,0
95579,TUG,0,0
95580,),0,0
95581,",",0,0
95582,sharpened,0,0
95583,Romberg,0,0
95584,",",0,0
95585,360-degree,0,1
95586,turns,0,0
95587,",",0,0
95588,25-foot,0,1
95589,walk,0,1
95590,",",0,0
95591,and,0,0
95592,computerized,1,1
95593,platform,1,1
95594,posturography,1,0
95595,.,1,0
95596,Participants,0,0
95597,were,0,0
95598,tested,0,0
95599,at,0,0
95600,baseline,0,0
95601,and,0,0
95602,again,0,0
95603,with,0,0
95604,weights,0,0
95605,placed,0,0
95606,according,0,0
95607,to,0,0
95608,group,0,0
95609,membership,0,0
95610,.,0,0
95611,In,0,0
95612,both,0,0
95613,phases,0,0
95614,",",0,0
95615,a,0,0
95616,physical,0,0
95617,therapist,0,1
95618,assessed,0,0
95619,balance,0,0
95620,for,0,0
95621,the,0,0
95622,BBTW,0,1
95623,group,0,0
95624,and,0,0
95625,then,0,0
95626,placed,0,0
95627,weights,0,0
95628,to,0,0
95629,decrease,0,0
95630,balance,0,0
95631,loss,0,0
95632,.,0,0
95633,In,0,0
95634,phase,0,0
95635,1,0,0
95636,",",0,0
95637,the,0,0
95638,control,0,0
95639,group,0,0
95640,had,0,0
95641,no,0,0
95642,weights,0,0
95643,placed,0,0
95644,.,0,0
95645,In,0,0
95646,phase,0,0
95647,2,0,0
95648,",",0,0
95649,the,0,0
95650,alternate,0,1
95651,treatment,0,0
95652,group,0,0
95653,received,0,0
95654,standard,0,1
95655,weight,0,0
95656,placement,0,0
95657,of,0,0
95658,1.5,0,0
95659,%,0,0
95660,body,0,0
95661,weight,0,0
95662,.,0,0
95663,RESULTS,0,0
95664,People,0,0
95665,with,0,0
95666,BBTW,1,0
95667,showed,0,0
95668,a,0,0
95669,significant,0,0
95670,improvement,0,0
95671,in,0,0
95672,the,0,0
95673,25-foot,0,1
95674,walk,0,1
95675,(,0,0
95676,P,0,0
95677,=,0,0
95678,.01,0,0
95679,),0,0
95680,over,0,0
95681,those,0,0
95682,with,0,0
95683,no,0,0
95684,weight,0,0
95685,",",0,0
95686,and,0,0
95687,the,0,0
95688,TUG,0,0
95689,(,0,0
95690,P,0,0
95691,=,0,0
95692,.01,0,0
95693,),0,0
95694,over,0,0
95695,those,0,0
95696,with,0,0
95697,standard,0,1
95698,weight,0,0
95699,placement,0,1
95700,.,0,0
95701,BBTW,0,0
95702,participants,0,0
95703,received,0,0
95704,an,0,0
95705,average,0,0
95706,of,0,0
95707,0.5,0,0
95708,kg,0,0
95709,",",0,0
95710,less,0,0
95711,than,0,0
95712,1.5,0,0
95713,%,0,0
95714,of,0,0
95715,any,0,0
95716,participant,0,0
95717,'s,0,0
95718,body,0,0
95719,weight,0,0
95720,.,0,0
95721,CONCLUSION,0,0
95722,BBTW,1,0
95723,can,0,0
95724,have,0,0
95725,immediate,0,0
95726,advantages,0,0
95727,over,0,0
95728,a,0,0
95729,nonweighted,0,0
95730,condition,0,0
95731,for,0,0
95732,gait,0,0
95733,velocity,0,0
95734,and,0,0
95735,over,0,0
95736,a,0,0
95737,standardized,0,0
95738,weighted,0,0
95739,condition,0,0
95740,for,0,0
95741,a,0,0
95742,functional,0,0
95743,activity,0,0
95744,in,0,0
95745,people,0,0
95746,with,0,0
95747,multiple,0,0
95748,sclerosis,0,0
95749,(,0,0
95750,MS,0,0
95751,),0,0
95752,who,0,0
95753,are,0,0
95754,ambulatory,0,0
95755,but,0,0
95756,have,0,0
95757,balance,0,0
95758,and,0,0
95759,mobility,0,0
95760,abnormalities,0,0
95761,.,0,0
95762,Effects,0,0
95763,of,0,0
95764,weight-bearing,1,0
95765,versus,1,0
95766,nonweight-bearing,1,1
95767,exercise,1,1
95768,on,0,0
95769,function,0,0
95770,",",0,0
95771,walking,0,0
95772,speed,0,0
95773,",",0,0
95774,and,0,0
95775,position,0,0
95776,sense,0,0
95777,in,0,0
95778,participants,0,0
95779,with,0,0
95780,knee,0,0
95781,osteoarthritis,0,0
95782,:,0,0
95783,a,0,0
95784,randomized,0,0
95785,controlled,0,0
95786,trial,0,0
95787,.,0,0
95788,OBJECTIVE,0,0
95789,To,0,0
95790,investigate,0,0
95791,whether,0,0
95792,weight-bearing,1,1
95793,(,1,0
95794,WB,1,0
95795,),1,0
95796,exercise,1,1
95797,enhances,0,0
95798,functional,0,0
95799,capacity,0,0
95800,to,0,0
95801,a,0,0
95802,greater,0,0
95803,extent,0,0
95804,than,0,0
95805,nonweight-bearing,1,1
95806,(,1,0
95807,NWB,1,1
95808,),1,0
95809,exercise,1,1
95810,in,0,0
95811,participants,0,0
95812,with,0,0
95813,knee,0,0
95814,osteoarthritis,0,0
95815,.,0,0
95816,DESIGN,0,0
95817,Randomized,0,0
95818,controlled,0,0
95819,trial,0,0
95820,.,0,0
95821,SETTING,0,0
95822,Kinesiology,0,1
95823,laboratory,0,0
95824,.,0,0
95825,PARTICIPANTS,0,0
95826,Participants,0,0
95827,(,0,0
95828,N=106,0,0
95829,),0,0
95830,were,0,0
95831,randomly,0,0
95832,assigned,0,0
95833,to,0,0
95834,WB,1,0
95835,exercise,1,1
95836,",",1,0
95837,NWB,1,1
95838,exercise,1,1
95839,",",0,0
95840,or,0,0
95841,a,0,0
95842,control,1,1
95843,group,1,0
95844,(,1,0
95845,no,1,0
95846,exercise,1,1
95847,),1,0
95848,.,1,0
95849,INTERVENTION,0,0
95850,WB,1,0
95851,exercise,1,1
95852,and,1,0
95853,NWB,1,1
95854,exercise,1,1
95855,groups,1,0
95856,underwent,1,0
95857,an,0,0
95858,8-week,1,1
95859,knee,1,0
95860,extension-flexion,1,1
95861,exercise,1,1
95862,program,1,1
95863,.,1,0
95864,MAIN,0,0
95865,OUTCOME,0,0
95866,MEASURES,0,0
95867,Western,0,1
95868,Ontario,0,0
95869,and,0,0
95870,McMaster,0,1
95871,Universities,0,0
95872,Osteoarthritis,0,0
95873,Index,0,1
95874,(,0,0
95875,WOMAC,0,1
95876,),0,1
95877,function,0,0
95878,scale,0,0
95879,",",0,0
95880,walking,0,0
95881,speed,0,0
95882,",",0,0
95883,muscle,0,0
95884,torque,0,0
95885,",",0,0
95886,and,0,0
95887,knee,0,0
95888,reposition,0,0
95889,error,0,0
95890,were,0,0
95891,assessed,0,0
95892,before,0,0
95893,and,0,0
95894,after,0,0
95895,intervention,0,1
95896,.,0,0
95897,RESULTS,0,0
95898,Equally,0,0
95899,significant,0,0
95900,improvements,0,0
95901,were,0,0
95902,apparent,0,0
95903,for,0,0
95904,all,0,0
95905,outcomes,0,0
95906,after,0,0
95907,WB,0,0
95908,exercise,0,1
95909,and,0,0
95910,NWB,0,1
95911,exercise,0,1
95912,",",0,0
95913,except,0,0
95914,for,0,0
95915,reposition,0,0
95916,error,0,0
95917,",",0,0
95918,for,0,0
95919,which,0,0
95920,improvement,0,0
95921,was,0,0
95922,greater,0,0
95923,in,0,0
95924,the,0,0
95925,WB,1,0
95926,exercise,1,1
95927,group,0,0
95928,.,0,0
95929,In,0,0
95930,contrast,0,0
95931,",",0,0
95932,there,0,0
95933,were,0,0
95934,no,0,0
95935,improvements,0,0
95936,in,0,0
95937,the,0,0
95938,control,0,0
95939,group,0,0
95940,.,0,0
95941,CONCLUSIONS,0,0
95942,Simple,0,0
95943,knee,0,0
95944,flexion,0,0
95945,and,0,0
95946,extension,0,0
95947,exercises,0,1
95948,(,1,0
95949,WB,1,0
95950,and,0,0
95951,NWB,1,1
95952,),1,0
95953,performed,0,0
95954,over,0,0
95955,8,0,0
95956,weeks,0,0
95957,resulted,0,0
95958,in,0,0
95959,significant,0,0
95960,improvement,0,0
95961,in,0,0
95962,the,0,0
95963,WOMAC,0,0
95964,function,0,0
95965,scale,0,0
95966,and,0,0
95967,knee,0,0
95968,strength,0,0
95969,compared,0,0
95970,with,0,0
95971,the,0,0
95972,control,0,0
95973,group,0,0
95974,.,0,0
95975,NWB,1,1
95976,exercise,1,0
95977,alone,0,1
95978,may,0,0
95979,be,0,0
95980,sufficient,0,0
95981,enough,0,0
95982,to,0,0
95983,improve,0,0
95984,function,0,0
95985,and,0,0
95986,muscle,0,0
95987,strength,0,0
95988,.,0,0
95989,The,0,0
95990,additional,0,0
95991,benefit,0,0
95992,of,0,0
95993,WB,1,0
95994,exercise,1,1
95995,was,0,0
95996,improved,0,0
95997,position,0,0
95998,sense,0,0
95999,",",0,0
96000,which,0,0
96001,may,0,0
96002,enhance,0,0
96003,complex,0,0
96004,walking,0,1
96005,tasks,0,1
96006,(,0,0
96007,walking,0,0
96008,on,0,0
96009,figure,0,0
96010,of,0,0
96011,8,0,0
96012,route,0,0
96013,and,0,0
96014,spongy,0,1
96015,surface,0,0
96016,),0,0
96017,.,0,0
96018,Loss,0,0
96019,of,0,0
96020,bone,0,0
96021,mineral,0,0
96022,density,0,0
96023,after,0,0
96024,antiretroviral,1,1
96025,therapy,1,1
96026,initiation,1,0
96027,",",0,0
96028,independent,0,0
96029,of,0,0
96030,antiretroviral,0,0
96031,regimen,0,0
96032,.,0,0
96033,BACKGROUND,0,0
96034,Decreased,0,0
96035,bone,0,0
96036,mineral,0,0
96037,density,0,0
96038,(,0,0
96039,BMD,0,0
96040,),0,1
96041,has,0,0
96042,been,0,0
96043,described,0,0
96044,in,0,0
96045,HIV-infected,0,0
96046,patients,0,0
96047,initiating,0,0
96048,antiretroviral,0,1
96049,therapy,0,1
96050,(,0,0
96051,ART,0,0
96052,),0,0
96053,",",0,0
96054,but,0,0
96055,the,0,0
96056,contributions,0,0
96057,of,0,0
96058,ART,0,0
96059,and,0,0
96060,immunologic,0,0
96061,and/or,0,0
96062,virologic,0,0
96063,factors,0,0
96064,remain,0,0
96065,unclear,0,0
96066,.,0,0
96067,METHODS,0,0
96068,We,0,0
96069,compared,0,0
96070,total,0,0
96071,BMD,0,0
96072,changes,0,0
96073,over,0,0
96074,96,0,0
96075,weeks,0,0
96076,in,0,0
96077,106,0,0
96078,ART-naive,0,0
96079,HIV-infected,0,0
96080,subjects,0,0
96081,who,0,0
96082,were,0,0
96083,randomized,0,0
96084,to,0,0
96085,receive,0,1
96086,efavirenz,1,1
96087,(,1,0
96088,EFV,1,1
96089,),1,0
96090,+,1,1
96091,zidovudine/lamivudine,1,1
96092,(,1,0
96093,n,1,0
96094,=,1,0
96095,32,1,0
96096,),1,0
96097,or,1,1
96098,lopinavir/ritonavir,1,1
96099,(,1,1
96100,LPV/r,1,0
96101,),1,0
96102,+,1,1
96103,zidovudine/lamivudine,1,1
96104,induction,1,1
96105,(,0,0
96106,n,0,0
96107,=,0,0
96108,74,0,0
96109,),0,0
96110,for,0,0
96111,24-48,0,0
96112,weeks,0,0
96113,followed,0,0
96114,by,0,0
96115,LPV/r,1,0
96116,monotherapy,1,1
96117,.,1,0
96118,We,0,0
96119,also,0,0
96120,sought,0,0
96121,to,0,0
96122,identify,0,0
96123,factors,0,0
96124,associated,0,0
96125,with,0,0
96126,BMD,0,0
96127,loss,0,0
96128,",",0,0
96129,including,0,0
96130,markers,0,0
96131,of,0,0
96132,systemic,0,0
96133,inflammation,0,0
96134,[,0,0
96135,soluble,0,1
96136,tumor,0,0
96137,necrosis,0,0
96138,factor-alpha,0,0
96139,receptors,0,0
96140,(,0,0
96141,sTNFR,0,0
96142,I,0,0
96143,and,0,0
96144,II,0,0
96145,),0,0
96146,],0,0
96147,.,0,0
96148,RESULTS,0,0
96149,After,0,0
96150,96,0,0
96151,weeks,0,0
96152,",",0,0
96153,the,0,0
96154,mean,0,0
96155,percent,0,0
96156,change,0,0
96157,from,0,0
96158,baseline,0,0
96159,in,0,0
96160,total,0,0
96161,BMD,0,0
96162,was,0,0
96163,-2.5,0,0
96164,%,0,0
96165,(,0,0
96166,LPV/r,0,0
96167,),0,0
96168,and,0,0
96169,-2.3,0,1
96170,%,0,0
96171,(,0,0
96172,EFV,0,1
96173,),0,1
96174,(,0,0
96175,P,0,0
96176,<,0,0
96177,0.01,0,0
96178,for,0,0
96179,within-group,0,0
96180,changes,0,0
96181,in,0,0
96182,either,0,0
96183,arm,0,0
96184,;,0,0
96185,P,0,0
96186,=,0,0
96187,0.86,0,0
96188,for,0,0
96189,between-group,0,0
96190,differences,0,0
96191,),0,0
96192,.,0,0
96193,No,0,0
96194,alteration,0,0
96195,in,0,0
96196,the,0,0
96197,rate,0,0
96198,of,0,0
96199,BMD,0,0
96200,change,0,0
96201,was,0,0
96202,observed,0,0
96203,upon,0,0
96204,simplification,0,0
96205,to,0,0
96206,LPV/r,0,0
96207,monotherapy,0,1
96208,.,0,0
96209,Although,0,0
96210,soluble,0,0
96211,tumor,0,0
96212,necrosis,0,0
96213,factor-alpha,0,0
96214,receptor,0,0
96215,II,0,0
96216,concentrations,0,0
96217,at,0,0
96218,baseline,0,0
96219,and,0,0
96220,24,0,0
96221,weeks,0,0
96222,were,0,0
96223,at,0,0
96224,least,0,0
96225,marginally,0,0
96226,associated,0,0
96227,with,0,0
96228,subsequent,0,0
96229,changes,0,0
96230,in,0,0
96231,BMD,0,0
96232,(,0,0
96233,P,0,0
96234,=,0,0
96235,0.06,0,0
96236,and,0,0
96237,P,0,0
96238,=,0,0
96239,0.028,0,0
96240,",",0,0
96241,respectively,0,0
96242,),0,0
96243,",",0,0
96244,these,0,0
96245,associations,0,0
96246,were,0,0
96247,no,0,0
96248,longer,0,0
96249,significant,0,0
96250,after,0,0
96251,adjustment,0,0
96252,for,0,0
96253,CD4,0,0
96254,T,0,0
96255,cell,0,0
96256,count,0,0
96257,.,0,0
96258,Subjects,0,0
96259,with,0,0
96260,lower,0,0
96261,baseline,0,0
96262,CD4,0,0
96263,T,0,0
96264,cell,0,0
96265,count,0,0
96266,",",0,0
96267,non-black,0,0
96268,race,0,0
96269,",",0,0
96270,and,0,0
96271,higher,0,0
96272,baseline,0,0
96273,glucose,0,0
96274,demonstrated,0,0
96275,a,0,0
96276,higher,0,0
96277,risk,0,0
96278,for,0,0
96279,>,0,0
96280,5,0,0
96281,%,0,0
96282,decrease,0,0
96283,in,0,0
96284,BMD,0,0
96285,.,0,0
96286,CONCLUSIONS,0,0
96287,Similar,0,0
96288,decreases,0,0
96289,in,0,0
96290,BMD,0,0
96291,over,0,0
96292,96,0,0
96293,weeks,0,0
96294,occurred,0,0
96295,in,0,0
96296,ART-naive,0,0
96297,subjects,0,0
96298,receiving,0,0
96299,either,0,0
96300,EFV-based,0,1
96301,regimen,0,1
96302,or,0,0
96303,LPV/r-based,0,0
96304,regimen,0,1
96305,",",0,0
96306,which,0,0
96307,was,0,0
96308,not,0,0
96309,altered,0,0
96310,by,0,0
96311,simplification,0,0
96312,to,0,0
96313,LPV/r,0,0
96314,monotherapy,0,1
96315,and,0,0
96316,was,0,0
96317,unrelated,0,0
96318,to,0,0
96319,markers,0,0
96320,of,0,0
96321,tumor,0,0
96322,necrosis,0,0
96323,factor-alpha,0,0
96324,activity,0,0
96325,.,0,0
96326,Aerobic,1,1
96327,and,1,0
96328,strength,1,0
96329,training,1,1
96330,reduces,0,0
96331,adiposity,0,0
96332,in,0,0
96333,overweight,0,0
96334,Latina,0,0
96335,adolescents,0,0
96336,.,0,0
96337,PURPOSE,0,0
96338,To,0,0
96339,date,0,0
96340,",",0,0
96341,no,0,0
96342,study,0,0
96343,has,0,0
96344,examined,0,0
96345,the,0,0
96346,synergistic,0,0
96347,effects,0,0
96348,of,0,0
96349,a,0,0
96350,nutrition,1,1
96351,and,0,0
96352,combination,1,1
96353,of,1,0
96354,aerobic,1,1
96355,and,1,0
96356,strength,1,0
96357,training,1,1
96358,(,1,0
96359,CAST,1,1
96360,),1,0
96361,on,0,0
96362,both,0,0
96363,adiposity,0,0
96364,and,0,0
96365,metabolic,0,0
96366,parameters,0,0
96367,in,0,0
96368,overweight,0,0
96369,Latina,0,0
96370,adolescent,0,0
96371,females,0,0
96372,.,0,0
96373,The,0,0
96374,goal,0,0
96375,was,0,0
96376,to,0,0
96377,assess,0,0
96378,if,0,0
96379,a,0,0
96380,16-wk,0,1
96381,nutrition,1,1
96382,plus,0,1
96383,CAST,1,1
96384,pilot,0,0
96385,study,0,0
96386,had,0,0
96387,stronger,0,0
96388,effects,0,0
96389,on,0,0
96390,reducing,0,0
96391,adiposity,0,0
96392,and,0,0
96393,on,0,0
96394,improving,0,0
96395,glucose/insulin,0,1
96396,indices,0,0
96397,compared,0,0
96398,with,0,0
96399,control,0,1
96400,(,0,0
96401,C,0,1
96402,),0,0
96403,",",0,0
96404,nutrition,1,1
96405,only,1,0
96406,(,0,0
96407,N,0,0
96408,),0,0
96409,",",0,0
96410,and,0,0
96411,a,0,0
96412,nutrition,1,1
96413,plus,0,1
96414,strength,1,0
96415,training,1,1
96416,(,0,0
96417,N,0,0
96418,+,0,1
96419,ST,0,0
96420,),0,0
96421,groups,0,0
96422,.,0,0
96423,METHODS,0,0
96424,In,0,0
96425,a,0,0
96426,16-wk,0,1
96427,randomized,0,0
96428,trial,0,0
96429,",",0,0
96430,41,0,0
96431,overweight,0,0
96432,Latina,0,0
96433,girls,0,0
96434,(,0,0
96435,15.2,0,0
96436,+/-,0,0
96437,1.1,0,0
96438,yr,0,0
96439,),0,0
96440,were,0,0
96441,randomly,0,0
96442,assigned,0,0
96443,to,0,0
96444,C,1,1
96445,(,0,0
96446,n,0,0
96447,=,0,0
96448,7,0,0
96449,),0,0
96450,",",0,0
96451,N,1,0
96452,(,0,0
96453,n,0,0
96454,=,0,0
96455,10,0,0
96456,),0,0
96457,",",0,0
96458,N,1,0
96459,+,1,1
96460,ST,1,1
96461,(,0,0
96462,n,0,0
96463,=,0,0
96464,9,0,0
96465,),0,0
96466,",",0,0
96467,or,0,1
96468,N,1,0
96469,+,1,1
96470,CAST,1,1
96471,(,0,0
96472,n,0,0
96473,=,0,0
96474,15,0,0
96475,),0,0
96476,.,0,0
96477,All,0,0
96478,intervention,0,0
96479,groups,0,0
96480,received,0,0
96481,modified,1,0
96482,carbohydrate,1,1
96483,nutrition,1,1
96484,classes,1,0
96485,(,0,0
96486,once,0,0
96487,a,0,0
96488,week,0,0
96489,),0,0
96490,",",0,0
96491,whereas,0,0
96492,the,0,0
96493,N,1,0
96494,+,1,1
96495,ST,1,0
96496,also,0,0
96497,received,1,0
96498,strength,1,0
96499,training,1,1
96500,(,0,0
96501,twice,0,0
96502,a,0,0
96503,week,0,0
96504,),0,0
96505,and,0,0
96506,the,0,0
96507,N,1,0
96508,+,1,1
96509,CAST,1,1
96510,received,0,0
96511,a,1,0
96512,combination,1,1
96513,of,1,0
96514,strength,1,0
96515,and,1,0
96516,aerobic,1,1
96517,training,1,1
96518,(,0,0
96519,twice,0,0
96520,a,0,0
96521,week,0,0
96522,),0,0
96523,.,0,0
96524,The,0,0
96525,following,0,0
96526,were,0,0
96527,measured,0,0
96528,before,0,0
96529,and,0,0
96530,after,0,0
96531,intervention,0,1
96532,:,0,0
96533,strength,0,0
96534,by,0,0
96535,one,0,0
96536,repetition,0,0
96537,maximum,0,0
96538,",",0,0
96539,physical,0,0
96540,activity,0,0
96541,by,0,0
96542,the,0,0
96543,7-d,0,1
96544,accelerometry,0,0
96545,and,0,0
96546,the,0,0
96547,3-d,0,1
96548,physical,0,1
96549,activity,0,0
96550,recall,0,0
96551,",",0,0
96552,dietary,0,0
96553,intake,0,0
96554,by,0,0
96555,3-d,0,1
96556,records,0,0
96557,",",0,0
96558,body,0,0
96559,composition,0,0
96560,by,0,0
96561,dual-energy,0,0
96562,x-ray,0,1
96563,absorptiometry,0,0
96564,(,0,0
96565,DEXA,0,1
96566,),0,0
96567,",",0,0
96568,glucose/insulin,0,1
96569,indices,0,0
96570,by,0,0
96571,oral,0,1
96572,glucose,0,0
96573,tolerance,0,0
96574,test,0,0
96575,",",0,0
96576,and,0,0
96577,intravenous,0,1
96578,glucose,0,1
96579,tolerance,0,0
96580,test,0,0
96581,with,0,0
96582,minimal,0,0
96583,modeling,0,0
96584,.,0,0
96585,Across,0,0
96586,intervention,0,1
96587,group,0,0
96588,",",0,0
96589,effects,0,0
96590,were,0,0
96591,tested,0,0
96592,using,0,0
96593,ANCOVA,0,1
96594,with,0,0
96595,post,0,0
96596,hoc,0,0
96597,pairwise,0,0
96598,comparisons,0,0
96599,.,0,0
96600,RESULTS,0,0
96601,There,0,0
96602,were,0,0
96603,significant,0,0
96604,overall,0,0
96605,intervention,0,1
96606,effects,0,0
96607,for,0,0
96608,all,0,0
96609,adiposity,0,0
96610,measures,0,0
96611,(,0,0
96612,weight,0,0
96613,",",0,0
96614,body,0,0
96615,mass,0,0
96616,index,0,0
96617,[,0,0
96618,BMI,0,0
96619,],0,0
96620,",",0,0
96621,BMI,0,0
96622,z-scores,0,0
96623,",",0,0
96624,and,0,0
96625,DEXA,0,1
96626,total,0,0
96627,body,0,0
96628,fat,0,0
96629,),0,0
96630,",",0,0
96631,with,0,0
96632,a,0,0
96633,decrease,0,0
96634,of,0,0
96635,3,0,0
96636,%,0,0
96637,in,0,0
96638,the,0,0
96639,N,1,0
96640,+,1,1
96641,CAST,1,1
96642,group,0,0
96643,compared,0,0
96644,with,0,0
96645,a,0,0
96646,3,0,0
96647,%,0,0
96648,increase,0,0
96649,in,0,0
96650,the,0,0
96651,N,1,0
96652,+,1,1
96653,ST,1,1
96654,group,0,0
96655,(,0,0
96656,P,0,0
96657,<,0,0
96658,or,0,0
96659,=,0,0
96660,0.05,0,0
96661,),0,0
96662,.,0,0
96663,There,0,0
96664,was,0,0
96665,also,0,0
96666,an,0,0
96667,intervention,0,1
96668,effect,0,0
96669,for,0,0
96670,fasting,0,0
96671,glucose,0,0
96672,with,0,0
96673,the,0,0
96674,N,1,0
96675,group,0,0
96676,increasing,0,0
96677,by,0,0
96678,3,0,0
96679,%,0,0
96680,and,0,0
96681,the,0,0
96682,N,1,0
96683,+,1,1
96684,CAST,1,1
96685,group,0,0
96686,decreasing,0,0
96687,by,0,0
96688,4,0,0
96689,%,0,0
96690,(,0,0
96691,P,0,0
96692,<,0,0
96693,or,0,0
96694,=,0,0
96695,0.05,0,0
96696,),0,0
96697,.,0,0
96698,CONCLUSION,0,0
96699,The,0,0
96700,CAST,1,1
96701,was,0,0
96702,more,0,0
96703,effective,0,0
96704,than,0,0
96705,nutrition,1,1
96706,alone,0,1
96707,or,0,1
96708,nutrition,1,1
96709,plus,0,1
96710,strength,1,0
96711,training,1,1
96712,for,0,0
96713,reducing,0,0
96714,multiple,0,0
96715,adiposity,0,0
96716,outcomes,0,0
96717,and,0,0
96718,fasting,0,0
96719,glucose,0,0
96720,in,0,0
96721,overweight,0,0
96722,Latina,0,0
96723,girls,0,0
96724,.,0,0
96725,However,0,0
96726,",",0,0
96727,further,0,0
96728,research,0,0
96729,investigating,0,0
96730,and,0,0
96731,identifying,0,0
96732,intervention,0,1
96733,approaches,0,0
96734,that,0,0
96735,improve,0,0
96736,both,0,0
96737,adiposity,0,0
96738,and,0,0
96739,insulin,0,1
96740,indices,0,0
96741,",",0,0
96742,particularly,0,0
96743,in,0,0
96744,high-risk,0,0
96745,populations,0,0
96746,",",0,0
96747,are,0,0
96748,warranted,0,0
96749,.,0,0
96750,[,0,0
96751,Clinical,0,0
96752,observation,0,0
96753,on,0,0
96754,acupuncture,1,1
96755,combined,0,0
96756,with,0,0
96757,Yizhi,1,1
96758,Jiannao,1,1
96759,granules,1,1
96760,for,0,0
96761,treatment,0,0
96762,of,0,0
96763,Alzheimer,0,0
96764,'s,0,0
96765,disease,0,0
96766,],0,0
96767,.,0,0
96768,OBJECTIVE,0,0
96769,To,0,0
96770,observe,0,0
96771,clinical,0,0
96772,therapeutic,0,0
96773,effect,0,0
96774,of,0,0
96775,acupuncture,1,1
96776,combined,0,0
96777,with,0,0
96778,Yizhi,1,1
96779,Jiannao,1,1
96780,Granules,1,1
96781,for,0,0
96782,treatment,0,0
96783,of,0,0
96784,Alzheimer,0,0
96785,'s,0,0
96786,disease,0,0
96787,and,0,0
96788,its,0,0
96789,effects,0,0
96790,on,0,0
96791,intelligence,0,0
96792,",",0,0
96793,daily,0,1
96794,life,0,0
96795,and,0,0
96796,social,0,1
96797,activity,0,0
96798,ability,0,0
96799,.,0,0
96800,METHODS,0,0
96801,Eighty-four,0,0
96802,cases,0,0
96803,were,0,0
96804,randomly,0,0
96805,divided,0,0
96806,into,0,0
96807,3,0,0
96808,groups,0,0
96809,",",0,0
96810,28,0,0
96811,cases,0,0
96812,in,0,0
96813,each,0,0
96814,group,0,0
96815,.,0,0
96816,The,0,0
96817,combined,0,0
96818,acupuncture,1,1
96819,and,0,0
96820,medication,0,1
96821,group,0,0
96822,was,0,0
96823,treated,0,0
96824,with,0,0
96825,acupuncture,1,1
96826,at,0,0
96827,Baihui,0,1
96828,(,0,0
96829,GV,0,0
96830,20,0,1
96831,),0,0
96832,",",0,0
96833,Sishencong,0,1
96834,(,0,0
96835,EX-HN,0,0
96836,1,0,0
96837,),0,0
96838,",",0,0
96839,Dazhui,0,1
96840,(,0,0
96841,GV,0,0
96842,14,0,0
96843,),0,0
96844,",",0,0
96845,Guanyuan,0,1
96846,(,0,0
96847,CV,0,1
96848,4,0,0
96849,),0,0
96850,",",0,0
96851,etc,0,0
96852,.,0,0
96853,and,0,0
96854,oral,0,1
96855,administration,0,0
96856,of,0,0
96857,Yizhi,1,1
96858,Jiannao,1,1
96859,Granules,1,1
96860,;,1,0
96861,the,0,0
96862,Chinese,0,1
96863,herb,0,1
96864,group,0,0
96865,was,0,0
96866,treated,0,0
96867,with,0,0
96868,Yizhi,1,1
96869,Jiannao,1,1
96870,Granules,1,1
96871,",",0,0
96872,and,0,0
96873,the,0,0
96874,western,1,0
96875,medicine,1,0
96876,group,1,0
96877,with,0,0
96878,oral,0,1
96879,administration,0,0
96880,of,0,0
96881,Aricept,1,1
96882,.,1,0
96883,The,0,0
96884,scores,0,0
96885,for,0,0
96886,the,0,0
96887,Mini-Mental,0,0
96888,State,0,1
96889,Examination,0,1
96890,(,0,0
96891,MMSE,0,1
96892,),0,0
96893,",",0,0
96894,Ability,0,0
96895,of,0,0
96896,Daily,0,0
96897,Life,0,0
96898,(,0,0
96899,ADL,0,0
96900,),0,0
96901,and,0,0
96902,the,0,0
96903,therapeutic,0,0
96904,effects,0,0
96905,were,0,0
96906,assessed,0,0
96907,and,0,0
96908,compared,0,0
96909,before,0,0
96910,treatment,0,0
96911,and,0,0
96912,after,0,0
96913,treatment,0,0
96914,for,0,0
96915,12,0,0
96916,weeks,0,0
96917,among,0,0
96918,the,0,0
96919,groups,0,0
96920,.,0,0
96921,RESULTS,0,0
96922,After,0,0
96923,treatment,0,0
96924,",",0,0
96925,the,0,0
96926,scores,0,0
96927,for,0,0
96928,MMSE,0,0
96929,and,0,0
96930,ADL,0,0
96931,were,0,0
96932,improved,0,0
96933,in,0,0
96934,the,0,0
96935,combined,1,1
96936,acupuncture,1,1
96937,and,1,0
96938,medication,1,1
96939,group,0,0
96940,",",0,0
96941,the,0,0
96942,Chinese,1,0
96943,herb,1,1
96944,group,0,0
96945,and,0,0
96946,the,0,0
96947,western,1,0
96948,medicine,1,0
96949,group,0,0
96950,",",0,0
96951,which,0,0
96952,were,0,0
96953,better,0,0
96954,in,0,0
96955,the,0,0
96956,combined,0,1
96957,acupuncture,1,1
96958,and,1,0
96959,medication,1,1
96960,group,0,1
96961,(,0,0
96962,P,0,0
96963,<,0,0
96964,0.05,0,0
96965,),0,0
96966,.,0,0
96967,The,0,0
96968,total,0,0
96969,effective,0,0
96970,rate,0,0
96971,of,0,0
96972,85.7,0,0
96973,%,0,0
96974,in,0,0
96975,the,0,0
96976,combined,1,1
96977,acupuncture,1,1
96978,and,1,0
96979,medication,1,1
96980,group,0,0
96981,was,0,0
96982,better,0,0
96983,than,0,0
96984,71.4,0,0
96985,%,0,0
96986,in,0,0
96987,the,0,0
96988,Chinese,0,0
96989,herb,0,1
96990,group,0,0
96991,and,0,0
96992,67.9,0,0
96993,%,0,0
96994,in,0,0
96995,the,0,0
96996,western,0,0
96997,medicine,0,0
96998,group,0,0
96999,.,0,0
97000,CONCLUSION,0,0
97001,Acupuncture,1,1
97002,combined,1,0
97003,with,1,0
97004,Yizhi,1,1
97005,Jiannao,1,1
97006,Granules,1,1
97007,has,0,0
97008,a,0,0
97009,significant,0,0
97010,therapeutic,0,0
97011,effect,0,0
97012,on,0,0
97013,Alzheimer,0,0
97014,'s,0,0
97015,disease,0,0
97016,",",0,0
97017,which,0,0
97018,is,0,0
97019,better,0,0
97020,than,0,0
97021,that,0,0
97022,of,0,0
97023,Yizhi,1,1
97024,Jiannao,1,1
97025,Granules,1,1
97026,or,0,0
97027,Aricept,1,1
97028,.,1,0
97029,Impact,0,0
97030,of,0,0
97031,preinduced,0,0
97032,quadriceps,0,0
97033,fatigue,0,0
97034,on,0,0
97035,exercise,0,1
97036,response,0,0
97037,in,0,0
97038,chronic,0,0
97039,obstructive,0,0
97040,pulmonary,0,0
97041,disease,0,0
97042,and,0,0
97043,healthy,0,0
97044,subjects,0,0
97045,.,0,0
97046,Exercise,0,1
97047,intolerance,0,0
97048,in,0,0
97049,chronic,0,0
97050,obstructive,0,0
97051,pulmonary,0,0
97052,disease,0,0
97053,(,0,0
97054,COPD,0,0
97055,),0,0
97056,results,0,0
97057,from,0,0
97058,a,0,0
97059,complex,0,0
97060,interaction,0,0
97061,between,0,0
97062,central,0,0
97063,(,0,0
97064,ventilatory,0,0
97065,),0,1
97066,and,0,0
97067,peripheral,0,0
97068,(,0,0
97069,limb,0,0
97070,muscles,0,1
97071,),0,0
97072,components,0,0
97073,of,0,0
97074,exercise,0,1
97075,limitation,0,0
97076,.,0,0
97077,The,0,0
97078,purpose,0,0
97079,of,0,0
97080,this,0,0
97081,study,0,0
97082,was,0,0
97083,to,0,0
97084,evaluate,0,0
97085,the,0,0
97086,influence,0,0
97087,of,0,0
97088,quadriceps,0,1
97089,muscle,0,0
97090,fatigue,0,0
97091,on,0,0
97092,exercise,0,1
97093,tolerance,0,0
97094,and,0,0
97095,ventilatory,0,0
97096,response,0,0
97097,during,0,0
97098,constant-workrate,1,1
97099,cycling,1,0
97100,exercise,1,1
97101,testing,1,0
97102,(,1,0
97103,CWT,1,0
97104,),1,0
97105,in,0,0
97106,patients,0,0
97107,with,0,0
97108,COPD,0,0
97109,and,0,0
97110,healthy,0,0
97111,subjects,0,0
97112,.,0,0
97113,Fifteen,0,0
97114,patients,0,0
97115,with,0,0
97116,COPD,0,0
97117,and,0,0
97118,nine,0,0
97119,age-matched,0,0
97120,healthy,0,0
97121,subjects,0,0
97122,performed,0,0
97123,",",0,0
97124,7,0,0
97125,days,0,0
97126,apart,0,0
97127,",",0,0
97128,two,0,0
97129,CWTs,1,0
97130,up,0,0
97131,to,0,0
97132,exhaustion,0,0
97133,at,0,0
97134,80,0,0
97135,%,0,0
97136,of,0,0
97137,their,0,0
97138,predetermined,0,0
97139,maximal,0,0
97140,work,0,0
97141,capacity,0,0
97142,.,0,0
97143,In,0,0
97144,a,0,0
97145,randomized,0,0
97146,order,0,0
97147,",",0,0
97148,one,0,0
97149,test,0,0
97150,was,0,0
97151,performed,0,0
97152,with,0,0
97153,preinduced,0,0
97154,quadriceps,0,1
97155,fatigue,0,0
97156,and,0,0
97157,the,0,0
97158,other,0,0
97159,in,0,0
97160,a,0,0
97161,fresh,0,0
97162,state,0,0
97163,.,0,0
97164,Quadriceps,0,0
97165,fatigue,0,0
97166,was,0,0
97167,produced,0,0
97168,by,0,0
97169,electrostimulation-induced,0,0
97170,contractions,0,0
97171,and,0,0
97172,quantified,0,0
97173,by,0,0
97174,maximal,0,0
97175,voluntary,0,1
97176,contraction,0,0
97177,and,0,0
97178,potentiated,0,0
97179,twitch,0,1
97180,force,0,1
97181,(,0,1
97182,TwQ,0,1
97183,(,0,1
97184,pot,0,1
97185,),0,0
97186,),0,0
97187,.,0,0
97188,Endurance,0,0
97189,time,0,0
97190,and,0,0
97191,ventilatory,0,0
97192,response,0,0
97193,during,0,0
97194,CWT,0,0
97195,were,0,0
97196,compared,0,0
97197,between,0,0
97198,fatigued,0,0
97199,and,0,0
97200,fresh,0,0
97201,state,0,0
97202,.,0,0
97203,Endurance,0,0
97204,time,0,0
97205,significantly,0,0
97206,decreased,0,0
97207,in,0,0
97208,the,0,0
97209,fatigued,0,0
97210,state,0,0
97211,compared,0,0
97212,with,0,0
97213,the,0,0
97214,fresh,0,0
97215,condition,0,0
97216,in,0,0
97217,COPD,0,0
97218,(,0,0
97219,356,0,0
97220,+/-,0,0
97221,69,0,0
97222,s,0,0
97223,vs.,0,0
97224,294,0,0
97225,+/-,0,0
97226,45,0,0
97227,s,0,0
97228,",",0,0
97229,P,0,0
97230,<,0,0
97231,0.05,0,0
97232,),0,0
97233,and,0,0
97234,controls,0,0
97235,(,0,0
97236,450,0,0
97237,+/-,0,0
97238,74,0,0
97239,s,0,0
97240,vs.,0,0
97241,340,0,0
97242,+/-,0,0
97243,45,0,0
97244,s,0,0
97245,",",0,0
97246,P,0,0
97247,<,0,0
97248,0.05,0,0
97249,),0,0
97250,.,0,0
97251,Controls,0,0
97252,showed,0,0
97253,significantly,0,0
97254,higher,0,0
97255,ventilation,0,0
97256,and,0,0
97257,end-exercise,0,1
97258,dyspnea,0,0
97259,scores,0,0
97260,in,0,0
97261,the,0,0
97262,fatigued,0,0
97263,condition,0,0
97264,",",0,0
97265,whereas,0,0
97266,",",0,0
97267,in,0,0
97268,COPD,0,0
97269,",",0,0
97270,fatigue,0,0
97271,did,0,0
97272,not,0,0
97273,influence,0,0
97274,ventilation,0,1
97275,or,0,1
97276,dyspnea,0,0
97277,during,0,0
97278,exercise,0,1
97279,.,0,0
97280,The,0,0
97281,degree,0,0
97282,of,0,0
97283,ventilatory,0,0
97284,limitation,0,0
97285,",",0,0
97286,as,0,0
97287,expressed,0,0
97288,by,0,0
97289,the,0,0
97290,Ve/maximum,0,0
97291,voluntary,0,1
97292,ventilation,0,1
97293,ratio,0,0
97294,",",0,0
97295,was,0,0
97296,similar,0,0
97297,in,0,0
97298,both,0,0
97299,conditions,0,0
97300,in,0,0
97301,patients,0,0
97302,with,0,0
97303,COPD,0,0
97304,.,0,0
97305,We,0,0
97306,conclude,0,0
97307,that,0,0
97308,it,0,0
97309,is,0,0
97310,possible,0,0
97311,to,0,0
97312,induce,0,0
97313,quadriceps,0,1
97314,fatigue,0,0
97315,by,0,0
97316,local,0,0
97317,electrostimulation-induced,0,0
97318,contractions,0,0
97319,.,0,0
97320,Our,0,0
97321,findings,0,0
97322,demonstrate,0,0
97323,that,0,0
97324,peripheral,0,0
97325,muscle,0,0
97326,fatigue,0,0
97327,is,0,0
97328,an,0,0
97329,additional,0,0
97330,important,0,0
97331,factor,0,0
97332,",",0,0
97333,besides,0,0
97334,intense,0,0
97335,dyspnea,0,0
97336,",",0,0
97337,that,0,0
97338,limits,0,0
97339,exercise,0,1
97340,tolerance,0,0
97341,in,0,0
97342,COPD,0,0
97343,.,0,0
97344,Excimer,1,1
97345,laser,1,1
97346,trabeculotomy,1,1
97347,vs,0,0
97348,180,1,0
97349,degrees,1,0
97350,selective,1,0
97351,laser,1,1
97352,trabeculoplasty,1,1
97353,in,0,0
97354,primary,0,0
97355,open-angle,0,0
97356,glaucoma,0,0
97357,.,0,0
97358,A,0,0
97359,2-year,0,0
97360,randomized,0,0
97361,",",0,0
97362,controlled,0,0
97363,trial,0,0
97364,.,0,0
97365,PURPOSE,0,0
97366,To,0,0
97367,compare,0,0
97368,the,0,0
97369,effectiveness,0,0
97370,and,0,0
97371,safety,0,0
97372,of,0,0
97373,excimer,1,1
97374,laser,1,1
97375,trabeculotomy,1,1
97376,(,1,0
97377,ELT,1,0
97378,),1,0
97379,ab,0,1
97380,interno,0,1
97381,vs,0,0
97382,selective,1,1
97383,laser,1,1
97384,trabeculoplasty,1,1
97385,(,1,0
97386,SLT,1,1
97387,),1,0
97388,over,0,0
97389,24,0,0
97390,months,0,0
97391,of,0,0
97392,follow-up,0,0
97393,in,0,0
97394,patients,0,0
97395,with,0,0
97396,primary,0,0
97397,open-angle,0,1
97398,glaucoma,0,1
97399,(,0,0
97400,POAG,0,1
97401,),0,0
97402,refractory,0,0
97403,to,0,0
97404,medical,0,0
97405,therapy,0,1
97406,.,0,0
97407,PATIENTS,0,0
97408,AND,0,0
97409,METHODS,0,0
97410,This,0,0
97411,prospective,0,0
97412,",",0,0
97413,randomized,0,0
97414,study,0,0
97415,included,0,0
97416,30,0,0
97417,consecutive,0,0
97418,eyes,0,0
97419,assigned,0,0
97420,randomly,0,0
97421,to,0,0
97422,either,0,0
97423,ELT,1,0
97424,or,0,1
97425,SLT,1,1
97426,group,0,0
97427,.,0,0
97428,ELT,1,0
97429,was,1,0
97430,carried,1,0
97431,out,1,0
97432,using,1,0
97433,a,1,0
97434,XeCl,1,0
97435,Excimer,1,1
97436,Laser,1,1
97437,with,1,0
97438,an,1,0
97439,emission,1,0
97440,wavelength,1,0
97441,of,1,0
97442,308,1,0
97443,nm,1,0
97444,.,1,0
97445,Eight,1,0
97446,spots,1,0
97447,were,1,0
97448,equally,1,0
97449,distributed,1,0
97450,at,1,0
97451,a,1,0
97452,distance,1,0
97453,of,1,0
97454,500,1,0
97455,microm,1,0
97456,from,1,0
97457,one,1,0
97458,another,1,0
97459,over,1,0
97460,the,1,0
97461,anterior,1,0
97462,trabeculum,1,0
97463,.,1,0
97464,The,0,0
97465,SLT,0,0
97466,patients,0,0
97467,were,0,0
97468,treated,1,0
97469,with,1,0
97470,a,1,0
97471,frequency-doubled,1,0
97472,q-switched,1,1
97473,neodymium,1,1
97474,:,1,0
97475,yytrium-aluminum-garnet,1,1
97476,laser,1,1
97477,(,1,0
97478,wavelength,1,0
97479,532,1,0
97480,nm,1,0
97481,),1,0
97482,.,1,0
97483,Approximately,1,0
97484,50,1,0
97485,adjacent,1,0
97486,",",1,0
97487,but,1,0
97488,not,1,0
97489,overlapping,1,0
97490,",",1,0
97491,laser,1,1
97492,spots,1,0
97493,were,1,0
97494,distributed,1,0
97495,over,1,0
97496,180,1,0
97497,degrees,1,0
97498,of,1,0
97499,the,1,0
97500,trabecular,1,0
97501,meshwork,1,1
97502,",",1,0
97503,using,1,0
97504,an,1,0
97505,energy,1,0
97506,level,1,0
97507,ranging,1,0
97508,from,1,0
97509,0.7,1,0
97510,to,1,0
97511,1.0,1,0
97512,mJ,1,0
97513,per,1,0
97514,pulse,1,0
97515,.,1,0
97516,The,0,0
97517,main,0,0
97518,outcome,0,0
97519,measure,0,0
97520,was,0,0
97521,intraocular,0,0
97522,pressure,0,0
97523,(,0,0
97524,IOP,0,0
97525,),0,0
97526,lowering,0,0
97527,after,0,0
97528,ELT,0,0
97529,and,0,0
97530,SLT,0,0
97531,.,0,0
97532,Success,0,0
97533,was,0,0
97534,defined,0,0
97535,as,0,0
97536,>,0,0
97537,or=20,0,0
97538,%,0,0
97539,reduction,0,0
97540,in,0,0
97541,IOP,0,0
97542,without,0,0
97543,further,0,0
97544,glaucoma,0,0
97545,intervention,0,1
97546,.,0,0
97547,RESULTS,0,0
97548,At,0,0
97549,24,0,0
97550,months,0,0
97551,",",0,0
97552,complete,0,0
97553,success,0,0
97554,rates,0,0
97555,were,0,0
97556,53.3,0,0
97557,%,0,0
97558,for,0,0
97559,the,0,0
97560,ELT,0,0
97561,group,0,0
97562,and,0,0
97563,40,0,0
97564,%,0,0
97565,for,0,0
97566,the,0,0
97567,SLT,0,1
97568,group,0,0
97569,(,0,0
97570,P=0.35,0,0
97571,",",0,0
97572,Fisher,0,1
97573,'s,0,0
97574,exact,0,0
97575,test,0,0
97576,),0,0
97577,;,0,0
97578,qualified,0,0
97579,success,0,0
97580,rates,0,0
97581,were,0,0
97582,33.3,0,0
97583,%,0,0
97584,for,0,0
97585,the,0,0
97586,ELT,0,0
97587,and,0,0
97588,26.6,0,0
97589,%,0,0
97590,for,0,0
97591,the,0,0
97592,SLT,0,1
97593,group,0,0
97594,(,0,0
97595,P=0.5,0,0
97596,",",0,0
97597,Fisher,0,1
97598,'s,0,0
97599,exact,0,0
97600,test,0,0
97601,),0,0
97602,.Mean,0,0
97603,IOP,0,0
97604,decreased,0,0
97605,from,0,0
97606,25.0+/-1.9,0,0
97607,to,0,0
97608,17.6+/-2.2,0,0
97609,mmHg,0,0
97610,(,0,0
97611,-29.6,0,0
97612,%,0,0
97613,;,0,0
97614,P,0,0
97615,<,0,0
97616,0.0001,0,0
97617,),0,0
97618,in,0,0
97619,the,0,0
97620,ELT,0,0
97621,group,0,0
97622,and,0,0
97623,from,0,0
97624,23.9+/-0.9,0,0
97625,to,0,0
97626,19.1+/-1.8,0,0
97627,mmHg,0,0
97628,(,0,0
97629,-21,0,0
97630,%,0,0
97631,;,0,0
97632,P,0,0
97633,<,0,0
97634,0.0001,0,0
97635,),0,0
97636,in,0,0
97637,the,0,0
97638,SLT,0,0
97639,group,0,0
97640,.,0,0
97641,CONCLUSIONS,0,0
97642,Both,0,1
97643,ELT,0,0
97644,and,0,0
97645,SLT,0,0
97646,proved,0,0
97647,to,0,0
97648,be,0,0
97649,effective,0,0
97650,techniques,0,1
97651,in,0,0
97652,the,0,0
97653,treatment,0,0
97654,of,0,0
97655,POAG,0,1
97656,refractory,0,0
97657,to,0,0
97658,medical,0,0
97659,therapy,0,1
97660,.,0,0
97661,Polycystic,0,0
97662,ovary,0,0
97663,syndrome,0,0
97664,and,0,0
97665,cardiovascular,0,0
97666,risk,0,0
97667,in,0,0
97668,young,0,0
97669,patients,0,0
97670,treated,0,0
97671,with,0,0
97672,drospirenone-ethinylestradiol,1,1
97673,or,1,1
97674,contraceptive,1,1
97675,vaginal,1,0
97676,ring,1,1
97677,.,1,0
97678,A,0,0
97679,prospective,0,0
97680,",",0,0
97681,randomized,0,0
97682,",",0,0
97683,pilot,0,0
97684,study,0,0
97685,.,0,0
97686,OBJECTIVE,0,0
97687,To,0,0
97688,compare,0,0
97689,the,0,0
97690,effects,0,0
97691,of,0,0
97692,a,0,0
97693,pill,1,1
97694,containing,1,1
97695,drospirenone,1,1
97696,with,1,0
97697,those,1,0
97698,of,1,0
97699,a,1,0
97700,combined,1,0
97701,contraceptive,1,1
97702,vaginal,1,0
97703,ring,1,1
97704,on,1,0
97705,the,0,0
97706,lipid,0,0
97707,and,0,0
97708,carbohydrate,0,1
97709,metabolism,0,0
97710,and,0,0
97711,on,0,0
97712,the,0,0
97713,surrogate,0,0
97714,markers,0,0
97715,of,0,0
97716,arterial,0,0
97717,function,0,0
97718,.,0,0
97719,SETTING,0,0
97720,Bologna,0,0
97721,University,0,0
97722,School,0,0
97723,of,0,0
97724,Medicine,0,1
97725,.,0,0
97726,PATIENT,0,0
97727,(,0,0
97728,S,0,0
97729,),0,0
97730,Thirty-seven,0,0
97731,women,0,0
97732,with,0,0
97733,polycystic,0,0
97734,ovary,0,0
97735,syndrome,0,0
97736,(,0,0
97737,PCOS,0,0
97738,),0,0
97739,were,0,0
97740,randomly,0,0
97741,submitted,0,0
97742,to,0,0
97743,drospirenone+ethinylestradiol,1,1
97744,(,0,0
97745,group,0,0
97746,I,0,0
97747,;,0,0
97748,n=19,0,0
97749,),0,0
97750,or,1,1
97751,combined,1,1
97752,contraceptive,1,1
97753,vaginal,1,1
97754,ring,1,1
97755,(,0,0
97756,group,0,0
97757,II,0,0
97758,;,0,0
97759,n=18,0,0
97760,),0,0
97761,therapy,1,1
97762,.,1,0
97763,The,0,0
97764,duration,0,0
97765,of,0,0
97766,the,0,0
97767,study,0,0
97768,was,0,0
97769,6,0,0
97770,months,0,0
97771,.,0,0
97772,INTERVENTION,0,0
97773,(,0,0
97774,S,0,0
97775,),0,0
97776,The,0,0
97777,effect,0,0
97778,of,0,0
97779,treatments,0,0
97780,was,0,0
97781,assessed,0,0
97782,after,0,0
97783,6,1,0
97784,months,1,0
97785,of,1,0
97786,therapy,1,1
97787,.,1,0
97788,MAIN,0,0
97789,OUTCOME,0,0
97790,MEASURE,0,0
97791,(,0,0
97792,S,0,1
97793,),0,0
97794,Utero-ovarian,0,0
97795,ultrasound,0,1
97796,analysis,0,0
97797,and,0,0
97798,color,0,1
97799,Doppler,0,1
97800,evaluation,0,0
97801,of,0,0
97802,uterine,0,0
97803,and,0,0
97804,stromal,0,0
97805,ovarian,0,0
97806,arteries,0,0
97807,.,0,0
97808,In,0,0
97809,addition,0,0
97810,",",0,0
97811,analysis,0,0
97812,of,0,0
97813,brachial,0,0
97814,artery,0,0
97815,flow-mediated,0,1
97816,vasodilatation,0,0
97817,and,0,0
97818,24-hour,0,1
97819,ambulatory,0,0
97820,blood,0,0
97821,pressure,0,0
97822,monitoring,0,0
97823,were,0,0
97824,performed,0,0
97825,.,0,0
97826,Fasting,0,0
97827,blood,0,0
97828,samples,0,0
97829,were,0,0
97830,drawn,0,0
97831,for,0,0
97832,testing,0,0
97833,biochemical,0,0
97834,and,0,0
97835,hormonal,0,0
97836,parameters,0,0
97837,and,0,0
97838,nitrites/nitrates,0,0
97839,.,0,0
97840,RESULT,0,0
97841,(,0,0
97842,S,0,0
97843,),0,0
97844,Both,0,1
97845,treatments,0,0
97846,improved,0,0
97847,hirsutism,0,0
97848,",",0,0
97849,hyperandrogenemia,0,0
97850,",",0,0
97851,and,0,0
97852,ultrasound,0,1
97853,and,0,0
97854,color,0,1
97855,Doppler,0,1
97856,ovarian,0,0
97857,parameters,0,0
97858,.,0,0
97859,Both,0,0
97860,drospirenone+ethinylestradiol,0,1
97861,or,0,0
97862,contraceptive,0,1
97863,vaginal,0,1
97864,ring,0,1
97865,induced,0,0
97866,a,0,0
97867,slight,0,0
97868,but,0,0
97869,significant,0,0
97870,increase,0,0
97871,of,0,0
97872,diurnal,0,0
97873,and,0,0
97874,24-hour,0,1
97875,blood,0,0
97876,pressure,0,0
97877,.,0,0
97878,Although,0,0
97879,both,0,0
97880,therapies,0,0
97881,worsened,0,0
97882,the,0,0
97883,lipid,0,0
97884,profile,0,0
97885,",",0,0
97886,the,0,0
97887,oral,0,1
97888,pill,0,1
97889,administration,0,0
97890,was,0,0
97891,associated,0,0
97892,with,0,0
97893,a,0,0
97894,more,0,0
97895,evident,0,0
97896,increase,0,0
97897,of,0,0
97898,circulating,0,0
97899,triglycerides,0,0
97900,.,0,0
97901,The,0,0
97902,6-month,0,0
97903,treatment,0,0
97904,with,0,0
97905,the,0,0
97906,vaginal,0,0
97907,ring,0,1
97908,significantly,0,0
97909,improved,0,0
97910,the,0,0
97911,area,0,0
97912,under,0,0
97913,the,0,0
97914,curve,0,0
97915,for,0,0
97916,glucose,0,0
97917,",",0,0
97918,insulin,0,1
97919,",",0,0
97920,and,0,0
97921,C-peptide,0,0
97922,",",0,0
97923,whereas,0,0
97924,the,0,0
97925,drospirenone+ethinylestradiol,0,1
97926,pill,0,1
97927,induced,0,0
97928,an,0,0
97929,increase,0,0
97930,in,0,0
97931,the,0,0
97932,insulinogenic,0,0
97933,index,0,0
97934,and,0,0
97935,homeostatic,0,0
97936,model,0,0
97937,assessment,0,0
97938,estimate,0,0
97939,for,0,0
97940,insulin,0,1
97941,resistance,0,0
97942,values,0,0
97943,.,0,0
97944,CONCLUSION,0,0
97945,(,0,0
97946,S,0,0
97947,),0,0
97948,Vaginal,0,1
97949,hormonal,0,1
97950,contraception,0,1
97951,appears,0,0
97952,to,0,0
97953,be,0,0
97954,preferable,0,0
97955,to,0,0
97956,oral,0,1
97957,ethinylestradiol,0,1
97958,+,0,1
97959,drospirenone,0,1
97960,administration,0,0
97961,in,0,0
97962,hyperinsulinemic,0,0
97963,patients,0,0
97964,with,0,0
97965,PCOS,0,0
97966,.,0,0
97967,Enhancing,0,0
97968,the,0,0
97969,working,0,0
97970,memory,0,0
97971,of,0,0
97972,stroke,0,0
97973,patients,0,0
97974,using,0,0
97975,tDCS,1,0
97976,.,1,0
97977,OBJECTIVES,0,0
97978,We,0,0
97979,investigated,0,0
97980,whether,0,0
97981,anodal,1,1
97982,transcranial,1,1
97983,direct,1,1
97984,current,1,0
97985,stimulation,1,1
97986,over,0,0
97987,the,0,0
97988,left,0,0
97989,dorsolateral,0,1
97990,prefrontal,0,0
97991,cortex,0,0
97992,affected,0,0
97993,the,0,0
97994,working,0,0
97995,memory,0,0
97996,performance,0,0
97997,of,0,0
97998,patients,0,0
97999,after,0,0
98000,a,0,0
98001,stroke,0,0
98002,.,0,0
98003,DESIGN,0,0
98004,Ten,0,0
98005,patients,0,0
98006,(,0,0
98007,mean,0,0
98008,age,0,0
98009,47.7,0,0
98010,yrs,0,0
98011,),0,0
98012,with,0,0
98013,cognitive,0,0
98014,deficits,0,0
98015,after,0,0
98016,a,0,0
98017,first-ever,0,0
98018,stroke,0,0
98019,participated,0,0
98020,in,0,0
98021,this,0,0
98022,single-blind,0,0
98023,",",0,0
98024,crossover,0,0
98025,",",0,0
98026,and,0,0
98027,sham-controlled,1,1
98028,experiment,0,0
98029,.,0,0
98030,Each,0,0
98031,patient,0,0
98032,was,0,0
98033,randomly,0,0
98034,assigned,0,0
98035,to,0,0
98036,undergo,0,0
98037,two,0,0
98038,transcranial,1,1
98039,direct,1,0
98040,current,1,0
98041,stimulation,1,1
98042,sessions,1,1
98043,:,1,0
98044,anodal,1,1
98045,dorsolateral,1,1
98046,prefrontal,1,0
98047,cortex,1,0
98048,and,1,0
98049,sham,1,1
98050,stimulation,1,1
98051,within,0,0
98052,48,0,0
98053,hrs,0,0
98054,of,0,0
98055,a,0,0
98056,washout,0,0
98057,period,0,0
98058,.,0,0
98059,All,0,0
98060,participants,0,0
98061,performed,0,0
98062,a,0,0
98063,two-back,1,1
98064,working,1,0
98065,memory,1,0
98066,task,1,1
98067,before,1,0
98068,and,1,0
98069,after,1,0
98070,the,0,0
98071,administration,0,0
98072,of,0,0
98073,the,0,0
98074,transcranial,0,1
98075,direct,0,0
98076,current,0,0
98077,stimulation,0,1
98078,.,0,0
98079,Accuracy,0,0
98080,(,0,0
98081,correction,0,0
98082,rate,0,0
98083,),0,0
98084,",",0,0
98085,recognition,0,1
98086,accuracy,0,0
98087,(,0,0
98088,correction,0,0
98089,rate-commission,0,1
98090,error,0,0
98091,rate,0,0
98092,),0,0
98093,",",0,0
98094,and,0,0
98095,response,0,0
98096,time,0,0
98097,were,0,0
98098,measured,0,0
98099,during,0,0
98100,each,0,0
98101,experiment,0,0
98102,.,0,0
98103,RESULTS,0,0
98104,Repeated-measures,0,0
98105,analysis,0,0
98106,of,0,0
98107,variance,0,0
98108,indicated,0,0
98109,a,0,0
98110,significant,0,0
98111,interaction,0,0
98112,effect,0,0
98113,of,0,0
98114,transcranial,0,1
98115,direct,0,1
98116,current,0,0
98117,stimulation,0,1
98118,type,0,0
98119,and,0,0
98120,time,0,0
98121,on,0,0
98122,the,0,0
98123,recognition,0,0
98124,accuracy,0,0
98125,.,0,0
98126,Post,0,0
98127,hoc,0,0
98128,analyses,0,0
98129,revealed,0,0
98130,a,0,0
98131,significant,0,0
98132,difference,0,0
98133,between,0,0
98134,prestimulation,0,1
98135,and,0,0
98136,poststimulation,0,0
98137,in,0,0
98138,the,0,0
98139,anodal,1,1
98140,stimulation,1,1
98141,group,0,0
98142,but,0,0
98143,not,0,0
98144,in,0,0
98145,the,0,0
98146,sham,0,1
98147,stimulation,0,1
98148,group,0,0
98149,.,0,0
98150,Regarding,0,0
98151,the,0,0
98152,accuracy,0,0
98153,",",0,0
98154,the,0,0
98155,paired,0,0
98156,t,0,0
98157,test,0,0
98158,indicated,0,0
98159,significant,0,0
98160,improvement,0,0
98161,only,0,0
98162,after,0,0
98163,anodal,1,1
98164,transcranial,1,1
98165,direct,1,1
98166,current,1,0
98167,stimulation,1,1
98168,without,0,0
98169,a,0,0
98170,significant,0,0
98171,interaction,0,0
98172,effect,0,0
98173,between,0,0
98174,the,0,0
98175,two,0,0
98176,transcranial,0,1
98177,direct,0,0
98178,current,0,0
98179,stimulation,0,0
98180,types,0,0
98181,.,0,0
98182,The,0,0
98183,response,0,0
98184,time,0,0
98185,was,0,0
98186,not,0,0
98187,significantly,0,0
98188,different,0,0
98189,in,0,0
98190,the,0,0
98191,anodal,0,1
98192,and,0,0
98193,sham,0,1
98194,stimulation,0,1
98195,groups,0,0
98196,.,0,0
98197,CONCLUSION,0,0
98198,Our,0,0
98199,results,0,0
98200,demonstrated,0,0
98201,that,0,0
98202,anodal,1,1
98203,transcranial,1,1
98204,direct,1,1
98205,current,1,0
98206,stimulation,1,1
98207,over,0,0
98208,the,0,0
98209,left,0,0
98210,dorsolateral,0,1
98211,prefrontal,0,0
98212,cortex,0,0
98213,was,0,0
98214,associated,0,0
98215,with,0,0
98216,enhanced,0,0
98217,working,0,1
98218,memory,0,0
98219,performance,0,0
98220,as,0,0
98221,indexed,0,0
98222,by,0,0
98223,the,0,0
98224,recognition,0,0
98225,accuracy,0,0
98226,in,0,0
98227,patients,0,0
98228,after,0,0
98229,a,0,0
98230,stroke,0,0
98231,.,0,0
98232,Ultrasonographic,1,0
98233,tissue,1,0
98234,characterisation,1,0
98235,of,0,0
98236,human,0,0
98237,Achilles,0,0
98238,tendons,0,1
98239,:,0,0
98240,quantification,0,0
98241,of,0,0
98242,tendon,0,0
98243,structure,0,0
98244,through,0,0
98245,a,0,0
98246,novel,0,0
98247,non-invasive,0,0
98248,approach,0,1
98249,.,0,0
98250,OBJECTIVE,0,0
98251,To,0,0
98252,assess,0,0
98253,whether,0,0
98254,three-dimensional,1,1
98255,imaging,1,0
98256,of,1,0
98257,the,1,0
98258,Achilles,1,0
98259,tendon,1,0
98260,by,1,0
98261,ultrasonographic,1,1
98262,tissue,1,0
98263,characterisation,1,0
98264,(,1,0
98265,UTC,1,0
98266,),1,0
98267,can,0,0
98268,differentiate,0,0
98269,between,0,0
98270,symptomatic,0,0
98271,and,0,0
98272,asymptomatic,0,0
98273,tendons,0,1
98274,.,0,0
98275,DESIGN,0,0
98276,Case-control,0,1
98277,study,0,0
98278,.,0,0
98279,SETTING,0,0
98280,Sports,0,0
98281,Medical,0,1
98282,Department,0,0
98283,of,0,0
98284,the,0,0
98285,Hague,0,0
98286,Medical,0,1
98287,Centre,0,0
98288,.,0,0
98289,PATIENTS,0,0
98290,Twenty-six,0,0
98291,tendons,0,1
98292,from,0,0
98293,patients,0,0
98294,with,0,0
98295,chronic,0,0
98296,midportion,0,0
98297,Achilles,0,1
98298,tendinopathy,0,0
98299,were,0,0
98300,included,0,0
98301,.,0,0
98302,The,0,0
98303,matched,0,0
98304,control,0,0
98305,group,0,0
98306,consisted,0,0
98307,of,0,0
98308,26,0,0
98309,asymptomatic,0,0
98310,tendons,0,1
98311,.,0,0
98312,INTERVENTIONS,0,0
98313,Symptomatic,1,0
98314,and,1,0
98315,asymptomatic,1,0
98316,tendons,1,1
98317,were,1,0
98318,scanned,1,1
98319,using,1,0
98320,the,1,0
98321,UTC,1,0
98322,procedure,1,0
98323,.,1,0
98324,One,1,0
98325,researcher,1,0
98326,performed,1,0
98327,the,1,0
98328,ultrasonographic,1,1
98329,data,1,0
98330,collection,1,0
98331,.,1,0
98332,These,0,0
98333,blinded,0,0
98334,data,0,0
98335,were,0,0
98336,randomised,0,0
98337,",",0,0
98338,and,0,0
98339,outcome,0,0
98340,measures,0,0
98341,were,0,0
98342,determined,0,0
98343,by,0,0
98344,two,0,0
98345,independent,0,0
98346,observers,0,0
98347,.,0,0
98348,MAIN,0,0
98349,OUTCOME,0,0
98350,MEASUREMENTS,0,0
98351,The,0,0
98352,raw,0,0
98353,ultrasonographic,0,0
98354,images,0,0
98355,were,0,0
98356,analysed,0,0
98357,with,0,0
98358,a,0,0
98359,custom-designed,0,1
98360,algorithm,0,0
98361,that,0,0
98362,quantifies,0,0
98363,the,0,0
98364,three-dimensional,0,1
98365,stability,0,0
98366,of,0,0
98367,echo,0,0
98368,patterns,0,0
98369,",",0,0
98370,qua,0,0
98371,intensity,0,0
98372,and,0,0
98373,distribution,0,0
98374,over,0,0
98375,contiguous,0,0
98376,transverse,0,0
98377,images,0,0
98378,.,0,0
98379,This,0,0
98380,three-dimensional,0,1
98381,stability,0,0
98382,was,0,0
98383,related,0,0
98384,to,0,0
98385,tendon,0,0
98386,structure,0,0
98387,in,0,0
98388,previous,0,0
98389,studies,0,0
98390,.,0,0
98391,UTC,0,0
98392,categorises,0,0
98393,four,0,0
98394,different,0,0
98395,echotypes,0,0
98396,that,0,0
98397,represent,0,0
98398,(,0,0
98399,I,0,0
98400,),0,0
98401,highly,0,0
98402,stable,0,0
98403,;,0,0
98404,(,0,0
98405,II,0,0
98406,),0,1
98407,medium,0,1
98408,stable,0,0
98409,;,0,0
98410,(,0,0
98411,III,0,0
98412,),0,0
98413,highly,0,0
98414,variable,0,0
98415,and,0,0
98416,(,0,0
98417,IV,0,0
98418,),0,0
98419,constantly,0,0
98420,low,0,0
98421,intensity,0,0
98422,and,0,0
98423,variable,0,0
98424,distribution,0,0
98425,.,0,0
98426,The,0,0
98427,percentages,0,0
98428,of,0,0
98429,echo-types,0,0
98430,were,0,0
98431,calculated,0,0
98432,",",0,0
98433,and,0,0
98434,the,0,0
98435,maximum,0,0
98436,tendon,0,0
98437,thickness,0,0
98438,was,0,0
98439,measured,0,0
98440,.,0,0
98441,Finally,0,0
98442,",",0,0
98443,the,0,0
98444,inter-observer,0,0
98445,reliability,0,0
98446,of,0,0
98447,UTC,1,0
98448,was,0,0
98449,determined,0,0
98450,.,0,0
98451,RESULTS,0,0
98452,Symptomatic,0,0
98453,tendons,0,1
98454,showed,0,0
98455,less,0,0
98456,pixels,0,0
98457,in,0,0
98458,echo-types,0,0
98459,I,0,0
98460,and,0,0
98461,II,0,0
98462,than,0,0
98463,asymptomatic,0,0
98464,tendons,0,1
98465,(,0,0
98466,51.5,0,0
98467,%,0,0
98468,vs,0,0
98469,76.6,0,0
98470,%,0,0
98471,",",0,0
98472,p,0,0
98473,<,0,0
98474,0.001,0,0
98475,),0,0
98476,",",0,0
98477,thus,0,0
98478,less,0,0
98479,three-dimensional,0,1
98480,stability,0,0
98481,of,0,0
98482,the,0,0
98483,echo,0,0
98484,pattern,0,0
98485,.,0,0
98486,The,0,0
98487,mean,0,0
98488,maximum,0,0
98489,tendon,0,0
98490,thickness,0,0
98491,was,0,0
98492,9.2,0,0
98493,mm,0,0
98494,in,0,0
98495,the,0,0
98496,symptomatic,0,0
98497,group,0,0
98498,and,0,0
98499,6.8,0,0
98500,mm,0,0
98501,in,0,0
98502,the,0,0
98503,asymptomatic,0,0
98504,group,0,0
98505,(,0,0
98506,p,0,0
98507,<,0,0
98508,0.001,0,0
98509,),0,0
98510,.,0,0
98511,The,0,0
98512,Intraclass,0,0
98513,Correlation,0,0
98514,Coefficient,0,0
98515,(,0,0
98516,ICC,0,0
98517,),0,0
98518,for,0,0
98519,the,0,0
98520,interobserver,0,0
98521,reliability,0,0
98522,of,0,0
98523,determining,0,0
98524,the,0,0
98525,echo-types,0,0
98526,I+II,0,0
98527,was,0,0
98528,0.95,0,0
98529,.,0,0
98530,The,0,0
98531,ICC,0,0
98532,for,0,0
98533,tendon,0,0
98534,thickness,0,0
98535,was,0,0
98536,0.84,0,0
98537,.,0,0
98538,CONCLUSION,0,0
98539,UTC,0,0
98540,can,0,0
98541,quantitatively,0,0
98542,evaluate,0,0
98543,tendon,0,0
98544,structure,0,0
98545,and,0,0
98546,thereby,0,0
98547,discriminate,0,0
98548,symptomatic,0,0
98549,and,0,0
98550,asymptomatic,0,0
98551,tendons,0,1
98552,.,0,0
98553,As,0,0
98554,such,0,0
98555,",",0,0
98556,UTC,1,0
98557,might,0,0
98558,be,0,0
98559,useful,0,0
98560,to,0,0
98561,monitor,0,0
98562,treatment,0,0
98563,protocols,0,0
98564,.,0,0
98565,Sustained,0,0
98566,benefit,0,0
98567,of,0,0
98568,continuous,0,1
98569,glucose,0,0
98570,monitoring,0,0
98571,on,0,0
98572,A1C,0,0
98573,",",0,0
98574,glucose,0,0
98575,profiles,0,0
98576,",",0,0
98577,and,0,0
98578,hypoglycemia,0,0
98579,in,0,0
98580,adults,0,0
98581,with,0,0
98582,type,0,0
98583,1,0,0
98584,diabetes,0,0
98585,.,0,0
98586,OBJECTIVE,0,0
98587,To,0,0
98588,evaluate,0,0
98589,long-term,0,0
98590,effects,0,0
98591,of,0,0
98592,continuous,1,1
98593,glucose,1,0
98594,monitoring,1,0
98595,(,1,0
98596,CGM,1,0
98597,),1,0
98598,in,0,0
98599,intensively,0,0
98600,treated,0,0
98601,adults,0,0
98602,with,0,0
98603,type,0,0
98604,1,0,0
98605,diabetes,0,0
98606,.,0,0
98607,RESEARCH,0,0
98608,DESIGN,0,0
98609,AND,0,0
98610,METHODS,0,0
98611,We,0,0
98612,studied,0,0
98613,83,0,0
98614,of,0,0
98615,86,0,0
98616,individuals,0,0
98617,>,0,0
98618,or=25,0,0
98619,years,0,0
98620,of,0,0
98621,age,0,0
98622,with,0,0
98623,type,0,0
98624,1,0,0
98625,diabetes,0,0
98626,who,0,0
98627,used,0,0
98628,CGM,0,0
98629,as,0,0
98630,part,0,0
98631,of,0,0
98632,a,0,0
98633,6-month,0,0
98634,randomized,0,0
98635,clinical,0,0
98636,trial,0,0
98637,in,0,0
98638,a,0,0
98639,subsequent,0,0
98640,6-month,0,0
98641,extension,0,0
98642,study,0,0
98643,.,0,0
98644,RESULTS,0,0
98645,After,0,0
98646,12,0,0
98647,months,0,0
98648,",",0,0
98649,median,0,0
98650,CGM,0,0
98651,use,0,0
98652,was,0,0
98653,6.8,0,0
98654,days,0,0
98655,per,0,0
98656,week,0,0
98657,.,0,0
98658,Mean,0,0
98659,change,0,0
98660,in,0,0
98661,A1C,0,0
98662,level,0,0
98663,from,0,0
98664,baseline,0,0
98665,to,0,0
98666,12,0,0
98667,months,0,0
98668,was,0,0
98669,-0.4,0,0
98670,+/-,0,0
98671,0.6,0,0
98672,%,0,0
98673,(,0,0
98674,P,0,0
98675,<,0,0
98676,0.001,0,0
98677,),0,0
98678,in,0,0
98679,subjects,0,0
98680,with,0,0
98681,baseline,0,0
98682,A1C,0,0
98683,>,0,0
98684,or=7.0,0,0
98685,%,0,0
98686,.,0,0
98687,A1C,0,0
98688,remained,0,0
98689,stable,0,0
98690,at,0,0
98691,6.4,0,0
98692,%,0,0
98693,in,0,0
98694,those,0,0
98695,with,0,0
98696,baseline,0,0
98697,A1C,0,0
98698,<,0,0
98699,7.0,0,0
98700,%,0,0
98701,.,0,0
98702,The,0,0
98703,incidence,0,0
98704,rate,0,0
98705,of,0,0
98706,severe,0,0
98707,hypoglycemia,0,0
98708,was,0,0
98709,21.8,0,0
98710,and,0,0
98711,7.1,0,0
98712,events,0,0
98713,per,0,0
98714,100,0,0
98715,person-years,0,0
98716,in,0,0
98717,the,0,0
98718,first,0,0
98719,and,0,0
98720,last,0,0
98721,6,0,0
98722,months,0,0
98723,",",0,0
98724,respectively,0,0
98725,.,0,0
98726,Time,0,0
98727,per,0,0
98728,day,0,0
98729,with,0,0
98730,glucose,0,0
98731,levels,0,0
98732,in,0,0
98733,the,0,0
98734,range,0,0
98735,of,0,0
98736,71-180,0,0
98737,mg/dl,0,0
98738,increased,0,0
98739,significantly,0,0
98740,(,0,0
98741,P,0,0
98742,=,0,0
98743,0.02,0,0
98744,),0,0
98745,from,0,0
98746,baseline,0,0
98747,to,0,0
98748,12,0,0
98749,months,0,0
98750,.,0,0
98751,CONCLUSIONS,0,0
98752,In,0,0
98753,intensively,0,0
98754,treated,0,0
98755,adults,0,0
98756,with,0,0
98757,type,0,0
98758,1,0,0
98759,diabetes,0,0
98760,",",0,0
98761,CGM,0,0
98762,use,0,0
98763,and,0,0
98764,benefit,0,0
98765,can,0,0
98766,be,0,0
98767,sustained,0,0
98768,for,0,0
98769,12,0,0
98770,months,0,0
98771,.,0,0
98772,Clinical,0,0
98773,effects,0,0
98774,of,0,0
98775,nanocrystalline,1,0
98776,hydroxyapatite,1,1
98777,paste,1,1
98778,in,0,0
98779,the,0,0
98780,treatment,0,0
98781,of,0,0
98782,intrabony,0,0
98783,periodontal,0,0
98784,defects,0,0
98785,:,0,0
98786,a,0,0
98787,randomized,0,0
98788,controlled,0,0
98789,clinical,0,0
98790,study,0,0
98791,.,0,0
98792,The,0,0
98793,purpose,0,0
98794,of,0,0
98795,the,0,0
98796,present,0,0
98797,randomized,0,0
98798,controlled,0,0
98799,clinical,0,0
98800,study,0,0
98801,was,0,0
98802,to,0,0
98803,compare,0,0
98804,the,0,0
98805,clinical,0,0
98806,outcomes,0,0
98807,of,0,0
98808,papilla,0,0
98809,preservation,0,0
98810,flap,0,1
98811,surgery,0,1
98812,with,0,0
98813,or,0,0
98814,without,0,0
98815,the,0,0
98816,application,0,0
98817,of,0,0
98818,a,0,0
98819,novel,0,0
98820,nanocrystalline,1,0
98821,hydroxyapatite,1,1
98822,(,1,0
98823,nano-HA,1,1
98824,),1,1
98825,bone,1,0
98826,graft,1,0
98827,substitute,1,0
98828,.,1,0
98829,Fourteen,0,0
98830,patients,0,0
98831,with,0,0
98832,paired,0,0
98833,intrabony,0,0
98834,periodontal,0,0
98835,defects,0,0
98836,of,0,0
98837,?,0,0
98838,4,0,0
98839,mm,0,0
98840,participated,0,0
98841,in,0,0
98842,this,0,0
98843,split-mouth,0,1
98844,design,0,0
98845,study,0,0
98846,.,0,0
98847,The,0,0
98848,defects,0,0
98849,in,0,0
98850,each,0,0
98851,subject,0,0
98852,were,1,0
98853,randomly,1,0
98854,selected,1,0
98855,to,1,0
98856,receive,1,0
98857,nano-HA,1,0
98858,paste,1,1
98859,in,1,0
98860,conjunction,1,1
98861,with,1,0
98862,papilla,1,0
98863,preservation,1,0
98864,flaps,1,1
98865,or,1,0
98866,papilla,1,0
98867,preservation,1,0
98868,flaps,1,1
98869,alone,1,0
98870,.,1,0
98871,Probing,1,0
98872,bone,1,0
98873,levels,1,0
98874,(,1,0
98875,PBL,1,0
98876,),1,0
98877,from,1,0
98878,a,1,0
98879,customized,1,1
98880,acrylic,1,1
98881,stent,1,1
98882,and,1,0
98883,probing,1,0
98884,pocket,1,0
98885,depths,1,0
98886,(,1,0
98887,PPD,1,1
98888,),1,0
98889,were,1,0
98890,measured,1,0
98891,at,1,0
98892,baseline,1,0
98893,and,1,0
98894,again,1,0
98895,6,1,0
98896,months,1,0
98897,following,1,0
98898,surgery,1,0
98899,.,1,0
98900,No,0,0
98901,differences,0,0
98902,in,0,0
98903,any,0,0
98904,of,0,0
98905,the,0,0
98906,investigated,0,0
98907,parameters,0,0
98908,were,0,0
98909,observed,0,0
98910,at,0,0
98911,baseline,0,0
98912,between,0,0
98913,the,0,0
98914,two,0,0
98915,groups,0,0
98916,.,0,0
98917,Healing,0,0
98918,was,0,0
98919,uneventful,0,0
98920,in,0,0
98921,all,0,0
98922,patients,0,0
98923,.,0,0
98924,Both,0,0
98925,treatments,0,0
98926,resulted,0,0
98927,in,0,0
98928,significant,0,0
98929,improvements,0,0
98930,between,0,0
98931,baseline,0,0
98932,and,0,0
98933,6,0,0
98934,months,0,0
98935,(,0,0
98936,p,0,0
98937,<,0,0
98938,0.05,0,0
98939,),0,0
98940,.,0,0
98941,At,0,0
98942,6,0,0
98943,months,0,0
98944,after,0,0
98945,therapy,0,1
98946,",",0,0
98947,the,0,0
98948,sites,0,0
98949,treated,0,0
98950,with,1,0
98951,nano-HA,1,0
98952,paste,1,1
98953,showed,1,0
98954,a,0,0
98955,reduction,0,0
98956,in,0,0
98957,mean,0,0
98958,PPD,0,1
98959,from,0,0
98960,8.3,0,0
98961,?,0,0
98962,1.2,0,0
98963,to,0,0
98964,4.0,0,0
98965,?,0,0
98966,1.1,0,0
98967,mm,0,0
98968,and,0,0
98969,a,0,0
98970,gain,0,0
98971,in,0,0
98972,PBL,0,0
98973,of,0,0
98974,4.3,0,0
98975,?,0,0
98976,1.4,0,0
98977,mm,0,0
98978,",",0,0
98979,whereas,0,0
98980,in,0,0
98981,the,0,0
98982,control,0,0
98983,group,0,0
98984,",",0,0
98985,the,0,0
98986,mean,0,0
98987,PPD,0,1
98988,changed,0,0
98989,from,0,0
98990,7.9,0,0
98991,?,0,0
98992,1.2,0,0
98993,mm,0,0
98994,to,0,0
98995,5.0,0,0
98996,?,0,0
98997,1.2,0,0
98998,mm,0,0
98999,and,0,0
99000,PBL,0,0
99001,gain,0,0
99002,was,0,0
99003,2.6,0,0
99004,?,0,0
99005,1.4,0,0
99006,mm,0,0
99007,.,0,0
99008,Results,0,0
99009,demonstrated,0,0
99010,statistically,0,0
99011,greater,0,0
99012,PPD,0,1
99013,reduction,0,0
99014,and,0,0
99015,PBL,0,1
99016,gain,0,0
99017,(,0,0
99018,p,0,0
99019,<,0,0
99020,0.05,0,0
99021,),0,0
99022,in,0,0
99023,the,0,0
99024,test,0,0
99025,group,0,0
99026,as,0,0
99027,compared,0,0
99028,with,0,0
99029,the,0,0
99030,control,0,0
99031,group,0,0
99032,.,0,0
99033,In,0,0
99034,conclusion,0,0
99035,",",0,0
99036,after,0,0
99037,6,0,0
99038,months,0,0
99039,",",0,0
99040,the,0,0
99041,treatment,0,0
99042,of,0,0
99043,intrabony,0,0
99044,periodontal,0,0
99045,defects,0,0
99046,with,0,0
99047,a,0,0
99048,nano-HA,0,0
99049,paste,0,1
99050,leads,0,0
99051,to,0,0
99052,significantly,0,0
99053,improved,0,0
99054,clinical,0,0
99055,outcomes,0,0
99056,when,0,0
99057,compared,0,0
99058,with,1,0
99059,papilla,1,0
99060,preservation,1,0
99061,flap,1,1
99062,surgery,1,0
99063,alone,0,0
99064,.,0,0
99065,Assessment,0,0
99066,of,0,0
99067,elementary,0,0
99068,school,0,0
99069,students,0,0
99070,',0,0
99071,sun,0,0
99072,protection,0,0
99073,behaviors,0,0
99074,.,0,0
99075,BACKGROUND/OBJECTIVES,0,0
99076,Studies,0,0
99077,suggest,0,0
99078,that,0,0
99079,excessive,0,0
99080,sun,0,0
99081,exposure,0,0
99082,in,0,0
99083,childhood,0,0
99084,contributes,0,0
99085,to,0,0
99086,the,0,0
99087,development,0,0
99088,of,0,0
99089,skin,0,0
99090,cancer,0,0
99091,later,0,0
99092,in,0,0
99093,life,0,0
99094,.,0,0
99095,METHODS,0,0
99096,This,0,0
99097,study,0,0
99098,explores,0,0
99099,4th,0,0
99100,grade,0,0
99101,student,0,0
99102,assessment,0,0
99103,of,0,0
99104,their,0,0
99105,sun,0,0
99106,protection,0,0
99107,behaviors,0,0
99108,.,0,0
99109,This,0,0
99110,study,0,0
99111,used,0,0
99112,baseline,0,0
99113,data,0,0
99114,collected,0,0
99115,in,0,0
99116,the,0,0
99117,Fall,0,0
99118,of,0,0
99119,2006,0,0
99120,for,0,0
99121,the,0,0
99122,Sun,0,1
99123,Protection,0,0
99124,for,0,0
99125,Florida,0,0
99126,'s,0,0
99127,Children,0,0
99128,(,0,0
99129,SPF,0,1
99130,),0,0
99131,project,0,0
99132,.,0,0
99133,In,0,0
99134,brief,0,0
99135,",",0,0
99136,the,0,0
99137,SPF,0,1
99138,project,0,0
99139,is,0,0
99140,a,0,0
99141,group,0,0
99142,randomized,0,0
99143,trial,0,0
99144,to,0,0
99145,test,0,0
99146,the,0,0
99147,effectiveness,0,0
99148,of,0,0
99149,a,0,0
99150,school,1,0
99151,based,1,0
99152,intervention,1,1
99153,promoting,1,0
99154,sun,1,0
99155,protection,1,0
99156,in,1,0
99157,general,1,0
99158,",",1,0
99159,and,1,0
99160,hat,1,1
99161,use,1,0
99162,in,1,0
99163,particular,1,0
99164,",",0,0
99165,in,0,0
99166,Hillsborough,0,0
99167,County,0,0
99168,Schools,0,1
99169,",",0,0
99170,Florida,0,0
99171,.,0,0
99172,The,0,0
99173,data,0,0
99174,reported,0,0
99175,in,0,0
99176,this,0,0
99177,study,0,0
99178,were,0,0
99179,collected,0,0
99180,at,0,0
99181,baseline,0,0
99182,before,0,0
99183,any,0,0
99184,intervention,0,1
99185,activities,0,0
99186,was,0,0
99187,initiated,0,0
99188,.,0,0
99189,RESULTS,0,0
99190,The,0,0
99191,self-reported,0,0
99192,use,0,0
99193,of,0,0
99194,various,0,0
99195,methods,0,0
99196,of,0,0
99197,sun,1,0
99198,protection,1,0
99199,was,0,0
99200,low,0,0
99201,.,0,0
99202,Only,0,0
99203,a,0,0
99204,small,0,0
99205,percentage,0,0
99206,of,0,0
99207,students,0,0
99208,wore,0,0
99209,long,1,0
99210,sleeves,1,1
99211,or,0,0
99212,a,0,0
99213,hat,1,1
99214,with,1,0
99215,a,1,0
99216,brim,1,1
99217,before,0,0
99218,leaving,0,0
99219,for,0,0
99220,school,0,0
99221,.,0,0
99222,In,0,0
99223,addition,0,0
99224,",",0,0
99225,few,0,0
99226,students,0,0
99227,wore,0,0
99228,a,0,0
99229,hat,1,1
99230,with,1,0
99231,a,1,0
99232,wide,1,0
99233,brim,1,1
99234,when,0,0
99235,outside,0,0
99236,but,0,0
99237,not,0,0
99238,at,0,0
99239,school,0,0
99240,.,0,0
99241,Students,0,0
99242,spent,0,0
99243,an,0,0
99244,average,0,0
99245,of,0,0
99246,59.1,0,0
99247,minutes,0,0
99248,per,0,0
99249,week,0,0
99250,outdoors,0,0
99251,while,0,0
99252,attending,0,0
99253,school,0,0
99254,and,0,0
99255,35.5,0,0
99256,minutes,0,0
99257,during,0,0
99258,peak,0,0
99259,sun,0,0
99260,exposure,0,0
99261,.,0,0
99262,CONCLUSION,0,0
99263,Sun,0,1
99264,exposure,0,0
99265,at,0,0
99266,school,0,0
99267,poses,0,0
99268,a,0,0
99269,significant,0,0
99270,risk,0,0
99271,to,0,0
99272,student,0,0
99273,health,0,0
99274,and,0,0
99275,more,0,0
99276,needs,0,0
99277,to,0,0
99278,be,0,0
99279,carried,0,0
99280,out,0,0
99281,to,0,0
99282,promote,0,0
99283,the,0,0
99284,use,0,0
99285,of,0,0
99286,a,0,0
99287,wide-brimmed,1,1
99288,hat,1,1
99289,and,0,0
99290,limiting,0,0
99291,student,0,0
99292,sun,0,0
99293,exposure,0,0
99294,.,0,0
99295,[,0,0
99296,Effect,0,0
99297,of,0,0
99298,transcranial,1,1
99299,electrostimulation,1,1
99300,on,0,0
99301,clinical,0,0
99302,and,0,0
99303,laboratory,0,0
99304,characteristics,0,0
99305,in,0,0
99306,patients,0,0
99307,with,0,0
99308,gastric,0,0
99309,ulcer,0,0
99310,],0,0
99311,.,0,0
99312,The,0,0
99313,study,0,0
99314,included,0,0
99315,100,0,0
99316,patients,0,0
99317,with,0,0
99318,gastric,0,0
99319,ulcer,0,0
99320,aged,0,0
99321,from,0,0
99322,16,0,0
99323,to,0,0
99324,60,0,0
99325,years,0,0
99326,.,0,0
99327,In,0,0
99328,58,0,0
99329,patients,0,0
99330,",",0,0
99331,traditional,1,1
99332,treatment,1,0
99333,was,1,0
99334,supplemented,1,1
99335,by,1,0
99336,transcranial,1,1
99337,electrotherapy,1,1
99338,using,1,0
99339,a,1,0
99340,TRANSAIR-02,1,0
99341,apparatus,1,0
99342,.,1,0
99343,Laboratory,0,0
99344,studies,0,0
99345,included,0,0
99346,measurements,0,0
99347,of,0,0
99348,lactoferrin,0,1
99349,(,0,0
99350,LF,0,0
99351,),0,1
99352,and,0,0
99353,tumour,0,0
99354,necrosis,0,0
99355,factor-alpha,0,0
99356,(,0,0
99357,TNF-alpha,0,1
99358,),0,0
99359,",",0,0
99360,besides,0,0
99361,standard,0,0
99362,analyses,0,0
99363,.,0,0
99364,Combined,1,0
99365,treatment,1,0
99366,(,1,0
99367,traditional,1,1
99368,therapy,1,1
99369,plus,1,1
99370,electrostimulation,1,1
99371,),1,0
99372,resulted,0,0
99373,in,0,0
99374,a,0,0
99375,significant,0,0
99376,reduction,0,0
99377,in,0,0
99378,duration,0,0
99379,of,0,0
99380,the,0,0
99381,main,0,0
99382,symptoms,0,0
99383,of,0,0
99384,the,0,0
99385,gastric,0,0
99386,ulcer,0,0
99387,depending,0,0
99388,on,0,0
99389,the,0,0
99390,severity,0,0
99391,of,0,0
99392,ulceration,0,0
99393,process,0,0
99394,",",0,0
99395,patients,0,0
99396,',0,0
99397,age,0,0
99398,and,0,0
99399,sex,0,0
99400,.,0,0
99401,Moreover,0,0
99402,",",0,0
99403,it,0,0
99404,facilitated,0,0
99405,ulcer,0,0
99406,scarring,0,0
99407,and,0,0
99408,had,0,0
99409,beneficial,0,0
99410,effect,0,0
99411,on,0,0
99412,dynamics,0,0
99413,of,0,0
99414,serum,0,0
99415,LF,0,0
99416,and,0,0
99417,TNF-alpha,0,0
99418,levels,0,0
99419,.,0,0
99420,Azelnidipine,1,1
99421,and,0,0
99422,amlodipine,1,1
99423,anti-coronary,0,0
99424,atherosclerosis,0,0
99425,trial,0,0
99426,in,0,0
99427,hypertensive,0,0
99428,patients,0,0
99429,undergoing,0,0
99430,coronary,0,0
99431,intervention,0,1
99432,by,0,0
99433,serial,0,0
99434,volumetric,0,1
99435,intravascular,0,0
99436,ultrasound,0,1
99437,analysis,0,0
99438,in,0,0
99439,Juntendo,0,1
99440,university,0,0
99441,(,0,0
99442,ALPS-J,0,1
99443,),0,0
99444,.,0,0
99445,PURPOSE,0,0
99446,Many,0,0
99447,trials,0,0
99448,have,0,0
99449,shown,0,0
99450,that,0,0
99451,calcium,0,1
99452,channel,0,0
99453,blockers,0,1
99454,(,0,0
99455,CCBs,0,0
99456,),0,0
99457,can,0,0
99458,reduce,0,0
99459,the,0,0
99460,cardiovascular,0,0
99461,(,0,0
99462,CV,0,1
99463,),0,0
99464,events,0,0
99465,in,0,0
99466,patients,0,0
99467,with,0,0
99468,coronary,0,0
99469,artery,0,0
99470,disease,0,0
99471,(,0,0
99472,CAD,0,0
99473,),0,0
99474,.,0,0
99475,The,0,0
99476,mechanisms,0,0
99477,of,0,0
99478,this,0,0
99479,effect,0,0
99480,could,0,0
99481,be,0,0
99482,associated,0,0
99483,with,0,0
99484,plaque,0,0
99485,regression,0,0
99486,due,0,0
99487,to,0,0
99488,the,0,0
99489,anti-atherosclerotic,0,0
99490,properties,0,0
99491,of,0,0
99492,CCBs,0,0
99493,.,0,0
99494,The,0,0
99495,goal,0,0
99496,of,0,0
99497,this,0,0
99498,study,0,0
99499,is,0,0
99500,to,0,0
99501,determine,0,0
99502,the,0,0
99503,effects,0,0
99504,of,0,0
99505,CCB,0,0
99506,on,0,0
99507,volumetric,0,0
99508,quantitative,0,0
99509,changes,0,0
99510,of,0,0
99511,coronary,0,0
99512,plaques,0,0
99513,accessed,0,0
99514,by,0,0
99515,intravascular,0,0
99516,ultrasound,0,1
99517,(,0,0
99518,IVUS,0,1
99519,),0,0
99520,.,0,0
99521,To,0,0
99522,confirm,0,0
99523,this,0,0
99524,hypothesis,0,0
99525,",",0,0
99526,a,0,0
99527,multicenter,0,0
99528,randomized,0,0
99529,trial,0,0
99530,of,0,0
99531,CCBs,0,1
99532,treatment,0,0
99533,with,0,0
99534,azelnidipine,1,1
99535,or,0,1
99536,amlodipine,1,1
99537,will,0,0
99538,be,0,0
99539,conducted,0,0
99540,in,0,0
99541,hypertensive,0,0
99542,CAD,0,0
99543,patients,0,0
99544,undergoing,0,0
99545,elective,0,0
99546,percutaneous,0,1
99547,coronary,0,0
99548,intervention,0,1
99549,(,0,0
99550,PCI,0,0
99551,),0,0
99552,.,0,0
99553,METHODS,0,0
99554,AND,0,0
99555,RESULTS,0,0
99556,Patients,0,0
99557,who,0,0
99558,have,0,0
99559,hypertension,0,0
99560,and,0,0
99561,are,0,0
99562,scheduled,0,0
99563,for,0,0
99564,PCI,0,0
99565,will,0,0
99566,be,0,0
99567,enrolled,0,0
99568,.,0,0
99569,Subjects,0,0
99570,will,0,0
99571,be,0,0
99572,randomized,0,0
99573,to,0,0
99574,azelnidipine,1,1
99575,or,0,0
99576,amlodipine,1,1
99577,and,0,0
99578,observed,0,0
99579,for,0,0
99580,48,0,0
99581,weeks,0,0
99582,.,0,0
99583,The,0,0
99584,primary,0,0
99585,endpoint,0,0
99586,will,0,0
99587,be,0,0
99588,the,0,0
99589,percent,0,0
99590,change,0,0
99591,of,0,0
99592,coronary,0,0
99593,plaque,0,0
99594,volume,0,0
99595,.,0,0
99596,The,0,0
99597,secondary,0,0
99598,endpoint,0,0
99599,will,0,0
99600,include,0,0
99601,inflammatory,0,0
99602,markers,0,0
99603,",",0,0
99604,antioxidant,0,1
99605,activity,0,0
99606,",",0,0
99607,and,0,0
99608,incidence,0,0
99609,of,0,0
99610,composite,0,0
99611,cardiovascular,0,0
99612,events,0,0
99613,.,0,0
99614,CONCLUSIONS,0,0
99615,In,0,0
99616,this,0,0
99617,study,0,0
99618,",",0,0
99619,we,0,0
99620,will,0,0
99621,investigate,0,0
99622,the,0,0
99623,improvement,0,0
99624,of,0,0
99625,coronary,0,0
99626,plaque,0,0
99627,with,0,0
99628,IVUS,0,1
99629,by,0,0
99630,treatment,0,0
99631,with,0,0
99632,two,0,0
99633,dihydropyridine,0,1
99634,CCBs,0,0
99635,in,0,0
99636,hypertensive,0,0
99637,patients,0,0
99638,undergoing,0,0
99639,elective,0,0
99640,PCI,0,1
99641,.,0,0
99642,This,0,0
99643,result,0,0
99644,will,0,0
99645,lead,0,0
99646,to,0,0
99647,the,0,0
99648,discovery,0,0
99649,of,0,0
99650,more,0,0
99651,effective,0,0
99652,drug,0,0
99653,therapy,0,1
99654,for,0,0
99655,inhibition,0,0
99656,of,0,0
99657,coronary,0,0
99658,events,0,0
99659,.,0,0
99660,Design,0,0
99661,of,0,0
99662,the,0,0
99663,DEFINE,0,1
99664,trial,0,0
99665,:,0,0
99666,determining,0,0
99667,the,0,0
99668,EFficacy,0,0
99669,and,0,0
99670,tolerability,0,0
99671,of,0,0
99672,CETP,0,1
99673,INhibition,0,0
99674,with,0,0
99675,AnacEtrapib,1,1
99676,.,1,0
99677,BACKGROUND,0,0
99678,Residual,0,1
99679,cardiovascular,0,0
99680,(,0,0
99681,CV,0,1
99682,),0,0
99683,risk,0,0
99684,often,0,0
99685,remains,0,0
99686,high,0,0
99687,despite,0,0
99688,statin,0,1
99689,therapy,0,1
99690,to,0,0
99691,lower,0,0
99692,low-density,0,0
99693,lipoprotein,0,0
99694,cholesterol,0,0
99695,(,0,0
99696,LDL-C,0,0
99697,),0,0
99698,.,0,0
99699,New,0,0
99700,therapies,0,0
99701,to,0,0
99702,raise,0,0
99703,high-density,0,0
99704,lipoprotein,0,0
99705,cholesterol,0,0
99706,(,0,0
99707,HDL-C,0,1
99708,),0,0
99709,are,0,0
99710,currently,0,0
99711,being,0,0
99712,investigated,0,0
99713,.,0,0
99714,Anacetrapib,1,1
99715,is,0,0
99716,a,0,0
99717,cholesteryl,0,0
99718,ester,0,1
99719,transfer,0,1
99720,protein,0,1
99721,(,0,0
99722,CETP,0,1
99723,),0,0
99724,inhibitor,0,1
99725,that,0,0
99726,raises,0,0
99727,HDL-C,0,0
99728,and,0,0
99729,reduces,0,0
99730,LDL-C,0,0
99731,when,0,0
99732,administered,0,0
99733,alone,0,0
99734,or,0,0
99735,with,0,0
99736,a,0,0
99737,statin,0,1
99738,.,0,0
99739,Adverse,0,0
99740,effects,0,0
99741,on,0,0
99742,blood,0,0
99743,pressure,0,0
99744,",",0,0
99745,electrolytes,0,0
99746,",",0,0
99747,and,0,0
99748,aldosterone,0,0
99749,levels,0,0
99750,",",0,0
99751,seen,0,0
99752,with,0,0
99753,another,0,0
99754,drug,0,0
99755,in,0,0
99756,this,0,0
99757,class,0,0
99758,",",0,0
99759,have,0,0
99760,not,0,0
99761,been,0,0
99762,noted,0,0
99763,in,0,0
99764,studies,0,0
99765,of,0,0
99766,anacetrapib,1,1
99767,to,0,0
99768,date,0,0
99769,.,0,0
99770,METHODS,0,0
99771,Determining,0,0
99772,the,0,0
99773,EFficacy,0,0
99774,and,0,0
99775,Tolerability,0,0
99776,of,0,0
99777,CETP,0,1
99778,INhibition,0,0
99779,with,0,0
99780,AnacEtrapib,1,1
99781,(,0,0
99782,DEFINE,0,1
99783,),0,1
99784,is,0,0
99785,a,0,0
99786,randomized,0,0
99787,",",0,0
99788,double-blind,0,0
99789,",",0,0
99790,placebo-controlled,1,1
99791,trial,0,0
99792,to,0,0
99793,assess,0,0
99794,the,0,0
99795,efficacy,0,0
99796,and,0,0
99797,safety,0,0
99798,profile,0,0
99799,of,0,0
99800,anacetrapib,1,1
99801,in,0,0
99802,patients,0,0
99803,with,0,0
99804,coronary,0,0
99805,heart,0,0
99806,disease,0,0
99807,(,0,0
99808,CHD,0,1
99809,),0,0
99810,or,0,1
99811,CHD,0,1
99812,risk,0,0
99813,equivalents,0,1
99814,(,0,0
99815,clinical,0,0
99816,trials.gov,0,0
99817,NCT00685776,0,1
99818,),0,0
99819,.,0,0
99820,Eligible,0,0
99821,patients,0,0
99822,at,0,0
99823,National,0,0
99824,Cholesterol,0,0
99825,Education,0,1
99826,Program-Adult,0,0
99827,Treatment,0,1
99828,Panel,0,0
99829,III,0,0
99830,LDL-C,0,0
99831,treatment,0,0
99832,goal,0,0
99833,on,0,0
99834,a,0,0
99835,statin,0,1
99836,",",0,0
99837,with,0,0
99838,or,0,0
99839,without,0,0
99840,other,0,0
99841,lipid-modifying,0,0
99842,medications,0,0
99843,",",0,0
99844,are,0,0
99845,treated,0,0
99846,with,0,0
99847,anacetrapib,1,1
99848,",",0,0
99849,100,0,0
99850,mg,0,0
99851,",",0,0
99852,or,0,0
99853,placebo,1,1
99854,for,0,0
99855,18,0,0
99856,months,0,0
99857,",",0,0
99858,followed,0,0
99859,by,0,0
99860,a,0,0
99861,3-month,0,0
99862,",",0,0
99863,poststudy,0,0
99864,follow-up,0,0
99865,.,0,0
99866,The,0,0
99867,primary,0,0
99868,end,0,0
99869,points,0,0
99870,are,0,0
99871,percent,0,0
99872,change,0,0
99873,from,0,0
99874,baseline,0,0
99875,in,0,0
99876,LDL-C,0,0
99877,and,0,0
99878,the,0,0
99879,safety,0,0
99880,and,0,0
99881,tolerability,0,0
99882,of,0,0
99883,anacetrapib,1,1
99884,.,1,0
99885,Comprehensive,0,0
99886,preplanned,0,0
99887,interim,0,0
99888,safety,0,0
99889,analyses,0,0
99890,will,0,0
99891,be,0,0
99892,performed,0,0
99893,at,0,0
99894,the,0,0
99895,6-,0,1
99896,and,0,0
99897,12-month,0,0
99898,time,0,0
99899,points,0,0
99900,to,0,0
99901,examine,0,0
99902,treatment,0,0
99903,effects,0,0
99904,on,0,0
99905,key,0,0
99906,safety,0,0
99907,end,0,0
99908,points,0,0
99909,",",0,0
99910,including,0,0
99911,blood,0,0
99912,pressure,0,0
99913,and,0,0
99914,electrolytes,0,0
99915,.,0,0
99916,A,0,0
99917,preplanned,0,0
99918,Bayesian,0,0
99919,analysis,0,0
99920,will,0,0
99921,be,0,0
99922,performed,0,0
99923,to,0,0
99924,interpret,0,0
99925,the,0,0
99926,CV,0,1
99927,event,0,0
99928,distribution,0,0
99929,",",0,0
99930,given,0,0
99931,the,0,0
99932,limited,0,0
99933,number,0,0
99934,of,0,0
99935,events,0,0
99936,expected,0,0
99937,in,0,0
99938,this,0,0
99939,study,0,0
99940,.,0,0
99941,RESULTS,0,0
99942,A,0,0
99943,total,0,0
99944,of,0,0
99945,"2,757",0,0
99946,patients,0,0
99947,were,0,0
99948,screened,0,0
99949,at,0,0
99950,153,0,0
99951,centers,0,0
99952,in,0,0
99953,20,0,0
99954,countries,0,0
99955,",",0,0
99956,and,0,0
99957,"1,623",0,0
99958,patients,0,0
99959,were,0,0
99960,randomized,0,0
99961,into,0,0
99962,the,0,0
99963,trial,0,0
99964,.,0,0
99965,Lipid,0,0
99966,results,0,0
99967,",",0,0
99968,clinical,0,0
99969,CV,0,1
99970,events,0,0
99971,",",0,0
99972,and,0,0
99973,safety,0,0
99974,outcomes,0,0
99975,from,0,0
99976,this,0,0
99977,trial,0,0
99978,are,0,0
99979,anticipated,0,0
99980,in,0,0
99981,2010,0,0
99982,.,0,0
99983,Comparison,0,0
99984,of,0,0
99985,the,0,0
99986,effect,0,0
99987,of,0,0
99988,intra-arterial,1,1
99989,versus,0,0
99990,intravenous,1,1
99991,heparin,1,1
99992,on,0,0
99993,radial,0,1
99994,artery,0,0
99995,occlusion,0,0
99996,after,0,0
99997,transradial,0,1
99998,catheterization,0,0
99999,.,0,0
100000,Radial,0,0
100001,artery,0,0
100002,occlusion,0,0
100003,(,0,0
100004,RAO,0,1
100005,),0,1
100006,is,0,0
100007,an,0,0
100008,infrequent,0,0
100009,",",0,0
100010,asymptomatic,0,0
100011,",",0,0
100012,complication,0,0
100013,of,0,0
100014,transradial,0,1
100015,catheterization,0,0
100016,and,0,0
100017,probably,0,0
100018,1,0,0
100019,of,0,0
100020,the,0,0
100021,few,0,0
100022,.,0,0
100023,Intravenous,0,0
100024,heparin,0,1
100025,and,0,0
100026,patent,0,0
100027,hemostasis,0,0
100028,lower,0,0
100029,its,0,0
100030,incidence,0,0
100031,.,0,0
100032,A,0,0
100033,possible,0,0
100034,local,0,0
100035,effect,0,0
100036,of,0,0
100037,intra-arterially,0,1
100038,administered,0,0
100039,heparin,1,1
100040,during,0,0
100041,transradial,0,1
100042,procedures,0,0
100043,has,0,0
100044,not,0,0
100045,been,0,0
100046,evaluated,0,0
100047,.,0,0
100048,We,0,0
100049,studied,0,0
100050,500,0,0
100051,consecutive,0,0
100052,patients,0,0
100053,randomized,1,0
100054,to,1,0
100055,an,1,0
100056,intravenous,1,1
100057,group,1,0
100058,(,1,0
100059,n,1,0
100060,=,1,0
100061,250,1,1
100062,),1,0
100063,",",1,0
100064,receiving,1,0
100065,50,1,0
100066,U/kg,1,0
100067,of,1,0
100068,unfractionated,1,1
100069,heparin,1,1
100070,(,1,0
100071,maximal,1,0
100072,dose,1,0
100073,"5,000",1,1
100074,U,1,1
100075,),1,0
100076,intravenously,1,1
100077,",",1,0
100078,and,1,0
100079,an,1,0
100080,intra-arterial,1,1
100081,group,1,0
100082,(,1,0
100083,n,1,0
100084,=,1,0
100085,250,1,1
100086,),1,0
100087,receiving,1,0
100088,the,1,0
100089,same,1,0
100090,dose,1,0
100091,intra-arterially,1,1
100092,.,1,0
100093,All,0,0
100094,patients,0,0
100095,received,0,0
100096,a,0,0
100097,vasodilator,1,0
100098,cocktail,1,1
100099,intra-arterially,1,1
100100,and,1,0
100101,underwent,1,0
100102,cardiac,1,0
100103,catheterization,1,0
100104,using,1,0
100105,a,1,0
100106,5F,1,0
100107,introducer,1,0
100108,sheath,1,0
100109,and,1,0
100110,catheters,1,1
100111,.,1,0
100112,The,0,0
100113,activated,0,0
100114,clotting,0,0
100115,time,0,0
100116,was,0,0
100117,measured,0,0
100118,at,0,0
100119,the,0,0
100120,end,0,0
100121,of,0,0
100122,the,0,0
100123,procedure,0,0
100124,.,0,0
100125,All,0,0
100126,patients,0,0
100127,received,0,0
100128,hemostasis,0,0
100129,with,0,0
100130,a,0,0
100131,radial,0,1
100132,compression,0,1
100133,device,0,1
100134,(,0,0
100135,TR,0,0
100136,Band,0,1
100137,),0,0
100138,",",0,0
100139,applied,0,0
100140,after,0,0
100141,sheath,0,0
100142,removal,0,0
100143,",",0,0
100144,for,0,0
100145,2,0,0
100146,hours,0,0
100147,.,0,0
100148,A,0,0
100149,plethysmographic,0,0
100150,evaluation,0,0
100151,for,0,0
100152,RAO,0,0
100153,was,0,0
100154,performed,0,0
100155,at,0,0
100156,24,0,0
100157,hours,0,0
100158,and,0,0
100159,30,0,0
100160,days,0,0
100161,after,0,0
100162,the,0,0
100163,procedure,0,0
100164,.,0,0
100165,Early,0,0
100166,RAO,0,0
100167,occurred,0,0
100168,in,0,0
100169,5.6,0,0
100170,%,0,0
100171,(,0,0
100172,n,0,0
100173,=,0,0
100174,14,0,0
100175,),0,0
100176,of,0,0
100177,the,0,0
100178,intravenous,0,1
100179,group,0,0
100180,and,0,0
100181,6,0,0
100182,%,0,0
100183,(,0,0
100184,n,0,0
100185,=,0,0
100186,15,0,0
100187,),0,0
100188,of,0,0
100189,the,0,0
100190,intra-arterial,0,1
100191,group,0,0
100192,.,0,0
100193,The,0,0
100194,difference,0,0
100195,was,0,0
100196,not,0,0
100197,statistically,0,0
100198,significant,0,0
100199,(,0,0
100200,chi-square,0,0
100201,=,0,0
100202,0.037,0,0
100203,",",0,0
100204,p,0,0
100205,>,0,0
100206,0.8,0,0
100207,),0,0
100208,.,0,0
100209,Chronic,0,0
100210,RAO,0,0
100211,occurred,0,0
100212,in,0,0
100213,3.2,0,0
100214,%,0,0
100215,",",0,0
100216,(,0,0
100217,n,0,0
100218,=,0,0
100219,8,0,0
100220,),0,0
100221,of,0,0
100222,the,0,0
100223,intravenous,0,1
100224,group,0,0
100225,compared,0,0
100226,to,0,0
100227,4,0,0
100228,%,0,0
100229,(,0,0
100230,n,0,0
100231,=,0,0
100232,10,0,0
100233,),0,0
100234,of,0,0
100235,the,0,0
100236,intra-arterial,0,1
100237,group,0,0
100238,.,0,0
100239,The,0,0
100240,difference,0,0
100241,was,0,0
100242,not,0,0
100243,statistically,0,0
100244,significant,0,0
100245,(,0,0
100246,chi-square,0,0
100247,=,0,0
100248,0.231,0,0
100249,",",0,0
100250,p,0,0
100251,>,0,0
100252,0.6,0,0
100253,),0,0
100254,.,0,0
100255,The,0,0
100256,activated,0,0
100257,clotting,0,0
100258,time,0,0
100259,was,0,0
100260,211,0,0
100261,+/-,0,0
100262,16,0,0
100263,seconds,0,0
100264,in,0,0
100265,the,0,0
100266,intravenous,0,1
100267,group,0,0
100268,and,0,0
100269,213,0,0
100270,+/-,0,0
100271,17,0,0
100272,seconds,0,0
100273,in,0,0
100274,the,0,0
100275,intra-arterial,0,1
100276,group,0,0
100277,",",0,0
100278,a,0,0
100279,statistically,0,0
100280,insignificant,0,0
100281,difference,0,0
100282,(,0,0
100283,t,0,0
100284,=,0,0
100285,-1.095,0,0
100286,",",0,0
100287,p,0,0
100288,>,0,0
100289,0.2,0,0
100290,),0,0
100291,.,0,0
100292,In,0,0
100293,conclusion,0,0
100294,",",0,0
100295,intra-arterial,0,1
100296,and,0,0
100297,intravenous,0,1
100298,heparin,0,1
100299,administration,0,0
100300,provide,0,0
100301,comparable,0,0
100302,efficacy,0,0
100303,in,0,0
100304,preventing,0,0
100305,RAO,0,1
100306,",",0,0
100307,favoring,0,0
100308,a,0,0
100309,probable,0,0
100310,systemically,0,0
100311,mediated,0,0
100312,mechanism,0,0
100313,of,0,0
100314,action,0,0
100315,",",0,0
100316,rather,0,0
100317,than,0,0
100318,a,0,0
100319,local,0,0
100320,effect,0,0
100321,.,0,0
100322,Unstable,0,0
100323,angina,0,0
100324,.,0,0
100325,Quality,0,0
100326,of,0,0
100327,life,0,0
100328,.,0,0
100329,Immunologic,0,0
100330,profiles,0,0
100331,of,0,0
100332,persons,0,0
100333,recruited,0,0
100334,for,0,0
100335,a,0,0
100336,randomized,0,0
100337,",",0,0
100338,placebo-controlled,1,1
100339,clinical,0,0
100340,trial,0,0
100341,of,0,0
100342,hookworm,0,0
100343,infection,0,0
100344,.,0,0
100345,Data,0,0
100346,from,0,0
100347,epidemiologic,0,0
100348,studies,0,0
100349,suggest,0,0
100350,that,0,0
100351,hookworm,0,0
100352,infections,0,0
100353,",",0,0
100354,in,0,0
100355,establishing,0,0
100356,an,0,0
100357,immunologic,0,0
100358,phenotype,0,0
100359,conducive,0,0
100360,to,0,0
100361,parasite,0,0
100362,survival,0,0
100363,",",0,0
100364,may,0,0
100365,protect,0,0
100366,against,0,0
100367,the,0,0
100368,development,0,0
100369,of,0,0
100370,allergic,0,0
100371,disease,0,0
100372,.,0,0
100373,We,0,0
100374,describe,0,0
100375,immunologic,0,0
100376,findings,0,0
100377,from,0,0
100378,a,0,0
100379,clinical,0,0
100380,study,0,0
100381,designed,0,0
100382,to,0,0
100383,investigate,0,0
100384,the,0,0
100385,safety,0,0
100386,of,0,0
100387,iatrogenic,1,0
100388,hookworm,1,1
100389,infection,1,0
100390,in,0,0
100391,participants,0,0
100392,with,0,0
100393,allergic,0,0
100394,rhinitis,0,0
100395,.,0,0
100396,The,0,0
100397,low,0,0
100398,",",0,0
100399,relatively,0,0
100400,safe,0,0
100401,level,0,0
100402,of,0,0
100403,hookworm,1,1
100404,infection,1,0
100405,used,0,0
100406,in,0,0
100407,this,0,0
100408,study,0,0
100409,was,0,0
100410,immunogenic,0,0
100411,",",0,0
100412,inducing,0,0
100413,eosinophilia,0,0
100414,and,0,0
100415,a,0,0
100416,significant,0,0
100417,specific,0,0
100418,IgG,0,0
100419,response,0,0
100420,.,0,0
100421,Importantly,0,0
100422,",",0,0
100423,no,0,0
100424,potentiation,0,0
100425,of,0,0
100426,IgE,0,1
100427,responses,0,0
100428,to,0,0
100429,the,0,0
100430,environmental,0,0
100431,allergens,0,0
100432,to,0,0
100433,which,0,0
100434,the,0,0
100435,participants,0,0
100436,were,0,0
100437,sensitized,0,0
100438,was,0,0
100439,seen,0,0
100440,.,0,0
100441,However,0,0
100442,",",0,0
100443,no,0,0
100444,evidence,0,0
100445,of,0,0
100446,systemic,0,0
100447,immune,0,0
100448,regulation,0,0
100449,was,0,0
100450,seen,0,0
100451,in,0,0
100452,infected,0,0
100453,participants,0,0
100454,.,0,0
100455,This,0,0
100456,finding,0,0
100457,may,0,0
100458,indicate,0,0
100459,that,0,0
100460,the,0,0
100461,level,0,0
100462,of,0,0
100463,infection,0,0
100464,or,0,1
100465,the,0,0
100466,frequency,0,0
100467,of,0,0
100468,infection,0,0
100469,may,0,0
100470,have,0,0
100471,to,0,0
100472,be,0,0
100473,altered,0,0
100474,in,0,0
100475,future,0,0
100476,trials,0,0
100477,to,0,0
100478,induce,0,0
100479,a,0,0
100480,therapeutically,0,0
100481,conducive,0,0
100482,immunologic,0,0
100483,phenotype,0,0
100484,.,0,0
100485,Screening,1,0
100486,",",1,0
100487,brief,1,1
100488,intervention,1,1
100489,",",1,0
100490,and,1,0
100491,referral,1,0
100492,to,1,0
100493,treatment,1,0
100494,(,1,0
100495,SBIRT,1,1
100496,),1,0
100497,in,0,0
100498,a,0,0
100499,Polish,0,0
100500,emergency,0,0
100501,department,0,0
100502,:,0,0
100503,three-month,0,0
100504,outcomes,0,0
100505,of,0,0
100506,a,0,0
100507,randomized,0,0
100508,",",0,0
100509,controlled,0,0
100510,clinical,0,0
100511,trial,0,0
100512,.,0,0
100513,OBJECTIVE,0,0
100514,A,0,0
100515,randomized,0,0
100516,",",0,0
100517,controlled,0,0
100518,trial,0,0
100519,of,0,0
100520,screening,1,0
100521,",",1,0
100522,brief,1,1
100523,intervention,1,1
100524,",",1,0
100525,and,1,0
100526,referral,1,0
100527,to,1,0
100528,treatment,1,0
100529,(,1,0
100530,SBIRT,1,1
100531,),1,0
100532,for,0,0
100533,drinking,0,0
100534,and,0,0
100535,related,0,0
100536,problems,0,0
100537,among,0,0
100538,at-risk,0,0
100539,and,0,0
100540,dependent,0,0
100541,drinkers,0,0
100542,was,0,0
100543,conducted,0,0
100544,in,0,0
100545,an,0,0
100546,emergency,0,1
100547,department,0,0
100548,(,0,0
100549,ED,0,1
100550,),0,0
100551,in,0,0
100552,Sosnowiec,0,0
100553,",",0,0
100554,Poland,0,0
100555,",",0,0
100556,among,0,0
100557,patients,0,0
100558,ages,0,0
100559,18,0,0
100560,years,0,0
100561,and,0,0
100562,older,0,0
100563,.,0,0
100564,METHOD,0,0
100565,Data,0,0
100566,were,0,0
100567,collected,0,0
100568,over,0,0
100569,a,0,0
100570,23-week,0,0
100571,period,0,0
100572,",",0,0
100573,from,0,0
100574,4:00,0,0
100575,PM,0,0
100576,to,0,0
100577,midnight,0,0
100578,",",0,0
100579,and,0,0
100580,resulted,0,0
100581,in,0,0
100582,446,0,0
100583,patients,0,0
100584,being,0,0
100585,recruited,0,0
100586,into,0,0
100587,the,0,0
100588,study,0,0
100589,(,0,0
100590,90,0,0
100591,%,0,0
100592,of,0,0
100593,those,0,0
100594,who,0,0
100595,screened,0,0
100596,positive,0,0
100597,),0,0
100598,and,0,0
100599,randomized,0,0
100600,to,0,0
100601,three,0,0
100602,conditions,0,0
100603,following,0,0
100604,a,0,0
100605,two-stage,0,0
100606,process,0,0
100607,:,0,0
100608,screened,1,0
100609,only,1,0
100610,(,0,0
100611,n,0,0
100612,=,0,0
100613,147,0,0
100614,),0,0
100615,",",0,0
100616,assessed,1,0
100617,(,0,0
100618,n,0,0
100619,=,0,0
100620,152,0,0
100621,),0,0
100622,",",0,0
100623,and,0,0
100624,received,1,1
100625,intervention,1,1
100626,(,0,0
100627,n,0,0
100628,=,0,0
100629,147,0,0
100630,),0,0
100631,.,0,0
100632,Patients,0,0
100633,in,0,0
100634,the,0,0
100635,assessment,1,0
100636,(,0,0
100637,85,0,0
100638,%,0,0
100639,),0,0
100640,and,0,0
100641,intervention,1,1
100642,(,0,0
100643,83,0,0
100644,%,0,0
100645,),0,0
100646,conditions,0,0
100647,were,0,0
100648,blindly,0,0
100649,reassessed,0,0
100650,at,0,0
100651,3,0,0
100652,months,0,0
100653,via,0,0
100654,a,0,0
100655,telephone,0,1
100656,interview,0,0
100657,.,0,0
100658,RESULTS,0,0
100659,At,0,0
100660,3-month,0,0
100661,follow-up,0,0
100662,",",0,0
100663,both,0,0
100664,groups,0,0
100665,showed,0,0
100666,significant,0,0
100667,decreases,0,0
100668,in,0,0
100669,the,0,0
100670,proportion,0,0
100671,who,0,0
100672,were,0,0
100673,positive,0,0
100674,for,0,0
100675,at-risk,0,0
100676,drinking,0,0
100677,",",0,0
100678,the,0,0
100679,primary,0,0
100680,outcome,0,0
100681,variable,0,0
100682,.,0,0
100683,Both,0,0
100684,groups,0,0
100685,also,0,0
100686,showed,0,0
100687,significant,0,0
100688,decreases,0,0
100689,in,0,0
100690,drinking,0,0
100691,days,0,0
100692,per,0,0
100693,week,0,0
100694,",",0,0
100695,drinks,0,1
100696,per,0,0
100697,drinking,0,0
100698,day,0,0
100699,",",0,0
100700,maximum,0,0
100701,drinks,0,1
100702,per,0,0
100703,occasion,0,0
100704,",",0,0
100705,and,0,0
100706,negative,0,0
100707,consequences,0,0
100708,of,0,0
100709,drinking,0,0
100710,.,0,0
100711,Using,0,0
100712,analysis,0,0
100713,of,0,0
100714,covariance,0,0
100715,to,0,0
100716,control,0,0
100717,for,0,0
100718,baseline,0,0
100719,measures,0,0
100720,and,0,0
100721,demographic,0,0
100722,characteristics,0,0
100723,",",0,0
100724,no,0,0
100725,difference,0,0
100726,in,0,0
100727,outcome,0,0
100728,measures,0,0
100729,was,0,0
100730,found,0,0
100731,between,0,0
100732,intervention,1,1
100733,and,0,0
100734,assessment,1,0
100735,conditions,0,0
100736,.,0,0
100737,Subgroup,0,0
100738,analysis,0,0
100739,found,0,0
100740,some,0,0
100741,significant,0,0
100742,interactions,0,0
100743,between,0,0
100744,intervention,1,1
100745,and,0,0
100746,secondary,0,0
100747,outcomes,0,0
100748,.,0,0
100749,CONCLUSIONS,0,0
100750,Although,0,0
100751,the,0,0
100752,main,0,0
100753,findings,0,0
100754,were,0,0
100755,similar,0,0
100756,to,0,0
100757,those,0,0
100758,from,0,0
100759,other,0,0
100760,brief-intervention,0,1
100761,studies,0,0
100762,in,0,0
100763,Western,0,0
100764,cultures,0,0
100765,",",0,0
100766,findings,0,0
100767,here,0,0
100768,also,0,0
100769,suggest,0,0
100770,that,0,0
100771,intervention,0,1
100772,may,0,0
100773,have,0,0
100774,differential,0,0
100775,benefits,0,0
100776,for,0,0
100777,specific,0,0
100778,subgroups,0,0
100779,of,0,0
100780,patients,0,0
100781,in,0,0
100782,the,0,0
100783,ED,0,1
100784,",",0,0
100785,an,0,0
100786,area,0,0
100787,of,0,0
100788,research,0,0
100789,that,0,0
100790,may,0,0
100791,warrant,0,0
100792,additional,0,0
100793,study,0,0
100794,of,0,0
100795,brief,0,1
100796,intervention,0,1
100797,in,0,0
100798,the,0,0
100799,ED,0,1
100800,setting,0,0
100801,.,0,0
100802,Intranasal,0,0
100803,oxytocin,1,1
100804,improves,0,0
100805,emotion,0,0
100806,recognition,0,0
100807,for,0,0
100808,youth,0,0
100809,with,0,0
100810,autism,0,0
100811,spectrum,0,0
100812,disorders,0,0
100813,.,0,0
100814,BACKGROUND,0,0
100815,A,0,0
100816,diagnostic,0,0
100817,hallmark,0,0
100818,of,0,0
100819,autism,0,0
100820,spectrum,0,0
100821,disorders,0,0
100822,is,0,0
100823,a,0,0
100824,qualitative,0,0
100825,impairment,0,0
100826,in,0,0
100827,social,0,1
100828,communication,0,0
100829,and,0,0
100830,interaction,0,0
100831,.,0,0
100832,Deficits,0,0
100833,in,0,0
100834,the,0,0
100835,ability,0,0
100836,to,0,0
100837,recognize,0,0
100838,the,0,0
100839,emotions,0,0
100840,of,0,0
100841,others,0,0
100842,are,0,0
100843,believed,0,0
100844,to,0,0
100845,contribute,0,0
100846,to,0,0
100847,this,0,0
100848,.,0,0
100849,There,0,0
100850,is,0,0
100851,currently,0,0
100852,no,0,0
100853,effective,0,0
100854,treatment,0,0
100855,for,0,0
100856,these,0,0
100857,problems,0,0
100858,.,0,0
100859,METHODS,0,0
100860,In,0,0
100861,a,0,0
100862,double-blind,0,0
100863,",",0,0
100864,randomized,0,0
100865,",",0,0
100866,placebo-controlled,0,1
100867,",",0,0
100868,crossover,0,0
100869,design,0,0
100870,",",0,0
100871,we,0,0
100872,administered,0,0
100873,oxytocin,1,1
100874,nasal,1,1
100875,spray,1,1
100876,(,0,0
100877,18,0,0
100878,or,0,0
100879,24,0,0
100880,IU,0,1
100881,),0,0
100882,or,0,0
100883,a,0,0
100884,placebo,1,1
100885,to,0,0
100886,16,0,0
100887,male,0,0
100888,youth,0,0
100889,aged,0,0
100890,12,0,0
100891,to,0,0
100892,19,0,0
100893,who,0,0
100894,were,0,0
100895,diagnosed,0,0
100896,with,0,0
100897,Autistic,0,0
100898,or,0,1
100899,Asperger,0,0
100900,'s,0,0
100901,Disorder,0,0
100902,.,0,0
100903,Participants,0,0
100904,then,0,0
100905,completed,0,0
100906,the,0,0
100907,Reading,0,0
100908,the,0,0
100909,Mind,0,0
100910,in,0,0
100911,the,0,0
100912,Eyes,0,0
100913,Task,0,1
100914,",",0,0
100915,a,0,0
100916,widely,0,0
100917,used,0,0
100918,and,0,0
100919,reliable,0,0
100920,test,0,0
100921,of,0,0
100922,emotion,0,0
100923,recognition,0,0
100924,.,0,0
100925,RESULTS,0,0
100926,In,0,0
100927,comparison,0,0
100928,with,0,0
100929,placebo,1,1
100930,",",1,0
100931,oxytocin,1,1
100932,administration,0,0
100933,improved,0,0
100934,performance,0,0
100935,on,0,0
100936,the,0,0
100937,Reading,0,0
100938,the,0,0
100939,Mind,0,0
100940,in,0,0
100941,the,0,0
100942,Eyes,0,0
100943,Task,0,1
100944,.,0,0
100945,This,0,0
100946,effect,0,0
100947,was,0,0
100948,also,0,0
100949,shown,0,0
100950,when,0,0
100951,analysis,0,0
100952,was,0,0
100953,restricted,0,0
100954,to,0,0
100955,the,0,0
100956,younger,0,0
100957,participants,0,0
100958,aged,0,0
100959,12,0,0
100960,to,0,0
100961,15,0,0
100962,who,0,0
100963,received,0,0
100964,the,0,0
100965,lower,0,0
100966,dose,0,0
100967,.,0,0
100968,CONCLUSIONS,0,0
100969,This,0,0
100970,study,0,0
100971,provides,0,0
100972,the,0,0
100973,first,0,0
100974,evidence,0,0
100975,that,0,0
100976,oxytocin,0,1
100977,nasal,0,0
100978,spray,0,1
100979,improves,0,0
100980,emotion,0,0
100981,recognition,0,0
100982,in,0,0
100983,young,0,0
100984,people,0,0
100985,diagnosed,0,0
100986,with,0,0
100987,autism,0,0
100988,spectrum,0,0
100989,disorders,0,0
100990,.,0,0
100991,Findings,0,0
100992,suggest,0,0
100993,the,0,0
100994,potential,0,0
100995,of,0,0
100996,earlier,0,0
100997,intervention,0,0
100998,and,0,0
100999,further,0,0
101000,evaluation,0,0
101001,of,0,0
101002,oxytocin,1,1
101003,nasal,0,0
101004,spray,0,1
101005,as,0,0
101006,a,0,0
101007,treatment,0,0
101008,to,0,0
101009,improve,0,0
101010,social,0,1
101011,communication,0,0
101012,and,0,0
101013,interaction,0,0
101014,in,0,0
101015,young,0,0
101016,people,0,0
101017,with,0,0
101018,autism,0,0
101019,spectrum,0,0
101020,disorders,0,0
101021,.,0,0
101022,Brief,0,1
101023,Report,0,0
101024,:,0,0
101025,Randomized,0,0
101026,test,0,0
101027,of,0,0
101028,the,0,0
101029,efficacy,0,0
101030,of,0,0
101031,picture,1,0
101032,exchange,1,1
101033,communication,1,0
101034,system,1,0
101035,on,0,0
101036,highly,0,0
101037,generalized,0,0
101038,picture,0,0
101039,exchanges,0,0
101040,in,0,0
101041,children,0,0
101042,with,0,0
101043,ASD,0,0
101044,.,0,0
101045,A,0,0
101046,randomized,0,0
101047,control,0,1
101048,trial,0,0
101049,comparing,0,0
101050,two,0,0
101051,social-communication,1,0
101052,interventions,1,0
101053,in,0,0
101054,young,0,0
101055,children,0,0
101056,with,0,0
101057,autism,0,0
101058,examined,0,0
101059,far-transfer,0,0
101060,of,0,0
101061,the,0,0
101062,use,0,0
101063,of,0,0
101064,picture,1,0
101065,exchange,1,1
101066,to,0,0
101067,communicate,0,0
101068,.,0,0
101069,Thirty-six,0,0
101070,children,0,0
101071,were,0,0
101072,randomly,0,0
101073,assigned,0,0
101074,to,0,0
101075,one,0,0
101076,of,0,0
101077,two,0,0
101078,treatment,0,0
101079,conditions,0,0
101080,",",0,0
101081,one,1,0
101082,of,1,0
101083,which,1,0
101084,was,1,0
101085,the,1,0
101086,Picture,1,0
101087,Exchange,1,1
101088,Communication,1,1
101089,System,1,0
101090,(,1,0
101091,PECS,1,0
101092,),1,0
101093,.,1,0
101094,All,0,0
101095,children,0,0
101096,had,0,0
101097,access,0,0
101098,to,0,0
101099,picture,1,0
101100,symbols,1,1
101101,during,1,0
101102,assessments,1,0
101103,.,1,0
101104,Post-treatment,0,0
101105,measurement,0,0
101106,of,0,0
101107,the,0,0
101108,number,0,0
101109,of,0,0
101110,picture,0,0
101111,exchanges,0,0
101112,in,0,0
101113,a,0,0
101114,far-transfer,0,0
101115,",",0,0
101116,assessment,0,0
101117,context,0,0
101118,favored,0,0
101119,the,0,0
101120,PECS,1,0
101121,intervention,0,1
101122,.,0,0
101123,These,0,0
101124,findings,0,0
101125,were,0,0
101126,interpreted,0,0
101127,as,0,0
101128,support,0,0
101129,for,0,0
101130,the,0,0
101131,hypothesis,0,0
101132,that,0,0
101133,the,0,0
101134,PECS,1,0
101135,curriculum,0,1
101136,can,0,0
101137,successfully,0,0
101138,teach,0,0
101139,a,0,0
101140,generalized,0,0
101141,means,0,0
101142,of,0,0
101143,showing,0,0
101144,coordinated,0,0
101145,attention,0,0
101146,to,0,0
101147,object,0,0
101148,and,0,0
101149,person,0,0
101150,without,0,1
101151,requiring,0,0
101152,eye,0,1
101153,contact,0,0
101154,to,0,0
101155,children,0,0
101156,with,0,0
101157,ASD,0,0
101158,.,0,0
101159,First-line,1,1
101160,cisplatin,1,1
101161,with,1,0
101162,docetaxel,1,1
101163,or,1,1
101164,vinorelbine,1,1
101165,in,0,0
101166,patients,0,0
101167,with,0,0
101168,advanced,0,0
101169,non-small-cell,0,0
101170,lung,0,0
101171,cancer,0,0
101172,:,0,0
101173,a,0,0
101174,quality,0,0
101175,of,0,0
101176,life,0,0
101177,directed,0,0
101178,phase,0,0
101179,II,0,0
101180,randomized,0,0
101181,trial,0,0
101182,of,0,0
101183,Gruppo,0,0
101184,Oncologico,0,0
101185,Italia,0,0
101186,Meridionale,0,0
101187,.,0,0
101188,BACKGROUND,0,0
101189,Quality,0,0
101190,of,0,0
101191,life,0,0
101192,(,0,0
101193,QoL,0,0
101194,),0,1
101195,has,0,0
101196,gained,0,0
101197,greater,0,0
101198,importance,0,0
101199,in,0,0
101200,the,0,0
101201,management,0,0
101202,of,0,0
101203,metastatic,0,0
101204,non-small-cell,0,0
101205,lung,0,0
101206,cancer,0,0
101207,due,0,0
101208,to,0,0
101209,the,0,0
101210,palliative,0,0
101211,nature,0,0
101212,of,0,0
101213,treatment,0,0
101214,.,0,0
101215,Docetaxel,1,1
101216,(,1,0
101217,DCT,1,0
101218,),1,1
101219,and,1,0
101220,cisplatin,1,1
101221,(,1,1
101222,CDDP,1,0
101223,),1,0
101224,doublet,1,1
101225,has,0,0
101226,been,0,0
101227,reported,0,0
101228,to,0,0
101229,be,0,0
101230,associated,0,0
101231,to,0,0
101232,a,0,0
101233,better,0,0
101234,QoL,0,0
101235,than,0,0
101236,the,0,0
101237,weekly,0,1
101238,vinorelbine,1,1
101239,(,1,0
101240,VNR,1,1
101241,),1,0
101242,and,1,0
101243,CDDP,1,0
101244,regimen,0,1
101245,.,0,0
101246,Recently,0,0
101247,a,0,0
101248,newer,0,0
101249,more,0,0
101250,tolerated,0,0
101251,schedule,0,0
101252,of,0,0
101253,the,0,0
101254,VNR/CDDP,1,0
101255,regimen,0,1
101256,has,0,0
101257,been,0,0
101258,published,0,0
101259,and,0,0
101260,is,0,0
101261,widely,0,0
101262,employed,0,0
101263,in,0,0
101264,medical,0,0
101265,practice,0,0
101266,.,0,0
101267,The,0,0
101268,impact,0,0
101269,of,0,0
101270,these,0,0
101271,regimens,0,0
101272,on,0,0
101273,patients,0,0
101274,',0,0
101275,QoL,0,0
101276,as,0,0
101277,well,0,0
101278,as,0,0
101279,symptoms,0,0
101280,control,0,0
101281,and,0,0
101282,type,0,0
101283,and,0,0
101284,grading,0,0
101285,chemo-related,0,0
101286,side-effects,0,0
101287,has,0,0
101288,been,0,0
101289,compared,0,0
101290,prospectically,0,0
101291,.,0,0
101292,METHODS,0,0
101293,Patients,0,0
101294,received,0,0
101295,CDDP,1,0
101296,75,1,0
101297,mg/m,1,1
101298,(,1,0
101299,2,1,0
101300,),1,0
101301,plus,1,1
101302,DCT,1,0
101303,75,1,0
101304,mg/m,1,1
101305,(,1,0
101306,2,1,0
101307,),1,0
101308,on,0,0
101309,day,0,0
101310,1,0,0
101311,every,0,0
101312,weeks,0,0
101313,(,0,0
101314,arm,0,0
101315,A,0,0
101316,),0,0
101317,or,0,0
101318,CDDP,1,0
101319,80,1,0
101320,mg/m,1,1
101321,(,1,0
101322,2,1,0
101323,),1,0
101324,on,1,0
101325,day,1,0
101326,1,1,0
101327,plus,1,1
101328,VNR,1,0
101329,30,1,1
101330,mg/m,1,1
101331,(,1,0
101332,2,1,0
101333,),1,0
101334,day,0,0
101335,1,0,0
101336,and,0,0
101337,8,0,0
101338,every,0,0
101339,3,0,0
101340,weeks,0,0
101341,(,0,0
101342,arm,0,0
101343,B,0,0
101344,),0,0
101345,.,0,0
101346,G-CSF,1,0
101347,and/or,1,0
101348,EPO,1,1
101349,were,0,0
101350,employed,0,0
101351,as,0,0
101352,needed,0,0
101353,.,0,0
101354,Health-related,0,0
101355,QoL,0,0
101356,was,0,0
101357,assessed,0,0
101358,at,0,0
101359,entry,0,0
101360,and,0,0
101361,after,0,0
101362,every,0,1
101363,cycle,0,0
101364,by,0,0
101365,the,0,0
101366,EORTC-QLQ-C30,0,0
101367,and,0,0
101368,LC13,0,0
101369,questionnaires,0,1
101370,",",0,0
101371,toxicity,0,0
101372,by,0,0
101373,the,0,0
101374,NCI-NCCN,0,1
101375,CTC,0,1
101376,vs,0,0
101377,2,0,0
101378,",",0,0
101379,and,0,0
101380,intent-to-treat,0,0
101381,objective,0,0
101382,response,0,0
101383,by,0,0
101384,the,0,0
101385,Recist,0,0
101386,criteria,0,0
101387,.,0,0
101388,RESULTS,0,0
101389,The,0,0
101390,QoL,0,0
101391,questionnaires,0,1
101392,were,0,0
101393,completed,0,0
101394,by,0,0
101395,37,0,0
101396,pts,0,0
101397,(,0,0
101398,88,0,0
101399,%,0,0
101400,),0,0
101401,in,0,0
101402,the,0,0
101403,DCT/CDDP,1,0
101404,arm,0,0
101405,and,0,0
101406,39,0,0
101407,pts,0,0
101408,(,0,0
101409,87,0,0
101410,%,0,0
101411,),0,0
101412,in,0,0
101413,the,0,0
101414,VNR/CDDP,1,0
101415,one,0,0
101416,.,0,0
101417,Baseline,0,0
101418,mean,0,0
101419,scores,0,0
101420,and,0,0
101421,rates,0,0
101422,at,0,0
101423,which,0,0
101424,pts,0,0
101425,failed,0,0
101426,to,0,0
101427,complete,0,0
101428,QoL,0,0
101429,assessment,0,0
101430,were,0,0
101431,similar,0,0
101432,in,0,0
101433,the,0,0
101434,two,0,0
101435,arms,0,0
101436,.,0,0
101437,Global,0,0
101438,health,0,0
101439,status,0,0
101440,of,0,0
101441,the,0,0
101442,EORTC,0,0
101443,QLQ-C30,0,0
101444,scale,0,0
101445,and,0,0
101446,specific,0,0
101447,symptoms,0,0
101448,control,0,0
101449,(,0,0
101450,LC13,0,0
101451,module,0,1
101452,),0,0
101453,improved,0,0
101454,during,0,0
101455,treatment,0,0
101456,without,0,0
101457,any,0,0
101458,statistically,0,0
101459,significant,0,0
101460,difference,0,0
101461,between,0,0
101462,the,0,0
101463,two,0,0
101464,arms,0,0
101465,.,0,0
101466,Emotional,0,0
101467,functioning,0,0
101468,remained,0,0
101469,stable,0,0
101470,in,0,0
101471,both,0,0
101472,groups,0,0
101473,during,0,0
101474,treatment,0,0
101475,",",0,0
101476,whereas,0,0
101477,physical,0,1
101478,and,0,0
101479,role,0,0
101480,improved,0,0
101481,slightly,0,0
101482,.,0,0
101483,In,0,0
101484,the,0,0
101485,DCT/CDDP,1,0
101486,arm,0,0
101487,14,0,0
101488,pts,0,0
101489,(,0,0
101490,33,0,0
101491,%,0,0
101492,;,0,0
101493,95,0,0
101494,%,0,0
101495,CL,0,1
101496,24-40,0,1
101497,%,0,0
101498,),0,0
101499,had,0,0
101500,PR,0,1
101501,",",0,0
101502,and,0,0
101503,10,0,0
101504,(,0,0
101505,24,0,0
101506,%,0,0
101507,),0,0
101508,SD,0,0
101509,for,0,0
101510,a,0,0
101511,57,0,0
101512,%,0,0
101513,TGCR,0,0
101514,.,0,0
101515,In,0,0
101516,the,0,0
101517,VNR/CDDP,1,0
101518,arm,0,0
101519,12,0,0
101520,pts,0,0
101521,(,0,0
101522,27,0,0
101523,%,0,0
101524,),0,0
101525,achieved,0,0
101526,PR,0,0
101527,",",0,0
101528,18,0,0
101529,(,0,0
101530,41,0,0
101531,%,0,0
101532,),0,0
101533,SD,0,0
101534,a,0,0
101535,68,0,0
101536,%,0,0
101537,TGCR,0,0
101538,.,0,0
101539,Differences,0,0
101540,were,0,0
101541,not,0,0
101542,statistically,0,0
101543,significant,0,0
101544,.,0,0
101545,Median,0,0
101546,time-to-progression,0,0
101547,was,0,0
101548,4.2,0,0
101549,months,0,0
101550,in,0,0
101551,the,0,0
101552,DCT/CDDP,1,0
101553,arm,0,0
101554,and,0,0
101555,4.5,0,0
101556,months,0,0
101557,in,0,0
101558,the,0,0
101559,VNR/CDDP,1,0
101560,one,0,0
101561,",",0,0
101562,and,0,0
101563,median,0,0
101564,overall,0,0
101565,survival,0,0
101566,was,0,0
101567,12.1,0,0
101568,(,0,0
101569,range,0,0
101570,1-26+,0,1
101571,months,0,0
101572,),0,0
101573,and,0,0
101574,12.5,0,0
101575,months,0,0
101576,(,0,0
101577,range,0,0
101578,1-28+,0,0
101579,months,0,0
101580,),0,0
101581,for,0,0
101582,DCT/CDDP,1,0
101583,and,0,0
101584,VNR/CDDP,1,0
101585,arms,0,0
101586,",",0,0
101587,respectively,0,0
101588,.,0,0
101589,Febrile,0,0
101590,neutropenia,0,0
101591,rate,0,0
101592,was,0,0
101593,higher,0,0
101594,in,0,0
101595,the,0,0
101596,VNR/CDDP,1,1
101597,arm,0,0
101598,(,0,0
101599,p=0.02,0,0
101600,),0,0
101601,as,0,0
101602,well,0,0
101603,as,0,0
101604,G3-4,0,0
101605,anemia,0,0
101606,(,0,0
101607,p=0.005,0,0
101608,),0,0
101609,and,0,0
101610,G-CSF/EPO,0,1
101611,use,0,0
101612,(,0,0
101613,p=0.019,0,0
101614,),0,0
101615,.,0,0
101616,CONCLUSIONS,0,0
101617,Global,0,0
101618,and,0,0
101619,specific,0,0
101620,health-related,0,1
101621,QoL,0,0
101622,data,0,0
101623,similar,0,0
101624,in,0,0
101625,both,0,0
101626,treatment,0,0
101627,groups,0,0
101628,with,0,0
101629,no,0,0
101630,statistically,0,0
101631,significant,0,0
101632,difference,0,0
101633,.,0,0
101634,Efficacy,0,0
101635,measures,0,0
101636,",",0,0
101637,overall,0,0
101638,response,0,0
101639,rate,0,0
101640,",",0,0
101641,time-to-progression,0,0
101642,and,0,0
101643,overall,0,0
101644,survival,0,0
101645,were,0,0
101646,equivalent,0,0
101647,in,0,0
101648,both,0,0
101649,arms,0,0
101650,.,0,0
101651,However,0,0
101652,",",0,0
101653,severe,0,0
101654,anemia,0,0
101655,and,0,0
101656,febrile,0,0
101657,neutropenia,0,0
101658,are,0,0
101659,statistically,0,0
101660,more,0,0
101661,frequent,0,0
101662,in,0,0
101663,the,0,0
101664,VNR/CDDP,1,0
101665,arm,0,0
101666,than,0,0
101667,in,0,0
101668,the,0,0
101669,DCT/CDDP,1,0
101670,one,0,0
101671,.,0,0
101672,These,0,0
101673,data,0,0
101674,should,0,0
101675,be,0,0
101676,considered,0,0
101677,in,0,0
101678,treatment,0,0
101679,decision-making,0,0
101680,for,0,0
101681,pts,0,0
101682,with,0,0
101683,advanced,0,0
101684,non-small-cell,0,0
101685,lung,0,0
101686,cancer,0,0
101687,and,0,0
101688,for,0,0
101689,the,0,0
101690,design,0,0
101691,of,0,0
101692,future,0,0
101693,trials,0,0
101694,with,0,0
101695,chemotherapy,0,1
101696,plus,0,1
101697,biologics,0,0
101698,.,0,0
101699,Dose-dependent,0,0
101700,effects,0,0
101701,of,0,0
101702,the,0,0
101703,CRF,1,1
101704,(,1,0
101705,1,1,0
101706,),1,0
101707,receptor,1,0
101708,antagonist,1,1
101709,R317573,1,0
101710,on,0,0
101711,regional,0,0
101712,brain,0,0
101713,activity,0,0
101714,in,0,0
101715,healthy,0,0
101716,male,0,0
101717,subjects,0,0
101718,.,0,0
101719,BACKGROUND,0,0
101720,Corticotropin-releasing,1,1
101721,factor,1,0
101722,receptor,1,0
101723,type,1,0
101724,1,1,0
101725,(,1,0
101726,CRF,1,1
101727,(,1,0
101728,1,1,0
101729,),1,0
101730,),1,0
101731,antagonists,0,1
101732,have,0,0
101733,been,0,0
101734,proposed,0,0
101735,as,0,0
101736,therapeutic,0,0
101737,agents,0,0
101738,in,0,0
101739,the,0,0
101740,treatment,0,0
101741,of,0,0
101742,mood,0,0
101743,and,0,0
101744,anxiety,0,0
101745,disorders,0,0
101746,although,0,0
101747,clinical,0,0
101748,evidence,0,0
101749,supporting,0,0
101750,their,0,0
101751,development,0,0
101752,and,0,0
101753,understanding,0,0
101754,of,0,0
101755,a,0,0
101756,dose-response,0,0
101757,relationship,0,0
101758,has,0,0
101759,been,0,0
101760,lacking,0,0
101761,.,0,0
101762,METHODS,0,0
101763,We,0,0
101764,tested,0,0
101765,two,0,0
101766,doses,0,0
101767,of,0,0
101768,the,0,0
101769,CRF,1,1
101770,(,1,0
101771,1,1,0
101772,),1,0
101773,antagonist,1,1
101774,R317573,1,0
101775,for,0,0
101776,effects,0,0
101777,on,0,0
101778,regional,0,0
101779,cerebral,0,0
101780,glucose,0,1
101781,metabolism,0,0
101782,(,0,0
101783,rCMglu,0,0
101784,),0,0
101785,using,0,0
101786,[,1,0
101787,(,1,0
101788,18,1,0
101789,),1,0
101790,F,1,0
101791,],1,0
101792,fluoro-2-deoxy-D,1,1
101793,:,1,1
101794,-glucose,1,1
101795,(,1,0
101796,FDG,1,1
101797,),1,1
101798,positron,1,0
101799,emission,1,1
101800,tomography,1,1
101801,(,1,0
101802,PET,1,1
101803,),1,0
101804,following,0,0
101805,single-dose,0,1
101806,challenges,0,0
101807,in,0,0
101808,a,0,0
101809,double-blind,0,0
101810,",",0,0
101811,placebo-controlled,0,1
101812,",",0,0
101813,cross-over,0,0
101814,design,0,0
101815,",",0,0
101816,in,0,0
101817,12,0,0
101818,healthy,0,0
101819,male,0,0
101820,volunteers,0,0
101821,.,0,0
101822,RESULTS,0,0
101823,Single,0,0
101824,30-,0,0
101825,and,0,0
101826,200-mg,0,1
101827,doses,0,0
101828,of,0,0
101829,R317573,1,0
101830,resulted,0,0
101831,in,0,0
101832,dose-related,0,0
101833,changes,0,0
101834,in,0,0
101835,rCMglu,0,0
101836,.,0,0
101837,Relative,0,0
101838,increases,0,0
101839,in,0,0
101840,rCMglu,0,0
101841,were,0,0
101842,observed,0,0
101843,in,0,0
101844,frontal,0,0
101845,cortical,0,0
101846,regions,0,0
101847,while,0,0
101848,relative,0,0
101849,decreases,0,0
101850,occurred,0,0
101851,in,0,0
101852,the,0,0
101853,putamen,0,0
101854,and,0,0
101855,right,0,0
101856,amygdala,0,0
101857,after,0,0
101858,both,0,0
101859,doses,0,0
101860,.,0,0
101861,Relative,0,0
101862,decreases,0,0
101863,occurred,0,0
101864,in,0,0
101865,cerebellum,0,0
101866,and,0,0
101867,right,0,0
101868,parahippocampal,0,0
101869,gyrus,0,0
101870,following,0,0
101871,the,0,0
101872,higher,0,0
101873,dose,0,0
101874,.,0,0
101875,CONCLUSIONS,0,0
101876,R317573,1,0
101877,appears,0,0
101878,to,0,0
101879,produce,0,0
101880,acute,0,0
101881,dose-dependent,0,0
101882,changes,0,0
101883,in,0,0
101884,rCMglu,0,0
101885,.,0,0
101886,Effects,0,0
101887,occurred,0,0
101888,in,0,0
101889,regions,0,0
101890,that,0,0
101891,may,0,0
101892,be,0,0
101893,behaviorally,0,0
101894,relevant,0,0
101895,to,0,0
101896,mood,0,0
101897,and,0,0
101898,anxiety,0,0
101899,disorders,0,0
101900,.,0,0
101901,In,0,0
101902,some,0,0
101903,regions,0,0
101904,",",0,0
101905,these,0,0
101906,effects,0,0
101907,may,0,0
101908,be,0,0
101909,related,0,0
101910,to,0,0
101911,the,0,0
101912,receptor,0,0
101913,(,0,0
101914,target,0,0
101915,),0,0
101916,density,0,0
101917,.,0,0
101918,Measuring,0,0
101919,acute,0,0
101920,effects,0,0
101921,on,0,0
101922,rCMglu,1,0
101923,with,0,0
101924,FDG-PET,1,0
101925,may,0,0
101926,offer,0,0
101927,a,0,0
101928,method,0,0
101929,for,0,0
101930,defining,0,0
101931,pharmacologically,0,0
101932,active,0,0
101933,doses,0,0
101934,for,0,0
101935,central,0,0
101936,nervous,0,0
101937,system,0,0
101938,targets,0,0
101939,for,0,0
101940,which,0,0
101941,selective,0,0
101942,radiotracers,0,0
101943,are,0,0
101944,lacking,0,0
101945,.,0,0
101946,The,0,0
101947,effect,0,0
101948,of,0,0
101949,posture,1,0
101950,on,0,0
101951,Cheyne-Stokes,0,1
101952,respirations,0,0
101953,and,0,0
101954,hemodynamics,0,0
101955,in,0,0
101956,patients,0,0
101957,with,0,0
101958,heart,0,0
101959,failure,0,0
101960,.,0,0
101961,STUDY,0,0
101962,OBJECTIVES,0,0
101963,Cheyne-Stokes,0,1
101964,respirations,0,0
101965,occur,0,0
101966,in,0,0
101967,40,0,0
101968,%,0,0
101969,of,0,0
101970,patients,0,0
101971,with,0,0
101972,heart,0,0
101973,failure,0,0
101974,.,0,0
101975,Orthopnea,0,0
101976,is,0,0
101977,a,0,0
101978,cardinal,0,0
101979,symptom,0,0
101980,of,0,0
101981,heart,0,0
101982,failure,0,0
101983,and,0,0
101984,may,0,0
101985,affect,0,0
101986,the,0,0
101987,patient,0,0
101988,'s,0,0
101989,sleeping,0,0
101990,angle,0,0
101991,.,0,0
101992,The,0,0
101993,objective,0,0
101994,of,0,0
101995,this,0,0
101996,study,0,0
101997,was,0,0
101998,to,0,0
101999,assess,0,0
102000,the,0,0
102001,respiratory,0,0
102002,and,0,0
102003,hemodynamic,0,0
102004,response,0,0
102005,to,0,0
102006,sleeping,1,0
102007,angle,1,0
102008,in,0,0
102009,a,0,0
102010,group,0,0
102011,of,0,0
102012,subjects,0,0
102013,with,0,0
102014,stable,0,0
102015,heart,0,0
102016,failure,0,0
102017,.,0,0
102018,DESIGN,0,0
102019,Twenty-five,0,0
102020,patients,0,0
102021,underwent,0,0
102022,overnight,0,0
102023,polysomnography,0,1
102024,with,0,0
102025,simultaneous,0,0
102026,and,0,0
102027,continuous,0,1
102028,impedance,0,0
102029,cardiographic,0,0
102030,monitoring,0,0
102031,.,0,0
102032,Sleeping,0,0
102033,polysomnographic,0,0
102034,and,0,0
102035,impedance,0,0
102036,cardiographic,0,0
102037,data,0,0
102038,were,0,0
102039,recorded,0,0
102040,.,0,0
102041,SETTING,0,0
102042,The,0,0
102043,study,0,0
102044,was,0,0
102045,conducted,0,0
102046,in,0,0
102047,a,0,0
102048,sleep,0,0
102049,center,0,0
102050,.,0,0
102051,PATIENTS,0,0
102052,All,0,0
102053,25,0,0
102054,patients,0,0
102055,had,0,0
102056,clinically,0,0
102057,stable,0,0
102058,heart,0,0
102059,failure,0,0
102060,and,0,0
102061,left,0,0
102062,ventricular,0,0
102063,ejection,0,0
102064,fractions,0,1
102065,<,0,0
102066,40,0,0
102067,%,0,0
102068,.,0,0
102069,INTERVENTIONS,0,0
102070,The,0,0
102071,patients,0,0
102072,slept,1,0
102073,at,1,0
102074,0,1,0
102075,degrees,1,0
102076,",",1,0
102077,15,1,0
102078,degrees,1,0
102079,",",1,0
102080,30,1,0
102081,degrees,1,0
102082,",",1,0
102083,and,1,0
102084,45,1,0
102085,degrees,1,0
102086,in,1,0
102087,random,1,0
102088,order,1,0
102089,.,1,0
102090,MEASUREMENTS,0,0
102091,AND,0,0
102092,RESULTS,0,0
102093,Seventeen,0,0
102094,patients,0,0
102095,had,0,0
102096,Cheyne-Stokes,0,1
102097,apneas,0,0
102098,(,0,0
102099,index,0,0
102100,>,0,0
102101,5/h,0,0
102102,),0,0
102103,and,0,0
102104,23,0,0
102105,patients,0,0
102106,had,0,0
102107,hypopneas,0,0
102108,(,0,0
102109,index,0,0
102110,>,0,0
102111,5/h,0,0
102112,),0,0
102113,.,0,0
102114,The,0,0
102115,hypopnea,0,0
102116,index,0,0
102117,showed,0,0
102118,no,0,0
102119,response,0,0
102120,to,0,0
102121,sleeping,0,0
102122,angle,0,0
102123,.,0,0
102124,The,0,0
102125,Cheyne-Stokes,0,0
102126,apnea,0,0
102127,index,0,0
102128,decreased,0,0
102129,with,0,0
102130,increasing,0,0
102131,sleeping,0,0
102132,angle,0,0
102133,(,0,0
102134,P,0,0
102135,<,0,0
102136,0.001,0,0
102137,),0,0
102138,.,0,0
102139,This,0,0
102140,effect,0,0
102141,was,0,0
102142,seen,0,0
102143,only,0,0
102144,during,0,0
102145,supine,0,1
102146,sleep,0,0
102147,and,0,0
102148,non-rapid,0,0
102149,eye,0,1
102150,movement,0,0
102151,sleep,0,0
102152,and,0,0
102153,was,0,0
102154,absent,0,0
102155,in,0,0
102156,non-supine,0,0
102157,sleep,0,0
102158,",",0,0
102159,rapid,0,0
102160,eye,0,1
102161,movement,0,0
102162,sleep,0,0
102163,",",0,0
102164,and,0,0
102165,during,0,0
102166,periods,0,0
102167,of,0,0
102168,wakefulness,0,0
102169,.,0,0
102170,Thoracic,0,0
102171,fluid,0,0
102172,content,0,0
102173,index,0,0
102174,and,0,0
102175,left,0,0
102176,ventricular,0,0
102177,hemodynamics,0,0
102178,measured,0,0
102179,by,0,0
102180,impedance,0,0
102181,cardiography,0,0
102182,showed,0,0
102183,no,0,0
102184,response,0,0
102185,to,0,0
102186,sleeping,0,0
102187,angle,0,0
102188,.,0,0
102189,CONCLUSIONS,0,0
102190,Changing,0,0
102191,the,0,0
102192,heart,0,0
102193,failure,0,0
102194,patient,0,0
102195,'s,0,0
102196,sleeping,0,0
102197,angle,0,0
102198,from,0,0
102199,0,0,0
102200,degrees,0,0
102201,to,0,0
102202,45,0,0
102203,degrees,0,0
102204,results,0,0
102205,in,0,0
102206,a,0,0
102207,significant,0,0
102208,decrease,0,0
102209,in,0,0
102210,Cheyne-Stokes,0,1
102211,apneas,0,0
102212,.,0,0
102213,This,0,0
102214,decrease,0,0
102215,occurs,0,0
102216,on,0,0
102217,a,0,0
102218,constant,0,0
102219,base,0,0
102220,of,0,0
102221,hypopneas,0,0
102222,.,0,0
102223,The,0,0
102224,changes,0,0
102225,in,0,0
102226,Cheyne-Stokes,0,0
102227,apneas,0,0
102228,are,0,0
102229,not,0,0
102230,related,0,0
102231,to,0,0
102232,changes,0,0
102233,in,0,0
102234,lung,0,0
102235,congestion,0,0
102236,and,0,0
102237,left,0,0
102238,ventricular,0,0
102239,hemodynamics,0,0
102240,.,0,0
102241,Randomized,0,0
102242,",",0,0
102243,controlled,0,0
102244,trial,0,0
102245,of,0,0
102246,an,0,0
102247,intervention,1,1
102248,for,0,0
102249,toddlers,0,0
102250,with,0,0
102251,autism,0,0
102252,:,0,0
102253,the,0,0
102254,Early,0,0
102255,Start,0,1
102256,Denver,0,0
102257,Model,0,0
102258,.,0,0
102259,OBJECTIVE,0,0
102260,To,0,0
102261,conduct,0,0
102262,a,0,0
102263,randomized,0,0
102264,",",0,0
102265,controlled,0,0
102266,trial,0,0
102267,to,0,0
102268,evaluate,0,0
102269,the,0,0
102270,efficacy,0,0
102271,of,0,0
102272,the,0,0
102273,Early,1,0
102274,Start,1,1
102275,Denver,1,0
102276,Model,1,0
102277,(,1,0
102278,ESDM,1,0
102279,),1,0
102280,",",0,0
102281,a,0,0
102282,comprehensive,0,0
102283,developmental,0,0
102284,behavioral,0,1
102285,intervention,0,1
102286,",",0,0
102287,for,0,0
102288,improving,0,0
102289,outcomes,0,0
102290,of,0,0
102291,toddlers,0,0
102292,diagnosed,0,0
102293,with,0,0
102294,autism,0,0
102295,spectrum,0,0
102296,disorder,0,0
102297,(,0,0
102298,ASD,0,0
102299,),0,0
102300,.,0,0
102301,METHODS,0,0
102302,Forty-eight,0,0
102303,children,0,0
102304,diagnosed,0,0
102305,with,0,0
102306,ASD,0,0
102307,between,0,0
102308,18,0,0
102309,and,0,0
102310,30,0,0
102311,months,0,0
102312,of,0,0
102313,age,0,0
102314,were,0,0
102315,randomly,0,0
102316,assigned,0,0
102317,to,0,0
102318,1,0,0
102319,of,0,0
102320,2,0,0
102321,groups,0,0
102322,:,0,0
102323,(,0,0
102324,1,0,0
102325,),0,0
102326,ESDM,1,0
102327,intervention,1,1
102328,",",0,0
102329,which,0,0
102330,is,0,0
102331,based,0,0
102332,on,0,0
102333,developmental,0,0
102334,and,0,0
102335,applied,0,0
102336,behavioral,0,1
102337,analytic,0,0
102338,principles,0,0
102339,and,0,0
102340,delivered,0,0
102341,by,0,0
102342,trained,0,1
102343,therapists,0,1
102344,and,0,0
102345,parents,0,0
102346,for,0,0
102347,2,0,0
102348,years,0,0
102349,;,0,0
102350,or,0,1
102351,(,0,0
102352,2,0,0
102353,),0,0
102354,referral,1,0
102355,to,1,0
102356,community,1,0
102357,providers,1,0
102358,for,1,0
102359,intervention,1,1
102360,commonly,1,0
102361,available,1,0
102362,in,1,0
102363,the,1,0
102364,community,1,0
102365,.,1,0
102366,RESULTS,0,0
102367,Compared,0,0
102368,with,0,0
102369,children,0,0
102370,who,0,0
102371,received,0,0
102372,community-intervention,0,1
102373,",",0,0
102374,children,0,0
102375,who,0,0
102376,received,0,0
102377,ESDM,0,0
102378,showed,0,0
102379,significant,0,0
102380,improvements,0,0
102381,in,0,0
102382,IQ,0,0
102383,",",0,0
102384,adaptive,0,0
102385,behavior,0,0
102386,",",0,0
102387,and,0,0
102388,autism,0,0
102389,diagnosis,0,0
102390,.,0,0
102391,Two,0,0
102392,years,0,0
102393,after,0,0
102394,entering,0,0
102395,intervention,0,1
102396,",",0,0
102397,the,0,0
102398,ESDM,0,0
102399,group,0,0
102400,on,0,0
102401,average,0,0
102402,improved,0,0
102403,17.6,0,0
102404,standard,0,0
102405,score,0,0
102406,points,0,0
102407,(,0,0
102408,1,0,0
102409,SD,0,0
102410,:,0,0
102411,15,0,0
102412,points,0,0
102413,),0,0
102414,compared,0,0
102415,with,0,0
102416,7.0,0,0
102417,points,0,0
102418,in,0,0
102419,the,0,0
102420,comparison,0,0
102421,group,0,0
102422,relative,0,0
102423,to,0,0
102424,baseline,0,0
102425,scores,0,0
102426,.,0,0
102427,The,0,0
102428,ESDM,0,0
102429,group,0,0
102430,maintained,0,0
102431,its,0,0
102432,rate,0,0
102433,of,0,0
102434,growth,0,0
102435,in,0,0
102436,adaptive,0,0
102437,behavior,0,0
102438,compared,0,0
102439,with,0,0
102440,a,0,0
102441,normative,0,0
102442,sample,0,0
102443,of,0,0
102444,typically,0,0
102445,developing,0,0
102446,children,0,0
102447,.,0,0
102448,In,0,0
102449,contrast,0,0
102450,",",0,0
102451,over,0,0
102452,the,0,0
102453,2-year,0,0
102454,span,0,0
102455,",",0,0
102456,the,0,0
102457,comparison,0,0
102458,group,0,0
102459,showed,0,0
102460,greater,0,0
102461,delays,0,0
102462,in,0,0
102463,adaptive,0,0
102464,behavior,0,0
102465,.,0,0
102466,Children,0,0
102467,who,0,0
102468,received,0,0
102469,ESDM,1,0
102470,also,0,0
102471,were,0,0
102472,more,0,0
102473,likely,0,0
102474,to,0,0
102475,experience,0,0
102476,a,0,0
102477,change,0,0
102478,in,0,0
102479,diagnosis,0,0
102480,from,0,0
102481,autism,0,0
102482,to,0,0
102483,pervasive,0,0
102484,developmental,0,0
102485,disorder,0,0
102486,",",0,0
102487,not,0,0
102488,otherwise,0,0
102489,specified,0,0
102490,",",0,0
102491,than,0,0
102492,the,0,0
102493,comparison,0,0
102494,group,0,0
102495,.,0,0
102496,CONCLUSIONS,0,0
102497,This,0,0
102498,is,0,0
102499,the,0,0
102500,first,0,0
102501,randomized,0,0
102502,",",0,0
102503,controlled,0,0
102504,trial,0,0
102505,to,0,0
102506,demonstrate,0,0
102507,the,0,0
102508,efficacy,0,0
102509,of,0,0
102510,a,0,0
102511,comprehensive,0,0
102512,developmental,0,0
102513,behavioral,0,1
102514,intervention,0,1
102515,for,0,0
102516,toddlers,0,0
102517,with,0,0
102518,ASD,0,0
102519,for,0,0
102520,improving,0,0
102521,cognitive,0,0
102522,and,0,0
102523,adaptive,0,1
102524,behavior,0,0
102525,and,0,0
102526,reducing,0,0
102527,severity,0,0
102528,of,0,0
102529,ASD,0,0
102530,diagnosis,0,0
102531,.,0,0
102532,Results,0,0
102533,of,0,0
102534,this,0,0
102535,study,0,0
102536,underscore,0,0
102537,the,0,0
102538,importance,0,0
102539,of,0,0
102540,early,0,0
102541,detection,0,0
102542,of,0,0
102543,and,0,0
102544,intervention,0,1
102545,in,0,0
102546,autism,0,0
102547,.,0,0
102548,Comparison,0,0
102549,between,0,0
102550,obtained,0,0
102551,mydriasis,0,0
102552,in,0,0
102553,type,0,0
102554,2,0,0
102555,diabetics,0,0
102556,and,0,0
102557,non-diabetic,0,0
102558,patients,0,0
102559,.,0,0
102560,BACKGROUND/AIMS,0,0
102561,To,0,0
102562,evaluate,0,0
102563,and,0,0
102564,compare,0,0
102565,obtained,0,0
102566,mydriasis,0,0
102567,with,0,0
102568,phenylephrine,1,1
102569,10,0,0
102570,%,0,0
102571,associated,0,0
102572,with,0,0
102573,tropicamide,1,1
102574,1,0,0
102575,%,0,0
102576,in,0,0
102577,type,0,0
102578,2,0,0
102579,diabetics,0,0
102580,and,0,0
102581,non-diabetic,0,0
102582,patients,0,0
102583,.,0,0
102584,METHODS,0,0
102585,A,0,0
102586,total,0,0
102587,of,0,0
102588,50,0,0
102589,patients,0,0
102590,(,0,0
102591,100,0,0
102592,eyes,0,0
102593,),0,0
102594,scheduled,0,0
102595,for,0,0
102596,fundoscopy,0,0
102597,were,0,0
102598,dilated,0,0
102599,with,0,0
102600,phenylephrine,1,1
102601,10,1,0
102602,%,1,0
102603,and,1,0
102604,yropicamide,1,1
102605,1,1,0
102606,%,1,0
102607,(,0,0
102608,group,0,0
102609,0,0,0
102610,:,0,0
102611,n,0,0
102612,=,0,0
102613,20,0,0
102614,type,0,0
102615,2,0,0
102616,diabetic,0,0
102617,patients,0,0
102618,",",0,0
102619,40,0,0
102620,eyes,0,0
102621,",",0,0
102622,and,0,0
102623,group,0,0
102624,1,0,0
102625,:,0,0
102626,n,0,0
102627,=,0,0
102628,30,0,0
102629,non-diabetic,0,0
102630,patients,0,0
102631,",",0,0
102632,60,0,0
102633,eyes,0,0
102634,),0,0
102635,.,0,0
102636,Only,0,0
102637,one,0,0
102638,drop,0,0
102639,per,0,0
102640,eye,0,0
102641,of,0,0
102642,each,0,0
102643,drug,0,0
102644,was,0,0
102645,administered,0,0
102646,.,0,0
102647,In,0,0
102648,both,0,0
102649,groups,0,0
102650,",",0,0
102651,pupil,0,0
102652,diameter,0,0
102653,was,0,0
102654,measured,0,0
102655,after,0,0
102656,40,0,0
102657,minutes,0,0
102658,of,0,0
102659,eye,0,0
102660,drops,0,1
102661,instillation,0,0
102662,.,0,0
102663,RESULTS,0,0
102664,Both,0,0
102665,groups,0,0
102666,were,0,0
102667,similar,0,0
102668,regarding,0,0
102669,age,0,0
102670,(,0,0
102671,p,0,0
102672,=,0,0
102673,0.06,0,0
102674,",",0,0
102675,Mann-Whitney,0,0
102676,test,0,0
102677,),0,0
102678,.,0,0
102679,Mean,0,0
102680,pupil,0,0
102681,diameter,0,0
102682,in,0,0
102683,group,0,0
102684,0,0,0
102685,was,0,0
102686,8.57,0,0
102687,and,0,0
102688,8.73,0,0
102689,in,0,0
102690,group,0,0
102691,1,0,0
102692,.,0,0
102693,There,0,0
102694,was,0,0
102695,no,0,0
102696,statistic,0,0
102697,difference,0,0
102698,between,0,0
102699,both,0,0
102700,groups,0,0
102701,(,0,0
102702,p,0,0
102703,=,0,0
102704,0.44,0,0
102705,),0,0
102706,.,0,0
102707,Pupil,0,0
102708,diameter,0,0
102709,was,0,0
102710,greater,0,0
102711,than,0,0
102712,7,0,0
102713,mm,0,0
102714,in,0,0
102715,all,0,0
102716,patients,0,0
102717,(,0,0
102718,100,0,1
102719,%,0,0
102720,),0,0
102721,.,0,0
102722,CONCLUSION,0,0
102723,When,0,0
102724,an,0,0
102725,appropriate,0,0
102726,drug,0,0
102727,combination,0,1
102728,is,0,0
102729,used,0,0
102730,",",0,0
102731,diabetic,0,0
102732,patients,0,0
102733,can,0,0
102734,achieve,0,0
102735,mydriasis,0,0
102736,as,0,0
102737,satisfactory,0,0
102738,as,0,0
102739,non-diabetic,0,0
102740,patients,0,0
102741,",",0,0
102742,allowing,0,0
102743,adequate,0,0
102744,fundus,0,0
102745,examination,0,0
102746,and/or,0,0
102747,retinopathy,0,0
102748,treatment,0,0
102749,.,0,0
102750,Breast,1,0
102751,reduction,1,0
102752,alleviates,0,0
102753,depression,0,0
102754,and,0,0
102755,anxiety,0,0
102756,and,0,0
102757,restores,0,0
102758,self-esteem,0,0
102759,:,0,0
102760,a,0,0
102761,prospective,0,0
102762,randomised,0,0
102763,clinical,0,0
102764,trial,0,0
102765,.,0,0
102766,Of,0,0
102767,women,0,0
102768,who,0,0
102769,seek,0,0
102770,reduction,0,0
102771,mammaplasty,0,0
102772,",",0,0
102773,up,0,0
102774,to,0,0
102775,a,0,0
102776,third,0,0
102777,have,0,0
102778,pathological,0,0
102779,degrees,0,0
102780,of,0,0
102781,anxiety,0,0
102782,or,0,1
102783,depression,0,0
102784,",",0,0
102785,or,0,0
102786,both,0,0
102787,.,0,0
102788,The,0,0
102789,psychological,0,0
102790,aspect,0,0
102791,of,0,0
102792,reduction,1,0
102793,mammaplasty,1,0
102794,is,0,0
102795,therefore,0,0
102796,an,0,0
102797,important,0,0
102798,consideration,0,0
102799,.,0,0
102800,We,0,0
102801,did,0,0
102802,a,0,0
102803,prospective,0,0
102804,randomised,0,0
102805,clinical,0,0
102806,trial,0,0
102807,to,0,0
102808,see,0,0
102809,how,0,0
102810,reduction,1,0
102811,mammaplasty,1,0
102812,affected,0,0
102813,macromastia,0,0
102814,patients,0,0
102815,',0,0
102816,depression,0,0
102817,",",0,0
102818,anxiety,0,0
102819,",",0,0
102820,and,0,0
102821,self-esteem,0,0
102822,.,0,0
102823,Eighty-two,0,0
102824,patients,0,0
102825,were,0,0
102826,randomised,0,0
102827,",",0,0
102828,40,0,0
102829,to,0,0
102830,have,0,0
102831,the,0,0
102832,operation,0,0
102833,",",0,0
102834,and,0,0
102835,42,0,0
102836,patients,0,0
102837,to,0,0
102838,conservative,0,1
102839,treatment,0,0
102840,.,0,0
102841,Both,0,0
102842,groups,0,0
102843,were,0,0
102844,followed,0,0
102845,for,0,0
102846,six,0,0
102847,months,0,0
102848,.,0,0
102849,The,0,0
102850,patients,0,0
102851,completed,0,0
102852,the,0,0
102853,RBDI,1,0
102854,questionnaire,1,1
102855,(,0,0
102856,Raitasalo,0,0
102857,'s,0,0
102858,modification,0,0
102859,of,0,0
102860,the,0,0
102861,short,0,0
102862,form,0,0
102863,of,0,0
102864,the,0,0
102865,Beck,0,1
102866,Depression,0,0
102867,Inventory,0,0
102868,),0,0
102869,.,0,0
102870,Twenty-nine,0,0
102871,patients,0,0
102872,in,0,0
102873,the,0,0
102874,operated,0,0
102875,group,0,0
102876,and,0,0
102877,35,0,0
102878,patients,0,0
102879,in,0,0
102880,the,0,0
102881,conservative,0,1
102882,group,0,0
102883,completed,0,0
102884,the,0,0
102885,study,0,0
102886,.,0,0
102887,At,0,0
102888,the,0,0
102889,second,0,0
102890,examination,0,0
102891,",",0,0
102892,the,0,0
102893,patients,0,0
102894,who,0,0
102895,had,0,0
102896,been,0,0
102897,operated,0,0
102898,on,0,0
102899,",",0,0
102900,had,0,0
102901,significantly,0,0
102902,less,0,0
102903,depression,0,0
102904,(,0,0
102905,p,0,0
102906,<,0,0
102907,0.01,0,0
102908,),0,0
102909,and,0,0
102910,better,0,0
102911,self-esteem,0,0
102912,(,0,0
102913,p=0.03,0,0
102914,),0,0
102915,than,0,0
102916,the,0,0
102917,conservative,0,1
102918,group,0,0
102919,.,0,0
102920,The,0,0
102921,proportions,0,0
102922,of,0,0
102923,depressed,0,0
102924,(,0,0
102925,p,0,0
102926,<,0,0
102927,0.01,0,0
102928,),0,0
102929,and,0,0
102930,anxious,0,0
102931,(,0,1
102932,p=0.04,0,0
102933,),0,0
102934,patients,0,0
102935,were,0,0
102936,also,0,0
102937,smaller,0,0
102938,in,0,0
102939,the,0,0
102940,group,0,0
102941,who,0,0
102942,were,0,0
102943,operated,0,0
102944,on,0,0
102945,.,0,0
102946,There,0,0
102947,is,0,0
102948,significantly,0,0
102949,less,0,0
102950,depression,0,0
102951,and,0,0
102952,anxiety,0,0
102953,after,0,0
102954,reduction,0,0
102955,mammaplasty,1,0
102956,",",0,0
102957,and,0,0
102958,patients,0,0
102959,',0,0
102960,self-esteem,0,0
102961,is,0,0
102962,restored,0,0
102963,.,0,0
102964,Effectiveness,0,0
102965,of,0,0
102966,initiating,0,0
102967,treatment,0,0
102968,with,0,0
102969,valsartan/hydrochlorothiazide,1,1
102970,in,0,0
102971,patients,0,0
102972,with,0,0
102973,stage-1,0,0
102974,or,0,1
102975,stage-2,0,0
102976,hypertension,0,0
102977,.,0,0
102978,This,0,0
102979,prospective,0,0
102980,",",0,0
102981,6-week,0,0
102982,",",0,0
102983,multicenter,0,0
102984,",",0,0
102985,double-blind,0,0
102986,study,0,0
102987,examined,0,0
102988,the,0,0
102989,benefits,0,0
102990,of,0,0
102991,initiating,0,0
102992,treatment,0,0
102993,with,0,0
102994,combination,0,1
102995,valsartan/hydrochlorothiazide,1,1
102996,(,1,0
102997,HCTZ,1,0
102998,),1,0
102999,compared,0,0
103000,with,0,0
103001,initial,0,0
103002,valsartan,0,1
103003,monotherapy,0,1
103004,for,0,0
103005,648,0,0
103006,patients,0,0
103007,with,0,0
103008,stage-1,0,0
103009,or,0,1
103010,stage-2,0,1
103011,hypertension,0,0
103012,(,0,0
103013,age=52.6+/-10,0,0
103014,years,0,0
103015,;,0,0
103016,54,0,0
103017,%,0,0
103018,male,0,0
103019,;,0,0
103020,baseline,0,0
103021,blood,0,0
103022,pressure,0,0
103023,(,0,0
103024,BP,0,0
103025,),0,0
103026,=161/98,0,0
103027,mm,0,0
103028,Hg,0,0
103029,",",0,0
103030,32,0,0
103031,%,0,0
103032,stage,0,0
103033,1,0,0
103034,),0,0
103035,.,0,0
103036,Patients,0,0
103037,were,0,0
103038,randomized,0,0
103039,to,0,0
103040,valsartan,1,1
103041,80,1,0
103042,mg,1,1
103043,(,1,0
103044,V-low,1,0
103045,),1,0
103046,",",1,0
103047,valsartan,1,1
103048,160,1,0
103049,mg,1,1
103050,(,1,0
103051,V-high,1,1
103052,),1,0
103053,or,1,0
103054,valsartan/HCTZ,1,1
103055,160/12.5,1,1
103056,mg,1,1
103057,(,1,0
103058,V/HCTZ,1,0
103059,),1,0
103060,",",1,0
103061,and,1,0
103062,electively,1,0
103063,titrated,1,0
103064,after,1,0
103065,weeks,1,0
103066,2,1,0
103067,and,1,0
103068,4,1,0
103069,to,1,0
103070,the,1,0
103071,next,1,0
103072,dosage,1,0
103073,level,1,0
103074,(,1,0
103075,maximum,1,0
103076,dose,1,0
103077,valsartan/HCTZ,1,1
103078,160/25,1,0
103079,mg,1,1
103080,),1,0
103081,if,1,0
103082,BP,1,0
103083,remained,1,0
103084,>,1,0
103085,140/90,1,0
103086,mm,1,0
103087,Hg,1,0
103088,.,1,0
103089,At,0,0
103090,end,0,0
103091,of,0,0
103092,the,0,0
103093,study,0,0
103094,",",0,0
103095,patients,0,0
103096,initiated,0,0
103097,with,0,0
103098,V/HCTZ,1,0
103099,required,0,0
103100,less,0,0
103101,titration,0,0
103102,steps,0,0
103103,compared,0,0
103104,with,0,0
103105,the,0,0
103106,initial,0,0
103107,valsartan,0,1
103108,monotherapy,0,1
103109,groups,0,0
103110,(,0,0
103111,63,0,0
103112,vs,0,0
103113,86,0,0
103114,%,0,0
103115,required,0,0
103116,titration,0,0
103117,by,0,0
103118,study,0,0
103119,end,0,0
103120,",",0,0
103121,respectively,0,0
103122,),0,0
103123,and,0,0
103124,reached,0,0
103125,the,0,0
103126,target,0,0
103127,BP,0,0
103128,goal,0,0
103129,of,0,0
103130,<,0,0
103131,140/90,0,0
103132,mm,0,0
103133,Hg,0,0
103134,in,0,0
103135,a,0,0
103136,shorter,0,0
103137,period,0,0
103138,of,0,0
103139,time,0,0
103140,(,0,0
103141,2.8,0,0
103142,weeks,0,0
103143,),0,0
103144,(,0,0
103145,P,0,0
103146,<,0,0
103147,0.0001,0,0
103148,),0,0
103149,vs,0,0
103150,V-low,0,0
103151,(,0,0
103152,4.3,0,0
103153,weeks,0,0
103154,),0,0
103155,and,0,0
103156,V-high,0,1
103157,(,0,0
103158,3.9,0,0
103159,weeks,0,0
103160,),0,0
103161,.,0,0
103162,Initial,0,0
103163,combination,0,1
103164,therapy,0,1
103165,was,0,0
103166,also,0,0
103167,associated,0,0
103168,with,0,0
103169,higher,0,0
103170,BP,0,0
103171,control,0,0
103172,rates,0,0
103173,and,0,0
103174,greater,0,0
103175,reductions,0,0
103176,in,0,0
103177,both,0,0
103178,systolic,0,0
103179,and,0,0
103180,diastolic,0,0
103181,BP,0,0
103182,from,0,0
103183,baseline,0,0
103184,(,0,0
103185,63,0,0
103186,%,0,0
103187,",",0,0
103188,-27.7+/-13/-15.1+/-8,0,0
103189,mm,0,0
103190,Hg,0,0
103191,),0,0
103192,compared,0,0
103193,with,0,0
103194,V-low,0,0
103195,(,0,0
103196,46,0,0
103197,%,0,0
103198,",",0,0
103199,-21.2+/-13/-11.4+/-8,0,0
103200,mm,0,0
103201,Hg,0,0
103202,",",0,0
103203,P,0,0
103204,<,0,0
103205,0.0001,0,0
103206,),0,0
103207,or,0,1
103208,V-high,0,1
103209,(,0,0
103210,51,0,0
103211,%,0,0
103212,",",0,0
103213,-24.0+/-13/-12.0+/-10,0,0
103214,mm,0,0
103215,Hg,0,0
103216,",",0,0
103217,P,0,0
103218,<,0,0
103219,0.01,0,0
103220,),0,0
103221,.,0,0
103222,Overall,0,0
103223,and,0,0
103224,drug-related,0,0
103225,AEs,0,0
103226,were,0,0
103227,mild,0,0
103228,to,0,0
103229,moderate,0,0
103230,and,0,0
103231,were,0,0
103232,similar,0,0
103233,between,0,0
103234,V/HCTZ,1,0
103235,(,0,0
103236,53.1,0,0
103237,and,0,0
103238,14.1,0,0
103239,%,0,0
103240,",",0,0
103241,respectively,0,0
103242,),0,0
103243,and,0,0
103244,the,0,0
103245,two,0,0
103246,monotherapy,0,0
103247,groups,0,0
103248,",",0,0
103249,V-low,0,0
103250,(,0,0
103251,50.5,0,0
103252,and,0,0
103253,13.8,0,0
103254,%,0,0
103255,),0,0
103256,and,0,0
103257,V-high,0,1
103258,(,0,0
103259,50.7,0,0
103260,and,0,0
103261,11.8,0,0
103262,%,0,0
103263,),0,0
103264,.,0,0
103265,In,0,0
103266,conclusion,0,0
103267,",",0,0
103268,initiating,0,0
103269,therapy,0,1
103270,with,0,0
103271,a,0,0
103272,combination,0,1
103273,of,0,0
103274,valsartan,1,1
103275,and,0,0
103276,low-dose,0,1
103277,HCTZ,1,0
103278,results,0,0
103279,in,0,0
103280,early,0,0
103281,",",0,0
103282,improved,0,0
103283,BP,0,0
103284,efficacy,0,0
103285,with,0,0
103286,similar,0,0
103287,tolerability,0,0
103288,as,0,0
103289,compared,0,0
103290,with,0,0
103291,starting,0,0
103292,treatment,0,0
103293,with,0,0
103294,a,0,0
103295,low,0,0
103296,or,0,0
103297,higher,0,0
103298,dose,0,0
103299,of,0,0
103300,valsartan,1,1
103301,for,0,0
103302,patients,0,0
103303,with,0,0
103304,stage-1,0,0
103305,and,0,0
103306,stage-2,0,0
103307,hypertension,0,0
103308,.,0,0
103309,Lack,0,1
103310,of,0,0
103311,lipotoxicity,0,0
103312,effect,0,0
103313,on,0,0
103314,{,0,0
103315,beta,0,1
103316,},0,0
103317,-cell,0,0
103318,dysfunction,0,0
103319,in,0,0
103320,ketosis-prone,0,0
103321,type,0,0
103322,2,0,0
103323,diabetes,0,0
103324,.,0,0
103325,OBJECTIVE,0,0
103326,Over,0,0
103327,half,0,0
103328,of,0,0
103329,newly,0,0
103330,diagnosed,0,0
103331,obese,0,0
103332,African,0,0
103333,Americans,0,0
103334,with,0,0
103335,diabetic,0,0
103336,ketoacidosis,0,0
103337,(,0,0
103338,DKA,0,1
103339,),0,0
103340,discontinue,0,0
103341,insulin,0,1
103342,therapy,0,1
103343,and,0,0
103344,go,0,1
103345,through,0,0
103346,a,0,0
103347,period,0,0
103348,of,0,0
103349,near-normoglycemia,0,0
103350,remission,0,0
103351,.,0,0
103352,This,0,0
103353,subtype,0,0
103354,of,0,0
103355,diabetes,0,0
103356,is,0,0
103357,known,0,0
103358,as,0,0
103359,ketosis-prone,0,0
103360,type,0,0
103361,2,0,0
103362,diabetes,0,0
103363,(,0,0
103364,KPDM,0,1
103365,),0,0
103366,.,0,0
103367,RESEARCH,0,0
103368,DESIGN,0,0
103369,AND,0,0
103370,METHODS,0,0
103371,To,0,0
103372,investigate,0,0
103373,the,0,0
103374,role,0,0
103375,of,0,0
103376,lipotoxicity,0,0
103377,on,0,0
103378,beta-cell,0,0
103379,function,0,0
103380,",",0,0
103381,eight,0,0
103382,obese,0,0
103383,African,0,0
103384,Americans,0,0
103385,with,0,0
103386,KPDM,0,1
103387,",",0,0
103388,eight,0,0
103389,obese,0,0
103390,subjects,0,0
103391,with,0,0
103392,type,0,0
103393,2,0,0
103394,diabetes,0,0
103395,with,0,0
103396,severe,0,0
103397,hyperglycemia,0,0
103398,without,0,1
103399,ketosis,0,0
103400,(,0,0
103401,ketosis-resistant,0,0
103402,type,0,0
103403,2,0,0
103404,diabetes,0,0
103405,),0,0
103406,",",0,0
103407,and,0,0
103408,nine,0,0
103409,nondiabetic,0,0
103410,obese,0,0
103411,control,0,0
103412,subjects,0,0
103413,underwent,0,0
103414,intravenous,1,0
103415,infusion,1,1
103416,of,1,0
103417,20,1,0
103418,%,1,0
103419,intralipid,1,1
103420,at,1,0
103421,40,1,0
103422,ml/h,1,0
103423,for,0,0
103424,48,0,0
103425,h.,0,0
103426,beta-Cell,0,0
103427,function,0,0
103428,was,0,0
103429,assessed,0,0
103430,by,0,0
103431,changes,0,0
103432,in,0,0
103433,insulin,0,1
103434,and,0,0
103435,C-peptide,0,1
103436,concentration,0,0
103437,during,0,0
103438,infusions,0,1
103439,and,0,0
103440,by,0,0
103441,changes,0,0
103442,in,0,0
103443,acute,0,0
103444,insulin,0,1
103445,response,0,0
103446,to,0,0
103447,arginine,0,1
103448,stimulation,0,1
103449,(,0,0
103450,AIR,0,1
103451,(,0,1
103452,arg,0,1
103453,),0,1
103454,),0,0
103455,before,0,0
103456,and,0,0
103457,after,0,0
103458,lipid,1,0
103459,infusion,1,1
103460,.,1,0
103461,RESULTS,0,0
103462,The,0,0
103463,mean,0,0
103464,time,0,0
103465,to,0,0
103466,discontinue,0,0
103467,insulin,0,1
103468,therapy,0,1
103469,was,0,0
103470,11.0,0,0
103471,+/-,0,0
103472,8.0,0,0
103473,weeks,0,0
103474,in,0,0
103475,KPDM,0,1
103476,and,0,0
103477,9.6,0,0
103478,+/-,0,0
103479,2.2,0,0
103480,weeks,0,0
103481,in,0,0
103482,ketosis-resistant,0,0
103483,type,0,0
103484,2,0,0
103485,diabetes,0,0
103486,(,0,0
103487,P,0,0
103488,=,0,0
103489,NS,0,0
103490,),0,0
103491,.,0,0
103492,At,0,0
103493,remission,0,0
103494,",",0,0
103495,KPDM,0,1
103496,and,0,0
103497,ketosis-resistant,0,0
103498,type,0,0
103499,2,0,0
103500,diabetes,0,0
103501,had,0,0
103502,similar,0,0
103503,glucose,0,0
103504,(,0,0
103505,94,0,0
103506,+/-,0,0
103507,14,0,0
103508,vs.,0,0
103509,109,0,0
103510,+/-,0,0
103511,20,0,0
103512,mg/dl,0,0
103513,),0,0
103514,",",0,0
103515,A1C,0,0
103516,(,0,0
103517,5.7,0,0
103518,+/-,0,0
103519,0.4,0,0
103520,vs.,0,0
103521,6.3,0,0
103522,+/-,0,0
103523,1.1,0,0
103524,%,0,0
103525,),0,0
103526,",",0,0
103527,and,0,0
103528,baseline,0,0
103529,AIR,0,1
103530,(,0,0
103531,arg,0,1
103532,),0,1
103533,response,0,0
103534,(,0,0
103535,34.8,0,0
103536,+/-,0,0
103537,30,0,0
103538,vs.,0,0
103539,64,0,0
103540,+/-,0,0
103541,69,0,0
103542,microU/ml,0,0
103543,),0,0
103544,.,0,0
103545,P,0,0
103546,=,0,0
103547,NS,0,0
103548,despite,0,0
103549,a,0,0
103550,fourfold,0,0
103551,increase,0,0
103552,in,0,0
103553,free,0,0
103554,fatty,0,1
103555,acid,0,1
103556,(,0,0
103557,FFA,0,0
103558,),0,1
103559,levels,0,0
103560,(,0,0
103561,0.4,0,0
103562,+/-,0,0
103563,0.3,0,0
103564,to,0,0
103565,1.8,0,0
103566,+/-,0,0
103567,1.1,0,0
103568,mmol/l,0,0
103569,",",0,0
103570,P,0,0
103571,<,0,0
103572,0.01,0,0
103573,),0,0
103574,during,0,0
103575,the,0,0
103576,48-h,0,0
103577,intralipid,1,1
103578,infusion,1,1
103579,;,1,0
103580,the,0,0
103581,response,0,0
103582,to,0,0
103583,AIR,0,1
103584,(,0,1
103585,arg,0,1
103586,),0,1
103587,stimulation,0,1
103588,",",0,0
103589,as,0,0
103590,well,0,0
103591,as,0,0
103592,changes,0,0
103593,in,0,0
103594,insulin,0,1
103595,and,0,0
103596,C-peptide,0,0
103597,levels,0,0
103598,",",0,0
103599,were,0,0
103600,similar,0,0
103601,among,0,0
103602,obese,0,0
103603,patients,0,0
103604,with,0,0
103605,KPDM,0,1
103606,",",0,0
103607,patients,0,0
103608,with,0,0
103609,ketosis-resistant,0,0
103610,type,0,0
103611,2,0,0
103612,diabetes,0,0
103613,",",0,0
103614,and,0,0
103615,nondiabetic,0,0
103616,control,0,0
103617,subjects,0,0
103618,.,0,0
103619,CONCLUSIONS,0,0
103620,Near-normoglycemia,0,0
103621,remission,0,0
103622,in,0,0
103623,obese,0,0
103624,African,0,0
103625,American,0,0
103626,patients,0,0
103627,with,0,0
103628,KPDM,0,1
103629,and,0,0
103630,ketosis-resistant,0,0
103631,type,0,0
103632,2,0,0
103633,diabetes,0,0
103634,is,0,0
103635,associated,0,0
103636,with,0,0
103637,a,0,0
103638,remarkable,0,0
103639,recovery,0,0
103640,in,0,0
103641,basal,0,0
103642,and,0,0
103643,stimulated,0,0
103644,insulin,0,1
103645,secretion,0,0
103646,.,0,0
103647,A,0,0
103648,high,0,0
103649,FFA,0,0
103650,level,0,0
103651,by,0,0
103652,intralipid,1,1
103653,infusion,1,1
103654,for,0,0
103655,48,0,0
103656,h,0,0
103657,was,0,0
103658,not,0,0
103659,associated,0,0
103660,with,0,0
103661,beta-cell,0,0
103662,decompensation,0,0
103663,(,0,0
103664,lipotoxicity,0,0
103665,),0,0
103666,in,0,0
103667,KPDM,0,1
103668,patients,0,0
103669,.,0,0
103670,Evidence,0,0
103671,for,0,0
103672,poorer,0,0
103673,outcome,0,0
103674,in,0,0
103675,patients,0,0
103676,with,0,0
103677,severe,0,0
103678,negative,0,0
103679,trauma-related,0,0
103680,cognitions,0,1
103681,receiving,0,0
103682,prolonged,1,0
103683,exposure,1,0
103684,plus,0,1
103685,cognitive,1,0
103686,restructuring,1,0
103687,:,1,0
103688,implications,0,0
103689,for,0,0
103690,treatment,0,0
103691,matching,0,0
103692,in,0,0
103693,posttraumatic,0,0
103694,stress,0,0
103695,disorder,0,0
103696,.,0,0
103697,In,0,0
103698,the,0,0
103699,current,0,0
103700,article,0,0
103701,",",0,0
103702,we,0,0
103703,address,0,0
103704,the,0,0
103705,existing,0,0
103706,assumption,0,0
103707,in,0,0
103708,the,0,0
103709,literature,0,0
103710,on,0,0
103711,cognitive,1,0
103712,behavioral,1,1
103713,treatment,1,0
103714,of,0,0
103715,PTSD,0,0
103716,that,0,0
103717,patients,0,0
103718,with,0,0
103719,severe,0,0
103720,negative,0,0
103721,trauma-related,0,0
103722,cognitions,0,0
103723,would,0,0
103724,benefit,0,0
103725,more,0,0
103726,from,0,0
103727,a,0,0
103728,treatment,0,0
103729,package,0,1
103730,that,0,0
103731,includes,0,0
103732,exposure,1,0
103733,and,1,0
103734,cognitive,1,0
103735,techniques,1,1
103736,compared,0,0
103737,with,0,0
103738,a,0,0
103739,treatment,0,0
103740,that,0,0
103741,includes,0,0
103742,exposure,1,0
103743,only,1,0
103744,.,1,0
103745,To,0,0
103746,test,0,0
103747,this,0,0
103748,assumption,0,0
103749,",",0,0
103750,54,0,0
103751,PTSD,0,0
103752,patients,0,0
103753,were,0,0
103754,randomized,0,0
103755,to,0,0
103756,prolonged,1,0
103757,exposure,1,0
103758,therapy,1,1
103759,or,1,1
103760,prolonged,1,0
103761,exposure,1,0
103762,therapy,1,1
103763,plus,1,1
103764,cognitive,1,0
103765,restructuring,1,0
103766,.,1,0
103767,Contrary,0,0
103768,to,0,0
103769,expectations,0,0
103770,",",0,0
103771,findings,0,0
103772,revealed,0,0
103773,that,0,0
103774,patients,0,0
103775,characterized,0,0
103776,by,0,0
103777,more,0,0
103778,severe,0,0
103779,pretreatment,0,0
103780,trauma-related,0,0
103781,cognitions,0,1
103782,(,0,0
103783,and,0,0
103784,more,0,0
103785,severe,0,0
103786,pretreatment,0,0
103787,PTSD,0,0
103788,symptoms,0,0
103789,),0,0
103790,fared,0,0
103791,slightly,0,0
103792,worse,0,0
103793,in,0,0
103794,treatment,0,0
103795,combining,0,0
103796,exposure,1,0
103797,and,1,0
103798,cognitive,1,0
103799,restructuring,1,0
103800,.,1,0
103801,However,0,0
103802,",",0,0
103803,there,0,0
103804,was,0,0
103805,no,0,0
103806,relationship,0,0
103807,between,0,0
103808,pre-,0,0
103809,and,0,0
103810,post-treatment,0,0
103811,measures,0,0
103812,of,0,0
103813,negative,0,0
103814,cognitions,0,1
103815,and,0,0
103816,PTSD,0,0
103817,symptoms,0,0
103818,in,0,0
103819,the,0,0
103820,exposure,1,0
103821,alone,1,1
103822,group,0,0
103823,.,0,0
103824,The,0,0
103825,implications,0,0
103826,of,0,0
103827,these,0,0
103828,findings,0,0
103829,for,0,0
103830,examining,0,0
103831,Person,0,0
103832,X,0,1
103833,Treatment,0,1
103834,interactions,0,0
103835,and,0,0
103836,the,0,0
103837,efficacy,0,0
103838,of,0,0
103839,combining,0,0
103840,treatments,0,0
103841,for,0,0
103842,PTSD,0,0
103843,are,0,0
103844,discussed,0,0
103845,.,0,0
103846,Monitoring,0,1
103847,acute,0,0
103848,effects,0,0
103849,on,0,0
103850,athletic,0,0
103851,performance,0,0
103852,with,0,0
103853,mixed,0,0
103854,linear,0,0
103855,modeling,0,0
103856,.,0,0
103857,UNLABELLED,0,0
103858,There,0,0
103859,is,0,0
103860,a,0,0
103861,need,0,0
103862,for,0,0
103863,a,0,0
103864,sophisticated,0,0
103865,approach,0,1
103866,to,0,0
103867,track,0,1
103868,athletic,0,0
103869,performance,0,0
103870,and,0,0
103871,to,0,0
103872,quantify,0,0
103873,factors,0,0
103874,affecting,0,0
103875,it,0,0
103876,in,0,0
103877,practical,0,0
103878,settings,0,0
103879,.,0,0
103880,PURPOSE,0,0
103881,To,0,0
103882,demonstrate,0,0
103883,the,0,0
103884,application,0,0
103885,of,0,0
103886,mixed,0,0
103887,linear,0,0
103888,modeling,0,0
103889,for,0,0
103890,monitoring,0,0
103891,athletic,0,0
103892,performance,0,0
103893,.,0,0
103894,METHODS,0,0
103895,Elite,0,1
103896,sprint,0,0
103897,and,0,0
103898,middle-distance,0,1
103899,swimmers,0,1
103900,(,0,0
103901,three,0,0
103902,females,0,0
103903,and,0,0
103904,six,0,0
103905,males,0,0
103906,;,0,0
103907,aged,0,0
103908,21-26,0,0
103909,yr,0,0
103910,),0,0
103911,performed,0,0
103912,6-13,0,0
103913,time,0,0
103914,trials,0,0
103915,in,0,0
103916,training,0,1
103917,and,0,0
103918,competition,0,0
103919,in,0,0
103920,the,0,0
103921,9,0,0
103922,wk,0,0
103923,before,0,0
103924,and,0,0
103925,including,0,0
103926,Olympic-qualifying,0,0
103927,trials,0,0
103928,",",0,0
103929,all,0,0
103930,in,0,0
103931,their,0,0
103932,specialty,0,0
103933,event,0,0
103934,.,0,0
103935,We,0,0
103936,included,0,0
103937,a,0,0
103938,double-blind,0,0
103939,",",0,0
103940,randomized,0,0
103941,",",0,0
103942,diet-controlled,1,0
103943,crossover,1,0
103944,intervention,1,1
103945,",",0,0
103946,in,0,0
103947,which,0,0
103948,the,0,0
103949,swimmers,0,0
103950,consumed,0,0
103951,caffeine,1,1
103952,(,0,0
103953,5,0,0
103954,mg,0,1
103955,x,0,0
103956,kg,0,1
103957,(,0,0
103958,-1,0,0
103959,),0,1
103960,body,0,0
103961,mass,0,0
103962,),0,0
103963,or,0,0
103964,placebo,1,1
103965,.,1,0
103966,The,0,0
103967,swimmers,0,0
103968,also,0,0
103969,knowingly,0,0
103970,consumed,0,0
103971,varying,0,0
103972,doses,0,0
103973,of,0,0
103974,caffeine,1,1
103975,in,0,0
103976,some,0,0
103977,time,0,0
103978,trials,0,0
103979,.,0,0
103980,We,0,0
103981,used,0,0
103982,mixed,0,0
103983,linear,0,0
103984,modeling,0,0
103985,of,0,0
103986,log-transformed,0,0
103987,swim,0,1
103988,time,0,0
103989,to,0,0
103990,quantify,0,0
103991,effects,0,0
103992,on,0,0
103993,performance,0,0
103994,in,0,0
103995,training,0,1
103996,versus,0,0
103997,competition,0,0
103998,",",0,0
103999,in,0,0
104000,morning,0,0
104001,versus,0,0
104002,evening,0,0
104003,swims,0,1
104004,",",0,0
104005,and,0,0
104006,with,0,0
104007,use,0,0
104008,of,0,0
104009,caffeine,0,1
104010,.,0,0
104011,Predictor,0,0
104012,variables,0,0
104013,were,0,0
104014,coded,0,0
104015,as,0,0
104016,0,0,0
104017,or,0,0
104018,1,0,0
104019,to,0,0
104020,represent,0,0
104021,absence,0,0
104022,or,0,1
104023,presence,0,0
104024,",",0,0
104025,respectively,0,0
104026,",",0,0
104027,of,0,0
104028,each,0,0
104029,condition,0,0
104030,and,0,0
104031,were,0,0
104032,included,0,0
104033,as,0,0
104034,fixed,0,0
104035,effects,0,0
104036,.,0,0
104037,The,0,0
104038,date,0,0
104039,of,0,0
104040,each,0,0
104041,performance,0,0
104042,test,0,0
104043,was,0,0
104044,included,0,0
104045,as,0,0
104046,a,0,0
104047,continuous,0,0
104048,linear,0,0
104049,fixed,0,0
104050,effect,0,0
104051,and,0,0
104052,interacted,0,0
104053,with,0,0
104054,the,0,0
104055,random,0,0
104056,effect,0,0
104057,for,0,0
104058,the,0,0
104059,athlete,0,0
104060,to,0,0
104061,represent,0,0
104062,individual,0,0
104063,differences,0,0
104064,in,0,0
104065,linear,0,0
104066,trends,0,0
104067,in,0,0
104068,performance,0,0
104069,.,0,0
104070,RESULTS,0,0
104071,Most,0,0
104072,effects,0,0
104073,were,0,0
104074,clear,0,0
104075,",",0,0
104076,owing,0,0
104077,to,0,0
104078,the,0,0
104079,high,0,0
104080,reliability,0,0
104081,of,0,0
104082,performance,0,0
104083,times,0,0
104084,in,0,0
104085,training,0,1
104086,and,0,0
104087,competition,0,0
104088,(,0,0
104089,typical,0,0
104090,errors,0,0
104091,of,0,0
104092,0.9,0,0
104093,%,0,0
104094,and,0,0
104095,0.8,0,0
104096,%,0,0
104097,",",0,0
104098,respectively,0,0
104099,),0,0
104100,.,0,0
104101,Performance,0,0
104102,time,0,0
104103,improved,0,0
104104,linearly,0,0
104105,by,0,0
104106,0.8,0,0
104107,%,0,0
104108,per,0,0
104109,4,0,0
104110,wk,0,0
104111,.,0,0
104112,The,0,0
104113,swimmers,0,0
104114,performed,0,0
104115,substantially,0,0
104116,better,0,0
104117,in,0,0
104118,evenings,0,0
104119,versus,0,0
104120,mornings,0,0
104121,and,0,0
104122,in,0,0
104123,competition,0,0
104124,versus,0,0
104125,training,0,1
104126,.,0,0
104127,A,0,0
104128,100-mg,0,1
104129,dose,0,0
104130,of,0,0
104131,caffeine,0,1
104132,enhanced,0,0
104133,performance,0,0
104134,in,0,0
104135,training,0,1
104136,and,0,0
104137,competition,0,0
104138,by,0,0
104139,approximately,0,0
104140,1.3,0,0
104141,%,0,0
104142,.,0,0
104143,There,0,0
104144,were,0,0
104145,substantial,0,0
104146,but,0,0
104147,unclear,0,0
104148,individual,0,0
104149,responses,0,0
104150,to,0,0
104151,training,0,1
104152,and,0,0
104153,caffeine,0,1
104154,(,0,0
104155,SD,0,0
104156,of,0,0
104157,0.3,0,0
104158,%,0,0
104159,and,0,0
104160,0.8,0,0
104161,%,0,0
104162,",",0,0
104163,respectively,0,0
104164,),0,0
104165,.,0,0
104166,CONCLUSIONS,0,0
104167,Mixed,0,0
104168,linear,0,0
104169,modeling,0,0
104170,can,0,0
104171,be,0,0
104172,applied,0,0
104173,successfully,0,0
104174,to,0,0
104175,monitor,0,0
104176,factors,0,0
104177,affecting,0,0
104178,performance,0,0
104179,in,0,0
104180,a,0,0
104181,squad,0,0
104182,of,0,0
104183,elite,0,0
104184,athletes,0,0
104185,.,0,0
104186,A,0,0
104187,comparative,0,0
104188,study,0,0
104189,of,0,0
104190,the,0,0
104191,effects,0,0
104192,of,0,0
104193,local,0,0
104194,estrogen,0,1
104195,with,0,0
104196,or,0,0
104197,without,0,0
104198,local,0,0
104199,testosterone,1,0
104200,on,0,0
104201,vulvovaginal,0,0
104202,and,0,0
104203,sexual,0,0
104204,dysfunction,0,0
104205,in,0,0
104206,postmenopausal,0,0
104207,women,0,0
104208,.,0,0
104209,INTRODUCTION,0,0
104210,A,0,0
104211,significant,0,0
104212,number,0,0
104213,of,0,0
104214,postmenopausal,0,0
104215,women,0,0
104216,suffer,0,0
104217,from,0,0
104218,distressing,0,0
104219,problems,0,0
104220,because,0,0
104221,of,0,0
104222,urogenital,0,0
104223,atrophy,0,0
104224,secondary,0,0
104225,to,0,0
104226,the,0,0
104227,decline,0,0
104228,in,0,0
104229,circulating,0,0
104230,estrogen,0,1
104231,levels,0,0
104232,.,0,0
104233,Treatment,0,0
104234,with,0,0
104235,topical,1,1
104236,hormones,1,0
104237,may,0,0
104238,provide,0,0
104239,relief,0,0
104240,in,0,0
104241,such,0,0
104242,women,0,0
104243,when,0,0
104244,used,0,0
104245,judiciously,0,0
104246,.,0,0
104247,AIM,0,0
104248,To,0,0
104249,study,0,0
104250,the,0,0
104251,effects,0,0
104252,of,0,0
104253,local,0,0
104254,estrogen,0,1
104255,with,0,0
104256,or,0,0
104257,without,0,0
104258,local,1,0
104259,testosterone,1,0
104260,on,0,0
104261,urogenital,0,0
104262,and,0,0
104263,sexual,0,0
104264,health,0,0
104265,in,0,0
104266,postmenopausal,0,0
104267,women,0,0
104268,.,0,0
104269,METHODS,0,0
104270,Seventy-five,0,0
104271,postmenopausal,0,0
104272,women,0,0
104273,symptomatic,0,0
104274,for,0,0
104275,urogenital,0,0
104276,atrophy,0,0
104277,and,0,0
104278,sexual,0,0
104279,dysfunction,0,0
104280,were,0,0
104281,randomly,0,0
104282,divided,0,0
104283,into,0,0
104284,two,0,0
104285,study,0,0
104286,groups,0,0
104287,and,0,0
104288,one,0,0
104289,control,0,0
104290,group,0,0
104291,.,0,0
104292,The,0,0
104293,women,0,0
104294,in,0,0
104295,study,0,0
104296,group,0,0
104297,1,0,0
104298,received,1,0
104299,local,1,0
104300,estrogen,1,1
104301,cream,1,1
104302,;,1,0
104303,study,1,0
104304,group,1,0
104305,2,1,0
104306,received,1,0
104307,local,1,0
104308,estrogen,1,1
104309,and,1,0
104310,testosterone,1,0
104311,cream,1,1
104312,;,1,0
104313,the,1,0
104314,control,1,0
104315,group,1,0
104316,received,1,0
104317,nonhormonal,1,1
104318,lubricant,1,0
104319,KY,1,0
104320,gel,1,1
104321,for,1,0
104322,12,1,0
104323,weeks,1,0
104324,.,1,0
104325,The,0,0
104326,urogenital,0,0
104327,and,0,0
104328,sexuality,0,1
104329,score,0,0
104330,",",0,0
104331,along,0,0
104332,with,0,0
104333,the,0,0
104334,vaginal,0,0
104335,health,0,0
104336,index,0,0
104337,and,0,0
104338,the,0,0
104339,vaginal,0,1
104340,maturation,0,0
104341,index,0,0
104342,(,0,0
104343,VMI,0,0
104344,),0,0
104345,",",0,0
104346,was,0,0
104347,calculated,0,0
104348,at,0,0
104349,the,0,0
104350,beginning,0,0
104351,of,0,0
104352,therapy,0,1
104353,and,0,0
104354,12,0,0
104355,weeks,0,0
104356,later,0,0
104357,.,0,0
104358,MAIN,0,0
104359,OUTCOME,0,0
104360,MEASURES,0,0
104361,Changes,0,0
104362,in,0,0
104363,the,0,0
104364,urogenital,0,0
104365,and,0,0
104366,sexuality,0,1
104367,score,0,0
104368,along,0,0
104369,with,0,0
104370,vaginal,0,0
104371,health,0,0
104372,index,0,0
104373,and,0,0
104374,VMI,0,0
104375,.,0,0
104376,RESULTS,0,0
104377,After,0,0
104378,12,0,0
104379,weeks,0,0
104380,of,0,0
104381,therapy,0,1
104382,",",0,0
104383,there,0,0
104384,was,0,0
104385,a,0,0
104386,significant,0,0
104387,improvement,0,0
104388,in,0,0
104389,all,0,0
104390,the,0,0
104391,four,0,0
104392,study,0,0
104393,parameters,0,0
104394,",",0,0
104395,which,0,0
104396,correlated,0,0
104397,well,0,0
104398,with,0,0
104399,the,0,0
104400,improvement,0,0
104401,in,0,0
104402,symptoms,0,0
104403,of,0,0
104404,urogenital,0,0
104405,atrophy,0,0
104406,and,0,0
104407,sexual,0,0
104408,dysfunction,0,0
104409,in,0,0
104410,both,0,0
104411,the,0,0
104412,study,0,0
104413,groups,0,0
104414,as,0,0
104415,compared,0,0
104416,with,0,0
104417,the,0,0
104418,control,0,0
104419,group,0,0
104420,.,0,0
104421,Improvement,0,0
104422,in,0,0
104423,sexuality,0,0
104424,score,0,0
104425,was,0,0
104426,greatest,0,0
104427,with,0,0
104428,combined,0,0
104429,estrogen-androgen,0,1
104430,therapy,0,1
104431,.,0,0
104432,There,0,0
104433,were,0,0
104434,no,0,0
104435,adverse,0,0
104436,effects,0,0
104437,and,0,0
104438,the,0,0
104439,therapies,0,0
104440,were,0,0
104441,well,0,0
104442,accepted,0,0
104443,without,0,0
104444,any,0,0
104445,compliance,0,0
104446,issue,0,0
104447,.,0,0
104448,CONCLUSION,0,0
104449,Local,1,0
104450,estrogen,1,1
104451,either,0,0
104452,alone,0,1
104453,or,0,1
104454,with,0,0
104455,androgen,0,1
104456,is,0,0
104457,highly,0,0
104458,effective,0,0
104459,in,0,0
104460,relieving,0,0
104461,symptoms,0,0
104462,of,0,0
104463,urogenital,0,0
104464,atrophy,0,0
104465,and,0,0
104466,in,0,0
104467,improving,0,0
104468,sexual,0,0
104469,function,0,0
104470,in,0,0
104471,symptomatic,0,0
104472,postmenopausal,0,0
104473,women,0,0
104474,.,0,0
104475,Comparable,0,0
104476,patencies,0,0
104477,of,0,0
104478,the,0,0
104479,radial,1,1
104480,artery,1,0
104481,and,0,0
104482,right,0,0
104483,internal,1,1
104484,thoracic,1,1
104485,artery,1,0
104486,or,0,1
104487,saphenous,1,1
104488,vein,1,0
104489,beyond,0,0
104490,5,0,0
104491,years,0,0
104492,:,0,0
104493,results,0,0
104494,from,0,0
104495,the,0,0
104496,Radial,0,0
104497,Artery,0,0
104498,Patency,0,0
104499,and,0,0
104500,Clinical,0,0
104501,Outcomes,0,0
104502,trial,0,0
104503,.,0,0
104504,OBJECTIVE,0,0
104505,To,0,0
104506,investigate,0,0
104507,the,0,0
104508,optimum,0,0
104509,conduit,0,0
104510,for,0,0
104511,coronary,0,0
104512,targets,0,0
104513,other,0,0
104514,than,0,0
104515,the,0,0
104516,left,0,0
104517,anterior,0,0
104518,descending,0,0
104519,artery,0,0
104520,",",0,0
104521,we,0,0
104522,evaluated,0,0
104523,long-term,0,0
104524,patencies,0,0
104525,and,0,0
104526,clinical,0,0
104527,outcomes,0,0
104528,of,0,0
104529,the,0,0
104530,radial,0,1
104531,artery,0,0
104532,",",0,0
104533,right,0,0
104534,internal,0,0
104535,thoracic,0,1
104536,artery,0,0
104537,",",0,0
104538,and,0,0
104539,saphenous,0,1
104540,vein,0,0
104541,through,0,0
104542,the,0,0
104543,Radial,0,0
104544,Artery,0,0
104545,Patency,0,0
104546,and,0,0
104547,Clinical,0,0
104548,Outcomes,0,0
104549,trial,0,0
104550,.,0,0
104551,METHODS,0,0
104552,As,0,0
104553,part,0,0
104554,of,0,0
104555,a,0,0
104556,10-year,0,0
104557,prospective,0,0
104558,",",0,0
104559,randomized,0,0
104560,",",0,0
104561,single-center,0,0
104562,trial,0,0
104563,",",0,0
104564,patients,0,0
104565,undergoing,0,0
104566,primary,0,0
104567,coronary,0,0
104568,surgery,0,0
104569,were,0,0
104570,allocated,0,0
104571,to,0,0
104572,the,0,0
104573,radial,0,1
104574,artery,0,0
104575,(,0,0
104576,n,0,0
104577,=,0,0
104578,198,0,0
104579,),0,0
104580,or,0,0
104581,free,0,0
104582,right,0,0
104583,internal,0,1
104584,thoracic,0,1
104585,artery,0,0
104586,(,0,0
104587,n,0,0
104588,=,0,0
104589,196,0,0
104590,),0,0
104591,if,0,0
104592,aged,0,0
104593,less,0,0
104594,than,0,0
104595,70,0,0
104596,years,0,0
104597,(,0,0
104598,group,0,0
104599,1,0,0
104600,),0,0
104601,",",0,0
104602,or,0,1
104603,radial,0,1
104604,artery,0,0
104605,(,0,0
104606,n,0,0
104607,=,0,0
104608,113,0,0
104609,),0,0
104610,or,0,0
104611,saphenous,0,1
104612,vein,0,0
104613,(,0,0
104614,n,0,0
104615,=,0,0
104616,112,0,0
104617,),0,0
104618,if,0,0
104619,aged,0,0
104620,at,0,0
104621,least,0,0
104622,70,0,0
104623,years,0,0
104624,(,0,0
104625,group,0,0
104626,2,0,0
104627,),0,0
104628,.,0,0
104629,All,0,0
104630,patients,0,0
104631,received,0,0
104632,a,0,0
104633,left,1,0
104634,internal,1,0
104635,thoracic,1,1
104636,artery,1,0
104637,to,1,0
104638,the,1,0
104639,left,1,0
104640,anterior,1,0
104641,descending,1,0
104642,",",0,0
104643,and,0,0
104644,the,0,0
104645,randomized,0,0
104646,conduit,0,0
104647,was,0,0
104648,used,0,0
104649,to,0,0
104650,graft,0,0
104651,the,0,0
104652,second,0,0
104653,largest,0,0
104654,target,0,0
104655,.,0,0
104656,Protocol-directed,1,0
104657,angiography,1,1
104658,has,0,0
104659,been,0,0
104660,performed,0,0
104661,at,0,0
104662,randomly,0,0
104663,assigned,0,0
104664,intervals,0,0
104665,",",0,0
104666,weighted,0,0
104667,toward,0,0
104668,the,0,0
104669,end,0,0
104670,of,0,0
104671,the,0,0
104672,study,0,0
104673,period,0,0
104674,.,0,0
104675,Grafts,0,0
104676,are,0,0
104677,defined,0,0
104678,as,0,0
104679,failed,0,0
104680,if,0,0
104681,there,0,0
104682,was,0,0
104683,occlusion,0,0
104684,",",0,0
104685,string,0,0
104686,sign,0,0
104687,",",0,0
104688,or,0,0
104689,greater,0,0
104690,than,0,0
104691,80,0,0
104692,%,0,0
104693,stenosis,0,0
104694,",",0,0
104695,independently,0,0
104696,reported,0,0
104697,by,0,0
104698,3,0,0
104699,assessors,0,0
104700,.,0,0
104701,Analysis,0,0
104702,is,0,0
104703,by,0,0
104704,intention,0,0
104705,to,0,0
104706,treat,0,0
104707,.,0,0
104708,RESULTS,0,0
104709,At,0,0
104710,mean,0,0
104711,follow,0,0
104712,up,0,0
104713,of,0,0
104714,5.5,0,0
104715,years,0,0
104716,",",0,0
104717,protocol,0,0
104718,angiography,0,1
104719,has,0,0
104720,been,0,0
104721,performed,0,0
104722,in,0,0
104723,groups,0,0
104724,1,0,0
104725,and,0,0
104726,2,0,0
104727,in,0,0
104728,237,0,0
104729,and,0,0
104730,113,0,0
104731,patients,0,0
104732,",",0,0
104733,respectively,0,0
104734,.,0,0
104735,There,0,0
104736,are,0,0
104737,no,0,0
104738,significant,0,0
104739,differences,0,0
104740,within,0,0
104741,each,0,0
104742,group,0,0
104743,in,0,0
104744,preoperative,0,0
104745,comorbidity,0,0
104746,",",0,0
104747,age,0,0
104748,",",0,0
104749,or,0,0
104750,urgency,0,0
104751,.,0,0
104752,Patencies,0,0
104753,were,0,0
104754,similar,0,0
104755,for,0,0
104756,either,0,0
104757,of,0,0
104758,the,0,0
104759,2,0,0
104760,conduits,0,0
104761,in,0,0
104762,each,0,0
104763,group,0,0
104764,(,0,0
104765,log,0,0
104766,rank,0,0
104767,analysis,0,0
104768,",",0,0
104769,P,0,0
104770,=,0,0
104771,.06,0,0
104772,and,0,0
104773,P,0,0
104774,=,0,0
104775,.54,0,0
104776,",",0,0
104777,respectively,0,0
104778,),0,0
104779,.,0,0
104780,The,0,0
104781,differences,0,0
104782,in,0,0
104783,estimated,0,0
104784,5-year,0,0
104785,patencies,0,0
104786,were,0,0
104787,6.6,0,0
104788,%,0,0
104789,(,0,0
104790,radial,0,1
104791,minus,0,1
104792,right,0,0
104793,internal,0,1
104794,thoracic,0,1
104795,artery,0,0
104796,),0,0
104797,in,0,0
104798,group,0,0
104799,1,0,0
104800,and,0,0
104801,2.9,0,0
104802,%,0,0
104803,(,0,0
104804,radial,0,1
104805,minus,0,1
104806,saphenous,0,1
104807,vein,0,0
104808,graft,0,0
104809,),0,0
104810,in,0,0
104811,group,0,0
104812,2,0,0
104813,.,0,0
104814,CONCLUSION,0,0
104815,At,0,0
104816,mean,0,0
104817,5-year,0,0
104818,angiography,0,1
104819,in,0,0
104820,largely,0,0
104821,asymptomatic,0,0
104822,patients,0,0
104823,",",0,0
104824,the,0,0
104825,selection,0,0
104826,of,0,0
104827,arterial,0,0
104828,or,0,1
104829,venous,0,0
104830,conduit,0,0
104831,for,0,0
104832,the,0,0
104833,second,0,0
104834,graft,0,0
104835,has,0,0
104836,not,0,0
104837,significantly,0,0
104838,affected,0,0
104839,patency,0,0
104840,.,0,0
104841,This,0,0
104842,finding,0,0
104843,offers,0,0
104844,surgeons,0,0
104845,",",0,0
104846,for,0,0
104847,now,0,0
104848,",",0,0
104849,enhanced,0,0
104850,flexibility,0,0
104851,in,0,0
104852,planning,0,0
104853,revascularization,0,0
104854,.,0,0
104855,Catheter,1,1
104856,ablation,1,1
104857,of,1,0
104858,stable,1,0
104859,ventricular,1,0
104860,tachycardia,1,0
104861,before,0,0
104862,defibrillator,1,1
104863,implantation,0,0
104864,in,0,0
104865,patients,0,0
104866,with,0,0
104867,coronary,0,0
104868,heart,0,0
104869,disease,0,0
104870,(,0,0
104871,VTACH,0,0
104872,),0,0
104873,:,0,0
104874,a,0,0
104875,multicentre,0,0
104876,randomised,0,0
104877,controlled,0,0
104878,trial,0,0
104879,.,0,0
104880,BACKGROUND,0,0
104881,In,0,0
104882,patients,0,0
104883,with,0,0
104884,ventricular,0,0
104885,tachycardia,0,0
104886,(,0,0
104887,VT,0,1
104888,),0,0
104889,and,0,0
104890,a,0,0
104891,history,0,0
104892,of,0,0
104893,myocardial,0,0
104894,infarction,0,0
104895,",",0,0
104896,intervention,0,1
104897,with,0,0
104898,an,0,0
104899,implantable,1,1
104900,cardioverter,1,1
104901,defibrillator,1,1
104902,(,1,0
104903,ICD,1,0
104904,),1,0
104905,can,0,0
104906,prevent,0,0
104907,sudden,0,0
104908,cardiac,0,0
104909,death,0,0
104910,and,0,0
104911,thereby,0,0
104912,reduce,0,0
104913,total,0,0
104914,mortality,0,0
104915,.,0,0
104916,However,0,0
104917,",",0,0
104918,ICD,0,0
104919,shocks,0,1
104920,are,0,0
104921,painful,0,0
104922,and,0,0
104923,do,0,0
104924,not,0,0
104925,provide,0,0
104926,complete,0,0
104927,protection,0,0
104928,against,0,0
104929,sudden,0,0
104930,cardiac,0,0
104931,death,0,0
104932,.,0,0
104933,We,0,0
104934,assessed,0,0
104935,the,0,0
104936,potential,0,0
104937,benefit,0,0
104938,of,0,0
104939,catheter,1,1
104940,ablation,1,1
104941,before,0,0
104942,implantation,0,0
104943,of,0,0
104944,a,0,0
104945,cardioverter,0,1
104946,defibrillator,0,1
104947,.,0,0
104948,METHODS,0,0
104949,The,0,0
104950,Ventricular,0,0
104951,Tachycardia,0,0
104952,Ablation,0,1
104953,in,0,0
104954,Coronary,0,0
104955,Heart,0,1
104956,Disease,0,0
104957,(,0,0
104958,VTACH,0,0
104959,),0,0
104960,study,0,0
104961,was,0,0
104962,a,0,0
104963,prospective,0,0
104964,",",0,0
104965,open,0,0
104966,",",0,0
104967,randomised,0,0
104968,controlled,0,0
104969,trial,0,0
104970,",",0,0
104971,undertaken,0,0
104972,in,0,0
104973,16,0,0
104974,centres,0,0
104975,in,0,0
104976,four,0,0
104977,European,0,0
104978,countries,0,0
104979,.,0,0
104980,Patients,0,0
104981,aged,0,0
104982,18-80,0,0
104983,years,0,0
104984,were,0,0
104985,eligible,0,0
104986,for,0,0
104987,enrolment,0,0
104988,if,0,0
104989,they,0,0
104990,had,0,0
104991,stable,0,0
104992,VT,0,1
104993,",",0,0
104994,previous,0,0
104995,myocardial,0,0
104996,infarction,0,0
104997,",",0,0
104998,and,0,0
104999,reduced,0,0
105000,left-ventricular,0,1
105001,ejection,0,0
105002,fraction,0,0
105003,(,0,0
105004,LVEF,0,0
105005,;,0,0
105006,<,0,0
105007,or=50,0,0
105008,%,0,0
105009,),0,0
105010,.,0,0
105011,110,0,0
105012,patients,0,0
105013,were,0,0
105014,randomly,0,0
105015,allocated,0,0
105016,in,0,0
105017,a,0,0
105018,1:1,0,0
105019,ratio,0,0
105020,to,0,0
105021,receive,1,1
105022,catheter,1,1
105023,ablation,1,1
105024,and,1,0
105025,an,1,0
105026,ICD,1,1
105027,(,1,0
105028,ablation,1,1
105029,group,1,0
105030,",",1,0
105031,n=54,1,0
105032,),1,0
105033,or,1,0
105034,ICD,1,1
105035,alone,1,1
105036,(,1,0
105037,control,1,0
105038,group,1,0
105039,",",1,0
105040,n=56,1,0
105041,),1,0
105042,.,1,0
105043,Randomisation,0,0
105044,was,0,0
105045,done,0,0
105046,by,0,0
105047,computer-generated,0,0
105048,randomly,0,0
105049,permuted,0,0
105050,blocks,0,0
105051,and,0,0
105052,stratified,0,0
105053,by,0,0
105054,centre,0,0
105055,and,0,0
105056,LVEF,0,1
105057,(,0,0
105058,<,0,0
105059,or=30,0,0
105060,%,0,0
105061,or,0,0
105062,>,0,0
105063,30,0,0
105064,%,0,0
105065,),0,0
105066,.,0,0
105067,Patients,0,0
105068,were,0,0
105069,followed,0,0
105070,up,0,0
105071,for,0,0
105072,at,0,0
105073,least,0,0
105074,1,0,0
105075,year,0,0
105076,.,0,0
105077,The,0,0
105078,primary,0,0
105079,endpoint,0,0
105080,was,0,0
105081,the,0,0
105082,time,0,0
105083,to,0,0
105084,first,0,0
105085,recurrence,0,0
105086,of,0,0
105087,VT,0,1
105088,or,0,1
105089,ventricular,0,0
105090,fibrillation,0,0
105091,(,0,0
105092,VF,0,1
105093,),0,0
105094,.,0,0
105095,Analysis,0,0
105096,was,0,0
105097,by,0,0
105098,intention,0,0
105099,to,0,0
105100,treat,0,0
105101,(,0,0
105102,ITT,0,0
105103,),0,0
105104,.,0,0
105105,This,0,0
105106,study,0,0
105107,is,0,0
105108,registered,0,0
105109,with,0,0
105110,ClinicalTrials.gov,0,0
105111,",",0,0
105112,number,0,0
105113,NCT00919373,0,0
105114,.,0,0
105115,FINDINGS,0,0
105116,107,0,0
105117,patients,0,0
105118,were,0,0
105119,included,0,0
105120,in,0,0
105121,the,0,0
105122,ITT,0,1
105123,population,0,0
105124,(,1,0
105125,ablation,1,1
105126,group,1,0
105127,",",0,0
105128,n=52,0,0
105129,;,0,0
105130,control,1,0
105131,group,0,0
105132,",",0,0
105133,n=55,0,0
105134,),0,0
105135,.,0,0
105136,Two,0,0
105137,patients,0,0
105138,(,0,0
105139,one,0,0
105140,in,0,0
105141,each,0,0
105142,group,0,0
105143,),0,0
105144,withdrew,0,0
105145,consent,0,0
105146,immediately,0,0
105147,after,0,0
105148,randomisation,0,0
105149,without,0,0
105150,any,0,0
105151,follow-up,0,0
105152,data,0,0
105153,and,0,0
105154,one,0,0
105155,patient,0,0
105156,(,0,0
105157,ablation,0,1
105158,group,0,0
105159,),0,0
105160,was,0,0
105161,excluded,0,0
105162,because,0,0
105163,of,0,0
105164,a,0,0
105165,protocol,0,0
105166,violaton,0,0
105167,.,0,0
105168,Mean,0,0
105169,follow-up,0,0
105170,was,0,0
105171,22.5,0,0
105172,months,0,0
105173,(,0,0
105174,SD,0,0
105175,9.0,0,0
105176,),0,0
105177,.,0,0
105178,Time,0,0
105179,to,0,0
105180,recurrence,0,0
105181,of,0,0
105182,VT,0,1
105183,or,0,1
105184,VF,0,1
105185,was,0,0
105186,longer,0,0
105187,in,0,0
105188,the,0,0
105189,ablation,1,1
105190,group,1,0
105191,(,0,0
105192,median,0,0
105193,18.6,0,0
105194,months,0,0
105195,[,0,0
105196,lower,0,0
105197,quartile,0,0
105198,2.4,0,0
105199,",",0,0
105200,upper,0,0
105201,quartile,0,0
105202,not,0,0
105203,determinable,0,0
105204,],0,0
105205,),0,0
105206,than,0,0
105207,in,0,0
105208,the,0,0
105209,control,1,1
105210,group,1,0
105211,(,0,0
105212,5.9,0,0
105213,months,0,0
105214,[,0,0
105215,IQR,0,0
105216,0.8-26.7,0,0
105217,],0,0
105218,),0,0
105219,.,0,0
105220,At,0,0
105221,2,0,0
105222,years,0,0
105223,",",0,0
105224,estimates,0,0
105225,for,0,0
105226,survival,0,0
105227,free,0,0
105228,from,0,0
105229,VT,0,1
105230,or,0,1
105231,VF,0,1
105232,were,0,0
105233,47,0,0
105234,%,0,0
105235,in,0,0
105236,the,0,0
105237,ablation,1,1
105238,group,1,0
105239,and,0,0
105240,29,0,0
105241,%,0,0
105242,in,0,0
105243,the,0,0
105244,control,1,1
105245,group,1,0
105246,(,0,0
105247,hazard,0,0
105248,ratio,0,0
105249,0.61,0,0
105250,;,0,0
105251,95,0,0
105252,%,0,0
105253,CI,0,0
105254,0.37-0.99,0,0
105255,;,0,0
105256,p=0.045,0,0
105257,),0,0
105258,.,0,0
105259,Complications,0,0
105260,related,0,0
105261,to,0,0
105262,the,0,0
105263,ablation,0,1
105264,procedure,0,0
105265,occurred,0,0
105266,in,0,0
105267,two,0,0
105268,patients,0,0
105269,;,0,0
105270,no,0,0
105271,deaths,0,0
105272,occurred,0,0
105273,within,0,0
105274,30,0,0
105275,days,0,0
105276,after,0,0
105277,ablation,0,1
105278,.,0,0
105279,15,0,0
105280,device-related,0,0
105281,complications,0,0
105282,requiring,0,0
105283,surgical,0,0
105284,intervention,0,1
105285,occurred,0,0
105286,in,0,0
105287,13,0,0
105288,patients,0,0
105289,(,1,0
105290,ablation,1,1
105291,group,1,0
105292,",",0,0
105293,four,0,0
105294,;,0,0
105295,control,1,0
105296,group,1,0
105297,",",0,0
105298,nine,0,0
105299,),0,0
105300,.,0,0
105301,Nine,0,1
105302,patients,0,0
105303,died,0,0
105304,during,0,0
105305,the,0,0
105306,study,0,0
105307,(,1,0
105308,ablation,1,1
105309,group,0,0
105310,",",0,0
105311,five,0,0
105312,;,0,0
105313,control,1,0
105314,group,0,0
105315,",",0,0
105316,four,0,0
105317,),0,0
105318,.,0,0
105319,INTERPRETATION,0,0
105320,Prophylactic,1,1
105321,VT,1,1
105322,ablation,1,1
105323,before,0,0
105324,defibrillator,1,1
105325,implantation,1,0
105326,seemed,0,0
105327,to,0,0
105328,prolong,0,0
105329,time,0,0
105330,to,0,0
105331,recurrence,0,0
105332,of,0,0
105333,VT,0,0
105334,in,0,0
105335,patients,0,0
105336,with,0,0
105337,stable,0,0
105338,VT,0,1
105339,",",0,0
105340,previous,0,0
105341,myocardial,0,0
105342,infarction,0,0
105343,",",0,0
105344,and,0,0
105345,reduced,0,0
105346,LVEF,0,0
105347,.,0,0
105348,Prophylactic,1,1
105349,catheter,1,1
105350,ablation,1,1
105351,should,0,0
105352,therefore,0,0
105353,be,0,0
105354,considered,0,0
105355,before,0,0
105356,implantation,0,0
105357,of,0,0
105358,a,0,0
105359,cardioverter,1,1
105360,defibrillator,1,1
105361,in,0,0
105362,such,0,0
105363,patients,0,0
105364,.,0,0
105365,FUNDING,0,0
105366,St,0,0
105367,Jude,0,0
105368,Medical,0,1
105369,.,0,0
105370,Enhancing,0,0
105371,caregiver,0,1
105372,health,0,0
105373,:,0,0
105374,findings,0,0
105375,from,0,0
105376,the,0,0
105377,resources,0,0
105378,for,0,0
105379,enhancing,0,0
105380,Alzheimer,0,0
105381,'s,0,0
105382,caregiver,0,1
105383,health,0,0
105384,II,0,0
105385,intervention,0,1
105386,.,0,0
105387,OBJECTIVES,0,0
105388,To,0,0
105389,examine,0,0
105390,the,0,0
105391,relationships,0,0
105392,between,0,0
105393,changes,0,0
105394,from,0,0
105395,baseline,0,0
105396,to,0,0
105397,post-Resources,1,0
105398,for,1,0
105399,Enhancing,1,0
105400,Alzheimer,1,0
105401,'s,1,0
105402,Caregiver,1,1
105403,Health,1,1
105404,(,1,0
105405,REACH,1,1
105406,),1,0
105407,intervention,1,1
105408,in,0,0
105409,caregiver,0,1
105410,(,0,0
105411,CG,0,0
105412,),0,0
105413,self-reported,0,0
105414,health,0,0
105415,",",0,0
105416,burden,0,0
105417,",",0,0
105418,and,0,0
105419,bother,0,0
105420,.,0,0
105421,DESIGN,0,0
105422,Randomized,0,0
105423,",",0,0
105424,multisite,0,0
105425,clinical,0,0
105426,trial,0,0
105427,.,0,0
105428,SETTING,0,0
105429,CG,0,0
105430,and,0,0
105431,care,0,1
105432,recipient,0,0
105433,(,0,0
105434,CR,0,1
105435,),0,0
105436,homes,0,1
105437,in,0,0
105438,five,0,0
105439,U.S.,0,0
105440,cities,0,0
105441,.,0,0
105442,PARTICIPANTS,0,0
105443,Four,0,0
105444,hundred,0,0
105445,ninety-five,0,0
105446,dementia,0,0
105447,CG,0,0
105448,and,0,0
105449,CR,0,1
105450,dyads,0,0
105451,(,0,0
105452,169,0,0
105453,Hispanic,0,0
105454,",",0,0
105455,160,0,0
105456,white,0,0
105457,",",0,0
105458,and,0,0
105459,166,0,0
105460,African,0,1
105461,American,0,0
105462,),0,0
105463,receiving,0,0
105464,intervention,0,1
105465,and,0,0
105466,their,0,0
105467,controls,0,0
105468,.,0,0
105469,INTERVENTION,0,0
105470,CGs,0,0
105471,were,0,0
105472,assigned,0,0
105473,to,0,0
105474,the,0,0
105475,REACH,1,1
105476,intervention,1,1
105477,or,1,1
105478,a,1,0
105479,no-treatment,1,1
105480,control,1,0
105481,group,1,0
105482,.,1,0
105483,Intervention,0,0
105484,subjects,0,0
105485,received,0,0
105486,individual,0,0
105487,risk,0,0
105488,profiles,0,0
105489,and,0,0
105490,the,0,0
105491,REACH,1,0
105492,intervention,1,1
105493,through,1,0
105494,nine,0,0
105495,in-home,1,1
105496,and,0,0
105497,three,0,0
105498,telephone,1,1
105499,sessions,1,1
105500,over,0,0
105501,6,0,0
105502,months,0,0
105503,.,0,0
105504,Control,0,0
105505,subjects,0,0
105506,received,0,0
105507,two,0,0
105508,brief,0,1
105509,check-in,1,1
105510,telephone,1,1
105511,calls,1,0
105512,during,0,0
105513,this,0,0
105514,6-month,0,0
105515,period,0,0
105516,.,0,0
105517,MEASUREMENTS,0,0
105518,The,0,0
105519,primary,0,0
105520,outcome,0,0
105521,was,0,0
105522,change,0,0
105523,in,0,0
105524,CG,0,0
105525,health,0,0
105526,status,0,0
105527,from,0,0
105528,baseline,0,0
105529,to,0,0
105530,after,0,0
105531,the,0,0
105532,intervention,0,1
105533,.,0,0
105534,Secondary,0,0
105535,outcomes,0,0
105536,were,0,0
105537,CG,0,0
105538,burden,0,0
105539,and,0,0
105540,bother,0,0
105541,after,0,0
105542,the,0,0
105543,intervention,0,1
105544,.,0,0
105545,RESULTS,0,0
105546,After,0,0
105547,the,0,0
105548,intervention,0,1
105549,",",0,0
105550,CGs,0,0
105551,reported,0,0
105552,better,0,0
105553,self-rated,0,0
105554,health,0,0
105555,",",0,0
105556,sleep,0,0
105557,quality,0,0
105558,",",0,0
105559,physical,0,0
105560,health,0,0
105561,",",0,0
105562,and,0,0
105563,emotional,0,0
105564,health,0,0
105565,",",0,0
105566,which,0,0
105567,was,0,0
105568,related,0,0
105569,to,0,0
105570,less,0,0
105571,burden,0,0
105572,and,0,0
105573,bother,0,0
105574,with,0,0
105575,their,0,0
105576,caregiving,0,0
105577,role,0,0
105578,than,0,0
105579,for,0,0
105580,CGs,0,0
105581,not,0,0
105582,receiving,0,0
105583,the,0,0
105584,intervention,0,1
105585,.,0,0
105586,Changes,0,0
105587,in,0,0
105588,depression,0,0
105589,appeared,0,0
105590,to,0,0
105591,mediate,0,0
105592,these,0,0
105593,relationships,0,0
105594,.,0,0
105595,Several,0,0
105596,racial,0,0
105597,and,0,0
105598,ethnic,0,0
105599,group,0,0
105600,differences,0,0
105601,existed,0,0
105602,in,0,0
105603,physical,0,0
105604,and,0,0
105605,emotional,0,0
105606,health,0,0
105607,",",0,0
105608,as,0,0
105609,well,0,0
105610,as,0,0
105611,in,0,0
105612,total,0,0
105613,frustration,0,0
105614,with,0,0
105615,caregiving,0,0
105616,",",0,0
105617,emotional,0,0
105618,burden,0,0
105619,",",0,0
105620,and,0,0
105621,CG-rated,0,0
105622,bother,0,0
105623,with,0,0
105624,CR,0,1
105625,'s,0,0
105626,activities,0,0
105627,of,0,0
105628,daily,0,1
105629,living,0,0
105630,and,0,0
105631,instrumental,0,0
105632,activities,0,0
105633,of,0,0
105634,daily,0,0
105635,living,0,0
105636,at,0,0
105637,baseline,0,0
105638,and,0,0
105639,at,0,0
105640,follow-up,0,0
105641,",",0,0
105642,although,0,0
105643,differences,0,0
105644,between,0,0
105645,baseline,0,0
105646,and,0,0
105647,posttest,0,0
105648,did,0,0
105649,not,0,0
105650,vary,0,0
105651,according,0,0
105652,to,0,0
105653,race,0,0
105654,.,0,0
105655,CONCLUSION,0,0
105656,A,0,0
105657,structured,0,0
105658,",",0,0
105659,multicomponent,0,0
105660,skills,0,1
105661,training,0,1
105662,intervention,0,1
105663,that,0,0
105664,targeted,0,0
105665,CG,0,0
105666,self-care,0,1
105667,behaviors,0,0
105668,as,0,0
105669,one,0,0
105670,of,0,0
105671,five,0,0
105672,target,0,0
105673,areas,0,0
105674,",",0,0
105675,improved,0,0
105676,self-reported,0,0
105677,health,0,0
105678,status,0,0
105679,",",0,0
105680,and,0,0
105681,decreased,0,0
105682,burden,0,0
105683,and,0,0
105684,bother,0,0
105685,in,0,0
105686,racially,0,0
105687,and,0,0
105688,ethnically,0,0
105689,diverse,0,0
105690,CGs,0,0
105691,of,0,0
105692,people,0,0
105693,with,0,0
105694,dementia,0,0
105695,.,0,0
105696,[,0,0
105697,Value,0,0
105698,of,0,0
105699,combining,0,0
105700,64,1,0
105701,multi-slice,1,0
105702,spiral,1,1
105703,computer,1,1
105704,tomography,1,1
105705,and,1,0
105706,serum,1,0
105707,amyloid,1,0
105708,A,1,0
105709,protein,1,0
105710,in,0,0
105711,surgical,0,0
105712,decision-making,0,0
105713,in,0,0
105714,rectal,0,0
105715,cancer,0,0
105716,],0,0
105717,.,0,0
105718,OBJECTIVE,0,0
105719,To,0,0
105720,determine,0,0
105721,the,0,0
105722,accuracy,0,0
105723,and,0,0
105724,clinical,0,0
105725,value,0,0
105726,of,0,0
105727,combining,0,0
105728,64,1,0
105729,multi-slice,1,0
105730,spiral,1,1
105731,computer,1,1
105732,tomography,1,1
105733,(,1,0
105734,MSCT,1,1
105735,),1,0
105736,and,1,0
105737,serum,1,0
105738,amyloid,1,0
105739,A,1,0
105740,protein,1,1
105741,(,1,0
105742,SAA,1,0
105743,),1,0
105744,in,0,0
105745,the,0,0
105746,preoperative,0,0
105747,staging,0,0
105748,of,0,0
105749,rectal,0,0
105750,cancer,0,0
105751,.,0,0
105752,METHODS,0,0
105753,Prospectively,0,0
105754,enrolled,0,0
105755,patients,0,0
105756,with,0,0
105757,rectal,0,0
105758,cancer,0,0
105759,from,0,0
105760,October,0,0
105761,2007,0,0
105762,to,0,0
105763,October,0,0
105764,2008,0,0
105765,.,0,0
105766,The,0,0
105767,patients,0,0
105768,were,0,0
105769,randomly,0,0
105770,assigned,0,0
105771,into,0,0
105772,two,0,0
105773,groups,0,0
105774,:,0,0
105775,MSCT,1,0
105776,and,1,0
105777,SAA,1,0
105778,combined,0,1
105779,group,0,0
105780,:,0,0
105781,both,0,0
105782,MSCT,1,0
105783,and,1,0
105784,SAA,1,0
105785,combinative,0,1
105786,assessment,0,0
105787,were,0,0
105788,performed,0,0
105789,for,0,0
105790,preoperative,0,0
105791,evaluation,0,0
105792,;,0,0
105793,MSCT,1,0
105794,group,1,0
105795,:,1,0
105796,only,1,0
105797,MSCT,1,0
105798,was,0,0
105799,performed,0,0
105800,preoperatively,0,0
105801,for,0,0
105802,tumor,0,0
105803,staging,0,0
105804,.,0,0
105805,The,0,0
105806,accuracy,0,0
105807,of,0,0
105808,the,0,0
105809,preoperative,0,0
105810,T,0,0
105811,",",0,0
105812,N,0,0
105813,",",0,0
105814,M,0,0
105815,",",0,0
105816,and,0,0
105817,TNM,0,1
105818,staging,0,0
105819,and,0,0
105820,the,0,0
105821,concordance,0,0
105822,rate,0,0
105823,of,0,0
105824,predictive,0,0
105825,operative,0,0
105826,strategy,0,0
105827,were,0,0
105828,compared,0,0
105829,between,0,0
105830,the,0,0
105831,two,0,0
105832,groups,0,0
105833,.,0,0
105834,RESULTS,0,0
105835,Total,0,0
105836,of,0,0
105837,225,0,0
105838,cases,0,0
105839,with,0,0
105840,rectal,0,0
105841,cancer,0,0
105842,were,0,0
105843,enrolled,0,0
105844,in,0,0
105845,this,0,0
105846,study,0,0
105847,.,0,0
105848,There,0,0
105849,were,0,0
105850,110,0,0
105851,cases,0,0
105852,in,0,0
105853,MSCT,1,0
105854,and,1,0
105855,SAA,1,0
105856,combined,1,1
105857,group,0,0
105858,and,0,0
105859,115,0,0
105860,cases,0,0
105861,in,0,0
105862,MSCT,1,0
105863,group,0,0
105864,.,0,0
105865,The,0,0
105866,baseline,0,0
105867,characteristics,0,0
105868,was,0,0
105869,comparable,0,0
105870,between,0,0
105871,the,0,0
105872,two,0,0
105873,groups,0,0
105874,.,0,0
105875,For,0,0
105876,MSCT,1,0
105877,and,1,0
105878,SAA,1,0
105879,combined,1,1
105880,group,0,0
105881,",",0,0
105882,the,0,0
105883,accuracies,0,0
105884,of,0,0
105885,preoperative,0,0
105886,staging,0,0
105887,of,0,0
105888,T,0,0
105889,",",0,0
105890,N,0,0
105891,",",0,0
105892,M,0,0
105893,and,0,0
105894,TNM,0,1
105895,was,0,0
105896,87.3,0,0
105897,%,0,0
105898,",",0,0
105899,85.2,0,0
105900,%,0,0
105901,",",0,0
105902,100,0,0
105903,%,0,0
105904,and,0,0
105905,86.4,0,0
105906,%,0,0
105907,",",0,0
105908,respectively,0,0
105909,;,0,0
105910,and,0,0
105911,for,0,0
105912,MSCT,0,0
105913,group,0,0
105914,",",0,0
105915,the,0,0
105916,corresponding,0,0
105917,rates,0,0
105918,was,0,0
105919,85.2,0,0
105920,%,0,0
105921,",",0,0
105922,67.0,0,0
105923,%,0,0
105924,",",0,0
105925,100,0,0
105926,%,0,0
105927,and,0,0
105928,66.1,0,0
105929,%,0,0
105930,",",0,0
105931,respectively,0,0
105932,.,0,0
105933,Statistical,0,0
105934,differences,0,0
105935,was,0,0
105936,found,0,0
105937,in,0,0
105938,the,0,0
105939,accuracy,0,0
105940,of,0,0
105941,preoperative,0,0
105942,N,0,0
105943,and,0,0
105944,TNM,0,1
105945,staging,0,0
105946,between,0,0
105947,the,0,0
105948,two,0,0
105949,groups,0,0
105950,(,0,0
105951,P,0,0
105952,=,0,0
105953,0.009,0,0
105954,and,0,0
105955,0.001,0,0
105956,",",0,0
105957,respectively,0,0
105958,),0,0
105959,.,0,0
105960,In,0,0
105961,addition,0,0
105962,",",0,0
105963,there,0,0
105964,was,0,0
105965,statistical,0,0
105966,difference,0,0
105967,in,0,0
105968,the,0,0
105969,accuracy,0,0
105970,of,0,0
105971,prediction,0,0
105972,to,0,0
105973,operative,0,0
105974,procedures,0,0
105975,between,0,0
105976,the,0,0
105977,two,0,0
105978,groups,0,0
105979,(,0,0
105980,94.7,0,0
105981,%,0,0
105982,vs.,0,0
105983,81.7,0,0
105984,%,0,0
105985,",",0,0
105986,P,0,0
105987,=,0,0
105988,0.003,0,0
105989,),0,0
105990,.,0,0
105991,CONCLUSION,0,0
105992,Combinative,0,1
105993,assessment,0,0
105994,of,0,0
105995,MSCT,1,0
105996,and,1,0
105997,SAA,1,0
105998,could,0,0
105999,improve,0,0
106000,the,0,0
106001,accuracy,0,0
106002,of,0,0
106003,preoperative,0,0
106004,staging,0,0
106005,",",0,0
106006,and,0,0
106007,thus,0,0
106008,provide,0,0
106009,higher,0,0
106010,predictive,0,0
106011,coincidence,0,0
106012,rate,0,0
106013,of,0,0
106014,operative,0,0
106015,procedures,0,0
106016,.,0,0
106017,A,0,0
106018,randomized,0,0
106019,comparison,0,0
106020,of,0,0
106021,the,0,0
106022,Endeavor,1,0
106023,zotarolimus-eluting,1,0
106024,stent,1,0
106025,versus,1,0
106026,the,1,0
106027,TAXUS,1,0
106028,paclitaxel-eluting,1,1
106029,stent,1,0
106030,in,0,0
106031,de,0,0
106032,novo,0,0
106033,native,0,0
106034,coronary,0,0
106035,lesions,0,0
106036,12-month,0,0
106037,outcomes,0,0
106038,from,0,0
106039,the,0,0
106040,ENDEAVOR,0,0
106041,IV,0,0
106042,trial,0,0
106043,.,0,0
106044,OBJECTIVES,0,0
106045,The,0,0
106046,ENDEAVOR,0,1
106047,IV,0,0
106048,(,0,0
106049,Randomized,0,0
106050,Comparison,0,0
106051,of,0,0
106052,Zotarolimus-Eluting,1,1
106053,and,0,0
106054,Paclitaxel-Eluting,1,1
106055,Stents,1,0
106056,in,0,0
106057,Patients,0,0
106058,with,0,0
106059,Coronary,0,0
106060,Artery,0,0
106061,Disease,0,0
106062,),0,0
106063,trial,0,0
106064,evaluated,0,0
106065,the,0,0
106066,safety,0,0
106067,and,0,0
106068,efficacy,0,0
106069,of,0,0
106070,the,0,0
106071,zotarolimus-eluting,1,0
106072,stent,1,1
106073,(,1,0
106074,ZES,1,0
106075,),1,0
106076,compared,1,0
106077,with,1,0
106078,the,1,0
106079,paclitaxel-eluting,1,1
106080,stent,1,1
106081,(,1,0
106082,PES,1,0
106083,),1,0
106084,.,0,0
106085,BACKGROUND,0,0
106086,First-generation,0,0
106087,drug-eluting,0,0
106088,stents,0,1
106089,have,0,0
106090,reduced,0,0
106091,angiographic,0,0
106092,and,0,0
106093,clinical,0,0
106094,restenosis,0,0
106095,",",0,0
106096,but,0,0
106097,long-term,0,0
106098,safety,0,0
106099,remains,0,0
106100,controversial,0,0
106101,.,0,0
106102,A,0,0
106103,second-generation,1,0
106104,drug-eluting,1,1
106105,stent,1,0
106106,",",0,0
106107,which,0,0
106108,delivers,0,0
106109,zotarolimus,1,1
106110,",",0,0
106111,a,0,0
106112,potent,0,0
106113,antiproliferative,0,0
106114,agent,0,0
106115,",",0,0
106116,via,0,0
106117,a,0,0
106118,biocompatible,0,1
106119,phosphorylcholine,0,1
106120,polymer,0,1
106121,on,0,0
106122,a,0,0
106123,cobalt,0,1
106124,alloy,0,1
106125,thin-strut,0,0
106126,stent,0,1
106127,has,0,0
106128,shown,0,0
106129,promising,0,0
106130,experimental,0,0
106131,and,0,0
106132,early,0,0
106133,clinical,0,0
106134,results,0,0
106135,.,0,0
106136,METHODS,0,0
106137,This,0,0
106138,is,0,0
106139,a,0,0
106140,prospective,0,0
106141,",",0,0
106142,randomized,0,0
106143,(,0,0
106144,1:1,0,1
106145,),0,0
106146,",",0,0
106147,single-blind,0,0
106148,",",0,0
106149,controlled,0,0
106150,trial,0,0
106151,comparing,0,0
106152,outcomes,0,0
106153,of,0,0
106154,patients,0,0
106155,with,0,0
106156,single,0,0
106157,de,0,0
106158,novo,0,0
106159,coronary,0,0
106160,lesions,0,0
106161,treated,0,0
106162,with,0,0
106163,ZES,0,0
106164,or,0,0
106165,PES,0,0
106166,.,0,0
106167,The,0,0
106168,primary,0,0
106169,end,0,0
106170,point,0,0
106171,was,0,0
106172,noninferiority,0,0
106173,of,0,0
106174,9-month,0,0
106175,target,0,0
106176,vessel,0,0
106177,failure,0,0
106178,defined,0,0
106179,as,0,0
106180,cardiac,0,0
106181,death,0,0
106182,",",0,0
106183,myocardial,0,0
106184,infarction,0,0
106185,",",0,0
106186,or,0,0
106187,target,0,0
106188,vessel,0,0
106189,revascularization,0,0
106190,.,0,0
106191,RESULTS,0,0
106192,Among,0,0
106193,a,0,0
106194,total,0,0
106195,of,0,0
106196,"1,548",0,0
106197,patients,0,0
106198,assigned,0,0
106199,to,0,0
106200,ZES,1,0
106201,(,0,0
106202,n,0,0
106203,=,0,0
106204,773,0,0
106205,),0,0
106206,or,0,1
106207,PES,0,1
106208,(,0,0
106209,n,0,0
106210,=,0,0
106211,775,0,0
106212,),0,0
106213,",",0,0
106214,at,0,0
106215,9,0,0
106216,months,0,0
106217,",",0,0
106218,ZES,0,0
106219,was,0,0
106220,noninferior,0,0
106221,to,0,0
106222,PES,0,0
106223,with,0,0
106224,rates,0,0
106225,of,0,0
106226,target,0,0
106227,vessel,0,0
106228,failure,0,0
106229,6.6,0,0
106230,%,0,0
106231,versus,0,0
106232,7.1,0,0
106233,%,0,0
106234,",",0,0
106235,respectively,0,0
106236,(,0,0
106237,p,0,0
106238,(,0,1
106239,noninferiority,0,0
106240,),0,1
106241,<,0,0
106242,or,0,1
106243,=,0,0
106244,0.001,0,0
106245,),0,0
106246,.,0,0
106247,There,0,0
106248,were,0,0
106249,fewer,0,0
106250,periprocedural,0,0
106251,myocardial,0,0
106252,infarctions,0,0
106253,with,0,0
106254,ZES,1,0
106255,(,0,0
106256,0.5,0,0
106257,%,0,0
106258,vs.,0,0
106259,2.2,0,0
106260,%,0,0
106261,;,0,0
106262,p,0,0
106263,=,0,0
106264,0.007,0,0
106265,),0,0
106266,",",0,0
106267,whereas,0,0
106268,at,0,0
106269,12,0,0
106270,months,0,0
106271,",",0,0
106272,there,0,0
106273,were,0,0
106274,no,0,0
106275,significant,0,0
106276,differences,0,0
106277,between,0,0
106278,groups,0,0
106279,in,0,0
106280,rates,0,0
106281,of,0,0
106282,cardiac,0,0
106283,death,0,0
106284,",",0,0
106285,myocardial,0,0
106286,infarction,0,0
106287,",",0,0
106288,target,0,0
106289,vessel,0,0
106290,revascularization,0,0
106291,",",0,0
106292,or,0,0
106293,stent,0,0
106294,thrombosis,0,0
106295,.,0,0
106296,Although,0,0
106297,incidence,0,0
106298,of,0,0
106299,8-month,0,0
106300,binary,0,0
106301,angiographic,0,1
106302,in-segment,0,0
106303,restenosis,0,0
106304,was,0,0
106305,higher,0,0
106306,in,0,0
106307,patients,0,0
106308,treated,0,0
106309,with,0,0
106310,ZES,1,0
106311,versus,0,1
106312,PES,0,1
106313,(,0,0
106314,15.3,0,0
106315,%,0,0
106316,vs.,0,0
106317,10.4,0,0
106318,%,0,0
106319,;,0,0
106320,p,0,0
106321,=,0,0
106322,0.284,0,0
106323,),0,0
106324,",",0,0
106325,rates,0,0
106326,of,0,0
106327,12-month,0,0
106328,target,0,0
106329,lesion,0,0
106330,revascularization,0,0
106331,were,0,0
106332,similar,0,0
106333,(,0,0
106334,4.5,0,0
106335,%,0,0
106336,vs.,0,0
106337,3.2,0,0
106338,%,0,0
106339,;,0,0
106340,p,0,0
106341,=,0,0
106342,0.228,0,0
106343,),0,0
106344,",",0,0
106345,especially,0,0
106346,in,0,0
106347,patients,0,0
106348,without,0,0
106349,planned,0,0
106350,angiographic,0,1
106351,follow-up,0,0
106352,(,0,0
106353,3.6,0,0
106354,%,0,0
106355,vs.,0,0
106356,3.2,0,0
106357,%,0,0
106358,;,0,0
106359,p,0,0
106360,=,0,0
106361,0.756,0,0
106362,),0,0
106363,.,0,0
106364,CONCLUSIONS,0,0
106365,These,0,0
106366,findings,0,0
106367,demonstrate,0,0
106368,that,0,0
106369,ZES,1,0
106370,has,0,0
106371,similar,0,0
106372,clinical,0,0
106373,safety,0,0
106374,and,0,0
106375,efficacy,0,0
106376,compared,0,0
106377,with,0,0
106378,PES,1,0
106379,in,0,0
106380,simple,0,1
106381,and,0,0
106382,medium,0,1
106383,complexity,0,0
106384,single,0,0
106385,de,0,0
106386,novo,0,0
106387,coronary,0,0
106388,lesions,0,0
106389,.,0,0
106390,(,0,0
106391,ENDEAVOR,0,0
106392,IV,0,0
106393,Clinical,0,0
106394,Trial,0,0
106395,;,0,0
106396,NCT00217269,0,0
106397,),0,0
106398,.,0,0
106399,Allogeneic,1,1
106400,marrow,1,0
106401,transplantation,1,0
106402,in,0,0
106403,patients,0,0
106404,with,0,0
106405,chronic,0,0
106406,myeloid,0,0
106407,leukemia,0,0
106408,in,0,0
106409,the,0,0
106410,chronic,0,0
106411,phase,0,0
106412,:,0,0
106413,a,0,0
106414,randomized,0,0
106415,trial,0,0
106416,of,0,0
106417,two,0,0
106418,irradiation,0,1
106419,regimens,0,0
106420,.,0,0
106421,A,0,0
106422,randomized,0,0
106423,trial,0,0
106424,was,0,0
106425,performed,0,0
106426,to,0,0
106427,compare,0,0
106428,two,0,0
106429,regimens,0,0
106430,of,0,0
106431,total,1,0
106432,body,1,0
106433,irradiation,1,1
106434,in,0,0
106435,patients,0,0
106436,with,0,0
106437,chronic,0,0
106438,myeloid,0,0
106439,leukemia,0,0
106440,treated,0,0
106441,by,0,0
106442,allogeneic,1,1
106443,marrow,1,0
106444,transplantation,1,0
106445,while,0,0
106446,in,0,0
106447,the,0,0
106448,chronic,0,0
106449,phase,0,0
106450,.,0,0
106451,All,0,0
106452,patients,0,0
106453,received,0,0
106454,cyclophosphamide,1,1
106455,120,0,0
106456,mg/kg,0,0
106457,followed,0,0
106458,by,0,0
106459,total,1,0
106460,body,1,0
106461,irradiation,1,1
106462,and,1,0
106463,marrow,1,0
106464,from,1,0
106465,HLA-identical,1,0
106466,siblings,1,0
106467,.,1,0
106468,Cyclosporine,1,1
106469,and,1,0
106470,methotrexate,1,1
106471,were,0,0
106472,used,0,0
106473,for,0,0
106474,prophylaxis,0,0
106475,against,0,0
106476,acute,0,0
106477,graft-versus-host,0,0
106478,disease,0,0
106479,.,0,0
106480,Fifty-seven,0,0
106481,patients,0,0
106482,were,0,0
106483,randomized,0,0
106484,to,0,0
106485,receive,0,0
106486,2.0,0,0
106487,Gy,0,1
106488,fractions,0,1
106489,of,0,0
106490,irradiation,1,1
106491,daily,0,0
106492,for,0,0
106493,6,0,0
106494,days,0,0
106495,and,0,0
106496,59,0,0
106497,were,0,0
106498,randomized,0,0
106499,to,0,0
106500,receive,0,0
106501,2.25,0,0
106502,Gy,0,1
106503,fractions,0,1
106504,daily,0,0
106505,for,0,0
106506,7,0,0
106507,days,0,0
106508,.,0,0
106509,The,0,0
106510,probabilities,0,0
106511,of,0,0
106512,relapse,0,0
106513,at,0,0
106514,4,0,0
106515,years,0,0
106516,were,0,0
106517,0.25,0,0
106518,for,0,0
106519,the,0,0
106520,12.0,0,0
106521,Gy,0,1
106522,group,0,0
106523,and,0,0
106524,0.00,0,0
106525,for,0,0
106526,the,0,0
106527,15.75,0,0
106528,Gy,0,1
106529,group,0,0
106530,(,0,0
106531,P,0,0
106532,=,0,0
106533,.008,0,0
106534,),0,0
106535,.,0,0
106536,The,0,0
106537,actuarial,0,0
106538,probabilities,0,0
106539,of,0,0
106540,survival,0,0
106541,and,0,0
106542,relapse-free,0,0
106543,survival,0,0
106544,at,0,0
106545,4,0,0
106546,years,0,0
106547,were,0,0
106548,0.60,0,0
106549,and,0,0
106550,0.58,0,0
106551,among,0,0
106552,the,0,0
106553,patients,0,0
106554,who,0,0
106555,received,0,0
106556,12.0,0,0
106557,Gy,0,1
106558,compared,0,0
106559,with,0,0
106560,0.66,0,0
106561,and,0,0
106562,0.66,0,0
106563,for,0,0
106564,those,0,0
106565,who,0,0
106566,received,0,0
106567,15.75,0,0
106568,Gy,0,1
106569,.,0,0
106570,The,0,0
106571,4-year,0,0
106572,probabilities,0,0
106573,of,0,0
106574,transplant-related,0,0
106575,mortality,0,0
106576,were,0,0
106577,0.24,0,0
106578,and,0,0
106579,0.34,0,0
106580,respectively,0,0
106581,(,0,0
106582,P,0,0
106583,=,0,0
106584,.13,0,0
106585,),0,0
106586,while,0,0
106587,the,0,0
106588,probability,0,0
106589,of,0,0
106590,moderate,0,0
106591,to,0,0
106592,severe,0,0
106593,acute,0,0
106594,graft-versus-host,0,0
106595,disease,0,0
106596,was,0,0
106597,0.33,0,0
106598,for,0,0
106599,the,0,0
106600,12.0,0,0
106601,Gy,0,1
106602,group,0,0
106603,and,0,0
106604,0.44,0,0
106605,for,0,0
106606,the,0,0
106607,15.75,0,0
106608,Gy,0,1
106609,group,0,0
106610,(,0,0
106611,P,0,0
106612,=,0,0
106613,.15,0,0
106614,),0,0
106615,.,0,0
106616,The,0,0
106617,lower,0,0
106618,relapse,0,0
106619,probability,0,0
106620,in,0,0
106621,the,0,0
106622,patients,0,0
106623,receiving,0,0
106624,the,0,0
106625,higher,0,0
106626,dose,0,0
106627,of,0,0
106628,total,1,0
106629,body,1,0
106630,irradiation,1,1
106631,did,0,0
106632,not,0,0
106633,result,0,0
106634,in,0,0
106635,improved,0,0
106636,survival,0,0
106637,because,0,0
106638,mortality,0,0
106639,from,0,0
106640,causes,0,0
106641,other,0,0
106642,than,0,0
106643,relapse,0,0
106644,was,0,0
106645,increased,0,0
106646,.,0,0
106647,Relief,0,0
106648,of,0,0
106649,periorbital,0,1
106650,pain,0,0
106651,after,0,0
106652,acute,0,0
106653,angle,0,0
106654,closure,0,0
106655,glaucoma,0,0
106656,attack,0,0
106657,by,0,0
106658,botulinum,1,1
106659,toxin,1,1
106660,type,1,0
106661,A,1,0
106662,.,1,0
106663,PURPOSE,0,0
106664,To,0,0
106665,assess,0,0
106666,the,0,0
106667,efficacy,0,0
106668,and,0,0
106669,safety,0,0
106670,of,0,0
106671,botulinum,1,1
106672,toxin,1,1
106673,type,1,0
106674,A,1,0
106675,(,1,0
106676,BoNT-A,1,1
106677,),1,0
106678,injection,0,1
106679,in,0,0
106680,patients,0,0
106681,suffering,0,0
106682,from,0,0
106683,intractable,0,0
106684,periorbital,0,1
106685,pain,0,0
106686,after,0,0
106687,acute,0,0
106688,angle,0,0
106689,closure,0,0
106690,glaucoma,0,1
106691,(,0,0
106692,AACG,0,0
106693,),0,0
106694,.,0,0
106695,PATIENTS,0,0
106696,AND,0,0
106697,METHODS,0,0
106698,In,0,0
106699,this,0,0
106700,prospective,0,0
106701,randomized,0,0
106702,intervention,0,1
106703,study,0,0
106704,",",0,0
106705,19,0,0
106706,patients,0,0
106707,suffering,0,0
106708,from,0,0
106709,periorbital,0,1
106710,pain,0,0
106711,after,0,0
106712,an,0,0
106713,AACG,0,0
106714,attack,0,0
106715,were,0,0
106716,injected,1,1
106717,with,1,0
106718,BoNT-A,1,1
106719,or,1,1
106720,placebo,1,1
106721,for,0,0
106722,pain,0,0
106723,relief,0,0
106724,.,0,0
106725,Patients,0,0
106726,were,0,0
106727,assessed,0,0
106728,on,0,0
106729,days,0,0
106730,1,0,0
106731,",",0,0
106732,2,0,0
106733,",",0,0
106734,7,0,0
106735,",",0,0
106736,14,0,0
106737,",",0,0
106738,30,0,0
106739,",",0,0
106740,60,0,0
106741,",",0,0
106742,and,0,0
106743,90,0,0
106744,.,0,0
106745,The,0,0
106746,main,0,0
106747,outcomes,0,0
106748,were,0,0
106749,mean,0,0
106750,change,0,0
106751,of,0,0
106752,visual,0,0
106753,analog,0,1
106754,rating,0,0
106755,scale,0,0
106756,(,0,0
106757,VARS,0,1
106758,),0,1
106759,and,0,0
106760,index,0,0
106761,scores,0,0
106762,measured,0,0
106763,through,0,0
106764,a,0,0
106765,quality-of-life,0,0
106766,questionnaire,0,1
106767,(,0,0
106768,EQ-5D,0,0
106769,),0,0
106770,",",0,0
106771,and,0,0
106772,changes,0,0
106773,in,0,0
106774,the,0,0
106775,visual,0,0
106776,analog,0,1
106777,scale,0,0
106778,(,0,0
106779,VAS,0,1
106780,),0,0
106781,",",0,0
106782,all,0,0
106783,of,0,0
106784,which,0,0
106785,were,0,0
106786,assessed,0,0
106787,at,0,0
106788,each,0,0
106789,visit,0,0
106790,.,0,0
106791,A,0,0
106792,secondary,0,0
106793,outcome,0,0
106794,was,0,0
106795,the,0,0
106796,frequency,0,0
106797,and,0,0
106798,nature,0,0
106799,of,0,0
106800,adverse,0,0
106801,events,0,0
106802,and,0,0
106803,the,0,0
106804,number,0,0
106805,of,0,0
106806,patients,0,0
106807,who,0,0
106808,withdrew,0,0
106809,from,0,0
106810,the,0,0
106811,study,0,0
106812,as,0,0
106813,a,0,0
106814,result,0,0
106815,.,0,0
106816,RESULTS,0,0
106817,In,0,0
106818,the,0,0
106819,treatment,0,0
106820,group,0,0
106821,(,0,0
106822,n=10,0,0
106823,),0,0
106824,",",0,0
106825,the,0,0
106826,mean,0,0
106827,index,0,0
106828,score,0,0
106829,of,0,0
106830,EQ-5D,0,0
106831,and,0,0
106832,VAS,0,0
106833,changed,0,0
106834,significantly,0,0
106835,from,0,0
106836,the,0,0
106837,placebo,1,1
106838,group,0,0
106839,(,0,0
106840,by,0,0
106841,0.299,0,0
106842,and,0,0
106843,2.61,0,0
106844,",",0,0
106845,respectively,0,0
106846,),0,0
106847,from,0,0
106848,day,0,0
106849,2,0,0
106850,(,0,0
106851,P,0,0
106852,<,0,0
106853,0.01,0,0
106854,),0,0
106855,.,0,0
106856,The,0,0
106857,VARS,0,1
106858,of,0,0
106859,EQ-5D,0,0
106860,also,0,0
106861,disclosed,0,0
106862,significant,0,0
106863,changes,0,0
106864,from,0,0
106865,day,0,0
106866,2,0,0
106867,(,0,0
106868,17,0,0
106869,",",0,0
106870,P,0,0
106871,<,0,0
106872,0.01,0,0
106873,),0,0
106874,.,0,0
106875,In,0,0
106876,addition,0,0
106877,",",0,0
106878,efficacy,0,0
106879,was,0,0
106880,maintained,0,0
106881,mainly,0,0
106882,between,0,0
106883,days,0,0
106884,2,0,0
106885,and,0,0
106886,60,0,0
106887,but,0,0
106888,declined,0,0
106889,slightly,0,0
106890,by,0,0
106891,day,0,0
106892,90,0,0
106893,.,0,0
106894,The,0,0
106895,most,0,0
106896,frequently,0,0
106897,reported,0,0
106898,treatment-related,0,0
106899,adverse,0,0
106900,events,0,0
106901,in,0,0
106902,the,0,0
106903,treatment,0,0
106904,and,0,0
106905,placebo,0,1
106906,groups,0,0
106907,were,0,0
106908,local,0,0
106909,tenderness,0,0
106910,(,0,0
106911,21,0,0
106912,%,0,0
106913,),0,0
106914,",",0,0
106915,subcutaneous,0,1
106916,hemorrhage,0,0
106917,(,0,0
106918,10.5,0,0
106919,%,0,0
106920,),0,0
106921,",",0,0
106922,and,0,0
106923,conjunctivitis,0,0
106924,(,0,0
106925,10.5,0,0
106926,%,0,0
106927,),0,0
106928,.,0,0
106929,No,0,0
106930,severe,0,0
106931,adverse,0,0
106932,events,0,0
106933,were,0,0
106934,reported,0,0
106935,during,0,0
106936,the,0,0
106937,study,0,0
106938,or,0,1
106939,follow-up,0,0
106940,period,0,0
106941,.,0,0
106942,CONCLUSIONS,0,0
106943,BoNT-A,1,1
106944,is,0,0
106945,effective,0,0
106946,and,0,0
106947,well,0,0
106948,tolerated,0,0
106949,for,0,0
106950,the,0,0
106951,treatment,0,0
106952,of,0,0
106953,periorbital,0,1
106954,pain,0,0
106955,after,0,0
106956,an,0,0
106957,AACG,0,0
106958,attack,0,0
106959,.,0,0
106960,Its,0,0
106961,effects,0,0
106962,may,0,0
106963,be,0,0
106964,maintained,0,0
106965,for,0,0
106966,3,0,0
106967,months,0,0
106968,.,0,0
106969,A,0,0
106970,randomized,0,0
106971,trial,0,0
106972,of,0,0
106973,tailored,0,1
106974,skin,0,0
106975,cancer,0,0
106976,prevention,0,0
106977,messages,0,1
106978,for,0,0
106979,adults,0,0
106980,:,0,0
106981,Project,0,0
106982,SCAPE,0,0
106983,.,0,0
106984,OBJECTIVES,0,0
106985,We,0,0
106986,evaluated,0,0
106987,the,0,0
106988,impact,0,0
106989,of,0,0
106990,a,0,0
106991,mailed,1,0
106992,",",1,0
106993,tailored,1,1
106994,intervention,1,1
106995,on,0,0
106996,skin,0,0
106997,cancer,0,0
106998,prevention,0,0
106999,and,0,0
107000,skin,0,0
107001,self-examination,0,1
107002,behaviors,0,0
107003,of,0,0
107004,adults,0,0
107005,at,0,0
107006,moderate,0,0
107007,and,0,0
107008,high,0,0
107009,risk,0,0
107010,for,0,0
107011,skin,0,0
107012,cancer,0,0
107013,.,0,0
107014,METHODS,0,0
107015,Adults,0,0
107016,at,0,0
107017,moderate,0,0
107018,and,0,0
107019,high,0,0
107020,risk,0,0
107021,for,0,0
107022,skin,0,0
107023,cancer,0,0
107024,were,0,0
107025,recruited,0,0
107026,in,0,0
107027,primary,0,0
107028,health,0,0
107029,care,0,1
107030,settings,0,0
107031,in,0,0
107032,Honolulu,0,0
107033,",",0,0
107034,HI,0,1
107035,",",0,0
107036,and,0,0
107037,Long,0,0
107038,Island,0,0
107039,",",0,0
107040,NY,0,0
107041,.,0,0
107042,After,0,0
107043,completing,0,0
107044,a,0,0
107045,baseline,0,0
107046,survey,0,0
107047,",",0,0
107048,participants,0,0
107049,were,0,0
107050,randomized,0,0
107051,to,0,0
107052,2,0,0
107053,groups,0,0
107054,.,0,0
107055,The,0,0
107056,treatment,0,0
107057,group,0,0
107058,received,0,0
107059,tailored,1,1
107060,materials,1,0
107061,",",1,0
107062,including,1,0
107063,personalized,1,1
107064,risk,1,0
107065,feedback,1,1
107066,",",0,0
107067,and,0,0
107068,the,0,0
107069,control,1,1
107070,group,0,0
107071,received,0,0
107072,general,1,0
107073,educational,1,0
107074,materials,1,0
107075,.,1,0
107076,Multivariate,0,0
107077,analyses,0,0
107078,compared,0,0
107079,sun,0,0
107080,protection,0,0
107081,and,0,0
107082,skin,0,0
107083,self-examination,0,1
107084,between,0,0
107085,groups,0,0
107086,",",0,0
107087,controlling,0,0
107088,for,0,0
107089,location,0,0
107090,",",0,0
107091,risk,0,0
107092,level,0,0
107093,",",0,0
107094,gender,0,0
107095,",",0,0
107096,and,0,0
107097,age,0,0
107098,.,0,0
107099,RESULTS,0,0
107100,A,0,0
107101,total,0,0
107102,of,0,0
107103,596,0,0
107104,adults,0,0
107105,completed,0,0
107106,the,0,0
107107,trial,0,0
107108,.,0,0
107109,The,0,0
107110,tailored,0,0
107111,materials,0,0
107112,had,0,0
107113,a,0,0
107114,significant,0,0
107115,effect,0,0
107116,on,0,0
107117,overall,0,0
107118,sun-protection,0,0
107119,habits,0,0
107120,",",0,0
107121,the,0,0
107122,use,0,0
107123,of,0,0
107124,hats,0,1
107125,",",0,0
107126,the,0,0
107127,use,0,0
107128,of,0,0
107129,sunglasses,0,1
107130,",",0,0
107131,and,0,0
107132,the,0,0
107133,recency,0,0
107134,of,0,0
107135,skin,0,0
107136,self-examination,0,1
107137,.,0,0
107138,Some,0,0
107139,effects,0,0
107140,were,0,0
107141,moderated,0,0
107142,by,0,0
107143,location,0,0
107144,and,0,0
107145,risk,0,0
107146,level,0,0
107147,.,0,0
107148,CONCLUSIONS,0,0
107149,Tailored,1,1
107150,communications,1,1
107151,including,0,0
107152,personalized,0,1
107153,risk,0,0
107154,feedback,0,1
107155,can,0,0
107156,improve,0,0
107157,sun-protection,0,0
107158,behaviors,0,0
107159,and,0,0
107160,skin,0,0
107161,self-examination,0,1
107162,among,0,0
107163,adults,0,0
107164,at,0,0
107165,increased,0,0
107166,risk,0,0
107167,for,0,0
107168,skin,0,0
107169,cancer,0,0
107170,.,0,0
107171,These,0,0
107172,convenient,0,0
107173,",",0,0
107174,low-cost,0,1
107175,interventions,0,0
107176,can,0,0
107177,be,0,0
107178,implemented,0,0
107179,in,0,0
107180,a,0,0
107181,variety,0,0
107182,of,0,0
107183,settings,0,0
107184,and,0,0
107185,should,0,0
107186,be,0,0
107187,tested,0,0
107188,further,0,0
107189,to,0,0
107190,assess,0,0
107191,their,0,0
107192,long-term,0,0
107193,effectiveness,0,0
107194,.,0,0
107195,Digestive,1,0
107196,enzyme,1,0
107197,supplementation,1,1
107198,for,0,0
107199,autism,0,0
107200,spectrum,0,0
107201,disorders,0,0
107202,:,0,0
107203,a,0,0
107204,double-blind,0,0
107205,randomized,0,0
107206,controlled,0,0
107207,trial,0,0
107208,.,0,0
107209,To,0,0
107210,examine,0,0
107211,the,0,0
107212,effects,0,0
107213,of,0,0
107214,a,0,0
107215,digestive,1,0
107216,enzyme,1,0
107217,supplement,1,1
107218,in,0,0
107219,improving,0,0
107220,expressive,0,0
107221,language,0,0
107222,",",0,0
107223,behaviour,0,0
107224,and,0,0
107225,other,0,0
107226,symptoms,0,0
107227,in,0,0
107228,children,0,0
107229,with,0,0
107230,Autism,0,0
107231,Spectrum,0,1
107232,Disorder,0,0
107233,.,0,0
107234,Randomized,0,0
107235,",",0,0
107236,double-blind,0,0
107237,placebo-controlled,1,1
107238,trial,0,0
107239,using,0,0
107240,crossover,0,0
107241,design,0,0
107242,over,0,0
107243,6,0,0
107244,months,0,0
107245,for,0,0
107246,43,0,0
107247,children,0,0
107248,",",0,0
107249,aged,0,0
107250,3-8,0,0
107251,years,0,0
107252,.,0,0
107253,Outcome,0,0
107254,measurement,0,0
107255,tools,0,0
107256,included,0,0
107257,monthly,0,0
107258,Global,0,0
107259,Behaviour,0,0
107260,Rating,0,0
107261,Scales,0,0
107262,",",0,0
107263,Additional,0,1
107264,Rating,0,0
107265,Scales,0,0
107266,of,0,0
107267,other,0,0
107268,symptoms,0,0
107269,by,0,0
107270,parents,0,0
107271,and,0,0
107272,therapists,0,1
107273,",",0,0
107274,and,0,0
107275,monthly,0,0
107276,completion,0,0
107277,of,0,0
107278,the,0,0
107279,Rescorla,0,0
107280,Language,0,1
107281,Development,0,0
107282,Survey,0,0
107283,.,0,0
107284,Compared,0,0
107285,with,0,0
107286,placebo,1,1
107287,",",0,0
107288,treatment,0,0
107289,with,0,0
107290,enzyme,1,0
107291,was,0,0
107292,not,0,0
107293,associated,0,0
107294,with,0,0
107295,clinically,0,0
107296,significant,0,0
107297,improvement,0,0
107298,in,0,0
107299,behaviour,0,0
107300,",",0,0
107301,food,0,0
107302,variety,0,0
107303,",",0,0
107304,gastrointestinal,0,0
107305,symptoms,0,0
107306,",",0,0
107307,sleep,0,0
107308,quality,0,0
107309,",",0,0
107310,engagement,0,0
107311,with,0,0
107312,therapist,0,1
107313,",",0,0
107314,or,0,0
107315,the,0,0
107316,Language,0,1
107317,Development,0,0
107318,Survey,0,0
107319,Vocabulary,0,1
107320,or,0,1
107321,Sentence,0,0
107322,Complexity,0,0
107323,Scores,0,0
107324,.,0,0
107325,A,0,0
107326,small,0,0
107327,statistically,0,0
107328,significant,0,0
107329,improvement,0,0
107330,on,0,0
107331,enzyme,0,0
107332,therapy,0,1
107333,was,0,0
107334,seen,0,0
107335,for,0,0
107336,the,0,0
107337,food,0,0
107338,variety,0,0
107339,scores,0,0
107340,.,0,0
107341,No,0,0
107342,clinically,0,0
107343,significant,0,0
107344,effect,0,0
107345,improvement,0,0
107346,of,0,0
107347,autism,0,0
107348,symptoms,0,0
107349,with,0,0
107350,enzyme,0,0
107351,use,0,0
107352,was,0,0
107353,shown,0,0
107354,with,0,0
107355,this,0,0
107356,trial,0,0
107357,",",0,0
107358,however,0,0
107359,",",0,0
107360,possible,0,0
107361,effects,0,0
107362,on,0,0
107363,improvement,0,0
107364,in,0,0
107365,food,0,0
107366,variety,0,0
107367,warrants,0,0
107368,further,0,0
107369,detailed,0,0
107370,investigation,0,0
107371,.,0,0
107372,Comparison,0,0
107373,of,0,0
107374,the,0,0
107375,in,0,0
107376,vitro,0,0
107377,and,0,0
107378,in,0,0
107379,vivo,0,0
107380,release,0,0
107381,of,0,0
107382,digoxin,1,1
107383,from,0,0
107384,four,0,0
107385,different,0,0
107386,soft,0,1
107387,gelatin,0,1
107388,capsule,1,1
107389,formulations,1,0
107390,.,1,0
107391,A,0,0
107392,blinded,0,0
107393,",",0,0
107394,four-treatment,0,0
107395,crossover,0,0
107396,study,0,0
107397,in,0,0
107398,16,0,0
107399,normal,0,0
107400,adult,0,0
107401,male,0,0
107402,volunteers,0,0
107403,compared,0,0
107404,plasma,0,0
107405,concentrations,0,0
107406,and,0,0
107407,urinary,0,0
107408,excretion,0,0
107409,of,0,0
107410,digoxin,1,1
107411,",",0,0
107412,measured,0,0
107413,by,0,0
107414,radioimmunoassay,0,0
107415,",",0,0
107416,after,0,0
107417,oral,0,1
107418,administration,0,0
107419,of,0,0
107420,soft,1,1
107421,gelatin,1,1
107422,capsule,1,1
107423,formulations,1,1
107424,of,1,0
107425,digoxin,1,1
107426,.,1,0
107427,Four,0,0
107428,0.4-mg,0,0
107429,formulations,1,0
107430,with,1,0
107431,different,1,0
107432,in,1,0
107433,vitro,1,0
107434,burst,1,0
107435,times,1,0
107436,and,0,0
107437,dissolution,1,0
107438,rates,1,0
107439,were,0,0
107440,administered,0,0
107441,",",0,0
107442,with,0,0
107443,2-week,0,0
107444,intervals,0,0
107445,between,0,0
107446,treatments,0,0
107447,.,0,0
107448,The,0,0
107449,two,0,0
107450,capsules,0,1
107451,with,0,0
107452,lowest,0,0
107453,in,0,0
107454,vitro,0,0
107455,burst,0,0
107456,times,0,0
107457,(,0,0
107458,2.9,0,0
107459,and,0,0
107460,16,0,0
107461,min,0,0
107462,),0,0
107463,gave,0,0
107464,comparable,0,0
107465,in,0,0
107466,vivo,0,0
107467,results,0,0
107468,.,0,0
107469,The,0,0
107470,other,0,0
107471,two,0,0
107472,capsules,0,1
107473,",",0,0
107474,with,0,0
107475,in,0,0
107476,vitro,0,0
107477,burst,0,0
107478,times,0,0
107479,of,0,0
107480,62,0,0
107481,and,0,0
107482,229,0,0
107483,min,0,0
107484,",",0,0
107485,produced,0,0
107486,significant,0,0
107487,delays,0,0
107488,in,0,0
107489,digoxin,0,1
107490,absorption,0,0
107491,.,0,0
107492,In,0,0
107493,vitro-in,0,0
107494,vivo,0,0
107495,correlations,0,0
107496,were,0,0
107497,obtained,0,0
107498,by,0,0
107499,comparing,0,0
107500,the,0,0
107501,logarithm,0,0
107502,of,0,0
107503,the,0,0
107504,in,0,0
107505,vitro,0,0
107506,burst,0,0
107507,time,0,0
107508,with,0,0
107509,time,0,0
107510,to,0,0
107511,peak,0,0
107512,plasma,0,0
107513,level,0,0
107514,and,0,0
107515,the,0,0
107516,time,0,0
107517,to,0,0
107518,the,0,0
107519,first,0,0
107520,measurable,0,0
107521,plasma,0,0
107522,level,0,0
107523,(,0,0
107524,>,0,0
107525,or,0,0
107526,=,0,0
107527,0,0,0
107528,.,0,0
107529,05,0,0
107530,ng/ml,0,0
107531,),0,0
107532,.,0,0
107533,Also,0,0
107534,",",0,0
107535,the,0,0
107536,mean,0,0
107537,time,0,0
107538,to,0,0
107539,peak,0,0
107540,plasma,0,0
107541,level,0,0
107542,correlated,0,0
107543,with,0,0
107544,the,0,0
107545,logarithm,0,0
107546,of,0,0
107547,the,0,0
107548,time,0,0
107549,required,0,0
107550,to,0,0
107551,release,0,0
107552,either,0,0
107553,50,0,0
107554,%,0,0
107555,or,0,0
107556,85,0,0
107557,%,0,0
107558,of,0,0
107559,the,0,0
107560,digoxin,0,1
107561,in,0,0
107562,vitro,0,0
107563,.,0,0
107564,No,0,0
107565,significant,0,0
107566,changes,0,0
107567,were,0,0
107568,found,0,0
107569,in,0,0
107570,the,0,0
107571,amount,0,0
107572,of,0,0
107573,digoxin,1,1
107574,absorbed,0,0
107575,from,0,0
107576,each,0,0
107577,capsule,0,1
107578,as,0,0
107579,determined,0,0
107580,by,0,0
107581,urinary,0,0
107582,excretion,0,0
107583,or,0,0
107584,AUC0-infinity,0,0
107585,.,0,0
107586,PSK,1,0
107587,may,0,0
107588,suppress,0,0
107589,CD57,0,0
107590,(,0,0
107591,+,0,1
107592,),0,0
107593,T,0,0
107594,cells,0,0
107595,to,0,0
107596,improve,0,0
107597,survival,0,0
107598,of,0,0
107599,advanced,0,0
107600,gastric,0,0
107601,cancer,0,0
107602,patients,0,0
107603,.,0,0
107604,BACKGROUND,0,0
107605,A,0,0
107606,recent,0,0
107607,report,0,0
107608,showed,0,0
107609,that,0,0
107610,oral,1,1
107611,adjuvant,1,1
107612,immunochemotherapy,1,1
107613,with,1,0
107614,protein-bound,1,1
107615,polysaccharide,1,1
107616,K,1,1
107617,(,1,0
107618,PSK,1,0
107619,),1,1
107620,and,1,0
107621,tegafur/uracil,1,1
107622,(,1,1
107623,UFT,1,1
107624,),1,0
107625,for,0,0
107626,stage,0,0
107627,II,0,0
107628,and,0,0
107629,III,0,0
107630,colorectal,0,0
107631,cancer,0,0
107632,improves,0,0
107633,overall,0,0
107634,survival,0,0
107635,compared,0,0
107636,with,0,0
107637,UFT,1,0
107638,alone,1,0
107639,.,1,0
107640,PSK,1,0
107641,has,0,0
107642,been,0,0
107643,supposed,0,0
107644,to,0,0
107645,improve,0,0
107646,survival,0,0
107647,through,0,0
107648,immunological,0,0
107649,mechanisms,0,0
107650,such,0,0
107651,as,0,0
107652,induction,0,0
107653,of,0,0
107654,cytokines,0,0
107655,",",0,0
107656,regulation,0,0
107657,of,0,0
107658,Th1/Th2,0,1
107659,balance,0,0
107660,",",0,0
107661,and,0,0
107662,inhibition,0,0
107663,of,0,0
107664,immunosuppressive,0,1
107665,molecules,0,0
107666,.,0,0
107667,METHODS,0,0
107668,We,0,0
107669,investigated,0,0
107670,the,0,0
107671,mechanisms,0,0
107672,by,0,0
107673,which,0,0
107674,PSK,1,0
107675,influences,0,0
107676,immunological,0,0
107677,parameters,0,0
107678,such,0,0
107679,as,0,0
107680,Th1,0,1
107681,cells,0,0
107682,(,0,0
107683,IFN-gamma-positive,0,0
107684,CD4,0,1
107685,(,0,0
107686,+,0,1
107687,),0,0
107688,T,0,0
107689,cells,0,0
107690,),0,0
107691,",",0,0
107692,Th2,0,1
107693,cells,0,0
107694,(,0,0
107695,IL-4-positive,0,0
107696,CD4,0,1
107697,(,0,0
107698,+,0,1
107699,),0,0
107700,T,0,0
107701,cells,0,0
107702,),0,0
107703,",",0,0
107704,Th1/Th2,0,1
107705,ratio,0,0
107706,",",0,0
107707,NKT,0,1
107708,cells,0,0
107709,(,0,0
107710,CD56,0,1
107711,(,0,1
107712,+,0,1
107713,),0,0
107714,T,0,0
107715,cells,0,0
107716,and,0,0
107717,CD57,0,0
107718,(,0,1
107719,+,0,1
107720,),0,0
107721,T,0,0
107722,cells,0,0
107723,),0,0
107724,",",0,0
107725,NK,0,0
107726,cells,0,0
107727,",",0,0
107728,and,0,0
107729,CD25,0,1
107730,(,0,1
107731,+,0,1
107732,),0,1
107733,CD4,0,0
107734,(,0,0
107735,+,0,1
107736,),0,0
107737,T,0,0
107738,cells,0,0
107739,in,0,0
107740,stage,0,0
107741,III,0,0
107742,gastric,0,0
107743,cancer,0,0
107744,patients,0,0
107745,.,0,0
107746,Patients,0,0
107747,were,0,0
107748,randomly,0,0
107749,assigned,0,0
107750,to,0,0
107751,receive,0,0
107752,either,0,0
107753,3,0,0
107754,g,0,1
107755,PSK,1,0
107756,plus,1,1
107757,300,1,1
107758,mg,1,1
107759,UFT,1,1
107760,(,1,0
107761,PSK,1,0
107762,group,1,1
107763,),1,0
107764,or,0,0
107765,300,0,1
107766,mg,0,1
107767,UFT,1,0
107768,alone,1,1
107769,(,0,0
107770,control,0,0
107771,),0,0
107772,orally,0,1
107773,each,0,0
107774,day,0,0
107775,for,0,0
107776,at,0,0
107777,least,0,0
107778,1,0,0
107779,year,0,0
107780,following,0,0
107781,their,0,0
107782,operation,0,0
107783,.,0,0
107784,RESULTS,0,0
107785,Twenty-one,0,0
107786,registered,0,0
107787,patients,0,0
107788,with,0,0
107789,stage,0,0
107790,III,0,0
107791,gastric,0,0
107792,cancer,0,0
107793,were,0,0
107794,analyzed,0,0
107795,.,0,0
107796,The,0,0
107797,3-year,0,0
107798,overall,0,0
107799,survival,0,0
107800,was,0,0
107801,62.2,0,0
107802,%,0,0
107803,in,0,0
107804,the,0,0
107805,PSK,1,0
107806,group,0,0
107807,(,0,0
107808,n,0,0
107809,=,0,0
107810,10,0,0
107811,),0,0
107812,and,0,0
107813,12.5,0,0
107814,%,0,0
107815,in,0,0
107816,the,0,0
107817,control,1,1
107818,group,1,0
107819,(,0,0
107820,n,0,0
107821,=,0,0
107822,11,0,0
107823,),0,0
107824,(,0,0
107825,P,0,0
107826,=,0,0
107827,0.038,0,0
107828,),0,0
107829,.,0,0
107830,Before,0,0
107831,operation,0,0
107832,",",0,0
107833,there,0,0
107834,were,0,0
107835,no,0,0
107836,significant,0,0
107837,differences,0,0
107838,in,0,0
107839,the,0,0
107840,proportions,0,0
107841,of,0,0
107842,Th1,0,0
107843,cells,0,0
107844,",",0,0
107845,Th2,0,0
107846,cells,0,0
107847,",",0,0
107848,Th1/Th2,0,1
107849,ratio,0,0
107850,",",0,0
107851,CD56,0,1
107852,(,0,0
107853,+,0,1
107854,),0,0
107855,T,0,0
107856,cells,0,0
107857,",",0,0
107858,CD57,0,0
107859,(,0,0
107860,+,0,1
107861,),0,0
107862,T,0,0
107863,cells,0,0
107864,",",0,0
107865,NK,0,0
107866,cells,0,0
107867,",",0,0
107868,and,0,0
107869,CD4,0,0
107870,(,0,1
107871,+,0,1
107872,),0,1
107873,CD25,0,1
107874,(,0,0
107875,+,0,1
107876,),0,0
107877,T,0,0
107878,cells,0,0
107879,between,0,0
107880,PSK,0,0
107881,and,0,0
107882,control,0,0
107883,groups,0,0
107884,.,0,0
107885,However,0,0
107886,",",0,0
107887,after,0,0
107888,operation,0,0
107889,",",0,0
107890,CD57,0,0
107891,(,0,0
107892,+,0,1
107893,),0,0
107894,T,0,0
107895,cells,0,0
107896,decreased,0,0
107897,significantly,0,0
107898,in,0,0
107899,the,0,0
107900,PSK,1,0
107901,group,0,0
107902,compared,0,0
107903,to,0,0
107904,the,0,0
107905,control,0,1
107906,(,0,0
107907,P,0,0
107908,=,0,0
107909,0.0486,0,0
107910,),0,0
107911,.,0,0
107912,When,0,0
107913,all,0,0
107914,patients,0,0
107915,were,0,0
107916,analyzed,0,0
107917,",",0,0
107918,patients,0,0
107919,with,0,0
107920,increased,0,0
107921,proportion,0,0
107922,(,0,0
107923,>,0,0
107924,18,0,0
107925,%,0,0
107926,),0,0
107927,of,0,0
107928,CD57,0,0
107929,(,0,0
107930,+,0,1
107931,),0,0
107932,T,0,0
107933,cells,0,0
107934,showed,0,0
107935,worse,0,0
107936,survival,0,0
107937,than,0,0
107938,those,0,0
107939,with,0,0
107940,lower,0,0
107941,(,0,0
107942,<,0,0
107943,or,0,0
107944,=,0,0
107945,18,0,0
107946,%,0,0
107947,),0,0
107948,CD57,0,0
107949,(,0,0
107950,+,0,1
107951,),0,0
107952,T,0,0
107953,cells,0,1
107954,(,0,0
107955,3-year,0,0
107956,survival,0,0
107957,",",0,0
107958,25.0,0,0
107959,and,0,0
107960,45.7,0,0
107961,%,0,0
107962,",",0,0
107963,respectively,0,0
107964,;,0,0
107965,P,0,0
107966,=,0,0
107967,0.046,0,0
107968,),0,0
107969,",",0,0
107970,consistent,0,0
107971,with,0,0
107972,our,0,0
107973,previous,0,0
107974,report,0,0
107975,that,0,0
107976,high,0,0
107977,CD57,0,0
107978,(,0,0
107979,+,0,1
107980,),0,1
107981,is,0,0
107982,an,0,0
107983,indicator,0,0
107984,of,0,0
107985,poor,0,0
107986,prognosis,0,0
107987,in,0,0
107988,patients,0,0
107989,with,0,0
107990,advanced,0,0
107991,gastric,0,0
107992,cancer,0,0
107993,.,0,0
107994,However,0,0
107995,",",0,0
107996,in,0,0
107997,the,0,0
107998,group,0,0
107999,treated,0,0
108000,with,0,0
108001,PSK,1,0
108002,+,1,1
108003,UFT,1,0
108004,",",0,0
108005,3-year,0,0
108006,survival,0,0
108007,of,0,0
108008,CD57-high,0,0
108009,patients,0,0
108010,was,0,0
108011,as,0,0
108012,great,0,0
108013,as,0,0
108014,that,0,0
108015,of,0,0
108016,CD57-low,0,0
108017,patients,0,0
108018,(,0,0
108019,66.7,0,0
108020,and,0,0
108021,51.4,0,0
108022,%,0,0
108023,",",0,0
108024,respectively,0,0
108025,;,0,0
108026,P,0,0
108027,=,0,0
108028,0.67,0,0
108029,),0,0
108030,.,0,0
108031,CONCLUSION,0,0
108032,The,0,0
108033,present,0,0
108034,findings,0,0
108035,suggest,0,0
108036,that,0,0
108037,PSK,1,0
108038,improves,0,0
108039,overall,0,0
108040,survival,0,0
108041,of,0,0
108042,stage,0,0
108043,III,0,0
108044,gastric,0,0
108045,cancer,0,0
108046,patients,0,0
108047,partly,0,0
108048,by,0,0
108049,inhibiting,0,0
108050,CD57,0,0
108051,(,0,1
108052,+,0,1
108053,),0,0
108054,T,0,0
108055,cells,0,0
108056,",",0,0
108057,a,0,0
108058,proven,0,0
108059,poor,0,0
108060,prognostic,0,0
108061,factor,0,0
108062,in,0,0
108063,advanced,0,0
108064,gastric,0,0
108065,cancer,0,0
108066,.,0,0
108067,Aminocaproic,1,1
108068,acid,1,1
108069,versus,0,0
108070,prednisone,1,1
108071,for,0,0
108072,the,0,0
108073,treatment,0,0
108074,of,0,0
108075,traumatic,0,0
108076,hyphema,0,0
108077,.,0,0
108078,A,0,0
108079,randomized,0,0
108080,clinical,0,0
108081,trial,0,0
108082,.,0,0
108083,One,0,0
108084,hundred,0,0
108085,twelve,0,0
108086,patients,0,0
108087,who,0,0
108088,sustained,0,0
108089,hyphema,0,0
108090,after,0,0
108091,blunt,0,0
108092,trauma,0,0
108093,were,0,0
108094,enrolled,0,0
108095,in,0,0
108096,a,0,0
108097,double-blind,0,0
108098,randomized,0,0
108099,clinical,0,0
108100,trial,0,0
108101,to,0,0
108102,determine,0,0
108103,the,0,0
108104,relative,0,0
108105,efficacies,0,0
108106,of,0,0
108107,aminocaproic,1,1
108108,acid,1,1
108109,(,1,0
108110,Amicar,1,1
108111,),1,1
108112,and,0,0
108113,systemic,1,0
108114,prednisone,1,1
108115,for,0,0
108116,reducing,0,0
108117,the,0,0
108118,rate,0,0
108119,of,0,0
108120,secondary,0,0
108121,hemorrhage,0,0
108122,.,0,0
108123,Fifty-six,0,0
108124,patients,0,0
108125,received,0,0
108126,an,0,0
108127,oral,1,1
108128,dosage,1,0
108129,of,1,0
108130,50,1,0
108131,mg/kg,1,0
108132,of,1,0
108133,aminocaproic,1,1
108134,acid,1,1
108135,every,0,0
108136,4,0,0
108137,hours,0,0
108138,for,0,0
108139,5,0,0
108140,days,0,0
108141,",",0,0
108142,up,0,0
108143,to,0,0
108144,a,0,0
108145,maximum,0,0
108146,of,0,0
108147,30,0,0
108148,g,0,0
108149,daily,0,0
108150,",",0,0
108151,and,0,0
108152,56,0,0
108153,patients,0,0
108154,received,0,0
108155,an,0,0
108156,oral,1,1
108157,dosage,1,0
108158,of,1,0
108159,40,1,0
108160,mg,1,0
108161,of,1,0
108162,prednisone,1,1
108163,daily,1,1
108164,(,0,0
108165,adjusted,0,0
108166,for,0,0
108167,weight,0,0
108168,),0,0
108169,in,0,0
108170,two,0,0
108171,divided,0,0
108172,doses,0,0
108173,.,0,0
108174,Placebo,1,1
108175,pills,0,1
108176,and,0,0
108177,liquids,0,1
108178,were,0,0
108179,given,0,0
108180,to,0,0
108181,each,0,0
108182,patient,0,0
108183,to,0,0
108184,mask,0,0
108185,the,0,0
108186,treatment,0,0
108187,schedules,0,0
108188,.,0,0
108189,There,0,0
108190,were,0,0
108191,no,0,0
108192,statistically,0,0
108193,significant,0,0
108194,differences,0,0
108195,between,0,0
108196,the,0,0
108197,patient,0,0
108198,populations,0,0
108199,for,0,0
108200,any,0,0
108201,demographic,0,0
108202,or,0,0
108203,clinical,0,0
108204,characteristic,0,0
108205,(,0,0
108206,e.g.,0,0
108207,",",0,0
108208,visual,0,0
108209,acuity,0,0
108210,",",0,0
108211,intraocular,0,0
108212,pressure,0,0
108213,[,0,0
108214,IOP,0,0
108215,],0,0
108216,",",0,0
108217,initial,0,0
108218,hyphema,0,0
108219,size,0,0
108220,),0,0
108221,measured,0,0
108222,in,0,0
108223,the,0,0
108224,study,0,0
108225,.,0,0
108226,Blacks,0,0
108227,comprised,0,0
108228,53,0,0
108229,%,0,0
108230,of,0,0
108231,the,0,0
108232,study,0,0
108233,population,0,0
108234,",",0,0
108235,and,0,0
108236,the,0,0
108237,mean,0,0
108238,age,0,0
108239,of,0,0
108240,the,0,0
108241,patients,0,0
108242,was,0,0
108243,23.5,0,0
108244,years,0,0
108245,.,0,0
108246,Four,0,0
108247,patients,0,0
108248,in,0,0
108249,each,0,0
108250,of,0,0
108251,the,0,0
108252,treatment,0,0
108253,groups,0,0
108254,experienced,0,0
108255,a,0,0
108256,secondary,0,0
108257,hemorrhage,0,0
108258,;,0,0
108259,the,0,0
108260,rebleed,0,0
108261,rate,0,0
108262,was,0,0
108263,7.1,0,0
108264,%,0,0
108265,in,0,0
108266,each,0,0
108267,group,0,0
108268,.,0,0
108269,Efficacy,0,0
108270,and,0,0
108271,safety,0,0
108272,of,0,0
108273,a,0,0
108274,high,1,0
108275,protein,1,0
108276,",",1,0
108277,low,1,0
108278,carbohydrate,1,1
108279,diet,1,1
108280,for,0,0
108281,weight,0,0
108282,loss,0,0
108283,in,0,0
108284,severely,0,0
108285,obese,0,0
108286,adolescents,0,0
108287,.,0,0
108288,OBJECTIVE,0,0
108289,To,0,0
108290,evaluate,0,0
108291,the,0,0
108292,efficacy,0,0
108293,and,0,0
108294,safety,0,0
108295,of,0,0
108296,a,0,0
108297,carbohydrate,1,1
108298,restricted,1,0
108299,versus,1,0
108300,a,1,0
108301,low,1,0
108302,fat,1,0
108303,diet,1,1
108304,on,0,0
108305,weight,0,0
108306,loss,0,0
108307,",",0,0
108308,metabolic,0,0
108309,markers,0,0
108310,",",0,0
108311,body,0,0
108312,composition,0,0
108313,",",0,0
108314,and,0,0
108315,cardiac,0,0
108316,function,0,0
108317,tests,0,0
108318,in,0,0
108319,severely,0,0
108320,obese,0,0
108321,adolescents,0,0
108322,.,0,0
108323,STUDY,0,0
108324,DESIGN,0,0
108325,Subjects,0,0
108326,were,0,0
108327,randomly,0,0
108328,assigned,0,0
108329,to,0,0
108330,1,0,0
108331,of,0,0
108332,2,0,0
108333,diets,1,0
108334,:,1,0
108335,a,1,0
108336,high,1,0
108337,protein,1,0
108338,",",1,0
108339,low,1,0
108340,carbohydrate,1,1
108341,(,1,0
108342,20,1,1
108343,g/d,1,1
108344,),1,0
108345,diet,1,1
108346,(,1,0
108347,high,1,0
108348,protein,1,1
108349,",",1,0
108350,low,1,0
108351,carbohydrate,1,1
108352,",",1,0
108353,HPLC,1,0
108354,),1,0
108355,or,1,1
108356,low,1,0
108357,fat,1,1
108358,(,1,0
108359,30,1,0
108360,%,1,0
108361,of,1,0
108362,calories,1,1
108363,),1,0
108364,regimen,1,0
108365,for,1,0
108366,13,1,0
108367,weeks,1,0
108368,;,1,0
108369,close,0,0
108370,monitoring,0,0
108371,was,0,0
108372,maintained,0,0
108373,to,0,0
108374,evaluate,0,0
108375,safety,0,0
108376,.,0,0
108377,After,0,0
108378,the,0,0
108379,intervention,0,1
108380,",",0,0
108381,no,0,0
108382,clinical,0,0
108383,contact,0,0
108384,was,0,0
108385,made,0,0
108386,until,0,0
108387,follow-up,0,0
108388,measurements,0,0
108389,were,0,0
108390,obtained,0,0
108391,at,0,0
108392,24,0,0
108393,and,0,0
108394,36,0,0
108395,weeks,0,0
108396,from,0,0
108397,baseline,0,0
108398,.,0,0
108399,The,0,0
108400,primary,0,0
108401,outcome,0,0
108402,was,0,0
108403,change,0,0
108404,in,0,0
108405,body,0,0
108406,mass,0,0
108407,index,0,0
108408,Z-score,0,0
108409,for,0,0
108410,age,0,0
108411,and,0,0
108412,sex,0,0
108413,(,0,1
108414,BMI-Z,0,0
108415,),0,0
108416,at,0,0
108417,13,0,0
108418,",",0,0
108419,24,0,0
108420,",",0,0
108421,and,0,0
108422,36,0,0
108423,weeks,0,0
108424,.,0,0
108425,RESULTS,0,0
108426,Forty-six,0,0
108427,subjects,0,0
108428,(,0,0
108429,24,0,0
108430,HPLC,0,0
108431,",",0,0
108432,22,0,0
108433,in,0,0
108434,low,0,0
108435,fat,0,0
108436,),0,0
108437,initiated,0,0
108438,and,0,0
108439,33,0,0
108440,subjects,0,0
108441,completed,0,0
108442,the,0,0
108443,intervention,0,1
108444,;,0,0
108445,follow-up,0,0
108446,data,0,0
108447,were,0,0
108448,available,0,0
108449,on,0,0
108450,approximately,0,0
108451,half,0,0
108452,of,0,0
108453,the,0,0
108454,subjects,0,0
108455,.,0,0
108456,Significant,0,0
108457,reduction,0,0
108458,in,0,0
108459,(,0,0
108460,BMI-Z,0,0
108461,),0,0
108462,was,0,0
108463,achieved,0,0
108464,in,0,0
108465,both,0,0
108466,groups,0,0
108467,during,0,0
108468,intervention,0,1
108469,and,0,0
108470,was,0,0
108471,significantly,0,0
108472,greater,0,0
108473,for,0,0
108474,the,0,0
108475,HPLC,0,0
108476,group,0,0
108477,(,0,0
108478,P,0,0
108479,=,0,0
108480,.03,0,0
108481,),0,0
108482,.,0,0
108483,Both,0,0
108484,groups,0,0
108485,maintained,0,0
108486,significant,0,0
108487,BMI-Z,0,0
108488,reduction,0,0
108489,at,0,0
108490,follow-up,0,0
108491,;,0,0
108492,changes,0,0
108493,were,0,0
108494,not,0,0
108495,significantly,0,0
108496,different,0,0
108497,between,0,0
108498,groups,0,0
108499,.,0,0
108500,Loss,0,0
108501,of,0,0
108502,lean,0,0
108503,body,0,0
108504,mass,0,0
108505,was,0,0
108506,not,0,0
108507,spared,0,0
108508,in,0,0
108509,the,0,0
108510,HPLC,0,0
108511,group,0,0
108512,.,0,0
108513,No,0,0
108514,serious,0,0
108515,adverse,0,0
108516,effects,0,0
108517,were,0,0
108518,observed,0,0
108519,related,0,0
108520,to,0,0
108521,metabolic,0,0
108522,profiles,0,0
108523,",",0,0
108524,cardiac,0,0
108525,function,0,0
108526,",",0,0
108527,or,0,0
108528,subjective,0,0
108529,complaints,0,0
108530,.,0,0
108531,CONCLUSIONS,0,0
108532,The,0,0
108533,HPLC,1,0
108534,diet,0,1
108535,is,0,0
108536,a,0,0
108537,safe,0,0
108538,and,0,0
108539,effective,0,0
108540,option,0,0
108541,for,0,0
108542,medically,0,0
108543,supervised,0,1
108544,weight,0,0
108545,loss,0,0
108546,in,0,0
108547,severely,0,0
108548,obese,0,0
108549,adolescents,0,0
108550,.,0,0
108551,Effects,0,0
108552,of,0,0
108553,early,1,0
108554,enteral,1,1
108555,feeding,1,0
108556,on,0,0
108557,fecal,0,0
108558,elastase,0,1
108559,1,0,0
108560,and,0,0
108561,plasma,0,0
108562,secretin,0,1
108563,.,0,0
108564,BACKGROUND,0,0
108565,Enteral,1,0
108566,feeding,1,0
108567,is,0,0
108568,known,0,0
108569,to,0,0
108570,be,0,0
108571,effective,0,0
108572,on,0,0
108573,the,0,0
108574,development,0,0
108575,of,0,0
108576,gut,0,0
108577,hormone,0,1
108578,secretion,0,0
108579,and,0,0
108580,pancreatic,0,0
108581,exocrine,0,1
108582,function,0,0
108583,.,0,0
108584,The,0,0
108585,aim,0,0
108586,of,0,0
108587,the,0,0
108588,present,0,0
108589,study,0,0
108590,was,0,0
108591,to,0,0
108592,examine,0,0
108593,the,0,0
108594,effects,0,0
108595,of,0,0
108596,extremely,0,0
108597,early,1,0
108598,enteral,1,1
108599,feedings,1,0
108600,on,0,0
108601,the,0,0
108602,development,0,0
108603,in,0,0
108604,very,0,0
108605,low-birthweight,0,0
108606,(,0,0
108607,VLBW,0,0
108608,),0,0
108609,infants,0,0
108610,.,0,0
108611,METHODS,0,0
108612,Fecal,0,0
108613,elastase,0,1
108614,1,0,0
108615,and,0,0
108616,plasma,0,0
108617,secretin,0,1
108618,concentrations,0,0
108619,were,0,0
108620,measured,0,0
108621,at,0,0
108622,four,0,0
108623,different,0,0
108624,periods,0,0
108625,during,0,0
108626,the,0,0
108627,first,0,0
108628,28,0,0
108629,days,0,0
108630,of,0,0
108631,life,0,0
108632,in,0,0
108633,VLBW,0,0
108634,infants,0,0
108635,",",0,0
108636,with,0,0
108637,extremely,0,0
108638,early,0,0
108639,enteral,0,1
108640,feeding,0,0
108641,starting,0,0
108642,within,0,0
108643,24,0,0
108644,h,0,0
108645,of,0,0
108646,birth,0,0
108647,",",0,0
108648,as,0,0
108649,well,0,0
108650,as,0,0
108651,in,0,0
108652,control,0,0
108653,infants,0,0
108654,.,0,0
108655,RESULTS,0,0
108656,Fecal,0,0
108657,concentrations,0,0
108658,of,0,0
108659,elastase,0,0
108660,1,0,0
108661,at,0,0
108662,7,0,0
108663,",",0,0
108664,14,0,0
108665,and,0,0
108666,28,0,0
108667,days,0,0
108668,after,0,0
108669,birth,0,0
108670,were,0,0
108671,significantly,0,0
108672,higher,0,0
108673,than,0,0
108674,those,0,0
108675,at,0,0
108676,1,0,0
108677,or,0,0
108678,2,0,0
108679,days,0,0
108680,in,0,0
108681,both,0,0
108682,the,0,0
108683,early,0,0
108684,feeding,0,0
108685,and,0,0
108686,control,0,0
108687,groups,0,0
108688,.,0,0
108689,Fecal,0,0
108690,elastase,0,0
108691,1,0,0
108692,levels,0,0
108693,in,0,0
108694,the,0,0
108695,early,0,0
108696,feeding,0,0
108697,group,0,0
108698,were,0,0
108699,significantly,0,0
108700,higher,0,0
108701,than,0,0
108702,those,0,0
108703,in,0,0
108704,the,0,0
108705,control,0,0
108706,group,0,0
108707,at,0,0
108708,7,0,0
108709,and,0,0
108710,14,0,0
108711,days,0,0
108712,after,0,0
108713,birth,0,0
108714,.,0,0
108715,The,0,0
108716,plasma,0,0
108717,concentration,0,0
108718,of,0,0
108719,secretin,0,1
108720,at,0,0
108721,14,0,0
108722,days,0,0
108723,after,0,0
108724,birth,0,0
108725,was,0,0
108726,significantly,0,0
108727,higher,0,0
108728,than,0,0
108729,that,0,0
108730,at,0,0
108731,1,0,0
108732,or,0,0
108733,2,0,0
108734,days,0,0
108735,and,0,0
108736,7,0,0
108737,days,0,0
108738,after,0,0
108739,birth,0,0
108740,in,0,0
108741,the,0,0
108742,early,0,0
108743,feeding,0,0
108744,group,0,0
108745,.,0,0
108746,No,0,0
108747,significant,0,0
108748,differences,0,0
108749,in,0,0
108750,plasma,0,0
108751,secretin,0,1
108752,levels,0,0
108753,were,0,0
108754,detected,0,0
108755,between,0,0
108756,the,0,0
108757,early,0,0
108758,feeding,0,0
108759,and,0,0
108760,control,0,0
108761,groups,0,0
108762,at,0,0
108763,1,0,0
108764,or,0,0
108765,2,0,0
108766,days,0,0
108767,",",0,0
108768,7,0,0
108769,days,0,0
108770,and,0,0
108771,28,0,0
108772,days,0,0
108773,after,0,0
108774,birth,0,0
108775,",",0,0
108776,but,0,0
108777,a,0,0
108778,significant,0,0
108779,difference,0,0
108780,in,0,0
108781,secretin,0,1
108782,level,0,0
108783,was,0,0
108784,observed,0,0
108785,between,0,0
108786,the,0,0
108787,two,0,0
108788,groups,0,0
108789,at,0,0
108790,14,0,0
108791,days,0,0
108792,after,0,0
108793,birth,0,0
108794,.,0,0
108795,CONCLUSIONS,0,0
108796,Extremely,1,0
108797,early,1,0
108798,enteral,1,1
108799,feedings,1,0
108800,may,0,0
108801,play,0,0
108802,an,0,0
108803,important,0,0
108804,role,0,0
108805,in,0,0
108806,the,0,0
108807,development,0,0
108808,of,0,0
108809,pancreatic,0,0
108810,exocrine,0,1
108811,function,0,0
108812,and,0,0
108813,secretin,0,1
108814,secretion,0,0
108815,in,0,0
108816,the,0,0
108817,early,0,0
108818,period,0,0
108819,of,0,0
108820,life,0,0
108821,in,0,0
108822,VLBW,0,0
108823,infants,0,0
108824,.,0,0
108825,Metformin,1,1
108826,",",1,0
108827,naltrexone,1,1
108828,",",1,0
108829,or,1,0
108830,the,1,0
108831,combination,1,1
108832,of,1,0
108833,prednisolone,1,1
108834,and,1,0
108835,antiandrogenic,1,1
108836,oral,1,1
108837,contraceptives,1,1
108838,as,0,0
108839,first-line,0,0
108840,therapy,0,1
108841,in,0,0
108842,hyperinsulinemic,0,0
108843,women,0,0
108844,with,0,0
108845,polycystic,0,0
108846,ovary,0,0
108847,syndrome,0,0
108848,.,0,0
108849,To,0,0
108850,compare,0,0
108851,the,0,0
108852,short-term,0,0
108853,effects,0,0
108854,of,0,0
108855,metformin,1,1
108856,(,1,0
108857,M,1,0
108858,),1,0
108859,",",1,0
108860,naltrexone,1,1
108861,(,1,0
108862,N,1,0
108863,),1,0
108864,",",1,0
108865,and,1,0
108866,a,1,0
108867,combination,1,1
108868,of,1,0
108869,OC,1,0
108870,and,1,0
108871,prednisolone,1,1
108872,(,1,1
108873,OC/Pr,1,1
108874,),1,0
108875,on,0,0
108876,the,0,0
108877,metabolic,0,0
108878,state,0,0
108879,and,0,0
108880,the,0,0
108881,ovarian,0,0
108882,function,0,0
108883,of,0,0
108884,PCOS,0,0
108885,women,0,0
108886,",",0,0
108887,we,0,0
108888,randomized,0,0
108889,29,0,0
108890,women,0,0
108891,to,0,0
108892,a,0,0
108893,3-month,0,0
108894,course,0,0
108895,of,0,0
108896,therapy,0,1
108897,.,0,0
108898,We,0,0
108899,observed,0,0
108900,significant,0,0
108901,improvements,0,0
108902,in,0,0
108903,hyperandrogenemia,0,0
108904,and,0,0
108905,ovulation,0,0
108906,rates,0,0
108907,in,0,0
108908,PCOS,0,0
108909,women,0,0
108910,of,0,0
108911,all,0,0
108912,three,0,0
108913,groups,0,0
108914,",",0,0
108915,in,0,0
108916,the,0,0
108917,absence,0,0
108918,of,0,0
108919,changes,0,0
108920,in,0,0
108921,the,0,0
108922,metabolic,0,0
108923,state,0,0
108924,",",0,0
108925,suggesting,0,0
108926,that,0,0
108927,insulin,0,1
108928,resistance,0,0
108929,in,0,0
108930,PCOS,0,0
108931,patients,0,0
108932,is,0,0
108933,only,0,0
108934,one,0,0
108935,of,0,0
108936,several,0,0
108937,factors,0,0
108938,leading,0,0
108939,to,0,0
108940,hyperandrogenemic,0,0
108941,ovarian,0,0
108942,failure,0,0
108943,.,0,0
108944,Effects,0,0
108945,of,0,0
108946,10,0,0
108947,Hz,0,1
108948,repetitive,1,1
108949,transcranial,1,1
108950,magnetic,1,1
108951,stimulation,1,1
108952,(,1,0
108953,rTMS,1,1
108954,),1,0
108955,on,0,0
108956,clinical,0,0
108957,global,0,0
108958,impression,0,1
108959,in,0,0
108960,chronic,0,0
108961,schizophrenia,0,0
108962,.,0,0
108963,UNLABELLED,0,0
108964,We,0,0
108965,conducted,0,0
108966,a,0,0
108967,randomized,0,0
108968,",",0,0
108969,sham-controlled,0,1
108970,repetitive,1,1
108971,transcranial,1,1
108972,magnetic,1,1
108973,stimulation,1,1
108974,(,1,0
108975,rTMS,1,1
108976,),1,1
108977,study,0,0
108978,in,0,0
108979,chronic,0,0
108980,schizophrenia,0,0
108981,in-patients,0,0
108982,(,0,0
108983,n=35,0,0
108984,),0,0
108985,to,0,0
108986,evaluate,0,0
108987,the,0,0
108988,therapeutic,0,0
108989,efficacy,0,0
108990,of,0,0
108991,10,1,0
108992,Hz,1,1
108993,stimulation,0,0
108994,.,0,0
108995,Patients,0,0
108996,",",0,0
108997,who,0,0
108998,were,0,0
108999,on,0,0
109000,stable,0,0
109001,antipsychotic,0,0
109002,treatment,0,0
109003,",",0,0
109004,were,0,0
109005,randomly,0,0
109006,assigned,0,0
109007,to,0,0
109008,the,0,0
109009,active,0,0
109010,or,0,0
109011,sham,0,1
109012,condition,0,0
109013,.,0,0
109014,In,0,0
109015,the,0,0
109016,active,0,0
109017,rTMS,1,1
109018,group,0,0
109019,",",0,0
109020,ten,0,0
109021,sessions,0,1
109022,with,0,0
109023,a,0,0
109024,total,0,0
109025,of,0,0
109026,"10,000",0,0
109027,stimuli,0,0
109028,were,0,0
109029,applied,0,0
109030,over,0,0
109031,the,0,0
109032,left,0,0
109033,dorsolateral,0,1
109034,prefrontal,0,0
109035,cortex,0,0
109036,at,0,0
109037,110,0,0
109038,%,0,0
109039,of,0,0
109040,motor,0,0
109041,threshold,0,0
109042,.,0,0
109043,The,0,0
109044,sham,1,1
109045,group,0,0
109046,received,0,0
109047,corresponding,0,0
109048,sham,1,1
109049,stimulation,1,1
109050,.,1,0
109051,Clinical,0,0
109052,improvement,0,0
109053,was,0,0
109054,measured,0,0
109055,by,0,0
109056,the,0,0
109057,Clinical,0,0
109058,Global,0,0
109059,Impression,0,0
109060,scale,0,0
109061,(,0,0
109062,primary,0,0
109063,outcome,0,0
109064,measure,0,0
109065,),0,0
109066,",",0,0
109067,the,0,0
109068,Global,0,0
109069,Assessment,0,0
109070,of,0,0
109071,Functioning,0,0
109072,Scale,0,1
109073,(,0,0
109074,GAF,0,1
109075,),0,0
109076,and,0,0
109077,the,0,0
109078,Positive,0,0
109079,and,0,0
109080,Negative,0,0
109081,Symptom,0,1
109082,Scale,0,1
109083,(,0,0
109084,PANSS,0,0
109085,;,0,0
109086,secondary,0,0
109087,outcome,0,0
109088,measures,0,0
109089,),0,0
109090,.,0,0
109091,Between-group,0,0
109092,comparisons,0,0
109093,revealed,0,0
109094,no,0,0
109095,significant,0,0
109096,differences,0,0
109097,in,0,0
109098,clinical,0,0
109099,outcome,0,0
109100,variables,0,0
109101,.,0,0
109102,Only,0,0
109103,a,0,0
109104,subgroup,0,0
109105,of,0,0
109106,patients,0,0
109107,with,0,0
109108,pronounced,0,0
109109,negative,0,0
109110,symptoms,0,0
109111,developed,0,0
109112,some,0,0
109113,clinical,0,0
109114,improvement,0,0
109115,as,0,0
109116,indicated,0,0
109117,by,0,0
109118,significant,0,0
109119,changes,0,0
109120,in,0,0
109121,the,0,0
109122,GAF-scale,0,0
109123,.,0,0
109124,Besides,0,0
109125,there,0,0
109126,is,0,0
109127,some,0,0
109128,evidence,0,0
109129,for,0,0
109130,a,0,0
109131,more,0,0
109132,favourable,0,0
109133,clinical,0,0
109134,outcome,0,0
109135,within,0,0
109136,this,0,0
109137,subgroup,0,0
109138,after,0,0
109139,rTMS,1,1
109140,in,0,0
109141,the,0,0
109142,CGI-S,0,0
109143,and,0,0
109144,PANSS,0,0
109145,negative,0,0
109146,scale,0,0
109147,",",0,0
109148,too,0,0
109149,.,0,0
109150,In,0,0
109151,line,0,0
109152,with,0,0
109153,earlier,0,0
109154,investigations,0,0
109155,",",0,0
109156,our,0,0
109157,results,0,0
109158,suggest,0,0
109159,a,0,0
109160,moderate,0,0
109161,-,0,0
109162,potentially,0,0
109163,clinically,0,0
109164,relevant,0,0
109165,-,0,0
109166,treatment,0,0
109167,effect,0,0
109168,of,0,0
109169,prefrontal,1,0
109170,10,1,0
109171,Hz,1,1
109172,rTMS,1,1
109173,stimulation,0,1
109174,in,0,0
109175,chronic,0,0
109176,patients,0,0
109177,.,0,0
109178,However,0,0
109179,",",0,0
109180,in,0,0
109181,our,0,0
109182,study,0,0
109183,this,0,0
109184,beneficial,0,0
109185,effect,0,0
109186,was,0,0
109187,restricted,0,0
109188,to,0,0
109189,subjects,0,0
109190,with,0,0
109191,pronounced,0,0
109192,negative,0,0
109193,symptoms,0,0
109194,.,0,0
109195,CLINICAL,0,0
109196,TRIAL,0,0
109197,REGISTRATION,0,0
109198,INFORMATION,0,0
109199,ClinicalTrial.gov,0,0
109200,Identifier,0,0
109201,:,0,0
109202,NCT00169689,0,0
109203,",",0,0
109204,http,0,0
109205,:,0,0
109206,//www.clinicaltrials.gov,0,0
109207,.,0,0
109208,The,0,0
109209,pulsed-dye,1,1
109210,laser,1,1
109211,as,0,0
109212,an,0,0
109213,adjuvant,0,1
109214,treatment,0,0
109215,modality,0,0
109216,in,0,0
109217,acne,0,0
109218,vulgaris,0,0
109219,:,0,0
109220,a,0,0
109221,randomized,0,0
109222,controlled,0,0
109223,single-blinded,0,0
109224,trial,0,0
109225,.,0,0
109226,BACKGROUND,0,0
109227,Acne,0,0
109228,vulgaris,0,1
109229,is,0,0
109230,the,0,0
109231,most,0,0
109232,common,0,0
109233,skin,0,0
109234,disease,0,0
109235,and,0,0
109236,can,0,0
109237,pose,0,0
109238,a,0,0
109239,substantial,0,0
109240,therapeutic,0,0
109241,challenge,0,0
109242,.,0,0
109243,Recently,0,0
109244,",",0,0
109245,several,0,0
109246,phototherapeutic,0,1
109247,modalities,0,0
109248,",",0,0
109249,most,0,0
109250,notably,0,0
109251,pulsed-dye,1,1
109252,laser,1,1
109253,(,1,0
109254,PDL,1,1
109255,),1,0
109256,treatment,0,0
109257,",",0,0
109258,have,0,0
109259,been,0,0
109260,introduced,0,0
109261,",",0,0
109262,but,0,0
109263,the,0,0
109264,published,0,0
109265,results,0,0
109266,-,0,0
109267,albeit,0,0
109268,promising,0,0
109269,-,0,0
109270,are,0,0
109271,controversial,0,0
109272,.,0,0
109273,OBJECTIVES,0,0
109274,To,0,0
109275,assess,0,0
109276,the,0,0
109277,efficacy,0,0
109278,of,0,0
109279,an,0,0
109280,adjuvant,0,1
109281,PDL,1,1
109282,treatment,0,0
109283,when,0,0
109284,combined,0,0
109285,with,0,0
109286,a,0,0
109287,proven,0,0
109288,topical,0,1
109289,treatment,0,0
109290,[,0,0
109291,fixed-combination,0,1
109292,clindamycin,0,1
109293,1,0,0
109294,%,0,0
109295,-benzoyl,0,1
109296,peroxide,0,1
109297,5,0,0
109298,%,0,0
109299,hydrating,0,1
109300,gel,0,1
109301,(,0,1
109302,C/BPO,0,1
109303,),0,0
109304,],0,0
109305,.,0,0
109306,METHODS,0,0
109307,Eighty,0,0
109308,patients,0,0
109309,(,0,0
109310,38,0,0
109311,males,0,0
109312,and,0,0
109313,42,0,0
109314,females,0,0
109315,",",0,0
109316,mean,0,0
109317,+/-,0,0
109318,SD,0,0
109319,age,0,0
109320,19.7,0,0
109321,+/-,0,0
109322,5.9,0,0
109323,years,0,0
109324,),0,0
109325,were,0,0
109326,randomized,0,0
109327,in,0,0
109328,a,0,0
109329,1,0,0
109330,:,0,0
109331,2,0,0
109332,ratio,0,0
109333,to,0,0
109334,receive,0,0
109335,C/BPO,1,1
109336,alone,1,1
109337,or,1,0
109338,in,1,0
109339,combination,1,1
109340,with,1,0
109341,PDL,1,1
109342,treatment,1,0
109343,(,0,0
109344,wavelength,0,0
109345,585,0,0
109346,nm,0,0
109347,",",0,0
109348,energy,0,0
109349,fluence,0,1
109350,3,0,0
109351,J,0,0
109352,cm,0,0
109353,(,0,0
109354,-2,0,0
109355,),0,0
109356,",",0,0
109357,pulse,0,1
109358,duration,0,0
109359,0.35,0,0
109360,ms,0,0
109361,",",0,0
109362,spot,0,1
109363,size,0,0
109364,7,0,0
109365,mm,0,0
109366,),0,0
109367,.,0,0
109368,Patients,0,0
109369,were,0,0
109370,evaluated,0,0
109371,at,0,0
109372,baseline,0,0
109373,and,0,0
109374,at,0,0
109375,2,0,0
109376,and,0,0
109377,4,0,0
109378,weeks,0,0
109379,after,0,0
109380,initial,0,0
109381,treatment,0,0
109382,.,0,0
109383,The,0,0
109384,primary,0,0
109385,end,0,0
109386,points,0,0
109387,were,0,0
109388,the,0,0
109389,Investigator,0,0
109390,'s,0,0
109391,Static,0,0
109392,Global,0,0
109393,Assessment,0,1
109394,(,0,0
109395,ISGA,0,1
109396,),0,1
109397,score,0,0
109398,and,0,0
109399,lesion,0,0
109400,count,0,0
109401,;,0,0
109402,the,0,0
109403,secondary,0,0
109404,end,0,0
109405,point,0,0
109406,was,0,0
109407,the,0,0
109408,Dermatology,0,0
109409,Life,0,0
109410,Quality,0,0
109411,Index,0,1
109412,(,0,0
109413,DLQI,0,0
109414,),0,0
109415,.,0,0
109416,RESULTS,0,0
109417,Both,0,0
109418,groups,0,0
109419,showed,0,0
109420,a,0,0
109421,significant,0,0
109422,improvement,0,0
109423,during,0,0
109424,observation,0,0
109425,[,0,0
109426,ISGA,0,1
109427,27.1,0,0
109428,%,0,0
109429,(,1,0
109430,C/BPO,1,1
109431,),1,0
109432,and,0,0
109433,24.6,0,0
109434,%,0,0
109435,(,1,0
109436,C/BPO,1,1
109437,+,1,1
109438,laser,1,1
109439,),1,0
109440,",",0,0
109441,total,0,0
109442,lesion,0,0
109443,count,0,0
109444,9.2,0,0
109445,%,0,0
109446,and,0,0
109447,9.0,0,0
109448,%,0,0
109449,",",0,0
109450,inflammatory,0,0
109451,lesion,0,0
109452,count,0,0
109453,36.3,0,0
109454,%,0,0
109455,and,0,0
109456,36.9,0,0
109457,%,0,0
109458,",",0,0
109459,DLQI,0,0
109460,54.5,0,0
109461,%,0,0
109462,and,0,0
109463,42.5,0,0
109464,%,0,0
109465,],0,0
109466,",",0,0
109467,but,0,0
109468,there,0,0
109469,was,0,0
109470,no,0,0
109471,significant,0,0
109472,or,0,0
109473,otherwise,0,0
109474,appreciable,0,0
109475,difference,0,0
109476,between,0,0
109477,treatment,0,0
109478,modalities,0,0
109479,as,0,0
109480,far,0,0
109481,as,0,0
109482,the,0,0
109483,extent,0,0
109484,of,0,0
109485,improvement,0,0
109486,was,0,0
109487,concerned,0,0
109488,.,0,0
109489,Patients,0,0
109490,with,0,0
109491,more,0,0
109492,severe,0,0
109493,findings,0,0
109494,at,0,0
109495,baseline,0,0
109496,had,0,0
109497,a,0,0
109498,greater,0,0
109499,benefit,0,0
109500,from,0,0
109501,either,0,0
109502,therapy,0,1
109503,regimen,0,1
109504,.,0,0
109505,CONCLUSIONS,0,0
109506,Our,0,0
109507,findings,0,0
109508,do,0,0
109509,not,0,0
109510,support,0,0
109511,the,0,0
109512,concept,0,0
109513,of,0,0
109514,a,0,0
109515,substantial,0,0
109516,benefit,0,0
109517,of,0,0
109518,PDL,1,1
109519,treatment,0,0
109520,in,0,0
109521,acne,0,0
109522,vulgaris,0,0
109523,.,0,0
109524,Stroke,0,1
109525,team,0,0
109526,remote,0,1
109527,evaluation,0,0
109528,using,0,0
109529,a,0,0
109530,digital,0,1
109531,observation,0,0
109532,camera,0,1
109533,in,0,0
109534,Arizona,0,0
109535,:,0,0
109536,the,0,0
109537,initial,0,0
109538,mayo,0,0
109539,clinic,0,0
109540,experience,0,0
109541,trial,0,0
109542,.,0,0
109543,BACKGROUND,0,0
109544,AND,0,0
109545,PURPOSE,0,0
109546,Telemedicine,0,1
109547,techniques,0,1
109548,can,0,0
109549,be,0,0
109550,used,0,0
109551,to,0,0
109552,address,0,0
109553,the,0,0
109554,rural-metropolitan,0,0
109555,disparity,0,0
109556,in,0,0
109557,acute,0,0
109558,stroke,0,0
109559,care,0,1
109560,.,0,0
109561,The,0,0
109562,Stroke,0,0
109563,Team,0,1
109564,Remote,0,1
109565,Evaluation,0,0
109566,Using,0,0
109567,a,0,0
109568,Digital,0,1
109569,Observation,0,1
109570,Camera,0,1
109571,(,0,0
109572,STRokE,0,1
109573,DOC,0,1
109574,),0,0
109575,trial,0,0
109576,reported,0,0
109577,more,0,0
109578,accurate,0,0
109579,decision,0,0
109580,making,0,0
109581,for,0,0
109582,telemedicine,1,1
109583,consultations,0,1
109584,compared,0,0
109585,with,0,0
109586,telephone-only,1,1
109587,and,0,0
109588,that,0,0
109589,the,0,0
109590,California-based,0,0
109591,research,0,0
109592,network,0,0
109593,facilitated,0,0
109594,a,0,0
109595,high,0,0
109596,rate,0,0
109597,of,0,0
109598,thrombolysis,0,1
109599,use,0,0
109600,",",0,0
109601,improved,0,0
109602,data,0,0
109603,collection,0,0
109604,",",0,0
109605,low,0,0
109606,risk,0,0
109607,of,0,0
109608,complications,0,0
109609,",",0,0
109610,low,0,0
109611,technical,0,0
109612,complications,0,0
109613,",",0,0
109614,and,0,0
109615,favorable,0,0
109616,assessment,0,0
109617,times,0,0
109618,.,0,0
109619,The,0,0
109620,main,0,0
109621,objective,0,0
109622,of,0,0
109623,the,0,0
109624,STRokE,0,0
109625,DOC,0,1
109626,Arizona,0,0
109627,TIME,0,1
109628,(,0,0
109629,The,0,0
109630,Initial,0,0
109631,Mayo,0,0
109632,Clinic,0,1
109633,Experience,0,0
109634,),0,0
109635,trial,0,0
109636,was,0,0
109637,to,0,0
109638,determine,0,0
109639,the,0,0
109640,feasibility,0,0
109641,of,0,0
109642,establishing,0,0
109643,",",0,0
109644,de,0,0
109645,novo,0,0
109646,",",0,0
109647,a,0,0
109648,single-hub,0,0
109649,",",0,0
109650,multirural,0,0
109651,spoke,0,0
109652,hospital,0,0
109653,telestroke,0,1
109654,research,0,0
109655,network,0,0
109656,across,0,0
109657,a,0,0
109658,large,0,0
109659,geographical,0,0
109660,area,0,0
109661,in,0,0
109662,Arizona,0,0
109663,by,0,0
109664,replicating,0,0
109665,the,0,0
109666,STRokE,0,1
109667,DOC,0,1
109668,protocol,0,0
109669,.,0,0
109670,METHODS,0,0
109671,Methods,0,0
109672,included,0,0
109673,prospective,0,0
109674,",",0,0
109675,single-hub,0,1
109676,",",0,0
109677,2-spoke,0,0
109678,",",0,0
109679,randomized,0,0
109680,",",0,0
109681,blinded,0,0
109682,",",0,0
109683,controlled,0,0
109684,trial,0,0
109685,of,0,0
109686,a,0,0
109687,2-way,0,0
109688,",",0,0
109689,site-independent,0,0
109690,",",0,0
109691,audiovisual,1,1
109692,telemedicine,1,1
109693,system,1,1
109694,designed,1,0
109695,for,1,0
109696,remote,1,1
109697,examination,1,0
109698,of,0,0
109699,adult,0,0
109700,patients,0,0
109701,with,0,0
109702,acute,0,0
109703,stroke,0,0
109704,versus,0,1
109705,telephone,1,1
109706,consultation,1,0
109707,to,1,0
109708,assess,1,0
109709,eligibility,1,0
109710,for,1,0
109711,treatment,1,0
109712,with,0,0
109713,intravenous,1,1
109714,thrombolysis,1,1
109715,.,1,0
109716,The,0,0
109717,primary,0,0
109718,outcome,0,0
109719,measure,0,0
109720,was,0,0
109721,whether,0,0
109722,the,0,0
109723,decision,0,0
109724,to,0,0
109725,give,0,0
109726,thrombolysis,0,1
109727,was,0,0
109728,correct,0,0
109729,.,0,0
109730,Secondary,0,0
109731,outcomes,0,0
109732,were,0,0
109733,rate,0,0
109734,of,0,0
109735,thrombolytic,0,1
109736,use,0,0
109737,",",0,0
109738,90-day,0,0
109739,functional,0,0
109740,outcomes,0,0
109741,",",0,0
109742,incidence,0,0
109743,of,0,0
109744,intracerebral,0,0
109745,hemorrhages,0,0
109746,",",0,0
109747,and,0,0
109748,technical,0,0
109749,observations,0,0
109750,.,0,0
109751,RESULTS,0,0
109752,From,0,0
109753,December,0,0
109754,2007,0,0
109755,to,0,0
109756,October,0,0
109757,2008,0,0
109758,",",0,0
109759,54,0,0
109760,patients,0,0
109761,were,0,0
109762,assessed,0,0
109763,",",0,0
109764,27,0,0
109765,of,0,0
109766,whom,0,0
109767,were,0,0
109768,randomized,0,0
109769,to,0,0
109770,each,0,0
109771,arm,0,0
109772,.,0,0
109773,Mean,0,0
109774,National,0,0
109775,Institutes,0,0
109776,of,0,0
109777,Health,0,0
109778,Stroke,0,1
109779,Scale,0,0
109780,score,0,0
109781,at,0,0
109782,presentation,0,0
109783,was,0,0
109784,7.3,0,0
109785,(,0,0
109786,SD,0,0
109787,6.2,0,0
109788,),0,0
109789,points,0,0
109790,.,0,0
109791,No,0,0
109792,consultations,0,0
109793,were,0,0
109794,aborted,0,0
109795,;,0,0
109796,however,0,0
109797,",",0,0
109798,technical,0,0
109799,problems,0,0
109800,(,0,0
109801,74,0,0
109802,%,0,0
109803,),0,0
109804,were,0,0
109805,prevalent,0,0
109806,in,0,0
109807,the,0,0
109808,telemedicine,0,1
109809,arm,0,0
109810,.,0,0
109811,Overall,0,0
109812,",",0,0
109813,the,0,0
109814,correct,0,0
109815,treatment,0,0
109816,decision,0,0
109817,was,0,0
109818,established,0,0
109819,in,0,0
109820,87,0,0
109821,%,0,0
109822,of,0,0
109823,the,0,0
109824,consultations,0,0
109825,.,0,0
109826,Both,0,0
109827,modalities,0,0
109828,",",0,0
109829,telephone,0,1
109830,(,0,0
109831,89,0,0
109832,%,0,0
109833,correct,0,0
109834,),0,0
109835,and,0,0
109836,telemedicine,0,1
109837,(,0,0
109838,85,0,0
109839,%,0,0
109840,correct,0,0
109841,),0,0
109842,",",0,0
109843,performed,0,0
109844,well,0,0
109845,.,0,0
109846,Intravenous,0,0
109847,thrombolytic,1,1
109848,treatment,1,0
109849,was,0,0
109850,used,0,0
109851,in,0,0
109852,30,0,0
109853,%,0,0
109854,of,0,0
109855,the,0,0
109856,telemedicine,0,1
109857,and,0,0
109858,telephone,0,1
109859,consultations,0,1
109860,.,0,0
109861,Good,0,0
109862,functional,0,0
109863,outcomes,0,0
109864,at,0,0
109865,90,0,0
109866,days,0,0
109867,were,0,0
109868,not,0,0
109869,significantly,0,0
109870,different,0,0
109871,.,0,0
109872,There,0,0
109873,were,0,0
109874,no,0,0
109875,statistically,0,0
109876,significant,0,0
109877,differences,0,0
109878,in,0,0
109879,mortality,0,0
109880,(,0,0
109881,4,0,0
109882,%,0,0
109883,in,0,0
109884,telemedicine,0,1
109885,and,0,0
109886,11,0,0
109887,%,0,0
109888,in,0,0
109889,telephone,0,1
109890,),0,0
109891,or,0,0
109892,rates,0,0
109893,of,0,0
109894,intracerebral,0,0
109895,hemorrhage,0,0
109896,(,0,0
109897,4,0,0
109898,%,0,0
109899,in,0,0
109900,telemedicine,0,1
109901,and,0,0
109902,0,0,0
109903,%,0,0
109904,in,0,0
109905,telephone,0,1
109906,),0,0
109907,.,0,0
109908,CONCLUSIONS,0,0
109909,It,0,0
109910,is,0,0
109911,feasible,0,0
109912,to,0,0
109913,extend,0,0
109914,the,0,0
109915,original,0,0
109916,STRokE,0,0
109917,DOC,0,1
109918,trial,0,0
109919,protocol,0,0
109920,to,0,0
109921,a,0,0
109922,new,0,0
109923,state,0,0
109924,and,0,0
109925,establish,0,0
109926,an,0,0
109927,operational,0,0
109928,single-hub,0,0
109929,",",0,0
109930,multispoke,0,0
109931,rural,0,0
109932,hospital,0,0
109933,telestroke,0,1
109934,research,0,0
109935,network,0,0
109936,in,0,0
109937,Arizona,0,0
109938,.,0,0
109939,The,0,0
109940,trial,0,0
109941,was,0,0
109942,not,0,0
109943,designed,0,0
109944,to,0,0
109945,have,0,0
109946,sufficient,0,0
109947,power,0,0
109948,to,0,0
109949,detect,0,0
109950,a,0,0
109951,difference,0,0
109952,between,0,0
109953,the,0,0
109954,2,0,0
109955,consultative,0,0
109956,modes,0,0
109957,:,0,0
109958,telemedicine,0,1
109959,and,0,0
109960,telephone-only,0,1
109961,.,0,0
109962,Whether,0,0
109963,by,0,0
109964,telemedicine,0,1
109965,or,0,1
109966,telephone,0,1
109967,consultative,0,0
109968,modalities,0,0
109969,",",0,0
109970,there,0,0
109971,were,0,0
109972,appropriate,0,0
109973,treatment,0,0
109974,decisions,0,0
109975,",",0,0
109976,high,0,0
109977,rates,0,0
109978,of,0,0
109979,thrombolysis,0,1
109980,use,0,0
109981,",",0,0
109982,improved,0,0
109983,data,0,0
109984,collection,0,0
109985,",",0,0
109986,low,0,0
109987,rates,0,0
109988,of,0,0
109989,intracerebral,0,0
109990,hemorrhage,0,0
109991,",",0,0
109992,and,0,0
109993,equally,0,0
109994,favorable,0,0
109995,time,0,0
109996,requirements,0,0
109997,.,0,0
109998,The,0,0
109999,learning,0,0
110000,curve,0,0
110001,was,0,0
110002,steep,0,0
110003,for,0,0
110004,the,0,0
110005,hub,0,1
110006,and,0,0
110007,spoke,0,0
110008,personnel,0,0
110009,of,0,0
110010,the,0,0
110011,new,0,0
110012,telestroke,0,1
110013,network,0,0
110014,",",0,0
110015,as,0,0
110016,reflected,0,0
110017,by,0,0
110018,frequent,0,0
110019,technical,0,0
110020,problems,0,0
110021,.,0,0
110022,Overall,0,0
110023,",",0,0
110024,the,0,0
110025,results,0,0
110026,support,0,0
110027,the,0,0
110028,effectiveness,0,0
110029,of,0,0
110030,highly,0,0
110031,organized,0,1
110032,and,0,0
110033,structured,0,1
110034,stroke,0,0
110035,telemedicine,0,1
110036,networks,0,1
110037,for,0,0
110038,extending,0,0
110039,expert,0,0
110040,stroke,0,0
110041,care,0,1
110042,into,0,0
110043,rural,0,0
110044,remote,0,1
110045,communities,0,0
110046,lacking,0,0
110047,sufficient,0,0
110048,neurological,0,0
110049,expertise,0,0
110050,.,0,0
110051,Beneficial,0,0
110052,effect,0,0
110053,of,0,0
110054,etidronate,1,1
110055,therapy,1,1
110056,in,0,0
110057,chronically,0,0
110058,hospitalized,0,0
110059,",",0,0
110060,disabled,0,0
110061,patients,0,0
110062,with,0,0
110063,stroke,0,0
110064,.,0,0
110065,Incidence,0,0
110066,of,0,0
110067,hip,0,0
110068,fractures,0,0
110069,is,0,0
110070,high,0,0
110071,in,0,0
110072,chronically,0,0
110073,hospitalized,0,0
110074,",",0,0
110075,disabled,0,0
110076,",",0,0
110077,elderly,0,0
110078,patients,0,0
110079,after,0,0
110080,stroke,0,0
110081,.,0,0
110082,Duration,0,0
110083,of,0,0
110084,hospitalization,0,0
110085,was,0,0
110086,more,0,0
110087,than,0,0
110088,1,0,0
110089,year,0,0
110090,because,0,0
110091,of,0,0
110092,insufficiency,0,0
110093,of,0,0
110094,nursing,0,0
110095,homes,0,1
110096,.,0,0
110097,Our,0,0
110098,study,0,0
110099,showed,0,0
110100,that,0,0
110101,immobilization-induced,0,0
110102,hypercalcemia,0,0
110103,and,0,0
110104,25-hydroxyvitamin,0,1
110105,D,0,1
110106,deficiency,0,0
110107,contribute,0,0
110108,to,0,0
110109,reduced,0,0
110110,bone,0,0
110111,mineral,0,0
110112,density,0,0
110113,(,0,0
110114,BMD,0,0
110115,),0,0
110116,.,0,0
110117,This,0,0
110118,study,0,0
110119,was,0,0
110120,designed,0,0
110121,to,0,0
110122,address,0,0
110123,the,0,0
110124,possibility,0,0
110125,that,0,0
110126,treatment,0,0
110127,with,0,0
110128,etidronate,1,1
110129,may,0,0
110130,reduce,0,0
110131,the,0,0
110132,bone,0,0
110133,resorption,0,0
110134,and,0,0
110135,lower,0,0
110136,the,0,0
110137,incidence,0,0
110138,of,0,0
110139,fractures,0,0
110140,in,0,0
110141,elderly,0,0
110142,patients,0,0
110143,who,0,0
110144,are,0,0
110145,chronically,0,0
110146,hospitalized,0,0
110147,and,0,0
110148,disabled,0,0
110149,as,0,0
110150,a,0,0
110151,result,0,0
110152,of,0,0
110153,hemiparesis,0,0
110154,after,0,0
110155,stroke,0,0
110156,.,0,0
110157,Patients,0,0
110158,with,0,0
110159,stroke,0,0
110160,were,0,0
110161,randomly,0,0
110162,assigned,0,0
110163,to,0,0
110164,daily,0,0
110165,treatment,0,0
110166,with,0,0
110167,400,0,0
110168,mg,0,0
110169,of,0,0
110170,etidronate,1,1
110171,(,0,0
110172,n,0,0
110173,=,0,0
110174,40,0,0
110175,),0,0
110176,or,0,0
110177,a,0,0
110178,placebo,1,1
110179,(,0,0
110180,n,0,0
110181,=,0,0
110182,40,0,0
110183,),0,0
110184,",",0,0
110185,and,0,0
110186,followed,0,0
110187,up,0,0
110188,for,0,0
110189,2,0,0
110190,years,0,0
110191,.,0,0
110192,At,0,0
110193,baseline,0,0
110194,",",0,0
110195,both,0,0
110196,groups,0,0
110197,had,0,0
110198,low,0,0
110199,BMD,0,0
110200,with,0,0
110201,high,0,0
110202,levels,0,0
110203,of,0,0
110204,serum,0,0
110205,ionized,0,1
110206,calcium,0,1
110207,and,0,0
110208,urinary,0,0
110209,deoxypyridinoline,0,0
110210,.,0,0
110211,In,0,0
110212,the,0,0
110213,etidronate,1,1
110214,group,0,0
110215,",",0,0
110216,serum,0,0
110217,calcium,0,1
110218,and,0,0
110219,urinary,0,0
110220,deoxypyridinoline,0,0
110221,levels,0,0
110222,decreased,0,0
110223,significantly,0,0
110224,during,0,0
110225,the,0,0
110226,study,0,0
110227,period,0,0
110228,",",0,0
110229,whereas,0,0
110230,the,0,0
110231,levels,0,0
110232,in,0,0
110233,the,0,0
110234,placebo,1,1
110235,group,0,0
110236,were,0,0
110237,increased,0,0
110238,.,0,0
110239,BMD,0,0
110240,on,0,0
110241,the,0,0
110242,hemiplegic,0,0
110243,side,0,0
110244,increased,0,0
110245,by,0,0
110246,1.4,0,0
110247,%,0,0
110248,in,0,0
110249,the,0,0
110250,etidronate,0,1
110251,group,0,0
110252,and,0,0
110253,decreased,0,0
110254,by,0,0
110255,2.2,0,0
110256,%,0,0
110257,in,0,0
110258,the,0,0
110259,placebo,0,1
110260,group,0,0
110261,(,0,0
110262,P,0,0
110263,<,0,0
110264,.001,0,0
110265,),0,0
110266,.,0,0
110267,Two,0,0
110268,patients,0,0
110269,sustained,0,0
110270,hip,0,0
110271,fractures,0,0
110272,in,0,0
110273,the,0,0
110274,placebo,1,1
110275,group,0,0
110276,",",0,0
110277,and,0,0
110278,no,0,0
110279,hip,0,0
110280,fracture,0,0
110281,occurred,0,0
110282,in,0,0
110283,the,0,0
110284,etidronate,1,1
110285,group,0,0
110286,.,0,0
110287,Treatment,0,0
110288,with,0,0
110289,etidronate,1,1
110290,increases,0,0
110291,BMD,0,0
110292,in,0,0
110293,chronically,0,0
110294,hospitalized,0,0
110295,patients,0,0
110296,poststroke,0,0
110297,",",0,0
110298,and,0,0
110299,may,0,0
110300,prevent,0,0
110301,hip,0,0
110302,fracture,0,0
110303,.,0,0
110304,Response,0,0
110305,to,0,0
110306,familiar,1,0
110307,faces,1,0
110308,",",1,0
110309,newly,1,0
110310,familiar,1,0
110311,faces,1,0
110312,",",0,0
110313,and,0,0
110314,novel,1,0
110315,faces,1,0
110316,as,0,0
110317,assessed,0,0
110318,by,0,0
110319,ERPs,0,1
110320,is,0,0
110321,intact,0,0
110322,in,0,0
110323,adults,0,0
110324,with,0,0
110325,autism,0,0
110326,spectrum,0,0
110327,disorders,0,0
110328,.,0,0
110329,Individuals,0,0
110330,with,0,0
110331,autism,0,0
110332,spectrum,0,0
110333,disorders,0,0
110334,(,0,0
110335,ASD,0,0
110336,),0,0
110337,have,0,0
110338,pervasive,0,0
110339,impairments,0,0
110340,in,0,0
110341,social,0,0
110342,functioning,0,0
110343,",",0,0
110344,which,0,0
110345,may,0,0
110346,include,0,0
110347,problems,0,0
110348,with,0,0
110349,processing,0,0
110350,and,0,0
110351,remembering,0,0
110352,faces,0,0
110353,.,0,0
110354,In,0,0
110355,this,0,0
110356,study,0,0
110357,",",0,0
110358,we,0,0
110359,examined,0,0
110360,whether,0,0
110361,posterior,0,1
110362,ERP,0,1
110363,components,0,0
110364,associated,0,0
110365,with,0,0
110366,identity,0,0
110367,processing,0,1
110368,(,0,0
110369,P2,0,1
110370,",",0,0
110371,N250,0,1
110372,and,0,0
110373,face-N400,0,1
110374,),0,0
110375,and,0,0
110376,components,0,0
110377,associated,0,0
110378,with,0,0
110379,early-stage,0,0
110380,face,0,0
110381,processing,0,1
110382,(,0,0
110383,P1,0,0
110384,and,0,0
110385,N170,0,0
110386,),0,0
110387,are,0,0
110388,atypical,0,0
110389,in,0,0
110390,ASD,0,0
110391,.,0,0
110392,We,0,0
110393,collected,0,0
110394,ERP,1,0
110395,responses,1,0
110396,to,0,0
110397,a,0,0
110398,familiar,1,1
110399,repeated,1,0
110400,face,1,0
110401,(,1,0
110402,Familiar,1,1
110403,),1,0
110404,",",0,0
110405,an,0,0
110406,unfamiliar,1,0
110407,repeated,1,0
110408,face,1,0
110409,(,1,0
110410,Other,1,0
110411,),1,0
110412,and,0,0
110413,novel,1,1
110414,faces,1,1
110415,(,1,0
110416,Novels,1,0
110417,),1,0
110418,in,0,0
110419,29,0,0
110420,high-functioning,0,0
110421,adults,0,0
110422,with,0,0
110423,ASD,0,0
110424,and,0,0
110425,matched,0,0
110426,controls,0,0
110427,.,0,0
110428,For,0,0
110429,both,0,0
110430,groups,0,0
110431,",",0,0
110432,the,0,0
110433,P2,0,1
110434,and,0,0
110435,N250,0,1
110436,were,0,0
110437,sensitive,0,0
110438,to,0,0
110439,repetition,0,1
110440,(,0,0
110441,Other,0,0
110442,vs.,0,0
110443,Novels,0,1
110444,),0,0
110445,and,0,0
110446,personal,0,1
110447,familiarity,0,1
110448,(,0,0
110449,Familiar,0,1
110450,vs.,0,0
110451,Other,0,0
110452,),0,0
110453,",",0,0
110454,and,0,0
110455,the,0,0
110456,face-N400,0,0
110457,was,0,0
110458,sensitive,0,0
110459,to,0,0
110460,repetition,0,0
110461,.,0,0
110462,Adults,0,0
110463,with,0,0
110464,ASD,0,0
110465,did,0,0
110466,not,0,0
110467,show,0,0
110468,significantly,0,0
110469,atypical,0,0
110470,processing,0,0
110471,of,0,0
110472,facial,0,0
110473,familiarity,0,0
110474,and,0,0
110475,repetition,0,1
110476,in,0,0
110477,an,0,0
110478,ERP,0,1
110479,paradigm,0,0
110480,",",0,0
110481,despite,0,0
110482,showing,0,0
110483,significantly,0,0
110484,poorer,0,0
110485,performance,0,0
110486,than,0,0
110487,controls,0,0
110488,on,0,0
110489,a,0,0
110490,behavioral,0,0
110491,test,0,0
110492,of,0,0
110493,face,0,0
110494,memory,0,0
110495,.,0,0
110496,This,0,0
110497,study,0,0
110498,found,0,0
110499,no,0,0
110500,evidence,0,0
110501,that,0,0
110502,early-stage,0,0
110503,facial,0,0
110504,identity,0,0
110505,processing,0,1
110506,is,0,0
110507,a,0,0
110508,primary,0,0
110509,contributor,0,0
110510,to,0,0
110511,the,0,0
110512,face,0,0
110513,recognition,0,0
110514,deficit,0,0
110515,in,0,0
110516,high-functioning,0,0
110517,ASD,0,0
110518,.,0,0
110519,Learning,0,0
110520,about,0,0
110521,the,0,0
110522,equal,0,0
110523,sign,0,0
110524,:,0,0
110525,does,0,0
110526,comparing,0,0
110527,with,0,0
110528,inequality,0,0
110529,symbols,0,1
110530,help,0,0
110531,?,0,0
110532,This,1,0
110533,study,1,0
110534,investigated,1,0
110535,whether,1,0
110536,instruction,1,1
110537,that,1,0
110538,involves,1,0
110539,comparing,1,0
110540,the,1,0
110541,equal,1,0
110542,sign,1,0
110543,with,1,0
110544,other,1,0
110545,relational,1,0
110546,symbols,1,1
110547,is,1,0
110548,more,1,0
110549,effective,1,0
110550,at,1,0
110551,imparting,1,0
110552,a,1,0
110553,relational,1,0
110554,interpretation,1,0
110555,of,1,0
110556,the,1,0
110557,equal,1,0
110558,sign,1,0
110559,than,1,0
110560,instruction,1,1
110561,about,1,0
110562,the,1,0
110563,equal,1,0
110564,sign,1,0
110565,alone,1,1
110566,.,1,0
110567,Third-,1,0
110568,and,1,0
110569,fourth-grade,1,0
110570,students,1,0
110571,in,1,0
110572,a,1,0
110573,comparing,1,0
110574,symbols,1,1
110575,group,1,0
110576,learned,1,0
110577,about,1,0
110578,the,1,0
110579,greater,1,0
110580,than,1,0
110581,",",1,0
110582,less,1,0
110583,than,1,0
110584,",",1,0
110585,and,1,0
110586,equal,1,0
110587,signs,1,0
110588,and,1,0
110589,had,1,0
110590,the,1,0
110591,opportunity,1,0
110592,to,1,0
110593,compare,1,0
110594,the,1,0
110595,inequality,1,0
110596,symbols,1,1
110597,with,1,0
110598,the,1,0
110599,equal,1,0
110600,sign,1,0
110601,.,1,0
110602,Students,1,0
110603,in,1,0
110604,an,1,0
110605,equal,1,0
110606,sign,1,0
110607,group,1,0
110608,learned,1,0
110609,about,1,0
110610,the,1,0
110611,equal,1,0
110612,sign,1,0
110613,only,1,0
110614,.,1,0
110615,A,1,0
110616,third,1,0
110617,group,1,0
110618,of,1,0
110619,students,1,0
110620,served,1,0
110621,as,1,0
110622,a,1,0
110623,control,1,0
110624,group,1,0
110625,.,1,0
110626,Three,0,0
110627,aspects,0,0
110628,of,0,0
110629,students,0,0
110630,',0,0
110631,knowledge,0,0
110632,were,0,0
110633,assessed,0,0
110634,before,0,0
110635,and,0,0
110636,after,0,0
110637,the,0,0
110638,lesson,0,0
110639,:,0,0
110640,(,0,0
110641,a,0,0
110642,),0,0
110643,conceptual,0,0
110644,understanding,0,0
110645,of,0,0
110646,the,0,0
110647,equal,0,0
110648,sign,0,0
110649,",",0,0
110650,(,0,0
110651,b,0,0
110652,),0,1
110653,equation,0,1
110654,encoding,0,1
110655,",",0,0
110656,and,0,0
110657,(,0,0
110658,c,0,1
110659,),0,1
110660,problem,0,0
110661,solving,0,0
110662,.,0,0
110663,Students,0,0
110664,in,0,0
110665,the,0,0
110666,comparing,0,0
110667,symbols,0,1
110668,group,0,0
110669,showed,0,0
110670,greater,0,0
110671,gains,0,0
110672,in,0,0
110673,conceptual,0,0
110674,understanding,0,0
110675,from,0,0
110676,pretest,0,0
110677,to,0,0
110678,posttest,0,0
110679,than,0,0
110680,students,0,0
110681,in,0,0
110682,the,0,0
110683,other,0,0
110684,two,0,0
110685,groups,0,0
110686,",",0,0
110687,and,0,0
110688,students,0,0
110689,in,0,0
110690,the,0,0
110691,comparing,0,0
110692,symbols,0,1
110693,group,0,0
110694,also,0,0
110695,scored,0,0
110696,higher,0,0
110697,on,0,0
110698,a,0,0
110699,posttest,0,0
110700,that,0,0
110701,assessed,0,0
110702,knowledge,0,0
110703,about,0,0
110704,inequality,0,0
110705,symbols,0,1
110706,and,0,0
110707,inequality,0,0
110708,problem,0,0
110709,solving,0,0
110710,.,0,0
110711,Thus,0,0
110712,",",0,0
110713,they,0,0
110714,learned,0,0
110715,about,0,0
110716,three,0,0
110717,symbols,0,0
110718,in,0,0
110719,the,0,0
110720,same,0,0
110721,amount,0,0
110722,of,0,0
110723,time,0,0
110724,as,0,0
110725,other,0,0
110726,students,0,0
110727,learned,0,0
110728,about,0,0
110729,the,0,0
110730,equal,0,0
110731,sign,0,0
110732,alone,0,1
110733,or,0,0
110734,not,0,0
110735,at,0,0
110736,all,0,0
110737,.,0,0
110738,Therefore,0,0
110739,",",0,0
110740,an,0,0
110741,instructional,0,1
110742,approach,0,1
110743,involving,0,0
110744,comparison,0,0
110745,can,0,0
110746,be,0,0
110747,an,0,0
110748,effective,0,0
110749,tool,0,0
110750,for,0,0
110751,learning,0,0
110752,about,0,0
110753,concepts,0,0
110754,in,0,0
110755,mathematics,0,0
110756,.,0,0
110757,Influence,0,0
110758,of,0,0
110759,bony,0,0
110760,defects,0,0
110761,on,0,0
110762,implant,0,1
110763,stability,0,0
110764,.,0,0
110765,INTRODUCTION,0,0
110766,The,0,0
110767,purpose,0,0
110768,of,0,0
110769,this,0,0
110770,study,0,0
110771,was,0,0
110772,to,0,0
110773,analyze,0,0
110774,the,0,0
110775,evolution,0,0
110776,of,0,0
110777,implant,0,1
110778,mechanical,0,0
110779,stability,0,0
110780,in,0,0
110781,different,0,0
110782,types/sizes,0,0
110783,of,0,0
110784,bony,0,0
110785,defects,0,0
110786,using,0,0
110787,both,0,0
110788,Periotest,1,1
110789,and,0,0
110790,Osstell,1,1
110791,devices,0,1
110792,as,0,0
110793,objective,0,0
110794,tools,0,0
110795,.,0,0
110796,MATERIALS,0,0
110797,AND,0,0
110798,METHODS,0,0
110799,Thirty-two,0,0
110800,implants,0,1
110801,were,0,0
110802,randomly,0,0
110803,allocated,0,0
110804,to,0,0
110805,one,0,0
110806,of,0,0
110807,the,0,0
110808,four,0,0
110809,types,0,0
110810,of,0,0
110811,bone,0,0
110812,defects,0,0
110813,:,0,0
110814,marginal,0,0
110815,bone,0,0
110816,loss,0,0
110817,",",0,0
110818,peri-apical,0,0
110819,bone,0,0
110820,defect,0,0
110821,",",0,0
110822,constant,0,0
110823,width,0,0
110824,dehiscence,0,0
110825,and,0,0
110826,constant,0,0
110827,length,0,0
110828,dehiscences,0,0
110829,.,0,0
110830,Periotest/Osstell,0,0
110831,measurements,0,0
110832,were,0,0
110833,completed,0,0
110834,before,0,0
110835,and,0,0
110836,during,0,0
110837,staged,0,1
110838,bone,0,0
110839,removal,0,1
110840,(,0,0
110841,to,0,0
110842,enlarge,0,0
110843,defect,0,0
110844,size,0,0
110845,),0,0
110846,.,0,0
110847,RESULTS,0,0
110848,Significant,0,0
110849,differences,0,0
110850,(,0,0
110851,P,0,0
110852,<,0,0
110853,0.05,0,0
110854,),0,0
110855,with,0,0
110856,initial,0,0
110857,values,0,0
110858,were,0,0
110859,found,0,0
110860,after,0,0
110861,a,0,0
110862,2,0,0
110863,mm,0,0
110864,marginal,0,0
110865,bone,0,1
110866,removal,0,1
110867,(,0,0
110868,Osstell/Periotest,0,1
110869,),0,0
110870,;,0,0
110871,for,0,0
110872,a,0,0
110873,peri-apical,0,0
110874,bone,0,0
110875,lesion,0,0
110876,",",0,0
110877,after,0,0
110878,removal,0,0
110879,of,0,0
110880,5,0,0
110881,mm,0,0
110882,(,1,0
110883,Osstell,1,1
110884,),1,0
110885,or,0,1
110886,8,0,0
110887,mm,0,0
110888,(,1,0
110889,Periotest,1,1
110890,),1,0
110891,;,1,0
110892,for,0,0
110893,a,0,0
110894,6-mm-long,0,1
110895,dehiscence,0,0
110896,",",0,0
110897,after,0,0
110898,removal,0,0
110899,up,0,0
110900,to,0,0
110901,180,0,0
110902,degrees,0,0
110903,of,0,0
110904,the,0,0
110905,implant,0,1
110906,perimeter,0,0
110907,(,0,0
110908,Osstell/Periotest,0,1
110909,),0,0
110910,;,0,0
110911,for,0,0
110912,a,0,0
110913,3-mm-wide,0,1
110914,dehiscence,0,0
110915,",",0,0
110916,after,0,0
110917,removal,0,0
110918,of,0,0
110919,10,0,0
110920,mm,0,0
110921,(,0,0
110922,Osstell,0,1
110923,),0,0
110924,or,0,1
110925,6,0,0
110926,mm,0,0
110927,(,0,0
110928,Periotest,0,1
110929,),0,0
110930,.,0,0
110931,CONCLUSION,0,0
110932,Periotest,1,0
110933,and,0,0
110934,Osstell,1,1
110935,are,0,0
110936,in,0,0
110937,general,0,0
110938,not,0,0
110939,very,0,0
110940,sensitive,0,0
110941,in,0,0
110942,the,0,0
110943,identification,0,0
110944,of,0,0
110945,peri-implant,0,0
110946,bone,0,0
110947,destruction,0,0
110948,",",0,0
110949,except,0,0
110950,for,0,0
110951,marginal,0,0
110952,bone,0,0
110953,loss,0,0
110954,.,0,0
110955,Effects,0,0
110956,of,0,0
110957,a,0,0
110958,leisure,1,0
110959,programme,1,1
110960,on,0,0
110961,quality,0,0
110962,of,0,0
110963,life,0,0
110964,and,0,0
110965,stress,0,0
110966,of,0,0
110967,individuals,0,0
110968,with,0,0
110969,ASD,0,0
110970,.,0,0
110971,BACKGROUND,0,0
110972,Even,0,1
110973,though,0,0
110974,there,0,0
110975,is,0,0
110976,research,0,0
110977,demonstrating,0,0
110978,a,0,0
110979,positive,0,0
110980,relationship,0,0
110981,between,0,0
110982,leisure,0,0
110983,participation,0,0
110984,and,0,0
110985,the,0,0
110986,two,0,0
110987,constructs,0,0
110988,of,0,0
110989,quality,0,0
110990,of,0,0
110991,life,0,0
110992,and,0,0
110993,stress,0,0
110994,reduction,0,0
110995,",",0,0
110996,current,0,0
110997,conceptualisation,0,0
110998,of,0,0
110999,leisure,0,0
111000,as,0,0
111001,a,0,0
111002,contributor,0,0
111003,to,0,0
111004,quality,0,0
111005,of,0,0
111006,life,0,0
111007,is,0,0
111008,limited,0,0
111009,.,0,0
111010,In,0,0
111011,addition,0,0
111012,",",0,0
111013,in,0,0
111014,spite,0,0
111015,of,0,0
111016,improvements,0,0
111017,in,0,0
111018,accurate,0,0
111019,diagnosis,0,0
111020,of,0,0
111021,autism,0,0
111022,spectrum,0,0
111023,disorder,0,0
111024,(,0,0
111025,ASD,0,0
111026,),0,0
111027,at,0,0
111028,increasingly,0,0
111029,earlier,0,0
111030,ages,0,0
111031,and,0,0
111032,proliferation,0,0
111033,of,0,0
111034,interventions,0,0
111035,",",0,0
111036,research,0,0
111037,associated,0,0
111038,with,0,0
111039,leisure,0,0
111040,and,0,0
111041,quality,0,0
111042,of,0,0
111043,life,0,0
111044,for,0,0
111045,people,0,0
111046,with,0,0
111047,ASD,0,0
111048,is,0,0
111049,lacking,0,0
111050,.,0,0
111051,METHODS,0,0
111052,Therefore,0,0
111053,",",0,0
111054,a,0,0
111055,study,0,0
111056,using,0,0
111057,a,0,0
111058,repeated,0,0
111059,measures,0,0
111060,design,0,0
111061,was,0,0
111062,used,0,0
111063,to,0,0
111064,measure,0,0
111065,effects,0,0
111066,of,0,0
111067,a,0,0
111068,1-year,1,0
111069,group,1,0
111070,leisure,1,0
111071,programme,1,1
111072,intended,0,0
111073,to,0,0
111074,facilitate,0,0
111075,interaction,1,0
111076,with,1,0
111077,media,1,1
111078,",",1,0
111079,engagement,1,0
111080,in,1,0
111081,exercise,1,1
111082,",",1,0
111083,playing,1,0
111084,games,1,1
111085,and,1,0
111086,doing,1,0
111087,crafts,1,1
111088,",",1,0
111089,attending,1,0
111090,events,1,0
111091,",",1,0
111092,and,1,0
111093,participating,1,0
111094,in,1,0
111095,other,1,0
111096,recreation,1,0
111097,activities,1,0
111098,on,0,0
111099,quality,0,0
111100,of,0,0
111101,life,0,0
111102,and,0,0
111103,stress,0,0
111104,of,0,0
111105,37,0,0
111106,participants,0,0
111107,(,0,0
111108,22,0,0
111109,male,0,0
111110,",",0,0
111111,15,0,0
111112,female,0,0
111113,),0,0
111114,",",0,0
111115,ages,0,0
111116,17-39,0,0
111117,(,0,0
111118,M,0,0
111119,=,0,0
111120,31.49,0,0
111121,),0,0
111122,years,0,0
111123,at,0,0
111124,the,0,0
111125,beginning,0,0
111126,of,0,0
111127,the,0,0
111128,programme,0,1
111129,),0,0
111130,diagnosed,0,0
111131,with,0,0
111132,an,0,0
111133,ASD,0,0
111134,and,0,0
111135,a,0,0
111136,group,0,0
111137,of,0,0
111138,34,0,0
111139,adults,0,0
111140,with,0,0
111141,ASD,0,0
111142,as,0,0
111143,control,1,1
111144,group,1,0
111145,(,1,0
111146,waiting,1,0
111147,list,1,1
111148,),1,1
111149,(,0,0
111150,19,0,0
111151,male,0,0
111152,",",0,0
111153,15,0,0
111154,female,0,0
111155,),0,0
111156,",",0,0
111157,ages,0,0
111158,24-38,0,0
111159,(,0,0
111160,M,0,0
111161,=,0,0
111162,30,0,0
111163,at,0,0
111164,programme,0,1
111165,initiation,0,0
111166,),0,0
111167,years,0,0
111168,.,0,0
111169,RESULTS,0,0
111170,There,0,0
111171,was,0,0
111172,a,0,0
111173,significant,0,0
111174,decrease,0,0
111175,in,0,0
111176,overall,0,0
111177,scores,0,0
111178,of,0,0
111179,stress,0,0
111180,levels,0,0
111181,for,0,0
111182,participants,0,0
111183,over,0,0
111184,the,0,0
111185,course,0,0
111186,of,0,0
111187,the,0,0
111188,study,0,0
111189,and,0,0
111190,there,0,0
111191,was,0,0
111192,a,0,0
111193,significant,0,0
111194,increase,0,0
111195,in,0,0
111196,the,0,0
111197,four,0,0
111198,factors,0,0
111199,of,0,0
111200,quality,0,0
111201,of,0,0
111202,life,0,0
111203,that,0,0
111204,were,0,0
111205,measured,0,0
111206,(,0,0
111207,satisfaction,0,0
111208,",",0,0
111209,independence,0,0
111210,",",0,0
111211,competence,0,0
111212,and,0,0
111213,social,0,1
111214,interaction,0,0
111215,),0,0
111216,as,0,0
111217,well,0,0
111218,as,0,0
111219,the,0,0
111220,total,0,0
111221,score,0,0
111222,for,0,0
111223,quality,0,0
111224,of,0,0
111225,life,0,0
111226,from,0,0
111227,baseline,0,0
111228,to,0,0
111229,the,0,0
111230,end,0,0
111231,of,0,0
111232,the,0,0
111233,intervention,0,1
111234,12,0,0
111235,months,0,0
111236,later,0,0
111237,.,0,0
111238,In,0,0
111239,contrast,0,0
111240,",",0,0
111241,the,0,0
111242,control,0,0
111243,group,0,0
111244,demonstrated,0,0
111245,no,0,0
111246,significant,0,0
111247,improvements,0,0
111248,related,0,0
111249,to,0,0
111250,stress,0,0
111251,or,0,1
111252,quality,0,0
111253,of,0,0
111254,life,0,0
111255,.,0,0
111256,Implications,0,0
111257,of,0,0
111258,these,0,0
111259,findings,0,0
111260,to,0,0
111261,leisure,0,0
111262,services,0,0
111263,and,0,0
111264,the,0,0
111265,quality,0,0
111266,of,0,0
111267,life,0,0
111268,of,0,0
111269,individuals,0,0
111270,with,0,0
111271,ASD,0,0
111272,are,0,0
111273,discussed,0,0
111274,.,0,0
111275,CONCLUSION,0,0
111276,Findings,0,0
111277,support,0,0
111278,the,0,0
111279,contention,0,0
111280,that,0,0
111281,participation,0,0
111282,in,0,0
111283,recreation,0,0
111284,activities,0,0
111285,positively,0,0
111286,influenced,0,0
111287,the,0,0
111288,stress,0,0
111289,and,0,0
111290,quality,0,0
111291,of,0,0
111292,life,0,0
111293,of,0,0
111294,adults,0,0
111295,with,0,0
111296,ASD,0,0
111297,.,0,0
111298,Magnocellular,1,0
111299,visual,1,0
111300,evoked,0,0
111301,potential,0,0
111302,delay,0,0
111303,with,0,0
111304,high,0,0
111305,autism,0,0
111306,spectrum,0,0
111307,quotient,0,0
111308,yields,0,0
111309,a,0,0
111310,neural,0,0
111311,mechanism,0,0
111312,for,0,0
111313,altered,0,0
111314,perception,0,0
111315,.,0,0
111316,Everyone,0,0
111317,has,0,0
111318,autistic,0,0
111319,characteristics,0,0
111320,to,0,0
111321,a,0,0
111322,greater,0,0
111323,or,0,0
111324,lesser,0,0
111325,degree,0,0
111326,",",0,0
111327,encapsulated,0,0
111328,in,0,0
111329,the,0,0
111330,Autism,0,0
111331,Spectrum,0,1
111332,Quotient,0,1
111333,",",0,0
111334,a,0,0
111335,scale,0,0
111336,that,0,0
111337,measures,0,0
111338,the,0,0
111339,degree,0,0
111340,to,0,0
111341,which,0,0
111342,an,0,0
111343,adult,0,0
111344,of,0,0
111345,normal,0,0
111346,intelligence,0,0
111347,displays,0,0
111348,traits,0,0
111349,associated,0,0
111350,with,0,0
111351,autism,0,0
111352,spectrum,0,0
111353,disorders,0,0
111354,.,0,0
111355,Recent,0,0
111356,psychophysical,0,0
111357,analyses,0,0
111358,of,0,0
111359,autism,0,0
111360,spectrum,0,0
111361,disorders,0,0
111362,point,0,0
111363,to,0,0
111364,superior,0,0
111365,local,0,0
111366,processing,0,0
111367,",",0,0
111368,and,0,0
111369,impaired,0,0
111370,or,0,1
111371,ignored,0,0
111372,global,0,0
111373,and,0,0
111374,contextual,0,0
111375,processing,0,0
111376,.,0,0
111377,The,0,0
111378,aim,0,0
111379,of,0,0
111380,this,0,0
111381,study,0,0
111382,was,0,0
111383,to,0,0
111384,test,0,0
111385,whether,0,0
111386,low-,1,1
111387,and,0,0
111388,high-scoring,1,0
111389,individuals,1,0
111390,on,1,0
111391,the,1,0
111392,Autism,1,0
111393,Spectrum,1,1
111394,Quotient,1,1
111395,differ,0,0
111396,on,0,0
111397,a,0,0
111398,measure,0,0
111399,of,0,0
111400,local,1,0
111401,and,1,0
111402,global,1,0
111403,processing,1,1
111404,",",1,0
111405,motion,1,0
111406,processing,1,1
111407,and,1,0
111408,visual,1,0
111409,pathway,1,0
111410,integrity,1,0
111411,.,1,0
111412,Fifteen,0,0
111413,low-scoring,0,0
111414,individuals,0,0
111415,and,0,0
111416,14,0,0
111417,high-scoring,0,0
111418,individuals,0,0
111419,derived,0,0
111420,from,0,0
111421,a,0,0
111422,normal,0,0
111423,population,0,0
111424,participated,0,0
111425,in,0,0
111426,the,0,0
111427,study,0,0
111428,.,0,0
111429,The,0,0
111430,results,0,0
111431,indicate,0,0
111432,that,0,0
111433,the,0,0
111434,initial,0,0
111435,cortical,0,0
111436,response,0,0
111437,to,0,0
111438,the,0,0
111439,magnocellular,0,0
111440,afferents,0,0
111441,is,0,0
111442,weaker,0,0
111443,at,0,0
111444,low,0,0
111445,contrast,0,0
111446,in,0,0
111447,the,0,0
111448,high,0,0
111449,autistic,0,0
111450,tendency,0,0
111451,group,0,0
111452,and,0,0
111453,that,0,0
111454,a,0,0
111455,second-order,0,0
111456,response,0,0
111457,",",0,0
111458,reflecting,0,0
111459,magnocellular,0,0
111460,activity,0,0
111461,",",0,0
111462,demonstrated,0,0
111463,a,0,0
111464,delay,0,0
111465,for,0,0
111466,high,0,0
111467,versus,0,0
111468,low,0,0
111469,scorers,0,0
111470,when,0,0
111471,the,0,0
111472,parvocellular,0,0
111473,pathway,0,0
111474,was,0,0
111475,also,0,0
111476,active,0,0
111477,in,0,0
111478,response,0,0
111479,to,0,0
111480,a,0,0
111481,high,0,0
111482,contrast,0,0
111483,stimulus,0,0
111484,.,0,0
111485,High-scoring,0,0
111486,individuals,0,0
111487,also,0,0
111488,demonstrated,0,0
111489,difficulty,0,0
111490,in,0,0
111491,identifying,0,0
111492,the,0,0
111493,global,0,0
111494,components,0,0
111495,of,0,0
111496,locally,0,0
111497,salient,0,0
111498,hierarchical,0,0
111499,Navon,0,1
111500,figures,0,0
111501,.,0,0
111502,Furthermore,0,0
111503,",",0,0
111504,cross-validated,0,0
111505,discriminant,0,0
111506,analysis,0,0
111507,",",0,0
111508,using,0,0
111509,four,0,0
111510,physiologically,0,0
111511,and,0,0
111512,three,0,0
111513,psychophysically,0,0
111514,derived,0,0
111515,parameters,0,0
111516,",",0,0
111517,correctly,0,0
111518,classified,0,0
111519,83,0,0
111520,%,0,0
111521,of,0,0
111522,individuals,0,0
111523,who,0,0
111524,scored,0,0
111525,either,0,0
111526,high,0,0
111527,or,0,1
111528,low,0,0
111529,on,0,0
111530,the,0,0
111531,Autism,0,0
111532,Spectrum,0,1
111533,Quotient,0,1
111534,.,0,0
111535,These,0,0
111536,findings,0,0
111537,in,0,0
111538,the,0,0
111539,group,0,0
111540,scoring,0,0
111541,high,0,0
111542,on,0,0
111543,the,0,0
111544,Autism,0,0
111545,Spectrum,0,1
111546,Quotient,0,1
111547,indicate,0,0
111548,that,0,0
111549,a,0,0
111550,delay,0,0
111551,in,0,0
111552,primary,0,0
111553,visual/prestriate,0,1
111554,cortical,0,0
111555,processing,0,0
111556,of,0,0
111557,magnocellular,0,0
111558,input,0,0
111559,diminishes,0,0
111560,the,0,0
111561,advantage,0,0
111562,of,0,0
111563,its,0,0
111564,early,0,0
111565,arrival,0,0
111566,to,0,0
111567,primary,0,0
111568,visual,0,0
111569,cortex,0,0
111570,.,0,0
111571,This,0,0
111572,appears,0,0
111573,to,0,0
111574,be,0,0
111575,associated,0,0
111576,with,0,0
111577,impaired,0,0
111578,global,0,0
111579,visual,0,0
111580,perception,0,0
111581,",",0,0
111582,predicting,0,0
111583,with,0,0
111584,high,0,0
111585,accuracy,0,0
111586,behavioural,0,0
111587,tendencies,0,0
111588,associated,0,0
111589,with,0,0
111590,autism,0,0
111591,spectrum,0,0
111592,disorders,0,0
111593,.,0,0
111594,It,0,0
111595,has,0,0
111596,been,0,0
111597,proposed,0,0
111598,that,0,0
111599,perceptual,0,1
111600,impairment,0,0
111601,in,0,0
111602,autism,0,0
111603,may,0,0
111604,be,0,0
111605,attributed,0,0
111606,to,0,0
111607,a,0,0
111608,dysfunction,0,0
111609,of,0,0
111610,horizontal,0,0
111611,connections,0,0
111612,within,0,0
111613,early,0,0
111614,visual,0,0
111615,areas,0,0
111616,",",0,0
111617,presumably,0,0
111618,parvocellular,0,0
111619,in,0,0
111620,nature,0,0
111621,.,0,0
111622,However,0,0
111623,",",0,0
111624,the,0,0
111625,timing,0,0
111626,of,0,0
111627,such,0,0
111628,form,0,0
111629,processing,0,0
111630,aberrations,0,0
111631,is,0,0
111632,much,0,0
111633,later,0,0
111634,than,0,0
111635,the,0,0
111636,timing,0,0
111637,of,0,0
111638,abnormal,0,0
111639,magnocellular,0,0
111640,visual,0,0
111641,processing,0,0
111642,measured,0,0
111643,directly,0,0
111644,here,0,0
111645,.,0,0
111646,Thus,0,0
111647,it,0,0
111648,is,0,0
111649,proposed,0,0
111650,that,0,0
111651,a,0,0
111652,magnocellular,0,0
111653,processing,0,0
111654,delay,0,0
111655,decreases,0,0
111656,the,0,0
111657,ability,0,0
111658,of,0,0
111659,autistic,0,0
111660,individuals,0,0
111661,to,0,0
111662,benefit,0,0
111663,perceptually,0,1
111664,from,0,0
111665,feedback,0,1
111666,normally,0,0
111667,associated,0,0
111668,with,0,0
111669,the,0,0
111670,magnocellular,0,0
111671,advantage,0,0
111672,.,0,0
111673,Ventilator-delivered,1,1
111674,mask,1,1
111675,ventilation,1,1
111676,compared,1,0
111677,with,1,0
111678,three,1,0
111679,standard,1,0
111680,methods,1,0
111681,of,1,0
111682,mask,1,0
111683,ventilation,1,1
111684,in,0,0
111685,a,0,0
111686,manikin,0,1
111687,model,0,0
111688,.,0,0
111689,BACKGROUND,0,0
111690,Little,0,0
111691,is,0,0
111692,known,0,0
111693,regarding,0,0
111694,the,0,0
111695,variations,0,0
111696,in,0,0
111697,effective,0,0
111698,ventilation,0,1
111699,during,0,0
111700,bag,1,1
111701,and,1,0
111702,mask,1,1
111703,resuscitation,1,1
111704,with,0,0
111705,standard,0,1
111706,methods,0,0
111707,compared,0,0
111708,with,0,0
111709,that,0,0
111710,delivered,0,0
111711,by,0,0
111712,ventilator-delivered,1,1
111713,mask,1,1
111714,ventilation,1,1
111715,(,1,0
111716,VDMV,1,1
111717,),1,0
111718,.,1,0
111719,AIM,0,0
111720,To,0,0
111721,measure,0,0
111722,the,0,0
111723,variations,0,0
111724,in,0,0
111725,delivered,0,1
111726,airway,0,0
111727,pressure,0,0
111728,",",0,0
111729,tidal,0,0
111730,volume,0,0
111731,(,0,0
111732,TV,0,0
111733,),0,0
111734,",",0,0
111735,minute,0,0
111736,ventilation,0,1
111737,(,0,0
111738,MV,0,0
111739,),0,1
111740,and,0,0
111741,inspiratory,0,0
111742,time,0,0
111743,during,0,0
111744,a,0,0
111745,3-min,0,1
111746,period,0,0
111747,of,0,0
111748,mask,0,1
111749,ventilation,0,1
111750,comparing,0,0
111751,VDMV,1,0
111752,with,0,0
111753,three,0,0
111754,commonly,0,0
111755,used,0,0
111756,hand-delivered,1,1
111757,methods,1,0
111758,of,1,0
111759,bag,1,1
111760,and,1,0
111761,mask,1,1
111762,ventilation,1,1
111763,:,1,0
111764,Laerdal,1,1
111765,self-inflating,1,1
111766,bag,1,1
111767,(,1,0
111768,SIB,1,0
111769,),1,0
111770,;,1,0
111771,anaesthetic,1,1
111772,bag,1,1
111773,and,1,0
111774,T-piece,1,1
111775,Neopuff,1,1
111776,.,1,0
111777,METHODS,0,0
111778,A,0,0
111779,modified,0,0
111780,resuscitation,0,1
111781,manikin,0,1
111782,was,0,0
111783,used,0,0
111784,to,0,0
111785,measure,0,0
111786,variation,0,0
111787,in,0,0
111788,mechanical,0,0
111789,ventilation,0,1
111790,during,0,0
111791,3-min,0,1
111792,periods,0,0
111793,of,0,0
111794,mask,1,0
111795,ventilation,1,1
111796,.,1,0
111797,Thirty-six,0,0
111798,experienced,0,0
111799,practitioners,0,0
111800,gave,0,0
111801,positive,0,0
111802,pressure,0,0
111803,mask,1,1
111804,ventilation,1,1
111805,targeting,0,0
111806,acceptable,0,0
111807,chest,0,1
111808,wall,0,0
111809,movement,0,0
111810,with,0,0
111811,a,0,0
111812,rate,0,0
111813,of,0,0
111814,60,0,0
111815,inflations/min,0,0
111816,and,0,0
111817,when,0,0
111818,pressures,0,0
111819,could,0,0
111820,be,0,0
111821,targeted,0,0
111822,or,0,0
111823,set,0,0
111824,",",0,0
111825,a,0,0
111826,peak,0,0
111827,inspiratory,0,0
111828,pressure,0,0
111829,(,0,0
111830,PIP,0,1
111831,),0,0
111832,of,0,0
111833,18,0,0
111834,cm,0,0
111835,water,0,1
111836,",",0,0
111837,positive,0,0
111838,end-expiratory,0,1
111839,pressure,0,0
111840,(,0,0
111841,PEEP,0,0
111842,),0,0
111843,of,0,0
111844,5,0,0
111845,cm,0,0
111846,water,0,1
111847,",",0,0
111848,for,0,0
111849,3,0,0
111850,min,0,0
111851,with,0,0
111852,each,0,0
111853,of,0,0
111854,the,0,0
111855,four,0,0
111856,mask,1,0
111857,ventilation,1,0
111858,methods,0,0
111859,.,0,0
111860,Each,0,0
111861,mode,0,0
111862,was,0,0
111863,randomly,0,0
111864,sequenced,0,0
111865,.,0,0
111866,RESULTS,0,0
111867,A,0,0
111868,total,0,0
111869,of,0,0
111870,21,0,0
111871,136,0,0
111872,inflations,0,0
111873,were,0,0
111874,recorded,0,0
111875,and,0,0
111876,analysed,0,0
111877,.,0,0
111878,VDMV,1,0
111879,achieved,0,0
111880,PIP,0,1
111881,and,0,0
111882,PEEP,0,0
111883,closest,0,0
111884,to,0,0
111885,that,0,0
111886,targeted,0,0
111887,and,0,0
111888,significantly,0,0
111889,lower,0,0
111890,variation,0,0
111891,in,0,0
111892,all,0,0
111893,measured,0,0
111894,parameters,0,0
111895,(,0,0
111896,p,0,0
111897,<,0,0
111898,0.001,0,0
111899,),0,0
111900,other,0,0
111901,than,0,0
111902,with,0,0
111903,PIP,0,1
111904,.,0,0
111905,SIB,0,0
111906,delivered,0,0
111907,TV,0,0
111908,and,0,0
111909,MV,0,0
111910,over,0,0
111911,twice,0,0
111912,that,0,0
111913,delivered,0,0
111914,by,0,0
111915,VDMV,1,0
111916,and,0,0
111917,Neopuff,1,1
111918,.,1,0
111919,CONCLUSION,0,0
111920,During,0,0
111921,3-min,0,1
111922,periods,0,0
111923,of,0,0
111924,mask,0,0
111925,ventilation,0,1
111926,on,0,0
111927,a,0,0
111928,manikin,0,1
111929,",",0,0
111930,VDMV,1,0
111931,produced,0,0
111932,the,0,0
111933,least,0,0
111934,variation,0,0
111935,in,0,0
111936,delivered,0,0
111937,ventilation,0,1
111938,.,0,0
111939,SIB,0,0
111940,produced,0,0
111941,wide,0,0
111942,variation,0,0
111943,and,0,0
111944,unacceptably,0,0
111945,high,0,0
111946,TV,0,0
111947,and,0,0
111948,MV,0,0
111949,in,0,0
111950,experienced,0,0
111951,hands,0,0
111952,.,0,0
111953,Comparison,0,0
111954,of,0,0
111955,inguinal,1,1
111956,approach,1,1
111957,",",1,0
111958,scrotal,1,0
111959,sclerotherapy,1,1
111960,and,0,0
111961,subinguinal,1,1
111962,antegrade,1,1
111963,sclerotherapy,1,1
111964,in,0,0
111965,varicocele,0,0
111966,treatment,0,0
111967,:,0,0
111968,a,0,0
111969,randomized,0,0
111970,prospective,0,0
111971,study,0,0
111972,.,0,0
111973,We,0,0
111974,compared,0,0
111975,outcome,0,0
111976,and,0,0
111977,complications,0,0
111978,of,0,0
111979,three,0,0
111980,simple,0,0
111981,varicocelectomy,0,1
111982,techniques,0,1
111983,.,0,0
111984,Groups,0,0
111985,were,0,0
111986,divided,0,0
111987,according,0,0
111988,to,0,0
111989,whether,0,0
111990,they,0,0
111991,would,0,0
111992,receive,0,0
111993,the,0,0
111994,Ivanissevich,1,1
111995,technique,1,1
111996,(,0,0
111997,n,0,0
111998,=,0,0
111999,55,0,0
112000,),0,0
112001,",",0,0
112002,Tauber,1,1
112003,'s,1,0
112004,technique,1,1
112005,(,0,0
112006,n,0,0
112007,=,0,0
112008,51,0,0
112009,),0,0
112010,or,0,0
112011,subinguinal,1,1
112012,sclerotherapy,1,1
112013,(,0,0
112014,n,0,0
112015,=,0,0
112016,49,0,0
112017,),0,0
112018,.,0,0
112019,Selection,0,0
112020,criteria,0,0
112021,were,0,0
112022,:,0,0
112023,infertility,0,0
112024,>,0,0
112025,1,0,0
112026,year,0,0
112027,",",0,0
112028,subnormal,0,0
112029,semen,0,0
112030,",",0,0
112031,sonographic,0,0
112032,diameter,0,0
112033,of,0,0
112034,veins,0,0
112035,>,0,0
112036,3,0,0
112037,mm,0,0
112038,and,0,0
112039,time,0,0
112040,of,0,0
112041,regurge,0,0
112042,>,0,0
112043,2,0,0
112044,s.,0,0
112045,Patients,0,0
112046,were,0,0
112047,randomly,0,0
112048,assigned,0,0
112049,to,0,0
112050,the,0,0
112051,groups,0,0
112052,of,0,0
112053,treatment,0,0
112054,",",0,0
112055,with,0,0
112056,follow-up,0,0
112057,every,0,0
112058,3,0,0
112059,months,0,0
112060,for,0,0
112061,1,0,0
112062,year,0,0
112063,.,0,0
112064,Improvement,0,0
112065,was,0,0
112066,only,0,0
112067,in,0,0
112068,sperm,0,1
112069,count,0,0
112070,and,0,0
112071,total,0,0
112072,motility,0,0
112073,for,0,0
112074,all,0,0
112075,groups,0,0
112076,.,0,0
112077,Pregnancy,0,0
112078,rates,0,0
112079,were,0,0
112080,20,0,0
112081,",",0,0
112082,13.73,0,0
112083,and,0,0
112084,12.24,0,0
112085,%,0,0
112086,",",0,0
112087,respectively,0,0
112088,",",0,0
112089,with,0,0
112090,no,0,0
112091,significant,0,0
112092,difference,0,0
112093,between,0,0
112094,groups,0,0
112095,.,0,0
112096,Hydrocele,0,0
112097,occurred,0,0
112098,only,0,0
112099,in,0,0
112100,the,0,0
112101,group,0,0
112102,which,0,0
112103,received,0,0
112104,the,0,0
112105,Ivanissevich,0,1
112106,technique,0,1
112107,(,0,0
112108,5.5,0,0
112109,%,0,0
112110,),0,0
112111,.,0,0
112112,Tauber,0,0
112113,'s,0,0
112114,technique,0,1
112115,is,0,0
112116,simple,0,0
112117,;,0,0
112118,however,0,0
112119,",",0,0
112120,it,0,0
112121,has,0,0
112122,the,0,0
112123,disadvantage,0,0
112124,of,0,0
112125,multiple,0,0
112126,branching,0,0
112127,of,0,0
112128,small,0,0
112129,veins,0,0
112130,.,0,0
112131,Melatonin,1,1
112132,versus,1,0
112133,placebo,1,1
112134,in,0,0
112135,children,0,0
112136,with,0,0
112137,autism,0,0
112138,spectrum,0,0
112139,conditions,0,0
112140,and,0,0
112141,severe,0,0
112142,sleep,0,0
112143,problems,0,0
112144,not,0,0
112145,amenable,0,0
112146,to,0,0
112147,behaviour,0,0
112148,management,0,0
112149,strategies,0,0
112150,:,0,0
112151,a,0,0
112152,randomised,0,0
112153,controlled,0,0
112154,crossover,0,0
112155,trial,0,0
112156,.,0,0
112157,Twenty-two,0,0
112158,children,0,0
112159,with,0,0
112160,autism,0,0
112161,spectrum,0,0
112162,disorders,0,0
112163,who,0,0
112164,had,0,0
112165,not,0,0
112166,responded,0,0
112167,to,0,0
112168,supported,0,0
112169,behaviour,0,0
112170,management,0,0
112171,strategies,0,0
112172,for,0,0
112173,severe,0,0
112174,dysomnias,0,0
112175,entered,0,0
112176,a,0,0
112177,double,0,0
112178,blind,0,0
112179,",",0,0
112180,randomised,0,0
112181,",",0,0
112182,controlled,0,0
112183,crossover,0,0
112184,trial,0,0
112185,involving,0,0
112186,3,0,0
112187,months,0,0
112188,of,0,0
112189,placebo,1,1
112190,versus,0,0
112191,3,0,0
112192,months,0,0
112193,of,0,0
112194,melatonin,1,1
112195,to,0,0
112196,a,0,0
112197,maximum,0,0
112198,dose,0,0
112199,of,0,0
112200,10,0,0
112201,mg.,0,0
112202,17,0,0
112203,children,0,0
112204,completed,0,0
112205,the,0,0
112206,study,0,0
112207,.,0,0
112208,There,0,0
112209,were,0,0
112210,no,0,0
112211,significant,0,0
112212,differences,0,0
112213,between,0,0
112214,sleep,0,0
112215,variables,0,0
112216,at,0,0
112217,baseline,0,0
112218,.,0,0
112219,Melatonin,1,0
112220,significantly,0,0
112221,improved,0,0
112222,sleep,0,0
112223,latency,0,0
112224,(,0,0
112225,by,0,0
112226,an,0,0
112227,average,0,0
112228,of,0,0
112229,47,0,0
112230,min,0,0
112231,),0,0
112232,and,0,0
112233,total,0,0
112234,sleep,0,0
112235,(,0,0
112236,by,0,0
112237,an,0,0
112238,average,0,0
112239,of,0,0
112240,52,0,0
112241,min,0,0
112242,),0,0
112243,compared,0,0
112244,to,0,0
112245,placebo,1,1
112246,",",0,0
112247,but,0,0
112248,not,0,0
112249,number,0,0
112250,of,0,0
112251,night,0,0
112252,wakenings,0,0
112253,.,0,0
112254,The,0,0
112255,side,0,0
112256,effect,0,0
112257,profile,0,0
112258,was,0,0
112259,low,0,0
112260,and,0,0
112261,not,0,0
112262,significantly,0,0
112263,different,0,0
112264,between,0,0
112265,the,0,0
112266,two,0,0
112267,arms,0,0
112268,.,0,0
112269,Standard,0,1
112270,versus,0,1
112271,newer,0,0
112272,antibacterial,0,0
112273,agents,0,0
112274,in,0,0
112275,the,0,0
112276,treatment,0,0
112277,of,0,0
112278,severe,0,0
112279,acute,0,0
112280,exacerbation,0,0
112281,of,0,0
112282,chronic,0,0
112283,obstructive,0,0
112284,pulmonary,0,0
112285,disease,0,0
112286,:,0,0
112287,a,0,0
112288,randomized,0,0
112289,trial,0,0
112290,of,0,0
112291,trimethoprim-sulfamethoxazole,1,1
112292,versus,0,0
112293,ciprofloxacin,0,1
112294,.,0,0
112295,BACKGROUND,0,0
112296,.,0,0
112297,Although,0,0
112298,the,0,0
112299,use,0,0
112300,of,0,0
112301,antibiotics,0,1
112302,in,0,0
112303,the,0,0
112304,treatment,0,0
112305,of,0,0
112306,acute,0,0
112307,exacerbation,0,0
112308,of,0,0
112309,chronic,0,0
112310,obstructive,0,0
112311,pulmonary,0,0
112312,disease,0,0
112313,(,0,0
112314,COPD,0,0
112315,),0,1
112316,is,0,0
112317,largely,0,0
112318,accepted,0,0
112319,",",0,0
112320,controversy,0,0
112321,remains,0,0
112322,regarding,0,0
112323,whether,0,0
112324,the,0,0
112325,choice,0,0
112326,of,0,0
112327,antibiotic,0,1
112328,has,0,0
112329,any,0,0
112330,impact,0,0
112331,on,0,0
112332,outcome,0,0
112333,.,0,0
112334,Our,0,0
112335,aim,0,0
112336,was,0,0
112337,to,0,0
112338,compare,0,0
112339,the,0,0
112340,effects,0,0
112341,of,0,0
112342,the,0,0
112343,combination,0,1
112344,of,0,0
112345,trimethoprim,1,1
112346,and,1,0
112347,sulfamethoxazole,1,1
112348,and,0,0
112349,ciprofloxacin,0,1
112350,in,0,0
112351,patients,0,0
112352,treated,0,0
112353,for,0,0
112354,severe,0,0
112355,COPD,0,0
112356,exacerbation,0,0
112357,requiring,0,0
112358,mechanical,0,0
112359,ventilation,0,1
112360,.,0,0
112361,METHODS,0,0
112362,.,0,0
112363,In,0,0
112364,a,0,0
112365,randomized,0,0
112366,",",0,0
112367,double-blind,0,0
112368,trial,0,0
112369,",",0,0
112370,we,0,0
112371,included,0,0
112372,170,0,0
112373,patients,0,0
112374,with,0,0
112375,an,0,0
112376,acute,0,0
112377,exacerbation,0,0
112378,of,0,0
112379,COPD,0,0
112380,requiring,0,0
112381,mechanical,0,0
112382,ventilation,0,1
112383,.,0,0
112384,Enrolled,0,0
112385,patients,0,0
112386,received,0,0
112387,trimethoprim-sulfamethoxazole,1,1
112388,(,0,0
112389,n,0,0
112390,=,0,0
112391,85,0,0
112392,),0,0
112393,or,0,1
112394,ciprofloxacin,1,1
112395,(,0,0
112396,n,0,0
112397,=,0,0
112398,85,0,0
112399,),0,0
112400,for,0,0
112401,10,0,0
112402,days,0,0
112403,.,0,0
112404,Main,0,0
112405,outcomes,0,0
112406,were,0,0
112407,hospital,0,0
112408,death,0,0
112409,and,0,0
112410,need,0,0
112411,for,0,0
112412,an,0,0
112413,additional,0,0
112414,course,0,0
112415,of,0,0
112416,antibiotics,0,1
112417,.,0,0
112418,Secondary,0,0
112419,outcomes,0,0
112420,were,0,0
112421,duration,0,0
112422,of,0,0
112423,mechanical,0,0
112424,ventilation,0,1
112425,",",0,0
112426,length,0,0
112427,of,0,0
112428,hospital,0,0
112429,stay,0,0
112430,",",0,0
112431,and,0,0
112432,exacerbation-free,0,0
112433,interval,0,0
112434,.,0,0
112435,RESULTS,0,0
112436,.,0,0
112437,Combined,0,0
112438,hospital,0,0
112439,death,0,0
112440,and,0,0
112441,additional,0,0
112442,antibiotic,0,1
112443,prescription,0,0
112444,rates,0,0
112445,were,0,0
112446,similar,0,0
112447,in,0,0
112448,the,0,0
112449,2,0,0
112450,groups,0,0
112451,(,0,0
112452,16.4,0,0
112453,%,0,0
112454,vs,0,0
112455,15.3,0,0
112456,%,0,0
112457,for,0,0
112458,trimethoprim-sulfamethoxazole,0,1
112459,group,0,0
112460,vs,0,0
112461,ciprofloxacin,0,1
112462,group,0,0
112463,;,0,0
112464,difference,0,0
112465,",",0,0
112466,1.1,0,0
112467,%,0,0
112468,;,0,0
112469,95,0,0
112470,%,0,0
112471,confidence,0,0
112472,interval,0,0
112473,[,0,0
112474,CI,0,0
112475,],0,0
112476,-9.8,0,0
112477,%,0,0
112478,to,0,0
112479,12.0,0,0
112480,%,0,0
112481,;,0,0
112482,P,0,0
112483,=,0,0
112484,.832,0,0
112485,),0,0
112486,.,0,0
112487,Hospital,0,0
112488,death,0,0
112489,occurred,0,0
112490,in,0,0
112491,7,0,0
112492,patients,0,0
112493,(,0,0
112494,8.2,0,0
112495,%,0,0
112496,),0,0
112497,receiving,0,0
112498,trimethoprim-sulfamethoxazole,1,1
112499,and,0,0
112500,8,0,0
112501,patients,0,0
112502,(,0,0
112503,9.4,0,0
112504,%,0,0
112505,),0,0
112506,receiving,0,1
112507,ciprofloxacin,0,1
112508,(,0,0
112509,difference,0,0
112510,",",0,0
112511,-1.2,0,0
112512,%,0,0
112513,;,0,0
112514,95,0,0
112515,%,0,0
112516,CI,0,0
112517,",",0,0
112518,-9.7,0,0
112519,to,0,0
112520,7.3,0,0
112521,;,0,0
112522,P,0,0
112523,=,0,0
112524,.90,0,0
112525,),0,0
112526,.,0,0
112527,The,0,0
112528,need,0,0
112529,for,0,0
112530,an,0,0
112531,additional,0,0
112532,antibiotic,0,1
112533,course,0,0
112534,was,0,0
112535,observed,0,0
112536,in,0,0
112537,8,0,0
112538,patients,0,0
112539,in,0,0
112540,the,0,0
112541,trimethoprim-sulfamethoxazole,1,1
112542,group,0,0
112543,and,0,0
112544,5,0,0
112545,patients,0,0
112546,in,0,0
112547,the,0,0
112548,ciprofloxacin,0,1
112549,group,0,0
112550,(,0,0
112551,difference,0,0
112552,",",0,0
112553,2.3,0,0
112554,%,0,0
112555,;,0,0
112556,95,0,0
112557,%,0,0
112558,CI,0,0
112559,",",0,0
112560,-5.4,0,0
112561,to,0,0
112562,10.0,0,0
112563,;,0,0
112564,P,0,0
112565,=,0,0
112566,.549,0,0
112567,),0,0
112568,.,0,0
112569,The,0,0
112570,mean,0,0
112571,exacerbation-free,0,0
112572,interval,0,0
112573,(,0,0
112574,+/-,0,0
112575,standard,0,1
112576,deviation,0,0
112577,),0,0
112578,was,0,0
112579,similar,0,0
112580,in,0,0
112581,both,0,0
112582,treatment,0,0
112583,groups,0,0
112584,(,0,0
112585,83,0,0
112586,+/-,0,0
112587,25,0,0
112588,vs,0,0
112589,79,0,0
112590,+/-,0,0
112591,22,0,0
112592,for,0,0
112593,the,0,0
112594,trimethoprim-sulfamethoxazole,1,1
112595,group,0,0
112596,vs,0,0
112597,ciprofloxacin,0,1
112598,group,0,0
112599,;,0,0
112600,difference,0,0
112601,",",0,0
112602,4,0,0
112603,days,0,0
112604,;,0,0
112605,95,0,0
112606,%,0,0
112607,CI,0,0
112608,",",0,0
112609,-15,0,0
112610,to,0,0
112611,19,0,0
112612,days,0,0
112613,;,0,0
112614,P,0,0
112615,=,0,0
112616,.41,0,0
112617,),0,0
112618,.,0,0
112619,Duration,0,0
112620,of,0,0
112621,mechanical,0,1
112622,ventilation,0,1
112623,and,0,0
112624,hospital,0,0
112625,stay,0,0
112626,was,0,0
112627,not,0,0
112628,significantly,0,0
112629,different,0,0
112630,between,0,0
112631,the,0,0
112632,2,0,0
112633,groups,0,0
112634,.,0,0
112635,CONCLUSIONS,0,0
112636,.,0,0
112637,In,0,0
112638,patients,0,0
112639,with,0,0
112640,acute,0,0
112641,exacerbation,0,0
112642,of,0,0
112643,COPD,0,0
112644,requiring,0,0
112645,mechanical,0,1
112646,ventilation,0,1
112647,",",0,0
112648,efficacy,0,0
112649,of,0,0
112650,trimethoprim-sulfamethoxazole,1,1
112651,was,0,0
112652,not,0,0
112653,inferior,0,0
112654,to,0,0
112655,ciprofloxacin,0,1
112656,.,0,0
112657,Trial,0,0
112658,registration,0,0
112659,.,0,0
112660,ClinicalTrials.gov,0,0
112661,identifier,0,0
112662,:,0,0
112663,NCT00791505,0,0
112664,.,0,0
112665,Comparing,0,0
112666,the,0,0
112667,effectiveness,0,0
112668,of,0,0
112669,peer,1,1
112670,mentoring,1,1
112671,and,0,0
112672,student,1,0
112673,mentoring,1,1
112674,in,0,0
112675,a,0,0
112676,35-week,0,0
112677,fitness,0,0
112678,program,0,1
112679,for,0,0
112680,older,0,0
112681,adults,0,0
112682,.,0,0
112683,To,0,0
112684,investigate,0,0
112685,the,0,0
112686,applicability,0,0
112687,and,0,0
112688,effectiveness,0,0
112689,of,0,0
112690,a,0,0
112691,peer-mentored,1,1
112692,exercise,1,1
112693,program,1,1
112694,",",0,0
112695,this,0,0
112696,study,0,0
112697,compared,0,0
112698,the,0,0
112699,retention,0,0
112700,and,0,0
112701,participation,0,0
112702,rates,0,0
112703,",",0,0
112704,and,0,0
112705,physical,0,0
112706,improvements,0,0
112707,of,0,0
112708,older,0,0
112709,adults,0,0
112710,trained,1,0
112711,by,1,0
112712,peer,1,1
112713,mentors,1,1
112714,(,1,0
112715,PM,1,0
112716,),1,0
112717,to,1,0
112718,a,1,0
112719,group,1,0
112720,trained,1,1
112721,by,1,0
112722,young,1,0
112723,qualified,1,0
112724,student,1,0
112725,mentors,1,1
112726,(,1,0
112727,SM,1,0
112728,),1,0
112729,.,1,0
112730,A,0,0
112731,group,0,0
112732,of,0,0
112733,older,0,0
112734,adults,0,0
112735,were,0,0
112736,prepared,0,0
112737,as,0,0
112738,peer,0,0
112739,mentors,0,1
112740,through,0,0
112741,a,0,0
112742,30-week,0,0
112743,preparation,0,1
112744,program,0,1
112745,.,0,0
112746,Later,0,0
112747,",",0,0
112748,60,0,0
112749,older,0,0
112750,adults,0,0
112751,(,0,0
112752,mean,0,0
112753,?,0,0
112754,SD,0,0
112755,age,0,0
112756,:,0,0
112757,68.7,0,0
112758,?,0,0
112759,6.1,0,0
112760,years,0,0
112761,),0,0
112762,were,0,0
112763,recruited,0,0
112764,and,0,0
112765,randomly,0,0
112766,assigned,0,0
112767,to,0,0
112768,either,0,0
112769,the,0,0
112770,PM,0,0
112771,or,0,1
112772,SM,0,0
112773,group,0,0
112774,.,0,0
112775,Both,0,0
112776,groups,0,0
112777,completed,0,0
112778,an,0,0
112779,identical,0,0
112780,35-week,0,0
112781,fitness,0,0
112782,program,0,1
112783,.,0,0
112784,Pre-,0,0
112785,",",0,0
112786,midterm-,0,0
112787,and,0,0
112788,post-training,0,1
112789,assessments,0,0
112790,of,0,0
112791,fitness,0,0
112792,were,0,0
112793,completed,0,0
112794,and,0,0
112795,rates,0,0
112796,of,0,0
112797,participation,0,0
112798,and,0,0
112799,retention,0,0
112800,were,0,0
112801,documented,0,0
112802,.,0,0
112803,The,0,0
112804,same,0,0
112805,retention,0,0
112806,rates,0,0
112807,were,0,0
112808,observed,0,0
112809,in,0,0
112810,the,0,0
112811,two,0,0
112812,groups,0,0
112813,",",0,0
112814,but,0,0
112815,SM,0,0
112816,group,0,0
112817,had,0,0
112818,higher,0,0
112819,participation,0,0
112820,.,0,0
112821,Both,0,0
112822,groups,0,0
112823,improved,0,0
112824,significantly,0,0
112825,in,0,0
112826,all,0,0
112827,measures,0,0
112828,of,0,0
112829,fitness,0,0
112830,and,0,0
112831,there,0,0
112832,were,0,0
112833,no,0,0
112834,significant,0,0
112835,post-test,0,0
112836,differences,0,0
112837,between,0,0
112838,the,0,0
112839,groups,0,0
112840,in,0,0
112841,the,0,0
112842,fitness,0,0
112843,measures,0,0
112844,.,0,0
112845,Findings,0,0
112846,suggest,0,0
112847,that,0,0
112848,the,0,0
112849,peer,0,1
112850,mentor,0,0
112851,model,0,0
112852,is,0,0
112853,applicable,0,0
112854,in,0,0
112855,an,0,0
112856,older,0,0
112857,adult,0,0
112858,exercise,0,1
112859,program,0,1
112860,and,0,0
112861,may,0,0
112862,be,0,0
112863,as,0,0
112864,effective,0,0
112865,as,0,0
112866,a,0,0
112867,program,0,1
112868,mentored,0,1
112869,by,0,0
112870,young,0,0
112871,professionals,0,0
112872,.,0,0
112873,A,0,0
112874,first-in-man,0,0
112875,",",0,0
112876,randomized,0,0
112877,",",0,0
112878,placebo-controlled,1,1
112879,study,0,0
112880,to,0,0
112881,evaluate,0,0
112882,the,0,0
112883,safety,0,0
112884,and,0,0
112885,feasibility,0,0
112886,of,0,0
112887,autologous,1,1
112888,delipidated,1,0
112889,high-density,1,0
112890,lipoprotein,1,0
112891,plasma,1,0
112892,infusions,1,1
112893,in,0,0
112894,patients,0,0
112895,with,0,0
112896,acute,0,0
112897,coronary,0,0
112898,syndrome,0,0
112899,.,0,0
112900,OBJECTIVES,0,0
112901,This,0,0
112902,study,0,0
112903,aimed,0,0
112904,to,0,0
112905,determine,0,0
112906,whether,0,0
112907,serial,1,0
112908,autologous,1,1
112909,infusions,1,1
112910,of,1,0
112911,selective,1,0
112912,high-density,1,0
112913,lipoprotein,1,0
112914,(,1,0
112915,HDL,1,1
112916,),1,0
112917,delipidated,1,0
112918,plasma,1,0
112919,are,0,0
112920,feasible,0,0
112921,and,0,0
112922,well,0,0
112923,tolerated,0,0
112924,in,0,0
112925,patients,0,0
112926,with,0,0
112927,acute,0,0
112928,coronary,0,0
112929,syndrome,0,0
112930,(,0,0
112931,ACS,0,1
112932,),0,0
112933,.,0,0
112934,BACKGROUND,0,0
112935,Low,0,0
112936,HDL,0,1
112937,is,0,0
112938,associated,0,0
112939,with,0,0
112940,increased,0,0
112941,risk,0,0
112942,of,0,0
112943,cardiovascular,0,0
112944,disease,0,0
112945,.,0,0
112946,Plasma,0,0
112947,selective,0,0
112948,delipidation,0,0
112949,converts,0,0
112950,alphaHDL,0,0
112951,to,0,0
112952,prebeta-like,0,0
112953,HDL,0,1
112954,",",0,0
112955,the,0,0
112956,most,0,0
112957,effective,0,0
112958,form,0,0
112959,of,0,0
112960,HDL,0,1
112961,for,0,0
112962,lipid,0,0
112963,removal,0,0
112964,from,0,0
112965,arterial,0,0
112966,plaques,0,0
112967,.,0,0
112968,METHODS,0,0
112969,ACS,0,1
112970,patients,0,0
112971,undergoing,0,0
112972,cardiac,0,0
112973,catheterization,0,0
112974,with,0,0
112975,>,0,0
112976,or=1,0,0
112977,nonobstructive,0,0
112978,native,0,0
112979,coronary,0,0
112980,artery,0,0
112981,atheroma,0,0
112982,were,0,0
112983,randomized,0,0
112984,to,0,0
112985,either,0,0
112986,7,0,0
112987,weekly,0,1
112988,HDL,1,1
112989,selective,1,1
112990,delipidated,1,0
112991,or,1,0
112992,control,1,0
112993,plasma,1,0
112994,apheresis/reinfusions,1,1
112995,.,1,0
112996,Patients,0,0
112997,underwent,0,0
112998,intravascular,1,0
112999,ultrasound,1,1
113000,(,0,0
113001,IVUS,0,1
113002,),0,0
113003,evaluation,0,0
113004,of,0,0
113005,the,0,0
113006,target,0,0
113007,vessel,0,0
113008,during,0,0
113009,the,0,0
113010,catheterization,0,0
113011,for,0,0
113012,ACS,0,1
113013,and,0,0
113014,up,0,0
113015,to,0,0
113016,14,0,0
113017,days,0,0
113018,following,0,0
113019,the,0,0
113020,final,0,0
113021,apheresis/reinfusion,1,1
113022,session,0,1
113023,.,0,0
113024,2-D,0,0
113025,gel,0,1
113026,electrophoresis,0,0
113027,of,0,0
113028,delipidated,0,0
113029,plasmas,0,0
113030,established,0,0
113031,successful,0,0
113032,conversion,0,0
113033,of,0,0
113034,alphaHDL,0,0
113035,to,0,0
113036,prebeta-like,0,0
113037,HDL,0,1
113038,.,0,0
113039,The,0,0
113040,trial,0,0
113041,was,0,0
113042,complete,0,0
113043,with,0,0
113044,28,0,0
113045,patients,0,0
113046,randomized,0,0
113047,.,0,0
113048,RESULTS,0,0
113049,All,0,0
113050,reinfusion,0,1
113051,sessions,0,1
113052,were,0,0
113053,tolerated,0,0
113054,well,0,0
113055,by,0,0
113056,all,0,0
113057,patients,0,0
113058,.,0,0
113059,The,0,0
113060,levels,0,0
113061,of,0,0
113062,prebeta-like,0,0
113063,HDL,0,1
113064,and,0,0
113065,alphaHDL,0,0
113066,in,0,0
113067,the,0,0
113068,delipidated,0,0
113069,plasma,0,0
113070,converted,0,0
113071,from,0,0
113072,5.6,0,0
113073,%,0,0
113074,to,0,0
113075,79.1,0,0
113076,%,0,0
113077,and,0,0
113078,92.8,0,0
113079,%,0,0
113080,to,0,0
113081,20.9,0,0
113082,%,0,0
113083,",",0,0
113084,respectively,0,0
113085,.,0,0
113086,The,0,0
113087,IVUS,0,0
113088,data,0,0
113089,demonstrated,0,0
113090,a,0,0
113091,numeric,0,0
113092,trend,0,0
113093,toward,0,0
113094,regression,0,0
113095,in,0,0
113096,the,0,0
113097,total,0,0
113098,atheroma,0,0
113099,volume,0,0
113100,of,0,0
113101,-12.18,0,0
113102,+/-,0,0
113103,36.75,0,0
113104,mm,0,0
113105,(,0,0
113106,3,0,0
113107,),0,0
113108,in,0,0
113109,the,0,0
113110,delipidated,0,0
113111,group,0,0
113112,versus,0,0
113113,an,0,0
113114,increase,0,0
113115,of,0,0
113116,total,0,0
113117,atheroma,0,0
113118,volume,0,0
113119,of,0,0
113120,2.80,0,0
113121,+/-,0,0
113122,21.25,0,0
113123,mm,0,0
113124,(,0,0
113125,3,0,0
113126,),0,0
113127,in,0,0
113128,the,0,0
113129,control,0,1
113130,group,0,0
113131,(,0,0
113132,p,0,0
113133,=,0,0
113134,0.268,0,0
113135,),0,0
113136,.,0,0
113137,CONCLUSIONS,0,0
113138,In,0,0
113139,ACS,0,1
113140,patients,0,0
113141,",",0,0
113142,serial,0,0
113143,autologous,0,1
113144,infusions,0,1
113145,of,0,0
113146,selective,1,0
113147,HDL,1,1
113148,delipidated,1,0
113149,plasma,1,0
113150,are,0,0
113151,clinically,0,0
113152,feasible,0,0
113153,and,0,0
113154,well,0,0
113155,tolerated,0,0
113156,.,0,0
113157,This,0,0
113158,therapy,0,0
113159,may,0,0
113160,offer,0,0
113161,a,0,0
113162,novel,0,0
113163,adjunct,0,1
113164,treatment,0,0
113165,for,0,0
113166,patients,0,0
113167,presenting,0,0
113168,with,0,0
113169,ACS,0,1
113170,.,0,0
113171,Further,0,0
113172,study,0,0
113173,will,0,0
113174,be,0,0
113175,needed,0,0
113176,to,0,0
113177,determine,0,0
113178,its,0,0
113179,ability,0,0
113180,to,0,0
113181,reduce,0,0
113182,clinical,0,0
113183,cardiovascular,0,0
113184,events,0,0
113185,.,0,0
113186,Dose-response,0,0
113187,relationship,0,0
113188,of,0,0
113189,sertindole,1,1
113190,and,1,0
113191,haloperidol,1,1
113192,using,0,0
113193,the,0,0
113194,pharmacopsychometric,0,0
113195,triangle,0,0
113196,.,0,0
113197,OBJECTIVE,0,0
113198,Renewed,0,0
113199,insight,0,0
113200,into,0,0
113201,dose-related,0,0
113202,effects,0,0
113203,of,0,0
113204,sertindole,1,1
113205,and,1,0
113206,haloperidol,1,1
113207,was,0,0
113208,sought,0,0
113209,by,0,0
113210,re-analysing,0,0
113211,published,0,0
113212,data,0,0
113213,for,0,0
113214,antipsychotic,0,0
113215,effect,0,0
113216,",",0,0
113217,extrapyramidal,0,0
113218,effect,0,0
113219,",",0,0
113220,and,0,0
113221,patient,0,0
113222,wellbeing,0,0
113223,-,0,0
113224,i.e.,0,0
113225,",",0,0
113226,the,0,0
113227,important,0,0
113228,pharmacopsychometric,0,0
113229,triangle,0,0
113230,domains,0,0
113231,.,0,0
113232,METHOD,0,0
113233,Selected,0,0
113234,Positive,0,0
113235,and,0,0
113236,Negative,0,0
113237,Syndrome,0,1
113238,Scale,0,1
113239,(,0,0
113240,PANSS,0,0
113241,),0,0
113242,subscales,0,0
113243,and,0,0
113244,the,0,0
113245,Simpson-Angus,0,0
113246,scale,0,0
113247,were,0,0
113248,tested,0,0
113249,for,0,0
113250,validity,0,0
113251,.,0,0
113252,Standardized,0,0
113253,effect,0,0
113254,sizes,0,0
113255,[,0,0
113256,last,0,0
113257,observation,0,0
113258,carried,0,0
113259,forward,0,0
113260,(,0,0
113261,LOCF,0,0
113262,),0,0
113263,],0,0
113264,at,0,0
113265,endpoint,0,0
113266,were,0,0
113267,calculated,0,0
113268,.,0,0
113269,RESULTS,0,0
113270,The,0,0
113271,scales,0,0
113272,were,0,0
113273,found,0,0
113274,to,0,0
113275,be,0,0
113276,valid,0,0
113277,instruments,0,0
113278,.,0,0
113279,The,0,0
113280,PANSS,0,0
113281,(,0,0
113282,11,0,0
113283,),0,0
113284,psychotic,0,0
113285,subscale,0,0
113286,showed,0,0
113287,clinically,0,0
113288,significant,0,0
113289,effect,0,0
113290,sizes,0,0
113291,for,0,0
113292,all,0,0
113293,doses,0,0
113294,of,0,0
113295,sertindole,1,1
113296,(,0,0
113297,12,0,0
113298,",",0,0
113299,20,0,0
113300,",",0,0
113301,and,0,0
113302,24,0,0
113303,mg,0,1
113304,),0,0
113305,and,0,0
113306,haloperidol,1,1
113307,(,0,0
113308,4,0,0
113309,",",0,0
113310,8,0,0
113311,",",0,0
113312,and,0,0
113313,16,0,0
113314,mg,0,1
113315,),0,0
113316,.,0,0
113317,Extrapyramidal,0,0
113318,effects,0,0
113319,were,0,0
113320,evident,0,0
113321,for,0,0
113322,all,0,0
113323,doses,0,0
113324,of,0,0
113325,haloperidol,1,1
113326,",",0,0
113327,but,0,0
113328,absent,0,0
113329,for,0,0
113330,the,0,0
113331,lower,0,0
113332,doses,0,0
113333,of,0,0
113334,sertindole,1,1
113335,.,1,0
113336,The,0,0
113337,PANSS,0,0
113338,(,0,0
113339,6,0,0
113340,),0,0
113341,depression,0,0
113342,subscale,0,0
113343,",",0,0
113344,a,0,0
113345,proxy,0,0
113346,measure,0,0
113347,of,0,0
113348,quality,0,0
113349,of,0,0
113350,life,0,0
113351,",",0,0
113352,showed,0,0
113353,a,0,0
113354,clinically,0,0
113355,significant,0,0
113356,effect,0,0
113357,for,0,0
113358,sertindole,1,1
113359,20,0,0
113360,mg,0,1
113361,and,0,0
113362,no,0,0
113363,effect,0,0
113364,for,0,0
113365,haloperidol,1,1
113366,.,1,0
113367,CONCLUSION,0,0
113368,This,0,0
113369,re-analysis,0,0
113370,confirmed,0,0
113371,the,0,0
113372,antipsychotic,0,0
113373,effect,0,0
113374,and,0,0
113375,absence,0,0
113376,of,0,0
113377,extrapyramidal,0,0
113378,effects,0,0
113379,for,0,0
113380,sertindole,1,1
113381,and,0,0
113382,",",0,0
113383,in,0,0
113384,addition,0,0
113385,",",0,0
113386,showed,0,0
113387,a,0,0
113388,clinically,0,0
113389,significant,0,0
113390,antidepressant,0,1
113391,effect,0,0
113392,.,0,0
113393,A,0,0
113394,profile,0,0
113395,for,0,0
113396,bipolar,0,0
113397,states,0,0
113398,emerged,0,0
113399,.,0,0
113400,Abnormal,0,0
113401,cardiac,0,0
113402,contractility,0,0
113403,in,0,0
113404,long-term,1,0
113405,exogenous,1,0
113406,subclinical,1,0
113407,hyperthyroid,1,0
113408,patients,0,0
113409,as,0,0
113410,demonstrated,0,0
113411,by,0,0
113412,two-dimensional,0,0
113413,echocardiography,0,0
113414,speckle,0,1
113415,tracking,0,1
113416,imaging,0,0
113417,.,0,0
113418,BACKGROUND,0,0
113419,Subclinical,0,0
113420,hyperthyroidism,0,0
113421,is,0,0
113422,associated,0,0
113423,with,0,0
113424,cardiovascular,0,0
113425,morbidity,0,0
113426,.,0,0
113427,Recent,0,0
113428,advances,0,0
113429,in,0,0
113430,echocardiography,0,0
113431,imaging,0,0
113432,have,0,0
113433,allowed,0,0
113434,sophisticated,0,0
113435,evaluation,0,0
113436,of,0,0
113437,myocardial,0,0
113438,tissue,0,0
113439,properties,0,0
113440,.,0,0
113441,OBJECTIVE,0,0
113442,To,0,0
113443,investigate,0,0
113444,the,0,0
113445,myocardial,0,0
113446,effects,0,0
113447,of,0,0
113448,long-term,0,0
113449,exogenous,1,0
113450,subclinical,1,0
113451,hyperthyroidism,1,0
113452,using,0,0
113453,two-dimensional,1,1
113454,speckle,1,1
113455,tracking,1,1
113456,echocardiography,1,1
113457,imaging,1,1
113458,(,1,0
113459,2D-STE,1,0
113460,),1,0
113461,.,0,0
113462,DESIGN,0,0
113463,Prospective,0,0
113464,",",0,0
113465,single-blinded,0,0
113466,",",0,0
113467,placebo-controlled,0,1
113468,randomized,0,0
113469,trial,0,0
113470,of,0,0
113471,6,0,0
113472,months,0,0
113473,duration,0,0
113474,with,0,0
113475,two,0,0
113476,parallel,0,0
113477,groups,0,0
113478,.,0,0
113479,PATIENTS,0,0
113480,AND,0,0
113481,METHODS,0,0
113482,Totally,0,0
113483,25,0,0
113484,patients,0,0
113485,with,0,0
113486,a,0,0
113487,history,0,0
113488,of,0,0
113489,differentiated,0,0
113490,thyroid,0,0
113491,carcinoma,0,0
113492,on,0,0
113493,long-term,0,0
113494,TSH-suppressive,0,1
113495,levothyroxine,0,1
113496,(,0,0
113497,l-T,0,1
113498,(,0,0
113499,4,0,0
113500,),0,0
113501,),0,0
113502,substitution,0,1
113503,were,0,0
113504,randomized,0,0
113505,to,0,0
113506,persistent,0,0
113507,TSH-suppressive,1,1
113508,l-T,1,1
113509,(,1,0
113510,4,1,0
113511,),1,0
113512,substitution,1,1
113513,(,0,0
113514,low-TSH,0,1
113515,group,0,1
113516,),0,0
113517,or,0,1
113518,restoration,1,0
113519,of,1,0
113520,euthyroidism,1,0
113521,.,1,0
113522,Additionally,0,0
113523,40,0,0
113524,euthyroid,0,0
113525,controls,0,0
113526,were,0,0
113527,studied,0,0
113528,.,0,0
113529,RESULTS,0,0
113530,(,0,0
113531,PROPOSAL,0,0
113532,),0,0
113533,:,0,0
113534,At,0,0
113535,baseline,0,0
113536,",",0,0
113537,the,0,0
113538,group,0,0
113539,of,0,0
113540,patients,0,0
113541,showed,0,0
113542,normal,0,0
113543,left,0,0
113544,ventricular,0,0
113545,(,0,0
113546,LV,0,1
113547,),0,0
113548,systolic,0,0
113549,function,0,0
113550,but,0,0
113551,impaired,0,0
113552,diastolic,0,0
113553,function,0,0
113554,as,0,0
113555,assessed,0,0
113556,with,0,0
113557,conventional,0,1
113558,echocardiographic,0,0
113559,parameters,0,0
113560,.,0,0
113561,Importantly,0,0
113562,",",0,0
113563,2D-STE,0,0
113564,analysis,0,0
113565,demonstrated,0,0
113566,the,0,0
113567,presence,0,0
113568,of,0,0
113569,subclinical,0,0
113570,LV,0,1
113571,systolic,0,0
113572,and,0,0
113573,diastolic,0,0
113574,dysfunction,0,0
113575,with,0,0
113576,impaired,0,0
113577,circumferential,0,0
113578,and,0,0
113579,longitudinal,0,0
113580,strain,0,0
113581,and,0,0
113582,strain,0,0
113583,rate,0,0
113584,at,0,0
113585,the,0,0
113586,isovolumic,0,0
113587,relaxation,0,1
113588,time,0,0
113589,.,0,0
113590,After,0,0
113591,restoration,0,0
113592,of,0,0
113593,euthyroidism,0,0
113594,",",0,0
113595,a,0,0
113596,significant,0,0
113597,improvement,0,0
113598,in,0,0
113599,LV,0,1
113600,systolic,0,0
113601,and,0,0
113602,diastolic,0,0
113603,function,0,0
113604,as,0,0
113605,assessed,0,0
113606,with,0,0
113607,2D-STE,0,0
113608,strain,0,0
113609,was,0,0
113610,observed,0,0
113611,.,0,0
113612,CONCLUSION,0,0
113613,Prolonged,1,0
113614,subclinical,1,0
113615,hyperthyroidism,1,0
113616,leads,0,0
113617,to,0,0
113618,systolic,0,0
113619,and,0,0
113620,diastolic,0,0
113621,dysfunction,0,0
113622,",",0,0
113623,which,0,0
113624,is,0,0
113625,reversible,0,0
113626,after,0,0
113627,restoration,0,0
113628,of,0,0
113629,euthyroidism,0,0
113630,.,0,0
113631,2D-STE,0,0
113632,is,0,0
113633,a,0,0
113634,more,0,0
113635,sensitive,0,0
113636,technique,0,1
113637,to,0,0
113638,evaluate,0,0
113639,subtle,0,0
113640,changes,0,0
113641,in,0,0
113642,LV,0,0
113643,performance,0,0
113644,of,0,0
113645,these,0,0
113646,patients,0,0
113647,.,0,0
113648,Comorbidity,0,0
113649,",",0,0
113650,age,0,0
113651,and,0,0
113652,overall,0,0
113653,survival,0,0
113654,in,0,0
113655,cetuximab-treated,1,0
113656,patients,0,0
113657,with,0,0
113658,advanced,0,0
113659,colorectal,0,0
113660,cancer,0,0
113661,(,0,0
113662,ACRC,0,0
113663,),0,0
113664,--,0,0
113665,results,0,0
113666,from,0,0
113667,NCIC,0,1
113668,CTG,0,0
113669,CO.17,0,0
113670,:,0,0
113671,a,0,0
113672,phase,0,0
113673,III,0,0
113674,trial,0,0
113675,of,0,0
113676,cetuximab,1,1
113677,versus,0,0
113678,best,1,0
113679,supportive,1,0
113680,care,1,0
113681,.,1,0
113682,BACKGROUND,0,0
113683,the,0,0
113684,interplay,0,0
113685,between,0,0
113686,comorbidity,0,0
113687,",",0,0
113688,age,0,0
113689,and,0,0
113690,performance,0,0
113691,status,0,0
113692,(,0,0
113693,PS,0,0
113694,),0,0
113695,as,0,0
113696,predictors,0,0
113697,of,0,0
113698,outcome,0,0
113699,in,0,0
113700,advanced,0,0
113701,colorectal,0,0
113702,cancer,0,0
113703,(,0,0
113704,ACRC,0,0
113705,),0,1
113706,is,0,0
113707,poorly,0,0
113708,understood,0,0
113709,.,0,0
113710,We,0,0
113711,examined,0,0
113712,these,0,0
113713,factors,0,0
113714,as,0,0
113715,predictors,0,0
113716,of,0,0
113717,treatment,0,0
113718,toxicity,0,0
113719,and,0,0
113720,outcome,0,0
113721,in,0,0
113722,cetuximab-treated,1,0
113723,patients,0,0
113724,with,0,0
113725,ACRC,0,0
113726,.,0,0
113727,PATIENTS,0,0
113728,AND,0,0
113729,METHODS,0,0
113730,comorbidity,0,0
113731,was,0,0
113732,independently,0,0
113733,evaluated,0,0
113734,using,0,0
113735,the,0,0
113736,Charlson,0,0
113737,Comorbidity,0,0
113738,Index,0,1
113739,(,0,0
113740,CCI,0,0
113741,),0,0
113742,",",0,0
113743,a,0,0
113744,validated,0,0
113745,measure,0,0
113746,of,0,0
113747,comorbidity,0,0
113748,based,0,0
113749,on,0,0
113750,the,0,0
113751,presence,0,0
113752,of,0,0
113753,medical,0,0
113754,conditions,0,0
113755,weighted,0,0
113756,according,0,0
113757,to,0,0
113758,their,0,0
113759,effect,0,0
113760,on,0,0
113761,mortality,0,0
113762,.,0,0
113763,CCI,0,0
113764,score,0,0
113765,was,0,0
113766,correlated,0,0
113767,with,0,0
113768,clinical,0,0
113769,and,0,0
113770,outcome,0,0
113771,data,0,0
113772,.,0,0
113773,RESULTS,0,0
113774,five,0,0
113775,hundred,0,0
113776,and,0,0
113777,seventy-two,0,0
113778,patients,0,0
113779,were,0,0
113780,included,0,0
113781,;,0,0
113782,41,0,0
113783,%,0,0
113784,were,0,0
113785,?,0,0
113786,65,0,0
113787,years,0,0
113788,and,0,0
113789,25,0,0
113790,%,0,0
113791,had,0,0
113792,comorbidities,0,0
113793,at,0,0
113794,randomization,0,0
113795,.,0,0
113796,In,0,0
113797,multivariate,0,0
113798,analysis,0,0
113799,(,0,0
113800,MVA,0,1
113801,),0,0
113802,of,0,0
113803,all,0,0
113804,covariates,0,0
113805,",",0,0
113806,only,0,0
113807,older,0,0
113808,age,0,0
113809,was,0,0
113810,associated,0,0
113811,with,0,0
113812,greater,0,0
113813,comorbidity,0,0
113814,(,0,0
113815,P,0,0
113816,=,0,0
113817,0.008,0,0
113818,),0,0
113819,.,0,0
113820,Overall,0,0
113821,survival,0,0
113822,(,0,0
113823,OS,0,0
113824,),0,0
113825,was,0,0
113826,significantly,0,0
113827,better,0,0
113828,for,0,0
113829,patients,0,0
113830,with,0,0
113831,greater,0,0
113832,comorbidity,0,0
113833,in,0,0
113834,univariate,0,0
113835,analysis,0,0
113836,(,0,0
113837,P,0,0
113838,=,0,0
113839,0.047,0,0
113840,),0,0
113841,.,0,0
113842,Conversely,0,0
113843,",",0,0
113844,better,0,0
113845,PS,0,0
113846,was,0,0
113847,associated,0,0
113848,with,0,0
113849,better,0,0
113850,OS,0,0
113851,in,0,0
113852,MVA,0,1
113853,(,0,0
113854,hazard,0,0
113855,ratio,0,0
113856,1.92,0,0
113857,for,0,0
113858,PS,0,0
113859,=,0,0
113860,2,0,0
113861,versus,0,0
113862,PS,0,0
113863,=,0,0
113864,0,0,0
113865,",",0,0
113866,P,0,0
113867,<,0,0
113868,0.0001,0,0
113869,),0,0
113870,.,0,0
113871,Age,0,0
113872,was,0,0
113873,not,0,0
113874,associated,0,0
113875,with,0,0
113876,OS,0,0
113877,(,0,0
113878,P,0,0
113879,=,0,0
113880,0.13,0,0
113881,),0,0
113882,.,0,0
113883,Elderly,0,0
113884,patients,0,0
113885,had,0,0
113886,significantly,0,0
113887,less,0,0
113888,grade,0,0
113889,?,0,0
113890,3,0,0
113891,vomiting,0,0
113892,(,0,0
113893,P,0,0
113894,=,0,0
113895,0.034,0,0
113896,),0,0
113897,but,0,0
113898,more,0,0
113899,dyspnea,0,0
113900,(,0,0
113901,P,0,0
113902,=,0,0
113903,0.005,0,0
113904,),0,0
113905,.,0,0
113906,Patients,0,0
113907,with,0,0
113908,greater,0,0
113909,comorbidity,0,0
113910,had,0,0
113911,significantly,0,0
113912,less,0,0
113913,grade,0,0
113914,?,0,0
113915,3,0,0
113916,vomiting,0,0
113917,(,0,0
113918,P,0,0
113919,=,0,0
113920,0.002,0,0
113921,),0,0
113922,but,0,0
113923,more,0,0
113924,non-neutropenic,0,0
113925,fever,0,0
113926,(,0,0
113927,P,0,0
113928,=,0,0
113929,0.005,0,0
113930,),0,0
113931,.,0,0
113932,CONCLUSION,0,0
113933,better,0,0
113934,PS,0,0
113935,was,0,0
113936,associated,0,0
113937,with,0,0
113938,improved,0,0
113939,OS,0,0
113940,.,0,0
113941,For,0,0
113942,patients,0,0
113943,with,0,0
113944,good,0,0
113945,PS,0,0
113946,",",0,0
113947,restricting,1,0
113948,cetuximab,1,1
113949,use,1,0
113950,in,1,0
113951,the,0,0
113952,setting,0,0
113953,of,0,0
113954,significant,0,0
113955,comorbidity,0,0
113956,does,0,0
113957,not,0,0
113958,appear,0,0
113959,justified,0,0
113960,.,0,0
113961,Efficacy,0,0
113962,of,0,0
113963,patient,1,0
113964,education,1,1
113965,and,1,0
113966,supervised,1,1
113967,exercise,1,1
113968,vs,0,0
113969,patient,1,0
113970,education,1,1
113971,alone,1,1
113972,in,0,0
113973,patients,0,0
113974,with,0,0
113975,hip,0,0
113976,osteoarthritis,0,0
113977,:,0,0
113978,a,0,0
113979,single,0,0
113980,blind,0,0
113981,randomized,0,0
113982,clinical,0,0
113983,trial,0,0
113984,.,0,0
113985,OBJECTIVE,0,0
113986,To,0,0
113987,compare,0,0
113988,the,0,0
113989,efficacy,0,0
113990,of,0,0
113991,patient,1,0
113992,education,1,1
113993,and,1,0
113994,supervised,1,1
113995,exercise,1,1
113996,with,0,0
113997,that,0,0
113998,of,0,0
113999,patient,1,0
114000,education,1,1
114001,alone,1,1
114002,for,0,0
114003,the,0,0
114004,management,0,0
114005,of,0,0
114006,pain,0,0
114007,in,0,0
114008,patients,0,0
114009,with,0,0
114010,hip,0,0
114011,osteoarthritis,0,0
114012,(,0,0
114013,OA,0,0
114014,),0,0
114015,.,0,0
114016,DESIGN,0,0
114017,Single,0,0
114018,blind,0,0
114019,randomized,0,0
114020,clinical,0,0
114021,trial,0,0
114022,.,0,0
114023,SETTING,0,0
114024,Recruitment,0,0
114025,of,0,0
114026,patients,0,0
114027,from,0,0
114028,hospitals,0,0
114029,",",0,0
114030,primary,0,0
114031,health,0,0
114032,care,0,1
114033,and,0,0
114034,advertisement,0,1
114035,",",0,0
114036,Oslo,0,0
114037,",",0,0
114038,Norway,0,0
114039,.,0,0
114040,PARTICIPANTS,0,0
114041,109,0,0
114042,patients,0,0
114043,with,0,0
114044,radiographic,0,0
114045,and,0,0
114046,symptomatic,0,0
114047,hip,0,0
114048,OA,0,0
114049,with,0,0
114050,mild,0,0
114051,to,0,0
114052,moderate,0,0
114053,symptoms,0,0
114054,.,0,0
114055,INTERVENTIONS,0,0
114056,Patient,1,1
114057,education,1,1
114058,(,1,0
114059,PE,1,1
114060,),1,0
114061,.,1,0
114062,Patient,1,0
114063,education,1,0
114064,and,1,0
114065,supervised,1,1
114066,exercise,1,1
114067,(,1,0
114068,PE+SE,1,0
114069,),1,0
114070,.,1,0
114071,PRIMARY,0,0
114072,OUTCOME,0,0
114073,MEASURE,0,0
114074,The,0,0
114075,pain,0,0
114076,subscale,0,0
114077,of,0,0
114078,the,0,0
114079,Western,0,0
114080,Ontario,0,0
114081,and,0,0
114082,McMaster,0,1
114083,Universities,0,0
114084,Osteoarthritis,0,0
114085,Index,0,1
114086,(,0,0
114087,WOMAC,0,1
114088,pain,0,0
114089,),0,0
114090,.,0,0
114091,RESULTS,0,0
114092,No,0,0
114093,significant,0,0
114094,between,0,0
114095,group,0,0
114096,differences,0,0
114097,were,0,0
114098,found,0,0
114099,for,0,0
114100,WOMAC,0,0
114101,pain,0,0
114102,over,0,0
114103,the,0,0
114104,16-month,0,0
114105,follow-up,0,0
114106,.,0,0
114107,Significant,0,0
114108,improvements,0,0
114109,were,0,0
114110,found,0,0
114111,for,0,0
114112,the,0,0
114113,secondary,0,0
114114,outcome,0,0
114115,WOMAC,0,1
114116,physical,0,1
114117,function,0,0
114118,(,0,0
114119,P=0.011,0,0
114120,),0,0
114121,in,0,0
114122,the,0,0
114123,group,0,0
114124,receiving,0,0
114125,PE+SE,1,0
114126,compared,0,0
114127,to,0,0
114128,the,0,0
114129,group,0,0
114130,receiving,0,0
114131,PE,1,1
114132,only,0,0
114133,.,0,0
114134,No,0,0
114135,significant,0,0
114136,differences,0,0
114137,were,0,0
114138,found,0,0
114139,for,0,0
114140,WOMAC,0,0
114141,stiffness,0,0
114142,",",0,0
114143,the,0,0
114144,SF-36,0,1
114145,subscales,0,0
114146,or,0,0
114147,the,0,0
114148,activity,0,0
114149,scale,0,0
114150,.,0,0
114151,The,0,0
114152,effect,0,0
114153,sizes,0,0
114154,(,0,0
114155,95,0,0
114156,%,0,0
114157,confidence,0,0
114158,interval,0,0
114159,),0,0
114160,for,0,0
114161,WOMAC,0,1
114162,pain,0,0
114163,were,0,0
114164,-0.26,0,0
114165,(,0,0
114166,0.11,0,0
114167,",",0,0
114168,-0.64,0,0
114169,),0,0
114170,",",0,0
114171,-0.35,0,0
114172,(,0,0
114173,0.07,0,0
114174,",",0,0
114175,-0.77,0,0
114176,),0,0
114177,",",0,0
114178,and,0,0
114179,-0.30,0,0
114180,(,0,0
114181,0.15,0,1
114182,",",0,0
114183,-0.75,0,0
114184,),0,0
114185,",",0,0
114186,and,0,0
114187,for,0,0
114188,WOMAC,0,1
114189,physical,0,1
114190,function,0,0
114191,-0.29,0,0
114192,(,0,0
114193,0.09,0,0
114194,",",0,0
114195,-0.67,0,0
114196,),0,0
114197,",",0,0
114198,-0.48,0,0
114199,(,0,0
114200,-0.06,0,0
114201,",",0,0
114202,-0.91,0,0
114203,),0,0
114204,",",0,0
114205,and,0,0
114206,-0.47,0,0
114207,(,0,0
114208,-0.02,0,0
114209,",",0,0
114210,-0.93,0,0
114211,),0,0
114212,at,0,0
114213,4,0,0
114214,",",0,0
114215,10,0,0
114216,and,0,0
114217,16,0,0
114218,months,0,0
114219,",",0,0
114220,respectively,0,0
114221,",",0,0
114222,in,0,0
114223,favor,0,0
114224,of,0,0
114225,the,0,0
114226,group,0,0
114227,receiving,0,0
114228,both,0,0
114229,PE,1,1
114230,and,1,0
114231,SE,1,1
114232,.,1,0
114233,All,0,0
114234,patients,0,0
114235,attended,0,0
114236,the,0,0
114237,three-session,0,1
114238,PE,1,1
114239,program,1,1
114240,",",0,0
114241,and,0,0
114242,75,0,0
114243,%,0,0
114244,performed,0,0
114245,?16,0,0
114246,sessions,0,1
114247,of,0,0
114248,the,0,0
114249,12-week,1,0
114250,SE,1,1
114251,program,1,1
114252,.,0,0
114253,CONCLUSION,0,0
114254,The,0,0
114255,study,0,0
114256,could,0,0
114257,not,0,0
114258,demonstrate,0,0
114259,a,0,0
114260,significant,0,0
114261,difference,0,0
114262,in,0,0
114263,pain,0,0
114264,reduction,0,0
114265,over,0,0
114266,time,0,0
114267,between,1,0
114268,PE+SE,1,0
114269,vs,1,0
114270,PE,1,1
114271,alone,1,1
114272,.,1,0
114273,Adding,1,0
114274,SE,1,0
114275,to,1,0
114276,PE,1,1
114277,may,1,0
114278,improve,0,0
114279,physical,0,0
114280,function,0,0
114281,",",0,0
114282,but,0,0
114283,the,0,0
114284,magnitude,0,0
114285,of,0,0
114286,possible,0,0
114287,benefit,0,0
114288,is,0,0
114289,unknown,0,0
114290,as,0,0
114291,the,0,0
114292,95,0,0
114293,%,0,0
114294,confidence,0,0
114295,intervals,0,0
114296,around,0,0
114297,the,0,0
114298,mean,0,0
114299,difference,0,0
114300,were,0,0
114301,wide,0,0
114302,.,0,0
114303,TRIAL,0,0
114304,REGISTRATION,0,0
114305,Clinical,0,0
114306,Trials,0,0
114307,NCT00319423,0,0
114308,.,0,0
114309,Effect,0,0
114310,of,0,0
114311,developmental,1,0
114312,speech,1,1
114313,and,1,0
114314,language,1,0
114315,training,1,1
114316,through,1,0
114317,music,1,1
114318,on,0,0
114319,speech,0,1
114320,production,0,0
114321,in,0,0
114322,children,0,0
114323,with,0,0
114324,autism,0,0
114325,spectrum,0,0
114326,disorders,0,0
114327,.,0,0
114328,The,0,0
114329,study,0,0
114330,compared,0,0
114331,the,0,0
114332,effect,0,0
114333,of,0,0
114334,music,1,1
114335,training,1,1
114336,",",1,0
114337,speech,1,1
114338,training,1,1
114339,and,0,0
114340,no-training,1,1
114341,on,0,0
114342,the,0,0
114343,verbal,0,1
114344,production,0,0
114345,of,0,0
114346,children,0,0
114347,with,0,0
114348,Autism,0,0
114349,Spectrum,0,1
114350,Disorders,0,0
114351,(,0,0
114352,ASD,0,0
114353,),0,0
114354,.,0,0
114355,Participants,0,0
114356,were,0,0
114357,50,0,0
114358,children,0,0
114359,with,0,0
114360,ASD,0,0
114361,",",0,0
114362,age,0,0
114363,range,0,0
114364,3,0,0
114365,to,0,0
114366,5,0,0
114367,years,0,0
114368,",",0,0
114369,who,0,0
114370,had,0,0
114371,previously,0,0
114372,been,0,0
114373,evaluated,0,0
114374,on,0,0
114375,standard,0,0
114376,tests,0,0
114377,of,0,0
114378,language,0,0
114379,and,0,0
114380,level,0,0
114381,of,0,0
114382,functioning,0,0
114383,.,0,0
114384,They,0,0
114385,were,0,0
114386,randomly,0,0
114387,assigned,0,0
114388,to,0,0
114389,one,0,0
114390,of,0,0
114391,three,0,0
114392,3-day,0,0
114393,conditions,0,0
114394,.,0,0
114395,Participants,0,0
114396,in,0,0
114397,music,1,1
114398,training,1,1
114399,(,0,0
114400,n,0,0
114401,=,0,0
114402,18,0,0
114403,),0,0
114404,watched,0,0
114405,a,0,0
114406,music,1,1
114407,video,1,1
114408,containing,1,1
114409,6,1,0
114410,songs,1,0
114411,and,1,0
114412,pictures,1,0
114413,of,1,0
114414,the,1,0
114415,36,1,0
114416,target,1,0
114417,words,1,1
114418,;,1,0
114419,those,0,0
114420,in,0,0
114421,speech,1,1
114422,training,1,1
114423,(,0,0
114424,n,0,0
114425,=,0,0
114426,18,0,0
114427,),0,0
114428,watched,0,0
114429,a,0,0
114430,speech,1,1
114431,video,1,1
114432,containing,1,1
114433,6,1,0
114434,stories,1,1
114435,and,1,0
114436,pictures,1,1
114437,",",0,0
114438,and,0,0
114439,those,0,0
114440,in,0,0
114441,the,0,0
114442,control,1,1
114443,condition,1,0
114444,(,0,0
114445,n,0,0
114446,=,0,0
114447,14,0,0
114448,),0,0
114449,received,0,0
114450,no,1,0
114451,treatment,1,0
114452,.,1,0
114453,Participants,0,0
114454,',0,0
114455,verbal,0,1
114456,production,0,0
114457,including,0,0
114458,semantics,0,0
114459,",",0,0
114460,phonology,0,0
114461,",",0,0
114462,pragmatics,0,0
114463,",",0,0
114464,and,0,0
114465,prosody,0,1
114466,was,0,0
114467,measured,0,0
114468,by,0,0
114469,an,0,0
114470,experimenter,0,0
114471,designed,0,0
114472,verbal,0,1
114473,production,0,0
114474,evaluation,0,0
114475,scale,0,0
114476,.,0,0
114477,Results,0,0
114478,showed,0,0
114479,that,0,0
114480,participants,0,0
114481,in,0,0
114482,both,0,0
114483,music,1,1
114484,and,0,0
114485,speech,1,1
114486,training,1,1
114487,significantly,0,0
114488,increased,0,0
114489,their,0,0
114490,pre,0,0
114491,to,0,0
114492,posttest,0,0
114493,verbal,0,1
114494,production,0,0
114495,.,0,0
114496,Results,0,0
114497,also,0,0
114498,indicated,0,0
114499,that,0,0
114500,both,0,0
114501,high,0,0
114502,and,0,0
114503,low,0,0
114504,functioning,0,0
114505,participants,0,0
114506,improved,0,0
114507,their,0,0
114508,speech,0,1
114509,production,0,0
114510,after,0,0
114511,receiving,0,0
114512,either,0,0
114513,music,0,1
114514,or,0,1
114515,speech,0,1
114516,training,0,1
114517,;,0,0
114518,however,0,0
114519,",",0,0
114520,low,0,0
114521,functioning,0,0
114522,participants,0,0
114523,showed,0,0
114524,a,0,0
114525,greater,0,0
114526,improvement,0,0
114527,after,0,0
114528,the,0,0
114529,music,1,1
114530,training,1,1
114531,than,0,0
114532,the,0,0
114533,speech,0,1
114534,training,0,1
114535,.,0,0
114536,Children,0,0
114537,with,0,0
114538,ASD,0,0
114539,perceive,0,0
114540,important,0,0
114541,linguistic,0,1
114542,information,0,0
114543,embedded,0,1
114544,in,0,0
114545,music,0,1
114546,stimuli,0,1
114547,organized,0,1
114548,by,0,0
114549,principles,0,0
114550,of,0,0
114551,pattern,0,0
114552,perception,0,0
114553,",",0,0
114554,and,0,0
114555,produce,0,0
114556,the,0,0
114557,functional,0,0
114558,speech,0,1
114559,.,0,0
114560,Prospective,0,0
114561,randomized,0,0
114562,trial,0,0
114563,of,0,0
114564,short-term,1,0
114565,neoadjuvant,1,1
114566,chemotherapy,1,1
114567,for,0,0
114568,advanced,0,0
114569,gastric,0,0
114570,cancer,0,0
114571,.,0,0
114572,BACKGROUND,0,0
114573,We,0,0
114574,performed,0,0
114575,short-term,1,0
114576,neoadjuvant,1,1
114577,chemotherapy,1,1
114578,(,1,0
114579,s-NAC,1,0
114580,),1,0
114581,to,0,0
114582,examine,0,0
114583,whether,0,0
114584,anticancer,0,0
114585,drugs,0,0
114586,can,0,0
114587,change,0,0
114588,the,0,0
114589,proliferative,0,0
114590,ability,0,0
114591,of,0,0
114592,cancer,0,0
114593,cells,0,0
114594,in,0,0
114595,gastric,0,0
114596,cancer,0,0
114597,patients,0,0
114598,.,0,0
114599,METHODS,0,0
114600,Chemotherapy,0,1
114601,was,0,0
114602,performed,0,0
114603,for,0,0
114604,72,0,0
114605,h,0,0
114606,before,0,0
114607,gastrectomy,0,0
114608,in,0,0
114609,63,0,0
114610,gastric,0,0
114611,cancer,0,0
114612,patients,0,0
114613,.,0,0
114614,Patients,0,0
114615,were,0,0
114616,classed,0,0
114617,into,0,0
114618,four,0,0
114619,groups,0,0
114620,:,0,0
114621,Group,0,0
114622,F,0,0
114623,",",0,0
114624,16,0,0
114625,cases,0,0
114626,who,0,0
114627,received,0,0
114628,a,0,0
114629,single,0,0
114630,administration,0,0
114631,of,0,0
114632,5-fluorouracil,1,1
114633,(,1,0
114634,5-FU,1,1
114635,),1,0
114636,;,1,0
114637,Group,0,0
114638,C,0,0
114639,",",0,0
114640,15,0,0
114641,cases,0,0
114642,who,0,0
114643,received,0,0
114644,a,0,0
114645,single,0,0
114646,administration,0,0
114647,of,0,0
114648,cis-diamminedichloroplatinum,1,1
114649,(,1,0
114650,CDDP,1,0
114651,;,1,0
114652,cisplatin,1,1
114653,),1,0
114654,;,1,0
114655,Group,0,0
114656,FC,0,0
114657,",",0,0
114658,16,0,0
114659,cases,0,0
114660,who,0,0
114661,received,0,0
114662,both,0,0
114663,5-FU+CDDP,1,0
114664,;,1,0
114665,and,0,0
114666,a,0,0
114667,Control,0,1
114668,group,0,0
114669,",",0,0
114670,16,0,0
114671,cases,0,0
114672,who,0,0
114673,did,0,0
114674,not,1,0
114675,receive,1,0
114676,chemotherapy,1,1
114677,.,1,0
114678,We,0,0
114679,reviewed,0,0
114680,neoadjuvant,0,1
114681,biopsy,0,1
114682,tissue,0,0
114683,and,0,0
114684,gastric,0,0
114685,cancer,0,0
114686,tissue,0,0
114687,delivered,0,1
114688,by,0,0
114689,operation,0,0
114690,in,0,0
114691,these,0,0
114692,cases,0,0
114693,.,0,0
114694,The,0,0
114695,TUNEL,0,0
114696,method,0,0
114697,and,0,0
114698,immunohistochemistry,0,0
114699,with,0,0
114700,an,0,0
114701,anti-MIB-1,0,0
114702,antibody,0,0
114703,were,0,0
114704,used,0,0
114705,to,0,0
114706,evaluate,0,0
114707,cellular,0,0
114708,apoptosis,0,0
114709,and,0,0
114710,proliferative,0,0
114711,ability,0,0
114712,",",0,0
114713,respectively,0,0
114714,.,0,0
114715,The,0,0
114716,apoptotic,0,0
114717,index,0,0
114718,(,0,0
114719,AI,0,1
114720,),0,0
114721,and,0,0
114722,an,0,0
114723,MIB-1,0,0
114724,index,0,0
114725,(,0,0
114726,MI,0,1
114727,),0,0
114728,were,0,0
114729,also,0,0
114730,calculated,0,0
114731,.,0,0
114732,RESULTS,0,0
114733,There,0,0
114734,were,0,0
114735,no,0,0
114736,differences,0,0
114737,in,0,0
114738,AI,0,0
114739,or,0,1
114740,MI,0,1
114741,in,0,0
114742,biopsy,0,1
114743,tissue,0,0
114744,between,0,0
114745,the,0,0
114746,groups,0,0
114747,.,0,0
114748,The,0,0
114749,AI,0,0
114750,of,0,0
114751,gastric,0,0
114752,cancer,0,0
114753,tissue,0,0
114754,in,0,0
114755,Group,0,0
114756,FC,0,0
114757,was,0,0
114758,significantly,0,0
114759,higher,0,0
114760,than,0,0
114761,in,0,0
114762,the,0,0
114763,other,0,0
114764,groups,0,0
114765,(,0,0
114766,P,0,0
114767,<,0,0
114768,0.01,0,0
114769,),0,0
114770,.,0,0
114771,The,0,0
114772,MI,0,0
114773,of,0,0
114774,Group,0,0
114775,FC,0,0
114776,was,0,0
114777,significantly,0,0
114778,lower,0,0
114779,than,0,0
114780,in,0,0
114781,the,0,0
114782,other,0,0
114783,groups,0,0
114784,(,0,0
114785,P,0,0
114786,<,0,0
114787,0.05,0,0
114788,),0,0
114789,.,0,0
114790,In,0,0
114791,addition,0,0
114792,",",0,0
114793,after,0,0
114794,s-NAC,1,0
114795,operation,0,0
114796,there,0,0
114797,was,0,0
114798,a,0,0
114799,significant,0,0
114800,inhibition,0,0
114801,of,0,0
114802,proliferative,0,0
114803,potency,0,0
114804,and,0,0
114805,an,0,0
114806,induction,0,0
114807,of,0,0
114808,apoptosis,0,0
114809,in,0,0
114810,Group,0,0
114811,FC,0,0
114812,.,0,0
114813,CONCLUSION,0,0
114814,Combination,1,0
114815,of,1,0
114816,CDDP,1,0
114817,and,1,0
114818,5-FU,1,1
114819,reduced,0,0
114820,proliferative,0,0
114821,potency,0,0
114822,and,0,0
114823,increased,0,0
114824,cellular,0,0
114825,apoptosis,0,0
114826,in,0,0
114827,gastric,0,0
114828,cancer,0,0
114829,cells,0,0
114830,.,0,0
114831,Niacin,1,1
114832,revisited,0,0
114833,.,0,0
114834,A,0,0
114835,randomized,0,0
114836,",",0,0
114837,controlled,0,0
114838,trial,0,0
114839,of,0,0
114840,wax-matrix,1,1
114841,sustained-release,1,1
114842,niacin,1,1
114843,in,0,0
114844,hypercholesterolemia,0,0
114845,.,0,0
114846,Two,0,0
114847,hundred,0,0
114848,one,0,0
114849,male,0,0
114850,and,0,0
114851,female,0,0
114852,subjects,0,0
114853,",",0,0
114854,aged,0,0
114855,20,0,0
114856,to,0,0
114857,70,0,0
114858,years,0,0
114859,",",0,0
114860,with,0,0
114861,elevated,0,0
114862,low-density,0,0
114863,lipoprotein,0,0
114864,cholesterol,0,0
114865,values,0,0
114866,(,0,0
114867,in,0,0
114868,the,0,0
114869,75th,0,0
114870,to,0,0
114871,95th,0,0
114872,percentiles,0,0
114873,),0,0
114874,",",0,0
114875,participated,0,0
114876,in,0,0
114877,a,0,0
114878,randomized,0,0
114879,",",0,0
114880,controlled,0,0
114881,",",0,0
114882,double-blind,0,0
114883,study,0,0
114884,using,0,0
114885,a,0,0
114886,new,0,0
114887,form,0,0
114888,of,0,0
114889,niacin,1,1
114890,(,1,0
114891,Enduracin,1,1
114892,),1,0
114893,",",0,0
114894,which,0,0
114895,employs,0,0
114896,a,0,0
114897,wax-matrix,0,1
114898,vehicle,0,1
114899,for,0,0
114900,sustained,0,0
114901,release,0,0
114902,.,0,0
114903,Four,0,0
114904,niacin,1,1
114905,treatment,0,0
114906,groups,0,0
114907,(,0,0
114908,daily,0,0
114909,doses,0,0
114910,of,0,0
114911,2000,0,0
114912,",",0,0
114913,1500,0,0
114914,",",0,0
114915,1250,0,0
114916,",",0,0
114917,and,0,0
114918,1000,0,0
114919,mg,0,1
114920,),0,0
114921,were,0,0
114922,compared,0,0
114923,with,0,0
114924,placebo-,1,1
114925,and,1,0
114926,diet-treated,1,0
114927,controls,1,0
114928,to,0,0
114929,determine,0,0
114930,side-effect,0,0
114931,profile,0,0
114932,and,0,0
114933,optimal,0,0
114934,range,0,0
114935,of,0,0
114936,efficacy,0,0
114937,.,0,0
114938,The,0,0
114939,groups,0,0
114940,given,0,0
114941,2000,0,0
114942,and,0,0
114943,1500,0,0
114944,mg,0,0
114945,demonstrated,0,0
114946,significant,0,0
114947,reductions,0,0
114948,in,0,0
114949,values,0,0
114950,of,0,0
114951,low-density,0,0
114952,lipoprotein,0,0
114953,cholesterol,0,0
114954,(,0,0
114955,-26,0,0
114956,%,0,0
114957,and,0,0
114958,-19.3,0,0
114959,%,0,0
114960,",",0,0
114961,respectively,0,0
114962,),0,0
114963,",",0,0
114964,total,0,0
114965,cholesterol,0,0
114966,(,0,0
114967,-18.4,0,0
114968,%,0,0
114969,and,0,0
114970,-13.3,0,0
114971,%,0,0
114972,),0,0
114973,",",0,0
114974,and,0,0
114975,total,0,0
114976,cholesterol-high-density,0,1
114977,lipoprotein,0,0
114978,cholesterol,0,0
114979,ratio,0,0
114980,(,0,0
114981,-20.4,0,0
114982,%,0,0
114983,and,0,0
114984,-19.4,0,0
114985,%,0,0
114986,),0,0
114987,when,0,0
114988,compared,0,0
114989,with,0,0
114990,diet-,0,0
114991,and,0,0
114992,placebo-treated,0,0
114993,controls,0,0
114994,.,0,0
114995,Smaller,0,0
114996,improvements,0,0
114997,were,0,0
114998,seen,0,0
114999,in,0,0
115000,high-density,0,0
115001,lipoprotein,0,0
115002,cholesterol,0,0
115003,and,0,0
115004,triglyceride,0,0
115005,levels,0,0
115006,.,0,0
115007,Blood,0,0
115008,chemistry,0,0
115009,monitoring,0,0
115010,indicated,0,0
115011,that,0,0
115012,reduction,0,0
115013,in,0,0
115014,low-density,0,0
115015,lipoprotein,0,0
115016,cholesterol,0,0
115017,level,0,0
115018,strongly,0,0
115019,correlated,0,0
115020,with,0,0
115021,an,0,0
115022,increase,0,0
115023,in,0,0
115024,baseline,0,0
115025,levels,0,0
115026,of,0,0
115027,some,0,0
115028,enzymes,0,0
115029,for,0,0
115030,niacin-treated,0,0
115031,subjects,0,0
115032,.,0,0
115033,The,0,0
115034,improved,0,0
115035,side-effect,0,0
115036,profile,0,0
115037,of,0,0
115038,the,0,0
115039,wax-matrix,0,1
115040,form,0,0
115041,of,0,0
115042,niacin,1,1
115043,was,0,0
115044,particularly,0,0
115045,notable,0,0
115046,.,0,0
115047,The,0,0
115048,dropout,0,0
115049,rate,0,0
115050,due,0,0
115051,to,0,0
115052,side,0,0
115053,effects,0,0
115054,was,0,0
115055,only,0,0
115056,3.4,0,0
115057,%,0,0
115058,and,0,0
115059,was,0,0
115060,coupled,0,0
115061,with,0,0
115062,good,0,0
115063,medication,0,0
115064,compliance,0,0
115065,.,0,0
115066,Rationale,0,0
115067,and,0,0
115068,design,0,0
115069,of,0,0
115070,a,0,0
115071,randomized,0,0
115072,trial,0,0
115073,to,0,0
115074,evaluate,0,0
115075,an,0,0
115076,evidence-based,1,1
115077,prescription,1,1
115078,drug,1,0
115079,label,1,0
115080,on,0,0
115081,actual,0,0
115082,medication,0,0
115083,use,0,0
115084,.,0,0
115085,BACKGROUND,0,0
115086,Medication,0,0
115087,errors,0,0
115088,are,0,0
115089,an,0,0
115090,important,0,0
115091,public,0,0
115092,health,0,0
115093,concern,0,0
115094,",",0,0
115095,and,0,0
115096,poor,0,0
115097,understanding,0,0
115098,of,0,0
115099,medication,0,0
115100,labels,0,0
115101,are,0,0
115102,a,0,0
115103,root,0,0
115104,cause,0,0
115105,.,0,0
115106,Research,0,0
115107,shows,0,0
115108,that,0,0
115109,labels,0,0
115110,are,0,0
115111,variable,0,0
115112,",",0,0
115113,of,0,0
115114,poor,0,0
115115,quality,0,0
115116,",",0,0
115117,and,0,0
115118,not,0,0
115119,patient-centered,0,1
115120,.,0,0
115121,No,0,0
115122,real-world,0,0
115123,trials,0,0
115124,have,0,0
115125,evaluated,0,0
115126,whether,0,0
115127,improved,0,0
115128,medication,0,0
115129,labels,0,0
115130,can,0,0
115131,affect,0,0
115132,appropriate,0,0
115133,medication,0,0
115134,use,0,0
115135,",",0,0
115136,adherence,0,0
115137,or,0,1
115138,health,0,0
115139,outcomes,0,0
115140,.,0,0
115141,TRIAL,0,0
115142,DESIGN,0,0
115143,We,0,0
115144,developed,0,0
115145,an,0,0
115146,evidence-based,1,1
115147,prescription,1,0
115148,label,1,0
115149,that,0,0
115150,addresses,0,0
115151,both,0,0
115152,content,0,0
115153,and,0,0
115154,format,0,1
115155,.,0,0
115156,The,0,0
115157,enhanced,1,0
115158,label,1,0
115159,includes,0,0
115160,a,0,0
115161,universal,0,0
115162,medication,0,1
115163,schedule,0,1
115164,(,0,0
115165,UMS,0,0
115166,),0,0
115167,that,0,0
115168,standardizes,0,0
115169,the,0,0
115170,directions,0,0
115171,for,0,0
115172,use,0,0
115173,incorporating,0,0
115174,1,0,0
115175,),0,0
115176,standard,0,1
115177,time,0,0
115178,periods,0,0
115179,for,0,0
115180,administration,0,0
115181,(,0,0
115182,morning,0,0
115183,",",0,0
115184,noon,0,0
115185,",",0,0
115186,evening,0,0
115187,",",0,0
115188,and,0,0
115189,bedtime,0,1
115190,),0,0
115191,",",0,0
115192,2,0,0
115193,),0,0
115194,numeric,0,0
115195,vs.,0,0
115196,alpha,0,0
115197,characters,0,0
115198,",",0,0
115199,3,0,0
115200,),0,0
115201,'carriage,0,0
115202,returns,0,0
115203,',0,0
115204,to,0,0
115205,separate,0,0
115206,daily,0,1
115207,dose,0,0
115208,and,0,0
115209,4,0,0
115210,),0,0
115211,a,0,0
115212,graphic,0,1
115213,aid,0,0
115214,to,0,0
115215,visually,0,0
115216,depict,0,0
115217,dose,0,0
115218,and,0,0
115219,frequency,0,0
115220,.,0,0
115221,We,0,0
115222,will,0,0
115223,evaluate,0,0
115224,the,0,0
115225,effect,0,0
115226,of,0,0
115227,providing,0,0
115228,this,0,0
115229,label,1,0
115230,to,0,0
115231,randomly,0,0
115232,sampled,0,0
115233,patients,0,0
115234,who,0,0
115235,receive,0,0
115236,their,0,0
115237,care,0,0
115238,from,0,0
115239,free,0,0
115240,clinics,0,0
115241,",",0,0
115242,mobile,0,1
115243,vans,0,1
115244,and,0,0
115245,federally,0,0
115246,qualified,0,0
115247,health,0,0
115248,centers,0,0
115249,(,0,0
115250,FQHCs,0,1
115251,),0,0
115252,in,0,0
115253,Northern,0,0
115254,Virginia,0,0
115255,.,0,0
115256,We,0,0
115257,will,0,0
115258,recruit,0,0
115259,patients,0,0
115260,with,0,0
115261,diabetes,0,0
115262,or,0,0
115263,hypertension,0,0
115264,;,0,0
115265,these,0,0
115266,patients,0,0
115267,will,0,0
115268,be,0,0
115269,randomly,0,0
115270,assigned,0,0
115271,to,0,0
115272,receive,0,0
115273,all,0,0
115274,of,0,0
115275,their,0,0
115276,medications,0,0
115277,with,0,0
115278,improved,0,0
115279,labels,0,0
115280,or,0,0
115281,to,0,0
115282,receive,0,0
115283,prescriptions,0,0
115284,with,0,0
115285,standard,0,0
115286,labels,0,0
115287,.,0,0
115288,The,0,0
115289,primary,0,0
115290,outcome,0,0
115291,will,0,0
115292,be,0,0
115293,the,0,0
115294,patient,0,0
115295,'s,0,0
115296,ability,0,0
115297,to,0,0
115298,correctly,0,0
115299,demonstrate,0,0
115300,dosing,0,0
115301,instructions,0,1
115302,.,0,0
115303,Other,0,0
115304,outcomes,0,0
115305,include,0,0
115306,adherence,0,0
115307,",",0,0
115308,error,0,0
115309,rates,0,0
115310,and,0,0
115311,health,0,0
115312,outcomes,0,0
115313,.,0,0
115314,CONCLUSION,0,0
115315,To,0,0
115316,our,0,0
115317,knowledge,0,0
115318,",",0,0
115319,this,0,0
115320,trial,0,0
115321,is,0,0
115322,the,0,0
115323,first,0,0
115324,to,0,0
115325,evaluate,0,0
115326,the,0,0
115327,effect,0,0
115328,of,0,0
115329,prescription,0,1
115330,label,0,0
115331,improvement,0,0
115332,on,0,0
115333,understanding,0,0
115334,",",0,0
115335,medication,0,1
115336,use,0,0
115337,and,0,0
115338,outcomes,0,0
115339,in,0,0
115340,a,0,0
115341,clinical,0,0
115342,setting,0,0
115343,.,0,0
115344,If,0,0
115345,successful,0,0
115346,",",0,0
115347,these,0,0
115348,findings,0,0
115349,could,0,0
115350,be,0,0
115351,implemented,0,0
115352,broadly,0,0
115353,to,0,0
115354,promote,0,0
115355,safe,0,0
115356,and,0,0
115357,appropriate,0,0
115358,medication,0,1
115359,use,0,0
115360,and,0,0
115361,to,0,0
115362,support,0,0
115363,evidence-based,0,1
115364,standards,0,0
115365,in,0,0
115366,the,0,0
115367,development,0,0
115368,of,0,0
115369,labels,0,0
115370,.,0,0
115371,Letter,0,0
115372,by,0,0
115373,Begg,0,1
115374,et,0,1
115375,al,0,0
115376,regarding,0,0
115377,article,0,0
115378,",",0,0
115379,The,0,0
115380,effects,0,0
115381,of,0,0
115382,vitamin,1,1
115383,d,1,1
115384,supplementation,1,1
115385,on,0,0
115386,physical,0,1
115387,function,0,0
115388,and,0,0
115389,quality,0,0
115390,of,0,0
115391,life,0,0
115392,in,0,0
115393,older,0,0
115394,heart,0,0
115395,failure,0,0
115396,patients,0,0
115397,:,0,0
115398,a,0,0
115399,randomized,0,0
115400,controlled,0,0
115401,trial,0,0
115402,.,0,0
115403,Tensile,0,1
115404,bond,0,0
115405,strength,0,0
115406,of,0,0
115407,a,0,0
115408,lithium-disilicate,1,1
115409,pressed,1,1
115410,glass,1,1
115411,ceramic,1,1
115412,to,0,0
115413,dentin,0,0
115414,of,0,0
115415,different,0,0
115416,surface,0,0
115417,treatments,0,0
115418,.,0,0
115419,The,0,0
115420,effects,0,0
115421,of,0,0
115422,desensitizer,0,1
115423,",",0,0
115424,disinfectant,0,1
115425,",",0,0
115426,saliva,0,0
115427,",",0,0
115428,blood,0,0
115429,",",0,0
115430,and,0,0
115431,hydrogen,0,1
115432,peroxide,0,1
115433,on,0,0
115434,the,0,0
115435,tensile,0,0
115436,bond,0,0
115437,strength,0,0
115438,between,0,0
115439,adhesive,0,1
115440,and,0,0
115441,ceramic,0,1
115442,as,0,0
115443,well,0,0
115444,as,0,0
115445,between,0,0
115446,adhesive,0,1
115447,and,0,0
115448,dentin,0,0
115449,were,0,0
115450,examined,0,0
115451,.,0,0
115452,Sixty,0,0
115453,7x3,0,1
115454,mm,0,0
115455,pressed,0,0
115456,ceramic,0,1
115457,discs,0,0
115458,of,0,0
115459,IPS,0,0
115460,e.max,0,0
115461,were,0,0
115462,fabricated,0,1
115463,and,0,0
115464,randomly,0,0
115465,assigned,0,0
115466,to,0,0
115467,six,0,0
115468,groups,0,0
115469,of,0,0
115470,different,0,0
115471,dentin,1,0
115472,surface,1,0
115473,treatments,1,1
115474,(,1,0
115475,control,1,0
115476,",",1,0
115477,desensitizer,1,1
115478,",",1,0
115479,disinfectant,1,1
115480,",",1,0
115481,saliva,1,0
115482,",",1,0
115483,blood,1,0
115484,",",1,0
115485,and,1,0
115486,hydrogen,1,1
115487,peroxide,1,1
115488,),1,0
115489,.,0,0
115490,Representative,0,0
115491,samples,0,0
115492,of,0,0
115493,fractured,0,0
115494,specimens,0,0
115495,were,0,0
115496,observed,0,0
115497,by,0,0
115498,SEM,0,1
115499,(,1,0
115500,scanning,1,1
115501,electron,1,1
115502,microscopy,1,1
115503,),1,0
115504,.,0,0
115505,There,0,0
115506,were,0,0
115507,significant,0,0
115508,differences,0,0
115509,between,0,0
115510,the,0,0
115511,control,0,1
115512,group,0,0
115513,and,0,0
115514,saliva,0,0
115515,",",0,0
115516,blood,0,0
115517,",",0,0
115518,and,0,0
115519,hydrogen,0,1
115520,peroxide,0,1
115521,groups,0,0
115522,(,0,0
115523,p,0,0
115524,<,0,0
115525,0.05,0,0
115526,),0,0
115527,.,0,0
115528,However,0,0
115529,",",0,0
115530,there,0,0
115531,were,0,0
115532,no,0,0
115533,significant,0,0
115534,differences,0,0
115535,between,0,0
115536,any,0,0
115537,other,0,0
115538,dentin,0,0
115539,surface,0,0
115540,treatment,0,0
115541,groups,0,0
115542,(,0,0
115543,p,0,0
115544,>,0,0
115545,0.05,0,0
115546,),0,0
115547,.,0,0
115548,Results,0,0
115549,of,0,0
115550,this,0,0
115551,study,0,0
115552,suggested,0,0
115553,that,0,0
115554,only,0,0
115555,saliva,0,0
115556,",",0,0
115557,blood,0,0
115558,",",0,0
115559,and,0,0
115560,hydrogen,0,1
115561,peroxide,0,1
115562,influenced,0,0
115563,the,0,0
115564,tensile,0,0
115565,bond,0,0
115566,strength,0,0
115567,between,0,0
115568,dentin,0,0
115569,and,0,0
115570,ceramic,0,1
115571,.,0,0
115572,Cost-effectiveness,0,0
115573,of,0,0
115574,cognitive-behavioral,1,1
115575,group,1,0
115576,therapy,1,1
115577,for,0,0
115578,dysfunctional,0,0
115579,fear,0,0
115580,of,0,0
115581,progression,0,0
115582,in,0,0
115583,cancer,0,0
115584,patients,0,0
115585,.,0,0
115586,Anxiety,0,0
115587,and,0,0
115588,fear,0,0
115589,are,0,0
115590,often,0,0
115591,associated,0,0
115592,with,0,0
115593,chronic,0,0
115594,conditions,0,0
115595,such,0,0
115596,as,0,0
115597,cancer,0,0
115598,.,0,0
115599,This,0,0
115600,paper,0,0
115601,targets,0,0
115602,the,0,0
115603,cost-effectiveness,0,0
115604,analysis,0,0
115605,of,0,0
115606,a,0,0
115607,cognitive-behavioral,1,1
115608,group,1,0
115609,therapy,1,1
115610,(,1,0
115611,CBT,1,1
115612,),1,0
115613,in,0,0
115614,comparison,0,0
115615,to,0,0
115616,a,0,0
115617,client-centered,1,1
115618,",",1,0
115619,supportive-experiential,1,1
115620,group,1,0
115621,therapy,1,1
115622,(,1,0
115623,SET,1,0
115624,),1,0
115625,in,0,0
115626,cancer,0,0
115627,patients,0,0
115628,with,0,0
115629,dysfunctional,0,0
115630,fear,0,0
115631,of,0,0
115632,progression,0,0
115633,.,0,0
115634,An,0,0
115635,incremental,0,0
115636,cost-effectiveness,0,0
115637,analysis,0,0
115638,was,0,0
115639,performed,0,0
115640,using,0,0
115641,data,0,0
115642,from,0,0
115643,a,0,0
115644,randomized,0,0
115645,controlled,0,0
115646,trial,0,0
115647,among,0,0
115648,cancer,0,0
115649,patients,0,0
115650,receiving,0,0
115651,inpatient,0,0
115652,rehabilitation,0,1
115653,.,0,0
115654,The,0,0
115655,means,0,0
115656,",",0,0
115657,95,0,0
115658,%,0,0
115659,confidence,0,0
115660,intervals,0,0
115661,[,0,0
115662,95,0,0
115663,%,0,0
115664,CI,0,0
115665,],0,0
115666,",",0,0
115667,incremental,0,0
115668,cost-effectiveness,0,0
115669,graphic,0,1
115670,and,0,0
115671,acceptability,0,0
115672,curve,0,0
115673,were,0,0
115674,obtained,0,0
115675,from,0,0
115676,"1,000",0,0
115677,bootstrap,0,0
115678,replications,0,0
115679,.,0,0
115680,A,0,0
115681,total,0,0
115682,of,0,0
115683,174,0,0
115684,patients,0,0
115685,were,0,0
115686,included,0,0
115687,in,0,0
115688,the,0,0
115689,economic,0,0
115690,evaluation,0,0
115691,.,0,0
115692,The,0,0
115693,estimated,0,0
115694,means,0,0
115695,[,0,0
115696,95,0,0
115697,%,0,0
115698,CI,0,0
115699,],0,0
115700,of,0,0
115701,direct,0,0
115702,costs,0,0
115703,and,0,0
115704,reduction,0,0
115705,of,0,0
115706,fear,0,0
115707,of,0,0
115708,progression,0,0
115709,were,0,0
115710,<,0,0
115711,euro,0,0
115712,>,0,0
115713,"9,045.03",0,0
115714,[,0,0
115715,"6,359.07",0,0
115716,;,0,0
115717,"12,091.87",0,0
115718,],0,0
115719,and,0,0
115720,1.41,0,0
115721,[,0,0
115722,0.93,0,0
115723,;,0,0
115724,1.92,0,0
115725,],0,0
115726,for,0,0
115727,patients,0,0
115728,in,0,0
115729,the,0,0
115730,SET,0,0
115731,and,0,0
115732,<,0,0
115733,euro,0,0
115734,>,0,0
115735,"6,682.78",0,0
115736,[,0,0
115737,"4,998.09",0,0
115738,;,0,0
115739,"8,440.95",0,0
115740,],0,0
115741,and,0,0
115742,1.44,0,0
115743,[,0,0
115744,1.02,0,0
115745,;,0,0
115746,1.09,0,0
115747,],0,0
115748,for,0,0
115749,patients,0,0
115750,in,0,0
115751,the,0,0
115752,CBT,1,1
115753,.,1,0
115754,The,0,0
115755,incremental,0,0
115756,cost-effectiveness,0,0
115757,ratio,0,0
115758,[,0,0
115759,95,0,0
115760,%,0,0
115761,CI,0,0
115762,],0,0
115763,amounts,0,0
115764,to,0,0
115765,minus,0,0
115766,<,0,0
115767,euro,0,0
115768,>,0,0
115769,"78,741.66",0,0
115770,[,0,0
115771,"-154,987.20",0,0
115772,;,0,0
115773,"110,486.32",0,0
115774,],0,0
115775,for,0,0
115776,an,0,0
115777,additional,0,0
115778,unit,0,0
115779,of,0,0
115780,effect,0,0
115781,.,0,0
115782,Given,0,0
115783,the,0,0
115784,acceptability,0,0
115785,curve,0,0
115786,",",0,0
115787,there,0,0
115788,is,0,0
115789,a,0,0
115790,92.4,0,0
115791,%,0,0
115792,chance,0,0
115793,that,0,0
115794,the,0,0
115795,CBT,1,1
115796,",",0,0
115797,compared,0,0
115798,with,0,0
115799,the,0,0
115800,SET,1,0
115801,",",0,0
115802,is,0,0
115803,cost-effective,0,0
115804,without,0,0
115805,the,0,0
115806,need,0,0
115807,of,0,0
115808,additional,0,0
115809,costs,0,0
115810,to,0,0
115811,payers,0,0
115812,.,0,0
115813,Our,0,0
115814,main,0,0
115815,result,0,0
115816,is,0,0
115817,the,0,0
115818,superior,0,0
115819,cost-effectiveness,0,0
115820,of,0,0
115821,the,0,0
115822,cognitive-behavioral,1,1
115823,intervention,1,1
115824,program,0,1
115825,in,0,0
115826,comparison,0,0
115827,to,0,0
115828,the,0,0
115829,non-directive,0,1
115830,encounter,0,0
115831,group,0,0
115832,for,0,0
115833,our,0,0
115834,sample,0,0
115835,of,0,0
115836,cancer,0,0
115837,patients,0,0
115838,with,0,0
115839,high,0,0
115840,levels,0,0
115841,of,0,0
115842,anxiety,0,0
115843,.,0,0
115844,Promoting,0,0
115845,imitation,0,0
115846,in,0,0
115847,young,0,0
115848,children,0,0
115849,with,0,0
115850,autism,0,0
115851,:,0,0
115852,a,0,0
115853,comparison,0,0
115854,of,0,0
115855,reciprocal,1,0
115856,imitation,1,1
115857,training,1,1
115858,and,0,0
115859,video,1,1
115860,modeling,1,0
115861,.,1,0
115862,The,0,0
115863,inability,0,0
115864,to,0,0
115865,imitate,0,0
115866,is,0,0
115867,a,0,0
115868,salient,0,0
115869,diagnostic,0,0
115870,marker,0,0
115871,for,0,0
115872,autism,0,0
115873,.,0,0
115874,It,0,0
115875,has,0,0
115876,been,0,0
115877,suggested,0,0
115878,that,0,0
115879,for,0,0
115880,children,0,0
115881,with,0,0
115882,autism,0,0
115883,",",0,0
115884,imitation,0,0
115885,may,0,0
115886,be,0,0
115887,a,0,0
115888,prerequisite,0,0
115889,skill,0,0
115890,that,0,0
115891,can,0,0
115892,assist,0,0
115893,in,0,0
115894,the,0,0
115895,development,0,0
115896,of,0,0
115897,various,0,0
115898,skills,0,0
115899,.,0,0
115900,Using,0,0
115901,a,0,0
115902,multiple,0,0
115903,baseline,0,0
115904,design,0,0
115905,across,0,0
115906,subjects,0,0
115907,",",0,0
115908,the,0,0
115909,purpose,0,0
115910,of,0,0
115911,this,0,0
115912,research,0,0
115913,was,0,0
115914,to,0,0
115915,determine,0,0
115916,if,0,0
115917,two,0,0
115918,interventions,0,0
115919,",",0,0
115920,reciprocal,1,0
115921,imitation,1,1
115922,training,1,1
115923,and,1,0
115924,video,1,1
115925,modeling,1,0
115926,were,0,0
115927,effective,0,0
115928,in,0,0
115929,promoting,0,1
115930,imitation,0,0
115931,acquisition,0,0
115932,in,0,0
115933,young,0,0
115934,children,0,0
115935,with,0,0
115936,autism,0,0
115937,.,0,0
115938,Six,0,0
115939,boys,0,0
115940,were,0,0
115941,matched,0,0
115942,across,0,0
115943,various,0,0
115944,features,0,0
115945,(,0,0
115946,i.e.,0,0
115947,",",0,0
115948,age,0,0
115949,",",0,0
115950,language,0,0
115951,",",0,0
115952,autism,0,0
115953,severity,0,0
115954,),0,0
115955,and,0,0
115956,randomly,0,0
115957,placed,0,0
115958,in,0,0
115959,a,0,0
115960,treatment,0,0
115961,condition,0,0
115962,.,0,0
115963,Results,0,0
115964,indicated,0,0
115965,that,0,0
115966,all,0,0
115967,six,0,0
115968,participants,0,0
115969,increased,0,0
115970,their,0,0
115971,imitation,0,0
115972,skills,0,0
115973,to,0,0
115974,varying,0,0
115975,degrees,0,0
115976,in,0,0
115977,both,0,0
115978,conditions,0,0
115979,",",0,0
115980,and,0,0
115981,imitation,0,0
115982,maintained,0,0
115983,and,0,0
115984,generalized,0,0
115985,at,0,0
115986,higher,0,0
115987,than,0,0
115988,baseline,0,0
115989,levels,0,0
115990,post,0,0
115991,treatment,0,0
115992,.,0,0
115993,Alinidine,1,1
115994,in,0,0
115995,chronic,0,0
115996,stable,0,0
115997,angina,0,0
115998,:,0,0
115999,the,0,0
116000,effect,0,0
116001,on,0,0
116002,diastolic,0,0
116003,perfusion,0,0
116004,time,0,0
116005,.,0,0
116006,The,0,0
116007,present,0,0
116008,study,0,0
116009,has,0,0
116010,been,0,0
116011,performed,0,0
116012,to,0,0
116013,assess,0,0
116014,the,0,0
116015,effects,0,0
116016,of,0,0
116017,alinidine,1,1
116018,on,0,0
116019,diastolic,0,0
116020,duration,0,0
116021,during,0,0
116022,exercise,0,1
116023,in,0,0
116024,chronic,0,0
116025,coronary,0,0
116026,artery,0,0
116027,disease,0,0
116028,.,0,0
116029,Twelve,0,0
116030,male,0,0
116031,patients,0,0
116032,with,0,0
116033,stable,0,0
116034,effort,0,0
116035,angina,0,0
116036,and,0,0
116037,without,0,0
116038,previous,0,0
116039,myocardial,0,0
116040,infarction,0,0
116041,were,0,0
116042,studied,0,0
116043,.,0,0
116044,They,0,0
116045,received,0,0
116046,alinidine,1,1
116047,or,1,1
116048,placebo,1,1
116049,in,0,0
116050,a,0,0
116051,double-blind,0,0
116052,randomized,0,0
116053,crossover,0,0
116054,trial,0,0
116055,for,0,0
116056,3,0,0
116057,days,0,0
116058,after,0,0
116059,a,0,0
116060,wash-out,0,1
116061,period,0,0
116062,of,0,0
116063,4,0,0
116064,days,0,0
116065,.,0,0
116066,Alinidine,1,0
116067,was,0,0
116068,administered,0,0
116069,at,0,0
116070,a,0,0
116071,dosage,0,0
116072,of,0,0
116073,30,0,0
116074,mg,0,0
116075,3,0,0
116076,times,0,0
116077,a,0,0
116078,day,0,0
116079,.,0,0
116080,At,0,0
116081,the,0,0
116082,end,0,0
116083,of,0,0
116084,each,0,0
116085,treatment,0,0
116086,the,0,0
116087,patients,0,0
116088,underwent,0,0
116089,upright,1,1
116090,bicycle,1,1
116091,exercise,1,1
116092,.,1,0
116093,Left,0,1
116094,ventricular,0,0
116095,time,0,0
116096,intervals,0,0
116097,were,0,0
116098,obtained,0,0
116099,by,0,0
116100,means,0,0
116101,of,0,0
116102,carotid,0,0
116103,thermistor,0,1
116104,plethysmography,0,1
116105,.,0,0
116106,Diastolic,0,0
116107,duration,0,0
116108,was,0,0
116109,calculated,0,0
116110,by,0,0
116111,subtracting,0,0
116112,the,0,0
116113,electromechanical,0,0
116114,systole,0,0
116115,from,0,0
116116,the,0,0
116117,R-R,0,0
116118,interval,0,0
116119,and,0,0
116120,expressed,0,0
116121,as,0,0
116122,a,0,0
116123,percentage,0,0
116124,of,0,0
116125,the,0,0
116126,cardiac,0,0
116127,cycle,0,0
116128,(,0,0
116129,%,0,0
116130,D,0,1
116131,),0,0
116132,.,0,0
116133,Alinidine,1,0
116134,increased,0,0
116135,both,0,0
116136,total,0,0
116137,exercise,0,1
116138,duration,0,0
116139,from,0,0
116140,246.7,0,0
116141,+/-,0,0
116142,120.7,0,0
116143,to,0,0
116144,346.6,0,0
116145,+/-,0,0
116146,114.1,0,0
116147,s,0,0
116148,(,0,0
116149,p,0,0
116150,less,0,0
116151,than,0,0
116152,0.05,0,0
116153,),0,0
116154,and,0,0
116155,time,0,0
116156,to,0,0
116157,0.1-mV,0,0
116158,ST,0,0
116159,segment,0,0
116160,depression,0,0
116161,from,0,0
116162,98.3,0,0
116163,+/-,0,0
116164,53,0,0
116165,to,0,0
116166,187.2,0,0
116167,+/-,0,0
116168,105,0,0
116169,s,0,0
116170,(,0,0
116171,p,0,0
116172,less,0,0
116173,than,0,0
116174,0.05,0,0
116175,),0,0
116176,.,0,0
116177,Similarly,0,0
116178,the,0,0
116179,drug,0,0
116180,induced,0,0
116181,a,0,0
116182,reduction,0,0
116183,of,0,0
116184,the,0,0
116185,rate-pressure,0,0
116186,product,0,0
116187,and,0,0
116188,of,0,0
116189,the,0,0
116190,extent,0,0
116191,of,0,0
116192,ischemic,0,0
116193,ST,0,0
116194,segment,0,0
116195,depression,0,0
116196,during,0,0
116197,exercise,0,1
116198,.,0,0
116199,%,0,0
116200,D,0,0
116201,was,0,0
116202,increased,0,0
116203,by,0,0
116204,alinidine,0,1
116205,both,0,0
116206,at,0,0
116207,rest,0,0
116208,and,0,0
116209,during,0,0
116210,exercise,0,1
116211,.,0,0
116212,A,0,0
116213,direct,0,0
116214,linear,0,0
116215,regression,0,0
116216,between,0,0
116217,R-R,0,0
116218,and,0,0
116219,%,0,0
116220,D,0,1
116221,was,0,0
116222,found,0,0
116223,after,0,0
116224,both,0,0
116225,alinidine,1,1
116226,and,0,0
116227,placebo,1,1
116228,treatments,0,0
116229,either,0,0
116230,at,0,0
116231,rest,0,0
116232,or,0,1
116233,during,0,0
116234,exercise,0,1
116235,.,0,0
116236,Nevertheless,0,0
116237,",",0,0
116238,no,0,0
116239,difference,0,0
116240,was,0,0
116241,observed,0,0
116242,between,0,0
116243,both,0,0
116244,slopes,0,0
116245,and,0,0
116246,intercepts,0,0
116247,.,0,0
116248,Therefore,0,0
116249,",",0,0
116250,since,0,0
116251,the,0,0
116252,relationship,0,0
116253,between,0,0
116254,R-R,0,0
116255,interval,0,0
116256,and,0,0
116257,%,0,0
116258,D,0,1
116259,was,0,0
116260,unaffected,0,0
116261,by,0,0
116262,alinidine,1,1
116263,",",0,0
116264,it,0,0
116265,was,0,0
116266,possible,0,0
116267,to,0,0
116268,hypothesize,0,0
116269,that,0,0
116270,the,0,0
116271,changes,0,0
116272,in,0,0
116273,diastolic,0,0
116274,duration,0,0
116275,were,0,0
116276,due,0,0
116277,only,0,0
116278,to,0,0
116279,the,0,0
116280,bradycardic,0,0
116281,action,0,0
116282,of,0,0
116283,the,0,0
116284,drug,0,0
116285,.,0,0
116286,[,0,0
116287,Therapy,0,1
116288,with,0,0
116289,alpha-interferon,1,1
116290,in,0,0
116291,non-Hodgkin,0,0
116292,'s,0,0
116293,lymphoma,0,0
116294,with,0,0
116295,a,0,0
116296,low,0,0
116297,grade,0,0
116298,of,0,0
116299,malignancy,0,0
116300,(,0,0
116301,correct,0,0
116302,title,0,0
116303,supplied,0,0
116304,from,0,0
116305,Table,0,0
116306,of,0,0
116307,Contents,0,0
116308,),0,0
116309,],0,0
116310,.,0,0
116311,Randomized,0,0
116312,controlled,0,0
116313,trial,0,0
116314,of,0,0
116315,electro-acupuncture,1,1
116316,for,0,0
116317,autism,0,0
116318,spectrum,0,0
116319,disorder,0,0
116320,.,0,0
116321,OBJECTIVE,0,0
116322,To,0,0
116323,study,0,0
116324,the,0,0
116325,efficacy,0,0
116326,",",0,0
116327,safety,0,0
116328,",",0,0
116329,and,0,0
116330,compliance,0,0
116331,of,0,0
116332,short-term,0,0
116333,electro-acupuncture,1,1
116334,for,0,0
116335,children,0,0
116336,with,0,0
116337,autism,0,0
116338,spectrum,0,0
116339,disorder,0,0
116340,(,0,0
116341,ASD,0,0
116342,),0,0
116343,.,0,0
116344,DESIGN,0,0
116345,Randomized,0,0
116346,",",0,0
116347,double-blind,0,0
116348,",",0,0
116349,sham-controlled,0,1
116350,",",0,0
116351,clinical,0,0
116352,trial,0,0
116353,.,0,0
116354,SUBJECTS,0,0
116355,AND,0,0
116356,METHODS,0,0
116357,Children,0,0
116358,with,0,0
116359,ASD,0,0
116360,were,0,0
116361,randomly,0,0
116362,assigned,0,0
116363,to,0,0
116364,an,0,0
116365,electro-acupuncture,1,1
116366,(,1,0
116367,EA,1,0
116368,),1,1
116369,group,1,0
116370,(,1,0
116371,n=30,1,1
116372,),1,0
116373,or,1,0
116374,a,1,0
116375,sham,1,1
116376,electro-acupuncture,1,1
116377,(,1,0
116378,SEA,1,0
116379,),1,1
116380,group,1,0
116381,(,0,0
116382,n=25,0,0
116383,),0,0
116384,matched,0,0
116385,by,0,0
116386,age,0,0
116387,and,0,0
116388,severity,0,0
116389,of,0,0
116390,autism,0,0
116391,.,0,0
116392,The,0,0
116393,EA,0,0
116394,group,0,0
116395,received,0,0
116396,electro-acupuncture,0,0
116397,for,0,0
116398,selected,0,0
116399,acupoints,0,1
116400,while,0,0
116401,the,0,0
116402,SEA,0,0
116403,group,0,0
116404,received,0,0
116405,sham,0,1
116406,electro-acupuncture,0,1
116407,to,0,0
116408,sham,0,1
116409,acupoints,0,1
116410,.,0,0
116411,A,0,0
116412,total,0,0
116413,of,0,0
116414,12,0,0
116415,EA,0,0
116416,and,0,0
116417,SEA,0,0
116418,sessions,0,1
116419,over,0,0
116420,four,0,0
116421,weeks,0,0
116422,were,0,0
116423,given,0,0
116424,.,0,0
116425,Primary,0,0
116426,outcome,0,0
116427,measures,0,0
116428,included,0,0
116429,Functional,0,0
116430,Independence,0,0
116431,Measure,0,0
116432,for,0,0
116433,Children,0,0
116434,(,0,0
116435,WeeFIM,0,1
116436,),0,0
116437,",",0,0
116438,Pediatric,0,1
116439,Evaluation,0,0
116440,of,0,0
116441,Disability,0,0
116442,Inventory,0,0
116443,(,0,0
116444,PEDI,0,1
116445,),0,0
116446,",",0,0
116447,Leiter,0,0
116448,International,0,0
116449,Performance,0,0
116450,Scale-Revised,0,1
116451,(,0,0
116452,Leiter-R,0,1
116453,),0,0
116454,",",0,0
116455,and,0,0
116456,Clinical,0,0
116457,Global,0,0
116458,Impression-Improvement,0,0
116459,(,0,0
116460,CGI-I,0,1
116461,),0,0
116462,scale,0,0
116463,.,0,0
116464,Secondary,0,0
116465,outcome,0,0
116466,measures,0,0
116467,consisted,0,0
116468,of,0,0
116469,Aberrant,0,0
116470,Behavior,0,0
116471,Checklist,0,1
116472,(,0,0
116473,ABC,0,1
116474,),0,0
116475,",",0,0
116476,Ritvo-Freeman,0,0
116477,Real,0,0
116478,Life,0,0
116479,Scale,0,1
116480,(,0,0
116481,RFRLS,0,1
116482,),0,0
116483,",",0,0
116484,Reynell,0,1
116485,Developmental,0,0
116486,Language,0,1
116487,Scale,0,1
116488,(,0,0
116489,RDLS,0,1
116490,),0,0
116491,",",0,0
116492,and,0,0
116493,a,0,0
116494,standardized,0,0
116495,parental,0,0
116496,report,0,0
116497,.,0,0
116498,Data,0,0
116499,were,0,0
116500,analyzed,0,0
116501,by,0,0
116502,the,0,0
116503,Mann-Whitney,0,0
116504,test,0,0
116505,.,0,0
116506,RESULTS,0,0
116507,There,0,0
116508,were,0,0
116509,significant,0,0
116510,improvements,0,0
116511,in,0,0
116512,the,0,0
116513,language,0,0
116514,comprehension,0,0
116515,domain,0,0
116516,of,0,0
116517,WeeFIM,0,1
116518,(,0,0
116519,p=0.02,0,0
116520,),0,0
116521,",",0,0
116522,self-care,0,1
116523,caregiver,0,1
116524,assistant,0,1
116525,domain,0,0
116526,of,0,0
116527,PEDI,0,1
116528,(,0,0
116529,p=0.028,0,0
116530,),0,0
116531,",",0,0
116532,and,0,0
116533,CGI-I,0,1
116534,(,0,1
116535,p=0.003,0,0
116536,),0,0
116537,in,0,0
116538,the,0,0
116539,EA,0,0
116540,group,0,0
116541,compared,0,0
116542,to,0,0
116543,the,0,0
116544,SEA,0,0
116545,group,0,0
116546,.,0,0
116547,As,0,0
116548,for,0,0
116549,the,0,0
116550,parental,0,0
116551,report,0,0
116552,",",0,0
116553,the,0,0
116554,EA,0,0
116555,group,0,0
116556,also,0,0
116557,showed,0,0
116558,significantly,0,0
116559,better,0,0
116560,social,0,1
116561,initiation,0,0
116562,(,0,0
116563,p=0.01,0,0
116564,),0,0
116565,",",0,0
116566,receptive,0,0
116567,language,0,0
116568,(,0,0
116569,p=0.006,0,0
116570,),0,0
116571,",",0,0
116572,motor,0,0
116573,skills,0,1
116574,(,0,0
116575,p=0.034,0,0
116576,),0,0
116577,",",0,0
116578,coordination,0,1
116579,(,0,0
116580,p=0.07,0,0
116581,),0,0
116582,",",0,0
116583,and,0,0
116584,attention,0,0
116585,span,0,1
116586,(,0,0
116587,p=0.003,0,0
116588,),0,0
116589,.,0,0
116590,More,0,0
116591,than,0,0
116592,70,0,0
116593,percent,0,0
116594,of,0,0
116595,children,0,0
116596,with,0,0
116597,ASD,0,0
116598,adapted,0,0
116599,to,0,0
116600,acupuncture,0,1
116601,easily,0,0
116602,",",0,0
116603,while,0,0
116604,eight,0,0
116605,percent,0,0
116606,had,0,0
116607,poor,0,0
116608,acupuncture,0,1
116609,compliance,0,0
116610,.,0,0
116611,Mild,0,0
116612,side,0,0
116613,effects,0,0
116614,of,0,0
116615,minor,0,0
116616,superficial,0,0
116617,bleeding,0,0
116618,or,0,1
116619,irritability,0,0
116620,during,0,0
116621,acupuncture,0,1
116622,were,0,0
116623,observed,0,0
116624,.,0,0
116625,CONCLUSION,0,0
116626,A,0,0
116627,short,0,0
116628,",",0,0
116629,four-week,0,1
116630,(,0,0
116631,12,0,0
116632,sessions,0,1
116633,),0,0
116634,course,0,0
116635,of,0,0
116636,electro-acupuncture,0,1
116637,is,0,0
116638,useful,0,0
116639,to,0,0
116640,improve,0,0
116641,specific,0,0
116642,functions,0,0
116643,in,0,0
116644,children,0,0
116645,with,0,0
116646,ASD,0,0
116647,",",0,0
116648,especially,0,0
116649,for,0,0
116650,language,0,0
116651,comprehension,0,0
116652,and,0,0
116653,self-care,0,1
116654,ability,0,0
116655,.,0,0
116656,A,0,0
116657,randomized,0,0
116658,trial,0,0
116659,of,0,0
116660,genetic,1,0
116661,and,1,0
116662,environmental,1,0
116663,risk,1,0
116664,assessment,1,0
116665,(,1,0
116666,GERA,1,0
116667,),1,0
116668,for,0,0
116669,colorectal,0,0
116670,cancer,0,0
116671,risk,0,0
116672,in,0,0
116673,primary,0,0
116674,care,0,1
116675,:,0,0
116676,trial,0,0
116677,design,0,0
116678,and,0,0
116679,baseline,0,0
116680,findings,0,0
116681,.,0,0
116682,PURPOSE,0,0
116683,This,0,0
116684,paper,0,0
116685,describes,0,0
116686,an,0,0
116687,ongoing,0,0
116688,randomized,0,0
116689,controlled,0,0
116690,trial,0,0
116691,designed,0,0
116692,to,0,0
116693,assess,0,0
116694,the,0,0
116695,impact,0,0
116696,of,0,0
116697,genetic,1,0
116698,and,1,0
116699,environmental,1,0
116700,risk,1,0
116701,assessment,1,0
116702,(,1,0
116703,GERA,1,0
116704,),1,0
116705,on,0,0
116706,colorectal,0,0
116707,cancer,0,0
116708,(,0,0
116709,CRC,0,1
116710,),0,0
116711,screening,0,0
116712,.,0,0
116713,METHODS,0,0
116714,The,0,0
116715,trial,0,0
116716,includes,0,0
116717,asymptomatic,0,0
116718,patients,0,0
116719,who,0,0
116720,are,0,0
116721,50-79years,0,0
116722,and,0,0
116723,are,0,0
116724,not,0,0
116725,up-to-date,0,0
116726,with,0,0
116727,CRC,0,1
116728,screening,0,0
116729,guidelines,0,0
116730,.,0,0
116731,Patients,0,0
116732,who,0,0
116733,responded,0,0
116734,to,0,0
116735,a,0,0
116736,baseline,0,0
116737,telephone,0,1
116738,survey,0,0
116739,are,0,0
116740,randomized,0,0
116741,to,0,0
116742,a,0,0
116743,GERA,1,0
116744,or,1,1
116745,Control,1,1
116746,group,1,0
116747,.,1,0
116748,GERA,1,0
116749,group,1,0
116750,participants,1,0
116751,meet,1,0
116752,with,1,0
116753,a,1,0
116754,nurse,1,1
116755,",",1,0
116756,decide,1,0
116757,whether,1,0
116758,to,1,0
116759,have,1,0
116760,a,1,0
116761,GERA,1,0
116762,blood,1,0
116763,test,1,0
116764,(,1,0
116765,a,1,0
116766,combination,1,1
116767,of,1,0
116768,genetic,1,0
116769,polymorphism,1,0
116770,and,1,0
116771,folate,1,1
116772,),1,0
116773,",",1,0
116774,and,1,0
116775,",",1,0
116776,if,1,0
116777,tested,1,0
116778,",",1,0
116779,receive,1,0
116780,GERA,1,0
116781,feedback,1,1
116782,.,1,0
116783,Follow-up,1,0
116784,telephone,1,1
116785,surveys,1,0
116786,are,1,0
116787,conducted,1,0
116788,at,1,0
116789,1,1,0
116790,and,1,0
116791,6months,1,0
116792,.,1,0
116793,A,1,0
116794,chart,1,0
116795,audit,1,0
116796,is,1,0
116797,performed,1,0
116798,at,1,0
116799,6months,1,0
116800,.,1,0
116801,RESULTS,0,0
116802,Of,0,0
116803,"2,223",0,0
116804,eligible,0,0
116805,patients,0,0
116806,",",0,0
116807,562,0,0
116808,(,0,0
116809,25,0,0
116810,%,0,0
116811,),0,0
116812,have,0,0
116813,enrolled,0,0
116814,.,0,0
116815,Patients,0,0
116816,who,0,0
116817,enrolled,0,0
116818,in,0,0
116819,the,0,0
116820,study,0,0
116821,were,0,0
116822,significantly,0,0
116823,younger,0,0
116824,than,0,0
116825,those,0,0
116826,who,0,0
116827,did,0,0
116828,not,0,0
116829,(,0,0
116830,p,0,0
116831,<,0,0
116832,0.001,0,0
116833,),0,0
116834,.,0,0
116835,Participants,0,0
116836,tended,0,0
116837,to,0,0
116838,be,0,0
116839,50-59years,0,0
116840,(,0,0
116841,64,0,0
116842,%,0,0
116843,),0,0
116844,",",0,0
116845,female,0,0
116846,(,0,0
116847,58,0,0
116848,%,0,0
116849,),0,0
116850,",",0,0
116851,white,0,0
116852,(,0,0
116853,52,0,0
116854,%,0,0
116855,),0,0
116856,",",0,0
116857,married,0,0
116858,(,0,0
116859,51,0,0
116860,%,0,0
116861,),0,0
116862,",",0,0
116863,and,0,0
116864,have,0,0
116865,more,0,0
116866,than,0,0
116867,a,0,0
116868,high,0,0
116869,school,0,0
116870,education,0,1
116871,(,0,0
116872,67,0,0
116873,%,0,0
116874,),0,0
116875,.,0,0
116876,At,0,0
116877,baseline,0,0
116878,",",0,0
116879,most,0,0
116880,participants,0,0
116881,had,0,0
116882,some,0,0
116883,knowledge,0,0
116884,of,0,0
116885,CRC,0,1
116886,screening,0,0
116887,and,0,0
116888,GERA,1,0
116889,",",0,0
116890,viewed,0,0
116891,CRC,0,1
116892,screening,0,0
116893,favorably,0,0
116894,",",0,0
116895,and,0,0
116896,reported,0,0
116897,that,0,0
116898,they,0,0
116899,had,0,0
116900,decided,0,0
116901,to,0,0
116902,do,0,0
116903,screening,0,0
116904,.,0,0
116905,Almost,0,0
116906,half,0,0
116907,had,0,0
116908,worries,0,0
116909,and,0,0
116910,concerns,0,0
116911,about,0,0
116912,CRC,0,1
116913,.,0,0
116914,CONCLUSIONS,0,0
116915,One,0,0
116916,in,0,0
116917,four,0,0
116918,eligible,0,0
116919,primary,0,0
116920,care,0,0
116921,patients,0,0
116922,enrolled,0,0
116923,in,0,0
116924,the,0,0
116925,study,0,0
116926,.,0,0
116927,Age,0,0
116928,was,0,0
116929,negatively,0,0
116930,associated,0,0
116931,with,0,0
116932,enrollment,0,0
116933,.,0,0
116934,Prospective,0,0
116935,analyses,0,0
116936,using,0,0
116937,data,0,0
116938,for,0,0
116939,all,0,0
116940,participants,0,0
116941,will,0,0
116942,provide,0,0
116943,more,0,0
116944,definitive,0,0
116945,information,0,0
116946,on,0,0
116947,GERA,1,0
116948,uptake,0,0
116949,and,0,0
116950,the,0,0
116951,impact,0,0
116952,of,0,0
116953,GERA,1,0
116954,feedback,0,1
116955,.,0,0
116956,Anti-angiogenic,0,0
116957,effects,0,0
116958,of,0,0
116959,epigallocatechin-3-gallate,1,1
116960,in,0,0
116961,human,0,0
116962,skin,0,0
116963,.,0,0
116964,Epigallocatechin-3-gallate,1,1
116965,(,1,0
116966,EGCG,1,0
116967,),1,1
116968,is,0,0
116969,the,0,0
116970,main,0,0
116971,polyphenol,0,1
116972,component,0,0
116973,of,0,0
116974,green,0,1
116975,tea,0,1
116976,.,0,0
116977,This,0,0
116978,compound,0,1
116979,exhibits,0,0
116980,antioxidant,0,0
116981,",",0,0
116982,immunomodulatory,0,0
116983,",",0,0
116984,photoprotective,0,0
116985,",",0,0
116986,anti-angiogenic,0,0
116987,",",0,0
116988,and,0,0
116989,anti-inflammatory,0,0
116990,properties,0,0
116991,.,0,0
116992,We,0,0
116993,conducted,0,0
116994,a,0,0
116995,small,0,0
116996,randomized,0,0
116997,",",0,0
116998,double,0,0
116999,blind,0,0
117000,",",0,0
117001,split,0,1
117002,face,0,0
117003,trial,0,0
117004,using,0,0
117005,a,0,0
117006,cream,1,1
117007,containing,1,1
117008,2.5,1,0
117009,%,1,0
117010,w/w,1,1
117011,of,1,0
117012,EGCG,1,0
117013,.,1,0
117014,Four,0,0
117015,healthy,0,0
117016,volunteers,0,0
117017,with,0,0
117018,significant,0,0
117019,erythema,0,0
117020,and,0,0
117021,telangiectasia,0,0
117022,on,0,0
117023,the,0,0
117024,face,0,0
117025,applied,0,0
117026,EGCG,1,0
117027,cream,1,1
117028,to,0,0
117029,one,0,0
117030,side,0,0
117031,of,0,0
117032,the,0,0
117033,face,0,0
117034,",",0,0
117035,and,0,0
117036,vehicle,1,1
117037,control,1,1
117038,cream,1,1
117039,to,0,0
117040,the,0,0
117041,other,0,0
117042,",",0,0
117043,twice,0,0
117044,daily,0,0
117045,for,0,0
117046,six,0,0
117047,weeks,0,0
117048,.,0,0
117049,After,0,0
117050,six,0,0
117051,weeks,0,0
117052,",",0,0
117053,biopsies,0,0
117054,were,0,0
117055,taken,0,0
117056,from,0,0
117057,EGCG,1,0
117058,and,0,0
117059,vehicle,1,1
117060,treated,1,0
117061,sites,0,0
117062,.,0,0
117063,Immunohistochemistry,0,0
117064,was,0,0
117065,used,0,0
117066,to,0,0
117067,measure,0,0
117068,VEGF,0,1
117069,and,0,0
117070,HIF-1,0,1
117071,?.,0,1
117072,HIF-1,0,1
117073,?,0,0
117074,expression,0,0
117075,was,0,0
117076,decreased,0,0
117077,in,0,0
117078,EGCG,1,0
117079,treated,1,0
117080,sites,0,0
117081,",",0,0
117082,such,0,0
117083,that,0,0
117084,28.4,0,0
117085,%,0,0
117086,of,0,0
117087,the,0,0
117088,epidermis,0,0
117089,showed,0,0
117090,positive,0,0
117091,staining,0,0
117092,in,0,0
117093,vehicle,0,1
117094,treated,0,0
117095,vs.,0,0
117096,13.8,0,0
117097,%,0,0
117098,in,0,0
117099,EGCG,1,0
117100,treated,1,0
117101,sites,0,0
117102,(,0,0
117103,p,0,0
117104,<,0,0
117105,0.001,0,0
117106,),0,0
117107,.,0,0
117108,A,0,0
117109,similar,0,0
117110,decrease,0,0
117111,in,0,0
117112,VEGF,0,1
117113,expression,0,0
117114,was,0,0
117115,found,0,0
117116,(,0,0
117117,6.7,0,0
117118,%,0,0
117119,in,0,0
117120,EGCG,1,0
117121,vs.,1,0
117122,11.0,0,0
117123,%,0,0
117124,in,0,0
117125,in,0,0
117126,vehicle-treated,1,0
117127,skin,1,0
117128,(,0,0
117129,p,0,0
117130,<,1,0
117131,0.005,1,0
117132,),1,0
117133,.,1,0
117134,EGCG,1,0
117135,topical,1,1
117136,treatments,0,0
117137,influence,0,0
117138,HIF-1,0,0
117139,?,0,0
117140,induction,0,0
117141,and,0,0
117142,VEGF,0,1
117143,expression,0,0
117144,and,0,0
117145,may,0,0
117146,serve,0,0
117147,as,0,0
117148,a,0,0
117149,potential,0,0
117150,agent,0,0
117151,in,0,0
117152,the,0,0
117153,prevention,0,0
117154,of,0,0
117155,telangiectasias,0,0
117156,.,0,0
117157,Early,0,1
117158,treatment,0,0
117159,of,0,0
117160,cold,0,0
117161,sores,0,0
117162,with,0,0
117163,topical,0,1
117164,ME-609,1,1
117165,decreases,0,0
117166,the,0,0
117167,frequency,0,0
117168,of,0,0
117169,ulcerative,0,0
117170,lesions,0,0
117171,:,0,0
117172,a,0,0
117173,randomized,0,0
117174,",",0,0
117175,double-blind,0,0
117176,",",0,0
117177,placebo-controlled,0,1
117178,",",0,0
117179,patient-initiated,0,0
117180,clinical,0,0
117181,trial,0,0
117182,.,0,0
117183,BACKGROUND,0,0
117184,Prior,0,0
117185,pilot,0,0
117186,studies,0,0
117187,support,0,0
117188,the,0,0
117189,use,0,0
117190,of,0,0
117191,antiviral,0,0
117192,medications,0,0
117193,with,0,0
117194,topical,0,1
117195,corticosteroids,0,1
117196,for,0,0
117197,herpes,0,0
117198,simplex,0,0
117199,labialis,0,0
117200,(,0,0
117201,HSL,0,1
117202,),0,0
117203,.,0,0
117204,ME-609,1,1
117205,(,1,0
117206,Xerese,1,0
117207,",",1,0
117208,Xerclear,1,0
117209,),1,0
117210,is,0,0
117211,a,0,0
117212,combination,0,0
117213,of,0,0
117214,5,0,0
117215,%,0,0
117216,acyclovir,1,1
117217,and,0,0
117218,1,0,0
117219,%,0,0
117220,hydrocortisone,1,1
117221,developed,0,0
117222,for,0,0
117223,the,0,0
117224,topical,0,1
117225,treatment,0,0
117226,of,0,0
117227,HSL,0,0
117228,.,0,0
117229,OBJECTIVES,0,0
117230,The,0,0
117231,primary,0,0
117232,study,0,0
117233,end,0,0
117234,point,0,0
117235,was,0,0
117236,the,0,0
117237,prevention,0,0
117238,of,0,0
117239,ulcerative,0,0
117240,HSL,0,0
117241,lesions,0,0
117242,.,0,0
117243,METHODS,0,0
117244,In,0,0
117245,all,0,0
117246,",",0,0
117247,2437,0,0
117248,patients,0,0
117249,with,0,0
117250,a,0,0
117251,history,0,0
117252,of,0,0
117253,HSL,0,0
117254,were,0,0
117255,randomized,1,0
117256,to,1,0
117257,self-initiate,1,1
117258,treatment,1,0
117259,with,1,0
117260,ME-609,1,1
117261,",",1,0
117262,5,1,0
117263,%,1,0
117264,acyclovir,1,1
117265,in,1,0
117266,ME-609,1,1
117267,vehicle,1,1
117268,",",1,0
117269,or,1,0
117270,ME-609,1,1
117271,vehicle,1,1
117272,(,1,0
117273,placebo,1,1
117274,),1,0
117275,at,1,0
117276,the,1,0
117277,earliest,1,0
117278,sign,1,0
117279,of,1,0
117280,a,1,0
117281,cold,1,1
117282,sore,1,0
117283,recurrence,1,0
117284,.,1,0
117285,Cream,1,1
117286,was,1,0
117287,applied,1,0
117288,5,1,0
117289,times/d,1,0
117290,for,1,0
117291,5,1,0
117292,days,1,0
117293,.,1,0
117294,A,0,0
117295,total,0,0
117296,of,0,0
117297,1443,0,0
117298,patients,0,0
117299,experienced,0,0
117300,a,0,0
117301,recurrence,0,0
117302,and,0,0
117303,initiated,0,0
117304,treatment,0,0
117305,with,0,0
117306,ME-609,1,1
117307,(,0,0
117308,n,0,0
117309,=,0,0
117310,601,0,0
117311,),0,0
117312,",",0,0
117313,acyclovir,1,1
117314,(,0,0
117315,n,0,0
117316,=,0,0
117317,610,0,0
117318,),0,0
117319,",",0,0
117320,or,0,1
117321,placebo,1,1
117322,(,0,0
117323,n,0,0
117324,=,0,0
117325,232,0,0
117326,),0,0
117327,.,0,0
117328,RESULTS,0,0
117329,Of,0,0
117330,patients,0,0
117331,receiving,0,0
117332,ME-609,0,1
117333,",",0,0
117334,42,0,0
117335,%,0,0
117336,did,0,0
117337,not,0,0
117338,develop,0,0
117339,an,0,0
117340,ulcerative,0,0
117341,lesion,0,0
117342,compared,0,0
117343,with,0,0
117344,35,0,0
117345,%,0,0
117346,of,0,0
117347,patients,0,0
117348,receiving,0,0
117349,acyclovir,1,1
117350,in,1,0
117351,ME-609,1,1
117352,vehicle,1,1
117353,(,0,0
117354,P,0,0
117355,=,0,0
117356,.014,0,0
117357,),0,0
117358,and,0,0
117359,26,0,0
117360,%,0,0
117361,of,0,0
117362,patients,0,0
117363,receiving,0,0
117364,placebo,0,1
117365,(,0,0
117366,P,0,0
117367,<,0,0
117368,.0001,0,0
117369,),0,0
117370,.,0,0
117371,In,0,0
117372,patients,0,0
117373,with,0,0
117374,ulcerative,0,0
117375,lesions,0,0
117376,",",0,0
117377,healing,0,0
117378,times,0,0
117379,were,0,0
117380,reduced,0,0
117381,in,0,0
117382,the,0,0
117383,ME-609,0,1
117384,and,0,0
117385,acyclovir,0,1
117386,groups,0,0
117387,compared,0,0
117388,with,0,0
117389,placebo,0,1
117390,(,0,0
117391,P,0,0
117392,<,0,0
117393,.01,0,0
117394,for,0,0
117395,both,0,0
117396,),0,0
117397,.,0,0
117398,The,0,0
117399,cumulative,0,0
117400,lesion,0,0
117401,area,0,0
117402,for,0,0
117403,all,0,0
117404,lesions,0,0
117405,was,0,0
117406,reduced,0,0
117407,50,0,0
117408,%,0,0
117409,in,0,0
117410,patients,0,0
117411,receiving,0,0
117412,ME-609,0,1
117413,compared,0,0
117414,with,0,0
117415,the,0,0
117416,placebo,0,1
117417,group,0,0
117418,(,0,0
117419,P,0,0
117420,<,0,0
117421,.0001,0,0
117422,),0,0
117423,.,0,0
117424,There,0,0
117425,were,0,0
117426,no,0,0
117427,differences,0,0
117428,among,0,0
117429,groups,0,0
117430,in,0,0
117431,the,0,0
117432,number,0,0
117433,of,0,0
117434,patients,0,0
117435,with,0,0
117436,positive,0,0
117437,herpes,0,0
117438,simplex,0,0
117439,virus,0,0
117440,cultures,0,0
117441,.,0,0
117442,The,0,0
117443,side-effect,0,0
117444,profile,0,0
117445,was,0,0
117446,similar,0,0
117447,among,0,0
117448,treatments,0,0
117449,.,0,0
117450,LIMITATIONS,0,0
117451,The,0,0
117452,study,0,0
117453,did,0,0
117454,not,0,0
117455,contain,0,0
117456,a,0,0
117457,group,0,0
117458,treated,0,0
117459,with,0,0
117460,a,0,0
117461,topical,0,1
117462,corticosteroid,0,1
117463,alone,0,1
117464,.,0,0
117465,CONCLUSIONS,0,0
117466,ME-609,0,1
117467,prevented,0,0
117468,progression,0,0
117469,of,0,0
117470,cold,0,0
117471,sores,0,0
117472,to,0,0
117473,ulcerative,0,0
117474,lesions,0,0
117475,and,0,0
117476,significantly,0,0
117477,reduced,0,0
117478,the,0,0
117479,cumulative,0,0
117480,lesion,0,0
117481,area,0,0
117482,compared,0,0
117483,with,0,0
117484,acyclovir,0,1
117485,and,0,0
117486,placebo,0,1
117487,.,0,0
117488,ME-609,0,0
117489,treatment,0,0
117490,offers,0,0
117491,additional,0,0
117492,therapeutic,0,0
117493,benefit,0,0
117494,compared,0,0
117495,with,0,0
117496,therapy,0,1
117497,with,0,0
117498,topical,0,1
117499,acyclovir,0,1
117500,alone,0,0
117501,.,0,0
117502,Acamprosate,1,1
117503,appears,0,0
117504,to,0,0
117505,decrease,0,0
117506,alcohol,0,1
117507,intake,0,0
117508,in,0,0
117509,weaned,0,0
117510,alcoholics,0,0
117511,.,0,0
117512,Five,0,0
117513,hundred,0,0
117514,and,0,0
117515,sixty-nine,0,0
117516,alcoholics,0,0
117517,were,0,0
117518,included,0,0
117519,in,0,0
117520,a,0,0
117521,double-blind,0,0
117522,placebo-controlled,1,1
117523,randomized,0,0
117524,multicenter,0,0
117525,study,0,0
117526,of,0,0
117527,the,0,0
117528,effects,0,0
117529,of,0,0
117530,Acamprosate,1,1
117531,(,1,0
117532,calcium,1,1
117533,acetylhomotaurinate,1,1
117534,(,1,0
117535,CA,1,1
117536,),1,0
117537,",",1,0
117538,1.3,1,0
117539,g/day,1,0
117540,),1,0
117541,on,0,0
117542,indicators,0,0
117543,of,0,0
117544,alcoholic,0,0
117545,relapse,0,0
117546,after,0,0
117547,withdrawal,0,0
117548,.,0,0
117549,One,0,0
117550,hundred,0,0
117551,and,0,0
117552,eighty-one,0,0
117553,patients,0,0
117554,in,0,0
117555,the,0,0
117556,CA,1,1
117557,group,0,0
117558,versus,0,0
117559,175,0,0
117560,in,0,0
117561,the,0,0
117562,placebo,1,1
117563,group,0,0
117564,completed,0,0
117565,the,0,0
117566,three-month,0,0
117567,study,0,0
117568,.,0,0
117569,The,0,0
117570,major,0,0
117571,efficacy,0,0
117572,criterion,0,0
117573,was,0,0
117574,plasma,0,0
117575,gamma-glutamyl,0,0
117576,transpeptidase,0,0
117577,(,0,0
117578,GGT,0,1
117579,),0,0
117580,",",0,0
117581,as,0,0
117582,an,0,0
117583,indicator,0,0
117584,of,0,0
117585,recent,0,0
117586,alcohol,0,0
117587,ingestion,0,0
117588,.,0,0
117589,This,0,0
117590,analysis,0,0
117591,was,0,0
117592,completed,0,0
117593,by,0,0
117594,criteria,0,0
117595,concordance,0,0
117596,analysis,0,0
117597,on,0,0
117598,a,0,0
117599,number,0,0
117600,of,0,0
117601,indicators,0,0
117602,of,0,0
117603,alcohol,0,0
117604,intake,0,0
117605,.,0,0
117606,Patients,0,0
117607,in,0,0
117608,both,0,0
117609,groups,0,0
117610,were,0,0
117611,similar,0,0
117612,initially,0,0
117613,.,0,0
117614,After,0,0
117615,3,0,0
117616,months,0,0
117617,of,0,0
117618,treatment,0,0
117619,",",0,0
117620,the,0,0
117621,patients,0,0
117622,in,0,0
117623,the,0,0
117624,CA,1,1
117625,group,0,0
117626,had,0,0
117627,significantly,0,0
117628,lower,0,0
117629,GGT,0,0
117630,(,0,0
117631,1.4,0,0
117632,+/-,0,0
117633,1.56,0,0
117634,versus,0,0
117635,2.0,0,0
117636,+/-,0,0
117637,3.19,0,0
117638,times,0,0
117639,normal,0,0
117640,",",0,0
117641,P,0,0
117642,=,0,0
117643,0.016,0,0
117644,),0,0
117645,.,0,0
117646,All,0,0
117647,significant,0,0
117648,differences,0,0
117649,(,0,0
117650,P,0,0
117651,less,0,0
117652,than,0,0
117653,0.05,0,0
117654,),0,0
117655,or,0,1
117656,trends,0,0
117657,(,0,0
117658,0.10,0,0
117659,greater,0,0
117660,than,0,0
117661,P,0,0
117662,greater,0,0
117663,than,0,0
117664,0.05,0,0
117665,),0,0
117666,were,0,0
117667,in,0,0
117668,favor,0,0
117669,of,0,0
117670,a,0,0
117671,superior,0,0
117672,effect,0,0
117673,of,0,0
117674,CA,1,1
117675,over,0,0
117676,placebo,1,1
117677,.,1,0
117678,The,0,0
117679,major,0,0
117680,side-effect,0,0
117681,of,0,0
117682,CA,1,0
117683,was,0,0
117684,diarrhea,0,0
117685,(,0,0
117686,present,0,0
117687,in,0,0
117688,13,0,0
117689,%,0,0
117690,of,0,0
117691,CA,0,0
117692,patients,0,0
117693,versus,0,0
117694,7,0,0
117695,%,0,0
117696,of,0,0
117697,placebo,1,1
117698,",",0,0
117699,P,0,0
117700,=,0,0
117701,0.04,0,0
117702,),0,0
117703,.,0,0
117704,CA,1,0
117705,proved,0,0
117706,superior,0,0
117707,to,0,0
117708,placebo,1,1
117709,on,0,0
117710,the,0,0
117711,evolution,0,0
117712,of,0,0
117713,markers,0,0
117714,of,0,0
117715,alcohol,0,0
117716,ingestion,0,0
117717,at,0,0
117718,three,0,0
117719,months,0,0
117720,",",0,0
117721,in,0,0
117722,this,0,0
117723,large-scale,0,0
117724,multicenter,0,0
117725,study,0,0
117726,.,0,0
117727,It,0,0
117728,could,0,0
117729,be,0,0
117730,a,0,0
117731,new,0,0
117732,modality,0,0
117733,in,0,0
117734,the,0,0
117735,drug,0,0
117736,therapy,0,1
117737,of,0,0
117738,alcoholism,0,0
117739,",",0,0
117740,not,0,0
117741,involving,0,0
117742,an,0,0
117743,antabuse,0,1
117744,effect,0,0
117745,",",0,0
117746,an,0,0
117747,antidepressant,0,1
117748,action,0,0
117749,",",0,0
117750,or,0,0
117751,conditioning,0,1
117752,.,0,0
117753,Multicenter,0,0
117754,",",0,0
117755,double-blind,0,0
117756,",",0,0
117757,placebo-controlled,0,1
117758,crossover,0,0
117759,study,0,0
117760,to,0,0
117761,assess,0,0
117762,the,0,0
117763,acute,0,0
117764,prokinetic,0,1
117765,efficacy,0,0
117766,of,0,0
117767,nizatidine-controlled,1,1
117768,release,1,1
117769,(,0,0
117770,150,0,0
117771,and,0,0
117772,300,0,1
117773,mg,0,1
117774,),0,0
117775,in,0,0
117776,patients,0,0
117777,with,0,0
117778,gastroesophageal,0,0
117779,reflux,0,0
117780,disease,0,0
117781,.,0,0
117782,INTRODUCTION,0,0
117783,The,0,0
117784,aim,0,0
117785,of,0,0
117786,the,0,0
117787,study,0,0
117788,is,0,0
117789,to,0,0
117790,test,0,0
117791,whether,0,0
117792,nizatidine,1,1
117793,delivered,0,0
117794,via,0,0
117795,a,0,0
117796,unique,0,0
117797,bimodal,0,0
117798,pulsatile-controlled,0,1
117799,release,0,0
117800,system,0,1
117801,",",0,0
117802,nizatidine,1,1
117803,controlled,1,0
117804,release,1,1
117805,(,1,0
117806,CR,1,1
117807,),1,0
117808,",",0,0
117809,accelerates,0,0
117810,gastric,0,0
117811,emptying,0,0
117812,in,0,0
117813,patients,0,0
117814,with,0,0
117815,gastroesophageal,0,0
117816,reflux,0,0
117817,disease,0,0
117818,(,0,0
117819,GERD,0,1
117820,),0,0
117821,.,0,0
117822,METHODS,0,0
117823,Combined,0,0
117824,data,0,0
117825,were,0,0
117826,analyzed,0,0
117827,on,0,0
117828,39,0,0
117829,patients,0,0
117830,with,0,0
117831,delayed,0,0
117832,gastric,0,0
117833,emptying,0,0
117834,(,0,0
117835,DGE,0,1
117836,),0,0
117837,from,0,0
117838,2,0,0
117839,studies,0,0
117840,(,0,0
117841,n,0,0
117842,=,0,0
117843,84,0,0
117844,),0,0
117845,assessing,0,0
117846,the,0,0
117847,prokinetic,0,1
117848,effect,0,0
117849,of,0,0
117850,nizatidine,1,1
117851,CR,1,1
117852,.,1,0
117853,A,0,0
117854,single-blind,1,0
117855,placebo,1,1
117856,baseline,1,0
117857,was,1,0
117858,followed,1,0
117859,by,1,0
117860,double-blind,1,0
117861,nizatidine,1,1
117862,CR,1,1
117863,(,1,0
117864,150,1,0
117865,and,1,0
117866,300,1,1
117867,mg,1,1
117868,),1,0
117869,in,1,0
117870,randomized,1,0
117871,sequence,1,0
117872,",",1,0
117873,2,1,0
117874,to,1,0
117875,5,1,0
117876,days,1,0
117877,apart,1,0
117878,.,1,0
117879,Each,1,0
117880,dose,1,0
117881,was,1,0
117882,followed,1,0
117883,1,1,0
117884,hour,1,0
117885,later,1,0
117886,by,1,0
117887,an,1,0
117888,egg-beater,1,0
117889,meal,1,0
117890,",",1,0
117891,labeled,1,0
117892,with,1,0
117893,Tc99m,1,1
117894,.,1,0
117895,Gamma,1,0
117896,camera,1,1
117897,images,1,0
117898,were,1,0
117899,obtained,1,0
117900,at,1,0
117901,meal,1,0
117902,completion,1,0
117903,",",1,0
117904,1-,1,0
117905,",",1,0
117906,2-,1,0
117907,",",1,0
117908,3-,1,1
117909,and,1,0
117910,4-hour,1,0
117911,postmeal,1,0
117912,.,1,0
117913,All,0,0
117914,the,0,0
117915,84,0,0
117916,patients,0,0
117917,were,0,0
117918,classified,0,0
117919,at,0,0
117920,baseline,0,0
117921,with,0,0
117922,DGE,0,1
117923,(,0,0
117924,gastric,0,0
117925,retention,0,0
117926,>,0,0
117927,6.3,0,0
117928,%,0,0
117929,at,0,0
117930,4,0,0
117931,hours,0,0
117932,),0,0
117933,or,0,0
117934,normal,0,0
117935,gastric,0,0
117936,emptying,0,0
117937,.,0,0
117938,RESULTS,0,0
117939,In,0,0
117940,the,0,0
117941,39,0,0
117942,patients,0,0
117943,identified,0,0
117944,with,0,0
117945,DGE,0,0
117946,",",0,0
117947,change,0,0
117948,from,0,0
117949,placebo,1,1
117950,baseline,0,0
117951,(,0,0
117952,CFB,0,1
117953,),0,0
117954,for,0,0
117955,percent,0,0
117956,gastric,0,0
117957,retention,0,0
117958,at,0,0
117959,4-hour,0,0
117960,postmeal,0,0
117961,with,0,0
117962,nizatidine,1,1
117963,CR,1,1
117964,(,0,0
117965,150,0,0
117966,and,0,0
117967,300,0,1
117968,mg,0,1
117969,),0,0
117970,was,0,0
117971,each,0,0
117972,improved,0,0
117973,and,0,0
117974,statistically,0,0
117975,significant,0,0
117976,(,0,0
117977,P,0,0
117978,<,0,0
117979,0.05,0,0
117980,),0,0
117981,.,0,0
117982,In,0,0
117983,a,0,0
117984,subgroup,0,0
117985,of,0,0
117986,diabetic,0,0
117987,patients,0,0
117988,with,0,0
117989,DGE,0,1
117990,(,0,0
117991,n,0,0
117992,=,0,0
117993,10,0,0
117994,),0,0
117995,",",0,0
117996,the,0,0
117997,CFB,0,1
117998,with,0,0
117999,nizatidine,0,1
118000,CR,0,1
118001,(,0,0
118002,300,0,1
118003,mg,0,1
118004,),0,0
118005,was,0,0
118006,significant,0,0
118007,(,0,0
118008,P,0,0
118009,<,0,0
118010,0.05,0,0
118011,),0,0
118012,at,0,0
118013,3-,0,1
118014,and,0,0
118015,4-hour,0,0
118016,postmeal,0,0
118017,.,0,0
118018,CONCLUSIONS,0,0
118019,Nizatidine,1,1
118020,CR,1,1
118021,(,0,0
118022,150,0,0
118023,and,0,0
118024,300,0,1
118025,mg,0,1
118026,),0,0
118027,significantly,0,0
118028,enhanced,0,0
118029,gastric,0,0
118030,emptying,0,0
118031,of,0,0
118032,a,0,0
118033,standard,0,1
118034,meal,0,0
118035,in,0,0
118036,patients,0,0
118037,with,0,0
118038,GERD,0,0
118039,with,0,0
118040,DGE,0,0
118041,.,0,0
118042,Anatomical,0,0
118043,benefit,0,0
118044,from,0,0
118045,ranibizumab,1,1
118046,treatment,0,0
118047,of,0,0
118048,predominantly,0,0
118049,classic,0,0
118050,neovascular,0,0
118051,age-related,0,0
118052,macular,0,0
118053,degeneration,0,0
118054,in,0,0
118055,the,0,0
118056,2-year,0,0
118057,anchor,0,0
118058,study,0,0
118059,.,0,0
118060,PURPOSE,0,0
118061,To,0,0
118062,compare,0,0
118063,lesion,0,0
118064,anatomical,0,0
118065,responses,0,0
118066,to,0,0
118067,ranibizumab,1,1
118068,versus,0,0
118069,verteporfin,1,1
118070,photodynamic,1,1
118071,therapy,1,1
118072,(,1,0
118073,PDT,1,1
118074,),1,0
118075,in,0,0
118076,the,0,0
118077,ANCHOR,0,0
118078,(,0,0
118079,Anti-VEGF,0,1
118080,Antibody,0,1
118081,for,0,0
118082,the,0,0
118083,Treatment,0,0
118084,of,0,0
118085,Predominantly,0,0
118086,Classic,0,1
118087,Choroidal,0,1
118088,Neovascularization,0,0
118089,[,0,0
118090,CNV,0,1
118091,],0,0
118092,in,0,0
118093,Age-Related,0,0
118094,Macular,0,0
118095,Degeneration,0,0
118096,),0,0
118097,study,0,0
118098,.,0,0
118099,METHODS,0,0
118100,In,0,0
118101,this,0,0
118102,2-year,0,0
118103,",",0,0
118104,Phase,0,0
118105,III,0,0
118106,",",0,0
118107,randomized,0,0
118108,",",0,0
118109,multicenter,0,0
118110,",",0,0
118111,double-masked,0,0
118112,trial,0,0
118113,",",0,0
118114,423,0,0
118115,patients,0,0
118116,received,0,0
118117,ranibizumab,1,1
118118,(,0,0
118119,0.3,0,0
118120,or,0,0
118121,0.5,0,1
118122,mg,0,1
118123,),0,0
118124,monthly,0,0
118125,+,0,1
118126,sham,1,1
118127,PDT,1,1
118128,or,1,1
118129,PDT,1,1
118130,+,1,1
118131,monthly,0,0
118132,sham,1,1
118133,injection,1,1
118134,.,1,0
118135,Photodynamic,1,1
118136,therapy,1,1
118137,(,1,0
118138,or,1,0
118139,sham,1,1
118140,PDT,1,1
118141,),1,0
118142,was,0,0
118143,administered,0,0
118144,at,0,0
118145,Day,0,0
118146,0,0,0
118147,and,0,0
118148,then,0,0
118149,quarterly,0,0
118150,as,0,0
118151,needed,0,0
118152,.,0,0
118153,A,0,0
118154,central,0,0
118155,reading,0,1
118156,center,0,0
118157,assessed,0,0
118158,fundus,0,0
118159,photography,0,1
118160,and,0,0
118161,fluorescein,0,1
118162,angiography,0,1
118163,images,0,0
118164,.,0,0
118165,A,0,0
118166,subset,0,0
118167,(,0,0
118168,n,0,0
118169,=,0,0
118170,61,0,0
118171,),0,0
118172,had,0,0
118173,optical,0,1
118174,coherence,0,0
118175,tomography,0,1
118176,assessments,0,0
118177,.,0,0
118178,Main,0,0
118179,outcome,0,0
118180,measures,0,0
118181,included,0,0
118182,mean,0,0
118183,change,0,0
118184,from,0,0
118185,baseline,0,0
118186,at,0,0
118187,Months,0,0
118188,12,0,0
118189,and,0,0
118190,24,0,0
118191,for,0,0
118192,area,0,0
118193,of,0,0
118194,classic,0,0
118195,CNV,0,1
118196,and,0,0
118197,total,0,0
118198,area,0,0
118199,of,0,0
118200,leakage,0,0
118201,from,0,0
118202,CNV,0,1
118203,.,0,0
118204,RESULTS,0,0
118205,At,0,0
118206,Months,0,0
118207,12,0,0
118208,and,0,0
118209,24,0,0
118210,",",0,0
118211,ranibizumab,1,1
118212,was,0,0
118213,superior,0,0
118214,to,0,0
118215,PDT,1,1
118216,(,0,0
118217,P,0,0
118218,<,0,0
118219,0.0001,0,0
118220,),0,0
118221,for,0,0
118222,mean,0,0
118223,changes,0,0
118224,from,0,0
118225,baseline,0,0
118226,in,0,0
118227,total,0,0
118228,area,0,0
118229,of,0,0
118230,lesion,0,0
118231,",",0,0
118232,CNV,0,1
118233,area,0,0
118234,",",0,0
118235,and,0,0
118236,total,0,0
118237,area,0,0
118238,CNV,0,1
118239,leakage,0,0
118240,.,0,0
118241,Month,0,0
118242,12,0,0
118243,optical,0,0
118244,coherence,0,0
118245,tomographies,0,1
118246,showed,0,0
118247,greater,0,0
118248,center,0,0
118249,point,0,0
118250,thickness,0,0
118251,decrease,0,0
118252,from,0,0
118253,baseline,0,0
118254,with,0,0
118255,ranibizumab,1,1
118256,than,0,0
118257,with,0,0
118258,PDT,1,1
118259,(,0,0
118260,P,0,0
118261,=,0,0
118262,0.0003,0,0
118263,),0,0
118264,.,0,0
118265,Ranibizumab,1,1
118266,benefits,0,0
118267,over,0,0
118268,PDT,1,1
118269,were,0,0
118270,evident,0,0
118271,by,0,0
118272,3,0,0
118273,months,0,0
118274,(,0,0
118275,fluorescein,0,1
118276,angiography,0,1
118277,),0,0
118278,and,0,0
118279,7,0,0
118280,days,0,0
118281,(,0,0
118282,optical,0,1
118283,coherence,0,0
118284,tomography,0,1
118285,),0,0
118286,.,0,0
118287,CONCLUSION,0,0
118288,Differences,0,0
118289,between,0,0
118290,the,0,0
118291,PDT,1,1
118292,and,0,0
118293,the,0,0
118294,ranibizumab,1,1
118295,groups,0,0
118296,in,0,0
118297,lesion,0,0
118298,anatomical,0,0
118299,outcomes,0,0
118300,were,0,0
118301,early,0,0
118302,",",0,0
118303,sustained,0,0
118304,",",0,0
118305,and,0,0
118306,favored,0,0
118307,ranibizumab,1,1
118308,.,1,0
118309,Late,0,1
118310,patient-reported,0,0
118311,toxicity,0,0
118312,after,0,0
118313,preoperative,0,0
118314,radiotherapy,1,1
118315,or,0,1
118316,chemoradiotherapy,1,1
118317,in,0,0
118318,nonresectable,0,0
118319,rectal,0,0
118320,cancer,0,0
118321,:,0,0
118322,results,0,0
118323,from,0,0
118324,a,0,0
118325,randomized,0,0
118326,Phase,0,0
118327,III,0,0
118328,study,0,0
118329,.,0,0
118330,PURPOSE,0,0
118331,Preoperative,1,1
118332,chemoradiotherapy,1,1
118333,(,0,0
118334,CRT,0,1
118335,),0,1
118336,is,0,0
118337,superior,0,0
118338,to,0,0
118339,radiotherapy,1,1
118340,(,0,0
118341,RT,0,0
118342,),0,0
118343,in,0,0
118344,locally,0,0
118345,advanced,0,0
118346,rectal,0,0
118347,cancer,0,0
118348,",",0,0
118349,but,0,0
118350,the,0,0
118351,survival,0,0
118352,gain,0,0
118353,is,0,0
118354,limited,0,0
118355,.,0,0
118356,Late,0,0
118357,toxicity,0,0
118358,is,0,0
118359,",",0,0
118360,therefore,0,0
118361,",",0,0
118362,important,0,0
118363,.,0,0
118364,The,0,0
118365,aim,0,0
118366,was,0,0
118367,to,0,0
118368,compare,0,0
118369,late,0,0
118370,bowel,0,0
118371,",",0,0
118372,urinary,0,0
118373,",",0,0
118374,and,0,0
118375,sexual,0,0
118376,functions,0,0
118377,after,0,0
118378,CRT,0,1
118379,or,0,0
118380,RT,0,0
118381,.,0,0
118382,METHODS,0,0
118383,AND,0,0
118384,MATERIALS,0,1
118385,Patients,0,0
118386,(,0,0
118387,N,0,0
118388,=,0,0
118389,207,0,0
118390,),0,0
118391,with,0,0
118392,nonresectable,0,0
118393,rectal,0,0
118394,cancer,0,0
118395,were,0,0
118396,randomized,0,0
118397,to,0,0
118398,preoperative,1,0
118399,CRT,1,1
118400,or,1,1
118401,RT,1,1
118402,(,0,0
118403,2,0,0
118404,Gy,0,1
118405,?,0,0
118406,25,0,0
118407,?,0,0
118408,5-fluorouracil/leucovorin,1,1
118409,),1,0
118410,.,1,0
118411,Extended,0,0
118412,surgery,0,0
118413,was,0,0
118414,often,0,0
118415,required,0,0
118416,.,0,0
118417,Self-reported,0,0
118418,late,0,0
118419,toxicity,0,0
118420,was,0,0
118421,scored,0,0
118422,according,0,0
118423,to,0,0
118424,the,0,0
118425,LENT,0,0
118426,SOMA,0,0
118427,criteria,0,0
118428,in,0,0
118429,a,0,0
118430,structured,0,1
118431,telephone,0,1
118432,interview,0,0
118433,and,0,0
118434,with,0,0
118435,questionnaires,0,1
118436,European,0,0
118437,Organisation,0,0
118438,for,0,0
118439,Research,0,0
118440,and,0,0
118441,Treatment,0,0
118442,of,0,0
118443,Cancer,0,0
118444,(,0,0
118445,EORTC,0,0
118446,),0,0
118447,Quality,0,0
118448,of,0,0
118449,Life,0,0
118450,Questionnaire,0,0
118451,(,0,0
118452,QLQ-C30,0,0
118453,),0,0
118454,",",0,0
118455,International,0,0
118456,Index,0,0
118457,of,0,0
118458,Erectile,0,1
118459,Function,0,0
118460,(,0,0
118461,IIEF,0,1
118462,),0,0
118463,",",0,0
118464,and,0,0
118465,sexual,0,0
118466,function-vaginal,0,0
118467,changes,0,0
118468,questionnaire,0,0
118469,(,0,0
118470,SVQ,0,0
118471,),0,0
118472,.,0,0
118473,RESULTS,0,0
118474,Of,0,0
118475,the,0,0
118476,105,0,0
118477,patients,0,0
118478,alive,0,0
118479,in,0,0
118480,Norway,0,0
118481,and,0,0
118482,Sweden,0,0
118483,after,0,0
118484,4,0,0
118485,to,0,0
118486,12,0,0
118487,years,0,0
118488,of,0,0
118489,follow-up,0,0
118490,",",0,0
118491,78,0,0
118492,(,0,0
118493,74,0,0
118494,%,0,0
118495,),0,0
118496,responded,0,0
118497,.,0,0
118498,More,0,0
118499,patients,0,0
118500,in,0,0
118501,the,0,0
118502,CRT,0,1
118503,group,0,0
118504,had,0,0
118505,received,0,0
118506,a,0,0
118507,stoma,0,1
118508,(,0,0
118509,73,0,0
118510,%,0,0
118511,vs.,0,0
118512,52,0,0
118513,%,0,0
118514,",",0,0
118515,p,0,0
118516,=,0,0
118517,0.09,0,0
118518,),0,0
118519,.,0,0
118520,Most,0,0
118521,patients,0,0
118522,without,0,0
118523,a,0,0
118524,stoma,0,1
118525,(,0,0
118526,7,0,0
118527,of,0,0
118528,12,0,0
118529,in,0,0
118530,CRT,0,1
118531,group,0,0
118532,and,0,0
118533,9,0,0
118534,of,0,0
118535,16,0,0
118536,in,0,0
118537,RT,0,0
118538,group,0,0
118539,),0,0
118540,had,0,0
118541,incontinence,0,0
118542,for,0,0
118543,liquid,0,1
118544,stools,0,0
118545,or,0,0
118546,gas,0,1
118547,.,0,0
118548,No,0,0
118549,stoma,0,1
118550,and,0,0
118551,good,0,0
118552,anal,0,1
118553,function,0,0
118554,were,0,0
118555,seen,0,0
118556,in,0,0
118557,5,0,0
118558,patients,0,0
118559,(,0,0
118560,11,0,0
118561,%,0,0
118562,),0,0
118563,in,0,0
118564,the,0,0
118565,CRT,0,1
118566,group,0,0
118567,and,0,0
118568,in,0,0
118569,11,0,0
118570,(,0,0
118571,30,0,0
118572,%,0,0
118573,),0,0
118574,in,0,0
118575,the,0,0
118576,RT,0,1
118577,group,0,0
118578,(,0,0
118579,p,0,0
118580,=,0,0
118581,0.046,0,0
118582,),0,0
118583,.,0,0
118584,Of,0,0
118585,44,0,0
118586,patients,0,0
118587,in,0,0
118588,the,0,0
118589,CRT,0,1
118590,group,0,0
118591,",",0,0
118592,12,0,0
118593,(,0,0
118594,28,0,0
118595,%,0,0
118596,),0,0
118597,had,0,0
118598,had,0,0
118599,bowel,0,0
118600,obstruction,0,0
118601,compared,0,0
118602,with,0,0
118603,5,0,0
118604,of,0,0
118605,33,0,0
118606,(,0,0
118607,15,0,0
118608,%,0,0
118609,),0,0
118610,in,0,0
118611,the,0,0
118612,RT,0,1
118613,group,0,0
118614,(,0,0
118615,p,0,0
118616,=,0,0
118617,0.27,0,0
118618,),0,0
118619,.,0,0
118620,One-quarter,0,0
118621,of,0,0
118622,the,0,0
118623,patients,0,0
118624,reported,0,0
118625,urinary,0,0
118626,incontinence,0,0
118627,.,0,0
118628,The,0,0
118629,majority,0,0
118630,of,0,0
118631,men,0,0
118632,had,0,0
118633,severe,0,0
118634,erectile,0,0
118635,dysfunction,0,0
118636,.,0,0
118637,Few,0,0
118638,women,0,0
118639,reported,0,0
118640,sexual,0,0
118641,activity,0,0
118642,during,0,0
118643,the,0,0
118644,previous,0,0
118645,month,0,0
118646,.,0,0
118647,However,0,0
118648,",",0,0
118649,the,0,0
118650,majority,0,0
118651,did,0,0
118652,not,0,0
118653,have,0,0
118654,concerns,0,0
118655,about,0,0
118656,their,0,0
118657,sex,0,0
118658,life,0,0
118659,.,0,0
118660,CONCLUSIONS,0,0
118661,Fecal,0,0
118662,incontinence,0,0
118663,and,0,0
118664,erectile,0,0
118665,dysfunction,0,0
118666,are,0,0
118667,frequent,0,0
118668,after,0,0
118669,combined,0,1
118670,treatment,0,0
118671,for,0,0
118672,locally,0,0
118673,advanced,0,0
118674,rectal,0,0
118675,cancer,0,0
118676,.,0,0
118677,There,0,0
118678,was,0,0
118679,a,0,0
118680,clear,0,0
118681,tendency,0,0
118682,for,0,0
118683,the,0,0
118684,problems,0,0
118685,to,0,0
118686,be,0,0
118687,more,0,0
118688,common,0,0
118689,after,0,0
118690,CRT,0,1
118691,than,0,0
118692,after,0,0
118693,RT,0,0
118694,.,0,0
118695,The,0,0
118696,maximal,1,0
118697,double,1,0
118698,step,1,0
118699,length,1,0
118700,test,1,0
118701,can,0,0
118702,evaluate,0,0
118703,more,0,0
118704,adequately,0,0
118705,the,0,0
118706,decrease,0,0
118707,of,0,0
118708,physical,0,0
118709,function,0,0
118710,with,0,0
118711,age,0,0
118712,",",0,0
118713,than,0,0
118714,the,0,0
118715,maximal,0,0
118716,single,0,0
118717,step,0,0
118718,length,0,0
118719,test,0,0
118720,.,0,0
118721,The,0,0
118722,maximal,1,0
118723,double,1,0
118724,step,1,1
118725,length,1,0
118726,(,0,0
118727,MDSL,0,1
118728,),0,0
118729,test,0,0
118730,is,0,0
118731,a,0,0
118732,modified,0,0
118733,version,0,0
118734,of,0,0
118735,the,0,0
118736,maximal,1,0
118737,step,1,1
118738,length,1,0
118739,(,1,0
118740,MSL,1,1
118741,),1,0
118742,test,1,0
118743,used,0,0
118744,to,0,0
118745,evaluate,0,0
118746,the,0,0
118747,dynamic,0,0
118748,balance,0,0
118749,related,0,0
118750,to,0,0
118751,falls,0,0
118752,in,0,0
118753,the,0,0
118754,elderly,0,0
118755,.,0,0
118756,Although,0,0
118757,this,0,0
118758,test,0,0
118759,can,0,0
118760,evaluate,0,0
118761,their,0,0
118762,physical,0,1
118763,function,0,0
118764,using,0,0
118765,movements,0,0
118766,similar,0,0
118767,to,0,0
118768,daily,0,0
118769,activities,0,0
118770,as,0,0
118771,compared,0,0
118772,to,0,0
118773,MSL,1,0
118774,",",0,0
118775,it,0,0
118776,has,0,0
118777,not,0,0
118778,been,0,0
118779,clarified,0,0
118780,whether,0,0
118781,it,0,0
118782,can,0,0
118783,adequately,0,0
118784,evaluate,0,0
118785,the,0,0
118786,activities,0,0
118787,of,0,0
118788,daily,0,1
118789,living,0,0
118790,(,0,0
118791,ADL,0,0
118792,),0,0
118793,abilities,0,0
118794,of,0,0
118795,the,0,0
118796,elderly,0,0
118797,",",0,0
118798,as,0,0
118799,they,0,0
118800,decrease,0,0
118801,with,0,0
118802,age,0,0
118803,.,0,0
118804,This,0,0
118805,study,0,0
118806,aimed,0,0
118807,to,0,0
118808,examine,0,0
118809,the,0,0
118810,relationship,0,0
118811,between,0,0
118812,both,0,0
118813,MSL,1,0
118814,and,0,0
118815,MDSL,1,0
118816,on,0,0
118817,age,0,0
118818,and,0,0
118819,ADL,0,0
118820,in,0,0
118821,elderly,0,0
118822,subjects,0,0
118823,.,0,0
118824,Fifty-seven,0,0
118825,elderly,0,0
118826,females,0,0
118827,who,0,0
118828,live,0,0
118829,independently,0,0
118830,(,0,0
118831,age,0,0
118832,74.8?5.6,0,0
118833,years,0,0
118834,),0,0
118835,were,0,0
118836,recruited,0,0
118837,.,0,0
118838,MSL,1,0
118839,and,1,0
118840,MDSL,1,0
118841,were,0,0
118842,conducted,0,0
118843,twice,0,0
118844,after,0,0
118845,completing,0,0
118846,an,0,0
118847,ADL,0,0
118848,questionnaire,0,0
118849,.,0,0
118850,Intra-class,0,0
118851,correlation,0,0
118852,coefficients,0,0
118853,(,0,0
118854,ICCs,0,1
118855,),0,0
118856,of,0,0
118857,both,0,0
118858,tests,0,0
118859,were,0,0
118860,high,0,0
118861,(,0,0
118862,for,1,0
118863,MSL,1,1
118864,:,1,0
118865,ICC=0.95,0,0
118866,",",0,0
118867,for,1,0
118868,MDSL,1,0
118869,:,1,0
118870,ICC=0.81-0.82,0,0
118871,),0,0
118872,.,0,0
118873,Age,0,0
118874,and,0,0
118875,ADL,0,0
118876,significantly,0,0
118877,correlated,0,0
118878,to,0,0
118879,MDSL,0,1
118880,(,0,0
118881,age,0,0
118882,:,0,0
118883,r=-0.32-0.41,0,0
118884,",",0,0
118885,ADL,0,0
118886,:,0,0
118887,r=0.28-0.48,0,0
118888,),0,0
118889,",",0,0
118890,but,0,0
118891,not,0,0
118892,to,0,0
118893,MSL,0,1
118894,(,0,0
118895,age,0,0
118896,:,0,0
118897,r=-0.19,0,0
118898,",",0,0
118899,ADL,0,0
118900,:,0,0
118901,r=0.15,0,0
118902,),0,0
118903,.,0,0
118904,MDSL,1,0
118905,has,0,0
118906,high,0,0
118907,reliability,0,0
118908,as,0,0
118909,it,0,0
118910,relates,0,0
118911,to,0,0
118912,age,0,0
118913,and,0,0
118914,ADL,0,0
118915,.,0,0
118916,It,0,0
118917,may,0,0
118918,be,0,0
118919,more,0,0
118920,useful,0,0
118921,to,0,0
118922,evaluate,0,0
118923,ADL,0,0
118924,required,0,0
118925,for,0,0
118926,independent,0,0
118927,living,0,0
118928,and,0,0
118929,prevent,0,0
118930,falls,0,0
118931,in,0,0
118932,the,0,0
118933,elderly,0,0
118934,better,0,0
118935,than,1,0
118936,MSL,1,0
118937,.,1,0
118938,The,0,0
118939,use,0,0
118940,of,0,0
118941,vitamin,1,1
118942,E,1,1
118943,for,0,0
118944,the,0,0
118945,prevention,0,0
118946,of,0,0
118947,chemotherapy-induced,0,0
118948,peripheral,0,0
118949,neuropathy,0,0
118950,:,0,0
118951,results,0,0
118952,of,0,0
118953,a,0,0
118954,randomized,0,0
118955,phase,0,0
118956,III,0,0
118957,clinical,0,0
118958,trial,0,0
118959,.,0,0
118960,BACKGROUND,0,0
118961,Chemotherapy-induced,0,0
118962,peripheral,0,0
118963,neuropathy,0,0
118964,(,0,0
118965,CIPN,0,1
118966,),0,1
118967,continues,0,0
118968,to,0,0
118969,be,0,0
118970,a,0,0
118971,substantial,0,0
118972,problem,0,0
118973,for,0,0
118974,many,0,0
118975,cancer,0,0
118976,patients,0,0
118977,.,0,0
118978,Pursuant,0,0
118979,to,0,0
118980,promising,0,0
118981,appearing,0,0
118982,pilot,0,0
118983,data,0,0
118984,",",0,0
118985,the,0,0
118986,current,0,0
118987,study,0,0
118988,evaluated,0,0
118989,the,0,0
118990,use,0,0
118991,of,0,0
118992,vitamin,1,1
118993,E,1,1
118994,for,0,0
118995,the,0,0
118996,prevention,0,0
118997,of,0,0
118998,CIPN,0,1
118999,.,0,0
119000,METHODS,0,0
119001,A,0,0
119002,phase,0,0
119003,III,0,0
119004,",",0,0
119005,randomized,0,0
119006,",",0,0
119007,double-blind,0,0
119008,",",0,0
119009,placebo-controlled,0,1
119010,study,0,0
119011,was,0,0
119012,conducted,0,0
119013,in,0,0
119014,patients,0,0
119015,undergoing,0,0
119016,therapy,0,1
119017,with,0,0
119018,neurotoxic,0,0
119019,chemotherapy,0,1
119020,",",0,0
119021,utilizing,0,0
119022,twice,1,0
119023,daily,1,1
119024,dosing,1,0
119025,of,1,0
119026,vitamin,1,1
119027,E,1,1
119028,(,1,0
119029,400,1,0
119030,mg,1,1
119031,),1,0
119032,/placebo,1,0
119033,.,1,0
119034,The,0,0
119035,primary,0,0
119036,endpoint,0,0
119037,was,0,0
119038,the,0,0
119039,incidence,0,0
119040,of,0,0
119041,grade,0,0
119042,2+,0,0
119043,sensory,0,0
119044,neuropathy,0,0
119045,(,0,0
119046,SN,0,1
119047,),0,1
119048,toxicity,0,0
119049,(,0,0
119050,CTCAE,0,0
119051,v,0,1
119052,3.0,0,0
119053,),0,0
119054,in,0,0
119055,each,0,0
119056,treatment,0,0
119057,arm,0,0
119058,",",0,0
119059,analyzed,0,0
119060,by,0,0
119061,chi-square,0,0
119062,testing,0,0
119063,.,0,0
119064,Planned,0,0
119065,sample,0,0
119066,size,0,0
119067,was,0,0
119068,100,0,0
119069,patients,0,0
119070,per,0,0
119071,arm,0,0
119072,to,0,0
119073,provide,0,0
119074,80,0,0
119075,%,0,0
119076,power,0,0
119077,to,0,0
119078,detect,0,0
119079,a,0,0
119080,difference,0,0
119081,in,0,0
119082,incidence,0,0
119083,of,0,0
119084,grade,0,0
119085,2+,0,0
119086,SN,0,1
119087,toxicity,0,0
119088,from,0,0
119089,25,0,0
119090,%,0,0
119091,in,0,0
119092,the,0,0
119093,placebo,0,1
119094,group,0,0
119095,to,0,0
119096,10,0,0
119097,%,0,0
119098,in,0,0
119099,the,0,0
119100,vitamin,0,1
119101,E,0,1
119102,group,0,0
119103,.,0,0
119104,RESULTS,0,0
119105,Two-hundred,0,0
119106,seven,0,0
119107,patients,0,0
119108,were,0,0
119109,enrolled,0,0
119110,between,0,0
119111,December,0,0
119112,1,0,0
119113,",",0,0
119114,2006,0,0
119115,and,0,0
119116,December,0,0
119117,14,0,0
119118,",",0,0
119119,2007,0,0
119120,",",0,0
119121,producing,0,0
119122,189,0,0
119123,evaluable,0,0
119124,cases,0,0
119125,for,0,0
119126,analysis,0,0
119127,.,0,0
119128,Cytotoxic,0,0
119129,agents,0,0
119130,included,0,0
119131,taxanes,0,1
119132,(,0,0
119133,109,0,0
119134,),0,0
119135,",",0,0
119136,cisplatin,0,1
119137,(,0,0
119138,8,0,0
119139,),0,0
119140,",",0,0
119141,carboplatin,0,1
119142,(,0,0
119143,2,0,0
119144,),0,0
119145,",",0,0
119146,oxaliplatin,0,1
119147,(,0,0
119148,50,0,0
119149,),0,0
119150,",",0,0
119151,or,0,1
119152,combination,0,1
119153,(,0,0
119154,20,0,0
119155,),0,0
119156,.,0,0
119157,There,0,0
119158,was,0,0
119159,no,0,0
119160,difference,0,0
119161,in,0,0
119162,the,0,0
119163,incidence,0,0
119164,of,0,0
119165,grade,0,0
119166,2+,0,0
119167,SN,0,1
119168,between,0,0
119169,the,0,0
119170,two,0,0
119171,arms,0,0
119172,(,1,0
119173,34,1,0
119174,%,1,0
119175,-vitamin,1,1
119176,E,1,1
119177,",",0,0
119178,29,0,0
119179,%,0,0
119180,-placebo,0,0
119181,;,0,0
119182,P,0,0
119183,=,0,0
119184,0.43,0,0
119185,),0,0
119186,.,0,0
119187,There,0,0
119188,were,0,0
119189,no,0,0
119190,significant,0,0
119191,differences,0,0
119192,between,0,0
119193,treatment,0,0
119194,arms,0,0
119195,for,0,0
119196,time,0,0
119197,to,0,0
119198,onset,0,0
119199,of,0,0
119200,neuropathy,0,0
119201,(,0,0
119202,P,0,0
119203,=,0,0
119204,0.58,0,0
119205,),0,0
119206,",",0,0
119207,for,0,0
119208,chemotherapy,0,1
119209,dose,0,0
119210,reductions,0,0
119211,due,0,0
119212,to,0,0
119213,neuropathy,0,0
119214,(,0,0
119215,P,0,0
119216,=,0,0
119217,0.21,0,0
119218,),0,0
119219,",",0,0
119220,or,0,0
119221,for,0,0
119222,secondary,0,0
119223,endpoints,0,0
119224,derived,0,0
119225,from,0,0
119226,patient-reported,0,0
119227,neuropathy,0,0
119228,symptom,0,0
119229,assessments,0,0
119230,.,0,0
119231,The,0,0
119232,treatment,0,0
119233,was,0,0
119234,well,0,0
119235,tolerated,0,0
119236,overall,0,0
119237,.,0,0
119238,CONCLUSIONS,0,0
119239,Vitamin,1,1
119240,E,1,1
119241,did,1,0
119242,not,0,0
119243,appear,0,0
119244,to,0,0
119245,reduce,0,0
119246,the,0,0
119247,incidence,0,0
119248,of,0,0
119249,sensory,0,0
119250,neuropathy,0,0
119251,in,0,0
119252,the,0,0
119253,studied,0,0
119254,group,0,0
119255,of,0,0
119256,patients,0,0
119257,receiving,0,0
119258,neurotoxic,0,0
119259,chemotherapy,0,1
119260,.,0,0
119261,Clofarabine,1,1
119262,?,1,0
119263,fludarabine,1,1
119264,with,0,0
119265,once,0,0
119266,daily,0,0
119267,i.v,0,1
119268,.,0,0
119269,busulfan,1,1
119270,as,0,0
119271,pretransplant,0,0
119272,conditioning,0,1
119273,therapy,0,1
119274,for,0,0
119275,advanced,0,0
119276,myeloid,0,0
119277,leukemia,0,0
119278,and,0,0
119279,MDS,0,0
119280,.,0,0
119281,Although,0,0
119282,a,0,0
119283,combination,0,1
119284,of,1,0
119285,i.v,1,1
119286,.,1,0
119287,busulfan,1,1
119288,(,1,0
119289,Bu,1,0
119290,),1,1
119291,and,1,0
119292,fludarabine,1,1
119293,(,1,1
119294,Flu,1,1
119295,),1,1
119296,is,0,0
119297,a,0,0
119298,safe,0,0
119299,",",0,0
119300,reduced-toxicity,0,0
119301,conditioning,0,1
119302,program,0,1
119303,for,0,0
119304,acute,0,0
119305,myelogenous,0,0
119306,leukemia/myelodysplastic,0,0
119307,syndromes,0,0
119308,(,0,0
119309,AML/MDS,0,0
119310,),0,0
119311,",",0,0
119312,recurrent,0,0
119313,leukemia,0,0
119314,posttransplantation,0,0
119315,remains,0,0
119316,a,0,0
119317,problem,0,0
119318,.,0,0
119319,To,0,0
119320,enhance,0,0
119321,the,0,0
119322,conditioning,0,1
119323,regimen,0,0
119324,'s,0,0
119325,antileukemic,0,1
119326,effect,0,0
119327,",",0,0
119328,we,0,0
119329,decided,0,0
119330,to,0,0
119331,supplant,1,0
119332,Flu,1,1
119333,with,1,0
119334,clofarabine,1,1
119335,(,1,0
119336,Clo,1,0
119337,),1,0
119338,",",1,0
119339,and,0,0
119340,assayed,0,0
119341,the,0,0
119342,interactions,0,0
119343,of,0,0
119344,these,0,0
119345,nucleoside,0,1
119346,analogs,0,0
119347,alone,0,0
119348,and,0,0
119349,in,0,0
119350,combination,0,1
119351,with,0,0
119352,Bu,0,0
119353,in,0,0
119354,Bu-resistant,0,0
119355,human,0,0
119356,cell,0,0
119357,lines,0,0
119358,in,0,0
119359,vitro,0,0
119360,.,0,0
119361,We,0,0
119362,found,0,0
119363,pronounced,0,0
119364,synergy,0,0
119365,between,0,0
119366,each,0,0
119367,nucleoside,0,1
119368,and,0,0
119369,the,0,0
119370,alkylator,0,1
119371,but,0,0
119372,even,0,0
119373,more,0,0
119374,enhanced,0,0
119375,cytotoxic,0,0
119376,synergy,0,0
119377,when,0,0
119378,the,0,0
119379,nucleoside,0,1
119380,analogs,0,0
119381,were,0,0
119382,combined,0,0
119383,prior,0,0
119384,to,0,0
119385,exposing,0,0
119386,the,0,0
119387,cells,0,0
119388,to,0,0
119389,Bu,0,0
119390,.,0,0
119391,We,0,0
119392,then,0,0
119393,designed,0,0
119394,a,0,0
119395,4-arm,0,0
119396,clinical,0,0
119397,trial,0,0
119398,in,0,0
119399,patients,0,0
119400,with,0,0
119401,myeloid,0,0
119402,leukemia,0,0
119403,undergoing,0,0
119404,allogeneic,0,1
119405,stem,0,1
119406,cell,0,0
119407,transplantation,0,1
119408,(,0,0
119409,allo-SCT,0,1
119410,),0,0
119411,.,0,0
119412,Patients,0,0
119413,were,0,0
119414,adaptively,0,0
119415,randomized,0,0
119416,as,0,0
119417,follows,0,0
119418,:,0,0
119419,Arm,0,0
119420,I-Clo,1,0
119421,:,1,0
119422,Flu,1,0
119423,10:30,0,0
119424,mg/m,0,0
119425,(,0,0
119426,2,0,0
119427,),0,0
119428,",",0,0
119429,Arm,0,0
119430,II-20:20,0,1
119431,mg/m,0,1
119432,(,0,0
119433,2,0,0
119434,),0,0
119435,",",0,0
119436,Arm,0,0
119437,III-30:10,0,1
119438,mg/m,0,1
119439,(,0,0
119440,2,0,0
119441,),0,0
119442,",",0,0
119443,and,0,0
119444,Arm,0,0
119445,IV-single-agent,1,1
119446,Clo,1,0
119447,at,0,0
119448,40,0,0
119449,mg/m,0,1
119450,(,0,0
119451,2,0,0
119452,),0,0
119453,.,0,0
119454,The,0,0
119455,nucleoside,0,1
119456,analog,0,1
119457,(,0,0
119458,s,0,0
119459,),0,0
119460,were/was,0,0
119461,infused,0,0
119462,over,0,0
119463,1,0,0
119464,hour,0,0
119465,once,0,0
119466,daily,0,0
119467,for,0,0
119468,4,0,0
119469,days,0,0
119470,",",0,0
119471,followed,0,0
119472,on,0,0
119473,each,0,0
119474,day,0,0
119475,by,0,0
119476,Bu,0,0
119477,",",0,0
119478,infused,0,0
119479,over,0,0
119480,3,0,0
119481,hours,0,0
119482,to,0,0
119483,a,0,0
119484,pharmacokinetically,0,0
119485,targeted,0,0
119486,daily,0,0
119487,area,0,0
119488,under,0,0
119489,the,0,0
119490,curve,0,0
119491,(,0,0
119492,AUC,0,0
119493,),0,0
119494,of,0,0
119495,6000,0,1
119496,?Mol-min,0,0
119497,?,0,0
119498,10,0,0
119499,%,0,0
119500,.,0,0
119501,Fifty-one,0,0
119502,patients,0,0
119503,have,0,0
119504,been,0,0
119505,enrolled,0,0
119506,with,0,0
119507,a,0,0
119508,minimum,0,0
119509,follow-up,0,0
119510,exceeding,0,0
119511,100,0,0
119512,days,0,0
119513,.,0,0
119514,There,0,0
119515,were,0,0
119516,32,0,0
119517,males,0,0
119518,and,0,0
119519,19,0,0
119520,females,0,0
119521,",",0,0
119522,with,0,0
119523,a,0,0
119524,median,0,0
119525,age,0,0
119526,of,0,0
119527,45,0,0
119528,years,0,0
119529,(,0,0
119530,range,0,0
119531,:,0,1
119532,6-59,0,0
119533,),0,0
119534,.,0,0
119535,Nine,0,1
119536,patients,0,0
119537,had,0,0
119538,chronic,0,0
119539,myeloid,0,0
119540,leukemia,0,0
119541,(,0,0
119542,CML,0,1
119543,),0,1
119544,(,0,0
119545,BC,0,0
119546,:,0,0
119547,2,0,0
119548,",",0,0
119549,second,0,0
119550,AP,0,0
119551,:,0,0
119552,3,0,0
119553,",",0,0
119554,and,0,0
119555,tyrosine-kinase,0,1
119556,inhibitor,0,1
119557,refractory,0,0
119558,first,0,0
119559,chronic,0,0
119560,phase,0,0
119561,[,0,0
119562,CP,0,1
119563,],0,0
119564,:,0,0
119565,4,0,0
119566,),0,0
119567,.,0,0
119568,Forty-two,0,0
119569,patients,0,0
119570,had,0,0
119571,AML,0,1
119572,:,0,0
119573,14,0,0
119574,were,0,0
119575,induction,0,0
119576,failures,0,0
119577,",",0,0
119578,8,0,0
119579,in,0,0
119580,first,0,0
119581,chemotherapy-refractory,0,0
119582,relapse,0,0
119583,",",0,0
119584,7,0,0
119585,in,0,0
119586,untreated,0,0
119587,relapse,0,0
119588,",",0,0
119589,3,0,0
119590,in,0,0
119591,second,0,0
119592,or,0,1
119593,subsequent,0,0
119594,relapse,0,0
119595,",",0,0
119596,4,0,0
119597,were,0,0
119598,in,0,0
119599,second,0,0
119600,complete,0,0
119601,remission,0,0
119602,(,0,0
119603,CR,0,1
119604,),0,0
119605,",",0,0
119606,and,0,0
119607,3,0,0
119608,in,0,0
119609,second,0,0
119610,CR,0,1
119611,without,0,0
119612,platelet,0,0
119613,recovery,0,0
119614,(,0,0
119615,CRp,0,0
119616,),0,0
119617,",",0,0
119618,2,0,0
119619,were,0,0
119620,in,0,0
119621,high-risk,0,0
119622,CR1,0,1
119623,.,0,0
119624,Finally,0,0
119625,",",0,0
119626,1,0,0
119627,patient,0,0
119628,was,0,0
119629,in,0,0
119630,first,0,0
119631,CRp,0,0
119632,.,0,0
119633,Graft-versus-host,0,0
119634,disease,0,0
119635,(,0,0
119636,GVHD,0,1
119637,),0,0
119638,prophylaxis,0,0
119639,was,0,0
119640,tacrolimus,0,1
119641,and,0,0
119642,mini-methorexate,0,1
119643,(,0,0
119644,MTX,0,1
119645,),0,0
119646,",",0,0
119647,and,0,0
119648,those,0,0
119649,who,0,0
119650,had,0,0
119651,an,0,0
119652,unrelated,0,0
119653,or,0,0
119654,1,0,0
119655,antigen-mismatched,0,0
119656,donor,0,0
119657,received,0,0
119658,low-dose,0,1
119659,rabbit-ATG,0,1
119660,(,0,0
119661,Thymoglobulin?,0,1
119662,),0,0
119663,.,0,0
119664,All,0,0
119665,patients,0,0
119666,engrafted,0,0
119667,.,0,0
119668,Forty-one,0,0
119669,patients,0,0
119670,had,0,0
119671,active,0,0
119672,leukemia,0,0
119673,at,0,0
119674,the,0,0
119675,time,0,0
119676,of,0,0
119677,transplant,0,0
119678,",",0,0
119679,and,0,0
119680,35,0,0
119681,achieved,0,0
119682,CR,0,1
119683,(,0,0
119684,85,0,0
119685,%,0,0
119686,),0,0
119687,.,0,0
119688,Twenty,0,0
119689,of,0,0
119690,the,0,0
119691,42,0,0
119692,AML,0,1
119693,patients,0,0
119694,and,0,0
119695,5,0,0
119696,of,0,0
119697,9,0,0
119698,CML,0,1
119699,patients,0,0
119700,are,0,0
119701,alive,0,0
119702,with,0,0
119703,a,0,0
119704,projected,0,0
119705,median,0,0
119706,overall,0,0
119707,survival,0,0
119708,(,0,0
119709,OS,0,0
119710,),0,0
119711,of,0,0
119712,23,0,0
119713,months,0,0
119714,.,0,0
119715,Marrow,0,0
119716,and,0,0
119717,blood,0,0
119718,(,0,0
119719,T,0,0
119720,cell,0,0
119721,),0,0
119722,chimerism,0,0
119723,studies,0,0
119724,at,0,0
119725,day,0,0
119726,+100,0,0
119727,revealed,0,0
119728,that,0,0
119729,both,0,0
119730,in,0,0
119731,the,0,0
119732,lower-dose,0,1
119733,Clo,0,0
119734,groups,0,0
119735,(,0,0
119736,groups,0,0
119737,1+2,0,0
119738,),0,0
119739,and,0,0
119740,the,0,0
119741,higher-dose,0,1
119742,Clo,0,0
119743,groups,0,0
119744,(,0,0
119745,groups,0,0
119746,3+4,0,0
119747,),0,0
119748,",",0,0
119749,the,0,0
119750,patients,0,0
119751,had,0,0
119752,a,0,0
119753,median,0,0
119754,of,0,0
119755,100,0,0
119756,%,0,0
119757,donor,0,0
119758,(,0,0
119759,T,0,0
119760,cell,0,0
119761,),0,0
119762,-derived,0,0
119763,DNA,0,0
119764,.,0,0
119765,There,0,0
119766,has,0,0
119767,been,0,0
119768,no,0,0
119769,secondary,0,0
119770,graft,0,0
119771,failure,0,0
119772,.,0,0
119773,In,0,0
119774,the,0,0
119775,first,0,0
119776,100,0,0
119777,days,0,0
119778,",",0,0
119779,1,0,0
119780,patient,0,0
119781,died,0,0
119782,of,0,0
119783,pneumonia,0,0
119784,",",0,0
119785,and,0,0
119786,1,0,0
119787,of,0,0
119788,liver,0,0
119789,GVHD,0,0
119790,.,0,0
119791,We,0,0
119792,conclude,0,0
119793,that,0,0
119794,(,0,0
119795,1,0,0
119796,),0,0
119797,Clo,0,0
119798,?,0,0
119799,Flu,0,0
119800,with,0,0
119801,i.v,0,0
119802,.,0,0
119803,Bu,0,0
119804,as,0,0
119805,pretransplant,0,0
119806,conditioning,0,1
119807,is,0,0
119808,safe,0,0
119809,in,0,0
119810,high-risk,0,0
119811,myeloid,0,0
119812,leukemia,0,0
119813,patients,0,0
119814,;,0,0
119815,(,0,0
119816,2,0,0
119817,),0,0
119818,clofarabine,0,1
119819,is,0,0
119820,sufficiently,0,0
119821,immunosuppressive,0,0
119822,to,0,0
119823,support,0,0
119824,allo-SCT,0,1
119825,in,0,0
119826,myeloid,0,0
119827,leukemia,0,0
119828,;,0,0
119829,and,0,0
119830,(,0,0
119831,3,0,0
119832,),0,0
119833,the,0,0
119834,median,0,0
119835,OS,0,0
119836,of,0,0
119837,23,0,0
119838,months,0,0
119839,in,0,0
119840,this,0,0
119841,high-risk,0,0
119842,patient,0,0
119843,population,0,0
119844,is,0,0
119845,encouraging,0,0
119846,.,0,0
119847,Additional,0,0
119848,studies,0,0
119849,to,0,0
119850,evaluate,0,0
119851,the,0,0
119852,antileukemic,0,1
119853,efficacy,1,0
119854,of,1,0
119855,Clo,1,0
119856,?,1,0
119857,Flu,1,0
119858,with,1,0
119859,i.v,1,0
119860,.,1,0
119861,Bu,1,0
119862,as,1,0
119863,pretransplant,0,0
119864,conditioning,0,1
119865,therapy,0,1
119866,are,0,0
119867,warranted,0,0
119868,.,0,0
119869,An,0,0
119870,explorative,0,1
119871,study,0,0
119872,on,0,0
119873,the,0,0
119874,clinical,0,0
119875,utility,0,0
119876,of,0,0
119877,baseline,0,0
119878,and,0,0
119879,serial,0,1
119880,serum,0,0
119881,tumour,0,0
119882,marker,0,0
119883,measurements,0,0
119884,in,0,0
119885,advanced,0,0
119886,upper,0,0
119887,gastrointestinal,0,0
119888,cancer,0,0
119889,.,0,0
119890,The,0,0
119891,value,0,0
119892,of,0,0
119893,early,0,0
119894,tumour,0,0
119895,marker,0,0
119896,changes,0,0
119897,during,0,0
119898,palliative,0,0
119899,chemotherapy,0,1
119900,in,0,0
119901,patients,0,0
119902,with,0,0
119903,upper,0,0
119904,gastrointestinal,0,0
119905,adenocarcinoma,0,0
119906,(,0,0
119907,UGIA,0,0
119908,),0,1
119909,is,0,0
119910,unclear,0,0
119911,.,0,0
119912,Seventy-three,0,0
119913,patients,0,0
119914,with,0,0
119915,advanced,0,0
119916,UGIA,0,0
119917,were,0,0
119918,randomised,0,0
119919,to,0,0
119920,receive,0,0
119921,45,1,0
119922,mg/m2,1,1
119923,docetaxel,1,1
119924,or,1,0
119925,180,1,0
119926,mg/m2,1,1
119927,irinotecan,1,1
119928,with,1,0
119929,5-FU/leucovorin,1,1
119930,.,1,0
119931,After,0,0
119932,every,0,0
119933,2nd,1,0
119934,course,1,0
119935,the,1,0
119936,patients,1,0
119937,were,1,0
119938,crossed,1,0
119939,over,1,0
119940,to,1,0
119941,the,1,0
119942,other,1,0
119943,regimen,1,0
119944,.,1,0
119945,Serum,0,0
119946,was,0,0
119947,sampled,0,0
119948,before,0,0
119949,start,0,0
119950,of,0,0
119951,chemotherapy,0,1
119952,and,0,0
119953,every,0,1
119954,2nd,0,0
119955,week,0,0
119956,during,0,0
119957,8,0,0
119958,weeks,0,0
119959,for,0,0
119960,CEA,0,0
119961,",",0,0
119962,TPA,0,0
119963,",",0,0
119964,TPS,0,0
119965,",",0,0
119966,CA72-4,0,0
119967,",",0,0
119968,CA19-9,0,1
119969,and,0,0
119970,CA242,0,0
119971,measurements,0,0
119972,.,0,0
119973,Eighteen,0,0
119974,patients,0,0
119975,(,0,0
119976,25,0,0
119977,%,0,0
119978,),0,0
119979,had,0,0
119980,partial,0,0
119981,response,0,0
119982,(,0,0
119983,PR,0,1
119984,),0,0
119985,and,0,0
119986,21,0,0
119987,patients,0,0
119988,had,0,0
119989,stable,0,0
119990,disease,0,0
119991,for,0,0
119992,at,0,0
119993,least,0,0
119994,4,0,0
119995,months,0,0
119996,(,0,0
119997,SD4,0,0
119998,),0,0
119999,.,0,0
120000,All,0,0
120001,baseline,0,0
120002,marker,0,0
120003,levels,0,0
120004,",",0,0
120005,except,0,0
120006,CA72-4,0,0
120007,",",0,0
120008,correlated,0,0
120009,with,0,0
120010,time,0,0
120011,to,0,0
120012,progression,0,0
120013,and,0,0
120014,survival,0,0
120015,.,0,0
120016,Patients,0,0
120017,with,0,0
120018,normal,0,0
120019,levels,0,0
120020,",",0,0
120021,except,0,0
120022,CA72-4,0,0
120023,",",0,0
120024,also,0,0
120025,had,0,0
120026,more,0,0
120027,clinical,0,0
120028,responses,0,0
120029,(,0,0
120030,PR+SD4,0,1
120031,),0,0
120032,than,0,0
120033,patients,0,0
120034,with,0,0
120035,elevated,0,0
120036,values,0,0
120037,.,0,0
120038,Tumour,0,0
120039,marker,0,0
120040,changes,0,0
120041,early,0,0
120042,during,0,0
120043,treatment,0,0
120044,provided,0,0
120045,modest,0,0
120046,predictive,0,0
120047,information,0,0
120048,for,0,0
120049,tumour,0,0
120050,response,0,0
120051,and,0,0
120052,survival,0,0
120053,.,0,0
120054,A,0,0
120055,model,0,0
120056,combining,0,0
120057,baseline,0,0
120058,level,0,0
120059,",",0,0
120060,the,0,0
120061,change,0,0
120062,and,0,0
120063,the,0,0
120064,interaction,0,0
120065,between,0,0
120066,them,0,0
120067,gave,0,0
120068,the,0,0
120069,best,0,0
120070,prediction,0,0
120071,of,0,0
120072,outcome,0,0
120073,",",0,0
120074,however,0,0
120075,",",0,0
120076,insignificantly,0,0
120077,better,0,0
120078,than,0,0
120079,baseline,0,0
120080,level,0,0
120081,for,0,0
120082,all,0,0
120083,markers,0,0
120084,except,0,0
120085,CA242,0,0
120086,.,0,0
120087,Baseline,0,0
120088,tumour,0,0
120089,marker,0,0
120090,levels,0,0
120091,provide,0,0
120092,prognostic,0,0
120093,information,0,0
120094,for,0,0
120095,patients,0,0
120096,with,0,0
120097,UGIA,0,0
120098,on,0,0
120099,palliative,0,0
120100,chemotherapy,0,1
120101,.,0,0
120102,Early,0,0
120103,changes,0,0
120104,generally,0,0
120105,failed,0,0
120106,to,0,0
120107,provide,0,0
120108,accurate,0,0
120109,information,0,0
120110,for,0,0
120111,tumour,0,0
120112,response,0,0
120113,and,0,0
120114,survival,0,0
120115,.,0,0
120116,Intensive,1,1
120117,case,1,0
120118,management,1,0
120119,before,0,0
120120,and,0,0
120121,after,0,0
120122,prison,0,0
120123,release,0,0
120124,is,0,0
120125,no,0,0
120126,more,0,0
120127,effective,0,0
120128,than,0,0
120129,comprehensive,1,0
120130,pre-release,1,1
120131,discharge,1,0
120132,planning,1,0
120133,in,0,0
120134,linking,0,0
120135,HIV-infected,0,0
120136,prisoners,0,0
120137,to,0,0
120138,care,0,0
120139,:,0,0
120140,a,0,0
120141,randomized,0,0
120142,trial,0,0
120143,.,0,0
120144,Imprisonment,0,0
120145,provides,0,0
120146,opportunities,0,0
120147,for,0,0
120148,the,0,0
120149,diagnosis,0,0
120150,and,0,0
120151,successful,0,0
120152,treatment,0,0
120153,of,0,0
120154,HIV,0,0
120155,",",0,0
120156,however,0,0
120157,",",0,0
120158,the,0,0
120159,benefits,0,0
120160,of,0,0
120161,antiretroviral,1,1
120162,therapy,1,1
120163,are,0,0
120164,frequently,0,0
120165,lost,0,0
120166,following,0,0
120167,release,0,0
120168,due,0,0
120169,to,0,0
120170,suboptimal,0,0
120171,access,0,0
120172,and,0,0
120173,utilization,0,0
120174,of,0,0
120175,health,0,0
120176,care,0,1
120177,and,0,0
120178,services,0,0
120179,.,0,0
120180,In,0,0
120181,response,0,0
120182,",",0,0
120183,some,0,0
120184,have,0,0
120185,advocated,0,0
120186,for,0,0
120187,development,0,0
120188,of,0,0
120189,intensive,0,1
120190,case-management,0,0
120191,interventions,0,1
120192,spanning,0,0
120193,incarceration,0,0
120194,and,0,0
120195,release,0,0
120196,to,0,0
120197,support,0,0
120198,treatment,0,0
120199,adherence,0,0
120200,and,0,0
120201,community,0,1
120202,re-entry,0,0
120203,for,0,0
120204,HIV-infected,0,0
120205,releasees,0,0
120206,.,0,0
120207,We,0,0
120208,conducted,0,0
120209,a,0,0
120210,randomized,0,0
120211,controlled,0,0
120212,trial,0,0
120213,of,0,0
120214,a,0,0
120215,motivational,1,0
120216,Strengths,1,0
120217,Model,1,0
120218,bridging,1,1
120219,case,1,0
120220,management,1,1
120221,intervention,1,1
120222,(,1,0
120223,BCM,1,0
120224,),1,0
120225,beginning,0,0
120226,approximately,0,0
120227,3,0,0
120228,months,0,0
120229,prior,0,0
120230,to,0,0
120231,and,0,0
120232,continuing,0,0
120233,6,0,0
120234,months,0,0
120235,after,0,0
120236,release,0,0
120237,versus,0,0
120238,a,0,0
120239,standard,1,1
120240,of,1,0
120241,care,1,1
120242,prison-administered,1,0
120243,discharge,1,0
120244,planning,1,1
120245,program,1,1
120246,(,1,1
120247,SOC,1,1
120248,),1,0
120249,for,1,0
120250,HIV-infected,0,0
120251,state,0,0
120252,prison,0,0
120253,inmates,0,0
120254,.,0,0
120255,The,0,0
120256,primary,0,0
120257,outcome,0,0
120258,variable,0,0
120259,was,0,0
120260,self-reported,0,0
120261,access,0,0
120262,to,0,0
120263,post-release,0,0
120264,medical,0,0
120265,care,0,0
120266,.,0,0
120267,Of,0,0
120268,the,0,0
120269,104,0,0
120270,inmates,0,0
120271,enrolled,0,0
120272,",",0,0
120273,89,0,0
120274,had,0,0
120275,at,0,0
120276,least,0,0
120277,1,0,0
120278,post-release,0,0
120279,study,0,0
120280,visit,0,0
120281,.,0,0
120282,Of,0,0
120283,these,0,0
120284,",",0,0
120285,65.1,0,0
120286,%,0,0
120287,of,0,0
120288,BCM,0,0
120289,and,0,0
120290,54.4,0,0
120291,%,0,0
120292,of,0,0
120293,SOC,1,0
120294,assigned,1,0
120295,participants,0,0
120296,attended,0,0
120297,a,0,0
120298,routine,0,0
120299,medical,0,0
120300,appointment,0,0
120301,within,0,0
120302,4,0,0
120303,weeks,0,0
120304,of,0,0
120305,release,0,0
120306,(,0,0
120307,P,0,0
120308,>,0,0
120309,0.3,0,0
120310,),0,0
120311,.,0,0
120312,By,0,0
120313,week,0,0
120314,12,0,0
120315,post-release,0,0
120316,",",0,0
120317,88.4,0,0
120318,%,0,0
120319,of,0,0
120320,the,1,0
120321,BCM,1,0
120322,arm,0,0
120323,and,0,0
120324,78.3,0,0
120325,%,0,0
120326,of,0,0
120327,the,0,0
120328,SOC,0,0
120329,arm,0,0
120330,had,0,0
120331,at,0,0
120332,attended,0,0
120333,at,0,0
120334,least,0,0
120335,one,0,0
120336,medical,0,0
120337,appointment,0,1
120338,(,0,0
120339,P,0,0
120340,=,0,0
120341,0.2,0,0
120342,),0,0
120343,",",0,0
120344,increasing,0,0
120345,in,0,0
120346,both,0,0
120347,arms,0,0
120348,at,0,0
120349,week,0,0
120350,24-90.7,0,0
120351,%,0,0
120352,with,0,0
120353,BCM,0,0
120354,and,0,0
120355,89.1,0,0
120356,%,0,0
120357,with,0,0
120358,SOC,0,1
120359,(,0,0
120360,P,0,0
120361,>,0,0
120362,0.5,0,0
120363,),0,0
120364,.,0,0
120365,No,0,0
120366,participant,0,0
120367,without,0,0
120368,a,0,0
120369,routine,0,0
120370,medical,0,0
120371,visit,0,0
120372,by,0,0
120373,week,0,0
120374,24,0,0
120375,attended,0,0
120376,an,0,0
120377,appointment,0,0
120378,from,0,0
120379,weeks,0,0
120380,24,0,0
120381,to,0,0
120382,48,0,0
120383,.,0,0
120384,The,0,0
120385,mean,0,0
120386,number,0,0
120387,of,0,0
120388,clinic,0,0
120389,visits,0,0
120390,during,0,0
120391,the,0,0
120392,48,0,0
120393,weeks,0,0
120394,post,0,0
120395,release,0,0
120396,was,0,0
120397,5.23,0,0
120398,(,0,0
120399,SD,0,0
120400,=,0,0
120401,3.14,0,0
120402,),0,0
120403,for,0,0
120404,BCM,0,0
120405,and,0,0
120406,4.07,0,0
120407,(,0,0
120408,SD,0,0
120409,=,0,0
120410,3.20,0,0
120411,),0,0
120412,for,0,0
120413,SOC,0,1
120414,(,0,0
120415,P,0,0
120416,>,0,0
120417,0.5,0,0
120418,),0,0
120419,.,0,0
120420,There,0,0
120421,were,0,0
120422,no,0,0
120423,significant,0,0
120424,differences,0,0
120425,between,0,0
120426,arms,0,0
120427,in,0,0
120428,social,0,0
120429,service,0,0
120430,utilization,0,0
120431,and,0,0
120432,re-incarceration,0,0
120433,rates,0,0
120434,were,0,0
120435,also,0,0
120436,similar,0,0
120437,.,0,0
120438,We,0,0
120439,found,0,0
120440,that,0,0
120441,a,0,0
120442,case,1,0
120443,management,1,0
120444,intervention,1,1
120445,bridging,1,1
120446,incarceration,1,0
120447,and,1,0
120448,release,0,0
120449,was,0,0
120450,no,0,0
120451,more,0,0
120452,effective,0,0
120453,than,0,0
120454,a,0,0
120455,less,0,0
120456,intensive,0,1
120457,pre-release,1,1
120458,discharge,1,0
120459,planning,1,0
120460,program,1,1
120461,in,1,0
120462,supporting,1,0
120463,health,0,0
120464,and,0,0
120465,social,0,1
120466,service,0,0
120467,utilization,0,0
120468,for,0,0
120469,HIV-infected,0,0
120470,individuals,0,0
120471,released,0,0
120472,from,0,0
120473,prison,0,0
120474,.,0,0
120475,Lead-time,0,0
120476,in,0,0
120477,the,0,0
120478,European,0,0
120479,Randomised,0,0
120480,Study,0,0
120481,of,0,0
120482,Screening,0,0
120483,for,0,0
120484,Prostate,0,0
120485,Cancer,0,0
120486,.,0,0
120487,BACKGROUND,0,0
120488,Lead-time,0,0
120489,is,0,0
120490,defined,0,0
120491,as,0,0
120492,the,0,0
120493,time,0,0
120494,by,0,0
120495,which,0,0
120496,screening,0,0
120497,advances,0,0
120498,the,0,0
120499,diagnosis,0,0
120500,compared,0,0
120501,with,0,0
120502,absence,0,0
120503,of,0,0
120504,screening,0,0
120505,.,0,0
120506,A,0,0
120507,sufficiently,0,0
120508,long,0,0
120509,lead-time,0,0
120510,needs,0,0
120511,to,0,0
120512,be,0,0
120513,achieved,0,0
120514,so,0,0
120515,that,0,0
120516,cancer,0,0
120517,can,0,0
120518,be,0,0
120519,detected,0,0
120520,while,0,0
120521,still,0,0
120522,curable,0,0
120523,.,0,0
120524,A,0,0
120525,very,0,0
120526,short,0,0
120527,lead-time,0,0
120528,may,0,0
120529,indicate,0,0
120530,poor,0,0
120531,sensitivity,0,0
120532,of,0,0
120533,the,0,0
120534,screening,0,0
120535,test,0,0
120536,",",0,0
120537,while,0,0
120538,a,0,0
120539,very,0,0
120540,long,0,0
120541,lead-time,0,0
120542,suggests,0,0
120543,overdiagnosis,0,0
120544,.,0,0
120545,MATERIAL,0,0
120546,AND,0,0
120547,METHODS,0,0
120548,In,0,0
120549,the,0,0
120550,first,0,0
120551,screening,0,0
120552,round,0,0
120553,",",0,0
120554,a,0,0
120555,total,0,0
120556,of,0,0
120557,"56,294",0,0
120558,men,0,0
120559,aged,0,0
120560,55-74,0,0
120561,years,0,0
120562,were,0,0
120563,screened,0,0
120564,with,0,0
120565,serum,1,0
120566,prostate,1,0
120567,specific,1,1
120568,antigen,1,0
120569,(,1,0
120570,PSA,1,0
120571,),1,0
120572,in,0,0
120573,five,0,0
120574,countries,0,0
120575,of,0,0
120576,the,0,0
120577,European,0,0
120578,Randomised,0,0
120579,Study,0,0
120580,of,0,0
120581,Screening,0,0
120582,for,0,0
120583,Prostate,0,1
120584,Cancer,0,1
120585,(,0,0
120586,ERSPC,0,1
120587,),0,0
120588,with,0,0
120589,an,0,0
120590,overall,0,0
120591,detection,0,0
120592,rate,0,0
120593,(,0,0
120594,prevalence,0,0
120595,),0,0
120596,of,0,0
120597,2.8,0,0
120598,%,0,0
120599,(,0,0
120600,1972,0,0
120601,prostate,0,0
120602,cancers,0,0
120603,),0,0
120604,.,0,0
120605,Prostate,0,0
120606,cancer,0,0
120607,incidence,0,0
120608,among,0,0
120609,"92,142",0,0
120610,men,0,0
120611,randomly,0,0
120612,allocated,0,0
120613,to,0,0
120614,the,0,0
120615,control,0,0
120616,arm,0,0
120617,of,0,0
120618,the,0,0
120619,trial,0,0
120620,was,0,0
120621,also,0,0
120622,assessed,0,0
120623,.,0,0
120624,Lead-time,0,0
120625,was,0,0
120626,estimated,0,0
120627,as,0,0
120628,the,0,0
120629,time,0,0
120630,required,0,0
120631,to,0,0
120632,accumulate,0,0
120633,a,0,0
120634,similar,0,0
120635,cumulative,0,0
120636,risk,0,0
120637,of,0,0
120638,prostate,0,0
120639,cancer,0,0
120640,in,0,0
120641,the,0,0
120642,control,0,0
120643,arm,0,0
120644,to,0,0
120645,the,0,0
120646,detection,0,0
120647,rate,0,0
120648,in,0,0
120649,the,0,0
120650,intervention,0,1
120651,arm,0,0
120652,",",0,0
120653,i.e,0,0
120654,.,0,0
120655,from,0,0
120656,the,0,0
120657,ratio,0,0
120658,of,0,0
120659,detection,0,0
120660,rate,0,0
120661,(,0,0
120662,prevalence,0,0
120663,of,0,0
120664,screen-detected,0,0
120665,cases,0,0
120666,),0,0
120667,and,0,0
120668,expected,0,0
120669,incidence,0,0
120670,(,0,0
120671,cumulative,0,0
120672,risk,0,0
120673,),0,0
120674,.,0,0
120675,RESULTS,0,0
120676,Using,0,0
120677,a,0,0
120678,serum,0,0
120679,PSA,0,0
120680,cut-off,0,0
120681,of,0,0
120682,4,0,0
120683,ng/ml,0,0
120684,",",0,0
120685,the,0,0
120686,mean,0,0
120687,lead-time,0,0
120688,in,0,0
120689,the,0,0
120690,whole,0,0
120691,study,0,0
120692,population,0,0
120693,was,0,0
120694,estimated,0,0
120695,as,0,0
120696,6.8,0,0
120697,years,0,0
120698,(,0,0
120699,95,0,0
120700,%,0,0
120701,confidence,0,0
120702,interval,0,0
120703,(,0,0
120704,95,0,0
120705,%,0,0
120706,CI,0,0
120707,),0,1
120708,7.9-8.4,0,0
120709,),0,0
120710,.,0,0
120711,It,0,0
120712,was,0,0
120713,8,0,0
120714,years,0,0
120715,in,0,0
120716,The,0,0
120717,Netherlands,0,0
120718,",",0,0
120719,6,0,0
120720,in,0,0
120721,Sweden,0,0
120722,and,0,0
120723,Finland,0,0
120724,",",0,0
120725,5,0,0
120726,in,0,0
120727,Italy,0,0
120728,and,0,0
120729,4,0,0
120730,in,0,0
120731,Belgium,0,0
120732,.,0,0
120733,The,0,0
120734,mean,0,0
120735,lead-time,0,0
120736,was,0,0
120737,similar,0,0
120738,",",0,0
120739,6-7,0,0
120740,years,0,0
120741,",",0,0
120742,at,0,0
120743,ages,0,0
120744,50-64,0,0
120745,years,0,0
120746,",",0,0
120747,but,0,0
120748,close,0,0
120749,to,0,0
120750,8,0,0
120751,years,0,0
120752,among,0,0
120753,men,0,0
120754,aged,0,0
120755,65-74,0,0
120756,years,0,0
120757,.,0,0
120758,A,0,0
120759,lower,0,0
120760,PSA,0,0
120761,cut-off,0,0
120762,level,0,0
120763,of,0,0
120764,3,0,0
120765,ng/ml,0,0
120766,used,0,0
120767,in,0,0
120768,Sweden,0,0
120769,and,0,0
120770,The,0,0
120771,Netherlands,0,0
120772,prolonged,0,0
120773,the,0,0
120774,mean,0,0
120775,lead-time,0,0
120776,by,0,0
120777,approximately,0,0
120778,1,0,0
120779,year,0,0
120780,.,0,0
120781,Lead-time,0,0
120782,based,0,0
120783,on,0,0
120784,advanced,0,0
120785,prostate,0,0
120786,cancer,0,0
120787,only,0,0
120788,was,0,0
120789,slightly,0,0
120790,shorter,0,0
120791,",",0,0
120792,mean,0,0
120793,5.3,0,0
120794,years,0,0
120795,(,0,0
120796,95,0,0
120797,%,0,0
120798,CI,0,0
120799,4.6-6.0,0,0
120800,),0,0
120801,.,0,0
120802,The,0,0
120803,lead-time,0,0
120804,for,0,0
120805,the,0,0
120806,second,0,0
120807,screening,0,0
120808,round,0,0
120809,was,0,0
120810,slightly,0,0
120811,shorter,0,0
120812,than,0,0
120813,that,0,0
120814,for,0,0
120815,the,0,0
120816,first,0,0
120817,(,0,0
120818,5.9,0,0
120819,",",0,0
120820,95,0,0
120821,%,0,0
120822,CI,0,0
120823,5.4-6.4,0,0
120824,),0,0
120825,",",0,0
120826,reflecting,0,0
120827,a,0,0
120828,similar,0,0
120829,relation,0,0
120830,between,0,0
120831,detection,0,0
120832,rate,0,0
120833,and,0,0
120834,control,0,1
120835,group,0,0
120836,incidence,0,0
120837,.,0,0
120838,CONCLUSION,0,0
120839,The,0,0
120840,lead-time,0,0
120841,for,0,0
120842,prostate,0,0
120843,cancer,0,0
120844,found,0,0
120845,in,0,0
120846,ERSPC,0,0
120847,substantially,0,0
120848,exceeded,0,0
120849,that,0,0
120850,found,0,0
120851,for,0,0
120852,breast,0,0
120853,",",0,0
120854,cervical,0,0
120855,and,0,0
120856,colorectal,0,0
120857,cancer,0,0
120858,screening,0,0
120859,.,0,0
120860,One,0,0
120861,round,0,0
120862,of,0,0
120863,prostate,0,0
120864,cancer,0,0
120865,screening,0,0
120866,can,0,0
120867,advance,0,0
120868,clinical,0,0
120869,diagnosis,0,0
120870,by,0,0
120871,4-8,0,0
120872,years,0,0
120873,.,0,0
120874,Overdiagnosis,0,0
120875,or,0,0
120876,detection,0,0
120877,of,0,0
120878,non-progressive,0,0
120879,tumours,0,0
120880,may,0,0
120881,contribute,0,0
120882,substantially,0,0
120883,to,0,0
120884,the,0,0
120885,lead-time,0,0
120886,.,0,0
120887,Dopexamine,1,1
120888,has,0,0
120889,no,0,0
120890,additional,0,0
120891,benefit,0,0
120892,in,0,0
120893,high-risk,0,0
120894,patients,0,0
120895,receiving,0,0
120896,goal-directed,1,1
120897,fluid,1,1
120898,therapy,1,1
120899,undergoing,1,0
120900,major,1,0
120901,abdominal,1,0
120902,surgery,1,0
120903,.,1,0
120904,BACKGROUND,0,0
120905,Dopexamine,1,1
120906,has,0,0
120907,been,0,0
120908,shown,0,0
120909,to,0,0
120910,reduce,0,0
120911,both,0,0
120912,mortality,0,0
120913,and,0,0
120914,morbidity,0,0
120915,in,0,0
120916,major,0,0
120917,surgery,0,0
120918,when,0,0
120919,it,0,0
120920,is,0,0
120921,used,0,0
120922,as,0,0
120923,part,0,0
120924,of,0,0
120925,a,0,0
120926,protocol,0,0
120927,to,0,0
120928,increase,0,0
120929,oxygen,0,1
120930,delivery,0,0
120931,in,0,0
120932,the,0,0
120933,perioperative,0,0
120934,period,0,0
120935,.,0,0
120936,A,0,0
120937,European,0,0
120938,multicenter,0,0
120939,study,0,0
120940,has,0,0
120941,examined,0,0
120942,the,0,0
120943,use,0,0
120944,of,0,0
120945,dopexamine,1,1
120946,in,0,0
120947,patients,0,0
120948,undergoing,0,0
120949,major,1,0
120950,abdominal,1,0
120951,surgery,1,0
120952,",",0,0
120953,showing,0,0
120954,a,0,0
120955,trend,0,0
120956,toward,0,0
120957,improved,0,0
120958,survival,0,0
120959,and,0,0
120960,reduced,0,0
120961,complications,0,0
120962,in,0,0
120963,high-risk,0,0
120964,patients,0,0
120965,when,0,0
120966,receiving,0,0
120967,low-dose,1,1
120968,dopexamine,1,1
120969,(,0,0
120970,0.5,0,0
120971,?g,0,0
120972,?,0,0
120973,kg,0,0
120974,(,0,0
120975,-1,0,0
120976,),0,0
120977,?,0,0
120978,min,0,0
120979,(,0,0
120980,-1,0,0
120981,),0,0
120982,),0,0
120983,.,0,0
120984,A,0,0
120985,reduced,0,0
120986,oxygen,0,1
120987,uptake,0,0
120988,at,0,0
120989,the,0,0
120990,anaerobic,0,1
120991,threshold,0,0
120992,(,0,0
120993,AT,0,1
120994,),0,1
120995,has,0,0
120996,been,0,0
120997,shown,0,0
120998,to,0,0
120999,confer,0,0
121000,a,0,0
121001,significant,0,0
121002,risk,0,0
121003,of,0,0
121004,mortality,0,0
121005,in,0,0
121006,patients,0,0
121007,undergoing,1,0
121008,major,1,0
121009,abdominal,1,0
121010,surgery,1,0
121011,and,1,0
121012,allows,0,0
121013,objective,0,0
121014,identification,0,0
121015,of,0,0
121016,a,0,0
121017,high-risk,0,0
121018,operative,0,0
121019,group,0,0
121020,.,0,0
121021,In,0,0
121022,this,0,0
121023,study,0,0
121024,",",0,0
121025,we,0,0
121026,assessed,0,0
121027,the,0,0
121028,effects,0,0
121029,of,0,0
121030,low-dose,1,1
121031,dopexamine,1,1
121032,on,1,0
121033,morbidity,0,0
121034,after,1,0
121035,major,1,0
121036,abdominal,1,0
121037,surgery,1,0
121038,in,1,0
121039,patients,0,0
121040,who,0,0
121041,were,0,0
121042,at,0,0
121043,increased,0,0
121044,risk,0,0
121045,by,0,0
121046,virtue,0,0
121047,of,0,0
121048,a,0,0
121049,reduced,0,0
121050,AT,0,0
121051,.,0,0
121052,METHODS,0,0
121053,Patients,0,0
121054,undergoing,0,0
121055,elective,0,0
121056,major,1,0
121057,colorectal,1,0
121058,or,1,1
121059,urological,1,0
121060,surgery,1,0
121061,who,1,0
121062,had,0,0
121063,an,0,0
121064,AT,0,0
121065,of,0,0
121066,<,0,0
121067,11,0,0
121068,mL,0,0
121069,?,0,0
121070,kg,0,0
121071,(,0,0
121072,-1,0,0
121073,),0,0
121074,?,0,0
121075,min,0,0
121076,(,0,0
121077,-1,0,0
121078,),0,0
121079,or,0,0
121080,an,0,0
121081,AT,0,0
121082,of,0,0
121083,11,0,0
121084,to,0,0
121085,14,0,0
121086,mL,0,0
121087,?,0,0
121088,kg,0,0
121089,(,0,0
121090,-1,0,0
121091,),0,0
121092,?,0,0
121093,min,0,0
121094,(,0,0
121095,-1,0,0
121096,),0,0
121097,with,0,0
121098,a,0,0
121099,history,0,0
121100,of,0,0
121101,ischemic,0,0
121102,heart,0,0
121103,disease,0,0
121104,were,0,0
121105,recruited,0,0
121106,.,0,0
121107,Before,0,0
121108,surgery,0,0
121109,",",0,0
121110,a,0,0
121111,radial,0,1
121112,arterial,0,0
121113,cannula,0,1
121114,was,0,0
121115,placed,0,0
121116,and,0,0
121117,attached,0,0
121118,to,0,0
121119,an,0,0
121120,Edwards,0,0
121121,Lifesciences,0,0
121122,FloTrac/Vigileo,0,1
121123,system,0,0
121124,for,0,0
121125,measuring,0,0
121126,cardiac,0,0
121127,output,0,0
121128,.,0,0
121129,Patients,0,0
121130,were,0,0
121131,given,0,0
121132,a,0,0
121133,250-mL,0,1
121134,bolus,0,1
121135,of,1,0
121136,Voluven,1,1
121137,(,1,0
121138,6,1,0
121139,%,1,0
121140,hydroxyethyl,1,1
121141,starch,1,1
121142,130/0.4,1,1
121143,in,1,0
121144,0.9,1,0
121145,%,1,0
121146,sodium,1,1
121147,chloride,1,1
121148,),1,0
121149,until,1,0
121150,the,0,0
121151,stroke,0,0
121152,volume,0,0
121153,no,0,0
121154,longer,0,0
121155,increased,0,0
121156,by,0,0
121157,10,0,0
121158,%,0,0
121159,",",0,0
121160,then,0,0
121161,received,0,0
121162,either,0,0
121163,dopexamine,1,1
121164,(,1,0
121165,0.5,1,0
121166,?g,1,0
121167,?,0,0
121168,kg,0,0
121169,(,0,0
121170,-1,0,0
121171,),0,0
121172,?,0,0
121173,min,0,0
121174,(,0,0
121175,-1,0,0
121176,),0,1
121177,),0,0
121178,or,1,0
121179,saline,1,1
121180,0.9,0,0
121181,%,0,0
121182,for,0,0
121183,24,0,0
121184,hours,0,0
121185,.,0,0
121186,During,0,0
121187,surgery,1,0
121188,",",1,0
121189,fluid,0,0
121190,boluses,0,0
121191,of,0,0
121192,Voluven,1,1
121193,were,1,0
121194,given,0,0
121195,if,0,0
121196,the,0,0
121197,stroke,0,0
121198,volume,0,0
121199,variation,0,0
121200,was,0,0
121201,>,0,0
121202,10,0,0
121203,%,0,0
121204,.,0,0
121205,No,0,0
121206,crystalloid,0,0
121207,was,0,0
121208,given,0,0
121209,during,0,0
121210,surgery,0,0
121211,.,0,0
121212,A,0,0
121213,standardized,0,0
121214,postoperative,0,0
121215,fluid,0,0
121216,regime,0,1
121217,with,1,0
121218,Hartmann,1,1
121219,solution,1,1
121220,was,0,0
121221,prescribed,0,0
121222,at,0,0
121223,1.5,0,0
121224,mL,0,0
121225,?,0,0
121226,kg,0,0
121227,(,0,0
121228,-1,0,0
121229,),0,0
121230,?,0,0
121231,h,0,0
121232,(,0,0
121233,-1,0,0
121234,),0,0
121235,for,0,0
121236,24,0,0
121237,hours,0,0
121238,.,0,0
121239,The,0,0
121240,primary,0,0
121241,outcome,0,0
121242,measure,0,0
121243,was,0,0
121244,postoperative,0,0
121245,morbidity,0,0
121246,measured,0,0
121247,by,0,0
121248,the,0,0
121249,Postoperative,0,0
121250,Morbidity,0,0
121251,Survey,0,0
121252,.,0,0
121253,RESULTS,0,0
121254,One,0,0
121255,hundred,0,0
121256,twenty-four,0,0
121257,patients,0,0
121258,were,0,0
121259,recruited,0,0
121260,over,0,0
121261,a,0,0
121262,23-month,0,0
121263,period,0,0
121264,.,0,0
121265,The,0,0
121266,incidence,0,0
121267,of,0,0
121268,morbidity,0,0
121269,as,0,0
121270,measured,0,0
121271,by,0,0
121272,the,0,0
121273,Postoperative,0,0
121274,Morbidity,0,0
121275,Survey,0,0
121276,on,0,0
121277,day,0,0
121278,5,0,0
121279,was,0,0
121280,55,0,0
121281,%,0,0
121282,in,0,0
121283,the,1,0
121284,control,1,0
121285,group,1,0
121286,versus,1,0
121287,47,0,0
121288,%,0,0
121289,in,1,0
121290,the,1,0
121291,dopexamine,1,1
121292,group,0,0
121293,(,0,0
121294,P,0,0
121295,=,0,0
121296,0.14,0,0
121297,),0,0
121298,.,0,0
121299,There,0,0
121300,was,0,0
121301,no,0,0
121302,significant,0,0
121303,reduction,0,0
121304,in,0,0
121305,morbidity,0,0
121306,on,0,0
121307,any,0,0
121308,measured,0,0
121309,postoperative,0,0
121310,day,0,0
121311,.,0,0
121312,Complication,0,0
121313,rates,0,0
121314,",",0,0
121315,mortality,0,0
121316,",",0,0
121317,and,0,0
121318,hospital,0,0
121319,length,0,0
121320,of,0,0
121321,stay,0,0
121322,were,0,0
121323,similar,0,0
121324,between,0,0
121325,the,0,0
121326,2,0,0
121327,groups,0,0
121328,;,0,0
121329,however,0,0
121330,",",0,0
121331,administration,1,0
121332,of,1,0
121333,dopexamine,1,1
121334,was,0,0
121335,associated,0,0
121336,with,0,0
121337,earlier,0,0
121338,return,0,0
121339,of,0,0
121340,tolerating,0,0
121341,an,0,0
121342,enteral,0,1
121343,diet,0,1
121344,.,0,0
121345,CONCLUSION,0,0
121346,With,0,0
121347,the,0,0
121348,effective,0,0
121349,use,1,0
121350,of,1,0
121351,goal-directed,1,1
121352,fluid,1,0
121353,therapy,1,1
121354,in,1,0
121355,elective,0,0
121356,surgical,0,0
121357,patients,0,0
121358,",",0,0
121359,the,0,0
121360,routine,0,0
121361,use,0,0
121362,of,1,0
121363,dopexamine,1,1
121364,does,0,0
121365,not,0,0
121366,confer,0,0
121367,an,0,0
121368,additional,0,0
121369,clinical,0,0
121370,benefit,0,0
121371,.,0,0
121372,Trachoma,0,0
121373,prevalence,0,0
121374,and,0,0
121375,associated,0,0
121376,risk,0,0
121377,factors,0,0
121378,in,0,0
121379,the,0,0
121380,gambia,0,0
121381,and,0,0
121382,Tanzania,0,0
121383,:,0,0
121384,baseline,0,0
121385,results,0,0
121386,of,0,0
121387,a,0,0
121388,cluster,0,0
121389,randomised,0,0
121390,controlled,0,0
121391,trial,0,0
121392,.,0,0
121393,BACKGROUND,0,0
121394,Blinding,0,0
121395,trachoma,0,0
121396,",",0,0
121397,caused,0,0
121398,by,0,0
121399,ocular,0,0
121400,infection,0,0
121401,with,0,0
121402,Chlamydia,0,0
121403,trachomatis,0,0
121404,",",0,0
121405,is,0,0
121406,targeted,0,0
121407,for,0,0
121408,global,0,0
121409,elimination,0,0
121410,by,0,0
121411,2020,0,0
121412,.,0,0
121413,Knowledge,0,0
121414,of,0,0
121415,risk,0,0
121416,factors,0,0
121417,can,0,0
121418,help,0,0
121419,target,0,0
121420,control,0,0
121421,interventions,0,0
121422,.,0,0
121423,METHODOLOGY/PRINCIPAL,0,0
121424,FINDINGS,0,0
121425,As,0,0
121426,part,0,0
121427,of,0,0
121428,a,0,0
121429,cluster,0,0
121430,randomised,0,0
121431,controlled,0,0
121432,trial,0,0
121433,",",0,0
121434,we,0,0
121435,assessed,0,0
121436,the,0,0
121437,baseline,0,0
121438,prevalence,0,0
121439,of,0,0
121440,",",0,0
121441,and,0,0
121442,risk,0,0
121443,factors,0,0
121444,for,0,0
121445,",",0,0
121446,active,0,0
121447,trachoma,0,0
121448,and,0,0
121449,ocular,0,0
121450,C.,0,1
121451,trachomatis,0,0
121452,infection,0,0
121453,in,0,0
121454,randomly,0,0
121455,selected,0,0
121456,children,0,0
121457,aged,0,0
121458,0-5,0,0
121459,years,0,0
121460,from,0,0
121461,48,0,0
121462,Gambian,0,0
121463,and,0,0
121464,36,0,0
121465,Tanzanian,0,0
121466,communities,0,0
121467,.,0,0
121468,Both,1,0
121469,children,1,0
121470,'s,1,0
121471,eyes,1,0
121472,were,1,0
121473,examined,1,0
121474,according,0,0
121475,to,0,0
121476,the,0,0
121477,World,0,0
121478,Health,0,1
121479,Organization,0,1
121480,(,0,0
121481,WHO,0,1
121482,),0,0
121483,simplified,0,0
121484,grading,0,0
121485,system,0,0
121486,",",0,0
121487,and,0,0
121488,an,1,0
121489,ocular,1,0
121490,swab,1,0
121491,was,1,0
121492,taken,1,0
121493,from,1,0
121494,each,1,0
121495,child,1,0
121496,'s,1,0
121497,right,1,0
121498,eye,1,1
121499,and,1,0
121500,processed,1,0
121501,by,1,0
121502,Amplicor,1,1
121503,polymerase,1,0
121504,chain,1,1
121505,reaction,1,0
121506,to,1,0
121507,test,1,0
121508,for,1,0
121509,the,1,0
121510,presence,1,0
121511,of,1,0
121512,C.,1,0
121513,trachomatis,1,0
121514,DNA,1,0
121515,.,1,0
121516,Prevalence,0,0
121517,of,0,0
121518,active,0,0
121519,trachoma,0,0
121520,was,0,0
121521,6.7,0,0
121522,%,0,0
121523,(,0,0
121524,335/5033,0,0
121525,),0,0
121526,in,0,0
121527,The,0,0
121528,Gambia,0,0
121529,and,0,0
121530,32.3,0,0
121531,%,0,0
121532,(,0,0
121533,1008/3122,0,0
121534,),0,0
121535,in,0,0
121536,Tanzania,0,0
121537,.,0,0
121538,The,0,0
121539,countries,0,0
121540,',0,0
121541,corresponding,0,0
121542,Amplicor,0,1
121543,positive,0,0
121544,prevalences,0,0
121545,were,0,0
121546,0.8,0,0
121547,%,0,0
121548,and,0,0
121549,21.9,0,0
121550,%,0,0
121551,.,0,0
121552,After,0,0
121553,adjustment,0,0
121554,",",0,0
121555,risk,0,0
121556,factors,0,0
121557,for,0,0
121558,follicular,0,0
121559,trachoma,0,0
121560,(,0,0
121561,TF,0,1
121562,),0,0
121563,in,0,0
121564,both,0,0
121565,countries,0,0
121566,were,0,0
121567,ocular,0,0
121568,or,0,1
121569,nasal,0,1
121570,discharge,0,0
121571,",",0,0
121572,a,0,0
121573,low,0,0
121574,level,0,0
121575,of,0,0
121576,household,0,0
121577,head,0,0
121578,education,0,1
121579,",",0,0
121580,and,0,0
121581,being,0,0
121582,aged,0,0
121583,?,0,0
121584,1,0,0
121585,year,0,0
121586,.,0,0
121587,Additional,0,0
121588,risk,0,0
121589,factors,0,0
121590,in,0,0
121591,Tanzania,0,0
121592,were,0,0
121593,flies,0,0
121594,on,0,0
121595,the,0,0
121596,child,0,0
121597,'s,0,0
121598,face,0,0
121599,",",0,0
121600,being,0,0
121601,Amplicor,0,1
121602,positive,0,0
121603,",",0,0
121604,and,0,0
121605,crowding,0,0
121606,(,0,0
121607,the,0,0
121608,number,0,0
121609,of,0,0
121610,children,0,0
121611,per,0,0
121612,household,0,0
121613,),0,0
121614,.,0,0
121615,The,0,0
121616,risk,0,0
121617,factors,0,0
121618,for,0,0
121619,being,0,0
121620,Amplicor,0,1
121621,positive,0,0
121622,in,0,0
121623,Tanzania,0,0
121624,were,0,0
121625,similar,0,0
121626,to,0,0
121627,those,0,0
121628,for,0,0
121629,TF,0,1
121630,",",0,0
121631,with,0,0
121632,the,0,0
121633,exclusion,0,0
121634,of,0,0
121635,flies,0,0
121636,and,0,0
121637,crowding,0,0
121638,.,0,0
121639,In,0,0
121640,The,0,0
121641,Gambia,0,0
121642,",",0,0
121643,only,0,0
121644,ocular,0,0
121645,discharge,0,0
121646,was,0,0
121647,associated,0,0
121648,with,0,0
121649,being,0,0
121650,Amplicor,0,0
121651,positive,0,0
121652,.,0,0
121653,CONCLUSIONS/SIGNIFICANCE,0,0
121654,These,0,0
121655,results,0,0
121656,indicate,0,0
121657,that,0,0
121658,although,0,0
121659,the,0,0
121660,prevalence,0,0
121661,of,0,0
121662,active,0,0
121663,trachoma,0,0
121664,and,0,0
121665,Amplicor,0,1
121666,positives,0,0
121667,were,0,0
121668,very,0,0
121669,different,0,0
121670,between,0,0
121671,the,0,0
121672,two,0,0
121673,countries,0,0
121674,",",0,0
121675,the,0,0
121676,risk,0,0
121677,factors,0,0
121678,for,0,0
121679,active,0,0
121680,trachoma,0,0
121681,were,0,0
121682,similar,0,0
121683,but,0,0
121684,those,0,0
121685,for,0,0
121686,being,0,0
121687,Amplicor,0,1
121688,positive,0,0
121689,were,0,0
121690,different,0,0
121691,.,0,0
121692,The,0,0
121693,lack,0,0
121694,of,0,0
121695,an,0,0
121696,association,0,0
121697,between,0,0
121698,being,0,0
121699,Amplicor,0,1
121700,positive,0,0
121701,and,0,0
121702,TF,0,1
121703,in,0,0
121704,The,0,0
121705,Gambia,0,0
121706,highlights,0,0
121707,the,0,0
121708,poor,0,0
121709,correlation,0,0
121710,between,0,0
121711,the,0,0
121712,presence,0,0
121713,of,0,0
121714,trachoma,0,0
121715,clinical,0,0
121716,signs,0,0
121717,and,0,0
121718,evidence,0,0
121719,of,0,0
121720,C.,0,0
121721,trachomatis,0,0
121722,infection,0,0
121723,in,0,0
121724,this,0,0
121725,setting,0,0
121726,.,0,0
121727,Only,0,0
121728,ocular,0,0
121729,discharge,0,0
121730,was,0,0
121731,associated,0,0
121732,with,0,0
121733,evidence,0,0
121734,of,0,0
121735,C.,0,0
121736,trachomatis,0,0
121737,DNA,0,0
121738,in,0,0
121739,The,0,0
121740,Gambia,0,0
121741,",",0,0
121742,suggesting,0,0
121743,that,0,0
121744,at,0,0
121745,this,0,0
121746,low,0,0
121747,endemicity,0,0
121748,",",0,0
121749,this,0,0
121750,may,0,0
121751,be,0,0
121752,the,0,0
121753,most,0,0
121754,important,0,0
121755,risk,0,0
121756,factor,0,0
121757,.,0,0
121758,TRIAL,0,0
121759,REGISTRATION,0,0
121760,ClinicalTrials.gov,0,0
121761,NCT00792922,0,0
121762,.,0,0
121763,A,0,0
121764,placebo-controlled,1,1
121765,",",0,0
121766,randomized,0,0
121767,clinical,0,0
121768,trial,0,0
121769,using,0,0
121770,testosterone,1,0
121771,undecanoate,1,1
121772,with,1,0
121773,injectable,1,1
121774,norethisterone,1,1
121775,enanthate,1,1
121776,:,1,0
121777,effect,0,0
121778,on,0,0
121779,anthropometric,0,0
121780,",",0,0
121781,metabolic,0,0
121782,and,0,0
121783,biochemical,0,0
121784,parameters,0,0
121785,.,0,0
121786,Testosterone,0,0
121787,administered,0,0
121788,alone,0,0
121789,or,0,0
121790,in,0,0
121791,combination,0,1
121792,with,0,0
121793,progestogens,0,0
121794,in,0,0
121795,male,0,0
121796,contraception,0,0
121797,induces,0,0
121798,reversible,0,0
121799,oligo-azoospermia,0,0
121800,",",0,0
121801,but,0,0
121802,its,0,0
121803,effects,0,0
121804,on,0,0
121805,body,0,0
121806,composition,0,0
121807,and,0,0
121808,metabolism,0,0
121809,are,0,0
121810,less,0,0
121811,known,0,0
121812,.,0,0
121813,We,0,0
121814,analysed,0,0
121815,anthropometric,0,0
121816,and,0,0
121817,metabolic,0,0
121818,parameters,0,0
121819,in,0,0
121820,five,0,0
121821,groups,0,0
121822,of,0,0
121823,10,0,0
121824,males,0,0
121825,:,0,0
121826,four,0,0
121827,receiving,0,0
121828,testosterone,1,1
121829,undecanoate,1,1
121830,(,0,0
121831,TU,0,1
121832,:,0,0
121833,1000,0,0
121834,mg,0,1
121835,),0,0
121836,plus,1,1
121837,norethisterone,1,1
121838,enanthate,1,1
121839,(,0,0
121840,NETE,0,0
121841,:,0,0
121842,200,0,1
121843,mg,0,0
121844,),0,0
121845,at,0,0
121846,different,0,0
121847,intervals,0,0
121848,(,0,0
121849,every,0,0
121850,8,0,0
121851,weeks,0,0
121852,:,0,0
121853,NETE-8,0,0
121854,;,0,0
121855,every,0,0
121856,12,0,0
121857,weeks,0,0
121858,:,0,0
121859,NETE-12,0,0
121860,;,0,0
121861,every,0,0
121862,6,0,0
121863,weeks,0,0
121864,for,0,0
121865,12,0,0
121866,weeks,0,0
121867,and,0,0
121868,then,0,0
121869,every,0,0
121870,12,0,0
121871,weeks,0,0
121872,:,0,0
121873,NETE-6/12,0,0
121874,;,0,0
121875,every,0,0
121876,6,0,0
121877,weeks,0,0
121878,for,0,0
121879,12,0,0
121880,weeks,0,0
121881,and,0,0
121882,then,0,0
121883,TU,1,1
121884,plus,1,1
121885,placebo,1,1
121886,every,0,0
121887,12,0,0
121888,weeks,0,0
121889,:,0,0
121890,NETE-6/12/0,0,1
121891,),0,0
121892,and,0,0
121893,one,0,1
121894,placebo,1,1
121895,(,0,0
121896,NETE-0/0,0,1
121897,),0,0
121898,for,0,0
121899,a,0,0
121900,total,0,0
121901,of,0,0
121902,48,0,0
121903,weeks,0,0
121904,.,0,0
121905,Body,0,1
121906,mass,0,0
121907,index,0,0
121908,(,0,0
121909,BMI,0,0
121910,),0,1
121911,and,0,0
121912,waist,0,0
121913,circumference,0,0
121914,did,0,0
121915,not,0,0
121916,change,0,0
121917,in,0,0
121918,any,0,0
121919,groups,0,0
121920,except,0,0
121921,for,0,0
121922,the,0,0
121923,NETE-8,0,1
121924,in,0,0
121925,which,0,0
121926,BMI,0,0
121927,increased,0,0
121928,significantly,0,0
121929,(,0,0
121930,p,0,0
121931,=,0,0
121932,0.02,0,0
121933,),0,0
121934,at,0,0
121935,the,0,0
121936,end,0,0
121937,of,0,0
121938,the,0,0
121939,treatment,0,0
121940,period,0,0
121941,.,0,0
121942,Lean,0,0
121943,body,0,0
121944,mass,0,0
121945,(,0,0
121946,MAMC,0,0
121947,or,0,1
121948,AMA,0,1
121949,),0,0
121950,increased,0,0
121951,significantly,0,0
121952,in,0,0
121953,the,0,0
121954,highest,0,0
121955,hormonal,0,0
121956,dose,0,0
121957,groups,0,0
121958,(,0,0
121959,p,0,0
121960,=,0,0
121961,0.04,0,0
121962,",",0,0
121963,NETE-6/12,0,1
121964,;,0,0
121965,p,0,0
121966,=,0,0
121967,0.004,0,0
121968,",",0,0
121969,NETE-8,0,1
121970,),0,0
121971,.,0,0
121972,No,0,0
121973,differences,0,0
121974,were,0,0
121975,observed,0,0
121976,in,0,0
121977,glucose,0,0
121978,levels,0,0
121979,",",0,0
121980,insulin,0,1
121981,sensitivity,0,0
121982,index,0,0
121983,and,0,0
121984,lipid,0,0
121985,profile,0,0
121986,as,0,0
121987,well,0,0
121988,as,0,0
121989,in,0,0
121990,biochemical,0,0
121991,and,0,0
121992,cell,0,0
121993,count,0,0
121994,parameters,0,0
121995,in,0,0
121996,any,0,0
121997,groups,0,0
121998,.,0,0
121999,In,0,0
122000,conclusion,0,0
122001,",",0,0
122002,NETE,0,0
122003,and,0,0
122004,TU,0,1
122005,for,0,0
122006,48,0,0
122007,weeks,0,0
122008,were,0,0
122009,not,0,0
122010,accompanied,0,0
122011,by,0,0
122012,any,0,0
122013,metabolic,0,0
122014,changes,0,0
122015,and,0,0
122016,any,0,0
122017,adverse,0,0
122018,effects,0,0
122019,.,0,0
122020,The,0,0
122021,weight,0,0
122022,gain,0,0
122023,of,0,0
122024,the,0,0
122025,highest,0,0
122026,NETE,0,0
122027,plus,0,1
122028,TU,0,1
122029,dosage,0,0
122030,was,0,0
122031,mainly,0,0
122032,because,0,0
122033,of,0,0
122034,gain,0,0
122035,in,0,0
122036,muscle,0,0
122037,mass,0,0
122038,.,0,0
122039,Blockade,0,1
122040,of,0,0
122041,cytotoxic,0,0
122042,T-lymphocyte,0,0
122043,antigen-4,0,0
122044,by,0,0
122045,ipilimumab,1,0
122046,results,0,0
122047,in,0,0
122048,dysregulation,0,0
122049,of,0,0
122050,gastrointestinal,0,0
122051,immunity,0,0
122052,in,0,0
122053,patients,0,0
122054,with,0,0
122055,advanced,0,0
122056,melanoma,0,0
122057,.,0,0
122058,Blockade,0,0
122059,of,0,0
122060,cytotoxic,0,0
122061,T-lymphocyte,0,0
122062,antigen-4,0,1
122063,(,0,0
122064,CTLA-4,0,1
122065,),0,0
122066,by,0,0
122067,ipilimumab,0,0
122068,leads,0,0
122069,to,0,0
122070,immune-mediated,0,0
122071,tumor,0,0
122072,regression,0,0
122073,and,0,0
122074,immune-related,0,0
122075,adverse,0,0
122076,events,0,0
122077,(,0,0
122078,irAEs,0,1
122079,),0,0
122080,",",0,0
122081,including,0,0
122082,diarrhea,0,0
122083,and,0,0
122084,colitis,0,0
122085,.,0,0
122086,The,0,0
122087,current,0,0
122088,analyses,0,0
122089,were,0,0
122090,undertaken,0,0
122091,to,0,0
122092,promote,0,0
122093,an,0,0
122094,understanding,0,0
122095,of,0,0
122096,the,0,0
122097,underlying,0,0
122098,mechanism,0,0
122099,of,0,0
122100,action,0,0
122101,and,0,0
122102,to,0,0
122103,identify,0,0
122104,potential,0,0
122105,biomarkers,0,0
122106,that,0,0
122107,could,0,0
122108,help,0,0
122109,in,0,0
122110,the,0,0
122111,prediction,0,0
122112,and,0,0
122113,management,0,0
122114,of,0,0
122115,ipilimumab-induced,0,0
122116,gastrointestinal,0,0
122117,irAEs,0,1
122118,.,0,0
122119,Treatment-na?ve,0,0
122120,or,0,0
122121,previously,0,0
122122,treated,0,0
122123,patients,0,0
122124,with,0,0
122125,unresectable,0,0
122126,stage,0,0
122127,III/IV,0,1
122128,melanoma,0,0
122129,(,0,0
122130,n,0,0
122131,=,0,0
122132,115,0,0
122133,),0,0
122134,received,1,0
122135,open-label,1,0
122136,ipilimumab,1,1
122137,(,1,0
122138,10,1,0
122139,mg/kg,1,0
122140,every,1,0
122141,3,1,0
122142,weeks,1,0
122143,for,1,0
122144,four,1,0
122145,doses,1,0
122146,),1,0
122147,and,1,0
122148,were,1,0
122149,randomized,1,0
122150,to,1,0
122151,receive,1,0
122152,concomitant,1,0
122153,blinded,1,0
122154,prophylactic,1,1
122155,oral,1,1
122156,budesonide,1,1
122157,(,1,0
122158,9,1,0
122159,mg/d,1,0
122160,with,1,0
122161,gradual,1,0
122162,taper,1,0
122163,through,1,0
122164,week,1,0
122165,16,1,0
122166,),1,0
122167,or,1,0
122168,placebo,1,1
122169,.,1,0
122170,Outcome,1,0
122171,measures,0,0
122172,included,0,0
122173,histologic,0,0
122174,assessment,0,0
122175,of,0,0
122176,bowel,0,0
122177,biopsies,0,0
122178,and,0,0
122179,assessment,0,0
122180,of,0,0
122181,serologic,0,0
122182,markers,0,0
122183,of,0,0
122184,inflammatory,0,0
122185,bowel,0,0
122186,disease,0,0
122187,(,0,0
122188,IBD,0,1
122189,),0,0
122190,",",0,0
122191,fecal,0,0
122192,calprotectin,0,0
122193,levels,0,0
122194,",",0,0
122195,and,0,0
122196,polymorphisms,0,0
122197,in,0,0
122198,immune-related,0,0
122199,genes,0,0
122200,.,1,0
122201,Ipilimumab,1,0
122202,resulted,1,0
122203,in,0,0
122204,dysregulation,0,0
122205,of,0,0
122206,gastrointestinal,0,0
122207,mucosal,0,0
122208,immunity,0,0
122209,as,0,0
122210,evidenced,0,0
122211,by,0,0
122212,altered,0,0
122213,antibody,0,0
122214,levels,0,0
122215,to,0,0
122216,enteric,0,0
122217,flora,0,0
122218,",",0,0
122219,inflammatory,0,0
122220,cell,0,0
122221,infiltration,0,0
122222,into,0,0
122223,gastrointestinal,0,0
122224,mucosa,0,0
122225,",",0,0
122226,and,0,0
122227,increased,0,0
122228,fecal,0,0
122229,calprotectin,0,0
122230,associated,0,0
122231,with,0,0
122232,diarrhea,0,0
122233,and,0,0
122234,clinical,0,0
122235,evidence,0,0
122236,of,0,0
122237,colitis,0,0
122238,.,0,0
122239,The,0,0
122240,pattern,0,0
122241,of,0,0
122242,ipilimumab-induced,0,0
122243,antibody,0,0
122244,titers,0,0
122245,to,0,0
122246,microbial,0,0
122247,flora,0,0
122248,and,0,0
122249,the,0,0
122250,histologic,0,0
122251,features,0,0
122252,and,0,0
122253,location,0,0
122254,of,0,0
122255,the,0,0
122256,inflammation,0,0
122257,were,0,0
122258,distinct,0,0
122259,from,0,0
122260,classic,0,0
122261,IBD,0,1
122262,.,0,0
122263,Prophylactic,1,1
122264,budesonide,1,1
122265,did,1,0
122266,not,0,0
122267,prevent,0,0
122268,ipilimumab-induced,0,0
122269,bowel,0,0
122270,inflammation,0,0
122271,.,0,0
122272,Despite,0,0
122273,an,0,0
122274,observed,0,0
122275,association,0,0
122276,between,0,0
122277,colonic,0,0
122278,inflammation,0,0
122279,and,0,0
122280,grade,0,0
122281,2,0,0
122282,or,0,0
122283,higher,0,0
122284,diarrhea,0,0
122285,",",0,0
122286,no,0,0
122287,baseline,0,0
122288,biomarkers,0,0
122289,could,0,0
122290,reliably,0,0
122291,predict,0,0
122292,development,0,0
122293,of,0,0
122294,gastrointestinal,0,0
122295,toxicity,0,0
122296,.,0,0
122297,Although,0,0
122298,classic,0,0
122299,IBD,0,1
122300,and,0,0
122301,ipilimumab-related,0,0
122302,gastrointestinal,0,0
122303,toxicity,0,0
122304,are,0,0
122305,both,0,0
122306,immune,0,0
122307,mediated,0,0
122308,",",0,0
122309,the,0,0
122310,observed,0,0
122311,pattern,0,0
122312,of,0,0
122313,biomarkers,0,0
122314,suggests,0,0
122315,ipilimumab-related,0,0
122316,gastrointestinal,0,0
122317,toxicity,0,0
122318,may,0,0
122319,be,0,0
122320,a,0,0
122321,distinct,0,0
122322,clinicopathologic,0,0
122323,entity,0,0
122324,.,0,0
122325,Inhibin,0,1
122326,A,0,0
122327,is,0,0
122328,down-regulated,0,0
122329,during,0,0
122330,chemotherapy,1,1
122331,in,0,0
122332,patients,0,0
122333,with,0,0
122334,breast,0,0
122335,cancer,0,0
122336,.,0,0
122337,BACKGROUND,0,0
122338,Inhibins,0,0
122339,are,0,0
122340,dimeric,0,0
122341,glycoproteins,0,0
122342,",",0,0
122343,composed,0,0
122344,of,0,0
122345,an,0,0
122346,alpha-subunit,0,1
122347,(,0,0
122348,INH-?,0,0
122349,),0,0
122350,and,0,0
122351,one,0,0
122352,of,0,0
122353,two,0,0
122354,possible,0,0
122355,beta-subunits,0,1
122356,(,0,0
122357,?A,0,0
122358,or,0,1
122359,?B,0,0
122360,),0,0
122361,",",0,0
122362,with,0,0
122363,substantial,0,0
122364,roles,0,0
122365,in,0,0
122366,human,0,0
122367,reproduction,0,0
122368,and,0,0
122369,in,0,0
122370,endocrine-responsive,0,0
122371,tumours,0,0
122372,.,0,0
122373,Aims,0,0
122374,of,0,0
122375,this,0,0
122376,study,0,0
122377,were,0,0
122378,to,0,0
122379,determine,0,0
122380,the,0,0
122381,serological,0,0
122382,measurement,0,0
122383,of,0,0
122384,inhibin,0,0
122385,A,0,0
122386,(,0,0
122387,?-?A,0,1
122388,),0,0
122389,in,0,0
122390,breast,0,0
122391,cancer,0,0
122392,patients,0,0
122393,during,0,0
122394,chemotherapy,0,1
122395,.,0,0
122396,PATIENTS,0,0
122397,AND,0,0
122398,METHODS,0,0
122399,A,0,0
122400,series,0,0
122401,of,0,0
122402,30,0,0
122403,breast,0,0
122404,cancer,0,0
122405,patients,0,0
122406,who,0,0
122407,underwent,1,0
122408,standardised,1,0
122409,chemotherapy,1,1
122410,were,1,0
122411,prospectively,0,0
122412,evaluated,0,0
122413,before,1,0
122414,chemotherapeutic,1,1
122415,treatment,1,0
122416,as,1,0
122417,well,1,0
122418,as,0,0
122419,four,0,0
122420,weeks,0,0
122421,after,0,0
122422,chemotherapy,1,1
122423,and,1,0
122424,two,0,0
122425,years,0,0
122426,after,0,0
122427,chemotherapy,1,1
122428,for,1,0
122429,the,0,0
122430,serological,0,0
122431,expression,0,0
122432,of,0,0
122433,inhibin,0,0
122434,A,0,0
122435,.,0,0
122436,For,0,0
122437,statistical,0,0
122438,analysis,0,0
122439,the,0,0
122440,Wilcoxon,0,0
122441,rank,0,0
122442,sum,0,0
122443,test,0,0
122444,was,0,0
122445,used,0,0
122446,for,0,0
122447,paired,0,0
122448,samples,0,0
122449,.,0,0
122450,Statistical,0,0
122451,significance,0,0
122452,was,0,0
122453,assumed,0,0
122454,at,0,0
122455,p,0,0
122456,<,0,0
122457,0.05,0,0
122458,.,0,0
122459,RESULTS,0,0
122460,The,0,0
122461,concentration,0,0
122462,of,0,0
122463,inhibin,0,0
122464,A,0,0
122465,showed,0,0
122466,a,0,0
122467,significant,0,0
122468,decrease,0,0
122469,between,0,0
122470,data,0,0
122471,obtained,0,0
122472,before,1,0
122473,chemotherapy,1,1
122474,and,1,0
122475,after,0,0
122476,chemotherapy,1,1
122477,(,1,0
122478,p,1,0
122479,<,1,0
122480,0.005,1,0
122481,),0,0
122482,and,0,0
122483,two-year,0,0
122484,follow-up,0,0
122485,(,0,0
122486,p,0,0
122487,<,0,0
122488,0.001,0,0
122489,),0,0
122490,.,0,0
122491,Interestingly,0,0
122492,",",0,0
122493,there,0,0
122494,were,0,0
122495,no,0,0
122496,differences,0,0
122497,in,0,0
122498,inhibin,0,0
122499,A,0,0
122500,concentrations,0,0
122501,between,0,0
122502,the,0,0
122503,four-week,0,1
122504,and,0,0
122505,two-year,0,0
122506,follow-up,0,0
122507,(,0,0
122508,p=0.744,0,0
122509,),0,0
122510,.,0,0
122511,DISCUSSION,1,0
122512,Chemotherapy,1,1
122513,significantly,1,0
122514,decreases,0,0
122515,inhibin,0,0
122516,A,0,0
122517,concentration,0,0
122518,during,0,0
122519,chemotherapy,0,1
122520,.,0,0
122521,This,0,0
122522,might,0,0
122523,reflect,0,0
122524,a,0,0
122525,suppression,0,0
122526,of,0,0
122527,ovarian,0,0
122528,function,0,0
122529,",",0,0
122530,being,0,0
122531,also,0,0
122532,a,0,0
122533,marker,0,0
122534,for,0,0
122535,chemotherapy-induced,0,0
122536,amenorrhoea,0,0
122537,.,0,0
122538,Moreover,0,0
122539,",",0,0
122540,it,0,0
122541,has,0,0
122542,been,0,0
122543,suggested,0,0
122544,that,0,0
122545,inhibin,0,0
122546,A,0,0
122547,might,0,0
122548,be,0,0
122549,a,0,0
122550,tumour,0,0
122551,marker,0,0
122552,for,0,0
122553,breast,0,0
122554,cancer,0,0
122555,",",0,0
122556,and,0,0
122557,therefore,0,0
122558,a,0,0
122559,sudden,0,0
122560,increase,0,0
122561,in,0,0
122562,its,0,0
122563,concentration,0,0
122564,might,0,0
122565,be,0,0
122566,indicative,0,0
122567,of,0,0
122568,breast,0,0
122569,cancer,0,0
122570,recurrence,0,0
122571,.,0,0
122572,[,0,0
122573,GISSI-2,0,0
122574,;,0,0
122575,the,0,0
122576,beginning,0,0
122577,of,0,0
122578,the,0,0
122579,end,0,0
122580,or,0,0
122581,the,0,0
122582,end,0,0
122583,of,0,0
122584,the,0,0
122585,beginning,0,0
122586,for,0,0
122587,tissue,1,0
122588,plasminogen,1,0
122589,activator,0,0
122590,in,0,0
122591,acute,0,0
122592,myocardial,0,0
122593,infarct,0,0
122594,?,0,0
122595,],0,0
122596,.,0,0
122597,Mechanisms,0,0
122598,underlying,0,0
122599,the,0,0
122600,lack,0,0
122601,of,0,0
122602,effect,0,0
122603,of,0,0
122604,implantable,1,1
122605,cardioverter-defibrillator,1,1
122606,therapy,1,1
122607,on,0,0
122608,mortality,0,0
122609,in,0,0
122610,high-risk,0,0
122611,patients,0,0
122612,with,0,0
122613,recent,0,0
122614,myocardial,0,0
122615,infarction,0,0
122616,:,0,0
122617,insights,0,0
122618,from,0,0
122619,the,0,0
122620,Defibrillation,0,1
122621,in,0,0
122622,Acute,0,0
122623,Myocardial,0,0
122624,Infarction,0,1
122625,Trial,0,1
122626,(,0,0
122627,DINAMIT,0,0
122628,),0,0
122629,.,0,0
122630,BACKGROUND,0,0
122631,although,0,0
122632,implantable,1,1
122633,cardioverter-defibrillators,1,1
122634,(,0,0
122635,ICDs,0,0
122636,),0,0
122637,lower,0,0
122638,mortality,0,0
122639,in,0,0
122640,stable,0,0
122641,patients,0,0
122642,with,0,0
122643,low,0,0
122644,ejection,0,0
122645,fraction,0,0
122646,late,0,0
122647,after,0,0
122648,myocardial,0,0
122649,infarction,0,0
122650,",",0,0
122651,randomized,0,0
122652,trials,0,0
122653,of,0,0
122654,ICD,1,0
122655,versus,0,0
122656,control,0,0
122657,subjects,0,0
122658,implanted,0,0
122659,early,0,0
122660,after,0,0
122661,myocardial,0,0
122662,infarction,0,0
122663,do,0,0
122664,not,0,0
122665,show,0,0
122666,mortality,0,0
122667,benefit,0,0
122668,.,0,0
122669,Our,0,0
122670,objective,0,0
122671,was,0,0
122672,to,0,0
122673,investigate,0,0
122674,possible,0,0
122675,mechanisms,0,0
122676,underlying,0,0
122677,the,0,0
122678,lack,0,0
122679,of,0,0
122680,mortality,0,0
122681,benefit,0,0
122682,in,0,0
122683,the,0,0
122684,Defibrillation,0,1
122685,in,0,0
122686,Acute,0,0
122687,Myocardial,0,0
122688,Infarction,0,1
122689,Trial,0,1
122690,(,0,0
122691,DINAMIT,0,0
122692,),0,0
122693,.,0,0
122694,METHODS,0,0
122695,AND,0,0
122696,RESULTS,0,0
122697,this,0,0
122698,is,0,0
122699,a,0,0
122700,secondary,0,0
122701,analysis,0,0
122702,of,0,0
122703,the,0,0
122704,prospective,0,0
122705,randomized,0,0
122706,clinical,0,0
122707,trial,0,0
122708,.,0,0
122709,Outpatients,0,0
122710,with,0,0
122711,recent,0,0
122712,(,0,0
122713,6,0,0
122714,to,0,0
122715,40,0,0
122716,days,0,0
122717,),0,0
122718,acute,0,0
122719,myocardial,0,0
122720,infarction,0,0
122721,",",0,0
122722,left,0,0
122723,ventricular,0,0
122724,dysfunction,0,0
122725,(,0,0
122726,ejection,0,0
122727,fraction,0,0
122728,<,0,0
122729,35,0,0
122730,%,0,0
122731,),0,0
122732,",",0,0
122733,and,0,0
122734,low,0,0
122735,heart,0,0
122736,rate,0,0
122737,variability,0,0
122738,were,0,0
122739,randomized,0,0
122740,to,0,0
122741,ICD,1,0
122742,(,0,1
122743,n=311,0,0
122744,),0,0
122745,or,0,0
122746,to,0,0
122747,standard,1,1
122748,medical,1,1
122749,therapy,1,1
122750,(,0,0
122751,n=342,0,0
122752,),0,0
122753,.,0,0
122754,In,0,0
122755,a,0,0
122756,competing-risks,0,0
122757,analysis,0,0
122758,",",0,0
122759,those,0,0
122760,factors,0,0
122761,that,0,0
122762,increased,0,0
122763,the,0,0
122764,risk,0,0
122765,of,0,0
122766,arrhythmic,0,0
122767,death,0,0
122768,also,0,0
122769,increased,0,0
122770,the,0,0
122771,risk,0,0
122772,of,0,0
122773,nonarrhythmic,0,0
122774,deaths,0,0
122775,.,0,0
122776,After,0,0
122777,adjustment,0,0
122778,for,0,0
122779,these,0,0
122780,factors,0,0
122781,",",0,0
122782,receiving,0,0
122783,an,0,0
122784,ICD,0,0
122785,was,0,0
122786,associated,0,0
122787,with,0,0
122788,a,0,0
122789,decreased,0,0
122790,risk,0,0
122791,of,0,0
122792,arrhythmic,0,0
122793,death,0,0
122794,(,0,0
122795,hazard,0,0
122796,ratio,0,0
122797,",",0,0
122798,0.33,0,0
122799,;,0,0
122800,95,0,0
122801,%,0,0
122802,confidence,0,0
122803,interval,0,0
122804,",",0,0
122805,0.15,0,0
122806,to,0,0
122807,0.71,0,0
122808,),0,0
122809,but,0,0
122810,an,0,0
122811,increase,0,0
122812,in,0,0
122813,nonarrhythmic,0,0
122814,death,0,0
122815,(,0,0
122816,hazard,0,0
122817,ratio,0,0
122818,",",0,0
122819,1.70,0,0
122820,;,0,0
122821,95,0,0
122822,%,0,0
122823,confidence,0,0
122824,interval,0,0
122825,",",0,0
122826,1.00,0,0
122827,to,0,0
122828,2.80,0,0
122829,),0,0
122830,.,0,0
122831,In,0,0
122832,an,0,0
122833,adjusted,0,0
122834,time-dependent,0,0
122835,analysis,0,0
122836,",",0,0
122837,patients,0,0
122838,receiving,0,0
122839,an,0,0
122840,ICD,0,0
122841,and,0,0
122842,having,0,0
122843,appropriate,0,0
122844,ICD,0,0
122845,therapy,0,1
122846,had,0,0
122847,a,0,0
122848,15.1,0,0
122849,%,0,0
122850,yearly,0,0
122851,hazard,0,0
122852,of,0,0
122853,mortality,0,0
122854,compared,0,0
122855,with,0,0
122856,5.2,0,0
122857,%,0,0
122858,in,0,0
122859,ICD,0,0
122860,patients,0,0
122861,with,0,0
122862,no,0,0
122863,appropriate,0,0
122864,therapy,0,1
122865,(,0,0
122866,P,0,0
122867,<,0,0
122868,0.001,0,0
122869,),0,0
122870,.,0,0
122871,The,0,0
122872,reduction,0,0
122873,in,0,0
122874,sudden,0,0
122875,death,0,0
122876,in,0,0
122877,ICD,0,0
122878,patients,0,0
122879,was,0,0
122880,completely,0,0
122881,offset,0,0
122882,by,0,0
122883,increased,0,0
122884,nonarrhythmic,0,0
122885,deaths,0,0
122886,",",0,0
122887,which,0,0
122888,were,0,0
122889,greatest,0,0
122890,in,0,0
122891,patients,0,0
122892,receiving,0,0
122893,ICD,0,0
122894,shock,0,1
122895,therapy,0,1
122896,(,0,0
122897,hazard,0,0
122898,ratio,0,0
122899,",",0,0
122900,6.0,0,0
122901,;,0,0
122902,95,0,0
122903,%,0,0
122904,confidence,0,0
122905,interval,0,0
122906,",",0,0
122907,2.8,0,0
122908,to,0,0
122909,12.7,0,0
122910,),0,0
122911,.,0,0
122912,CONCLUSIONS,0,0
122913,in,0,0
122914,patients,0,0
122915,receiving,0,0
122916,ICDs,0,0
122917,early,0,0
122918,after,0,0
122919,myocardial,0,0
122920,infarction,0,0
122921,",",0,0
122922,those,0,0
122923,factors,0,0
122924,that,0,0
122925,are,0,0
122926,associated,0,0
122927,with,0,0
122928,arrhythmia,0,0
122929,requiring,0,0
122930,ICD,0,0
122931,therapy,0,1
122932,are,0,0
122933,also,0,0
122934,associated,0,0
122935,with,0,0
122936,a,0,0
122937,high,0,0
122938,risk,0,0
122939,of,0,0
122940,nonsudden,0,0
122941,death,0,0
122942,",",0,0
122943,negating,0,0
122944,the,0,0
122945,benefit,0,0
122946,of,0,0
122947,ICDs,0,0
122948,in,0,0
122949,this,0,0
122950,setting,0,0
122951,.,0,0
122952,Cost-effectiveness,0,0
122953,of,0,0
122954,ablation,1,1
122955,surgery,1,0
122956,in,0,0
122957,patients,0,0
122958,with,0,0
122959,atrial,0,0
122960,fibrillation,0,0
122961,undergoing,0,0
122962,cardiac,0,0
122963,surgery,0,0
122964,.,0,0
122965,This,0,0
122966,study,0,0
122967,was,0,0
122968,performed,0,0
122969,to,0,0
122970,assess,0,0
122971,the,0,0
122972,cost-effectiveness,0,0
122973,of,0,0
122974,concomitant,0,0
122975,ablation,1,1
122976,surgery,1,1
122977,(,1,0
122978,AS,1,0
122979,),1,0
122980,compared,0,0
122981,to,0,0
122982,regular,0,1
122983,cardiac,1,0
122984,surgery,1,0
122985,in,0,0
122986,atrial,0,0
122987,fibrillation,0,0
122988,(,0,0
122989,AF,0,1
122990,),0,0
122991,patients,0,0
122992,over,0,0
122993,a,0,0
122994,one-year,0,0
122995,follow-up,0,0
122996,.,0,0
122997,Cost,0,0
122998,analysis,0,0
122999,was,0,0
123000,performed,0,0
123001,from,0,0
123002,a,0,0
123003,societal,0,1
123004,perspective,0,0
123005,alongside,0,0
123006,a,0,0
123007,prospective,0,0
123008,",",0,0
123009,randomised,0,0
123010,",",0,0
123011,double-blinded,0,0
123012,",",0,0
123013,multicentre,0,0
123014,trial,0,0
123015,.,0,0
123016,One,0,0
123017,hundred,0,0
123018,and,0,0
123019,fifty,0,0
123020,patients,0,0
123021,with,0,0
123022,documented,0,0
123023,AF,0,0
123024,were,0,0
123025,randomly,1,0
123026,assigned,1,0
123027,to,1,0
123028,undergo,1,0
123029,cardiac,1,0
123030,surgery,1,0
123031,with,1,0
123032,or,1,0
123033,without,1,0
123034,AS,1,0
123035,.,1,0
123036,One,0,0
123037,hundred,0,0
123038,and,0,0
123039,thirty-two,0,0
123040,patients,0,0
123041,were,0,0
123042,included,0,0
123043,in,0,0
123044,the,0,0
123045,cost-effectiveness,1,0
123046,study,0,0
123047,.,0,0
123048,All,0,0
123049,costs,0,0
123050,(,0,0
123051,medical,0,0
123052,and,0,0
123053,non-medical,0,1
123054,),0,0
123055,were,0,0
123056,measured,0,0
123057,during,0,0
123058,follow-up,0,0
123059,.,0,0
123060,Costs,0,0
123061,data,0,0
123062,were,0,0
123063,combined,0,0
123064,with,0,0
123065,quality,0,0
123066,adjusted,0,0
123067,life,0,0
123068,years,0,0
123069,(,0,0
123070,QALYs,0,1
123071,),0,0
123072,to,0,0
123073,obtain,0,0
123074,the,0,0
123075,incremental,0,0
123076,costs,0,0
123077,per,0,0
123078,QALY,0,0
123079,.,0,0
123080,Total,0,0
123081,costs,0,0
123082,of,0,0
123083,the,0,0
123084,AS,1,0
123085,group,0,0
123086,were,0,0
123087,significantly,0,0
123088,higher,0,0
123089,compared,0,0
123090,to,0,0
123091,the,0,0
123092,regular,0,1
123093,cardiac,0,0
123094,surgery,0,1
123095,group,0,0
123096,[,0,0
123097,cost,0,0
123098,difference,0,0
123099,bootstrap,0,1
123100,:,0,0
123101,"?4,724",0,0
123102,;,0,0
123103,95,0,0
123104,%,0,0
123105,uncertainty,0,0
123106,interval,0,0
123107,(,0,0
123108,UI,0,1
123109,),0,0
123110,",",0,0
123111,"?2,770-?6,678",0,0
123112,],0,0
123113,.,0,0
123114,The,0,0
123115,bootstrapped,0,0
123116,difference,0,0
123117,in,0,0
123118,QALYs,0,1
123119,was,0,0
123120,not,0,0
123121,statistically,0,0
123122,significant,0,0
123123,(,0,0
123124,0.06,0,0
123125,;,0,0
123126,95,0,0
123127,%,0,0
123128,UI,0,1
123129,:,0,0
123130,-0.024,0,0
123131,to,0,0
123132,0.14,0,0
123133,),0,0
123134,.,0,0
123135,The,0,0
123136,incremental,0,0
123137,cost-effectiveness,0,0
123138,ratio,0,0
123139,is,0,0
123140,"?73,359",0,0
123141,per,0,0
123142,QALY,0,0
123143,.,0,0
123144,The,0,0
123145,acceptability,0,0
123146,curve,0,0
123147,showed,0,0
123148,that,0,0
123149,",",0,0
123150,even,0,0
123151,in,0,0
123152,the,0,0
123153,case,0,0
123154,of,0,0
123155,a,0,0
123156,maximum,0,0
123157,threshold,0,0
123158,value,0,0
123159,of,0,0
123160,"?80,000",0,0
123161,per,0,0
123162,QALY,0,0
123163,gained,0,0
123164,",",0,0
123165,the,0,0
123166,probability,1,0
123167,of,1,0
123168,AS,1,0
123169,being,1,0
123170,more,0,0
123171,cost-effective,0,0
123172,than,0,0
123173,regular,0,1
123174,cardiac,0,0
123175,surgery,0,0
123176,did,0,0
123177,not,0,0
123178,reach,0,0
123179,beyond,0,0
123180,50,0,0
123181,%,0,0
123182,.,0,0
123183,Concluding,0,0
123184,that,0,0
123185,concomitant,1,0
123186,AS,1,0
123187,in,1,0
123188,AF,1,0
123189,is,0,0
123190,not,0,0
123191,cost-effective,0,0
123192,after,0,0
123193,a,0,0
123194,one-year,0,0
123195,follow-up,0,0
123196,compared,0,0
123197,to,0,0
123198,regular,0,1
123199,cardiac,0,0
123200,surgery,0,0
123201,.,0,0
123202,Effect,0,0
123203,of,0,0
123204,L-arginine,1,1
123205,or,1,0
123206,L-citrulline,1,1
123207,oral,1,1
123208,supplementation,1,1
123209,on,0,0
123210,blood,0,0
123211,pressure,0,0
123212,and,0,0
123213,right,0,0
123214,ventricular,0,0
123215,function,0,0
123216,in,0,0
123217,heart,0,0
123218,failure,0,0
123219,patients,0,0
123220,with,0,0
123221,preserved,0,0
123222,ejection,0,0
123223,fraction,0,0
123224,.,0,0
123225,BACKGROUND,0,0
123226,The,0,0
123227,effect,0,0
123228,of,0,0
123229,L-arginine,1,1
123230,and,1,0
123231,L-citrulline,1,1
123232,on,0,0
123233,blood,0,0
123234,pressure,0,0
123235,and,0,0
123236,right,0,0
123237,ventricular,0,0
123238,function,0,0
123239,in,0,0
123240,heart,0,0
123241,failure,0,0
123242,patients,0,0
123243,with,0,0
123244,preserved,0,0
123245,ejection,0,0
123246,fraction,0,0
123247,(,0,0
123248,HFpEF,0,0
123249,),0,1
123250,is,0,0
123251,unknown,0,0
123252,.,0,0
123253,We,0,0
123254,have,0,0
123255,therefore,0,0
123256,evaluated,0,0
123257,",",0,0
123258,in,0,0
123259,a,0,0
123260,randomized,0,0
123261,clinical,0,0
123262,trial,0,0
123263,",",0,0
123264,the,0,0
123265,effect,0,0
123266,of,0,0
123267,these,0,0
123268,aminoacids,0,1
123269,in,0,0
123270,chronic,0,0
123271,outstanding,0,0
123272,and,0,0
123273,stable,0,0
123274,patients,0,0
123275,with,0,0
123276,HFpEF,0,0
123277,.,0,0
123278,METHODS,0,0
123279,AND,0,0
123280,RESULTS,0,0
123281,All,0,0
123282,patients,0,0
123283,underwent,0,0
123284,an,0,0
123285,echocardiogram,1,0
123286,and,1,0
123287,radioisotopic,1,1
123288,ventriculography,1,1
123289,rest/exercise,1,1
123290,",",0,0
123291,and,0,0
123292,were,0,0
123293,randomized,0,0
123294,in,0,0
123295,a,0,0
123296,consecutive,0,0
123297,manner,0,0
123298,to,0,0
123299,the,0,0
123300,L-arginine,1,1
123301,group,1,0
123302,(,0,0
123303,n,0,0
123304,=,0,0
123305,15,0,0
123306,;,0,0
123307,8,0,0
123308,g/day,0,0
123309,),0,0
123310,;,0,0
123311,and,0,0
123312,the,0,0
123313,citrulline,1,1
123314,malate,1,0
123315,group,1,0
123316,(,0,0
123317,n,0,0
123318,=,0,0
123319,15,0,0
123320,;,0,0
123321,3,0,0
123322,g/day,0,0
123323,),0,0
123324,.,0,0
123325,The,0,0
123326,duration,0,0
123327,of,0,0
123328,follow-up,0,0
123329,was,0,0
123330,two,0,0
123331,months,0,0
123332,.,0,0
123333,The,0,0
123334,principal,0,0
123335,echocardiographic,0,0
123336,finding,0,0
123337,was,0,0
123338,a,0,0
123339,statistically,0,0
123340,significant,0,0
123341,decrease,0,0
123342,in,0,0
123343,pulmonary,0,0
123344,artery,0,0
123345,pressure,0,0
123346,in,0,0
123347,the,0,0
123348,L-arginine,1,1
123349,(,0,0
123350,56.3,0,0
123351,?,0,0
123352,10,0,0
123353,vs,0,0
123354,44,0,0
123355,?,0,0
123356,16.5,0,0
123357,mm,0,0
123358,Hg,0,0
123359,",",0,0
123360,p,0,0
123361,<,0,0
123362,0.05,0,0
123363,),0,0
123364,and,0,0
123365,the,1,0
123366,citrulline,1,1
123367,(,1,0
123368,56.67,0,0
123369,?,0,0
123370,7.96,0,0
123371,vs,0,0
123372,47.67,0,0
123373,?,0,0
123374,8.59,0,0
123375,mm,0,0
123376,Hg,0,0
123377,",",0,0
123378,p,0,0
123379,<,0,0
123380,0.05,0,0
123381,),0,0
123382,groups,0,0
123383,.,0,0
123384,Duration,0,0
123385,on,0,0
123386,treadmill,0,1
123387,and,0,0
123388,right,0,0
123389,ventricular,0,0
123390,ejection,0,0
123391,fraction,0,0
123392,post,0,0
123393,exercise,0,1
123394,increased,0,0
123395,",",0,0
123396,while,0,0
123397,diastolic,0,0
123398,and,0,0
123399,systolic,0,0
123400,artery,0,0
123401,pressure,0,0
123402,decreased,0,0
123403,significantly,0,0
123404,in,0,0
123405,both,0,0
123406,groups,0,0
123407,.,0,0
123408,There,0,0
123409,were,0,0
123410,no,0,0
123411,other,0,0
123412,statistically,0,0
123413,significant,0,0
123414,differences,0,0
123415,between,0,0
123416,the,0,0
123417,groups,0,0
123418,.,0,0
123419,CONCLUSIONS,0,0
123420,Administration,1,0
123421,of,1,0
123422,L-arginine,1,1
123423,and,1,0
123424,citrulline,1,0
123425,to,1,0
123426,patients,0,0
123427,with,0,0
123428,HFpEF,0,0
123429,improved,0,0
123430,right,0,0
123431,ventricular,0,0
123432,function,0,0
123433,by,0,0
123434,increasing,0,0
123435,right,0,0
123436,ventricular,0,0
123437,ejection,0,0
123438,fraction,0,0
123439,",",0,0
123440,and,0,0
123441,probably,0,0
123442,decreasing,0,0
123443,systolic,0,0
123444,pulmonary,0,0
123445,artery,0,0
123446,pressure,0,0
123447,.,0,0
123448,In,0,0
123449,vitro,0,0
123450,determination,0,0
123451,of,0,0
123452,the,0,0
123453,chromatic,0,1
123454,effect,0,0
123455,of,0,0
123456,a,0,0
123457,silver,1,1
123458,nanoparticles,1,1
123459,solution,1,1
123460,linked,0,0
123461,to,0,0
123462,the,0,0
123463,gantrez,1,1
123464,S-97,1,0
123465,copolymer,1,1
123466,on,0,0
123467,tooth,0,0
123468,enamel,0,0
123469,.,0,0
123470,Silver,1,1
123471,nanoparticles,1,0
123472,(,1,0
123473,NNPs,1,1
123474,),1,0
123475,",",0,0
123476,alone,0,1
123477,or,0,0
123478,in,0,0
123479,combination,0,1
123480,with,0,0
123481,the,0,0
123482,bioadhesive,0,0
123483,Gantrez,1,1
123484,S-97,1,0
123485,",",0,0
123486,have,0,0
123487,demonstrated,0,0
123488,their,0,0
123489,efficacy,0,0
123490,against,0,0
123491,Streptococcus,0,0
123492,mutans,0,0
123493,;,0,0
123494,however,0,0
123495,",",0,0
123496,it,0,0
123497,is,0,0
123498,not,0,0
123499,known,0,0
123500,if,0,0
123501,this,0,0
123502,combination,0,1
123503,changes,0,0
123504,the,0,0
123505,color,0,0
123506,of,0,0
123507,teeth,0,0
123508,.,0,0
123509,The,0,0
123510,aim,0,0
123511,of,0,0
123512,this,0,0
123513,work,0,0
123514,was,0,0
123515,to,0,0
123516,measure,0,0
123517,the,0,0
123518,color,0,0
123519,changes,0,0
123520,occurring,0,0
123521,after,0,0
123522,the,0,0
123523,use,0,0
123524,of,0,0
123525,a,0,0
123526,Gantrez-NNP,1,1
123527,combination,1,1
123528,on,0,0
123529,enamel,0,0
123530,tooth,0,0
123531,blocks,0,0
123532,.,0,0
123533,Two,0,0
123534,study,0,0
123535,groups,0,0
123536,were,0,0
123537,randomly,0,0
123538,formed,0,0
123539,:,0,0
123540,enamel,0,0
123541,blocks,0,1
123542,brushed,0,1
123543,with,0,0
123544,(,0,0
123545,a,0,0
123546,),0,0
123547,the,1,0
123548,Gantrez-NNP,1,1
123549,combination,1,1
123550,and,1,0
123551,(,1,0
123552,b,1,0
123553,),1,1
123554,conventional,1,1
123555,toothpaste,1,1
123556,",",0,0
123557,for,0,0
123558,1,0,0
123559,minute,0,0
123560,once,0,0
123561,daily,0,0
123562,for,0,0
123563,4,0,0
123564,weeks,0,0
123565,",",0,0
123566,then,0,0
123567,rinsed,1,1
123568,with,1,0
123569,distilled,1,1
123570,water,1,1
123571,and,1,0
123572,placed,1,0
123573,in,1,0
123574,thymol,1,1
123575,solution,1,1
123576,.,1,0
123577,Color,0,0
123578,changes,0,0
123579,in,0,0
123580,the,0,0
123581,enamel,0,0
123582,blocks,0,0
123583,were,0,0
123584,measured,0,0
123585,using,0,0
123586,a,0,0
123587,Minolta,0,1
123588,colorimeter,0,0
123589,CR300,0,0
123590,.,0,0
123591,Analysis,0,0
123592,of,0,0
123593,mixed,0,0
123594,models,0,0
123595,was,0,0
123596,performed,0,0
123597,with,0,0
123598,R,0,0
123599,2.10.1,0,0
123600,at,0,0
123601,a,0,0
123602,95,0,0
123603,%,0,0
123604,confidence,0,0
123605,level,0,0
123606,",",0,0
123607,using,0,0
123608,the,0,0
123609,nonlinear,0,0
123610,mixed,0,0
123611,effects,0,0
123612,(,0,0
123613,NLME,0,0
123614,),0,0
123615,package,0,1
123616,.,0,0
123617,The,0,0
123618,results,0,0
123619,showed,0,0
123620,that,0,0
123621,there,0,0
123622,were,0,0
123623,no,0,0
123624,color,0,0
123625,changes,0,0
123626,over,0,0
123627,time,0,0
123628,",",0,0
123629,only,0,0
123630,a,0,0
123631,high,0,0
123632,luminosity,0,0
123633,equal,0,0
123634,in,0,0
123635,both,0,0
123636,groups,0,0
123637,.,0,0
123638,Our,0,0
123639,study,0,0
123640,showed,0,0
123641,that,0,0
123642,the,0,0
123643,use,0,0
123644,of,0,0
123645,the,0,0
123646,Gantrez-NNP,1,1
123647,combination,1,1
123648,is,0,0
123649,safe,0,0
123650,with,0,0
123651,respect,0,0
123652,to,0,0
123653,dental,0,0
123654,esthetics,0,1
123655,in,0,0
123656,the,0,0
123657,control,0,0
123658,of,0,0
123659,S.,0,0
123660,mutans,0,0
123661,.,0,0
123662,Controlled,0,0
123663,",",0,0
123664,prospective,0,0
123665,",",0,0
123666,randomized,0,0
123667,",",0,0
123668,clinical,0,0
123669,evaluation,0,0
123670,of,0,0
123671,partial,1,0
123672,ceramic,1,1
123673,crowns,1,1
123674,inserted,0,1
123675,with,0,0
123676,RelyX,1,0
123677,Unicem,1,1
123678,with,1,0
123679,or,1,0
123680,without,1,0
123681,selective,1,1
123682,enamel,1,0
123683,etching,1,1
123684,.,1,0
123685,1-year,0,0
123686,results,0,0
123687,.,0,0
123688,PURPOSE,0,0
123689,To,0,0
123690,compare,0,0
123691,the,0,0
123692,performance,0,0
123693,of,0,0
123694,partial,1,0
123695,ceramic,1,1
123696,crowns,1,1
123697,(,1,0
123698,PCCs,1,1
123699,),1,0
123700,inserted,1,1
123701,with,1,0
123702,RelyX,1,1
123703,Unicem,1,1
123704,(,1,0
123705,RXU,1,1
123706,),1,0
123707,either,1,0
123708,with,1,0
123709,(,1,0
123710,RXU+E,1,1
123711,),1,0
123712,or,1,1
123713,without,1,1
123714,(,1,0
123715,RXU,1,0
123716,),1,0
123717,selective,1,1
123718,enamel,1,0
123719,etching,1,1
123720,.,1,0
123721,METHODS,0,0
123722,34,0,0
123723,patients,0,0
123724,(,0,0
123725,15,0,0
123726,male,0,0
123727,",",0,0
123728,19,0,0
123729,female,0,0
123730,),0,0
123731,participated,0,0
123732,in,0,0
123733,the,0,0
123734,investigation,0,0
123735,",",0,0
123736,with,0,0
123737,a,0,0
123738,total,0,0
123739,of,0,0
123740,68,0,0
123741,PCC,0,0
123742,restorations,0,1
123743,.,0,0
123744,In,0,0
123745,each,0,0
123746,patient,0,0
123747,",",0,0
123748,one,0,0
123749,PCC,1,0
123750,was,0,0
123751,randomly,0,0
123752,assigned,0,0
123753,to,0,0
123754,insertion,0,0
123755,with,0,0
123756,RXU,1,0
123757,",",0,0
123758,the,0,0
123759,second,0,0
123760,PCC,1,0
123761,was,0,0
123762,assigned,0,0
123763,to,0,0
123764,insertion,0,0
123765,with,0,0
123766,RXU+E,1,0
123767,.,1,0
123768,The,0,0
123769,PCCs,0,1
123770,were,0,0
123771,CAD/CAM,0,0
123772,fabricated,0,1
123773,using,0,0
123774,the,0,0
123775,Cerec,1,0
123776,3,1,0
123777,system,1,0
123778,.,1,0
123779,RXU,1,0
123780,:,1,0
123781,25,0,0
123782,PCCs,0,1
123783,were,0,0
123784,placed,0,0
123785,in,0,0
123786,molars,0,0
123787,",",0,0
123788,nine,0,0
123789,in,0,0
123790,premolars,0,0
123791,.,0,0
123792,RXU+E,1,0
123793,:,1,0
123794,26,0,0
123795,PCCs,0,1
123796,were,0,0
123797,placed,0,0
123798,in,0,0
123799,molars,0,0
123800,",",0,0
123801,eight,0,0
123802,in,0,0
123803,premolars,0,0
123804,.,0,0
123805,The,0,0
123806,restorations,0,0
123807,were,0,0
123808,clinically,0,0
123809,rated,0,0
123810,using,0,0
123811,modified,0,0
123812,United,0,0
123813,States,0,0
123814,Public,0,0
123815,Health,0,1
123816,Service,0,1
123817,(,0,0
123818,USPHS,0,0
123819,),0,0
123820,criteria,0,0
123821,at,0,0
123822,baseline,0,0
123823,",",0,0
123824,6,0,0
123825,and,0,0
123826,12,0,0
123827,months,0,0
123828,after,0,0
123829,placement,0,0
123830,.,0,0
123831,The,0,0
123832,median,0,0
123833,patient,0,0
123834,age,0,0
123835,was,0,0
123836,41,0,0
123837,years,0,0
123838,(,0,0
123839,24-59,0,0
123840,years,0,0
123841,),0,0
123842,.,0,0
123843,The,0,0
123844,median,0,0
123845,(,0,0
123846,25-75,0,0
123847,%,0,0
123848,),0,0
123849,PBI,0,0
123850,was,0,0
123851,6,0,0
123852,%,0,0
123853,(,0,0
123854,3-9,0,1
123855,%,0,0
123856,),0,0
123857,.,0,0
123858,RESULTS,0,0
123859,All,0,0
123860,patients,0,0
123861,were,0,0
123862,available,0,0
123863,for,0,0
123864,the,0,0
123865,three,0,0
123866,recall,0,0
123867,appointments,0,0
123868,.,0,0
123869,One,0,0
123870,PCC,0,0
123871,(,1,0
123872,RXU,1,0
123873,),1,0
123874,debonded,0,0
123875,after,0,0
123876,11,0,0
123877,months,0,0
123878,in,0,0
123879,situ,0,0
123880,",",0,0
123881,one,0,0
123882,PCC,0,0
123883,(,1,0
123884,RXU+E,1,0
123885,),1,0
123886,fractured,0,0
123887,after,0,0
123888,12,0,0
123889,months,0,0
123890,in,0,0
123891,situ,0,0
123892,.,0,0
123893,Both,0,0
123894,restorations,0,0
123895,had,0,0
123896,to,0,0
123897,be,0,0
123898,replaced,0,0
123899,.,0,0
123900,At,0,0
123901,the,0,0
123902,12,0,0
123903,months,0,0
123904,recall,0,0
123905,",",0,0
123906,66,0,0
123907,of,0,0
123908,68,0,0
123909,controlled,0,0
123910,restorations,0,1
123911,were,0,0
123912,functional,0,0
123913,without,0,0
123914,need,0,0
123915,of,0,0
123916,replacement,0,1
123917,.,0,0
123918,The,0,0
123919,evaluation,0,0
123920,using,0,0
123921,USHPS,0,0
123922,criteria,0,0
123923,revealed,0,0
123924,a,0,0
123925,significant,0,0
123926,decrease,0,0
123927,of,0,0
123928,alfa,0,1
123929,ratings,0,0
123930,over,0,0
123931,time,0,0
123932,with,0,0
123933,respect,0,0
123934,to,0,0
123935,criteria,0,0
123936,marginal,0,0
123937,adaptation,0,0
123938,and,0,0
123939,marginal,0,0
123940,discoloration,0,0
123941,.,0,0
123942,No,0,0
123943,statistically,0,0
123944,significant,0,0
123945,differences,0,0
123946,between,0,0
123947,the,0,0
123948,two,0,0
123949,luting,0,0
123950,techniques,0,1
123951,",",0,0
123952,RXU,1,0
123953,and,1,0
123954,RXU+E,1,0
123955,",",0,0
123956,we,0,0
123957,reobserved,0,0
123958,during,0,0
123959,the,0,0
123960,observation,0,0
123961,period,0,0
123962,of,0,0
123963,1,0,0
123964,year,0,0
123965,.,0,0
123966,Within,0,0
123967,the,0,0
123968,limitations,0,0
123969,of,0,0
123970,the,0,0
123971,present,0,0
123972,study,0,0
123973,",",0,0
123974,adhesive,0,1
123975,luting,0,1
123976,with,0,0
123977,RXU,1,0
123978,with,0,0
123979,or,0,0
123980,without,0,0
123981,selective,0,1
123982,enamel,0,0
123983,etching,0,1
123984,can,0,0
123985,be,0,0
123986,recommended,0,0
123987,.,0,0
123988,Factors,0,0
123989,predictive,0,0
123990,of,0,0
123991,severe,0,0
123992,hypoglycemia,0,0
123993,in,0,0
123994,type,0,0
123995,1,0,0
123996,diabetes,0,0
123997,:,0,0
123998,analysis,0,0
123999,from,0,0
124000,the,0,0
124001,Juvenile,0,0
124002,Diabetes,0,0
124003,Research,0,0
124004,Foundation,0,0
124005,continuous,0,1
124006,glucose,0,0
124007,monitoring,0,0
124008,randomized,0,0
124009,control,0,1
124010,trial,0,0
124011,dataset,0,0
124012,.,0,0
124013,OBJECTIVE,0,0
124014,Identify,0,0
124015,factors,0,0
124016,predictive,0,0
124017,of,0,0
124018,severe,0,0
124019,hypoglycemia,0,0
124020,(,0,0
124021,SH,0,1
124022,),0,0
124023,and,0,0
124024,assess,0,0
124025,the,0,0
124026,clinical,0,0
124027,utility,0,0
124028,of,0,0
124029,continuous,1,1
124030,glucose,1,0
124031,monitoring,1,0
124032,(,1,0
124033,CGM,1,0
124034,),1,0
124035,to,0,0
124036,warn,0,0
124037,of,0,0
124038,impending,0,0
124039,SH,0,0
124040,.,0,0
124041,RESEARCH,0,0
124042,DESIGN,0,0
124043,AND,0,0
124044,METHODS,0,0
124045,In,0,0
124046,a,0,0
124047,multicenter,0,0
124048,randomized,0,0
124049,clinical,0,0
124050,trial,0,0
124051,",",0,0
124052,436,0,0
124053,children,0,0
124054,and,0,0
124055,adults,0,0
124056,with,0,0
124057,type,0,0
124058,1,0,0
124059,diabetes,0,0
124060,were,0,0
124061,randomized,0,0
124062,to,0,0
124063,a,0,0
124064,treatment,0,0
124065,group,0,0
124066,that,0,0
124067,used,0,0
124068,CGM,1,0
124069,(,0,0
124070,N,0,0
124071,=,0,0
124072,224,0,0
124073,),0,0
124074,",",0,0
124075,or,0,0
124076,a,0,0
124077,control,1,1
124078,group,0,0
124079,that,0,0
124080,used,0,0
124081,standard,1,1
124082,home,1,1
124083,blood,1,0
124084,glucose,1,1
124085,monitoring,1,0
124086,(,0,0
124087,N,0,0
124088,=,0,0
124089,212,0,0
124090,),0,0
124091,and,0,0
124092,completed,0,0
124093,12,0,0
124094,months,0,0
124095,of,0,0
124096,follow-up,0,0
124097,.,0,0
124098,After,0,0
124099,6,0,0
124100,months,0,0
124101,",",0,0
124102,the,0,0
124103,original,0,0
124104,control,0,0
124105,group,0,0
124106,initiated,0,0
124107,CGM,1,0
124108,while,0,0
124109,the,0,0
124110,treatment,0,0
124111,group,0,0
124112,continued,0,0
124113,use,0,0
124114,of,0,0
124115,CGM,0,0
124116,for,0,0
124117,6,0,0
124118,months,0,0
124119,.,0,0
124120,Baseline,0,0
124121,risk,0,0
124122,factors,0,0
124123,for,0,0
124124,SH,0,0
124125,were,0,0
124126,evaluated,0,0
124127,over,0,0
124128,12,0,0
124129,months,0,0
124130,of,0,0
124131,follow-up,0,0
124132,using,0,0
124133,proportional,0,0
124134,hazards,0,0
124135,regression,0,0
124136,.,0,0
124137,CGM-derived,0,0
124138,indices,0,0
124139,of,0,0
124140,hypoglycemia,0,0
124141,were,0,0
124142,used,0,0
124143,to,0,0
124144,predict,0,0
124145,episodes,0,0
124146,of,0,0
124147,SH,0,0
124148,over,0,0
124149,a,0,0
124150,24-h,0,1
124151,time,0,0
124152,horizon,0,0
124153,.,0,0
124154,RESULTS,0,0
124155,The,0,0
124156,SH,0,0
124157,rate,0,0
124158,was,0,0
124159,17.9,0,0
124160,per,0,0
124161,100,0,0
124162,person-years,0,0
124163,",",0,0
124164,and,0,0
124165,a,0,0
124166,higher,0,0
124167,rate,0,0
124168,was,0,0
124169,associated,0,0
124170,with,0,0
124171,the,0,0
124172,occurrence,0,0
124173,of,0,0
124174,SH,0,0
124175,in,0,0
124176,the,0,0
124177,prior,0,0
124178,6,0,0
124179,months,0,0
124180,and,0,0
124181,female,0,0
124182,sex,0,0
124183,.,0,0
124184,SH,0,0
124185,frequency,0,0
124186,increased,0,0
124187,eightfold,0,0
124188,when,0,0
124189,30,0,0
124190,%,0,0
124191,of,0,0
124192,CGM,1,0
124193,values,0,0
124194,were,0,0
124195,?,0,0
124196,70,0,0
124197,mg/dL,0,0
124198,on,0,0
124199,the,0,0
124200,prior,0,0
124201,day,0,0
124202,(,0,0
124203,4.5,0,0
124204,vs.,0,0
124205,0.5,0,0
124206,%,0,0
124207,;,0,0
124208,P,0,0
124209,<,0,0
124210,0.001,0,0
124211,),0,0
124212,",",0,0
124213,but,0,0
124214,the,0,0
124215,positive,0,0
124216,predictive,0,0
124217,value,0,0
124218,(,0,0
124219,PPV,0,0
124220,),0,0
124221,was,0,0
124222,low,0,0
124223,(,0,0
124224,<,0,0
124225,5,0,1
124226,%,0,0
124227,),0,0
124228,.,0,0
124229,Results,0,0
124230,were,0,0
124231,similar,0,0
124232,for,0,0
124233,hypoglycemic,0,0
124234,area,0,0
124235,under,0,0
124236,the,0,0
124237,curve,0,0
124238,and,0,0
124239,the,0,0
124240,low,0,0
124241,blood,0,0
124242,glucose,0,0
124243,index,0,0
124244,calculated,0,0
124245,by,0,0
124246,CGM,1,0
124247,.,1,0
124248,CONCLUSIONS,0,0
124249,SH,0,0
124250,in,0,0
124251,the,0,0
124252,6,0,0
124253,months,0,0
124254,prior,0,0
124255,to,0,0
124256,the,0,0
124257,study,0,0
124258,was,0,0
124259,the,0,0
124260,strongest,0,0
124261,predictor,0,0
124262,of,0,0
124263,SH,0,0
124264,during,0,0
124265,the,0,0
124266,study,1,0
124267,.,1,0
124268,CGM-measured,1,0
124269,hypoglycemia,1,0
124270,over,0,0
124271,a,0,0
124272,24-h,0,0
124273,span,0,0
124274,is,0,0
124275,highly,0,0
124276,associated,0,0
124277,with,0,0
124278,SH,0,0
124279,the,0,0
124280,following,0,0
124281,day,0,0
124282,(,0,0
124283,P,0,0
124284,<,0,0
124285,0.001,0,0
124286,),0,0
124287,",",0,0
124288,but,0,0
124289,the,0,0
124290,PPV,0,1
124291,is,0,0
124292,low,0,0
124293,.,0,0
124294,Using,0,0
124295,personalized,1,1
124296,feedback,1,1
124297,to,0,0
124298,reduce,0,0
124299,alcohol,0,1
124300,use,0,0
124301,among,0,0
124302,hazardous,0,0
124303,drinking,0,0
124304,college,0,0
124305,students,0,0
124306,:,0,0
124307,the,0,0
124308,moderating,0,0
124309,effect,0,0
124310,of,0,0
124311,alcohol-related,0,0
124312,negative,0,0
124313,consequences,0,0
124314,.,0,0
124315,UNLABELLED,0,0
124316,Web-based,1,1
124317,screening,1,0
124318,and,1,0
124319,brief,1,1
124320,interventions,1,0
124321,that,0,0
124322,include,0,0
124323,personalized,0,1
124324,feedback,0,1
124325,about,0,0
124326,their,0,0
124327,alcohol,0,0
124328,use,0,0
124329,have,0,0
124330,proven,0,0
124331,to,0,0
124332,be,0,0
124333,particularly,0,0
124334,promising,0,0
124335,for,0,0
124336,reducing,0,0
124337,hazardous,0,0
124338,drinking,0,0
124339,among,0,0
124340,university,0,0
124341,students,0,0
124342,.,0,0
124343,Despite,0,0
124344,the,0,0
124345,increasing,0,0
124346,use,0,0
124347,of,0,0
124348,these,0,0
124349,approaches,0,0
124350,",",0,0
124351,there,0,0
124352,is,0,0
124353,still,0,0
124354,relatively,0,0
124355,little,0,0
124356,known,0,0
124357,about,0,0
124358,how,0,0
124359,the,0,0
124360,content,0,0
124361,of,0,0
124362,these,0,0
124363,interventions,0,0
124364,may,0,0
124365,influence,0,0
124366,outcomes,0,0
124367,and,0,0
124368,who,0,0
124369,may,0,0
124370,benefit,0,0
124371,most,0,0
124372,from,0,0
124373,these,0,0
124374,approaches,0,0
124375,.,0,0
124376,The,0,0
124377,current,0,0
124378,study,0,0
124379,sought,0,0
124380,to,0,0
124381,address,0,0
124382,these,0,0
124383,issues,0,0
124384,by,0,0
124385,examining,0,0
124386,how,0,0
124387,individual,0,0
124388,differences,0,0
124389,in,0,0
124390,alcohol,0,0
124391,consequences,0,0
124392,influence,0,0
124393,outcomes,0,0
124394,of,0,0
124395,a,0,0
124396,laboratory-based,1,0
124397,computerized,1,1
124398,intervention,1,1
124399,.,1,0
124400,METHODS,0,0
124401,One-hundred,0,0
124402,and,0,0
124403,nineteen,0,0
124404,introductory,0,1
124405,psychology,0,0
124406,students,0,0
124407,who,0,0
124408,either,0,0
124409,had,0,0
124410,two,0,0
124411,episodes,0,0
124412,of,0,0
124413,heavy,0,0
124414,episodic,0,0
124415,drinking,0,0
124416,in,0,0
124417,the,0,0
124418,past,0,0
124419,month,0,0
124420,or,0,1
124421,scored,0,0
124422,?8,0,0
124423,on,0,0
124424,the,0,0
124425,AUDIT,0,0
124426,participated,0,0
124427,in,0,0
124428,this,0,0
124429,randomized,0,0
124430,controlled,0,0
124431,trial,0,0
124432,for,0,0
124433,course,0,0
124434,credit,0,1
124435,.,0,0
124436,Participants,0,0
124437,were,0,0
124438,assigned,0,0
124439,to,0,0
124440,1,0,0
124441,of,0,0
124442,4,0,0
124443,conditions,0,0
124444,in,0,0
124445,this,0,0
124446,2,0,0
124447,Intervention,1,1
124448,(,1,0
124449,Alcohol,1,1
124450,Feedback,1,1
124451,vs.,1,0
124452,Control,1,1
124453,),1,0
124454,?2,1,0
124455,Assessment,1,1
124456,(,1,0
124457,Motivational,1,0
124458,Assessment,1,0
124459,vs.,1,0
124460,No,1,0
124461,Motivational,1,0
124462,Assessment,1,1
124463,),1,0
124464,between-subjects,1,0
124465,design,0,0
124466,.,0,0
124467,Quantity,0,0
124468,of,0,0
124469,alcohol,0,0
124470,consumed,0,0
124471,per,0,0
124472,week,0,0
124473,and,0,0
124474,heavy,0,1
124475,episodic,0,0
124476,drinking,0,0
124477,one,0,0
124478,month,0,0
124479,later,0,0
124480,were,0,0
124481,the,0,0
124482,primary,0,0
124483,dependent,0,0
124484,variables,0,0
124485,.,0,0
124486,RESULTS,0,0
124487,Controlling,0,0
124488,for,0,0
124489,corresponding,0,0
124490,baseline,0,0
124491,alcohol,0,1
124492,measures,0,0
124493,",",0,0
124494,hierarchical,0,0
124495,linear,0,0
124496,regression,0,0
124497,analyses,0,0
124498,showed,0,0
124499,a,0,0
124500,significant,0,0
124501,interaction,0,0
124502,between,0,0
124503,intervention,0,1
124504,condition,0,0
124505,and,0,0
124506,baseline,0,0
124507,alcohol-related,0,0
124508,consequences,0,0
124509,.,0,0
124510,For,0,0
124511,those,0,0
124512,who,0,0
124513,reported,0,0
124514,more,0,0
124515,alcohol,0,0
124516,consequences,0,0
124517,at,0,0
124518,baseline,0,0
124519,",",0,0
124520,the,0,0
124521,alcohol,0,0
124522,intervention,0,1
124523,resulted,0,0
124524,in,0,0
124525,significantly,0,0
124526,less,0,0
124527,alcohol,0,0
124528,use,0,0
124529,and,0,0
124530,fewer,0,0
124531,heavy,0,0
124532,drinking,0,0
124533,episodes,0,0
124534,at,0,0
124535,follow-up,0,0
124536,",",0,0
124537,while,0,0
124538,no,0,0
124539,difference,0,0
124540,was,0,0
124541,observed,0,0
124542,between,0,0
124543,intervention,0,1
124544,conditions,0,0
124545,for,0,0
124546,those,0,0
124547,with,0,0
124548,few,0,0
124549,baseline,0,0
124550,consequences,0,0
124551,.,0,0
124552,Assessment,0,0
124553,did,0,0
124554,not,0,0
124555,moderate,0,0
124556,intervention,0,0
124557,effects,0,0
124558,.,0,0
124559,DISCUSSION,0,0
124560,These,0,0
124561,findings,0,0
124562,suggest,0,0
124563,that,1,0
124564,a,1,0
124565,feedback-based,1,1
124566,computerized,1,1
124567,intervention,1,1
124568,that,1,0
124569,includes,0,0
124570,normative,0,0
124571,information,0,0
124572,about,0,0
124573,alcohol,0,1
124574,use,0,0
124575,and,0,0
124576,consequences,0,0
124577,may,0,0
124578,be,0,0
124579,more,0,0
124580,effective,0,0
124581,for,0,0
124582,hazardous,0,0
124583,drinking,0,0
124584,students,0,0
124585,who,0,0
124586,are,0,0
124587,experiencing,0,0
124588,higher,0,0
124589,levels,0,0
124590,of,0,0
124591,alcohol-related,0,0
124592,consequences,0,0
124593,.,0,0
124594,Effects,0,0
124595,of,0,0
124596,diet,1,1
124597,and,1,0
124598,Aspergillus,1,0
124599,oryzae,1,0
124600,extract,1,1
124601,or,1,0
124602,Saccharomyces,1,0
124603,cervisiae,1,0
124604,on,0,0
124605,growth,0,0
124606,and,0,0
124607,carcass,0,0
124608,characteristics,0,0
124609,of,0,0
124610,lambs,0,1
124611,and,0,0
124612,steers,0,0
124613,fed,0,0
124614,to,0,0
124615,meet,0,0
124616,requirements,0,0
124617,of,0,0
124618,natural,0,0
124619,markets,0,0
124620,.,0,0
124621,Two,0,0
124622,studies,0,0
124623,were,0,0
124624,conducted,0,0
124625,to,0,0
124626,determine,0,0
124627,the,0,0
124628,effects,0,0
124629,of,0,0
124630,diet,1,1
124631,and,1,0
124632,feed,1,0
124633,additive,1,1
124634,on,0,0
124635,growth,0,0
124636,and,0,0
124637,carcass,0,0
124638,characteristics,0,0
124639,of,0,0
124640,lambs,0,1
124641,and,0,0
124642,cattle,0,0
124643,destined,0,0
124644,for,0,0
124645,all,0,0
124646,natural,0,0
124647,markets,0,0
124648,.,0,0
124649,In,0,0
124650,Exp,0,0
124651,.,0,0
124652,1,0,0
124653,",",0,0
124654,48,0,0
124655,Dorset,0,0
124656,?,0,0
124657,Hampshire,0,0
124658,lambs,0,1
124659,(,0,0
124660,initial,0,0
124661,BW,0,1
124662,29.4,0,0
124663,?,0,0
124664,0.1,0,0
124665,kg,0,0
124666,),0,0
124667,were,0,0
124668,used,0,0
124669,in,0,0
124670,a,0,0
124671,randomized,0,0
124672,complete,0,0
124673,block,0,0
124674,experiment,0,0
124675,to,0,0
124676,determine,0,0
124677,the,0,0
124678,effects,0,0
124679,of,0,0
124680,Aspergillus,1,0
124681,oryzae,1,0
124682,extract,1,1
124683,",",1,0
124684,Amaferm,1,1
124685,(,1,0
124686,AMF,1,1
124687,),1,1
124688,supplementation,1,1
124689,(,1,0
124690,1,0,0
124691,g/d,0,1
124692,),0,0
124693,in,0,0
124694,an,0,0
124695,85,0,0
124696,%,1,0
124697,concentrate,1,1
124698,diet,1,1
124699,on,1,0
124700,growth,0,0
124701,and,0,0
124702,carcass,0,0
124703,characteristics,0,0
124704,.,0,0
124705,Lambs,0,0
124706,were,0,0
124707,allotted,0,0
124708,to,0,0
124709,12,0,0
124710,pens,0,1
124711,(,0,0
124712,4,0,0
124713,lambs,0,1
124714,per,0,0
124715,pen,0,1
124716,),0,0
124717,",",0,0
124718,and,0,0
124719,blocked,0,0
124720,by,0,0
124721,sex,0,0
124722,and,0,0
124723,BW,0,1
124724,.,0,0
124725,Lambs,0,0
124726,were,0,0
124727,fed,0,0
124728,until,0,0
124729,the,0,0
124730,average,0,0
124731,BW,0,1
124732,of,0,0
124733,each,0,0
124734,pen,0,1
124735,reached,0,0
124736,a,0,0
124737,target,0,0
124738,BW,0,1
124739,(,0,0
124740,55.4,0,0
124741,kg,0,0
124742,for,0,0
124743,wethers,0,1
124744,and,0,0
124745,50.0,0,0
124746,kg,0,0
124747,for,0,0
124748,ewes,0,0
124749,),0,0
124750,",",0,0
124751,at,0,0
124752,which,0,0
124753,time,0,0
124754,the,0,0
124755,entire,0,0
124756,pen,0,1
124757,of,0,0
124758,lambs,0,1
124759,was,0,0
124760,slaughtered,0,0
124761,.,0,0
124762,Amaferm,0,0
124763,resulted,0,0
124764,in,0,0
124765,a,0,0
124766,greater,0,0
124767,(,0,0
124768,P=0.07,0,0
124769,),0,0
124770,G,0,0
124771,:,0,0
124772,F.,0,0
124773,In,0,0
124774,Exp,0,1
124775,.,0,0
124776,2,0,0
124777,",",0,0
124778,168,0,0
124779,crossbred,0,0
124780,steers,0,1
124781,(,0,0
124782,initial,0,0
124783,BW,0,1
124784,300,0,0
124785,?,0,0
124786,0.7,0,0
124787,kg,0,0
124788,),0,0
124789,were,0,0
124790,used,0,0
124791,in,0,0
124792,a,0,0
124793,trial,0,0
124794,with,0,0
124795,a,0,0
124796,3,0,0
124797,?,0,0
124798,2,0,0
124799,factorial,0,0
124800,arrangement,0,0
124801,of,0,0
124802,treatments,0,0
124803,to,0,0
124804,examine,0,0
124805,the,0,0
124806,effects,0,0
124807,of,0,0
124808,0.5,0,0
124809,g/d,0,1
124810,of,1,0
124811,Saccaromyces,1,1
124812,cervisiae,1,0
124813,boulardii,1,1
124814,CNCM,1,0
124815,1079-Levucell,1,1
124816,SB,1,1
124817,(,1,0
124818,LEV,1,1
124819,),1,0
124820,",",1,0
124821,or,1,0
124822,3,0,0
124823,g/d,0,1
124824,of,1,0
124825,AMF,1,0
124826,with,0,0
124827,2,0,0
124828,corn,0,0
124829,sources,1,0
124830,",",1,0
124831,dry,1,0
124832,whole-shelled,1,1
124833,corn,1,1
124834,or,1,1
124835,high,1,0
124836,moisture,1,0
124837,corn,1,1
124838,",",1,0
124839,on,1,0
124840,growth,0,0
124841,and,0,0
124842,carcass,0,0
124843,characteristics,0,0
124844,.,0,0
124845,Neither,1,0
124846,LEV,1,0
124847,nor,1,0
124848,AMF,1,1
124849,improved,0,0
124850,(,0,0
124851,P,0,0
124852,>,0,0
124853,0.10,0,0
124854,),0,0
124855,carcass,0,0
124856,characteristics,0,0
124857,compared,0,0
124858,with,0,0
124859,control,0,0
124860,or,0,0
124861,non-feed-supplemented,0,1
124862,steers,0,1
124863,.,0,0
124864,Addition,1,0
124865,of,1,0
124866,LEV,1,0
124867,to,0,0
124868,high-concentrate,0,1
124869,",",0,0
124870,corn-based,0,1
124871,diets,0,1
124872,did,0,0
124873,not,0,0
124874,improve,0,0
124875,(,0,0
124876,P,0,0
124877,>,0,0
124878,0.10,0,0
124879,),0,0
124880,growth,0,0
124881,performance,0,0
124882,of,0,0
124883,feedlot,0,0
124884,steers,0,0
124885,.,0,0
124886,However,0,0
124887,",",0,0
124888,addition,1,0
124889,of,1,0
124890,AMF,1,0
124891,to,0,0
124892,a,0,0
124893,diet,0,1
124894,composed,0,0
124895,of,0,0
124896,dry,0,0
124897,whole-shelled,0,1
124898,corn,0,1
124899,resulted,0,0
124900,in,0,0
124901,an,0,0
124902,improvement,0,0
124903,(,0,0
124904,P,0,0
124905,<,0,0
124906,0.05,0,0
124907,),0,0
124908,in,0,0
124909,G,0,0
124910,:,0,0
124911,F,0,0
124912,(,0,0
124913,0.208,0,0
124914,vs.,0,0
124915,0.194,0,0
124916,),0,0
124917,.,0,0
124918,Results,0,0
124919,indicate,0,0
124920,that,0,0
124921,at,0,0
124922,the,0,0
124923,amounts,0,0
124924,fed,0,0
124925,",",0,0
124926,AMF,1,0
124927,may,0,0
124928,improve,0,0
124929,G,0,0
124930,:,0,0
124931,F,0,0
124932,for,0,0
124933,lambs,0,1
124934,and,0,0
124935,steers,0,1
124936,fed,0,0
124937,dry,0,0
124938,corn-based,0,1
124939,finishing,0,0
124940,diets,0,1
124941,.,0,0
124942,Human,0,1
124943,primary,0,0
124944,visual,0,1
124945,cortex,0,0
124946,(,0,0
124947,V1,0,0
124948,),0,1
124949,is,0,0
124950,selective,0,0
124951,for,0,0
124952,second-order,0,0
124953,spatial,0,0
124954,frequency,0,0
124955,.,0,0
124956,A,0,0
124957,variety,0,0
124958,of,0,0
124959,cues,0,0
124960,can,0,0
124961,differentiate,0,0
124962,objects,0,0
124963,from,0,0
124964,their,0,0
124965,surrounds,0,0
124966,.,0,0
124967,These,0,0
124968,include,0,0
124969,first-order,0,0
124970,cues,0,0
124971,such,0,0
124972,as,0,0
124973,luminance,0,1
124974,modulations,0,0
124975,and,0,0
124976,second-order,0,0
124977,cues,0,0
124978,involving,0,0
124979,modulations,0,0
124980,of,0,0
124981,orientation,0,0
124982,and,0,0
124983,contrast,0,0
124984,.,0,0
124985,Human,0,0
124986,sensitivity,0,0
124987,to,0,0
124988,first-order,0,0
124989,modulations,0,0
124990,is,0,0
124991,well,0,0
124992,described,0,0
124993,by,0,0
124994,a,0,0
124995,computational,0,0
124996,model,0,0
124997,involving,0,0
124998,spatially,0,0
124999,localized,0,0
125000,filters,0,1
125001,that,0,0
125002,are,0,0
125003,selective,0,0
125004,for,0,0
125005,orientation,0,0
125006,and,0,0
125007,spatial,0,0
125008,frequency,0,0
125009,(,0,0
125010,SF,0,0
125011,),0,0
125012,.,0,0
125013,It,0,0
125014,is,0,0
125015,widely,0,0
125016,held,0,0
125017,that,0,0
125018,first-order,0,0
125019,modulations,0,0
125020,are,0,0
125021,represented,0,0
125022,by,0,0
125023,the,0,0
125024,firing,0,0
125025,rates,0,0
125026,of,0,0
125027,simple,0,0
125028,and,0,0
125029,complex,0,0
125030,cells,0,1
125031,(,0,0
125032,first-order,0,0
125033,neurons,0,0
125034,),0,0
125035,in,0,0
125036,primary,0,0
125037,visual,0,0
125038,cortex,0,0
125039,(,0,0
125040,V1,0,0
125041,),0,0
125042,that,0,0
125043,",",0,0
125044,likewise,0,0
125045,",",0,0
125046,have,0,0
125047,spatially,0,0
125048,localized,0,0
125049,receptive,0,0
125050,fields,0,0
125051,that,0,0
125052,are,0,0
125053,selective,0,0
125054,for,0,0
125055,orientation-,0,0
125056,and,0,0
125057,SF,0,0
125058,.,0,0
125059,Human,0,0
125060,sensitivity,0,0
125061,to,0,0
125062,second-order,0,0
125063,modulations,0,0
125064,is,0,0
125065,well,0,0
125066,described,0,0
125067,by,0,0
125068,a,0,0
125069,filter-rectify-filter,0,1
125070,(,0,0
125071,FRF,0,0
125072,),0,0
125073,model,0,0
125074,",",0,0
125075,with,0,0
125076,first-,0,0
125077,and,0,0
125078,second-order,0,0
125079,filters,0,1
125080,selective,0,0
125081,for,0,0
125082,orientation,0,0
125083,and,0,0
125084,SF,0,0
125085,.,0,0
125086,However,0,0
125087,",",0,0
125088,little,0,0
125089,is,0,0
125090,known,0,0
125091,about,0,0
125092,how,0,0
125093,neuronal,0,0
125094,activity,0,0
125095,in,0,0
125096,visual,0,0
125097,cortex,0,0
125098,represents,0,0
125099,second-order,0,0
125100,modulations,0,0
125101,.,0,0
125102,We,0,0
125103,tested,0,0
125104,the,0,0
125105,FRF,1,0
125106,model,1,0
125107,by,0,0
125108,using,0,0
125109,an,0,0
125110,functional,1,0
125111,(,1,0
125112,f,1,0
125113,),1,1
125114,MRI-adaptation,1,0
125115,protocol,1,0
125116,to,0,0
125117,characterize,0,0
125118,the,0,0
125119,selectivity,0,0
125120,of,0,0
125121,activity,0,0
125122,in,0,0
125123,visual,0,0
125124,cortex,0,0
125125,to,0,0
125126,second-order,0,0
125127,",",0,0
125128,orientation-defined,0,0
125129,gratings,0,1
125130,of,0,0
125131,two,0,0
125132,different,0,0
125133,SFs,0,0
125134,.,0,0
125135,fMRI,0,0
125136,responses,0,0
125137,throughout,0,0
125138,early,0,0
125139,visual,0,0
125140,cortex,0,0
125141,exhibited,0,0
125142,selective,0,0
125143,adaptation,0,0
125144,to,0,0
125145,these,0,0
125146,stimuli,0,1
125147,.,0,0
125148,The,0,0
125149,low-SF,0,0
125150,grating,0,1
125151,was,0,0
125152,a,0,0
125153,more,0,0
125154,effective,0,0
125155,adapter,0,0
125156,than,0,0
125157,the,0,0
125158,high-SF,0,0
125159,grating,0,1
125160,",",0,0
125161,incompatible,0,0
125162,with,0,0
125163,the,0,0
125164,FRF,0,0
125165,model,0,0
125166,.,0,0
125167,To,0,0
125168,explain,0,0
125169,the,0,0
125170,results,0,0
125171,",",0,0
125172,we,0,0
125173,extended,0,0
125174,the,0,0
125175,FRF,0,0
125176,model,0,0
125177,by,0,0
125178,incorporating,0,0
125179,normalization,0,0
125180,",",0,0
125181,yielding,0,0
125182,a,0,0
125183,filter-rectify-normalize-filter,0,1
125184,model,0,0
125185,",",0,0
125186,in,0,0
125187,which,0,0
125188,normalization,0,0
125189,enhances,0,0
125190,selectivity,0,0
125191,for,0,0
125192,second-order,0,0
125193,SF,0,0
125194,but,0,0
125195,only,0,0
125196,for,0,0
125197,low,0,0
125198,spatial,0,0
125199,frequencies,0,0
125200,.,0,0
125201,We,0,0
125202,conclude,0,0
125203,that,0,0
125204,neurons,0,0
125205,in,0,0
125206,human,0,0
125207,visual,0,0
125208,cortex,0,0
125209,are,0,0
125210,selective,0,0
125211,for,0,0
125212,second-order,0,0
125213,SF,0,0
125214,",",0,0
125215,that,0,0
125216,normalization,0,0
125217,(,0,0
125218,surround,0,0
125219,suppression,0,0
125220,),0,0
125221,contributes,0,0
125222,to,0,0
125223,this,0,0
125224,selectivity,0,0
125225,",",0,0
125226,and,0,0
125227,that,0,0
125228,the,0,0
125229,selectivity,0,0
125230,in,0,0
125231,higher,0,0
125232,visual,0,0
125233,areas,0,0
125234,is,0,0
125235,simply,0,0
125236,fed,0,0
125237,forward,0,0
125238,from,0,0
125239,V1,0,0
125240,.,0,0
125241,Delayed,0,0
125242,perceptual,0,1
125243,awareness,0,0
125244,in,0,0
125245,rapid,0,0
125246,perceptual,0,0
125247,decisions,0,0
125248,.,0,0
125249,The,0,0
125250,flourishing,0,0
125251,of,0,0
125252,studies,0,0
125253,on,0,0
125254,the,0,0
125255,neural,0,0
125256,correlates,0,0
125257,of,0,0
125258,decision-making,0,0
125259,calls,0,0
125260,for,0,0
125261,an,0,0
125262,appraisal,0,0
125263,of,0,0
125264,the,0,0
125265,relation,0,0
125266,between,0,0
125267,perceptual,0,1
125268,decisions,0,0
125269,and,0,0
125270,conscious,0,0
125271,perception,0,0
125272,.,0,0
125273,By,0,0
125274,exploiting,0,0
125275,the,0,0
125276,long,1,0
125277,integration,1,0
125278,time,1,0
125279,of,1,0
125280,noisy,1,1
125281,motion,1,0
125282,stimuli,1,1
125283,",",1,0
125284,and,1,0
125285,by,1,0
125286,forcing,1,0
125287,human,1,0
125288,observers,1,0
125289,to,1,0
125290,make,1,0
125291,difficult,1,0
125292,speeded,1,0
125293,decisions,1,0
125294,--,1,0
125295,sometimes,1,0
125296,a,1,0
125297,blind,1,0
125298,guess,1,0
125299,--,1,0
125300,about,1,0
125301,stimulus,1,0
125302,direction,1,0
125303,",",0,0
125304,we,0,0
125305,traced,0,0
125306,the,0,0
125307,temporal,0,0
125308,buildup,0,0
125309,of,0,0
125310,motion,0,0
125311,discrimination,0,0
125312,capability,0,0
125313,and,0,0
125314,perceptual,0,1
125315,awareness,0,0
125316,",",0,0
125317,as,0,0
125318,assessed,0,0
125319,trial,0,0
125320,by,0,0
125321,trial,0,0
125322,through,0,0
125323,direct,0,0
125324,rating,0,0
125325,.,0,0
125326,We,0,0
125327,found,0,0
125328,that,0,0
125329,both,0,0
125330,increased,0,0
125331,gradually,0,0
125332,with,0,0
125333,motion,0,0
125334,coherence,0,0
125335,and,0,0
125336,viewing,0,1
125337,time,0,0
125338,",",0,0
125339,but,0,0
125340,discrimination,0,0
125341,was,0,0
125342,systematically,0,0
125343,leading,0,0
125344,awareness,0,0
125345,",",0,0
125346,reaching,0,0
125347,a,0,0
125348,plateau,0,0
125349,much,0,0
125350,earlier,0,0
125351,.,0,0
125352,Sensitivity,0,0
125353,and,0,0
125354,criterion,0,0
125355,changes,0,0
125356,contributed,0,0
125357,jointly,0,0
125358,to,0,0
125359,the,0,0
125360,slow,0,0
125361,buildup,0,0
125362,of,0,0
125363,perceptual,0,1
125364,awareness,0,0
125365,.,0,0
125366,It,0,0
125367,made,0,0
125368,no,0,0
125369,difference,0,0
125370,whether,0,0
125371,motion,0,0
125372,discrimination,0,0
125373,was,0,0
125374,accomplished,0,0
125375,by,0,0
125376,saccades,0,0
125377,or,0,0
125378,verbal,0,0
125379,responses,0,0
125380,.,0,0
125381,These,0,0
125382,findings,0,0
125383,suggest,0,0
125384,that,0,0
125385,perceptual,0,1
125386,awareness,0,0
125387,emerges,0,0
125388,on,0,0
125389,the,0,0
125390,top,0,0
125391,of,0,0
125392,a,0,0
125393,developing,0,0
125394,or,0,0
125395,even,0,0
125396,mature,0,0
125397,perceptual,0,1
125398,decision,0,0
125399,.,0,0
125400,We,0,0
125401,argue,0,0
125402,that,0,0
125403,the,0,0
125404,middle,0,0
125405,temporal,0,0
125406,(,0,0
125407,MT,0,1
125408,),0,0
125409,cortical,0,0
125410,region,0,0
125411,does,0,0
125412,not,0,0
125413,confer,0,0
125414,us,0,0
125415,the,0,0
125416,full,0,0
125417,phenomenic,0,0
125418,depth,0,0
125419,of,0,0
125420,motion,0,0
125421,perception,0,0
125422,",",0,0
125423,although,0,0
125424,it,0,0
125425,may,0,0
125426,represent,0,0
125427,a,0,0
125428,precursor,0,0
125429,stage,0,0
125430,in,0,0
125431,building,0,0
125432,our,0,0
125433,subjective,0,0
125434,sense,0,0
125435,of,0,0
125436,visual,0,0
125437,motion,0,0
125438,.,0,0
125439,Role,0,0
125440,of,0,0
125441,oxidized,1,1
125442,regenerated,1,0
125443,cellulose,1,1
125444,in,0,0
125445,preventing,0,0
125446,infections,0,0
125447,at,0,0
125448,the,0,0
125449,surgical,0,0
125450,site,0,0
125451,:,0,0
125452,prospective,0,0
125453,",",0,0
125454,randomized,0,0
125455,study,0,0
125456,in,0,0
125457,98,0,0
125458,patients,0,0
125459,affected,0,0
125460,by,0,0
125461,a,0,0
125462,dirty,0,0
125463,wound,0,0
125464,.,0,0
125465,AIM,0,0
125466,The,0,0
125467,aim,0,0
125468,of,0,0
125469,this,0,0
125470,study,0,0
125471,was,0,0
125472,to,0,0
125473,evaluate,0,0
125474,whether,0,0
125475,oxidized,1,1
125476,regenerated,1,1
125477,cellulose,1,1
125478,(,1,0
125479,ORC,1,0
125480,),1,0
125481,",",0,0
125482,applied,0,0
125483,to,0,0
125484,dirty,0,0
125485,surgical,0,0
125486,wounds,0,0
125487,",",0,0
125488,is,0,0
125489,able,0,0
125490,to,0,0
125491,reduce,0,0
125492,the,0,0
125493,microbial,0,0
125494,load,0,0
125495,and,0,0
125496,",",0,0
125497,consequently,0,0
125498,",",0,0
125499,the,0,0
125500,infection,0,0
125501,rate,0,0
125502,as,0,0
125503,compared,0,0
125504,to,0,0
125505,conventional,0,1
125506,local,0,1
125507,wound,0,0
125508,treatment,0,0
125509,.,0,0
125510,METHODS,0,0
125511,The,0,0
125512,study,0,0
125513,included,0,0
125514,98,0,0
125515,patients,0,0
125516,who,0,0
125517,underwent,0,0
125518,intestinal,0,0
125519,recanalization,0,0
125520,procedures,0,0
125521,between,0,0
125522,December,0,0
125523,2003,0,0
125524,and,0,0
125525,December,0,0
125526,2008,0,0
125527,",",0,0
125528,with,0,0
125529,the,0,0
125530,stoma,0,1
125531,as,0,0
125532,the,0,0
125533,surgical,0,0
125534,site,0,0
125535,.,0,0
125536,Authors,0,0
125537,considered,0,0
125538,several,0,0
125539,risk,0,0
125540,factors,0,0
125541,for,0,0
125542,SSI,0,0
125543,.,0,0
125544,The,0,0
125545,patients,0,0
125546,were,0,0
125547,divided,0,0
125548,into,0,0
125549,two,0,0
125550,groups,0,0
125551,.,0,0
125552,In,0,0
125553,group,0,0
125554,A,0,0
125555,(,0,0
125556,50,0,0
125557,patients,0,0
125558,),0,0
125559,",",0,0
125560,the,0,0
125561,surgical,0,0
125562,wound,0,0
125563,",",0,0
125564,previous,0,0
125565,site,0,0
125566,of,0,0
125567,the,0,0
125568,stoma,0,1
125569,",",0,0
125570,was,0,0
125571,packed,1,0
125572,with,1,0
125573,ORC,1,0
125574,",",0,0
125575,whereas,0,0
125576,in,0,0
125577,group,0,0
125578,B,0,0
125579,(,0,0
125580,48,0,0
125581,patients,0,0
125582,),0,0
125583,gauze,1,1
125584,soaked,1,1
125585,in,1,0
125586,iodine,1,1
125587,was,0,0
125588,used,0,0
125589,.,0,0
125590,Microbial,0,0
125591,contamination,0,0
125592,was,0,0
125593,evaluated,0,0
125594,with,0,0
125595,three,0,0
125596,swabs,0,0
125597,(,0,0
125598,in,0,0
125599,subcutaneous,0,1
125600,tissue,0,0
125601,and,0,0
125602,the,0,0
125603,dermis,0,0
125604,),0,0
125605,",",0,0
125606,in,0,0
125607,the,0,0
125608,operating,0,0
125609,room,0,0
125610,before,0,0
125611,wound,0,0
125612,packing,0,1
125613,and,0,0
125614,on,0,0
125615,the,0,0
125616,2nd,0,0
125617,and,0,0
125618,3rd,0,0
125619,postoperative,0,0
125620,day,0,0
125621,(,0,0
125622,before,0,0
125623,suturing,0,1
125624,the,0,0
125625,skin,0,0
125626,),0,0
125627,.,0,0
125628,RESULTS,0,0
125629,There,0,0
125630,were,0,0
125631,no,0,0
125632,cases,0,0
125633,of,0,0
125634,wound,0,0
125635,dehiscence,0,0
125636,and,0,0
125637,no,0,0
125638,clinically,0,0
125639,evident,0,0
125640,superficial,0,0
125641,or,0,1
125642,deep,0,1
125643,surgical,0,1
125644,site,0,0
125645,infections,0,0
125646,in,0,0
125647,either,0,0
125648,group,0,0
125649,.,0,0
125650,Analysis,0,0
125651,of,0,0
125652,all,0,0
125653,data,0,0
125654,revealed,0,0
125655,that,0,0
125656,there,0,0
125657,was,0,0
125658,no,0,0
125659,or,0,0
125660,reduced,0,0
125661,bacterial,0,0
125662,contamination,0,0
125663,in,0,0
125664,the,0,0
125665,second,0,0
125666,and,0,0
125667,third,0,0
125668,swab,0,0
125669,in,0,0
125670,33,0,0
125671,patients,0,0
125672,(,0,0
125673,66,0,0
125674,%,0,0
125675,),0,0
125676,of,0,0
125677,Group,0,0
125678,A,0,0
125679,versus,0,0
125680,12,0,0
125681,patients,0,0
125682,(,0,0
125683,25,0,0
125684,%,0,0
125685,),0,0
125686,of,0,0
125687,Group,0,0
125688,B,0,0
125689,.,0,0
125690,CONCLUSION,0,0
125691,Although,0,0
125692,it,0,0
125693,is,0,0
125694,necessary,0,0
125695,to,0,0
125696,consider,0,0
125697,all,0,0
125698,factors,0,0
125699,which,0,0
125700,can,0,0
125701,have,0,0
125702,an,0,0
125703,influence,0,0
125704,on,0,0
125705,SSI,0,1
125706,and,0,0
125707,use,0,0
125708,all,0,0
125709,the,0,0
125710,means,0,0
125711,shown,0,0
125712,to,0,0
125713,be,0,0
125714,effective,0,0
125715,to,0,0
125716,reduce,0,0
125717,the,0,0
125718,risk,0,0
125719,of,0,0
125720,SSI,0,0
125721,",",0,0
125722,there,0,0
125723,is,0,0
125724,a,0,0
125725,rationale,0,0
125726,for,0,0
125727,using,0,0
125728,ORC,1,0
125729,to,0,0
125730,prevent,0,0
125731,this,0,0
125732,kind,0,0
125733,of,0,0
125734,infection,0,0
125735,",",0,0
125736,especially,0,0
125737,in,0,0
125738,patients,0,0
125739,who,0,0
125740,undergo,0,0
125741,dirty,0,0
125742,surgery,0,0
125743,.,0,0
125744,Correlation,0,0
125745,of,0,0
125746,adenosinergic,0,0
125747,activity,0,0
125748,with,0,0
125749,superior,0,0
125750,efficacy,0,0
125751,of,0,0
125752,clozapine,1,1
125753,for,0,0
125754,treatment,0,0
125755,of,0,0
125756,chronic,0,0
125757,schizophrenia,0,0
125758,:,0,0
125759,a,0,0
125760,double,0,0
125761,blind,0,0
125762,randomised,0,0
125763,trial,0,0
125764,.,0,0
125765,OBJECTIVE,0,0
125766,It,0,0
125767,has,0,0
125768,been,0,0
125769,proposed,0,0
125770,that,0,0
125771,a,0,0
125772,deficit,0,0
125773,of,0,0
125774,adenosinergic,0,0
125775,activity,0,0
125776,could,0,0
125777,contribute,0,0
125778,to,0,0
125779,the,0,0
125780,pathophysiology,0,0
125781,of,0,0
125782,schizophrenia,0,0
125783,.,0,0
125784,The,0,0
125785,authors,0,0
125786,undertook,0,0
125787,this,0,0
125788,study,0,0
125789,to,0,0
125790,further,0,0
125791,evaluate,0,0
125792,the,0,0
125793,level,0,0
125794,of,0,0
125795,adenosine,0,1
125796,deaminase,0,1
125797,(,0,0
125798,ADA,0,1
125799,),0,0
125800,in,0,0
125801,patients,0,0
125802,with,0,0
125803,chronic,0,0
125804,schizophrenia,0,0
125805,treated,0,0
125806,with,0,0
125807,monotherapy,1,1
125808,of,1,0
125809,haloperidol,1,1
125810,",",1,0
125811,risperidone,1,1
125812,or,1,1
125813,clozapine,1,1
125814,and,0,0
125815,correlation,0,0
125816,between,0,0
125817,the,0,0
125818,ADA,0,0
125819,level,0,0
125820,with,0,0
125821,response,0,0
125822,to,0,0
125823,treatment,0,0
125824,.,0,0
125825,METHODS,0,0
125826,The,0,0
125827,trial,0,0
125828,was,0,0
125829,a,0,0
125830,prospective,0,0
125831,",",0,0
125832,8-week,0,0
125833,",",0,0
125834,double,0,1
125835,blind,0,0
125836,study,0,0
125837,of,0,0
125838,parallel,0,0
125839,groups,0,0
125840,of,0,0
125841,patients,0,0
125842,with,0,0
125843,chronic,0,0
125844,schizophrenia,0,0
125845,.,0,0
125846,Eligible,0,0
125847,participants,0,0
125848,in,0,0
125849,the,0,0
125850,study,0,0
125851,were,0,0
125852,51,0,0
125853,patients,0,0
125854,with,0,0
125855,chronic,0,0
125856,schizophrenia,0,0
125857,with,0,0
125858,ages,0,0
125859,ranging,0,0
125860,from,0,0
125861,20,0,0
125862,to,0,0
125863,45,0,0
125864,years,0,0
125865,.,0,0
125866,All,0,0
125867,participants,0,0
125868,were,0,0
125869,inpatients,0,0
125870,",",0,0
125871,in,0,0
125872,the,0,0
125873,active,0,0
125874,phase,0,0
125875,of,0,0
125876,illness,0,0
125877,",",0,0
125878,and,0,0
125879,met,0,0
125880,DSM-IV-TR,0,0
125881,criteria,0,0
125882,for,0,0
125883,schizophrenia,0,0
125884,.,0,0
125885,Patients,0,0
125886,were,0,0
125887,randomly,0,0
125888,allocated,0,0
125889,(,0,0
125890,17,0,0
125891,patients,0,0
125892,in,0,0
125893,each,0,0
125894,group,0,0
125895,),0,0
125896,to,0,0
125897,risperidone,1,1
125898,(,0,0
125899,6,0,0
125900,mg/day,0,1
125901,),0,0
125902,or,0,0
125903,haloperidol,1,1
125904,15,0,0
125905,mg/day,0,0
125906,or,0,1
125907,clozapine,1,1
125908,(,0,0
125909,300,0,1
125910,mg/day,0,0
125911,),0,0
125912,.,0,0
125913,Serum,0,0
125914,ADA,0,0
125915,activity,0,0
125916,was,0,0
125917,measured,0,0
125918,at,0,0
125919,baseline,0,0
125920,and,0,0
125921,week,0,0
125922,8,0,0
125923,.,0,0
125924,RESULTS,0,0
125925,The,0,0
125926,plasma,0,0
125927,levels,0,0
125928,of,0,0
125929,ADA,0,0
125930,in,0,0
125931,patients,0,0
125932,with,0,0
125933,chronic,0,0
125934,schizophrenia,0,0
125935,who,0,0
125936,received,0,0
125937,clozapine,1,1
125938,were,0,0
125939,significantly,0,0
125940,higher,0,0
125941,than,0,0
125942,patients,0,0
125943,who,0,0
125944,received,0,0
125945,haloperidol,0,1
125946,.,0,0
125947,In,0,0
125948,addition,0,0
125949,",",0,0
125950,response,0,0
125951,to,0,0
125952,treatment,0,0
125953,was,0,0
125954,positively,0,0
125955,correlated,0,0
125956,with,0,0
125957,plasma,0,0
125958,levels,0,0
125959,of,0,0
125960,ADA,0,0
125961,only,0,0
125962,in,0,0
125963,the,0,0
125964,clozapine,1,1
125965,group,0,0
125966,(,0,0
125967,r,0,0
125968,=,0,0
125969,0.46,0,0
125970,and,0,0
125971,p,0,0
125972,=,0,0
125973,0.04,0,0
125974,),0,0
125975,.,0,0
125976,CONCLUSION,0,0
125977,The,0,0
125978,results,0,0
125979,indicate,0,0
125980,an,0,0
125981,increased,0,0
125982,activity,0,0
125983,of,0,0
125984,the,0,0
125985,enzyme,0,0
125986,ADA,0,0
125987,in,0,0
125988,the,0,0
125989,serum,0,0
125990,of,0,0
125991,schizophrenic,0,0
125992,patients,0,0
125993,being,0,0
125994,treated,0,0
125995,with,1,0
125996,clozapine,1,1
125997,and,1,0
125998,this,1,0
125999,increase,0,0
126000,may,0,0
126001,be,0,0
126002,correlated,1,0
126003,with,1,0
126004,clozapine,1,1
126005,'s,1,0
126006,superior,1,0
126007,antipsychotic,0,0
126008,efficacy,0,0
126009,.,0,0
126010,Efficacy,0,0
126011,and,0,0
126012,safety,0,0
126013,of,0,0
126014,transient,1,0
126015,ulnar,1,1
126016,artery,1,0
126017,compression,1,1
126018,to,0,0
126019,recanalize,0,0
126020,acute,0,0
126021,radial,0,1
126022,artery,0,0
126023,occlusion,0,0
126024,after,0,0
126025,transradial,0,1
126026,catheterization,0,0
126027,.,0,0
126028,Radial,0,0
126029,artery,0,0
126030,occlusion,0,0
126031,(,0,0
126032,RAO,0,1
126033,),0,0
126034,can,0,0
126035,result,0,0
126036,from,0,0
126037,transradial,0,1
126038,catheterization,0,0
126039,.,0,0
126040,We,0,0
126041,compared,0,0
126042,the,0,0
126043,incidence,0,0
126044,of,0,0
126045,RAO,0,0
126046,with,0,0
126047,2,0,0
126048,heparin,0,1
126049,dosage,0,0
126050,regimens,0,0
126051,after,0,0
126052,transradial,0,1
126053,coronary,0,0
126054,angiography,0,1
126055,",",0,0
126056,and,0,0
126057,we,0,0
126058,evaluated,0,0
126059,the,0,0
126060,efficacy,0,0
126061,and,0,0
126062,safety,0,0
126063,of,0,0
126064,transient,0,0
126065,homolateral,0,0
126066,ulnar,0,1
126067,artery,0,0
126068,compression,0,1
126069,to,0,0
126070,achieve,0,0
126071,acute,0,0
126072,radial,0,1
126073,artery,0,0
126074,recanalization,0,0
126075,.,0,0
126076,Patients,0,0
126077,referred,0,0
126078,for,0,0
126079,coronary,0,0
126080,angiography,0,1
126081,were,0,0
126082,randomized,0,0
126083,to,0,0
126084,very-low-dose,1,1
126085,heparin,1,1
126086,(,0,0
126087,"2,000",0,0
126088,IU,0,1
126089,),0,0
126090,or,0,1
126091,low-dose,1,1
126092,heparin,1,1
126093,(,0,0
126094,"5,000",0,1
126095,IU,0,1
126096,),0,0
126097,.,0,0
126098,On,0,0
126099,sheath,0,0
126100,removal,0,0
126101,",",0,0
126102,hemostasis,0,0
126103,was,0,0
126104,obtained,0,0
126105,using,0,0
126106,the,0,0
126107,TR,0,0
126108,band,0,0
126109,with,0,0
126110,a,0,0
126111,plethysmography-guided,0,1
126112,patent,0,0
126113,hemostasis,0,0
126114,technique,0,1
126115,.,0,0
126116,In,0,0
126117,the,0,0
126118,case,0,0
126119,of,0,0
126120,RAO,0,0
126121,as,0,0
126122,assessed,0,0
126123,by,0,0
126124,duplex,0,1
126125,ultrasonography,0,1
126126,3,0,0
126127,to,0,0
126128,4,0,0
126129,hours,0,0
126130,after,0,0
126131,hemostasis,0,0
126132,",",0,0
126133,immediate,0,0
126134,1-hour,0,1
126135,ulnar,0,1
126136,artery,0,0
126137,compression,0,1
126138,was,0,0
126139,applied,0,0
126140,.,0,0
126141,Hematomas,0,0
126142,>,0,0
126143,15,0,0
126144,cm,0,0
126145,(,0,0
126146,2,0,0
126147,),0,0
126148,were,0,0
126149,also,0,0
126150,assessed,0,0
126151,.,0,0
126152,We,0,0
126153,randomized,0,0
126154,465,0,0
126155,patients,0,0
126156,",",0,0
126157,222,0,0
126158,in,0,0
126159,the,0,0
126160,"2,000-IU",0,1
126161,group,0,0
126162,and,0,0
126163,243,0,0
126164,in,0,0
126165,the,0,0
126166,"5,000-IU",0,0
126167,group,0,0
126168,.,0,0
126169,The,0,0
126170,baseline,0,0
126171,and,0,0
126172,procedural,0,0
126173,characteristics,0,0
126174,were,0,0
126175,comparable,0,0
126176,in,0,0
126177,both,0,0
126178,groups,0,0
126179,.,0,0
126180,The,0,0
126181,incidence,0,0
126182,of,0,0
126183,initial,0,0
126184,RAO,0,1
126185,was,0,0
126186,5.9,0,0
126187,%,0,0
126188,in,0,0
126189,the,0,0
126190,"2,000-IU",0,1
126191,group,0,0
126192,and,0,0
126193,2.9,0,0
126194,%,0,0
126195,in,0,0
126196,the,0,0
126197,"5,000-IU",0,1
126198,group,0,0
126199,(,0,0
126200,p,0,0
126201,=,0,0
126202,0.17,0,0
126203,),0,0
126204,",",0,0
126205,with,0,0
126206,a,0,0
126207,compression,0,1
126208,time,0,0
126209,of,0,0
126210,2.10,0,0
126211,?,0,0
126212,0.78,0,0
126213,hours,0,0
126214,and,0,0
126215,2.25,0,0
126216,?,0,0
126217,0.82,0,0
126218,hours,0,0
126219,",",0,0
126220,respectively,0,0
126221,(,0,0
126222,p,0,0
126223,=,0,0
126224,0.051,0,0
126225,),0,0
126226,.,0,0
126227,After,1,0
126228,ulnar,1,0
126229,artery,1,0
126230,compression,1,1
126231,",",1,0
126232,the,0,0
126233,final,0,0
126234,incidence,0,0
126235,of,0,0
126236,RAO,0,0
126237,was,0,0
126238,4.1,0,0
126239,%,0,0
126240,in,0,0
126241,the,0,0
126242,"2,000-IU",0,1
126243,group,0,0
126244,and,0,0
126245,0.8,0,0
126246,%,0,0
126247,in,0,0
126248,the,0,0
126249,"5,000-IU",0,1
126250,group,0,0
126251,(,0,0
126252,p,0,0
126253,=,0,0
126254,0.03,0,0
126255,),0,0
126256,.,0,0
126257,The,0,0
126258,incidence,0,0
126259,of,0,0
126260,local,0,0
126261,hematoma,0,0
126262,was,0,0
126263,2.3,0,0
126264,%,0,0
126265,and,0,0
126266,3.7,0,0
126267,%,0,0
126268,in,0,0
126269,the,0,0
126270,"2,000-",0,0
126271,and,0,0
126272,"5,000-IU",0,1
126273,groups,0,0
126274,",",0,0
126275,respectively,0,0
126276,(,0,0
126277,p,0,0
126278,=,0,0
126279,0.42,0,0
126280,),0,0
126281,.,0,0
126282,In,0,0
126283,conclusion,0,0
126284,",",0,0
126285,acute,0,0
126286,RAO,0,1
126287,after,0,0
126288,transradial,0,1
126289,catheterization,0,0
126290,can,0,0
126291,be,0,0
126292,recanalized,0,0
126293,by,0,0
126294,early,0,0
126295,1-hour,1,0
126296,homolateral,1,0
126297,ulnar,1,1
126298,artery,1,0
126299,compression,1,1
126300,.,1,0
126301,This,0,0
126302,simple,0,0
126303,nonpharmacologic,0,1
126304,method,0,0
126305,was,0,0
126306,effective,0,0
126307,and,0,0
126308,safe,0,0
126309,in,0,0
126310,patients,0,0
126311,with,0,0
126312,very-low-,0,1
126313,and,0,0
126314,low-dose,0,1
126315,heparin,0,1
126316,.,0,0
126317,Nevertheless,0,0
126318,",",0,0
126319,the,0,0
126320,incidence,0,0
126321,of,0,0
126322,final,0,0
126323,RAO,0,1
126324,remained,0,0
126325,significantly,0,0
126326,lower,0,0
126327,after,0,0
126328,a,0,0
126329,higher,0,0
126330,anticoagulation,0,0
126331,level,0,0
126332,.,0,0
126333,A,0,0
126334,double-blind,0,0
126335,",",0,0
126336,placebo-controlled,1,1
126337,trial,0,0
126338,of,0,0
126339,intravenous,1,1
126340,immunoglobulin,1,1
126341,therapy,1,1
126342,in,0,0
126343,patients,0,0
126344,with,0,0
126345,chronic,0,0
126346,fatigue,0,0
126347,syndrome,0,0
126348,.,0,0
126349,PURPOSE,0,0
126350,The,0,0
126351,chronic,0,0
126352,fatigue,0,0
126353,syndrome,0,0
126354,(,0,0
126355,CFS,0,1
126356,),0,1
126357,is,0,0
126358,characterized,0,0
126359,by,0,0
126360,profound,0,0
126361,fatigue,0,0
126362,",",0,0
126363,neuropsychiatric,0,0
126364,dysfunction,0,0
126365,",",0,0
126366,and,0,0
126367,frequent,0,0
126368,abnormalities,0,0
126369,in,0,0
126370,cell-mediated,0,0
126371,immunity,0,0
126372,.,0,0
126373,No,0,0
126374,effective,0,0
126375,therapy,0,1
126376,is,0,0
126377,known,0,0
126378,.,0,0
126379,PATIENTS,0,0
126380,AND,0,0
126381,METHODS,0,0
126382,Forty-nine,0,0
126383,patients,0,0
126384,(,0,0
126385,40,0,0
126386,with,0,0
126387,abnormal,0,0
126388,cell-mediated,0,0
126389,immunity,0,0
126390,),0,0
126391,participated,0,0
126392,in,0,0
126393,a,0,0
126394,randomized,0,0
126395,",",0,0
126396,double-blind,0,0
126397,",",0,0
126398,placebo-controlled,1,1
126399,trial,0,0
126400,to,0,0
126401,determine,0,0
126402,the,0,0
126403,effectiveness,0,0
126404,of,0,0
126405,high-dose,0,1
126406,intravenously,1,1
126407,administered,1,0
126408,immunoglobulin,1,1
126409,G.,1,1
126410,The,0,0
126411,patients,0,0
126412,received,0,0
126413,three,0,0
126414,intravenous,0,0
126415,infusions,0,0
126416,of,0,0
126417,a,0,0
126418,placebo,1,1
126419,solution,1,1
126420,or,1,1
126421,immunoglobulin,1,1
126422,at,0,0
126423,a,0,0
126424,dose,0,0
126425,of,0,0
126426,2,0,0
126427,g/kg/month,0,0
126428,.,0,0
126429,Assessment,0,0
126430,of,0,0
126431,the,0,0
126432,severity,0,0
126433,of,0,0
126434,symptoms,0,0
126435,and,0,0
126436,associated,0,0
126437,disability,0,0
126438,",",0,0
126439,both,0,0
126440,before,0,0
126441,and,0,0
126442,after,0,0
126443,treatment,0,0
126444,",",0,0
126445,was,0,0
126446,completed,0,0
126447,at,0,0
126448,detailed,0,0
126449,interviews,0,0
126450,by,0,0
126451,a,0,0
126452,physician,0,0
126453,and,0,0
126454,psychiatrist,0,0
126455,",",0,0
126456,who,0,0
126457,were,0,0
126458,unaware,0,0
126459,of,0,0
126460,the,0,0
126461,treatment,0,0
126462,status,0,0
126463,.,0,0
126464,In,0,0
126465,addition,0,0
126466,",",0,0
126467,any,0,0
126468,change,0,0
126469,in,0,0
126470,physical,0,0
126471,symptoms,0,0
126472,and,0,0
126473,functional,0,0
126474,capacity,0,0
126475,was,0,0
126476,recorded,0,0
126477,using,0,0
126478,visual,0,0
126479,analogue,0,0
126480,scales,0,0
126481,",",0,0
126482,while,0,0
126483,changes,0,0
126484,in,0,0
126485,psychologic,0,0
126486,morbidity,0,0
126487,were,0,0
126488,assessed,0,0
126489,using,0,0
126490,patient-rated,0,0
126491,indices,0,0
126492,of,0,0
126493,depression,0,0
126494,.,0,0
126495,Cell-mediated,0,0
126496,immunity,0,0
126497,was,0,0
126498,evaluated,0,0
126499,by,0,0
126500,T-cell,0,0
126501,subset,0,0
126502,analysis,0,0
126503,",",0,0
126504,delayed-type,0,0
126505,hypersensitivity,0,0
126506,skin,0,0
126507,testing,0,0
126508,",",0,0
126509,and,0,0
126510,lymphocyte,0,0
126511,transformation,0,0
126512,with,0,0
126513,phytohemagglutinin,0,1
126514,.,0,0
126515,RESULTS,0,0
126516,At,0,0
126517,the,0,0
126518,interview,0,0
126519,conducted,0,0
126520,by,0,0
126521,the,0,0
126522,physician,0,0
126523,3,0,0
126524,months,0,0
126525,after,0,0
126526,the,0,0
126527,final,0,0
126528,infusion,0,1
126529,",",0,0
126530,10,0,0
126531,of,0,0
126532,23,0,0
126533,(,0,0
126534,43,0,0
126535,%,0,0
126536,),0,0
126537,immunoglobulin,0,1
126538,recipients,0,0
126539,and,0,0
126540,three,0,0
126541,of,0,0
126542,the,0,0
126543,26,0,0
126544,(,0,0
126545,12,0,0
126546,%,0,0
126547,),0,0
126548,placebo,0,1
126549,recipients,0,0
126550,were,0,0
126551,assessed,0,0
126552,as,0,0
126553,having,0,0
126554,responded,0,0
126555,with,0,0
126556,a,0,0
126557,substantial,0,0
126558,reduction,0,0
126559,in,0,0
126560,their,0,0
126561,symptoms,0,0
126562,and,0,0
126563,recommencement,0,0
126564,of,0,0
126565,work,0,0
126566,",",0,0
126567,leisure,0,0
126568,",",0,0
126569,and,0,0
126570,social,0,0
126571,activities,0,0
126572,.,0,0
126573,The,0,0
126574,patients,0,0
126575,designated,0,0
126576,as,0,0
126577,having,0,0
126578,responded,0,0
126579,had,0,0
126580,improvement,0,0
126581,in,0,0
126582,physical,0,0
126583,",",0,0
126584,psychologic,0,0
126585,",",0,0
126586,and,0,0
126587,immunologic,0,0
126588,measures,0,0
126589,(,0,0
126590,p,0,0
126591,less,0,0
126592,than,0,0
126593,0.01,0,0
126594,for,0,0
126595,each,0,0
126596,),0,0
126597,.,0,0
126598,CONCLUSION,0,0
126599,Immunomodulatory,1,0
126600,treatment,1,0
126601,with,0,0
126602,immunoglobulin,1,1
126603,is,0,0
126604,effective,0,0
126605,in,0,0
126606,a,0,0
126607,significant,0,0
126608,number,0,0
126609,of,0,0
126610,patients,0,0
126611,with,0,0
126612,CFS,0,0
126613,",",0,0
126614,a,0,0
126615,finding,0,0
126616,that,0,0
126617,supports,0,0
126618,the,0,0
126619,concept,0,0
126620,that,0,0
126621,an,0,0
126622,immunologic,0,0
126623,disturbance,0,0
126624,may,0,0
126625,be,0,0
126626,important,0,0
126627,in,0,0
126628,the,0,0
126629,pathogenesis,0,0
126630,of,0,0
126631,this,0,0
126632,disorder,0,0
126633,.,0,0
126634,A,0,0
126635,randomized,0,0
126636,study,0,0
126637,on,0,0
126638,hormone-resistant,0,0
126639,prostatic,0,0
126640,cancer,0,0
126641,:,0,0
126642,estramustine,1,1
126643,phosphate,1,1
126644,versus,0,0
126645,low,1,0
126646,dose,1,0
126647,epirubicin,1,1
126648,with,1,0
126649,or,1,0
126650,without,1,0
126651,medroxyprogesterone,1,1
126652,acetate,1,1
126653,.,1,0
126654,A,0,0
126655,Norwegian,0,0
126656,multicenter,0,0
126657,study,0,0
126658,.,0,0
126659,A,0,0
126660,prospective,0,0
126661,randomized,0,0
126662,study,0,0
126663,has,0,0
126664,been,0,0
126665,carried,0,0
126666,out,0,0
126667,in,0,0
126668,order,0,0
126669,to,0,0
126670,compare,0,0
126671,three,0,0
126672,different,0,0
126673,treatment,0,0
126674,modalities,0,0
126675,for,0,0
126676,symptomatic,0,0
126677,metastatic,0,0
126678,hormone-resistant,0,1
126679,prostatic,0,0
126680,cancer,0,0
126681,.,0,0
126682,A,0,0
126683,total,0,0
126684,of,0,0
126685,79,0,0
126686,patients,0,0
126687,were,0,0
126688,included,0,0
126689,.,0,0
126690,One,0,0
126691,group,0,0
126692,was,0,0
126693,treated,1,0
126694,with,1,0
126695,estramustine,1,1
126696,phosphate,1,1
126697,",",1,0
126698,another,1,0
126699,with,1,0
126700,Epirubicin,1,1
126701,plus,1,1
126702,Medroxyprogesterone,1,1
126703,acetate,1,1
126704,(,1,0
126705,MPA,1,1
126706,),1,0
126707,",",1,0
126708,while,1,0
126709,the,1,0
126710,third,1,0
126711,arm,1,0
126712,consisted,1,0
126713,of,1,0
126714,Epirubicin,1,1
126715,plus,1,1
126716,placebo,1,1
126717,.,1,0
126718,Best,0,0
126719,palliation,0,0
126720,was,0,0
126721,obtained,0,0
126722,by,0,0
126723,the,0,0
126724,combination,0,0
126725,of,0,0
126726,Epirubicin,1,1
126727,and,1,0
126728,MPA,1,1
126729,.,1,0
126730,This,0,0
126731,combination,0,0
126732,also,0,0
126733,seemed,0,0
126734,to,0,0
126735,be,0,0
126736,associated,0,0
126737,with,0,0
126738,the,0,0
126739,longest,0,0
126740,response,0,0
126741,duration,0,0
126742,.,0,0
126743,A,0,0
126744,randomized,0,0
126745,placebo-controlled,1,1
126746,prevention,0,0
126747,trial,0,0
126748,of,0,0
126749,aspirin,1,1
126750,and/or,1,0
126751,resistant,1,0
126752,starch,1,1
126753,in,0,0
126754,young,0,0
126755,people,0,0
126756,with,0,0
126757,familial,0,0
126758,adenomatous,0,0
126759,polyposis,0,0
126760,.,0,0
126761,Evidence,0,0
126762,supporting,0,0
126763,aspirin,1,1
126764,and,1,0
126765,resistant,1,0
126766,starch,1,1
126767,(,1,0
126768,RS,1,1
126769,),1,0
126770,for,0,0
126771,colorectal,0,0
126772,cancer,0,0
126773,prevention,0,0
126774,comes,0,0
126775,from,0,0
126776,epidemiologic,0,0
126777,and,0,0
126778,laboratory,0,0
126779,studies,0,0
126780,(,1,0
126781,aspirin,1,1
126782,and,1,0
126783,RS,1,1
126784,),1,0
126785,and,0,0
126786,randomized,0,0
126787,controlled,0,0
126788,clinical,0,0
126789,trials,0,0
126790,(,1,0
126791,aspirin,1,1
126792,),1,0
126793,.,0,0
126794,Familial,0,0
126795,adenomatous,0,0
126796,polyposis,0,0
126797,(,0,0
126798,FAP,0,0
126799,),0,1
126800,strikes,0,0
126801,young,0,0
126802,people,0,0
126803,and,0,0
126804,",",0,0
126805,untreated,0,0
126806,",",0,0
126807,confers,0,0
126808,virtually,0,0
126809,a,0,0
126810,100,0,0
126811,%,0,0
126812,risk,0,0
126813,of,0,0
126814,colorectal,0,0
126815,cancer,0,0
126816,and,0,0
126817,early,0,0
126818,death,0,0
126819,.,0,0
126820,We,0,0
126821,conducted,0,0
126822,an,0,0
126823,international,0,0
126824,",",0,0
126825,multicenter,0,0
126826,",",0,0
126827,randomized,0,0
126828,",",0,0
126829,placebo-controlled,1,1
126830,trial,0,0
126831,of,0,0
126832,aspirin,1,1
126833,(,0,0
126834,600,0,1
126835,mg/d,0,0
126836,),0,0
126837,and/or,0,0
126838,RS,1,1
126839,(,0,0
126840,30,0,0
126841,g/d,0,1
126842,),0,0
126843,for,0,0
126844,from,0,0
126845,1,0,0
126846,to,0,0
126847,12,0,0
126848,years,0,0
126849,to,0,0
126850,prevent,0,0
126851,disease,0,0
126852,progression,0,0
126853,in,0,0
126854,FAP,0,0
126855,patients,0,0
126856,from,0,0
126857,10,0,0
126858,to,0,0
126859,21,0,0
126860,years,0,0
126861,of,0,0
126862,age,0,0
126863,.,0,0
126864,In,0,0
126865,a,0,0
126866,2,0,0
126867,?,0,0
126868,2,0,0
126869,factorial,0,0
126870,design,0,0
126871,",",0,0
126872,patients,0,0
126873,were,0,0
126874,randomly,0,0
126875,assigned,0,0
126876,to,0,0
126877,the,0,0
126878,following,0,0
126879,four,0,0
126880,study,0,0
126881,arms,1,0
126882,:,1,0
126883,aspirin,1,1
126884,plus,1,1
126885,RS,1,1
126886,placebo,1,1
126887,;,1,0
126888,RS,1,1
126889,plus,1,1
126890,aspirin,1,1
126891,placebo,1,1
126892,;,1,0
126893,aspirin,1,1
126894,plus,1,1
126895,RS,1,1
126896,;,1,0
126897,RS,1,1
126898,placebo,1,1
126899,plus,1,1
126900,aspirin,1,1
126901,placebo,1,1
126902,;,1,0
126903,they,0,0
126904,were,0,0
126905,followed,0,0
126906,with,0,0
126907,standard,0,1
126908,annual,0,0
126909,clinical,0,0
126910,examinations,0,1
126911,including,0,0
126912,endoscopy,0,0
126913,.,0,0
126914,The,0,0
126915,primary,0,0
126916,endpoint,0,0
126917,was,0,0
126918,polyp,0,0
126919,number,0,0
126920,in,0,0
126921,the,0,0
126922,rectum,0,0
126923,and,0,0
126924,sigmoid,0,0
126925,colon,0,0
126926,(,0,0
126927,at,0,0
126928,the,0,0
126929,end,0,0
126930,of,0,0
126931,intervention,0,1
126932,),0,0
126933,",",0,0
126934,and,0,0
126935,the,0,0
126936,major,0,0
126937,secondary,0,0
126938,endpoint,0,0
126939,was,0,0
126940,size,0,0
126941,of,0,0
126942,the,0,0
126943,largest,0,0
126944,polyp,0,0
126945,.,0,0
126946,A,0,0
126947,total,0,0
126948,of,0,0
126949,206,0,0
126950,randomized,0,0
126951,FAP,0,0
126952,patients,0,0
126953,commenced,0,0
126954,intervention,0,1
126955,",",0,0
126956,of,0,0
126957,whom,0,0
126958,133,0,0
126959,had,0,0
126960,at,0,0
126961,least,0,0
126962,one,0,0
126963,follow-up,0,0
126964,endoscopy,0,0
126965,and,0,0
126966,were,0,0
126967,therefore,0,0
126968,included,0,0
126969,in,0,0
126970,the,0,0
126971,primary,0,0
126972,analysis,0,0
126973,.,0,0
126974,Neither,0,0
126975,intervention,0,1
126976,significantly,0,0
126977,reduced,0,0
126978,polyp,0,0
126979,count,0,0
126980,in,0,0
126981,the,0,0
126982,rectum,0,0
126983,and,0,0
126984,sigmoid,0,0
126985,colon,0,0
126986,:,0,0
126987,aspirin,0,1
126988,relative,0,0
126989,risk,0,0
126990,=,0,0
126991,0.77,0,0
126992,(,0,0
126993,95,0,0
126994,%,0,0
126995,CI,0,0
126996,",",0,0
126997,0.54-1.10,0,0
126998,;,0,0
126999,versus,0,0
127000,nonaspirin,0,1
127001,arms,0,0
127002,),0,0
127003,;,0,0
127004,RS,0,1
127005,relative,0,0
127006,risk,0,0
127007,=,0,0
127008,1.05,0,0
127009,(,0,0
127010,95,0,0
127011,%,0,0
127012,CI,0,0
127013,",",0,0
127014,0.73-1.49,0,0
127015,;,0,0
127016,versus,0,0
127017,non-RS,0,0
127018,arms,0,0
127019,),0,0
127020,.,0,0
127021,There,0,0
127022,was,0,0
127023,a,0,0
127024,trend,0,0
127025,toward,0,0
127026,a,0,0
127027,smaller,0,0
127028,size,0,0
127029,of,0,0
127030,largest,0,0
127031,polyp,0,0
127032,in,0,0
127033,patients,0,0
127034,treated,0,0
127035,with,0,0
127036,aspirin,0,1
127037,versus,0,0
127038,nonaspirin,0,0
127039,--,0,0
127040,mean,0,0
127041,3.8,0,0
127042,mm,0,0
127043,versus,0,0
127044,5.5,0,0
127045,mm,0,0
127046,for,0,0
127047,patients,0,0
127048,treated,0,0
127049,1,0,0
127050,or,0,0
127051,more,0,0
127052,years,0,0
127053,(,0,0
127054,adjusted,0,0
127055,P,0,0
127056,=,0,0
127057,0.09,0,0
127058,),0,0
127059,and,0,0
127060,mean,0,0
127061,3.0,0,0
127062,mm,0,0
127063,versus,0,0
127064,6.0,0,0
127065,mm,0,0
127066,for,0,0
127067,patients,0,0
127068,treated,0,0
127069,more,0,0
127070,than,0,0
127071,1,0,0
127072,year,0,0
127073,(,0,0
127074,P,0,0
127075,=,0,0
127076,0.02,0,0
127077,),0,0
127078,;,0,0
127079,there,0,0
127080,were,0,0
127081,similar,0,0
127082,weaker,0,0
127083,trends,0,0
127084,with,0,0
127085,RS,0,1
127086,versus,0,0
127087,non-RS,0,0
127088,.,0,0
127089,Exploratory,0,0
127090,translational,0,0
127091,endpoints,0,0
127092,included,0,0
127093,crypt,0,0
127094,length,0,0
127095,(,0,0
127096,which,0,0
127097,was,0,0
127098,significantly,0,0
127099,shorter,0,0
127100,in,0,0
127101,normal-appearing,0,0
127102,mucosa,0,0
127103,in,0,0
127104,the,0,0
127105,RS,0,1
127106,group,0,0
127107,over,0,0
127108,time,0,0
127109,),0,0
127110,and,0,0
127111,laboratory,0,0
127112,measures,0,0
127113,of,0,0
127114,proliferation,0,0
127115,(,0,0
127116,including,0,0
127117,Ki67,0,0
127118,),0,0
127119,.,0,0
127120,This,0,0
127121,clinical,0,0
127122,trial,0,0
127123,is,0,0
127124,the,0,0
127125,largest,0,0
127126,ever,0,0
127127,conducted,0,0
127128,in,0,0
127129,the,0,0
127130,setting,0,0
127131,of,0,0
127132,FAP,0,0
127133,and,0,0
127134,found,0,0
127135,a,0,0
127136,trend,0,0
127137,of,0,0
127138,reduced,0,0
127139,polyp,0,0
127140,load,0,0
127141,(,0,0
127142,number,0,0
127143,and,0,0
127144,size,0,0
127145,),0,0
127146,with,0,0
127147,600,0,0
127148,mg,0,0
127149,of,1,0
127150,aspirin,1,1
127151,daily,0,0
127152,.,0,0
127153,RS,0,0
127154,had,0,0
127155,no,0,0
127156,clinical,0,0
127157,effect,0,0
127158,on,0,0
127159,adenomas,0,0
127160,.,0,0
127161,Comparison,0,0
127162,of,0,0
127163,the,0,0
127164,evolutional,0,0
127165,process,0,0
127166,of,0,0
127167,children,0,0
127168,with,0,0
127169,autism,0,0
127170,spectrum,0,0
127171,disorders,0,0
127172,in,0,0
127173,different,0,0
127174,language,1,0
127175,therapeutic,1,0
127176,interventions,1,0
127177,.,1,0
127178,PURPOSE,0,0
127179,To,0,0
127180,analyze,0,0
127181,and,0,0
127182,compare,0,0
127183,the,0,0
127184,extension,0,0
127185,and,0,0
127186,the,0,0
127187,speed,0,0
127188,of,0,0
127189,the,0,0
127190,evolutional,0,0
127191,process,0,0
127192,of,0,0
127193,children,0,0
127194,with,0,0
127195,Autism,0,0
127196,Spectrum,0,1
127197,Disorders,0,0
127198,in,0,0
127199,direct,1,0
127200,and,1,0
127201,indirect,1,0
127202,interventions,1,0
127203,as,0,0
127204,opposed,0,0
127205,to,0,0
127206,only,0,0
127207,indirect,0,0
127208,intervention,0,1
127209,.,0,0
127210,METHODS,0,0
127211,The,0,0
127212,design,0,0
127213,of,0,0
127214,this,0,0
127215,study,0,0
127216,is,0,0
127217,a,0,0
127218,clinical,0,0
127219,trial,0,0
127220,.,0,0
127221,The,0,0
127222,sample,0,0
127223,was,0,0
127224,composed,0,0
127225,of,0,0
127226,11,0,0
127227,children,0,0
127228,diagnosed,0,0
127229,with,0,0
127230,Autism,0,0
127231,(,0,0
127232,n=6,0,1
127233,),0,0
127234,and,0,0
127235,Asperger,0,0
127236,syndrome,0,0
127237,(,0,0
127238,n=5,0,1
127239,),0,0
127240,by,0,0
127241,a,0,0
127242,multidisciplinary,0,0
127243,team,0,0
127244,",",0,0
127245,that,0,0
127246,attended,0,0
127247,specialized,0,0
127248,speech-language,0,0
127249,pathology,0,0
127250,therapy,0,1
127251,at,0,0
127252,the,0,0
127253,institution,0,0
127254,were,0,0
127255,the,0,0
127256,study,0,0
127257,was,0,0
127258,carried,0,0
127259,out,0,0
127260,.,0,0
127261,These,0,0
127262,children,0,0
127263,were,0,0
127264,randomly,0,0
127265,divided,0,0
127266,into,0,0
127267,two,0,0
127268,groups,0,0
127269,:,0,0
127270,Therapy,1,1
127271,Group,1,0
127272,(,1,0
127273,TG,1,0
127274,),1,0
127275,-,1,0
127276,composed,1,0
127277,by,1,0
127278,six,1,0
127279,subjects,1,0
127280,receiving,1,0
127281,both,1,0
127282,direct,1,1
127283,and,1,0
127284,indirect,1,0
127285,intervention,1,1
127286,;,1,0
127287,and,1,0
127288,Orientation,1,1
127289,Group,1,0
127290,(,1,0
127291,OG,1,1
127292,),1,0
127293,-,1,0
127294,constituted,1,0
127295,by,1,0
127296,five,1,0
127297,subjects,1,0
127298,receiving,1,0
127299,exclusively,1,0
127300,indirect,1,0
127301,intervention,1,1
127302,.,1,0
127303,It,0,0
127304,was,0,0
127305,used,0,0
127306,the,0,0
127307,Autism,1,0
127308,Behavior,1,0
127309,Checklist,1,1
127310,(,1,0
127311,ABC,1,1
127312,),1,0
127313,to,1,0
127314,interview,1,0
127315,the,1,0
127316,mothers,1,0
127317,",",1,0
127318,and,1,0
127319,the,1,0
127320,Sample,1,0
127321,of,1,0
127322,Vocal,1,1
127323,Behavior,1,0
127324,(,1,0
127325,SVB,1,1
127326,),1,0
127327,",",1,0
127328,in,1,0
127329,three,1,0
127330,occasions,1,0
127331,:,1,0
127332,at,1,0
127333,the,1,0
127334,beginning,1,0
127335,of,1,0
127336,the,1,0
127337,intervention,1,1
127338,process,1,0
127339,(,1,0
127340,time,1,0
127341,0,1,0
127342,),1,0
127343,",",1,0
127344,six,1,0
127345,months,1,0
127346,later,1,0
127347,(,1,0
127348,time,1,0
127349,1,1,0
127350,),1,0
127351,and,1,0
127352,12,1,0
127353,months,1,0
127354,later,1,0
127355,(,1,0
127356,time,1,0
127357,2,1,0
127358,),1,0
127359,.,1,0
127360,RESULTS,0,0
127361,It,0,0
127362,was,0,0
127363,observed,0,0
127364,greater,0,0
127365,speed,0,0
127366,and,0,0
127367,extension,0,0
127368,in,0,0
127369,the,0,0
127370,evolutional,0,0
127371,process,0,0
127372,of,0,0
127373,the,0,0
127374,TG,0,0
127375,Group,0,0
127376,",",0,0
127377,both,0,0
127378,in,0,0
127379,the,0,0
127380,analysis,0,0
127381,of,0,0
127382,the,0,0
127383,Autism,0,0
127384,Behavior,0,0
127385,Checklist,0,1
127386,(,0,0
127387,total,0,0
127388,and,0,0
127389,partial,0,0
127390,scores,0,0
127391,),0,0
127392,and,0,0
127393,the,0,0
127394,Sample,0,0
127395,of,0,0
127396,Vocal,0,0
127397,Behavior,0,0
127398,",",0,0
127399,especially,0,0
127400,in,0,0
127401,the,0,0
127402,item,0,0
127403,Full,0,0
127404,Language,0,1
127405,.,0,0
127406,The,0,0
127407,performance,0,0
127408,of,0,0
127409,children,0,0
127410,with,0,0
127411,Asperger,0,0
127412,syndrome,0,0
127413,was,0,0
127414,considered,0,0
127415,more,0,0
127416,positive,0,0
127417,when,0,0
127418,compared,0,0
127419,to,0,0
127420,that,0,0
127421,of,0,0
127422,children,0,0
127423,with,0,0
127424,autism,0,0
127425,.,0,0
127426,There,0,0
127427,was,0,0
127428,greater,0,0
127429,evolution,0,0
127430,in,0,0
127431,younger,0,0
127432,children,0,0
127433,and,0,0
127434,with,0,0
127435,normal,0,0
127436,",",0,0
127437,mild,0,0
127438,",",0,0
127439,and,0,0
127440,moderate,0,0
127441,adaptive,0,0
127442,functioning,0,0
127443,.,0,0
127444,CONCLUSION,0,0
127445,The,0,0
127446,tendency,0,0
127447,towards,0,0
127448,better,0,0
127449,performance,0,0
127450,of,0,0
127451,the,0,0
127452,children,0,0
127453,attending,0,0
127454,direct,1,0
127455,and,1,0
127456,indirect,1,0
127457,intervention,1,1
127458,showed,0,0
127459,that,0,0
127460,this,0,0
127461,association,0,0
127462,is,0,0
127463,fundamental,0,0
127464,in,0,0
127465,the,0,0
127466,therapeutic,0,0
127467,process,0,0
127468,of,0,0
127469,children,0,0
127470,with,0,0
127471,Autism,0,0
127472,Spectrum,0,1
127473,Disorders,0,0
127474,.,0,0
127475,On,0,0
127476,the,0,0
127477,benign,0,0
127478,qualities,0,0
127479,of,0,0
127480,behavioral,1,0
127481,disinhibition,1,0
127482,:,1,0
127483,because,0,0
127484,of,0,0
127485,the,0,0
127486,prosocial,0,0
127487,nature,0,0
127488,of,0,0
127489,people,0,0
127490,",",0,0
127491,behavioral,0,0
127492,disinhibition,0,0
127493,can,0,0
127494,weaken,0,0
127495,pleasure,0,0
127496,with,0,0
127497,getting,0,0
127498,more,0,0
127499,than,0,0
127500,you,0,0
127501,deserve,0,0
127502,.,0,0
127503,This,0,0
127504,article,0,0
127505,focuses,0,0
127506,on,0,0
127507,social,0,0
127508,situations,0,0
127509,in,0,0
127510,which,0,0
127511,people,0,0
127512,are,0,0
127513,surprised,0,0
127514,about,0,0
127515,what,0,0
127516,is,0,0
127517,happening,0,0
127518,and,0,0
127519,inhibited,0,0
127520,about,0,0
127521,how,0,0
127522,to,0,0
127523,respond,0,0
127524,to,0,0
127525,the,0,0
127526,situation,0,0
127527,at,0,0
127528,hand,0,0
127529,.,0,0
127530,We,0,0
127531,study,0,0
127532,these,0,0
127533,situations,0,0
127534,by,0,0
127535,examining,0,0
127536,a,0,0
127537,classic,0,0
127538,topic,0,0
127539,in,0,0
127540,social,0,0
127541,psychology,0,0
127542,:,0,0
127543,how,0,0
127544,people,0,0
127545,respond,0,0
127546,to,0,0
127547,receiving,0,0
127548,better,0,0
127549,outcomes,0,0
127550,than,0,0
127551,are,0,0
127552,deserved,0,0
127553,.,0,0
127554,In,0,0
127555,these,0,0
127556,situations,0,0
127557,",",0,0
127558,the,0,0
127559,actions,0,0
127560,of,0,0
127561,an,0,0
127562,authority,0,0
127563,or,0,0
127564,a,0,0
127565,coworker,0,0
127566,push,0,1
127567,in,0,0
127568,the,0,0
127569,direction,0,0
127570,of,0,0
127571,accepting,0,0
127572,and,0,0
127573,enjoying,0,0
127574,the,0,0
127575,unfair,0,0
127576,outcome,0,0
127577,",",0,0
127578,whereas,0,0
127579,personal,0,1
127580,values,0,0
127581,for,0,0
127582,most,0,0
127583,people,0,0
127584,push,0,0
127585,in,0,0
127586,the,0,0
127587,direction,0,0
127588,of,0,0
127589,rejecting,0,0
127590,or,0,0
127591,being,0,0
127592,displeased,0,0
127593,with,0,0
127594,the,0,0
127595,outcome,0,0
127596,.,0,0
127597,This,0,0
127598,conflict,0,0
127599,may,0,0
127600,inhibit,0,0
127601,people,0,0
127602,'s,0,0
127603,response,0,0
127604,to,0,0
127605,the,0,0
127606,advantageous,0,0
127607,but,0,0
127608,unfair,0,0
127609,outcomes,0,0
127610,.,0,0
127611,If,0,0
127612,people,0,0
127613,are,0,0
127614,indeed,0,0
127615,inhibited,0,0
127616,about,0,0
127617,how,0,0
127618,to,0,0
127619,respond,0,0
127620,to,0,0
127621,these,0,0
127622,kinds,0,0
127623,of,0,0
127624,outcomes,0,0
127625,",",0,0
127626,then,0,0
127627,lowering,0,0
127628,behavioral,0,1
127629,inhibition,0,0
127630,by,0,0
127631,reminding,0,0
127632,people,0,0
127633,of,0,0
127634,having,0,0
127635,acted,0,0
127636,in,0,0
127637,the,0,0
127638,past,0,0
127639,without,0,0
127640,inhibitions,0,0
127641,(,0,0
127642,in,0,0
127643,a,0,0
127644,manner,0,0
127645,that,0,0
127646,is,0,0
127647,unrelated,0,0
127648,to,0,0
127649,the,0,0
127650,outcomes,0,0
127651,participants,0,0
127652,subsequently,0,0
127653,receive,0,0
127654,),0,0
127655,should,0,0
127656,affect,0,0
127657,reactions,0,0
127658,to,0,0
127659,the,0,0
127660,outcomes,0,0
127661,.,0,0
127662,Specifically,0,0
127663,",",0,0
127664,we,0,0
127665,hypothesize,0,0
127666,that,0,0
127667,because,0,0
127668,many,0,0
127669,people,0,0
127670,are,0,0
127671,prosocial,0,0
127672,and,0,0
127673,want,0,0
127674,to,0,0
127675,adhere,0,0
127676,to,0,0
127677,principles,0,0
127678,of,0,0
127679,fairness,0,0
127680,",",0,0
127681,reminders,0,1
127682,of,0,0
127683,behavioral,1,0
127684,disinhibition,1,0
127685,will,0,0
127686,lead,0,0
127687,to,0,0
127688,less,0,0
127689,pleasure,0,0
127690,with,0,0
127691,the,0,0
127692,unfairly,0,0
127693,obtained,0,0
127694,outcomes,0,0
127695,.,0,0
127696,The,0,0
127697,results,0,0
127698,of,0,0
127699,8,0,0
127700,experiments,1,0
127701,(,0,0
127702,conducted,0,0
127703,both,0,0
127704,inside,1,0
127705,and,1,0
127706,outside,1,0
127707,the,1,0
127708,psychology,1,0
127709,laboratory,1,0
127710,),1,0
127711,revealed,0,0
127712,evidence,0,0
127713,for,0,0
127714,this,0,0
127715,benign,0,0
127716,disinhibition,0,0
127717,effect,0,0
127718,on,0,0
127719,various,0,0
127720,reactions,0,0
127721,to,0,0
127722,outcomes,0,0
127723,that,0,0
127724,are,0,0
127725,better,0,0
127726,than,0,0
127727,deserved,0,0
127728,.,0,0
127729,In,0,0
127730,further,0,0
127731,accordance,0,0
127732,with,0,0
127733,our,0,0
127734,line,0,0
127735,of,0,0
127736,reasoning,0,0
127737,",",0,0
127738,the,0,0
127739,effect,0,0
127740,is,0,0
127741,particularly,0,0
127742,pronounced,0,0
127743,among,0,0
127744,those,0,0
127745,who,0,0
127746,adhere,0,0
127747,to,0,0
127748,a,0,0
127749,prosocial,0,0
127750,orientation,0,0
127751,or,0,0
127752,who,0,0
127753,have,0,0
127754,adopted,0,0
127755,a,0,0
127756,prosocial,0,0
127757,mindset,0,0
127758,and,0,0
127759,is,0,0
127760,not,0,0
127761,observed,0,0
127762,among,0,0
127763,those,0,0
127764,with,0,0
127765,proself,0,0
127766,orientations,0,0
127767,or,0,0
127768,mindsets,0,0
127769,.,0,0
127770,Impact,0,0
127771,of,0,0
127772,dronedarone,1,1
127773,on,0,0
127774,hospitalization,0,0
127775,burden,0,0
127776,in,0,0
127777,patients,0,0
127778,with,0,0
127779,atrial,0,0
127780,fibrillation,0,0
127781,:,0,0
127782,results,0,0
127783,from,0,0
127784,the,0,0
127785,ATHENA,0,1
127786,study,0,0
127787,.,0,0
127788,AIMS,0,0
127789,Cardiovascular,0,0
127790,(,0,0
127791,CV,0,1
127792,),0,0
127793,hospitalization,0,0
127794,is,0,0
127795,a,0,0
127796,predictor,0,0
127797,of,0,0
127798,CV,0,1
127799,mortality,0,0
127800,and,0,0
127801,has,0,0
127802,a,0,0
127803,negative,0,0
127804,impact,0,0
127805,on,0,0
127806,patients,0,0
127807,',0,0
127808,quality,0,0
127809,of,0,0
127810,life,0,0
127811,.,0,0
127812,The,0,0
127813,primary,0,0
127814,endpoint,0,0
127815,of,0,0
127816,A,0,0
127817,placebo-controlled,0,1
127818,",",0,0
127819,double-blind,0,0
127820,",",0,0
127821,parallel-arm,0,0
127822,Trial,0,0
127823,to,0,0
127824,assess,0,0
127825,the,0,0
127826,efficacy,0,0
127827,of,0,0
127828,dronedarone,1,1
127829,400,0,0
127830,mg,0,1
127831,bid,0,1
127832,for,0,0
127833,the,0,0
127834,prevention,0,0
127835,of,0,0
127836,cardiovascular,0,0
127837,Hospitalization,0,0
127838,or,0,1
127839,death,0,0
127840,from,0,0
127841,any,0,0
127842,cause,0,0
127843,in,0,0
127844,patiENTs,0,0
127845,with,0,0
127846,Atrial,0,0
127847,fibrillation/atrial,0,0
127848,flutter,0,1
127849,(,0,0
127850,ATHENA,0,1
127851,),0,0
127852,",",0,0
127853,a,0,0
127854,composite,0,0
127855,of,0,0
127856,first,0,0
127857,CV,0,1
127858,hospitalization,0,0
127859,or,0,1
127860,death,0,0
127861,from,0,0
127862,any,0,0
127863,cause,0,0
127864,",",0,0
127865,was,0,0
127866,significantly,0,0
127867,reduced,0,0
127868,by,0,0
127869,dronedarone,1,1
127870,.,1,0
127871,This,0,0
127872,post,0,0
127873,hoc,0,0
127874,analysis,0,0
127875,evaluated,0,0
127876,the,0,0
127877,secondary,0,0
127878,endpoint,0,0
127879,of,0,0
127880,CV,0,1
127881,hospitalization,0,0
127882,and,0,0
127883,the,0,0
127884,clinical,0,0
127885,benefit,0,0
127886,of,0,0
127887,dronedarone,1,1
127888,on,0,0
127889,the,0,0
127890,number,0,0
127891,and,0,0
127892,duration,0,0
127893,of,0,0
127894,CV,0,1
127895,hospitalizations,0,0
127896,in,0,0
127897,patients,0,0
127898,with,0,0
127899,atrial,0,0
127900,fibrillation,0,0
127901,(,0,0
127902,AF,0,0
127903,),0,0
127904,.,0,0
127905,METHODS,0,0
127906,AND,0,0
127907,RESULTS,0,0
127908,ATHENA,0,1
127909,was,0,0
127910,a,0,0
127911,double-blind,0,0
127912,",",0,0
127913,parallel,0,0
127914,group,0,0
127915,study,0,0
127916,in,0,0
127917,4628,0,0
127918,patients,0,0
127919,with,0,0
127920,a,0,0
127921,history,0,0
127922,of,0,0
127923,paroxysmal/persistent,0,0
127924,AF,0,1
127925,and,0,0
127926,additional,0,0
127927,risk,0,0
127928,factors,0,0
127929,",",0,0
127930,treated,0,0
127931,with,0,0
127932,placebo,1,1
127933,or,1,0
127934,dronedarone,1,1
127935,.,1,0
127936,Dronedarone,1,1
127937,treatment,0,0
127938,significantly,0,0
127939,reduced,0,0
127940,the,0,0
127941,risk,0,0
127942,of,0,0
127943,first,0,0
127944,CV,0,1
127945,hospitalization,0,0
127946,(,0,0
127947,P,0,0
127948,<,0,0
127949,0.0001,0,0
127950,vs.,0,0
127951,placebo,1,1
127952,),1,0
127953,",",0,0
127954,while,0,0
127955,the,0,0
127956,risk,0,0
127957,of,0,0
127958,first,0,0
127959,non-CV,0,0
127960,hospitalization,0,0
127961,was,0,0
127962,similar,0,0
127963,in,0,0
127964,both,0,0
127965,groups,0,0
127966,(,0,0
127967,P,0,0
127968,=,0,0
127969,0.77,0,0
127970,),0,0
127971,.,0,0
127972,About,0,0
127973,half,0,0
127974,of,0,0
127975,the,0,0
127976,CV,0,0
127977,hospitalizations,0,0
127978,were,0,0
127979,AF-related,0,0
127980,",",0,0
127981,with,0,0
127982,a,0,0
127983,median,0,0
127984,duration,0,0
127985,of,0,0
127986,hospital,0,0
127987,stay,0,0
127988,of,0,0
127989,four,0,0
127990,nights,0,0
127991,.,0,0
127992,The,0,0
127993,risk,0,0
127994,of,0,0
127995,any,0,0
127996,hospitalization,0,0
127997,for,0,0
127998,AF,0,1
127999,[,0,0
128000,hazard,0,0
128001,ratio,0,0
128002,(,0,0
128003,95,0,0
128004,%,0,0
128005,confidence,0,0
128006,interval,0,0
128007,),0,0
128008,0.626,0,0
128009,(,0,0
128010,0.546-0.719,0,0
128011,),0,1
128012,],0,0
128013,and,0,0
128014,duration,0,0
128015,of,0,0
128016,hospital,0,0
128017,stay,0,0
128018,were,0,0
128019,significantly,0,0
128020,reduced,0,0
128021,by,0,0
128022,dronedarone,1,1
128023,(,0,0
128024,P,0,0
128025,<,0,0
128026,0.0001,0,0
128027,vs.,0,0
128028,placebo,1,1
128029,),1,0
128030,.,0,0
128031,Dronedarone,1,1
128032,treatment,0,0
128033,reduced,0,0
128034,total,0,0
128035,hospitalizations,0,0
128036,for,0,0
128037,acute,0,0
128038,coronary,0,0
128039,syndrome,0,0
128040,(,0,0
128041,P,0,0
128042,=,0,0
128043,0.0105,0,0
128044,),0,0
128045,and,0,0
128046,the,0,0
128047,time,0,0
128048,between,0,0
128049,the,0,0
128050,first,0,0
128051,AF/atrial,0,1
128052,flutter,0,1
128053,recurrence,0,0
128054,and,0,0
128055,CV,0,1
128056,hospitalization/death,0,0
128057,(,0,0
128058,P,0,0
128059,=,0,0
128060,0.0048,0,0
128061,),0,0
128062,.,0,0
128063,Hospitalization,0,0
128064,burden,0,0
128065,was,0,0
128066,significantly,0,0
128067,reduced,0,0
128068,across,0,0
128069,all,0,0
128070,levels,0,0
128071,of,0,0
128072,care,0,1
128073,(,0,0
128074,P,0,0
128075,<,0,0
128076,0.05,0,0
128077,),0,0
128078,.,0,0
128079,Cumulative,0,0
128080,incidence,0,0
128081,data,0,0
128082,indicated,0,0
128083,that,0,0
128084,the,0,0
128085,effects,0,0
128086,of,0,0
128087,dronedarone,1,1
128088,persisted,0,0
128089,for,0,0
128090,at,0,0
128091,least,0,0
128092,24,0,0
128093,months,0,0
128094,.,0,0
128095,CONCLUSION,0,0
128096,Dronedarone,1,1
128097,reduced,0,0
128098,the,0,0
128099,risk,0,0
128100,for,0,0
128101,CV,0,1
128102,hospitalization,0,0
128103,and,0,0
128104,the,0,0
128105,total,0,0
128106,hospitalization,0,0
128107,burden,0,0
128108,in,0,0
128109,this,0,0
128110,patient,0,0
128111,group,0,0
128112,.,0,0
128113,The,0,0
128114,trial,0,0
128115,is,0,0
128116,registered,0,0
128117,under,0,0
128118,ClinicalTrials.gov,0,0
128119,#,0,0
128120,NCT,0,0
128121,00174785,0,0
128122,.,0,0
128123,Effect,0,0
128124,of,0,0
128125,a,0,0
128126,multi-faceted,1,0
128127,intervention,1,1
128128,on,0,0
128129,gingival,0,0
128130,health,0,0
128131,among,0,0
128132,adults,0,0
128133,with,0,0
128134,systemic,0,0
128135,sclerosis,0,0
128136,.,0,0
128137,OBJECTIVES,0,0
128138,To,0,0
128139,evaluate,0,0
128140,the,0,0
128141,effect,0,0
128142,of,0,0
128143,adaptive,1,0
128144,oral,1,1
128145,hygiene,1,1
128146,devices,1,1
128147,and,0,0
128148,orofacial,1,0
128149,exercise,1,1
128150,to,0,0
128151,improve,0,0
128152,gingival,0,0
128153,health,0,0
128154,among,0,0
128155,adults,0,0
128156,with,0,0
128157,systemic,0,0
128158,sclerosis,0,0
128159,(,0,0
128160,SSc,0,0
128161,),0,0
128162,.,0,0
128163,METHODS,0,0
128164,Forty-eight,0,0
128165,patients,0,0
128166,with,0,0
128167,SSc,0,0
128168,were,0,0
128169,assigned,0,0
128170,randomly,0,0
128171,to,0,0
128172,the,0,0
128173,multifaceted,1,0
128174,oral,1,1
128175,health,1,0
128176,intervention,1,1
128177,or,0,1
128178,usual,1,1
128179,dental,1,1
128180,care,1,1
128181,control,0,0
128182,group,0,0
128183,.,0,0
128184,Participants,0,0
128185,in,0,0
128186,the,0,0
128187,intervention,0,1
128188,group,0,0
128189,received,0,0
128190,a,0,0
128191,rechargeable,0,1
128192,",",0,0
128193,powered,0,0
128194,Oral-B?,1,1
128195,oscillating-rotating-pulsating,1,1
128196,toothbrush,1,1
128197,and,1,0
128198,a,1,0
128199,Reach?,1,0
128200,Access?,1,1
128201,Flosser,1,1
128202,that,1,0
128203,has,0,0
128204,a,0,0
128205,toothbrush-like,0,1
128206,handle,0,0
128207,.,0,0
128208,For,0,0
128209,those,0,0
128210,with,0,0
128211,an,0,0
128212,oral,0,1
128213,aperture,0,0
128214,of,0,0
128215,less,0,0
128216,than,0,0
128217,40,0,0
128218,mm,0,0
128219,",",0,0
128220,orofacial,1,0
128221,exercises,1,1
128222,were,1,0
128223,taught,0,0
128224,.,0,0
128225,Participants,0,0
128226,in,0,0
128227,the,0,0
128228,control,0,0
128229,group,0,0
128230,were,0,0
128231,each,0,0
128232,given,0,0
128233,a,0,0
128234,manual,0,1
128235,toothbrush,0,1
128236,and,0,0
128237,dental,0,1
128238,floss,0,1
128239,.,0,0
128240,Participants,0,0
128241,in,0,0
128242,both,0,0
128243,groups,0,0
128244,received,0,0
128245,instructions,0,1
128246,and,0,0
128247,demonstration,0,0
128248,on,0,0
128249,the,0,0
128250,use,0,0
128251,of,0,0
128252,the,0,0
128253,devices,0,0
128254,",",0,0
128255,and,0,0
128256,were,0,0
128257,requested,0,0
128258,to,0,0
128259,perform,0,0
128260,the,0,0
128261,respective,0,0
128262,intervention,0,1
128263,twice,0,0
128264,a,0,0
128265,day,0,0
128266,for,0,0
128267,6,0,0
128268,months,0,0
128269,.,0,0
128270,Evaluations,0,0
128271,were,0,0
128272,at,0,0
128273,baseline,0,0
128274,",",0,0
128275,3-,0,0
128276,",",0,0
128277,and,0,0
128278,6-months,0,0
128279,.,0,0
128280,The,0,0
128281,main,0,0
128282,outcome,0,0
128283,was,0,0
128284,gingival,0,0
128285,index,0,0
128286,(,0,0
128287,GI,0,0
128288,),0,0
128289,",",0,0
128290,an,0,0
128291,indicator,0,0
128292,of,0,0
128293,gingival,0,0
128294,inflammation,0,0
128295,.,0,0
128296,RESULTS,0,0
128297,Both,0,0
128298,groups,0,0
128299,showed,0,0
128300,significant,0,0
128301,reduction,0,0
128302,in,0,0
128303,GI,0,0
128304,scores,0,0
128305,at,0,0
128306,6,0,0
128307,months,0,0
128308,(,0,0
128309,ps,0,0
128310,<,0,0
128311,0.005,0,0
128312,),0,0
128313,.,0,0
128314,Reduction,0,0
128315,in,0,0
128316,GI,0,0
128317,scores,0,0
128318,of,0,0
128319,the,0,0
128320,intervention,0,1
128321,group,0,0
128322,at,0,0
128323,6,0,0
128324,months,0,0
128325,was,0,0
128326,20.8,0,0
128327,%,0,0
128328,which,0,0
128329,is,0,0
128330,considered,0,0
128331,to,0,0
128332,be,0,0
128333,clinically,0,0
128334,significant,0,0
128335,.,0,0
128336,Compared,0,0
128337,to,0,0
128338,the,0,0
128339,control,0,0
128340,group,0,0
128341,",",0,0
128342,the,0,0
128343,intervention,0,1
128344,group,0,0
128345,showed,0,0
128346,a,0,0
128347,significant,0,0
128348,and,0,0
128349,larger,0,0
128350,reduction,0,0
128351,in,0,0
128352,GI,0,0
128353,score,0,0
128354,by,0,0
128355,8,0,0
128356,%,0,0
128357,at,0,0
128358,6,0,0
128359,months,0,0
128360,(,0,0
128361,p=0.0007,0,0
128362,),0,0
128363,.,0,0
128364,CONCLUSIONS,0,0
128365,Results,0,0
128366,support,0,0
128367,the,0,0
128368,use,0,0
128369,of,1,0
128370,adaptive,1,0
128371,devices,1,1
128372,and,1,0
128373,orofacial,1,0
128374,exercise,1,1
128375,to,1,0
128376,improve,0,0
128377,gingival,0,0
128378,health,0,0
128379,in,0,0
128380,adults,0,0
128381,with,0,0
128382,SSc,0,0
128383,when,0,0
128384,compared,0,0
128385,to,0,0
128386,use,0,0
128387,of,1,0
128388,manual,1,1
128389,toothbrushing,1,1
128390,and,1,0
128391,finger-held,1,0
128392,flossing,1,1
128393,.,1,0
128394,Recommending,1,0
128395,and,0,0
128396,educating,0,1
128397,patients,0,0
128398,with,0,0
128399,SSc,0,0
128400,to,0,0
128401,use,0,0
128402,adaptive,0,0
128403,devices,0,0
128404,to,0,0
128405,clean,0,0
128406,the,0,0
128407,tooth,0,0
128408,surfaces,0,1
128409,looks,0,0
128410,promising,0,0
128411,for,0,0
128412,long-term,0,0
128413,oral,0,1
128414,health,0,0
128415,improvement,0,0
128416,.,0,0
128417,Poor,0,0
128418,self-rated,0,0
128419,health,0,0
128420,is,0,0
128421,not,0,0
128422,associated,0,0
128423,with,0,0
128424,a,0,0
128425,high,0,0
128426,total,0,0
128427,allostatic,0,0
128428,load,0,0
128429,in,0,0
128430,type,0,0
128431,2,0,0
128432,diabetic,0,0
128433,patients,0,0
128434,--,0,0
128435,but,0,0
128436,high,0,0
128437,blood,0,0
128438,pressure,0,0
128439,is,0,0
128440,.,0,0
128441,OBJECTIVE,0,0
128442,Allostatic,0,0
128443,load,0,0
128444,has,0,0
128445,been,0,0
128446,linked,0,0
128447,to,0,0
128448,self-rated,0,0
128449,health,0,0
128450,(,0,0
128451,SRH,0,1
128452,),0,0
128453,",",0,0
128454,cardiovascular,0,0
128455,disease,0,0
128456,and,0,0
128457,mortality,0,0
128458,in,0,0
128459,non-diabetic,0,0
128460,individuals,0,0
128461,.,0,0
128462,The,0,0
128463,aim,0,0
128464,of,0,0
128465,this,0,0
128466,study,0,0
128467,was,0,0
128468,to,0,0
128469,construct,0,0
128470,an,0,0
128471,allostatic,0,0
128472,load,0,0
128473,score,0,0
128474,and,0,0
128475,to,0,0
128476,find,0,0
128477,any,0,0
128478,correlations,0,0
128479,with,0,0
128480,SRH,0,0
128481,.,0,0
128482,METHODS,0,0
128483,The,0,0
128484,subjects,0,0
128485,included,0,0
128486,in,0,0
128487,the,0,0
128488,study,0,0
128489,came,0,0
128490,from,0,0
128491,a,0,0
128492,randomized,0,0
128493,",",0,0
128494,controlled,0,0
128495,trial,0,0
128496,of,0,0
128497,type,0,0
128498,2,0,0
128499,diabetes,0,0
128500,.,0,0
128501,Blood,0,0
128502,samples,0,0
128503,were,0,0
128504,drawn,0,0
128505,",",0,0
128506,urine,0,0
128507,was,0,0
128508,collected,0,0
128509,for,0,0
128510,24h,0,0
128511,",",0,0
128512,and,0,0
128513,questionnaires,0,1
128514,",",0,0
128515,including,0,0
128516,SRH,0,0
128517,",",0,0
128518,were,0,0
128519,filled,0,0
128520,out,0,0
128521,on,0,0
128522,three,0,0
128523,occasions,0,0
128524,:,0,0
128525,at,0,0
128526,baseline,0,0
128527,;,0,0
128528,after,0,0
128529,the,0,0
128530,10-week,0,1
128531,intervention,0,1
128532,;,0,0
128533,and,0,0
128534,at,0,0
128535,a,0,0
128536,follow-up,0,0
128537,3,0,0
128538,months,0,0
128539,after,0,0
128540,the,0,0
128541,intervention,0,1
128542,.,0,0
128543,Allostatic,0,0
128544,load,0,0
128545,was,0,0
128546,estimated,0,0
128547,using,0,0
128548,a,0,0
128549,wide,0,0
128550,range,0,0
128551,of,0,0
128552,variables,0,0
128553,",",0,0
128554,including,0,0
128555,systolic,0,0
128556,and,0,0
128557,diastolic,0,0
128558,blood,0,0
128559,pressure,0,0
128560,",",0,0
128561,pulse,0,1
128562,pressure,0,0
128563,",",0,0
128564,cortisol,0,0
128565,",",0,0
128566,catecholamines,0,0
128567,",",0,0
128568,HbA,0,0
128569,(,0,0
128570,1c,0,0
128571,),0,0
128572,",",0,0
128573,insulin,0,0
128574,",",0,0
128575,plasma,0,0
128576,glucose,0,0
128577,and,0,0
128578,waist,0,0
128579,circumference,0,0
128580,.,0,0
128581,RESULTS,0,0
128582,There,0,0
128583,was,0,0
128584,no,0,0
128585,association,0,0
128586,between,0,0
128587,SRH,0,0
128588,and,0,0
128589,allostatic,0,0
128590,load,0,0
128591,.,0,0
128592,However,0,0
128593,",",0,0
128594,three,0,0
128595,other,0,0
128596,components,0,0
128597,were,0,0
128598,significantly,0,0
128599,correlated,0,0
128600,with,0,0
128601,allostatic,0,0
128602,load,0,0
128603,at,0,0
128604,the,0,0
128605,baseline,0,0
128606,investigation,0,0
128607,and,0,0
128608,the,0,0
128609,two,0,0
128610,follow-up,0,0
128611,investigations,0,0
128612,-,0,0
128613,namely,0,0
128614,",",0,0
128615,systolic,0,0
128616,blood,0,0
128617,pressure,0,0
128618,",",0,0
128619,diastolic,0,0
128620,blood,0,0
128621,pressure,0,0
128622,and,0,0
128623,HbA,0,0
128624,(,0,0
128625,1c,0,0
128626,),0,0
128627,.,0,0
128628,CONCLUSION,0,0
128629,The,0,0
128630,absence,0,0
128631,of,0,0
128632,an,0,0
128633,association,0,0
128634,between,0,0
128635,allostatic,0,0
128636,load,0,0
128637,and,0,0
128638,SRH,0,0
128639,in,0,0
128640,diabetic,0,0
128641,individuals,0,0
128642,contrasts,0,0
128643,with,0,0
128644,previous,0,0
128645,findings,0,0
128646,in,0,0
128647,non-diabetic,0,0
128648,women,0,0
128649,",",0,0
128650,and,0,0
128651,shows,0,0
128652,that,0,0
128653,it,0,0
128654,is,0,0
128655,hazardous,0,0
128656,to,0,0
128657,apply,0,0
128658,findings,0,0
128659,in,0,0
128660,one,0,0
128661,population,0,0
128662,to,0,0
128663,another,0,0
128664,",",0,0
128665,especially,0,0
128666,diabetic,0,0
128667,and,0,0
128668,non-diabetic,0,0
128669,populations,0,0
128670,.,0,0
128671,Exemestane,1,1
128672,for,0,0
128673,breast-cancer,0,0
128674,prevention,0,0
128675,in,0,0
128676,postmenopausal,0,0
128677,women,0,0
128678,.,0,0
128679,BACKGROUND,0,0
128680,Tamoxifen,0,1
128681,and,0,0
128682,raloxifene,0,1
128683,have,0,0
128684,limited,0,0
128685,patient,0,0
128686,acceptance,0,0
128687,for,0,0
128688,primary,0,0
128689,prevention,0,0
128690,of,0,0
128691,breast,0,0
128692,cancer,0,0
128693,.,0,0
128694,Aromatase,0,0
128695,inhibitors,0,0
128696,prevent,0,0
128697,more,0,0
128698,contralateral,0,0
128699,breast,0,0
128700,cancers,0,0
128701,and,0,0
128702,cause,0,0
128703,fewer,0,0
128704,side,0,0
128705,effects,0,0
128706,than,0,0
128707,tamoxifen,0,1
128708,in,0,0
128709,patients,0,0
128710,with,0,0
128711,early-stage,0,0
128712,breast,0,0
128713,cancer,0,0
128714,.,0,0
128715,METHODS,0,0
128716,In,0,0
128717,a,0,0
128718,randomized,0,0
128719,",",0,0
128720,placebo-controlled,1,1
128721,",",0,0
128722,double-blind,0,0
128723,trial,0,0
128724,of,0,0
128725,exemestane,1,1
128726,designed,0,0
128727,to,0,0
128728,detect,0,0
128729,a,0,0
128730,65,0,0
128731,%,0,0
128732,relative,0,0
128733,reduction,0,0
128734,in,0,0
128735,invasive,0,0
128736,breast,0,0
128737,cancer,0,0
128738,",",0,0
128739,eligible,0,0
128740,postmenopausal,0,0
128741,women,0,0
128742,35,0,0
128743,years,0,0
128744,of,0,0
128745,age,0,0
128746,or,0,0
128747,older,0,0
128748,had,0,0
128749,at,0,0
128750,least,0,0
128751,one,0,0
128752,of,0,0
128753,the,0,0
128754,following,0,0
128755,risk,0,0
128756,factors,0,0
128757,:,0,0
128758,60,0,0
128759,years,0,0
128760,of,0,0
128761,age,0,0
128762,or,0,0
128763,older,0,0
128764,;,0,0
128765,Gail,0,0
128766,5-year,0,0
128767,risk,0,0
128768,score,0,0
128769,greater,0,0
128770,than,0,0
128771,1.66,0,0
128772,%,0,0
128773,(,0,0
128774,chances,0,0
128775,in,0,0
128776,100,0,0
128777,of,0,0
128778,invasive,0,0
128779,breast,0,0
128780,cancer,0,0
128781,developing,0,0
128782,within,0,0
128783,5,0,0
128784,years,0,0
128785,),0,0
128786,;,0,0
128787,prior,0,0
128788,atypical,0,0
128789,ductal,0,0
128790,or,0,1
128791,lobular,0,0
128792,hyperplasia,0,0
128793,or,0,1
128794,lobular,0,0
128795,carcinoma,0,0
128796,in,0,0
128797,situ,0,0
128798,;,0,0
128799,or,0,0
128800,ductal,0,0
128801,carcinoma,0,0
128802,in,0,0
128803,situ,0,0
128804,with,0,0
128805,mastectomy,0,1
128806,.,0,0
128807,Toxic,0,0
128808,effects,0,0
128809,and,0,0
128810,health-related,0,0
128811,and,0,0
128812,menopause-specific,0,0
128813,qualities,0,0
128814,of,0,0
128815,life,0,0
128816,were,0,0
128817,measured,0,0
128818,.,0,0
128819,RESULTS,0,0
128820,A,0,0
128821,total,0,0
128822,of,0,0
128823,4560,0,0
128824,women,0,0
128825,for,0,0
128826,whom,0,0
128827,the,0,0
128828,median,0,0
128829,age,0,0
128830,was,0,0
128831,62.5,0,0
128832,years,0,0
128833,and,0,0
128834,the,0,0
128835,median,0,0
128836,Gail,0,1
128837,risk,0,0
128838,score,0,0
128839,was,0,0
128840,2.3,0,0
128841,%,0,0
128842,were,0,0
128843,randomly,0,0
128844,assigned,0,0
128845,to,0,0
128846,either,0,0
128847,exemestane,1,1
128848,or,1,0
128849,placebo,1,1
128850,.,1,0
128851,At,0,0
128852,a,0,0
128853,median,0,0
128854,follow-up,0,0
128855,of,0,0
128856,35,0,0
128857,months,0,0
128858,",",0,0
128859,11,0,0
128860,invasive,0,0
128861,breast,0,0
128862,cancers,0,0
128863,were,0,0
128864,detected,0,0
128865,in,0,0
128866,those,0,0
128867,given,0,0
128868,exemestane,1,1
128869,and,0,0
128870,in,0,0
128871,32,0,0
128872,of,0,0
128873,those,0,0
128874,given,0,0
128875,placebo,1,1
128876,",",0,0
128877,with,0,0
128878,a,0,0
128879,65,0,0
128880,%,0,0
128881,relative,0,0
128882,reduction,0,0
128883,in,0,0
128884,the,0,0
128885,annual,0,0
128886,incidence,0,0
128887,of,0,0
128888,invasive,0,0
128889,breast,0,0
128890,cancer,0,0
128891,(,0,0
128892,0.19,0,0
128893,%,0,0
128894,vs.,0,0
128895,0.55,0,0
128896,%,0,0
128897,;,0,0
128898,hazard,0,0
128899,ratio,0,0
128900,",",0,0
128901,0.35,0,0
128902,;,0,0
128903,95,0,0
128904,%,0,0
128905,confidence,0,0
128906,interval,0,0
128907,[,0,0
128908,CI,0,0
128909,],0,0
128910,",",0,0
128911,0.18,0,0
128912,to,0,0
128913,0.70,0,0
128914,;,0,0
128915,P=0.002,0,0
128916,),0,0
128917,.,0,0
128918,The,0,0
128919,annual,0,0
128920,incidence,0,0
128921,of,0,0
128922,invasive,0,0
128923,plus,0,1
128924,noninvasive,0,0
128925,(,0,0
128926,ductal,0,0
128927,carcinoma,0,0
128928,in,0,0
128929,situ,0,0
128930,),0,0
128931,breast,0,0
128932,cancers,0,0
128933,was,0,0
128934,0.35,0,0
128935,%,0,0
128936,on,0,0
128937,exemestane,0,1
128938,and,0,0
128939,0.77,0,0
128940,%,0,0
128941,on,0,0
128942,placebo,1,1
128943,(,0,0
128944,hazard,0,0
128945,ratio,0,0
128946,",",0,0
128947,0.47,0,0
128948,;,0,0
128949,95,0,0
128950,%,0,0
128951,CI,0,0
128952,",",0,0
128953,0.27,0,0
128954,to,0,0
128955,0.79,0,0
128956,;,0,0
128957,P=0.004,0,0
128958,),0,0
128959,.,0,0
128960,Adverse,0,0
128961,events,0,0
128962,occurred,0,0
128963,in,0,0
128964,88,0,0
128965,%,0,0
128966,of,0,0
128967,the,0,0
128968,exemestane,0,1
128969,group,0,0
128970,and,0,0
128971,85,0,0
128972,%,0,0
128973,of,0,0
128974,the,0,0
128975,placebo,0,1
128976,group,0,0
128977,(,0,0
128978,P=0.003,0,0
128979,),0,0
128980,",",0,0
128981,with,0,0
128982,no,0,0
128983,significant,0,0
128984,differences,0,0
128985,between,0,0
128986,the,0,0
128987,two,0,0
128988,groups,0,0
128989,in,0,0
128990,terms,0,0
128991,of,0,0
128992,skeletal,0,0
128993,fractures,0,0
128994,",",0,0
128995,cardiovascular,0,0
128996,events,0,0
128997,",",0,0
128998,other,0,0
128999,cancers,0,0
129000,",",0,0
129001,or,0,0
129002,treatment-related,0,0
129003,deaths,0,0
129004,.,0,0
129005,Minimal,0,0
129006,quality-of-life,0,0
129007,differences,0,0
129008,were,0,0
129009,observed,0,0
129010,.,0,0
129011,CONCLUSIONS,0,0
129012,Exemestane,1,1
129013,significantly,0,0
129014,reduced,0,0
129015,invasive,0,0
129016,breast,0,0
129017,cancers,0,0
129018,in,0,0
129019,postmenopausal,0,0
129020,women,0,0
129021,who,0,0
129022,were,0,0
129023,at,0,0
129024,moderately,0,0
129025,increased,0,0
129026,risk,0,0
129027,for,0,0
129028,breast,0,0
129029,cancer,0,0
129030,.,0,0
129031,During,0,0
129032,a,0,0
129033,median,0,0
129034,follow-up,0,0
129035,period,0,0
129036,of,0,0
129037,3,0,0
129038,years,0,0
129039,",",0,0
129040,exemestane,0,1
129041,was,0,0
129042,associated,0,0
129043,with,0,0
129044,no,0,0
129045,serious,0,0
129046,toxic,0,0
129047,effects,0,0
129048,and,0,0
129049,only,0,0
129050,minimal,0,0
129051,changes,0,0
129052,in,0,0
129053,health-related,0,0
129054,quality,0,0
129055,of,0,0
129056,life,0,0
129057,.,0,0
129058,(,0,0
129059,Funded,0,0
129060,by,0,0
129061,Pfizer,0,1
129062,and,0,0
129063,others,0,0
129064,;,0,0
129065,NCIC,0,1
129066,CTG,0,0
129067,MAP.3,0,1
129068,ClinicalTrials.gov,0,0
129069,number,0,0
129070,",",0,0
129071,NCT00083174,0,0
129072,.,0,0
129073,),0,0
129074,.,0,0
129075,[,1,0
129076,Diabetic,1,1
129077,retinopathy,1,0
129078,candesartan,1,1
129079,trial,0,0
129080,],0,0
129081,.,0,0
129082,A,0,0
129083,pilot,0,0
129084,study,0,0
129085,to,0,0
129086,improve,0,0
129087,venipuncture,0,1
129088,compliance,0,0
129089,in,0,0
129090,children,0,0
129091,and,0,0
129092,adolescents,0,0
129093,with,0,0
129094,autism,0,0
129095,spectrum,0,0
129096,disorders,0,0
129097,.,0,0
129098,OBJECTIVE,0,0
129099,Medical,0,0
129100,procedures,0,0
129101,",",0,0
129102,particularly,0,0
129103,venipuncture,0,1
129104,(,0,0
129105,the,0,0
129106,puncture,0,0
129107,of,0,0
129108,a,0,0
129109,vein,0,0
129110,especially,0,0
129111,for,0,0
129112,the,0,0
129113,withdrawal,0,0
129114,of,0,0
129115,blood,0,0
129116,),0,0
129117,",",0,0
129118,can,0,0
129119,cause,0,0
129120,serious,0,0
129121,distress,0,0
129122,and,0,0
129123,behavior,0,0
129124,disturbance,0,0
129125,for,0,0
129126,many,0,0
129127,children,0,0
129128,.,0,0
129129,Noncompliance,0,0
129130,to,0,0
129131,blood,0,0
129132,draws,0,0
129133,can,0,0
129134,have,0,0
129135,significant,0,0
129136,ramifications,0,0
129137,in,0,0
129138,both,0,0
129139,research,0,0
129140,and,0,0
129141,clinical,0,0
129142,settings,0,0
129143,.,0,0
129144,The,0,0
129145,negative,0,0
129146,reactions,0,0
129147,may,0,0
129148,be,0,0
129149,exacerbated,0,0
129150,in,0,0
129151,individuals,0,0
129152,with,0,0
129153,autism,0,0
129154,spectrum,0,0
129155,disorders,0,0
129156,.,0,0
129157,Even,0,0
129158,so,0,0
129159,",",0,0
129160,there,0,0
129161,has,0,0
129162,been,0,0
129163,little,0,0
129164,research,0,0
129165,into,0,0
129166,the,0,0
129167,prevalence,0,0
129168,of,0,0
129169,the,0,0
129170,problem,0,0
129171,or,0,1
129172,effective,0,0
129173,intervention,0,1
129174,procedures,0,0
129175,.,0,0
129176,In,0,0
129177,response,0,0
129178,to,0,0
129179,these,0,0
129180,concerns,0,0
129181,",",0,0
129182,we,0,0
129183,developed,0,0
129184,and,0,0
129185,evaluated,0,0
129186,the,0,0
129187,Blood,1,0
129188,Draw,1,1
129189,Intervention,1,1
129190,Program,1,1
129191,.,1,0
129192,The,0,0
129193,program,0,0
129194,was,0,0
129195,designed,0,0
129196,to,0,0
129197,be,0,0
129198,easy,0,0
129199,to,0,0
129200,use,0,0
129201,",",0,0
129202,require,0,0
129203,little,0,0
129204,provider,0,1
129205,or,0,1
129206,family,0,0
129207,time,0,0
129208,",",0,0
129209,effectively,0,0
129210,reduce,0,0
129211,negative,0,0
129212,behaviors,0,0
129213,",",0,0
129214,and,0,0
129215,increase,0,0
129216,blood,0,0
129217,draw,0,0
129218,compliance,0,0
129219,.,0,0
129220,METHOD,0,0
129221,In,0,0
129222,a,0,0
129223,quasi-randomized,0,0
129224,trial,0,0
129225,over,0,0
129226,the,0,0
129227,course,0,0
129228,of,0,0
129229,?,0,0
129230,18,0,0
129231,months,0,0
129232,",",0,0
129233,58,0,0
129234,of,0,0
129235,210,0,0
129236,families,0,0
129237,with,0,0
129238,children,0,0
129239,with,0,0
129240,autism,0,0
129241,spectrum,0,0
129242,disorders,0,0
129243,participating,0,0
129244,in,0,0
129245,a,0,0
129246,larger,0,0
129247,study,0,0
129248,of,0,0
129249,phenotypic,0,0
129250,and,0,0
129251,genotypic,0,0
129252,factors,0,0
129253,reported,0,0
129254,significant,0,0
129255,concerns,0,0
129256,about,0,0
129257,blood,0,0
129258,draws,0,0
129259,and,0,0
129260,elected,0,0
129261,to,0,0
129262,use,0,0
129263,the,0,0
129264,Blood,0,0
129265,Draw,0,1
129266,Intervention,0,1
129267,Program,0,1
129268,.,0,0
129269,RESULTS,0,0
129270,Completion,0,0
129271,of,0,0
129272,the,0,0
129273,program,0,1
129274,increased,0,0
129275,blood,0,0
129276,draw,0,0
129277,compliance,0,0
129278,rates,0,0
129279,from,0,0
129280,85.4,0,0
129281,%,0,0
129282,to,0,0
129283,96.6,0,0
129284,%,0,0
129285,(,0,0
129286,odds,0,0
129287,ratio,0,0
129288,=,0,0
129289,4.80,0,0
129290,;,0,0
129291,95,0,0
129292,%,0,0
129293,confidence,0,0
129294,interval,0,0
129295,=,0,0
129296,1.12,0,0
129297,",",0,0
129298,20.59,0,0
129299,;,0,0
129300,p,0,0
129301,=,0,0
129302,.03,0,0
129303,),0,0
129304,.,0,0
129305,CONCLUSION,0,0
129306,Results,0,0
129307,indicate,0,0
129308,the,0,0
129309,efficacy,0,0
129310,of,0,0
129311,the,0,0
129312,program,0,1
129313,in,0,0
129314,a,0,0
129315,research,0,0
129316,setting,0,0
129317,and,0,0
129318,suggest,0,0
129319,a,0,0
129320,potential,0,0
129321,clinical,0,0
129322,application,0,0
129323,.,0,0
129324,The,0,0
129325,current,0,0
129326,intervention,0,1
129327,",",0,0
129328,unlike,0,0
129329,many,0,0
129330,others,0,0
129331,for,0,0
129332,the,0,0
129333,same,0,0
129334,or,0,0
129335,similar,0,0
129336,difficulties,0,0
129337,proposed,0,0
129338,in,0,0
129339,the,0,0
129340,past,0,0
129341,",",0,0
129342,was,0,0
129343,successful,0,0
129344,without,0,0
129345,requiring,0,0
129346,extensive,0,0
129347,time,0,0
129348,",",0,0
129349,training,0,1
129350,",",0,0
129351,or,0,0
129352,effort,0,0
129353,on,0,0
129354,the,0,0
129355,part,0,0
129356,of,0,0
129357,providers,0,0
129358,and,0,0
129359,parents,0,0
129360,or,0,0
129361,their,0,0
129362,children,0,0
129363,",",0,0
129364,nor,0,0
129365,did,0,0
129366,it,0,0
129367,require,0,0
129368,large-scale,0,0
129369,institutional,0,0
129370,changes,0,0
129371,.,0,0
129372,Cross-modal,0,1
129373,attention-switching,0,1
129374,is,0,0
129375,impaired,0,0
129376,in,0,0
129377,autism,0,0
129378,spectrum,0,0
129379,disorders,0,0
129380,.,0,0
129381,This,0,0
129382,investigation,0,0
129383,aimed,0,0
129384,to,0,0
129385,determine,0,0
129386,if,0,0
129387,children,0,0
129388,with,0,0
129389,ASD,0,0
129390,are,0,0
129391,impaired,0,0
129392,in,0,0
129393,their,0,0
129394,ability,0,0
129395,to,0,0
129396,switch,0,0
129397,attention,0,0
129398,between,0,0
129399,different,0,0
129400,tasks,0,1
129401,",",0,0
129402,and,0,0
129403,whether,0,0
129404,performance,0,0
129405,is,0,0
129406,further,0,0
129407,impaired,0,0
129408,when,0,0
129409,required,0,0
129410,to,0,0
129411,switch,0,0
129412,across,0,0
129413,two,0,0
129414,separate,0,0
129415,modalities,0,0
129416,(,0,0
129417,visual,0,0
129418,and,0,0
129419,auditory,0,1
129420,),0,0
129421,.,0,0
129422,Eighteen,0,0
129423,children,0,0
129424,with,0,0
129425,ASD,0,0
129426,(,0,0
129427,9-13,0,0
129428,years,0,0
129429,old,0,0
129430,),0,0
129431,were,0,0
129432,compared,0,0
129433,with,0,0
129434,18,0,0
129435,typically-developing,0,0
129436,children,0,0
129437,matched,0,0
129438,with,0,0
129439,the,0,0
129440,ASD,0,0
129441,group,0,0
129442,for,0,0
129443,mental,0,0
129444,age,0,0
129445,",",0,0
129446,and,0,0
129447,also,0,0
129448,with,0,0
129449,18,0,0
129450,subjects,0,0
129451,with,0,0
129452,learning,0,0
129453,difficulties,0,0
129454,matched,0,0
129455,with,0,0
129456,the,0,0
129457,ASD,0,0
129458,group,0,0
129459,for,0,0
129460,mental,0,0
129461,and,0,0
129462,chronological,0,0
129463,age,0,0
129464,.,0,0
129465,Individuals,0,0
129466,alternated,0,0
129467,between,0,0
129468,two,1,0
129469,different,1,0
129470,visual,1,0
129471,tasks,1,1
129472,",",1,0
129473,and,1,0
129474,between,1,0
129475,a,1,0
129476,different,1,0
129477,visual,1,0
129478,task,1,1
129479,and,1,0
129480,an,1,0
129481,auditory,1,1
129482,task,1,0
129483,.,1,0
129484,Children,0,0
129485,with,0,0
129486,ASD,0,0
129487,performed,0,0
129488,worse,0,0
129489,than,0,0
129490,both,0,0
129491,comparison,0,0
129492,groups,0,0
129493,at,0,0
129494,both,0,0
129495,switching,0,0
129496,tasks,0,0
129497,.,0,0
129498,Moreover,0,0
129499,",",0,0
129500,children,0,0
129501,with,0,0
129502,ASD,0,0
129503,had,0,0
129504,greater,0,0
129505,difficulty,0,0
129506,when,0,0
129507,different,0,0
129508,modalities,0,0
129509,were,0,0
129510,required,0,0
129511,than,0,0
129512,where,0,0
129513,only,0,0
129514,one,0,0
129515,modality,0,0
129516,was,0,0
129517,required,0,0
129518,in,0,0
129519,the,0,0
129520,switching,0,0
129521,task,0,1
129522,in,0,0
129523,comparison,0,0
129524,with,0,0
129525,participants,0,0
129526,matched,0,0
129527,in,0,0
129528,terms,0,0
129529,of,0,0
129530,mental,0,0
129531,and,0,0
129532,chronological,0,0
129533,age,0,0
129534,.,0,0
129535,Nepafenac,1,1
129536,for,0,0
129537,epiretinal,0,0
129538,membrane,0,0
129539,surgery,0,0
129540,.,0,0
129541,Increased,0,0
129542,5?-reductase,0,0
129543,type,0,0
129544,2,0,0
129545,expression,0,0
129546,in,0,0
129547,human,0,0
129548,breast,0,0
129549,carcinoma,0,0
129550,following,1,0
129551,aromatase,1,1
129552,inhibitor,1,1
129553,therapy,1,1
129554,:,1,0
129555,the,0,0
129556,correlation,0,0
129557,with,0,0
129558,decreased,0,0
129559,tumor,0,0
129560,cell,0,0
129561,proliferation,0,0
129562,.,0,0
129563,Tumor,0,0
129564,cell,0,0
129565,proliferation,0,0
129566,and,0,0
129567,progression,0,0
129568,of,0,0
129569,breast,0,0
129570,cancer,0,0
129571,are,0,0
129572,influenced,0,0
129573,by,0,0
129574,female,0,0
129575,sex,0,0
129576,steroids,0,1
129577,.,0,0
129578,However,0,0
129579,",",0,0
129580,not,0,0
129581,all,0,0
129582,breast,0,0
129583,cancer,0,0
129584,patients,0,0
129585,respond,0,0
129586,to,1,0
129587,aromatase,1,0
129588,inhibitors,1,1
129589,(,1,0
129590,AI,1,0
129591,),1,0
129592,",",1,0
129593,and,0,0
129594,many,0,0
129595,patients,0,0
129596,become,0,0
129597,unresponsive,0,1
129598,or,0,0
129599,relapse,0,0
129600,.,0,0
129601,Recent,0,0
129602,studies,0,0
129603,demonstrate,0,0
129604,that,0,0
129605,not,0,0
129606,only,0,0
129607,estrogens,0,1
129608,but,0,0
129609,also,0,0
129610,androgens,0,0
129611,may,0,0
129612,serve,0,0
129613,as,0,0
129614,regulators,0,0
129615,of,0,0
129616,estrogen-responsive,0,0
129617,as,0,0
129618,well,0,0
129619,as,0,0
129620,estrogen-unresponsive,0,0
129621,human,0,0
129622,breast,0,0
129623,cancers,0,0
129624,.,0,0
129625,However,0,0
129626,",",0,0
129627,the,0,0
129628,mechanism,0,0
129629,underlying,0,0
129630,these,0,0
129631,androgenic,0,0
129632,actions,0,0
129633,has,0,0
129634,remained,0,0
129635,relatively,0,0
129636,unknown,0,0
129637,.,0,0
129638,Therefore,0,0
129639,",",0,0
129640,in,0,0
129641,this,0,0
129642,study,0,0
129643,",",0,0
129644,we,0,0
129645,evaluated,0,0
129646,the,0,0
129647,effects,0,0
129648,of,0,0
129649,AI,0,0
129650,upon,0,0
129651,the,0,0
129652,expression,0,0
129653,of,0,0
129654,enzymes,0,0
129655,involved,0,0
129656,in,0,0
129657,intratumoral,0,0
129658,androgen,0,1
129659,production,0,0
129660,including,0,0
129661,17?-hydroxysteroid,0,0
129662,dehydrogenase,0,0
129663,type,0,0
129664,5,0,0
129665,(,0,0
129666,17?HSD5,0,0
129667,),0,0
129668,",",0,0
129669,5?-reductase,0,0
129670,types,0,0
129671,1,0,0
129672,and,0,0
129673,2,0,0
129674,(,0,0
129675,5?Red1,0,1
129676,and,0,0
129677,5?Red2,0,1
129678,),0,0
129679,as,0,0
129680,well,0,0
129681,as,0,0
129682,androgen,0,1
129683,receptor,0,0
129684,(,0,0
129685,AR,0,1
129686,),0,0
129687,levels,0,0
129688,and,0,0
129689,correlated,0,0
129690,the,0,0
129691,findings,0,0
129692,with,0,0
129693,therapeutic,0,0
129694,responses,0,0
129695,including,0,0
129696,Ki67,0,0
129697,labeling,0,1
129698,index,0,0
129699,(,0,1
129700,Ki67,0,0
129701,),0,0
129702,.,0,0
129703,Eighty-two,0,0
129704,postmenopausal,0,0
129705,invasive,0,0
129706,ductal,0,0
129707,carcinoma,0,0
129708,patients,0,0
129709,were,0,0
129710,enrolled,0,0
129711,in,0,0
129712,CAAN,0,0
129713,study,0,0
129714,from,0,0
129715,November,0,0
129716,2001,0,0
129717,to,0,0
129718,April,0,1
129719,2004,0,0
129720,.,0,0
129721,Pre-,0,0
129722,and,0,0
129723,post-treatment,0,0
129724,specimens,0,0
129725,of,0,0
129726,29,0,0
129727,cases,0,0
129728,were,0,0
129729,available,0,0
129730,for,0,0
129731,this,0,0
129732,study,0,0
129733,.,0,0
129734,The,0,0
129735,status,0,0
129736,of,0,0
129737,17?HSD5,0,0
129738,",",0,0
129739,5?Red1,0,0
129740,",",0,0
129741,5?Red2,0,0
129742,",",0,0
129743,and,0,0
129744,Ki67,0,0
129745,in,0,0
129746,pre-,0,0
129747,and,0,0
129748,post-treatment,0,0
129749,specimens,0,0
129750,were,0,0
129751,evaluated,0,0
129752,.,0,0
129753,The,0,0
129754,significant,0,0
129755,increments,0,0
129756,of,0,0
129757,5?Red2,0,0
129758,as,0,0
129759,well,0,0
129760,as,0,0
129761,AR,0,1
129762,were,0,0
129763,detected,0,0
129764,in,0,0
129765,biological,0,0
129766,response,0,0
129767,group,0,0
129768,whose,0,0
129769,Ki67,0,0
129770,LI,0,1
129771,decreased,0,0
129772,by,0,0
129773,more,0,0
129774,than,0,0
129775,40,0,0
129776,%,0,0
129777,of,0,0
129778,the,0,0
129779,pre-treatment,0,0
129780,level,0,0
129781,.,0,0
129782,This,0,0
129783,is,0,0
129784,the,0,0
129785,first,0,0
129786,study,0,0
129787,demonstrating,0,0
129788,an,0,0
129789,increment,0,0
129790,of,0,0
129791,5?Red2,0,0
129792,and,0,0
129793,AR,0,1
129794,in,0,0
129795,the,0,0
129796,group,0,0
129797,of,0,0
129798,the,0,0
129799,patients,0,0
129800,associated,0,0
129801,with,0,0
129802,Ki67,0,0
129803,decrement,0,0
129804,following,0,0
129805,AI,0,1
129806,treatment,0,0
129807,.,0,0
129808,These,0,0
129809,results,0,0
129810,suggest,0,0
129811,that,0,0
129812,increased,0,0
129813,5?Red2,0,0
129814,and,0,0
129815,AR,0,1
129816,following,0,0
129817,AI,0,1
129818,treatment,0,0
129819,may,0,0
129820,partly,0,0
129821,contribute,0,0
129822,to,0,0
129823,reduce,0,0
129824,the,0,0
129825,tumor,0,0
129826,cell,0,0
129827,proliferation,0,0
129828,through,0,0
129829,increasing,0,0
129830,intratumoral,0,0
129831,androgen,0,1
129832,concentrations,0,0
129833,and,0,0
129834,its,0,0
129835,receptor,0,0
129836,.,0,0
129837,To,0,0
129838,share,0,0
129839,or,0,0
129840,not,0,0
129841,to,0,0
129842,share,0,0
129843,:,0,0
129844,a,0,0
129845,randomized,0,0
129846,trial,0,0
129847,of,0,0
129848,consent,1,0
129849,for,1,0
129850,data,1,0
129851,sharing,1,0
129852,in,0,0
129853,genome,0,0
129854,research,0,0
129855,.,0,0
129856,PURPOSE,0,0
129857,Despite,0,0
129858,growing,0,0
129859,concerns,0,0
129860,toward,0,0
129861,maintaining,0,0
129862,participants,0,0
129863,',0,0
129864,privacy,0,0
129865,",",0,0
129866,individual,0,0
129867,investigators,0,0
129868,collecting,0,0
129869,tissue,0,0
129870,and,0,0
129871,other,0,0
129872,biological,0,0
129873,specimens,0,0
129874,for,0,0
129875,genomic,0,0
129876,analysis,0,0
129877,are,0,0
129878,encouraged,0,0
129879,to,0,0
129880,obtain,0,0
129881,informed,1,0
129882,consent,1,0
129883,for,0,0
129884,broad,0,0
129885,data,0,0
129886,sharing,0,0
129887,.,0,0
129888,Our,0,0
129889,purpose,0,0
129890,was,0,0
129891,to,0,0
129892,assess,0,0
129893,the,0,0
129894,effect,0,0
129895,on,0,0
129896,research,0,0
129897,enrollment,0,0
129898,and,0,0
129899,data,0,0
129900,sharing,0,0
129901,decisions,0,0
129902,of,0,0
129903,three,0,0
129904,different,0,0
129905,consent,0,0
129906,types,0,1
129907,(,0,0
129908,traditional,0,1
129909,",",0,0
129910,binary,0,0
129911,",",0,0
129912,or,0,1
129913,tiered,0,0
129914,),0,0
129915,with,0,0
129916,varying,0,0
129917,levels,0,0
129918,of,0,0
129919,control,0,0
129920,and,0,0
129921,choices,0,0
129922,regarding,0,0
129923,data,0,0
129924,sharing,0,0
129925,.,0,0
129926,METHODS,0,0
129927,A,0,0
129928,single-blinded,0,0
129929,",",0,0
129930,randomized,0,0
129931,controlled,1,0
129932,trial,0,0
129933,was,0,0
129934,conducted,0,0
129935,with,0,0
129936,323,0,0
129937,eligible,0,0
129938,adult,0,0
129939,participants,0,0
129940,being,0,0
129941,recruited,0,0
129942,into,0,0
129943,one,0,0
129944,of,0,0
129945,six,0,0
129946,genome,0,0
129947,studies,0,0
129948,at,0,0
129949,Baylor,0,0
129950,College,0,0
129951,of,0,0
129952,Medicine,0,1
129953,in,0,0
129954,Houston,0,0
129955,",",0,0
129956,Texas,0,0
129957,",",0,0
129958,between,0,0
129959,January,0,0
129960,2008,0,0
129961,and,0,0
129962,August,0,0
129963,2009,0,0
129964,.,0,0
129965,Participants,0,0
129966,were,0,0
129967,randomly,0,0
129968,assigned,0,0
129969,to,0,0
129970,one,0,0
129971,of,0,0
129972,three,0,0
129973,experimental,1,0
129974,consent,1,0
129975,documents,1,0
129976,(,0,0
129977,traditional,0,1
129978,",",0,0
129979,n,0,0
129980,=,0,0
129981,110,0,0
129982,;,0,0
129983,binary,0,0
129984,",",0,0
129985,n,0,0
129986,=,0,0
129987,103,0,0
129988,;,0,0
129989,and,0,0
129990,tiered,0,0
129991,",",0,0
129992,n,0,0
129993,=,0,0
129994,110,0,0
129995,),0,0
129996,.,0,0
129997,Debriefing,0,1
129998,in,0,0
129999,follow-up,0,0
130000,visits,0,0
130001,provided,0,0
130002,participants,0,0
130003,a,0,0
130004,detailed,0,0
130005,review,0,0
130006,of,0,0
130007,all,0,0
130008,consent,0,0
130009,types,0,0
130010,and,0,0
130011,the,0,0
130012,chance,0,0
130013,to,0,0
130014,change,0,0
130015,data,0,0
130016,sharing,0,0
130017,choices,0,0
130018,or,0,0
130019,decline,0,0
130020,genome,0,0
130021,study,0,0
130022,participation,0,0
130023,.,0,0
130024,RESULTS,0,0
130025,Before,0,0
130026,debriefing,0,1
130027,",",0,0
130028,83.9,0,0
130029,%,0,0
130030,of,0,0
130031,participants,0,0
130032,chose,0,0
130033,public,0,0
130034,data,0,0
130035,release,0,0
130036,.,0,0
130037,After,0,0
130038,debriefing,0,1
130039,",",0,0
130040,53.1,0,0
130041,%,0,0
130042,chose,0,0
130043,public,0,0
130044,data,0,0
130045,release,0,0
130046,",",0,0
130047,33.1,0,0
130048,%,0,0
130049,chose,0,0
130050,restricted,0,0
130051,(,0,0
130052,controlled,0,0
130053,access,0,1
130054,database,0,0
130055,),0,0
130056,release,0,0
130057,",",0,0
130058,and,0,0
130059,13.7,0,0
130060,%,0,0
130061,opted,0,0
130062,out,0,0
130063,of,0,0
130064,data,1,0
130065,sharing,1,0
130066,.,1,0
130067,Only,0,0
130068,one,0,0
130069,participant,0,0
130070,declined,0,0
130071,genome,0,0
130072,study,0,0
130073,participation,0,0
130074,due,0,0
130075,to,0,0
130076,data,0,0
130077,sharing,0,0
130078,concerns,0,0
130079,.,0,0
130080,CONCLUSION,0,0
130081,Our,0,0
130082,findings,0,0
130083,indicate,0,0
130084,that,0,0
130085,most,0,0
130086,participants,0,0
130087,are,0,0
130088,willing,0,0
130089,to,0,0
130090,publicly,0,0
130091,release,0,0
130092,their,0,0
130093,genomic,0,0
130094,data,0,0
130095,;,0,0
130096,however,0,0
130097,",",0,0
130098,a,0,0
130099,significant,0,0
130100,portion,0,0
130101,prefers,0,0
130102,restricted,0,0
130103,release,0,0
130104,.,0,0
130105,These,0,0
130106,results,0,0
130107,suggest,0,0
130108,discordance,0,0
130109,between,0,0
130110,existing,0,0
130111,data,0,0
130112,sharing,0,0
130113,policies,0,0
130114,and,0,0
130115,participants,0,0
130116,',0,0
130117,judgments,0,0
130118,and,0,0
130119,desires,0,0
130120,.,0,0
130121,Effect,0,0
130122,of,0,0
130123,ginseng,1,1
130124,extract,1,1
130125,supplementation,1,1
130126,on,0,0
130127,testicular,0,0
130128,functions,0,0
130129,in,0,0
130130,diabetic,0,0
130131,rats,0,0
130132,.,0,0
130133,OBJECTIVE,0,0
130134,It,0,0
130135,was,0,0
130136,aimed,0,0
130137,to,0,0
130138,investigate,0,0
130139,the,0,0
130140,effect,0,0
130141,of,0,0
130142,standardized,0,0
130143,ginseng,1,1
130144,extract,1,1
130145,on,0,0
130146,fertility,0,0
130147,parameters,0,0
130148,in,0,0
130149,diabetic,0,0
130150,rats,0,0
130151,.,0,0
130152,METHODS,0,0
130153,Thirty,0,0
130154,male,0,0
130155,rats,0,0
130156,were,0,0
130157,randomly,0,0
130158,allocated,0,0
130159,into,0,0
130160,three,0,0
130161,groups,0,0
130162,of,0,0
130163,10,0,0
130164,rats,0,0
130165,each,0,0
130166,:,0,0
130167,1.,0,0
130168,controls,0,0
130169,",",0,0
130170,2.,0,0
130171,diabetes,0,0
130172,(,0,0
130173,D,0,1
130174,),0,0
130175,and,0,0
130176,3.,0,0
130177,diabetes,0,0
130178,+,0,0
130179,ginseng,0,1
130180,(,0,0
130181,DG,0,0
130182,),0,0
130183,.,0,0
130184,The,0,0
130185,latter,0,0
130186,two,0,0
130187,groups,0,0
130188,were,0,0
130189,rendered,0,0
130190,diabetic,0,0
130191,by,0,0
130192,i.p,0,1
130193,.,0,0
130194,injection,0,0
130195,of,0,0
130196,streptozotocin,1,0
130197,(,0,0
130198,STZ,0,1
130199,;,0,0
130200,50,0,0
130201,mg/kg,0,0
130202,),0,0
130203,.,0,0
130204,Standardized,1,0
130205,ginseng,1,1
130206,extract,1,1
130207,(,0,0
130208,Dansk,0,0
130209,Droge,0,1
130210,A/S,0,0
130211,",",0,0
130212,Copenhagen,0,0
130213,",",0,0
130214,Denmark,0,0
130215,),0,0
130216,was,0,0
130217,administered,0,0
130218,per,0,0
130219,os,0,0
130220,(,0,0
130221,100,0,0
130222,mg/kg,0,1
130223,BW,0,1
130224,),0,0
130225,by,0,0
130226,stomach,0,0
130227,tube,0,1
130228,daily,0,0
130229,for,0,0
130230,90,0,0
130231,days,0,0
130232,starting,0,0
130233,one,0,0
130234,week,0,0
130235,after,0,0
130236,STZ,0,0
130237,.,0,0
130238,Ninety,0,0
130239,days,0,0
130240,post,0,0
130241,STZ,0,0
130242,the,0,0
130243,rats,0,0
130244,were,0,0
130245,sacrificed,0,0
130246,",",0,0
130247,and,0,0
130248,testis,0,1
130249,",",0,0
130250,epididymis,0,0
130251,",",0,0
130252,prostate,0,0
130253,",",0,0
130254,and,0,0
130255,seminal,0,0
130256,vesicles,0,0
130257,were,0,0
130258,weighed,0,0
130259,and,0,0
130260,subjected,0,0
130261,to,0,0
130262,histological,0,0
130263,examination,0,0
130264,.,0,0
130265,In,0,0
130266,addition,0,0
130267,",",0,0
130268,spermiogram,0,0
130269,",",0,0
130270,testicular,0,0
130271,enzyme,0,0
130272,markers,0,0
130273,",",0,0
130274,intratesticular,0,0
130275,steroid,0,1
130276,hormonal,0,1
130277,profile,0,0
130278,and,0,0
130279,testicular,0,0
130280,antioxidant,0,1
130281,status,0,0
130282,were,0,0
130283,estimated,0,0
130284,.,0,0
130285,RESULTS,0,0
130286,The,0,0
130287,administration,0,0
130288,of,0,0
130289,ginseng,1,1
130290,extract,1,1
130291,resulted,0,0
130292,in,0,0
130293,a,0,0
130294,significant,0,0
130295,improvement,0,0
130296,of,0,0
130297,fertility,0,0
130298,parameters,0,0
130299,and,0,0
130300,testicular,0,0
130301,antioxidants,0,1
130302,together,0,0
130303,with,0,0
130304,a,0,0
130305,decrease,0,0
130306,in,0,0
130307,malondialdehyde,0,0
130308,and,0,0
130309,testicular,0,0
130310,pathological,0,0
130311,signs,0,0
130312,including,0,0
130313,degenerative,0,0
130314,changes,0,0
130315,of,0,0
130316,the,0,0
130317,seminiferous,0,0
130318,tubules,0,0
130319,.,0,0
130320,CONCLUSION,0,0
130321,Ginseng,1,1
130322,extract,1,1
130323,may,0,0
130324,be,0,0
130325,a,0,0
130326,beneficial,0,0
130327,adjuvant,0,1
130328,therapy,0,1
130329,for,0,0
130330,diabetics,0,0
130331,suffering,0,0
130332,from,0,0
130333,infertility,0,0
130334,as,0,0
130335,a,0,0
130336,complication,0,0
130337,.,0,0
130338,[,0,0
130339,Use,0,0
130340,of,0,0
130341,Tachocomb,1,1
130342,for,0,0
130343,prevention,0,0
130344,of,0,0
130345,postoperative,0,0
130346,lymphatic,0,0
130347,leaks,0,0
130348,in,0,0
130349,the,0,0
130350,abdomen,0,0
130351,],0,0
130352,.,0,0
130353,The,0,0
130354,effect,0,0
130355,of,0,0
130356,knee,1,0
130357,position,1,0
130358,on,0,0
130359,blood,0,0
130360,loss,0,0
130361,and,0,0
130362,range,0,0
130363,of,0,0
130364,motion,0,0
130365,following,0,0
130366,total,0,0
130367,knee,0,0
130368,arthroplasty,0,0
130369,.,0,0
130370,PURPOSE,0,0
130371,This,0,0
130372,study,0,0
130373,prospectively,0,0
130374,assessed,0,0
130375,the,0,0
130376,effects,0,0
130377,of,0,0
130378,knee,1,0
130379,position,1,0
130380,on,0,0
130381,blood,0,0
130382,loss,0,0
130383,and,0,0
130384,range,0,0
130385,of,0,0
130386,motion,0,0
130387,after,0,0
130388,primary,0,0
130389,total,0,0
130390,knee,0,0
130391,arthroplasty,0,0
130392,(,0,0
130393,TKA,0,1
130394,),0,0
130395,.,0,0
130396,METHODS,0,0
130397,One,0,0
130398,hundred,0,0
130399,and,0,0
130400,ten,0,0
130401,consecutive,0,0
130402,TKA,0,1
130403,patients,0,0
130404,were,0,0
130405,randomized,0,0
130406,into,0,0
130407,flexion,0,0
130408,group,0,0
130409,and,0,0
130410,extension,0,0
130411,group,0,0
130412,.,0,0
130413,Both,0,0
130414,groups,0,0
130415,had,0,0
130416,the,0,0
130417,leg,1,0
130418,elevated,1,0
130419,30?,1,0
130420,at,1,0
130421,the,1,0
130422,hip,1,0
130423,over,1,0
130424,an,1,0
130425,inactive,1,0
130426,CPM,1,0
130427,for,1,0
130428,72,1,0
130429,h,1,0
130430,postoperatively,1,0
130431,.,1,0
130432,The,0,0
130433,flexion,0,0
130434,group,0,0
130435,had,0,0
130436,the,1,0
130437,knee,1,0
130438,flexed,1,0
130439,to,1,0
130440,30?,1,0
130441,during,1,0
130442,this,1,0
130443,period,1,0
130444,.,1,0
130445,The,0,0
130446,extension,0,0
130447,group,0,0
130448,had,0,0
130449,the,1,0
130450,knee,1,0
130451,extended,1,0
130452,fully,1,0
130453,.,1,0
130454,Perioperative,0,0
130455,blood,0,0
130456,loss,0,0
130457,",",0,0
130458,hidden,0,0
130459,blood,0,0
130460,loss,0,0
130461,",",0,0
130462,knee,0,0
130463,swelling,0,0
130464,",",0,0
130465,ecchymosis,0,0
130466,",",0,0
130467,analgesia,0,0
130468,requirements,0,0
130469,",",0,0
130470,range,0,0
130471,of,0,0
130472,motion,0,0
130473,(,0,0
130474,ROM,0,0
130475,),0,0
130476,",",0,0
130477,fixed,0,0
130478,flexion,0,0
130479,deformity,0,0
130480,(,0,0
130481,FFD,0,0
130482,),0,0
130483,",",0,0
130484,straight-leg,0,0
130485,raising,0,0
130486,action,0,0
130487,",",0,0
130488,and,0,0
130489,postoperative,0,0
130490,complications,0,0
130491,within,0,0
130492,6,0,0
130493,weeks,0,0
130494,of,0,0
130495,surgery,0,0
130496,were,0,0
130497,measured,0,0
130498,for,0,0
130499,evaluation,0,0
130500,and,0,0
130501,comparison,0,0
130502,.,0,0
130503,RESULTS,0,0
130504,The,0,0
130505,postoperative,0,0
130506,hidden,0,0
130507,blood,0,0
130508,loss,0,0
130509,",",0,0
130510,knee,0,0
130511,swelling,0,0
130512,",",0,0
130513,and,0,0
130514,scope,0,0
130515,of,0,0
130516,ecchymosis,0,0
130517,were,0,0
130518,significantly,0,0
130519,lower,0,0
130520,in,0,0
130521,the,0,0
130522,flexion,0,0
130523,group,0,0
130524,than,0,0
130525,in,0,0
130526,the,0,0
130527,extension,0,0
130528,group,0,0
130529,",",0,0
130530,and,0,0
130531,ROM,0,0
130532,and,0,0
130533,straight-leg,0,1
130534,raising,0,0
130535,action,0,0
130536,were,0,0
130537,significantly,0,0
130538,higher,0,0
130539,during,0,0
130540,the,0,0
130541,early,0,0
130542,period,0,0
130543,after,0,0
130544,operation,0,0
130545,.,0,0
130546,No,0,0
130547,significant,0,0
130548,difference,0,0
130549,was,0,0
130550,observed,0,0
130551,in,0,0
130552,perioperative,0,0
130553,blood,0,0
130554,loss,0,0
130555,",",0,0
130556,the,0,0
130557,amount,0,0
130558,of,0,0
130559,morphine,0,1
130560,used,0,0
130561,",",0,0
130562,or,0,0
130563,FFD,0,0
130564,in,0,0
130565,the,0,0
130566,early,0,0
130567,postoperative,0,0
130568,period,0,0
130569,or,0,0
130570,in,0,0
130571,ROM,0,0
130572,and,0,0
130573,FFD,0,0
130574,at,0,0
130575,6,0,0
130576,weeks,0,0
130577,postoperatively,0,0
130578,.,0,0
130579,CONCLUSIONS,0,0
130580,The,0,0
130581,findings,0,0
130582,of,0,0
130583,this,0,0
130584,study,0,0
130585,indicate,0,0
130586,that,1,0
130587,flexion,1,0
130588,of,1,0
130589,the,1,0
130590,knee,1,0
130591,to,1,0
130592,30?,0,0
130593,with,0,0
130594,the,0,0
130595,leg,0,0
130596,elevated,0,0
130597,30?,0,0
130598,at,0,0
130599,the,0,0
130600,hip,0,0
130601,after,0,0
130602,total,0,0
130603,knee,0,0
130604,arthroplasty,0,0
130605,may,0,0
130606,mitigate,0,0
130607,knee,0,0
130608,swelling,0,0
130609,and,0,0
130610,provide,0,0
130611,other,0,0
130612,beneficial,0,0
130613,results,0,0
130614,during,0,0
130615,the,0,0
130616,early,0,0
130617,rehabilitation,0,1
130618,following,0,0
130619,TKA,0,1
130620,.,0,0
130621,LEVEL,0,0
130622,OF,0,0
130623,EVIDENCE,0,0
130624,Prospective,0,0
130625,comparative,0,0
130626,study,0,0
130627,",",0,0
130628,Level,0,0
130629,I,0,0
130630,.,0,0
130631,Comparative,0,0
130632,effectiveness,0,0
130633,of,0,0
130634,exercise,0,1
130635,electrocardiography,0,0
130636,with,0,0
130637,or,0,0
130638,without,0,0
130639,myocardial,0,0
130640,perfusion,0,0
130641,single,0,0
130642,photon,0,1
130643,emission,0,0
130644,computed,0,1
130645,tomography,0,1
130646,in,0,0
130647,women,0,0
130648,with,0,0
130649,suspected,0,0
130650,coronary,0,0
130651,artery,0,0
130652,disease,0,0
130653,:,0,0
130654,results,0,0
130655,from,0,0
130656,the,0,0
130657,What,0,0
130658,Is,0,0
130659,the,0,0
130660,Optimal,0,0
130661,Method,0,0
130662,for,0,0
130663,Ischemia,0,0
130664,Evaluation,0,0
130665,in,0,0
130666,Women,0,0
130667,(,0,0
130668,WOMEN,0,1
130669,),0,0
130670,trial,0,0
130671,.,0,0
130672,BACKGROUND,0,0
130673,There,0,0
130674,is,0,0
130675,a,0,0
130676,paucity,0,0
130677,of,0,0
130678,randomized,0,0
130679,trials,0,0
130680,regarding,0,0
130681,diagnostic,0,0
130682,testing,0,0
130683,in,0,0
130684,women,0,0
130685,with,0,0
130686,suspected,0,0
130687,coronary,0,0
130688,artery,0,0
130689,disease,0,0
130690,(,0,0
130691,CAD,0,0
130692,),0,0
130693,.,0,0
130694,It,0,0
130695,remains,0,0
130696,unclear,0,0
130697,whether,0,0
130698,the,0,0
130699,addition,0,0
130700,of,0,0
130701,myocardial,0,0
130702,perfusion,0,1
130703,imaging,0,1
130704,(,0,0
130705,MPI,0,1
130706,),0,0
130707,to,0,0
130708,the,0,0
130709,standard,0,1
130710,ECG,0,1
130711,exercise,0,1
130712,treadmill,0,1
130713,test,0,0
130714,(,0,0
130715,ETT,0,1
130716,),0,1
130717,provides,0,0
130718,incremental,0,0
130719,information,0,0
130720,to,0,0
130721,improve,0,0
130722,clinical,0,0
130723,decision,0,0
130724,making,0,0
130725,in,0,0
130726,women,0,0
130727,with,0,0
130728,suspected,0,0
130729,CAD,0,0
130730,.,0,0
130731,METHODS,0,0
130732,AND,0,0
130733,RESULTS,0,0
130734,We,0,0
130735,randomized,0,0
130736,symptomatic,0,0
130737,women,0,0
130738,with,0,0
130739,suspected,0,0
130740,CAD,0,0
130741,",",0,0
130742,an,1,0
130743,interpretable,1,0
130744,ECG,1,0
130745,",",1,0
130746,and,1,0
130747,?5,1,1
130748,metabolic,1,0
130749,equivalents,1,0
130750,on,1,0
130751,the,0,0
130752,Duke,0,0
130753,Activity,0,0
130754,Status,0,0
130755,Index,0,1
130756,to,0,0
130757,1,0,0
130758,of,0,0
130759,2,0,0
130760,diagnostic,0,0
130761,strategies,1,0
130762,:,1,0
130763,ETT,1,1
130764,or,1,1
130765,exercise,1,1
130766,MPI,1,1
130767,.,1,0
130768,The,0,0
130769,primary,0,0
130770,end,0,0
130771,point,0,0
130772,was,0,0
130773,2-year,0,0
130774,incidence,0,0
130775,of,0,0
130776,major,0,0
130777,adverse,0,0
130778,cardiac,0,0
130779,events,0,0
130780,",",0,0
130781,defined,0,0
130782,as,0,0
130783,CAD,0,0
130784,death,0,0
130785,or,0,1
130786,hospitalization,0,0
130787,for,0,0
130788,an,0,0
130789,acute,0,0
130790,coronary,0,0
130791,syndrome,0,0
130792,or,0,1
130793,heart,0,0
130794,failure,0,0
130795,.,0,0
130796,A,0,0
130797,total,0,0
130798,of,0,0
130799,824,0,0
130800,women,0,0
130801,were,0,0
130802,randomized,0,0
130803,to,0,0
130804,ETT,1,1
130805,or,1,1
130806,exercise,1,1
130807,MPI,1,1
130808,.,1,0
130809,For,0,0
130810,women,0,0
130811,randomized,0,0
130812,to,0,0
130813,ETT,1,1
130814,",",1,0
130815,ECG,0,0
130816,results,0,0
130817,were,0,0
130818,normal,0,0
130819,in,0,0
130820,64,0,0
130821,%,0,0
130822,",",0,0
130823,indeterminate,0,0
130824,in,0,0
130825,16,0,0
130826,%,0,0
130827,",",0,0
130828,and,0,0
130829,abnormal,0,0
130830,in,0,0
130831,20,0,0
130832,%,0,0
130833,.,0,0
130834,By,0,0
130835,comparison,0,0
130836,",",0,0
130837,the,0,0
130838,exercise,0,1
130839,MPI,0,1
130840,results,0,0
130841,were,0,0
130842,normal,0,0
130843,in,0,0
130844,91,0,0
130845,%,0,0
130846,",",0,0
130847,mildly,0,0
130848,abnormal,0,0
130849,in,0,0
130850,3,0,0
130851,%,0,0
130852,",",0,0
130853,and,0,0
130854,moderate,0,0
130855,to,0,0
130856,severely,0,0
130857,abnormal,0,0
130858,in,0,0
130859,6,0,0
130860,%,0,0
130861,.,0,0
130862,At,0,0
130863,2,0,0
130864,years,0,0
130865,",",0,0
130866,there,0,0
130867,was,0,0
130868,no,0,0
130869,difference,0,0
130870,in,0,0
130871,major,0,0
130872,adverse,0,0
130873,cardiac,0,0
130874,events,0,0
130875,(,0,0
130876,98.0,0,0
130877,%,0,0
130878,for,0,0
130879,ETT,0,1
130880,and,0,0
130881,97.7,0,0
130882,%,0,0
130883,for,0,0
130884,MPI,0,1
130885,;,0,0
130886,P=0.59,0,0
130887,),0,0
130888,.,0,0
130889,Compared,0,0
130890,with,0,0
130891,ETT,0,1
130892,",",0,0
130893,index,0,0
130894,testing,0,0
130895,costs,0,0
130896,were,0,0
130897,higher,0,0
130898,for,0,0
130899,exercise,0,1
130900,MPI,0,1
130901,(,0,0
130902,P,0,0
130903,<,0,0
130904,0.001,0,0
130905,),0,0
130906,",",0,0
130907,whereas,0,0
130908,downstream,0,0
130909,procedural,0,0
130910,costs,0,0
130911,were,0,0
130912,slightly,0,0
130913,lower,0,0
130914,(,0,0
130915,P=0.0008,0,0
130916,),0,0
130917,.,0,0
130918,Overall,0,0
130919,",",0,0
130920,the,0,0
130921,cumulative,0,0
130922,diagnostic,0,0
130923,cost,0,0
130924,savings,0,0
130925,was,0,0
130926,48,0,0
130927,%,0,0
130928,for,0,0
130929,ETT,0,1
130930,compared,0,0
130931,with,0,0
130932,exercise,0,1
130933,MPI,0,1
130934,(,0,0
130935,P,0,0
130936,<,0,0
130937,0.001,0,0
130938,),0,0
130939,.,0,0
130940,CONCLUSIONS,0,0
130941,In,0,0
130942,low-risk,0,0
130943,",",0,0
130944,exercising,0,0
130945,women,0,0
130946,",",0,0
130947,a,0,0
130948,diagnostic,0,0
130949,strategy,0,0
130950,that,0,0
130951,uses,0,0
130952,ETT,0,1
130953,versus,0,0
130954,exercise,0,1
130955,MPI,0,1
130956,yields,0,0
130957,similar,0,0
130958,2-year,0,0
130959,posttest,0,0
130960,outcomes,0,0
130961,while,0,0
130962,providing,0,0
130963,significant,0,0
130964,diagnostic,0,0
130965,cost,0,0
130966,savings,0,0
130967,.,0,0
130968,The,0,0
130969,ETT,0,0
130970,with,0,0
130971,selective,0,0
130972,follow-up,0,0
130973,testing,0,0
130974,should,0,0
130975,be,0,0
130976,considered,0,0
130977,as,0,0
130978,the,0,0
130979,initial,0,0
130980,diagnostic,0,0
130981,strategy,0,0
130982,in,0,0
130983,symptomatic,0,0
130984,women,0,0
130985,with,0,0
130986,suspected,0,0
130987,CAD,0,0
130988,.,0,0
130989,CLINICAL,0,0
130990,TRIAL,0,0
130991,REGISTRATION,0,0
130992,http,0,0
130993,:,0,0
130994,//www.clinicaltrials.gov,0,0
130995,.,0,0
130996,Unique,0,0
130997,identifier,0,0
130998,:,0,0
130999,NCT00282711,0,0
131000,.,0,0
131001,[,0,0
131002,Clinical,0,0
131003,study,0,0
131004,on,0,0
131005,treatment,0,0
131006,of,0,0
131007,endometriosis-related,0,0
131008,infertility,0,0
131009,patients,0,0
131010,by,0,0
131011,laparoscopic,1,1
131012,surgery,1,0
131013,in,1,0
131014,combination,1,1
131015,of,1,0
131016,quyu,1,1
131017,jiedu,1,1
131018,recipe,1,1
131019,],1,0
131020,.,0,0
131021,OBJECTIVE,0,0
131022,To,0,0
131023,study,0,0
131024,the,0,0
131025,clinical,0,0
131026,efficacy,0,0
131027,of,0,0
131028,the,0,0
131029,laparoscopic,1,1
131030,surgery,1,0
131031,in,1,0
131032,combination,1,1
131033,of,1,0
131034,Quyu,1,1
131035,Jiedu,1,1
131036,Recipe,1,1
131037,(,1,0
131038,QYJDR,1,1
131039,),1,0
131040,on,0,0
131041,endometriosis,0,0
131042,(,0,0
131043,EMs,0,1
131044,),0,0
131045,-related,0,0
131046,infertility,0,0
131047,patients,0,0
131048,.,0,0
131049,METHODS,0,0
131050,130,0,0
131051,EMs-related,0,0
131052,infertility,0,0
131053,patients,0,0
131054,of,0,0
131055,blood,0,0
131056,stasis,0,0
131057,and,0,0
131058,toxin,0,1
131059,accumulation,0,0
131060,syndrome,0,0
131061,diagnosed,0,0
131062,and,0,0
131063,treated,0,0
131064,by,0,0
131065,laparoscopic,1,1
131066,surgery,1,0
131067,were,0,0
131068,randomly,0,0
131069,assigned,0,0
131070,to,0,0
131071,two,0,0
131072,groups,0,0
131073,",",0,0
131074,i.e.,0,0
131075,",",0,0
131076,the,0,0
131077,test,1,0
131078,group,1,0
131079,(,0,0
131080,75,0,0
131081,cases,0,0
131082,),0,0
131083,and,0,0
131084,the,0,0
131085,control,1,1
131086,group,1,0
131087,(,0,0
131088,55,0,0
131089,cases,0,0
131090,),0,0
131091,.,0,0
131092,All,0,0
131093,patients,0,0
131094,received,0,0
131095,routine,0,0
131096,progesterone,1,0
131097,treatment,1,0
131098,after,1,0
131099,laparoscopic,1,1
131100,surgery,1,0
131101,.,1,0
131102,QYJDR,1,0
131103,was,0,0
131104,given,0,0
131105,to,0,0
131106,patients,0,0
131107,in,0,0
131108,the,0,0
131109,test,0,0
131110,group,0,0
131111,after,0,0
131112,laparoscopic,1,1
131113,surgery,1,0
131114,",",0,0
131115,lasting,0,0
131116,for,0,0
131117,twelve,0,0
131118,months,0,0
131119,.,0,0
131120,The,0,0
131121,pregnancy,0,0
131122,rate,0,0
131123,within,0,0
131124,one,0,0
131125,year,0,0
131126,after,0,0
131127,laparoscopic,1,1
131128,surgery,1,0
131129,were,0,0
131130,compared,0,0
131131,between,0,0
131132,the,0,0
131133,two,0,0
131134,groups,0,0
131135,.,0,0
131136,The,0,0
131137,Chinese,1,0
131138,medicine,1,0
131139,syndrome,0,0
131140,integrals,0,1
131141,",",0,0
131142,serum,0,0
131143,endometrium,0,0
131144,antibody,0,1
131145,(,0,0
131146,EMAb,0,1
131147,),0,1
131148,and,0,0
131149,cancer,0,0
131150,antigen,0,0
131151,125,0,0
131152,(,0,0
131153,CA125,0,1
131154,),0,0
131155,levels,0,0
131156,were,0,0
131157,compared,0,0
131158,between,0,0
131159,before,0,0
131160,drug,1,0
131161,therapy,1,1
131162,and,0,0
131163,three,0,0
131164,months,0,0
131165,after,0,0
131166,drug,1,0
131167,therapy,1,1
131168,.,1,0
131169,RESULTS,0,0
131170,The,0,0
131171,pregnancy,0,0
131172,rate,0,0
131173,within,0,0
131174,one,0,0
131175,year,0,0
131176,after,0,0
131177,laparoscopic,1,1
131178,surgery,1,0
131179,was,0,0
131180,higher,0,0
131181,in,0,0
131182,the,0,0
131183,test,1,0
131184,group,1,0
131185,than,0,0
131186,in,0,0
131187,the,0,0
131188,control,1,0
131189,group,1,0
131190,[,0,0
131191,61.33,0,0
131192,%,0,0
131193,(,0,0
131194,46/75,0,0
131195,),0,0
131196,vs,0,0
131197,45.45,0,0
131198,%,0,0
131199,(,0,0
131200,25/55,0,0
131201,),0,0
131202,],0,0
131203,",",0,0
131204,showing,0,0
131205,significant,0,0
131206,difference,0,0
131207,(,0,0
131208,P,0,0
131209,<,0,0
131210,0.05,0,0
131211,),0,0
131212,.,0,0
131213,The,0,0
131214,Chinese,1,0
131215,medicine,1,0
131216,syndrome,0,0
131217,integral,0,0
131218,was,0,0
131219,(,0,0
131220,16.07,0,0
131221,+/-,0,0
131222,6.77,0,0
131223,),0,0
131224,score,0,0
131225,and,0,0
131226,(,0,0
131227,7.25,0,0
131228,+/-,0,0
131229,3.27,0,0
131230,),0,0
131231,score,0,0
131232,before,0,0
131233,and,0,0
131234,3,0,0
131235,months,0,0
131236,after,0,0
131237,drug,1,0
131238,therapy,1,1
131239,in,0,0
131240,the,0,0
131241,test,1,0
131242,group,1,0
131243,",",0,0
131244,while,0,0
131245,it,0,0
131246,was,0,0
131247,(,0,0
131248,15.92,0,0
131249,+/-,0,0
131250,7.51,0,0
131251,),0,0
131252,score,0,0
131253,and,0,0
131254,(,0,0
131255,12.73,0,0
131256,+/-,0,0
131257,6.12,0,0
131258,),0,0
131259,score,0,0
131260,in,0,0
131261,the,0,0
131262,control,1,0
131263,group,1,0
131264,.,1,0
131265,The,0,0
131266,Chinese,1,0
131267,medicine,1,0
131268,syndrome,0,0
131269,integral,0,0
131270,after,0,0
131271,drug,1,0
131272,therapy,1,1
131273,was,0,0
131274,lower,0,0
131275,than,0,0
131276,that,0,0
131277,before,0,0
131278,drug,1,0
131279,therapy,1,1
131280,in,0,0
131281,the,0,0
131282,same,0,0
131283,group,0,0
131284,.,0,0
131285,Besides,0,0
131286,",",0,0
131287,the,0,0
131288,integral,0,0
131289,difference,0,0
131290,between,0,0
131291,before,0,0
131292,and,0,0
131293,after,0,0
131294,drug,1,0
131295,therapy,1,1
131296,was,0,0
131297,higher,0,0
131298,in,0,0
131299,the,0,0
131300,test,1,0
131301,group,1,0
131302,than,0,0
131303,in,0,0
131304,the,0,0
131305,control,1,0
131306,group,1,0
131307,[,0,0
131308,(,0,0
131309,9.12,0,0
131310,+/-,0,0
131311,6.16,0,0
131312,),0,0
131313,score,0,0
131314,vs,0,0
131315,(,0,0
131316,3.48,0,0
131317,+/-,0,0
131318,2.06,0,0
131319,),0,0
131320,score,0,0
131321,),0,0
131322,],0,0
131323,",",0,0
131324,showing,0,0
131325,statistical,0,0
131326,difference,0,0
131327,(,0,0
131328,P,0,0
131329,<,0,0
131330,0.05,0,0
131331,),0,0
131332,.,0,0
131333,After,0,0
131334,three-month,0,0
131335,drug,0,0
131336,therapy,0,1
131337,",",0,0
131338,the,0,0
131339,serum,0,0
131340,EMAb,0,1
131341,negative,0,0
131342,conversion,0,0
131343,rate,0,0
131344,was,0,0
131345,obviously,0,0
131346,higher,0,0
131347,in,0,0
131348,the,0,0
131349,test,1,0
131350,group,1,0
131351,than,0,0
131352,in,0,0
131353,the,0,0
131354,control,1,1
131355,group,1,0
131356,(,0,0
131357,44.44,0,0
131358,%,0,0
131359,vs,0,0
131360,15.62,0,0
131361,%,0,0
131362,),0,0
131363,",",0,0
131364,showing,0,0
131365,statistical,0,0
131366,difference,0,0
131367,(,0,0
131368,P,0,0
131369,<,0,0
131370,0.05,0,0
131371,),0,0
131372,.,0,0
131373,The,0,0
131374,serum,0,0
131375,CA125,0,1
131376,level,0,0
131377,was,0,0
131378,(,0,0
131379,31.88,0,0
131380,+/-,0,0
131381,15.78,0,0
131382,),0,0
131383,U/mL,0,0
131384,before,0,0
131385,drug,1,0
131386,therapy,1,1
131387,and,0,0
131388,(,0,0
131389,18.82,0,0
131390,+/-,0,0
131391,10.08,0,0
131392,),0,0
131393,U/mL,0,0
131394,three,0,0
131395,months,0,0
131396,after,0,0
131397,drug,1,0
131398,therapy,1,1
131399,in,0,0
131400,the,0,0
131401,test,0,0
131402,group,0,0
131403,",",0,0
131404,while,0,0
131405,it,0,0
131406,was,0,0
131407,(,0,0
131408,30.63,0,0
131409,+/-,0,0
131410,19.28,0,0
131411,),0,0
131412,U/mL,0,1
131413,and,0,0
131414,(,0,0
131415,18.05,0,0
131416,+/-,0,0
131417,11.20,0,0
131418,),0,0
131419,U/mL,0,0
131420,respectively,0,0
131421,in,0,0
131422,the,0,0
131423,control,1,0
131424,group,1,0
131425,.,1,0
131426,It,0,0
131427,was,0,0
131428,lowered,0,0
131429,after,0,0
131430,drug,1,0
131431,therapy,1,1
131432,in,0,0
131433,the,0,0
131434,two,0,0
131435,groups,0,0
131436,with,0,0
131437,statistical,0,0
131438,difference,0,0
131439,(,0,0
131440,P,0,0
131441,<,0,0
131442,0.05,0,0
131443,),0,0
131444,.,0,0
131445,There,0,0
131446,was,0,0
131447,no,0,0
131448,statistical,0,0
131449,difference,0,0
131450,between,0,0
131451,the,0,0
131452,two,0,0
131453,groups,0,0
131454,after,0,0
131455,drug,1,0
131456,therapy,1,1
131457,(,0,0
131458,P,0,0
131459,>,0,0
131460,0.05,0,0
131461,),0,0
131462,.,0,0
131463,CONCLUSIONS,0,0
131464,The,0,0
131465,laparoscopic,1,1
131466,surgery,1,0
131467,in,1,0
131468,combination,1,1
131469,of,1,0
131470,QYJDR,1,0
131471,could,0,0
131472,effectively,0,0
131473,improve,0,0
131474,clinical,0,0
131475,symptoms,0,0
131476,of,0,0
131477,EMs,0,0
131478,patients,0,0
131479,of,0,0
131480,blood,0,0
131481,stasis,0,0
131482,and,0,0
131483,toxin,0,1
131484,accumulation,0,0
131485,syndrome,0,0
131486,",",0,0
131487,promote,0,0
131488,negative,0,0
131489,conversion,0,0
131490,of,0,0
131491,EMAb,0,0
131492,",",0,0
131493,lower,0,0
131494,serum,0,0
131495,CA125,0,1
131496,levels,0,0
131497,",",0,0
131498,and,0,0
131499,elevate,0,0
131500,the,0,0
131501,clinical,0,0
131502,pregnancy,0,0
131503,rate,0,0
131504,.,0,0
131505,QYJDR,1,0
131506,is,0,0
131507,an,0,0
131508,effective,0,0
131509,formula,0,1
131510,in,0,0
131511,treatment,0,0
131512,of,0,0
131513,EMs-related,0,0
131514,infertility,0,0
131515,.,0,0
131516,A,0,0
131517,physiotherapy,1,1
131518,service,1,0
131519,to,0,0
131520,an,0,0
131521,emergency,0,0
131522,extended,0,1
131523,care,0,1
131524,unit,0,0
131525,does,0,0
131526,not,0,0
131527,decrease,0,0
131528,admission,0,0
131529,rates,0,0
131530,to,0,0
131531,hospital,0,0
131532,:,0,0
131533,a,0,0
131534,randomised,0,0
131535,trial,0,0
131536,.,0,0
131537,BACKGROUND,0,0
131538,One,0,0
131539,of,0,0
131540,the,0,0
131541,reasons,0,0
131542,physiotherapy,1,1
131543,services,1,0
131544,are,0,0
131545,provided,0,0
131546,to,0,0
131547,emergency,0,0
131548,departments,0,0
131549,(,0,0
131550,EDs,0,0
131551,),0,1
131552,and,0,0
131553,emergency,0,1
131554,extended,0,1
131555,care,0,1
131556,units,0,1
131557,(,0,0
131558,EECUs,0,0
131559,),0,1
131560,is,0,0
131561,to,0,0
131562,review,0,0
131563,patients,0,0
131564,',0,0
131565,mobility,0,0
131566,to,0,0
131567,ensure,0,0
131568,they,0,0
131569,are,0,0
131570,safe,0,0
131571,to,0,0
131572,be,0,0
131573,discharged,0,0
131574,home,0,0
131575,.,0,0
131576,AIM,0,0
131577,To,0,0
131578,investigate,0,0
131579,whether,0,0
131580,a,0,0
131581,physiotherapy,1,1
131582,service,1,0
131583,to,0,0
131584,an,0,0
131585,EECU,0,0
131586,altered,0,0
131587,the,0,0
131588,rate,0,0
131589,of,0,0
131590,hospital,0,0
131591,admission,0,0
131592,",",0,0
131593,rate,0,0
131594,of,0,0
131595,re-presentation,0,0
131596,to,0,0
131597,the,0,0
131598,ED,0,1
131599,",",0,0
131600,visits,0,0
131601,to,0,0
131602,community,0,0
131603,healthcare,0,0
131604,practitioners,0,0
131605,",",0,0
131606,return,0,0
131607,to,0,0
131608,usual,0,1
131609,work/home/leisure,0,0
131610,activities,0,0
131611,and,0,0
131612,patient,0,0
131613,satisfaction,0,0
131614,.,0,0
131615,METHODS,0,0
131616,A,0,0
131617,randomised,0,0
131618,trial,0,0
131619,with,0,0
131620,concealed,0,0
131621,allocation,0,0
131622,",",0,0
131623,assessor,0,0
131624,blinding,0,0
131625,and,0,0
131626,intention-to-treat,0,0
131627,analysis,0,0
131628,was,0,0
131629,undertaken,0,0
131630,in,0,0
131631,an,0,0
131632,EECU,0,0
131633,.,0,0
131634,The,0,0
131635,sample,0,0
131636,comprised,0,0
131637,186,0,0
131638,patients,0,0
131639,(,0,0
131640,mean,0,0
131641,age,0,0
131642,70,0,0
131643,years,0,0
131644,",",0,0
131645,123,0,0
131646,(,0,0
131647,66,0,0
131648,%,0,0
131649,),0,0
131650,female,0,0
131651,patients,0,0
131652,",",0,0
131653,130,0,0
131654,(,0,0
131655,70,0,0
131656,%,0,0
131657,),0,0
131658,trauma,0,0
131659,),0,0
131660,who,0,0
131661,were,0,0
131662,referred,0,0
131663,for,0,0
131664,physiotherapy,1,1
131665,assessment/intervention,1,0
131666,.,1,0
131667,Referral,0,0
131668,occurred,0,0
131669,at,0,0
131670,any,0,0
131671,stage,0,0
131672,of,0,0
131673,the,0,0
131674,patients,0,0
131675,',0,0
131676,EECU,0,0
131677,admission,0,0
131678,.,0,0
131679,All,0,0
131680,participants,0,0
131681,received,0,0
131682,medical/nursing,1,1
131683,care,1,0
131684,as,0,0
131685,required,0,0
131686,.,0,0
131687,The,0,0
131688,physiotherapy,1,1
131689,group,0,0
131690,also,0,0
131691,received,0,0
131692,physiotherapy,1,1
131693,assessment/intervention,1,0
131694,.,1,0
131695,RESULTS,0,0
131696,The,0,0
131697,physiotherapy,1,1
131698,group,0,0
131699,had,0,0
131700,a,0,0
131701,4,0,0
131702,%,0,0
131703,(,0,0
131704,95,0,0
131705,%,0,0
131706,CI,0,0
131707,-18,0,0
131708,%,0,0
131709,to,0,0
131710,9,0,0
131711,%,0,0
131712,),0,0
131713,lower,0,0
131714,rate,0,0
131715,of,0,0
131716,admission,0,0
131717,to,0,0
131718,hospital,0,0
131719,than,0,0
131720,the,0,0
131721,control,0,1
131722,group,0,0
131723,and,0,0
131724,a,0,0
131725,4,0,0
131726,%,0,0
131727,(,0,0
131728,95,0,0
131729,%,0,0
131730,CI,0,0
131731,-6,0,0
131732,%,0,0
131733,to,0,0
131734,13,0,0
131735,%,0,0
131736,),0,0
131737,higher,0,0
131738,rate,0,0
131739,of,0,0
131740,re-presentation,0,0
131741,to,0,0
131742,the,0,0
131743,ED,0,1
131744,",",0,0
131745,which,0,0
131746,were,0,0
131747,statistically,0,0
131748,non-significant,0,0
131749,(,0,0
131750,p?0.45,0,0
131751,),0,0
131752,.,0,0
131753,Differences,0,0
131754,between,0,0
131755,groups,0,0
131756,for,0,0
131757,use,0,0
131758,of,0,0
131759,community,0,0
131760,healthcare,0,0
131761,resources,0,0
131762,",",0,0
131763,return,0,0
131764,to,0,0
131765,usual,0,1
131766,work/home/leisure,0,0
131767,activities,0,0
131768,and,0,0
131769,satisfaction,0,0
131770,with,0,0
131771,their,0,0
131772,EECU,0,0
131773,care,0,0
131774,were,0,0
131775,small,0,0
131776,and,0,0
131777,not,0,0
131778,significant,0,0
131779,.,0,0
131780,CONCLUSION,0,0
131781,A,0,0
131782,physiotherapy,1,1
131783,service,1,0
131784,for,1,0
131785,EECU,0,0
131786,patients,0,0
131787,",",0,0
131788,as,0,0
131789,provided,0,0
131790,in,0,0
131791,this,0,0
131792,study,0,0
131793,",",0,0
131794,did,0,0
131795,not,0,0
131796,reduce,0,0
131797,the,0,0
131798,rate,0,0
131799,of,0,0
131800,hospital,0,0
131801,admission,0,0
131802,",",0,0
131803,rate,0,0
131804,of,0,0
131805,re-presentation,0,0
131806,to,0,0
131807,the,0,0
131808,ED,0,1
131809,",",0,0
131810,use,0,0
131811,of,0,0
131812,community,0,0
131813,healthcare,0,0
131814,resources,0,0
131815,",",0,0
131816,or,0,0
131817,improve,0,0
131818,the,0,0
131819,rate,0,0
131820,of,0,0
131821,return,0,0
131822,to,0,0
131823,usual,0,1
131824,work/home/leisure,0,0
131825,activities,0,0
131826,or,0,0
131827,patient,0,0
131828,satisfaction,0,0
131829,.,0,0
131830,Trial,0,0
131831,registration,0,0
131832,number,0,0
131833,ANZCTRN12609000106235,0,0
131834,.,0,0
131835,[,1,0
131836,Cisapride,1,1
131837,for,0,0
131838,the,0,0
131839,treatment,0,0
131840,of,0,0
131841,irritable,0,0
131842,stomach,0,0
131843,--,0,0
131844,results,0,0
131845,of,0,0
131846,2,0,0
131847,multicenter,0,0
131848,studies,0,0
131849,],0,0
131850,.,0,0
131851,Effect,0,0
131852,of,0,0
131853,intravenous,0,1
131854,dezocine,1,1
131855,on,0,0
131856,fentanyl-induced,0,0
131857,cough,0,0
131858,during,0,0
131859,general,0,0
131860,anesthesia,0,1
131861,induction,0,0
131862,:,0,0
131863,a,0,0
131864,double-blinded,0,0
131865,",",0,0
131866,prospective,0,0
131867,",",0,0
131868,randomized,0,0
131869,",",0,0
131870,controlled,0,0
131871,trial,0,0
131872,.,0,0
131873,PURPOSE,0,0
131874,To,0,0
131875,evaluate,0,0
131876,the,0,0
131877,suppressive,0,0
131878,effect,0,0
131879,of,0,0
131880,intravenous,0,1
131881,dezocine,1,1
131882,on,0,0
131883,fentanyl-induced,0,0
131884,cough,0,0
131885,during,0,0
131886,the,0,0
131887,induction,0,0
131888,of,0,0
131889,general,0,0
131890,anesthesia,0,1
131891,.,0,0
131892,METHODS,0,0
131893,A,0,0
131894,total,0,0
131895,of,0,0
131896,120,0,0
131897,patients,0,0
131898,",",0,0
131899,American,0,0
131900,Society,0,0
131901,of,0,0
131902,Anesthesiologists,0,0
131903,(,0,0
131904,ASA,0,1
131905,),0,0
131906,physical,0,1
131907,status,0,0
131908,I-II,0,0
131909,",",0,0
131910,were,0,0
131911,randomized,0,0
131912,into,0,0
131913,two,0,0
131914,equally,0,0
131915,sized,0,0
131916,groups,0,0
131917,(,0,0
131918,n,0,0
131919,=,0,0
131920,60,0,0
131921,),0,0
131922,.,0,0
131923,These,0,0
131924,two,0,0
131925,groups,0,0
131926,were,0,0
131927,given,0,0
131928,either,0,0
131929,intravenous,1,1
131930,dezocine,1,1
131931,0.1,0,1
131932,mg/kg,0,0
131933,or,1,0
131934,a,1,0
131935,matching,1,0
131936,placebo,1,1
131937,(,0,0
131938,equal,0,0
131939,volume,0,0
131940,of,0,0
131941,0.9,0,0
131942,%,0,0
131943,saline,0,1
131944,),0,0
131945,10,0,0
131946,min,0,0
131947,before,0,0
131948,the,0,0
131949,induction,0,0
131950,of,0,0
131951,general,0,0
131952,anesthesia,0,1
131953,.,0,0
131954,Patients,0,0
131955,were,0,0
131956,induced,0,0
131957,with,0,0
131958,midazolam,1,1
131959,0.1,1,0
131960,mg/kg,1,0
131961,",",1,0
131962,fentanyl,1,1
131963,5,1,0
131964,?g/kg,1,0
131965,",",1,0
131966,propofol,1,1
131967,1-1.5,1,0
131968,mg/kg,1,1
131969,",",1,0
131970,and,1,0
131971,suxamethonium,1,1
131972,1.5,0,0
131973,mg/kg,0,0
131974,.,0,0
131975,The,0,0
131976,injection,0,0
131977,time,0,0
131978,of,0,0
131979,fentanyl,0,1
131980,was,0,0
131981,less,0,0
131982,than,0,0
131983,2,0,0
131984,s,0,0
131985,in,0,0
131986,all,0,0
131987,patients,0,0
131988,.,0,0
131989,The,0,0
131990,occurrence,0,0
131991,of,0,0
131992,cough,0,0
131993,was,0,0
131994,recorded,0,0
131995,2,0,0
131996,min,0,0
131997,after,0,0
131998,fentanyl,0,1
131999,bolus,0,1
132000,.,0,0
132001,RESULTS,0,0
132002,No,0,0
132003,patient,0,0
132004,in,0,0
132005,the,0,0
132006,dezocine,0,1
132007,group,0,0
132008,had,0,0
132009,cough,0,0
132010,",",0,0
132011,and,0,0
132012,42,0,0
132013,patients,0,0
132014,in,0,0
132015,the,0,0
132016,control,0,0
132017,group,0,0
132018,had,0,0
132019,cough,0,0
132020,.,0,0
132021,This,0,0
132022,difference,0,0
132023,was,0,0
132024,statistically,0,0
132025,different,0,0
132026,between,0,0
132027,these,0,0
132028,two,0,0
132029,groups,0,0
132030,(,0,0
132031,P,0,0
132032,=,0,0
132033,0.000,0,0
132034,),0,0
132035,.,0,0
132036,CONCLUSION,0,0
132037,These,0,0
132038,results,0,0
132039,demonstrate,0,0
132040,that,0,0
132041,intravenous,1,1
132042,dezocine,1,1
132043,0.1,0,0
132044,mg/kg,0,0
132045,10,0,0
132046,min,0,0
132047,prior,0,0
132048,to,0,0
132049,induction,0,0
132050,was,0,0
132051,effective,0,0
132052,in,0,0
132053,suppressing,0,0
132054,fentanyl-induced,0,1
132055,cough,0,0
132056,in,0,0
132057,our,0,0
132058,patients,0,0
132059,.,0,0
132060,Learning,0,0
132061,through,0,0
132062,interaction,0,0
132063,in,0,0
132064,children,0,0
132065,with,0,0
132066,autism,0,0
132067,:,0,0
132068,preliminary,0,0
132069,data,0,0
132070,from,0,0
132071,asocial-communication-based,0,0
132072,intervention,0,1
132073,.,0,0
132074,The,0,0
132075,study,0,0
132076,evaluates,0,0
132077,a,0,0
132078,social-communication-based,1,0
132079,approach,1,1
132080,to,0,0
132081,autism,0,0
132082,intervention,0,1
132083,aimed,0,0
132084,at,0,0
132085,improving,0,0
132086,the,0,0
132087,social,0,0
132088,interaction,0,0
132089,skills,0,0
132090,of,0,0
132091,children,0,0
132092,with,0,0
132093,autism,0,0
132094,spectrum,0,0
132095,disorder,0,0
132096,.,0,0
132097,We,0,0
132098,report,0,0
132099,preliminary,0,0
132100,results,0,0
132101,from,0,0
132102,an,0,0
132103,ongoing,0,0
132104,randomized,0,0
132105,controlled,0,0
132106,trial,0,0
132107,of,0,0
132108,51,0,0
132109,children,0,0
132110,aged,0,0
132111,2,0,0
132112,years,0,0
132113,0,0,0
132114,months,0,0
132115,to,0,0
132116,4,0,0
132117,years,0,0
132118,11,0,0
132119,months,0,0
132120,.,0,0
132121,Participants,0,0
132122,were,0,0
132123,assigned,0,0
132124,to,0,0
132125,either,0,0
132126,a,0,0
132127,target,0,0
132128,treatment,0,0
132129,or,0,1
132130,community,0,1
132131,treatment,0,0
132132,group,0,0
132133,.,0,0
132134,Families,0,0
132135,in,0,0
132136,the,0,0
132137,target,0,0
132138,treatment,0,0
132139,group,0,0
132140,were,0,0
132141,given,0,0
132142,2,0,0
132143,hours,0,0
132144,of,0,0
132145,therapy,1,1
132146,and,1,0
132147,coaching,1,1
132148,each,0,0
132149,week,0,0
132150,in,0,0
132151,an,0,0
132152,intervention,0,1
132153,emphasizing,0,0
132154,social-interaction,1,1
132155,and,1,0
132156,the,1,0
132157,parent-child,1,1
132158,relationship,1,0
132159,.,1,0
132160,Children,0,0
132161,in,0,0
132162,the,0,0
132163,community,1,0
132164,treatment,1,0
132165,group,0,0
132166,received,0,0
132167,a,0,0
132168,variety,1,0
132169,of,1,0
132170,services,1,0
132171,averaging,1,0
132172,3.9,1,0
132173,hours,1,0
132174,per,1,0
132175,week,1,0
132176,.,1,0
132177,After,0,0
132178,12,0,0
132179,months,0,0
132180,",",0,0
132181,outcomes,0,0
132182,were,0,0
132183,measured,0,0
132184,to,0,0
132185,determine,0,0
132186,changes,0,0
132187,in,0,0
132188,the,0,0
132189,groups,0,0
132190,in,0,0
132191,social,0,0
132192,interaction,0,0
132193,and,0,0
132194,communication,0,0
132195,.,0,0
132196,In,0,0
132197,addition,0,0
132198,",",0,0
132199,a,0,0
132200,regression,0,0
132201,analysis,0,0
132202,was,0,0
132203,conducted,0,0
132204,to,0,0
132205,determine,0,0
132206,whether,0,0
132207,changes,0,0
132208,in,0,0
132209,social,0,0
132210,interaction,0,0
132211,skills,0,0
132212,were,0,0
132213,associated,0,0
132214,with,0,0
132215,language,0,0
132216,development,0,0
132217,.,0,0
132218,Results,0,0
132219,suggest,0,0
132220,that,0,0
132221,children,0,0
132222,in,0,0
132223,the,0,0
132224,treatment,0,0
132225,group,0,0
132226,made,0,0
132227,significantly,0,0
132228,greater,0,0
132229,gains,0,0
132230,in,0,0
132231,social,0,0
132232,interaction,0,0
132233,skills,0,1
132234,in,0,0
132235,comparison,0,0
132236,to,0,0
132237,the,0,0
132238,community,0,1
132239,treatment,0,0
132240,group,0,0
132241,",",0,0
132242,but,0,0
132243,no,0,0
132244,between-group,0,0
132245,differences,0,0
132246,were,0,0
132247,found,0,0
132248,for,0,0
132249,standard,0,1
132250,language,0,0
132251,assessments,0,0
132252,.,0,0
132253,Initiation,0,0
132254,of,0,0
132255,joint,0,0
132256,attention,0,0
132257,",",0,0
132258,involvement,0,0
132259,",",0,0
132260,and,0,0
132261,severity,0,0
132262,of,0,0
132263,language,0,0
132264,delay,0,0
132265,were,0,0
132266,found,0,0
132267,to,0,0
132268,be,0,0
132269,significantly,0,0
132270,associated,0,0
132271,with,0,0
132272,improvement,0,0
132273,of,0,0
132274,language,0,0
132275,skills,0,0
132276,in,0,0
132277,children,0,0
132278,with,0,0
132279,autism,0,0
132280,.,0,0
132281,Finally,0,0
132282,caregiver,0,0
132283,skills,0,0
132284,targeted,0,0
132285,by,0,0
132286,the,0,0
132287,intervention,0,1
132288,were,0,0
132289,found,0,0
132290,to,0,0
132291,be,0,0
132292,significantly,0,0
132293,associated,0,0
132294,with,0,0
132295,changes,0,0
132296,in,0,0
132297,children,0,0
132298,'s,0,0
132299,interaction,0,0
132300,skills,0,0
132301,.,0,0
132302,Post,0,1
132303,hoc,0,0
132304,analysis,0,0
132305,of,0,0
132306,a,0,0
132307,single,0,0
132308,IV,0,0
132309,infusion,0,1
132310,of,0,0
132311,zoledronic,1,1
132312,acid,1,1
132313,versus,0,0
132314,daily,0,0
132315,oral,0,1
132316,risedronate,1,1
132317,on,0,0
132318,lumbar,0,1
132319,spine,0,1
132320,bone,0,0
132321,mineral,0,0
132322,density,0,0
132323,in,0,0
132324,different,0,0
132325,subgroups,0,0
132326,with,0,0
132327,glucocorticoid-induced,0,0
132328,osteoporosis,0,0
132329,.,0,0
132330,This,0,0
132331,study,0,0
132332,summarizes,0,0
132333,the,0,0
132334,treatment,0,0
132335,effect,0,0
132336,of,0,0
132337,zoledronic,1,1
132338,acid,1,1
132339,infusion,0,1
132340,on,0,0
132341,lumbar,0,1
132342,spine,0,1
132343,bone,0,0
132344,mineral,0,0
132345,density,0,0
132346,in,0,0
132347,different,0,0
132348,subgroups,0,0
132349,with,0,0
132350,glucocorticoid-induced,0,0
132351,osteoporosis,0,0
132352,.,0,0
132353,Zoledronic,1,0
132354,acid,1,1
132355,is,0,0
132356,significantly,0,0
132357,more,0,0
132358,effective,0,0
132359,than,0,0
132360,risedronate,1,1
132361,in,0,0
132362,increasing,0,0
132363,lumbar,0,1
132364,spine,0,1
132365,(,0,0
132366,LS,0,1
132367,),0,1
132368,bone,0,0
132369,mineral,0,1
132370,density,0,0
132371,(,0,0
132372,BMD,0,0
132373,),0,0
132374,in,0,0
132375,both,0,0
132376,prevention,0,0
132377,and,0,0
132378,treatment,0,0
132379,of,0,0
132380,glucocorticoid-induced,0,0
132381,osteoporosis,0,0
132382,.,0,0
132383,Introduction,0,0
132384,In,0,0
132385,patients,0,0
132386,on,0,0
132387,glucocorticoids,1,1
132388,",",0,0
132389,a,0,0
132390,single,0,0
132391,zoledronic,1,1
132392,acid,1,1
132393,infusion,0,1
132394,significantly,0,0
132395,increased,0,0
132396,BMD,0,0
132397,versus,0,0
132398,daily,0,0
132399,oral,0,1
132400,risedronate,1,1
132401,.,1,0
132402,We,0,0
132403,assessed,0,0
132404,treatment,0,0
132405,effect,0,0
132406,on,0,0
132407,LS,0,1
132408,BMD,0,0
132409,in,0,0
132410,different,0,0
132411,patient,0,0
132412,subgroups,0,0
132413,at,0,0
132414,month,0,0
132415,12,0,0
132416,that,0,0
132417,contributed,0,0
132418,to,0,0
132419,the,0,0
132420,risk,0,0
132421,of,0,0
132422,osteoporosis,0,0
132423,in,0,0
132424,addition,0,0
132425,to,0,0
132426,glucocorticoids,0,1
132427,.,0,0
132428,Methods,0,0
132429,Patients,0,0
132430,randomized,0,0
132431,to,0,0
132432,a,0,0
132433,single,0,0
132434,IV,0,0
132435,infusion,0,1
132436,of,0,0
132437,zoledronic,1,1
132438,acid,1,1
132439,5,0,0
132440,mg,0,1
132441,or,0,1
132442,risedronate,1,1
132443,(,0,0
132444,5,0,0
132445,mg/day,0,1
132446,),0,0
132447,and,0,0
132448,stratified,0,0
132449,based,0,0
132450,on,0,0
132451,glucocorticoids,1,1
132452,duration,0,0
132453,[,0,0
132454,treatment,0,0
132455,(,0,0
132456,>,0,0
132457,3,0,0
132458,months,0,0
132459,),0,0
132460,and,0,0
132461,prevention,0,0
132462,(,0,0
132463,?,0,0
132464,3,0,0
132465,months,0,0
132466,),0,0
132467,subpopulations,0,0
132468,],0,0
132469,were,0,0
132470,subgrouped,0,0
132471,by,0,0
132472,age,0,0
132473,;,0,0
132474,gender,0,0
132475,;,0,0
132476,menopausal,0,0
132477,status,0,0
132478,in,0,0
132479,women,0,0
132480,;,0,0
132481,dose,0,0
132482,and,0,0
132483,duration,0,0
132484,of,0,0
132485,prednisone,1,1
132486,during,1,0
132487,the,0,0
132488,trial,0,0
132489,;,0,0
132490,and,0,0
132491,baseline,0,0
132492,serum,0,0
132493,25-OH,0,0
132494,vitamin,0,1
132495,D,0,1
132496,",",0,0
132497,LS,0,1
132498,BMD,0,0
132499,T-score,0,0
132500,",",0,0
132501,creatinine,0,0
132502,clearance,0,0
132503,",",0,0
132504,and,0,0
132505,concomitant,0,0
132506,medication,0,1
132507,use,0,0
132508,.,0,0
132509,Results,0,0
132510,At,0,0
132511,month,0,0
132512,12,0,0
132513,",",1,0
132514,zoledronic,1,1
132515,acid,1,1
132516,significantly,1,0
132517,increased,0,0
132518,LS,0,1
132519,BMD,0,0
132520,versus,1,0
132521,risedronate,1,1
132522,in,1,0
132523,patients,0,0
132524,?,0,0
132525,74,0,0
132526,years,0,0
132527,(,0,0
132528,P,0,0
132529,<,0,0
132530,0.05,0,0
132531,),0,0
132532,in,0,0
132533,the,0,0
132534,treatment,0,0
132535,and,0,0
132536,65-74,0,0
132537,years,0,0
132538,(,0,0
132539,P,0,0
132540,=,0,0
132541,0.0008,0,0
132542,),0,0
132543,in,0,0
132544,the,0,0
132545,prevention,0,0
132546,subpopulation,0,0
132547,.,0,0
132548,At,0,0
132549,month,0,0
132550,12,0,0
132551,",",0,0
132552,zoledronic,1,1
132553,acid,1,1
132554,significantly,1,0
132555,increased,0,0
132556,LS,0,1
132557,BMD,0,0
132558,versus,1,0
132559,risedronate,1,1
132560,in,1,0
132561,both,0,0
132562,subpopulations,0,0
132563,irrespective,0,0
132564,of,0,0
132565,gender,0,0
132566,(,0,0
132567,all,0,0
132568,P,0,0
132569,<,0,0
132570,0.05,0,0
132571,),0,0
132572,",",0,0
132573,cumulative,0,0
132574,prednisone,0,1
132575,dose,0,0
132576,(,0,0
132577,all,0,0
132578,P,0,0
132579,<,0,0
132580,0.01,0,0
132581,),0,0
132582,",",0,0
132583,and,0,0
132584,postmenopausal,0,0
132585,status,0,0
132586,(,0,0
132587,all,0,0
132588,P,0,0
132589,<,0,0
132590,0.05,0,0
132591,),0,0
132592,.,0,0
132593,In,0,0
132594,premenopausal,0,0
132595,women,0,0
132596,",",0,0
132597,in,0,0
132598,both,0,0
132599,subpopulations,1,0
132600,",",1,0
132601,zoledronic,1,1
132602,acid,1,1
132603,significantly,1,0
132604,increased,0,0
132605,total,0,0
132606,hip,0,0
132607,BMD,0,0
132608,(,0,0
132609,all,0,0
132610,P,0,0
132611,<,0,0
132612,0.05,0,0
132613,),0,0
132614,versus,1,0
132615,risedronate,1,1
132616,at,1,0
132617,month,0,0
132618,12,0,0
132619,but,0,0
132620,not,0,0
132621,LS,0,1
132622,BMD,0,0
132623,.,0,0
132624,Osteoporotic,0,0
132625,patients,0,0
132626,in,0,0
132627,the,0,0
132628,prevention,0,0
132629,(,0,0
132630,P=0.0189,0,0
132631,),0,1
132632,and,0,0
132633,osteopenic,0,0
132634,patients,0,0
132635,in,0,0
132636,the,0,0
132637,treatment,0,0
132638,subpopulation,0,0
132639,(,0,0
132640,P=0.0305,0,0
132641,),0,0
132642,showed,0,0
132643,significant,0,0
132644,LS,0,1
132645,BMD,0,0
132646,increases,0,0
132647,with,0,0
132648,zoledronic,1,1
132649,acid,1,1
132650,versus,1,0
132651,risedronate,1,1
132652,at,1,0
132653,month,0,0
132654,12,0,0
132655,.,0,0
132656,Conclusions,0,0
132657,This,0,0
132658,post,0,0
132659,hoc,0,0
132660,analysis,0,0
132661,suggests,0,0
132662,that,0,0
132663,zoledronic,1,1
132664,acid,1,1
132665,is,1,0
132666,significantly,0,0
132667,more,0,0
132668,effective,0,0
132669,than,0,0
132670,risedronate,1,1
132671,in,1,0
132672,increasing,0,0
132673,LS,0,1
132674,BMD,0,0
132675,in,0,0
132676,prevention,0,0
132677,and,0,0
132678,treatment,0,0
132679,of,0,0
132680,glucocorticoid-induced,0,0
132681,osteoporosis,0,0
132682,across,0,0
132683,a,0,0
132684,wide,0,0
132685,range,0,0
132686,of,0,0
132687,patients,0,0
132688,.,0,0
132689,[,0,0
132690,Treatment,0,0
132691,of,0,0
132692,primary,0,0
132693,osteoporosis,0,0
132694,with,0,0
132695,calcium,1,1
132696,and,1,0
132697,salmon,1,1
132698,calcitonin,1,1
132699,],1,0
132700,.,0,0
132701,Fifty-nine,0,0
132702,consecutive,0,0
132703,patients,0,0
132704,(,0,0
132705,19,0,0
132706,men,0,0
132707,",",0,0
132708,40,0,0
132709,women,0,0
132710,",",0,0
132711,mean,0,0
132712,age,0,0
132713,60.8,0,0
132714,[,0,0
132715,27-80,0,0
132716,],0,0
132717,years,0,0
132718,),0,0
132719,with,0,0
132720,primary,0,0
132721,osteoporosis,0,0
132722,were,0,0
132723,studied,0,0
132724,to,0,0
132725,see,0,0
132726,if,0,0
132727,there,0,0
132728,was,0,0
132729,any,0,0
132730,significant,0,0
132731,gain,0,0
132732,in,0,0
132733,bone,0,0
132734,mass,0,0
132735,after,0,0
132736,treatment,0,0
132737,with,0,0
132738,salmon,1,0
132739,calcitonin,1,1
132740,.,1,0
132741,All,0,0
132742,the,0,0
132743,patients,0,0
132744,were,0,0
132745,given,0,0
132746,1,0,0
132747,g,0,1
132748,calcium,1,1
132749,by,0,0
132750,mouth,0,0
132751,every,0,0
132752,morning,0,0
132753,.,0,0
132754,Group,0,0
132755,1,0,0
132756,(,0,0
132757,n,0,0
132758,=,0,0
132759,20,0,0
132760,),0,0
132761,received,0,0
132762,no,0,0
132763,other,0,0
132764,specific,0,0
132765,medication,0,0
132766,while,0,0
132767,group,0,0
132768,2,0,0
132769,(,0,0
132770,n,0,0
132771,=,0,0
132772,19,0,0
132773,),0,0
132774,were,0,0
132775,given,0,0
132776,100,1,0
132777,I.U,1,0
132778,.,1,0
132779,calcitonin,1,0
132780,subcutaneously,1,0
132781,every,1,0
132782,second,1,0
132783,evening,1,0
132784,and,1,0
132785,group,1,0
132786,3,1,1
132787,(,1,0
132788,n,1,0
132789,=,1,0
132790,20,1,0
132791,),1,0
132792,received,1,0
132793,the,1,0
132794,same,1,0
132795,dose,1,0
132796,every,1,1
132797,evening,1,0
132798,.,1,0
132799,The,0,0
132800,pain,0,0
132801,reported,0,0
132802,by,0,0
132803,the,0,0
132804,patients,0,0
132805,was,0,0
132806,subdivided,0,0
132807,into,0,0
132808,four,0,0
132809,severity,0,0
132810,grades,0,0
132811,",",0,0
132812,and,0,0
132813,analgesic,0,0
132814,consumption,0,0
132815,was,0,0
132816,recorded,0,0
132817,.,0,0
132818,In,0,0
132819,group,0,0
132820,1,0,0
132821,there,0,0
132822,was,0,0
132823,a,0,0
132824,nonsignificant,0,0
132825,decrease,0,0
132826,in,0,0
132827,pain,0,0
132828,",",0,0
132829,but,0,0
132830,in,0,0
132831,groups,0,0
132832,2,0,0
132833,and,0,0
132834,3,0,0
132835,there,0,0
132836,was,0,0
132837,a,0,0
132838,highly,0,0
132839,significant,0,0
132840,diminution,0,0
132841,in,0,0
132842,pain,0,0
132843,(,0,0
132844,P,0,0
132845,less,0,0
132846,than,0,0
132847,0.005,0,0
132848,),0,0
132849,and,0,0
132850,in,0,0
132851,analgesic,0,1
132852,intake,0,0
132853,(,0,0
132854,P,0,0
132855,less,0,0
132856,than,0,0
132857,0.01,0,0
132858,),0,0
132859,.,0,0
132860,Measurements,0,0
132861,of,0,0
132862,bone,0,0
132863,density,0,0
132864,carried,0,0
132865,out,0,0
132866,by,0,0
132867,photon,0,1
132868,absorption,0,0
132869,at,0,0
132870,the,0,0
132871,end,0,0
132872,of,0,0
132873,12,0,0
132874,months,0,0
132875,showed,0,0
132876,a,0,0
132877,5.5,0,0
132878,%,0,0
132879,increase,0,0
132880,in,0,0
132881,the,0,0
132882,distal,0,0
132883,radius,0,0
132884,in,0,0
132885,group,0,0
132886,2,0,0
132887,(,0,0
132888,P,0,0
132889,=,0,0
132890,0.0001,0,0
132891,),0,0
132892,and,0,0
132893,a,0,0
132894,7.1,0,0
132895,%,0,0
132896,increase,0,0
132897,in,0,0
132898,group,0,0
132899,3,0,0
132900,(,0,0
132901,P,0,0
132902,=,0,0
132903,0.0001,0,0
132904,),0,0
132905,",",0,0
132906,while,0,0
132907,in,0,0
132908,group,0,0
132909,1,0,0
132910,mineral,0,0
132911,content,0,0
132912,had,0,0
132913,decreased,0,0
132914,by,0,0
132915,4.3,0,0
132916,%,0,0
132917,(,0,0
132918,nonsignificant,0,0
132919,),0,0
132920,.,0,0
132921,These,0,0
132922,results,0,0
132923,show,0,0
132924,that,0,0
132925,a,0,0
132926,significant,0,0
132927,gain,0,0
132928,in,0,0
132929,bone,0,0
132930,mass,0,0
132931,can,0,0
132932,be,0,0
132933,achieved,0,0
132934,by,0,0
132935,administration,0,0
132936,of,0,0
132937,calcitonin,0,1
132938,",",0,0
132939,either,0,0
132940,daily,0,1
132941,or,0,0
132942,on,0,0
132943,alternate,0,0
132944,days,0,0
132945,.,0,0
132946,The,0,0
132947,incidence,0,0
132948,of,0,0
132949,extravertebral,0,0
132950,fractures,0,0
132951,and,0,0
132952,of,0,0
132953,new,0,0
132954,or,0,0
132955,progressive,0,0
132956,vertebral,0,0
132957,deformity,0,0
132958,tended,0,0
132959,to,0,0
132960,be,0,0
132961,lower,0,0
132962,in,0,0
132963,groups,0,0
132964,2,0,0
132965,and,0,0
132966,3,0,0
132967,than,0,0
132968,in,0,0
132969,group,0,0
132970,1,0,0
132971,.,0,0
132972,Early,0,1
132973,intervention,0,1
132974,for,0,0
132975,autism,0,0
132976,with,0,0
132977,a,0,0
132978,parent-delivered,1,1
132979,Qigong,1,1
132980,massage,1,1
132981,program,1,1
132982,:,1,0
132983,a,0,0
132984,randomized,0,0
132985,controlled,0,0
132986,trial,0,0
132987,.,0,0
132988,A,0,0
132989,recent,0,0
132990,randomized,0,0
132991,controlled,0,0
132992,trial,0,0
132993,(,0,0
132994,RCT,0,0
132995,),0,0
132996,of,0,0
132997,a,0,0
132998,dual,1,0
132999,parent,1,1
133000,and,1,0
133001,trainer-delivered,1,1
133002,qigong,1,1
133003,massage,1,1
133004,intervention,0,1
133005,for,0,0
133006,young,0,0
133007,children,0,0
133008,with,0,0
133009,autism,0,0
133010,resulted,0,0
133011,in,0,0
133012,improvement,0,0
133013,of,0,0
133014,measures,0,0
133015,of,0,0
133016,autism,0,0
133017,as,0,0
133018,well,0,0
133019,as,0,0
133020,improvement,0,0
133021,of,0,0
133022,abnormal,0,0
133023,sensory,0,0
133024,responses,0,0
133025,and,0,0
133026,self-regulation,0,0
133027,.,0,0
133028,The,0,0
133029,RCT,0,0
133030,evaluated,0,0
133031,the,0,0
133032,effects,0,0
133033,of,0,0
133034,the,0,0
133035,parent-delivered,0,1
133036,component,0,0
133037,of,0,0
133038,the,0,0
133039,intervention,0,1
133040,.,0,0
133041,Forty-seven,0,0
133042,children,0,0
133043,were,0,0
133044,randomly,0,0
133045,assigned,0,0
133046,to,0,0
133047,treatment,0,0
133048,and,0,0
133049,wait-list,0,1
133050,control,0,0
133051,groups,0,0
133052,.,0,0
133053,Treatment,0,0
133054,group,0,0
133055,children,0,0
133056,received,0,0
133057,the,0,0
133058,parent-delivered,1,1
133059,program,1,1
133060,for,1,0
133061,4,1,0
133062,mo,1,0
133063,.,1,0
133064,Trained,0,0
133065,therapists,0,0
133066,provided,0,0
133067,parent,1,1
133068,training,1,1
133069,and,1,0
133070,support,1,0
133071,.,1,0
133072,Improvement,0,0
133073,was,0,0
133074,evaluated,0,0
133075,in,0,0
133076,two,0,0
133077,settings,0,0
133078,--,0,0
133079,preschool,0,0
133080,and,0,0
133081,home,0,1
133082,--,0,0
133083,by,0,0
133084,teachers,0,0
133085,(,0,0
133086,blind,0,0
133087,to,0,0
133088,group,0,0
133089,),0,0
133090,and,0,0
133091,parents,0,0
133092,.,0,0
133093,Results,0,0
133094,showed,0,0
133095,that,0,0
133096,the,0,0
133097,parent-delivered,0,1
133098,program,0,1
133099,was,0,0
133100,effective,0,0
133101,in,0,0
133102,improving,0,0
133103,measures,0,0
133104,of,0,0
133105,autism,0,0
133106,(,0,0
133107,medium,0,1
133108,effect,0,0
133109,size,0,0
133110,),0,0
133111,and,0,0
133112,sensory,0,0
133113,and,0,0
133114,self-regulatory,0,1
133115,responses,0,0
133116,(,0,0
133117,large,0,0
133118,effect,0,0
133119,size,0,0
133120,),0,0
133121,.,0,0
133122,Teacher,0,0
133123,data,0,0
133124,on,0,0
133125,measures,0,0
133126,of,0,0
133127,autism,0,0
133128,were,0,0
133129,confirmed,0,0
133130,by,0,0
133131,parent,0,0
133132,data,0,0
133133,.,0,0
133134,Results,0,0
133135,indicate,0,0
133136,that,0,0
133137,the,0,0
133138,parent-delivered,1,1
133139,component,1,0
133140,of,0,0
133141,the,0,0
133142,program,0,1
133143,provided,0,0
133144,effective,0,0
133145,early,0,0
133146,intervention,0,1
133147,for,0,0
133148,autism,0,0
133149,that,0,0
133150,was,0,0
133151,suitable,0,0
133152,for,0,0
133153,delivery,0,0
133154,at,0,0
133155,home,0,0
133156,.,0,0
133157,Long-term,1,0
133158,oral,1,1
133159,branched-chain,1,0
133160,amino,1,1
133161,acid,1,1
133162,treatment,1,0
133163,in,0,0
133164,chronic,0,0
133165,hepatic,0,0
133166,encephalopathy,0,0
133167,.,0,0
133168,A,0,0
133169,randomized,0,0
133170,double-blind,0,0
133171,casein-controlled,0,1
133172,trial,0,0
133173,.,0,0
133174,The,0,0
133175,Italian,0,0
133176,Multicenter,0,0
133177,Study,0,0
133178,Group,0,0
133179,.,0,0
133180,In,0,0
133181,a,0,0
133182,double,0,0
133183,blind,0,0
133184,randomized,0,0
133185,study,0,0
133186,",",0,0
133187,branched-chain,1,0
133188,amino,1,1
133189,acids,1,1
133190,and,0,0
133191,placebo,1,1
133192,(,1,1
133193,casein,1,1
133194,),1,0
133195,were,0,0
133196,compared,0,0
133197,as,0,0
133198,a,0,0
133199,treatment,0,0
133200,for,0,0
133201,chronic,0,0
133202,hepatic,0,0
133203,encephalopathy,0,0
133204,in,0,0
133205,cirrhosis,0,0
133206,.,0,0
133207,After,0,0
133208,a,0,0
133209,15-day,0,0
133210,run-in,0,0
133211,period,0,0
133212,with,0,0
133213,controlled,0,0
133214,diet,0,1
133215,(,0,0
133216,45-65,0,0
133217,g,0,1
133218,protein,0,1
133219,),0,0
133220,",",0,0
133221,the,0,0
133222,patients,0,0
133223,were,0,0
133224,administered,0,0
133225,",",0,0
133226,in,0,0
133227,addition,0,0
133228,to,0,0
133229,their,0,0
133230,diet,0,1
133231,",",0,0
133232,branched-chain,1,0
133233,amino,1,1
133234,acids,1,1
133235,(,0,0
133236,0.24,0,0
133237,g/kg,0,0
133238,",",0,0
133239,30,0,0
133240,patients,0,0
133241,),0,0
133242,or,0,0
133243,an,0,0
133244,equinitrogenous,1,1
133245,amount,1,0
133246,of,1,0
133247,casein,1,1
133248,(,0,0
133249,34,0,0
133250,patients,0,0
133251,),0,0
133252,.,0,0
133253,One,0,0
133254,patient,0,0
133255,on,0,0
133256,branched-chain,0,0
133257,amino,0,1
133258,acids,0,1
133259,and,0,0
133260,two,0,0
133261,on,0,0
133262,casein,0,0
133263,were,0,0
133264,lost,0,0
133265,to,0,0
133266,the,0,0
133267,study,0,0
133268,.,0,0
133269,After,0,0
133270,3,0,0
133271,months,0,0
133272,",",0,0
133273,the,0,0
133274,index,0,0
133275,of,0,0
133276,portal-systemic,0,0
133277,encephalopathy,0,0
133278,significantly,0,0
133279,improved,0,0
133280,in,0,0
133281,patients,0,0
133282,on,0,0
133283,active,1,0
133284,treatment,1,0
133285,(,0,0
133286,from,0,0
133287,40,0,0
133288,[,0,0
133289,S.D,0,0
133290,.,0,0
133291,14,0,0
133292,],0,0
133293,%,0,0
133294,to,0,0
133295,21,0,0
133296,[,0,0
133297,17,0,0
133298,],0,0
133299,),0,0
133300,",",0,0
133301,but,0,0
133302,was,0,0
133303,not,0,0
133304,in,0,0
133305,subjects,0,0
133306,receiving,0,0
133307,casein,1,1
133308,(,0,0
133309,from,0,0
133310,37,0,0
133311,[,0,0
133312,13,0,0
133313,],0,0
133314,%,0,0
133315,to,0,0
133316,36,0,0
133317,[,0,0
133318,12,0,0
133319,],0,0
133320,),0,0
133321,.,0,0
133322,Two,0,0
133323,or,0,0
133324,more,0,0
133325,parameters,0,0
133326,of,0,0
133327,the,0,0
133328,index,0,0
133329,improved,0,0
133330,in,0,0
133331,24,0,0
133332,patients,0,0
133333,treated,0,0
133334,with,0,0
133335,amino,1,1
133336,acids,1,1
133337,(,0,0
133338,80,0,0
133339,%,0,0
133340,;,0,0
133341,confidence,0,0
133342,limits,0,0
133343,",",0,0
133344,61-92,0,0
133345,%,0,0
133346,),0,0
133347,",",0,0
133348,and,0,0
133349,only,0,0
133350,in,0,0
133351,12,0,0
133352,receiving,0,0
133353,casein,1,1
133354,(,0,0
133355,35,0,0
133356,%,0,0
133357,;,0,0
133358,confidence,0,0
133359,limits,0,0
133360,",",0,0
133361,20-54,0,0
133362,%,0,0
133363,;,0,0
133364,p,0,0
133365,less,0,0
133366,than,0,0
133367,0.001,0,0
133368,),0,0
133369,.,0,0
133370,Patients,0,0
133371,who,0,0
133372,did,0,0
133373,not,0,0
133374,improve,0,0
133375,were,0,0
133376,given,0,0
133377,an,0,0
133378,alternative,1,0
133379,treatment,1,0
133380,for,0,0
133381,3,0,0
133382,more,0,0
133383,months,0,0
133384,.,0,0
133385,Casein-treated,0,0
133386,patients,0,0
133387,given,0,0
133388,branched-chain,0,0
133389,amino,1,1
133390,acids,1,1
133391,rapidly,0,0
133392,improved,0,0
133393,.,0,0
133394,The,0,0
133395,changes,0,0
133396,in,0,0
133397,neuropsychologic,0,0
133398,function,0,0
133399,were,0,0
133400,associated,0,0
133401,with,0,0
133402,an,0,0
133403,improvement,0,0
133404,in,0,0
133405,semiquantitative,0,0
133406,nitrogen,0,0
133407,balance,0,0
133408,",",0,0
133409,which,0,0
133410,became,0,0
133411,consistently,0,0
133412,positive,0,0
133413,in,0,0
133414,amino,1,1
133415,acid-treated,1,0
133416,subjects,0,0
133417,;,0,0
133418,there,0,0
133419,was,0,0
133420,also,0,0
133421,a,0,0
133422,mild,0,0
133423,improvement,0,0
133424,in,0,0
133425,nutritional,0,1
133426,parameters,0,0
133427,and,0,0
133428,in,0,0
133429,liver,0,0
133430,function,0,0
133431,tests,0,0
133432,.,0,0
133433,The,0,0
133434,supplementation,0,0
133435,of,0,0
133436,oral,1,1
133437,branched-chain,1,0
133438,amino,1,1
133439,acids,1,1
133440,to,0,0
133441,the,0,0
133442,diet,0,1
133443,is,0,0
133444,superior,0,0
133445,to,0,0
133446,casein,1,0
133447,as,0,0
133448,a,0,0
133449,treatment,0,0
133450,for,0,0
133451,providing,0,0
133452,adequate,0,0
133453,nitrogen,0,1
133454,supply,0,1
133455,and,0,0
133456,improving,0,0
133457,the,0,0
133458,mental,0,0
133459,state,0,0
133460,of,0,0
133461,cirrhotic,0,0
133462,patients,0,0
133463,with,0,0
133464,chronic,0,0
133465,encephalopathy,0,0
133466,.,0,0
133467,Evaluation,0,0
133468,of,0,0
133469,oral,0,1
133470,beclomethasone,1,1
133471,dipropionate,1,1
133472,for,0,0
133473,prevention,0,0
133474,of,0,0
133475,acute,0,0
133476,graft-versus-host,0,0
133477,disease,0,0
133478,.,0,0
133479,Results,0,0
133480,from,0,0
133481,two,0,0
133482,randomized,0,0
133483,trials,0,0
133484,have,0,0
133485,shown,0,0
133486,that,0,0
133487,oral,1,1
133488,beclomethasone,1,1
133489,dipropionate,1,1
133490,(,1,0
133491,BDP,1,0
133492,),1,1
133493,is,0,0
133494,effective,0,0
133495,for,0,0
133496,treatment,0,0
133497,of,0,0
133498,acute,0,0
133499,gastrointestinal,0,0
133500,graft-versus-host,0,0
133501,disease,0,0
133502,.,0,0
133503,Here,0,0
133504,",",0,0
133505,we,0,0
133506,report,0,0
133507,results,0,0
133508,of,0,0
133509,a,0,0
133510,double-blind,0,0
133511,",",0,0
133512,randomized,0,0
133513,placebo-controlled,0,1
133514,phase,0,0
133515,II,0,0
133516,study,0,0
133517,designed,0,0
133518,to,0,0
133519,test,0,0
133520,the,0,0
133521,hypothesis,0,0
133522,that,0,0
133523,acute,0,0
133524,graft-versus-host,0,0
133525,disease,0,0
133526,could,0,0
133527,be,0,0
133528,prevented,0,0
133529,by,0,0
133530,administration,0,0
133531,of,0,0
133532,oral,1,1
133533,BDP,1,0
133534,",",0,0
133535,beginning,0,0
133536,before,0,0
133537,hematopoietic,0,1
133538,cell,0,0
133539,transplantation,0,1
133540,and,0,0
133541,continuing,0,0
133542,until,0,0
133543,day,0,0
133544,75,0,0
133545,after,0,0
133546,hematopoietic,0,0
133547,cell,0,0
133548,transplantation,0,0
133549,after,0,0
133550,myeloablative,0,1
133551,conditioning,0,1
133552,.,0,0
133553,Study,1,0
133554,drug,1,0
133555,(,1,0
133556,BDP,1,0
133557,or,1,1
133558,placebo,1,1
133559,),1,0
133560,was,0,0
133561,administered,0,0
133562,as,0,0
133563,1-mg,0,1
133564,immediate-release,0,1
133565,formulation,0,0
133566,plus,0,1
133567,1-mg,0,1
133568,delayed-release,0,1
133569,formulation,0,0
133570,orally,0,1
133571,four,0,0
133572,times,0,0
133573,daily,0,0
133574,.,0,0
133575,According,0,0
133576,to,0,0
133577,the,0,0
133578,primary,0,0
133579,endpoint,0,0
133580,",",0,0
133581,systemic,0,0
133582,glucocorticoid,1,1
133583,treatment,0,0
133584,for,0,0
133585,graft-versus-host,0,0
133586,disease,0,0
133587,was,0,0
133588,given,0,0
133589,to,0,0
133590,60,0,0
133591,of,0,0
133592,the,0,0
133593,92,0,0
133594,participants,0,0
133595,(,0,0
133596,65,0,0
133597,%,0,0
133598,),0,0
133599,in,0,0
133600,the,0,0
133601,BDP,1,0
133602,arm,0,0
133603,",",0,0
133604,versus,0,0
133605,31,0,0
133606,of,0,0
133607,46,0,0
133608,participants,0,0
133609,(,0,0
133610,67,0,0
133611,%,0,0
133612,),0,0
133613,in,0,0
133614,the,0,0
133615,placebo,1,1
133616,arm,0,0
133617,.,0,0
133618,The,0,0
133619,secondary,0,0
133620,efficacy,0,0
133621,endpoints,0,0
133622,showed,0,0
133623,no,0,0
133624,statistically,0,0
133625,significant,0,0
133626,differences,0,0
133627,between,0,0
133628,the,0,0
133629,two,0,0
133630,arms,0,0
133631,.,0,0
133632,The,0,0
133633,proportion,0,0
133634,of,0,0
133635,participants,0,0
133636,who,0,0
133637,took,0,0
133638,at,0,0
133639,least,0,0
133640,90,0,0
133641,%,0,0
133642,of,0,0
133643,the,0,0
133644,prescribed,0,0
133645,study,0,0
133646,drug,0,0
133647,during,0,0
133648,the,0,0
133649,first,0,0
133650,4,0,0
133651,weeks,0,0
133652,after,0,0
133653,hematopoietic,1,0
133654,cell,1,0
133655,transplantation,1,0
133656,was,0,0
133657,54,0,0
133658,%,0,0
133659,overall,0,0
133660,.,0,0
133661,Lower,0,0
133662,severity,0,0
133663,of,0,0
133664,mucositis,0,0
133665,strongly,0,0
133666,correlated,0,0
133667,with,0,0
133668,higher,0,0
133669,adherence,0,0
133670,to,0,0
133671,the,0,0
133672,schedule,0,0
133673,of,0,0
133674,study,0,0
133675,drug,0,0
133676,administration,0,0
133677,.,0,0
133678,Inconsistent,0,0
133679,adherence,0,0
133680,related,0,0
133681,to,0,0
133682,mucositis,0,0
133683,during,0,0
133684,recovery,0,0
133685,after,0,0
133686,myeloablative,1,1
133687,conditioning,1,1
133688,may,0,0
133689,have,0,0
133690,obscured,0,0
133691,a,0,0
133692,beneficial,0,0
133693,therapeutic,0,0
133694,effect,0,0
133695,in,0,0
133696,the,0,0
133697,current,0,0
133698,study,0,0
133699,.,0,0
133700,Paracetamol,1,1
133701,and,0,0
133702,opioid,0,1
133703,pathways,0,0
133704,:,0,0
133705,a,0,0
133706,pilot,0,0
133707,randomized,0,0
133708,clinical,0,0
133709,trial,0,0
133710,.,0,0
133711,Previous,0,0
133712,studies,0,0
133713,suggest,0,0
133714,that,0,0
133715,the,0,0
133716,antinociceptive,0,0
133717,action,0,0
133718,of,0,0
133719,paracetamol,1,1
133720,(,1,0
133721,acetaminophen,1,1
133722,",",1,0
133723,APAP,1,0
133724,),1,0
133725,might,0,0
133726,involve,0,0
133727,descending,0,0
133728,inhibitory,0,0
133729,pain,0,0
133730,pathways,0,0
133731,and,0,0
133732,the,0,0
133733,opioidergic,0,0
133734,system,0,0
133735,:,0,0
133736,this,0,0
133737,study,0,0
133738,explores,0,0
133739,this,0,0
133740,issue,0,0
133741,in,0,0
133742,humans,0,0
133743,with,0,0
133744,naloxone,1,1
133745,",",1,0
133746,the,1,0
133747,opioid,1,1
133748,antagonist,1,1
133749,.,1,0
133750,After,0,0
133751,ethical,0,0
133752,approval,0,0
133753,",",0,0
133754,12,0,0
133755,healthy,0,0
133756,male,0,0
133757,volunteers,0,0
133758,were,0,0
133759,included,0,0
133760,in,0,0
133761,this,0,0
133762,randomized,0,0
133763,",",0,0
133764,controlled,0,0
133765,",",0,0
133766,double-blind,0,0
133767,",",0,0
133768,crossover,0,0
133769,",",0,0
133770,four-arm,0,0
133771,study,0,0
133772,.,0,0
133773,They,0,0
133774,were,0,0
133775,administered,0,0
133776,intravenous,1,1
133777,paracetamol,1,1
133778,(,1,0
133779,APAP,1,0
133780,1,1,0
133781,g,1,1
133782,),1,0
133783,or,1,1
133784,saline,1,1
133785,(,1,0
133786,placebo,1,1
133787,",",1,0
133788,pl,1,0
133789,),1,0
133790,followed,0,0
133791,at,0,0
133792,100,0,0
133793,min,0,0
133794,with,0,0
133795,IV,1,0
133796,naloxone,1,1
133797,(,1,0
133798,Nal,1,0
133799,8,1,0
133800,mg,1,1
133801,),1,0
133802,or,1,1
133803,saline,1,1
133804,",",0,0
133805,every,0,0
133806,week,0,0
133807,for,0,0
133808,4,0,0
133809,weeks,0,0
133810,.,0,0
133811,The,0,0
133812,amplitude,0,0
133813,of,0,0
133814,cerebral,0,0
133815,potentials,0,0
133816,evoked,0,0
133817,by,0,0
133818,thermal/painful,0,0
133819,stimuli,0,1
133820,applied,0,0
133821,on,0,0
133822,the,0,0
133823,arm,0,0
133824,was,0,0
133825,recorded,0,0
133826,nine,0,0
133827,times,0,0
133828,over,0,0
133829,150,0,0
133830,min,0,0
133831,",",0,0
133832,witnessing,0,0
133833,of,0,0
133834,pain,0,0
133835,integration,0,0
133836,at,0,0
133837,central,0,0
133838,level,0,0
133839,.,0,0
133840,Amplitude,0,0
133841,changes,0,0
133842,as,0,0
133843,well,0,0
133844,as,0,0
133845,areas,0,0
133846,under,0,0
133847,the,0,0
133848,curve,0,0
133849,(,0,0
133850,AUCs,0,1
133851,),0,0
133852,over,0,0
133853,150,0,0
133854,min,0,0
133855,were,0,0
133856,compared,0,0
133857,for,0,0
133858,the,0,0
133859,four,0,0
133860,treatments,0,0
133861,by,0,0
133862,repeated,0,0
133863,measures,0,0
133864,ANOVA,0,1
133865,(,0,0
133866,significance,0,0
133867,0.05,0,0
133868,),0,0
133869,.,0,0
133870,Amplitude,0,0
133871,changes,0,0
133872,were,0,0
133873,significant,0,0
133874,for,0,0
133875,APAP/pl,1,0
133876,vs.,0,0
133877,pl/pl,0,1
133878,at,0,0
133879,t150,0,0
133880,:,0,0
133881,-44,0,0
133882,%,0,0
133883,(,0,0
133884,95,0,0
133885,%,0,0
133886,CI,0,0
133887,-58,0,0
133888,to,0,0
133889,-30,0,0
133890,),0,0
133891,vs.,0,0
133892,-27,0,0
133893,%,0,0
133894,(,0,0
133895,95,0,0
133896,%,0,0
133897,CI,0,0
133898,-37,0,0
133899,to,0,0
133900,-17,0,0
133901,;,0,0
133902,P,0,0
133903,<,0,0
133904,0.05,0,0
133905,),0,0
133906,but,0,0
133907,not,0,0
133908,vs.,0,0
133909,APAP/Nal,1,0
133910,.,1,0
133911,AUC,0,0
133912,(,0,0
133913,0-150,0,0
133914,),0,0
133915,of,0,0
133916,APAP/pl,0,1
133917,is,0,0
133918,significantly,0,0
133919,different,0,0
133920,from,0,0
133921,pl/pl,0,1
133922,(,0,0
133923,-3452,0,0
133924,%,0,0
133925,.min,0,1
133926,(,0,0
133927,95,0,0
133928,%,0,0
133929,CI,0,0
133930,-4705,0,0
133931,to,0,0
133932,-2199,0,0
133933,),0,0
133934,vs.,0,0
133935,-933,0,1
133936,%,0,0
133937,min,0,1
133938,(,0,0
133939,95,0,0
133940,%,0,0
133941,CI,0,0
133942,-2273,0,1
133943,to,0,0
133944,407,0,0
133945,;,0,0
133946,P,0,0
133947,=,0,0
133948,0.015,0,0
133949,),0,0
133950,but,0,0
133951,not,0,0
133952,from,0,0
133953,APAP/Nal,1,0
133954,(,0,0
133955,-1731,0,1
133956,%,0,0
133957,min,0,1
133958,(,0,0
133959,95,0,0
133960,%,0,0
133961,CI,0,0
133962,-3676,0,0
133963,to,0,0
133964,214,0,0
133965,;,0,0
133966,P,0,0
133967,=,0,0
133968,0.08,0,0
133969,),0,0
133970,and,0,0
133971,other,0,0
133972,treatments,0,0
133973,.,0,0
133974,AUC,0,0
133975,(,0,0
133976,90-150,0,0
133977,),0,0
133978,is,0,0
133979,not,0,0
133980,significantly,0,0
133981,different,0,0
133982,.,0,0
133983,This,0,0
133984,pilot,0,0
133985,study,0,0
133986,shows,0,0
133987,for,0,0
133988,the,0,0
133989,first,0,0
133990,time,0,0
133991,in,0,0
133992,human,0,0
133993,volunteers,0,0
133994,that,0,0
133995,naloxone,1,1
133996,does,0,0
133997,not,0,0
133998,inhibit,0,0
133999,paracetamol,1,1
134000,antinociception,0,0
134001,",",0,0
134002,suggesting,0,0
134003,no,0,0
134004,significant,0,0
134005,implication,0,0
134006,of,0,0
134007,the,0,0
134008,opioid,0,1
134009,system,0,0
134010,in,0,0
134011,paracetamol,1,1
134012,mechanism,0,0
134013,of,0,0
134014,action,0,0
134015,:,0,0
134016,this,0,0
134017,needs,0,0
134018,be,0,0
134019,confirmed,0,0
134020,on,0,0
134021,a,0,0
134022,larger,0,0
134023,number,0,0
134024,of,0,0
134025,subjects,0,0
134026,.,0,0
134027,Maintaining,0,0
134028,tissue,0,0
134029,orientation,0,0
134030,during,0,0
134031,mohs,1,1
134032,micrographic,1,1
134033,surgery,1,0
134034,:,1,0
134035,scalpel,1,1
134036,versus,1,0
134037,marker,1,0
134038,.,1,0
134039,BACKGROUND,0,0
134040,Critical,0,0
134041,to,0,0
134042,the,0,0
134043,accuracy,0,0
134044,of,0,0
134045,Mohs,1,1
134046,surgery,1,0
134047,is,0,0
134048,the,0,0
134049,ability,0,0
134050,to,0,0
134051,maintain,0,0
134052,proper,0,0
134053,orientation,0,0
134054,of,0,0
134055,excised,0,1
134056,tissue,0,0
134057,with,0,0
134058,respect,0,0
134059,to,0,0
134060,the,0,0
134061,surrounding,0,0
134062,skin,0,0
134063,.,0,0
134064,Several,0,0
134065,techniques,0,0
134066,have,0,0
134067,been,0,0
134068,described,0,0
134069,for,0,0
134070,maintaining,0,0
134071,this,0,0
134072,orientation,0,0
134073,",",0,0
134074,although,0,0
134075,no,0,0
134076,prior,0,0
134077,investigations,0,0
134078,directly,0,0
134079,compare,0,0
134080,these,0,0
134081,techniques,0,1
134082,.,0,0
134083,OBJECTIVE,0,0
134084,To,0,0
134085,compare,0,0
134086,the,0,0
134087,incidence,0,0
134088,of,0,0
134089,tissue,0,0
134090,orientation,0,0
134091,loss,0,0
134092,resulting,0,0
134093,from,0,0
134094,inability,0,0
134095,to,0,0
134096,identify,0,0
134097,skin,0,0
134098,score,0,0
134099,marks,0,0
134100,with,0,0
134101,that,0,0
134102,occurring,0,0
134103,from,0,0
134104,failure,0,0
134105,to,0,0
134106,identify,0,0
134107,marks,0,0
134108,made,0,0
134109,using,0,0
134110,a,0,0
134111,gentian,1,1
134112,violet,1,1
134113,marker,1,0
134114,during,0,0
134115,Mohs,1,1
134116,micrographic,1,1
134117,surgery,1,1
134118,(,1,0
134119,MMS,1,1
134120,),1,0
134121,.,1,0
134122,We,0,0
134123,also,0,0
134124,sought,0,0
134125,to,0,0
134126,determine,0,0
134127,the,0,0
134128,incidence,0,0
134129,of,0,0
134130,scars,0,0
134131,resulting,0,0
134132,from,0,0
134133,skin,0,0
134134,scoring,0,0
134135,.,0,0
134136,MATERIALS,0,0
134137,AND,0,0
134138,METHODS,0,0
134139,Patients,0,0
134140,undergoing,0,0
134141,MMS,1,1
134142,were,0,0
134143,prospectively,0,0
134144,randomized,0,0
134145,to,0,0
134146,have,0,0
134147,their,0,0
134148,tissue,1,0
134149,margins,1,0
134150,oriented,1,0
134151,using,1,0
134152,light,1,0
134153,scoring,1,0
134154,using,1,0
134155,a,1,0
134156,scalpel,1,1
134157,versus,1,0
134158,marking,1,0
134159,them,1,0
134160,using,1,0
134161,a,1,0
134162,gentian,1,1
134163,violet,1,1
134164,marker,1,0
134165,.,1,0
134166,Incidence,0,0
134167,of,0,0
134168,scoring,0,0
134169,scars,0,0
134170,and,0,0
134171,tissue,0,0
134172,orientation,0,0
134173,loss,0,0
134174,were,0,0
134175,the,0,0
134176,primary,0,0
134177,outcome,0,0
134178,measures,0,0
134179,.,0,0
134180,RESULTS,0,0
134181,Data,0,0
134182,were,0,0
134183,analyzed,0,0
134184,for,0,0
134185,101,0,0
134186,tumors,0,0
134187,.,0,0
134188,There,0,0
134189,were,0,0
134190,no,0,0
134191,instances,0,0
134192,of,0,0
134193,tissue,0,0
134194,orientation,0,0
134195,loss,0,0
134196,in,0,0
134197,the,0,0
134198,scalpel,0,1
134199,or,0,1
134200,marker,0,0
134201,arms,0,0
134202,",",0,0
134203,nor,0,0
134204,were,0,0
134205,there,0,0
134206,any,0,0
134207,visible,0,0
134208,score,0,0
134209,mark,0,0
134210,scars,0,0
134211,at,0,0
134212,follow-up,0,0
134213,.,0,0
134214,CONCLUSION,0,0
134215,Incidence,0,0
134216,of,0,0
134217,excessive,0,0
134218,scars,0,0
134219,resulting,0,0
134220,from,0,0
134221,lightly,0,1
134222,scored,0,0
134223,tissue,0,0
134224,or,0,1
134225,loss,0,0
134226,of,0,0
134227,tissue,0,0
134228,orientation,0,0
134229,caused,0,0
134230,by,0,0
134231,lost,0,0
134232,gentian,0,1
134233,violet,0,1
134234,markings,0,0
134235,appears,0,0
134236,to,0,0
134237,be,0,0
134238,low,0,0
134239,.,0,0
134240,Both,0,0
134241,methods,0,0
134242,worked,0,0
134243,well,0,0
134244,within,0,0
134245,the,0,0
134246,confines,0,0
134247,of,0,0
134248,this,0,0
134249,study,0,0
134250,.,0,0
134251,Making,0,0
134252,the,0,0
134253,connection,0,0
134254,:,0,0
134255,randomized,0,0
134256,controlled,0,0
134257,trial,0,0
134258,of,0,0
134259,social,0,0
134260,skills,0,0
134261,at,0,0
134262,school,0,0
134263,for,0,0
134264,children,0,0
134265,with,0,0
134266,autism,0,0
134267,spectrum,0,0
134268,disorders,0,0
134269,.,0,0
134270,BACKGROUND,0,0
134271,This,0,0
134272,study,0,0
134273,compared,0,0
134274,two,0,0
134275,interventions,0,0
134276,for,0,0
134277,improving,0,0
134278,the,0,0
134279,social,0,0
134280,skills,0,0
134281,of,0,0
134282,high,0,0
134283,functioning,0,0
134284,children,0,0
134285,with,0,0
134286,autism,0,0
134287,spectrum,0,0
134288,disorders,0,0
134289,in,0,0
134290,general,0,0
134291,education,0,0
134292,classrooms,0,0
134293,.,0,0
134294,One,0,0
134295,intervention,0,0
134296,involved,0,0
134297,a,0,0
134298,peer-mediated,1,1
134299,approach,1,1
134300,(,1,0
134301,PEER,1,1
134302,),1,0
134303,and,0,0
134304,the,0,0
134305,other,0,0
134306,involved,0,0
134307,a,0,0
134308,child-assisted,1,1
134309,approach,1,1
134310,(,1,0
134311,CHILD,1,1
134312,),1,0
134313,.,1,0
134314,METHOD,0,0
134315,The,0,0
134316,two,0,0
134317,interventions,0,0
134318,were,0,0
134319,crossed,0,0
134320,in,0,0
134321,a,0,0
134322,2,0,0
134323,?,0,0
134324,2,0,0
134325,factorial,0,0
134326,design,0,0
134327,yielding,0,0
134328,control,1,0
134329,",",1,0
134330,PEER,1,0
134331,",",1,0
134332,CHILD,1,1
134333,",",1,0
134334,and,1,0
134335,both,0,0
134336,PEER,1,1
134337,and,1,0
134338,CHILD,1,0
134339,conditions,1,0
134340,.,0,0
134341,Sixty,0,0
134342,children,0,0
134343,participated,0,0
134344,from,0,0
134345,56,0,0
134346,classrooms,0,0
134347,in,0,0
134348,30,0,0
134349,schools,0,0
134350,.,0,0
134351,Interventions,0,0
134352,involved,0,0
134353,12,0,0
134354,sessions,0,0
134355,over,0,0
134356,6,0,0
134357,weeks,0,0
134358,",",0,0
134359,with,0,0
134360,a,0,0
134361,3-month,0,0
134362,follow-up,0,0
134363,.,0,0
134364,Outcome,0,0
134365,measures,0,0
134366,included,0,0
134367,self,0,0
134368,",",0,0
134369,peer,0,0
134370,and,0,0
134371,teacher,0,1
134372,reports,0,0
134373,of,0,0
134374,social,0,0
134375,skills,0,0
134376,and,0,0
134377,independent,0,0
134378,weekly,0,1
134379,observations,0,0
134380,of,0,0
134381,children,0,0
134382,on,0,0
134383,their,0,0
134384,school,0,0
134385,playground,0,1
134386,over,0,0
134387,the,0,0
134388,course,0,0
134389,of,0,0
134390,the,0,0
134391,intervention,0,1
134392,.,0,0
134393,RESULTS,0,0
134394,Significant,0,0
134395,improvements,0,0
134396,were,0,0
134397,found,0,0
134398,in,0,0
134399,social,0,0
134400,network,0,0
134401,salience,0,0
134402,",",0,0
134403,number,0,0
134404,of,0,0
134405,friendship,0,0
134406,nominations,0,0
134407,",",0,0
134408,teacher,0,1
134409,report,0,0
134410,of,0,0
134411,social,0,0
134412,skills,0,0
134413,in,0,0
134414,the,0,0
134415,classroom,0,1
134416,",",0,0
134417,and,0,0
134418,decreased,0,0
134419,isolation,0,0
134420,on,0,0
134421,the,0,0
134422,playground,0,0
134423,for,0,0
134424,children,0,0
134425,who,0,0
134426,received,1,0
134427,PEER,1,0
134428,interventions,0,0
134429,.,0,0
134430,Changes,0,0
134431,obtained,0,0
134432,at,0,0
134433,the,0,0
134434,end,0,0
134435,of,0,0
134436,the,0,0
134437,treatment,0,0
134438,persisted,0,0
134439,to,0,0
134440,the,0,0
134441,3-month,0,0
134442,follow-up,0,0
134443,.,0,0
134444,CONCLUSIONS,0,0
134445,These,0,0
134446,data,0,0
134447,suggest,0,0
134448,that,0,0
134449,significant,0,0
134450,improvements,0,0
134451,can,0,0
134452,be,0,0
134453,made,0,0
134454,in,0,0
134455,peer,0,0
134456,social,0,0
134457,connections,0,0
134458,for,0,0
134459,children,0,0
134460,with,0,0
134461,autism,0,0
134462,spectrum,0,0
134463,disorders,0,0
134464,in,0,0
134465,general,0,0
134466,education,0,1
134467,classrooms,0,0
134468,with,0,0
134469,a,0,0
134470,brief,0,1
134471,intervention,0,1
134472,",",0,0
134473,and,0,0
134474,that,0,0
134475,these,0,0
134476,gains,0,0
134477,persist,0,0
134478,over,0,0
134479,time,0,0
134480,.,0,0
134481,MSLT,1,1
134482,in,0,0
134483,primary,0,0
134484,insomnia,0,0
134485,:,0,0
134486,stability,0,0
134487,and,0,0
134488,relation,0,0
134489,to,0,0
134490,nocturnal,0,0
134491,sleep,0,0
134492,.,0,0
134493,STUDY,0,0
134494,OBJECTIVES,0,0
134495,To,0,0
134496,assess,0,0
134497,the,0,0
134498,stability,0,0
134499,of,0,0
134500,the,0,0
134501,multiple,1,0
134502,sleep,1,0
134503,latency,1,0
134504,test,1,0
134505,(,1,0
134506,MSLT,1,1
134507,),1,0
134508,in,0,0
134509,primary,0,0
134510,insomnia,0,0
134511,and,0,0
134512,its,0,0
134513,relation,0,0
134514,to,0,0
134515,total,0,0
134516,sleep,0,0
134517,time,0,0
134518,.,0,0
134519,DESIGN,0,0
134520,Randomized,0,0
134521,",",0,0
134522,double-blind,0,0
134523,",",0,0
134524,placebo,0,1
134525,controlled,0,0
134526,",",0,0
134527,clinical,0,0
134528,trial,0,0
134529,.,0,0
134530,SETTING,0,0
134531,Outpatient,0,0
134532,with,0,0
134533,sleep,0,0
134534,laboratory,0,0
134535,assessments,0,0
134536,in,0,0
134537,months,0,0
134538,1,0,0
134539,and,0,0
134540,8,0,0
134541,of,0,0
134542,treatment,0,0
134543,.,0,0
134544,PARTICIPANTS,0,0
134545,Ninety-five,0,0
134546,primary,0,0
134547,insomniacs,0,0
134548,",",0,0
134549,32-64,0,0
134550,years,0,0
134551,old,0,0
134552,and,0,0
134553,55,0,0
134554,age-,0,0
134555,and,0,0
134556,sex-matched,0,0
134557,general,0,0
134558,population-based,0,0
134559,",",0,0
134560,representative,0,0
134561,controls,0,0
134562,.,0,0
134563,INTERVENTIONS,0,0
134564,After,0,0
134565,a,0,0
134566,screening,0,0
134567,nocturnal,1,0
134568,polysomnograms,1,1
134569,(,1,0
134570,NPSG,1,0
134571,),1,0
134572,and,0,0
134573,MSLT,1,1
134574,the,0,0
134575,following,0,0
134576,day,0,0
134577,",",0,0
134578,participants,0,0
134579,with,0,0
134580,primary,0,0
134581,insomnia,0,0
134582,were,0,0
134583,randomized,0,0
134584,to,0,0
134585,take,0,0
134586,zolpidem,1,1
134587,10,0,0
134588,mg,0,1
134589,(,0,0
134590,n,0,0
134591,=,0,0
134592,50,0,0
134593,),0,0
134594,or,0,1
134595,placebo,1,1
134596,(,0,0
134597,n,0,0
134598,=,0,0
134599,45,0,0
134600,),0,0
134601,nightly,0,1
134602,for,0,0
134603,12,0,0
134604,months,0,0
134605,.,0,0
134606,During,0,0
134607,months,0,0
134608,1,0,0
134609,and,0,0
134610,8,0,0
134611,",",0,0
134612,while,0,0
134613,taking,0,0
134614,their,0,0
134615,prescribed,0,0
134616,treatments,0,0
134617,",",0,0
134618,NPSGs,0,0
134619,and,0,0
134620,MSLTs,1,0
134621,the,0,0
134622,following,0,0
134623,day,0,0
134624,were,0,0
134625,conducted,0,0
134626,.,0,0
134627,A,0,0
134628,population-based,0,0
134629,sample,0,0
134630,served,0,0
134631,as,0,0
134632,controls,0,0
134633,and,0,0
134634,received,0,0
134635,a,0,0
134636,single,0,0
134637,NPSG,0,0
134638,followed,0,0
134639,by,0,0
134640,MSLT,1,0
134641,.,1,0
134642,RESULTS,0,0
134643,Mean,0,0
134644,daily,0,1
134645,sleep,0,0
134646,latency,0,0
134647,on,0,0
134648,the,0,0
134649,screening,0,0
134650,MSLT,1,1
134651,of,0,0
134652,insomniacs,0,0
134653,was,0,0
134654,normally,0,0
134655,distributed,0,0
134656,across,0,0
134657,the,0,0
134658,full,0,0
134659,range,0,0
134660,of,0,0
134661,MSLT,1,1
134662,scores,0,0
134663,and,0,0
134664,significantly,0,0
134665,higher,0,0
134666,than,0,0
134667,those,0,0
134668,of,0,0
134669,a,0,0
134670,population-based,0,0
134671,representative,0,0
134672,control,0,1
134673,sample,0,0
134674,(,0,0
134675,P,0,0
134676,<,0,0
134677,0.006,0,0
134678,),0,0
134679,.,0,0
134680,The,0,0
134681,insomniacs,0,0
134682,with,0,0
134683,the,0,0
134684,highest,0,0
134685,screening,0,0
134686,MSLTs,1,0
134687,had,0,0
134688,the,0,0
134689,shortest,0,0
134690,screening,0,0
134691,total,0,0
134692,sleep,0,0
134693,times,0,0
134694,(,0,0
134695,P,0,0
134696,<,0,0
134697,0.05,0,0
134698,),0,0
134699,.,0,0
134700,The,0,0
134701,MSLTs,1,0
134702,of,0,0
134703,insomniacs,0,0
134704,during,0,0
134705,treatment,0,0
134706,in,0,0
134707,study,0,0
134708,month,0,0
134709,1,0,0
134710,were,0,0
134711,correlated,0,0
134712,(,0,0
134713,r,0,0
134714,=,0,0
134715,0.44,0,0
134716,",",0,0
134717,P,0,0
134718,<,0,0
134719,0.001,0,0
134720,),0,0
134721,with,0,0
134722,their,0,0
134723,month,0,0
134724,8,0,0
134725,MSLT,0,0
134726,.,0,0
134727,The,0,0
134728,mean,0,0
134729,MSLT,1,1
134730,score,0,0
134731,of,0,0
134732,the,0,0
134733,zolpidem,0,1
134734,group,0,0
134735,did,0,0
134736,not,0,0
134737,differ,0,0
134738,from,0,0
134739,that,0,0
134740,of,0,0
134741,the,0,0
134742,placebo,0,1
134743,group,0,0
134744,",",0,0
134745,and,0,0
134746,the,0,0
134747,stability,0,0
134748,within,0,0
134749,treatment,0,0
134750,groups,0,0
134751,also,0,0
134752,did,0,0
134753,not,0,0
134754,differ,0,0
134755,.,0,0
134756,CONCLUSIONS,0,0
134757,These,0,0
134758,data,0,0
134759,support,0,0
134760,the,0,0
134761,hypothesis,0,0
134762,that,0,0
134763,some,0,0
134764,insomniacs,0,0
134765,show,0,0
134766,a,0,0
134767,reliable,0,0
134768,disorder,0,0
134769,of,0,0
134770,hyperarousal,0,0
134771,with,0,0
134772,increased,0,0
134773,wake,0,0
134774,drive,0,0
134775,both,0,0
134776,at,0,0
134777,night,0,0
134778,and,0,0
134779,during,0,0
134780,the,0,0
134781,day,0,0
134782,.,0,0
134783,Brief,0,1
134784,report,0,0
134785,:,0,0
134786,effect,0,0
134787,of,0,0
134788,a,0,0
134789,focused,1,0
134790,imitation,1,0
134791,intervention,1,1
134792,on,0,0
134793,social,0,0
134794,functioning,0,0
134795,in,0,0
134796,children,0,0
134797,with,0,0
134798,autism,0,0
134799,.,0,0
134800,Imitation,0,1
134801,is,0,0
134802,an,0,0
134803,early,0,0
134804,skill,0,0
134805,thought,0,0
134806,to,0,0
134807,play,0,0
134808,a,0,0
134809,role,0,0
134810,in,0,0
134811,social,0,0
134812,development,0,0
134813,",",0,0
134814,leading,0,0
134815,some,0,0
134816,to,0,0
134817,suggest,0,0
134818,that,0,0
134819,teaching,0,0
134820,imitation,0,0
134821,to,0,0
134822,children,0,0
134823,with,0,0
134824,autism,0,0
134825,should,0,0
134826,lead,0,0
134827,to,0,0
134828,improvements,0,0
134829,in,0,0
134830,social,0,0
134831,functioning,0,0
134832,.,0,0
134833,This,0,0
134834,study,0,0
134835,used,0,0
134836,a,0,0
134837,randomized,0,0
134838,controlled,0,0
134839,trial,0,0
134840,to,0,0
134841,evaluate,0,0
134842,the,0,0
134843,effect,0,0
134844,of,0,0
134845,a,0,0
134846,focused,1,0
134847,imitation,1,0
134848,intervention,1,1
134849,on,0,0
134850,initiation,0,0
134851,of,0,0
134852,joint,0,0
134853,attention,0,0
134854,and,0,0
134855,social-emotional,0,0
134856,functioning,0,0
134857,in,0,0
134858,27,0,0
134859,young,0,0
134860,children,0,0
134861,with,0,0
134862,autism,0,0
134863,.,0,0
134864,Results,0,0
134865,indicated,0,0
134866,the,0,0
134867,treatment,0,0
134868,group,0,0
134869,made,0,0
134870,significantly,0,0
134871,more,0,0
134872,gains,0,0
134873,in,0,0
134874,joint,0,0
134875,attention,0,0
134876,initiations,0,0
134877,at,0,0
134878,post-treatment,0,0
134879,and,0,0
134880,follow-up,0,0
134881,and,0,0
134882,social-emotional,0,0
134883,functioning,0,0
134884,at,0,0
134885,follow-up,0,0
134886,than,0,0
134887,the,0,0
134888,control,0,0
134889,group,0,0
134890,.,0,0
134891,Although,0,0
134892,gains,0,0
134893,in,0,0
134894,social,0,0
134895,functioning,0,0
134896,were,0,0
134897,associated,0,0
134898,with,0,0
134899,treatment,0,0
134900,",",0,0
134901,a,0,0
134902,mediation,0,0
134903,analysis,0,0
134904,did,0,0
134905,not,0,0
134906,support,0,0
134907,imitation,1,0
134908,as,0,0
134909,the,0,0
134910,mechanism,0,0
134911,of,0,0
134912,action,0,0
134913,.,0,0
134914,These,0,0
134915,findings,0,0
134916,suggest,0,0
134917,the,0,0
134918,intervention,0,1
134919,improves,0,0
134920,social,0,0
134921,functioning,0,0
134922,in,0,0
134923,children,0,0
134924,with,0,0
134925,ASD,0,0
134926,.,0,0
134927,Comparison,0,0
134928,of,0,0
134929,cefuroxime,1,1
134930,axetil,1,1
134931,",",1,0
134932,cefaclor,1,1
134933,",",0,0
134934,and,0,0
134935,amoxicillin-clavulanate,1,1
134936,potassium,1,1
134937,suspensions,0,0
134938,in,0,0
134939,acute,0,0
134940,otitis,0,0
134941,media,0,1
134942,in,0,0
134943,infants,0,0
134944,and,0,0
134945,children,0,0
134946,.,0,0
134947,In,0,0
134948,this,0,0
134949,randomized,0,0
134950,",",0,0
134951,blinded,0,0
134952,",",0,0
134953,multicenter,0,0
134954,comparison,0,0
134955,study,0,0
134956,",",0,0
134957,377,0,0
134958,infants,0,0
134959,and,0,0
134960,children,0,0
134961,with,0,0
134962,acute,0,0
134963,otitis,0,0
134964,media,0,1
134965,(,0,0
134966,AOM,0,0
134967,),0,0
134968,received,0,0
134969,a,0,0
134970,10-day,0,0
134971,course,0,0
134972,of,0,0
134973,an,0,0
134974,oral,0,1
134975,suspension,0,1
134976,of,0,0
134977,one,0,0
134978,of,0,0
134979,the,0,0
134980,following,0,0
134981,:,0,0
134982,cefuroxime,1,1
134983,axetil,1,1
134984,(,1,0
134985,CAE,1,1
134986,),1,0
134987,",",0,0
134988,30,0,0
134989,mg/kg/day,0,0
134990,;,0,0
134991,cefaclor,1,1
134992,(,1,0
134993,CEC,1,1
134994,),1,0
134995,",",0,0
134996,40,0,0
134997,mg/kg/day,0,0
134998,;,0,0
134999,or,0,0
135000,amoxicillin-clavulanate,1,1
135001,potassium,1,1
135002,(,1,0
135003,AMX-CL,1,0
135004,),1,0
135005,",",0,0
135006,40,0,0
135007,mg/kg/day,0,0
135008,.,0,0
135009,Clinical,0,0
135010,efficacy,0,0
135011,was,0,0
135012,determined,0,0
135013,by,0,0
135014,pneumatic,0,1
135015,otoscopy,0,1
135016,and,0,0
135017,tympanometric,0,0
135018,testing,0,0
135019,3,0,0
135020,to,0,0
135021,5,0,0
135022,",",0,0
135023,11,0,0
135024,to,0,0
135025,14,0,0
135026,",",0,0
135027,and,0,0
135028,22,0,0
135029,to,0,0
135030,26,0,0
135031,days,0,0
135032,after,0,0
135033,the,0,0
135034,initiation,0,0
135035,of,0,0
135036,therapy,0,1
135037,.,0,0
135038,There,0,0
135039,was,0,0
135040,a,0,0
135041,statistically,0,0
135042,significant,0,0
135043,difference,0,0
135044,among,0,0
135045,the,0,0
135046,three,0,0
135047,treatment,0,0
135048,groups,0,0
135049,with,0,0
135050,respect,0,0
135051,to,0,0
135052,clinical,0,0
135053,outcome,0,0
135054,;,0,0
135055,more,0,0
135056,patients,0,0
135057,in,0,0
135058,the,0,0
135059,CAE,1,1
135060,group,0,0
135061,(,0,0
135062,62,0,0
135063,%,0,0
135064,),0,0
135065,than,0,0
135066,in,0,0
135067,the,0,0
135068,CEC,0,1
135069,group,0,0
135070,(,0,0
135071,46,0,0
135072,%,0,0
135073,),0,0
135074,or,0,0
135075,the,0,0
135076,AMX-CL,1,0
135077,group,0,0
135078,(,0,0
135079,52,0,0
135080,%,0,0
135081,),0,0
135082,had,0,0
135083,complete,0,0
135084,resolution,0,0
135085,of,0,0
135086,signs,0,0
135087,and,0,0
135088,symptoms,0,0
135089,of,0,0
135090,AOM,0,0
135091,(,0,0
135092,including,0,0
135093,effusion,0,0
135094,),0,0
135095,.,0,0
135096,Paired,0,0
135097,comparisons,0,0
135098,revealed,0,0
135099,a,0,0
135100,significant,0,0
135101,difference,0,0
135102,in,0,0
135103,efficacy,0,0
135104,between,0,0
135105,CAE,1,1
135106,and,0,0
135107,CEC,1,1
135108,and,0,0
135109,a,0,0
135110,nearly,0,0
135111,significant,0,0
135112,difference,0,0
135113,between,0,0
135114,AMX-CL,1,0
135115,and,0,0
135116,CEC,1,1
135117,.,1,0
135118,Taste,0,1
135119,acceptability,0,0
135120,was,0,0
135121,highest,0,0
135122,for,0,0
135123,CEC,1,0
135124,and,0,0
135125,lowest,0,0
135126,for,0,0
135127,this,0,0
135128,formulation,0,0
135129,of,0,0
135130,CAE,1,1
135131,.,1,0
135132,Significantly,0,0
135133,more,0,0
135134,patients,0,0
135135,in,0,0
135136,the,0,0
135137,AMX-CL,1,0
135138,group,0,0
135139,than,0,0
135140,in,0,0
135141,the,0,0
135142,CAE,1,1
135143,or,0,1
135144,CEC,1,1
135145,group,0,0
135146,had,0,0
135147,a,0,0
135148,side,0,0
135149,effect,0,0
135150,",",0,0
135151,primarily,0,0
135152,diarrhea,0,0
135153,",",0,0
135154,vomiting,0,0
135155,",",0,0
135156,or,0,1
135157,diaper,0,1
135158,rash,0,0
135159,.,0,0
135160,We,0,0
135161,conclude,0,0
135162,that,0,0
135163,CAE,0,1
135164,suspension,0,1
135165,has,0,0
135166,greater,0,0
135167,clinical,0,0
135168,efficacy,0,0
135169,than,0,0
135170,CEC,0,0
135171,and,0,0
135172,fewer,0,0
135173,side,0,0
135174,effects,0,0
135175,than,0,0
135176,AMX-CL,1,0
135177,.,1,0
135178,Granulocyte-colony,1,1
135179,stimulating,1,0
135180,factor,1,0
135181,for,0,0
135182,mobilizing,0,1
135183,bone,0,0
135184,marrow,0,0
135185,stem,0,1
135186,cells,0,0
135187,in,0,0
135188,subacute,0,0
135189,stroke,0,0
135190,:,0,0
135191,the,0,0
135192,stem,1,1
135193,cell,1,0
135194,trial,0,0
135195,of,0,0
135196,recovery,0,0
135197,enhancement,0,0
135198,after,0,0
135199,stroke,0,0
135200,2,0,0
135201,randomized,0,0
135202,controlled,0,0
135203,trial,0,0
135204,.,0,0
135205,BACKGROUND,0,0
135206,AND,0,0
135207,PURPOSE,0,1
135208,Granulocyte-colony,1,1
135209,stimulating,1,0
135210,factor,1,0
135211,(,1,1
135212,G-CSF,1,1
135213,),1,1
135214,is,0,0
135215,neuroprotective,0,0
135216,in,0,0
135217,experimental,0,0
135218,stroke,0,0
135219,and,0,0
135220,mobilizes,0,1
135221,CD34,0,0
135222,(,0,0
135223,+,0,1
135224,),0,0
135225,peripheral,0,0
135226,blood,0,0
135227,stem,0,1
135228,cells,0,0
135229,into,0,0
135230,the,0,0
135231,circulation,0,0
135232,.,0,0
135233,We,0,0
135234,assessed,0,0
135235,the,0,0
135236,safety,0,0
135237,of,0,0
135238,G-CSF,1,1
135239,in,0,0
135240,recent,0,0
135241,stroke,0,0
135242,in,0,0
135243,a,0,0
135244,phase,0,0
135245,IIb,0,1
135246,single-center,0,0
135247,randomized,0,0
135248,",",0,0
135249,controlled,0,0
135250,trial,0,0
135251,.,0,0
135252,METHODS,0,0
135253,G-CSF,1,1
135254,(,1,0
135255,10,1,0
135256,?g/kg,1,0
135257,),1,0
135258,or,1,1
135259,placebo,1,1
135260,(,0,0
135261,ratio,0,0
135262,2:1,0,0
135263,),0,0
135264,was,0,0
135265,given,1,0
135266,SC,1,0
135267,for,0,0
135268,5,0,0
135269,days,0,0
135270,to,0,0
135271,60,0,0
135272,patients,0,0
135273,3,0,0
135274,to,0,0
135275,30,0,0
135276,days,0,0
135277,after,0,0
135278,ischemic,0,0
135279,or,0,1
135280,hemorrhagic,0,0
135281,stroke,0,0
135282,.,0,0
135283,The,0,0
135284,primary,0,0
135285,outcome,0,0
135286,was,0,0
135287,the,0,0
135288,frequency,0,0
135289,of,0,0
135290,serious,0,0
135291,adverse,0,0
135292,events,0,0
135293,.,0,0
135294,Peripheral,0,0
135295,blood,0,0
135296,counts,0,0
135297,",",0,0
135298,CD34,0,0
135299,(,0,0
135300,+,0,1
135301,),0,0
135302,count,0,0
135303,",",0,0
135304,and,0,0
135305,functional,0,0
135306,outcome,0,0
135307,were,0,0
135308,measured,0,0
135309,.,0,0
135310,MRI,0,0
135311,assessed,0,0
135312,lesion,0,0
135313,volume,0,0
135314,",",0,0
135315,atrophy,0,0
135316,",",0,0
135317,and,0,0
135318,the,0,0
135319,presence,0,0
135320,of,0,0
135321,iron-labeled,0,1
135322,CD34,0,1
135323,(,0,0
135324,+,0,1
135325,),0,0
135326,cells,0,0
135327,reinjected,0,0
135328,on,0,0
135329,day,0,0
135330,6,0,0
135331,.,0,0
135332,RESULTS,0,0
135333,Sixty,0,0
135334,patients,0,0
135335,were,0,0
135336,recruited,0,0
135337,at,0,0
135338,mean,0,0
135339,of,0,0
135340,8,0,0
135341,days,0,0
135342,(,0,0
135343,SD,0,0
135344,?,0,0
135345,5,0,0
135346,),0,0
135347,post,0,0
135348,ictus,0,0
135349,",",0,0
135350,with,0,0
135351,mean,0,0
135352,age,0,0
135353,71,0,0
135354,years,0,0
135355,(,0,0
135356,?,0,0
135357,12,0,0
135358,years,0,0
135359,),0,0
135360,and,0,0
135361,53,0,0
135362,%,0,0
135363,men,0,0
135364,.,0,0
135365,The,0,0
135366,groups,0,0
135367,were,0,0
135368,well,0,0
135369,matched,0,0
135370,for,0,0
135371,baseline,0,0
135372,minimization/prognostic,0,0
135373,factors,0,0
135374,.,0,0
135375,There,0,0
135376,were,0,0
135377,no,0,0
135378,significant,0,0
135379,differences,0,0
135380,between,0,0
135381,groups,0,0
135382,in,0,0
135383,the,0,0
135384,number,0,0
135385,of,0,0
135386,participants,0,0
135387,with,0,0
135388,serious,0,0
135389,adverse,0,0
135390,events,1,0
135391,:,1,0
135392,G-CSF,1,0
135393,15,1,0
135394,(,0,0
135395,37.5,0,0
135396,%,0,0
135397,),0,0
135398,of,0,0
135399,40,0,0
135400,versus,1,0
135401,placebo,1,1
135402,7,1,0
135403,(,0,0
135404,35,0,0
135405,%,0,0
135406,),0,0
135407,of,0,0
135408,20,0,0
135409,",",0,0
135410,death,0,0
135411,or,0,1
135412,dependency,0,0
135413,(,0,0
135414,modified,0,0
135415,Rankin,0,1
135416,Score,0,0
135417,:,0,0
135418,G-CSF,0,0
135419,3.3,0,0
135420,?,0,0
135421,1.3,0,0
135422,",",0,0
135423,placebo,1,1
135424,3.0,1,0
135425,?,0,0
135426,1.3,0,0
135427,),0,0
135428,at,0,0
135429,90,0,0
135430,days,0,0
135431,",",0,0
135432,or,0,0
135433,the,0,0
135434,number,0,0
135435,of,0,0
135436,injections,0,1
135437,received,1,0
135438,.,1,0
135439,G-CSF,1,0
135440,increased,1,0
135441,CD34,0,1
135442,(,0,0
135443,+,0,1
135444,),0,1
135445,and,0,0
135446,total,0,0
135447,white,0,0
135448,cell,0,0
135449,counts,0,0
135450,of,0,0
135451,9.5-,0,0
135452,and,0,0
135453,4.2-fold,0,0
135454,",",0,0
135455,respectively,0,0
135456,.,0,0
135457,There,0,0
135458,was,0,0
135459,a,0,0
135460,trend,0,0
135461,toward,0,0
135462,reduction,0,0
135463,in,0,0
135464,MRI,0,0
135465,ischemic,0,0
135466,lesion,0,0
135467,volume,0,0
135468,with,0,0
135469,respect,0,0
135470,to,0,0
135471,change,0,0
135472,from,0,0
135473,baseline,1,0
135474,in,1,0
135475,G-CSF-treated,1,0
135476,patients,1,0
135477,(,0,0
135478,P=0.06,0,0
135479,),0,0
135480,.,0,0
135481,In,0,0
135482,1,0,0
135483,participant,0,0
135484,",",0,0
135485,there,0,0
135486,was,0,0
135487,suggestion,0,0
135488,that,0,0
135489,labeled,0,1
135490,CD34,0,1
135491,(,0,0
135492,+,0,1
135493,),0,0
135494,cells,0,0
135495,had,0,0
135496,migrated,0,0
135497,to,0,0
135498,the,0,0
135499,ischemic,0,0
135500,lesion,0,0
135501,.,0,0
135502,CONCLUSIONS,0,0
135503,This,0,0
135504,randomized,0,0
135505,",",0,0
135506,double-blind,0,0
135507,",",0,0
135508,placebo-controlled,0,1
135509,trial,0,0
135510,suggests,0,0
135511,that,0,0
135512,G-CSF,1,0
135513,is,1,0
135514,safe,1,0
135515,when,0,0
135516,administered,0,0
135517,subacutely,0,0
135518,.,0,0
135519,It,0,0
135520,is,0,0
135521,feasible,0,0
135522,to,0,0
135523,label,0,0
135524,and,0,0
135525,readminister,0,0
135526,iron-labeled,0,1
135527,CD34,0,1
135528,(,0,0
135529,+,0,1
135530,),0,0
135531,cells,0,0
135532,in,0,0
135533,patients,0,0
135534,with,0,0
135535,ischemic,0,0
135536,stroke,0,0
135537,.,0,0
135538,CLINICAL,0,0
135539,TRIAL,0,0
135540,REGISTRATION,0,0
135541,URL,0,1
135542,:,0,0
135543,www.controlled-trials.com,0,0
135544,.,0,0
135545,Unique,0,0
135546,identifier,0,0
135547,:,0,0
135548,ISRCTN63336619,0,0
135549,.,0,0
135550,Pilot,0,0
135551,study,0,0
135552,of,0,0
135553,the,0,0
135554,effectiveness,0,0
135555,of,0,0
135556,weighted,1,0
135557,vests,1,1
135558,.,1,0
135559,OBJECTIVE,0,0
135560,In,0,0
135561,this,0,0
135562,pilot,0,0
135563,study,0,0
135564,",",0,0
135565,we,0,0
135566,determined,0,0
135567,the,0,0
135568,effectiveness,0,0
135569,of,0,0
135570,a,0,0
135571,weighted,1,0
135572,vest,1,1
135573,on,0,0
135574,attention,0,0
135575,to,0,0
135576,task,0,1
135577,for,0,0
135578,second-grade,0,0
135579,general,0,0
135580,education,0,1
135581,students,0,0
135582,with,0,0
135583,difficulty,0,0
135584,attending,0,0
135585,.,0,0
135586,METHOD,0,0
135587,We,0,0
135588,used,0,0
135589,an,0,0
135590,intervention,1,1
135591,and,0,0
135592,a,0,0
135593,control,1,1
135594,group,0,0
135595,and,0,0
135596,an,0,0
135597,ABA,0,1
135598,design,0,0
135599,to,0,0
135600,compare,0,0
135601,participants,0,0
135602,',0,0
135603,percentage,0,0
135604,of,0,0
135605,time,0,0
135606,on,0,0
135607,task,0,1
135608,with,1,0
135609,and,1,0
135610,without,1,0
135611,a,1,0
135612,vest,1,1
135613,.,1,0
135614,Ten,0,0
135615,participants,0,0
135616,from,0,0
135617,nine,0,0
135618,elementary,0,0
135619,schools,0,0
135620,in,0,0
135621,a,0,0
135622,suburban,0,0
135623,Texas,0,0
135624,school,0,0
135625,district,0,0
135626,were,0,0
135627,randomly,0,0
135628,assigned,0,0
135629,to,0,0
135630,an,0,0
135631,intervention,1,1
135632,or,0,0
135633,a,0,0
135634,control,1,0
135635,group,0,0
135636,.,0,0
135637,Control,0,0
135638,group,0,0
135639,participants,0,0
135640,wore,0,0
135641,a,0,0
135642,nonweighted,1,0
135643,vest,1,1
135644,.,1,0
135645,Participants,0,0
135646,",",0,0
135647,classroom,0,1
135648,teachers,0,0
135649,",",0,0
135650,and,0,0
135651,research,0,0
135652,assistants,0,0
135653,who,0,0
135654,coded,0,0
135655,the,0,0
135656,data,0,0
135657,were,0,0
135658,blind,0,0
135659,as,0,0
135660,to,0,0
135661,the,0,0
135662,group,0,0
135663,to,0,0
135664,which,0,0
135665,the,0,0
135666,participants,0,0
135667,were,0,0
135668,assigned,0,0
135669,.,0,0
135670,RESULTS,0,0
135671,A,0,0
135672,repeated,0,0
135673,measures,0,0
135674,analysis,0,0
135675,of,0,0
135676,variance,0,0
135677,indicated,0,0
135678,no,0,0
135679,significant,0,0
135680,differences,0,0
135681,between,0,0
135682,groups,0,0
135683,or,0,0
135684,between,0,0
135685,baseline,0,0
135686,",",0,0
135687,intervention,0,1
135688,",",0,0
135689,and,0,0
135690,withdrawal,0,0
135691,conditions,0,0
135692,.,0,0
135693,CONCLUSION,0,0
135694,Our,0,0
135695,results,0,0
135696,indicated,0,0
135697,that,0,0
135698,the,0,0
135699,weighted,1,0
135700,vests,1,0
135701,were,0,0
135702,not,0,0
135703,effective,0,0
135704,in,0,0
135705,increasing,0,0
135706,time,0,0
135707,on,0,0
135708,task,0,0
135709,.,0,0
135710,These,0,0
135711,results,0,0
135712,should,0,0
135713,be,0,0
135714,generalized,0,0
135715,cautiously,0,0
135716,owing,0,0
135717,to,0,0
135718,the,0,0
135719,small,0,0
135720,sample,0,0
135721,size,0,0
135722,and,0,0
135723,participant,0,1
135724,selection,0,0
135725,process,0,0
135726,.,0,0
135727,[,0,0
135728,Branch,0,0
135729,atheromatous,0,0
135730,disease,0,0
135731,:,0,0
135732,prognosis,0,0
135733,and,0,0
135734,management,0,0
135735,.,0,0
135736,The,0,0
135737,SPS3,1,0
135738,experience,0,0
135739,],0,0
135740,.,0,0
135741,Bilateral,1,1
135742,transversus,1,1
135743,abdominis,1,1
135744,plane,1,0
135745,block,1,0
135746,does,0,0
135747,not,0,0
135748,decrease,0,0
135749,postoperative,0,0
135750,pain,0,0
135751,after,0,0
135752,laparoscopic,0,1
135753,cholecystectomy,0,1
135754,when,0,0
135755,compared,0,0
135756,with,0,0
135757,local,1,0
135758,anesthetic,1,1
135759,infiltration,1,0
135760,of,1,0
135761,trocar,1,1
135762,insertion,1,0
135763,sites,1,0
135764,.,1,0
135765,BACKGROUND,0,0
135766,AND,0,0
135767,OBJECTIVES,0,1
135768,Transversus,1,1
135769,abdominis,1,1
135770,plane,1,0
135771,(,1,0
135772,TAP,1,0
135773,),1,0
135774,block,1,0
135775,has,0,0
135776,been,0,0
135777,shown,0,0
135778,to,0,0
135779,reduce,0,0
135780,pain,0,0
135781,and,0,0
135782,analgesic,0,0
135783,requirements,0,0
135784,after,0,0
135785,abdominal,0,0
135786,surgery,0,0
135787,.,0,0
135788,Our,0,0
135789,hypothesis,0,0
135790,was,0,0
135791,that,0,0
135792,bilateral,1,0
135793,TAP,1,0
135794,blocks,1,1
135795,decrease,0,0
135796,pain,0,0
135797,after,0,0
135798,laparoscopic,0,1
135799,cholecystectomy,0,1
135800,when,0,0
135801,compared,0,0
135802,with,0,0
135803,local,1,0
135804,anesthetic,1,1
135805,infiltration,1,0
135806,of,0,0
135807,trocar,0,1
135808,insertion,0,0
135809,sites,0,0
135810,.,0,0
135811,METHODS,0,0
135812,Eighty,0,0
135813,patients,0,0
135814,undergoing,0,0
135815,laparoscopic,0,1
135816,cholecystectomy,0,1
135817,were,0,0
135818,randomized,0,0
135819,to,0,0
135820,receive,0,0
135821,either,0,0
135822,bilateral,1,0
135823,TAP,1,0
135824,blocks,1,1
135825,or,1,0
135826,local,1,0
135827,anesthetic,1,1
135828,infiltration,1,0
135829,of,1,0
135830,trocar,1,1
135831,insertion,1,1
135832,sites,1,0
135833,with,1,0
135834,ropivacaine,1,1
135835,0.5,1,0
135836,%,1,0
135837,.,1,0
135838,Postoperative,0,0
135839,pain,0,0
135840,scores,0,0
135841,and,0,0
135842,analgesic,0,0
135843,use,0,0
135844,for,0,0
135845,the,0,0
135846,first,0,0
135847,24,0,0
135848,hrs,0,0
135849,were,0,0
135850,recorded,0,0
135851,.,0,0
135852,RESULTS,0,0
135853,Eighty,0,0
135854,patients,0,0
135855,were,0,0
135856,enrolled,0,0
135857,in,0,0
135858,the,0,0
135859,study,0,0
135860,.,0,0
135861,After,0,0
135862,exclusions,0,0
135863,",",0,0
135864,data,0,0
135865,were,0,0
135866,analyzed,0,0
135867,on,0,0
135868,39,0,0
135869,patients,0,0
135870,in,0,0
135871,group,0,0
135872,T,0,0
135873,(,0,0
135874,bilateral,0,1
135875,TAP,1,1
135876,block,1,0
135877,),1,0
135878,and,0,0
135879,35,0,0
135880,patients,0,0
135881,in,0,0
135882,group,0,0
135883,I,0,0
135884,(,0,0
135885,infiltration,0,0
135886,),0,0
135887,.,0,0
135888,There,0,0
135889,was,0,0
135890,no,0,0
135891,statistically,0,0
135892,significant,0,0
135893,difference,0,0
135894,in,0,0
135895,pain,0,0
135896,scores,0,0
135897,on,0,0
135898,the,0,0
135899,numeric,0,0
135900,analog,0,1
135901,scale,0,0
135902,(,0,0
135903,0-10,0,0
135904,),0,0
135905,between,0,0
135906,the,0,0
135907,groups,0,0
135908,at,0,0
135909,4,0,0
135910,hrs,0,0
135911,after,0,0
135912,surgery,0,1
135913,(,0,0
135914,P,0,0
135915,=,0,0
135916,0.18,0,0
135917,),0,0
135918,or,0,0
135919,during,0,0
135920,the,0,0
135921,24,0,0
135922,hrs,0,0
135923,after,0,0
135924,surgery,0,1
135925,(,0,0
135926,P,0,0
135927,=,0,0
135928,0.23,0,0
135929,),0,0
135930,.,0,0
135931,The,0,0
135932,time,0,0
135933,interval,0,0
135934,from,0,0
135935,anesthesia,0,1
135936,start,0,0
135937,to,0,0
135938,surgery,0,0
135939,start,0,0
135940,was,0,0
135941,greater,0,0
135942,in,0,0
135943,group,0,0
135944,T,0,0
135945,than,0,0
135946,group,0,0
135947,I,0,0
135948,(,0,0
135949,48,0,0
135950,vs,0,0
135951,35,0,0
135952,mins,0,0
135953,",",0,0
135954,P,0,0
135955,<,0,0
135956,0.001,0,0
135957,),0,0
135958,.,0,0
135959,There,0,0
135960,was,0,0
135961,no,0,0
135962,significant,0,0
135963,difference,0,0
135964,found,0,0
135965,in,0,0
135966,analgesic,0,0
135967,use,0,0
135968,during,0,0
135969,the,0,0
135970,first,0,0
135971,24,0,0
135972,hrs,0,0
135973,after,0,0
135974,surgery,0,0
135975,.,0,0
135976,CONCLUSIONS,0,0
135977,Bilateral,1,0
135978,ultrasound-guided,1,1
135979,TAP,1,0
135980,block,1,0
135981,is,0,0
135982,equivalent,0,0
135983,to,0,0
135984,local,1,0
135985,anesthetic,1,1
135986,infiltration,1,0
135987,of,0,0
135988,trocar,0,1
135989,insertion,0,1
135990,sites,0,0
135991,for,0,0
135992,overall,0,0
135993,postoperative,0,0
135994,pain,0,0
135995,in,0,0
135996,a,0,0
135997,heterogeneous,0,0
135998,group,0,0
135999,of,0,0
136000,patients,0,0
136001,undergoing,0,0
136002,laparoscopic,0,1
136003,cholecystectomy,0,1
136004,.,0,0
136005,Efficacy,0,0
136006,and,0,0
136007,safety,0,0
136008,of,0,0
136009,leuprolide,1,1
136010,acetate,1,1
136011,3-month,1,0
136012,depot,0,0
136013,11.25,0,0
136014,milligrams,0,1
136015,or,0,0
136016,30,0,0
136017,milligrams,0,0
136018,for,0,0
136019,the,0,0
136020,treatment,0,0
136021,of,0,0
136022,central,0,0
136023,precocious,0,0
136024,puberty,0,0
136025,.,0,0
136026,CONTEXT,0,0
136027,GnRH,0,1
136028,agonist,0,1
136029,(,0,0
136030,GnRHa,0,1
136031,),0,0
136032,monthly,0,0
136033,injections,0,1
136034,are,0,0
136035,frequently,0,0
136036,used,0,0
136037,in,0,0
136038,the,0,0
136039,treatment,0,0
136040,of,0,0
136041,central,0,0
136042,precocious,0,0
136043,puberty,0,0
136044,(,0,0
136045,CPP,0,1
136046,),0,0
136047,.,0,0
136048,The,0,0
136049,3-month,1,0
136050,leuprolide,1,1
136051,depot,1,1
136052,11.25-,1,1
136053,and,0,0
136054,30-mg,0,1
136055,formulations,0,0
136056,are,0,0
136057,newly,0,0
136058,approved,0,0
136059,treatment,0,0
136060,options,0,0
136061,.,0,0
136062,OBJECTIVE,0,0
136063,The,0,0
136064,aim,0,0
136065,of,0,0
136066,the,0,0
136067,study,0,0
136068,was,0,0
136069,to,0,0
136070,investigate,0,0
136071,the,0,0
136072,safety,0,0
136073,and,0,0
136074,efficacy,0,0
136075,of,0,0
136076,leuprolide,1,1
136077,acetate,1,1
136078,3-month,1,0
136079,depot,0,0
136080,formulations,0,0
136081,for,0,0
136082,the,0,0
136083,treatment,0,0
136084,of,0,0
136085,CPP,0,0
136086,in,0,0
136087,children,0,0
136088,.,0,0
136089,DESIGN,0,0
136090,This,0,0
136091,was,0,0
136092,a,0,0
136093,phase,0,0
136094,III,0,0
136095,",",0,0
136096,randomized,0,0
136097,",",0,0
136098,open-label,0,0
136099,",",0,0
136100,dose-ranging,0,0
136101,6-month,0,0
136102,study,0,0
136103,.,0,0
136104,SETTING,0,0
136105,Twenty-two,0,0
136106,U.S.,0,1
136107,medical,0,1
136108,centers,0,0
136109,(,0,0
136110,including,0,0
136111,Puerto,0,1
136112,Rico,0,0
136113,),0,0
136114,participated,0,0
136115,.,0,0
136116,PATIENTS,0,0
136117,Children,0,0
136118,diagnosed,0,0
136119,with,0,0
136120,CPP,0,1
136121,(,0,0
136122,n,0,0
136123,=,0,0
136124,84,0,0
136125,),0,0
136126,",",0,0
136127,who,0,0
136128,were,0,0
136129,either,0,0
136130,treatment,0,0
136131,naive,0,0
136132,or,0,0
136133,previously,0,0
136134,treated,0,0
136135,with,0,0
136136,GnRHa,0,0
136137,",",0,0
136138,were,0,0
136139,recruited,0,0
136140,.,0,0
136141,Chronological,0,0
136142,age,0,0
136143,at,0,0
136144,onset,0,0
136145,of,0,0
136146,pubertal,0,0
136147,signs,0,0
136148,was,0,0
136149,less,0,0
136150,than,0,0
136151,8,0,0
136152,yr,0,0
136153,in,0,0
136154,girls,0,0
136155,and,0,0
136156,less,0,0
136157,than,0,0
136158,9,0,0
136159,yr,0,0
136160,in,0,0
136161,boys,0,0
136162,",",0,0
136163,and,0,0
136164,bone,0,0
136165,age,0,0
136166,was,0,0
136167,advanced,0,0
136168,over,0,0
136169,chronological,0,0
136170,age,0,0
136171,at,0,0
136172,least,0,0
136173,1,0,0
136174,yr,0,0
136175,.,0,0
136176,INTERVENTION,0,0
136177,Leuprolide,1,1
136178,acetate,1,1
136179,depot,1,1
136180,(,0,0
136181,11.25,0,0
136182,or,0,0
136183,30,0,0
136184,mg,0,1
136185,),0,0
136186,was,0,0
136187,administered,0,0
136188,im,0,0
136189,every,0,0
136190,3,0,0
136191,months,0,0
136192,.,0,0
136193,MAIN,0,0
136194,OUTCOME,0,0
136195,MEASURES,0,0
136196,Biochemical,0,0
136197,[,0,0
136198,peak-stimulated,0,0
136199,LH,0,1
136200,",",0,0
136201,estradiol,0,1
136202,(,0,0
136203,girls,0,0
136204,),0,0
136205,",",0,0
136206,and,0,0
136207,testosterone,0,1
136208,(,0,0
136209,boys,0,0
136210,),0,0
136211,],0,0
136212,and,0,0
136213,anthropometric,0,1
136214,(,0,0
136215,growth,0,0
136216,rate,0,0
136217,",",0,0
136218,bone,0,0
136219,age,0,0
136220,acceleration,0,0
136221,",",0,0
136222,pubertal,0,0
136223,progression,0,0
136224,),0,0
136225,parameters,0,0
136226,and,0,0
136227,safety,0,0
136228,were,0,0
136229,assessed,0,0
136230,.,0,0
136231,RESULTS,0,0
136232,Peak-stimulated,0,0
136233,LH,0,0
136234,was,0,0
136235,suppressed,0,0
136236,in,0,0
136237,the,0,0
136238,11.25-,0,0
136239,and,0,0
136240,30-mg,0,1
136241,dose,0,0
136242,groups,0,0
136243,in,0,0
136244,78.4,0,0
136245,and,0,0
136246,95.2,0,0
136247,%,0,0
136248,",",0,0
136249,respectively,0,0
136250,",",0,0
136251,of,0,0
136252,children,0,0
136253,from,0,0
136254,months,0,0
136255,2,0,0
136256,through,0,0
136257,6,0,0
136258,.,0,0
136259,There,0,0
136260,were,0,0
136261,nine,0,0
136262,treatment,0,0
136263,failures,0,0
136264,(,0,0
136265,peak-stimulated,0,0
136266,LH,0,1
136267,>,0,0
136268,4,0,0
136269,IU/liter,0,0
136270,),0,0
136271,in,0,0
136272,the,0,0
136273,11.25-mg,0,1
136274,group,0,0
136275,and,0,0
136276,two,0,0
136277,in,0,0
136278,the,0,0
136279,30-mg,0,1
136280,group,0,0
136281,.,0,0
136282,Basal,0,0
136283,sex,0,0
136284,steroid,0,1
136285,suppression,0,0
136286,",",0,0
136287,growth,0,0
136288,rates,0,0
136289,",",0,0
136290,pubertal,0,0
136291,progression,0,0
136292,",",0,0
136293,bone,0,0
136294,age,0,0
136295,advancement,0,0
136296,",",0,0
136297,and,0,0
136298,adverse,0,0
136299,events,0,0
136300,were,0,0
136301,similar,0,0
136302,with,0,0
136303,either,0,0
136304,dose,0,0
136305,.,0,0
136306,CONCLUSIONS,0,0
136307,Treatment,0,0
136308,with,0,0
136309,leuprolide,1,1
136310,acetate,1,1
136311,3-month,0,0
136312,depot,0,0
136313,formulations,0,1
136314,(,0,0
136315,11.25,0,0
136316,and,0,0
136317,30,0,0
136318,mg,0,1
136319,),0,0
136320,effectively,0,0
136321,suppressed,0,0
136322,the,0,0
136323,GnRH,0,1
136324,axis,0,0
136325,",",0,0
136326,was,0,0
136327,well,0,0
136328,tolerated,0,0
136329,",",0,0
136330,and,0,0
136331,may,0,0
136332,positively,0,0
136333,impact,0,0
136334,patient,0,0
136335,convenience,0,0
136336,and,0,0
136337,compliance,0,0
136338,.,0,0
136339,Effects,0,0
136340,of,0,0
136341,large,0,0
136342,doses,0,0
136343,of,0,0
136344,arachidonic,1,0
136345,acid,1,1
136346,added,0,0
136347,to,0,0
136348,docosahexaenoic,1,1
136349,acid,1,1
136350,on,0,0
136351,social,0,0
136352,impairment,0,0
136353,in,0,0
136354,individuals,0,0
136355,with,0,0
136356,autism,0,0
136357,spectrum,0,0
136358,disorders,0,0
136359,:,0,0
136360,a,0,0
136361,double-blind,0,0
136362,",",0,0
136363,placebo-controlled,1,1
136364,",",0,0
136365,randomized,0,0
136366,trial,0,0
136367,.,0,0
136368,Autism,0,0
136369,spectrum,0,0
136370,disorders,0,0
136371,are,0,0
136372,a,0,0
136373,neurodevelopmental,0,0
136374,disorders,0,0
136375,with,0,0
136376,reduced,0,0
136377,cortical,0,0
136378,functional,0,0
136379,connectivity,0,0
136380,relating,0,0
136381,to,0,0
136382,social,0,0
136383,cognition,0,0
136384,.,0,0
136385,Polyunsaturated,1,1
136386,fatty,1,0
136387,acids,1,1
136388,arachidonic,1,0
136389,acid,1,1
136390,(,1,0
136391,ARA,1,0
136392,),1,1
136393,and,0,0
136394,docosahexaenoic,1,1
136395,acid,1,1
136396,(,1,0
136397,DHA,1,0
136398,),1,0
136399,may,0,0
136400,have,0,0
136401,key,0,0
136402,role,0,0
136403,in,0,0
136404,brain,0,0
136405,network,0,0
136406,maturation,0,0
136407,.,0,0
136408,In,0,0
136409,particularly,0,0
136410,",",0,0
136411,ARA,1,0
136412,is,0,0
136413,important,0,0
136414,in,0,0
136415,signal,0,0
136416,transduction,0,0
136417,related,0,0
136418,to,0,0
136419,neuronal,0,0
136420,maturation,0,0
136421,.,0,0
136422,Supplementation,0,0
136423,with,0,0
136424,larger,0,0
136425,ARA,1,0
136426,doses,1,0
136427,added,1,0
136428,to,1,0
136429,DHA,1,0
136430,may,0,0
136431,therefore,0,0
136432,mitigate,0,0
136433,social,0,0
136434,impairment,0,0
136435,.,0,0
136436,In,0,0
136437,a,0,0
136438,16-week,0,0
136439,",",0,0
136440,double-blind,0,0
136441,",",0,0
136442,randomized,0,0
136443,",",0,0
136444,placebo-controlled,1,1
136445,trial,0,0
136446,",",0,0
136447,we,0,0
136448,evaluated,0,0
136449,the,0,0
136450,efficacy,0,0
136451,of,0,0
136452,supplementation,0,1
136453,with,0,0
136454,large,0,0
136455,doses,0,0
136456,of,0,0
136457,ARA,1,0
136458,added,1,0
136459,to,1,0
136460,DHA,1,1
136461,(,1,0
136462,n,1,0
136463,=,1,0
136464,7,1,0
136465,),1,0
136466,or,0,1
136467,placebo,1,1
136468,(,1,0
136469,n,1,0
136470,=,1,0
136471,6,1,0
136472,),1,0
136473,in,0,0
136474,13,0,0
136475,participants,0,0
136476,(,0,0
136477,mean,0,0
136478,age,0,0
136479,",",0,0
136480,14.6,0,0
136481,[,0,0
136482,SD,0,0
136483,",",0,0
136484,5.9,0,0
136485,],0,0
136486,years,0,0
136487,),0,0
136488,.,0,0
136489,To,0,0
136490,examine,0,0
136491,underlying,0,0
136492,mechanisms,0,0
136493,underlying,0,0
136494,the,0,0
136495,effect,0,0
136496,of,0,0
136497,our,0,0
136498,supplementation,0,1
136499,regimen,0,0
136500,",",0,0
136501,we,0,0
136502,examined,0,0
136503,plasma,0,0
136504,levels,0,0
136505,of,0,0
136506,antioxidants,0,1
136507,transferrin,0,0
136508,and,0,0
136509,superoxide,0,0
136510,dismutase,0,0
136511,",",0,0
136512,which,0,0
136513,are,0,0
136514,useful,0,0
136515,markers,0,0
136516,of,0,0
136517,signal,0,0
136518,transduction,0,0
136519,.,0,0
136520,The,0,0
136521,outcome,0,0
136522,measures,0,0
136523,were,0,0
136524,the,0,0
136525,Social,0,0
136526,Responsiveness,0,0
136527,Scale,0,0
136528,and,0,0
136529,the,0,0
136530,Aberrant,0,0
136531,Behavior,0,0
136532,Checklist-Community,0,0
136533,.,0,0
136534,Repeated-measures,0,0
136535,analysis,0,0
136536,of,0,0
136537,variance,0,0
136538,revealed,0,0
136539,that,0,0
136540,our,0,0
136541,supplementation,0,1
136542,regimen,0,0
136543,significantly,0,0
136544,improved,0,0
136545,Aberrant,0,0
136546,Behavior,0,0
136547,Checklist-Community-measured,0,0
136548,social,0,1
136549,withdrawal,0,1
136550,and,0,0
136551,Social,0,0
136552,Responsiveness,0,0
136553,Scale-measured,0,0
136554,communication,0,0
136555,.,0,0
136556,Treatment,0,0
136557,effect,0,0
136558,sizes,0,0
136559,were,0,0
136560,more,0,0
136561,favorable,0,0
136562,for,0,0
136563,the,0,0
136564,treatment,0,0
136565,group,0,0
136566,compared,0,0
136567,with,0,0
136568,the,0,0
136569,placebo,1,1
136570,group,0,0
136571,(,0,0
136572,communication,0,0
136573,:,0,0
136574,treatment,0,0
136575,groups,0,0
136576,",",0,0
136577,0.87,0,0
136578,vs,0,0
136579,",",0,0
136580,placebo,1,1
136581,",",0,0
136582,0.44,0,0
136583,;,0,0
136584,social,0,0
136585,withdrawal,0,0
136586,:,0,0
136587,treatment,0,0
136588,groups,0,0
136589,",",0,0
136590,0.88,0,0
136591,",",0,0
136592,vs,0,0
136593,placebo,1,1
136594,",",0,0
136595,0.54,0,0
136596,),0,0
136597,.,0,0
136598,There,0,0
136599,was,0,0
136600,a,0,0
136601,significant,0,0
136602,difference,0,0
136603,in,0,0
136604,the,0,0
136605,change,0,0
136606,in,0,0
136607,plasma,0,0
136608,transferrin,0,0
136609,levels,0,0
136610,and,0,0
136611,a,0,0
136612,trend,0,0
136613,toward,0,0
136614,a,0,0
136615,significant,0,0
136616,difference,0,0
136617,in,0,0
136618,the,0,0
136619,change,0,0
136620,in,0,0
136621,plasma,0,0
136622,superoxide,0,0
136623,dismutase,0,0
136624,levels,0,0
136625,between,0,0
136626,the,0,0
136627,2,0,0
136628,groups,0,0
136629,.,0,0
136630,This,0,0
136631,preliminary,0,0
136632,study,0,0
136633,suggests,0,0
136634,that,0,0
136635,supplementation,0,0
136636,with,0,0
136637,larger,0,0
136638,ARA,1,0
136639,doses,1,0
136640,added,1,0
136641,to,1,0
136642,DHA,1,0
136643,improves,0,0
136644,impaired,0,0
136645,social,0,0
136646,interaction,0,0
136647,in,0,0
136648,individuals,0,0
136649,with,0,0
136650,autism,0,0
136651,spectrum,0,0
136652,disorder,0,0
136653,by,0,0
136654,up-regulating,0,0
136655,signal,0,0
136656,transduction,0,0
136657,.,0,0
136658,Efficiency,0,0
136659,of,0,0
136660,slush,1,1
136661,nitrogen,1,0
136662,vitrification,1,1
136663,of,0,0
136664,human,0,0
136665,oocytes,0,0
136666,vitrified,1,1
136667,with,1,0
136668,or,1,0
136669,without,1,0
136670,cumulus,1,0
136671,cells,1,0
136672,in,0,0
136673,relation,0,0
136674,to,0,0
136675,survival,0,0
136676,rate,0,0
136677,and,0,0
136678,meiotic,0,0
136679,spindle,0,0
136680,competence,0,0
136681,.,0,0
136682,OBJECTIVE,0,0
136683,To,0,0
136684,evaluate,0,0
136685,the,0,0
136686,efficiency,0,0
136687,of,0,0
136688,slush,1,1
136689,nitrogen,1,0
136690,vitrification,1,1
136691,of,0,0
136692,human,0,0
136693,oocytes,0,0
136694,with,1,0
136695,or,1,0
136696,without,1,0
136697,cumulus,1,0
136698,cells,1,0
136699,in,0,0
136700,terms,0,0
136701,of,0,0
136702,survival,0,0
136703,rate,0,0
136704,and,0,0
136705,maintenance,0,0
136706,of,0,0
136707,meiotic,0,0
136708,spindle,0,0
136709,.,0,0
136710,DESIGN,0,0
136711,Randomized,0,0
136712,",",0,0
136713,comparative,0,0
136714,study,0,0
136715,.,0,0
136716,SETTING,0,0
136717,Medical,0,0
136718,center,0,0
136719,.,0,0
136720,PATIENT,0,0
136721,(,0,0
136722,S,0,0
136723,),0,1
136724,A,0,0
136725,total,0,0
136726,of,0,0
136727,274,0,0
136728,oocytes,0,0
136729,obtained,0,0
136730,from,0,0
136731,46,0,0
136732,couples,0,0
136733,undergoing,0,0
136734,infertility,0,0
136735,treatment,0,0
136736,.,0,0
136737,INTERVENTION,0,0
136738,(,0,0
136739,S,0,0
136740,),0,0
136741,Metaphase,0,0
136742,II,0,0
136743,oocytes,0,0
136744,were,0,0
136745,divided,0,0
136746,into,0,0
136747,groups,0,0
136748,A,0,0
136749,and,0,0
136750,B,0,0
136751,",",0,0
136752,vitrified,1,1
136753,with,1,0
136754,and,1,0
136755,without,1,0
136756,cumulus,1,0
136757,cells,1,0
136758,",",0,0
136759,respectively,0,0
136760,.,0,0
136761,MAIN,0,0
136762,OUTCOMES,0,0
136763,MEASURE,0,0
136764,(,0,0
136765,S,0,0
136766,),0,0
136767,Survival,0,0
136768,rates,0,0
136769,and,0,0
136770,maintenance,0,0
136771,of,0,0
136772,meiotic,0,0
136773,spindle,0,0
136774,observed,0,0
136775,immediately,0,0
136776,after,0,0
136777,warming,0,0
136778,and,0,0
136779,3,0,0
136780,hours,0,0
136781,after,0,0
136782,incubation,0,0
136783,.,0,0
136784,RESULT,0,0
136785,(,0,0
136786,S,0,0
136787,),0,0
136788,No,0,0
136789,statistically,0,0
136790,significant,0,0
136791,difference,0,0
136792,was,0,0
136793,detected,0,0
136794,between,0,0
136795,the,0,0
136796,two,0,0
136797,groups,0,0
136798,in,0,0
136799,terms,0,0
136800,of,0,0
136801,survival,0,0
136802,rate,0,0
136803,",",0,0
136804,but,0,0
136805,a,0,0
136806,significantly,0,0
136807,higher,0,0
136808,percentage,0,0
136809,of,0,0
136810,detectable,0,0
136811,spindle,0,0
136812,was,0,0
136813,observed,0,0
136814,in,0,0
136815,group,0,0
136816,B,0,0
136817,(,0,0
136818,completely,0,0
136819,denuded,0,1
136820,oocytes,0,0
136821,),0,0
136822,",",0,0
136823,either,0,0
136824,immediately,0,0
136825,after,0,0
136826,warming,0,0
136827,or,0,0
136828,3,0,0
136829,hours,0,0
136830,after,0,0
136831,incubation,0,0
136832,.,0,0
136833,CONCLUSION,0,0
136834,(,0,0
136835,S,0,0
136836,),0,1
136837,Complete,0,0
136838,denudation,0,0
136839,of,0,0
136840,oocytes,0,0
136841,before,0,0
136842,slush,0,1
136843,nitrogen,0,0
136844,vitrification,0,1
136845,does,0,0
136846,not,0,0
136847,influence,0,0
136848,survival,0,0
136849,rates,0,0
136850,but,0,0
136851,positively,0,0
136852,affects,0,0
136853,oocyte,0,0
136854,meiotic,0,0
136855,spindle,0,0
136856,competence,0,0
136857,.,0,0
136858,These,0,0
136859,data,0,0
136860,support,0,0
136861,the,0,0
136862,hypothesis,0,0
136863,that,0,0
136864,cumulus,0,0
136865,cells,0,0
136866,during,0,0
136867,vitrification,0,1
136868,represent,0,0
136869,an,0,0
136870,obstacle,0,0
136871,to,0,0
136872,cryoprotectant,0,1
136873,penetration,0,0
136874,more,0,0
136875,than,0,0
136876,having,0,0
136877,a,0,0
136878,protective,0,0
136879,role,0,0
136880,for,0,0
136881,the,0,0
136882,oocyte,0,0
136883,.,0,0
136884,Theta,1,1
136885,burst,1,0
136886,stimulation,1,1
136887,in,0,0
136888,the,0,0
136889,rehabilitation,0,1
136890,of,0,0
136891,the,0,0
136892,upper,0,0
136893,limb,0,0
136894,:,0,0
136895,a,0,0
136896,semirandomized,0,0
136897,",",0,0
136898,placebo-controlled,0,1
136899,trial,0,0
136900,in,0,0
136901,chronic,0,0
136902,stroke,0,0
136903,patients,0,0
136904,.,0,0
136905,BACKGROUND,0,0
136906,Noninvasive,0,0
136907,cortical,1,0
136908,stimulation,1,1
136909,could,0,0
136910,represent,0,0
136911,an,0,0
136912,add-on,0,1
136913,treatment,0,0
136914,to,0,0
136915,enhance,0,0
136916,motor,0,0
136917,recovery,0,0
136918,after,0,0
136919,stroke,0,0
136920,.,0,0
136921,However,0,0
136922,",",0,0
136923,its,0,0
136924,clinical,0,0
136925,value,0,0
136926,",",0,0
136927,including,0,0
136928,anticipated,0,0
136929,size,0,0
136930,and,0,0
136931,duration,0,0
136932,of,0,0
136933,the,0,0
136934,treatment,0,0
136935,effects,0,0
136936,",",0,0
136937,remains,0,0
136938,largely,0,0
136939,unknown,0,0
136940,.,0,0
136941,OBJECTIVE,0,0
136942,The,0,0
136943,authors,0,0
136944,designed,0,0
136945,a,0,0
136946,small,0,0
136947,semi-randomized,0,0
136948,clinical,0,0
136949,trial,0,0
136950,to,0,0
136951,explore,0,0
136952,whether,0,0
136953,long-lasting,0,0
136954,clinically,0,0
136955,important,0,0
136956,gains,0,0
136957,can,0,0
136958,be,0,0
136959,achieved,0,0
136960,by,0,0
136961,adding,0,0
136962,theta,1,0
136963,burst,1,0
136964,stimulation,1,1
136965,(,1,0
136966,TBS,1,0
136967,),1,0
136968,",",0,0
136969,a,0,0
136970,form,0,0
136971,of,0,0
136972,repetitive,0,1
136973,transcranial,1,1
136974,magnetic,1,1
136975,stimulation,1,1
136976,(,1,0
136977,TMS,1,1
136978,),1,0
136979,",",0,0
136980,to,0,0
136981,a,0,0
136982,rehabilitation,0,1
136983,program,0,1
136984,for,0,0
136985,the,0,0
136986,hand,0,0
136987,.,0,0
136988,METHODS,0,0
136989,A,0,0
136990,total,0,0
136991,of,0,0
136992,41,0,0
136993,chronic,0,0
136994,stroke,0,0
136995,patients,0,0
136996,received,0,0
136997,excitatory,0,0
136998,TBS,1,0
136999,to,0,0
137000,the,0,0
137001,ipsilesional,0,0
137002,hemisphere,0,0
137003,or,0,1
137004,inhibitory,1,0
137005,TBS,1,0
137006,to,0,0
137007,the,0,0
137008,contralesional,0,0
137009,hemisphere,0,0
137010,in,0,0
137011,2,0,0
137012,centers,0,0
137013,;,0,0
137014,each,0,0
137015,active,0,0
137016,group,0,0
137017,was,0,0
137018,compared,0,0
137019,with,0,0
137020,a,0,0
137021,group,0,0
137022,receiving,0,0
137023,sham,1,1
137024,TBS,1,0
137025,.,1,0
137026,TBS,1,0
137027,was,0,0
137028,followed,0,0
137029,by,0,0
137030,physical,0,0
137031,therapy,0,1
137032,for,0,0
137033,10,0,0
137034,working,0,0
137035,days,0,0
137036,.,0,0
137037,Patients,0,0
137038,and,0,0
137039,therapists,0,0
137040,were,0,0
137041,blinded,0,0
137042,to,0,0
137043,the,0,0
137044,type,0,0
137045,of,0,0
137046,TBS,1,0
137047,.,1,0
137048,Primary,0,0
137049,outcome,0,0
137050,measures,0,0
137051,(,0,0
137052,9-hole,0,1
137053,Peg,0,1
137054,Test,0,0
137055,[,0,0
137056,9HPT,0,0
137057,],0,0
137058,",",0,0
137059,Jebsen,0,0
137060,Taylor,0,0
137061,Test,0,0
137062,[,0,0
137063,JTT,0,0
137064,],0,0
137065,",",0,0
137066,and,0,0
137067,grip,0,0
137068,and,0,0
137069,pinch-grip,0,1
137070,dynamometry,0,0
137071,),0,0
137072,were,0,0
137073,assessed,0,0
137074,4,0,0
137075,",",0,0
137076,30,0,0
137077,",",0,0
137078,and,0,0
137079,90,0,0
137080,days,0,0
137081,post,0,0
137082,treatment,0,0
137083,.,0,0
137084,The,0,0
137085,clinically,0,0
137086,important,0,0
137087,difference,0,0
137088,was,0,0
137089,defined,0,0
137090,as,0,0
137091,10,0,0
137092,%,0,0
137093,of,0,0
137094,the,0,0
137095,maximum,0,0
137096,score,0,0
137097,.,0,0
137098,RESULTS,0,0
137099,There,0,0
137100,were,0,0
137101,no,0,0
137102,differences,0,0
137103,between,0,0
137104,the,0,0
137105,active,0,0
137106,treatment,0,0
137107,and,0,0
137108,sham,0,1
137109,groups,0,0
137110,in,0,0
137111,any,0,0
137112,of,0,0
137113,the,0,0
137114,outcome,0,0
137115,measures,0,0
137116,.,0,0
137117,All,0,0
137118,patients,0,0
137119,achieved,0,0
137120,small,0,0
137121,sustainable,0,0
137122,improvements,0,0
137123,--,0,0
137124,9HPT,0,0
137125,",",0,0
137126,5,0,0
137127,%,0,0
137128,of,0,0
137129,maximum,0,0
137130,(,0,0
137131,confidence,0,0
137132,interval,0,0
137133,[,0,0
137134,CI,0,0
137135,],0,0
137136,=,0,0
137137,3,0,0
137138,%,0,0
137139,-7,0,0
137140,%,0,0
137141,),0,0
137142,;,0,0
137143,JTT,0,0
137144,",",0,0
137145,5.7,0,0
137146,%,0,0
137147,(,0,0
137148,CI,0,0
137149,=,0,0
137150,3,0,0
137151,%,0,0
137152,-8,0,0
137153,%,0,0
137154,),0,0
137155,;,0,0
137156,and,0,0
137157,grip,0,0
137158,strength,0,0
137159,",",0,0
137160,6,0,0
137161,%,0,0
137162,(,0,0
137163,CI,0,0
137164,=,0,0
137165,2,0,0
137166,%,0,0
137167,-10,0,0
137168,%,0,0
137169,),0,0
137170,--,0,0
137171,all,0,0
137172,below,0,0
137173,the,0,0
137174,defined,0,0
137175,clinically,0,0
137176,important,0,0
137177,level,0,0
137178,.,0,0
137179,CONCLUSIONS,0,0
137180,Cortical,0,0
137181,stimulation,0,1
137182,did,0,0
137183,not,0,0
137184,augment,0,0
137185,the,0,0
137186,gains,0,0
137187,from,0,0
137188,a,0,0
137189,late,0,0
137190,rehabilitation,0,1
137191,program,0,1
137192,.,0,0
137193,The,0,0
137194,effect,0,0
137195,size,0,0
137196,anticipated,0,0
137197,by,0,0
137198,the,0,0
137199,authors,0,0
137200,was,0,0
137201,overestimated,0,0
137202,.,0,0
137203,These,0,0
137204,results,0,0
137205,can,0,0
137206,improve,0,0
137207,the,0,0
137208,design,0,0
137209,of,0,0
137210,future,0,0
137211,work,0,0
137212,on,0,0
137213,therapeutic,0,0
137214,uses,0,0
137215,of,0,0
137216,TMS,0,0
137217,.,0,0
137218,Noradrenergic,0,1
137219,moderation,0,0
137220,of,0,0
137221,working,0,0
137222,memory,0,0
137223,impairments,0,0
137224,in,0,0
137225,adults,0,0
137226,with,0,0
137227,autism,0,0
137228,spectrum,0,0
137229,disorder,0,0
137230,.,0,0
137231,In,0,0
137232,addition,0,0
137233,to,0,0
137234,having,0,0
137235,difficulties,0,0
137236,with,0,0
137237,social,0,0
137238,communications,0,1
137239,",",0,0
137240,individuals,0,0
137241,with,0,0
137242,an,0,0
137243,autism,0,0
137244,spectrum,0,0
137245,disorder,0,0
137246,(,0,0
137247,ASD,0,0
137248,),0,0
137249,often,0,0
137250,also,0,0
137251,experience,0,0
137252,impairment,0,0
137253,in,0,0
137254,higher-order,0,0
137255,",",0,0
137256,executive,0,0
137257,skills,0,0
137258,.,0,0
137259,The,0,0
137260,present,0,0
137261,study,0,0
137262,examined,0,0
137263,the,0,0
137264,effects,0,0
137265,of,0,0
137266,pharmacological,0,0
137267,modulation,0,0
137268,of,0,0
137269,the,0,0
137270,norepinephrine,0,0
137271,system,0,0
137272,on,0,0
137273,the,0,0
137274,severity,0,0
137275,of,0,0
137276,such,0,0
137277,impairments,0,0
137278,.,0,0
137279,A,0,0
137280,sample,0,0
137281,of,0,0
137282,14,0,0
137283,high-functioning,0,0
137284,adults,0,0
137285,with,0,0
137286,ASD,0,0
137287,and,0,0
137288,a,0,0
137289,demographically-matched,0,0
137290,comparison,0,0
137291,group,0,0
137292,of,0,0
137293,13,0,0
137294,typically,0,0
137295,developing,0,0
137296,individuals,0,0
137297,participated,0,0
137298,.,0,0
137299,An,0,0
137300,AX,0,0
137301,continuous,0,1
137302,performance,0,0
137303,test,0,0
137304,(,0,0
137305,AX-CPT,0,1
137306,),0,0
137307,was,0,0
137308,used,0,0
137309,to,0,0
137310,evaluate,0,0
137311,working,0,1
137312,memory,0,0
137313,and,0,0
137314,inhibitory,0,0
137315,control,0,1
137316,.,0,0
137317,AX-CPT,0,0
137318,performance,0,0
137319,was,0,0
137320,assessed,0,0
137321,following,0,0
137322,administration,0,0
137323,of,0,0
137324,a,0,0
137325,single,0,0
137326,dose,0,0
137327,of,0,0
137328,propranolol,1,1
137329,(,1,0
137330,a,1,0
137331,beta,1,1
137332,adrenergic,1,1
137333,antagonist,1,1
137334,),1,0
137335,and,1,0
137336,following,1,0
137337,placebo,1,1
137338,(,0,1
137339,sugar,0,1
137340,pill,0,1
137341,),0,0
137342,administration,0,0
137343,.,0,0
137344,Individuals,0,0
137345,with,0,0
137346,ASD,0,0
137347,performed,0,0
137348,more,0,0
137349,poorly,0,0
137350,than,0,0
137351,non-ASD,0,0
137352,individuals,0,0
137353,in,0,0
137354,the,0,0
137355,working,0,0
137356,memory,0,0
137357,condition,0,1
137358,(,0,0
137359,BX,0,1
137360,trials,0,0
137361,),0,0
137362,.,0,0
137363,Importantly,0,0
137364,",",0,0
137365,administration,0,0
137366,of,0,0
137367,propranolol,1,1
137368,attenuated,0,0
137369,this,0,0
137370,impairment,0,0
137371,",",0,0
137372,with,0,0
137373,the,0,0
137374,ASD,0,0
137375,group,0,0
137376,performing,0,0
137377,significantly,0,0
137378,better,0,0
137379,in,0,0
137380,the,0,0
137381,propranolol,0,1
137382,condition,0,0
137383,than,0,0
137384,the,0,0
137385,placebo,0,1
137386,condition,0,0
137387,.,0,0
137388,Working,0,1
137389,memory,0,0
137390,performance,0,0
137391,of,0,0
137392,the,0,0
137393,non-ASD,0,0
137394,group,0,0
137395,was,0,0
137396,unaffected,0,0
137397,by,0,0
137398,propranolol/placebo,0,1
137399,administration,0,0
137400,.,0,0
137401,No,0,0
137402,group,0,0
137403,or,0,1
137404,medication,0,0
137405,effects,0,0
137406,were,0,0
137407,observed,0,0
137408,for,0,0
137409,the,0,0
137410,inhibition,0,1
137411,condition,0,0
137412,(,0,0
137413,AY,0,1
137414,trials,0,0
137415,),0,0
137416,.,0,0
137417,The,0,0
137418,present,0,0
137419,findings,0,0
137420,suggest,0,0
137421,that,0,0
137422,norepinephrine,0,0
137423,may,0,0
137424,play,0,0
137425,a,0,0
137426,role,0,0
137427,in,0,0
137428,some,0,0
137429,",",0,0
137430,but,0,0
137431,not,0,0
137432,necessarily,0,0
137433,all,0,0
137434,",",0,0
137435,cognitive,0,0
137436,impairments,0,0
137437,associated,0,0
137438,with,0,0
137439,ASD,0,0
137440,.,0,0
137441,Additional,0,0
137442,research,0,0
137443,is,0,0
137444,needed,0,0
137445,to,0,0
137446,fully,0,0
137447,understand,0,0
137448,whether,0,0
137449,this,0,0
137450,role,0,0
137451,is,0,0
137452,primarily,0,0
137453,causal,0,0
137454,or,0,1
137455,compensatory,0,0
137456,in,0,0
137457,nature,0,0
137458,.,0,0
137459,Elevated,0,0
137460,concentration,0,0
137461,of,0,0
137462,placental,0,0
137463,growth,0,0
137464,factor,0,0
137465,(,0,0
137466,PlGF,0,0
137467,),0,1
137468,and,0,0
137469,long,0,0
137470,term,0,0
137471,risk,0,0
137472,in,0,0
137473,patients,0,0
137474,with,0,0
137475,acute,0,0
137476,coronary,0,0
137477,syndrome,0,0
137478,in,0,0
137479,the,0,0
137480,PROVE,0,0
137481,IT-TIMI,0,0
137482,22,0,0
137483,trial,0,0
137484,.,0,0
137485,Placental,1,0
137486,growth,1,0
137487,factor,1,0
137488,(,0,0
137489,PlGF,0,0
137490,),0,0
137491,",",0,0
137492,a,0,0
137493,member,0,0
137494,of,0,0
137495,the,0,0
137496,vascular,0,0
137497,endothelial,0,0
137498,growth,0,1
137499,factor,0,0
137500,(,0,0
137501,VEGF,0,1
137502,),0,0
137503,family,0,0
137504,",",0,0
137505,acts,0,0
137506,via,0,0
137507,the,0,0
137508,flt-1,0,1
137509,receptor,0,0
137510,and,0,0
137511,promotes,0,0
137512,endothelial,0,0
137513,activation,0,0
137514,and,0,0
137515,macrophage,0,0
137516,recruitment,0,0
137517,into,0,0
137518,atherosclerotic,0,0
137519,lesions,0,0
137520,.,0,0
137521,We,0,0
137522,investigated,0,0
137523,the,0,0
137524,relationship,0,0
137525,of,0,0
137526,PlGF,0,0
137527,with,0,0
137528,cardiovascular,0,0
137529,outcomes,0,0
137530,in,0,0
137531,a,0,0
137532,large,0,0
137533,cohort,0,0
137534,of,0,0
137535,patients,0,0
137536,presenting,0,0
137537,across,0,0
137538,the,0,0
137539,spectrum,0,0
137540,of,0,0
137541,ACS,0,1
137542,.,0,0
137543,PlGF,0,0
137544,was,0,0
137545,measured,0,0
137546,at,0,0
137547,baseline,0,0
137548,(,0,0
137549,n,0,0
137550,=,0,0
137551,"3,761",0,0
137552,),0,0
137553,and,0,0
137554,at,0,0
137555,four-months,0,0
137556,(,0,0
137557,n,0,0
137558,=,0,0
137559,"3,369",0,0
137560,),0,0
137561,in,0,0
137562,patients,0,0
137563,randomized,0,0
137564,to,0,0
137565,atorvastatin,1,1
137566,80,1,0
137567,mg,1,1
137568,or,1,1
137569,pravastatin,1,1
137570,40,1,0
137571,mg,1,0
137572,after,1,0
137573,ACS,1,1
137574,in,0,0
137575,the,0,0
137576,PROVE,0,0
137577,IT-TIMI,0,0
137578,22,0,0
137579,trial,0,0
137580,.,0,0
137581,The,0,0
137582,primary,0,0
137583,endpoint,0,0
137584,was,0,0
137585,death,0,0
137586,",",0,0
137587,myocardial,0,0
137588,infarction,0,0
137589,(,0,0
137590,MI,0,1
137591,),0,0
137592,",",0,0
137593,unstable,0,0
137594,angina,0,0
137595,",",0,0
137596,revascularization,0,0
137597,or,0,1
137598,stroke,0,0
137599,(,0,0
137600,mean,0,0
137601,follow-up,0,0
137602,24,0,0
137603,months,0,0
137604,),0,0
137605,.,0,0
137606,Elevated,0,0
137607,baseline,0,0
137608,PlGF,0,0
137609,was,0,0
137610,associated,0,0
137611,with,0,0
137612,a,0,0
137613,higher,0,0
137614,incidence,0,0
137615,of,0,0
137616,the,0,0
137617,primary,0,0
137618,endpoint,0,0
137619,through,0,0
137620,2,0,0
137621,years,0,0
137622,(,0,0
137623,Q1,0,1
137624,vs.,0,0
137625,Q5,0,1
137626,:,0,0
137627,18.7,0,0
137628,vs.,0,0
137629,29.3,0,0
137630,%,0,0
137631,",",0,0
137632,p,0,0
137633,<,0,0
137634,0.0001,0,0
137635,),0,0
137636,.,0,0
137637,The,0,0
137638,risk,0,0
137639,of,0,0
137640,death,0,0
137641,or,0,1
137642,MI,0,1
137643,was,0,0
137644,also,0,0
137645,higher,0,0
137646,in,0,0
137647,patients,0,0
137648,with,0,0
137649,elevated,0,0
137650,baseline,0,0
137651,PlGF,0,0
137652,(,0,0
137653,Q1,0,1
137654,vs.,0,0
137655,Q5,0,1
137656,:,0,0
137657,7.0,0,0
137658,vs.,0,0
137659,11.6,0,0
137660,%,0,0
137661,",",0,0
137662,p,0,0
137663,=,0,0
137664,0.029,0,0
137665,),0,0
137666,.,0,0
137667,Adjusting,0,0
137668,for,0,0
137669,baseline,0,0
137670,characteristics,0,0
137671,and,0,0
137672,risk,0,0
137673,factors,0,0
137674,",",0,0
137675,elevated,0,0
137676,baseline,0,0
137677,PlGF,0,0
137678,was,0,0
137679,independently,0,0
137680,associated,0,0
137681,with,0,0
137682,the,0,0
137683,risk,0,0
137684,of,0,0
137685,the,0,0
137686,primary,0,0
137687,endpoint,0,0
137688,(,0,0
137689,adjusted-HR,0,0
137690,for,0,0
137691,Q5,0,1
137692,vs.,0,0
137693,Q1,0,1
137694,1.45,0,0
137695,;,0,0
137696,95,0,0
137697,%,0,0
137698,CI,0,0
137699,1.16-1.83,0,0
137700,;,0,0
137701,p,0,0
137702,=,0,0
137703,0.001,0,0
137704,),0,0
137705,.,0,0
137706,Elevated,0,0
137707,PlGF,0,0
137708,at,0,0
137709,four,0,0
137710,months,0,0
137711,was,0,0
137712,associated,0,0
137713,with,0,0
137714,higher,0,0
137715,risk,0,0
137716,of,0,0
137717,death,0,0
137718,or,0,1
137719,MI,0,1
137720,(,0,0
137721,Adjusted,0,0
137722,HR,0,0
137723,Q5,0,1
137724,vs.,0,0
137725,Q1,0,1
137726,2.79,0,0
137727,",",0,0
137728,95,0,0
137729,%,0,0
137730,CI,0,0
137731,:,0,0
137732,1.37-5.68,0,0
137733,;,0,0
137734,p,0,0
137735,=,0,0
137736,0.005,0,0
137737,),0,0
137738,",",0,0
137739,and,0,0
137740,higher,0,0
137741,risk,0,0
137742,of,0,0
137743,the,0,0
137744,primary,0,0
137745,endpoint,0,0
137746,(,0,0
137747,Adjusted,0,0
137748,HR,0,0
137749,Q5,0,1
137750,vs.,0,0
137751,Q1,0,1
137752,1.78,0,0
137753,",",0,0
137754,95,0,0
137755,%,0,0
137756,CI,0,0
137757,:,0,0
137758,1.26-2.51,0,0
137759,;,0,0
137760,p,0,0
137761,=,0,0
137762,0.001,0,0
137763,),0,0
137764,.,0,0
137765,Higher,0,0
137766,concentration,0,0
137767,of,0,0
137768,PlGF,0,0
137769,after,0,0
137770,ACS,0,1
137771,is,0,0
137772,associated,0,0
137773,with,0,0
137774,long-term,0,0
137775,risk,0,0
137776,of,0,0
137777,recurrent,0,0
137778,cardiovascular,0,0
137779,events,0,0
137780,independent,0,0
137781,of,0,0
137782,traditional,0,1
137783,risk,0,0
137784,factors,0,0
137785,.,0,0
137786,This,0,0
137787,association,0,0
137788,is,0,0
137789,present,0,0
137790,early,0,0
137791,after,0,0
137792,ACS,0,1
137793,and,0,0
137794,appears,0,0
137795,to,0,0
137796,be,0,0
137797,stronger,0,0
137798,at,0,0
137799,four,0,0
137800,months,0,0
137801,.,0,0
137802,[,1,0
137803,Simvastatin,1,1
137804,versus,1,0
137805,gemfibrozil,1,1
137806,in,0,0
137807,the,0,0
137808,treatment,0,0
137809,of,0,0
137810,primary,0,0
137811,hypercholesterolemia,0,0
137812,in,0,0
137813,hypertensive,0,0
137814,patients,0,0
137815,treated,0,0
137816,with,0,0
137817,hydrochlorothiazide,1,1
137818,],1,0
137819,.,0,0
137820,Recent,0,0
137821,pharmacological,0,0
137822,studies,0,0
137823,confirmed,0,0
137824,the,0,0
137825,role,0,0
137826,of,0,0
137827,hypercholesterolemia,0,0
137828,in,0,0
137829,the,0,0
137830,pathogenesis,0,0
137831,of,0,0
137832,coronary,0,0
137833,atherosclerosis,0,0
137834,.,0,0
137835,A,0,0
137836,10,0,0
137837,%,0,0
137838,reduction,0,0
137839,in,0,0
137840,cholesterol,0,0
137841,levels,0,0
137842,can,0,0
137843,reduce,0,0
137844,the,0,0
137845,risk,0,0
137846,of,0,0
137847,coronary,0,0
137848,heart,0,0
137849,disease,0,0
137850,by,0,0
137851,15,0,0
137852,%,0,0
137853,.,0,0
137854,However,0,0
137855,many,0,0
137856,hypercholesterolemic,0,0
137857,patients,0,0
137858,often,0,0
137859,suffer,0,0
137860,from,0,0
137861,arterial,0,0
137862,hypertension,0,0
137863,and,0,0
137864,drugs,0,1
137865,such,0,0
137866,as,0,0
137867,thiazide,1,1
137868,diuretics,1,1
137869,cause,0,0
137870,an,0,0
137871,imbalance,0,0
137872,in,0,0
137873,lipid,0,0
137874,metabolism,0,0
137875,.,0,0
137876,The,0,0
137877,efficacy,0,0
137878,and,0,0
137879,the,0,0
137880,tolerability,0,0
137881,of,0,0
137882,simvastatin,1,1
137883,(,0,0
137884,a,0,0
137885,inhibitor,0,1
137886,of,0,0
137887,HGM-CoA,0,1
137888,reductase,0,1
137889,),0,0
137890,with,0,0
137891,that,0,0
137892,of,0,0
137893,gemfibrozil,1,1
137894,(,0,0
137895,a,0,0
137896,fibric,0,1
137897,acid,0,1
137898,derivative,0,1
137899,",",0,0
137900,which,0,0
137901,can,0,0
137902,reduce,0,0
137903,the,0,0
137904,VLDL,0,1
137905,level,0,0
137906,),0,0
137907,were,0,0
137908,compared,0,0
137909,in,0,0
137910,a,0,0
137911,placebo-controlled,1,1
137912,study,0,0
137913,in,0,0
137914,2,0,0
137915,groups,0,0
137916,of,0,0
137917,patients,0,0
137918,with,0,0
137919,primary,0,0
137920,hypercholesterolemia,0,0
137921,and,0,0
137922,mild-to-moderate,0,0
137923,essential,0,0
137924,hypertension,0,0
137925,treated,0,0
137926,with,0,0
137927,hydrochlorothiazide,0,1
137928,.,0,0
137929,After,0,0
137930,10,0,0
137931,weeks,0,0
137932,standard,1,0
137933,hypolipidemic,1,0
137934,diet,1,1
137935,and,1,0
137936,hydrochlorothiazide,1,1
137937,(,0,0
137938,25,0,0
137939,mg,0,1
137940,od,0,0
137941,),0,0
137942,therapy,0,1
137943,",",0,0
137944,30,0,0
137945,patients,0,0
137946,whose,0,0
137947,cholesterol,0,0
137948,levels,0,0
137949,were,0,0
137950,still,0,0
137951,greater,0,0
137952,than,0,0
137953,or,0,0
137954,equal,0,0
137955,to,0,0
137956,250,0,0
137957,mg/100,0,0
137958,ml,0,0
137959,and,0,0
137960,whose,0,0
137961,diastolic,0,0
137962,blood,0,0
137963,pressure,0,0
137964,was,0,0
137965,less,0,0
137966,than,0,0
137967,95,0,0
137968,mmHg,0,0
137969,were,0,0
137970,randomized,0,0
137971,to,0,0
137972,one,0,0
137973,of,0,0
137974,the,0,0
137975,following,0,0
137976,treatments,0,0
137977,:,0,0
137978,simvastatin,1,1
137979,",",0,0
137980,20,0,0
137981,mg,0,0
137982,od,0,0
137983,",",0,0
137984,gemfibrozil,1,1
137985,",",0,0
137986,600,0,1
137987,mg,0,1
137988,bid,0,1
137989,or,1,1
137990,placebo,1,1
137991,",",0,0
137992,while,0,0
137993,continuing,0,0
137994,dietetic,0,1
137995,and,0,0
137996,diuretic,0,1
137997,treatment,0,0
137998,.,0,0
137999,After,0,0
138000,24,0,0
138001,weeks,0,0
138002,treatment,0,0
138003,",",0,0
138004,simvastatin,1,1
138005,induced,0,0
138006,a,0,0
138007,37,0,0
138008,%,0,0
138009,reduction,0,0
138010,in,0,0
138011,cholesterol,0,0
138012,plasma,0,0
138013,levels,0,0
138014,",",0,0
138015,a,0,0
138016,9,0,0
138017,%,0,0
138018,increase,0,0
138019,of,0,0
138020,HDL,0,1
138021,and,0,0
138022,a,0,0
138023,16,0,0
138024,%,0,0
138025,reduction,0,0
138026,of,0,0
138027,LDL,0,0
138028,.,0,0
138029,APO-A1,0,0
138030,showed,0,0
138031,a,0,0
138032,4,0,0
138033,%,0,0
138034,increase,0,0
138035,",",0,0
138036,while,0,0
138037,APO-B,0,0
138038,showed,0,0
138039,a,0,0
138040,3,0,0
138041,%,0,0
138042,reduction,0,0
138043,.,0,0
138044,Gemfibrozil,1,1
138045,induced,0,0
138046,a,0,0
138047,20,0,0
138048,%,0,0
138049,reduction,0,0
138050,in,0,0
138051,plasma,0,0
138052,triglycerides,0,0
138053,and,0,0
138054,a,0,0
138055,13,0,0
138056,%,0,0
138057,decrease,0,0
138058,in,0,0
138059,plasma,0,0
138060,cholesterol,0,0
138061,",",0,0
138062,with,0,0
138063,a,0,0
138064,significant,0,0
138065,19,0,0
138066,%,0,0
138067,increase,0,0
138068,in,0,0
138069,HDL,0,1
138070,and,0,0
138071,a,0,0
138072,11,0,0
138073,%,0,0
138074,reduction,0,0
138075,in,0,0
138076,LDL,0,0
138077,.,0,0
138078,No,0,0
138079,significant,0,0
138080,variations,0,0
138081,in,0,0
138082,any,0,0
138083,of,0,0
138084,the,0,0
138085,lipid,0,0
138086,parameters,0,0
138087,monitored,0,0
138088,were,0,0
138089,observed,0,0
138090,in,0,0
138091,the,0,0
138092,placebo,1,1
138093,group,0,0
138094,.,0,0
138095,Treatment,0,0
138096,with,0,0
138097,simvastatin,1,1
138098,or,0,1
138099,gemfibrozil,1,1
138100,in,0,0
138101,hypertensive,0,0
138102,patients,0,0
138103,in,0,0
138104,hydrochlorothiazide,1,1
138105,monotherapy,0,1
138106,can,0,0
138107,reduce,0,0
138108,total,0,0
138109,cholesterol,0,0
138110,and,0,0
138111,LDL-cholesterol,0,1
138112,plasma,0,0
138113,levels,0,0
138114,",",0,0
138115,while,0,0
138116,significantly,0,0
138117,increasing,0,0
138118,HDL,0,1
138119,plasma,0,0
138120,levels,0,0
138121,compared,0,0
138122,to,0,0
138123,placebo,0,1
138124,.,0,0
138125,Simvastatin,1,1
138126,",",0,0
138127,however,0,0
138128,",",0,0
138129,resulted,0,0
138130,more,0,0
138131,efficient,0,0
138132,than,0,0
138133,gemfibrozil,1,1
138134,on,0,0
138135,total,0,0
138136,cholesterol,0,0
138137,or,0,1
138138,cholesterol,0,0
138139,fractions,0,1
138140,.,0,0
138141,Impact,0,0
138142,of,0,0
138143,the,0,0
138144,quantity,0,0
138145,and,0,0
138146,flavonoid,0,1
138147,content,0,0
138148,of,0,0
138149,fruits,1,1
138150,and,1,0
138151,vegetables,1,1
138152,on,0,0
138153,markers,0,0
138154,of,0,0
138155,intake,0,0
138156,in,0,0
138157,adults,0,0
138158,with,0,0
138159,an,0,0
138160,increased,0,0
138161,risk,0,0
138162,of,0,0
138163,cardiovascular,0,0
138164,disease,0,0
138165,:,0,0
138166,the,0,0
138167,FLAVURS,0,0
138168,trial,0,0
138169,.,0,0
138170,PURPOSE,0,0
138171,Limited,0,0
138172,robust,0,0
138173,randomised,0,0
138174,controlled,0,0
138175,trials,0,0
138176,investigating,0,0
138177,fruit,1,1
138178,and,1,0
138179,vegetable,1,1
138180,(,1,0
138181,F,1,0
138182,&,1,0
138183,V,1,1
138184,),1,0
138185,intake,1,0
138186,in,0,0
138187,people,0,0
138188,at,0,0
138189,risk,0,0
138190,of,0,0
138191,cardiovascular,0,0
138192,disease,0,0
138193,(,0,0
138194,CVD,0,1
138195,),0,0
138196,exist,0,0
138197,.,0,0
138198,We,0,0
138199,aimed,0,0
138200,to,0,0
138201,design,0,0
138202,and,0,0
138203,validate,0,0
138204,a,0,0
138205,dietary,1,0
138206,strategy,1,0
138207,of,1,0
138208,increasing,1,0
138209,flavonoid-rich,1,1
138210,versus,1,0
138211,flavonoid-poor,1,1
138212,F,1,0
138213,&,1,0
138214,V,1,1
138215,consumption,1,0
138216,on,0,0
138217,nutrient,0,1
138218,biomarker,0,0
138219,profile,0,0
138220,.,0,0
138221,METHODS,0,0
138222,A,0,0
138223,parallel,0,0
138224,",",0,0
138225,randomised,0,0
138226,",",0,0
138227,controlled,0,0
138228,",",0,0
138229,dose-response,0,0
138230,dietary,0,1
138231,intervention,0,1
138232,study,0,0
138233,.,0,0
138234,Participants,0,0
138235,with,0,0
138236,a,0,0
138237,CVD,0,1
138238,relative,0,0
138239,risk,0,0
138240,of,0,0
138241,1.5,0,0
138242,assessed,0,0
138243,by,0,0
138244,risk,0,0
138245,scores,0,0
138246,were,0,0
138247,randomly,0,0
138248,assigned,0,0
138249,to,0,0
138250,one,0,0
138251,of,0,0
138252,the,0,0
138253,3,0,0
138254,groups,0,0
138255,:,0,0
138256,habitual,1,0
138257,(,1,0
138258,control,1,0
138259,",",1,0
138260,CT,1,0
138261,),1,0
138262,",",1,0
138263,high-flavonoid,1,1
138264,(,1,0
138265,HF,1,0
138266,),1,1
138267,or,1,1
138268,low-flavonoid,1,1
138269,(,1,0
138270,LF,1,0
138271,),1,0
138272,diets,1,1
138273,.,1,0
138274,While,0,0
138275,the,0,0
138276,CT,0,0
138277,group,0,0
138278,(,0,0
138279,n,0,0
138280,=,0,0
138281,57,0,0
138282,),0,0
138283,consumed,0,0
138284,their,0,0
138285,habitual,0,0
138286,diet,0,1
138287,throughout,0,0
138288,",",0,0
138289,the,0,0
138290,HF,0,0
138291,(,0,0
138292,n,0,0
138293,=,0,0
138294,58,0,0
138295,),0,0
138296,and,0,0
138297,LF,0,0
138298,(,0,0
138299,n,0,0
138300,=,0,0
138301,59,0,0
138302,),0,0
138303,groups,0,0
138304,sequentially,0,0
138305,increased,0,0
138306,their,0,0
138307,daily,0,1
138308,F,0,0
138309,&,0,0
138310,V,0,1
138311,intake,0,0
138312,by,0,0
138313,an,0,0
138314,additional,0,0
138315,2,0,0
138316,",",0,0
138317,4,0,0
138318,and,0,0
138319,6,0,0
138320,portions,0,0
138321,for,0,0
138322,6-week,0,0
138323,periods,0,0
138324,during,0,0
138325,the,0,0
138326,18-week,0,0
138327,study,0,0
138328,.,0,0
138329,RESULTS,0,0
138330,Compliance,0,0
138331,to,0,0
138332,target,0,0
138333,numbers,0,0
138334,and,0,0
138335,types,0,0
138336,of,0,0
138337,F,0,0
138338,&,0,0
138339,V,0,1
138340,was,0,0
138341,broadly,0,0
138342,met,0,0
138343,and,0,0
138344,verified,0,0
138345,by,0,0
138346,dietary,0,0
138347,records,0,0
138348,",",0,0
138349,and,0,0
138350,plasma,0,0
138351,and,0,0
138352,urinary,0,0
138353,biomarkers,0,0
138354,.,0,0
138355,Mean,0,0
138356,(,0,0
138357,?,0,0
138358,SEM,0,1
138359,),0,0
138360,number,0,0
138361,of,0,0
138362,F,0,0
138363,&,0,0
138364,V,0,1
138365,portions/day,0,0
138366,consumed,0,0
138367,by,0,0
138368,the,0,0
138369,HF,0,0
138370,and,0,0
138371,LF,0,0
138372,groups,0,0
138373,at,0,0
138374,baseline,0,0
138375,(,0,0
138376,3.8,0,0
138377,?,0,0
138378,0.3,0,0
138379,and,0,0
138380,3.4,0,0
138381,?,0,0
138382,0.3,0,0
138383,),0,0
138384,",",0,0
138385,6,0,0
138386,weeks,0,0
138387,(,0,0
138388,6.3,0,0
138389,?,0,0
138390,0.4,0,0
138391,and,0,0
138392,5.8,0,0
138393,?,0,0
138394,0.3,0,0
138395,),0,0
138396,",",0,0
138397,12,0,0
138398,weeks,0,0
138399,(,0,0
138400,7.0,0,0
138401,?,0,0
138402,0.3,0,0
138403,and,0,0
138404,6.8,0,0
138405,?,0,0
138406,0.3,0,0
138407,),0,0
138408,and,0,0
138409,18,0,0
138410,weeks,0,0
138411,(,0,0
138412,7.6,0,0
138413,?,0,0
138414,0.4,0,0
138415,and,0,0
138416,8.1,0,0
138417,?,0,0
138418,0.4,0,0
138419,),0,0
138420,",",0,0
138421,respectively,0,0
138422,",",0,0
138423,was,0,0
138424,similar,0,0
138425,at,0,0
138426,baseline,0,0
138427,yet,0,0
138428,higher,0,0
138429,than,0,0
138430,the,0,0
138431,CT,0,0
138432,group,0,0
138433,(,0,0
138434,3.9,0,0
138435,?,0,0
138436,0.3,0,0
138437,",",0,0
138438,4.3,0,0
138439,?,0,0
138440,0.3,0,0
138441,",",0,0
138442,4.6,0,0
138443,?,0,0
138444,0.4,0,0
138445,",",0,0
138446,4.5,0,0
138447,?,0,0
138448,0.3,0,0
138449,),0,0
138450,(,0,0
138451,P,0,0
138452,=,0,0
138453,0.015,0,0
138454,),0,0
138455,.,0,0
138456,There,0,0
138457,was,0,0
138458,a,0,0
138459,dose-dependent,0,0
138460,increase,0,0
138461,in,0,0
138462,dietary,0,0
138463,and,0,0
138464,urinary,0,0
138465,flavonoids,0,1
138466,in,0,0
138467,the,0,0
138468,HF,0,0
138469,group,0,0
138470,",",0,0
138471,with,0,0
138472,no,0,0
138473,change,0,0
138474,in,0,0
138475,other,0,0
138476,groups,0,0
138477,(,0,0
138478,P,0,0
138479,=,0,0
138480,0.0001,0,0
138481,),0,0
138482,.,0,0
138483,Significantly,0,0
138484,higher,0,0
138485,dietary,0,0
138486,intakes,0,0
138487,of,0,0
138488,folate,0,0
138489,(,0,0
138490,P,0,0
138491,=,0,0
138492,0.035,0,0
138493,),0,0
138494,",",0,0
138495,non-starch,0,1
138496,polysaccharides,0,1
138497,(,0,0
138498,P,0,0
138499,=,0,0
138500,0.001,0,0
138501,),0,0
138502,",",0,0
138503,vitamin,0,1
138504,C,0,1
138505,(,0,0
138506,P,0,0
138507,=,0,0
138508,0.0001,0,0
138509,),0,0
138510,and,0,0
138511,carotenoids,0,1
138512,(,0,0
138513,P,0,0
138514,=,0,0
138515,0.0001,0,0
138516,),0,0
138517,were,0,0
138518,observed,0,0
138519,in,0,0
138520,both,0,0
138521,intervention,0,1
138522,groups,0,0
138523,compared,0,0
138524,with,0,0
138525,CT,0,0
138526,",",0,0
138527,which,0,0
138528,were,0,0
138529,broadly,0,0
138530,supported,0,0
138531,by,0,0
138532,nutrient,0,1
138533,biomarker,0,0
138534,analysis,0,0
138535,.,0,0
138536,CONCLUSIONS,0,0
138537,The,0,0
138538,success,0,0
138539,of,0,0
138540,improving,0,0
138541,nutrient,0,1
138542,profile,0,0
138543,by,0,0
138544,active,0,0
138545,encouragement,0,0
138546,of,0,0
138547,F,0,0
138548,&,0,0
138549,V,0,1
138550,intake,0,0
138551,in,0,0
138552,an,0,0
138553,intervention,0,1
138554,study,0,0
138555,implies,0,0
138556,the,0,0
138557,need,0,0
138558,for,0,0
138559,a,0,0
138560,more,0,0
138561,hands-on,0,1
138562,public,0,0
138563,health,0,0
138564,approach,0,1
138565,.,0,0
138566,Procalcitonin,1,0
138567,is,0,0
138568,a,0,0
138569,good,0,0
138570,tool,0,0
138571,to,0,0
138572,guide,0,0
138573,duration,0,0
138574,of,0,0
138575,antibiotic,1,1
138576,therapy,1,1
138577,in,0,0
138578,patients,0,0
138579,with,0,0
138580,severe,0,0
138581,acute,0,0
138582,pancreatitis,0,0
138583,.,0,0
138584,A,0,0
138585,randomized,0,0
138586,prospective,0,0
138587,single-center,0,0
138588,controlled,0,0
138589,trial,0,0
138590,.,0,0
138591,OBJECTIVE,0,0
138592,To,0,0
138593,investigate,0,0
138594,the,0,0
138595,clinical,0,0
138596,usefulness,0,0
138597,of,0,0
138598,procalcitonin,1,0
138599,(,0,0
138600,PCT,0,1
138601,),0,0
138602,for,0,0
138603,guiding,0,0
138604,duration,0,0
138605,of,0,0
138606,antibiotic,1,1
138607,therapy,1,1
138608,in,0,0
138609,patients,0,0
138610,with,0,0
138611,severe,0,0
138612,acute,0,0
138613,pancreatitis,0,0
138614,(,0,0
138615,SAP,0,0
138616,),0,0
138617,.,0,0
138618,METHODS,0,0
138619,A,0,0
138620,total,0,0
138621,of,0,0
138622,71,0,0
138623,patients,0,0
138624,with,0,0
138625,confirmed,0,0
138626,severe,0,0
138627,acute,0,0
138628,pancreatitis,0,0
138629,from,0,0
138630,March,0,0
138631,2009,0,0
138632,to,0,0
138633,September,0,0
138634,2011,0,0
138635,in,0,0
138636,the,0,0
138637,Department,0,0
138638,of,0,0
138639,Critical,0,0
138640,Care,0,0
138641,Medicine,0,1
138642,of,0,0
138643,Huizhou,0,0
138644,Municipal,0,0
138645,Central,0,0
138646,Hospital,0,0
138647,",",0,0
138648,Guangdong,0,0
138649,",",0,0
138650,China,0,0
138651,were,0,0
138652,enrolled,0,0
138653,in,0,0
138654,this,0,0
138655,study,0,0
138656,.,0,0
138657,Procalcitonin,1,0
138658,was,1,0
138659,measured,1,0
138660,daily,1,0
138661,by,1,0
138662,a,1,0
138663,semi-quantitative,1,0
138664,immunoassay,1,0
138665,in,1,0
138666,the,1,0
138667,study,1,0
138668,group,1,0
138669,.,1,0
138670,Patients,0,0
138671,were,0,0
138672,randomly,0,0
138673,assigned,0,0
138674,into,0,0
138675,2,1,0
138676,groups,1,0
138677,including,1,0
138678,a,1,0
138679,PCT-guided,1,1
138680,group,1,0
138681,(,1,0
138682,study,1,0
138683,group,1,0
138684,),1,0
138685,and,1,0
138686,a,1,0
138687,prophylactic,1,1
138688,antibiotic,1,1
138689,therapy,1,1
138690,(,1,0
138691,control,1,1
138692,group,1,0
138693,),1,0
138694,.,0,0
138695,Antibiotic,1,1
138696,therapy,1,1
138697,in,1,0
138698,the,1,0
138699,study,1,0
138700,group,1,0
138701,was,1,0
138702,not,1,0
138703,applied,1,0
138704,until,1,0
138705,clinical,1,0
138706,signs,1,0
138707,and,1,0
138708,symptoms,1,0
138709,of,1,0
138710,infection,1,0
138711,appeared,1,0
138712,(,1,0
138713,PCT,1,1
138714,value,1,0
138715,was,1,0
138716,>,1,0
138717,0.5ng/ml,1,0
138718,),1,0
138719,.,0,0
138720,We,0,0
138721,discontinued,0,0
138722,the,0,0
138723,antibiotic,0,1
138724,therapy,0,1
138725,if,0,0
138726,clinical,0,0
138727,signs,0,0
138728,and,0,0
138729,symptoms,0,0
138730,of,0,0
138731,infection,0,0
138732,improved,0,0
138733,and,0,0
138734,PCT,0,1
138735,was,0,0
138736,<,0,0
138737,0.5ng/ml,0,0
138738,over,0,0
138739,3,0,0
138740,days,0,0
138741,.,0,0
138742,In,0,0
138743,the,0,0
138744,control,0,0
138745,group,0,0
138746,",",0,0
138747,antibiotic,0,1
138748,therapy,0,1
138749,was,0,0
138750,administrated,0,0
138751,for,0,0
138752,2,0,0
138753,weeks,0,0
138754,",",0,0
138755,or,0,0
138756,antibiotic,1,1
138757,therapy,1,1
138758,was,0,0
138759,continued,0,0
138760,because,0,0
138761,of,0,0
138762,confirmed,0,0
138763,infection,0,0
138764,until,0,0
138765,clinical,0,0
138766,signs,0,0
138767,and,0,0
138768,symptoms,0,0
138769,of,0,0
138770,infection,0,0
138771,disappeared,0,0
138772,over,0,0
138773,3,0,0
138774,days,0,0
138775,.,0,0
138776,RESULTS,0,0
138777,In,0,0
138778,the,0,0
138779,study,0,0
138780,group,0,0
138781,(,0,0
138782,35,0,0
138783,patients,0,0
138784,),0,0
138785,",",0,0
138786,the,0,0
138787,duration,0,0
138788,of,0,0
138789,antibiotic,0,1
138790,therapy,0,1
138791,and,0,0
138792,hospitalization,0,0
138793,was,0,0
138794,significantly,0,0
138795,shorter,0,0
138796,than,0,0
138797,the,0,0
138798,control,0,1
138799,group,0,0
138800,(,0,0
138801,36,0,0
138802,patients,0,0
138803,),0,0
138804,(,0,0
138805,10.89+/-2.85,0,0
138806,versus,0,0
138807,16.06+/-2.48,0,0
138808,days,0,0
138809,",",0,0
138810,p,0,0
138811,<,0,0
138812,0.001,0,0
138813,",",0,0
138814,and,0,0
138815,16.66+/-4.02,0,0
138816,days,0,0
138817,versus,0,0
138818,23.81+/-7.56,0,0
138819,days,0,0
138820,",",0,0
138821,p,0,0
138822,<,0,0
138823,0.001,0,0
138824,),0,0
138825,without,0,0
138826,negative,0,0
138827,clinical,0,0
138828,effects,0,0
138829,and,0,0
138830,the,0,0
138831,cost,0,0
138832,of,0,0
138833,hospitalization,0,0
138834,was,0,0
138835,significantly,0,0
138836,lower,0,0
138837,.,0,0
138838,CONCLUSION,0,0
138839,Procalcitonin,1,0
138840,is,0,0
138841,a,0,0
138842,helpful,0,0
138843,and,0,0
138844,safe,0,0
138845,tool,0,0
138846,for,0,0
138847,guiding,0,0
138848,duration,0,0
138849,of,0,0
138850,antibiotic,0,1
138851,treatment,0,0
138852,in,0,0
138853,patients,0,0
138854,with,0,0
138855,severe,0,0
138856,acute,0,0
138857,pancreatitis,0,0
138858,.,0,0
138859,Laryngeal,0,0
138860,preservation,0,0
138861,with,0,0
138862,induction,1,0
138863,chemotherapy,1,1
138864,for,0,0
138865,hypopharyngeal,0,0
138866,squamous,0,0
138867,cell,0,0
138868,carcinoma,0,0
138869,:,0,0
138870,10-year,0,0
138871,results,0,0
138872,of,0,0
138873,EORTC,0,0
138874,trial,0,0
138875,24891,0,0
138876,.,0,0
138877,BACKGROUND,0,0
138878,We,0,0
138879,report,0,0
138880,the,0,0
138881,10-year,0,0
138882,results,0,0
138883,of,0,0
138884,the,0,0
138885,EORTC,0,0
138886,trial,0,0
138887,24891,0,0
138888,comparing,0,0
138889,a,0,0
138890,larynx-preservation,1,1
138891,approach,1,1
138892,to,0,0
138893,immediate,1,0
138894,surgery,1,0
138895,in,0,0
138896,hypopharynx,0,0
138897,and,0,0
138898,lateral,0,1
138899,epilarynx,0,1
138900,squamous,0,0
138901,cell,0,0
138902,carcinoma,0,0
138903,.,0,0
138904,MATERIAL,0,0
138905,AND,0,0
138906,METHODS,0,0
138907,Two,0,1
138908,hundred,0,0
138909,and,0,0
138910,two,0,0
138911,patients,0,0
138912,were,0,0
138913,randomized,0,0
138914,to,0,0
138915,either,0,0
138916,the,0,0
138917,surgical,0,1
138918,approach,0,1
138919,(,1,0
138920,total,1,0
138921,laryngectomy,1,1
138922,with,1,0
138923,partial,1,0
138924,pharyngectomy,1,1
138925,and,1,0
138926,neck,1,0
138927,dissection,1,0
138928,",",1,0
138929,followed,1,0
138930,by,1,0
138931,irradiation,1,1
138932,),1,0
138933,or,1,0
138934,to,1,0
138935,the,1,0
138936,chemotherapy,1,1
138937,arm,1,0
138938,up,1,0
138939,to,1,0
138940,three,1,0
138941,cycles,1,0
138942,of,1,0
138943,induction,1,0
138944,chemotherapy,1,1
138945,(,1,0
138946,cisplatin,1,1
138947,100,0,1
138948,mg/m,0,1
138949,(,0,0
138950,2,0,0
138951,),0,0
138952,day,0,0
138953,1,0,0
138954,+,0,0
138955,5-FU,0,0
138956,1000,0,0
138957,mg/m,0,1
138958,(,0,0
138959,2,0,0
138960,),0,0
138961,day,0,0
138962,1-5,0,0
138963,),0,0
138964,followed,0,0
138965,for,0,0
138966,complete,0,0
138967,responders,0,0
138968,by,0,0
138969,irradiation,1,1
138970,and,0,0
138971,otherwise,0,0
138972,by,0,0
138973,conventional,1,1
138974,treatment,1,0
138975,.,1,0
138976,The,0,0
138977,end,0,0
138978,points,0,0
138979,were,0,0
138980,overall,0,0
138981,survival,0,0
138982,[,0,0
138983,OS,0,0
138984,",",0,0
138985,noninferiority,0,0
138986,:,0,0
138987,hazard,0,0
138988,ratio,0,0
138989,(,0,0
138990,preservation/surgery,0,1
138991,),0,0
138992,?,0,0
138993,1.428,0,0
138994,",",0,0
138995,one-sided,0,0
138996,?,0,0
138997,=,0,0
138998,0.05,0,0
138999,],0,0
139000,",",0,0
139001,progression-free,0,0
139002,survival,0,0
139003,(,0,0
139004,PFS,0,0
139005,),0,1
139006,and,0,0
139007,survival,0,0
139008,with,0,0
139009,a,0,0
139010,functional,0,0
139011,larynx,0,0
139012,(,0,0
139013,SFL,0,0
139014,),0,0
139015,.,0,0
139016,RESULTS,0,0
139017,At,0,0
139018,a,0,0
139019,median,0,0
139020,follow-up,0,0
139021,of,0,0
139022,10.5,0,0
139023,years,0,0
139024,on,0,0
139025,194,0,0
139026,eligible,0,0
139027,patients,0,0
139028,",",0,0
139029,disease,0,0
139030,evolution,0,0
139031,was,0,0
139032,seen,0,0
139033,in,0,0
139034,54,0,0
139035,and,0,0
139036,49,0,0
139037,patients,0,0
139038,in,0,0
139039,the,0,0
139040,surgery,0,0
139041,and,0,0
139042,chemotherapy,0,1
139043,arm,0,0
139044,",",0,0
139045,respectively,0,0
139046,",",0,0
139047,and,0,0
139048,81,0,0
139049,and,0,0
139050,83,0,0
139051,patients,0,0
139052,had,0,0
139053,died,0,0
139054,.,0,0
139055,The,0,0
139056,10-year,0,0
139057,OS,0,0
139058,rate,0,0
139059,was,0,0
139060,13.8,0,0
139061,%,0,0
139062,in,0,0
139063,the,0,0
139064,surgery,0,0
139065,arm,0,0
139066,and,0,0
139067,13.1,0,0
139068,%,0,0
139069,in,0,0
139070,the,0,0
139071,chemotherapy,0,1
139072,arm,0,0
139073,.,0,0
139074,The,0,0
139075,10-year,0,0
139076,PFS,0,0
139077,rates,0,0
139078,were,0,0
139079,8.5,0,0
139080,%,0,0
139081,and,0,0
139082,10.8,0,0
139083,%,0,0
139084,",",0,0
139085,respectively,0,0
139086,.,0,0
139087,In,0,0
139088,the,0,0
139089,chemotherapy,0,1
139090,arm,0,0
139091,",",0,0
139092,the,0,0
139093,10-year,0,0
139094,SFL,0,0
139095,rate,0,0
139096,was,0,0
139097,8.7,0,0
139098,%,0,0
139099,.,0,0
139100,CONCLUSION,0,0
139101,This,0,0
139102,strategy,0,0
139103,did,0,0
139104,not,0,0
139105,compromise,0,0
139106,disease,0,0
139107,control,0,1
139108,or,0,1
139109,survival,0,0
139110,(,0,0
139111,that,0,0
139112,remained,0,0
139113,poor,0,0
139114,),0,0
139115,and,0,0
139116,allowed,0,0
139117,more,0,0
139118,than,0,0
139119,half,0,0
139120,of,0,0
139121,the,0,0
139122,survivors,0,0
139123,to,0,0
139124,retain,0,0
139125,their,0,0
139126,larynx,0,0
139127,.,0,0
139128,Kata,1,1
139129,techniques,1,1
139130,training,1,1
139131,consistently,0,0
139132,decreases,0,0
139133,stereotypy,0,0
139134,in,0,0
139135,children,0,0
139136,with,0,0
139137,autism,0,0
139138,spectrum,0,0
139139,disorder,0,0
139140,.,0,0
139141,The,0,0
139142,effects,0,0
139143,of,0,0
139144,14,0,0
139145,weeks,0,0
139146,of,0,0
139147,Kata,1,1
139148,techniques,1,1
139149,training,1,1
139150,on,0,0
139151,stereotypic,0,0
139152,behaviors,0,0
139153,of,0,0
139154,children,0,0
139155,with,0,0
139156,autism,0,0
139157,spectrum,0,0
139158,disorders,0,0
139159,(,0,0
139160,ASD,0,0
139161,),0,0
139162,were,0,0
139163,investigated,0,0
139164,.,0,0
139165,The,0,0
139166,study,0,0
139167,included,0,0
139168,30,0,0
139169,eligible,0,0
139170,(,0,0
139171,diagnosed,0,0
139172,ASD,0,0
139173,",",0,0
139174,school,0,0
139175,age,0,0
139176,),0,0
139177,children,0,0
139178,with,0,0
139179,ages,0,0
139180,ranging,0,0
139181,from,0,0
139182,5,0,0
139183,to,0,0
139184,16,0,0
139185,years,0,0
139186,whom,0,0
139187,they,0,0
139188,assigned,0,0
139189,to,0,0
139190,an,0,0
139191,exercise,0,1
139192,(,0,0
139193,n=15,0,0
139194,),0,0
139195,or,0,0
139196,a,0,0
139197,no-exercise,1,1
139198,control,1,1
139199,group,1,0
139200,(,0,0
139201,n=15,0,0
139202,),0,0
139203,.,0,0
139204,Participants,0,0
139205,of,0,0
139206,the,0,0
139207,exercise,0,1
139208,group,0,0
139209,received,0,0
139210,Kata,1,1
139211,techniques,1,1
139212,instruction,1,1
139213,four,0,0
139214,times,0,0
139215,per,0,0
139216,week,0,0
139217,for,0,0
139218,14,0,0
139219,weeks,0,0
139220,(,0,0
139221,56,0,0
139222,sessions,0,1
139223,),0,0
139224,.,0,0
139225,Stereotypy,1,0
139226,was,0,0
139227,assessed,0,0
139228,at,0,0
139229,baseline,0,0
139230,(,0,0
139231,pre-intervention,0,0
139232,),0,0
139233,",",0,0
139234,week,0,0
139235,14,0,0
139236,(,0,0
139237,post-intervention,0,0
139238,),0,0
139239,",",0,0
139240,and,0,0
139241,at,0,0
139242,one,0,0
139243,month,0,0
139244,follow,0,0
139245,up,0,0
139246,in,0,0
139247,both,0,0
139248,groups,0,0
139249,.,0,0
139250,Results,0,0
139251,showed,0,0
139252,that,0,0
139253,Kata,0,1
139254,techniques,0,1
139255,training,0,1
139256,significantly,0,0
139257,reduced,0,0
139258,stereotypy,0,0
139259,in,0,0
139260,the,0,0
139261,exercise,0,1
139262,group,0,0
139263,.,0,0
139264,Following,0,0
139265,participation,0,0
139266,in,0,0
139267,Kata,0,1
139268,techniques,0,1
139269,training,0,1
139270,",",0,0
139271,stereotypy,0,0
139272,decreased,0,0
139273,from,0,0
139274,baseline,0,0
139275,levels,0,0
139276,by,0,0
139277,a,0,0
139278,M,0,0
139279,of,0,0
139280,42.54,0,0
139281,%,0,0
139282,across,0,0
139283,participants,0,0
139284,.,0,0
139285,Interestingly,0,0
139286,",",0,0
139287,after,0,0
139288,30,0,0
139289,days,0,0
139290,of,0,0
139291,no,0,0
139292,practice,0,0
139293,",",0,0
139294,stereotypy,0,0
139295,in,0,0
139296,the,0,0
139297,exercise,0,1
139298,group,0,0
139299,remained,0,0
139300,significantly,0,0
139301,decreased,0,0
139302,compared,0,0
139303,to,0,0
139304,pre-intervention,0,0
139305,time,0,0
139306,.,0,0
139307,The,0,0
139308,participants,0,0
139309,of,0,0
139310,the,0,0
139311,control,0,0
139312,group,0,0
139313,did,0,0
139314,not,0,0
139315,show,0,0
139316,significant,0,0
139317,changes,0,0
139318,in,0,0
139319,the,0,0
139320,stereotypy,0,0
139321,.,0,0
139322,Teaching,0,0
139323,martial,0,0
139324,arts,0,1
139325,techniques,0,0
139326,to,0,0
139327,children,0,0
139328,with,0,0
139329,ASD,0,0
139330,for,0,0
139331,a,0,0
139332,long,0,0
139333,period,0,0
139334,of,0,0
139335,time,0,0
139336,consistently,0,0
139337,decreased,0,0
139338,their,0,0
139339,stereotypic,0,0
139340,behaviors,0,0
139341,.,0,0
139342,Successful,0,0
139343,treatment,0,0
139344,of,0,0
139345,blepharitis,0,0
139346,with,0,0
139347,bibrocathol,1,1
139348,(,1,0
139349,Posiformin?,1,0
139350,2,1,1
139351,%,1,0
139352,),1,0
139353,.,1,0
139354,BACKGROUND,1,0
139355,Bibrocathol,1,1
139356,is,0,0
139357,a,0,0
139358,well-established,1,0
139359,antiseptic,1,1
139360,drug,1,0
139361,for,0,0
139362,the,0,0
139363,treatment,0,0
139364,of,0,0
139365,acute,0,0
139366,eyelid,0,0
139367,diseases,0,0
139368,like,0,0
139369,blepharitis,0,0
139370,.,0,0
139371,Despite,0,0
139372,its,0,0
139373,frequent,0,0
139374,use,0,0
139375,in,0,0
139376,clinical,0,0
139377,practice,0,0
139378,",",0,0
139379,no,0,0
139380,controlled,0,0
139381,clinical,0,0
139382,trial,0,0
139383,on,0,0
139384,the,0,0
139385,efficacy,0,0
139386,of,1,0
139387,bibrocathol,1,1
139388,2,1,0
139389,%,1,0
139390,eye,0,1
139391,ointment,0,1
139392,has,0,0
139393,been,0,0
139394,performed,0,0
139395,until,0,0
139396,now,0,0
139397,.,0,0
139398,The,0,0
139399,aim,0,0
139400,of,0,0
139401,the,0,0
139402,study,0,0
139403,was,0,0
139404,to,0,0
139405,investigate,0,0
139406,efficacy,0,0
139407,",",0,0
139408,safety,0,0
139409,and,0,0
139410,tolerability,0,0
139411,of,1,0
139412,bibrocathol,1,1
139413,(,1,0
139414,Posiformin?,1,0
139415,2,1,1
139416,%,0,0
139417,),0,0
139418,eye,0,1
139419,ointment,0,1
139420,in,0,0
139421,patients,0,0
139422,diagnosed,0,0
139423,with,0,0
139424,blepharitis,0,0
139425,.,0,0
139426,METHODS,0,0
139427,In,0,0
139428,this,0,0
139429,multi-center,0,0
139430,",",0,0
139431,randomized,0,0
139432,",",0,0
139433,double-masked,1,0
139434,",",1,0
139435,placebo-controlled,1,1
139436,parallel-group,1,0
139437,comparison,0,0
139438,",",0,0
139439,the,0,0
139440,change,0,0
139441,of,0,0
139442,signs,0,0
139443,and,0,0
139444,symptoms,0,0
139445,(,0,0
139446,sum,0,0
139447,score,0,0
139448,),0,0
139449,of,0,0
139450,blepharitis,0,0
139451,in,0,0
139452,197,0,0
139453,patients,0,0
139454,(,0,0
139455,ITT,0,1
139456,(,0,1
139457,intention-to-treat-group,0,0
139458,),0,0
139459,;,0,0
139460,mean,0,0
139461,age,0,0
139462,56,0,0
139463,?,0,0
139464,18,0,0
139465,years,0,0
139466,",",0,0
139467,56,0,0
139468,%,0,0
139469,female,0,0
139470,",",0,0
139471,active,0,0
139472,drug,0,0
139473,:,0,0
139474,vehicle,0,1
139475,=,0,0
139476,97:100,0,0
139477,),0,0
139478,over,0,0
139479,2,0,0
139480,weeks,0,0
139481,treatment,0,0
139482,with,0,0
139483,bibrocathol,1,1
139484,2,1,0
139485,%,1,0
139486,eye,1,1
139487,ointment,1,1
139488,was,1,0
139489,evaluated,0,0
139490,.,0,0
139491,RESULTS,0,0
139492,Patients,0,0
139493,receiving,1,0
139494,bibrocathol,1,1
139495,2,1,0
139496,%,1,0
139497,showed,0,0
139498,greater,0,0
139499,improvement,0,0
139500,in,0,0
139501,the,0,0
139502,sum,0,0
139503,score,0,0
139504,than,0,0
139505,the,1,0
139506,placebo,1,1
139507,patients,0,0
139508,(,0,0
139509,p,0,0
139510,<,0,0
139511,0.0001,0,0
139512,",",0,0
139513,Cohen,0,0
139514,'s,0,0
139515,effect,0,0
139516,size,0,0
139517,d,0,1
139518,=,0,0
139519,0.73,0,0
139520,),0,0
139521,.,0,0
139522,Also,0,0
139523,",",0,0
139524,the,0,0
139525,results,0,0
139526,from,0,0
139527,further,0,0
139528,efficacy,0,0
139529,assessments,0,0
139530,improvement,0,0
139531,of,0,0
139532,single,0,0
139533,symptoms,0,0
139534,and,0,0
139535,ocular,0,0
139536,discomfort,0,0
139537,measured,0,0
139538,by,0,0
139539,a,0,0
139540,VAS,0,1
139541,(,0,0
139542,visual,0,0
139543,analogue,0,1
139544,scale,0,0
139545,),0,0
139546,supported,0,0
139547,treatment,0,0
139548,with,0,0
139549,bibrocathol,1,1
139550,.,1,0
139551,Patients,1,0
139552,and,0,0
139553,investigators,0,0
139554,provided,0,0
139555,favorable,0,0
139556,tolerability,0,0
139557,ratings,0,0
139558,preferring,1,0
139559,bibrocathol,1,1
139560,over,1,0
139561,placebo,1,1
139562,.,0,0
139563,No,0,0
139564,safety,0,0
139565,issues,0,0
139566,were,0,0
139567,observed,0,0
139568,with,0,0
139569,regard,0,0
139570,to,0,0
139571,intraocular,0,0
139572,pressure,0,0
139573,",",0,0
139574,visual,0,0
139575,acuity,0,0
139576,",",0,0
139577,or,0,0
139578,occurrence,0,0
139579,of,0,0
139580,adverse,0,0
139581,events,0,0
139582,.,0,0
139583,CONCLUSIONS,0,0
139584,Blepharitis,0,0
139585,therapy,0,1
139586,with,0,0
139587,the,1,0
139588,antiseptic,1,1
139589,bibrocathol,1,1
139590,2,1,0
139591,%,1,0
139592,in,1,0
139593,this,1,0
139594,trial,0,0
139595,was,0,0
139596,highly,0,0
139597,efficacious,0,0
139598,and,0,0
139599,safe,0,0
139600,.,0,0
139601,Effect,0,0
139602,of,0,0
139603,a,0,0
139604,mobile,1,1
139605,safety,1,0
139606,alarm,1,0
139607,on,0,0
139608,going,0,0
139609,outside,0,0
139610,",",0,0
139611,feeling,0,0
139612,safe,0,0
139613,",",0,0
139614,fear,0,0
139615,of,0,0
139616,falling,0,0
139617,",",0,0
139618,and,0,0
139619,quality,0,0
139620,of,0,0
139621,life,0,0
139622,in,0,0
139623,community-living,0,0
139624,older,0,0
139625,persons,0,0
139626,:,0,0
139627,a,0,0
139628,randomized,0,0
139629,controlled,0,0
139630,trial,0,0
139631,.,0,0
139632,Ambient,1,1
139633,temperature,1,0
139634,and,1,0
139635,biomarkers,1,0
139636,of,0,0
139637,heart,0,0
139638,failure,0,0
139639,:,0,0
139640,a,0,0
139641,repeated,0,0
139642,measures,0,0
139643,analysis,0,0
139644,.,0,0
139645,BACKGROUND,0,0
139646,Extreme,0,0
139647,temperatures,0,0
139648,have,0,0
139649,been,0,0
139650,associated,0,0
139651,with,0,0
139652,hospitalization,0,0
139653,and,0,0
139654,death,0,0
139655,among,0,0
139656,individuals,0,0
139657,with,0,0
139658,heart,0,0
139659,failure,0,0
139660,",",0,0
139661,but,0,0
139662,few,0,0
139663,studies,0,0
139664,have,0,0
139665,explored,0,0
139666,the,0,0
139667,underlying,0,0
139668,mechanisms,0,0
139669,.,0,0
139670,OBJECTIVES,0,0
139671,We,0,0
139672,hypothesized,0,0
139673,that,0,0
139674,outdoor,0,1
139675,temperature,0,0
139676,in,0,0
139677,the,0,0
139678,Boston,0,0
139679,",",0,0
139680,Massachusetts,0,0
139681,",",0,0
139682,area,0,0
139683,(,0,0
139684,1-,0,0
139685,to,0,0
139686,4-day,0,0
139687,moving,0,0
139688,averages,0,0
139689,),0,0
139690,would,0,0
139691,be,0,0
139692,associated,0,0
139693,with,0,0
139694,higher,0,0
139695,levels,0,0
139696,of,0,0
139697,biomarkers,1,0
139698,of,0,0
139699,inflammation,0,0
139700,and,0,0
139701,myocyte,0,0
139702,injury,0,0
139703,in,0,0
139704,a,0,0
139705,repeated-measures,0,0
139706,study,0,0
139707,of,0,0
139708,individuals,0,0
139709,with,0,0
139710,stable,0,0
139711,heart,0,0
139712,failure,0,0
139713,.,0,0
139714,METHODS,0,0
139715,We,0,0
139716,analyzed,0,0
139717,data,0,0
139718,from,0,0
139719,a,0,0
139720,completed,0,0
139721,clinical,0,0
139722,trial,0,0
139723,that,0,0
139724,randomized,0,0
139725,100,0,0
139726,patients,0,0
139727,to,0,0
139728,12,1,0
139729,weeks,1,0
139730,of,1,0
139731,tai,1,1
139732,chi,1,0
139733,classes,1,0
139734,or,1,0
139735,to,1,0
139736,time-matched,1,1
139737,education,1,1
139738,control,1,0
139739,.,1,0
139740,B-type,0,0
139741,natriuretic,0,1
139742,peptide,0,1
139743,(,0,0
139744,BNP,0,0
139745,),0,0
139746,",",0,0
139747,C-reactive,0,0
139748,protein,0,1
139749,(,0,0
139750,CRP,0,1
139751,),0,0
139752,",",0,0
139753,and,0,0
139754,tumor,0,0
139755,necrosis,0,0
139756,factor,0,0
139757,(,0,0
139758,TNF,0,0
139759,),0,0
139760,were,0,0
139761,measured,0,0
139762,at,0,0
139763,baseline,0,0
139764,",",0,0
139765,6,0,0
139766,weeks,0,0
139767,",",0,0
139768,and,0,0
139769,12,0,0
139770,weeks,0,0
139771,.,0,0
139772,Endothelin-1,0,0
139773,was,0,0
139774,measured,0,0
139775,at,0,0
139776,baseline,0,0
139777,and,0,0
139778,12,0,0
139779,weeks,0,0
139780,.,0,0
139781,We,0,0
139782,used,0,0
139783,fixed,0,0
139784,effects,0,0
139785,models,0,0
139786,to,0,0
139787,evaluate,0,0
139788,associations,0,0
139789,with,0,0
139790,measures,0,0
139791,of,0,0
139792,temperature,0,0
139793,that,0,0
139794,were,0,0
139795,adjusted,0,0
139796,for,0,0
139797,time-varying,0,0
139798,covariates,0,0
139799,.,0,0
139800,RESULTS,0,0
139801,Higher,0,0
139802,apparent,0,0
139803,temperature,0,0
139804,was,0,0
139805,associated,0,0
139806,with,0,0
139807,higher,0,0
139808,levels,0,0
139809,of,0,0
139810,BNP,0,0
139811,beginning,0,0
139812,with,0,0
139813,2-day,0,0
139814,moving,0,0
139815,averages,0,0
139816,and,0,0
139817,reached,0,0
139818,statistical,0,0
139819,significance,0,0
139820,for,0,0
139821,3-,0,1
139822,and,0,0
139823,4-day,0,0
139824,moving,0,0
139825,averages,0,0
139826,.,0,0
139827,CRP,0,0
139828,results,0,0
139829,followed,0,0
139830,a,0,0
139831,similar,0,0
139832,pattern,0,0
139833,but,0,0
139834,were,0,0
139835,delayed,0,0
139836,by,0,0
139837,1,0,0
139838,day,0,0
139839,.,0,0
139840,A,0,0
139841,5?C,0,0
139842,change,0,0
139843,in,0,0
139844,3-,0,1
139845,and,0,0
139846,4-day,0,0
139847,moving,0,0
139848,averages,0,0
139849,of,0,0
139850,apparent,0,0
139851,temperature,0,0
139852,was,0,0
139853,associated,0,0
139854,with,0,0
139855,11.3,0,0
139856,%,0,0
139857,[,0,0
139858,95,0,0
139859,%,0,0
139860,confidence,0,0
139861,interval,0,0
139862,(,0,0
139863,CI,0,0
139864,),0,0
139865,:,0,0
139866,1.1,0,0
139867,",",0,0
139868,22.5,0,0
139869,;,0,0
139870,p,0,0
139871,=,0,0
139872,0.03,0,0
139873,),0,0
139874,and,0,0
139875,11.4,0,0
139876,%,0,0
139877,(,0,0
139878,95,0,0
139879,%,0,0
139880,CI,0,0
139881,:,0,0
139882,1.2,0,0
139883,",",0,0
139884,22.5,0,0
139885,;,0,0
139886,p,0,0
139887,=,0,0
139888,0.03,0,0
139889,),0,0
139890,higher,0,0
139891,BNP,0,0
139892,.,0,0
139893,A,0,0
139894,5?C,0,0
139895,change,0,0
139896,in,0,0
139897,the,0,0
139898,4-day,0,0
139899,moving,0,0
139900,average,0,0
139901,of,0,0
139902,apparent,0,0
139903,temperature,0,0
139904,was,0,0
139905,associated,0,0
139906,with,0,0
139907,21.6,0,0
139908,%,0,0
139909,(,0,0
139910,95,0,0
139911,%,0,0
139912,CI,0,0
139913,:,0,0
139914,2.5,0,0
139915,",",0,0
139916,44.2,0,0
139917,;,0,0
139918,p,0,0
139919,=,0,0
139920,0.03,0,0
139921,),0,0
139922,higher,0,0
139923,CRP,0,1
139924,.,0,0
139925,No,0,0
139926,clear,0,0
139927,associations,0,0
139928,with,0,0
139929,TNF,0,0
139930,or,0,0
139931,endothelin-1,0,0
139932,were,0,0
139933,observed,0,0
139934,.,0,0
139935,CONCLUSIONS,0,0
139936,Among,0,0
139937,patients,0,0
139938,undergoing,0,0
139939,treatment,0,0
139940,for,0,0
139941,heart,0,0
139942,failure,0,0
139943,",",0,0
139944,we,0,0
139945,observed,0,0
139946,positive,0,0
139947,associations,0,0
139948,between,0,0
139949,temperature,0,0
139950,and,0,0
139951,both,0,0
139952,BNP,0,0
139953,and,0,0
139954,CRP-predictors,0,0
139955,of,0,0
139956,heart,0,0
139957,failure,0,0
139958,prognosis,0,0
139959,and,0,0
139960,severity,0,0
139961,.,0,0
139962,A,0,0
139963,comparison,0,0
139964,of,0,0
139965,a,0,0
139966,short,1,0
139967,nurse-based,1,1
139968,and,1,0
139969,a,1,0
139970,long,1,0
139971,multidisciplinary,1,0
139972,version,1,0
139973,of,1,0
139974,structured,1,1
139975,patient,1,0
139976,education,1,1
139977,in,0,0
139978,irritable,0,0
139979,bowel,0,0
139980,syndrome,0,0
139981,.,0,0
139982,OBJECTIVE,0,0
139983,Structured,1,0
139984,multidisciplinary,1,1
139985,patient,1,0
139986,group,1,0
139987,education,1,1
139988,has,0,0
139989,positive,0,0
139990,effects,0,0
139991,on,0,0
139992,symptoms,0,0
139993,",",0,0
139994,health-related,0,0
139995,quality,0,0
139996,of,0,0
139997,life,0,0
139998,",",0,0
139999,and,0,0
140000,disease-related,0,0
140001,knowledge,0,0
140002,in,0,0
140003,patients,0,0
140004,with,0,0
140005,irritable,0,0
140006,bowel,0,0
140007,syndrome,0,0
140008,(,0,0
140009,IBS,0,0
140010,),0,0
140011,",",0,0
140012,but,0,0
140013,few,0,0
140014,studies,0,0
140015,comparing,0,0
140016,different,0,0
140017,forms,0,0
140018,of,0,0
140019,educational,0,0
140020,interventions,0,0
140021,are,0,0
140022,available,0,0
140023,.,0,0
140024,Our,0,0
140025,aim,0,0
140026,was,0,0
140027,to,0,0
140028,compare,0,0
140029,the,0,0
140030,effects,0,0
140031,of,0,0
140032,long,1,0
140033,multidisciplinary,1,0
140034,group,1,0
140035,education,1,1
140036,with,0,0
140037,a,0,0
140038,short,1,0
140039,nurse-based,1,1
140040,group,1,0
140041,education,1,1
140042,with,0,0
140043,regard,0,0
140044,to,0,0
140045,symptoms,0,0
140046,",",0,0
140047,knowledge,0,0
140048,",",0,0
140049,quality,0,0
140050,of,0,0
140051,life,0,0
140052,",",0,0
140053,and,0,0
140054,satisfaction,0,0
140055,with,0,0
140056,the,0,0
140057,intervention,0,1
140058,in,0,0
140059,IBS,0,0
140060,patients,0,0
140061,.,0,0
140062,METHODS,0,0
140063,Patients,0,0
140064,with,0,0
140065,IBS,0,0
140066,according,0,0
140067,to,0,0
140068,the,0,0
140069,Rome,0,1
140070,II,0,0
140071,criteria,0,0
140072,were,0,0
140073,randomized,0,0
140074,to,0,0
140075,either,0,0
140076,short,1,0
140077,nurse-based,1,1
140078,or,1,0
140079,a,1,0
140080,long,1,0
140081,multidisciplinary-based,1,0
140082,education,1,1
140083,.,1,0
140084,The,0,0
140085,effects,0,0
140086,were,0,0
140087,evaluated,0,0
140088,by,0,0
140089,self-administered,1,0
140090,questionnaires,1,1
140091,at,0,0
140092,3,0,0
140093,",",0,0
140094,6,0,0
140095,",",0,0
140096,and,0,0
140097,12,0,0
140098,months,0,0
140099,after,0,0
140100,baseline,0,0
140101,",",0,0
140102,and,0,0
140103,compared,0,0
140104,between,0,0
140105,the,0,0
140106,groups,0,0
140107,.,0,0
140108,RESULTS,0,0
140109,No,0,0
140110,differences,0,0
140111,in,0,0
140112,effects,0,0
140113,were,0,0
140114,detected,0,0
140115,in,0,0
140116,the,0,0
140117,between-group,0,0
140118,comparisons,0,0
140119,at,0,0
140120,any,0,0
140121,of,0,0
140122,the,0,0
140123,follow-up,0,0
140124,assessments,0,0
140125,.,0,0
140126,However,0,0
140127,",",0,0
140128,positive,0,0
140129,effects,0,0
140130,on,0,0
140131,symptoms,0,0
140132,",",0,0
140133,knowledge,0,0
140134,",",0,0
140135,quality,0,0
140136,of,0,0
140137,life,0,0
140138,",",0,0
140139,and,0,0
140140,satisfaction,0,0
140141,with,0,0
140142,the,0,0
140143,intervention,0,1
140144,were,0,0
140145,found,0,0
140146,in,0,0
140147,both,0,0
140148,the,0,0
140149,short,0,0
140150,and,0,0
140151,the,0,0
140152,long,0,0
140153,version,0,0
140154,.,0,0
140155,CONCLUSION,0,0
140156,A,0,0
140157,short,1,0
140158,",",1,0
140159,nurse-based,1,1
140160,educational,1,1
140161,intervention,1,1
140162,seems,0,0
140163,to,0,0
140164,be,0,0
140165,as,0,0
140166,efficacious,0,0
140167,as,0,0
140168,a,0,0
140169,longer,1,0
140170,multidisciplinary,1,0
140171,version,0,0
140172,.,0,0
140173,In,0,0
140174,both,0,0
140175,groups,0,0
140176,",",0,0
140177,positive,0,0
140178,effects,0,0
140179,on,0,0
140180,patients,0,0
140181,',0,0
140182,well-being,0,0
140183,were,0,0
140184,found,0,0
140185,to,0,0
140186,a,0,0
140187,similar,0,0
140188,extent,0,0
140189,.,0,0
140190,This,0,0
140191,is,0,0
140192,an,0,0
140193,important,0,0
140194,finding,0,0
140195,that,0,0
140196,",",0,0
140197,from,0,0
140198,a,0,0
140199,cost-effective,0,0
140200,perspective,0,0
140201,",",0,0
140202,could,0,0
140203,contribute,0,0
140204,toward,0,0
140205,an,0,0
140206,optimized,0,0
140207,management,0,0
140208,of,0,0
140209,patients,0,0
140210,with,0,0
140211,IBS,0,0
140212,.,0,0
140213,Impact,0,0
140214,on,0,0
140215,learning,0,0
140216,of,0,0
140217,an,0,0
140218,e-learning,1,1
140219,module,1,1
140220,on,0,0
140221,leukaemia,0,0
140222,:,0,0
140223,a,0,0
140224,randomised,0,0
140225,controlled,0,0
140226,trial,0,0
140227,.,0,0
140228,BACKGROUND,0,0
140229,e-learning,1,1
140230,resources,0,0
140231,may,0,0
140232,be,0,0
140233,beneficial,0,0
140234,for,0,0
140235,complex,0,0
140236,or,0,0
140237,conceptually,0,0
140238,difficult,0,0
140239,topics,0,0
140240,.,0,0
140241,Leukaemia,0,0
140242,is,0,0
140243,one,0,0
140244,such,0,0
140245,topic,0,0
140246,",",0,0
140247,yet,0,0
140248,there,0,0
140249,are,0,0
140250,no,0,0
140251,reports,0,0
140252,on,0,0
140253,the,0,0
140254,efficacy,0,0
140255,of,0,0
140256,e-learning,0,1
140257,for,0,0
140258,leukaemia,0,0
140259,.,0,0
140260,This,0,0
140261,study,0,0
140262,compared,0,0
140263,the,0,0
140264,learning,0,0
140265,impact,0,0
140266,on,0,0
140267,senior,0,0
140268,medical,0,0
140269,students,0,0
140270,of,0,0
140271,a,0,0
140272,purpose-built,0,1
140273,e-learning,1,1
140274,module,1,1
140275,on,0,0
140276,leukaemia,0,0
140277,",",0,0
140278,compared,0,0
140279,with,0,0
140280,existing,1,0
140281,online,1,0
140282,resources,1,0
140283,.,1,0
140284,METHODS,0,0
140285,A,0,0
140286,randomised,0,0
140287,controlled,0,0
140288,trial,0,0
140289,was,0,0
140290,performed,0,0
140291,utilising,0,0
140292,volunteer,0,0
140293,senior,0,0
140294,medical,0,0
140295,students,0,0
140296,.,0,0
140297,Participants,0,0
140298,were,0,0
140299,randomly,0,0
140300,allocated,0,0
140301,to,0,0
140302,Study,0,0
140303,and,0,0
140304,Control,0,1
140305,groups,0,0
140306,.,0,0
140307,Following,0,0
140308,a,0,0
140309,pre-test,0,0
140310,on,0,0
140311,leukaemia,0,0
140312,administered,0,0
140313,to,0,0
140314,both,0,0
140315,groups,0,0
140316,",",0,0
140317,the,0,0
140318,Study,0,0
140319,group,0,0
140320,was,0,0
140321,provided,0,0
140322,with,0,0
140323,access,0,0
140324,to,0,0
140325,the,0,0
140326,new,1,0
140327,e-learning,1,1
140328,module,1,1
140329,",",0,0
140330,while,0,0
140331,the,0,0
140332,Control,0,1
140333,group,0,0
140334,was,0,0
140335,directed,1,0
140336,to,1,0
140337,existing,1,0
140338,online,1,0
140339,resources,1,0
140340,.,1,0
140341,A,0,0
140342,post-test,0,0
140343,and,0,0
140344,an,0,0
140345,evaluation,0,0
140346,questionnaire,0,0
140347,were,0,0
140348,administered,0,0
140349,to,0,0
140350,both,0,0
140351,groups,0,0
140352,at,0,0
140353,the,0,0
140354,end,0,0
140355,of,0,0
140356,the,0,0
140357,trial,0,0
140358,period,0,0
140359,.,0,0
140360,RESULTS,0,0
140361,Study,0,0
140362,and,0,0
140363,Control,0,1
140364,groups,0,0
140365,were,0,0
140366,equivalent,0,0
140367,in,0,0
140368,gender,0,0
140369,distribution,0,0
140370,",",0,0
140371,mean,0,0
140372,academic,0,0
140373,ability,0,0
140374,",",0,0
140375,pre-test,0,0
140376,performance,0,0
140377,and,0,0
140378,time,0,0
140379,studying,0,0
140380,leukaemia,0,0
140381,during,0,0
140382,the,0,0
140383,trial,0,0
140384,.,0,0
140385,The,0,0
140386,Study,0,0
140387,group,0,0
140388,performed,0,0
140389,significantly,0,0
140390,better,0,0
140391,than,0,0
140392,the,0,0
140393,Control,0,1
140394,group,0,0
140395,in,0,0
140396,the,0,0
140397,post-test,0,0
140398,",",0,0
140399,in,0,0
140400,which,0,0
140401,the,0,0
140402,group,0,0
140403,to,0,0
140404,which,0,0
140405,the,0,0
140406,students,0,0
140407,had,0,0
140408,been,0,0
140409,allocated,0,0
140410,was,0,0
140411,the,0,0
140412,only,0,0
140413,significant,0,0
140414,predictor,0,0
140415,of,0,0
140416,performance,0,0
140417,.,0,0
140418,The,0,0
140419,Study,0,0
140420,group,0,0
140421,'s,0,0
140422,evaluation,0,0
140423,of,0,0
140424,the,0,0
140425,module,0,0
140426,was,0,0
140427,overwhelmingly,0,0
140428,positive,0,0
140429,.,0,0
140430,CONCLUSIONS,0,0
140431,A,0,0
140432,targeted,0,0
140433,e-learning,1,1
140434,module,1,1
140435,on,0,0
140436,leukaemia,0,0
140437,had,0,0
140438,a,0,0
140439,significant,0,0
140440,effect,0,0
140441,on,0,0
140442,learning,0,0
140443,in,0,0
140444,this,0,0
140445,cohort,0,0
140446,",",0,0
140447,compared,0,0
140448,with,0,0
140449,existing,0,0
140450,online,0,0
140451,resources,0,0
140452,.,0,0
140453,We,0,0
140454,believe,0,0
140455,that,0,0
140456,the,0,0
140457,interactivity,0,0
140458,",",0,0
140459,dialogic,0,1
140460,feedback,0,1
140461,and,0,0
140462,integration,0,0
140463,with,0,0
140464,the,0,0
140465,curriculum,0,1
140466,offered,0,0
140467,by,0,0
140468,the,0,0
140469,e-learning,1,1
140470,module,1,1
140471,contributed,0,0
140472,to,0,0
140473,its,0,0
140474,impact,0,0
140475,.,0,0
140476,This,0,0
140477,has,0,0
140478,implications,0,0
140479,for,0,0
140480,e-learning,1,1
140481,design,0,0
140482,in,0,0
140483,medicine,0,0
140484,and,0,0
140485,other,0,0
140486,disciplines,0,0
140487,.,0,0
140488,Can,0,0
140489,simvastatin,1,1
140490,improve,0,0
140491,erectile,0,0
140492,function,0,0
140493,and,0,0
140494,health-related,0,1
140495,quality,0,0
140496,of,0,0
140497,life,0,0
140498,in,0,0
140499,men,0,0
140500,aged,0,0
140501,?40,0,0
140502,years,0,0
140503,with,0,0
140504,erectile,0,0
140505,dysfunction,0,0
140506,?,0,0
140507,Results,0,0
140508,of,0,0
140509,the,0,0
140510,Erectile,0,0
140511,Dysfunction,0,0
140512,and,0,0
140513,Statins,0,1
140514,Trial,0,1
140515,[,0,0
140516,ISRCTN66772971,0,0
140517,],0,0
140518,.,0,0
140519,OBJECTIVE,0,0
140520,To,0,0
140521,evaluate,0,0
140522,the,0,0
140523,effectiveness,0,0
140524,and,0,0
140525,cost-effectiveness,0,0
140526,of,0,0
140527,simvastatin,1,1
140528,on,1,0
140529,erectile,0,0
140530,function,0,0
140531,and,0,0
140532,health-related,0,1
140533,quality,0,0
140534,of,0,0
140535,life,0,0
140536,in,0,0
140537,men,0,0
140538,aged,0,0
140539,?40,0,0
140540,years,0,0
140541,with,0,0
140542,erectile,0,0
140543,dysfunction,0,0
140544,(,0,0
140545,ED,0,1
140546,),0,0
140547,.,0,0
140548,PATIENTS,0,0
140549,AND,0,0
140550,METHODS,0,0
140551,ED,0,1
140552,is,0,0
140553,common,0,0
140554,in,0,0
140555,men,0,0
140556,aged,0,0
140557,?40,0,1
140558,years,0,0
140559,and,0,0
140560,impacts,0,0
140561,upon,0,0
140562,their,0,0
140563,overall,0,0
140564,health-related,0,0
140565,quality,0,0
140566,of,0,0
140567,life,0,0
140568,and,0,0
140569,that,0,0
140570,of,0,0
140571,their,0,0
140572,partners,0,0
140573,.,0,0
140574,Men,0,0
140575,aged,0,0
140576,?40,0,1
140577,years,0,0
140578,who,0,0
140579,were,0,0
140580,not,0,0
140581,receiving,0,0
140582,lipid,0,0
140583,lowering,0,0
140584,or,0,1
140585,anti-hypertensive,0,1
140586,medication,0,1
140587,and,0,0
140588,not,0,0
140589,at,0,0
140590,high,0,0
140591,cardiovascular,0,0
140592,risk,0,0
140593,were,0,0
140594,recruited,0,0
140595,from,0,0
140596,10,0,0
140597,general,0,0
140598,practices,0,0
140599,in,0,0
140600,the,0,0
140601,East,0,0
140602,of,0,0
140603,England,0,0
140604,.,0,0
140605,In,0,0
140606,total,0,0
140607,",",0,0
140608,173,0,0
140609,eligible,0,0
140610,men,0,0
140611,with,0,0
140612,untreated,0,0
140613,ED,0,1
140614,were,0,0
140615,randomized,0,0
140616,to,0,0
140617,double-blind,0,0
140618,treatment,1,0
140619,with,1,0
140620,40,1,0
140621,mg,1,0
140622,of,1,0
140623,simvastatin,1,1
140624,or,1,1
140625,placebo,1,1
140626,once,0,1
140627,daily,0,0
140628,for,0,0
140629,6,0,0
140630,months,0,0
140631,.,0,0
140632,Data,0,0
140633,were,0,0
140634,collected,0,0
140635,at,0,0
140636,three,0,0
140637,points,0,0
140638,over,0,0
140639,30,0,0
140640,weeks,0,0
140641,.,0,0
140642,The,0,0
140643,main,0,0
140644,outcome,0,0
140645,was,0,0
140646,erectile,0,0
140647,function,0,0
140648,(,0,0
140649,International,0,0
140650,Index,0,1
140651,of,0,0
140652,Erectile,0,1
140653,Function-5,0,0
140654,score,0,0
140655,),0,0
140656,.,0,0
140657,Secondary,0,0
140658,outcomes,0,0
140659,included,0,0
140660,male,0,0
140661,ED-specific,0,0
140662,quality,0,0
140663,of,0,0
140664,life,0,0
140665,(,0,0
140666,MED-QoL,0,0
140667,),0,0
140668,",",0,0
140669,quality-adjusted,0,0
140670,life,0,0
140671,years,0,0
140672,(,0,0
140673,QALYs,0,1
140674,),0,0
140675,using,0,0
140676,the,0,0
140677,generic,0,0
140678,Euroqol,0,1
140679,measure,0,0
140680,(,0,0
140681,EQ-5D,0,0
140682,),0,0
140683,",",0,0
140684,endothelial,0,0
140685,function,0,0
140686,",",0,0
140687,cardiovascular,0,0
140688,risk,0,0
140689,",",0,0
140690,cholesterol,0,0
140691,and,0,0
140692,health,0,0
140693,service,0,0
140694,costs,0,0
140695,.,0,0
140696,RESULTS,0,0
140697,There,0,0
140698,was,0,0
140699,no,0,0
140700,significant,0,0
140701,difference,0,0
140702,in,0,0
140703,erectile,0,0
140704,function,0,0
140705,between,0,0
140706,the,1,0
140707,simvastatin,1,1
140708,and,1,0
140709,placebo,1,1
140710,groups,0,0
140711,(,0,0
140712,mean,0,0
140713,change,0,0
140714,",",0,0
140715,1.28,0,0
140716,vs,0,0
140717,0.07,0,0
140718,",",0,0
140719,z,0,0
140720,=,0,0
140721,1.1,0,0
140722,",",0,0
140723,p,0,0
140724,=,0,0
140725,0.27,0,0
140726,),0,0
140727,",",0,0
140728,although,0,0
140729,a,0,0
140730,significant,0,0
140731,improvement,0,0
140732,in,0,0
140733,MED-QoL,0,0
140734,was,0,0
140735,observed,0,0
140736,(,0,0
140737,5,0,0
140738,%,0,0
140739,vs,0,0
140740,2,0,0
140741,%,0,0
140742,",",0,0
140743,z,0,0
140744,=,0,0
140745,2.09,0,0
140746,",",0,0
140747,p,0,0
140748,=,0,0
140749,0.04,0,0
140750,),0,0
140751,.,0,0
140752,Both,0,0
140753,10-year,0,0
140754,cardiovascular,0,0
140755,risk,0,0
140756,and,0,0
140757,low-density,0,0
140758,lipoprotein,0,0
140759,were,0,0
140760,reduced,0,0
140761,(,0,0
140762,cardiovascular,0,0
140763,risk,0,0
140764,",",0,0
140765,z,0,0
140766,=,0,0
140767,-3.67,0,0
140768,",",0,0
140769,p,0,0
140770,<,0,0
140771,0.001,0,0
140772,;,0,0
140773,low-density,0,0
140774,lipoprotein,0,0
140775,",",0,0
140776,z,0,0
140777,=,0,0
140778,-5.46,0,0
140779,",",0,0
140780,p,0,0
140781,<,0,0
140782,0.001,0,0
140783,),0,0
140784,",",0,0
140785,with,0,0
140786,no,0,0
140787,consistent,0,0
140788,change,0,0
140789,in,0,0
140790,endothelial,0,0
140791,function,0,0
140792,.,0,0
140793,The,0,0
140794,frequency,0,0
140795,of,0,0
140796,sexual,0,0
140797,encounters,0,0
140798,is,0,0
140799,correlated,0,0
140800,with,0,0
140801,improved,0,0
140802,erectile,0,0
140803,function,0,0
140804,.,0,0
140805,The,0,0
140806,joint,0,0
140807,distribution,0,0
140808,of,0,0
140809,costs,0,0
140810,and,0,0
140811,QALY,0,0
140812,benefits,0,0
140813,indicates,0,0
140814,that,0,0
140815,the,0,0
140816,probability,0,0
140817,of,0,0
140818,simvastatin,0,1
140819,being,0,0
140820,cost-effective,0,0
140821,for,0,0
140822,willingness-to-pay,0,0
140823,thresholds,0,0
140824,of,0,0
140825,"?20,000",0,0
140826,and,0,0
140827,"?30,000",0,0
140828,is,0,0
140829,86,0,0
140830,%,0,0
140831,and,0,0
140832,83,0,0
140833,%,0,0
140834,",",0,0
140835,respectively,0,0
140836,.,0,0
140837,CONCLUSIONS,0,0
140838,Identifying,0,0
140839,men,0,0
140840,with,0,0
140841,ED,0,1
140842,provides,0,0
140843,an,0,0
140844,opportunity,0,0
140845,to,0,0
140846,modify,0,0
140847,future,0,0
140848,cardiovascular,0,0
140849,risk,0,0
140850,and,0,0
140851,to,0,0
140852,improve,0,0
140853,MED-QoL,0,0
140854,by,0,0
140855,treating,0,0
140856,them,0,0
140857,with,0,0
140858,40,0,0
140859,mg,0,0
140860,of,1,0
140861,simvastatin,1,1
140862,.,1,0
140863,The,1,0
140864,joint,1,0
140865,analysis,0,0
140866,of,0,0
140867,costs,0,0
140868,and,0,0
140869,QALY,0,0
140870,benefits,0,0
140871,suggests,0,0
140872,that,0,0
140873,there,0,0
140874,is,0,0
140875,high,0,0
140876,probability,0,0
140877,that,0,0
140878,simvastatin,0,1
140879,is,0,0
140880,a,0,0
140881,cost-effective,0,0
140882,strategy,0,0
140883,in,0,0
140884,men,0,0
140885,with,0,0
140886,ED,0,1
140887,.,0,0
140888,The,0,0
140889,findings,0,0
140890,could,0,0
140891,influence,0,0
140892,urological,0,0
140893,and,0,0
140894,primary,0,0
140895,care,0,1
140896,practice,0,0
140897,by,0,0
140898,including,0,0
140899,questions,0,0
140900,on,0,0
140901,ED,0,1
140902,during,0,0
140903,routine,0,0
140904,consultations,0,1
140905,and,0,0
140906,relevant,0,0
140907,clinical,0,0
140908,protocols,0,0
140909,.,0,0
140910,This,0,0
140911,provides,0,0
140912,an,0,0
140913,opportunity,0,0
140914,to,0,0
140915,impart,0,0
140916,lifestyle,0,1
140917,advice,0,1
140918,.,0,0
140919,The,0,0
140920,effects,0,0
140921,of,0,0
140922,orthotic,1,1
140923,heel,1,0
140924,lifts,1,1
140925,on,0,0
140926,Achilles,0,0
140927,tendon,0,1
140928,force,0,1
140929,and,0,0
140930,strain,0,0
140931,during,0,0
140932,running,0,0
140933,.,0,0
140934,This,0,0
140935,study,0,0
140936,assessed,0,0
140937,the,0,0
140938,effects,0,0
140939,of,0,0
140940,orthotic,1,1
140941,heel,1,0
140942,lifts,1,1
140943,on,0,0
140944,Achilles,0,1
140945,tendon,0,1
140946,(,0,0
140947,AT,0,1
140948,),0,1
140949,force,0,1
140950,and,0,0
140951,strain,0,0
140952,during,0,0
140953,running,0,0
140954,.,0,0
140955,Ten,0,0
140956,females,0,0
140957,ran,0,0
140958,barefoot,0,0
140959,over,0,0
140960,a,0,0
140961,force,0,1
140962,plate,0,0
140963,in,0,0
140964,three,0,0
140965,conditions,0,0
140966,:,0,0
140967,no,1,0
140968,heel,1,0
140969,lifts,1,1
140970,(,0,0
140971,NHL,0,0
140972,),0,0
140973,",",0,0
140974,with,0,0
140975,12,1,0
140976,mm,1,0
140977,heel,1,0
140978,lifts,1,1
140979,(,0,0
140980,12HL,0,0
140981,),0,0
140982,and,0,0
140983,with,0,0
140984,18,1,0
140985,mm,1,0
140986,heel,1,0
140987,lifts,1,1
140988,(,0,0
140989,18HL,0,0
140990,),0,0
140991,.,0,0
140992,Kinematics,0,0
140993,for,0,0
140994,the,0,0
140995,right,0,0
140996,lower,0,0
140997,limb,0,0
140998,were,0,0
140999,collected,0,0
141000,(,0,0
141001,200,0,1
141002,Hz,0,1
141003,),0,0
141004,.,0,0
141005,AT,0,0
141006,force,0,0
141007,was,0,0
141008,calculated,0,0
141009,from,0,0
141010,inverse,0,0
141011,dynamics,0,0
141012,.,0,0
141013,AT,0,0
141014,strain,0,0
141015,was,0,0
141016,determined,0,0
141017,from,0,0
141018,kinematics,0,0
141019,and,0,0
141020,ultrasound,0,1
141021,images,0,0
141022,of,0,0
141023,medial,0,0
141024,gastrocnemius,0,1
141025,(,0,0
141026,50,0,0
141027,Hz,0,1
141028,),0,0
141029,.,0,0
141030,Peak,0,0
141031,AT,0,0
141032,strain,0,0
141033,was,0,0
141034,less,0,0
141035,for,0,0
141036,18HL,0,0
141037,(,0,0
141038,5.5,0,0
141039,?,0,0
141040,4.4,0,0
141041,%,0,0
141042,),0,0
141043,than,0,0
141044,for,0,0
141045,NHL,0,0
141046,(,0,0
141047,7.4,0,0
141048,?,0,0
141049,4.2,0,0
141050,%,0,0
141051,),0,0
141052,(,0,0
141053,p,0,0
141054,=,0,0
141055,.029,0,0
141056,",",0,0
141057,effect,0,0
141058,size,0,0
141059,[,0,0
141060,ES,0,1
141061,],0,0
141062,=,0,0
141063,0.44,0,0
141064,),0,0
141065,but,0,0
141066,not,0,0
141067,for,0,0
141068,12HL,0,0
141069,(,0,0
141070,5.8,0,0
141071,?,0,0
141072,4.8,0,0
141073,%,0,0
141074,),0,0
141075,versus,0,1
141076,NHL,0,1
141077,(,0,0
141078,ES,0,1
141079,=,0,0
141080,0.35,0,0
141081,),0,0
141082,.,0,0
141083,Peak,0,0
141084,AT,0,0
141085,force,0,1
141086,was,0,0
141087,significantly,0,0
141088,(,0,0
141089,p,0,0
141090,=,0,0
141091,.024,0,0
141092,",",0,0
141093,ES,0,1
141094,=,0,0
141095,0.42,0,0
141096,),0,0
141097,less,0,0
141098,for,0,0
141099,18HL,0,0
141100,(,0,0
141101,2382,0,0
141102,?,0,0
141103,717,0,0
141104,N,0,0
141105,),0,0
141106,than,0,0
141107,for,0,0
141108,NHL,0,0
141109,(,0,0
141110,2710,0,0
141111,?,0,0
141112,830,0,0
141113,N,0,0
141114,),0,0
141115,but,0,0
141116,not,0,0
141117,for,0,0
141118,12HL,0,0
141119,(,0,0
141120,2538,0,0
141121,?,0,0
141122,823,0,0
141123,N,0,0
141124,",",0,0
141125,ES,0,1
141126,=,0,0
141127,0.21,0,0
141128,),0,0
141129,.,0,0
141130,The,0,0
141131,18HL,0,0
141132,reduced,0,0
141133,ankle,0,0
141134,dorsiflexion,0,0
141135,but,0,0
141136,not,0,0
141137,flexion-extension,0,0
141138,ankle,0,0
141139,moments,0,0
141140,and,0,0
141141,increased,0,0
141142,the,0,0
141143,AT,0,1
141144,moment,0,0
141145,arm,0,0
141146,compared,0,0
141147,with,0,0
141148,NHL,0,0
141149,.,0,0
141150,Thus,0,0
141151,",",0,0
141152,18HL,0,0
141153,reduced,0,0
141154,force,0,1
141155,and,0,0
141156,strain,0,0
141157,on,0,0
141158,the,0,0
141159,AT,0,0
141160,during,0,0
141161,running,0,0
141162,via,0,0
141163,a,0,0
141164,reduction,0,0
141165,in,0,0
141166,dorsiflexion,0,0
141167,",",0,0
141168,which,0,0
141169,lengthened,0,0
141170,the,0,0
141171,AT,0,1
141172,moment,0,0
141173,arm,0,0
141174,.,0,0
141175,Therefore,1,0
141176,",",1,0
141177,heel,1,0
141178,lifts,1,1
141179,could,0,0
141180,be,0,0
141181,used,0,0
141182,to,0,0
141183,reduce,0,0
141184,AT,0,1
141185,loading,0,1
141186,and,0,0
141187,strain,0,0
141188,during,0,0
141189,the,0,0
141190,rehabilitation,0,1
141191,of,0,0
141192,AT,0,0
141193,injuries,0,0
141194,.,0,0
141195,The,0,0
141196,effect,0,0
141197,of,0,0
141198,magnesium,1,1
141199,added,0,0
141200,to,0,0
141201,levobupivacaine,1,1
141202,for,0,0
141203,femoral,0,1
141204,nerve,0,0
141205,block,0,0
141206,on,0,0
141207,postoperative,0,0
141208,analgesia,0,0
141209,in,0,0
141210,patients,0,0
141211,undergoing,0,0
141212,ACL,0,0
141213,reconstruction,0,1
141214,.,0,0
141215,PURPOSE,0,0
141216,The,0,0
141217,aim,0,0
141218,of,0,0
141219,this,0,0
141220,prospective,0,0
141221,randomised,0,0
141222,double-blind,0,0
141223,study,0,0
141224,is,0,0
141225,to,0,0
141226,investigate,0,0
141227,the,0,0
141228,effect,0,0
141229,of,0,0
141230,magnesium,1,1
141231,added,0,0
141232,to,0,0
141233,local,0,0
141234,anaesthetics,0,1
141235,on,0,0
141236,postoperative,0,0
141237,VAS,0,0
141238,scores,0,0
141239,",",0,0
141240,total,0,0
141241,opioid,0,1
141242,consumption,0,0
141243,",",0,0
141244,time,0,0
141245,to,0,0
141246,first,0,0
141247,mobilisation,0,1
141248,",",0,0
141249,patient,0,0
141250,satisfaction,0,0
141251,and,0,0
141252,rescue,0,0
141253,analgesic,0,0
141254,requirements,0,0
141255,in,0,0
141256,arthroscopic,0,1
141257,ACL,0,1
141258,reconstruction,0,1
141259,surgery,0,0
141260,.,0,0
141261,METHODS,0,0
141262,A,0,0
141263,total,0,0
141264,of,0,0
141265,107,0,0
141266,American,0,0
141267,Society,0,0
141268,of,0,0
141269,Anaesthesiologists,0,0
141270,physical,0,1
141271,status,0,0
141272,grade,0,0
141273,I,0,0
141274,and,0,0
141275,II,0,0
141276,patients,0,0
141277,between,0,0
141278,18,0,0
141279,and,0,0
141280,65,0,0
141281,years,0,0
141282,of,0,0
141283,age,0,0
141284,who,0,0
141285,were,0,0
141286,scheduled,0,0
141287,to,0,0
141288,undergo,0,0
141289,elective,0,0
141290,anterior,0,0
141291,crucial,0,0
141292,ligament,0,1
141293,(,0,0
141294,ACL,0,1
141295,),0,0
141296,reconstruction,0,1
141297,with,0,0
141298,hamstring,0,0
141299,autografts,0,1
141300,were,0,0
141301,enrolled,0,0
141302,in,0,0
141303,the,0,0
141304,study,0,0
141305,.,0,0
141306,The,0,0
141307,patients,0,0
141308,were,0,0
141309,randomly,0,0
141310,allocated,0,0
141311,to,0,0
141312,Groups,0,0
141313,L,0,1
141314,(,0,0
141315,n,0,0
141316,=,0,0
141317,51,0,0
141318,),0,0
141319,and,0,0
141320,LM,0,1
141321,(,0,0
141322,n,0,0
141323,=,0,0
141324,56,0,0
141325,),0,0
141326,using,0,0
141327,the,0,0
141328,closed-envelope,0,1
141329,method,0,0
141330,.,0,0
141331,Group,0,0
141332,LM,0,0
141333,was,0,0
141334,administered,0,0
141335,19,0,0
141336,ml,0,0
141337,of,0,0
141338,0.25,1,1
141339,%,1,0
141340,levobupivacaine,1,1
141341,and,1,0
141342,1,1,0
141343,ml,1,0
141344,of,1,0
141345,15,1,0
141346,%,1,0
141347,magnesium,1,1
141348,sulphate,1,1
141349,",",0,0
141350,while,0,0
141351,Group,1,0
141352,L,1,0
141353,was,1,0
141354,administered,1,0
141355,20,1,0
141356,ml,1,0
141357,of,1,0
141358,0.25,1,1
141359,%,1,0
141360,levobupivacaine,1,1
141361,for,0,0
141362,femoral,0,0
141363,blockade,0,0
141364,.,0,0
141365,General,0,0
141366,anaesthesia,0,1
141367,was,0,0
141368,administered,0,0
141369,using,0,0
141370,laryngeal,0,0
141371,airway,0,0
141372,masks,0,1
141373,following,0,0
141374,neural,0,0
141375,blockade,0,0
141376,in,0,0
141377,both,0,0
141378,groups,0,0
141379,.,0,0
141380,The,0,0
141381,patients,0,0
141382,were,0,0
141383,evaluated,0,0
141384,for,0,0
141385,heart,0,0
141386,rate,0,0
141387,and,0,0
141388,mean,0,0
141389,arterial,0,0
141390,pressure,0,0
141391,",",0,0
141392,oxygen,0,1
141393,saturation,0,0
141394,",",0,0
141395,visual,0,0
141396,analogue,0,0
141397,score,0,0
141398,(,0,0
141399,VAS,0,1
141400,),0,0
141401,",",0,0
141402,verbal,0,1
141403,rating,0,0
141404,scale,0,0
141405,(,0,0
141406,VRS,0,1
141407,),0,0
141408,",",0,0
141409,rescue,0,0
141410,analgesic,0,0
141411,requirements,0,0
141412,",",0,0
141413,total,0,0
141414,opioid,0,1
141415,consumption,0,0
141416,",",0,0
141417,side,0,0
141418,effects,0,0
141419,and,0,0
141420,time,0,0
141421,to,0,0
141422,first,0,0
141423,mobilisation,0,1
141424,at,0,0
141425,the,0,0
141426,1st,0,0
141427,",",0,0
141428,2nd,0,0
141429,",",0,0
141430,4th,0,0
141431,",",0,0
141432,6th,0,0
141433,",",0,0
141434,12th,0,0
141435,and,0,0
141436,24th,0,0
141437,hours,0,0
141438,postoperatively,0,0
141439,.,0,0
141440,RESULTS,0,0
141441,There,0,0
141442,was,0,0
141443,no,0,0
141444,statistically,0,0
141445,significant,0,0
141446,difference,0,0
141447,in,0,0
141448,terms,0,0
141449,of,0,0
141450,demographic,0,0
141451,data,0,0
141452,",",0,0
141453,mean,0,0
141454,arterial,0,0
141455,pressure,0,0
141456,",",0,0
141457,heart,0,0
141458,rate,0,0
141459,or,0,1
141460,oxygen,0,1
141461,saturation,0,0
141462,between,0,0
141463,groups,0,0
141464,.,0,0
141465,The,0,0
141466,area,0,0
141467,under,0,0
141468,the,0,0
141469,curve,0,0
141470,VAS,0,1
141471,and,0,0
141472,VRS,0,1
141473,scores,0,0
141474,were,0,0
141475,lower,0,0
141476,at,0,0
141477,4,0,0
141478,",",0,0
141479,6,0,0
141480,",",0,0
141481,12,0,0
141482,and,0,0
141483,24,0,0
141484,h,0,0
141485,in,0,0
141486,Group,0,0
141487,LM,0,1
141488,(,0,0
141489,p,0,0
141490,=,0,0
141491,0.001,0,0
141492,",",0,0
141493,p,0,0
141494,=,0,0
141495,0.016,0,0
141496,",",0,0
141497,respectively,0,0
141498,),0,0
141499,.,0,0
141500,The,0,0
141501,rescue,0,0
141502,analgesic,0,1
141503,requirement,0,0
141504,and,0,0
141505,the,0,0
141506,total,0,0
141507,opioid,0,1
141508,consumption,0,0
141509,were,0,0
141510,significantly,0,0
141511,lower,0,0
141512,in,0,0
141513,Group,0,0
141514,LM,0,1
141515,(,0,0
141516,p,0,0
141517,=,0,0
141518,0.015,0,0
141519,",",0,0
141520,p,0,0
141521,=,0,0
141522,0.019,0,0
141523,",",0,0
141524,respectively,0,0
141525,),0,0
141526,.,0,0
141527,The,0,0
141528,time,0,0
141529,to,0,0
141530,first,0,0
141531,mobilisation,0,1
141532,and,0,0
141533,the,0,0
141534,Likert,0,0
141535,score,0,0
141536,(,0,0
141537,completely,0,0
141538,comfortable,0,0
141539,;,0,0
141540,quite,0,0
141541,comfortable,0,0
141542,;,0,0
141543,slight,0,0
141544,discomfort,0,0
141545,;,0,0
141546,painful,0,0
141547,;,0,0
141548,very,0,0
141549,painful,0,0
141550,),0,0
141551,were,0,0
141552,higher,0,0
141553,",",0,0
141554,and,0,0
141555,the,0,0
141556,block,0,0
141557,onset,0,0
141558,time,0,0
141559,was,0,0
141560,lower,0,0
141561,in,0,0
141562,Group,0,0
141563,LM,0,1
141564,(,0,0
141565,p,0,0
141566,=,0,0
141567,0.014,0,0
141568,and,0,0
141569,p,0,0
141570,=,0,0
141571,0.012,0,0
141572,",",0,0
141573,respectively,0,0
141574,),0,0
141575,.,0,0
141576,There,0,0
141577,was,0,0
141578,no,0,0
141579,difference,0,0
141580,in,0,0
141581,terms,0,0
141582,of,0,0
141583,side,0,0
141584,effects,0,0
141585,.,0,0
141586,CONCLUSIONS,0,0
141587,The,0,0
141588,addition,0,0
141589,of,0,0
141590,magnesium,1,1
141591,to,0,0
141592,levobupivacaine,0,1
141593,prolongs,0,0
141594,the,0,0
141595,sensory,0,0
141596,and,0,0
141597,motor,0,0
141598,block,0,0
141599,duration,0,0
141600,without,0,0
141601,increasing,0,0
141602,side,0,0
141603,effects,0,0
141604,",",0,0
141605,enhances,0,0
141606,the,0,0
141607,quality,0,0
141608,of,0,0
141609,postoperative,0,0
141610,analgesia,0,0
141611,and,0,0
141612,increases,0,0
141613,patient,0,0
141614,satisfaction,0,0
141615,;,0,0
141616,however,0,0
141617,",",0,0
141618,the,0,0
141619,addition,0,0
141620,of,0,0
141621,magnesium,0,1
141622,delays,0,0
141623,the,0,0
141624,time,0,0
141625,to,0,0
141626,first,0,0
141627,mobilisation,0,1
141628,and,0,0
141629,decreases,0,0
141630,rescue,0,0
141631,analgesic,0,0
141632,requirements,0,0
141633,.,0,0
141634,A,0,0
141635,randomized,0,0
141636,double-blind,0,0
141637,study,0,0
141638,of,0,0
141639,atomoxetine,1,1
141640,versus,0,0
141641,placebo,1,1
141642,for,0,0
141643,attention-deficit/hyperactivity,0,0
141644,disorder,0,0
141645,symptoms,0,0
141646,in,0,0
141647,children,0,0
141648,with,0,0
141649,autism,0,0
141650,spectrum,0,0
141651,disorder,0,0
141652,.,0,0
141653,OBJECTIVE,0,0
141654,The,0,0
141655,efficacy,0,0
141656,of,0,0
141657,atomoxetine,1,1
141658,as,0,0
141659,treatment,0,0
141660,of,0,0
141661,symptoms,0,0
141662,of,0,0
141663,attention-deficit/hyperactivity,0,0
141664,disorder,0,0
141665,(,0,0
141666,ADHD,0,1
141667,),0,0
141668,in,0,0
141669,patients,0,0
141670,with,0,0
141671,autism,0,0
141672,spectrum,0,0
141673,disorder,0,0
141674,(,0,0
141675,ASD,0,0
141676,),0,1
141677,has,0,0
141678,not,0,0
141679,been,0,0
141680,established,0,0
141681,.,0,0
141682,METHOD,0,0
141683,In,0,0
141684,this,0,0
141685,study,0,0
141686,",",0,0
141687,97,0,0
141688,patients,0,0
141689,aged,0,0
141690,6,0,0
141691,to,0,0
141692,17,0,0
141693,years,0,0
141694,with,0,0
141695,ADHD,0,1
141696,and,0,0
141697,ASD,0,0
141698,were,0,0
141699,randomly,0,0
141700,assigned,0,0
141701,to,0,0
141702,double-blind,0,0
141703,treatment,0,0
141704,with,0,0
141705,1.2,0,0
141706,mg/kg/day,0,0
141707,atomoxetine,1,1
141708,or,1,1
141709,placebo,1,1
141710,for,0,0
141711,8,0,0
141712,weeks,0,0
141713,.,0,0
141714,The,0,0
141715,primary,0,0
141716,endpoint,0,0
141717,was,0,0
141718,the,0,0
141719,ADHD,0,1
141720,Rating,0,0
141721,Scale,0,1
141722,(,0,0
141723,ADHD-RS,0,1
141724,),0,0
141725,score,0,0
141726,;,0,0
141727,secondary,0,0
141728,endpoints,0,0
141729,were,0,0
141730,the,0,0
141731,Clinical,0,0
141732,Global,0,0
141733,Impression,0,0
141734,of,0,0
141735,ADHD-Improvement,0,0
141736,(,0,0
141737,CGI-I,0,1
141738,),0,0
141739,and,0,0
141740,the,0,0
141741,Conners,0,0
141742,Teacher,0,0
141743,Rating,0,0
141744,Scale-Revised,0,0
141745,:,0,0
141746,Short,0,1
141747,Form,0,1
141748,(,0,0
141749,CTRS-R,0,1
141750,:,0,1
141751,S,0,0
141752,),0,0
141753,score,0,0
141754,.,0,0
141755,RESULTS,0,0
141756,Baseline,0,0
141757,mean,0,0
141758,ADHD-RS,0,0
141759,scores,0,0
141760,for,0,0
141761,atomoxetine,1,1
141762,versus,0,0
141763,placebo,1,1
141764,were,0,0
141765,40.7,0,0
141766,and,0,0
141767,38.6,0,0
141768,;,0,0
141769,after,0,0
141770,8,0,0
141771,weeks,0,0
141772,",",0,0
141773,mixed-effect,0,0
141774,model,0,0
141775,repeated-measure,0,0
141776,means,0,0
141777,were,0,0
141778,31.6,0,0
141779,(,0,0
141780,95,0,0
141781,%,0,0
141782,confidence,0,0
141783,interval,0,0
141784,29.2-33.9,0,0
141785,),0,0
141786,and,0,0
141787,38.3,0,0
141788,(,0,0
141789,36.0-40.6,0,0
141790,),0,0
141791,",",0,0
141792,respectively,0,0
141793,",",0,0
141794,with,0,0
141795,a,0,0
141796,difference,0,0
141797,in,0,0
141798,least,0,0
141799,square,0,0
141800,means,0,0
141801,of,0,0
141802,-6.7,0,0
141803,(,0,0
141804,-10.0,0,0
141805,to,0,0
141806,-3.4,0,0
141807,;,0,0
141808,p,0,0
141809,<,0,0
141810,.001,0,0
141811,),0,0
141812,.,0,0
141813,The,0,0
141814,CTRS-R,0,0
141815,:,0,0
141816,S,0,0
141817,Hyperactivity,0,0
141818,subscore,0,0
141819,also,0,0
141820,improved,0,0
141821,significantly,0,0
141822,for,0,0
141823,atomoxetine,1,1
141824,compared,0,0
141825,with,0,0
141826,placebo,1,1
141827,",",0,0
141828,but,0,0
141829,not,0,0
141830,the,0,0
141831,other,0,0
141832,CTRS-R,0,1
141833,:,0,0
141834,S,0,0
141835,subscores,0,0
141836,.,0,0
141837,However,0,0
141838,",",0,0
141839,there,0,0
141840,were,0,0
141841,not,0,0
141842,significantly,0,0
141843,more,0,0
141844,patients,0,0
141845,on,0,0
141846,atomoxetine,1,1
141847,(,0,0
141848,20.9,0,0
141849,%,0,0
141850,),0,0
141851,who,0,0
141852,improved,0,0
141853,much,0,0
141854,",",0,0
141855,or,0,0
141856,very,0,0
141857,much,0,0
141858,according,0,0
141859,to,0,0
141860,the,0,0
141861,CGI-I,0,0
141862,",",0,0
141863,than,0,0
141864,on,0,0
141865,placebo,1,1
141866,(,0,0
141867,8.7,0,0
141868,%,0,0
141869,;,0,0
141870,p,0,0
141871,=,0,0
141872,0.14,0,0
141873,),0,0
141874,.,0,0
141875,Adverse,0,0
141876,events,0,0
141877,(,0,0
141878,mostly,0,0
141879,nausea,0,0
141880,",",0,0
141881,decrease,0,0
141882,in,0,0
141883,appetite,0,0
141884,",",0,0
141885,fatigue,0,0
141886,",",0,0
141887,and,0,0
141888,early,0,0
141889,morning,0,0
141890,awakening,0,0
141891,),0,0
141892,were,0,0
141893,reported,0,0
141894,in,0,0
141895,81.3,0,0
141896,%,0,0
141897,of,0,0
141898,atomoxetine,1,1
141899,patients,0,0
141900,and,0,0
141901,65.3,0,0
141902,%,0,0
141903,of,0,0
141904,placebo,1,1
141905,patients,0,0
141906,(,0,0
141907,p,0,0
141908,>,0,0
141909,.1,0,0
141910,),0,0
141911,.,0,0
141912,There,0,0
141913,were,0,0
141914,no,0,0
141915,serious,0,0
141916,adverse,0,0
141917,events,0,0
141918,.,0,0
141919,CONCLUSIONS,0,0
141920,Atomoxetine,1,1
141921,moderately,0,0
141922,improved,0,0
141923,ADHD,0,0
141924,symptoms,0,0
141925,in,0,0
141926,patients,0,0
141927,with,0,0
141928,ASD,0,0
141929,and,0,0
141930,was,0,0
141931,generally,0,0
141932,well,0,0
141933,tolerated,0,0
141934,.,0,0
141935,Adverse,0,0
141936,events,0,0
141937,in,0,0
141938,this,0,0
141939,study,0,0
141940,were,0,0
141941,similar,0,0
141942,to,0,0
141943,those,0,0
141944,in,0,0
141945,other,0,0
141946,studies,0,0
141947,with,0,0
141948,ADHD,0,0
141949,patients,0,0
141950,without,0,0
141951,ASD,0,0
141952,.,0,0
141953,Clinical,0,0
141954,trial,0,0
141955,registration,0,0
141956,information-A,0,0
141957,Randomized,0,0
141958,Double-Blind,0,1
141959,Study,0,0
141960,of,0,0
141961,Atomoxetine,1,1
141962,Versus,0,0
141963,Placebo,1,1
141964,for,0,0
141965,ADHD,0,1
141966,Symptoms,0,0
141967,in,0,0
141968,Children,0,0
141969,with,0,0
141970,ASD,0,0
141971,;,0,0
141972,www.clinicaltrials.gov,0,0
141973,;,0,0
141974,NCT00380692,0,0
141975,.,0,0
141976,Effect,0,0
141977,of,0,0
141978,chelation,1,1
141979,therapy,1,1
141980,on,0,0
141981,progressive,0,0
141982,diabetic,0,0
141983,nephropathy,0,0
141984,in,0,0
141985,patients,0,0
141986,with,0,0
141987,type,0,0
141988,2,0,0
141989,diabetes,0,0
141990,and,0,0
141991,high-normal,0,0
141992,body,0,0
141993,lead,0,0
141994,burdens,0,0
141995,.,0,0
141996,BACKGROUND,0,0
141997,A,0,0
141998,previous,0,0
141999,study,0,0
142000,in,0,0
142001,type,0,0
142002,2,0,0
142003,diabetic,0,0
142004,patients,0,0
142005,with,0,0
142006,high-normal,0,0
142007,body,0,0
142008,lead,0,0
142009,burdens,0,0
142010,showed,0,0
142011,that,0,0
142012,EDTA,1,0
142013,chelation,1,1
142014,therapy,1,1
142015,for,0,0
142016,3,0,0
142017,months,0,0
142018,slows,0,0
142019,progressive,0,0
142020,diabetic,0,0
142021,nephropathy,0,0
142022,during,0,0
142023,a,0,0
142024,12-month,0,0
142025,follow-up,0,0
142026,.,0,0
142027,The,0,0
142028,effect,0,0
142029,of,0,0
142030,a,0,0
142031,longer,0,0
142032,course,0,0
142033,of,0,0
142034,therapy,0,1
142035,on,0,0
142036,kidney,0,0
142037,function,0,0
142038,decrease,0,0
142039,over,0,0
142040,a,0,0
142041,longer,0,0
142042,follow-up,0,0
142043,is,0,0
142044,not,0,0
142045,known,0,0
142046,.,0,0
142047,STUDY,0,0
142048,DESIGN,0,0
142049,A,0,0
142050,12-month,0,0
142051,run-in,0,0
142052,phase,0,0
142053,",",0,0
142054,then,0,0
142055,a,0,0
142056,randomized,0,0
142057,single-blind,0,0
142058,study,0,0
142059,with,0,0
142060,a,0,0
142061,27-month,0,0
142062,intervention,0,1
142063,.,0,0
142064,SETTING,0,0
142065,&,0,0
142066,PARTICIPANTS,0,0
142067,University,0,0
142068,medical,0,1
142069,center,0,0
142070,;,0,0
142071,50,0,0
142072,patients,0,0
142073,(,0,0
142074,serum,0,0
142075,creatinine,0,0
142076,",",0,0
142077,1.5-3.9,0,0
142078,mg/dL,0,1
142079,),0,0
142080,with,0,0
142081,high-normal,0,0
142082,body,0,0
142083,lead,0,1
142084,burden,0,0
142085,(,0,0
142086,?80-,0,1
142087,<,0,0
142088,600,0,1
142089,?g,0,0
142090,),0,0
142091,were,0,0
142092,randomly,0,0
142093,assigned,0,0
142094,to,0,0
142095,the,0,0
142096,treatment,1,0
142097,and,1,0
142098,control,1,0
142099,groups,1,0
142100,.,1,0
142101,INTERVENTION,1,0
142102,The,0,0
142103,treatment,0,0
142104,group,0,0
142105,received,0,0
142106,weekly,1,1
142107,chelation,1,1
142108,therapy,1,1
142109,for,1,0
142110,3,0,0
142111,months,0,0
142112,to,0,0
142113,reduce,0,0
142114,their,0,0
142115,body,0,0
142116,lead,0,0
142117,burden,0,0
142118,to,0,0
142119,<,0,0
142120,60,0,0
142121,?g,0,0
142122,and,0,0
142123,then,0,0
142124,as,0,0
142125,needed,0,0
142126,for,0,0
142127,24,0,0
142128,months,0,0
142129,to,0,0
142130,maintain,0,0
142131,this,0,0
142132,level,0,0
142133,.,0,0
142134,The,0,0
142135,control,0,0
142136,group,0,0
142137,received,1,0
142138,placebo,1,1
142139,for,1,0
142140,3,0,0
142141,months,0,0
142142,and,0,0
142143,then,0,0
142144,weekly,0,1
142145,for,0,0
142146,5,0,0
142147,weeks,0,0
142148,at,0,0
142149,6-month,0,0
142150,intervals,0,0
142151,for,0,0
142152,24,0,0
142153,months,0,0
142154,.,0,0
142155,OUTCOMES,0,0
142156,The,0,0
142157,primary,0,0
142158,end,0,0
142159,point,0,0
142160,was,0,0
142161,change,0,0
142162,in,0,0
142163,estimated,0,0
142164,glomerular,0,0
142165,filtration,0,1
142166,rate,0,0
142167,(,0,0
142168,eGFR,0,0
142169,),0,0
142170,over,0,0
142171,time,0,0
142172,.,0,0
142173,A,0,0
142174,secondary,0,0
142175,end,0,0
142176,point,0,0
142177,was,0,0
142178,a,0,0
142179,2-fold,0,0
142180,increase,0,0
142181,in,0,0
142182,baseline,0,0
142183,serum,0,0
142184,creatinine,0,0
142185,level,0,0
142186,or,0,1
142187,the,0,0
142188,requirement,0,0
142189,for,0,0
142190,renal,0,0
142191,replacement,0,1
142192,therapy,0,1
142193,.,0,0
142194,MEASUREMENTS,0,0
142195,Body,0,1
142196,lead,0,0
142197,burdens,0,0
142198,were,0,0
142199,assessed,0,0
142200,by,0,0
142201,EDTA,0,0
142202,mobilization,0,0
142203,tests,0,0
142204,and,0,0
142205,eGFR,0,0
142206,was,0,0
142207,calculated,0,0
142208,using,0,0
142209,the,0,0
142210,equation,0,1
142211,for,0,0
142212,Chinese,0,0
142213,patients,0,0
142214,with,0,0
142215,type,0,0
142216,2,0,0
142217,diabetes,0,0
142218,.,0,0
142219,RESULTS,0,0
142220,Mean,0,0
142221,baseline,0,0
142222,eGFRs,0,0
142223,in,0,0
142224,the,0,0
142225,treatment,0,0
142226,and,0,0
142227,control,0,0
142228,groups,0,0
142229,were,0,0
142230,similar,0,0
142231,.,0,0
142232,After,0,0
142233,3,0,0
142234,months,0,0
142235,of,0,0
142236,chelation,0,1
142237,therapy,0,1
142238,",",0,0
142239,the,0,0
142240,change,0,0
142241,in,0,0
142242,eGFR,0,0
142243,in,0,0
142244,the,0,0
142245,treatment,0,0
142246,group,0,0
142247,(,0,0
142248,+1.0,0,1
142249,?,0,0
142250,4.8,0,0
142251,mL/min/1.73,0,0
142252,m,0,0
142253,(,0,0
142254,2,0,0
142255,),0,0
142256,),0,0
142257,differed,0,0
142258,significantly,0,0
142259,from,0,0
142260,that,0,0
142261,in,0,0
142262,the,0,0
142263,control,0,1
142264,group,0,0
142265,(,0,0
142266,-1.5,0,0
142267,?,0,0
142268,4.8,0,0
142269,mL/min/1.73,0,0
142270,m,0,0
142271,(,0,0
142272,2,0,0
142273,),0,0
142274,;,0,0
142275,P,0,0
142276,=,0,0
142277,0.04,0,0
142278,),0,0
142279,.,0,0
142280,In,0,0
142281,the,0,0
142282,subsequent,0,0
142283,24-month,0,0
142284,intervention,0,1
142285,",",0,0
142286,the,0,0
142287,yearly,0,0
142288,rate,0,0
142289,of,0,0
142290,decrease,0,0
142291,in,0,0
142292,eGFR,0,0
142293,(,0,0
142294,5.6,0,0
142295,?,0,0
142296,5.0,0,0
142297,mL/min/1.73,0,0
142298,m,0,0
142299,(,0,0
142300,2,0,0
142301,),0,0
142302,per,0,0
142303,year,0,0
142304,),0,0
142305,in,0,0
142306,the,0,0
142307,treatment,0,0
142308,group,0,0
142309,was,0,0
142310,slower,0,0
142311,than,0,0
142312,that,0,0
142313,(,0,0
142314,9.2,0,0
142315,?,0,0
142316,3.6,0,0
142317,mL/min/1.73,0,0
142318,m,0,0
142319,(,0,0
142320,2,0,0
142321,),0,0
142322,per,0,0
142323,year,0,0
142324,;,0,0
142325,P,0,0
142326,=,0,0
142327,0.04,0,0
142328,),0,0
142329,in,0,0
142330,the,0,0
142331,control,0,0
142332,group,0,0
142333,.,0,0
142334,17,0,0
142335,(,0,0
142336,68,0,0
142337,%,0,0
142338,),0,0
142339,control-group,0,1
142340,patients,0,0
142341,and,0,0
142342,9,0,0
142343,(,0,0
142344,36,0,0
142345,%,0,0
142346,),0,0
142347,treatment-group,0,0
142348,patients,0,0
142349,achieved,0,0
142350,the,0,0
142351,secondary,0,0
142352,end,0,0
142353,point,0,0
142354,.,0,0
142355,LIMITATIONS,0,0
142356,Small,0,1
142357,sample,0,0
142358,size,0,0
142359,",",0,0
142360,not,0,0
142361,double,0,0
142362,blind,0,0
142363,.,0,0
142364,CONCLUSIONS,0,0
142365,A,0,0
142366,27-month,0,0
142367,course,0,0
142368,of,0,0
142369,EDTA,0,0
142370,chelation,0,1
142371,therapy,0,1
142372,retards,0,0
142373,the,0,0
142374,progression,0,0
142375,of,0,0
142376,diabetic,0,0
142377,nephropathy,0,0
142378,in,0,0
142379,type,0,0
142380,2,0,0
142381,diabetic,0,0
142382,patients,0,0
142383,with,0,0
142384,high-normal,0,0
142385,body,0,0
142386,lead,0,0
142387,burdens,0,0
142388,.,0,0
142389,The,0,0
142390,in,0,0
142391,vitro,0,0
142392,effects,0,0
142393,of,0,0
142394,verbascoside,1,1
142395,on,0,0
142396,human,0,0
142397,platelet,0,0
142398,aggregation,0,0
142399,.,0,0
142400,Preliminary,0,0
142401,in,0,0
142402,vitro,0,0
142403,and,0,0
142404,animal,0,0
142405,studies,0,0
142406,have,0,0
142407,shown,0,0
142408,that,0,0
142409,verbascoside,1,1
142410,",",0,0
142411,a,0,0
142412,phenolic,0,1
142413,compound,0,1
142414,",",0,0
142415,may,0,0
142416,have,0,0
142417,several,0,0
142418,favourable,0,0
142419,biological,0,0
142420,activities,0,0
142421,",",0,0
142422,including,0,0
142423,an,0,0
142424,influence,0,0
142425,on,0,0
142426,endothelial,0,0
142427,function,0,0
142428,and,0,0
142429,on,0,0
142430,platelet,0,0
142431,aggregation,0,0
142432,.,0,0
142433,We,0,0
142434,sought,0,0
142435,to,0,0
142436,evaluate,0,0
142437,the,0,0
142438,effects,0,0
142439,of,0,0
142440,verbascoside,1,1
142441,",",0,0
142442,biotechnologically,0,0
142443,produced,0,0
142444,from,0,0
142445,plant,0,0
142446,cell,0,0
142447,cultures,0,0
142448,",",0,0
142449,on,0,0
142450,human,0,0
142451,platelet,0,0
142452,aggregation,0,0
142453,(,0,0
142454,PA,0,1
142455,),0,0
142456,.,0,0
142457,The,0,0
142458,blood,0,0
142459,from,0,0
142460,40,0,0
142461,aspirin-na?ve,0,0
142462,volunteers,0,0
142463,with,0,0
142464,at,0,0
142465,least,0,0
142466,one,0,0
142467,cardiovascular,0,0
142468,risk,0,0
142469,factor,0,0
142470,was,0,0
142471,preincubated,0,0
142472,in,0,0
142473,vitro,0,0
142474,with,1,0
142475,verbascoside,1,1
142476,(,0,0
142477,1,0,0
142478,and,0,0
142479,2,0,0
142480,mg/dL,0,1
142481,),0,0
142482,and,1,0
142483,aspirin,1,1
142484,(,1,0
142485,100,0,1
142486,?M,0,0
142487,),0,0
142488,.,0,0
142489,The,0,0
142490,blood,0,0
142491,from,0,0
142492,20,0,0
142493,patients,0,0
142494,with,0,0
142495,a,0,0
142496,prior,0,0
142497,diagnosis,0,0
142498,of,0,0
142499,coronary,0,0
142500,heart,0,0
142501,disease,0,0
142502,who,0,0
142503,were,0,0
142504,chronically,0,0
142505,assuming,1,0
142506,aspirin,1,1
142507,was,1,0
142508,preincubated,0,0
142509,in,0,0
142510,vitro,0,0
142511,with,0,0
142512,verbascoside,1,1
142513,(,1,0
142514,1,1,0
142515,and,0,0
142516,2,0,0
142517,mg/dL,0,1
142518,),0,0
142519,.,0,0
142520,PA,0,0
142521,is,0,0
142522,measured,0,0
142523,with,0,0
142524,a,0,0
142525,light,0,0
142526,transmission,0,0
142527,aggregometry,0,0
142528,and,0,0
142529,multiplate,0,1
142530,analyzer,0,0
142531,.,0,0
142532,As,0,0
142533,compared,0,0
142534,to,0,0
142535,reference,0,0
142536,",",0,0
142537,preincubation,0,0
142538,with,0,0
142539,verbascoside,0,1
142540,resulted,0,0
142541,in,0,0
142542,a,0,0
142543,significant,0,0
142544,inhibition,0,0
142545,of,0,0
142546,adenosine,0,1
142547,diphosphate,0,1
142548,(,0,0
142549,ADP,0,0
142550,),0,1
142551,and,0,0
142552,arachidonic,0,1
142553,acid,0,1
142554,(,0,0
142555,AA,0,1
142556,),0,0
142557,-induced,0,0
142558,PA,0,1
142559,(,0,0
142560,p,0,0
142561,<,0,0
142562,0.01,0,0
142563,for,0,0
142564,both,0,0
142565,),0,0
142566,.,0,0
142567,Verbascoside,1,1
142568,2,1,0
142569,mg/dL,1,0
142570,did,0,0
142571,not,0,0
142572,show,0,0
142573,a,0,0
142574,stronger,0,0
142575,effect,0,0
142576,as,0,0
142577,compared,0,0
142578,to,0,0
142579,verbascoside,0,1
142580,1,0,0
142581,mg/dL,0,1
142582,(,0,0
142583,p,0,0
142584,=,0,0
142585,0.4,0,0
142586,),0,0
142587,.,0,0
142588,As,0,0
142589,expected,0,0
142590,",",0,0
142591,the,0,0
142592,in,0,0
142593,vitro,0,0
142594,addition,0,0
142595,of,0,0
142596,aspirin,0,1
142597,reduced,0,0
142598,AA,0,0
142599,induced,0,0
142600,PA,0,1
142601,(,0,0
142602,p,0,0
142603,<,0,0
142604,0.01,0,0
142605,),0,0
142606,",",0,0
142607,but,0,0
142608,not,0,0
142609,that,0,0
142610,induced,0,0
142611,by,0,0
142612,ADP,0,0
142613,(,0,0
142614,p,0,0
142615,=,0,0
142616,0.5,0,0
142617,),0,0
142618,.,0,0
142619,The,0,0
142620,addition,0,0
142621,of,0,0
142622,verbascoside,0,1
142623,to,0,0
142624,the,0,0
142625,blood,0,0
142626,of,0,0
142627,aspirin-treated,1,0
142628,patients,0,0
142629,did,0,0
142630,not,0,0
142631,improve,0,0
142632,the,0,0
142633,values,0,0
142634,of,0,0
142635,PA,0,0
142636,after,0,0
142637,AA,0,1
142638,stimulus,0,0
142639,(,0,0
142640,p,0,0
142641,=,0,0
142642,0.8,0,0
142643,),0,0
142644,",",0,0
142645,whereas,0,0
142646,it,0,0
142647,ensured,0,0
142648,a,0,0
142649,stronger,0,0
142650,inhibition,0,0
142651,after,0,0
142652,ADP,0,0
142653,stimulus,0,0
142654,(,0,0
142655,p,0,0
142656,<,0,0
142657,0.01,1,0
142658,),1,0
142659,.,1,0
142660,Verbascoside,1,1
142661,in,1,0
142662,vitro,1,0
142663,affects,0,0
142664,PA,0,0
142665,by,0,0
142666,mildly,0,0
142667,inhibiting,0,0
142668,aggregation,0,0
142669,",",0,0
142670,triggered,0,0
142671,both,0,0
142672,by,0,0
142673,ADP,0,0
142674,and,0,0
142675,AA,0,0
142676,.,0,0
142677,These,0,0
142678,preliminary,0,0
142679,data,0,0
142680,",",0,0
142681,while,0,0
142682,intriguing,0,0
142683,",",0,0
142684,require,0,0
142685,confirmation,0,0
142686,in,0,0
142687,subjects,0,0
142688,receiving,0,0
142689,verbascoside,1,1
142690,orally,1,1
142691,in,0,0
142692,order,0,0
142693,to,0,0
142694,determine,0,0
142695,whether,0,0
142696,these,0,0
142697,findings,0,0
142698,are,0,0
142699,clinically,0,0
142700,relevant,0,0
142701,.,0,0
142702,Phase,0,0
142703,II,0,0
142704,trial,0,0
142705,of,0,0
142706,nab-paclitaxel,0,1
142707,compared,0,0
142708,with,0,0
142709,docetaxel,1,1
142710,as,0,0
142711,first-line,0,0
142712,chemotherapy,0,1
142713,in,0,0
142714,patients,0,0
142715,with,0,0
142716,metastatic,0,0
142717,breast,0,0
142718,cancer,0,0
142719,:,0,0
142720,final,0,0
142721,analysis,0,0
142722,of,0,0
142723,overall,0,0
142724,survival,0,0
142725,.,0,0
142726,BACKGROUND,0,0
142727,A,0,0
142728,randomized,0,0
142729,phase,0,0
142730,II,0,0
142731,study,0,0
142732,in,0,0
142733,first-line,0,0
142734,MBC,0,0
142735,demonstrated,0,0
142736,superior,0,0
142737,efficacy,0,0
142738,and,0,0
142739,safety,0,0
142740,of,0,0
142741,weekly,0,1
142742,nab-paclitaxel,0,1
142743,compared,0,0
142744,with,0,0
142745,docetaxel,1,1
142746,.,1,0
142747,Final,0,0
142748,survival,0,0
142749,analyses,0,0
142750,and,0,0
142751,updated,0,0
142752,safety,0,0
142753,results,0,0
142754,are,0,0
142755,reported,0,0
142756,.,0,0
142757,PATIENTS,0,0
142758,AND,0,0
142759,METHODS,0,0
142760,Three,0,1
142761,hundred,0,0
142762,two,0,0
142763,patients,0,0
142764,with,0,0
142765,no,0,0
142766,previous,0,0
142767,chemotherapy,0,1
142768,for,0,0
142769,MBC,0,0
142770,were,0,0
142771,randomized,1,0
142772,to,1,0
142773,receive,1,0
142774,nab-paclitaxel,1,1
142775,300,1,1
142776,mg/m,1,1
142777,(,1,0
142778,2,1,0
142779,),1,0
142780,q3w,1,0
142781,",",1,0
142782,nab-paclitaxel,1,1
142783,100,1,1
142784,mg/m,1,1
142785,(,1,0
142786,2,1,0
142787,),1,0
142788,or,1,0
142789,150,1,1
142790,mg/m,1,1
142791,(,1,0
142792,2,1,0
142793,),1,0
142794,the,1,0
142795,first,1,0
142796,3,1,0
142797,of,1,0
142798,4,1,0
142799,weeks,1,0
142800,(,1,0
142801,qw,1,0
142802,3/4,1,0
142803,),1,0
142804,",",1,0
142805,or,1,0
142806,docetaxel,1,1
142807,100,1,1
142808,mg/m,1,1
142809,(,1,0
142810,2,1,0
142811,),1,0
142812,q3w,1,0
142813,.,1,0
142814,The,0,0
142815,trial,0,0
142816,was,0,0
142817,powered,0,0
142818,for,0,0
142819,analyses,0,0
142820,of,0,0
142821,antitumor,0,0
142822,activity,0,0
142823,and,0,0
142824,safety,0,0
142825,.,0,0
142826,RESULTS,0,0
142827,Treatment,0,0
142828,with,0,0
142829,nab-paclitaxel,0,1
142830,150,0,0
142831,mg/m,0,1
142832,(,0,0
142833,2,0,0
142834,),0,0
142835,qw,0,0
142836,3/4,0,0
142837,resulted,0,0
142838,in,0,0
142839,a,0,0
142840,median,0,0
142841,overall,0,0
142842,survival,0,0
142843,(,0,0
142844,OS,0,0
142845,),0,0
142846,of,0,0
142847,33.8,0,0
142848,months,0,0
142849,compared,0,0
142850,with,0,0
142851,22.2,0,0
142852,",",0,0
142853,27.7,0,0
142854,",",0,0
142855,and,0,0
142856,26.6,0,0
142857,months,0,0
142858,for,0,0
142859,nab-paclitaxel,0,1
142860,100,0,1
142861,mg/m,0,1
142862,(,0,0
142863,2,0,0
142864,),0,0
142865,qw,0,0
142866,3/4,0,0
142867,",",0,0
142868,nab-paclitaxel,0,1
142869,300,0,1
142870,mg/m,0,1
142871,(,0,0
142872,2,0,0
142873,),0,0
142874,q3w,0,0
142875,",",0,0
142876,and,0,0
142877,docetaxel,1,1
142878,",",0,0
142879,respectively,0,0
142880,(,0,0
142881,overall,0,0
142882,P,0,0
142883,=,0,0
142884,.047,0,0
142885,),0,0
142886,.,0,0
142887,Patients,0,0
142888,receiving,0,0
142889,150,0,0
142890,mg/m,0,1
142891,(,0,0
142892,2,0,0
142893,),0,0
142894,nab-paclitaxel,0,1
142895,had,0,0
142896,prolonged,0,0
142897,median,0,0
142898,OS,0,0
142899,compared,0,0
142900,with,0,0
142901,those,0,0
142902,in,0,0
142903,the,0,0
142904,100,0,1
142905,mg/m,0,0
142906,(,0,0
142907,2,0,0
142908,),0,0
142909,nab-paclitaxel,0,1
142910,arm,0,0
142911,(,0,0
142912,hazard,0,0
142913,ratio,0,0
142914,",",0,0
142915,0.575,0,0
142916,;,0,0
142917,P,0,0
142918,=,0,0
142919,.008,0,0
142920,),0,0
142921,.,0,0
142922,A,0,0
142923,trend,0,0
142924,toward,0,0
142925,a,0,0
142926,longer,0,0
142927,OS,0,0
142928,was,0,0
142929,noted,0,0
142930,in,0,0
142931,the,0,0
142932,150,0,0
142933,mg/m,0,0
142934,(,0,0
142935,2,0,0
142936,),0,0
142937,nab-paclitaxel,0,1
142938,arm,0,0
142939,versus,0,1
142940,docetaxel,1,1
142941,arm,0,0
142942,(,0,0
142943,hazard,0,0
142944,ratio,0,0
142945,",",0,0
142946,0.688,0,0
142947,),0,0
142948,.,0,0
142949,Grade,0,0
142950,3,0,0
142951,or,0,0
142952,4,0,0
142953,fatigue,0,0
142954,",",0,0
142955,neutropenia,0,0
142956,",",0,0
142957,and,0,0
142958,febrile,0,0
142959,neutropenia,0,0
142960,were,0,0
142961,less,0,0
142962,frequent,0,0
142963,in,0,0
142964,all,0,0
142965,nab-paclitaxel,0,1
142966,arms,0,0
142967,compared,0,0
142968,with,0,0
142969,docetaxel,1,1
142970,.,1,0
142971,CONCLUSIONS,0,0
142972,Consistent,0,0
142973,with,0,0
142974,previously,0,0
142975,published,0,0
142976,efficacy,0,0
142977,results,0,0
142978,",",0,0
142979,these,0,0
142980,data,0,0
142981,suggest,0,0
142982,that,0,0
142983,150,0,0
142984,mg/m,0,1
142985,(,0,0
142986,2,0,0
142987,),0,0
142988,qw,0,0
142989,3/4,0,0
142990,may,0,0
142991,represent,0,0
142992,the,0,0
142993,most,0,0
142994,clinically,0,0
142995,efficacious,0,0
142996,nab-paclitaxel,0,1
142997,dosing,0,0
142998,regimen,0,0
142999,for,0,0
143000,patients,0,0
143001,with,0,0
143002,no,0,0
143003,previous,0,0
143004,chemotherapy,0,1
143005,for,0,0
143006,MBC,0,0
143007,.,0,0
143008,A,0,0
143009,phase,0,0
143010,III,0,0
143011,trial,0,0
143012,confirming,0,0
143013,these,0,0
143014,results,0,0
143015,would,0,0
143016,be,0,0
143017,necessary,0,0
143018,and,0,0
143019,prudent,0,0
143020,before,0,0
143021,widespread,0,0
143022,adoption,0,0
143023,of,0,0
143024,the,0,0
143025,150,0,0
143026,mg/m,0,0
143027,(,0,0
143028,2,0,0
143029,),0,0
143030,dose,0,0
143031,in,0,0
143032,clinical,0,0
143033,practice,0,0
143034,.,0,0
143035,Parent-implemented,1,1
143036,enhanced,1,0
143037,milieu,1,1
143038,teaching,1,1
143039,with,0,0
143040,preschool,0,0
143041,children,0,0
143042,who,0,0
143043,have,0,0
143044,intellectual,0,0
143045,disabilities,0,0
143046,.,0,0
143047,PURPOSE,0,0
143048,The,0,0
143049,purpose,0,0
143050,of,0,0
143051,this,0,0
143052,study,0,0
143053,was,0,0
143054,to,0,0
143055,compare,0,0
143056,the,0,0
143057,effects,0,0
143058,of,0,0
143059,enhanced,1,0
143060,milieu,1,1
143061,teaching,1,1
143062,(,1,0
143063,EMT,1,0
143064,),1,0
143065,implemented,0,0
143066,by,0,0
143067,parents,0,0
143068,and,0,0
143069,therapists,0,0
143070,versus,0,0
143071,therapists,0,0
143072,only,0,0
143073,on,0,0
143074,the,0,0
143075,language,0,0
143076,skills,0,0
143077,of,0,0
143078,preschool,0,0
143079,children,0,0
143080,with,0,0
143081,intellectual,0,0
143082,disabilities,0,0
143083,(,0,0
143084,IDs,0,0
143085,),0,0
143086,",",0,0
143087,including,0,0
143088,children,0,0
143089,with,0,0
143090,Down,0,0
143091,syndrome,0,0
143092,and,0,0
143093,children,0,0
143094,with,0,0
143095,autism,0,0
143096,spectrum,0,0
143097,disorders,0,0
143098,.,0,0
143099,METHOD,0,0
143100,Seventy-seven,0,0
143101,children,0,0
143102,were,0,0
143103,randomly,0,0
143104,assigned,0,0
143105,to,0,0
143106,2,0,0
143107,treatments,0,0
143108,(,1,0
143109,parent,1,1
143110,+,1,1
143111,therapist,1,1
143112,EMT,1,0
143113,or,0,0
143114,therapist-only,1,1
143115,EMT,1,0
143116,),1,0
143117,and,0,0
143118,received,0,0
143119,36,0,0
143120,intervention,0,0
143121,sessions,0,1
143122,.,0,0
143123,Children,0,0
143124,were,0,0
143125,assessed,0,0
143126,before,0,0
143127,",",0,0
143128,immediately,0,0
143129,after,0,0
143130,",",0,0
143131,6,0,0
143132,months,0,0
143133,after,0,0
143134,",",0,0
143135,and,0,0
143136,12,0,0
143137,months,0,0
143138,after,0,0
143139,intervention,0,1
143140,.,0,0
143141,Separate,0,0
143142,linear,0,0
143143,regressions,0,0
143144,were,0,0
143145,conducted,0,0
143146,for,0,0
143147,each,0,0
143148,standardized,0,0
143149,and,0,0
143150,observational,0,0
143151,measure,0,0
143152,at,0,0
143153,each,0,0
143154,time,0,0
143155,point,0,0
143156,.,0,0
143157,RESULTS,0,0
143158,Parents,0,0
143159,in,0,0
143160,the,0,0
143161,parent,0,1
143162,+,0,1
143163,therapist,0,1
143164,group,0,0
143165,demonstrated,0,0
143166,greater,0,0
143167,use,0,0
143168,of,0,0
143169,EMT,1,0
143170,strategies,1,0
143171,at,0,0
143172,home,0,0
143173,than,0,0
143174,untrained,0,0
143175,parents,0,0
143176,in,0,0
143177,the,0,0
143178,therapist-only,0,1
143179,group,0,0
143180,",",0,0
143181,and,0,0
143182,these,0,0
143183,effects,0,0
143184,maintained,0,0
143185,over,0,0
143186,time,0,0
143187,.,0,0
143188,Effect,0,0
143189,sizes,0,0
143190,for,0,0
143191,observational,0,0
143192,measures,0,0
143193,ranged,0,0
143194,from,0,0
143195,d,0,0
143196,=,0,0
143197,0.10,0,0
143198,to,0,0
143199,d,0,0
143200,=,0,0
143201,1.32,0,0
143202,favoring,0,0
143203,the,0,0
143204,parent,0,1
143205,+,0,1
143206,therapist,0,1
143207,group,0,0
143208,",",0,0
143209,with,0,0
143210,the,0,0
143211,largest,0,0
143212,effect,0,0
143213,sizes,0,0
143214,found,0,0
143215,12,0,0
143216,months,0,0
143217,after,0,0
143218,intervention,0,1
143219,.,0,0
143220,CONCLUSION,0,0
143221,Findings,0,0
143222,from,0,0
143223,this,0,0
143224,study,0,0
143225,indicate,0,0
143226,generally,0,0
143227,that,0,0
143228,there,0,0
143229,are,0,0
143230,benefits,0,0
143231,to,0,0
143232,training,0,1
143233,parents,0,0
143234,to,0,0
143235,implement,0,0
143236,naturalistic,1,0
143237,language,1,0
143238,intervention,1,1
143239,strategies,1,0
143240,with,0,0
143241,preschool,0,0
143242,children,0,0
143243,who,0,0
143244,have,0,0
143245,ID,0,0
143246,and,0,0
143247,significant,0,0
143248,language,0,0
143249,impairments,0,0
143250,.,0,0
143251,[,0,0
143252,Localised,0,0
143253,prostate,0,0
143254,cancer,0,0
143255,:,0,0
143256,the,0,0
143257,PREFERE,0,0
143258,trial,0,0
143259,],0,0
143260,.,0,0
143261,Prostate,0,0
143262,cancer,0,0
143263,is,0,0
143264,the,0,0
143265,most,0,0
143266,common,0,0
143267,carcinoma,0,0
143268,of,0,0
143269,the,0,0
143270,elderly,0,0
143271,man,0,0
143272,and,0,0
143273,holds,0,0
143274,the,0,0
143275,third,0,0
143276,place,0,0
143277,in,0,0
143278,the,0,0
143279,ranking,0,0
143280,of,0,0
143281,cancer-specific,0,0
143282,mortality,0,0
143283,.,0,0
143284,However,0,0
143285,",",0,0
143286,mortality,0,0
143287,rates,0,0
143288,of,0,0
143289,3,0,0
143290,%,0,0
143291,are,0,0
143292,low,0,0
143293,",",0,0
143294,and,0,0
143295,half,0,0
143296,of,0,0
143297,the,0,0
143298,patients,0,0
143299,will,0,0
143300,die,0,0
143301,from,0,0
143302,intercurrent,0,0
143303,disease,0,0
143304,.,0,0
143305,Due,0,1
143306,to,0,0
143307,the,0,0
143308,significantly,0,0
143309,improved,0,0
143310,diagnostic,0,0
143311,methods,0,0
143312,and,0,0
143313,the,0,0
143314,increasing,0,0
143315,use,0,0
143316,of,0,0
143317,PSA,0,0
143318,screening,0,0
143319,",",0,0
143320,there,0,0
143321,has,0,0
143322,been,0,0
143323,a,0,0
143324,stage,0,0
143325,migration,0,0
143326,towards,0,0
143327,early,0,0
143328,tumour,0,0
143329,stages,0,0
143330,that,0,0
143331,are,0,0
143332,prognostically,0,0
143333,heterogeneous,0,0
143334,and,0,0
143335,require,0,0
143336,differentiated,0,0
143337,treatment,0,0
143338,.,0,0
143339,Based,0,0
143340,on,0,0
143341,the,0,0
143342,discussions,0,0
143343,of,0,0
143344,the,0,0
143345,Joint,0,0
143346,Federal,0,1
143347,Committee,0,1
143348,(,0,0
143349,G-BA,0,1
143350,),0,0
143351,and,0,0
143352,the,0,0
143353,conceptual,0,0
143354,work,0,0
143355,of,0,0
143356,the,0,0
143357,MDS,0,0
143358,",",0,0
143359,the,0,0
143360,Competence,0,0
143361,Centre,0,0
143362,Oncology,0,0
143363,of,0,0
143364,the,0,0
143365,MDK,0,0
143366,",",0,0
143367,the,0,0
143368,IQWIG,0,0
143369,and,0,0
143370,the,0,0
143371,National,0,0
143372,Association,0,0
143373,of,0,0
143374,Statutory,0,1
143375,Health,0,0
143376,Insurance,0,1
143377,Funds,0,0
143378,(,0,0
143379,GKV-Spitzenverband,0,1
143380,),0,0
143381,",",0,0
143382,a,0,0
143383,prospective,0,0
143384,randomised,0,0
143385,multicentre,0,0
143386,trial,0,0
143387,was,0,0
143388,developed,0,0
143389,comparing,0,0
143390,the,0,0
143391,four,0,0
143392,treatments,0,0
143393,actually,0,0
143394,recommended,0,0
143395,by,0,0
143396,the,0,0
143397,German,0,1
143398,and,0,0
143399,European,0,0
143400,guidelines,0,0
143401,for,0,0
143402,localised,0,0
143403,prostate,0,0
143404,cancer,0,0
143405,(,1,0
143406,radical,1,1
143407,prostatectomy,1,1
143408,",",1,0
143409,percutaneous,1,1
143410,radiotherapy,1,1
143411,and,1,0
143412,permanent,1,0
143413,seed,1,1
143414,implantation,1,1
143415,and,1,0
143416,active,1,1
143417,surveillance,1,0
143418,),1,0
143419,allowing,0,0
143420,a,0,0
143421,rejection,0,0
143422,of,0,0
143423,one,0,0
143424,or,0,0
143425,two,0,0
143426,treatment,0,0
143427,options,0,0
143428,.,0,0
143429,The,0,0
143430,trial,0,0
143431,is,0,0
143432,expected,0,0
143433,to,0,0
143434,start,0,0
143435,at,0,0
143436,the,0,0
143437,beginning,0,0
143438,of,0,0
143439,next,0,0
143440,year,0,0
143441,.,0,0
143442,In,0,0
143443,vitro,0,0
143444,biocompatibility,0,0
143445,tests,0,0
143446,of,0,0
143447,glass,0,1
143448,ionomer,0,1
143449,cements,0,1
143450,impregnated,0,1
143451,with,0,0
143452,collagen,0,0
143453,or,0,1
143454,bioactive,0,1
143455,glass,0,1
143456,to,0,0
143457,fibroblasts,0,0
143458,.,0,0
143459,AIM,0,0
143460,AND,0,0
143461,DESIGN,0,0
143462,To,0,0
143463,evaluate,0,0
143464,the,0,0
143465,biocompatibility,0,0
143466,of,0,0
143467,glass,0,1
143468,ionomer,0,1
143469,cement,0,1
143470,(,0,0
143471,GIC,0,0
143472,),0,0
143473,impregnated,0,1
143474,with,0,0
143475,collagen,0,0
143476,or,0,1
143477,bioactive,0,1
143478,glass,0,1
143479,to,0,0
143480,BHK-21,0,0
143481,fibroblasts,0,0
143482,in,0,0
143483,vitro,0,0
143484,.,0,0
143485,Mineral,0,0
143486,Trioxide,0,1
143487,Aggregate,0,0
143488,was,0,0
143489,used,0,0
143490,as,0,0
143491,the,0,0
143492,standard,0,1
143493,for,0,0
143494,comparison,0,0
143495,.,0,0
143496,Human,0,0
143497,maxillary,0,0
143498,central,0,0
143499,incisors,0,0
143500,(,0,0
143501,n,0,0
143502,=,0,0
143503,70,0,0
143504,),0,0
143505,were,0,0
143506,instrumented,0,0
143507,with,0,0
143508,a,0,0
143509,rotary,0,1
143510,NiTi,0,1
143511,system,0,1
143512,and,0,0
143513,filled,0,0
143514,.,0,0
143515,Following,0,0
143516,resection,0,0
143517,of,0,0
143518,the,0,0
143519,apical,0,0
143520,3mm,0,0
143521,",",0,0
143522,root,0,0
143523,end,0,0
143524,cavities,0,1
143525,were,0,0
143526,prepared,0,1
143527,and,0,0
143528,restored,0,0
143529,with,0,0
143530,conventional,1,1
143531,GIC,1,0
143532,(,1,0
143533,group,1,0
143534,1,1,0
143535,),1,0
143536,or,1,0
143537,GIC,1,0
143538,with,1,0
143539,0.01,1,0
143540,%,1,0
143541,",",1,0
143542,0.1,1,0
143543,%,1,0
143544,or,1,0
143545,1,1,0
143546,%,1,0
143547,collagen,1,1
143548,(,1,0
143549,groups,1,0
143550,2,1,0
143551,",",1,0
143552,3,1,0
143553,",",1,0
143554,4,1,0
143555,respectively,1,0
143556,),1,0
143557,or,1,0
143558,",",1,0
143559,10,1,0
143560,%,1,0
143561,",",1,0
143562,30,1,0
143563,%,1,0
143564,or,1,0
143565,50,1,0
143566,%,1,0
143567,bioactive,1,1
143568,glass,1,1
143569,(,1,0
143570,groups,1,0
143571,5,1,0
143572,",",1,0
143573,6,1,0
143574,",",1,0
143575,7,1,0
143576,respectively,1,0
143577,),1,0
143578,",",1,0
143579,or,1,1
143580,Mineral,1,1
143581,Trioxide,1,1
143582,Aggregate,1,1
143583,(,1,0
143584,group,1,0
143585,8,1,0
143586,),1,0
143587,.,1,0
143588,The,0,0
143589,root,0,0
143590,slices,0,0
143591,were,0,0
143592,incubated,0,0
143593,in,0,0
143594,tissue,0,0
143595,culture,0,0
143596,plates,0,1
143597,with,0,0
143598,BHK-21,0,0
143599,fibroblast,0,0
143600,cell,0,0
143601,line,0,0
143602,.,0,0
143603,Phase,0,0
143604,contrast,0,0
143605,and,0,0
143606,scanning,0,1
143607,electron,0,1
143608,microscopes,0,1
143609,were,0,0
143610,used,0,0
143611,to,0,0
143612,score,0,0
143613,cell,0,0
143614,quantity,0,0
143615,",",0,0
143616,morphology,0,0
143617,and,0,0
143618,cell,0,0
143619,attachment,0,0
143620,.,0,0
143621,The,0,0
143622,data,0,0
143623,were,0,0
143624,statistically,0,0
143625,analyzed,0,0
143626,by,0,0
143627,one,0,0
143628,way,0,0
143629,ANOVA,0,1
143630,with,0,0
143631,Post,0,1
143632,Hoc,0,0
143633,Tukey,0,1
143634,HSD,0,1
143635,test,0,1
143636,(,0,0
143637,p,0,0
143638,=,0,0
143639,0.05,0,0
143640,),0,0
143641,.,0,0
143642,RESULTS,0,0
143643,AND,0,0
143644,CONCLUSIONS,0,0
143645,Group,0,0
143646,5,0,0
143647,showed,0,0
143648,the,0,0
143649,highest,0,0
143650,scores,0,0
143651,which,0,0
143652,was,0,0
143653,significantly,0,0
143654,higher,0,0
143655,than,0,0
143656,all,0,0
143657,other,0,0
143658,groups,0,0
143659,(,0,0
143660,p,0,0
143661,<,0,0
143662,0.05,0,0
143663,),0,0
143664,except,0,0
143665,group,0,0
143666,8,0,0
143667,",",0,0
143668,with,0,0
143669,which,0,0
143670,there,0,0
143671,was,0,0
143672,no,0,0
143673,significant,0,0
143674,difference,0,0
143675,(,0,0
143676,p,0,0
143677,>,0,0
143678,0.05,0,0
143679,),0,0
143680,.,0,0
143681,Glass,0,0
143682,ionomer,0,1
143683,cement,0,1
143684,with,0,0
143685,10,0,0
143686,%,0,0
143687,bioactive,0,0
143688,glass,0,1
143689,showed,0,0
143690,better,0,0
143691,adhesion,0,0
143692,and,0,0
143693,spreading,0,0
143694,of,0,0
143695,cells,0,0
143696,than,0,0
143697,glass,0,1
143698,ionomer,0,1
143699,cement,0,1
143700,with,0,0
143701,0.01,0,0
143702,%,0,0
143703,collagen,0,0
143704,.,0,0
143705,The,0,0
143706,biocompatibility,0,0
143707,of,0,0
143708,collagen,0,0
143709,and,0,0
143710,bioactive,0,1
143711,glass,0,1
143712,was,0,0
143713,concentration,0,0
143714,dependent,0,0
143715,.,0,0
143716,The,0,0
143717,addition,0,0
143718,of,0,0
143719,bioactive,0,0
143720,glass,0,1
143721,improved,0,0
143722,the,0,0
143723,biocompatibility,0,0
143724,of,0,0
143725,glass,0,1
143726,ionomer,0,1
143727,cement,0,1
143728,to,0,0
143729,fibroblasts,0,0
143730,better,0,0
143731,than,0,0
143732,addition,0,0
143733,of,0,0
143734,collagen,0,0
143735,.,0,0
143736,Effect,0,0
143737,of,0,0
143738,rosuvastatin,1,1
143739,monotherapy,1,1
143740,or,1,1
143741,in,1,0
143742,combination,1,1
143743,with,1,0
143744,fenofibrate,1,1
143745,or,1,1
143746,?-3,1,1
143747,fatty,1,1
143748,acids,1,1
143749,on,1,0
143750,lipoprotein,1,0
143751,subfraction,0,0
143752,profile,0,0
143753,in,0,0
143754,patients,0,0
143755,with,0,0
143756,mixed,0,0
143757,dyslipidaemia,0,0
143758,and,0,0
143759,metabolic,0,0
143760,syndrome,0,0
143761,.,0,0
143762,BACKGROUND,0,0
143763,Raised,0,0
143764,triglycerides,0,0
143765,(,0,0
143766,TG,0,0
143767,),0,0
143768,",",0,0
143769,decreased,0,0
143770,high-density,0,0
143771,lipoprotein,0,0
143772,cholesterol,0,0
143773,(,0,0
143774,HDL-C,0,1
143775,),0,0
143776,levels,0,0
143777,and,0,0
143778,a,0,0
143779,predominance,0,0
143780,of,0,0
143781,small,0,0
143782,dense,0,0
143783,low,0,0
143784,density,0,0
143785,lipoproteins,0,0
143786,(,0,0
143787,sdLDL,0,0
143788,),0,0
143789,are,0,0
143790,characteristics,0,0
143791,of,0,0
143792,the,0,0
143793,metabolic,0,0
143794,syndrome,0,0
143795,(,0,0
143796,MetS,0,0
143797,),0,0
143798,.,0,0
143799,OBJECTIVE,0,0
143800,To,0,0
143801,compare,0,0
143802,the,0,0
143803,effect,0,0
143804,of,0,0
143805,high-dose,1,1
143806,rosuvastatin,1,1
143807,monotherapy,1,1
143808,with,0,0
143809,moderate,0,0
143810,dosing,1,0
143811,combined,1,1
143812,with,1,0
143813,fenofibrate,1,1
143814,or,1,1
143815,?-3,1,1
143816,fatty,1,1
143817,acids,1,1
143818,on,1,0
143819,the,1,0
143820,lipoprotein,1,0
143821,subfraction,1,0
143822,profile,0,0
143823,in,0,0
143824,patients,0,0
143825,with,0,0
143826,mixed,0,0
143827,dyslipidaemia,0,0
143828,and,0,0
143829,MetS,0,0
143830,.,0,0
143831,METHODS,0,0
143832,We,0,0
143833,previously,0,0
143834,randomised,0,0
143835,patients,0,0
143836,with,0,0
143837,low-density,0,0
143838,lipoprotein,0,0
143839,cholesterol,0,0
143840,(,0,0
143841,LDL-C,0,0
143842,),0,1
143843,>,0,0
143844,160,0,0
143845,and,0,0
143846,TG,0,0
143847,>,0,0
143848,200,1,1
143849,mg/dl,1,0
143850,to,1,0
143851,rosuvastatin,1,1
143852,monotherapy,1,1
143853,40,1,0
143854,mg/day,1,0
143855,(,1,0
143856,R,1,0
143857,group,1,0
143858,",",0,0
143859,n,0,0
143860,=,0,0
143861,30,0,0
143862,),0,0
143863,or,0,0
143864,rosuvastatin,1,1
143865,10,1,0
143866,mg/day,1,0
143867,combined,1,0
143868,with,1,0
143869,fenofibrate,1,1
143870,200,1,1
143871,mg/day,1,0
143872,(,1,0
143873,RF,1,0
143874,group,1,0
143875,",",0,0
143876,n,0,0
143877,=,0,0
143878,30,0,0
143879,),0,0
143880,or,0,0
143881,?-3,1,1
143882,fatty,1,1
143883,acids,1,1
143884,2,0,0
143885,g/day,0,0
143886,(,0,0
143887,R?,1,0
143888,group,1,0
143889,",",0,0
143890,n,0,0
143891,=,0,0
143892,30,0,0
143893,),0,0
143894,.,0,0
143895,In,0,0
143896,the,0,0
143897,present,0,0
143898,study,0,0
143899,",",0,0
143900,only,0,0
143901,patients,0,0
143902,with,0,0
143903,MetS,0,0
143904,were,0,0
143905,included,0,0
143906,(,0,0
143907,24,0,0
143908,",",0,0
143909,23,0,0
143910,and,0,0
143911,24,0,0
143912,in,0,0
143913,the,0,0
143914,R,0,0
143915,",",0,0
143916,RF,0,0
143917,and,0,0
143918,R?,0,0
143919,groups,0,0
143920,respectively,0,0
143921,),0,0
143922,.,0,0
143923,At,0,0
143924,baseline,0,0
143925,and,0,0
143926,after,0,0
143927,12,0,0
143928,weeks,0,0
143929,of,0,0
143930,treatment,0,0
143931,",",0,0
143932,the,0,0
143933,lipoprotein,0,0
143934,subfraction,0,0
143935,profile,0,0
143936,was,0,0
143937,determined,0,0
143938,by,0,0
143939,polyacrylamide,0,1
143940,3,0,0
143941,%,0,0
143942,gel,0,1
143943,electrophoresis,0,0
143944,.,0,0
143945,RESULTS,0,0
143946,The,0,0
143947,mean,0,0
143948,LDL,0,0
143949,size,0,0
143950,was,0,0
143951,significantly,0,0
143952,increased,0,0
143953,in,0,0
143954,all,0,0
143955,groups,0,0
143956,.,0,0
143957,This,0,0
143958,change,0,0
143959,was,0,0
143960,more,0,0
143961,prominent,0,0
143962,with,1,0
143963,RF,1,0
143964,than,0,0
143965,with,0,0
143966,other,0,0
143967,treatments,0,0
143968,in,0,0
143969,parallel,0,0
143970,with,0,0
143971,its,0,0
143972,greater,0,0
143973,hypotriglyceridemic,0,0
143974,capacity,0,0
143975,(,0,0
143976,p,0,0
143977,<,0,0
143978,0.05,0,0
143979,compared,0,0
143980,with,0,0
143981,R,0,0
143982,and,0,0
143983,R?,0,0
143984,),0,0
143985,.,0,0
143986,A,0,0
143987,decrease,0,0
143988,in,0,0
143989,insulin,0,1
143990,resistance,0,0
143991,by,0,0
143992,RF,0,0
143993,was,0,0
143994,also,0,0
143995,noted,0,0
143996,.,0,0
143997,Only,1,0
143998,RF,1,0
143999,significantly,0,0
144000,raised,0,0
144001,HDL-C,0,0
144002,levels,0,0
144003,(,0,0
144004,by,0,0
144005,7.7,0,0
144006,%,0,0
144007,",",0,0
144008,p,0,0
144009,<,0,0
144010,0.05,0,0
144011,),0,0
144012,by,0,0
144013,increasing,0,0
144014,the,0,0
144015,cholesterol,0,0
144016,of,0,0
144017,small,0,0
144018,HDL,0,0
144019,particles,0,0
144020,.,0,0
144021,The,0,0
144022,cholesterol,0,0
144023,of,0,0
144024,larger,0,0
144025,HDL,0,0
144026,subclasses,0,0
144027,was,0,0
144028,significantly,0,0
144029,increased,0,0
144030,by,1,0
144031,R,1,0
144032,and,1,0
144033,R?,1,0
144034,.,1,0
144035,CONCLUSIONS,0,0
144036,All,0,0
144037,regimens,0,1
144038,increased,0,0
144039,mean,0,0
144040,LDL,0,0
144041,size,0,0
144042,;,0,0
144043,RF,0,0
144044,was,0,0
144045,the,0,0
144046,most,0,0
144047,effective,0,0
144048,.,0,0
144049,A,0,0
144050,differential,0,0
144051,effect,0,0
144052,of,0,0
144053,treatments,0,0
144054,was,0,0
144055,noted,0,0
144056,on,0,0
144057,the,0,0
144058,HDL,0,1
144059,subfraction,0,0
144060,profile,0,0
144061,.,0,0
144062,Is,0,0
144063,EEG-biofeedback,1,0
144064,an,0,0
144065,effective,0,0
144066,treatment,0,0
144067,in,0,0
144068,autism,0,0
144069,spectrum,0,0
144070,disorders,0,0
144071,?,0,0
144072,A,0,0
144073,randomized,0,0
144074,controlled,0,0
144075,trial,0,0
144076,.,0,0
144077,EEG-biofeedback,1,1
144078,has,0,0
144079,been,0,0
144080,reported,0,0
144081,to,0,0
144082,reduce,0,0
144083,symptoms,0,0
144084,of,0,0
144085,autism,0,0
144086,spectrum,0,0
144087,disorders,0,0
144088,(,0,0
144089,ASD,0,0
144090,),0,0
144091,in,0,0
144092,several,0,0
144093,studies,0,0
144094,.,0,0
144095,However,0,0
144096,",",0,0
144097,these,0,0
144098,studies,0,0
144099,did,0,0
144100,not,0,0
144101,control,0,0
144102,for,0,0
144103,nonspecific,0,0
144104,effects,0,0
144105,of,0,0
144106,EEG-biofeedback,1,1
144107,and,0,0
144108,did,0,0
144109,not,0,0
144110,distinguish,0,0
144111,between,0,0
144112,participants,0,0
144113,who,0,0
144114,succeeded,0,0
144115,in,0,0
144116,influencing,0,0
144117,their,0,0
144118,own,0,0
144119,EEG,0,1
144120,activity,0,0
144121,and,0,0
144122,participants,0,0
144123,who,0,0
144124,did,0,0
144125,not,0,0
144126,.,0,0
144127,To,0,0
144128,overcome,0,0
144129,these,0,0
144130,methodological,0,0
144131,shortcomings,0,0
144132,",",0,0
144133,this,0,0
144134,study,0,0
144135,evaluated,0,0
144136,the,0,0
144137,effects,0,0
144138,of,0,0
144139,EEG-biofeedback,0,1
144140,in,0,0
144141,ASD,0,0
144142,in,0,0
144143,a,0,0
144144,randomized,0,0
144145,pretest-posttest,0,0
144146,control,0,1
144147,group,0,0
144148,design,0,0
144149,with,0,0
144150,blinded,0,0
144151,active,0,0
144152,comparator,0,0
144153,and,0,0
144154,six,0,0
144155,months,0,0
144156,follow-up,0,0
144157,.,0,0
144158,Thirty-eight,0,0
144159,participants,0,0
144160,were,0,0
144161,randomly,0,0
144162,allocated,0,0
144163,to,0,0
144164,the,0,0
144165,EEG-biofeedback,1,1
144166,",",1,0
144167,skin,1,0
144168,conductance,1,0
144169,(,1,0
144170,SC,1,1
144171,),1,1
144172,-biofeedback,1,1
144173,or,0,1
144174,waiting,0,0
144175,list,0,0
144176,group,0,0
144177,.,0,0
144178,EEG-,1,0
144179,and,1,0
144180,SC-biofeedback,1,1
144181,sessions,0,1
144182,were,0,0
144183,similar,0,0
144184,and,0,0
144185,participants,0,0
144186,were,0,0
144187,blinded,0,0
144188,to,0,0
144189,the,0,0
144190,type,0,0
144191,of,0,0
144192,feedback,0,1
144193,they,0,0
144194,received,0,0
144195,.,0,0
144196,Assessments,0,0
144197,pre-treatment,0,0
144198,",",0,0
144199,post-treatment,0,0
144200,",",0,0
144201,and,0,0
144202,after,0,0
144203,6,0,0
144204,months,0,0
144205,included,0,0
144206,parent,0,0
144207,ratings,0,0
144208,of,0,0
144209,symptoms,0,0
144210,of,0,0
144211,ASD,0,0
144212,",",0,0
144213,executive,0,0
144214,function,0,0
144215,tasks,0,1
144216,",",0,0
144217,and,0,0
144218,19-channel,0,1
144219,EEG,0,0
144220,recordings,0,0
144221,.,0,0
144222,Fifty-four,0,0
144223,percent,0,0
144224,of,0,0
144225,the,0,0
144226,participants,0,0
144227,significantly,0,0
144228,reduced,0,0
144229,delta,0,0
144230,and/or,0,0
144231,theta,0,0
144232,power,0,0
144233,during,0,0
144234,EEG-biofeedback,1,1
144235,sessions,1,1
144236,and,0,0
144237,were,0,0
144238,identified,0,0
144239,as,0,0
144240,EEG-regulators,0,0
144241,.,0,0
144242,In,0,0
144243,these,0,0
144244,EEG-regulators,0,0
144245,",",0,0
144246,no,0,0
144247,statistically,0,0
144248,significant,0,0
144249,reductions,0,0
144250,of,0,0
144251,symptoms,0,0
144252,of,0,0
144253,ASD,0,0
144254,were,0,0
144255,observed,0,0
144256,",",0,0
144257,but,0,0
144258,they,0,0
144259,showed,0,0
144260,significant,0,0
144261,improvement,0,0
144262,in,0,0
144263,cognitive,0,0
144264,flexibility,0,0
144265,as,0,0
144266,compared,0,0
144267,to,0,0
144268,participants,0,0
144269,who,0,0
144270,managed,0,0
144271,to,0,0
144272,regulate,0,0
144273,SC,0,1
144274,.,0,0
144275,EEG-biofeedback,0,1
144276,seems,0,0
144277,to,0,0
144278,be,0,0
144279,an,0,0
144280,applicable,0,0
144281,tool,0,0
144282,to,0,0
144283,regulate,0,0
144284,EEG,0,1
144285,activity,0,0
144286,and,0,0
144287,has,0,0
144288,specific,0,0
144289,effects,0,0
144290,on,0,0
144291,cognitive,0,0
144292,flexibility,0,0
144293,",",0,0
144294,but,0,0
144295,it,0,0
144296,did,0,0
144297,not,0,0
144298,result,0,0
144299,in,0,0
144300,significant,0,0
144301,reductions,0,0
144302,in,0,0
144303,symptoms,0,0
144304,of,0,0
144305,ASD,0,0
144306,.,0,0
144307,An,0,0
144308,important,0,0
144309,finding,0,0
144310,was,0,0
144311,that,0,0
144312,no,0,0
144313,nonspecific,0,0
144314,effects,0,0
144315,of,0,0
144316,EEG-biofeedback,1,1
144317,were,0,0
144318,demonstrated,0,0
144319,.,0,0
144320,Computer-delivered,1,1
144321,tailored,1,1
144322,intervention,1,1
144323,improves,0,0
144324,colon,0,0
144325,cancer,0,0
144326,screening,0,1
144327,knowledge,0,0
144328,and,0,0
144329,health,0,0
144330,beliefs,0,1
144331,of,0,0
144332,African-Americans,0,0
144333,.,0,0
144334,We,0,0
144335,conducted,0,0
144336,a,0,0
144337,randomized,0,0
144338,controlled,0,0
144339,trial,0,0
144340,among,0,0
144341,African-American,0,0
144342,patients,0,0
144343,attending,0,0
144344,a,0,0
144345,primary-care,0,0
144346,provider,0,1
144347,visit,0,0
144348,to,0,0
144349,compare,0,0
144350,efficacy,0,0
144351,of,0,0
144352,a,0,0
144353,computer-delivered,1,1
144354,tailored,1,1
144355,intervention,1,1
144356,to,0,0
144357,increase,0,0
144358,colorectal,0,0
144359,cancer,0,0
144360,(,0,0
144361,CRC,0,1
144362,),0,1
144363,screening,0,1
144364,(,0,0
144365,n,0,0
144366,=,0,0
144367,273,0,0
144368,),0,0
144369,with,0,0
144370,non-tailored,1,1
144371,print,1,1
144372,material-an,1,0
144373,American,0,0
144374,Cancer,0,0
144375,Society,0,0
144376,brochure,0,1
144377,on,0,0
144378,CRC,0,1
144379,screening,0,1
144380,(,0,0
144381,n,0,0
144382,=,0,0
144383,283,0,0
144384,),0,0
144385,.,0,0
144386,Health,0,0
144387,Belief,0,0
144388,Model,0,0
144389,constructs,0,0
144390,were,0,0
144391,used,0,0
144392,to,0,0
144393,develop,0,0
144394,tailored,0,1
144395,messages,0,1
144396,and,0,0
144397,examined,0,0
144398,as,0,0
144399,outcomes,0,0
144400,.,0,0
144401,Analysis,0,0
144402,of,0,0
144403,covariance,0,0
144404,models,0,0
144405,were,0,0
144406,used,0,0
144407,to,0,0
144408,compare,0,0
144409,changes,0,0
144410,between,0,0
144411,CRC,0,1
144412,knowledge,0,0
144413,and,0,0
144414,health,0,0
144415,belief,0,0
144416,scores,0,0
144417,at,0,0
144418,baseline,0,0
144419,and,0,0
144420,1,0,0
144421,week,0,0
144422,post-intervention,0,0
144423,.,0,0
144424,At,0,0
144425,1,0,0
144426,week,0,0
144427,",",0,0
144428,patients,0,0
144429,who,0,0
144430,received,0,0
144431,the,0,0
144432,computer-delivered,1,1
144433,tailored,1,1
144434,intervention,1,0
144435,had,0,0
144436,greater,0,0
144437,changes,0,0
144438,in,0,0
144439,CRC,0,1
144440,knowledge,0,0
144441,scores,0,0
144442,(,0,0
144443,P,0,0
144444,<,0,0
144445,0.001,0,0
144446,),0,0
144447,",",0,0
144448,perceived,0,0
144449,CRC,0,1
144450,risk,0,0
144451,scores,0,0
144452,(,0,0
144453,P,0,0
144454,=,0,0
144455,0.005,0,0
144456,),0,0
144457,",",0,0
144458,FOBT,0,1
144459,barriers,0,0
144460,scores,0,0
144461,(,0,0
144462,P,0,0
144463,=,0,0
144464,0.034,0,0
144465,),0,0
144466,and,0,0
144467,colonoscopy,0,1
144468,benefit,0,0
144469,scores,0,0
144470,(,0,0
144471,P,0,0
144472,<,0,0
144473,0.001,0,0
144474,),0,0
144475,.,0,0
144476,Findings,0,0
144477,show,0,0
144478,that,0,0
144479,computer-delivered,0,1
144480,tailored,0,1
144481,interventions,0,0
144482,are,0,0
144483,an,0,0
144484,effective,0,0
144485,adjunct,0,0
144486,to,0,0
144487,the,0,0
144488,clinical,0,0
144489,encounter,0,0
144490,that,0,0
144491,can,0,0
144492,improve,0,0
144493,knowledge,0,0
144494,and,0,0
144495,health,0,0
144496,beliefs,0,1
144497,about,0,0
144498,CRC,0,1
144499,screening,0,0
144500,",",0,0
144501,necessary,0,0
144502,precursors,0,0
144503,to,0,0
144504,behavior,0,0
144505,change,0,0
144506,.,0,0
144507,A,0,0
144508,prospective,0,0
144509,",",0,0
144510,randomized,0,0
144511,",",0,0
144512,double,0,0
144513,dummy,0,0
144514,",",0,0
144515,placebo-controlled,0,1
144516,trial,0,0
144517,of,0,0
144518,oral,0,0
144519,cefditoren,1,1
144520,pivoxil,1,1
144521,400mg,0,0
144522,once,0,0
144523,daily,0,0
144524,as,0,0
144525,switch,0,0
144526,therapy,0,1
144527,after,0,0
144528,intravenous,0,1
144529,ceftriaxone,0,1
144530,in,0,0
144531,the,0,0
144532,treatment,0,0
144533,of,0,0
144534,acute,0,0
144535,pyelonephritis,0,0
144536,.,0,0
144537,OBJECTIVES,0,0
144538,To,0,0
144539,compare,0,0
144540,the,0,0
144541,clinical,0,0
144542,and,0,0
144543,bacteriological,0,0
144544,effectiveness,0,0
144545,of,0,0
144546,intravenous,0,1
144547,(,0,0
144548,IV,0,0
144549,),0,0
144550,ceftriaxone,1,1
144551,followed,0,0
144552,by,0,0
144553,oral,0,0
144554,cefditoren,1,1
144555,pivoxil,1,1
144556,or,0,0
144557,IV,1,0
144558,ceftriaxone,1,1
144559,for,0,0
144560,acute,0,0
144561,pyelonephritis,0,0
144562,.,0,0
144563,METHODS,0,0
144564,A,0,0
144565,prospective,0,0
144566,randomized,0,0
144567,controlled,0,0
144568,trial,0,0
144569,of,0,0
144570,patients,0,0
144571,with,0,0
144572,a,0,0
144573,presumptive,0,0
144574,diagnosis,0,0
144575,of,0,0
144576,acute,0,0
144577,pyelonephritis,0,0
144578,was,0,0
144579,performed,0,0
144580,.,0,0
144581,Daily,0,0
144582,2g,1,1
144583,IV,1,0
144584,ceftriaxone,1,1
144585,was,0,0
144586,initially,0,0
144587,given,0,0
144588,to,0,0
144589,all,0,0
144590,patients,0,0
144591,.,0,0
144592,After,0,0
144593,day,0,0
144594,3,0,0
144595,",",0,0
144596,patients,0,0
144597,who,0,0
144598,satisfied,0,0
144599,the,0,0
144600,criteria,0,0
144601,for,0,0
144602,switch,0,0
144603,therapy,0,1
144604,were,0,0
144605,randomized,0,0
144606,to,0,0
144607,either,0,0
144608,group,0,0
144609,A,0,0
144610,(,1,0
144611,IV,1,0
144612,ceftriaxone,1,1
144613,),1,0
144614,or,0,1
144615,group,1,1
144616,B,1,1
144617,(,1,0
144618,oral,1,1
144619,cefditoren,1,1
144620,pivoxil,1,1
144621,400mg,1,0
144622,once,0,0
144623,daily,0,0
144624,),0,0
144625,.,0,0
144626,RESULTS,0,0
144627,Eighty-two,0,0
144628,patients,0,0
144629,were,0,0
144630,enrolled,0,0
144631,;,0,0
144632,41,0,0
144633,(,0,0
144634,50,0,0
144635,%,0,0
144636,),0,0
144637,patients,0,0
144638,in,0,0
144639,group,0,0
144640,A,0,0
144641,and,0,0
144642,41,0,0
144643,(,0,0
144644,50,0,0
144645,%,0,0
144646,),0,0
144647,patients,0,0
144648,in,0,0
144649,group,0,0
144650,B,0,0
144651,were,0,0
144652,evaluated,0,0
144653,.,0,0
144654,There,0,0
144655,was,0,0
144656,no,0,0
144657,statistically,0,0
144658,significant,0,0
144659,difference,0,0
144660,in,0,0
144661,baseline,0,0
144662,characteristics,0,0
144663,between,0,0
144664,the,0,0
144665,two,0,0
144666,groups,0,0
144667,.,0,0
144668,Clinical,0,0
144669,cure,0,0
144670,was,0,0
144671,observed,0,0
144672,in,0,0
144673,39,0,0
144674,of,0,0
144675,41,0,0
144676,(,0,0
144677,95.1,0,0
144678,%,0,0
144679,),0,0
144680,patients,0,0
144681,in,0,0
144682,group,0,0
144683,A,0,0
144684,and,0,0
144685,41,0,0
144686,of,0,0
144687,41,0,0
144688,(,0,0
144689,100,0,1
144690,%,0,0
144691,),0,0
144692,patients,0,0
144693,in,0,0
144694,group,0,0
144695,B,0,1
144696,(,0,0
144697,p=0.15,0,0
144698,",",0,0
144699,95,0,0
144700,%,0,0
144701,confidence,0,0
144702,interval,0,0
144703,(,0,0
144704,CI,0,0
144705,),0,0
144706,-0.12,0,0
144707,to,0,0
144708,0.02,0,0
144709,),0,0
144710,.,0,0
144711,Urine,0,1
144712,bacteriological,0,0
144713,eradication,0,0
144714,was,0,0
144715,found,0,0
144716,in,0,0
144717,63.4,0,0
144718,%,0,0
144719,in,0,0
144720,group,0,0
144721,A,0,0
144722,and,0,0
144723,60,0,0
144724,%,0,0
144725,in,0,0
144726,group,0,0
144727,B,0,1
144728,(,0,0
144729,p=0.75,0,0
144730,",",0,0
144731,95,0,0
144732,%,0,0
144733,CI,0,0
144734,-0.18,0,0
144735,to,0,0
144736,0.25,0,0
144737,),0,0
144738,.,0,0
144739,There,0,0
144740,was,0,0
144741,no,0,0
144742,statistically,0,0
144743,significant,0,0
144744,difference,0,0
144745,in,0,0
144746,adverse,0,0
144747,effects,0,0
144748,between,0,0
144749,the,0,0
144750,two,0,0
144751,treatment,0,0
144752,groups,0,0
144753,.,0,0
144754,CONCLUSION,0,0
144755,These,0,0
144756,data,0,0
144757,suggest,0,0
144758,that,0,0
144759,IV,0,0
144760,ceftriaxone,1,1
144761,followed,0,0
144762,by,0,0
144763,oral,0,1
144764,cefditoren,1,1
144765,pivoxil,1,1
144766,is,0,0
144767,highly,0,0
144768,effective,0,0
144769,and,0,0
144770,well-tolerated,0,0
144771,for,0,0
144772,the,0,0
144773,treatment,0,0
144774,of,0,0
144775,acute,0,0
144776,pyelonephritis,0,0
144777,",",0,0
144778,even,0,0
144779,for,0,0
144780,uropathogens,0,0
144781,with,0,0
144782,a,0,0
144783,high,0,0
144784,proportion,0,0
144785,of,0,0
144786,quinolone-resistant,0,0
144787,strains,0,0
144788,.,0,0
144789,Mindfulness-based,1,1
144790,therapy,1,1
144791,in,0,0
144792,adults,0,0
144793,with,0,0
144794,an,0,0
144795,autism,0,0
144796,spectrum,0,0
144797,disorder,0,0
144798,:,0,0
144799,a,0,0
144800,randomized,0,0
144801,controlled,0,0
144802,trial,0,0
144803,.,0,0
144804,Research,0,0
144805,shows,0,0
144806,that,0,0
144807,depression,0,0
144808,and,0,0
144809,anxiety,0,0
144810,disorders,0,0
144811,are,0,0
144812,the,0,0
144813,most,0,0
144814,common,0,0
144815,psychiatric,0,0
144816,concern,0,0
144817,in,0,0
144818,autism,0,0
144819,spectrum,0,0
144820,disorders,0,0
144821,(,0,0
144822,ASD,0,0
144823,),0,0
144824,.,0,0
144825,Mindfulness-based,1,1
144826,therapy,1,1
144827,(,1,0
144828,MBT,1,1
144829,),1,1
144830,has,0,0
144831,been,0,0
144832,found,0,0
144833,effective,0,0
144834,in,0,0
144835,reducing,0,0
144836,anxiety,0,0
144837,and,0,0
144838,depression,0,0
144839,symptoms,0,0
144840,",",0,0
144841,however,0,0
144842,research,0,0
144843,in,0,0
144844,autism,0,0
144845,is,0,0
144846,limited,0,0
144847,.,0,0
144848,Therefore,0,0
144849,",",0,0
144850,we,0,0
144851,examined,0,0
144852,the,0,0
144853,effects,0,0
144854,of,0,0
144855,a,0,0
144856,modified,1,0
144857,MBT,1,1
144858,protocol,1,1
144859,(,1,0
144860,MBT-AS,1,0
144861,),1,0
144862,in,0,0
144863,high-functioning,0,0
144864,adults,0,0
144865,with,0,0
144866,ASD,0,0
144867,.,0,0
144868,42,0,0
144869,participants,0,0
144870,were,0,0
144871,randomized,0,0
144872,into,0,0
144873,a,0,0
144874,9-week,0,0
144875,MBT-AS,1,0
144876,training,1,1
144877,or,0,1
144878,a,0,0
144879,wait-list,1,1
144880,control,1,0
144881,group,1,0
144882,.,1,0
144883,Results,0,0
144884,showed,0,0
144885,a,0,0
144886,significant,0,0
144887,reduction,0,0
144888,in,0,0
144889,depression,0,0
144890,",",0,0
144891,anxiety,0,0
144892,and,0,0
144893,rumination,0,0
144894,in,0,0
144895,the,0,0
144896,intervention,0,1
144897,group,0,0
144898,",",0,0
144899,as,0,0
144900,opposed,0,0
144901,to,0,0
144902,the,0,0
144903,control,0,0
144904,group,0,0
144905,.,0,0
144906,Furthermore,0,0
144907,",",0,0
144908,positive,0,0
144909,affect,0,0
144910,increased,0,0
144911,in,0,0
144912,the,0,0
144913,intervention,0,1
144914,group,0,0
144915,",",0,0
144916,but,0,0
144917,not,0,0
144918,in,0,0
144919,the,0,0
144920,control,0,0
144921,group,0,0
144922,.,0,0
144923,Concluding,0,0
144924,",",0,0
144925,the,0,0
144926,present,0,0
144927,study,0,0
144928,is,0,0
144929,the,0,0
144930,first,0,0
144931,controlled,0,0
144932,trial,0,0
144933,to,0,0
144934,demonstrate,0,0
144935,that,0,0
144936,adults,0,0
144937,with,0,0
144938,ASD,0,0
144939,can,0,0
144940,benefit,0,0
144941,from,0,0
144942,MBT-AS,1,0
144943,.,1,0
144944,Preschool,0,0
144945,based,0,0
144946,JASPER,1,0
144947,intervention,1,1
144948,in,0,0
144949,minimally,0,0
144950,verbal,0,0
144951,children,0,0
144952,with,0,0
144953,autism,0,0
144954,:,0,0
144955,pilot,0,0
144956,RCT,0,0
144957,.,0,0
144958,In,0,0
144959,this,0,0
144960,pilot,0,0
144961,study,0,0
144962,",",0,0
144963,we,0,0
144964,tested,0,0
144965,the,0,0
144966,effects,0,0
144967,of,0,0
144968,a,0,0
144969,novel,0,0
144970,intervention,0,1
144971,(,1,0
144972,JASPER,1,0
144973,",",1,0
144974,Joint,1,0
144975,Attention,1,0
144976,Symbolic,1,0
144977,Play,1,1
144978,Engagement,1,0
144979,and,1,0
144980,Regulation,1,0
144981,),1,0
144982,on,0,0
144983,3,0,0
144984,to,0,0
144985,5,0,0
144986,year,0,0
144987,old,0,0
144988,",",0,0
144989,minimally,0,0
144990,verbal,0,0
144991,children,0,0
144992,with,0,0
144993,autism,0,0
144994,who,0,0
144995,were,0,0
144996,attending,0,0
144997,a,0,0
144998,non-public,0,1
144999,preschool,0,0
145000,.,0,0
145001,Participants,0,0
145002,were,1,0
145003,randomized,1,0
145004,to,1,0
145005,a,1,0
145006,control,1,1
145007,group,1,0
145008,(,1,0
145009,treatment,1,0
145010,as,1,0
145011,usual,1,1
145012,",",1,0
145013,30,1,0
145014,h,1,0
145015,of,1,0
145016,ABA-based,1,0
145017,therapy,1,1
145018,per,1,0
145019,week,1,0
145020,),1,0
145021,or,1,1
145022,a,1,0
145023,treatment,1,0
145024,group,1,0
145025,(,1,0
145026,substitution,1,0
145027,of,1,0
145028,30,1,0
145029,min,1,0
145030,of,1,0
145031,JASPER,1,0
145032,treatment,1,0
145033,",",1,0
145034,twice,1,0
145035,weekly,1,1
145036,during,1,0
145037,their,1,0
145038,regular,1,1
145039,program,1,1
145040,),1,0
145041,.,1,0
145042,A,1,0
145043,baseline,0,0
145044,of,0,0
145045,12,0,0
145046,weeks,0,0
145047,in,0,0
145048,which,0,0
145049,no,0,0
145050,changes,0,0
145051,were,0,0
145052,noted,0,0
145053,in,0,0
145054,core,0,0
145055,deficits,0,0
145056,was,0,0
145057,followed,0,0
145058,by,0,0
145059,12,0,0
145060,weeks,0,0
145061,of,0,0
145062,intervention,0,1
145063,for,0,0
145064,children,0,0
145065,randomized,0,0
145066,to,0,0
145067,the,0,0
145068,JASPER,1,0
145069,treatment,1,0
145070,.,0,0
145071,Participants,0,0
145072,in,0,0
145073,the,0,0
145074,treatment,0,0
145075,group,0,0
145076,demonstrated,0,0
145077,greater,0,0
145078,play,0,0
145079,diversity,0,0
145080,on,0,0
145081,a,0,0
145082,standardized,0,0
145083,assessment,0,0
145084,.,0,0
145085,Effects,0,0
145086,also,0,0
145087,generalized,0,0
145088,to,0,0
145089,the,0,0
145090,classroom,0,1
145091,",",0,0
145092,where,0,0
145093,participants,0,0
145094,in,0,0
145095,the,0,0
145096,treatment,0,0
145097,group,0,0
145098,initiated,0,0
145099,more,0,0
145100,gestures,0,0
145101,and,0,0
145102,spent,0,0
145103,less,0,0
145104,time,0,0
145105,unengaged,0,0
145106,.,0,0
145107,These,0,0
145108,results,0,0
145109,provide,0,0
145110,further,0,0
145111,support,0,0
145112,that,0,0
145113,even,0,0
145114,brief,0,1
145115,",",0,0
145116,targeted,0,0
145117,interventions,0,0
145118,on,0,0
145119,joint,0,0
145120,attention,0,0
145121,and,0,0
145122,play,0,0
145123,can,0,0
145124,improve,0,0
145125,core,0,0
145126,deficits,0,0
145127,in,0,0
145128,minimally,0,0
145129,verbal,0,0
145130,children,0,0
145131,with,0,0
145132,ASD,0,0
145133,.,0,0
145134,Clinical,0,0
145135,efficacy,0,0
145136,of,0,0
145137,antazoline,1,1
145138,in,0,0
145139,rapid,0,0
145140,cardioversion,0,1
145141,of,0,0
145142,paroxysmal,0,0
145143,atrial,0,0
145144,fibrillation,0,0
145145,--,0,0
145146,a,0,0
145147,protocol,0,0
145148,of,0,0
145149,a,0,0
145150,single,0,0
145151,center,0,0
145152,",",0,0
145153,randomized,0,0
145154,",",0,0
145155,double-blind,0,0
145156,",",0,0
145157,placebo-controlled,0,1
145158,study,0,0
145159,(,0,0
145160,the,0,0
145161,AnPAF,0,1
145162,Study,0,0
145163,),0,0
145164,.,0,0
145165,BACKGROUND,0,0
145166,Rapid,0,0
145167,conversion,0,0
145168,of,0,0
145169,atrial,0,0
145170,fibrillation,0,0
145171,(,0,0
145172,AF,0,1
145173,),0,0
145174,to,0,0
145175,sinus,0,0
145176,rhythm,0,1
145177,may,0,0
145178,be,0,0
145179,achieved,0,0
145180,by,0,0
145181,the,0,0
145182,administration,0,0
145183,of,0,0
145184,class,1,0
145185,IA,1,0
145186,",",1,0
145187,IC,1,1
145188,and,1,0
145189,III,1,0
145190,antiarrhythmic,1,1
145191,drugs,1,1
145192,or,1,0
145193,vernakalant,1,1
145194,hydrochloride,1,1
145195,.,1,0
145196,However,0,0
145197,",",0,0
145198,that,0,0
145199,treatment,0,0
145200,may,0,0
145201,be,0,0
145202,related,0,0
145203,to,0,0
145204,potential,0,0
145205,pro-arrhythmia,0,0
145206,",",0,0
145207,lack,0,0
145208,of,0,0
145209,efficacy,0,0
145210,or,0,0
145211,the,0,0
145212,exceptionally,0,0
145213,high,0,0
145214,cost,0,0
145215,of,0,0
145216,a,0,0
145217,compound,0,1
145218,used,0,0
145219,.,0,0
145220,Antazoline,1,1
145221,is,0,0
145222,a,0,0
145223,first,0,0
145224,generation,0,0
145225,antihistaminic,0,1
145226,agent,0,0
145227,with,0,0
145228,chinidin-like,0,1
145229,properties,0,0
145230,.,0,0
145231,When,0,0
145232,administered,0,0
145233,intravenously,0,0
145234,",",0,0
145235,antazoline,1,1
145236,exerts,0,0
145237,a,0,0
145238,strong,0,0
145239,antiarrhythmic,0,0
145240,effect,0,0
145241,on,0,0
145242,supraventricular,0,0
145243,arrhythmia,0,0
145244,",",0,0
145245,especially,0,0
145246,on,0,0
145247,AF,0,0
145248,",",0,0
145249,facilitating,0,0
145250,rapid,0,0
145251,conversion,0,0
145252,to,0,0
145253,sinus,0,0
145254,rhythm,0,1
145255,.,0,0
145256,Despite,0,0
145257,a,0,0
145258,relative,0,0
145259,lack,0,0
145260,of,0,0
145261,published,0,0
145262,data,0,0
145263,antazoline,0,1
145264,has,0,0
145265,been,0,0
145266,marketed,0,0
145267,in,0,0
145268,Poland,0,0
145269,and,0,0
145270,widely,0,0
145271,used,0,0
145272,in,0,0
145273,cardiology,0,0
145274,wards,0,0
145275,and,0,0
145276,emergency,0,0
145277,rooms,0,1
145278,for,0,0
145279,many,0,0
145280,years,0,0
145281,due,0,0
145282,to,0,0
145283,its,0,0
145284,efficacy,0,0
145285,",",0,0
145286,safety,0,0
145287,and,0,0
145288,rapid,0,0
145289,onset,0,0
145290,of,0,0
145291,action,0,0
145292,within,0,0
145293,minutes,0,0
145294,of,0,0
145295,administration,0,0
145296,.,0,0
145297,METHODS/DESIGN,0,0
145298,A,0,0
145299,randomized,0,0
145300,",",0,0
145301,double,0,0
145302,blind,0,0
145303,",",0,0
145304,placebo-controlled,1,1
145305,",",0,0
145306,superiority,0,0
145307,clinical,0,0
145308,trial,0,0
145309,was,0,0
145310,designed,0,0
145311,to,0,0
145312,assess,0,0
145313,clinical,0,0
145314,efficacy,0,0
145315,of,0,0
145316,antazoline,1,1
145317,in,0,0
145318,rapid,0,0
145319,conversion,0,0
145320,of,0,0
145321,AF,0,0
145322,to,0,0
145323,sinus,0,0
145324,rhythm,0,1
145325,.,0,0
145326,Eligible,0,0
145327,patients,0,0
145328,will,0,0
145329,present,0,0
145330,AF,0,0
145331,lasting,0,0
145332,less,0,0
145333,than,0,0
145334,43,0,0
145335,hours,0,0
145336,",",0,0
145337,will,0,0
145338,be,0,0
145339,in,0,0
145340,stable,0,0
145341,cardio-pulmonary,0,0
145342,condition,0,0
145343,and,0,0
145344,will,0,0
145345,have,0,0
145346,no,0,0
145347,prior,0,0
145348,history,0,0
145349,of,0,0
145350,advanced,0,0
145351,heart,0,0
145352,failure,0,0
145353,or,0,1
145354,significant,0,0
145355,valvular,0,0
145356,disease,0,0
145357,.,0,0
145358,Long-term,0,0
145359,antiarrhythmic,0,0
145360,therapy,0,1
145361,is,0,0
145362,not,0,0
145363,considered,0,0
145364,an,0,0
145365,exclusion,0,0
145366,criterion,0,0
145367,.,0,0
145368,Subjects,0,0
145369,who,0,0
145370,fulfill,0,0
145371,selection,0,0
145372,criteria,0,0
145373,will,0,0
145374,be,0,0
145375,randomly,0,0
145376,assigned,0,0
145377,to,0,0
145378,receive,0,0
145379,intravenously,0,0
145380,either,0,0
145381,antazoline,1,1
145382,or,0,1
145383,placebo,1,1
145384,in,0,0
145385,divided,0,0
145386,doses,0,0
145387,and,0,0
145388,observed,0,0
145389,for,0,0
145390,1.5,0,0
145391,hours,0,0
145392,after,0,0
145393,conversion,0,0
145394,to,0,0
145395,sinus,0,0
145396,rhythm,0,1
145397,or,0,0
145398,after,0,0
145399,the,0,0
145400,last,0,0
145401,i.v,0,1
145402,.,0,0
145403,bolus,0,0
145404,.,0,0
145405,Primary,0,0
145406,end,0,0
145407,point,0,0
145408,will,0,0
145409,be,0,0
145410,the,0,0
145411,conversion,0,0
145412,of,0,0
145413,AF,0,0
145414,to,0,0
145415,sinus,0,0
145416,rhythm,0,1
145417,confirmed,0,0
145418,in,0,0
145419,an,0,0
145420,electrocardiogram,0,0
145421,(,0,0
145422,ECG,0,1
145423,),0,0
145424,during,0,0
145425,the,0,0
145426,observation,0,0
145427,period,0,0
145428,.,0,0
145429,Secondary,0,0
145430,end,0,0
145431,points,0,0
145432,will,0,0
145433,be,0,0
145434,comprised,0,0
145435,of,0,0
145436,time,0,0
145437,to,0,0
145438,conversion,0,0
145439,and,0,0
145440,return,0,0
145441,of,0,0
145442,AF,0,0
145443,during,0,0
145444,the,0,0
145445,observation,0,0
145446,period,0,0
145447,.,0,0
145448,Special,0,0
145449,consideration,0,0
145450,will,0,0
145451,be,0,0
145452,given,0,0
145453,to,0,0
145454,the,0,0
145455,observation,0,0
145456,of,0,0
145457,any,0,0
145458,adverse,0,0
145459,events,0,0
145460,.,0,0
145461,A,0,0
145462,sample,0,0
145463,size,0,0
145464,of,0,0
145465,80,0,0
145466,patients,0,0
145467,was,0,0
145468,calculated,0,0
145469,based,0,0
145470,on,0,0
145471,the,0,0
145472,following,0,0
145473,assumptions,0,0
145474,:,0,0
145475,two-tailed,0,0
145476,test,0,0
145477,",",0,0
145478,a,0,0
145479,type,0,0
145480,I,0,0
145481,error,0,0
145482,of,0,0
145483,0.01,0,0
145484,",",0,0
145485,a,0,0
145486,power,0,0
145487,of,0,0
145488,90,0,0
145489,%,0,0
145490,",",0,0
145491,efficacy,0,0
145492,of,0,0
145493,placebo,1,1
145494,5,0,0
145495,%,0,0
145496,",",0,0
145497,efficacy,0,0
145498,of,0,0
145499,antazoline,1,1
145500,50,0,0
145501,%,0,0
145502,and,0,0
145503,20,0,0
145504,%,0,0
145505,drop-out,0,0
145506,rate,0,0
145507,to,0,0
145508,fulfill,0,0
145509,the,0,0
145510,criteria,0,0
145511,of,0,0
145512,intention-to-treat,0,0
145513,analysis,0,0
145514,.,0,0
145515,Due,0,1
145516,to,0,0
145517,the,0,0
145518,presumed,0,0
145519,lack,0,0
145520,of,0,0
145521,statistical,0,0
145522,power,0,0
145523,",",0,0
145524,the,0,0
145525,secondary,0,0
145526,end,0,0
145527,points,0,0
145528,and,0,0
145529,safety,0,0
145530,endpoints,0,0
145531,will,0,0
145532,be,0,0
145533,considered,0,0
145534,exploratory,0,0
145535,.,0,0
145536,CLINICAL,0,0
145537,TRIALS,0,0
145538,REGISTRY,0,0
145539,ClinicalTrials.gov,0,0
145540,",",0,0
145541,NCT01527279,0,0
145542,.,0,0
145543,A,0,0
145544,randomised,0,0
145545,group,0,0
145546,comparison,0,0
145547,controlled,0,0
145548,trial,0,0
145549,of,0,0
145550,'preschoolers,0,0
145551,with,0,0
145552,autism,0,0
145553,',0,0
145554,:,0,0
145555,a,0,0
145556,parent,1,1
145557,education,1,1
145558,and,1,0
145559,skills,1,1
145560,training,1,1
145561,intervention,1,1
145562,for,0,0
145563,young,0,0
145564,children,0,0
145565,with,0,0
145566,autistic,0,0
145567,disorder,0,0
145568,.,0,0
145569,AIM,0,0
145570,To,0,0
145571,determine,0,0
145572,the,0,0
145573,effect,0,0
145574,of,0,0
145575,parent,1,1
145576,education,1,1
145577,on,1,0
145578,adaptive,1,0
145579,behaviour,1,0
145580,",",1,0
145581,autism,1,0
145582,symptoms,1,0
145583,and,1,0
145584,cognitive/language,1,0
145585,skills,1,1
145586,of,0,0
145587,young,0,0
145588,children,0,0
145589,with,0,0
145590,autistic,0,0
145591,disorder,0,0
145592,.,0,0
145593,METHOD,0,0
145594,A,0,0
145595,randomised,0,0
145596,group,0,0
145597,comparison,0,0
145598,design,0,0
145599,involving,0,0
145600,a,0,0
145601,parent,1,1
145602,education,1,1
145603,and,1,0
145604,counselling,1,1
145605,intervention,1,1
145606,and,1,0
145607,a,1,0
145608,parent,1,1
145609,education,1,1
145610,and,1,0
145611,behaviour,1,0
145612,management,1,1
145613,intervention,1,1
145614,to,1,0
145615,control,1,0
145616,for,1,0
145617,parent,1,0
145618,skills,1,1
145619,training,1,1
145620,and,1,0
145621,a,1,0
145622,control,1,0
145623,sample,1,0
145624,.,1,0
145625,Two,0,0
145626,rural,0,0
145627,and,0,0
145628,two,0,0
145629,metropolitan,0,0
145630,regions,0,0
145631,were,0,0
145632,randomly,0,0
145633,allocated,0,0
145634,to,0,0
145635,intervention,1,1
145636,groups,1,0
145637,(,0,0
145638,n,0,0
145639,=,0,0
145640,70,0,0
145641,),0,0
145642,or,1,1
145643,control,1,1
145644,(,0,0
145645,n,0,0
145646,=,0,0
145647,35,0,0
145648,),0,0
145649,.,0,0
145650,Parents,0,0
145651,from,0,0
145652,autism,0,0
145653,assessment,0,0
145654,services,0,0
145655,in,0,0
145656,the,0,0
145657,intervention,0,1
145658,regions,0,0
145659,were,0,0
145660,randomly,0,0
145661,allocated,0,0
145662,to,0,0
145663,parent,1,1
145664,education,1,1
145665,and,1,0
145666,behaviour,1,0
145667,management,1,1
145668,(,0,0
145669,n,0,0
145670,=,0,0
145671,35,0,0
145672,),0,0
145673,or,1,0
145674,parent,1,1
145675,education,1,1
145676,and,1,0
145677,counselling,1,1
145678,(,0,0
145679,n,0,0
145680,=,0,0
145681,35,0,0
145682,),0,0
145683,.,0,0
145684,RESULTS,0,0
145685,Parent,0,0
145686,education,0,1
145687,and,0,0
145688,behaviour,0,0
145689,management,0,0
145690,resulted,0,0
145691,in,0,0
145692,significant,0,0
145693,improvement,0,0
145694,in,0,0
145695,adaptive,0,0
145696,behaviour,0,0
145697,and,0,0
145698,autism,0,0
145699,symptoms,0,0
145700,at,0,0
145701,6,0,0
145702,months,0,0
145703,follow-up,0,0
145704,for,0,0
145705,children,0,0
145706,with,0,0
145707,greater,0,0
145708,delays,0,0
145709,in,0,0
145710,adaptive,0,0
145711,behaviour,0,0
145712,.,0,0
145713,Parent,0,0
145714,education,0,1
145715,and,0,0
145716,behaviour,0,0
145717,management,0,0
145718,was,0,0
145719,superior,0,0
145720,to,0,0
145721,parent,0,1
145722,education,0,1
145723,and,0,0
145724,counselling,0,1
145725,.,0,0
145726,We,0,0
145727,conclude,0,0
145728,that,0,0
145729,a,0,0
145730,20-week,0,0
145731,parent,0,1
145732,education,0,1
145733,programme,0,1
145734,including,0,0
145735,skills,0,1
145736,training,0,1
145737,for,0,0
145738,parents,0,0
145739,of,0,0
145740,young,0,0
145741,children,0,0
145742,with,0,0
145743,autistic,0,0
145744,disorder,0,0
145745,provides,0,0
145746,significant,0,0
145747,improvements,0,0
145748,in,0,0
145749,child,0,0
145750,adaptive,0,0
145751,behaviour,0,0
145752,and,0,0
145753,symptoms,0,0
145754,of,0,0
145755,autism,0,0
145756,for,0,0
145757,low-functioning,0,0
145758,children,0,0
145759,.,0,0
145760,Airway,0,0
145761,responses,0,0
145762,and,0,0
145763,inflammation,0,0
145764,in,0,0
145765,subjects,0,0
145766,with,0,0
145767,asthma,0,0
145768,after,0,0
145769,four,0,0
145770,days,0,0
145771,of,0,0
145772,repeated,1,0
145773,high-single-dose,1,1
145774,allergen,1,1
145775,challenge,1,0
145776,.,1,0
145777,BACKGROUND,0,0
145778,Both,0,1
145779,standard,0,1
145780,and,0,0
145781,low-dose,0,1
145782,allergen,0,1
145783,provocations,0,0
145784,are,0,0
145785,an,0,0
145786,established,0,0
145787,tool,0,0
145788,in,0,0
145789,asthma,0,0
145790,research,0,0
145791,to,0,0
145792,improve,0,0
145793,our,0,0
145794,understanding,0,0
145795,of,0,0
145796,the,0,0
145797,pathophysiological,0,0
145798,mechanism,0,0
145799,of,0,0
145800,allergic,0,0
145801,asthma,0,0
145802,.,0,0
145803,However,0,0
145804,",",0,0
145805,clinical,0,0
145806,symptoms,0,0
145807,are,0,0
145808,less,0,0
145809,likely,0,0
145810,to,0,0
145811,be,0,0
145812,induced,0,0
145813,.,0,0
145814,Therefore,0,0
145815,",",0,0
145816,we,0,0
145817,designed,0,0
145818,a,0,0
145819,protocol,0,0
145820,for,0,0
145821,repetitive,0,1
145822,high-dose,0,1
145823,bronchial,0,0
145824,allergen,0,1
145825,challenges,0,0
145826,to,0,0
145827,generate,0,0
145828,clinical,0,0
145829,symptoms,0,0
145830,and,0,0
145831,airway,0,0
145832,inflammation,0,0
145833,.,0,0
145834,METHODS,0,0
145835,A,0,0
145836,total,0,0
145837,of,0,0
145838,27,0,0
145839,patients,0,0
145840,aged,0,0
145841,18,0,0
145842,to,0,0
145843,40,0,0
145844,years,0,0
145845,with,0,0
145846,positive,0,0
145847,skin-prick,0,0
145848,tests,0,0
145849,and,0,0
145850,mild,0,0
145851,asthma,0,0
145852,underwent,0,0
145853,repetitive,1,1
145854,high-dose,1,1
145855,allergen,1,1
145856,challenges,1,0
145857,with,1,0
145858,household,1,0
145859,dust,1,1
145860,mites,1,0
145861,for,1,0
145862,four,1,0
145863,consecutive,1,0
145864,days,1,0
145865,.,1,0
145866,Pulmonary,0,0
145867,function,0,0
145868,and,0,0
145869,exhaled,0,0
145870,NO,0,0
145871,were,0,0
145872,measured,0,0
145873,at,0,0
145874,every,0,0
145875,visit,0,0
145876,.,0,0
145877,Induced,0,0
145878,sputum,0,0
145879,was,0,0
145880,analysed,0,0
145881,before,0,0
145882,and,0,0
145883,after,0,0
145884,the,0,0
145885,allergen,0,1
145886,challenges,0,0
145887,for,0,0
145888,cell,0,0
145889,counts,0,0
145890,",",0,0
145891,ECP,0,0
145892,",",0,0
145893,IL-5,0,0
145894,",",0,0
145895,INF-?,0,0
145896,",",0,0
145897,IL-8,0,0
145898,",",0,0
145899,and,0,0
145900,the,0,0
145901,transcription,0,0
145902,factor,0,0
145903,Foxp3,0,1
145904,.,0,0
145905,RESULTS,0,0
145906,We,0,0
145907,found,0,0
145908,a,0,0
145909,significant,0,0
145910,decrease,0,0
145911,in,0,0
145912,pulmonary,0,0
145913,function,0,0
145914,",",0,0
145915,an,0,0
145916,increased,0,0
145917,use,0,0
145918,of,0,0
145919,salbutamol,0,1
145920,and,0,0
145921,the,0,0
145922,development,0,0
145923,of,0,0
145924,a,0,0
145925,late,0,0
145926,asthmatic,0,0
145927,response,0,0
145928,and,0,0
145929,bronchial,0,0
145930,hyperresponsiveness,0,0
145931,",",0,0
145932,as,0,0
145933,well,0,0
145934,as,0,0
145935,a,0,0
145936,significant,0,0
145937,induction,0,0
145938,of,0,0
145939,eNO,0,0
145940,",",0,0
145941,eosinophils,0,0
145942,",",0,0
145943,and,0,0
145944,Th-2,0,0
145945,cytokines,0,0
145946,.,0,0
145947,Repeated,0,0
145948,provocation,0,0
145949,was,0,0
145950,feasible,0,0
145951,in,0,0
145952,the,0,0
145953,majority,0,0
145954,of,0,0
145955,patients,0,0
145956,.,0,0
145957,Two,0,0
145958,subjects,0,0
145959,had,0,0
145960,severe,0,0
145961,adverse,0,0
145962,events,0,0
145963,requiring,1,0
145964,prednisolone,1,1
145965,to,0,0
145966,cope,0,0
145967,with,0,0
145968,nocturnal,0,0
145969,asthma,0,0
145970,symptoms,0,0
145971,.,0,0
145972,CONCLUSIONS,0,0
145973,Repeated,0,0
145974,high-dose,0,1
145975,bronchial,0,0
145976,allergen,0,1
145977,challenges,0,0
145978,resulted,0,0
145979,in,0,0
145980,severe,0,0
145981,asthma,0,0
145982,symptoms,0,0
145983,and,0,0
145984,marked,0,0
145985,Th-2-mediated,0,0
145986,allergic,0,0
145987,airway,0,0
145988,inflammation,0,0
145989,.,0,0
145990,The,0,0
145991,high-dose,0,1
145992,challenge,0,0
145993,model,0,0
145994,is,0,0
145995,suitable,0,0
145996,only,0,0
145997,in,0,0
145998,an,0,0
145999,attenuated,0,0
146000,form,0,0
146001,in,0,0
146002,diseased,0,0
146003,volunteers,0,0
146004,for,0,0
146005,proof-of-concept,0,0
146006,studies,0,0
146007,and,0,0
146008,in,0,0
146009,clinical,0,0
146010,settings,0,0
146011,to,0,0
146012,reduce,0,0
146013,the,0,0
146014,risk,0,0
146015,of,0,0
146016,severe,0,0
146017,asthma,0,0
146018,exacerbations,0,0
146019,.,0,0
146020,TRIAL,0,0
146021,REGISTRATION,0,0
146022,ClinicalTrials.govNCT00677209,0,0
146023,.,0,0
146024,The,0,0
146025,role,0,0
146026,of,0,0
146027,nasal,1,0
146028,IgA,1,0
146029,in,0,0
146030,children,0,0
146031,vaccinated,0,0
146032,with,0,0
146033,live,0,0
146034,attenuated,0,0
146035,influenza,0,1
146036,vaccine,0,1
146037,.,0,0
146038,BACKGROUND,0,0
146039,Immunoglobulin,1,1
146040,A,1,0
146041,(,1,0
146042,IgA,1,0
146043,),1,1
146044,is,0,0
146045,the,0,0
146046,predominant,0,0
146047,antibody,0,0
146048,produced,0,0
146049,in,0,0
146050,response,0,0
146051,to,0,0
146052,mucosal,0,0
146053,infections,0,0
146054,.,0,0
146055,The,0,0
146056,role,0,0
146057,of,0,0
146058,IgA,1,0
146059,in,0,0
146060,providing,0,0
146061,protection,0,0
146062,against,0,0
146063,influenza,0,1
146064,in,0,0
146065,children,0,0
146066,vaccinated,0,0
146067,with,0,0
146068,live,1,0
146069,attenuated,1,0
146070,influenza,1,1
146071,vaccine,1,1
146072,(,1,0
146073,LAIV,1,0
146074,),1,1
146075,has,0,0
146076,not,0,0
146077,been,0,0
146078,well,0,0
146079,described,0,0
146080,.,0,0
146081,METHODS,0,0
146082,Nasal,0,0
146083,IgA,0,0
146084,responses,0,0
146085,were,0,0
146086,assessed,0,0
146087,using,0,0
146088,data,0,0
146089,from,0,0
146090,3,0,0
146091,prospective,0,0
146092,",",0,0
146093,2-year,0,0
146094,",",0,0
146095,randomized,0,0
146096,studies,0,0
146097,comparing,0,0
146098,LAIV,1,0
146099,with,0,0
146100,placebo,1,1
146101,in,0,0
146102,children,0,0
146103,6-36,0,0
146104,months,0,0
146105,of,0,0
146106,age,0,0
146107,.,0,0
146108,In,0,0
146109,each,0,0
146110,study,0,0
146111,",",0,0
146112,samples,0,0
146113,were,0,0
146114,collected,0,0
146115,in,0,0
146116,a,0,0
146117,subset,0,0
146118,of,0,0
146119,patients,0,0
146120,;,0,0
146121,a,0,0
146122,new,0,0
146123,cohort,0,0
146124,was,0,0
146125,enrolled,0,0
146126,each,0,0
146127,year,0,0
146128,.,0,0
146129,Ratios,0,0
146130,of,0,0
146131,strain-specific,0,0
146132,nasal,1,0
146133,IgA,1,0
146134,to,0,0
146135,total,0,0
146136,nasal,0,0
146137,IgA,0,0
146138,were,0,0
146139,calculated,0,0
146140,and,0,0
146141,prevaccination,0,0
146142,to,0,0
146143,postvaccination,0,0
146144,geometric,0,0
146145,mean,0,0
146146,fold-rises,0,0
146147,(,0,0
146148,GMFRs,0,1
146149,),0,0
146150,were,0,0
146151,evaluated,0,0
146152,.,0,0
146153,Mean,0,0
146154,postvaccination,0,0
146155,IgA,1,0
146156,ratios,0,0
146157,were,0,0
146158,compared,0,0
146159,for,0,0
146160,subjects,0,0
146161,with,0,0
146162,and,0,0
146163,without,0,0
146164,confirmed,0,0
146165,influenza,0,1
146166,illness,0,0
146167,by,0,0
146168,study,0,0
146169,and,0,0
146170,in,0,0
146171,pooled,0,0
146172,analyses,0,0
146173,.,0,0
146174,RESULTS,0,0
146175,Across,0,0
146176,studies,0,0
146177,",",0,0
146178,a,0,0
146179,higher,0,0
146180,percentage,0,0
146181,of,0,0
146182,children,0,0
146183,receiving,0,0
146184,LAIV,1,0
146185,had,0,0
146186,a,0,0
146187,?,0,0
146188,2-fold,0,0
146189,increase,0,0
146190,in,0,0
146191,strain-specific,0,0
146192,IgA,0,0
146193,ratio,0,0
146194,compared,0,0
146195,with,0,0
146196,placebo,0,1
146197,recipients,0,0
146198,.,0,0
146199,GMFRs,0,0
146200,after,0,0
146201,LAIV,1,0
146202,in,1,0
146203,years,0,0
146204,1,0,0
146205,and,0,0
146206,2,0,0
146207,ranged,0,0
146208,from,0,0
146209,1.2,0,0
146210,to,0,0
146211,6.2,0,0
146212,",",0,0
146213,compared,0,0
146214,with,0,0
146215,0.5-2.2,0,0
146216,among,0,0
146217,placebo,0,1
146218,recipients,0,0
146219,.,0,0
146220,Similar,0,0
146221,responses,0,0
146222,were,0,0
146223,observed,0,0
146224,in,0,0
146225,subjects,0,0
146226,who,0,0
146227,were,0,0
146228,baseline,0,0
146229,seronegative,0,0
146230,and,0,0
146231,seropositive,0,0
146232,based,0,0
146233,on,0,0
146234,serum,0,0
146235,hemagglutination,0,1
146236,inhibition,0,0
146237,antibody,0,0
146238,titers,0,0
146239,.,0,0
146240,In,0,0
146241,years,0,0
146242,1,0,0
146243,and,0,0
146244,2,0,0
146245,",",0,0
146246,the,0,0
146247,mean,0,0
146248,postvaccination,0,0
146249,strain-specific,0,0
146250,to,0,0
146251,total,0,0
146252,IgA,0,0
146253,ratio,0,0
146254,was,0,0
146255,3.1-fold,0,0
146256,(,0,0
146257,P,0,0
146258,<,0,0
146259,0.01,0,0
146260,),0,0
146261,and,0,0
146262,2.0-fold,0,0
146263,(,0,0
146264,P,0,0
146265,<,0,0
146266,0.03,0,0
146267,),0,0
146268,higher,0,0
146269,among,0,0
146270,LAIV,0,0
146271,recipients,0,0
146272,with,0,0
146273,no,0,0
146274,evidence,0,0
146275,of,0,0
146276,culture-confirmed,0,0
146277,influenza,0,1
146278,illness,0,0
146279,compared,0,0
146280,with,0,0
146281,LAIV,0,0
146282,recipients,0,0
146283,who,0,0
146284,developed,0,0
146285,culture-confirmed,0,0
146286,influenza,0,1
146287,illness,0,0
146288,;,0,0
146289,a,0,0
146290,similar,0,0
146291,and,0,0
146292,consistent,0,0
146293,trend,0,0
146294,was,0,0
146295,observed,0,0
146296,for,0,0
146297,each,0,0
146298,individual,0,0
146299,study,0,0
146300,and,0,0
146301,type/subtype,0,0
146302,.,0,0
146303,CONCLUSIONS,0,0
146304,The,0,0
146305,current,0,0
146306,analysis,0,0
146307,demonstrates,0,0
146308,that,0,0
146309,nasal,0,0
146310,IgA,0,0
146311,contributes,0,0
146312,to,0,0
146313,the,0,0
146314,efficacy,0,0
146315,of,0,0
146316,LAIV,1,0
146317,and,1,0
146318,can,0,0
146319,provide,0,0
146320,evidence,0,0
146321,of,0,0
146322,vaccine-induced,0,0
146323,immunity,0,0
146324,.,0,0
146325,However,0,0
146326,",",0,0
146327,the,0,0
146328,inherent,0,0
146329,heterogeneity,0,0
146330,in,0,0
146331,nasal,0,0
146332,antibody,0,0
146333,levels,0,0
146334,and,0,0
146335,variability,0,0
146336,in,0,0
146337,nasal,0,0
146338,specimen,0,0
146339,collection,0,0
146340,hinders,0,0
146341,the,0,0
146342,precise,0,0
146343,evaluation,0,0
146344,of,0,0
146345,mucosal,0,0
146346,antibody,0,0
146347,responses,0,0
146348,.,0,0
146349,Other,0,0
146350,studies,0,0
146351,have,0,0
146352,demonstrated,0,0
146353,that,1,0
146354,LAIV-induced,1,0
146355,immunity,1,0
146356,is,0,0
146357,also,0,0
146358,partially,0,0
146359,explained,0,0
146360,by,0,0
146361,T-cell,0,0
146362,immunity,0,0
146363,",",0,0
146364,serum,0,0
146365,antibody,0,0
146366,responses,0,0
146367,",",0,0
146368,and,0,0
146369,innate,0,0
146370,immunity,0,0
146371,",",0,0
146372,consistent,0,0
146373,with,0,0
146374,the,0,0
146375,multi-faceted,0,0
146376,nature,0,0
146377,of,0,0
146378,immunity,0,0
146379,induced,0,0
146380,by,0,0
146381,wild-type,0,0
146382,influenza,0,1
146383,infection,0,0
146384,and,0,0
146385,other,0,0
146386,live,0,0
146387,virus,0,0
146388,vaccines,0,1
146389,.,0,0
146390,Iron,1,1
146391,in,0,0
146392,relation,0,0
146393,to,0,0
146394,gastric,0,0
146395,cancer,0,0
146396,in,0,0
146397,the,0,0
146398,Alpha-tocopherol,0,1
146399,",",0,0
146400,Beta-carotene,0,1
146401,Cancer,0,0
146402,Prevention,0,1
146403,Study,0,0
146404,.,0,0
146405,BACKGROUND,0,0
146406,Iron,1,1
146407,is,0,0
146408,an,0,0
146409,essential,0,0
146410,micronutrient,0,1
146411,that,0,0
146412,can,0,0
146413,have,0,0
146414,carcinogenic,0,0
146415,effects,0,0
146416,when,0,0
146417,at,0,0
146418,high,0,0
146419,or,0,0
146420,low,0,0
146421,concentrations,0,0
146422,.,0,0
146423,Previous,0,0
146424,studies,0,0
146425,of,0,0
146426,iron,0,1
146427,in,0,0
146428,relation,0,0
146429,to,0,0
146430,gastric,0,0
146431,cancer,0,0
146432,have,0,0
146433,not,0,0
146434,assessed,0,0
146435,subtype-specific,0,0
146436,relationships,0,0
146437,.,0,0
146438,We,0,0
146439,used,0,0
146440,the,0,0
146441,prospective,0,0
146442,Alpha-Tocopherol,0,1
146443,",",0,0
146444,Beta-Carotene,0,1
146445,(,0,0
146446,ATBC,0,1
146447,),0,0
146448,Cancer,0,0
146449,Prevention,0,1
146450,Study,0,0
146451,to,0,0
146452,assess,0,0
146453,whether,0,0
146454,iron,0,1
146455,metrics,0,0
146456,were,0,0
146457,associated,0,0
146458,with,0,0
146459,gastric,0,0
146460,cardia,0,0
146461,cancer,0,0
146462,(,0,0
146463,GCC,0,0
146464,),0,1
146465,and,0,0
146466,gastric,0,0
146467,noncardia,0,0
146468,cancer,0,0
146469,(,0,0
146470,GNCC,0,1
146471,),0,0
146472,.,0,0
146473,METHODS,0,0
146474,We,0,0
146475,selected,0,0
146476,341,0,0
146477,incident,0,0
146478,gastric,0,0
146479,cancer,0,0
146480,cases,0,0
146481,(,0,0
146482,86,0,0
146483,cardia,0,0
146484,",",0,0
146485,172,0,0
146486,noncardia,0,0
146487,",",0,0
146488,and,0,0
146489,83,0,0
146490,nonspecified,0,0
146491,),0,0
146492,",",0,0
146493,accrued,0,0
146494,during,0,0
146495,22,0,0
146496,years,0,0
146497,of,0,0
146498,follow-up,0,0
146499,",",0,0
146500,and,0,0
146501,341,0,0
146502,individually,0,0
146503,matched,0,0
146504,controls,0,0
146505,.,0,0
146506,We,0,0
146507,measured,0,0
146508,prediagnostic,0,0
146509,serum,0,0
146510,iron,0,1
146511,",",0,0
146512,ferritin,0,0
146513,",",0,0
146514,unsaturated,0,1
146515,iron,0,1
146516,binding,0,0
146517,capacity,0,0
146518,",",0,0
146519,and,0,0
146520,C-reactive,0,0
146521,protein,0,1
146522,.,0,0
146523,Total,0,0
146524,iron-binding,0,0
146525,capacity,0,0
146526,(,0,0
146527,TIBC,0,1
146528,),0,1
146529,and,0,0
146530,transferrin,0,0
146531,saturation,0,0
146532,were,0,0
146533,estimated,0,0
146534,from,0,0
146535,these,0,0
146536,metrics,0,0
146537,.,0,0
146538,Dietary,1,0
146539,iron,1,1
146540,exposures,0,0
146541,were,0,0
146542,estimated,0,0
146543,from,0,0
146544,a,0,0
146545,food,0,0
146546,frequency,0,0
146547,questionnaire,0,0
146548,.,0,0
146549,Multivariable,0,0
146550,logistic,0,0
146551,regression,0,0
146552,was,0,0
146553,used,0,0
146554,for,0,0
146555,analysis,0,0
146556,.,0,0
146557,RESULTS,0,0
146558,Serum,0,0
146559,iron,0,1
146560,metrics,0,0
146561,were,0,0
146562,not,0,0
146563,associated,0,0
146564,with,0,0
146565,GCC,0,0
146566,",",0,0
146567,except,0,0
146568,for,0,0
146569,a,0,0
146570,potential,0,0
146571,n,0,0
146572,-shaped,0,0
146573,relationship,0,0
146574,with,0,0
146575,TIBC,0,1
146576,(,0,0
146577,global,0,0
146578,P,0,0
146579,=,0,0
146580,0.038,0,0
146581,),0,0
146582,.,0,0
146583,GNCC,0,0
146584,was,0,0
146585,inversely,0,0
146586,associated,0,0
146587,with,0,0
146588,serum,0,0
146589,ferritin,0,1
146590,(,0,0
146591,global,0,0
146592,P,0,0
146593,=,0,0
146594,0.024,0,0
146595,),0,0
146596,",",0,0
146597,serum,0,0
146598,iron,0,1
146599,(,0,0
146600,global,0,0
146601,P,0,0
146602,=,0,0
146603,0.060,0,0
146604,),0,0
146605,and,0,0
146606,",",0,0
146607,possibly,0,0
146608,",",0,0
146609,transferrin,0,0
146610,saturation,0,0
146611,.,0,0
146612,TIBC,0,0
146613,appeared,0,0
146614,to,0,0
146615,share,0,0
146616,a,0,0
146617,u,0,0
146618,-shaped,0,0
146619,relationship,0,0
146620,with,0,0
146621,GNCC,0,1
146622,(,0,0
146623,global,0,0
146624,P,0,0
146625,=,0,0
146626,0.033,0,0
146627,),0,0
146628,.,0,0
146629,Dietary,0,1
146630,iron,1,1
146631,exposures,0,0
146632,were,0,0
146633,not,0,0
146634,associated,0,0
146635,with,0,0
146636,either,0,0
146637,subsite,0,0
146638,.,0,0
146639,Adjustment,0,0
146640,for,0,0
146641,Helicobacter,0,0
146642,pylori,0,0
146643,and,0,0
146644,gastric,0,0
146645,atrophy,0,0
146646,had,0,0
146647,little,0,0
146648,effect,0,0
146649,on,0,0
146650,observed,0,0
146651,associations,0,0
146652,.,0,0
146653,CONCLUSIONS,0,0
146654,We,0,0
146655,found,0,0
146656,little,0,0
146657,evidence,0,0
146658,for,0,0
146659,the,0,0
146660,involvement,0,0
146661,of,0,0
146662,iron,1,1
146663,exposure,0,0
146664,in,0,0
146665,the,0,0
146666,pathogenesis,0,0
146667,of,0,0
146668,GCC,0,0
146669,.,0,0
146670,GNCC,0,0
146671,was,0,0
146672,associated,0,0
146673,with,0,0
146674,an,0,0
146675,iron,1,1
146676,profile,0,0
146677,similar,0,0
146678,to,0,0
146679,that,0,0
146680,of,0,0
146681,iron,0,1
146682,deficiency,0,0
146683,.,0,0
146684,IMPACT,0,0
146685,Our,0,0
146686,findings,0,0
146687,indicate,0,0
146688,that,0,0
146689,inverse,0,0
146690,associations,0,0
146691,between,0,0
146692,iron,0,1
146693,metrics,0,0
146694,and,0,0
146695,gastric,0,0
146696,cancer,0,0
146697,are,0,0
146698,driven,0,0
146699,by,0,0
146700,associations,0,0
146701,with,0,0
146702,GNCC,0,0
146703,.,0,0
146704,Further,0,0
146705,elucidation,0,0
146706,of,0,0
146707,potential,0,0
146708,mechanisms,0,0
146709,is,0,0
146710,warranted,0,0
146711,.,0,0
146712,Sensitivity,0,0
146713,to,0,0
146714,musical,0,1
146715,structure,0,0
146716,in,0,0
146717,the,0,0
146718,human,0,0
146719,brain,0,0
146720,.,0,0
146721,Evidence,0,0
146722,from,0,0
146723,brain-damaged,0,0
146724,patients,0,0
146725,suggests,0,0
146726,that,0,0
146727,regions,0,0
146728,in,0,0
146729,the,0,0
146730,temporal,0,0
146731,lobes,0,0
146732,",",0,0
146733,distinct,0,0
146734,from,0,0
146735,those,0,0
146736,engaged,0,0
146737,in,0,0
146738,lower-level,0,0
146739,auditory,0,1
146740,analysis,0,0
146741,",",0,0
146742,process,0,0
146743,the,0,0
146744,pitch,0,0
146745,and,0,0
146746,rhythmic,0,0
146747,structure,0,0
146748,in,0,0
146749,music,0,1
146750,.,0,0
146751,In,0,0
146752,contrast,0,0
146753,",",0,0
146754,neuroimaging,0,0
146755,studies,0,0
146756,targeting,0,0
146757,the,0,0
146758,representation,0,0
146759,of,0,0
146760,music,0,1
146761,structure,0,0
146762,have,0,0
146763,primarily,0,0
146764,implicated,0,0
146765,regions,0,0
146766,in,0,0
146767,the,0,0
146768,inferior,0,0
146769,frontal,0,0
146770,cortices,0,0
146771,.,0,0
146772,Combining,0,0
146773,individual-subject,1,0
146774,fMRI,1,0
146775,analyses,1,0
146776,with,0,0
146777,a,0,0
146778,scrambling,0,0
146779,method,0,0
146780,that,0,0
146781,manipulated,0,0
146782,musical,0,1
146783,structure,0,0
146784,",",0,0
146785,we,0,0
146786,provide,0,0
146787,evidence,0,0
146788,of,0,0
146789,brain,0,0
146790,regions,0,0
146791,sensitive,0,0
146792,to,0,0
146793,musical,0,1
146794,structure,0,0
146795,bilaterally,0,0
146796,in,0,0
146797,the,0,0
146798,temporal,0,0
146799,lobes,0,0
146800,",",0,0
146801,thus,0,0
146802,reconciling,0,0
146803,the,0,0
146804,neuroimaging,0,0
146805,and,0,0
146806,patient,0,0
146807,findings,0,0
146808,.,0,0
146809,We,0,0
146810,further,0,0
146811,show,0,0
146812,that,0,0
146813,these,0,0
146814,regions,0,0
146815,are,0,0
146816,sensitive,0,0
146817,to,0,0
146818,the,0,0
146819,scrambling,0,0
146820,of,0,0
146821,both,0,0
146822,pitch,0,0
146823,and,0,0
146824,rhythmic,0,1
146825,structure,0,0
146826,but,0,0
146827,are,0,0
146828,insensitive,0,0
146829,to,0,0
146830,high-level,0,0
146831,linguistic,0,0
146832,structure,0,0
146833,.,0,0
146834,Our,0,0
146835,results,0,0
146836,suggest,0,0
146837,the,0,0
146838,existence,0,0
146839,of,0,0
146840,brain,0,0
146841,regions,0,0
146842,with,0,0
146843,representations,0,0
146844,of,0,0
146845,musical,0,1
146846,structure,0,0
146847,that,0,0
146848,are,0,0
146849,distinct,0,0
146850,from,0,0
146851,high-level,0,0
146852,linguistic,0,0
146853,representations,0,1
146854,and,0,0
146855,lower-level,0,0
146856,acoustic,0,0
146857,representations,0,1
146858,.,0,0
146859,These,0,0
146860,regions,0,0
146861,provide,0,0
146862,targets,0,0
146863,for,0,0
146864,future,0,0
146865,research,0,0
146866,investigating,0,0
146867,possible,0,0
146868,neural,0,0
146869,specialization,0,0
146870,for,0,0
146871,music,0,1
146872,or,0,0
146873,its,0,0
146874,associated,0,0
146875,mental,0,0
146876,processes,0,0
146877,.,0,0
146878,Computer-navigated,1,1
146879,versus,1,0
146880,conventional,1,1
146881,total,1,0
146882,knee,1,0
146883,arthroplasty,1,0
146884,a,0,0
146885,prospective,0,0
146886,randomized,0,0
146887,trial,0,0
146888,.,0,0
146889,BACKGROUND,0,0
146890,The,0,0
146891,literature,0,0
146892,lacks,0,0
146893,studies,0,0
146894,that,0,0
146895,confirm,0,0
146896,whether,0,0
146897,the,0,0
146898,improved,0,0
146899,radiographic,0,0
146900,alignment,0,0
146901,that,0,0
146902,can,0,0
146903,be,0,0
146904,achieved,0,0
146905,with,0,0
146906,computer-navigated,1,1
146907,total,1,0
146908,knee,1,0
146909,arthroplasty,1,0
146910,improves,0,0
146911,patients?,0,0
146912,activities,0,0
146913,of,0,0
146914,daily,0,1
146915,living,0,0
146916,or,0,1
146917,the,0,0
146918,durability,0,0
146919,of,0,0
146920,total,0,0
146921,knee,0,0
146922,prostheses,0,1
146923,.,0,0
146924,The,0,0
146925,purpose,0,0
146926,of,0,0
146927,this,0,0
146928,study,0,0
146929,was,0,0
146930,to,0,0
146931,determine,0,0
146932,whether,1,0
146933,computer-navigated,1,1
146934,total,1,0
146935,knee,1,0
146936,arthroplasty,1,0
146937,improves,1,0
146938,the,0,0
146939,clinical,0,0
146940,function,0,0
146941,",",0,0
146942,alignment,0,0
146943,",",0,0
146944,and,0,0
146945,survivorship,0,0
146946,of,0,0
146947,the,0,0
146948,components,0,0
146949,.,0,0
146950,METHODS,0,0
146951,We,0,0
146952,prospectively,0,0
146953,compared,0,0
146954,the,0,0
146955,results,0,0
146956,of,0,0
146957,520,0,0
146958,patients,0,0
146959,with,0,0
146960,osteoarthritis,0,0
146961,who,0,0
146962,underwent,1,0
146963,computer-navigated,1,1
146964,total,1,0
146965,knee,1,0
146966,arthroplasty,1,0
146967,for,1,0
146968,one,1,0
146969,knee,1,0
146970,and,1,0
146971,conventional,1,1
146972,total,1,0
146973,knee,1,0
146974,arthroplasty,1,0
146975,for,1,0
146976,the,1,0
146977,other,1,0
146978,.,1,0
146979,The,0,0
146980,assignment,0,0
146981,of,0,0
146982,the,0,0
146983,knee,0,0
146984,to,0,0
146985,navigation,0,1
146986,or,0,0
146987,not,0,0
146988,was,0,0
146989,done,0,0
146990,randomly,0,0
146991,.,0,0
146992,There,0,0
146993,were,0,0
146994,452,0,0
146995,women,0,0
146996,(,0,0
146997,904,0,0
146998,knees,0,0
146999,),0,0
147000,and,0,0
147001,sixty-eight,0,0
147002,men,0,0
147003,(,0,0
147004,136,0,0
147005,knees,0,0
147006,),0,0
147007,with,0,0
147008,a,0,0
147009,mean,0,0
147010,age,0,0
147011,of,0,0
147012,sixty-eight,0,0
147013,years,0,0
147014,(,0,0
147015,range,0,0
147016,",",0,0
147017,forty-nine,0,0
147018,to,0,0
147019,eighty-eight,0,0
147020,years,0,0
147021,),0,0
147022,at,0,0
147023,the,0,0
147024,time,0,0
147025,of,0,0
147026,the,0,0
147027,index,0,0
147028,arthroplasty,0,0
147029,.,0,0
147030,The,0,0
147031,mean,0,0
147032,follow-up,0,0
147033,period,0,0
147034,was,0,0
147035,10.8,0,0
147036,years,0,0
147037,(,0,0
147038,range,0,0
147039,",",0,0
147040,ten,0,0
147041,to,0,0
147042,twelve,0,0
147043,years,0,0
147044,),0,0
147045,.,0,0
147046,The,0,0
147047,patients,0,0
147048,were,0,0
147049,assessed,0,0
147050,clinically,0,0
147051,and,0,0
147052,radiographically,0,0
147053,with,0,0
147054,the,0,0
147055,rating,0,0
147056,system,0,0
147057,of,0,0
147058,the,0,0
147059,Knee,0,0
147060,Society,0,0
147061,and,0,0
147062,with,0,0
147063,the,0,0
147064,Western,0,0
147065,Ontario,0,0
147066,and,0,0
147067,McMaster,0,1
147068,Universities,0,0
147069,Osteoarthritis,0,0
147070,Index,0,1
147071,(,0,0
147072,WOMAC,0,1
147073,),0,0
147074,score,0,0
147075,at,0,0
147076,three,0,0
147077,months,0,0
147078,",",0,0
147079,one,0,0
147080,year,0,0
147081,",",0,0
147082,and,0,0
147083,annually,0,0
147084,thereafter,0,0
147085,.,0,0
147086,RESULTS,0,0
147087,Total,0,0
147088,knee,0,0
147089,scores,0,0
147090,",",0,0
147091,knee,0,0
147092,function,0,0
147093,scores,0,0
147094,",",0,0
147095,pain,0,0
147096,scores,0,0
147097,",",0,0
147098,WOMAC,0,0
147099,scores,0,0
147100,",",0,0
147101,knee,0,0
147102,motion,0,0
147103,",",0,0
147104,and,0,0
147105,activity,0,0
147106,scores,0,0
147107,did,0,0
147108,not,0,0
147109,show,0,0
147110,statistically,0,0
147111,significant,0,0
147112,differences,0,0
147113,between,0,0
147114,the,0,0
147115,two,0,0
147116,groups,0,0
147117,preoperatively,0,0
147118,or,0,0
147119,at,0,0
147120,the,0,0
147121,time,0,0
147122,of,0,0
147123,the,0,0
147124,final,0,0
147125,follow-up,0,0
147126,.,0,0
147127,Alignment,0,0
147128,and,0,0
147129,the,0,0
147130,survivorship,0,0
147131,of,0,0
147132,the,0,0
147133,components,0,0
147134,were,0,0
147135,not,0,0
147136,significantly,0,0
147137,different,0,0
147138,between,0,0
147139,the,0,0
147140,two,0,0
147141,groups,0,0
147142,.,0,0
147143,The,0,0
147144,Kaplan-Meier,0,0
147145,survivorship,0,0
147146,with,0,0
147147,revision,0,0
147148,as,0,0
147149,the,0,0
147150,end,0,0
147151,point,0,0
147152,at,0,0
147153,10.8,0,0
147154,years,0,0
147155,was,0,0
147156,98.8,0,0
147157,%,0,0
147158,(,0,0
147159,95,0,0
147160,%,0,0
147161,confidence,0,0
147162,interval,0,0
147163,[,0,0
147164,CI,0,0
147165,],0,0
147166,",",0,0
147167,0.96,0,0
147168,to,0,0
147169,1.00,0,0
147170,),0,0
147171,in,0,0
147172,the,1,0
147173,computernavigated,1,1
147174,total,1,0
147175,knee,1,0
147176,arthroplasty,1,0
147177,group,1,0
147178,and,0,0
147179,99.2,0,0
147180,%,0,0
147181,(,0,0
147182,95,0,0
147183,%,0,0
147184,CI,0,0
147185,",",0,0
147186,0.96,0,0
147187,to,0,0
147188,1.00,0,0
147189,),0,0
147190,in,0,0
147191,the,1,0
147192,conventional,1,1
147193,total,1,0
147194,knee,1,0
147195,arthroplasty,1,0
147196,group,1,0
147197,.,0,0
147198,CONCLUSIONS,0,0
147199,Our,0,0
147200,data,0,0
147201,demonstrated,0,0
147202,no,0,0
147203,difference,0,0
147204,in,0,0
147205,clinical,0,0
147206,function,0,0
147207,or,0,1
147208,alignment,0,0
147209,and,0,0
147210,survivorship,0,0
147211,of,0,0
147212,the,0,0
147213,components,0,0
147214,between,0,0
147215,the,0,0
147216,knees,0,0
147217,that,0,0
147218,underwent,1,0
147219,computer-navigated,1,1
147220,total,1,0
147221,knee,1,0
147222,arthroplasty,1,0
147223,and,1,0
147224,those,0,0
147225,that,0,0
147226,underwent,1,0
147227,conventional,1,1
147228,total,1,0
147229,knee,1,0
147230,arthroplasty,1,0
147231,.,1,0
147232,The,0,0
147233,effects,0,0
147234,of,0,0
147235,a,0,0
147236,six-week,0,1
147237,supervised,0,1
147238,multimodal,1,1
147239,exercise,1,1
147240,intervention,1,1
147241,during,0,0
147242,chemotherapy,1,1
147243,on,0,0
147244,cancer-related,0,0
147245,fatigue,0,0
147246,.,0,0
147247,PURPOSE,0,0
147248,Cancer,0,0
147249,related,0,0
147250,fatigue,0,0
147251,(,0,0
147252,CRF,0,1
147253,),0,1
147254,is,0,0
147255,a,0,0
147256,common,0,0
147257,problem,0,0
147258,for,0,0
147259,cancer,0,0
147260,patients,0,0
147261,across,0,0
147262,diagnoses,0,0
147263,during,0,0
147264,chemotherapy,1,1
147265,and,0,0
147266,is,0,0
147267,associated,0,0
147268,with,0,0
147269,physical,0,0
147270,inactivity,0,0
147271,",",0,0
147272,lower,0,0
147273,functional,0,0
147274,level,0,0
147275,and,0,0
147276,lack,0,0
147277,of,0,0
147278,energy,0,0
147279,.,0,0
147280,Few,0,0
147281,RCT,0,0
147282,exercise,1,1
147283,intervention,1,1
147284,studies,0,0
147285,have,0,0
147286,included,0,0
147287,cancer,0,0
147288,patients,0,0
147289,undergoing,0,0
147290,chemotherapy,0,1
147291,.,0,0
147292,The,0,0
147293,objective,0,0
147294,of,0,0
147295,this,0,0
147296,study,0,0
147297,is,0,0
147298,to,0,0
147299,evaluate,0,0
147300,whether,0,0
147301,a,0,0
147302,six-week,0,1
147303,supervised,1,1
147304,multimodal,1,1
147305,exercise,1,1
147306,intervention,1,1
147307,",",1,0
147308,adjunct,1,0
147309,to,1,0
147310,chemotherapy,1,1
147311,and,1,0
147312,standard,1,1
147313,care,1,0
147314,",",0,0
147315,can,0,0
147316,reduce,0,0
147317,the,0,0
147318,patient,0,0
147319,'s,0,0
147320,CRF,0,1
147321,level,0,0
147322,.,0,0
147323,METHODS,0,0
147324,Data,0,0
147325,is,0,0
147326,based,0,0
147327,on,0,0
147328,analyses,0,0
147329,of,0,0
147330,a,0,0
147331,prospective,0,0
147332,randomised,0,0
147333,controlled,0,0
147334,trial,0,0
147335,'The,0,0
147336,Body,0,1
147337,&,0,0
147338,Cancer,0,0
147339,Trial,0,0
147340,',0,0
147341,.,0,0
147342,213,0,0
147343,cancer,0,0
147344,patients,0,0
147345,with,0,0
147346,different,0,0
147347,diagnoses,0,0
147348,were,0,0
147349,randomised,0,0
147350,into,0,0
147351,an,0,0
147352,intervention,1,1
147353,group,1,0
147354,or,0,1
147355,wait-list,1,1
147356,control,1,1
147357,group,1,0
147358,.,1,0
147359,The,0,0
147360,primary,0,0
147361,outcome,0,0
147362,",",0,0
147363,Fatigue,0,0
147364,score,0,0
147365,(,0,0
147366,CRF,0,1
147367,),0,0
147368,",",0,0
147369,was,0,0
147370,evaluated,0,0
147371,by,0,0
147372,the,0,0
147373,Functional,0,0
147374,Assessment,0,0
147375,of,0,0
147376,Cancer,0,0
147377,Therapy-Anaemia,0,0
147378,Questionnaire,0,1
147379,(,0,0
147380,FACT-An-,0,1
147381,),0,1
147382,(,0,0
147383,FACT-G,0,1
147384,score,0,0
147385,&,0,0
147386,FACT-An,0,1
147387,Anemia,0,0
147388,subscale,0,0
147389,),0,0
147390,.,0,0
147391,INTERVENTION,0,0
147392,Supervised,1,1
147393,exercise,1,1
147394,",",1,0
147395,comprising,1,0
147396,high-intensity,1,1
147397,cardiovascular,1,0
147398,and,1,0
147399,heavy,1,1
147400,resistance,1,0
147401,training,1,1
147402,",",1,0
147403,relaxation-,1,1
147404,and,1,0
147405,body,1,0
147406,awareness,1,0
147407,training,1,1
147408,and,1,0
147409,massage,1,1
147410,",",0,0
147411,9,0,0
147412,h,0,0
147413,weekly,0,1
147414,for,0,0
147415,6,0,0
147416,weeks,0,0
147417,.,0,0
147418,RESULTS,0,0
147419,CRF,0,1
147420,was,0,0
147421,significantly,0,0
147422,reduced,0,0
147423,in,0,0
147424,the,0,0
147425,intervention,0,1
147426,group,0,0
147427,",",0,0
147428,corresponding,0,0
147429,to,0,0
147430,a,0,0
147431,Fatigue,0,0
147432,score,0,0
147433,reduction,0,0
147434,of,0,0
147435,3.04,0,0
147436,(,0,0
147437,effect,0,0
147438,size,0,0
147439,of,0,0
147440,0.44,0,0
147441,",",0,0
147442,95,0,0
147443,%,0,0
147444,CI,0,0
147445,0.17-0.72,0,0
147446,),0,0
147447,(,0,0
147448,P,0,0
147449,=,0,0
147450,.002,0,0
147451,),0,0
147452,",",0,0
147453,the,0,0
147454,FACT-An,0,1
147455,score,0,0
147456,by,0,0
147457,5.40,0,0
147458,(,0,0
147459,P,0,0
147460,=,0,0
147461,.015,0,0
147462,),0,0
147463,",",0,0
147464,the,0,0
147465,FACT-An,0,1
147466,Toi,0,0
147467,score,0,0
147468,by,0,0
147469,5.22,0,0
147470,(,0,0
147471,P,0,0
147472,=,0,0
147473,.009,0,0
147474,),0,0
147475,and,0,0
147476,the,0,0
147477,Anaemia-ANS,0,0
147478,by,0,0
147479,3.76,0,0
147480,(,0,0
147481,P,0,0
147482,=,0,0
147483,.002,0,0
147484,),0,0
147485,.,0,0
147486,There,0,0
147487,was,0,0
147488,no,0,0
147489,statistically,0,0
147490,significant,0,0
147491,effect,0,0
147492,on,0,0
147493,the,0,0
147494,General,0,1
147495,Quality,0,0
147496,of,0,0
147497,Life,0,0
147498,score,0,0
147499,(,0,0
147500,FACT-G,0,1
147501,),0,0
147502,or,0,0
147503,on,0,0
147504,any,0,0
147505,of,0,0
147506,the,0,0
147507,individual,0,0
147508,wellbeing,0,0
147509,scores,0,0
147510,;,0,0
147511,Physical,0,0
147512,(,0,0
147513,P,0,0
147514,=,0,0
147515,.13,0,0
147516,),0,0
147517,",",0,0
147518,Emotional,0,1
147519,(,0,0
147520,P,0,0
147521,=,0,0
147522,.87,0,0
147523,),0,0
147524,",",0,0
147525,Social,0,0
147526,(,0,0
147527,P,0,0
147528,=,0,0
147529,.83,0,0
147530,),0,0
147531,and,0,0
147532,Functional,0,1
147533,(,0,0
147534,P,0,0
147535,=,0,0
147536,.26,0,0
147537,),0,0
147538,.,0,0
147539,CONCLUSION,0,0
147540,In,0,0
147541,summary,0,0
147542,",",0,0
147543,this,0,0
147544,six-week,0,1
147545,supervised,1,1
147546,multimodal,1,1
147547,exercise,1,1
147548,intervention,1,1
147549,can,0,0
147550,lead,0,0
147551,to,0,0
147552,significant,0,0
147553,reduction,0,0
147554,in,0,0
147555,self-reported,0,0
147556,CRF,0,1
147557,in,0,0
147558,cancer,0,0
147559,patients,0,0
147560,undergoing,0,0
147561,chemotherapy,0,1
147562,.,0,0
147563,Dysfunctional,0,0
147564,attitudes,0,0
147565,as,0,0
147566,a,0,0
147567,moderator,0,0
147568,of,0,0
147569,pharmacotherapy,1,1
147570,and,0,0
147571,psychotherapy,1,1
147572,for,0,0
147573,chronic,0,0
147574,depression,0,0
147575,.,0,0
147576,OBJECTIVE,0,0
147577,Individuals,0,0
147578,with,0,0
147579,chronic,0,0
147580,depression,0,0
147581,exhibit,0,0
147582,heterogeneous,0,0
147583,responses,0,0
147584,to,0,0
147585,treatment,0,0
147586,.,0,0
147587,Important,0,0
147588,individual,0,0
147589,differences,0,0
147590,may,0,0
147591,therefore,0,0
147592,exist,0,0
147593,within,0,0
147594,this,0,0
147595,particularly,0,0
147596,difficult,0,0
147597,to,0,0
147598,treat,0,0
147599,population,0,0
147600,that,0,0
147601,act,0,0
147602,as,0,0
147603,moderators,0,0
147604,of,0,0
147605,treatment,0,0
147606,response,0,0
147607,.,0,0
147608,METHOD,0,0
147609,The,0,0
147610,present,0,0
147611,study,0,0
147612,examined,0,0
147613,whether,0,0
147614,pretreatment,0,0
147615,levels,0,0
147616,of,0,0
147617,dysfunctional,0,0
147618,attitudes,0,0
147619,(,0,0
147620,DA,0,1
147621,),0,0
147622,moderated,0,0
147623,treatment,0,0
147624,response,0,0
147625,in,0,0
147626,a,0,0
147627,large,0,0
147628,sample,0,0
147629,of,0,0
147630,chronically,0,0
147631,depressed,0,0
147632,individuals,0,0
147633,.,0,0
147634,Data,0,0
147635,were,0,0
147636,taken,0,0
147637,from,0,0
147638,the,0,0
147639,Research,0,0
147640,Evaluating,0,0
147641,the,0,0
147642,Value,0,0
147643,of,0,0
147644,Augmenting,0,0
147645,Medication,0,0
147646,with,0,0
147647,Psychotherapy,0,1
147648,(,0,0
147649,REVAMP,0,1
147650,),0,1
147651,treatment,0,0
147652,study,0,0
147653,--,0,0
147654,a,0,0
147655,multi-site,0,0
147656,treatment,0,0
147657,and,0,0
147658,augmentation,0,0
147659,study,0,0
147660,of,0,0
147661,808,0,0
147662,chronically,0,0
147663,depressed,0,0
147664,individuals,0,0
147665,.,0,0
147666,REVAMP,0,0
147667,comprised,0,0
147668,two,0,0
147669,phases,0,0
147670,:,0,0
147671,1,0,0
147672,),0,0
147673,a,0,0
147674,12-week,1,0
147675,open-label,1,0
147676,antidepressant,1,1
147677,trial,1,0
147678,and,0,0
147679,2,0,0
147680,),0,0
147681,",",0,0
147682,a,0,0
147683,subsequent,0,0
147684,phase,0,0
147685,",",0,0
147686,in,0,0
147687,which,0,0
147688,phase,0,0
147689,1,0,0
147690,non-remitters,0,0
147691,(,0,0
147692,N,0,0
147693,=,0,0
147694,491,0,0
147695,),0,0
147696,were,0,0
147697,randomized,0,0
147698,to,0,0
147699,either,0,0
147700,receive,0,0
147701,an,0,0
147702,ongoing,1,0
147703,medication,1,0
147704,algorithm,1,0
147705,alone,1,1
147706,",",1,0
147707,medication,1,0
147708,plus,1,1
147709,cognitive,1,0
147710,behavioral,1,1
147711,analysis,1,0
147712,system,1,1
147713,of,1,0
147714,psychotherapy,1,1
147715,",",1,0
147716,or,1,1
147717,medication,1,1
147718,plus,1,1
147719,brief,1,1
147720,supportive,1,1
147721,psychotherapy,1,1
147722,.,1,0
147723,RESULT,0,0
147724,In,0,0
147725,phase,0,0
147726,1,0,0
147727,",",0,0
147728,compared,0,0
147729,to,0,0
147730,the,0,0
147731,pharmacotherapy,0,1
147732,response,0,0
147733,of,0,0
147734,patients,0,0
147735,with,0,0
147736,lower,0,0
147737,DA,0,0
147738,scores,0,0
147739,",",0,0
147740,the,0,0
147741,response,0,0
147742,for,0,0
147743,patients,0,0
147744,with,0,0
147745,higher,0,0
147746,DA,0,0
147747,scores,0,0
147748,was,0,0
147749,steeper,0,0
147750,",",0,0
147751,but,0,0
147752,leveled,0,0
147753,off,0,0
147754,toward,0,0
147755,the,0,0
147756,end,0,0
147757,of,0,0
147758,the,0,0
147759,phase,0,0
147760,.,0,0
147761,In,0,0
147762,phase,0,0
147763,2,0,0
147764,",",0,0
147765,DA,0,0
147766,predicted,0,0
147767,a,0,0
147768,differential,0,0
147769,response,0,0
147770,in,0,0
147771,the,0,0
147772,medication,0,0
147773,only,0,0
147774,arm,0,0
147775,",",0,0
147776,but,0,0
147777,not,0,0
147778,in,0,0
147779,the,0,0
147780,two,0,0
147781,psychotherapy,1,1
147782,+,1,1
147783,medication,1,0
147784,conditions,0,0
147785,.,0,0
147786,Specifically,0,0
147787,",",0,0
147788,in,0,0
147789,the,0,0
147790,phase,0,0
147791,2,0,0
147792,medication,1,0
147793,only,0,0
147794,condition,0,0
147795,",",0,0
147796,patients,0,0
147797,with,0,0
147798,higher,0,0
147799,DA,0,0
147800,improved,0,0
147801,while,0,0
147802,those,0,0
147803,with,0,0
147804,lower,0,0
147805,DA,0,0
147806,scores,0,0
147807,did,0,0
147808,not,0,0
147809,.,0,0
147810,CONCLUSION,0,0
147811,These,0,0
147812,results,0,0
147813,indicate,0,0
147814,that,0,0
147815,the,0,0
147816,relation,0,0
147817,between,0,0
147818,DA,0,1
147819,and,0,0
147820,treatment,0,0
147821,response,0,0
147822,in,0,0
147823,chronic,0,0
147824,depression,0,0
147825,is,0,0
147826,complex,0,0
147827,",",0,0
147828,but,0,0
147829,suggest,0,0
147830,that,0,0
147831,greater,0,0
147832,DA,0,0
147833,may,0,0
147834,be,0,0
147835,associated,0,0
147836,with,0,0
147837,a,0,0
147838,steeper,0,0
147839,reduction,0,0
147840,and/or,0,0
147841,better,0,0
147842,response,0,0
147843,to,0,0
147844,pharmacotherapy,1,1
147845,.,1,0
147846,Role,0,0
147847,of,0,0
147848,posterior,1,1
147849,tibial,1,1
147850,nerve,1,0
147851,stimulation,1,1
147852,in,0,0
147853,the,0,0
147854,treatment,0,0
147855,of,0,0
147856,refractory,0,0
147857,monosymptomatic,0,0
147858,nocturnal,0,0
147859,enuresis,0,0
147860,:,0,0
147861,a,0,0
147862,pilot,0,0
147863,study,0,0
147864,.,0,0
147865,PURPOSE,0,0
147866,We,0,0
147867,evaluated,0,0
147868,the,0,0
147869,early,0,0
147870,clinical,0,0
147871,and,0,0
147872,urodynamic,0,0
147873,results,0,0
147874,of,0,0
147875,posterior,1,0
147876,tibial,1,1
147877,nerve,1,0
147878,stimulation,1,1
147879,in,0,0
147880,patients,0,0
147881,with,0,0
147882,refractory,0,0
147883,monosymptomatic,0,0
147884,nocturnal,0,0
147885,enuresis,0,0
147886,.,0,0
147887,MATERIALS,0,0
147888,AND,0,0
147889,METHODS,0,0
147890,We,0,0
147891,randomly,0,0
147892,assigned,0,0
147893,28,0,0
147894,patients,0,0
147895,with,0,0
147896,refractory,0,0
147897,monosymptomatic,0,0
147898,nocturnal,0,0
147899,enuresis,0,0
147900,to,0,0
147901,2,0,0
147902,equal,0,0
147903,groups,0,0
147904,.,0,0
147905,Group,0,0
147906,1,0,0
147907,received,0,0
147908,a,0,0
147909,weekly,0,1
147910,session,0,1
147911,of,0,0
147912,posterior,1,1
147913,tibial,1,1
147914,nerve,1,0
147915,stimulation,1,1
147916,for,0,0
147917,12,0,0
147918,weeks,0,0
147919,and,0,0
147920,group,0,0
147921,2,0,0
147922,was,0,0
147923,the,0,0
147924,placebo,1,1
147925,group,1,0
147926,.,1,0
147927,Evaluation,0,0
147928,was,0,0
147929,performed,0,0
147930,in,0,0
147931,each,0,0
147932,group,0,0
147933,at,0,0
147934,baseline,0,0
147935,and,0,0
147936,after,0,0
147937,posterior,0,1
147938,tibial,0,1
147939,nerve,0,0
147940,stimulation,0,1
147941,to,0,0
147942,compare,0,0
147943,clinical,0,0
147944,and,0,0
147945,urodynamic,0,0
147946,findings,0,0
147947,.,0,0
147948,Another,0,0
147949,clinical,0,0
147950,assessment,0,0
147951,was,0,0
147952,done,0,0
147953,3,0,0
147954,months,0,0
147955,after,0,0
147956,the,0,0
147957,first,0,0
147958,followup,0,0
147959,.,0,0
147960,RESULTS,0,0
147961,The,0,0
147962,2,0,0
147963,groups,0,0
147964,were,0,0
147965,comparable,0,0
147966,in,0,0
147967,baseline,0,0
147968,clinical,0,0
147969,and,0,0
147970,urodynamic,0,0
147971,data,0,0
147972,.,0,0
147973,Overall,0,0
147974,",",0,0
147975,13,0,0
147976,patients,0,0
147977,(,0,0
147978,46.4,0,0
147979,%,0,0
147980,),0,0
147981,had,0,0
147982,detrusor,0,0
147983,overactivity,0,0
147984,and,0,0
147985,14,0,0
147986,(,0,0
147987,50,0,0
147988,%,0,0
147989,),0,0
147990,had,0,0
147991,decreased,0,0
147992,bladder,0,0
147993,capacity,0,0
147994,.,0,0
147995,After,0,0
147996,treatment,0,0
147997,11,0,0
147998,group,0,0
147999,1,0,0
148000,patients,0,0
148001,(,0,0
148002,78.6,0,0
148003,%,0,0
148004,),0,0
148005,had,0,0
148006,a,0,0
148007,partial,0,0
148008,or,0,0
148009,full,0,0
148010,response,0,0
148011,to,0,0
148012,posterior,0,1
148013,tibial,0,1
148014,nerve,0,0
148015,stimulation,0,1
148016,but,0,0
148017,only,0,0
148018,2,0,0
148019,(,0,0
148020,14.3,0,0
148021,%,0,0
148022,),0,0
148023,in,0,0
148024,group,0,0
148025,2,0,0
148026,had,0,0
148027,a,0,0
148028,partial,0,0
148029,response,0,0
148030,(,0,0
148031,p,0,0
148032,=,0,0
148033,0.002,0,0
148034,),0,0
148035,.,0,0
148036,Also,0,0
148037,",",0,0
148038,the,0,0
148039,average,0,0
148040,number,0,0
148041,of,0,0
148042,wet,0,0
148043,nights,0,0
148044,in,0,0
148045,group,0,0
148046,1,0,0
148047,was,0,0
148048,significantly,0,0
148049,lower,0,0
148050,than,0,0
148051,at,0,0
148052,baseline,0,0
148053,(,0,0
148054,p,0,0
148055,=,0,0
148056,0.002,0,0
148057,),0,0
148058,.,0,0
148059,All,0,0
148060,urodynamic,0,0
148061,parameters,0,0
148062,significantly,0,0
148063,improved,0,0
148064,in,0,0
148065,group,0,0
148066,1,0,0
148067,.,0,0
148068,In,0,0
148069,contrast,0,0
148070,",",0,0
148071,the,0,0
148072,number,0,0
148073,of,0,0
148074,wet,0,1
148075,nights,0,0
148076,and,0,0
148077,urodynamic,0,0
148078,parameters,0,0
148079,did,0,0
148080,not,0,0
148081,change,0,0
148082,significantly,0,0
148083,in,0,0
148084,group,0,0
148085,2,0,0
148086,.,0,0
148087,At,0,0
148088,3-month,0,0
148089,followup,0,0
148090,the,0,0
148091,number,0,0
148092,of,0,0
148093,patients,0,0
148094,with,0,0
148095,a,0,0
148096,partial,0,0
148097,or,0,0
148098,full,0,0
148099,response,0,0
148100,in,0,0
148101,group,0,0
148102,1,0,0
148103,had,0,0
148104,decreased,0,0
148105,from,0,0
148106,11,0,0
148107,(,0,0
148108,78.6,0,0
148109,%,0,0
148110,),0,0
148111,to,0,0
148112,6,0,0
148113,(,0,0
148114,42.9,0,0
148115,%,0,0
148116,),0,0
148117,.,0,0
148118,No,0,0
148119,change,0,0
148120,was,0,0
148121,evident,0,0
148122,in,0,0
148123,group,0,0
148124,2,0,0
148125,.,0,0
148126,CONCLUSIONS,0,0
148127,Posterior,1,0
148128,tibial,1,1
148129,nerve,1,0
148130,stimulation,1,1
148131,can,0,0
148132,be,0,0
148133,a,0,0
148134,viable,0,0
148135,treatment,0,0
148136,option,0,0
148137,in,0,0
148138,some,0,0
148139,patients,0,0
148140,with,0,0
148141,refractory,0,0
148142,monosymptomatic,0,0
148143,nocturnal,0,0
148144,enuresis,0,0
148145,.,0,0
148146,However,0,0
148147,",",0,0
148148,deterioration,0,0
148149,in,0,0
148150,some,0,0
148151,responders,0,0
148152,with,0,0
148153,time,0,0
148154,suggests,0,0
148155,the,0,0
148156,need,0,0
148157,for,0,0
148158,maintenance,0,0
148159,protocols,0,0
148160,.,0,0
148161,Acceleration,0,0
148162,of,0,0
148163,insulin,0,1
148164,pharmacodynamic,0,0
148165,profile,0,0
148166,by,0,0
148167,a,0,0
148168,novel,0,0
148169,insulin,1,1
148170,infusion,1,1
148171,site,1,0
148172,warming,1,0
148173,device,1,1
148174,.,1,0
148175,BACKGROUND,0,0
148176,AND,0,0
148177,OBJECTIVE,0,0
148178,Subcutaneously,0,0
148179,injected,0,1
148180,rapid-acting,0,1
148181,insulin,0,0
148182,analogs,0,0
148183,do,0,0
148184,not,0,0
148185,replicate,0,0
148186,physiologic,0,0
148187,insulin,0,1
148188,action,0,0
148189,due,0,0
148190,to,0,0
148191,delays,0,0
148192,in,0,0
148193,their,0,0
148194,onset,0,0
148195,and,0,0
148196,peak,0,0
148197,action,0,0
148198,resulting,0,0
148199,in,0,0
148200,postprandial,0,0
148201,glucose,0,0
148202,excursions,0,0
148203,.,0,0
148204,The,1,0
148205,InsuPatch,1,0
148206,(,1,0
148207,IP,1,1
148208,),1,1
148209,is,0,0
148210,a,0,0
148211,novel,0,0
148212,insulin,0,1
148213,infusion,0,1
148214,site,0,0
148215,warming,0,0
148216,device,0,1
148217,developed,0,0
148218,to,0,0
148219,accelerate,0,0
148220,insulin,0,1
148221,action,0,0
148222,by,0,0
148223,increasing,0,0
148224,blood,0,0
148225,flow,0,0
148226,to,0,0
148227,the,0,0
148228,area,0,0
148229,of,0,0
148230,insulin,0,1
148231,absorption,0,0
148232,.,0,0
148233,Thirteen,0,0
148234,adolescents,0,0
148235,with,0,0
148236,type,0,0
148237,1,0,0
148238,diabetes,0,0
148239,(,0,0
148240,T1D,0,0
148241,",",0,0
148242,mean,0,0
148243,age,0,0
148244,14,0,0
148245,?,0,0
148246,4,0,0
148247,yr,0,0
148248,),0,0
148249,were,0,0
148250,enrolled,0,0
148251,in,0,0
148252,this,0,0
148253,study,0,0
148254,to,0,0
148255,investigate,0,0
148256,the,0,0
148257,effect,0,0
148258,of,0,0
148259,the,0,0
148260,IP,1,0
148261,on,0,0
148262,the,0,0
148263,pharmacodynamics,0,0
148264,and,0,0
148265,pharmacokinetics,0,0
148266,of,0,0
148267,a,0,0
148268,0.2,0,0
148269,unit/kg,0,0
148270,bolus,0,1
148271,dose,1,0
148272,of,1,0
148273,aspart,1,1
148274,insulin,1,1
148275,using,1,0
148276,the,1,0
148277,euglycemic,1,0
148278,clamp,1,1
148279,technique,1,1
148280,.,1,0
148281,RESEARCH,1,0
148282,DESIGN,0,0
148283,AND,0,0
148284,METHODS,0,0
148285,Each,0,0
148286,subject,0,0
148287,underwent,0,0
148288,two,1,0
148289,euglycemic,1,0
148290,clamp,1,1
148291,procedures,1,0
148292,on,1,0
148293,separate,1,0
148294,occasions,0,0
148295,:,0,0
148296,one,0,0
148297,with,0,0
148298,IP,1,1
148299,and,0,0
148300,one,1,0
148301,without,1,0
148302,IP,1,1
148303,activation,1,0
148304,in,0,0
148305,random,0,0
148306,order,0,0
148307,.,0,0
148308,RESULTS,0,0
148309,When,0,0
148310,the,0,0
148311,insulin,0,1
148312,bolus,0,1
148313,was,0,0
148314,given,0,0
148315,with,0,0
148316,IP,0,1
148317,activation,0,0
148318,as,0,0
148319,compared,0,0
148320,to,0,0
148321,without,0,0
148322,IP,0,1
148323,activation,0,0
148324,",",0,0
148325,time,0,0
148326,to,0,0
148327,reach,0,0
148328,maximum,0,0
148329,insulin,0,1
148330,action,0,0
148331,(,0,1
148332,T,0,0
148333,(,0,1
148334,GIRmax,0,1
148335,),0,1
148336,),0,0
148337,and,0,0
148338,to,0,0
148339,reach,0,0
148340,50,0,0
148341,%,0,0
148342,maximum,0,0
148343,action,0,0
148344,(,0,1
148345,T,0,0
148346,(,0,0
148347,50,0,0
148348,%,0,0
148349,GIRmax,0,0
148350,),0,0
148351,),0,0
148352,were,0,0
148353,35,0,0
148354,and,0,0
148355,18,0,0
148356,min,0,0
148357,earlier,0,0
148358,(,0,0
148359,125,0,0
148360,?,0,0
148361,8,0,0
148362,min,0,0
148363,vs.,0,0
148364,90,0,0
148365,?,0,0
148366,6,0,0
148367,min,0,0
148368,",",0,0
148369,p,0,0
148370,=,0,0
148371,0.002,0,0
148372,and,0,0
148373,58,0,0
148374,?,0,0
148375,5,0,0
148376,min,0,0
148377,.,0,0
148378,vs.,0,0
148379,40,0,0
148380,?,0,0
148381,3,0,0
148382,min,0,0
148383,",",0,0
148384,p,0,0
148385,=,0,0
148386,0.01,0,0
148387,",",0,0
148388,respectively,0,0
148389,),0,0
148390,",",0,0
148391,and,0,0
148392,the,0,0
148393,area,0,0
148394,under,0,0
148395,curve,0,0
148396,",",0,0
148397,AUC,0,0
148398,(,0,0
148399,GIR,0,1
148400,0-90,0,0
148401,min,0,1
148402,),0,0
148403,",",0,0
148404,reflecting,0,0
148405,early,0,0
148406,glucodynamic,0,1
148407,action,0,0
148408,",",0,0
148409,was,0,0
148410,significantly,0,0
148411,greater,0,0
148412,(,0,0
148413,p,0,0
148414,=,0,0
148415,0.001,0,0
148416,),0,0
148417,.,0,0
148418,IP,0,0
148419,activation,0,0
148420,also,0,0
148421,accelerated,0,1
148422,the,0,0
148423,rise,0,0
148424,in,0,0
148425,plasma,0,0
148426,insulin,0,0
148427,levels,0,0
148428,after,0,0
148429,the,0,0
148430,bolus,0,1
148431,(,0,0
148432,p,0,0
148433,=,0,0
148434,0.03,0,0
148435,),0,0
148436,and,0,0
148437,resulted,0,0
148438,in,0,0
148439,a,0,0
148440,higher,0,0
148441,peak,0,0
148442,(,0,0
148443,p,0,0
148444,=,0,0
148445,0.04,0,0
148446,),0,0
148447,and,0,0
148448,greater,0,0
148449,overall,0,0
148450,increase,0,0
148451,(,0,0
148452,p,0,0
148453,=,0,0
148454,0.02,0,0
148455,),0,0
148456,in,0,0
148457,plasma,0,0
148458,insulin,0,0
148459,levels,0,0
148460,.,0,0
148461,CONCLUSIONS,0,0
148462,Our,0,0
148463,results,1,0
148464,show,1,0
148465,that,1,0
148466,insulin,1,1
148467,infusion,1,1
148468,site,0,0
148469,warming,0,0
148470,with,0,0
148471,IP,0,1
148472,activation,0,0
148473,accelerates,0,0
148474,the,0,0
148475,time,0,0
148476,action,0,0
148477,profile,0,0
148478,of,0,0
148479,aspart,0,1
148480,insulin,0,1
148481,which,0,0
148482,may,0,0
148483,be,0,0
148484,of,0,0
148485,benefit,0,0
148486,to,0,0
148487,current,0,0
148488,open-loop,0,1
148489,and,0,0
148490,future,0,0
148491,closed-loop,0,1
148492,insulin,0,1
148493,delivery,0,0
148494,in,0,0
148495,patients,0,0
148496,with,0,0
148497,T1D,0,0
148498,.,0,0
148499,Effects,0,0
148500,of,0,0
148501,strontium,1,1
148502,on,0,0
148503,the,0,0
148504,quality,0,0
148505,of,0,0
148506,bone,0,0
148507,apatite,0,0
148508,crystals,0,0
148509,:,0,0
148510,a,0,0
148511,paired,0,0
148512,biopsy,0,1
148513,study,0,0
148514,in,0,0
148515,postmenopausal,0,0
148516,osteoporotic,0,0
148517,women,0,0
148518,.,0,0
148519,UNLABELLED,0,0
148520,In,0,0
148521,paired,0,0
148522,biopsies,0,0
148523,of,0,0
148524,osteoporotic,0,0
148525,women,0,0
148526,treated,0,0
148527,with,0,0
148528,either,0,0
148529,strontium,1,1
148530,ranelate,1,1
148531,or,0,1
148532,a,0,0
148533,placebo,1,1
148534,for,0,0
148535,36,0,0
148536,months,0,0
148537,",",0,0
148538,characteristics,0,0
148539,of,0,0
148540,bone,0,0
148541,apatite,0,0
148542,crystals,0,0
148543,were,0,0
148544,not,0,0
148545,influenced,0,0
148546,by,0,0
148547,the,0,0
148548,presence,0,0
148549,of,0,0
148550,strontium,1,1
148551,.,1,0
148552,The,0,0
148553,mean,0,0
148554,rate,0,0
148555,of,0,0
148556,substitutions,0,0
148557,of,0,0
148558,calcium,0,1
148559,by,0,0
148560,strontium,0,1
148561,ions,0,0
148562,was,0,0
148563,4.5,0,0
148564,%,0,0
148565,.,0,0
148566,INTRODUCTION,0,0
148567,The,0,0
148568,potential,0,0
148569,effect,0,0
148570,of,0,0
148571,strontium,1,1
148572,(,0,0
148573,Sr,0,0
148574,),0,0
148575,on,0,0
148576,bone,0,0
148577,apatite,0,0
148578,crystals,0,0
148579,was,0,0
148580,investigated,0,0
148581,in,0,0
148582,paired,0,0
148583,biopsies,0,0
148584,of,0,0
148585,osteoporotic,0,0
148586,women,0,0
148587,treated,0,0
148588,with,0,0
148589,either,0,0
148590,strontium,1,1
148591,ranelate,1,1
148592,(,1,0
148593,SrRan,1,0
148594,),1,0
148595,or,0,1
148596,a,0,0
148597,placebo,1,1
148598,for,0,0
148599,36,0,0
148600,months,0,0
148601,.,0,0
148602,METHODS,0,0
148603,In,0,0
148604,ten,0,0
148605,paired,0,0
148606,biopsies,0,0
148607,",",0,0
148608,crystallinity,0,0
148609,",",0,0
148610,apparent,0,0
148611,length,0,0
148612,and,0,0
148613,width/thickness,0,0
148614,of,0,0
148615,crystals,0,0
148616,",",0,0
148617,interplanar,0,0
148618,distances,0,0
148619,",",0,0
148620,and,0,0
148621,lattice,0,0
148622,parameters,0,0
148623,of,0,0
148624,unit,0,0
148625,cells,0,0
148626,were,0,0
148627,assessed,0,0
148628,by,0,0
148629,X-ray,0,0
148630,diffraction,0,0
148631,and,0,0
148632,selected,0,0
148633,area,0,0
148634,electron,0,0
148635,diffraction,0,0
148636,.,0,0
148637,RESULTS,0,0
148638,All,0,0
148639,these,0,0
148640,parameters,0,0
148641,",",0,0
148642,reflecting,0,0
148643,crystal,0,0
148644,and,0,0
148645,unit,0,0
148646,cell,0,0
148647,characteristics,0,0
148648,",",0,0
148649,were,0,0
148650,not,0,0
148651,influenced,0,0
148652,by,0,0
148653,the,0,0
148654,presence,0,0
148655,of,0,0
148656,Sr,0,0
148657,and,0,0
148658,were,0,0
148659,similar,0,0
148660,in,0,0
148661,SrRan,1,0
148662,and,0,0
148663,placebo,1,1
148664,groups,0,0
148665,after,0,0
148666,36,0,0
148667,months,0,0
148668,of,0,0
148669,treatment,0,0
148670,.,0,0
148671,The,0,0
148672,mean,0,0
148673,rate,0,0
148674,of,0,0
148675,substitutions,0,0
148676,of,0,0
148677,calcium,0,1
148678,by,0,0
148679,Sr,0,0
148680,ions,0,0
148681,was,0,0
148682,4.5,0,0
148683,%,0,0
148684,.,0,0
148685,CONCLUSION,0,0
148686,Overall,0,0
148687,",",0,0
148688,the,0,0
148689,quality,0,0
148690,of,0,0
148691,bone,0,0
148692,apatite,0,0
148693,crystals,0,0
148694,was,0,0
148695,maintained,0,0
148696,after,0,0
148697,36,0,0
148698,months,0,0
148699,of,0,0
148700,treatment,0,0
148701,with,0,0
148702,SrRan,1,0
148703,.,1,0
148704,Social,0,0
148705,robots,0,1
148706,as,0,0
148707,embedded,0,0
148708,reinforcers,0,1
148709,of,0,0
148710,social,0,0
148711,behavior,0,0
148712,in,0,0
148713,children,0,0
148714,with,0,0
148715,autism,0,0
148716,.,0,0
148717,In,0,0
148718,this,0,0
148719,study,0,0
148720,we,0,0
148721,examined,0,0
148722,the,0,0
148723,social,0,0
148724,behaviors,0,0
148725,of,0,0
148726,4-,0,1
148727,to,0,0
148728,12-year-old,0,0
148729,children,0,0
148730,with,0,0
148731,autism,0,0
148732,spectrum,0,0
148733,disorders,0,0
148734,(,0,0
148735,ASD,0,0
148736,;,0,0
148737,N,0,0
148738,=,0,0
148739,24,0,0
148740,),0,0
148741,during,0,0
148742,three,0,0
148743,tradic,0,0
148744,interactions,0,0
148745,with,0,0
148746,an,0,0
148747,adult,1,0
148748,confederate,1,1
148749,and,1,0
148750,an,1,0
148751,interaction,1,0
148752,partner,1,0
148753,",",1,0
148754,where,0,0
148755,the,0,0
148756,interaction,0,0
148757,partner,0,0
148758,varied,0,0
148759,randomly,0,0
148760,among,0,0
148761,(,0,0
148762,1,0,0
148763,),1,0
148764,another,1,0
148765,adult,1,0
148766,human,1,0
148767,",",1,0
148768,(,1,0
148769,2,1,0
148770,),1,0
148771,a,1,0
148772,touchscreen,1,1
148773,computer,1,1
148774,game,1,1
148775,",",1,0
148776,and,1,0
148777,(,1,0
148778,3,1,0
148779,),1,0
148780,a,1,0
148781,social,1,1
148782,dinosaur,1,0
148783,robot,1,1
148784,.,1,0
148785,Children,0,0
148786,spoke,0,0
148787,more,0,0
148788,in,0,0
148789,general,0,0
148790,",",0,0
148791,and,0,0
148792,directed,0,0
148793,more,0,0
148794,speech,0,0
148795,to,0,0
148796,the,0,0
148797,adult,0,0
148798,confederate,0,0
148799,",",0,0
148800,when,0,0
148801,the,0,0
148802,interaction,0,0
148803,partner,0,0
148804,was,0,0
148805,a,0,0
148806,robot,0,1
148807,",",0,0
148808,as,0,0
148809,compared,0,0
148810,to,0,0
148811,a,0,0
148812,human,0,0
148813,or,0,1
148814,computer,0,1
148815,game,0,1
148816,interaction,0,0
148817,partner,0,0
148818,.,0,0
148819,Children,0,0
148820,spoke,0,0
148821,as,0,0
148822,much,0,0
148823,to,0,0
148824,the,0,0
148825,robot,0,1
148826,as,0,0
148827,to,0,0
148828,the,0,0
148829,adult,0,0
148830,interaction,0,0
148831,partner,0,0
148832,.,0,0
148833,This,0,0
148834,study,0,0
148835,provides,0,0
148836,the,0,0
148837,largest,0,0
148838,demonstration,0,0
148839,of,0,0
148840,social,0,0
148841,human-robot,0,1
148842,interaction,0,0
148843,in,0,0
148844,children,0,0
148845,with,0,0
148846,autism,0,0
148847,to,0,0
148848,date,0,0
148849,.,0,0
148850,Our,0,0
148851,findings,0,0
148852,suggest,0,0
148853,that,0,0
148854,social,0,0
148855,robots,0,1
148856,may,0,0
148857,be,0,0
148858,developed,0,0
148859,into,0,0
148860,useful,0,0
148861,tools,0,0
148862,for,0,0
148863,social,0,0
148864,skills,0,1
148865,and,0,0
148866,communication,0,0
148867,therapies,0,0
148868,",",0,0
148869,specifically,0,0
148870,by,0,0
148871,embedding,0,0
148872,social,0,0
148873,interaction,0,0
148874,into,0,0
148875,intrinsic,0,0
148876,reinforcers,0,1
148877,and,0,0
148878,motivators,0,0
148879,.,0,0
148880,Clinical,0,0
148881,trial,0,0
148882,:,0,0
148883,marine,1,0
148884,lipid,1,0
148885,suppositories,1,1
148886,as,0,0
148887,laxatives,0,1
148888,.,0,0
148889,UNLABELLED,0,0
148890,Cod-liver,0,1
148891,oil,0,1
148892,and,0,0
148893,other,0,0
148894,marine,0,0
148895,products,0,0
148896,containing,0,0
148897,polyunsaturated,0,1
148898,fatty,0,1
148899,acids,0,1
148900,have,0,0
148901,anti-inflammatory,0,0
148902,",",0,0
148903,anti-bacterial,0,0
148904,and,0,0
148905,anti-viral,0,1
148906,effects,0,0
148907,and,0,0
148908,may,0,0
148909,be,0,0
148910,useful,0,0
148911,in,0,0
148912,the,0,0
148913,treatment,0,0
148914,of,0,0
148915,various,0,0
148916,inflammatory,0,0
148917,and,0,0
148918,infectious,0,0
148919,diseases,0,0
148920,.,0,0
148921,We,0,0
148922,developed,0,0
148923,suppositories,1,1
148924,and,1,0
148925,ointment,1,1
148926,with,1,0
148927,30,1,0
148928,%,1,0
148929,free,1,0
148930,fatty,1,1
148931,acid,1,1
148932,(,1,0
148933,FFA,1,0
148934,),1,0
148935,extract,1,1
148936,from,1,0
148937,omega-3,1,1
148938,fish,1,1
148939,oil,1,1
148940,.,1,0
148941,Our,0,0
148942,purpose,0,0
148943,was,0,0
148944,to,0,0
148945,evaluate,0,0
148946,the,0,0
148947,safety,0,0
148948,of,0,0
148949,marine,0,0
148950,lipid,0,0
148951,suppositories,0,1
148952,and,0,0
148953,ointment,0,1
148954,in,0,0
148955,healthy,0,0
148956,volunteers,0,0
148957,and,0,0
148958,to,0,0
148959,explore,0,0
148960,the,0,0
148961,laxative,0,1
148962,effect,0,0
148963,of,0,0
148964,the,0,0
148965,suppositories,0,1
148966,.,0,0
148967,Thirty,0,0
148968,healthy,0,0
148969,volunteers,0,0
148970,were,0,0
148971,randomized,0,0
148972,either,0,0
148973,to,0,0
148974,a,0,0
148975,study,0,0
148976,group,0,0
148977,administrating,0,0
148978,30,0,0
148979,%,0,0
148980,FFA,1,0
148981,suppositories,1,1
148982,and,0,0
148983,applying,0,0
148984,30,0,0
148985,%,0,0
148986,FFA,1,0
148987,ointment,1,1
148988,to,0,0
148989,the,0,0
148990,perianal,0,0
148991,region,0,0
148992,twice,0,0
148993,per,0,0
148994,day,0,0
148995,for,0,0
148996,two,0,0
148997,weeks,0,0
148998,",",0,0
148999,or,0,0
149000,to,0,0
149001,a,0,0
149002,control,0,1
149003,group,0,0
149004,using,0,0
149005,placebo,1,1
149006,suppositories,1,1
149007,and,0,0
149008,ointment,0,1
149009,in,0,0
149010,a,0,0
149011,double,0,0
149012,blinded,0,0
149013,manner,0,0
149014,.,0,0
149015,RESULTS,0,0
149016,No,0,0
149017,serious,0,0
149018,toxic,0,0
149019,effects,0,0
149020,or,0,0
149021,irritation,0,0
149022,were,0,0
149023,observed,0,0
149024,.,0,0
149025,In,0,0
149026,the,0,0
149027,study,0,0
149028,group,0,0
149029,93,0,0
149030,%,0,0
149031,felt,0,0
149032,the,0,0
149033,urge,0,0
149034,to,0,0
149035,defecate,0,0
149036,after,0,0
149037,administration,0,0
149038,of,0,0
149039,the,0,0
149040,suppositories,0,1
149041,as,0,0
149042,compared,0,0
149043,to,0,0
149044,37,0,0
149045,%,0,0
149046,in,0,0
149047,the,0,0
149048,control,0,1
149049,group,0,0
149050,(,0,0
149051,P,0,0
149052,=,0,0
149053,0.001,0,0
149054,),0,0
149055,.,0,0
149056,Subsequently,0,0
149057,90,0,0
149058,%,0,0
149059,in,0,0
149060,the,0,0
149061,study,0,0
149062,group,0,0
149063,defecated,0,0
149064,",",0,0
149065,compared,0,0
149066,to,0,0
149067,33,0,0
149068,%,0,0
149069,in,0,0
149070,the,0,0
149071,control,0,1
149072,group,0,0
149073,(,0,0
149074,P,0,0
149075,=,0,0
149076,0.001,0,0
149077,),0,0
149078,.,0,0
149079,CONCLUSION,0,0
149080,The,0,0
149081,marine,0,0
149082,lipid,0,0
149083,suppositories,0,1
149084,and,0,0
149085,ointment,0,1
149086,were,0,0
149087,well,0,0
149088,tolerated,0,0
149089,with,0,0
149090,no,0,0
149091,significant,0,0
149092,toxic,0,0
149093,side,0,0
149094,effects,0,0
149095,observed,0,0
149096,during,0,0
149097,the,0,0
149098,study,0,0
149099,period,0,0
149100,.,0,0
149101,The,0,0
149102,suppositories,0,1
149103,have,0,0
149104,a,0,0
149105,distinct,0,0
149106,laxative,0,1
149107,effect,0,0
149108,and,0,0
149109,we,0,0
149110,aim,0,0
149111,to,0,0
149112,explore,0,0
149113,this,0,0
149114,effect,0,0
149115,in,0,0
149116,further,0,0
149117,clinical,0,0
149118,trials,0,0
149119,.,0,0
149120,Prognostic,0,0
149121,interaction,0,0
149122,between,0,0
149123,expression,0,0
149124,of,0,0
149125,p53,0,0
149126,and,0,0
149127,estrogen,0,1
149128,receptor,0,0
149129,in,0,0
149130,patients,0,0
149131,with,0,0
149132,node-negative,0,0
149133,breast,0,0
149134,cancer,0,0
149135,:,0,0
149136,results,0,0
149137,from,0,0
149138,IBCSG,0,1
149139,Trials,0,1
149140,VIII,0,0
149141,and,0,0
149142,IX,0,1
149143,.,0,0
149144,INTRODUCTION,0,0
149145,The,0,0
149146,prognostic,0,0
149147,significance,0,0
149148,of,0,0
149149,p53,0,0
149150,protein,0,1
149151,expression,0,0
149152,in,0,0
149153,early,0,0
149154,breast,0,0
149155,cancer,0,0
149156,remains,0,0
149157,uncertain,0,0
149158,",",0,0
149159,with,0,0
149160,some,0,0
149161,but,0,0
149162,not,0,0
149163,all,0,0
149164,studies,0,0
149165,finding,0,0
149166,an,0,0
149167,association,0,0
149168,with,0,0
149169,poorer,0,0
149170,outcomes,0,0
149171,.,0,0
149172,Estrogen,0,0
149173,receptor,0,0
149174,(,0,0
149175,ER,0,1
149176,),0,0
149177,expression,0,0
149178,is,0,0
149179,both,0,0
149180,a,0,0
149181,positive,0,0
149182,prognostic,0,0
149183,marker,0,0
149184,and,0,0
149185,predictive,0,0
149186,of,0,0
149187,response,0,0
149188,to,0,0
149189,endocrine,0,0
149190,therapies,0,0
149191,.,0,0
149192,The,0,0
149193,relationship,0,0
149194,between,0,0
149195,these,0,0
149196,biomarkers,0,0
149197,is,0,0
149198,unknown,0,0
149199,.,0,0
149200,METHODS,0,0
149201,We,0,0
149202,constructed,0,0
149203,tissue,0,0
149204,microarrays,0,0
149205,(,0,0
149206,TMAs,0,0
149207,),0,0
149208,from,0,0
149209,available,0,0
149210,pathological,0,0
149211,material,0,0
149212,from,0,0
149213,1113,0,0
149214,patients,0,0
149215,participating,0,0
149216,in,0,0
149217,two,0,0
149218,randomized,0,0
149219,clinical,0,0
149220,trials,0,0
149221,comparing,0,0
149222,endocrine,1,0
149223,therapy,1,1
149224,alone,1,1
149225,versus,1,0
149226,chemo-endocrine,1,1
149227,therapy,1,1
149228,in,1,0
149229,node-negative,0,0
149230,breast,0,0
149231,cancer,0,0
149232,.,0,0
149233,Expression,0,0
149234,of,0,0
149235,p53,0,0
149236,defined,0,0
149237,as,0,0
149238,>,0,0
149239,10,0,0
149240,%,0,0
149241,positive,0,0
149242,nuclei,0,0
149243,was,0,0
149244,analyzed,0,0
149245,together,0,0
149246,with,0,0
149247,prior,0,0
149248,immunohistochemical,0,0
149249,assays,0,0
149250,of,0,0
149251,ER,0,0
149252,performed,0,0
149253,at,0,0
149254,central,0,0
149255,pathological,0,0
149256,review,0,0
149257,of,0,0
149258,whole,0,0
149259,tumor,0,0
149260,sections,0,0
149261,.,0,0
149262,RESULTS,0,0
149263,ER,0,0
149264,was,0,0
149265,present,0,0
149266,(,0,0
149267,i.e,0,0
149268,.,0,0
149269,>,0,0
149270,1,0,0
149271,%,0,0
149272,positive,0,0
149273,tumor,0,0
149274,cell,0,0
149275,nuclei,0,1
149276,),0,0
149277,in,0,0
149278,80.1,0,0
149279,%,0,0
149280,(,0,0
149281,880/1092,0,0
149282,),0,0
149283,.,0,0
149284,p53,0,0
149285,expression,0,0
149286,was,0,0
149287,significantly,0,0
149288,more,0,0
149289,frequent,0,0
149290,when,0,0
149291,ER,0,0
149292,was,0,0
149293,absent,0,0
149294,",",0,0
149295,125/212,0,0
149296,(,0,0
149297,59,0,0
149298,%,0,0
149299,),0,0
149300,than,0,0
149301,when,0,0
149302,ER,0,0
149303,was,0,0
149304,present,0,0
149305,",",0,0
149306,171/880,0,0
149307,(,0,0
149308,19,0,0
149309,%,0,0
149310,),0,0
149311,",",0,0
149312,p,0,0
149313,<,0,0
149314,0.0001,0,0
149315,.,0,0
149316,A,0,0
149317,significant,0,0
149318,qualitative,0,0
149319,interaction,0,0
149320,was,0,0
149321,observed,0,0
149322,such,0,0
149323,that,0,0
149324,p53,0,0
149325,expression,0,0
149326,was,0,0
149327,associated,0,0
149328,with,0,0
149329,better,0,0
149330,disease-free,0,0
149331,survival,0,0
149332,(,0,0
149333,DFS,0,0
149334,),0,1
149335,and,0,0
149336,overall,0,0
149337,survival,0,0
149338,(,0,0
149339,OS,0,0
149340,),0,0
149341,among,0,0
149342,patients,0,0
149343,whose,0,0
149344,tumors,0,0
149345,did,0,0
149346,not,0,0
149347,express,0,0
149348,ER,0,0
149349,",",0,0
149350,but,0,0
149351,worse,0,0
149352,DFS,0,0
149353,and,0,0
149354,OS,0,0
149355,among,0,0
149356,patients,0,0
149357,whose,0,0
149358,tumors,0,0
149359,expressed,0,0
149360,ER,0,0
149361,.,0,0
149362,The,0,0
149363,interaction,0,0
149364,remained,0,0
149365,significant,0,0
149366,after,0,0
149367,allowance,0,0
149368,for,0,0
149369,pathologic,0,0
149370,variables,0,0
149371,",",0,0
149372,and,0,0
149373,treatment,0,0
149374,.,0,0
149375,Similar,0,0
149376,effects,0,0
149377,were,0,0
149378,seen,0,0
149379,when,0,0
149380,luminal,0,0
149381,and,0,0
149382,non-luminal,0,0
149383,intrinsic,0,0
149384,subtypes,0,0
149385,were,0,0
149386,compared,0,0
149387,.,0,0
149388,CONCLUSIONS,0,0
149389,Interpretation,0,0
149390,of,0,0
149391,the,0,0
149392,prognostic,0,0
149393,significance,0,0
149394,of,0,0
149395,p53,0,0
149396,expression,0,0
149397,requires,0,0
149398,knowledge,0,0
149399,of,0,0
149400,concurrent,0,1
149401,expression,0,0
149402,of,0,0
149403,ER,0,0
149404,.,0,0
149405,The,0,0
149406,reason,0,0
149407,for,0,0
149408,the,0,0
149409,interaction,0,0
149410,between,0,0
149411,p53,0,0
149412,and,0,0
149413,ER,0,1
149414,is,0,0
149415,unknown,0,0
149416,but,0,0
149417,may,0,0
149418,reflect,0,0
149419,qualitatively,0,0
149420,different,0,0
149421,p53,0,0
149422,mutations,0,0
149423,underlying,0,0
149424,the,0,0
149425,p53,0,0
149426,expression,0,0
149427,in,0,0
149428,tumors,0,0
149429,with,0,0
149430,or,0,0
149431,without,0,0
149432,ER,0,0
149433,expression,0,0
149434,.,0,0
149435,TRIAL,0,0
149436,REGISTRATION,0,0
149437,Current,0,0
149438,Controlled,0,0
149439,Trials,0,1
149440,ACTRN12607000037404,0,1
149441,(,0,0
149442,Trial,0,1
149443,VIII,0,1
149444,),0,0
149445,and,0,0
149446,ACTRN12607000029493,0,1
149447,(,0,0
149448,Trial,0,1
149449,IX,0,1
149450,),0,0
149451,.,0,0
149452,Thrombin-activatable,1,0
149453,fibrinolysis,1,0
149454,inhibitor,1,1
149455,in,0,0
149456,hypothyroidism,0,0
149457,and,0,0
149458,hyperthyroxinaemia,0,0
149459,.,0,0
149460,Endocrine,0,0
149461,disorders,0,0
149462,affect,0,0
149463,both,0,0
149464,the,0,0
149465,coagulation,0,0
149466,and,0,0
149467,fibrinolytic,0,0
149468,systems,0,0
149469,",",0,0
149470,and,0,0
149471,have,0,0
149472,been,0,0
149473,associated,0,0
149474,with,0,0
149475,the,0,0
149476,development,0,0
149477,of,0,0
149478,cardiovascular,0,0
149479,diseases,0,0
149480,.,0,0
149481,Thrombin-activatable,1,0
149482,fibrinolysis,1,0
149483,inhibitor,1,1
149484,(,1,0
149485,TAFI,1,1
149486,),1,1
149487,is,0,0
149488,a,0,0
149489,link,0,0
149490,between,0,0
149491,coagulation,0,0
149492,and,0,0
149493,the,0,0
149494,fibrinolytic,0,0
149495,system,0,0
149496,.,0,0
149497,The,0,0
149498,aim,0,0
149499,of,0,0
149500,this,0,0
149501,study,0,0
149502,was,0,0
149503,to,0,0
149504,determine,0,0
149505,the,0,0
149506,effect,0,0
149507,of,0,0
149508,thyroid,0,0
149509,hormone,0,1
149510,excess,0,0
149511,and,0,0
149512,deficiency,0,0
149513,on,0,0
149514,TAFI,1,1
149515,levels,0,0
149516,and,0,0
149517,function,0,0
149518,.,0,0
149519,The,0,0
149520,effect,0,0
149521,of,0,0
149522,hyperthyroxinemia,0,0
149523,on,0,0
149524,TAFI,1,0
149525,was,0,0
149526,studied,0,0
149527,in,0,0
149528,healthy,0,0
149529,volunteers,0,0
149530,who,0,0
149531,were,0,0
149532,randomised,0,0
149533,to,0,0
149534,receive,0,1
149535,levothyroxine,1,1
149536,or,0,1
149537,no,1,0
149538,medication,1,0
149539,for,0,0
149540,14,0,0
149541,days,0,0
149542,in,0,0
149543,a,0,0
149544,crossover,0,0
149545,design,0,0
149546,.,0,0
149547,The,0,0
149548,effect,0,0
149549,of,0,0
149550,hypothyroidism,0,0
149551,on,0,0
149552,TAFI,1,0
149553,was,0,0
149554,studied,0,0
149555,in,0,0
149556,a,0,0
149557,multicentre,0,0
149558,observational,0,0
149559,cohort,0,0
149560,study,0,0
149561,.,0,0
149562,Blood,0,0
149563,was,0,0
149564,drawn,0,0
149565,before,0,0
149566,treatment,0,0
149567,of,0,0
149568,patients,0,0
149569,with,0,0
149570,newly,0,0
149571,diagnosed,0,0
149572,hypothyroidism,0,0
149573,and,0,0
149574,when,0,0
149575,euthyroidism,0,0
149576,was,0,0
149577,achieved,0,0
149578,.,0,0
149579,Plasma,0,0
149580,clot-lysis,0,0
149581,times,0,0
149582,",",0,0
149583,activated,0,0
149584,TAFI,1,1
149585,(,1,0
149586,TAFIa,1,0
149587,),1,1
149588,-dependent,1,0
149589,prolongation,0,0
149590,of,0,0
149591,clot-lysis,0,0
149592,and,0,0
149593,TAFI,0,1
149594,levels,0,0
149595,were,0,0
149596,measured,0,0
149597,.,0,0
149598,Thyroid,0,0
149599,hormone,0,0
149600,excess,0,0
149601,resulted,0,0
149602,in,0,0
149603,a,0,0
149604,hypofibrinolytic,0,0
149605,condition,0,0
149606,and,0,0
149607,in,0,0
149608,an,0,0
149609,enhanced,0,0
149610,TAFIa-dependent,0,0
149611,prolongation,0,0
149612,of,0,0
149613,clot,0,0
149614,lysis,0,0
149615,.,0,0
149616,A,0,0
149617,trend,0,0
149618,towards,0,0
149619,decreased,0,0
149620,plasma,0,0
149621,TAFI,1,0
149622,levels,0,0
149623,was,0,0
149624,observed,0,0
149625,in,0,0
149626,healthy,0,0
149627,volunteers,0,0
149628,who,0,0
149629,used,0,0
149630,levothyroxine,1,1
149631,.,1,0
149632,Hypothyroidism,0,0
149633,resulted,0,0
149634,in,0,0
149635,hyperfibrinolysis,0,0
149636,and,0,0
149637,a,0,0
149638,reduced,0,0
149639,TAFIa-dependent,0,0
149640,prolongation,0,0
149641,of,0,0
149642,clot,0,0
149643,lysis,0,0
149644,.,0,0
149645,In,0,0
149646,conclusion,0,0
149647,",",0,0
149648,alterations,0,0
149649,of,0,0
149650,TAFIa-dependent,1,0
149651,prolongation,0,0
149652,of,0,0
149653,clot,0,0
149654,lysis,0,0
149655,in,0,0
149656,patients,0,0
149657,with,0,0
149658,thyroid,0,0
149659,disorders,0,0
149660,may,0,0
149661,cause,0,0
149662,an,0,0
149663,impaired,0,0
149664,haemostatic,0,0
149665,balance,0,0
149666,.,0,0
149667,The,0,0
149668,disturbed,0,0
149669,haemostatic,0,0
149670,balance,0,0
149671,in,0,0
149672,patients,0,0
149673,with,0,0
149674,hyperthyroidism,0,0
149675,might,0,0
149676,make,0,0
149677,them,0,0
149678,prone,0,0
149679,to,0,0
149680,thrombosis,0,0
149681,",",0,0
149682,while,0,0
149683,the,0,0
149684,risk,0,0
149685,for,0,0
149686,bleeding,0,0
149687,may,0,0
149688,increase,0,0
149689,in,0,0
149690,patients,0,0
149691,with,0,0
149692,hypothyroidism,0,0
149693,.,0,0
149694,Simvastatin,1,1
149695,reduces,0,0
149696,sympathetic,0,0
149697,outflow,0,0
149698,and,0,0
149699,augments,0,0
149700,endothelium-independent,0,1
149701,dilation,0,0
149702,in,0,0
149703,non-hyperlipidaemic,0,0
149704,primary,0,0
149705,hypertension,0,0
149706,.,0,0
149707,OBJECTIVES,0,0
149708,Previous,0,0
149709,reports,0,0
149710,",",0,0
149711,involving,0,0
149712,hypercholesterolaemic,0,0
149713,hypertensive,0,0
149714,subjects,0,0
149715,",",0,0
149716,that,0,0
149717,statins,0,1
149718,reduce,0,0
149719,muscle,0,0
149720,sympathetic,0,0
149721,nerve,0,1
149722,activity,0,0
149723,(,0,0
149724,MSNA,0,1
149725,),0,0
149726,did,0,0
149727,not,0,0
149728,investigate,0,0
149729,potential,0,0
149730,neural,0,0
149731,sites,0,0
149732,of,0,0
149733,such,0,0
149734,sympathoinhibition,0,0
149735,or,0,0
149736,determine,0,0
149737,its,0,0
149738,consequences,0,0
149739,for,0,0
149740,endothelial,0,0
149741,function,0,0
149742,or,0,1
149743,insulin,0,1
149744,resistance,0,0
149745,.,0,0
149746,This,0,0
149747,study,0,0
149748,of,0,0
149749,hypertensive,0,0
149750,subjects,0,0
149751,with,0,0
149752,lower,0,0
149753,plasma,0,0
149754,cholesterol,0,0
149755,tested,0,0
149756,the,0,0
149757,hypotheses,0,0
149758,that,0,0
149759,lipophilic,0,1
149760,simvastatin,1,1
149761,would,0,0
149762,attenuate,0,0
149763,resting,0,0
149764,sympathoexcitation,0,0
149765,and,0,0
149766,augment,0,0
149767,baroreflex,0,0
149768,modulation,0,0
149769,of,0,0
149770,MSNA,0,1
149771,and,0,0
149772,heart,0,0
149773,rate,0,0
149774,(,0,0
149775,HR,0,0
149776,),0,0
149777,",",0,0
149778,flow-mediated,0,0
149779,vasodilation,0,0
149780,and,0,0
149781,insulin,0,1
149782,sensitivity,0,0
149783,.,0,0
149784,DESIGN,0,0
149785,Prospective,0,0
149786,",",0,0
149787,randomised,0,0
149788,",",0,0
149789,double-blind,0,0
149790,",",0,0
149791,placebo-controlled,0,1
149792,crossover,0,0
149793,study,0,0
149794,.,0,0
149795,SETTING,0,0
149796,Academic,0,0
149797,hospital-based,0,0
149798,study,0,0
149799,.,0,0
149800,PATIENTS,0,0
149801,Fourteen,0,0
149802,non-hyperlipidaemic,0,0
149803,primary,0,0
149804,hypertensive,0,0
149805,subjects,0,0
149806,(,0,0
149807,10,0,0
149808,men,0,0
149809,;,0,0
149810,overall,0,0
149811,mean?SD,0,0
149812,age,0,0
149813,58?12,0,0
149814,years,0,0
149815,),0,0
149816,.,0,0
149817,INTERVENTIONS,0,0
149818,Four,0,0
149819,weeks,0,0
149820,of,0,0
149821,simvastatin,1,1
149822,(,1,0
149823,80,1,0
149824,mg/day,1,1
149825,),1,0
149826,or,1,0
149827,placebo,1,1
149828,.,1,0
149829,MAIN,0,0
149830,OUTCOME,0,0
149831,MEASURES,0,0
149832,Resting,0,0
149833,blood,0,0
149834,pressure,0,0
149835,(,0,0
149836,BP,0,0
149837,),0,0
149838,",",0,0
149839,HR,0,0
149840,",",0,0
149841,MSNA,0,0
149842,",",0,0
149843,spontaneous,0,0
149844,arterial,0,0
149845,baroreflex,0,0
149846,MSNA,0,1
149847,and,0,0
149848,HR,0,0
149849,modulation,0,0
149850,",",0,0
149851,endothelium-dependent,0,0
149852,and,0,0
149853,endothelium-independent,0,1
149854,vasodilation,0,0
149855,",",0,0
149856,and,0,0
149857,the,0,0
149858,homoeostatic,0,0
149859,model,0,0
149860,assessment,0,0
149861,of,0,0
149862,insulin,0,1
149863,resistance,0,0
149864,(,0,0
149865,HOMA-IR,0,0
149866,),0,0
149867,.,0,0
149868,RESULTS,1,0
149869,Simvastatin,1,1
149870,lowered,1,0
149871,MSNA,0,0
149872,burst,0,0
149873,frequency,0,0
149874,(,0,0
149875,from,0,0
149876,32?12,0,0
149877,to,0,0
149878,25?9,0,0
149879,bursts/min,0,0
149880,),0,0
149881,and,0,0
149882,MSNA,0,1
149883,burst,0,1
149884,incidence,0,0
149885,(,0,0
149886,from,0,0
149887,55?23,0,0
149888,%,0,0
149889,to,0,0
149890,43?17,0,0
149891,%,0,0
149892,;,0,0
149893,all,0,0
149894,p,0,0
149895,<,0,0
149896,0.01,0,0
149897,),0,0
149898,without,0,0
149899,affecting,0,0
149900,BP,0,0
149901,",",0,0
149902,HR,0,0
149903,",",0,0
149904,baroreflex,0,0
149905,modulation,0,0
149906,of,0,0
149907,either,0,0
149908,MSNA,0,0
149909,or,0,0
149910,HR,0,0
149911,",",0,0
149912,or,0,1
149913,HR,0,0
149914,variability,0,0
149915,(,0,0
149916,all,0,0
149917,p,0,0
149918,>,0,0
149919,0.05,0,0
149920,),0,0
149921,.,0,0
149922,Plasma,0,0
149923,glucose,0,0
149924,",",0,0
149925,insulin,0,0
149926,",",0,0
149927,HOMA-IR,0,0
149928,and,0,0
149929,endothelium-dependent,0,0
149930,vasodilation,0,0
149931,(,0,0
149932,all,0,0
149933,p,0,0
149934,>,0,0
149935,0.05,0,0
149936,),0,0
149937,were,0,0
149938,unchanged,0,0
149939,",",0,0
149940,whereas,0,0
149941,endothelium-independent,0,1
149942,vasodilation,0,0
149943,increased,0,0
149944,(,0,0
149945,7.1?3.8,0,0
149946,%,0,0
149947,to,0,0
149948,9.7?3.9,0,0
149949,%,0,0
149950,",",0,0
149951,n=13,0,0
149952,;,0,0
149953,p,0,0
149954,<,0,0
149955,0.01,0,0
149956,),0,0
149957,.,0,0
149958,The,0,0
149959,fall,0,0
149960,in,0,0
149961,MSNA,0,0
149962,was,0,0
149963,unrelated,0,0
149964,to,0,0
149965,the,0,0
149966,decrease,0,0
149967,in,0,0
149968,low-density,0,0
149969,lipoprotein,0,0
149970,cholesterol,0,0
149971,(,0,0
149972,r=0.41,0,0
149973,",",0,0
149974,p=0.14,0,0
149975,),0,0
149976,.,0,0
149977,CONCLUSIONS,0,0
149978,These,0,0
149979,findings,0,0
149980,are,0,0
149981,consistent,0,0
149982,with,0,0
149983,the,0,0
149984,concept,0,0
149985,that,0,0
149986,",",0,0
149987,in,0,0
149988,non-hyperlipidaemic,0,0
149989,subjects,0,0
149990,with,0,0
149991,primary,0,0
149992,hypertension,0,0
149993,",",0,0
149994,simvastatin,0,1
149995,causes,0,0
149996,a,0,0
149997,cholesterol-independent,0,0
149998,reduction,0,0
149999,in,0,0
150000,an,0,0
150001,elevated,0,0
150002,central,0,0
150003,set-point,0,0
150004,for,0,0
150005,MSNA,0,0
150006,",",0,0
150007,without,0,0
150008,affecting,0,0
150009,arterial,0,0
150010,baroreflex,0,0
150011,modulation,0,0
150012,of,0,0
150013,either,0,0
150014,MSNA,0,0
150015,or,0,0
150016,HR,0,0
150017,.,0,0
150018,There,0,0
150019,may,0,0
150020,be,0,0
150021,less,0,0
150022,neurogenic,0,0
150023,constraint,0,0
150024,on,0,0
150025,endothelium-independent,0,1
150026,vasodilation,0,0
150027,as,0,0
150028,a,0,0
150029,consequence,0,0
150030,.,0,0
150031,A,0,0
150032,phase,0,0
150033,III,0,0
150034,study,0,0
150035,of,0,0
150036,laparoscopy-assisted,1,1
150037,versus,1,0
150038,open,1,1
150039,distal,1,0
150040,gastrectomy,1,1
150041,with,0,0
150042,nodal,0,0
150043,dissection,0,0
150044,for,0,0
150045,clinical,0,0
150046,stage,0,0
150047,IA/IB,0,0
150048,gastric,0,0
150049,Cancer,0,1
150050,(,0,0
150051,JCOG0912,0,0
150052,),0,0
150053,.,0,0
150054,A,0,0
150055,Phase,0,0
150056,III,0,0
150057,study,0,0
150058,was,0,0
150059,started,0,0
150060,in,0,0
150061,Japan,0,1
150062,to,0,0
150063,evaluate,0,0
150064,the,0,0
150065,non-inferiority,0,0
150066,of,0,0
150067,overall,0,0
150068,survival,0,0
150069,of,0,0
150070,laparoscopy-assisted,1,1
150071,distal,1,0
150072,gastrectomy,1,1
150073,with,1,0
150074,open,1,0
150075,distal,1,0
150076,gastrectomy,1,0
150077,in,0,0
150078,patients,0,0
150079,with,0,0
150080,clinical,0,0
150081,IA,0,0
150082,(,0,0
150083,T1N0,0,1
150084,),0,0
150085,or,0,1
150086,IB,0,1
150087,[,0,0
150088,T1N1,0,1
150089,or,0,1
150090,T2,0,0
150091,(,0,1
150092,MP,0,1
150093,),0,0
150094,N0,0,1
150095,],0,0
150096,gastric,0,0
150097,cancer,0,0
150098,.,0,0
150099,This,0,0
150100,study,0,0
150101,followed,0,0
150102,the,0,0
150103,previous,0,0
150104,Phase,0,0
150105,II,0,0
150106,study,0,0
150107,to,0,0
150108,confirm,0,0
150109,the,0,0
150110,safety,0,0
150111,of,0,0
150112,laparoscopy-assisted,1,1
150113,distal,1,0
150114,gastrectomy,1,1
150115,(,0,0
150116,JCOG0703,0,1
150117,),0,0
150118,and,0,0
150119,began,0,0
150120,in,0,0
150121,March,0,0
150122,2010,0,0
150123,.,0,0
150124,A,0,0
150125,total,0,0
150126,of,0,0
150127,920,0,0
150128,patients,0,0
150129,will,0,0
150130,be,0,0
150131,accrued,0,0
150132,from,0,0
150133,33,0,0
150134,institutions,0,0
150135,within,0,0
150136,5,0,0
150137,years,0,0
150138,.,0,0
150139,The,0,0
150140,primary,0,0
150141,endpoint,0,0
150142,is,0,0
150143,overall,0,0
150144,survival,0,0
150145,.,0,0
150146,The,0,0
150147,secondary,0,0
150148,endpoints,0,0
150149,are,0,0
150150,relapse-free,0,0
150151,survival,0,0
150152,",",0,0
150153,proportion,0,0
150154,of,0,0
150155,laparoscopy-assisted,1,1
150156,distal,1,0
150157,gastrectomy,1,1
150158,completion,0,0
150159,",",0,0
150160,proportion,0,0
150161,of,0,0
150162,conversion,0,0
150163,to,0,0
150164,open,0,0
150165,surgery,1,0
150166,",",0,0
150167,adverse,0,0
150168,events,0,0
150169,",",0,0
150170,short-term,0,0
150171,clinical,0,0
150172,outcomes,0,0
150173,",",0,0
150174,postoperative,0,0
150175,quality,0,0
150176,of,0,0
150177,life,0,0
150178,.,0,0
150179,Only,0,0
150180,a,0,0
150181,credentialed,0,0
150182,surgeon,0,0
150183,can,0,0
150184,be,0,0
150185,responsible,0,0
150186,for,0,0
150187,both,0,0
150188,open,1,0
150189,distal,1,0
150190,gastrectomy,1,1
150191,and,0,0
150192,laparoscopy-assisted,1,1
150193,distal,1,0
150194,gastrectomy,1,0
150195,.,0,0
150196,Treatment,0,0
150197,of,0,0
150198,adults,0,0
150199,with,0,0
150200,acute,0,0
150201,lymphoblastic,0,0
150202,leukemia,0,0
150203,:,0,0
150204,do,0,0
150205,the,0,0
150206,specifics,0,0
150207,of,0,0
150208,the,0,0
150209,regimen,0,0
150210,matter,0,0
150211,?,0,0
150212,:,0,0
150213,Results,0,0
150214,from,0,0
150215,a,0,0
150216,prospective,0,0
150217,randomized,0,0
150218,trial,0,0
150219,.,0,0
150220,BACKGROUND,0,0
150221,Induction,0,1
150222,therapy,0,1
150223,for,0,0
150224,adults,0,0
150225,with,0,0
150226,acute,0,0
150227,lymphoblastic,0,0
150228,leukemia,0,0
150229,(,0,0
150230,ALL,0,0
150231,),0,0
150232,is,0,0
150233,similar,0,0
150234,across,0,0
150235,essentially,0,0
150236,all,0,0
150237,regimens,0,0
150238,",",0,0
150239,comprised,0,0
150240,of,0,0
150241,vincristine,1,1
150242,",",1,0
150243,corticosteroids,1,1
150244,",",1,0
150245,and,1,0
150246,anthracyclines,1,1
150247,intensified,1,0
150248,with,1,0
150249,cyclophosphamide,1,1
150250,",",1,0
150251,asparaginase,1,1
150252,",",1,0
150253,or,1,0
150254,both,1,0
150255,.,1,0
150256,Given,0,0
150257,the,0,0
150258,lack,0,0
150259,of,0,0
150260,randomized,0,0
150261,data,0,0
150262,",",0,0
150263,to,0,0
150264,date,0,0
150265,",",0,0
150266,no,0,0
150267,regimen,0,0
150268,has,0,0
150269,emerged,0,0
150270,as,0,0
150271,standard,0,0
150272,.,0,0
150273,The,0,0
150274,authors,0,0
150275,previously,0,0
150276,evaluated,0,0
150277,cytarabine,1,1
150278,3,0,0
150279,g/m,0,1
150280,(,0,0
150281,2,0,0
150282,),0,0
150283,daily,0,0
150284,for,0,0
150285,5,0,0
150286,days,0,0
150287,with,0,0
150288,mitoxantrone,1,1
150289,80,0,0
150290,mg/m,0,1
150291,(,0,0
150292,2,0,0
150293,),0,0
150294,(,0,0
150295,the,0,0
150296,ALL-2,0,1
150297,regimen,0,1
150298,),0,0
150299,as,0,0
150300,a,0,0
150301,novel,0,0
150302,induction,0,0
150303,regimen,0,1
150304,.,0,0
150305,Compared,0,0
150306,with,0,0
150307,historic,0,0
150308,controls,0,0
150309,",",0,0
150310,the,0,0
150311,ALL-2,0,0
150312,regimen,0,0
150313,was,0,0
150314,superior,0,0
150315,in,0,0
150316,terms,0,0
150317,of,0,0
150318,incidence,0,0
150319,of,0,0
150320,complete,0,0
150321,remission,0,0
150322,",",0,0
150323,failure,0,0
150324,with,0,0
150325,resistant,0,0
150326,disease,0,0
150327,",",0,0
150328,and,0,0
150329,activity,0,0
150330,in,0,0
150331,patients,0,0
150332,with,0,0
150333,Philadelphia,0,0
150334,chromosome,0,0
150335,(,0,0
150336,Ph,0,0
150337,),0,0
150338,-positive,0,0
150339,ALL,0,0
150340,.,0,0
150341,METHODS,0,0
150342,The,0,0
150343,authors,0,0
150344,conducted,0,0
150345,a,0,0
150346,multicenter,0,0
150347,",",0,0
150348,prospective,0,0
150349,",",0,0
150350,randomized,0,0
150351,trial,0,0
150352,of,0,0
150353,the,0,0
150354,ALL-2,0,0
150355,regimen,0,1
150356,compared,0,0
150357,with,0,0
150358,a,0,0
150359,standard,0,1
150360,4-drug,1,1
150361,induction,1,1
150362,(,1,0
150363,the,1,0
150364,L-20,1,1
150365,regimen,1,0
150366,),1,0
150367,.,1,0
150368,Patients,0,0
150369,also,0,0
150370,received,0,0
150371,consolidation,1,0
150372,",",1,0
150373,maintenance,1,0
150374,therapy,1,1
150375,",",1,0
150376,and,1,0
150377,central,1,0
150378,nervous,1,0
150379,system,1,0
150380,prophylaxis,1,0
150381,.,1,0
150382,The,0,0
150383,trial,0,0
150384,accrued,0,0
150385,patients,0,0
150386,from,0,0
150387,August,0,0
150388,1996,0,0
150389,to,0,0
150390,October,0,0
150391,2004,0,0
150392,.,0,0
150393,RESULTS,0,0
150394,The,0,0
150395,median,0,0
150396,follow-up,0,0
150397,for,0,0
150398,survivors,0,0
150399,was,0,0
150400,7,0,0
150401,years,0,0
150402,",",0,0
150403,and,0,0
150404,the,0,0
150405,median,0,0
150406,patient,0,0
150407,age,0,0
150408,was,0,0
150409,43,0,0
150410,years,0,0
150411,.,0,0
150412,Responses,0,0
150413,were,0,0
150414,evaluated,0,0
150415,in,0,0
150416,164,0,0
150417,patients,0,0
150418,.,0,0
150419,The,0,0
150420,treatment,0,0
150421,arms,0,0
150422,were,0,0
150423,balanced,0,0
150424,in,0,0
150425,terms,0,0
150426,of,0,0
150427,pretreatment,0,0
150428,characteristics,0,0
150429,.,0,0
150430,The,0,0
150431,frequency,0,0
150432,of,0,0
150433,complete,0,0
150434,remission,0,0
150435,for,0,0
150436,the,0,0
150437,ALL-2,0,0
150438,regimen,0,0
150439,versus,0,0
150440,the,0,0
150441,L-20,0,1
150442,regimen,0,0
150443,was,0,0
150444,83,0,0
150445,%,0,0
150446,versus,0,0
150447,71,0,0
150448,%,0,0
150449,(,0,0
150450,P,0,0
150451,=,0,0
150452,.06,0,0
150453,),0,0
150454,.,0,0
150455,More,0,0
150456,patients,0,0
150457,on,0,0
150458,the,0,0
150459,L-20,0,1
150460,arm,0,0
150461,failed,0,0
150462,with,0,0
150463,resistant,0,0
150464,disease,0,0
150465,(,0,0
150466,21,0,0
150467,%,0,0
150468,vs,0,0
150469,8,0,0
150470,%,0,0
150471,;,0,0
150472,P,0,0
150473,=,0,0
150474,.02,0,0
150475,),0,0
150476,.,0,0
150477,Induction,0,0
150478,deaths,0,0
150479,were,0,0
150480,comparable,0,0
150481,at,0,0
150482,9,0,0
150483,%,0,0
150484,(,0,0
150485,ALL-2,0,1
150486,),0,0
150487,versus,0,0
150488,7,0,0
150489,%,0,0
150490,(,0,0
150491,L-20,0,1
150492,),0,0
150493,.,0,0
150494,The,0,0
150495,median,0,0
150496,survival,0,0
150497,was,0,0
150498,similar,0,0
150499,;,0,0
150500,and,0,0
150501,",",0,0
150502,at,0,0
150503,5,0,0
150504,years,0,0
150505,",",0,0
150506,the,0,0
150507,survival,0,0
150508,rate,0,0
150509,was,0,0
150510,33,0,0
150511,%,0,0
150512,alive,0,0
150513,on,0,0
150514,the,0,0
150515,ALL-2,0,1
150516,arm,0,0
150517,versus,0,0
150518,27,0,0
150519,%,0,0
150520,on,0,0
150521,the,0,0
150522,L-20,0,1
150523,.,0,0
150524,CONCLUSIONS,0,0
150525,Despite,0,0
150526,superior,0,0
150527,results,0,0
150528,of,0,0
150529,induction,0,0
150530,therapy,0,1
150531,with,0,0
150532,the,0,0
150533,ALL-2,0,0
150534,regimen,0,0
150535,",",0,0
150536,this,0,0
150537,treatment,0,0
150538,did,0,0
150539,not,0,0
150540,improve,0,0
150541,long-term,0,0
150542,outcomes,0,0
150543,.,0,0
150544,When,0,0
150545,coupled,0,0
150546,to,0,0
150547,the,0,0
150548,reported,0,0
150549,experience,0,0
150550,of,0,0
150551,other,0,0
150552,studies,0,0
150553,in,0,0
150554,adults,0,0
150555,with,0,0
150556,ALL,0,0
150557,",",0,0
150558,the,0,0
150559,results,0,0
150560,of,0,0
150561,this,0,0
150562,randomized,0,0
150563,trial,0,0
150564,raise,0,0
150565,the,0,0
150566,possibility,0,0
150567,that,0,0
150568,ultimate,0,0
150569,outcomes,0,0
150570,in,0,0
150571,adult,0,0
150572,ALL,0,0
150573,may,0,0
150574,be,0,0
150575,independent,0,0
150576,of,0,0
150577,the,0,0
150578,specific,0,0
150579,regimen,0,0
150580,chosen,0,0
150581,.,0,0
150582,Cancer,0,0
150583,2013,0,0
150584,.,0,0
150585,?,0,0
150586,2012,0,0
150587,American,0,0
150588,Cancer,0,0
150589,Society,0,0
150590,.,0,0
150591,The,0,0
150592,effect,0,0
150593,of,0,0
150594,cognitive-behavioral,1,1
150595,therapy,1,1
150596,versus,0,0
150597,treatment,1,0
150598,as,1,0
150599,usual,1,1
150600,for,0,0
150601,anxiety,0,0
150602,in,0,0
150603,children,0,0
150604,with,0,0
150605,autism,0,0
150606,spectrum,0,0
150607,disorders,0,0
150608,:,0,0
150609,a,0,0
150610,randomized,0,0
150611,",",0,0
150612,controlled,0,0
150613,trial,0,0
150614,.,0,0
150615,OBJECTIVE,0,0
150616,To,0,0
150617,examine,0,0
150618,the,0,0
150619,efficacy,0,0
150620,of,0,0
150621,a,0,0
150622,modular,1,0
150623,cognitive-behavioral,1,1
150624,therapy,1,1
150625,(,1,0
150626,CBT,1,1
150627,),1,0
150628,protocol,1,0
150629,relative,0,0
150630,to,0,0
150631,treatment,1,0
150632,as,1,0
150633,usual,1,1
150634,(,1,0
150635,TAU,1,1
150636,),1,0
150637,among,0,0
150638,children,0,0
150639,with,0,0
150640,high-functioning,0,0
150641,autism,0,0
150642,spectrum,0,0
150643,disorders,0,0
150644,(,0,0
150645,ASD,0,0
150646,),0,0
150647,and,0,0
150648,clinically,0,0
150649,significant,0,0
150650,anxiety,0,0
150651,.,0,0
150652,METHOD,0,0
150653,A,0,0
150654,total,0,0
150655,of,0,0
150656,45,0,0
150657,children,0,0
150658,(,0,0
150659,7-11,0,0
150660,years,0,0
150661,of,0,0
150662,age,0,0
150663,),0,0
150664,with,0,0
150665,high-functioning,0,0
150666,ASD,0,0
150667,and,0,0
150668,clinically,0,0
150669,significant,0,0
150670,anxiety,0,0
150671,were,0,0
150672,randomized,0,0
150673,to,0,0
150674,receive,0,0
150675,16,0,0
150676,sessions,0,0
150677,of,0,0
150678,weekly,1,1
150679,CBT,1,1
150680,or,1,1
150681,TAU,1,1
150682,for,0,0
150683,an,0,0
150684,equivalent,0,0
150685,duration,0,0
150686,.,0,0
150687,After,0,0
150688,screening,0,0
150689,",",0,0
150690,assessments,0,0
150691,were,0,0
150692,conducted,0,0
150693,at,0,0
150694,baseline,0,0
150695,",",0,0
150696,post-treatment,0,0
150697,",",0,0
150698,and,0,0
150699,3-month,0,0
150700,follow-up,0,0
150701,.,0,0
150702,Raters,0,0
150703,were,0,0
150704,blind,0,0
150705,to,0,0
150706,treatment,0,0
150707,condition,0,0
150708,.,0,0
150709,RESULTS,0,0
150710,Youth,0,0
150711,receiving,0,0
150712,CBT,1,1
150713,showed,0,0
150714,substantial,0,0
150715,improvement,0,0
150716,relative,0,0
150717,to,0,0
150718,TAU,1,0
150719,on,0,0
150720,primary,0,0
150721,anxiety,0,0
150722,outcomes,0,0
150723,.,0,0
150724,Of,0,0
150725,24,0,0
150726,children,0,0
150727,randomized,0,0
150728,to,0,0
150729,the,0,0
150730,CBT,1,1
150731,arm,0,0
150732,",",0,0
150733,18,0,0
150734,(,0,0
150735,75,0,0
150736,%,0,0
150737,),0,0
150738,were,0,0
150739,treatment,0,0
150740,responders,0,0
150741,",",0,0
150742,versus,0,0
150743,only,0,0
150744,3,0,0
150745,of,0,0
150746,21,0,0
150747,children,0,0
150748,(,0,0
150749,14,0,0
150750,%,0,0
150751,),0,0
150752,in,0,0
150753,the,0,0
150754,TAU,1,0
150755,arm,0,0
150756,.,0,0
150757,Gains,0,0
150758,were,0,0
150759,generally,0,0
150760,maintained,0,0
150761,at,0,0
150762,3-month,0,0
150763,follow-up,0,0
150764,for,0,0
150765,CBT,1,0
150766,responders,0,0
150767,.,0,0
150768,CONCLUSIONS,0,0
150769,Relative,0,0
150770,to,0,0
150771,usual,0,1
150772,care,0,1
150773,",",0,0
150774,CBT,1,1
150775,adapted,0,0
150776,for,0,0
150777,anxious,0,0
150778,youth,0,0
150779,with,0,0
150780,high-functioning,0,0
150781,ASD,0,0
150782,demonstrates,0,0
150783,large,0,0
150784,effects,0,0
150785,in,0,0
150786,reducing,0,0
150787,anxiety,0,0
150788,symptoms,0,0
150789,.,0,0
150790,This,0,0
150791,study,0,0
150792,contributes,0,0
150793,to,0,0
150794,the,0,0
150795,growing,0,0
150796,literature,0,0
150797,supporting,0,0
150798,adapted,0,0
150799,CBT,1,1
150800,approaches,0,0
150801,for,0,0
150802,treating,0,0
150803,anxiety,0,0
150804,in,0,0
150805,youth,0,0
150806,with,0,0
150807,ASD,0,0
150808,.,0,0
150809,Design,0,0
150810,and,0,0
150811,development,0,0
150812,of,0,0
150813,a,0,0
150814,Virtual,1,1
150815,Dolphinarium,1,0
150816,for,0,0
150817,children,0,0
150818,with,0,0
150819,autism,0,0
150820,.,0,0
150821,The,0,0
150822,recent,0,0
150823,proliferation,0,0
150824,of,0,0
150825,virtual,1,1
150826,reality,1,1
150827,(,1,0
150828,VR,1,1
150829,),1,0
150830,technology,1,0
150831,applications,1,0
150832,in,0,0
150833,the,0,0
150834,autism,0,0
150835,therapy,0,1
150836,to,0,0
150837,promote,0,0
150838,learning,0,0
150839,and,0,0
150840,positive,0,0
150841,behavior,0,0
150842,among,0,0
150843,such,0,0
150844,children,0,0
150845,has,0,0
150846,produced,0,0
150847,optimistic,0,0
150848,results,0,0
150849,in,0,0
150850,developing,0,0
150851,a,0,0
150852,variety,0,0
150853,of,0,0
150854,skills,0,0
150855,and,0,0
150856,abilities,0,0
150857,in,0,0
150858,them,0,0
150859,.,0,0
150860,Dolphin-assisted,1,1
150861,therapy,1,1
150862,has,0,0
150863,also,0,0
150864,become,0,0
150865,a,0,0
150866,topic,0,0
150867,of,0,0
150868,public,0,0
150869,and,0,0
150870,research,0,0
150871,interest,0,0
150872,for,0,0
150873,autism,0,0
150874,intervention,0,1
150875,and,0,0
150876,treatment,0,0
150877,.,0,0
150878,This,0,0
150879,paper,0,0
150880,will,0,0
150881,present,0,0
150882,an,0,0
150883,innovative,0,0
150884,design,0,0
150885,and,0,0
150886,development,0,0
150887,of,0,0
150888,a,0,0
150889,Virtual,1,1
150890,Dolphinarium,1,0
150891,for,0,0
150892,potential,0,0
150893,autism,0,0
150894,intervention,0,1
150895,.,0,0
150896,Instead,0,0
150897,of,0,0
150898,emulating,0,0
150899,the,0,0
150900,swimming,0,0
150901,with,0,0
150902,dolphins,0,0
150903,",",0,0
150904,our,0,0
150905,virtual,0,1
150906,dolphin,0,0
150907,interaction,0,0
150908,program,0,1
150909,will,0,0
150910,allow,0,0
150911,children,0,0
150912,with,0,0
150913,autism,0,0
150914,to,0,0
150915,act,0,0
150916,as,0,0
150917,dolphin,0,0
150918,trainers,0,1
150919,at,0,0
150920,the,0,0
150921,poolside,0,0
150922,and,0,0
150923,to,0,0
150924,learn,0,1
150925,(,0,0
150926,nonverbal,0,0
150927,),0,0
150928,communication,0,0
150929,through,0,0
150930,hand,0,0
150931,gestures,0,1
150932,with,0,0
150933,the,0,0
150934,virtual,0,0
150935,dolphins,0,0
150936,.,0,0
150937,Immersive,1,1
150938,visualization,1,0
150939,and,0,0
150940,gesture-based,1,0
150941,interaction,1,0
150942,are,0,0
150943,implemented,0,0
150944,to,0,0
150945,engage,0,0
150946,children,0,0
150947,with,0,0
150948,autism,0,0
150949,within,0,0
150950,an,0,0
150951,immersive,0,1
150952,room,0,0
150953,equipped,0,0
150954,with,0,0
150955,a,0,0
150956,curved,0,0
150957,screen,0,0
150958,spanning,0,0
150959,a,0,0
150960,320,0,0
150961,(,0,0
150962,?,0,0
150963,),0,0
150964,and,0,0
150965,a,0,0
150966,high-end,0,1
150967,five-panel,0,1
150968,projection,0,1
150969,system,0,0
150970,.,0,0
150971,This,0,0
150972,paper,0,0
150973,will,0,0
150974,also,0,0
150975,report,0,0
150976,a,0,0
150977,pilot,0,0
150978,study,0,0
150979,to,0,0
150980,establish,0,0
150981,trial,0,0
150982,protocol,0,0
150983,of,0,0
150984,autism,0,0
150985,screening,0,0
150986,to,0,0
150987,explore,0,0
150988,the,0,0
150989,participants,0,0
150990,',0,0
150991,readiness,0,0
150992,for,0,0
150993,the,1,0
150994,virtual,1,1
150995,dolphin,1,0
150996,interaction,1,0
150997,.,1,0
150998,This,0,0
150999,research,0,0
151000,will,0,0
151001,have,0,0
151002,two,0,0
151003,potential,0,0
151004,benefits,0,0
151005,in,0,0
151006,the,0,0
151007,sense,0,0
151008,of,0,0
151009,helping,0,0
151010,children,0,0
151011,with,0,0
151012,autism,0,0
151013,and,0,0
151014,protecting,0,0
151015,the,0,0
151016,endangered,0,0
151017,species,0,0
151018,.,0,0
151019,Practice,0,1
151020,makes,0,0
151021,improvement,0,0
151022,:,0,0
151023,how,0,0
151024,adults,0,0
151025,with,0,0
151026,autism,0,0
151027,out-perform,0,0
151028,others,0,0
151029,in,0,0
151030,a,0,0
151031,naturalistic,0,0
151032,visual,0,0
151033,search,0,0
151034,task,0,1
151035,.,0,0
151036,People,0,0
151037,with,0,0
151038,autism,0,0
151039,spectrum,0,0
151040,disorder,0,0
151041,(,0,0
151042,ASD,0,0
151043,),0,0
151044,often,0,0
151045,exhibit,0,0
151046,superior,0,0
151047,performance,0,0
151048,in,0,0
151049,visual,0,0
151050,search,0,0
151051,compared,0,0
151052,to,0,0
151053,others,0,0
151054,.,0,0
151055,However,0,0
151056,",",0,0
151057,most,0,0
151058,studies,0,0
151059,demonstrating,0,0
151060,this,0,0
151061,advantage,0,0
151062,have,0,0
151063,employed,0,0
151064,simple,0,0
151065,",",0,0
151066,uncluttered,0,0
151067,images,0,0
151068,with,0,0
151069,fully,0,0
151070,visible,0,0
151071,targets,0,0
151072,.,0,0
151073,We,0,0
151074,compare,0,0
151075,the,0,0
151076,performance,0,0
151077,of,0,0
151078,high-functioning,0,0
151079,adults,0,0
151080,with,0,0
151081,ASD,0,0
151082,and,0,0
151083,matched,0,0
151084,controls,0,0
151085,on,0,0
151086,a,0,0
151087,naturalistic,1,0
151088,luggage,1,1
151089,screening,1,0
151090,task,1,1
151091,.,1,0
151092,Although,0,0
151093,the,0,0
151094,two,0,0
151095,groups,0,0
151096,were,0,0
151097,equally,0,0
151098,accurate,0,0
151099,in,0,0
151100,detecting,0,0
151101,targets,0,0
151102,",",0,0
151103,the,0,0
151104,ASD,0,0
151105,adults,0,0
151106,improve,0,0
151107,in,0,0
151108,their,0,0
151109,correct,0,0
151110,elimination,0,0
151111,of,0,0
151112,target-absent,0,0
151113,bags,0,1
151114,faster,0,0
151115,than,0,0
151116,controls,0,0
151117,.,0,0
151118,This,0,0
151119,feature,0,0
151120,of,0,0
151121,their,0,0
151122,behavior,0,0
151123,is,0,0
151124,extremely,0,0
151125,important,0,0
151126,for,0,0
151127,many,0,0
151128,real-world,0,0
151129,monitoring,0,0
151130,tasks,0,0
151131,that,0,0
151132,require,0,0
151133,sustained,0,0
151134,attention,0,0
151135,for,0,0
151136,long,0,0
151137,time,0,0
151138,periods,0,0
151139,.,0,0
151140,Further,0,0
151141,analyses,0,0
151142,suggest,0,0
151143,that,0,0
151144,this,0,0
151145,improvement,0,0
151146,is,0,0
151147,attributable,0,0
151148,neither,0,0
151149,to,0,0
151150,the,0,0
151151,motor,0,0
151152,speed,0,0
151153,nor,0,0
151154,to,0,0
151155,the,0,0
151156,level,0,0
151157,of,0,0
151158,intelligence,0,0
151159,of,0,0
151160,the,0,0
151161,adults,0,0
151162,with,0,0
151163,ASD,0,0
151164,.,0,0
151165,These,0,0
151166,findings,0,0
151167,may,0,0
151168,have,0,0
151169,possible,0,0
151170,implications,0,0
151171,for,0,0
151172,employment,0,0
151173,opportunities,0,0
151174,of,0,0
151175,adult,0,0
151176,individuals,0,0
151177,with,0,0
151178,ASD,0,0
151179,.,0,0
151180,Heat-exercise,0,1
151181,performance,0,0
151182,of,0,0
151183,pyridostigmine-treated,1,1
151184,subjects,0,0
151185,wearing,0,0
151186,chemical,0,0
151187,protective,0,0
151188,clothing,0,1
151189,.,0,0
151190,Pyridostigmine,1,0
151191,bromide,1,1
151192,is,0,0
151193,currently,0,0
151194,the,0,0
151195,pretreatment,0,0
151196,of,0,0
151197,choice,0,0
151198,for,0,0
151199,operation,0,0
151200,in,0,0
151201,a,0,0
151202,chemical,0,1
151203,warfare,0,0
151204,(,0,0
151205,CW,0,1
151206,),0,0
151207,environment,0,0
151208,.,0,0
151209,Under,0,0
151210,CW,0,1
151211,conditions,0,0
151212,",",0,0
151213,subjects,0,0
151214,are,0,0
151215,exposed,0,0
151216,to,0,0
151217,thermal,0,0
151218,stress,0,0
151219,caused,0,0
151220,by,0,0
151221,CW,0,1
151222,protective,0,0
151223,clothing,0,1
151224,.,0,0
151225,This,0,0
151226,investigation,0,0
151227,was,0,0
151228,conducted,0,0
151229,to,0,0
151230,determine,0,0
151231,if,0,0
151232,pyridostigmine,1,1
151233,affects,0,0
151234,various,0,0
151235,physiological,0,0
151236,and,0,0
151237,biophysical,0,0
151238,parameters,0,0
151239,of,0,0
151240,human,0,0
151241,temperature,0,0
151242,regulation,0,0
151243,in,0,0
151244,subjects,0,0
151245,wearing,0,0
151246,CW,0,1
151247,protective,0,0
151248,clothing,0,1
151249,.,0,0
151250,Pyridostigmine,1,0
151251,was,1,0
151252,administered,1,0
151253,orally,1,0
151254,in,0,0
151255,a,0,0
151256,randomized,0,0
151257,double-blind,0,0
151258,cross-over,0,0
151259,study,0,0
151260,in,0,0
151261,four,0,0
151262,doses,0,0
151263,of,0,0
151264,30,0,0
151265,mg,0,0
151266,every,0,0
151267,8,0,0
151268,h.,0,0
151269,An,0,0
151270,average,0,0
151271,of,0,0
151272,33,0,0
151273,%,0,0
151274,whole,0,1
151275,blood,0,0
151276,cholinesterase,0,0
151277,inhibition,0,0
151278,was,0,0
151279,induced,0,0
151280,in,0,0
151281,the,0,0
151282,pyridostigmine,1,1
151283,treated,0,0
151284,group,0,0
151285,4,0,0
151286,h,0,0
151287,after,0,0
151288,ingestion,0,0
151289,of,0,0
151290,last,0,0
151291,tablet,0,1
151292,.,0,0
151293,The,0,0
151294,subjects,0,0
151295,were,0,0
151296,exposed,0,0
151297,to,0,0
151298,170,0,0
151299,min,0,0
151300,exercise-heat,0,1
151301,stress,0,0
151302,(,0,0
151303,Tdb,0,1
151304,=,0,0
151305,33,0,0
151306,degrees,0,0
151307,C,0,0
151308,;,0,0
151309,rh,0,0
151310,=,0,0
151311,60,0,0
151312,%,0,0
151313,),0,0
151314,consisting,0,0
151315,of,0,0
151316,60,0,0
151317,min,0,0
151318,in,0,0
151319,a,0,0
151320,sitting,0,1
151321,position,0,0
151322,and,0,0
151323,two,0,0
151324,50-min,0,1
151325,walks,0,1
151326,(,0,0
151327,1.39,0,0
151328,m.s-1,0,0
151329,",",0,0
151330,5,0,0
151331,%,0,0
151332,grade,0,0
151333,),0,0
151334,separated,0,0
151335,by,0,0
151336,10,0,0
151337,min,0,0
151338,of,0,0
151339,rest,0,0
151340,.,0,0
151341,Non-evaporative,0,0
151342,heat,0,0
151343,exchange,0,1
151344,was,0,0
151345,significantly,0,0
151346,higher,0,0
151347,",",0,0
151348,-14.0,0,0
151349,and,0,0
151350,-10.6,0,0
151351,W.m-2,0,1
151352,(,0,0
151353,p,0,0
151354,less,0,0
151355,than,0,0
151356,0.03,0,0
151357,),0,0
151358,",",0,0
151359,for,0,0
151360,the,0,0
151361,pyridostigmine-treated,1,0
151362,subjects,0,0
151363,.,0,0
151364,No,0,0
151365,additional,0,0
151366,differences,0,0
151367,were,0,0
151368,found,0,0
151369,between,0,0
151370,treatments,0,0
151371,in,0,0
151372,the,0,0
151373,physiological,0,0
151374,responses,0,0
151375,and,0,0
151376,heat,0,1
151377,balance,0,0
151378,parameters,0,0
151379,at,0,0
151380,the,0,0
151381,end,0,0
151382,of,0,0
151383,exposure,0,0
151384,:,0,0
151385,heart,0,0
151386,rate,0,0
151387,(,0,0
151388,HR,0,0
151389,),0,1
151390,was,0,0
151391,(,0,0
151392,mean,0,0
151393,+/-,0,0
151394,S.D,0,0
151395,.,0,0
151396,),0,0
151397,154,0,0
151398,+/-,0,0
151399,16,0,0
151400,and,0,0
151401,151,0,0
151402,+/-,0,0
151403,24,0,0
151404,bpm,0,0
151405,",",0,0
151406,rectal,0,0
151407,temperature,0,0
151408,(,0,0
151409,Tre,0,1
151410,),0,0
151411,was,0,0
151412,39.0,0,0
151413,+/-,0,0
151414,0.4,0,0
151415,and,0,0
151416,38.9,0,0
151417,+/-,0,0
151418,0.2,0,0
151419,degrees,0,0
151420,C,0,0
151421,",",0,0
151422,heat,0,1
151423,storage,0,1
151424,over,0,0
151425,the,0,0
151426,2,0,0
151427,h,0,0
151428,of,0,0
151429,exercise,0,1
151430,was,0,0
151431,62,0,0
151432,+/-,0,0
151433,15,0,0
151434,and,0,0
151435,70,0,0
151436,+/-,0,0
151437,15,0,0
151438,W.m-2,0,0
151439,",",0,0
151440,and,0,0
151441,sweat,0,0
151442,rate,0,0
151443,was,0,0
151444,832,0,0
151445,+/-,0,0
151446,185,0,0
151447,and,0,0
151448,748,0,0
151449,+/-,0,0
151450,52,0,0
151451,g.h-1,0,0
151452,",",0,0
151453,in,0,0
151454,the,0,0
151455,pyridostigmine,0,1
151456,and,0,0
151457,placebo,0,1
151458,treatments,0,0
151459,",",0,0
151460,respectively,0,0
151461,.,0,0
151462,(,0,0
151463,ABSTRACT,0,0
151464,TRUNCATED,0,1
151465,AT,0,1
151466,250,0,1
151467,WORDS,0,0
151468,),0,0
151469,Disparities,0,0
151470,in,0,0
151471,transition,1,0
151472,planning,1,0
151473,for,0,0
151474,youth,0,0
151475,with,0,0
151476,autism,0,0
151477,spectrum,0,0
151478,disorder,0,0
151479,.,0,0
151480,OBJECTIVE,0,0
151481,Little,0,0
151482,is,0,0
151483,known,0,0
151484,about,0,0
151485,accessibility,0,0
151486,to,0,0
151487,health,1,0
151488,care,1,1
151489,transition,1,0
151490,(,1,0
151491,HCT,1,0
151492,),1,0
151493,services,0,0
151494,for,0,0
151495,youth,0,0
151496,with,0,0
151497,autism,0,0
151498,spectrum,0,0
151499,disorder,0,0
151500,(,0,0
151501,ASD,0,0
151502,),0,0
151503,.,0,0
151504,This,0,0
151505,study,0,0
151506,expands,0,0
151507,our,0,0
151508,understanding,0,0
151509,by,0,0
151510,examining,0,0
151511,the,0,0
151512,receipt,0,0
151513,of,0,0
151514,HCT,0,0
151515,services,0,0
151516,in,0,0
151517,youth,0,0
151518,with,0,0
151519,ASD,0,0
151520,compared,0,0
151521,with,0,0
151522,youth,0,0
151523,with,0,0
151524,other,0,0
151525,special,0,0
151526,health,0,0
151527,care,0,1
151528,needs,0,0
151529,(,0,0
151530,OSHCN,0,0
151531,),0,0
151532,.,0,0
151533,METHODS,0,0
151534,We,0,0
151535,used,0,0
151536,the,0,0
151537,2005-2006,0,0
151538,National,0,0
151539,Survey,0,0
151540,of,0,0
151541,Children,0,0
151542,with,0,0
151543,Special,0,0
151544,Health,0,0
151545,Care,0,0
151546,Needs,0,0
151547,to,0,0
151548,examine,0,0
151549,receipt,0,0
151550,of,0,0
151551,HCT,1,0
151552,services,1,0
151553,for,0,0
151554,youth,0,0
151555,(,0,0
151556,aged,0,0
151557,12-17,0,0
151558,years,0,0
151559,),0,0
151560,with,0,0
151561,ASD,0,0
151562,and,0,0
151563,youth,0,0
151564,with,0,0
151565,OSHCN,0,0
151566,.,0,0
151567,Logistic,0,0
151568,regression,0,0
151569,analyses,0,0
151570,explored,0,0
151571,whether,0,0
151572,individual,0,0
151573,",",0,0
151574,family,0,0
151575,",",0,0
151576,or,0,1
151577,health,0,0
151578,system,0,0
151579,factors,0,0
151580,were,0,0
151581,associated,0,0
151582,with,0,0
151583,receipt,0,0
151584,of,0,0
151585,HCT,0,0
151586,services,0,0
151587,for,0,0
151588,youth,0,0
151589,with,0,0
151590,ASD,0,0
151591,.,0,0
151592,RESULTS,0,0
151593,Whereas,0,0
151594,half,0,0
151595,of,0,0
151596,youth,0,0
151597,with,0,0
151598,OSHCN,0,0
151599,received,0,0
151600,HCT,0,0
151601,services,0,0
151602,",",0,0
151603,less,0,0
151604,than,0,0
151605,a,0,0
151606,quarter,0,0
151607,of,0,0
151608,youth,0,0
151609,with,0,0
151610,ASD,0,0
151611,did,0,0
151612,.,0,0
151613,Only,0,0
151614,14,0,0
151615,%,0,0
151616,of,0,0
151617,youth,0,0
151618,with,0,0
151619,ASD,0,0
151620,had,0,0
151621,a,0,0
151622,discussion,0,0
151623,with,0,0
151624,their,0,0
151625,pediatrician,0,0
151626,about,0,0
151627,transitioning,0,0
151628,to,0,0
151629,an,0,0
151630,adult,0,0
151631,provider,0,0
151632,",",0,0
151633,less,0,0
151634,than,0,0
151635,a,0,0
151636,quarter,0,0
151637,had,0,0
151638,a,0,0
151639,discussion,0,0
151640,about,0,0
151641,health,0,0
151642,insurance,0,0
151643,retention,0,0
151644,",",0,0
151645,and,0,0
151646,just,0,0
151647,under,0,0
151648,half,0,0
151649,discussed,0,0
151650,adult,0,0
151651,health,0,0
151652,care,0,1
151653,needs,0,0
151654,or,0,0
151655,were,0,0
151656,encouraged,0,0
151657,to,0,0
151658,take,0,0
151659,on,0,0
151660,appropriate,0,0
151661,responsibility,0,0
151662,.,0,0
151663,Logistic,0,0
151664,regression,0,0
151665,analyses,0,0
151666,indicated,0,0
151667,that,0,0
151668,having,0,0
151669,a,0,0
151670,developmental,0,0
151671,disability,0,0
151672,or,0,1
151673,multiple,0,0
151674,health,0,0
151675,conditions,0,0
151676,in,0,0
151677,addition,0,0
151678,to,0,0
151679,ASD,0,0
151680,and,0,0
151681,quality,0,0
151682,of,0,0
151683,health,0,0
151684,care,0,0
151685,were,0,0
151686,strong,0,0
151687,predictors,0,0
151688,of,0,0
151689,HCT,0,0
151690,",",0,0
151691,whereas,0,0
151692,demographic,0,0
151693,and,0,0
151694,family,0,0
151695,variables,0,0
151696,accounted,0,0
151697,for,0,0
151698,little,0,0
151699,variance,0,0
151700,.,0,0
151701,CONCLUSIONS,0,0
151702,Youth,0,0
151703,with,0,0
151704,ASD,0,0
151705,experience,0,0
151706,disparities,0,0
151707,in,0,0
151708,access,0,0
151709,to,0,0
151710,HCT,1,0
151711,services,0,0
151712,.,0,0
151713,Youth,0,0
151714,with,0,0
151715,comorbid,0,0
151716,conditions,0,0
151717,are,0,0
151718,at,0,0
151719,greatest,0,0
151720,risk,0,0
151721,for,0,0
151722,poor,0,0
151723,access,0,0
151724,to,0,0
151725,HCT,1,0
151726,services,0,1
151727,and,0,0
151728,increased,0,0
151729,quality,0,0
151730,of,0,0
151731,care,0,1
151732,has,0,0
151733,a,0,0
151734,positive,0,0
151735,effect,0,0
151736,.,0,0
151737,Research,0,0
151738,is,0,0
151739,needed,0,0
151740,to,0,0
151741,understand,0,0
151742,barriers,0,0
151743,to,0,0
151744,care,0,0
151745,and,0,0
151746,develop,0,0
151747,policy,0,0
151748,and,0,0
151749,practice,0,0
151750,guidelines,0,0
151751,tailored,0,0
151752,for,0,0
151753,youth,0,0
151754,with,0,0
151755,ASD,0,0
151756,.,0,0
151757,Rifampicin,1,1
151758,plus,1,1
151759,isoniazid,1,1
151760,for,0,0
151761,the,0,0
151762,prevention,0,0
151763,of,0,0
151764,tuberculosis,0,0
151765,in,0,0
151766,an,0,0
151767,immigrant,0,0
151768,population,0,0
151769,.,0,0
151770,OBJECTIVES,0,0
151771,To,0,0
151772,compare,0,0
151773,the,0,0
151774,tolerance,0,0
151775,",",0,0
151776,adherence,0,0
151777,and,0,0
151778,effectiveness,0,0
151779,of,0,0
151780,two,0,0
151781,approaches,0,0
151782,for,0,0
151783,the,0,0
151784,treatment,0,0
151785,of,0,0
151786,latent,0,0
151787,tuberculosis,0,1
151788,infection,0,0
151789,(,0,0
151790,LTBI,0,1
151791,),0,0
151792,:,0,0
151793,6,0,0
151794,months,0,0
151795,of,0,0
151796,isoniazid,1,1
151797,(,1,0
151798,6H,1,0
151799,),1,0
151800,vs.,0,0
151801,3,0,0
151802,months,0,0
151803,of,0,0
151804,isoniazid,1,1
151805,plus,1,1
151806,rifampicin,1,1
151807,(,1,0
151808,3RH,1,1
151809,),1,0
151810,.,1,0
151811,POPULATION,0,0
151812,Immigrants,0,0
151813,with,0,0
151814,LTBI,0,1
151815,.,0,0
151816,METHODS,0,0
151817,Participants,0,0
151818,were,0,0
151819,enrolled,0,0
151820,in,0,0
151821,a,0,0
151822,controlled,0,0
151823,",",0,0
151824,randomised,0,0
151825,clinical,0,0
151826,trial,0,0
151827,in,0,0
151828,Barcelona,0,0
151829,",",0,0
151830,Spain,0,0
151831,",",0,0
151832,from,0,0
151833,April,0,1
151834,2001,0,0
151835,to,0,0
151836,April,0,1
151837,2005,0,0
151838,.,0,0
151839,Monthly,0,0
151840,follow-up,0,0
151841,was,0,0
151842,done,0,0
151843,to,0,0
151844,assess,0,0
151845,tolerance,0,0
151846,",",0,0
151847,side,0,0
151848,effects,0,0
151849,and,0,0
151850,adherence,0,0
151851,.,0,0
151852,Effectiveness,0,0
151853,was,0,0
151854,evaluated,0,0
151855,at,0,0
151856,5,0,0
151857,years,0,0
151858,.,0,0
151859,RESULTS,0,0
151860,In,0,0
151861,the,0,0
151862,590,0,0
151863,subjects,0,0
151864,enrolled,0,0
151865,",",0,0
151866,the,0,0
151867,rate,0,0
151868,of,0,0
151869,adherence,0,0
151870,was,0,0
151871,greater,0,0
151872,in,0,0
151873,the,0,0
151874,3RH,0,1
151875,than,0,0
151876,in,0,0
151877,the,0,0
151878,6H,0,0
151879,arm,0,0
151880,(,0,0
151881,72,0,0
151882,%,0,0
151883,vs.,0,0
151884,52.4,0,0
151885,%,0,0
151886,",",0,0
151887,P,0,0
151888,=,0,0
151889,0.001,0,0
151890,),0,0
151891,.,0,0
151892,No,0,0
151893,differences,0,0
151894,between,0,0
151895,study,0,0
151896,arms,0,0
151897,were,0,0
151898,observed,0,0
151899,with,0,0
151900,respect,0,0
151901,to,0,0
151902,hepatotoxicity,0,0
151903,or,0,1
151904,side,0,0
151905,effects,0,0
151906,.,0,0
151907,Variables,0,0
151908,associated,0,0
151909,with,0,0
151910,non-adherence,0,0
151911,were,0,0
151912,diagnosis,0,0
151913,by,0,0
151914,screening,0,1
151915,(,0,0
151916,OR,0,0
151917,1.88,0,0
151918,",",0,0
151919,95,0,0
151920,%,0,0
151921,CI,0,0
151922,1.26-2.82,0,0
151923,",",0,0
151924,P,0,0
151925,=,0,0
151926,0.001,0,0
151927,),0,0
151928,",",0,0
151929,illegal,0,0
151930,immigration,0,0
151931,status,0,0
151932,(,0,0
151933,OR,0,0
151934,1.48,0,0
151935,",",0,0
151936,95,0,0
151937,%,0,0
151938,CI,0,0
151939,1.01-2.15,0,0
151940,",",0,0
151941,P,0,0
151942,=,0,0
151943,0.03,0,0
151944,),0,0
151945,",",0,0
151946,unemployment,0,0
151947,(,0,0
151948,OR,0,0
151949,1.91,0,0
151950,",",0,0
151951,95,0,0
151952,%,0,0
151953,CI,0,0
151954,1.28-2.85,0,0
151955,",",0,0
151956,P,0,0
151957,=,0,0
151958,0.0008,0,0
151959,),0,0
151960,",",0,0
151961,illiteracy,0,0
151962,(,0,0
151963,OR,0,0
151964,1.73,0,0
151965,",",0,0
151966,95,0,0
151967,%,0,0
151968,CI,0,0
151969,1.04-2.88,0,0
151970,",",0,0
151971,P,0,0
151972,=,0,0
151973,0.02,0,0
151974,),0,0
151975,",",0,0
151976,lack,0,0
151977,of,0,0
151978,family,0,1
151979,support,0,1
151980,(,0,0
151981,OR,0,0
151982,3.7,0,0
151983,",",0,0
151984,95,0,0
151985,%,0,0
151986,CI,0,0
151987,2.54-5.4,0,0
151988,",",0,0
151989,P,0,0
151990,=,0,0
151991,0.001,0,0
151992,),0,0
151993,and,0,0
151994,the,0,0
151995,6-month,0,0
151996,treatment,0,0
151997,regimen,0,1
151998,(,0,0
151999,OR,0,0
152000,2.45,0,0
152001,",",0,0
152002,95,0,0
152003,%,0,0
152004,CI,0,0
152005,1.68-3.57,0,0
152006,",",0,0
152007,P,0,0
152008,=,0,0
152009,0.0001,0,0
152010,),0,0
152011,.,0,0
152012,None,0,0
152013,of,0,0
152014,the,0,0
152015,patients,0,0
152016,who,0,0
152017,completed,0,0
152018,either,0,0
152019,treatment,0,0
152020,developed,0,0
152021,tuberculosis,0,0
152022,.,0,0
152023,CONCLUSIONS,0,0
152024,The,0,0
152025,3RH,1,1
152026,regimen,1,0
152027,facilitates,0,0
152028,adherence,0,0
152029,to,0,0
152030,LTBI,0,1
152031,treatment,0,0
152032,and,0,0
152033,offers,0,0
152034,a,0,0
152035,safe,0,0
152036,",",0,0
152037,well-tolerated,0,0
152038,and,0,0
152039,effective,0,0
152040,alternative,0,0
152041,.,0,0
152042,Safety,0,0
152043,",",0,0
152044,pharmacokinetics,0,0
152045,and,0,0
152046,pharmacodynamics,0,0
152047,of,0,0
152048,GS-9620,1,0
152049,",",0,0
152050,an,0,0
152051,oral,0,1
152052,Toll-like,0,0
152053,receptor,0,0
152054,7,0,0
152055,agonist,0,1
152056,.,0,0
152057,BACKGROUND,0,0
152058,GS-9620,1,1
152059,is,0,0
152060,a,0,0
152061,novel,0,0
152062,oral,0,1
152063,agonist,0,1
152064,of,0,0
152065,Toll-like,0,0
152066,receptor,0,0
152067,7,0,0
152068,(,0,0
152069,TLR7,0,0
152070,),0,0
152071,in,0,0
152072,development,0,0
152073,for,0,0
152074,the,0,0
152075,treatment,0,0
152076,of,0,0
152077,chronic,0,0
152078,viral,0,0
152079,hepatitis,0,0
152080,.,0,0
152081,TLR7,0,0
152082,is,0,0
152083,a,0,0
152084,highly,0,0
152085,conserved,0,0
152086,innate,0,0
152087,immune,0,0
152088,receptor,0,0
152089,expressed,0,0
152090,primarily,0,0
152091,on,0,0
152092,plasmacytoid,0,1
152093,dendritic,0,0
152094,cells,0,0
152095,and,0,0
152096,B,0,0
152097,lymphocytes,0,0
152098,.,0,0
152099,The,0,0
152100,aim,0,0
152101,of,0,0
152102,this,0,0
152103,double-blind,0,0
152104,",",0,0
152105,placebo-controlled,1,1
152106,",",0,0
152107,single,0,0
152108,ascending-dose,0,1
152109,study,0,0
152110,was,0,0
152111,to,0,0
152112,investigate,0,0
152113,the,0,0
152114,safety,0,0
152115,",",0,0
152116,tolerability,0,0
152117,",",0,0
152118,pharmacokinetics,0,0
152119,and,0,0
152120,pharmacodynamics,0,0
152121,of,0,0
152122,GS-9620,1,0
152123,in,0,0
152124,healthy,0,0
152125,volunteers,0,0
152126,.,0,0
152127,METHODS,0,0
152128,In,0,0
152129,total,0,0
152130,",",0,0
152131,75,0,0
152132,healthy,0,0
152133,volunteers,0,0
152134,(,0,0
152135,8,0,0
152136,subjects,0,0
152137,in,0,0
152138,each,0,0
152139,of,0,0
152140,the,0,0
152141,10,0,0
152142,cohorts,0,0
152143,;,0,0
152144,5,0,0
152145,subjects,0,0
152146,participated,0,0
152147,in,0,0
152148,two,0,0
152149,cohorts,0,0
152150,),0,0
152151,were,0,0
152152,randomized,0,0
152153,(,0,0
152154,6:2,0,0
152155,),0,0
152156,to,0,0
152157,receive,0,0
152158,a,0,0
152159,single,1,0
152160,dose,1,0
152161,of,1,0
152162,GS-9620,1,1
152163,(,1,0
152164,0.3,1,0
152165,",",1,0
152166,1,1,0
152167,",",1,0
152168,2,1,0
152169,",",1,0
152170,4,1,0
152171,",",1,0
152172,6,1,0
152173,",",1,0
152174,8,1,0
152175,or,1,0
152176,12,1,0
152177,mg,1,1
152178,),1,0
152179,or,1,0
152180,placebo,1,1
152181,.,1,0
152182,RESULTS,0,0
152183,GS-9620,1,0
152184,was,0,0
152185,well-absorbed,0,0
152186,and,0,0
152187,well-tolerated,0,0
152188,in,0,0
152189,oral,0,0
152190,doses,0,0
152191,up,0,0
152192,to,0,0
152193,12,0,0
152194,mg,0,0
152195,.,0,0
152196,Minimal,0,0
152197,treatment-related,0,0
152198,adverse,0,0
152199,events,0,0
152200,were,0,0
152201,seen,0,0
152202,at,0,0
152203,doses,0,0
152204,up,0,0
152205,to,0,0
152206,8,0,0
152207,mg.,0,1
152208,Serum,0,0
152209,interferon,0,1
152210,(,0,0
152211,IFN,0,0
152212,),0,0
152213,-?,0,0
152214,was,0,0
152215,only,0,0
152216,detected,0,0
152217,in,0,0
152218,subjects,0,0
152219,who,0,0
152220,received,0,0
152221,8,0,0
152222,or,0,0
152223,12,0,0
152224,mg,0,0
152225,doses,0,0
152226,",",0,0
152227,and,0,0
152228,the,0,0
152229,adverse,0,0
152230,event,0,0
152231,profile,0,0
152232,at,0,0
152233,8,0,0
152234,and,0,0
152235,12,0,0
152236,mg,0,0
152237,doses,0,0
152238,was,0,0
152239,generally,0,0
152240,consistent,0,0
152241,with,0,0
152242,that,0,0
152243,associated,0,0
152244,with,0,0
152245,IFN-?,0,0
152246,exposure,0,0
152247,(,0,0
152248,flu-like,0,0
152249,symptoms,0,0
152250,),0,0
152251,",",0,0
152252,consistent,0,0
152253,with,0,0
152254,the,0,0
152255,mechanism,0,0
152256,of,0,0
152257,TLR7,0,0
152258,agonism,0,0
152259,.,0,0
152260,All,0,0
152261,adverse,0,0
152262,events,0,0
152263,resolved,0,0
152264,within,0,0
152265,72,0,0
152266,h.,0,0
152267,Induction,0,1
152268,of,0,0
152269,chemokines/cytokines,0,0
152270,and,0,0
152271,IFN-stimulated,0,0
152272,genes,0,0
152273,were,0,0
152274,seen,0,0
152275,at,0,0
152276,GS-9620,1,0
152277,doses,1,0
152278,?,0,0
152279,2,0,0
152280,mg,0,0
152281,",",0,0
152282,well,0,0
152283,below,0,0
152284,doses,0,0
152285,that,0,0
152286,induced,0,0
152287,serum,0,0
152288,IFN-?,0,0
152289,or,0,1
152290,led,0,0
152291,to,0,0
152292,clinical,0,0
152293,adverse,0,0
152294,events,0,0
152295,.,0,0
152296,CONCLUSIONS,1,0
152297,GS-9620,1,1
152298,demonstrates,1,0
152299,safety,0,0
152300,and,0,0
152301,pharmacodynamic,0,0
152302,activity,0,0
152303,at,0,0
152304,doses,0,0
152305,up,0,0
152306,to,0,0
152307,12,0,0
152308,mg.,0,1
152309,Pharmacodynamic,0,0
152310,activity,0,0
152311,is,0,0
152312,seen,0,0
152313,before,0,0
152314,adverse,0,0
152315,events,0,0
152316,",",0,0
152317,suggesting,0,0
152318,the,0,0
152319,potential,0,0
152320,for,0,0
152321,induction,0,0
152322,of,0,0
152323,an,0,0
152324,antiviral,0,0
152325,response,0,0
152326,without,0,0
152327,systemic,0,0
152328,adverse,0,0
152329,events,0,0
152330,in,0,0
152331,subjects,0,0
152332,with,0,0
152333,chronic,0,0
152334,viral,0,0
152335,hepatitis,0,0
152336,.,0,0
152337,Intervention,1,1
152338,for,1,0
152339,ineffective,1,0
152340,airway,1,0
152341,clearance,1,0
152342,in,1,0
152343,asthmatic,1,0
152344,children,1,0
152345,:,1,0
152346,a,0,0
152347,controlled,0,0
152348,and,0,0
152349,randomized,0,0
152350,clinical,0,0
152351,trial,0,0
152352,.,0,0
152353,This,0,0
152354,study,0,0
152355,aimed,0,0
152356,to,0,0
152357,analyse,0,0
152358,the,0,0
152359,effectiveness,0,0
152360,of,0,0
152361,an,0,0
152362,intervention,0,1
152363,for,0,0
152364,the,0,0
152365,nursing,0,1
152366,diagnosis,0,0
152367,of,0,0
152368,ineffective,0,0
152369,airway,0,0
152370,clearance,0,0
152371,in,0,0
152372,asthmatic,0,0
152373,children,0,0
152374,.,0,0
152375,A,0,0
152376,blinded,0,0
152377,",",0,0
152378,randomized,0,0
152379,and,0,0
152380,controlled,0,0
152381,clinical,0,0
152382,trial,0,0
152383,was,0,0
152384,developed,0,0
152385,in,0,0
152386,a,0,0
152387,paediatric,0,0
152388,hospital,0,0
152389,located,0,0
152390,on,0,0
152391,northeast,0,0
152392,of,0,0
152393,Brazil,0,0
152394,with,0,0
152395,42,0,0
152396,asthmatic,0,0
152397,children,0,0
152398,aged,0,0
152399,?,0,0
152400,36,0,0
152401,months,0,0
152402,.,0,0
152403,The,0,0
152404,children,0,0
152405,were,0,0
152406,randomly,0,0
152407,divided,0,0
152408,into,0,0
152409,two,0,0
152410,groups,0,0
152411,(,0,0
152412,intervention,0,1
152413,and,1,0
152414,control,1,1
152415,),1,0
152416,by,1,0
152417,means,0,0
152418,of,0,0
152419,a,0,0
152420,simple,0,0
152421,drawing,0,0
152422,.,0,0
152423,The,0,0
152424,applied,0,0
152425,intervention,0,1
152426,included,0,0
152427,actions,0,0
152428,related,0,0
152429,to,0,0
152430,change,1,0
152431,of,1,0
152432,positioning,1,0
152433,and,1,0
152434,stimulation,1,1
152435,of,1,0
152436,cough,1,0
152437,.,1,0
152438,The,0,0
152439,main,0,0
152440,findings,0,0
152441,of,0,0
152442,this,0,0
152443,study,0,0
152444,show,0,0
152445,that,0,0
152446,before,0,0
152447,the,0,0
152448,intervention,0,1
152449,",",0,0
152450,no,0,0
152451,significant,0,0
152452,difference,0,0
152453,was,0,0
152454,observed,0,0
152455,in,0,0
152456,the,0,0
152457,health,0,0
152458,status,0,0
152459,of,0,0
152460,the,0,0
152461,children,0,0
152462,.,0,0
152463,After,0,0
152464,the,0,0
152465,intervention,0,1
152466,",",0,0
152467,the,0,0
152468,indicators,0,0
152469,of,0,0
152470,choking,0,0
152471,(,0,0
152472,16.83,0,0
152473,vs.,0,0
152474,26.17,0,0
152475,",",0,0
152476,P,0,0
152477,=,0,0
152478,0.007,0,0
152479,),0,0
152480,and,0,0
152481,adventitious,0,0
152482,breath,0,0
152483,sounds,0,1
152484,(,0,0
152485,16.4,0,0
152486,vs.,0,0
152487,26.6,0,0
152488,",",0,0
152489,P,0,0
152490,=,0,0
152491,0.005,0,0
152492,),0,0
152493,were,0,0
152494,higher,0,0
152495,",",0,0
152496,on,0,0
152497,average,0,0
152498,",",0,0
152499,in,0,0
152500,the,0,0
152501,intervention,0,1
152502,group,0,0
152503,.,0,0
152504,It,0,0
152505,was,0,0
152506,observed,0,0
152507,an,0,0
152508,improvement,0,0
152509,in,0,0
152510,obstructive,0,0
152511,symptoms,0,0
152512,in,0,0
152513,children,0,0
152514,who,0,0
152515,received,0,0
152516,the,0,0
152517,intervention,0,1
152518,proposed,0,0
152519,.,0,0
152520,Comparative,0,0
152521,in,0,0
152522,vitro,0,0
152523,dissolution,0,0
152524,and,0,0
152525,in,0,0
152526,vivo,0,0
152527,bioavailability,0,0
152528,of,0,0
152529,diflunisal/naproxen,0,1
152530,fixed-dose,0,1
152531,combination,0,1
152532,tablets,0,1
152533,and,0,0
152534,concomitant,0,0
152535,administration,0,0
152536,of,0,0
152537,diflunisal,0,1
152538,and,0,0
152539,naproxen,0,1
152540,in,0,0
152541,healthy,0,0
152542,adult,0,0
152543,subjects,0,0
152544,.,0,0
152545,A,0,0
152546,simple,0,0
152547,validated,0,0
152548,high-performance,0,0
152549,liquid,0,1
152550,chromatography,0,1
152551,(,0,0
152552,HPLC,0,0
152553,),0,0
152554,assay,0,0
152555,was,0,0
152556,developed,0,0
152557,for,0,0
152558,determination,0,0
152559,of,0,0
152560,diflunisal,0,1
152561,and,0,0
152562,naproxen,0,1
152563,in,0,0
152564,human,0,0
152565,plasma,0,0
152566,samples,0,0
152567,.,0,0
152568,This,0,0
152569,is,0,0
152570,to,0,0
152571,compare,0,0
152572,the,0,0
152573,bioavailability,0,0
152574,of,0,0
152575,diflunisal-naproxen,0,1
152576,fixed-dose,0,1
152577,combination,0,1
152578,(,0,0
152579,FDC,0,1
152580,),0,0
152581,with,0,0
152582,their,0,0
152583,separate,0,0
152584,dosage,0,0
152585,forms,0,0
152586,.,0,0
152587,The,0,0
152588,in,0,0
152589,vitro,0,0
152590,dissolution,0,0
152591,study,0,0
152592,was,0,0
152593,adopted,0,0
152594,to,0,0
152595,compare,0,0
152596,the,0,0
152597,dissolution,0,0
152598,behavior,0,0
152599,of,0,0
152600,FDC,0,1
152601,with,0,0
152602,respect,0,0
152603,to,0,0
152604,separate,0,0
152605,marketed,0,0
152606,tablets,0,1
152607,.,0,0
152608,In,0,0
152609,vivo,0,0
152610,study,0,0
152611,was,0,0
152612,conducted,0,0
152613,according,0,0
152614,to,0,0
152615,a,0,0
152616,single-center,0,0
152617,",",0,0
152618,randomized,0,0
152619,",",0,0
152620,single-dose,0,0
152621,",",0,0
152622,laboratory-blinded,0,0
152623,",",0,0
152624,2,0,0
152625,Way,0,0
152626,",",0,0
152627,Cross-Over,0,0
152628,Study,0,0
152629,with,0,0
152630,a,0,0
152631,washout,0,0
152632,period,0,0
152633,of,0,0
152634,10,0,0
152635,days,0,0
152636,.,0,0
152637,Under,0,0
152638,fasting,0,0
152639,conditions,0,0
152640,",",0,0
152641,24,0,0
152642,healthy,0,0
152643,Egyptian,0,0
152644,male,0,0
152645,volunteers,0,0
152646,were,0,0
152647,randomly,1,0
152648,allocated,1,0
152649,to,1,0
152650,receive,1,0
152651,a,1,0
152652,single,1,0
152653,oral,1,1
152654,dose,1,0
152655,of,1,0
152656,either,1,0
152657,one,1,0
152658,FDC,1,1
152659,tablet,1,1
152660,or,1,1
152661,co-administration,1,1
152662,of,1,0
152663,two,1,0
152664,separate,1,0
152665,diflunisal,1,1
152666,and,1,0
152667,naproxen,1,1
152668,marketed,1,0
152669,tablets,1,1
152670,.,1,0
152671,Plasma,1,0
152672,samples,1,0
152673,were,1,0
152674,obtained,1,0
152675,over,1,0
152676,a,1,0
152677,72-h,1,0
152678,interval,1,0
152679,and,1,0
152680,analyzed,1,0
152681,for,1,0
152682,diflunisal,1,1
152683,and,1,0
152684,naproxen,1,1
152685,by,1,0
152686,reversed,1,1
152687,phase,1,0
152688,liquid,1,1
152689,chromatography,1,1
152690,with,1,0
152691,UV,1,1
152692,detection,1,0
152693,.,1,0
152694,The,0,0
152695,pharmacokinetic,0,0
152696,parameters,0,0
152697,Cmax,0,0
152698,",",0,0
152699,AUC0-t,0,1
152700,",",0,0
152701,AUC0-?,0,0
152702,",",0,0
152703,tmax,0,0
152704,",",0,0
152705,and,0,0
152706,t1/2,0,0
152707,were,0,0
152708,determined,0,0
152709,from,0,0
152710,plasma,0,0
152711,concentration-time,0,0
152712,profiles,0,0
152713,.,0,0
152714,The,0,0
152715,90,0,0
152716,%,0,0
152717,confidence,0,0
152718,intervals,0,0
152719,for,0,0
152720,the,0,0
152721,ratio,0,0
152722,of,0,0
152723,log,0,0
152724,transformed,0,0
152725,values,0,0
152726,of,0,0
152727,Cmax,0,0
152728,",",0,0
152729,AUC0-t,0,1
152730,",",0,0
152731,and,0,0
152732,AUCt-?,0,0
152733,of,0,0
152734,the,0,0
152735,2,0,0
152736,treatments,0,0
152737,were,0,0
152738,within,0,0
152739,the,0,0
152740,acceptable,0,0
152741,range,0,0
152742,(,0,0
152743,0.8-1.25,0,0
152744,),0,0
152745,for,0,0
152746,bioequivalence,0,0
152747,.,0,0
152748,From,0,0
152749,pharmacokinetic,0,0
152750,and,0,0
152751,in,0,0
152752,vitro,0,0
152753,studies,0,0
152754,perspectives,0,0
152755,",",0,0
152756,1,0,0
152757,FDC,0,1
152758,tablet,0,1
152759,demonstrated,0,0
152760,similar,0,0
152761,relative,0,0
152762,bioavailability,0,0
152763,with,0,0
152764,the,0,0
152765,2,0,0
152766,individual,0,0
152767,-reference,0,0
152768,tablets,0,1
152769,.,0,0
152770,Association,0,0
152771,between,0,0
152772,frequency,0,0
152773,of,0,0
152774,ready-to-eat,0,0
152775,cereal,0,1
152776,consumption,0,0
152777,",",0,0
152778,nutrient,0,0
152779,intakes,0,0
152780,",",0,0
152781,and,0,0
152782,body,0,0
152783,mass,0,0
152784,index,0,0
152785,in,0,0
152786,fourth-,0,0
152787,to,0,0
152788,sixth-grade,0,0
152789,low-income,0,0
152790,minority,0,0
152791,children,0,0
152792,.,0,0
152793,BACKGROUND,0,0
152794,The,0,0
152795,consumption,0,0
152796,of,0,0
152797,non-ready-to-eat,0,0
152798,cereal,0,1
152799,and,0,0
152800,ready-to-eat,1,0
152801,cereal,1,1
152802,(,1,0
152803,RTEC,1,0
152804,),1,0
152805,breakfasts,0,1
152806,have,0,0
152807,been,0,0
152808,associated,0,0
152809,with,0,0
152810,increased,0,0
152811,nutrient,0,1
152812,intakes,0,0
152813,and,0,0
152814,lower,0,0
152815,body,0,0
152816,mass,0,0
152817,index,0,0
152818,(,0,0
152819,BMI,0,0
152820,),0,0
152821,.,0,0
152822,These,0,0
152823,relationships,0,0
152824,have,0,0
152825,not,0,0
152826,been,0,0
152827,examined,0,0
152828,in,0,0
152829,low-income,0,0
152830,minority,0,0
152831,children,0,0
152832,.,0,0
152833,OBJECTIVES,0,0
152834,To,0,0
152835,evaluate,0,0
152836,",",0,0
152837,in,0,0
152838,low-income,0,0
152839,minority,0,0
152840,children,0,0
152841,",",0,0
152842,whether,0,0
152843,there,0,0
152844,is,0,0
152845,a,0,0
152846,relationship,0,0
152847,among,0,0
152848,the,0,0
152849,frequency,0,0
152850,of,0,0
152851,RTEC,1,0
152852,consumption,0,0
152853,and,0,0
152854,nutrient,0,1
152855,intakes,0,0
152856,measured,0,0
152857,at,0,0
152858,baseline,0,0
152859,",",0,0
152860,and,0,0
152861,whether,0,0
152862,there,0,0
152863,is,0,0
152864,a,0,0
152865,relationship,0,0
152866,between,0,0
152867,the,0,0
152868,frequency,0,0
152869,of,0,0
152870,RTEC,1,0
152871,and,0,0
152872,BMI,0,0
152873,controlling,0,0
152874,for,0,0
152875,age,0,0
152876,",",0,0
152877,sex,0,0
152878,",",0,0
152879,ethnicity,0,0
152880,",",0,0
152881,and,0,0
152882,energy,0,0
152883,intake,0,0
152884,.,0,0
152885,DESIGN,0,0
152886,A,0,0
152887,longitudinal,0,0
152888,study,0,0
152889,design,0,0
152890,where,0,0
152891,a,0,0
152892,cohort,0,0
152893,was,0,0
152894,followed,0,0
152895,for,0,0
152896,3,0,0
152897,years,0,0
152898,.,0,0
152899,SUBJECTS/SETTING,0,0
152900,Participants,0,0
152901,were,0,0
152902,625,0,0
152903,fourth-,0,0
152904,through,0,0
152905,sixth-grade,0,0
152906,",",0,0
152907,low-income,0,0
152908,children,0,0
152909,living,0,0
152910,in,0,0
152911,San,0,1
152912,Antonio,0,0
152913,",",0,0
152914,Texas,0,0
152915,",",0,0
152916,and,0,0
152917,enrolled,0,0
152918,in,0,0
152919,the,0,0
152920,control,0,0
152921,arm,0,0
152922,of,0,0
152923,the,0,0
152924,Bienestar,0,0
152925,Diabetes,0,0
152926,Prevention,0,1
152927,Program,0,1
152928,'s,0,0
152929,cluster,0,0
152930,randomized,0,0
152931,trial,0,0
152932,.,0,0
152933,Three,0,0
152934,multiple-pass,0,0
152935,24-hour,0,0
152936,dietary,0,0
152937,recalls,0,0
152938,were,0,0
152939,collected,0,0
152940,at,0,0
152941,the,0,0
152942,beginning,0,0
152943,of,0,0
152944,their,0,0
152945,fourth-grade,0,0
152946,year,0,0
152947,and,0,0
152948,at,0,0
152949,the,0,0
152950,end,0,0
152951,of,0,0
152952,their,0,0
152953,fifth-,0,0
152954,and,0,0
152955,sixth-grade,0,0
152956,years,0,0
152957,.,0,0
152958,Children,0,0
152959,'s,0,0
152960,age,0,0
152961,",",0,0
152962,sex,0,0
152963,",",0,0
152964,ethnicity,0,0
152965,",",0,0
152966,and,0,0
152967,height,0,0
152968,and,0,1
152969,weight,0,0
152970,(,0,0
152971,used,0,0
152972,to,0,0
152973,calculate,0,0
152974,BMI,0,0
152975,),0,0
152976,were,0,0
152977,collected,0,0
152978,between,0,0
152979,August,0,0
152980,2001,0,0
152981,and,0,0
152982,May,0,0
152983,2004,0,0
152984,.,0,0
152985,STATISTICAL,0,0
152986,ANALYSES,0,0
152987,PERFORMED,0,1
152988,Descriptive,0,0
152989,and,0,0
152990,inferential,0,0
152991,statistical,0,0
152992,analyses,0,0
152993,were,0,0
152994,performed,0,0
152995,.,0,0
152996,The,0,0
152997,frequency,0,0
152998,of,0,0
152999,breakfast,0,1
153000,consumption,0,0
153001,was,0,0
153002,examined,0,0
153003,using,0,0
153004,a,0,0
153005,6?4,0,0
153006,cross-tabulation,0,0
153007,table,0,0
153008,with,0,0
153009,?,0,0
153010,(,0,0
153011,2,0,0
153012,),0,0
153013,test,0,0
153014,to,0,0
153015,establish,0,0
153016,categorical,0,0
153017,differences,0,0
153018,.,0,0
153019,The,0,0
153020,degree,0,0
153021,of,0,0
153022,association,0,0
153023,between,0,0
153024,BMI,0,0
153025,percentile,0,0
153026,and,0,0
153027,frequency,0,0
153028,of,0,0
153029,RTEC,1,0
153030,consumption,1,0
153031,adjusted,0,0
153032,for,0,0
153033,age,0,0
153034,",",0,0
153035,sex,0,0
153036,",",0,0
153037,ethnicity,0,0
153038,",",0,0
153039,and,0,0
153040,nutrition-related,0,0
153041,parameters,0,0
153042,were,0,0
153043,calculated,0,0
153044,using,0,0
153045,a,0,0
153046,partial,0,0
153047,correlation,0,0
153048,multivariate,0,0
153049,linear,0,0
153050,model,0,0
153051,analysis,0,0
153052,.,0,0
153053,RESULTS,0,0
153054,There,0,0
153055,was,0,0
153056,a,0,0
153057,significant,0,0
153058,positive,0,0
153059,relationship,0,0
153060,between,0,0
153061,the,0,0
153062,frequency,0,0
153063,of,0,0
153064,RTEC,1,0
153065,consumption,1,0
153066,and,0,0
153067,nutrient,0,1
153068,intakes,0,0
153069,measured,0,0
153070,at,0,0
153071,baseline,0,0
153072,.,0,0
153073,There,0,0
153074,was,0,0
153075,also,0,0
153076,a,0,0
153077,significant,0,0
153078,inverse,0,0
153079,relationship,0,0
153080,between,0,0
153081,frequency,0,0
153082,of,0,0
153083,RTEC,1,0
153084,consumption,1,0
153085,and,0,0
153086,BMI,0,0
153087,percentile,0,0
153088,over,0,0
153089,the,0,0
153090,cumulative,0,0
153091,3-year,0,0
153092,period,0,0
153093,controlling,0,0
153094,for,0,0
153095,age,0,0
153096,",",0,0
153097,sex,0,0
153098,",",0,0
153099,ethnicity,0,0
153100,",",0,0
153101,and,0,0
153102,energy,0,0
153103,intake,0,0
153104,.,0,0
153105,CONCLUSIONS,0,0
153106,Children,0,0
153107,who,0,0
153108,frequently,0,0
153109,consumed,1,0
153110,RTEC,1,0
153111,had,1,0
153112,greater,0,0
153113,intakes,0,0
153114,of,0,0
153115,essential,0,0
153116,nutrients,0,0
153117,at,0,0
153118,baseline,0,0
153119,and,0,0
153120,significantly,0,0
153121,lower,0,0
153122,BMI,0,0
153123,over,0,0
153124,a,0,0
153125,3-year,0,0
153126,period,0,0
153127,.,0,0
153128,Neurophysiological,0,0
153129,responses,0,0
153130,to,0,0
153131,faces,0,0
153132,and,0,0
153133,gaze,0,0
153134,direction,0,0
153135,differentiate,0,0
153136,children,0,0
153137,with,0,0
153138,ASD,0,0
153139,",",0,0
153140,ADHD,0,1
153141,and,0,0
153142,ASD+ADHD,0,1
153143,.,0,0
153144,Children,0,0
153145,with,0,0
153146,autism,0,0
153147,spectrum,0,0
153148,disorder,0,0
153149,(,0,0
153150,ASD,0,0
153151,),0,1
153152,and,0,0
153153,attention,0,0
153154,deficit,0,0
153155,hyperactivity,0,0
153156,disorder,0,0
153157,(,0,0
153158,ADHD,0,1
153159,),0,0
153160,demonstrate,0,0
153161,face,0,0
153162,processing,0,0
153163,abnormalities,0,0
153164,that,0,0
153165,may,0,0
153166,underlie,0,0
153167,social,0,0
153168,impairment,0,0
153169,.,0,0
153170,Despite,0,0
153171,substantial,0,0
153172,overlap,0,0
153173,between,0,0
153174,ASD,0,0
153175,and,0,0
153176,ADHD,0,1
153177,",",0,0
153178,ERP,0,0
153179,markers,0,0
153180,of,0,0
153181,face,0,0
153182,and,0,0
153183,gaze,0,0
153184,processing,0,0
153185,have,0,0
153186,not,0,0
153187,been,0,0
153188,directly,0,0
153189,compared,0,0
153190,across,0,0
153191,pure,0,0
153192,and,0,0
153193,comorbid,0,0
153194,cases,0,0
153195,.,0,0
153196,Children,0,0
153197,with,0,0
153198,ASD,0,0
153199,(,0,0
153200,n=19,0,0
153201,),0,0
153202,",",0,0
153203,ADHD,0,1
153204,(,0,0
153205,n=18,0,0
153206,),0,0
153207,",",0,0
153208,comorbid,0,0
153209,ASD+ADHD,0,1
153210,(,0,0
153211,n=29,0,0
153212,),0,0
153213,and,0,0
153214,typically,0,0
153215,developing,0,0
153216,(,0,0
153217,TD,0,1
153218,),0,1
153219,controls,0,0
153220,(,0,0
153221,n=26,0,0
153222,),0,0
153223,were,0,0
153224,presented,0,0
153225,with,0,0
153226,upright/inverted,1,1
153227,faces,1,0
153228,with,1,0
153229,direct/averted,1,0
153230,gaze,1,0
153231,",",0,0
153232,with,0,0
153233,concurrent,0,1
153234,recording,0,0
153235,of,0,0
153236,the,0,0
153237,P1,0,0
153238,and,0,0
153239,N170,0,0
153240,components,0,0
153241,.,0,0
153242,While,0,0
153243,the,0,0
153244,N170,0,0
153245,was,0,0
153246,predominant,0,0
153247,in,0,0
153248,the,0,0
153249,right,0,0
153250,hemisphere,0,0
153251,in,0,0
153252,TD,0,1
153253,and,0,0
153254,ADHD,0,1
153255,",",0,0
153256,children,0,0
153257,with,0,0
153258,ASD,0,0
153259,(,0,0
153260,ASD/ASD+ADHD,0,1
153261,),0,0
153262,showed,0,0
153263,a,0,0
153264,bilateral,0,0
153265,distribution,0,0
153266,.,0,0
153267,In,0,0
153268,addition,0,0
153269,",",0,0
153270,children,0,0
153271,with,0,0
153272,ASD,0,0
153273,demonstrated,0,0
153274,altered,0,0
153275,response,0,0
153276,to,0,0
153277,gaze,0,0
153278,direction,0,0
153279,on,0,0
153280,P1,0,0
153281,latency,0,0
153282,and,0,0
153283,no,0,0
153284,sensitivity,0,0
153285,to,0,0
153286,gaze,0,0
153287,direction,0,0
153288,on,0,0
153289,midline-N170,0,0
153290,amplitude,0,0
153291,compared,0,0
153292,to,0,0
153293,TD,0,1
153294,and,0,0
153295,ADHD,0,1
153296,.,0,0
153297,In,0,0
153298,contrast,0,0
153299,",",0,0
153300,children,0,0
153301,with,0,0
153302,ADHD,0,1
153303,(,0,0
153304,ADHD/ASD+ADHD,0,1
153305,),0,0
153306,exhibited,0,0
153307,a,0,0
153308,reduced,0,0
153309,face,0,0
153310,inversion,0,0
153311,effect,0,0
153312,on,0,0
153313,P1,0,0
153314,latency,0,0
153315,compared,0,0
153316,to,0,0
153317,TD,0,1
153318,and,0,0
153319,ASD,0,0
153320,.,0,0
153321,These,0,0
153322,findings,0,0
153323,suggest,0,0
153324,children,0,0
153325,with,0,0
153326,ASD,0,0
153327,have,0,0
153328,specific,0,0
153329,abnormalities,0,0
153330,in,0,0
153331,gaze,0,0
153332,processing,0,1
153333,and,0,0
153334,altered,0,0
153335,neural,0,0
153336,specialisation,0,1
153337,",",0,0
153338,whereas,0,0
153339,children,0,0
153340,with,0,0
153341,ADHD,0,1
153342,show,0,0
153343,abnormalities,0,0
153344,at,0,0
153345,early,0,0
153346,visual,0,0
153347,attention,0,0
153348,stages,0,0
153349,.,0,0
153350,Children,0,0
153351,with,0,0
153352,ASD+ADHD,0,1
153353,are,0,0
153354,an,0,0
153355,additive,0,0
153356,co-occurrence,0,0
153357,with,0,0
153358,deficits,0,0
153359,of,0,0
153360,both,0,0
153361,disorders,0,0
153362,.,0,0
153363,Elucidating,0,0
153364,the,0,0
153365,neural,0,0
153366,basis,0,0
153367,of,0,0
153368,the,0,0
153369,overlap,0,0
153370,between,0,0
153371,ASD,0,0
153372,and,0,0
153373,ADHD,0,1
153374,is,0,0
153375,likely,0,0
153376,to,0,0
153377,inform,0,0
153378,aetiological,0,0
153379,investigation,0,0
153380,and,0,0
153381,clinical,0,0
153382,assessment,0,0
153383,.,0,0
153384,Development,0,0
153385,of,0,0
153386,the,0,0
153387,Therapist,0,1
153388,Empathy,0,0
153389,Scale,0,0
153390,.,0,0
153391,BACKGROUND,0,0
153392,Few,0,0
153393,measures,0,0
153394,exist,0,0
153395,to,0,0
153396,examine,0,0
153397,therapist,0,1
153398,empathy,0,0
153399,as,0,0
153400,it,0,0
153401,occurs,0,0
153402,in,0,0
153403,session,0,0
153404,.,0,0
153405,AIMS,0,0
153406,A,0,0
153407,9-item,0,0
153408,observer,0,0
153409,rating,0,0
153410,scale,0,0
153411,",",0,0
153412,called,0,0
153413,the,0,0
153414,Therapist,1,1
153415,Empathy,1,0
153416,Scale,1,1
153417,(,0,0
153418,TES,0,0
153419,),0,0
153420,",",0,0
153421,was,0,0
153422,developed,0,0
153423,based,0,0
153424,on,0,0
153425,Watson,0,0
153426,'s,0,0
153427,(,0,0
153428,1999,0,0
153429,),0,0
153430,work,0,0
153431,to,0,0
153432,assess,0,0
153433,affective,0,0
153434,",",0,0
153435,cognitive,0,0
153436,",",0,0
153437,attitudinal,0,0
153438,",",0,0
153439,and,0,0
153440,attunement,0,0
153441,aspects,0,0
153442,of,0,0
153443,therapist,0,1
153444,empathy,0,0
153445,.,0,0
153446,The,0,0
153447,aim,0,0
153448,of,0,0
153449,this,0,0
153450,study,0,0
153451,was,0,0
153452,to,0,0
153453,evaluate,0,0
153454,the,0,0
153455,inter-rater,0,0
153456,reliability,0,0
153457,",",0,0
153458,internal,0,0
153459,consistency,0,0
153460,",",0,0
153461,and,0,0
153462,construct,0,0
153463,and,0,0
153464,criterion,0,0
153465,validity,0,0
153466,of,0,0
153467,the,0,0
153468,TES,0,0
153469,.,0,0
153470,METHOD,0,0
153471,Raters,0,0
153472,evaluated,0,0
153473,therapist,0,1
153474,empathy,0,0
153475,in,0,0
153476,315,0,0
153477,client,1,0
153478,sessions,1,1
153479,conducted,0,0
153480,by,0,0
153481,91,0,0
153482,therapists,0,0
153483,",",0,0
153484,using,0,0
153485,data,0,0
153486,from,0,0
153487,a,0,0
153488,multi-site,0,0
153489,therapist,0,1
153490,training,0,1
153491,trial,0,0
153492,(,0,0
153493,Martino,0,0
153494,et,0,0
153495,al.,0,0
153496,",",0,0
153497,2010,0,0
153498,),0,0
153499,in,0,0
153500,Motivational,1,0
153501,Interviewing,1,1
153502,(,1,0
153503,MI,1,1
153504,),1,0
153505,.,1,0
153506,RESULTS,0,0
153507,Inter-rater,0,0
153508,reliability,0,0
153509,(,0,0
153510,ICC,0,0
153511,=,0,0
153512,.87,0,0
153513,to,0,0
153514,.91,0,0
153515,),0,0
153516,and,0,0
153517,internal,0,1
153518,consistency,0,0
153519,(,0,0
153520,Cronbach,0,0
153521,'s,0,0
153522,alpha,0,1
153523,=,0,0
153524,.94,0,0
153525,),0,0
153526,were,0,0
153527,high,0,0
153528,.,0,0
153529,Confirmatory,0,0
153530,factor,0,0
153531,analyses,0,0
153532,indicated,0,0
153533,some,0,0
153534,support,0,0
153535,for,0,0
153536,single-factor,0,0
153537,fit,0,0
153538,.,0,0
153539,Convergent,0,0
153540,validity,0,0
153541,was,0,0
153542,supported,0,0
153543,by,0,0
153544,correlations,0,0
153545,between,0,0
153546,TES,0,0
153547,scores,0,0
153548,and,0,0
153549,MI,0,1
153550,fundamental,0,0
153551,adherence,0,0
153552,(,0,0
153553,r,0,0
153554,range,0,0
153555,.50,0,0
153556,to,0,0
153557,.67,0,0
153558,),0,0
153559,and,0,0
153560,competence,0,0
153561,scores,0,0
153562,(,0,0
153563,r,0,0
153564,range,0,0
153565,.56,0,0
153566,to,0,0
153567,.69,0,0
153568,),0,0
153569,.,0,0
153570,Discriminant,0,0
153571,validity,0,0
153572,was,0,0
153573,indicated,0,0
153574,by,0,0
153575,negative,0,0
153576,or,0,0
153577,nonsignificant,0,0
153578,correlations,0,0
153579,between,0,0
153580,TES,0,0
153581,and,0,0
153582,MI-inconsistent,0,0
153583,behavior,0,0
153584,(,0,0
153585,r,0,0
153586,range,0,0
153587,.05,0,0
153588,to,0,0
153589,-.33,0,0
153590,),0,0
153591,.,0,0
153592,CONCLUSIONS,0,0
153593,The,0,0
153594,TES,0,0
153595,demonstrates,0,0
153596,excellent,0,0
153597,inter-rater,0,0
153598,reliability,0,0
153599,and,0,0
153600,internal,0,0
153601,consistency,0,0
153602,.,0,0
153603,RESULTS,0,0
153604,indicate,0,0
153605,some,0,0
153606,support,0,0
153607,for,0,0
153608,a,0,0
153609,single-factor,0,1
153610,solution,0,1
153611,and,0,0
153612,convergent,0,1
153613,and,0,0
153614,discriminant,0,0
153615,validity,0,0
153616,.,0,0
153617,Future,0,0
153618,studies,0,0
153619,should,0,0
153620,examine,0,0
153621,the,0,0
153622,use,0,0
153623,of,0,0
153624,the,0,0
153625,TES,0,0
153626,to,0,0
153627,evaluate,0,0
153628,therapist,0,1
153629,empathy,0,0
153630,in,0,0
153631,different,0,0
153632,psychotherapy,0,1
153633,approaches,0,0
153634,and,0,0
153635,to,0,0
153636,determine,0,0
153637,the,0,0
153638,impact,0,0
153639,of,0,0
153640,therapist,0,1
153641,empathy,0,0
153642,on,0,0
153643,client,0,0
153644,outcome,0,0
153645,.,0,0
153646,Effects,0,0
153647,of,0,0
153648,low,0,0
153649,and,0,0
153650,high,0,0
153651,protein,0,1
153652,:,0,0
153653,carbohydrate,0,1
153654,ratios,0,0
153655,in,0,0
153656,the,0,0
153657,diet,0,1
153658,of,0,0
153659,pregnant,0,0
153660,gilts,0,1
153661,on,0,0
153662,maternal,0,0
153663,cortisol,0,0
153664,concentrations,0,0
153665,and,0,0
153666,the,0,0
153667,adrenocortical,0,0
153668,and,0,0
153669,sympathoadrenal,0,0
153670,reactivity,0,0
153671,in,0,0
153672,their,0,0
153673,offspring,0,0
153674,.,0,0
153675,Inadequate,0,0
153676,maternal,0,0
153677,nutrition,0,1
153678,during,0,0
153679,gestation,0,0
153680,may,0,0
153681,cause,0,0
153682,an,0,0
153683,adverse,0,0
153684,environment,0,0
153685,for,0,0
153686,the,0,0
153687,fetus,0,0
153688,leading,0,0
153689,to,0,0
153690,alterations,0,0
153691,of,0,0
153692,the,0,0
153693,hypothalamic-pituitary-adrenal,0,0
153694,(,0,0
153695,HPA,0,0
153696,),0,1
153697,and,0,0
153698,sympatho-adrenomedullary,0,0
153699,(,0,0
153700,SAM,0,0
153701,),0,0
153702,systems,0,0
153703,later,0,0
153704,in,0,0
153705,life,0,0
153706,.,0,0
153707,In,0,0
153708,the,0,0
153709,present,0,0
153710,study,0,0
153711,",",0,0
153712,we,0,0
153713,investigated,0,0
153714,the,0,0
153715,effects,0,0
153716,of,0,0
153717,diets,1,1
153718,with,1,0
153719,low,1,0
153720,and,1,0
153721,high,1,0
153722,protein,1,1
153723,:,1,0
153724,carbohydrate,1,1
153725,ratios,0,0
153726,on,0,0
153727,cortisol,0,0
153728,concentrations,0,0
153729,of,0,0
153730,pregnant,0,0
153731,gilts,0,1
153732,as,0,0
153733,well,0,0
153734,as,0,0
153735,the,0,0
153736,long-term,0,0
153737,effects,0,0
153738,on,0,0
153739,the,0,0
153740,function,0,0
153741,of,0,0
153742,the,0,0
153743,HPA,0,0
153744,and,0,0
153745,SAM,0,0
153746,axes,0,0
153747,in,0,0
153748,their,0,0
153749,offspring,0,0
153750,.,0,0
153751,Throughout,0,0
153752,gestation,0,0
153753,",",0,0
153754,33,0,0
153755,German,0,0
153756,Landrace,0,0
153757,gilts,0,1
153758,were,0,0
153759,fed,0,0
153760,high,1,0
153761,(,1,0
153762,HP,1,0
153763,",",1,0
153764,30,1,0
153765,%,1,0
153766,),1,0
153767,",",1,0
153768,low,1,0
153769,(,1,0
153770,LP,1,1
153771,",",1,0
153772,6.5,1,0
153773,%,1,0
153774,),1,0
153775,",",1,0
153776,or,1,1
153777,adequate,1,0
153778,(,1,0
153779,AP,1,0
153780,",",1,0
153781,12.1,1,0
153782,%,1,0
153783,),1,0
153784,protein,1,0
153785,diets,1,1
153786,",",0,0
153787,which,0,0
153788,were,0,0
153789,made,0,0
153790,isocaloric,0,1
153791,by,0,0
153792,adjusting,0,0
153793,the,0,0
153794,carbohydrate,0,1
153795,content,0,0
153796,.,0,0
153797,The,0,0
153798,salivary,0,0
153799,cortisol,0,0
153800,concentrations,0,0
153801,of,0,0
153802,the,0,0
153803,sows,0,0
153804,were,0,0
153805,measured,0,0
153806,in,0,0
153807,the,0,0
153808,course,0,0
153809,of,0,0
153810,the,0,0
153811,gestation,0,0
153812,period,0,0
153813,.,0,0
153814,The,0,0
153815,offspring,0,0
153816,were,0,0
153817,cross-fostered,0,0
153818,",",0,0
153819,and,0,0
153820,the,0,0
153821,plasma,0,0
153822,cortisol,0,0
153823,and,0,0
153824,catecholamine,0,0
153825,concentrations,0,0
153826,of,0,0
153827,the,0,0
153828,offspring,0,0
153829,were,0,0
153830,determined,0,0
153831,on,0,0
153832,postnatal,0,0
153833,d,0,1
153834,(,0,0
153835,PND,0,1
153836,),0,0
153837,1,0,0
153838,and,0,0
153839,27,0,0
153840,and,0,0
153841,under,0,0
153842,specific,0,0
153843,challenging,0,0
153844,conditions,0,0
153845,:,0,0
153846,after,0,0
153847,weaning,0,0
153848,(,0,0
153849,PND,0,1
153850,29,0,0
153851,),0,0
153852,and,0,0
153853,after,0,0
153854,ACTH,0,0
153855,and,0,0
153856,insulin,0,1
153857,challenges,0,0
153858,(,0,0
153859,PND,0,1
153860,68,0,0
153861,and,0,0
153862,70,0,0
153863,",",0,0
153864,respectively,0,0
153865,),0,0
153866,.,0,0
153867,Glucocorticoid,0,1
153868,receptor,0,0
153869,(,0,0
153870,GR,0,0
153871,),0,1
153872,binding,0,0
153873,and,0,0
153874,neurotransmitter,0,0
153875,concentrations,0,0
153876,were,0,0
153877,measured,0,0
153878,in,0,0
153879,stress-related,0,0
153880,brain,0,0
153881,regions,0,0
153882,",",0,0
153883,and,0,0
153884,histological,0,0
153885,analyses,0,0
153886,of,0,0
153887,the,0,0
153888,adrenal,0,0
153889,were,0,0
153890,performed,0,0
153891,.,0,0
153892,Maternal,0,0
153893,salivary,0,0
153894,cortisol,0,0
153895,concentrations,0,0
153896,increased,0,0
153897,throughout,0,0
153898,gestation,0,0
153899,(,0,0
153900,P,0,0
153901,<,0,0
153902,0.001,0,0
153903,),0,0
153904,and,0,0
153905,the,0,0
153906,LP,0,1
153907,gilts,0,0
153908,had,0,0
153909,greater,0,0
153910,salivary,0,0
153911,cortisol,0,0
153912,compared,0,0
153913,with,0,0
153914,the,0,0
153915,AP,0,0
153916,and,0,0
153917,HP,0,1
153918,gilts,0,1
153919,(,0,0
153920,P,0,0
153921,<,0,0
153922,0.05,0,0
153923,),0,0
153924,.,0,0
153925,No,0,0
153926,differences,0,0
153927,between,0,0
153928,diets,0,1
153929,were,0,0
153930,found,0,0
153931,for,0,0
153932,cortisol,0,0
153933,",",0,0
153934,corticosteroid-binding,0,0
153935,globulin,0,1
153936,",",0,0
153937,and,0,0
153938,catecholamine,0,0
153939,concentrations,0,0
153940,in,0,0
153941,plasma,0,0
153942,and,0,0
153943,for,0,0
153944,GR,0,0
153945,binding,0,0
153946,in,0,0
153947,hippocampus,0,0
153948,and,0,0
153949,hypothalamus,0,0
153950,in,0,0
153951,piglets,0,0
153952,at,0,0
153953,PND,0,1
153954,1,0,0
153955,and,0,0
153956,27,0,0
153957,.,0,0
153958,However,0,0
153959,",",0,0
153960,the,0,0
153961,cortisol,0,0
153962,response,0,0
153963,to,0,0
153964,weaning,0,0
153965,was,0,0
153966,increased,0,0
153967,in,0,0
153968,LP,0,1
153969,piglets,0,0
153970,(,0,0
153971,P,0,0
153972,<,0,0
153973,0.05,0,0
153974,),0,0
153975,",",0,0
153976,and,0,0
153977,in,0,0
153978,HP,0,0
153979,offspring,0,0
153980,the,0,0
153981,basal,0,0
153982,plasma,0,0
153983,noradrenaline,0,0
153984,concentrations,0,0
153985,were,0,0
153986,increased,0,0
153987,(,0,0
153988,P,0,0
153989,<,0,0
153990,0.05,0,0
153991,),0,0
153992,.,0,0
153993,The,0,0
153994,cortisol,0,0
153995,response,0,0
153996,to,0,0
153997,the,0,0
153998,ACTH,0,0
153999,and,0,0
154000,the,0,0
154001,insulin,0,1
154002,challenge,0,0
154003,did,0,0
154004,not,0,0
154005,differ,0,0
154006,between,0,0
154007,diets,0,1
154008,.,0,0
154009,On,0,0
154010,PND,0,0
154011,81,0,0
154012,",",0,0
154013,an,0,0
154014,increased,0,0
154015,adrenal,0,0
154016,medulla,0,0
154017,area,0,0
154018,was,0,0
154019,observed,0,0
154020,in,0,0
154021,LP,0,1
154022,offspring,0,0
154023,compared,0,0
154024,with,0,0
154025,the,0,0
154026,AP,0,0
154027,offspring,0,0
154028,(,0,0
154029,P,0,0
154030,<,0,0
154031,0.05,0,0
154032,),0,0
154033,.,0,0
154034,Our,0,0
154035,results,0,0
154036,show,0,0
154037,that,0,0
154038,maternal,1,0
154039,diets,1,1
154040,with,1,0
154041,aberrant,1,0
154042,protein,1,0
154043,:,1,0
154044,carbohydrate,1,1
154045,ratios,1,0
154046,during,1,0
154047,gestation,1,0
154048,have,0,0
154049,moderate,0,0
154050,long-term,0,0
154051,effects,0,0
154052,on,0,0
154053,the,0,0
154054,function,0,0
154055,of,0,0
154056,the,0,0
154057,HPA,0,0
154058,and,0,0
154059,SAM,0,0
154060,system,0,0
154061,in,0,0
154062,the,0,0
154063,offspring,0,0
154064,",",0,0
154065,which,0,0
154066,indicates,0,0
154067,that,0,0
154068,pigs,0,0
154069,show,0,0
154070,a,0,0
154071,considerable,0,0
154072,plasticity,0,0
154073,to,0,0
154074,cope,0,0
154075,with,0,0
154076,maternal,0,0
154077,malnutrition,0,0
154078,.,0,0
154079,Satisfactory,0,0
154080,sampling,0,0
154081,in,0,0
154082,cytological,0,0
154083,cervical,0,0
154084,diagnosis,0,0
154085,:,0,0
154086,comparison,0,0
154087,between,0,0
154088,a,0,0
154089,conventional,1,1
154090,and,1,0
154091,a,1,0
154092,new,1,0
154093,sampling,1,0
154094,device,1,1
154095,.,1,0
154096,AIM,0,0
154097,Inadequate,0,0
154098,cervical,0,0
154099,sampling,0,0
154100,is,0,0
154101,the,0,0
154102,most,0,0
154103,frequent,0,0
154104,cause,0,0
154105,of,0,0
154106,misdiagnosis,0,0
154107,in,0,0
154108,cervical,0,0
154109,cancer,0,0
154110,screening,0,0
154111,.,0,0
154112,The,0,0
154113,aim,0,0
154114,of,0,0
154115,this,0,0
154116,study,0,0
154117,was,0,0
154118,to,0,0
154119,test,0,0
154120,the,0,0
154121,ability,0,0
154122,of,0,0
154123,PapCone?,1,0
154124,versus,1,0
154125,the,1,0
154126,conventional,1,1
154127,sampling,1,0
154128,method,1,1
154129,(,1,0
154130,Ayre,1,1
154131,'s,1,0
154132,spatula,1,1
154133,plus,1,1
154134,cytobrush,1,1
154135,),1,0
154136,to,0,0
154137,collect,0,0
154138,ectocervical,0,1
154139,and,0,0
154140,glandular,0,0
154141,cells,0,0
154142,.,0,0
154143,MATERIALS,0,0
154144,AND,0,0
154145,METHODS,0,0
154146,In,0,0
154147,18,0,0
154148,healthy,0,0
154149,women,0,0
154150,",",0,0
154151,two,0,0
154152,ecto-endocervical,0,0
154153,samples,0,0
154154,",",0,0
154155,obtained,0,0
154156,by,0,0
154157,two,0,0
154158,different,0,0
154159,methods,0,0
154160,",",0,0
154161,were,0,0
154162,obtained,0,0
154163,at,0,0
154164,a,0,0
154165,three-month,0,0
154166,interval,0,0
154167,.,0,0
154168,Qualitative,0,0
154169,and,0,0
154170,quantitative,0,0
154171,parameters,0,0
154172,were,0,0
154173,evaluated,0,0
154174,.,0,0
154175,Ultrastructure,0,0
154176,features,0,0
154177,of,0,0
154178,sampling,0,0
154179,devices,0,0
154180,were,0,0
154181,analyzed,0,0
154182,by,0,0
154183,scanning,0,1
154184,electron,0,1
154185,microscopy,0,1
154186,(,0,0
154187,SEM,0,1
154188,),0,0
154189,before,0,0
154190,and,0,0
154191,after,0,0
154192,sampling,0,0
154193,.,0,0
154194,RESULTS,0,0
154195,The,0,0
154196,?,0,0
154197,(,0,0
154198,2,0,0
154199,),0,0
154200,test,0,0
154201,revealed,0,0
154202,a,0,0
154203,statistically,0,0
154204,significant,0,0
154205,difference,0,0
154206,between,0,0
154207,the,0,0
154208,two,0,0
154209,methods,0,0
154210,:,0,0
154211,PapCone?,0,0
154212,caused,0,0
154213,less,0,0
154214,cell,0,0
154215,overlap,0,0
154216,and,0,0
154217,sampled,0,0
154218,less,0,0
154219,white,0,0
154220,blood,0,0
154221,cells,0,1
154222,(,0,0
154223,p,0,0
154224,<,0,0
154225,0.05,0,0
154226,),0,0
154227,and,0,0
154228,more,0,0
154229,metaplastic,0,1
154230,cells,0,0
154231,(,0,0
154232,p,0,0
154233,<,0,0
154234,0.01,0,0
154235,),0,0
154236,.,0,0
154237,SEM,0,0
154238,evaluation,0,0
154239,highlighted,0,0
154240,the,0,0
154241,porous,0,0
154242,and,0,0
154243,spongy,0,1
154244,structure,0,0
154245,of,0,0
154246,PapCone?,0,0
154247,that,0,0
154248,was,0,0
154249,responsible,0,0
154250,for,0,0
154251,the,0,0
154252,large,0,0
154253,number,0,0
154254,of,0,0
154255,glandular,0,0
154256,cells,0,0
154257,on,0,0
154258,its,0,0
154259,surface,0,0
154260,.,0,0
154261,CONCLUSION,0,0
154262,Cervical,0,0
154263,smears,0,0
154264,performed,0,0
154265,by,0,0
154266,PapCone?,0,0
154267,were,0,0
154268,adequate,0,0
154269,and,0,0
154270,generally,0,0
154271,easier,0,0
154272,to,0,0
154273,screen,0,0
154274,than,0,0
154275,conventionally,0,0
154276,performed,0,0
154277,ones,0,0
154278,.,0,0
154279,MEG,0,1
154280,premotor,0,0
154281,abnormalities,0,0
154282,in,0,0
154283,children,0,0
154284,with,0,0
154285,Asperger,0,0
154286,'s,0,0
154287,syndrome,0,0
154288,:,0,0
154289,determinants,0,0
154290,of,0,0
154291,social,0,0
154292,behavior,0,0
154293,?,0,0
154294,Children,0,0
154295,with,0,0
154296,Asperger,0,0
154297,'s,0,0
154298,syndrome,0,0
154299,show,0,0
154300,deficits,0,0
154301,in,0,0
154302,social,0,0
154303,functioning,0,0
154304,while,0,0
154305,their,0,0
154306,intellectual,0,0
154307,and,0,0
154308,language,0,0
154309,development,0,0
154310,is,0,0
154311,intact,0,0
154312,suggesting,0,0
154313,a,0,0
154314,specific,0,0
154315,dysfunction,0,0
154316,in,0,0
154317,mechanisms,0,0
154318,mediating,0,0
154319,social,0,0
154320,cognition,0,0
154321,.,0,0
154322,An,0,0
154323,action,0,0
154324,observation/execution,0,0
154325,matching,0,0
154326,system,0,0
154327,might,0,0
154328,be,0,0
154329,one,0,0
154330,such,0,0
154331,mechanism,0,0
154332,.,0,0
154333,Recent,0,0
154334,studies,0,0
154335,indeed,0,0
154336,showed,0,0
154337,that,0,0
154338,electrophysiological,0,0
154339,modulation,0,0
154340,of,0,0
154341,the,0,0
154342,Mu-rhythm,0,0
154343,in,0,0
154344,the,0,0
154345,10-12Hz,0,0
154346,range,0,0
154347,is,0,0
154348,weaker,0,0
154349,when,0,0
154350,individuals,0,0
154351,with,0,0
154352,Asperger,0,0
154353,'s,0,0
154354,syndrome,0,0
154355,observe,0,0
154356,actions,0,0
154357,performed,0,0
154358,by,0,0
154359,others,0,0
154360,compared,0,0
154361,to,0,0
154362,controls,0,0
154363,.,0,0
154364,However,0,0
154365,",",0,0
154366,electrophysiological,0,0
154367,studies,0,0
154368,typically,0,0
154369,fall,0,0
154370,short,0,0
154371,in,0,0
154372,revealing,0,0
154373,the,0,0
154374,neural,0,0
154375,generators,0,1
154376,of,0,0
154377,this,0,0
154378,activity,0,0
154379,.,0,0
154380,To,0,0
154381,fill,0,0
154382,this,0,0
154383,gap,0,0
154384,we,0,0
154385,assessed,0,0
154386,magnetoencephalographic,1,0
154387,Mu-modulations,1,0
154388,in,0,0
154389,Asperger,0,0
154390,'s,0,0
154391,and,0,0
154392,typically,0,0
154393,developed,0,0
154394,children,0,0
154395,",",0,0
154396,while,0,0
154397,observing,1,0
154398,grasping,1,0
154399,movements,1,0
154400,.,1,0
154401,Mu-power,0,0
154402,increased,0,0
154403,at,0,0
154404,frontal,0,0
154405,and,0,0
154406,central,0,0
154407,sensors,0,1
154408,during,0,0
154409,movement,0,0
154410,observation,0,0
154411,.,0,0
154412,This,0,0
154413,modulation,0,0
154414,was,0,0
154415,stronger,0,0
154416,in,0,0
154417,typical,0,0
154418,than,0,0
154419,in,0,0
154420,Asperger,0,0
154421,children,0,0
154422,.,0,0
154423,Source,0,0
154424,localization,0,0
154425,revealed,0,0
154426,stronger,0,0
154427,sources,0,0
154428,in,0,0
154429,premotor,0,0
154430,cortex,0,0
154431,",",0,0
154432,the,0,0
154433,intraparietal,0,0
154434,lobule,0,0
154435,(,0,0
154436,IPL,0,1
154437,),0,0
154438,and,0,0
154439,the,0,0
154440,mid-occipito-temporal,0,0
154441,gyrus,0,0
154442,(,0,0
154443,MOTG,0,1
154444,),0,0
154445,and,0,0
154446,weaker,0,0
154447,sources,0,0
154448,in,0,0
154449,prefrontal,0,0
154450,cortex,0,0
154451,in,0,0
154452,typical,0,0
154453,participants,0,0
154454,compared,0,0
154455,to,0,0
154456,Asperger,0,0
154457,.,0,0
154458,Activity,0,0
154459,in,0,0
154460,premotor,0,0
154461,regions,0,0
154462,",",0,0
154463,IPL,0,1
154464,and,0,0
154465,MOTG,0,0
154466,correlated,0,0
154467,positively,0,0
154468,with,0,0
154469,social,0,0
154470,competence,0,0
154471,",",0,0
154472,whereas,0,0
154473,prefrontal,0,0
154474,Mu-sources,0,1
154475,correlated,0,0
154476,negatively,0,0
154477,with,0,0
154478,social,0,0
154479,competence,0,0
154480,.,0,0
154481,No,0,0
154482,correlation,0,0
154483,with,0,0
154484,intellectual,0,0
154485,ability,0,0
154486,was,0,0
154487,found,0,0
154488,at,0,0
154489,any,0,0
154490,of,0,0
154491,these,0,0
154492,sites,0,0
154493,.,0,0
154494,These,0,0
154495,findings,0,0
154496,localize,0,0
154497,abnormal,0,0
154498,Mu-activity,0,0
154499,in,0,0
154500,the,0,0
154501,brain,0,0
154502,of,0,0
154503,Asperger,0,0
154504,children,0,0
154505,providing,0,0
154506,evidence,0,0
154507,which,0,0
154508,associates,0,0
154509,motor-system,0,0
154510,abnormalities,0,0
154511,with,0,0
154512,social-function,0,0
154513,deficits,0,0
154514,.,0,0
154515,Nasal,0,0
154516,eosinophilia,0,0
154517,and,0,0
154518,serum,0,0
154519,soluble,0,1
154520,intercellular,0,0
154521,adhesion,0,0
154522,molecule,0,0
154523,1,0,0
154524,in,0,0
154525,patients,0,0
154526,with,0,0
154527,allergic,0,0
154528,rhinitis,0,0
154529,treated,0,0
154530,with,0,0
154531,montelukast,1,1
154532,alone,1,1
154533,or,0,0
154534,in,0,0
154535,combination,0,1
154536,with,0,0
154537,desloratadine,1,1
154538,or,0,0
154539,levocetirizine,1,1
154540,.,1,0
154541,BACKGROUND,0,0
154542,Because,0,0
154543,intercellular,0,0
154544,adhesion,0,0
154545,molecule,0,0
154546,(,0,0
154547,ICAM,0,1
154548,),0,0
154549,1,0,0
154550,and,0,0
154551,recruitment,0,0
154552,of,0,0
154553,eosinophils,0,0
154554,are,0,0
154555,crucial,0,0
154556,in,0,0
154557,supporting,0,0
154558,allergic,0,0
154559,inflammation,0,0
154560,",",0,0
154561,their,0,0
154562,down-regulation,0,0
154563,may,0,0
154564,bring,0,0
154565,additional,0,0
154566,benefits,0,0
154567,in,0,0
154568,patients,0,0
154569,',0,0
154570,recovery,0,0
154571,.,0,0
154572,We,0,0
154573,have,0,0
154574,assessed,0,0
154575,nasal,0,0
154576,eosinophilia,0,0
154577,and,0,0
154578,serum,0,0
154579,soluble,0,1
154580,ICAM-1,0,0
154581,(,0,0
154582,sICAM-1,0,0
154583,),0,0
154584,concentrations,0,0
154585,in,0,0
154586,relation,0,0
154587,to,0,0
154588,nasal,0,0
154589,symptoms,0,0
154590,in,0,0
154591,patients,0,0
154592,with,0,0
154593,persistent,0,0
154594,allergic,0,0
154595,rhinitis,0,0
154596,(,0,0
154597,AR,0,1
154598,),0,0
154599,treated,0,0
154600,for,0,0
154601,6,0,0
154602,weeks,0,0
154603,with,0,0
154604,either,0,0
154605,desloratadine,1,1
154606,",",1,0
154607,levocetirizine,1,1
154608,",",1,0
154609,montelukast,1,1
154610,alone,1,1
154611,",",0,0
154612,or,0,0
154613,in,0,0
154614,combination,1,1
154615,.,1,0
154616,METHODS,0,0
154617,In,0,0
154618,this,0,0
154619,single-center,0,0
154620,",",0,0
154621,randomized,0,0
154622,",",0,0
154623,double-blind,0,0
154624,",",0,0
154625,placebo-controlled,1,1
154626,",",0,0
154627,crossover,0,0
154628,",",0,0
154629,two-arm,0,0
154630,study,0,0
154631,",",0,0
154632,40,0,0
154633,patients,0,0
154634,with,0,0
154635,persistent,0,0
154636,AR,0,1
154637,were,0,0
154638,randomized,0,0
154639,to,0,0
154640,receive,0,0
154641,either,0,0
154642,montelukast,1,1
154643,and/or,1,0
154644,levocetirizine,1,1
154645,or,1,1
154646,placebo,1,1
154647,(,0,0
154648,n,0,0
154649,=,0,0
154650,20,0,1
154651,),0,0
154652,or,0,0
154653,to,0,0
154654,receive,0,1
154655,treatment,0,0
154656,with,0,0
154657,montelukast,1,1
154658,and/or,1,0
154659,desloratadine,1,1
154660,or,0,1
154661,placebo,1,1
154662,(,0,0
154663,n,0,0
154664,=,0,0
154665,20,0,0
154666,),0,0
154667,.,0,0
154668,Nasal,0,0
154669,eosinophilia,0,0
154670,and,0,0
154671,concentration,0,0
154672,of,0,0
154673,sICAM-1,0,0
154674,in,0,0
154675,peripheral,0,0
154676,blood,0,0
154677,were,0,0
154678,assessed,0,0
154679,before,0,0
154680,and,0,0
154681,on,0,0
154682,the,0,0
154683,last,0,0
154684,day,0,0
154685,of,0,0
154686,each,0,0
154687,treatment,0,0
154688,period,0,0
154689,.,0,0
154690,RESULTS,0,0
154691,All,0,0
154692,active,0,0
154693,treatments,0,0
154694,in,0,0
154695,both,0,0
154696,arms,0,0
154697,of,0,0
154698,the,0,0
154699,study,0,0
154700,resulted,0,0
154701,in,0,0
154702,the,0,0
154703,decrease,0,0
154704,of,0,0
154705,sICAM-1,0,0
154706,and,0,0
154707,nasal,0,1
154708,eosinophilia,0,0
154709,",",0,0
154710,which,0,0
154711,correlated,0,0
154712,with,0,0
154713,the,0,0
154714,severity,0,0
154715,of,0,0
154716,nasal,0,0
154717,symptoms,0,0
154718,.,0,0
154719,In,0,0
154720,the,0,0
154721,montelukast/levocetirizine,1,1
154722,arm,0,0
154723,",",0,0
154724,montelukast,1,1
154725,decreased,0,0
154726,nasal,0,0
154727,eosinophilia,0,0
154728,more,0,0
154729,significantly,0,0
154730,than,0,0
154731,levocetirizine,1,0
154732,",",0,0
154733,whereas,0,0
154734,in,0,0
154735,reduction,0,0
154736,of,0,0
154737,sICAM-1,0,0
154738,all,0,0
154739,active,0,0
154740,treatment,0,0
154741,options,0,0
154742,were,0,0
154743,equally,0,0
154744,effective,0,0
154745,.,0,0
154746,However,0,0
154747,",",0,0
154748,in,0,0
154749,the,0,0
154750,desloratadine/montelukast,1,1
154751,arm,0,0
154752,",",0,0
154753,the,0,0
154754,resulting,0,0
154755,improvement,0,0
154756,of,0,0
154757,combination,0,1
154758,therapy,0,1
154759,of,0,0
154760,sICAM-1,0,0
154761,and,0,0
154762,the,0,0
154763,influx,0,0
154764,of,0,0
154765,eosinophils,0,0
154766,was,0,0
154767,not,0,0
154768,statistically,0,0
154769,significant,0,0
154770,.,0,0
154771,CONCLUSION,0,0
154772,The,0,0
154773,improvement,0,0
154774,of,0,0
154775,nasal,0,0
154776,symptoms,0,0
154777,in,0,0
154778,patients,0,0
154779,with,0,0
154780,AR,0,1
154781,treated,0,0
154782,with,0,0
154783,antihistamines,0,1
154784,",",0,0
154785,with,0,0
154786,or,0,0
154787,without,0,0
154788,montelukast,1,1
154789,",",0,0
154790,may,0,0
154791,additionally,0,0
154792,result,0,0
154793,from,0,0
154794,the,0,0
154795,reduction,0,0
154796,of,0,0
154797,sICAM-1,0,0
154798,and,0,0
154799,nasal,0,0
154800,eosinophilia,0,0
154801,.,0,0
154802,Because,0,0
154803,the,0,0
154804,combination,0,1
154805,therapy,0,1
154806,may,0,0
154807,bring,0,0
154808,inconclusive,0,0
154809,benefits,0,0
154810,in,0,0
154811,this,0,0
154812,area,0,0
154813,there,0,0
154814,is,0,0
154815,a,0,0
154816,strong,0,0
154817,need,0,0
154818,of,0,0
154819,further,0,0
154820,studies,0,0
154821,to,0,0
154822,find,0,0
154823,mechanisms,0,0
154824,that,0,0
154825,favor,0,0
154826,combination,0,1
154827,therapy,0,1
154828,.,0,0
154829,Long-term,0,0
154830,treatment,0,0
154831,with,0,0
154832,atomoxetine,1,1
154833,for,0,0
154834,attention-deficit/hyperactivity,0,0
154835,disorder,0,0
154836,symptoms,0,0
154837,in,0,0
154838,children,0,0
154839,and,0,0
154840,adolescents,0,0
154841,with,0,0
154842,autism,0,0
154843,spectrum,0,0
154844,disorder,0,0
154845,:,0,0
154846,an,0,0
154847,open-label,0,0
154848,extension,0,0
154849,study,0,0
154850,.,0,0
154851,OBJECTIVE,0,0
154852,The,0,0
154853,efficacy,0,0
154854,and,0,0
154855,tolerability,0,0
154856,of,0,0
154857,long-term,0,0
154858,treatment,0,0
154859,with,0,0
154860,atomoxetine,1,1
154861,for,0,0
154862,symptoms,0,0
154863,of,0,0
154864,attention-deficit/hyperactivity,0,0
154865,disorder,0,0
154866,(,0,0
154867,ADHD,0,1
154868,),0,0
154869,in,0,0
154870,children,0,0
154871,with,0,0
154872,autism,0,0
154873,spectrum,0,0
154874,disorder,0,0
154875,(,0,0
154876,ASD,0,0
154877,),0,1
154878,has,0,0
154879,not,0,0
154880,been,0,0
154881,established,0,0
154882,.,0,0
154883,METHODS,0,0
154884,In,0,0
154885,this,0,0
154886,study,0,0
154887,",",0,0
154888,88,0,0
154889,patients,0,0
154890,6-17,0,0
154891,years,0,0
154892,of,0,0
154893,age,0,0
154894,",",0,0
154895,with,0,0
154896,ADHD,0,1
154897,and,0,0
154898,ASD,0,0
154899,",",0,0
154900,were,0,0
154901,treated,0,0
154902,with,0,0
154903,1.2,0,0
154904,mg/kg/day,0,0
154905,atomoxetine,1,1
154906,for,0,0
154907,20,0,0
154908,weeks,0,0
154909,as,0,0
154910,follow-up,0,0
154911,of,0,0
154912,an,0,0
154913,8,0,0
154914,week,0,0
154915,double-blind,0,0
154916,placebo-controlled,1,1
154917,period,0,0
154918,.,0,0
154919,Primary,0,0
154920,endpoint,0,0
154921,was,0,0
154922,the,0,0
154923,ADHD,0,1
154924,Rating,0,0
154925,Scale,0,1
154926,(,0,0
154927,ADHD-RS,0,1
154928,),0,0
154929,.,0,0
154930,RESULTS,0,0
154931,After,0,0
154932,8,0,0
154933,weeks,0,0
154934,of,0,0
154935,initial,0,0
154936,treatment,0,0
154937,",",0,0
154938,the,0,0
154939,mean,0,0
154940,total,0,0
154941,",",0,0
154942,inattention,0,0
154943,",",0,0
154944,and,0,0
154945,hyperactivity-impulsivity,0,0
154946,ADHD-RS,0,1
154947,further,0,0
154948,decreased,0,0
154949,significantly,0,0
154950,from,0,0
154951,34.9,0,0
154952,to,0,0
154953,27.0,0,0
154954,for,0,0
154955,the,0,0
154956,total,0,0
154957,ADHD-RS,0,0
154958,",",0,0
154959,from,0,0
154960,18.3,0,0
154961,to,0,0
154962,14.5,0,0
154963,for,0,0
154964,the,0,0
154965,ADHD-RS,0,1
154966,inattention,0,0
154967,subscale,0,0
154968,",",0,0
154969,and,0,0
154970,from,0,0
154971,16.5,0,0
154972,to,0,0
154973,12.6,0,0
154974,for,0,0
154975,the,0,0
154976,hyperactivity-impulsivity,0,0
154977,subscale,0,0
154978,.,0,0
154979,Adverse,0,0
154980,events,0,0
154981,were,0,0
154982,mild,0,0
154983,and,0,0
154984,tended,0,0
154985,to,0,0
154986,diminish,0,0
154987,over,0,0
154988,time,0,0
154989,during,0,0
154990,continued,0,0
154991,treatment,0,0
154992,",",0,0
154993,especially,0,0
154994,regarding,0,0
154995,nausea,0,0
154996,and,0,0
154997,fatigue,0,0
154998,.,0,0
154999,There,0,0
155000,were,0,0
155001,no,0,0
155002,serious,0,0
155003,adverse,0,0
155004,events,0,0
155005,.,0,0
155006,CONCLUSIONS,0,0
155007,The,0,0
155008,results,0,0
155009,of,0,0
155010,the,0,0
155011,present,0,0
155012,analysis,0,0
155013,suggest,0,0
155014,that,0,0
155015,continued,0,0
155016,treatment,0,0
155017,with,0,0
155018,atomoxetine,1,1
155019,up,0,0
155020,to,0,0
155021,28,0,0
155022,weeks,0,0
155023,further,0,0
155024,improve,0,0
155025,ADHD,0,0
155026,symptoms,0,0
155027,in,0,0
155028,children,0,0
155029,and,0,0
155030,adolescents,0,0
155031,with,0,0
155032,ASD,0,0
155033,",",0,0
155034,while,0,0
155035,adverse,0,0
155036,events,0,0
155037,tend,0,0
155038,to,0,0
155039,subside,0,0
155040,.,0,0
155041,Future,0,0
155042,studies,0,0
155043,investigating,0,0
155044,the,0,0
155045,long-term,0,0
155046,efficacy,0,0
155047,of,0,0
155048,atomoxetine,1,1
155049,in,0,0
155050,children,0,0
155051,and,0,0
155052,adolescents,0,0
155053,with,0,0
155054,ASD,0,0
155055,should,0,0
155056,be,0,0
155057,randomized,0,0
155058,and,0,0
155059,placebo,0,1
155060,controlled,0,0
155061,.,0,0
155062,This,0,0
155063,study,0,0
155064,has,0,0
155065,been,0,0
155066,registered,0,0
155067,in,0,0
155068,ClinicalTrials.gov,0,0
155069,(,0,0
155070,www.clinicaltrials.gov,0,0
155071,),0,0
155072,under,0,0
155073,registration,0,0
155074,number,0,0
155075,NCT00380692,0,0
155076,.,0,0
155077,Effects,0,0
155078,of,0,0
155079,parecoxib,1,1
155080,on,0,0
155081,morphine,0,1
155082,analgesia,0,0
155083,after,0,0
155084,gynecology,0,0
155085,tumor,0,0
155086,operation,0,0
155087,:,0,0
155088,a,0,0
155089,randomized,0,0
155090,trial,0,0
155091,of,0,0
155092,parecoxib,1,1
155093,used,0,0
155094,in,0,0
155095,postsurgical,0,0
155096,pain,0,0
155097,management,0,0
155098,.,0,0
155099,BACKGROUND,0,0
155100,The,0,0
155101,analgesic,0,0
155102,efficacy,0,0
155103,of,0,0
155104,parecoxib,1,1
155105,in,0,0
155106,postsurgical,0,0
155107,pain,0,0
155108,management,0,0
155109,has,0,0
155110,been,0,0
155111,confirmed,0,0
155112,in,0,0
155113,minimally,0,0
155114,invasive,0,0
155115,surgery,0,0
155116,.,0,0
155117,However,0,0
155118,",",0,0
155119,little,0,0
155120,is,0,0
155121,known,0,0
155122,about,0,0
155123,its,0,0
155124,effects,0,0
155125,used,0,0
155126,in,0,0
155127,combination,0,0
155128,with,0,0
155129,opioids,0,1
155130,and,0,0
155131,about,0,0
155132,its,0,0
155133,potential,0,0
155134,for,0,0
155135,opioid-sparing,0,0
155136,effects,0,0
155137,in,0,0
155138,complex,0,0
155139,operations,0,0
155140,.,0,0
155141,This,0,0
155142,study,0,0
155143,was,0,0
155144,performed,0,0
155145,to,0,0
155146,investigate,0,0
155147,the,0,0
155148,influence,0,0
155149,of,0,0
155150,parecoxib,1,1
155151,on,1,0
155152,morphine,1,1
155153,analgesia,0,0
155154,after,0,0
155155,gynecological,0,0
155156,tumor,0,0
155157,surgery,0,0
155158,.,0,0
155159,METHODS,0,0
155160,Eighty,0,0
155161,patients,0,0
155162,undergoing,0,0
155163,gynecological,0,0
155164,tumor,0,0
155165,resection,0,1
155166,were,0,0
155167,randomized,0,0
155168,to,0,0
155169,receive,0,0
155170,either,0,0
155171,intravenous,1,1
155172,parecoxib,1,1
155173,at,1,0
155174,a,1,0
155175,dose,1,0
155176,of,1,0
155177,40,1,0
155178,mg,1,1
155179,(,1,0
155180,Group,1,0
155181,P,1,0
155182,",",1,0
155183,n,1,0
155184,=,1,0
155185,40,1,0
155186,),1,0
155187,followed,1,0
155188,by,1,0
155189,40,1,0
155190,mg,1,0
155191,every,1,0
155192,12,1,0
155193,h,1,0
155194,for,1,0
155195,48,1,0
155196,h,1,0
155197,or,1,1
155198,saline,1,1
155199,as,1,0
155200,a,1,0
155201,control,1,1
155202,(,1,0
155203,Group,1,0
155204,C,1,1
155205,",",1,0
155206,n,1,0
155207,=,1,0
155208,40,1,0
155209,),1,0
155210,30,1,0
155211,min,1,0
155212,before,1,0
155213,induction,1,0
155214,of,1,0
155215,anesthesia,1,1
155216,",",1,0
155217,followed,1,0
155218,by,1,0
155219,saline,1,1
155220,at,1,0
155221,the,1,0
155222,same,1,0
155223,time,1,0
155224,points,1,0
155225,after,1,0
155226,the,1,0
155227,operation,1,0
155228,.,1,0
155229,All,1,0
155230,patients,0,0
155231,had,0,0
155232,access,1,0
155233,to,1,0
155234,patient-controlled,1,1
155235,analgesia,1,0
155236,with,1,0
155237,intravenous,1,1
155238,morphine,1,1
155239,.,1,0
155240,Patients,1,0
155241,were,0,0
155242,assessed,0,0
155243,with,0,0
155244,respect,0,0
155245,to,0,0
155246,pain,0,0
155247,score,0,0
155248,(,0,0
155249,visual,0,0
155250,analog,0,1
155251,scale,0,0
155252,from,0,0
155253,0-10,0,0
155254,),0,0
155255,",",0,0
155256,cumulative,0,0
155257,morphine,0,1
155258,requirement,0,0
155259,",",0,0
155260,satisfaction,0,0
155261,score,0,0
155262,",",0,0
155263,and,0,0
155264,side,0,0
155265,effects,0,0
155266,at,0,0
155267,2,0,0
155268,",",0,0
155269,6,0,0
155270,",",0,0
155271,12,0,0
155272,",",0,0
155273,24,0,0
155274,",",0,0
155275,and,0,0
155276,48,0,0
155277,h,0,0
155278,after,0,0
155279,surgery,0,0
155280,.,0,0
155281,RESULTS,0,0
155282,A,0,0
155283,total,0,0
155284,of,0,0
155285,79,0,0
155286,patients,0,0
155287,were,0,0
155288,evaluated,0,0
155289,.,0,0
155290,The,0,0
155291,cumulative,0,0
155292,dose,0,0
155293,of,0,0
155294,morphine,0,1
155295,administered,0,0
155296,at,0,0
155297,each,0,0
155298,time,0,0
155299,point,0,0
155300,was,0,0
155301,lower,0,0
155302,in,0,0
155303,Group,0,0
155304,P,0,0
155305,than,0,0
155306,in,0,0
155307,Group,0,0
155308,C,0,1
155309,(,0,0
155310,P,0,0
155311,<,0,0
155312,0.05,0,0
155313,),0,0
155314,",",0,0
155315,at,0,0
155316,2,0,0
155317,h,0,0
155318,(,0,0
155319,3.81,0,0
155320,?,0,0
155321,0.35,0,0
155322,versus,0,0
155323,4.13,0,0
155324,?,0,0
155325,0.45,0,0
155326,;,0,0
155327,P,0,0
155328,=,0,0
155329,0.01,0,0
155330,),0,0
155331,",",0,0
155332,6,0,0
155333,h,0,0
155334,(,0,0
155335,16.20,0,0
155336,?,0,0
155337,1.49,0,0
155338,versus,0,0
155339,19.60,0,0
155340,?,0,0
155341,0.35,0,0
155342,;,0,0
155343,P,0,0
155344,<,0,0
155345,0.001,0,0
155346,),0,0
155347,",",0,0
155348,12,0,0
155349,h,0,0
155350,(,0,0
155351,26.29,0,0
155352,?,0,0
155353,2.75,0,0
155354,versus,0,0
155355,32.49,0,0
155356,?,0,0
155357,2.42,0,0
155358,;,0,0
155359,P,0,0
155360,<,0,0
155361,0.001,0,0
155362,),0,0
155363,",",0,0
155364,24,0,0
155365,h,0,0
155366,(,0,0
155367,41.72,0,0
155368,?,0,0
155369,2.70,0,0
155370,versus,0,0
155371,49.97,0,0
155372,?,0,0
155373,4.53,0,0
155374,;,0,0
155375,P,0,0
155376,<,0,0
155377,0.001,0,0
155378,),0,0
155379,",",0,0
155380,and,0,0
155381,48,0,0
155382,h,0,0
155383,(,0,0
155384,60.06,0,0
155385,?,0,0
155386,4.00,0,0
155387,versus,0,0
155388,65.68,0,0
155389,?,0,0
155390,3.23,0,0
155391,;,0,0
155392,P,0,0
155393,<,0,0
155394,0.001,0,0
155395,),0,0
155396,.,0,0
155397,Compared,0,0
155398,with,0,0
155399,Group,0,0
155400,C,0,0
155401,",",0,0
155402,Group,0,0
155403,P,0,0
155404,had,0,0
155405,significantly,0,0
155406,lower,0,0
155407,visual,0,0
155408,analog,0,0
155409,scale,0,0
155410,scores,0,0
155411,at,0,0
155412,rest,0,0
155413,and,0,0
155414,with,0,0
155415,movement,0,0
155416,",",0,0
155417,respectively,0,0
155418,",",0,0
155419,at,0,0
155420,2,0,0
155421,h,0,0
155422,(,0,0
155423,4.2,0,0
155424,",",0,0
155425,P,0,0
155426,<,0,0
155427,0.001,0,0
155428,and,0,0
155429,5.0,0,0
155430,",",0,0
155431,P,0,0
155432,<,0,0
155433,0.001,0,0
155434,),0,0
155435,",",0,0
155436,6,0,0
155437,h,0,0
155438,(,0,0
155439,3.6,0,0
155440,",",0,0
155441,P,0,0
155442,<,0,0
155443,0.001,0,0
155444,and,0,0
155445,4.5,0,0
155446,",",0,0
155447,P,0,0
155448,<,0,0
155449,0.001,0,0
155450,),0,0
155451,",",0,0
155452,12,0,0
155453,h,0,0
155454,(,0,0
155455,3.0,0,0
155456,",",0,0
155457,P,0,0
155458,=,0,0
155459,0.017,0,0
155460,and,0,0
155461,4.0,0,0
155462,",",0,0
155463,P,0,0
155464,<,0,0
155465,0.001,0,0
155466,),0,0
155467,",",0,0
155468,24,0,0
155469,h,0,0
155470,(,0,0
155471,2.1,0,0
155472,",",0,0
155473,P,0,0
155474,<,0,0
155475,0.001,0,0
155476,and,0,0
155477,3.4,0,0
155478,",",0,0
155479,P,0,0
155480,<,0,0
155481,0.001,0,0
155482,),0,0
155483,",",0,0
155484,and,0,0
155485,48,0,0
155486,h,0,0
155487,(,0,0
155488,1.8,0,0
155489,",",0,0
155490,P,0,0
155491,<,0,0
155492,0.001,0,0
155493,and,0,0
155494,2.6,0,0
155495,",",0,0
155496,P,0,0
155497,<,0,0
155498,0.001,0,0
155499,),0,0
155500,.,0,0
155501,The,0,0
155502,satisfaction,0,0
155503,score,0,0
155504,was,0,0
155505,higher,0,0
155506,in,0,0
155507,Group,0,0
155508,P,0,0
155509,than,0,0
155510,in,0,0
155511,Group,0,0
155512,C,0,1
155513,(,0,0
155514,8.6,0,0
155515,?,0,0
155516,0.3,0,0
155517,versus,0,0
155518,6.8,0,0
155519,?,0,0
155520,0.7,0,0
155521,",",0,0
155522,P,0,0
155523,<,0,0
155524,0.001,0,0
155525,),0,0
155526,.,0,0
155527,There,0,0
155528,were,0,0
155529,no,0,0
155530,significant,0,0
155531,differences,0,0
155532,in,0,0
155533,side,0,0
155534,effects,0,0
155535,between,0,0
155536,the,0,0
155537,two,0,0
155538,groups,0,0
155539,(,0,0
155540,P,0,0
155541,>,0,0
155542,0.05,0,0
155543,),0,0
155544,.,0,0
155545,CONCLUSIONS,0,0
155546,The,0,0
155547,use,0,0
155548,of,0,0
155549,parecoxib,1,1
155550,with,1,0
155551,patient-controlled,0,1
155552,analgesic,0,0
155553,morphine,0,1
155554,in,0,0
155555,postoperative,0,0
155556,analgesia,0,0
155557,resulted,0,0
155558,in,0,0
155559,comprehensive,0,0
155560,enhancement,0,0
155561,of,0,0
155562,the,0,0
155563,analgesic,0,0
155564,efficacy,0,0
155565,",",0,0
155566,reducing,0,0
155567,the,0,0
155568,opioid,0,1
155569,requirement,0,0
155570,and,0,0
155571,increasing,0,0
155572,patient,0,0
155573,satisfaction,0,0
155574,after,0,0
155575,gynecological,0,0
155576,tumor,0,0
155577,surgery,0,0
155578,.,0,0
155579,Prevalence,0,0
155580,and,0,0
155581,treatment,0,0
155582,outcome,0,0
155583,of,0,0
155584,cervicitis,0,0
155585,of,0,0
155586,unknown,0,0
155587,etiology,0,0
155588,.,0,0
155589,BACKGROUND,0,0
155590,Mucopurulent,0,0
155591,cervicitis,0,0
155592,(,0,0
155593,MPC,0,1
155594,),0,1
155595,is,0,0
155596,a,0,0
155597,clinical,0,0
155598,syndrome,0,0
155599,characterized,0,0
155600,by,0,0
155601,mucopurulent,0,0
155602,discharge,0,0
155603,from,0,0
155604,the,0,0
155605,cervix,0,0
155606,and,0,0
155607,other,0,0
155608,signs,0,0
155609,of,0,0
155610,inflammation,0,0
155611,.,0,0
155612,This,0,0
155613,was,0,0
155614,a,0,0
155615,phase,0,0
155616,III,0,0
155617,",",0,0
155618,multicenter,0,0
155619,study,0,0
155620,designed,0,0
155621,to,0,0
155622,evaluate,0,0
155623,the,0,0
155624,effectiveness,0,0
155625,of,0,0
155626,placebo,1,1
155627,versus,0,0
155628,empiric,1,0
155629,antibiotic,1,1
155630,treatment,1,0
155631,for,0,0
155632,clinical,0,0
155633,cure,0,0
155634,of,0,0
155635,MPC,0,1
155636,of,0,0
155637,unknown,0,0
155638,etiology,0,0
155639,at,0,0
155640,2-month,0,0
155641,follow-up,0,0
155642,.,0,0
155643,Unfortunately,0,0
155644,",",0,0
155645,enrollment,0,0
155646,was,0,0
155647,terminated,0,0
155648,because,0,0
155649,of,0,0
155650,low,0,0
155651,accrual,0,0
155652,of,0,0
155653,women,0,0
155654,with,0,0
155655,cervicitis,0,0
155656,of,0,0
155657,unknown,0,0
155658,etiology,0,0
155659,",",0,0
155660,but,0,0
155661,important,0,0
155662,prevalence,0,0
155663,and,0,0
155664,outcome,0,0
155665,data,0,0
155666,were,0,0
155667,obtained,0,0
155668,.,0,0
155669,METHODS,0,0
155670,Five,0,0
155671,hundred,0,0
155672,seventy-seven,0,0
155673,women,0,0
155674,were,0,0
155675,screened,0,0
155676,for,0,0
155677,MPC,0,1
155678,.,0,0
155679,Women,0,0
155680,with,0,0
155681,MPC,0,1
155682,were,0,0
155683,randomized,0,0
155684,to,0,0
155685,the,0,0
155686,treatment,0,0
155687,or,0,1
155688,placebo,1,1
155689,arm,0,0
155690,of,0,0
155691,the,0,0
155692,study,0,0
155693,",",0,0
155694,and,0,0
155695,the,0,0
155696,2,0,0
155697,arms,0,0
155698,were,0,0
155699,evaluated,0,0
155700,based,0,0
155701,on,0,0
155702,the,0,0
155703,etiology,0,0
155704,",",0,0
155705,clinical,0,0
155706,cure,0,0
155707,rates,0,0
155708,",",0,0
155709,adverse,0,0
155710,events,0,0
155711,(,0,0
155712,AEs,0,0
155713,),0,0
155714,",",0,0
155715,and,0,0
155716,rates,0,0
155717,of,0,0
155718,pelvic,0,0
155719,inflammatory,0,0
155720,disease,0,0
155721,.,0,0
155722,RESULTS,0,0
155723,One,0,0
155724,hundred,0,0
155725,thirty-one,0,0
155726,(,0,0
155727,23,0,0
155728,%,0,0
155729,[,0,0
155730,131/577,0,0
155731,],0,0
155732,),0,0
155733,screened,0,0
155734,women,0,0
155735,were,0,0
155736,found,0,0
155737,to,0,0
155738,have,0,0
155739,MPC,0,1
155740,.,0,0
155741,Eighty-seven,0,0
155742,were,0,0
155743,enrolled,0,0
155744,and,0,0
155745,randomized,0,0
155746,.,0,0
155747,After,0,0
155748,excluding,0,0
155749,women,0,0
155750,with,0,0
155751,sexually,0,0
155752,transmitted,0,0
155753,infections,0,0
155754,and,0,0
155755,other,0,0
155756,exclusions,0,0
155757,",",0,0
155758,61,0,0
155759,%,0,0
155760,(,0,0
155761,53/87,0,0
155762,),0,0
155763,had,0,0
155764,cervicitis,0,0
155765,of,0,0
155766,unknown,0,0
155767,etiology,0,0
155768,.,0,0
155769,The,0,0
155770,overall,0,0
155771,clinical,0,0
155772,failure,0,0
155773,rate,0,0
155774,was,0,0
155775,30,0,0
155776,%,0,0
155777,(,0,0
155778,10/33,0,0
155779,),0,0
155780,",",0,0
155781,and,0,0
155782,the,0,0
155783,clinical,0,0
155784,cure,0,0
155785,rate,0,0
155786,was,0,0
155787,only,0,0
155788,24,0,0
155789,%,0,0
155790,(,0,0
155791,8/33,0,0
155792,),0,0
155793,.,0,0
155794,Rates,0,0
155795,were,0,0
155796,not,0,0
155797,significantly,0,0
155798,different,0,0
155799,between,0,0
155800,the,0,0
155801,arms,0,0
155802,.,0,0
155803,There,0,0
155804,were,0,0
155805,24,0,0
155806,gastrointestinal,0,0
155807,AEs,0,0
155808,in,0,0
155809,the,0,0
155810,treatment,0,0
155811,arm,0,0
155812,compared,0,0
155813,with,0,0
155814,1,0,0
155815,AE,0,0
155816,in,0,0
155817,the,0,0
155818,placebo,1,1
155819,arm,0,0
155820,.,0,0
155821,CONCLUSIONS,0,0
155822,More,0,0
155823,than,0,0
155824,half,0,0
155825,of,0,0
155826,the,0,0
155827,cases,0,0
155828,of,0,0
155829,MPC,0,1
155830,were,0,0
155831,of,0,0
155832,unknown,0,0
155833,etiology,0,0
155834,.,0,0
155835,Clinical,0,0
155836,cure,0,0
155837,rates,0,0
155838,for,0,0
155839,the,0,0
155840,placebo,1,1
155841,and,0,0
155842,treatment,0,0
155843,arms,0,0
155844,were,0,0
155845,extremely,0,0
155846,low,0,0
155847,",",0,0
155848,with,0,0
155849,most,0,0
155850,women,0,0
155851,concluding,0,0
155852,the,0,0
155853,study,0,0
155854,with,0,0
155855,a,0,0
155856,partial,0,0
155857,response,0,0
155858,.,0,0
155859,Gastrointestinal,0,0
155860,AEs,0,0
155861,were,0,0
155862,higher,0,0
155863,in,0,0
155864,the,0,0
155865,treatment,0,0
155866,arm,0,0
155867,.,0,0
155868,Is,0,0
155869,the,0,0
155870,effect,0,0
155871,of,0,0
155872,mobile,1,1
155873,phone,1,0
155874,radiofrequency,1,1
155875,waves,1,0
155876,on,0,0
155877,human,0,0
155878,skin,0,0
155879,perfusion,0,0
155880,non-thermal,0,1
155881,?,0,0
155882,OBJECTIVE,0,0
155883,To,0,0
155884,establish,0,0
155885,whether,0,0
155886,SkBF,0,0
155887,can,0,0
155888,be,0,0
155889,modified,0,0
155890,by,0,0
155891,exposure,0,0
155892,to,0,0
155893,the,0,0
155894,radiofrequency,1,1
155895,waves,1,0
155896,emitted,1,0
155897,by,1,0
155898,a,1,0
155899,mobile,1,1
155900,phone,1,0
155901,when,0,0
155902,the,0,0
155903,latter,0,0
155904,is,0,0
155905,held,0,0
155906,against,0,0
155907,the,0,0
155908,jaw,0,0
155909,and,0,0
155910,ear,0,0
155911,.,0,0
155912,METHODS,0,0
155913,Variations,0,0
155914,in,0,0
155915,SkBF,0,1
155916,and,0,0
155917,Tsk,0,1
155918,in,0,0
155919,adult,0,0
155920,volunteers,0,0
155921,were,0,0
155922,simultaneously,0,0
155923,recorded,1,0
155924,with,1,0
155925,a,1,0
155926,thermostatic,1,0
155927,laser,1,1
155928,Doppler,1,1
155929,system,1,0
155930,during,1,0
155931,a,1,0
155932,20-minute,1,1
155933,radiofrequency,1,1
155934,exposure,1,0
155935,session,1,1
155936,and,1,0
155937,a,1,0
155938,20-minute,1,1
155939,sham,1,1
155940,session,1,1
155941,.,1,0
155942,The,0,0
155943,skin,0,0
155944,microvessels,0,1
155945,',0,0
155946,vasodilatory,0,0
155947,reserve,0,0
155948,was,0,0
155949,assessed,0,0
155950,with,0,0
155951,a,0,0
155952,heat,0,0
155953,challenge,0,0
155954,at,0,0
155955,the,0,0
155956,end,0,0
155957,of,0,0
155958,the,0,0
155959,protocol,0,0
155960,.,0,0
155961,RESULTS,0,0
155962,During,0,0
155963,the,0,0
155964,radiofrequency,1,1
155965,exposure,1,0
155966,session,1,1
155967,",",0,0
155968,SkBF,0,1
155969,increased,0,0
155970,(,0,0
155971,vs.,0,0
155972,baseline,0,0
155973,),0,0
155974,more,0,0
155975,than,0,0
155976,during,0,0
155977,the,0,0
155978,sham,1,1
155979,exposure,1,0
155980,session,1,1
155981,.,1,0
155982,The,0,0
155983,sessions,0,0
155984,did,0,0
155985,not,0,0
155986,differ,0,0
155987,significant,0,0
155988,in,0,0
155989,terms,0,0
155990,of,0,0
155991,the,0,0
155992,Tsk,0,1
155993,time-course,0,0
155994,response,0,0
155995,.,0,0
155996,The,0,0
155997,skin,0,0
155998,microvessels,0,1
155999,',0,0
156000,vasodilatory,0,0
156001,ability,0,0
156002,was,0,0
156003,found,0,0
156004,to,0,0
156005,be,0,0
156006,greater,0,0
156007,during,0,0
156008,radiofrequency,0,1
156009,exposure,0,0
156010,than,0,0
156011,during,0,0
156012,sham,0,1
156013,exposure,0,0
156014,.,0,0
156015,CONCLUSIONS,0,0
156016,Our,0,0
156017,results,0,0
156018,reveal,0,0
156019,the,0,0
156020,existence,0,0
156021,of,0,0
156022,a,0,0
156023,specific,0,0
156024,vasodilatory,0,0
156025,effect,0,0
156026,of,0,0
156027,mobile,1,1
156028,phone,1,1
156029,radiofrequency,1,1
156030,emission,1,0
156031,on,0,0
156032,skin,0,0
156033,perfusion,0,0
156034,.,0,0
156035,Memantine,1,1
156036,add-on,1,1
156037,to,1,0
156038,risperidone,1,1
156039,for,0,0
156040,treatment,0,0
156041,of,0,0
156042,negative,0,0
156043,symptoms,0,0
156044,in,0,0
156045,patients,0,0
156046,with,0,0
156047,stable,0,0
156048,schizophrenia,0,0
156049,:,0,0
156050,randomized,0,0
156051,",",0,0
156052,double-blind,0,0
156053,",",0,0
156054,placebo-controlled,0,1
156055,study,0,0
156056,.,0,0
156057,We,0,0
156058,aimed,0,0
156059,to,0,0
156060,evaluate,0,0
156061,the,0,0
156062,efficacy,0,0
156063,of,0,0
156064,memantine,1,1
156065,add-on,0,1
156066,in,0,0
156067,the,0,0
156068,treatment,0,0
156069,of,0,0
156070,primary,0,0
156071,negative,0,0
156072,symptoms,0,0
156073,of,0,0
156074,patients,0,0
156075,with,0,0
156076,stable,0,0
156077,schizophrenia,0,0
156078,.,0,0
156079,In,0,0
156080,a,0,0
156081,double-blind,0,0
156082,placebo-controlled,0,1
156083,clinical,0,0
156084,trial,0,0
156085,",",0,0
156086,40,0,0
156087,patients,0,0
156088,with,0,0
156089,schizophrenia,0,0
156090,(,0,0
156091,Diagnostic,0,0
156092,and,0,0
156093,Statistical,0,0
156094,Manual,0,0
156095,of,0,0
156096,Mental,0,0
156097,Disorders,0,0
156098,",",0,0
156099,Fourth,0,0
156100,Edition,0,0
156101,),0,0
156102,who,0,0
156103,were,0,0
156104,stabilized,0,0
156105,on,0,0
156106,risperidone,1,1
156107,for,0,0
156108,a,0,0
156109,minimum,0,0
156110,of,0,0
156111,8,0,0
156112,weeks,0,0
156113,were,0,0
156114,randomized,0,0
156115,to,0,0
156116,either,0,0
156117,memantine,1,1
156118,(,0,0
156119,20,0,1
156120,mg,0,1
156121,),0,0
156122,or,0,1
156123,placebo,1,1
156124,in,0,0
156125,addition,0,0
156126,to,0,0
156127,risperidone,1,1
156128,",",0,0
156129,6,0,0
156130,mg/d,0,0
156131,",",0,0
156132,for,0,0
156133,eight,0,0
156134,weeks,0,0
156135,.,0,0
156136,Assessment,0,0
156137,was,0,0
156138,done,0,0
156139,using,0,0
156140,the,0,0
156141,Positive,0,0
156142,and,0,0
156143,Negative,0,0
156144,Syndrome,0,0
156145,Scale,0,0
156146,at,0,0
156147,baseline,0,0
156148,",",0,0
156149,week,0,0
156150,4,0,0
156151,",",0,0
156152,and,0,0
156153,week,0,0
156154,8,0,0
156155,.,0,0
156156,The,0,0
156157,Hamilton,0,0
156158,Depression,0,0
156159,Rating,0,0
156160,Scale,0,0
156161,and,0,0
156162,the,0,0
156163,Extrapyramidal,0,0
156164,Symptom,0,0
156165,Rating,0,0
156166,Scale,0,0
156167,at,0,0
156168,baseline,0,0
156169,and,0,0
156170,week,0,0
156171,8,0,0
156172,were,0,0
156173,used,0,0
156174,to,0,0
156175,assess,0,0
156176,depression,0,0
156177,and,0,0
156178,extrapyramidal,0,0
156179,symptoms,0,0
156180,",",0,0
156181,respectively,0,0
156182,.,0,0
156183,All,0,0
156184,40,0,0
156185,patients,0,0
156186,had,0,0
156187,at,0,0
156188,least,0,0
156189,one,0,0
156190,postbaseline,0,0
156191,measurement,0,0
156192,",",0,0
156193,and,0,0
156194,38,0,0
156195,patients,0,0
156196,completed,0,0
156197,the,0,0
156198,trial,0,0
156199,.,0,0
156200,Patients,0,0
156201,in,0,0
156202,the,0,0
156203,memantine,0,1
156204,group,0,0
156205,showed,0,0
156206,a,0,0
156207,significantly,0,0
156208,greater,0,0
156209,improvement,0,0
156210,on,0,0
156211,negative,0,0
156212,subscale,0,0
156213,than,0,0
156214,the,0,0
156215,placebo,1,1
156216,group,0,0
156217,at,0,0
156218,end,0,0
156219,point,0,0
156220,(,0,0
156221,P,0,0
156222,<,0,0
156223,0.001,0,0
156224,),0,0
156225,.,0,0
156226,The,0,0
156227,same,0,0
156228,effect,0,0
156229,was,0,0
156230,observed,0,0
156231,for,0,0
156232,the,0,0
156233,total,0,0
156234,score,0,0
156235,(,0,0
156236,P,0,0
156237,<,0,0
156238,0.001,0,0
156239,),0,0
156240,and,0,0
156241,the,0,0
156242,general,0,0
156243,psychopathology,0,0
156244,subscale,0,0
156245,score,0,0
156246,(,0,0
156247,P,0,0
156248,=,0,0
156249,0.002,0,0
156250,),0,0
156251,.,0,0
156252,There,0,0
156253,was,0,0
156254,no,0,0
156255,significant,0,0
156256,difference,0,0
156257,in,0,0
156258,reduction,0,0
156259,of,0,0
156260,positive,0,0
156261,symptoms,0,0
156262,score,0,0
156263,between,0,0
156264,the,0,0
156265,2,0,0
156266,groups,0,0
156267,(,0,0
156268,P,0,0
156269,=,0,0
156270,0.757,0,0
156271,),0,0
156272,.,0,0
156273,Changes,0,0
156274,in,0,0
156275,the,0,0
156276,Hamilton,0,0
156277,Depression,0,0
156278,Rating,0,0
156279,Scale,0,0
156280,and,0,0
156281,the,0,0
156282,Extrapyramidal,0,0
156283,Symptom,0,0
156284,Rating,0,0
156285,Scale,0,0
156286,scores,0,0
156287,and,0,0
156288,frequency,0,0
156289,of,0,0
156290,adverse,0,0
156291,effects,0,0
156292,did,0,0
156293,not,0,0
156294,differ,0,0
156295,between,0,0
156296,the,0,0
156297,2,0,0
156298,groups,0,0
156299,.,0,0
156300,Our,0,0
156301,study,0,0
156302,showed,0,0
156303,that,0,0
156304,memantine,0,1
156305,is,0,0
156306,a,0,0
156307,tolerable,0,0
156308,and,0,0
156309,efficacious,0,0
156310,add-on,0,1
156311,treatment,0,0
156312,for,0,0
156313,primary,0,0
156314,negative,0,0
156315,symptoms,0,0
156316,of,0,0
156317,schizophrenia,0,0
156318,.,0,0
156319,Galactomannan,1,1
156320,and,1,0
156321,PCR,1,1
156322,versus,0,1
156323,culture,0,0
156324,and,0,0
156325,histology,0,0
156326,for,0,0
156327,directing,0,0
156328,use,0,0
156329,of,0,0
156330,antifungal,0,1
156331,treatment,0,0
156332,for,0,0
156333,invasive,0,0
156334,aspergillosis,0,0
156335,in,0,0
156336,high-risk,0,0
156337,haematology,0,0
156338,patients,0,0
156339,:,0,0
156340,a,0,0
156341,randomised,0,0
156342,controlled,0,0
156343,trial,0,0
156344,.,0,0
156345,BACKGROUND,0,0
156346,Empirical,0,0
156347,treatment,0,0
156348,with,0,0
156349,antifungal,0,1
156350,drugs,0,1
156351,is,0,0
156352,often,0,0
156353,used,0,0
156354,in,0,0
156355,haematology,0,0
156356,patients,0,0
156357,at,0,0
156358,high,0,0
156359,risk,0,0
156360,of,0,0
156361,invasive,0,0
156362,aspergillosis,0,0
156363,.,0,0
156364,We,0,0
156365,compared,0,0
156366,a,0,0
156367,standard,0,1
156368,diagnostic,0,0
156369,strategy,0,1
156370,(,0,0
156371,culture,0,0
156372,and,0,0
156373,histology,0,0
156374,),0,0
156375,with,0,0
156376,a,0,0
156377,rapid,0,0
156378,biomarker-based,0,0
156379,diagnostic,0,0
156380,strategy,0,1
156381,(,0,0
156382,aspergillus,0,0
156383,galactomannan,0,1
156384,and,0,0
156385,PCR,0,1
156386,),0,0
156387,for,0,0
156388,directing,0,0
156389,the,0,0
156390,use,0,0
156391,of,0,0
156392,antifungal,0,1
156393,treatment,0,0
156394,in,0,0
156395,this,0,0
156396,group,0,0
156397,of,0,0
156398,patients,0,0
156399,.,0,0
156400,METHODS,0,0
156401,In,0,0
156402,this,0,0
156403,open-label,0,0
156404,",",0,0
156405,parallel-group,0,0
156406,",",0,0
156407,randomised,0,0
156408,controlled,0,0
156409,trial,0,0
156410,",",0,0
156411,eligible,0,0
156412,patients,0,0
156413,were,0,0
156414,adults,0,0
156415,undergoing,0,0
156416,allogeneic,0,1
156417,stem-cell,0,0
156418,transplantation,0,1
156419,or,0,1
156420,chemotherapy,1,1
156421,for,0,0
156422,acute,0,0
156423,leukaemia,0,0
156424,",",0,0
156425,with,0,0
156426,no,0,0
156427,history,0,0
156428,of,0,0
156429,invasive,0,0
156430,fungal,0,0
156431,disease,0,0
156432,.,0,0
156433,Enrolled,0,0
156434,patients,0,0
156435,were,0,0
156436,randomly,0,0
156437,assigned,0,0
156438,(,0,0
156439,1:1,0,1
156440,),0,0
156441,by,0,0
156442,a,0,0
156443,computer-generated,0,0
156444,schedule,0,0
156445,to,0,0
156446,follow,0,0
156447,either,0,0
156448,a,0,0
156449,standard,1,1
156450,diagnostic,1,0
156451,strategy,1,1
156452,(,0,0
156453,based,0,0
156454,on,0,0
156455,culture,0,0
156456,and,0,0
156457,histology,0,0
156458,),0,0
156459,or,0,0
156460,a,0,0
156461,biomarker-based,1,0
156462,diagnostic,1,0
156463,strategy,1,1
156464,(,1,0
156465,aspergillus,1,0
156466,galactomannan,1,1
156467,and,1,0
156468,PCR,1,1
156469,),1,0
156470,to,0,0
156471,direct,0,1
156472,treatment,0,0
156473,with,0,0
156474,antifungal,0,1
156475,drugs,0,0
156476,.,0,0
156477,Patients,0,0
156478,",",0,0
156479,were,0,0
156480,followed,0,0
156481,up,0,0
156482,for,0,0
156483,26,0,0
156484,weeks,0,0
156485,or,0,0
156486,until,0,0
156487,death,0,0
156488,.,0,0
156489,Masking,0,0
156490,of,0,0
156491,the,0,0
156492,use,0,0
156493,of,0,0
156494,different,0,0
156495,diagnostic,0,0
156496,tests,0,0
156497,was,0,0
156498,not,0,0
156499,possible,0,0
156500,for,0,0
156501,patients,0,0
156502,",",0,0
156503,treating,0,0
156504,physicians,0,0
156505,",",0,0
156506,or,0,0
156507,investigators,0,0
156508,.,0,0
156509,The,0,0
156510,primary,0,0
156511,endpoint,0,0
156512,was,0,0
156513,empirical,0,0
156514,treatment,0,0
156515,with,0,0
156516,antifungal,0,1
156517,drugs,0,0
156518,in,0,0
156519,the,0,0
156520,26,0,0
156521,weeks,0,0
156522,after,0,0
156523,enrolment,0,0
156524,(,0,0
156525,for,0,0
156526,the,0,0
156527,biomarker-based,0,0
156528,diagnostic,0,0
156529,strategy,0,0
156530,",",0,0
156531,a,0,0
156532,single,0,0
156533,postive,0,0
156534,galactomannan,0,1
156535,or,0,1
156536,PCR,0,1
156537,result,0,0
156538,was,0,0
156539,deemed,0,0
156540,insufficient,0,0
156541,to,0,0
156542,confirm,0,0
156543,invasive,0,0
156544,aspergillosis,0,0
156545,",",0,0
156546,so,0,0
156547,treatment,0,0
156548,in,0,0
156549,this,0,0
156550,context,0,0
156551,was,0,0
156552,classified,0,0
156553,as,0,0
156554,empirical,0,0
156555,),0,0
156556,.,0,0
156557,This,0,0
156558,outcome,0,0
156559,was,0,0
156560,assessed,0,0
156561,by,0,0
156562,an,0,0
156563,independent,0,0
156564,data,0,0
156565,review,0,0
156566,committee,0,0
156567,from,0,0
156568,which,0,0
156569,the,0,0
156570,study,0,0
156571,allocations,0,0
156572,were,0,0
156573,masked,0,0
156574,.,0,0
156575,Analyses,0,0
156576,were,0,0
156577,by,0,0
156578,intention,0,0
156579,to,0,0
156580,treat,0,0
156581,and,0,0
156582,included,0,0
156583,all,0,0
156584,enrolled,0,0
156585,patients,0,0
156586,.,0,0
156587,This,0,0
156588,study,0,0
156589,is,0,0
156590,registered,0,0
156591,with,0,0
156592,ClinicalTrial.gov,0,0
156593,",",0,0
156594,number,0,0
156595,NCT00163722,0,1
156596,.,0,0
156597,FINDINGS,0,0
156598,240,0,0
156599,eligible,0,0
156600,patients,0,0
156601,were,0,0
156602,recruited,0,0
156603,from,0,0
156604,six,0,0
156605,Australian,0,0
156606,centres,0,0
156607,between,0,0
156608,Sept,0,1
156609,30,0,0
156610,",",0,0
156611,2005,0,0
156612,",",0,0
156613,and,0,0
156614,Nov,0,1
156615,19,0,0
156616,",",0,0
156617,2009,0,0
156618,.,0,0
156619,122,0,0
156620,were,0,0
156621,assigned,0,0
156622,the,0,0
156623,standard,0,1
156624,diagnostic,0,0
156625,strategy,0,0
156626,and,0,0
156627,118,0,0
156628,the,0,0
156629,biomarker-based,0,0
156630,diagnostic,0,0
156631,strategy,0,0
156632,.,0,0
156633,39,0,0
156634,patients,0,0
156635,(,0,0
156636,32,0,0
156637,%,0,0
156638,),0,0
156639,in,0,0
156640,the,0,0
156641,standard,0,1
156642,diagnosis,0,0
156643,group,0,0
156644,and,0,0
156645,18,0,0
156646,(,0,0
156647,15,0,0
156648,%,0,0
156649,),0,0
156650,in,0,0
156651,the,0,0
156652,biomarker,0,0
156653,diagnosis,0,0
156654,group,0,0
156655,received,0,0
156656,empirical,0,0
156657,antifungal,0,1
156658,treatment,0,1
156659,(,0,0
156660,difference,0,0
156661,17,0,0
156662,%,0,0
156663,",",0,0
156664,95,0,0
156665,%,0,0
156666,CI,0,0
156667,4-26,0,0
156668,;,0,0
156669,p=0?002,0,0
156670,),0,0
156671,.,0,0
156672,The,0,0
156673,numbers,0,0
156674,of,0,0
156675,patients,0,0
156676,who,0,0
156677,had,0,0
156678,hepatotoxic,0,0
156679,and,0,0
156680,nephrotoxic,0,0
156681,effects,0,0
156682,did,0,0
156683,not,0,0
156684,differ,0,0
156685,significantly,0,0
156686,between,0,0
156687,the,0,0
156688,standard,0,1
156689,diagnosis,0,0
156690,and,0,0
156691,biomarker,0,0
156692,diagnosis,0,0
156693,groups,0,0
156694,(,0,0
156695,hepatotoxic,0,0
156696,effects,0,0
156697,:,0,0
156698,21,0,0
156699,[,0,0
156700,17,0,0
156701,%,0,0
156702,],0,0
156703,vs,0,0
156704,12,0,0
156705,[,0,0
156706,10,0,0
156707,%,0,0
156708,],0,0
156709,",",0,0
156710,p=0?11,0,0
156711,;,0,0
156712,nephrotoxic,0,0
156713,effects,0,0
156714,:,0,0
156715,52,0,0
156716,[,0,0
156717,43,0,0
156718,%,0,0
156719,],0,0
156720,vs,0,0
156721,60,0,0
156722,[,0,0
156723,51,0,0
156724,%,0,0
156725,],0,0
156726,",",0,0
156727,p=0?20,0,0
156728,),0,0
156729,.,0,0
156730,INTERPRETATION,0,0
156731,Use,0,0
156732,of,0,0
156733,aspergillus,0,0
156734,galactomannan,0,1
156735,and,0,0
156736,PCR,0,0
156737,to,0,0
156738,direct,0,0
156739,treatment,0,0
156740,reduced,0,0
156741,use,0,0
156742,of,0,0
156743,empirical,1,0
156744,antifungal,1,1
156745,treatment,1,0
156746,.,1,0
156747,This,1,0
156748,approach,0,0
156749,is,0,0
156750,an,0,0
156751,effective,0,0
156752,strategy,0,0
156753,for,0,0
156754,the,0,0
156755,management,0,0
156756,of,0,0
156757,invasive,0,0
156758,aspergillosis,0,0
156759,in,0,0
156760,high-risk,0,0
156761,haematology,0,0
156762,patients,0,0
156763,.,0,0
156764,FUNDING,0,0
156765,Australian,0,0
156766,National,0,0
156767,Health,0,1
156768,and,0,0
156769,Medical,0,1
156770,Research,0,0
156771,Council,0,1
156772,",",0,0
156773,Cancer,0,0
156774,Council,0,1
156775,New,0,0
156776,South,0,0
156777,Wales,0,0
156778,",",0,0
156779,Pfizer,0,1
156780,",",0,0
156781,Merck,0,0
156782,",",0,0
156783,Gilead,0,0
156784,Sciences,0,0
156785,.,0,0
156786,The,0,0
156787,efficacy,0,0
156788,",",0,0
156789,safety,0,0
156790,and,0,0
156791,cost-effectiveness,0,0
156792,of,0,0
156793,hydrotalcite,1,1
156794,versus,0,0
156795,esomeprazole,1,1
156796,in,0,0
156797,on-demand,0,1
156798,therapy,0,1
156799,of,0,0
156800,NERD,0,1
156801,:,0,0
156802,A,0,0
156803,multicenter,0,0
156804,",",0,0
156805,randomized,0,0
156806,",",0,0
156807,open-label,0,0
156808,study,0,0
156809,in,0,0
156810,China,0,0
156811,.,0,0
156812,OBJECTIVE,0,0
156813,The,0,0
156814,aim,0,0
156815,of,0,0
156816,the,0,0
156817,study,0,0
156818,was,0,0
156819,to,0,0
156820,investigate,0,0
156821,whether,0,0
156822,hydrotalcite,1,1
156823,was,0,0
156824,comparable,0,0
156825,to,0,0
156826,esomeprazole,1,1
156827,",",0,0
156828,a,0,0
156829,proton,0,1
156830,pump,0,1
156831,inhibitor,0,1
156832,",",0,0
156833,in,0,0
156834,on-demand,0,1
156835,therapy,0,1
156836,for,0,0
156837,non-erosive,0,0
156838,reflux,0,0
156839,disease,0,0
156840,(,0,0
156841,NERD,0,1
156842,),0,0
156843,.,0,0
156844,METHODS,0,0
156845,This,0,0
156846,was,0,0
156847,a,0,0
156848,multicenter,0,0
156849,",",0,0
156850,randomized,0,0
156851,",",0,0
156852,open-label,0,0
156853,clinical,0,0
156854,trial,0,0
156855,with,0,0
156856,initial,0,0
156857,and,0,0
156858,on-demand,0,1
156859,therapy,0,1
156860,.,0,0
156861,Patients,0,0
156862,who,0,0
156863,had,0,0
156864,complete,0,0
156865,symptom,0,0
156866,relief,0,0
156867,in,0,0
156868,the,0,0
156869,initial,0,0
156870,therapy,0,1
156871,were,0,0
156872,randomized,0,0
156873,to,0,0
156874,either,0,0
156875,hydrotalcite,1,1
156876,or,1,1
156877,esomeprazole,1,1
156878,in,0,0
156879,the,0,0
156880,on-demand,0,1
156881,therapy,0,1
156882,.,0,0
156883,The,0,0
156884,percentage,0,0
156885,of,0,0
156886,patients,0,0
156887,who,0,0
156888,quit,0,0
156889,on-demand,0,1
156890,therapy,0,1
156891,in,0,0
156892,the,0,0
156893,two,0,0
156894,groups,0,0
156895,and,0,0
156896,the,0,0
156897,cost-effectiveness,0,0
156898,of,0,0
156899,the,0,0
156900,treatment,0,0
156901,were,0,0
156902,evaluated,0,0
156903,as,0,0
156904,primary,0,0
156905,end,0,0
156906,points,0,0
156907,.,0,0
156908,The,0,0
156909,rate,0,0
156910,of,0,0
156911,symptom,0,0
156912,relief,0,0
156913,and,0,0
156914,the,0,0
156915,improvement,0,0
156916,of,0,0
156917,symptom,0,0
156918,score,0,0
156919,for,0,0
156920,initial,0,0
156921,therapy,0,1
156922,and,0,0
156923,the,0,0
156924,weekly,0,1
156925,average,0,0
156926,symptom,0,0
156927,score,0,0
156928,and,0,0
156929,weekly,0,1
156930,average,0,0
156931,number,0,0
156932,of,0,0
156933,days,0,0
156934,on,0,0
156935,treatment,0,0
156936,for,0,0
156937,on-demand,0,1
156938,therapy,0,1
156939,were,0,0
156940,evaluated,0,0
156941,as,0,0
156942,secondary,0,0
156943,end,0,0
156944,points,0,0
156945,.,0,0
156946,RESULTS,0,0
156947,In,0,0
156948,total,0,0
156949,",",0,0
156950,398,0,0
156951,patients,0,0
156952,were,0,0
156953,recruited,0,0
156954,in,0,0
156955,the,0,0
156956,initial,0,0
156957,therapy,0,1
156958,group,0,0
156959,",",0,0
156960,among,0,0
156961,whom,0,0
156962,253,0,0
156963,were,0,0
156964,included,0,0
156965,in,0,0
156966,on-demand,0,1
156967,therapy,0,1
156968,",",0,0
156969,with,0,0
156970,127,0,0
156971,patients,0,0
156972,in,0,0
156973,the,0,0
156974,hydrotalcite,1,1
156975,group,0,0
156976,and,0,0
156977,the,0,0
156978,remaining,0,0
156979,126,0,0
156980,in,0,0
156981,the,0,0
156982,esomeprazole,1,1
156983,group,0,0
156984,.,0,0
156985,14,0,0
156986,(,0,0
156987,11.0,0,0
156988,%,0,0
156989,),0,0
156990,patients,0,0
156991,in,0,0
156992,the,0,0
156993,hydrotalcite,1,1
156994,group,0,0
156995,and,0,0
156996,six,0,0
156997,(,0,0
156998,4.8,0,0
156999,%,0,0
157000,),0,0
157001,in,0,0
157002,the,0,0
157003,esomeprazole,1,1
157004,group,0,0
157005,quit,0,0
157006,the,0,0
157007,on-demand,0,1
157008,therapy,0,1
157009,due,0,0
157010,to,0,0
157011,unsatisfactory,0,0
157012,symptom,0,0
157013,control,0,1
157014,(,0,0
157015,P,0,0
157016,=,0,0
157017,0.065,0,0
157018,),0,0
157019,.,0,0
157020,Cost-effectiveness,0,0
157021,calculated,0,0
157022,as,0,0
157023,the,0,0
157024,ratio,0,0
157025,of,0,0
157026,the,0,0
157027,cost,0,0
157028,of,1,0
157029,hydrotalcite,1,1
157030,to,1,0
157031,that,0,0
157032,of,1,0
157033,esomeprazole,1,1
157034,(,1,0
157035,per,1,0
157036,person/day,0,1
157037,),0,0
157038,was,0,0
157039,35.3,0,0
157040,%,0,0
157041,in,0,0
157042,the,0,0
157043,on-demand,0,1
157044,therapy,0,1
157045,.,0,0
157046,Similar,0,0
157047,number,0,0
157048,of,0,0
157049,patients,0,0
157050,achieved,0,0
157051,symptom,0,0
157052,relief,0,0
157053,in,0,0
157054,both,0,0
157055,groups,0,0
157056,.,0,0
157057,CONCLUSION,1,0
157058,Hydrotalcite,1,1
157059,is,1,0
157060,a,0,0
157061,good,0,0
157062,option,0,0
157063,of,0,0
157064,on-demand,0,1
157065,therapy,0,1
157066,for,0,0
157067,NERD,0,1
157068,patients,0,0
157069,due,0,0
157070,to,0,0
157071,its,0,0
157072,cost-effectiveness,0,0
157073,and,0,0
157074,speed,0,0
157075,of,0,0
157076,action,0,0
157077,.,0,0
157078,Supporting,0,0
157079,families,0,0
157080,in,0,0
157081,challenging,0,0
157082,contexts,0,0
157083,:,0,0
157084,the,0,0
157085,CAPEDP,0,0
157086,project,0,0
157087,.,0,0
157088,Although,0,0
157089,France,0,0
157090,has,0,0
157091,one,0,0
157092,of,0,0
157093,the,0,0
157094,most,0,0
157095,generous,0,0
157096,health,0,0
157097,and,0,0
157098,social,0,1
157099,care,0,1
157100,systems,0,0
157101,for,0,0
157102,infant,0,0
157103,and,0,0
157104,maternal,0,0
157105,well-being,0,0
157106,in,0,0
157107,the,0,0
157108,Western,0,0
157109,world,0,0
157110,",",0,0
157111,professionals,0,0
157112,have,0,0
157113,been,0,0
157114,increasingly,0,0
157115,concerned,0,0
157116,by,0,0
157117,the,0,0
157118,rising,0,0
157119,number,0,0
157120,of,0,0
157121,children,0,0
157122,being,0,0
157123,referred,0,0
157124,for,0,0
157125,mental,0,0
157126,health,0,0
157127,problems,0,0
157128,.,0,0
157129,The,0,0
157130,present,0,0
157131,article,0,0
157132,describes,0,0
157133,the,0,0
157134,first,0,0
157135,home-visiting,1,1
157136,program,1,1
157137,in,0,0
157138,France,0,0
157139,to,0,0
157140,specifically,0,0
157141,target,0,0
157142,mental,0,0
157143,health,0,0
157144,questions,0,0
157145,in,0,0
157146,families,0,0
157147,living,0,0
157148,in,0,0
157149,vulnerable,0,0
157150,contexts,0,0
157151,.,0,0
157152,The,0,0
157153,CAPEDP,0,0
157154,project,0,0
157155,",",0,0
157156,involving,0,0
157157,440,0,0
157158,women,0,0
157159,and,0,0
157160,their,0,0
157161,families,0,0
157162,",",0,0
157163,took,0,0
157164,place,0,0
157165,in,0,0
157166,Paris,0,0
157167,and,0,0
157168,its,0,0
157169,inner,0,0
157170,suburbs,0,0
157171,from,0,0
157172,2006,0,0
157173,to,0,0
157174,2011,0,0
157175,.,0,0
157176,To,0,0
157177,be,0,0
157178,eligible,0,0
157179,for,0,0
157180,inclusion,0,0
157181,",",0,0
157182,women,0,0
157183,had,0,0
157184,to,0,0
157185,be,0,0
157186,(,0,0
157187,i,0,0
157188,),0,0
157189,under,0,0
157190,26,0,0
157191,years,0,0
157192,old,0,0
157193,",",0,0
157194,(,0,0
157195,ii,0,0
157196,),0,0
157197,less,0,0
157198,that,0,0
157199,27,0,0
157200,weeks,0,0
157201,pregnant,0,0
157202,",",0,0
157203,(,0,0
157204,iii,0,0
157205,),0,0
157206,sufficiently,0,0
157207,fluent,0,0
157208,in,0,0
157209,French,0,0
157210,to,0,0
157211,give,0,0
157212,truly,0,0
157213,informed,0,0
157214,consent,0,0
157215,to,0,0
157216,participate,0,0
157217,in,0,0
157218,the,0,0
157219,study,0,0
157220,and,0,0
157221,benefit,0,0
157222,from,0,0
157223,the,0,0
157224,intervention,0,1
157225,and,0,0
157226,(,0,0
157227,iv,0,0
157228,),0,0
157229,presenting,0,0
157230,with,0,0
157231,one,0,0
157232,or,0,0
157233,more,0,0
157234,of,0,0
157235,the,0,0
157236,following,0,0
157237,social,0,0
157238,vulnerability,0,0
157239,factors,0,0
157240,:,0,0
157241,low,0,0
157242,income,0,0
157243,",",0,0
157244,low,0,0
157245,educational,0,1
157246,level,0,0
157247,",",0,0
157248,and/or,0,0
157249,intending,0,0
157250,to,0,0
157251,bring,0,0
157252,up,0,0
157253,the,0,0
157254,child,0,0
157255,without,0,0
157256,the,0,0
157257,child,0,0
157258,'s,0,0
157259,father,0,0
157260,.,0,0
157261,The,1,0
157262,intervention,1,0
157263,consisted,1,0
157264,of,1,0
157265,44,1,0
157266,home,1,0
157267,visits,1,0
157268,from,1,0
157269,the,1,0
157270,third,1,0
157271,trimester,1,0
157272,of,1,0
157273,pregnancy,1,0
157274,through,1,0
157275,to,1,0
157276,the,1,0
157277,child,1,0
157278,'s,1,0
157279,second,1,0
157280,birthday,1,0
157281,.,1,0
157282,The,0,0
157283,aim,0,0
157284,of,0,0
157285,the,0,0
157286,intervention,0,1
157287,was,0,0
157288,to,0,0
157289,promote,0,0
157290,infant,0,0
157291,mental,0,0
157292,health,0,0
157293,and,0,0
157294,reduce,0,0
157295,the,0,0
157296,incidence,0,0
157297,of,0,0
157298,infant,0,0
157299,mental,0,0
157300,health,0,0
157301,problems,0,0
157302,at,0,0
157303,the,0,0
157304,age,0,0
157305,of,0,0
157306,two,0,0
157307,years,0,0
157308,.,0,0
157309,The,0,0
157310,intervention,0,0
157311,paid,0,0
157312,particular,0,0
157313,attention,0,0
157314,to,0,0
157315,postnatal,0,0
157316,maternal,0,0
157317,depression,0,0
157318,and,0,0
157319,promoting,0,1
157320,parenting,0,1
157321,skills,0,1
157322,and,0,0
157323,attachment,0,0
157324,security,0,0
157325,",",0,0
157326,particularly,0,0
157327,through,0,0
157328,the,0,0
157329,use,1,0
157330,of,1,0
157331,video,1,1
157332,during,1,0
157333,home-visits,1,1
157334,.,1,0
157335,A,0,0
157336,major,0,0
157337,issue,0,0
157338,was,0,0
157339,that,0,0
157340,of,0,0
157341,adapting,0,0
157342,international,0,0
157343,best,0,0
157344,practice,0,0
157345,recommendations,0,0
157346,with,0,0
157347,regard,0,0
157348,to,0,0
157349,home-visiting,0,0
157350,programs,0,0
157351,to,0,0
157352,the,0,0
157353,particularities,0,0
157354,of,0,0
157355,the,0,0
157356,existing,0,0
157357,French,0,0
157358,social,0,1
157359,and,0,0
157360,health,0,0
157361,care,0,1
157362,system,0,0
157363,.,0,0
157364,An,0,0
157365,original,0,0
157366,aspect,0,0
157367,of,0,0
157368,the,0,0
157369,intervention,0,1
157370,was,0,0
157371,to,0,0
157372,use,0,0
157373,trained,0,1
157374,clinical,0,0
157375,psychologists,0,0
157376,to,0,0
157377,conduct,0,0
157378,all,0,0
157379,home,0,0
157380,visits,0,0
157381,.,0,0
157382,Haloperidol,1,1
157383,blood,0,0
157384,levels,0,0
157385,and,0,0
157386,effects,0,0
157387,in,0,0
157388,schizophrenia,0,0
157389,and,0,0
157390,schizoaffective,0,0
157391,disorder,0,0
157392,:,0,0
157393,a,0,0
157394,progress,0,0
157395,report,0,0
157396,.,0,0
157397,To,0,0
157398,test,0,0
157399,the,0,0
157400,hypothesis,0,0
157401,of,0,0
157402,a,0,0
157403,therapeutic,0,0
157404,window,0,0
157405,",",0,0
157406,we,0,0
157407,have,0,0
157408,randomly,0,0
157409,assigned,0,0
157410,acutely,0,0
157411,exacerbating,0,0
157412,schizophrenic,0,0
157413,or,0,1
157414,schizoaffective,0,0
157415,patients,0,0
157416,to,0,0
157417,one,0,0
157418,of,0,0
157419,three,0,0
157420,plasma,0,0
157421,levels,0,0
157422,of,0,0
157423,haloperidol,1,1
157424,(,1,0
157425,HAL,1,0
157426,),1,0
157427,:,1,0
157428,2-13,0,0
157429,",",0,0
157430,13.1-24,0,0
157431,",",0,0
157432,or,0,0
157433,24.1-35,0,0
157434,ng/ml,0,0
157435,.,0,0
157436,Patients,0,0
157437,who,0,0
157438,did,0,0
157439,not,0,0
157440,improve,0,0
157441,after,0,0
157442,6,0,0
157443,weeks,0,0
157444,of,0,0
157445,this,0,0
157446,treatment,0,0
157447,were,0,0
157448,randomly,0,0
157449,assigned,0,0
157450,to,0,0
157451,one,0,0
157452,of,0,0
157453,the,0,0
157454,three,0,0
157455,haloperidol,1,1
157456,levels,0,0
157457,for,0,0
157458,another,0,0
157459,6,0,0
157460,weeks,0,0
157461,.,0,0
157462,The,0,0
157463,improvement,0,0
157464,was,0,0
157465,defined,0,0
157466,as,0,0
157467,at,0,0
157468,least,0,0
157469,50,0,0
157470,percent,0,0
157471,reduction,0,0
157472,of,0,0
157473,the,0,0
157474,Brief,0,1
157475,Psychiatric,0,0
157476,Rating,0,0
157477,Scale,0,1
157478,(,0,0
157479,BPRS,0,1
157480,),0,1
157481,total,0,0
157482,score,0,0
157483,.,0,0
157484,The,0,0
157485,results,0,0
157486,obtained,0,0
157487,in,0,0
157488,111,0,0
157489,patients,0,0
157490,do,0,0
157491,not,0,0
157492,support,0,0
157493,any,0,0
157494,consistent,0,0
157495,relationship,0,0
157496,between,0,0
157497,plasma,0,0
157498,level,0,0
157499,of,0,0
157500,haloperidol,1,1
157501,and,0,0
157502,clinical,0,0
157503,improvement,0,0
157504,.,0,0
157505,Patients,0,0
157506,in,0,0
157507,the,0,0
157508,high,0,0
157509,haloperidol,1,1
157510,plasma,0,0
157511,range,0,0
157512,tended,0,0
157513,to,0,0
157514,have,0,0
157515,more,0,0
157516,side,0,0
157517,effects,0,0
157518,.,0,0
157519,These,0,0
157520,results,0,0
157521,suggest,0,0
157522,that,0,0
157523,the,0,0
157524,haloperidol,1,1
157525,doses,0,0
157526,used,0,0
157527,in,0,0
157528,clinical,0,0
157529,practice,0,0
157530,may,0,0
157531,be,0,0
157532,higher,0,0
157533,than,0,0
157534,necessary,0,0
157535,.,0,0
157536,A,0,0
157537,randomised,0,0
157538,trial,0,0
157539,comparing,0,0
157540,preoperative,1,0
157541,to,1,0
157542,perioperative,1,0
157543,chemotherapy,1,1
157544,in,0,0
157545,early-stage,0,0
157546,non-small-cell,0,0
157547,lung,0,0
157548,cancer,0,0
157549,(,0,0
157550,IFCT,0,0
157551,0002,0,0
157552,trial,0,0
157553,),0,0
157554,.,0,0
157555,HYPOTHESIS,0,0
157556,There,0,0
157557,will,0,0
157558,be,0,0
157559,a,0,0
157560,detectable,0,0
157561,increase,0,0
157562,in,0,0
157563,overall,0,0
157564,survival,0,0
157565,(,0,0
157566,OS,0,0
157567,),0,0
157568,using,0,0
157569,preoperative,1,0
157570,(,1,0
157571,PRE,1,1
157572,),1,0
157573,as,1,0
157574,opposed,1,0
157575,to,1,0
157576,perioperative,1,0
157577,(,1,0
157578,PERI,1,1
157579,),1,0
157580,chemotherapy,1,1
157581,in,0,0
157582,resectable,0,0
157583,StageI-II,0,0
157584,non-small-cell,0,0
157585,lung,0,0
157586,cancer,0,0
157587,(,0,0
157588,NSCLC,0,0
157589,),0,0
157590,.,0,0
157591,METHODS,0,0
157592,This,0,0
157593,multicenter,0,0
157594,",",0,0
157595,open-label,0,0
157596,",",0,0
157597,randomised,0,0
157598,trial,0,0
157599,with,0,0
157600,a,0,0
157601,2?2,0,1
157602,factorial,0,0
157603,design,0,0
157604,first,0,0
157605,compared,0,0
157606,two,0,0
157607,chemotherapy,0,1
157608,strategies,0,0
157609,(,0,0
157610,PRE,0,1
157611,versus,0,1
157612,PERI,0,1
157613,),0,0
157614,",",0,0
157615,then,0,0
157616,two,1,0
157617,chemotherapy,1,1
157618,regimens,1,1
157619,(,1,0
157620,gemcitabine-cisplatin,1,1
157621,[,1,0
157622,GP,1,0
157623,],1,0
157624,versus,1,0
157625,paclitaxel-carboplatin,1,1
157626,[,1,0
157627,TC,1,1
157628,],1,0
157629,),1,0
157630,.,1,0
157631,The,1,0
157632,PRE,1,0
157633,group,0,0
157634,received,0,0
157635,two,0,0
157636,preoperative,0,0
157637,cycles,0,0
157638,followed,0,0
157639,by,0,0
157640,two,0,0
157641,additional,0,0
157642,preoperative,0,0
157643,cycles,0,0
157644,",",0,0
157645,while,0,0
157646,the,1,0
157647,PERI,1,1
157648,group,0,0
157649,underwent,0,0
157650,two,0,0
157651,preoperative,0,0
157652,cycles,0,0
157653,followed,0,0
157654,by,0,0
157655,two,0,0
157656,postoperative,0,0
157657,cycles,0,0
157658,",",0,0
157659,the,0,0
157660,3rd,0,0
157661,and,0,0
157662,4th,0,0
157663,cycles,0,0
157664,being,0,0
157665,given,0,0
157666,only,0,0
157667,to,0,0
157668,responders,0,0
157669,in,0,0
157670,both,0,0
157671,cases,0,0
157672,.,0,0
157673,RESULTS,0,0
157674,A,0,0
157675,total,0,0
157676,of,0,0
157677,528,0,0
157678,patients,0,0
157679,were,0,0
157680,randomised,0,0
157681,",",0,0
157682,267,0,0
157683,of,0,0
157684,which,0,0
157685,were,0,0
157686,assigned,0,0
157687,to,0,0
157688,the,0,0
157689,PRE,0,1
157690,group,0,0
157691,and,0,0
157692,261,0,0
157693,to,0,0
157694,the,0,0
157695,PERI,0,1
157696,group,0,0
157697,.,0,0
157698,Three-year,0,0
157699,OS,0,0
157700,did,0,0
157701,not,0,0
157702,differ,0,0
157703,between,0,0
157704,the,0,0
157705,two,0,0
157706,groups,0,0
157707,(,0,0
157708,67.4,0,0
157709,%,0,0
157710,and,0,0
157711,67.7,0,0
157712,%,0,0
157713,",",0,0
157714,respectively,0,0
157715,;,0,0
157716,hazard,0,0
157717,ratio,0,0
157718,(,0,0
157719,HR,0,0
157720,),0,0
157721,=1.01,0,0
157722,[,0,0
157723,0.79-1.30,0,0
157724,],0,0
157725,",",0,0
157726,p=0.92,0,0
157727,),0,0
157728,",",0,0
157729,nor,0,0
157730,did,0,0
157731,3-year,0,0
157732,disease-free,0,0
157733,survival,0,0
157734,",",0,0
157735,response,0,0
157736,rates,0,0
157737,",",0,0
157738,toxicity,0,0
157739,",",0,0
157740,or,0,0
157741,postoperative,0,0
157742,mortality,0,0
157743,.,0,0
157744,Pathological,0,0
157745,complete,0,0
157746,response,0,0
157747,was,0,0
157748,observed,0,0
157749,in,0,0
157750,22,0,0
157751,(,0,0
157752,8.2,0,0
157753,%,0,0
157754,),0,0
157755,and,0,0
157756,16,0,0
157757,patients,0,0
157758,(,0,0
157759,6.1,0,0
157760,%,0,0
157761,),0,0
157762,",",0,0
157763,respectively,0,0
157764,.,0,0
157765,Although,0,0
157766,quality,0,0
157767,of,0,0
157768,life,0,0
157769,did,0,0
157770,not,0,0
157771,differ,0,0
157772,significantly,0,0
157773,",",0,0
157774,chemotherapy,0,1
157775,compliance,0,0
157776,was,0,0
157777,significantly,0,0
157778,higher,0,0
157779,in,0,0
157780,the,0,0
157781,PRE,0,1
157782,group,0,0
157783,.,0,0
157784,The,0,0
157785,proportion,0,0
157786,of,0,0
157787,responders,0,0
157788,who,0,0
157789,received,0,0
157790,Cycles,0,1
157791,3,0,0
157792,and,0,0
157793,4,0,0
157794,was,0,0
157795,significantly,0,0
157796,higher,0,0
157797,in,0,0
157798,the,0,0
157799,PRE,0,1
157800,group,0,0
157801,(,0,0
157802,90.4,0,0
157803,%,0,0
157804,versus,0,0
157805,75.2,0,0
157806,%,0,0
157807,",",0,0
157808,p=0.001,0,0
157809,),0,0
157810,.,0,0
157811,In,0,0
157812,responders,0,0
157813,",",0,0
157814,the,0,0
157815,dose,0,0
157816,intensity,0,0
157817,of,0,0
157818,Cycles,0,1
157819,3,0,0
157820,and,0,0
157821,4,0,0
157822,was,0,0
157823,higher,0,0
157824,in,0,0
157825,the,0,0
157826,PRE,0,1
157827,group,0,0
157828,than,0,0
157829,in,0,0
157830,the,0,0
157831,PERI,0,1
157832,group,0,0
157833,(,0,0
157834,mean,0,0
157835,relative,0,0
157836,dose,0,0
157837,intensity,0,0
157838,of,0,0
157839,90.4,0,0
157840,%,0,0
157841,versus,0,0
157842,82.6,0,0
157843,%,0,0
157844,",",0,0
157845,respectively,0,0
157846,;,0,0
157847,p=0.0007,0,0
157848,),0,0
157849,.,0,0
157850,There,0,0
157851,was,0,0
157852,no,0,0
157853,difference,0,0
157854,between,0,0
157855,GP,0,0
157856,and,0,0
157857,TC,0,0
157858,in,0,0
157859,3-year,0,0
157860,OS,0,0
157861,(,0,0
157862,HR=0.97,0,0
157863,[,0,0
157864,95,0,0
157865,%,0,0
157866,confidence,0,0
157867,interval,0,0
157868,(,0,0
157869,CI,0,0
157870,),0,0
157871,:,0,0
157872,0.76-1.25,0,0
157873,],0,0
157874,",",0,0
157875,p=0.80,0,0
157876,),0,0
157877,or,0,1
157878,response,0,0
157879,rates,0,0
157880,.,0,0
157881,However,0,0
157882,",",0,0
157883,the,0,0
157884,regimens,0,0
157885,',0,0
157886,toxicity,0,0
157887,profiles,0,0
157888,differed,0,0
157889,.,0,0
157890,CONCLUSIONS,0,0
157891,This,0,0
157892,study,0,0
157893,failed,0,0
157894,to,0,0
157895,demonstrate,0,0
157896,any,0,0
157897,difference,0,0
157898,in,0,0
157899,survival,0,0
157900,between,0,0
157901,patients,0,0
157902,receiving,1,0
157903,preoperative,1,0
157904,and,1,0
157905,perioperative,1,0
157906,chemotherapy,1,1
157907,in,0,0
157908,early-stage,0,0
157909,NSCLC,0,0
157910,.,0,0
157911,The,0,0
157912,increase,0,0
157913,from,0,0
157914,two,0,0
157915,to,0,0
157916,four,0,0
157917,preoperative,0,0
157918,chemotherapy,0,1
157919,cycles,0,0
157920,did,0,0
157921,not,0,0
157922,increase,0,0
157923,the,0,0
157924,pathological,0,0
157925,response,0,0
157926,rate,0,0
157927,.,0,0
157928,Effect,0,0
157929,of,0,0
157930,resistance,1,0
157931,exercise,1,1
157932,contraction,1,1
157933,mode,1,0
157934,and,0,0
157935,protein,1,1
157936,supplementation,1,1
157937,on,0,0
157938,members,0,0
157939,of,0,0
157940,the,0,0
157941,STARS,0,1
157942,signalling,0,0
157943,pathway,0,0
157944,.,0,0
157945,The,0,0
157946,striated,0,0
157947,muscle,0,0
157948,activator,0,0
157949,of,0,0
157950,Rho,0,1
157951,signalling,0,0
157952,(,0,0
157953,STARS,0,1
157954,),0,0
157955,pathway,0,0
157956,is,0,0
157957,suggested,0,0
157958,to,0,0
157959,provide,0,0
157960,a,0,0
157961,link,0,0
157962,between,0,0
157963,external,0,1
157964,stress,0,0
157965,responses,0,0
157966,and,0,0
157967,transcriptional,0,0
157968,regulation,0,0
157969,in,0,0
157970,muscle,0,0
157971,.,0,0
157972,However,0,0
157973,",",0,0
157974,the,0,0
157975,sensitivity,0,0
157976,of,0,0
157977,STARS,0,1
157978,signalling,0,0
157979,to,0,0
157980,different,0,0
157981,mechanical,0,0
157982,stresses,0,0
157983,has,0,0
157984,not,0,0
157985,been,0,0
157986,investigated,0,0
157987,.,0,0
157988,In,0,0
157989,a,0,0
157990,comparative,0,0
157991,study,0,0
157992,",",0,0
157993,we,0,0
157994,examined,0,0
157995,the,0,0
157996,regulation,0,0
157997,of,0,0
157998,the,0,0
157999,STARS,0,1
158000,signalling,0,0
158001,pathway,0,0
158002,in,0,0
158003,response,0,0
158004,to,0,0
158005,unilateral,0,0
158006,resistance,1,0
158007,exercise,1,1
158008,performed,0,0
158009,as,0,0
158010,either,0,0
158011,eccentric,1,1
158012,(,1,0
158013,ECC,1,0
158014,),1,1
158015,or,1,1
158016,concentric,1,1
158017,(,1,0
158018,CONC,1,1
158019,),1,0
158020,contractions,1,0
158021,as,0,0
158022,well,0,0
158023,as,0,0
158024,prolonged,1,0
158025,training,1,1
158026,;,1,0
158027,with,0,0
158028,and,0,0
158029,without,0,0
158030,whey,1,1
158031,protein,1,0
158032,supplementation,1,1
158033,.,1,0
158034,Skeletal,0,0
158035,muscle,0,0
158036,STARS,0,1
158037,",",0,0
158038,myocardian-related,0,0
158039,transcription,0,0
158040,factor-A,0,1
158041,(,0,0
158042,MRTF-A,0,0
158043,),0,1
158044,and,0,0
158045,serum,0,0
158046,response,0,0
158047,factor,0,0
158048,(,0,0
158049,SRF,0,1
158050,),0,1
158051,mRNA,0,0
158052,and,0,0
158053,protein,0,0
158054,",",0,0
158055,as,0,0
158056,well,0,0
158057,as,0,0
158058,muscle,0,0
158059,cross-sectional,0,0
158060,area,0,0
158061,and,0,0
158062,maximal,0,0
158063,voluntary,0,1
158064,contraction,0,0
158065,",",0,0
158066,were,0,0
158067,measured,0,0
158068,.,0,0
158069,A,0,0
158070,single-bout,0,1
158071,of,0,0
158072,exercise,1,1
158073,produced,0,0
158074,increases,0,0
158075,in,0,0
158076,STARS,0,1
158077,and,0,0
158078,SRF,0,1
158079,mRNA,0,0
158080,and,0,0
158081,decreases,0,0
158082,in,0,0
158083,MRTF-A,0,0
158084,mRNA,0,0
158085,with,0,0
158086,both,0,0
158087,ECC,1,0
158088,and,1,0
158089,CONC,1,1
158090,exercise,1,1
158091,",",0,0
158092,but,0,0
158093,with,0,0
158094,an,0,0
158095,enhanced,0,0
158096,response,0,0
158097,occurring,0,0
158098,following,0,0
158099,ECC,1,0
158100,exercise,1,1
158101,.,1,0
158102,A,0,0
158103,31,0,0
158104,%,0,0
158105,increase,0,0
158106,in,0,0
158107,STARS,0,1
158108,protein,0,0
158109,was,0,0
158110,observed,0,0
158111,exclusively,0,0
158112,after,0,0
158113,CONC,1,1
158114,exercise,1,1
158115,(,0,0
158116,P,0,0
158117,<,0,0
158118,0.001,0,0
158119,),0,0
158120,",",0,0
158121,while,0,0
158122,pSRF,0,0
158123,protein,0,0
158124,levels,0,0
158125,increased,0,0
158126,similarly,0,0
158127,by,0,0
158128,48,0,0
158129,%,0,0
158130,with,0,0
158131,both,0,0
158132,CONC,0,0
158133,and,0,0
158134,ECC,0,0
158135,exercise,0,1
158136,(,0,0
158137,P,0,0
158138,<,0,0
158139,0.001,0,0
158140,),0,0
158141,.,0,0
158142,Prolonged,0,0
158143,ECC,0,0
158144,and,0,0
158145,CONC,0,1
158146,training,0,1
158147,equally,0,0
158148,stimulated,0,0
158149,muscle,0,0
158150,hypertrophy,0,0
158151,and,0,0
158152,produced,0,0
158153,increases,0,0
158154,in,0,0
158155,MRTF-A,0,0
158156,protein,0,0
158157,of,0,0
158158,125,0,0
158159,%,0,0
158160,and,0,0
158161,99,0,0
158162,%,0,0
158163,",",0,0
158164,respectively,0,0
158165,(,0,0
158166,P,0,0
158167,<,0,0
158168,0.001,0,0
158169,),0,0
158170,.,0,0
158171,No,0,0
158172,changes,0,0
158173,occurred,0,0
158174,for,0,0
158175,total,0,0
158176,SRF,0,1
158177,protein,0,0
158178,.,0,0
158179,There,0,0
158180,was,0,0
158181,no,0,0
158182,effect,0,0
158183,of,0,0
158184,whey,1,1
158185,protein,1,0
158186,supplementation,1,1
158187,.,1,0
158188,These,0,0
158189,results,0,0
158190,show,0,0
158191,that,0,0
158192,resistance,0,0
158193,exercise,0,1
158194,provides,0,0
158195,an,0,0
158196,acute,0,0
158197,stimulation,0,0
158198,of,0,0
158199,the,0,0
158200,STARS,0,1
158201,pathway,0,0
158202,that,0,0
158203,is,0,0
158204,contraction,0,0
158205,mode,0,0
158206,dependent,0,0
158207,.,0,0
158208,The,0,0
158209,responses,0,0
158210,to,0,0
158211,acute,1,0
158212,exercise,1,1
158213,were,0,0
158214,more,0,0
158215,pronounced,0,0
158216,than,0,0
158217,responses,0,0
158218,to,0,0
158219,accumulated,1,0
158220,training,1,1
158221,",",0,0
158222,suggesting,0,0
158223,that,0,0
158224,STARS,0,1
158225,signalling,0,0
158226,is,0,0
158227,primarily,0,0
158228,involved,0,0
158229,in,0,0
158230,the,0,0
158231,initial,0,0
158232,phase,0,0
158233,of,0,0
158234,exercise-induced,0,0
158235,muscle,0,0
158236,adaptations,0,0
158237,.,0,0
158238,Prospective,0,0
158239,",",0,0
158240,blinded,0,0
158241,exploratory,0,0
158242,evaluation,0,0
158243,of,0,0
158244,the,0,0
158245,PlayWisely,1,0
158246,program,1,1
158247,in,0,0
158248,children,0,0
158249,with,0,0
158250,autism,0,0
158251,spectrum,0,0
158252,disorder,0,0
158253,.,0,0
158254,The,0,0
158255,purpose,0,0
158256,of,0,0
158257,the,0,0
158258,study,0,0
158259,was,0,0
158260,to,0,0
158261,explore,0,0
158262,a,0,0
158263,low-cost,1,1
158264,intervention,1,1
158265,that,0,0
158266,targets,0,0
158267,an,0,0
158268,increasingly,0,0
158269,common,0,0
158270,developmental,0,0
158271,disorder,0,0
158272,.,0,0
158273,The,0,0
158274,study,0,0
158275,was,0,0
158276,a,0,0
158277,blinded,0,0
158278,",",0,0
158279,exploratory,0,0
158280,evaluation,0,0
158281,of,0,0
158282,the,0,0
158283,PlayWisely,1,0
158284,program,1,1
158285,on,0,0
158286,autism,0,0
158287,symptoms,0,0
158288,and,0,0
158289,essential,0,0
158290,learning,0,0
158291,foundation,0,0
158292,skills,0,1
158293,(,0,0
158294,attention,0,0
158295,",",0,0
158296,recognition,0,0
158297,",",0,0
158298,and,0,0
158299,memory,0,0
158300,skills,0,1
158301,),0,0
158302,in,0,0
158303,children,0,0
158304,with,0,0
158305,a,0,0
158306,diagnosis,0,0
158307,of,0,0
158308,autism,0,0
158309,",",0,0
158310,autism,0,0
158311,spectrum,0,0
158312,disorder,0,0
158313,(,0,0
158314,ASD,0,0
158315,),0,0
158316,",",0,0
158317,pervasive,0,0
158318,developmental,0,0
158319,disorder,0,0
158320,-,0,0
158321,not,0,0
158322,otherwise,0,0
158323,specified,0,0
158324,(,0,0
158325,PDD-NOS,0,0
158326,),0,0
158327,",",0,0
158328,and,0,0
158329,Asperger,0,0
158330,syndrome,0,0
158331,(,0,0
158332,AS,0,0
158333,),0,0
158334,.,0,0
158335,Eighteen,0,0
158336,children,0,0
158337,",",0,0
158338,1,0,0
158339,to,0,0
158340,10,0,0
158341,years,0,0
158342,of,0,0
158343,age,0,0
158344,",",0,0
158345,were,0,0
158346,evaluated,0,0
158347,using,0,0
158348,the,0,0
158349,Childhood,0,0
158350,Autism,0,0
158351,Rating,0,0
158352,Scale,0,0
158353,",",0,0
158354,Second,0,0
158355,Edition,0,0
158356,(,0,0
158357,CARS2,0,1
158358,),0,0
158359,;,0,0
158360,the,0,0
158361,PlayWisely,0,0
158362,Interactive,0,1
158363,Test,0,0
158364,of,0,0
158365,Attention,0,0
158366,",",0,0
158367,Recognition,0,0
158368,",",0,0
158369,and,0,0
158370,Memory,0,0
158371,Skills,0,0
158372,;,0,0
158373,Autism,0,0
158374,Treatment,0,0
158375,Evaluation,0,1
158376,Checklist,0,1
158377,(,0,0
158378,ATEC,0,1
158379,),0,0
158380,",",0,0
158381,and,0,0
158382,the,0,0
158383,Modified,0,0
158384,Checklist,0,0
158385,for,0,0
158386,Autism,0,0
158387,in,0,0
158388,Toddlers,0,0
158389,(,0,0
158390,M-CHAT,0,0
158391,),0,0
158392,.,0,0
158393,There,0,0
158394,were,0,0
158395,significant,0,0
158396,treatment,0,0
158397,effects,0,0
158398,for,0,0
158399,the,0,0
158400,PlayWisely,0,0
158401,measure,0,0
158402,on,0,0
158403,the,0,0
158404,Yellow,0,0
158405,Sets,0,0
158406,that,0,0
158407,examine,0,0
158408,recognition,0,0
158409,;,0,0
158410,Purple,0,1
158411,Sets,0,0
158412,that,0,0
158413,examine,0,0
158414,brain,0,0
158415,region,0,0
158416,agility,0,0
158417,and,0,0
158418,early,0,0
158419,memory,0,0
158420,skills,0,0
158421,;,0,0
158422,Blue,0,0
158423,Sets,0,0
158424,that,0,0
158425,examine,0,0
158426,phonemic,0,0
158427,awareness,0,0
158428,and,0,0
158429,recognition,0,0
158430,;,0,0
158431,and,0,0
158432,for,0,0
158433,the,0,0
158434,Total,0,0
158435,Sets,0,0
158436,",",0,0
158437,with,0,0
158438,a,0,0
158439,similar,0,0
158440,trend,0,0
158441,toward,0,0
158442,improvement,0,0
158443,in,0,0
158444,the,0,0
158445,Green,0,0
158446,Sets,0,0
158447,that,0,0
158448,examine,0,0
158449,perception,0,0
158450,and,0,0
158451,Red,0,0
158452,Sets,0,1
158453,that,0,0
158454,examine,0,0
158455,attention,0,0
158456,.,0,0
158457,No,0,0
158458,other,0,0
158459,measures,0,0
158460,reached,0,0
158461,statistical,0,0
158462,significance,0,0
158463,.,0,0
158464,The,0,0
158465,results,0,0
158466,suggest,0,0
158467,that,0,0
158468,PlayWisely,0,0
158469,can,0,0
158470,improve,0,0
158471,recognition,0,0
158472,",",0,0
158473,brain,0,0
158474,region,0,0
158475,agility,0,0
158476,",",0,0
158477,phonemic,0,0
158478,awareness,0,0
158479,",",0,0
158480,letter,0,1
158481,recognition,0,0
158482,",",0,0
158483,and,0,0
158484,early,0,0
158485,memory,0,0
158486,skills,0,0
158487,in,0,0
158488,ASD,0,0
158489,.,0,0
158490,It,0,0
158491,was,0,0
158492,observed,0,0
158493,by,0,0
158494,the,0,0
158495,parents,0,0
158496,",",0,0
158497,coaches,0,1
158498,",",0,0
158499,and,0,0
158500,study,0,0
158501,investigators,0,0
158502,that,0,0
158503,the,0,0
158504,children,0,0
158505,who,0,0
158506,were,0,0
158507,less,0,0
158508,than,0,0
158509,3,0,0
158510,years,0,0
158511,of,0,0
158512,age,0,0
158513,showed,0,0
158514,improvements,0,0
158515,in,0,0
158516,autism,0,0
158517,symptoms,0,0
158518,;,0,0
158519,however,0,0
158520,",",0,0
158521,the,0,0
158522,group,0,0
158523,was,0,0
158524,too,0,0
158525,small,0,0
158526,to,0,0
158527,reach,0,0
158528,statistical,0,0
158529,significance,0,0
158530,.,0,0
158531,Future,0,0
158532,studies,0,0
158533,are,0,0
158534,needed,0,0
158535,to,0,0
158536,see,0,0
158537,if,0,0
158538,this,0,0
158539,intervention,0,1
158540,can,0,0
158541,mitigate,0,0
158542,autism,0,0
158543,symptoms,0,0
158544,in,0,0
158545,very,0,0
158546,young,0,0
158547,children,0,0
158548,with,0,0
158549,ASD,0,0
158550,.,0,0
158551,Effects,0,0
158552,of,0,0
158553,extended,0,1
158554,release,0,1
158555,methylphenidate,1,1
158556,treatment,1,0
158557,on,0,0
158558,ratings,0,0
158559,of,0,0
158560,attention-deficit/hyperactivity,0,0
158561,disorder,0,0
158562,(,0,0
158563,ADHD,0,1
158564,),0,0
158565,and,0,0
158566,associated,0,0
158567,behavior,0,0
158568,in,0,0
158569,children,0,0
158570,with,0,0
158571,autism,0,0
158572,spectrum,0,0
158573,disorders,0,0
158574,and,0,0
158575,ADHD,0,0
158576,symptoms,0,0
158577,.,0,0
158578,OBJECTIVE,0,0
158579,The,0,0
158580,purpose,0,0
158581,of,0,0
158582,this,0,0
158583,study,0,0
158584,was,0,0
158585,to,0,0
158586,examine,0,0
158587,the,0,0
158588,behavioral,0,0
158589,effects,0,0
158590,of,0,0
158591,four,0,0
158592,doses,0,0
158593,of,0,0
158594,psychostimulant,1,1
158595,medication,1,0
158596,",",1,0
158597,combining,1,0
158598,extended-release,1,1
158599,methylphenidate,1,1
158600,(,1,0
158601,MPH,1,1
158602,),1,0
158603,in,1,0
158604,the,1,0
158605,morning,1,0
158606,with,1,0
158607,immediate-release,1,1
158608,MPH,1,0
158609,in,1,0
158610,the,1,0
158611,afternoon,1,0
158612,.,1,0
158613,METHOD,0,0
158614,The,0,0
158615,sample,0,0
158616,comprised,0,0
158617,24,0,0
158618,children,0,0
158619,(,0,0
158620,19,0,0
158621,boys,0,0
158622,;,0,0
158623,5,0,0
158624,girls,0,0
158625,),0,0
158626,who,0,0
158627,met,0,0
158628,American,0,0
158629,Psychiatric,0,0
158630,Association,0,0
158631,",",0,0
158632,Diagnostic,0,0
158633,and,0,0
158634,Statistical,0,0
158635,Manual,0,0
158636,of,0,0
158637,Mental,0,0
158638,Disorders,0,0
158639,",",0,0
158640,4th,0,0
158641,ed,0,0
158642,.,0,0
158643,(,0,0
158644,DSM-IV-TR,0,0
158645,),0,0
158646,criteria,0,0
158647,for,0,0
158648,an,0,0
158649,autism,0,0
158650,spectrum,0,0
158651,disorder,0,0
158652,(,0,0
158653,ASD,0,0
158654,),0,0
158655,on,0,0
158656,the,0,0
158657,Autism,0,0
158658,Diagnostic,0,0
158659,Interview-Revised,0,0
158660,(,0,0
158661,ADI-R,0,1
158662,),0,0
158663,and,0,0
158664,the,0,0
158665,Autism,0,0
158666,Diagnostic,0,0
158667,Observation,0,1
158668,Schedule,0,1
158669,(,0,0
158670,ADOS,0,1
158671,),0,0
158672,",",0,0
158673,and,0,0
158674,had,0,0
158675,significant,0,0
158676,symptoms,0,0
158677,of,0,0
158678,attention-deficit/hyperactivity,0,0
158679,disorder,0,0
158680,(,0,0
158681,ADHD,0,1
158682,),0,0
158683,.,0,0
158684,This,0,0
158685,sample,0,0
158686,consisted,0,0
158687,of,0,0
158688,elementary,0,0
158689,school-age,0,0
158690,",",0,0
158691,community-based,0,0
158692,children,0,0
158693,(,0,0
158694,mean,0,0
158695,chronological,0,0
158696,age=8.8,0,0
158697,years,0,0
158698,",",0,0
158699,SD=1.7,0,0
158700,;,0,0
158701,mean,0,0
158702,intelligence,0,0
158703,quotient,0,0
158704,[,0,0
158705,IQ,0,0
158706,],0,0
158707,=85,0,0
158708,;,0,0
158709,SD=16.8,0,0
158710,),0,0
158711,.,0,0
158712,Effects,0,0
158713,of,0,0
158714,four,0,0
158715,dose,0,0
158716,levels,0,0
158717,of,0,0
158718,MPH,1,0
158719,on,0,0
158720,parent,0,1
158721,and,0,0
158722,teacher,0,1
158723,behavioral,0,0
158724,ratings,0,0
158725,were,0,0
158726,investigated,0,0
158727,using,0,0
158728,a,0,0
158729,within-subject,0,0
158730,",",0,0
158731,crossover,0,0
158732,",",0,0
158733,placebo-controlled,0,1
158734,design,0,0
158735,.,0,0
158736,RESULTS,0,0
158737,MPH,1,0
158738,treatment,0,0
158739,was,0,0
158740,associated,0,0
158741,with,0,0
158742,significant,0,0
158743,declines,0,0
158744,in,0,0
158745,hyperactive,0,0
158746,and,0,0
158747,impulsive,0,0
158748,behavior,0,0
158749,at,0,0
158750,both,0,0
158751,home,0,1
158752,and,0,0
158753,school,0,0
158754,.,0,0
158755,Parents,0,0
158756,noted,0,0
158757,significant,0,0
158758,declines,0,0
158759,in,0,0
158760,inattentive,0,0
158761,and,0,0
158762,oppositional,0,0
158763,behavior,0,0
158764,",",0,0
158765,and,0,0
158766,improvements,0,0
158767,in,0,0
158768,social,0,0
158769,skills,0,0
158770,.,0,0
158771,No,0,0
158772,exacerbation,0,0
158773,of,0,0
158774,stereotypies,0,0
158775,was,0,0
158776,noted,0,0
158777,",",0,0
158778,and,0,0
158779,side,0,0
158780,effects,0,0
158781,were,0,0
158782,similar,0,0
158783,to,0,0
158784,those,0,0
158785,seen,0,0
158786,in,0,0
158787,typically,0,0
158788,developing,0,0
158789,children,0,0
158790,with,0,0
158791,ADHD,0,0
158792,.,0,0
158793,Dose,0,0
158794,response,0,0
158795,was,0,0
158796,primarily,0,0
158797,linear,0,0
158798,in,0,0
158799,the,0,0
158800,dose,0,0
158801,range,0,0
158802,studied,0,0
158803,.,0,0
158804,CONCLUSIONS,0,0
158805,The,0,0
158806,results,0,0
158807,of,0,0
158808,this,0,0
158809,study,0,0
158810,suggest,0,0
158811,that,0,0
158812,MPH,0,0
158813,formulations,0,0
158814,are,0,0
158815,efficacious,0,0
158816,and,0,0
158817,well-tolerated,0,0
158818,for,0,0
158819,children,0,0
158820,with,0,0
158821,ASD,0,0
158822,and,0,0
158823,significant,0,0
158824,ADHD,0,1
158825,symptoms,0,0
158826,.,0,0
158827,Perceptual,1,0
158828,learning,1,0
158829,of,1,0
158830,speech,1,1
158831,under,0,0
158832,optimal,0,0
158833,and,0,0
158834,adverse,0,0
158835,conditions,0,0
158836,.,0,0
158837,Humans,0,0
158838,have,0,0
158839,a,0,0
158840,remarkable,0,0
158841,ability,0,0
158842,to,0,0
158843,understand,0,0
158844,spoken,0,0
158845,language,0,0
158846,despite,0,0
158847,the,0,0
158848,large,0,0
158849,amount,0,0
158850,of,0,0
158851,variability,0,0
158852,in,0,0
158853,speech,0,1
158854,.,0,0
158855,Previous,0,0
158856,research,0,0
158857,has,0,0
158858,shown,0,0
158859,that,0,0
158860,listeners,0,0
158861,can,0,0
158862,use,0,0
158863,lexical,1,0
158864,information,1,0
158865,to,0,0
158866,guide,0,0
158867,their,0,0
158868,interpretation,0,0
158869,of,0,0
158870,atypical,0,0
158871,sounds,0,1
158872,in,0,0
158873,speech,0,1
158874,(,0,0
158875,Norris,0,0
158876,",",0,0
158877,McQueen,0,0
158878,",",0,0
158879,&,0,0
158880,Cutler,0,0
158881,",",0,0
158882,2003,0,0
158883,),0,0
158884,.,0,0
158885,This,0,0
158886,kind,0,0
158887,of,0,0
158888,lexically,1,0
158889,induced,1,0
158890,perceptual,1,1
158891,learning,1,0
158892,enables,0,0
158893,people,0,0
158894,to,0,0
158895,adjust,0,0
158896,to,0,0
158897,the,0,0
158898,variations,0,0
158899,in,0,0
158900,utterances,0,0
158901,due,0,0
158902,to,0,0
158903,talker-specific,0,0
158904,characteristics,0,0
158905,",",0,0
158906,such,0,0
158907,as,0,0
158908,individual,0,0
158909,identity,0,0
158910,and,0,0
158911,dialect,0,1
158912,.,0,0
158913,The,0,0
158914,current,0,0
158915,study,0,0
158916,investigated,0,0
158917,perceptual,1,1
158918,learning,1,0
158919,in,0,0
158920,two,0,0
158921,optimal,0,0
158922,conditions,0,0
158923,:,0,0
158924,conversational,1,0
158925,speech,1,1
158926,(,1,0
158927,Experiment,1,0
158928,1,0,0
158929,),0,0
158930,versus,0,0
158931,clear,1,1
158932,speech,1,1
158933,(,0,0
158934,Experiment,0,0
158935,2,0,0
158936,),0,0
158937,",",0,0
158938,and,0,0
158939,three,0,0
158940,adverse,0,0
158941,conditions,0,0
158942,:,0,0
158943,noise,1,0
158944,(,0,0
158945,Experiment,0,0
158946,3a,0,1
158947,),0,0
158948,versus,0,0
158949,two,1,0
158950,cognitive,1,0
158951,loads,1,0
158952,(,0,0
158953,Experiments,0,0
158954,4a,0,1
158955,and,0,0
158956,4b,0,1
158957,),0,0
158958,.,0,0
158959,Perceptual,1,0
158960,learning,1,0
158961,occurred,0,0
158962,in,0,0
158963,the,0,0
158964,two,0,0
158965,optimal,1,0
158966,conditions,1,0
158967,and,0,0
158968,in,0,0
158969,the,0,0
158970,two,0,0
158971,cognitive,1,0
158972,load,1,0
158973,conditions,1,0
158974,",",0,0
158975,but,0,0
158976,not,0,0
158977,in,0,0
158978,the,0,0
158979,noise,1,0
158980,condition,1,0
158981,.,1,0
158982,Furthermore,0,0
158983,",",0,0
158984,perceptual,1,1
158985,learning,1,0
158986,occurred,0,0
158987,only,0,0
158988,in,0,0
158989,the,0,0
158990,first,0,0
158991,of,0,0
158992,two,0,0
158993,sessions,0,0
158994,for,0,0
158995,each,0,0
158996,participant,0,0
158997,",",0,0
158998,and,0,0
158999,only,0,0
159000,for,0,0
159001,atypical,0,0
159002,/s/,0,0
159003,sounds,0,1
159004,and,0,0
159005,not,0,0
159006,for,0,0
159007,atypical,0,0
159008,/f/,0,0
159009,sounds,0,1
159010,.,0,0
159011,This,0,0
159012,pattern,0,0
159013,of,0,0
159014,learning,0,0
159015,and,0,0
159016,nonlearning,0,0
159017,reflects,0,0
159018,a,0,0
159019,balance,0,0
159020,between,0,0
159021,flexibility,0,0
159022,and,0,0
159023,stability,0,0
159024,that,0,0
159025,the,0,0
159026,speech,0,1
159027,system,0,0
159028,must,0,0
159029,have,0,0
159030,to,0,0
159031,deal,0,0
159032,with,0,0
159033,speech,0,1
159034,variability,0,0
159035,in,0,0
159036,the,0,0
159037,diverse,0,0
159038,conditions,0,0
159039,that,0,0
159040,speech,0,1
159041,is,0,0
159042,encountered,0,0
159043,.,0,0
159044,Reputation,0,0
159045,management,0,0
159046,:,0,0
159047,evidence,0,0
159048,for,0,0
159049,ability,0,0
159050,but,0,0
159051,reduced,0,0
159052,propensity,0,0
159053,in,0,0
159054,autism,0,0
159055,.,0,0
159056,Previous,0,0
159057,research,0,0
159058,has,0,0
159059,reported,0,0
159060,that,0,0
159061,autistic,0,0
159062,adults,0,0
159063,do,0,0
159064,not,0,0
159065,manage,0,0
159066,their,0,0
159067,reputation,0,0
159068,",",0,0
159069,purportedly,0,0
159070,due,0,0
159071,to,0,0
159072,problems,0,0
159073,with,0,0
159074,theory,0,0
159075,of,0,0
159076,mind,0,0
159077,[,0,0
159078,Izuma,0,0
159079,",",0,0
159080,Matsumoto,0,0
159081,",",0,0
159082,Camerer,0,0
159083,",",0,0
159084,&,0,0
159085,Adolphs,0,1
159086,],0,0
159087,.,0,0
159088,The,0,0
159089,current,0,0
159090,study,0,0
159091,aimed,0,0
159092,to,0,0
159093,test,1,0
159094,alternative,1,0
159095,explanations,1,0
159096,for,0,0
159097,this,0,0
159098,apparent,0,0
159099,lack,0,0
159100,of,0,0
159101,reputation,0,0
159102,management,0,0
159103,.,0,0
159104,Twenty,0,0
159105,typical,0,0
159106,and,0,0
159107,19,0,0
159108,autistic,0,0
159109,adults,0,0
159110,donated,1,0
159111,to,1,0
159112,charity,1,0
159113,and,1,0
159114,to,1,0
159115,a,1,0
159116,person,1,0
159117,",",0,0
159118,both,0,0
159119,when,0,0
159120,alone,0,0
159121,and,0,0
159122,when,0,0
159123,observed,0,0
159124,.,0,0
159125,In,0,0
159126,an,0,0
159127,additional,0,0
159128,manipulation,0,0
159129,",",0,0
159130,for,0,0
159131,half,0,0
159132,of,0,0
159133,the,0,0
159134,participants,0,0
159135,",",0,0
159136,the,0,0
159137,observer,0,0
159138,was,0,0
159139,also,0,0
159140,the,0,0
159141,recipient,0,0
159142,of,0,0
159143,their,0,0
159144,donations,0,0
159145,",",0,0
159146,and,0,0
159147,participants,0,0
159148,were,0,0
159149,told,0,0
159150,that,0,0
159151,this,0,0
159152,observer,0,0
159153,would,0,0
159154,subsequently,0,0
159155,have,0,0
159156,the,0,0
159157,opportunity,0,0
159158,to,0,0
159159,donate,1,0
159160,to,0,0
159161,them,0,0
159162,(,0,0
159163,motivation,0,1
159164,condition,0,0
159165,),0,0
159166,.,0,0
159167,This,0,0
159168,manipulation,0,0
159169,was,0,0
159170,designed,0,0
159171,to,0,0
159172,encourage,0,0
159173,an,0,0
159174,expectation,0,0
159175,of,0,0
159176,a,0,0
159177,reciprocal,0,0
159178,tit-for-tat,0,1
159179,strategy,0,0
159180,in,0,0
159181,the,0,0
159182,participant,0,0
159183,",",0,0
159184,which,0,0
159185,may,0,0
159186,motivate,0,0
159187,participants,0,0
159188,to,0,0
159189,change,0,0
159190,their,0,0
159191,behavior,0,0
159192,to,0,0
159193,receive,0,0
159194,more,0,0
159195,donations,0,0
159196,.,0,0
159197,The,0,0
159198,remaining,0,0
159199,participants,0,0
159200,were,0,0
159201,told,0,0
159202,that,0,0
159203,the,0,0
159204,person,0,0
159205,watching,0,0
159206,was,0,0
159207,just,0,0
159208,observing,0,0
159209,the,0,0
159210,procedure,0,1
159211,(,0,0
159212,no,0,0
159213,motivation,0,1
159214,condition,0,0
159215,),0,0
159216,.,0,0
159217,Our,0,0
159218,results,0,0
159219,replicated,0,0
159220,Izuma,0,0
159221,et,0,0
159222,al,0,0
159223,.,0,0
159224,'s,0,0
159225,finding,0,0
159226,that,0,0
159227,autistic,0,0
159228,adults,0,0
159229,did,0,0
159230,not,1,0
159231,donate,1,0
159232,more,1,0
159233,to,0,0
159234,charity,0,0
159235,when,0,0
159236,observed,0,0
159237,.,0,0
159238,Yet,0,0
159239,",",0,0
159240,in,0,0
159241,the,0,0
159242,motivation,0,0
159243,condition,0,0
159244,",",0,0
159245,both,0,0
159246,typical,0,0
159247,and,0,0
159248,autistic,0,0
159249,adults,1,0
159250,donated,1,0
159251,significantly,1,0
159252,more,0,0
159253,to,0,0
159254,the,0,0
159255,observer,0,0
159256,when,0,0
159257,watched,0,0
159258,",",0,0
159259,although,0,0
159260,this,0,0
159261,effect,0,0
159262,was,0,0
159263,significantly,0,0
159264,attenuated,0,0
159265,in,0,0
159266,autistic,0,0
159267,individuals,0,0
159268,.,0,0
159269,Results,0,0
159270,indicate,0,0
159271,that,0,0
159272,",",0,0
159273,while,0,0
159274,individuals,0,0
159275,with,0,0
159276,autism,0,0
159277,may,0,0
159278,have,0,0
159279,the,0,0
159280,ability,0,0
159281,to,0,0
159282,think,0,0
159283,about,0,0
159284,reputation,0,0
159285,",",0,0
159286,a,0,0
159287,reduced,0,0
159288,expectation,0,0
159289,of,0,0
159290,reciprocal,0,0
159291,behavior,0,0
159292,from,0,0
159293,others,0,0
159294,may,0,0
159295,reduce,0,0
159296,the,0,0
159297,degree,0,0
159298,to,0,0
159299,which,0,0
159300,they,0,0
159301,engage,0,0
159302,in,0,0
159303,reputation,0,0
159304,management,0,0
159305,.,0,0
159306,Total,0,0
159307,intravenous,0,1
159308,anesthesia,0,1
159309,using,0,0
159310,remifentanil,1,1
159311,in,0,0
159312,extracorporeal,1,1
159313,shock,1,0
159314,wave,1,1
159315,lithotripsy,1,1
159316,(,1,0
159317,ESWL,1,1
159318,),1,0
159319,.,1,0
159320,Comparison,0,0
159321,of,0,0
159322,two,0,0
159323,dosages,0,0
159324,:,0,0
159325,a,0,0
159326,randomized,0,0
159327,clinical,0,0
159328,trial,0,0
159329,.,0,0
159330,BACKGROUND,0,0
159331,Extracorporeal,1,1
159332,Shock,1,0
159333,Wave,1,0
159334,Lithotripsy,1,1
159335,is,0,0
159336,usually,0,0
159337,performed,0,0
159338,in,0,0
159339,day,0,0
159340,surgery,0,0
159341,setting,0,0
159342,",",0,0
159343,consequently,0,0
159344,people,0,0
159345,who,0,0
159346,undergo,0,0
159347,to,0,0
159348,this,0,0
159349,procedure,0,0
159350,need,0,0
159351,a,0,0
159352,safe,0,0
159353,and,0,0
159354,fast,0,1
159355,recovery,0,0
159356,.,0,0
159357,Conscious,0,0
159358,sedation,0,0
159359,with,0,0
159360,remifentanil,1,1
159361,can,0,0
159362,relieve,0,0
159363,from,0,0
159364,pain,0,0
159365,and,0,0
159366,keep,0,0
159367,patients,0,0
159368,in,0,0
159369,touch,0,0
159370,with,0,0
159371,anaesthesiologists,0,0
159372,.,0,0
159373,Few,0,0
159374,publications,0,0
159375,tell,0,0
159376,about,0,0
159377,infusion,0,0
159378,rates,0,0
159379,administered,0,0
159380,to,0,0
159381,perform,0,0
159382,this,0,0
159383,procedure7,0,0
159384,.,0,0
159385,The,0,0
159386,aim,0,0
159387,of,0,0
159388,this,0,0
159389,study,0,0
159390,is,0,0
159391,to,0,0
159392,assess,0,0
159393,which,0,0
159394,is,0,0
159395,the,0,0
159396,most,0,0
159397,appropriate,0,0
159398,infusion,0,1
159399,rate,0,0
159400,.,0,0
159401,METHODS,0,0
159402,Patients,0,0
159403,were,0,0
159404,randomly,0,0
159405,assigned,0,0
159406,to,0,0
159407,two,0,0
159408,groups,0,0
159409,.,0,0
159410,Two,0,0
159411,different,0,0
159412,infusion,0,1
159413,rates,0,0
159414,were,0,0
159415,compared,0,0
159416,:,0,0
159417,"0,05",0,0
159418,mcg/kg/min,0,0
159419,",",0,0
159420,GROUP,0,1
159421,A,0,0
159422,(,0,0
159423,N.=114,0,0
159424,),0,0
159425,",",0,0
159426,vs.,0,0
159427,0.1,0,0
159428,?g/kg/min,0,1
159429,",",0,0
159430,GROUP,0,1
159431,B,0,0
159432,(,0,0
159433,N.=114,0,0
159434,),0,0
159435,.,0,0
159436,Patients,0,0
159437,',0,0
159438,vital,0,0
159439,signs,0,0
159440,",",0,0
159441,additional,0,0
159442,analgesic,0,0
159443,requests,0,0
159444,",",0,0
159445,PONV,0,0
159446,(,0,0
159447,postoperative,0,0
159448,nausea,0,0
159449,and,0,0
159450,vomiting,0,0
159451,),0,0
159452,and,0,0
159453,other,0,0
159454,side,0,0
159455,effects,0,0
159456,were,0,0
159457,registered,0,0
159458,.,0,0
159459,The,0,0
159460,deepness,0,0
159461,of,0,0
159462,sedation,0,0
159463,and,0,0
159464,patient,0,0
159465,'s,0,0
159466,satisfaction,0,0
159467,were,0,0
159468,evaluated,0,0
159469,referring,0,0
159470,to,0,0
159471,Obsever,0,0
159472,'s,0,0
159473,Assessment,0,0
159474,of,0,0
159475,Alertness,0,0
159476,and,0,0
159477,Sedation,0,0
159478,scale,0,0
159479,(,0,0
159480,O/ASS,0,0
159481,),0,1
159482,and,0,0
159483,using,0,0
159484,a,0,0
159485,Likert,0,0
159486,'s,0,0
159487,scale,0,0
159488,respectively,0,0
159489,.,0,0
159490,Pain,0,0
159491,intensity,0,0
159492,was,0,0
159493,assessed,0,0
159494,with,0,0
159495,a,0,0
159496,11-points,0,0
159497,VAS,0,0
159498,(,0,0
159499,visual,0,0
159500,analogue,0,1
159501,scale,0,0
159502,),0,0
159503,.,0,0
159504,Differences,0,0
159505,between,0,0
159506,groups,0,0
159507,were,0,0
159508,analyzed,0,0
159509,using,0,0
159510,Student,0,1
159511,t,0,0
159512,test,0,0
159513,for,0,0
159514,independent,0,0
159515,variables,0,0
159516,.,0,0
159517,The,0,0
159518,?2,0,0
159519,test,0,0
159520,was,0,0
159521,used,0,0
159522,to,0,0
159523,analyze,0,0
159524,categorical,0,0
159525,variables,0,0
159526,.,0,0
159527,RESULTS,0,0
159528,The,0,0
159529,study,0,0
159530,enrolled,0,0
159531,228,0,0
159532,patients,0,0
159533,and,0,0
159534,assigned,0,0
159535,them,0,0
159536,to,0,0
159537,two,0,0
159538,groups,0,0
159539,(,0,0
159540,N.=114,0,0
159541,),0,0
159542,.,0,0
159543,No,0,0
159544,significant,0,0
159545,differences,0,0
159546,were,0,0
159547,found,0,0
159548,regarding,0,0
159549,Likert,0,0
159550,'s,0,0
159551,scale,0,0
159552,values,0,0
159553,(,0,0
159554,P=0.20,0,0
159555,),0,0
159556,",",0,0
159557,additional,0,0
159558,analgesic,0,1
159559,request,0,0
159560,(,0,0
159561,P=0.30,0,0
159562,),0,1
159563,and,0,0
159564,mean,0,0
159565,VAS,0,1
159566,values,0,0
159567,(,0,0
159568,P,0,0
159569,>,0,0
159570,0.05,0,0
159571,),0,0
159572,between,0,0
159573,the,0,0
159574,two,0,0
159575,groups,0,0
159576,.,0,0
159577,The,0,0
159578,difference,0,0
159579,between,0,0
159580,the,0,0
159581,two,0,0
159582,groups,0,0
159583,about,0,0
159584,PONV,0,0
159585,",",0,0
159586,hypotension,0,0
159587,",",0,0
159588,oxygen,0,1
159589,desaturation,0,0
159590,and,0,0
159591,respiratory,0,0
159592,depression,0,0
159593,was,0,0
159594,statistically,0,0
159595,significant,0,0
159596,(,0,0
159597,P,0,0
159598,<,0,0
159599,0.05,0,0
159600,),0,0
159601,",",0,0
159602,as,0,0
159603,a,0,0
159604,matter,0,0
159605,of,0,0
159606,fact,0,0
159607,in,0,0
159608,group,0,0
159609,A,0,0
159610,these,0,0
159611,side,0,0
159612,effects,0,0
159613,occurred,0,0
159614,less,0,0
159615,frequently,0,0
159616,.,0,0
159617,The,0,0
159618,fifth,0,0
159619,degree,0,0
159620,of,0,0
159621,O/ASS,0,0
159622,was,0,0
159623,estimated,0,0
159624,in,0,0
159625,about,0,0
159626,1.61?0.19,0,0
159627,min,0,0
159628,and,0,0
159629,2.987?0.20,0,0
159630,min,0,0
159631,in,0,0
159632,group,0,0
159633,A,0,0
159634,and,0,0
159635,in,0,0
159636,group,0,0
159637,B,0,0
159638,respectively,0,0
159639,(,0,0
159640,P,0,0
159641,<,0,0
159642,0.05,0,0
159643,),0,0
159644,.,0,0
159645,CONCLUSION,0,0
159646,According,0,0
159647,with,0,0
159648,previous,0,0
159649,results,0,0
159650,remifentanil,0,1
159651,at,0,0
159652,the,0,0
159653,infusion,0,1
159654,rate,0,0
159655,of,0,0
159656,0.05,0,0
159657,?g/kg/min,0,1
159658,provides,0,0
159659,an,0,0
159660,effective,0,0
159661,analgesia,0,0
159662,",",0,0
159663,causing,0,0
159664,a,0,0
159665,lower,0,0
159666,incidence,0,0
159667,of,0,0
159668,side,0,0
159669,effect,0,0
159670,than,0,0
159671,0.1,0,0
159672,?g/kg/min,0,1
159673,",",0,0
159674,granting,0,0
159675,a,0,0
159676,fast,0,1
159677,and,0,0
159678,safe,0,0
159679,recovery,0,0
159680,.,0,0
159681,Bayesian,1,0
159682,adaptive,1,0
159683,trials,0,0
159684,offer,0,0
159685,advantages,0,0
159686,in,0,0
159687,comparative,0,0
159688,effectiveness,0,0
159689,trials,0,0
159690,:,0,0
159691,an,0,0
159692,example,0,0
159693,in,0,0
159694,status,0,0
159695,epilepticus,0,0
159696,.,0,0
159697,OBJECTIVE,0,0
159698,We,0,0
159699,present,0,0
159700,a,0,0
159701,novel,0,0
159702,Bayesian,1,0
159703,adaptive,1,0
159704,comparative,0,0
159705,effectiveness,0,0
159706,trial,0,0
159707,comparing,0,0
159708,three,1,0
159709,treatments,1,0
159710,for,0,0
159711,status,0,0
159712,epilepticus,0,0
159713,that,0,0
159714,uses,0,0
159715,adaptive,0,0
159716,randomization,0,0
159717,with,0,0
159718,potential,0,0
159719,early,0,0
159720,stopping,0,0
159721,.,0,0
159722,STUDY,0,0
159723,DESIGN,0,0
159724,AND,0,0
159725,SETTING,0,0
159726,The,0,0
159727,trial,0,0
159728,will,0,0
159729,enroll,0,0
159730,720,0,0
159731,unique,0,0
159732,patients,0,0
159733,in,0,0
159734,emergency,0,0
159735,departments,0,0
159736,and,0,0
159737,uses,0,0
159738,a,0,0
159739,Bayesian,1,0
159740,adaptive,1,0
159741,design,1,0
159742,.,1,0
159743,RESULTS,0,0
159744,The,0,0
159745,trial,0,0
159746,design,0,0
159747,is,0,0
159748,compared,0,0
159749,to,0,0
159750,a,0,0
159751,trial,0,0
159752,without,0,0
159753,adaptive,0,0
159754,randomization,0,0
159755,and,0,0
159756,produces,0,0
159757,an,0,0
159758,efficient,0,0
159759,trial,0,0
159760,in,0,0
159761,which,0,0
159762,a,0,0
159763,higher,0,0
159764,proportion,0,0
159765,of,0,0
159766,patients,0,0
159767,are,0,0
159768,likely,0,0
159769,to,0,0
159770,be,0,0
159771,randomized,0,0
159772,to,0,0
159773,the,0,0
159774,most,0,0
159775,effective,0,0
159776,treatment,0,0
159777,arm,0,0
159778,while,0,0
159779,generally,0,0
159780,using,0,0
159781,fewer,0,0
159782,total,0,0
159783,patients,0,0
159784,and,0,0
159785,offers,0,0
159786,higher,0,0
159787,power,0,0
159788,than,0,0
159789,an,0,0
159790,analogous,0,0
159791,trial,0,0
159792,with,0,0
159793,fixed,0,0
159794,randomization,0,0
159795,when,0,0
159796,identifying,0,0
159797,a,0,0
159798,superior,0,0
159799,treatment,0,0
159800,.,0,0
159801,CONCLUSION,0,0
159802,When,0,0
159803,one,0,0
159804,treatment,0,0
159805,is,0,0
159806,superior,0,0
159807,to,0,0
159808,the,0,0
159809,other,0,0
159810,two,0,0
159811,",",0,0
159812,the,0,0
159813,trial,0,0
159814,design,0,0
159815,provides,0,0
159816,better,0,0
159817,patient,0,0
159818,care,0,0
159819,",",0,0
159820,higher,0,0
159821,power,0,0
159822,",",0,0
159823,and,0,0
159824,a,0,0
159825,lower,0,0
159826,expected,0,0
159827,sample,0,0
159828,size,0,0
159829,.,0,0
159830,CT,0,0
159831,and,0,0
159832,MRI,0,0
159833,measurements,0,0
159834,of,0,0
159835,tibial,0,1
159836,tubercle-trochlear,0,0
159837,groove,0,0
159838,distances,0,0
159839,are,0,0
159840,not,0,0
159841,equivalent,0,0
159842,in,0,0
159843,patients,0,0
159844,with,0,0
159845,patellar,0,0
159846,instability,0,0
159847,.,0,0
159848,BACKGROUND,0,0
159849,Tibial,0,0
159850,tubercle-trochlear,0,0
159851,groove,0,1
159852,distance,0,0
159853,(,0,0
159854,TT-TG,0,0
159855,),0,1
159856,is,0,0
159857,a,0,0
159858,commonly,0,0
159859,used,0,0
159860,measurement,0,0
159861,for,0,0
159862,surgical,0,0
159863,decision,0,0
159864,making,0,0
159865,in,0,0
159866,patients,0,0
159867,with,0,0
159868,patellofemoral,0,0
159869,malalignment,0,0
159870,and,0,0
159871,instability,0,0
159872,.,0,0
159873,This,0,0
159874,measurement,0,0
159875,has,0,0
159876,historically,0,0
159877,been,0,0
159878,performed,0,0
159879,utilizing,0,0
159880,axial,0,0
159881,computed,0,1
159882,tomography,0,1
159883,(,0,0
159884,CT,0,0
159885,),0,0
159886,.,0,0
159887,More,0,0
159888,recently,0,0
159889,",",0,0
159890,magnetic,0,1
159891,resonance,0,1
159892,imaging,0,1
159893,(,0,0
159894,MRI,0,1
159895,),0,1
159896,has,0,0
159897,been,0,0
159898,proposed,0,0
159899,as,0,0
159900,an,0,0
159901,equivalent,0,0
159902,method,0,0
159903,",",0,0
159904,but,0,0
159905,this,0,0
159906,has,0,0
159907,not,0,0
159908,yet,0,0
159909,been,0,0
159910,fully,0,0
159911,validated,0,0
159912,.,0,0
159913,PURPOSE,0,0
159914,To,0,0
159915,determine,0,0
159916,the,0,0
159917,reliability,0,0
159918,of,0,0
159919,TT-TG,0,0
159920,distance,0,0
159921,measurements,0,0
159922,on,0,0
159923,both,0,0
159924,MRI,0,0
159925,and,0,0
159926,CT,0,0
159927,and,0,0
159928,to,0,0
159929,determine,0,0
159930,whether,0,0
159931,the,0,0
159932,measurements,0,0
159933,are,0,0
159934,interchangeable,0,0
159935,with,0,0
159936,one,0,0
159937,another,0,0
159938,.,0,0
159939,STUDY,0,0
159940,DESIGN,0,0
159941,Cohort,0,1
159942,study,0,0
159943,(,0,0
159944,diagnosis,0,0
159945,),0,0
159946,;,0,0
159947,Level,0,0
159948,of,0,0
159949,evidence,0,0
159950,",",0,0
159951,2,0,0
159952,.,0,0
159953,METHODS,0,0
159954,All,0,0
159955,patients,0,0
159956,with,0,0
159957,patellar,0,0
159958,instability,0,0
159959,who,0,0
159960,underwent,0,0
159961,both,0,0
159962,CT,1,0
159963,and,1,0
159964,MRI,1,0
159965,of,0,0
159966,the,0,0
159967,knee,0,0
159968,from,0,0
159969,2003,0,0
159970,to,0,0
159971,2011,0,0
159972,were,0,0
159973,included,0,0
159974,(,0,0
159975,n,0,0
159976,=,0,0
159977,59,0,0
159978,knees,0,0
159979,in,0,0
159980,54,0,0
159981,patients,0,0
159982,),0,0
159983,.,0,0
159984,Two,0,0
159985,fellowship-trained,0,0
159986,musculoskeletal,0,0
159987,radiologists,0,0
159988,measured,0,0
159989,the,0,0
159990,TT-TG,0,0
159991,distances,0,0
159992,for,0,0
159993,each,0,0
159994,patient,0,0
159995,by,0,0
159996,CT,1,0
159997,and,1,0
159998,MRI,1,0
159999,in,0,0
160000,a,0,0
160001,randomized,0,0
160002,",",0,0
160003,blinded,0,0
160004,fashion,0,0
160005,.,0,0
160006,Interobserver,0,0
160007,reliability,0,0
160008,was,0,0
160009,calculated,0,0
160010,between,0,0
160011,radiologists,0,0
160012,for,0,0
160013,both,0,0
160014,imaging,0,0
160015,modalities,0,0
160016,",",0,0
160017,and,0,0
160018,intermethod,0,0
160019,reliability,0,0
160020,was,0,0
160021,calculated,0,0
160022,between,0,0
160023,the,0,0
160024,2,0,0
160025,imaging,0,0
160026,modalities,0,0
160027,.,0,0
160028,The,0,0
160029,results,0,0
160030,are,0,0
160031,reported,0,0
160032,using,0,0
160033,intraclass,0,0
160034,correlation,0,0
160035,coefficients,0,0
160036,(,0,0
160037,ICCs,0,1
160038,),0,1
160039,and,0,0
160040,Bland-Altman,0,0
160041,analysis,0,0
160042,.,0,0
160043,RESULTS,0,0
160044,The,0,0
160045,59,0,0
160046,knees,0,0
160047,had,0,0
160048,a,0,0
160049,mean,0,0
160050,TT-TG,0,0
160051,distance,0,0
160052,of,0,0
160053,16.9,0,0
160054,mm,0,0
160055,(,0,0
160056,range,0,0
160057,",",0,0
160058,8.3-25.8,0,0
160059,mm,0,0
160060,),0,0
160061,by,0,0
160062,CT,0,0
160063,and,0,0
160064,14.7,0,0
160065,mm,0,0
160066,(,0,0
160067,range,0,0
160068,",",0,0
160069,1.5-25.1,0,0
160070,mm,0,0
160071,),0,0
160072,by,0,0
160073,MRI,0,0
160074,.,0,0
160075,Interobserver,0,0
160076,reliability,0,0
160077,between,0,0
160078,the,0,0
160079,radiologists,0,0
160080,was,0,0
160081,considered,0,0
160082,excellent,0,0
160083,for,0,0
160084,both,0,0
160085,CT,1,0
160086,and,0,0
160087,MRI,1,1
160088,(,0,0
160089,ICC,0,0
160090,=,0,0
160091,0.777,0,0
160092,and,0,0
160093,0.843,0,0
160094,",",0,0
160095,respectively,0,0
160096,),0,0
160097,.,0,0
160098,When,0,0
160099,comparing,0,0
160100,CT,0,0
160101,to,0,0
160102,MRI,0,0
160103,",",0,0
160104,the,0,0
160105,ICC,0,0
160106,was,0,0
160107,considered,0,0
160108,only,0,0
160109,fair,0,0
160110,for,0,0
160111,each,0,0
160112,of,0,0
160113,the,0,0
160114,raters,0,0
160115,(,0,0
160116,0.532,0,0
160117,and,0,0
160118,0.539,0,0
160119,),0,0
160120,.,0,0
160121,Eleven,0,1
160122,patients,0,0
160123,(,0,0
160124,19,0,0
160125,%,0,0
160126,),0,0
160127,had,0,0
160128,a,0,0
160129,TT-TG,0,0
160130,distance,0,0
160131,of,0,0
160132,?20,0,0
160133,mm,0,0
160134,on,0,0
160135,CT,0,0
160136,preoperatively,0,0
160137,and,0,0
160138,underwent,0,0
160139,distal,0,0
160140,realignment,0,0
160141,by,0,0
160142,tibial,0,1
160143,tubercle,0,1
160144,osteotomy,0,1
160145,.,0,0
160146,In,0,0
160147,this,0,0
160148,surgical,0,0
160149,subgroup,0,0
160150,",",0,0
160151,the,0,0
160152,mean,0,0
160153,TT-TG,0,0
160154,distance,0,0
160155,was,0,0
160156,22.5,0,0
160157,mm,0,0
160158,(,0,0
160159,range,0,0
160160,",",0,0
160161,19.8-25.8,0,0
160162,mm,0,0
160163,),0,0
160164,by,0,0
160165,CT,0,0
160166,and,0,0
160167,only,0,0
160168,18.7,0,0
160169,mm,0,0
160170,(,0,0
160171,range,0,0
160172,",",0,0
160173,14.4-22.8,0,0
160174,mm,0,0
160175,),0,0
160176,by,0,0
160177,MRI,0,0
160178,for,0,0
160179,a,0,0
160180,mean,0,0
160181,difference,0,0
160182,of,0,0
160183,3.80,0,0
160184,mm,0,0
160185,(,0,0
160186,P,0,0
160187,<,0,0
160188,.001,0,0
160189,),0,0
160190,.,0,0
160191,CONCLUSION,0,0
160192,The,0,0
160193,TT-TG,0,0
160194,distance,0,0
160195,can,0,0
160196,be,0,0
160197,measured,0,0
160198,with,0,0
160199,excellent,0,0
160200,interrater,0,0
160201,reliability,0,0
160202,on,0,0
160203,both,0,0
160204,MRI,0,0
160205,and,0,0
160206,CT,0,0
160207,;,0,0
160208,however,0,0
160209,",",0,0
160210,the,0,0
160211,values,0,0
160212,derived,0,0
160213,from,0,0
160214,these,0,0
160215,2,0,0
160216,tests,0,0
160217,may,0,0
160218,not,0,0
160219,be,0,0
160220,interchangeable,0,0
160221,.,0,0
160222,This,0,0
160223,observation,0,0
160224,should,0,0
160225,be,0,0
160226,taken,0,0
160227,into,0,0
160228,consideration,0,0
160229,when,0,0
160230,MRI,0,0
160231,is,0,0
160232,used,0,0
160233,for,0,0
160234,surgical,0,0
160235,planning,0,0
160236,because,0,0
160237,MRI,0,0
160238,may,0,0
160239,underestimate,0,0
160240,the,0,0
160241,TT-TG,0,0
160242,distance,0,0
160243,when,0,0
160244,compared,0,0
160245,with,0,0
160246,CT,0,0
160247,.,0,0
160248,A,0,0
160249,randomized,0,0
160250,double,0,1
160251,blind,0,0
160252,placebo,1,1
160253,controlled,0,0
160254,clinical,0,0
160255,trial,0,0
160256,of,0,0
160257,N-Acetylcysteine,1,1
160258,added,1,0
160259,to,1,0
160260,risperidone,1,1
160261,for,0,0
160262,treating,0,0
160263,autistic,0,0
160264,disorders,0,0
160265,.,0,0
160266,BACKGROUND,0,0
160267,This,0,0
160268,study,0,0
160269,examined,0,0
160270,the,0,0
160271,efficacy,0,0
160272,and,0,0
160273,safety,0,0
160274,of,0,0
160275,N-acetylcysteine,1,1
160276,(,1,0
160277,NAC,1,1
160278,),1,0
160279,augmentation,0,0
160280,for,0,0
160281,treating,0,0
160282,irritability,0,0
160283,in,0,0
160284,children,0,0
160285,and,0,0
160286,adolescents,0,0
160287,with,0,0
160288,autism,0,0
160289,spectrum,0,0
160290,disorders,0,0
160291,(,0,0
160292,ASD,0,0
160293,),0,0
160294,.,0,0
160295,METHOD,0,0
160296,Forty,0,0
160297,children,0,0
160298,and,0,0
160299,adolescents,0,0
160300,met,0,0
160301,diagnostic,0,0
160302,criteria,0,0
160303,for,0,0
160304,ASD,0,0
160305,according,0,0
160306,to,0,0
160307,DSM-IV,0,0
160308,.,0,0
160309,They,0,0
160310,were,0,0
160311,randomly,0,0
160312,allocated,0,0
160313,into,0,0
160314,one,0,0
160315,of,0,0
160316,the,0,0
160317,two,0,0
160318,groups,0,0
160319,of,0,0
160320,NAC,1,1
160321,(,1,0
160322,1200,1,1
160323,mg/day,1,1
160324,),1,0
160325,+risperidone,1,1
160326,or,1,1
160327,placebo+risperidone,1,1
160328,.,1,0
160329,NAC,1,0
160330,and,1,0
160331,placebo,1,1
160332,were,1,0
160333,administered,0,0
160334,in,0,0
160335,the,0,0
160336,form,0,0
160337,of,0,0
160338,effervescent,0,1
160339,and,0,0
160340,in,0,0
160341,two,0,0
160342,divided,0,0
160343,doses,0,0
160344,for,0,0
160345,8,0,0
160346,weeks,0,0
160347,.,0,0
160348,Irritability,0,0
160349,subscale,0,0
160350,score,0,0
160351,of,0,0
160352,Aberrant,0,0
160353,Behavior,0,0
160354,Checklist,0,1
160355,(,0,0
160356,ABC,0,1
160357,),0,0
160358,was,0,0
160359,considered,0,0
160360,as,0,0
160361,the,0,0
160362,main,0,0
160363,outcome,0,0
160364,measure,0,0
160365,.,0,0
160366,Adverse,0,0
160367,effects,0,0
160368,were,0,0
160369,also,0,0
160370,checked,0,0
160371,.,0,0
160372,RESULTS,0,0
160373,The,0,0
160374,mean,0,0
160375,score,0,0
160376,of,0,0
160377,irritability,0,0
160378,in,0,0
160379,the,1,0
160380,NAC+risperidone,1,1
160381,and,1,0
160382,placebo+risperidone,1,1
160383,groups,1,0
160384,at,0,0
160385,baseline,0,0
160386,was,0,0
160387,13.2,0,0
160388,(,0,0
160389,5.3,0,0
160390,),0,0
160391,and,0,0
160392,16.7,0,0
160393,(,0,0
160394,7.8,0,0
160395,),0,0
160396,",",0,0
160397,respectively,0,0
160398,.,0,0
160399,The,0,0
160400,scores,0,0
160401,after,0,0
160402,8,0,0
160403,weeks,0,0
160404,were,0,0
160405,9.7,0,0
160406,(,0,0
160407,4.1,0,0
160408,),0,0
160409,and,0,0
160410,15.1,0,0
160411,(,0,0
160412,7.8,0,0
160413,),0,0
160414,",",0,0
160415,respectively,0,0
160416,.,0,0
160417,Repeated,0,0
160418,measures,0,0
160419,of,0,0
160420,ANOVA,0,0
160421,showed,0,0
160422,that,0,0
160423,there,0,0
160424,was,0,0
160425,a,0,0
160426,significant,0,0
160427,difference,0,0
160428,between,0,0
160429,the,0,0
160430,two,0,0
160431,groups,0,0
160432,after,0,0
160433,8,0,0
160434,weeks,0,0
160435,.,0,0
160436,The,0,0
160437,most,0,0
160438,common,0,0
160439,adverse,0,0
160440,effects,0,0
160441,in,0,0
160442,the,1,0
160443,NAC+risperidone,1,1
160444,group,1,0
160445,were,0,0
160446,constipation,0,0
160447,(,0,0
160448,16.1,0,0
160449,%,0,0
160450,),0,0
160451,",",0,0
160452,increased,0,0
160453,appetite,0,0
160454,(,0,0
160455,16.1,0,0
160456,%,0,0
160457,),0,0
160458,",",0,0
160459,fatigue,0,0
160460,(,0,0
160461,12.9,0,0
160462,%,0,0
160463,),0,0
160464,",",0,0
160465,nervousness,0,0
160466,(,0,0
160467,12.9,0,0
160468,%,0,0
160469,),0,0
160470,",",0,0
160471,and,0,0
160472,daytime,0,0
160473,drowsiness,0,0
160474,(,0,0
160475,12.9,0,0
160476,%,0,0
160477,),0,0
160478,.,0,0
160479,There,0,0
160480,was,0,0
160481,no,0,0
160482,fatal,0,0
160483,adverse,0,0
160484,effect,0,0
160485,.,0,0
160486,CONCLUSIONS,1,0
160487,Risperidone,1,1
160488,plus,1,1
160489,NAC,1,0
160490,more,1,0
160491,than,0,0
160492,risperidone,0,1
160493,plus,0,1
160494,placebo,0,1
160495,decreased,0,0
160496,irritability,0,0
160497,in,0,0
160498,children,0,0
160499,and,0,0
160500,adolescents,0,0
160501,with,0,0
160502,ASD,0,0
160503,.,0,0
160504,Meanwhile,0,0
160505,",",0,0
160506,it,0,0
160507,did,0,0
160508,not,0,0
160509,change,0,0
160510,the,0,0
160511,core,0,0
160512,symptoms,0,0
160513,of,0,0
160514,autism,0,0
160515,.,0,0
160516,Adverse,0,0
160517,effects,0,0
160518,were,0,0
160519,not,0,0
160520,common,0,0
160521,and,1,0
160522,NAC,1,1
160523,was,1,0
160524,generally,0,0
160525,tolerated,0,0
160526,well,0,0
160527,.,0,0
160528,TRIAL,0,0
160529,REGISTRATION,0,0
160530,This,0,0
160531,trial,0,0
160532,was,0,0
160533,registered,0,0
160534,at,0,0
160535,http,0,0
160536,:,0,0
160537,//www.irct.ir,0,0
160538,.,0,0
160539,The,0,0
160540,registration,0,0
160541,number,0,0
160542,of,0,0
160543,this,0,0
160544,trial,0,0
160545,was,0,0
160546,IRCT201106103930N6,0,0
160547,.,0,0
160548,[,0,0
160549,Treating,0,0
160550,rheumatoid,0,0
160551,arthritis,0,0
160552,patients,0,0
160553,of,0,0
160554,Shen,0,1
160555,deficiency,0,0
160556,and,0,0
160557,cold,0,1
160558,invading,0,0
160559,syndrome,0,0
160560,by,0,0
160561,bushen,1,1
160562,quhan,1,0
160563,zhiwang,1,0
160564,decoction,1,1
160565,combined,1,1
160566,methotrexate,1,1
160567,:,1,0
160568,an,0,0
160569,evaluation,0,0
160570,of,0,0
160571,clinical,0,0
160572,efficacy,0,0
160573,and,0,0
160574,safety,0,0
160575,],0,0
160576,.,0,0
160577,OBJECTIVE,0,0
160578,To,0,0
160579,evaluate,0,0
160580,the,0,0
160581,clinical,0,0
160582,efficacy,0,0
160583,and,0,0
160584,safety,0,0
160585,of,0,0
160586,bushen,1,1
160587,quhan,1,0
160588,zhiwang,1,1
160589,decoction,1,1
160590,(,1,0
160591,BQZD,1,0
160592,),1,1
160593,combined,1,1
160594,methotrexate,1,1
160595,(,1,0
160596,MTX,1,1
160597,),1,0
160598,in,0,0
160599,treating,0,0
160600,rheumatoid,0,0
160601,arthritis,0,1
160602,(,0,0
160603,RA,0,0
160604,),0,0
160605,.,0,0
160606,METHODS,0,0
160607,A,0,0
160608,prospective,0,0
160609,",",0,0
160610,randomized,0,0
160611,controlled,0,0
160612,study,0,0
160613,was,0,0
160614,carried,0,0
160615,out,0,0
160616,.,0,0
160617,RA,0,0
160618,patients,0,0
160619,of,0,0
160620,Shen,0,1
160621,deficiency,0,0
160622,and,0,0
160623,cold,0,1
160624,invading,0,0
160625,syndrome,0,0
160626,in,0,0
160627,the,0,0
160628,treatment,0,0
160629,group,0,0
160630,(,0,0
160631,120,0,0
160632,cases,0,0
160633,),0,0
160634,were,0,0
160635,treated,0,0
160636,with,0,0
160637,BQZD,1,0
160638,and,1,0
160639,MTX,1,1
160640,(,1,0
160641,10,1,0
160642,mg/week,1,1
160643,),1,0
160644,",",0,0
160645,while,0,0
160646,those,0,0
160647,in,0,0
160648,the,0,0
160649,control,0,1
160650,group,0,0
160651,(,0,0
160652,120,0,0
160653,cases,0,0
160654,),0,0
160655,were,0,0
160656,treated,1,0
160657,with,1,0
160658,MTX,1,1
160659,(,1,0
160660,10,1,0
160661,mg/week,1,1
160662,),1,0
160663,alone,1,0
160664,.,1,0
160665,The,0,0
160666,therapeutic,0,0
160667,course,0,0
160668,for,0,0
160669,all,0,0
160670,was,0,0
160671,24,0,0
160672,weeks,0,0
160673,.,0,0
160674,The,0,0
160675,efficacy,0,0
160676,and,0,0
160677,safety,0,0
160678,indices,0,0
160679,were,0,0
160680,evaluated,0,0
160681,at,0,0
160682,the,0,0
160683,baseline,0,0
160684,and,0,0
160685,24,0,0
160686,weeks,0,0
160687,after,0,0
160688,treatment,0,0
160689,",",0,0
160690,including,0,0
160691,clinical,0,0
160692,signs,0,0
160693,and,0,0
160694,symptoms,0,0
160695,",",0,0
160696,condition,0,0
160697,assessment,0,0
160698,",",0,0
160699,Health,0,0
160700,Assessment,0,1
160701,Questionnaire,0,1
160702,(,0,0
160703,HAQ,0,0
160704,),0,0
160705,",",0,0
160706,disease,0,0
160707,activity,0,0
160708,index,0,0
160709,28,0,0
160710,(,0,0
160711,DAS28,0,0
160712,),0,0
160713,",",0,0
160714,laboratory,0,0
160715,parameters,0,0
160716,of,0,0
160717,erythrocyte,0,0
160718,sedimentation,0,1
160719,rate,0,0
160720,(,0,0
160721,ESR,0,1
160722,),0,1
160723,and,0,0
160724,C-reactive,0,0
160725,protein,0,1
160726,(,0,0
160727,CRP,0,1
160728,),0,0
160729,",",0,0
160730,safety,0,0
160731,indicators,0,0
160732,",",0,0
160733,and,0,0
160734,Chinese,0,1
160735,medical,0,1
160736,syndrome,0,0
160737,integrals,0,1
160738,.,0,0
160739,RESULTS,0,0
160740,The,0,0
160741,total,0,0
160742,effective,0,0
160743,rate,0,0
160744,was,0,0
160745,80,0,0
160746,.,0,0
160747,0,0,0
160748,%,0,0
160749,in,0,0
160750,the,0,0
160751,treatment,0,0
160752,group,0,0
160753,",",0,0
160754,better,0,0
160755,than,0,0
160756,that,0,0
160757,of,0,0
160758,the,0,0
160759,control,0,1
160760,group,0,0
160761,(,0,0
160762,66.7,0,0
160763,%,0,0
160764,),0,0
160765,",",0,0
160766,showing,0,0
160767,statistical,0,0
160768,difference,0,0
160769,(,0,0
160770,P,0,0
160771,<,0,0
160772,0.01,0,0
160773,),0,0
160774,.,0,0
160775,In,0,0
160776,the,0,0
160777,two,0,0
160778,groups,0,0
160779,significant,0,0
160780,improvement,0,0
160781,of,0,0
160782,clinical,0,0
160783,signs,0,0
160784,and,0,0
160785,symptoms,0,0
160786,",",0,0
160787,ESR,0,0
160788,",",0,0
160789,CRP,0,1
160790,",",0,0
160791,visual,0,0
160792,analogue,0,0
160793,scale,0,0
160794,(,0,0
160795,VAS,0,1
160796,),0,0
160797,by,0,0
160798,both,0,0
160799,physicians,0,0
160800,and,0,0
160801,patients,0,0
160802,",",0,0
160803,HAQ,0,0
160804,",",0,0
160805,DAS28,0,0
160806,",",0,0
160807,and,0,0
160808,Chinese,0,1
160809,medical,0,1
160810,syndrome,0,0
160811,integrals,0,1
160812,after,0,0
160813,treatment,0,0
160814,were,0,0
160815,shown,0,0
160816,(,0,0
160817,P,0,0
160818,<,0,0
160819,0.01,0,0
160820,),0,0
160821,.,0,0
160822,Better,0,0
160823,effects,0,0
160824,were,0,0
160825,obtained,0,0
160826,in,0,0
160827,the,0,0
160828,treatment,0,0
160829,group,0,0
160830,in,0,0
160831,lessening,0,0
160832,tender,0,0
160833,joint,0,0
160834,numbers,0,0
160835,and,0,0
160836,swollen,0,0
160837,joint,0,0
160838,numbers,0,0
160839,",",0,0
160840,VAS,0,0
160841,by,0,0
160842,both,0,0
160843,physicians,0,0
160844,and,0,0
160845,patients,0,0
160846,",",0,0
160847,DAS28,0,0
160848,",",0,0
160849,and,0,0
160850,Chinese,0,1
160851,medical,0,1
160852,syndrome,0,0
160853,integrals,0,1
160854,(,0,0
160855,P,0,0
160856,<,0,0
160857,0.05,0,0
160858,),0,0
160859,.,0,0
160860,Besides,0,0
160861,",",0,0
160862,adverse,0,0
160863,reactions,0,0
160864,occurred,0,0
160865,less,0,0
160866,in,0,0
160867,the,0,0
160868,treatment,0,0
160869,group,0,0
160870,than,0,0
160871,in,0,0
160872,the,0,0
160873,control,0,1
160874,group,0,0
160875,(,0,0
160876,P,0,0
160877,<,0,0
160878,0.05,0,0
160879,),0,0
160880,.,0,0
160881,CONCLUSIONS,0,0
160882,BQZD,1,0
160883,had,0,0
160884,roles,0,0
160885,in,0,0
160886,relieving,0,0
160887,symptoms,0,0
160888,",",0,0
160889,improving,0,0
160890,joint,0,0
160891,functions,0,0
160892,",",0,0
160893,signs,0,0
160894,",",0,0
160895,ESR,0,1
160896,",",0,0
160897,and,0,0
160898,CRP,0,1
160899,.,0,0
160900,It,0,0
160901,was,0,0
160902,an,0,0
160903,effective,0,0
160904,herb,0,1
160905,for,0,0
160906,RA,0,0
160907,patients,0,0
160908,of,0,0
160909,Shen,0,1
160910,deficiency,0,0
160911,and,0,0
160912,cold,0,1
160913,invading,0,0
160914,syndrome,0,0
160915,.,0,0
160916,It,0,0
160917,could,0,0
160918,enhance,0,0
160919,the,0,0
160920,efficacy,0,0
160921,and,0,0
160922,reduce,0,0
160923,adverse,0,0
160924,reactions,0,0
160925,of,0,0
160926,MTX,0,0
160927,through,0,0
160928,synergistic,0,0
160929,effects,0,0
160930,with,0,0
160931,MTX,0,0
160932,.,0,0
160933,[,0,0
160934,Risk,0,1
160935,factors,0,0
160936,for,0,0
160937,atherosclerotic,0,0
160938,disease,0,0
160939,from,0,0
160940,the,0,0
160941,Japanese,0,0
160942,Elderly,1,0
160943,Diabetes,1,0
160944,Intervention,1,1
160945,Trial,0,1
160946,(,0,0
160947,J-EDIT,0,1
160948,),0,0
160949,],0,0
160950,.,0,0
160951,Successful,0,0
160952,production,0,0
160953,of,0,0
160954,piglets,0,0
160955,derived,0,0
160956,from,0,0
160957,expanded,0,0
160958,blastocysts,0,0
160959,vitrified,0,1
160960,using,0,0
160961,a,0,0
160962,micro,1,1
160963,volume,1,0
160964,air,1,1
160965,cooling,1,1
160966,method,1,0
160967,without,0,0
160968,direct,0,0
160969,exposure,0,0
160970,to,0,0
160971,liquid,0,1
160972,nitrogen,0,0
160973,.,0,0
160974,This,0,0
160975,study,0,0
160976,was,0,0
160977,conducted,0,0
160978,to,0,0
160979,clarify,0,0
160980,the,0,0
160981,feasibility,0,0
160982,of,0,0
160983,newly,0,0
160984,developed,0,0
160985,vitrification,0,1
160986,techniques,0,1
160987,for,0,0
160988,porcine,0,1
160989,embryos,0,0
160990,using,0,0
160991,the,0,0
160992,micro,1,1
160993,volume,1,0
160994,air,1,1
160995,cooling,1,1
160996,(,1,0
160997,MVAC,1,0
160998,),1,0
160999,method,0,0
161000,without,0,0
161001,direct,0,0
161002,contact,0,0
161003,with,0,0
161004,liquid,0,1
161005,nitrogen,0,0
161006,(,0,0
161007,LN?,0,0
161008,),0,0
161009,.,0,0
161010,Expanded,0,0
161011,blastocysts,0,0
161012,were,0,0
161013,vitrified,0,1
161014,in,0,0
161015,a,0,0
161016,solution,0,1
161017,containing,1,1
161018,6,1,0
161019,M,1,0
161020,ethylene,1,1
161021,glycol,1,1
161022,",",1,0
161023,0.6,1,0
161024,M,1,0
161025,trehalose,1,1
161026,and,1,0
161027,2,1,0
161028,%,1,0
161029,(,1,0
161030,wt/vol,1,1
161031,),1,1
161032,polyethylene,1,1
161033,glycol,1,1
161034,in,1,0
161035,10,1,0
161036,%,1,0
161037,HEPES-buffered,1,0
161038,PZM-5,1,0
161039,.,1,0
161040,The,0,0
161041,blastocysts,0,0
161042,were,0,0
161043,collected,0,0
161044,from,0,0
161045,gilts,0,1
161046,and,0,0
161047,vitrified,0,1
161048,using,0,0
161049,the,1,0
161050,new,1,0
161051,device,1,1
161052,(,1,0
161053,MVAC,1,0
161054,),1,0
161055,or,1,0
161056,a,1,0
161057,Cryotop,1,0
161058,(,1,0
161059,CT,1,0
161060,),1,0
161061,.,1,0
161062,Blastocysts,0,0
161063,were,0,0
161064,stored,0,0
161065,in,0,0
161066,LN?,0,0
161067,for,0,0
161068,at,0,0
161069,least,0,0
161070,1,0,0
161071,month,0,0
161072,.,0,0
161073,After,0,0
161074,warming,0,0
161075,",",0,0
161076,cryoprotective,0,1
161077,agents,0,0
161078,were,0,0
161079,removed,0,0
161080,using,0,0
161081,a,0,0
161082,single,0,0
161083,step,0,0
161084,.,0,0
161085,Survival,0,0
161086,of,0,0
161087,the,0,0
161088,embryos,0,0
161089,was,0,0
161090,assessed,0,0
161091,by,0,0
161092,in,0,0
161093,vitro,0,0
161094,culture,0,0
161095,(,0,0
161096,Experiment,0,0
161097,1,0,0
161098,),0,0
161099,and,0,0
161100,by,0,0
161101,embryo,0,0
161102,transfer,0,0
161103,to,0,0
161104,recipients,0,0
161105,(,0,0
161106,Experiment,0,0
161107,2,0,0
161108,),0,0
161109,.,0,0
161110,In,0,0
161111,Experiment,0,0
161112,1,0,0
161113,",",0,0
161114,the,0,0
161115,embryos,0,0
161116,vitrified,0,1
161117,by,0,0
161118,the,0,0
161119,MVAC,1,0
161120,or,1,1
161121,CT,1,0
161122,and,0,0
161123,fresh,0,0
161124,embryos,0,0
161125,without,0,1
161126,vitrification,0,1
161127,(,0,0
161128,Control,0,1
161129,),0,0
161130,were,0,0
161131,used,0,0
161132,.,0,0
161133,The,0,0
161134,survival,0,0
161135,rates,0,0
161136,of,0,0
161137,embryos,0,0
161138,in,0,0
161139,the,0,0
161140,MVAC,1,0
161141,",",1,0
161142,CT,1,0
161143,and,0,0
161144,Control,0,1
161145,groups,0,0
161146,were,0,0
161147,88.9,0,0
161148,%,0,0
161149,(,0,0
161150,32/36,0,0
161151,),0,0
161152,",",0,0
161153,91.7,0,0
161154,%,0,0
161155,(,0,0
161156,33/36,0,1
161157,),0,0
161158,and,0,0
161159,100,0,1
161160,%,0,0
161161,(,0,0
161162,34/34,0,0
161163,),0,0
161164,",",0,0
161165,respectively,0,0
161166,",",0,0
161167,after,0,0
161168,48,0,0
161169,h,0,0
161170,culture,0,0
161171,",",0,0
161172,and,0,0
161173,the,0,0
161174,hatching,0,0
161175,rates,0,0
161176,of,0,0
161177,embryos,0,0
161178,after,0,0
161179,48,0,0
161180,h,0,0
161181,incubation,0,0
161182,were,0,0
161183,69.4,0,0
161184,%,0,0
161185,(,0,0
161186,25/36,0,0
161187,),0,0
161188,",",0,0
161189,63.9,0,0
161190,%,0,0
161191,(,0,0
161192,23/36,0,0
161193,),0,0
161194,and,0,0
161195,94.1,0,0
161196,%,0,0
161197,(,0,0
161198,32/34,0,0
161199,),0,0
161200,",",0,0
161201,respectively,0,0
161202,.,0,0
161203,In,0,0
161204,Experiment,0,0
161205,2,0,0
161206,",",0,0
161207,64,0,0
161208,vitrified,0,1
161209,embryos,0,0
161210,were,0,0
161211,transferred,0,0
161212,to,0,0
161213,5,0,0
161214,recipient,0,0
161215,gilts,0,1
161216,",",0,0
161217,and,0,0
161218,8,0,0
161219,healthy,0,0
161220,piglets,0,0
161221,were,0,0
161222,produced,0,0
161223,from,0,0
161224,3,0,0
161225,recipients,0,0
161226,in,0,0
161227,the,0,0
161228,MVAC,1,0
161229,group,1,0
161230,.,0,0
161231,Similarly,0,0
161232,",",0,0
161233,66,0,0
161234,vitrified,0,1
161235,embryos,0,0
161236,were,0,0
161237,transferred,0,0
161238,to,0,0
161239,5,0,0
161240,recipient,0,0
161241,gilts,0,1
161242,",",0,0
161243,and,0,0
161244,9,0,0
161245,healthy,0,0
161246,piglets,0,0
161247,were,0,0
161248,produced,0,0
161249,from,0,0
161250,2,0,0
161251,recipients,0,0
161252,in,0,0
161253,the,0,0
161254,CT,1,0
161255,group,0,0
161256,.,0,0
161257,These,0,0
161258,results,0,0
161259,indicated,0,0
161260,that,0,0
161261,porcine,0,1
161262,expanded,0,0
161263,blastocysts,0,0
161264,can,0,0
161265,be,0,0
161266,cryopreserved,0,0
161267,using,0,0
161268,the,0,0
161269,MVAC,1,0
161270,method,1,0
161271,without,0,0
161272,potential,0,0
161273,pathogen,0,0
161274,contamination,0,0
161275,from,0,0
161276,LN?,0,0
161277,.,0,0
161278,Efficacy,0,0
161279,and,0,0
161280,safety,0,0
161281,of,0,0
161282,diclofenac,1,1
161283,diethylamine,1,1
161284,1.16,0,0
161285,%,0,0
161286,gel,0,1
161287,in,0,0
161288,acute,0,0
161289,neck,0,0
161290,pain,0,0
161291,:,0,0
161292,a,0,0
161293,randomized,0,0
161294,",",0,0
161295,double-blind,0,0
161296,",",0,0
161297,placebo-controlled,0,1
161298,study,0,0
161299,.,0,0
161300,BACKGROUND,0,0
161301,Neck,0,0
161302,pain,0,0
161303,(,0,0
161304,NP,0,1
161305,),0,1
161306,is,0,0
161307,a,0,0
161308,common,0,0
161309,musculoskeletal,0,0
161310,disorder,0,0
161311,in,0,0
161312,primary,0,0
161313,care,0,0
161314,that,0,0
161315,frequently,0,0
161316,causes,0,0
161317,discomfort,0,0
161318,.,0,0
161319,Non-steroidal,0,0
161320,anti-inflammatory,0,0
161321,drugs,0,1
161322,(,0,0
161323,NSAIDs,0,0
161324,),0,0
161325,may,0,0
161326,be,0,0
161327,used,0,0
161328,to,0,0
161329,reduce,0,0
161330,neck,0,0
161331,pain,0,0
161332,and,0,0
161333,associated,0,0
161334,inflammation,0,0
161335,and,0,0
161336,facilitate,0,0
161337,earlier,0,0
161338,recovery,0,0
161339,.,0,0
161340,Topical,1,0
161341,diclofenac,1,1
161342,diethylamine,1,1
161343,(,1,0
161344,DDEA,1,1
161345,),1,0
161346,1.16,1,0
161347,%,1,0
161348,gel,1,1
161349,is,0,0
161350,clinically,0,0
161351,proven,0,0
161352,to,0,0
161353,be,0,0
161354,effective,0,0
161355,and,0,0
161356,well,0,0
161357,tolerated,0,0
161358,in,0,0
161359,acute,0,0
161360,and,0,0
161361,chronic,0,0
161362,musculoskeletal,0,0
161363,conditions,0,0
161364,",",0,0
161365,but,0,0
161366,until,0,0
161367,now,0,0
161368,no,0,0
161369,clinical,0,0
161370,data,0,0
161371,existed,0,0
161372,for,0,0
161373,its,0,0
161374,use,0,0
161375,in,0,0
161376,acute,0,0
161377,NP,0,0
161378,.,0,0
161379,The,0,0
161380,aim,0,0
161381,of,0,0
161382,this,0,0
161383,study,0,0
161384,was,0,0
161385,to,0,0
161386,assess,0,0
161387,the,0,0
161388,efficacy,0,0
161389,and,0,0
161390,safety,0,0
161391,of,0,0
161392,DDEA,0,1
161393,1.16,0,0
161394,%,0,0
161395,gel,0,1
161396,compared,0,0
161397,with,0,0
161398,placebo,1,1
161399,gel,1,1
161400,in,0,0
161401,acute,0,0
161402,NP,0,0
161403,.,0,0
161404,METHODS,0,0
161405,In,0,0
161406,a,0,0
161407,randomized,0,0
161408,",",0,0
161409,double-blind,0,0
161410,",",0,0
161411,placebo-controlled,0,1
161412,study,0,0
161413,",",0,0
161414,patients,0,0
161415,with,0,0
161416,acute,0,0
161417,NP,0,1
161418,(,0,0
161419,n,0,0
161420,=,0,0
161421,72,0,0
161422,),0,0
161423,were,0,0
161424,treated,0,0
161425,with,0,0
161426,DDEA,0,1
161427,1.16,0,0
161428,%,0,0
161429,gel,0,1
161430,(,0,0
161431,2,0,0
161432,g,0,1
161433,",",0,0
161434,4x/day,0,1
161435,",",0,0
161436,for,0,0
161437,5,0,0
161438,days,0,0
161439,),0,0
161440,or,0,0
161441,placebo,0,1
161442,.,0,0
161443,Efficacy,0,0
161444,assessments,0,0
161445,included,0,0
161446,pain-on-movement,0,0
161447,(,0,0
161448,POM,0,1
161449,),0,0
161450,",",0,0
161451,pain-at-rest,0,0
161452,(,0,0
161453,PAR,0,1
161454,),0,0
161455,",",0,0
161456,functional,0,0
161457,neck,0,0
161458,disability,0,0
161459,index,0,0
161460,(,0,0
161461,NDI,0,0
161462,),0,1
161463,and,0,0
161464,response,0,0
161465,to,0,0
161466,treatment,0,0
161467,(,0,0
161468,decrease,0,0
161469,in,0,0
161470,POM,0,0
161471,by,0,0
161472,50,0,0
161473,%,0,0
161474,after,0,0
161475,48,0,0
161476,h,0,0
161477,),0,0
161478,.,0,0
161479,Adverse,0,0
161480,events,0,0
161481,(,0,0
161482,AEs,0,0
161483,),0,0
161484,were,0,0
161485,recorded,0,0
161486,throughout,0,0
161487,the,0,0
161488,study,0,0
161489,.,0,0
161490,RESULTS,0,0
161491,The,0,0
161492,primary,0,0
161493,outcome,0,0
161494,",",0,0
161495,POM,0,0
161496,at,0,0
161497,48,0,0
161498,h,0,0
161499,",",0,0
161500,was,0,0
161501,statistically,0,0
161502,significantly,0,0
161503,lower,0,0
161504,with,0,0
161505,DDEA,0,1
161506,gel,0,1
161507,(,0,0
161508,19.5,0,0
161509,mm,0,0
161510,),0,0
161511,vs.,0,0
161512,placebo,0,1
161513,(,0,0
161514,56.9,0,0
161515,mm,0,0
161516,),0,0
161517,(,0,0
161518,p,0,0
161519,<,0,0
161520,0.0001,0,0
161521,),0,0
161522,",",0,0
161523,representing,0,0
161524,a,0,0
161525,clinically,0,0
161526,relevant,0,0
161527,decrease,0,0
161528,from,0,0
161529,baseline,0,0
161530,(,0,0
161531,75,0,0
161532,%,0,0
161533,vs.,0,0
161534,23,0,0
161535,%,0,0
161536,",",0,0
161537,respectively,0,0
161538,),0,0
161539,.,0,0
161540,All,0,0
161541,POM,0,0
161542,scores,0,0
161543,were,0,0
161544,significantly,0,0
161545,lower,1,0
161546,with,1,0
161547,DDEA,1,1
161548,gel,1,1
161549,vs.,0,0
161550,placebo,0,1
161551,from,0,0
161552,1,0,0
161553,h,0,0
161554,",",0,0
161555,as,0,0
161556,were,0,0
161557,PAR,0,0
161558,and,0,0
161559,NDI,0,0
161560,scores,0,0
161561,from,0,0
161562,first,0,0
161563,assessment,0,0
161564,(,0,0
161565,24,0,0
161566,h,0,0
161567,),0,0
161568,onwards,0,0
161569,(,0,0
161570,all,0,0
161571,p,0,0
161572,<,0,0
161573,0.0001,0,0
161574,),0,0
161575,.,0,0
161576,Response,0,0
161577,to,0,0
161578,treatment,0,0
161579,was,0,0
161580,significantly,0,0
161581,higher,0,0
161582,with,1,0
161583,DDEA,1,1
161584,gel,1,1
161585,(,0,0
161586,94.4,0,0
161587,%,0,0
161588,),0,0
161589,vs.,0,0
161590,placebo,0,1
161591,(,0,0
161592,8.3,0,0
161593,%,0,0
161594,),0,0
161595,(,0,0
161596,p,0,0
161597,<,0,0
161598,0.0001,0,0
161599,),0,0
161600,.,0,0
161601,There,0,0
161602,were,0,0
161603,no,0,0
161604,AEs,0,0
161605,with,0,0
161606,DDEA,0,1
161607,gel,0,1
161608,.,0,0
161609,CONCLUSIONS,0,0
161610,DDEA,0,1
161611,1.16,0,0
161612,%,0,0
161613,gel,0,1
161614,",",0,0
161615,which,0,0
161616,is,0,0
161617,available,0,0
161618,over-the-counter,0,0
161619,",",0,0
161620,was,0,0
161621,effective,0,0
161622,and,0,0
161623,well,0,0
161624,tolerated,0,0
161625,in,0,0
161626,the,0,0
161627,treatment,0,0
161628,of,0,0
161629,acute,0,0
161630,neck,0,0
161631,pain,0,0
161632,.,0,0
161633,The,0,0
161634,tools,0,0
161635,used,0,0
161636,to,0,0
161637,assess,0,0
161638,efficacy,0,0
161639,suggest,0,0
161640,that,0,0
161641,it,0,0
161642,quickly,0,0
161643,reduced,0,0
161644,neck,0,0
161645,pain,0,0
161646,and,0,0
161647,improved,0,0
161648,neck,0,0
161649,function,0,0
161650,.,0,0
161651,However,0,0
161652,",",0,0
161653,questions,0,0
161654,remain,0,0
161655,regarding,0,0
161656,the,0,0
161657,comparability,0,0
161658,and,0,0
161659,validity,0,0
161660,of,0,0
161661,such,0,0
161662,tools,0,0
161663,.,0,0
161664,Further,0,0
161665,studies,0,0
161666,will,0,0
161667,help,0,0
161668,ascertain,0,0
161669,whether,0,0
161670,DDEA,0,1
161671,1.16,0,0
161672,%,0,0
161673,gel,0,1
161674,offers,0,0
161675,an,0,0
161676,alternative,0,0
161677,treatment,0,0
161678,option,0,0
161679,in,0,0
161680,this,0,0
161681,common,0,0
161682,",",0,0
161683,often,0,0
161684,debilitating,0,0
161685,condition,0,0
161686,.,0,0
161687,TRIAL,0,0
161688,REGISTRATION,0,0
161689,ClinicalTrials.gov,0,0
161690,identifier,0,0
161691,:,0,0
161692,NCT01335724,0,0
161693,.,0,0
161694,Assessment,0,0
161695,of,0,0
161696,global,0,0
161697,functioning,0,0
161698,in,0,0
161699,adolescents,0,0
161700,with,0,0
161701,autism,0,0
161702,spectrum,0,0
161703,disorders,0,0
161704,:,0,0
161705,utility,0,0
161706,of,0,0
161707,the,0,0
161708,Developmental,1,0
161709,Disability-Child,1,0
161710,Global,1,0
161711,Assessment,1,0
161712,Scale,1,0
161713,.,1,0
161714,Assessment,0,0
161715,of,0,0
161716,global,0,0
161717,functioning,0,0
161718,is,0,0
161719,an,0,0
161720,important,0,0
161721,consideration,0,0
161722,in,0,0
161723,treatment,0,0
161724,outcome,0,0
161725,research,0,0
161726,;,0,0
161727,yet,0,0
161728,",",0,0
161729,there,0,0
161730,is,0,0
161731,little,0,0
161732,guidance,0,0
161733,on,0,0
161734,its,0,0
161735,evidence-based,0,1
161736,assessment,0,0
161737,for,0,0
161738,children,0,0
161739,with,0,0
161740,autism,0,0
161741,spectrum,0,0
161742,disorders,0,0
161743,.,0,0
161744,This,0,0
161745,study,0,0
161746,investigated,0,0
161747,the,0,0
161748,utility,0,0
161749,and,0,0
161750,validity,0,0
161751,of,0,0
161752,clinician-rated,0,0
161753,global,0,0
161754,functioning,0,0
161755,using,0,0
161756,the,0,0
161757,Developmental,1,0
161758,Disability-Child,1,0
161759,Global,1,0
161760,Assessment,1,0
161761,Scale,1,0
161762,in,0,0
161763,a,0,0
161764,sample,0,0
161765,of,0,0
161766,higher,0,0
161767,functioning,0,0
161768,adolescents,0,0
161769,with,0,0
161770,autism,0,0
161771,spectrum,0,0
161772,disorders,0,0
161773,and,0,0
161774,comorbid,0,0
161775,anxiety,0,0
161776,disorders,0,0
161777,enrolled,0,0
161778,in,0,0
161779,a,0,0
161780,randomized,0,0
161781,controlled,1,0
161782,trial,0,0
161783,(,0,0
161784,n,0,0
161785,=,0,0
161786,30,0,0
161787,),0,0
161788,.,0,0
161789,Pretreatment,0,0
161790,Developmental,1,0
161791,Disability-Child,1,0
161792,Global,1,0
161793,Assessment,1,0
161794,Scale,1,0
161795,scores,0,0
161796,correlated,0,0
161797,with,0,0
161798,severity,0,0
161799,of,0,0
161800,autism,0,0
161801,spectrum,0,0
161802,disorders,0,0
161803,core,0,0
161804,symptoms,0,0
161805,(,0,0
161806,r,0,0
161807,=,0,0
161808,-.388,0,0
161809,",",0,0
161810,p,0,0
161811,=,0,0
161812,.034,0,0
161813,),0,0
161814,",",0,0
161815,pragmatic,0,0
161816,communication,0,1
161817,(,0,0
161818,r,0,0
161819,=,0,0
161820,.407,0,0
161821,",",0,0
161822,p,0,0
161823,=,0,0
161824,.032,0,0
161825,),0,0
161826,",",0,0
161827,and,0,0
161828,verbal,0,1
161829,ability,0,0
161830,(,0,0
161831,r,0,0
161832,=,0,0
161833,.449,0,0
161834,",",0,0
161835,p,0,0
161836,=,0,0
161837,.013,0,0
161838,),0,0
161839,and,0,0
161840,did,0,0
161841,not,0,0
161842,correlate,0,0
161843,with,0,0
161844,severity,0,0
161845,of,0,0
161846,anxiety,0,0
161847,symptoms,0,0
161848,or,0,0
161849,with,0,0
161850,parent-reported,0,0
161851,adaptive,0,0
161852,behavior,0,0
161853,.,0,0
161854,Change,0,0
161855,in,0,0
161856,Developmental,1,0
161857,Disability-Child,1,0
161858,Global,1,0
161859,Assessment,1,0
161860,Scale,1,0
161861,scores,0,0
161862,during,0,0
161863,treatment,0,0
161864,was,0,0
161865,associated,0,0
161866,with,0,0
161867,autism,0,0
161868,spectrum,0,0
161869,disorders,0,0
161870,symptomatic,0,0
161871,improvement,0,0
161872,(,0,0
161873,r,0,0
161874,=,0,0
161875,.414,0,0
161876,",",0,0
161877,p,0,0
161878,=,0,0
161879,.040,0,0
161880,),0,0
161881,and,0,0
161882,with,0,0
161883,improved,0,0
161884,general,0,0
161885,communication,0,1
161886,(,0,0
161887,r,0,0
161888,=,0,0
161889,.499,0,0
161890,",",0,0
161891,p,0,0
161892,=,0,0
161893,.013,0,0
161894,),0,0
161895,.,0,0
161896,Results,0,0
161897,support,0,0
161898,the,0,0
161899,importance,0,0
161900,of,0,0
161901,assessing,0,0
161902,global,0,0
161903,functioning,0,0
161904,in,0,0
161905,addition,0,0
161906,to,0,0
161907,symptom,0,0
161908,change,0,0
161909,and,0,0
161910,treatment,0,0
161911,response,0,0
161912,in,0,0
161913,clinical,0,0
161914,trials,0,0
161915,.,0,0
161916,Intravesical,1,1
161917,seeding,1,0
161918,of,1,0
161919,upper,1,0
161920,urinary,1,0
161921,tract,1,0
161922,urothelial,1,0
161923,carcinoma,1,0
161924,cells,1,0
161925,during,0,0
161926,nephroureterectomy,1,1
161927,:,1,0
161928,an,0,0
161929,exploratory,0,0
161930,analysis,0,0
161931,from,0,0
161932,the,0,0
161933,THPMG,0,0
161934,trial,0,0
161935,.,0,0
161936,OBJECTIVE,0,0
161937,The,0,0
161938,Pirarubicin,0,1
161939,Monotherapy,0,1
161940,Study,0,0
161941,Group,0,0
161942,trial,0,0
161943,was,0,0
161944,a,0,0
161945,randomized,0,0
161946,Phase,0,0
161947,II,0,0
161948,study,0,0
161949,that,0,0
161950,evaluated,0,0
161951,the,0,0
161952,efficacy,0,0
161953,of,0,0
161954,intravesical,0,1
161955,instillation,0,0
161956,of,0,0
161957,pirarubicin,1,1
161958,in,0,0
161959,the,0,0
161960,prevention,0,0
161961,of,0,0
161962,bladder,0,0
161963,recurrence,0,0
161964,after,0,0
161965,nephroureterectomy,0,1
161966,for,0,0
161967,upper,0,0
161968,urinary,0,0
161969,tract,0,0
161970,urothelial,0,0
161971,carcinoma,0,0
161972,.,0,0
161973,This,0,0
161974,study,0,0
161975,conducted,0,0
161976,further,0,0
161977,analysis,0,0
161978,of,0,0
161979,the,0,0
161980,Pirarubicin,0,1
161981,Monotherapy,0,1
161982,Study,0,0
161983,Group,0,0
161984,cohort,0,0
161985,",",0,0
161986,focusing,0,0
161987,on,0,0
161988,intravesical,1,1
161989,seeding,1,0
161990,of,1,0
161991,cancer,1,0
161992,cells,1,0
161993,.,1,0
161994,METHODS,0,0
161995,Using,0,0
161996,the,0,0
161997,data,0,0
161998,from,0,0
161999,the,0,0
162000,Pirarubicin,0,1
162001,Monotherapy,0,1
162002,Study,0,0
162003,Group,0,0
162004,trial,0,0
162005,",",0,0
162006,bladder,0,0
162007,recurrence-free,0,0
162008,survival,0,0
162009,rates,0,0
162010,and,0,0
162011,factors,0,0
162012,associated,0,0
162013,with,0,0
162014,bladder,0,0
162015,recurrence,0,0
162016,in,0,0
162017,the,0,0
162018,control,0,0
162019,group,0,0
162020,were,0,0
162021,analyzed,0,0
162022,.,0,0
162023,RESULTS,0,0
162024,Of,0,0
162025,36,0,0
162026,patients,0,0
162027,in,0,0
162028,the,0,0
162029,control,1,0
162030,group,0,0
162031,",",0,0
162032,14,0,0
162033,with,0,0
162034,positive,0,0
162035,urine,0,0
162036,cytology,0,0
162037,had,0,0
162038,more,0,0
162039,frequent,0,0
162040,recurrence,0,0
162041,when,0,0
162042,compared,0,0
162043,with,0,0
162044,the,0,0
162045,22,0,0
162046,patients,0,0
162047,with,0,0
162048,negative,0,0
162049,cytology,0,0
162050,(,0,0
162051,P,0,0
162052,=,0,0
162053,0.004,0,0
162054,),0,0
162055,.,0,0
162056,Based,0,0
162057,on,0,0
162058,the,0,0
162059,multivariate,0,0
162060,analysis,0,0
162061,in,0,0
162062,the,0,0
162063,control,0,0
162064,group,0,0
162065,",",0,0
162066,voided,0,0
162067,urine,0,0
162068,cytology,0,0
162069,was,0,0
162070,an,0,0
162071,independent,0,0
162072,predictive,0,0
162073,factor,0,0
162074,of,0,0
162075,bladder,0,1
162076,recurrence,0,0
162077,(,0,0
162078,hazard,0,0
162079,ratio,0,0
162080,",",0,0
162081,5.54,0,0
162082,;,0,0
162083,95,0,0
162084,%,0,0
162085,confidence,0,0
162086,interval,0,0
162087,1.12-27.5,0,0
162088,;,0,0
162089,P,0,0
162090,=,0,0
162091,0.036,0,0
162092,),0,0
162093,.,0,0
162094,Of,0,0
162095,72,0,0
162096,patients,0,0
162097,in,0,0
162098,the,0,0
162099,Pirarubicin,0,1
162100,Monotherapy,0,1
162101,Study,0,0
162102,Group,0,0
162103,trial,0,0
162104,",",0,0
162105,31,0,0
162106,had,0,0
162107,positive,0,0
162108,urine,0,0
162109,cytology,0,0
162110,.,0,0
162111,Among,0,0
162112,the,0,0
162113,31,0,0
162114,patients,0,0
162115,",",0,0
162116,17,0,0
162117,patients,0,0
162118,who,0,0
162119,received,0,0
162120,pirarubicin,1,1
162121,instillation,1,0
162122,had,0,0
162123,fewer,0,0
162124,recurrences,0,0
162125,when,0,0
162126,compared,0,0
162127,with,0,0
162128,14,0,0
162129,patients,0,0
162130,who,0,0
162131,received,0,0
162132,control,1,1
162133,treatment,0,0
162134,(,0,0
162135,P,0,0
162136,=,0,0
162137,0.0001,0,0
162138,),0,0
162139,.,0,0
162140,On,0,0
162141,multivariate,0,0
162142,analysis,0,0
162143,",",0,0
162144,pirarubicin,1,1
162145,instillation,1,0
162146,was,0,0
162147,an,0,0
162148,independent,0,0
162149,predictor,0,0
162150,of,0,0
162151,better,0,0
162152,recurrence-free,0,0
162153,survival,0,0
162154,rates,0,0
162155,in,0,0
162156,the,0,0
162157,patients,0,0
162158,with,0,0
162159,positive,0,0
162160,urine,0,0
162161,cytology,0,0
162162,(,0,0
162163,hazard,0,0
162164,ratio,0,0
162165,",",0,0
162166,0.02,0,0
162167,;,0,0
162168,95,0,0
162169,%,0,0
162170,confidence,0,0
162171,interval,0,0
162172,",",0,0
162173,0.00-0.53,0,0
162174,;,0,0
162175,P,0,0
162176,=,0,0
162177,0.018,0,0
162178,),0,0
162179,.,0,0
162180,Of,0,0
162181,21,0,0
162182,patients,0,0
162183,with,0,0
162184,bladder,0,0
162185,recurrence,0,0
162186,",",0,0
162187,17,0,0
162188,had,0,0
162189,recurrent,0,0
162190,tumor,0,0
162191,around,0,0
162192,cystotomy,0,1
162193,or,0,0
162194,in,0,0
162195,the,0,0
162196,bladder,0,0
162197,neck,0,0
162198,compromised,0,0
162199,by,0,0
162200,the,0,0
162201,urethral,0,1
162202,catheter,0,1
162203,",",0,0
162204,supporting,0,0
162205,the,0,0
162206,notion,0,0
162207,that,0,0
162208,tumor,0,0
162209,cells,0,0
162210,seeded,0,0
162211,in,0,0
162212,the,0,0
162213,injured,0,0
162214,urothelium,0,0
162215,.,0,0
162216,CONCLUSIONS,0,0
162217,Intravesical,1,1
162218,instillation,1,0
162219,of,1,0
162220,pirarubicin,1,1
162221,immediately,0,0
162222,after,0,0
162223,nephroureterectomy,1,1
162224,significantly,0,0
162225,reduced,0,0
162226,the,0,0
162227,bladder,0,0
162228,recurrence,0,0
162229,rate,0,0
162230,in,0,0
162231,patients,0,0
162232,with,0,0
162233,positive,0,0
162234,voided,0,0
162235,urine,0,0
162236,cytology,0,0
162237,.,0,0
162238,The,0,0
162239,results,0,0
162240,suggest,0,0
162241,that,0,0
162242,intravesical,0,1
162243,seeding,0,0
162244,of,0,0
162245,upper,0,0
162246,urinary,0,0
162247,tract,0,0
162248,urothelial,0,0
162249,carcinoma,0,0
162250,occurs,0,0
162251,during,0,0
162252,nephroureterectomy,0,0
162253,.,0,0
162254,A,0,0
162255,randomized,0,0
162256,",",0,0
162257,double-blind,0,0
162258,comparison,0,0
162259,of,0,0
162260,atomoxetine,1,1
162261,and,1,0
162262,placebo,1,1
162263,on,0,0
162264,response,0,0
162265,inhibition,0,0
162266,and,0,0
162267,interference,0,0
162268,control,0,0
162269,in,0,0
162270,children,0,0
162271,and,0,0
162272,adolescents,0,0
162273,with,0,0
162274,autism,0,0
162275,spectrum,0,0
162276,disorder,0,0
162277,and,0,0
162278,comorbid,0,0
162279,attention-deficit/hyperactivity,0,0
162280,disorder,0,0
162281,symptoms,0,0
162282,.,0,0
162283,Novel,0,0
162284,population,0,0
162285,pharmacokinetic,0,0
162286,method,0,0
162287,compared,0,0
162288,to,0,0
162289,the,0,0
162290,standard,0,1
162291,noncompartmental,0,0
162292,approach,0,1
162293,to,0,0
162294,assess,0,0
162295,bioequivalence,0,1
162296,of,0,0
162297,iron,0,1
162298,gluconate,0,0
162299,formulations,0,0
162300,.,0,0
162301,PURPOSE,0,0
162302,Iron-containing,0,0
162303,products,0,0
162304,are,0,0
162305,atypical,0,0
162306,in,0,0
162307,terms,0,0
162308,of,0,0
162309,their,0,0
162310,pharmacokinetic,0,0
162311,properties,0,0
162312,because,0,0
162313,iron,0,1
162314,is,0,0
162315,only,0,0
162316,removed,0,0
162317,by,0,0
162318,plasma,0,0
162319,sampling,0,0
162320,and,0,0
162321,is,0,0
162322,non-linear,0,0
162323,.,0,0
162324,This,0,0
162325,study,0,0
162326,aims,0,0
162327,to,0,0
162328,present,0,0
162329,a,0,0
162330,novel,0,0
162331,way,0,0
162332,of,0,0
162333,assessing,0,0
162334,the,0,0
162335,relative,0,0
162336,bioavailability,0,0
162337,of,0,0
162338,two,0,0
162339,sodium,1,1
162340,ferric,1,1
162341,gluconate,1,1
162342,complex,1,0
162343,(,1,0
162344,SFGC,1,0
162345,),1,0
162346,formulations,0,0
162347,and,0,0
162348,compare,0,0
162349,this,0,0
162350,approach,0,1
162351,to,0,0
162352,a,0,0
162353,standard,0,1
162354,previously,0,0
162355,published,0,0
162356,noncompartmental,0,0
162357,approach,0,1
162358,.,0,0
162359,METHODS,0,0
162360,Data,0,0
162361,were,0,0
162362,from,0,0
162363,open-label,0,0
162364,",",0,0
162365,randomized,0,0
162366,",",0,0
162367,single-dose,0,1
162368,studies,0,0
162369,(,0,0
162370,Study,0,0
162371,1,0,0
162372,was,0,0
162373,parallel,0,0
162374,whereas,0,0
162375,Study,0,0
162376,2,0,0
162377,was,0,0
162378,crossover,0,0
162379,),0,0
162380,.,0,0
162381,Subjects,0,0
162382,with,0,0
162383,low,0,0
162384,but,0,0
162385,normal,0,0
162386,iron,0,1
162387,levels,0,0
162388,were,0,0
162389,infused,0,0
162390,IV,1,0
162391,SFGC,1,0
162392,in,1,0
162393,sucrose,1,1
162394,by,0,0
162395,GeneraMedix,0,1
162396,Inc.,0,0
162397,and/or,0,0
162398,Ferrlecit,1,1
162399,?,1,0
162400,Injection,1,0
162401,(,0,0
162402,Watson,0,0
162403,Laboratories,0,1
162404,Inc.,0,0
162405,),0,0
162406,.,0,0
162407,In,0,0
162408,Study,0,0
162409,1,0,0
162410,(,0,0
162411,n=240,0,0
162412,),0,0
162413,",",0,0
162414,125,0,0
162415,mg,0,0
162416,was,0,0
162417,infused,0,0
162418,over,0,0
162419,10,0,0
162420,minutes,0,0
162421,.,0,0
162422,In,0,0
162423,Study,0,0
162424,2,0,0
162425,(,0,0
162426,n=29,0,0
162427,),0,0
162428,",",0,0
162429,62.5,0,0
162430,mg,0,0
162431,was,0,0
162432,infused,0,0
162433,over,0,0
162434,30,0,0
162435,minutes,0,0
162436,.,0,0
162437,Samples,0,0
162438,were,0,0
162439,assayed,0,0
162440,for,0,0
162441,total,0,0
162442,iron,0,1
162443,(,0,0
162444,TI,0,0
162445,),0,1
162446,and,0,0
162447,transferrin-bound,0,1
162448,iron,0,1
162449,(,0,0
162450,TBI,0,0
162451,),0,0
162452,over,0,0
162453,36,0,0
162454,hours,0,0
162455,(,0,0
162456,Study,0,0
162457,1,0,0
162458,),0,0
162459,or,0,0
162460,72,0,0
162461,hours,0,0
162462,(,0,0
162463,Study,0,0
162464,2,0,0
162465,),0,0
162466,post-dose,0,0
162467,.,0,0
162468,Studies,0,0
162469,1,0,0
162470,and,0,0
162471,2,0,0
162472,used,0,0
162473,standard,0,1
162474,noncompartmental,0,0
162475,analysis,0,0
162476,.,0,0
162477,Study,0,0
162478,2,0,0
162479,also,0,0
162480,used,0,0
162481,population,0,0
162482,PK,0,1
162483,(,0,0
162484,PPK,0,1
162485,),0,1
162486,analyses,0,0
162487,with,0,0
162488,ADAPT,0,0
162489,5?,0,0
162490,.,0,0
162491,The,0,0
162492,final,0,0
162493,model,0,0
162494,predicted,0,0
162495,SFGC,0,1
162496,area-under-the-curve,0,0
162497,(,0,0
162498,AUCpred,0,0
162499,),0,1
162500,and,0,0
162501,maximal,0,0
162502,concentration,0,0
162503,(,0,0
162504,Cmaxpred,0,0
162505,),0,0
162506,.,0,0
162507,Analyses,0,0
162508,of,0,0
162509,variance,0,0
162510,was,0,0
162511,conducted,0,0
162512,on,0,0
162513,ln-transformed,0,0
162514,PK,0,1
162515,parameters,0,0
162516,.,0,0
162517,Ratios,0,0
162518,of,0,0
162519,means,0,0
162520,and,0,0
162521,90,0,0
162522,%,0,0
162523,confidence,0,0
162524,intervals,0,0
162525,(,0,0
162526,CIs,0,0
162527,),0,0
162528,were,0,0
162529,estimated,0,0
162530,.,0,0
162531,Bioequivalence,0,0
162532,was,0,0
162533,demonstrated,0,0
162534,if,0,0
162535,values,0,0
162536,were,0,0
162537,within,0,0
162538,80-125,0,0
162539,%,0,0
162540,.,0,0
162541,RESULTS,0,0
162542,For,0,0
162543,Study,0,0
162544,1,0,0
162545,",",0,0
162546,ratios,0,0
162547,and,0,0
162548,90,0,0
162549,%,0,0
162550,CIs,0,0
162551,for,0,0
162552,TI,0,0
162553,baseline-corrected,0,0
162554,Cmax,0,0
162555,and,0,0
162556,AUC0-36,0,0
162557,were,0,0
162558,100.4,0,0
162559,(,0,0
162560,96.5,0,0
162561,-,0,0
162562,104.5,0,0
162563,),0,0
162564,and,0,0
162565,99.7,0,0
162566,(,0,0
162567,94.2,0,0
162568,-,0,0
162569,105.5,0,0
162570,),0,0
162571,.,0,0
162572,For,0,0
162573,TBI,0,0
162574,",",0,0
162575,results,0,0
162576,for,0,0
162577,TI,0,0
162578,baseline-corrected,0,0
162579,Cmax,0,0
162580,and,0,0
162581,AUC0-36,0,0
162582,were,0,0
162583,86.8,0,0
162584,(,0,0
162585,82.7,0,0
162586,-,0,0
162587,91.1,0,0
162588,),0,0
162589,and,0,0
162590,92.4,0,0
162591,(,0,0
162592,85.6,0,0
162593,-,0,0
162594,99.7,0,0
162595,),0,0
162596,.,0,0
162597,For,0,0
162598,Study,0,0
162599,2,0,0
162600,",",0,0
162601,a,0,0
162602,multi-compartmental,0,0
162603,model,0,0
162604,simultaneously,0,0
162605,described,0,0
162606,the,0,0
162607,PK,0,1
162608,of,0,0
162609,TI,0,0
162610,",",0,0
162611,TBI,0,0
162612,and,0,0
162613,SFGC,0,0
162614,.,0,0
162615,Ratios,0,0
162616,and,0,0
162617,90,0,0
162618,%,0,0
162619,CIs,0,0
162620,for,0,0
162621,SFGC,0,0
162622,Cmaxpred,0,0
162623,and,0,0
162624,AUCpred,0,0
162625,were,0,0
162626,89.9,0,0
162627,(,0,0
162628,85.9,0,0
162629,-,0,0
162630,94.0,0,0
162631,),0,0
162632,and,0,0
162633,89.7,0,0
162634,(,0,0
162635,85.7,0,0
162636,-,0,0
162637,93.9,0,0
162638,),0,0
162639,",",0,0
162640,while,0,0
162641,ratios,0,0
162642,and,0,0
162643,90,0,0
162644,%,0,0
162645,CI,0,0
162646,obtained,0,0
162647,from,0,0
162648,the,0,0
162649,noncompartmental,0,0
162650,analysis,0,0
162651,of,0,0
162652,Study,0,0
162653,2,0,0
162654,did,0,0
162655,not,0,0
162656,meet,0,0
162657,BE,0,1
162658,criteria,0,0
162659,because,0,0
162660,of,0,0
162661,low,0,0
162662,power,0,0
162663,.,0,0
162664,CONCLUSIONS,0,0
162665,Both,0,1
162666,the,0,0
162667,standard,0,1
162668,and,0,0
162669,PPK,0,1
162670,modeling,0,0
162671,approach,0,1
162672,suggested,0,0
162673,bioequivalence,0,0
162674,between,0,0
162675,the,0,0
162676,iron,0,1
162677,products,0,0
162678,.,0,0
162679,However,0,0
162680,",",0,0
162681,with,0,0
162682,the,0,0
162683,PPK,0,0
162684,method,0,0
162685,",",0,0
162686,less,0,0
162687,subjects,0,0
162688,were,0,0
162689,required,0,0
162690,to,0,0
162691,meet,0,0
162692,study,0,0
162693,objectives,0,0
162694,compared,0,0
162695,to,0,0
162696,the,0,0
162697,standard,0,1
162698,noncompartmental,0,0
162699,approach,0,1
162700,which,0,0
162701,required,0,0
162702,considerably,0,0
162703,more,0,0
162704,subjects,0,0
162705,(,0,0
162706,29,0,0
162707,vs,0,0
162708,240,0,0
162709,),0,0
162710,.,0,0
162711,Effectiveness,0,0
162712,of,0,0
162713,a,0,0
162714,theory-based,1,1
162715,intervention,1,1
162716,to,0,0
162717,increase,0,0
162718,colorectal,0,0
162719,cancer,0,0
162720,screening,0,0
162721,among,0,0
162722,Iranian,0,0
162723,health,0,0
162724,club,0,0
162725,members,0,0
162726,:,0,0
162727,a,0,0
162728,randomized,0,0
162729,trial,0,0
162730,.,0,0
162731,Colorectal,0,0
162732,cancer,0,0
162733,is,0,0
162734,the,0,0
162735,third,0,0
162736,most,0,0
162737,commonly,0,0
162738,diagnosed,0,0
162739,cancer,0,0
162740,and,0,0
162741,the,0,0
162742,fourth,0,0
162743,leading,0,0
162744,cause,0,0
162745,of,0,0
162746,death,0,0
162747,in,0,0
162748,the,0,0
162749,world,0,0
162750,.,0,0
162751,There,0,0
162752,are,0,0
162753,few,0,0
162754,published,0,0
162755,studies,0,0
162756,that,0,0
162757,have,0,0
162758,used,0,0
162759,theory-based,1,1
162760,interventions,1,0
162761,designed,0,0
162762,to,0,0
162763,increase,0,0
162764,colorectal,0,0
162765,cancer,0,0
162766,screening,0,0
162767,in,0,0
162768,community,0,0
162769,lay,0,0
162770,health,0,0
162771,organizations,0,0
162772,.,0,0
162773,The,0,0
162774,present,0,0
162775,study,0,0
162776,was,0,0
162777,guided,0,1
162778,by,0,0
162779,the,0,0
162780,theoretical,0,0
162781,concepts,0,0
162782,of,0,0
162783,the,0,0
162784,preventive,0,0
162785,health,0,0
162786,model,0,0
162787,.,0,0
162788,Twelve,0,0
162789,health,0,0
162790,clubs,0,0
162791,of,0,0
162792,a,0,0
162793,municipal,0,0
162794,district,0,0
162795,in,0,0
162796,Tehran,0,0
162797,were,0,0
162798,randomized,0,0
162799,to,0,0
162800,two,0,0
162801,study,0,0
162802,groups,0,0
162803,with,0,0
162804,equal,0,0
162805,ratio,0,0
162806,.,0,0
162807,The,0,0
162808,control,0,0
162809,group,0,0
162810,received,1,0
162811,usual,1,1
162812,services,1,0
162813,throughout,1,0
162814,the,1,0
162815,study,1,0
162816,while,0,0
162817,the,0,0
162818,intervention,0,1
162819,group,0,0
162820,also,0,0
162821,received,1,0
162822,a,1,0
162823,theory-based,1,1
162824,educational,1,1
162825,program,1,1
162826,on,1,0
162827,colorectal,1,0
162828,cancer,1,0
162829,screening,1,0
162830,plus,1,1
162831,a,1,0
162832,reminder,1,1
162833,call,1,0
162834,.,1,0
162835,Screening,0,0
162836,behavior,0,0
162837,",",0,0
162838,the,0,0
162839,main,0,0
162840,outcome,0,0
162841,",",0,0
162842,was,0,0
162843,assessed,0,0
162844,4,0,0
162845,months,0,0
162846,after,0,0
162847,randomization,0,0
162848,.,0,0
162849,A,0,0
162850,total,0,0
162851,of,0,0
162852,360,0,0
162853,members,0,0
162854,aged,0,0
162855,50,0,0
162856,and,0,0
162857,older,0,0
162858,from,0,0
162859,12,0,0
162860,health,0,0
162861,clubs,0,0
162862,completed,0,0
162863,a,0,0
162864,baseline,0,0
162865,survey,0,0
162866,.,0,0
162867,Participants,0,0
162868,in,0,0
162869,the,0,0
162870,intervention,0,1
162871,group,0,0
162872,reported,0,0
162873,increased,0,0
162874,knowledge,0,0
162875,of,0,0
162876,colorectal,0,0
162877,cancer,0,0
162878,and,0,0
162879,screening,0,0
162880,tests,0,0
162881,at,0,0
162882,4,0,0
162883,months,0,0
162884,follow-up,0,0
162885,(,0,0
162886,p,0,0
162887,'s,0,0
162888,<,0,0
162889,.001,0,0
162890,),0,0
162891,.,0,0
162892,Moreover,0,0
162893,",",0,0
162894,exposure,0,0
162895,to,0,0
162896,the,0,0
162897,theory-based,1,1
162898,intervention,1,1
162899,significantly,0,0
162900,improved,0,0
162901,self-efficacy,0,0
162902,",",0,0
162903,perceived,0,0
162904,susceptibility,0,0
162905,",",0,0
162906,efficacy,0,0
162907,of,0,0
162908,screening,0,0
162909,",",0,0
162910,social,0,0
162911,support,0,0
162912,",",0,0
162913,and,0,0
162914,intention,0,0
162915,to,0,0
162916,be,0,0
162917,screened,0,0
162918,for,0,0
162919,colorectal,0,0
162920,cancer,0,0
162921,",",0,0
162922,from,0,0
162923,baseline,0,0
162924,to,0,0
162925,4,0,0
162926,months,0,0
162927,follow-up,0,0
162928,(,0,0
162929,p,0,0
162930,'s,0,0
162931,<,0,0
162932,.001,0,0
162933,),0,0
162934,.,0,0
162935,The,0,0
162936,screening,0,0
162937,rate,0,0
162938,for,0,0
162939,colorectal,0,0
162940,cancer,0,0
162941,was,0,0
162942,significantly,0,0
162943,higher,0,0
162944,in,0,0
162945,the,0,0
162946,intervention,0,1
162947,group,0,0
162948,compared,0,0
162949,to,0,0
162950,the,0,0
162951,control,0,1
162952,group,0,0
162953,(,0,0
162954,odds,0,0
162955,ratio,0,0
162956,=,0,0
162957,15.93,0,0
162958,",",0,0
162959,95,0,0
162960,%,0,0
162961,CI,0,0
162962,=,0,0
162963,5.57,0,0
162964,",",0,0
162965,45.53,0,0
162966,),0,0
162967,.,0,0
162968,Our,0,0
162969,theory-based,0,1
162970,intervention,0,1
162971,was,0,0
162972,found,0,0
162973,to,0,0
162974,have,0,0
162975,a,0,0
162976,significant,0,0
162977,effect,0,0
162978,on,0,0
162979,colorectal,0,0
162980,cancer,0,0
162981,screening,0,0
162982,use,0,0
162983,as,0,0
162984,measured,0,0
162985,by,0,0
162986,self-report,0,0
162987,.,0,0
162988,The,0,0
162989,findings,0,0
162990,could,0,0
162991,have,0,0
162992,implications,0,0
162993,for,0,0
162994,colorectal,0,0
162995,cancer,0,0
162996,screening,0,1
162997,program,0,1
162998,development,0,0
162999,and,0,0
163000,implementation,0,0
163001,in,0,0
163002,primary,0,0
163003,health,0,0
163004,care,0,1
163005,settings,0,0
163006,and,0,0
163007,through,0,0
163008,other,0,0
163009,community,0,0
163010,organizations,0,0
163011,.,0,0
163012,Oxytocin,1,1
163013,promotes,0,0
163014,facial,0,0
163015,emotion,0,0
163016,recognition,0,0
163017,and,0,0
163018,amygdala,0,0
163019,reactivity,0,0
163020,in,0,0
163021,adults,0,0
163022,with,0,0
163023,asperger,0,0
163024,syndrome,0,0
163025,.,0,0
163026,The,0,0
163027,neuropeptide,1,0
163028,oxytocin,1,1
163029,has,0,0
163030,recently,0,0
163031,been,0,0
163032,shown,0,0
163033,to,0,0
163034,enhance,0,0
163035,eye,0,1
163036,gaze,0,0
163037,and,0,0
163038,emotion,0,0
163039,recognition,0,0
163040,in,0,0
163041,healthy,0,0
163042,men,0,0
163043,.,0,0
163044,Here,0,0
163045,",",0,0
163046,we,0,0
163047,report,0,0
163048,a,0,0
163049,randomized,0,0
163050,double-blind,0,0
163051,",",0,0
163052,placebo-controlled,1,1
163053,trial,0,0
163054,that,0,0
163055,examined,0,0
163056,the,0,0
163057,neural,0,0
163058,and,0,0
163059,behavioral,0,0
163060,effects,0,0
163061,of,0,0
163062,a,0,0
163063,single,0,0
163064,dose,0,0
163065,of,0,0
163066,intranasal,1,1
163067,oxytocin,1,1
163068,on,0,0
163069,emotion,0,0
163070,recognition,0,0
163071,in,0,0
163072,individuals,0,0
163073,with,0,0
163074,Asperger,0,0
163075,syndrome,0,0
163076,(,0,0
163077,AS,0,0
163078,),0,0
163079,",",0,0
163080,a,0,0
163081,clinical,0,0
163082,condition,0,0
163083,characterized,0,0
163084,by,0,0
163085,impaired,0,0
163086,eye,0,1
163087,gaze,0,0
163088,and,0,0
163089,facial,0,0
163090,emotion,0,0
163091,recognition,0,0
163092,.,0,0
163093,Using,0,0
163094,functional,1,0
163095,magnetic,1,1
163096,resonance,1,1
163097,imaging,1,0
163098,",",0,0
163099,we,0,0
163100,examined,0,0
163101,whether,0,0
163102,oxytocin,1,1
163103,would,0,0
163104,enhance,0,0
163105,emotion,0,0
163106,recognition,0,0
163107,from,0,0
163108,facial,0,0
163109,sections,0,0
163110,of,0,0
163111,the,0,0
163112,eye,0,1
163113,vs,0,0
163114,the,0,0
163115,mouth,0,0
163116,region,0,0
163117,and,0,0
163118,modulate,0,0
163119,regional,0,0
163120,activity,0,0
163121,in,0,0
163122,brain,0,0
163123,areas,0,0
163124,associated,0,0
163125,with,0,0
163126,face,0,0
163127,perception,0,0
163128,in,0,0
163129,both,0,0
163130,adults,0,0
163131,with,0,0
163132,AS,0,0
163133,",",0,0
163134,and,0,0
163135,a,0,0
163136,neurotypical,1,0
163137,control,1,0
163138,group,0,0
163139,.,0,0
163140,Intranasal,0,0
163141,administration,0,0
163142,of,0,0
163143,the,0,0
163144,neuropeptide,1,0
163145,oxytocin,1,1
163146,improved,0,0
163147,performance,0,0
163148,in,0,0
163149,a,0,0
163150,facial,0,0
163151,emotion,0,0
163152,recognition,0,0
163153,task,0,1
163154,in,0,0
163155,individuals,0,0
163156,with,0,0
163157,AS,0,0
163158,.,0,0
163159,This,0,0
163160,was,0,0
163161,linked,0,0
163162,to,0,0
163163,increased,0,0
163164,left,0,0
163165,amygdala,0,0
163166,reactivity,0,0
163167,in,0,0
163168,response,0,0
163169,to,0,0
163170,facial,0,0
163171,stimuli,0,1
163172,and,0,0
163173,increased,0,0
163174,activity,0,0
163175,in,0,0
163176,the,0,0
163177,neural,0,0
163178,network,0,0
163179,involved,0,0
163180,in,0,0
163181,social,0,0
163182,cognition,0,0
163183,.,0,0
163184,Our,0,0
163185,data,0,0
163186,suggest,0,0
163187,that,0,0
163188,the,0,0
163189,amygdala,0,0
163190,",",0,0
163191,together,0,0
163192,with,0,0
163193,functionally,0,0
163194,associated,0,0
163195,cortical,0,0
163196,areas,0,0
163197,mediate,0,0
163198,the,0,0
163199,positive,0,0
163200,effect,0,0
163201,of,0,0
163202,oxytocin,1,1
163203,on,0,0
163204,social,0,0
163205,cognitive,0,0
163206,functioning,0,0
163207,in,0,0
163208,AS,0,0
163209,.,0,0
163210,A,0,0
163211,shortened,0,0
163212,versus,0,0
163213,standard,0,1
163214,matched,0,0
163215,postpartum,1,0
163216,magnesium,1,1
163217,sulphate,1,1
163218,regimen,1,1
163219,in,0,0
163220,the,0,0
163221,treatment,0,0
163222,of,0,0
163223,eclampsia,0,0
163224,:,0,0
163225,a,0,0
163226,randomised,0,0
163227,controlled,0,0
163228,trial,0,0
163229,.,0,0
163230,Magnesium,1,1
163231,sulphate,1,0
163232,is,0,0
163233,currently,0,0
163234,the,0,0
163235,most,0,0
163236,ideal,0,0
163237,drug,0,0
163238,for,0,0
163239,the,0,0
163240,treatment,0,0
163241,of,0,0
163242,eclampsia,0,0
163243,but,0,0
163244,its,0,0
163245,use,0,0
163246,in,0,0
163247,Nigeria,0,0
163248,is,0,0
163249,still,0,0
163250,limited,0,0
163251,due,0,0
163252,its,0,0
163253,cost,0,0
163254,and,0,0
163255,clinicians,0,0
163256,inexperience,0,0
163257,with,0,0
163258,the,0,0
163259,drug,0,0
163260,.,0,0
163261,The,0,0
163262,purpose,0,0
163263,of,0,0
163264,this,0,0
163265,study,0,0
163266,was,0,0
163267,to,0,0
163268,determine,0,0
163269,whether,0,0
163270,a,0,0
163271,shortened,0,0
163272,postpartum,0,0
163273,course,0,0
163274,of,0,0
163275,magnesium,1,1
163276,sulphate,1,1
163277,is,0,0
163278,as,0,0
163279,effective,0,0
163280,as,0,0
163281,the,0,0
163282,standard,0,1
163283,Pritchard,0,0
163284,regimen,0,1
163285,in,0,0
163286,controlling,0,0
163287,fits,0,0
163288,in,0,0
163289,eclampsia,0,0
163290,Between,0,0
163291,January,0,0
163292,and,0,0
163293,June,0,0
163294,2011,0,0
163295,",",0,0
163296,98,0,0
163297,eclamptic,0,0
163298,mothers,0,0
163299,presenting,0,0
163300,at,0,0
163301,the,0,0
163302,labour,0,0
163303,ward,0,0
163304,of,0,0
163305,the,0,0
163306,University,0,0
163307,of,0,0
163308,Maiduguri,0,0
163309,Teaching,0,0
163310,Hospital,0,0
163311,were,0,0
163312,randomised,0,0
163313,to,0,0
163314,receive,0,0
163315,either,0,0
163316,the,0,0
163317,standard,1,1
163318,Pritchard,1,0
163319,regimen,1,1
163320,of,1,0
163321,magnesium,1,1
163322,sulphate,1,1
163323,or,0,1
163324,a,0,0
163325,shortened,1,0
163326,postpartum,1,0
163327,course,1,0
163328,in,0,0
163329,which,0,0
163330,only,0,0
163331,two,0,0
163332,doses,0,0
163333,of,0,0
163334,intramuscular,1,1
163335,magnesium,1,1
163336,sulphate,1,1
163337,is,0,0
163338,given,0,0
163339,four,0,0
163340,hours,0,0
163341,apart,0,0
163342,.,0,0
163343,The,0,0
163344,maternal,0,0
163345,and,0,0
163346,fetal,0,0
163347,outcomes,0,0
163348,were,0,0
163349,compared,0,0
163350,.,0,0
163351,The,0,0
163352,primary,0,0
163353,outcome,0,0
163354,measure,0,0
163355,was,0,0
163356,recurrence,0,0
163357,of,0,0
163358,fits,0,0
163359,.,0,0
163360,The,0,0
163361,recurrence,0,0
163362,of,0,0
163363,fits,0,0
163364,and,0,0
163365,other,0,0
163366,maternal,0,0
163367,complications,0,0
163368,were,0,0
163369,similar,0,0
163370,in,0,0
163371,the,0,0
163372,two,0,0
163373,groups,0,0
163374,.,0,0
163375,The,0,0
163376,total,0,0
163377,dosage,0,0
163378,of,0,0
163379,magnesium,1,1
163380,sulphate,1,0
163381,in,0,0
163382,the,0,0
163383,shortened,0,0
163384,group,0,0
163385,was,0,0
163386,reduced,0,0
163387,by,0,0
163388,40,0,0
163389,%,0,0
163390,in,0,0
163391,66,0,0
163392,%,0,0
163393,of,0,0
163394,patients,0,0
163395,.,0,0
163396,The,0,0
163397,shortened,0,0
163398,postpartum,0,0
163399,course,0,0
163400,of,0,0
163401,magnesium,1,1
163402,sulphate,1,1
163403,is,0,0
163404,as,0,0
163405,effective,0,0
163406,as,0,0
163407,the,0,0
163408,standard,0,1
163409,Pritchard,0,0
163410,regimen,0,1
163411,in,0,0
163412,the,0,0
163413,management,0,0
163414,of,0,0
163415,eclampsia,0,0
163416,.,0,0
163417,Effectiveness,0,0
163418,of,0,0
163419,nonpharmacologic,1,1
163420,treatments,1,0
163421,for,0,0
163422,acute,0,0
163423,seasonal,0,0
163424,allergic,0,0
163425,conjunctivitis,0,0
163426,.,0,0
163427,OBJECTIVE,0,0
163428,To,0,0
163429,investigate,0,0
163430,whether,0,0
163431,artificial,0,0
163432,tears,0,0
163433,and,0,0
163434,cold,0,1
163435,compress,0,1
163436,alone,0,1
163437,or,0,0
163438,in,0,0
163439,combination,0,1
163440,provide,0,0
163441,a,0,0
163442,treatment,0,0
163443,benefit,0,0
163444,and,0,0
163445,whether,0,0
163446,they,0,0
163447,were,0,0
163448,as,0,0
163449,effective,0,0
163450,as,0,0
163451,or,0,0
163452,could,0,0
163453,enhance,0,0
163454,topical,1,1
163455,antiallergic,1,0
163456,medication,1,0
163457,.,1,0
163458,DESIGN,0,0
163459,Randomized,0,0
163460,",",0,0
163461,masked,0,0
163462,clinical,0,0
163463,trial,0,0
163464,.,0,0
163465,PARTICIPANTS,0,0
163466,Eighteen,0,0
163467,subjects,0,0
163468,(,0,0
163469,mean,0,0
163470,age,0,0
163471,",",0,0
163472,29.5?11.0,0,0
163473,years,0,0
163474,),0,0
163475,allergic,0,0
163476,to,0,0
163477,grass,0,1
163478,pollen,0,1
163479,.,0,0
163480,INTERVENTION,1,0
163481,Controlled,1,0
163482,exposure,1,0
163483,to,1,0
163484,grass,1,1
163485,pollen,1,1
163486,using,1,0
163487,an,1,0
163488,environmental,1,0
163489,chamber,1,0
163490,to,1,0
163491,stimulate,1,0
163492,an,1,0
163493,ocular,1,0
163494,allergic,1,0
163495,reaction,1,1
163496,followed,1,0
163497,by,1,0
163498,application,1,0
163499,of,1,0
163500,artificial,1,0
163501,tears,1,0
163502,(,1,0
163503,ATs,1,1
163504,),1,0
163505,",",1,0
163506,5,1,0
163507,minutes,1,0
163508,of,1,0
163509,cold,1,1
163510,compress,1,1
163511,(,1,0
163512,CC,1,0
163513,),1,0
163514,",",1,0
163515,ATs,1,1
163516,combined,1,0
163517,with,1,0
163518,CC,1,0
163519,",",1,0
163520,or,1,0
163521,no,1,0
163522,treatment,1,0
163523,applied,1,0
163524,at,1,0
163525,each,1,0
163526,separate,1,0
163527,visit,1,0
163528,in,1,0
163529,random,1,0
163530,order,1,0
163531,.,1,0
163532,A,0,0
163533,subset,0,0
163534,of,0,0
163535,11,0,0
163536,subjects,0,0
163537,also,0,0
163538,had,1,0
163539,epinastine,1,1
163540,hydrochloride,1,1
163541,(,1,0
163542,EH,1,1
163543,),1,0
163544,applied,1,0
163545,alone,1,1
163546,and,1,0
163547,combined,1,0
163548,with,1,0
163549,CC,1,0
163550,in,1,0
163551,random,1,0
163552,order,1,0
163553,or,1,1
163554,instillation,1,0
163555,of,1,0
163556,a,1,0
163557,volume-matched,1,1
163558,saline,1,1
163559,control,1,0
163560,.,1,0
163561,MAIN,0,0
163562,OUTCOME,0,0
163563,MEASURES,0,0
163564,Bulbar,0,0
163565,conjunctival,0,1
163566,hyperemia,0,0
163567,",",0,0
163568,ocular,0,0
163569,surface,0,0
163570,temperature,0,0
163571,",",0,0
163572,and,0,0
163573,ocular,0,0
163574,symptoms,0,0
163575,repeated,0,0
163576,before,0,0
163577,and,0,0
163578,every,0,0
163579,10,0,0
163580,minutes,0,0
163581,after,0,0
163582,treatment,0,0
163583,for,0,0
163584,1,0,0
163585,hour,0,0
163586,.,0,0
163587,RESULTS,0,0
163588,Bulbar,0,0
163589,conjunctival,0,1
163590,hyperemia,0,0
163591,and,0,0
163592,ocular,0,0
163593,symptoms,0,0
163594,decreased,0,0
163595,and,0,0
163596,temperature,0,0
163597,recovered,0,0
163598,to,0,0
163599,baseline,0,0
163600,faster,0,0
163601,with,1,0
163602,nonpharmaceutical,1,1
163603,treatments,1,0
163604,compared,0,0
163605,with,1,0
163606,no,1,0
163607,treatment,1,0
163608,(,0,0
163609,P,0,0
163610,<,0,0
163611,0.05,0,0
163612,),0,0
163613,.,0,0
163614,Artificial,0,0
163615,tears,0,0
163616,combined,0,0
163617,with,1,0
163618,CC,1,0
163619,reduced,0,0
163620,hyperemia,0,0
163621,more,0,0
163622,than,0,0
163623,other,0,0
163624,treatments,0,0
163625,(,0,0
163626,P,0,0
163627,<,0,0
163628,0.05,0,0
163629,),0,0
163630,.,0,0
163631,The,0,0
163632,treatment,0,0
163633,effect,1,0
163634,of,1,0
163635,EH,1,1
163636,was,1,0
163637,enhanced,0,0
163638,by,0,0
163639,combining,0,0
163640,it,0,0
163641,with,0,0
163642,a,0,0
163643,CC,0,0
163644,(,0,0
163645,P,0,0
163646,<,0,0
163647,0.001,0,0
163648,),0,0
163649,.,0,0
163650,Cold,0,0
163651,compress,0,1
163652,combined,1,0
163653,with,1,0
163654,ATs,1,1
163655,or,1,1
163656,EH,1,1
163657,lowered,0,0
163658,the,0,0
163659,antigen-raised,0,0
163660,ocular,0,0
163661,surface,0,0
163662,temperature,0,0
163663,to,0,0
163664,less,0,0
163665,than,0,0
163666,the,0,0
163667,pre-exposure,0,1
163668,baseline,0,0
163669,.,0,0
163670,Artificial,0,0
163671,tear,0,0
163672,instillation,0,0
163673,alone,0,1
163674,or,1,0
163675,CC,1,0
163676,combined,0,1
163677,with,0,0
163678,ATs,0,1
163679,or,0,1
163680,EH,0,1
163681,significantly,0,0
163682,reduced,0,0
163683,the,0,0
163684,temperature,0,0
163685,(,0,0
163686,P,0,0
163687,<,0,0
163688,0.05,0,0
163689,),0,0
163690,.,0,0
163691,Cold,0,0
163692,compress,0,1
163693,combined,0,0
163694,with,1,0
163695,ATs,1,1
163696,or,1,1
163697,EH,1,1
163698,had,1,0
163699,a,0,0
163700,similar,0,0
163701,cooling,0,1
163702,effect,0,0
163703,(,0,0
163704,P,0,0
163705,>,0,0
163706,0.05,0,0
163707,),0,0
163708,.,0,0
163709,At,0,0
163710,all,0,0
163711,measurement,0,0
163712,intervals,0,0
163713,",",0,0
163714,symptoms,0,0
163715,were,0,0
163716,reduced,0,0
163717,for,0,0
163718,both,0,0
163719,EH,0,1
163720,and,0,0
163721,EH,0,1
163722,combined,0,1
163723,with,0,0
163724,CC,0,0
163725,than,0,0
163726,CC,0,0
163727,or,0,1
163728,ATs,0,1
163729,alone,0,1
163730,or,0,0
163731,in,0,0
163732,combination,0,1
163733,(,0,0
163734,P,0,0
163735,<,0,0
163736,0.014,0,0
163737,),0,0
163738,.,0,0
163739,CONCLUSIONS,0,0
163740,After,0,0
163741,controlled,0,0
163742,exposure,0,0
163743,to,0,0
163744,grass,0,1
163745,pollen,0,1
163746,",",0,0
163747,CC,0,0
163748,and,0,0
163749,AT,0,1
163750,treatment,0,0
163751,showed,0,0
163752,a,0,0
163753,therapeutic,0,0
163754,effect,0,0
163755,on,0,0
163756,the,0,0
163757,signs,0,0
163758,and,0,0
163759,symptoms,0,0
163760,of,0,0
163761,allergic,0,0
163762,conjunctivitis,0,0
163763,.,0,0
163764,A,0,0
163765,CC,0,0
163766,enhanced,0,0
163767,the,0,0
163768,use,0,0
163769,of,0,0
163770,EH,0,1
163771,alone,0,1
163772,and,0,0
163773,was,0,0
163774,the,0,0
163775,only,0,0
163776,treatment,0,0
163777,to,0,0
163778,reduce,0,0
163779,symptoms,0,0
163780,to,0,0
163781,baseline,0,0
163782,within,0,0
163783,1,0,0
163784,hour,0,0
163785,of,0,0
163786,antigenic,0,0
163787,challenge,0,0
163788,.,0,0
163789,Signs,0,0
163790,of,0,0
163791,allergic,0,0
163792,conjunctivitis,0,0
163793,generally,0,0
163794,were,0,0
163795,reduced,0,0
163796,most,0,0
163797,by,0,0
163798,a,0,0
163799,combination,0,0
163800,of,1,0
163801,a,1,0
163802,CC,1,0
163803,in,1,0
163804,combination,1,1
163805,with,1,0
163806,ATs,1,1
163807,or,1,0
163808,EH,1,1
163809,.,1,0
163810,Japan,0,1
163811,useful,0,0
163812,medication,0,1
163813,program,0,1
163814,for,0,0
163815,schizophrenia,0,0
163816,(,0,0
163817,JUMPs,0,0
163818,),0,0
163819,-long-term,0,0
163820,study,0,0
163821,on,0,0
163822,discontinuation,0,0
163823,rate,0,0
163824,",",0,0
163825,resolution,0,0
163826,and,0,0
163827,remission,0,0
163828,",",0,0
163829,and,0,0
163830,improvement,0,0
163831,in,0,0
163832,social,0,0
163833,functioning,0,0
163834,rate,0,0
163835,associated,0,0
163836,with,0,0
163837,atypical,1,0
163838,antipsychotic,1,0
163839,medications,1,0
163840,in,0,0
163841,patients,0,0
163842,with,0,0
163843,schizophrenia,0,0
163844,.,0,0
163845,BACKGROUND,0,0
163846,It,0,0
163847,is,0,0
163848,desirable,0,0
163849,to,0,0
163850,establish,0,0
163851,evidence,0,0
163852,for,0,0
163853,the,0,0
163854,selection,0,0
163855,of,0,0
163856,antipsychotics,1,1
163857,from,0,0
163858,the,0,0
163859,viewpoint,0,0
163860,of,0,0
163861,recovery,0,0
163862,of,0,0
163863,social,0,0
163864,activity,0,0
163865,in,0,0
163866,individual,0,0
163867,patient,0,0
163868,with,0,0
163869,schizophrenia,0,0
163870,receiving,0,0
163871,medication,0,0
163872,.,0,0
163873,From,0,0
163874,this,0,0
163875,perspective,0,0
163876,",",0,0
163877,awareness,0,0
163878,of,0,0
163879,the,0,0
163880,importance,0,0
163881,of,0,0
163882,studies,0,0
163883,about,0,0
163884,drug,0,0
163885,effectiveness,0,0
163886,on,0,0
163887,treatment,0,0
163888,discontinuation,0,0
163889,rate,0,0
163890,",",0,0
163891,remission,0,0
163892,rate,0,0
163893,",",0,0
163894,and,0,0
163895,improvement,0,0
163896,in,0,0
163897,QOL,0,1
163898,has,0,0
163899,grown,0,0
163900,recently,0,0
163901,.,0,0
163902,In,0,0
163903,Western,0,0
163904,countries,0,0
163905,",",0,0
163906,numerous,0,0
163907,reports,0,0
163908,are,0,0
163909,available,0,0
163910,in,0,0
163911,effectiveness,0,0
163912,studies,0,0
163913,",",0,0
163914,which,0,0
163915,are,0,0
163916,related,0,0
163917,to,0,0
163918,olanzapine,0,1
163919,and,0,0
163920,risperidone,0,1
163921,primarily,0,0
163922,",",0,0
163923,whereas,0,0
163924,evidence,0,0
163925,for,0,0
163926,other,0,0
163927,second-generation,0,0
163928,antipsychotics,0,1
163929,(,0,0
163930,SGAs,0,0
163931,),0,1
163932,is,0,0
163933,poor,0,0
163934,.,0,0
163935,In,0,0
163936,Japan,0,0
163937,",",0,0
163938,no,0,0
163939,effectiveness,0,0
163940,study,0,0
163941,has,0,0
163942,been,0,0
163943,reported,0,0
163944,:,0,0
163945,thus,0,0
163946,",",0,0
163947,it,0,0
163948,is,0,0
163949,desirable,0,0
163950,to,0,0
163951,collect,0,0
163952,data,0,0
163953,that,0,0
163954,will,0,0
163955,serve,0,0
163956,as,0,0
163957,evidence,0,0
163958,for,0,0
163959,selection,0,0
163960,of,0,0
163961,the,0,0
163962,3,0,0
163963,SGAs,0,0
163964,approved,0,0
163965,after,0,0
163966,olanzapine,0,1
163967,.,0,0
163968,METHODS,0,0
163969,The,0,0
163970,present,0,0
163971,study,0,0
163972,was,0,0
163973,a,0,0
163974,long-term,0,0
163975,effectiveness,0,0
163976,study,0,0
163977,under,0,0
163978,healthcare,0,0
163979,setting,0,0
163980,in,0,0
163981,Japan,0,1
163982,.,0,0
163983,It,0,0
163984,was,0,0
163985,designed,0,0
163986,as,0,0
163987,an,0,0
163988,open-label,0,0
163989,",",0,0
163990,multicenter,0,0
163991,",",0,0
163992,randomized,0,0
163993,",",0,0
163994,comparative,0,0
163995,study,0,0
163996,involving,0,0
163997,104-week,0,0
163998,oral,0,1
163999,treatment,0,0
164000,with,0,0
164001,1,1,0
164002,of,1,0
164003,the,1,0
164004,3,1,0
164005,drugs,1,0
164006,(,1,0
164007,aripiprazole,1,1
164008,",",1,0
164009,blonanserin,1,1
164010,",",1,0
164011,and,1,0
164012,paliperidone,1,1
164013,),1,0
164014,in,0,0
164015,patients,0,0
164016,with,0,0
164017,schizophrenia,0,0
164018,aged,0,0
164019,20,0,0
164020,years,0,0
164021,or,0,0
164022,over,0,0
164023,who,0,0
164024,required,0,0
164025,antipsychotic,1,0
164026,medication,1,1
164027,or,0,1
164028,switching,0,0
164029,of,0,0
164030,the,0,0
164031,current,0,0
164032,medication,0,0
164033,to,0,0
164034,others,0,0
164035,for,0,0
164036,reasons,0,0
164037,such,0,0
164038,as,0,0
164039,lack,0,0
164040,of,0,0
164041,efficacy,0,0
164042,and,0,0
164043,intolerability,0,0
164044,.,0,0
164045,The,0,0
164046,primary,0,0
164047,endpoint,0,0
164048,is,0,0
164049,treatment,0,0
164050,discontinuation,0,0
164051,rate,0,0
164052,for,0,0
164053,any,0,0
164054,causes,0,0
164055,.,0,0
164056,The,0,0
164057,secondary,0,0
164058,endpoints,0,0
164059,include,0,0
164060,remission,0,0
164061,rate,0,0
164062,",",0,0
164063,improvement,0,0
164064,of,0,0
164065,social,0,0
164066,activity,0,0
164067,",",0,0
164068,alleviation,0,0
164069,",",0,0
164070,aggravation,0,0
164071,or,0,1
164072,recurrence,0,0
164073,of,0,0
164074,psychiatric,0,0
164075,symptoms,0,0
164076,",",0,0
164077,and,0,0
164078,safety,0,0
164079,.,0,0
164080,The,0,0
164081,target,0,0
164082,number,0,0
164083,of,0,0
164084,subjects,0,0
164085,was,0,0
164086,set,0,0
164087,at,0,0
164088,300,0,0
164089,.,0,0
164090,DISCUSSION,0,0
164091,Because,0,0
164092,this,0,0
164093,study,0,0
164094,is,0,0
164095,expected,0,0
164096,to,0,0
164097,yield,0,0
164098,evidence,0,0
164099,regarding,0,0
164100,the,0,0
164101,selection,0,0
164102,of,0,0
164103,antipsychotics,0,1
164104,for,0,0
164105,facilitating,0,0
164106,the,0,0
164107,recovery,0,0
164108,of,0,0
164109,social,0,0
164110,activity,0,0
164111,in,0,0
164112,patients,0,0
164113,with,0,0
164114,schizophrenia,0,0
164115,",",0,0
164116,it,0,0
164117,is,0,0
164118,considered,0,0
164119,highly,0,0
164120,valuable,0,0
164121,to,0,0
164122,perform,0,0
164123,this,0,0
164124,effectiveness,0,0
164125,study,0,0
164126,under,0,0
164127,ordinary,0,1
164128,healthcare,0,0
164129,setting,0,0
164130,in,0,0
164131,Japan,0,1
164132,.,0,0
164133,TRIAL,0,0
164134,REGISTRATION,0,0
164135,UMIN,0,0
164136,Clinical,0,0
164137,Trials,0,1
164138,Registry,0,0
164139,000007942,0,0
164140,.,0,0
164141,The,0,0
164142,efficacy,0,0
164143,and,0,0
164144,safety,0,0
164145,of,0,0
164146,simultaneous,0,0
164147,transurethral,1,1
164148,GreenLight,1,1
164149,photoselective,1,1
164150,vaporization,1,1
164151,of,0,0
164152,bladder,0,1
164153,tumor,0,0
164154,and,0,0
164155,prostate,0,0
164156,in,0,0
164157,patients,0,0
164158,with,0,0
164159,bladder,0,0
164160,tumor,0,0
164161,and,0,0
164162,lower,0,0
164163,urinary,0,0
164164,tract,0,0
164165,symptoms,0,0
164166,.,0,0
164167,PURPOSE,0,0
164168,We,0,0
164169,compared,0,0
164170,the,0,0
164171,safety,0,0
164172,and,0,0
164173,efficacy,0,0
164174,of,0,0
164175,simultaneous,1,0
164176,transurethral,1,1
164177,GreenLight,1,1
164178,photoselective,1,1
164179,vaporization,1,1
164180,of,1,0
164181,bladder,1,1
164182,tumor,1,0
164183,and,1,0
164184,prostate,1,0
164185,(,1,1
164186,PVBT/PVP,1,1
164187,),1,0
164188,in,0,0
164189,patients,0,0
164190,with,0,0
164191,bladder,0,0
164192,tumor,0,0
164193,and,0,0
164194,bladder,0,1
164195,outlet,0,0
164196,obstruction,0,0
164197,caused,0,0
164198,by,0,0
164199,benign,0,0
164200,prostate,0,0
164201,hyperplasia,0,0
164202,(,0,0
164203,BPH,0,0
164204,),0,0
164205,.,0,0
164206,METHODS,0,0
164207,Sixty-two,0,0
164208,patients,0,0
164209,with,0,0
164210,bladder,0,0
164211,tumor,0,0
164212,were,0,0
164213,enrolled,0,0
164214,in,0,0
164215,our,0,0
164216,prospective,0,0
164217,and,0,0
164218,randomized,0,0
164219,trial,0,0
164220,.,0,0
164221,A,0,0
164222,total,0,0
164223,of,0,0
164224,37,0,0
164225,men,0,0
164226,underwent,0,0
164227,simultaneous,0,0
164228,transurethral,1,1
164229,PVBT/PVP,1,1
164230,",",0,0
164231,and,0,0
164232,25,0,0
164233,patients,0,0
164234,underwent,0,0
164235,PVBT,1,0
164236,alone,0,1
164237,.,0,0
164238,The,0,0
164239,clinicopathological,0,0
164240,parameters,0,0
164241,and,0,0
164242,the,0,0
164243,recurrence,0,0
164244,of,0,0
164245,bladder,0,0
164246,tumor,0,0
164247,on,0,0
164248,the,0,0
164249,bladder,0,0
164250,neck/prostatic,0,0
164251,fossa,0,0
164252,were,0,0
164253,evaluated,0,0
164254,in,0,0
164255,all,0,0
164256,patients,0,0
164257,.,0,0
164258,RESULTS,0,0
164259,Clinicopathological,0,0
164260,parameters,0,0
164261,of,0,0
164262,both,0,0
164263,groups,0,0
164264,were,0,0
164265,similar,0,0
164266,.,0,0
164267,The,0,0
164268,rates,0,0
164269,of,0,0
164270,recurrence,0,0
164271,",",0,0
164272,progression,0,0
164273,and,0,0
164274,tumor,0,0
164275,recurrence,0,0
164276,of,0,0
164277,bladder,0,0
164278,neck/prostatic,0,1
164279,fossa,0,0
164280,were,0,0
164281,16.0,0,0
164282,",",0,0
164283,4.0,0,0
164284,and,0,0
164285,4.0,0,0
164286,%,0,0
164287,in,0,0
164288,the,0,0
164289,simultaneous,0,0
164290,resection,0,1
164291,group,0,0
164292,",",0,0
164293,and,0,0
164294,18.9,0,0
164295,",",0,0
164296,5.4,0,0
164297,and,0,0
164298,8.1,0,0
164299,%,0,0
164300,in,0,0
164301,the,0,0
164302,group,0,0
164303,PVBT,0,0
164304,",",0,0
164305,respectively,0,0
164306,.,0,0
164307,No,0,0
164308,statistically,0,0
164309,significant,0,0
164310,differences,0,0
164311,were,0,0
164312,found,0,0
164313,between,0,0
164314,the,0,0
164315,two,0,0
164316,groups,0,0
164317,(,0,0
164318,P,0,0
164319,>,0,0
164320,0.05,0,0
164321,),0,0
164322,.,0,0
164323,CONCLUSIONS,0,0
164324,Simultaneous,0,0
164325,PVBT/PVP,1,1
164326,may,0,0
164327,help,0,0
164328,decrease,0,0
164329,the,0,0
164330,overall,0,0
164331,recurrence,0,0
164332,rate,0,0
164333,and,0,0
164334,tumor,0,0
164335,recurrence,0,0
164336,in,0,0
164337,bladder,0,0
164338,neck/prostatic,0,0
164339,fossa,0,0
164340,.,0,0
164341,PVBT/PVP,1,0
164342,can,0,0
164343,be,0,0
164344,performed,0,0
164345,effectively,0,0
164346,and,0,0
164347,safely,0,0
164348,in,0,0
164349,patients,0,0
164350,with,0,0
164351,bladder,0,0
164352,tumor,0,0
164353,and,0,0
164354,BPH,0,0
164355,.,0,0
164356,Long-term,0,0
164357,exposure,0,0
164358,to,0,0
164359,belatacept,0,1
164360,in,0,0
164361,recipients,0,0
164362,of,0,0
164363,extended,0,0
164364,criteria,0,0
164365,donor,0,0
164366,kidneys,0,0
164367,.,0,0
164368,Patients,0,0
164369,in,0,0
164370,the,0,0
164371,BENEFIT-EXT,0,0
164372,study,0,0
164373,received,0,0
164374,extended,0,0
164375,criteria,0,0
164376,donor,0,0
164377,kidneys,0,0
164378,and,0,0
164379,a,0,0
164380,more,1,0
164381,intensive,1,1
164382,(,1,0
164383,MI,1,1
164384,),1,0
164385,or,1,0
164386,less,1,0
164387,intensive,1,1
164388,(,1,0
164389,LI,1,1
164390,),1,0
164391,belatacept,1,1
164392,immunosuppression,1,1
164393,regimen,1,1
164394,",",1,0
164395,or,1,0
164396,cyclosporine,1,1
164397,A,1,0
164398,(,1,0
164399,CsA,1,1
164400,),1,0
164401,.,1,0
164402,Patients,0,0
164403,who,0,0
164404,remained,0,0
164405,on,0,0
164406,assigned,0,0
164407,therapy,0,1
164408,through,0,0
164409,year,0,0
164410,3,0,0
164411,were,0,0
164412,eligible,0,0
164413,to,0,0
164414,enter,0,0
164415,a,0,0
164416,long-term,0,0
164417,extension,0,0
164418,(,0,0
164419,LTE,0,1
164420,),0,0
164421,study,0,0
164422,.,0,0
164423,Three,0,0
164424,hundred,0,0
164425,four,0,0
164426,patients,0,0
164427,entered,0,0
164428,the,0,0
164429,LTE,0,1
164430,(,0,0
164431,n,0,0
164432,=,0,0
164433,104,0,0
164434,MI,0,1
164435,;,0,0
164436,n,0,0
164437,=,0,0
164438,113,0,0
164439,LI,0,1
164440,;,0,0
164441,n,0,0
164442,=,0,0
164443,87,0,0
164444,CsA,0,1
164445,),0,0
164446,",",0,0
164447,and,0,0
164448,260,0,0
164449,continued,0,0
164450,treatment,0,0
164451,through,0,0
164452,year,0,0
164453,5,0,0
164454,(,0,0
164455,n,0,0
164456,=,0,0
164457,91,0,0
164458,MI,0,1
164459,;,0,0
164460,n,0,0
164461,=,0,0
164462,100,0,0
164463,LI,0,1
164464,;,0,0
164465,n,0,0
164466,=,0,0
164467,69,0,0
164468,CsA,0,0
164469,),0,0
164470,.,0,0
164471,Twenty,0,0
164472,patients,0,0
164473,died,0,0
164474,during,0,0
164475,the,0,0
164476,LTE,0,1
164477,(,0,0
164478,n,0,0
164479,=,0,0
164480,5,0,0
164481,MI,0,1
164482,;,0,0
164483,n,0,0
164484,=,0,0
164485,9,0,0
164486,LI,0,1
164487,;,0,0
164488,n,0,0
164489,=,0,0
164490,6,0,0
164491,CsA,0,1
164492,),0,0
164493,",",0,0
164494,and,0,0
164495,eight,0,0
164496,experienced,0,0
164497,graft,0,0
164498,loss,0,0
164499,(,0,0
164500,n,0,0
164501,=,0,0
164502,2,0,0
164503,MI,0,1
164504,;,0,0
164505,n,0,0
164506,=,0,0
164507,1,0,0
164508,LI,0,1
164509,;,0,0
164510,n,0,0
164511,=,0,0
164512,5,0,0
164513,CsA,0,0
164514,),0,0
164515,.,0,0
164516,Three,0,0
164517,patients,0,0
164518,experienced,0,0
164519,an,0,0
164520,acute,0,0
164521,rejection,0,0
164522,episode,0,0
164523,(,0,0
164524,n,0,0
164525,=,0,0
164526,2,0,0
164527,MI,0,1
164528,;,0,0
164529,n,0,0
164530,=,0,0
164531,1,0,0
164532,LI,0,1
164533,),0,0
164534,.,0,0
164535,The,0,0
164536,incidence,0,0
164537,rate,0,0
164538,of,0,0
164539,serious,0,0
164540,adverse,0,0
164541,events,0,0
164542,",",0,0
164543,viral,0,0
164544,infections,0,0
164545,and,0,0
164546,fungal,0,0
164547,infections,0,0
164548,was,0,0
164549,similar,0,0
164550,across,0,0
164551,groups,0,0
164552,during,0,0
164553,the,0,0
164554,LTE,0,0
164555,.,0,0
164556,There,0,0
164557,were,0,0
164558,four,0,0
164559,cases,0,0
164560,of,0,0
164561,posttransplant,0,0
164562,lymphoproliferative,0,0
164563,disorder,0,0
164564,(,0,0
164565,PTLD,0,1
164566,),0,0
164567,from,0,0
164568,the,0,0
164569,beginning,0,0
164570,of,0,0
164571,the,0,0
164572,LTE,0,1
164573,to,0,0
164574,year,0,0
164575,5,0,1
164576,(,0,0
164577,n,0,0
164578,=,0,0
164579,3,0,0
164580,LI,0,1
164581,;,0,0
164582,n,0,0
164583,=,0,0
164584,1,0,0
164585,CsA,0,1
164586,),0,0
164587,;,0,0
164588,two,0,0
164589,of,0,0
164590,three,0,0
164591,PTLD,0,0
164592,cases,0,0
164593,in,0,0
164594,the,0,0
164595,LI,0,1
164596,group,0,0
164597,were,0,0
164598,in,0,0
164599,patients,0,0
164600,who,0,0
164601,were,0,0
164602,seronegative,0,0
164603,for,0,0
164604,Epstein-Barr,0,1
164605,virus,0,1
164606,(,0,1
164607,EBV,0,1
164608,(,0,0
164609,-,0,0
164610,),0,0
164611,),0,0
164612,at,0,0
164613,transplantation,0,0
164614,.,0,0
164615,Mean,0,0
164616,?,0,0
164617,SD,0,0
164618,calculated,0,0
164619,GFR,0,0
164620,at,0,0
164621,year,0,0
164622,5,0,0
164623,was,0,0
164624,55.9,0,0
164625,?,0,0
164626,17.5,0,0
164627,(,0,0
164628,MI,0,1
164629,),0,0
164630,",",0,0
164631,59.0,0,0
164632,?,0,0
164633,29.1,0,0
164634,(,0,0
164635,LI,0,1
164636,),0,0
164637,and,0,0
164638,44.6,0,0
164639,?,0,0
164640,16.4,0,0
164641,(,0,0
164642,CsA,0,1
164643,),0,1
164644,mL/min/1.73,0,0
164645,m,0,0
164646,(,0,0
164647,2,0,0
164648,),0,0
164649,.,0,0
164650,Continued,0,0
164651,treatment,0,0
164652,with,0,0
164653,belatacept,0,1
164654,was,0,0
164655,associated,0,0
164656,with,0,0
164657,a,0,0
164658,consistent,0,0
164659,safety,0,0
164660,profile,0,0
164661,and,0,0
164662,sustained,0,0
164663,improvement,0,0
164664,in,0,0
164665,renal,0,0
164666,function,0,0
164667,versus,0,0
164668,CsA,0,1
164669,over,0,0
164670,time,0,0
164671,.,0,0
164672,Effect,0,0
164673,of,0,0
164674,clinical,0,0
164675,context,0,0
164676,on,0,0
164677,simulator-based,0,1
164678,assessment,0,0
164679,of,0,0
164680,blood,0,0
164681,pressure,0,0
164682,taking,0,0
164683,-,0,0
164684,a,0,0
164685,pilot,0,0
164686,randomized,0,0
164687,study,0,0
164688,.,0,0
164689,BACKGROUND,0,0
164690,Blood,0,0
164691,pressure,0,0
164692,measurement,0,0
164693,is,0,0
164694,an,0,0
164695,essential,0,0
164696,clinical,0,0
164697,skill,0,0
164698,that,0,0
164699,can,0,0
164700,readily,0,0
164701,be,0,0
164702,assessed,0,0
164703,in,0,0
164704,objective,0,0
164705,structured,0,1
164706,clinical,0,0
164707,examination,0,0
164708,(,0,0
164709,OSCE,0,0
164710,),0,0
164711,.,0,0
164712,While,0,0
164713,the,0,0
164714,use,0,0
164715,of,0,0
164716,simulators,1,1
164717,can,0,0
164718,enhance,0,0
164719,test,0,0
164720,validity,0,0
164721,and,0,0
164722,reliability,0,0
164723,",",0,0
164724,the,0,0
164725,given,0,0
164726,clinical,0,0
164727,context,0,0
164728,may,0,0
164729,also,0,0
164730,affect,0,0
164731,student,0,0
164732,performance,0,0
164733,.,0,0
164734,AIMS,0,0
164735,To,0,0
164736,investigate,0,0
164737,the,0,0
164738,impact,0,0
164739,of,0,0
164740,variations,0,0
164741,in,0,0
164742,clinical,0,0
164743,context,0,0
164744,on,0,0
164745,blood,0,0
164746,pressure,0,0
164747,measurement,0,0
164748,in,0,0
164749,a,0,0
164750,simulator-based,1,0
164751,OSCE,1,0
164752,.,1,0
164753,METHOD,0,0
164754,We,0,0
164755,randomized,0,0
164756,162,0,0
164757,first-year,0,0
164758,medical,0,0
164759,students,0,0
164760,into,0,0
164761,four,0,0
164762,groups,0,0
164763,that,0,0
164764,received,0,0
164765,different,0,0
164766,lead-in,0,0
164767,statements,0,0
164768,before,0,0
164769,measuring,0,0
164770,blood,0,0
164771,pressure,0,0
164772,on,0,0
164773,a,0,0
164774,manikin,1,1
164775,simulator,1,1
164776,.,1,0
164777,These,0,0
164778,statements,0,0
164779,described,0,0
164780,hypothetical,0,0
164781,patients,0,0
164782,with,0,0
164783,different,0,0
164784,likelihoods,0,0
164785,of,0,0
164786,having,0,0
164787,systemic,0,0
164788,hypertension,0,0
164789,.,0,0
164790,RESULTS,0,0
164791,The,0,0
164792,lead-in,0,0
164793,that,0,0
164794,described,0,0
164795,the,0,0
164796,highest,0,0
164797,likelihood,0,0
164798,of,0,0
164799,hypertension,0,0
164800,was,0,0
164801,associated,0,0
164802,with,0,0
164803,significantly,0,0
164804,higher,0,0
164805,reported,0,0
164806,readings,0,0
164807,and,0,0
164808,lower,0,0
164809,accuracy,0,0
164810,.,0,0
164811,The,0,0
164812,lead-in,0,0
164813,that,0,0
164814,suggested,0,0
164815,normality,0,0
164816,yielded,0,0
164817,the,0,0
164818,best,0,0
164819,performance,0,0
164820,.,0,0
164821,CONCLUSION,0,0
164822,Student,0,0
164823,performance,0,0
164824,in,0,0
164825,simulator-based,1,1
164826,OSCE,1,0
164827,may,0,0
164828,be,0,0
164829,affected,0,0
164830,by,0,0
164831,the,0,0
164832,clinical,0,0
164833,context,0,0
164834,provided,0,0
164835,.,0,0
164836,However,0,0
164837,",",0,0
164838,we,0,0
164839,argue,0,0
164840,that,0,0
164841,construct,0,0
164842,validity,0,0
164843,should,0,0
164844,be,0,0
164845,viewed,0,0
164846,in,0,0
164847,light,0,0
164848,of,0,0
164849,the,0,0
164850,application,0,0
164851,of,0,0
164852,a,0,0
164853,test,0,0
164854,",",0,0
164855,in,0,0
164856,that,0,0
164857,patients,0,0
164858,may,0,0
164859,also,0,0
164860,present,0,0
164861,with,0,0
164862,different,0,0
164863,cues,0,0
164864,and,0,0
164865,likelihoods,0,0
164866,of,0,0
164867,having,0,0
164868,hypertension,0,0
164869,.,0,0
164870,Variations,0,0
164871,in,0,0
164872,construct,0,0
164873,design,0,0
164874,should,0,0
164875,be,0,0
164876,further,0,0
164877,explored,0,0
164878,to,0,0
164879,enhance,0,0
164880,the,0,0
164881,training,0,1
164882,and,0,0
164883,assessment,0,0
164884,of,0,0
164885,clinical,0,0
164886,competence,0,0
164887,that,0,0
164888,reflects,0,0
164889,the,0,0
164890,unpredictability,0,0
164891,encountered,0,0
164892,in,0,0
164893,daily,0,0
164894,clinical,0,0
164895,practice,0,0
164896,.,0,0
164897,A,0,0
164898,prospective,0,0
164899,randomized,1,0
164900,trial,0,0
164901,comparing,0,0
164902,hypofractionation,0,1
164903,with,0,0
164904,conventional,0,1
164905,fractionation,0,1
164906,radiotherapy,0,1
164907,for,0,0
164908,T1-2,0,0
164909,glottic,0,0
164910,squamous,0,0
164911,cell,0,0
164912,carcinomas,0,0
164913,:,0,0
164914,results,0,0
164915,of,0,0
164916,a,0,0
164917,Korean,0,0
164918,Radiation,0,0
164919,Oncology,0,0
164920,Group,0,0
164921,(,0,0
164922,KROG-0201,0,1
164923,),0,0
164924,study,0,0
164925,.,0,0
164926,BACKGROUND,0,0
164927,AND,0,0
164928,PURPOSE,0,0
164929,To,0,0
164930,prospectively,0,0
164931,investigate,0,0
164932,the,0,0
164933,effect,0,0
164934,of,0,0
164935,radiotherapy,0,1
164936,fraction,0,0
164937,size,0,0
164938,on,0,0
164939,clinical,0,0
164940,outcomes,0,0
164941,in,0,0
164942,early,0,0
164943,glottic,0,0
164944,carcinoma,0,0
164945,METHODS,0,0
164946,AND,0,0
164947,MATERIALS,0,0
164948,Patients,0,0
164949,with,0,0
164950,T1-2,0,0
164951,glottic,0,0
164952,carcinoma,0,0
164953,were,0,0
164954,eligible,0,0
164955,for,0,0
164956,the,0,0
164957,protocol,0,0
164958,.,0,0
164959,Although,0,0
164960,282,0,0
164961,patients,0,0
164962,were,0,0
164963,required,0,0
164964,",",0,0
164965,the,0,0
164966,study,0,0
164967,was,0,0
164968,closed,0,0
164969,prematurely,0,0
164970,due,0,0
164971,to,0,0
164972,poor,0,0
164973,accrual,0,0
164974,with,0,0
164975,only,0,0
164976,156,0,0
164977,patients,0,0
164978,.,0,0
164979,Of,0,0
164980,these,0,0
164981,",",0,0
164982,82,0,0
164983,patients,0,0
164984,were,0,0
164985,allocated,0,0
164986,to,0,0
164987,conventional,1,1
164988,fractionation,1,1
164989,(,1,0
164990,CONV,1,0
164991,),1,1
164992,arm,1,0
164993,(,1,0
164994,66,1,0
164995,Gy/33,1,0
164996,fractions,1,1
164997,for,1,0
164998,T1,1,0
164999,and,1,0
165000,70,1,0
165001,Gy/35,1,0
165002,fractions,1,1
165003,for,1,0
165004,T2,1,0
165005,),1,0
165006,",",1,0
165007,with,1,0
165008,74,1,0
165009,patients,1,0
165010,to,1,0
165011,hypofractionation,1,1
165012,(,1,0
165013,HYPO,1,1
165014,),1,1
165015,arm,1,0
165016,(,1,0
165017,63,1,0
165018,Gy/28,1,1
165019,fractions,1,1
165020,for,1,0
165021,T1,1,0
165022,and,1,0
165023,67.5,1,0
165024,Gy/30,1,1
165025,fractions,1,1
165026,for,1,0
165027,T2,1,0
165028,),1,0
165029,.,1,0
165030,The,0,0
165031,primary,0,0
165032,objective,0,0
165033,was,0,0
165034,local,0,0
165035,progression-free,0,0
165036,survival,0,0
165037,(,0,0
165038,LPFS,0,0
165039,),0,0
165040,.,0,0
165041,RESULTS,0,0
165042,With,0,0
165043,a,0,0
165044,median,0,0
165045,follow-up,0,0
165046,of,0,0
165047,67,0,0
165048,months,0,0
165049,(,0,0
165050,range,0,0
165051,",",0,0
165052,2-122,0,0
165053,months,0,0
165054,),0,0
165055,",",0,0
165056,the,0,0
165057,5-year,0,0
165058,LPFS,0,0
165059,was,0,0
165060,77.8,0,0
165061,%,0,0
165062,for,0,0
165063,CONV,0,0
165064,arm,0,0
165065,and,0,0
165066,88.5,0,0
165067,%,0,0
165068,for,0,0
165069,HYPO,0,1
165070,arm,0,0
165071,(,0,0
165072,HR,0,0
165073,1.55,0,0
165074,",",0,0
165075,p=0.213,0,0
165076,),0,0
165077,.,0,0
165078,No,0,0
165079,significant,0,0
165080,difference,0,0
165081,was,0,0
165082,observed,0,0
165083,in,0,0
165084,the,0,0
165085,toxicity,0,0
165086,profile,0,0
165087,between,0,0
165088,the,0,0
165089,two,0,0
165090,arms,0,0
165091,.,0,0
165092,In,0,0
165093,a,0,0
165094,subgroup,0,0
165095,exploratory,0,0
165096,analysis,0,0
165097,for,0,0
165098,T1a,0,1
165099,disease,0,0
165100,",",0,0
165101,the,0,0
165102,5-year,0,0
165103,LPFS,0,0
165104,trended,0,0
165105,positively,0,0
165106,in,0,0
165107,HYPO,0,1
165108,arm,0,0
165109,(,0,0
165110,76.7,0,0
165111,%,0,0
165112,vs.,0,0
165113,93.0,0,0
165114,%,0,0
165115,",",0,0
165116,HR,0,0
165117,3.65,0,0
165118,",",0,0
165119,p=0.056,0,0
165120,),0,0
165121,.,0,0
165122,CONCLUSIONS,0,0
165123,Given,0,0
165124,that,0,0
165125,HYPO,0,1
165126,is,0,0
165127,at,0,0
165128,least,0,0
165129,not,0,0
165130,inferior,0,0
165131,to,0,0
165132,CONV,0,0
165133,with,0,0
165134,a,0,0
165135,similar,0,0
165136,toxicity,0,0
165137,profile,0,0
165138,",",0,0
165139,the,0,0
165140,hypofractionation,0,1
165141,scheme,0,1
165142,used,0,0
165143,in,0,0
165144,this,0,0
165145,study,0,0
165146,can,0,0
165147,be,0,0
165148,offered,0,0
165149,to,0,0
165150,patients,0,0
165151,with,0,0
165152,T1-2,0,0
165153,glottic,0,0
165154,carcinoma,0,0
165155,with,0,0
165156,potential,0,0
165157,advantages,0,0
165158,in,0,0
165159,terms,0,0
165160,of,0,0
165161,local,0,0
165162,control,0,0
165163,and,0,0
165164,a,0,0
165165,shortened,0,0
165166,overall,0,0
165167,treatment,0,0
165168,time,0,0
165169,.,0,0
165170,Central,0,0
165171,5-HT4,0,1
165172,receptor,0,0
165173,binding,0,0
165174,as,0,0
165175,biomarker,0,0
165176,of,0,0
165177,serotonergic,0,0
165178,tonus,0,0
165179,in,0,0
165180,humans,0,0
165181,:,0,0
165182,a,0,0
165183,[,0,0
165184,11C,0,0
165185,],0,0
165186,SB207145,0,0
165187,PET,0,1
165188,study,0,0
165189,.,0,0
165190,Identification,0,0
165191,of,0,0
165192,a,0,0
165193,biomarker,0,0
165194,that,0,0
165195,can,0,0
165196,inform,0,0
165197,on,0,0
165198,extracellular,0,0
165199,serotonin,0,1
165200,(,0,0
165201,5-HT,0,1
165202,),0,0
165203,levels,0,0
165204,in,0,0
165205,the,0,0
165206,brains,0,0
165207,of,0,0
165208,living,0,0
165209,humans,0,0
165210,would,0,0
165211,enable,0,0
165212,greater,0,0
165213,understanding,0,0
165214,of,0,0
165215,the,0,0
165216,way,0,0
165217,brain,0,0
165218,circuits,0,0
165219,are,0,0
165220,modulated,0,0
165221,by,0,0
165222,serotonergic,0,0
165223,neurotransmission,0,0
165224,.,0,0
165225,Substantial,0,0
165226,evidence,0,0
165227,from,0,0
165228,studies,0,0
165229,in,0,0
165230,animals,0,0
165231,and,0,0
165232,humans,0,0
165233,indicates,0,0
165234,an,0,0
165235,inverse,0,0
165236,relationship,0,0
165237,between,0,0
165238,central,0,0
165239,5-HT,0,1
165240,tonus,0,0
165241,and,0,0
165242,5-HT,0,1
165243,type,0,0
165244,4,0,1
165245,receptor,0,0
165246,(,0,0
165247,5-HT4R,0,0
165248,),0,0
165249,density,0,0
165250,",",0,0
165251,suggesting,0,0
165252,that,0,0
165253,5-HT4R,0,0
165254,receptor,0,0
165255,density,0,0
165256,may,0,0
165257,be,0,0
165258,a,0,0
165259,biomarker,0,0
165260,marker,0,0
165261,for,0,0
165262,5-HT,0,1
165263,tonus,0,0
165264,.,0,0
165265,Here,0,0
165266,",",0,0
165267,we,0,0
165268,investigated,0,0
165269,whether,0,0
165270,a,0,0
165271,3-week,0,0
165272,administration,0,0
165273,of,0,0
165274,a,0,0
165275,selective,0,0
165276,serotonin,0,1
165277,reuptake,0,1
165278,inhibitor,0,1
165279,",",0,0
165280,expected,0,0
165281,to,0,0
165282,increase,0,0
165283,brain,0,0
165284,5-HT,0,1
165285,levels,0,0
165286,",",0,0
165287,is,0,0
165288,associated,0,0
165289,with,0,0
165290,a,0,0
165291,decline,0,0
165292,in,0,0
165293,brain,0,0
165294,5-HT4R,0,0
165295,binding,0,0
165296,.,0,0
165297,A,0,0
165298,total,0,0
165299,of,0,0
165300,35,0,0
165301,healthy,0,0
165302,men,0,0
165303,were,0,0
165304,studied,0,0
165305,in,0,0
165306,a,0,0
165307,placebo-controlled,1,1
165308,",",0,0
165309,randomized,0,0
165310,",",0,0
165311,double-blind,0,0
165312,study,0,0
165313,.,0,0
165314,Participants,0,0
165315,were,0,0
165316,assigned,0,0
165317,to,0,0
165318,receive,0,0
165319,3,0,0
165320,weeks,0,0
165321,of,0,0
165322,oral,1,1
165323,dosing,1,0
165324,with,1,0
165325,placebo,1,1
165326,or,1,1
165327,fluoxetine,1,1
165328,",",1,0
165329,40,1,0
165330,mg,1,0
165331,per,1,0
165332,day,1,0
165333,.,1,0
165334,Brain,0,0
165335,5-HT4R,0,0
165336,binding,0,0
165337,was,0,0
165338,quantified,0,0
165339,at,0,0
165340,baseline,0,0
165341,and,0,0
165342,at,0,0
165343,follow-up,0,0
165344,with,0,0
165345,[,1,0
165346,(,1,0
165347,11,1,0
165348,),1,0
165349,C,1,0
165350,],1,0
165351,SB207145,1,0
165352,positron,1,0
165353,emission,1,1
165354,tomography,1,1
165355,(,1,0
165356,PET,1,1
165357,),1,0
165358,.,0,0
165359,Three,0,0
165360,weeks,0,0
165361,of,0,0
165362,intervention,0,1
165363,with,0,0
165364,fluoxetine,0,1
165365,was,0,0
165366,associated,0,0
165367,with,0,0
165368,a,0,0
165369,5.2,0,0
165370,%,0,0
165371,reduction,0,0
165372,in,0,0
165373,brain,0,0
165374,5-HT4R,0,0
165375,binding,0,0
165376,(,0,0
165377,P=0.017,0,0
165378,),0,0
165379,",",0,0
165380,whereas,0,0
165381,placebo,0,1
165382,intervention,0,1
165383,did,0,0
165384,not,0,0
165385,change,0,0
165386,5-HT4R,0,0
165387,binding,0,0
165388,(,0,0
165389,P=0.52,0,0
165390,),0,0
165391,.,0,0
165392,Our,0,0
165393,findings,0,0
165394,are,0,0
165395,consistent,0,0
165396,with,0,0
165397,a,0,0
165398,model,0,0
165399,",",0,0
165400,wherein,0,0
165401,the,0,0
165402,5-HT4R,0,0
165403,density,0,0
165404,adjusts,0,0
165405,to,0,0
165406,changes,0,0
165407,in,0,0
165408,the,0,0
165409,extracellular,0,0
165410,5-HT,0,1
165411,tonus,0,0
165412,.,0,0
165413,Our,0,0
165414,data,0,0
165415,demonstrate,0,0
165416,for,0,0
165417,the,0,0
165418,first,0,0
165419,time,0,0
165420,in,0,0
165421,humans,0,0
165422,that,0,0
165423,the,0,0
165424,imaging,0,0
165425,of,0,0
165426,central,0,0
165427,5-HT4R,0,0
165428,binding,0,0
165429,may,0,0
165430,be,0,0
165431,used,0,0
165432,as,0,0
165433,an,0,0
165434,in,0,0
165435,vivo,0,0
165436,biomarker,0,0
165437,of,0,0
165438,the,0,0
165439,central,0,0
165440,5-HT,0,1
165441,tonus,0,0
165442,.,0,0
165443,Iron,1,1
165444,supplementation,1,1
165445,improves,0,0
165446,energetic,0,0
165447,efficiency,0,0
165448,in,0,0
165449,iron-depleted,0,1
165450,female,0,0
165451,rowers,0,0
165452,.,0,0
165453,PURPOSE,0,0
165454,Studies,0,0
165455,in,0,0
165456,both,0,0
165457,animals,0,0
165458,and,0,0
165459,humans,0,0
165460,show,0,0
165461,a,0,0
165462,relationship,0,0
165463,between,0,0
165464,iron,0,1
165465,depletion,0,0
165466,without,0,1
165467,anemia,0,0
165468,(,0,0
165469,IDNA,0,1
165470,),0,1
165471,and,0,0
165472,physical,0,1
165473,performance,0,0
165474,.,0,0
165475,Compared,0,0
165476,with,0,0
165477,their,0,0
165478,sedentary,0,0
165479,counterparts,0,0
165480,",",0,0
165481,female,0,0
165482,endurance,0,0
165483,athletes,0,0
165484,are,0,0
165485,at,0,0
165486,greater,0,0
165487,risk,0,0
165488,of,0,0
165489,IDNA,0,1
165490,",",0,0
165491,and,0,0
165492,consequences,0,0
165493,relevant,0,0
165494,to,0,0
165495,endurance,0,0
165496,athletes,0,0
165497,include,0,0
165498,reduced,0,0
165499,work,0,0
165500,capacity,0,0
165501,and,0,0
165502,energetic,0,1
165503,efficiency,0,0
165504,(,0,0
165505,EF,0,1
165506,),0,0
165507,.,0,0
165508,We,0,0
165509,conducted,0,0
165510,a,0,0
165511,randomized,0,0
165512,placebo-controlled,1,1
165513,trial,0,0
165514,to,0,0
165515,investigate,0,0
165516,the,0,0
165517,effects,0,0
165518,of,0,0
165519,iron,1,1
165520,(,1,0
165521,Fe,1,1
165522,),1,0
165523,supplementation,1,1
165524,on,0,0
165525,Fe,0,0
165526,status,0,0
165527,and,0,0
165528,performance,0,0
165529,in,0,0
165530,nonanemic,0,0
165531,female,0,0
165532,rowers,0,0
165533,during,0,0
165534,training,0,1
165535,.,0,0
165536,METHODS,0,0
165537,At,0,0
165538,the,0,0
165539,beginning,0,0
165540,of,0,0
165541,a,0,0
165542,training,0,1
165543,season,0,0
165544,",",0,0
165545,40,0,0
165546,rowers,0,0
165547,were,0,0
165548,randomized,0,0
165549,to,0,0
165550,receive,0,0
165551,either,0,0
165552,100,1,0
165553,mg?d,1,0
165554,FeSO4,1,1
165555,(,0,0
165556,n,0,0
165557,=,0,0
165558,21,0,0
165559,),0,0
165560,or,1,1
165561,placebo,1,1
165562,(,0,0
165563,n,0,0
165564,=,0,0
165565,19,0,0
165566,),0,0
165567,using,0,0
165568,a,0,0
165569,double-blind,0,0
165570,design,0,0
165571,.,0,0
165572,Thirty-one,0,0
165573,(,0,0
165574,n,0,0
165575,=,0,0
165576,15,1,0
165577,Fe,1,0
165578,",",1,0
165579,16,1,0
165580,placebo,1,1
165581,),1,0
165582,completed,0,0
165583,the,0,0
165584,6-wk,0,1
165585,trial,0,0
165586,.,0,0
165587,Fe,0,0
165588,status,0,0
165589,(,0,0
165590,hemoglobin,0,0
165591,",",0,0
165592,serum,0,0
165593,ferritin,0,0
165594,",",0,0
165595,soluble,0,1
165596,transferrin,0,0
165597,receptor,0,0
165598,),0,0
165599,",",0,0
165600,body,0,0
165601,composition,0,0
165602,",",0,0
165603,and,0,0
165604,laboratory,0,0
165605,tests,0,0
165606,of,0,0
165607,physical,0,1
165608,performance,0,0
165609,(,0,0
165610,4-km,0,0
165611,time,0,0
165612,trial,0,0
165613,",",0,0
165614,V?O2peak,0,0
165615,",",0,0
165616,energetic,0,0
165617,EF,0,1
165618,",",0,0
165619,and,0,0
165620,blood,0,0
165621,lactate,0,0
165622,),0,0
165623,were,0,0
165624,assessed,0,0
165625,at,0,0
165626,baseline,0,0
165627,and,0,0
165628,after,0,0
165629,training,0,1
165630,.,0,0
165631,RESULTS,0,0
165632,Rowers,0,0
165633,in,0,0
165634,both,0,0
165635,groups,0,0
165636,increased,0,0
165637,their,0,0
165638,fat-free,0,1
165639,mass,0,0
165640,(,0,0
165641,P,0,0
165642,<,0,0
165643,0.001,0,0
165644,),0,0
165645,and,0,0
165646,V?O2peak,0,1
165647,(,0,0
165648,P,0,0
165649,<,0,0
165650,0.001,0,0
165651,),0,0
165652,after,0,0
165653,training,0,1
165654,.,0,0
165655,Multiple,0,0
165656,regression,0,0
165657,analyses,0,0
165658,revealed,0,0
165659,improvements,0,0
165660,in,0,0
165661,Fe,0,0
165662,stores,0,1
165663,(,0,0
165664,serum,0,0
165665,ferritin,0,1
165666,),0,0
165667,in,0,0
165668,the,0,0
165669,Fe,0,0
165670,treatment,0,0
165671,group,0,0
165672,after,0,0
165673,controlling,0,0
165674,for,0,0
165675,baseline,0,0
165676,Fe,0,0
165677,stores,0,0
165678,(,0,0
165679,P,0,0
165680,=,0,0
165681,0.07,0,0
165682,),0,0
165683,.,0,0
165684,Rowers,0,0
165685,in,0,0
165686,the,0,0
165687,Fe,0,0
165688,group,0,0
165689,had,0,0
165690,slower,0,0
165691,lactate,0,0
165692,response,0,0
165693,during,0,0
165694,the,0,0
165695,first,0,0
165696,half,0,0
165697,of,0,0
165698,the,0,0
165699,time,0,0
165700,trial,0,0
165701,and,0,0
165702,after,0,0
165703,5,0,0
165704,min,0,0
165705,of,0,0
165706,recovery,0,0
165707,(,0,0
165708,P,0,0
165709,=,0,0
165710,0.05,0,0
165711,),0,0
165712,and,0,0
165713,showed,0,0
165714,greater,0,0
165715,improvements,0,0
165716,in,0,0
165717,energy,0,0
165718,expenditure,0,0
165719,(,0,0
165720,P,0,0
165721,=,0,0
165722,0.01,0,0
165723,for,0,0
165724,group-by,0,1
165725,time,0,0
165726,),0,0
165727,and,0,0
165728,energetic,0,0
165729,EF,0,1
165730,compared,0,0
165731,with,0,0
165732,placebo,0,1
165733,(,0,0
165734,P,0,0
165735,=,0,0
165736,0.03,0,0
165737,for,0,0
165738,group-by,0,1
165739,time,0,0
165740,),0,0
165741,.,0,0
165742,CONCLUSIONS,0,0
165743,Female,0,0
165744,rowers,0,0
165745,with,0,0
165746,depleted,0,0
165747,Fe,0,0
165748,stores,0,0
165749,who,0,0
165750,consumed,0,0
165751,supplemental,0,0
165752,Fe,0,0
165753,during,0,0
165754,training,0,1
165755,improved,0,0
165756,their,0,0
165757,Fe,0,0
165758,status,0,0
165759,and,0,0
165760,energetic,0,0
165761,EF,0,1
165762,during,0,0
165763,endurance,0,0
165764,exercise,0,1
165765,.,0,0
165766,These,0,0
165767,results,0,0
165768,are,0,0
165769,important,0,0
165770,for,0,0
165771,endurance,0,0
165772,athletes,0,0
165773,whose,0,0
165774,dietary,0,0
165775,patterns,0,0
165776,and,0,0
165777,physical,0,1
165778,training,0,1
165779,increase,0,0
165780,their,0,0
165781,risk,0,0
165782,of,0,0
165783,IDNA,0,1
165784,and,0,0
165785,suggest,0,0
165786,that,0,0
165787,Fe,0,0
165788,supplementation,0,1
165789,may,0,0
165790,maximize,0,0
165791,the,0,0
165792,benefits,0,0
165793,of,0,0
165794,endurance,0,0
165795,training,0,1
165796,.,0,0
165797,Hypotension,0,0
165798,in,0,0
165799,response,0,0
165800,to,0,0
165801,iloprost,1,1
165802,",",0,0
165803,a,0,0
165804,prostacyclin,0,0
165805,analogue,0,0
165806,.,0,0
165807,QT/QTc,0,1
165808,study,0,0
165809,conducted,0,0
165810,in,0,0
165811,Japanese,0,0
165812,adult,0,0
165813,healthy,0,0
165814,subjects,0,0
165815,:,0,0
165816,a,0,0
165817,novel,0,0
165818,xanthine,0,1
165819,oxidase,0,1
165820,inhibitor,0,1
165821,topiroxostat,1,1
165822,was,0,0
165823,not,0,0
165824,associated,0,0
165825,with,0,0
165826,QT,0,0
165827,prolongation,0,0
165828,.,0,0
165829,A,0,0
165830,QT/QTc,0,0
165831,study,0,0
165832,was,0,0
165833,conducted,0,0
165834,in,0,0
165835,compliance,0,0
165836,with,0,0
165837,ICH,0,0
165838,E14,0,1
165839,guideline,0,0
165840,to,0,0
165841,evaluate,0,0
165842,the,0,0
165843,effects,0,0
165844,of,0,0
165845,a,0,0
165846,new,1,0
165847,xanthine,1,1
165848,oxidase,1,1
165849,inhibitor,1,1
165850,topiroxostat,1,1
165851,in,0,0
165852,Japanese,0,0
165853,healthy,0,0
165854,subjects,0,0
165855,.,0,0
165856,Forty-eight,0,0
165857,Japanese,0,0
165858,healthy,0,0
165859,subjects,0,0
165860,(,0,0
165861,males,0,0
165862,24,0,0
165863,;,0,0
165864,females,0,0
165865,24,0,0
165866,),0,0
165867,received,0,0
165868,a,0,0
165869,single,0,0
165870,oral,1,1
165871,dose,1,0
165872,of,1,0
165873,topiroxostat,1,1
165874,(,0,0
165875,60,0,0
165876,or,0,0
165877,180,1,0
165878,mg,1,1
165879,),1,0
165880,",",1,0
165881,moxifloxacin,1,1
165882,(,1,0
165883,400,1,0
165884,mg,1,1
165885,),1,0
165886,or,1,1
165887,placebo,1,1
165888,in,1,0
165889,a,0,0
165890,single-center,0,0
165891,",",0,0
165892,double-blind,0,0
165893,",",0,0
165894,four-period,0,1
165895,crossover,0,0
165896,design,0,0
165897,.,0,0
165898,Fridericia,0,0
165899,'s,0,0
165900,formula,0,1
165901,(,0,0
165902,QTcF,0,0
165903,=,0,0
165904,QT/RR,0,0
165905,(,0,0
165906,0.33,0,0
165907,),0,0
165908,),0,0
165909,was,0,0
165910,used,0,0
165911,as,0,0
165912,a,0,0
165913,primary,0,0
165914,method,0,0
165915,for,0,0
165916,QT-interval,0,0
165917,correction,0,0
165918,.,0,0
165919,The,0,0
165920,mean,0,0
165921,QTcF,0,0
165922,was,0,0
165923,prolonged,1,0
165924,by,1,0
165925,moxifloxacin,1,1
165926,",",1,0
165927,of,1,0
165928,which,1,0
165929,largest,0,0
165930,time-matched,0,0
165931,difference,0,0
165932,from,0,0
165933,placebo,0,1
165934,administration,0,0
165935,was,0,0
165936,13.6,0,0
165937,milliseconds,0,0
165938,with,0,0
165939,90,0,0
165940,%,0,0
165941,confidence,0,0
165942,interval,0,0
165943,(,0,0
165944,CI,0,0
165945,),0,0
165946,of,0,0
165947,11.2,0,0
165948,and,0,0
165949,15.9,0,0
165950,milliseconds,0,0
165951,at,0,0
165952,4,0,0
165953,hours,0,0
165954,post-dose,0,0
165955,.,0,0
165956,The,0,0
165957,mean,0,0
165958,QTcF,0,0
165959,was,0,0
165960,hardly,0,0
165961,affected,0,0
165962,by,0,0
165963,either,0,0
165964,dose,0,0
165965,of,0,0
165966,topiroxostat,0,1
165967,",",0,0
165968,of,0,0
165969,which,0,0
165970,largest,0,0
165971,time-matched,0,0
165972,difference,0,0
165973,from,0,0
165974,placebo,0,1
165975,administration,0,0
165976,was,0,0
165977,2.9,0,0
165978,milliseconds,0,0
165979,with,0,0
165980,90,0,0
165981,%,0,0
165982,CI,0,0
165983,of,0,0
165984,0.6,0,0
165985,and,0,0
165986,5.3,0,0
165987,milliseconds,0,0
165988,at,0,0
165989,4,0,0
165990,hours,0,0
165991,post-dose,0,0
165992,for,0,0
165993,60,0,0
165994,mg,0,0
165995,",",0,0
165996,and,0,0
165997,2.3,0,0
165998,milliseconds,0,0
165999,with,0,0
166000,90,0,0
166001,%,0,0
166002,CI,0,0
166003,of,0,0
166004,0,0,0
166005,and,0,0
166006,4.7,0,0
166007,milliseconds,0,0
166008,at,0,0
166009,1,0,0
166010,hour,0,0
166011,post-dose,0,0
166012,for,0,0
166013,180,0,0
166014,mg,0,0
166015,.,0,0
166016,The,0,0
166017,results,0,0
166018,were,0,0
166019,essentially,0,0
166020,the,0,0
166021,same,0,0
166022,in,0,0
166023,the,0,0
166024,sex,0,0
166025,subgroup,0,0
166026,analysis,0,0
166027,.,0,0
166028,Moxifloxacin,1,1
166029,can,1,0
166030,be,1,0
166031,used,0,0
166032,as,0,0
166033,a,0,0
166034,positive,0,0
166035,control,0,0
166036,for,0,0
166037,QT/QTc,0,0
166038,studies,0,0
166039,in,0,0
166040,Japanese,0,0
166041,subjects,0,0
166042,;,0,0
166043,and,0,0
166044,topiroxostat,0,1
166045,may,0,0
166046,not,0,0
166047,cause,0,0
166048,QT-interval,0,0
166049,prolongation,0,0
166050,in,0,0
166051,males,0,0
166052,as,0,0
166053,well,0,0
166054,as,0,0
166055,females,0,0
166056,.,0,0
166057,Promoting,0,0
166058,gynecologic,0,0
166059,cancer,0,0
166060,awareness,1,0
166061,at,0,0
166062,a,0,0
166063,critical,0,0
166064,juncture,0,0
166065,--,0,0
166066,where,0,0
166067,women,0,0
166068,and,0,0
166069,providers,0,0
166070,meet,0,0
166071,.,0,0
166072,Given,0,0
166073,the,0,0
166074,absence,0,0
166075,of,0,0
166076,effective,0,0
166077,population-based,0,0
166078,screening,0,0
166079,tests,0,0
166080,for,0,0
166081,ovarian,0,0
166082,",",0,0
166083,uterine,0,0
166084,",",0,0
166085,vaginal,0,0
166086,",",0,0
166087,and,0,0
166088,vulvar,0,0
166089,cancers,0,0
166090,",",0,0
166091,early,0,0
166092,detection,0,0
166093,can,0,0
166094,depend,0,0
166095,on,0,0
166096,women,0,0
166097,and,0,0
166098,health,0,0
166099,care,0,1
166100,providers,0,0
166101,recognizing,0,0
166102,the,0,0
166103,potential,0,0
166104,significance,0,0
166105,of,0,0
166106,symptoms,0,0
166107,.,0,0
166108,In,0,0
166109,2008,0,0
166110,",",0,0
166111,the,0,0
166112,Centers,0,0
166113,for,0,0
166114,Disease,0,0
166115,Control,0,1
166116,and,0,0
166117,Prevention,0,1
166118,'s,0,0
166119,(,0,0
166120,CDC,0,1
166121,),0,0
166122,Inside,0,1
166123,Knowledge,0,1
166124,campaign,0,0
166125,began,0,0
166126,distributing,0,0
166127,consumer,1,0
166128,education,1,1
166129,materials,1,1
166130,promoting,1,0
166131,awareness,1,0
166132,of,1,0
166133,gynecologic,1,0
166134,cancer,1,0
166135,symptoms,1,0
166136,.,1,0
166137,We,0,0
166138,investigated,0,0
166139,providers,0,0
166140,',0,0
166141,in-office,0,1
166142,use,0,0
166143,of,0,0
166144,CDC,0,1
166145,gynecologic,0,0
166146,cancer,0,0
166147,materials,0,1
166148,and,0,0
166149,their,0,0
166150,recognition,0,0
166151,of,0,0
166152,the,0,0
166153,symptoms,0,0
166154,highlighted,0,0
166155,in,0,0
166156,the,0,0
166157,materials,0,0
166158,.,0,0
166159,We,0,0
166160,analyzed,0,0
166161,data,0,0
166162,from,0,0
166163,a,0,0
166164,national,0,0
166165,2012,0,0
166166,survey,0,0
166167,of,0,0
166168,US,0,1
166169,primary,0,0
166170,care,0,0
166171,physicians,0,0
166172,",",0,0
166173,nurse,0,1
166174,practitioners,0,0
166175,",",0,0
166176,and,0,0
166177,gynecologists,0,0
166178,(,0,0
166179,N,0,0
166180,=,0,0
166181,"1,380",0,0
166182,),0,0
166183,.,0,0
166184,Less,0,0
166185,than,0,0
166186,a,0,0
166187,quarter,0,0
166188,of,0,0
166189,providers,0,0
166190,(,0,0
166191,19.4,0,0
166192,%,0,0
166193,),0,0
166194,reported,0,0
166195,using,0,0
166196,CDC,0,1
166197,gynecologic,0,0
166198,cancer,0,0
166199,education,0,1
166200,materials,0,0
166201,in,0,0
166202,their,0,0
166203,offices,0,0
166204,.,0,0
166205,The,0,0
166206,provider,0,0
166207,characteristics,0,0
166208,associated,0,0
166209,with,0,0
166210,the,0,0
166211,use,0,0
166212,of,0,0
166213,CDC,0,1
166214,materials,0,0
166215,were,0,0
166216,not,0,0
166217,consistent,0,0
166218,across,0,0
166219,specialties,0,0
166220,.,0,0
166221,However,0,0
166222,",",0,0
166223,recognition,0,0
166224,of,0,0
166225,symptoms,0,0
166226,associated,0,0
166227,with,0,0
166228,gynecologic,0,0
166229,cancers,0,0
166230,was,0,0
166231,consistently,0,0
166232,higher,0,0
166233,among,0,0
166234,providers,0,0
166235,who,0,0
166236,reported,0,0
166237,using,0,0
166238,CDC,0,1
166239,materials,0,1
166240,.,0,0
166241,The,0,0
166242,possibility,0,0
166243,that,0,0
166244,providers,0,0
166245,were,0,0
166246,educated,0,0
166247,about,0,0
166248,gynecologic,0,0
166249,cancer,0,0
166250,symptoms,0,0
166251,through,0,0
166252,the,0,0
166253,dissemination,0,0
166254,of,0,0
166255,materials,0,0
166256,intended,0,0
166257,for,0,0
166258,their,0,0
166259,patients,0,0
166260,is,0,0
166261,intriguing,0,0
166262,and,0,0
166263,warrants,0,0
166264,further,0,0
166265,investigation,0,0
166266,.,0,0
166267,Distributing,0,0
166268,consumer,0,0
166269,education,0,1
166270,materials,0,1
166271,in,0,0
166272,health,0,0
166273,care,0,1
166274,provider,0,1
166275,offices,0,1
166276,remains,0,0
166277,a,0,0
166278,priority,0,0
166279,for,0,0
166280,the,0,0
166281,Inside,0,1
166282,Knowledge,0,0
166283,campaign,0,0
166284,",",0,0
166285,as,0,0
166286,the,0,0
166287,setting,0,0
166288,where,0,0
166289,women,0,0
166290,and,0,0
166291,health,0,0
166292,care,0,1
166293,providers,0,0
166294,interact,0,0
166295,is,0,0
166296,one,0,0
166297,of,0,0
166298,the,0,0
166299,most,0,0
166300,crucial,0,0
166301,venues,0,0
166302,to,0,0
166303,promote,0,0
166304,awareness,0,0
166305,of,0,0
166306,gynecologic,0,0
166307,cancer,0,0
166308,symptoms,0,0
166309,.,0,0
166310,[,0,0
166311,Preoperative,0,0
166312,chemotherapy,1,1
166313,of,0,0
166314,esophageal,0,0
166315,cancer,0,0
166316,],0,0
166317,.,0,0
166318,A,0,0
166319,series,0,0
166320,of,0,0
166321,25,0,0
166322,patients,0,0
166323,with,0,0
166324,advanced,0,0
166325,esophageal,0,0
166326,cancer,0,0
166327,treated,0,0
166328,from,0,0
166329,Mar,0,0
166330,.,0,0
166331,1981,0,0
166332,to,0,0
166333,Sep.,0,0
166334,1982,0,0
166335,by,0,0
166336,preoperative,1,0
166337,chemotherapy,1,1
166338,plus,1,1
166339,surgery,1,1
166340,is,0,0
166341,reported,0,0
166342,.,0,0
166343,All,0,0
166344,the,0,0
166345,patients,0,0
166346,came,0,0
166347,from,0,0
166348,the,0,0
166349,hospitals,0,0
166350,of,0,0
166351,the,0,0
166352,cooperative,0,0
166353,research,0,0
166354,group,0,0
166355,and,0,0
166356,were,0,0
166357,randomized,0,0
166358,into,0,0
166359,chemotherapy,1,1
166360,and,0,0
166361,control,1,0
166362,groups,0,0
166363,.,0,0
166364,They,0,0
166365,were,0,0
166366,proved,0,0
166367,by,0,0
166368,X-ray,0,0
166369,",",0,0
166370,cytology,0,0
166371,and,0,0
166372,histopathology,0,0
166373,prior,0,0
166374,to,0,0
166375,treatment,0,0
166376,.,0,0
166377,By,0,0
166378,histology,0,0
166379,",",0,0
166380,22,0,0
166381,cases,0,0
166382,were,0,0
166383,squamous,0,0
166384,cell,0,0
166385,carcinoma,0,0
166386,",",0,0
166387,1,0,0
166388,adenocarcinoma,0,0
166389,and,0,0
166390,2,0,0
166391,squamous,0,0
166392,adenocarcinoma,0,0
166393,.,0,0
166394,The,0,0
166395,COF,0,1
166396,chemotherapy,1,1
166397,consisted,0,0
166398,of,0,0
166399,Vincristine,1,1
166400,1,1,0
166401,mg,1,0
166402,",",1,0
166403,cyclophosphamide,1,1
166404,600,1,0
166405,mg,1,0
166406,and,1,0
166407,5-fluorouracil,1,1
166408,500,1,0
166409,mg,1,0
166410,IV,1,0
166411,on,0,0
166412,days,0,0
166413,1,0,0
166414,and,0,0
166415,8,0,0
166416,with,0,0
166417,or,0,0
166418,without,0,0
166419,the,0,0
166420,addition,0,0
166421,of,0,0
166422,Pingyangmycin,1,1
166423,",",0,0
166424,a,0,0
166425,drug,0,0
166426,equivalent,0,0
166427,to,0,0
166428,Bleomycin,1,1
166429,A5,1,1
166430,",",0,0
166431,at,0,0
166432,the,0,0
166433,dose,0,0
166434,of,0,0
166435,10,0,0
166436,mg,0,0
166437,IM,0,0
166438,on,0,0
166439,days,0,0
166440,1,0,0
166441,",",0,0
166442,3,0,0
166443,",",0,0
166444,6,0,0
166445,and,0,0
166446,8,0,0
166447,.,0,0
166448,The,0,0
166449,interval,0,0
166450,between,0,0
166451,the,0,0
166452,ending,0,0
166453,of,0,0
166454,chemotherapy,1,1
166455,and,0,0
166456,the,0,0
166457,surgical,1,0
166458,resection,1,1
166459,was,0,0
166460,5-6,0,0
166461,days,0,0
166462,.,0,0
166463,The,0,0
166464,results,0,0
166465,showed,0,0
166466,that,0,0
166467,preoperative,0,0
166468,chemotherapy,0,1
166469,caused,0,0
166470,no,0,0
166471,myelosuppression,0,0
166472,",",0,0
166473,but,0,0
166474,merely,0,0
166475,mild,0,0
166476,gastrointestinal,0,0
166477,symptoms,0,0
166478,.,0,0
166479,All,0,0
166480,patients,0,0
166481,were,0,0
166482,operated,0,0
166483,and,0,0
166484,resected,0,0
166485,without,0,0
166486,difficulty,0,0
166487,.,0,0
166488,The,0,0
166489,subjective,0,0
166490,improvement,0,0
166491,in,0,0
166492,various,0,0
166493,degrees,0,0
166494,and,0,0
166495,the,0,0
166496,shrinkage,0,0
166497,of,0,0
166498,tumor,0,0
166499,in,0,0
166500,the,0,0
166501,X-ray,0,0
166502,films,0,0
166503,were,0,0
166504,present,0,0
166505,in,0,0
166506,5/25,0,0
166507,cases,0,0
166508,who,0,0
166509,received,0,0
166510,preoperative,0,0
166511,chemotherapy,1,1
166512,.,1,0
166513,The,0,0
166514,histopathological,0,0
166515,changes,0,0
166516,in,0,0
166517,the,0,0
166518,chemotherapy,0,1
166519,and,0,0
166520,control,0,1
166521,groups,0,0
166522,(,0,0
166523,16,0,0
166524,specimens,0,0
166525,),0,0
166526,were,0,0
166527,different,0,0
166528,.,0,0
166529,In,0,0
166530,the,0,0
166531,chemotherapy,1,1
166532,group,0,0
166533,",",0,0
166534,excessive,0,0
166535,keratinization,0,0
166536,in,0,0
166537,the,0,0
166538,squamous,0,0
166539,component,0,0
166540,of,0,0
166541,the,0,0
166542,esophageal,0,0
166543,cancerous,0,0
166544,tissue,0,0
166545,appeared,0,0
166546,in,0,0
166547,the,0,0
166548,resected,0,0
166549,specimens,0,0
166550,.,0,0
166551,The,0,0
166552,incidence,0,0
166553,of,0,0
166554,degeneration,0,0
166555,and,0,0
166556,necrosis,0,0
166557,in,0,0
166558,the,0,0
166559,squamous,0,0
166560,epithelium,0,0
166561,adjacent,0,0
166562,to,0,0
166563,carcinoma,0,0
166564,was,0,0
166565,higher,0,0
166566,in,0,0
166567,the,0,0
166568,chemotherapy,1,1
166569,group,0,0
166570,(,0,0
166571,P,0,0
166572,less,0,0
166573,than,0,0
166574,0.01,0,0
166575,),0,0
166576,.,0,0
166577,The,0,0
166578,results,0,0
166579,suggested,0,0
166580,that,0,0
166581,such,0,0
166582,combined,0,1
166583,modality,0,0
166584,is,0,0
166585,worth,0,0
166586,further,0,0
166587,study,0,0
166588,.,0,0
166589,The,0,0
166590,efficacy,0,0
166591,and,0,0
166592,safety,0,0
166593,of,0,0
166594,cyclosporine,1,1
166595,reduction,1,0
166596,in,0,0
166597,de,0,0
166598,novo,0,0
166599,renal,0,0
166600,allograft,0,0
166601,patients,0,0
166602,receiving,0,0
166603,sirolimus,0,1
166604,and,0,0
166605,corticosteroids,0,1
166606,:,0,0
166607,results,0,0
166608,from,0,0
166609,an,0,0
166610,open-label,0,0
166611,comparative,0,0
166612,study,0,0
166613,.,0,0
166614,This,0,0
166615,study,0,0
166616,evaluated,0,0
166617,the,0,0
166618,safety,0,0
166619,and,0,0
166620,efficacy,0,0
166621,of,0,0
166622,a,0,0
166623,sirolimus,1,1
166624,",",1,0
166625,corticosteroid,1,1
166626,",",1,0
166627,and,1,0
166628,cyclosporine,1,1
166629,reduction,1,0
166630,regimen,0,0
166631,in,0,0
166632,an,0,0
166633,open-label,0,0
166634,",",0,0
166635,12-month,0,0
166636,trial,0,0
166637,of,0,0
166638,420,0,0
166639,de,0,0
166640,novo,0,0
166641,renal,0,0
166642,allograft,0,0
166643,recipients,0,0
166644,at,0,0
166645,49,0,0
166646,European,0,0
166647,transplant,0,0
166648,centers,0,0
166649,.,0,0
166650,One,0,0
166651,month,0,0
166652,post-transplantation,0,0
166653,",",0,0
166654,357,0,0
166655,patients,0,0
166656,were,0,0
166657,randomized,0,0
166658,to,0,0
166659,receive,0,0
166660,standard-dose,1,1
166661,cyclosporine,1,1
166662,(,1,0
166663,sCsA,1,0
166664,",",0,0
166665,n,0,0
166666,=,0,0
166667,179,0,0
166668,),0,0
166669,or,0,0
166670,reduced-dose,1,1
166671,cyclosporine,1,1
166672,(,1,0
166673,rCsA,1,0
166674,",",0,0
166675,n,0,0
166676,=,0,0
166677,178,0,0
166678,),0,0
166679,.,0,0
166680,All,0,0
166681,patients,0,0
166682,also,0,0
166683,received,0,0
166684,sirolimus,1,1
166685,and,1,0
166686,corticosteroids,1,1
166687,.,1,0
166688,The,0,0
166689,primary,0,0
166690,end,0,0
166691,points,0,0
166692,were,0,0
166693,the,0,0
166694,rate,0,0
166695,of,0,0
166696,biopsy-confirmed,0,0
166697,acute,0,0
166698,rejection,0,0
166699,(,0,0
166700,BCAR,0,0
166701,),0,1
166702,and,0,0
166703,renal,0,0
166704,function,0,0
166705,",",0,0
166706,as,0,0
166707,measured,0,0
166708,by,0,0
166709,serum,0,0
166710,creatinine,0,0
166711,.,0,0
166712,Baseline,0,0
166713,demographic,0,0
166714,and,0,0
166715,donor,0,0
166716,characteristics,0,0
166717,were,0,0
166718,similar,0,0
166719,between,0,0
166720,groups,0,0
166721,.,0,0
166722,BCAR,0,0
166723,rates,0,0
166724,at,0,0
166725,12,0,0
166726,months,0,0
166727,were,0,0
166728,not,0,0
166729,significantly,0,0
166730,different,0,0
166731,:,0,0
166732,11.2,0,0
166733,%,0,0
166734,for,0,0
166735,rCsA,0,0
166736,patients,0,0
166737,and,0,0
166738,16.2,0,0
166739,%,0,0
166740,for,0,0
166741,sCsA,0,0
166742,patients,0,0
166743,.,0,0
166744,Mean,0,0
166745,serum,0,0
166746,creatinine,0,0
166747,(,0,0
166748,?SEM,0,1
166749,),0,0
166750,was,0,0
166751,significantly,0,0
166752,lower,0,0
166753,(,0,0
166754,1.75,0,0
166755,?,0,0
166756,0.10,0,0
166757,vs.,0,0
166758,1.97,0,0
166759,?,0,0
166760,0.07,0,0
166761,mg/dl,0,0
166762,",",0,0
166763,P,0,0
166764,<,0,0
166765,0.001,0,0
166766,),0,0
166767,",",0,0
166768,and,0,0
166769,creatinine,0,0
166770,clearance,0,0
166771,(,0,0
166772,?SEM,0,1
166773,;,0,0
166774,Nankivell,0,1
166775,method,0,0
166776,),0,0
166777,was,0,0
166778,significantly,0,0
166779,higher,0,0
166780,(,0,0
166781,57.8,0,0
166782,?,0,0
166783,1.78,0,0
166784,vs.,0,0
166785,49.5,0,0
166786,?,0,0
166787,2.46,0,0
166788,ml/min,0,0
166789,",",0,0
166790,P,0,0
166791,<,0,0
166792,0.001,0,0
166793,),0,0
166794,in,0,0
166795,patients,0,0
166796,receiving,0,0
166797,rCsA,0,0
166798,versus,0,1
166799,sCsA,0,0
166800,at,0,0
166801,1,0,0
166802,year,0,0
166803,",",0,0
166804,respectively,0,0
166805,.,0,0
166806,Patient,0,0
166807,and,0,0
166808,graft,0,0
166809,survival,0,0
166810,exceeded,0,0
166811,98,0,0
166812,%,0,0
166813,in,0,0
166814,both,0,0
166815,groups,0,0
166816,.,0,0
166817,No,0,0
166818,significant,0,0
166819,differences,0,0
166820,in,0,0
166821,infection,0,0
166822,or,0,1
166823,malignancy,0,0
166824,were,0,0
166825,noted,0,0
166826,between,0,0
166827,groups,0,0
166828,.,0,0
166829,The,0,0
166830,rCsA,0,0
166831,with,0,0
166832,sirolimus,0,1
166833,and,0,0
166834,corticosteroid,0,1
166835,regimen,0,1
166836,resulted,0,0
166837,in,0,0
166838,excellent,0,0
166839,12-month,0,0
166840,patient,0,0
166841,and,0,0
166842,graft,0,0
166843,survival,0,0
166844,",",0,0
166845,a,0,0
166846,low,0,0
166847,incidence,0,0
166848,of,0,0
166849,BCAR,0,0
166850,",",0,0
166851,and,0,0
166852,improved,0,0
166853,renal,0,0
166854,function,0,0
166855,in,0,0
166856,renal,0,0
166857,allograft,0,0
166858,recipients,0,0
166859,.,0,0
166860,Sirolimus,0,1
166861,administered,0,0
166862,with,0,0
166863,rCsA,0,0
166864,and,0,0
166865,corticosteroids,0,1
166866,provided,0,0
166867,adequate,0,0
166868,immunosuppression,0,1
166869,while,0,0
166870,reducing,0,0
166871,the,0,0
166872,potential,0,0
166873,for,0,0
166874,the,0,0
166875,nephrotoxic,0,0
166876,effects,0,0
166877,of,0,0
166878,cyclosporine,0,1
166879,.,0,0
166880,These,0,0
166881,findings,0,0
166882,may,0,0
166883,help,0,0
166884,to,0,0
166885,improve,0,0
166886,long-term,0,0
166887,renal,0,0
166888,allograft,0,0
166889,outcomes,0,0
166890,.,0,0
166891,Continuous,0,1
166892,glucose,0,0
166893,monitoring,0,0
166894,in,0,0
166895,acute,0,0
166896,coronary,0,0
166897,syndrome,0,0
166898,.,0,0
166899,BACKGROUND,0,0
166900,Diabetes,0,0
166901,mellitus,0,0
166902,is,0,0
166903,an,0,0
166904,independent,0,0
166905,risk,0,0
166906,factor,0,0
166907,for,0,0
166908,cardiovascular,0,0
166909,disease,0,0
166910,.,0,0
166911,OBJECTIVE,0,0
166912,To,0,0
166913,compare,0,0
166914,the,0,0
166915,efficacy,0,0
166916,of,0,0
166917,devices,0,0
166918,for,0,0
166919,continuous,0,1
166920,glucose,0,0
166921,monitoring,0,0
166922,and,0,0
166923,capillary,0,0
166924,glucose,0,0
166925,monitoring,0,0
166926,in,0,0
166927,hospitalized,0,0
166928,patients,0,0
166929,with,0,0
166930,acute,0,0
166931,coronary,0,0
166932,syndrome,0,0
166933,using,0,0
166934,the,0,0
166935,following,0,0
166936,parameters,0,0
166937,:,0,0
166938,time,0,0
166939,to,0,0
166940,achieve,0,0
166941,normoglycemia,0,0
166942,",",0,0
166943,period,0,0
166944,of,0,0
166945,time,0,0
166946,in,0,0
166947,normoglycemia,0,0
166948,",",0,0
166949,and,0,0
166950,episodes,0,0
166951,of,0,0
166952,hypoglycemia,0,0
166953,.,0,0
166954,METHODS,0,0
166955,We,0,0
166956,performed,0,0
166957,a,0,0
166958,pilot,0,0
166959,",",0,0
166960,non-randomized,0,0
166961,",",0,0
166962,unblinded,0,0
166963,clinical,0,0
166964,trial,0,0
166965,that,0,0
166966,included,0,0
166967,16,0,0
166968,patients,0,0
166969,with,0,0
166970,acute,0,0
166971,coronary,0,0
166972,artery,0,0
166973,syndrome,0,0
166974,",",0,0
166975,a,0,0
166976,capillary,0,0
166977,or,0,0
166978,venous,0,0
166979,blood,0,0
166980,glucose,0,0
166981,?,0,0
166982,140,0,0
166983,mg/dl,0,0
166984,",",0,0
166985,and,0,0
166986,treatment,0,0
166987,with,0,0
166988,a,0,0
166989,continuous,0,1
166990,infusion,0,1
166991,of,0,0
166992,fast,0,0
166993,acting,0,0
166994,human,1,0
166995,insulin,1,1
166996,.,1,0
166997,These,0,0
166998,patients,0,0
166999,were,0,0
167000,randomized,0,0
167001,into,0,0
167002,2,0,0
167003,groups,0,0
167004,:,0,0
167005,a,0,0
167006,conventional,0,1
167007,group,0,0
167008,",",0,0
167009,in,0,0
167010,which,1,0
167011,capillary,1,0
167012,measurement,1,0
167013,and,1,0
167014,recording,1,0
167015,as,1,0
167016,well,1,0
167017,as,1,0
167018,insulin,1,1
167019,adjustment,1,0
167020,were,1,0
167021,made,0,0
167022,every,0,0
167023,4h,0,0
167024,",",0,0
167025,and,0,0
167026,an,0,0
167027,intervention,0,1
167028,group,0,0
167029,",",0,0
167030,in,0,0
167031,which,1,0
167032,measurement,1,0
167033,and,1,0
167034,recording,1,0
167035,as,1,0
167036,well,1,0
167037,as,1,0
167038,insulin,1,1
167039,adjustment,1,0
167040,were,1,0
167041,made,1,0
167042,every,1,0
167043,hour,1,0
167044,with,1,0
167045,a,1,0
167046,subcutaneous,1,0
167047,continuous,1,1
167048,monitoring,1,0
167049,system,1,1
167050,.,1,0
167051,Student,0,0
167052,'s,0,0
167053,t-test,0,0
167054,was,0,0
167055,applied,0,0
167056,for,0,0
167057,mean,0,0
167058,differences,0,0
167059,and,0,0
167060,the,0,0
167061,X,0,1
167062,(,0,0
167063,2,0,0
167064,),0,0
167065,test,0,0
167066,for,0,0
167067,qualitative,0,0
167068,variables,0,0
167069,.,0,0
167070,RESULTS,0,0
167071,We,0,0
167072,observed,0,0
167073,a,0,0
167074,statistically,0,0
167075,significant,0,0
167076,difference,0,0
167077,in,0,0
167078,the,0,0
167079,mean,0,0
167080,time,0,0
167081,for,0,0
167082,achieving,0,0
167083,normoglycemia,0,0
167084,",",0,0
167085,favoring,0,0
167086,the,0,0
167087,conventional,0,1
167088,group,0,0
167089,with,0,0
167090,a,0,0
167091,P,0,0
167092,=,0,0
167093,0.02,0,0
167094,.,0,0
167095,CONCLUSION,0,0
167096,Continuous,0,1
167097,monitoring,0,0
167098,systems,0,0
167099,are,0,0
167100,as,0,0
167101,useful,0,0
167102,as,0,0
167103,capillary,0,0
167104,monitoring,0,0
167105,for,0,0
167106,achieving,0,0
167107,normoglycemia,0,0
167108,.,0,0
167109,Influence,0,0
167110,of,0,0
167111,two,0,0
167112,different,0,0
167113,doses,0,0
167114,of,0,0
167115,antithymocyte,1,1
167116,globulin,1,1
167117,in,0,0
167118,patients,0,0
167119,with,0,0
167120,standard-risk,0,0
167121,disease,0,0
167122,following,0,0
167123,haploidentical,0,1
167124,transplantation,0,0
167125,:,0,0
167126,a,0,0
167127,randomized,0,0
167128,trial,0,0
167129,.,0,0
167130,To,0,0
167131,evaluate,0,0
167132,the,0,0
167133,effect,0,0
167134,of,0,0
167135,the,0,0
167136,different,0,0
167137,doses,0,0
167138,of,0,0
167139,antithymocyte,1,1
167140,globulin,1,1
167141,(,1,0
167142,ATG,1,1
167143,),1,0
167144,on,0,0
167145,the,0,0
167146,incidence,0,0
167147,of,0,0
167148,acute,0,0
167149,GVHD,0,0
167150,among,0,0
167151,patients,0,0
167152,receiving,0,0
167153,hematopoietic,0,0
167154,SCT,0,0
167155,without,0,0
167156,ex,0,0
167157,vivo,0,0
167158,T-cell-depletion,0,1
167159,from,0,0
167160,haploidentical,0,0
167161,donors,0,0
167162,",",0,0
167163,224,0,0
167164,patients,0,0
167165,with,0,0
167166,standard-risk,0,0
167167,hematological,0,0
167168,malignancy,0,0
167169,were,0,0
167170,randomized,0,0
167171,in,0,0
167172,this,0,0
167173,study,0,0
167174,.,0,0
167175,One,0,0
167176,hundred,0,0
167177,and,0,0
167178,twelve,0,0
167179,patients,0,0
167180,received,0,0
167181,6,1,0
167182,mg/kg,1,0
167183,ATG,1,1
167184,",",1,0
167185,whereas,0,0
167186,the,0,0
167187,remaining,0,0
167188,patients,0,0
167189,received,1,0
167190,10,1,0
167191,mg/kg,1,0
167192,ATG,1,1
167193,.,0,0
167194,This,0,0
167195,study,0,0
167196,was,0,0
167197,registered,0,0
167198,at,0,0
167199,http,0,0
167200,:,0,0
167201,//www.chictr.org,0,0
167202,as,0,0
167203,No,0,0
167204,.,0,0
167205,ChiCTR-TRC-11001761,0,0
167206,.,0,0
167207,The,0,0
167208,incidence,0,0
167209,of,0,0
167210,grade,0,0
167211,III-IV,0,0
167212,acute,0,0
167213,GVHD,0,0
167214,was,0,0
167215,higher,0,0
167216,in,0,0
167217,the,0,0
167218,ATG-6,1,1
167219,group,1,0
167220,(,0,0
167221,16.1,0,0
167222,%,0,0
167223,",",0,0
167224,95,0,0
167225,%,0,0
167226,confidence,0,0
167227,interval,0,0
167228,(,0,0
167229,CI,0,0
167230,),0,0
167231,",",0,0
167232,9.1-23.1,0,0
167233,%,0,0
167234,),0,0
167235,than,0,0
167236,in,0,0
167237,the,0,0
167238,ATG-10,1,1
167239,group,1,0
167240,(,0,0
167241,4.5,0,0
167242,%,0,0
167243,",",0,0
167244,CI,0,0
167245,",",0,0
167246,0.7-8.3,0,0
167247,%,0,0
167248,",",0,0
167249,P=0.005,0,0
167250,",",0,0
167251,95,0,0
167252,%,0,0
167253,CI,0,0
167254,for,0,0
167255,the,0,0
167256,difference,0,0
167257,",",0,0
167258,-19.4,0,0
167259,%,0,0
167260,to,0,0
167261,-3.8,0,0
167262,%,0,0
167263,),0,0
167264,.,0,0
167265,EBV,0,0
167266,reactivation,0,0
167267,occurred,0,0
167268,more,0,0
167269,frequently,0,0
167270,in,0,0
167271,the,0,0
167272,ATG-10,1,1
167273,group,1,0
167274,(,0,0
167275,25.3,0,0
167276,%,0,0
167277,",",0,0
167278,17.1-33.5,0,0
167279,%,0,0
167280,),0,0
167281,than,0,0
167282,in,0,0
167283,the,0,0
167284,ATG-6,1,1
167285,group,1,0
167286,(,0,0
167287,9.6,0,0
167288,%,0,0
167289,(,0,0
167290,4.0-15.2,0,0
167291,%,0,0
167292,),0,0
167293,",",0,0
167294,P=0.001,0,0
167295,),0,0
167296,.,0,0
167297,The,0,0
167298,1-year,0,0
167299,disease-free,0,0
167300,survival,0,0
167301,rates,0,0
167302,were,0,0
167303,84.3,0,0
167304,%,0,0
167305,(,0,0
167306,77.3-91.3,0,0
167307,%,0,0
167308,),0,0
167309,and,0,0
167310,86.0,0,0
167311,%,0,0
167312,(,0,0
167313,79.2-92.8,0,0
167314,%,0,0
167315,),0,0
167316,for,0,0
167317,the,0,0
167318,ATG-6,1,0
167319,group,1,0
167320,and,0,0
167321,ATG-10,1,1
167322,groups,1,0
167323,",",0,0
167324,respectively,0,0
167325,(,0,0
167326,P=0.88,0,0
167327,),0,0
167328,.,0,0
167329,In,0,0
167330,conclusion,0,0
167331,",",0,0
167332,although,1,0
167333,6,1,0
167334,mg/kg,1,0
167335,ATG,1,0
167336,applied,1,0
167337,in,0,0
167338,haploidentical,0,0
167339,transplantation,0,0
167340,decreased,0,0
167341,the,0,0
167342,risk,0,0
167343,of,0,0
167344,EBV,0,0
167345,reactivation,0,0
167346,compared,1,0
167347,with,1,0
167348,10,1,0
167349,mg/kg,1,0
167350,ATG,1,0
167351,",",1,0
167352,this,1,0
167353,treatment,0,0
167354,exposes,0,0
167355,patients,0,0
167356,to,0,0
167357,a,0,0
167358,higher,0,0
167359,risk,0,0
167360,for,0,0
167361,severe,0,0
167362,acute,0,0
167363,GVHD,0,0
167364,.,0,0
167365,Short-term,1,1
167366,amiodarone,1,1
167367,therapy,1,1
167368,after,0,0
167369,reversion,0,0
167370,of,0,0
167371,persistent,0,0
167372,atrial,0,0
167373,fibrillation,0,0
167374,reduces,0,0
167375,recurrences,0,0
167376,at,0,0
167377,18,0,0
167378,months,0,0
167379,.,0,0
167380,BACKGROUND,0,0
167381,The,0,0
167382,aim,0,0
167383,of,0,0
167384,this,0,0
167385,study,0,0
167386,was,0,0
167387,to,0,0
167388,compare,0,0
167389,the,0,0
167390,outcome,0,0
167391,of,0,0
167392,3,0,0
167393,months,0,0
167394,vs.,0,0
167395,18,0,0
167396,months,0,0
167397,of,0,0
167398,amiodarone,1,1
167399,treatment,0,0
167400,after,0,0
167401,atrial,0,0
167402,fibrillation,0,0
167403,(,0,0
167404,AF,0,1
167405,),0,0
167406,conversion,0,0
167407,in,0,0
167408,patients,0,0
167409,who,0,0
167410,experienced,0,0
167411,the,0,0
167412,first,0,0
167413,episode,0,0
167414,of,0,0
167415,persistent,0,0
167416,AF,0,0
167417,.,0,0
167418,METHODS,0,0
167419,We,0,0
167420,included,0,0
167421,51,0,0
167422,patients,0,0
167423,who,0,0
167424,experienced,0,0
167425,the,0,0
167426,first,0,0
167427,episode,0,0
167428,of,0,0
167429,persistent,0,0
167430,AF,0,1
167431,receiving,0,1
167432,amiodarone,1,1
167433,(,0,0
167434,600,0,1
167435,mg,0,1
167436,),0,0
167437,daily,0,0
167438,for,0,0
167439,4-6,0,0
167440,weeks,0,0
167441,.,0,0
167442,If,0,0
167443,AF,0,0
167444,persisted,0,0
167445,",",0,0
167446,electrical,1,1
167447,cardioversion,1,1
167448,(,1,0
167449,ECV,1,1
167450,),1,0
167451,was,0,0
167452,performed,0,0
167453,.,0,0
167454,All,0,0
167455,patients,0,0
167456,received,0,0
167457,amiodarone,1,1
167458,(,0,0
167459,200,0,0
167460,mg,0,1
167461,daily,0,0
167462,),0,0
167463,for,0,0
167464,3,0,0
167465,months,0,0
167466,and,0,0
167467,then,0,0
167468,were,0,0
167469,randomized,0,0
167470,to,0,0
167471,amiodarone,1,1
167472,(,0,0
167473,Group,0,0
167474,I,0,0
167475,),0,0
167476,or,1,1
167477,placebo,1,1
167478,(,0,0
167479,Group,0,0
167480,II,0,1
167481,),0,0
167482,and,0,0
167483,followed,0,0
167484,for,0,0
167485,15,0,0
167486,months,0,0
167487,.,0,0
167488,The,0,0
167489,control,0,0
167490,group,0,0
167491,comprised,0,0
167492,9,0,0
167493,untreated,0,0
167494,patients,0,0
167495,undergoing,0,0
167496,ECV,1,0
167497,.,1,0
167498,Treatment,0,0
167499,effectiveness,0,0
167500,was,0,0
167501,evaluated,0,0
167502,using,0,0
167503,a,0,0
167504,Bayesian,0,0
167505,model,0,0
167506,.,0,0
167507,RESULTS,0,0
167508,Eighteen,0,0
167509,months,0,0
167510,after,0,0
167511,AF,0,0
167512,reversion,0,0
167513,",",0,0
167514,22,0,0
167515,(,0,0
167516,81.5,0,0
167517,%,0,0
167518,),0,0
167519,patients,0,0
167520,in,0,0
167521,Group,0,0
167522,I,0,0
167523,",",0,0
167524,13,0,0
167525,(,0,0
167526,54.2,0,0
167527,%,0,0
167528,),0,0
167529,patients,0,0
167530,in,0,0
167531,Group,0,0
167532,II,0,0
167533,",",0,0
167534,and,0,0
167535,1,0,0
167536,(,0,0
167537,11.1,0,0
167538,%,0,0
167539,),0,0
167540,patient,0,0
167541,in,0,0
167542,the,0,0
167543,control,0,0
167544,group,0,0
167545,remained,0,0
167546,in,0,0
167547,sinus,0,0
167548,rhythm,0,1
167549,.,0,0
167550,No,0,0
167551,differences,0,0
167552,were,0,0
167553,found,0,0
167554,between,0,0
167555,Group,0,0
167556,I,0,0
167557,patients,0,0
167558,who,0,0
167559,required,0,0
167560,ECV,1,0
167561,and,0,0
167562,Group,0,0
167563,II,0,0
167564,patients,0,0
167565,.,0,0
167566,Sinus,0,0
167567,rhythm,0,0
167568,was,0,0
167569,preserved,0,0
167570,in,0,0
167571,all,0,0
167572,Group,0,0
167573,I,0,0
167574,patients,0,0
167575,when,0,0
167576,it,0,0
167577,was,0,0
167578,achieved,0,0
167579,during,0,0
167580,amiodarone,0,1
167581,administration,0,0
167582,.,0,0
167583,Limiting,0,0
167584,adverse,0,0
167585,effects,0,0
167586,occurred,0,0
167587,in,0,0
167588,3,0,0
167589,(,0,0
167590,11.1,0,0
167591,%,0,0
167592,),0,0
167593,patients,0,0
167594,in,0,0
167595,Group,0,0
167596,I,0,0
167597,.,0,0
167598,CONCLUSIONS,0,0
167599,In,0,0
167600,patients,0,0
167601,regaining,0,0
167602,sinus,0,0
167603,rhythm,0,1
167604,after,0,0
167605,the,0,0
167606,first,0,0
167607,episode,0,0
167608,of,0,0
167609,persistent,0,0
167610,AF,0,0
167611,",",0,0
167612,a,0,0
167613,3-month,0,0
167614,amiodarone,1,1
167615,treatment,0,0
167616,after,0,0
167617,reversion,0,0
167618,is,0,0
167619,a,0,0
167620,reasonable,0,0
167621,option,0,0
167622,for,0,0
167623,rhythm,0,1
167624,control,0,0
167625,.,0,0
167626,Radiation,0,1
167627,and,0,0
167628,contrast,0,0
167629,agent,0,0
167630,doses,0,0
167631,reductions,0,0
167632,by,0,0
167633,using,0,0
167634,80-kV,0,0
167635,tube,0,1
167636,voltage,0,0
167637,in,0,0
167638,coronary,0,0
167639,computed,0,0
167640,tomographic,0,0
167641,angiography,0,1
167642,:,0,0
167643,a,0,0
167644,comparative,0,0
167645,study,0,0
167646,.,0,0
167647,OBJECTIVE,0,0
167648,To,0,0
167649,investigate,0,0
167650,the,0,0
167651,effects,0,0
167652,of,0,0
167653,80-kilovoltage,1,1
167654,(,1,0
167655,kV,1,1
167656,),1,1
167657,tube,1,1
167658,voltage,1,0
167659,coronary,1,0
167660,computed,1,0
167661,tomographic,1,1
167662,angiography,1,1
167663,(,1,0
167664,CCTA,1,0
167665,),1,0
167666,with,0,0
167667,a,0,0
167668,reduced,0,0
167669,amount,0,0
167670,of,0,0
167671,contrast,0,0
167672,agent,0,0
167673,on,0,0
167674,qualitative,0,0
167675,and,0,0
167676,quantitative,0,0
167677,image,0,1
167678,quality,0,0
167679,parameters,0,0
167680,and,0,0
167681,on,0,0
167682,radiation,0,1
167683,dose,0,0
167684,in,0,0
167685,patients,0,0
167686,with,0,0
167687,a,0,0
167688,body,0,0
167689,mass,0,0
167690,index,0,0
167691,(,0,0
167692,BMI,0,0
167693,),0,0
167694,<,0,0
167695,23.0,0,0
167696,kg/m,0,0
167697,(,0,0
167698,2,0,0
167699,),0,0
167700,.,0,0
167701,METHODS,0,0
167702,One,0,0
167703,hundred,0,0
167704,and,0,0
167705,twenty,0,0
167706,consecutive,0,0
167707,patients,0,0
167708,with,0,0
167709,a,0,0
167710,BMI,0,0
167711,<,0,0
167712,23.0,0,0
167713,kg/m,0,0
167714,(,0,0
167715,2,0,0
167716,),0,0
167717,and,0,0
167718,a,0,0
167719,low,0,0
167720,calcium,0,1
167721,load,0,0
167722,undergoing,0,0
167723,retrospective,1,0
167724,electrocardiogram,1,1
167725,(,1,0
167726,ECG,1,1
167727,),1,0
167728,-gated,1,1
167729,dual-source,1,0
167730,CCTA,1,0
167731,were,0,0
167732,randomized,0,0
167733,into,0,0
167734,two,0,0
167735,groups,0,0
167736,[,1,0
167737,standard-tube,1,1
167738,voltage,1,0
167739,(,1,0
167740,120-kV,1,0
167741,),1,0
167742,vs.,1,0
167743,low-tube,1,1
167744,voltage,1,0
167745,(,1,0
167746,80-kV,1,0
167747,),1,0
167748,],1,0
167749,.,0,0
167750,The,0,0
167751,injection,0,0
167752,flow,0,0
167753,rate,0,0
167754,of,0,0
167755,contrast,0,0
167756,agent,0,0
167757,(,0,0
167758,350,0,0
167759,mg,0,1
167760,I/mL,0,1
167761,),0,0
167762,was,0,0
167763,adjusted,0,0
167764,to,0,0
167765,body,0,0
167766,weight,0,0
167767,of,0,0
167768,each,0,0
167769,patient,0,0
167770,(,0,0
167771,4.5-5.5,0,0
167772,mL/s,0,0
167773,in,0,0
167774,the,0,0
167775,120-kV,0,0
167776,group,0,0
167777,and,0,0
167778,2.8-3.8,0,0
167779,mL/s,0,0
167780,in,0,0
167781,the,0,0
167782,80-kV,0,0
167783,group,0,0
167784,),0,0
167785,.,0,0
167786,Radiation,0,0
167787,and,0,0
167788,contrast,0,0
167789,agent,0,0
167790,doses,0,0
167791,were,0,0
167792,evaluated,0,0
167793,.,0,0
167794,Quantitative,0,0
167795,image,0,0
167796,quality,0,0
167797,parameters,0,0
167798,and,0,0
167799,figure,0,0
167800,of,0,0
167801,merit,0,0
167802,(,0,0
167803,FOM,0,0
167804,),0,0
167805,of,0,0
167806,coronary,0,0
167807,artery,0,0
167808,were,0,0
167809,evaluated,0,0
167810,.,0,0
167811,Each,0,0
167812,coronary,0,0
167813,segment,0,0
167814,was,0,0
167815,evaluated,0,0
167816,for,0,0
167817,image,0,1
167818,quality,0,0
167819,on,0,0
167820,a,0,0
167821,4-point,0,0
167822,scale,0,0
167823,.,0,0
167824,RESULTS,0,0
167825,Compared,0,0
167826,with,0,0
167827,the,0,0
167828,120-kV,0,0
167829,group,0,0
167830,",",0,0
167831,effective,0,0
167832,dose,0,0
167833,and,0,0
167834,amount,0,0
167835,of,0,0
167836,contrast,0,0
167837,agent,0,0
167838,in,0,0
167839,the,0,0
167840,80-kV,1,0
167841,group,0,0
167842,were,0,0
167843,decreased,0,0
167844,by,0,0
167845,57.8,0,0
167846,%,0,0
167847,and,0,0
167848,30.5,0,0
167849,%,0,0
167850,(,0,0
167851,effective,0,0
167852,dose:2.7,0,1
167853,?,0,0
167854,0.5,0,0
167855,vs.,0,0
167856,6.4,0,0
167857,?,0,0
167858,1.3,0,0
167859,mSv,0,0
167860,;,0,0
167861,amount,0,0
167862,of,0,0
167863,contrast,0,0
167864,agent:57.1,0,1
167865,?,0,0
167866,3.2,0,0
167867,vs.,0,0
167868,82.1,0,0
167869,?,0,0
167870,6.1,0,0
167871,mL,0,0
167872,;,0,0
167873,both,0,0
167874,p,0,0
167875,<,0,0
167876,0.0001,0,0
167877,),0,0
167878,",",0,0
167879,respectively,0,0
167880,.,0,0
167881,Image,0,0
167882,noise,0,0
167883,was,0,0
167884,22.7,0,0
167885,?,0,0
167886,2.1HU,0,0
167887,for,0,0
167888,120-kV,0,0
167889,images,0,0
167890,and,0,0
167891,33.2,0,0
167892,?,0,0
167893,5.2,0,0
167894,HU,0,0
167895,for,0,0
167896,80-kV,0,0
167897,images,0,0
167898,(,0,0
167899,p,0,0
167900,<,0,0
167901,0.0001,0,0
167902,),0,0
167903,.,0,0
167904,Signal-to-noise,0,0
167905,ratio,0,0
167906,(,0,0
167907,SNR,0,1
167908,),0,1
167909,and,0,0
167910,contrast-to-noise,0,1
167911,ratio,0,0
167912,(,0,0
167913,CNR,0,0
167914,),0,0
167915,in,0,0
167916,the,0,0
167917,proximal,0,0
167918,right,0,0
167919,coronary,0,0
167920,artery,0,0
167921,(,0,0
167922,RCA,0,1
167923,),0,0
167924,and,0,0
167925,left,0,0
167926,main,0,0
167927,coronary,0,0
167928,artery,0,0
167929,(,0,0
167930,LMA,0,1
167931,),0,0
167932,were,0,0
167933,all,0,0
167934,lower,0,0
167935,in,0,0
167936,80-kV,0,0
167937,than,0,0
167938,120-kV,0,0
167939,images,0,0
167940,(,0,0
167941,SNR,0,0
167942,in,0,0
167943,the,0,0
167944,proximal,0,0
167945,RCA,0,1
167946,:,0,0
167947,16.5,0,0
167948,?,0,0
167949,1.8,0,0
167950,vs.,0,0
167951,19.4,0,0
167952,?,0,0
167953,2.8,0,0
167954,;,0,0
167955,SNR,0,0
167956,in,0,0
167957,the,0,0
167958,LMA,0,0
167959,:,0,0
167960,16.3,0,0
167961,?,0,0
167962,2.0,0,0
167963,vs.19.6,0,0
167964,?,0,0
167965,2.7,0,0
167966,;,0,0
167967,CNR,0,0
167968,in,0,0
167969,the,0,0
167970,proximal,0,0
167971,RCA,0,1
167972,:,0,0
167973,19.4,0,0
167974,?,0,0
167975,2.3,0,0
167976,vs.22.9,0,0
167977,?,0,0
167978,3.0,0,0
167979,;,0,0
167980,CNR,0,0
167981,in,0,0
167982,the,0,0
167983,LMA,0,0
167984,:,0,0
167985,18.8,0,0
167986,?,0,0
167987,2.4,0,0
167988,vs.,0,0
167989,22.7,0,0
167990,?,0,0
167991,2.9,0,0
167992,;,0,0
167993,all,0,0
167994,p,0,0
167995,<,0,0
167996,0.0001,0,0
167997,),0,0
167998,.,0,0
167999,FOM,0,0
168000,were,0,0
168001,all,0,0
168002,significantly,0,0
168003,higher,0,0
168004,in,0,0
168005,80-kV,0,0
168006,than,0,0
168007,120-kV,0,0
168008,images,0,0
168009,(,0,0
168010,proximal,0,0
168011,RCA,0,1
168012,:,0,0
168013,146.7,0,0
168014,?,0,0
168015,45.1,0,0
168016,vs.,0,0
168017,93.4,0,0
168018,?,0,0
168019,32.0,0,0
168020,;,0,0
168021,LMA,0,0
168022,:,0,0
168023,139.1,0,0
168024,?,0,0
168025,47.2,0,0
168026,vs.,0,0
168027,91.6,0,0
168028,?,0,0
168029,31.1,0,0
168030,;,0,0
168031,all,0,0
168032,p,0,0
168033,<,0,0
168034,0.0001,0,0
168035,),0,0
168036,.,0,0
168037,There,0,0
168038,was,0,0
168039,no,0,0
168040,significant,0,0
168041,difference,0,0
168042,in,0,0
168043,image,0,1
168044,quality,0,0
168045,score,0,0
168046,between,0,0
168047,the,0,0
168048,two,0,0
168049,groups,0,0
168050,(,0,0
168051,3.3,0,0
168052,?,0,0
168053,0.8,0,0
168054,vs.,0,0
168055,3.3,0,0
168056,?,0,0
168057,0.8,0,0
168058,",",0,0
168059,p=0.068,0,0
168060,),0,0
168061,despite,0,0
168062,decreased,0,0
168063,SNR,0,0
168064,and,0,0
168065,CNR,0,0
168066,of,0,0
168067,coronary,0,0
168068,artery,0,0
168069,in,0,0
168070,the,0,0
168071,80-kV,0,0
168072,group,0,0
168073,.,0,0
168074,CONCLUSION,0,0
168075,The,1,0
168076,80-kV,1,0
168077,protocol,1,0
168078,significantly,0,0
168079,reduces,0,0
168080,radiation,0,1
168081,and,0,0
168082,contrast,0,0
168083,agent,0,0
168084,doses,0,0
168085,in,0,0
168086,CCTA,0,0
168087,in,0,0
168088,patients,0,0
168089,with,0,0
168090,a,0,0
168091,low,0,0
168092,BMI,0,0
168093,<,0,0
168094,23.0,0,0
168095,kg/m,0,0
168096,(,0,0
168097,2,0,0
168098,),0,0
168099,and,0,0
168100,a,0,0
168101,low,0,0
168102,calcium,0,1
168103,load,0,0
168104,while,0,0
168105,maintaining,0,0
168106,image,0,1
168107,quality,0,0
168108,.,0,0
168109,Randomized,0,0
168110,clinical,0,0
168111,trial,0,0
168112,of,0,0
168113,cutting,1,1
168114,balloon,1,1
168115,angioplasty,1,1
168116,versus,0,1
168117,high-pressure,1,1
168118,balloon,1,1
168119,angioplasty,1,1
168120,in,0,0
168121,hemodialysis,0,0
168122,arteriovenous,0,1
168123,fistula,0,1
168124,stenoses,0,0
168125,resistant,0,0
168126,to,0,0
168127,conventional,0,1
168128,balloon,0,1
168129,angioplasty,0,0
168130,.,0,0
168131,PURPOSE,0,0
168132,To,0,0
168133,compare,0,0
168134,the,0,0
168135,efficacy,0,0
168136,and,0,0
168137,safety,0,0
168138,of,0,0
168139,cutting,1,1
168140,balloon,1,1
168141,angioplasty,1,1
168142,(,1,0
168143,CBA,1,1
168144,),1,0
168145,versus,1,1
168146,high-pressure,1,1
168147,balloon,1,1
168148,angioplasty,1,1
168149,(,1,0
168150,HPBA,1,0
168151,),1,0
168152,for,0,0
168153,the,0,0
168154,treatment,0,0
168155,of,0,0
168156,hemodialysis,0,0
168157,autogenous,0,1
168158,fistula,0,1
168159,stenoses,0,0
168160,resistant,0,0
168161,to,0,0
168162,conventional,0,1
168163,percutaneous,0,1
168164,transluminal,0,1
168165,angioplasty,0,1
168166,(,0,0
168167,PTA,0,0
168168,),0,0
168169,.,0,0
168170,MATERIALS,0,0
168171,AND,0,0
168172,METHODS,0,0
168173,In,0,0
168174,a,0,0
168175,prospective,0,0
168176,",",0,0
168177,randomized,0,0
168178,clinical,0,0
168179,trial,0,0
168180,involving,0,0
168181,patients,0,0
168182,with,0,0
168183,dysfunctional,0,0
168184,",",0,0
168185,stenotic,0,0
168186,hemodialysis,0,0
168187,arteriovenous,0,1
168188,fistulas,0,0
168189,(,0,0
168190,AVFs,0,0
168191,),0,0
168192,",",0,0
168193,patients,0,0
168194,were,0,0
168195,randomized,0,0
168196,to,0,0
168197,receive,0,0
168198,CBA,1,0
168199,or,0,1
168200,HPBA,1,0
168201,if,0,0
168202,conventional,0,1
168203,PTA,0,0
168204,had,0,0
168205,suboptimal,0,0
168206,results,0,0
168207,(,0,0
168208,ie,0,0
168209,",",0,0
168210,residual,0,0
168211,stenosis,0,0
168212,>,0,0
168213,30,0,0
168214,%,0,0
168215,),0,0
168216,.,0,0
168217,A,0,0
168218,total,0,0
168219,of,0,0
168220,516,0,0
168221,patients,0,0
168222,consented,0,0
168223,to,0,0
168224,participate,0,0
168225,in,0,0
168226,the,0,0
168227,study,0,0
168228,from,0,0
168229,October,0,0
168230,2008,0,0
168231,to,0,0
168232,September,0,0
168233,2011,0,0
168234,",",0,0
168235,85,0,0
168236,%,0,0
168237,of,0,0
168238,whom,0,0
168239,(,0,0
168240,n,0,0
168241,=,0,0
168242,439,0,0
168243,),0,0
168244,had,0,0
168245,technically,0,0
168246,successful,0,0
168247,conventional,0,1
168248,PTA,0,0
168249,.,0,0
168250,The,0,0
168251,remaining,0,0
168252,71,0,0
168253,patients,0,0
168254,(,0,0
168255,mean,0,0
168256,age,0,0
168257,",",0,0
168258,60,0,0
168259,y,0,0
168260,;,0,0
168261,49,0,0
168262,men,0,0
168263,),0,0
168264,with,0,0
168265,suboptimal,0,0
168266,PTA,0,0
168267,results,0,0
168268,were,0,0
168269,eventually,0,0
168270,randomized,0,0
168271,:,0,0
168272,36,0,0
168273,to,0,0
168274,the,0,0
168275,CBA,1,1
168276,arm,0,0
168277,and,0,0
168278,35,0,0
168279,to,0,0
168280,the,0,0
168281,HPBA,0,0
168282,arm,0,0
168283,.,0,0
168284,Primary,0,0
168285,and,0,0
168286,secondary,0,0
168287,target,0,0
168288,lesion,0,0
168289,patencies,0,0
168290,were,0,0
168291,determined,0,0
168292,by,0,0
168293,Kaplan-Meier,0,0
168294,analysis,0,0
168295,.,0,0
168296,RESULTS,0,0
168297,Clinical,0,0
168298,success,0,0
168299,rates,0,0
168300,were,0,0
168301,100,0,0
168302,%,0,0
168303,in,0,0
168304,both,0,0
168305,arms,0,0
168306,.,0,0
168307,Primary,0,0
168308,target,0,0
168309,lesion,0,0
168310,patency,0,0
168311,rates,0,0
168312,at,0,0
168313,6,0,0
168314,months,0,0
168315,were,0,0
168316,66.4,0,0
168317,%,0,0
168318,and,0,0
168319,39.9,0,0
168320,%,0,0
168321,for,0,0
168322,CBA,1,0
168323,and,0,0
168324,HPBA,1,0
168325,",",0,0
168326,respectively,0,0
168327,(,0,0
168328,P,0,0
168329,=,0,0
168330,.01,0,0
168331,),0,0
168332,.,0,0
168333,Secondary,0,0
168334,target,0,0
168335,lesion,0,0
168336,patency,0,0
168337,rates,0,0
168338,at,0,0
168339,6,0,0
168340,months,0,0
168341,were,0,0
168342,96.5,0,0
168343,%,0,0
168344,for,0,0
168345,CBA,1,0
168346,and,0,0
168347,80.0,0,0
168348,%,0,0
168349,for,0,0
168350,HPBA,1,0
168351,(,0,0
168352,P,0,0
168353,=,0,0
168354,.03,0,0
168355,),0,0
168356,.,0,0
168357,There,0,0
168358,was,0,0
168359,a,0,0
168360,single,0,0
168361,major,0,0
168362,complication,0,0
168363,of,0,0
168364,venous,0,0
168365,perforation,0,0
168366,following,0,0
168367,CBA,1,0
168368,.,1,0
168369,The,0,0
168370,30-day,0,0
168371,mortality,0,0
168372,rate,0,0
168373,was,0,0
168374,1.4,0,0
168375,%,0,0
168376,",",0,0
168377,with,0,0
168378,one,0,0
168379,non-procedure-related,0,0
168380,death,0,0
168381,in,0,0
168382,the,0,0
168383,HPBA,1,0
168384,group,0,0
168385,.,0,0
168386,CONCLUSIONS,0,0
168387,Primary,0,0
168388,and,0,0
168389,secondary,0,0
168390,target,0,0
168391,lesion,0,0
168392,patency,0,0
168393,rates,0,0
168394,of,0,0
168395,CBA,1,0
168396,were,0,0
168397,statistically,0,0
168398,superior,0,0
168399,to,0,0
168400,those,0,0
168401,of,0,0
168402,HPBA,1,0
168403,following,0,0
168404,suboptimal,0,0
168405,conventional,0,1
168406,PTA,0,0
168407,.,0,0
168408,For,0,0
168409,AVF,0,0
168410,stenoses,0,0
168411,resistant,0,0
168412,to,0,0
168413,conventional,0,1
168414,PTA,0,0
168415,",",0,0
168416,CBA,1,0
168417,may,0,0
168418,be,0,0
168419,a,0,0
168420,better,0,0
168421,second-line,0,0
168422,treatment,0,0
168423,given,0,0
168424,its,0,0
168425,superior,0,0
168426,patency,0,0
168427,rates,0,0
168428,.,0,0
168429,Intraluminal,0,0
168430,exfoliated,0,1
168431,cancer,0,0
168432,cells,0,0
168433,and,0,0
168434,effectiveness,0,0
168435,of,0,0
168436,bowel,0,0
168437,ligatures,0,1
168438,during,0,0
168439,sigmoidectomy,1,0
168440,for,0,0
168441,sigmoid,0,0
168442,colon,0,0
168443,cancer,0,0
168444,.,0,0
168445,PURPOSES,0,0
168446,To,0,0
168447,establish,0,0
168448,the,0,0
168449,efficiency,0,0
168450,of,0,0
168451,bowel,0,0
168452,ligatures,0,1
168453,in,0,0
168454,colon,1,0
168455,cancer,1,0
168456,surgery,1,0
168457,",",0,0
168458,focusing,0,0
168459,on,0,0
168460,the,0,0
168461,extent,0,0
168462,to,0,0
168463,which,0,0
168464,exfoliated,0,1
168465,cancer,0,0
168466,cells,0,0
168467,are,0,0
168468,shed,0,0
168469,in,0,0
168470,the,0,0
168471,colonic,0,0
168472,lumen,0,0
168473,during,0,0
168474,sigmoidectomy,1,0
168475,.,1,0
168476,METHODS,0,0
168477,Twenty,0,0
168478,consecutive,0,0
168479,patients,0,0
168480,who,0,0
168481,underwent,0,0
168482,sigmoidectomy,1,0
168483,for,0,0
168484,sigmoid,0,0
168485,colon,0,0
168486,cancer,0,0
168487,were,0,0
168488,prospectively,0,0
168489,randomized,0,0
168490,into,0,0
168491,two,0,0
168492,groups,0,0
168493,:,0,0
168494,the,1,0
168495,ligatures,1,1
168496,group,1,0
168497,",",1,0
168498,in,1,0
168499,which,1,0
168500,bowel,1,0
168501,ligatures,1,1
168502,were,1,0
168503,placed,1,0
168504,",",1,0
168505,3,1,0
168506,",",1,0
168507,5,1,0
168508,",",1,0
168509,10,1,0
168510,cm,1,0
168511,from,1,0
168512,the,1,0
168513,tumor,1,0
168514,proximally,1,0
168515,and,1,0
168516,distally,1,0
168517,before,1,0
168518,dissection,1,0
168519,;,1,0
168520,and,1,0
168521,the,1,0
168522,no,1,0
168523,ligatures,1,1
168524,group,1,0
168525,",",1,0
168526,in,1,0
168527,which,1,0
168528,the,1,0
168529,corresponding,1,0
168530,sites,1,0
168531,were,1,0
168532,ligated,1,0
168533,only,1,0
168534,immediately,1,0
168535,before,1,0
168536,taking,1,0
168537,the,1,0
168538,specimen,1,0
168539,out,1,0
168540,.,1,0
168541,Each,0,0
168542,colonic,0,0
168543,segment,0,0
168544,ligated,0,0
168545,was,0,0
168546,irrigated,1,1
168547,with,1,0
168548,saline,1,1
168549,and,0,0
168550,samples,0,0
168551,were,0,0
168552,sent,0,0
168553,for,0,0
168554,blind,0,0
168555,cytological,0,0
168556,examination,0,0
168557,.,0,0
168558,RESULTS,0,0
168559,Cancer,0,0
168560,cells,0,0
168561,were,0,0
168562,found,0,0
168563,in,0,0
168564,the,0,0
168565,colonic,0,0
168566,segment,0,0
168567,where,0,0
168568,the,0,0
168569,tumor,0,0
168570,was,0,0
168571,located,0,0
168572,",",0,0
168573,in,0,0
168574,18,0,0
168575,of,0,0
168576,20,0,0
168577,samples,0,0
168578,.,0,0
168579,The,0,0
168580,frequency,0,0
168581,of,0,0
168582,free,0,0
168583,cancer,0,0
168584,cells,0,0
168585,decreased,0,0
168586,from,0,0
168587,50,0,0
168588,to,0,0
168589,0,0,0
168590,%,0,0
168591,(,0,0
168592,p,0,0
168593,<,0,0
168594,0.04,0,0
168595,),0,0
168596,in,0,0
168597,the,0,0
168598,distal,0,0
168599,3-5,0,0
168600,cm,0,0
168601,colonic,0,0
168602,segment,0,0
168603,and,0,0
168604,from,0,0
168605,80,0,0
168606,to,0,0
168607,20,0,0
168608,%,0,0
168609,(,0,0
168610,p,0,0
168611,<,0,0
168612,0.03,0,0
168613,),0,0
168614,in,0,0
168615,the,0,0
168616,proximal,0,0
168617,colonic,0,0
168618,segment,0,0
168619,after,0,0
168620,performing,0,0
168621,bowel,0,0
168622,ligatures,0,1
168623,.,0,0
168624,Free,0,0
168625,cancer,0,0
168626,cells,0,0
168627,were,0,0
168628,confirmed,0,0
168629,in,0,0
168630,1,0,0
168631,of,0,0
168632,10,0,0
168633,samples,0,0
168634,at,0,0
168635,both,0,0
168636,colonic,0,0
168637,segments,0,0
168638,5-10,0,0
168639,cm,0,0
168640,from,0,0
168641,the,0,0
168642,tumor,0,0
168643,",",0,0
168644,even,0,0
168645,after,0,0
168646,bowel,0,0
168647,ligatures,0,1
168648,.,0,0
168649,CONCLUSIONS,0,0
168650,Intraluminal,0,0
168651,exfoliated,0,1
168652,cancer,0,0
168653,cells,0,0
168654,could,0,0
168655,be,0,0
168656,eliminated,0,0
168657,by,0,0
168658,placing,0,0
168659,bowel,0,0
168660,ligatures,0,1
168661,during,0,0
168662,sigmoidectomy,0,0
168663,.,0,0
168664,Measures,0,0
168665,should,0,0
168666,be,0,0
168667,considered,0,0
168668,to,0,0
168669,eliminate,0,0
168670,exfoliated,0,1
168671,cancer,0,0
168672,cells,0,0
168673,during,0,0
168674,colectomy,0,0
168675,",",0,0
168676,even,0,0
168677,after,0,0
168678,placing,0,0
168679,bowel,0,0
168680,ligatures,0,1
168681,.,0,0
168682,Conduit,0,1
168683,artery,0,0
168684,structure,0,0
168685,and,0,0
168686,function,0,0
168687,in,0,0
168688,lowlanders,0,0
168689,and,0,0
168690,native,0,0
168691,highlanders,0,0
168692,:,0,0
168693,relationships,0,0
168694,with,0,0
168695,oxidative,0,0
168696,stress,0,0
168697,and,0,0
168698,role,0,0
168699,of,0,0
168700,sympathoexcitation,0,0
168701,.,0,0
168702,Research,0,0
168703,detailing,0,0
168704,the,0,0
168705,normal,0,0
168706,vascular,0,0
168707,adaptions,0,0
168708,to,0,0
168709,high,0,0
168710,altitude,0,1
168711,is,0,0
168712,minimal,0,0
168713,and,0,0
168714,often,0,0
168715,confounded,0,0
168716,by,0,0
168717,pathology,0,0
168718,(,0,0
168719,e.g.,0,0
168720,",",0,0
168721,chronic,0,0
168722,mountain,0,0
168723,sickness,0,1
168724,),0,0
168725,and,0,0
168726,methodological,0,0
168727,issues,0,0
168728,.,0,0
168729,We,0,0
168730,examined,0,0
168731,vascular,0,0
168732,function,0,0
168733,and,0,0
168734,structure,0,0
168735,in,0,0
168736,:,0,0
168737,(,0,0
168738,1,0,0
168739,),0,0
168740,healthy,0,0
168741,lowlanders,0,0
168742,during,0,0
168743,acute,0,0
168744,hypoxia,0,0
168745,and,0,0
168746,prolonged,0,0
168747,(,0,0
168748,?2,0,0
168749,weeks,1,1
168750,),1,0
168751,exposure,1,0
168752,to,1,0
168753,high,1,0
168754,altitude,1,1
168755,",",1,0
168756,and,0,0
168757,(,0,0
168758,2,0,0
168759,),0,0
168760,high-altitude,0,0
168761,natives,0,0
168762,at,0,0
168763,5050,0,0
168764,m,0,0
168765,(,0,0
168766,highlanders,0,0
168767,),0,0
168768,.,0,0
168769,In,0,0
168770,12,0,0
168771,healthy,0,0
168772,lowlanders,0,0
168773,(,0,0
168774,aged,0,0
168775,32,0,0
168776,?,0,0
168777,7,0,0
168778,years,0,0
168779,),0,0
168780,and,0,0
168781,12,0,0
168782,highlanders,0,0
168783,(,0,0
168784,Sherpa,0,0
168785,;,0,0
168786,33,0,0
168787,?,0,0
168788,14,0,0
168789,years,0,0
168790,),0,0
168791,we,0,0
168792,assessed,0,0
168793,brachial,0,0
168794,endothelium-dependent,0,0
168795,flow-mediated,0,1
168796,dilatation,0,1
168797,(,0,0
168798,FMD,0,0
168799,),0,0
168800,",",0,0
168801,endothelium-independent,0,1
168802,dilatation,0,1
168803,(,0,0
168804,via,0,0
168805,glyceryl,1,1
168806,trinitrate,1,1
168807,;,1,0
168808,GTN,1,1
168809,),1,0
168810,",",1,0
168811,common,1,0
168812,carotid,0,0
168813,intima-media,0,0
168814,thickness,0,0
168815,(,0,0
168816,CIMT,0,1
168817,),0,1
168818,and,0,0
168819,diameter,0,0
168820,(,0,0
168821,ultrasound,0,1
168822,),0,0
168823,",",0,0
168824,and,0,0
168825,arterial,0,0
168826,stiffness,0,0
168827,via,0,0
168828,pulse,1,1
168829,wave,1,1
168830,velocity,1,0
168831,(,1,0
168832,PWV,1,1
168833,;,1,0
168834,applanation,1,1
168835,tonometry,1,0
168836,),1,0
168837,.,1,0
168838,Cephalic,1,0
168839,venous,0,0
168840,biomarkers,0,0
168841,of,0,0
168842,free,0,0
168843,radical-mediated,0,0
168844,lipid,0,0
168845,peroxidation,0,0
168846,(,0,0
168847,lipid,0,0
168848,hydroperoxides,0,0
168849,",",0,0
168850,LOOH,0,1
168851,),0,0
168852,",",0,0
168853,nitrite,0,1
168854,(,0,0
168855,NO2-,0,1
168856,),0,1
168857,and,0,0
168858,lipid,0,0
168859,soluble,0,1
168860,antioxidants,0,1
168861,were,0,0
168862,also,0,0
168863,obtained,0,0
168864,at,0,0
168865,rest,0,0
168866,.,0,0
168867,In,0,0
168868,lowlanders,0,0
168869,",",0,0
168870,measurements,0,0
168871,were,0,0
168872,performed,0,0
168873,at,0,0
168874,sea,0,1
168875,level,0,0
168876,(,0,0
168877,334,0,0
168878,m,0,0
168879,),0,0
168880,and,0,0
168881,between,0,0
168882,days,0,0
168883,3-4,0,0
168884,(,0,0
168885,acute,0,0
168886,high,0,0
168887,altitude,0,1
168888,),0,0
168889,and,0,0
168890,12-14,0,1
168891,(,0,0
168892,chronic,0,0
168893,high,0,0
168894,altitude,0,1
168895,),0,0
168896,following,0,0
168897,arrival,0,0
168898,to,0,0
168899,5050,0,0
168900,m.,0,0
168901,Highlanders,0,0
168902,were,0,0
168903,assessed,0,0
168904,once,0,0
168905,at,0,0
168906,5050,0,0
168907,m.,0,0
168908,Compared,0,0
168909,with,0,0
168910,sea,0,1
168911,level,0,0
168912,",",0,0
168913,acute,0,0
168914,high,0,0
168915,altitude,0,0
168916,reduced,0,0
168917,lowlanders,0,0
168918,',0,0
168919,FMD,0,0
168920,(,0,0
168921,7.9,0,0
168922,?,0,0
168923,0.4,0,0
168924,vs.,0,0
168925,6.8,0,0
168926,?,0,0
168927,0.4,0,0
168928,%,0,0
168929,;,0,0
168930,P,0,0
168931,=,0,0
168932,0.004,0,0
168933,),0,0
168934,and,0,0
168935,GTN-induced,0,0
168936,dilatation,0,1
168937,(,0,0
168938,16.6,0,0
168939,?,0,0
168940,0.9,0,0
168941,vs.,0,0
168942,14.5,0,0
168943,?,0,0
168944,0.8,0,0
168945,%,0,0
168946,;,0,0
168947,P,0,0
168948,=,0,0
168949,0.006,0,0
168950,),0,0
168951,",",0,0
168952,and,0,0
168953,raised,0,0
168954,central,0,0
168955,PWV,0,1
168956,(,0,0
168957,6.0,0,0
168958,?,0,0
168959,0.2,0,0
168960,vs.,0,0
168961,6.6,0,0
168962,?,0,0
168963,0.3,0,0
168964,m,0,0
168965,s,0,0
168966,(,0,0
168967,-1,0,0
168968,),0,0
168969,;,0,0
168970,P,0,0
168971,=,0,0
168972,0.001,0,0
168973,),0,0
168974,.,0,0
168975,These,0,0
168976,changes,0,0
168977,persisted,0,0
168978,at,0,0
168979,days,0,0
168980,12-14,0,0
168981,",",0,0
168982,and,0,0
168983,after,0,0
168984,allometrically,0,0
168985,scaling,0,0
168986,FMD,0,0
168987,to,0,0
168988,adjust,0,0
168989,for,0,0
168990,altered,0,0
168991,baseline,0,0
168992,diameter,0,0
168993,.,0,0
168994,Compared,0,0
168995,to,0,0
168996,lowlanders,0,0
168997,at,0,0
168998,sea,0,1
168999,level,0,0
169000,and,0,0
169001,high,0,0
169002,altitude,0,0
169003,",",0,0
169004,highlanders,0,0
169005,had,0,0
169006,a,0,0
169007,lower,0,0
169008,carotid,0,0
169009,wall,0,0
169010,:,0,0
169011,lumen,0,0
169012,ratio,0,0
169013,(,0,0
169014,?19,0,0
169015,%,0,0
169016,",",0,0
169017,P,0,0
169018,?,0,0
169019,0.04,0,0
169020,),0,0
169021,",",0,0
169022,attributable,0,0
169023,to,0,0
169024,a,0,0
169025,narrower,0,0
169026,CIMT,0,0
169027,and,0,0
169028,wider,0,0
169029,lumen,0,0
169030,.,0,0
169031,Although,0,0
169032,both,0,0
169033,LOOH,0,1
169034,and,0,0
169035,NO2-,0,0
169036,increased,0,0
169037,with,0,0
169038,high,0,0
169039,altitude,0,0
169040,in,0,0
169041,lowlanders,0,0
169042,",",0,0
169043,only,0,0
169044,LOOH,0,0
169045,correlated,0,0
169046,with,0,0
169047,the,0,0
169048,reduction,0,0
169049,in,0,0
169050,GTN-induced,0,0
169051,dilatation,0,0
169052,evident,0,0
169053,during,0,0
169054,acute,0,0
169055,(,0,0
169056,n,0,0
169057,=,0,0
169058,11,0,0
169059,",",0,0
169060,r,0,0
169061,=,0,0
169062,-0.53,0,0
169063,),0,0
169064,and,0,0
169065,chronic,0,0
169066,(,0,0
169067,n,0,0
169068,=,0,0
169069,7,0,0
169070,",",0,0
169071,r,0,0
169072,=,0,0
169073,-0.69,0,0
169074,;,0,0
169075,P,0,0
169076,?,0,0
169077,0.01,0,0
169078,),0,0
169079,exposure,0,0
169080,to,0,0
169081,5050,0,0
169082,m.,0,0
169083,In,0,0
169084,a,0,0
169085,follow-up,0,0
169086,",",0,0
169087,placebo-controlled,1,1
169088,experiment,0,0
169089,(,0,0
169090,n,0,0
169091,=,0,0
169092,11,0,0
169093,healthy,0,0
169094,lowlanders,0,0
169095,),0,0
169096,conducted,1,0
169097,in,1,0
169098,a,1,0
169099,normobaric,1,1
169100,hypoxic,1,1
169101,chamber,1,1
169102,(,0,0
169103,inspired,0,1
169104,O2,0,1
169105,fraction,0,0
169106,(,0,0
169107,F,0,0
169108,IO,0,0
169109,2,0,0
169110,),0,0
169111,=,0,0
169112,0.11,0,0
169113,;,0,0
169114,6,0,0
169115,h,0,0
169116,),0,0
169117,",",0,0
169118,a,0,0
169119,sustained,0,0
169120,reduction,0,0
169121,in,0,0
169122,FMD,0,0
169123,was,0,0
169124,evident,0,0
169125,within,0,0
169126,1,0,0
169127,h,0,0
169128,of,0,0
169129,hypoxic,0,0
169130,exposure,0,0
169131,when,0,0
169132,compared,0,0
169133,to,0,0
169134,normoxic,0,1
169135,baseline,0,0
169136,(,0,0
169137,5.7,0,0
169138,?,0,0
169139,1.6,0,0
169140,vs.,0,0
169141,8.0,0,0
169142,?1.3,0,0
169143,%,0,0
169144,;,0,0
169145,P,0,0
169146,<,0,0
169147,0.01,0,0
169148,),0,0
169149,;,0,0
169150,this,0,0
169151,decline,0,0
169152,in,0,0
169153,FMD,0,0
169154,was,0,0
169155,largely,0,0
169156,reversed,0,0
169157,following,0,0
169158,?1-adrenoreceptor,0,1
169159,blockade,0,0
169160,.,0,0
169161,In,0,0
169162,conclusion,0,0
169163,",",0,0
169164,high-altitude,0,0
169165,exposure,0,0
169166,in,0,0
169167,lowlanders,0,0
169168,caused,0,0
169169,persistent,0,0
169170,impairment,0,0
169171,in,0,0
169172,vascular,0,0
169173,function,0,0
169174,",",0,0
169175,which,0,0
169176,was,0,0
169177,mediated,0,0
169178,partially,0,0
169179,via,0,0
169180,oxidative,0,0
169181,stress,0,0
169182,and,0,0
169183,sympathoexcitation,0,0
169184,.,0,0
169185,Although,0,0
169186,a,0,0
169187,lifetime,0,0
169188,of,0,0
169189,high-altitude,0,0
169190,exposure,0,0
169191,neither,0,0
169192,intensifies,0,0
169193,nor,0,0
169194,attenuates,0,0
169195,the,0,0
169196,impairments,0,0
169197,seen,0,0
169198,with,0,0
169199,short-term,0,0
169200,exposure,0,0
169201,",",1,0
169202,chronic,1,0
169203,high-altitude,1,0
169204,exposure,1,0
169205,appears,0,0
169206,to,0,0
169207,be,0,0
169208,associated,0,0
169209,with,0,0
169210,arterial,0,0
169211,remodelling,0,0
169212,.,0,0
169213,Using,0,0
169214,the,0,0
169215,virtual,1,1
169216,reality-cognitive,1,1
169217,rehabilitation,1,1
169218,approach,0,1
169219,to,0,0
169220,improve,0,0
169221,contextual,0,0
169222,processing,0,0
169223,in,0,0
169224,children,0,0
169225,with,0,0
169226,autism,0,0
169227,.,0,0
169228,BACKGROUND,0,0
169229,This,0,0
169230,pilot,0,0
169231,study,0,0
169232,investigated,0,0
169233,the,0,0
169234,efficacy,0,0
169235,of,0,0
169236,a,0,0
169237,novel,1,0
169238,virtual,1,1
169239,reality-cognitive,1,1
169240,rehabilitation,1,1
169241,(,1,0
169242,VR-CR,1,1
169243,),1,0
169244,intervention,1,1
169245,to,0,0
169246,improve,0,0
169247,contextual,0,0
169248,processing,0,0
169249,of,0,0
169250,objects,0,1
169251,in,0,0
169252,children,0,0
169253,with,0,0
169254,autism,0,0
169255,.,0,0
169256,Previous,0,0
169257,research,0,0
169258,supports,0,0
169259,that,0,0
169260,children,0,0
169261,with,0,0
169262,autism,0,0
169263,show,0,0
169264,deficits,0,0
169265,in,0,0
169266,contextual,0,0
169267,processing,0,0
169268,",",0,0
169269,as,0,0
169270,well,0,0
169271,as,0,0
169272,deficits,0,0
169273,in,0,0
169274,its,0,0
169275,elementary,0,0
169276,components,0,0
169277,:,0,0
169278,abstraction,0,0
169279,and,0,0
169280,cognitive,0,0
169281,flexibility,0,0
169282,.,0,0
169283,METHODS,0,0
169284,Four,0,0
169285,children,0,0
169286,with,0,0
169287,autism,0,0
169288,participated,0,0
169289,in,0,0
169290,a,0,0
169291,multiple-baseline,0,0
169292,",",0,0
169293,single-subject,0,0
169294,study,0,0
169295,.,0,0
169296,The,0,0
169297,children,0,0
169298,were,0,0
169299,taught,0,0
169300,how,0,0
169301,to,0,0
169302,see,0,0
169303,objects,0,1
169304,in,0,0
169305,context,0,0
169306,by,0,0
169307,reinforcing,0,0
169308,attention,0,0
169309,to,0,0
169310,pivotal,0,0
169311,contextual,0,0
169312,information,0,0
169313,.,0,0
169314,RESULTS,0,0
169315,All,0,0
169316,children,0,0
169317,demonstrated,0,0
169318,statistically,0,0
169319,significant,0,0
169320,improvements,0,0
169321,in,0,0
169322,contextual,0,0
169323,processing,0,0
169324,and,0,0
169325,cognitive,0,0
169326,flexibility,0,0
169327,.,0,0
169328,Mixed,0,0
169329,results,0,0
169330,were,0,0
169331,found,0,0
169332,on,0,0
169333,the,0,0
169334,control,0,1
169335,test,0,0
169336,and,0,0
169337,changes,0,0
169338,in,0,0
169339,context-related,0,0
169340,behaviours,0,0
169341,.,0,0
169342,CONCLUSIONS,0,0
169343,Larger-scale,0,0
169344,studies,0,0
169345,are,0,0
169346,warranted,0,0
169347,to,0,0
169348,determine,0,0
169349,the,0,0
169350,effectiveness,0,0
169351,and,0,0
169352,usability,0,0
169353,in,0,0
169354,comprehensive,0,0
169355,educational,0,0
169356,programs,0,0
169357,.,0,0
169358,Randomized,0,0
169359,study,0,0
169360,comparing,0,0
169361,use,0,0
169362,of,0,0
169363,THUNDERBEAT,0,0
169364,technology,0,0
169365,vs,0,0
169366,standard,0,1
169367,electrosurgery,0,1
169368,during,0,0
169369,laparoscopic,0,1
169370,radical,0,1
169371,hysterectomy,0,1
169372,and,0,0
169373,pelvic,0,1
169374,lymphadenectomy,0,1
169375,for,0,0
169376,gynecologic,0,0
169377,cancer,0,0
169378,.,0,0
169379,STUDY,0,0
169380,OBJECTIVE,0,0
169381,To,0,0
169382,compare,0,0
169383,operative,0,0
169384,time,0,0
169385,with,0,0
169386,use,0,0
169387,of,0,0
169388,THUNDERBEAT,1,0
169389,(,0,0
169390,TB,0,1
169391,),0,0
169392,vs,0,0
169393,standard,1,1
169394,electrosurgery,1,1
169395,(,0,0
169396,SES,0,1
169397,),0,0
169398,during,0,0
169399,laparoscopic,0,1
169400,radical,0,1
169401,hysterectomy,0,1
169402,and,0,0
169403,pelvic,0,1
169404,lymphadenectomy,0,1
169405,to,0,0
169406,treat,0,0
169407,gynecologic,0,0
169408,tumors,0,0
169409,.,0,0
169410,DESIGN,0,0
169411,Evidence,0,0
169412,obtained,0,0
169413,from,0,0
169414,a,0,0
169415,properly,0,0
169416,designed,0,0
169417,",",0,0
169418,randomized,0,0
169419,",",0,0
169420,controlled,0,0
169421,trial,0,0
169422,(,0,0
169423,Canadian,0,0
169424,Task,0,1
169425,Force,0,0
169426,classification,0,0
169427,I,0,0
169428,),0,0
169429,.,0,0
169430,SETTING,0,0
169431,Gynecologic,0,0
169432,Oncology,0,0
169433,Unit,0,0
169434,of,0,0
169435,the,0,0
169436,Catholic,0,0
169437,University,0,0
169438,of,0,0
169439,the,0,0
169440,Sacred,0,0
169441,Heart,0,0
169442,in,0,0
169443,Rome,0,0
169444,",",0,0
169445,Italy,0,0
169446,.,0,0
169447,PATIENTS,0,0
169448,Fifty,0,0
169449,patients,0,0
169450,with,0,0
169451,early,0,0
169452,cervical,0,0
169453,cancer,0,0
169454,(,0,0
169455,FIGO,0,0
169456,stages,0,0
169457,IA2,0,0
169458,",",0,0
169459,IB1,0,0
169460,",",0,0
169461,IIA,0,0
169462,<,0,0
169463,2,0,0
169464,cm,0,0
169465,),0,0
169466,or,0,0
169467,locally,0,0
169468,advanced,0,0
169469,cervical,0,0
169470,cancer,0,0
169471,(,0,0
169472,FIGO,0,0
169473,stages,0,0
169474,IB2,0,0
169475,",",0,0
169476,IIA,0,0
169477,>,0,0
169478,2cm,0,0
169479,",",0,0
169480,IIB,0,0
169481,),0,0
169482,who,0,0
169483,received,0,0
169484,neoadjuvant,1,1
169485,treatment,1,0
169486,(,1,0
169487,chemotherapy,1,1
169488,or,1,1
169489,radiochemotherapy,1,1
169490,),1,0
169491,and,0,0
169492,demonstrated,0,0
169493,a,0,0
169494,complete,0,0
169495,or,0,0
169496,partial,0,0
169497,clinical,0,0
169498,response,0,0
169499,and,0,0
169500,early,0,0
169501,stage,0,0
169502,endometrioid,0,0
169503,endometrial,0,0
169504,cancer,0,0
169505,(,0,0
169506,FIGO,0,0
169507,stages,0,0
169508,IB,0,0
169509,",",0,0
169510,II,0,0
169511,),0,0
169512,were,0,0
169513,randomly,0,0
169514,assigned,0,0
169515,to,0,0
169516,undergo,0,0
169517,TB,0,1
169518,(,0,0
169519,arm,0,0
169520,A,0,0
169521,),0,0
169522,or,0,1
169523,SES,0,1
169524,(,0,0
169525,arm,0,0
169526,B,0,0
169527,),0,0
169528,.,0,0
169529,INTERVENTION,0,0
169530,Laparoscopic,1,1
169531,radical,1,1
169532,hysterectomy,1,1
169533,with,1,0
169534,bilateral,1,1
169535,pelvic,1,0
169536,lymphadenectomy,1,1
169537,",",0,0
169538,using,0,0
169539,an,0,0
169540,easily,0,0
169541,reproducible,0,0
169542,technique,0,1
169543,was,0,0
169544,performed,0,0
169545,.,0,0
169546,MEASUREMENTS,0,0
169547,AND,0,0
169548,MAIN,0,0
169549,RESULTS,0,0
169550,Fifty,0,0
169551,patients,0,0
169552,were,0,0
169553,available,0,0
169554,for,0,0
169555,analysis,0,0
169556,",",0,0
169557,with,0,0
169558,25,0,0
169559,women,0,0
169560,randomly,0,0
169561,assigned,0,0
169562,to,0,0
169563,TB,0,1
169564,(,0,0
169565,arm,0,0
169566,A,0,0
169567,),0,0
169568,and,0,0
169569,25,0,0
169570,to,0,0
169571,SES,0,1
169572,(,0,0
169573,arm,0,0
169574,B,0,0
169575,),0,0
169576,.,0,0
169577,The,0,0
169578,median,0,0
169579,operative,0,0
169580,time,0,0
169581,was,0,0
169582,85,0,0
169583,minutes,0,0
169584,for,0,0
169585,TB,0,1
169586,vs,0,0
169587,115,0,0
169588,minutes,0,0
169589,for,0,0
169590,SES,0,1
169591,(,0,0
169592,p,0,0
169593,=,0,0
169594,.001,0,0
169595,),0,0
169596,.,0,0
169597,At,0,0
169598,multivariate,0,0
169599,analysis,0,0
169600,",",0,0
169601,endometrial,0,0
169602,cancer,0,0
169603,(,0,0
169604,p,0,0
169605,=,0,0
169606,.001,0,0
169607,),0,0
169608,and,0,0
169609,TB,0,1
169610,(,0,0
169611,p,0,0
169612,=,0,0
169613,.001,0,0
169614,),0,0
169615,were,0,0
169616,independently,0,0
169617,associated,0,0
169618,with,0,0
169619,shorter,0,0
169620,operating,0,0
169621,time,0,0
169622,.,0,0
169623,No,0,0
169624,differences,0,0
169625,in,0,0
169626,perioperative,0,0
169627,outcomes,0,0
169628,and,0,0
169629,postoperative,0,0
169630,complications,0,0
169631,were,0,0
169632,observed,0,0
169633,between,0,0
169634,the,0,0
169635,2,0,0
169636,arms,0,0
169637,.,0,0
169638,Patients,0,0
169639,who,0,0
169640,underwent,0,0
169641,TB,0,1
169642,reported,0,0
169643,less,0,0
169644,postoperative,0,0
169645,pain,0,0
169646,",",0,0
169647,both,0,0
169648,at,0,0
169649,rest,0,0
169650,(,0,0
169651,p,0,0
169652,=,0,0
169653,.005,0,0
169654,),0,0
169655,and,0,0
169656,after,0,0
169657,the,0,0
169658,Valsalva,0,1
169659,maneuver,0,1
169660,(,0,0
169661,p,0,0
169662,=,0,0
169663,.008,0,0
169664,),0,0
169665,",",0,0
169666,with,0,0
169667,less,0,0
169668,additional,0,0
169669,analgesic,0,0
169670,therapy,0,1
169671,other,0,0
169672,than,0,0
169673,standard,0,1
169674,therapy,0,1
169675,required,0,0
169676,in,0,0
169677,patients,0,0
169678,who,0,0
169679,underwent,0,0
169680,SES,0,1
169681,(,0,0
169682,p,0,0
169683,=,0,0
169684,.02,0,0
169685,),0,0
169686,.,0,0
169687,CONCLUSION,0,0
169688,TB,0,1
169689,is,0,0
169690,associated,0,0
169691,with,0,0
169692,shorter,0,0
169693,operative,0,0
169694,time,0,0
169695,and,0,0
169696,less,0,0
169697,postoperative,0,0
169698,pain,0,0
169699,than,0,0
169700,is,0,0
169701,the,0,0
169702,standard,0,1
169703,technique,0,1
169704,(,0,0
169705,SES,0,1
169706,),0,0
169707,in,0,0
169708,patients,0,0
169709,with,0,0
169710,uterine,0,0
169711,cancer,0,0
169712,.,0,0
169713,Impact,0,0
169714,of,0,0
169715,vitamin,1,1
169716,D,1,1
169717,supplementation,1,1
169718,on,0,0
169719,inflammatory,0,0
169720,markers,0,0
169721,in,0,0
169722,African,0,0
169723,Americans,0,0
169724,:,0,0
169725,results,0,0
169726,of,0,0
169727,a,0,0
169728,four-arm,0,0
169729,",",0,0
169730,randomized,0,0
169731,",",0,0
169732,placebo-controlled,0,1
169733,trial,0,0
169734,.,0,0
169735,African,0,0
169736,Americans,0,0
169737,have,0,0
169738,a,0,0
169739,disproportionate,0,0
169740,burden,0,0
169741,of,0,0
169742,inflammation-associated,0,0
169743,chronic,0,0
169744,diseases,0,0
169745,such,0,0
169746,as,0,0
169747,cancer,0,0
169748,and,0,0
169749,lower,0,0
169750,circulating,0,0
169751,levels,0,0
169752,of,0,0
169753,25-hydroxyvitamin,0,0
169754,D,0,1
169755,[,0,0
169756,25,0,0
169757,(,0,0
169758,OH,0,0
169759,),0,0
169760,D,0,1
169761,],0,0
169762,.,0,0
169763,The,0,0
169764,effect,0,0
169765,of,0,0
169766,vitamin,1,1
169767,D3,1,1
169768,(,1,0
169769,cholecalciferol,1,1
169770,),1,1
169771,supplementation,1,1
169772,on,0,0
169773,inflammatory,0,0
169774,markers,0,0
169775,is,0,0
169776,uncertain,0,0
169777,.,0,0
169778,We,0,0
169779,conducted,0,0
169780,a,0,0
169781,randomized,0,0
169782,",",0,0
169783,double-blind,0,0
169784,",",0,0
169785,placebo-controlled,0,1
169786,trial,0,0
169787,of,0,0
169788,supplemental,1,0
169789,oral,1,1
169790,vitamin,1,1
169791,D,1,1
169792,(,1,0
169793,placebo,1,1
169794,",",0,0
169795,"1,000",0,0
169796,",",0,0
169797,"2,000",0,0
169798,",",0,0
169799,or,0,0
169800,"4,000",0,0
169801,IU/day,0,0
169802,of,0,0
169803,vitamin,0,1
169804,D3,0,1
169805,orally,0,1
169806,for,0,0
169807,3,0,0
169808,months,0,0
169809,),0,0
169810,in,0,0
169811,328,0,0
169812,African,0,0
169813,Americans,0,0
169814,(,0,0
169815,median,0,0
169816,age,0,0
169817,",",0,0
169818,51,0,0
169819,years,0,0
169820,),0,0
169821,of,0,0
169822,public,0,0
169823,housing,0,1
169824,communities,0,0
169825,in,0,0
169826,Boston,0,0
169827,",",0,0
169828,MA,0,0
169829,",",0,0
169830,who,0,0
169831,were,0,0
169832,enrolled,0,0
169833,over,0,0
169834,three,0,0
169835,consecutive,0,0
169836,winter,0,0
169837,periods,0,0
169838,(,0,0
169839,2007-2010,0,0
169840,),0,0
169841,.,0,0
169842,Change,0,0
169843,from,0,0
169844,0,0,0
169845,to,0,0
169846,3,0,0
169847,months,0,0
169848,of,0,0
169849,plasma,0,0
169850,levels,0,0
169851,of,0,0
169852,25,0,0
169853,(,0,0
169854,OH,0,0
169855,),0,0
169856,D,0,1
169857,",",0,0
169858,high-sensitivity,0,0
169859,C-reactive,0,0
169860,protein,0,1
169861,(,0,0
169862,CRP,0,1
169863,),0,0
169864,",",0,0
169865,interleukin,0,1
169866,(,0,0
169867,IL,0,1
169868,),0,0
169869,-6,0,0
169870,",",0,0
169871,IL-10,0,0
169872,",",0,0
169873,and,0,0
169874,soluble,0,1
169875,TNF-?,0,1
169876,receptor,0,0
169877,type,0,0
169878,2,0,0
169879,(,0,0
169880,sTNF-R2,0,0
169881,),0,0
169882,in,0,0
169883,292,0,0
169884,(,0,0
169885,89,0,0
169886,%,0,0
169887,),0,0
169888,participants,0,0
169889,were,0,0
169890,measured,0,0
169891,.,0,0
169892,Overall,0,0
169893,",",0,0
169894,no,0,0
169895,statistically,0,0
169896,significant,0,0
169897,changes,0,0
169898,in,0,0
169899,CRP,0,1
169900,",",0,0
169901,IL-6,0,0
169902,",",0,0
169903,IL-10,0,0
169904,",",0,0
169905,and,0,0
169906,sTNF-R2,0,0
169907,were,0,0
169908,observed,0,0
169909,after,0,0
169910,the,0,0
169911,vitamin,0,1
169912,D,0,1
169913,supplementation,0,1
169914,period,0,0
169915,.,0,0
169916,Baseline,0,0
169917,CRP,0,1
169918,was,0,0
169919,significantly,0,0
169920,inversely,0,0
169921,associated,0,0
169922,with,0,0
169923,the,0,0
169924,baseline,0,0
169925,25,0,0
169926,(,0,0
169927,OH,0,0
169928,),0,1
169929,D,0,1
169930,level,0,0
169931,(,0,0
169932,P,0,0
169933,<,0,0
169934,0.001,0,0
169935,),0,0
169936,in,0,0
169937,unadjusted,0,0
169938,and,0,0
169939,adjusted,0,0
169940,models,0,0
169941,.,0,0
169942,An,0,0
169943,interaction,0,0
169944,between,0,0
169945,baseline,0,0
169946,25,0,0
169947,(,0,0
169948,OH,0,0
169949,),0,1
169950,D,0,1
169951,and,0,0
169952,vitamin,0,1
169953,D,0,1
169954,supplementation,0,1
169955,was,0,0
169956,observed,0,0
169957,for,0,0
169958,outcome,0,0
169959,change,0,0
169960,in,0,0
169961,log,0,0
169962,CRP,0,1
169963,(,0,0
169964,month,0,0
169965,3-month,0,0
169966,0,0,0
169967,;,0,0
169968,P,0,0
169969,for,0,0
169970,interaction,0,0
169971,=,0,0
169972,0.04,0,0
169973,),0,0
169974,.,0,0
169975,Within,0,0
169976,an,0,0
169977,unselected,0,0
169978,population,0,0
169979,of,0,0
169980,African,0,0
169981,Americans,0,0
169982,",",0,0
169983,short-term,1,0
169984,exposure,1,0
169985,to,1,0
169986,vitamin,1,1
169987,D,1,1
169988,supplementation,1,1
169989,produced,0,0
169990,no,0,0
169991,change,0,0
169992,in,0,0
169993,circulating,0,0
169994,inflammatory,0,0
169995,markers,0,0
169996,.,0,0
169997,This,0,0
169998,study,0,0
169999,confirms,0,0
170000,the,0,0
170001,strong,0,0
170002,independent,0,0
170003,association,0,0
170004,of,0,0
170005,CRP,0,1
170006,with,0,0
170007,25,0,0
170008,(,0,0
170009,OH,0,0
170010,),0,1
170011,D,0,1
170012,status,0,0
170013,even,0,0
170014,after,0,0
170015,adjusting,0,0
170016,for,0,0
170017,body,0,0
170018,mass,0,0
170019,index,0,0
170020,.,0,0
170021,Future,0,0
170022,studies,0,0
170023,of,0,0
170024,longer,0,0
170025,supplemental,0,0
170026,vitamin,0,1
170027,D3,0,1
170028,duration,0,0
170029,are,0,0
170030,necessary,0,0
170031,to,0,0
170032,examine,0,0
170033,the,0,0
170034,complex,0,0
170035,influence,0,0
170036,of,0,0
170037,vitamin,0,1
170038,D3,0,1
170039,on,0,0
170040,CRP,0,1
170041,and,0,0
170042,other,0,0
170043,chronic,0,0
170044,inflammatory,0,0
170045,cytokines,0,0
170046,for,0,0
170047,possible,0,0
170048,reduction,0,0
170049,of,0,0
170050,cancer,0,0
170051,health,0,0
170052,disparities,0,0
170053,in,0,0
170054,African,0,0
170055,Americans,0,0
170056,.,0,0
170057,Phosphorylated,1,0
170058,p-70S6K,1,0
170059,predicts,0,0
170060,tamoxifen,1,1
170061,resistance,0,0
170062,in,0,0
170063,postmenopausal,0,0
170064,breast,0,0
170065,cancer,0,0
170066,patients,0,0
170067,randomized,0,0
170068,between,0,0
170069,adjuvant,0,1
170070,tamoxifen,1,1
170071,versus,0,0
170072,no,1,0
170073,systemic,1,0
170074,treatment,1,0
170075,.,1,0
170076,INTRODUCTION,0,0
170077,Activation,0,0
170078,of,0,0
170079,the,0,0
170080,phosphatidylinositol-3-kinase,1,1
170081,(,1,0
170082,PI3K,1,1
170083,),1,0
170084,and/or,0,0
170085,mitogen-activated,1,0
170086,protein,1,1
170087,kinase,1,0
170088,(,1,0
170089,MAPK,1,1
170090,),1,1
170091,pathways,0,0
170092,results,0,0
170093,in,0,0
170094,anti-estrogen,0,1
170095,resistance,0,0
170096,in,0,0
170097,vitro,0,0
170098,",",0,0
170099,but,0,0
170100,a,0,0
170101,biomarker,0,0
170102,with,0,0
170103,clinical,0,0
170104,validity,0,0
170105,to,0,0
170106,predict,0,0
170107,intrinsic,0,0
170108,resistance,0,0
170109,has,0,0
170110,not,0,0
170111,been,0,0
170112,identified,0,0
170113,.,0,0
170114,In,0,0
170115,metastatic,0,0
170116,breast,0,0
170117,cancer,0,0
170118,patients,0,0
170119,with,0,0
170120,previous,0,0
170121,exposure,0,0
170122,to,0,0
170123,endocrine,1,0
170124,therapy,1,1
170125,",",0,0
170126,the,0,0
170127,addition,0,0
170128,of,0,0
170129,a,0,0
170130,mammalian,0,0
170131,target,0,0
170132,of,0,0
170133,rapamycine,1,1
170134,(,1,0
170135,mTOR,1,0
170136,),1,1
170137,inhibitor,0,1
170138,has,0,0
170139,been,0,0
170140,shown,0,0
170141,to,0,0
170142,be,0,0
170143,beneficial,0,0
170144,.,0,0
170145,Whether,0,0
170146,or,0,0
170147,not,0,0
170148,patients,0,0
170149,on,0,0
170150,adjuvant,1,1
170151,endocrine,1,0
170152,treatment,1,0
170153,might,0,0
170154,benefit,0,0
170155,from,0,0
170156,these,0,0
170157,drugs,0,0
170158,is,0,0
170159,currently,0,0
170160,unclear,0,0
170161,.,0,0
170162,A,0,0
170163,biomarker,0,0
170164,that,0,0
170165,predicts,0,0
170166,intrinsic,0,0
170167,resistance,0,0
170168,could,0,0
170169,potentially,0,0
170170,be,0,0
170171,used,0,0
170172,as,0,0
170173,companion,0,0
170174,diagnostic,0,0
170175,in,0,0
170176,this,0,0
170177,setting,0,0
170178,.,0,0
170179,We,0,0
170180,tested,0,0
170181,the,0,0
170182,clinical,0,0
170183,validity,0,0
170184,of,0,0
170185,different,0,0
170186,downstream-activated,0,0
170187,proteins,0,0
170188,in,0,0
170189,the,0,0
170190,PI3K,0,1
170191,and/or,0,0
170192,MAPK,0,1
170193,pathways,0,0
170194,to,0,0
170195,predict,0,0
170196,intrinsic,0,0
170197,tamoxifen,1,1
170198,resistance,0,0
170199,in,0,0
170200,postmenopausal,0,0
170201,primary,0,0
170202,breast,0,0
170203,cancer,0,0
170204,patients,0,0
170205,.,0,0
170206,METHODS,0,0
170207,We,0,0
170208,recollected,0,0
170209,primary,0,0
170210,tumor,0,0
170211,tissue,0,0
170212,from,0,0
170213,patients,0,0
170214,who,0,0
170215,participated,0,0
170216,in,0,0
170217,a,0,0
170218,randomized,0,0
170219,trial,0,0
170220,of,0,0
170221,adjuvant,1,1
170222,tamoxifen,1,1
170223,(,1,0
170224,1-3,1,0
170225,years,1,0
170226,),1,0
170227,versus,1,0
170228,observation,1,0
170229,.,1,0
170230,After,0,0
170231,constructing,0,0
170232,a,0,0
170233,tissue,1,0
170234,micro-array,1,0
170235,",",0,0
170236,cores,0,0
170237,from,0,0
170238,563,0,0
170239,estrogen,0,1
170240,receptor,0,0
170241,?,0,0
170242,positive,0,0
170243,were,0,0
170244,immunostained,0,0
170245,for,0,0
170246,p-AKT,0,0
170247,(,0,0
170248,Thr308,0,0
170249,),0,0
170250,",",0,0
170251,p-AKT,0,0
170252,(,0,0
170253,Ser473,0,0
170254,),0,0
170255,",",0,0
170256,p-mTOR,0,0
170257,",",0,0
170258,p-p706SK,0,0
170259,and,0,0
170260,p-ERK1/2,0,0
170261,.,0,0
170262,Cox,0,0
170263,proportional,0,0
170264,hazard,0,0
170265,models,0,0
170266,for,0,0
170267,recurrence,0,0
170268,free,0,0
170269,interval,0,0
170270,were,0,0
170271,used,0,0
170272,to,0,0
170273,assess,0,0
170274,hazard,0,0
170275,ratios,0,0
170276,and,0,0
170277,interactions,0,0
170278,between,0,0
170279,these,0,0
170280,markers,0,0
170281,and,1,0
170282,tamoxifen,1,1
170283,treatment,0,0
170284,efficacy,0,0
170285,.,0,0
170286,RESULTS,0,0
170287,Interactions,0,0
170288,were,0,0
170289,identified,0,0
170290,between,1,0
170291,tamoxifen,1,1
170292,and,1,0
170293,p-AKT,1,0
170294,(,1,1
170295,Thr308,1,0
170296,),1,0
170297,",",1,0
170298,p-mTOR,1,0
170299,",",1,0
170300,p-p70S6K,1,0
170301,and,1,0
170302,p-ERK1/2,1,0
170303,.,1,0
170304,Applying,0,0
170305,a,0,0
170306,conservative,0,1
170307,level,0,0
170308,of,0,0
170309,significance,0,0
170310,",",0,0
170311,p-p70S6K,1,0
170312,remained,0,0
170313,significantly,0,0
170314,associated,0,0
170315,with,1,0
170316,tamoxifen,1,1
170317,resistance,0,0
170318,.,0,0
170319,Patients,0,0
170320,with,0,0
170321,p-p70S6K,0,0
170322,negative,0,0
170323,tumors,0,0
170324,derived,0,0
170325,significant,0,0
170326,benefit,0,0
170327,from,1,0
170328,tamoxifen,1,1
170329,(,0,0
170330,HR,0,0
170331,0.24,0,0
170332,",",0,0
170333,P,0,0
170334,<,0,0
170335,0.0001,0,0
170336,),0,0
170337,",",0,0
170338,while,0,0
170339,patients,0,0
170340,whose,0,0
170341,tumor,0,0
170342,did,0,0
170343,express,0,0
170344,p-p70S6K,0,0
170345,did,0,0
170346,not,0,0
170347,(,0,0
170348,HR,0,0
170349,=,0,0
170350,1.02,0,0
170351,",",0,0
170352,P,0,0
170353,=0.95,0,0
170354,),0,0
170355,",",0,0
170356,P,0,0
170357,for,0,0
170358,interaction,0,0
170359,0.004,0,0
170360,.,0,0
170361,In,0,0
170362,systemically,0,0
170363,untreated,0,0
170364,breast,0,0
170365,cancer,0,0
170366,patients,0,0
170367,",",0,0
170368,p-p70S6K,0,0
170369,was,0,0
170370,associated,0,0
170371,with,0,0
170372,a,0,0
170373,decreased,0,0
170374,risk,0,0
170375,for,0,0
170376,recurrence,0,0
170377,.,0,0
170378,CONCLUSIONS,0,0
170379,Patients,0,0
170380,whose,0,0
170381,tumor,0,0
170382,expresses,0,0
170383,p-p70S6K,0,0
170384,",",0,0
170385,as,0,0
170386,a,0,0
170387,marker,0,0
170388,of,0,0
170389,downstream,0,0
170390,PI3K,0,1
170391,and/or,0,0
170392,MAPK,0,1
170393,pathway,0,0
170394,activation,0,0
170395,",",0,0
170396,have,0,0
170397,a,0,0
170398,favorable,0,0
170399,prognosis,0,0
170400,",",0,0
170401,but,0,0
170402,do,0,0
170403,not,0,0
170404,benefit,0,0
170405,from,0,0
170406,adjuvant,0,1
170407,tamoxifen,1,1
170408,.,1,0
170409,A,1,0
170410,potential,1,0
170411,benefit,0,0
170412,from,0,0
170413,inhibitors,0,1
170414,of,0,0
170415,the,0,0
170416,PI3K/Akt/mTOR,0,1
170417,pathway,0,0
170418,in,0,0
170419,these,0,0
170420,patients,0,0
170421,needs,0,0
170422,to,0,0
170423,be,0,0
170424,further,0,0
170425,explored,0,0
170426,.,0,0
170427,Assessment,0,0
170428,of,0,0
170429,osteopontin,0,1
170430,in,0,0
170431,early,0,0
170432,breast,0,0
170433,cancer,0,0
170434,:,0,0
170435,correlative,0,0
170436,study,0,0
170437,in,0,0
170438,a,0,0
170439,randomised,0,0
170440,clinical,0,0
170441,trial,0,0
170442,.,0,0
170443,INTRODUCTION,0,0
170444,Osteopontin,1,0
170445,(,0,0
170446,OPN,0,0
170447,),0,1
170448,is,0,0
170449,a,0,0
170450,malignancy-associated,0,0
170451,glycoprotein,0,0
170452,that,0,0
170453,contributes,0,0
170454,functionally,0,0
170455,to,0,0
170456,tumor,0,0
170457,aggressiveness,0,0
170458,.,0,0
170459,In,0,0
170460,metastatic,0,0
170461,breast,0,0
170462,cancer,0,0
170463,",",0,0
170464,we,0,0
170465,previously,0,0
170466,demonstrated,0,0
170467,that,0,0
170468,elevated,0,0
170469,OPN,0,0
170470,in,0,0
170471,primary,0,0
170472,tumor,0,0
170473,and,0,0
170474,blood,0,0
170475,was,0,0
170476,associated,0,0
170477,with,0,0
170478,poor,0,0
170479,prognosis,0,0
170480,.,0,0
170481,METHODS,0,0
170482,We,0,0
170483,measured,0,0
170484,OPN,1,0
170485,in,0,0
170486,plasma,0,0
170487,by,0,0
170488,ELISA,0,0
170489,",",0,0
170490,and,0,0
170491,in,0,0
170492,tumors,0,0
170493,by,0,0
170494,immunohistochemistry,1,0
170495,",",0,0
170496,in,0,0
170497,624,0,0
170498,(,0,0
170499,94,0,0
170500,%,0,0
170501,),0,0
170502,and,0,0
170503,462,0,0
170504,(,0,0
170505,69,0,0
170506,%,0,0
170507,),0,0
170508,",",0,0
170509,respectively,0,0
170510,",",0,0
170511,of,0,0
170512,667,0,0
170513,postmenopausal,0,0
170514,women,0,0
170515,with,0,0
170516,hormone,0,0
170517,responsive,0,0
170518,early,0,0
170519,breast,0,0
170520,cancer,0,0
170521,treated,0,0
170522,by,0,0
170523,surgery,1,0
170524,followed,0,0
170525,by,0,0
170526,adjuvant,0,1
170527,treatment,0,0
170528,with,0,0
170529,tamoxifen,1,1
170530,+/-,1,0
170531,octreotide,1,1
170532,in,0,0
170533,a,0,0
170534,randomized,0,0
170535,trial,0,0
170536,(,0,0
170537,NCIC,0,1
170538,CTG,0,1
170539,MA.14,0,0
170540,;,0,0
170541,National,0,0
170542,Cancer,0,0
170543,Institute,0,0
170544,of,0,0
170545,Canada,0,0
170546,Clinical,0,0
170547,Trials,0,1
170548,Group,0,0
170549,Mammary.14,0,0
170550,),0,0
170551,.,0,0
170552,RESULTS,0,0
170553,Plasma,0,0
170554,OPN,0,0
170555,was,0,0
170556,measured,0,0
170557,in,0,0
170558,"2,540",0,0
170559,samples,0,0
170560,;,0,0
170561,688,0,0
170562,at,0,0
170563,baseline,0,0
170564,and,0,0
170565,"1,852",0,0
170566,collected,0,0
170567,during,0,0
170568,follow-up,0,0
170569,.,0,0
170570,Mean,0,0
170571,baseline,0,0
170572,plasma,0,0
170573,OPN,0,0
170574,was,0,0
170575,46,0,0
170576,ng/ml,0,0
170577,(,0,0
170578,range,0,0
170579,22.6,0,0
170580,to,0,0
170581,290,0,0
170582,),0,0
170583,which,0,0
170584,did,0,0
170585,not,0,0
170586,differ,0,0
170587,from,0,0
170588,normal,0,0
170589,levels,0,0
170590,.,0,0
170591,Mean,0,0
170592,percentage,0,0
170593,OPN,0,0
170594,tumor,0,0
170595,cell,0,0
170596,positivity,0,0
170597,was,0,0
170598,33.9,0,0
170599,(,0,0
170600,95,0,0
170601,%,0,0
170602,CI,0,0
170603,:,0,0
170604,30.2,0,0
170605,to,0,0
170606,37.9,0,0
170607,),0,0
170608,.,0,0
170609,There,0,0
170610,was,0,0
170611,no,0,0
170612,correlation,0,0
170613,between,0,0
170614,plasma,0,0
170615,and,0,0
170616,tumor,0,0
170617,OPN,0,0
170618,values,0,0
170619,.,0,0
170620,In,0,0
170621,multivariate,0,0
170622,analysis,0,0
170623,",",0,0
170624,neither,0,0
170625,was,0,0
170626,associated,0,0
170627,with,0,0
170628,event-free,0,0
170629,survival,0,0
170630,(,0,0
170631,EFS,0,0
170632,),0,0
170633,",",0,0
170634,relapse-free,0,0
170635,survival,0,0
170636,(,0,0
170637,RFS,0,1
170638,),0,0
170639,",",0,0
170640,overall,0,0
170641,survival,0,0
170642,(,0,0
170643,OS,0,0
170644,),0,0
170645,",",0,0
170646,bone,0,0
170647,RFS,0,1
170648,or,0,1
170649,non-bone,0,0
170650,RFS,0,0
170651,.,0,0
170652,An,0,0
170653,exploratory,0,0
170654,analysis,0,0
170655,in,0,0
170656,patients,0,0
170657,with,0,0
170658,recurrence,0,0
170659,showed,0,0
170660,higher,0,0
170661,mean,0,0
170662,OPN,0,0
170663,plasma,0,0
170664,levels,0,0
170665,60.7,0,0
170666,ng/ml,0,0
170667,(,0,0
170668,23.9,0,0
170669,to,0,0
170670,543,0,0
170671,),0,0
170672,in,0,0
170673,the,0,0
170674,recurrence,0,0
170675,period,0,0
170676,compared,0,0
170677,with,0,0
170678,baseline,0,0
170679,levels,0,0
170680,.,0,0
170681,CONCLUSIONS,0,0
170682,The,0,0
170683,hypothesis,0,0
170684,that,0,0
170685,OPN,0,0
170686,tumor,0,0
170687,expression,0,0
170688,would,0,0
170689,have,0,0
170690,independent,0,0
170691,prognostic,0,0
170692,value,0,0
170693,in,0,0
170694,early,0,0
170695,breast,0,0
170696,cancer,0,0
170697,was,0,0
170698,not,0,0
170699,supported,0,0
170700,by,0,0
170701,multivariate,0,0
170702,analysis,0,0
170703,of,0,0
170704,this,0,0
170705,study,0,0
170706,population,0,0
170707,.,0,0
170708,Plasma,0,0
170709,OPN,0,0
170710,levels,0,0
170711,in,0,0
170712,women,0,0
170713,with,0,0
170714,hormone,0,0
170715,responsive,0,0
170716,early,0,0
170717,breast,0,0
170718,cancer,0,0
170719,in,0,0
170720,the,0,0
170721,MA.14,0,0
170722,trial,0,0
170723,were,0,0
170724,not,0,0
170725,elevated,0,0
170726,and,0,0
170727,there,0,0
170728,was,0,0
170729,no,0,0
170730,evidence,0,0
170731,for,0,0
170732,prognostic,0,0
170733,value,0,0
170734,of,0,0
170735,plasma,0,0
170736,OPN,0,0
170737,in,0,0
170738,this,0,0
170739,defined,0,0
170740,group,0,0
170741,of,0,0
170742,patients,0,0
170743,.,0,0
170744,However,0,0
170745,",",0,0
170746,our,0,0
170747,finding,0,0
170748,of,0,0
170749,elevated,0,0
170750,mean,0,0
170751,OPN,0,0
170752,plasma,0,0
170753,level,0,0
170754,around,0,0
170755,the,0,0
170756,time,0,0
170757,of,0,0
170758,recurrence,0,0
170759,warrants,0,0
170760,further,0,0
170761,study,0,0
170762,.,0,0
170763,TRIAL,0,0
170764,REGISTRATION,0,0
170765,NCT00002864,0,0
170766,",",0,0
170767,http,0,0
170768,:,0,0
170769,//clinicaltrials.gov/show/NCT00002864,0,0
170770,.,0,0
170771,Examining,0,0
170772,the,0,0
170773,effectiveness,0,0
170774,of,0,0
170775,psychological,1,0
170776,strategies,1,0
170777,on,0,0
170778,physiologic,0,0
170779,markers,0,0
170780,:,0,0
170781,evidence-based,0,0
170782,suggestions,0,0
170783,for,0,0
170784,holistic,0,1
170785,care,0,0
170786,of,0,0
170787,the,0,0
170788,athlete,0,0
170789,.,0,0
170790,CONTEXT,0,0
170791,Current,0,0
170792,holistic,1,1
170793,rehabilitation,1,1
170794,blends,0,1
170795,both,0,0
170796,physical,0,0
170797,and,0,0
170798,psychological,0,0
170799,techniques,0,1
170800,.,0,0
170801,However,0,0
170802,",",0,0
170803,validation,0,0
170804,of,0,0
170805,the,0,0
170806,usefulness,0,0
170807,of,0,0
170808,psychological,1,0
170809,strategies,1,0
170810,is,0,0
170811,limited,0,0
170812,in,0,0
170813,the,0,0
170814,literature,0,0
170815,.,0,0
170816,OBJECTIVE,0,0
170817,To,0,0
170818,quantify,0,0
170819,the,0,0
170820,effects,0,0
170821,of,0,0
170822,psychological,0,0
170823,strategies,0,0
170824,on,0,0
170825,both,0,0
170826,physiologic,0,0
170827,(,0,0
170828,salivary,0,0
170829,cortisol,0,0
170830,),0,0
170831,and,0,0
170832,subjective,0,0
170833,assessments,0,0
170834,of,0,0
170835,stress,0,0
170836,.,0,0
170837,DESIGN,0,0
170838,Randomized,0,0
170839,controlled,0,0
170840,clinical,0,0
170841,trial,0,0
170842,.,0,0
170843,SETTING,0,0
170844,Laboratory,0,0
170845,.,0,0
170846,PATIENTS,0,0
170847,OR,0,0
170848,OTHER,0,0
170849,PARTICIPANTS,0,0
170850,A,0,0
170851,total,0,0
170852,of,0,0
170853,97,0,0
170854,college-aged,0,0
170855,students,0,0
170856,(,0,0
170857,age,0,0
170858,=,0,0
170859,20.65,0,0
170860,?,0,0
170861,4.38,0,0
170862,years,0,0
170863,),0,0
170864,",",0,0
170865,most,0,0
170866,with,0,0
170867,little,0,0
170868,to,0,0
170869,no,0,0
170870,experience,0,0
170871,with,0,0
170872,psychological,0,0
170873,strategies,0,0
170874,.,0,0
170875,INTERVENTION,0,0
170876,(,0,0
170877,S,0,0
170878,),0,0
170879,A,0,0
170880,15-minute,1,1
170881,script,1,0
170882,via,1,0
170883,an,1,0
170884,iPod,1,0
170885,led,0,0
170886,the,0,0
170887,participant,0,0
170888,through,1,0
170889,visual,1,0
170890,imagery,1,1
170891,(,1,0
170892,cognitive,1,0
170893,relaxation,1,1
170894,),1,0
170895,or,1,1
170896,deep,1,1
170897,breathing,1,1
170898,exercises,1,1
170899,(,1,0
170900,somatic,1,0
170901,relaxation,1,1
170902,),1,0
170903,cues,0,0
170904,.,0,0
170905,The,0,0
170906,control,0,0
170907,group,0,0
170908,listened,0,0
170909,to,0,0
170910,15,0,0
170911,minutes,0,0
170912,of,1,0
170913,ambient,1,1
170914,nature,1,0
170915,sounds,1,1
170916,.,1,0
170917,MAIN,0,0
170918,OUTCOME,0,0
170919,MEASURE,0,0
170920,(,0,0
170921,S,0,0
170922,),0,0
170923,Two,0,1
170924,samples,0,0
170925,(,0,0
170926,pretest,0,0
170927,",",0,0
170928,posttest,0,0
170929,),0,0
170930,of,0,0
170931,salivary,0,0
170932,cortisol,0,0
170933,were,0,0
170934,analyzed,0,0
170935,using,0,0
170936,an,0,0
170937,enzyme,0,0
170938,immunoassay,0,0
170939,kit,0,0
170940,;,0,0
170941,the,0,0
170942,average,0,0
170943,was,0,0
170944,used,0,0
170945,for,0,0
170946,statistical,0,0
170947,analysis,0,0
170948,.,0,0
170949,Descriptive,0,0
170950,statistics,0,0
170951,and,0,0
170952,correlations,0,0
170953,were,0,0
170954,conducted,0,0
170955,to,0,0
170956,examine,0,0
170957,group,0,0
170958,differences,0,0
170959,in,0,0
170960,time,0,0
170961,of,0,0
170962,day,0,0
170963,",",0,0
170964,salivary,0,0
170965,cortisol,0,0
170966,",",0,0
170967,sex,0,0
170968,",",0,0
170969,Stress-O-Meter,0,0
170970,values,0,0
170971,",",0,0
170972,and,0,0
170973,Perceived,0,0
170974,Stress,0,1
170975,Scale,0,0
170976,scores,0,0
170977,.,0,0
170978,RESULTS,0,0
170979,Salivary,0,0
170980,cortisol,0,0
170981,levels,0,0
170982,were,0,0
170983,lower,0,0
170984,in,0,0
170985,the,1,0
170986,treatment,1,0
170987,group,1,0
170988,than,0,0
170989,the,1,0
170990,control,1,1
170991,group,1,0
170992,(,0,0
170993,"F2,97",0,0
170994,=,0,0
170995,15.62,0,0
170996,",",0,0
170997,P,0,0
170998,<,0,0
170999,.001,0,0
171000,),0,0
171001,.,0,0
171002,Females,0,0
171003,had,0,0
171004,higher,0,0
171005,scores,0,0
171006,on,0,0
171007,both,0,0
171008,the,0,0
171009,pretest,0,0
171010,Stress-O-Meter,0,0
171011,(,0,0
171012,5.15,0,0
171013,?,0,0
171014,1.796,0,0
171015,),0,0
171016,and,0,0
171017,the,0,0
171018,Perceived,0,0
171019,Stress,0,1
171020,Scale,0,1
171021,(,0,0
171022,18.31,0,0
171023,?,0,0
171024,5.833,0,0
171025,),0,0
171026,than,0,0
171027,males,0,0
171028,(,0,0
171029,4.25,0,0
171030,?,0,0
171031,1.741,0,0
171032,and,0,0
171033,15.272,0,0
171034,?,0,0
171035,5.390,0,0
171036,",",0,0
171037,respectively,0,0
171038,),0,0
171039,.,0,0
171040,CONCLUSIONS,0,0
171041,Both,0,1
171042,cognitive,1,0
171043,and,1,0
171044,somatic,1,0
171045,relaxation,1,1
171046,strategies,1,0
171047,reduced,1,0
171048,cortisol,0,0
171049,levels,0,0
171050,.,0,0
171051,Participants,0,0
171052,who,0,0
171053,received,0,0
171054,verbal,0,1
171055,guidance,0,0
171056,achieved,0,0
171057,a,0,0
171058,larger,0,0
171059,cortisol,0,0
171060,reduction,0,0
171061,.,0,0
171062,However,0,0
171063,",",0,0
171064,the,0,0
171065,change,0,0
171066,in,0,0
171067,cortisol,0,0
171068,level,0,0
171069,was,0,0
171070,uncorrelated,0,0
171071,with,0,0
171072,the,0,0
171073,change,0,0
171074,in,0,0
171075,report,0,0
171076,of,0,0
171077,acute,0,0
171078,stress,0,0
171079,;,0,0
171080,females,0,0
171081,reported,0,0
171082,higher,0,0
171083,levels,0,0
171084,of,0,0
171085,stress,0,0
171086,.,0,0
171087,Clinical,0,0
171088,implications,0,0
171089,include,0,0
171090,attention,0,0
171091,to,0,0
171092,sex,0,0
171093,when,0,0
171094,assessing,0,0
171095,stress,0,0
171096,and,0,0
171097,providing,0,0
171098,coping,0,0
171099,skills,0,0
171100,during,0,0
171101,the,0,0
171102,rehabilitation,0,1
171103,process,0,0
171104,.,0,0
171105,Addictive,0,0
171106,internet,0,0
171107,use,0,0
171108,among,0,0
171109,Korean,0,0
171110,adolescents,0,0
171111,:,0,0
171112,a,0,0
171113,national,0,0
171114,survey,0,0
171115,.,0,0
171116,BACKGROUND,0,0
171117,A,0,0
171118,psychological,0,0
171119,disorder,0,0
171120,called,0,0
171121,'Internet,1,1
171122,addiction,1,0
171123,',1,0
171124,has,0,0
171125,newly,0,0
171126,emerged,0,0
171127,along,0,0
171128,with,0,0
171129,a,0,0
171130,dramatic,0,0
171131,increase,0,0
171132,of,0,0
171133,worldwide,0,0
171134,Internet,0,1
171135,use,0,0
171136,.,0,0
171137,However,0,0
171138,",",0,0
171139,few,0,0
171140,studies,0,0
171141,have,0,0
171142,used,0,0
171143,population-level,0,0
171144,samples,0,0
171145,nor,0,0
171146,taken,0,0
171147,into,0,0
171148,account,0,0
171149,contextual,0,0
171150,factors,0,0
171151,on,0,0
171152,Internet,0,1
171153,addiction,0,0
171154,.,0,0
171155,METHODS,0,0
171156,AND,0,0
171157,FINDINGS,0,0
171158,We,0,0
171159,identified,0,0
171160,"57,857",0,0
171161,middle,0,0
171162,and,0,0
171163,high,0,0
171164,school,0,0
171165,students,0,0
171166,(,0,0
171167,13-18,0,0
171168,year,0,0
171169,olds,0,0
171170,),0,0
171171,from,0,0
171172,a,0,0
171173,Korean,0,0
171174,nationally,0,0
171175,representative,0,0
171176,survey,0,0
171177,",",0,0
171178,which,0,0
171179,was,0,0
171180,surveyed,0,0
171181,in,0,0
171182,2009,0,0
171183,.,0,0
171184,To,0,0
171185,identify,0,0
171186,associated,0,0
171187,factors,0,0
171188,with,0,0
171189,addictive,0,0
171190,Internet,0,1
171191,use,0,0
171192,",",0,0
171193,two-level,0,0
171194,multilevel,0,0
171195,regression,0,0
171196,models,0,0
171197,were,0,0
171198,fitted,0,0
171199,with,0,0
171200,individual-level,1,0
171201,responses,1,0
171202,(,0,0
171203,1st,0,0
171204,level,0,0
171205,),0,0
171206,nested,0,0
171207,within,0,0
171208,schools,0,0
171209,(,0,0
171210,2nd,0,0
171211,level,0,0
171212,),0,0
171213,to,0,0
171214,estimate,0,0
171215,associations,0,0
171216,of,0,0
171217,individual,0,0
171218,and,0,0
171219,school,0,0
171220,characteristics,0,0
171221,simultaneously,0,0
171222,.,0,0
171223,Gender,0,0
171224,differences,0,0
171225,of,0,0
171226,addictive,0,0
171227,Internet,0,1
171228,use,0,0
171229,were,0,0
171230,estimated,0,0
171231,with,0,0
171232,the,0,0
171233,regression,0,0
171234,model,0,0
171235,stratified,0,0
171236,by,0,0
171237,gender,0,0
171238,.,0,0
171239,Significant,0,0
171240,associations,0,0
171241,were,0,0
171242,found,0,0
171243,between,0,0
171244,addictive,0,0
171245,Internet,0,1
171246,use,0,0
171247,and,0,0
171248,school,0,0
171249,grade,0,0
171250,",",0,0
171251,parental,0,0
171252,education,0,1
171253,",",0,0
171254,alcohol,0,1
171255,use,0,0
171256,",",0,0
171257,tobacco,0,1
171258,use,0,0
171259,",",0,0
171260,and,0,0
171261,substance,0,0
171262,use,0,0
171263,.,0,0
171264,Female,0,0
171265,students,0,0
171266,in,0,0
171267,girls,0,0
171268,',0,0
171269,schools,0,0
171270,were,0,0
171271,more,0,0
171272,likely,0,0
171273,to,0,0
171274,use,0,0
171275,Internet,0,1
171276,addictively,0,0
171277,than,0,0
171278,those,0,0
171279,in,0,0
171280,coeducational,0,1
171281,schools,0,0
171282,.,0,0
171283,Our,0,0
171284,results,0,0
171285,also,0,0
171286,revealed,0,0
171287,significant,0,0
171288,gender,0,0
171289,differences,0,0
171290,of,0,0
171291,addictive,0,0
171292,Internet,0,1
171293,use,0,0
171294,in,0,0
171295,its,0,0
171296,associated,0,0
171297,individual-,0,0
171298,and,0,0
171299,school-level,0,0
171300,factors,0,0
171301,.,0,0
171302,CONCLUSIONS,0,0
171303,Our,0,0
171304,results,0,0
171305,suggest,0,0
171306,that,0,0
171307,multilevel,0,0
171308,risk,0,0
171309,factors,0,0
171310,along,0,0
171311,with,0,0
171312,gender,0,0
171313,differences,0,0
171314,should,0,0
171315,be,0,0
171316,considered,0,0
171317,to,0,0
171318,protect,0,0
171319,adolescents,0,0
171320,from,0,0
171321,addictive,1,0
171322,Internet,1,1
171323,use,1,0
171324,.,1,0
171325,Alleviating,0,0
171326,social,0,1
171327,avoidance,0,0
171328,:,0,0
171329,effects,0,0
171330,of,0,0
171331,single,1,0
171332,dose,1,0
171333,testosterone,1,0
171334,administration,1,0
171335,on,0,0
171336,approach-avoidance,0,0
171337,action,0,0
171338,.,0,0
171339,Testosterone,1,0
171340,is,0,0
171341,an,0,0
171342,important,0,0
171343,regulator,0,0
171344,of,0,0
171345,social-motivational,0,0
171346,behavior,0,0
171347,and,0,0
171348,is,0,0
171349,known,0,0
171350,for,0,0
171351,its,0,0
171352,dominance-enhancing,0,0
171353,and,0,0
171354,social-anxiolytic,0,0
171355,properties,0,0
171356,.,0,0
171357,However,0,0
171358,",",0,0
171359,to,0,0
171360,date,0,0
171361,no,0,0
171362,studies,0,0
171363,have,0,0
171364,systematically,0,0
171365,investigated,0,0
171366,the,0,0
171367,causal,0,0
171368,effect,0,0
171369,of,0,0
171370,testosterone,0,0
171371,on,0,0
171372,actual,0,0
171373,social,0,1
171374,approach-avoidance,0,0
171375,behavior,0,0
171376,in,0,0
171377,humans,0,0
171378,.,0,0
171379,The,0,0
171380,present,0,0
171381,study,0,0
171382,sets,0,0
171383,out,0,0
171384,to,0,0
171385,test,0,0
171386,the,0,0
171387,effects,0,0
171388,of,0,0
171389,testosterone,1,0
171390,administration,1,0
171391,in,0,0
171392,healthy,0,0
171393,female,0,0
171394,volunteers,0,0
171395,using,0,0
171396,an,0,0
171397,objective,0,0
171398,implicit,0,0
171399,measure,0,0
171400,of,0,0
171401,social,0,0
171402,motivational,0,1
171403,behavior,0,0
171404,:,0,0
171405,the,0,0
171406,social,0,0
171407,Approach-Avoidance,0,0
171408,Task,0,1
171409,",",0,0
171410,a,0,0
171411,reaction,0,0
171412,time,0,0
171413,task,0,1
171414,requiring,0,0
171415,participants,0,0
171416,to,0,0
171417,approach,0,1
171418,or,0,0
171419,avoid,0,0
171420,visually,0,0
171421,presented,0,0
171422,emotional,0,0
171423,(,0,0
171424,happy,0,1
171425,",",0,0
171426,angry,0,0
171427,",",0,0
171428,and,0,0
171429,neutral,0,1
171430,),0,0
171431,faces,0,0
171432,.,0,0
171433,Participants,0,0
171434,showed,0,0
171435,significantly,0,0
171436,diminished,0,0
171437,avoidance,0,0
171438,tendencies,0,0
171439,to,0,0
171440,angry,0,0
171441,faces,0,0
171442,after,0,0
171443,testosterone,1,0
171444,administration,0,0
171445,.,0,0
171446,Testosterone,1,0
171447,did,0,0
171448,not,0,0
171449,affect,0,0
171450,approach-avoidance,0,0
171451,tendencies,0,0
171452,to,0,0
171453,social,0,0
171454,affiliation,0,0
171455,(,0,0
171456,happy,0,1
171457,),0,0
171458,faces,0,0
171459,.,0,0
171460,Thus,0,0
171461,",",0,0
171462,a,0,0
171463,single,0,0
171464,dose,0,0
171465,testosterone,1,0
171466,administration,0,0
171467,reduces,0,0
171468,automatic,0,0
171469,avoidance,0,0
171470,of,0,0
171471,social,0,1
171472,threat,0,0
171473,and,0,0
171474,promotes,0,0
171475,relative,0,0
171476,increase,0,0
171477,of,0,0
171478,threat,0,0
171479,approach,0,1
171480,tendencies,0,0
171481,in,0,0
171482,healthy,0,0
171483,females,0,0
171484,.,0,0
171485,These,0,0
171486,findings,0,0
171487,further,0,0
171488,the,0,0
171489,understanding,0,0
171490,of,0,0
171491,the,0,0
171492,neuroendocrine,0,0
171493,regulation,0,0
171494,of,0,0
171495,social,0,0
171496,motivational,0,1
171497,behavior,0,0
171498,and,0,0
171499,may,0,0
171500,have,0,0
171501,direct,0,0
171502,treatment,0,0
171503,implications,0,0
171504,for,0,0
171505,social,0,0
171506,anxiety,0,0
171507,",",0,0
171508,characterized,0,0
171509,by,0,0
171510,persistent,0,0
171511,social,0,0
171512,avoidance,0,0
171513,.,0,0
171514,Accumulated,1,0
171515,brisk,1,0
171516,walking,1,0
171517,reduces,0,0
171518,arterial,0,0
171519,stiffness,0,0
171520,in,0,0
171521,overweight,0,0
171522,adults,0,0
171523,:,0,0
171524,evidence,0,0
171525,from,0,0
171526,a,0,0
171527,randomized,0,0
171528,control,0,0
171529,trial,0,0
171530,.,0,0
171531,Arterial,0,0
171532,stiffness,0,0
171533,is,0,0
171534,a,0,0
171535,major,0,0
171536,contributor,0,0
171537,to,0,0
171538,the,0,0
171539,development,0,0
171540,of,0,0
171541,atherosclerosis,0,0
171542,and,0,0
171543,consequently,0,0
171544,cardiovascular,0,0
171545,disease,0,0
171546,.,0,0
171547,This,0,0
171548,study,0,0
171549,aimed,0,0
171550,to,0,0
171551,examine,0,0
171552,whether,0,0
171553,6,0,0
171554,months,0,0
171555,of,0,0
171556,accumulated,0,0
171557,(,0,0
171558,3,0,0
171559,?,0,0
171560,10,0,0
171561,minutes,0,0
171562,",",0,0
171563,5,0,0
171564,days/week,1,1
171565,),1,0
171566,brisk,1,0
171567,walking,1,1
171568,was,0,0
171569,sufficient,0,0
171570,to,0,0
171571,reduce,0,0
171572,arterial,0,0
171573,stiffness,0,0
171574,in,0,0
171575,sedentary,0,0
171576,",",0,0
171577,overweight,0,0
171578,individuals,0,0
171579,.,0,0
171580,Seventy-seven,0,0
171581,individuals,0,0
171582,(,0,0
171583,19,0,0
171584,men,0,0
171585,",",0,0
171586,58,0,0
171587,women,0,0
171588,;,0,0
171589,age,0,0
171590,",",0,0
171591,30-55,0,0
171592,years,0,0
171593,),0,0
171594,were,0,0
171595,randomly,0,0
171596,allocated,0,0
171597,to,0,0
171598,one,0,0
171599,of,0,0
171600,three,0,0
171601,groups,0,0
171602,;,0,0
171603,two,0,0
171604,groups,0,0
171605,completed,1,0
171606,30,1,0
171607,minutes,1,0
171608,of,1,0
171609,accumulated,1,0
171610,walking,1,0
171611,with,1,0
171612,either,1,0
171613,monthly,1,0
171614,or,1,0
171615,weekly,1,1
171616,telephone,1,1
171617,support,1,0
171618,;,1,0
171619,the,0,0
171620,third,1,0
171621,group,1,0
171622,(,1,0
171623,control,1,1
171624,),1,0
171625,performed,1,0
171626,stretching,1,1
171627,exercises,1,1
171628,.,1,0
171629,The,0,0
171630,walking,0,0
171631,groups,0,0
171632,were,0,0
171633,combined,0,0
171634,and,0,0
171635,telephone,0,1
171636,support,0,0
171637,included,0,0
171638,as,0,0
171639,a,0,0
171640,covariate,0,0
171641,.,0,0
171642,Anthropometry,0,0
171643,",",0,0
171644,blood,0,0
171645,pressure,0,0
171646,(,0,0
171647,BP,0,0
171648,),0,0
171649,",",0,0
171650,blood,0,0
171651,lipids,0,0
171652,",",0,0
171653,pulse,0,0
171654,wave,0,1
171655,velocity,0,0
171656,(,0,0
171657,PWV,0,1
171658,),0,0
171659,",",0,0
171660,and,0,0
171661,NOx,0,1
171662,(,0,0
171663,surrogate,0,0
171664,marker,0,0
171665,for,0,0
171666,nitric,0,1
171667,oxide,0,1
171668,),0,0
171669,were,0,0
171670,measured,0,0
171671,at,0,0
171672,baseline,0,0
171673,",",0,0
171674,post-intervention,0,0
171675,and,0,0
171676,4,0,0
171677,months,0,0
171678,post-intervention,0,0
171679,.,0,0
171680,No,0,0
171681,changes,0,0
171682,were,0,0
171683,observed,0,0
171684,for,0,0
171685,anthropometry,0,0
171686,",",0,0
171687,BP,0,0
171688,",",0,0
171689,or,0,0
171690,lipids,0,0
171691,.,0,0
171692,However,0,0
171693,",",0,0
171694,at,0,0
171695,the,0,0
171696,end,0,0
171697,of,0,0
171698,the,0,0
171699,intervention,0,1
171700,",",0,0
171701,there,0,0
171702,was,0,0
171703,a,0,0
171704,decrease,0,0
171705,in,0,0
171706,PWV,0,1
171707,(,0,0
171708,P,0,0
171709,<,0,0
171710,.001,0,0
171711,),0,0
171712,accompanied,0,0
171713,by,0,0
171714,an,0,0
171715,increase,0,0
171716,in,0,0
171717,NOx,0,0
171718,(,0,0
171719,P,0,0
171720,<,0,0
171721,.001,0,0
171722,),0,0
171723,",",0,0
171724,with,0,0
171725,changes,0,0
171726,maintained,0,0
171727,4,0,0
171728,months,0,0
171729,post-intervention,0,0
171730,.,0,0
171731,A,0,0
171732,strong,0,0
171733,negative,0,0
171734,correlation,0,0
171735,between,0,0
171736,PWV,0,1
171737,and,0,0
171738,NOx,0,0
171739,was,0,0
171740,also,0,0
171741,observed,0,0
171742,(,0,0
171743,P,0,0
171744,<,0,0
171745,.001,0,0
171746,;,0,0
171747,r,0,0
171748,=,0,0
171749,-0.65,0,0
171750,),0,0
171751,.,0,0
171752,A,0,0
171753,lifestyle,0,1
171754,approach,0,1
171755,to,0,0
171756,meeting,0,0
171757,current,1,0
171758,physical,1,1
171759,activity,1,0
171760,guidelines,0,0
171761,results,0,0
171762,in,0,0
171763,favorable,0,0
171764,alterations,0,0
171765,in,0,0
171766,arterial,0,0
171767,function,0,0
171768,in,0,0
171769,overweight,0,0
171770,individuals,0,0
171771,.,0,0
171772,Evaluation,0,0
171773,of,0,0
171774,the,0,0
171775,efficacy,0,0
171776,and,0,0
171777,safety,0,0
171778,of,0,0
171779,the,0,0
171780,ophthalmic,1,0
171781,insert,1,1
171782,Mydriasert,1,1
171783,in,0,0
171784,patients,0,0
171785,undergoing,0,0
171786,retinal,0,0
171787,angiography,0,1
171788,.,0,0
171789,PURPOSE,0,0
171790,To,0,0
171791,verify,0,0
171792,the,0,0
171793,efficacy,0,0
171794,to,0,0
171795,obtain,0,0
171796,mydriasis,0,1
171797,and,0,0
171798,cardiovascular,0,0
171799,safety,0,0
171800,of,0,0
171801,Mydriasert,1,1
171802,(,1,0
171803,ophthalmic,1,0
171804,insert,1,1
171805,containing,1,1
171806,tropicamide,1,1
171807,and,1,0
171808,phenylephrine,1,1
171809,),1,0
171810,in,0,0
171811,diabetic,0,0
171812,and,0,0
171813,nondiabetic,0,0
171814,patients,0,0
171815,undergoing,0,0
171816,retinal,0,0
171817,angiography,0,1
171818,by,0,0
171819,comparing,0,0
171820,it,0,0
171821,with,0,0
171822,usually,0,0
171823,administered,0,0
171824,eyedrops,0,1
171825,(,1,0
171826,tropicamide,1,1
171827,1,1,0
171828,%,1,0
171829,and,1,0
171830,phenylephrine,1,1
171831,10,1,0
171832,%,1,0
171833,),1,0
171834,.,0,0
171835,METHODS,0,0
171836,This,0,0
171837,was,0,0
171838,a,0,0
171839,prospective,0,0
171840,randomized,0,0
171841,study,0,0
171842,.,0,0
171843,A,0,0
171844,total,0,0
171845,of,0,0
171846,154,0,0
171847,eyes,0,0
171848,of,0,0
171849,77,0,0
171850,patients,0,0
171851,were,0,0
171852,randomly,0,0
171853,divided,0,0
171854,into,0,0
171855,2,0,0
171856,groups,0,0
171857,:,0,0
171858,group,0,0
171859,1,0,0
171860,consisted,0,0
171861,of,0,0
171862,78,0,0
171863,eyes,0,0
171864,",",0,0
171865,group,0,0
171866,2,0,0
171867,consisted,0,0
171868,of,0,0
171869,76,0,0
171870,eyes,0,0
171871,",",0,0
171872,and,0,0
171873,the,0,0
171874,patients,0,0
171875,were,0,0
171876,monitored,0,0
171877,for,0,0
171878,pupillary,0,0
171879,dilation,0,0
171880,",",0,0
171881,blood,0,0
171882,pressure,0,0
171883,",",0,0
171884,heart,0,0
171885,rate,0,0
171886,",",0,0
171887,and,0,0
171888,possible,0,0
171889,adverse,0,0
171890,effects,0,0
171891,at,0,0
171892,0,0,0
171893,",",0,0
171894,20,0,0
171895,",",0,0
171896,40,0,0
171897,",",0,0
171898,60,0,0
171899,",",0,0
171900,and,0,0
171901,90,0,0
171902,minutes,0,0
171903,.,0,0
171904,RESULTS,0,0
171905,No,0,0
171906,severe,0,0
171907,adverse,0,0
171908,effects,0,0
171909,were,0,0
171910,observed,0,0
171911,in,0,0
171912,either,0,0
171913,group,0,0
171914,.,0,0
171915,In,0,0
171916,the,0,0
171917,entire,0,0
171918,sample,0,0
171919,studied,0,0
171920,",",0,0
171921,the,0,0
171922,mean,0,0
171923,pupillary,0,0
171924,diameter,0,0
171925,was,0,0
171926,greater,0,0
171927,in,0,0
171928,the,0,0
171929,eyedrops,0,1
171930,group,0,0
171931,after,0,0
171932,20,0,0
171933,and,0,0
171934,40,0,0
171935,minutes,0,0
171936,",",0,0
171937,while,0,0
171938,mydriasis,0,0
171939,was,0,0
171940,similar,0,0
171941,in,0,0
171942,the,0,0
171943,2,0,0
171944,groups,0,0
171945,after,0,0
171946,60,0,0
171947,minutes,0,0
171948,.,0,0
171949,The,0,0
171950,diabetic,0,0
171951,patients,0,0
171952,treated,0,0
171953,with,0,0
171954,Mydriasert,1,0
171955,had,0,0
171956,less,0,0
171957,mydriasis,0,0
171958,than,0,0
171959,those,0,0
171960,treated,0,0
171961,with,0,0
171962,eyedrops,0,1
171963,after,0,0
171964,20,0,0
171965,and,0,0
171966,40,0,0
171967,minutes,0,0
171968,",",0,0
171969,and,0,0
171970,diabetic,0,0
171971,patients,0,0
171972,showed,0,0
171973,less,0,0
171974,mydriasis,0,0
171975,than,0,0
171976,the,0,0
171977,nondiabetic,0,0
171978,patients,0,0
171979,after,0,0
171980,60,0,0
171981,and,0,0
171982,90,0,0
171983,minutes,0,0
171984,.,0,0
171985,There,0,0
171986,was,0,0
171987,no,0,0
171988,significant,0,0
171989,between-group,0,0
171990,difference,0,0
171991,in,0,0
171992,mean,0,0
171993,heart,0,0
171994,rate,0,0
171995,or,0,1
171996,systolic,0,0
171997,and,0,0
171998,diastolic,0,0
171999,blood,0,0
172000,pressure,0,0
172001,at,0,0
172002,any,0,0
172003,of,0,0
172004,the,0,0
172005,time,0,0
172006,points,0,0
172007,.,0,0
172008,CONCLUSIONS,0,0
172009,Mydriasert,1,1
172010,assures,0,0
172011,an,0,0
172012,adequate,0,0
172013,degree,0,0
172014,of,0,0
172015,mydriasis,0,0
172016,for,0,0
172017,retinal,0,0
172018,angiography,0,1
172019,in,0,0
172020,both,0,0
172021,diabetic,0,0
172022,and,0,0
172023,nondiabetic,0,0
172024,patients,0,0
172025,.,0,0
172026,There,0,0
172027,are,0,0
172028,no,0,0
172029,differences,0,0
172030,in,0,0
172031,efficacy,0,0
172032,or,0,1
172033,safety,0,0
172034,between,0,0
172035,the,0,0
172036,insert,0,0
172037,and,0,0
172038,the,0,0
172039,usually,0,0
172040,administered,0,0
172041,eyedrops,0,1
172042,",",0,0
172043,but,0,0
172044,the,0,0
172045,low,0,0
172046,total,0,0
172047,drug,0,0
172048,dose,0,0
172049,administered,0,0
172050,with,0,0
172051,the,0,0
172052,insert,0,1
172053,reduces,0,0
172054,the,0,0
172055,risk,0,0
172056,of,0,0
172057,cardiovascular,0,0
172058,side,0,0
172059,effects,0,0
172060,.,0,0
172061,Decreased,0,0
172062,expression,0,0
172063,of,0,0
172064,Yes-associated,0,0
172065,protein,0,0
172066,is,0,0
172067,associated,0,0
172068,with,0,0
172069,outcome,0,0
172070,in,0,0
172071,the,0,0
172072,luminal,0,0
172073,A,0,0
172074,breast,0,0
172075,cancer,0,0
172076,subgroup,0,0
172077,and,0,0
172078,with,0,0
172079,an,0,0
172080,impaired,0,0
172081,tamoxifen,1,1
172082,response,0,0
172083,.,0,0
172084,BACKGROUND,0,0
172085,Yes-associated,0,0
172086,protein,0,1
172087,(,0,0
172088,YAP1,0,0
172089,),0,1
172090,is,0,0
172091,frequently,0,0
172092,reported,0,0
172093,to,0,0
172094,function,0,0
172095,as,0,0
172096,an,0,0
172097,oncogene,0,0
172098,in,0,0
172099,many,0,0
172100,types,0,0
172101,of,0,0
172102,cancer,0,0
172103,",",0,0
172104,but,0,0
172105,in,0,0
172106,breast,0,0
172107,cancer,0,0
172108,results,0,0
172109,remain,0,0
172110,controversial,0,0
172111,.,0,0
172112,We,0,0
172113,set,0,0
172114,out,0,0
172115,to,0,0
172116,clarify,0,0
172117,the,0,0
172118,role,0,0
172119,of,0,0
172120,YAP1,0,0
172121,in,0,0
172122,breast,0,0
172123,cancer,0,0
172124,by,0,0
172125,examining,0,0
172126,gene,0,0
172127,and,0,0
172128,protein,0,1
172129,expression,0,0
172130,in,0,0
172131,subgroups,0,0
172132,of,0,0
172133,patient,0,0
172134,material,0,0
172135,and,0,0
172136,by,0,0
172137,downregulating,0,0
172138,YAP1,0,0
172139,in,0,0
172140,vitro,0,0
172141,and,0,0
172142,studying,0,0
172143,its,0,0
172144,role,0,0
172145,in,0,0
172146,response,0,0
172147,to,0,0
172148,the,0,0
172149,widely,0,0
172150,used,0,0
172151,anti-estrogen,0,1
172152,tamoxifen,1,1
172153,.,1,0
172154,METHODS,0,0
172155,YAP1,0,0
172156,protein,0,1
172157,intensity,0,0
172158,was,0,0
172159,scored,0,0
172160,as,0,0
172161,absent,0,0
172162,",",0,0
172163,weak,0,0
172164,",",0,0
172165,intermediate,0,0
172166,or,0,0
172167,strong,0,0
172168,in,0,0
172169,two,0,0
172170,primary,0,0
172171,breast,0,0
172172,cancer,0,0
172173,cohorts,0,0
172174,(,0,0
172175,n,0,0
172176,=,0,0
172177,144,0,0
172178,and,0,0
172179,n,0,0
172180,=,0,0
172181,564,0,0
172182,),0,0
172183,and,0,0
172184,mRNA,0,0
172185,expression,0,0
172186,of,0,0
172187,YAP1,0,0
172188,was,0,0
172189,evaluated,0,0
172190,in,0,0
172191,a,0,0
172192,gene,0,0
172193,expression,0,0
172194,dataset,0,0
172195,(,0,0
172196,n,0,0
172197,=,0,0
172198,1107,0,0
172199,),0,0
172200,.,0,0
172201,Recurrence-free,0,0
172202,survival,0,0
172203,was,0,0
172204,analysed,0,0
172205,using,0,0
172206,the,0,0
172207,log-rank,0,0
172208,test,0,0
172209,and,0,0
172210,Cox,0,1
172211,multivariate,0,0
172212,analysis,0,0
172213,was,0,0
172214,used,0,0
172215,to,0,0
172216,test,0,0
172217,for,0,0
172218,independence,0,0
172219,.,0,0
172220,WST-1,1,0
172221,assay,1,0
172222,was,0,0
172223,employed,0,0
172224,to,0,0
172225,measure,0,0
172226,cell,0,0
172227,viability,0,0
172228,and,0,0
172229,a,0,0
172230,luciferase,0,0
172231,ERE,0,0
172232,(,0,0
172233,estrogen,0,1
172234,responsive,0,1
172235,element,0,1
172236,),0,0
172237,construct,0,0
172238,was,0,0
172239,used,0,0
172240,to,0,0
172241,study,0,0
172242,the,0,0
172243,effect,0,0
172244,of,0,0
172245,tamoxifen,1,1
172246,",",0,0
172247,following,0,0
172248,downregulation,0,0
172249,of,0,0
172250,YAP1,0,0
172251,using,0,0
172252,siRNAs,0,0
172253,.,0,0
172254,RESULTS,0,0
172255,In,0,0
172256,the,0,0
172257,ER+,0,1
172258,(,0,0
172259,Estrogen,0,1
172260,Receptor,0,1
172261,?,0,0
172262,positive,0,0
172263,),0,0
172264,subgroup,0,0
172265,of,0,0
172266,the,0,0
172267,randomised,0,0
172268,cohort,0,0
172269,",",0,0
172270,YAP1,0,0
172271,expression,0,0
172272,was,0,0
172273,inversely,0,0
172274,correlated,0,0
172275,to,0,0
172276,histological,0,0
172277,grade,0,0
172278,and,0,0
172279,proliferation,0,0
172280,(,0,0
172281,p,0,0
172282,=,0,0
172283,0.001,0,0
172284,and,0,0
172285,p,0,0
172286,=,0,0
172287,0.016,0,0
172288,",",0,0
172289,respectively,0,0
172290,),0,0
172291,whereas,0,0
172292,in,0,0
172293,the,0,0
172294,ER-,0,1
172295,(,0,0
172296,Estrogen,0,1
172297,Receptor,0,1
172298,?,0,0
172299,negative,0,0
172300,),0,0
172301,subgroup,0,0
172302,YAP1,0,0
172303,expression,0,0
172304,correlated,0,0
172305,positively,0,0
172306,to,0,0
172307,proliferation,0,0
172308,(,0,0
172309,p,0,0
172310,=,0,0
172311,0.005,0,0
172312,),0,0
172313,.,0,0
172314,Notably,0,0
172315,",",0,0
172316,low,0,0
172317,YAP1,0,0
172318,mRNA,0,0
172319,was,0,0
172320,independently,0,0
172321,associated,0,0
172322,with,0,0
172323,decreased,0,0
172324,recurrence-free,0,0
172325,survival,0,0
172326,in,0,0
172327,the,0,0
172328,gene,0,0
172329,expression,0,0
172330,dataset,0,0
172331,",",0,0
172332,specifically,0,0
172333,for,0,0
172334,the,0,0
172335,luminal,0,0
172336,A,0,0
172337,subgroup,0,0
172338,(,0,0
172339,p,0,0
172340,<,0,0
172341,0.001,0,0
172342,),0,0
172343,which,0,0
172344,includes,0,0
172345,low,0,0
172346,proliferating,0,0
172347,tumours,0,0
172348,of,0,0
172349,lower,0,0
172350,grade,0,0
172351,",",0,0
172352,usually,0,0
172353,associated,0,0
172354,with,0,0
172355,a,0,0
172356,good,0,0
172357,prognosis,0,0
172358,.,0,0
172359,This,0,0
172360,subgroup,0,0
172361,specificity,0,0
172362,led,0,0
172363,us,0,0
172364,to,0,0
172365,hypothesize,0,0
172366,that,0,0
172367,YAP1,0,0
172368,may,0,0
172369,be,0,0
172370,important,0,0
172371,for,0,0
172372,response,0,0
172373,to,0,0
172374,endocrine,0,0
172375,therapies,0,0
172376,",",0,0
172377,such,0,0
172378,as,0,0
172379,tamoxifen,1,1
172380,",",1,0
172381,extensively,0,0
172382,used,0,0
172383,for,0,0
172384,luminal,0,0
172385,A,0,0
172386,breast,0,0
172387,cancers,0,0
172388,.,0,0
172389,In,0,0
172390,a,0,0
172391,tamoxifen,1,1
172392,randomised,1,0
172393,patient,0,0
172394,material,0,0
172395,",",0,0
172396,absent,0,0
172397,YAP1,0,0
172398,protein,0,1
172399,expression,0,0
172400,was,0,0
172401,associated,0,0
172402,with,0,0
172403,impaired,1,0
172404,tamoxifen,1,1
172405,response,1,0
172406,which,0,0
172407,was,0,0
172408,significant,0,0
172409,upon,0,0
172410,interaction,0,0
172411,analysis,0,0
172412,(,0,0
172413,p,0,0
172414,=,0,0
172415,0.042,0,0
172416,),0,0
172417,.,0,0
172418,YAP1,0,0
172419,downregulation,0,0
172420,resulted,0,0
172421,in,0,0
172422,increased,0,0
172423,progesterone,0,1
172424,receptor,0,0
172425,(,0,0
172426,PgR,0,1
172427,),0,1
172428,expression,0,0
172429,and,0,0
172430,a,0,0
172431,delayed,0,0
172432,and,0,0
172433,weaker,1,0
172434,tamoxifen,1,1
172435,in,1,0
172436,support,0,0
172437,of,0,0
172438,the,0,0
172439,clinical,0,0
172440,data,0,0
172441,.,0,0
172442,CONCLUSIONS,0,0
172443,Decreased,0,0
172444,YAP1,0,0
172445,expression,0,0
172446,is,0,0
172447,an,0,0
172448,independent,0,0
172449,prognostic,0,0
172450,factor,0,0
172451,for,0,0
172452,recurrence,0,0
172453,in,0,0
172454,the,0,0
172455,less,0,0
172456,aggressive,0,0
172457,luminal,0,0
172458,A,0,0
172459,breast,0,0
172460,cancer,0,0
172461,subgroup,0,0
172462,",",0,0
172463,likely,0,0
172464,due,0,0
172465,to,0,0
172466,the,0,0
172467,decreased,1,0
172468,tamoxifen,1,1
172469,sensitivity,1,0
172470,conferred,0,0
172471,by,0,0
172472,YAP1,0,0
172473,downregulation,0,0
172474,.,0,0
172475,Brief,0,1
172476,acceptance-based,1,0
172477,intervention,1,1
172478,for,0,0
172479,increasing,0,0
172480,intake,0,0
172481,attendance,0,0
172482,at,0,0
172483,a,0,0
172484,community,0,0
172485,mental,0,0
172486,health,0,0
172487,center,0,0
172488,.,0,0
172489,Intake,0,0
172490,no-show,0,0
172491,rates,0,0
172492,for,0,0
172493,psychotherapy,0,1
172494,vary,0,0
172495,from,0,0
172496,20,0,0
172497,%,0,0
172498,to,0,0
172499,57,0,0
172500,%,0,0
172501,(,0,0
172502,Swenson,0,0
172503,&,0,0
172504,Pekarik,0,0
172505,",",0,0
172506,1988,0,0
172507,),0,0
172508,",",0,0
172509,and,0,0
172510,experiential,0,1
172511,avoidance,0,0
172512,may,0,0
172513,be,0,0
172514,related,0,0
172515,to,0,0
172516,failure,0,0
172517,to,0,0
172518,attend,0,0
172519,intake,0,0
172520,sessions,0,1
172521,.,0,0
172522,This,0,0
172523,pilot,0,0
172524,study,0,0
172525,attempted,0,0
172526,to,0,0
172527,increase,0,0
172528,intake,0,0
172529,attendance,0,0
172530,at,0,0
172531,a,0,0
172532,community,0,0
172533,mental,0,0
172534,health,0,0
172535,center,0,0
172536,by,0,0
172537,employing,0,0
172538,a,0,0
172539,brief,0,1
172540,experiential,0,0
172541,acceptance-based,0,0
172542,intervention,0,1
172543,.,0,0
172544,Those,0,0
172545,who,0,0
172546,scheduled,0,0
172547,intakes,0,0
172548,were,0,0
172549,randomly,0,0
172550,assigned,0,0
172551,to,0,0
172552,1,0,0
172553,of,0,0
172554,2,0,0
172555,groups,0,0
172556,:,0,0
172557,orientation,1,0
172558,letter,1,1
172559,or,1,1
172560,acceptance-enhanced,1,1
172561,orientation,1,0
172562,letter,1,1
172563,;,1,0
172564,rates,0,0
172565,from,0,0
172566,these,0,0
172567,conditions,0,0
172568,were,0,0
172569,compared,0,0
172570,with,0,0
172571,a,0,0
172572,retrospective,0,0
172573,comparison,0,0
172574,control,0,0
172575,group,0,0
172576,.,0,0
172577,Participants,0,0
172578,were,0,0
172579,randomized,0,0
172580,by,0,0
172581,way,0,0
172582,of,0,0
172583,an,0,0
172584,online,0,1
172585,random,0,0
172586,number,0,0
172587,generator,0,1
172588,.,0,0
172589,Persons,0,0
172590,assigned,0,0
172591,to,0,0
172592,the,0,0
172593,orientation,0,0
172594,group,0,0
172595,did,0,0
172596,not,0,0
172597,have,0,0
172598,a,0,0
172599,higher,0,0
172600,show,0,0
172601,rate,0,0
172602,than,0,0
172603,persons,0,0
172604,within,0,0
172605,the,0,0
172606,control,1,1
172607,group,0,0
172608,(,0,0
172609,?48,0,0
172610,%,0,0
172611,compared,0,0
172612,with,0,0
172613,?52,0,0
172614,%,0,0
172615,),0,0
172616,.,0,0
172617,Persons,0,0
172618,assigned,0,0
172619,to,0,0
172620,the,0,0
172621,acceptance,1,0
172622,group,1,0
172623,did,0,0
172624,have,0,0
172625,higher,0,0
172626,show,0,0
172627,rates,0,0
172628,than,0,0
172629,persons,0,0
172630,in,0,0
172631,the,0,0
172632,other,0,0
172633,two,0,0
172634,groups,0,0
172635,(,0,0
172636,?67,0,0
172637,%,0,0
172638,compared,0,0
172639,with,0,0
172640,?48,0,0
172641,%,0,0
172642,and,0,0
172643,?52,0,0
172644,%,0,0
172645,",",0,0
172646,respectively,0,0
172647,),0,0
172648,",",0,0
172649,however,0,0
172650,this,0,0
172651,difference,0,0
172652,was,0,0
172653,nonsignificant,0,0
172654,.,0,0
172655,Results,0,0
172656,suggest,0,0
172657,that,0,0
172658,brief,0,1
172659,acceptance-based,0,0
172660,interventions,0,0
172661,should,0,0
172662,be,0,0
172663,further,0,0
172664,studied,0,0
172665,for,0,0
172666,their,0,0
172667,potential,0,0
172668,value,0,0
172669,in,0,0
172670,maximizing,0,0
172671,client,0,0
172672,attendance,0,0
172673,.,0,0
172674,Omitting,0,0
172675,radiotherapy,0,1
172676,in,0,0
172677,early,0,0
172678,positron,0,0
172679,emission,0,0
172680,tomography-negative,0,0
172681,stage,0,0
172682,I/II,0,1
172683,Hodgkin,0,0
172684,lymphoma,0,0
172685,is,0,0
172686,associated,0,0
172687,with,0,0
172688,an,0,0
172689,increased,0,0
172690,risk,0,0
172691,of,0,0
172692,early,0,0
172693,relapse,0,0
172694,:,0,0
172695,Clinical,0,0
172696,results,0,0
172697,of,0,0
172698,the,0,0
172699,preplanned,0,0
172700,interim,0,0
172701,analysis,0,0
172702,of,0,0
172703,the,0,0
172704,randomized,0,0
172705,EORTC/LYSA/FIL,0,0
172706,H10,0,0
172707,trial,0,0
172708,.,0,0
172709,PURPOSE,0,0
172710,Combined-modality,1,1
172711,treatment,1,0
172712,is,0,0
172713,standard,0,0
172714,treatment,0,0
172715,for,0,0
172716,patients,0,0
172717,with,0,0
172718,clinical,0,0
172719,stage,0,0
172720,I/II,0,1
172721,Hodgkin,0,0
172722,lymphoma,0,0
172723,(,0,0
172724,HL,0,0
172725,),0,0
172726,.,0,0
172727,We,0,0
172728,hypothesized,0,0
172729,that,0,0
172730,an,0,0
172731,early,0,0
172732,positron,1,0
172733,emission,1,1
172734,tomography,1,1
172735,(,1,0
172736,PET,1,1
172737,),1,0
172738,scan,0,1
172739,could,0,0
172740,be,0,0
172741,used,0,0
172742,to,0,0
172743,adapt,0,0
172744,treatment,0,0
172745,.,0,0
172746,Therefore,0,0
172747,",",0,0
172748,we,0,0
172749,started,0,0
172750,the,0,0
172751,randomized,0,0
172752,EORTC/LYSA/FIL,0,0
172753,Intergroup,0,0
172754,H10,0,1
172755,trial,0,0
172756,evaluating,0,0
172757,whether,0,0
172758,involved-node,1,1
172759,radiotherapy,1,1
172760,(,1,0
172761,IN-RT,1,0
172762,),1,0
172763,could,0,0
172764,be,0,0
172765,omitted,0,0
172766,without,0,0
172767,compromising,0,0
172768,progression-free,0,0
172769,survival,0,0
172770,in,0,0
172771,patients,0,0
172772,attaining,0,0
172773,a,0,0
172774,negative,0,0
172775,early,0,0
172776,PET,0,1
172777,scan,0,1
172778,after,0,0
172779,two,0,0
172780,cycles,0,0
172781,of,0,0
172782,ABVD,1,0
172783,(,1,0
172784,doxorubicin,1,1
172785,",",1,0
172786,bleomycin,1,1
172787,",",1,0
172788,vinblastine,1,1
172789,",",1,0
172790,and,1,0
172791,dacarbazine,1,1
172792,),1,0
172793,as,0,0
172794,compared,0,0
172795,with,0,0
172796,standard,0,1
172797,combined-modality,1,1
172798,treatment,1,0
172799,.,1,0
172800,PATIENTS,0,0
172801,AND,0,0
172802,METHODS,0,0
172803,Patients,0,0
172804,age,0,0
172805,15,0,0
172806,to,0,0
172807,70,0,0
172808,years,0,0
172809,with,0,0
172810,untreated,0,0
172811,clinical,0,0
172812,stage,0,0
172813,I/II,0,1
172814,HL,0,0
172815,were,0,0
172816,eligible,0,0
172817,.,0,0
172818,Here,0,0
172819,we,0,0
172820,report,0,0
172821,the,0,0
172822,clinical,0,0
172823,outcome,0,0
172824,of,0,0
172825,the,0,0
172826,preplanned,0,0
172827,interim,0,0
172828,futility,0,0
172829,analysis,0,0
172830,scheduled,0,0
172831,to,0,0
172832,occur,0,0
172833,after,0,0
172834,documentation,0,0
172835,of,0,0
172836,34,0,0
172837,events,0,0
172838,in,0,0
172839,the,0,0
172840,early,0,0
172841,PET-negative,0,0
172842,group,0,0
172843,.,0,0
172844,Because,0,0
172845,testing,0,0
172846,for,0,0
172847,futility,0,0
172848,in,0,0
172849,this,0,0
172850,noninferiority,0,0
172851,trial,0,0
172852,corresponds,0,0
172853,to,0,0
172854,testing,0,0
172855,the,0,0
172856,hypothesis,0,0
172857,of,0,0
172858,no,0,0
172859,difference,0,0
172860,",",0,0
172861,a,0,0
172862,one-sided,0,0
172863,superiority,0,0
172864,test,0,0
172865,was,0,0
172866,conducted,0,0
172867,.,0,0
172868,RESULTS,0,0
172869,The,0,0
172870,analysis,0,0
172871,included,0,0
172872,"1,137",0,0
172873,patients,0,0
172874,.,0,0
172875,In,0,0
172876,the,0,0
172877,favorable,0,0
172878,subgroup,0,0
172879,",",0,0
172880,85.8,0,0
172881,%,0,0
172882,had,0,0
172883,a,0,0
172884,negative,0,0
172885,early,0,0
172886,PET,1,1
172887,scan,1,1
172888,(,0,0
172889,standard,0,1
172890,arm,0,0
172891,",",0,0
172892,one,0,0
172893,event,0,0
172894,v,0,0
172895,experimental,0,0
172896,arm,0,0
172897,",",0,0
172898,nine,0,0
172899,events,0,0
172900,),0,0
172901,.,0,0
172902,In,0,0
172903,the,0,0
172904,unfavorable,0,0
172905,subgroup,0,0
172906,",",0,0
172907,74.8,0,0
172908,%,0,0
172909,had,0,0
172910,a,0,0
172911,negative,0,0
172912,early,0,0
172913,PET,1,1
172914,scan,1,1
172915,(,0,0
172916,standard,0,1
172917,arm,0,0
172918,",",0,0
172919,seven,0,0
172920,events,0,0
172921,v,0,0
172922,experimental,0,0
172923,arm,0,0
172924,",",0,0
172925,16,0,0
172926,events,0,0
172927,),0,0
172928,.,0,0
172929,The,0,0
172930,independent,0,0
172931,data,0,0
172932,monitoring,0,0
172933,committee,0,0
172934,concluded,0,0
172935,it,0,0
172936,was,0,0
172937,unlikely,0,0
172938,that,0,0
172939,we,0,0
172940,would,0,0
172941,show,0,0
172942,noninferiority,0,0
172943,in,0,0
172944,the,0,0
172945,final,0,0
172946,results,0,0
172947,for,0,0
172948,the,0,0
172949,experimental,0,0
172950,arm,0,0
172951,and,0,0
172952,advised,0,0
172953,stopping,0,0
172954,random,0,0
172955,assignment,0,0
172956,for,0,0
172957,early,0,0
172958,PET-negative,1,0
172959,patients,0,0
172960,.,0,0
172961,CONCLUSION,0,0
172962,On,0,0
172963,the,0,0
172964,basis,0,0
172965,of,0,0
172966,this,0,0
172967,analysis,0,0
172968,",",0,0
172969,combined-modality,0,1
172970,treatment,0,0
172971,resulted,0,0
172972,in,0,0
172973,fewer,0,0
172974,early,0,0
172975,progressions,0,0
172976,in,0,0
172977,clinical,0,0
172978,stage,0,0
172979,I/II,0,1
172980,HL,0,0
172981,",",0,0
172982,although,0,0
172983,early,0,0
172984,outcome,0,0
172985,was,0,0
172986,excellent,0,0
172987,in,0,0
172988,both,0,0
172989,arms,0,0
172990,.,0,0
172991,The,0,0
172992,final,0,0
172993,analysis,0,0
172994,will,0,0
172995,reveal,0,0
172996,whether,0,0
172997,this,0,0
172998,finding,0,0
172999,is,0,0
173000,maintained,0,0
173001,over,0,0
173002,time,0,0
173003,.,0,0
173004,Older,0,0
173005,patients,0,0
173006,with,0,0
173007,chronic,0,0
173008,myeloid,0,0
173009,leukemia,0,0
173010,(,0,0
173011,?65,0,0
173012,years,0,0
173013,),0,0
173014,profit,0,0
173015,more,0,0
173016,from,0,0
173017,higher,1,0
173018,imatinib,1,1
173019,doses,1,0
173020,than,0,0
173021,younger,0,0
173022,patients,0,0
173023,:,0,0
173024,a,0,0
173025,subanalysis,0,0
173026,of,0,0
173027,the,0,0
173028,randomized,0,0
173029,CML-Study,0,0
173030,IV,0,0
173031,.,0,0
173032,The,0,0
173033,impact,0,0
173034,of,0,0
173035,imatinib,1,1
173036,dose,1,0
173037,on,0,0
173038,response,0,0
173039,rates,0,0
173040,and,0,0
173041,survival,0,0
173042,in,0,0
173043,older,0,0
173044,patients,0,0
173045,with,0,0
173046,chronic,0,0
173047,myeloid,0,0
173048,leukemia,0,0
173049,in,0,0
173050,chronic,0,0
173051,phase,0,0
173052,has,0,0
173053,not,0,0
173054,been,0,0
173055,studied,0,0
173056,well,0,0
173057,.,0,0
173058,We,0,0
173059,analyzed,0,0
173060,data,0,0
173061,from,0,0
173062,the,0,0
173063,German,0,1
173064,CML-Study,0,0
173065,IV,0,0
173066,",",0,0
173067,a,0,0
173068,randomized,0,0
173069,five-arm,0,1
173070,treatment,0,0
173071,optimization,0,1
173072,study,0,0
173073,in,0,0
173074,newly,0,0
173075,diagnosed,0,0
173076,BCR-ABL-positive,0,0
173077,chronic,0,0
173078,myeloid,0,0
173079,leukemia,0,0
173080,in,0,0
173081,chronic,0,0
173082,phase,0,0
173083,.,0,0
173084,Patients,0,0
173085,randomized,0,0
173086,to,0,0
173087,imatinib,1,1
173088,400,1,0
173089,mg/day,0,0
173090,(,0,0
173091,IM400,0,1
173092,),0,0
173093,or,0,0
173094,imatinib,1,1
173095,800,1,1
173096,mg/day,0,0
173097,(,0,0
173098,IM800,0,1
173099,),0,0
173100,and,0,0
173101,stratified,0,0
173102,according,0,0
173103,to,0,0
173104,age,0,0
173105,(,0,0
173106,?65,0,0
173107,years,0,0
173108,vs.,0,0
173109,<,0,0
173110,65,0,0
173111,years,0,0
173112,),0,0
173113,were,0,0
173114,compared,0,0
173115,regarding,0,0
173116,dose,0,0
173117,",",0,0
173118,response,0,0
173119,",",0,0
173120,adverse,0,0
173121,events,0,0
173122,",",0,0
173123,rates,0,0
173124,of,0,0
173125,progression,0,0
173126,",",0,0
173127,and,0,0
173128,survival,0,0
173129,.,0,0
173130,The,0,0
173131,full,0,0
173132,800,0,0
173133,mg,0,1
173134,dose,0,0
173135,was,0,0
173136,given,0,0
173137,after,0,0
173138,a,0,0
173139,6-week,0,0
173140,run-in,0,0
173141,period,0,0
173142,with,0,0
173143,imatinib,1,1
173144,400,1,0
173145,mg/day,0,0
173146,.,0,0
173147,The,0,0
173148,dose,0,0
173149,could,0,0
173150,then,0,0
173151,be,0,0
173152,reduced,0,0
173153,according,0,0
173154,to,0,0
173155,tolerability,0,0
173156,.,0,0
173157,A,0,0
173158,total,0,0
173159,of,0,0
173160,828,0,0
173161,patients,0,0
173162,were,0,0
173163,randomized,0,0
173164,to,0,0
173165,IM400,0,1
173166,or,0,1
173167,IM800,0,1
173168,.,0,0
173169,Seven,0,0
173170,hundred,0,0
173171,eighty-four,0,0
173172,patients,0,0
173173,were,0,0
173174,evaluable,0,0
173175,(,0,0
173176,IM400,0,1
173177,",",0,0
173178,382,0,0
173179,;,0,0
173180,IM800,0,0
173181,",",0,0
173182,402,0,0
173183,),0,0
173184,.,0,0
173185,One,0,0
173186,hundred,0,0
173187,ten,0,0
173188,patients,0,0
173189,(,0,0
173190,29,0,0
173191,%,0,0
173192,),0,0
173193,on,0,0
173194,IM400,0,1
173195,and,0,0
173196,83,0,0
173197,(,0,0
173198,21,0,0
173199,%,0,0
173200,),0,0
173201,on,0,0
173202,IM800,0,1
173203,were,0,0
173204,?65,0,0
173205,years,0,0
173206,.,0,0
173207,The,0,0
173208,median,0,0
173209,dose,0,0
173210,per,0,0
173211,day,0,0
173212,was,0,0
173213,lower,0,0
173214,for,0,0
173215,patients,0,0
173216,?65,0,0
173217,years,0,0
173218,on,0,0
173219,IM800,0,0
173220,",",0,0
173221,with,0,0
173222,the,0,0
173223,highest,0,0
173224,median,0,0
173225,dose,0,0
173226,in,0,0
173227,the,0,0
173228,first,0,0
173229,year,0,0
173230,(,0,0
173231,466,0,0
173232,mg/day,0,0
173233,for,0,0
173234,patients,0,0
173235,?65,0,0
173236,years,0,0
173237,vs.,0,0
173238,630,0,0
173239,mg/day,0,0
173240,for,0,0
173241,patients,0,0
173242,<,0,0
173243,65,0,0
173244,years,0,0
173245,),0,0
173246,.,0,0
173247,Older,0,0
173248,patients,0,0
173249,on,0,0
173250,IM800,0,0
173251,achieved,0,0
173252,major,0,0
173253,molecular,0,0
173254,remission,0,0
173255,and,0,0
173256,deep,0,1
173257,molecular,0,0
173258,remission,0,0
173259,as,0,0
173260,fast,0,0
173261,as,0,0
173262,younger,0,0
173263,patients,0,0
173264,",",0,0
173265,in,0,0
173266,contrast,0,0
173267,to,0,0
173268,standard,0,1
173269,dose,0,0
173270,imatinib,0,1
173271,with,0,0
173272,which,0,0
173273,older,0,0
173274,patients,0,0
173275,achieved,0,0
173276,remissions,0,0
173277,much,0,0
173278,later,0,0
173279,than,0,0
173280,younger,0,0
173281,patients,0,0
173282,.,0,0
173283,Grades,0,0
173284,3,0,0
173285,and,0,0
173286,4,0,0
173287,adverse,0,0
173288,events,0,0
173289,were,0,0
173290,similar,0,0
173291,in,0,0
173292,both,0,0
173293,age,0,0
173294,groups,0,0
173295,.,0,0
173296,Five-year,0,0
173297,relative,0,0
173298,survival,0,0
173299,for,0,0
173300,older,0,0
173301,patients,0,0
173302,was,0,0
173303,comparable,0,0
173304,to,0,0
173305,that,0,0
173306,of,0,0
173307,younger,0,0
173308,patients,0,0
173309,.,0,0
173310,We,0,0
173311,suggest,0,0
173312,that,0,0
173313,the,0,0
173314,optimal,0,0
173315,dose,0,0
173316,for,0,0
173317,older,0,0
173318,patients,0,0
173319,is,0,0
173320,higher,0,0
173321,than,0,0
173322,400,0,0
173323,mg/day,0,0
173324,.,0,0
173325,ClinicalTrials.gov,0,0
173326,identifier,0,0
173327,:,0,0
173328,NCT00055874,0,1
173329,Custom,0,1
173330,tray,0,1
173331,application,0,0
173332,of,0,0
173333,peroxide,1,1
173334,gel,1,1
173335,as,0,0
173336,an,0,0
173337,adjunct,0,0
173338,to,0,0
173339,scaling,1,0
173340,and,1,0
173341,root,1,0
173342,planing,1,1
173343,in,0,0
173344,the,0,0
173345,treatment,0,0
173346,of,0,0
173347,periodontitis,0,0
173348,:,0,0
173349,results,0,0
173350,of,0,0
173351,a,0,0
173352,randomized,0,0
173353,controlled,0,0
173354,trial,0,0
173355,after,0,0
173356,six,0,0
173357,months,0,0
173358,.,0,0
173359,OBJECTIVE,0,0
173360,Scaling,1,0
173361,and,1,0
173362,root,1,1
173363,planing,1,1
173364,(,1,0
173365,SRP,1,1
173366,),1,1
173367,is,0,0
173368,the,0,0
173369,primary,0,0
173370,non-surgical,0,1
173371,treatment,0,0
173372,for,0,0
173373,periodontitis,0,0
173374,",",0,0
173375,but,0,0
173376,its,0,0
173377,effectiveness,0,0
173378,is,0,0
173379,limited,0,0
173380,.,0,0
173381,Consequently,0,0
173382,",",0,0
173383,various,0,0
173384,adjunctive,0,1
173385,therapies,0,0
173386,have,0,0
173387,been,0,0
173388,investigated,0,0
173389,to,0,0
173390,improve,0,0
173391,clinical,0,0
173392,outcome,0,0
173393,.,0,0
173394,This,0,0
173395,study,0,0
173396,evaluated,0,0
173397,the,0,0
173398,clinical,0,0
173399,effects,0,0
173400,of,0,0
173401,one,0,0
173402,SRP,1,0
173403,procedure,0,0
173404,alone,0,1
173405,or,0,0
173406,combined,0,0
173407,with,0,0
173408,local,0,0
173409,administration,0,0
173410,of,0,0
173411,hydrogen,1,1
173412,peroxide,1,1
173413,gel,1,1
173414,using,0,0
173415,customized,0,1
173416,trays,0,1
173417,for,0,0
173418,the,0,0
173419,treatment,0,0
173420,of,0,0
173421,subjects,0,0
173422,with,0,0
173423,chronic,0,0
173424,periodontitis,0,0
173425,over,0,0
173426,a,0,0
173427,period,0,0
173428,of,0,0
173429,six,0,0
173430,months,0,0
173431,.,0,0
173432,METHODS,0,0
173433,An,0,0
173434,examiner-blind,0,0
173435,clinical,0,0
173436,trial,0,0
173437,was,0,0
173438,conducted,0,0
173439,among,0,0
173440,30,0,0
173441,subjects,0,0
173442,with,0,0
173443,moderate,0,0
173444,to,0,0
173445,advanced,0,0
173446,periodontitis,0,0
173447,who,0,0
173448,were,0,0
173449,randomized,0,0
173450,to,0,0
173451,SRP,1,0
173452,alone,0,1
173453,or,0,0
173454,SRP,1,0
173455,combined,1,1
173456,with,0,0
173457,prescription,0,0
173458,custom-tray,0,1
173459,application,0,1
173460,(,0,0
173461,Perio,0,1
173462,Tray,0,1
173463,),0,0
173464,of,0,0
173465,1.7,1,0
173466,%,1,0
173467,hydrogen,1,1
173468,peroxide,1,1
173469,gel,1,1
173470,(,1,0
173471,Perio,1,1
173472,Gel,1,1
173473,),1,0
173474,for,0,0
173475,a,0,0
173476,period,0,0
173477,of,0,0
173478,three,0,0
173479,months,0,0
173480,",",0,0
173481,then,0,0
173482,extended,0,0
173483,to,0,0
173484,six,0,0
173485,months,0,0
173486,.,0,0
173487,Following,0,0
173488,impressions,0,0
173489,for,0,0
173490,the,0,0
173491,test,0,0
173492,group,0,0
173493,",",0,0
173494,all,0,0
173495,subjects,0,0
173496,brushed,1,0
173497,twice,1,0
173498,daily,1,0
173499,with,1,0
173500,a,1,0
173501,regular,1,1
173502,dentifrice,1,1
173503,and,1,0
173504,toothbrush,1,1
173505,for,0,0
173506,a,0,0
173507,four-week,0,1
173508,acclimation,0,0
173509,phase,0,0
173510,to,0,0
173511,standardize,0,0
173512,oral,0,1
173513,conditions,0,0
173514,(,0,0
173515,while,0,0
173516,trays,0,1
173517,were,0,0
173518,fabricated,0,0
173519,),0,0
173520,prior,0,0
173521,to,0,0
173522,initiating,0,0
173523,the,0,0
173524,treatment,0,0
173525,phase,0,0
173526,.,0,0
173527,SRP,1,0
173528,was,0,0
173529,performed,0,0
173530,three,0,0
173531,weeks,0,0
173532,after,0,0
173533,baseline,0,0
173534,",",0,0
173535,and,0,0
173536,clinical,0,0
173537,assessments,0,0
173538,",",0,0
173539,i.e.,0,0
173540,",",0,0
173541,pocket,0,0
173542,probing,0,0
173543,depth,0,0
173544,(,0,1
173545,PPD,0,1
173546,),0,1
173547,and,0,0
173548,bleeding,0,0
173549,index,0,0
173550,(,0,1
173551,BI,0,1
173552,),0,0
173553,",",0,0
173554,were,0,0
173555,conducted,0,0
173556,at,0,0
173557,baseline,0,0
173558,and,0,0
173559,after,0,0
173560,two,0,0
173561,",",0,0
173562,five,0,0
173563,",",0,0
173564,13,0,0
173565,",",0,0
173566,and,0,0
173567,26,0,0
173568,weeks,0,0
173569,of,0,0
173570,peroxide,1,1
173571,gel,1,1
173572,applications,0,0
173573,.,0,0
173574,Clinical,0,0
173575,variables,0,0
173576,were,0,0
173577,compared,0,0
173578,by,0,0
173579,ANCOVA,0,0
173580,and,0,0
173581,paired,0,0
173582,t-tests,0,0
173583,after,0,0
173584,each,0,0
173585,treatment,0,0
173586,interval,0,0
173587,.,0,0
173588,RESULTS,0,0
173589,A,0,0
173590,total,0,0
173591,of,0,0
173592,13,0,0
173593,test,0,0
173594,and,0,0
173595,15,0,0
173596,control,0,0
173597,subjects,0,0
173598,completed,0,0
173599,the,0,0
173600,original,0,0
173601,three-month,0,0
173602,trial,0,0
173603,",",0,0
173604,of,0,0
173605,whom,0,0
173606,10,0,0
173607,test,0,0
173608,and,0,0
173609,13,0,0
173610,control,0,0
173611,subjects,0,0
173612,finished,0,0
173613,the,0,0
173614,three-month,0,0
173615,extension,0,0
173616,.,0,0
173617,After,0,0
173618,two,0,0
173619,weeks,0,0
173620,of,0,0
173621,peroxide,1,1
173622,gel,1,1
173623,use,0,0
173624,prior,0,0
173625,to,0,0
173626,SRP,1,0
173627,",",0,0
173628,mean,0,0
173629,PPD,0,1
173630,for,0,0
173631,the,0,0
173632,test,0,0
173633,group,0,0
173634,significantly,0,0
173635,decreased,0,0
173636,from,0,0
173637,baseline,0,0
173638,by,0,0
173639,0.21,0,0
173640,mm,0,0
173641,and,0,0
173642,mean,0,0
173643,BI,0,0
173644,significantly,0,0
173645,dropped,0,0
173646,by,0,0
173647,0.14,0,0
173648,;,0,0
173649,clinical,0,0
173650,parameters,0,0
173651,for,0,0
173652,the,0,0
173653,control,0,0
173654,group,0,0
173655,were,0,0
173656,unchanged,0,0
173657,.,0,0
173658,Two,0,0
173659,weeks,0,0
173660,following,0,0
173661,SRP,1,0
173662,",",0,0
173663,mean,0,0
173664,PPD,0,1
173665,significantly,0,0
173666,decreased,0,0
173667,from,0,0
173668,baseline,0,0
173669,by,0,0
173670,0.65,0,0
173671,mm,0,0
173672,for,0,0
173673,the,0,0
173674,test,0,0
173675,group,0,0
173676,and,0,0
173677,0.17,0,0
173678,mm,0,0
173679,for,0,0
173680,the,0,0
173681,control,0,0
173682,;,0,0
173683,mean,0,0
173684,BI,0,0
173685,significantly,0,0
173686,dropped,0,0
173687,by,0,0
173688,0.17,0,0
173689,for,0,0
173690,the,0,0
173691,test,0,0
173692,group,0,0
173693,and,0,0
173694,0.05,0,0
173695,for,0,0
173696,the,0,0
173697,control,0,0
173698,.,0,0
173699,Ten,0,0
173700,weeks,0,0
173701,following,0,0
173702,SRP,1,0
173703,",",0,0
173704,mean,0,0
173705,PPD,0,1
173706,decreases,0,0
173707,were,0,0
173708,0.77,0,0
173709,mm,0,0
173710,for,0,0
173711,the,0,0
173712,test,0,0
173713,group,0,0
173714,and,0,0
173715,0.13,0,0
173716,mm,0,0
173717,for,0,0
173718,the,0,0
173719,control,0,0
173720,",",0,0
173721,and,0,0
173722,mean,0,0
173723,BI,0,0
173724,reductions,0,0
173725,were,0,0
173726,0.14,0,0
173727,for,0,0
173728,the,0,0
173729,test,0,0
173730,group,0,0
173731,and,0,0
173732,0.00,0,0
173733,for,0,0
173734,the,0,0
173735,control,0,0
173736,.,0,0
173737,For,0,0
173738,subjects,0,0
173739,who,0,0
173740,completed,0,0
173741,the,0,0
173742,three-month,0,0
173743,extension,0,0
173744,(,0,0
173745,i.e.,0,0
173746,",",0,0
173747,23,0,0
173748,weeks,0,0
173749,post-SRP,0,0
173750,),0,0
173751,",",0,0
173752,mean,0,0
173753,PPD,0,1
173754,decreases,0,0
173755,were,0,0
173756,0.72,0,0
173757,mm,0,0
173758,for,0,0
173759,the,0,0
173760,test,0,0
173761,group,0,0
173762,and,0,0
173763,0.13,0,0
173764,mm,0,0
173765,for,0,0
173766,the,0,0
173767,control,0,0
173768,",",0,0
173769,and,0,0
173770,mean,0,0
173771,BI,0,0
173772,reductions,0,0
173773,were,0,0
173774,0.05,0,0
173775,for,0,0
173776,the,0,0
173777,test,0,0
173778,group,0,0
173779,and,0,0
173780,0.01,0,0
173781,for,0,0
173782,the,0,0
173783,control,0,0
173784,.,0,0
173785,Analysis,0,0
173786,of,0,0
173787,deeper,0,0
173788,pockets,0,0
173789,(,0,0
173790,i.e.,0,0
173791,",",0,0
173792,>,0,0
173793,5,0,0
173794,mm,0,0
173795,at,0,0
173796,baseline,0,0
173797,),0,0
173798,showed,0,0
173799,the,0,0
173800,same,0,0
173801,relationship,0,0
173802,for,0,0
173803,PPD,0,1
173804,",",0,0
173805,but,0,0
173806,with,0,0
173807,larger,0,0
173808,differences,0,0
173809,between,0,0
173810,groups,0,0
173811,.,0,0
173812,For,0,0
173813,example,0,0
173814,",",0,0
173815,after,0,0
173816,two,0,0
173817,weeks,0,0
173818,of,0,0
173819,peroxide,1,1
173820,gel,1,1
173821,use,0,0
173822,prior,0,0
173823,to,0,0
173824,SRP,1,0
173825,",",0,0
173826,mean,0,0
173827,PPD,0,1
173828,decreased,0,0
173829,by,0,0
173830,0.48,0,0
173831,mm,0,0
173832,for,0,0
173833,the,0,0
173834,test,0,0
173835,group,0,0
173836,compared,0,0
173837,to,0,0
173838,0.04,0,0
173839,mm,0,0
173840,for,0,0
173841,the,0,0
173842,control,0,0
173843,.,0,0
173844,Two,0,0
173845,weeks,0,0
173846,after,0,0
173847,SRP,1,0
173848,",",0,0
173849,mean,0,0
173850,PPD,0,1
173851,decreased,0,0
173852,from,0,0
173853,baseline,0,0
173854,by,0,0
173855,1.40,0,0
173856,mm,0,0
173857,for,0,0
173858,the,0,0
173859,test,0,0
173860,group,0,0
173861,and,0,0
173862,0.60,0,0
173863,mm,0,0
173864,for,0,0
173865,the,0,0
173866,control,0,0
173867,",",0,0
173868,and,0,0
173869,10,0,0
173870,weeks,0,0
173871,after,0,0
173872,SRP,0,0
173873,by,0,0
173874,1.57,0,0
173875,mm,0,0
173876,for,0,0
173877,the,0,0
173878,test,0,0
173879,group,0,0
173880,and,0,0
173881,0.58,0,0
173882,mm,0,0
173883,for,0,0
173884,the,0,0
173885,control,0,0
173886,.,0,0
173887,After,0,0
173888,the,0,0
173889,extension,0,0
173890,(,0,0
173891,i.e.,0,0
173892,",",0,0
173893,23,0,0
173894,weeks,0,0
173895,post-SRP,0,0
173896,),0,0
173897,",",0,0
173898,mean,0,0
173899,PPD,0,1
173900,changed,0,0
173901,from,0,0
173902,baseline,0,0
173903,by,0,0
173904,1.50,0,0
173905,mm,0,0
173906,for,0,0
173907,the,0,0
173908,test,0,0
173909,group,0,0
173910,and,0,0
173911,0.55,0,0
173912,mm,0,0
173913,for,0,0
173914,the,0,0
173915,control,0,0
173916,.,0,0
173917,With,0,0
173918,the,0,0
173919,exception,0,0
173920,of,0,0
173921,BI,0,0
173922,at,0,0
173923,23,0,0
173924,weeks,0,0
173925,post-SRP,0,0
173926,",",0,0
173927,all,0,0
173928,reductions,0,0
173929,cited,0,0
173930,above,0,0
173931,for,0,0
173932,the,0,0
173933,test,0,0
173934,group,0,0
173935,were,0,0
173936,statistically,0,0
173937,significantly,0,0
173938,different,0,0
173939,from,0,0
173940,the,0,0
173941,control,0,0
173942,group,0,0
173943,for,0,0
173944,both,0,0
173945,PPD,0,1
173946,and,0,0
173947,BI,0,0
173948,for,0,0
173949,all,0,0
173950,comparisons,0,0
173951,.,0,0
173952,CONCLUSION,0,0
173953,When,0,0
173954,compared,0,0
173955,with,0,0
173956,SRP,1,0
173957,alone,0,1
173958,",",0,0
173959,clinical,0,0
173960,improvements,0,0
173961,in,0,0
173962,PPD,0,1
173963,(,0,0
173964,e.g.,0,0
173965,",",0,0
173966,-1.0,0,0
173967,mm,0,0
173968,for,0,0
173969,pockets,0,0
173970,>,0,0
173971,5,0,0
173972,mm,0,0
173973,at,0,0
173974,baseline,0,0
173975,),0,0
173976,were,0,0
173977,maintained,0,0
173978,for,0,0
173979,up,0,0
173980,to,0,0
173981,six,0,0
173982,months,0,0
173983,after,0,0
173984,SRP,1,0
173985,with,0,0
173986,adjunctive,0,1
173987,use,0,0
173988,of,0,0
173989,1.7,0,0
173990,%,0,0
173991,hydrogen,1,1
173992,peroxide,1,1
173993,gel,1,1
173994,",",0,0
173995,locally,0,0
173996,administered,0,0
173997,using,0,0
173998,prescription,0,0
173999,customized,0,1
174000,trays,0,1
174001,in,0,0
174002,the,0,0
174003,treatment,0,0
174004,of,0,0
174005,subjects,0,0
174006,with,0,0
174007,moderate,0,0
174008,to,0,0
174009,advanced,0,0
174010,periodontitis,0,0
174011,.,0,0
174012,Compensation,0,0
174013,in,0,0
174014,intergroup,0,0
174015,relations,0,0
174016,:,0,0
174017,an,0,0
174018,investigation,0,0
174019,of,0,0
174020,its,0,0
174021,structural,0,0
174022,and,0,0
174023,strategic,0,0
174024,foundations,0,0
174025,.,0,0
174026,Recent,0,0
174027,work,0,0
174028,in,0,0
174029,intergroup,0,0
174030,relations,0,0
174031,stresses,0,0
174032,the,0,0
174033,role,0,0
174034,of,0,0
174035,two,0,0
174036,fundamental,0,0
174037,dimensions,0,0
174038,",",0,0
174039,competence,0,0
174040,and,0,0
174041,warmth,0,0
174042,",",0,0
174043,which,0,0
174044,organize,0,0
174045,the,0,0
174046,perception,0,0
174047,of,0,0
174048,social,0,0
174049,groups,0,0
174050,.,0,0
174051,A,0,0
174052,pattern,0,0
174053,often,0,0
174054,encountered,0,0
174055,in,0,0
174056,people,0,0
174057,'s,0,0
174058,ratings,0,0
174059,is,0,0
174060,one,0,0
174061,of,0,0
174062,compensation,0,0
174063,in,0,0
174064,that,0,0
174065,a,0,0
174066,group,0,0
174067,that,0,0
174068,is,0,0
174069,evaluated,0,0
174070,higher,0,0
174071,than,0,0
174072,another,0,0
174073,group,0,0
174074,on,0,0
174075,one,0,0
174076,of,0,0
174077,the,0,0
174078,two,0,0
174079,fundamental,0,0
174080,dimensions,0,0
174081,is,0,0
174082,also,0,0
174083,judged,0,0
174084,lower,0,0
174085,on,0,0
174086,the,0,0
174087,other,0,0
174088,fundamental,0,0
174089,dimension,0,0
174090,.,0,0
174091,Based,0,0
174092,on,0,0
174093,Social,0,0
174094,Identity,0,0
174095,Theory,0,0
174096,",",0,0
174097,the,0,0
174098,present,0,0
174099,work,0,0
174100,extends,0,0
174101,previous,0,0
174102,research,0,0
174103,on,0,0
174104,compensation,0,0
174105,by,0,0
174106,examining,0,0
174107,boundary,0,0
174108,conditions,0,0
174109,as,0,0
174110,well,0,0
174111,as,0,0
174112,underlying,0,0
174113,psychological,0,0
174114,processes,0,0
174115,.,0,0
174116,Two,0,0
174117,studies,0,0
174118,involving,0,0
174119,experimental,0,0
174120,and,0,0
174121,correlational,0,0
174122,evidence,0,0
174123,",",0,0
174124,minimal,0,0
174125,and,0,0
174126,real,0,0
174127,groups,0,0
174128,",",0,0
174129,and,0,0
174130,different,1,0
174131,kinds,1,0
174132,of,1,0
174133,conflict,1,0
174134,",",0,0
174135,reveal,0,0
174136,that,0,0
174137,compensation,0,0
174138,is,0,0
174139,more,0,0
174140,likely,0,0
174141,when,0,0
174142,the,0,0
174143,groups,0,0
174144,are,0,0
174145,in,0,0
174146,asymmetrical,0,0
174147,relation,0,0
174148,and,0,0
174149,share,0,0
174150,a,0,0
174151,cooperative,0,0
174152,view,0,0
174153,of,0,0
174154,the,0,0
174155,intergroup,0,0
174156,setting,0,0
174157,.,0,0
174158,Our,0,0
174159,data,0,0
174160,also,0,0
174161,suggest,0,0
174162,that,0,0
174163,",",0,0
174164,among,0,0
174165,members,0,0
174166,of,0,0
174167,low,0,0
174168,status,0,0
174169,groups,0,0
174170,",",0,0
174171,compensation,0,0
174172,is,0,0
174173,associated,0,0
174174,with,0,0
174175,social,0,0
174176,creativity,0,0
174177,.,0,0
174178,In,0,0
174179,contrast,0,0
174180,",",0,0
174181,and,0,0
174182,in,0,0
174183,line,0,0
174184,with,0,0
174185,the,0,0
174186,'noblesse,0,0
174187,oblige,0,0
174188,',0,0
174189,effect,0,0
174190,",",0,0
174191,members,0,0
174192,of,0,0
174193,the,0,0
174194,high,0,0
174195,status,0,0
174196,group,0,0
174197,would,0,0
174198,seem,0,0
174199,to,0,0
174200,rely,0,0
174201,on,0,0
174202,compensation,0,0
174203,as,0,0
174204,a,0,0
174205,means,0,0
174206,to,0,0
174207,appear,0,0
174208,non-discriminatory,0,0
174209,.,0,0
174210,Pegylated,1,1
174211,feline,1,0
174212,granulocyte,1,0
174213,colony-stimulating,1,1
174214,factor,1,0
174215,increases,0,0
174216,neutrophil,0,0
174217,levels,0,0
174218,in,0,0
174219,cats,0,0
174220,.,0,0
174221,Neutropenia,0,0
174222,can,0,0
174223,often,0,0
174224,be,0,0
174225,corrected,0,0
174226,by,0,0
174227,treatment,0,0
174228,with,0,0
174229,granulocyte-colony,1,1
174230,stimulating,1,0
174231,factor,1,0
174232,(,1,1
174233,G-CSF,1,1
174234,),1,1
174235,and,0,0
174236,off-label,1,0
174237,use,1,0
174238,of,1,0
174239,commercial,1,0
174240,human,1,1
174241,G-CSF,1,1
174242,(,1,0
174243,HuG-CSF,1,1
174244,),1,1
174245,is,0,0
174246,a,0,0
174247,commonly,0,0
174248,used,0,0
174249,treatment,0,0
174250,for,0,0
174251,neutropenic,0,0
174252,animals,0,0
174253,.,0,0
174254,However,0,0
174255,",",0,0
174256,long-term,0,0
174257,HuG-CSF,1,0
174258,treatment,1,0
174259,can,0,0
174260,be,0,0
174261,associated,0,0
174262,with,0,0
174263,adverse,0,0
174264,effects,0,0
174265,",",0,0
174266,including,0,0
174267,neutropenia,0,0
174268,.,0,0
174269,Here,0,0
174270,",",0,0
174271,feline,0,0
174272,(,0,0
174273,Fe,0,0
174274,),0,0
174275,G-CSF,0,1
174276,was,0,0
174277,produced,0,0
174278,in,0,0
174279,Pichia,0,0
174280,pastoris,0,1
174281,",",0,0
174282,pegylated,0,1
174283,(,0,0
174284,Peg,0,1
174285,),0,1
174286,FeG-CSF,0,0
174287,and,0,0
174288,tested,0,0
174289,in,0,0
174290,cats,0,0
174291,.,0,0
174292,A,0,0
174293,randomized,0,0
174294,controlled,0,0
174295,clinical,0,0
174296,trial,0,0
174297,was,0,0
174298,conducted,0,0
174299,to,0,0
174300,evaluate,0,0
174301,the,0,0
174302,efficacy,0,0
174303,of,0,0
174304,PegFeG-CSF,1,0
174305,compared,0,0
174306,to,0,0
174307,FeG-CSF,1,0
174308,or,1,1
174309,HuG-CSF,1,0
174310,in,0,0
174311,FIV-infected,0,0
174312,(,0,0
174313,n=14,0,0
174314,),0,0
174315,",",0,0
174316,FIV-uninfected,0,0
174317,healthy,0,0
174318,cats,0,1
174319,(,0,0
174320,n=19,0,0
174321,),0,0
174322,",",0,0
174323,and,0,0
174324,in,0,0
174325,HuG-CSF-induced,0,0
174326,neutropenic,0,0
174327,cats,0,1
174328,(,0,0
174329,n=4,0,0
174330,),0,0
174331,.,0,0
174332,Daily,0,0
174333,FeG-CSF,1,0
174334,doses,0,0
174335,induced,0,0
174336,higher,0,0
174337,neutrophil,0,0
174338,production,0,0
174339,than,0,0
174340,HuG-CSF,1,0
174341,after,0,0
174342,the,0,0
174343,second,0,0
174344,week,0,0
174345,of,0,0
174346,treatment,0,0
174347,(,0,0
174348,P,0,0
174349,?,0,0
174350,0.002,0,0
174351,),0,0
174352,.,0,0
174353,Weekly,0,1
174354,doses,0,0
174355,of,0,0
174356,PegFeG-CSF,1,0
174357,induced,1,0
174358,higher,0,0
174359,neutrophil,0,0
174360,counts,0,0
174361,and,0,0
174362,showed,0,0
174363,greater,0,0
174364,sustained,0,0
174365,activity,0,0
174366,than,0,0
174367,weekly,0,1
174368,doses,0,0
174369,of,0,0
174370,FeG-CSF,1,0
174371,.,1,0
174372,PegFeG-CSF,1,0
174373,provided,1,0
174374,the,0,0
174375,most,0,0
174376,therapeutic,0,0
174377,and,0,0
174378,sustainable,0,0
174379,neutrophil,0,0
174380,production,0,0
174381,(,0,0
174382,P,0,0
174383,<,0,0
174384,0.001,0,0
174385,),0,0
174386,in,0,0
174387,both,0,0
174388,FIV-uninfected,0,0
174389,and,0,0
174390,FIV-infected,0,0
174391,cats,0,0
174392,",",0,0
174393,without,0,0
174394,the,0,0
174395,development,0,0
174396,of,0,0
174397,neutralizing,0,0
174398,antibodies,0,0
174399,.,0,0
174400,Conversely,0,0
174401,",",0,0
174402,all,1,0
174403,HuG-CSF-treated,1,0
174404,cats,1,0
174405,developed,0,0
174406,neutralizing,0,0
174407,antibodies,0,0
174408,",",0,0
174409,suggesting,0,0
174410,cross-reactive,0,0
174411,antibodies,0,0
174412,to,0,0
174413,endogenous,0,0
174414,G-CSF,0,1
174415,in,0,0
174416,a,0,0
174417,majority,0,0
174418,of,0,0
174419,the,0,0
174420,cases,0,0
174421,with,0,0
174422,severe,0,0
174423,neutropenia,0,0
174424,.,0,0
174425,Strikingly,0,0
174426,",",0,0
174427,when,1,0
174428,PegFeG-CSF,1,0
174429,was,1,0
174430,used,0,0
174431,to,0,0
174432,rescue,0,0
174433,cats,0,0
174434,with,1,0
174435,HuG-CSF-induced,1,0
174436,neutropenia,1,0
174437,",",0,0
174438,clinically,0,0
174439,normal,0,0
174440,neutrophil,0,0
174441,numbers,0,0
174442,returned,0,0
174443,.,0,0
174444,Thus,1,0
174445,",",1,0
174446,PegFeG-CSF,1,0
174447,appears,1,0
174448,to,0,0
174449,be,0,0
174450,a,0,0
174451,superior,0,0
174452,treatment,0,0
174453,for,0,0
174454,neutropenia,0,0
174455,in,0,0
174456,feline,0,0
174457,patients,0,0
174458,.,0,0
174459,A,0,0
174460,randomized,0,0
174461,controlled,0,0
174462,trial,0,0
174463,of,0,0
174464,an,0,0
174465,inference,1,0
174466,generation,1,0
174467,strategy,1,0
174468,intervention,1,1
174469,for,0,0
174470,adults,0,0
174471,with,0,0
174472,high-functioning,0,0
174473,autism,0,0
174474,spectrum,0,0
174475,disorder,0,0
174476,.,0,0
174477,PURPOSE,0,0
174478,The,0,0
174479,present,0,0
174480,intervention,0,1
174481,study,0,0
174482,investigated,0,0
174483,the,0,0
174484,efficacy,0,0
174485,of,0,0
174486,the,0,0
174487,ACT,1,0
174488,&,1,0
174489,Check,1,1
174490,Strategy,1,1
174491,intervention,1,1
174492,to,0,0
174493,improve,0,0
174494,inference,0,0
174495,generation,0,0
174496,when,0,0
174497,reading,0,1
174498,",",0,0
174499,metacognitive,0,0
174500,ability,0,0
174501,",",0,0
174502,general,0,0
174503,reading,0,1
174504,comprehension,0,0
174505,",",0,0
174506,and,0,0
174507,social,0,1
174508,inference,0,0
174509,ability,0,0
174510,in,0,0
174511,adults,0,0
174512,with,0,0
174513,high-functioning,0,0
174514,autism,0,0
174515,spectrum,0,0
174516,disorder,0,0
174517,(,0,0
174518,HF-ASD,0,0
174519,),0,0
174520,.,0,0
174521,METHOD,0,0
174522,Twenty-five,0,0
174523,adults,0,0
174524,with,0,0
174525,HF-ASD,0,0
174526,were,0,0
174527,randomly,0,0
174528,assigned,0,0
174529,to,0,0
174530,either,0,0
174531,a,0,0
174532,treatment,0,0
174533,or,0,0
174534,a,0,0
174535,control,1,0
174536,group,1,0
174537,.,1,0
174538,Treatment,0,0
174539,sessions,0,0
174540,were,0,0
174541,conducted,0,0
174542,in,0,0
174543,1-hr,0,0
174544,sessions,0,1
174545,",",0,0
174546,twice,0,0
174547,a,0,0
174548,week,0,0
174549,",",0,0
174550,for,0,0
174551,a,0,0
174552,total,0,0
174553,of,0,0
174554,6,0,0
174555,weeks,0,0
174556,.,0,0
174557,Treatment,0,0
174558,focused,0,0
174559,on,0,0
174560,explicit,1,1
174561,instruction,1,1
174562,of,1,0
174563,components,1,0
174564,of,1,0
174565,inference,1,0
174566,generation,1,0
174567,",",1,0
174568,categories,1,0
174569,of,1,0
174570,inferences,1,0
174571,",",1,0
174572,and,1,0
174573,increasingly,1,0
174574,independent,1,0
174575,strategy,1,0
174576,use,1,0
174577,.,1,0
174578,RESULTS,0,0
174579,The,0,0
174580,treatment,0,0
174581,group,0,0
174582,demonstrated,0,0
174583,significantly,0,0
174584,superior,0,0
174585,performance,0,0
174586,on,0,0
174587,1,0,0
174588,of,0,0
174589,2,0,0
174590,measures,0,0
174591,of,0,0
174592,inference,0,0
174593,generation,0,0
174594,in,0,0
174595,reading,0,1
174596,and,0,0
174597,1,0,0
174598,measure,0,0
174599,of,0,0
174600,metacognitive,0,0
174601,ability,0,0
174602,compared,0,0
174603,with,0,0
174604,the,0,0
174605,control,0,0
174606,group,0,0
174607,.,0,0
174608,Significant,0,0
174609,differences,0,0
174610,between,0,0
174611,groups,0,0
174612,were,0,0
174613,not,0,0
174614,found,0,0
174615,on,0,0
174616,measures,0,0
174617,of,0,0
174618,reading,0,1
174619,comprehension,0,0
174620,or,0,1
174621,social,0,1
174622,inference,0,0
174623,ability,0,0
174624,.,0,0
174625,CONCLUSION,0,0
174626,These,0,0
174627,findings,0,0
174628,suggest,0,0
174629,that,0,0
174630,the,0,0
174631,ACT,1,0
174632,&,1,0
174633,Check,1,1
174634,Strategy,1,1
174635,was,0,0
174636,effective,0,0
174637,in,0,0
174638,improving,0,0
174639,participants,0,0
174640,',0,0
174641,ability,0,0
174642,to,0,0
174643,generate,0,0
174644,inferences,0,0
174645,in,0,0
174646,reading,0,1
174647,and,0,0
174648,certain,0,0
174649,metacognitive,0,0
174650,abilities,0,0
174651,",",0,0
174652,but,0,0
174653,the,0,0
174654,skills,0,0
174655,do,0,0
174656,not,0,0
174657,appear,0,0
174658,to,0,0
174659,generalize,0,0
174660,to,0,0
174661,other,0,0
174662,social,0,1
174663,communication,0,0
174664,contexts,0,0
174665,",",0,0
174666,such,0,0
174667,as,0,0
174668,social,0,0
174669,inference,0,0
174670,generation,0,0
174671,.,0,0
174672,This,0,0
174673,research,0,0
174674,provides,0,0
174675,a,0,0
174676,measure,0,0
174677,of,0,0
174678,support,0,0
174679,for,0,0
174680,explicitly,0,0
174681,teaching,0,1
174682,inference,0,0
174683,generation,0,0
174684,to,0,0
174685,address,0,0
174686,a,0,0
174687,reading,0,1
174688,inference,0,0
174689,deficit,0,0
174690,in,0,0
174691,adults,0,0
174692,with,0,0
174693,HF-ASD,0,0
174694,.,0,0
174695,Cytokine,1,0
174696,and,0,0
174697,clinical,0,0
174698,response,0,0
174699,to,0,0
174700,Saccharomyces,1,0
174701,boulardii,1,1
174702,therapy,1,1
174703,in,0,0
174704,diarrhea-dominant,0,0
174705,irritable,0,0
174706,bowel,0,0
174707,syndrome,0,0
174708,:,0,0
174709,a,0,0
174710,randomized,0,0
174711,trial,0,0
174712,.,0,0
174713,INTRODUCTION,0,0
174714,This,0,0
174715,preliminary,0,0
174716,study,0,0
174717,aimed,0,0
174718,to,0,0
174719,investigate,0,0
174720,the,0,0
174721,effects,0,0
174722,of,0,0
174723,the,0,0
174724,probiotic,1,1
174725,Saccharomyces,1,0
174726,boulardii,1,1
174727,on,0,0
174728,proinflammatory,0,0
174729,and,0,0
174730,anti-inflammatory,0,1
174731,cytokines,0,0
174732,in,0,0
174733,patients,0,0
174734,with,0,0
174735,diarrhea-dominant,0,0
174736,irritable,0,0
174737,bowel,0,1
174738,syndrome,0,0
174739,(,0,0
174740,IBS-D,0,0
174741,),0,0
174742,.,0,0
174743,The,0,0
174744,other,0,0
174745,objectives,0,0
174746,were,0,0
174747,to,0,0
174748,document,0,0
174749,any,0,0
174750,clinical,0,0
174751,improvement,0,0
174752,as,0,0
174753,judged,0,0
174754,by,0,0
174755,symptoms,0,0
174756,",",0,0
174757,quality,0,0
174758,of,0,0
174759,life,0,0
174760,",",0,0
174761,and,0,0
174762,histology,0,0
174763,.,0,0
174764,PATIENTS,0,0
174765,AND,0,0
174766,METHODS,0,0
174767,This,0,0
174768,was,0,0
174769,a,0,0
174770,randomized,0,0
174771,",",0,0
174772,double,0,0
174773,blind,0,0
174774,",",0,0
174775,placebo-controlled,1,1
174776,trial,0,0
174777,in,0,0
174778,which,0,0
174779,S.,1,1
174780,boulardii,1,1
174781,",",1,0
174782,750,1,1
174783,mg/day,1,0
174784,",",1,0
174785,or,1,0
174786,placebo,1,1
174787,was,1,0
174788,administered,1,0
174789,for,1,0
174790,6,1,0
174791,weeks,1,0
174792,in,1,0
174793,IBS-D,1,0
174794,patients,1,0
174795,",",1,0
174796,in,1,0
174797,addition,1,0
174798,to,1,0
174799,ispaghula,1,1
174800,husk,1,1
174801,standard,1,1
174802,treatment,1,0
174803,.,1,0
174804,RESULTS,0,0
174805,Thirty-seven,0,0
174806,patients,0,0
174807,received,0,0
174808,S.,1,1
174809,boulardii,1,1
174810,and,0,0
174811,35,0,0
174812,patients,0,0
174813,received,0,0
174814,the,0,0
174815,placebo,1,1
174816,.,1,0
174817,As,0,0
174818,compared,0,0
174819,with,0,0
174820,placebo,1,1
174821,",",0,0
174822,the,0,0
174823,S.,1,1
174824,boulardii,1,1
174825,group,0,0
174826,showed,0,0
174827,a,0,0
174828,significant,0,0
174829,decrease,0,0
174830,in,0,0
174831,blood,0,0
174832,and,0,0
174833,tissue,0,0
174834,levels,0,0
174835,of,0,0
174836,proinflammatory,0,0
174837,cytokines,0,0
174838,interleukin-8,0,0
174839,(,0,0
174840,IL-8,0,1
174841,),0,1
174842,and,0,0
174843,tumor,0,0
174844,necrosis,0,0
174845,factor-?,0,1
174846,(,0,0
174847,P,0,0
174848,<,0,0
174849,0.001,0,0
174850,),0,0
174851,and,0,0
174852,an,0,0
174853,increase,0,0
174854,in,0,0
174855,anti-inflammatory,0,1
174856,IL-10,0,0
174857,levels,0,0
174858,",",0,0
174859,as,0,0
174860,well,0,0
174861,as,0,0
174862,an,0,0
174863,increase,0,0
174864,in,0,0
174865,the,0,0
174866,tissue,0,0
174867,IL-10/IL-12,0,1
174868,ratio,0,0
174869,(,0,0
174870,P,0,0
174871,<,0,0
174872,0.001,0,0
174873,),0,0
174874,.,0,0
174875,No,0,0
174876,significant,0,0
174877,change,0,0
174878,in,0,0
174879,the,0,0
174880,blood,0,0
174881,and,0,0
174882,tissue,0,0
174883,levels,0,0
174884,of,0,0
174885,cytokines,0,0
174886,was,0,0
174887,found,0,0
174888,in,0,0
174889,the,0,0
174890,placebo,0,1
174891,group,0,0
174892,.,0,0
174893,Bowel-related,0,0
174894,IBS-D,0,0
174895,symptoms,0,0
174896,reported,0,0
174897,in,0,0
174898,the,0,0
174899,patients,0,0
174900,',0,0
174901,daily,0,0
174902,diary,0,1
174903,improved,0,0
174904,in,0,0
174905,both,0,0
174906,groups,0,0
174907,.,0,0
174908,However,0,0
174909,",",0,0
174910,overall,0,0
174911,improvement,0,0
174912,in,0,0
174913,the,0,0
174914,quality,0,0
174915,of,0,0
174916,life,0,0
174917,was,0,0
174918,more,0,0
174919,marked,0,0
174920,in,0,0
174921,the,1,0
174922,S.,1,1
174923,boulardii,1,1
174924,group,0,0
174925,.,0,0
174926,Although,0,0
174927,baseline,0,0
174928,histological,0,0
174929,findings,0,0
174930,were,0,0
174931,mild,0,0
174932,",",0,0
174933,an,0,0
174934,improvement,0,0
174935,was,0,0
174936,observed,0,0
174937,in,0,0
174938,the,0,0
174939,probiotic,0,1
174940,group,0,0
174941,in,0,0
174942,the,0,0
174943,lymphocyte,0,0
174944,and,0,0
174945,neutrophil,0,0
174946,infiltrates,0,0
174947,(,0,0
174948,P=0.017,0,0
174949,and,0,0
174950,0.018,0,0
174951,),0,0
174952,",",0,0
174953,epithelial,0,0
174954,mitosis,0,0
174955,(,0,0
174956,P=0.003,0,0
174957,),0,0
174958,",",0,0
174959,and,0,0
174960,intraepithelial,0,0
174961,lymphocytes,0,0
174962,(,0,0
174963,P=0.024,0,0
174964,),0,0
174965,.,0,0
174966,No,0,0
174967,serious,0,0
174968,adverse,0,0
174969,events,0,0
174970,were,0,0
174971,found,0,0
174972,in,0,0
174973,either,0,0
174974,group,0,0
174975,.,0,0
174976,CONCLUSION,0,0
174977,S.,1,1
174978,boulardii,1,1
174979,with,0,0
174980,ispaghula,0,1
174981,husk,0,1
174982,was,0,0
174983,superior,0,0
174984,to,0,0
174985,placebo,0,1
174986,with,0,0
174987,ispaghula,0,1
174988,husk,0,1
174989,in,0,0
174990,improving,0,0
174991,the,0,0
174992,cytokine,0,0
174993,profile,0,0
174994,",",0,0
174995,histology,0,0
174996,",",0,0
174997,and,0,0
174998,quality,0,0
174999,of,0,0
175000,life,0,0
175001,of,0,0
175002,patients,0,0
175003,with,0,0
175004,IBS-D,0,0
175005,.,0,0
175006,These,0,0
175007,preliminary,0,0
175008,results,0,0
175009,need,0,0
175010,to,0,0
175011,be,0,0
175012,confirmed,0,0
175013,in,0,0
175014,a,0,0
175015,well-powered,0,0
175016,trial,0,0
175017,.,0,0
175018,Hysteroscopic,1,1
175019,morcellation,1,1
175020,compared,0,0
175021,with,0,0
175022,electrical,1,1
175023,resection,1,1
175024,of,0,0
175025,endometrial,0,0
175026,polyps,0,0
175027,:,0,0
175028,a,0,0
175029,randomized,0,0
175030,controlled,0,0
175031,trial,0,0
175032,.,0,0
175033,OBJECTIVE,0,0
175034,To,0,0
175035,evaluate,0,0
175036,whether,0,0
175037,hysteroscopic,1,1
175038,morcellation,1,1
175039,or,0,1
175040,bipolar,1,0
175041,electrosurgical,1,1
175042,resection,1,1
175043,is,0,0
175044,more,0,0
175045,favorable,0,0
175046,for,0,0
175047,removing,0,0
175048,endometrial,0,0
175049,polyps,0,0
175050,in,0,0
175051,an,0,0
175052,office,0,0
175053,setting,0,0
175054,in,0,0
175055,terms,0,0
175056,of,0,0
175057,feasibility,0,0
175058,",",0,0
175059,speed,0,0
175060,",",0,0
175061,pain,0,0
175062,",",0,0
175063,and,0,0
175064,acceptability,0,0
175065,.,0,0
175066,METHODS,0,0
175067,A,0,0
175068,multicenter,0,0
175069,",",0,0
175070,single-blind,0,0
175071,",",0,0
175072,randomized,0,0
175073,",",0,0
175074,controlled,0,0
175075,trial,0,0
175076,of,0,0
175077,office,1,1
175078,hysteroscopic,1,1
175079,morcellation,1,1
175080,compared,0,0
175081,with,0,0
175082,electrosurgical,1,1
175083,resection,1,1
175084,was,0,0
175085,conducted,0,0
175086,.,0,0
175087,A,0,0
175088,total,0,0
175089,of,0,0
175090,121,0,0
175091,women,0,0
175092,were,0,0
175093,randomly,0,0
175094,allocated,0,0
175095,to,0,0
175096,polyp,0,0
175097,removal,0,0
175098,by,0,0
175099,one,0,0
175100,of,0,0
175101,the,0,0
175102,two,0,0
175103,methods,0,0
175104,in,0,0
175105,an,0,0
175106,office,0,0
175107,setting,0,0
175108,.,0,0
175109,The,0,0
175110,outcomes,0,0
175111,assessed,0,0
175112,were,0,0
175113,time,0,0
175114,taken,0,0
175115,to,0,0
175116,complete,0,0
175117,the,0,0
175118,endometrial,0,0
175119,polypectomy,0,0
175120,",",0,0
175121,defined,0,0
175122,as,0,0
175123,the,0,0
175124,time,0,0
175125,from,0,0
175126,insertion,0,1
175127,to,0,0
175128,removal,0,0
175129,of,0,0
175130,vaginal,0,0
175131,instrumentation,0,0
175132,",",0,0
175133,completeness,0,0
175134,of,0,0
175135,polyp,0,0
175136,removal,0,0
175137,",",0,0
175138,acceptability,0,0
175139,",",0,0
175140,and,0,0
175141,pain,0,0
175142,measured,0,0
175143,on,0,0
175144,a,0,0
175145,100-mm,0,1
175146,visual,0,0
175147,analog,0,0
175148,scale,0,0
175149,.,0,0
175150,RESULTS,0,0
175151,The,0,0
175152,median,0,0
175153,time,0,0
175154,taken,0,0
175155,to,0,0
175156,complete,0,0
175157,the,0,0
175158,procedure,0,0
175159,was,0,0
175160,5,0,0
175161,minutes,0,0
175162,and,0,0
175163,28,0,0
175164,seconds,0,0
175165,for,0,0
175166,morcellation,0,1
175167,compared,0,0
175168,with,0,0
175169,10,0,0
175170,minutes,0,0
175171,and,0,0
175172,12,0,0
175173,seconds,0,0
175174,for,0,0
175175,electrosurgical,0,1
175176,resection,0,1
175177,(,0,0
175178,P,0,0
175179,<,0,0
175180,.001,0,0
175181,),0,0
175182,.,0,0
175183,The,0,0
175184,polyps,0,0
175185,were,0,0
175186,completely,0,0
175187,removed,0,0
175188,in,0,0
175189,61,0,0
175190,out,0,0
175191,of,0,0
175192,62,0,0
175193,(,0,0
175194,98,0,0
175195,%,0,0
175196,),0,0
175197,women,0,0
175198,assigned,0,0
175199,to,0,0
175200,morcellation,1,1
175201,compared,0,0
175202,with,0,0
175203,49,0,0
175204,out,0,0
175205,of,0,0
175206,59,0,0
175207,(,0,0
175208,83,0,0
175209,%,0,0
175210,),0,0
175211,women,0,0
175212,treated,0,0
175213,with,0,0
175214,electrosurgical,1,1
175215,resection,1,1
175216,(,0,0
175217,odds,0,0
175218,ratio,0,0
175219,12.5,0,0
175220,;,0,0
175221,95,0,0
175222,%,0,0
175223,confidence,0,0
175224,interval,0,0
175225,[,0,0
175226,CI,0,0
175227,],0,0
175228,1.5-100.6,0,0
175229,;,0,0
175230,P=.02,0,0
175231,),0,0
175232,.,0,0
175233,The,0,0
175234,mean,0,0
175235,pain,0,0
175236,scores,0,0
175237,during,0,0
175238,the,0,0
175239,procedure,0,0
175240,favored,0,0
175241,morcellation,1,1
175242,by,0,0
175243,16.1,0,0
175244,points,0,0
175245,on,0,0
175246,average,0,0
175247,(,0,0
175248,35.9,0,0
175249,compared,0,0
175250,with,0,0
175251,52.0,0,0
175252,;,0,0
175253,95,0,0
175254,%,0,0
175255,CI,0,0
175256,for,0,0
175257,difference,0,0
175258,",",0,0
175259,-24.7,0,0
175260,to,0,0
175261,-7.6,0,0
175262,;,0,0
175263,P,0,0
175264,<,0,0
175265,.001,0,0
175266,),0,0
175267,.,0,0
175268,Overall,0,0
175269,",",0,0
175270,99,0,0
175271,%,0,0
175272,of,0,0
175273,women,0,0
175274,found,0,0
175275,office,0,0
175276,polypectomy,0,0
175277,to,0,0
175278,be,0,0
175279,acceptable,0,0
175280,",",0,0
175281,with,0,0
175282,only,0,0
175283,one,0,0
175284,woman,0,0
175285,in,0,0
175286,the,0,0
175287,electrosurgical,1,1
175288,resection,1,1
175289,group,0,0
175290,considering,0,0
175291,the,0,0
175292,procedure,0,0
175293,unacceptable,0,0
175294,.,0,0
175295,CONCLUSION,0,0
175296,In,0,0
175297,comparison,0,0
175298,to,0,0
175299,electrosurgical,1,1
175300,resection,1,1
175301,during,0,0
175302,hysteroscopic,0,1
175303,polypectomy,0,1
175304,",",0,0
175305,morcellation,1,1
175306,was,0,0
175307,significantly,0,0
175308,quicker,0,0
175309,",",0,0
175310,less,0,0
175311,painful,0,0
175312,",",0,0
175313,more,0,0
175314,acceptable,0,0
175315,to,0,0
175316,women,0,0
175317,",",0,0
175318,and,0,0
175319,more,0,0
175320,likely,0,0
175321,to,0,0
175322,completely,0,0
175323,remove,0,0
175324,endometrial,0,0
175325,polyps,0,0
175326,compared,0,0
175327,with,0,0
175328,electrosurgical,1,1
175329,resection,1,1
175330,.,1,0
175331,CLINICAL,0,0
175332,TRIAL,0,0
175333,REGISTRATION,0,0
175334,ClinicalTrials.gov,0,0
175335,",",0,0
175336,www.clinicaltrials.gov,0,0
175337,",",0,0
175338,NCT01509313,0,0
175339,.,0,0
175340,Virtual,1,1
175341,reality,1,1
175342,job,1,0
175343,interview,1,0
175344,training,1,1
175345,in,0,0
175346,adults,0,0
175347,with,0,0
175348,autism,0,0
175349,spectrum,0,0
175350,disorder,0,0
175351,.,0,0
175352,The,0,0
175353,feasibility,0,0
175354,and,0,0
175355,efficacy,0,0
175356,of,0,0
175357,virtual,1,1
175358,reality,1,1
175359,job,1,0
175360,interview,1,0
175361,training,1,1
175362,(,1,0
175363,VR-JIT,1,1
175364,),1,0
175365,was,0,0
175366,assessed,0,0
175367,in,0,0
175368,a,0,0
175369,single-blinded,0,0
175370,randomized,0,0
175371,controlled,0,0
175372,trial,0,0
175373,.,0,0
175374,Adults,0,0
175375,with,0,0
175376,autism,0,0
175377,spectrum,0,0
175378,disorder,0,0
175379,were,0,0
175380,randomized,0,0
175381,to,0,0
175382,VR-JIT,1,1
175383,(,0,0
175384,n,0,0
175385,=,0,0
175386,16,0,0
175387,),0,0
175388,or,0,1
175389,treatment-as-usual,1,1
175390,(,1,0
175391,TAU,1,1
175392,),1,1
175393,(,0,0
175394,n,0,0
175395,=,0,0
175396,10,0,0
175397,),0,0
175398,groups,0,0
175399,.,0,0
175400,VR-JIT,1,0
175401,consisted,1,0
175402,of,1,0
175403,simulated,1,0
175404,job,1,0
175405,interviews,1,1
175406,with,1,0
175407,a,1,0
175408,virtual,1,1
175409,character,1,0
175410,and,1,0
175411,didactic,1,1
175412,training,1,1
175413,.,1,0
175414,Participants,0,0
175415,attended,0,0
175416,90,0,0
175417,%,0,0
175418,of,0,0
175419,laboratory-based,0,0
175420,training,0,1
175421,sessions,0,1
175422,",",0,0
175423,found,0,0
175424,VR-JIT,1,0
175425,easy,0,0
175426,to,0,0
175427,use,0,0
175428,and,0,0
175429,enjoyable,0,1
175430,",",0,0
175431,and,0,0
175432,they,0,0
175433,felt,0,0
175434,prepared,0,0
175435,for,0,0
175436,future,0,0
175437,interviews,0,0
175438,.,0,0
175439,VR-JIT,1,0
175440,participants,0,0
175441,had,0,0
175442,greater,0,0
175443,improvement,0,0
175444,during,0,0
175445,live,0,0
175446,standardized,0,0
175447,job,0,0
175448,interview,0,0
175449,role-play,0,1
175450,performances,0,0
175451,than,0,0
175452,TAU,1,1
175453,participants,0,0
175454,(,0,0
175455,p,0,0
175456,=,0,0
175457,0.046,0,0
175458,),0,0
175459,.,0,0
175460,A,0,0
175461,similar,0,0
175462,pattern,0,0
175463,was,0,0
175464,observed,0,0
175465,for,0,0
175466,self-reported,0,0
175467,self-confidence,0,0
175468,at,0,0
175469,a,0,0
175470,trend,0,0
175471,level,0,0
175472,(,0,0
175473,p,0,0
175474,=,0,0
175475,0.060,0,0
175476,),0,0
175477,.,0,0
175478,VR-JIT,1,0
175479,simulation,0,0
175480,performance,0,0
175481,scores,0,0
175482,increased,0,0
175483,over,0,0
175484,time,0,0
175485,(,0,0
175486,R,0,1
175487,(,0,0
175488,2,0,0
175489,),0,0
175490,=,0,0
175491,0.83,0,0
175492,),0,0
175493,.,0,0
175494,Results,0,0
175495,indicate,0,0
175496,preliminary,0,0
175497,support,0,0
175498,for,0,0
175499,the,0,0
175500,feasibility,0,0
175501,and,0,0
175502,efficacy,0,0
175503,of,0,0
175504,VR-JIT,1,0
175505,",",0,0
175506,which,0,0
175507,can,0,0
175508,be,0,0
175509,administered,0,0
175510,using,0,0
175511,computer,0,1
175512,software,0,1
175513,or,0,0
175514,via,0,0
175515,the,0,0
175516,internet,0,0
175517,.,0,0
175518,Sociopsychological,0,0
175519,tailoring,0,1
175520,to,0,0
175521,address,0,0
175522,colorectal,0,0
175523,cancer,0,0
175524,screening,0,0
175525,disparities,0,0
175526,:,0,0
175527,a,0,0
175528,randomized,0,0
175529,controlled,0,0
175530,trial,0,0
175531,.,0,0
175532,PURPOSE,0,0
175533,Interventions,1,1
175534,tailored,1,1
175535,to,1,0
175536,sociopsychological,1,0
175537,factors,1,0
175538,associated,1,0
175539,with,1,0
175540,health,1,0
175541,behaviors,1,0
175542,have,0,0
175543,promise,0,0
175544,for,0,0
175545,reducing,0,0
175546,colorectal,0,0
175547,cancer,0,0
175548,screening,0,0
175549,disparities,0,0
175550,",",0,0
175551,but,0,0
175552,limited,0,0
175553,research,0,0
175554,has,0,0
175555,assessed,0,0
175556,their,0,0
175557,impact,0,0
175558,in,0,0
175559,multiethnic,0,0
175560,populations,0,0
175561,.,0,0
175562,We,0,0
175563,examined,0,0
175564,whether,0,0
175565,an,0,0
175566,interactive,1,1
175567,multimedia,1,1
175568,computer,1,1
175569,program,1,1
175570,(,1,0
175571,IMCP,1,1
175572,),1,0
175573,tailored,0,1
175574,to,0,0
175575,expanded,0,0
175576,health,0,0
175577,belief,0,0
175578,model,0,0
175579,sociopsychological,0,0
175580,factors,0,0
175581,could,0,0
175582,promote,0,0
175583,colorectal,0,0
175584,cancer,0,0
175585,screening,0,0
175586,in,0,0
175587,a,0,0
175588,multiethnic,0,0
175589,sample,0,0
175590,.,0,0
175591,METHODS,0,0
175592,We,0,0
175593,undertook,0,0
175594,a,0,0
175595,randomized,0,0
175596,controlled,0,0
175597,trial,0,0
175598,",",0,0
175599,comparing,0,0
175600,an,0,0
175601,IMCP,1,0
175602,tailored,1,1
175603,to,1,0
175604,colorectal,1,0
175605,cancer,1,0
175606,screening,1,0
175607,self-efficacy,1,0
175608,",",1,0
175609,knowledge,1,0
175610,",",1,0
175611,barriers,1,0
175612,",",1,0
175613,readiness,1,0
175614,",",1,0
175615,test,1,0
175616,preference,1,0
175617,",",1,0
175618,and,1,0
175619,experiences,1,0
175620,with,1,0
175621,a,1,0
175622,nontailored,1,1
175623,informational,1,0
175624,program,1,1
175625,",",0,0
175626,both,0,0
175627,delivered,0,0
175628,before,0,0
175629,office,0,0
175630,visits,0,0
175631,.,0,0
175632,The,0,0
175633,primary,0,0
175634,outcome,0,0
175635,was,0,0
175636,record-documented,0,0
175637,colorectal,0,0
175638,cancer,0,0
175639,screening,0,0
175640,during,0,0
175641,a,0,0
175642,12-month,0,0
175643,follow-up,0,0
175644,period,0,0
175645,.,0,0
175646,Secondary,0,0
175647,outcomes,0,0
175648,included,0,0
175649,postvisit,0,0
175650,sociopsychological,0,0
175651,factor,0,0
175652,status,0,0
175653,and,0,0
175654,discussion,0,0
175655,",",0,0
175656,as,0,0
175657,well,0,0
175658,as,0,0
175659,clinician,0,0
175660,recommendation,0,0
175661,of,0,0
175662,screening,0,0
175663,during,0,0
175664,office,0,0
175665,visits,0,0
175666,.,0,0
175667,We,0,0
175668,enrolled,0,0
175669,"1,164",0,0
175670,patients,0,0
175671,stratified,0,0
175672,by,0,0
175673,ethnicity,0,0
175674,and,0,0
175675,language,0,0
175676,(,0,0
175677,49.3,0,0
175678,%,0,0
175679,non-Hispanic,0,0
175680,",",0,0
175681,27.2,0,0
175682,%,0,0
175683,Hispanic/English,0,0
175684,",",0,0
175685,23.4,0,0
175686,%,0,0
175687,Hispanic/Spanish,0,0
175688,),0,0
175689,from,0,0
175690,26,0,0
175691,offices,0,0
175692,around,0,0
175693,5,0,0
175694,centers,0,0
175695,(,0,0
175696,Sacramento,0,0
175697,",",0,0
175698,California,0,0
175699,;,0,0
175700,Rochester,0,0
175701,and,0,0
175702,the,0,0
175703,Bronx,0,0
175704,",",0,0
175705,New,0,0
175706,York,0,0
175707,;,0,0
175708,Denver,0,0
175709,",",0,0
175710,Colorado,0,0
175711,;,0,0
175712,and,0,0
175713,San,0,1
175714,Antonio,0,0
175715,",",0,0
175716,Texas,0,0
175717,),0,0
175718,.,0,0
175719,RESULTS,0,0
175720,Adjusting,0,0
175721,for,0,0
175722,ethnicity/language,0,0
175723,",",0,0
175724,study,0,0
175725,center,0,0
175726,",",0,0
175727,and,0,0
175728,the,0,0
175729,previsit,0,0
175730,value,0,0
175731,of,0,0
175732,the,0,0
175733,dependent,0,0
175734,variable,0,0
175735,",",0,0
175736,compared,0,0
175737,with,0,0
175738,control,0,0
175739,patients,0,0
175740,",",0,0
175741,the,0,0
175742,IMCP,0,0
175743,led,0,0
175744,to,0,0
175745,significantly,0,0
175746,greater,0,0
175747,colorectal,0,0
175748,cancer,0,0
175749,screening,0,0
175750,knowledge,0,0
175751,",",0,0
175752,self-efficacy,0,0
175753,",",0,0
175754,readiness,0,0
175755,",",0,0
175756,test,0,0
175757,preference,0,0
175758,specificity,0,0
175759,",",0,0
175760,discussion,0,0
175761,",",0,0
175762,and,0,0
175763,recommendation,0,0
175764,.,0,0
175765,During,0,0
175766,the,0,0
175767,followup,0,0
175768,period,0,0
175769,",",0,0
175770,132,0,0
175771,(,0,0
175772,23,0,0
175773,%,0,0
175774,),0,0
175775,IMCP,0,0
175776,and,0,0
175777,123,0,0
175778,(,0,0
175779,22,0,0
175780,%,0,0
175781,),0,0
175782,control,0,0
175783,patients,0,0
175784,received,0,0
175785,screening,0,0
175786,(,0,0
175787,adjusted,0,0
175788,difference,0,0
175789,=,0,0
175790,0.5,0,0
175791,percentage,0,0
175792,points,0,0
175793,",",0,0
175794,95,0,0
175795,%,0,0
175796,CI,0,0
175797,-4.3,0,0
175798,to,0,0
175799,5.3,0,0
175800,),0,0
175801,.,0,0
175802,IMCP,0,0
175803,effects,0,0
175804,did,0,0
175805,not,0,0
175806,differ,0,0
175807,significantly,0,0
175808,by,0,0
175809,ethnicity/language,0,0
175810,.,0,0
175811,CONCLUSIONS,0,0
175812,Sociopsychological,0,0
175813,factor,0,0
175814,tailoring,0,1
175815,was,0,0
175816,no,0,0
175817,more,0,0
175818,effective,0,0
175819,than,0,0
175820,nontailored,0,1
175821,information,0,0
175822,in,0,0
175823,encouraging,0,0
175824,colorectal,0,0
175825,cancer,0,0
175826,screening,0,0
175827,in,0,0
175828,a,0,0
175829,multiethnic,0,0
175830,sample,0,0
175831,",",0,0
175832,despite,0,0
175833,enhancing,0,0
175834,sociopsychological,0,0
175835,factors,0,0
175836,and,0,0
175837,visit,0,0
175838,behaviors,0,0
175839,associated,0,0
175840,with,0,0
175841,screening,0,0
175842,.,0,0
175843,The,0,0
175844,utility,0,0
175845,of,0,0
175846,sociopsychological,0,0
175847,tailoring,0,1
175848,in,0,0
175849,addressing,0,0
175850,screening,0,0
175851,disparities,0,0
175852,remains,0,0
175853,uncertain,0,0
175854,.,0,0
175855,Caudal,1,0
175856,epidural,1,1
175857,analgesia,1,0
175858,using,0,0
175859,lidocaine,1,1
175860,alone,1,1
175861,or,0,0
175862,in,0,0
175863,combination,1,1
175864,with,1,0
175865,ketamine,1,1
175866,in,0,0
175867,dromedary,0,0
175868,camels,0,0
175869,Camelus,0,0
175870,dromedarius,0,0
175871,.,0,0
175872,This,0,0
175873,study,0,0
175874,was,0,0
175875,performed,0,0
175876,to,0,0
175877,investigate,0,0
175878,the,0,0
175879,analgesic,0,0
175880,effect,0,0
175881,of,0,0
175882,lidocaine,1,1
175883,and,1,0
175884,a,1,0
175885,combination,1,1
175886,of,1,0
175887,lidocaine,1,1
175888,and,1,0
175889,ketamine,1,1
175890,following,0,0
175891,epidural,0,1
175892,administration,0,0
175893,in,0,0
175894,dromedary,0,0
175895,camels,0,0
175896,.,0,0
175897,Ten,0,0
175898,12-18-month-old,0,0
175899,camels,0,0
175900,were,0,0
175901,randomly,0,0
175902,divided,0,0
175903,into,0,0
175904,two,0,0
175905,equal,0,0
175906,groups,0,0
175907,.,0,0
175908,In,0,0
175909,group,0,0
175910,L,0,0
175911,",",0,0
175912,the,0,0
175913,animals,0,0
175914,received,0,0
175915,2,0,0
175916,%,0,0
175917,lidocaine,1,1
175918,(,0,0
175919,0.22,0,0
175920,mg/kg,0,1
175921,),0,0
175922,and,0,0
175923,in,0,0
175924,group,0,0
175925,LK,0,1
175926,the,0,0
175927,animals,0,0
175928,received,0,0
175929,a,0,0
175930,mixture,0,1
175931,of,0,0
175932,10,0,0
175933,%,0,0
175934,ketamine,1,1
175935,(,0,0
175936,1,0,0
175937,mg/kg,0,1
175938,),0,0
175939,and,0,0
175940,2,0,0
175941,%,0,0
175942,lidocaine,1,1
175943,(,0,0
175944,0.22,0,0
175945,mg/kg,0,1
175946,),0,0
175947,administered,0,0
175948,into,0,0
175949,the,0,0
175950,first,0,0
175951,intercoccygeal,0,0
175952,(,0,0
175953,Co1-Co2,0,1
175954,),0,0
175955,epidural,0,1
175956,space,0,0
175957,while,0,0
175958,standing,0,0
175959,.,0,0
175960,Onset,0,0
175961,time,0,0
175962,and,0,0
175963,duration,0,0
175964,of,0,0
175965,caudal,0,0
175966,analgesia,0,0
175967,",",0,0
175968,sedation,0,0
175969,level,0,0
175970,and,0,0
175971,ataxia,0,0
175972,were,0,0
175973,recorded,0,0
175974,after,0,0
175975,drug,0,0
175976,administration,0,0
175977,.,0,0
175978,Data,0,0
175979,were,0,0
175980,analysed,0,0
175981,by,0,0
175982,U,0,1
175983,Mann-Whitney,0,0
175984,tests,0,0
175985,and,0,0
175986,significance,0,0
175987,was,0,0
175988,taken,0,0
175989,as,0,0
175990,p,0,0
175991,&,0,0
175992,lt,0,0
175993,;,0,0
175994,0.05,0,0
175995,.,0,0
175996,The,0,0
175997,results,0,0
175998,showed,0,0
175999,that,0,0
176000,epidural,1,1
176001,lidocaine,1,1
176002,and,0,0
176003,co-administration,0,1
176004,of,0,0
176005,lidocaine,1,1
176006,and,1,0
176007,ketamine,1,1
176008,produced,0,0
176009,complete,0,0
176010,analgesia,0,0
176011,in,0,0
176012,the,0,0
176013,tail,0,0
176014,",",0,0
176015,anus,0,0
176016,and,0,0
176017,perineum,0,1
176018,.,0,0
176019,Epidural,0,0
176020,administration,0,0
176021,of,0,0
176022,the,0,0
176023,lidocaine-ketamine,1,1
176024,mixture,1,1
176025,resulted,0,0
176026,in,0,0
176027,mild,0,0
176028,to,0,0
176029,moderate,0,0
176030,sedation,0,0
176031,",",0,0
176032,whilst,0,0
176033,the,0,0
176034,animals,0,0
176035,that,0,0
176036,received,0,0
176037,epidural,1,1
176038,lidocaine,1,1
176039,alone,0,1
176040,were,0,0
176041,alert,0,0
176042,and,0,0
176043,nervous,0,0
176044,during,0,0
176045,the,0,0
176046,study,0,0
176047,.,0,0
176048,Ataxia,0,0
176049,was,0,0
176050,observed,0,0
176051,in,0,0
176052,all,0,0
176053,test,0,0
176054,subjects,0,0
176055,and,0,0
176056,was,0,0
176057,slightly,0,0
176058,more,0,0
176059,severe,0,0
176060,in,0,0
176061,camels,0,0
176062,that,0,0
176063,received,0,0
176064,the,0,0
176065,lidocaine-ketamine,1,1
176066,mixture,1,1
176067,.,1,0
176068,It,0,0
176069,was,0,0
176070,concluded,0,0
176071,that,0,0
176072,epidural,0,1
176073,administration,0,0
176074,of,0,0
176075,lidocaine,1,1
176076,plus,1,1
176077,ketamine,1,1
176078,resulted,0,0
176079,in,0,0
176080,longer,0,0
176081,caudal,0,0
176082,analgesia,0,0
176083,in,0,0
176084,standing,0,0
176085,conscious,0,0
176086,dromedary,0,0
176087,camels,0,0
176088,compared,0,0
176089,with,0,0
176090,the,0,0
176091,effect,0,0
176092,of,0,0
176093,administering,0,0
176094,lidocaine,1,1
176095,alone,0,0
176096,.,0,0
176097,Antibacterial,0,0
176098,effects,0,0
176099,of,0,0
176100,fluoride,0,1
176101,varnish,0,1
176102,compared,0,0
176103,with,0,0
176104,chlorhexidine,0,1
176105,plus,0,1
176106,fluoride,0,1
176107,in,0,0
176108,disabled,0,0
176109,children,0,0
176110,.,0,0
176111,PURPOSE,0,0
176112,To,0,0
176113,evaluate,0,0
176114,the,0,0
176115,effects,0,0
176116,of,0,0
176117,fluoride,0,1
176118,varnish,0,1
176119,vs,0,0
176120,a,0,0
176121,combination,0,1
176122,of,0,0
176123,chlorhexidine-thymol,0,1
176124,varnish,0,1
176125,plus,0,1
176126,a,0,0
176127,gel,0,1
176128,containing,0,1
176129,chlorhexidine,0,1
176130,and,0,0
176131,fluoride,0,1
176132,on,0,0
176133,oral,0,1
176134,hygiene,0,1
176135,and,0,0
176136,caries,0,0
176137,prevention,0,0
176138,in,0,0
176139,disabled,0,0
176140,children,0,0
176141,.,0,0
176142,MATERIALS,0,0
176143,AND,0,0
176144,METHODS,0,0
176145,Ninety,0,1
176146,patients,0,0
176147,aged,0,0
176148,3-17,0,0
176149,years,0,0
176150,who,0,0
176151,were,0,0
176152,treated,0,0
176153,under,0,0
176154,general,0,0
176155,anaesthesia,0,1
176156,were,0,0
176157,randomly,0,0
176158,assigned,0,0
176159,into,0,0
176160,three,0,0
176161,groups,0,0
176162,as,0,0
176163,follows,0,0
176164,:,0,0
176165,group,0,0
176166,1,0,0
176167,:,0,0
176168,Fluor,1,1
176169,Protector,1,1
176170,(,1,0
176171,0.1,1,0
176172,%,1,0
176173,fluoride,1,1
176174,varnish,1,1
176175,),1,0
176176,;,1,0
176177,group,1,0
176178,2,1,0
176179,:,1,0
176180,Cervitec,1,1
176181,Plus,1,1
176182,(,1,0
176183,1,1,0
176184,%,1,0
176185,chlorhexidine-,1,1
176186,1,1,0
176187,%,1,0
176188,thymol,1,1
176189,varnish,1,1
176190,),1,0
176191,+,1,0
176192,Cervitec,1,1
176193,Gel,1,1
176194,(,1,0
176195,0.2,1,0
176196,%,1,0
176197,chlorhexidine-0.2,1,1
176198,%,1,0
176199,sodium,1,1
176200,fluoride,1,1
176201,),1,0
176202,;,1,0
176203,group,1,0
176204,3,1,0
176205,:,1,0
176206,control,1,1
176207,(,1,0
176208,toothbrushing,1,1
176209,only,0,0
176210,),0,0
176211,.,0,0
176212,Mutans,0,0
176213,streptococci,0,0
176214,(,0,0
176215,MS,0,0
176216,),0,0
176217,and,0,0
176218,lactobacilli,0,1
176219,(,0,0
176220,LB,0,0
176221,),0,0
176222,levels,0,0
176223,",",0,0
176224,visible,0,0
176225,plaque,0,0
176226,index,0,0
176227,(,0,0
176228,VPI,0,1
176229,),0,1
176230,and,0,0
176231,gingival,0,0
176232,bleeding,0,0
176233,index,0,0
176234,(,0,0
176235,GBI,0,1
176236,),0,0
176237,were,0,0
176238,evaluated,0,0
176239,at,0,0
176240,four,0,0
176241,stages,0,0
176242,:,0,0
176243,T0,0,0
176244,",",0,0
176245,before,0,0
176246,general,0,0
176247,anaesthesia,0,1
176248,;,0,0
176249,T1,0,0
176250,",",0,0
176251,one,0,0
176252,month,0,0
176253,after,0,0
176254,treatment,0,0
176255,;,0,0
176256,T2,0,0
176257,",",0,0
176258,six,0,0
176259,months,0,0
176260,after,0,0
176261,treatment,0,0
176262,;,0,0
176263,T3,0,1
176264,",",0,0
176265,twelve,0,0
176266,months,0,0
176267,after,0,0
176268,treatment,0,0
176269,.,0,0
176270,The,0,0
176271,data,0,0
176272,were,0,0
176273,evaluated,0,0
176274,using,0,0
176275,Kruskal-Wallis,0,0
176276,and,0,0
176277,Mann-Whitney,0,1
176278,U-tests,0,0
176279,(,0,0
176280,P,0,0
176281,<,0,0
176282,0.05,0,0
176283,),0,0
176284,.,0,0
176285,RESULTS,0,0
176286,Groups,0,0
176287,1,0,0
176288,and,0,0
176289,2,0,0
176290,showed,0,0
176291,significantly,0,0
176292,lower,0,0
176293,scores,0,0
176294,than,0,0
176295,group,0,0
176296,3,0,0
176297,for,0,0
176298,all,0,0
176299,parameters,0,0
176300,at,0,0
176301,T1,0,0
176302,and,0,0
176303,T2,0,0
176304,.,0,0
176305,No,0,0
176306,statistically,0,0
176307,significant,0,0
176308,difference,0,0
176309,was,0,0
176310,detected,0,0
176311,among,0,0
176312,any,0,0
176313,of,0,0
176314,the,0,0
176315,the,0,0
176316,groups,0,0
176317,at,0,0
176318,T3,0,1
176319,(,0,0
176320,P,0,0
176321,>,0,0
176322,0.05,0,0
176323,),0,0
176324,.,0,0
176325,CONCLUSION,0,0
176326,The,0,0
176327,use,0,0
176328,of,0,0
176329,materials,0,0
176330,that,0,0
176331,include,0,0
176332,both,0,0
176333,fluoride,0,1
176334,and,0,0
176335,chlorhexidine,0,1
176336,as,0,0
176337,routine,0,0
176338,treatment,0,0
176339,of,0,0
176340,children,0,0
176341,with,0,0
176342,disability,0,0
176343,may,0,0
176344,increase,0,0
176345,the,0,0
176346,success,0,0
176347,of,0,0
176348,restorations,0,1
176349,by,0,0
176350,improving,0,0
176351,oral,0,1
176352,hygiene,0,1
176353,",",0,0
176354,reduce,0,0
176355,the,0,0
176356,need,0,0
176357,for,0,0
176358,future,0,0
176359,restorative,0,1
176360,treatments,0,0
176361,and,0,0
176362,thus,0,0
176363,the,0,0
176364,need,0,0
176365,for,0,0
176366,general,0,0
176367,anaesthesia,0,1
176368,.,0,0
176369,Mechanical,0,1
176370,sensitivity,0,0
176371,of,0,0
176372,the,0,0
176373,human,0,0
176374,conjunctiva,0,0
176375,.,0,0
176376,PURPOSE,0,0
176377,The,0,0
176378,aim,0,0
176379,of,0,0
176380,this,0,0
176381,study,0,0
176382,was,0,0
176383,to,0,0
176384,map,0,1
176385,the,0,0
176386,sensitivity,0,0
176387,of,0,0
176388,the,0,0
176389,marginal,0,0
176390,and,0,0
176391,other,0,0
176392,conjunctival,0,1
176393,regions,0,0
176394,and,0,0
176395,to,0,0
176396,investigate,0,0
176397,changes,0,0
176398,in,0,0
176399,the,0,0
176400,sensitivity,0,0
176401,of,0,0
176402,these,0,0
176403,regions,0,0
176404,when,0,0
176405,determined,0,0
176406,in,0,0
176407,the,0,0
176408,morning,0,0
176409,and,0,0
176410,evening,0,0
176411,.,0,0
176412,METHODS,0,0
176413,Thirty-five,0,0
176414,healthy,0,0
176415,",",0,0
176416,noncontact,0,0
176417,lens,0,1
176418,wearers,0,0
176419,(,0,0
176420,20,0,0
176421,female,0,0
176422,",",0,0
176423,15,0,0
176424,male,0,0
176425,;,0,0
176426,age,0,0
176427,27.7,0,0
176428,?,0,0
176429,7.3,0,0
176430,years,0,0
176431,),0,0
176432,were,0,0
176433,enrolled,0,0
176434,.,0,0
176435,Mechanical,1,0
176436,sensitivity,1,0
176437,was,1,0
176438,measured,1,0
176439,at,1,0
176440,8,1,0
176441,locations,1,0
176442,on,1,0
176443,the,1,0
176444,ocular,1,0
176445,surface,1,0
176446,and,1,0
176447,adnexa,1,1
176448,(,1,0
176449,cornea,1,0
176450,",",1,0
176451,marginal,1,0
176452,",",1,0
176453,bulbar,1,0
176454,",",1,0
176455,and,1,0
176456,tarsal,1,0
176457,conjunctiva,1,0
176458,),1,0
176459,using,1,0
176460,a,1,0
176461,Cochet-Bonnet,1,1
176462,esthesiometer,1,0
176463,(,1,0
176464,0.12-mm,1,0
176465,diameter,1,0
176466,filament,1,0
176467,),1,0
176468,.,1,0
176469,A,0,0
176470,subgroup,0,0
176471,of,0,0
176472,11,0,0
176473,subjects,0,0
176474,(,0,0
176475,6,0,0
176476,female,0,0
176477,",",0,0
176478,5,0,0
176479,male,0,0
176480,;,0,0
176481,age,0,0
176482,28.9,0,0
176483,?,0,0
176484,9.9,0,0
176485,years,0,0
176486,),0,0
176487,returned,0,0
176488,after,0,0
176489,12,0,0
176490,hours,0,0
176491,when,0,0
176492,this,0,0
176493,protocol,0,0
176494,was,0,0
176495,repeated,0,0
176496,.,0,0
176497,RESULTS,0,0
176498,The,0,0
176499,cornea,0,0
176500,was,0,0
176501,found,0,0
176502,to,0,0
176503,be,0,0
176504,the,0,0
176505,most,0,0
176506,sensitive,0,0
176507,region,0,0
176508,(,0,0
176509,all,0,0
176510,P,0,0
176511,<,0,0
176512,0.001,0,0
176513,),0,0
176514,.,0,0
176515,The,0,0
176516,marginal,0,0
176517,conjunctiva,0,0
176518,showed,0,0
176519,greater,0,0
176520,sensitivity,0,0
176521,than,0,0
176522,did,0,0
176523,the,0,0
176524,bulbar,0,0
176525,and,0,0
176526,tarsal,0,0
176527,conjunctiva,0,0
176528,(,0,0
176529,all,0,0
176530,P,0,0
176531,<,0,0
176532,0.001,0,0
176533,),0,0
176534,.,0,0
176535,The,0,0
176536,temporal,0,0
176537,marginal,0,0
176538,conjunctiva,0,0
176539,was,0,0
176540,more,0,0
176541,sensitive,0,0
176542,than,0,0
176543,the,0,0
176544,central,0,0
176545,marginal,0,0
176546,conjunctiva,0,0
176547,(,0,0
176548,all,0,0
176549,P,0,0
176550,<,0,0
176551,0.05,0,0
176552,),0,0
176553,.,0,0
176554,No,0,0
176555,difference,0,0
176556,in,0,0
176557,marginal,0,0
176558,conjunctival,0,1
176559,sensitivity,0,0
176560,was,0,0
176561,found,0,0
176562,between,0,0
176563,upper,0,0
176564,and,0,0
176565,lower,0,0
176566,eyelids,0,0
176567,(,0,0
176568,all,0,0
176569,P,0,0
176570,>,0,0
176571,0.05,0,0
176572,),0,0
176573,.,0,0
176574,The,0,0
176575,upper,0,0
176576,tarsal,0,0
176577,conjunctiva,0,0
176578,was,0,0
176579,more,0,0
176580,sensitive,0,0
176581,than,0,0
176582,the,0,0
176583,lower,0,0
176584,tarsal,0,0
176585,conjunctiva,0,0
176586,(,0,0
176587,P,0,0
176588,=,0,0
176589,0.04,0,0
176590,),0,0
176591,.,0,0
176592,There,0,0
176593,was,0,0
176594,no,0,0
176595,significant,0,0
176596,difference,0,0
176597,in,0,0
176598,the,0,0
176599,sensitivity,0,0
176600,determined,0,0
176601,in,0,0
176602,the,0,0
176603,morning,0,0
176604,and,0,0
176605,the,0,0
176606,evening,0,0
176607,for,0,0
176608,any,0,0
176609,of,0,0
176610,the,0,0
176611,locations,0,0
176612,investigated,0,0
176613,(,0,0
176614,Bonferroni,0,0
176615,adjusted,0,0
176616,",",0,0
176617,P,0,0
176618,>,0,0
176619,0.006,0,0
176620,),0,0
176621,.,0,0
176622,CONCLUSIONS,0,0
176623,This,0,0
176624,work,0,0
176625,has,0,0
176626,demonstrated,0,0
176627,that,0,0
176628,the,0,0
176629,marginal,0,0
176630,conjunctiva,0,0
176631,was,0,0
176632,the,0,0
176633,most,0,0
176634,sensitive,0,0
176635,of,0,0
176636,all,0,0
176637,the,0,0
176638,conjunctival,0,1
176639,regions,0,0
176640,and,0,0
176641,that,0,0
176642,this,0,0
176643,does,0,0
176644,not,0,0
176645,alter,0,0
176646,over,0,0
176647,the,0,0
176648,course,0,0
176649,of,0,0
176650,the,0,0
176651,day,0,0
176652,.,0,0
176653,Quantifying,0,0
176654,narrative,0,1
176655,ability,0,0
176656,in,0,0
176657,autism,0,0
176658,spectrum,0,0
176659,disorder,0,0
176660,:,0,0
176661,a,0,0
176662,computational,0,0
176663,linguistic,0,0
176664,analysis,0,0
176665,of,0,0
176666,narrative,0,1
176667,coherence,0,0
176668,.,0,0
176669,Autism,0,0
176670,is,0,0
176671,a,0,0
176672,neurodevelopmental,0,0
176673,disorder,0,0
176674,characterized,0,0
176675,by,0,0
176676,serious,0,0
176677,difficulties,0,0
176678,with,0,0
176679,the,0,0
176680,social,0,0
176681,use,0,0
176682,of,0,0
176683,language,0,0
176684,",",0,0
176685,along,0,0
176686,with,0,0
176687,impaired,0,0
176688,social,0,1
176689,functioning,0,0
176690,and,0,0
176691,ritualistic/repetitive,0,1
176692,behaviors,0,0
176693,(,0,0
176694,American,0,0
176695,Psychiatric,0,0
176696,Association,0,0
176697,in,0,0
176698,Diagnostic,0,0
176699,and,0,0
176700,statistical,0,0
176701,manual,0,0
176702,of,0,0
176703,mental,0,0
176704,disorders,0,0
176705,:,0,0
176706,DSM-5,0,0
176707,",",0,0
176708,5th,0,0
176709,edn,0,0
176710,.,0,0
176711,American,0,0
176712,Psychiatric,0,0
176713,Association,0,0
176714,",",0,0
176715,Arlington,0,0
176716,",",0,0
176717,2013,0,0
176718,),0,0
176719,.,0,0
176720,While,0,0
176721,substantial,0,0
176722,heterogeneity,0,0
176723,exists,0,0
176724,in,0,0
176725,symptom,0,0
176726,expression,0,0
176727,",",0,0
176728,impairments,0,0
176729,in,0,0
176730,language,0,0
176731,discourse,0,0
176732,skills,0,1
176733,",",0,0
176734,including,0,0
176735,narrative,0,1
176736,(,0,0
176737,or,0,1
176738,storytelling,0,1
176739,),0,0
176740,",",0,0
176741,are,0,0
176742,universally,0,0
176743,observed,0,0
176744,in,0,0
176745,autism,0,0
176746,(,0,0
176747,Tager-Flusberg,0,0
176748,et,0,0
176749,al,0,0
176750,.,0,0
176751,in,0,0
176752,Handbook,0,0
176753,on,0,0
176754,autism,0,0
176755,and,0,0
176756,pervasive,0,0
176757,developmental,0,0
176758,disorders,0,0
176759,",",0,0
176760,3rd,0,0
176761,edn,0,0
176762,.,0,0
176763,Wiley,0,0
176764,",",0,0
176765,New,0,0
176766,York,0,0
176767,",",0,0
176768,pp,0,0
176769,335-364,0,0
176770,",",0,0
176771,2005,0,0
176772,),0,0
176773,.,0,0
176774,This,0,0
176775,study,0,0
176776,applied,0,0
176777,a,0,0
176778,computational,1,0
176779,linguistic,1,0
176780,tool,1,0
176781,",",1,0
176782,Latent,1,0
176783,Semantic,1,1
176784,Analysis,1,1
176785,(,1,0
176786,LSA,1,1
176787,),1,0
176788,",",0,0
176789,to,0,0
176790,objectively,0,0
176791,characterize,0,0
176792,narrative,0,1
176793,performance,0,0
176794,in,0,0
176795,high-functioning,0,0
176796,individuals,0,0
176797,with,0,0
176798,autism,0,0
176799,and,0,0
176800,typically-developing,0,0
176801,controls,0,0
176802,",",0,0
176803,across,0,0
176804,two,0,0
176805,different,0,0
176806,narrative,0,1
176807,contexts,0,0
176808,that,0,0
176809,differ,0,0
176810,in,0,0
176811,the,0,0
176812,interpersonal,0,0
176813,and,0,0
176814,cognitive,0,0
176815,demands,0,0
176816,placed,0,0
176817,on,0,0
176818,the,0,0
176819,narrator,0,0
176820,.,0,0
176821,Results,0,0
176822,indicated,0,0
176823,that,0,0
176824,high-functioning,0,0
176825,individuals,0,0
176826,with,0,0
176827,autism,0,0
176828,produced,0,0
176829,narratives,0,0
176830,comparable,0,0
176831,in,0,0
176832,semantic,0,0
176833,content,0,0
176834,to,0,0
176835,those,0,0
176836,produced,0,0
176837,by,0,0
176838,controls,0,0
176839,when,0,0
176840,narrating,0,1
176841,from,0,0
176842,a,0,0
176843,picture,0,0
176844,book,0,1
176845,",",0,0
176846,but,0,0
176847,produced,0,0
176848,narratives,0,1
176849,diminished,0,0
176850,in,0,0
176851,semantic,0,0
176852,quality,0,0
176853,in,0,0
176854,a,0,0
176855,more,0,0
176856,demanding,0,0
176857,narrative,0,1
176858,recall,0,0
176859,task,0,1
176860,.,0,0
176861,This,0,0
176862,pattern,0,0
176863,is,0,0
176864,similar,0,0
176865,to,0,0
176866,that,0,0
176867,detected,0,0
176868,from,0,0
176869,analyses,0,0
176870,of,0,0
176871,hand-coded,0,1
176872,picture,0,0
176873,book,0,1
176874,narratives,0,1
176875,in,0,0
176876,prior,0,0
176877,research,0,0
176878,",",0,0
176879,and,0,0
176880,extends,0,0
176881,findings,0,0
176882,to,0,0
176883,an,0,0
176884,additional,0,0
176885,narrative,0,1
176886,context,0,0
176887,that,0,0
176888,proves,0,0
176889,particularly,0,0
176890,challenging,0,0
176891,for,0,0
176892,individuals,0,0
176893,with,0,0
176894,autism,0,0
176895,.,0,0
176896,Results,0,0
176897,are,0,0
176898,discussed,0,0
176899,in,0,0
176900,terms,0,0
176901,of,0,0
176902,the,0,0
176903,utility,0,0
176904,of,0,0
176905,LSA,0,1
176906,as,0,0
176907,a,0,0
176908,quantitative,0,0
176909,",",0,0
176910,objective,0,0
176911,",",0,0
176912,and,0,0
176913,efficient,0,0
176914,measure,0,0
176915,of,0,0
176916,narrative,0,1
176917,ability,0,0
176918,.,0,0
176919,Intravenous,1,0
176920,flecainide,1,1
176921,versus,1,0
176922,verapamil,1,1
176923,for,0,0
176924,acute,0,0
176925,conversion,0,0
176926,of,0,0
176927,paroxysmal,0,0
176928,atrial,0,0
176929,fibrillation,0,0
176930,or,0,1
176931,flutter,0,0
176932,to,0,0
176933,sinus,0,0
176934,rhythm,0,1
176935,.,0,0
176936,In,0,0
176937,a,0,0
176938,single-blind,0,0
176939,randomized,0,0
176940,study,0,0
176941,",",0,0
176942,the,0,0
176943,efficacy,0,0
176944,of,0,0
176945,intravenous,1,1
176946,flecainide,1,1
176947,(,0,0
176948,2,0,0
176949,mg/kg/10,0,1
176950,minutes,0,0
176951,),0,0
176952,versus,1,1
176953,verapamil,1,1
176954,(,0,0
176955,10,0,0
176956,mg/1,0,1
176957,minute,0,0
176958,),0,0
176959,was,0,0
176960,assessed,0,0
176961,in,0,0
176962,40,0,0
176963,patients,0,0
176964,with,0,0
176965,paroxysmal,0,0
176966,atrial,0,0
176967,fibrillation,0,0
176968,(,0,0
176969,AF,0,1
176970,),0,1
176971,or,0,1
176972,atrial,0,1
176973,flutter,0,1
176974,(,0,0
176975,AFI,0,0
176976,),0,0
176977,.,0,0
176978,The,0,0
176979,treatment,0,0
176980,was,0,0
176981,considered,0,0
176982,successful,0,0
176983,if,0,0
176984,sinus,0,0
176985,rhythm,0,1
176986,occurred,0,0
176987,within,0,0
176988,1,0,0
176989,hour,0,0
176990,.,0,0
176991,Of,0,0
176992,20,0,0
176993,patients,0,0
176994,receiving,0,0
176995,flecainide,1,1
176996,",",0,0
176997,14,0,0
176998,of,0,0
176999,17,0,0
177000,(,0,0
177001,82,0,0
177002,%,0,0
177003,),0,0
177004,with,0,0
177005,AF,0,0
177006,converted,0,0
177007,to,0,0
177008,sinus,0,0
177009,rhythm,0,1
177010,",",0,0
177011,but,0,0
177012,in,0,0
177013,3,0,0
177014,patients,0,0
177015,with,0,0
177016,AFI,0,0
177017,flecainide,1,1
177018,failed,0,0
177019,.,0,0
177020,All,0,0
177021,patients,0,0
177022,treated,0,0
177023,with,0,0
177024,verapamil,1,1
177025,(,0,0
177026,17,0,0
177027,AF,0,0
177028,",",0,0
177029,3,0,0
177030,AFI,0,0
177031,),0,0
177032,showed,0,0
177033,lower,0,0
177034,ventricular,0,0
177035,rates,0,0
177036,after,0,0
177037,1,0,0
177038,hour,0,0
177039,;,0,0
177040,however,0,0
177041,",",0,0
177042,only,0,0
177043,1,0,0
177044,(,0,0
177045,6,0,0
177046,%,0,0
177047,),0,0
177048,with,0,0
177049,AF,0,0
177050,converted,0,0
177051,to,0,0
177052,sinus,0,0
177053,rhythm,0,1
177054,and,0,0
177055,1,0,0
177056,(,0,0
177057,6,0,0
177058,%,0,0
177059,),0,0
177060,converted,0,0
177061,to,0,0
177062,AFI,0,0
177063,.,0,0
177064,Patients,0,0
177065,who,0,0
177066,did,0,0
177067,not,0,0
177068,convert,0,0
177069,to,0,0
177070,sinus,0,0
177071,rhythm,0,1
177072,after,0,0
177073,treatment,0,0
177074,with,0,0
177075,verapamil,1,1
177076,were,0,0
177077,treated,0,0
177078,with,0,0
177079,flecainide,1,1
177080,and,0,0
177081,observed,0,0
177082,for,0,0
177083,another,0,0
177084,hour,0,0
177085,.,0,0
177086,After,0,0
177087,the,0,0
177088,change,0,0
177089,to,0,0
177090,flecainide,0,1
177091,",",0,0
177092,9,0,0
177093,of,0,0
177094,15,0,0
177095,patients,0,0
177096,(,0,0
177097,60,0,0
177098,%,0,0
177099,),0,0
177100,with,0,0
177101,AF,0,0
177102,still,0,0
177103,converted,0,0
177104,.,0,0
177105,Thus,0,0
177106,",",0,0
177107,23,0,0
177108,of,0,0
177109,32,0,0
177110,patients,0,0
177111,(,0,0
177112,72,0,0
177113,%,0,0
177114,),0,0
177115,with,0,0
177116,AF,0,1
177117,and,0,0
177118,none,0,0
177119,of,0,0
177120,7,0,0
177121,with,0,0
177122,AFI,0,0
177123,converted,0,0
177124,to,0,0
177125,sinus,0,0
177126,rhythm,0,1
177127,after,0,0
177128,treatment,0,0
177129,with,0,0
177130,flecainide,0,1
177131,.,0,0
177132,Conversion,0,0
177133,to,0,0
177134,sinus,0,0
177135,rhythm,0,1
177136,was,0,0
177137,achieved,0,0
177138,in,0,0
177139,19,0,0
177140,of,0,0
177141,22,0,0
177142,patients,0,0
177143,(,0,0
177144,86,0,0
177145,%,0,0
177146,),0,0
177147,when,0,0
177148,AF,0,0
177149,lasted,0,0
177150,less,0,0
177151,than,0,0
177152,24,0,0
177153,hours,0,0
177154,and,0,0
177155,in,0,0
177156,4,0,0
177157,of,0,0
177158,10,0,0
177159,(,0,0
177160,40,0,0
177161,%,0,0
177162,),0,0
177163,when,0,0
177164,the,0,0
177165,arrhythmia,0,0
177166,lasted,0,0
177167,greater,0,0
177168,than,0,0
177169,24,0,0
177170,hours,0,0
177171,.,0,0
177172,Transient,0,0
177173,adverse,0,0
177174,effects,0,0
177175,were,0,0
177176,noted,0,0
177177,in,0,0
177178,10,0,0
177179,patients,0,0
177180,(,0,0
177181,26,0,0
177182,%,0,0
177183,),0,0
177184,after,0,0
177185,flecainide,0,1
177186,.,0,0
177187,In,0,0
177188,summary,0,0
177189,",",0,0
177190,flecainide,1,1
177191,is,0,0
177192,an,0,0
177193,effective,0,0
177194,and,0,0
177195,safe,0,0
177196,drug,0,0
177197,for,0,0
177198,conversion,0,0
177199,of,0,0
177200,paroxysmal,0,0
177201,AF,0,0
177202,to,0,0
177203,sinus,0,0
177204,rhythm,0,1
177205,",",0,0
177206,but,0,0
177207,ineffective,0,0
177208,for,0,0
177209,AFI,0,0
177210,.,0,0
177211,Verapamil,1,1
177212,appears,0,0
177213,to,0,0
177214,be,0,0
177215,of,0,0
177216,no,0,0
177217,use,0,0
177218,for,0,0
177219,conversion,0,0
177220,of,0,0
177221,AF,0,0
177222,or,0,1
177223,AFI,0,0
177224,to,0,0
177225,sinus,0,0
177226,rhythm,0,0
177227,.,0,0
177228,Effect,0,0
177229,of,0,0
177230,selumetinib,1,1
177231,vs,0,0
177232,chemotherapy,1,1
177233,on,0,0
177234,progression-free,0,0
177235,survival,0,0
177236,in,0,0
177237,uveal,0,0
177238,melanoma,0,0
177239,:,0,0
177240,a,0,0
177241,randomized,0,0
177242,clinical,0,0
177243,trial,0,0
177244,.,0,0
177245,IMPORTANCE,0,0
177246,Uveal,0,0
177247,melanoma,0,0
177248,is,0,0
177249,characterized,0,0
177250,by,0,0
177251,mutations,0,0
177252,in,0,0
177253,GNAQ,0,0
177254,and,0,0
177255,GNA11,0,0
177256,",",0,0
177257,resulting,0,0
177258,in,0,0
177259,mitogen-activated,0,0
177260,protein,0,0
177261,kinase,0,0
177262,pathway,0,0
177263,activation,0,0
177264,.,0,0
177265,OBJECTIVE,0,0
177266,To,0,0
177267,assess,0,0
177268,the,0,0
177269,efficacy,0,0
177270,of,0,0
177271,selumetinib,1,1
177272,",",0,0
177273,a,0,0
177274,selective,0,0
177275,",",0,0
177276,non-adenosine,0,1
177277,triphosphate,0,1
177278,competitive,0,0
177279,inhibitor,0,1
177280,of,0,0
177281,MEK1,0,1
177282,and,0,0
177283,MEK2,0,0
177284,",",0,0
177285,in,0,0
177286,uveal,0,0
177287,melanoma,0,0
177288,.,0,0
177289,DESIGN,0,0
177290,",",0,0
177291,SETTING,0,0
177292,",",0,0
177293,AND,0,0
177294,PARTICIPANTS,0,0
177295,Randomized,0,0
177296,",",0,0
177297,open-label,0,0
177298,",",0,0
177299,phase,0,0
177300,2,0,0
177301,clinical,0,0
177302,trial,0,0
177303,comparing,0,0
177304,selumetinib,1,1
177305,vs,0,0
177306,chemotherapy,1,1
177307,conducted,0,0
177308,from,0,0
177309,August,0,0
177310,2010,0,0
177311,through,0,0
177312,December,0,0
177313,2013,0,0
177314,among,0,0
177315,120,0,0
177316,patients,0,0
177317,with,0,0
177318,metastatic,0,0
177319,uveal,0,0
177320,melanoma,0,0
177321,at,0,0
177322,15,0,0
177323,academic,0,0
177324,oncology,0,0
177325,centers,0,0
177326,in,0,0
177327,the,0,0
177328,United,0,0
177329,States,0,0
177330,and,0,0
177331,Canada,0,0
177332,.,0,0
177333,INTERVENTIONS,0,0
177334,One,0,0
177335,hundred,0,0
177336,one,0,0
177337,patients,0,0
177338,were,0,0
177339,randomized,0,0
177340,in,0,0
177341,a,0,0
177342,1:1,0,0
177343,ratio,0,0
177344,to,0,0
177345,receive,0,0
177346,selumetinib,1,1
177347,",",0,0
177348,75,0,0
177349,mg,0,0
177350,orally,0,0
177351,twice,0,0
177352,daily,0,0
177353,on,0,0
177354,a,0,0
177355,continual,0,0
177356,basis,0,0
177357,(,0,0
177358,n,0,0
177359,=,0,0
177360,50,0,0
177361,),0,0
177362,",",0,0
177363,or,0,1
177364,chemotherapy,1,1
177365,(,1,0
177366,temozolomide,1,1
177367,",",1,0
177368,150,1,0
177369,mg/m2,0,0
177370,orally,0,0
177371,daily,0,0
177372,for,0,0
177373,5,0,0
177374,of,0,0
177375,every,0,0
177376,28,0,0
177377,days,0,0
177378,",",0,0
177379,or,0,0
177380,dacarbazine,1,1
177381,",",1,0
177382,1000,1,0
177383,mg/m2,0,0
177384,intravenously,0,0
177385,every,0,0
177386,21,0,0
177387,days,0,0
177388,[,0,0
177389,investigator,0,0
177390,choice,0,0
177391,],0,0
177392,;,0,0
177393,n,0,0
177394,=,0,0
177395,51,0,0
177396,),0,0
177397,until,0,0
177398,disease,0,0
177399,progression,0,0
177400,",",0,0
177401,death,0,0
177402,",",0,0
177403,intolerable,0,0
177404,adverse,0,0
177405,effects,0,0
177406,",",0,0
177407,or,0,0
177408,withdrawal,0,1
177409,of,0,0
177410,consent,0,0
177411,.,0,0
177412,After,0,0
177413,primary,0,0
177414,outcome,0,0
177415,analysis,0,0
177416,",",0,0
177417,19,0,0
177418,patients,0,0
177419,were,0,0
177420,registered,0,0
177421,and,0,0
177422,18,0,0
177423,treated,0,0
177424,with,0,0
177425,selumetinib,0,1
177426,without,0,0
177427,randomization,0,0
177428,to,0,0
177429,complete,0,0
177430,the,0,0
177431,planned,0,0
177432,120-patient,0,0
177433,enrollment,0,0
177434,.,0,0
177435,Patients,0,0
177436,in,1,0
177437,the,1,0
177438,chemotherapy,1,1
177439,group,1,0
177440,could,1,0
177441,receive,0,0
177442,selumetinib,1,1
177443,at,1,0
177444,the,1,0
177445,time,0,0
177446,of,0,0
177447,radiographic,0,0
177448,progression,0,0
177449,.,0,0
177450,MAIN,0,0
177451,OUTCOMES,0,0
177452,AND,0,0
177453,MEASURES,0,0
177454,Progression-free,0,0
177455,survival,0,0
177456,",",0,0
177457,the,0,0
177458,primary,0,0
177459,end,0,0
177460,point,0,0
177461,",",0,0
177462,was,0,0
177463,assessed,0,0
177464,as,0,0
177465,of,0,0
177466,April,0,1
177467,22,0,0
177468,",",0,0
177469,2013,0,0
177470,.,0,0
177471,Additional,0,0
177472,end,0,0
177473,points,0,0
177474,",",0,0
177475,including,0,0
177476,overall,0,0
177477,survival,0,0
177478,",",0,0
177479,response,0,0
177480,rate,0,0
177481,",",0,0
177482,and,0,0
177483,safety/toxicity,0,0
177484,",",0,0
177485,were,0,0
177486,assessed,0,0
177487,as,0,0
177488,of,0,0
177489,December,0,0
177490,31,0,0
177491,",",0,0
177492,2013,0,0
177493,.,0,0
177494,RESULTS,0,0
177495,Median,0,0
177496,progression-free,0,0
177497,survival,0,0
177498,among,0,0
177499,patients,0,0
177500,randomized,1,0
177501,to,1,0
177502,chemotherapy,1,1
177503,was,1,0
177504,7,1,0
177505,weeks,1,0
177506,(,0,0
177507,95,0,0
177508,%,0,0
177509,CI,0,0
177510,",",0,0
177511,4.3-8.4,0,0
177512,weeks,0,0
177513,;,0,0
177514,median,0,0
177515,treatment,0,0
177516,duration,0,0
177517,",",0,0
177518,8,0,0
177519,weeks,0,0
177520,;,0,0
177521,interquartile,0,0
177522,range,0,0
177523,[,0,0
177524,IQR,0,1
177525,],0,0
177526,",",0,0
177527,4.3-16,0,0
177528,weeks,0,0
177529,),0,0
177530,and,0,0
177531,among,0,0
177532,those,0,0
177533,randomized,1,0
177534,to,1,0
177535,selumetinib,1,1
177536,was,1,0
177537,15.9,1,0
177538,weeks,0,0
177539,(,0,0
177540,95,0,0
177541,%,0,0
177542,CI,0,0
177543,",",0,0
177544,8.4-21.1,0,0
177545,weeks,0,0
177546,;,0,0
177547,median,0,0
177548,treatment,0,0
177549,duration,0,0
177550,",",0,0
177551,16.1,0,0
177552,weeks,0,0
177553,;,0,0
177554,IQR,0,0
177555,",",0,0
177556,8.1-25.3,0,0
177557,weeks,0,1
177558,),0,0
177559,(,0,0
177560,hazard,0,0
177561,ratio,0,0
177562,",",0,0
177563,0.46,0,0
177564,;,0,0
177565,95,0,0
177566,%,0,0
177567,CI,0,0
177568,",",0,0
177569,0.30-0.71,0,0
177570,;,0,0
177571,P,0,0
177572,<,0,0
177573,.001,0,0
177574,),0,0
177575,.,0,0
177576,Median,0,0
177577,overall,0,0
177578,survival,0,0
177579,time,0,0
177580,was,0,0
177581,9.1,0,0
177582,months,0,0
177583,(,0,0
177584,95,0,0
177585,%,0,0
177586,CI,0,0
177587,",",0,0
177588,6.1-11.1,0,0
177589,months,0,0
177590,),0,0
177591,with,0,0
177592,chemotherapy,0,1
177593,and,0,0
177594,11.8,0,0
177595,months,0,0
177596,(,0,0
177597,95,0,0
177598,%,0,0
177599,CI,0,0
177600,",",0,0
177601,9.8-15.7,0,0
177602,months,0,0
177603,),0,0
177604,with,0,0
177605,selumetinib,1,1
177606,(,0,0
177607,hazard,0,0
177608,ratio,0,0
177609,",",0,0
177610,0.66,0,0
177611,;,0,0
177612,95,0,0
177613,%,0,0
177614,CI,0,0
177615,",",0,0
177616,0.41-1.06,0,0
177617,;,0,0
177618,P,0,0
177619,=,0,0
177620,.09,0,0
177621,),0,0
177622,.,0,0
177623,No,0,0
177624,objective,0,0
177625,responses,0,0
177626,were,0,0
177627,observed,0,0
177628,with,1,0
177629,chemotherapy,1,1
177630,.,1,0
177631,Forty-nine,1,0
177632,percent,0,0
177633,of,0,0
177634,patients,0,0
177635,treated,0,0
177636,with,1,0
177637,selumetinib,1,1
177638,achieved,1,0
177639,tumor,0,0
177640,regression,0,0
177641,",",0,0
177642,with,0,0
177643,14,0,0
177644,%,0,0
177645,achieving,0,0
177646,an,0,0
177647,objective,0,0
177648,radiographic,0,0
177649,response,0,0
177650,to,0,0
177651,therapy,0,1
177652,.,0,0
177653,Treatment-related,0,0
177654,adverse,0,0
177655,events,0,0
177656,were,0,0
177657,observed,0,0
177658,in,0,0
177659,97,0,0
177660,%,0,0
177661,of,0,0
177662,patients,0,0
177663,treated,0,0
177664,with,0,0
177665,selumetinib,0,1
177666,",",0,0
177667,with,0,0
177668,37,0,0
177669,%,0,0
177670,requiring,0,0
177671,at,0,0
177672,least,0,0
177673,1,0,0
177674,dose,0,0
177675,reduction,0,0
177676,.,0,0
177677,CONCLUSIONS,0,0
177678,AND,0,0
177679,RELEVANCE,0,0
177680,In,0,0
177681,this,0,0
177682,hypothesis-generating,0,0
177683,study,0,0
177684,of,0,0
177685,patients,0,0
177686,with,0,0
177687,advanced,0,0
177688,uveal,0,0
177689,melanoma,0,0
177690,",",0,0
177691,selumetinib,0,1
177692,compared,1,0
177693,with,1,0
177694,chemotherapy,1,1
177695,resulted,1,0
177696,in,0,0
177697,a,0,0
177698,modestly,0,0
177699,improved,0,0
177700,progression-free,0,0
177701,survival,0,0
177702,and,0,0
177703,response,0,0
177704,rate,0,0
177705,;,0,0
177706,however,0,0
177707,",",0,0
177708,no,0,0
177709,improvement,0,0
177710,in,0,0
177711,overall,0,0
177712,survival,0,0
177713,was,0,0
177714,observed,0,0
177715,.,0,0
177716,Improvement,0,0
177717,in,0,0
177718,clinical,0,0
177719,outcomes,0,0
177720,was,0,0
177721,accompanied,0,0
177722,by,0,0
177723,a,0,0
177724,high,0,0
177725,rate,0,0
177726,of,0,0
177727,adverse,0,0
177728,events,0,0
177729,.,0,0
177730,TRIAL,0,0
177731,REGISTRATION,0,0
177732,clinicaltrials.gov,0,0
177733,Identifier,0,0
177734,:,0,0
177735,NCT01143402,0,0
177736,.,0,0
177737,A,0,0
177738,further,0,0
177739,investigation,0,0
177740,of,0,0
177741,goal-directed,1,1
177742,intention,1,0
177743,understanding,1,0
177744,in,0,0
177745,young,0,0
177746,children,0,0
177747,with,0,0
177748,autism,0,0
177749,spectrum,0,0
177750,disorders,0,0
177751,.,0,0
177752,Findings,0,0
177753,from,0,0
177754,research,0,0
177755,investigating,0,0
177756,goal-directed,1,1
177757,intention,1,0
177758,understanding,1,0
177759,in,0,0
177760,children,0,0
177761,with,0,0
177762,autism,0,0
177763,spectrum,0,0
177764,disorders,0,0
177765,(,0,0
177766,ASD,0,0
177767,),0,0
177768,have,0,0
177769,been,0,0
177770,equivocal,0,0
177771,",",0,0
177772,in,0,0
177773,part,0,0
177774,because,0,0
177775,of,0,0
177776,the,0,0
177777,varying,0,0
177778,methodologies,0,0
177779,used,0,0
177780,across,0,0
177781,studies,0,0
177782,.,0,0
177783,This,0,0
177784,study,0,0
177785,compares,0,0
177786,both,0,0
177787,object-oriented,1,1
177788,and,1,0
177789,social-communicatively,1,0
177790,cued,1,0
177791,goal-directed,1,1
177792,intention,1,0
177793,understanding,1,0
177794,in,0,0
177795,children,0,0
177796,with,0,0
177797,ASD,0,0
177798,and,0,0
177799,typically-developing,0,0
177800,children,0,0
177801,.,0,0
177802,Relative,0,0
177803,to,0,0
177804,matched,0,0
177805,controls,0,0
177806,",",0,0
177807,children,0,0
177808,with,0,0
177809,ASD,0,0
177810,did,0,0
177811,not,0,0
177812,exhibit,0,0
177813,deficits,0,0
177814,in,0,0
177815,object-oriented,1,1
177816,intention,1,0
177817,understanding,1,0
177818,.,1,0
177819,While,0,0
177820,children,0,0
177821,with,0,0
177822,ASD,0,0
177823,also,0,0
177824,demonstrated,0,0
177825,the,0,0
177826,ability,0,0
177827,to,0,0
177828,understand,0,0
177829,intention,0,0
177830,when,0,0
177831,cued,0,0
177832,by,0,0
177833,social-communication,0,0
177834,indicators,0,0
177835,",",0,0
177836,typically-developing,0,0
177837,children,0,0
177838,differentiated,0,0
177839,between,0,0
177840,intentional,0,0
177841,and,0,0
177842,unintentional,0,0
177843,acts,0,0
177844,at,0,0
177845,a,0,0
177846,significantly,0,0
177847,greater,0,0
177848,level,0,0
177849,.,0,0
177850,Group,0,0
177851,differences,0,0
177852,in,0,0
177853,performance,0,0
177854,were,0,0
177855,eliminated,0,0
177856,if,0,0
177857,only,0,0
177858,trials,0,0
177859,in,0,0
177860,which,0,0
177861,children,0,0
177862,attended,0,0
177863,to,0,0
177864,the,0,0
177865,experimenter,0,0
177866,'s,0,0
177867,face,0,0
177868,were,0,0
177869,considered,0,0
177870,.,0,0
177871,Results,0,0
177872,suggest,0,0
177873,that,0,0
177874,children,0,0
177875,with,0,0
177876,ASD,0,0
177877,have,0,0
177878,intact,0,0
177879,object-oriented,0,1
177880,intention,0,0
177881,understanding,0,0
177882,abilities,0,0
177883,",",0,0
177884,and,0,0
177885,are,0,0
177886,able,0,0
177887,to,0,0
177888,use,0,0
177889,social-communicative,0,0
177890,cues,0,0
177891,to,0,0
177892,understand,0,0
177893,intention,0,0
177894,.,0,0
177895,However,0,0
177896,",",0,0
177897,their,0,0
177898,ability,0,0
177899,to,0,0
177900,demonstrate,0,0
177901,social-communicatively,1,0
177902,cued,1,0
177903,intention,1,0
177904,understanding,1,0
177905,is,0,0
177906,limited,0,0
177907,by,0,0
177908,a,0,0
177909,lack,0,0
177910,of,0,0
177911,attention,0,0
177912,to,0,0
177913,relevant,0,0
177914,social-communicative,0,0
177915,information,0,0
177916,.,0,0
177917,TEN,1,1
177918,versus,0,1
177919,TPN,1,0
177920,following,0,0
177921,major,0,0
177922,abdominal,0,0
177923,trauma,0,0
177924,--,0,0
177925,reduced,0,0
177926,septic,0,0
177927,morbidity,0,0
177928,.,0,0
177929,Recent,0,0
177930,animal,0,0
177931,models,0,0
177932,suggest,0,0
177933,that,0,0
177934,enteral,1,1
177935,feeding,1,1
177936,(,1,0
177937,TEN,1,1
177938,),1,0
177939,compared,0,0
177940,to,0,0
177941,parenteral,1,1
177942,nutrition,1,1
177943,(,1,0
177944,TPN,1,0
177945,),1,1
177946,improves,0,0
177947,resistance,0,0
177948,to,0,0
177949,infection,0,0
177950,.,0,0
177951,This,0,0
177952,prospective,0,0
177953,clinical,0,0
177954,trial,0,0
177955,examined,0,0
177956,the,0,0
177957,impact,0,0
177958,of,0,0
177959,early,0,0
177960,TEN,1,1
177961,vs.,0,0
177962,TPN,1,0
177963,in,0,0
177964,the,0,0
177965,critically,0,0
177966,injured,0,0
177967,.,0,0
177968,Seventy-five,0,0
177969,patients,0,0
177970,with,0,0
177971,an,0,0
177972,abdominal,0,0
177973,trauma,0,0
177974,index,0,0
177975,(,0,0
177976,ATI,0,1
177977,),0,0
177978,greater,0,0
177979,than,0,0
177980,15,0,0
177981,and,0,0
177982,less,0,0
177983,than,0,0
177984,40,0,0
177985,were,0,0
177986,randomized,0,0
177987,at,0,0
177988,initial,1,0
177989,laparotomy,1,1
177990,to,0,0
177991,receive,1,0
177992,either,1,0
177993,TEN,1,1
177994,(,1,0
177995,Vivonex,1,1
177996,TEN,1,1
177997,),1,0
177998,or,1,1
177999,TPN,1,1
178000,(,1,0
178001,Freamine,1,1
178002,HBC,1,1
178003,6.9,1,0
178004,%,1,0
178005,and,1,0
178006,Trophamine,1,1
178007,6,1,0
178008,%,1,0
178009,),1,0
178010,;,1,0
178011,both,0,0
178012,regimens,0,0
178013,contained,0,0
178014,2.5,0,0
178015,%,0,0
178016,fat,0,0
178017,",",0,0
178018,33,0,0
178019,%,0,0
178020,branched,0,0
178021,chain,0,0
178022,amino,0,1
178023,acids,0,1
178024,",",0,0
178025,and,0,0
178026,had,0,0
178027,a,0,0
178028,calorie,0,1
178029,to,0,0
178030,nitrogen,0,0
178031,ratio,0,0
178032,of,0,0
178033,150:1,0,1
178034,.,0,0
178035,TEN,1,0
178036,was,0,0
178037,delivered,0,0
178038,via,0,0
178039,a,0,0
178040,needle,0,1
178041,catheter,0,1
178042,jejunostomy,0,1
178043,.,0,0
178044,Nutritional,0,0
178045,support,0,0
178046,was,0,0
178047,initiated,0,0
178048,within,0,0
178049,12,0,0
178050,hours,0,0
178051,postoperatively,0,0
178052,in,0,0
178053,both,0,0
178054,groups,0,0
178055,",",0,0
178056,and,0,0
178057,infused,0,0
178058,at,0,0
178059,a,0,0
178060,rate,0,0
178061,sufficient,0,0
178062,to,0,0
178063,render,0,0
178064,the,0,0
178065,patients,0,0
178066,in,0,0
178067,positive,0,0
178068,nitrogen,0,0
178069,balance,0,0
178070,.,0,0
178071,The,0,0
178072,study,0,0
178073,groups,0,0
178074,(,1,0
178075,TEN,1,1
178076,=,0,0
178077,29,0,0
178078,vs,0,0
178079,TPN,1,0
178080,=,0,0
178081,30,0,0
178082,),0,0
178083,were,0,0
178084,comparable,0,0
178085,in,0,0
178086,age,0,0
178087,",",0,0
178088,injury,0,0
178089,severity,0,0
178090,and,0,0
178091,initial,0,0
178092,metabolic,0,0
178093,stress,0,0
178094,.,0,0
178095,Jejunal,0,0
178096,feeding,0,0
178097,was,0,0
178098,tolerated,0,0
178099,unconditionally,0,0
178100,in,0,0
178101,25,0,0
178102,(,0,0
178103,86,0,0
178104,%,0,0
178105,),0,0
178106,of,0,0
178107,the,0,0
178108,TEN,1,1
178109,group,0,0
178110,.,0,0
178111,Nitrogen,0,0
178112,balance,0,0
178113,remained,0,0
178114,equivalent,0,0
178115,throughout,0,0
178116,the,0,0
178117,study,0,0
178118,period,0,0
178119,",",0,0
178120,at,0,0
178121,day,0,0
178122,5,0,0
178123,TEN,1,0
178124,=,0,0
178125,-0.3,0,0
178126,+/-,0,0
178127,1.0,0,0
178128,vs.,0,0
178129,TPN,1,0
178130,0.1,0,0
178131,+/-,0,0
178132,0.8,0,0
178133,gm/day,0,0
178134,.,0,0
178135,Traditional,0,0
178136,nutritional,0,1
178137,protein,0,1
178138,markers,0,0
178139,(,0,0
178140,albumin,0,1
178141,",",0,0
178142,transferrin,0,0
178143,",",0,0
178144,and,0,0
178145,retinol,0,1
178146,binding,0,0
178147,protein,0,1
178148,),0,0
178149,were,0,0
178150,restored,0,0
178151,better,0,0
178152,in,0,0
178153,the,0,0
178154,TEN,1,1
178155,group,0,0
178156,.,0,0
178157,Infections,0,0
178158,developed,0,0
178159,in,0,0
178160,5,0,0
178161,(,0,0
178162,17,0,0
178163,%,0,0
178164,),0,0
178165,of,0,0
178166,the,0,0
178167,TEN,1,0
178168,patients,0,0
178169,compared,0,0
178170,to,0,0
178171,11,0,0
178172,(,0,0
178173,37,0,0
178174,%,0,0
178175,),0,0
178176,of,0,0
178177,the,0,0
178178,TPN,1,0
178179,group,0,0
178180,.,0,0
178181,The,0,0
178182,incidence,0,0
178183,of,0,0
178184,major,0,0
178185,septic,0,0
178186,morbidity,0,0
178187,was,0,0
178188,3,0,0
178189,%,0,0
178190,(,0,0
178191,1,0,0
178192,=,0,0
178193,abdominal,0,0
178194,abscess,0,0
178195,),0,0
178196,in,0,0
178197,the,0,0
178198,TEN,1,1
178199,group,0,0
178200,contrasted,0,0
178201,to,0,0
178202,20,0,0
178203,%,0,0
178204,(,0,0
178205,2,0,0
178206,=,0,0
178207,abdominal,0,0
178208,abscess,0,0
178209,",",0,0
178210,6,0,0
178211,=,0,0
178212,pneumonia,0,0
178213,),0,0
178214,with,0,0
178215,TPN,1,0
178216,.,1,0
178217,This,0,0
178218,clinical,0,0
178219,study,0,0
178220,demonstrates,0,0
178221,that,0,0
178222,TEN,1,0
178223,is,0,0
178224,well,0,0
178225,tolerated,0,0
178226,in,0,0
178227,the,0,0
178228,severely,0,0
178229,injured,0,0
178230,",",0,0
178231,and,0,0
178232,that,0,0
178233,early,0,0
178234,feeding,0,0
178235,via,0,0
178236,the,0,0
178237,gut,0,0
178238,reduces,0,0
178239,septic,0,0
178240,complications,0,0
178241,in,0,0
178242,the,0,0
178243,stressed,0,0
178244,patient,0,0
178245,.,0,0
178246,Examining,0,0
178247,the,0,0
178248,temperature,0,0
178249,of,0,0
178250,embryo,0,0
178251,culture,0,0
178252,in,0,0
178253,in,0,0
178254,vitro,0,0
178255,fertilization,0,0
178256,:,0,0
178257,a,0,0
178258,randomized,0,0
178259,controlled,0,0
178260,trial,0,0
178261,comparing,0,0
178262,traditional,0,1
178263,core,0,1
178264,temperature,0,0
178265,(,0,0
178266,37?C,0,0
178267,),0,0
178268,to,0,0
178269,a,0,0
178270,more,0,0
178271,physiologic,0,0
178272,",",0,0
178273,cooler,0,1
178274,temperature,0,0
178275,(,0,0
178276,36?C,0,0
178277,),0,0
178278,.,0,0
178279,OBJECTIVE,0,0
178280,To,0,0
178281,determine,0,0
178282,whether,0,0
178283,culture,0,0
178284,at,0,0
178285,a,0,0
178286,more,0,0
178287,physiologically,0,0
178288,cooler,0,1
178289,temperature,0,0
178290,",",0,0
178291,as,0,0
178292,suggested,0,0
178293,by,0,0
178294,limited,0,0
178295,human,0,0
178296,and,0,0
178297,animal,0,0
178298,data,0,0
178299,",",0,0
178300,would,0,0
178301,improve,0,0
178302,blastulation,0,0
178303,and,0,0
178304,pregnancy,0,0
178305,rates,0,0
178306,in,0,0
178307,human,0,0
178308,clinical,0,0
178309,IVF,0,0
178310,.,0,0
178311,DESIGN,0,0
178312,Paired,0,0
178313,randomized,0,0
178314,controlled,0,0
178315,trial,0,0
178316,.,0,0
178317,SETTING,0,0
178318,Academic,0,0
178319,.,0,0
178320,PATIENT,0,0
178321,(,0,0
178322,S,0,0
178323,),0,0
178324,Infertile,0,1
178325,couples,0,0
178326,(,0,0
178327,n=52,0,0
178328,),0,0
178329,with,0,0
178330,a,0,0
178331,female,0,0
178332,partner,0,0
178333,less,0,0
178334,than,0,0
178335,42,0,0
178336,years,0,0
178337,old,0,0
178338,with,0,0
178339,eight,0,0
178340,or,0,0
178341,more,0,0
178342,mature,0,0
178343,oocytes,0,0
178344,retrieved,0,0
178345,.,0,0
178346,INTERVENTION,0,0
178347,(,0,0
178348,S,0,0
178349,),0,0
178350,Mature,0,0
178351,oocytes,0,1
178352,obtained,0,0
178353,from,0,0
178354,a,0,0
178355,single,0,0
178356,cohort,0,0
178357,of,0,0
178358,oocytes,0,0
178359,were,0,0
178360,randomly,0,0
178361,divided,0,0
178362,into,0,0
178363,two,0,0
178364,groups,1,0
178365,;,1,0
178366,one,1,0
178367,was,1,0
178368,cultured,1,0
178369,at,1,0
178370,37?C,1,0
178371,and,1,0
178372,the,1,0
178373,other,1,0
178374,at,1,0
178375,36?C,1,0
178376,from,1,0
178377,the,0,0
178378,time,0,0
178379,of,1,0
178380,ICSI,1,1
178381,to,1,0
178382,the,0,0
178383,time,1,0
178384,of,1,0
178385,embryo,1,0
178386,transfer,1,1
178387,or,1,1
178388,vitrification,1,1
178389,.,1,0
178390,Paired,1,0
178391,embryo,0,0
178392,transfers,0,0
178393,were,0,0
178394,accomplished,0,0
178395,by,0,0
178396,transferring,0,1
178397,one,0,0
178398,euploid,0,0
178399,embryo,0,0
178400,from,0,0
178401,each,0,0
178402,group,1,0
178403,.,1,0
178404,DNA,1,0
178405,fingerprinting,1,0
178406,was,1,0
178407,used,0,0
178408,as,0,0
178409,needed,0,0
178410,to,0,0
178411,determine,0,0
178412,the,0,0
178413,outcome,0,0
178414,for,0,0
178415,each,0,0
178416,embryo,0,0
178417,.,0,0
178418,MAIN,0,0
178419,OUTCOME,0,0
178420,MEASURE,0,0
178421,(,0,0
178422,S,0,0
178423,),0,0
178424,Rate,0,1
178425,of,0,0
178426,development,0,0
178427,of,0,0
178428,expanded,0,0
178429,blastocysts,0,0
178430,suitable,0,0
178431,for,0,0
178432,transfer,0,1
178433,or,0,1
178434,vitrification,0,1
178435,(,0,0
178436,primary,0,0
178437,outcome,0,0
178438,),0,0
178439,",",0,0
178440,fertilization,0,0
178441,",",0,0
178442,aneuploidy,0,0
178443,",",0,0
178444,and,0,0
178445,sustained,0,0
178446,implantation,0,0
178447,.,0,0
178448,RESULT,0,0
178449,(,0,0
178450,S,0,0
178451,),0,1
178452,A,0,0
178453,total,0,0
178454,of,0,0
178455,805,0,0
178456,mature,0,0
178457,oocytes,0,0
178458,were,0,0
178459,cultured,0,0
178460,;,0,0
178461,399,0,0
178462,at,0,0
178463,36?C,0,0
178464,and,0,0
178465,406,0,0
178466,at,0,0
178467,37?C,0,0
178468,.,0,0
178469,Paired,0,0
178470,analysis,0,0
178471,demonstrated,0,0
178472,a,0,0
178473,higher,0,0
178474,rate,0,0
178475,of,0,0
178476,usable,0,0
178477,blastocyst,0,0
178478,formation,0,0
178479,per,0,0
178480,zygote,0,0
178481,at,0,0
178482,37?C,0,0
178483,(,0,0
178484,48.4,0,0
178485,%,0,0
178486,),0,0
178487,vs.,0,0
178488,at,0,0
178489,36?C,0,0
178490,(,0,0
178491,41.2,0,0
178492,%,0,0
178493,),0,0
178494,.,0,0
178495,Rates,0,0
178496,of,0,0
178497,fertilization,0,0
178498,",",0,0
178499,aneuploidy,0,0
178500,",",0,0
178501,and,0,0
178502,sustained,0,0
178503,implantation,0,1
178504,were,0,0
178505,equivalent,0,0
178506,.,0,0
178507,CONCLUSION,0,0
178508,(,0,0
178509,S,0,0
178510,),0,1
178511,IVF,0,0
178512,culture,0,0
178513,at,0,0
178514,36?C,0,0
178515,does,0,0
178516,not,0,0
178517,improve,0,0
178518,clinically,0,0
178519,relevant,0,0
178520,parameters,0,0
178521,of,0,0
178522,embryo,0,0
178523,development,0,0
178524,or,0,1
178525,sustained,0,0
178526,implantation,0,0
178527,rates,0,0
178528,.,0,0
178529,CLINICAL,0,0
178530,TRIAL,0,0
178531,REGISTRATION,0,0
178532,NUMBER,0,0
178533,NCT01506089,0,0
178534,.,0,0
178535,Reducing,0,0
178536,the,0,0
178537,psychological,0,0
178538,distress,0,0
178539,of,0,0
178540,family,0,0
178541,caregivers,0,0
178542,of,0,0
178543,home,0,0
178544,based,0,0
178545,palliative,0,0
178546,care,0,0
178547,patients,0,0
178548,:,0,0
178549,longer,0,0
178550,term,0,0
178551,effects,0,0
178552,from,0,0
178553,a,0,0
178554,randomised,0,0
178555,controlled,0,0
178556,trial,0,0
178557,.,0,0
178558,BACKGROUND,0,0
178559,Palliative,0,0
178560,care,0,1
178561,incorporates,0,0
178562,comprehensive,0,0
178563,support,0,0
178564,of,0,0
178565,family,0,0
178566,caregivers,0,0
178567,because,0,0
178568,many,0,0
178569,of,0,0
178570,them,0,0
178571,experience,0,0
178572,burden,0,0
178573,and,0,0
178574,distress,0,0
178575,.,0,0
178576,However,0,0
178577,",",0,0
178578,evidence-based,0,1
178579,support,0,0
178580,initiatives,0,0
178581,are,0,0
178582,few,0,0
178583,.,0,0
178584,PURPOSE,0,0
178585,We,0,0
178586,evaluated,0,0
178587,a,0,0
178588,one-to-one,1,0
178589,psychoeducational,1,1
178590,intervention,0,1
178591,aimed,0,0
178592,at,0,0
178593,mitigating,0,0
178594,the,0,0
178595,distress,0,0
178596,of,0,0
178597,caregivers,0,0
178598,of,0,0
178599,patients,0,0
178600,with,0,0
178601,advanced,0,0
178602,cancer,0,0
178603,receiving,0,0
178604,home-based,0,1
178605,palliative,0,0
178606,care,0,0
178607,.,0,0
178608,We,0,0
178609,hypothesised,0,0
178610,that,0,0
178611,caregivers,0,0
178612,would,0,0
178613,report,0,0
178614,decreased,0,0
178615,distress,0,0
178616,as,0,0
178617,assessed,0,0
178618,by,0,0
178619,the,0,0
178620,General,0,1
178621,Health,0,1
178622,Questionnaire,0,1
178623,(,0,0
178624,GHQ,0,0
178625,),0,0
178626,.,0,0
178627,METHOD,0,0
178628,A,0,0
178629,randomised,0,0
178630,controlled,0,0
178631,trial,0,0
178632,comparing,0,0
178633,two,1,0
178634,versions,1,0
178635,of,1,0
178636,the,1,0
178637,delivery,1,0
178638,of,1,0
178639,the,1,0
178640,intervention,1,1
178641,(,1,0
178642,one,1,0
178643,face-to-face,1,1
178644,home,1,1
178645,visit,1,0
178646,plus,1,1
178647,telephone,1,1
178648,calls,1,0
178649,versus,1,0
178650,two,1,0
178651,visits,1,0
178652,),1,0
178653,plus,1,1
178654,standard,1,1
178655,care,1,1
178656,to,1,0
178657,a,1,0
178658,control,1,1
178659,group,1,0
178660,(,1,0
178661,standard,1,1
178662,care,1,1
178663,only,1,0
178664,),1,0
178665,across,0,0
178666,four,0,0
178667,sites,0,0
178668,in,0,0
178669,Australia,0,0
178670,.,0,0
178671,RESULTS,0,0
178672,Recruitment,0,0
178673,to,0,0
178674,the,0,0
178675,one,0,0
178676,visit,0,0
178677,condition,0,0
178678,was,0,0
178679,57,0,0
178680,",",0,0
178681,the,0,0
178682,two,0,0
178683,visit,0,0
178684,condition,0,0
178685,93,0,0
178686,",",0,0
178687,and,0,0
178688,the,0,0
178689,control,0,0
178690,148,0,0
178691,.,0,0
178692,We,0,0
178693,previously,0,0
178694,reported,0,0
178695,non-significant,0,0
178696,changes,0,0
178697,in,0,0
178698,distress,0,0
178699,between,0,0
178700,times,0,0
178701,1,0,0
178702,(,0,0
178703,baseline,0,0
178704,),0,0
178705,and,0,0
178706,2,0,0
178707,(,0,0
178708,1-week,0,0
178709,post-intervention,0,1
178710,),0,0
178711,but,0,0
178712,significant,0,0
178713,gains,0,0
178714,in,0,0
178715,competence,0,0
178716,and,0,0
178717,preparedness,0,0
178718,.,0,0
178719,We,0,0
178720,report,0,0
178721,here,0,0
178722,changes,0,0
178723,in,0,0
178724,distress,0,0
178725,between,0,0
178726,times,0,0
178727,1,0,0
178728,and,0,0
178729,3,0,0
178730,(,0,0
178731,8-week,0,1
178732,post-death,0,0
178733,),0,0
178734,.,0,0
178735,There,0,0
178736,was,0,0
178737,significantly,0,0
178738,less,0,0
178739,worsening,0,0
178740,in,0,0
178741,distress,0,0
178742,between,0,0
178743,times,0,0
178744,1,0,0
178745,and,0,0
178746,3,0,0
178747,in,0,0
178748,the,0,0
178749,one,0,0
178750,visit,0,0
178751,intervention,0,1
178752,group,0,0
178753,than,0,0
178754,in,0,0
178755,the,0,0
178756,control,0,0
178757,group,0,0
178758,;,0,0
178759,however,0,0
178760,",",0,0
178761,no,0,0
178762,significant,0,0
178763,difference,0,0
178764,was,0,0
178765,found,0,0
178766,between,0,0
178767,the,0,0
178768,two,0,0
178769,visit,0,0
178770,intervention,0,1
178771,and,0,0
178772,the,0,0
178773,control,0,0
178774,group,0,0
178775,.,0,0
178776,CONCLUSIONS,0,0
178777,These,0,0
178778,results,0,0
178779,are,0,0
178780,consistent,0,0
178781,with,0,0
178782,the,0,0
178783,aim,0,0
178784,of,0,0
178785,the,0,0
178786,intervention,0,1
178787,",",0,0
178788,and,0,0
178789,they,0,0
178790,support,0,0
178791,existing,0,0
178792,evidence,0,0
178793,demonstrating,0,0
178794,that,0,0
178795,relatively,0,0
178796,short,0,0
178797,psychoeducational,0,1
178798,interventions,0,0
178799,can,0,0
178800,help,0,0
178801,family,0,0
178802,caregivers,0,0
178803,who,0,0
178804,are,0,0
178805,supporting,0,0
178806,a,0,0
178807,dying,0,0
178808,relative,0,0
178809,.,0,0
178810,The,0,0
178811,sustained,0,0
178812,benefit,0,0
178813,during,0,0
178814,the,0,0
178815,bereavement,0,0
178816,period,0,0
178817,may,0,0
178818,also,0,0
178819,have,0,0
178820,positive,0,0
178821,resource,0,0
178822,implications,0,0
178823,",",0,0
178824,which,0,0
178825,should,0,0
178826,be,0,0
178827,the,0,0
178828,subject,0,0
178829,of,0,0
178830,future,0,0
178831,inquiry,0,0
178832,.,0,0
178833,Prior,0,0
178834,experience,0,0
178835,with,0,0
178836,a,0,0
178837,pain,0,0
178838,stimulus,0,0
178839,as,0,0
178840,a,0,0
178841,predictor,0,0
178842,of,0,0
178843,placebo,0,1
178844,analgesia,0,0
178845,.,0,0
178846,Placebo,1,1
178847,effects,0,0
178848,are,0,0
178849,important,0,0
178850,in,0,0
178851,pain,0,0
178852,reduction,0,0
178853,",",0,0
178854,but,0,0
178855,the,0,0
178856,effects,0,0
178857,are,0,0
178858,inconsistent,0,0
178859,.,0,0
178860,Prior,0,0
178861,experience,0,0
178862,with,0,0
178863,a,0,0
178864,pain,0,0
178865,stimulus,0,0
178866,may,0,0
178867,moderate,0,0
178868,placebo,0,1
178869,analgesia,0,0
178870,.,0,0
178871,The,0,0
178872,current,0,0
178873,study,0,0
178874,tests,0,0
178875,the,0,0
178876,effect,0,0
178877,of,0,0
178878,prior,0,0
178879,experience,0,0
178880,with,0,0
178881,a,0,0
178882,pain,0,0
178883,stimulus,0,0
178884,on,0,0
178885,placebo,0,1
178886,analgesia,0,0
178887,during,0,0
178888,a,0,0
178889,laboratory,0,0
178890,pain,0,0
178891,task,0,1
178892,.,0,0
178893,Healthy,0,0
178894,normotensive,0,0
178895,undergraduates,0,0
178896,(,0,0
178897,66,0,0
178898,women,0,0
178899,",",0,0
178900,68,0,0
178901,men,0,0
178902,),0,0
178903,who,0,0
178904,either,0,0
178905,did,0,0
178906,or,0,0
178907,did,0,0
178908,not,0,0
178909,report,0,0
178910,prior,0,0
178911,experience,0,0
178912,with,0,0
178913,pain,0,0
178914,from,0,0
178915,submerging,0,1
178916,a,0,0
178917,limb,0,0
178918,in,0,0
178919,cold,0,1
178920,water,0,1
178921,were,0,0
178922,enrolled,0,0
178923,.,0,0
178924,In,0,0
178925,the,0,0
178926,laboratory,0,0
178927,",",0,0
178928,an,0,0
178929,experimenter,0,0
178930,applied,0,0
178931,an,0,0
178932,inert,0,0
178933,",",0,0
178934,medicinal-smelling,1,0
178935,cream,1,1
178936,to,0,0
178937,participants,0,0
178938,',0,0
178939,non-dominant,0,0
178940,hand,0,0
178941,.,0,0
178942,Participants,0,0
178943,randomized,0,0
178944,to,0,0
178945,the,0,0
178946,no-expectation,0,0
178947,group,0,0
178948,were,0,0
178949,told,0,0
178950,that,0,0
178951,the,0,0
178952,cream,1,1
178953,was,1,0
178954,a,1,0
178955,hand,1,0
178956,cleanser,1,1
178957,.,1,0
178958,Participants,0,0
178959,randomized,0,0
178960,to,0,0
178961,the,0,0
178962,placebo,1,1
178963,expectation,0,0
178964,group,0,0
178965,were,0,0
178966,told,0,0
178967,that,0,0
178968,the,0,0
178969,cream,1,1
178970,would,0,0
178971,reduce,0,0
178972,the,0,0
178973,pain,0,0
178974,associated,0,0
178975,with,0,0
178976,the,0,0
178977,cold,1,1
178978,pressor,1,0
178979,task,1,1
178980,.,1,0
178981,Participants,0,0
178982,then,0,0
178983,completed,0,0
178984,the,0,0
178985,cold,1,1
178986,pressor,1,1
178987,task,1,1
178988,and,0,0
178989,reported,0,0
178990,their,0,0
178991,pain,0,0
178992,on,0,0
178993,the,0,0
178994,short,0,0
178995,form,0,0
178996,of,0,0
178997,the,0,0
178998,McGill,0,0
178999,Pain,0,0
179000,Questionnaire,0,0
179001,.,0,0
179002,Analysis,0,0
179003,of,0,0
179004,variance,0,0
179005,revealed,0,0
179006,a,0,0
179007,main,0,0
179008,effect,0,0
179009,of,0,0
179010,expectation,0,0
179011,(,0,0
179012,p,0,0
179013,<,0,0
179014,.05,0,0
179015,),0,0
179016,",",0,0
179017,such,0,0
179018,that,0,0
179019,participants,0,0
179020,in,0,0
179021,the,0,0
179022,placebo,0,1
179023,expectation,0,0
179024,group,0,0
179025,reported,0,0
179026,less,0,0
179027,pain,0,0
179028,.,0,0
179029,An,0,0
179030,interaction,0,0
179031,was,0,0
179032,also,0,0
179033,found,0,0
179034,between,0,0
179035,expectation,0,0
179036,and,0,0
179037,prior,0,0
179038,experience,0,0
179039,(,0,0
179040,p,0,0
179041,<,0,0
179042,.05,0,0
179043,),0,0
179044,",",0,0
179045,such,0,0
179046,that,0,0
179047,participants,0,0
179048,with,0,0
179049,prior,0,0
179050,experience,0,0
179051,with,0,0
179052,pain,0,0
179053,from,0,0
179054,cold,0,1
179055,water,0,1
179056,immersion,0,0
179057,showed,0,0
179058,no,0,0
179059,difference,0,0
179060,in,0,0
179061,pain,0,0
179062,reports,0,0
179063,between,0,0
179064,expectation,0,0
179065,groups,0,0
179066,.,0,0
179067,In,0,0
179068,a,0,0
179069,pain,0,0
179070,context,0,0
179071,",",0,0
179072,prior,0,0
179073,experience,0,0
179074,with,0,0
179075,the,0,0
179076,pain,0,0
179077,stimulus,0,0
179078,may,0,0
179079,prevent,1,0
179080,a,1,0
179081,placebo,1,1
179082,expectation,1,0
179083,from,0,0
179084,reducing,0,0
179085,the,0,0
179086,experience,0,0
179087,of,0,0
179088,pain,0,0
179089,.,0,0
179090,A,0,0
179091,comparison,0,0
179092,of,0,0
179093,multiphasic,1,0
179094,oral,1,1
179095,contraceptives,1,1
179096,containing,1,1
179097,norgestimate,1,1
179098,or,1,1
179099,desogestrel,1,1
179100,in,0,0
179101,acne,0,0
179102,treatment,0,0
179103,:,0,0
179104,a,0,0
179105,randomized,0,0
179106,trial,0,0
179107,.,0,0
179108,OBJECTIVE,0,0
179109,This,0,0
179110,study,0,0
179111,aimed,0,0
179112,to,0,0
179113,compare,0,0
179114,the,0,0
179115,effectiveness,0,0
179116,and,0,0
179117,safety,0,0
179118,of,0,0
179119,triphasic,1,0
179120,combined,1,0
179121,oral,1,1
179122,contraceptives,1,1
179123,(,1,0
179124,OCs,1,1
179125,),1,0
179126,containing,1,1
179127,ethinyl,1,1
179128,estradiol,1,1
179129,(,1,0
179130,EE,1,1
179131,),1,1
179132,and,1,0
179133,norgestimate,1,1
179134,(,1,0
179135,NGM,1,0
179136,),1,1
179137,and,0,0
179138,biphasic,1,0
179139,combined,1,1
179140,OCs,1,1
179141,containing,1,1
179142,EE,1,0
179143,and,1,0
179144,desogestrel,1,1
179145,(,1,1
179146,DSG,1,0
179147,),1,0
179148,in,0,0
179149,the,0,0
179150,treatment,0,0
179151,of,0,0
179152,mild,0,0
179153,to,0,0
179154,moderate,0,0
179155,acne,0,0
179156,.,0,0
179157,STUDY,0,0
179158,DESIGN,0,0
179159,This,0,0
179160,was,0,0
179161,an,0,0
179162,investigator-blinded,0,0
179163,",",0,0
179164,randomized,0,0
179165,",",0,0
179166,parallel,0,0
179167,group,0,0
179168,trial,0,0
179169,conducted,0,0
179170,at,0,0
179171,3,0,0
179172,centers,0,0
179173,in,0,0
179174,Thailand,0,0
179175,.,0,0
179176,Female,0,0
179177,subjects,0,0
179178,18-45,0,0
179179,years,0,0
179180,old,0,0
179181,were,0,0
179182,assigned,0,0
179183,to,0,0
179184,one,0,0
179185,or,0,0
179186,the,0,0
179187,other,0,0
179188,OCs,0,1
179189,and,0,0
179190,evaluated,0,0
179191,for,0,0
179192,efficacy,0,0
179193,and,0,0
179194,safety,0,0
179195,parameters,0,0
179196,at,0,0
179197,the,0,0
179198,baseline,0,0
179199,visit,0,0
179200,and,0,0
179201,after,0,0
179202,1,0,0
179203,",",0,0
179204,3,0,0
179205,and,0,0
179206,6,0,0
179207,months,0,0
179208,of,0,0
179209,treatment,0,0
179210,.,0,0
179211,RESULTS,0,0
179212,Among,0,0
179213,201,0,0
179214,randomized,0,0
179215,subjects,0,0
179216,",",0,0
179217,data,0,0
179218,from,0,0
179219,93,0,0
179220,subjects,0,0
179221,in,0,0
179222,the,0,0
179223,EE/NGM,1,0
179224,group,0,0
179225,and,0,0
179226,95,0,0
179227,subjects,0,0
179228,in,0,0
179229,the,0,0
179230,EE/DSG,1,0
179231,group,0,0
179232,were,0,0
179233,analyzed,0,0
179234,.,0,0
179235,After,0,0
179236,6,0,0
179237,months,0,0
179238,of,0,0
179239,treatment,0,0
179240,with,0,0
179241,EE/NGM,1,0
179242,and,1,0
179243,EE/DSG,1,0
179244,",",0,0
179245,no,0,0
179246,differences,0,0
179247,between,0,0
179248,formulations,0,0
179249,were,0,0
179250,found,0,0
179251,for,0,0
179252,the,0,0
179253,decrease,0,0
179254,in,0,0
179255,total,0,0
179256,acne,0,0
179257,lesion,0,0
179258,counts,0,0
179259,(,0,0
179260,74.4,0,0
179261,%,0,0
179262,vs.,0,0
179263,65.1,0,0
179264,%,0,0
179265,",",0,0
179266,respectively,0,0
179267,",",0,0
179268,p=.070,0,0
179269,),0,0
179270,or,0,1
179271,facial,0,0
179272,improvement,0,0
179273,score,0,0
179274,.,0,0
179275,More,0,0
179276,women,0,0
179277,using,0,0
179278,EE/NGM,1,0
179279,showed,0,0
179280,a,0,0
179281,decrease,0,0
179282,in,0,0
179283,severity,0,0
179284,of,0,0
179285,facial,0,0
179286,seborrhea,0,0
179287,than,0,0
179288,those,0,0
179289,using,0,0
179290,EE/DSG,1,0
179291,(,0,1
179292,p=.005,0,0
179293,),0,0
179294,.,0,0
179295,No,0,0
179296,changes,0,0
179297,in,0,0
179298,weight,0,0
179299,were,0,0
179300,noted,0,0
179301,in,0,0
179302,either,0,0
179303,group,0,0
179304,as,0,0
179305,compared,0,0
179306,to,0,0
179307,baseline,0,0
179308,.,0,0
179309,CONCLUSION,0,0
179310,Multiphasic,0,1
179311,OCs,1,1
179312,containing,0,1
179313,EE/NGM,1,0
179314,and,1,0
179315,EE/DSG,1,0
179316,provided,0,0
179317,comparable,0,0
179318,efficacy,0,0
179319,and,0,0
179320,tolerability,0,0
179321,in,0,0
179322,the,0,0
179323,treatment,0,0
179324,of,0,0
179325,acne,0,0
179326,.,0,0
179327,However,0,0
179328,",",0,0
179329,EE/NGM,1,0
179330,had,0,0
179331,a,0,0
179332,more,0,0
179333,beneficial,0,0
179334,effect,0,0
179335,on,0,0
179336,facial,0,0
179337,seborrhea,0,0
179338,reduction,0,0
179339,than,0,0
179340,EE/DSG,1,0
179341,.,1,0
179342,IMPLICATIONS,0,0
179343,EE/NGM,1,0
179344,and,1,0
179345,EE/DSG,1,0
179346,are,0,0
179347,multiphasic,1,0
179348,OCs,1,1
179349,",",0,0
179350,which,0,0
179351,were,0,0
179352,shown,0,0
179353,to,0,0
179354,be,0,0
179355,clinically,0,0
179356,equally,0,0
179357,effective,0,0
179358,for,0,0
179359,mild,0,0
179360,to,0,0
179361,moderate,0,0
179362,facial,0,0
179363,acne,0,0
179364,",",0,0
179365,and,0,0
179366,the,0,0
179367,multiphasic,0,0
179368,combined,0,0
179369,OC,0,0
179370,with,0,0
179371,NGM,0,0
179372,was,0,0
179373,more,0,0
179374,effective,0,0
179375,for,0,0
179376,women,0,0
179377,with,0,0
179378,facial,0,0
179379,seborrhea,0,0
179380,.,0,0
179381,Clinicians,0,0
179382,may,0,0
179383,apply,0,0
179384,the,0,0
179385,results,0,0
179386,of,0,0
179387,this,0,0
179388,study,0,0
179389,when,0,0
179390,considering,0,0
179391,treatment,0,0
179392,options,0,0
179393,for,0,0
179394,facial,0,0
179395,acne,0,0
179396,and,0,0
179397,seborrhea,0,0
179398,.,0,0
179399,Gene,0,1
179400,variants,0,0
179401,in,0,0
179402,CYP2C19,0,0
179403,are,0,0
179404,associated,0,0
179405,with,0,0
179406,altered,0,0
179407,in,0,0
179408,vivo,0,0
179409,bupropion,1,1
179410,pharmacokinetics,0,0
179411,but,0,0
179412,not,0,0
179413,bupropion-assisted,0,1
179414,smoking,0,0
179415,cessation,0,1
179416,outcomes,0,0
179417,.,0,0
179418,Bupropion,1,0
179419,is,0,0
179420,used,0,0
179421,clinically,0,0
179422,to,0,0
179423,treat,0,0
179424,depression,0,0
179425,and,0,0
179426,to,0,0
179427,promote,0,0
179428,smoking,0,0
179429,cessation,0,1
179430,.,0,0
179431,It,0,0
179432,is,0,0
179433,metabolized,0,0
179434,by,0,0
179435,CYP2B6,0,0
179436,to,0,0
179437,its,0,0
179438,active,0,0
179439,metabolite,0,0
179440,hydroxybupropion,0,1
179441,",",0,0
179442,yet,0,0
179443,alterations,0,0
179444,in,0,0
179445,CYP2B6,0,0
179446,activity,0,0
179447,have,0,0
179448,little,0,0
179449,impact,0,0
179450,on,0,0
179451,bupropion,0,1
179452,plasma,0,0
179453,levels,0,0
179454,.,0,0
179455,Furthermore,0,0
179456,",",0,0
179457,less,0,0
179458,than,0,0
179459,10,0,0
179460,%,0,0
179461,of,0,0
179462,a,0,0
179463,bupropion,1,1
179464,dose,0,0
179465,is,0,0
179466,excreted,0,0
179467,as,0,0
179468,urinary,0,0
179469,bupropion,1,1
179470,and,0,0
179471,its,0,0
179472,characterized,0,0
179473,metabolites,0,0
179474,hydroxybupropion,0,1
179475,",",0,0
179476,threohydrobupropion,0,0
179477,",",0,0
179478,and,0,0
179479,erythrohydrobupropion,0,1
179480,",",0,0
179481,suggesting,0,0
179482,that,0,0
179483,alternative,0,0
179484,metabolic,0,0
179485,pathways,0,0
179486,may,0,0
179487,exist,0,0
179488,.,0,0
179489,In,0,0
179490,vitro,0,0
179491,data,0,0
179492,suggested,0,0
179493,CYP2C19,0,0
179494,could,0,0
179495,metabolize,0,0
179496,bupropion,1,1
179497,.,1,0
179498,The,0,0
179499,current,0,0
179500,study,0,0
179501,investigated,0,0
179502,the,0,0
179503,impact,0,0
179504,of,0,0
179505,functional,0,0
179506,CYP2C19,0,0
179507,genetic,0,0
179508,variants,0,0
179509,on,0,0
179510,bupropion,0,1
179511,pharmacokinetics,0,0
179512,and,0,0
179513,treatment,0,0
179514,outcomes,0,0
179515,.,0,0
179516,In,0,0
179517,42,0,0
179518,healthy,0,0
179519,volunteers,0,0
179520,",",0,0
179521,CYP2C19*2,0,0
179522,(,0,0
179523,a,0,0
179524,reduced,0,0
179525,activity,0,0
179526,allele,0,0
179527,),0,0
179528,was,0,0
179529,associated,0,0
179530,with,0,0
179531,higher,0,0
179532,bupropion,1,1
179533,area,0,0
179534,under,0,0
179535,the,0,0
179536,plasma,0,0
179537,concentration-time,0,0
179538,curve,0,0
179539,(,0,0
179540,AUC,0,0
179541,),0,0
179542,",",0,0
179543,but,0,0
179544,similar,0,0
179545,hydroxybupropion,0,1
179546,AUC,0,0
179547,.,0,0
179548,The,0,0
179549,mean,0,0
179550,bupropion,0,1
179551,AUC,0,0
179552,was,0,0
179553,771,0,0
179554,versus,0,0
179555,670,0,0
179556,hours?ng/ml,0,0
179557,in,0,0
179558,individuals,0,0
179559,with,0,0
179560,and,0,0
179561,without,0,0
179562,CYP2C19*2,0,0
179563,",",0,0
179564,respectively,0,0
179565,(,0,0
179566,P,0,0
179567,=,0,0
179568,0.017,0,0
179569,),0,0
179570,.,0,0
179571,CYP2C19*2,0,0
179572,was,0,0
179573,also,0,0
179574,associated,0,0
179575,with,0,0
179576,higher,0,0
179577,threohydrobupropion,0,0
179578,and,0,0
179579,erythrohydrobupropion,0,1
179580,AUC,0,1
179581,(,0,0
179582,P,0,0
179583,<,0,0
179584,0.005,0,0
179585,),0,0
179586,.,0,0
179587,Adjusting,0,0
179588,for,0,0
179589,CYP2B6,0,0
179590,genotype,0,0
179591,did,0,0
179592,not,0,0
179593,alter,0,0
179594,these,0,0
179595,associations,0,0
179596,",",0,0
179597,and,0,0
179598,CYP2C19,0,0
179599,variants,0,0
179600,did,0,0
179601,not,0,0
179602,alter,0,0
179603,the,0,0
179604,utility,0,0
179605,of,0,0
179606,the,0,0
179607,hydroxybupropion/bupropion,0,1
179608,ratio,0,0
179609,as,0,0
179610,a,0,0
179611,measure,0,0
179612,of,0,0
179613,CYP2B6,0,0
179614,activity,0,0
179615,.,0,0
179616,Finally,0,0
179617,",",0,0
179618,in,0,0
179619,a,0,0
179620,clinical,0,0
179621,trial,0,0
179622,of,0,0
179623,540,0,0
179624,smokers,0,0
179625,",",0,0
179626,CYP2C19,0,0
179627,genotype,0,0
179628,was,0,0
179629,not,0,0
179630,associated,0,0
179631,with,0,0
179632,smoking,0,0
179633,cessation,0,1
179634,outcomes,0,0
179635,",",0,0
179636,supporting,0,0
179637,the,0,0
179638,hypothesis,0,0
179639,that,1,0
179640,bupropion,1,1
179641,response,1,0
179642,is,0,0
179643,mediated,0,0
179644,by,0,0
179645,hydroxybupropion,0,1
179646,",",0,0
179647,which,0,0
179648,is,0,0
179649,not,0,0
179650,altered,0,0
179651,by,0,0
179652,CYP2C19,0,0
179653,.,0,0
179654,In,0,0
179655,conclusion,0,0
179656,",",0,0
179657,our,0,0
179658,study,0,0
179659,reports,0,0
179660,the,0,0
179661,first,0,0
179662,in,0,0
179663,vivo,0,0
179664,evidence,0,0
179665,that,0,0
179666,reduced,0,0
179667,CYP2C19,0,0
179668,activity,0,0
179669,significantly,0,0
179670,increases,0,0
179671,the,0,0
179672,steady-state,0,0
179673,exposure,0,0
179674,to,0,0
179675,bupropion,1,1
179676,and,1,0
179677,its,0,0
179678,reductive,0,1
179679,metabolites,0,0
179680,threohydrobupropion,0,0
179681,and,0,0
179682,erythrohydrobupropion,0,1
179683,.,0,0
179684,These,0,0
179685,pharmacokinetic,0,0
179686,changes,0,0
179687,were,0,0
179688,not,0,0
179689,associated,0,0
179690,with,0,0
179691,differences,0,0
179692,in,0,0
179693,bupropion,0,1
179694,'s,0,0
179695,ability,0,0
179696,to,0,0
179697,promote,0,0
179698,smoking,0,0
179699,cessation,0,1
179700,in,0,0
179701,smokers,0,1
179702,",",0,0
179703,but,0,0
179704,may,0,0
179705,influence,0,0
179706,the,0,0
179707,side,0,0
179708,effects,0,0
179709,and,0,0
179710,toxicity,0,0
179711,associated,0,0
179712,with,1,0
179713,bupropion,1,1
179714,.,1,0
179715,Safety,0,0
179716,",",0,0
179717,pharmacokinetics,0,0
179718,",",0,0
179719,pharmacogenomics,0,0
179720,and,0,0
179721,QT,0,0
179722,concentration-effect,0,0
179723,modelling,0,0
179724,of,0,0
179725,the,0,0
179726,SirT1,1,1
179727,inhibitor,1,1
179728,selisistat,1,1
179729,in,0,0
179730,healthy,0,0
179731,volunteers,0,0
179732,.,0,0
179733,AIM,0,0
179734,Selisistat,1,1
179735,(,1,0
179736,SEN0014196,1,0
179737,),1,0
179738,",",1,0
179739,a,1,0
179740,first-in-class,1,0
179741,SirT1,1,1
179742,inhibitor,1,1
179743,",",0,0
179744,is,0,0
179745,being,0,0
179746,developed,0,0
179747,as,0,0
179748,a,0,0
179749,disease-modifying,0,1
179750,therapy,0,1
179751,for,0,0
179752,Huntington,0,0
179753,'s,0,0
179754,disease,0,0
179755,.,0,0
179756,This,0,0
179757,first-in-human,0,0
179758,study,0,0
179759,investigated,0,0
179760,the,0,0
179761,safety,0,0
179762,",",0,0
179763,pharmacokinetics,0,0
179764,and,0,0
179765,pharmacogenomics,0,0
179766,of,0,0
179767,single,0,0
179768,and,0,0
179769,multiple,0,0
179770,doses,0,0
179771,of,0,0
179772,selisistat,1,1
179773,in,0,0
179774,healthy,0,0
179775,male,0,0
179776,and,0,0
179777,female,0,0
179778,subjects,0,0
179779,.,0,0
179780,METHOD,0,0
179781,In,0,0
179782,this,0,0
179783,double-blind,0,0
179784,",",0,0
179785,randomized,0,0
179786,",",0,0
179787,placebo-controlled,1,1
179788,study,0,0
179789,",",0,0
179790,seven,0,0
179791,cohorts,0,0
179792,of,0,0
179793,eight,0,0
179794,subjects,0,0
179795,received,0,0
179796,a,0,0
179797,single,0,0
179798,dose,0,0
179799,of,0,0
179800,selisistat,1,1
179801,at,0,0
179802,dose,0,0
179803,levels,0,0
179804,of,0,0
179805,5,0,0
179806,",",0,0
179807,25,0,0
179808,",",0,0
179809,75,0,0
179810,",",0,0
179811,150,0,0
179812,",",0,0
179813,300,0,0
179814,and,0,0
179815,600,0,0
179816,mg,0,1
179817,and,0,0
179818,four,0,0
179819,cohorts,0,0
179820,of,0,0
179821,eight,0,0
179822,subjects,0,0
179823,were,0,0
179824,administered,0,0
179825,100,0,0
179826,",",0,0
179827,200,0,0
179828,and,0,0
179829,300,0,1
179830,mg,0,0
179831,once,0,0
179832,daily,0,0
179833,for,0,0
179834,7,0,0
179835,days,0,0
179836,.,0,0
179837,Blood,0,0
179838,sampling,0,0
179839,and,0,0
179840,safety,0,0
179841,assessments,0,0
179842,were,0,0
179843,conducted,0,0
179844,throughout,0,0
179845,the,0,0
179846,study,0,0
179847,.,0,0
179848,RESULTS,0,0
179849,Selisistat,1,0
179850,was,0,0
179851,rapidly,0,0
179852,absorbed,0,0
179853,and,0,0
179854,systemic,0,0
179855,exposure,0,0
179856,increased,0,0
179857,in,0,0
179858,proportion,0,0
179859,to,0,0
179860,dose,0,0
179861,in,0,0
179862,the,0,0
179863,5-300,0,1
179864,mg,0,1
179865,range,0,0
179866,.,0,0
179867,Steady-state,0,0
179868,plasma,0,0
179869,concentrations,0,0
179870,were,0,0
179871,achieved,0,0
179872,within,0,0
179873,4,0,0
179874,days,0,0
179875,of,0,0
179876,repeated,0,0
179877,dosing,0,0
179878,.,0,0
179879,The,0,0
179880,incidence,0,0
179881,of,0,0
179882,drug,0,0
179883,related,0,0
179884,adverse,0,0
179885,events,0,0
179886,showed,0,0
179887,no,0,0
179888,correlation,0,0
179889,with,0,0
179890,dose,0,0
179891,level,0,0
179892,or,0,1
179893,number,0,0
179894,of,0,0
179895,doses,0,0
179896,received,0,0
179897,and,0,0
179898,was,0,0
179899,comparable,0,0
179900,with,0,0
179901,the,0,0
179902,placebo,1,1
179903,group,0,0
179904,.,0,0
179905,No,0,0
179906,serious,0,0
179907,adverse,0,0
179908,events,0,0
179909,were,0,0
179910,reported,0,0
179911,and,0,0
179912,no,0,0
179913,subjects,0,0
179914,were,0,0
179915,withdrawn,0,0
179916,due,0,0
179917,to,0,0
179918,adverse,0,0
179919,events,0,0
179920,.,0,0
179921,There,0,0
179922,were,0,0
179923,no,0,0
179924,trends,0,0
179925,in,0,0
179926,clinical,0,0
179927,laboratory,0,0
179928,parameters,0,0
179929,or,0,0
179930,vital,0,0
179931,signs,0,0
179932,.,0,0
179933,No,0,0
179934,trends,0,0
179935,in,0,0
179936,heart,0,0
179937,rate,0,0
179938,or,0,1
179939,ECG,0,0
179940,parameters,0,0
179941,",",0,0
179942,including,0,0
179943,the,0,0
179944,QTc,0,0
179945,interval,0,0
179946,and,0,0
179947,T-wave,0,1
179948,morphology,0,0
179949,",",0,0
179950,were,0,0
179951,observed,0,0
179952,.,0,0
179953,There,0,0
179954,were,0,0
179955,no,0,0
179956,findings,0,0
179957,in,0,0
179958,physical,0,0
179959,or,0,0
179960,neurological,0,0
179961,examinations,0,1
179962,or,0,0
179963,postural,0,0
179964,control,0,0
179965,.,0,0
179966,Transcriptional,0,0
179967,alteration,0,0
179968,was,0,0
179969,observed,0,0
179970,in,0,0
179971,peripheral,0,0
179972,blood,0,0
179973,.,0,0
179974,CONCLUSION,0,0
179975,Selisistat,1,0
179976,was,0,0
179977,safe,0,0
179978,and,0,0
179979,well,0,0
179980,tolerated,0,0
179981,by,0,0
179982,healthy,0,0
179983,male,0,0
179984,and,0,0
179985,female,0,0
179986,subjects,0,0
179987,after,0,0
179988,single,0,0
179989,doses,0,0
179990,up,0,0
179991,to,0,0
179992,600,0,0
179993,mg,0,1
179994,and,0,0
179995,multiple,0,0
179996,doses,0,0
179997,up,0,0
179998,to,0,0
179999,300,0,0
180000,mg,0,1
180001,day,0,0
180002,(,0,0
180003,-1,0,0
180004,),0,0
180005,.,0,0
180006,The,0,0
180007,REFLO-STEMI,0,0
180008,trial,0,0
180009,comparing,0,0
180010,intracoronary,1,1
180011,adenosine,1,1
180012,",",1,0
180013,sodium,1,1
180014,nitroprusside,1,1
180015,and,1,0
180016,standard,1,1
180017,therapy,1,1
180018,for,0,0
180019,the,0,0
180020,attenuation,0,0
180021,of,0,0
180022,infarct,0,0
180023,size,0,0
180024,and,0,0
180025,microvascular,0,0
180026,obstruction,0,0
180027,during,0,0
180028,primary,0,0
180029,percutaneous,0,1
180030,coronary,0,0
180031,intervention,0,1
180032,:,0,0
180033,study,0,0
180034,protocol,0,0
180035,for,0,0
180036,a,0,0
180037,randomised,0,0
180038,controlled,0,0
180039,trial,0,0
180040,.,0,0
180041,BACKGROUND,0,0
180042,Microvascular,0,0
180043,obstruction,0,0
180044,(,0,0
180045,MVO,0,1
180046,),0,0
180047,secondary,0,0
180048,to,0,0
180049,ischaemic-reperfusion,0,1
180050,injury,0,0
180051,is,0,0
180052,an,0,0
180053,important,0,0
180054,but,0,0
180055,underappreciated,0,0
180056,determinant,0,0
180057,of,0,0
180058,short-,0,0
180059,and,0,0
180060,longer-term,0,0
180061,outcome,0,0
180062,following,0,0
180063,percutaneous,1,1
180064,coronary,1,0
180065,intervention,1,1
180066,(,1,0
180067,PCI,1,1
180068,),1,0
180069,treatment,0,0
180070,of,0,0
180071,ST-elevation,0,0
180072,myocardial,0,0
180073,infarction,0,0
180074,(,0,0
180075,STEMI,0,0
180076,),0,0
180077,.,0,0
180078,Several,0,0
180079,small,0,0
180080,studies,0,0
180081,have,0,0
180082,demonstrated,0,0
180083,a,0,0
180084,reduction,0,0
180085,in,0,0
180086,the,0,0
180087,degree,0,0
180088,of,0,0
180089,MVO,0,1
180090,utilising,0,0
180091,a,0,0
180092,variety,0,0
180093,of,0,0
180094,vasoactive,1,1
180095,agents,1,0
180096,",",1,0
180097,with,1,0
180098,adenosine,1,1
180099,and,1,0
180100,sodium,1,1
180101,nitroprusside,1,1
180102,(,1,0
180103,SNP,1,1
180104,),1,0
180105,being,0,0
180106,most,0,0
180107,evaluated,0,0
180108,.,0,0
180109,However,0,0
180110,",",0,0
180111,the,0,0
180112,evidence,0,0
180113,base,0,0
180114,remains,0,0
180115,weak,0,0
180116,as,0,0
180117,the,0,0
180118,trials,0,0
180119,have,0,0
180120,had,0,0
180121,variable,0,0
180122,endpoints,0,0
180123,",",0,0
180124,differing,0,0
180125,drug,0,0
180126,doses,0,0
180127,and,0,0
180128,delivery,0,0
180129,.,0,0
180130,As,0,0
180131,such,0,0
180132,",",0,0
180133,the,0,0
180134,results,0,0
180135,regarding,0,0
180136,benefit,0,0
180137,are,0,0
180138,conflicting,0,0
180139,.,0,0
180140,METHODS,0,0
180141,The,0,0
180142,REperfusion,0,0
180143,Facilitated,0,0
180144,by,0,0
180145,LOcal,1,0
180146,adjunctive,1,1
180147,therapy,1,1
180148,in,1,0
180149,STEMI,1,0
180150,(,1,0
180151,REFLO-STEMI,1,0
180152,),1,0
180153,trial,0,0
180154,is,0,0
180155,a,0,0
180156,multicentre,0,0
180157,",",0,0
180158,prospective,0,0
180159,",",0,0
180160,randomised,0,0
180161,",",0,0
180162,controlled,0,0
180163,",",0,0
180164,open,0,0
180165,label,0,0
180166,",",0,0
180167,study,0,0
180168,with,0,0
180169,blinded,0,0
180170,endpoint,0,0
180171,analysis,0,0
180172,:,0,0
180173,Patients,0,0
180174,presenting,0,0
180175,within,0,0
180176,6,0,0
180177,h,0,0
180178,of,0,0
180179,onset,0,0
180180,of,0,0
180181,STEMI,0,0
180182,and,0,0
180183,undergoing,0,0
180184,planned,0,0
180185,primary,0,0
180186,PCI,0,1
180187,(,0,0
180188,P-PCI,0,1
180189,),0,0
180190,with,0,0
180191,TIMI,0,1
180192,0/1,0,0
180193,flow,0,0
180194,in,0,0
180195,the,0,0
180196,infarct-related,0,0
180197,artery,0,0
180198,(,0,0
180199,IRA,0,1
180200,),0,0
180201,and,0,0
180202,no,0,0
180203,significant,0,0
180204,bystander,0,0
180205,coronary,0,0
180206,artery,0,0
180207,disease,0,0
180208,on,0,0
180209,angiography,1,1
180210,",",0,0
180211,are,0,0
180212,randomised,0,0
180213,into,0,0
180214,one,0,0
180215,of,0,0
180216,three,0,0
180217,groups,0,0
180218,:,0,0
180219,PCI,0,0
180220,with,0,0
180221,adjunctive,0,1
180222,pharmacotherapy,0,1
180223,(,0,0
180224,intracoronary,0,1
180225,adenosine,0,1
180226,or,0,1
180227,SNP,0,1
180228,),0,1
180229,or,0,1
180230,control,0,1
180231,(,0,0
180232,standard,0,1
180233,PCI,0,1
180234,),0,0
180235,.,0,0
180236,All,0,0
180237,receive,0,0
180238,Bivalirudin,1,1
180239,anticoagulation,1,1
180240,and,1,0
180241,thrombus,1,0
180242,aspiration,1,0
180243,.,1,0
180244,The,0,0
180245,primary,0,0
180246,outcome,0,0
180247,is,0,0
180248,infarct,0,0
180249,size,0,0
180250,(,0,0
180251,IS,0,1
180252,),0,1
180253,(,0,0
180254,determined,0,0
180255,as,0,0
180256,a,0,0
180257,percentage,0,0
180258,of,0,0
180259,total,0,0
180260,left,0,0
180261,ventricular,0,0
180262,mass,0,0
180263,),0,0
180264,measured,0,0
180265,by,0,0
180266,cardiac,0,0
180267,magnetic,0,1
180268,resonance,0,1
180269,imaging,0,1
180270,(,0,0
180271,CMRI,0,1
180272,),0,0
180273,undertaken,0,0
180274,at,0,0
180275,48,0,0
180276,to,0,0
180277,72,0,0
180278,h,0,0
180279,post,0,0
180280,P-PCI,0,0
180281,.,0,0
180282,Secondary,0,0
180283,outcome,0,0
180284,measures,0,0
180285,include,0,0
180286,MVO,0,1
180287,(,0,0
180288,hypoenhancement,0,0
180289,within,0,0
180290,infarct,0,0
180291,core,0,0
180292,),0,0
180293,on,0,0
180294,CMRI,0,1
180295,",",0,0
180296,angiographic,0,0
180297,markers,0,0
180298,of,0,0
180299,microvascular,0,0
180300,perfusion,0,0
180301,and,0,0
180302,MACE,0,0
180303,during,0,0
180304,1-month,0,0
180305,follow-up,0,0
180306,.,0,0
180307,The,0,0
180308,study,0,0
180309,aims,0,0
180310,to,0,0
180311,recruit,0,0
180312,240,0,0
180313,patients,0,0
180314,(,0,0
180315,powered,0,0
180316,at,0,0
180317,80,0,0
180318,%,0,0
180319,to,0,0
180320,detect,0,0
180321,a,0,0
180322,5,0,0
180323,%,0,0
180324,absolute,0,0
180325,reduction,0,0
180326,in,0,0
180327,IS,0,1
180328,),0,0
180329,.,0,0
180330,DISCUSSION,0,0
180331,The,0,0
180332,REFLO-STEMI,0,0
180333,study,0,0
180334,has,0,0
180335,been,0,0
180336,designed,0,0
180337,to,0,0
180338,address,0,0
180339,the,0,0
180340,weaknesses,0,0
180341,of,0,0
180342,previous,0,0
180343,trials,0,0
180344,",",0,0
180345,which,0,0
180346,have,0,0
180347,collectively,0,0
180348,failed,0,0
180349,to,0,0
180350,demonstrate,0,0
180351,whether,0,0
180352,adjunctive,1,1
180353,pharmacotherapy,1,1
180354,with,0,0
180355,adenosine,0,1
180356,and/or,0,0
180357,SNP,0,1
180358,can,0,0
180359,reduce,0,0
180360,measures,0,0
180361,of,0,0
180362,myocardial,0,0
180363,injury,0,0
180364,(,0,0
180365,infarct,0,0
180366,size,0,0
180367,and,0,0
180368,MVO,0,1
180369,),0,0
180370,and,0,0
180371,improve,0,0
180372,clinical,0,0
180373,outcome,0,0
180374,",",0,0
180375,despite,0,0
180376,good,0,0
180377,basic,0,1
180378,evidence,0,0
180379,that,0,0
180380,they,0,0
180381,have,0,0
180382,the,0,0
180383,potential,0,0
180384,to,0,0
180385,attenuate,0,0
180386,this,0,0
180387,process,0,0
180388,.,0,0
180389,The,0,0
180390,REFLO-STEMI,0,0
180391,study,0,0
180392,will,0,0
180393,be,0,0
180394,the,0,0
180395,most,0,0
180396,scientifically,0,0
180397,robust,0,0
180398,trial,0,0
180399,to,0,0
180400,date,0,0
180401,evaluating,0,0
180402,whether,0,0
180403,adjunctive,1,1
180404,therapy,1,1
180405,(,1,0
180406,intracoronary,1,1
180407,adenosine,1,1
180408,or,1,1
180409,SNP,1,1
180410,following,1,0
180411,thrombus,1,0
180412,aspiration,1,1
180413,),1,0
180414,reduces,0,0
180415,CMRI,0,0
180416,measured,0,0
180417,IS,0,1
180418,and,0,0
180419,MVO,0,1
180420,in,0,0
180421,patients,0,0
180422,undergoing,0,0
180423,P-PCI,0,0
180424,within,0,0
180425,6,0,0
180426,h,0,0
180427,of,0,0
180428,onset,0,0
180429,of,0,0
180430,STEMI,0,0
180431,.,0,0
180432,TRIAL,0,0
180433,REGISTRATION,0,0
180434,Trial,0,0
180435,registered,0,0
180436,20th,0,0
180437,November,0,0
180438,2012,0,0
180439,:,0,0
180440,ClinicalTrials.gov,0,0
180441,Identifier,0,0
180442,NCT01747174,0,0
180443,.,0,0
180444,Effects,0,0
180445,of,0,0
180446,aerobic,1,0
180447,exercise,1,1
180448,on,0,0
180449,cognition,0,0
180450,and,0,0
180451,hippocampal,0,0
180452,volume,0,0
180453,in,0,0
180454,Alzheimer,0,0
180455,'s,0,0
180456,disease,0,0
180457,:,0,0
180458,study,0,0
180459,protocol,0,0
180460,of,0,0
180461,a,0,0
180462,randomized,0,0
180463,controlled,0,0
180464,trial,0,0
180465,(,0,0
180466,The,0,0
180467,FIT-AD,0,0
180468,trial,0,0
180469,),0,0
180470,.,0,0
180471,BACKGROUND,0,0
180472,Alzheimer,0,0
180473,'s,0,0
180474,disease,0,0
180475,",",0,0
180476,a,0,0
180477,global,0,0
180478,public,0,0
180479,health,0,0
180480,issue,0,0
180481,",",0,0
180482,accounts,0,0
180483,for,0,0
180484,60,0,0
180485,to,0,0
180486,80,0,0
180487,%,0,0
180488,of,0,0
180489,all,0,0
180490,dementias,0,0
180491,.,0,0
180492,Alzheimer,0,0
180493,'s,0,0
180494,disease,0,0
180495,primarily,0,0
180496,causes,0,0
180497,cognitive,0,0
180498,impairment,0,0
180499,and,0,0
180500,drugs,0,0
180501,have,0,0
180502,only,0,0
180503,modest,0,0
180504,short-term,0,0
180505,effects,0,0
180506,",",0,0
180507,highlighting,0,0
180508,a,0,0
180509,pressing,0,1
180510,need,0,0
180511,to,0,0
180512,develop,0,0
180513,effective,0,0
180514,interventions,0,0
180515,.,0,0
180516,Aerobic,1,0
180517,exercise,1,1
180518,holds,0,0
180519,promise,0,0
180520,for,0,0
180521,treating,0,0
180522,cognitive,0,0
180523,impairment,0,0
180524,in,0,0
180525,Alzheimer,0,0
180526,'s,0,0
180527,disease,0,0
180528,through,0,0
180529,biologically,0,0
180530,sound,0,0
180531,mechanisms,0,0
180532,.,0,0
180533,Nonetheless,0,0
180534,",",0,0
180535,aerobic,1,1
180536,exercise,1,1
180537,studies,0,0
180538,in,0,0
180539,Alzheimer,0,0
180540,'s,0,0
180541,disease,0,0
180542,are,0,0
180543,limited,0,0
180544,with,0,0
180545,mixed,0,0
180546,findings,0,0
180547,.,0,0
180548,METHODS/DESIGN,0,0
180549,This,0,0
180550,pilot,0,0
180551,randomized,0,0
180552,controlled,0,0
180553,trial,0,0
180554,will,0,0
180555,investigate,0,0
180556,the,0,0
180557,effects,0,0
180558,of,0,0
180559,a,0,0
180560,6-month,0,0
180561,",",0,0
180562,individualized,0,0
180563,",",0,0
180564,moderate-intensity,1,1
180565,cycling,1,0
180566,intervention,1,1
180567,(,0,0
180568,20,0,0
180569,to,0,0
180570,50,0,0
180571,minutes,0,0
180572,per,0,0
180573,session,0,1
180574,",",0,0
180575,3,0,0
180576,times,0,0
180577,a,0,0
180578,week,0,0
180579,),0,0
180580,on,0,0
180581,cognition,0,0
180582,and,0,0
180583,hippocampal,0,0
180584,volume,0,0
180585,in,0,0
180586,community-dwelling,0,0
180587,older,0,0
180588,adults,0,0
180589,with,0,0
180590,mild-to-moderate,0,0
180591,Alzheimer,0,0
180592,'s,0,0
180593,disease,0,0
180594,.,0,0
180595,The,0,0
180596,specific,0,0
180597,aims,0,0
180598,are,0,0
180599,to,0,0
180600,:,0,0
180601,1,0,0
180602,),0,0
180603,determine,0,0
180604,the,0,0
180605,immediate,0,0
180606,effect,0,0
180607,of,0,0
180608,the,0,0
180609,cycling,0,0
180610,intervention,0,1
180611,on,0,0
180612,cognition,0,0
180613,in,0,0
180614,Alzheimer,0,0
180615,'s,0,0
180616,disease,0,0
180617,;,0,0
180618,2,0,0
180619,),0,0
180620,examine,0,0
180621,if,0,0
180622,the,0,0
180623,cycling,0,0
180624,intervention,0,1
180625,slows,0,0
180626,cognitive,0,0
180627,decline,0,0
180628,in,0,0
180629,Alzheimer,0,0
180630,'s,0,0
180631,disease,0,0
180632,from,0,0
180633,baseline,0,0
180634,to,0,0
180635,12,0,0
180636,months,0,0
180637,;,0,0
180638,and,0,0
180639,3,0,0
180640,),0,0
180641,assess,0,0
180642,the,0,0
180643,effect,0,0
180644,of,0,0
180645,aerobic,1,1
180646,exercise,1,1
180647,on,0,0
180648,hippocampal,0,0
180649,volume,0,0
180650,over,0,0
180651,12,0,0
180652,months,0,0
180653,.,0,0
180654,Ninety,0,0
180655,subjects,0,0
180656,will,0,0
180657,be,0,0
180658,randomized,0,0
180659,on,0,0
180660,a,0,0
180661,2:1,0,0
180662,allocation,0,0
180663,ratio,0,0
180664,to,0,0
180665,cycling,1,0
180666,or,0,1
180667,attention,0,0
180668,control,0,1
180669,(,1,0
180670,low-intensity,1,1
180671,stretching,1,1
180672,),1,0
180673,and,0,0
180674,followed,0,0
180675,for,0,0
180676,another,0,0
180677,6,0,0
180678,months,0,0
180679,.,0,0
180680,Allocations,0,0
180681,will,0,0
180682,be,0,0
180683,concealed,0,0
180684,to,0,0
180685,all,0,0
180686,investigators,0,0
180687,and,0,0
180688,outcome,0,0
180689,assessors,0,0
180690,will,0,0
180691,be,0,0
180692,blinded,0,0
180693,to,0,0
180694,group,0,0
180695,assignments,0,0
180696,and,0,0
180697,previous,0,0
180698,data,0,0
180699,.,0,0
180700,Cognition,0,0
180701,will,0,0
180702,be,0,0
180703,measured,0,0
180704,by,0,0
180705,the,0,0
180706,Alzheimer,0,0
180707,'s,0,0
180708,disease,0,0
180709,Assessment,0,0
180710,Scale-Cognition,0,0
180711,at,0,0
180712,baseline,0,0
180713,before,0,0
180714,randomization,0,0
180715,and,0,0
180716,at,0,0
180717,3,0,0
180718,",",0,0
180719,6,0,0
180720,",",0,0
180721,9,0,0
180722,",",0,0
180723,and,0,0
180724,12,0,0
180725,months,0,0
180726,.,0,0
180727,Hippocampal,0,0
180728,volume,0,0
180729,will,0,0
180730,be,0,0
180731,measured,0,0
180732,by,0,0
180733,magnetic,0,1
180734,resonance,0,1
180735,imaging,0,0
180736,at,0,0
180737,baseline,0,0
180738,and,0,0
180739,6,0,0
180740,and,0,0
180741,12,0,0
180742,months,0,0
180743,.,0,0
180744,The,0,0
180745,sample,0,0
180746,size,0,0
180747,of,0,0
180748,90,0,0
180749,will,0,0
180750,give,0,0
180751,80,0,0
180752,%,0,0
180753,power,0,0
180754,to,0,0
180755,detect,0,0
180756,a,0,0
180757,2.5-point,0,0
180758,difference,0,0
180759,in,0,0
180760,within-group,0,0
180761,changes,0,0
180762,in,0,0
180763,the,0,0
180764,Alzheimer,0,0
180765,'s,0,0
180766,disease,0,0
180767,Assessment,0,0
180768,Scale-Cognition,0,0
180769,at,0,0
180770,6,0,0
180771,months,0,0
180772,for,0,0
180773,the,0,0
180774,cycling,0,0
180775,group,0,0
180776,.,0,0
180777,DISCUSSION,0,0
180778,Findings,0,0
180779,from,0,0
180780,this,0,0
180781,study,0,0
180782,will,0,0
180783,address,0,0
180784,the,0,0
180785,critical,0,0
180786,gap,0,0
180787,of,0,0
180788,exercise,0,1
180789,efficacy,0,0
180790,in,0,0
180791,Alzheimer,0,0
180792,'s,0,0
180793,disease,0,0
180794,and,0,0
180795,use,0,0
180796,of,0,0
180797,magnetic,0,1
180798,resonance,0,1
180799,imaging,0,0
180800,as,0,0
180801,an,0,0
180802,outcome,0,0
180803,measure,0,0
180804,in,0,0
180805,clinical,0,0
180806,trials,0,0
180807,.,0,0
180808,This,0,0
180809,study,0,0
180810,will,0,0
180811,provide,0,0
180812,a,0,0
180813,potential,0,0
180814,treatment,0,0
180815,that,0,0
180816,may,0,0
180817,increase,0,0
180818,physical,0,0
180819,function,0,0
180820,and,0,0
180821,quality,0,0
180822,of,0,0
180823,life,0,0
180824,and,0,0
180825,curb,0,0
180826,the,0,0
180827,prohibitive,0,0
180828,costs,0,0
180829,for,0,0
180830,the,0,0
180831,growing,0,0
180832,dementia,0,0
180833,population,0,0
180834,.,0,0
180835,TRIAL,0,0
180836,REGISTRATION,0,0
180837,Primary,0,1
180838,registration,0,0
180839,:,0,0
180840,(,0,0
180841,NCT01954550,0,0
180842,;,0,0
180843,date,0,0
180844,of,0,0
180845,registration,0,0
180846,:,0,0
180847,20,0,0
180848,September,0,0
180849,2013,0,0
180850,),0,0
180851,.,0,0
180852,Secondary,0,0
180853,registration,0,0
180854,:,0,0
180855,(,0,0
180856,NCT01954550,0,0
180857,;,0,0
180858,date,0,0
180859,of,0,0
180860,registration,0,0
180861,:,0,0
180862,1,0,0
180863,October,0,0
180864,2013,0,0
180865,),0,0
180866,.,0,0
180867,?-Smooth,0,0
180868,muscle,0,0
180869,actin,0,0
180870,expression,0,0
180871,and,0,0
180872,desmoplastic,0,0
180873,stromal,0,1
180874,reaction,0,0
180875,in,0,0
180876,pancreatic,0,0
180877,cancer,0,0
180878,:,0,0
180879,results,0,0
180880,from,0,0
180881,the,0,0
180882,CONKO-001,0,0
180883,study,0,0
180884,.,0,0
180885,BACKGROUND,0,0
180886,Previous,0,0
180887,investigations,0,0
180888,in,0,0
180889,pancreatic,0,0
180890,cancer,0,0
180891,suggest,0,0
180892,a,0,0
180893,prognostic,0,0
180894,role,0,0
180895,for,0,0
180896,?-smooth,0,0
180897,muscle,0,0
180898,actin,0,0
180899,(,0,0
180900,?-SMA,0,0
180901,),0,1
180902,expression,0,0
180903,and,0,0
180904,stromal,0,1
180905,density,0,0
180906,in,0,0
180907,the,0,0
180908,peritumoural,0,0
180909,stroma,0,0
180910,.,0,0
180911,The,0,0
180912,aim,0,0
180913,of,0,0
180914,this,0,0
180915,study,0,0
180916,was,0,0
180917,to,0,0
180918,further,0,0
180919,validate,0,0
180920,the,0,0
180921,impact,0,0
180922,of,0,0
180923,?-SMA,0,0
180924,expression,0,0
180925,and,0,0
180926,stromal,0,1
180927,density,0,0
180928,in,0,0
180929,resectable,0,0
180930,pancreatic,0,0
180931,cancer,0,0
180932,patients,0,0
180933,treated,0,0
180934,with,0,0
180935,adjuvant,1,1
180936,gemcitabine,1,1
180937,compared,1,0
180938,with,0,0
180939,untreated,0,0
180940,patients,0,0
180941,.,0,0
180942,METHODS,0,0
180943,CONKO-001,0,0
180944,was,0,0
180945,a,0,0
180946,prospective,0,0
180947,randomised,0,0
180948,phase,0,0
180949,III,0,0
180950,study,0,0
180951,investigating,0,0
180952,the,0,0
180953,role,0,0
180954,of,1,0
180955,adjuvant,1,1
180956,gemcitabine,1,1
180957,as,1,0
180958,compared,0,0
180959,with,0,0
180960,observation,0,0
180961,.,0,0
180962,Tissue,0,0
180963,samples,0,0
180964,of,0,0
180965,162,0,0
180966,patients,0,0
180967,were,0,0
180968,available,0,0
180969,for,0,0
180970,immunohistochemistry,0,0
180971,on,0,0
180972,tissue,0,0
180973,microarrays,0,0
180974,to,0,0
180975,evaluate,0,0
180976,the,0,0
180977,impact,0,0
180978,of,0,0
180979,?-SMA,0,0
180980,expression,0,0
180981,and,0,0
180982,stromal,0,1
180983,density,0,0
180984,impact,0,0
180985,on,0,0
180986,patient,0,0
180987,outcome,0,0
180988,.,0,0
180989,RESULTS,0,0
180990,High,0,0
180991,?-SMA,0,0
180992,expression,0,0
180993,in,0,0
180994,tumour,0,0
180995,stroma,0,0
180996,was,0,0
180997,associated,0,0
180998,with,0,0
180999,worse,0,0
181000,patient,0,0
181001,outcome,0,0
181002,(,0,0
181003,DFS,0,0
181004,:,0,0
181005,P=0.05,0,0
181006,",",0,0
181007,OS,0,0
181008,:,0,0
181009,P=0.047,0,0
181010,),0,0
181011,.,0,0
181012,A,0,0
181013,dense,0,0
181014,stroma,0,1
181015,reaction,0,0
181016,was,0,0
181017,associated,0,0
181018,with,0,0
181019,improved,0,0
181020,disease-free,0,0
181021,survival,0,0
181022,(,0,0
181023,DFS,0,0
181024,),0,1
181025,and,0,0
181026,overall,0,0
181027,survival,0,0
181028,(,0,0
181029,OS,0,0
181030,),0,0
181031,in,0,0
181032,the,0,0
181033,overall,0,0
181034,study,0,0
181035,population,0,0
181036,(,0,0
181037,DFS,0,0
181038,:,0,0
181039,P=0.001,0,0
181040,",",0,0
181041,OS,0,0
181042,:,0,0
181043,P=0.001,0,0
181044,),0,0
181045,.,0,0
181046,This,0,0
181047,positive,0,0
181048,prognostic,0,0
181049,impact,0,0
181050,was,0,0
181051,restricted,0,0
181052,to,0,0
181053,patients,0,0
181054,with,0,0
181055,no,0,0
181056,adjuvant,0,1
181057,treatment,0,0
181058,(,0,0
181059,DFS,0,0
181060,:,0,0
181061,P,0,0
181062,<,0,0
181063,0.001,0,0
181064,",",0,0
181065,OS,0,0
181066,:,0,0
181067,P,0,0
181068,<,0,0
181069,0.001,0,0
181070,),0,0
181071,.,0,0
181072,In,0,0
181073,multivariable,0,0
181074,analysis,0,0
181075,",",0,0
181076,?-SMA,0,0
181077,and,0,0
181078,stromal,0,1
181079,density,0,0
181080,expression,0,0
181081,were,0,0
181082,independently,0,0
181083,predictive,0,0
181084,factors,0,0
181085,for,0,0
181086,survival,0,0
181087,.,0,0
181088,CONCLUSIONS,0,0
181089,Our,0,0
181090,data,0,0
181091,confirm,0,0
181092,the,0,0
181093,negative,0,0
181094,prognostic,0,0
181095,impact,0,0
181096,of,0,0
181097,high,0,0
181098,?-SMA,0,0
181099,expression,0,0
181100,in,0,0
181101,pancreatic,0,0
181102,cancer,0,0
181103,patients,0,0
181104,after,0,0
181105,curatively,0,0
181106,intended,0,0
181107,resection,0,0
181108,.,0,0
181109,In,0,0
181110,contrast,0,0
181111,to,0,0
181112,former,0,0
181113,investigations,0,0
181114,",",0,0
181115,we,0,0
181116,found,0,0
181117,a,0,0
181118,positive,0,0
181119,prognostic,0,0
181120,impact,0,0
181121,for,0,0
181122,a,0,0
181123,dense,0,0
181124,stroma,0,0
181125,.,0,0
181126,This,0,0
181127,significant,0,0
181128,influence,0,0
181129,was,0,0
181130,restricted,0,0
181131,to,0,0
181132,patients,0,0
181133,who,0,0
181134,received,0,0
181135,no,0,0
181136,adjuvant,0,1
181137,therapy,0,1
181138,.,0,0
181139,A,0,0
181140,randomized,0,0
181141,controlled,0,0
181142,trial,0,0
181143,of,0,0
181144,Pivotal,1,0
181145,Response,1,0
181146,Treatment,1,1
181147,Group,1,0
181148,for,0,0
181149,parents,0,0
181150,of,0,0
181151,children,0,0
181152,with,0,0
181153,autism,0,0
181154,.,0,0
181155,BACKGROUND,0,0
181156,With,0,0
181157,rates,0,0
181158,of,0,0
181159,autism,0,0
181160,diagnosis,0,0
181161,continuing,0,0
181162,to,0,0
181163,rise,0,0
181164,",",0,0
181165,there,0,0
181166,is,0,0
181167,an,0,0
181168,urgent,0,0
181169,need,0,0
181170,for,0,0
181171,effective,0,0
181172,and,0,0
181173,efficient,0,0
181174,service,0,0
181175,delivery,0,0
181176,models,0,0
181177,.,0,0
181178,Pivotal,1,0
181179,Response,1,0
181180,Treatment,1,1
181181,(,1,0
181182,PRT,1,1
181183,),1,1
181184,is,0,0
181185,considered,0,0
181186,an,0,0
181187,established,0,0
181188,treatment,0,0
181189,for,0,0
181190,autism,0,0
181191,spectrum,0,0
181192,disorder,0,0
181193,(,0,0
181194,ASD,0,0
181195,),0,0
181196,;,0,0
181197,however,0,0
181198,",",0,0
181199,there,0,0
181200,have,0,0
181201,been,0,0
181202,few,0,0
181203,well-controlled,0,0
181204,studies,0,0
181205,with,0,0
181206,adequate,0,0
181207,sample,0,0
181208,size,0,0
181209,.,0,0
181210,The,0,0
181211,aim,0,0
181212,of,0,0
181213,this,0,0
181214,study,0,0
181215,was,0,0
181216,to,0,0
181217,conduct,0,0
181218,a,0,0
181219,randomized,0,0
181220,controlled,0,0
181221,trial,0,0
181222,to,0,0
181223,evaluate,0,0
181224,PRT,1,1
181225,parent,1,1
181226,training,1,1
181227,group,1,0
181228,(,1,1
181229,PRTG,1,1
181230,),1,0
181231,for,0,0
181232,targeting,0,0
181233,language,0,0
181234,deficits,0,0
181235,in,0,0
181236,young,0,0
181237,children,0,0
181238,with,0,0
181239,ASD,0,0
181240,.,0,0
181241,METHODS,0,0
181242,Fifty-three,0,0
181243,children,0,0
181244,with,0,0
181245,autism,0,0
181246,and,0,0
181247,significant,0,0
181248,language,0,0
181249,delay,0,0
181250,between,0,0
181251,2,0,0
181252,and,0,0
181253,6,0,0
181254,years,0,0
181255,old,0,0
181256,were,0,0
181257,randomized,0,0
181258,to,1,0
181259,PRTG,1,1
181260,(,1,0
181261,N,1,0
181262,=,1,0
181263,27,1,0
181264,),1,0
181265,or,1,1
181266,psychoeducation,1,1
181267,group,1,1
181268,(,1,0
181269,PEG,1,1
181270,;,0,0
181271,N,0,0
181272,=,0,0
181273,26,0,0
181274,),0,0
181275,for,0,0
181276,12,0,0
181277,weeks,0,0
181278,.,0,0
181279,The,0,0
181280,PRTG,0,0
181281,taught,0,0
181282,parents,0,0
181283,behavioral,0,0
181284,techniques,0,1
181285,to,0,0
181286,facilitate,0,0
181287,language,0,0
181288,development,0,0
181289,.,0,0
181290,The,0,0
181291,PEG,0,1
181292,taught,0,0
181293,general,0,0
181294,information,0,0
181295,about,0,0
181296,ASD,0,0
181297,(,0,0
181298,clinical,0,0
181299,trial,0,0
181300,NCT01881750,0,1
181301,;,0,0
181302,http,0,0
181303,:,0,0
181304,//www.clinicaltrials.gov,0,0
181305,),0,0
181306,.,0,0
181307,RESULTS,0,0
181308,Analysis,0,0
181309,of,0,0
181310,child,0,0
181311,utterances,0,0
181312,during,0,0
181313,the,0,0
181314,structured,0,1
181315,laboratory,0,0
181316,observation,0,1
181317,(,0,0
181318,primary,0,0
181319,outcome,0,0
181320,),0,0
181321,indicated,0,0
181322,that,0,0
181323,",",0,0
181324,compared,0,0
181325,with,0,0
181326,children,0,0
181327,in,0,0
181328,the,0,0
181329,PEG,0,1
181330,",",0,0
181331,children,0,0
181332,in,0,0
181333,the,0,0
181334,PRTG,0,0
181335,demonstrated,0,0
181336,greater,0,0
181337,improvement,0,0
181338,in,0,0
181339,frequency,0,0
181340,of,0,0
181341,utterances,0,0
181342,(,0,0
181343,F,0,0
181344,(,0,0
181345,2,0,0
181346,",",0,0
181347,43,0,0
181348,),0,0
181349,=,0,0
181350,3.53,0,0
181351,",",0,0
181352,p,0,0
181353,=,0,0
181354,.038,0,0
181355,",",0,0
181356,d,0,0
181357,=,0,0
181358,0.42,0,0
181359,),0,0
181360,.,0,0
181361,Results,0,0
181362,indicated,0,0
181363,that,0,0
181364,parents,0,0
181365,were,0,0
181366,able,0,0
181367,to,0,0
181368,learn,1,0
181369,PRT,1,0
181370,in,1,0
181371,a,0,0
181372,group,0,0
181373,format,0,0
181374,",",0,0
181375,as,0,0
181376,the,0,0
181377,majority,0,0
181378,of,0,0
181379,parents,0,0
181380,in,0,0
181381,the,0,0
181382,PRTG,0,1
181383,(,0,0
181384,84,0,0
181385,%,0,0
181386,),0,0
181387,met,0,0
181388,fidelity,0,0
181389,of,0,0
181390,implementation,0,0
181391,criteria,0,0
181392,after,0,0
181393,12,0,0
181394,weeks,0,0
181395,.,0,0
181396,Children,0,0
181397,also,0,0
181398,demonstrated,0,0
181399,greater,0,0
181400,improvement,0,0
181401,in,0,0
181402,adaptive,0,0
181403,communication,0,0
181404,skills,0,1
181405,(,0,0
181406,Vineland-II,0,1
181407,),0,0
181408,following,0,0
181409,PRTG,0,1
181410,and,0,0
181411,baseline,0,0
181412,Mullen,0,0
181413,visual,0,0
181414,reception,0,0
181415,scores,0,0
181416,predicted,0,0
181417,treatment,0,0
181418,response,0,0
181419,to,0,0
181420,PRTG,0,1
181421,.,0,0
181422,CONCLUSIONS,0,0
181423,This,0,0
181424,is,0,0
181425,the,0,0
181426,first,0,0
181427,randomized,0,0
181428,controlled,0,0
181429,trial,0,0
181430,of,0,0
181431,group-delivered,0,1
181432,PRT,0,0
181433,and,0,0
181434,one,0,0
181435,of,0,0
181436,the,0,0
181437,largest,0,0
181438,experimental,0,0
181439,investigations,0,0
181440,of,0,0
181441,the,0,0
181442,PRT,0,0
181443,model,0,0
181444,to,0,0
181445,date,0,0
181446,.,0,0
181447,The,0,0
181448,findings,0,0
181449,suggest,0,0
181450,that,0,0
181451,specific,0,0
181452,instruction,0,1
181453,in,1,0
181454,PRT,1,0
181455,results,1,0
181456,in,0,0
181457,greater,0,0
181458,skill,0,0
181459,acquisition,0,0
181460,for,0,0
181461,both,0,0
181462,parents,0,0
181463,and,0,0
181464,children,0,0
181465,",",0,0
181466,especially,0,0
181467,in,0,0
181468,functional,0,0
181469,and,0,0
181470,adaptive,0,0
181471,communication,0,0
181472,skills,0,0
181473,.,0,0
181474,Further,0,0
181475,research,1,0
181476,in,1,0
181477,PRT,1,0
181478,is,1,0
181479,warranted,1,0
181480,to,0,0
181481,replicate,0,0
181482,the,0,0
181483,observed,0,0
181484,results,0,0
181485,and,0,0
181486,address,0,0
181487,other,0,0
181488,core,0,0
181489,ASD,0,0
181490,symptoms,0,0
181491,.,0,0
181492,Parent-implemented,1,1
181493,social,1,1
181494,intervention,1,1
181495,for,0,0
181496,toddlers,0,0
181497,with,0,0
181498,autism,0,0
181499,:,0,0
181500,an,0,0
181501,RCT,0,0
181502,.,0,0
181503,OBJECTIVES,0,0
181504,To,0,0
181505,compare,0,0
181506,the,0,0
181507,effects,0,0
181508,of,0,0
181509,two,0,0
181510,9-month,0,0
181511,parent-implemented,1,0
181512,interventions,1,0
181513,within,0,0
181514,the,0,0
181515,Early,1,0
181516,Social,1,0
181517,Interaction,1,0
181518,(,1,0
181519,ESI,1,1
181520,),1,0
181521,Project,1,0
181522,.,1,0
181523,Both,0,0
181524,individual-ESI,1,0
181525,",",0,0
181526,offered,0,0
181527,2,0,0
181528,or,0,0
181529,3,0,0
181530,times,0,0
181531,per,0,0
181532,week,0,0
181533,at,0,0
181534,home,0,1
181535,or,0,0
181536,in,0,0
181537,the,0,0
181538,community,0,0
181539,",",0,0
181540,and,0,0
181541,group-ESI,1,0
181542,",",0,0
181543,offered,0,0
181544,once,0,0
181545,per,0,0
181546,week,0,0
181547,in,0,0
181548,a,0,0
181549,clinic,0,0
181550,",",0,0
181551,taught,0,0
181552,parents,0,0
181553,how,0,0
181554,to,0,0
181555,embed,1,0
181556,strategies,1,0
181557,to,1,0
181558,support,1,0
181559,social,1,0
181560,communication,1,0
181561,throughout,0,0
181562,everyday,0,0
181563,activities,0,0
181564,.,0,0
181565,METHODS,0,0
181566,Participants,0,0
181567,in,0,0
181568,the,0,0
181569,randomized,0,0
181570,controlled,0,0
181571,trial,0,0
181572,included,0,0
181573,82,0,0
181574,children,0,0
181575,diagnosed,0,0
181576,with,0,0
181577,autism,0,0
181578,spectrum,0,0
181579,disorder,0,0
181580,at,0,0
181581,16,0,0
181582,to,0,0
181583,20,0,0
181584,months,0,0
181585,.,0,0
181586,Children,0,0
181587,were,0,0
181588,matched,0,0
181589,on,0,0
181590,pretreatment,0,0
181591,nonverbal,0,0
181592,developmental,0,0
181593,level,0,0
181594,and,0,0
181595,pairs,0,0
181596,were,0,0
181597,randomly,0,0
181598,assigned,0,0
181599,to,0,0
181600,treatment,0,0
181601,condition,0,0
181602,.,0,0
181603,Child,0,0
181604,outcomes,0,0
181605,included,0,0
181606,measures,0,0
181607,of,0,0
181608,social,0,0
181609,communication,0,0
181610,",",0,0
181611,autism,0,0
181612,symptoms,0,0
181613,",",0,0
181614,adaptive,0,0
181615,behavior,0,0
181616,",",0,0
181617,and,0,0
181618,developmental,0,0
181619,level,0,0
181620,.,0,0
181621,Child,0,0
181622,outcomes,0,0
181623,are,0,0
181624,reported,0,0
181625,from,0,0
181626,baseline,0,0
181627,to,0,0
181628,the,0,0
181629,end,0,0
181630,of,0,0
181631,the,0,0
181632,9-month,0,0
181633,interventions,0,0
181634,.,0,0
181635,RESULTS,0,0
181636,Children,0,0
181637,in,0,0
181638,individual-ESI,1,0
181639,showed,0,0
181640,differential,0,0
181641,change,0,0
181642,on,0,0
181643,a,0,0
181644,standardized,0,0
181645,examiner-administered,0,0
181646,observational,0,0
181647,measure,0,0
181648,of,0,0
181649,social,0,0
181650,communication,0,0
181651,",",0,0
181652,as,0,0
181653,they,0,0
181654,improved,0,0
181655,at,0,0
181656,a,0,0
181657,faster,0,0
181658,rate,0,0
181659,than,0,0
181660,children,0,0
181661,in,0,0
181662,group-ESI,1,0
181663,.,1,0
181664,Individual-ESI,1,0
181665,also,0,0
181666,showed,0,0
181667,differential,0,0
181668,efficacy,0,0
181669,on,0,0
181670,a,0,0
181671,parent,0,1
181672,report,0,0
181673,measure,0,0
181674,of,0,0
181675,communication,0,0
181676,",",0,0
181677,daily,0,0
181678,living,0,0
181679,",",0,0
181680,and,0,0
181681,social,0,0
181682,skills,0,0
181683,",",0,0
181684,as,0,0
181685,they,0,0
181686,showed,0,0
181687,improvement,0,0
181688,or,0,1
181689,stability,0,0
181690,",",0,0
181691,whereas,0,0
181692,group-ESI,1,0
181693,led,0,0
181694,to,0,0
181695,worsening,0,0
181696,or,0,1
181697,no,0,0
181698,significant,0,0
181699,change,0,0
181700,on,0,0
181701,these,0,0
181702,skills,0,0
181703,.,0,0
181704,Finally,0,0
181705,",",0,0
181706,individual-ESI,1,0
181707,showed,0,0
181708,differential,0,0
181709,change,0,0
181710,on,0,0
181711,examiner-administered,0,0
181712,measures,0,0
181713,of,0,0
181714,receptive,0,0
181715,language,0,0
181716,skills,0,0
181717,",",0,0
181718,as,0,0
181719,children,0,0
181720,in,0,0
181721,individual-ESI,0,0
181722,improved,0,0
181723,significantly,0,0
181724,",",0,0
181725,whereas,0,0
181726,group-ESI,1,0
181727,showed,0,0
181728,no,0,0
181729,change,0,0
181730,.,0,0
181731,CONCLUSIONS,0,0
181732,These,0,0
181733,findings,0,0
181734,support,0,0
181735,the,0,0
181736,efficacy,0,0
181737,of,0,0
181738,individual-ESI,1,0
181739,compared,0,0
181740,with,0,0
181741,group-ESI,1,0
181742,on,0,0
181743,child,0,0
181744,outcomes,0,0
181745,",",0,0
181746,suggesting,0,0
181747,the,0,0
181748,importance,0,0
181749,of,0,0
181750,individualized,1,0
181751,parent,1,1
181752,coaching,1,1
181753,in,0,0
181754,natural,0,0
181755,environments,0,0
181756,.,0,0
181757,The,0,0
181758,efficacy,0,0
181759,of,0,0
181760,a,0,0
181761,parent-implemented,1,1
181762,intervention,1,1
181763,using,0,0
181764,little,0,0
181765,professional,0,1
181766,time,0,0
181767,has,0,0
181768,potential,0,0
181769,for,0,0
181770,community,0,0
181771,viability,0,0
181772,",",0,0
181773,which,0,0
181774,is,0,0
181775,particularly,0,0
181776,important,0,0
181777,in,0,0
181778,light,0,0
181779,of,0,0
181780,the,0,0
181781,lack,0,0
181782,of,0,0
181783,main,0,0
181784,effects,0,0
181785,on,0,0
181786,child,0,0
181787,outcomes,0,0
181788,of,0,0
181789,most,0,0
181790,other,0,0
181791,parent-implemented,1,0
181792,interventions,1,0
181793,.,1,0
181794,Zoledronic,1,1
181795,acid,1,1
181796,combined,1,1
181797,with,1,0
181798,adjuvant,1,1
181799,endocrine,1,0
181800,therapy,1,1
181801,of,1,0
181802,tamoxifen,1,1
181803,versus,0,1
181804,anastrozol,1,1
181805,plus,1,1
181806,ovarian,1,0
181807,function,1,0
181808,suppression,1,0
181809,in,0,0
181810,premenopausal,0,0
181811,early,0,0
181812,breast,0,0
181813,cancer,0,0
181814,:,0,0
181815,final,0,0
181816,analysis,0,0
181817,of,0,0
181818,the,0,0
181819,Austrian,0,0
181820,Breast,0,0
181821,and,0,0
181822,Colorectal,0,0
181823,Cancer,0,0
181824,Study,0,0
181825,Group,0,0
181826,Trial,0,0
181827,12,0,0
181828,.,0,0
181829,BACKGROUND,0,0
181830,Zoledronic,1,1
181831,acid,1,1
181832,(,1,0
181833,ZOL,1,1
181834,),1,1
181835,plus,1,1
181836,adjuvant,1,1
181837,endocrine,1,0
181838,therapy,1,1
181839,significantly,0,0
181840,improved,0,0
181841,disease-free,0,0
181842,survival,0,0
181843,(,0,0
181844,DFS,0,0
181845,),0,0
181846,at,0,0
181847,48-,0,1
181848,and,0,0
181849,62-month,0,0
181850,follow-up,0,0
181851,in,0,0
181852,the,0,0
181853,ABCSG-12,0,0
181854,trial,0,0
181855,.,0,0
181856,We,0,0
181857,present,0,0
181858,efficacy,0,0
181859,results,0,0
181860,of,0,0
181861,a,0,0
181862,final,0,0
181863,additional,0,0
181864,analysis,0,0
181865,after,0,0
181866,94.4,0,0
181867,months,0,0
181868,.,0,0
181869,PATIENTS,0,0
181870,AND,0,0
181871,METHODS,0,0
181872,Patients,0,0
181873,were,0,0
181874,premenopausal,0,0
181875,women,0,0
181876,who,0,0
181877,had,0,0
181878,undergone,0,0
181879,primary,0,0
181880,surgery,0,0
181881,for,0,0
181882,stage,0,0
181883,I/II,0,1
181884,estrogen-receptor-positive,0,0
181885,and/or,0,0
181886,progesterone-receptor-positive,0,0
181887,breast,0,0
181888,cancer,0,0
181889,with,0,0
181890,<,0,0
181891,10,0,0
181892,positive,0,0
181893,lymph,0,0
181894,nodes,0,0
181895,",",0,0
181896,and,0,0
181897,were,0,0
181898,scheduled,0,0
181899,for,0,0
181900,standard,0,1
181901,goserelin,0,1
181902,therapy,0,1
181903,.,0,0
181904,All,0,0
181905,1803,0,0
181906,patients,0,0
181907,received,0,0
181908,goserelin,1,1
181909,(,1,0
181910,3.6,1,0
181911,mg,1,1
181912,every,1,0
181913,28,1,0
181914,days,1,0
181915,),1,0
181916,and,1,0
181917,were,1,0
181918,randomized,1,0
181919,to,1,0
181920,tamoxifen,1,1
181921,(,1,0
181922,20,1,0
181923,mg/days,1,1
181924,),1,0
181925,or,1,1
181926,anastrozole,1,1
181927,(,1,0
181928,1,1,0
181929,mg/days,1,0
181930,),1,0
181931,",",1,0
181932,both,1,0
181933,with,1,0
181934,or,1,0
181935,without,1,0
181936,ZOL,1,1
181937,(,1,0
181938,4,1,0
181939,mg,1,1
181940,every,1,0
181941,6,1,0
181942,months,1,0
181943,),1,0
181944,for,1,0
181945,3,1,0
181946,years,1,0
181947,.,1,0
181948,The,0,0
181949,primary,0,0
181950,end,0,0
181951,point,0,0
181952,was,0,0
181953,DFS,0,0
181954,;,0,0
181955,recurrence-free,0,0
181956,survival,0,0
181957,and,0,0
181958,overall,0,0
181959,survival,0,0
181960,(,0,0
181961,OS,0,0
181962,),0,0
181963,were,0,0
181964,secondary,0,0
181965,end,0,0
181966,points,0,0
181967,.,0,0
181968,RESULTS,0,0
181969,After,0,0
181970,94.4-month,0,0
181971,median,0,0
181972,follow-up,0,0
181973,(,0,0
181974,range,0,0
181975,",",0,0
181976,0-114,0,0
181977,months,0,0
181978,),0,0
181979,",",0,0
181980,relative,0,0
181981,risks,0,0
181982,of,0,0
181983,disease,0,0
181984,progression,0,0
181985,[,0,0
181986,hazard,0,0
181987,ratio,0,0
181988,(,0,0
181989,HR,0,0
181990,),0,1
181991,=,0,0
181992,0.77,0,0
181993,;,0,0
181994,95,0,0
181995,%,0,0
181996,confidence,0,0
181997,interval,0,0
181998,(,0,0
181999,CI,0,0
182000,),0,0
182001,0.60-0.99,0,0
182002,;,0,0
182003,P,0,0
182004,=,0,0
182005,0.042,0,0
182006,],0,0
182007,and,0,0
182008,of,0,0
182009,death,0,0
182010,(,0,0
182011,HR,0,0
182012,=,0,0
182013,0.66,0,0
182014,;,0,0
182015,95,0,0
182016,%,0,0
182017,CI,0,0
182018,0.43-1.02,0,0
182019,;,0,0
182020,P,0,0
182021,=,0,0
182022,0.064,0,0
182023,),0,0
182024,are,0,0
182025,still,0,0
182026,reduced,0,0
182027,by,0,0
182028,ZOL,0,0
182029,although,0,0
182030,no,0,0
182031,longer,0,0
182032,significant,0,0
182033,at,0,0
182034,the,0,0
182035,predefined,0,0
182036,significance,0,0
182037,level,0,0
182038,.,0,0
182039,Overall,0,0
182040,",",0,0
182041,251,0,0
182042,DFS,0,0
182043,events,0,0
182044,and,0,0
182045,86,0,0
182046,deaths,0,0
182047,were,0,0
182048,reported,0,0
182049,.,0,0
182050,Absolute,0,0
182051,risk,0,0
182052,reductions,0,0
182053,with,0,0
182054,ZOL,0,0
182055,were,0,0
182056,3.4,0,0
182057,%,0,0
182058,for,0,0
182059,DFS,0,0
182060,and,0,0
182061,2.2,0,0
182062,%,0,0
182063,for,0,0
182064,OS,0,0
182065,.,0,0
182066,There,0,0
182067,was,0,0
182068,no,0,0
182069,DFS,0,0
182070,difference,0,0
182071,between,0,0
182072,tamoxifen,0,1
182073,alone,0,1
182074,versus,0,0
182075,anastrozole,0,1
182076,alone,0,1
182077,",",0,0
182078,but,0,0
182079,there,0,0
182080,was,0,0
182081,a,0,0
182082,pronounced,0,0
182083,higher,0,0
182084,risk,0,0
182085,of,0,0
182086,death,0,0
182087,for,0,0
182088,anastrozole-treated,0,1
182089,patients,0,0
182090,(,0,0
182091,HR,0,0
182092,=,0,0
182093,1.63,0,0
182094,;,0,0
182095,95,0,0
182096,%,0,0
182097,CI,0,0
182098,1.05-1.45,0,0
182099,;,0,0
182100,P,0,0
182101,=,0,0
182102,0.030,0,0
182103,),0,0
182104,.,0,0
182105,Treatments,0,0
182106,were,0,0
182107,generally,0,0
182108,well,0,0
182109,tolerated,0,0
182110,",",0,0
182111,with,0,0
182112,no,0,0
182113,reports,0,0
182114,of,0,0
182115,renal,0,0
182116,failure,0,0
182117,or,0,1
182118,osteonecrosis,0,0
182119,of,0,0
182120,the,0,0
182121,jaw,0,0
182122,.,0,0
182123,CONCLUSION,0,0
182124,These,0,0
182125,final,0,0
182126,results,0,0
182127,from,0,0
182128,ABCSG,0,0
182129,12,0,0
182130,suggest,0,0
182131,that,0,0
182132,twice-yearly,0,1
182133,ZOL,1,0
182134,enhances,0,0
182135,the,0,0
182136,efficacy,0,0
182137,of,0,0
182138,adjuvant,0,1
182139,endocrine,0,0
182140,treatment,0,0
182141,",",0,0
182142,and,0,0
182143,this,0,0
182144,benefit,0,0
182145,is,0,0
182146,maintained,0,0
182147,long-term,0,0
182148,.,0,0
182149,CLINICALTRIALSGOV,0,0
182150,NCT00295646,0,0
182151,(,0,0
182152,http,0,0
182153,:,0,0
182154,//www.clinicaltrials.gov/ct2/results,0,0
182155,?,0,0
182156,term=00295646,0,0
182157,),0,0
182158,.,0,0
182159,Anthropometric,0,0
182160,indices,0,0
182161,of,0,0
182162,Gambian,0,0
182163,children,0,0
182164,after,0,0
182165,one,0,0
182166,or,0,0
182167,three,0,0
182168,annual,0,0
182169,rounds,0,0
182170,of,0,0
182171,mass,1,0
182172,drug,1,0
182173,administration,1,0
182174,with,0,0
182175,azithromycin,1,1
182176,for,0,0
182177,trachoma,0,0
182178,control,0,0
182179,.,0,0
182180,BACKGROUND,0,0
182181,Mass,0,0
182182,drug,0,1
182183,administration,0,0
182184,(,0,0
182185,MDA,0,1
182186,),0,0
182187,with,0,0
182188,azithromycin,1,1
182189,",",0,0
182190,carried,0,0
182191,out,0,0
182192,for,0,0
182193,the,0,0
182194,control,0,0
182195,of,0,0
182196,blinding,0,0
182197,trachoma,0,0
182198,",",0,0
182199,has,0,0
182200,been,0,0
182201,linked,0,0
182202,to,0,0
182203,reduced,0,0
182204,mortality,0,0
182205,in,0,0
182206,children,0,0
182207,.,0,0
182208,While,0,0
182209,the,0,0
182210,mechanism,0,0
182211,behind,0,0
182212,this,0,0
182213,reduction,0,0
182214,is,0,0
182215,unclear,0,0
182216,",",0,0
182217,it,0,0
182218,may,0,0
182219,be,0,0
182220,due,0,0
182221,",",0,0
182222,in,0,0
182223,part,0,0
182224,",",0,0
182225,to,0,0
182226,improved,0,0
182227,nutritional,0,1
182228,status,0,0
182229,via,0,0
182230,a,0,0
182231,potential,0,0
182232,reduction,0,0
182233,in,0,0
182234,the,0,0
182235,community,0,0
182236,burden,0,0
182237,of,0,0
182238,infectious,0,0
182239,disease,0,0
182240,.,0,0
182241,To,0,0
182242,determine,0,0
182243,whether,0,0
182244,MDA,1,1
182245,with,1,0
182246,azithromycin,1,1
182247,improves,0,0
182248,anthropometric,0,0
182249,indices,0,0
182250,at,0,0
182251,the,0,0
182252,community,0,0
182253,level,0,0
182254,",",0,0
182255,we,0,0
182256,measured,0,0
182257,the,0,0
182258,heights,0,0
182259,and,0,0
182260,weights,0,0
182261,of,0,0
182262,children,0,0
182263,aged,0,0
182264,1,0,0
182265,to,0,0
182266,4,0,0
182267,years,0,0
182268,in,0,0
182269,communities,0,0
182270,where,0,0
182271,one,0,0
182272,(,0,0
182273,single,0,0
182274,MDA,0,1
182275,arm,0,0
182276,),0,0
182277,or,0,0
182278,three,0,0
182279,annual,0,0
182280,rounds,0,1
182281,(,0,0
182282,annual,0,0
182283,MDA,0,1
182284,arm,0,0
182285,),0,0
182286,of,0,0
182287,azithromycin,1,1
182288,had,0,0
182289,been,0,0
182290,distributed,0,0
182291,.,0,0
182292,METHODS,0,0
182293,Data,0,0
182294,collection,0,0
182295,took,0,1
182296,place,0,0
182297,three,0,0
182298,years,0,0
182299,after,0,0
182300,treatment,0,0
182301,in,0,0
182302,the,0,0
182303,single,0,0
182304,MDA,0,1
182305,arm,0,0
182306,and,0,0
182307,one,0,0
182308,year,0,0
182309,after,0,0
182310,the,0,0
182311,final,0,0
182312,round,0,0
182313,of,0,0
182314,treatment,0,0
182315,in,0,0
182316,the,0,0
182317,annual,0,0
182318,MDA,0,1
182319,arm,0,0
182320,.,0,0
182321,Mean,0,0
182322,height-for-age,0,0
182323,",",0,0
182324,weight-for-age,0,0
182325,and,0,0
182326,weight-for-height,0,0
182327,z,0,0
182328,scores,0,0
182329,were,0,0
182330,compared,0,0
182331,between,0,0
182332,treatment,0,0
182333,arms,0,0
182334,.,0,0
182335,RESULTS,0,0
182336,No,0,0
182337,significant,0,0
182338,differences,0,0
182339,in,0,0
182340,mean,0,0
182341,height-for-age,0,0
182342,",",0,0
182343,weight-for-age,0,0
182344,or,0,1
182345,weight-for-height,0,0
182346,z,0,0
182347,scores,0,0
182348,were,0,0
182349,found,0,0
182350,between,0,0
182351,the,0,0
182352,annual,0,0
182353,MDA,0,1
182354,and,0,0
182355,single,0,0
182356,MDA,0,1
182357,arms,0,0
182358,",",0,0
182359,nor,0,0
182360,was,0,0
182361,there,0,0
182362,a,0,0
182363,significant,0,0
182364,reduction,0,0
182365,in,0,0
182366,prevalence,0,0
182367,of,0,0
182368,stunting,0,0
182369,",",0,0
182370,wasting,0,0
182371,or,0,0
182372,underweight,0,0
182373,between,0,0
182374,arms,0,0
182375,.,0,0
182376,CONCLUSIONS,0,0
182377,Our,0,0
182378,data,0,0
182379,do,0,0
182380,not,0,0
182381,provide,0,0
182382,evidence,0,0
182383,that,0,0
182384,community,0,0
182385,MDA,1,1
182386,with,1,0
182387,azithromycin,1,1
182388,improved,0,0
182389,anthropometric,0,0
182390,outcomes,0,0
182391,of,0,0
182392,children,0,0
182393,in,0,0
182394,The,0,0
182395,Gambia,0,0
182396,.,0,0
182397,This,0,0
182398,may,0,0
182399,suggest,0,0
182400,reductions,0,0
182401,in,0,0
182402,mortality,0,0
182403,associated,0,0
182404,with,0,0
182405,azithromycin,1,1
182406,MDA,1,1
182407,are,0,0
182408,due,0,0
182409,to,0,0
182410,a,0,0
182411,mechanism,0,0
182412,other,0,0
182413,than,0,0
182414,improved,0,0
182415,nutritional,0,1
182416,status,0,0
182417,.,0,0
182418,Duration,0,0
182419,of,0,0
182420,chemotherapy,0,1
182421,in,0,0
182422,small,0,0
182423,cell,0,0
182424,lung,0,0
182425,cancer,0,0
182426,:,0,0
182427,a,0,0
182428,Cancer,0,0
182429,Research,0,0
182430,Campaign,0,0
182431,trial,0,0
182432,.,0,0
182433,A,0,0
182434,total,0,0
182435,of,0,0
182436,610,0,0
182437,patients,0,0
182438,with,0,0
182439,small,0,0
182440,cell,0,0
182441,lung,0,0
182442,cancer,0,0
182443,were,0,0
182444,entered,0,0
182445,into,0,0
182446,a,0,0
182447,randomised,0,0
182448,trial,0,0
182449,designed,0,0
182450,to,0,0
182451,assess,0,0
182452,the,0,0
182453,effect,0,0
182454,of,0,0
182455,duration,0,0
182456,of,0,0
182457,initial,0,0
182458,chemotherapy,0,1
182459,on,0,0
182460,survival,0,0
182461,.,0,0
182462,Patients,0,0
182463,were,0,0
182464,randomised,0,0
182465,to,0,0
182466,receive,0,0
182467,either,0,0
182468,four,0,0
182469,or,0,0
182470,eight,0,0
182471,courses,0,0
182472,of,0,0
182473,cytotoxic,1,0
182474,chemotherapy,1,1
182475,with,1,0
182476,cyclophosphamide,1,1
182477,",",1,0
182478,vincristine,1,1
182479,and,1,0
182480,etoposide,1,1
182481,and,0,0
182482,also,0,0
182483,randomised,0,0
182484,to,0,0
182485,receive,0,0
182486,",",0,0
182487,on,0,0
182488,disease,0,0
182489,progression,0,0
182490,",",0,0
182491,either,0,0
182492,second,1,0
182493,line,1,0
182494,chemotherapy,1,1
182495,(,1,0
182496,methotrexate,1,1
182497,and,1,0
182498,doxorubicin,1,1
182499,),1,0
182500,or,1,1
182501,symptomatic,1,0
182502,treatment,1,0
182503,only,1,0
182504,.,1,0
182505,In,0,0
182506,the,0,0
182507,whole,0,0
182508,study,0,0
182509,196,0,0
182510,(,0,0
182511,32.1,0,0
182512,%,0,0
182513,),0,0
182514,had,0,0
182515,limited,0,0
182516,disease,0,0
182517,and,0,0
182518,414,0,0
182519,(,0,0
182520,67.9,0,0
182521,%,0,0
182522,),0,0
182523,extensive,0,0
182524,disease,0,0
182525,.,0,0
182526,During,0,0
182527,initial,0,0
182528,chemotherapy,0,1
182529,the,0,0
182530,response,0,0
182531,rate,0,0
182532,(,0,0
182533,complete,0,0
182534,and,0,0
182535,partial,0,0
182536,responses,0,0
182537,),0,0
182538,after,0,0
182539,four,0,0
182540,courses,0,0
182541,of,0,0
182542,treatment,0,0
182543,was,0,0
182544,61,0,0
182545,%,0,0
182546,with,0,0
182547,no,0,0
182548,significant,0,0
182549,increase,0,0
182550,in,0,0
182551,patients,0,0
182552,receiving,0,0
182553,eight,0,0
182554,courses,0,0
182555,(,0,0
182556,63,0,0
182557,%,0,0
182558,),0,0
182559,.,0,0
182560,In,0,0
182561,those,0,0
182562,randomised,0,0
182563,to,0,0
182564,receive,0,0
182565,relapse,0,0
182566,chemotherapy,0,1
182567,the,0,0
182568,response,0,0
182569,rate,0,0
182570,was,0,0
182571,improved,0,0
182572,slightly,0,0
182573,for,0,0
182574,those,0,0
182575,who,0,0
182576,had,0,0
182577,originally,0,0
182578,received,0,0
182579,four,0,0
182580,courses,0,0
182581,of,0,0
182582,chemotherapy,0,1
182583,(,0,0
182584,25.6,0,0
182585,%,0,0
182586,),0,0
182587,over,0,0
182588,those,0,0
182589,receiving,0,0
182590,eight,0,0
182591,(,0,0
182592,18.7,0,0
182593,%,0,0
182594,),0,0
182595,.,0,0
182596,The,0,0
182597,overall,0,0
182598,results,0,0
182599,show,0,0
182600,that,0,0
182601,of,0,0
182602,the,0,0
182603,four,0,0
182604,possible,0,0
182605,treatment,0,0
182606,randomizations,0,0
182607,",",0,0
182608,four,0,0
182609,courses,0,0
182610,of,0,0
182611,chemotherapy,0,1
182612,alone,0,1
182613,is,0,0
182614,inferior,0,0
182615,in,0,0
182616,terms,0,0
182617,of,0,0
182618,overall,0,0
182619,survival,0,0
182620,(,0,0
182621,30,0,0
182622,weeks,0,0
182623,median,0,0
182624,survival,0,0
182625,),0,0
182626,to,0,0
182627,the,0,0
182628,other,0,0
182629,three,0,0
182630,treatment,0,0
182631,options,0,0
182632,(,0,0
182633,39,0,0
182634,weeks,0,0
182635,median,0,0
182636,survival,0,0
182637,",",0,0
182638,P,0,0
182639,less,0,0
182640,than,0,0
182641,0.01,0,0
182642,),0,0
182643,.,0,0
182644,In,0,0
182645,patients,0,0
182646,responding,0,0
182647,to,0,0
182648,initial,0,0
182649,chemotherapy,0,1
182650,the,0,0
182651,disadvantage,0,0
182652,of,0,0
182653,four,0,0
182654,courses,0,0
182655,of,0,0
182656,chemotherapy,0,1
182657,alone,0,1
182658,was,0,0
182659,apparent,0,0
182660,(,0,0
182661,median,0,0
182662,survival,0,0
182663,of,0,0
182664,40,0,0
182665,weeks,0,0
182666,versus,0,0
182667,49,0,0
182668,weeks,0,0
182669,",",0,0
182670,P,0,0
182671,=,0,0
182672,0.003,0,0
182673,),0,0
182674,but,0,0
182675,not,0,0
182676,if,0,0
182677,drug,0,0
182678,treatment,0,0
182679,was,0,0
182680,given,0,0
182681,on,0,0
182682,relapse,0,0
182683,.,0,0
182684,The,0,0
182685,study,0,0
182686,shows,0,0
182687,that,0,0
182688,limiting,0,0
182689,treatment,0,0
182690,to,0,0
182691,four,0,0
182692,courses,0,0
182693,of,0,0
182694,chemotherapy,0,1
182695,alone,0,1
182696,is,0,0
182697,associated,0,0
182698,with,0,0
182699,inferior,0,0
182700,survival,0,0
182701,",",0,0
182702,but,0,0
182703,this,0,0
182704,is,0,0
182705,not,0,0
182706,the,0,0
182707,case,0,0
182708,if,0,0
182709,chemotherapy,0,1
182710,is,0,0
182711,given,0,0
182712,at,0,0
182713,relapse,0,0
182714,.,0,0
182715,Exercise,0,1
182716,echocardiography,0,1
182717,demonstrates,0,0
182718,biventricular,0,0
182719,systolic,0,0
182720,dysfunction,0,0
182721,and,0,0
182722,reveals,0,0
182723,decreased,0,0
182724,left,0,0
182725,ventricular,0,0
182726,contractile,0,0
182727,reserve,0,0
182728,in,0,0
182729,children,0,0
182730,after,0,0
182731,tetralogy,0,0
182732,of,0,0
182733,Fallot,0,0
182734,repair,0,1
182735,.,0,0
182736,BACKGROUND,0,0
182737,Long-term,0,0
182738,biventricular,0,1
182739,systolic,0,0
182740,performance,0,0
182741,is,0,0
182742,a,0,0
182743,key,0,0
182744,determinant,0,0
182745,of,0,0
182746,clinical,0,0
182747,outcomes,0,0
182748,late,0,0
182749,after,0,0
182750,tetralogy,1,0
182751,of,1,0
182752,Fallot,1,1
182753,(,1,0
182754,TOF,1,1
182755,),1,0
182756,repair,1,1
182757,.,1,0
182758,A,0,0
182759,need,0,0
182760,exists,0,0
182761,for,0,0
182762,early,0,0
182763,indices,0,0
182764,of,0,0
182765,both,0,0
182766,left,0,0
182767,ventricular,0,0
182768,(,0,0
182769,LV,0,1
182770,),0,1
182771,and,0,0
182772,right,0,0
182773,ventricular,0,0
182774,(,0,0
182775,RV,0,1
182776,),0,0
182777,compromise,0,0
182778,in,0,0
182779,this,0,0
182780,population,0,0
182781,.,0,0
182782,METHODS,0,0
182783,Twenty-nine,0,0
182784,children,0,0
182785,(,0,0
182786,age,0,0
182787,range,0,0
182788,",",0,0
182789,5-18,0,0
182790,years,0,0
182791,),0,0
182792,with,0,0
182793,repaired,0,0
182794,TOF,0,0
182795,and,0,0
182796,44,0,0
182797,healthy,0,0
182798,controls,0,0
182799,were,0,0
182800,prospectively,0,0
182801,evaluated,0,0
182802,.,0,0
182803,M-mode,1,1
182804,and,1,0
182805,tissue,1,0
182806,Doppler,1,1
182807,data,1,0
182808,were,0,0
182809,obtained,0,0
182810,for,0,0
182811,each,0,0
182812,ventricle,0,0
182813,and,0,0
182814,the,0,0
182815,RV,0,1
182816,outflow,0,0
182817,tract,0,0
182818,at,0,0
182819,rest,0,0
182820,and,0,0
182821,during,0,0
182822,semisupine,1,1
182823,bicycle,1,1
182824,exercise,1,1
182825,.,1,0
182826,By,0,0
182827,making,0,0
182828,measurements,0,0
182829,of,0,0
182830,myocardial,0,0
182831,acceleration,0,0
182832,during,0,0
182833,isovolumic,0,0
182834,contraction,0,0
182835,during,0,0
182836,exercise,0,1
182837,",",0,0
182838,at,0,0
182839,increasing,0,0
182840,heart,0,0
182841,rates,0,0
182842,",",0,0
182843,LV,0,0
182844,force-frequency,0,0
182845,curves,0,0
182846,were,0,0
182847,constructed,0,0
182848,.,0,0
182849,Patients,0,0
182850,also,0,0
182851,underwent,0,0
182852,cardiac,1,0
182853,magnetic,1,1
182854,resonance,1,1
182855,imaging,1,0
182856,",",1,0
182857,cardiopulmonary,1,1
182858,exercise,1,1
182859,testing,1,0
182860,",",1,0
182861,and,1,0
182862,measurement,1,0
182863,of,1,0
182864,serum,1,0
182865,neurohormonal,1,0
182866,markers,1,0
182867,.,1,0
182868,RESULTS,0,0
182869,Children,0,0
182870,with,0,0
182871,repaired,0,0
182872,TOF,0,0
182873,had,0,0
182874,dilated,0,0
182875,right,0,0
182876,ventricles,0,0
182877,(,0,0
182878,RV,0,1
182879,end-diastolic,0,0
182880,volume,0,0
182881,index,0,0
182882,=,0,0
182883,153,0,0
182884,?,0,0
182885,37.3,0,0
182886,mL/m,0,0
182887,(,0,0
182888,2,0,0
182889,),0,0
182890,),0,0
182891,but,0,0
182892,normal,0,0
182893,ejection,0,0
182894,fractions,0,1
182895,as,0,0
182896,measured,0,0
182897,on,0,0
182898,magnetic,0,1
182899,resonance,0,1
182900,imaging,0,1
182901,(,0,0
182902,LV,0,1
182903,ejection,0,0
182904,fraction,0,0
182905,=,0,0
182906,59.3,0,0
182907,?,0,0
182908,6.2,0,0
182909,%,0,0
182910,",",0,0
182911,RV,0,1
182912,ejection,0,0
182913,fraction,0,0
182914,=,0,0
182915,50.2,0,0
182916,?,0,0
182917,8.5,0,0
182918,%,0,0
182919,),0,0
182920,and,0,0
182921,normal,0,0
182922,serum,0,0
182923,neurohormonal,0,0
182924,markers,0,0
182925,.,0,0
182926,Detailed,0,0
182927,resting,0,0
182928,echocardiography,0,0
182929,detected,0,0
182930,abnormal,0,0
182931,ventricular,0,0
182932,function,0,0
182933,",",0,0
182934,worst,0,0
182935,in,0,0
182936,the,0,0
182937,right,0,0
182938,ventricle,0,0
182939,and,0,0
182940,RV,0,1
182941,outflow,0,0
182942,tract,0,0
182943,.,0,0
182944,Exercise,0,0
182945,exacerbated,0,0
182946,these,0,0
182947,findings,0,0
182948,and,0,0
182949,provoked,0,0
182950,significant,0,0
182951,decline,0,0
182952,in,0,0
182953,LV,0,0
182954,indices,0,0
182955,.,0,0
182956,The,0,0
182957,LV,0,0
182958,force-frequency,0,0
182959,curves,0,0
182960,of,0,0
182961,patients,0,0
182962,were,0,0
182963,attenuated,0,0
182964,",",0,0
182965,with,0,0
182966,an,0,0
182967,early,0,0
182968,plateau,0,0
182969,and,0,0
182970,inadequate,0,0
182971,increase,0,0
182972,of,0,0
182973,isovolumic,0,0
182974,contraction,0,0
182975,.,0,0
182976,Correlations,0,0
182977,were,0,0
182978,seen,0,0
182979,between,0,0
182980,peak,0,0
182981,exercise,0,1
182982,LV,0,1
182983,isovolumic,0,0
182984,contraction,0,0
182985,and,0,0
182986,percentage,0,0
182987,predicted,0,0
182988,peak,0,0
182989,oxygen,0,1
182990,uptake,0,0
182991,(,0,0
182992,r,0,0
182993,=,0,0
182994,0.51,0,0
182995,",",0,0
182996,P,0,0
182997,=,0,0
182998,.02,0,0
182999,),0,0
183000,",",0,0
183001,LV,0,1
183002,and,0,0
183003,RV,0,1
183004,ejection,0,0
183005,fractions,0,1
183006,(,0,0
183007,r,0,0
183008,=,0,0
183009,0.41,0,0
183010,",",0,0
183011,P,0,0
183012,=,0,0
183013,.03,0,0
183014,),0,0
183015,",",0,0
183016,and,0,0
183017,RV,0,1
183018,and,0,0
183019,LV,0,1
183020,long-axis,0,1
183021,fractional,0,0
183022,shortening,0,0
183023,(,0,0
183024,r,0,0
183025,=,0,0
183026,0.44,0,0
183027,",",0,0
183028,P,0,0
183029,=,0,0
183030,.02,0,0
183031,),0,0
183032,.,0,0
183033,CONCLUSIONS,0,0
183034,The,0,0
183035,postsurgical,0,0
183036,pathophysiology,0,0
183037,of,0,0
183038,TOF,0,0
183039,begins,0,0
183040,early,0,0
183041,after,0,0
183042,repair,0,1
183043,.,0,0
183044,At,0,0
183045,a,0,0
183046,time,0,0
183047,when,0,0
183048,clinically,0,0
183049,well,0,0
183050,and,0,0
183051,while,0,0
183052,routine,0,0
183053,indices,0,0
183054,of,0,0
183055,heart,0,0
183056,function,0,0
183057,remain,0,0
183058,normal,0,0
183059,",",0,0
183060,children,0,0
183061,with,0,0
183062,repaired,0,0
183063,TOF,0,0
183064,exhibit,0,0
183065,RV,0,1
183066,dilatation,0,1
183067,and,0,0
183068,subtle,0,0
183069,",",0,0
183070,interlinked,0,0
183071,biventricular,0,0
183072,abnormalities,0,0
183073,on,0,0
183074,resting,0,0
183075,echocardiography,1,0
183076,.,1,0
183077,Exercise,1,1
183078,echocardiography,1,0
183079,provides,0,0
183080,additional,0,0
183081,information,0,0
183082,and,0,0
183083,reveals,0,0
183084,abnormal,0,0
183085,LV,0,1
183086,excitation-contractile,0,1
183087,coupling,0,0
183088,that,0,0
183089,may,0,0
183090,be,0,0
183091,linked,0,0
183092,to,0,0
183093,impaired,0,0
183094,exercise,0,1
183095,capacity,0,0
183096,.,0,0
183097,Parents,0,0
183098,',0,0
183099,Adoption,0,0
183100,of,0,0
183101,Social,1,0
183102,Communication,1,1
183103,Intervention,1,1
183104,Strategies,1,0
183105,:,1,0
183106,Families,0,0
183107,Including,0,0
183108,Children,0,0
183109,with,0,0
183110,Autism,0,0
183111,Spectrum,0,1
183112,Disorder,0,0
183113,Who,0,0
183114,are,0,0
183115,Minimally,0,1
183116,Verbal,0,1
183117,.,0,0
183118,Notably,0,0
183119,absent,0,0
183120,from,0,0
183121,the,0,0
183122,intervention,0,1
183123,literature,0,0
183124,are,0,0
183125,parent,0,1
183126,training,0,1
183127,programs,0,1
183128,targeting,0,0
183129,school-aged,0,0
183130,children,0,0
183131,with,0,0
183132,autism,0,0
183133,who,0,0
183134,have,0,0
183135,limited,0,0
183136,communication,0,0
183137,skills,0,1
183138,(,0,0
183139,Tager-Flusberg,0,0
183140,and,0,0
183141,Kasari,0,1
183142,in,0,0
183143,Autism,0,0
183144,Res,0,0
183145,6:468-478,0,0
183146,",",0,0
183147,2013,0,0
183148,),0,0
183149,.,0,0
183150,Sixty-one,0,0
183151,children,0,0
183152,with,0,0
183153,autism,0,0
183154,age,0,0
183155,5-8,0,0
183156,with,0,0
183157,minimal,0,0
183158,spontaneous,0,0
183159,communication,0,0
183160,received,0,0
183161,a,0,0
183162,6-month,1,0
183163,social,1,0
183164,communication,1,1
183165,intervention,1,1
183166,including,1,0
183167,parent,1,1
183168,training,1,1
183169,.,1,0
183170,Parent-child,0,0
183171,play,0,0
183172,interactions,0,0
183173,were,0,0
183174,coded,0,0
183175,for,0,0
183176,parents,0,0
183177,',0,0
183178,strategy,0,0
183179,implementation,0,0
183180,and,0,0
183181,children,0,0
183182,'s,0,0
183183,time,0,0
183184,jointly,0,0
183185,engaged,0,0
183186,(,0,0
183187,Adamson,0,0
183188,et,0,0
183189,al,0,0
183190,.,0,0
183191,in,0,0
183192,J,0,0
183193,Autism,0,0
183194,Dev,0,1
183195,Disord,0,0
183196,39:84-96,0,0
183197,",",0,0
183198,2009,0,0
183199,),0,0
183200,.,0,0
183201,Parents,0,0
183202,mastered,0,0
183203,an,0,0
183204,average,0,0
183205,of,0,0
183206,70,0,0
183207,%,0,0
183208,of,0,0
183209,the,0,0
183210,strategies,0,0
183211,.,0,0
183212,Further,0,0
183213,analyses,0,0
183214,indicated,0,0
183215,some,0,0
183216,gains,0,0
183217,in,0,0
183218,implementation,0,0
183219,occurred,0,0
183220,from,0,0
183221,mere,0,0
183222,observation,0,0
183223,of,0,0
183224,sessions,0,1
183225,",",0,0
183226,while,0,0
183227,the,0,0
183228,greatest,0,0
183229,gains,0,0
183230,occurred,0,0
183231,in,0,0
183232,the,0,0
183233,first,0,0
183234,month,0,0
183235,of,0,0
183236,active,0,0
183237,coaching,0,1
183238,and,0,0
183239,workshops,0,1
183240,.,0,0
183241,Children,0,0
183242,'s,0,0
183243,joint,0,0
183244,engagement,0,0
183245,was,0,0
183246,associated,0,0
183247,with,0,0
183248,parents,0,0
183249,',0,0
183250,implementation,0,0
183251,success,0,0
183252,across,0,0
183253,time,0,0
183254,demonstrating,0,0
183255,parents,0,0
183256,',0,0
183257,implementation,0,0
183258,was,0,0
183259,relevant,0,0
183260,to,0,0
183261,children,0,0
183262,'s,0,0
183263,social,0,0
183264,engagement,0,0
183265,.,0,0
183266,Effect,0,0
183267,of,0,0
183268,L-type,0,1
183269,calcium,0,1
183270,channel,0,0
183271,blocker,0,1
183272,(,1,0
183273,amlodipine,1,1
183274,),1,0
183275,on,0,0
183276,myocardial,0,0
183277,iron,0,1
183278,deposition,0,0
183279,in,0,0
183280,patients,0,0
183281,with,0,0
183282,thalassaemia,0,0
183283,with,0,0
183284,moderate-to-severe,0,0
183285,myocardial,0,0
183286,iron,0,1
183287,deposition,0,0
183288,:,0,0
183289,protocol,0,0
183290,for,0,0
183291,a,0,0
183292,randomised,0,0
183293,",",0,0
183294,controlled,0,0
183295,trial,0,0
183296,.,0,0
183297,INTRODUCTION,0,0
183298,Sideroblastic,0,0
183299,cardiomyopathy,0,0
183300,secondary,0,0
183301,to,0,0
183302,repeated,0,0
183303,blood,0,0
183304,transfusions,0,0
183305,is,0,0
183306,a,0,0
183307,feared,0,0
183308,complication,0,0
183309,in,0,0
183310,thalassaemia,0,0
183311,.,0,0
183312,Control,0,0
183313,of,0,0
183314,myocardial,0,0
183315,iron,0,1
183316,is,0,0
183317,thus,0,0
183318,becoming,0,0
183319,the,0,0
183320,cornerstone,0,0
183321,of,0,0
183322,thalassaemia,0,0
183323,management,0,0
183324,.,0,0
183325,Recent,0,0
183326,evidence,0,0
183327,suggests,0,0
183328,a,0,0
183329,role,0,0
183330,for,0,0
183331,L-type,0,1
183332,Ca,0,0
183333,(,0,0
183334,2+,0,0
183335,),0,0
183336,channels,0,0
183337,in,0,0
183338,mediating,0,0
183339,iron,0,1
183340,uptake,0,0
183341,by,0,0
183342,the,0,0
183343,heart,0,0
183344,.,0,0
183345,Blocking,0,0
183346,the,0,0
183347,cellular,0,0
183348,iron,0,1
183349,uptake,0,0
183350,through,0,0
183351,these,0,0
183352,channels,0,0
183353,may,0,0
183354,add,0,0
183355,to,0,0
183356,the,0,0
183357,benefit,0,0
183358,of,0,0
183359,therapy,0,1
183360,to,0,0
183361,standard,0,1
183362,chelation,0,1
183363,in,0,0
183364,reducing,0,0
183365,myocardial,0,0
183366,iron,0,1
183367,.,0,0
183368,We,0,0
183369,aim,0,0
183370,to,0,0
183371,determine,0,0
183372,the,0,0
183373,efficacy,0,0
183374,of,0,0
183375,amlodipine,1,1
183376,(,0,0
183377,a,0,0
183378,calcium,0,1
183379,channel,0,0
183380,blocker,0,1
183381,),0,0
183382,as,0,0
183383,an,0,0
183384,adjunct,0,0
183385,to,0,0
183386,standard,0,1
183387,aggressive,0,0
183388,chelation,0,1
183389,in,0,0
183390,retarding,0,0
183391,myocardial,0,0
183392,iron,0,1
183393,deposition,0,0
183394,in,0,0
183395,thalassaemics,0,0
183396,with,0,0
183397,or,0,0
183398,without,0,0
183399,cardiomyopathy,0,0
183400,.,0,0
183401,OUTCOMES,0,0
183402,The,0,0
183403,primary,0,0
183404,outcome,0,0
183405,is,0,0
183406,to,0,0
183407,compare,0,0
183408,the,0,0
183409,efficacy,0,0
183410,of,0,0
183411,amlodipine+chelation,1,1
183412,(,1,0
183413,intervention,1,1
183414,),1,0
183415,versus,0,0
183416,standard,1,1
183417,chelation,1,1
183418,(,1,0
183419,control,1,1
183420,),1,0
183421,in,0,0
183422,retarding,0,0
183423,myocardial,0,0
183424,iron,0,1
183425,deposition,0,0
183426,.,0,0
183427,Secondary,0,0
183428,outcomes,0,0
183429,include,0,0
183430,the,0,0
183431,effect,0,0
183432,of,0,0
183433,amlodipine,1,1
183434,therapy,0,1
183435,on,0,0
183436,systolic,0,0
183437,and,0,0
183438,diastolic,0,0
183439,function,0,0
183440,",",0,0
183441,strain,0,0
183442,and,0,0
183443,strain,0,0
183444,rate,0,0
183445,and,0,0
183446,liver,0,0
183447,iron,0,1
183448,content,0,0
183449,.,0,0
183450,METHODS,0,0
183451,AND,0,0
183452,ANALYSIS,0,1
183453,This,0,0
183454,is,0,0
183455,a,0,0
183456,single-centre,0,0
183457,",",0,0
183458,parallel-group,0,0
183459,",",0,0
183460,prospective,0,0
183461,randomised,0,0
183462,control,0,0
183463,trial,0,0
183464,.,0,0
183465,Twenty,0,0
183466,patients,0,0
183467,will,0,0
183468,be,0,0
183469,randomised,0,0
183470,in,0,0
183471,a,0,0
183472,1:1,0,1
183473,allocation,0,0
183474,ratio,0,0
183475,into,0,0
183476,the,0,0
183477,intervention,0,1
183478,and,0,0
183479,control,0,0
183480,arms,0,0
183481,.,0,0
183482,In,0,0
183483,addition,0,0
183484,to,0,0
183485,conventional,0,1
183486,echocardiography,0,0
183487,",",0,0
183488,MRI,0,0
183489,T2*,0,1
183490,values,0,0
183491,for,0,0
183492,assessment,0,0
183493,of,0,0
183494,cardiac,0,0
183495,and,0,0
183496,liver,0,0
183497,iron,0,1
183498,load,0,0
183499,will,0,0
183500,be,0,0
183501,obtained,0,0
183502,at,0,0
183503,baseline,0,0
183504,and,0,0
183505,at,0,0
183506,6,0,0
183507,and,0,0
183508,12,0,0
183509,months,0,0
183510,.,0,0
183511,Cardiac,0,0
183512,T2*,0,1
183513,will,0,0
183514,be,0,0
183515,reported,0,0
183516,as,0,0
183517,the,0,0
183518,geometric,0,0
183519,mean,0,0
183520,and,0,0
183521,per,0,0
183522,cent,0,0
183523,coefficient,0,0
183524,of,0,0
183525,variation,0,0
183526,",",0,0
183527,and,0,0
183528,an,0,0
183529,increase,0,0
183530,in,0,0
183531,cardiac,0,0
183532,T2*,0,1
183533,values,0,0
183534,from,0,0
183535,baseline,0,0
183536,will,0,0
183537,be,0,0
183538,used,0,0
183539,as,0,0
183540,an,0,0
183541,end,0,0
183542,point,0,0
183543,to,0,0
183544,compare,0,0
183545,the,0,0
183546,efficacy,0,0
183547,of,0,0
183548,therapy,0,1
183549,.,0,0
183550,A,0,0
183551,p,0,0
183552,Value,0,0
183553,of,0,0
183554,<,0,0
183555,0.05,0,0
183556,will,0,0
183557,be,0,0
183558,considered,0,0
183559,significant,0,0
183560,.,0,0
183561,STUDY,0,0
183562,SETTING,0,0
183563,Department,0,0
183564,of,0,0
183565,Pediatric,0,1
183566,and,0,0
183567,Child,0,0
183568,Health,0,0
183569,",",0,0
183570,Aga,0,1
183571,Khan,0,0
183572,University,0,0
183573,Hospital,0,0
183574,",",0,0
183575,Karachi,0,0
183576,",",0,0
183577,Pakistan,0,0
183578,.,0,0
183579,ETHICS,0,1
183580,AND,0,0
183581,DISSEMINATION,0,0
183582,This,0,0
183583,study,0,0
183584,has,0,0
183585,been,0,0
183586,approved,0,0
183587,by,0,0
183588,the,0,0
183589,Ethics,0,0
183590,Review,0,1
183591,Committee,0,1
183592,and,0,0
183593,Clinical,0,0
183594,Trials,0,1
183595,Unit,0,0
183596,at,0,0
183597,The,0,0
183598,Aga,0,1
183599,Khan,0,0
183600,University,0,0
183601,with,0,0
183602,respect,0,0
183603,to,0,0
183604,scientific,0,0
183605,content,0,0
183606,and,0,0
183607,compliance,0,0
183608,with,0,0
183609,applicable,0,0
183610,research,0,0
183611,and,0,0
183612,human,0,0
183613,subjects,0,0
183614,regulations,0,0
183615,.,0,0
183616,Findings,0,0
183617,will,0,0
183618,be,0,0
183619,reported,0,0
183620,through,0,0
183621,scientific,0,0
183622,publications,0,0
183623,and,0,0
183624,research,0,0
183625,conferences,0,1
183626,and,0,0
183627,project,0,0
183628,summary,0,0
183629,papers,0,0
183630,for,0,0
183631,participants,0,0
183632,.,0,0
183633,TRIAL,0,0
183634,REGISTRATION,0,0
183635,NUMBER,0,0
183636,ClinicalTrials.Gov,0,0
183637,.,0,0
183638,Registration,0,0
183639,no,0,0
183640,:,0,0
183641,NCT02065492,0,0
183642,.,0,0
183643,Carboplatin,1,1
183644,and,1,0
183645,pegylated,1,1
183646,liposomal,1,1
183647,doxorubicin,1,1
183648,versus,0,1
183649,carboplatin,1,1
183650,and,1,0
183651,paclitaxel,1,1
183652,in,0,0
183653,very,0,0
183654,platinum-sensitive,0,0
183655,ovarian,0,0
183656,cancer,0,0
183657,patients,0,0
183658,:,0,0
183659,results,0,0
183660,from,0,0
183661,a,0,0
183662,subset,0,0
183663,analysis,0,0
183664,of,0,0
183665,the,0,0
183666,CALYPSO,0,0
183667,phase,0,0
183668,III,0,0
183669,trial,0,0
183670,.,0,0
183671,AIM,0,0
183672,To,0,0
183673,perform,0,0
183674,a,0,0
183675,subset,0,0
183676,analysis,0,0
183677,of,0,0
183678,patients,0,0
183679,with,0,0
183680,very,0,0
183681,platinum-sensitive,0,0
183682,recurrent,0,0
183683,ovarian,0,0
183684,cancer,0,0
183685,(,0,0
183686,ROC,0,1
183687,),0,0
183688,enrolled,0,0
183689,in,0,0
183690,the,0,0
183691,phase,0,0
183692,III,0,0
183693,CALYPSO,0,0
183694,trial,0,0
183695,.,0,0
183696,PATIENTS,0,0
183697,AND,0,0
183698,METHODS,0,0
183699,The,0,0
183700,international,0,0
183701,non-inferiority,0,0
183702,trial,0,0
183703,enrolled,0,0
183704,women,0,0
183705,with,0,0
183706,ROC,0,0
183707,that,0,0
183708,relapsed,0,0
183709,>,0,0
183710,6,0,0
183711,months,0,0
183712,following,0,0
183713,first-,0,0
183714,or,0,1
183715,second-line,0,1
183716,platinum-,1,1
183717,and,1,0
183718,paclitaxel-based,1,1
183719,therapies,1,0
183720,.,1,0
183721,Patients,0,0
183722,were,0,0
183723,randomised,0,0
183724,to,0,0
183725,CD,1,0
183726,[,1,0
183727,carboplatin-pegylated,1,1
183728,liposomal,1,1
183729,doxorubicin,1,1
183730,(,1,0
183731,PLD,1,1
183732,),1,0
183733,],1,0
183734,or,1,1
183735,CP,1,1
183736,(,1,1
183737,carboplatin-paclitaxel,1,1
183738,),1,0
183739,and,0,0
183740,stratified,0,0
183741,by,0,0
183742,treatment-free,0,0
183743,interval,0,0
183744,(,0,0
183745,TFI,0,1
183746,),0,0
183747,.,0,0
183748,In,0,0
183749,this,0,0
183750,analysis,0,0
183751,",",0,0
183752,patients,0,0
183753,with,0,0
183754,a,0,0
183755,TFI,0,0
183756,>,0,0
183757,24,0,0
183758,months,0,0
183759,were,0,0
183760,analysed,0,0
183761,separately,0,0
183762,for,0,0
183763,progression,0,0
183764,free,0,0
183765,survival,0,0
183766,(,0,0
183767,PFS,0,0
183768,),0,0
183769,",",0,0
183770,the,0,0
183771,primary,0,0
183772,endpoint,0,0
183773,of,0,0
183774,CALYPSO,0,0
183775,",",0,0
183776,overall,0,0
183777,survival,0,0
183778,(,0,0
183779,OS,0,0
183780,),0,1
183781,and,0,0
183782,safety,0,0
183783,.,0,0
183784,RESULTS,0,0
183785,A,0,0
183786,total,0,0
183787,of,0,0
183788,259,0,0
183789,very,0,0
183790,platinum-sensitive,0,0
183791,patients,0,0
183792,were,0,0
183793,included,0,0
183794,(,0,0
183795,n=131,0,0
183796,",",0,0
183797,CD,0,0
183798,;,0,0
183799,n=128,0,0
183800,",",0,0
183801,CP,0,1
183802,),0,0
183803,.,0,0
183804,Median,0,0
183805,PFS,0,0
183806,was,0,0
183807,12.0,0,0
183808,months,0,0
183809,for,0,0
183810,the,0,0
183811,CD,1,0
183812,arm,0,0
183813,and,0,0
183814,12.3,0,0
183815,months,0,0
183816,for,0,0
183817,CP,1,1
183818,[,0,0
183819,HR=1.05,0,0
183820,(,0,0
183821,95,0,0
183822,%,0,0
183823,CI,0,0
183824,",",0,0
183825,0.79-1.40,0,0
183826,),0,0
183827,;,0,0
183828,P=0.73,0,0
183829,for,0,0
183830,superiority,0,0
183831,],0,0
183832,and,0,0
183833,median,0,0
183834,OS,0,0
183835,was,0,0
183836,40.2,0,0
183837,months,0,0
183838,for,0,0
183839,CD,0,0
183840,and,0,0
183841,43.9,0,0
183842,for,0,0
183843,CP,0,1
183844,[,0,0
183845,HR=1.18,0,0
183846,(,0,0
183847,95,0,0
183848,%,0,0
183849,CI,0,0
183850,0.85-1.63,0,0
183851,),0,0
183852,;,0,0
183853,P=0.33,0,0
183854,for,0,0
183855,superiority,0,0
183856,],0,0
183857,.,0,0
183858,Overall,0,0
183859,response,0,0
183860,rates,0,0
183861,were,0,0
183862,42,0,0
183863,%,0,0
183864,and,0,0
183865,38,0,0
183866,%,0,0
183867,",",0,0
183868,respectively,0,0
183869,(,0,0
183870,P=0.46,0,0
183871,),0,0
183872,.,0,0
183873,Toxicities,0,0
183874,were,0,0
183875,more,0,0
183876,common,0,0
183877,with,0,0
183878,CP,1,1
183879,versus,0,0
183880,CD,1,0
183881,",",0,0
183882,including,0,0
183883,grade,0,0
183884,3/4,0,0
183885,neutropenia,0,0
183886,(,0,0
183887,40.8,0,0
183888,%,0,0
183889,versus,0,0
183890,27.5,0,0
183891,%,0,0
183892,;,0,0
183893,P=0.025,0,0
183894,),0,0
183895,",",0,0
183896,nausea,0,0
183897,(,0,0
183898,4.8,0,0
183899,%,0,0
183900,versus,0,0
183901,3.1,0,0
183902,%,0,0
183903,;,0,0
183904,P=0.47,0,0
183905,),0,0
183906,",",0,0
183907,allergic,0,0
183908,reaction,0,1
183909,(,0,0
183910,8,0,0
183911,%,0,0
183912,versus,0,0
183913,3.1,0,0
183914,%,0,0
183915,;,0,0
183916,P=0.082,0,0
183917,),0,0
183918,sensory,0,0
183919,neuropathy,0,0
183920,(,0,0
183921,4.8,0,0
183922,%,0,0
183923,versus,0,0
183924,2.3,0,0
183925,%,0,0
183926,;,0,0
183927,P=0.27,0,0
183928,),0,0
183929,and,0,0
183930,grade,0,0
183931,2,0,0
183932,alopecia,0,0
183933,(,0,0
183934,88,0,0
183935,%,0,0
183936,versus,0,0
183937,9.2,0,0
183938,%,0,0
183939,;,0,0
183940,P,0,0
183941,<,0,0
183942,0.001,0,0
183943,),0,0
183944,.,0,0
183945,Grade,0,0
183946,3/4,0,0
183947,thrombocytopenia,0,0
183948,(,0,0
183949,12.2,0,0
183950,%,0,0
183951,versus,0,0
183952,3.2,0,0
183953,%,0,0
183954,;,0,0
183955,P=0.007,0,0
183956,),0,0
183957,and,0,0
183958,mucositis,0,0
183959,(,0,0
183960,2.3,0,0
183961,%,0,0
183962,versus,0,0
183963,0,0,0
183964,%,0,0
183965,;,0,0
183966,P=0.089,0,0
183967,),0,0
183968,were,0,0
183969,more,0,0
183970,common,0,0
183971,with,0,0
183972,CD,1,0
183973,.,1,0
183974,Grade,0,0
183975,3/4,0,0
183976,hand-foot,0,0
183977,syndrome,0,0
183978,occurred,0,0
183979,rarely,0,0
183980,with,0,0
183981,CD,1,1
183982,(,0,0
183983,3,0,0
183984,patients,0,0
183985,versus,0,0
183986,0,0,0
183987,in,0,0
183988,CP,0,1
183989,arm,0,0
183990,;,0,0
183991,P=0.089,0,0
183992,),0,0
183993,.,0,0
183994,CONCLUSION,0,0
183995,CP,0,1
183996,and,0,0
183997,CD,0,1
183998,were,0,0
183999,equally,0,0
184000,effective,0,0
184001,treatment,0,0
184002,regimens,0,0
184003,for,0,0
184004,patients,0,0
184005,with,0,0
184006,very,0,0
184007,platinum-sensitive,0,0
184008,ROC,0,0
184009,.,0,0
184010,The,0,0
184011,favourable,0,0
184012,risk-benefit,0,0
184013,profile,0,0
184014,suggests,0,0
184015,carboplatin-PLD,1,1
184016,as,0,0
184017,treatment,0,0
184018,of,0,0
184019,choice,0,0
184020,for,0,0
184021,these,0,0
184022,patients,0,0
184023,.,0,0
184024,N-acetylcysteine,1,1
184025,as,0,0
184026,an,0,0
184027,adjunctive,1,1
184028,therapy,1,1
184029,to,0,0
184030,risperidone,1,1
184031,for,0,0
184032,treatment,0,0
184033,of,0,0
184034,irritability,0,0
184035,in,0,0
184036,autism,0,0
184037,:,0,0
184038,a,0,0
184039,randomized,0,0
184040,",",0,0
184041,double-blind,0,0
184042,",",0,0
184043,placebo-controlled,0,1
184044,clinical,0,0
184045,trial,0,0
184046,of,0,0
184047,efficacy,0,0
184048,and,0,0
184049,safety,0,0
184050,.,0,0
184051,OBJECTIVES,0,0
184052,According,0,0
184053,to,0,0
184054,the,0,0
184055,proposed,0,0
184056,interference,0,0
184057,of,0,0
184058,N-acetylcysteine,1,1
184059,(,1,0
184060,NAC,1,1
184061,),1,0
184062,with,0,0
184063,pathophysiologic,0,0
184064,processes,0,0
184065,of,0,0
184066,autistic,0,0
184067,disorders,0,0
184068,(,0,0
184069,ADs,0,0
184070,),0,0
184071,",",0,0
184072,we,0,0
184073,aimed,0,0
184074,to,0,0
184075,assess,0,0
184076,the,0,0
184077,effectiveness,0,0
184078,and,0,0
184079,safety,0,0
184080,of,0,0
184081,NAC,1,0
184082,as,0,0
184083,an,0,0
184084,adjunct,0,0
184085,to,0,0
184086,risperidone,1,1
184087,in,0,0
184088,the,0,0
184089,treatment,0,0
184090,of,0,0
184091,ADs,0,0
184092,in,0,0
184093,a,0,0
184094,randomized,0,0
184095,",",0,0
184096,double-blind,0,0
184097,",",0,0
184098,clinical,0,0
184099,trial,0,0
184100,.,0,0
184101,METHODS,0,0
184102,The,0,0
184103,participants,0,0
184104,were,0,0
184105,referred,0,0
184106,outpatients,0,0
184107,between,0,0
184108,4,0,0
184109,and,0,0
184110,12,0,0
184111,years,0,0
184112,of,0,0
184113,age,0,0
184114,with,0,0
184115,the,0,0
184116,diagnosis,0,0
184117,of,0,0
184118,ADs,0,0
184119,and,0,0
184120,a,0,0
184121,score,0,0
184122,of,0,0
184123,more,0,0
184124,than,0,0
184125,12,0,0
184126,on,0,0
184127,Aberrant,0,0
184128,Behavior,0,0
184129,Checklist-Community,0,1
184130,(,0,0
184131,ABC-C,0,1
184132,),0,1
184133,Irritability,0,0
184134,subscale,0,0
184135,score,0,0
184136,.,0,0
184137,The,0,0
184138,participants,0,0
184139,were,0,0
184140,randomized,0,0
184141,into,0,0
184142,2,0,0
184143,groups,0,0
184144,.,0,0
184145,One,0,0
184146,group,0,0
184147,received,0,0
184148,risperidone,1,1
184149,plus,1,1
184150,NAC,1,1
184151,",",0,0
184152,and,0,0
184153,the,0,0
184154,other,0,0
184155,group,0,0
184156,received,0,0
184157,risperidone,1,1
184158,plus,1,1
184159,placebo,1,1
184160,.,1,0
184161,The,0,0
184162,dose,0,0
184163,of,0,0
184164,risperidone,1,1
184165,was,0,0
184166,titrated,0,0
184167,between,0,0
184168,1,0,0
184169,and,0,0
184170,2.0,0,0
184171,mg/d,0,0
184172,",",0,0
184173,and,0,0
184174,the,0,0
184175,dose,0,0
184176,of,0,0
184177,NAC,1,0
184178,was,0,0
184179,600,0,0
184180,to,0,0
184181,900,0,1
184182,mg/d,0,0
184183,.,0,0
184184,The,0,0
184185,main,0,0
184186,outcome,0,0
184187,was,0,0
184188,mean,0,0
184189,decrease,0,0
184190,in,0,0
184191,the,0,0
184192,ABC-C,0,1
184193,irritability,0,0
184194,subscale,0,0
184195,score,0,0
184196,from,0,0
184197,baseline,0,0
184198,at,0,0
184199,5,0,0
184200,and,0,0
184201,10,0,0
184202,weeks,0,0
184203,.,0,0
184204,Changes,0,0
184205,in,0,0
184206,other,0,0
184207,subscales,0,0
184208,were,0,0
184209,considered,0,0
184210,as,0,0
184211,secondary,0,0
184212,outcome,0,0
184213,measures,0,0
184214,.,0,0
184215,RESULTS,0,0
184216,Forty,0,0
184217,patients,0,0
184218,completed,0,0
184219,the,0,0
184220,10-week,0,1
184221,trial,0,0
184222,.,0,0
184223,Baseline,0,0
184224,characteristics,0,0
184225,including,0,0
184226,age,0,0
184227,",",0,0
184228,sex,0,0
184229,and,0,0
184230,body,0,0
184231,weight,0,0
184232,",",0,0
184233,as,0,0
184234,well,0,0
184235,as,0,0
184236,baseline,0,0
184237,scores,0,0
184238,in,0,0
184239,5,0,0
184240,subscales,0,0
184241,did,0,0
184242,not,0,0
184243,demonstrate,0,0
184244,statistically,0,0
184245,significant,0,0
184246,difference,0,0
184247,between,0,0
184248,the,0,0
184249,2,0,0
184250,groups,0,0
184251,.,0,0
184252,Repeated-measures,0,0
184253,analysis,0,0
184254,showed,0,0
184255,significant,0,0
184256,effect,0,0
184257,for,0,0
184258,time,0,0
184259,?,0,0
184260,treatment,0,0
184261,interaction,0,0
184262,in,0,0
184263,irritability,0,0
184264,(,0,0
184265,P,0,0
184266,=,0,0
184267,0.01,0,0
184268,),0,0
184269,and,0,0
184270,hyperactivity/noncompliance,0,0
184271,(,0,0
184272,P,0,0
184273,=,0,0
184274,0.02,0,0
184275,),0,0
184276,subscales,0,0
184277,.,0,0
184278,By,0,0
184279,week,0,0
184280,10,0,0
184281,",",0,0
184282,the,1,0
184283,NAC,1,1
184284,group,0,0
184285,showed,0,0
184286,significantly,0,0
184287,more,0,0
184288,reduction,0,0
184289,in,0,0
184290,irritability,0,0
184291,(,0,0
184292,P,0,0
184293,=,0,0
184294,0.02,0,0
184295,),0,0
184296,and,0,0
184297,hyperactivity/noncompliance,0,0
184298,(,0,0
184299,P,0,0
184300,=,0,0
184301,0.01,0,0
184302,),0,0
184303,subscales,0,0
184304,scores,0,0
184305,.,0,0
184306,CONCLUSIONS,1,0
184307,N-acetylcysteine,1,1
184308,can,0,0
184309,be,0,0
184310,considered,0,0
184311,as,0,0
184312,an,0,0
184313,adjuvant,0,1
184314,therapy,0,1
184315,for,0,0
184316,ADs,0,0
184317,with,0,0
184318,beneficial,0,0
184319,therapeutic,0,0
184320,outcomes,0,0
184321,.,0,0
184322,Effect,0,0
184323,of,0,0
184324,self-collection,1,0
184325,of,1,0
184326,HPV,1,0
184327,DNA,1,0
184328,offered,0,0
184329,by,0,0
184330,community,0,0
184331,health,0,0
184332,workers,0,0
184333,at,0,0
184334,home,0,0
184335,visits,0,0
184336,on,0,0
184337,uptake,0,0
184338,of,0,0
184339,screening,0,0
184340,for,0,0
184341,cervical,0,0
184342,cancer,0,0
184343,(,0,0
184344,the,0,0
184345,EMA,0,0
184346,study,0,0
184347,),0,0
184348,:,0,0
184349,a,0,0
184350,population-based,0,0
184351,cluster-randomised,0,0
184352,trial,0,0
184353,.,0,0
184354,BACKGROUND,0,0
184355,Control,0,1
184356,of,0,0
184357,cervical,0,0
184358,cancer,0,0
184359,in,0,0
184360,developing,0,0
184361,countries,0,0
184362,has,0,0
184363,been,0,0
184364,hampered,0,0
184365,by,0,0
184366,a,0,0
184367,failure,0,0
184368,to,0,0
184369,achieve,0,0
184370,high,0,0
184371,screening,0,0
184372,uptake,0,0
184373,.,0,0
184374,HPV,1,0
184375,DNA,1,0
184376,self-collection,1,0
184377,could,0,0
184378,increase,0,0
184379,screening,0,0
184380,coverage,0,0
184381,",",0,0
184382,but,0,0
184383,implementation,0,0
184384,of,0,0
184385,this,0,0
184386,technology,0,0
184387,is,0,0
184388,difficult,0,0
184389,in,0,0
184390,countries,0,0
184391,of,0,0
184392,middle,0,0
184393,and,0,0
184394,low,0,0
184395,income,0,0
184396,.,0,0
184397,We,0,0
184398,investigated,0,0
184399,whether,0,0
184400,offering,0,0
184401,HPV,1,0
184402,DNA,1,0
184403,self-collection,1,0
184404,during,0,0
184405,routine,0,0
184406,home,0,0
184407,visits,0,0
184408,by,0,0
184409,community,0,0
184410,health,0,0
184411,workers,0,0
184412,could,0,0
184413,increase,0,0
184414,cervical,0,0
184415,screening,0,0
184416,.,0,0
184417,METHODS,0,0
184418,We,0,0
184419,did,0,0
184420,a,0,0
184421,population-based,0,0
184422,cluster-randomised,0,0
184423,trial,0,0
184424,in,0,0
184425,the,0,0
184426,province,0,0
184427,of,0,0
184428,Jujuy,0,0
184429,",",0,0
184430,Argentina,0,0
184431,",",0,0
184432,between,0,0
184433,July,0,0
184434,1,0,0
184435,",",0,0
184436,2012,0,0
184437,",",0,0
184438,and,0,0
184439,Dec,0,1
184440,31,0,0
184441,",",0,0
184442,2012,0,0
184443,.,0,0
184444,Community,0,0
184445,health,0,0
184446,workers,0,0
184447,were,0,0
184448,eligible,0,0
184449,for,0,0
184450,the,0,0
184451,study,0,0
184452,if,0,0
184453,they,0,0
184454,scored,0,0
184455,highly,0,0
184456,on,0,0
184457,a,0,0
184458,performance,0,0
184459,score,0,0
184460,",",0,0
184461,and,0,0
184462,women,0,0
184463,aged,0,0
184464,30,0,0
184465,years,0,0
184466,or,0,0
184467,older,0,0
184468,were,0,0
184469,eligible,0,0
184470,for,0,0
184471,enrolment,0,0
184472,by,0,0
184473,the,0,0
184474,community,0,0
184475,health,0,0
184476,worker,0,0
184477,.,0,0
184478,200,0,0
184479,community,0,0
184480,health,0,0
184481,workers,0,0
184482,were,0,0
184483,randomly,0,0
184484,allocated,0,0
184485,in,0,0
184486,a,0,0
184487,1:1,0,0
184488,ratio,0,0
184489,to,0,0
184490,either,0,0
184491,the,0,0
184492,intervention,1,1
184493,group,1,0
184494,(,1,0
184495,offered,1,0
184496,women,1,0
184497,the,1,0
184498,chance,1,0
184499,to,1,0
184500,self-collect,1,1
184501,a,1,0
184502,sample,1,0
184503,for,1,0
184504,cervical,1,0
184505,screening,1,0
184506,during,1,0
184507,a,1,0
184508,home,1,1
184509,visit,1,0
184510,),1,0
184511,or,0,1
184512,the,0,0
184513,control,1,1
184514,group,1,0
184515,(,1,0
184516,advised,1,0
184517,women,1,0
184518,to,1,0
184519,attend,1,0
184520,a,1,0
184521,health,1,0
184522,clinic,1,0
184523,for,1,0
184524,cervical,1,0
184525,screening,1,0
184526,),1,0
184527,.,0,0
184528,The,0,0
184529,primary,0,0
184530,outcome,0,0
184531,was,0,0
184532,screening,0,0
184533,uptake,0,0
184534,",",0,0
184535,measured,0,0
184536,as,0,0
184537,the,0,0
184538,proportion,0,0
184539,of,0,0
184540,women,0,0
184541,having,0,0
184542,any,0,0
184543,HPV,0,0
184544,screening,0,0
184545,test,0,0
184546,within,0,0
184547,6,0,0
184548,months,0,0
184549,of,0,0
184550,the,0,0
184551,community,0,0
184552,health,0,0
184553,worker,0,0
184554,visit,0,0
184555,.,0,0
184556,Analysis,0,0
184557,was,0,0
184558,by,0,0
184559,intention,0,0
184560,to,0,0
184561,treat,0,0
184562,.,0,0
184563,This,0,0
184564,trial,0,0
184565,is,0,0
184566,registered,0,0
184567,with,0,0
184568,ClinicalTrials.gov,0,0
184569,",",0,0
184570,number,0,0
184571,NCT02095561,0,0
184572,.,0,0
184573,FINDINGS,0,0
184574,100,0,0
184575,community,0,0
184576,health,0,0
184577,workers,0,0
184578,were,0,0
184579,randomly,0,0
184580,allocated,0,0
184581,to,0,0
184582,the,0,0
184583,intervention,0,1
184584,group,0,0
184585,and,0,0
184586,100,0,0
184587,were,0,0
184588,assigned,0,0
184589,to,0,0
184590,the,0,0
184591,control,0,0
184592,group,0,0
184593,;,0,0
184594,nine,0,0
184595,did,0,0
184596,not,0,0
184597,take,0,0
184598,part,0,0
184599,.,0,0
184600,191,0,0
184601,participating,0,0
184602,community,0,0
184603,health,0,0
184604,workers,0,0
184605,(,0,0
184606,94,0,0
184607,in,0,0
184608,the,0,0
184609,intervention,0,1
184610,group,0,0
184611,and,0,0
184612,97,0,0
184613,in,0,0
184614,the,0,0
184615,control,0,1
184616,group,0,0
184617,),0,0
184618,initially,0,0
184619,contacted,0,0
184620,7650,0,0
184621,women,0,0
184622,;,0,0
184623,of,0,0
184624,3632,0,0
184625,women,0,0
184626,contacted,0,0
184627,by,0,0
184628,community,0,0
184629,health,0,0
184630,workers,0,0
184631,in,0,0
184632,the,0,0
184633,intervention,0,1
184634,group,0,0
184635,",",0,0
184636,3049,0,0
184637,agreed,0,0
184638,to,0,0
184639,participate,0,0
184640,;,0,0
184641,of,0,0
184642,4018,0,0
184643,women,0,0
184644,contacted,0,0
184645,by,0,0
184646,community,0,0
184647,health,0,0
184648,workers,0,0
184649,in,0,0
184650,the,0,0
184651,control,0,0
184652,group,0,0
184653,",",0,0
184654,2964,0,0
184655,agreed,0,0
184656,to,0,0
184657,participate,0,0
184658,.,0,0
184659,2618,0,0
184660,(,0,0
184661,86,0,0
184662,%,0,0
184663,),0,0
184664,of,0,0
184665,3049,0,0
184666,women,0,0
184667,in,0,0
184668,the,0,0
184669,intervention,0,1
184670,group,0,0
184671,had,0,0
184672,any,0,0
184673,HPV,0,0
184674,test,0,0
184675,within,0,0
184676,6,0,0
184677,months,0,0
184678,of,0,0
184679,the,0,0
184680,community,0,0
184681,health,0,0
184682,worker,0,0
184683,visit,0,0
184684,",",0,0
184685,compared,0,0
184686,with,0,0
184687,599,0,0
184688,(,0,0
184689,20,0,0
184690,%,0,0
184691,),0,0
184692,of,0,0
184693,2964,0,0
184694,in,0,0
184695,the,0,0
184696,control,0,1
184697,group,0,0
184698,(,0,0
184699,risk,0,0
184700,ratio,0,0
184701,4?02,0,0
184702,",",0,0
184703,95,0,0
184704,%,0,0
184705,CI,0,0
184706,3?44-4?71,0,0
184707,),0,0
184708,.,0,0
184709,INTERPRETATION,0,0
184710,Offering,0,0
184711,self-collection,0,0
184712,of,0,0
184713,samples,0,0
184714,for,0,0
184715,HPV,1,0
184716,testing,1,0
184717,by,1,0
184718,community,0,1
184719,health,0,0
184720,workers,0,0
184721,during,0,0
184722,home,0,0
184723,visits,0,0
184724,resulted,0,0
184725,in,0,0
184726,a,0,0
184727,four-fold,0,0
184728,increase,0,0
184729,in,0,0
184730,screening,0,0
184731,uptake,0,0
184732,",",0,0
184733,showing,0,0
184734,that,0,0
184735,this,0,0
184736,strategy,0,0
184737,is,0,0
184738,effective,0,0
184739,to,0,0
184740,improve,0,0
184741,cervical,0,0
184742,screening,0,0
184743,coverage,0,0
184744,.,0,0
184745,This,0,0
184746,intervention,0,1
184747,reduces,0,0
184748,women,0,0
184749,'s,0,0
184750,barriers,0,0
184751,to,0,0
184752,screening,0,0
184753,and,0,0
184754,results,0,0
184755,in,0,0
184756,a,0,0
184757,substantial,0,0
184758,and,0,0
184759,rapid,0,0
184760,increase,0,0
184761,in,0,0
184762,coverage,0,0
184763,.,0,0
184764,Our,0,0
184765,findings,0,0
184766,suggest,0,0
184767,that,0,0
184768,HPV,0,0
184769,testing,0,0
184770,could,0,0
184771,be,0,0
184772,extended,0,0
184773,throughout,0,0
184774,Argentina,0,0
184775,and,0,0
184776,in,0,0
184777,other,0,0
184778,countries,0,0
184779,to,0,0
184780,increase,0,0
184781,cervical,0,0
184782,screening,0,0
184783,coverage,0,0
184784,.,0,0
184785,FUNDING,0,0
184786,Instituto,0,0
184787,Nacional,0,0
184788,del,0,0
184789,C?ncer,0,1
184790,(,0,0
184791,Argentina,0,0
184792,),0,0
184793,.,0,0
184794,Using,0,0
184795,behavioral,0,1
184796,economics,0,0
184797,to,0,0
184798,predict,0,0
184799,opioid,0,1
184800,use,0,0
184801,during,0,0
184802,prescription,0,0
184803,opioid,0,1
184804,dependence,0,0
184805,treatment,0,0
184806,.,0,0
184807,BACKGROUND,0,0
184808,Research,0,0
184809,grounded,0,0
184810,in,0,0
184811,behavioral,0,0
184812,economics,0,0
184813,has,0,0
184814,previously,0,0
184815,linked,0,0
184816,addictive,0,0
184817,behavior,0,0
184818,to,0,0
184819,disrupted,0,0
184820,decision-making,0,0
184821,and,0,0
184822,reward-processing,0,1
184823,",",0,0
184824,but,0,0
184825,these,0,0
184826,principles,0,0
184827,have,0,0
184828,not,0,0
184829,been,0,0
184830,examined,0,0
184831,in,0,0
184832,prescription,0,0
184833,opioid,0,1
184834,addiction,0,0
184835,",",0,0
184836,which,0,0
184837,is,0,0
184838,currently,0,0
184839,a,0,0
184840,major,0,0
184841,public,0,0
184842,health,0,0
184843,problem,0,0
184844,.,0,0
184845,This,0,0
184846,study,0,0
184847,examined,0,0
184848,whether,0,0
184849,pre-treatment,0,0
184850,drug,0,0
184851,reinforcement,0,1
184852,value,0,0
184853,predicted,0,0
184854,opioid,0,1
184855,use,0,0
184856,during,0,0
184857,outpatient,0,0
184858,treatment,0,0
184859,of,0,0
184860,prescription,0,0
184861,opioid,0,1
184862,addiction,0,0
184863,.,0,0
184864,METHODS,0,0
184865,Secondary,0,0
184866,analyses,0,0
184867,examined,0,0
184868,participants,0,0
184869,with,0,0
184870,prescription,0,0
184871,opioid,0,1
184872,dependence,0,0
184873,who,0,0
184874,received,0,0
184875,12,0,0
184876,weeks,0,0
184877,of,0,0
184878,buprenorphine-naloxone,1,1
184879,and,1,0
184880,counseling,1,1
184881,in,0,0
184882,a,0,0
184883,multi-site,0,0
184884,clinical,0,0
184885,trial,0,0
184886,(,0,0
184887,N=353,0,0
184888,),0,0
184889,.,0,0
184890,Baseline,0,0
184891,measures,0,0
184892,assessed,0,0
184893,opioid,0,1
184894,source,0,0
184895,and,0,0
184896,indices,0,0
184897,of,0,0
184898,drug,0,0
184899,reinforcement,0,1
184900,value,0,0
184901,",",0,0
184902,including,0,0
184903,the,0,0
184904,total,0,0
184905,amount,0,0
184906,and,0,0
184907,proportion,0,0
184908,of,0,0
184909,income,0,0
184910,spent,0,0
184911,on,0,0
184912,drugs,0,0
184913,.,0,0
184914,Weekly,0,1
184915,urine,0,0
184916,drug,0,0
184917,screens,0,0
184918,measured,0,0
184919,opioid,0,1
184920,use,0,0
184921,.,0,0
184922,RESULTS,0,0
184923,Obtaining,0,0
184924,opioids,0,1
184925,from,0,0
184926,doctors,0,0
184927,was,0,0
184928,associated,0,0
184929,with,0,0
184930,lower,0,0
184931,pre-treatment,0,0
184932,drug,0,0
184933,spending,0,0
184934,",",0,0
184935,while,0,0
184936,obtaining,0,0
184937,opioids,0,1
184938,from,0,0
184939,dealers/patients,0,0
184940,was,0,0
184941,associated,0,0
184942,with,0,0
184943,greater,0,0
184944,spending,0,0
184945,.,0,0
184946,Controlling,0,0
184947,for,0,0
184948,demographics,0,0
184949,",",0,0
184950,opioid,0,1
184951,use,0,0
184952,history,0,0
184953,",",0,0
184954,and,0,0
184955,opioid,0,1
184956,source,0,0
184957,frequency,0,0
184958,",",0,0
184959,patients,0,0
184960,who,0,0
184961,spent,0,0
184962,a,0,0
184963,greater,0,0
184964,total,0,0
184965,amount,0,0
184966,(,0,0
184967,OR=1.30,0,0
184968,",",0,0
184969,p,0,0
184970,<,0,0
184971,.001,0,0
184972,),0,0
184973,and,0,0
184974,a,0,0
184975,greater,0,0
184976,proportion,0,0
184977,of,0,0
184978,their,0,0
184979,income,0,0
184980,on,0,0
184981,drugs,0,1
184982,(,0,0
184983,OR=1.31,0,0
184984,",",0,0
184985,p,0,0
184986,<,0,0
184987,.001,0,0
184988,),0,0
184989,were,0,0
184990,more,0,0
184991,likely,0,0
184992,to,0,0
184993,use,0,0
184994,opioids,0,1
184995,during,0,0
184996,treatment,0,0
184997,.,0,0
184998,CONCLUSIONS,0,0
184999,Individual,0,0
185000,differences,0,0
185001,in,0,0
185002,drug,0,0
185003,reinforcement,0,1
185004,value,0,0
185005,",",0,0
185006,as,0,0
185007,indicated,0,0
185008,by,0,0
185009,pre-treatment,0,0
185010,allocation,0,0
185011,of,0,0
185012,economic,0,0
185013,resources,0,0
185014,to,0,0
185015,drugs,0,0
185016,",",0,0
185017,reflects,0,0
185018,propensity,0,0
185019,for,0,0
185020,continued,0,0
185021,opioid,0,1
185022,use,0,0
185023,during,0,0
185024,treatment,0,0
185025,among,0,0
185026,individuals,0,0
185027,with,0,0
185028,prescription,0,0
185029,opioid,0,1
185030,addiction,0,0
185031,.,0,0
185032,Future,0,0
185033,studies,0,0
185034,should,0,0
185035,examine,0,0
185036,disrupted,0,0
185037,decision-making,0,0
185038,and,0,0
185039,reward-processing,0,1
185040,in,0,0
185041,prescription,0,0
185042,opioid,0,1
185043,users,0,0
185044,more,0,0
185045,directly,0,0
185046,and,0,0
185047,test,0,0
185048,whether,0,0
185049,reinforcer,0,1
185050,pathology,0,0
185051,can,0,0
185052,be,0,0
185053,remediated,0,0
185054,in,0,0
185055,this,0,0
185056,population,0,0
185057,.,0,0
185058,Reducing,0,0
185059,cancer,0,0
185060,screening,0,0
185061,disparities,0,0
185062,in,0,0
185063,medicare,0,0
185064,beneficiaries,0,0
185065,through,0,0
185066,cancer,1,0
185067,patient,1,0
185068,navigation,1,1
185069,.,1,0
185070,Significant,0,0
185071,racial,0,0
185072,disparities,0,0
185073,in,0,0
185074,cancer,0,0
185075,mortality,0,0
185076,are,0,0
185077,seen,0,0
185078,between,0,0
185079,Medicare,0,0
185080,beneficiaries,0,0
185081,.,0,0
185082,A,0,0
185083,randomized,0,0
185084,controlled,0,0
185085,trial,0,0
185086,tested,0,0
185087,the,0,0
185088,use,0,0
185089,of,0,0
185090,lay,1,0
185091,navigators,1,1
185092,(,1,0
185093,care,1,0
185094,managers,1,1
185095,),1,0
185096,to,1,0
185097,increase,1,0
185098,cancer,1,0
185099,screening,1,0
185100,of,0,0
185101,Asian,0,0
185102,and,0,0
185103,Pacific,0,0
185104,Islander,0,1
185105,Medicare,0,1
185106,beneficiaries,0,0
185107,.,0,0
185108,The,0,0
185109,study,0,0
185110,setting,0,0
185111,was,0,0
185112,Moloka'i,0,1
185113,General,0,1
185114,Hospital,0,0
185115,on,0,0
185116,the,0,0
185117,island,0,0
185118,of,0,0
185119,Moloka'i,0,1
185120,",",0,0
185121,Hawai'i,0,0
185122,",",0,0
185123,which,0,0
185124,was,0,0
185125,one,0,0
185126,of,0,0
185127,six,0,0
185128,sites,0,0
185129,participating,0,0
185130,in,0,0
185131,the,0,0
185132,Cancer,0,0
185133,Prevention,0,1
185134,and,0,0
185135,Treatment,0,1
185136,Demonstration,0,0
185137,sponsored,0,0
185138,by,0,0
185139,the,0,0
185140,Centers,0,0
185141,for,0,0
185142,Medicare,0,1
185143,and,0,0
185144,Medicaid,0,0
185145,Services,0,1
185146,.,0,0
185147,Between,0,0
185148,2006,0,0
185149,and,0,0
185150,2009,0,0
185151,",",0,0
185152,488,0,0
185153,Medicare,0,0
185154,beneficiaries,0,0
185155,(,0,0
185156,45,0,0
185157,%,0,0
185158,Hawaiian,0,0
185159,",",0,0
185160,35,0,0
185161,%,0,0
185162,Filipino,0,0
185163,",",0,0
185164,11,0,0
185165,%,0,0
185166,Japanese,0,0
185167,",",0,0
185168,8,0,0
185169,%,0,0
185170,other,0,0
185171,),0,0
185172,were,0,0
185173,randomized,0,0
185174,to,0,0
185175,have,0,0
185176,a,0,0
185177,navigator,1,1
185178,help,1,0
185179,them,1,0
185180,access,1,0
185181,cancer,1,0
185182,screening,1,1
185183,services,1,1
185184,(,1,0
185185,experimental,1,0
185186,condition,1,0
185187,",",0,0
185188,n,0,0
185189,=,0,0
185190,242,0,0
185191,),0,0
185192,or,1,1
185193,cancer,1,0
185194,education,1,1
185195,(,1,0
185196,control,1,1
185197,condition,1,0
185198,",",0,0
185199,n,0,0
185200,=,0,0
185201,246,0,0
185202,),0,0
185203,.,0,0
185204,Self-reported,0,0
185205,data,0,0
185206,on,0,0
185207,screening,0,0
185208,participation,0,0
185209,were,0,0
185210,collected,0,0
185211,at,0,0
185212,baseline,1,0
185213,and,0,0
185214,exit,0,0
185215,from,0,0
185216,the,0,0
185217,study,0,0
185218,",",0,0
185219,and,0,0
185220,differences,0,0
185221,were,0,0
185222,tested,0,0
185223,using,0,0
185224,chi-square,0,0
185225,.,0,0
185226,Groups,0,0
185227,were,0,0
185228,similar,0,0
185229,in,0,0
185230,demographic,0,0
185231,characteristics,0,0
185232,and,0,0
185233,baseline,0,0
185234,screening,0,1
185235,prevalence,0,0
185236,of,0,0
185237,breast,0,0
185238,",",0,0
185239,cervical,0,0
185240,",",0,0
185241,prostate,0,0
185242,",",0,0
185243,and,0,0
185244,colorectal,0,0
185245,cancers,0,0
185246,.,0,0
185247,At,0,0
185248,study,0,0
185249,exit,0,0
185250,",",0,0
185251,57.0,0,0
185252,%,0,0
185253,of,0,0
185254,women,0,0
185255,in,0,0
185256,the,0,0
185257,experimental,0,0
185258,arm,0,0
185259,and,0,0
185260,36.4,0,0
185261,%,0,0
185262,of,0,0
185263,controls,0,0
185264,had,0,0
185265,had,0,0
185266,a,0,0
185267,Papanicolaou,0,1
185268,test,0,0
185269,in,0,0
185270,the,0,0
185271,past,0,0
185272,24,0,0
185273,months,0,0
185274,(,0,0
185275,P,0,0
185276,=,0,0
185277,.001,0,0
185278,),0,0
185279,",",0,0
185280,61.7,0,0
185281,%,0,0
185282,of,0,0
185283,women,0,0
185284,in,0,0
185285,the,0,0
185286,experimental,0,0
185287,arm,0,0
185288,and,0,0
185289,42.4,0,0
185290,%,0,0
185291,of,0,0
185292,controls,0,0
185293,had,0,0
185294,had,0,0
185295,a,0,0
185296,mammogram,0,0
185297,in,0,0
185298,the,0,0
185299,past,0,0
185300,12,0,0
185301,months,0,0
185302,(,0,0
185303,P,0,0
185304,=,0,0
185305,.003,0,0
185306,),0,0
185307,",",0,0
185308,54.4,0,0
185309,%,0,0
185310,of,0,0
185311,men,0,0
185312,in,0,0
185313,the,0,0
185314,experimental,0,0
185315,arm,0,0
185316,and,0,0
185317,36.0,0,0
185318,%,0,0
185319,of,0,0
185320,controls,0,0
185321,had,0,0
185322,had,0,0
185323,a,0,0
185324,prostate-specific,0,0
185325,antigen,0,0
185326,test,0,0
185327,in,0,0
185328,the,0,0
185329,past,0,0
185330,12,0,0
185331,months,0,0
185332,(,0,0
185333,P,0,0
185334,=,0,0
185335,.008,0,0
185336,),0,0
185337,",",0,0
185338,and,0,0
185339,43.0,0,0
185340,%,0,0
185341,of,0,0
185342,both,0,0
185343,sexes,0,0
185344,in,0,0
185345,the,0,0
185346,experimental,0,0
185347,arm,0,0
185348,and,0,0
185349,27.2,0,0
185350,%,0,0
185351,of,0,0
185352,controls,0,0
185353,had,0,0
185354,had,0,0
185355,a,0,0
185356,flexible,0,1
185357,sigmoidoscopy,0,1
185358,or,0,1
185359,colonoscopy,0,0
185360,in,0,0
185361,the,0,0
185362,past,0,0
185363,5,0,0
185364,years,0,0
185365,(,0,0
185366,P,0,0
185367,<,0,0
185368,.001,0,0
185369,),0,0
185370,.,0,0
185371,Findings,0,0
185372,suggest,0,0
185373,that,0,0
185374,navigation,1,1
185375,services,1,0
185376,can,0,0
185377,increase,0,0
185378,cancer,0,0
185379,screening,0,0
185380,in,0,0
185381,Medicare,0,1
185382,beneficiaries,0,0
185383,in,0,0
185384,groups,0,0
185385,with,0,0
185386,significant,0,0
185387,disparities,0,0
185388,.,0,0
185389,Baseline,0,1
185390,distribution,0,0
185391,of,0,0
185392,participants,0,0
185393,with,0,0
185394,depression,0,0
185395,and,0,0
185396,impaired,0,0
185397,quality,0,0
185398,of,0,0
185399,life,0,0
185400,in,0,0
185401,the,0,0
185402,Treatment,0,0
185403,of,0,0
185404,Preserved,0,0
185405,Cardiac,0,0
185406,Function,0,0
185407,Heart,0,0
185408,Failure,0,0
185409,with,0,0
185410,an,0,0
185411,Aldosterone,0,1
185412,Antagonist,0,1
185413,Trial,0,0
185414,.,0,0
185415,BACKGROUND,0,0
185416,Previous,0,0
185417,studies,0,0
185418,have,0,0
185419,demonstrated,0,0
185420,the,0,0
185421,psychosocial,0,0
185422,effect,0,0
185423,of,0,0
185424,heart,0,0
185425,failure,0,0
185426,in,0,0
185427,patients,0,0
185428,with,0,0
185429,reduced,0,0
185430,ejection,0,0
185431,fraction,0,0
185432,.,0,0
185433,However,0,0
185434,",",0,0
185435,the,0,0
185436,effects,0,0
185437,on,0,0
185438,patients,0,0
185439,with,0,0
185440,preserved,0,0
185441,ejection,0,0
185442,fraction,0,0
185443,have,0,0
185444,not,0,0
185445,yet,0,0
185446,been,0,0
185447,elucidated,0,0
185448,.,0,0
185449,This,0,0
185450,study,0,0
185451,aimed,0,0
185452,to,0,0
185453,determine,0,0
185454,the,0,0
185455,baseline,0,0
185456,characteristics,0,0
185457,of,0,0
185458,participants,0,0
185459,with,0,0
185460,heart,0,0
185461,failure,0,0
185462,with,0,0
185463,preserved,0,0
185464,ejection,0,0
185465,fraction,0,0
185466,as,0,0
185467,it,0,0
185468,relates,0,0
185469,to,0,0
185470,impaired,0,0
185471,quality,0,0
185472,of,0,0
185473,life,0,0
185474,(,0,0
185475,QOL,0,1
185476,),0,1
185477,and,0,0
185478,depression,0,0
185479,",",0,0
185480,identify,0,0
185481,predictors,0,0
185482,of,0,0
185483,poor,0,0
185484,QOL,0,1
185485,and,0,0
185486,depression,0,0
185487,",",0,0
185488,and,0,0
185489,determine,0,0
185490,the,0,0
185491,correlation,0,0
185492,between,0,0
185493,QOL,0,1
185494,and,0,0
185495,depression,0,0
185496,.,0,0
185497,METHODS,0,0
185498,AND,0,0
185499,RESULTS,0,0
185500,Among,0,0
185501,patients,0,0
185502,enrolled,0,0
185503,in,0,0
185504,the,0,0
185505,Treatment,0,0
185506,of,0,0
185507,Preserved,0,0
185508,Cardiac,0,0
185509,Function,0,0
185510,Heart,0,0
185511,Failure,0,0
185512,With,0,0
185513,an,0,0
185514,Aldosterone,1,1
185515,Antagonist,1,1
185516,Trial,1,1
185517,(,1,0
185518,TOPCAT,1,1
185519,),1,0
185520,",",0,0
185521,3400,0,0
185522,patients,0,0
185523,completed,0,0
185524,the,0,0
185525,Kansas,0,0
185526,City,0,0
185527,Cardiomyopathy,0,0
185528,Questionnaire,0,0
185529,",",0,0
185530,3395,0,0
185531,patients,0,0
185532,completed,0,0
185533,European,1,0
185534,QOL,1,0
185535,5D,1,0
185536,Visual,1,0
185537,Analog,1,1
185538,Scale,1,0
185539,",",0,0
185540,and,0,0
185541,1431,0,0
185542,patients,0,0
185543,in,0,0
185544,United,0,0
185545,States,0,0
185546,and,0,0
185547,Canada,0,0
185548,completed,0,0
185549,the,0,0
185550,Patient,0,0
185551,Health,0,0
185552,Questionnaire-9,0,0
185553,.,0,0
185554,The,0,0
185555,mean,0,0
185556,summary,0,0
185557,score,0,0
185558,on,0,0
185559,the,0,0
185560,Kansas,0,0
185561,City,0,0
185562,Cardiomyopathy,0,0
185563,Questionnaire,0,0
185564,was,0,0
185565,54.8,0,0
185566,",",0,0
185567,and,0,0
185568,on,0,0
185569,European,0,0
185570,QOL,0,0
185571,5D,0,0
185572,Visual,0,0
185573,Analog,0,1
185574,Scale,0,0
185575,",",0,0
185576,it,0,0
185577,was,0,0
185578,60.3,0,0
185579,;,0,0
185580,27,0,0
185581,%,0,0
185582,of,0,0
185583,patients,0,0
185584,had,0,0
185585,moderate,0,0
185586,to,0,0
185587,severe,0,0
185588,depression,0,0
185589,.,0,0
185590,Factors,0,0
185591,associated,0,0
185592,with,0,0
185593,better,0,0
185594,Kansas,0,0
185595,City,0,0
185596,Cardiomyopathy,0,0
185597,Questionnaire,0,0
185598,and,0,0
185599,European,0,1
185600,QOL,0,1
185601,5D,0,0
185602,Visual,0,0
185603,Analog,0,1
185604,Scale,0,0
185605,via,0,0
185606,multiple,0,0
185607,logistic,0,0
185608,regression,0,0
185609,analysis,0,0
185610,were,0,0
185611,American,0,0
185612,region,0,0
185613,",",0,0
185614,older,0,0
185615,age,0,0
185616,",",0,0
185617,no,0,0
185618,history,0,0
185619,of,0,0
185620,angina,0,0
185621,pectoris,0,1
185622,or,0,1
185623,asthma,0,0
185624,",",0,0
185625,no,0,0
185626,use,0,0
185627,of,0,0
185628,hypoglycemic,0,0
185629,agent,0,0
185630,",",0,0
185631,more,0,0
185632,activity,0,0
185633,level,0,0
185634,",",0,0
185635,and,0,0
185636,lower,0,0
185637,New,0,0
185638,York,0,0
185639,Heart,0,1
185640,Association,0,0
185641,class,0,0
185642,.,0,0
185643,Factors,0,0
185644,associated,0,0
185645,with,0,0
185646,depression,0,0
185647,via,0,0
185648,multiple,0,0
185649,logistic,0,0
185650,regression,0,0
185651,analysis,0,0
185652,included,0,0
185653,younger,0,0
185654,age,0,0
185655,",",0,0
185656,female,0,0
185657,sex,0,0
185658,",",0,0
185659,comorbid,0,0
185660,angina,0,0
185661,",",0,0
185662,chronic,0,0
185663,obstructive,0,0
185664,pulmonary,0,0
185665,disease,0,0
185666,",",0,0
185667,use,0,0
185668,of,0,0
185669,a,0,0
185670,hypoglycemic,0,0
185671,agent,0,0
185672,",",0,0
185673,lower,0,0
185674,activity,0,0
185675,level,0,0
185676,",",0,0
185677,higher,0,0
185678,New,0,0
185679,York,0,0
185680,Heart,0,1
185681,Association,0,0
185682,class,0,0
185683,",",0,0
185684,and,0,0
185685,selective,0,1
185686,serotonin,0,1
185687,reuptake,0,1
185688,inhibitor,0,1
185689,use,0,0
185690,.,0,0
185691,There,0,0
185692,were,0,0
185693,significant,0,0
185694,correlations,0,0
185695,between,0,0
185696,each,0,0
185697,of,0,0
185698,the,0,0
185699,QOL,0,0
185700,scores,0,0
185701,and,0,0
185702,depression,0,0
185703,.,0,0
185704,CONCLUSIONS,0,0
185705,Patients,0,0
185706,with,0,0
185707,heart,0,0
185708,failure,0,0
185709,with,0,0
185710,preserved,0,0
185711,ejection,0,0
185712,fraction,0,0
185713,",",0,0
185714,who,0,0
185715,were,0,0
185716,younger,0,0
185717,had,0,0
185718,higher,0,0
185719,New,0,0
185720,York,0,0
185721,Heart,0,1
185722,Association,0,0
185723,class,0,0
185724,or,0,1
185725,comorbid,0,0
185726,angina,0,0
185727,pectoris,0,0
185728,",",0,0
185729,had,0,0
185730,lower,0,0
185731,activity,0,0
185732,levels,0,0
185733,",",0,0
185734,lived,0,0
185735,in,0,0
185736,Eastern,0,0
185737,Europe,0,1
185738,or,0,1
185739,were,0,0
185740,taking,0,0
185741,hypoglycemic,0,0
185742,agents,0,0
185743,",",0,0
185744,were,0,0
185745,more,0,0
185746,likely,0,0
185747,to,0,0
185748,have,0,0
185749,impaired,0,0
185750,QOL,0,1
185751,and,0,0
185752,depression,0,0
185753,.,0,0
185754,CLINICAL,0,0
185755,TRIAL,0,0
185756,REGISTRATION,0,0
185757,URL,0,1
185758,:,0,0
185759,http,0,0
185760,:,0,0
185761,//www.clinicaltrials.gov,0,0
185762,.,0,0
185763,Unique,0,0
185764,identifier,0,0
185765,:,0,0
185766,NCT00094302,0,0
185767,.,0,0
185768,A,0,0
185769,randomized,0,0
185770,controlled,0,0
185771,trial,0,0
185772,of,0,0
185773,guided,1,1
185774,self-help,1,1
185775,for,0,0
185776,improving,0,0
185777,the,0,0
185778,experience,0,0
185779,of,0,0
185780,caring,0,0
185781,for,0,0
185782,carers,0,0
185783,of,0,0
185784,clients,0,0
185785,with,0,0
185786,depression,0,0
185787,.,0,0
185788,AIM,0,0
185789,To,0,0
185790,evaluate,0,0
185791,the,0,0
185792,effectiveness,0,0
185793,of,0,0
185794,a,0,0
185795,cognitive,1,0
185796,behaviour,1,0
185797,therapy,1,1
185798,guided,1,1
185799,self-help,1,1
185800,manual,1,0
185801,for,0,0
185802,enhancing,0,0
185803,the,0,0
185804,experience,0,0
185805,of,0,0
185806,caregiving,0,0
185807,of,0,0
185808,family,0,0
185809,carers,0,0
185810,of,0,0
185811,individuals,0,0
185812,with,0,0
185813,depression,0,0
185814,.,0,0
185815,BACKGROUND,0,0
185816,The,0,0
185817,prevalence,0,0
185818,of,0,0
185819,depression,0,0
185820,is,0,0
185821,increasing,0,0
185822,markedly,0,0
185823,in,0,0
185824,Thailand,0,0
185825,.,0,0
185826,While,0,0
185827,primary,0,0
185828,carers,0,0
185829,give,0,0
185830,most,0,0
185831,of,0,0
185832,the,0,0
185833,support,0,0
185834,for,0,0
185835,individuals,0,0
185836,with,0,0
185837,depression,0,0
185838,",",0,0
185839,they,0,0
185840,receive,0,0
185841,little,0,0
185842,support,0,0
185843,from,0,0
185844,mental,0,0
185845,health,0,0
185846,services,0,0
185847,in,0,0
185848,this,0,0
185849,critical,0,0
185850,role,0,0
185851,.,0,0
185852,DESIGN,0,0
185853,A,0,0
185854,randomized,0,0
185855,controlled,0,0
185856,trial,0,0
185857,.,0,0
185858,METHOD,0,0
185859,Carers,0,0
185860,were,0,0
185861,randomized,0,0
185862,to,0,0
185863,guided,1,1
185864,self-help,1,1
185865,(,0,0
185866,n,0,0
185867,=,0,0
185868,27,0,0
185869,),0,0
185870,",",0,0
185871,while,0,0
185872,the,0,0
185873,control,1,0
185874,group,1,0
185875,received,1,0
185876,standard,1,1
185877,information,1,0
185878,and,1,0
185879,support,1,1
185880,(,0,0
185881,n,0,0
185882,=,0,0
185883,27,0,0
185884,),0,0
185885,.,0,0
185886,Both,0,0
185887,groups,0,0
185888,also,0,0
185889,received,0,0
185890,a,0,0
185891,short,1,0
185892,weekly,1,1
185893,telephone,1,1
185894,call,1,0
185895,.,1,0
185896,Participants,0,0
185897,were,0,0
185898,assessed,0,0
185899,at,0,0
185900,three,0,0
185901,time,0,0
185902,points,0,0
185903,;,0,0
185904,the,0,0
185905,outcome,0,0
185906,measure,0,0
185907,was,0,0
185908,the,0,0
185909,Experience,0,0
185910,of,0,0
185911,Caregiving,1,0
185912,Inventory,1,0
185913,.,1,0
185914,A,0,0
185915,doubly,0,0
185916,multivariate,0,0
185917,analysis,0,0
185918,of,0,0
185919,variance,0,0
185920,(,0,0
185921,anova,0,0
185922,),0,0
185923,procedure,0,0
185924,",",0,0
185925,including,0,0
185926,between-group,0,0
185927,and,0,0
185928,within-group,0,0
185929,factors,0,0
185930,",",0,0
185931,was,0,0
185932,implemented,0,0
185933,.,0,0
185934,Fieldwork,0,0
185935,was,0,0
185936,from,0,0
185937,October,0,0
185938,2007-May,0,0
185939,2008,0,0
185940,.,0,0
185941,RESULTS,0,0
185942,Fifty-four,0,0
185943,carers,0,0
185944,completed,0,0
185945,the,0,0
185946,study,0,0
185947,and,0,0
185948,intent-to-treat,0,0
185949,analyses,0,0
185950,were,0,0
185951,undertaken,0,0
185952,.,0,0
185953,The,0,0
185954,findings,0,0
185955,showed,0,0
185956,there,0,0
185957,was,0,0
185958,a,0,0
185959,significant,0,0
185960,reduction,0,0
185961,in,0,0
185962,the,0,0
185963,total,0,0
185964,negative,0,0
185965,experience,0,0
185966,of,0,0
185967,caring,0,0
185968,",",0,0
185969,from,0,0
185970,baseline,0,0
185971,to,0,0
185972,post-treatment,0,0
185973,",",0,0
185974,in,0,0
185975,the,0,0
185976,intervention,0,1
185977,group,0,0
185978,recipients,0,0
185979,of,0,0
185980,the,0,0
185981,manual,0,0
185982,compared,0,0
185983,with,0,0
185984,the,0,0
185985,control,0,1
185986,group,0,0
185987,and,0,0
185988,treatment,0,0
185989,effects,0,0
185990,were,0,0
185991,maintained,0,0
185992,at,0,0
185993,one-month,0,0
185994,follow-up,0,0
185995,.,0,0
185996,Similarly,0,0
185997,",",0,0
185998,a,0,0
185999,significant,0,0
186000,improvement,0,0
186001,in,0,0
186002,the,0,0
186003,total,0,0
186004,positive,0,0
186005,experience,0,0
186006,of,0,0
186007,caring,0,0
186008,occurred,0,0
186009,",",0,0
186010,from,0,0
186011,baseline,0,0
186012,to,0,0
186013,post-treatment,0,0
186014,",",0,0
186015,in,0,0
186016,the,0,0
186017,intervention,0,1
186018,group,0,0
186019,in,0,0
186020,contrast,0,0
186021,with,0,0
186022,the,0,0
186023,control,0,1
186024,group,0,0
186025,and,0,0
186026,these,0,0
186027,outcomes,0,0
186028,were,0,0
186029,sustained,0,0
186030,at,0,0
186031,one-month,0,0
186032,follow-up,0,0
186033,.,0,0
186034,CONCLUSION,0,0
186035,Guided,1,1
186036,self-help,1,1
186037,strengthen,0,0
186038,carers,0,0
186039,',0,0
186040,positive,0,0
186041,and,0,0
186042,reduces,0,0
186043,their,0,0
186044,negative,0,0
186045,",",0,0
186046,experience,0,0
186047,of,0,0
186048,caring,0,0
186049,.,0,0
186050,The,0,0
186051,study,0,0
186052,contributes,0,0
186053,to,0,0
186054,the,0,0
186055,limited,0,0
186056,evidence,0,0
186057,base,0,0
186058,about,0,0
186059,this,0,0
186060,approach,0,1
186061,in,0,0
186062,a,0,0
186063,developing,0,0
186064,country,0,0
186065,such,0,0
186066,as,0,0
186067,Thailand,0,0
186068,.,0,0
186069,Oxytocin,1,1
186070,increases,0,0
186071,eye,0,0
186072,contact,0,0
186073,during,0,0
186074,a,0,0
186075,real-time,0,0
186076,",",0,0
186077,naturalistic,0,0
186078,social,0,0
186079,interaction,0,0
186080,in,0,0
186081,males,0,0
186082,with,0,0
186083,and,0,0
186084,without,0,0
186085,autism,0,0
186086,.,0,0
186087,Autism,0,0
186088,spectrum,0,0
186089,conditions,0,0
186090,(,0,0
186091,autism,0,0
186092,),0,0
186093,affect,0,0
186094,~1,0,0
186095,%,0,0
186096,of,0,0
186097,the,0,0
186098,population,0,0
186099,and,0,0
186100,are,0,0
186101,characterized,0,0
186102,by,0,0
186103,deficits,0,0
186104,in,0,0
186105,social,0,0
186106,communication,0,0
186107,.,0,0
186108,Oxytocin,1,1
186109,has,0,0
186110,been,0,0
186111,widely,0,0
186112,reported,0,0
186113,to,0,0
186114,affect,0,0
186115,social-communicative,0,0
186116,function,0,0
186117,and,0,0
186118,its,0,0
186119,neural,0,0
186120,underpinnings,0,0
186121,.,0,0
186122,Here,0,0
186123,we,0,0
186124,report,0,0
186125,the,0,0
186126,first,0,0
186127,evidence,0,0
186128,that,0,0
186129,intranasal,1,1
186130,oxytocin,1,1
186131,administration,0,0
186132,improves,0,0
186133,a,0,0
186134,core,0,0
186135,problem,0,0
186136,that,0,0
186137,individuals,0,0
186138,with,0,0
186139,autism,0,0
186140,have,0,0
186141,in,0,0
186142,using,0,0
186143,eye,0,1
186144,contact,0,0
186145,appropriately,0,0
186146,in,0,0
186147,real-world,0,0
186148,social,0,0
186149,settings,0,0
186150,.,0,0
186151,A,0,0
186152,randomized,0,0
186153,double-blind,0,0
186154,",",0,0
186155,placebo-controlled,1,1
186156,",",0,0
186157,within-subjects,0,0
186158,design,0,0
186159,is,0,0
186160,used,0,0
186161,to,0,0
186162,examine,0,0
186163,how,0,0
186164,intranasal,0,1
186165,administration,0,0
186166,of,0,0
186167,24,1,0
186168,IU,1,1
186169,of,1,0
186170,oxytocin,1,1
186171,affects,1,0
186172,gaze,0,0
186173,behavior,0,0
186174,for,0,0
186175,32,0,0
186176,adult,0,0
186177,males,0,0
186178,with,0,0
186179,autism,0,0
186180,and,0,0
186181,34,0,0
186182,controls,0,0
186183,in,0,0
186184,a,0,0
186185,real-time,0,1
186186,interaction,0,0
186187,with,0,0
186188,a,0,0
186189,researcher,0,0
186190,.,0,0
186191,This,0,0
186192,interactive,0,0
186193,paradigm,0,0
186194,bypasses,0,0
186195,many,0,0
186196,of,0,0
186197,the,0,0
186198,limitations,0,0
186199,encountered,0,0
186200,with,0,0
186201,conventional,0,1
186202,static,0,1
186203,or,0,0
186204,computer-based,0,1
186205,stimuli,0,1
186206,.,0,0
186207,Eye,0,0
186208,movements,0,0
186209,are,0,0
186210,recorded,0,0
186211,using,0,0
186212,eye,0,1
186213,tracking,0,1
186214,",",0,0
186215,providing,0,0
186216,an,0,0
186217,objective,0,0
186218,measurement,0,0
186219,of,0,0
186220,looking,0,0
186221,patterns,0,0
186222,.,0,0
186223,The,0,0
186224,measure,0,0
186225,is,0,0
186226,shown,0,0
186227,to,0,0
186228,be,0,0
186229,sensitive,0,0
186230,to,0,0
186231,the,0,0
186232,reduced,0,0
186233,eye,0,1
186234,contact,0,0
186235,commonly,0,0
186236,reported,0,0
186237,in,0,0
186238,autism,0,0
186239,",",0,0
186240,with,0,0
186241,the,0,0
186242,autism,0,0
186243,group,0,0
186244,spending,0,0
186245,less,0,0
186246,time,0,0
186247,looking,0,0
186248,to,0,0
186249,the,0,0
186250,eye,0,1
186251,region,0,0
186252,of,0,0
186253,the,0,0
186254,face,0,0
186255,than,0,0
186256,controls,1,0
186257,.,1,0
186258,Oxytocin,1,1
186259,administration,1,0
186260,selectively,0,0
186261,enhanced,0,0
186262,gaze,0,0
186263,to,0,0
186264,the,0,0
186265,eyes,0,0
186266,in,0,0
186267,both,0,0
186268,the,0,0
186269,autism,0,0
186270,and,0,0
186271,control,0,1
186272,groups,0,0
186273,(,0,0
186274,transformed,0,0
186275,mean,0,0
186276,eye-fixation,0,1
186277,difference,0,0
186278,per,0,0
186279,second=0.082,0,0
186280,;,0,0
186281,95,0,0
186282,%,0,0
186283,CI:0.025-0.14,0,0
186284,",",0,0
186285,P=0.006,0,0
186286,),0,0
186287,.,0,0
186288,Within,0,0
186289,the,0,0
186290,autism,0,0
186291,group,0,0
186292,",",0,0
186293,oxytocin,0,1
186294,has,0,0
186295,the,0,0
186296,most,0,0
186297,effect,0,0
186298,on,0,0
186299,fixation,0,1
186300,duration,0,0
186301,in,0,0
186302,individuals,0,0
186303,with,0,0
186304,impaired,0,0
186305,levels,0,0
186306,of,0,0
186307,eye,0,1
186308,contact,0,0
186309,at,0,0
186310,baseline,0,0
186311,(,0,0
186312,Cohen,0,0
186313,'s,0,1
186314,d=0.86,0,0
186315,),0,0
186316,.,0,0
186317,These,0,0
186318,findings,0,0
186319,demonstrate,0,0
186320,that,0,0
186321,the,0,0
186322,potential,0,0
186323,benefits,0,0
186324,of,0,0
186325,oxytocin,0,1
186326,in,0,0
186327,autism,0,0
186328,extend,0,0
186329,to,0,0
186330,a,0,0
186331,real-time,0,1
186332,interaction,0,0
186333,",",0,0
186334,providing,0,0
186335,evidence,0,0
186336,of,0,0
186337,a,0,0
186338,therapeutic,0,0
186339,effect,0,0
186340,in,0,0
186341,a,0,0
186342,key,0,0
186343,aspect,0,0
186344,of,0,0
186345,social,0,0
186346,communication,0,0
186347,.,0,0
186348,Effects,0,0
186349,of,0,0
186350,sodium,1,1
186351,and,1,0
186352,potassium,1,1
186353,supplementation,1,1
186354,on,0,0
186355,blood,0,0
186356,pressure,0,0
186357,and,0,0
186358,arterial,0,0
186359,stiffness,0,0
186360,:,0,0
186361,a,0,0
186362,fully,0,0
186363,controlled,0,0
186364,dietary,0,1
186365,intervention,0,1
186366,study,0,0
186367,.,0,0
186368,We,0,0
186369,performed,0,0
186370,a,0,0
186371,randomised,0,0
186372,",",0,0
186373,placebo-controlled,0,1
186374,",",0,0
186375,crossover,0,0
186376,study,0,0
186377,to,0,0
186378,examine,0,0
186379,the,0,0
186380,effects,0,0
186381,of,0,0
186382,sodium,1,1
186383,and,1,0
186384,potassium,1,1
186385,supplementation,1,1
186386,on,0,0
186387,blood,0,0
186388,pressure,0,0
186389,(,0,0
186390,BP,0,0
186391,),0,1
186392,and,0,0
186393,arterial,0,0
186394,stiffness,0,0
186395,in,0,0
186396,untreated,0,0
186397,(,0,0
186398,pre,0,0
186399,),0,0
186400,hypertensive,0,0
186401,individuals,0,0
186402,.,0,0
186403,During,0,0
186404,the,0,0
186405,study,0,0
186406,",",0,0
186407,subjects,0,0
186408,were,0,0
186409,on,0,0
186410,a,0,0
186411,fully,0,0
186412,controlled,0,0
186413,diet,0,1
186414,that,0,0
186415,was,0,0
186416,relatively,0,0
186417,low,0,0
186418,in,0,0
186419,sodium,0,1
186420,and,0,0
186421,potassium,0,1
186422,.,0,0
186423,After,0,0
186424,a,0,0
186425,1-week,0,0
186426,run-in,0,0
186427,period,0,0
186428,",",0,0
186429,subjects,0,0
186430,received,1,0
186431,capsules,1,1
186432,with,1,0
186433,supplemental,1,1
186434,sodium,1,1
186435,(,1,0
186436,3,1,0
186437,g,1,1
186438,d,1,1
186439,(,1,0
186440,-1,1,0
186441,),1,0
186442,",",1,0
186443,equals,1,0
186444,7.6,1,0
186445,g,1,1
186446,d,1,1
186447,(,1,0
186448,-1,1,0
186449,),1,0
186450,of,1,0
186451,salt,1,1
186452,),1,0
186453,",",1,0
186454,supplemental,1,1
186455,potassium,1,1
186456,(,1,0
186457,3,1,0
186458,g,1,1
186459,d,1,1
186460,(,1,0
186461,-1,1,0
186462,),1,1
186463,),1,0
186464,or,1,1
186465,placebo,1,1
186466,",",1,0
186467,for,1,0
186468,4,1,0
186469,weeks,1,0
186470,each,1,0
186471,",",1,0
186472,in,1,0
186473,random,1,0
186474,order,1,0
186475,.,1,0
186476,Fasting,1,0
186477,office,1,0
186478,BP,1,0
186479,",",1,0
186480,24-h,1,1
186481,ambulatory,1,0
186482,BP,1,0
186483,and,1,0
186484,measures,1,0
186485,of,1,0
186486,arterial,1,0
186487,stiffness,1,0
186488,were,1,0
186489,assessed,1,0
186490,at,1,0
186491,baseline,1,0
186492,and,1,0
186493,every,1,0
186494,4,1,0
186495,weeks,1,0
186496,.,1,0
186497,Of,1,0
186498,37,0,0
186499,randomized,0,0
186500,subjects,0,0
186501,",",0,0
186502,36,0,0
186503,completed,0,0
186504,the,0,0
186505,study,0,0
186506,.,0,0
186507,They,0,0
186508,had,0,0
186509,a,0,0
186510,mean,0,0
186511,pre-treatment,0,0
186512,BP,0,0
186513,of,0,0
186514,145/81,0,0
186515,mm,0,0
186516,Hg,0,0
186517,and,0,0
186518,69,0,0
186519,%,0,0
186520,had,0,0
186521,systolic,0,0
186522,BP,0,0
186523,?140,0,1
186524,mm,0,0
186525,Hg,0,0
186526,.,0,0
186527,Sodium,0,0
186528,excretion,0,0
186529,was,0,0
186530,increased,0,0
186531,by,0,0
186532,98,0,0
186533,mmol,0,0
186534,per,0,0
186535,24,0,0
186536,h,0,0
186537,and,0,0
186538,potassium,0,1
186539,excretion,0,0
186540,by,0,0
186541,63,0,0
186542,mmol,0,0
186543,per,0,0
186544,24,0,0
186545,h,0,0
186546,during,0,0
186547,active,0,0
186548,interventions,0,0
186549,",",0,0
186550,compared,0,0
186551,with,0,0
186552,placebo,0,1
186553,.,0,0
186554,During,1,0
186555,sodium,1,1
186556,supplementation,1,1
186557,",",1,0
186558,office,1,0
186559,BP,0,0
186560,was,0,0
186561,significantly,0,0
186562,increased,0,0
186563,by,0,0
186564,7.5/3.3,0,0
186565,mm,0,0
186566,Hg,0,0
186567,",",0,0
186568,24-h,0,0
186569,BP,0,0
186570,by,0,0
186571,7.5/2.7,0,0
186572,mm,0,0
186573,Hg,0,0
186574,and,0,0
186575,central,0,0
186576,BP,0,0
186577,by,0,0
186578,8.5/3.6,0,0
186579,mm,0,0
186580,Hg,0,0
186581,.,0,0
186582,During,1,0
186583,potassium,1,0
186584,supplementation,1,1
186585,",",1,0
186586,24-h,1,0
186587,BP,0,0
186588,was,0,0
186589,significantly,0,0
186590,reduced,0,0
186591,by,0,0
186592,3.9/1.6,0,0
186593,mm,0,0
186594,Hg,0,0
186595,and,0,0
186596,central,0,0
186597,pulse,0,1
186598,pressure,0,0
186599,by,0,0
186600,2.9,0,0
186601,mm,0,0
186602,Hg,0,0
186603,.,0,0
186604,Pulse,0,1
186605,wave,0,1
186606,velocity,0,0
186607,and,0,0
186608,augmentation,0,0
186609,index,0,0
186610,were,0,0
186611,not,0,0
186612,significantly,0,0
186613,affected,1,0
186614,by,1,0
186615,sodium,1,1
186616,or,1,1
186617,potassium,1,1
186618,supplementation,1,1
186619,.,1,0
186620,In,1,0
186621,conclusion,1,0
186622,",",0,0
186623,increasing,0,0
186624,the,0,0
186625,intake,0,0
186626,of,0,0
186627,sodium,0,1
186628,caused,0,0
186629,a,0,0
186630,substantial,0,0
186631,increase,0,0
186632,in,0,0
186633,BP,0,0
186634,in,0,0
186635,subjects,0,0
186636,with,0,0
186637,untreated,0,0
186638,elevated,0,0
186639,BP,0,0
186640,.,0,0
186641,Increased,0,0
186642,potassium,0,0
186643,intake,0,0
186644,",",0,0
186645,on,0,0
186646,top,0,0
186647,of,0,0
186648,a,0,0
186649,relatively,0,0
186650,low-sodium,0,1
186651,diet,0,1
186652,",",0,0
186653,had,0,0
186654,a,0,0
186655,beneficial,0,0
186656,effect,0,0
186657,on,0,0
186658,BP,0,0
186659,.,0,0
186660,Arterial,0,0
186661,stiffness,0,0
186662,did,0,0
186663,not,0,0
186664,materially,0,0
186665,change,0,0
186666,during,0,0
186667,4-week,0,0
186668,interventions,0,0
186669,with,0,0
186670,sodium,0,1
186671,or,0,0
186672,potassium,0,1
186673,.,0,0
186674,The,0,0
186675,nature,0,0
186676,of,0,0
186677,placebo,1,1
186678,response,0,0
186679,in,0,0
186680,clinical,0,0
186681,studies,0,0
186682,of,0,0
186683,major,0,0
186684,depressive,0,0
186685,disorder,0,0
186686,.,0,0
186687,OBJECTIVE,0,0
186688,To,0,0
186689,review,0,0
186690,factors,0,0
186691,influencing,0,0
186692,placebo,1,1
186693,response,0,0
186694,and,0,0
186695,clinical,0,0
186696,trial,0,0
186697,outcome,0,0
186698,in,0,0
186699,depression,0,0
186700,",",0,0
186701,and,0,0
186702,suggest,0,0
186703,ways,0,0
186704,to,0,0
186705,optimize,0,0
186706,trial,0,0
186707,success,0,0
186708,in,0,0
186709,mood,0,0
186710,disorders,0,0
186711,.,0,0
186712,DATA,0,0
186713,SOURCES,0,0
186714,PubMed,0,0
186715,searches,0,0
186716,were,0,0
186717,conducted,0,0
186718,by,0,0
186719,cross-referencing,0,0
186720,the,0,0
186721,terms,0,0
186722,depression,0,0
186723,",",0,0
186724,depressive,0,0
186725,with,0,0
186726,placebo,1,1
186727,",",0,0
186728,clinical,0,0
186729,trial,0,0
186730,",",0,0
186731,and,0,0
186732,clinical,0,0
186733,trials,0,0
186734,for,0,0
186735,studies,0,0
186736,published,0,0
186737,in,0,0
186738,English,0,0
186739,between,0,0
186740,1970,0,0
186741,and,0,0
186742,September,0,0
186743,2013,0,0
186744,.,0,0
186745,STUDY,0,0
186746,SELECTION,0,0
186747,Relevant,0,0
186748,abstracts,0,0
186749,were,0,0
186750,identified,0,0
186751,in,0,0
186752,PubMed,0,0
186753,",",0,0
186754,including,0,0
186755,clinical,0,0
186756,trials,0,0
186757,",",0,0
186758,quantitative,0,0
186759,studies,0,0
186760,",",0,0
186761,and,0,0
186762,qualitative,0,0
186763,research,0,0
186764,.,0,0
186765,We,0,0
186766,obtained,0,0
186767,and,0,0
186768,reviewed,0,0
186769,relevant,0,0
186770,articles,0,0
186771,and,0,0
186772,utilized,0,0
186773,their,0,0
186774,information,0,0
186775,to,0,0
186776,synthesize,0,0
186777,the,0,0
186778,present,0,0
186779,review,0,0
186780,.,0,0
186781,DATA,0,0
186782,EXTRACTION,0,0
186783,Included,0,0
186784,articles,0,0
186785,were,0,0
186786,grouped,0,0
186787,in,0,0
186788,the,0,0
186789,following,0,0
186790,areas,0,0
186791,of,0,0
186792,relevance,0,0
186793,:,0,0
186794,(,0,0
186795,1,0,0
186796,),0,0
186797,biological,0,0
186798,validity,0,0
186799,of,0,0
186800,illness,0,0
186801,",",0,0
186802,(,0,0
186803,2,0,0
186804,),0,0
186805,baseline,0,0
186806,severity,0,0
186807,of,0,0
186808,illness,0,0
186809,",",0,0
186810,(,0,0
186811,3,0,0
186812,),0,0
186813,chronicity,0,0
186814,of,0,0
186815,the,0,0
186816,index,0,0
186817,episode,0,0
186818,of,0,0
186819,depression,0,0
186820,",",0,0
186821,(,0,0
186822,4,0,0
186823,),0,0
186824,age,0,0
186825,of,0,0
186826,participants,0,0
186827,",",0,0
186828,(,0,0
186829,5,0,0
186830,),0,0
186831,medical,0,0
186832,and,0,0
186833,psychiatric,0,0
186834,comorbidity,0,0
186835,",",0,0
186836,(,0,0
186837,6,0,0
186838,),0,0
186839,probability,0,0
186840,of,0,0
186841,receiving,1,0
186842,placebo,1,1
186843,",",0,0
186844,(,0,0
186845,7,0,0
186846,),0,0
186847,use,0,0
186848,of,0,0
186849,prospective,0,0
186850,treatment,0,0
186851,phases,0,0
186852,(,0,0
186853,lead-in,0,0
186854,),0,1
186855,(,0,0
186856,8,0,0
186857,),0,0
186858,dosing,0,0
186859,schedule,0,1
186860,",",0,0
186861,(,0,0
186862,9,0,0
186863,),0,0
186864,trial,0,0
186865,duration,0,0
186866,",",0,0
186867,(,0,0
186868,10,0,0
186869,),0,0
186870,frequency,0,0
186871,of,0,0
186872,follow-up,0,0
186873,assessments,0,0
186874,",",0,0
186875,and,0,0
186876,(,0,0
186877,11,0,0
186878,),0,0
186879,study,0,0
186880,outcome,0,0
186881,measure,0,0
186882,.,0,0
186883,RESULTS,0,0
186884,Several,0,0
186885,key,0,0
186886,elements,0,0
186887,emerge,0,0
186888,as,0,0
186889,critical,0,0
186890,to,0,0
186891,the,0,0
186892,ultimate,0,0
186893,success,0,0
186894,of,0,0
186895,a,0,0
186896,clinical,0,0
186897,trial,0,0
186898,",",0,0
186899,including,0,0
186900,the,0,0
186901,probability,0,0
186902,of,0,0
186903,receiving,0,0
186904,placebo,1,1
186905,",",0,0
186906,study,0,0
186907,duration,0,0
186908,",",0,0
186909,dosing,0,0
186910,schedule,0,1
186911,",",0,0
186912,visit,0,0
186913,frequency,0,0
186914,",",0,0
186915,the,0,0
186916,use,0,0
186917,of,0,0
186918,blinded,0,0
186919,lead-in,0,0
186920,phases,0,0
186921,",",0,0
186922,the,0,0
186923,use,0,0
186924,of,0,0
186925,centralized,0,0
186926,raters,0,0
186927,",",0,0
186928,illness,0,0
186929,severity,0,0
186930,and,0,0
186931,duration,0,0
186932,",",0,0
186933,and,0,0
186934,comorbid,0,0
186935,anxiety,0,0
186936,.,0,0
186937,CONCLUSIONS,0,0
186938,Our,0,0
186939,increasing,0,0
186940,understanding,0,0
186941,of,0,0
186942,the,0,0
186943,placebo,1,1
186944,response,0,0
186945,in,0,0
186946,clinical,0,0
186947,trials,0,0
186948,of,0,0
186949,major,0,0
186950,depressive,0,0
186951,disorder,0,0
186952,lends,0,0
186953,to,0,0
186954,a,0,0
186955,",",0,0
186956,gradually,0,0
186957,",",0,0
186958,more,0,0
186959,predictable,0,0
186960,phenomenon,0,0
186961,and,0,0
186962,",",0,0
186963,hopefully,0,0
186964,",",0,0
186965,to,0,0
186966,one,0,0
186967,that,0,0
186968,becomes,0,0
186969,lesser,0,0
186970,in,0,0
186971,magnitude,0,0
186972,and,0,0
186973,variability,0,0
186974,.,0,0
186975,Several,0,0
186976,elements,0,0
186977,have,0,0
186978,emerged,0,0
186979,that,0,0
186980,seem,0,0
186981,to,0,0
186982,play,0,0
186983,a,0,0
186984,critical,0,0
186985,role,0,0
186986,in,0,0
186987,trial,0,0
186988,success,0,0
186989,",",0,0
186990,gradually,0,0
186991,reshaping,0,0
186992,the,0,0
186993,design,0,0
186994,of,0,0
186995,clinical,0,0
186996,",",0,0
186997,translational,0,0
186998,",",0,0
186999,as,0,0
187000,well,0,0
187001,as,0,0
187002,mechanistic,0,0
187003,studies,0,0
187004,in,0,0
187005,depression,0,0
187006,.,0,0
187007,Long-term,0,0
187008,functional,0,0
187009,outcomes,0,0
187010,and,0,0
187011,predictors,0,0
187012,of,0,0
187013,shunt-dependent,0,0
187014,hydrocephalus,0,0
187015,after,0,0
187016,treatment,0,0
187017,of,0,0
187018,ruptured,0,0
187019,intracranial,0,0
187020,aneurysms,0,0
187021,in,0,0
187022,the,0,0
187023,BRAT,0,0
187024,trial,0,0
187025,:,0,0
187026,revisiting,0,0
187027,the,0,0
187028,clip,0,1
187029,vs,0,0
187030,coil,0,0
187031,debate,0,0
187032,.,0,0
187033,BACKGROUND,0,0
187034,Acute,0,0
187035,hydrocephalus,0,0
187036,is,0,0
187037,a,0,0
187038,well-known,0,0
187039,sequela,0,0
187040,of,0,0
187041,aneurysmal,0,0
187042,subarachnoid,0,0
187043,hemorrhage,0,0
187044,(,0,0
187045,SAH,0,0
187046,),0,0
187047,.,0,0
187048,Controversy,0,0
187049,exists,0,0
187050,about,0,0
187051,whether,0,0
187052,open,0,0
187053,microsurgical,0,1
187054,methods,0,0
187055,serve,0,0
187056,to,0,0
187057,reduce,0,0
187058,shunt,0,1
187059,dependency,0,0
187060,compared,0,0
187061,with,0,0
187062,endovascular,0,0
187063,techniques,0,1
187064,.,0,0
187065,OBJECTIVE,0,0
187066,To,0,0
187067,determine,0,0
187068,predictors,0,0
187069,of,0,0
187070,shunt-dependent,0,0
187071,hydrocephalus,0,0
187072,and,0,0
187073,functional,0,0
187074,outcomes,0,0
187075,after,0,0
187076,aneurysmal,0,0
187077,SAH,0,0
187078,.,0,0
187079,METHODS,0,0
187080,A,0,0
187081,total,0,0
187082,of,0,0
187083,471,0,0
187084,patients,0,0
187085,who,0,0
187086,were,0,0
187087,part,0,0
187088,of,0,0
187089,a,0,0
187090,prospective,0,0
187091,",",0,0
187092,randomized,0,0
187093,",",0,0
187094,controlled,0,0
187095,trial,0,0
187096,from,0,0
187097,2003,0,0
187098,to,0,0
187099,2007,0,0
187100,were,0,0
187101,retrospectively,0,0
187102,reviewed,0,0
187103,.,0,0
187104,All,0,0
187105,variables,0,0
187106,including,0,0
187107,demographic,0,0
187108,data,0,0
187109,",",0,0
187110,medical,0,0
187111,history,0,0
187112,",",0,0
187113,treatment,0,0
187114,",",0,0
187115,imaging,0,0
187116,",",0,0
187117,and,0,0
187118,functional,0,0
187119,outcomes,0,0
187120,were,0,0
187121,included,0,0
187122,as,0,0
187123,part,0,0
187124,of,0,0
187125,the,0,0
187126,trial,0,0
187127,.,0,0
187128,No,0,0
187129,additional,0,0
187130,variables,0,0
187131,were,0,0
187132,retrospectively,0,0
187133,collected,0,0
187134,.,0,0
187135,RESULTS,0,0
187136,Ultimately,0,0
187137,",",0,0
187138,147,0,0
187139,patients,0,0
187140,(,0,0
187141,31.2,0,0
187142,%,0,0
187143,),0,0
187144,required,0,0
187145,a,0,0
187146,ventriculoperitoneal,0,0
187147,shunt,0,1
187148,(,0,0
187149,VPS,0,0
187150,),0,0
187151,in,0,0
187152,our,0,0
187153,series,0,0
187154,.,0,0
187155,Age,0,0
187156,",",0,0
187157,dissecting,0,0
187158,aneurysm,0,0
187159,type,0,0
187160,",",0,0
187161,ruptured,0,0
187162,vertebrobasilar,0,0
187163,aneurysm,0,0
187164,",",0,0
187165,Fisher,0,1
187166,grade,0,0
187167,",",0,0
187168,Hunt,0,0
187169,and,0,0
187170,Hess,0,0
187171,grade,0,0
187172,",",0,0
187173,admission,0,0
187174,intraventricular,0,0
187175,hemorrhage,0,0
187176,",",0,0
187177,admission,0,0
187178,intraparenchymal,0,0
187179,hemorrhage,0,0
187180,",",0,0
187181,blood,0,0
187182,in,0,0
187183,the,0,0
187184,fourth,0,0
187185,ventricle,0,0
187186,on,0,0
187187,admission,0,0
187188,",",0,0
187189,perioperative,0,0
187190,ventriculostomy,0,0
187191,",",0,0
187192,and,0,0
187193,hemicraniectomy,0,0
187194,were,0,0
187195,significant,0,0
187196,risk,0,0
187197,factors,0,0
187198,(,0,0
187199,P,0,0
187200,<,0,0
187201,.05,0,0
187202,),0,0
187203,associated,0,0
187204,with,0,0
187205,shunt-dependent,0,0
187206,hydrocephalus,0,0
187207,on,0,0
187208,univariate,0,0
187209,analysis,0,0
187210,.,0,0
187211,On,0,0
187212,multivariate,0,0
187213,analysis,0,0
187214,",",0,0
187215,intraventricular,0,0
187216,hemorrhage,0,0
187217,and,0,0
187218,intraparenchymal,0,0
187219,hemorrhage,0,0
187220,were,0,0
187221,independent,0,0
187222,risk,0,0
187223,factors,0,0
187224,for,0,0
187225,shunt,0,1
187226,dependency,0,0
187227,(,0,0
187228,P,0,0
187229,<,0,0
187230,.05,0,0
187231,),0,0
187232,.,0,0
187233,Clipping,1,0
187234,vs,0,0
187235,coiling,1,0
187236,treatment,0,0
187237,was,0,0
187238,not,0,0
187239,statistically,0,0
187240,associated,0,0
187241,with,0,0
187242,VPS,0,0
187243,after,0,0
187244,SAH,0,0
187245,on,0,0
187246,both,0,0
187247,univariate,0,0
187248,and,0,0
187249,multivariate,0,0
187250,analyses,0,0
187251,.,0,0
187252,Patients,0,0
187253,who,0,0
187254,did,0,0
187255,not,0,0
187256,receive,0,0
187257,a,0,0
187258,VPS,0,0
187259,at,0,0
187260,discharge,0,0
187261,had,0,0
187262,higher,0,0
187263,Glasgow,0,0
187264,Outcome,0,0
187265,Scale,0,0
187266,and,0,0
187267,Barthel,0,0
187268,Index,0,1
187269,scores,0,0
187270,and,0,0
187271,were,0,0
187272,more,0,0
187273,likely,0,0
187274,to,0,0
187275,be,0,0
187276,functionally,0,0
187277,independent,0,0
187278,and,0,0
187279,to,0,0
187280,return,0,0
187281,to,0,0
187282,work,0,0
187283,72,0,0
187284,months,0,0
187285,after,0,0
187286,surgery,0,0
187287,(,0,0
187288,P,0,0
187289,<,0,0
187290,.05,0,0
187291,),0,0
187292,.,0,0
187293,CONCLUSION,0,0
187294,There,0,0
187295,is,0,0
187296,no,0,0
187297,difference,0,0
187298,in,0,0
187299,shunt,0,0
187300,dependency,0,0
187301,after,0,0
187302,SAH,0,0
187303,among,0,0
187304,patients,0,0
187305,treated,0,0
187306,by,0,0
187307,endovascular,0,0
187308,or,0,0
187309,microsurgical,0,1
187310,means,0,0
187311,.,0,0
187312,Patients,0,0
187313,in,0,0
187314,whom,0,0
187315,shunt-dependent,0,0
187316,hydrocephalus,0,0
187317,does,0,0
187318,not,0,0
187319,develop,0,0
187320,after,0,0
187321,SAH,0,0
187322,tend,0,0
187323,to,0,0
187324,have,0,0
187325,improved,0,0
187326,long-term,0,0
187327,functional,0,0
187328,outcomes,0,0
187329,.,0,0
187330,Effect,0,0
187331,of,0,0
187332,finasteride,1,1
187333,on,0,0
187334,serum,0,0
187335,androstenedione,0,0
187336,and,0,0
187337,risk,0,0
187338,of,0,0
187339,prostate,0,0
187340,cancer,0,0
187341,within,0,0
187342,the,0,0
187343,prostate,0,0
187344,cancer,0,0
187345,prevention,0,0
187346,trial,0,0
187347,:,0,0
187348,differential,0,0
187349,effect,0,0
187350,on,0,0
187351,high-,0,0
187352,and,0,0
187353,low-grade,0,0
187354,disease,0,0
187355,.,0,0
187356,OBJECTIVE,0,0
187357,To,0,0
187358,evaluate,0,0
187359,the,0,0
187360,effect,0,0
187361,of,0,0
187362,finasteride,1,1
187363,on,0,0
187364,serum,0,0
187365,"androst-4-ene-3,17-dione",0,1
187366,(,0,0
187367,androstenedione,0,0
187368,),0,0
187369,and,0,0
187370,its,0,0
187371,association,0,0
187372,with,0,0
187373,prostate,0,0
187374,cancer,0,0
187375,risk,0,0
187376,among,0,0
187377,subjects,0,0
187378,who,0,0
187379,participated,0,0
187380,in,0,0
187381,the,0,0
187382,Prostate,0,0
187383,Cancer,0,0
187384,Prevention,0,1
187385,Trial,0,0
187386,.,0,0
187387,METHODS,0,0
187388,We,0,0
187389,analyzed,0,0
187390,serum,0,0
187391,androstenedione,0,0
187392,levels,0,0
187393,in,0,0
187394,317,0,0
187395,prostate,0,0
187396,cancer,0,0
187397,cases,0,0
187398,and,0,0
187399,353,0,0
187400,controls,0,0
187401,",",0,0
187402,nested,0,0
187403,in,0,0
187404,the,0,0
187405,Prostate,0,0
187406,Cancer,0,0
187407,Prevention,0,1
187408,Trial,0,0
187409,",",0,0
187410,a,0,0
187411,randomized,0,0
187412,placebo-controlled,1,1
187413,trial,0,0
187414,that,0,0
187415,found,0,0
187416,finasteride,1,1
187417,decreased,0,0
187418,prostate,0,0
187419,cancer,0,0
187420,risk,0,0
187421,.,0,0
187422,Androstenedione,0,0
187423,is,0,0
187424,the,0,0
187425,second,0,0
187426,most,0,0
187427,important,0,0
187428,circulating,0,0
187429,androgen,0,0
187430,in,0,0
187431,men,0,0
187432,besides,0,0
187433,testosterone,0,0
187434,and,0,0
187435,also,0,0
187436,a,0,0
187437,substrate,0,0
187438,for,0,0
187439,5?-reductase,0,0
187440,enzyme,0,0
187441,.,0,0
187442,RESULTS,0,0
187443,We,0,0
187444,observed,0,0
187445,a,0,0
187446,22,0,0
187447,%,0,0
187448,increase,0,0
187449,in,0,0
187450,androstenedione,0,0
187451,levels,0,0
187452,compared,0,0
187453,with,0,0
187454,the,0,0
187455,baseline,0,0
187456,values,0,0
187457,in,0,0
187458,subjects,0,0
187459,who,0,0
187460,were,0,0
187461,treated,0,0
187462,with,1,0
187463,finasteride,1,1
187464,for,0,0
187465,3,0,0
187466,years,0,0
187467,.,0,0
187468,This,0,0
187469,significant,0,0
187470,increase,0,0
187471,did,0,0
187472,not,0,0
187473,vary,0,0
187474,by,0,0
187475,case-control,0,0
187476,status,0,0
187477,.,0,0
187478,Adjusted,0,0
187479,odds,0,0
187480,ratio,0,0
187481,and,0,0
187482,95,0,0
187483,%,0,0
187484,confidence,0,0
187485,interval,0,0
187486,for,0,0
187487,the,0,0
187488,third,0,0
187489,tertile,0,0
187490,of,0,0
187491,absolute,0,0
187492,change,0,0
187493,in,0,0
187494,androstenedione,0,0
187495,levels,0,0
187496,compared,0,0
187497,with,0,0
187498,the,0,0
187499,first,0,0
187500,tertile,0,0
187501,were,0,0
187502,0.42,0,0
187503,(,0,0
187504,95,0,0
187505,%,0,0
187506,confidence,0,0
187507,interval,0,0
187508,",",0,0
187509,0.19-0.94,0,0
187510,),0,0
187511,for,0,0
187512,low-grade,0,0
187513,(,0,0
187514,Gleason,0,0
187515,score,0,0
187516,<,0,0
187517,7,0,0
187518,),0,0
187519,cases,0,0
187520,.,0,0
187521,Similar,0,0
187522,results,0,0
187523,were,0,0
187524,observed,0,0
187525,when,0,0
187526,analyzed,0,0
187527,using,0,0
187528,percent,0,0
187529,change,0,0
187530,.,0,0
187531,There,0,0
187532,were,0,0
187533,no,0,0
187534,significant,0,0
187535,associations,0,0
187536,between,0,0
187537,serum,0,0
187538,androstenedione,0,0
187539,levels,0,0
187540,and,0,0
187541,the,0,0
187542,risk,0,0
187543,of,0,0
187544,high-grade,0,0
187545,disease,0,0
187546,.,0,0
187547,CONCLUSION,0,0
187548,The,0,0
187549,results,0,0
187550,of,0,0
187551,this,0,0
187552,nested,0,0
187553,case-control,0,0
187554,study,0,0
187555,confirm,0,0
187556,that,1,0
187557,finasteride,1,1
187558,blocks,0,1
187559,the,0,0
187560,conversion,0,0
187561,of,0,0
187562,testosterone,0,0
187563,to,0,0
187564,dihydrotestosterone,0,1
187565,(,0,0
187566,DHT,0,0
187567,),0,0
187568,and,0,0
187569,of,0,0
187570,androstenedione,0,0
187571,to,0,0
187572,"5?-androstanedione-3,17-dione",0,1
187573,",",0,0
187574,which,0,0
187575,also,0,0
187576,leads,0,0
187577,to,0,0
187578,the,0,0
187579,reduction,0,0
187580,of,0,0
187581,DHT,0,0
187582,formation,0,0
187583,.,0,0
187584,This,0,0
187585,decrease,0,0
187586,in,0,0
187587,DHT,0,0
187588,may,0,0
187589,help,0,0
187590,reduce,0,0
187591,the,0,0
187592,risk,0,0
187593,of,0,0
187594,low-grade,0,0
187595,prostate,0,0
187596,cancer,0,0
187597,in,0,0
187598,men,0,0
187599,.,0,0
187600,Our,0,0
187601,data,0,0
187602,on,0,0
187603,a,0,0
187604,differential,0,0
187605,effect,0,0
187606,of,0,0
187607,androstenedione,0,0
187608,also,0,0
187609,suggest,0,0
187610,that,0,0
187611,some,0,0
187612,high-grade,0,0
187613,prostate,0,0
187614,cancers,0,0
187615,may,0,0
187616,not,0,0
187617,require,0,0
187618,androgen,0,0
187619,for,0,0
187620,progression,0,0
187621,.,0,0
187622,Lateral,1,0
187623,MI,1,1
187624,Explains,0,0
187625,the,0,0
187626,Presence,0,0
187627,of,0,0
187628,Prominent,0,0
187629,R,0,1
187630,Wave,0,0
187631,(,0,0
187632,R,0,0
187633,?,0,0
187634,S,0,0
187635,),0,0
187636,in,0,0
187637,V1,0,0
187638,.,0,0
187639,AIMS,0,0
187640,It,0,0
187641,is,0,0
187642,necessary,0,0
187643,to,0,0
187644,clarify,0,0
187645,if,0,0
187646,the,0,0
187647,presence,0,0
187648,of,0,0
187649,a,0,0
187650,prominent,0,0
187651,R,0,0
187652,wave,0,1
187653,in,0,0
187654,V1,0,0
187655,",",0,0
187656,in,0,0
187657,post-myocardial,0,0
187658,infarction,0,0
187659,(,0,0
187660,MI,0,1
187661,),0,0
187662,patients,0,0
187663,",",0,0
187664,is,0,0
187665,due,0,0
187666,to,0,0
187667,the,0,0
187668,involvement,0,0
187669,of,0,0
187670,the,1,0
187671,posterior,1,1
187672,wall,1,0
187673,(,1,0
187674,currently,1,0
187675,inferobasal,1,0
187676,segment,1,0
187677,),1,0
187678,or,1,0
187679,the,1,0
187680,lateral,1,1
187681,wall,1,0
187682,(,1,0
187683,as,0,0
187684,has,0,0
187685,been,0,0
187686,demonstrated,0,0
187687,recently,0,0
187688,by,0,0
187689,electrocardiographic,0,0
187690,contrast-enhanced,0,1
187691,cardiac,0,0
187692,magnetic,0,1
187693,resonance,0,1
187694,[,0,0
187695,ECG-CE-CMR,0,0
187696,],0,0
187697,correlations,0,0
187698,studies,0,0
187699,),0,0
187700,.,0,0
187701,METHODS,0,0
187702,In,0,0
187703,155,0,0
187704,patients,0,0
187705,with,0,0
187706,inferolateral,0,0
187707,zone,0,0
187708,MI,0,1
187709,",",0,0
187710,as,0,0
187711,detected,0,0
187712,by,0,0
187713,CE-CMR,0,0
187714,",",0,0
187715,the,0,0
187716,following,0,0
187717,ECG,0,0
187718,parameters,0,0
187719,were,0,0
187720,evaluated,0,0
187721,and,0,0
187722,correlated,0,0
187723,with,0,0
187724,MI,0,1
187725,location,0,0
187726,according,0,0
187727,to,0,0
187728,CE-CMR,0,0
187729,:,0,0
187730,R/S,0,0
187731,ratio,0,0
187732,in,0,0
187733,V1,0,0
187734,?,0,0
187735,1,0,0
187736,(,0,0
187737,classic,0,0
187738,criteria,0,0
187739,for,0,0
187740,posterior,0,1
187741,MI,0,1
187742,),0,0
187743,",",0,0
187744,R/S,0,0
187745,ratio,0,0
187746,in,0,0
187747,V1,0,0
187748,?,0,0
187749,0.5,0,0
187750,",",0,0
187751,and,0,0
187752,R,0,0
187753,in,0,0
187754,V1,0,0
187755,?,0,0
187756,3,0,0
187757,mm,0,0
187758,.,0,0
187759,RESULTS,0,0
187760,R/S,0,0
187761,?,0,0
187762,1,0,0
187763,criterion,0,0
187764,:,0,0
187765,Present,0,0
187766,in,0,0
187767,20,0,0
187768,cases,0,0
187769,:,0,0
187770,3,0,0
187771,of,1,0
187772,lateral,1,0
187773,MI,1,1
187774,",",1,0
187775,17,1,0
187776,of,1,0
187777,inferolateral,1,0
187778,MI,1,1
187779,",",1,0
187780,0,1,0
187781,of,1,0
187782,inferior,1,0
187783,MI,1,1
187784,.,1,0
187785,Absent,1,0
187786,in,0,0
187787,135,0,0
187788,cases,0,0
187789,",",0,0
187790,81,0,0
187791,of,1,0
187792,lateral/inferolateral,1,0
187793,MI,1,1
187794,(,1,0
187795,28/53,1,0
187796,),0,0
187797,",",0,0
187798,54,0,0
187799,of,0,0
187800,inferior,0,0
187801,MI,0,1
187802,(,0,0
187803,SE,0,1
187804,19.8,0,0
187805,%,0,0
187806,",",0,0
187807,SP,0,0
187808,100,0,1
187809,%,0,0
187810,),0,0
187811,.,0,0
187812,R/S,0,0
187813,?,0,0
187814,0.5,0,0
187815,criterion,0,0
187816,:,0,0
187817,Present,0,0
187818,in,0,0
187819,47,0,0
187820,cases,0,0
187821,:,0,0
187822,6,0,0
187823,of,0,0
187824,lateral,1,0
187825,MI,1,1
187826,",",1,0
187827,39,1,0
187828,of,1,0
187829,inferolateral,1,0
187830,MI,1,1
187831,",",1,0
187832,2,1,0
187833,of,1,0
187834,inferior,1,0
187835,MI,0,1
187836,.,0,0
187837,Absent,0,0
187838,in,0,0
187839,108,0,0
187840,cases,0,0
187841,",",0,0
187842,56,0,0
187843,of,0,0
187844,lateral/inferolateral,1,0
187845,MI,1,1
187846,(,1,0
187847,25/31,1,0
187848,),1,0
187849,",",1,0
187850,52,0,0
187851,of,1,0
187852,inferior,1,0
187853,MI,1,1
187854,(,0,0
187855,SE,0,1
187856,44.6,0,0
187857,%,0,0
187858,",",0,0
187859,SP,0,0
187860,96.4,0,0
187861,%,0,0
187862,),0,0
187863,.,0,0
187864,R,0,0
187865,?,0,0
187866,3,0,0
187867,mm,0,0
187868,criterion,0,0
187869,:,0,0
187870,Present,0,0
187871,in,0,0
187872,30,0,0
187873,cases,0,0
187874,:,0,0
187875,5,0,0
187876,of,0,0
187877,IM,1,0
187878,lateral,1,0
187879,",",0,0
187880,23,0,0
187881,of,0,0
187882,inferolateral,1,0
187883,MI,1,1
187884,",",1,0
187885,2,1,0
187886,of,1,0
187887,inferior,1,0
187888,MI,1,1
187889,.,1,0
187890,Absent,0,0
187891,in,0,0
187892,125,0,0
187893,cases,0,0
187894,",",0,0
187895,73,0,0
187896,lateral/inferolateral,1,0
187897,MI,1,1
187898,(,1,0
187899,26/47,1,0
187900,),1,0
187901,",",1,0
187902,52,1,0
187903,inferior,1,0
187904,MI,1,1
187905,(,1,0
187906,SE,0,1
187907,27.7,0,0
187908,%,0,0
187909,",",0,0
187910,SP,0,0
187911,96.4,0,0
187912,%,0,0
187913,),0,0
187914,.,0,0
187915,CONCLUSIONS,0,0
187916,The,0,0
187917,presence,0,0
187918,of,0,0
187919,prominent,0,0
187920,the,0,0
187921,R,0,0
187922,wave,0,0
187923,in,0,0
187924,V1,0,0
187925,is,0,0
187926,due,0,0
187927,to,0,0
187928,the,0,0
187929,lateral,1,1
187930,MI,1,1
187931,and,1,0
187932,not,0,0
187933,to,0,0
187934,the,0,0
187935,involvement,0,0
187936,of,0,0
187937,inferobasal,0,0
187938,segment,0,0
187939,of,0,0
187940,inferior,0,0
187941,wall,0,0
187942,(,0,0
187943,old,0,0
187944,posterior,0,1
187945,wall,0,0
187946,),0,0
187947,.,0,0
187948,[,0,0
187949,European,0,0
187950,topic,0,0
187951,:,0,0
187952,liver,1,0
187953,surgery,1,0
187954,II,1,0
187955,--,1,0
187956,regional,1,0
187957,chemotherapy,1,1
187958,],1,0
187959,.,0,0
187960,The,0,0
187961,most,0,0
187962,important,0,0
187963,methods,0,0
187964,of,0,0
187965,regional,1,0
187966,chemotherapy,1,1
187967,are,0,0
187968,exemplified,0,0
187969,by,0,0
187970,657,0,0
187971,cases,0,0
187972,of,0,0
187973,primary,0,0
187974,and,0,0
187975,secondary,0,0
187976,liver,0,0
187977,only,0,0
187978,malignancies,0,0
187979,.,0,0
187980,I,0,0
187981,.,0,0
187982,Adjuvant,1,0
187983,portal,1,0
187984,therapy,1,1
187985,of,1,0
187986,the,1,0
187987,liver,1,0
187988,with,1,0
187989,resection,1,0
187990,of,1,0
187991,the,1,0
187992,colorectal,1,0
187993,primary,1,0
187994,malignancy,1,0
187995,seems,0,0
187996,to,0,0
187997,be,0,0
187998,advantageous,0,0
187999,for,0,0
188000,advanced,0,0
188001,tumors,0,0
188002,.,0,0
188003,II,0,0
188004,.,0,0
188005,It,0,0
188006,is,0,0
188007,still,0,0
188008,unresolved,0,0
188009,whether,0,0
188010,survival,0,0
188011,is,0,0
188012,prolonged,0,0
188013,by,0,0
188014,adjuvant,0,1
188015,treatment,0,0
188016,of,0,0
188017,the,0,0
188018,liver,0,0
188019,following,0,0
188020,curative,1,0
188021,resection,1,1
188022,of,1,0
188023,colorectal,1,0
188024,liver,1,0
188025,metastases,1,0
188026,.,1,0
188027,III,0,0
188028,.,0,0
188029,The,0,0
188030,median,0,0
188031,survival,0,0
188032,time,0,0
188033,(,0,0
188034,FUDR,0,0
188035,",",0,0
188036,pump,0,1
188037,),0,0
188038,is,0,0
188039,17,0,0
188040,months,0,0
188041,for,0,0
188042,palliative,1,0
188043,local,1,0
188044,chemotherapy,1,1
188045,of,0,0
188046,unresectable,0,0
188047,colorectal,0,0
188048,liver,0,0
188049,metastases,0,0
188050,.,0,0
188051,IV,0,0
188052,.,0,0
188053,Primary,0,0
188054,non-resectable,0,0
188055,liver,0,0
188056,malignancies,0,0
188057,show,0,0
188058,the,0,0
188059,best,0,0
188060,results,0,0
188061,after,0,0
188062,chemoembolisation,0,1
188063,(,0,0
188064,Frankfurt,0,0
188065,method,0,0
188066,),0,0
188067,.,0,0
188068,Qingre,0,1
188069,quyu,0,1
188070,granule,0,0
188071,stabilizes,0,0
188072,plaques,0,0
188073,through,0,0
188074,inhibiting,0,0
188075,the,0,0
188076,expression,0,0
188077,of,0,0
188078,tenascin-C,0,0
188079,in,0,0
188080,patients,0,0
188081,with,0,0
188082,severe,0,0
188083,carotid,0,0
188084,stenosis,0,0
188085,.,0,0
188086,OBJECTIVE,0,0
188087,To,0,0
188088,investigate,0,0
188089,the,0,0
188090,therapeutic,0,0
188091,effects,0,0
188092,of,0,0
188093,Qingre,1,1
188094,Quyu,1,1
188095,Granule,1,0
188096,(,1,0
188097,QQG,1,1
188098,),1,0
188099,on,0,0
188100,the,0,0
188101,patients,0,0
188102,with,0,0
188103,severe,0,0
188104,carotid,0,0
188105,stenosis,0,0
188106,",",0,0
188107,and,0,0
188108,to,0,0
188109,explore,0,0
188110,the,0,0
188111,mechanism,0,0
188112,of,0,0
188113,it,0,0
188114,.,0,0
188115,METHODS,0,0
188116,Ninety-six,0,0
188117,patients,0,0
188118,with,0,0
188119,severe,0,0
188120,carotid,0,0
188121,stenosis,0,0
188122,were,0,0
188123,enrolled,0,0
188124,in,0,0
188125,the,0,0
188126,study,0,0
188127,and,0,0
188128,were,0,0
188129,classified,0,0
188130,into,0,0
188131,a,0,0
188132,QQG,1,1
188133,group,0,0
188134,(,0,0
188135,n=48,0,0
188136,),0,0
188137,and,0,0
188138,a,0,0
188139,control,1,1
188140,group,1,0
188141,(,0,0
188142,n=48,0,0
188143,),0,0
188144,randomly,0,0
188145,using,0,0
188146,consecutively,0,0
188147,numbered,0,0
188148,envelopes,0,0
188149,.,0,0
188150,The,0,0
188151,patients,0,0
188152,in,0,0
188153,the,0,0
188154,QQG,1,1
188155,group,0,0
188156,were,0,0
188157,given,0,0
188158,QQG,1,1
188159,and,0,0
188160,Western,1,0
188161,medicine,1,1
188162,",",0,0
188163,those,0,0
188164,in,0,0
188165,the,0,0
188166,control,0,0
188167,group,0,0
188168,were,0,0
188169,given,0,0
188170,Western,1,0
188171,medicine,1,0
188172,merely,0,0
188173,",",0,0
188174,the,0,0
188175,course,0,0
188176,of,0,0
188177,treatment,0,0
188178,was,0,0
188179,16,0,0
188180,weeks,0,0
188181,.,0,0
188182,All,0,0
188183,patients,0,0
188184,went,0,0
188185,through,0,0
188186,endarterectomy,0,0
188187,after,0,0
188188,treatment,0,0
188189,.,0,0
188190,Plaques,0,0
188191,were,0,0
188192,subjected,0,0
188193,to,0,0
188194,the,0,0
188195,analysis,0,0
188196,of,0,0
188197,CD3,0,1
188198,",",0,0
188199,CD68,0,1
188200,",",0,0
188201,soluble,0,1
188202,intercellular,0,0
188203,adhesion,0,0
188204,molecule,0,0
188205,1,0,0
188206,(,0,0
188207,ICAM-1,0,0
188208,),0,0
188209,",",0,0
188210,matrix,0,1
188211,metalloprotease-9,0,0
188212,(,0,0
188213,MMP-9,0,0
188214,),0,0
188215,",",0,0
188216,CD40L,0,1
188217,",",0,0
188218,tenascin-C,0,0
188219,",",0,0
188220,and,0,0
188221,collagen,0,1
188222,content,0,0
188223,lipid,0,0
188224,content,0,0
188225,by,0,0
188226,immunohistochemistry,0,0
188227,or,0,1
188228,polarized,0,0
188229,light,0,0
188230,analysis,0,0
188231,.,0,0
188232,RESULTS,0,0
188233,By,0,0
188234,the,0,0
188235,end,0,0
188236,of,0,0
188237,experiment,0,0
188238,",",0,0
188239,the,0,0
188240,expressions,0,0
188241,of,0,0
188242,CD3,0,1
188243,",",0,0
188244,CD68,0,1
188245,",",0,0
188246,ICAM-1,0,0
188247,",",0,0
188248,MMP9,0,1
188249,",",0,0
188250,CD40L,0,1
188251,and,0,0
188252,tenascin-C,0,1
188253,on,0,0
188254,the,0,0
188255,plaques,0,0
188256,were,0,0
188257,statistically,0,0
188258,significant,0,0
188259,lower,0,0
188260,in,0,0
188261,the,0,0
188262,QQG,0,1
188263,group,0,0
188264,compared,0,0
188265,with,0,0
188266,the,0,0
188267,control,0,1
188268,group,0,0
188269,(,0,0
188270,P,0,0
188271,<,0,0
188272,0.01,0,0
188273,),0,0
188274,.,0,0
188275,The,0,0
188276,lipid,0,0
188277,content,0,0
188278,of,0,0
188279,the,0,0
188280,plaque,0,0
188281,was,0,0
188282,also,0,0
188283,significantly,0,0
188284,lower,0,0
188285,in,0,0
188286,the,0,0
188287,QQG,1,1
188288,group,0,0
188289,compared,0,0
188290,with,0,0
188291,the,0,0
188292,control,0,1
188293,group,0,0
188294,(,0,0
188295,P,0,0
188296,<,0,0
188297,0.01,0,0
188298,),0,0
188299,.,0,0
188300,The,0,0
188301,interstitial,0,0
188302,collagen,0,0
188303,in,0,0
188304,the,0,0
188305,tissue,0,0
188306,sections,0,0
188307,of,0,0
188308,the,0,0
188309,plaques,0,0
188310,was,0,0
188311,also,0,0
188312,significantly,0,0
188313,higher,0,0
188314,in,0,0
188315,the,0,0
188316,QQG,1,1
188317,group,0,0
188318,in,0,0
188319,comparison,0,0
188320,with,0,0
188321,the,0,0
188322,control,0,1
188323,group,0,0
188324,(,0,0
188325,P,0,0
188326,<,0,0
188327,0.01,0,0
188328,),0,0
188329,.,0,0
188330,CONCLUSION,0,0
188331,QQG,1,0
188332,could,0,0
188333,stabilize,0,0
188334,carotid,0,0
188335,artery,0,0
188336,plaques,0,0
188337,through,0,0
188338,inhibiting,0,0
188339,pro-inflammation,0,0
188340,factors,0,0
188341,and,0,0
188342,restraining,0,0
188343,the,0,0
188344,tenascin-C,0,1
188345,and,0,0
188346,MMP9,0,1
188347,pathway,0,0
188348,.,0,0
188349,The,0,0
188350,Impact,0,0
188351,of,0,0
188352,Partial,1,0
188353,Vascular,1,0
188354,Occlusion,1,0
188355,on,0,0
188356,Oxidative,0,0
188357,Stress,0,1
188358,Markers,0,0
188359,during,0,0
188360,Resistance,1,0
188361,Exercise,1,1
188362,.,1,0
188363,This,0,0
188364,study,0,0
188365,sought,0,0
188366,to,0,0
188367,examine,0,0
188368,the,0,0
188369,effects,0,0
188370,of,0,0
188371,partial,1,0
188372,vascular,1,0
188373,occlusion,1,0
188374,(,1,0
188375,PVO,1,1
188376,),1,0
188377,on,0,0
188378,oxidative,0,0
188379,stress,0,0
188380,markers,0,0
188381,in,0,0
188382,response,0,0
188383,to,0,0
188384,resistance,1,0
188385,exercise,1,1
188386,and,0,0
188387,at,0,0
188388,rest,0,0
188389,in,0,0
188390,young,0,0
188391,resistance-trained,0,0
188392,males,0,0
188393,.,0,0
188394,12,0,0
188395,resistance-trained,0,0
188396,males,0,0
188397,performed,0,0
188398,6,0,0
188399,conditions,0,0
188400,in,0,0
188401,random,0,0
188402,counterbalanced,0,0
188403,order,0,0
188404,:,0,0
188405,rest,1,0
188406,(,1,0
188407,R,1,0
188408,),1,0
188409,",",1,0
188410,low-intensity,1,1
188411,(,1,0
188412,LIRE,1,0
188413,:,1,0
188414,30,0,0
188415,%,0,0
188416,1RM,0,0
188417,),0,0
188418,and,0,0
188419,moderate-intensity,1,1
188420,(,1,0
188421,MIRE,1,0
188422,:,1,0
188423,70,0,0
188424,%,0,0
188425,1RM,0,0
188426,),0,0
188427,resistance,1,0
188428,exercise,1,1
188429,with,1,0
188430,or,1,0
188431,without,1,0
188432,PVO,1,1
188433,.,1,0
188434,Blood,0,0
188435,samples,0,0
188436,were,0,0
188437,obtained,0,0
188438,before,0,0
188439,and,0,0
188440,immediately,0,0
188441,after,0,0
188442,each,0,0
188443,condition,0,0
188444,and,0,0
188445,plasma,0,0
188446,protein,0,1
188447,carbonyls,0,1
188448,(,0,0
188449,PC,0,1
188450,),0,0
188451,",",0,0
188452,glutathione,0,0
188453,ratio,0,0
188454,",",0,0
188455,oxygen,0,1
188456,radical,0,1
188457,absorbance,0,0
188458,capacity,0,0
188459,(,0,0
188460,ORAC,0,0
188461,),0,0
188462,",",0,0
188463,and,0,0
188464,xanthine,0,1
188465,oxidase,0,1
188466,(,0,0
188467,XO,0,1
188468,),0,0
188469,were,0,0
188470,evaluated,0,0
188471,.,0,0
188472,The,0,0
188473,addition,0,0
188474,of,0,0
188475,PVO,1,0
188476,resulted,0,0
188477,in,0,0
188478,significantly,0,0
188479,greater,0,0
188480,plasma,0,0
188481,PC,0,0
188482,and,0,0
188483,glutathione,0,0
188484,ratio,0,0
188485,in,0,0
188486,the,0,0
188487,rest,0,0
188488,condition,0,0
188489,.,0,0
188490,During,0,0
188491,LIRE,1,0
188492,the,0,0
188493,addition,0,0
188494,of,0,0
188495,PVO,1,0
188496,significantly,0,0
188497,attenuated,0,0
188498,plasma,0,0
188499,PC,0,0
188500,.,0,0
188501,The,0,0
188502,MIRE,0,0
188503,condition,0,0
188504,",",0,0
188505,independent,0,0
188506,of,0,0
188507,PVO,1,0
188508,",",0,0
188509,resulted,0,0
188510,in,0,0
188511,significantly,0,0
188512,higher,0,0
188513,PC,0,0
188514,concentration,0,0
188515,and,0,0
188516,glutathione,0,0
188517,ratio,0,0
188518,compared,0,0
188519,to,0,0
188520,the,0,0
188521,rest,0,0
188522,and,0,0
188523,LIRE,0,0
188524,conditions,0,0
188525,.,0,0
188526,The,0,0
188527,addition,1,0
188528,of,0,0
188529,PVO,1,0
188530,during,1,0
188531,MIRE,1,0
188532,resulted,0,0
188533,in,0,0
188534,a,0,0
188535,significant,0,0
188536,increase,0,0
188537,in,0,0
188538,PC,0,1
188539,.,0,0
188540,Thus,0,0
188541,",",0,0
188542,this,0,0
188543,study,0,0
188544,revealed,0,0
188545,that,0,0
188546,PVO,1,0
188547,increased,0,0
188548,oxidative,0,0
188549,stress,0,0
188550,at,0,0
188551,rest,0,0
188552,and,0,0
188553,enhanced,0,0
188554,the,0,0
188555,oxidative,0,0
188556,stress,0,0
188557,response,0,0
188558,to,0,0
188559,MIRE,1,0
188560,",",0,0
188561,but,0,0
188562,when,0,0
188563,combined,0,0
188564,with,0,0
188565,LIRE,1,0
188566,oxidative,0,0
188567,stress,0,0
188568,was,0,0
188569,attenuated,0,0
188570,.,0,0
188571,These,0,0
188572,findings,0,0
188573,suggest,0,0
188574,that,0,0
188575,the,0,0
188576,utilization,0,0
188577,of,0,0
188578,PVO,1,0
188579,during,0,0
188580,LIRE,1,0
188581,may,0,0
188582,alter,0,0
188583,ROS-induced,0,0
188584,accumulation,0,0
188585,in,0,0
188586,the,0,0
188587,blood,0,0
188588,which,0,0
188589,may,0,0
188590,influence,0,0
188591,cellular,0,0
188592,signaling,0,0
188593,.,0,0
188594,Role,0,0
188595,of,0,0
188596,warm,1,0
188597,saline,1,1
188598,mouth,1,1
188599,rinse,1,1
188600,in,0,0
188601,prevention,0,0
188602,of,0,0
188603,alveolar,0,0
188604,osteitis,0,0
188605,:,0,0
188606,a,0,0
188607,randomized,0,0
188608,controlled,0,0
188609,trial,0,0
188610,.,0,0
188611,BACKGROUND,0,0
188612,The,0,0
188613,present,0,0
188614,study,0,0
188615,was,0,0
188616,aimed,0,0
188617,at,0,0
188618,determining,0,0
188619,the,0,0
188620,role,0,0
188621,warm,1,0
188622,saline,1,1
188623,rinse,1,1
188624,in,0,0
188625,the,0,0
188626,prevention,0,0
188627,of,0,0
188628,alveolar,0,0
188629,osteitis,0,0
188630,following,0,0
188631,dental,0,0
188632,extractions,0,0
188633,.,0,0
188634,MATERIALS,0,0
188635,AND,0,0
188636,METHODS,0,0
188637,Apparently,0,0
188638,patients,0,0
188639,aged,0,0
188640,16,0,0
188641,and,0,0
188642,above,0,0
188643,who,0,0
188644,were,0,0
188645,referred,0,0
188646,to,0,0
188647,the,0,0
188648,Oral,0,0
188649,Surgery,0,1
188650,Clinic,0,1
188651,of,0,0
188652,our,0,0
188653,institution,0,0
188654,",",0,0
188655,with,0,0
188656,an,0,0
188657,indication,0,0
188658,for,0,0
188659,non-surgical,0,1
188660,extraction,0,1
188661,of,0,0
188662,pathologic,0,0
188663,teeth,0,0
188664,were,0,0
188665,prospectively,0,0
188666,and,0,0
188667,uniformly,0,0
188668,randomized,0,0
188669,into,0,0
188670,warm,1,0
188671,saline,1,1
188672,group,1,0
188673,and,0,0
188674,control,1,0
188675,.,1,0
188676,The,0,0
188677,experimental,0,0
188678,group,0,0
188679,(,0,0
188680,n,0,0
188681,=,0,0
188682,80,0,0
188683,),0,0
188684,were,0,0
188685,instructed,0,0
188686,to,0,0
188687,gargle,1,1
188688,6,1,0
188689,times,1,0
188690,daily,1,0
188691,with,1,0
188692,warm,1,0
188693,saline,1,1
188694,and,0,0
188695,no,1,0
188696,such,1,0
188697,instructions,1,0
188698,were,0,0
188699,given,0,0
188700,to,0,0
188701,the,0,0
188702,second,0,0
188703,group,0,0
188704,(,0,0
188705,n,0,0
188706,=,0,0
188707,80,0,0
188708,),0,0
188709,to,0,0
188710,serve,0,0
188711,as,0,0
188712,controls,1,0
188713,.,1,0
188714,Information,0,0
188715,on,0,0
188716,demographic,0,0
188717,",",0,0
188718,indications,0,0
188719,for,0,0
188720,extraction,0,0
188721,",",0,0
188722,and,0,0
188723,development,0,0
188724,of,0,0
188725,alveolar,0,0
188726,osteitis,0,0
188727,were,0,0
188728,obtained,0,0
188729,and,0,0
188730,analyzed,0,0
188731,.,0,0
188732,Comparative,0,0
188733,statistics,0,0
188734,were,0,0
188735,done,0,0
188736,using,0,0
188737,Pearson,0,0
188738,'s,0,0
188739,chi,0,0
188740,square,0,0
188741,or,0,1
188742,Fisher,0,1
188743,'s,0,0
188744,exact,0,0
188745,test,0,0
188746,as,0,0
188747,appropriate,0,0
188748,.,0,0
188749,A,0,0
188750,p,0,0
188751,value,0,0
188752,of,0,0
188753,less,0,0
188754,than,0,0
188755,0.05,0,0
188756,was,0,0
188757,considered,0,0
188758,significant,0,0
188759,.,0,0
188760,RESULTS,0,0
188761,The,0,0
188762,demographic,0,0
188763,and,0,0
188764,other,0,0
188765,baseline,0,0
188766,parameters,0,0
188767,such,0,0
188768,as,0,0
188769,indications,0,0
188770,for,0,0
188771,extractions,0,0
188772,were,0,0
188773,comparable,0,0
188774,among,0,0
188775,the,0,0
188776,study,0,0
188777,groups,0,0
188778,(,0,0
188779,p,0,0
188780,>,0,0
188781,0.05,0,0
188782,),0,0
188783,.,0,0
188784,The,0,0
188785,overall,0,0
188786,prevalence,0,0
188787,of,0,0
188788,alveolar,0,0
188789,osteitis,0,0
188790,was,0,0
188791,13.7,0,0
188792,%,0,0
188793,.,0,0
188794,There,0,0
188795,was,0,0
188796,a,0,0
188797,statistical,0,0
188798,significant,0,0
188799,difference,0,0
188800,between,0,0
188801,the,0,0
188802,study,0,0
188803,groups,0,0
188804,with,0,0
188805,respect,0,0
188806,to,0,0
188807,development,0,0
188808,of,0,0
188809,alveolar,0,0
188810,osteitis,0,0
188811,(,0,0
188812,X2,0,1
188813,=,0,0
188814,15.00,0,0
188815,",",0,0
188816,df,0,0
188817,=,0,0
188818,1,0,0
188819,",",0,0
188820,p,0,0
188821,=,0,0
188822,0.001,0,0
188823,),0,0
188824,.The,0,0
188825,risk,0,0
188826,of,0,0
188827,development,0,0
188828,of,0,0
188829,alveolar,0,0
188830,osteitis,0,0
188831,was,0,0
188832,4,0,0
188833,times,0,0
188834,higher,0,0
188835,in,0,0
188836,the,0,0
188837,control,0,1
188838,group,0,0
188839,(,0,0
188840,OR,0,0
188841,=,0,0
188842,4.33,0,0
188843,",",0,0
188844,P,0,0
188845,=,0,0
188846,0.001,0,0
188847,),0,0
188848,.,0,0
188849,CONCLUSION,0,0
188850,Warm,1,1
188851,saline,1,1
188852,mouth,1,1
188853,rinse,1,1
188854,instruction,0,1
188855,is,0,0
188856,beneficial,0,0
188857,in,0,0
188858,the,0,0
188859,prevention,0,0
188860,of,0,0
188861,development,0,0
188862,of,0,0
188863,alveolar,0,0
188864,osteitis,0,0
188865,after,0,0
188866,dental,0,0
188867,extractions,0,0
188868,.,0,0
188869,Serotonergic,1,1
188870,psychedelics,1,1
188871,temporarily,0,0
188872,modify,0,0
188873,information,0,0
188874,transfer,0,0
188875,in,0,0
188876,humans,0,0
188877,.,0,0
188878,BACKGROUND,0,0
188879,Psychedelics,1,0
188880,induce,0,0
188881,intense,0,0
188882,modifications,0,0
188883,in,0,0
188884,the,0,0
188885,sensorium,0,0
188886,",",0,0
188887,the,0,0
188888,sense,0,0
188889,of,0,0
188890,self,0,0
188891,",",0,0
188892,and,0,0
188893,the,0,0
188894,experience,0,0
188895,of,0,0
188896,reality,0,1
188897,.,0,0
188898,Despite,0,0
188899,advances,0,0
188900,in,0,0
188901,our,0,0
188902,understanding,0,0
188903,of,0,0
188904,the,0,0
188905,molecular,0,0
188906,and,0,0
188907,cellular,0,0
188908,level,0,0
188909,mechanisms,0,0
188910,of,0,0
188911,these,0,0
188912,drugs,0,0
188913,",",0,0
188914,knowledge,0,0
188915,of,0,0
188916,their,0,0
188917,actions,0,0
188918,on,0,0
188919,global,0,0
188920,brain,0,0
188921,dynamics,0,0
188922,is,0,0
188923,still,0,0
188924,incomplete,0,0
188925,.,0,0
188926,Recent,0,0
188927,imaging,0,0
188928,studies,0,0
188929,have,0,0
188930,found,0,0
188931,changes,0,0
188932,in,0,0
188933,functional,0,0
188934,coupling,0,0
188935,between,0,0
188936,frontal,0,0
188937,and,0,0
188938,parietal,0,0
188939,brain,0,0
188940,structures,0,0
188941,",",0,0
188942,suggesting,0,0
188943,a,0,0
188944,modification,0,0
188945,in,0,0
188946,information,0,0
188947,flow,0,0
188948,between,0,0
188949,brain,0,0
188950,regions,0,0
188951,during,0,0
188952,acute,0,0
188953,effects,0,0
188954,.,0,0
188955,METHODS,0,0
188956,Here,0,0
188957,we,0,0
188958,assessed,0,0
188959,the,0,0
188960,psychedelic-induced,0,0
188961,changes,0,0
188962,in,0,0
188963,directionality,0,0
188964,of,0,0
188965,information,0,0
188966,flow,0,0
188967,during,0,0
188968,the,0,0
188969,acute,0,0
188970,effects,0,0
188971,of,0,0
188972,a,0,0
188973,psychedelic,0,0
188974,in,0,0
188975,humans,0,0
188976,.,0,0
188977,We,0,0
188978,measured,0,0
188979,modifications,0,0
188980,in,0,0
188981,connectivity,0,0
188982,of,0,0
188983,brain,0,0
188984,oscillations,0,1
188985,using,0,0
188986,transfer,0,0
188987,entropy,0,0
188988,",",0,0
188989,a,0,0
188990,nonlinear,0,0
188991,measure,0,0
188992,of,0,0
188993,directed,0,0
188994,functional,0,0
188995,connectivity,0,0
188996,based,0,0
188997,on,0,0
188998,information,0,0
188999,theory,0,0
189000,.,0,0
189001,Ten,0,0
189002,healthy,0,0
189003,male,0,0
189004,volunteers,0,0
189005,with,0,0
189006,prior,0,0
189007,experience,0,0
189008,with,0,0
189009,psychedelics,1,1
189010,participated,0,0
189011,in,0,0
189012,2,0,0
189013,experimental,0,0
189014,sessions,0,1
189015,.,0,0
189016,They,0,0
189017,received,0,0
189018,a,0,0
189019,placebo,1,1
189020,or,1,0
189021,a,1,0
189022,dose,1,0
189023,of,1,0
189024,ayahuasca,1,1
189025,",",1,0
189026,a,1,0
189027,psychedelic,1,0
189028,preparation,1,1
189029,containing,1,1
189030,the,1,0
189031,serotonergic,1,0
189032,5-HT2A,1,1
189033,agonist,1,1
189034,N,1,0
189035,",",1,0
189036,N-dimethyltryptamine,1,1
189037,.,1,0
189038,RESULTS,0,0
189039,The,0,0
189040,analysis,0,0
189041,showed,0,0
189042,significant,0,0
189043,changes,0,0
189044,in,0,0
189045,the,0,0
189046,coupling,0,0
189047,of,0,0
189048,brain,0,0
189049,oscillations,0,1
189050,between,0,0
189051,anterior,0,0
189052,and,0,0
189053,posterior,0,1
189054,recording,0,0
189055,sites,0,0
189056,.,0,0
189057,Transfer,0,0
189058,entropy,0,0
189059,analysis,0,0
189060,showed,0,0
189061,that,0,0
189062,frontal,0,0
189063,sources,0,0
189064,decreased,0,0
189065,their,0,0
189066,influence,0,0
189067,over,0,0
189068,central,0,0
189069,",",0,0
189070,parietal,0,0
189071,",",0,0
189072,and,0,0
189073,occipital,0,0
189074,sites,0,0
189075,.,0,0
189076,Conversely,0,0
189077,",",0,0
189078,sources,0,0
189079,in,0,0
189080,posterior,0,0
189081,locations,0,0
189082,increased,0,0
189083,their,0,0
189084,influence,0,0
189085,over,0,0
189086,signals,0,0
189087,measured,0,0
189088,at,0,0
189089,anterior,0,0
189090,locations,0,0
189091,.,0,0
189092,Exploratory,0,0
189093,correlations,0,0
189094,found,0,0
189095,that,0,0
189096,anterior-to-posterior,0,0
189097,transfer,0,1
189098,entropy,0,0
189099,decreases,0,0
189100,were,0,0
189101,correlated,0,0
189102,with,0,0
189103,the,0,0
189104,intensity,0,0
189105,of,0,0
189106,subjective,0,0
189107,effects,0,0
189108,",",0,0
189109,while,0,0
189110,the,0,0
189111,imbalance,0,0
189112,between,0,0
189113,anterior-to-posterior,0,0
189114,and,0,0
189115,posterior-to-anterior,0,1
189116,transfer,0,1
189117,entropy,0,0
189118,correlated,0,0
189119,with,0,0
189120,the,0,0
189121,degree,0,0
189122,of,0,0
189123,incapacitation,0,0
189124,experienced,0,0
189125,.,0,0
189126,CONCLUSIONS,0,0
189127,These,0,0
189128,results,0,0
189129,suggest,0,0
189130,that,0,0
189131,psychedelics,1,0
189132,induce,0,0
189133,a,0,0
189134,temporary,0,0
189135,disruption,0,0
189136,of,0,0
189137,neural,0,0
189138,hierarchies,0,0
189139,by,0,0
189140,reducing,0,0
189141,top-down,0,1
189142,control,0,1
189143,and,0,0
189144,increasing,0,0
189145,bottom-up,0,1
189146,information,0,0
189147,transfer,0,0
189148,in,0,0
189149,the,0,0
189150,human,0,0
189151,brain,0,0
189152,.,0,0
189153,1H,0,0
189154,nuclear,0,0
189155,magnetic,0,1
189156,resonance-based,0,0
189157,metabolomic,0,0
189158,study,0,0
189159,on,0,0
189160,efficacy,0,0
189161,of,0,0
189162,Qingrehuatan,1,1
189163,decoction,1,1
189164,against,0,0
189165,abundant,0,0
189166,phlegm-heat,0,0
189167,syndrome,0,0
189168,in,0,0
189169,young,0,0
189170,adults,0,0
189171,with,0,0
189172,essential,0,0
189173,hypertension,0,0
189174,.,0,0
189175,OBJECTIVE,0,0
189176,To,0,0
189177,observe,0,0
189178,the,0,0
189179,influence,0,0
189180,of,0,0
189181,Qingrehuatan,1,1
189182,decoction,1,1
189183,(,1,0
189184,QRHT,1,1
189185,),1,0
189186,on,0,0
189187,serum,0,0
189188,metabolic,0,0
189189,profile,0,0
189190,in,0,0
189191,young,0,0
189192,essential,0,0
189193,hypertension,0,0
189194,(,0,0
189195,YEH,0,1
189196,),0,0
189197,patients,0,0
189198,with,0,0
189199,abundant,0,0
189200,phlegm-heat,0,0
189201,syndrome,0,0
189202,and,0,0
189203,provide,0,0
189204,a,0,0
189205,basis,0,0
189206,for,0,0
189207,treatment,0,0
189208,with,0,0
189209,the,0,0
189210,decoction,0,1
189211,.,0,0
189212,METHODS,0,0
189213,Twelve,0,0
189214,male,0,0
189215,YEH,0,1
189216,patients,0,0
189217,were,0,0
189218,randomly,0,0
189219,selected,0,0
189220,and,0,0
189221,serum,0,0
189222,samples,0,0
189223,were,0,0
189224,collected,0,0
189225,for,0,0
189226,examination,0,0
189227,before,0,0
189228,and,0,0
189229,after,0,0
189230,4,0,0
189231,weeks,0,0
189232,of,0,0
189233,the,0,0
189234,treatment,0,0
189235,with,0,0
189236,QRHT,1,0
189237,.,1,0
189238,Twelve,0,0
189239,healthy,0,0
189240,males,0,0
189241,were,0,0
189242,randomly,0,0
189243,selected,0,0
189244,and,0,0
189245,their,0,0
189246,serum,0,0
189247,samples,0,0
189248,were,0,0
189249,collected,0,0
189250,as,0,0
189251,a,0,0
189252,control,0,0
189253,.,0,0
189254,All,0,0
189255,serum,0,0
189256,samples,0,0
189257,were,0,0
189258,detected,0,0
189259,using,0,0
189260,metabolomic,0,0
189261,technology,0,0
189262,with,0,0
189263,1H,0,0
189264,nuclear,0,0
189265,magnetic,0,1
189266,resonance,0,1
189267,.,0,0
189268,Differences,0,0
189269,in,0,0
189270,metabolites,0,0
189271,were,0,0
189272,studied,0,0
189273,by,0,0
189274,principal,0,0
189275,component,0,0
189276,analysis,0,0
189277,and,0,0
189278,partial,0,0
189279,least,0,0
189280,squares-discriminate,0,0
189281,analysis,0,0
189282,",",0,0
189283,which,0,0
189284,produced,0,0
189285,scores,0,0
189286,and,0,0
189287,loadings,0,0
189288,plots,0,0
189289,.,0,0
189290,RESULTS,0,0
189291,After,0,0
189292,4,0,0
189293,weeks,0,0
189294,of,0,0
189295,treatment,0,0
189296,",",0,0
189297,serum,0,0
189298,substances,0,0
189299,could,0,0
189300,be,0,0
189301,distinguished,0,0
189302,between,0,0
189303,the,0,0
189304,YEH,0,1
189305,patients,0,0
189306,with,0,0
189307,abundant,0,0
189308,phlegm-heat,0,0
189309,syndrome,0,0
189310,and,0,0
189311,the,0,0
189312,control,0,0
189313,patients,0,0
189314,.,0,0
189315,The,0,0
189316,specific,0,0
189317,serum,0,0
189318,endog-,0,1
189319,enous,0,0
189320,metabolites,0,0
189321,tended,0,0
189322,to,0,0
189323,improve,0,0
189324,after,0,0
189325,the,0,0
189326,treatment,0,0
189327,.,0,0
189328,QRHT,1,0
189329,can,0,0
189330,appropriately,0,0
189331,increase,0,0
189332,the,0,0
189333,levels,0,0
189334,of,0,0
189335,glucose,0,0
189336,",",0,0
189337,lactic,0,1
189338,acid,0,1
189339,",",0,0
189340,citric,0,0
189341,acid,0,1
189342,",",0,0
189343,high-density,0,0
189344,lipoprotein,0,0
189345,",",0,0
189346,phosphatidylcholine,0,1
189347,",",0,0
189348,glycerophosphate,0,0
189349,choline,0,1
189350,",",0,0
189351,hydroxybutyrate,0,1
189352,",",0,0
189353,alanine,0,0
189354,",",0,0
189355,and,0,0
189356,glutamate,0,0
189357,.,0,0
189358,QRHT,1,0
189359,could,0,0
189360,also,0,0
189361,decrease,0,0
189362,the,0,0
189363,levels,0,0
189364,of,0,0
189365,low-density,0,0
189366,lipoprotein/very,0,0
189367,low-density,0,0
189368,lipoprotein,0,0
189369,",",0,0
189370,lipids,0,0
189371,",",0,0
189372,N-acetyl,0,1
189373,glycoprotein,0,1
189374,",",0,0
189375,and,0,0
189376,O-acetyl,0,1
189377,glycoprotein,0,1
189378,.,0,0
189379,CONCLUSION,0,0
189380,QRHT,0,0
189381,can,0,0
189382,effectively,0,0
189383,ameliorate,0,0
189384,metabolic,0,0
189385,disorders,0,0
189386,in,0,0
189387,YEH,0,1
189388,Patients,0,0
189389,with,0,0
189390,abundant,0,0
189391,phlegm-heat,0,0
189392,syndrome,0,0
189393,.,0,0
189394,1H,0,0
189395,NMR-based,0,0
189396,metabolomic,0,0
189397,technology,0,0
189398,can,0,0
189399,provide,0,0
189400,an,0,0
189401,objective,0,0
189402,basis,0,0
189403,for,0,0
189404,the,0,0
189405,treatment,0,0
189406,of,0,0
189407,YEH,0,1
189408,patients,0,0
189409,with,0,0
189410,abundant,0,0
189411,phlegm-heat,0,0
189412,syndrome,0,0
189413,using,0,0
189414,QRHT,1,0
189415,.,1,0
189416,Peritoneovenous,1,1
189417,shunting,1,0
189418,as,0,0
189419,compared,0,0
189420,with,0,0
189421,medical,1,0
189422,treatment,1,0
189423,in,0,0
189424,patients,0,0
189425,with,0,0
189426,alcoholic,0,0
189427,cirrhosis,0,0
189428,and,0,0
189429,massive,0,0
189430,ascites,0,0
189431,.,0,0
189432,Veterans,0,0
189433,Administration,0,0
189434,Cooperative,0,0
189435,Study,0,0
189436,on,0,0
189437,Treatment,0,0
189438,of,0,0
189439,Alcoholic,0,0
189440,Cirrhosis,0,0
189441,with,0,0
189442,Ascites,0,0
189443,.,0,0
189444,The,0,0
189445,optimal,0,0
189446,management,0,0
189447,of,0,0
189448,severe,0,0
189449,ascites,0,0
189450,in,0,0
189451,patients,0,0
189452,with,0,0
189453,alcoholic,0,0
189454,cirrhosis,0,0
189455,has,0,0
189456,not,0,0
189457,been,0,0
189458,defined,0,0
189459,.,0,0
189460,in,0,0
189461,a,0,0
189462,5,0,0
189463,1/2-year,0,0
189464,study,0,0
189465,",",0,0
189466,we,0,0
189467,randomly,0,0
189468,assigned,0,0
189469,299,0,0
189470,men,0,0
189471,with,0,0
189472,alcoholic,0,0
189473,cirrhosis,0,0
189474,",",0,0
189475,who,0,0
189476,had,0,0
189477,persistent,0,0
189478,or,0,1
189479,recurrent,0,0
189480,severe,0,0
189481,ascites,0,0
189482,despite,0,0
189483,a,0,0
189484,standard,0,1
189485,medical,0,0
189486,regimen,0,0
189487,",",0,0
189488,to,0,0
189489,receive,0,0
189490,either,0,0
189491,intensive,1,1
189492,medical,1,1
189493,treatment,1,0
189494,or,1,1
189495,peritoneovenous,1,1
189496,(,1,0
189497,LeVeen,1,1
189498,),1,0
189499,shunting,1,0
189500,.,1,0
189501,We,0,0
189502,identified,0,0
189503,three,0,0
189504,risk,0,0
189505,groups,0,0
189506,:,0,0
189507,Group,0,0
189508,1,0,0
189509,had,0,0
189510,normal,0,0
189511,or,0,0
189512,mildly,0,0
189513,abnormal,0,0
189514,results,0,0
189515,on,0,0
189516,liver-function,0,0
189517,tests,0,0
189518,",",0,0
189519,Group,0,0
189520,2,0,0
189521,had,0,0
189522,more,0,0
189523,severe,0,0
189524,liver,0,0
189525,dysfunction,0,0
189526,or,0,1
189527,previous,0,0
189528,complications,0,0
189529,",",0,0
189530,and,0,0
189531,Group,0,0
189532,3,0,0
189533,had,0,0
189534,severe,0,0
189535,prerenal,0,0
189536,azotemia,0,0
189537,without,0,0
189538,kidney,0,0
189539,disease,0,0
189540,.,0,0
189541,For,0,0
189542,the,0,0
189543,patients,0,0
189544,who,0,0
189545,received,0,0
189546,the,0,0
189547,medical,0,0
189548,treatment,0,0
189549,and,0,0
189550,those,0,0
189551,who,0,0
189552,received,0,0
189553,the,0,0
189554,surgical,0,0
189555,treatment,0,0
189556,combined,0,0
189557,",",0,0
189558,the,0,0
189559,median,0,0
189560,survival,0,0
189561,times,0,0
189562,were,0,0
189563,1093,0,0
189564,days,0,0
189565,in,0,0
189566,Group,0,0
189567,1,0,0
189568,",",0,0
189569,222,0,0
189570,days,0,0
189571,in,0,0
189572,Group,0,0
189573,2,0,0
189574,",",0,0
189575,and,0,0
189576,37,0,0
189577,days,0,0
189578,in,0,0
189579,Group,0,0
189580,3,0,0
189581,(,0,0
189582,P,0,0
189583,less,0,0
189584,than,0,0
189585,or,0,0
189586,equal,0,0
189587,to,0,0
189588,0.01,0,0
189589,),0,0
189590,for,0,0
189591,all,0,0
189592,comparisons,0,0
189593,),0,0
189594,.,0,0
189595,For,0,0
189596,all,0,0
189597,the,0,0
189598,groups,0,0
189599,combined,0,0
189600,",",0,0
189601,the,0,0
189602,median,0,0
189603,time,0,0
189604,to,0,0
189605,the,0,0
189606,resolution,0,0
189607,of,0,0
189608,ascites,0,0
189609,was,0,0
189610,5.4,0,0
189611,weeks,0,0
189612,for,0,0
189613,medical,0,0
189614,patients,0,0
189615,and,0,0
189616,3.0,0,0
189617,weeks,0,0
189618,for,0,0
189619,surgical,0,0
189620,patients,0,0
189621,(,0,0
189622,P,0,0
189623,less,0,0
189624,than,0,0
189625,0.01,0,0
189626,),0,0
189627,.,0,0
189628,Within,0,0
189629,each,0,0
189630,risk,0,0
189631,group,0,0
189632,",",0,0
189633,mortality,0,0
189634,during,0,0
189635,the,0,0
189636,initial,0,0
189637,hospitalization,0,0
189638,and,0,0
189639,median,0,0
189640,long-term,0,0
189641,survival,0,0
189642,were,0,0
189643,similar,0,0
189644,among,0,0
189645,patients,0,0
189646,receiving,0,0
189647,either,0,0
189648,treatment,0,0
189649,.,0,0
189650,However,0,0
189651,",",0,0
189652,the,0,0
189653,median,0,0
189654,time,0,0
189655,to,0,0
189656,the,0,0
189657,recurrence,0,0
189658,of,0,0
189659,ascites,0,0
189660,in,0,0
189661,Group,0,0
189662,1,0,0
189663,was,0,0
189664,4,0,0
189665,months,0,0
189666,in,0,0
189667,medical,0,0
189668,patients,0,0
189669,",",0,0
189670,as,0,0
189671,compared,0,0
189672,with,0,0
189673,18,0,0
189674,months,0,0
189675,in,0,0
189676,surgical,0,0
189677,patients,0,0
189678,(,0,0
189679,P,0,0
189680,=,0,0
189681,0.01,0,0
189682,),0,0
189683,;,0,0
189684,in,0,0
189685,Group,0,0
189686,2,0,0
189687,it,0,0
189688,was,0,0
189689,3,0,0
189690,months,0,0
189691,in,0,0
189692,medical,0,0
189693,patients,0,0
189694,as,0,0
189695,compared,0,0
189696,with,0,0
189697,12,0,0
189698,months,0,0
189699,in,0,0
189700,surgical,0,0
189701,patients,0,0
189702,(,0,0
189703,P,0,0
189704,=,0,0
189705,0.04,0,0
189706,),0,0
189707,.,0,0
189708,The,0,0
189709,median,0,0
189710,duration,0,0
189711,of,0,0
189712,hospitalization,0,0
189713,was,0,0
189714,longer,0,0
189715,in,0,0
189716,medical,0,0
189717,patients,0,0
189718,than,0,0
189719,in,0,0
189720,surgical,0,0
189721,patients,0,0
189722,(,0,0
189723,6.1,0,0
189724,vs.,0,0
189725,2.4,0,0
189726,weeks,0,0
189727,in,0,0
189728,Group,0,0
189729,1,0,0
189730,[,0,0
189731,P,0,0
189732,less,0,0
189733,than,0,0
189734,0.001,0,0
189735,],0,0
189736,and,0,0
189737,5.0,0,0
189738,vs.,0,0
189739,3.1,0,0
189740,weeks,0,0
189741,in,0,0
189742,Group,0,0
189743,2,0,0
189744,[,0,0
189745,P,0,0
189746,less,0,0
189747,than,0,0
189748,0.01,0,0
189749,],0,0
189750,),0,0
189751,.,0,0
189752,Group,0,0
189753,3,0,0
189754,was,0,0
189755,too,0,0
189756,small,0,0
189757,to,0,0
189758,permit,0,0
189759,a,0,0
189760,meaningful,0,0
189761,comparison,0,0
189762,.,0,0
189763,During,0,0
189764,the,0,0
189765,initial,0,0
189766,hospitalization,0,0
189767,",",0,0
189768,the,0,0
189769,incidence,0,0
189770,of,0,0
189771,infections,0,0
189772,",",0,0
189773,gastrointestinal,0,0
189774,bleeding,0,0
189775,",",0,0
189776,and,0,0
189777,encephalopathy,0,0
189778,was,0,0
189779,similar,0,0
189780,among,0,0
189781,the,0,0
189782,medical,0,0
189783,and,0,0
189784,surgical,0,0
189785,patients,0,0
189786,.,0,0
189787,We,0,0
189788,conclude,0,0
189789,that,0,0
189790,peritoneovenous,0,1
189791,shunting,0,0
189792,alleviated,0,0
189793,disabling,0,0
189794,ascites,0,0
189795,more,0,0
189796,rapidly,0,0
189797,than,0,0
189798,medical,0,0
189799,management,0,0
189800,.,0,0
189801,However,0,0
189802,",",0,0
189803,survival,0,0
189804,was,0,0
189805,closely,0,0
189806,related,0,0
189807,to,0,0
189808,the,0,0
189809,severity,0,0
189810,of,0,0
189811,the,0,0
189812,illness,0,0
189813,at,0,0
189814,the,0,0
189815,time,0,0
189816,of,0,0
189817,randomization,0,0
189818,and,0,0
189819,was,0,0
189820,not,0,0
189821,altered,0,0
189822,by,0,0
189823,shunting,0,0
189824,.,0,0
189825,Effect,0,0
189826,of,0,0
189827,parent,1,1
189828,training,1,1
189829,vs,1,0
189830,parent,1,1
189831,education,1,1
189832,on,0,0
189833,behavioral,0,0
189834,problems,0,0
189835,in,0,0
189836,children,0,0
189837,with,0,0
189838,autism,0,0
189839,spectrum,0,0
189840,disorder,0,0
189841,:,0,0
189842,a,0,0
189843,randomized,0,0
189844,clinical,0,0
189845,trial,0,0
189846,.,0,0
189847,IMPORTANCE,0,0
189848,Disruptive,0,0
189849,behavior,0,0
189850,is,0,0
189851,common,0,0
189852,in,0,0
189853,children,0,0
189854,with,0,0
189855,autism,0,0
189856,spectrum,0,0
189857,disorder,0,0
189858,.,0,0
189859,Behavioral,0,0
189860,interventions,0,0
189861,are,0,0
189862,used,0,0
189863,to,0,0
189864,treat,0,0
189865,disruptive,0,0
189866,behavior,0,0
189867,but,0,0
189868,have,0,0
189869,not,0,0
189870,been,0,0
189871,evaluated,0,0
189872,in,0,0
189873,large-scale,0,0
189874,randomized,0,0
189875,trials,0,0
189876,.,0,0
189877,OBJECTIVE,0,0
189878,To,0,0
189879,evaluate,0,0
189880,the,0,0
189881,efficacy,0,0
189882,of,0,0
189883,parent,1,1
189884,training,1,1
189885,for,0,0
189886,children,0,0
189887,with,0,0
189888,autism,0,0
189889,spectrum,0,0
189890,disorder,0,0
189891,and,0,0
189892,disruptive,0,0
189893,behavior,0,0
189894,.,0,0
189895,DESIGN,0,0
189896,",",0,0
189897,SETTING,0,0
189898,",",0,0
189899,AND,0,0
189900,PARTICIPANTS,0,0
189901,This,0,0
189902,24-week,0,0
189903,randomized,0,0
189904,trial,0,0
189905,compared,0,0
189906,parent,1,1
189907,training,1,1
189908,(,1,0
189909,n,1,0
189910,=,1,0
189911,89,1,0
189912,),1,0
189913,to,1,0
189914,parent,1,1
189915,education,1,1
189916,(,1,0
189917,n,1,0
189918,=,0,0
189919,91,0,0
189920,),0,0
189921,at,0,0
189922,6,0,0
189923,centers,0,0
189924,(,0,0
189925,Emory,0,0
189926,University,0,0
189927,",",0,0
189928,Indiana,0,0
189929,University,0,0
189930,",",0,0
189931,Ohio,0,0
189932,State,0,1
189933,University,0,0
189934,",",0,0
189935,University,0,0
189936,of,0,0
189937,Pittsburgh,0,0
189938,",",0,0
189939,University,0,0
189940,of,0,0
189941,Rochester,0,0
189942,",",0,0
189943,Yale,0,0
189944,University,0,0
189945,),0,0
189946,.,0,0
189947,We,0,0
189948,screened,0,0
189949,267,0,0
189950,children,0,0
189951,;,0,0
189952,180,0,0
189953,children,0,0
189954,(,0,0
189955,aged,0,0
189956,3-7,0,0
189957,years,0,0
189958,),0,0
189959,with,0,0
189960,autism,0,0
189961,spectrum,0,0
189962,disorder,0,0
189963,and,0,0
189964,disruptive,0,0
189965,behaviors,0,0
189966,were,0,0
189967,randomly,0,0
189968,assigned,0,0
189969,(,0,0
189970,86,0,0
189971,%,0,0
189972,white,0,0
189973,",",0,0
189974,88,0,0
189975,%,0,0
189976,male,0,0
189977,),0,0
189978,between,0,0
189979,September,0,0
189980,2010,0,0
189981,and,0,0
189982,February,0,0
189983,2014,0,0
189984,.,0,0
189985,INTERVENTIONS,1,0
189986,Parent,1,0
189987,training,1,1
189988,(,1,0
189989,11,1,0
189990,core,1,0
189991,",",1,0
189992,2,1,0
189993,optional,1,0
189994,sessions,1,1
189995,;,1,0
189996,2,1,0
189997,telephone,1,1
189998,boosters,1,0
189999,;,1,0
190000,2,1,0
190001,home,1,0
190002,visits,1,0
190003,),1,0
190004,provided,0,0
190005,specific,0,0
190006,strategies,0,0
190007,to,0,0
190008,manage,0,0
190009,disruptive,0,0
190010,behavior,0,0
190011,.,1,0
190012,Parent,1,0
190013,education,1,1
190014,(,1,0
190015,12,1,0
190016,core,1,0
190017,sessions,1,1
190018,",",1,0
190019,1,1,0
190020,home,1,0
190021,visit,1,0
190022,),1,0
190023,provided,0,0
190024,information,0,0
190025,about,0,0
190026,autism,0,0
190027,but,0,0
190028,no,0,0
190029,behavior,0,0
190030,management,0,0
190031,strategies,0,0
190032,.,0,0
190033,MAIN,0,0
190034,OUTCOMES,0,0
190035,AND,0,0
190036,MEASURES,0,0
190037,Parents,0,0
190038,rated,0,0
190039,disruptive,0,0
190040,behavior,0,0
190041,and,0,0
190042,noncompliance,0,0
190043,on,0,0
190044,co-primary,0,0
190045,outcomes,0,0
190046,:,0,0
190047,the,0,0
190048,Aberrant,0,0
190049,Behavior,0,0
190050,Checklist-Irritability,0,0
190051,subscale,0,0
190052,(,0,0
190053,range,0,0
190054,",",0,0
190055,0-45,0,0
190056,),0,0
190057,and,0,0
190058,the,0,0
190059,Home,0,1
190060,Situations,0,0
190061,Questionnaire-Autism,0,0
190062,Spectrum,0,1
190063,Disorder,0,0
190064,(,0,0
190065,range,0,0
190066,",",0,0
190067,0-9,0,0
190068,),0,0
190069,.,0,0
190070,On,0,0
190071,both,0,0
190072,measures,0,0
190073,",",0,0
190074,higher,0,0
190075,scores,0,0
190076,indicate,0,0
190077,greater,0,0
190078,severity,0,0
190079,and,0,0
190080,a,0,0
190081,25,0,0
190082,%,0,0
190083,reduction,0,0
190084,indicates,0,0
190085,clinical,0,0
190086,improvement,0,0
190087,.,0,0
190088,A,0,0
190089,clinician,0,0
190090,blind,0,0
190091,to,0,0
190092,treatment,0,0
190093,assignment,0,0
190094,rated,0,0
190095,the,0,0
190096,Improvement,0,0
190097,scale,0,0
190098,of,0,0
190099,the,0,0
190100,Clinical,0,0
190101,Global,0,0
190102,Impression,0,0
190103,(,0,0
190104,range,0,0
190105,",",0,0
190106,1-7,0,1
190107,),0,0
190108,",",0,0
190109,a,0,0
190110,secondary,0,0
190111,outcome,0,0
190112,",",0,0
190113,with,0,0
190114,a,0,0
190115,positive,0,0
190116,response,0,0
190117,less,0,0
190118,than,0,0
190119,3,0,0
190120,.,0,0
190121,RESULTS,0,0
190122,At,0,0
190123,week,0,0
190124,24,0,0
190125,",",0,0
190126,the,0,0
190127,Aberrant,0,0
190128,Behavior,0,0
190129,Checklist-Irritability,0,0
190130,subscale,0,0
190131,declined,0,0
190132,47.7,0,0
190133,%,0,0
190134,in,0,0
190135,parent,1,1
190136,training,1,1
190137,(,1,0
190138,from,1,0
190139,23.7,1,0
190140,to,0,0
190141,12.4,0,0
190142,),0,0
190143,compared,0,0
190144,with,0,0
190145,31.8,0,0
190146,%,0,0
190147,for,1,0
190148,parent,1,1
190149,education,1,1
190150,(,1,0
190151,23.9,1,0
190152,to,1,0
190153,16.3,0,0
190154,),0,0
190155,(,0,0
190156,treatment,0,0
190157,effect,0,0
190158,",",0,0
190159,-3.9,0,0
190160,;,0,0
190161,95,0,0
190162,%,0,0
190163,CI,0,0
190164,",",0,0
190165,-6.2,0,0
190166,to,0,0
190167,-1.7,0,0
190168,;,0,0
190169,P,0,0
190170,<,0,0
190171,.001,0,0
190172,",",0,0
190173,standardized,0,0
190174,effect,0,0
190175,size,0,0
190176,=,0,0
190177,0.62,0,0
190178,),0,0
190179,.,0,0
190180,The,0,0
190181,Home,0,0
190182,Situations,0,0
190183,Questionnaire-Autism,0,0
190184,Spectrum,0,1
190185,Disorder,0,0
190186,declined,0,0
190187,55,0,0
190188,%,0,0
190189,(,0,0
190190,from,0,0
190191,4.0,0,0
190192,to,0,0
190193,1.8,0,0
190194,),0,0
190195,compared,0,0
190196,with,0,0
190197,34.2,0,0
190198,%,0,0
190199,in,0,0
190200,parent,0,1
190201,education,0,1
190202,(,0,0
190203,3.8,0,0
190204,to,0,0
190205,2.5,0,0
190206,),0,0
190207,(,0,0
190208,treatment,0,0
190209,effect,0,0
190210,",",0,0
190211,-0.7,0,0
190212,;,0,0
190213,95,0,0
190214,%,0,0
190215,CI,0,0
190216,",",0,0
190217,-1.1,0,0
190218,to,0,0
190219,-0.3,0,0
190220,;,0,0
190221,P,0,0
190222,<,0,0
190223,.001,0,0
190224,",",0,0
190225,standardized,0,0
190226,effect,0,0
190227,size,0,0
190228,=,0,0
190229,0.45,0,0
190230,),0,0
190231,.,0,0
190232,Neither,0,0
190233,measure,0,0
190234,met,0,0
190235,the,0,0
190236,prespecified,0,0
190237,minimal,0,0
190238,clinically,0,0
190239,important,0,0
190240,difference,0,0
190241,.,0,0
190242,The,0,0
190243,proportions,0,0
190244,with,0,0
190245,a,0,0
190246,positive,0,0
190247,response,0,0
190248,on,0,0
190249,the,0,0
190250,Clinical,0,0
190251,Global,0,0
190252,Impression-Improvement,0,0
190253,scale,0,0
190254,were,0,0
190255,68.5,0,0
190256,%,0,0
190257,for,0,0
190258,parent,0,1
190259,training,0,1
190260,vs,0,0
190261,39.6,0,0
190262,%,0,0
190263,for,0,0
190264,parent,0,1
190265,education,0,1
190266,(,0,0
190267,P,0,0
190268,<,0,0
190269,.001,0,0
190270,),0,0
190271,.,0,0
190272,CONCLUSIONS,0,0
190273,AND,0,0
190274,RELEVANCE,0,0
190275,For,0,0
190276,children,0,0
190277,with,0,0
190278,autism,0,0
190279,spectrum,0,0
190280,disorder,0,0
190281,",",0,0
190282,a,0,0
190283,24-week,0,0
190284,parent,0,1
190285,training,0,1
190286,program,0,1
190287,was,0,0
190288,superior,1,0
190289,to,1,0
190290,parent,1,1
190291,education,1,1
190292,for,1,0
190293,reducing,1,0
190294,disruptive,0,0
190295,behavior,0,0
190296,on,0,0
190297,parent-reported,0,0
190298,outcomes,0,0
190299,",",0,0
190300,although,0,0
190301,the,0,0
190302,clinical,0,0
190303,significance,0,0
190304,of,0,0
190305,the,0,0
190306,improvement,0,0
190307,is,0,0
190308,unclear,0,0
190309,.,0,0
190310,The,0,0
190311,rate,0,0
190312,of,0,0
190313,positive,0,0
190314,response,0,0
190315,judged,0,0
190316,by,0,0
190317,a,0,0
190318,blinded,0,0
190319,clinician,0,0
190320,was,0,0
190321,greater,1,0
190322,for,1,0
190323,parent,1,0
190324,training,1,1
190325,vs,1,0
190326,parent,1,1
190327,education,1,1
190328,.,1,0
190329,TRIAL,1,0
190330,REGISTRATION,0,0
190331,clinicaltrials.gov,0,0
190332,Identifier,0,0
190333,:,0,0
190334,NCT01233414,0,0
190335,.,0,0
190336,Differential,0,0
190337,effect,0,0
190338,of,0,0
190339,aspirin,1,1
190340,on,0,0
190341,thromboxane,0,0
190342,and,0,0
190343,prostaglandin,0,1
190344,biosynthesis,0,0
190345,in,0,0
190346,man,0,0
190347,.,0,0
190348,1,0,0
190349,.,0,0
190350,Effects,0,0
190351,of,0,0
190352,a,0,0
190353,single,0,0
190354,intravenous,0,1
190355,dose,0,0
190356,of,0,0
190357,aspirin,1,1
190358,(,0,0
190359,600,0,1
190360,mg,0,1
190361,),0,0
190362,on,0,0
190363,bradykinin-stimulated,0,1
190364,prostaglandin,0,1
190365,(,0,0
190366,PG,0,0
190367,),0,0
190368,and,0,0
190369,on,0,0
190370,thromboxane,0,0
190371,(,0,0
190372,TX,0,0
190373,),0,0
190374,biosynthesis,0,0
190375,were,0,0
190376,determined,0,0
190377,in,0,0
190378,nine,0,0
190379,healthy,0,0
190380,male,0,0
190381,volunteers,0,0
190382,.,0,0
190383,Plasma,0,0
190384,concentrations,0,0
190385,of,0,0
190386,6-oxo-PGF1,0,0
190387,alpha,0,1
190388,and,0,0
190389,"13,14-dihydro-15-oxo-PGF2",0,1
190390,alpha,0,1
190391,were,0,0
190392,measured,0,0
190393,in,0,0
190394,samples,0,0
190395,obtained,0,0
190396,during,0,0
190397,repeated,0,0
190398,10,0,0
190399,min,0,0
190400,intravenous,0,1
190401,infusions,0,1
190402,of,0,0
190403,bradykinin,0,1
190404,before,0,0
190405,and,0,0
190406,up,0,0
190407,to,0,0
190408,6,0,0
190409,h,0,0
190410,after,0,0
190411,the,0,0
190412,dose,0,0
190413,of,0,0
190414,aspirin,1,1
190415,.,1,0
190416,TXB2,0,0
190417,was,0,0
190418,measured,0,0
190419,in,0,0
190420,serum,0,0
190421,from,0,0
190422,blood,0,0
190423,allowed,0,0
190424,to,0,0
190425,clot,0,0
190426,at,0,0
190427,37,0,0
190428,degrees,0,0
190429,C.,0,0
190430,2,0,0
190431,.,0,0
190432,Aspirin,1,1
190433,inhibited,0,0
190434,bradykinin,0,1
190435,stimulated,0,0
190436,PG,0,0
190437,and,0,0
190438,platelet,0,0
190439,TX,0,0
190440,biosynthesis,0,0
190441,0.5,0,1
190442,h,0,0
190443,after,0,0
190444,the,0,0
190445,dose,0,0
190446,.,0,0
190447,Serum,0,0
190448,TXB2,0,0
190449,remained,0,0
190450,low,0,0
190451,",",0,0
190452,whereas,0,0
190453,PG,0,0
190454,synthesis,0,0
190455,recovered,0,0
190456,within,0,0
190457,6,0,0
190458,h.,0,0
190459,3,0,0
190460,.,0,0
190461,Effects,0,0
190462,of,0,0
190463,intravenous,1,1
190464,sodium,1,1
190465,salicylate,1,1
190466,(,0,0
190467,600,0,1
190468,mg,0,1
190469,),0,0
190470,were,0,0
190471,studied,0,0
190472,identically,0,0
190473,in,0,0
190474,eight,0,0
190475,subjects,0,0
190476,.,0,0
190477,Prostanoid,0,0
190478,biosynthesis,0,0
190479,was,0,0
190480,not,0,0
190481,inhibited,0,0
190482,.,0,0
190483,4,0,0
190484,.,0,0
190485,Biosynthesis,0,0
190486,of,0,0
190487,prostacyclin,0,1
190488,and,0,0
190489,TXA2,0,1
190490,under,0,0
190491,basal,0,0
190492,conditions,0,0
190493,was,0,0
190494,studied,0,0
190495,in,0,0
190496,eight,0,0
190497,subjects,0,0
190498,by,0,0
190499,measuring,0,0
190500,"2,3-dinor-6-oxo-PGF1",0,0
190501,alpha,0,1
190502,and,0,0
190503,"2,3-dinor-TXB2",0,0
190504,in,0,0
190505,hourly,0,0
190506,urine,0,0
190507,samples,0,0
190508,obtained,0,0
190509,during,0,0
190510,and,0,0
190511,after,0,0
190512,intravenous,0,1
190513,infusion,1,1
190514,of,1,0
190515,aspirin,1,1
190516,and,0,0
190517,",",0,0
190518,on,0,0
190519,a,0,0
190520,separate,0,0
190521,occasion,0,0
190522,",",0,0
190523,of,0,0
190524,vehicle,0,1
190525,.,0,0
190526,5,0,0
190527,.,0,0
190528,Aspirin,1,1
190529,infusion,1,0
190530,reduced,0,0
190531,urinary,0,0
190532,excretion,0,0
190533,of,0,0
190534,both,0,0
190535,metabolites,0,0
190536,greater,0,0
190537,than,0,0
190538,90,0,0
190539,%,0,0
190540,",",0,0
190541,but,0,0
190542,excretion,0,0
190543,of,0,0
190544,"2,3-dinor-6-oxo-PGF1",0,0
190545,alpha,0,1
190546,recovered,0,0
190547,more,0,0
190548,rapidly,0,0
190549,than,0,0
190550,did,0,0
190551,that,0,0
190552,of,0,0
190553,"2,3-dinor-TXB2",0,0
190554,.,0,0
190555,6,0,0
190556,.,0,0
190557,We,0,0
190558,conclude,0,0
190559,that,0,0
190560,cyclo-oxygenase,0,1
190561,is,0,0
190562,rapidly,0,0
190563,synthesised,0,0
190564,in,0,0
190565,bradykinin-responsive,0,0
190566,tissues,0,0
190567,in,0,0
190568,vivo,0,0
190569,and,0,0
190570,that,0,0
190571,this,0,0
190572,reflects,0,0
190573,similarly,0,0
190574,rapid,0,0
190575,enzyme,0,0
190576,biosynthesis,0,0
190577,in,0,0
190578,tissues,0,0
190579,that,0,0
190580,produce,0,0
190581,PGI2,0,0
190582,under,0,0
190583,basal,0,0
190584,conditions,0,0
190585,.,0,0
190586,Effect,0,0
190587,of,0,0
190588,cooling,0,1
190589,proparacaine,1,1
190590,0.5,1,1
190591,%,1,0
190592,eye,1,0
190593,drops,1,1
190594,on,0,0
190595,patient,0,0
190596,'s,0,0
190597,comfort,0,0
190598,during,0,0
190599,instillation,0,0
190600,.,0,0
190601,The,0,0
190602,effects,0,0
190603,of,0,0
190604,preoperative,1,0
190605,oral,1,1
190606,pregabalin,1,1
190607,and,1,0
190608,perioperative,1,0
190609,intravenous,1,1
190610,lidocaine,1,1
190611,infusion,1,1
190612,on,0,0
190613,postoperative,0,0
190614,morphine,0,1
190615,requirement,0,0
190616,in,0,0
190617,patients,0,0
190618,undergoing,0,0
190619,laparatomy,0,0
190620,.,0,0
190621,OBJECTIVES,0,0
190622,To,0,0
190623,evaluate,0,0
190624,and,0,0
190625,compare,0,0
190626,the,0,0
190627,effects,0,0
190628,of,0,0
190629,preoperative,1,0
190630,oral,1,1
190631,pregabalin,1,1
190632,and,1,0
190633,perioperative,1,0
190634,intravenous,1,1
190635,lidocaine,1,1
190636,infusion,1,1
190637,on,0,0
190638,postoperative,0,0
190639,morphine,0,1
190640,requirement,0,0
190641,",",0,0
190642,adverse,0,0
190643,effects,0,0
190644,",",0,0
190645,patients,0,0
190646,',0,0
190647,satisfaction,0,0
190648,",",0,0
190649,mobilization,0,0
190650,",",0,0
190651,time,0,0
190652,to,0,0
190653,first,0,0
190654,defecation,0,0
190655,and,0,0
190656,time,0,0
190657,to,0,0
190658,discharge,0,0
190659,in,0,0
190660,patients,0,0
190661,undergoing,0,0
190662,laparotomy,0,1
190663,.,0,0
190664,METHODS,0,0
190665,Eighty,0,0
190666,patients,0,0
190667,(,0,0
190668,18,0,0
190669,to,0,0
190670,65,0,0
190671,years,0,0
190672,of,0,0
190673,age,0,0
190674,),0,0
190675,undergoing,0,0
190676,elective,0,1
190677,laparotomy,0,1
190678,were,0,0
190679,randomly,0,0
190680,divided,0,0
190681,into,0,0
190682,four,0,0
190683,groups,0,0
190684,(,0,0
190685,n=20,0,0
190686,in,0,0
190687,each,0,0
190688,group,0,0
190689,),0,0
190690,:,0,0
190691,group,0,0
190692,C,0,0
190693,",",0,0
190694,placebo,1,1
190695,capsules,1,1
190696,and,1,0
190697,normal,1,0
190698,saline,1,1
190699,infusion,1,1
190700,perioperatively,1,0
190701,(,0,0
190702,control,0,0
190703,),0,0
190704,;,0,0
190705,group,0,0
190706,L,0,0
190707,",",0,0
190708,placebo,1,1
190709,capsules,1,1
190710,and,1,0
190711,lidocaine,1,1
190712,1,1,0
190713,mg?kg,1,0
190714,intravenous,1,1
190715,bolus,1,1
190716,dose,1,0
190717,followed,1,0
190718,by,1,0
190719,2,1,0
190720,mg?kg?h,1,0
190721,infusion,1,1
190722,until,1,0
190723,skin,1,0
190724,closure,1,0
190725,;,1,0
190726,group,1,0
190727,P,1,0
190728,",",1,0
190729,150,1,0
190730,mg,0,0
190731,oral,1,1
190732,pregabalin,1,1
190733,and,1,0
190734,normal,1,0
190735,saline,1,1
190736,infusion,1,1
190737,perioperatively,1,0
190738,;,1,0
190739,and,1,0
190740,group,1,0
190741,PL,1,0
190742,",",1,0
190743,150,1,0
190744,&,0,0
190745,nbsp,1,0
190746,;,1,0
190747,mg,1,1
190748,oral,1,1
190749,pregabalin,1,1
190750,and,1,0
190751,lidocaine,1,1
190752,2,1,0
190753,mg?kg?h,1,0
190754,infusion,1,1
190755,until,1,0
190756,skin,1,0
190757,closure,1,0
190758,.,1,0
190759,Hemodynamic,0,0
190760,parameters,0,0
190761,",",0,0
190762,visual,0,0
190763,analogue,0,0
190764,scale,0,0
190765,(,0,0
190766,VAS,0,1
190767,),0,1
190768,scores,0,0
190769,",",0,0
190770,analgesic,0,0
190771,consumption,0,0
190772,",",0,0
190773,side,0,0
190774,effects,0,0
190775,",",0,0
190776,time,0,0
190777,to,0,0
190778,mobilization,0,0
190779,",",0,0
190780,time,0,0
190781,to,0,0
190782,first,0,0
190783,defecation,0,0
190784,",",0,0
190785,time,0,0
190786,to,0,0
190787,discharge,0,0
190788,and,0,0
190789,patients,0,0
190790,',0,0
190791,satisfaction,0,0
190792,were,0,0
190793,recorded,0,0
190794,.,0,0
190795,RESULTS,0,0
190796,VAS,0,0
190797,scores,0,0
190798,of,0,0
190799,group,0,0
190800,L,0,0
190801,",",0,0
190802,group,0,0
190803,P,0,0
190804,and,0,0
190805,group,0,0
190806,PL,0,0
190807,were,0,0
190808,lower,0,0
190809,than,0,0
190810,group,0,0
190811,C,0,1
190812,(,0,0
190813,P,0,0
190814,<,0,0
190815,0.05,0,0
190816,),0,0
190817,.,0,0
190818,Morphine,0,1
190819,consumption,0,0
190820,of,0,0
190821,group,0,0
190822,P,0,0
190823,and,0,0
190824,group,0,0
190825,PL,0,0
190826,was,0,0
190827,lower,0,0
190828,than,0,0
190829,group,0,0
190830,C,0,1
190831,(,0,0
190832,P,0,0
190833,<,0,0
190834,0.05,0,0
190835,),0,0
190836,.,0,0
190837,Incidence,0,0
190838,of,0,0
190839,nausea,0,0
190840,in,0,0
190841,group,0,0
190842,C,0,0
190843,was,0,0
190844,higher,0,0
190845,than,0,0
190846,group,0,0
190847,L,0,1
190848,and,0,0
190849,group,0,0
190850,PL,0,0
190851,.,0,0
190852,Time,0,0
190853,to,0,0
190854,first,0,0
190855,defecation,0,0
190856,and,0,0
190857,mobilization,0,0
190858,were,0,0
190859,shorter,0,0
190860,in,0,0
190861,group,0,0
190862,L,0,1
190863,and,0,0
190864,group,0,0
190865,PL,0,0
190866,compared,0,0
190867,with,0,0
190868,group,0,0
190869,C,0,1
190870,(,0,0
190871,P,0,0
190872,<,0,0
190873,0.05,0,0
190874,),0,0
190875,.,0,0
190876,CONCLUSION,0,0
190877,Preoperative,1,0
190878,oral,1,1
190879,pregabalin,1,1
190880,and,1,0
190881,perioperative,1,0
190882,intravenous,1,1
190883,lidocaine,1,1
190884,infusion,1,1
190885,decreased,0,0
190886,postoperative,0,0
190887,VAS,0,0
190888,scores,0,0
190889,.,1,0
190890,Preoperative,1,0
190891,oral,1,0
190892,pregabalin,1,1
190893,decreased,1,0
190894,morphine,0,1
190895,requirement,0,0
190896,and,0,0
190897,perioperative,0,0
190898,intravenous,1,1
190899,lidocaine,1,1
190900,infusion,1,1
190901,hastened,0,0
190902,gastrointestinal,0,0
190903,motility,0,0
190904,and,0,0
190905,mobilization,0,1
190906,",",0,0
190907,and,0,0
190908,decreased,0,0
190909,the,0,0
190910,incidence,0,0
190911,of,0,0
190912,nausea,0,0
190913,in,0,0
190914,patients,0,0
190915,undergoing,0,0
190916,laparotomy,0,1
190917,.,0,0
190918,Therefore,0,0
190919,",",0,0
190920,preoperative,1,0
190921,pregabalin,1,1
190922,with,1,0
190923,or,1,0
190924,without,1,0
190925,lidocaine,1,1
190926,provides,0,0
190927,superior,0,0
190928,pain,0,0
190929,relief,0,0
190930,in,0,0
190931,patients,0,0
190932,undergoing,0,0
190933,laparatomy,0,0
190934,.,0,0
190935,Multicomponent,0,1
190936,interdisciplinary,0,0
190937,group,0,0
190938,intervention,0,1
190939,for,0,0
190940,self-management,0,1
190941,of,0,0
190942,fibromyalgia,0,0
190943,:,0,0
190944,a,0,0
190945,mixed-methods,0,0
190946,randomized,0,0
190947,controlled,0,0
190948,trial,0,0
190949,.,0,0
190950,BACKGROUND,0,0
190951,This,0,0
190952,study,0,0
190953,evaluated,0,0
190954,the,0,0
190955,efficacy,0,0
190956,of,0,0
190957,the,0,0
190958,PASSAGE,1,1
190959,Program,1,1
190960,",",0,0
190961,a,0,0
190962,structured,0,1
190963,multicomponent,1,0
190964,interdisciplinary,1,0
190965,group,1,0
190966,intervention,1,1
190967,for,0,0
190968,the,0,0
190969,self-management,0,0
190970,of,0,0
190971,FMS,0,0
190972,.,0,0
190973,METHODS,0,0
190974,A,0,0
190975,mixed-methods,0,0
190976,randomized,0,0
190977,controlled,0,0
190978,trial,0,0
190979,(,1,0
190980,intervention,1,1
190981,(,1,1
190982,INT,1,1
190983,),1,0
190984,vs.,1,0
190985,waitlist,1,0
190986,(,1,0
190987,WL,1,1
190988,),1,1
190989,),1,0
190990,was,0,0
190991,conducted,0,0
190992,with,0,0
190993,patients,0,0
190994,suffering,0,0
190995,from,0,0
190996,FMS,0,0
190997,.,0,0
190998,Data,0,0
190999,were,0,0
191000,collected,0,0
191001,at,0,0
191002,baseline,0,0
191003,(,0,0
191004,T0,0,1
191005,),0,0
191006,",",0,0
191007,at,0,0
191008,the,0,0
191009,end,0,0
191010,of,0,0
191011,the,0,0
191012,intervention,0,1
191013,(,0,0
191014,T1,0,1
191015,),0,0
191016,",",0,0
191017,and,0,0
191018,3,0,0
191019,months,0,0
191020,later,0,0
191021,(,0,0
191022,T2,0,0
191023,),0,0
191024,.,0,0
191025,The,0,0
191026,primary,0,0
191027,outcome,0,0
191028,was,0,0
191029,change,0,0
191030,in,0,0
191031,pain,0,0
191032,intensity,0,0
191033,(,0,0
191034,0-10,0,0
191035,),0,0
191036,.,0,0
191037,Secondary,0,0
191038,outcomes,0,0
191039,were,0,0
191040,fibromyalgia,0,0
191041,severity,0,0
191042,",",0,0
191043,pain,0,0
191044,interference,0,0
191045,",",0,0
191046,sleep,0,0
191047,quality,0,0
191048,",",0,0
191049,pain,0,0
191050,coping,0,0
191051,strategies,0,0
191052,",",0,0
191053,depression,0,0
191054,",",0,0
191055,health-related,0,0
191056,quality,0,0
191057,of,0,0
191058,life,0,0
191059,",",0,0
191060,patient,0,0
191061,global,0,0
191062,impression,0,1
191063,of,0,0
191064,change,0,0
191065,(,0,0
191066,PGIC,0,1
191067,),0,0
191068,",",0,0
191069,and,0,0
191070,perceived,0,0
191071,pain,0,0
191072,relief,0,0
191073,.,0,0
191074,Qualitative,0,0
191075,group,0,0
191076,interviews,0,1
191077,with,0,0
191078,a,0,0
191079,subset,0,0
191080,of,0,0
191081,patients,0,0
191082,were,0,0
191083,also,0,0
191084,conducted,0,0
191085,.,0,0
191086,Complete,0,0
191087,data,0,0
191088,from,0,0
191089,T0,0,1
191090,to,0,0
191091,T2,0,0
191092,were,0,0
191093,available,0,0
191094,for,0,0
191095,43,0,0
191096,patients,0,0
191097,.,0,0
191098,RESULTS,0,0
191099,The,0,0
191100,intervention,0,1
191101,had,0,0
191102,a,0,0
191103,statistically,0,0
191104,significant,0,0
191105,impact,0,0
191106,on,0,0
191107,the,0,0
191108,three,0,0
191109,PGIC,0,0
191110,measures,0,0
191111,.,0,0
191112,At,0,0
191113,the,0,0
191114,end,0,0
191115,of,0,0
191116,the,0,0
191117,PASSAGE,0,1
191118,Program,0,1
191119,",",0,0
191120,the,0,0
191121,percentages,0,0
191122,of,0,0
191123,patients,0,0
191124,who,0,0
191125,perceived,0,0
191126,overall,0,0
191127,improvement,0,0
191128,in,0,0
191129,their,0,0
191130,pain,0,0
191131,levels,0,0
191132,",",0,0
191133,functioning,0,0
191134,and,0,0
191135,quality,0,0
191136,of,0,0
191137,life,0,0
191138,were,0,0
191139,significantly,0,0
191140,higher,0,0
191141,in,0,0
191142,the,0,0
191143,INT,0,1
191144,Group,0,0
191145,(,0,0
191146,73,0,0
191147,%,0,0
191148,",",0,0
191149,55,0,0
191150,%,0,0
191151,",",0,0
191152,77,0,0
191153,%,0,0
191154,respectively,0,0
191155,),0,0
191156,than,0,0
191157,in,0,0
191158,the,0,0
191159,WL,0,1
191160,Group,0,0
191161,(,0,0
191162,8,0,0
191163,%,0,0
191164,",",0,0
191165,12,0,0
191166,%,0,0
191167,",",0,0
191168,20,0,0
191169,%,0,0
191170,),0,0
191171,.,0,0
191172,The,0,0
191173,same,0,0
191174,differences,0,0
191175,were,0,0
191176,observed,0,0
191177,3,0,0
191178,months,0,0
191179,post-intervention,0,0
191180,(,0,0
191181,Intervention,0,1
191182,group,0,0
191183,:,0,0
191184,62,0,0
191185,%,0,0
191186,",",0,0
191187,43,0,0
191188,%,0,0
191189,",",0,0
191190,38,0,0
191191,%,0,0
191192,vs,0,0
191193,Waitlist,0,1
191194,Group,0,0
191195,:,0,0
191196,13,0,0
191197,%,0,0
191198,",",0,0
191199,13,0,0
191200,%,0,0
191201,",",0,0
191202,9,0,0
191203,%,0,0
191204,),0,0
191205,.,0,0
191206,The,0,0
191207,proportion,0,0
191208,of,0,0
191209,patients,0,0
191210,who,0,0
191211,reported,0,0
191212,?,0,0
191213,50,0,0
191214,%,0,0
191215,pain,0,0
191216,relief,0,0
191217,was,0,0
191218,also,0,0
191219,significantly,0,0
191220,higher,0,0
191221,in,0,0
191222,the,0,0
191223,INT,0,1
191224,Group,0,0
191225,at,0,0
191226,the,0,0
191227,end,0,0
191228,of,0,0
191229,the,0,0
191230,intervention,0,1
191231,(,0,0
191232,36,0,0
191233,%,0,0
191234,vs,0,0
191235,12,0,0
191236,%,0,0
191237,),0,0
191238,and,0,0
191239,3,0,0
191240,months,0,0
191241,post-intervention,0,0
191242,(,0,0
191243,33,0,0
191244,%,0,0
191245,vs,0,0
191246,4,0,0
191247,%,0,0
191248,),0,0
191249,.,0,0
191250,Results,0,0
191251,of,0,0
191252,the,0,0
191253,qualitative,0,0
191254,analysis,0,0
191255,were,0,0
191256,in,0,0
191257,line,0,0
191258,with,0,0
191259,the,0,0
191260,quantitative,0,0
191261,findings,0,0
191262,regarding,0,0
191263,the,0,0
191264,efficacy,0,0
191265,of,0,0
191266,the,0,0
191267,intervention,0,1
191268,.,0,0
191269,The,0,0
191270,improvement,0,0
191271,",",0,0
191272,however,0,0
191273,",",0,0
191274,was,0,0
191275,not,0,0
191276,reflected,0,0
191277,in,0,0
191278,the,0,0
191279,primary,0,0
191280,outcome,0,0
191281,and,0,0
191282,other,0,0
191283,secondary,0,0
191284,outcome,0,0
191285,measures,0,0
191286,.,0,0
191287,CONCLUSION,0,0
191288,The,0,0
191289,PASSAGE,0,1
191290,Program,0,1
191291,was,0,0
191292,effective,0,0
191293,in,0,0
191294,helping,0,0
191295,FMS,0,0
191296,patients,0,0
191297,gain,0,0
191298,a,0,0
191299,sense,0,0
191300,of,0,0
191301,control,0,0
191302,over,0,0
191303,their,0,0
191304,symptoms,0,0
191305,.,0,0
191306,We,0,0
191307,suggest,0,0
191308,including,0,0
191309,PGIC,0,1
191310,in,0,0
191311,future,0,0
191312,clinical,0,0
191313,trials,0,0
191314,on,0,0
191315,FMS,0,0
191316,as,0,0
191317,they,0,0
191318,appear,0,0
191319,to,0,0
191320,capture,0,0
191321,important,0,0
191322,aspects,0,0
191323,of,0,0
191324,the,0,0
191325,patients,0,0
191326,',0,0
191327,experience,0,0
191328,.,0,0
191329,TRIAL,0,0
191330,REGISTRATION,0,0
191331,International,0,0
191332,Standard,0,1
191333,Randomized,0,0
191334,Controlled,0,0
191335,Trial,0,0
191336,Number,0,0
191337,Register,0,0
191338,ISRCTN14526380,0,0
191339,.,0,0
191340,A,0,0
191341,randomized,0,0
191342,",",0,0
191343,double-blind,0,0
191344,",",0,0
191345,placebo-controlled,1,1
191346,study,0,0
191347,of,0,0
191348,the,0,0
191349,efficacy,0,0
191350,and,0,0
191351,safety,0,0
191352,of,0,0
191353,2,0,0
191354,doses,0,0
191355,of,0,0
191356,vortioxetine,1,1
191357,in,0,0
191358,adults,0,0
191359,with,0,0
191360,major,0,0
191361,depressive,0,0
191362,disorder,0,0
191363,.,0,0
191364,BACKGROUND,0,0
191365,This,0,0
191366,8-week,0,0
191367,",",0,0
191368,randomized,0,0
191369,",",0,0
191370,double-blind,0,0
191371,",",0,0
191372,placebo-controlled,1,1
191373,study,0,0
191374,",",0,0
191375,conducted,0,0
191376,August,0,0
191377,2010-May,0,0
191378,2012,0,0
191379,in,0,0
191380,the,0,0
191381,United,0,0
191382,States,0,0
191383,",",0,0
191384,evaluated,0,0
191385,the,0,0
191386,safety,0,0
191387,and,0,0
191388,efficacy,0,0
191389,of,0,0
191390,vortioxetine,1,1
191391,10,0,0
191392,mg,0,1
191393,and,0,0
191394,15,0,0
191395,mg,0,0
191396,in,0,0
191397,patients,0,0
191398,with,0,0
191399,major,0,0
191400,depressive,0,0
191401,disorder,0,0
191402,(,0,0
191403,MDD,0,0
191404,),0,0
191405,.,0,0
191406,The,0,0
191407,mechanism,0,0
191408,of,0,0
191409,action,0,0
191410,of,0,0
191411,vortioxetine,1,1
191412,is,0,0
191413,thought,0,0
191414,to,0,0
191415,be,0,0
191416,related,0,0
191417,to,0,0
191418,direct,0,0
191419,modulation,0,0
191420,of,0,0
191421,serotonin,0,1
191422,(,0,0
191423,5-HT,0,1
191424,),0,1
191425,receptor,0,0
191426,activity,0,0
191427,and,0,0
191428,inhibition,0,0
191429,of,0,0
191430,the,0,0
191431,serotonin,0,0
191432,transporter,0,0
191433,.,0,0
191434,METHOD,0,0
191435,Adults,0,0
191436,aged,0,0
191437,18-75,0,0
191438,years,0,0
191439,with,0,0
191440,MDD,0,0
191441,(,0,0
191442,DSM-IV-TR,0,0
191443,),0,0
191444,and,0,0
191445,Montgomery-Asberg,0,0
191446,Depression,0,0
191447,Rating,0,0
191448,Scale,0,1
191449,(,0,0
191450,MADRS,0,1
191451,),0,1
191452,total,0,0
191453,score,0,0
191454,?,0,0
191455,26,0,0
191456,were,0,0
191457,randomized,0,0
191458,(,0,0
191459,1:1:1,0,0
191460,),0,0
191461,to,0,0
191462,receive,1,1
191463,vortioxetine,1,1
191464,10,1,0
191465,mg,0,1
191466,or,0,0
191467,15,0,0
191468,mg,0,1
191469,or,0,1
191470,placebo,1,1
191471,once,1,1
191472,daily,0,0
191473,",",0,0
191474,with,0,0
191475,the,0,0
191476,primary,0,0
191477,efficacy,0,0
191478,end,0,0
191479,point,0,0
191480,being,0,0
191481,change,0,0
191482,from,0,0
191483,baseline,0,0
191484,at,0,0
191485,week,0,0
191486,8,0,0
191487,in,0,0
191488,MADRS,0,1
191489,analyzed,0,0
191490,by,0,0
191491,mixed,0,0
191492,model,0,0
191493,for,0,0
191494,repeated,0,0
191495,measures,0,0
191496,.,0,0
191497,Adverse,0,0
191498,events,0,0
191499,were,0,0
191500,recorded,0,0
191501,during,0,0
191502,the,0,0
191503,study,0,0
191504,",",0,0
191505,suicidal,0,0
191506,ideation,0,0
191507,and,0,0
191508,behavior,0,0
191509,were,0,0
191510,assessed,0,0
191511,using,0,0
191512,the,0,0
191513,Columbia-Suicide,0,0
191514,Severity,0,0
191515,Rating,0,0
191516,Scale,0,1
191517,(,0,0
191518,C-SSRS,0,1
191519,),0,0
191520,",",0,0
191521,and,0,0
191522,sexual,0,0
191523,dysfunction,0,0
191524,was,0,0
191525,assessed,0,0
191526,using,0,0
191527,the,0,0
191528,Arizona,0,0
191529,Sexual,0,0
191530,Experience,0,0
191531,(,0,0
191532,ASEX,0,0
191533,),0,0
191534,scale,0,0
191535,.,0,0
191536,RESULTS,0,0
191537,Of,0,0
191538,the,0,0
191539,"1,111",0,0
191540,subjects,0,0
191541,screened,0,0
191542,",",0,0
191543,469,0,0
191544,subjects,0,0
191545,were,0,0
191546,randomized,0,0
191547,:,0,0
191548,160,0,0
191549,to,0,0
191550,placebo,1,1
191551,",",1,0
191552,157,0,0
191553,to,0,0
191554,vortioxetine,1,1
191555,10,1,0
191556,mg,0,0
191557,",",0,0
191558,and,0,0
191559,152,0,0
191560,to,0,0
191561,vortioxetine,1,1
191562,15,1,0
191563,mg,0,0
191564,.,0,0
191565,Differences,0,0
191566,from,1,0
191567,placebo,1,1
191568,in,1,0
191569,the,0,0
191570,primary,0,0
191571,efficacy,0,0
191572,end,0,0
191573,point,0,0
191574,were,0,0
191575,not,0,0
191576,statistically,0,0
191577,significant,0,0
191578,for,1,0
191579,vortioxetine,1,1
191580,10,1,0
191581,mg,0,1
191582,or,0,1
191583,vortioxetine,0,1
191584,15,0,0
191585,mg.,0,1
191586,Nausea,0,1
191587,",",0,0
191588,headache,0,0
191589,",",0,0
191590,dry,0,0
191591,mouth,0,0
191592,",",0,0
191593,constipation,0,0
191594,",",0,0
191595,diarrhea,0,0
191596,",",0,0
191597,vomiting,0,0
191598,",",0,0
191599,dizziness,0,0
191600,",",0,0
191601,and,0,0
191602,flatulence,0,0
191603,were,0,0
191604,reported,0,0
191605,in,0,0
191606,?,0,0
191607,5,0,0
191608,%,0,0
191609,of,0,0
191610,subjects,0,0
191611,receiving,0,0
191612,vortioxetine,0,1
191613,.,0,0
191614,Discontinuation,0,0
191615,due,0,0
191616,to,0,0
191617,adverse,0,0
191618,events,0,0
191619,occurred,0,0
191620,in,0,0
191621,7,0,0
191622,subjects,0,0
191623,(,0,0
191624,4.4,0,0
191625,%,0,0
191626,),0,0
191627,in,0,0
191628,the,0,0
191629,placebo,1,1
191630,group,1,0
191631,",",0,0
191632,8,0,0
191633,(,0,0
191634,5.2,0,0
191635,%,0,0
191636,),0,0
191637,in,0,0
191638,the,0,0
191639,vortioxetine,1,1
191640,10,1,0
191641,mg,0,1
191642,group,0,0
191643,",",0,0
191644,and,0,0
191645,12,0,0
191646,(,0,0
191647,7.9,0,0
191648,%,0,0
191649,),0,0
191650,in,0,0
191651,the,0,0
191652,vortioxetine,1,1
191653,15,1,0
191654,mg,0,0
191655,group,0,0
191656,.,0,0
191657,ASEX,0,0
191658,total,0,0
191659,scores,0,0
191660,were,0,0
191661,similar,0,0
191662,across,0,0
191663,groups,0,0
191664,.,0,0
191665,There,0,0
191666,were,0,0
191667,no,0,0
191668,clinically,0,0
191669,significant,0,0
191670,trends,0,0
191671,within,0,0
191672,or,0,0
191673,between,0,0
191674,treatment,0,0
191675,groups,0,0
191676,on,0,0
191677,the,0,0
191678,C-SSRS,0,0
191679,",",0,0
191680,laboratory,0,0
191681,values,0,0
191682,",",0,0
191683,electrocardiogram,0,0
191684,",",0,0
191685,or,0,0
191686,vital,0,0
191687,sign,0,0
191688,parameters,0,0
191689,.,0,0
191690,CONCLUSIONS,0,0
191691,In,0,0
191692,this,0,0
191693,study,1,0
191694,",",1,0
191695,vortioxetine,1,1
191696,did,1,0
191697,not,0,0
191698,differ,0,0
191699,significantly,0,0
191700,from,0,0
191701,placebo,1,1
191702,on,1,0
191703,MADRS,0,1
191704,total,0,0
191705,score,0,0
191706,after,0,0
191707,8,0,0
191708,weeks,0,0
191709,of,0,0
191710,treatment,0,0
191711,in,0,0
191712,MDD,0,0
191713,subjects,0,0
191714,.,0,0
191715,TRIAL,0,0
191716,REGISTRATION,0,0
191717,ClinicalTrials.gov,0,0
191718,identifier,0,0
191719,:,0,0
191720,NCT01179516,0,0
191721,.,0,0
191722,The,0,0
191723,Beyond,0,0
191724,Ageing,0,0
191725,Project,0,0
191726,Phase,0,0
191727,2,0,0
191728,--,0,0
191729,a,0,0
191730,double-blind,0,0
191731,",",0,0
191732,selective,0,0
191733,prevention,0,0
191734,",",0,0
191735,randomised,0,0
191736,",",0,0
191737,placebo-controlled,0,1
191738,trial,0,0
191739,of,0,0
191740,omega-3,1,1
191741,fatty,1,1
191742,acids,1,1
191743,and,1,0
191744,sertraline,1,1
191745,in,0,0
191746,an,0,0
191747,older,0,0
191748,age,0,0
191749,cohort,0,0
191750,at,0,0
191751,risk,0,0
191752,for,0,0
191753,depression,0,0
191754,:,0,0
191755,study,0,0
191756,protocol,0,0
191757,for,0,0
191758,a,0,0
191759,randomized,0,0
191760,controlled,0,0
191761,trial,0,0
191762,.,0,0
191763,BACKGROUND,0,0
191764,Late-life,0,0
191765,depression,0,0
191766,is,0,0
191767,associated,0,0
191768,with,0,0
191769,high,0,0
191770,rates,0,0
191771,of,0,0
191772,morbidity,0,0
191773,",",0,0
191774,premature,0,0
191775,mortality,0,0
191776,",",0,0
191777,disability,0,0
191778,",",0,0
191779,functional,0,0
191780,decline,0,0
191781,",",0,0
191782,caregiver,0,1
191783,burden,0,0
191784,and,0,0
191785,increased,0,0
191786,health,0,0
191787,care,0,0
191788,costs,0,0
191789,.,0,0
191790,While,0,0
191791,clinical,0,0
191792,and,0,0
191793,public,0,0
191794,health,0,0
191795,approaches,0,0
191796,are,0,0
191797,focused,0,0
191798,on,0,0
191799,prevention,0,0
191800,or,0,1
191801,early,0,0
191802,intervention,0,1
191803,strategies,0,0
191804,",",0,0
191805,the,0,0
191806,ideal,0,0
191807,method,0,0
191808,of,0,0
191809,intervention,0,1
191810,remains,0,0
191811,unclear,0,0
191812,.,0,0
191813,No,0,0
191814,study,0,0
191815,has,0,0
191816,set,0,0
191817,out,0,0
191818,to,0,0
191819,evaluate,0,0
191820,the,0,0
191821,role,0,0
191822,of,0,0
191823,neurobiological,0,0
191824,agents,0,0
191825,in,0,0
191826,preventing,0,0
191827,depressive,0,0
191828,symptoms,0,0
191829,in,0,0
191830,older,0,0
191831,populations,0,0
191832,at,0,0
191833,risk,0,0
191834,of,0,0
191835,depression,0,0
191836,.,0,0
191837,METHODS/DESIGN,0,0
191838,Subjects,0,0
191839,with,0,0
191840,previously,0,0
191841,reported,0,0
191842,sub-threshold,0,0
191843,depressive,0,0
191844,symptoms,0,0
191845,",",0,0
191846,aged,0,0
191847,60,0,0
191848,to,0,0
191849,74,0,0
191850,years,0,0
191851,",",0,0
191852,will,0,0
191853,be,0,0
191854,screened,0,0
191855,to,0,0
191856,participate,0,0
191857,in,0,0
191858,a,0,0
191859,single-centre,0,0
191860,",",0,0
191861,double-blind,0,0
191862,",",0,0
191863,randomised,0,0
191864,controlled,0,0
191865,trial,0,0
191866,with,1,0
191867,three,1,0
191868,parallel,1,0
191869,groups,1,0
191870,involving,1,0
191871,omega-3,1,1
191872,fatty,1,1
191873,acid,1,1
191874,supplementation,1,1
191875,or,1,1
191876,sertraline,1,1
191877,hydrochloride,1,1
191878,",",1,0
191879,compared,1,0
191880,with,1,0
191881,matching,1,0
191882,placebo,1,1
191883,.,1,0
191884,Subjects,0,0
191885,will,0,0
191886,be,0,0
191887,excluded,0,0
191888,if,0,0
191889,they,0,0
191890,have,0,0
191891,current,0,0
191892,depression,0,0
191893,or,0,1
191894,suicide,0,0
191895,ideation,0,0
191896,;,0,0
191897,are,0,0
191898,taking,0,0
191899,antidepressants,0,1
191900,or,0,0
191901,any,0,0
191902,supplement,0,1
191903,containing,0,1
191904,omega-3,0,1
191905,fatty,0,1
191906,acid,0,1
191907,;,0,0
191908,or,0,0
191909,have,0,0
191910,a,0,0
191911,prior,0,0
191912,history,0,0
191913,of,0,0
191914,stroke,0,0
191915,or,0,1
191916,other,0,0
191917,serious,0,0
191918,cerebrovascular,0,0
191919,or,0,1
191920,cardiovascular,0,0
191921,disease,0,0
191922,",",0,0
191923,neurological,0,0
191924,disease,0,0
191925,",",0,0
191926,significant,0,0
191927,psychiatric,0,0
191928,disease,0,0
191929,(,0,0
191930,other,0,0
191931,than,0,0
191932,depression,0,0
191933,),0,0
191934,or,0,1
191935,neurodegenerative,0,0
191936,disease,0,0
191937,.,0,0
191938,The,0,0
191939,trial,0,0
191940,will,0,0
191941,consist,0,0
191942,of,0,0
191943,a,0,0
191944,12,0,0
191945,month,0,0
191946,treatment,0,0
191947,phase,0,0
191948,with,0,0
191949,follow-up,0,0
191950,at,0,0
191951,three,0,0
191952,months,0,0
191953,and,0,0
191954,12,0,0
191955,months,0,0
191956,to,0,0
191957,assess,0,0
191958,outcome,0,0
191959,events,0,0
191960,.,0,0
191961,At,1,0
191962,three,1,0
191963,months,1,0
191964,",",1,0
191965,subjects,1,0
191966,will,1,0
191967,undergo,1,0
191968,structural,1,0
191969,neuroimaging,1,0
191970,to,1,0
191971,assess,1,0
191972,whether,1,0
191973,treatment,1,0
191974,effects,1,0
191975,on,1,0
191976,depressive,1,0
191977,symptoms,1,0
191978,correlate,1,0
191979,with,1,0
191980,brain,1,0
191981,changes,1,0
191982,.,1,0
191983,Additionally,0,0
191984,",",0,0
191985,proton,0,1
191986,spectroscopy,0,0
191987,techniques,0,1
191988,will,0,0
191989,be,0,0
191990,used,0,0
191991,to,0,0
191992,capture,0,0
191993,brain-imaging,0,0
191994,markers,0,0
191995,of,0,0
191996,the,0,0
191997,biological,0,0
191998,effects,0,0
191999,of,0,0
192000,the,0,0
192001,interventions,0,0
192002,.,0,0
192003,The,0,0
192004,trial,0,0
192005,will,0,0
192006,be,0,0
192007,conducted,0,0
192008,in,0,0
192009,urban,0,0
192010,New,0,0
192011,South,0,0
192012,Wales,0,0
192013,",",0,0
192014,Australia,0,0
192015,",",0,0
192016,and,0,0
192017,will,0,0
192018,recruit,0,0
192019,a,0,0
192020,community-based,0,0
192021,sample,0,0
192022,of,0,0
192023,450,0,0
192024,adults,0,0
192025,.,0,0
192026,Using,0,0
192027,intention-to-treat,0,0
192028,methods,0,0
192029,",",0,0
192030,the,0,0
192031,primary,0,0
192032,endpoint,0,0
192033,is,0,0
192034,an,0,0
192035,absence,0,0
192036,of,0,0
192037,clinically,0,0
192038,relevant,0,0
192039,depression,0,0
192040,scores,0,0
192041,at,0,0
192042,12,0,0
192043,months,0,0
192044,between,0,0
192045,the,0,0
192046,omega-3,0,1
192047,fatty,0,1
192048,acid,0,1
192049,and,0,0
192050,sertraline,0,1
192051,interventions,0,1
192052,and,0,0
192053,the,0,0
192054,placebo,0,1
192055,condition,0,0
192056,.,0,0
192057,DISCUSSION,0,0
192058,The,0,0
192059,current,0,0
192060,health,0,0
192061,",",0,0
192062,social,0,0
192063,and,0,0
192064,economic,0,0
192065,costs,0,0
192066,of,0,0
192067,late-life,0,0
192068,depression,0,0
192069,make,0,0
192070,prevention,0,0
192071,imperative,0,0
192072,from,0,0
192073,a,0,0
192074,public,0,0
192075,health,0,0
192076,perspective,0,0
192077,.,0,0
192078,This,0,0
192079,innovative,0,0
192080,trial,0,0
192081,aims,0,0
192082,to,0,0
192083,address,0,0
192084,the,0,0
192085,long-neglected,0,0
192086,area,0,0
192087,of,0,0
192088,prevention,0,0
192089,of,0,0
192090,depression,0,0
192091,in,0,0
192092,older,0,0
192093,adults,0,0
192094,.,0,0
192095,The,0,0
192096,interventions,0,0
192097,are,0,0
192098,targeted,0,0
192099,to,0,0
192100,the,0,0
192101,pathophysiology,0,0
192102,of,0,0
192103,disease,0,0
192104,",",0,0
192105,and,0,0
192106,regardless,0,0
192107,of,0,0
192108,the,0,0
192109,effect,0,0
192110,size,0,0
192111,of,0,0
192112,treatment,0,0
192113,",",0,0
192114,the,0,0
192115,outcomes,0,0
192116,will,0,0
192117,offer,0,0
192118,major,0,0
192119,scientific,0,0
192120,advances,0,0
192121,regarding,0,0
192122,the,0,0
192123,neurobiological,0,0
192124,action,0,0
192125,of,0,0
192126,these,0,0
192127,agents,0,0
192128,.,0,0
192129,The,0,0
192130,main,0,0
192131,results,0,0
192132,are,0,0
192133,expected,0,0
192134,to,0,0
192135,be,0,0
192136,available,0,0
192137,in,0,0
192138,2017,0,0
192139,.,0,0
192140,TRIAL,0,0
192141,REGISTRATION,0,0
192142,Australian,0,1
192143,and,0,0
192144,New,0,0
192145,Zealand,0,0
192146,Clinical,0,0
192147,Trials,0,1
192148,Registry,0,0
192149,ACTRN12610000032055,0,0
192150,(,0,0
192151,12,0,0
192152,January,0,0
192153,2010,0,0
192154,),0,0
192155,.,0,0
192156,The,0,0
192157,effects,0,0
192158,of,0,0
192159,parental,1,0
192160,components,1,0
192161,in,0,0
192162,a,0,0
192163,trauma-focused,1,1
192164,cognitive,1,0
192165,behavioral,1,1
192166,based,1,0
192167,therapy,1,1
192168,for,0,0
192169,children,0,0
192170,exposed,0,0
192171,to,0,0
192172,interparental,0,0
192173,violence,0,0
192174,:,0,0
192175,study,0,0
192176,protocol,0,0
192177,for,0,0
192178,a,0,0
192179,randomized,0,0
192180,controlled,0,0
192181,trial,0,0
192182,.,0,0
192183,BACKGROUND,0,0
192184,Interparental,0,0
192185,violence,0,0
192186,is,0,0
192187,both,0,0
192188,common,0,0
192189,and,0,0
192190,harmful,0,0
192191,and,0,0
192192,impacts,0,0
192193,children,0,0
192194,'s,0,0
192195,lives,0,0
192196,directly,0,0
192197,and,0,0
192198,indirectly,0,0
192199,.,0,0
192200,Direct,0,0
192201,effects,0,0
192202,refer,0,0
192203,to,0,0
192204,affective,0,0
192205,",",0,0
192206,behavioral,0,0
192207,",",0,0
192208,and,0,0
192209,cognitive,0,0
192210,responses,0,0
192211,to,0,0
192212,interparental,0,0
192213,violence,0,0
192214,and,0,0
192215,psychosocial,0,0
192216,adjustment,0,0
192217,.,0,0
192218,Indirect,0,0
192219,effects,0,0
192220,refer,0,0
192221,to,0,0
192222,deteriorated,0,0
192223,parental,0,1
192224,availability,0,0
192225,and,0,0
192226,parent-child,0,1
192227,interaction,0,0
192228,.,0,0
192229,Standard,0,1
192230,Trauma,1,0
192231,Focused,1,0
192232,Cognitive,1,0
192233,Behavioral,1,0
192234,Therapy,1,1
192235,may,0,0
192236,be,0,0
192237,insufficient,0,0
192238,for,0,0
192239,children,0,0
192240,traumatized,0,0
192241,by,0,0
192242,exposure,0,0
192243,to,0,0
192244,interparental,0,0
192245,violence,0,0
192246,",",0,0
192247,given,0,0
192248,the,0,0
192249,pervasive,0,0
192250,impact,0,0
192251,of,0,0
192252,interparental,0,0
192253,violence,0,0
192254,on,0,0
192255,the,0,0
192256,family,0,0
192257,system,0,0
192258,.,0,0
192259,HORIZON,0,0
192260,is,0,0
192261,a,0,0
192262,trauma,1,0
192263,focused,1,0
192264,cognitive,1,0
192265,behavioral,1,1
192266,therapy,1,1
192267,based,0,0
192268,group,0,0
192269,program,0,1
192270,with,0,0
192271,the,0,0
192272,added,0,0
192273,component,0,0
192274,of,0,0
192275,a,0,0
192276,preparatory,1,1
192277,parenting,1,1
192278,program,1,1
192279,aimed,0,0
192280,at,0,0
192281,improving,0,0
192282,parental,0,0
192283,availability,0,0
192284,;,0,0
192285,and,0,0
192286,the,0,0
192287,added,0,0
192288,component,0,0
192289,of,0,0
192290,parent-child,0,1
192291,sessions,0,1
192292,to,0,0
192293,improve,0,0
192294,parent-child,0,1
192295,interaction,0,0
192296,.,0,0
192297,METHODS/DESIGN,0,0
192298,This,0,0
192299,is,0,0
192300,a,0,0
192301,multicenter,0,0
192302,",",0,0
192303,multi-informant,0,0
192304,and,0,0
192305,multi-method,0,0
192306,randomized,0,0
192307,clinical,0,0
192308,trial,0,0
192309,study,0,0
192310,with,0,0
192311,a,0,0
192312,2,0,0
192313,by,0,0
192314,2,0,0
192315,factorial,0,0
192316,experimental,0,0
192317,design,0,0
192318,.,0,0
192319,Participants,0,0
192320,(,0,0
192321,N,0,0
192322,=,0,0
192323,100,0,1
192324,),0,0
192325,are,0,0
192326,children,0,0
192327,(,0,0
192328,4-12,0,0
192329,years,0,0
192330,),0,0
192331,",",0,0
192332,and,0,0
192333,their,0,0
192334,parents,0,0
192335,",",0,0
192336,who,0,0
192337,have,0,0
192338,been,0,0
192339,exposed,0,0
192340,to,0,0
192341,interparental,0,0
192342,violence,0,0
192343,.,0,0
192344,The,0,0
192345,main,0,0
192346,aim,0,0
192347,of,0,0
192348,the,0,0
192349,study,0,0
192350,is,0,0
192351,to,0,0
192352,test,0,0
192353,the,0,0
192354,effects,0,0
192355,of,0,0
192356,two,0,0
192357,parental,0,0
192358,components,0,0
192359,as,0,0
192360,an,0,0
192361,addition,0,0
192362,to,0,0
192363,a,0,0
192364,trauma,1,0
192365,focused,1,0
192366,cognitive,1,0
192367,behavioral,1,1
192368,based,1,0
192369,group,1,0
192370,therapy,1,1
192371,for,1,0
192372,reducing,0,0
192373,children,0,0
192374,'s,0,0
192375,symptoms,0,0
192376,.,0,0
192377,Primary,0,0
192378,outcome,0,0
192379,measures,0,0
192380,are,0,0
192381,posttraumatic,0,0
192382,stress,0,0
192383,symptoms,0,0
192384,",",0,0
192385,and,0,0
192386,internalizing,0,0
192387,and,0,0
192388,externalizing,0,0
192389,problems,0,0
192390,in,0,0
192391,children,0,0
192392,.,0,0
192393,The,0,0
192394,secondary,0,0
192395,aim,0,0
192396,of,0,0
192397,the,0,0
192398,study,0,0
192399,is,0,0
192400,to,0,0
192401,test,0,0
192402,the,0,0
192403,effect,0,0
192404,of,0,0
192405,the,0,0
192406,two,0,0
192407,added,0,0
192408,components,0,0
192409,on,0,0
192410,adjustment,0,0
192411,problems,0,0
192412,in,0,0
192413,children,0,0
192414,and,0,0
192415,to,0,0
192416,test,0,0
192417,whether,0,0
192418,enhanced,0,0
192419,effects,0,0
192420,can,0,0
192421,be,0,0
192422,explained,0,0
192423,by,0,0
192424,changes,0,0
192425,in,0,0
192426,children,0,0
192427,'s,0,0
192428,responses,0,0
192429,towards,0,0
192430,experienced,0,0
192431,violence,0,0
192432,",",0,0
192433,in,0,0
192434,parental,0,0
192435,availability,0,0
192436,",",0,0
192437,and,0,0
192438,in,0,0
192439,quality,0,0
192440,of,0,0
192441,parent-child,0,1
192442,interaction,0,0
192443,.,0,0
192444,To,0,0
192445,address,0,0
192446,this,0,0
192447,secondary,0,0
192448,aim,0,0
192449,",",0,0
192450,the,0,0
192451,main,0,0
192452,parameters,0,0
192453,are,0,0
192454,observational,0,0
192455,and,0,0
192456,questionnaire,0,0
192457,measures,0,0
192458,of,0,0
192459,parental,0,0
192460,availability,0,0
192461,",",0,0
192462,parent-child,0,1
192463,relationship,0,0
192464,variables,0,0
192465,",",0,0
192466,children,0,0
192467,'s,0,0
192468,adjustment,0,0
192469,problems,0,0
192470,and,0,0
192471,children,0,0
192472,'s,0,0
192473,responses,0,0
192474,to,0,0
192475,interparental,0,0
192476,violence,0,0
192477,.,0,0
192478,Data,0,0
192479,are,0,0
192480,collected,0,0
192481,three,0,0
192482,times,0,0
192483,:,0,0
192484,before,0,0
192485,and,0,0
192486,after,0,0
192487,the,0,0
192488,program,0,1
192489,and,0,0
192490,six,0,0
192491,months,0,0
192492,later,0,0
192493,.,0,0
192494,Both,0,0
192495,intention-to-treat,0,0
192496,and,0,0
192497,completer,0,0
192498,analyses,0,0
192499,will,0,0
192500,be,0,0
192501,done,0,0
192502,.,0,0
192503,DISCUSSION,0,0
192504,The,0,0
192505,current,0,0
192506,study,0,0
192507,will,0,0
192508,enhance,0,0
192509,our,0,0
192510,understanding,0,0
192511,of,0,0
192512,the,0,0
192513,efficacy,1,0
192514,interparental,1,0
192515,violence-related,1,0
192516,parental,1,0
192517,components,1,0
192518,added,1,0
192519,to,1,0
192520,trauma,1,0
192521,focused,1,0
192522,cognitive,1,0
192523,behavioral,1,1
192524,group,1,0
192525,program,1,1
192526,for,1,0
192527,children,0,0
192528,who,0,0
192529,have,0,0
192530,been,0,0
192531,exposed,0,0
192532,to,0,0
192533,IPV,0,0
192534,.,0,0
192535,It,0,0
192536,will,0,0
192537,illuminate,0,0
192538,mechanisms,0,0
192539,underlying,0,0
192540,change,0,0
192541,by,0,0
192542,considering,0,0
192543,multiple,0,0
192544,dimensions,0,0
192545,of,0,0
192546,child,0,0
192547,responses,0,0
192548,",",0,0
192549,parenting,0,0
192550,variables,0,0
192551,and,0,0
192552,identify,0,0
192553,selection,0,0
192554,criteria,0,0
192555,for,0,0
192556,participation,0,0
192557,in,0,0
192558,treatment,0,0
192559,.,0,0
192560,TRIAL,0,0
192561,REGISTRATION,0,0
192562,Netherlands,0,0
192563,Trial,0,0
192564,Register,0,0
192565,NTR4015,0,0
192566,.,0,0
192567,Registered,0,0
192568,4th,0,0
192569,of,0,0
192570,June,0,0
192571,",",0,0
192572,2013,0,0
192573,.,0,0
192574,Predicting,0,0
192575,Overall,0,0
192576,Survival,0,0
192577,After,0,0
192578,Stereotactic,1,1
192579,Ablative,1,1
192580,Radiation,1,1
192581,Therapy,1,1
192582,in,0,0
192583,Early-Stage,0,0
192584,Lung,0,1
192585,Cancer,0,0
192586,:,0,0
192587,Development,0,0
192588,and,0,0
192589,External,0,0
192590,Validation,0,0
192591,of,0,0
192592,the,0,0
192593,Amsterdam,0,0
192594,Prognostic,0,0
192595,Model,0,0
192596,.,0,0
192597,PURPOSE,0,0
192598,A,0,0
192599,prognostic,0,0
192600,model,0,0
192601,for,0,0
192602,5-year,0,0
192603,overall,0,0
192604,survival,0,0
192605,(,0,0
192606,OS,0,0
192607,),0,0
192608,",",0,0
192609,consisting,0,0
192610,of,0,0
192611,recursive,0,1
192612,partitioning,0,1
192613,analysis,0,0
192614,(,0,0
192615,RPA,0,1
192616,),0,0
192617,and,0,0
192618,a,0,0
192619,nomogram,0,1
192620,",",0,0
192621,was,0,0
192622,developed,0,0
192623,for,0,0
192624,patients,0,0
192625,with,0,0
192626,early-stage,0,0
192627,non-small,0,0
192628,cell,0,0
192629,lung,0,0
192630,cancer,0,0
192631,(,0,0
192632,ES-NSCLC,0,0
192633,),0,0
192634,treated,0,0
192635,with,0,0
192636,stereotactic,1,1
192637,ablative,1,1
192638,radiation,1,1
192639,therapy,1,1
192640,(,1,0
192641,SABR,1,0
192642,),1,0
192643,.,1,0
192644,METHODS,0,0
192645,AND,0,0
192646,MATERIALS,0,0
192647,A,0,0
192648,primary,0,0
192649,dataset,0,0
192650,of,0,0
192651,703,0,0
192652,ES-NSCLC,0,0
192653,SABR,1,0
192654,patients,0,0
192655,was,0,0
192656,randomly,0,0
192657,divided,0,0
192658,into,0,0
192659,a,0,0
192660,training,0,1
192661,(,0,0
192662,67,0,0
192663,%,0,0
192664,),0,0
192665,and,0,0
192666,an,0,0
192667,internal,0,1
192668,validation,0,0
192669,(,0,0
192670,33,0,0
192671,%,0,0
192672,),0,0
192673,dataset,0,0
192674,.,0,0
192675,In,0,0
192676,the,0,0
192677,former,0,0
192678,group,0,0
192679,",",0,0
192680,21,0,0
192681,unique,0,0
192682,parameters,0,0
192683,consisting,0,0
192684,of,0,0
192685,patient,0,0
192686,",",0,0
192687,treatment,0,0
192688,",",0,0
192689,and,0,0
192690,tumor,0,0
192691,factors,0,0
192692,were,0,0
192693,entered,0,0
192694,into,0,0
192695,an,0,0
192696,RPA,0,1
192697,model,0,0
192698,to,0,0
192699,predict,0,0
192700,OS,0,0
192701,.,0,0
192702,Univariate,0,0
192703,and,0,0
192704,multivariate,0,0
192705,models,0,0
192706,were,0,0
192707,constructed,0,0
192708,for,0,0
192709,RPA-selected,0,0
192710,factors,0,0
192711,to,0,0
192712,evaluate,0,0
192713,their,0,0
192714,relationship,0,0
192715,with,0,0
192716,OS,0,0
192717,.,0,0
192718,A,0,0
192719,nomogram,0,0
192720,for,0,0
192721,OS,0,0
192722,was,0,0
192723,constructed,0,0
192724,based,0,0
192725,on,0,0
192726,factors,0,0
192727,significant,0,0
192728,in,0,0
192729,multivariate,0,0
192730,modeling,0,0
192731,and,0,0
192732,validated,0,0
192733,with,0,0
192734,calibration,0,0
192735,plots,0,0
192736,.,0,0
192737,Both,0,0
192738,the,0,0
192739,RPA,0,1
192740,and,0,0
192741,the,0,0
192742,nomogram,0,1
192743,were,0,0
192744,externally,0,0
192745,validated,0,0
192746,in,0,0
192747,independent,0,0
192748,surgical,0,1
192749,(,0,0
192750,n,0,0
192751,=,0,0
192752,193,0,0
192753,),0,0
192754,and,0,0
192755,SABR,0,1
192756,(,0,0
192757,n,0,0
192758,=,0,0
192759,543,0,0
192760,),0,0
192761,datasets,0,0
192762,.,0,0
192763,RESULTS,0,0
192764,RPA,0,1
192765,identified,0,0
192766,2,0,0
192767,distinct,0,0
192768,risk,0,0
192769,classes,0,0
192770,based,0,0
192771,on,0,0
192772,tumor,0,0
192773,diameter,0,0
192774,",",0,0
192775,age,0,0
192776,",",0,0
192777,World,0,0
192778,Health,0,1
192779,Organization,0,1
192780,performance,0,0
192781,status,0,0
192782,(,0,0
192783,PS,0,0
192784,),0,0
192785,and,0,0
192786,Charlson,0,0
192787,comorbidity,0,0
192788,index,0,0
192789,.,0,0
192790,This,0,0
192791,RPA,0,0
192792,had,0,0
192793,moderate,0,0
192794,discrimination,0,0
192795,in,0,0
192796,SABR,0,1
192797,datasets,0,0
192798,(,0,0
192799,c-index,0,0
192800,range,0,0
192801,:,0,0
192802,0.52-0.60,0,0
192803,),0,0
192804,but,0,0
192805,was,0,0
192806,of,0,0
192807,limited,0,0
192808,value,0,0
192809,in,0,0
192810,the,0,0
192811,surgical,0,0
192812,validation,0,0
192813,cohort,0,0
192814,.,0,0
192815,The,0,0
192816,nomogram,0,0
192817,predicting,0,0
192818,OS,0,0
192819,included,0,0
192820,smoking,0,0
192821,history,0,0
192822,in,0,0
192823,addition,0,0
192824,to,0,0
192825,RPA-identified,0,0
192826,factors,0,0
192827,.,0,0
192828,In,0,0
192829,contrast,0,0
192830,to,0,0
192831,RPA,0,1
192832,",",0,0
192833,validation,0,0
192834,of,0,0
192835,the,0,0
192836,nomogram,0,0
192837,performed,0,0
192838,well,0,0
192839,in,0,0
192840,internal,0,1
192841,validation,0,0
192842,(,0,1
192843,r,0,0
192844,(,0,0
192845,2,0,0
192846,),0,0
192847,=,0,0
192848,0.97,0,0
192849,),0,0
192850,and,0,0
192851,external,0,1
192852,SABR,0,1
192853,(,0,1
192854,r,0,0
192855,(,0,0
192856,2,0,0
192857,),0,0
192858,=,0,0
192859,0.79,0,0
192860,),0,0
192861,and,0,0
192862,surgical,0,1
192863,cohorts,0,0
192864,(,0,0
192865,r,0,0
192866,(,0,0
192867,2,0,0
192868,),0,0
192869,=,0,0
192870,0.91,0,0
192871,),0,0
192872,.,0,0
192873,CONCLUSIONS,0,0
192874,The,0,0
192875,Amsterdam,0,0
192876,prognostic,0,0
192877,model,0,0
192878,is,0,0
192879,the,0,0
192880,first,0,0
192881,externally,0,0
192882,validated,0,0
192883,prognostication,0,0
192884,tool,0,0
192885,for,0,0
192886,OS,0,0
192887,in,0,0
192888,ES-NSCLC,0,0
192889,treated,0,0
192890,with,0,0
192891,SABR,0,0
192892,available,0,0
192893,to,0,0
192894,individualize,0,0
192895,patient,0,0
192896,decision,0,0
192897,making,0,0
192898,.,0,0
192899,The,0,0
192900,nomogram,0,0
192901,retained,0,0
192902,strong,0,0
192903,performance,0,0
192904,across,0,0
192905,surgical,0,0
192906,and,0,0
192907,SABR,0,1
192908,external,0,1
192909,validation,0,0
192910,datasets,0,0
192911,.,0,0
192912,RPA,0,0
192913,performance,0,0
192914,was,0,0
192915,poor,0,0
192916,in,0,0
192917,surgical,0,0
192918,patients,0,0
192919,",",0,0
192920,suggesting,0,0
192921,that,0,0
192922,2,0,0
192923,different,0,0
192924,distinct,0,0
192925,patient,0,0
192926,populations,0,0
192927,are,0,0
192928,being,0,0
192929,treated,0,0
192930,with,0,0
192931,these,0,0
192932,2,0,0
192933,effective,0,0
192934,modalities,0,0
192935,.,0,0
192936,Multiorgan,0,0
192937,protection,0,0
192938,of,0,0
192939,remote,1,1
192940,ischemic,1,0
192941,perconditioning,1,0
192942,in,0,0
192943,valve,0,1
192944,replacement,0,1
192945,surgery,0,0
192946,.,0,0
192947,BACKGROUND,0,0
192948,Remote,1,0
192949,ischemic,1,0
192950,perconditioning,1,1
192951,(,1,0
192952,RIPerc,1,1
192953,),1,1
192954,is,0,0
192955,a,0,0
192956,new,0,0
192957,alternative,0,0
192958,of,0,0
192959,remote,0,1
192960,ischemic,0,0
192961,conditioning,0,1
192962,and,0,0
192963,has,0,0
192964,not,0,0
192965,been,0,0
192966,well,0,0
192967,studied,0,0
192968,.,0,0
192969,RIPerc,0,0
192970,attenuates,0,0
192971,myocardial,0,0
192972,injury,0,0
192973,when,0,0
192974,applied,0,0
192975,during,0,0
192976,cardiac,0,0
192977,surgery,0,0
192978,.,0,0
192979,However,0,0
192980,",",0,0
192981,its,0,0
192982,protective,0,0
192983,effects,0,0
192984,on,0,0
192985,other,0,0
192986,organs,0,0
192987,remain,0,0
192988,unknown,0,0
192989,.,0,0
192990,MATERIALS,0,0
192991,AND,0,0
192992,METHODS,0,0
192993,Patients,0,0
192994,with,0,0
192995,rheumatic,0,0
192996,heart,0,0
192997,disease,0,0
192998,undergoing,0,0
192999,valve,0,1
193000,replacement,0,1
193001,surgery,0,0
193002,were,0,0
193003,randomized,0,0
193004,into,0,0
193005,the,0,0
193006,RIPerc,1,1
193007,group,0,0
193008,(,0,0
193009,n,0,0
193010,=,0,0
193011,101,0,0
193012,),0,0
193013,or,0,0
193014,the,1,0
193015,control,1,1
193016,group,1,0
193017,(,1,0
193018,n,1,0
193019,=,1,0
193020,100,1,0
193021,),1,0
193022,.,1,0
193023,RIPerc,1,0
193024,was,1,0
193025,achieved,0,0
193026,by,0,0
193027,three,0,0
193028,cycles,0,0
193029,of,0,0
193030,5-min,0,0
193031,ischemia-5-min,0,1
193032,reperfusion,0,0
193033,in,0,0
193034,the,0,0
193035,right,0,0
193036,thigh,0,0
193037,during,0,0
193038,surgery,0,0
193039,.,0,0
193040,Clinical,0,0
193041,data,0,0
193042,and,0,0
193043,the,0,0
193044,levels,0,0
193045,of,0,0
193046,injury,0,0
193047,biomarkers,0,0
193048,for,0,0
193049,the,0,0
193050,heart,0,0
193051,",",0,0
193052,lungs,0,0
193053,",",0,0
193054,liver,0,0
193055,",",0,0
193056,and,0,0
193057,kidneys,0,0
193058,within,0,0
193059,48,0,0
193060,h,0,0
193061,after,0,0
193062,surgery,0,0
193063,were,0,0
193064,compared,0,0
193065,using,0,0
193066,one-way,0,0
193067,or,0,1
193068,repeated,0,0
193069,measurement,0,0
193070,analysis,0,0
193071,of,0,0
193072,variance,0,0
193073,.,0,0
193074,RESULTS,0,0
193075,In,0,0
193076,the,1,0
193077,RIPerc,1,1
193078,group,1,0
193079,",",0,0
193080,the,0,0
193081,release,0,0
193082,of,0,0
193083,serum,0,0
193084,cardiac,0,0
193085,troponin,0,0
193086,I,0,0
193087,(,0,0
193088,128.68,0,0
193089,?,0,0
193090,102.56,0,0
193091,versus,0,0
193092,172.33,0,0
193093,?,0,0
193094,184.38,0,0
193095,",",0,0
193096,P,0,0
193097,=,0,0
193098,0.04,0,0
193099,),0,0
193100,and,0,0
193101,the,0,0
193102,inotropic,0,1
193103,score,0,0
193104,(,0,0
193105,96.4,0,0
193106,?,0,0
193107,73.8,0,0
193108,versus,0,0
193109,121.5,0,0
193110,?,0,0
193111,89.6,0,0
193112,",",0,0
193113,P,0,0
193114,=,0,0
193115,0.032,0,0
193116,),0,0
193117,decreased,0,0
193118,compared,0,0
193119,with,0,0
193120,that,0,0
193121,of,0,0
193122,the,0,0
193123,control,0,0
193124,;,0,0
193125,postoperative,0,0
193126,drainage,0,1
193127,(,0,0
193128,458.2,0,0
193129,?,0,0
193130,264.2,0,0
193131,versus,0,0
193132,545.1,0,0
193133,?,0,0
193134,349.0,0,0
193135,ml,0,0
193136,",",0,0
193137,P,0,0
193138,=,0,0
193139,0.048,0,0
193140,),0,0
193141,and,0,0
193142,the,0,0
193143,incidence,0,0
193144,of,0,0
193145,acute,0,0
193146,lung,0,0
193147,injury,0,0
193148,was,0,0
193149,reduced,0,0
193150,(,0,0
193151,36.6,0,0
193152,%,0,0
193153,versus,0,0
193154,51,0,0
193155,%,0,0
193156,",",0,0
193157,P,0,0
193158,=,0,0
193159,0.04,0,0
193160,),0,0
193161,",",0,0
193162,and,0,0
193163,the,0,0
193164,extent,0,0
193165,of,0,0
193166,hyperbilirubinemia,0,0
193167,was,0,0
193168,also,0,0
193169,attenuated,0,0
193170,.,0,0
193171,No,0,0
193172,significant,0,0
193173,difference,0,0
193174,was,0,0
193175,observed,0,0
193176,in,0,0
193177,the,0,0
193178,levels,0,0
193179,of,0,0
193180,biomarkers,0,0
193181,for,0,0
193182,renal,0,0
193183,injury,0,0
193184,and,0,0
193185,systemic,0,0
193186,inflammation,0,0
193187,response,0,0
193188,.,0,0
193189,CONCLUSIONS,1,0
193190,RIPerc,1,0
193191,applied,1,0
193192,during,0,0
193193,the,0,0
193194,valve,0,0
193195,replacement,0,1
193196,surgery,0,0
193197,induced,0,0
193198,multiple,0,0
193199,beneficial,0,0
193200,effects,0,0
193201,postoperatively,0,0
193202,including,0,0
193203,reduced,0,0
193204,drainage,0,1
193205,and,0,0
193206,myocardial,0,0
193207,damage,0,0
193208,",",0,0
193209,lower,0,0
193210,incidence,0,0
193211,of,0,0
193212,acute,0,0
193213,lung,0,0
193214,injury,0,0
193215,",",0,0
193216,and,0,0
193217,attenuated,0,0
193218,hyperbilirubinemia,0,0
193219,.,0,0
193220,Radiofrequency,1,1
193221,thermocoagulation,1,1
193222,combined,1,1
193223,with,1,0
193224,pulsed,1,1
193225,radiofrequency,1,1
193226,helps,0,0
193227,relieve,0,0
193228,postoperative,0,0
193229,complications,0,0
193230,of,0,0
193231,trigeminal,0,0
193232,neuralgia,0,0
193233,.,0,0
193234,Trigeminal,0,0
193235,neuralgia,0,0
193236,is,0,0
193237,a,0,0
193238,sudden,0,0
193239,",",0,0
193240,severe,0,0
193241,condition,0,0
193242,characterized,0,0
193243,by,0,0
193244,stabbing,0,0
193245,and,0,0
193246,recurrent,0,0
193247,pain,0,0
193248,.,0,0
193249,Radiofrequency,1,1
193250,thermocoagulation,1,1
193251,(,1,0
193252,RFT,1,0
193253,),1,1
193254,and,1,0
193255,pulsed,1,1
193256,radiofrequency,1,1
193257,(,1,0
193258,PRF,1,1
193259,),1,0
193260,are,0,0
193261,common,0,0
193262,surgical,0,0
193263,interventions,0,0
193264,used,0,0
193265,to,0,0
193266,treat,0,0
193267,trigeminal,0,0
193268,neuralgia,0,0
193269,.,0,0
193270,This,0,0
193271,study,0,0
193272,aimed,0,0
193273,to,0,0
193274,investigate,0,0
193275,the,0,0
193276,therapeutic,0,0
193277,effects,0,0
193278,and,0,0
193279,associated,0,0
193280,complications,0,0
193281,of,0,0
193282,a,0,0
193283,combination,0,0
193284,of,0,0
193285,RFT,0,0
193286,and,0,0
193287,PRF,0,1
193288,in,0,0
193289,the,0,0
193290,treatment,0,0
193291,of,0,0
193292,trigeminal,0,0
193293,neuralgia,0,0
193294,.,0,0
193295,Computed,1,0
193296,tomography-guided,1,1
193297,percutaneous,1,1
193298,RFT,1,0
193299,of,0,0
193300,the,0,0
193301,Gasserian,0,0
193302,ganglion,0,0
193303,was,0,0
193304,performed,0,0
193305,on,0,0
193306,80,0,0
193307,patients,0,0
193308,with,0,0
193309,trigeminal,0,0
193310,neuralgia,0,0
193311,.,0,0
193312,Patients,0,0
193313,were,0,0
193314,randomly,0,0
193315,assigned,0,0
193316,to,0,0
193317,either,0,0
193318,group,0,0
193319,A,1,0
193320,(,1,0
193321,RFT,1,0
193322,at,1,0
193323,70?C,1,0
193324,),1,0
193325,or,1,0
193326,group,1,1
193327,B,1,1
193328,(,1,0
193329,RFT,1,0
193330,at,1,0
193331,75?C,1,0
193332,),1,0
193333,.,1,0
193334,Patients,0,0
193335,in,0,0
193336,each,0,0
193337,group,0,0
193338,were,0,0
193339,divided,0,0
193340,into,0,0
193341,2,0,0
193342,subgroups,0,0
193343,",",0,0
193344,receiving,1,0
193345,percutaneous,1,1
193346,RFT,1,0
193347,(,1,0
193348,240,1,0
193349,s,1,0
193350,),1,0
193351,with,1,0
193352,or,1,0
193353,without,1,0
193354,PRF,1,1
193355,(,1,0
193356,42?C,1,0
193357,",",1,0
193358,2,1,0
193359,Hz,1,0
193360,",",1,0
193361,240,1,0
193362,s,1,0
193363,),1,0
193364,.,1,0
193365,Six,1,0
193366,months,0,0
193367,later,0,0
193368,",",0,0
193369,pain,0,0
193370,relief,0,0
193371,and,0,0
193372,complication,0,0
193373,status,0,0
193374,were,0,0
193375,evaluated,0,0
193376,.,0,0
193377,There,0,0
193378,was,0,0
193379,no,0,0
193380,significant,0,0
193381,difference,0,0
193382,in,0,0
193383,visual,0,0
193384,analogue,0,0
193385,scores,0,0
193386,among,0,0
193387,groups,0,0
193388,with,0,0
193389,RFT,0,0
193390,at,0,0
193391,70?,0,0
193392,or,0,0
193393,75?C,0,0
193394,",",0,0
193395,with,0,0
193396,or,0,0
193397,without,0,0
193398,PRF,0,1
193399,.,0,0
193400,Data,0,0
193401,showed,0,0
193402,that,0,0
193403,facial,0,0
193404,numbness,0,0
193405,and,0,0
193406,postoperative,0,0
193407,masticatory,0,1
193408,muscle,0,0
193409,weakness,0,0
193410,recovered,0,0
193411,more,0,0
193412,rapidly,0,0
193413,in,0,0
193414,patients,0,0
193415,receiving,0,0
193416,combined,0,1
193417,RFT,0,0
193418,and,0,0
193419,PRF,0,1
193420,treatment,0,0
193421,.,0,0
193422,Decreased,0,0
193423,corneal,0,0
193424,reflex,0,0
193425,was,0,0
193426,relieved,0,0
193427,to,0,0
193428,a,0,0
193429,significantly,0,0
193430,greater,0,0
193431,extent,0,0
193432,in,0,0
193433,groups,0,0
193434,receiving,0,0
193435,PRF,0,1
193436,than,0,0
193437,those,0,0
193438,without,0,0
193439,.,0,0
193440,Thus,0,0
193441,",",0,0
193442,compared,0,0
193443,to,0,0
193444,the,0,0
193445,use,0,0
193446,of,0,0
193447,RFT,0,0
193448,at,0,0
193449,75?C,0,0
193450,alone,0,0
193451,",",0,0
193452,the,0,0
193453,combination,0,0
193454,of,0,0
193455,PRF,0,1
193456,and,0,0
193457,RFT,0,0
193458,helped,0,0
193459,eliminate,0,0
193460,postoperative,0,0
193461,complications,0,0
193462,",",0,0
193463,such,0,0
193464,as,0,0
193465,facial,0,0
193466,numbness,0,0
193467,",",0,0
193468,masticatory,0,0
193469,muscle,0,0
193470,weakness,0,0
193471,",",0,0
193472,and,0,0
193473,decreased,0,0
193474,corneal,0,0
193475,reflex,0,0
193476,",",0,0
193477,indicating,0,0
193478,that,0,0
193479,it,0,0
193480,could,0,0
193481,be,0,0
193482,useful,0,0
193483,for,0,0
193484,surgically,0,0
193485,treating,0,0
193486,trigeminal,0,0
193487,neuralgia,0,0
193488,.,0,0
193489,Women,0,0
193490,With,0,0
193491,Gestational,0,0
193492,Diabetes,0,0
193493,Mellitus,0,0
193494,Randomized,0,0
193495,to,0,0
193496,a,0,0
193497,Higher-Complex,0,0
193498,Carbohydrate/Low-Fat,0,1
193499,Diet,0,1
193500,Manifest,0,0
193501,Lower,0,1
193502,Adipose,0,1
193503,Tissue,0,0
193504,Insulin,0,1
193505,Resistance,0,0
193506,",",0,0
193507,Inflammation,0,0
193508,",",0,0
193509,Glucose,0,1
193510,",",0,0
193511,and,0,0
193512,Free,0,1
193513,Fatty,0,1
193514,Acids,0,0
193515,:,0,0
193516,A,0,0
193517,Pilot,0,0
193518,Study,0,0
193519,.,0,0
193520,OBJECTIVE,0,0
193521,Diet,0,1
193522,therapy,0,1
193523,in,0,0
193524,gestational,0,0
193525,diabetes,0,0
193526,mellitus,0,0
193527,(,0,0
193528,GDM,0,0
193529,),0,1
193530,has,0,0
193531,focused,0,0
193532,on,0,0
193533,carbohydrate,0,1
193534,restriction,0,1
193535,but,0,0
193536,is,0,0
193537,poorly,0,0
193538,substantiated,0,0
193539,.,0,0
193540,In,0,0
193541,this,0,0
193542,pilot,0,0
193543,randomized,0,0
193544,clinical,0,0
193545,trial,0,0
193546,",",0,0
193547,we,0,0
193548,challenged,0,0
193549,the,0,0
193550,conventional,1,1
193551,low-carbohydrate/higher-fat,1,1
193552,(,1,0
193553,LC/CONV,1,1
193554,),1,0
193555,diet,1,1
193556,",",0,0
193557,hypothesizing,0,0
193558,that,0,0
193559,a,0,0
193560,higher-complex,1,0
193561,carbohydrate/lower-fat,1,1
193562,(,1,0
193563,CHOICE,1,1
193564,),1,0
193565,diet,1,1
193566,would,0,0
193567,improve,0,0
193568,maternal,0,0
193569,insulin,0,1
193570,resistance,0,0
193571,(,0,0
193572,IR,0,1
193573,),0,0
193574,",",0,0
193575,adipose,0,0
193576,tissue,0,0
193577,(,0,0
193578,AT,0,1
193579,),0,0
193580,lipolysis,0,0
193581,",",0,0
193582,and,0,0
193583,infant,0,0
193584,adiposity,0,0
193585,.,0,0
193586,RESEARCH,0,0
193587,DESIGN,0,0
193588,AND,0,0
193589,METHODS,0,0
193590,At,0,0
193591,31,0,0
193592,weeks,0,0
193593,",",0,0
193594,12,0,0
193595,diet-controlled,0,0
193596,overweight/obese,0,0
193597,women,0,0
193598,with,0,0
193599,GDM,0,0
193600,were,0,0
193601,randomized,0,0
193602,to,0,0
193603,an,0,0
193604,isocaloric,0,1
193605,LC/CONV,0,1
193606,(,0,0
193607,40,0,0
193608,%,0,0
193609,carbohydrate/45,0,1
193610,%,0,0
193611,fat/15,0,1
193612,%,0,0
193613,protein,0,1
193614,;,0,0
193615,n,0,0
193616,=,0,0
193617,6,0,0
193618,),0,0
193619,or,0,1
193620,CHOICE,1,1
193621,(,0,0
193622,60,0,0
193623,%,0,0
193624,/25,0,0
193625,%,0,0
193626,/15,0,0
193627,%,0,0
193628,;,0,0
193629,n,0,0
193630,=,0,0
193631,6,0,0
193632,),0,0
193633,diet,1,1
193634,.,1,0
193635,All,0,0
193636,meals,1,0
193637,were,0,0
193638,provided,0,0
193639,.,0,0
193640,AT,0,0
193641,was,0,0
193642,biopsied,0,0
193643,at,0,0
193644,37,0,0
193645,weeks,0,0
193646,.,0,0
193647,RESULTS,0,0
193648,After,0,0
193649,?7,0,0
193650,weeks,0,0
193651,",",0,0
193652,fasting,0,0
193653,glucose,0,0
193654,(,0,0
193655,P,0,0
193656,=,0,0
193657,0.03,0,0
193658,),0,0
193659,and,0,0
193660,free,0,0
193661,fatty,0,1
193662,acids,0,1
193663,(,0,0
193664,P,0,0
193665,=,0,0
193666,0.06,0,0
193667,),0,0
193668,decreased,0,0
193669,on,0,0
193670,CHOICE,0,0
193671,",",0,0
193672,whereas,0,0
193673,fasting,0,0
193674,glucose,0,0
193675,increased,0,0
193676,on,0,0
193677,LC/CONV,0,1
193678,(,0,0
193679,P,0,0
193680,=,0,0
193681,0.03,0,0
193682,),0,0
193683,.,0,0
193684,Insulin,0,1
193685,suppression,0,0
193686,of,0,0
193687,AT,0,1
193688,lipolysis,0,0
193689,was,0,0
193690,improved,0,0
193691,on,0,0
193692,CHOICE,0,0
193693,versus,0,1
193694,LC/CONV,0,1
193695,(,0,0
193696,56,0,0
193697,vs.,0,0
193698,31,0,0
193699,%,0,0
193700,",",0,0
193701,P,0,0
193702,=,0,0
193703,0.005,0,0
193704,),0,0
193705,",",0,0
193706,consistent,0,0
193707,with,0,0
193708,improved,0,0
193709,IR,0,1
193710,.,0,0
193711,AT,0,0
193712,expression,0,0
193713,of,0,0
193714,multiple,0,0
193715,proinflammatory,0,0
193716,genes,0,0
193717,was,0,0
193718,lower,0,0
193719,on,0,0
193720,CHOICE,0,0
193721,(,0,0
193722,P,0,0
193723,<,0,0
193724,0.01,0,0
193725,),0,0
193726,.,0,0
193727,Infant,0,0
193728,adiposity,0,0
193729,trended,0,0
193730,lower,0,0
193731,with,0,0
193732,CHOICE,0,0
193733,(,0,0
193734,10.1,0,0
193735,?,0,0
193736,1.4,0,0
193737,vs.,0,0
193738,12.6,0,0
193739,?,0,0
193740,2,0,0
193741,%,0,0
193742,",",0,0
193743,respectively,0,0
193744,),0,0
193745,.,0,0
193746,CONCLUSIONS,0,0
193747,A,0,0
193748,CHOICE,0,0
193749,diet,0,1
193750,may,0,0
193751,improve,0,0
193752,maternal,0,0
193753,IR,0,1
193754,and,0,0
193755,infant,0,0
193756,adiposity,0,0
193757,",",0,0
193758,challenging,0,0
193759,recommendations,0,0
193760,for,0,0
193761,a,0,0
193762,LC/CONV,0,0
193763,diet,0,1
193764,.,0,0
193765,The,0,0
193766,VA,1,1
193767,augmentation,1,0
193768,and,1,0
193769,switching,1,0
193770,treatments,1,0
193771,for,0,0
193772,improving,0,0
193773,depression,0,0
193774,outcomes,0,0
193775,(,0,0
193776,VAST-D,0,0
193777,),0,0
193778,study,0,0
193779,:,0,0
193780,Rationale,0,0
193781,and,0,0
193782,design,0,0
193783,considerations,0,0
193784,.,0,0
193785,Because,0,0
193786,two-thirds,0,0
193787,of,0,0
193788,patients,0,0
193789,with,0,0
193790,Major,0,0
193791,Depressive,0,0
193792,Disorder,0,0
193793,do,0,0
193794,not,0,0
193795,achieve,0,0
193796,remission,0,0
193797,with,0,0
193798,their,0,0
193799,first,0,0
193800,antidepressant,0,1
193801,",",0,0
193802,we,0,0
193803,designed,0,0
193804,a,0,0
193805,trial,0,0
193806,of,0,0
193807,three,0,0
193808,next-step,0,0
193809,strategies,0,0
193810,:,0,0
193811,switching,1,0
193812,to,1,0
193813,another,1,0
193814,antidepressant,1,1
193815,(,1,0
193816,bupropion-SR,1,1
193817,),1,1
193818,or,0,1
193819,augmenting,1,1
193820,the,1,0
193821,current,1,0
193822,antidepressant,1,1
193823,with,1,0
193824,either,1,0
193825,another,1,0
193826,antidepressant,1,1
193827,(,1,0
193828,bupropion-SR,1,1
193829,),1,0
193830,or,1,0
193831,with,1,0
193832,an,1,0
193833,atypical,1,0
193834,antipsychotic,1,1
193835,(,1,0
193836,aripiprazole,1,1
193837,),1,0
193838,.,1,0
193839,The,0,0
193840,study,0,0
193841,will,0,0
193842,compare,0,0
193843,12-week,0,0
193844,remission,0,0
193845,rates,0,0
193846,and,0,0
193847,",",0,0
193848,among,0,0
193849,those,0,0
193850,who,0,0
193851,have,0,0
193852,at,0,0
193853,least,0,0
193854,a,0,0
193855,partial,0,0
193856,response,0,0
193857,",",0,0
193858,relapse,0,0
193859,rates,0,0
193860,for,0,0
193861,up,0,0
193862,to,0,0
193863,6,0,0
193864,months,0,0
193865,of,0,0
193866,additional,0,0
193867,treatment,0,0
193868,.,0,0
193869,We,0,0
193870,review,0,0
193871,seven,0,0
193872,key,0,0
193873,efficacy/effectiveness,0,0
193874,design,0,0
193875,decisions,0,0
193876,in,0,0
193877,this,0,0
193878,mixed,0,0
193879,efficacy-effectiveness,0,0
193880,trial,0,0
193881,.,0,0
193882,Recruitment,0,0
193883,and,0,0
193884,Reasons,0,0
193885,for,0,0
193886,Non-Participation,0,0
193887,in,0,0
193888,a,0,0
193889,Family-Coping-Orientated,1,0
193890,Palliative,1,1
193891,Home,1,1
193892,Care,1,0
193893,Trial,0,1
193894,(,0,0
193895,FamCope,0,1
193896,),0,0
193897,.,0,0
193898,Cancer,0,0
193899,patients,0,0
193900,and,0,0
193901,their,0,0
193902,family,0,0
193903,caregivers,0,0
193904,need,0,0
193905,support,0,0
193906,to,0,0
193907,cope,0,0
193908,with,0,0
193909,physical,0,0
193910,",",0,0
193911,psychosocial,0,0
193912,",",0,0
193913,and,0,0
193914,existential,0,0
193915,problems,0,0
193916,early,0,0
193917,in,0,0
193918,the,0,0
193919,palliative,0,0
193920,care,0,0
193921,trajectory,0,0
193922,.,0,0
193923,Many,0,0
193924,interventions,0,0
193925,target,0,0
193926,patient,0,0
193927,symptomatology,0,0
193928,",",0,0
193929,with,0,0
193930,health,0,0
193931,care,0,1
193932,professionals,0,0
193933,acting,0,0
193934,as,0,0
193935,problem-solvers,0,0
193936,.,0,0
193937,Family,0,0
193938,coping,0,0
193939,",",0,0
193940,however,0,0
193941,",",0,0
193942,is,0,0
193943,a,0,0
193944,new,0,0
193945,research,0,0
193946,area,0,0
193947,within,0,0
193948,palliative,0,0
193949,care,0,0
193950,.,0,0
193951,The,0,0
193952,FamCope,1,0
193953,intervention,1,1
193954,was,0,0
193955,developed,0,0
193956,to,0,0
193957,test,0,0
193958,if,0,0
193959,a,0,0
193960,nurse-led,1,1
193961,family-coping-orientated,1,1
193962,palliative,1,1
193963,home,1,1
193964,care,1,1
193965,intervention,1,1
193966,would,0,0
193967,help,0,0
193968,families,0,0
193969,cope,0,0
193970,with,0,0
193971,physical,0,0
193972,and,0,0
193973,psychosocial,0,0
193974,problems,0,0
193975,at,0,0
193976,home,0,0
193977,--,0,0
193978,together,0,0
193979,as,0,0
193980,a,0,0
193981,family,0,0
193982,and,0,0
193983,in,0,0
193984,interaction,0,0
193985,with,0,0
193986,health,0,0
193987,care,0,0
193988,professionals,0,0
193989,.,0,0
193990,However,0,0
193991,",",0,0
193992,an,0,0
193993,unexpectedly,0,0
193994,high,0,0
193995,number,0,0
193996,of,0,0
193997,families,0,0
193998,declined,0,0
193999,participation,0,0
194000,in,0,0
194001,the,0,0
194002,trial,0,0
194003,.,0,0
194004,We,0,0
194005,describe,0,0
194006,and,0,0
194007,discuss,0,0
194008,the,0,0
194009,recruitment,0,0
194010,strategy,0,0
194011,and,0,0
194012,patient,0,0
194013,reported,0,0
194014,reasons,0,0
194015,for,0,0
194016,non-participation,0,0
194017,to,0,0
194018,add,0,0
194019,to,0,0
194020,the,0,0
194021,knowledge,0,0
194022,about,0,0
194023,what,0,0
194024,impedes,0,0
194025,recruitment,0,0
194026,and,0,0
194027,to,0,0
194028,identify,0,0
194029,the,0,0
194030,factors,0,0
194031,that,0,0
194032,influence,0,0
194033,willingness,0,0
194034,to,0,0
194035,participate,0,0
194036,in,0,0
194037,research,0,0
194038,aimed,0,0
194039,at,0,0
194040,family,0,0
194041,coping,0,0
194042,early,0,0
194043,in,0,0
194044,the,0,0
194045,palliative,0,0
194046,care,0,0
194047,trajectory,0,0
194048,.,0,0
194049,Patients,0,0
194050,with,0,0
194051,advanced,0,0
194052,cancer,0,0
194053,and,0,0
194054,their,0,0
194055,closest,0,0
194056,relative,0,0
194057,were,0,0
194058,recruited,0,0
194059,from,0,0
194060,medical,0,0
194061,",",0,0
194062,surgical,0,0
194063,",",0,0
194064,and,0,0
194065,oncological,0,0
194066,departments,0,0
194067,.,0,0
194068,Reasons,0,0
194069,for,0,0
194070,non-participation,0,0
194071,were,0,0
194072,registered,0,0
194073,and,0,0
194074,characteristics,0,0
194075,of,0,0
194076,participants,0,0
194077,and,0,0
194078,non-participants,0,0
194079,were,0,0
194080,compared,0,0
194081,to,0,0
194082,evaluate,0,0
194083,differences,0,0
194084,between,0,0
194085,subgroups,0,0
194086,of,0,0
194087,non-participants,0,0
194088,based,0,0
194089,on,0,0
194090,reasons,0,0
194091,not,0,0
194092,to,0,0
194093,participate,0,0
194094,and,0,0
194095,reasons,0,0
194096,to,0,0
194097,participate,0,0
194098,in,0,0
194099,the,0,0
194100,trial,0,0
194101,.,0,0
194102,A,0,0
194103,total,0,0
194104,of,0,0
194105,65.9,0,0
194106,%,0,0
194107,of,0,0
194108,the,0,0
194109,families,0,0
194110,declined,0,0
194111,participation,0,0
194112,.,0,0
194113,Two,0,0
194114,main,0,0
194115,categories,0,0
194116,for,0,0
194117,declining,0,0
194118,participation,0,0
194119,emerged,0,0
194120,:,0,0
194121,first,0,0
194122,",",0,0
194123,that,0,0
194124,the,0,0
194125,burden,0,0
194126,of,0,0
194127,illness,0,0
194128,is,0,0
194129,too,0,0
194130,great,0,0
194131,and,0,0
194132,",",0,0
194133,second,0,0
194134,",",0,0
194135,that,0,0
194136,it,0,0
194137,was,0,0
194138,too,0,0
194139,soon,0,0
194140,to,0,0
194141,receive,0,0
194142,this,0,0
194143,kind,0,0
194144,of,0,0
194145,support,0,0
194146,.,0,0
194147,Men,0,0
194148,were,0,0
194149,more,0,0
194150,likely,0,0
194151,to,0,0
194152,participate,0,0
194153,than,0,0
194154,women,0,0
194155,.,0,0
194156,Patients,0,0
194157,in,0,0
194158,the,0,0
194159,too,0,0
194160,soon,0,0
194161,group,0,0
194162,had,0,0
194163,similar,0,0
194164,characteristics,0,0
194165,to,0,0
194166,participants,0,0
194167,in,0,0
194168,the,0,0
194169,trial,0,0
194170,.,0,0
194171,Timing,0,0
194172,of,0,0
194173,interventions,0,1
194174,and,0,0
194175,readiness,0,0
194176,of,0,0
194177,patients,0,0
194178,and,0,0
194179,their,0,0
194180,relatives,0,0
194181,seems,0,0
194182,to,0,0
194183,affect,0,0
194184,willingness,0,0
194185,to,0,0
194186,receive,0,0
194187,a,0,0
194188,family-coping-orientated,0,1
194189,care,0,1
194190,approach,0,1
194191,and,0,0
194192,impeded,0,0
194193,recruitment,0,0
194194,to,0,0
194195,this,0,0
194196,trial,0,0
194197,.,0,0
194198,Our,0,0
194199,findings,0,0
194200,can,0,0
194201,be,0,0
194202,used,0,0
194203,in,0,0
194204,further,0,0
194205,research,0,0
194206,and,0,0
194207,in,0,0
194208,clinical,0,0
194209,practice,0,0
194210,in,0,0
194211,order,0,0
194212,to,0,0
194213,construct,0,0
194214,interventions,0,1
194215,and,0,0
194216,target,0,0
194217,relevant,0,0
194218,populations,0,0
194219,for,0,0
194220,early,0,0
194221,family-coping-orientated,0,1
194222,palliative,1,0
194223,care,1,0
194224,.,1,0
194225,Use,0,0
194226,of,0,0
194227,the,0,0
194228,learning,1,0
194229,conversation,1,0
194230,improves,0,0
194231,instructor,0,1
194232,confidence,0,0
194233,in,0,0
194234,life,0,0
194235,support,0,0
194236,training,0,1
194237,:,0,0
194238,An,0,0
194239,open,0,0
194240,randomised,0,0
194241,controlled,0,0
194242,cross-over,0,0
194243,trial,0,0
194244,comparing,0,0
194245,teaching,0,1
194246,feedback,0,1
194247,mechanisms,0,0
194248,.,0,0
194249,AIMS,0,0
194250,Feedback,0,1
194251,is,0,0
194252,vital,0,0
194253,for,0,0
194254,the,0,0
194255,effective,0,0
194256,delivery,0,0
194257,of,0,0
194258,skills-based,0,1
194259,education,0,1
194260,.,0,0
194261,We,0,0
194262,sought,0,0
194263,to,0,0
194264,compare,0,0
194265,the,0,0
194266,sandwich,1,1
194267,technique,1,1
194268,and,0,0
194269,learning,1,0
194270,conversation,1,0
194271,structured,0,1
194272,methods,0,0
194273,of,0,0
194274,feedback,0,1
194275,delivery,0,0
194276,in,0,0
194277,competency-based,0,1
194278,basic,0,1
194279,life,0,0
194280,support,0,1
194281,(,0,0
194282,BLS,0,1
194283,),0,0
194284,training,0,1
194285,.,0,0
194286,METHODS,0,0
194287,Open,0,1
194288,randomised,0,0
194289,crossover,0,0
194290,study,0,0
194291,undertaken,0,0
194292,between,0,0
194293,October,0,0
194294,2014,0,0
194295,and,0,0
194296,March,0,0
194297,2015,0,0
194298,at,0,0
194299,the,0,0
194300,University,0,0
194301,of,0,0
194302,Birmingham,0,0
194303,",",0,0
194304,United,0,0
194305,Kingdom,0,0
194306,.,0,0
194307,Six-hundred,0,0
194308,and,0,0
194309,forty,0,0
194310,healthcare,0,0
194311,students,0,0
194312,undertaking,0,0
194313,a,0,0
194314,European,0,0
194315,Resuscitation,0,1
194316,Council,0,1
194317,(,0,0
194318,ERC,0,0
194319,),0,1
194320,BLS,0,1
194321,course,0,0
194322,were,0,0
194323,enrolled,0,0
194324,",",0,0
194325,each,0,0
194326,of,0,0
194327,whom,0,0
194328,was,0,0
194329,randomised,0,0
194330,to,0,0
194331,receive,0,0
194332,teaching,1,1
194333,using,1,0
194334,either,1,0
194335,the,1,0
194336,sandwich,1,1
194337,technique,1,1
194338,or,1,1
194339,the,1,0
194340,learning,1,0
194341,conversation,1,0
194342,.,1,0
194343,Fifty-eight,0,0
194344,instructors,0,1
194345,were,0,0
194346,randomised,0,0
194347,to,0,0
194348,initially,0,0
194349,teach,0,1
194350,using,0,0
194351,either,0,0
194352,the,0,0
194353,learning,1,0
194354,conversation,1,0
194355,or,1,1
194356,sandwich,1,1
194357,technique,1,1
194358,",",0,0
194359,prior,0,0
194360,to,0,0
194361,crossing-over,0,0
194362,and,0,0
194363,teaching,0,1
194364,with,0,0
194365,the,0,0
194366,alternative,0,0
194367,technique,0,1
194368,after,0,0
194369,a,0,0
194370,pre-defined,0,0
194371,time,0,0
194372,period,0,0
194373,.,0,0
194374,Outcome,0,0
194375,measures,0,0
194376,included,0,0
194377,skill,0,0
194378,acquisition,0,0
194379,as,0,0
194380,measured,0,0
194381,by,0,0
194382,an,0,0
194383,end-of-course,0,0
194384,competency,0,0
194385,assessment,0,0
194386,",",0,0
194387,instructors,0,1
194388,',0,0
194389,perception,0,0
194390,of,0,0
194391,teaching,0,0
194392,with,0,0
194393,each,0,0
194394,feedback,0,1
194395,technique,0,1
194396,and,0,0
194397,candidates,0,0
194398,',0,0
194399,perception,0,0
194400,of,0,0
194401,the,0,0
194402,feedback,0,1
194403,they,0,0
194404,were,0,0
194405,provided,0,0
194406,with,0,0
194407,.,0,0
194408,RESULTS,0,0
194409,Scores,0,0
194410,assigned,0,0
194411,to,0,0
194412,use,0,0
194413,of,0,0
194414,the,0,0
194415,learning,0,0
194416,conversation,0,0
194417,by,0,0
194418,instructors,0,1
194419,were,0,0
194420,significantly,0,0
194421,more,0,0
194422,favourable,0,0
194423,than,0,0
194424,for,0,0
194425,the,0,0
194426,sandwich,0,1
194427,technique,0,1
194428,across,0,0
194429,all,0,0
194430,but,0,0
194431,two,0,0
194432,assessed,0,0
194433,domains,0,0
194434,relating,0,0
194435,to,0,0
194436,instructor,0,1
194437,perception,0,0
194438,of,0,0
194439,the,0,0
194440,feedback,0,1
194441,technique,0,1
194442,",",0,0
194443,including,0,0
194444,all,0,0
194445,skills-based,0,1
194446,domains,0,0
194447,.,0,0
194448,No,0,0
194449,difference,0,0
194450,was,0,0
194451,seen,0,0
194452,in,0,0
194453,either,0,0
194454,assessment,0,0
194455,pass,0,0
194456,rates,0,0
194457,(,0,0
194458,80.9,0,0
194459,%,0,0
194460,sandwich,0,1
194461,technique,0,1
194462,vs.,0,0
194463,77.2,0,0
194464,%,0,0
194465,learning,0,0
194466,conversation,0,0
194467,;,0,0
194468,OR,0,0
194469,1.2,0,0
194470,",",0,0
194471,95,0,0
194472,%,0,0
194473,CI,0,0
194474,0.85-1.84,0,0
194475,;,0,0
194476,p=0.29,0,0
194477,),0,0
194478,or,0,1
194479,any,0,0
194480,domain,0,1
194481,relating,0,0
194482,to,0,0
194483,candidates,0,0
194484,',0,0
194485,perception,0,0
194486,of,0,0
194487,their,0,0
194488,teaching,0,0
194489,technique,0,1
194490,.,0,0
194491,CONCLUSIONS,0,0
194492,&,0,0
194493,RELEVANCE,0,0
194494,This,0,0
194495,is,0,0
194496,the,0,0
194497,first,0,0
194498,direct,0,0
194499,comparison,0,0
194500,of,0,0
194501,two,0,0
194502,feedback,0,1
194503,techniques,0,1
194504,in,0,0
194505,clinical,0,0
194506,medical,0,1
194507,education,0,1
194508,using,0,0
194509,both,0,0
194510,quantitative,0,0
194511,and,0,0
194512,qualitative,0,0
194513,methodology,0,0
194514,.,0,0
194515,The,0,0
194516,learning,1,0
194517,conversation,1,0
194518,is,0,0
194519,preferred,0,0
194520,by,0,0
194521,instructors,0,1
194522,providing,0,0
194523,competency-based,0,1
194524,life,0,0
194525,support,0,1
194526,training,0,1
194527,and,0,0
194528,is,0,0
194529,perceived,0,0
194530,to,0,0
194531,favour,0,0
194532,skills,0,0
194533,acquisition,0,0
194534,.,0,0
194535,Oxygen,0,1
194536,saturation,0,0
194537,targets,0,0
194538,in,0,0
194539,infants,0,0
194540,with,0,0
194541,bronchiolitis,0,0
194542,(,0,0
194543,BIDS,0,1
194544,),0,0
194545,:,0,0
194546,a,0,0
194547,double-blind,0,0
194548,",",0,0
194549,randomised,0,0
194550,",",0,0
194551,equivalence,0,0
194552,trial,0,0
194553,.,0,0
194554,BACKGROUND,0,0
194555,The,0,0
194556,American,0,0
194557,Academy,0,0
194558,of,0,0
194559,Pediatrics,0,0
194560,recommends,0,0
194561,a,0,0
194562,permissive,0,0
194563,hypoxaemic,0,0
194564,target,0,0
194565,for,0,0
194566,an,0,0
194567,oxygen,0,1
194568,saturation,0,0
194569,of,0,0
194570,90,0,0
194571,%,0,0
194572,for,0,0
194573,children,0,0
194574,with,0,0
194575,bronchiolitis,0,0
194576,",",0,0
194577,which,0,0
194578,is,0,0
194579,consistent,0,0
194580,with,0,0
194581,the,0,0
194582,WHO,0,0
194583,recommendations,0,0
194584,for,0,0
194585,targets,0,0
194586,in,0,0
194587,children,0,0
194588,with,0,0
194589,lower,0,0
194590,respiratory,0,0
194591,tract,0,0
194592,infections,0,0
194593,.,0,0
194594,No,0,0
194595,evidence,0,0
194596,exists,0,0
194597,to,0,0
194598,support,0,0
194599,this,0,0
194600,threshold,0,0
194601,.,0,0
194602,We,0,0
194603,aimed,0,0
194604,to,0,0
194605,assess,0,0
194606,whether,0,0
194607,the,0,0
194608,90,0,0
194609,%,0,0
194610,or,0,0
194611,higher,0,0
194612,target,0,0
194613,for,0,0
194614,management,0,0
194615,of,0,0
194616,oxygen,1,1
194617,supplementation,1,1
194618,was,0,0
194619,equivalent,0,0
194620,to,0,0
194621,a,0,0
194622,normoxic,0,1
194623,94,0,0
194624,%,0,0
194625,or,0,0
194626,higher,0,0
194627,target,0,0
194628,for,0,0
194629,infants,0,0
194630,admitted,0,0
194631,to,0,0
194632,hospital,0,0
194633,with,0,0
194634,viral,0,0
194635,bronchiolitis,0,0
194636,.,0,0
194637,METHODS,0,0
194638,We,0,0
194639,did,0,0
194640,a,0,0
194641,parallel-group,0,0
194642,",",0,0
194643,randomised,0,0
194644,",",0,0
194645,controlled,0,0
194646,",",0,0
194647,equivalence,0,0
194648,trial,0,0
194649,of,0,0
194650,infants,0,0
194651,aged,0,0
194652,6,0,0
194653,weeks,0,0
194654,to,0,0
194655,12,0,0
194656,months,0,0
194657,of,0,0
194658,age,0,0
194659,with,0,0
194660,physician-diagnosed,0,0
194661,bronchiolitis,0,0
194662,newly,0,0
194663,admitted,0,0
194664,into,0,0
194665,eight,0,0
194666,paediatric,0,0
194667,hospital,0,0
194668,units,0,1
194669,in,0,0
194670,the,0,0
194671,UK,0,0
194672,(,0,0
194673,the,0,0
194674,Bronchiolitis,0,0
194675,of,0,0
194676,Infancy,0,0
194677,Discharge,0,0
194678,Study,0,0
194679,[,0,0
194680,BIDS,0,1
194681,],0,0
194682,),0,0
194683,.,0,0
194684,A,0,0
194685,central,0,0
194686,computer,0,1
194687,randomly,0,0
194688,allocated,0,0
194689,(,0,0
194690,1:1,0,1
194691,),0,0
194692,infants,0,0
194693,",",0,0
194694,in,0,0
194695,varying,0,0
194696,length,0,0
194697,blocks,0,1
194698,of,0,0
194699,four,0,0
194700,and,0,0
194701,six,0,0
194702,and,0,0
194703,without,0,0
194704,stratification,0,0
194705,",",0,0
194706,to,0,0
194707,be,0,0
194708,clipped,0,0
194709,to,0,0
194710,standard,1,1
194711,oximeters,1,1
194712,(,0,0
194713,patients,0,0
194714,treated,0,0
194715,with,0,0
194716,oxygen,0,0
194717,if,0,0
194718,pulse,0,1
194719,oxygen,0,1
194720,saturation,0,0
194721,[,0,0
194722,SpO2,0,1
194723,],0,0
194724,<,0,0
194725,94,0,0
194726,%,0,0
194727,),0,0
194728,or,0,1
194729,modified,1,0
194730,oximeters,1,1
194731,(,0,0
194732,displayed,0,0
194733,a,0,0
194734,measured,0,0
194735,value,0,0
194736,of,0,0
194737,90,0,0
194738,%,0,0
194739,as,0,0
194740,94,0,0
194741,%,0,0
194742,",",0,0
194743,therefore,0,0
194744,oxygen,0,0
194745,not,0,0
194746,given,0,0
194747,until,0,0
194748,SpO2,0,1
194749,<,0,0
194750,90,0,0
194751,%,0,0
194752,),0,0
194753,.,0,0
194754,All,0,0
194755,parents,0,0
194756,",",0,0
194757,clinical,0,0
194758,staff,0,0
194759,",",0,0
194760,and,0,0
194761,outcome,0,0
194762,assessors,0,0
194763,were,0,0
194764,masked,0,0
194765,to,0,0
194766,allocation,0,0
194767,.,0,0
194768,The,0,0
194769,primary,0,0
194770,outcome,0,0
194771,was,0,0
194772,time,0,0
194773,to,0,0
194774,resolution,0,0
194775,of,0,0
194776,cough,0,0
194777,(,0,0
194778,prespecified,0,0
194779,equivalence,0,0
194780,limits,0,0
194781,of,0,0
194782,plus,0,1
194783,or,0,1
194784,minus,0,0
194785,2,0,0
194786,days,0,0
194787,),0,0
194788,in,0,0
194789,the,0,0
194790,intention-to-treat,0,0
194791,population,0,0
194792,.,0,0
194793,This,0,0
194794,trial,0,0
194795,is,0,0
194796,registered,0,0
194797,with,0,0
194798,ISRCTN,0,0
194799,",",0,0
194800,number,0,0
194801,ISRCTN28405428,0,1
194802,.,0,0
194803,FINDINGS,0,0
194804,Between,0,0
194805,Oct,0,0
194806,3,0,0
194807,",",0,0
194808,and,0,0
194809,March,0,0
194810,30,0,0
194811,",",0,0
194812,2012,0,0
194813,",",0,0
194814,and,0,0
194815,Oct,0,0
194816,1,0,0
194817,",",0,0
194818,and,0,0
194819,March,0,0
194820,29,0,0
194821,",",0,0
194822,2013,0,0
194823,",",0,0
194824,we,0,0
194825,randomly,0,0
194826,assigned,0,0
194827,308,0,0
194828,infants,0,0
194829,to,0,0
194830,standard,0,1
194831,oximeters,0,1
194832,and,0,0
194833,307,0,0
194834,infants,0,0
194835,to,0,0
194836,modified,0,0
194837,oximeters,0,1
194838,.,0,0
194839,Cough,0,0
194840,resolved,0,0
194841,by,0,0
194842,15?0,0,0
194843,days,0,0
194844,(,0,0
194845,median,0,0
194846,),0,0
194847,in,0,0
194848,both,0,0
194849,groups,0,0
194850,(,0,0
194851,95,0,0
194852,%,0,0
194853,CI,0,0
194854,for,0,0
194855,difference,0,0
194856,-1,0,0
194857,to,0,0
194858,2,0,0
194859,),0,0
194860,and,0,0
194861,so,0,0
194862,oxygen,0,1
194863,thresholds,0,0
194864,were,0,0
194865,equivalent,0,0
194866,.,0,0
194867,We,0,0
194868,recorded,0,0
194869,35,0,0
194870,serious,0,0
194871,adverse,0,0
194872,events,0,0
194873,in,0,0
194874,32,0,0
194875,infants,0,0
194876,in,0,0
194877,the,0,0
194878,standard,0,1
194879,care,0,1
194880,group,0,0
194881,and,0,0
194882,25,0,0
194883,serious,0,0
194884,adverse,0,0
194885,events,0,0
194886,in,0,0
194887,24,0,0
194888,infants,0,0
194889,in,0,0
194890,the,0,0
194891,modified,0,0
194892,care,0,0
194893,group,0,0
194894,.,0,0
194895,In,0,0
194896,the,0,0
194897,standard,0,1
194898,care,0,1
194899,group,0,0
194900,",",0,0
194901,eight,0,0
194902,infants,0,0
194903,transferred,0,0
194904,to,0,0
194905,a,0,0
194906,high-dependency,0,0
194907,unit,0,0
194908,",",0,0
194909,23,0,0
194910,were,0,0
194911,readmitted,0,0
194912,",",0,0
194913,and,0,0
194914,one,0,0
194915,had,0,0
194916,a,0,0
194917,prolonged,0,0
194918,hospital,0,0
194919,stay,0,0
194920,.,0,0
194921,In,0,0
194922,the,0,0
194923,modified,0,0
194924,care,0,1
194925,group,0,0
194926,",",0,0
194927,12,0,0
194928,infants,0,0
194929,were,0,0
194930,transferred,0,0
194931,to,0,0
194932,a,0,0
194933,high-dependency,0,0
194934,unit,0,0
194935,and,0,0
194936,12,0,0
194937,were,0,0
194938,readmitted,0,0
194939,to,0,0
194940,hospital,0,0
194941,.,0,0
194942,Recorded,0,0
194943,adverse,0,0
194944,events,0,0
194945,did,0,0
194946,not,0,0
194947,differ,0,0
194948,significantly,0,0
194949,.,0,0
194950,INTERPRETATION,0,0
194951,Management,0,0
194952,of,0,0
194953,infants,0,0
194954,with,0,0
194955,bronchiolitis,0,0
194956,to,0,0
194957,an,0,0
194958,oxygen,0,1
194959,saturation,0,0
194960,target,0,0
194961,of,0,0
194962,90,0,0
194963,%,0,0
194964,or,0,0
194965,higher,0,0
194966,is,0,0
194967,as,0,0
194968,safe,0,0
194969,and,0,0
194970,clinically,0,0
194971,effective,0,0
194972,as,0,0
194973,one,0,0
194974,of,0,0
194975,94,0,0
194976,%,0,0
194977,or,0,0
194978,higher,0,0
194979,.,0,0
194980,Future,0,0
194981,research,0,0
194982,should,0,0
194983,assess,0,0
194984,the,0,0
194985,benefits,0,0
194986,and,0,0
194987,risks,0,0
194988,of,0,0
194989,different,0,0
194990,oxygen,0,1
194991,saturation,0,0
194992,targets,0,0
194993,in,0,0
194994,acute,0,0
194995,respiratory,0,0
194996,infection,0,0
194997,in,0,0
194998,older,0,0
194999,children,0,0
195000,",",0,0
195001,particularly,0,0
195002,in,0,0
195003,developing,0,0
195004,nations,0,0
195005,where,0,0
195006,resources,0,0
195007,are,0,0
195008,scarce,0,0
195009,.,0,0
195010,FUNDING,0,0
195011,National,0,0
195012,Institute,0,0
195013,for,0,0
195014,Health,0,0
195015,Research,0,0
195016,",",0,0
195017,Health,0,0
195018,Technology,0,0
195019,Assessment,0,0
195020,programme,0,1
195021,.,0,0
195022,The,0,0
195023,neuropeptide,1,0
195024,oxytocin,1,1
195025,modulates,0,0
195026,consumer,0,0
195027,brand,0,1
195028,relationships,0,0
195029,.,0,0
195030,Each,0,0
195031,year,0,0
195032,",",0,0
195033,companies,0,0
195034,invest,0,0
195035,billions,0,0
195036,of,0,0
195037,dollars,0,0
195038,into,0,0
195039,marketing,0,0
195040,activities,0,0
195041,to,0,0
195042,embellish,0,0
195043,brands,0,1
195044,as,0,0
195045,valuable,0,0
195046,relationship,0,0
195047,partners,0,0
195048,assuming,0,0
195049,that,0,0
195050,consumer,0,0
195051,brand,0,1
195052,relationships,0,0
195053,(,0,0
195054,CBRs,0,0
195055,),0,1
195056,and,0,0
195057,interpersonal,0,0
195058,relationships,0,0
195059,rest,0,0
195060,upon,0,0
195061,the,0,0
195062,same,0,0
195063,neurobiological,0,0
195064,underpinnings,0,0
195065,.,0,0
195066,Given,0,0
195067,the,0,0
195068,crucial,0,0
195069,role,0,0
195070,of,0,0
195071,the,0,0
195072,neuropeptide,1,0
195073,oxytocin,1,1
195074,(,1,0
195075,OXT,1,0
195076,),1,0
195077,in,0,0
195078,social,0,0
195079,bonding,0,0
195080,",",0,0
195081,this,0,0
195082,study,0,0
195083,tests,0,0
195084,whether,0,0
195085,OXT-based,0,0
195086,mechanisms,0,0
195087,also,0,0
195088,determine,0,0
195089,the,0,0
195090,bond,0,0
195091,between,0,0
195092,consumers,0,0
195093,and,0,0
195094,brands,0,1
195095,.,0,0
195096,We,0,0
195097,conducted,0,0
195098,a,0,0
195099,randomized,0,0
195100,",",0,0
195101,placebo-controlled,0,1
195102,study,0,0
195103,involving,0,0
195104,101,0,0
195105,subjects,0,0
195106,and,0,0
195107,analyzed,0,0
195108,the,0,0
195109,effect,0,0
195110,of,0,0
195111,intranasal,1,1
195112,OXT,1,0
195113,on,0,0
195114,consumers,0,0
195115,',0,0
195116,attribution,0,0
195117,of,0,0
195118,relationship,0,0
195119,qualities,0,0
195120,to,0,0
195121,brands,0,1
195122,",",0,0
195123,brands,0,1
195124,paired,0,0
195125,with,0,0
195126,human,0,0
195127,celebrity,0,0
195128,endorsers,0,0
195129,",",0,0
195130,and,0,0
195131,familiar,0,0
195132,persons,0,0
195133,.,0,0
195134,OXT,1,0
195135,indeed,0,0
195136,promoted,0,0
195137,the,0,0
195138,attribution,0,0
195139,of,0,0
195140,relationship,0,0
195141,qualities,0,0
195142,not,0,0
195143,only,0,0
195144,in,0,0
195145,the,0,0
195146,case,0,0
195147,of,0,0
195148,social,0,0
195149,and,0,0
195150,semi-social,0,0
195151,stimuli,0,1
195152,",",0,0
195153,but,0,0
195154,also,0,0
195155,brands,0,1
195156,.,0,0
195157,Intriguingly,0,0
195158,",",0,0
195159,for,0,0
195160,subjects,0,0
195161,scoring,0,0
195162,high,0,0
195163,on,0,0
195164,autistic-like,0,0
195165,traits,0,0
195166,",",0,0
195167,the,0,0
195168,effect,0,0
195169,of,0,0
195170,OXT,1,0
195171,was,0,0
195172,completely,0,0
195173,reversed,0,0
195174,",",0,0
195175,evident,0,0
195176,in,0,0
195177,even,0,0
195178,lower,0,0
195179,relationship,0,0
195180,qualities,0,0
195181,across,0,0
195182,all,0,0
195183,stimulus,0,0
195184,categories,0,0
195185,.,0,0
195186,The,0,0
195187,importance,0,0
195188,of,0,0
195189,OXT,1,0
195190,in,0,0
195191,a,0,0
195192,CBR,0,0
195193,context,0,0
195194,is,0,0
195195,further,0,0
195196,corroborated,0,0
195197,by,0,0
195198,a,0,0
195199,three-fold,0,0
195200,increase,0,0
195201,in,0,0
195202,endogenous,0,0
195203,release,0,0
195204,of,0,0
195205,OXT,1,0
195206,following,0,0
195207,exposure,0,0
195208,to,0,0
195209,one,0,0
195210,'s,0,0
195211,favorite,0,1
195212,brand,0,1
195213,and,0,0
195214,positive,0,0
195215,associations,0,0
195216,between,0,0
195217,baseline,0,0
195218,peripheral,0,0
195219,OXT,1,0
195220,concentrations,0,0
195221,and,0,0
195222,brand,0,1
195223,relationship,0,0
195224,qualities,0,0
195225,.,0,0
195226,Collectively,0,0
195227,",",0,0
195228,our,0,0
195229,findings,0,0
195230,indicate,0,0
195231,that,0,0
195232,OXT,1,0
195233,not,0,0
195234,only,0,0
195235,plays,0,0
195236,a,0,0
195237,fundamental,0,0
195238,role,0,0
195239,in,0,0
195240,developing,0,0
195241,interpersonal,0,0
195242,relationships,0,0
195243,",",0,0
195244,but,0,0
195245,also,0,0
195246,enables,0,0
195247,relationship,0,0
195248,formation,0,0
195249,with,0,0
195250,objects,0,1
195251,such,0,0
195252,as,0,0
195253,brands,0,1
195254,.,0,0
195255,Preoperative,0,1
195256,Local,0,0
195257,Administration,0,0
195258,of,0,0
195259,Morphine,1,1
195260,as,0,0
195261,an,0,0
195262,Add-on,0,0
195263,Therapy,0,1
195264,in,0,0
195265,Patients,0,0
195266,Undergoing,0,0
195267,Surgical,0,0
195268,Removal,0,0
195269,of,0,0
195270,an,0,0
195271,Odontogenic,0,0
195272,Maxillary,0,0
195273,Cyst,0,1
195274,.,0,0
195275,A,0,0
195276,Randomized,0,0
195277,",",0,0
195278,Double-Blind,0,0
195279,Pilot,0,0
195280,Study,0,0
195281,.,0,0
195282,AIMS,0,0
195283,To,0,0
195284,evaluate,0,0
195285,whether,0,0
195286,a,0,0
195287,combination,0,0
195288,of,0,0
195289,locally,0,0
195290,administered,0,1
195291,morphine,1,1
195292,(,0,0
195293,1,0,0
195294,mg,0,1
195295,),0,0
195296,and,0,0
195297,lidocaine,1,1
195298,as,0,0
195299,part,0,0
195300,of,0,0
195301,a,0,0
195302,multimodal,0,1
195303,analgesic,0,0
195304,approach,0,1
195305,is,0,0
195306,safe,0,0
195307,",",0,0
195308,and,0,0
195309,whether,0,0
195310,it,0,0
195311,improves,0,0
195312,pain,0,0
195313,control,0,0
195314,during,0,0
195315,the,0,0
195316,first,0,0
195317,24,0,0
195318,hours,0,0
195319,after,0,0
195320,odontogenic,0,0
195321,maxillary,0,0
195322,cyst,0,1
195323,removal,0,0
195324,under,0,0
195325,general,0,0
195326,anesthesia,0,1
195327,compared,0,0
195328,to,0,0
195329,local,0,0
195330,lidocaine,0,1
195331,alone,0,1
195332,.,0,0
195333,METHODS,0,0
195334,In,0,0
195335,a,0,0
195336,double-blind,0,0
195337,",",0,0
195338,sham-controlled,0,1
195339,",",0,0
195340,single-center,0,0
195341,trial,0,0
195342,",",0,0
195343,patients,0,0
195344,scheduled,0,0
195345,for,0,0
195346,surgical,0,0
195347,removal,0,0
195348,of,0,0
195349,an,0,0
195350,odontogenic,0,0
195351,maxillary,0,0
195352,cyst,0,0
195353,under,0,0
195354,general,0,0
195355,anesthesia,0,1
195356,were,0,0
195357,randomly,0,0
195358,assigned,0,0
195359,to,0,0
195360,receive,0,0
195361,a,0,0
195362,local,0,0
195363,injection,0,0
195364,of,0,0
195365,lidocaine,1,1
195366,solution,1,1
195367,with,1,0
195368,either,1,0
195369,1,1,0
195370,mg,1,0
195371,of,1,0
195372,morphine,1,1
195373,(,1,0
195374,MLA,1,0
195375,group,0,1
195376,),0,0
195377,or,1,0
195378,with,1,0
195379,no,1,0
195380,morphine,1,1
195381,(,1,0
195382,LA,1,1
195383,group,0,0
195384,),0,0
195385,.,0,0
195386,Pain,0,0
195387,management,0,0
195388,included,0,0
195389,intravenous,0,1
195390,acetaminophen,1,1
195391,(,0,0
195392,1,0,0
195393,g,0,1
195394,every,0,0
195395,6,0,0
195396,hours,0,0
195397,),0,0
195398,in,0,0
195399,all,0,0
195400,patients,0,0
195401,.,0,0
195402,Upon,0,0
195403,request,0,0
195404,",",0,0
195405,the,0,0
195406,patients,0,0
195407,could,0,0
195408,additionally,0,0
195409,receive,0,0
195410,ketoprofen,1,1
195411,(,0,0
195412,first-line,0,1
195413,additional,0,1
195414,analgesia,0,1
195415,),0,0
195416,or,1,1
195417,tramadol,1,1
195418,(,0,0
195419,second-line,0,1
195420,additional,0,1
195421,analgesia,0,0
195422,),0,0
195423,.,0,0
195424,Pain,0,0
195425,intensity,0,0
195426,was,0,0
195427,assessed,0,0
195428,using,0,0
195429,a,0,0
195430,numeric,0,0
195431,rating,0,0
195432,scale,0,0
195433,.,0,0
195434,Primary,0,0
195435,outcome,0,0
195436,measures,0,0
195437,were,0,0
195438,(,0,0
195439,1,0,0
195440,),0,0
195441,no,0,0
195442,need,0,0
195443,for,0,0
195444,any,0,0
195445,additional,0,0
195446,analgesic,0,0
195447,therapy,0,1
195448,and,0,0
195449,(,0,0
195450,2,0,0
195451,),0,0
195452,time,0,0
195453,to,0,0
195454,the,0,0
195455,first,0,0
195456,rescue,0,0
195457,analgesic,0,0
195458,therapy,0,1
195459,during,0,0
195460,the,0,0
195461,first,0,0
195462,24,0,0
195463,hours,0,0
195464,after,0,0
195465,the,0,0
195466,surgery,0,0
195467,.,0,0
195468,RESULTS,0,0
195469,Of,0,0
195470,48,0,0
195471,eligible,0,0
195472,patients,0,0
195473,",",0,0
195474,24,0,0
195475,were,0,0
195476,allocated,0,0
195477,to,0,0
195478,the,0,0
195479,MLA,0,0
195480,group,0,0
195481,and,0,0
195482,24,0,0
195483,to,0,0
195484,the,0,0
195485,LA,0,0
195486,group,0,0
195487,.,0,0
195488,The,0,0
195489,necessity,0,0
195490,of,0,0
195491,additional,0,0
195492,ketoprofen,1,1
195493,therapy,0,1
195494,did,0,0
195495,not,0,0
195496,differ,0,0
195497,significantly,0,0
195498,between,0,0
195499,the,0,0
195500,groups,0,0
195501,(,0,0
195502,25.0,0,0
195503,%,0,0
195504,vs,0,0
195505,50.0,0,0
195506,%,0,0
195507,",",0,0
195508,P=.074,0,0
195509,),0,0
195510,.,0,0
195511,According,0,0
195512,to,0,0
195513,the,0,0
195514,Kaplan-Meier,0,0
195515,analysis,0,0
195516,",",0,0
195517,the,0,0
195518,probability,0,0
195519,of,0,0
195520,remaining,0,0
195521,without,0,0
195522,additional,0,0
195523,analgesic,0,0
195524,intervention,0,1
195525,was,0,0
195526,significantly,0,0
195527,higher,0,0
195528,in,0,0
195529,the,0,0
195530,MLA,0,0
195531,group,0,0
195532,(,0,0
195533,log-rank,0,0
195534,test,0,0
195535,",",0,0
195536,P=.040,0,0
195537,),0,0
195538,",",0,0
195539,but,0,0
195540,there,0,0
195541,were,0,0
195542,no,0,0
195543,significant,0,0
195544,(,0,0
195545,P,0,0
195546,>,0,0
195547,.05,0,0
195548,),0,0
195549,differences,0,0
195550,in,0,0
195551,overall,0,0
195552,and,0,0
195553,maximum,0,0
195554,pain,0,0
195555,severity,0,0
195556,between,0,0
195557,the,0,0
195558,two,0,0
195559,groups,0,0
195560,.,0,0
195561,No,0,0
195562,adverse,0,0
195563,effects,0,0
195564,of,0,0
195565,morphine,0,1
195566,were,0,0
195567,recorded,0,0
195568,.,0,0
195569,CONCLUSION,0,0
195570,Within,0,0
195571,the,0,0
195572,limitations,0,0
195573,of,0,0
195574,this,0,0
195575,study,0,0
195576,",",0,0
195577,local,0,0
195578,administration,0,0
195579,of,0,0
195580,1,0,0
195581,mg,0,0
195582,of,0,0
195583,morphine,1,1
195584,prior,0,0
195585,to,0,0
195586,the,0,0
195587,surgical,0,0
195588,removal,0,0
195589,of,0,0
195590,an,0,0
195591,odontogenic,0,0
195592,maxillary,0,0
195593,cyst,0,0
195594,was,0,0
195595,safe,0,0
195596,",",0,0
195597,but,0,0
195598,it,0,0
195599,did,0,0
195600,not,0,0
195601,prove,0,0
195602,to,0,0
195603,be,0,0
195604,very,0,0
195605,effective,0,0
195606,as,0,0
195607,an,0,0
195608,add-on,0,1
195609,therapy,0,1
195610,for,0,0
195611,postoperative,0,0
195612,pain,0,0
195613,control,0,0
195614,.,0,0
195615,Socio-demographic,0,0
195616,",",0,0
195617,anthropometric,0,0
195618,",",0,0
195619,and,0,0
195620,psychosocial,0,0
195621,predictors,0,0
195622,of,0,0
195623,attrition,0,0
195624,across,0,0
195625,behavioral,0,0
195626,weight-loss,0,0
195627,trials,0,0
195628,.,0,0
195629,Preventing,0,0
195630,attrition,0,0
195631,is,0,0
195632,a,0,0
195633,major,0,0
195634,concern,0,0
195635,in,0,0
195636,behavioral,0,1
195637,weight,0,0
195638,loss,0,0
195639,intervention,0,1
195640,studies,0,0
195641,.,0,0
195642,The,0,0
195643,purpose,0,0
195644,of,0,0
195645,this,0,0
195646,analysis,0,0
195647,was,0,0
195648,to,0,0
195649,identify,0,0
195650,baseline,0,0
195651,and,0,0
195652,six-month,0,0
195653,predictors,0,0
195654,associated,0,0
195655,with,0,0
195656,participant,0,0
195657,attrition,0,0
195658,across,0,0
195659,three,0,0
195660,independent,0,0
195661,clinical,0,0
195662,trials,0,0
195663,of,0,0
195664,behavioral,0,0
195665,weight,0,0
195666,loss,0,0
195667,interventions,0,1
195668,(,1,0
195669,PREFER,1,0
195670,",",1,0
195671,SELF,1,0
195672,",",0,0
195673,and,0,0
195674,SMART,1,1
195675,),1,0
195676,that,0,0
195677,were,0,0
195678,conducted,0,0
195679,over,0,0
195680,10,0,0
195681,years,0,0
195682,.,0,0
195683,Baseline,1,0
195684,measures,1,0
195685,included,1,0
195686,body,1,0
195687,mass,1,0
195688,index,1,0
195689,",",1,0
195690,Barriers,1,0
195691,to,1,0
195692,Healthy,1,0
195693,Eating,1,0
195694,",",1,0
195695,Beck,1,1
195696,Depression,1,0
195697,Inventory-II,1,1
195698,(,1,0
195699,BDI,1,0
195700,),1,0
195701,",",1,0
195702,Hunger,1,1
195703,Satiety,1,0
195704,Scale,1,1
195705,(,1,0
195706,HSS,1,1
195707,),1,0
195708,",",1,0
195709,Binge,1,0
195710,Eating,1,1
195711,Scale,1,1
195712,(,1,0
195713,BES,1,1
195714,),1,0
195715,",",1,0
195716,Medical,1,1
195717,Outcome,1,0
195718,Study,1,0
195719,Short,1,1
195720,Form,1,1
195721,(,1,0
195722,MOS,1,1
195723,SF-36,1,1
195724,v2,1,0
195725,),1,0
195726,and,1,0
195727,Weight,1,0
195728,Efficacy,1,0
195729,Lifestyle,1,1
195730,Questionnaire,1,1
195731,(,1,0
195732,WEL,1,0
195733,),1,0
195734,.,1,0
195735,We,0,0
195736,also,0,0
195737,examined,0,0
195738,early,1,0
195739,weight,1,0
195740,loss,1,0
195741,and,1,0
195742,attendance,1,0
195743,at,1,0
195744,group,1,0
195745,sessions,1,1
195746,during,1,0
195747,the,1,0
195748,first,1,0
195749,6,1,0
195750,months,1,0
195751,.,1,0
195752,Attrition,0,0
195753,was,0,0
195754,recorded,0,0
195755,at,0,0
195756,the,0,0
195757,end,0,0
195758,of,0,0
195759,the,0,0
195760,trials,0,0
195761,.,0,0
195762,Participants,0,0
195763,included,0,0
195764,504,0,0
195765,overweight,0,0
195766,and,0,0
195767,obese,0,0
195768,adults,0,0
195769,seeking,0,0
195770,weight,0,0
195771,loss,0,0
195772,treatment,0,0
195773,.,0,0
195774,The,0,0
195775,sample,0,0
195776,was,0,0
195777,84.92,0,0
195778,%,0,0
195779,female,0,0
195780,and,0,0
195781,73.61,0,0
195782,%,0,0
195783,white,0,0
195784,",",0,0
195785,with,0,0
195786,a,0,0
195787,mean,0,0
195788,(,0,0
195789,?,0,0
195790,SD,0,0
195791,),0,0
195792,age,0,0
195793,of,0,0
195794,47.35,0,0
195795,?,0,0
195796,9.75,0,0
195797,years,0,0
195798,.,0,0
195799,After,0,0
195800,controlling,0,0
195801,for,0,0
195802,the,0,0
195803,specific,0,0
195804,trial,0,0
195805,",",0,0
195806,for,0,0
195807,every,0,0
195808,one,0,0
195809,unit,0,0
195810,increase,0,0
195811,in,0,0
195812,BMI,0,0
195813,",",0,0
195814,the,0,0
195815,odds,0,0
195816,of,0,0
195817,attrition,0,0
195818,increased,0,0
195819,by,0,0
195820,11,0,0
195821,%,0,0
195822,.,0,0
195823,For,0,0
195824,every,0,0
195825,year,0,0
195826,increase,0,0
195827,in,0,0
195828,education,1,1
195829,",",1,0
195830,the,0,0
195831,odds,0,0
195832,of,0,0
195833,attrition,0,0
195834,decreased,0,0
195835,by,0,0
195836,10,0,0
195837,%,0,0
195838,.,0,0
195839,Additional,0,0
195840,predictors,0,0
195841,of,0,0
195842,attrition,0,0
195843,included,0,0
195844,previous,0,0
195845,attempts,0,0
195846,to,0,0
195847,lose,0,0
195848,50-79,0,0
195849,lbs,0,0
195850,",",0,0
195851,age,0,0
195852,",",0,0
195853,not,0,0
195854,possessing,0,0
195855,health,0,0
195856,insurance,0,0
195857,",",0,0
195858,and,0,0
195859,BES,0,1
195860,",",0,0
195861,BDI,0,0
195862,",",0,0
195863,and,0,0
195864,HSS,0,0
195865,scores,0,0
195866,.,0,0
195867,At,0,0
195868,6,0,0
195869,months,0,0
195870,",",0,0
195871,the,0,0
195872,odds,0,0
195873,of,0,0
195874,attrition,0,0
195875,increased,0,0
195876,by,0,0
195877,10,0,0
195878,%,0,0
195879,with,0,0
195880,reduced,0,0
195881,group,0,0
195882,session,0,1
195883,attendance,0,0
195884,.,0,0
195885,There,0,0
195886,was,0,0
195887,also,0,0
195888,an,0,0
195889,interaction,0,0
195890,between,0,0
195891,percent,0,0
195892,weight,0,0
195893,change,0,0
195894,and,0,0
195895,trial,0,0
195896,(,0,0
195897,p,0,0
195898,<,0,0
195899,.001,0,0
195900,),0,0
195901,.,0,0
195902,Multivariate,0,0
195903,analysis,0,0
195904,of,0,0
195905,the,0,0
195906,three,0,0
195907,trials,0,0
195908,showed,0,0
195909,education,0,1
195910,",",0,0
195911,age,0,0
195912,",",0,0
195913,BMI,0,0
195914,",",0,0
195915,and,0,0
195916,BES,0,1
195917,scores,0,0
195918,were,0,0
195919,independently,0,0
195920,associated,0,0
195921,with,0,0
195922,attrition,0,0
195923,(,0,0
195924,ps,0,0
195925,?,0,0
195926,.01,0,0
195927,),0,0
195928,.,0,0
195929,These,0,0
195930,findings,0,0
195931,may,0,0
195932,inform,0,0
195933,the,0,0
195934,development,0,0
195935,of,0,0
195936,more,0,0
195937,robust,0,0
195938,strategies,0,0
195939,for,0,0
195940,reducing,0,0
195941,attrition,0,0
195942,.,0,0
195943,Influence,0,0
195944,of,0,0
195945,ibopamine,1,1
195946,on,0,0
195947,heart,0,0
195948,rate,0,0
195949,and,0,0
195950,arrhythmic,0,0
195951,pattern,0,0
195952,in,0,0
195953,patients,0,0
195954,with,0,0
195955,congestive,0,0
195956,heart,0,0
195957,failure,0,0
195958,.,0,0
195959,A,0,0
195960,double-blind,0,0
195961,multicentre,0,0
195962,study,0,0
195963,.,0,0
195964,Ibopamine,1,1
195965,is,0,0
195966,a,0,0
195967,dopaminergic,0,0
195968,and,0,0
195969,adrenergic,0,1
195970,receptor,0,0
195971,agonist,0,1
195972,",",0,0
195973,which,0,0
195974,is,0,0
195975,active,0,0
195976,in,0,0
195977,the,0,0
195978,treatment,0,0
195979,of,0,0
195980,congestive,0,0
195981,heart,0,0
195982,failure,0,0
195983,.,0,0
195984,Since,0,0
195985,the,0,0
195986,long-term,0,0
195987,prognosis,0,0
195988,for,0,0
195989,patients,0,0
195990,with,0,0
195991,congestive,0,0
195992,heart,0,0
195993,failure,0,0
195994,remains,0,0
195995,very,0,0
195996,poor,0,0
195997,and,0,0
195998,the,0,0
195999,incidence,0,0
196000,of,0,0
196001,arrhythmic,0,0
196002,death,0,0
196003,is,0,0
196004,high,0,0
196005,",",0,0
196006,every,0,0
196007,new,0,0
196008,drug,0,0
196009,to,0,0
196010,be,0,0
196011,employed,0,0
196012,against,0,0
196013,this,0,0
196014,disease,0,0
196015,should,0,0
196016,be,0,0
196017,thoroughly,0,0
196018,tested,0,0
196019,in,0,0
196020,order,0,0
196021,to,0,0
196022,rule,0,0
196023,out,0,0
196024,any,0,0
196025,possible,0,0
196026,arrhythmogenic,0,0
196027,action,0,0
196028,.,0,0
196029,This,0,0
196030,multicentre,0,0
196031,study,0,0
196032,was,0,0
196033,designed,0,0
196034,to,0,0
196035,evaluate,0,0
196036,the,0,0
196037,effect,0,0
196038,of,0,0
196039,ibopamine,1,1
196040,versus,0,0
196041,placebo,1,1
196042,in,0,0
196043,double-blind,0,0
196044,conditions,0,0
196045,on,0,0
196046,heart,0,0
196047,rate,0,0
196048,",",0,0
196049,rhythm,0,1
196050,and,0,0
196051,electrical,0,1
196052,safety,0,0
196053,.,0,0
196054,Ibopamine,1,1
196055,was,1,0
196056,employed,1,0
196057,at,1,0
196058,a,1,0
196059,dose,1,0
196060,of,1,0
196061,100,1,0
196062,mg,1,0
196063,t.i.d,1,1
196064,.,1,0
196065,in,1,0
196066,97,1,0
196067,patients,1,0
196068,(,1,0
196069,aged,1,0
196070,31-83,1,0
196071,years,1,0
196072,),1,0
196073,belonging,1,0
196074,to,1,0
196075,NYHA,1,0
196076,class,1,0
196077,II,1,0
196078,and,1,0
196079,III,1,0
196080,with,1,0
196081,congestive,1,0
196082,heart,1,0
196083,failure,1,0
196084,of,1,0
196085,different,1,0
196086,aetiology,1,0
196087,",",1,0
196088,but,1,0
196089,without,1,0
196090,any,1,0
196091,complex,1,0
196092,ventricular,1,0
196093,arrhythmias,1,0
196094,in,1,0
196095,basal,1,0
196096,conditions,1,0
196097,(,1,0
196098,couplets,1,0
196099,with,1,0
196100,R'-R,1,0
196101,less,1,0
196102,than,1,0
196103,or,1,0
196104,equal,1,0
196105,to,1,0
196106,400,1,0
196107,msec,1,0
196108,",",1,0
196109,ventricular,1,0
196110,tachycardia,1,0
196111,",",1,0
196112,R,1,0
196113,on,1,0
196114,T,1,0
196115,phenomena,1,0
196116,),1,0
196117,.,0,0
196118,Using,0,0
196119,a,0,0
196120,random,0,0
196121,cross-over,0,0
196122,design,0,0
196123,the,0,0
196124,patients,0,0
196125,were,0,0
196126,submitted,0,0
196127,to,0,0
196128,48,0,0
196129,hr,0,0
196130,.,0,0
196131,Holter,1,0
196132,recordings,1,0
196133,in,1,0
196134,basal,1,0
196135,conditions,1,0
196136,and,1,0
196137,following,1,0
196138,7,1,0
196139,days,1,0
196140,of,1,0
196141,ibopamine,1,1
196142,and,1,0
196143,placebo,1,1
196144,treatment,1,0
196145,.,1,0
196146,No,0,0
196147,influence,0,0
196148,on,0,0
196149,heart,0,0
196150,rhythm,0,1
196151,was,0,0
196152,noted,0,0
196153,.,0,0
196154,No,0,0
196155,significant,0,0
196156,variations,0,0
196157,in,0,0
196158,maximum,0,0
196159,heart,0,0
196160,rate,0,0
196161,(,0,0
196162,ibopamine,0,1
196163,117.7,0,0
196164,+/-,0,0
196165,20.9,0,0
196166,;,0,0
196167,placebo,0,1
196168,118.1,0,0
196169,+/-,0,0
196170,20.7,0,0
196171,),0,0
196172,",",0,0
196173,medium,0,1
196174,heart,0,0
196175,rate,0,0
196176,(,0,0
196177,ibopamine,0,1
196178,71.8,0,0
196179,+/-,0,0
196180,10.2,0,0
196181,;,0,0
196182,placebo,0,1
196183,72.6,0,0
196184,+/-,0,0
196185,10.1,0,0
196186,),0,0
196187,or,0,0
196188,minimum,0,0
196189,heart,0,0
196190,rate,0,0
196191,(,0,0
196192,ibopamine,0,1
196193,55.3,0,0
196194,+/-,0,0
196195,11.7,0,0
196196,;,0,0
196197,placebo,0,1
196198,54.6,0,0
196199,+/-,0,0
196200,10.6,0,0
196201,),0,0
196202,were,0,0
196203,observed,0,0
196204,.,0,0
196205,The,0,0
196206,mean,0,0
196207,number/hr,0,0
196208,.,0,0
196209,of,0,0
196210,ectopic,0,0
196211,supraventricular,0,0
196212,beats,0,0
196213,was,0,0
196214,26.1,0,0
196215,+/-,0,0
196216,61.9,0,0
196217,after,0,0
196218,ibopamine,0,0
196219,and,0,0
196220,21.7,0,0
196221,+/-,0,0
196222,35.8,0,0
196223,after,0,0
196224,placebo,0,1
196225,(,0,0
196226,p,0,0
196227,=,0,0
196228,ns,0,0
196229,),0,0
196230,.,0,0
196231,The,0,0
196232,complexity,0,0
196233,of,0,0
196234,ectopic,0,0
196235,supraventricular,0,0
196236,beats,0,0
196237,did,0,0
196238,not,0,0
196239,change,0,0
196240,.,0,0
196241,The,0,0
196242,mean,0,0
196243,number/hr,0,0
196244,.,0,0
196245,of,0,0
196246,ectopic,0,0
196247,ventricular,0,0
196248,beats,0,0
196249,was,0,0
196250,31.1,0,0
196251,+/-,0,0
196252,52.5,0,0
196253,after,0,0
196254,ibopamine,0,0
196255,and,0,0
196256,30.4,0,0
196257,+/-,0,0
196258,57.8,0,0
196259,after,0,0
196260,placebo,0,1
196261,(,0,0
196262,p,0,0
196263,=,0,0
196264,ns,0,0
196265,),0,0
196266,.,0,0
196267,Neither,0,0
196268,the,0,0
196269,distribution,0,0
196270,of,0,0
196271,the,0,0
196272,patients,0,0
196273,among,0,0
196274,Lown,0,0
196275,classification,0,0
196276,nor,0,0
196277,the,0,0
196278,Final,0,0
196279,Score,0,0
196280,of,0,0
196281,the,0,0
196282,Italian,0,0
196283,Lown,0,0
196284,Classification,0,0
196285,(,0,0
196286,26.1,0,0
196287,+/-,0,0
196288,18.0,0,0
196289,and,0,0
196290,26.6,0,0
196291,+/-,0,0
196292,17.9,0,0
196293,in,0,0
196294,the,0,0
196295,1st,0,0
196296,and,0,0
196297,2nd,0,0
196298,day,0,0
196299,of,0,0
196300,monitoring,0,0
196301,after,0,0
196302,ibopamine,0,1
196303,and,0,0
196304,25.7,0,0
196305,+/-,0,0
196306,18.6,0,0
196307,and,0,0
196308,25.7,0,0
196309,+/-,0,0
196310,18.8,0,0
196311,after,0,0
196312,placebo,0,1
196313,;,0,0
196314,p,0,0
196315,=,0,0
196316,ns,0,0
196317,),0,0
196318,showed,0,0
196319,any,0,0
196320,difference,0,0
196321,between,0,0
196322,active,0,0
196323,treatment,0,0
196324,and,0,0
196325,placebo,0,1
196326,.,0,0
196327,Similar,0,0
196328,results,0,0
196329,were,0,0
196330,achieved,0,0
196331,when,0,0
196332,the,0,0
196333,patients,0,0
196334,were,0,0
196335,sub-divided,0,0
196336,into,0,0
196337,subgroups,0,0
196338,according,0,0
196339,to,0,0
196340,sequences,0,0
196341,of,0,0
196342,treatment,0,0
196343,(,0,0
196344,basal,0,0
196345,--,0,0
196346,--,0,0
196347,ibopamine,0,0
196348,--,0,0
196349,--,0,0
196350,placebo,0,1
196351,and,0,0
196352,basal,0,0
196353,--,0,0
196354,--,0,0
196355,placebo,0,1
196356,--,0,0
196357,--,0,0
196358,ibopamine,0,1
196359,),0,0
196360,",",0,0
196361,NYHA,0,0
196362,class,0,0
196363,II,0,0
196364,or,0,1
196365,III,0,0
196366,",",0,0
196367,aetiology,0,0
196368,of,0,0
196369,congestive,0,0
196370,heart,0,0
196371,failure,0,0
196372,(,0,0
196373,dilatative,0,0
196374,cardiomyopathy,0,0
196375,",",0,0
196376,ischemic,0,0
196377,cardiomyopathy,0,0
196378,and,0,0
196379,other,0,0
196380,aetiologies,0,0
196381,),0,0
196382,",",0,0
196383,associated,0,0
196384,treatment,0,0
196385,with,0,0
196386,digitalis,0,1
196387,or,0,1
196388,diuretics,0,1
196389,and,0,0
196390,the,0,0
196391,number,0,0
196392,and,0,0
196393,complexity,0,0
196394,of,0,0
196395,base,0,0
196396,ectopic,0,1
196397,ventricular,0,0
196398,beats,0,0
196399,.,0,0
196400,None,0,0
196401,of,0,0
196402,the,0,0
196403,patients,0,0
196404,experienced,0,0
196405,sustained,0,0
196406,ventricular,0,0
196407,tachycardia,0,0
196408,.,0,0
196409,(,0,0
196410,ABSTRACT,0,0
196411,TRUNCATED,0,1
196412,AT,0,1
196413,400,0,0
196414,WORDS,0,0
196415,),0,0
196416,Ultrasound,1,1
196417,is,0,0
196418,at,0,0
196419,least,0,0
196420,as,0,0
196421,good,0,0
196422,as,0,0
196423,magnetic,1,1
196424,resonance,1,1
196425,imaging,1,0
196426,in,0,0
196427,predicting,0,0
196428,tumour,0,0
196429,size,0,0
196430,post-neoadjuvant,0,0
196431,chemotherapy,0,1
196432,in,0,0
196433,breast,0,0
196434,cancer,0,0
196435,.,0,0
196436,BACKGROUND,0,0
196437,The,0,0
196438,aim,0,0
196439,of,0,0
196440,this,0,0
196441,study,0,0
196442,was,0,0
196443,to,0,0
196444,evaluate,0,0
196445,the,0,0
196446,accuracy,0,0
196447,of,0,0
196448,clinical,0,0
196449,imaging,0,0
196450,of,0,0
196451,the,0,0
196452,primary,1,0
196453,breast,1,0
196454,tumour,1,0
196455,post-neoadjuvant,1,0
196456,chemotherapy,1,1
196457,(,1,0
196458,NAC,1,1
196459,),1,0
196460,related,0,0
196461,to,0,0
196462,the,0,0
196463,post-neoadjuvant,0,0
196464,histological,0,0
196465,tumour,0,0
196466,size,0,0
196467,(,0,0
196468,gold,0,1
196469,standard,0,1
196470,),0,0
196471,and,0,0
196472,whether,0,0
196473,this,0,0
196474,varies,0,0
196475,with,0,0
196476,breast,0,0
196477,cancer,0,0
196478,subtype,0,0
196479,.,0,0
196480,In,0,0
196481,this,0,0
196482,study,0,0
196483,",",0,0
196484,results,0,0
196485,of,0,0
196486,both,0,0
196487,magnetic,1,1
196488,resonance,1,1
196489,imaging,1,1
196490,(,1,0
196491,MRI,1,1
196492,),1,1
196493,and,1,0
196494,ultrasound,1,1
196495,(,1,1
196496,US,1,1
196497,),1,0
196498,were,0,0
196499,reported,0,0
196500,.,0,0
196501,METHODS,0,0
196502,Patients,0,0
196503,with,0,0
196504,invasive,0,0
196505,breast,0,0
196506,cancer,0,0
196507,were,0,0
196508,enrolled,0,0
196509,in,0,0
196510,the,0,0
196511,INTENS,0,0
196512,study,0,0
196513,between,0,0
196514,2006,0,0
196515,and,0,0
196516,2009,0,0
196517,.,0,0
196518,We,0,0
196519,included,0,0
196520,182,0,0
196521,patients,0,0
196522,",",0,0
196523,of,0,0
196524,whom,0,0
196525,data,0,0
196526,were,0,0
196527,available,0,0
196528,for,0,0
196529,post-NAC,0,0
196530,MRI,1,1
196531,(,0,0
196532,n=155,0,0
196533,),0,0
196534,",",0,0
196535,US,1,1
196536,(,0,0
196537,n=123,0,0
196538,),0,0
196539,",",0,0
196540,and,0,0
196541,histopathological,0,0
196542,tumour,0,0
196543,size,0,0
196544,.,0,0
196545,RESULTS,0,0
196546,MRI,0,0
196547,estimated,0,0
196548,residual,0,0
196549,tumour,0,0
196550,size,0,0
196551,with,0,0
196552,<,0,0
196553,10-mm,0,0
196554,discordance,0,0
196555,in,0,0
196556,54,0,0
196557,%,0,0
196558,of,0,0
196559,patients,0,0
196560,",",0,0
196561,overestimated,0,0
196562,size,0,0
196563,in,0,0
196564,28,0,0
196565,%,0,0
196566,and,0,0
196567,underestimated,0,0
196568,size,0,0
196569,in,0,0
196570,18,0,0
196571,%,0,0
196572,of,0,0
196573,patients,0,0
196574,.,0,0
196575,With,0,0
196576,US,0,1
196577,",",0,0
196578,this,0,0
196579,was,0,0
196580,63,0,0
196581,%,0,0
196582,",",0,0
196583,20,0,0
196584,%,0,0
196585,and,0,0
196586,17,0,0
196587,%,0,0
196588,",",0,0
196589,respectively,0,0
196590,.,0,0
196591,The,0,0
196592,negative,0,0
196593,predictive,0,0
196594,value,0,0
196595,in,0,0
196596,hormone,0,0
196597,receptor-positive,0,0
196598,tumours,0,0
196599,for,0,0
196600,both,0,0
196601,MRI,0,0
196602,and,0,0
196603,US,0,1
196604,was,0,0
196605,low,0,0
196606,",",0,0
196607,26,0,0
196608,%,0,0
196609,and,0,0
196610,33,0,0
196611,%,0,0
196612,",",0,0
196613,respectively,0,0
196614,.,0,0
196615,The,0,0
196616,median,0,0
196617,deviation,0,0
196618,in,0,0
196619,clinical,0,0
196620,tumour,0,0
196621,size,0,0
196622,as,0,0
196623,percentage,0,0
196624,of,0,0
196625,pathological,0,0
196626,tumour,0,0
196627,was,0,0
196628,63,0,0
196629,%,0,0
196630,(,0,0
196631,P25=26,0,0
196632,",",0,0
196633,P75=100,0,1
196634,),0,0
196635,and,0,0
196636,49,0,0
196637,%,0,0
196638,(,0,0
196639,P25=22,0,1
196640,",",0,0
196641,P75=100,0,0
196642,),0,0
196643,for,0,0
196644,MRI,0,1
196645,and,0,0
196646,US,0,1
196647,",",0,0
196648,respectively,0,0
196649,(,0,0
196650,P=0.06,0,0
196651,),0,0
196652,.,0,0
196653,CONCLUSIONS,0,0
196654,In,0,0
196655,this,0,0
196656,study,0,0
196657,",",0,0
196658,US,0,1
196659,was,0,0
196660,at,0,0
196661,least,0,0
196662,as,0,0
196663,good,0,0
196664,as,0,0
196665,breast,0,0
196666,MRI,0,0
196667,in,0,0
196668,providing,0,0
196669,information,0,0
196670,on,0,0
196671,residual,0,0
196672,tumour,0,0
196673,size,0,0
196674,post-neoadjuvant,0,0
196675,chemotherapy,0,1
196676,.,0,0
196677,However,0,0
196678,",",0,0
196679,both,0,0
196680,modalities,0,0
196681,suffered,0,0
196682,from,0,0
196683,a,0,0
196684,substantial,0,0
196685,percentage,0,0
196686,of,0,0
196687,over-,0,0
196688,and,0,0
196689,underestimation,0,0
196690,of,0,0
196691,tumour,0,0
196692,size,0,0
196693,and,0,0
196694,in,0,0
196695,addition,0,0
196696,both,0,0
196697,showed,0,0
196698,a,0,0
196699,low,0,0
196700,negative,0,0
196701,predictive,0,0
196702,value,0,0
196703,of,0,0
196704,pathologic,0,0
196705,complete,0,0
196706,remission,0,0
196707,(,0,0
196708,Gov,0,0
196709,nr,0,1
196710,:,0,0
196711,NCT00314977,0,0
196712,),0,0
196713,.,0,0
196714,Amiprilose,1,1
196715,hydrochloride,1,1
196716,for,0,0
196717,rheumatoid,0,0
196718,arthritis,0,0
196719,.,0,0
196720,STUDY,0,0
196721,OBJECTIVE,0,0
196722,To,0,0
196723,assess,0,0
196724,the,0,0
196725,safety,0,0
196726,and,0,0
196727,efficacy,0,0
196728,of,0,0
196729,amiprilose,1,1
196730,hydrochloride,1,1
196731,(,1,0
196732,HCl,1,1
196733,),1,0
196734,",",0,0
196735,a,0,0
196736,novel,0,0
196737,synthetic,0,0
196738,carbohydrate,0,1
196739,with,0,0
196740,anti-inflammatory,0,1
196741,and,0,0
196742,immunomodulatory,0,0
196743,properties,0,0
196744,",",0,0
196745,in,0,0
196746,patients,0,0
196747,with,0,0
196748,rheumatoid,0,0
196749,arthritis,0,0
196750,.,0,0
196751,DESIGN,0,0
196752,Prospective,0,0
196753,",",0,0
196754,multicenter,0,0
196755,",",0,0
196756,randomized,0,0
196757,",",0,0
196758,parallel,0,0
196759,group,0,0
196760,",",0,0
196761,double-blind,0,0
196762,placebo-controlled,1,1
196763,12-week,0,0
196764,trial,0,0
196765,.,0,0
196766,PATIENTS,0,0
196767,Two,0,0
196768,hundred,0,0
196769,and,0,0
196770,one,0,0
196771,functional,0,0
196772,class,0,0
196773,I,0,0
196774,and,0,0
196775,II,0,0
196776,patients,0,0
196777,with,0,0
196778,definite,0,0
196779,or,0,1
196780,classic,0,0
196781,rheumatoid,0,0
196782,arthritis,0,0
196783,",",0,0
196784,previously,0,0
196785,untreated,0,0
196786,with,0,0
196787,disease,0,0
196788,modifying,0,0
196789,antirheumatic,0,0
196790,drugs,0,1
196791,.,0,0
196792,INTERVENTIONS,0,0
196793,Patients,0,0
196794,were,0,0
196795,withdrawn,0,0
196796,from,0,0
196797,nonsteroidal,0,1
196798,anti-inflammatory,0,1
196799,drug,0,0
196800,therapy,0,1
196801,.,0,0
196802,Those,0,0
196803,who,0,0
196804,flared,0,0
196805,were,0,0
196806,randomly,0,0
196807,assigned,0,0
196808,to,0,0
196809,amiprilose,1,1
196810,HCl,1,0
196811,",",1,0
196812,6,1,0
196813,g/d,1,1
196814,",",1,0
196815,or,1,0
196816,placebo,1,1
196817,for,0,0
196818,12,0,0
196819,weeks,0,0
196820,.,0,0
196821,No,0,0
196822,concomitant,0,0
196823,anti-inflammatory,0,1
196824,or,0,1
196825,antirheumatic,0,1
196826,drug,0,0
196827,therapy,0,1
196828,was,0,0
196829,permitted,0,0
196830,during,0,0
196831,the,0,0
196832,study,0,0
196833,.,0,0
196834,Combination,0,0
196835,acetaminophen,0,1
196836,and,0,0
196837,propoxyphene,0,1
196838,napsylate,0,1
196839,was,0,0
196840,the,0,0
196841,only,0,0
196842,supplemental,0,0
196843,analgesic,0,0
196844,medication,0,0
196845,allowed,0,0
196846,.,0,0
196847,MEASUREMENTS,0,0
196848,AND,0,0
196849,MAIN,0,0
196850,RESULTS,0,0
196851,The,0,0
196852,number,0,0
196853,of,0,0
196854,painful,0,0
196855,joints,0,0
196856,and,0,0
196857,swollen,0,0
196858,joints,0,0
196859,",",0,0
196860,joint,0,0
196861,pain,0,0
196862,and,0,0
196863,joint,0,0
196864,swelling,0,0
196865,indices,0,0
196866,",",0,0
196867,left,0,0
196868,and,0,0
196869,right,0,0
196870,grip,0,0
196871,strength,0,0
196872,",",0,0
196873,investigator,0,0
196874,global,0,0
196875,assessment,0,0
196876,",",0,0
196877,and,0,0
196878,patient,0,0
196879,global,0,0
196880,assessment,0,0
196881,returned,0,0
196882,to,0,0
196883,baseline,0,0
196884,for,0,0
196885,the,0,0
196886,amiprilose,1,1
196887,group,0,0
196888,and,0,0
196889,showed,0,0
196890,statistically,0,0
196891,significant,0,0
196892,(,0,0
196893,P,0,0
196894,less,0,0
196895,than,0,0
196896,0.05,0,0
196897,),0,0
196898,differences,0,0
196899,from,0,0
196900,the,0,0
196901,placebo,1,1
196902,group,0,0
196903,within,0,0
196904,4,0,0
196905,to,0,0
196906,6,0,0
196907,weeks,0,0
196908,.,0,0
196909,The,0,0
196910,protocol,0,0
196911,criteria,0,0
196912,for,0,0
196913,overall,0,0
196914,therapeutic,0,0
196915,response,0,0
196916,were,0,0
196917,satisfied,0,0
196918,by,0,0
196919,41,0,0
196920,%,0,0
196921,of,0,0
196922,the,0,0
196923,amiprilose,1,1
196924,patients,0,0
196925,",",0,0
196926,compared,0,0
196927,with,0,0
196928,21,0,0
196929,%,0,0
196930,of,0,0
196931,the,0,0
196932,placebo,1,1
196933,group,0,0
196934,(,0,0
196935,P,0,0
196936,=,0,0
196937,0.003,0,0
196938,),0,0
196939,.,0,0
196940,Approximately,0,0
196941,0.5,0,0
196942,tablet,0,0
196943,per,0,0
196944,day,0,0
196945,less,0,0
196946,analgesic,0,0
196947,medication,0,0
196948,was,0,0
196949,taken,0,0
196950,by,0,0
196951,the,0,0
196952,amiprilose,0,1
196953,group,0,0
196954,(,0,0
196955,P,0,0
196956,less,0,0
196957,than,0,0
196958,0.05,0,0
196959,at,0,0
196960,weeks,0,0
196961,6,0,0
196962,and,0,0
196963,12,0,0
196964,),0,0
196965,.,0,0
196966,There,0,0
196967,were,0,0
196968,no,0,0
196969,statistically,0,0
196970,significant,0,0
196971,differences,0,0
196972,in,0,0
196973,morning,0,0
196974,stiffness,0,0
196975,",",0,0
196976,walking,0,0
196977,time,0,0
196978,",",0,0
196979,erythrocyte,0,0
196980,sedimentation,0,0
196981,rate,0,0
196982,",",0,0
196983,C-reactive,0,0
196984,protein,0,0
196985,",",0,0
196986,or,0,0
196987,rheumatoid,0,0
196988,factor,0,0
196989,between,0,0
196990,the,0,0
196991,groups,0,0
196992,.,0,0
196993,A,0,0
196994,similar,0,0
196995,number,0,0
196996,of,0,0
196997,adverse,0,0
196998,experiences,0,0
196999,were,0,0
197000,reported,0,0
197001,by,0,0
197002,the,0,0
197003,patients,0,0
197004,on,0,0
197005,amiprilose,1,1
197006,(,0,0
197007,67,0,0
197008,%,0,0
197009,),0,0
197010,and,0,0
197011,on,0,0
197012,placebo,1,1
197013,(,0,0
197014,63,0,0
197015,%,0,0
197016,),0,0
197017,.,0,0
197018,One,0,0
197019,patient,0,0
197020,on,0,0
197021,amiprilose,1,1
197022,developed,0,0
197023,thrombocytopenia,0,0
197024,of,0,0
197025,unknown,0,0
197026,cause,0,0
197027,;,0,0
197028,no,0,0
197029,other,0,0
197030,reported,0,0
197031,adverse,0,0
197032,effects,0,0
197033,were,0,0
197034,serious,0,0
197035,.,0,0
197036,CONCLUSIONS,0,0
197037,Amiprilose,1,1
197038,HCl,1,1
197039,has,0,0
197040,significant,0,0
197041,anti-inflammatory,0,1
197042,activity,0,0
197043,and,0,0
197044,a,0,0
197045,favorable,0,0
197046,safety,0,0
197047,profile,0,0
197048,when,0,0
197049,used,0,0
197050,as,0,0
197051,the,0,0
197052,sole,0,0
197053,antirheumatic,0,1
197054,therapy,0,1
197055,in,0,0
197056,patients,0,0
197057,with,0,0
197058,active,0,0
197059,rheumatoid,0,0
197060,arthritis,0,0
197061,.,0,0
197062,Synthetic,0,0
197063,carbohydrates,0,1
197064,may,0,0
197065,represent,0,0
197066,an,0,0
197067,important,0,0
197068,new,0,0
197069,class,0,0
197070,of,0,0
197071,drugs,0,0
197072,for,0,0
197073,the,0,0
197074,treatment,0,0
197075,of,0,0
197076,inflammatory,0,0
197077,",",0,0
197078,autoimmune,0,0
197079,diseases,0,0
197080,.,0,0
197081,[,1,0
197082,EMLA,1,0
197083,cream,1,1
197084,(,1,0
197085,lidocaine/prilocaine,1,1
197086,),1,1
197087,versus,1,1
197088,infiltration,1,0
197089,analgesia,1,0
197090,with,1,0
197091,carbocaine,1,1
197092,(,1,0
197093,mepivacaine,1,1
197094,),1,0
197095,in,0,0
197096,vasectomy,0,1
197097,],0,0
197098,.,0,0
197099,The,0,0
197100,analgesic,0,0
197101,efficacy,0,0
197102,of,0,0
197103,EMLA,1,0
197104,cream,1,1
197105,was,0,0
197106,compared,0,0
197107,with,0,0
197108,infiltration,1,0
197109,with,1,0
197110,1,1,0
197111,%,1,0
197112,carbocaine,1,1
197113,in,0,0
197114,13,0,0
197115,bilateral,0,0
197116,vasectomies,0,0
197117,.,0,0
197118,Twelve,0,0
197119,patients,0,0
197120,preferred,0,0
197121,infiltration,0,0
197122,analgesia,0,0
197123,.,0,0
197124,EMLA,1,0
197125,analgesia,1,0
197126,was,0,0
197127,only,0,0
197128,effective,0,0
197129,in,0,0
197130,the,0,0
197131,skin,0,0
197132,",",0,0
197133,and,0,0
197134,had,0,0
197135,to,0,0
197136,be,0,0
197137,supplemented,0,1
197138,as,0,0
197139,the,0,0
197140,incision,0,1
197141,reached,0,0
197142,subcutaneous,0,0
197143,tissue,0,0
197144,.,0,0
197145,Dacarbazine,1,1
197146,versus,1,0
197147,dacarbazine-vindesine,1,1
197148,in,0,0
197149,disseminated,0,0
197150,malignant,0,0
197151,melanoma,0,0
197152,:,0,0
197153,a,0,0
197154,randomized,0,0
197155,phase,0,0
197156,II,0,0
197157,study,0,0
197158,.,0,0
197159,In,0,0
197160,a,0,0
197161,phase,0,0
197162,II,0,0
197163,study,0,0
197164,119,0,0
197165,patients,0,0
197166,with,0,0
197167,disseminated,0,0
197168,malignant,0,0
197169,melanoma,0,0
197170,were,0,0
197171,randomized,0,0
197172,to,0,0
197173,receive,0,0
197174,treatment,0,0
197175,with,0,0
197176,dacarbazine,1,1
197177,alone,0,1
197178,or,0,1
197179,in,0,0
197180,combination,0,1
197181,with,0,0
197182,vindesine,0,1
197183,.,0,0
197184,The,0,0
197185,study,0,0
197186,was,0,0
197187,designed,0,0
197188,to,0,0
197189,reveal,0,0
197190,an,0,0
197191,additive,0,1
197192,response,0,0
197193,rate,0,0
197194,when,0,0
197195,the,0,0
197196,drugs,0,0
197197,were,0,0
197198,combined,0,0
197199,.,0,0
197200,Dacarbazine,1,1
197201,was,1,0
197202,given,1,0
197203,i.v,1,0
197204,.,1,0
197205,at,1,0
197206,250,1,0
197207,mg,1,0
197208,m-2,1,0
197209,per,1,0
197210,day,1,0
197211,X,1,1
197212,V,1,1
197213,every,1,0
197214,4,1,0
197215,weeks,1,0
197216,.,1,0
197217,In,0,0
197218,the,0,0
197219,combination,0,0
197220,regimen,0,0
197221,vindesine,1,1
197222,given,0,0
197223,at,0,0
197224,3,0,0
197225,mg,0,0
197226,m-2,0,0
197227,per,0,0
197228,week,0,0
197229,was,0,0
197230,included,0,0
197231,.,0,0
197232,One,0,0
197233,hundred,0,0
197234,and,0,0
197235,ten,0,0
197236,patients,0,0
197237,were,0,0
197238,available,0,0
197239,for,0,0
197240,evaluation,0,0
197241,of,0,0
197242,response,0,0
197243,.,0,0
197244,With,0,0
197245,dacarbazine,1,1
197246,4/51,0,0
197247,patients,0,0
197248,obtained,0,0
197249,a,0,0
197250,complete,0,0
197251,remission,0,0
197252,(,0,0
197253,8,0,0
197254,%,0,0
197255,),0,0
197256,and,0,0
197257,5/51,0,0
197258,patients,0,0
197259,a,0,0
197260,partial,0,0
197261,remission,0,0
197262,(,0,0
197263,10,0,0
197264,%,0,0
197265,),0,0
197266,.,0,0
197267,Overall,0,0
197268,response,0,0
197269,rate,0,0
197270,was,0,0
197271,18,0,0
197272,%,0,0
197273,.,0,0
197274,With,0,0
197275,dacarbazine-vindesine,1,1
197276,8/59,0,0
197277,patients,0,0
197278,obtained,0,0
197279,a,0,0
197280,complete,0,0
197281,remission,0,0
197282,(,0,0
197283,13,0,0
197284,%,0,0
197285,),0,0
197286,and,0,0
197287,7/59,0,0
197288,patients,0,0
197289,a,0,0
197290,partial,0,0
197291,remission,0,0
197292,(,0,0
197293,12,0,0
197294,%,0,0
197295,),0,0
197296,.,0,0
197297,Overall,0,0
197298,response,0,0
197299,rate,0,0
197300,was,0,0
197301,25,0,0
197302,%,0,0
197303,.,0,0
197304,The,0,0
197305,difference,0,0
197306,in,0,0
197307,response,0,0
197308,rates,0,0
197309,observed,0,0
197310,between,0,0
197311,the,0,0
197312,treatment,0,0
197313,arms,0,0
197314,is,0,0
197315,not,0,0
197316,statistically,0,0
197317,significant,0,0
197318,.,0,0
197319,Median,0,0
197320,response,0,0
197321,duration,0,0
197322,was,0,0
197323,123,0,0
197324,days,0,0
197325,for,0,0
197326,dacarbazine,0,1
197327,patients,0,0
197328,and,0,0
197329,171,0,0
197330,days,0,0
197331,for,0,0
197332,patients,0,0
197333,receiving,0,0
197334,dacarbazine-vindesine,0,1
197335,(,0,0
197336,difference,0,0
197337,not,0,0
197338,statistically,0,0
197339,significant,0,0
197340,),0,0
197341,.,0,0
197342,[,0,0
197343,Dose-reduced,0,0
197344,antihypertensive,1,0
197345,agents,1,0
197346,--,1,0
197347,use,1,0
197348,in,0,0
197349,complex,0,0
197350,nonmedicamentous,1,0
197351,therapy,0,1
197352,of,0,0
197353,hypertension,0,0
197354,],0,0
197355,.,0,0
197356,In,0,0
197357,order,0,0
197358,to,0,0
197359,estimate,0,0
197360,the,0,0
197361,influence,0,0
197362,of,0,0
197363,a,0,0
197364,non-medicamentous,1,1
197365,therapy,1,1
197366,(,1,0
197367,CNT,1,1
197368,),1,0
197369,on,0,0
197370,the,0,0
197371,consumption,0,0
197372,of,0,0
197373,medicaments,0,1
197374,and,0,0
197375,coronary,0,0
197376,risk,0,0
197377,in,0,0
197378,high,0,0
197379,blood,0,0
197380,pressure,0,0
197381,73,0,0
197382,hypertensives,0,0
197383,of,0,0
197384,a,0,0
197385,medicamentously,0,0
197386,stabilized,0,0
197387,CNT-group,0,0
197388,were,0,0
197389,examined,0,0
197390,in,0,0
197391,comparison,0,0
197392,to,0,0
197393,a,0,0
197394,group,0,0
197395,of,0,0
197396,the,0,0
197397,same,0,0
197398,size,0,0
197399,of,0,0
197400,patients,0,0
197401,with,0,0
197402,hypertension,0,0
197403,who,0,0
197404,were,0,0
197405,managed,0,0
197406,exclusively,0,0
197407,medicamentously,0,0
197408,for,0,0
197409,behaviour,0,0
197410,of,0,0
197411,blood,0,0
197412,pressure,0,0
197413,",",0,0
197414,need,0,0
197415,of,0,0
197416,antihypertensive,1,1
197417,drugs,1,1
197418,and,0,0
197419,changes,0,0
197420,of,0,0
197421,hypertension-associated,0,0
197422,risk,0,0
197423,factors,0,0
197424,.,0,0
197425,After,0,0
197426,an,0,0
197427,exactly,0,0
197428,controlled,0,0
197429,6-month,0,0
197430,treatment,0,0
197431,hypertensives,0,0
197432,with,0,0
197433,additionally,0,0
197434,recommended,0,0
197435,far-reaching,0,0
197436,CNT,0,1
197437,showed,0,0
197438,an,0,0
197439,economization,0,0
197440,of,0,0
197441,medicaments,0,1
197442,by,0,0
197443,scarcely,0,0
197444,the,0,0
197445,half,0,0
197446,in,0,0
197447,comparison,0,0
197448,to,0,0
197449,the,0,0
197450,reference,0,0
197451,group,0,0
197452,.,0,0
197453,By,0,0
197454,means,0,0
197455,of,0,0
197456,suitable,0,0
197457,control,0,0
197458,methods,0,0
197459,a,0,0
197460,causal,0,0
197461,non-medicamentously,1,0
197462,conditioned,0,1
197463,decrease,0,0
197464,of,0,0
197465,blood,0,0
197466,pressure,0,0
197467,could,0,0
197468,be,0,0
197469,excluded,0,0
197470,.,0,0
197471,A,0,0
197472,different,0,0
197473,need,0,0
197474,of,0,0
197475,antihypertensive,1,0
197476,drugs,1,0
197477,was,0,0
197478,simulated,0,0
197479,by,0,0
197480,the,0,0
197481,exacter,0,0
197482,intake,0,0
197483,of,0,0
197484,medicaments,0,1
197485,in,0,0
197486,the,0,0
197487,index-patients,0,0
197488,.,0,0
197489,Notwithstanding,0,0
197490,the,0,0
197491,metabolic,0,0
197492,effects,0,0
197493,of,0,0
197494,the,0,0
197495,additional,0,0
197496,therapy,0,1
197497,have,0,0
197498,induced,0,0
197499,a,0,0
197500,positive,0,0
197501,change,0,0
197502,of,0,0
197503,atherogenic,0,0
197504,lipids,0,0
197505,.,0,0
197506,The,0,0
197507,examinations,0,0
197508,indicate,0,0
197509,in,0,0
197510,general,0,0
197511,the,0,0
197512,difficulty,0,0
197513,of,0,0
197514,the,0,0
197515,judgement,0,0
197516,of,0,0
197517,efficacy,0,0
197518,of,0,0
197519,non-medicamentous,1,0
197520,therapeutic,1,0
197521,measures,0,0
197522,in,0,0
197523,connection,0,0
197524,with,0,0
197525,a,0,0
197526,rational,0,0
197527,dose-reduced,0,0
197528,long-term,0,0
197529,therapy,0,1
197530,with,0,0
197531,antihypertensive,0,0
197532,drugs,0,0
197533,.,0,0
197534,[,0,0
197535,Diabetic,0,0
197536,constipation,0,0
197537,treated,0,0
197538,with,0,0
197539,acupoint,1,1
197540,embedding,1,1
197541,therapy,1,1
197542,and,1,0
197543,forlax,1,1
197544,:,1,0
197545,a,0,0
197546,randomized,0,0
197547,controlled,0,0
197548,trial,0,0
197549,],0,0
197550,.,0,0
197551,OBJECTIVE,0,0
197552,To,0,0
197553,compare,0,0
197554,the,0,0
197555,difference,0,0
197556,among,0,0
197557,the,0,0
197558,combined,0,0
197559,method,0,0
197560,of,0,0
197561,oral,1,1
197562,administration,1,0
197563,of,1,0
197564,forlaxand,1,1
197565,acupoint,1,1
197566,embedding,1,1
197567,therapy,1,1
197568,",",0,0
197569,the,0,0
197570,simple,1,1
197571,acupoint,1,1
197572,embedding,1,1
197573,therapy,1,1
197574,and,0,0
197575,the,0,0
197576,simple,1,1
197577,oral,1,1
197578,administration,1,0
197579,of,1,0
197580,for-lax,1,1
197581,in,0,0
197582,the,0,0
197583,clinical,0,0
197584,efficacy,0,0
197585,on,0,0
197586,diabetic,0,0
197587,constipation,0,0
197588,.,0,0
197589,METHODS,0,0
197590,One,0,0
197591,hundred,0,0
197592,and,0,0
197593,fifty,0,0
197594,patients,0,0
197595,were,0,0
197596,randomized,0,0
197597,intoa,0,0
197598,comprehensive,0,0
197599,group,0,0
197600,",",0,0
197601,an,0,0
197602,acupoint,1,1
197603,embedding,1,1
197604,group,1,0
197605,and,1,0
197606,a,1,0
197607,forlax,1,1
197608,group,1,0
197609,",",0,0
197610,50,0,0
197611,cases,0,0
197612,in,0,0
197613,each,0,0
197614,one,0,0
197615,.,0,0
197616,In,0,0
197617,the,0,0
197618,acupointembedding,1,1
197619,group,1,0
197620,",",0,0
197621,the,0,0
197622,embedding,1,0
197623,therapy,1,1
197624,was,0,0
197625,applied,0,0
197626,to,0,0
197627,bilateral,1,1
197628,Tianshu,1,1
197629,(,1,0
197630,ST,1,0
197631,25,1,0
197632,),1,0
197633,",",1,0
197634,Daheng,1,1
197635,(,1,0
197636,SP,1,1
197637,15,1,0
197638,),1,0
197639,",",1,0
197640,Shangjuxu,1,1
197641,(,1,0
197642,ST,1,0
197643,37,1,0
197644,),1,0
197645,and,1,0
197646,Dachangshu,1,1
197647,(,0,0
197648,BL,0,1
197649,25,0,0
197650,),0,0
197651,",",0,0
197652,once,0,0
197653,a,0,0
197654,week,0,0
197655,.,0,0
197656,In,0,0
197657,the,0,0
197658,forlax,1,1
197659,group,1,0
197660,",",1,0
197661,forlax,1,1
197662,(,1,0
197663,polyethylene,1,1
197664,glycol,1,1
197665,),1,0
197666,was,0,0
197667,prescribedfor,0,0
197668,oral,0,1
197669,administration,0,0
197670,",",0,0
197671,once,0,0
197672,a,0,0
197673,day,0,0
197674,",",0,0
197675,10,0,0
197676,g,0,0
197677,each,0,0
197678,time,0,0
197679,.,0,0
197680,In,0,0
197681,the,0,0
197682,comprehensive,1,0
197683,group,1,0
197684,",",0,0
197685,the,0,0
197686,acupoint,1,1
197687,embedding,1,1
197688,therapyand,1,1
197689,forlax,1,1
197690,were,1,0
197691,combined,1,0
197692,and,0,0
197693,the,0,0
197694,methods,0,0
197695,were,0,0
197696,the,0,0
197697,same,0,0
197698,as,0,0
197699,the,0,0
197700,first,0,0
197701,two,0,0
197702,groups,0,0
197703,.,0,0
197704,The,0,0
197705,treatment,0,0
197706,for,0,0
197707,4,0,0
197708,weeks,0,0
197709,wasas,0,0
197710,one,0,0
197711,session,0,1
197712,",",0,0
197713,and,0,0
197714,2,0,0
197715,sessions,0,1
197716,were,0,0
197717,required,0,0
197718,in,0,0
197719,the,0,0
197720,three,0,0
197721,groups,0,0
197722,.,0,0
197723,Separately,0,0
197724,",",0,0
197725,in,0,0
197726,4,0,0
197727,weeks,0,0
197728,",",0,0
197729,8,0,0
197730,weeks,0,0
197731,of,0,0
197732,treatment,0,0
197733,and2,0,0
197734,months,0,0
197735,after,0,0
197736,treatment,0,0
197737,",",0,0
197738,the,0,0
197739,constipation,0,0
197740,symptom,0,0
197741,scores,0,0
197742,were,0,0
197743,compared,0,0
197744,among,0,0
197745,the,0,0
197746,three,0,0
197747,groups,0,0
197748,.,0,0
197749,At,0,0
197750,the,0,0
197751,end,0,0
197752,of2,0,0
197753,sessions,0,1
197754,of,0,0
197755,treatment,0,0
197756,",",0,0
197757,the,0,0
197758,clinical,0,0
197759,efficacy,0,0
197760,and,0,0
197761,adverse,0,0
197762,reactions,0,0
197763,were,0,0
197764,compared,0,0
197765,among,0,0
197766,the,0,0
197767,three,0,0
197768,groups,0,0
197769,.,0,0
197770,In2,0,0
197771,months,0,0
197772,after,0,0
197773,treatment,0,0
197774,",",0,0
197775,the,0,0
197776,recurrence,0,0
197777,rate,0,0
197778,was,0,0
197779,compared,0,0
197780,among,0,0
197781,the,0,0
197782,three,0,0
197783,groups,0,0
197784,.,0,0
197785,RESULTS,0,0
197786,The,0,0
197787,total,0,0
197788,effectiverate,0,0
197789,was,0,0
197790,98,0,0
197791,.,0,0
197792,0,0,0
197793,%,0,0
197794,(,0,0
197795,49/50,0,0
197796,),0,0
197797,in,0,0
197798,the,0,0
197799,comprehensive,0,0
197800,group,0,0
197801,",",0,0
197802,better,0,0
197803,than,0,0
197804,86,0,0
197805,.,0,0
197806,0,0,0
197807,%,0,0
197808,(,0,0
197809,43/50,0,0
197810,),0,0
197811,in,0,0
197812,the,0,0
197813,acupoint,0,1
197814,embeddinggroup,0,1
197815,and,0,0
197816,78,0,0
197817,.,0,0
197818,0,0,0
197819,%,0,0
197820,(,0,0
197821,11/50,0,0
197822,),0,0
197823,in,0,0
197824,the,0,0
197825,forlax,0,1
197826,group,0,0
197827,(,0,0
197828,both,0,0
197829,P,0,0
197830,<,0,0
197831,0,0,0
197832,.,0,0
197833,01,0,0
197834,),0,0
197835,.,0,0
197836,In,0,0
197837,the,0,0
197838,4,0,0
197839,weeks,0,0
197840,and,0,0
197841,8,0,0
197842,weeks,0,0
197843,of,0,0
197844,treatment,0,0
197845,",",0,0
197846,the,0,0
197847,con-stipation,0,0
197848,symptom,0,0
197849,scores,0,0
197850,were,0,0
197851,reduced,0,0
197852,significantly,0,0
197853,as,0,0
197854,compared,0,0
197855,with,0,0
197856,those,0,0
197857,before,0,0
197858,treatment,0,0
197859,in,0,0
197860,the,0,0
197861,three,0,0
197862,groups,0,0
197863,(,0,0
197864,all,0,0
197865,P,0,0
197866,<,0,0
197867,0,0,0
197868,.,0,0
197869,05,0,0
197870,),0,0
197871,.,0,0
197872,The,0,0
197873,results,0,0
197874,in,0,0
197875,the,0,0
197876,comprehensive,0,0
197877,group,0,0
197878,were,0,0
197879,lower,0,0
197880,than,0,0
197881,those,0,0
197882,in,0,0
197883,the,0,0
197884,other,0,0
197885,two,0,0
197886,groups,0,0
197887,(,0,0
197888,all,0,0
197889,P,0,0
197890,<,0,0
197891,0,0,0
197892,.,0,0
197893,05,0,0
197894,),0,0
197895,.,0,0
197896,In,0,0
197897,the,0,0
197898,4,0,0
197899,weeks,0,0
197900,of,0,0
197901,treatment,0,0
197902,",",0,0
197903,the,0,0
197904,scores,0,0
197905,were,0,0
197906,not,0,0
197907,different,0,0
197908,significantly,0,0
197909,between,0,0
197910,the,0,0
197911,acupoint,0,1
197912,embedding,0,1
197913,group,0,0
197914,and,0,0
197915,the,0,0
197916,forlax,0,1
197917,group,0,0
197918,(,0,0
197919,P,0,0
197920,>,0,0
197921,0.05,0,0
197922,),0,0
197923,.,0,0
197924,In,0,0
197925,8,0,0
197926,weeks,0,0
197927,of,0,0
197928,treatment,0,0
197929,and,0,0
197930,2,0,0
197931,months,0,0
197932,after,0,0
197933,treatment,0,0
197934,",",0,0
197935,the,0,0
197936,scores,0,0
197937,in,0,0
197938,the,0,0
197939,acupoint,0,1
197940,embedding,0,1
197941,group,0,0
197942,were,0,0
197943,better,0,0
197944,tan,0,0
197945,those,0,0
197946,in,0,0
197947,the,0,0
197948,forlax,0,1
197949,group,0,0
197950,(,0,0
197951,all,0,0
197952,p,0,0
197953,<,0,0
197954,0.05,0,0
197955,),0,0
197956,.,0,0
197957,There,0,0
197958,were,0,0
197959,2,0,0
197960,cases,0,0
197961,of,0,0
197962,drug,0,0
197963,adverse,0,0
197964,reaction,0,0
197965,in,0,0
197966,the,0,0
197967,comprehensive,0,0
197968,group,0,0
197969,",",0,0
197970,6,0,0
197971,cases,0,0
197972,in,0,0
197973,the,0,0
197974,forlax,0,1
197975,group,0,0
197976,and,0,0
197977,0,0,0
197978,case,0,0
197979,in,0,0
197980,the,0,0
197981,acupoint,0,1
197982,embedding,0,0
197983,group,0,0
197984,.,0,0
197985,The,0,0
197986,recurrence,0,0
197987,rate,0,0
197988,was,0,0
197989,8.1,0,0
197990,%,0,0
197991,(,0,0
197992,4/49,0,0
197993,),0,0
197994,in,0,0
197995,the,0,0
197996,comprehensive,0,0
197997,group,0,0
197998,",",0,0
197999,lower,0,0
198000,than,0,0
198001,32.6,0,0
198002,%,0,0
198003,(,0,0
198004,14/43,0,0
198005,),0,0
198006,in,0,0
198007,the,0,0
198008,acupoint,0,1
198009,embedding,0,1
198010,group,0,0
198011,and,0,0
198012,59.0,0,0
198013,%,0,0
198014,(,0,0
198015,23/39,0,0
198016,),0,0
198017,in,0,0
198018,the,0,0
198019,forlax,0,1
198020,group,0,0
198021,(,0,0
198022,both,0,0
198023,P,0,0
198024,<,0,0
198025,0.01,0,0
198026,),0,0
198027,.,0,0
198028,CONCLUSION,0,0
198029,the,0,0
198030,combined,1,0
198031,therapy,1,1
198032,of,1,0
198033,acupoint,1,1
198034,embedding,1,1
198035,and,1,0
198036,forlax,1,1
198037,achieves,0,0
198038,the,0,0
198039,better,0,0
198040,clinical,0,0
198041,efficacy,0,0
198042,on,0,0
198043,diabetic,0,0
198044,constipation,0,0
198045,and,0,0
198046,constipation,0,0
198047,symptom,0,0
198048,scores,0,0
198049,as,0,0
198050,compared,0,0
198051,with,0,0
198052,the,0,0
198053,simple,1,1
198054,acupoint,1,1
198055,embedding,1,1
198056,therapy,1,1
198057,and,0,0
198058,the,0,0
198059,oral,1,1
198060,administration,1,0
198061,of,1,0
198062,forlax,1,0
198063,the,0,0
198064,short-term,0,0
198065,efficacy,0,0
198066,of,0,0
198067,the,0,0
198068,simple,0,1
198069,acupoint,0,1
198070,embedding,0,1
198071,therapy,0,1
198072,is,0,0
198073,not,0,0
198074,different,0,0
198075,significantly,0,0
198076,from,0,0
198077,the,0,0
198078,simple,0,0
198079,forlax,0,1
198080,medication,0,1
198081,",",0,0
198082,but,0,0
198083,the,0,0
198084,long-term,0,0
198085,efficacy,0,0
198086,and,0,0
198087,safety,0,0
198088,are,0,0
198089,better,0,0
198090,than,0,0
198091,those,0,0
198092,of,0,0
198093,simple,0,0
198094,forlax,0,1
198095,medicaiton,0,0
198096,.,0,0
198097,Randomized,0,0
198098,clinical,0,0
198099,trial,0,0
198100,comparing,0,0
198101,systemic,0,0
198102,interferon,1,1
198103,with,0,0
198104,diathermocoagulation,1,1
198105,in,0,0
198106,primary,0,0
198107,multiple,0,0
198108,and,0,0
198109,widespread,0,0
198110,anogenital,0,0
198111,condyloma,0,0
198112,.,0,0
198113,Two,0,0
198114,hundred,0,0
198115,three,0,0
198116,patients,0,0
198117,(,0,0
198118,median,0,0
198119,age,0,0
198120,26,0,0
198121,years,0,0
198122,;,0,0
198123,range,0,0
198124,18-45,0,0
198125,),0,0
198126,with,0,0
198127,untreated,0,0
198128,multiple,0,0
198129,and,0,0
198130,widespread,0,0
198131,anogenital,0,0
198132,condyloma,0,0
198133,were,0,0
198134,randomly,0,0
198135,assigned,0,0
198136,to,0,0
198137,one,0,0
198138,of,0,0
198139,four,0,0
198140,study,0,0
198141,arms,0,0
198142,in,0,0
198143,order,0,0
198144,to,0,0
198145,compare,0,0
198146,the,0,0
198147,efficacy,0,0
198148,",",0,0
198149,toxicity,0,0
198150,",",0,0
198151,and,0,0
198152,tolerability,0,0
198153,of,0,0
198154,recombinant,1,1
198155,interferon,1,1
198156,alpha-2b,1,1
198157,with,1,0
198158,those,1,0
198159,of,1,0
198160,diathermocoagulation,1,1
198161,.,1,0
198162,Of,0,0
198163,200,0,0
198164,evaluable,0,0
198165,patients,0,0
198166,",",0,0
198167,51,0,0
198168,were,0,0
198169,treated,0,0
198170,intramuscularly,1,1
198171,(,0,0
198172,IM,0,1
198173,),0,0
198174,with,0,0
198175,3,0,0
198176,x,0,0
198177,10,0,0
198178,(,0,0
198179,6,0,0
198180,),0,0
198181,U,0,1
198182,(,0,0
198183,3,0,0
198184,MU,0,1
198185,),0,0
198186,/m2,0,0
198187,daily,0,0
198188,for,0,0
198189,3,0,0
198190,weeks,0,0
198191,(,0,0
198192,total,0,0
198193,dose,0,0
198194,63,0,0
198195,MU/m2,0,1
198196,),0,0
198197,",",0,0
198198,50,0,0
198199,received,0,0
198200,subcutaneous,1,0
198201,thrice-weekly,1,1
198202,injections,1,1
198203,of,1,0
198204,3,1,0
198205,MU/m2,1,1
198206,for,1,0
198207,4,1,0
198208,weeks,1,0
198209,(,0,0
198210,total,0,0
198211,dose,0,0
198212,36,0,0
198213,MU/m2,0,1
198214,),0,0
198215,",",0,0
198216,51,0,0
198217,underwent,0,0
198218,diathermocoagulation,1,1
198219,",",0,0
198220,and,0,0
198221,48,0,0
198222,were,0,0
198223,not,0,0
198224,treated,0,0
198225,and,0,0
198226,were,0,0
198227,used,0,0
198228,as,0,0
198229,a,0,0
198230,control,0,0
198231,group,0,0
198232,.,0,0
198233,Six,0,0
198234,months,0,0
198235,after,0,0
198236,the,0,0
198237,end,0,0
198238,of,0,0
198239,treatment,0,0
198240,",",0,0
198241,the,0,0
198242,overall,0,0
198243,response,0,0
198244,rate,0,0
198245,(,0,0
198246,complete,0,0
198247,and,0,0
198248,partial,0,0
198249,responses,0,0
198250,),0,0
198251,was,0,0
198252,70,0,0
198253,%,0,0
198254,:,0,0
198255,57,0,0
198256,and,0,0
198257,82,0,0
198258,%,0,0
198259,for,0,0
198260,patients,0,0
198261,receiving,0,0
198262,interferon,1,1
198263,alpha-2b,1,1
198264,(,0,0
198265,IM,0,1
198266,and,0,0
198267,subcutaneously,0,1
198268,),0,0
198269,and,0,0
198270,diathermocoagulation,1,1
198271,",",0,0
198272,respectively,0,0
198273,",",0,0
198274,and,0,0
198275,8,0,0
198276,%,0,0
198277,for,0,0
198278,the,0,0
198279,control,0,0
198280,group,0,0
198281,.,0,0
198282,After,0,0
198283,6,0,0
198284,months,0,0
198285,from,0,0
198286,therapy,0,1
198287,",",0,0
198288,no,0,0
198289,significant,0,0
198290,differences,0,0
198291,in,0,0
198292,complete,0,0
198293,response,0,0
198294,were,0,0
198295,found,0,0
198296,among,0,0
198297,the,0,0
198298,different,0,0
198299,types,0,0
198300,of,0,0
198301,treatment,0,0
198302,:,0,0
198303,20,0,0
198304,",",0,0
198305,20,0,0
198306,",",0,0
198307,and,0,0
198308,35,0,0
198309,%,0,0
198310,for,0,0
198311,the,0,0
198312,two,0,0
198313,interferon,0,0
198314,groups,0,0
198315,and,0,0
198316,the,0,0
198317,diathermocoagulation,1,1
198318,group,0,0
198319,",",0,0
198320,respectively,0,0
198321,.,0,0
198322,Fifteen,0,0
198323,and,0,0
198324,two,0,0
198325,complete,0,0
198326,responders,0,0
198327,in,0,0
198328,the,0,0
198329,cauterization,0,1
198330,and,0,0
198331,interferon,0,1
198332,groups,0,0
198333,",",0,0
198334,respectively,0,0
198335,",",0,0
198336,experienced,0,0
198337,disease,0,0
198338,recurrence,0,0
198339,(,0,0
198340,P,0,0
198341,less,0,0
198342,than,0,0
198343,.01,0,0
198344,),0,0
198345,.,0,0
198346,All,0,0
198347,patients,0,0
198348,given,0,0
198349,interferon,1,1
198350,therapy,1,1
198351,complained,0,0
198352,of,0,0
198353,flu-like,0,0
198354,symptoms,0,0
198355,",",0,0
198356,which,0,0
198357,declined,0,0
198358,progressively,0,0
198359,after,0,0
198360,the,0,0
198361,first,0,0
198362,week,0,0
198363,of,0,0
198364,treatment,0,0
198365,.,0,0
198366,Fatigue,0,0
198367,",",0,0
198368,lasting,0,0
198369,as,0,0
198370,long,0,0
198371,as,0,0
198372,patients,0,0
198373,received,0,0
198374,interferon,1,0
198375,",",0,0
198376,was,0,0
198377,the,0,0
198378,most,0,0
198379,prevalent,0,0
198380,chronic,0,0
198381,side,0,0
198382,effect,0,0
198383,.,0,0
198384,We,0,0
198385,conclude,0,0
198386,that,0,0
198387,systemic,0,0
198388,recombinant,0,1
198389,interferon,0,1
198390,alpha-2b,0,1
198391,is,0,0
198392,active,0,0
198393,in,0,0
198394,treating,0,0
198395,patients,0,0
198396,with,0,0
198397,primary,0,0
198398,condyloma,0,0
198399,lesions,0,0
198400,and,0,0
198401,does,0,0
198402,so,0,0
198403,as,0,0
198404,well,0,0
198405,as,0,0
198406,cauterization,0,1
198407,.,0,0
198408,(,0,0
198409,ABSTRACT,0,0
198410,TRUNCATED,0,1
198411,AT,0,1
198412,250,0,1
198413,WORDS,0,0
198414,),0,0
198415,[,0,0
198416,The,0,0
198417,sympatho-adrenergic,0,0
198418,stress,0,0
198419,reaction,0,0
198420,in,0,0
198421,ear,0,0
198422,surgery,0,0
198423,using,0,0
198424,various,0,0
198425,anesthesia,1,1
198426,technics,1,0
198427,],1,0
198428,.,0,0
198429,The,0,0
198430,aim,0,0
198431,of,0,0
198432,the,0,0
198433,present,0,0
198434,study,0,0
198435,was,0,0
198436,to,0,0
198437,investigate,0,0
198438,the,0,0
198439,effects,0,0
198440,of,0,0
198441,various,0,0
198442,anaesthetic,0,1
198443,procedures,0,0
198444,on,0,0
198445,the,0,0
198446,endocrine,0,0
198447,stress,0,0
198448,responses,0,0
198449,during,0,0
198450,ear,0,0
198451,microsurgical,0,1
198452,operations,0,0
198453,.,0,0
198454,Simple,1,0
198455,mastoidectomies,1,1
198456,",",1,0
198457,radical,1,1
198458,mastoidectomies,1,1
198459,and,0,0
198460,tympano,1,0
198461,plastics,1,1
198462,were,0,0
198463,carried,0,0
198464,out,0,0
198465,in,0,0
198466,49,0,0
198467,patients,0,0
198468,under,0,0
198469,the,0,0
198470,following,0,0
198471,randomised,0,0
198472,anaesthetic,0,1
198473,procedures,0,0
198474,:,0,0
198475,Group,0,0
198476,1,0,0
198477,halothane,1,1
198478,anaesthesia,1,1
198479,and,1,0
198480,retroauricular,1,1
198481,infiltration,1,0
198482,anaesthesia,1,1
198483,with,1,0
198484,lidocaine,1,1
198485,and,1,0
198486,ornipressin,1,1
198487,(,0,0
198488,n,0,0
198489,=,0,0
198490,14,0,0
198491,),0,0
198492,",",0,0
198493,Group,0,0
198494,2,0,0
198495,fentanyl,1,1
198496,anaesthesia,1,1
198497,and,1,0
198498,retroauricular,1,1
198499,anaesthesia,1,1
198500,with,1,0
198501,lidocaine,1,1
198502,and,1,0
198503,ornipressin,1,1
198504,(,0,0
198505,n,0,0
198506,=,0,0
198507,10,0,0
198508,),0,0
198509,",",0,0
198510,Group,0,0
198511,3,0,0
198512,fentanyl,1,1
198513,anaesthesia,1,1
198514,and,1,0
198515,retroauricular,1,1
198516,infiltration,1,0
198517,anaesthesia,1,1
198518,with,1,0
198519,lidocaine,1,1
198520,and,1,0
198521,epinephrine,1,1
198522,(,0,0
198523,n,0,0
198524,=,0,0
198525,14,0,0
198526,),0,0
198527,",",0,0
198528,and,0,0
198529,Group,0,0
198530,4,0,0
198531,retroauricular,1,1
198532,infiltration,1,0
198533,anaesthesia,1,1
198534,with,1,0
198535,prilocaine,1,1
198536,and,1,0
198537,epinephrine,1,1
198538,(,0,0
198539,n,0,0
198540,=,0,0
198541,14,0,0
198542,),0,0
198543,.,0,0
198544,The,0,0
198545,plasma,0,0
198546,levels,0,0
198547,of,0,0
198548,epinephrine,0,1
198549,",",0,0
198550,norepinephrine,0,0
198551,",",0,0
198552,glucose,0,0
198553,",",0,0
198554,lactate,0,0
198555,and,0,0
198556,free,0,0
198557,glycerol,0,1
198558,were,0,0
198559,measured,0,0
198560,in,0,0
198561,addition,0,0
198562,to,0,0
198563,mean,0,0
198564,arterial,0,0
198565,pressure,0,0
198566,(,0,0
198567,MAP,0,1
198568,),0,1
198569,and,0,0
198570,heart,0,0
198571,rate,0,0
198572,(,0,0
198573,HR,0,0
198574,),0,0
198575,immediately,0,0
198576,before,0,0
198577,anaesthesia,0,1
198578,",",0,0
198579,10,0,0
198580,minutes,0,0
198581,after,0,0
198582,skin,0,0
198583,incision,0,1
198584,",",0,0
198585,10,0,0
198586,minutes,0,0
198587,after,0,0
198588,having,0,0
198589,started,0,0
198590,bone,0,0
198591,drilling,0,0
198592,",",0,0
198593,at,0,0
198594,the,0,0
198595,end,0,0
198596,of,0,0
198597,the,0,0
198598,operation,0,0
198599,and,0,0
198600,3,0,0
198601,hours,0,0
198602,after,0,0
198603,operation,0,0
198604,.,0,0
198605,All,0,0
198606,data,0,0
198607,were,0,0
198608,subjected,0,0
198609,to,0,0
198610,covariance,0,0
198611,analysis,0,0
198612,including,0,0
198613,the,0,0
198614,age,0,0
198615,factor,0,0
198616,.,0,0
198617,Plasma,0,0
198618,catecholamine,0,0
198619,concentrations,0,0
198620,remained,0,0
198621,within,0,0
198622,the,0,0
198623,normal,0,0
198624,range,0,0
198625,during,0,0
198626,the,0,0
198627,investigation,0,0
198628,in,0,0
198629,patients,0,0
198630,subjected,0,0
198631,to,0,0
198632,general,0,0
198633,anaesthesia,0,1
198634,(,0,0
198635,Groups,0,0
198636,1-3,0,1
198637,),0,0
198638,.,0,0
198639,Plasma,0,0
198640,catecholamines,0,0
198641,(,0,0
198642,epinephrine,0,1
198643,and,0,0
198644,norepinephrine,0,1
198645,),0,0
198646,increased,0,0
198647,significantly,0,0
198648,in,0,0
198649,Group,0,0
198650,4,0,0
198651,(,0,0
198652,retroauricular,0,1
198653,infiltration,0,0
198654,anaesthesia,0,1
198655,),0,0
198656,.,0,0
198657,There,0,0
198658,were,0,0
198659,no,0,0
198660,group,0,0
198661,variabilities,0,0
198662,with,0,0
198663,regard,0,0
198664,to,0,0
198665,MAP,0,1
198666,and,0,0
198667,HR,0,0
198668,.,0,0
198669,The,0,0
198670,plasma,0,0
198671,levels,0,0
198672,of,0,0
198673,epinephrine,0,1
198674,and,0,0
198675,norepinephrine,0,1
198676,demonstrate,0,0
198677,a,0,0
198678,direct,0,0
198679,response,0,0
198680,to,0,0
198681,stress,0,0
198682,followed,0,0
198683,by,0,0
198684,a,0,0
198685,secondary,0,0
198686,change,0,0
198687,in,0,0
198688,glucose,0,0
198689,",",0,0
198690,lactate,0,0
198691,and,0,0
198692,free,0,0
198693,glycerol,0,1
198694,.,0,0
198695,The,0,0
198696,beneficial,0,0
198697,effect,0,0
198698,of,0,0
198699,general,0,0
198700,anaesthesia,0,1
198701,is,0,0
198702,documented,0,0
198703,by,0,0
198704,normal,0,0
198705,plasma,0,0
198706,levels,0,0
198707,of,0,0
198708,epinephrine,0,1
198709,and,0,0
198710,norepinephrine,0,0
198711,throughout,0,0
198712,the,0,0
198713,operation,0,0
198714,.,0,0
198715,(,0,0
198716,ABSTRACT,0,0
198717,TRUNCATED,0,1
198718,AT,0,1
198719,250,0,1
198720,WORDS,0,0
198721,),0,0
198722,Propranolol,1,1
198723,in,0,0
198724,acute,0,0
198725,myocardial,0,0
198726,infarction,0,0
198727,:,0,0
198728,the,0,0
198729,MILIS,0,0
198730,experience,0,0
198731,.,0,0
198732,The,0,0
198733,results,0,0
198734,of,0,0
198735,the,0,0
198736,propranolol,1,1
198737,limb,0,0
198738,of,0,0
198739,the,0,0
198740,Multicenter,0,0
198741,Investigation,0,0
198742,of,0,0
198743,the,0,0
198744,Limitation,0,0
198745,of,0,0
198746,Infarct,0,0
198747,Size,0,0
198748,are,0,0
198749,reviewed,0,0
198750,.,0,0
198751,A,0,0
198752,total,0,0
198753,of,0,0
198754,269,0,0
198755,patients,0,0
198756,",",0,0
198757,who,0,0
198758,presented,0,0
198759,with,0,0
198760,symptoms,0,0
198761,and,0,0
198762,electrocardiographic,0,0
198763,signs,0,0
198764,suggesting,0,0
198765,acute,0,0
198766,myocardial,0,0
198767,infarction,0,0
198768,were,0,0
198769,randomized,0,0
198770,to,0,0
198771,acute,0,0
198772,intravenous,0,1
198773,and,0,0
198774,subsequent,0,0
198775,oral,0,1
198776,therapy,0,1
198777,with,0,0
198778,propranolol,1,1
198779,(,0,0
198780,n,0,0
198781,=,0,0
198782,134,0,0
198783,),0,0
198784,or,1,1
198785,placebo,1,1
198786,(,0,0
198787,n,0,0
198788,=,0,0
198789,135,0,0
198790,),0,0
198791,.,0,0
198792,Eligibility,0,0
198793,for,0,0
198794,acute,0,0
198795,beta-blocker,0,1
198796,therapy,0,1
198797,was,0,0
198798,determined,0,0
198799,on,0,0
198800,the,0,0
198801,basis,0,0
198802,of,0,0
198803,readily,0,0
198804,available,0,0
198805,",",0,0
198806,noninvasive,0,0
198807,tests,0,0
198808,.,0,0
198809,Therapy,0,0
198810,was,0,0
198811,started,0,0
198812,at,0,0
198813,an,0,0
198814,average,0,0
198815,time,0,0
198816,of,0,0
198817,8.5,0,0
198818,hours,0,0
198819,after,0,0
198820,onset,0,0
198821,of,0,0
198822,symptoms,0,0
198823,.,0,0
198824,The,0,0
198825,full,0,0
198826,induction,0,0
198827,dose,0,0
198828,of,0,0
198829,intravenous,0,1
198830,propranolol,1,1
198831,(,0,0
198832,0.1,0,1
198833,mg/kg,0,1
198834,),0,0
198835,was,0,0
198836,tolerated,0,0
198837,by,0,0
198838,90,0,0
198839,%,0,0
198840,of,0,0
198841,treated,0,0
198842,patients,0,0
198843,",",0,0
198844,and,0,0
198845,oral,0,1
198846,maintenance,0,0
198847,therapy,0,1
198848,was,0,0
198849,being,0,0
198850,continued,0,0
198851,in,0,0
198852,82,0,0
198853,%,0,0
198854,of,0,0
198855,treated,0,0
198856,patients,0,0
198857,on,0,0
198858,the,0,0
198859,second,0,0
198860,hospital,0,0
198861,day,0,0
198862,.,0,0
198863,There,0,0
198864,was,0,0
198865,a,0,0
198866,significant,0,0
198867,reduction,0,0
198868,in,0,0
198869,heart,0,0
198870,rate,0,0
198871,throughout,0,0
198872,maintenance,0,0
198873,therapy,0,1
198874,with,0,0
198875,propranolol,0,1
198876,",",0,0
198877,which,0,0
198878,continued,0,0
198879,through,0,0
198880,the,0,0
198881,tenth,0,0
198882,hospital,0,0
198883,day,0,0
198884,.,0,0
198885,There,0,0
198886,was,0,0
198887,no,0,0
198888,significant,0,0
198889,difference,0,0
198890,in,0,0
198891,the,0,0
198892,incidence,0,0
198893,of,0,0
198894,congestive,0,0
198895,heart,0,0
198896,failure,0,0
198897,between,0,0
198898,propranolol-,1,1
198899,and,0,0
198900,placebo-treated,1,0
198901,groups,0,0
198902,.,0,0
198903,There,0,0
198904,was,0,0
198905,also,0,0
198906,no,0,0
198907,significant,0,0
198908,difference,0,0
198909,between,0,0
198910,the,0,0
198911,2,0,0
198912,groups,0,0
198913,in,0,0
198914,infarct,0,0
198915,size,0,0
198916,estimated,0,0
198917,by,0,0
198918,measurement,0,0
198919,of,0,0
198920,serum,0,0
198921,CK-MB,0,0
198922,",",0,0
198923,planimetry,0,0
198924,of,0,0
198925,infarct,0,0
198926,area,0,0
198927,on,0,0
198928,technetium,0,1
198929,pyrophosphate,0,1
198930,myocardial,0,0
198931,scintigrams,0,1
198932,or,0,0
198933,R-wave,0,0
198934,measurements,0,0
198935,in,0,0
198936,patients,0,0
198937,with,0,0
198938,transmural,0,0
198939,anterior,0,0
198940,and,0,0
198941,inferior,0,0
198942,infarcts,0,0
198943,.,0,0
198944,There,0,0
198945,was,0,0
198946,no,0,0
198947,significant,0,0
198948,difference,0,0
198949,in,0,0
198950,mortality,0,0
198951,between,0,0
198952,the,0,0
198953,2,0,0
198954,groups,0,0
198955,during,0,0
198956,an,0,0
198957,average,0,0
198958,of,0,0
198959,36,0,0
198960,months,0,0
198961,',0,0
198962,follow-up,0,0
198963,.,0,0
198964,Although,0,0
198965,propranolol,1,1
198966,can,0,0
198967,be,0,0
198968,administered,0,0
198969,safely,0,0
198970,to,0,0
198971,patients,0,0
198972,with,0,0
198973,acute,0,0
198974,myocardial,0,0
198975,infarction,0,0
198976,who,0,0
198977,are,0,0
198978,selected,0,0
198979,on,0,0
198980,the,0,0
198981,basis,0,0
198982,of,0,0
198983,simple,0,0
198984,clinical,0,0
198985,criteria,0,0
198986,",",0,0
198987,there,0,0
198988,is,0,0
198989,no,0,0
198990,evidence,0,0
198991,of,0,0
198992,reduction,0,0
198993,of,0,0
198994,infarct,0,0
198995,size,0,0
198996,when,0,0
198997,beta,0,1
198998,blockade,0,0
198999,is,0,0
199000,begun,0,0
199001,8.5,0,0
199002,hours,0,0
199003,after,0,0
199004,the,0,0
199005,onset,0,0
199006,of,0,0
199007,symptoms,0,0
199008,.,0,0
199009,Protective,0,0
199010,effect,0,0
199011,of,0,0
199012,high-dose,1,1
199013,medroxyprogesterone,1,1
199014,acetate,1,1
199015,(,1,0
199016,HD-MPA,1,0
199017,),1,0
199018,on,0,0
199019,hematological,0,0
199020,toxicity,0,0
199021,induced,0,0
199022,by,0,0
199023,chemotherapy,1,1
199024,for,0,0
199025,advanced,0,0
199026,solid,0,0
199027,tumors,0,0
199028,:,0,0
199029,a,0,0
199030,multicentric,0,0
199031,controlled,0,0
199032,clinical,0,0
199033,trial,0,0
199034,.,0,0
199035,MPA-Hematology,0,0
199036,Italian,0,0
199037,Cooperative,0,0
199038,Group,0,0
199039,.,0,0
199040,A,0,0
199041,multicenter,0,0
199042,",",0,0
199043,randomized,0,0
199044,",",0,0
199045,controlled,0,0
199046,trial,0,0
199047,was,0,0
199048,conducted,0,0
199049,comparing,0,0
199050,active,0,0
199051,treatment,0,0
199052,with,0,0
199053,placebo,1,1
199054,in,0,0
199055,227,0,0
199056,patients,0,0
199057,with,0,0
199058,breast,0,0
199059,",",0,0
199060,colorectal,0,0
199061,",",0,0
199062,lung,0,0
199063,and,0,0
199064,other,0,0
199065,solid,0,0
199066,forms,0,0
199067,of,0,0
199068,cancer,0,0
199069,.,0,0
199070,Combination,1,0
199071,therapy,1,1
199072,",",1,0
199073,(,1,0
199074,CT,1,0
199075,),1,0
199076,conventionally,0,1
199077,employed,0,0
199078,for,0,0
199079,the,0,0
199080,various,0,0
199081,types,0,0
199082,of,0,0
199083,tumor,0,0
199084,involved,0,0
199085,",",0,0
199086,was,0,0
199087,associated,0,0
199088,with,0,0
199089,MPA,1,1
199090,(,0,0
199091,117,0,0
199092,patients,0,0
199093,),0,0
199094,or,0,1
199095,placebo,1,1
199096,(,0,0
199097,110,0,0
199098,patients,0,0
199099,),0,0
199100,.,0,0
199101,MPA,0,0
199102,was,0,0
199103,given,0,0
199104,orally,0,0
199105,as,0,0
199106,tablets,0,1
199107,",",0,0
199108,as,0,0
199109,a,0,0
199110,dose,0,0
199111,of,0,0
199112,500,0,0
199113,mg,0,0
199114,b.i.d,0,1
199115,.,0,0
199116,for,0,0
199117,6,0,0
199118,months,0,0
199119,.,0,0
199120,The,0,0
199121,results,0,0
199122,were,0,0
199123,",",0,0
199124,briefly,0,0
199125,",",0,0
199126,as,0,0
199127,follows,0,0
199128,:,0,0
199129,The,0,0
199130,incidence,0,0
199131,of,0,0
199132,leukopenia,0,0
199133,was,0,0
199134,significantly,0,0
199135,lower,0,0
199136,in,0,0
199137,the,0,0
199138,groups,0,0
199139,receiving,0,0
199140,MPA,1,1
199141,in,0,0
199142,patients,0,0
199143,with,0,0
199144,breast,0,0
199145,and,0,0
199146,colorectal,0,0
199147,cancer,0,0
199148,(,0,0
199149,P,0,0
199150,less,0,0
199151,than,0,0
199152,0.02,0,0
199153,),0,0
199154,.,0,0
199155,Tumors,0,0
199156,of,0,0
199157,the,0,0
199158,lung,0,0
199159,and,0,0
199160,other,0,0
199161,solid,0,0
199162,forms,0,0
199163,showed,0,0
199164,no,0,0
199165,such,0,0
199166,difference,0,0
199167,.,0,0
199168,The,0,0
199169,incidence,0,0
199170,of,0,0
199171,thrombocytopenia,0,0
199172,was,0,0
199173,the,0,0
199174,same,0,0
199175,in,0,0
199176,all,0,0
199177,disease,0,0
199178,groups,0,0
199179,.,0,0
199180,Objective,0,0
199181,responses,0,0
199182,(,0,0
199183,CR,0,1
199184,+,0,1
199185,PR,0,1
199186,),0,0
199187,were,0,0
199188,observed,0,0
199189,in,0,0
199190,23/46,0,0
199191,(,0,0
199192,50,0,0
199193,%,0,0
199194,),0,0
199195,of,0,0
199196,breast,0,0
199197,cancer,0,0
199198,patients,0,0
199199,treated,0,0
199200,with,0,0
199201,CT,1,0
199202,+,1,1
199203,MPA,1,1
199204,",",0,0
199205,and,0,0
199206,in,0,0
199207,13/47,0,0
199208,(,0,0
199209,28,0,0
199210,%,0,0
199211,),0,0
199212,of,0,0
199213,those,0,0
199214,given,0,0
199215,CT,1,0
199216,+,1,1
199217,placebo,1,1
199218,.,1,0
199219,The,0,0
199220,difference,0,0
199221,was,0,0
199222,significant,0,0
199223,(,0,0
199224,P,0,0
199225,less,0,0
199226,than,0,0
199227,0.02,0,0
199228,),0,0
199229,.,0,0
199230,Subjective,0,0
199231,parameters,0,0
199232,also,0,0
199233,showed,0,0
199234,more,0,0
199235,improvement,0,0
199236,in,0,0
199237,the,0,0
199238,MPA,1,1
199239,group,0,0
199240,than,0,0
199241,in,0,0
199242,the,0,0
199243,patients,0,0
199244,given,0,0
199245,CT,0,0
199246,alone,0,0
199247,.,0,0
199248,No,0,0
199249,significant,0,0
199250,differences,0,0
199251,were,0,0
199252,found,0,0
199253,for,0,0
199254,the,0,0
199255,other,0,0
199256,types,0,0
199257,of,0,0
199258,tumor,0,0
199259,",",0,0
199260,but,0,0
199261,the,0,0
199262,numbers,0,0
199263,in,0,0
199264,this,0,0
199265,population,0,0
199266,were,0,0
199267,very,0,0
199268,limited,0,0
199269,.,0,0
199270,In,0,0
199271,a,0,0
199272,group,0,0
199273,of,0,0
199274,45,0,0
199275,patients,0,0
199276,",",0,0
199277,antithrombin,0,0
199278,III,0,0
199279,a,0,0
199280,(,0,0
199281,%,0,0
199282,),0,0
199283,",",0,0
199284,antithrombin,0,0
199285,III,0,0
199286,R,0,0
199287,:,0,0
199288,Ag,0,0
199289,(,0,0
199290,%,0,0
199291,),0,0
199292,",",0,0
199293,plasminogen,0,1
199294,(,0,0
199295,mg/dl,0,0
199296,),0,0
199297,",",0,0
199298,alpha-2,0,1
199299,macroglobulin,0,1
199300,(,0,0
199301,%,0,0
199302,),0,0
199303,",",0,0
199304,factor,0,0
199305,VIII,0,1
199306,C,0,1
199307,(,0,0
199308,%,0,0
199309,),0,0
199310,",",0,0
199311,factor,0,0
199312,VIII,0,0
199313,R,0,0
199314,:,0,0
199315,Ag,0,0
199316,(,0,0
199317,%,0,0
199318,),0,1
199319,and,0,0
199320,factor,0,0
199321,IX,0,1
199322,C,0,1
199323,(,0,0
199324,%,0,0
199325,),0,0
199326,were,0,0
199327,determined,0,0
199328,.,0,0
199329,The,0,0
199330,most,0,0
199331,interesting,0,0
199332,post-treatment,0,0
199333,findings,0,0
199334,were,0,0
199335,an,0,0
199336,increase,0,0
199337,in,0,0
199338,anti-thrombin,0,1
199339,III,0,0
199340,(,0,0
199341,activity,0,0
199342,and,0,0
199343,antigen,0,0
199344,level,0,0
199345,),0,0
199346,and,0,0
199347,in,0,0
199348,plasminogen,0,0
199349,.,0,0
199350,This,0,0
199351,suggests,0,0
199352,that,0,0
199353,MPA,0,1
199354,does,0,0
199355,not,0,0
199356,increase,0,0
199357,the,0,0
199358,risk,0,0
199359,of,0,0
199360,thrombosis,0,0
199361,",",0,0
199362,and,0,0
199363,might,0,0
199364,even,0,0
199365,",",0,0
199366,to,0,0
199367,some,0,0
199368,extent,0,0
199369,",",0,0
199370,impede,0,0
199371,tumor-induced,0,0
199372,thrombophilia,0,0
199373,.,0,0
199374,(,0,0
199375,ABSTRACT,0,0
199376,TRUNCATED,0,1
199377,AT,0,1
199378,250,0,1
199379,WORDS,0,0
199380,),0,0
199381,Antibiotic,0,1
199382,elimination,0,0
199383,of,0,0
199384,group-B,0,0
199385,streptococci,0,1
199386,in,0,0
199387,urine,0,0
199388,in,0,0
199389,prevention,0,0
199390,of,0,0
199391,preterm,0,0
199392,labour,0,0
199393,.,0,0
199394,The,0,0
199395,presence,0,0
199396,of,0,0
199397,group-B,0,0
199398,streptococci,0,0
199399,in,0,0
199400,the,0,0
199401,urine,0,0
199402,of,0,0
199403,pregnant,0,0
199404,women,0,0
199405,seems,0,0
199406,to,0,0
199407,be,0,0
199408,associated,0,0
199409,with,0,0
199410,preterm,0,0
199411,labour,0,0
199412,.,0,0
199413,Urine,0,1
199414,samples,0,0
199415,from,0,0
199416,4122,0,0
199417,women,0,0
199418,at,0,0
199419,27-31,0,0
199420,weeks,0,0
199421,',0,0
199422,gestation,0,0
199423,were,0,0
199424,examined,0,0
199425,for,0,0
199426,bacteria,0,0
199427,.,0,0
199428,Group-B,0,0
199429,streptococci,0,0
199430,were,0,0
199431,found,0,0
199432,in,0,0
199433,the,0,0
199434,urine,0,0
199435,of,0,0
199436,69,0,0
199437,women,0,0
199438,.,0,0
199439,In,0,0
199440,a,0,0
199441,double-blind,0,0
199442,",",0,0
199443,controlled,0,0
199444,study,0,0
199445,these,0,0
199446,patients,0,0
199447,were,0,0
199448,given,0,0
199449,either,0,0
199450,penicillin,1,1
199451,(,0,0
199452,10,0,0
199453,(,0,0
199454,6,0,0
199455,),0,0
199456,IU,0,1
199457,three,0,0
199458,times,0,0
199459,daily,0,0
199460,for,0,0
199461,6,0,0
199462,days,0,0
199463,;,0,0
199464,37,0,0
199465,patients,0,0
199466,),0,0
199467,or,0,1
199468,placebo,1,1
199469,(,0,0
199470,32,0,0
199471,patients,0,0
199472,),0,0
199473,.,0,0
199474,The,0,0
199475,rates,0,0
199476,of,0,0
199477,primary,0,0
199478,rupture,0,0
199479,of,0,0
199480,the,0,0
199481,membranes,0,0
199482,(,0,0
199483,11,0,0
199484,%,0,0
199485,v,0,0
199486,53,0,0
199487,%,0,0
199488,;,0,0
199489,p,0,0
199490,less,0,0
199491,than,0,0
199492,0.001,0,0
199493,),0,0
199494,and,0,0
199495,preterm,0,1
199496,labour,0,0
199497,(,0,0
199498,5.4,0,0
199499,%,0,0
199500,v,0,0
199501,38,0,0
199502,%,0,0
199503,;,0,0
199504,p,0,0
199505,less,0,0
199506,than,0,0
199507,0.002,0,0
199508,),0,0
199509,were,0,0
199510,significantly,0,0
199511,lower,0,0
199512,in,0,0
199513,the,0,0
199514,penicillin,1,1
199515,group,0,0
199516,than,0,0
199517,in,0,0
199518,the,0,0
199519,placebo,1,1
199520,group,0,0
199521,.,0,0
199522,These,0,0
199523,results,0,0
199524,suggest,0,0
199525,that,0,0
199526,treatment,0,0
199527,and,0,0
199528,follow-up,0,0
199529,to,0,0
199530,prevent,0,0
199531,recolonisation,0,0
199532,in,0,0
199533,pregnant,0,0
199534,women,0,0
199535,with,0,0
199536,group-B,0,0
199537,streptococci,0,0
199538,in,0,0
199539,the,0,0
199540,urine,0,0
199541,may,0,0
199542,reduce,0,0
199543,the,0,0
199544,frequency,0,0
199545,of,0,0
199546,preterm,0,0
199547,labour,0,0
199548,in,0,0
199549,these,0,0
199550,patients,0,0
199551,.,0,0
199552,Motion,0,0
199553,aftereffects,0,0
199554,with,0,0
199555,horizontally,0,0
199556,moving,0,0
199557,sound,0,0
199558,sources,0,0
199559,in,0,0
199560,the,0,0
199561,free,0,0
199562,field,0,0
199563,.,0,0
199564,A,0,0
199565,horizontally,1,0
199566,moving,1,0
199567,sound,1,0
199568,was,0,0
199569,presented,0,0
199570,to,0,0
199571,an,0,0
199572,observer,0,0
199573,seated,0,0
199574,in,0,0
199575,the,0,0
199576,center,0,0
199577,of,0,0
199578,an,0,0
199579,anechoic,0,0
199580,chamber,0,0
199581,.,0,0
199582,The,0,0
199583,sound,0,0
199584,",",0,0
199585,either,0,0
199586,a,0,0
199587,500-Hz,1,1
199588,low-pass,1,0
199589,noise,1,0
199590,or,1,1
199591,a,1,0
199592,6300-Hz,1,1
199593,high-pass,1,1
199594,noise,1,0
199595,",",0,0
199596,repeatedly,0,0
199597,traversed,0,0
199598,a,0,0
199599,semicircular,0,0
199600,arc,0,1
199601,in,0,0
199602,the,0,0
199603,observer,0,0
199604,'s,0,0
199605,front,0,0
199606,hemifield,0,0
199607,at,0,0
199608,ear,0,0
199609,level,0,0
199610,(,0,0
199611,distance,0,0
199612,:,0,0
199613,1.5,0,0
199614,m,0,0
199615,),0,0
199616,.,0,0
199617,At,0,0
199618,10-sec,0,0
199619,intervals,0,0
199620,this,0,0
199621,adaptor,0,0
199622,was,0,0
199623,interrupted,0,0
199624,",",0,0
199625,and,0,0
199626,a,0,0
199627,750-msec,0,0
199628,moving,1,0
199629,probe,1,1
199630,(,0,0
199631,a,0,0
199632,500-Hz,0,1
199633,low-pass,0,1
199634,noise,0,0
199635,),0,0
199636,was,0,0
199637,presented,0,0
199638,from,0,0
199639,a,0,0
199640,horizontal,0,0
199641,arc,0,1
199642,1.6,0,0
199643,m,0,0
199644,in,0,0
199645,front,0,0
199646,of,0,0
199647,the,0,0
199648,observer,0,0
199649,.,0,0
199650,During,0,0
199651,a,0,0
199652,run,0,0
199653,",",0,0
199654,the,0,0
199655,adaptor,0,0
199656,was,0,0
199657,presented,0,0
199658,at,0,0
199659,a,0,0
199660,constant,0,0
199661,velocity,0,0
199662,(,0,0
199663,-200,0,1
199664,degrees,0,0
199665,to,0,0
199666,+200,0,0
199667,degrees/sec,0,1
199668,),0,0
199669,",",0,0
199670,while,0,0
199671,probes,0,0
199672,with,0,0
199673,velocities,0,0
199674,varying,0,0
199675,from,0,0
199676,-10,0,0
199677,degrees,0,0
199678,to,0,0
199679,+10,0,0
199680,degrees/sec,0,1
199681,were,0,0
199682,presented,0,0
199683,in,0,0
199684,a,0,0
199685,random,0,0
199686,order,0,0
199687,.,0,0
199688,Observers,0,0
199689,judged,0,0
199690,the,0,0
199691,direction,0,0
199692,of,0,0
199693,motion,0,0
199694,(,0,0
199695,left,0,0
199696,or,0,1
199697,right,0,0
199698,),0,0
199699,of,0,0
199700,each,0,0
199701,probe,0,0
199702,.,0,0
199703,As,0,0
199704,in,0,0
199705,the,0,0
199706,case,0,0
199707,of,0,0
199708,stimuli,0,1
199709,presented,0,0
199710,over,0,0
199711,headphones,0,1
199712,(,0,0
199713,Grantham,0,1
199714,&,0,0
199715,Wightman,0,0
199716,",",0,0
199717,1979,0,0
199718,),0,0
199719,",",0,0
199720,an,0,0
199721,auditory,0,1
199722,motion,0,0
199723,aftereffect,0,0
199724,(,0,0
199725,MAE,0,1
199726,),0,0
199727,occurred,0,0
199728,:,0,0
199729,subjects,0,0
199730,responded,0,0
199731,left,0,0
199732,to,0,0
199733,probes,0,0
199734,more,0,0
199735,often,0,0
199736,when,0,0
199737,the,0,0
199738,adaptor,0,0
199739,moved,0,0
199740,right,0,0
199741,than,0,0
199742,when,0,0
199743,it,0,0
199744,moved,0,0
199745,left,0,0
199746,.,0,0
199747,When,0,0
199748,the,0,0
199749,adaptor,0,0
199750,and,0,0
199751,probe,0,1
199752,were,0,0
199753,spectrally,0,0
199754,the,0,0
199755,same,0,0
199756,",",0,0
199757,the,0,0
199758,MAE,0,0
199759,was,0,0
199760,greater,0,0
199761,than,0,0
199762,when,0,0
199763,they,0,0
199764,were,0,0
199765,from,0,0
199766,different,0,0
199767,spectral,0,0
199768,regions,0,0
199769,;,0,0
199770,the,0,0
199771,magnitude,0,0
199772,of,0,0
199773,this,0,0
199774,difference,0,0
199775,depended,0,0
199776,on,0,0
199777,adaptor,0,1
199778,speed,0,0
199779,and,0,0
199780,was,0,0
199781,subject-dependent,0,0
199782,.,0,0
199783,It,0,0
199784,is,0,0
199785,proposed,0,0
199786,that,0,0
199787,there,0,0
199788,are,0,0
199789,two,0,0
199790,components,0,0
199791,underlying,0,0
199792,the,0,0
199793,auditory,0,1
199794,MAE,0,0
199795,:,0,0
199796,(,0,0
199797,1,0,0
199798,),0,0
199799,a,0,0
199800,generalized,0,0
199801,bias,0,0
199802,to,0,0
199803,respond,0,0
199804,that,0,0
199805,probes,0,0
199806,move,0,0
199807,in,0,0
199808,the,0,0
199809,direction,0,0
199810,opposite,0,0
199811,to,0,0
199812,that,0,0
199813,of,0,0
199814,the,0,0
199815,adaptor,0,0
199816,",",0,0
199817,independent,0,0
199818,of,0,0
199819,their,0,0
199820,spectra,0,0
199821,;,0,0
199822,and,0,0
199823,(,0,0
199824,2,0,0
199825,),0,0
199826,a,0,0
199827,loss,0,0
199828,of,0,0
199829,sensitivity,0,0
199830,to,0,0
199831,the,0,0
199832,velocity,0,0
199833,of,0,0
199834,moving,0,0
199835,sounds,0,1
199836,after,0,0
199837,prolonged,0,0
199838,exposure,0,0
199839,to,0,0
199840,moving,0,0
199841,sounds,0,1
199842,having,0,0
199843,the,0,0
199844,same,0,0
199845,spectral,0,0
199846,content,0,0
199847,.,0,0
199848,Comparative,0,0
199849,efficacy,0,0
199850,of,0,0
199851,oral,1,0
199852,erythromycin,1,1
199853,versus,1,0
199854,oral,1,1
199855,tetracycline,1,1
199856,in,0,0
199857,the,0,0
199858,treatment,0,0
199859,of,0,0
199860,acne,0,0
199861,vulgaris,0,0
199862,.,0,0
199863,A,0,0
199864,double-blind,0,0
199865,study,0,0
199866,.,0,0
199867,The,0,0
199868,efficacy,0,0
199869,of,0,0
199870,erythromycin,1,1
199871,base,1,0
199872,(,0,0
199873,E-Mycin,0,1
199874,tablets,0,1
199875,",",0,0
199876,333,0,0
199877,mg,0,1
199878,),0,0
199879,and,0,0
199880,the,0,0
199881,efficacy,0,0
199882,of,0,0
199883,tetracycline,1,1
199884,hydrochloride,1,1
199885,(,0,0
199886,Panmycin,0,1
199887,tablets,0,1
199888,),0,0
199889,were,0,0
199890,compared,0,0
199891,in,0,0
199892,this,0,0
199893,double-blind,0,0
199894,",",0,0
199895,randomized,0,0
199896,study,0,0
199897,.,0,0
199898,Two,0,0
199899,hundred,0,0
199900,patients,0,0
199901,with,0,0
199902,moderate,0,0
199903,to,0,0
199904,moderately,0,0
199905,severe,0,0
199906,acne,0,0
199907,vulgaris,0,0
199908,were,0,0
199909,randomly,0,0
199910,assigned,0,0
199911,to,0,0
199912,the,0,0
199913,study,0,0
199914,.,0,0
199915,One,0,0
199916,hundred,0,0
199917,patients,0,0
199918,received,0,0
199919,1,1,0
199920,gm,1,1
199921,of,1,0
199922,erythromycin,1,1
199923,base,1,0
199924,by,0,0
199925,mouth,0,0
199926,per,0,0
199927,day,0,0
199928,for,0,0
199929,4,0,0
199930,weeks,0,0
199931,",",0,0
199932,followed,0,0
199933,by,0,0
199934,333,0,0
199935,mg/day,0,0
199936,for,0,0
199937,8,0,0
199938,weeks,0,0
199939,",",0,0
199940,plus,0,1
199941,placebo,1,1
199942,for,1,0
199943,tetracycline,1,1
199944,.,1,0
199945,The,0,0
199946,second,0,0
199947,group,0,0
199948,of,0,0
199949,patients,0,0
199950,received,0,0
199951,1,0,0
199952,gm,0,1
199953,of,0,0
199954,tetracycline,1,1
199955,by,0,0
199956,mouth,0,0
199957,per,0,0
199958,day,0,0
199959,for,0,0
199960,4,0,0
199961,weeks,0,0
199962,",",0,0
199963,followed,0,0
199964,by,0,0
199965,500,0,0
199966,mg/day,0,0
199967,for,0,0
199968,8,0,0
199969,weeks,0,0
199970,",",0,0
199971,plus,0,1
199972,placebo,1,1
199973,for,1,0
199974,erythromycin,1,1
199975,.,1,0
199976,Both,0,0
199977,drugs,0,0
199978,reduced,0,0
199979,acne,0,0
199980,severity,0,0
199981,to,0,0
199982,the,0,0
199983,same,0,0
199984,extent,0,0
199985,.,0,0
199986,Pustules,0,0
199987,",",0,0
199988,papules,0,0
199989,",",0,0
199990,and,0,0
199991,open,0,1
199992,comedo,0,0
199993,counts,0,0
199994,decreased,0,0
199995,significantly,0,0
199996,over,0,0
199997,the,0,0
199998,12-week,0,0
199999,period,0,0
200000,.,0,0
200001,Seventy-seven,0,0
200002,percent,0,0
200003,of,0,0
200004,the,0,0
200005,erythromycin-treated,0,0
200006,patients,0,0
200007,and,0,0
200008,89,0,0
200009,%,0,0
200010,of,0,0
200011,the,0,0
200012,tetracycline-treated,0,0
200013,patients,0,0
200014,stated,0,0
200015,that,0,0
200016,their,0,0
200017,acne,0,0
200018,was,0,0
200019,markedly,0,0
200020,improved,0,0
200021,or,0,0
200022,improved,0,0
200023,by,0,0
200024,week,0,0
200025,12,0,0
200026,.,0,0
200027,Most,0,0
200028,of,0,0
200029,the,0,0
200030,side,0,0
200031,effects,0,0
200032,in,0,0
200033,patients,0,0
200034,treated,0,0
200035,with,0,0
200036,erythromycin,0,1
200037,were,0,0
200038,gastrointestinal,0,0
200039,symptoms,0,0
200040,.,0,0
200041,Among,0,0
200042,the,0,0
200043,side,0,0
200044,effects,0,0
200045,in,0,0
200046,patients,0,0
200047,treated,0,0
200048,with,0,0
200049,tetracycline,0,1
200050,were,0,0
200051,Candida,0,0
200052,vaginitis,0,0
200053,in,0,0
200054,one,0,0
200055,patient,0,0
200056,and,0,0
200057,pseudotumor,0,0
200058,cerebri,0,0
200059,in,0,0
200060,one,0,0
200061,patient,0,0
200062,.,0,0
200063,Comparison,0,0
200064,of,0,0
200065,ketanserin,1,1
200066,and,0,0
200067,pindolol,1,1
200068,in,0,0
200069,hypertension,0,0
200070,.,0,0
200071,The,0,0
200072,antihypertensive,0,0
200073,effects,0,0
200074,of,0,0
200075,ketanserin,1,1
200076,(,0,0
200077,40,0,0
200078,mg,0,1
200079,twice,0,0
200080,daily,0,1
200081,),0,0
200082,and,0,0
200083,pindolol,1,1
200084,(,0,0
200085,5,0,0
200086,mg,0,1
200087,twice,0,0
200088,daily,0,1
200089,),0,0
200090,as,0,0
200091,monotherapy,0,1
200092,were,0,0
200093,compared,0,0
200094,in,0,0
200095,a,0,0
200096,crossover,0,0
200097,",",0,0
200098,double-blind,0,0
200099,trial,0,0
200100,in,0,0
200101,17,0,0
200102,patients,0,0
200103,with,0,0
200104,essential,0,0
200105,hypertension,0,0
200106,.,0,0
200107,Both,0,0
200108,ketanserin,1,1
200109,and,0,0
200110,pindolol,1,1
200111,decreased,0,0
200112,supine,0,1
200113,systolic,0,0
200114,and,0,0
200115,diastolic,0,0
200116,blood,0,0
200117,pressure,0,0
200118,significantly,0,0
200119,(,0,0
200120,P,0,0
200121,less,0,0
200122,than,0,0
200123,0.01,0,0
200124,for,0,0
200125,systolic,0,0
200126,and,0,0
200127,P,0,0
200128,less,0,0
200129,than,0,0
200130,0.001,0,0
200131,for,0,0
200132,diastolic,0,0
200133,),0,0
200134,when,0,0
200135,evaluated,0,0
200136,at,0,0
200137,the,0,0
200138,end,0,0
200139,of,0,0
200140,the,0,0
200141,2-month,0,0
200142,treatment,0,0
200143,periods,0,0
200144,.,0,0
200145,There,0,0
200146,was,0,0
200147,no,0,0
200148,significant,0,0
200149,difference,0,0
200150,between,0,0
200151,the,0,0
200152,two,0,0
200153,drugs,0,0
200154,.,0,0
200155,No,0,0
200156,significant,0,0
200157,changes,0,0
200158,in,0,0
200159,heart,0,0
200160,rate,0,0
200161,were,0,0
200162,observed,0,0
200163,on,0,0
200164,either,0,0
200165,drug,0,0
200166,.,0,0
200167,Both,0,0
200168,drugs,0,0
200169,were,0,0
200170,well,0,0
200171,tolerated,0,0
200172,.,0,0
200173,[,0,0
200174,Therapeutic,0,0
200175,value,0,0
200176,of,0,0
200177,a,0,0
200178,combination,0,1
200179,of,0,0
200180,trimetazidine,1,1
200181,with,0,0
200182,a,0,0
200183,calcium,0,1
200184,inhibitor,0,1
200185,in,0,0
200186,the,0,0
200187,treatment,0,0
200188,of,0,0
200189,chronic,0,0
200190,coronary,0,0
200191,insufficiency,0,0
200192,],0,0
200193,.,0,0
200194,This,0,0
200195,double-blind,0,0
200196,",",0,0
200197,placebo-controlled,0,1
200198,study,0,0
200199,sought,0,0
200200,to,0,0
200201,examine,0,0
200202,the,0,0
200203,short-term,0,0
200204,benefit,0,0
200205,of,0,0
200206,adding,0,0
200207,60,0,0
200208,mg,0,1
200209,of,0,0
200210,trimetazidine,1,1
200211,to,0,0
200212,the,0,0
200213,daily,0,0
200214,therapeutic,0,0
200215,regimen,0,0
200216,of,0,0
200217,29,0,0
200218,male,0,0
200219,patients,0,0
200220,with,0,0
200221,coronary,0,0
200222,insufficiency,0,0
200223,who,0,0
200224,had,0,0
200225,persistent,0,0
200226,ST,0,0
200227,depression,0,0
200228,on,0,0
200229,exercise,0,1
200230,tolerance,0,0
200231,test,0,0
200232,(,0,0
200233,greater,0,0
200234,than,0,0
200235,or,0,0
200236,equal,0,0
200237,to,0,0
200238,1,0,0
200239,mm,0,0
200240,),0,0
200241,",",0,0
200242,despite,0,0
200243,treatment,0,0
200244,with,0,0
200245,nifedipine,1,1
200246,40,0,0
200247,mg,0,0
200248,per,0,0
200249,day,0,0
200250,.,0,0
200251,As,0,0
200252,compared,0,0
200253,with,0,0
200254,the,0,0
200255,placebo,1,1
200256,group,0,0
200257,",",0,0
200258,after,0,0
200259,only,0,0
200260,14,0,0
200261,days,0,0
200262,",",0,0
200263,the,0,0
200264,patients,0,0
200265,treated,0,0
200266,with,0,0
200267,trimetazidine,0,1
200268,showed,0,0
200269,statistically,0,0
200270,significant,0,0
200271,increases,0,0
200272,in,0,0
200273,the,0,0
200274,maximum,0,0
200275,workload,0,0
200276,level,0,0
200277,attained,0,0
200278,before,0,0
200279,ST,0,0
200280,depression,0,0
200281,occurred,0,0
200282,(,0,0
200283,31,0,0
200284,%,0,0
200285,versus,0,0
200286,-,0,0
200287,6,0,0
200288,%,0,0
200289,;,0,0
200290,P,0,0
200291,=,0,0
200292,0.009,0,0
200293,),0,0
200294,",",0,0
200295,the,0,0
200296,total,0,0
200297,work,0,0
200298,performed,0,0
200299,(,0,0
200300,31,0,0
200301,%,0,0
200302,versus,0,0
200303,2,0,0
200304,%,0,0
200305,;,0,0
200306,P,0,0
200307,=,0,0
200308,0.024,0,0
200309,),0,0
200310,and,0,0
200311,a,0,0
200312,significant,0,0
200313,decrease,0,0
200314,in,0,0
200315,the,0,0
200316,systolic,0,0
200317,tension,0,1
200318,time,0,0
200319,(,0,0
200320,double,0,1
200321,product,0,0
200322,),0,0
200323,/workload,0,0
200324,ratio,0,0
200325,(,0,0
200326,-5,0,0
200327,%,0,0
200328,versus,0,0
200329,+11,0,0
200330,%,0,0
200331,;,0,0
200332,P,0,0
200333,=,0,0
200334,0.005,0,0
200335,),0,0
200336,.,0,0
200337,Throughout,0,0
200338,the,0,0
200339,study,0,0
200340,the,0,0
200341,clinical,0,0
200342,acceptability,0,0
200343,was,0,0
200344,excellent,0,0
200345,",",0,0
200346,with,0,0
200347,no,0,0
200348,side,0,0
200349,effects,0,0
200350,attributable,0,0
200351,to,0,0
200352,trimetazidine,0,1
200353,being,0,0
200354,recorded,0,0
200355,.,0,0
200356,This,0,0
200357,study,0,0
200358,shows,0,0
200359,that,0,0
200360,the,0,0
200361,addition,0,0
200362,of,0,0
200363,trimetazidine,0,1
200364,to,0,0
200365,a,0,0
200366,calcium,0,1
200367,antagonist,0,1
200368,brings,0,0
200369,a,0,0
200370,valuable,0,0
200371,improvement,0,0
200372,in,0,0
200373,therapeutic,0,0
200374,results,0,0
200375,.,0,0
200376,No,0,0
200377,effect,0,0
200378,of,0,0
200379,acetylsalicylic,1,1
200380,acid,1,1
200381,on,0,0
200382,B-thromboglobulin,0,0
200383,and,0,0
200384,platelet,0,0
200385,factor,0,0
200386,4,0,0
200387,plasma,0,0
200388,levels,0,0
200389,in,0,0
200390,patients,0,0
200391,with,0,0
200392,transient,0,0
200393,ischaemic,0,0
200394,attacks,0,0
200395,.,0,0
200396,We,0,0
200397,studied,0,0
200398,the,0,0
200399,effect,0,0
200400,of,0,0
200401,acetylsalicylic,1,1
200402,acid,1,1
200403,(,1,0
200404,ASA,1,1
200405,),1,1
200406,versus,1,0
200407,placebo,1,1
200408,on,0,0
200409,B-thromboglobulin,0,0
200410,(,0,0
200411,B-TG,0,1
200412,),0,1
200413,and,0,0
200414,platelet,0,0
200415,factor,0,0
200416,4,0,0
200417,(,0,0
200418,PF4,0,1
200419,),0,0
200420,plasma,0,0
200421,levels,0,0
200422,and,0,0
200423,ADP-induced,0,0
200424,platelet,0,0
200425,aggregation,0,0
200426,in,0,0
200427,25,0,0
200428,male,0,0
200429,patients,0,0
200430,with,0,0
200431,transient,0,0
200432,ischaemic,0,1
200433,attacks,0,0
200434,(,0,0
200435,TIA,0,0
200436,),0,0
200437,.,0,0
200438,The,0,0
200439,patients,0,0
200440,were,0,0
200441,allocated,0,0
200442,randomly,0,0
200443,to,0,0
200444,two,0,0
200445,groups,0,0
200446,:,0,0
200447,14,0,0
200448,patients,0,0
200449,received,0,0
200450,oral,0,1
200451,treatment,0,0
200452,with,0,0
200453,ASA,1,0
200454,500,0,0
200455,mg,0,0
200456,b.i.d,0,1
200457,.,0,0
200458,for,0,0
200459,14,0,0
200460,days,0,0
200461,",",0,0
200462,11,0,0
200463,patients,0,0
200464,placebo,1,1
200465,b.i.d,0,1
200466,.,0,0
200467,for,0,0
200468,the,0,0
200469,same,0,0
200470,period,0,0
200471,.,0,0
200472,B-TG,0,0
200473,and,0,0
200474,PF4,0,1
200475,plasma,0,0
200476,levels,0,0
200477,and,0,0
200478,ADP-induced,0,0
200479,platelet,0,0
200480,aggregation,0,0
200481,were,0,0
200482,determined,0,0
200483,in,0,0
200484,basal,0,0
200485,conditions,0,0
200486,",",0,0
200487,and,0,0
200488,two,0,0
200489,hours,0,0
200490,",",0,0
200491,and,0,0
200492,seven,0,0
200493,and,0,0
200494,fourteen,0,0
200495,days,0,0
200496,after,0,0
200497,starting,0,0
200498,with,0,0
200499,ASA,0,1
200500,or,0,0
200501,placebo,0,1
200502,.,0,0
200503,In,0,0
200504,addition,0,0
200505,",",0,0
200506,the,0,0
200507,same,0,0
200508,parameters,0,0
200509,were,0,0
200510,studied,0,0
200511,in,0,0
200512,a,0,0
200513,group,0,0
200514,of,0,0
200515,20,0,0
200516,healthy,0,0
200517,males,0,0
200518,of,0,0
200519,matched,0,0
200520,age,0,0
200521,.,0,0
200522,Basal,0,0
200523,levels,0,0
200524,of,0,0
200525,plasma,0,0
200526,B-TG,0,1
200527,and,0,0
200528,PF4,0,1
200529,and,0,0
200530,the,0,0
200531,maximal,0,0
200532,amplitude,0,0
200533,of,0,0
200534,ADP-induced,0,0
200535,platelet,0,0
200536,aggregation,0,0
200537,were,0,0
200538,abnormally,0,0
200539,high,0,0
200540,in,0,0
200541,TIA,0,0
200542,patients,0,0
200543,.,0,0
200544,ASA,0,0
200545,caused,0,0
200546,a,0,0
200547,significant,0,0
200548,reduction,0,0
200549,of,0,0
200550,B-TG,0,1
200551,plasma,0,0
200552,levels,0,0
200553,in,0,0
200554,TIA,0,0
200555,patients,0,0
200556,2,0,0
200557,hours,0,0
200558,after,0,0
200559,the,0,0
200560,first,0,0
200561,administration,0,0
200562,",",0,0
200563,but,0,0
200564,no,0,0
200565,effect,0,0
200566,was,0,0
200567,observed,0,0
200568,at,0,0
200569,the,0,0
200570,7th,0,0
200571,and,0,0
200572,14th,0,0
200573,day,0,0
200574,of,0,0
200575,treatment,0,0
200576,.,0,0
200577,PF4,0,1
200578,plasma,0,0
200579,levels,0,0
200580,were,0,0
200581,unaffected,0,0
200582,by,0,0
200583,ASA,0,0
200584,treatment,0,0
200585,.,0,0
200586,It,0,0
200587,is,0,0
200588,concluded,0,0
200589,that,0,0
200590,ASA,0,0
200591,",",0,0
200592,at,0,0
200593,the,0,0
200594,dose,0,0
200595,conventionally,0,0
200596,used,0,0
200597,in,0,0
200598,clinical,0,0
200599,trials,0,0
200600,",",0,0
200601,does,0,0
200602,not,0,0
200603,affect,0,0
200604,the,0,0
200605,release,0,0
200606,of,0,0
200607,two,0,0
200608,alpha-granule,0,0
200609,proteins,0,0
200610,.,0,0
200611,Flow-cytometric,0,0
200612,studies,0,0
200613,with,0,0
200614,eleutherococcus,1,0
200615,senticosus,1,1
200616,extract,1,1
200617,as,0,0
200618,an,0,0
200619,immunomodulatory,0,0
200620,agent,0,0
200621,.,0,0
200622,A,0,0
200623,placebo-controlled,1,1
200624,study,0,0
200625,of,0,0
200626,the,0,0
200627,effect,0,0
200628,of,0,0
200629,an,0,0
200630,Eleutherococcus,1,1
200631,senticosus,1,1
200632,extract,1,1
200633,(,1,0
200634,Eleukokk,1,1
200635,),1,0
200636,on,0,0
200637,the,0,0
200638,immune,0,0
200639,system,0,0
200640,was,0,0
200641,performed,0,0
200642,with,0,0
200643,36,0,0
200644,healthy,0,0
200645,volunteers,0,0
200646,utilising,0,0
200647,quantitative,0,0
200648,multi-parameter,0,0
200649,flow,0,0
200650,cytometry,0,1
200651,with,0,0
200652,monoclonal,0,1
200653,antibodies,0,0
200654,directed,0,0
200655,against,0,0
200656,specific,0,0
200657,surface,0,0
200658,markers,0,0
200659,of,0,0
200660,human,0,0
200661,lymphocyte,0,0
200662,subsets,0,0
200663,.,0,0
200664,Volunteers,0,0
200665,in,0,0
200666,the,0,0
200667,verum,0,0
200668,group,0,0
200669,received,0,0
200670,10,0,0
200671,ml,0,0
200672,of,0,0
200673,an,0,0
200674,ethanolic,1,1
200675,(,1,0
200676,vincamine,1,1
200677,free,1,0
200678,),1,0
200679,eleutherococcus,1,0
200680,senticosus,1,1
200681,preparation,1,1
200682,",",0,0
200683,3,0,0
200684,times,0,0
200685,daily,0,0
200686,for,0,0
200687,4,0,0
200688,weeks,0,0
200689,.,0,0
200690,In,0,0
200691,the,0,0
200692,placebo,1,1
200693,",",1,0
200694,the,1,0
200695,eleutherococcus,1,0
200696,extract,1,1
200697,was,1,0
200698,substituted,1,1
200699,by,1,0
200700,additional,1,0
200701,wine,1,1
200702,",",1,0
200703,resulting,1,0
200704,in,1,0
200705,identical,1,0
200706,final,1,0
200707,concentrations,1,0
200708,of,1,0
200709,ethanol,1,0
200710,in,1,0
200711,both,1,0
200712,preparations,1,0
200713,.,1,0
200714,The,0,0
200715,purpose,0,0
200716,of,0,0
200717,the,0,0
200718,double-blind,0,0
200719,study,0,0
200720,was,0,0
200721,the,0,0
200722,demonstration,0,0
200723,of,0,0
200724,possible,0,0
200725,effects,0,0
200726,on,0,0
200727,the,0,0
200728,cellular,0,0
200729,immune,0,0
200730,status,0,0
200731,",",0,0
200732,as,0,0
200733,determined,0,0
200734,by,0,0
200735,quantitative,0,0
200736,flow,0,0
200737,cytometry,0,1
200738,.,0,0
200739,The,0,0
200740,most,0,0
200741,salient,0,0
200742,feature,0,0
200743,in,0,0
200744,the,0,0
200745,verum,0,0
200746,group,0,0
200747,was,0,0
200748,a,0,0
200749,drastic,0,0
200750,increase,0,0
200751,in,0,0
200752,the,0,0
200753,absolute,0,0
200754,number,0,0
200755,of,0,0
200756,immunocompetent,0,0
200757,cells,0,0
200758,",",0,0
200759,with,0,0
200760,an,0,0
200761,especially,0,0
200762,pronounced,0,0
200763,effect,0,0
200764,on,0,0
200765,T,0,0
200766,lymphocytes,0,0
200767,",",0,0
200768,predominantly,0,0
200769,of,0,0
200770,the,0,0
200771,helper/inducer,0,0
200772,type,0,0
200773,",",0,0
200774,but,0,0
200775,also,0,0
200776,on,0,0
200777,cytotoxic,0,0
200778,and,0,0
200779,natural,0,0
200780,killer,0,0
200781,cells,0,0
200782,.,0,0
200783,In,0,0
200784,addition,0,0
200785,",",0,0
200786,a,0,0
200787,general,0,0
200788,enhancement,0,0
200789,of,0,0
200790,the,0,0
200791,activation,0,0
200792,state,0,0
200793,of,0,0
200794,T,0,0
200795,lymphocytes,0,0
200796,was,0,0
200797,observed,0,0
200798,.,0,0
200799,No,0,0
200800,side,0,0
200801,effects,0,0
200802,were,0,0
200803,observed,0,0
200804,during,0,0
200805,the,0,0
200806,trial,0,0
200807,or,0,1
200808,afterwards,0,0
200809,(,0,0
200810,observation,0,0
200811,period,0,0
200812,6,0,0
200813,months,0,0
200814,),0,0
200815,.,0,0
200816,Lack,0,1
200817,of,0,0
200818,effect,0,0
200819,of,0,0
200820,warfarin,1,1
200821,on,0,0
200822,the,0,0
200823,restenosis,0,0
200824,rate,0,0
200825,or,0,1
200826,on,0,0
200827,clinical,0,0
200828,outcome,0,0
200829,after,0,0
200830,balloon,0,1
200831,coronary,0,0
200832,angioplasty,0,0
200833,.,0,0
200834,Between,0,0
200835,September,0,0
200836,1985,0,0
200837,and,0,0
200838,April,0,1
200839,1987,0,0
200840,",",0,0
200841,110,0,0
200842,consecutive,0,0
200843,patients,0,0
200844,who,0,0
200845,had,0,0
200846,successful,0,0
200847,coronary,0,0
200848,angioplasty,0,0
200849,were,0,0
200850,included,0,0
200851,in,0,0
200852,a,0,0
200853,randomised,0,0
200854,prospective,0,0
200855,controlled,0,0
200856,evaluation,0,0
200857,of,0,0
200858,the,0,0
200859,effects,0,0
200860,of,0,0
200861,warfarin,1,1
200862,on,0,0
200863,restenosis,0,0
200864,.,0,0
200865,The,0,0
200866,warfarin,1,1
200867,(,0,0
200868,n,0,0
200869,=,0,0
200870,56,0,0
200871,),0,0
200872,and,0,0
200873,the,0,0
200874,control,1,1
200875,(,0,0
200876,n,0,0
200877,=,0,0
200878,54,0,0
200879,),0,0
200880,groups,0,0
200881,were,0,0
200882,not,0,0
200883,different,0,0
200884,in,0,0
200885,terms,0,0
200886,of,0,0
200887,age,0,0
200888,",",0,0
200889,sex,0,0
200890,",",0,0
200891,previous,0,0
200892,coronary,0,0
200893,bypass,0,1
200894,surgery,0,1
200895,or,0,1
200896,coronary,0,0
200897,balloon,0,1
200898,angioplasty,0,1
200899,",",0,0
200900,severity,0,0
200901,of,0,0
200902,symptoms,0,0
200903,",",0,0
200904,and,0,0
200905,frequency,0,0
200906,of,0,0
200907,multivessel,0,0
200908,disease,0,0
200909,or,0,1
200910,of,0,0
200911,total,0,0
200912,coronary,0,0
200913,occlusions,0,0
200914,.,0,0
200915,Warfarin,1,1
200916,was,0,0
200917,started,0,0
200918,on,0,0
200919,the,0,0
200920,day,0,0
200921,of,0,0
200922,the,0,0
200923,procedure,0,0
200924,and,0,0
200925,the,0,0
200926,dosage,0,0
200927,was,0,0
200928,adjusted,0,0
200929,to,0,0
200930,maintain,0,0
200931,the,0,0
200932,thromboplastin,0,0
200933,international,0,0
200934,normalised,0,0
200935,ratio,0,0
200936,greater,0,0
200937,than,0,0
200938,or,0,0
200939,equal,0,0
200940,to,0,0
200941,2.5,0,0
200942,.,0,0
200943,One,0,0
200944,hundred,0,0
200945,and,0,0
200946,five,0,0
200947,(,0,0
200948,96,0,0
200949,%,0,0
200950,),0,0
200951,of,0,0
200952,the,0,0
200953,patients,0,0
200954,were,0,0
200955,given,0,0
200956,verapamil,1,1
200957,and,0,0
200958,other,1,0
200959,antianginal,1,1
200960,drugs,1,0
200961,were,0,0
200962,prescribed,0,0
200963,as,0,0
200964,needed,0,0
200965,.,0,0
200966,Low,1,0
200967,molecular,1,0
200968,weight,1,0
200969,dextran,1,1
200970,and,1,0
200971,heparin,1,1
200972,were,0,0
200973,given,0,0
200974,during,0,0
200975,the,0,0
200976,procedure,0,0
200977,and,0,0
200978,heparin,1,1
200979,was,0,0
200980,continued,0,0
200981,for,0,0
200982,24,0,0
200983,hours,0,0
200984,in,0,0
200985,all,0,0
200986,patients,0,0
200987,.,0,0
200988,One,0,0
200989,hundred,0,0
200990,and,0,0
200991,eight,0,0
200992,(,0,0
200993,98,0,0
200994,%,0,0
200995,),0,0
200996,of,0,0
200997,patients,0,0
200998,were,0,0
200999,followed,0,0
201000,up,0,0
201001,clinically,0,0
201002,after,0,0
201003,a,0,0
201004,median,0,0
201005,of,0,0
201006,five,0,0
201007,months,0,0
201008,(,0,0
201009,range,0,0
201010,1-20,0,0
201011,),0,0
201012,.,0,0
201013,Eighty,0,0
201014,five,0,0
201015,(,0,0
201016,77,0,0
201017,%,0,0
201018,),0,0
201019,had,0,0
201020,follow,0,0
201021,up,0,0
201022,angiography,0,1
201023,at,0,0
201024,five,0,0
201025,months,0,0
201026,.,0,0
201027,In,0,0
201028,the,0,0
201029,warfarin,1,1
201030,group,0,0
201031,symptoms,0,0
201032,improved,0,0
201033,in,0,0
201034,46,0,0
201035,(,0,0
201036,85,0,0
201037,%,0,0
201038,),0,0
201039,patients,0,0
201040,by,0,0
201041,at,0,0
201042,least,0,0
201043,1,0,0
201044,angina,0,0
201045,class,0,0
201046,and,0,0
201047,31,0,0
201048,(,0,0
201049,57,0,0
201050,%,0,0
201051,),0,0
201052,were,0,0
201053,symptom,0,0
201054,free,0,0
201055,;,0,0
201056,the,0,0
201057,exercise,0,1
201058,test,0,0
201059,remained,0,0
201060,positive,0,0
201061,in,0,0
201062,20,0,0
201063,(,0,0
201064,36,0,0
201065,%,0,0
201066,),0,0
201067,patients,0,0
201068,and,0,0
201069,the,0,0
201070,angiographic,0,1
201071,restenosis,0,0
201072,rate,0,0
201073,was,0,0
201074,25,0,0
201075,%,0,0
201076,per,0,0
201077,lesion,0,0
201078,and,0,0
201079,29,0,0
201080,%,0,0
201081,per,0,0
201082,patient,0,0
201083,.,0,0
201084,There,0,0
201085,were,0,0
201086,no,0,0
201087,major,0,0
201088,bleeding,0,0
201089,complications,0,0
201090,.,0,0
201091,In,0,0
201092,the,0,0
201093,control,1,0
201094,group,0,0
201095,46,0,0
201096,(,0,0
201097,85,0,0
201098,%,0,0
201099,),0,0
201100,patients,0,0
201101,were,0,0
201102,improved,0,0
201103,by,0,0
201104,at,0,0
201105,least,0,0
201106,1,0,0
201107,angina,0,0
201108,class,0,0
201109,and,0,0
201110,31,0,0
201111,(,0,0
201112,57,0,0
201113,%,0,0
201114,),0,0
201115,were,0,0
201116,symptom,0,0
201117,free,0,0
201118,;,0,0
201119,the,0,0
201120,exercise,0,1
201121,test,0,0
201122,was,0,0
201123,positive,0,0
201124,in,0,0
201125,11,0,0
201126,(,0,0
201127,21,0,0
201128,%,0,0
201129,),0,0
201130,patients,0,0
201131,and,0,0
201132,the,0,0
201133,angiographic,0,1
201134,restenosis,0,0
201135,rate,0,0
201136,was,0,0
201137,33,0,0
201138,%,0,0
201139,per,0,0
201140,lesion,0,0
201141,and,0,0
201142,37,0,0
201143,%,0,0
201144,per,0,0
201145,patient,0,0
201146,.,0,0
201147,Although,0,0
201148,the,0,0
201149,incidence,0,0
201150,of,0,0
201151,angiographic,0,0
201152,restenosis,0,0
201153,tended,0,0
201154,to,0,0
201155,be,0,0
201156,lower,0,0
201157,with,0,0
201158,warfarin,1,1
201159,",",0,0
201160,none,0,0
201161,of,0,0
201162,these,0,0
201163,differences,0,0
201164,was,0,0
201165,significant,0,0
201166,.,0,0
201167,These,0,0
201168,data,0,0
201169,suggest,0,0
201170,that,0,0
201171,the,0,0
201172,combination,0,1
201173,of,0,0
201174,verapamil,1,1
201175,and,0,0
201176,warfarin,1,1
201177,",",0,0
201178,in,0,0
201179,the,0,0
201180,absence,0,0
201181,of,0,0
201182,aspirin,1,1
201183,",",0,0
201184,is,0,0
201185,not,0,0
201186,significantly,0,0
201187,better,0,0
201188,than,0,0
201189,verapamil,0,1
201190,alone,0,1
201191,in,0,0
201192,preventing,0,0
201193,symptom,0,0
201194,recurrence,0,0
201195,or,0,1
201196,angiographic,0,1
201197,restenosis,0,0
201198,after,0,0
201199,coronary,0,0
201200,angioplasty,0,0
201201,.,0,0
201202,Treatment,0,0
201203,of,0,0
201204,varicella-zoster,0,0
201205,virus,0,0
201206,infection,0,0
201207,in,0,0
201208,severely,0,0
201209,immunocompromised,0,0
201210,patients,0,0
201211,.,0,0
201212,A,0,0
201213,randomized,0,0
201214,comparison,0,0
201215,of,0,0
201216,acyclovir,1,1
201217,and,1,0
201218,vidarabine,1,1
201219,.,1,0
201220,In,0,0
201221,a,0,0
201222,prospective,0,0
201223,",",0,0
201224,randomized,0,0
201225,trial,0,0
201226,",",0,0
201227,we,0,0
201228,compared,0,0
201229,intravenous,1,1
201230,acyclovir,1,1
201231,and,1,0
201232,vidarabine,1,1
201233,in,0,0
201234,the,0,0
201235,treatment,0,0
201236,of,0,0
201237,varicella-zoster,0,0
201238,virus,0,0
201239,infection,0,0
201240,in,0,0
201241,severely,0,0
201242,immunocompromised,0,0
201243,patients,0,0
201244,who,0,0
201245,presented,0,0
201246,within,0,0
201247,72,0,0
201248,hours,0,0
201249,of,0,0
201250,onset,0,0
201251,of,0,0
201252,the,0,0
201253,infection,0,0
201254,.,0,0
201255,Eleven,0,0
201256,patients,0,0
201257,were,0,0
201258,treated,0,0
201259,in,0,0
201260,each,0,0
201261,group,0,0
201262,.,0,0
201263,Cutaneous,0,0
201264,dissemination,0,0
201265,of,0,0
201266,infection,0,0
201267,occurred,0,0
201268,in,0,0
201269,none,0,0
201270,of,0,0
201271,the,0,0
201272,10,0,0
201273,acyclovir,1,1
201274,recipients,0,0
201275,and,0,0
201276,in,0,0
201277,5,0,0
201278,of,0,0
201279,the,0,0
201280,10,0,0
201281,vidarabine,1,1
201282,recipients,0,0
201283,who,0,0
201284,had,0,0
201285,presented,0,0
201286,with,0,0
201287,localized,0,0
201288,dermatomal,0,1
201289,disease,0,0
201290,(,0,0
201291,P,0,0
201292,=,0,0
201293,0.016,0,0
201294,),0,0
201295,.,0,0
201296,As,0,0
201297,compared,0,0
201298,with,0,0
201299,vidarabine,0,1
201300,",",0,0
201301,acyclovir,0,1
201302,treatment,0,0
201303,shortened,0,0
201304,the,0,0
201305,median,0,0
201306,periods,0,0
201307,during,0,0
201308,which,0,0
201309,cultures,0,0
201310,were,0,0
201311,positive,0,0
201312,for,0,0
201313,the,0,0
201314,virus,0,0
201315,(,0,0
201316,four,0,0
201317,vs.,0,0
201318,seven,0,0
201319,days,0,0
201320,",",0,0
201321,P,0,0
201322,=,0,0
201323,0.004,0,0
201324,),0,0
201325,and,0,0
201326,new,0,0
201327,lesions,0,0
201328,formed,0,0
201329,(,0,0
201330,three,0,0
201331,vs.,0,0
201332,six,0,0
201333,days,0,0
201334,",",0,0
201335,P,0,0
201336,=,0,0
201337,0.03,0,0
201338,),0,0
201339,.,0,0
201340,Acyclovir,1,1
201341,also,0,0
201342,shortened,0,0
201343,the,0,0
201344,median,0,0
201345,interval,0,0
201346,until,0,0
201347,the,0,0
201348,first,0,0
201349,decrease,0,0
201350,in,0,0
201351,pain,0,0
201352,(,0,0
201353,4,0,0
201354,vs.,0,0
201355,7,0,0
201356,days,0,0
201357,",",0,0
201358,P,0,0
201359,=,0,0
201360,0.005,0,0
201361,),0,0
201362,",",0,0
201363,the,0,0
201364,pustulation,0,0
201365,of,0,0
201366,all,0,0
201367,lesions,0,0
201368,(,0,0
201369,4,0,0
201370,vs.,0,0
201371,7,0,0
201372,days,0,0
201373,",",0,0
201374,P,0,0
201375,=,0,0
201376,0.0004,0,0
201377,),0,0
201378,",",0,0
201379,the,0,0
201380,crusting,0,0
201381,of,0,0
201382,all,0,0
201383,lesions,0,0
201384,(,0,0
201385,7,0,0
201386,vs.,0,0
201387,17,0,0
201388,days,0,0
201389,",",0,0
201390,P,0,0
201391,=,0,0
201392,0.0003,0,0
201393,),0,0
201394,",",0,0
201395,and,0,0
201396,the,0,0
201397,complete,0,0
201398,healing,0,0
201399,of,0,0
201400,lesions,0,0
201401,(,0,0
201402,17,0,0
201403,vs.,0,0
201404,28,0,0
201405,days,0,0
201406,",",0,0
201407,P,0,0
201408,=,0,0
201409,0.003,0,0
201410,),0,0
201411,.,0,0
201412,In,0,0
201413,addition,0,0
201414,",",0,0
201415,acyclovir,1,1
201416,reduced,0,0
201417,the,0,0
201418,incidence,0,0
201419,of,0,0
201420,fever,0,0
201421,(,0,0
201422,two,0,0
201423,vs.,0,0
201424,eight,0,0
201425,patients,0,0
201426,",",0,0
201427,P,0,0
201428,=,0,0
201429,0.015,0,0
201430,),0,0
201431,.,0,0
201432,We,0,0
201433,conclude,0,0
201434,that,0,0
201435,acyclovir,1,1
201436,is,0,0
201437,better,0,0
201438,than,0,0
201439,vidarabine,1,1
201440,for,0,0
201441,the,0,0
201442,treatment,0,0
201443,of,0,0
201444,varicella-zoster,0,0
201445,infection,0,0
201446,in,0,0
201447,immunocompromised,0,0
201448,patients,0,0
201449,.,0,0
201450,Antihypertensive,0,1
201451,effect,0,0
201452,of,0,0
201453,single,0,0
201454,doses,0,0
201455,of,0,0
201456,enalapril,1,1
201457,in,0,0
201458,hypertensive,0,0
201459,patients,0,0
201460,treated,0,0
201461,with,0,0
201462,bendrofluazide,1,1
201463,.,1,0
201464,This,0,0
201465,study,0,0
201466,was,0,0
201467,designed,0,0
201468,to,0,0
201469,investigate,0,0
201470,the,0,0
201471,validity,0,0
201472,of,0,0
201473,the,0,0
201474,then,0,0
201475,current,0,0
201476,recommendations,0,0
201477,for,0,0
201478,initiation,0,0
201479,of,0,0
201480,therapy,0,1
201481,with,0,0
201482,enalapril,1,1
201483,in,0,0
201484,hypertensive,0,0
201485,patients,0,0
201486,on,0,0
201487,treatment,0,0
201488,with,0,0
201489,a,0,0
201490,diuretic,0,1
201491,.,0,0
201492,Enalapril,1,1
201493,in,0,0
201494,single,0,0
201495,doses,0,0
201496,of,0,0
201497,10,0,0
201498,and,0,0
201499,20,0,0
201500,mg,0,0
201501,was,0,0
201502,given,0,0
201503,to,0,0
201504,13,0,0
201505,hypertensive,0,0
201506,patients,0,0
201507,on,0,0
201508,treatment,0,0
201509,with,0,0
201510,bendrofluazide,1,1
201511,5,0,0
201512,mg,0,0
201513,daily,0,0
201514,in,0,0
201515,a,0,0
201516,randomised,0,0
201517,",",0,0
201518,crossover,0,0
201519,",",0,0
201520,placebo,1,1
201521,controlled,0,0
201522,study,0,0
201523,.,0,0
201524,The,0,0
201525,mean,0,0
201526,maximal,0,0
201527,reduction,0,0
201528,in,0,0
201529,blood,0,0
201530,pressure,0,0
201531,was,0,0
201532,similar,0,0
201533,with,0,0
201534,both,0,0
201535,doses,0,0
201536,(,0,0
201537,35/20,0,0
201538,mmHg,0,0
201539,supine,0,0
201540,",",0,0
201541,38/20,0,0
201542,mmHg,0,0
201543,standing,0,0
201544,),0,0
201545,",",0,0
201546,occurred,0,0
201547,on,0,0
201548,average,0,0
201549,within,0,0
201550,6,0,0
201551,h,0,0
201552,of,0,0
201553,tablet,0,1
201554,ingestion,0,0
201555,",",0,0
201556,and,0,0
201557,was,0,0
201558,not,0,0
201559,accompanied,0,0
201560,by,0,0
201561,any,0,0
201562,significant,0,0
201563,change,0,0
201564,in,0,0
201565,heart,0,0
201566,rate,0,0
201567,.,0,0
201568,Three,0,0
201569,patients,0,0
201570,experienced,0,0
201571,symptomatic,0,0
201572,hypotension,0,0
201573,.,0,0
201574,In,0,0
201575,one,0,0
201576,patient,0,0
201577,this,0,0
201578,was,0,0
201579,incapacitating,0,0
201580,after,0,0
201581,10,0,0
201582,mg,0,0
201583,and,0,0
201584,precluded,0,0
201585,exposure,0,0
201586,to,0,0
201587,20,0,0
201588,mg,0,0
201589,.,0,0
201590,This,0,0
201591,study,0,0
201592,shows,0,0
201593,that,0,0
201594,in,0,0
201595,hypertensive,0,0
201596,patients,0,0
201597,receiving,0,0
201598,treatment,0,0
201599,with,0,0
201600,diuretics,0,1
201601,",",0,0
201602,the,0,0
201603,addition,0,0
201604,of,0,0
201605,enalapril,0,1
201606,should,0,0
201607,be,0,0
201608,undertaken,0,0
201609,with,0,0
201610,caution,0,0
201611,.,0,0
201612,An,0,0
201613,optimal,0,0
201614,starting,0,0
201615,dose,0,0
201616,of,0,0
201617,enalapril,0,1
201618,in,0,0
201619,such,0,0
201620,patients,0,0
201621,remains,0,0
201622,to,0,0
201623,be,0,0
201624,confirmed,0,0
201625,.,0,0
201626,Caudal,0,0
201627,analgesia,0,0
201628,for,0,0
201629,perianal,0,0
201630,surgery,0,0
201631,.,0,0
201632,A,0,0
201633,comparison,0,0
201634,between,0,0
201635,bupivacaine,1,1
201636,and,0,0
201637,diamorphine,1,1
201638,.,1,0
201639,Seventy-three,0,0
201640,patients,0,0
201641,undergoing,0,0
201642,elective,0,0
201643,perianal,0,0
201644,surgery,0,0
201645,were,0,0
201646,randomly,0,0
201647,divided,0,0
201648,into,0,0
201649,a,1,0
201650,control,1,0
201651,group,1,0
201652,",",1,0
201653,a,1,0
201654,group,1,0
201655,who,1,0
201656,received,1,0
201657,a,1,0
201658,caudal,1,0
201659,injection,1,0
201660,of,1,0
201661,20,1,0
201662,ml,1,0
201663,bupivacaine,1,1
201664,0.5,1,0
201665,%,1,0
201666,plain,1,1
201667,and,1,0
201668,a,1,0
201669,group,1,0
201670,who,1,0
201671,received,1,0
201672,diamorphine,1,1
201673,2.5,1,0
201674,mg,1,0
201675,in,1,0
201676,10,1,0
201677,ml,1,0
201678,normal,1,0
201679,saline,1,1
201680,by,1,0
201681,caudal,1,0
201682,injection,1,0
201683,;,1,0
201684,a,1,0
201685,comparison,1,0
201686,was,1,0
201687,then,1,0
201688,made,1,0
201689,of,1,0
201690,postoperative,1,0
201691,analgesia,1,0
201692,requirements,1,0
201693,.,1,0
201694,The,0,0
201695,bupivacaine,1,1
201696,group,0,0
201697,had,0,0
201698,better,0,0
201699,analgesia,0,0
201700,than,0,0
201701,the,0,0
201702,control,0,0
201703,group,0,0
201704,for,0,0
201705,the,0,0
201706,first,0,0
201707,8,0,0
201708,hours,0,0
201709,",",0,0
201710,after,0,0
201711,which,0,0
201712,there,0,0
201713,was,0,0
201714,no,0,0
201715,difference,0,0
201716,.,0,0
201717,The,0,0
201718,diamorphine,1,1
201719,group,0,0
201720,had,0,0
201721,better,0,0
201722,analgesia,0,0
201723,than,0,0
201724,the,0,0
201725,control,0,0
201726,group,0,0
201727,for,0,0
201728,the,0,0
201729,first,0,0
201730,24,0,0
201731,hours,0,0
201732,postoperatively,0,0
201733,.,0,0
201734,Side,0,0
201735,effects,0,0
201736,were,0,0
201737,less,0,0
201738,in,0,0
201739,the,0,0
201740,diamorphine,1,1
201741,group,0,0
201742,than,0,0
201743,the,0,0
201744,control,0,0
201745,",",0,0
201746,or,0,0
201747,the,0,0
201748,bupivacaine,1,1
201749,group,0,0
201750,.,0,0
201751,In,0,0
201752,particular,0,0
201753,",",0,0
201754,41,0,0
201755,%,0,0
201756,of,0,0
201757,the,0,0
201758,bupivacaine,1,1
201759,group,0,0
201760,complained,0,0
201761,of,0,0
201762,some,0,0
201763,degree,0,0
201764,of,0,0
201765,urinary,0,0
201766,retention,0,0
201767,and,0,0
201768,one,0,0
201769,patient,0,0
201770,required,0,0
201771,temporary,0,0
201772,catheterisation,0,1
201773,.,0,0
201774,It,0,0
201775,is,0,0
201776,concluded,0,0
201777,that,0,0
201778,caudal,0,0
201779,diamorphine,1,1
201780,gives,0,0
201781,good,0,0
201782,postoperative,0,0
201783,analgesia,0,0
201784,for,0,0
201785,perianal,0,0
201786,operations,0,0
201787,",",0,0
201788,particularly,0,0
201789,when,0,0
201790,motor,0,0
201791,blockade,0,0
201792,is,0,0
201793,not,0,0
201794,wanted,0,0
201795,by,0,0
201796,the,0,0
201797,surgeon,0,0
201798,.,0,0
201799,Chemotherapy,0,1
201800,of,0,0
201801,advanced,0,0
201802,gastric,0,0
201803,carcinoma,0,0
201804,(,0,0
201805,stage,0,0
201806,IV,0,0
201807,),0,0
201808,:,0,0
201809,a,0,0
201810,randomized,0,0
201811,study,0,0
201812,of,0,0
201813,FAM,1,0
201814,versus,0,0
201815,5-FU,1,0
201816,plus,1,1
201817,BCNU,1,0
201818,.,1,0
201819,Forty-six,0,0
201820,patients,0,0
201821,with,0,0
201822,advanced,0,0
201823,gastric,0,0
201824,carcinoma,0,0
201825,(,0,0
201826,Stage,0,0
201827,IV,0,0
201828,),0,0
201829,were,0,0
201830,evaluated,0,0
201831,in,0,0
201832,a,0,0
201833,prospective,0,0
201834,randomized,0,0
201835,comparison,0,0
201836,of,0,0
201837,two,0,0
201838,chemotherapy,1,1
201839,regimens,0,1
201840,(,1,0
201841,FAM,1,0
201842,versus,1,1
201843,5-FU,1,0
201844,plus,1,1
201845,BCNU,1,0
201846,),1,0
201847,to,0,0
201848,identify,0,0
201849,therapeutic,0,0
201850,activity,0,0
201851,.,0,0
201852,Treatment,0,0
201853,groups,0,0
201854,were,0,0
201855,well,0,0
201856,balanced,0,0
201857,with,0,0
201858,respect,0,0
201859,to,0,0
201860,known,0,0
201861,prognostic,0,0
201862,factors,0,0
201863,.,0,0
201864,Thirty-three,0,0
201865,patients,0,0
201866,had,0,0
201867,measurable,0,0
201868,disease,0,0
201869,and,0,0
201870,thirteen,0,0
201871,had,0,0
201872,only,0,0
201873,microscopic,0,0
201874,residual,0,0
201875,disease,0,0
201876,in,0,0
201877,the,0,0
201878,resection,0,0
201879,margins,0,0
201880,.,0,0
201881,The,0,0
201882,overall,0,0
201883,median,0,0
201884,survival,0,0
201885,of,0,0
201886,the,0,0
201887,entire,0,0
201888,group,0,0
201889,was,0,0
201890,13.2,0,0
201891,months,0,0
201892,.,0,0
201893,Two,0,0
201894,(,0,0
201895,6,0,0
201896,%,0,0
201897,),0,0
201898,patients,0,0
201899,with,0,0
201900,measurable,0,0
201901,disease,0,0
201902,reached,0,0
201903,complete,0,0
201904,response,0,0
201905,(,0,0
201906,CR,0,1
201907,),0,0
201908,",",0,0
201909,1,0,0
201910,(,0,0
201911,3,0,0
201912,%,0,0
201913,),0,0
201914,partial,0,0
201915,response,0,0
201916,(,0,0
201917,PR,0,1
201918,),0,0
201919,",",0,0
201920,12,0,0
201921,(,0,0
201922,36,0,0
201923,%,0,0
201924,),0,0
201925,had,0,0
201926,stable,0,0
201927,disease,0,0
201928,(,0,0
201929,SD,0,0
201930,),0,0
201931,and,0,0
201932,18,0,0
201933,(,0,0
201934,56,0,0
201935,%,0,0
201936,),0,0
201937,had,0,0
201938,progressive,0,1
201939,disease,0,0
201940,(,0,0
201941,PD,0,0
201942,),0,0
201943,.,0,0
201944,The,0,0
201945,responders,0,0
201946,had,0,0
201947,not,0,0
201948,reached,0,0
201949,the,0,0
201950,median,0,0
201951,survival,0,0
201952,yet,0,0
201953,",",0,0
201954,the,0,0
201955,patients,0,0
201956,with,0,0
201957,SD,0,0
201958,had,0,0
201959,a,0,0
201960,median,0,0
201961,survival,0,0
201962,of,0,0
201963,14.7,0,0
201964,months,0,0
201965,and,0,0
201966,the,0,0
201967,PD,0,0
201968,9.5,0,0
201969,months,0,0
201970,.,0,0
201971,In,0,0
201972,the,0,0
201973,FAM,1,0
201974,arm,0,0
201975,there,0,0
201976,were,0,0
201977,3,0,0
201978,(,0,0
201979,18,0,0
201980,%,0,0
201981,),0,0
201982,responders,0,0
201983,(,0,0
201984,2,0,0
201985,CR,0,1
201986,and,0,0
201987,1,0,0
201988,PR,0,0
201989,),0,0
201990,",",0,0
201991,7,0,0
201992,(,0,0
201993,41,0,0
201994,%,0,0
201995,),0,0
201996,SD,0,0
201997,and,0,0
201998,7,0,0
201999,(,0,0
202000,41,0,0
202001,%,0,0
202002,),0,0
202003,PD,0,0
202004,",",0,0
202005,versus,0,0
202006,O,0,0
202007,responders,0,0
202008,",",0,0
202009,5,0,0
202010,(,0,0
202011,31,0,0
202012,%,0,0
202013,),0,0
202014,SD,0,0
202015,and,0,0
202016,11,0,0
202017,(,0,0
202018,69,0,0
202019,%,0,0
202020,),0,0
202021,PD,0,0
202022,in,0,0
202023,the,0,0
202024,5-FU,0,0
202025,plus,0,1
202026,BCNU,0,0
202027,arm,0,0
202028,.,0,0
202029,In,0,0
202030,the,0,0
202031,FAM,1,0
202032,arm,0,0
202033,the,0,0
202034,median,0,0
202035,survival,0,0
202036,was,0,0
202037,15.7,0,0
202038,months,0,0
202039,versus,0,0
202040,9.9,0,0
202041,months,0,0
202042,in,0,0
202043,the,0,0
202044,other,0,0
202045,therapeutic,0,0
202046,arm,0,0
202047,.,0,0
202048,The,0,0
202049,statistical,0,0
202050,analysis,0,0
202051,indicated,0,0
202052,that,0,0
202053,survival,0,0
202054,associated,0,0
202055,with,0,0
202056,FAM,1,0
202057,regimen,0,0
202058,was,0,0
202059,superior,0,0
202060,to,0,0
202061,that,0,0
202062,reached,0,0
202063,with,0,0
202064,the,0,0
202065,5-FU,1,0
202066,plus,1,1
202067,BCNU,1,0
202068,regimen,0,1
202069,.,0,0
202070,Thirteen,0,0
202071,patients,0,0
202072,with,0,0
202073,unmeasurable,0,0
202074,disease,0,0
202075,had,0,0
202076,a,0,0
202077,median,0,0
202078,survival,0,0
202079,of,0,0
202080,15.9,0,0
202081,months,0,0
202082,.,0,0
202083,Antibiotic,1,1
202084,prophylaxis,1,0
202085,in,0,0
202086,high-risk,0,0
202087,head,0,0
202088,and,0,0
202089,neck,0,0
202090,surgery,0,1
202091,:,0,0
202092,one-day,1,0
202093,vs.,0,0
202094,five-day,1,0
202095,therapy,1,1
202096,.,1,0
202097,Patients,0,0
202098,who,0,0
202099,undergo,0,0
202100,major,0,0
202101,contaminated,0,0
202102,surgery,0,0
202103,of,0,0
202104,the,0,0
202105,head,0,0
202106,and,0,0
202107,neck,0,0
202108,benefit,0,0
202109,from,0,0
202110,perioperative,0,0
202111,antibiotic,1,1
202112,prophylaxis,1,0
202113,.,1,0
202114,This,0,0
202115,study,0,0
202116,was,0,0
202117,developed,0,0
202118,to,0,0
202119,determine,0,0
202120,if,0,0
202121,5,0,0
202122,days,0,0
202123,of,0,0
202124,antibiotic,1,1
202125,administration,1,0
202126,would,0,0
202127,be,0,0
202128,more,0,0
202129,effective,0,0
202130,than,0,0
202131,1,0,0
202132,day,0,0
202133,.,0,0
202134,A,0,0
202135,multi-institutional,0,0
202136,prospective,0,0
202137,randomized,0,0
202138,double-blind,0,0
202139,study,0,0
202140,was,0,0
202141,designed,0,0
202142,.,0,0
202143,Patients,0,0
202144,who,0,0
202145,were,0,0
202146,identified,0,0
202147,as,0,0
202148,requiring,0,0
202149,pedicled,0,1
202150,flap,0,1
202151,reconstruction,0,1
202152,were,0,0
202153,potential,0,0
202154,candidates,0,0
202155,for,0,0
202156,the,0,0
202157,study,0,0
202158,.,0,0
202159,Later,0,0
202160,",",0,0
202161,patients,0,0
202162,were,0,0
202163,randomly,0,0
202164,assigned,0,0
202165,to,0,0
202166,receive,0,1
202167,cefoperazone,1,1
202168,sodium,1,1
202169,for,0,0
202170,either,0,0
202171,24,1,0
202172,hours,1,0
202173,or,1,0
202174,120,1,0
202175,hours,1,0
202176,.,1,0
202177,In,0,0
202178,each,0,0
202179,case,0,0
202180,",",0,0
202181,the,0,0
202182,drug,0,0
202183,was,0,0
202184,administered,0,0
202185,intravenously,0,0
202186,",",0,0
202187,beginning,0,0
202188,1,0,0
202189,to,0,0
202190,2,0,0
202191,hours,0,0
202192,preoperatively,0,0
202193,and,0,0
202194,continued,0,0
202195,for,0,0
202196,the,0,0
202197,prescribed,0,0
202198,period,0,0
202199,.,0,0
202200,One,0,0
202201,hundred,0,0
202202,nine,0,0
202203,patients,0,0
202204,were,0,0
202205,evaluable,0,0
202206,.,0,0
202207,Fifty-three,0,0
202208,patients,0,0
202209,were,0,0
202210,assigned,0,0
202211,to,0,0
202212,1,0,0
202213,day,0,0
202214,of,0,0
202215,perioperative,0,0
202216,prophylaxis,0,0
202217,.,0,0
202218,Wound,0,0
202219,infection,0,0
202220,developed,0,0
202221,in,0,0
202222,ten,0,0
202223,patients,0,0
202224,(,0,0
202225,18.9,0,0
202226,%,0,0
202227,),0,0
202228,.,0,0
202229,Fifty-six,0,0
202230,patients,0,0
202231,were,0,0
202232,assigned,0,0
202233,to,0,0
202234,5,0,0
202235,days,0,0
202236,of,0,0
202237,perioperative,1,0
202238,antibiotic,1,1
202239,prophylaxis,1,0
202240,.,1,0
202241,Wound,0,0
202242,infection,0,0
202243,developed,0,0
202244,in,0,0
202245,14,0,0
202246,(,0,0
202247,25,0,0
202248,%,0,0
202249,),0,0
202250,of,0,0
202251,these,0,0
202252,patients,0,0
202253,(,0,0
202254,P,0,0
202255,greater,0,0
202256,than,0,0
202257,.05,0,0
202258,),0,0
202259,.,0,0
202260,These,0,0
202261,data,0,0
202262,suggest,0,0
202263,that,0,0
202264,no,0,0
202265,beneficial,0,0
202266,effect,0,0
202267,from,0,0
202268,administration,0,0
202269,of,0,0
202270,antibiotics,1,0
202271,for,0,0
202272,longer,0,0
202273,than,0,0
202274,24,0,0
202275,hours,0,0
202276,postoperatively,0,0
202277,can,0,0
202278,be,0,0
202279,achieved,0,0
202280,in,0,0
202281,patients,0,0
202282,who,0,0
202283,undergo,0,0
202284,myocutaneous,0,0
202285,flap,0,1
202286,reconstruction,0,0
202287,.,0,0
202288,Postoperative,0,0
202289,pain,0,0
202290,control,0,0
202291,for,0,0
202292,outpatient,0,0
202293,oral,0,1
202294,surgery,0,0
202295,.,0,0
202296,16,0,0
202297,healthy,0,0
202298,patients,0,0
202299,requiring,0,0
202300,removal,0,0
202301,of,0,0
202302,bilateral,0,1
202303,symmetrically-impacted,0,0
202304,mandibular,0,0
202305,third,0,0
202306,molars,0,0
202307,participated,0,0
202308,in,0,0
202309,a,0,0
202310,double-blind,0,0
202311,randomised,0,0
202312,crossover,0,0
202313,trial,0,0
202314,to,0,0
202315,test,0,0
202316,the,0,0
202317,effectiveness,0,0
202318,of,0,0
202319,postoperative,0,0
202320,pain,0,0
202321,control,0,1
202322,using,0,0
202323,a,0,0
202324,long-acting,0,1
202325,anti-inflammatory,0,1
202326,agent,0,0
202327,(,1,0
202328,diflunisal,1,1
202329,),1,0
202330,in,0,0
202331,combination,0,1
202332,with,0,0
202333,a,0,0
202334,long-acting,0,1
202335,local,0,0
202336,anaesthetic,0,1
202337,agent,0,0
202338,(,1,0
202339,bupivacaine,1,1
202340,),1,0
202341,.,0,0
202342,Results,0,0
202343,were,0,0
202344,compared,0,0
202345,to,0,0
202346,the,0,0
202347,more,0,0
202348,traditional,0,1
202349,method,0,0
202350,of,0,0
202351,using,0,0
202352,an,0,0
202353,oral,0,1
202354,analgesic,0,0
202355,with,0,0
202356,shorter,0,0
202357,duration,0,0
202358,of,0,0
202359,action,0,0
202360,(,1,0
202361,paracetamol,1,1
202362,with,1,0
202363,codeine,1,1
202364,),1,0
202365,with,0,0
202366,lignocaine,1,1
202367,as,0,0
202368,the,0,0
202369,local,0,0
202370,anaesthetic,0,1
202371,.,0,0
202372,Using,0,0
202373,a,0,0
202374,visual,0,0
202375,analogue,0,0
202376,pain,0,0
202377,scale,0,0
202378,",",0,0
202379,patients,0,0
202380,reported,0,0
202381,that,0,0
202382,significantly,0,0
202383,reduced,0,0
202384,pain,0,0
202385,was,0,0
202386,experienced,0,0
202387,over,0,0
202388,the,0,0
202389,first,0,0
202390,4,0,0
202391,days,0,0
202392,postoperatively,0,0
202393,with,0,0
202394,the,0,0
202395,diflunisal/bupivacaine,1,1
202396,treatment,1,0
202397,and,0,0
202398,patient,0,0
202399,preference,0,0
202400,for,0,0
202401,this,0,0
202402,treatment,0,0
202403,was,0,0
202404,highly,0,0
202405,significant,0,0
202406,.,0,0
202407,This,0,0
202408,report,0,0
202409,represents,0,0
202410,the,0,0
202411,first,0,0
202412,such,0,0
202413,study,0,0
202414,of,0,0
202415,diflunisal,1,1
202416,used,0,0
202417,for,0,0
202418,an,0,0
202419,extended,0,1
202420,course,0,0
202421,in,0,0
202422,oral,0,1
202423,surgery,0,0
202424,with,0,0
202425,pain,0,0
202426,assessment,0,0
202427,over,0,0
202428,the,0,0
202429,same,0,0
202430,period,0,0
202431,.,0,0
202432,No,0,0
202433,significant,0,0
202434,side-effects,0,0
202435,or,0,0
202436,adverse,0,0
202437,reactions,0,0
202438,were,0,0
202439,encountered,0,0
202440,.,0,0
202441,[,1,0
202442,Bupivacaine-CO2,1,1
202443,and,1,0
202444,bupivacaine-HCl,1,1
202445,at,0,0
202446,various,0,0
202447,injection,0,0
202448,temperatures,0,0
202449,in,0,0
202450,peridural,1,1
202451,anesthesia,1,1
202452,for,0,0
202453,extracorporeal,0,1
202454,shock,0,0
202455,wave,0,1
202456,lithotripsy,0,1
202457,],0,0
202458,.,0,0
202459,INTRODUCTION,0,0
202460,The,0,0
202461,effect,0,0
202462,of,0,0
202463,different,0,0
202464,injection,0,0
202465,temperatures,0,0
202466,on,0,0
202467,carbonated,1,1
202468,anesthetics,1,1
202469,has,0,0
202470,been,0,0
202471,controversial,0,0
202472,since,0,0
202473,1965,0,0
202474,.,0,0
202475,The,0,0
202476,current,0,0
202477,study,0,0
202478,was,0,0
202479,undertaken,0,0
202480,to,0,0
202481,determine,0,0
202482,onset,0,0
202483,times,0,0
202484,of,0,0
202485,sensory,0,0
202486,and,0,0
202487,motor,0,0
202488,blockade,0,0
202489,after,0,0
202490,epidural,1,1
202491,anesthesia,1,1
202492,with,0,0
202493,0.5,0,0
202494,%,0,0
202495,bupivacaine-CO2,1,1
202496,and,0,0
202497,0.5,0,1
202498,%,0,0
202499,bupivacaine-HCl,1,1
202500,at,0,0
202501,various,0,0
202502,injection,0,0
202503,temperatures,0,0
202504,.,0,0
202505,MATERIALS,0,0
202506,AND,0,0
202507,METHODS,0,0
202508,The,0,0
202509,study,0,0
202510,was,0,0
202511,performed,0,0
202512,on,0,0
202513,90,0,0
202514,ASA,0,0
202515,class,0,0
202516,I-II,0,0
202517,urologic,0,0
202518,patients,0,0
202519,during,0,0
202520,extracorporeal,1,1
202521,shock,1,0
202522,wave,1,1
202523,lithotripsy,1,1
202524,.,1,0
202525,The,0,0
202526,patients,0,0
202527,were,0,0
202528,randomized,0,0
202529,in,0,0
202530,six,0,0
202531,groups,0,0
202532,to,0,0
202533,receive,0,0
202534,either,0,0
202535,0.5,0,0
202536,%,0,0
202537,bupivacaine-CO2,1,1
202538,or,0,1
202539,0.5,0,1
202540,%,0,0
202541,bupivacaine-HCl,1,1
202542,at,0,0
202543,temperatures,0,0
202544,of,0,0
202545,4,0,0
202546,degrees,0,0
202547,",",0,0
202548,20,0,0
202549,degrees,0,0
202550,",",0,0
202551,or,0,0
202552,36,0,0
202553,degrees,0,0
202554,C.,0,0
202555,The,0,0
202556,six,0,0
202557,groups,0,0
202558,were,0,0
202559,comparable,0,0
202560,in,0,0
202561,age,0,0
202562,",",0,0
202563,height,0,0
202564,",",0,0
202565,and,0,0
202566,weight,0,0
202567,.,0,0
202568,Epidural,1,0
202569,anesthesia,1,1
202570,was,0,0
202571,performed,0,0
202572,at,0,0
202573,the,0,0
202574,L2-3,0,0
202575,interspace,0,0
202576,with,0,0
202577,an,0,0
202578,18-gauge,1,1
202579,Tuohy,1,1
202580,needle,0,1
202581,using,0,0
202582,loss,0,0
202583,of,0,0
202584,resistance,0,0
202585,.,0,0
202586,A,0,0
202587,catheter,0,0
202588,was,0,0
202589,advanced,0,0
202590,4,0,0
202591,cm,0,0
202592,in,0,0
202593,the,0,0
202594,epidural,0,1
202595,space,0,0
202596,and,0,0
202597,4,0,0
202598,ml,0,0
202599,0.5,0,0
202600,%,0,0
202601,bupivacaine,1,1
202602,with,1,0
202603,adrenaline,1,0
202604,"1:200,000",0,1
202605,was,0,0
202606,given,0,0
202607,as,0,0
202608,a,0,0
202609,test,0,0
202610,dose,0,0
202611,.,0,0
202612,After,0,0
202613,4,0,0
202614,min,0,0
202615,the,0,0
202616,full,0,0
202617,anesthetic,0,1
202618,dose,0,0
202619,",",0,0
202620,based,0,0
202621,on,0,0
202622,body,0,0
202623,size,0,0
202624,",",0,0
202625,was,0,0
202626,injected,0,1
202627,with,0,0
202628,the,0,0
202629,patient,0,0
202630,supine,0,0
202631,.,0,0
202632,Sensory,0,0
202633,blockade,0,0
202634,was,0,0
202635,determined,0,0
202636,by,0,0
202637,the,0,0
202638,pinprick,0,0
202639,method,0,0
202640,and,0,0
202641,motor,0,0
202642,blockade,0,0
202643,by,0,0
202644,the,0,0
202645,Bromage,0,0
202646,method,0,0
202647,at,0,0
202648,2-min,0,1
202649,intervals,0,0
202650,for,0,0
202651,the,0,0
202652,first,0,0
202653,20,0,0
202654,min,0,0
202655,",",0,0
202656,at,0,0
202657,5-min,0,0
202658,intervals,0,0
202659,for,0,0
202660,the,0,0
202661,next,0,0
202662,10,0,0
202663,min,0,0
202664,",",0,0
202665,and,0,0
202666,then,0,0
202667,every,0,0
202668,15,0,0
202669,min,0,0
202670,to,0,0
202671,a,0,0
202672,total,0,0
202673,of,0,0
202674,240,0,0
202675,min,0,0
202676,.,0,0
202677,Statistical,0,0
202678,analysis,0,0
202679,was,0,0
202680,done,0,0
202681,by,0,0
202682,the,0,0
202683,Mann-Whitney,0,0
202684,test,0,0
202685,",",0,0
202686,with,0,0
202687,P,0,0
202688,less,0,0
202689,than,0,0
202690,0.05,0,0
202691,considered,0,0
202692,significant,0,0
202693,.,0,0
202694,RESULTS,0,0
202695,Spread,0,0
202696,of,0,0
202697,sensory,0,0
202698,blockade,0,0
202699,was,0,0
202700,significantly,0,0
202701,faster,0,0
202702,with,0,0
202703,bupivacaine-CO2,1,1
202704,and,0,0
202705,-HCl,1,1
202706,at,0,0
202707,a,0,0
202708,temperature,0,0
202709,of,0,0
202710,36,0,0
202711,degrees,0,0
202712,C,0,0
202713,as,0,0
202714,compared,0,0
202715,to,0,0
202716,4,0,0
202717,degrees,0,0
202718,or,0,0
202719,20,0,0
202720,degrees,0,0
202721,C,0,0
202722,(,0,0
202723,P,0,0
202724,less,0,0
202725,than,0,0
202726,0.05,0,0
202727,),0,0
202728,(,0,0
202729,Figs,0,0
202730,.,0,0
202731,1,0,0
202732,",",0,0
202733,2,0,0
202734,and,0,0
202735,Table,0,0
202736,2,0,0
202737,),0,0
202738,.,0,0
202739,(,0,0
202740,ABSTRACT,0,0
202741,TRUNCATED,0,1
202742,AT,0,1
202743,250,0,1
202744,WORDS,0,0
202745,),0,0
202746,Metabolic,0,0
202747,and,0,0
202748,ventilatory,0,0
202749,responses,0,0
202750,during,0,0
202751,very,1,0
202752,low,1,0
202753,level,1,0
202754,exercise,1,1
202755,.,1,0
202756,1,0,0
202757,.,0,0
202758,Nine,0,1
202759,male,0,0
202760,and,0,0
202761,six,0,0
202762,female,0,0
202763,healthy,0,0
202764,subjects,0,0
202765,were,0,0
202766,studied,0,0
202767,during,0,0
202768,supine,1,1
202769,bicycle,1,1
202770,exercise,1,1
202771,at,0,0
202772,workloads,0,0
202773,of,0,0
202774,12,0,0
202775,and,0,0
202776,37,0,0
202777,W,0,0
202778,;,0,0
202779,pedalling,0,0
202780,rates,0,0
202781,varied,0,0
202782,between,0,0
202783,30,0,0
202784,and,0,0
202785,50,0,0
202786,cycles/min,0,0
202787,at,0,0
202788,each,0,0
202789,workload,0,0
202790,.,0,0
202791,Measurements,0,0
202792,were,0,0
202793,made,0,0
202794,of,0,0
202795,oxygen,0,1
202796,consumption,0,0
202797,(,0,0
202798,VO2,0,1
202799,),0,0
202800,",",0,0
202801,carbon,0,1
202802,dioxide,0,1
202803,production,0,0
202804,(,0,0
202805,VCO2,0,0
202806,),0,0
202807,",",0,0
202808,minute,0,0
202809,ventilation,0,1
202810,(,0,0
202811,VE,0,0
202812,),0,0
202813,",",0,0
202814,tidal,0,0
202815,volume,0,0
202816,(,0,0
202817,VT,0,1
202818,),0,0
202819,",",0,0
202820,respiratory,0,0
202821,frequency,0,0
202822,(,0,0
202823,fR,0,0
202824,),0,0
202825,",",0,0
202826,inspiratory,0,0
202827,and,0,0
202828,expiratory,0,0
202829,time,0,0
202830,(,0,0
202831,TI,0,0
202832,",",0,0
202833,TE,0,1
202834,),0,0
202835,and,0,0
202836,mean,0,0
202837,inspiratory,0,0
202838,flow,0,0
202839,(,0,0
202840,VT/TI,0,0
202841,),0,0
202842,using,0,0
202843,a,0,0
202844,non-invasive,0,0
202845,canopy-computer-spirometer,0,1
202846,system,0,0
202847,.,0,0
202848,2,0,0
202849,.,0,0
202850,At,0,0
202851,rest,0,0
202852,",",0,0
202853,males,0,0
202854,had,0,0
202855,greater,0,0
202856,values,0,0
202857,of,0,0
202858,VE,0,0
202859,",",0,0
202860,VT,0,0
202861,",",0,0
202862,TI,0,0
202863,",",0,0
202864,inspiratory,0,0
202865,duty,0,1
202866,cycle,0,0
202867,(,0,0
202868,TI/TTOT,0,0
202869,),0,0
202870,",",0,0
202871,VCO2,0,0
202872,and,0,0
202873,VO2,0,1
202874,",",0,0
202875,and,0,0
202876,a,0,0
202877,lower,0,0
202878,fR,0,0
202879,",",0,0
202880,than,0,0
202881,females,0,0
202882,.,0,0
202883,3,0,0
202884,.,0,0
202885,At,0,0
202886,the,0,0
202887,lower,0,0
202888,workload,0,0
202889,",",0,0
202890,VO2,0,0
202891,",",0,0
202892,VCO2,0,0
202893,",",0,0
202894,VE,0,0
202895,",",0,0
202896,VT,0,1
202897,and,0,0
202898,VT/TI,0,0
202899,increased,0,0
202900,linearly,0,0
202901,with,0,0
202902,increasing,0,0
202903,pedalling,0,0
202904,rate,0,0
202905,",",0,0
202906,whereas,0,0
202907,at,0,0
202908,the,0,0
202909,higher,0,0
202910,workload,0,0
202911,there,0,0
202912,was,0,0
202913,a,0,0
202914,decrease,0,0
202915,in,0,0
202916,VO2,0,0
202917,and,0,0
202918,little,0,0
202919,or,0,1
202920,no,0,0
202921,change,0,0
202922,in,0,0
202923,ventilatory,0,0
202924,parameters,0,0
202925,from,0,0
202926,30,0,0
202927,to,0,0
202928,50,0,0
202929,cycles/min,0,0
202930,except,0,0
202931,for,0,0
202932,an,0,0
202933,increase,0,0
202934,in,0,0
202935,fR,0,0
202936,in,0,0
202937,females,0,0
202938,.,0,0
202939,4,0,0
202940,.,0,0
202941,While,0,0
202942,performing,0,0
202943,supine,1,1
202944,exercise,1,1
202945,",",0,0
202946,there,0,0
202947,was,0,0
202948,an,0,0
202949,effect,0,0
202950,of,0,0
202951,pedalling,0,0
202952,rate,0,0
202953,on,0,0
202954,ventilatory,0,0
202955,and,0,0
202956,metabolic,0,0
202957,parameters,0,0
202958,at,0,0
202959,the,0,0
202960,low,0,0
202961,workload,0,0
202962,(,0,0
202963,12,0,0
202964,W,0,1
202965,),0,0
202966,which,0,0
202967,diminished,0,0
202968,at,0,0
202969,the,0,0
202970,higher,0,0
202971,workload,0,0
202972,(,0,0
202973,37,0,0
202974,W,0,0
202975,),0,0
202976,.,0,0
202977,An,0,0
202978,increase,0,0
202979,in,0,0
202980,pedalling,0,0
202981,rate,0,0
202982,appears,0,0
202983,to,0,0
202984,enhance,0,0
202985,efficiency,0,0
202986,at,0,0
202987,these,0,0
202988,low,0,0
202989,workloads,0,0
202990,.,0,0
202991,5,0,0
202992,.,0,0
202993,Differences,0,0
202994,between,0,0
202995,the,0,0
202996,sexes,0,0
202997,during,0,0
202998,exercise,0,1
202999,generally,0,0
203000,include,0,0
203001,:,0,0
203002,(,0,0
203003,a,0,0
203004,),0,0
203005,a,0,0
203006,higher,0,0
203007,breathing,0,0
203008,frequency,0,0
203009,",",0,0
203010,(,0,0
203011,b,0,0
203012,),0,0
203013,a,0,0
203014,greater,0,0
203015,mechanical,0,0
203016,efficiency,0,0
203017,",",0,0
203018,and,0,0
203019,(,0,0
203020,c,0,0
203021,),0,0
203022,lower,0,0
203023,ventilatory,0,0
203024,equivalents,0,0
203025,of,0,0
203026,O2,0,0
203027,and,0,0
203028,CO2,0,1
203029,(,0,0
203030,VE/VO2,0,0
203031,and,0,0
203032,VE/VCO2,0,1
203033,),0,0
203034,during,0,0
203035,the,0,0
203036,higher,0,0
203037,workload,0,0
203038,in,0,0
203039,females,0,0
203040,than,0,0
203041,males,0,0
203042,.,0,0
203043,Serum,0,0
203044,C-peptide,0,1
203045,after,0,0
203046,6,0,0
203047,months,0,0
203048,on,0,0
203049,glibenclamide,1,1
203050,remains,0,0
203051,higher,0,0
203052,than,0,0
203053,during,0,0
203054,insulin,0,0
203055,treatment,0,0
203056,.,0,0
203057,Serum,0,0
203058,C-peptide,0,0
203059,was,0,0
203060,measured,0,0
203061,fasting,0,0
203062,and,0,0
203063,6,1,0
203064,minutes,1,0
203065,after,1,0
203066,glucagon,1,1
203067,(,1,0
203068,1,1,0
203069,mg,1,1
203070,given,1,0
203071,intravenously,1,0
203072,),1,0
203073,in,0,0
203074,49,0,0
203075,patients,0,0
203076,with,0,0
203077,non-insulin-dependent,0,0
203078,diabetes,0,0
203079,mellitus,0,0
203080,",",0,0
203081,after,1,0
203082,4,1,0
203083,and,1,0
203084,6,1,0
203085,months,1,0
203086,of,1,0
203087,successive,1,0
203088,periods,1,0
203089,of,1,0
203090,treatment,1,0
203091,with,1,0
203092,insulin,1,1
203093,and,1,0
203094,oral,1,1
203095,hypoglycaemics,1,1
203096,(,1,0
203097,glibenclamide,1,1
203098,and,1,0
203099,metformin,1,1
203100,),1,0
203101,",",0,0
203102,given,0,0
203103,in,0,0
203104,random,0,0
203105,order,0,0
203106,.,0,0
203107,Glycaemic,0,0
203108,control,0,0
203109,was,0,0
203110,not,0,0
203111,significantly,0,0
203112,different,0,0
203113,on,0,0
203114,the,0,0
203115,two,0,0
203116,treatments,0,0
203117,",",0,0
203118,but,0,0
203119,C-peptide,0,0
203120,was,0,0
203121,much,0,0
203122,higher,0,0
203123,while,0,0
203124,the,0,0
203125,patients,0,0
203126,were,0,0
203127,on,0,0
203128,glibenclamide,0,1
203129,.,0,0
203130,We,0,0
203131,conclude,0,0
203132,that,0,0
203133,glibenclamide,1,1
203134,stimulates,0,0
203135,pancreatic,0,0
203136,insulin,0,0
203137,production,0,0
203138,even,0,0
203139,after,0,0
203140,6,0,0
203141,months,0,0
203142,treatment,0,0
203143,.,0,0
203144,Dexamethasone,1,1
203145,therapy,1,1
203146,and,0,0
203147,cortisol,0,0
203148,excretion,0,0
203149,in,0,0
203150,severe,0,0
203151,pediatric,0,0
203152,head,0,0
203153,injury,0,0
203154,.,0,0
203155,Glucocorticoids,1,0
203156,are,0,0
203157,used,0,0
203158,in,0,0
203159,an,0,0
203160,attempt,0,0
203161,to,0,0
203162,reduce,0,0
203163,brain,0,0
203164,edema,0,0
203165,secondary,0,0
203166,to,0,0
203167,head,0,0
203168,injury,0,0
203169,.,0,0
203170,Nevertheless,0,0
203171,",",0,0
203172,their,0,0
203173,usefulness,0,0
203174,remains,0,0
203175,uncertain,0,0
203176,and,0,0
203177,contradictory,0,0
203178,.,0,0
203179,In,0,0
203180,a,0,0
203181,randomized,0,0
203182,study,0,0
203183,of,0,0
203184,24,0,0
203185,children,0,0
203186,with,0,0
203187,severe,0,0
203188,head,0,0
203189,injury,0,0
203190,",",0,0
203191,urinary,0,0
203192,free,0,0
203193,cortisol,0,0
203194,was,0,0
203195,measured,0,0
203196,by,0,0
203197,radioimmunoassay,1,0
203198,.,1,0
203199,Twelve,0,0
203200,patients,0,0
203201,(,0,0
203202,group,0,0
203203,1,0,0
203204,),0,0
203205,received,0,0
203206,dexamethasone,1,1
203207,and,0,0
203208,12,0,0
203209,(,0,0
203210,group,0,0
203211,2,0,0
203212,),0,0
203213,did,0,0
203214,not,0,0
203215,.,0,0
203216,All,0,0
203217,patients,0,0
203218,were,0,0
203219,treated,0,0
203220,with,0,0
203221,a,0,0
203222,standardized,0,0
203223,regimen,0,0
203224,.,0,0
203225,In,0,0
203226,group,0,0
203227,1,0,0
203228,there,0,0
203229,was,0,0
203230,complete,0,0
203231,suppression,0,0
203232,of,0,0
203233,endogenous,0,0
203234,cortisol,0,0
203235,production,0,0
203236,.,0,0
203237,In,0,0
203238,group,0,0
203239,2,0,0
203240,free,0,0
203241,cortisol,0,0
203242,was,0,0
203243,up,0,0
203244,to,0,0
203245,20-fold,0,0
203246,higher,0,0
203247,than,0,0
203248,under,0,0
203249,basal,0,0
203250,conditions,0,0
203251,and,0,0
203252,reached,0,0
203253,maximum,0,0
203254,values,0,0
203255,on,0,0
203256,days,0,0
203257,1-3,0,0
203258,.,0,0
203259,Since,0,0
203260,the,0,0
203261,excretion,0,0
203262,of,0,0
203263,cortisol,0,0
203264,in,0,0
203265,urine,0,0
203266,reflects,0,0
203267,the,0,0
203268,production,0,0
203269,rate,0,0
203270,closely,0,0
203271,and,0,0
203272,is,0,0
203273,not,0,0
203274,influenced,0,0
203275,by,0,0
203276,liver,0,0
203277,function,0,0
203278,and,0,0
203279,barbiturates,0,1
203280,",",0,0
203281,the,0,0
203282,results,0,0
203283,in,0,0
203284,group,0,0
203285,2,0,0
203286,show,0,0
203287,that,0,0
203288,the,0,0
203289,endogenous,0,0
203290,production,0,0
203291,of,0,0
203292,steroids,0,1
203293,is,0,0
203294,an,0,0
203295,adequate,0,0
203296,reaction,0,0
203297,to,0,0
203298,severe,0,0
203299,head,0,0
203300,injury,0,0
203301,.,0,0
203302,Exogenous,0,0
203303,glucocorticoids,1,1
203304,are,0,0
203305,thus,0,0
203306,unlikely,0,0
203307,to,0,0
203308,have,0,0
203309,any,0,0
203310,more,0,0
203311,beneficial,0,0
203312,effects,0,0
203313,than,0,0
203314,endogenous,0,0
203315,cortisol,1,0
203316,.,1,0
203317,Alpha,1,1
203318,interferon,1,1
203319,clinical,0,0
203320,trial,0,0
203321,for,0,0
203322,multiple,0,0
203323,sclerosis,0,0
203324,:,0,0
203325,design,0,0
203326,considerations,0,0
203327,.,0,0
203328,The,0,0
203329,design,0,0
203330,and,0,0
203331,course,0,0
203332,of,0,0
203333,a,0,0
203334,placebo-controlled,1,1
203335,alpha-2,1,1
203336,interferon,1,1
203337,trial,0,0
203338,in,0,0
203339,MS,0,0
203340,patients,0,0
203341,are,0,0
203342,described,0,0
203343,.,0,0
203344,No,0,0
203345,beneficial,0,0
203346,effect,0,0
203347,of,0,0
203348,the,0,0
203349,interferon,1,1
203350,on,0,0
203351,the,0,0
203352,course,0,0
203353,of,0,0
203354,MS,0,0
203355,could,0,0
203356,be,0,0
203357,shown,0,0
203358,.,0,0
203359,Incidence,0,0
203360,of,0,0
203361,infectious,0,0
203362,symptoms,0,0
203363,after,0,0
203364,radiation,1,1
203365,therapy,1,1
203366,for,0,0
203367,breast,0,0
203368,cancer,0,0
203369,.,0,0
203370,Long-term,0,0
203371,effects,0,0
203372,.,0,0
203373,The,0,0
203374,incidence,0,0
203375,of,0,0
203376,symptoms,0,0
203377,generally,0,0
203378,associated,0,0
203379,with,0,0
203380,infectious,0,0
203381,disease,0,0
203382,was,0,0
203383,assessed,0,0
203384,by,0,0
203385,a,0,0
203386,questionnaire,0,0
203387,sent,0,0
203388,out,0,0
203389,to,0,0
203390,519,0,0
203391,disease-free,0,0
203392,breast,0,0
203393,cancer,0,0
203394,patients,0,0
203395,7,0,0
203396,to,0,0
203397,12,0,0
203398,years,0,0
203399,after,0,0
203400,primary,0,0
203401,treatment,0,0
203402,.,0,0
203403,All,0,0
203404,patients,0,0
203405,were,0,0
203406,treated,0,0
203407,in,0,0
203408,the,0,0
203409,context,0,0
203410,of,0,0
203411,a,0,0
203412,randomized,0,0
203413,trial,0,0
203414,where,0,0
203415,pre-,1,0
203416,and,1,0
203417,postoperative,1,0
203418,radiation,1,1
203419,(,1,0
203420,45,1,0
203421,Gy,1,1
203422,),1,0
203423,was,0,0
203424,evaluated,0,0
203425,versus,0,0
203426,surgery,1,0
203427,only,1,0
203428,.,1,0
203429,The,0,0
203430,results,0,0
203431,indicate,0,0
203432,a,0,0
203433,significantly,0,0
203434,higher,0,0
203435,morbidity,0,0
203436,among,0,0
203437,patients,0,0
203438,treated,0,0
203439,with,0,0
203440,preoperative,1,0
203441,irradiation,1,1
203442,compared,0,0
203443,with,0,0
203444,those,0,0
203445,irradiated,1,1
203446,postoperative,1,0
203447,(,0,0
203448,p,0,0
203449,less,0,0
203450,than,0,0
203451,0.05,0,0
203452,),0,0
203453,.,0,0
203454,This,0,0
203455,increased,0,0
203456,morbidity,0,0
203457,mainly,0,0
203458,seemed,0,0
203459,to,0,0
203460,be,0,0
203461,caused,0,0
203462,by,0,0
203463,symptoms,0,0
203464,usually,0,0
203465,associated,0,0
203466,with,0,0
203467,respiratory,0,0
203468,tract,0,0
203469,infection,0,0
203470,(,0,0
203471,p,0,0
203472,less,0,0
203473,than,0,0
203474,0.05,0,0
203475,),0,0
203476,.,0,0
203477,Although,0,0
203478,statistically,0,0
203479,not,0,0
203480,significant,0,0
203481,the,0,0
203482,preoperatively,1,0
203483,irradiated,1,0
203484,patients,0,0
203485,also,0,0
203486,had,0,0
203487,a,0,0
203488,higher,0,0
203489,morbidity,0,0
203490,than,0,0
203491,those,0,0
203492,treated,0,0
203493,with,0,0
203494,surgery,1,0
203495,alone,0,0
203496,.,0,0
203497,There,0,0
203498,was,0,0
203499,no,0,0
203500,difference,0,0
203501,between,0,0
203502,postoperatively,1,0
203503,irradiated,1,0
203504,patients,0,0
203505,and,0,0
203506,patients,0,0
203507,treated,0,0
203508,with,0,0
203509,surgery,1,0
203510,only,0,0
203511,.,0,0
203512,A,0,0
203513,significantly,0,0
203514,higher,0,0
203515,integral,0,0
203516,dose,0,0
203517,(,0,0
203518,absorbed,0,0
203519,energy,0,0
203520,within,0,0
203521,the,0,0
203522,body,0,0
203523,),0,0
203524,of,0,0
203525,the,0,0
203526,pre-,0,0
203527,compared,0,0
203528,with,0,0
203529,the,0,0
203530,postoperative,0,0
203531,group,0,0
203532,(,0,0
203533,p,0,0
203534,less,0,0
203535,than,0,0
203536,0.025,0,0
203537,),0,0
203538,is,0,0
203539,associated,0,0
203540,with,0,0
203541,the,0,0
203542,differences,0,0
203543,in,0,0
203544,morbidity,0,0
203545,between,0,0
203546,the,0,0
203547,two,0,0
203548,irradiated,0,0
203549,groups,0,0
203550,.,0,0
203551,An,0,0
203552,explanation,0,0
203553,for,0,0
203554,the,0,0
203555,increased,0,0
203556,morbidity,0,0
203557,seems,0,0
203558,to,0,0
203559,be,0,0
203560,that,0,0
203561,the,0,0
203562,volume,0,0
203563,of,0,0
203564,lung,0,0
203565,tissue,0,0
203566,",",0,0
203567,encompassed,0,0
203568,within,0,0
203569,the,0,0
203570,full-dose,0,1
203571,target,0,0
203572,volume,0,0
203573,",",0,0
203574,is,0,0
203575,the,0,0
203576,crucial,0,0
203577,factor,0,0
203578,.,0,0
203579,This,0,0
203580,volume,0,0
203581,was,0,0
203582,considerable,0,0
203583,in,0,0
203584,the,0,0
203585,preoperatively,1,0
203586,treated,1,0
203587,patients,0,0
203588,but,0,0
203589,kept,0,0
203590,at,0,0
203591,a,0,0
203592,minimum,0,0
203593,in,0,0
203594,the,0,0
203595,postoperative,1,0
203596,group,0,0
203597,.,0,0
203598,[,0,0
203599,Prevention,0,1
203600,of,0,0
203601,migraine,0,0
203602,with,0,0
203603,flunarizine,1,1
203604,and,0,0
203605,acetylsalicylic,1,1
203606,acid,1,1
203607,.,1,0
203608,A,0,0
203609,double-blind,0,0
203610,study,0,0
203611,],0,0
203612,.,0,0
203613,UNLABELLED,0,0
203614,30,0,0
203615,children,0,0
203616,between,0,0
203617,7,0,0
203618,and,0,0
203619,17,0,0
203620,years,0,0
203621,suffering,0,0
203622,from,0,0
203623,at,0,0
203624,least,0,0
203625,2,0,0
203626,attacks/month,0,0
203627,of,0,0
203628,common,0,0
203629,or,0,1
203630,classical,0,1
203631,migraine,0,0
203632,since,0,0
203633,more,0,0
203634,than,0,0
203635,1,0,0
203636,year,0,0
203637,were,0,0
203638,studied,0,0
203639,.,0,0
203640,After,0,0
203641,clinical,0,0
203642,exclusion,0,0
203643,of,0,0
203644,symptomatic,0,0
203645,headache,0,0
203646,4,0,0
203647,weeks,0,0
203648,were,0,0
203649,documented,0,0
203650,by,0,0
203651,means,0,0
203652,of,0,0
203653,a,0,0
203654,migraine,0,0
203655,diary,0,1
203656,.,0,0
203657,Prophylaxis,0,1
203658,with,0,0
203659,Calcium,0,1
203660,entry,0,0
203661,blocker,1,1
203662,Flunarizine,1,1
203663,(,1,0
203664,Sibelium,1,1
203665,),1,0
203666,or,0,0
203667,Thromboxane,0,0
203668,A,0,0
203669,inhibitor,0,1
203670,Acetylsalicylic,1,1
203671,acid,1,1
203672,(,1,0
203673,ASS,1,1
203674,),1,0
203675,was,0,0
203676,carried,0,0
203677,out,0,0
203678,in,0,0
203679,a,0,0
203680,double,0,0
203681,blind,0,0
203682,design,0,0
203683,for,0,0
203684,3,0,0
203685,months,0,0
203686,.,0,0
203687,Medication,0,0
203688,was,0,0
203689,given,0,0
203690,as,0,0
203691,one,0,0
203692,dosage,0,0
203693,in,0,0
203694,the,0,0
203695,evening,0,0
203696,:,0,0
203697,2-5,0,0
203698,mg/kg,0,1
203699,KG,0,1
203700,ASS,1,1
203701,or,0,1
203702,5-10,0,1
203703,mg,0,1
203704,Flunarizine,1,1
203705,.,1,0
203706,Documented,0,0
203707,attack,0,0
203708,frequency,0,0
203709,and,0,0
203710,duration,0,0
203711,were,0,0
203712,controlled,0,0
203713,at,0,0
203714,monthly,0,0
203715,physical,0,0
203716,examinations,0,0
203717,.,0,0
203718,Final,0,0
203719,results,0,0
203720,showed,0,0
203721,no,0,0
203722,differences,0,0
203723,in,0,0
203724,significant,0,0
203725,reduction,0,0
203726,of,0,0
203727,attack,0,0
203728,frequency,0,0
203729,or,0,0
203730,symptoms,0,0
203731,between,0,0
203732,both,0,0
203733,different,0,0
203734,therapeutic,0,0
203735,principals,0,0
203736,.,0,0
203737,72.4,0,0
203738,%,0,0
203739,(,0,0
203740,ASS,0,1
203741,73.3,0,0
203742,%,0,0
203743,;,0,0
203744,Flunarizine,1,1
203745,71.4,0,0
203746,%,0,0
203747,),0,0
203748,of,0,0
203749,patients,0,0
203750,were,0,0
203751,attack-free,0,0
203752,or,0,0
203753,had,0,0
203754,at,0,0
203755,least,0,0
203756,a,0,0
203757,50,0,0
203758,%,0,0
203759,reduction,0,0
203760,.,0,0
203761,Migraine,0,0
203762,frequency,0,0
203763,of,0,0
203764,initially,0,0
203765,7-8,0,0
203766,was,0,0
203767,reduced,0,0
203768,to,0,0
203769,1-2,0,0
203770,attacks/month,0,0
203771,.,0,0
203772,Duration,0,0
203773,remained,0,0
203774,constant,0,0
203775,in,0,0
203776,both,0,0
203777,groups,0,0
203778,(,0,0
203779,1-3,0,0
203780,h,0,1
203781,),0,0
203782,.,0,0
203783,Side,0,0
203784,effects,0,0
203785,were,0,0
203786,slight,0,0
203787,body,0,0
203788,weight,0,0
203789,gain,0,0
203790,or,0,1
203791,abdominal,0,0
203792,pain,0,0
203793,after,0,0
203794,intake,0,0
203795,",",0,0
203796,prophylaxis,0,0
203797,had,0,0
203798,not,0,0
203799,to,0,0
203800,be,0,0
203801,interrupted,0,0
203802,therefore,0,0
203803,.,0,0
203804,Longtime,0,0
203805,prognosis,0,0
203806,is,0,0
203807,not,0,0
203808,yet,0,0
203809,possible,0,0
203810,because,0,0
203811,the,0,0
203812,time,0,0
203813,of,0,0
203814,observation,0,0
203815,is,0,0
203816,too,0,0
203817,short,0,0
203818,so,0,0
203819,far,0,0
203820,.,0,0
203821,CONCLUSION,0,0
203822,Both,0,0
203823,substances,0,0
203824,are,0,0
203825,definitely,0,0
203826,useful,0,0
203827,and,0,0
203828,have,0,0
203829,few,0,0
203830,side,0,0
203831,effects,0,0
203832,in,0,0
203833,childhood,0,0
203834,migraine,0,0
203835,.,0,0
203836,If,0,0
203837,the,0,0
203838,response,0,0
203839,to,0,0
203840,one,0,0
203841,is,0,0
203842,insufficient,0,0
203843,the,0,0
203844,other,0,0
203845,substance,0,0
203846,should,0,0
203847,be,0,0
203848,tried,0,0
203849,.,0,0
203850,An,0,0
203851,evaluation,0,0
203852,of,0,0
203853,family,1,0
203854,therapy,1,1
203855,in,0,0
203856,anorexia,0,0
203857,nervosa,0,0
203858,and,0,0
203859,bulimia,0,0
203860,nervosa,0,0
203861,.,0,0
203862,A,0,0
203863,controlled,0,0
203864,trial,0,0
203865,comparing,0,0
203866,family,1,0
203867,therapy,1,1
203868,with,0,0
203869,individual,0,0
203870,supportive,0,1
203871,therapy,0,1
203872,in,0,0
203873,anorexia,0,0
203874,nervosa,0,0
203875,and,0,0
203876,bulimia,0,0
203877,nervosa,0,0
203878,was,0,0
203879,undertaken,0,0
203880,.,0,0
203881,Eighty,0,0
203882,patients,0,0
203883,(,0,0
203884,57,0,0
203885,with,0,0
203886,anorexia,0,0
203887,nervosa,0,0
203888,;,0,0
203889,23,0,0
203890,with,0,0
203891,bulimia,0,0
203892,nervosa,0,0
203893,),0,0
203894,were,0,0
203895,first,0,0
203896,admitted,0,0
203897,to,0,0
203898,a,0,0
203899,specialized,0,0
203900,unit,0,0
203901,to,0,0
203902,restore,0,0
203903,their,0,0
203904,weight,0,0
203905,to,0,0
203906,normal,0,0
203907,.,0,0
203908,Before,0,0
203909,discharge,0,0
203910,",",0,0
203911,they,0,0
203912,were,0,0
203913,randomly,0,0
203914,allocated,0,0
203915,to,0,0
203916,family,1,0
203917,therapy,1,1
203918,or,1,1
203919,the,1,0
203920,control,1,1
203921,treatment,1,0
203922,(,1,0
203923,individual,1,0
203924,supportive,1,1
203925,therapy,1,1
203926,),1,0
203927,.,0,0
203928,After,0,0
203929,one,0,0
203930,year,0,0
203931,of,0,0
203932,psychological,0,0
203933,treatment,0,0
203934,",",0,0
203935,they,0,0
203936,were,0,0
203937,reassessed,0,0
203938,",",0,0
203939,using,0,0
203940,body,0,0
203941,weight,0,0
203942,",",0,0
203943,menstrual,0,0
203944,function,0,0
203945,",",0,0
203946,and,0,0
203947,ratings,0,0
203948,on,0,0
203949,the,0,0
203950,Morgan,0,0
203951,and,0,0
203952,Russell,0,0
203953,scales,0,0
203954,.,0,0
203955,Family,0,0
203956,therapy,0,1
203957,was,0,0
203958,found,0,0
203959,to,0,0
203960,be,0,0
203961,more,0,0
203962,effective,0,0
203963,than,0,0
203964,individual,0,0
203965,therapy,0,1
203966,in,0,0
203967,patients,0,0
203968,whose,0,0
203969,illness,0,0
203970,was,0,0
203971,not,0,0
203972,chronic,0,0
203973,and,0,0
203974,had,0,0
203975,begun,0,0
203976,before,0,0
203977,the,0,0
203978,age,0,0
203979,of,0,0
203980,19,0,0
203981,years,0,0
203982,.,0,0
203983,A,0,0
203984,more,0,0
203985,tentative,0,0
203986,finding,0,0
203987,was,0,0
203988,the,0,0
203989,greater,0,0
203990,value,0,0
203991,of,0,0
203992,individual,0,0
203993,supportive,0,1
203994,therapy,0,1
203995,in,0,0
203996,older,0,0
203997,patients,0,0
203998,.,0,0
203999,To,0,0
204000,our,0,0
204001,knowledge,0,0
204002,",",0,0
204003,this,0,0
204004,is,0,0
204005,the,0,0
204006,first,0,0
204007,controlled,0,0
204008,trial,0,0
204009,of,0,0
204010,family,0,0
204011,therapy,0,1
204012,in,0,0
204013,anorexia,0,0
204014,nervosa,0,0
204015,and,0,0
204016,clarifies,0,0
204017,the,0,0
204018,specific,0,0
204019,indications,0,0
204020,for,0,0
204021,this,0,0
204022,treatment,0,0
204023,.,0,0
204024,Pouch,1,0
204025,versus,1,0
204026,esophagojejunostomy,1,1
204027,after,0,0
204028,total,0,0
204029,gastrectomy,0,0
204030,:,0,0
204031,a,0,0
204032,randomized,0,0
204033,clinical,0,0
204034,trial,0,0
204035,.,0,0
204036,Hemolytic,1,0
204037,streptococcus,1,1
204038,preparation,1,1
204039,OK-432,1,1
204040,;,1,0
204041,beneficial,0,0
204042,adjuvant,0,1
204043,therapy,0,1
204044,in,0,0
204045,recurrent,0,0
204046,gastric,0,0
204047,carcinoma,0,0
204048,.,0,0
204049,The,0,0
204050,administration,0,0
204051,of,0,0
204052,a,0,0
204053,hemolytic,1,0
204054,streptococcus,1,0
204055,preparation,1,1
204056,",",0,0
204057,OK-432,0,1
204058,",",0,0
204059,is,0,0
204060,thought,0,0
204061,to,0,0
204062,be,0,0
204063,of,0,0
204064,therapeutic,0,0
204065,value,0,0
204066,in,0,0
204067,the,0,0
204068,treatment,0,0
204069,of,0,0
204070,cancer,0,0
204071,patients,0,0
204072,through,0,0
204073,a,0,0
204074,stimulatory,0,0
204075,effect,0,0
204076,on,0,0
204077,the,0,0
204078,immune,0,0
204079,system,0,0
204080,.,0,0
204081,In,0,0
204082,order,0,0
204083,to,0,0
204084,evaluate,0,0
204085,any,0,0
204086,beneficial,0,0
204087,effect,0,0
204088,of,0,0
204089,such,0,0
204090,an,0,0
204091,administration,0,0
204092,",",0,0
204093,a,0,0
204094,group,0,0
204095,of,0,0
204096,patients,0,0
204097,with,0,0
204098,recurrent,0,0
204099,gastric,0,0
204100,cancer,0,0
204101,was,0,0
204102,studied,0,0
204103,.,0,0
204104,This,0,0
204105,group,0,0
204106,was,0,0
204107,randomly,0,0
204108,subdivided,0,0
204109,into,0,0
204110,3,1,0
204111,groups,1,0
204112,:,1,0
204113,1,1,0
204114,),1,0
204115,Intradermal,1,0
204116,group,1,0
204117,(,1,0
204118,ID,1,1
204119,Group,1,0
204120,),1,0
204121,",",1,0
204122,42,1,0
204123,patients,1,0
204124,given,1,0
204125,an,1,0
204126,intradermal,1,0
204127,injections,1,1
204128,of,1,0
204129,OK-432,1,0
204130,.,1,0
204131,2,1,0
204132,),1,0
204133,Intramuscular,1,1
204134,group,1,0
204135,(,1,0
204136,IM,1,1
204137,Group,1,0
204138,),1,0
204139,",",1,0
204140,40,1,0
204141,patients,1,0
204142,given,1,0
204143,an,1,0
204144,intramuscular,1,0
204145,injections,1,1
204146,of,1,0
204147,OK-432,1,0
204148,.,1,0
204149,3,1,0
204150,),1,0
204151,Control,1,1
204152,group,1,0
204153,(,1,0
204154,C,1,1
204155,Group,1,0
204156,),1,0
204157,",",1,0
204158,39,1,0
204159,patients,1,0
204160,not,1,0
204161,given,1,0
204162,injections,1,1
204163,.,1,0
204164,Each,0,0
204165,group,0,0
204166,was,0,0
204167,studied,0,0
204168,in,0,0
204169,regards,0,0
204170,to,0,0
204171,the,0,0
204172,length,0,0
204173,of,0,0
204174,survival,0,0
204175,",",0,0
204176,the,0,0
204177,host,0,0
204178,immune,0,0
204179,response,0,0
204180,and,0,0
204181,the,0,0
204182,incidence,0,0
204183,of,0,0
204184,side,0,0
204185,effects,0,0
204186,.,0,0
204187,When,0,0
204188,compared,0,0
204189,to,0,0
204190,the,0,0
204191,IM,0,1
204192,and,0,0
204193,C,0,1
204194,Groups,0,0
204195,",",0,0
204196,the,0,0
204197,ID,0,0
204198,Group,0,0
204199,showed,0,0
204200,improved,0,0
204201,survival,0,0
204202,.,0,0
204203,Accompanying,0,0
204204,this,0,0
204205,improved,0,0
204206,survival,0,0
204207,",",0,0
204208,the,0,0
204209,ID,0,0
204210,Group,0,0
204211,also,0,0
204212,had,0,0
204213,greater,0,0
204214,white,0,0
204215,cell,0,0
204216,and,0,0
204217,lymphocyte,0,0
204218,counts,0,0
204219,",",0,0
204220,a,0,0
204221,greater,0,0
204222,number,0,0
204223,of,0,0
204224,T,0,0
204225,cells,0,0
204226,",",0,0
204227,and,0,0
204228,a,0,0
204229,more,0,0
204230,dramatic,0,0
204231,skin,0,0
204232,reaction,0,0
204233,to,0,0
204234,the,0,0
204235,extracted,0,0
204236,cell,0,0
204237,wall,0,0
204238,polysaccharide,0,0
204239,of,0,0
204240,hemolytic,0,0
204241,streptococcus,0,1
204242,Su-strain,0,0
204243,(,0,0
204244,Su-PS,0,0
204245,),0,0
204246,.,0,0
204247,The,0,0
204248,ID,0,0
204249,Group,0,0
204250,",",0,0
204251,following,0,0
204252,OK-432,0,1
204253,injection,0,1
204254,",",0,0
204255,had,0,0
204256,a,0,0
204257,4.8,0,0
204258,%,0,0
204259,incidence,0,0
204260,of,0,0
204261,fever,0,0
204262,and,0,0
204263,a,0,0
204264,52.4,0,0
204265,%,0,0
204266,incidence,0,0
204267,of,0,0
204268,local,0,0
204269,abscess,0,0
204270,formation,0,0
204271,at,0,0
204272,the,0,0
204273,injection,0,0
204274,site,0,0
204275,.,0,0
204276,90,0,0
204277,%,0,0
204278,of,0,0
204279,the,0,0
204280,IM,0,1
204281,Group,0,0
204282,developed,0,0
204283,fever,0,0
204284,but,0,0
204285,abscess,0,0
204286,formation,0,0
204287,was,0,0
204288,absent,0,0
204289,in,0,0
204290,all,0,0
204291,patients,0,0
204292,.,0,0
204293,From,0,0
204294,these,0,0
204295,results,0,0
204296,",",0,0
204297,it,0,0
204298,was,0,0
204299,concluded,0,0
204300,that,0,0
204301,in,0,0
204302,the,0,0
204303,patients,0,0
204304,tested,0,0
204305,",",0,0
204306,intradermal,0,0
204307,injection,0,0
204308,of,0,0
204309,OK-432,0,1
204310,appears,0,0
204311,to,0,0
204312,be,0,0
204313,clinically,0,0
204314,superior,0,0
204315,to,0,0
204316,intramuscular,0,1
204317,injection,0,0
204318,.,0,0
204319,An,0,0
204320,analysis,0,0
204321,of,0,0
204322,the,0,0
204323,radiation,0,1
204324,related,0,0
204325,morbidity,0,0
204326,observed,0,0
204327,in,0,0
204328,a,0,0
204329,randomized,0,0
204330,trial,0,0
204331,of,0,0
204332,neutron,1,1
204333,therapy,1,1
204334,for,0,0
204335,bladder,0,0
204336,cancer,0,0
204337,.,0,0
204338,This,0,0
204339,report,0,0
204340,is,0,0
204341,an,0,0
204342,analysis,0,0
204343,of,0,0
204344,the,0,0
204345,morbidity,0,0
204346,in,0,0
204347,the,0,0
204348,bladder,0,0
204349,and,0,0
204350,bowel,0,0
204351,observed,0,0
204352,in,0,0
204353,a,0,0
204354,randomized,0,0
204355,trial,0,0
204356,of,0,0
204357,d,1,1
204358,(,1,0
204359,15,1,0
204360,),1,0
204361,+Be,1,1
204362,neutrons,1,1
204363,versus,0,0
204364,megavoltage,1,1
204365,photons,1,0
204366,in,0,0
204367,the,0,0
204368,treatment,0,0
204369,of,0,0
204370,bladder,0,0
204371,cancer,0,0
204372,.,0,0
204373,Acute,0,0
204374,reactions,0,0
204375,in,0,0
204376,the,0,0
204377,bladder,0,0
204378,and,0,0
204379,bowel,0,0
204380,were,0,0
204381,significantly,0,0
204382,worse,0,0
204383,after,0,0
204384,photon,1,0
204385,therapy,1,1
204386,.,1,0
204387,Of,0,0
204388,the,0,0
204389,patients,0,0
204390,treated,0,0
204391,with,0,0
204392,photons,1,0
204393,45.7,0,0
204394,%,0,0
204395,had,0,0
204396,severe,0,0
204397,reactions,0,0
204398,in,0,0
204399,the,0,0
204400,bladder,0,0
204401,compared,0,0
204402,with,0,0
204403,10.6,0,0
204404,%,0,0
204405,after,0,0
204406,neutron,1,1
204407,therapy,1,1
204408,(,0,0
204409,p,0,0
204410,less,0,0
204411,than,0,0
204412,0.001,0,0
204413,),0,0
204414,.,0,0
204415,Severe,0,0
204416,acute,0,0
204417,bowel,0,0
204418,reactions,0,0
204419,were,0,0
204420,observed,0,0
204421,in,0,0
204422,8.5,0,0
204423,%,0,0
204424,of,0,0
204425,the,0,0
204426,patients,0,0
204427,after,0,0
204428,photon,1,1
204429,therapy,1,1
204430,compared,0,0
204431,with,0,0
204432,3.8,0,0
204433,%,0,0
204434,after,0,0
204435,neutron,1,1
204436,therapy,1,1
204437,(,0,0
204438,p,0,0
204439,less,0,0
204440,than,0,0
204441,0.05,0,0
204442,),0,0
204443,.,0,0
204444,Late,0,0
204445,reactions,0,0
204446,were,0,0
204447,significantly,0,0
204448,worse,0,0
204449,after,0,0
204450,neutrons,1,0
204451,.,1,0
204452,Severe,0,0
204453,late,0,0
204454,reactions,0,0
204455,in,0,0
204456,the,0,0
204457,bladder,0,0
204458,were,0,0
204459,seen,0,0
204460,in,0,0
204461,58.5,0,0
204462,%,0,0
204463,of,0,0
204464,patients,0,0
204465,after,0,0
204466,neutron,1,1
204467,therapy,1,1
204468,and,0,0
204469,in,0,0
204470,40.5,0,0
204471,%,0,0
204472,after,0,0
204473,photon,1,1
204474,therapy,1,1
204475,(,0,0
204476,p,0,0
204477,less,0,0
204478,than,0,0
204479,0.05,0,0
204480,),0,0
204481,.,0,0
204482,In,0,0
204483,the,0,0
204484,bowel,0,0
204485,they,0,0
204486,were,0,0
204487,observed,0,0
204488,in,0,0
204489,53.3,0,0
204490,%,0,0
204491,of,0,0
204492,patients,0,0
204493,after,0,0
204494,neutron,1,1
204495,therapy,1,1
204496,compared,0,0
204497,with,0,0
204498,8,0,0
204499,%,0,0
204500,after,0,0
204501,photon,1,1
204502,therapy,1,1
204503,(,0,0
204504,p,0,0
204505,less,0,0
204506,than,0,0
204507,0.0001,0,0
204508,),0,0
204509,.,0,0
204510,The,0,0
204511,disparity,0,0
204512,in,0,0
204513,the,0,0
204514,degree,0,0
204515,of,0,0
204516,early,0,0
204517,and,0,0
204518,late,0,0
204519,complications,0,0
204520,makes,0,0
204521,assessment,0,0
204522,of,0,0
204523,RBE,0,0
204524,values,0,0
204525,difficult,0,0
204526,.,0,0
204527,It,0,0
204528,is,0,0
204529,estimated,0,0
204530,that,0,0
204531,for,0,0
204532,bladder,0,0
204533,morbidity,0,0
204534,the,0,0
204535,RBE,0,0
204536,value,0,0
204537,",",0,0
204538,for,0,0
204539,photon,0,1
204540,dose,0,0
204541,fractions,0,1
204542,of,0,0
204543,2.75,0,0
204544,Gy,0,1
204545,",",0,0
204546,is,0,0
204547,less,0,0
204548,than,0,0
204549,3.3,0,0
204550,for,0,0
204551,early,0,0
204552,reactions,0,0
204553,and,0,0
204554,equal,0,0
204555,to,0,0
204556,3.4,0,0
204557,for,0,0
204558,late,0,0
204559,effects,0,0
204560,.,0,0
204561,The,0,0
204562,respective,0,0
204563,RBE,0,0
204564,values,0,0
204565,for,0,0
204566,early,0,0
204567,and,0,0
204568,late,0,0
204569,effects,0,0
204570,in,0,0
204571,the,0,0
204572,bowel,0,0
204573,are,0,0
204574,less,0,0
204575,than,0,0
204576,3.4,0,0
204577,and,0,0
204578,3.8,0,0
204579,.,0,0
204580,Comparison,0,0
204581,of,0,0
204582,inhaled,1,1
204583,albuterol,1,1
204584,powder,1,1
204585,and,1,0
204586,aerosol,1,1
204587,in,0,0
204588,asthma,0,0
204589,.,0,0
204590,In,0,0
204591,this,0,0
204592,multicenter,0,0
204593,",",0,0
204594,randomized,0,0
204595,",",0,0
204596,double-blind,0,0
204597,study,0,0
204598,comparing,0,0
204599,the,0,0
204600,efficacy,0,0
204601,and,0,0
204602,safety,0,0
204603,of,0,0
204604,aerosolized,1,0
204605,albuterol,1,1
204606,with,1,0
204607,the,1,0
204608,dry,1,0
204609,powder,1,1
204610,formulation,1,0
204611,",",0,0
204612,231,0,0
204613,patients,0,0
204614,with,0,0
204615,chronic,0,0
204616,reversible,0,0
204617,obstructive,0,0
204618,airway,0,0
204619,disease,0,0
204620,were,0,0
204621,randomly,0,0
204622,allocated,0,0
204623,to,0,0
204624,receive,0,0
204625,either,0,0
204626,placebo,1,1
204627,albuterol,1,1
204628,aerosol,1,1
204629,followed,0,0
204630,immediately,0,0
204631,by,0,0
204632,active,1,0
204633,albuterol,1,1
204634,powder,1,1
204635,(,0,0
204636,200,0,1
204637,micrograms,0,1
204638,),0,0
204639,or,0,0
204640,active,1,1
204641,albuterol,1,1
204642,aerosol,1,1
204643,(,0,0
204644,two,0,0
204645,puffs,0,1
204646,",",0,0
204647,180,0,0
204648,micrograms,0,1
204649,),0,0
204650,followed,0,0
204651,immediately,0,0
204652,by,0,0
204653,placebo,1,1
204654,lactose,1,1
204655,powder,1,1
204656,four,0,0
204657,times,0,0
204658,a,0,0
204659,day,0,0
204660,for,0,0
204661,a,0,0
204662,period,0,0
204663,of,0,0
204664,12,0,0
204665,weeks,0,0
204666,.,0,0
204667,No,0,0
204668,statistically,0,0
204669,significant,0,0
204670,differences,0,0
204671,were,0,0
204672,found,0,0
204673,between,0,0
204674,the,0,0
204675,powder,1,1
204676,and,0,0
204677,aerosol,1,1
204678,formulations,0,1
204679,with,0,0
204680,respect,0,0
204681,to,0,0
204682,pulmonary,0,0
204683,function,0,0
204684,",",0,0
204685,length,0,0
204686,of,0,0
204687,time,0,0
204688,mean,0,0
204689,FEV1,0,0
204690,remained,0,0
204691,greater,0,0
204692,than,0,0
204693,or,0,0
204694,equal,0,0
204695,to,0,0
204696,15,0,0
204697,%,0,0
204698,above,0,0
204699,baseline,0,0
204700,",",0,0
204701,physicians,0,0
204702,',0,0
204703,assessments,0,0
204704,of,0,0
204705,patients,0,0
204706,',0,0
204707,clinical,0,0
204708,response,0,0
204709,",",0,0
204710,or,0,0
204711,patients,0,0
204712,',0,0
204713,subjective,0,0
204714,symptom,0,0
204715,scores,0,0
204716,.,0,0
204717,There,0,0
204718,were,0,0
204719,also,0,0
204720,no,0,0
204721,significant,0,0
204722,differences,0,0
204723,between,0,0
204724,treatment,0,0
204725,groups,0,0
204726,in,0,0
204727,cardiovascular,0,0
204728,effects,0,0
204729,",",0,0
204730,laboratory,0,0
204731,values,0,0
204732,",",0,0
204733,or,0,0
204734,adverse,0,0
204735,events,0,0
204736,.,0,0
204737,Among,0,0
204738,patients,0,0
204739,who,0,0
204740,expressed,0,0
204741,a,0,0
204742,preference,0,0
204743,for,0,0
204744,one,0,0
204745,of,0,0
204746,the,0,0
204747,delivery,0,0
204748,systems,0,0
204749,",",0,0
204750,half,0,0
204751,preferred,0,0
204752,using,0,0
204753,the,0,0
204754,powder,0,1
204755,.,0,0
204756,Results,0,0
204757,of,0,0
204758,this,0,0
204759,study,0,0
204760,demonstrate,0,0
204761,that,0,0
204762,200,0,0
204763,micrograms,0,0
204764,of,0,0
204765,albuterol,1,1
204766,powder,1,1
204767,is,0,0
204768,as,0,0
204769,safe,0,0
204770,and,0,0
204771,effective,0,0
204772,as,0,0
204773,180,0,0
204774,micrograms,0,0
204775,of,0,0
204776,albuterol,1,1
204777,aerosol,1,1
204778,.,1,0
204779,The,0,0
204780,efficacy,0,0
204781,and,0,0
204782,safety,0,0
204783,of,0,0
204784,fenfluramine,1,1
204785,in,0,0
204786,autistic,0,0
204787,children,0,0
204788,:,0,0
204789,preliminary,0,0
204790,analysis,0,0
204791,of,0,0
204792,a,0,0
204793,double-blind,0,0
204794,study,0,0
204795,.,0,0
204796,[,0,0
204797,The,0,0
204798,chemotherapy,1,1
204799,of,0,0
204800,advanced,0,0
204801,breast,0,0
204802,cancer,0,0
204803,.,0,0
204804,A,0,0
204805,report,0,0
204806,on,0,0
204807,the,0,0
204808,first,0,0
204809,600,0,0
204810,cases,0,0
204811,in,0,0
204812,a,0,0
204813,cooperative,0,0
204814,programme,0,1
204815,to,0,0
204816,carry,0,0
204817,out,0,0
204818,a,0,0
204819,systematic,0,0
204820,study,0,0
204821,(,0,0
204822,1974-1977,0,0
204823,),0,1
204824,(,0,0
204825,author,0,0
204826,'s,0,1
204827,transl,0,0
204828,),0,0
204829,],0,0
204830,.,0,0
204831,The,0,0
204832,authors,0,0
204833,explain,0,0
204834,the,0,0
204835,objectives,0,0
204836,and,0,0
204837,the,0,0
204838,structure,0,0
204839,of,0,0
204840,a,0,0
204841,programme,0,1
204842,evolved,0,0
204843,for,0,0
204844,the,0,0
204845,methodic,0,0
204846,study,0,0
204847,of,0,0
204848,advanced,0,0
204849,breast,0,0
204850,cancers,0,0
204851,which,0,0
204852,they,0,0
204853,have,0,0
204854,worked,0,0
204855,out,0,0
204856,and,0,0
204857,carried,0,0
204858,out,0,0
204859,in,0,0
204860,cooperation,0,0
204861,with,0,0
204862,the,0,0
204863,departments,0,0
204864,of,0,0
204865,medicine,0,0
204866,in,0,0
204867,eight,0,0
204868,French,0,0
204869,anticancer,0,0
204870,centres,0,0
204871,.,0,0
204872,They,0,0
204873,analyse,0,0
204874,the,0,0
204875,initial,0,0
204876,phases,0,0
204877,",",0,0
204878,which,0,0
204879,correspond,0,0
204880,to,0,0
204881,the,0,0
204882,three,0,0
204883,first,0,0
204884,years,0,0
204885,of,0,0
204886,work,0,0
204887,.,0,0
204888,They,0,0
204889,give,0,0
204890,the,0,0
204891,state,0,0
204892,of,0,0
204893,the,0,0
204894,results,0,0
204895,that,0,0
204896,have,0,0
204897,been,0,0
204898,obtained,0,0
204899,in,0,0
204900,603,0,0
204901,patients,0,0
204902,using,0,0
204903,three,0,0
204904,protocols,0,0
204905,for,0,0
204906,treatment,0,0
204907,.,0,0
204908,These,0,0
204909,consisted,0,0
204910,of,0,0
204911,the,0,0
204912,administration,0,0
204913,in,0,0
204914,interrupted,0,0
204915,doses,0,0
204916,of,0,0
204917,chemotherapy,1,1
204918,which,0,0
204919,consisted,0,0
204920,of,0,0
204921,vincristine,1,1
204922,associated,1,0
204923,for,1,0
204924,the,1,0
204925,one,1,0
204926,part,1,0
204927,with,1,0
204928,cyclophosphamide,1,1
204929,and,1,0
204930,5-fluoro-uracil,1,1
204931,and,0,0
204932,on,0,0
204933,the,0,0
204934,other,0,0
204935,hand,0,0
204936,with,0,0
204937,doxorubicine,1,1
204938,or/and,1,0
204939,with,1,0
204940,methotrexate,1,1
204941,.,1,0
204942,From,0,0
204943,this,0,0
204944,study,0,0
204945,there,0,0
204946,emerged,0,0
204947,the,0,0
204948,value,0,0
204949,of,0,0
204950,combined,1,1
204951,therapy,1,1
204952,using,1,0
204953,doxorubicine,1,1
204954,as,0,0
204955,much,0,0
204956,because,0,0
204957,of,0,0
204958,the,0,0
204959,frequency,0,0
204960,with,0,0
204961,which,0,0
204962,results,0,0
204963,better,0,0
204964,than,0,0
204965,50,0,0
204966,%,0,0
204967,were,0,0
204968,obtained,0,0
204969,(,0,0
204970,in,0,0
204971,a,0,0
204972,randomised,0,0
204973,trial,0,0
204974,),0,0
204975,as,0,0
204976,by,0,0
204977,their,0,0
204978,quality,0,0
204979,",",0,0
204980,which,0,0
204981,was,0,0
204982,made,0,0
204983,clear,0,0
204984,in,0,0
204985,an,0,0
204986,important,0,0
204987,series,0,0
204988,of,0,0
204989,240,0,0
204990,cases,0,0
204991,.,0,0
204992,They,0,0
204993,point,0,0
204994,out,0,0
204995,the,0,0
204996,conditions,0,0
204997,required,0,0
204998,to,0,0
204999,initiate,0,0
205000,the,0,0
205001,place,0,0
205002,of,0,0
205003,such,0,0
205004,a,0,0
205005,scheme,0,0
205006,in,0,0
205007,all,0,0
205008,complex,0,0
205009,therapy,0,1
205010,which,0,0
205011,aims,0,0
205012,as,0,0
205013,much,0,0
205014,at,0,0
205015,palliation,0,0
205016,as,0,0
205017,at,0,0
205018,cure,0,0
205019,",",0,0
205020,and,0,0
205021,point,0,0
205022,out,0,0
205023,how,0,0
205024,important,0,0
205025,it,0,0
205026,is,0,0
205027,to,0,0
205028,be,0,0
205029,methodical,0,0
205030,in,0,0
205031,the,0,0
205032,application,0,0
205033,of,0,0
205034,chemotherapy,1,1
205035,in,0,0
205036,order,0,0
205037,to,0,0
205038,ensure,0,0
205039,its,0,0
205040,development,0,0
205041,as,0,0
205042,an,0,0
205043,anticancer,0,0
205044,therapy,0,1
205045,.,0,0
205046,[,0,0
205047,Opposing,0,0
205048,effects,0,0
205049,of,0,0
205050,propranolol,1,1
205051,and,1,0
205052,diltiazem,1,1
205053,on,0,0
205054,the,0,0
205055,angina,0,0
205056,threshold,0,0
205057,during,0,0
205058,an,0,0
205059,exercise,0,1
205060,test,0,0
205061,in,0,0
205062,patients,0,0
205063,with,0,0
205064,syndrome,0,0
205065,X,0,0
205066,],0,0
205067,.,0,0
205068,Patients,0,0
205069,with,0,0
205070,angina,0,0
205071,pectoris,0,0
205072,",",0,0
205073,exercise,0,1
205074,induced,0,0
205075,myocardial,0,0
205076,ischemia,0,0
205077,",",0,0
205078,normal,0,0
205079,coronary,0,0
205080,arteries,0,0
205081,and,0,0
205082,no,0,0
205083,evidence,0,0
205084,of,0,0
205085,epicardial,0,0
205086,spasm,0,0
205087,",",0,0
205088,i.e,0,0
205089,.,0,0
205090,patients,0,0
205091,with,0,0
205092,syndrome,0,0
205093,x,0,0
205094,",",0,0
205095,have,0,0
205096,been,0,0
205097,suggested,0,0
205098,to,0,0
205099,haven,0,0
205100,inadequate,0,0
205101,increase,0,0
205102,in,0,0
205103,coronary,0,0
205104,blood,0,0
205105,flow,0,0
205106,during,0,0
205107,tachycardia,0,0
205108,",",0,0
205109,possibly,0,0
205110,due,0,0
205111,to,0,0
205112,a,0,0
205113,functional,0,0
205114,disorder,0,0
205115,of,0,0
205116,small,0,0
205117,coronary,0,0
205118,vessels,0,0
205119,.,0,0
205120,To,0,0
205121,evaluate,0,0
205122,the,0,0
205123,best,0,0
205124,medical,0,0
205125,management,0,0
205126,of,0,0
205127,this,0,0
205128,syndrome,0,0
205129,we,0,0
205130,studied,0,0
205131,13,0,0
205132,patients,0,0
205133,who,0,0
205134,showed,0,0
205135,the,0,0
205136,above,0,0
205137,set,0,0
205138,of,0,0
205139,findings,0,0
205140,.,0,0
205141,Patients,0,0
205142,were,0,0
205143,given,0,0
205144,propranolol,1,1
205145,(,0,0
205146,160,0,0
205147,mg,0,1
205148,daily,0,0
205149,),0,0
205150,",",0,0
205151,diltiazem,1,1
205152,(,0,0
205153,360,0,0
205154,mg,0,1
205155,daily,0,0
205156,),0,0
205157,and,1,0
205158,placebo,1,1
205159,for,0,0
205160,2,0,0
205161,weeks,0,0
205162,",",0,0
205163,using,0,0
205164,a,0,0
205165,randomized,0,0
205166,single,0,0
205167,blind,0,0
205168,protocol,0,0
205169,.,0,0
205170,Upright,1,0
205171,bicycle,1,1
205172,ergometer,1,1
205173,testing,1,0
205174,was,0,0
205175,performed,0,0
205176,at,0,0
205177,the,0,0
205178,end,0,0
205179,of,0,0
205180,each,0,0
205181,period,0,0
205182,of,0,0
205183,treatment,0,0
205184,.,0,0
205185,Compared,0,0
205186,to,0,0
205187,placebo,1,1
205188,",",1,0
205189,diltiazem,1,1
205190,significantly,0,0
205191,(,0,0
205192,p,0,0
205193,less,0,0
205194,than,0,0
205195,0.001,0,0
205196,),0,0
205197,prolonged,0,0
205198,exercise,0,1
205199,duration,0,0
205200,(,0,0
205201,x,0,0
205202,+/-,0,0
205203,SD,0,0
205204,:,0,0
205205,365,0,0
205206,+/-,0,0
205207,86,0,0
205208,vs,0,0
205209,303,0,0
205210,+/-,0,0
205211,89,0,0
205212,sec,0,0
205213,),0,0
205214,and,0,0
205215,time,0,0
205216,to,0,0
205217,onset,0,0
205218,of,0,0
205219,angina,0,0
205220,(,0,0
205221,358,0,0
205222,+/-,0,0
205223,88,0,0
205224,vs,0,0
205225,276,0,0
205226,+/-,0,0
205227,90,0,0
205228,sec,0,0
205229,),0,0
205230,.,0,0
205231,Angina,0,0
205232,appeared,0,0
205233,in,0,0
205234,7,0,0
205235,patients,0,0
205236,with,0,0
205237,diltiazem,1,1
205238,vs,0,0
205239,13,0,0
205240,patients,0,0
205241,with,0,0
205242,placebo,1,1
205243,and,0,0
205244,occurred,0,0
205245,at,0,0
205246,a,0,0
205247,higher,0,0
205248,rate,0,0
205249,pressure,0,0
205250,product,0,0
205251,(,0,0
205252,26.3,0,0
205253,+/-,0,0
205254,3.5,0,0
205255,vs,0,0
205256,24.1,0,0
205257,+/-,0,0
205258,2.8,0,0
205259,X,0,0
205260,10,0,0
205261,(,0,0
205262,-3,0,0
205263,),0,0
205264,;,0,0
205265,p,0,0
205266,less,0,0
205267,than,0,0
205268,0.02,0,0
205269,),0,0
205270,.,0,0
205271,Conversely,0,0
205272,",",0,0
205273,following,0,0
205274,propranolol,0,1
205275,exercise,0,1
205276,duration,0,0
205277,and,0,0
205278,time,0,0
205279,to,0,0
205280,onset,0,0
205281,of,0,0
205282,angina,0,0
205283,were,0,0
205284,unchanged,0,0
205285,and,0,0
205286,angina,0,0
205287,appeared,0,0
205288,in,0,0
205289,all,0,0
205290,patients,0,0
205291,at,0,0
205292,a,0,0
205293,lower,0,0
205294,rate,0,0
205295,pressure,0,0
205296,product,0,0
205297,(,0,0
205298,18.3,0,0
205299,+/-,0,0
205300,2.9,0,0
205301,vs,0,0
205302,24.4,0,0
205303,+/-,0,0
205304,3.6,0,0
205305,X,0,0
205306,10,0,0
205307,(,0,0
205308,-3,0,0
205309,),0,0
205310,;,0,0
205311,p,0,0
205312,less,0,0
205313,than,0,0
205314,0.001,0,0
205315,),0,0
205316,.,0,0
205317,The,0,0
205318,most,0,0
205319,likely,0,0
205320,explanations,0,0
205321,for,0,0
205322,these,0,0
205323,findings,0,0
205324,are,0,0
205325,:,0,0
205326,propranolol,1,1
205327,counteracts,0,0
205328,beta,0,0
205329,2-adrenergic,0,1
205330,receptors,0,0
205331,",",0,0
205332,thus,0,0
205333,further,0,0
205334,reducing,0,0
205335,coronary,0,0
205336,reserve,0,0
205337,.,0,0
205338,This,0,0
205339,may,0,0
205340,lower,0,0
205341,the,0,0
205342,anginal,0,0
205343,threshold,0,0
205344,;,0,0
205345,Diltiazem,1,1
205346,reduces,0,0
205347,smooth,0,0
205348,muscle,0,0
205349,tone,0,1
205350,in,0,0
205351,small,0,0
205352,coronary,0,0
205353,vessels,0,0
205354,.,0,0
205355,This,0,0
205356,may,0,0
205357,result,0,0
205358,in,0,0
205359,increased,0,0
205360,coronary,0,0
205361,reserve,0,0
205362,and,0,0
205363,exercise,0,1
205364,duration,0,0
205365,.,0,0
205366,Intravenous,1,0
205367,regional,1,0
205368,anaesthesia,1,1
205369,below,0,0
205370,the,0,0
205371,knee,0,0
205372,.,0,0
205373,A,0,0
205374,cross-over,0,0
205375,study,0,0
205376,with,0,0
205377,prilocaine,1,1
205378,in,0,0
205379,volunteers,0,0
205380,.,0,0
205381,The,0,0
205382,quality,0,0
205383,of,0,0
205384,anaesthesia,0,1
205385,provided,0,0
205386,by,0,0
205387,three,0,0
205388,dosages,0,0
205389,of,0,0
205390,prilocaine,1,1
205391,",",0,0
205392,40,0,0
205393,ml,0,0
205394,0.5,0,0
205395,%,0,0
205396,",",0,0
205397,20,0,0
205398,ml,0,0
205399,1,0,0
205400,%,0,0
205401,",",0,0
205402,or,0,0
205403,40,0,0
205404,ml,0,0
205405,1,0,0
205406,%,0,0
205407,",",0,0
205408,administered,0,0
205409,in,0,0
205410,random,0,0
205411,order,0,0
205412,",",0,0
205413,for,0,0
205414,intravenous,0,1
205415,regional,0,0
205416,anaesthesia,0,1
205417,of,0,0
205418,the,0,0
205419,lower,0,0
205420,extremity,0,0
205421,below,0,0
205422,the,0,0
205423,knee,0,0
205424,was,0,0
205425,compared,0,0
205426,in,0,0
205427,six,0,0
205428,volunteers,0,0
205429,.,0,0
205430,Limited,0,0
205431,sensory,0,0
205432,blockade,0,0
205433,was,0,0
205434,achieved,0,0
205435,in,0,0
205436,the,0,0
205437,groups,0,0
205438,with,0,0
205439,40,0,0
205440,ml,0,0
205441,0.5,0,0
205442,%,0,0
205443,and,0,0
205444,20,0,0
205445,ml,0,0
205446,1,0,0
205447,%,0,0
205448,during,0,0
205449,the,0,0
205450,30-minute,0,1
205451,test,0,0
205452,period,0,0
205453,.,0,0
205454,One,0,0
205455,subject,0,0
205456,was,0,0
205457,not,0,0
205458,fully,0,0
205459,anaesthetised,0,0
205460,with,0,0
205461,any,0,0
205462,of,0,0
205463,the,0,0
205464,dosages,0,0
205465,used,0,0
205466,.,0,0
205467,Recovery,0,0
205468,was,0,0
205469,rapid,0,0
205470,(,0,0
205471,mean,0,0
205472,12-13,0,0
205473,minutes,0,0
205474,),0,0
205475,in,0,0
205476,these,0,0
205477,two,0,0
205478,groups,0,0
205479,.,0,0
205480,In,0,0
205481,two,0,0
205482,subjects,0,0
205483,given,0,0
205484,40,0,0
205485,ml,0,0
205486,of,0,0
205487,1,0,0
205488,%,0,0
205489,",",0,0
205490,complete,0,0
205491,recovery,0,0
205492,took,0,0
205493,90,0,0
205494,minutes,0,0
205495,.,0,0
205496,At,0,0
205497,30,0,0
205498,minutes,0,0
205499,",",0,0
205500,the,0,0
205501,degree,0,0
205502,of,0,0
205503,flexion,0,0
205504,remaining,0,0
205505,in,0,0
205506,the,0,0
205507,great,0,0
205508,toe,0,0
205509,(,0,0
205510,control,0,0
205511,100,0,1
205512,%,0,0
205513,),0,0
205514,was,0,0
205515,4,0,0
205516,%,0,0
205517,in,0,0
205518,the,0,0
205519,groups,0,0
205520,who,0,0
205521,received,0,0
205522,40,0,0
205523,ml,0,0
205524,of,0,0
205525,0.5,0,1
205526,%,0,0
205527,and,0,0
205528,1,0,0
205529,%,0,0
205530,",",0,0
205531,but,0,0
205532,34,0,0
205533,%,0,0
205534,in,0,0
205535,those,0,0
205536,who,0,0
205537,received,0,0
205538,20,0,0
205539,ml,0,0
205540,of,0,0
205541,1,0,0
205542,%,0,0
205543,respectively,0,0
205544,.,0,0
205545,Full,0,0
205546,motor,0,0
205547,recovery,0,0
205548,was,0,0
205549,achieved,0,0
205550,in,0,0
205551,8-9,0,0
205552,minutes,0,0
205553,.,0,0
205554,Five,0,0
205555,of,0,0
205556,six,0,0
205557,volunteers,0,0
205558,who,0,0
205559,received,0,0
205560,the,0,0
205561,400-mg,0,1
205562,dose,0,0
205563,experienced,0,0
205564,subjective,0,0
205565,signs,0,0
205566,of,0,0
205567,central,0,0
205568,nervous,0,0
205569,system,0,1
205570,side,0,0
205571,effects,0,0
205572,when,0,0
205573,the,0,0
205574,cuff,0,0
205575,was,0,0
205576,released,0,0
205577,.,0,0
205578,In,0,0
205579,this,0,0
205580,group,0,0
205581,",",0,0
205582,the,0,0
205583,mean,0,0
205584,plasma,0,0
205585,level,0,0
205586,of,0,0
205587,prilocaine,1,1
205588,at,0,0
205589,2,0,0
205590,minutes,0,0
205591,was,0,0
205592,1.22,0,0
205593,micrograms/ml,0,0
205594,",",0,0
205595,maximum,0,0
205596,2.12,0,0
205597,micrograms/ml,0,0
205598,.,0,0
205599,In,0,0
205600,a,0,0
205601,radiological,0,0
205602,examination,0,0
205603,",",0,0
205604,no,0,0
205605,leak,0,0
205606,of,0,0
205607,contrast,0,0
205608,medium,0,0
205609,under,0,0
205610,the,0,0
205611,tourniquet,0,1
205612,cuff,0,1
205613,(,0,0
205614,300,0,1
205615,mmHg,0,0
205616,),0,0
205617,was,0,0
205618,detected,0,0
205619,.,0,0
205620,The,0,0
205621,development,0,0
205622,of,0,0
205623,anaesthesia,0,1
205624,was,0,0
205625,fastest,0,0
205626,following,0,0
205627,the,0,0
205628,largest,0,0
205629,dose,0,0
205630,",",0,0
205631,but,0,0
205632,the,0,0
205633,large,0,0
205634,number,0,0
205635,of,0,0
205636,central,0,0
205637,side,0,0
205638,effects,0,0
205639,makes,0,0
205640,that,0,0
205641,dosage,0,0
205642,less,0,0
205643,suitable,0,0
205644,for,0,0
205645,clinical,0,0
205646,work,0,0
205647,.,0,0
205648,Beta-adrenoceptor,0,1
205649,blockade,0,0
205650,and,0,0
205651,cardiovascular,0,0
205652,response,0,0
205653,to,0,0
205654,the,0,0
205655,cold,0,1
205656,pressor,0,0
205657,test,0,0
205658,.,0,0
205659,Seven,0,0
205660,healthy,0,0
205661,subjects,0,0
205662,immersed,0,0
205663,a,0,0
205664,hand,0,0
205665,in,0,0
205666,random,0,0
205667,order,0,0
205668,in,0,0
205669,either,0,0
205670,warm,0,0
205671,water,0,1
205672,or,0,1
205673,in,0,0
205674,cold,0,1
205675,water,0,1
205676,at,0,0
205677,5,0,0
205678,degrees,0,0
205679,C,0,0
205680,for,0,0
205681,2,0,0
205682,min,0,0
205683,",",0,0
205684,after,0,0
205685,taking,0,0
205686,orally,0,1
205687,a,0,0
205688,single,0,0
205689,dose,0,0
205690,of,0,0
205691,120,0,0
205692,mg,0,0
205693,of,0,0
205694,propranolol,1,1
205695,or,1,1
205696,a,1,0
205697,placebo,1,1
205698,in,0,0
205699,a,0,0
205700,double,0,0
205701,blind,0,0
205702,fashion,0,0
205703,.,0,0
205704,The,0,0
205705,cold,0,0
205706,stress,0,0
205707,resulted,0,0
205708,in,0,0
205709,a,0,0
205710,significant,0,0
205711,increase,0,0
205712,in,0,0
205713,blood,0,0
205714,pressure,0,0
205715,and,0,0
205716,the,0,0
205717,rate,0,0
205718,pressure,0,0
205719,product,0,0
205720,without,0,0
205721,a,0,0
205722,change,0,0
205723,in,0,0
205724,heart,0,0
205725,rate,0,0
205726,.,0,0
205727,Beta-adrenoceptor,0,1
205728,blockade,0,0
205729,did,0,0
205730,not,0,0
205731,affect,0,0
205732,the,0,0
205733,pressor,0,1
205734,response,0,0
205735,the,0,0
205736,cold,0,0
205737,.,0,0
205738,The,0,0
205739,changes,0,0
205740,induced,0,0
205741,by,0,0
205742,the,0,0
205743,cold,0,1
205744,stress,0,0
205745,in,0,0
205746,the,0,0
205747,cardiovascular,0,0
205748,variables,0,0
205749,in,0,0
205750,the,0,0
205751,placebo,0,1
205752,and,0,0
205753,propranolol,0,1
205754,experiments,0,0
205755,were,0,0
205756,not,0,0
205757,statistically,0,0
205758,different,0,0
205759,.,0,0
205760,The,0,0
205761,highest,0,0
205762,rate,0,0
205763,pressure,0,0
205764,product,0,0
205765,during,0,0
205766,the,0,0
205767,cold,0,1
205768,pressor,0,1
205769,test,0,0
205770,was,0,0
205771,about,0,0
205772,109,0,0
205773,units,0,0
205774,.,0,0
205775,This,0,0
205776,was,0,0
205777,well,0,0
205778,below,0,0
205779,the,0,0
205780,pain,0,0
205781,threshold,0,0
205782,value,0,0
205783,of,0,0
205784,about,0,0
205785,200,0,0
205786,found,0,0
205787,during,0,0
205788,exercise,0,1
205789,in,0,0
205790,patients,0,0
205791,with,0,0
205792,ischaemic,0,0
205793,heart,0,0
205794,disease,0,0
205795,.,0,0
205796,In,0,0
205797,the,0,0
205798,recovery,0,0
205799,phase,0,0
205800,",",0,0
205801,the,0,0
205802,cardiovascular,0,0
205803,variables,0,0
205804,reverted,0,0
205805,to,0,0
205806,pre-immersion,0,0
205807,values,0,0
205808,within,0,0
205809,1,0,0
205810,min,0,0
205811,inspite,0,0
205812,of,0,0
205813,continued,0,0
205814,low,0,0
205815,hand,0,1
205816,skin,0,0
205817,temperature,0,0
205818,.,0,0
205819,Parietal,0,0
205820,cell,0,0
205821,density,0,0
205822,in,0,0
205823,duodenal,0,0
205824,ulcer,0,0
205825,patients,0,0
205826,after,0,0
205827,short-term,0,0
205828,treatment,0,0
205829,with,0,0
205830,cimetidine,1,1
205831,and,1,0
205832,antacids,1,1
205833,.,1,0
205834,In,0,0
205835,a,0,0
205836,prospective,0,0
205837,study,0,0
205838,",",0,0
205839,20,0,0
205840,patients,0,0
205841,with,0,0
205842,endoscopically,0,0
205843,proven,0,0
205844,duodenal,0,0
205845,ulcers,0,0
205846,were,0,0
205847,randomised,0,0
205848,to,0,0
205849,be,0,0
205850,treated,0,0
205851,with,0,0
205852,cimetidine,1,1
205853,1,1,0
205854,g,1,1
205855,daily,1,0
205856,or,1,0
205857,with,1,0
205858,antacids,1,1
205859,350,1,0
205860,mmol,1,0
205861,daily,1,0
205862,.,1,0
205863,The,0,0
205864,duration,0,0
205865,of,0,0
205866,treatment,0,0
205867,was,0,0
205868,30,0,0
205869,days,0,0
205870,",",0,0
205871,but,0,0
205872,this,0,0
205873,was,0,0
205874,extended,0,0
205875,to,0,0
205876,three,0,0
205877,months,0,0
205878,in,0,0
205879,3,0,0
205880,patients,0,0
205881,in,0,0
205882,the,0,0
205883,cimetidine,1,1
205884,group,0,0
205885,and,0,0
205886,4,0,0
205887,patients,0,0
205888,in,0,0
205889,the,0,0
205890,antacid,1,1
205891,group,0,0
205892,.,0,0
205893,A,0,0
205894,morphological,0,0
205895,study,0,0
205896,of,0,0
205897,biopsies,0,0
205898,taken,0,0
205899,via,0,0
205900,a,0,0
205901,gastroscope,0,1
205902,from,0,0
205903,the,0,0
205904,corpus,0,0
205905,mucosa,0,0
205906,showed,0,0
205907,no,0,0
205908,change,0,0
205909,in,0,0
205910,mucosal,0,0
205911,height,0,0
205912,",",0,0
205913,parietal,0,0
205914,cell,0,0
205915,density,0,0
205916,per,0,0
205917,unit,0,0
205918,volume,0,0
205919,or,0,0
205920,changes,0,0
205921,in,0,0
205922,cellular,0,0
205923,infiltration,0,0
205924,after,0,0
205925,30,0,0
205926,and,0,0
205927,90,0,0
205928,days,0,0
205929,treatment,0,0
205930,in,0,0
205931,the,0,0
205932,two,0,0
205933,groups,0,0
205934,.,0,0
205935,Neither,0,0
205936,H-2,1,0
205937,receptor,1,0
205938,blockers,1,1
205939,nor,0,0
205940,antacids,1,1
205941,alter,0,0
205942,mucosal,0,0
205943,height,0,0
205944,or,0,0
205945,parietal,0,0
205946,cell,0,0
205947,density,0,0
205948,.,0,0
205949,Treatment,0,0
205950,was,0,0
205951,not,0,0
205952,found,0,0
205953,to,0,0
205954,induce,0,0
205955,gastritic,0,0
205956,changes,0,0
205957,in,0,0
205958,the,0,0
205959,mucosa,0,0
205960,.,0,0
205961,Prophylactic,1,1
205962,lidocaine,1,1
205963,in,0,0
205964,the,0,0
205965,early,0,0
205966,phase,0,0
205967,of,0,0
205968,suspected,0,0
205969,myocardial,0,0
205970,infarction,0,0
205971,.,0,0
205972,Four,0,0
205973,hundred,0,0
205974,two,0,0
205975,patients,0,0
205976,with,0,0
205977,suspected,0,0
205978,myocardial,0,0
205979,infarction,0,0
205980,seen,0,0
205981,within,0,0
205982,6,0,0
205983,hours,0,0
205984,of,0,0
205985,the,0,0
205986,onset,0,0
205987,of,0,0
205988,symptoms,0,0
205989,entered,0,0
205990,a,0,0
205991,double-blind,0,0
205992,randomized,0,0
205993,trial,0,0
205994,of,0,0
205995,lidocaine,1,1
205996,vs,1,0
205997,placebo,1,1
205998,.,1,0
205999,During,0,0
206000,the,0,0
206001,1,0,0
206002,hour,0,0
206003,after,0,0
206004,administration,0,0
206005,of,0,0
206006,the,0,0
206007,drug,0,0
206008,the,0,0
206009,incidence,0,0
206010,of,0,0
206011,ventricular,0,0
206012,fibrillation,0,0
206013,or,0,1
206014,sustained,0,0
206015,ventricular,0,0
206016,tachycardia,0,0
206017,among,0,0
206018,the,0,0
206019,204,0,0
206020,patients,0,0
206021,with,0,0
206022,acute,0,0
206023,myocardial,0,0
206024,infarction,0,0
206025,was,0,0
206026,low,0,0
206027,",",0,0
206028,1.5,0,0
206029,%,0,0
206030,.,0,0
206031,Lidocaine,1,1
206032,",",0,0
206033,given,0,0
206034,in,0,0
206035,a,0,0
206036,300,0,0
206037,mg,0,0
206038,dose,0,0
206039,intramuscularly,0,1
206040,followed,0,0
206041,by,0,0
206042,100,0,0
206043,mg,0,0
206044,intravenously,0,0
206045,",",0,0
206046,did,0,0
206047,not,0,0
206048,prevent,0,0
206049,sustained,0,0
206050,ventricular,0,0
206051,tachycardia,0,0
206052,",",0,0
206053,although,0,0
206054,there,0,0
206055,was,0,0
206056,a,0,0
206057,significant,0,0
206058,reduction,0,0
206059,in,0,0
206060,the,0,0
206061,number,0,0
206062,of,0,0
206063,patients,0,0
206064,with,0,0
206065,warning,0,0
206066,arrhythmias,0,0
206067,between,0,0
206068,15,0,0
206069,and,0,0
206070,45,0,0
206071,minutes,0,0
206072,after,0,0
206073,the,0,0
206074,administration,0,0
206075,of,0,0
206076,lidocaine,1,1
206077,(,0,0
206078,p,0,0
206079,less,0,0
206080,than,0,0
206081,0.05,0,0
206082,),0,0
206083,.,0,0
206084,The,0,0
206085,average,0,0
206086,plasma,0,0
206087,lidocaine,1,1
206088,level,0,0
206089,10,0,0
206090,minutes,0,0
206091,after,0,0
206092,administration,0,0
206093,for,0,0
206094,patients,0,0
206095,without,0,0
206096,a,0,0
206097,myocardial,0,0
206098,infarction,0,0
206099,was,0,0
206100,significantly,0,0
206101,higher,0,0
206102,than,0,0
206103,that,0,0
206104,for,0,0
206105,patients,0,0
206106,with,0,0
206107,an,0,0
206108,acute,0,0
206109,infarction,0,0
206110,.,0,0
206111,The,0,0
206112,mean,0,0
206113,plasma,0,0
206114,lidocaine,1,1
206115,level,0,0
206116,of,0,0
206117,patients,0,0
206118,on,0,0
206119,beta-blocking,0,0
206120,agents,0,0
206121,was,0,0
206122,no,0,0
206123,different,0,0
206124,from,0,0
206125,that,0,0
206126,in,0,0
206127,patients,0,0
206128,not,0,0
206129,on,0,0
206130,beta,0,1
206131,blocking,0,0
206132,agents,0,0
206133,.,0,0
206134,During,0,0
206135,the,0,0
206136,1-hour,0,1
206137,study,0,0
206138,period,0,0
206139,",",0,0
206140,the,0,0
206141,incidence,0,0
206142,of,0,0
206143,central,0,0
206144,nervous,0,0
206145,system,0,1
206146,side,0,0
206147,effects,0,0
206148,was,0,0
206149,significantly,0,0
206150,greater,0,0
206151,in,0,0
206152,the,0,0
206153,lidocaine,0,1
206154,group,0,0
206155,",",0,0
206156,hypotension,0,0
206157,occurred,0,0
206158,in,0,0
206159,11,0,0
206160,patients,0,0
206161,",",0,0
206162,nine,0,0
206163,of,0,0
206164,whom,0,0
206165,had,0,0
206166,received,0,0
206167,lidocaine,0,1
206168,",",0,0
206169,and,0,0
206170,four,0,0
206171,patients,0,0
206172,died,0,0
206173,from,0,0
206174,asystole,0,0
206175,",",0,0
206176,three,0,0
206177,of,0,0
206178,whom,0,0
206179,had,0,0
206180,had,0,0
206181,lidocaine,1,1
206182,.,1,0
206183,We,0,0
206184,can,0,0
206185,not,0,0
206186,advocate,0,0
206187,the,0,0
206188,administration,0,0
206189,of,0,0
206190,lidocaine,1,1
206191,prophylactically,0,0
206192,in,0,0
206193,the,0,0
206194,early,0,0
206195,hours,0,0
206196,of,0,0
206197,suspected,0,0
206198,myocardial,0,0
206199,infarction,0,0
206200,.,0,0
206201,New,1,0
206202,drug,1,0
206203,trials,1,0
206204,in,0,0
206205,attention,0,0
206206,deficit,0,0
206207,disorder,0,0
206208,.,0,0
206209,Relief,0,0
206210,of,0,0
206211,pain,0,0
206212,by,0,0
206213,infusion,0,1
206214,of,0,0
206215,morphine,1,1
206216,after,0,0
206217,operation,0,0
206218,:,0,0
206219,does,0,0
206220,tolerance,0,0
206221,develop,0,0
206222,?,0,0
206223,To,0,0
206224,see,0,0
206225,whether,0,0
206226,continuous,0,1
206227,intravenous,0,1
206228,infusion,0,1
206229,of,0,0
206230,opiates,0,1
206231,provides,0,0
206232,more,0,0
206233,effective,0,0
206234,postoperative,0,0
206235,relief,0,0
206236,of,0,0
206237,pain,0,0
206238,than,0,0
206239,conventional,0,1
206240,intramuscular,0,1
206241,injection,0,1
206242,these,0,0
206243,regimens,0,0
206244,were,0,0
206245,compared,0,0
206246,in,0,0
206247,a,0,0
206248,prospective,0,0
206249,double,0,0
206250,blind,0,0
206251,trial,0,0
206252,.,0,0
206253,Thirty,0,0
206254,patients,0,0
206255,undergoing,0,0
206256,elective,0,0
206257,cholecystectomy,0,1
206258,were,0,0
206259,allocated,0,0
206260,randomly,0,0
206261,to,0,0
206262,receive,0,0
206263,an,0,0
206264,infusion,0,1
206265,of,0,0
206266,morphine,1,1
206267,or,0,1
206268,an,0,0
206269,infusion,0,1
206270,of,0,0
206271,placebo,1,1
206272,(,0,0
206273,control,0,1
206274,group,0,0
206275,),0,0
206276,for,0,0
206277,24,0,0
206278,hours,0,0
206279,.,0,0
206280,Both,0,0
206281,groups,0,0
206282,were,0,0
206283,allowed,0,0
206284,supplementary,0,1
206285,morphine,1,1
206286,boluses,0,0
206287,as,0,0
206288,requested,0,0
206289,.,0,0
206290,During,0,0
206291,the,0,0
206292,first,0,0
206293,48,0,0
206294,hours,0,0
206295,after,0,0
206296,operation,0,0
206297,the,0,0
206298,degree,0,0
206299,of,0,0
206300,pain,0,0
206301,was,0,0
206302,almost,0,0
206303,identical,0,0
206304,between,0,0
206305,the,0,0
206306,groups,0,0
206307,.,0,0
206308,Surprisingly,0,0
206309,",",0,0
206310,the,0,0
206311,group,0,0
206312,that,0,0
206313,was,0,0
206314,given,0,0
206315,the,0,0
206316,infusion,0,1
206317,of,0,0
206318,morphine,0,1
206319,received,0,0
206320,as,0,0
206321,much,0,0
206322,supplementary,0,1
206323,morphine,1,1
206324,as,0,0
206325,the,0,0
206326,control,0,0
206327,group,0,0
206328,during,0,0
206329,the,0,0
206330,first,0,0
206331,24,0,0
206332,hours,0,0
206333,and,0,0
206334,appreciably,0,0
206335,more,0,0
206336,during,0,0
206337,the,0,0
206338,24,0,0
206339,hours,0,0
206340,after,0,0
206341,the,0,0
206342,infusion,0,0
206343,had,0,0
206344,been,0,0
206345,withdrawn,0,0
206346,.,0,0
206347,Nausea,0,0
206348,and,0,0
206349,vomiting,0,0
206350,were,0,0
206351,more,0,0
206352,prevalent,0,0
206353,among,0,0
206354,the,0,0
206355,patients,0,0
206356,given,0,0
206357,the,0,0
206358,infusion,0,1
206359,of,0,0
206360,morphine,1,1
206361,.,1,0
206362,These,0,0
206363,results,0,0
206364,suggest,0,0
206365,that,0,0
206366,continuous,0,1
206367,infusion,0,1
206368,of,0,0
206369,morphine,1,1
206370,may,0,0
206371,be,0,0
206372,an,0,0
206373,inferior,0,0
206374,regimen,0,0
206375,to,0,0
206376,intermittent,0,1
206377,bolus,0,1
206378,administration,0,0
206379,in,0,0
206380,the,0,0
206381,relief,0,0
206382,of,0,0
206383,postoperative,0,0
206384,pain,0,0
206385,.,0,0
206386,This,0,0
206387,may,0,0
206388,be,0,0
206389,explained,0,0
206390,by,0,0
206391,the,0,0
206392,development,0,0
206393,of,0,0
206394,tolerance,0,0
206395,in,0,0
206396,patients,0,0
206397,who,0,0
206398,received,0,0
206399,the,0,0
206400,infusion,0,1
206401,of,0,0
206402,morphine,1,1
206403,.,1,0
206404,Drug,0,1
206405,preference,0,0
206406,in,0,0
206407,normal,0,0
206408,volunteers,0,0
206409,:,0,0
206410,effects,0,0
206411,of,0,0
206412,age,0,0
206413,and,0,0
206414,time,0,0
206415,of,0,0
206416,day,0,0
206417,.,0,0
206418,These,0,0
206419,experiments,0,0
206420,assessed,0,0
206421,the,0,0
206422,influence,0,0
206423,of,0,0
206424,two,0,0
206425,variables,0,0
206426,",",0,0
206427,age,0,0
206428,of,0,0
206429,subjects,0,0
206430,and,0,0
206431,time,0,0
206432,of,0,0
206433,drug,0,0
206434,administration,0,0
206435,",",0,0
206436,on,0,0
206437,the,0,0
206438,reinforcing,0,0
206439,properties,0,0
206440,of,0,0
206441,amphetamine,1,1
206442,and,0,0
206443,of,0,0
206444,diazepam,1,1
206445,in,0,0
206446,normal,0,0
206447,volunteers,0,0
206448,.,0,0
206449,Three,0,0
206450,groups,0,0
206451,of,0,0
206452,subjects,0,0
206453,were,0,0
206454,tested,0,0
206455,:,0,0
206456,i,0,0
206457,),0,0
206458,a,0,0
206459,group,0,0
206460,of,0,0
206461,40-55-year-old,0,0
206462,subjects,0,0
206463,(,0,0
206464,AGE,0,1
206465,group,0,0
206466,;,0,0
206467,N,0,0
206468,=,0,0
206469,11,0,0
206470,),0,0
206471,who,0,0
206472,were,0,0
206473,tested,0,0
206474,in,0,0
206475,the,0,0
206476,morning,0,0
206477,",",0,0
206478,ii,0,0
206479,),0,0
206480,a,0,0
206481,group,0,0
206482,of,0,0
206483,21-35-year-old,0,0
206484,subjects,0,0
206485,(,0,0
206486,CTL,0,0
206487,group,0,0
206488,;,0,0
206489,N,0,0
206490,=,0,0
206491,12,0,0
206492,),0,0
206493,who,0,0
206494,were,0,0
206495,also,0,0
206496,tested,0,0
206497,in,0,0
206498,the,0,0
206499,morning,0,0
206500,",",0,0
206501,and,0,0
206502,iii,0,0
206503,),0,0
206504,a,0,0
206505,group,0,0
206506,of,0,0
206507,21-35-year-olds,0,0
206508,who,0,0
206509,were,0,0
206510,tested,0,0
206511,in,0,0
206512,the,0,0
206513,late,0,0
206514,afternoon,0,0
206515,(,0,0
206516,AFT,0,0
206517,group,0,0
206518,;,0,0
206519,N,0,0
206520,=,0,0
206521,13,0,0
206522,),0,0
206523,.,0,0
206524,All,0,0
206525,subjects,0,0
206526,participated,0,0
206527,in,0,0
206528,three,0,0
206529,separate,0,0
206530,experiments,0,0
206531,comparing,0,0
206532,one,0,0
206533,drug,0,0
206534,(,0,0
206535,5,0,0
206536,mg,0,1
206537,d,1,0
206538,",",1,0
206539,l-amphetamine,1,1
206540,",",0,0
206541,5,0,0
206542,mg,0,1
206543,diazepam,1,1
206544,or,0,0
206545,10,0,0
206546,mg,0,1
206547,diazepam,1,1
206548,),1,0
206549,to,0,0
206550,placebo,1,1
206551,.,1,0
206552,Each,0,0
206553,experiment,0,0
206554,consisted,0,0
206555,of,0,0
206556,nine,0,0
206557,sessions,0,0
206558,:,0,0
206559,On,0,0
206560,the,0,0
206561,first,0,0
206562,four,0,0
206563,sessions,0,0
206564,subjects,0,0
206565,sampled,0,0
206566,two,0,0
206567,color-coded,0,0
206568,capsules,0,1
206569,on,0,0
206570,alternate,0,1
206571,sessions,0,1
206572,and,0,0
206573,on,0,0
206574,the,0,0
206575,following,0,0
206576,five,0,0
206577,sessions,0,0
206578,they,0,0
206579,chose,0,0
206580,and,0,0
206581,ingested,0,1
206582,the,0,0
206583,capsule,0,1
206584,they,0,0
206585,preferred,0,0
206586,.,0,0
206587,Subjective,0,0
206588,effects,0,0
206589,of,0,0
206590,the,0,0
206591,drugs,0,0
206592,were,0,0
206593,monitored,0,0
206594,using,0,0
206595,the,0,0
206596,Profile,0,0
206597,of,0,0
206598,Mood,0,0
206599,States,0,0
206600,(,0,0
206601,POMS,0,0
206602,),0,0
206603,and,0,0
206604,a,0,0
206605,shortened,0,0
206606,version,0,0
206607,of,0,0
206608,the,0,0
206609,Addiction,0,0
206610,Research,0,0
206611,Center,0,0
206612,Inventory,0,1
206613,(,0,0
206614,ARCI,0,1
206615,),0,0
206616,.,0,0
206617,Subjects,0,0
206618,in,0,0
206619,all,0,0
206620,three,0,0
206621,groups,0,0
206622,chose,0,0
206623,5,0,0
206624,mg,0,0
206625,diazepam,1,1
206626,as,0,0
206627,often,0,0
206628,as,0,0
206629,placebo,0,1
206630,but,0,0
206631,preferred,0,0
206632,placebo,1,1
206633,to,0,0
206634,10,0,0
206635,mg,0,0
206636,diazepam,1,1
206637,.,1,0
206638,In,0,0
206639,contrast,0,0
206640,",",0,0
206641,they,0,0
206642,chose,0,0
206643,amphetamine,1,1
206644,either,0,0
206645,as,0,0
206646,often,0,0
206647,as,0,0
206648,or,0,0
206649,more,0,0
206650,often,0,0
206651,than,0,0
206652,placebo,1,1
206653,.,1,0
206654,The,0,0
206655,subjective,0,0
206656,effects,0,0
206657,of,0,0
206658,diazepam,1,1
206659,(,0,0
206660,i.e,0,0
206661,.,0,1
206662,sedation,0,0
206663,),0,0
206664,were,0,0
206665,similar,0,0
206666,across,0,0
206667,all,0,0
206668,three,0,0
206669,groups,0,0
206670,",",0,0
206671,but,0,0
206672,after,0,0
206673,amphetamine,0,1
206674,the,0,0
206675,AGE,0,1
206676,group,0,0
206677,showed,0,0
206678,greater,0,0
206679,stimulant,0,0
206680,effects,0,0
206681,.,0,0
206682,In,0,0
206683,addition,0,0
206684,",",0,0
206685,the,0,0
206686,AFT,0,0
206687,group,0,0
206688,showed,0,0
206689,fewer,0,0
206690,positive,0,0
206691,mood,0,0
206692,effects,0,0
206693,after,0,0
206694,amphetamine,0,1
206695,than,0,0
206696,the,0,0
206697,CTL,0,0
206698,group,0,0
206699,.,0,0
206700,(,0,0
206701,ABSTRACT,0,0
206702,TRUNCATED,0,1
206703,AT,0,1
206704,250,0,1
206705,WORDS,0,0
206706,),0,0
206707,[,0,0
206708,The,0,0
206709,use,0,0
206710,of,0,0
206711,cephalosporins,1,1
206712,in,0,0
206713,hospital,0,0
206714,practice,0,0
206715,],0,0
206716,.,0,0
206717,Therapist,0,1
206718,success,0,0
206719,and,0,0
206720,its,0,0
206721,determinants,0,0
206722,.,0,0
206723,This,0,0
206724,study,0,0
206725,examined,0,0
206726,the,0,0
206727,relatively,0,0
206728,unexplored,0,0
206729,contribution,0,0
206730,of,0,0
206731,the,0,0
206732,therapist,0,1
206733,'s,0,0
206734,performance,0,0
206735,in,0,0
206736,determining,0,0
206737,outcomes,0,0
206738,of,0,0
206739,treatment,0,0
206740,.,0,0
206741,Nine,0,1
206742,therapists,0,0
206743,were,0,0
206744,studied,1,0
206745,:,1,0
206746,three,1,0
206747,performed,1,0
206748,supportive-expressive,1,0
206749,psychotherapy,1,1
206750,;,1,0
206751,three,1,0
206752,",",1,0
206753,cognitive-behavioral,1,1
206754,psychotherapy,1,1
206755,;,1,0
206756,and,1,0
206757,three,1,0
206758,",",1,0
206759,drug,1,0
206760,counseling,1,1
206761,.,1,0
206762,Profound,0,0
206763,differences,0,0
206764,were,0,0
206765,discovered,0,0
206766,in,0,0
206767,the,0,0
206768,therapists,0,0
206769,',0,0
206770,success,0,0
206771,with,0,0
206772,the,0,0
206773,patients,0,0
206774,in,0,0
206775,their,0,0
206776,case,0,0
206777,loads,0,0
206778,.,0,0
206779,Four,0,0
206780,potential,0,0
206781,determinants,0,0
206782,of,0,0
206783,these,0,0
206784,differences,0,0
206785,were,0,0
206786,explored,0,0
206787,:,0,0
206788,patient,0,0
206789,factors,0,0
206790,;,0,0
206791,therapist,0,1
206792,factors,0,0
206793,;,0,0
206794,patient-therapist,0,1
206795,relationship,0,0
206796,factors,0,0
206797,;,0,0
206798,and,0,0
206799,therapy,0,1
206800,factors,0,0
206801,.,0,0
206802,Results,0,0
206803,showed,0,0
206804,that,0,0
206805,patient,0,0
206806,characteristics,0,0
206807,within,0,0
206808,each,0,0
206809,case,0,0
206810,load,0,0
206811,(,0,0
206812,after,0,0
206813,random,0,0
206814,assignments,0,0
206815,),0,0
206816,were,0,0
206817,similar,0,0
206818,and,0,0
206819,disclosed,0,0
206820,no,0,0
206821,differences,0,0
206822,that,0,0
206823,would,0,0
206824,have,0,0
206825,explained,0,0
206826,the,0,0
206827,differences,0,0
206828,in,0,0
206829,success,0,0
206830,;,0,0
206831,therapist,0,1
206832,'s,0,0
206833,personal,0,1
206834,qualities,0,0
206835,were,0,0
206836,correlated,0,0
206837,with,0,0
206838,outcomes,0,0
206839,but,0,0
206840,not,0,0
206841,significantly,0,0
206842,(,0,0
206843,mean,0,0
206844,r,0,0
206845,=,0,0
206846,.32,0,0
206847,),0,0
206848,;,0,0
206849,an,0,0
206850,early-in-treatment,0,0
206851,measure,0,0
206852,of,0,0
206853,the,0,0
206854,patient-therapist,0,1
206855,relationship,0,0
206856,",",0,0
206857,the,0,0
206858,Helping,0,0
206859,Alliance,0,0
206860,Questionnaire,0,0
206861,",",0,0
206862,yielded,0,0
206863,significant,0,0
206864,correlations,0,0
206865,with,0,0
206866,outcomes,0,0
206867,(,0,0
206868,mean,0,0
206869,r,0,0
206870,=,0,0
206871,.65,0,0
206872,),0,0
206873,;,0,0
206874,among,0,0
206875,the,0,0
206876,therapy,0,1
206877,techniques,0,1
206878,",",0,0
206879,purity,0,0
206880,provided,0,0
206881,significant,0,0
206882,correlations,0,0
206883,with,0,0
206884,outcomes,0,0
206885,(,0,0
206886,mean,0,0
206887,r,0,0
206888,=,0,0
206889,.44,0,0
206890,),0,0
206891,",",0,0
206892,both,0,0
206893,across,0,0
206894,therapists,0,0
206895,and,0,0
206896,within,0,0
206897,each,0,0
206898,therapist,0,1
206899,'s,0,0
206900,case,0,0
206901,load,0,0
206902,.,0,0
206903,The,0,0
206904,three,0,0
206905,therapist-related,0,0
206906,factors,0,0
206907,were,0,0
206908,moderately,0,0
206909,associated,0,0
206910,with,0,0
206911,each,0,0
206912,other,0,0
206913,.,0,0
206914,Mass,0,0
206915,inoculation,0,0
206916,in,0,0
206917,a,0,0
206918,community,0,0
206919,:,0,0
206920,the,0,0
206921,effect,0,0
206922,of,0,0
206923,primary,0,0
206924,prevention,0,0
206925,of,0,0
206926,stress,0,0
206927,reactions,0,0
206928,.,0,0
206929,This,0,0
206930,study,0,0
206931,assessed,0,0
206932,the,0,0
206933,effectiveness,0,0
206934,of,0,0
206935,a,0,0
206936,brief,0,1
206937,",",0,0
206938,situation-specific,0,0
206939,",",0,0
206940,group-administered,0,0
206941,preparatory,0,1
206942,intervention,0,1
206943,in,0,0
206944,a,0,0
206945,nonclient,0,0
206946,school,0,0
206947,population,0,0
206948,undergoing,0,0
206949,mass,1,0
206950,inoculation,1,0
206951,against,1,0
206952,rubella,1,0
206953,.,1,0
206954,Fifty-one,0,0
206955,girls,0,0
206956,were,0,0
206957,randomly,0,0
206958,assigned,0,0
206959,to,0,0
206960,practice,1,0
206961,",",1,0
206962,no-practice,1,1
206963,",",1,0
206964,or,1,0
206965,control,1,0
206966,groups,1,0
206967,.,1,0
206968,Both,0,0
206969,the,0,0
206970,practice,0,0
206971,and,0,0
206972,the,0,0
206973,no-practice,0,1
206974,groups,0,0
206975,received,0,0
206976,information,0,0
206977,that,0,0
206978,described,0,0
206979,the,0,0
206980,inoculation,0,0
206981,procedure,0,0
206982,and,0,0
206983,how,0,0
206984,to,0,0
206985,cope,0,0
206986,with,0,0
206987,it,0,0
206988,by,0,0
206989,using,0,0
206990,cognitive-behavioral,0,1
206991,coping,0,0
206992,skills,0,0
206993,.,0,0
206994,The,0,0
206995,practice,0,0
206996,group,0,0
206997,was,0,0
206998,encouraged,0,0
206999,to,0,0
207000,perform,0,0
207001,coping,0,0
207002,techniques,0,1
207003,of,0,0
207004,this,0,0
207005,type,0,0
207006,",",0,0
207007,whereas,0,0
207008,the,0,0
207009,no-practice,0,1
207010,group,0,0
207011,was,0,0
207012,told,0,0
207013,only,0,0
207014,that,0,0
207015,the,0,0
207016,intervention,0,1
207017,would,0,0
207018,help,0,0
207019,them,0,0
207020,during,0,0
207021,the,0,0
207022,inoculation,0,0
207023,.,0,0
207024,Subjects,0,0
207025,in,0,0
207026,both,0,0
207027,practice,0,0
207028,and,0,0
207029,no-practice,0,1
207030,groups,0,0
207031,reported,0,0
207032,less,0,0
207033,anxiety,0,0
207034,and,0,0
207035,exhibited,0,0
207036,more,0,0
207037,cooperative,0,0
207038,behavior,0,0
207039,during,0,0
207040,inoculation,0,0
207041,than,0,0
207042,subjects,0,0
207043,in,0,0
207044,the,0,0
207045,control,0,0
207046,group,0,0
207047,",",0,0
207048,and,0,0
207049,those,0,0
207050,who,0,0
207051,were,0,0
207052,guided,0,1
207053,and,0,0
207054,prompted,0,0
207055,to,0,0
207056,actively,0,0
207057,practice,0,0
207058,derived,0,0
207059,greater,0,0
207060,benefit,0,0
207061,.,0,0
207062,Comparison,0,0
207063,of,0,0
207064,the,0,0
207065,potassium-,0,1
207066,retaining,0,0
207067,effects,0,0
207068,of,0,0
207069,amiloride,1,1
207070,and,1,0
207071,spironolactone,1,1
207072,in,0,0
207073,hypertensive,0,0
207074,patients,0,0
207075,with,0,0
207076,thiazide-induced,0,0
207077,hypokalaemia,0,0
207078,.,0,0
207079,PRL-8-53,1,0
207080,:,1,0
207081,enhanced,0,0
207082,learning,0,0
207083,and,0,0
207084,subsequent,0,0
207085,retention,0,0
207086,in,0,0
207087,humans,0,0
207088,as,0,0
207089,a,0,0
207090,result,0,0
207091,of,0,0
207092,low,0,0
207093,oral,0,1
207094,doses,0,0
207095,of,0,0
207096,new,0,0
207097,psychotropic,1,1
207098,agent,0,0
207099,.,0,0
207100,The,0,0
207101,effect,0,0
207102,of,0,0
207103,3-,1,1
207104,(,1,0
207105,2-benzylmethylaminoethyl,1,1
207106,),1,1
207107,benzoic,1,1
207108,acid,1,1
207109,methyl,1,1
207110,ester,1,1
207111,hydrochloride,1,1
207112,(,1,0
207113,PRL-8-53,1,1
207114,),1,0
207115,on,0,0
207116,learning,0,0
207117,and,0,0
207118,on,0,0
207119,retention,0,0
207120,of,0,0
207121,verbal,0,1
207122,information,0,0
207123,in,0,0
207124,human,0,0
207125,subjects,0,0
207126,was,0,0
207127,investigated,0,0
207128,.,0,0
207129,Using,0,0
207130,the,0,0
207131,serial,0,0
207132,anticipation,0,0
207133,method,0,0
207134,under,0,0
207135,double-blind,0,0
207136,conditions,0,0
207137,it,0,0
207138,was,0,0
207139,found,0,0
207140,that,0,0
207141,PRL-8-53,1,0
207142,causes,0,0
207143,slight,0,0
207144,improvement,0,0
207145,of,0,0
207146,acquisition,0,0
207147,.,0,0
207148,Retinetion,0,0
207149,of,0,0
207150,verbal,0,1
207151,information,0,0
207152,was,0,0
207153,found,0,0
207154,improved,0,0
207155,to,0,0
207156,a,0,0
207157,statistically,0,0
207158,significant,0,0
207159,degree,0,0
207160,(,0,0
207161,most,0,0
207162,P,0,0
207163,values,0,0
207164,better,0,0
207165,than,0,0
207166,0.01,0,0
207167,",",0,0
207168,some,0,0
207169,better,0,0
207170,than,0,0
207171,0.001,0,0
207172,),0,0
207173,.,0,0
207174,No,0,0
207175,significant,0,0
207176,changes,0,0
207177,were,0,0
207178,found,0,0
207179,for,0,0
207180,either,0,0
207181,visual,0,0
207182,reaction,0,1
207183,time,0,0
207184,or,0,1
207185,motor,0,0
207186,control,0,1
207187,after,0,0
207188,drug,0,0
207189,when,0,0
207190,compared,0,0
207191,with,0,0
207192,placebo,1,1
207193,values,0,0
207194,.,0,0
207195,Joint,0,0
207196,study,0,0
207197,of,0,0
207198,extracranial,0,0
207199,arterial,0,0
207200,occlusion,0,0
207201,.,0,0
207202,VI,0,0
207203,.,0,0
207204,Racial,0,0
207205,differences,0,0
207206,in,0,0
207207,hospitalized,0,0
207208,patients,0,0
207209,with,0,0
207210,ischemic,0,0
207211,stroke,0,0
207212,.,0,0
207213,A,0,0
207214,randomized,0,0
207215,controlled,0,0
207216,trial,0,0
207217,of,0,0
207218,ergotamine,1,1
207219,tartrate,1,1
207220,.,1,0
207221,Protection,0,0
207222,of,0,0
207223,man,0,0
207224,from,0,0
207225,natural,0,0
207226,infection,0,0
207227,with,0,0
207228,influenza,0,1
207229,A2,0,0
207230,Hong,0,1
207231,Kong,0,0
207232,virus,0,0
207233,by,0,0
207234,amantadine,1,1
207235,:,1,0
207236,a,0,0
207237,controlled,0,0
207238,field,0,0
207239,trial,0,0
207240,.,0,0
207241,Prophylactic,0,0
207242,administration,0,0
207243,of,0,0
207244,amantadine,1,1
207245,in,0,0
207246,doses,0,0
207247,of,0,0
207248,100,0,0
207249,mg.,0,0
207250,twice,0,0
207251,a,0,0
207252,day,0,0
207253,offered,0,0
207254,statistically,0,0
207255,significant,0,0
207256,protection,0,0
207257,against,0,0
207258,influenza,0,1
207259,A2,0,0
207260,infection,0,0
207261,in,0,0
207262,a,0,0
207263,double-blind,0,0
207264,field,0,0
207265,trial,0,0
207266,involving,0,0
207267,391,0,0
207268,medical,0,0
207269,student,0,0
207270,volunteers,0,0
207271,during,0,0
207272,the,0,0
207273,influenza,0,1
207274,A2,0,0
207275,Hong,0,0
207276,Kong,0,0
207277,epidemic,0,0
207278,in,0,0
207279,Helsinki,0,0
207280,in,0,0
207281,the,0,0
207282,winter,0,0
207283,of,0,0
207284,1969,0,0
207285,.,0,0
207286,Serologically,0,0
207287,verified,0,0
207288,influenza,0,1
207289,",",0,0
207290,as,0,0
207291,measured,0,0
207292,by,0,0
207293,complement,0,0
207294,fixation,0,1
207295,and/or,0,0
207296,haemagglutination,0,0
207297,inhibition,0,0
207298,",",0,0
207299,occurred,0,0
207300,in,0,0
207301,27,0,0
207302,out,0,0
207303,of,0,0
207304,192,0,0
207305,students,0,0
207306,in,0,0
207307,the,0,0
207308,amantadine,1,1
207309,group,1,0
207310,against,0,0
207311,57,0,0
207312,out,0,0
207313,of,0,0
207314,199,0,0
207315,in,0,0
207316,the,0,0
207317,placebo,1,1
207318,group,1,0
207319,",",0,0
207320,giving,0,0
207321,a,0,0
207322,protection,0,0
207323,rate,0,0
207324,of,0,0
207325,52,0,0
207326,%,0,0
207327,.,0,0
207328,Persistent,0,0
207329,phenothiazine,0,1
207330,dyskinesia,0,0
207331,treated,0,0
207332,with,0,0
207333,tetrabenazine,1,1
207334,.,1,0
207335,Six,0,0
207336,patients,0,0
207337,with,0,0
207338,persistent,0,0
207339,phenothiazine,0,1
207340,dyskinesia,0,0
207341,were,0,0
207342,treated,0,0
207343,in,0,0
207344,a,0,0
207345,double-blind,0,0
207346,controlled,0,0
207347,trial,0,0
207348,with,0,0
207349,tetrabenazine,1,1
207350,100,1,0
207351,mg,1,0
207352,in,1,0
207353,divided,1,0
207354,dosage,1,0
207355,.,1,0
207356,In,0,0
207357,three,0,0
207358,patients,0,0
207359,the,0,0
207360,abnormal,0,0
207361,movements,0,0
207362,were,0,0
207363,abolished,0,0
207364,and,0,0
207365,in,0,0
207366,two,0,0
207367,others,0,0
207368,there,0,0
207369,was,0,0
207370,some,0,0
207371,improvement,0,0
207372,",",0,0
207373,but,0,0
207374,this,0,0
207375,was,0,0
207376,no,0,0
207377,greater,0,0
207378,than,0,0
207379,that,0,0
207380,achieved,0,0
207381,with,0,0
207382,the,0,0
207383,diazepam,1,1
207384,control,0,0
207385,.,0,0
207386,Tetrabenazine,1,1
207387,may,0,0
207388,be,0,0
207389,useful,0,0
207390,in,0,0
207391,the,0,0
207392,treatment,0,0
207393,of,0,0
207394,some,0,0
207395,patients,0,0
207396,with,0,0
207397,persistent,0,0
207398,phenothiazine,0,1
207399,dyskinesia,0,0
207400,.,0,0
207401,Response,0,0
207402,latencies,0,0
207403,to,0,0
207404,auditory,1,0
207405,stimuli,1,1
207406,in,0,0
207407,autistic,0,0
207408,children,0,0
207409,engaged,0,0
207410,in,0,0
207411,self-stimulatory,0,0
207412,behavior,0,0
207413,.,0,0
207414,Triamcinolone,1,1
207415,acetonide,1,1
207416,in,0,0
207417,the,0,0
207418,treatment,0,0
207419,of,0,0
207420,bursitis,0,0
207421,and,0,0
207422,other,0,0
207423,foot,0,0
207424,disorders,0,0
207425,.,0,0
207426,A,0,0
207427,double,0,0
207428,blind,0,0
207429,trial,0,0
207430,of,0,0
207431,terfenadine,1,1
207432,and,0,0
207433,placebo,1,1
207434,in,0,0
207435,hay,0,0
207436,fever,0,0
207437,using,0,0
207438,a,0,0
207439,substitution,0,1
207440,technique,0,1
207441,for,0,0
207442,non-responders,0,0
207443,.,0,0
207444,A,0,0
207445,double-blind,0,0
207446,study,0,0
207447,of,0,0
207448,terfenadine,1,1
207449,and,0,0
207450,placebo,1,1
207451,in,0,0
207452,110,0,0
207453,patients,0,0
207454,suffering,0,0
207455,from,0,0
207456,hay,0,1
207457,fever,0,0
207458,(,0,0
207459,confirmed,0,0
207460,by,0,0
207461,skin,0,0
207462,tests,0,0
207463,),0,0
207464,was,0,0
207465,conducted,0,0
207466,.,0,0
207467,A,0,0
207468,novel,0,0
207469,technique,0,1
207470,was,0,0
207471,applied,0,0
207472,using,0,0
207473,an,0,0
207474,escape,0,0
207475,envelope,0,0
207476,containing,0,1
207477,a,0,0
207478,reference,1,0
207479,drug,1,0
207480,which,0,0
207481,could,0,0
207482,be,0,0
207483,taken,0,0
207484,under,0,0
207485,controlled,0,0
207486,conditions,0,0
207487,if,0,0
207488,",",0,0
207489,after,0,0
207490,48,0,0
207491,hours,0,0
207492,",",0,0
207493,the,0,0
207494,patient,0,0
207495,experienced,0,0
207496,no,0,0
207497,relief,0,0
207498,.,0,0
207499,Significantly,0,0
207500,more,0,0
207501,patients,0,0
207502,on,0,0
207503,placebo,1,1
207504,opened,0,1
207505,the,0,0
207506,envelope,0,0
207507,than,0,0
207508,patients,0,0
207509,taking,0,0
207510,the,0,0
207511,active,0,0
207512,drug,0,0
207513,.,0,0
207514,Terfenadine,1,1
207515,was,0,0
207516,demonstrated,0,0
207517,to,0,0
207518,be,0,0
207519,an,0,0
207520,effective,0,0
207521,drug,0,0
207522,in,0,0
207523,hay,0,0
207524,fever,0,0
207525,and,0,0
207526,produced,0,0
207527,no,0,0
207528,more,0,0
207529,drowsiness,0,0
207530,than,0,0
207531,placebo,0,1
207532,.,0,0
207533,A,0,0
207534,comparative,0,0
207535,trial,0,0
207536,of,0,0
207537,fixed,0,0
207538,ratio,0,0
207539,beta-adrenoceptor,1,1
207540,blocker,1,1
207541,and,1,0
207542,diuretic,1,1
207543,combination,1,1
207544,products,1,0
207545,in,0,0
207546,moderate,0,0
207547,hypertension,0,0
207548,.,0,0
207549,Two,0,0
207550,fixed,0,0
207551,ratio,0,0
207552,combination,0,1
207553,tablets,0,1
207554,",",0,0
207555,10,0,0
207556,mg,0,0
207557,pindolol,1,1
207558,combined,1,0
207559,with,1,0
207560,5,1,0
207561,mg,1,1
207562,clopamide,1,1
207563,and,0,0
207564,100,0,1
207565,mg,0,1
207566,metoprolol,1,1
207567,combined,1,0
207568,with,1,0
207569,12.5,1,0
207570,mg,1,0
207571,hydrochlorothiazide,1,1
207572,",",0,0
207573,were,0,0
207574,compared,0,0
207575,at,0,0
207576,two,0,0
207577,dose,0,0
207578,levels,0,0
207579,in,0,0
207580,a,0,0
207581,double-blind,0,0
207582,crossover,0,0
207583,trial,0,0
207584,in,0,0
207585,10,0,0
207586,previously,0,0
207587,untreated,1,0
207588,hypertensive,0,0
207589,patients,0,0
207590,.,0,0
207591,No,0,0
207592,significant,0,0
207593,difference,0,0
207594,was,0,0
207595,observed,0,0
207596,between,0,0
207597,resting,0,0
207598,blood,0,0
207599,pressure,0,0
207600,on,0,0
207601,the,0,0
207602,two,0,0
207603,combinations,0,0
207604,at,0,0
207605,either,0,0
207606,dose,0,0
207607,level,0,0
207608,.,0,0
207609,Exercise,0,1
207610,systolic,0,0
207611,pressure,0,0
207612,was,0,0
207613,lower,0,0
207614,after,0,0
207615,the,0,0
207616,pindolol/clopamide,1,1
207617,combination,0,1
207618,at,0,0
207619,low,0,0
207620,dose,0,0
207621,(,0,0
207622,p,0,0
207623,less,0,0
207624,than,0,0
207625,0.05,0,0
207626,),0,0
207627,.,0,0
207628,The,0,0
207629,incidence,0,0
207630,of,0,0
207631,side-effects,0,0
207632,in,0,0
207633,this,0,0
207634,trial,0,0
207635,was,0,0
207636,high,0,0
207637,but,0,0
207638,proper,0,0
207639,comparison,0,0
207640,of,0,0
207641,the,0,0
207642,two,0,0
207643,products,0,0
207644,could,0,0
207645,not,0,0
207646,be,0,0
207647,made,0,0
207648,because,0,0
207649,of,0,0
207650,the,0,0
207651,small,0,0
207652,number,0,0
207653,of,0,0
207654,patients,0,0
207655,.,0,0
207656,It,0,0
207657,is,0,0
207658,suggested,0,0
207659,that,0,0
207660,combination,1,0
207661,products,1,0
207662,should,0,0
207663,be,0,0
207664,used,0,0
207665,only,0,0
207666,after,0,0
207667,patients,0,0
207668,have,0,0
207669,failed,0,0
207670,to,0,0
207671,respond,0,0
207672,adequately,0,0
207673,to,0,0
207674,a,0,0
207675,single,0,0
207676,agent,0,0
207677,.,0,0
207678,[,0,0
207679,Local,0,0
207680,application,0,0
207681,of,0,0
207682,anti-cancer,1,0
207683,drugs,1,0
207684,for,0,0
207685,the,0,0
207686,treatment,0,0
207687,of,0,0
207688,malignant,0,0
207689,pleural,0,0
207690,and,0,0
207691,pericardial,0,0
207692,effusion,0,0
207693,],0,0
207694,.,0,0
207695,Pleural,0,0
207696,effusion,0,0
207697,is,0,0
207698,a,0,0
207699,common,0,0
207700,complication,0,0
207701,in,0,0
207702,patients,0,0
207703,with,0,0
207704,malignant,0,0
207705,neoplasm,0,0
207706,.,0,0
207707,A,0,0
207708,randomized,0,0
207709,controlled,0,0
207710,study,0,0
207711,of,0,0
207712,intrapleural,0,1
207713,instillation,0,0
207714,of,0,0
207715,Adriamycin,1,1
207716,(,0,0
207717,control,0,1
207718,group,0,0
207719,",",0,0
207720,30,0,0
207721,patients,0,0
207722,),0,0
207723,and,0,0
207724,Adriamycin,1,1
207725,Nocardia,1,1
207726,rubra,1,0
207727,cell,1,0
207728,wall,1,0
207729,skeleton,1,0
207730,(,0,0
207731,N-CWS,0,1
207732,group,0,0
207733,",",0,0
207734,26,0,0
207735,patients,0,0
207736,),0,0
207737,with,0,0
207738,tube,1,1
207739,thoracostomy,1,1
207740,was,0,0
207741,performed,0,0
207742,in,0,0
207743,55,0,0
207744,patients,0,0
207745,with,0,0
207746,malignant,0,0
207747,pleural,0,0
207748,effusion,0,0
207749,due,0,0
207750,to,0,0
207751,primary,0,0
207752,lung,0,0
207753,cancer,0,0
207754,.,0,0
207755,The,0,0
207756,response,0,0
207757,rates,0,0
207758,for,0,0
207759,control,0,0
207760,of,0,0
207761,pleural,0,0
207762,effusion,0,0
207763,were,0,0
207764,73.4,0,0
207765,%,0,0
207766,in,0,0
207767,the,0,0
207768,N-CWS,1,1
207769,group,1,0
207770,and,0,0
207771,46.1,0,0
207772,%,0,0
207773,in,0,0
207774,the,0,0
207775,N-CWS,1,0
207776,group,1,0
207777,.,1,0
207778,These,0,0
207779,results,0,0
207780,suggest,0,0
207781,that,0,0
207782,intrapleural,0,1
207783,instillation,0,0
207784,using,0,0
207785,a,0,0
207786,combination,0,1
207787,of,0,0
207788,anti-cancer,1,0
207789,agent,1,0
207790,and,1,0
207791,immunopotentiator,1,0
207792,is,0,0
207793,an,0,0
207794,effective,0,0
207795,treatment,0,0
207796,for,0,0
207797,malignant,0,0
207798,pleurisy,0,0
207799,.,0,0
207800,Cardiac,0,0
207801,tamponade,0,0
207802,secondary,0,0
207803,to,0,0
207804,cancer,0,0
207805,is,0,0
207806,a,0,0
207807,life-threatening,0,0
207808,complication,0,0
207809,requiring,0,0
207810,immediate,0,0
207811,treatment,0,0
207812,.,0,0
207813,Twenty-four,0,0
207814,patients,0,0
207815,with,0,0
207816,malignant,0,0
207817,pericardial,0,0
207818,effusion,0,0
207819,were,0,0
207820,treated,0,0
207821,by,0,0
207822,intrapericardial,0,0
207823,instillation,0,0
207824,of,0,0
207825,anti-cancer,1,0
207826,drugs,1,0
207827,",",0,0
207828,such,0,0
207829,as,0,0
207830,Carbazilquinone,1,1
207831,",",1,0
207832,Mitomycin-C,1,1
207833,or,0,1
207834,ACNU,1,0
207835,",",0,0
207836,with,0,0
207837,pericardial,1,0
207838,drainage,1,1
207839,.,1,0
207840,The,0,0
207841,range,0,0
207842,of,0,0
207843,survival,0,0
207844,time,0,0
207845,from,0,0
207846,the,0,0
207847,instillation,0,0
207848,of,0,0
207849,anti-cancer,1,0
207850,drug,1,0
207851,was,0,0
207852,3-365,0,0
207853,days,0,0
207854,(,0,0
207855,average,0,0
207856,days,0,0
207857,),0,0
207858,.,0,0
207859,In,0,0
207860,only,0,0
207861,4,0,0
207862,patients,0,0
207863,",",0,0
207864,reaccumulation,0,0
207865,of,0,0
207866,pericardial,0,0
207867,effusion,0,0
207868,was,0,0
207869,recognized,0,0
207870,.,0,0
207871,There,0,0
207872,were,0,0
207873,no,0,0
207874,serious,0,0
207875,complications,0,0
207876,with,0,0
207877,this,0,0
207878,procedure,0,0
207879,.,0,0
207880,It,0,0
207881,was,0,0
207882,considered,0,0
207883,that,0,0
207884,local,0,0
207885,instillation,0,0
207886,of,0,0
207887,anti-cancer,1,0
207888,agents,1,0
207889,with,0,0
207890,pericardial,1,0
207891,drainage,1,1
207892,was,0,0
207893,a,0,0
207894,useful,0,0
207895,therapeutic,0,0
207896,modality,0,0
207897,for,0,0
207898,malignant,0,0
207899,pericarditis,0,0
207900,.,0,0
207901,Effects,0,0
207902,of,0,0
207903,nutritional,1,1
207904,supplementation,1,1
207905,on,0,0
207906,IQ,0,0
207907,and,0,0
207908,certain,0,0
207909,other,0,0
207910,variables,0,0
207911,associated,0,0
207912,with,0,0
207913,Down,0,0
207914,syndrome,0,0
207915,.,0,0
207916,In,0,0
207917,a,0,0
207918,double-blind,0,0
207919,study,0,0
207920,",",0,0
207921,24,0,0
207922,Down,0,0
207923,syndrome,0,0
207924,children,0,0
207925,",",0,0
207926,ages,0,0
207927,6,0,0
207928,to,0,0
207929,17,0,0
207930,years,0,0
207931,living,0,0
207932,at,0,0
207933,home,0,0
207934,",",0,0
207935,were,0,0
207936,given,0,0
207937,a,0,0
207938,megadose,1,1
207939,multi-vitamin/mineral,1,1
207940,supplement,1,1
207941,for,0,0
207942,4,0,0
207943,months,0,0
207944,.,0,0
207945,A,0,0
207946,matched,0,0
207947,group,0,0
207948,of,0,0
207949,23,0,0
207950,children,0,0
207951,received,0,0
207952,a,0,0
207953,placebo,1,1
207954,in,0,0
207955,identical,0,0
207956,form,0,0
207957,.,0,0
207958,The,0,0
207959,children,0,0
207960,'s,0,0
207961,IQ,0,0
207962,",",0,0
207963,vision,0,0
207964,",",0,0
207965,and,0,0
207966,visual-motor,0,0
207967,integration,0,0
207968,were,0,0
207969,tested,0,0
207970,before,0,0
207971,and,0,0
207972,after,0,0
207973,supplementation,0,1
207974,",",0,0
207975,and,0,0
207976,weekly,0,1
207977,checks,0,0
207978,were,0,0
207979,made,0,0
207980,to,0,0
207981,monitor,0,0
207982,behavioral,0,0
207983,changes,0,0
207984,.,0,0
207985,No,0,0
207986,differences,0,0
207987,were,0,0
207988,found,0,0
207989,on,0,0
207990,any,0,0
207991,measures,0,0
207992,as,0,0
207993,a,0,0
207994,result,0,0
207995,of,0,0
207996,supplementation,0,1
207997,.,0,0
207998,[,0,0
207999,Metastatic,0,0
208000,breast,0,0
208001,cancer,0,0
208002,:,0,0
208003,a,0,0
208004,comparative,0,0
208005,study,0,0
208006,of,0,0
208007,the,0,0
208008,efficacy,0,0
208009,of,0,0
208010,tamoxifen,1,1
208011,and,0,0
208012,the,0,0
208013,sequential,0,0
208014,administration,0,0
208015,of,0,0
208016,tamoxifen,1,1
208017,and,1,0
208018,medroxyprogesterone,1,1
208019,acetate,1,1
208020,],1,0
208021,.,1,0
208022,Seventy-nine,0,0
208023,patients,0,0
208024,with,0,0
208025,an,0,0
208026,histologically,0,0
208027,proven,0,0
208028,disseminated,0,0
208029,breast,0,0
208030,cancer,0,0
208031,",",0,0
208032,never,0,0
208033,treated,0,0
208034,before,0,0
208035,with,0,0
208036,additive,0,0
208037,hormonal,0,0
208038,therapy,0,1
208039,",",0,0
208040,entered,0,0
208041,into,0,0
208042,a,0,0
208043,randomized,0,0
208044,trial,0,0
208045,between,0,0
208046,june,0,0
208047,1981,0,0
208048,and,0,0
208049,december,0,0
208050,1982,0,0
208051,.,0,0
208052,In,0,0
208053,the,0,0
208054,first,0,0
208055,group,0,0
208056,44,0,0
208057,patients,0,0
208058,were,0,0
208059,given,0,0
208060,continually,0,0
208061,a,0,0
208062,daily,0,0
208063,dose,0,0
208064,of,0,0
208065,tamoxifen,1,1
208066,(,1,0
208067,TAM,1,1
208068,),1,0
208069,of,0,0
208070,20,0,0
208071,mg/m2,0,0
208072,.,0,0
208073,In,0,0
208074,the,0,0
208075,2nd,0,0
208076,group,0,0
208077,35,0,0
208078,patients,0,0
208079,were,0,0
208080,given,0,0
208081,a,0,0
208082,daily,0,0
208083,dose,0,0
208084,of,0,0
208085,TAM,1,0
208086,of,0,0
208087,20,0,0
208088,mg/m2,0,0
208089,for,0,0
208090,15,0,0
208091,days,0,0
208092,and,0,0
208093,then,0,0
208094,an,0,0
208095,oral,0,1
208096,daily,0,0
208097,dose,0,0
208098,of,0,0
208099,medroxyprogesterone,1,1
208100,acetate,1,1
208101,of,0,0
208102,350,0,0
208103,mg/m2,0,0
208104,for,0,0
208105,the,0,0
208106,next,0,0
208107,15,0,0
208108,days,0,0
208109,.,0,0
208110,In,0,0
208111,both,0,0
208112,groups,0,0
208113,I,0,0
208114,and,0,0
208115,II,0,0
208116,",",0,0
208117,the,0,0
208118,treatment,0,0
208119,was,0,0
208120,stopped,0,0
208121,at,0,0
208122,the,0,0
208123,first,0,0
208124,manifestation,0,0
208125,of,0,0
208126,progression,0,0
208127,of,0,0
208128,the,0,0
208129,disease,0,0
208130,.,0,0
208131,The,0,0
208132,hormonal,0,0
208133,receptor,0,0
208134,status,0,0
208135,was,0,0
208136,determined,0,0
208137,in,0,0
208138,30,0,0
208139,patients,0,0
208140,of,0,0
208141,the,0,0
208142,group,0,0
208143,I,0,0
208144,and,0,0
208145,23,0,0
208146,patients,0,0
208147,of,0,0
208148,the,0,0
208149,group,0,0
208150,II,0,0
208151,.,0,0
208152,An,0,0
208153,objective,0,0
208154,response,0,0
208155,to,0,0
208156,treatment,0,0
208157,was,0,0
208158,observed,0,0
208159,in,0,0
208160,48,0,0
208161,per,0,0
208162,cent,0,0
208163,of,0,0
208164,the,0,0
208165,patients,0,0
208166,of,0,0
208167,the,0,0
208168,group,0,0
208169,I,0,0
208170,and,0,0
208171,60,0,0
208172,per,0,0
208173,cent,0,0
208174,of,0,0
208175,the,0,0
208176,group,0,0
208177,II,0,0
208178,.,0,0
208179,This,0,0
208180,difference,0,0
208181,is,0,0
208182,not,0,0
208183,significant,0,0
208184,(,0,0
208185,X2,0,1
208186,=,0,0
208187,"1,05",0,0
208188,),0,0
208189,.,0,0
208190,However,0,0
208191,",",0,0
208192,the,0,0
208193,mean,0,0
208194,duration,0,0
208195,of,0,0
208196,therapeutic,0,0
208197,response,0,0
208198,is,0,0
208199,significantly,0,0
208200,higher,0,0
208201,in,0,0
208202,the,0,0
208203,group,0,0
208204,II,0,0
208205,(,0,0
208206,p,0,0
208207,=,0,0
208208,"0,01",0,0
208209,),0,0
208210,.,0,0
208211,A,0,0
208212,comparative,0,0
208213,study,0,0
208214,of,0,0
208215,netilmicin-cefoxitin,1,1
208216,and,0,0
208217,gentamicin-cefoxitin,1,1
208218,in,0,0
208219,surgical,0,0
208220,patients,0,0
208221,with,0,0
208222,serious,0,0
208223,systemic,0,0
208224,infection,0,0
208225,.,0,0
208226,A,0,0
208227,double-blind,0,0
208228,",",0,0
208229,randomized,0,0
208230,study,0,0
208231,of,0,0
208232,gentamicin,1,1
208233,and,0,0
208234,netilmicin,1,1
208235,",",0,0
208236,each,0,0
208237,in,0,0
208238,combination,0,1
208239,with,0,0
208240,cefoxitin,1,1
208241,",",0,0
208242,was,0,0
208243,done,0,0
208244,to,0,0
208245,compare,0,0
208246,their,0,0
208247,respective,0,0
208248,efficacy,0,0
208249,and,0,0
208250,toxicity,0,0
208251,in,0,0
208252,patients,0,0
208253,with,0,0
208254,serious,0,0
208255,systemic,0,0
208256,infection,0,0
208257,.,0,0
208258,Thirty-seven,0,0
208259,surgical,0,0
208260,patients,0,0
208261,were,0,0
208262,evaluated,0,0
208263,for,0,0
208264,efficacy,0,0
208265,and,0,0
208266,46,0,0
208267,patients,0,0
208268,were,0,0
208269,evaluated,0,0
208270,for,0,0
208271,toxicity,0,0
208272,.,0,0
208273,The,0,0
208274,most,0,0
208275,frequently,0,0
208276,cultured,0,0
208277,organisms,0,0
208278,were,0,0
208279,Escherichia,0,0
208280,coli,0,0
208281,(,0,0
208282,15,0,0
208283,),0,0
208284,",",0,0
208285,Klebsiella,0,0
208286,sp,0,0
208287,(,0,0
208288,9,0,0
208289,),0,0
208290,",",0,0
208291,Proteus,0,1
208292,sp,0,0
208293,(,0,0
208294,6,0,0
208295,),0,0
208296,",",0,0
208297,and,0,0
208298,Bacteroides,0,0
208299,sp,0,0
208300,(,0,0
208301,4,0,0
208302,),0,0
208303,.,0,0
208304,For,0,0
208305,23,0,0
208306,patients,0,0
208307,treated,0,0
208308,with,0,0
208309,gentamicin-cefoxitin,1,1
208310,(,0,0
208311,G-C,0,0
208312,),0,0
208313,",",0,0
208314,the,0,0
208315,clinical,0,0
208316,response,0,0
208317,was,0,0
208318,favorable,0,0
208319,in,0,0
208320,20/21,0,0
208321,(,0,0
208322,95.2,0,0
208323,%,0,0
208324,),0,0
208325,evaluable,0,0
208326,cases,0,0
208327,",",0,0
208328,and,0,0
208329,elimination,0,0
208330,or,0,1
208331,marked,0,0
208332,reduction,0,0
208333,of,0,0
208334,33/34,0,0
208335,(,0,0
208336,97.1,0,0
208337,%,0,0
208338,),0,0
208339,organisms,0,0
208340,was,0,0
208341,achieved,0,0
208342,.,0,0
208343,For,0,0
208344,14,0,0
208345,patients,0,0
208346,treated,0,0
208347,with,0,0
208348,netilmicin-cefoxitin,1,1
208349,(,0,0
208350,N-C,0,0
208351,),0,0
208352,",",0,0
208353,the,0,0
208354,clinical,0,0
208355,response,0,0
208356,was,0,0
208357,favorable,0,0
208358,in,0,0
208359,13/13,0,0
208360,(,0,0
208361,100,0,1
208362,%,0,0
208363,),0,0
208364,evaluable,0,0
208365,cases,0,0
208366,",",0,0
208367,and,0,0
208368,19/20,0,0
208369,(,0,0
208370,95,0,0
208371,%,0,0
208372,),0,0
208373,organisms,0,0
208374,were,0,0
208375,eliminated,0,0
208376,or,0,0
208377,markedly,0,0
208378,reduced,0,0
208379,.,0,0
208380,Nephrotoxicity,0,0
208381,was,0,0
208382,defined,0,0
208383,as,0,0
208384,an,0,0
208385,increase,0,0
208386,in,0,0
208387,serum,0,0
208388,creatinine,0,0
208389,to,0,0
208390,greater,0,0
208391,than,0,0
208392,25,0,0
208393,%,0,0
208394,over,0,0
208395,baseline,0,0
208396,with,0,0
208397,an,0,0
208398,absolute,0,0
208399,rise,0,0
208400,of,0,0
208401,at,0,0
208402,least,0,0
208403,0.5,0,0
208404,mg/100,0,0
208405,ml,0,0
208406,to,0,0
208407,a,0,0
208408,value,0,0
208409,greater,0,0
208410,than,0,0
208411,or,0,0
208412,equal,0,0
208413,to,0,0
208414,1.3,0,0
208415,mg/100,0,0
208416,ml,0,0
208417,.,0,0
208418,Based,0,0
208419,on,0,0
208420,these,0,0
208421,criteria,0,0
208422,",",0,0
208423,nephrotoxicity,0,0
208424,was,0,0
208425,seen,0,0
208426,in,0,0
208427,2/27,0,0
208428,(,0,0
208429,7.4,0,0
208430,%,0,0
208431,),0,0
208432,patients,0,0
208433,treated,0,0
208434,with,0,0
208435,G-C,0,0
208436,and,0,0
208437,in,0,0
208438,3/19,0,0
208439,(,0,0
208440,15.8,0,0
208441,%,0,0
208442,),0,0
208443,patients,0,0
208444,treated,0,0
208445,with,0,0
208446,N-C.,0,0
208447,Ototoxicity,0,0
208448,was,0,0
208449,defined,0,0
208450,as,0,0
208451,a,0,0
208452,greater,0,0
208453,than,0,0
208454,20,0,0
208455,dB,0,0
208456,loss,0,0
208457,at,0,0
208458,any,0,0
208459,frequency,0,0
208460,.,0,0
208461,Based,0,0
208462,on,0,0
208463,these,0,0
208464,criteria,0,0
208465,",",0,0
208466,ototoxicity,0,0
208467,was,0,0
208468,seen,0,0
208469,in,0,0
208470,5/27,0,0
208471,(,0,0
208472,18.5,0,0
208473,%,0,0
208474,),0,0
208475,patients,0,0
208476,treated,0,0
208477,with,0,0
208478,G-C,0,0
208479,and,0,0
208480,2/19,0,0
208481,(,0,0
208482,10.5,0,0
208483,%,0,0
208484,),0,0
208485,patients,0,0
208486,treated,0,0
208487,with,0,0
208488,N-C,0,0
208489,.,0,0
208490,The,0,0
208491,data,0,0
208492,show,0,0
208493,no,0,0
208494,significant,0,0
208495,difference,0,0
208496,in,0,0
208497,toxicity,0,0
208498,and,0,0
208499,suggest,0,0
208500,that,0,0
208501,netilmicin,0,1
208502,and,0,0
208503,gentamicin,0,1
208504,are,0,0
208505,both,0,0
208506,highly,0,0
208507,effective,0,0
208508,in,0,0
208509,combination,0,1
208510,with,0,0
208511,cefoxitin,0,1
208512,in,0,0
208513,patients,0,0
208514,who,0,0
208515,have,0,0
208516,serious,0,0
208517,infections,0,0
208518,after,0,0
208519,surgery,0,0
208520,.,0,0
208521,Fat,0,1
208522,embolism,0,0
208523,prophylaxis,0,0
208524,with,0,0
208525,corticosteroids,1,1
208526,.,1,0
208527,A,0,0
208528,prospective,0,0
208529,study,0,0
208530,in,0,0
208531,high-risk,0,0
208532,patients,0,0
208533,.,0,0
208534,The,0,0
208535,efficacy,0,0
208536,of,0,0
208537,corticosteroid,1,1
208538,treatment,0,0
208539,in,0,0
208540,the,0,0
208541,prophylaxis,0,0
208542,of,0,0
208543,the,0,0
208544,fat,0,0
208545,embolism,0,0
208546,syndrome,0,0
208547,was,0,0
208548,evaluated,0,0
208549,in,0,0
208550,a,0,0
208551,prospective,0,0
208552,",",0,0
208553,randomized,0,0
208554,",",0,0
208555,double-blind,0,0
208556,study,0,0
208557,of,0,0
208558,high-risk,0,0
208559,patients,0,0
208560,with,0,0
208561,long-bone,0,0
208562,fractures,0,0
208563,.,0,0
208564,Using,0,0
208565,a,0,0
208566,set,0,0
208567,of,0,0
208568,objective,0,0
208569,diagnostic,0,0
208570,criteria,0,0
208571,",",0,0
208572,we,0,0
208573,saw,0,0
208574,a,0,0
208575,significant,0,0
208576,difference,0,0
208577,in,0,0
208578,the,0,0
208579,incidence,0,0
208580,of,0,0
208581,the,0,0
208582,syndrome,0,0
208583,between,0,0
208584,corticosteroid-,1,1
208585,(,0,0
208586,0,0,0
208587,of,0,0
208588,21,0,0
208589,),0,0
208590,and,0,0
208591,placebo-treated,1,0
208592,patients,0,0
208593,(,0,0
208594,9,0,0
208595,of,0,0
208596,41,0,0
208597,),0,0
208598,(,0,0
208599,p,0,0
208600,less,0,0
208601,than,0,0
208602,0.05,0,0
208603,),0,0
208604,.,0,0
208605,There,0,0
208606,were,0,0
208607,no,0,0
208608,complications,0,0
208609,related,0,0
208610,to,0,0
208611,corticosteroid,1,1
208612,treatment,0,0
208613,.,0,0
208614,No,0,0
208615,routine,0,0
208616,laboratory,0,0
208617,or,0,1
208618,physical,0,0
208619,findings,0,0
208620,reliably,0,0
208621,predicted,0,0
208622,the,0,0
208623,development,0,0
208624,of,0,0
208625,the,0,0
208626,fat,0,0
208627,embolism,0,0
208628,syndrome,0,0
208629,except,0,0
208630,petechial,0,0
208631,rash,0,0
208632,",",0,0
208633,which,0,0
208634,occurred,0,0
208635,only,0,0
208636,in,0,0
208637,5,0,0
208638,placebo-treated,0,0
208639,patients,0,0
208640,who,0,0
208641,developed,0,0
208642,the,0,0
208643,syndrome,0,0
208644,.,0,0
208645,Complement,0,0
208646,activation,0,0
208647,was,0,0
208648,present,0,0
208649,in,0,0
208650,all,0,0
208651,patients,0,0
208652,studied,0,0
208653,who,0,0
208654,had,0,0
208655,the,0,0
208656,syndrome,0,0
208657,(,0,0
208658,5,0,0
208659,of,0,0
208660,27,0,0
208661,),0,0
208662,but,0,0
208663,also,0,0
208664,in,0,0
208665,many,0,0
208666,patients,0,0
208667,who,0,0
208668,did,0,0
208669,not,0,0
208670,meet,0,0
208671,our,0,0
208672,diagnostic,0,0
208673,criteria,0,0
208674,",",0,0
208675,suggesting,0,0
208676,a,0,0
208677,multifactorial,0,0
208678,cause,0,0
208679,.,0,0
208680,These,0,0
208681,data,0,0
208682,support,0,0
208683,the,0,0
208684,prophylactic,0,1
208685,value,0,0
208686,of,0,0
208687,corticosteroid,1,1
208688,treatment,0,0
208689,in,0,0
208690,patients,0,0
208691,at,0,0
208692,high,0,0
208693,risk,0,0
208694,for,0,0
208695,the,0,0
208696,fat,0,0
208697,embolism,0,0
208698,syndrome,0,0
208699,",",0,0
208700,particularly,0,0
208701,if,0,0
208702,several,0,0
208703,unfavorable,0,0
208704,predictors,0,0
208705,are,0,0
208706,present,0,0
208707,.,0,0
208708,Comparison,0,0
208709,of,0,0
208710,tocainide,1,1
208711,and,1,0
208712,prajmalium,1,1
208713,bitartrate,1,1
208714,for,0,0
208715,the,0,0
208716,treatment,0,0
208717,of,0,0
208718,ventricular,0,0
208719,arrhythmias,0,0
208720,.,0,0
208721,The,0,0
208722,antiarrhythmic,0,0
208723,efficacy,0,0
208724,of,0,0
208725,tocainide,1,1
208726,",",0,0
208727,a,0,0
208728,new,0,0
208729,antiarrhythmic,0,0
208730,substance,0,0
208731,",",0,0
208732,has,0,0
208733,been,0,0
208734,compared,0,0
208735,with,0,0
208736,that,0,0
208737,of,0,0
208738,prajmalium,1,1
208739,bitartrate,1,1
208740,",",0,0
208741,a,0,0
208742,drug,0,0
208743,in,0,0
208744,clinical,0,0
208745,use,0,0
208746,for,0,0
208747,many,0,0
208748,years,0,0
208749,in,0,0
208750,the,0,0
208751,German,0,1
208752,speaking,0,0
208753,countries,0,0
208754,.,0,0
208755,The,0,0
208756,investigation,0,0
208757,was,0,0
208758,performed,0,0
208759,as,0,0
208760,a,0,0
208761,double-blind,0,0
208762,cross-over,0,0
208763,study,0,0
208764,in,0,0
208765,20,0,0
208766,patients,0,0
208767,with,0,0
208768,ventricular,0,0
208769,arrhythmias,0,0
208770,(,0,0
208771,VA,0,1
208772,),0,0
208773,of,0,0
208774,various,0,0
208775,origin,0,0
208776,.,0,0
208777,The,0,0
208778,efficacy,0,0
208779,was,0,0
208780,assessed,0,0
208781,by,0,0
208782,serial,0,0
208783,Holter,0,0
208784,monitoring,0,0
208785,.,0,0
208786,Plasma,0,0
208787,levels,0,0
208788,were,0,0
208789,measured,0,0
208790,to,0,0
208791,study,0,0
208792,the,0,0
208793,dose-effect,0,0
208794,relationship,0,0
208795,.,0,0
208796,Applying,0,0
208797,to,0,0
208798,the,0,0
208799,criterion,0,0
208800,of,0,0
208801,a,0,0
208802,reduction,0,0
208803,of,0,0
208804,VA,0,0
208805,of,0,0
208806,more,0,0
208807,than,0,0
208808,75,0,0
208809,%,0,0
208810,or,0,0
208811,an,0,0
208812,improvement,0,0
208813,according,0,0
208814,to,0,0
208815,the,0,0
208816,Lown,0,0
208817,grading,0,0
208818,8,0,0
208819,pts,0,0
208820,.,0,0
208821,under,0,0
208822,tocainide,0,1
208823,and,0,0
208824,7,0,0
208825,under,0,0
208826,prajmalium,1,1
208827,bitartrate,1,1
208828,were,0,0
208829,responders,0,0
208830,.,0,0
208831,Side,0,0
208832,effects,0,0
208833,were,0,0
208834,few,0,0
208835,and,0,0
208836,under,0,0
208837,tocainide,0,1
208838,only,0,0
208839,2,0,0
208840,pts,0,0
208841,.,0,0
208842,had,0,0
208843,to,0,0
208844,discontinue,0,0
208845,the,0,0
208846,therapy,0,1
208847,.,0,0
208848,From,0,0
208849,the,0,0
208850,present,0,0
208851,findings,0,0
208852,tocainide,1,1
208853,and,0,0
208854,prajmalium,1,1
208855,bitartrate,1,1
208856,have,0,0
208857,the,0,0
208858,same,0,0
208859,efficient,0,0
208860,antiarrhythmic,0,0
208861,effects,0,0
208862,in,0,0
208863,the,0,0
208864,majority,0,0
208865,of,0,0
208866,patients,0,0
208867,.,0,0
208868,Absence,0,0
208869,of,0,0
208870,central,0,0
208871,effects,0,0
208872,in,0,0
208873,man,0,0
208874,of,0,0
208875,the,0,0
208876,benzodiazepine,1,1
208877,antagonist,0,1
208878,Ro,1,0
208879,15-1788,1,1
208880,.,1,0
208881,The,0,0
208882,benzodiazepines,0,0
208883,are,0,0
208884,typified,0,0
208885,by,0,0
208886,a,0,0
208887,profile,0,0
208888,of,0,0
208889,side,0,0
208890,effects,0,0
208891,which,0,0
208892,includes,0,0
208893,drowsiness,0,0
208894,",",0,0
208895,ataxia,0,0
208896,and,0,0
208897,incoordination,0,0
208898,.,0,0
208899,Ro,1,0
208900,15-1788,1,1
208901,",",0,0
208902,an,0,0
208903,imidazodiazepine,0,1
208904,derivative,0,0
208905,",",0,0
208906,exhibits,0,0
208907,marked,0,0
208908,antagonism,0,0
208909,of,0,0
208910,the,0,0
208911,behavioural,0,0
208912,and,0,0
208913,biochemical,0,0
208914,effects,0,0
208915,of,0,0
208916,the,0,0
208917,benzodiazepines,0,1
208918,in,0,0
208919,animals,0,0
208920,and,0,0
208921,man,0,0
208922,.,0,0
208923,It,0,0
208924,is,0,0
208925,devoid,0,0
208926,of,0,0
208927,any,0,0
208928,behavioural,0,0
208929,activity,0,0
208930,in,0,0
208931,animals,0,0
208932,",",0,0
208933,except,0,0
208934,at,0,0
208935,very,0,0
208936,high,0,0
208937,doses,0,0
208938,.,0,0
208939,In,0,0
208940,the,0,0
208941,present,0,0
208942,study,0,0
208943,the,0,0
208944,effects,0,0
208945,of,0,0
208946,single,0,0
208947,rising,0,0
208948,oral,0,1
208949,doses,0,0
208950,of,0,0
208951,Ro,1,0
208952,15-1788,1,1
208953,on,0,0
208954,cognitive,0,0
208955,",",0,0
208956,psychomotor,0,0
208957,and,0,0
208958,subjective,0,0
208959,function,0,0
208960,in,0,0
208961,man,0,0
208962,have,0,0
208963,been,0,0
208964,assessed,0,0
208965,using,0,0
208966,a,0,0
208967,battery,0,1
208968,of,0,0
208969,psychometric,0,0
208970,tests,0,0
208971,designed,0,0
208972,to,0,0
208973,identify,0,0
208974,the,0,0
208975,sedative,0,1
208976,action,0,0
208977,of,0,0
208978,the,0,0
208979,benzodiazepines,0,1
208980,.,0,0
208981,At,0,0
208982,all,0,0
208983,doses,0,0
208984,up,0,0
208985,to,0,0
208986,600,0,0
208987,mg,0,0
208988,",",0,0
208989,Ro,0,0
208990,15-1788,0,1
208991,demonstrated,0,0
208992,none,0,0
208993,of,0,0
208994,the,0,0
208995,classical,0,0
208996,behavioural,0,0
208997,effects,0,0
208998,of,0,0
208999,the,0,0
209000,benzodiazepines,0,1
209001,.,0,0
209002,Rational-emotive,1,1
209003,therapy,1,1
209004,and,0,0
209005,the,0,0
209006,reduction,0,0
209007,of,0,0
209008,interpersonal,0,0
209009,anxiety,0,0
209010,in,0,0
209011,junior,0,0
209012,high,0,0
209013,school,0,0
209014,students,0,0
209015,.,0,0
209016,This,0,0
209017,study,0,0
209018,evaluated,0,0
209019,the,0,0
209020,effectiveness,0,0
209021,of,0,0
209022,rational-emotive,1,1
209023,therapy,1,1
209024,and,1,0
209025,rational-emotive,1,0
209026,imagery,1,1
209027,.,1,0
209028,Fifty-nine,0,0
209029,junior,0,0
209030,high,0,0
209031,school,0,0
209032,students,0,0
209033,who,0,0
209034,volunteered,0,0
209035,to,0,0
209036,participate,0,0
209037,in,0,0
209038,treatment,0,0
209039,for,0,0
209040,interpersonal,0,0
209041,anxiety,0,0
209042,were,0,0
209043,randomly,0,0
209044,assigned,0,0
209045,to,0,0
209046,rational-emotive,1,0
209047,therapy,1,1
209048,without,1,1
209049,imagery,1,1
209050,(,1,0
209051,RET,1,0
209052,),1,0
209053,",",1,0
209054,rational-emotive,1,0
209055,therapy,1,1
209056,with,1,0
209057,imagery,1,1
209058,(,1,0
209059,REI,1,1
209060,),1,0
209061,",",1,0
209062,relationship-oriented,1,1
209063,counseling,1,1
209064,(,1,0
209065,ROC,1,1
209066,),1,0
209067,",",1,0
209068,and,1,0
209069,waiting-list,1,1
209070,control,1,1
209071,(,1,0
209072,WLC,1,0
209073,),1,0
209074,groups,1,0
209075,.,1,0
209076,Groups,0,0
209077,met,0,0
209078,for,0,0
209079,seven,0,0
209080,50-minute,0,1
209081,treatment,0,0
209082,sessions,0,1
209083,during,0,0
209084,a,0,0
209085,three-week,0,1
209086,period,0,0
209087,.,0,0
209088,Assessments,0,0
209089,were,0,0
209090,conducted,0,0
209091,at,0,0
209092,pretreatment,0,0
209093,",",0,0
209094,posttreatment,0,0
209095,",",0,0
209096,and,0,0
209097,three-week,0,1
209098,follow-up,0,0
209099,.,0,0
209100,Both,0,0
209101,self-report,0,0
209102,and,0,0
209103,sociometric,0,0
209104,measures,0,0
209105,were,0,0
209106,used,0,0
209107,to,0,0
209108,evaluate,0,0
209109,treatment,0,0
209110,outcome,0,0
209111,.,0,0
209112,At,0,0
209113,postassessment,0,0
209114,",",0,0
209115,both,0,0
209116,the,0,0
209117,RET,0,0
209118,and,0,0
209119,REI,0,0
209120,groups,0,0
209121,were,0,0
209122,rated,0,0
209123,on,0,0
209124,sociometric,0,0
209125,measures,0,0
209126,as,0,0
209127,significantly,0,0
209128,less,0,0
209129,interpersonally,0,0
209130,anxious,0,0
209131,than,0,0
209132,the,0,0
209133,WLC,0,0
209134,group,0,0
209135,.,0,0
209136,Mean,0,0
209137,scores,0,0
209138,favored,0,0
209139,the,0,0
209140,RET,0,0
209141,and,0,0
209142,REI,0,0
209143,groups,0,0
209144,",",0,0
209145,but,0,0
209146,no,0,0
209147,significant,0,0
209148,differences,0,0
209149,between,0,0
209150,these,0,0
209151,groups,0,0
209152,and,0,0
209153,the,0,0
209154,ROC,0,0
209155,group,0,0
209156,were,0,0
209157,obtained,0,0
209158,.,0,0
209159,The,0,0
209160,self-report,0,0
209161,measure,0,0
209162,did,0,0
209163,not,0,0
209164,significantly,0,0
209165,differentiate,0,0
209166,between,0,0
209167,groups,0,0
209168,",",0,0
209169,but,0,0
209170,the,0,0
209171,REI,0,1
209172,group,0,0
209173,demonstrated,0,0
209174,significant,0,0
209175,pre-,0,0
209176,to,0,0
209177,follow-up,0,0
209178,changes,0,0
209179,.,0,0
209180,Both,0,0
209181,the,0,0
209182,RET,0,0
209183,and,0,0
209184,REI,0,0
209185,groups,0,0
209186,yielded,0,0
209187,greater,0,0
209188,reductions,0,0
209189,in,0,0
209190,irrational,0,0
209191,thinking,0,0
209192,than,0,0
209193,did,0,0
209194,the,0,0
209195,ROC,0,0
209196,and,0,0
209197,WLC,0,0
209198,groups,0,0
209199,.,0,0
209200,In,0,0
209201,addition,0,0
209202,",",0,0
209203,the,0,0
209204,pattern,0,0
209205,of,0,0
209206,the,0,0
209207,results,0,0
209208,supported,0,0
209209,the,0,0
209210,use,0,0
209211,of,0,0
209212,rational-emotive,1,0
209213,imagery,1,1
209214,as,0,0
209215,a,0,0
209216,component,0,0
209217,of,0,0
209218,rational-emotive,1,0
209219,therapy,1,1
209220,.,1,0
209221,The,0,0
209222,practical,0,0
209223,implications,0,0
209224,of,0,0
209225,these,0,0
209226,findings,0,0
209227,are,0,0
209228,discussed,0,0
209229,.,0,0
209230,Failure,0,0
209231,of,0,0
209232,pyridoxine,0,1
209233,to,0,0
209234,suppress,0,0
209235,raised,0,0
209236,serum,0,0
209237,prolactin,0,0
209238,levels,0,0
209239,.,0,0
209240,Pyridoxine,0,1
209241,has,0,0
209242,been,0,0
209243,reported,0,0
209244,as,0,0
209245,having,0,0
209246,an,0,0
209247,antilactogenic,0,1
209248,effect,0,0
209249,",",0,0
209250,presumably,0,0
209251,by,0,0
209252,suppressing,0,0
209253,prolactin,0,0
209254,secretion,0,0
209255,.,0,0
209256,We,0,0
209257,have,0,0
209258,measured,0,0
209259,serum,0,0
209260,prolactin,0,0
209261,levels,0,0
209262,during,0,0
209263,pyridoxine,1,1
209264,administration,1,0
209265,in,0,0
209266,two,0,0
209267,groups,0,0
209268,of,0,0
209269,hyperprolactinaemic,1,0
209270,subjects,1,0
209271,.,1,0
209272,In,0,0
209273,normal,0,0
209274,postpartum,0,0
209275,women,0,0
209276,",",0,0
209277,the,0,0
209278,postdelivery,0,0
209279,fall,0,0
209280,in,0,0
209281,serum,0,0
209282,prolactin,0,0
209283,levels,0,0
209284,did,0,0
209285,not,0,0
209286,differ,0,0
209287,significantly,0,0
209288,in,0,0
209289,treated,0,0
209290,and,0,0
209291,control,0,0
209292,subjects,0,0
209293,.,0,0
209294,In,0,0
209295,patients,0,0
209296,with,0,0
209297,chlorpromazine-induced,0,0
209298,hyperprolactinaemia,0,0
209299,and,0,0
209300,galactorrhoea,0,0
209301,",",0,0
209302,pyridoxine,0,1
209303,did,0,0
209304,not,0,0
209305,reduce,0,0
209306,the,0,0
209307,elevated,0,0
209308,levels,0,0
209309,.,0,0
209310,In,0,0
209311,neither,0,0
209312,group,0,0
209313,was,0,0
209314,milk,0,1
209315,production,0,0
209316,suppressed,0,0
209317,.,0,0
209318,[,0,0
209319,Tocolysis,0,0
209320,with,0,0
209321,hexoprenalin,1,1
209322,and,0,0
209323,salbutamol,1,1
209324,in,0,0
209325,a,0,0
209326,clinical,0,0
209327,comparison,0,0
209328,],0,0
209329,.,0,0
209330,140,0,0
209331,patients,0,0
209332,with,0,0
209333,a,0,0
209334,threatening,0,0
209335,premature,0,0
209336,birth,0,0
209337,at,0,0
209338,the,0,0
209339,greater,0,0
209340,than,0,0
209341,or,0,0
209342,equal,0,0
209343,to,0,0
209344,24-less,0,1
209345,than,0,0
209346,37,0,0
209347,week,0,0
209348,of,0,0
209349,gestation,0,0
209350,were,0,0
209351,in,0,0
209352,this,0,0
209353,study,0,0
209354,randomly,0,0
209355,treated,0,0
209356,with,0,0
209357,hexoprenalin,1,1
209358,or,1,0
209359,salbutamol,1,1
209360,.,1,0
209361,In,0,0
209362,77,0,0
209363,%,0,0
209364,in,0,0
209365,the,0,0
209366,hexoprenalin,1,1
209367,and,0,0
209368,in,0,0
209369,74,0,0
209370,%,0,0
209371,in,0,0
209372,the,0,0
209373,salbutamol,1,1
209374,group,0,0
209375,the,0,0
209376,weight,0,0
209377,of,0,0
209378,the,0,0
209379,newborn,0,0
209380,was,0,0
209381,greater,0,0
209382,than,0,0
209383,or,0,0
209384,equal,0,0
209385,to,0,0
209386,2500,0,0
209387,g.,0,0
209388,In,0,0
209389,66,0,0
209390,%,0,0
209391,in,0,0
209392,both,0,0
209393,study,0,0
209394,groups,0,0
209395,the,0,0
209396,birth,0,0
209397,occurred,0,0
209398,after,0,0
209399,the,0,0
209400,completed,0,0
209401,37,0,0
209402,weeks,0,0
209403,of,0,0
209404,gestation,0,0
209405,.,0,0
209406,During,0,0
209407,infusion,0,0
209408,of,0,0
209409,hexoprenalin,1,1
209410,tachycardia,0,0
209411,in,0,0
209412,mothers,0,0
209413,occurred,0,0
209414,statistically,0,0
209415,highly,0,0
209416,significantly,0,0
209417,less,0,0
209418,than,0,0
209419,during,0,0
209420,salbutamol,1,1
209421,.,1,0
209422,11,0,0
209423,%,0,0
209424,of,0,0
209425,the,0,0
209426,mothers,0,0
209427,in,0,0
209428,the,0,0
209429,hexoprenalin,1,1
209430,group,0,0
209431,had,0,0
209432,side-effects,0,0
209433,during,0,0
209434,infusion,0,1
209435,compared,0,0
209436,to,0,0
209437,30,0,0
209438,%,0,0
209439,in,0,0
209440,the,0,0
209441,salbutamol,1,1
209442,group,0,0
209443,.,0,0
209444,The,0,0
209445,correlation,0,0
209446,between,0,0
209447,the,0,0
209448,tocolysis-index,0,0
209449,(,0,0
209450,Baumgarten,0,1
209451,),0,0
209452,and,0,0
209453,the,0,0
209454,prolongation-index,0,0
209455,(,0,0
209456,Richter,0,1
209457,),0,0
209458,given,0,0
209459,by,0,0
209460,the,0,0
209461,regression,0,0
209462,lines,0,0
209463,facilitates,0,0
209464,in,0,0
209465,some,0,0
209466,measure,0,0
209467,the,0,0
209468,comparison,0,0
209469,of,0,0
209470,different,0,0
209471,tocolytic,0,1
209472,drugs,0,1
209473,concerning,0,0
209474,its,0,0
209475,tocolytic,0,1
209476,effect,0,0
209477,.,0,0
209478,High-dose,1,1
209479,weekly,1,1
209480,fractionation,1,1
209481,radiotherapy,1,1
209482,in,0,0
209483,advanced,0,0
209484,cancer,0,0
209485,of,0,0
209486,the,0,0
209487,uterine,0,0
209488,cervix,0,0
209489,.,0,0
209490,A,0,0
209491,trial,0,0
209492,comparing,0,0
209493,two,0,0
209494,different,0,0
209495,radiotherapy,1,1
209496,techniques,0,1
209497,and,0,0
209498,schedules,0,0
209499,in,0,0
209500,the,0,0
209501,treatment,0,0
209502,of,0,0
209503,83,0,0
209504,patients,0,0
209505,with,0,0
209506,advanced,0,0
209507,cancer,0,0
209508,of,0,0
209509,the,0,0
209510,uterine,0,0
209511,cervix,0,0
209512,(,0,0
209513,stage,0,0
209514,IIIB,0,1
209515,),0,0
209516,employing,0,0
209517,external,1,1
209518,irradiation,1,1
209519,alone,0,1
209520,is,0,0
209521,described,0,0
209522,.,0,0
209523,The,0,0
209524,one,0,0
209525,technique,0,0
209526,",",0,0
209527,used,0,0
209528,routinely,0,0
209529,in,0,0
209530,this,0,0
209531,department,0,0
209532,",",0,0
209533,employed,0,0
209534,a,0,0
209535,conventional,0,1
209536,daily,0,1
209537,fractionation,0,1
209538,schedule,0,1
209539,while,0,0
209540,the,0,0
209541,other,0,0
209542,used,0,0
209543,a,0,0
209544,high-dose,0,1
209545,weekly,0,1
209546,fractionation,0,1
209547,regimen,0,1
209548,.,0,0
209549,The,0,0
209550,techniques,0,0
209551,are,0,0
209552,described,0,0
209553,.,0,0
209554,The,0,0
209555,aim,0,0
209556,of,0,0
209557,the,0,0
209558,trial,0,0
209559,was,0,0
209560,to,0,0
209561,compare,0,0
209562,the,0,0
209563,efficacy,0,0
209564,and,0,0
209565,morbidity,0,0
209566,of,0,0
209567,these,0,0
209568,two,0,0
209569,methods,0,0
209570,of,0,0
209571,treatment,0,0
209572,.,0,0
209573,Dose,0,0
209574,distribution,0,0
209575,curves,0,0
209576,in,0,0
209577,cross-section,0,0
209578,and,0,0
209579,midsagittal,0,0
209580,planes,0,0
209581,are,0,0
209582,shown,0,0
209583,and,0,0
209584,calculations,0,0
209585,or,0,0
209586,equivalent,0,0
209587,doses,0,0
209588,at,0,0
209589,various,0,0
209590,selected,0,0
209591,points,0,0
209592,using,0,0
209593,Ellis,0,0
209594,'s,0,0
209595,nominal,0,0
209596,single-dose,0,1
209597,formula,0,1
209598,are,0,0
209599,tabulated,0,0
209600,.,0,0
209601,The,0,0
209602,2-year,0,0
209603,survival,0,0
209604,figures,0,0
209605,were,0,0
209606,33,0,0
209607,%,0,0
209608,for,0,0
209609,the,0,0
209610,daily,0,1
209611,fractionation,0,1
209612,technique,0,1
209613,and,0,0
209614,22,0,0
209615,%,0,0
209616,for,0,0
209617,the,0,0
209618,weekly,0,1
209619,regimen,0,0
209620,.,0,0
209621,Serious,0,0
209622,late,0,0
209623,complication,0,0
209624,rates,0,0
209625,were,0,0
209626,6,0,0
209627,%,0,0
209628,for,0,0
209629,the,0,0
209630,daily,0,0
209631,regimen,0,1
209632,and,0,0
209633,22,0,0
209634,%,0,0
209635,for,0,0
209636,the,0,0
209637,weekly,0,1
209638,schedule,0,0
209639,.,0,0
209640,These,0,0
209641,differences,0,0
209642,are,0,0
209643,not,0,0
209644,statistically,0,0
209645,significant,0,0
209646,.,0,0
209647,Late,0,0
209648,complication,0,0
209649,rates,0,0
209650,in,0,0
209651,the,0,0
209652,weekly,0,1
209653,fractionation,0,1
209654,regimen,0,1
209655,appeared,0,0
209656,to,0,0
209657,be,0,0
209658,lower,0,0
209659,than,0,0
209660,figures,0,0
209661,quoted,0,0
209662,by,0,0
209663,other,0,0
209664,authors,0,0
209665,.,0,0
209666,Local,0,0
209667,control,0,0
209668,within,0,0
209669,the,0,0
209670,irradiated,0,0
209671,volume,0,0
209672,was,0,0
209673,better,0,0
209674,in,0,0
209675,the,0,0
209676,group,0,0
209677,treated,0,0
209678,by,0,0
209679,the,0,0
209680,daily,0,1
209681,fractionation,0,1
209682,method,0,0
209683,.,0,0
209684,A,0,0
209685,comparison,0,0
209686,of,0,0
209687,the,0,0
209688,serologic,0,0
209689,responses,0,0
209690,to,0,0
209691,oral,0,1
209692,and,0,0
209693,injectable,0,1
209694,trivalent,1,0
209695,poliovirus,1,0
209696,vaccines,1,1
209697,.,1,0
209698,United,0,0
209699,States,0,0
209700,children,0,0
209701,two,0,0
209702,months,0,0
209703,of,0,0
209704,age,0,0
209705,were,0,0
209706,randomly,0,0
209707,assigned,0,0
209708,to,0,0
209709,two,0,0
209710,groups,0,0
209711,that,0,0
209712,received,0,0
209713,either,0,0
209714,the,0,0
209715,commercially,0,0
209716,available,0,0
209717,oral,1,1
209718,trivalent,1,0
209719,poliovirus,1,1
209720,vaccine,1,1
209721,(,1,0
209722,OPV,1,1
209723,),1,0
209724,or,0,0
209725,an,0,0
209726,injectable,1,1
209727,(,1,0
209728,inactivated,1,1
209729,),1,0
209730,trivalent,1,0
209731,poliovirus,1,1
209732,vaccine,1,1
209733,(,1,0
209734,IPV,1,0
209735,),1,0
209736,with,0,0
209737,a,0,0
209738,confirmed,0,0
209739,minimum,0,0
209740,D-antigen,0,1
209741,content,0,0
209742,of,0,0
209743,27,0,0
209744,",",0,0
209745,3.5,0,0
209746,",",0,0
209747,and,0,0
209748,29,0,0
209749,units,0,0
209750,for,0,0
209751,poliovirus,0,0
209752,types,0,0
209753,1,0,0
209754,",",0,0
209755,2,0,0
209756,",",0,0
209757,and,0,0
209758,3,0,0
209759,",",0,0
209760,respectively,0,0
209761,.,0,0
209762,Vaccine,0,0
209763,was,0,0
209764,given,0,0
209765,at,0,0
209766,two,0,0
209767,",",0,0
209768,four,0,0
209769,",",0,0
209770,and,0,0
209771,18,0,0
209772,months,0,0
209773,of,0,0
209774,age,0,0
209775,.,0,0
209776,Sera,0,0
209777,obtained,0,0
209778,from,0,0
209779,439,0,0
209780,children,0,0
209781,at,0,0
209782,two,0,0
209783,",",0,0
209784,four,0,0
209785,",",0,0
209786,and,0,0
209787,six,0,0
209788,months,0,0
209789,of,0,0
209790,age,0,0
209791,and,0,0
209792,from,0,0
209793,85,0,0
209794,children,0,0
209795,at,0,0
209796,18,0,0
209797,and,0,0
209798,20,0,0
209799,months,0,0
209800,of,0,0
209801,age,0,0
209802,were,0,0
209803,examined,0,0
209804,for,0,0
209805,neutralizing,0,0
209806,antibodies,0,0
209807,.,0,0
209808,The,0,0
209809,percentage,0,0
209810,of,0,0
209811,children,0,0
209812,with,0,0
209813,detectable,0,0
209814,antibodies,0,0
209815,and,0,0
209816,the,0,0
209817,reciprocal,0,0
209818,geometric,0,0
209819,mean,0,0
209820,titers,0,0
209821,were,0,0
209822,similar,0,0
209823,for,0,0
209824,both,0,0
209825,groups,0,0
209826,at,0,0
209827,two,0,0
209828,months,0,0
209829,of,0,0
209830,age,0,0
209831,for,0,0
209832,antibodies,0,0
209833,to,0,0
209834,all,0,0
209835,three,0,0
209836,poliovirus,0,0
209837,types,0,0
209838,.,0,0
209839,At,0,0
209840,20,0,0
209841,months,0,0
209842,of,0,0
209843,age,0,0
209844,",",0,0
209845,all,0,0
209846,children,0,0
209847,but,0,0
209848,one,0,0
209849,had,0,0
209850,detectable,0,0
209851,antibodies,0,0
209852,to,0,0
209853,all,0,0
209854,three,0,0
209855,poliovirus,0,0
209856,types,0,0
209857,.,0,0
209858,Significantly,0,0
209859,higher,0,0
209860,geometric,0,0
209861,mean,0,0
209862,titers,0,0
209863,against,0,0
209864,types,0,0
209865,2,0,0
209866,and,0,0
209867,3,0,0
209868,were,0,0
209869,noted,0,0
209870,at,0,0
209871,20,0,0
209872,months,0,0
209873,of,0,0
209874,age,0,0
209875,for,0,0
209876,the,0,0
209877,IPV,1,0
209878,group,0,0
209879,.,0,0
209880,Comparative,0,0
209881,efficacy,0,0
209882,and,0,0
209883,safety,0,0
209884,of,0,0
209885,lofexidine,1,1
209886,and,1,0
209887,clonidine,1,1
209888,given,0,0
209889,alone,0,0
209890,or,0,0
209891,concomitantly,0,0
209892,with,0,0
209893,hydrochlorothiazide,1,1
209894,in,0,0
209895,hypertensive,0,0
209896,outpatients,0,0
209897,.,0,0
209898,Breathlessness,0,0
209899,and,0,0
209900,psychiatric,0,0
209901,morbidity,0,0
209902,in,0,0
209903,chronic,0,0
209904,bronchitis,0,0
209905,and,0,0
209906,emphysema,0,0
209907,:,0,0
209908,a,0,0
209909,study,0,0
209910,of,0,0
209911,psychotherapeutic,1,1
209912,management,1,0
209913,.,1,0
209914,This,0,0
209915,paper,0,0
209916,describes,0,0
209917,a,0,0
209918,study,0,0
209919,of,0,0
209920,the,0,0
209921,outcome,0,0
209922,of,0,0
209923,psychotherapy,1,1
209924,with,0,0
209925,patients,0,0
209926,disabled,0,0
209927,by,0,0
209928,chronic,0,0
209929,obstructive,0,0
209930,airways,0,0
209931,disease,0,0
209932,giving,0,0
209933,rise,0,0
209934,to,0,0
209935,dyspnoea,0,0
209936,.,0,0
209937,Forty-three,0,0
209938,men,0,0
209939,and,0,0
209940,22,0,0
209941,women,0,0
209942,with,0,0
209943,severe,0,0
209944,COAD,0,0
209945,were,0,0
209946,randomly,0,0
209947,allocated,0,0
209948,for,0,0
209949,8,1,0
209950,weeks,1,0
209951,to,1,0
209952,one,1,0
209953,of,1,0
209954,three,1,0
209955,types,1,0
209956,of,1,0
209957,psychotherapy,1,1
209958,or,1,0
209959,to,1,0
209960,an,1,0
209961,untreated,1,0
209962,control,1,0
209963,group,1,0
209964,",",1,0
209965,and,1,0
209966,were,1,0
209967,followed,1,0
209968,up,1,0
209969,six,1,0
209970,months,1,0
209971,later,1,0
209972,.,1,0
209973,The,0,0
209974,group,0,0
209975,treated,0,0
209976,by,0,0
209977,a,0,0
209978,medical,0,0
209979,nurse,0,1
209980,without,0,0
209981,training,0,1
209982,in,0,0
209983,psychotherapy,1,1
209984,experienced,0,0
209985,sustained,0,0
209986,relief,0,0
209987,of,0,0
209988,dyspnoea,0,0
209989,but,0,0
209990,tended,0,0
209991,to,0,0
209992,undergo,0,0
209993,less,0,0
209994,psychodynamic,0,0
209995,change,0,0
209996,;,0,0
209997,psychiatric,0,0
209998,symptoms,0,0
209999,were,0,0
210000,reduced,0,0
210001,in,0,0
210002,those,0,0
210003,receiving,0,0
210004,supportive,0,1
210005,",",0,0
210006,but,0,0
210007,not,0,0
210008,analytical,0,0
210009,",",0,0
210010,psychotherapy,1,1
210011,.,1,0
210012,The,0,0
210013,psychosomatic,0,0
210014,mechanisms,0,0
210015,involved,0,0
210016,and,0,0
210017,the,0,0
210018,implications,0,0
210019,for,0,0
210020,medical,0,0
210021,and,0,0
210022,nursing,0,1
210023,practice,0,0
210024,and,0,0
210025,for,0,0
210026,liaison,0,1
210027,psychotherapy,0,1
210028,are,0,0
210029,discussed,0,0
210030,.,0,0
210031,Postoperative,0,0
210032,dreaming,0,0
210033,.,0,0
210034,A,0,0
210035,comparison,0,0
210036,of,0,0
210037,the,0,0
210038,incidence,0,0
210039,following,0,0
210040,pentazocine,1,1
210041,and,0,0
210042,morphine,1,1
210043,premedication,0,0
210044,.,0,0
210045,The,0,0
210046,incidence,0,0
210047,of,0,0
210048,postoperative,0,0
210049,dreaming,0,0
210050,following,0,0
210051,the,0,0
210052,use,0,0
210053,of,0,0
210054,morphine,1,1
210055,and,1,0
210056,pentazocine,1,1
210057,as,0,0
210058,premedicants,0,0
210059,in,0,0
210060,an,0,0
210061,otherwise,0,0
210062,standard,0,1
210063,anaesthetic,0,1
210064,sequence,0,0
210065,is,0,0
210066,compared,0,0
210067,in,0,0
210068,healthy,0,0
210069,volunteers,0,0
210070,.,0,0
210071,No,0,0
210072,statistically,0,0
210073,significant,0,0
210074,difference,0,0
210075,was,0,0
210076,demonstrated,0,0
210077,between,0,0
210078,the,0,0
210079,two,0,0
210080,drugs,0,0
210081,.,0,0
210082,The,0,0
210083,causes,0,0
210084,of,0,0
210085,psychotomimetic,0,0
210086,problems,0,0
210087,in,0,0
210088,the,0,0
210089,postoperative,0,0
210090,period,0,0
210091,and,0,0
210092,the,0,0
210093,difficulty,0,0
210094,of,0,0
210095,precise,0,0
210096,definition,0,0
210097,of,0,0
210098,hallucinations,0,0
210099,are,0,0
210100,discussed,0,0
210101,.,0,0
210102,Adriamycin,1,1
210103,and,1,0
210104,chlorambucil,1,1
210105,versus,1,1
210106,adriamycin,1,1
210107,and,1,0
210108,thiabendazole,1,1
210109,in,0,0
210110,the,0,0
210111,treatment,0,0
210112,of,0,0
210113,extensive,0,0
210114,",",0,0
210115,non-small,0,0
210116,cell,0,0
210117,carcinoma,0,0
210118,of,0,0
210119,the,0,0
210120,lung,0,0
210121,:,0,0
210122,a,0,0
210123,Southwest,0,0
210124,Oncology,0,0
210125,Group,0,0
210126,pilot,0,0
210127,study,0,0
210128,.,0,0
210129,Pharmacokinetics,0,0
210130,of,0,0
210131,naproxen,1,1
210132,after,0,0
210133,oral,0,1
210134,administration,0,0
210135,of,0,0
210136,two,0,0
210137,tablet,0,0
210138,formulations,0,0
210139,in,0,0
210140,healthy,0,0
210141,volunteers,0,0
210142,.,0,0
210143,The,0,0
210144,pharmacokinetics,0,0
210145,of,0,0
210146,two,0,0
210147,naproxen,1,1
210148,tablet,0,1
210149,formulations,0,0
210150,were,0,0
210151,compared,0,0
210152,after,0,0
210153,oral,0,0
210154,administration,0,0
210155,.,0,0
210156,The,0,0
210157,250-mg,1,1
210158,naproxen,1,1
210159,tablets,1,1
210160,",",0,0
210161,tablet,0,0
210162,I,0,0
210163,from,0,0
210164,AFI,0,0
210165,",",0,0
210166,Oslo,0,0
210167,",",0,0
210168,Norway,0,0
210169,",",0,0
210170,and,0,0
210171,tablet,0,1
210172,II,0,0
210173,Naprosyn,0,0
210174,",",0,0
210175,Astra-Syntex,0,0
210176,",",0,0
210177,were,0,0
210178,taken,0,0
210179,by,0,0
210180,12,0,0
210181,healthy,0,0
210182,volunteers,0,0
210183,in,0,0
210184,a,0,0
210185,randomized,0,0
210186,two-period,0,0
210187,crossover,0,0
210188,study,0,0
210189,.,0,0
210190,Plasma,0,0
210191,levels,0,0
210192,of,0,0
210193,naproxen,1,1
210194,were,0,0
210195,measured,0,0
210196,by,0,0
210197,a,0,0
210198,sensitive,0,0
210199,and,0,0
210200,specific,0,0
210201,HPLC,0,0
210202,method,0,0
210203,.,0,0
210204,The,0,0
210205,data,0,0
210206,were,0,0
210207,analyzed,0,0
210208,by,0,0
210209,means,0,0
210210,of,0,0
210211,two-way,0,0
210212,analysis,0,0
210213,of,0,0
210214,variance,0,0
210215,to,0,0
210216,test,0,0
210217,for,0,0
210218,significant,0,0
210219,differences,0,0
210220,between,0,0
210221,tablet,0,1
210222,formulation,0,0
210223,and,0,0
210224,differences,0,0
210225,between,0,0
210226,the,0,0
210227,first,0,0
210228,and,0,0
210229,second,0,0
210230,trial,0,0
210231,periods,0,0
210232,.,0,0
210233,Rapid,0,0
210234,absorption,0,0
210235,",",0,0
210236,with,0,0
210237,most,0,0
210238,Cmax,0,0
210239,values,0,0
210240,from,0,0
210241,50-60,0,0
210242,micrograms/ml,0,0
210243,reached,0,0
210244,within,0,0
210245,1.5-3,0,0
210246,h,0,0
210247,",",0,0
210248,was,0,0
210249,found,0,0
210250,for,0,0
210251,both,0,0
210252,tablet,0,0
210253,formulations,0,0
210254,.,0,0
210255,No,0,0
210256,significant,0,0
210257,difference,0,0
210258,was,0,0
210259,found,0,0
210260,in,0,0
210261,the,0,0
210262,rate,0,0
210263,and,0,0
210264,extent,0,0
210265,of,0,0
210266,absorption,0,0
210267,between,0,0
210268,the,0,0
210269,two,0,0
210270,formulations,0,0
210271,:,0,0
210272,the,0,0
210273,relative,0,0
210274,bioavailability,0,0
210275,of,0,0
210276,tablet,0,1
210277,I,0,0
210278,compared,0,0
210279,to,0,0
210280,tablet,0,1
210281,II,0,0
210282,was,0,0
210283,1.05,0,0
210284,+/-,0,0
210285,0.21,0,0
210286,(,0,0
210287,mean,0,0
210288,+/-,0,0
210289,SD,0,0
210290,),0,0
210291,.,0,0
210292,The,0,0
210293,naproxen,1,1
210294,concentration,0,0
210295,2,0,0
210296,h,0,0
210297,after,0,0
210298,ingestion,0,0
210299,and,0,0
210300,the,0,0
210301,Cmax,0,0
210302,were,0,0
210303,higher,0,0
210304,on,0,0
210305,the,0,0
210306,second,0,0
210307,occasion,0,0
210308,",",0,0
210309,regardless,0,0
210310,of,0,0
210311,preparation,0,1
210312,",",0,0
210313,suggesting,0,0
210314,that,0,0
210315,the,0,0
210316,subjects,0,0
210317,were,0,0
210318,clinically,0,0
210319,different,0,0
210320,on,0,0
210321,the,0,0
210322,two,0,0
210323,occasions,0,0
210324,.,0,0
210325,Cardiovascular,0,0
210326,complications,0,0
210327,to,0,0
210328,treatment,0,0
210329,of,0,0
210330,prostate,0,0
210331,cancer,0,0
210332,with,0,0
210333,estramustine,1,1
210334,phosphate,1,1
210335,(,1,0
210336,Estracyt,1,1
210337,),1,1
210338,or,1,1
210339,conventional,1,1
210340,estrogen,1,1
210341,.,1,0
210342,A,0,0
210343,follow-up,0,0
210344,of,0,0
210345,212,0,0
210346,randomized,0,0
210347,patients,0,0
210348,.,0,0
210349,Two,0,0
210350,hundred,0,0
210351,and,0,0
210352,twelve,0,0
210353,patients,0,0
210354,treated,0,0
210355,for,0,0
210356,prostatic,0,0
210357,cancer,0,0
210358,grade,0,0
210359,I,0,0
210360,or,0,0
210361,II,0,0
210362,were,0,0
210363,investigated,0,0
210364,for,0,0
210365,cardiovascular,0,0
210366,complications,0,0
210367,.,0,0
210368,The,0,0
210369,patients,0,0
210370,were,0,0
210371,part,0,0
210372,of,0,0
210373,a,0,0
210374,multicentre,0,0
210375,study,0,0
210376,in,0,0
210377,the,0,0
210378,Stockholm,0,0
210379,area,0,0
210380,and,0,0
210381,had,0,0
210382,been,0,0
210383,randomized,0,0
210384,to,0,0
210385,treatment,0,0
210386,with,0,0
210387,either,0,0
210388,estramustine,1,1
210389,phosphate,1,1
210390,(,1,0
210391,Estracyt,1,1
210392,),1,1
210393,or,1,1
210394,polyestradiol,1,1
210395,phosphate,1,1
210396,and,1,0
210397,ethinyl,1,1
210398,estradiol,1,1
210399,.,1,0
210400,Cardiovascular,0,0
210401,complications,0,0
210402,categorized,0,0
210403,as,0,0
210404,impaired,0,0
210405,arterial,0,0
210406,circulation,0,0
210407,including,0,0
210408,ischemic,0,0
210409,heart,0,0
210410,disease,0,0
210411,",",0,0
210412,venous,0,0
210413,thromboembolism,0,0
210414,",",0,0
210415,cardiac,0,0
210416,incompensation,0,0
210417,and,0,0
210418,cerebral,0,0
210419,depression,0,0
210420,were,0,0
210421,found,0,0
210422,to,0,0
210423,be,0,0
210424,equally,0,0
210425,frequent,0,0
210426,following,0,0
210427,the,0,0
210428,two,0,0
210429,different,0,0
210430,forms,0,0
210431,of,0,0
210432,treatment,0,0
210433,.,0,0
210434,Among,0,0
210435,the,0,0
210436,patients,0,0
210437,getting,0,0
210438,cardiovascular,0,0
210439,complications,0,0
210440,",",0,0
210441,these,0,0
210442,occurred,0,0
210443,within,0,0
210444,two,0,0
210445,months,0,0
210446,after,0,0
210447,the,0,0
210448,start,0,0
210449,of,0,0
210450,treatment,0,0
210451,in,0,0
210452,50,0,0
210453,%,0,0
210454,and,0,0
210455,within,0,0
210456,one,0,0
210457,year,0,0
210458,in,0,0
210459,85,0,0
210460,%,0,0
210461,of,0,0
210462,them,0,0
210463,.,0,0
210464,There,0,0
210465,was,0,0
210466,a,0,0
210467,statistically,0,0
210468,significant,0,0
210469,correlation,0,0
210470,between,0,0
210471,the,0,0
210472,incidence,0,0
210473,of,0,0
210474,cardiovascular,0,0
210475,complications,0,0
210476,and,0,0
210477,a,0,0
210478,history,0,0
210479,of,0,0
210480,previous,0,0
210481,cardiovascular,0,0
210482,disease,0,0
210483,.,0,0
210484,This,0,0
210485,criterion,0,0
210486,was,0,0
210487,however,0,0
210488,in,0,0
210489,retrospect,0,0
210490,found,0,0
210491,to,0,0
210492,predict,0,0
210493,cardiovascular,0,0
210494,complications,0,0
210495,in,0,0
210496,only,0,0
210497,67,0,0
210498,of,0,0
210499,the,0,0
210500,126,0,0
210501,patients,0,0
210502,getting,0,0
210503,one,0,0
210504,or,0,0
210505,several,0,0
210506,of,0,0
210507,these,0,0
210508,complications,0,0
210509,.,0,0
210510,EORTC,0,0
210511,protocols,0,0
210512,in,0,0
210513,prostatic,0,0
210514,cancer,0,0
210515,.,0,0
210516,An,0,0
210517,interim,0,0
210518,report,0,0
210519,.,0,0
210520,Two,0,0
210521,parallel,0,0
210522,prospective,0,0
210523,randomized,0,0
210524,studies,0,0
210525,have,0,0
210526,been,0,0
210527,undertaken,0,0
210528,by,0,0
210529,the,0,0
210530,EORTC,0,0
210531,Urological,0,0
210532,Group,0,0
210533,in,0,0
210534,previously,0,0
210535,untreated,0,0
210536,patients,0,0
210537,with,0,0
210538,prostatic,0,0
210539,cancer,0,0
210540,in,0,0
210541,order,0,0
210542,to,0,0
210543,compare,0,0
210544,low,0,0
210545,dose,0,0
210546,Stilboestrol,1,1
210547,versus,1,1
210548,Cyproterone,1,1
210549,acetate,1,1
210550,versus,1,1
210551,Medroxyprogesterone,1,1
210552,acetate,1,1
210553,in,0,0
210554,the,0,0
210555,first,0,0
210556,trial,0,0
210557,",",0,0
210558,and,0,0
210559,Stilboestrol,1,1
210560,versus,0,0
210561,Estracyt,1,1
210562,in,0,0
210563,the,0,0
210564,second,0,0
210565,trial,0,0
210566,.,0,0
210567,Although,0,0
210568,the,0,0
210569,follow,0,0
210570,up,0,0
210571,is,0,0
210572,still,0,0
210573,short,0,0
210574,",",0,0
210575,no,0,0
210576,superiority,0,0
210577,of,0,0
210578,the,0,0
210579,other,0,0
210580,drugs,0,0
210581,over,0,0
210582,Stilboestrol,1,1
210583,had,0,0
210584,appeared,0,0
210585,so,0,0
210586,far,0,0
210587,with,0,0
210588,regard,0,0
210589,to,0,0
210590,either,0,0
210591,objective,0,0
210592,response,0,0
210593,or,0,1
210594,significant,0,0
210595,side,0,0
210596,effects,0,0
210597,apart,0,0
210598,from,0,0
210599,gynaecomastia,0,0
210600,.,0,0
210601,In,0,0
210602,the,0,0
210603,third,0,0
210604,trial,0,0
210605,",",0,0
210606,patients,0,0
210607,with,0,0
210608,advanced,0,0
210609,disease,0,0
210610,no,0,0
210611,longer,0,0
210612,responsive,0,0
210613,to,0,0
210614,hormonal,0,0
210615,treatment,0,0
210616,were,0,0
210617,randomized,0,0
210618,to,0,0
210619,either,0,0
210620,Adriamycin,1,1
210621,or,0,0
210622,Procarbazine,1,1
210623,.,1,0
210624,Toxicity,0,0
210625,and,0,0
210626,early,0,0
210627,death,0,0
210628,were,0,0
210629,particularly,0,0
210630,frequent,0,0
210631,in,0,0
210632,Procarbazine,1,1
210633,treated,0,0
210634,patients,0,0
210635,",",0,0
210636,whereas,0,0
210637,most,0,0
210638,patients,0,0
210639,progressed,0,0
210640,in,0,0
210641,both,0,0
210642,treatment,0,0
210643,groups,0,0
210644,.,0,0
210645,A,0,0
210646,comparative,0,0
210647,trial,0,0
210648,of,0,0
210649,liver,0,0
210650,biopsy,1,1
210651,needles,0,1
210652,.,0,0
210653,A,0,0
210654,sheathed,1,1
210655,needle,1,1
210656,(,0,0
210657,Tru-Cut,0,0
210658,),0,0
210659,was,0,0
210660,compared,0,0
210661,with,0,0
210662,a,0,0
210663,suction,1,1
210664,biopsy,1,1
210665,needle,1,1
210666,(,1,0
210667,Menghini,1,1
210668,),1,0
210669,in,0,0
210670,a,0,0
210671,randomised,0,0
210672,prospective,0,0
210673,trial,0,0
210674,over,0,0
210675,18,0,0
210676,months,0,0
210677,to,0,0
210678,determine,0,0
210679,whether,0,0
210680,the,0,0
210681,former,0,0
210682,offered,0,0
210683,any,0,0
210684,special,0,0
210685,advantages,0,0
210686,in,0,0
210687,routine,1,0
210688,percutaneous,1,1
210689,liver,1,0
210690,biopsy,1,1
210691,.,1,0
210692,Seventy-seven,0,0
210693,consecutive,0,0
210694,biopsies,1,0
210695,were,0,0
210696,performed,0,0
210697,by,0,0
210698,a,0,0
210699,single,0,0
210700,operator,0,0
210701,.,0,0
210702,Although,0,0
210703,biopsy,0,0
210704,fragmentation,0,0
210705,was,0,0
210706,commoner,0,0
210707,with,0,0
210708,the,0,0
210709,suction,1,1
210710,needle,1,1
210711,",",0,0
210712,the,0,0
210713,length,0,0
210714,and,0,0
210715,volume,0,0
210716,of,0,0
210717,the,0,0
210718,largest,0,0
210719,core,0,0
210720,obtained,0,0
210721,was,0,0
210722,similar,0,0
210723,to,0,0
210724,results,0,0
210725,with,0,0
210726,the,0,0
210727,sheathed,1,0
210728,needle,1,1
210729,.,1,0
210730,Cytology,0,0
210731,provided,0,0
210732,useful,0,0
210733,additional,0,0
210734,information,0,0
210735,with,0,0
210736,the,0,0
210737,Menghini,1,1
210738,technique,1,1
210739,.,1,0
210740,The,0,0
210741,suction,1,1
210742,needle,1,1
210743,was,0,0
210744,repeatedly,0,0
210745,reusable,0,0
210746,and,0,0
210747,considerably,0,0
210748,cheaper,0,0
210749,than,0,0
210750,the,0,0
210751,sheathed,1,1
210752,needle,1,1
210753,",",0,0
210754,which,0,0
210755,may,0,0
210756,be,0,0
210757,used,0,0
210758,once,0,0
210759,only,0,0
210760,.,0,0
210761,Changes,0,0
210762,in,0,0
210763,the,0,0
210764,fatty,0,0
210765,acid,0,1
210766,composition,0,0
210767,of,0,0
210768,the,0,0
210769,plasma,0,0
210770,lipid,0,0
210771,esters,0,1
210772,during,0,0
210773,lipid-lowering,1,1
210774,treatment,1,0
210775,with,0,0
210776,diet,1,1
210777,",",1,0
210778,clofibrate,1,1
210779,and,0,0
210780,niceritrol,1,1
210781,.,1,0
210782,Reduction,0,0
210783,of,0,0
210784,the,0,0
210785,proportion,0,0
210786,of,0,0
210787,linoleate,0,1
210788,by,0,0
210789,clofibrate,0,1
210790,but,0,0
210791,not,0,0
210792,by,0,0
210793,niceritrol,0,1
210794,.,0,0
210795,The,0,0
210796,fatty,0,0
210797,acid,0,1
210798,composition,0,0
210799,of,0,0
210800,the,0,0
210801,plasma,0,0
210802,lipid,0,0
210803,esters,0,1
210804,has,0,0
210805,been,0,0
210806,studied,0,0
210807,during,0,0
210808,lipid-lowering,1,1
210809,treatment,1,0
210810,of,0,0
210811,95,0,0
210812,patients,0,0
210813,with,0,0
210814,atherosclerotic,0,0
210815,disease,0,0
210816,.,0,0
210817,During,0,0
210818,the,0,0
210819,first,0,0
210820,two,0,0
210821,months,0,0
210822,of,0,0
210823,the,0,0
210824,trial,0,0
210825,only,0,0
210826,a,0,0
210827,diet,1,1
210828,was,0,0
210829,prescribed,0,0
210830,.,0,0
210831,During,0,0
210832,the,0,0
210833,ensuing,0,0
210834,two,0,0
210835,months,0,0
210836,either,0,0
210837,clofibrate,1,1
210838,or,1,1
210839,niceritrol,1,1
210840,",",1,0
210841,a,1,0
210842,nicotinic,1,1
210843,acid,1,1
210844,ester,1,1
210845,",",0,0
210846,was,0,0
210847,added,0,0
210848,in,0,0
210849,a,0,0
210850,randomized,0,0
210851,order,0,0
210852,.,0,0
210853,During,0,0
210854,the,0,0
210855,last,0,0
210856,two,0,0
210857,months,0,0
210858,the,0,0
210859,second,0,0
210860,drug,0,0
210861,was,0,0
210862,added,0,0
210863,.,0,0
210864,The,0,0
210865,combined,0,0
210866,treatment,0,0
210867,with,0,0
210868,diet,1,1
210869,",",1,0
210870,clofibrate,1,1
210871,and,1,0
210872,niceritrol,1,1
210873,caused,0,0
210874,highly,0,0
210875,significant,0,0
210876,serum,0,0
210877,lipid,0,0
210878,reductions,0,0
210879,.,0,0
210880,The,0,0
210881,fatty,0,0
210882,acid,0,1
210883,composition,0,0
210884,in,0,0
210885,the,0,0
210886,plasma,0,0
210887,lipid,0,0
210888,esters,0,1
210889,was,0,0
210890,determined,0,0
210891,in,0,0
210892,samples,0,0
210893,from,0,0
210894,each,0,0
210895,trial,0,0
210896,period,0,0
210897,to,0,0
210898,measure,0,0
210899,the,0,0
210900,degree,0,0
210901,of,0,0
210902,dietary,0,0
210903,adherence,0,0
210904,.,0,0
210905,During,0,0
210906,dietary,0,0
210907,treatment,0,0
210908,the,0,0
210909,relative,0,0
210910,content,0,0
210911,of,0,0
210912,saturated,0,0
210913,and,0,0
210914,monounsaturated,0,1
210915,fatty,0,0
210916,acids,0,1
210917,secreased,0,0
210918,and,0,0
210919,the,0,0
210920,polyunsaturated,0,1
210921,fatty,0,0
210922,acids,0,1
210923,increased,0,0
210924,with,0,0
210925,an,0,0
210926,increasing,0,0
210927,ratio,0,0
210928,between,0,0
210929,pulyunsaturated,0,1
210930,and,0,0
210931,saturated,0,0
210932,fatty,0,1
210933,acids,0,1
210934,(,0,0
210935,P/S,0,0
210936,ratio,0,0
210937,),0,0
210938,in,0,0
210939,the,0,0
210940,cholesterol,0,0
210941,esters,0,1
210942,and,0,0
210943,triglycerides,0,0
210944,.,0,0
210945,Only,0,0
210946,minor,0,0
210947,changes,0,0
210948,were,0,0
210949,seen,0,0
210950,in,0,0
210951,the,0,0
210952,phospholipids,0,0
210953,.,0,0
210954,The,0,0
210955,changes,0,0
210956,caused,0,0
210957,by,0,0
210958,the,0,0
210959,diet,1,1
210960,were,0,0
210961,partly,0,0
210962,reversed,0,0
210963,by,0,0
210964,clofibrate,1,1
210965,while,0,0
210966,niceritrol,1,1
210967,did,0,0
210968,not,0,0
210969,cause,0,0
210970,any,0,0
210971,major,0,0
210972,changes,0,0
210973,of,0,0
210974,the,0,0
210975,fatty,0,0
210976,acid,0,1
210977,composition,0,0
210978,.,0,0
210979,Clofibrate,1,0
210980,treatment,1,0
210981,coincided,0,0
210982,with,0,0
210983,increasing,0,0
210984,amounts,0,0
210985,of,0,0
210986,monounsaturated,0,1
210987,fatty,0,0
210988,acids,0,1
210989,",",0,0
210990,especially,0,0
210991,oleate,0,1
210992,(,0,0
210993,18,0,0
210994,:,0,0
210995,1,0,0
210996,),0,0
210997,",",0,0
210998,in,0,0
210999,the,0,0
211000,cholesterol,0,0
211001,esters,0,1
211002,",",0,0
211003,triglycerides,0,0
211004,and,0,0
211005,phospholipids,0,0
211006,while,0,0
211007,there,0,0
211008,were,0,0
211009,significant,0,0
211010,reductions,0,0
211011,of,0,0
211012,the,0,0
211013,content,0,0
211014,of,0,0
211015,linoleic,0,1
211016,(,0,0
211017,18,0,0
211018,:,0,0
211019,2,0,0
211020,),0,0
211021,acid,0,1
211022,in,0,0
211023,both,0,0
211024,the,0,0
211025,cholesterol,0,0
211026,esters,0,1
211027,and,0,0
211028,triglycerides,0,0
211029,.,0,0
211030,The,0,0
211031,18,0,0
211032,:,0,0
211033,2/18,0,0
211034,:,0,0
211035,1,0,0
211036,ratio,0,0
211037,decreased,0,0
211038,significantly,0,0
211039,in,0,0
211040,all,0,0
211041,the,0,0
211042,lipid,0,0
211043,esters,0,1
211044,analyzed,0,0
211045,.,0,0
211046,However,0,0
211047,",",0,0
211048,the,0,0
211049,P/S,0,0
211050,ratio,0,0
211051,was,0,0
211052,not,0,0
211053,significantly,0,0
211054,affected,0,0
211055,",",0,0
211056,partly,0,0
211057,because,0,0
211058,the,0,0
211059,relative,0,0
211060,content,0,0
211061,of,0,0
211062,saturated,0,0
211063,fatty,0,0
211064,acids,0,1
211065,also,0,0
211066,tended,0,0
211067,to,0,0
211068,decrease,0,0
211069,during,0,0
211070,clofibrate,0,1
211071,treatment,0,0
211072,.,0,0
211073,It,0,0
211074,is,0,0
211075,concluded,0,0
211076,that,0,0
211077,addition,0,0
211078,of,0,0
211079,clofibrate,0,1
211080,treatment,0,0
211081,to,0,0
211082,patients,0,0
211083,who,0,0
211084,are,0,0
211085,on,0,0
211086,a,0,0
211087,diet,0,1
211088,enriched,0,1
211089,with,0,0
211090,polyunsaturated,0,1
211091,fats,0,1
211092,is,0,0
211093,associated,0,0
211094,with,0,0
211095,a,0,0
211096,change,0,0
211097,from,0,0
211098,polyunsaturated,0,1
211099,to,0,0
211100,monounsaturated,0,1
211101,fatty,0,0
211102,acids,0,1
211103,in,0,0
211104,the,0,0
211105,plasma,0,0
211106,lipid,0,0
211107,esters,0,1
211108,but,0,0
211109,does,0,0
211110,not,0,0
211111,significantly,0,0
211112,effect,0,0
211113,the,0,0
211114,ratio,0,0
211115,between,0,0
211116,polyunsaturated,0,1
211117,and,0,0
211118,saturated,0,0
211119,fatty,0,0
211120,acids,0,1
211121,.,0,0
211122,The,0,0
211123,fatty,0,0
211124,acid,0,1
211125,changes,0,0
211126,caused,0,0
211127,by,0,0
211128,clofibrate,1,1
211129,treatment,1,0
211130,and,0,0
211131,counteracted,0,0
211132,by,0,0
211133,an,0,0
211134,increased,0,0
211135,amount,0,0
211136,of,0,0
211137,polyunsaturated,0,1
211138,fat,0,0
211139,in,0,0
211140,the,0,0
211141,diet,1,1
211142,.,1,0
211143,[,1,0
211144,Median,1,0
211145,and,1,0
211146,mediolateral,1,0
211147,episiotomy,1,0
211148,],1,0
211149,.,0,0
211150,[,0,0
211151,Prevention,0,1
211152,of,0,0
211153,stress,0,0
211154,ulcers,0,0
211155,with,0,0
211156,synthetic,1,0
211157,depot,1,0
211158,secretin,1,1
211159,],1,0
211160,.,0,0
211161,The,0,0
211162,pathogenesis,0,0
211163,of,0,0
211164,stress,0,0
211165,ulcers,0,0
211166,is,0,0
211167,still,0,0
211168,far,0,0
211169,from,0,0
211170,being,0,0
211171,understood,0,0
211172,.,0,0
211173,It,0,0
211174,is,0,0
211175,reported,0,0
211176,about,0,0
211177,a,0,0
211178,synthetic,1,1
211179,secretin,1,1
211180,(,1,0
211181,Hoe,1,0
211182,069,1,0
211183,+,1,0
211184,depot,1,1
211185,component,1,0
211186,),1,0
211187,given,0,0
211188,prophylactically,0,0
211189,to,0,0
211190,100,0,0
211191,patients,0,0
211192,postoperatively,0,0
211193,.,0,0
211194,It,0,0
211195,eliminated,0,0
211196,or,0,0
211197,ameliorated,0,0
211198,stress,0,0
211199,ulcers,0,0
211200,.,0,0
211201,The,0,0
211202,result,0,0
211203,",",0,0
211204,confirmed,0,0
211205,by,0,0
211206,gastroscopy,0,0
211207,",",0,0
211208,demonstrates,0,0
211209,the,0,0
211210,treatment,1,0
211211,with,1,0
211212,secretin,1,1
211213,plus,1,1
211214,depot,1,0
211215,component,1,0
211216,as,0,0
211217,a,0,0
211218,highly,0,0
211219,recommendable,0,0
211220,prophylaxis,0,0
211221,in,0,0
211222,the,0,0
211223,postsurgical,0,0
211224,intensive,0,1
211225,care,0,1
211226,treatment,0,0
211227,.,0,0
211228,A,0,0
211229,controlled,0,0
211230,trial,0,0
211231,with,0,0
211232,diclofensine,1,1
211233,",",0,0
211234,a,0,0
211235,new,0,0
211236,psychoactive,0,0
211237,drug,0,0
211238,",",0,0
211239,in,0,0
211240,the,0,0
211241,treatment,0,0
211242,of,0,0
211243,depression,0,0
211244,.,0,0
211245,Diclofensine,1,1
211246,inhibits,0,0
211247,the,0,0
211248,uptake,0,0
211249,of,0,0
211250,serotonin,0,1
211251,",",0,0
211252,noradrenaline,0,0
211253,and,0,0
211254,dopamine,0,1
211255,.,0,0
211256,In,0,0
211257,a,0,0
211258,controlled,0,0
211259,study,0,0
211260,",",0,0
211261,out-patients,0,0
211262,suffering,0,0
211263,from,0,0
211264,moderate,0,0
211265,to,0,0
211266,severe,0,0
211267,depression,0,0
211268,were,0,0
211269,treated,0,0
211270,with,0,0
211271,the,0,0
211272,objective,0,0
211273,of,0,0
211274,assessing,0,0
211275,the,0,0
211276,new,0,0
211277,drug,0,0
211278,'s,0,0
211279,therapeutically,0,0
211280,effective,0,0
211281,dose,0,0
211282,range,0,0
211283,.,0,0
211284,Maprotiline,1,1
211285,was,0,0
211286,used,0,0
211287,as,0,0
211288,a,0,0
211289,reference,0,0
211290,drug,0,0
211291,:,0,0
211292,fourteen,0,0
211293,patients,0,0
211294,were,0,0
211295,assigned,0,0
211296,to,0,0
211297,receive,0,1
211298,diclofensine,1,1
211299,and,0,0
211300,thirteen,0,0
211301,to,0,0
211302,receive,0,0
211303,maprotiline,1,1
211304,in,0,0
211305,a,0,0
211306,double-blind,0,0
211307,design,0,0
211308,.,0,0
211309,Depending,0,0
211310,on,0,0
211311,tolerance,0,0
211312,and,0,0
211313,efficacy,0,0
211314,",",0,0
211315,they,0,0
211316,were,0,0
211317,treated,0,0
211318,for,0,0
211319,periods,0,0
211320,ranging,0,0
211321,from,0,0
211322,5,0,0
211323,to,0,0
211324,150,0,0
211325,days,0,0
211326,.,0,0
211327,Doses,0,0
211328,were,0,0
211329,titrated,0,0
211330,to,0,0
211331,the,0,0
211332,optimum,0,0
211333,.,0,0
211334,Findings,0,0
211335,suggest,0,0
211336,that,0,0
211337,a,0,0
211338,50,0,0
211339,mg,0,0
211340,daily,0,0
211341,dose,0,0
211342,of,0,0
211343,diclofensine,1,1
211344,would,0,0
211345,be,0,0
211346,sufficient,0,0
211347,for,0,0
211348,the,0,0
211349,majority,0,0
211350,of,0,0
211351,the,0,0
211352,patients,0,0
211353,.,0,0
211354,The,0,0
211355,dosage,0,0
211356,can,0,0
211357,be,0,0
211358,safely,0,0
211359,increased,0,0
211360,up,0,0
211361,to,0,0
211362,150,0,0
211363,mg,0,1
211364,daily,0,0
211365,but,0,0
211366,this,0,0
211367,offers,0,0
211368,few,0,0
211369,therapeutic,0,0
211370,advantages,0,0
211371,.,0,0
211372,While,0,0
211373,the,0,0
211374,efficacy,0,0
211375,index,0,0
211376,of,0,0
211377,the,0,0
211378,two,0,0
211379,drugs,0,0
211380,was,0,0
211381,similar,0,0
211382,(,0,0
211383,approximately,0,0
211384,60,0,0
211385,%,0,0
211386,),0,0
211387,",",0,0
211388,they,0,0
211389,differed,0,0
211390,greatly,0,0
211391,in,0,0
211392,their,0,0
211393,profile,0,0
211394,of,0,0
211395,side-effects,0,0
211396,.,0,0
211397,No,0,0
211398,signs,0,0
211399,of,0,0
211400,abrupt,0,0
211401,dissipation,0,0
211402,of,0,0
211403,the,0,0
211404,achieved,0,0
211405,clinical,0,0
211406,effects,0,0
211407,were,0,0
211408,observed,0,0
211409,during,0,0
211410,continued,0,0
211411,treatment,0,0
211412,",",0,0
211413,and,0,0
211414,no,0,0
211415,withdrawal,0,0
211416,reactions,0,0
211417,were,0,0
211418,observed,0,0
211419,when,0,0
211420,the,0,0
211421,treatment,0,0
211422,was,0,0
211423,stopped,0,0
211424,.,0,0
211425,The,0,0
211426,new,0,0
211427,drug,0,0
211428,may,0,0
211429,be,0,0
211430,more,0,0
211431,effective,0,0
211432,in,0,0
211433,treating,0,0
211434,patients,0,0
211435,in,0,0
211436,whom,0,0
211437,a,0,0
211438,psycho-energizing,0,1
211439,and,0,0
211440,mood,0,0
211441,alleviating,0,0
211442,effect,0,0
211443,is,0,0
211444,desired,0,0
211445,.,0,0
211446,[,1,0
211447,Cred?,1,0
211448,'s,1,0
211449,prevention,1,0
211450,method,1,0
211451,has,0,0
211452,lost,0,0
211453,its,0,0
211454,justification,0,0
211455,today,0,0
211456,],0,0
211457,.,0,0
211458,Lidocaine,1,1
211459,and,0,0
211460,bupivacaine,1,1
211461,mixtures,0,1
211462,for,0,0
211463,epidural,0,1
211464,blockade,0,0
211465,.,0,0
211466,In,0,0
211467,a,0,0
211468,prospective,0,0
211469,double-blind,0,0
211470,clinical,0,0
211471,study,0,0
211472,",",0,0
211473,single-dose,0,1
211474,lumbar,0,1
211475,epidural,0,1
211476,blockade,0,0
211477,was,0,0
211478,instituted,0,0
211479,in,0,0
211480,60,0,0
211481,healthy,0,0
211482,patients,0,0
211483,undergoing,0,0
211484,lower,0,0
211485,abdominal,0,0
211486,surgery,0,0
211487,.,0,0
211488,Patients,0,0
211489,were,0,0
211490,randomly,0,0
211491,assigned,0,0
211492,to,0,0
211493,one,0,0
211494,of,0,0
211495,five,0,0
211496,groups,0,0
211497,.,0,0
211498,Each,0,0
211499,group,0,0
211500,received,0,0
211501,treatment,0,0
211502,with,0,0
211503,a,0,0
211504,different,0,0
211505,local,0,0
211506,anesthetic,0,1
211507,solution,0,1
211508,containing,0,1
211509,"1:200,000",0,1
211510,epinephrine,1,1
211511,.,1,0
211512,Local,0,0
211513,anesthetic,0,0
211514,solutions,0,1
211515,used,0,0
211516,were,0,0
211517,0.5,1,0
211518,per,1,0
211519,cent,1,0
211520,bupivacaine,1,1
211521,HCl,1,1
211522,",",1,0
211523,2,1,0
211524,per,1,0
211525,cent,1,0
211526,lidocaine,1,1
211527,HCl,1,1
211528,",",1,0
211529,and,1,0
211530,lidocaine-bupivacaine,1,1
211531,mixtures,1,1
211532,in,0,0
211533,the,0,0
211534,ratios,0,0
211535,of,0,0
211536,1:3,0,0
211537,",",0,0
211538,1:1,0,0
211539,or,0,0
211540,3:1,0,0
211541,by,0,0
211542,volume,0,0
211543,.,0,0
211544,Onset,0,0
211545,and,0,0
211546,complete,0,0
211547,spread,0,0
211548,of,0,0
211549,sensory,0,0
211550,blockade,0,0
211551,were,0,0
211552,similar,0,0
211553,in,0,0
211554,all,0,0
211555,five,0,0
211556,groups,0,0
211557,.,0,0
211558,Time,0,0
211559,to,0,0
211560,regression,0,0
211561,to,0,0
211562,two,0,0
211563,segments,0,0
211564,of,0,0
211565,partial,0,0
211566,and,0,0
211567,complete,0,0
211568,sensory,0,0
211569,blockade,0,0
211570,was,0,0
211571,positively,0,0
211572,correlated,0,0
211573,(,0,0
211574,P,0,0
211575,less,0,0
211576,than,0,0
211577,0.05,0,0
211578,),0,0
211579,with,0,0
211580,increasing,0,0
211581,dose,0,0
211582,of,0,0
211583,bupivacaine,1,1
211584,in,0,0
211585,the,0,0
211586,solutions,0,1
211587,and,0,0
211588,ranged,0,0
211589,from,0,0
211590,84,0,0
211591,min,0,0
211592,(,0,0
211593,partial,0,0
211594,),0,0
211595,and,0,0
211596,70,0,0
211597,min,0,0
211598,(,0,0
211599,complete,0,0
211600,),0,0
211601,for,0,0
211602,lidocaine,1,1
211603,",",0,0
211604,to,0,0
211605,128,0,0
211606,min,0,0
211607,(,0,0
211608,partial,0,0
211609,),0,0
211610,and,0,0
211611,101,0,0
211612,min,0,0
211613,(,0,0
211614,complete,0,0
211615,),0,0
211616,for,0,0
211617,bupivacaine,1,1
211618,.,1,0
211619,Using,0,0
211620,skin,0,0
211621,temperature,0,0
211622,as,0,0
211623,a,0,0
211624,criterion,0,0
211625,of,0,0
211626,sympathetic,0,0
211627,blockade,0,0
211628,",",0,0
211629,all,0,0
211630,three,0,0
211631,mixtures,0,0
211632,demonstrated,0,0
211633,a,0,0
211634,duration,0,0
211635,of,0,0
211636,action,0,0
211637,intermediate,0,0
211638,between,0,0
211639,the,0,0
211640,two,0,0
211641,single,0,0
211642,drugs,0,0
211643,",",0,0
211644,lidocaine,0,1
211645,(,0,0
211646,124,0,0
211647,+/-,0,0
211648,13,0,0
211649,min,0,0
211650,),0,0
211651,and,0,0
211652,bupivacaine,1,1
211653,(,0,0
211654,286,0,0
211655,+/-,0,0
211656,32,0,0
211657,min,0,0
211658,),0,0
211659,.,0,0
211660,Onset,0,0
211661,of,0,0
211662,complete,0,0
211663,motor,0,0
211664,blockade,0,0
211665,was,0,0
211666,fastest,0,0
211667,and,0,0
211668,the,0,0
211669,degree,0,0
211670,of,0,0
211671,motor,0,0
211672,blockade,0,0
211673,was,0,0
211674,most,0,0
211675,profound,0,0
211676,with,0,0
211677,the,0,0
211678,mixture,0,1
211679,containing,0,1
211680,equal,0,0
211681,proportions,0,0
211682,of,0,0
211683,lidocaine,1,1
211684,and,0,0
211685,bupivacaine,1,1
211686,.,1,0
211687,Pharmacokinetics,0,0
211688,of,0,0
211689,individual,0,0
211690,drugs,0,0
211691,were,0,0
211692,unaltered,0,0
211693,in,0,0
211694,any,0,0
211695,of,0,0
211696,the,0,0
211697,mixtures,0,0
211698,.,0,0
211699,Treatment,0,0
211700,of,0,0
211701,human,0,0
211702,tungiasis,0,0
211703,with,0,0
211704,niridazole,1,1
211705,(,1,0
211706,Ambilhar,1,1
211707,),1,0
211708,a,0,0
211709,double-blind,0,0
211710,placebo-controlled,0,1
211711,trial,0,0
211712,.,0,0
211713,The,0,0
211714,pharmacokinetics,0,0
211715,of,0,0
211716,metronidazole,1,1
211717,and,1,0
211718,tinidazole,1,1
211719,in,0,0
211720,patients,0,0
211721,with,0,0
211722,mixed,0,0
211723,aerobic,0,0
211724,--,0,0
211725,anaerobic,0,0
211726,infections,0,0
211727,.,0,0
211728,Menstrual,0,0
211729,cycle,0,0
211730,symptoms,0,0
211731,in,0,0
211732,infertile,0,0
211733,and,0,0
211734,control,0,0
211735,subjects,0,0
211736,:,0,0
211737,a,0,0
211738,re-evaluation,1,0
211739,of,1,0
211740,the,1,0
211741,evidence,1,0
211742,for,0,0
211743,psychological,0,0
211744,changes,0,0
211745,.,0,0
211746,Breast,0,0
211747,cancer,0,0
211748,screening,1,0
211749,in,0,0
211750,Sweden,0,0
211751,.,0,0
211752,The,0,0
211753,single,0,0
211754,modality,0,0
211755,approach,0,1
211756,.,0,0
211757,Four,0,0
211758,population-based,0,0
211759,breast,0,0
211760,cancer,0,0
211761,screening,0,0
211762,projects,0,0
211763,are,0,0
211764,in,0,0
211765,progress,0,0
211766,in,0,0
211767,Sweden,0,0
211768,",",0,0
211769,three,0,0
211770,of,0,0
211771,which,0,0
211772,are,0,0
211773,randomized,0,0
211774,studies,0,0
211775,.,0,0
211776,Mammography,1,0
211777,is,0,0
211778,the,0,0
211779,only,0,0
211780,screening,0,0
211781,method,0,0
211782,.,0,0
211783,51,0,0
211784,%,0,0
211785,of,0,0
211786,all,0,0
211787,carcinomas,0,0
211788,detected,0,0
211789,at,0,0
211790,the,0,0
211791,first,0,0
211792,screening,0,0
211793,were,0,0
211794,either,0,0
211795,in,0,0
211796,situ,0,0
211797,or,0,0
211798,invasive,0,0
211799,with,0,0
211800,a,0,0
211801,diameter,0,0
211802,of,0,0
211803,10,0,0
211804,mm,0,0
211805,or,0,0
211806,less,0,0
211807,.,0,0
211808,Axillary,0,0
211809,metastases,0,0
211810,were,0,0
211811,found,0,0
211812,in,0,0
211813,16,0,0
211814,%,0,0
211815,of,0,0
211816,the,0,0
211817,patients,0,0
211818,.,0,0
211819,Sensitivity,0,0
211820,was,0,0
211821,over,0,0
211822,90,0,0
211823,%,0,0
211824,in,0,0
211825,all,0,0
211826,projects,0,0
211827,.,0,0
211828,The,0,0
211829,ultimate,0,0
211830,aim,0,0
211831,of,0,0
211832,the,0,0
211833,randomized,0,0
211834,projects,0,0
211835,is,0,0
211836,to,0,0
211837,demonstrate,0,0
211838,the,0,0
211839,effect,0,0
211840,of,0,0
211841,screening,1,0
211842,on,0,0
211843,breast,0,0
211844,cancer,0,0
211845,mortality,0,0
211846,.,0,0
211847,It,0,0
211848,is,0,0
211849,estimated,0,0
211850,that,0,0
211851,mortality,0,0
211852,statistics,0,0
211853,will,0,0
211854,reach,0,0
211855,significant,0,0
211856,levels,0,0
211857,in,0,0
211858,1983.,0,0
211859,",",0,0
211860,Theophylline,1,1
211861,concentrations,0,0
211862,in,0,0
211863,serum,0,0
211864,and,0,0
211865,saliva,0,0
211866,after,0,0
211867,oral,0,1
211868,microcrystalline,1,1
211869,and,0,0
211870,sustained-release,1,1
211871,preparations,1,1
211872,in,0,0
211873,asthmatics,0,0
211874,.,0,0
211875,Theophylline,1,1
211876,concentrations,0,0
211877,in,0,0
211878,saliva,0,0
211879,have,0,0
211880,been,0,0
211881,compared,0,0
211882,with,0,0
211883,those,0,0
211884,in,0,0
211885,serum,0,0
211886,in,0,0
211887,13,0,0
211888,asthmatic,0,0
211889,patients,0,0
211890,after,0,0
211891,single,0,0
211892,and,0,0
211893,multiple,0,0
211894,oral,0,1
211895,dosage,0,0
211896,of,0,0
211897,a,0,0
211898,microcrystalline,1,1
211899,theophylline,1,1
211900,tablet,1,1
211901,(,0,0
211902,Nuelin,0,1
211903,),0,0
211904,and,0,0
211905,a,0,0
211906,sustained-release,1,1
211907,preparation,1,1
211908,(,0,0
211909,Nuelin,0,1
211910,Retard,0,1
211911,),0,0
211912,.,0,0
211913,There,0,0
211914,was,0,0
211915,wide,0,0
211916,individual,0,0
211917,variation,0,0
211918,in,0,0
211919,the,0,0
211920,ratio,0,0
211921,of,0,0
211922,serum,0,0
211923,to,0,0
211924,saliva,0,0
211925,concentrations,0,0
211926,indicating,0,0
211927,that,0,0
211928,",",0,0
211929,even,0,0
211930,when,0,0
211931,individual,0,0
211932,serum,0,0
211933,to,0,0
211934,saliva,0,0
211935,ratios,0,0
211936,have,0,0
211937,been,0,0
211938,established,0,0
211939,",",0,0
211940,the,0,0
211941,use,0,0
211942,of,0,0
211943,saliva,0,0
211944,theophylline,1,1
211945,measurements,0,0
211946,alone,0,0
211947,is,0,0
211948,unreliable,0,0
211949,for,0,0
211950,the,0,0
211951,routine,0,0
211952,monitoring,0,0
211953,of,0,0
211954,theophylline,1,1
211955,therapy,1,1
211956,.,1,0
211957,Both,0,0
211958,preparations,0,0
211959,produced,0,0
211960,mean,0,0
211961,serum,0,0
211962,theophylline,0,1
211963,concentrations,0,0
211964,within,0,0
211965,the,0,0
211966,10,0,0
211967,--,0,0
211968,20,0,0
211969,mcg/ml,0,0
211970,range,0,0
211971,",",0,0
211972,the,0,0
211973,sustained-release,0,1
211974,tablet,0,0
211975,giving,0,0
211976,higher,0,0
211977,monitoring,0,0
211978,through,0,0
211979,values,0,0
211980,and,0,0
211981,smaller,0,0
211982,through,0,0
211983,to,0,0
211984,peak,0,0
211985,variation,0,0
211986,.,0,0
211987,The,0,0
211988,preparations,0,0
211989,were,0,0
211990,equally,0,0
211991,and,0,0
211992,highly,0,0
211993,bioavailable,0,0
211994,.,0,0
211995,Side,0,0
211996,effects,0,0
211997,were,0,0
211998,reported,0,0
211999,by,0,0
212000,three,0,0
212001,patients,0,0
212002,",",0,0
212003,which,0,0
212004,were,0,0
212005,the,0,0
212006,patients,0,0
212007,with,0,0
212008,the,0,0
212009,highest,0,0
212010,AUC,0,0
212011,.,0,0
212012,The,0,0
212013,Nuelin,1,1
212014,Retard,1,0
212015,preparation,0,1
212016,appears,0,0
212017,to,0,0
212018,provide,0,0
212019,smooth,0,0
212020,",",0,0
212021,sustained,0,0
212022,serum,0,0
212023,theophylline,0,1
212024,concentrations,0,0
212025,within,0,0
212026,the,0,0
212027,therapeutic,0,0
212028,range,0,0
212029,and,0,0
212030,the,0,0
212031,simple,0,0
212032,",",0,0
212033,twice-daily,0,1
212034,dosage,0,0
212035,should,0,0
212036,result,0,0
212037,in,0,0
212038,improved,0,0
212039,patient,0,0
212040,compliance,0,0
212041,.,0,0
212042,Topical,1,0
212043,treatment,1,0
212044,of,0,0
212045,alopecia,0,0
212046,areata,0,0
212047,.,0,0
212048,It,0,0
212049,has,0,0
212050,been,0,0
212051,shown,0,0
212052,previously,0,0
212053,that,0,0
212054,alopecia,0,0
212055,areata,0,0
212056,can,0,0
212057,be,0,0
212058,treated,0,0
212059,with,0,0
212060,dinitrochlorobenzene,1,1
212061,(,1,0
212062,DNCB,1,0
212063,),1,1
212064,and,0,0
212065,other,0,0
212066,contact,1,0
212067,allergens,1,0
212068,.,1,0
212069,Whether,0,0
212070,these,0,0
212071,agents,0,0
212072,work,0,0
212073,by,0,0
212074,inducing,0,0
212075,immunologic,0,0
212076,stimulation,0,1
212077,or,0,0
212078,simply,0,0
212079,a,0,0
212080,nonspecific,0,0
212081,inflammatory,0,0
212082,reaction,0,1
212083,has,0,0
212084,not,0,0
212085,been,0,0
212086,definitively,0,0
212087,demonstrated,0,0
212088,.,0,0
212089,To,0,0
212090,test,0,0
212091,the,0,0
212092,relative,0,0
212093,importance,0,0
212094,of,0,0
212095,these,0,0
212096,two,0,0
212097,mechanisms,0,0
212098,",",0,0
212099,we,0,0
212100,have,0,0
212101,randomly,0,0
212102,studied,0,0
212103,22,0,0
212104,patients,0,0
212105,with,0,0
212106,alopecia,0,0
212107,areata,0,0
212108,to,0,0
212109,whom,0,0
212110,either,0,0
212111,DNCB,1,0
212112,or,1,0
212113,croton,1,1
212114,oil,1,1
212115,was,0,0
212116,applied,0,0
212117,topically,0,0
212118,.,0,0
212119,Sixty-three,0,0
212120,percent,0,0
212121,of,0,0
212122,patients,0,0
212123,without,0,0
212124,spontaneous,0,0
212125,regrowth,0,0
212126,of,0,0
212127,hair,0,0
212128,regrew,0,0
212129,hair,0,0
212130,after,0,0
212131,DNCB,0,0
212132,application,0,0
212133,.,0,0
212134,None,0,0
212135,of,0,0
212136,those,0,0
212137,treated,0,0
212138,with,0,0
212139,croton,1,1
212140,oil,1,1
212141,regrew,0,0
212142,hair,0,0
212143,when,0,0
212144,treated,0,0
212145,later,0,0
212146,with,0,0
212147,DNCB,1,0
212148,.,1,0
212149,Therefore,0,0
212150,",",0,0
212151,a,0,0
212152,proved,0,0
212153,contact,0,0
212154,allergen,0,1
212155,was,0,0
212156,shown,0,0
212157,to,0,0
212158,be,0,0
212159,required,0,0
212160,for,0,0
212161,therapeutic,0,0
212162,success,0,0
212163,.,0,0
212164,Patient,0,0
212165,acceptance,0,0
212166,of,0,0
212167,the,0,0
212168,induced,0,0
212169,contact,0,0
212170,dermatitis,0,0
212171,was,0,0
212172,excellent,0,0
212173,.,0,0
212174,In,0,0
212175,light,0,0
212176,of,0,0
212177,recent,0,0
212178,data,0,0
212179,on,0,0
212180,the,0,0
212181,mutagenicity,0,0
212182,of,0,0
212183,DNCB,1,0
212184,to,0,0
212185,bacteria,0,0
212186,",",0,0
212187,other,0,0
212188,contact,0,0
212189,allergens,0,0
212190,for,0,0
212191,topical,0,1
212192,immunotherapy,0,1
212193,are,0,0
212194,being,0,0
212195,sought,0,0
212196,.,0,0
212197,Comparison,0,0
212198,of,0,0
212199,autologous,0,1
212200,bone,0,0
212201,marrow,0,0
212202,transplantation,0,0
212203,with,0,0
212204,sequential,0,0
212205,chemotherapy,0,1
212206,for,0,0
212207,intermediate-grade,0,0
212208,and,0,0
212209,high-grade,0,0
212210,non-Hodgkin,0,0
212211,'s,0,0
212212,lymphoma,0,0
212213,in,0,0
212214,first,0,0
212215,complete,0,0
212216,remission,0,0
212217,:,0,0
212218,a,0,0
212219,study,0,0
212220,of,0,0
212221,464,0,0
212222,patients,0,0
212223,.,0,0
212224,Groupe,0,0
212225,d'Etude,0,0
212226,des,0,1
212227,Lymphomes,0,0
212228,de,0,0
212229,l'Adulte,0,0
212230,.,0,0
212231,PURPOSE,0,0
212232,Intensive,0,0
212233,chemotherapy,0,1
212234,followed,0,0
212235,by,0,0
212236,autotransplantation,0,0
212237,has,0,0
212238,given,0,0
212239,promising,0,0
212240,results,0,0
212241,in,0,0
212242,partially,0,0
212243,responding,0,0
212244,or,0,0
212245,sensitive,0,0
212246,relapsed,0,0
212247,patients,0,0
212248,with,0,0
212249,aggressive,0,0
212250,non-Hodgkin,0,0
212251,'s,0,0
212252,lymphoma,0,0
212253,.,0,0
212254,In,0,0
212255,1987,0,0
212256,",",0,0
212257,we,0,0
212258,designed,0,0
212259,a,0,0
212260,randomized,0,0
212261,study,0,0
212262,to,0,0
212263,evaluate,0,0
212264,the,0,0
212265,potential,0,0
212266,benefit,0,0
212267,of,0,0
212268,a,0,0
212269,high-dose,1,1
212270,regimen,1,1
212271,containing,1,1
212272,cyclophosphamide,1,1
212273,",",1,0
212274,carmustine,1,1
212275,",",1,0
212276,and,1,0
212277,etoposide,1,1
212278,(,1,0
212279,CBV,1,1
212280,),1,0
212281,followed,1,0
212282,by,1,0
212283,autotransplantation,1,0
212284,over,1,0
212285,a,1,0
212286,consolidative,1,0
212287,sequential,1,0
212288,chemotherapy,1,1
212289,(,1,0
212290,ifosfamide,1,1
212291,",",1,0
212292,etoposide,1,1
212293,",",1,0
212294,asparaginase,1,1
212295,",",1,0
212296,and,1,0
212297,cytarabine,1,1
212298,),1,0
212299,in,0,0
212300,patients,0,0
212301,in,0,0
212302,first,0,0
212303,complete,0,0
212304,remission,0,0
212305,with,0,0
212306,intermediate-,0,1
212307,and,0,0
212308,high-grade,0,0
212309,non-Hodgkin,0,0
212310,'s,0,0
212311,lymphoma,0,0
212312,.,0,0
212313,PATIENTS,0,0
212314,AND,0,0
212315,METHODS,0,0
212316,Patients,0,0
212317,were,0,0
212318,younger,0,0
212319,than,0,0
212320,55,0,0
212321,years,0,0
212322,and,0,0
212323,had,0,0
212324,at,0,0
212325,least,0,0
212326,one,0,0
212327,adverse,0,0
212328,prognostic,0,0
212329,factor,0,0
212330,.,0,0
212331,Induction,0,0
212332,treatment,0,0
212333,was,0,0
212334,that,0,0
212335,of,0,0
212336,the,0,0
212337,LNH84,0,0
212338,protocol,0,0
212339,with,0,0
212340,an,0,0
212341,open,0,0
212342,randomization,0,0
212343,on,0,0
212344,the,0,0
212345,anthracycline,1,1
212346,.,1,0
212347,Patients,0,0
212348,in,0,0
212349,complete,0,0
212350,remission,0,0
212351,were,0,0
212352,further,0,0
212353,randomly,0,0
212354,assigned,0,0
212355,to,0,0
212356,receive,0,0
212357,either,0,0
212358,consolidation,0,0
212359,procedure,0,0
212360,.,0,0
212361,RESULTS,0,0
212362,After,0,0
212363,induction,0,0
212364,treatment,0,0
212365,",",0,0
212366,464,0,0
212367,patients,0,0
212368,were,0,0
212369,assessable,0,0
212370,for,0,0
212371,the,0,0
212372,consolidation,0,0
212373,phase,0,0
212374,.,0,0
212375,With,0,0
212376,a,0,0
212377,median,0,0
212378,follow-up,0,0
212379,duration,0,0
212380,of,0,0
212381,28,0,0
212382,months,0,0
212383,",",0,0
212384,the,0,0
212385,3-year,0,0
212386,disease-free,0,0
212387,survival,0,0
212388,rate,0,0
212389,was,0,0
212390,52,0,0
212391,%,0,0
212392,(,0,0
212393,95,0,0
212394,%,0,0
212395,confidence,0,0
212396,interval,0,0
212397,",",0,0
212398,45,0,0
212399,%,0,0
212400,to,0,0
212401,59,0,0
212402,%,0,0
212403,),0,0
212404,in,0,0
212405,the,0,0
212406,sequential,0,0
212407,chemotherapy,0,1
212408,arm,0,0
212409,and,0,0
212410,59,0,0
212411,%,0,0
212412,(,0,0
212413,95,0,0
212414,%,0,0
212415,confidence,0,0
212416,interval,0,0
212417,",",0,0
212418,52,0,0
212419,%,0,0
212420,to,0,0
212421,66,0,0
212422,%,0,0
212423,),0,0
212424,in,0,0
212425,the,0,0
212426,autologous,0,1
212427,transplant,0,1
212428,arm,0,0
212429,(,0,0
212430,P,0,0
212431,=,0,0
212432,.46,0,0
212433,",",0,0
212434,relative,0,0
212435,risk,0,0
212436,=,0,0
212437,0.90,0,0
212438,),0,0
212439,.,0,0
212440,The,0,0
212441,3-year,0,0
212442,survival,0,0
212443,rate,0,0
212444,did,0,0
212445,not,0,0
212446,differ,0,0
212447,between,0,0
212448,sequential,0,0
212449,chemotherapy,0,1
212450,and,0,0
212451,autotransplantation,0,0
212452,",",0,0
212453,at,0,0
212454,71,0,0
212455,%,0,0
212456,(,0,0
212457,95,0,0
212458,%,0,0
212459,confidence,0,0
212460,interval,0,0
212461,",",0,0
212462,64,0,0
212463,%,0,0
212464,to,0,0
212465,78,0,0
212466,%,0,0
212467,),0,0
212468,and,0,0
212469,69,0,0
212470,%,0,0
212471,(,0,0
212472,95,0,0
212473,%,0,0
212474,confidence,0,0
212475,interval,0,0
212476,",",0,0
212477,62,0,0
212478,%,0,0
212479,to,0,0
212480,76,0,0
212481,%,0,0
212482,),0,0
212483,",",0,0
212484,respectively,0,0
212485,(,0,0
212486,P,0,0
212487,=,0,0
212488,.60,0,0
212489,",",0,0
212490,relative,0,0
212491,risk,0,0
212492,=,0,0
212493,1.11,0,0
212494,),0,0
212495,.,0,0
212496,CONCLUSION,0,0
212497,For,0,0
212498,such,0,0
212499,a,0,0
212500,subset,0,0
212501,of,0,0
212502,patients,0,0
212503,",",0,0
212504,consolidation,0,0
212505,with,0,0
212506,the,0,0
212507,CBV,0,0
212508,regimen,0,1
212509,followed,0,0
212510,by,0,0
212511,autologous,0,1
212512,bone,0,0
212513,marrow,0,0
212514,transplantation,0,1
212515,is,0,0
212516,not,0,0
212517,superior,0,0
212518,to,0,0
212519,sequential,0,0
212520,chemotherapy,0,1
212521,.,0,0
212522,Lisinopril,1,1
212523,administration,0,0
212524,improves,0,0
212525,insulin,0,0
212526,action,0,0
212527,in,0,0
212528,aged,0,0
212529,patients,0,0
212530,with,0,0
212531,hypertension,0,0
212532,.,0,0
212533,Thirty,0,0
212534,elderly,0,0
212535,",",0,0
212536,mildly,0,0
212537,hypertensive,0,0
212538,patients,0,0
212539,were,0,0
212540,enrolled,0,0
212541,for,0,0
212542,a,0,0
212543,single-blind,0,0
212544,",",0,0
212545,randomised,0,0
212546,cross-over,0,0
212547,placebo,1,1
212548,controlled,0,0
212549,trial,0,0
212550,in,0,0
212551,which,0,0
212552,placebo,1,1
212553,and,1,0
212554,lisinopril,1,1
212555,(,0,0
212556,20,0,0
212557,mg/day,0,0
212558,before,0,0
212559,breakfast,0,1
212560,),0,0
212561,were,0,0
212562,given,0,0
212563,for,0,0
212564,4,0,0
212565,and,0,0
212566,8,0,0
212567,weeks,0,0
212568,",",0,0
212569,respectively,0,0
212570,.,0,0
212571,A,0,0
212572,wash-out,0,0
212573,period,0,0
212574,of,0,0
212575,3,0,0
212576,weeks,0,0
212577,between,0,0
212578,placebo,1,1
212579,and,1,0
212580,lisinopril,1,1
212581,was,0,0
212582,observed,0,0
212583,.,0,0
212584,In,0,0
212585,each,0,0
212586,patient,0,0
212587,a,0,0
212588,euglycaemic,0,1
212589,glucose,0,0
212590,clamp,0,1
212591,with,0,0
212592,simultaneous,0,0
212593,indirect,0,0
212594,calorimetry,0,0
212595,allowed,0,0
212596,us,0,0
212597,to,0,0
212598,determine,0,0
212599,whole,0,1
212600,body,0,0
212601,glucose,0,1
212602,disposal,0,0
212603,and,0,0
212604,substrate,0,1
212605,oxidation,0,0
212606,.,0,0
212607,Changes,0,0
212608,in,0,0
212609,morning,0,0
212610,SBP,0,0
212611,and,0,0
212612,DBP,0,0
212613,were,0,0
212614,also,0,0
212615,determined,0,0
212616,.,0,0
212617,Lisinopril,1,1
212618,vs.,1,0
212619,placebo,1,1
212620,significantly,0,0
212621,improved,0,0
212622,whole,0,0
212623,body,0,0
212624,glucose,0,1
212625,disposal,0,0
212626,(,0,0
212627,40.4,0,0
212628,+/-,0,0
212629,0.4,0,0
212630,vs.,0,0
212631,30.3,0,0
212632,+/-,0,0
212633,0.4,0,0
212634,mumol/kg,0,0
212635,LBM,0,0
212636,x,0,0
212637,min,0,0
212638,;,0,0
212639,P,0,0
212640,<,0,0
212641,0.01,0,0
212642,),0,0
212643,",",0,0
212644,non-oxidative,0,0
212645,glucose,0,0
212646,metabolism,0,0
212647,(,0,0
212648,18.1,0,0
212649,+/-,0,0
212650,0.7,0,0
212651,vs.,0,0
212652,10.9,0,0
212653,+/-,0,0
212654,0.6,0,0
212655,mumol/kg,0,0
212656,LBM,0,0
212657,x,0,0
212658,min,0,0
212659,;,0,0
212660,P,0,0
212661,<,0,0
212662,0.01,0,0
212663,),0,0
212664,and,0,0
212665,fasting,0,0
212666,plasma,0,0
212667,potassium,0,1
212668,levels,0,0
212669,(,0,0
212670,4.8,0,0
212671,+/-,0,0
212672,3,0,0
212673,vs.,0,0
212674,4.4,0,0
212675,+/-,0,0
212676,0.4,0,0
212677,mmol/l,0,0
212678,;,0,0
212679,P,0,0
212680,<,0,0
212681,0.05,0,0
212682,),0,0
212683,.,0,0
212684,SBP,0,0
212685,(,0,0
212686,175,0,0
212687,+/-,0,0
212688,3.3,0,0
212689,vs.,0,0
212690,160,0,0
212691,+/-,0,0
212692,3.0,0,0
212693,mm,0,0
212694,Hg,0,0
212695,;,0,0
212696,P,0,0
212697,<,0,0
212698,0.001,0,0
212699,),0,0
212700,and,0,0
212701,DBP,0,0
212702,(,0,0
212703,106,0,0
212704,+/-,0,0
212705,2.3,0,0
212706,vs.,0,0
212707,95,0,0
212708,+/-,0,0
212709,2.0,0,0
212710,mm,0,0
212711,Hg,0,0
212712,;,0,0
212713,P,0,0
212714,<,0,0
212715,0.001,0,0
212716,),0,0
212717,were,0,0
212718,significantly,0,0
212719,reduced,0,0
212720,by,0,0
212721,lisinopril,1,1
212722,administration,0,0
212723,.,0,0
212724,After,0,0
212725,ACE,0,0
212726,inhibition,0,0
212727,",",0,0
212728,fasting,0,0
212729,plasma,0,0
212730,potassium,0,1
212731,levels,0,0
212732,correlated,0,0
212733,with,0,0
212734,the,0,0
212735,decline,0,0
212736,in,0,0
212737,mean,0,0
212738,arterial,0,0
212739,BP,0,0
212740,(,0,0
212741,r,0,0
212742,=,0,0
212743,-0.71,0,0
212744,;,0,0
212745,P,0,0
212746,<,0,0
212747,0.006,0,0
212748,),0,0
212749,.,0,0
212750,In,0,0
212751,conclusion,0,0
212752,",",0,0
212753,lisinopril,1,1
212754,administration,0,0
212755,reduces,0,0
212756,arterial,0,0
212757,BP,0,0
212758,and,0,0
212759,improves,0,0
212760,insulin,0,0
212761,sensitivity,0,0
212762,in,0,0
212763,elderly,0,0
212764,hypertensive,0,0
212765,patients,0,0
212766,.,0,0
212767,Why,0,0
212768,are,0,0
212769,there,0,0
212770,sometimes,0,0
212771,concreteness,0,0
212772,effects,0,0
212773,in,0,0
212774,memory,0,0
212775,for,0,0
212776,prose,0,1
212777,?,0,0
212778,Four,0,0
212779,experiments,0,0
212780,explored,0,0
212781,on-line,0,1
212782,encoding,0,1
212783,strategies,0,0
212784,and,0,0
212785,memory,0,0
212786,for,0,0
212787,high,0,0
212788,imagery,0,1
212789,and,0,0
212790,low,0,0
212791,imagery,0,1
212792,texts,0,1
212793,.,0,0
212794,Results,0,0
212795,consistently,0,0
212796,indicated,0,0
212797,that,0,0
212798,concreteness,0,0
212799,effects,0,0
212800,in,0,0
212801,memory,0,0
212802,for,0,0
212803,text,0,0
212804,depend,0,0
212805,on,0,0
212806,how,0,0
212807,materials,0,0
212808,are,0,0
212809,presented,0,0
212810,in,0,0
212811,several,0,0
212812,different,0,0
212813,respects,0,0
212814,.,0,0
212815,Most,0,0
212816,importantly,0,0
212817,",",0,0
212818,the,0,0
212819,experiments,0,0
212820,clarified,0,0
212821,apparently,0,0
212822,contradictory,0,0
212823,results,0,0
212824,of,0,0
212825,previous,0,0
212826,studies,0,0
212827,by,0,0
212828,indicating,0,0
212829,that,0,0
212830,concreteness,0,0
212831,effects,0,0
212832,generally,0,0
212833,do,0,0
212834,not,0,0
212835,occur,0,0
212836,in,0,0
212837,memory,0,0
212838,for,0,0
212839,prose,0,1
212840,when,0,0
212841,imageability,0,0
212842,is,0,0
212843,manipulated,0,0
212844,between-subjects,0,0
212845,",",0,0
212846,and,0,0
212847,that,0,0
212848,their,0,0
212849,occurrence,0,0
212850,when,0,0
212851,imageability,0,0
212852,is,0,0
212853,manipulated,0,0
212854,within-subjects,0,0
212855,depends,0,0
212856,on,0,0
212857,the,0,0
212858,order,0,0
212859,occurrence,0,0
212860,when,0,0
212861,imageability,0,0
212862,is,0,0
212863,manipulated,0,0
212864,within-subjects,0,0
212865,depends,0,0
212866,on,0,0
212867,the,0,0
212868,order,0,0
212869,of,0,0
212870,presentation,0,0
212871,.,0,0
212872,In,0,0
212873,addition,0,0
212874,",",0,0
212875,moving,0,0
212876,window,0,0
212877,analyses,0,0
212878,of,0,0
212879,text,1,0
212880,processing,1,0
212881,strategies,1,0
212882,indicated,0,0
212883,that,0,0
212884,differential,0,0
212885,strategies,0,0
212886,observed,0,0
212887,in,0,0
212888,previous,0,0
212889,studies,0,0
212890,when,0,0
212891,subjects,0,0
212892,listened,0,0
212893,to,0,0
212894,high,0,0
212895,vs,0,0
212896,low,0,0
212897,imagery,0,1
212898,text,0,0
212899,do,0,0
212900,not,0,0
212901,generalize,0,0
212902,to,0,0
212903,reading,0,0
212904,of,0,0
212905,the,0,0
212906,same,0,0
212907,materials,0,0
212908,.,0,0
212909,Potential,0,0
212910,explanations,0,0
212911,for,0,0
212912,the,0,0
212913,pattern,0,0
212914,of,0,0
212915,results,0,0
212916,are,0,0
212917,evaluated,0,0
212918,",",0,0
212919,and,0,0
212920,implications,0,0
212921,for,0,0
212922,theories,0,0
212923,of,0,0
212924,mental,0,0
212925,imagery,0,1
212926,and,0,0
212927,memory,0,0
212928,are,0,0
212929,considered,0,0
212930,.,0,0
212931,The,0,0
212932,efficacy,0,0
212933,of,0,0
212934,prophylactic,0,1
212935,ondansetron,1,1
212936,",",1,0
212937,droperidol,1,1
212938,",",1,0
212939,perphenazine,1,1
212940,",",1,0
212941,and,1,0
212942,metoclopramide,1,1
212943,in,0,0
212944,the,0,0
212945,prevention,0,0
212946,of,0,0
212947,nausea,0,0
212948,and,0,0
212949,vomiting,0,0
212950,after,0,0
212951,major,0,0
212952,gynecologic,0,0
212953,surgery,0,0
212954,.,0,0
212955,The,0,0
212956,prophylactic,0,0
212957,antiemetic,0,0
212958,efficacy,0,0
212959,of,0,0
212960,intravenous,1,1
212961,(,1,0
212962,i.v,1,1
212963,.,1,0
212964,),1,0
212965,ondansetron,1,1
212966,",",1,0
212967,droperidol,1,1
212968,",",1,0
212969,perphenazine,1,1
212970,",",1,0
212971,and,1,0
212972,metoclopramide,1,1
212973,was,0,0
212974,evaluated,0,0
212975,in,0,0
212976,a,0,0
212977,prospective,0,0
212978,",",0,0
212979,double-blind,0,0
212980,study,0,0
212981,of,0,0
212982,360,0,0
212983,ASA,0,0
212984,physical,0,0
212985,status,0,0
212986,I-III,0,0
212987,patients,0,0
212988,undergoing,0,0
212989,total,0,0
212990,abdominal,0,0
212991,hysterectomy,0,1
212992,(,0,0
212993,TAH,0,0
212994,),0,0
212995,.,0,0
212996,Subjects,0,0
212997,were,0,0
212998,randomized,0,0
212999,to,0,0
213000,receive,0,0
213001,i.v.,0,1
213002,",",0,0
213003,one,0,0
213004,of,0,0
213005,ondansetron,1,1
213006,4,0,0
213007,mg,0,0
213008,",",0,0
213009,droperidol,1,1
213010,1.25,0,0
213011,mg,0,0
213012,",",0,0
213013,perphenazine,1,1
213014,5,0,0
213015,mg,0,0
213016,",",0,0
213017,metoclopramide,1,1
213018,10,0,0
213019,mg,0,0
213020,",",0,0
213021,or,1,0
213022,placebo,1,1
213023,prior,0,0
213024,to,0,0
213025,induction,0,0
213026,of,0,0
213027,anesthesia,0,1
213028,.,0,0
213029,Hypotension,0,0
213030,immediately,0,0
213031,after,0,0
213032,administration,0,0
213033,of,0,0
213034,metoclopramide,1,1
213035,was,0,0
213036,observed,0,0
213037,in,0,0
213038,two,0,0
213039,patients,0,0
213040,and,0,0
213041,four,0,0
213042,patients,0,0
213043,given,0,0
213044,ondansetron,0,1
213045,developed,0,0
213046,profound,0,0
213047,systolic,0,0
213048,hypotension,0,0
213049,at,0,0
213050,induction,0,0
213051,of,0,0
213052,anesthesia,0,1
213053,.,0,0
213054,Twenty-two,0,0
213055,percent,0,0
213056,of,0,0
213057,patients,0,0
213058,receiving,0,0
213059,droperidol,0,1
213060,became,0,0
213061,sedated,0,0
213062,.,0,0
213063,Postoperatively,0,0
213064,",",0,0
213065,patients,0,0
213066,developing,0,0
213067,severe,0,0
213068,nausea,0,0
213069,",",0,0
213070,retching,0,0
213071,",",0,0
213072,or,0,0
213073,vomiting,0,0
213074,",",0,0
213075,defined,0,0
213076,as,0,0
213077,severe,0,0
213078,emetic,0,0
213079,sequelae,0,0
213080,(,0,0
213081,SES,0,1
213082,),0,0
213083,",",0,0
213084,were,0,0
213085,deemed,0,0
213086,to,0,0
213087,have,0,0
213088,failed,0,0
213089,antiemetic,0,1
213090,prophylaxis,0,0
213091,and,0,0
213092,received,0,0
213093,antiemetic,0,0
213094,rescue,0,0
213095,.,0,0
213096,A,0,0
213097,significantly,0,0
213098,larger,0,0
213099,number,0,0
213100,of,0,0
213101,patients,0,0
213102,who,0,0
213103,received,0,0
213104,i.v,0,0
213105,.,0,0
213106,ondansetron,0,1
213107,(,0,0
213108,63,0,0
213109,%,0,0
213110,),0,0
213111,",",0,0
213112,droperidol,0,1
213113,(,0,0
213114,76,0,0
213115,%,0,0
213116,),0,0
213117,",",0,0
213118,and,0,0
213119,perphenazine,0,1
213120,(,0,0
213121,70,0,0
213122,%,0,0
213123,),0,0
213124,were,0,0
213125,free,0,0
213126,of,0,0
213127,SES,0,1
213128,when,0,0
213129,compared,0,0
213130,to,0,0
213131,placebo,0,1
213132,(,0,0
213133,43,0,0
213134,%,0,0
213135,),0,0
213136,;,0,0
213137,P,0,0
213138,<,0,0
213139,0.05,0,0
213140,.,0,0
213141,Metoclopramide,0,1
213142,was,0,0
213143,ineffective,0,0
213144,.,0,0
213145,Although,0,0
213146,ondansetron,0,1
213147,",",0,0
213148,droperidol,0,1
213149,",",0,0
213150,and,0,0
213151,perphenazine,0,1
213152,were,0,0
213153,effective,0,0
213154,in,0,0
213155,providing,0,0
213156,antiemetic,0,0
213157,prophylaxis,0,0
213158,",",0,0
213159,only,0,0
213160,i.v,0,0
213161,.,0,0
213162,perphenazine,0,1
213163,was,0,0
213164,free,0,0
213165,of,0,0
213166,side,0,0
213167,effects,0,0
213168,.,0,0
213169,Hence,0,0
213170,",",0,0
213171,we,0,0
213172,conclude,0,0
213173,that,0,0
213174,perphenazine,0,1
213175,is,0,0
213176,the,0,0
213177,best,0,0
213178,choice,0,0
213179,for,0,0
213180,antiemetic,0,0
213181,prophylaxis,0,0
213182,after,0,0
213183,TAH,0,0
213184,.,0,0
213185,A,0,0
213186,randomized,0,0
213187,",",0,0
213188,controlled,0,0
213189,trial,0,0
213190,of,0,0
213191,the,0,0
213192,efficacy,0,0
213193,of,0,0
213194,a,0,0
213195,heparin,1,1
213196,and,1,0
213197,vancomycin,1,1
213198,solution,1,1
213199,in,0,0
213200,preventing,0,0
213201,central,0,0
213202,venous,0,0
213203,catheter,0,1
213204,infections,0,0
213205,in,0,0
213206,children,0,0
213207,.,0,0
213208,OBJECTIVE,0,0
213209,To,0,0
213210,determine,0,0
213211,whether,0,0
213212,adding,0,0
213213,vancomycin,1,1
213214,to,1,0
213215,central,1,0
213216,venous,1,0
213217,catheter,1,1
213218,(,1,0
213219,CVC,1,0
213220,),1,1
213221,flush,1,1
213222,solution,0,1
213223,would,0,0
213224,significantly,0,0
213225,reduce,0,0
213226,the,0,0
213227,incidence,0,0
213228,of,0,0
213229,bacteremia,0,0
213230,attributable,0,0
213231,to,0,0
213232,luminal,0,0
213233,colonization,0,0
213234,with,0,0
213235,vancomycin-susceptible,0,0
213236,organisms,0,0
213237,.,0,0
213238,STUDY,0,0
213239,DESIGN,0,0
213240,Fifty-five,0,0
213241,children,0,0
213242,with,0,0
213243,cancer,0,0
213244,and,0,0
213245,eight,0,0
213246,children,0,0
213247,given,0,0
213248,total,0,0
213249,parenteral,0,1
213250,nutrition,0,1
213251,by,0,0
213252,the,0,0
213253,surgery,0,0
213254,or,0,1
213255,nutrition,0,1
213256,support,0,0
213257,services,0,0
213258,were,0,0
213259,randomly,0,0
213260,assigned,0,0
213261,to,0,0
213262,receive,0,0
213263,a,0,0
213264,heparin,1,1
213265,CVC,1,0
213266,flush,1,1
213267,solution,1,1
213268,(,0,0
213269,n,0,0
213270,=,0,0
213271,31,0,0
213272,),0,0
213273,or,0,0
213274,a,0,0
213275,heparin-vancomycin,1,1
213276,CVC,1,0
213277,flush,1,1
213278,solution,1,1
213279,(,0,0
213280,n,0,0
213281,=,0,0
213282,32,0,0
213283,),0,0
213284,.,0,0
213285,RESULTS,0,0
213286,During,0,0
213287,9158,0,0
213288,catheter,0,0
213289,days,0,0
213290,",",0,0
213291,6.5,0,0
213292,%,0,0
213293,of,0,0
213294,the,0,0
213295,patients,0,0
213296,in,0,0
213297,the,0,0
213298,heparin,0,1
213299,group,0,0
213300,and,0,0
213301,15.6,0,0
213302,%,0,0
213303,of,0,0
213304,the,0,0
213305,patients,0,0
213306,in,0,0
213307,the,0,0
213308,heparin-vancomycin,0,1
213309,group,0,0
213310,had,0,0
213311,bacteremia,0,0
213312,attributable,0,0
213313,to,0,0
213314,luminal,0,0
213315,colonization,0,0
213316,with,0,0
213317,vancomycin-susceptible,0,0
213318,organisms,0,0
213319,(,0,0
213320,p,0,0
213321,=,0,0
213322,0.43,0,0
213323,),0,0
213324,.,0,0
213325,The,0,0
213326,mean,0,0
213327,rates,0,0
213328,of,0,0
213329,bacteremia,0,0
213330,attributable,0,0
213331,to,0,0
213332,luminal,0,0
213333,colonization,0,0
213334,with,0,0
213335,vancomycin-susceptible,0,0
213336,organisms,0,0
213337,were,0,0
213338,0.6/1000,0,0
213339,catheter,0,0
213340,days,0,0
213341,in,0,0
213342,the,0,0
213343,heparin,0,1
213344,group,0,0
213345,and,0,0
213346,1.4/1000,0,0
213347,catheter,0,0
213348,days,0,0
213349,in,0,0
213350,the,0,0
213351,heparin-vancomycin,0,1
213352,group,0,0
213353,(,0,0
213354,p,0,0
213355,=,0,0
213356,0.25,0,0
213357,),0,0
213358,.,0,0
213359,There,0,0
213360,was,0,0
213361,no,0,0
213362,significant,0,0
213363,difference,0,0
213364,between,0,0
213365,the,0,0
213366,groups,0,0
213367,when,0,0
213368,the,0,0
213369,time,0,0
213370,to,0,0
213371,the,0,0
213372,first,0,0
213373,episode,0,0
213374,of,0,0
213375,bacteremia,0,0
213376,attributable,0,0
213377,to,0,0
213378,luminal,0,0
213379,colonization,0,0
213380,with,0,0
213381,a,0,0
213382,vancomycin-susceptible,0,0
213383,organism,0,0
213384,was,0,0
213385,compared,0,0
213386,by,0,0
213387,means,0,0
213388,of,0,0
213389,Kaplan-Meier,0,0
213390,survival,0,0
213391,estimates,0,0
213392,.,0,0
213393,Streptococcus,0,0
213394,viridans,0,0
213395,infection,0,0
213396,was,0,0
213397,not,0,0
213398,attributable,0,0
213399,to,0,0
213400,luminal,0,0
213401,colonization,0,0
213402,.,0,0
213403,CONCLUSION,0,0
213404,The,0,0
213405,addition,0,0
213406,of,0,0
213407,vancomycin,0,1
213408,to,0,0
213409,heparin,0,1
213410,CVC,0,0
213411,flush,0,1
213412,solution,0,1
213413,did,0,0
213414,not,0,0
213415,reduce,0,0
213416,bacteremia,0,0
213417,with,0,0
213418,vancomycin-susceptible,0,0
213419,organisms,0,0
213420,.,0,0
213421,Bacteremia,0,0
213422,with,0,0
213423,Streptococcus,0,0
213424,viridans,0,0
213425,was,0,0
213426,not,0,0
213427,related,0,0
213428,to,0,0
213429,the,0,0
213430,use,0,0
213431,of,0,0
213432,a,0,0
213433,CVC,0,0
213434,.,0,0
213435,Efficacy,0,0
213436,of,0,0
213437,Contractubex,0,1
213438,gel,0,1
213439,in,0,0
213440,the,0,0
213441,treatment,0,0
213442,of,0,0
213443,fresh,0,0
213444,scars,0,0
213445,after,0,0
213446,thoracic,0,0
213447,surgery,0,0
213448,in,0,0
213449,children,0,0
213450,and,0,0
213451,adolescents,0,0
213452,.,0,0
213453,Scar,0,0
213454,development,0,0
213455,was,0,0
213456,investigated,0,0
213457,in,0,0
213458,45,0,0
213459,young,0,0
213460,patients,0,0
213461,who,0,0
213462,had,0,0
213463,undergone,0,0
213464,thoracic,0,0
213465,surgery,0,0
213466,.,0,0
213467,Patients,0,0
213468,were,0,0
213469,randomly,0,0
213470,assigned,0,0
213471,either,0,0
213472,to,0,0
213473,a,0,0
213474,group,0,0
213475,which,0,0
213476,was,0,0
213477,treated,1,0
213478,topically,1,0
213479,with,1,0
213480,Contractubex,1,1
213481,gel,1,1
213482,(,1,0
213483,Merz,1,1
213484,+,1,1
213485,Co.,1,0
213486,",",0,0
213487,D-Frankfurt/Main,1,0
213488,),1,0
213489,",",1,0
213490,containing,1,1
213491,10,1,0
213492,%,1,0
213493,onion,1,1
213494,extract,1,1
213495,",",1,0
213496,50/U,1,0
213497,of,1,0
213498,sodium,1,1
213499,heparin,1,1
213500,per,1,0
213501,one,1,0
213502,g,1,0
213503,of,1,0
213504,gel,1,1
213505,and,1,0
213506,1,1,0
213507,%,1,0
213508,allantoin,1,1
213509,",",1,0
213510,or,1,0
213511,to,1,0
213512,a,1,0
213513,group,1,0
213514,receiving,1,0
213515,no,1,0
213516,treatment,1,0
213517,.,1,0
213518,The,0,0
213519,treatment,0,0
213520,began,0,0
213521,on,0,0
213522,average,1,0
213523,26,1,0
213524,days,1,0
213525,after,1,0
213526,the,1,0
213527,operation,1,0
213528,and,1,0
213529,was,1,0
213530,continued,1,0
213531,for,1,0
213532,one,1,0
213533,year,1,0
213534,.,1,0
213535,The,0,0
213536,scars,0,0
213537,of,0,0
213538,all,0,0
213539,treated,0,0
213540,and,0,0
213541,untreated,0,0
213542,patients,0,0
213543,were,0,0
213544,evaluated,0,0
213545,at,0,0
213546,monthly,0,0
213547,intervals,0,0
213548,.,0,0
213549,The,0,0
213550,appearance,0,0
213551,of,0,0
213552,the,0,0
213553,scar,0,0
213554,",",0,0
213555,including,0,0
213556,scar,0,1
213557,type,0,0
213558,and,0,0
213559,scar,0,0
213560,size,0,0
213561,as,0,0
213562,well,0,0
213563,as,0,0
213564,scar,0,0
213565,colour,0,1
213566,",",0,0
213567,was,0,0
213568,assessed,0,0
213569,by,0,0
213570,the,0,0
213571,physician,0,0
213572,.,0,0
213573,A,0,0
213574,reduction,0,0
213575,of,0,0
213576,the,0,0
213577,increase,0,0
213578,of,0,0
213579,scar,0,0
213580,width,0,0
213581,was,0,0
213582,seen,0,0
213583,in,0,0
213584,the,0,0
213585,Contractubex-treated,0,0
213586,group,0,0
213587,as,0,0
213588,compared,0,0
213589,with,0,0
213590,the,0,0
213591,untreated,0,0
213592,group,0,0
213593,.,0,0
213594,Further,0,0
213595,",",0,0
213596,physiological,0,0
213597,scars,0,0
213598,and,0,0
213599,skin-coloured,0,0
213600,scars,0,0
213601,were,0,0
213602,more,0,0
213603,frequent,0,0
213604,in,0,0
213605,the,0,0
213606,treated,0,0
213607,group,0,0
213608,than,0,0
213609,in,0,0
213610,the,0,0
213611,untreated,0,0
213612,group,0,0
213613,.,0,0
213614,Hypertrophic,0,0
213615,or,0,0
213616,keloidal,0,0
213617,scars,0,0
213618,were,0,0
213619,less,0,0
213620,frequent,0,0
213621,in,0,0
213622,the,0,0
213623,treated,0,0
213624,group,0,0
213625,.,0,0
213626,No,0,0
213627,differences,0,0
213628,in,0,0
213629,scar,0,0
213630,length,0,0
213631,and,0,0
213632,scar,0,0
213633,height,0,0
213634,were,0,0
213635,seen,0,0
213636,.,0,0
213637,At,0,0
213638,the,0,0
213639,end,0,0
213640,of,0,0
213641,the,0,0
213642,observation,0,0
213643,period,0,0
213644,",",0,0
213645,the,0,0
213646,clinical,0,0
213647,course,0,0
213648,of,0,0
213649,scar,0,0
213650,development,0,0
213651,was,0,0
213652,rated,0,0
213653,as,0,0
213654,very,0,0
213655,good,0,0
213656,or,0,0
213657,good,0,0
213658,in,0,0
213659,more,0,0
213660,than,0,0
213661,90,0,0
213662,%,0,0
213663,of,0,0
213664,the,0,0
213665,treated,0,0
213666,patients,0,0
213667,",",0,0
213668,good,0,0
213669,in,0,0
213670,less,0,0
213671,than,0,0
213672,40,0,0
213673,%,0,0
213674,and,0,0
213675,moderate,0,0
213676,or,0,1
213677,bad,0,0
213678,in,0,0
213679,more,0,0
213680,than,0,0
213681,60,0,0
213682,%,0,0
213683,of,0,0
213684,the,0,0
213685,untreated,0,0
213686,cases,0,0
213687,.,0,0
213688,The,0,0
213689,tolerability,0,0
213690,of,0,0
213691,the,0,0
213692,drug,0,0
213693,was,0,0
213694,good,0,0
213695,or,0,0
213696,very,0,0
213697,good,0,0
213698,in,0,0
213699,all,0,0
213700,cases,0,0
213701,.,0,0
213702,In,0,0
213703,conclusion,0,0
213704,",",0,0
213705,Contractubex,0,1
213706,gel,0,1
213707,is,0,0
213708,useful,0,0
213709,in,0,0
213710,scar,0,0
213711,treatment,0,0
213712,after,0,0
213713,thoracic,0,0
213714,surgery,0,0
213715,.,0,0
213716,[,0,0
213717,Late,0,1
213718,cardiac,0,0
213719,toxicity,0,0
213720,in,0,0
213721,Hodgkin,0,0
213722,'s,0,0
213723,disease,0,0
213724,.,0,0
213725,A,0,0
213726,study,0,0
213727,with,0,0
213728,pulsed,1,1
213729,Doppler,1,1
213730,echocardiography,1,0
213731,],1,0
213732,.,0,0
213733,49,0,0
213734,patients,0,0
213735,(,0,0
213736,22,0,0
213737,women,0,0
213738,",",0,0
213739,27,0,0
213740,men,0,0
213741,",",0,0
213742,mean,0,0
213743,age,0,0
213744,43.7,0,0
213745,[,0,0
213746,21-65,0,0
213747,],0,0
213748,years,0,0
213749,),0,0
213750,with,0,0
213751,Hodgkin,0,0
213752,'s,0,0
213753,disease,0,0
213754,were,0,0
213755,examined,0,0
213756,by,0,0
213757,Doppler,1,0
213758,echocardiography,1,0
213759,a,0,0
213760,median,0,0
213761,of,0,0
213762,5.37,0,0
213763,(,0,0
213764,2-10,0,0
213765,),0,0
213766,years,0,0
213767,after,0,0
213768,the,0,0
213769,end,0,0
213770,of,0,0
213771,chemotherapy,0,1
213772,(,0,0
213773,given,0,0
213774,according,0,0
213775,to,0,0
213776,the,0,0
213777,COPP/ABVD,0,0
213778,scheme,0,0
213779,",",0,0
213780,with,0,0
213781,or,0,0
213782,without,0,0
213783,mediastinal,1,0
213784,irradiation,1,1
213785,),1,0
213786,for,0,0
213787,possible,0,0
213788,chronic,0,0
213789,changes,0,0
213790,in,0,0
213791,myocardium,0,0
213792,",",0,0
213793,pericardium,0,0
213794,or,0,0
213795,cardiac,0,0
213796,valves,0,0
213797,",",0,0
213798,as,0,0
213799,well,0,0
213800,as,0,0
213801,for,0,0
213802,any,0,0
213803,haemodynamic,0,0
213804,sequelae,0,0
213805,.,0,0
213806,Maximal,0,0
213807,and,0,0
213808,integrated,0,0
213809,early,0,0
213810,(,0,0
213811,E,0,1
213812,",",0,0
213813,Ei,0,1
213814,),0,0
213815,and,0,0
213816,late,0,0
213817,(,0,0
213818,A,0,0
213819,",",0,0
213820,Ai,0,0
213821,),0,0
213822,diastolic,0,0
213823,flow,0,0
213824,velocities,0,0
213825,and,0,0
213826,their,0,0
213827,ratio,0,0
213828,(,0,0
213829,E/A,0,1
213830,",",0,0
213831,Ei/Ai,0,0
213832,),0,0
213833,were,0,0
213834,measured,0,0
213835,by,0,0
213836,pulsed,1,1
213837,Doppler,1,0
213838,over,0,0
213839,the,0,0
213840,mitral,0,0
213841,and,0,0
213842,tricuspid,0,0
213843,valves,0,0
213844,.,0,0
213845,Although,0,0
213846,on,0,0
213847,two-dimensional,0,0
213848,echo,0,0
213849,21,0,0
213850,patients,0,0
213851,(,0,0
213852,42.9,0,0
213853,%,0,0
213854,),0,0
213855,were,0,0
213856,found,0,0
213857,to,0,0
213858,have,0,0
213859,valvar,0,0
213860,thickening,0,0
213861,",",0,0
213862,19,0,0
213863,(,0,0
213864,38.8,0,0
213865,%,0,0
213866,),0,0
213867,pericardial,0,0
213868,thickening,0,0
213869,and,0,0
213870,9,0,0
213871,(,0,0
213872,18.4,0,0
213873,%,0,0
213874,),0,0
213875,a,0,0
213876,reduced,0,0
213877,fibre,0,1
213878,shortening,0,0
213879,fraction,0,0
213880,",",0,0
213881,the,0,0
213882,Doppler,0,0
213883,indices,0,0
213884,were,0,0
213885,statistically,0,0
213886,not,0,0
213887,significantly,0,0
213888,different,0,0
213889,from,0,0
213890,those,0,0
213891,in,0,0
213892,25,0,0
213893,controls,0,0
213894,with,0,0
213895,normal,0,0
213896,hearts,0,0
213897,.,0,0
213898,These,0,0
213899,echocardiographic,0,0
213900,data,0,0
213901,of,0,0
213902,functional,0,0
213903,and,0,0
213904,morphological,0,0
213905,parameters,0,0
213906,indicate,0,0
213907,that,0,0
213908,there,0,0
213909,was,0,0
213910,no,0,0
213911,effect,0,0
213912,on,0,0
213913,various,0,0
213914,measurements,0,0
213915,of,0,0
213916,diastolic,0,0
213917,function,0,0
213918,after,0,0
213919,chemotherapy,0,1
213920,with,0,0
213921,or,0,0
213922,without,0,0
213923,mediastinal,0,0
213924,radiation,0,1
213925,.,0,0
213926,In,0,0
213927,successfully,0,0
213928,treated,0,0
213929,patients,0,0
213930,with,0,0
213931,Hodgkin,0,0
213932,'s,0,0
213933,disease,0,0
213934,the,0,0
213935,described,0,0
213936,changes,0,0
213937,are,0,0
213938,of,0,0
213939,minor,0,0
213940,significance,0,0
213941,.,0,0
213942,Early,1,1
213943,educational,1,1
213944,intervention,1,1
213945,for,0,0
213946,very,0,0
213947,low,0,0
213948,birth,0,0
213949,weight,0,0
213950,infants,0,0
213951,:,0,0
213952,results,0,0
213953,from,0,0
213954,the,0,0
213955,Infant,1,0
213956,Health,1,0
213957,and,1,0
213958,Development,1,0
213959,Program,1,1
213960,.,1,0
213961,OBJECTIVE,0,0
213962,To,0,0
213963,examine,0,0
213964,the,0,0
213965,effect,0,0
213966,of,0,0
213967,early,1,0
213968,educational,1,1
213969,intervention,1,1
213970,after,0,0
213971,discharge,0,0
213972,from,0,0
213973,the,0,0
213974,hospital,0,0
213975,on,0,0
213976,the,0,0
213977,health,0,0
213978,and,0,0
213979,developmental,0,0
213980,status,0,0
213981,of,0,0
213982,very,0,0
213983,low,0,0
213984,birth,0,0
213985,weight,0,0
213986,(,0,0
213987,<,0,0
213988,or,0,0
213989,=,0,0
213990,1500,0,0
213991,gm,0,1
213992,),0,0
213993,infants,0,0
213994,.,0,0
213995,DESIGN,0,0
213996,Randomized,0,0
213997,",",0,0
213998,controlled,0,0
213999,trial,0,0
214000,",",0,0
214001,with,0,0
214002,post,0,0
214003,hoc,0,0
214004,analysis,0,0
214005,.,0,0
214006,SETTING,0,0
214007,Eight,0,0
214008,sites,0,0
214009,",",0,0
214010,heterogeneous,0,0
214011,for,0,0
214012,sociodemographic,0,0
214013,and,0,0
214014,health,0,0
214015,care,0,1
214016,use,0,0
214017,.,0,0
214018,PARTICIPANTS,0,0
214019,Infants,0,0
214020,(,0,0
214021,N,0,0
214022,=,0,0
214023,280,0,0
214024,),0,0
214025,born,0,0
214026,weighing,0,0
214027,<,0,0
214028,or,0,1
214029,=,0,0
214030,1500,0,1
214031,gm,0,1
214032,and,0,0
214033,selected,0,0
214034,for,0,0
214035,the,0,0
214036,Infant,0,0
214037,Health,0,0
214038,and,0,0
214039,Development,0,0
214040,Program,0,1
214041,.,0,0
214042,Eligibility,0,0
214043,was,0,0
214044,limited,0,0
214045,primarily,0,0
214046,by,0,0
214047,geographic,0,0
214048,distance,0,0
214049,from,0,0
214050,the,0,0
214051,day,0,0
214052,care,0,0
214053,center,0,0
214054,.,0,0
214055,One,0,0
214056,third,0,0
214057,were,0,0
214058,randomly,0,0
214059,assigned,0,0
214060,to,0,0
214061,the,0,0
214062,intervention,0,1
214063,(,0,0
214064,INT,0,1
214065,),0,1
214066,group,0,0
214067,and,0,0
214068,two,0,0
214069,thirds,0,0
214070,to,0,0
214071,follow-up,1,0
214072,only,1,0
214073,.,1,0
214074,INTERVENTIONS,0,0
214075,All,0,0
214076,children,0,0
214077,received,0,0
214078,intensive,1,1
214079,pediatric,1,0
214080,and,1,0
214081,developmental,1,0
214082,surveillance,1,0
214083,.,1,0
214084,The,0,0
214085,INT,0,1
214086,group,0,0
214087,received,1,0
214088,home,1,0
214089,visits,1,0
214090,and,1,0
214091,center-based,1,0
214092,educational,1,1
214093,interventions,1,0
214094,until,0,0
214095,36,0,0
214096,months,0,0
214097,of,0,0
214098,age,0,0
214099,(,0,0
214100,corrected,0,0
214101,for,0,0
214102,gestational,0,0
214103,age,0,0
214104,when,0,0
214105,final,0,0
214106,assessments,0,0
214107,were,0,0
214108,completed,0,0
214109,),0,0
214110,.,0,0
214111,OUTCOMES,0,0
214112,Cognitive,0,0
214113,development,0,0
214114,(,0,0
214115,Stanford-Binet,0,0
214116,Intelligence,0,0
214117,Scale,0,0
214118,),0,0
214119,",",0,0
214120,behavioral,0,1
214121,competence,0,0
214122,(,0,0
214123,Achebach,0,0
214124,Child,0,0
214125,Behavior,0,0
214126,Checklist,0,1
214127,),0,0
214128,",",0,0
214129,and,0,0
214130,health,0,0
214131,status,0,0
214132,(,0,0
214133,indexes,0,0
214134,summarizing,0,0
214135,reported,0,0
214136,morbidity,0,0
214137,",",0,0
214138,the,0,0
214139,Functional,0,0
214140,Status,0,0
214141,II,0,0
214142,(,0,0
214143,R,0,0
214144,),0,0
214145,Scale,0,0
214146,",",0,0
214147,and,0,0
214148,General,0,1
214149,Health,0,1
214150,Ratings,0,0
214151,Index,0,1
214152,),0,0
214153,.,0,0
214154,RESULTS,0,0
214155,Cognitive,0,0
214156,development,0,0
214157,scores,0,0
214158,were,0,0
214159,7.2,0,0
214160,points,0,0
214161,higher,0,0
214162,(,0,0
214163,p,0,0
214164,=,0,0
214165,0.002,0,0
214166,),0,0
214167,in,0,0
214168,the,0,0
214169,INT,0,1
214170,group,0,0
214171,",",0,0
214172,after,0,0
214173,adjustment,0,0
214174,for,0,0
214175,baseline,0,0
214176,differences,0,0
214177,in,0,0
214178,site,0,0
214179,",",0,0
214180,sociodemographic,0,0
214181,characteristics,0,0
214182,",",0,0
214183,and,0,0
214184,neonatal,0,0
214185,morbidity,0,0
214186,",",0,0
214187,and,0,0
214188,were,0,0
214189,9.4,0,0
214190,points,0,0
214191,higher,0,0
214192,(,0,0
214193,p,0,0
214194,<,0,0
214195,0.0003,0,0
214196,),0,0
214197,when,0,0
214198,the,0,0
214199,29,0,0
214200,children,0,0
214201,with,0,0
214202,significant,0,0
214203,cerebral,0,0
214204,palsy,0,0
214205,were,0,0
214206,removed,0,0
214207,.,0,0
214208,No,0,0
214209,differences,0,0
214210,in,0,0
214211,behavior,0,0
214212,",",0,0
214213,serious,0,0
214214,morbidity,0,0
214215,",",0,0
214216,functional,0,0
214217,status,0,0
214218,",",0,0
214219,or,0,1
214220,health,0,0
214221,rating,0,0
214222,were,0,0
214223,found,0,0
214224,overall,0,0
214225,.,0,0
214226,The,0,0
214227,infants,0,0
214228,in,0,0
214229,the,0,0
214230,INT,0,1
214231,group,0,0
214232,who,0,0
214233,weighted,0,0
214234,<,0,0
214235,or,0,0
214236,=,0,0
214237,1000,0,0
214238,gm,0,1
214239,at,0,0
214240,birth,0,0
214241,had,0,0
214242,significantly,0,0
214243,lower,0,0
214244,behavior,0,0
214245,problem,0,0
214246,scores,0,0
214247,but,0,0
214248,no,0,0
214249,differences,0,0
214250,on,0,0
214251,other,0,0
214252,outcomes,0,0
214253,.,0,0
214254,All,0,0
214255,children,0,0
214256,in,0,0
214257,the,0,0
214258,INT,0,1
214259,group,0,0
214260,had,0,0
214261,slightly,0,0
214262,higher,0,0
214263,rates,0,0
214264,of,0,0
214265,less,0,0
214266,serious,0,0
214267,morbidity,0,0
214268,.,0,0
214269,CONCLUSION,0,0
214270,The,0,0
214271,advantage,0,0
214272,conferred,0,0
214273,by,0,0
214274,being,0,0
214275,in,0,0
214276,the,0,0
214277,INT,0,1
214278,group,0,0
214279,",",0,0
214280,as,0,0
214281,previously,0,0
214282,reported,0,0
214283,for,0,0
214284,heavier,0,0
214285,infants,0,0
214286,",",0,0
214287,extends,0,0
214288,to,0,0
214289,very,0,0
214290,low,0,0
214291,birth,0,0
214292,weight,0,0
214293,children,0,0
214294,",",0,0
214295,supporting,0,0
214296,the,0,0
214297,use,0,0
214298,of,0,0
214299,early,0,0
214300,intervention,0,1
214301,in,0,0
214302,this,0,0
214303,group,0,0
214304,.,0,0
214305,[,0,0
214306,Postoperative,0,0
214307,analgesia,0,0
214308,:,0,0
214309,peridural,1,1
214310,morphine,1,1
214311,versus,0,0
214312,sublingual,1,1
214313,buprenorphine,1,1
214314,.,1,0
214315,Comparative,0,0
214316,clinical,0,0
214317,study,0,0
214318,],0,0
214319,.,0,0
214320,The,0,0
214321,authors,0,0
214322,herein,0,0
214323,present,0,0
214324,their,0,0
214325,personal,0,1
214326,series,0,0
214327,on,0,0
214328,the,0,0
214329,clinical,0,0
214330,evaluation,0,0
214331,of,0,0
214332,the,0,0
214333,analgesic,0,0
214334,efficacy,0,0
214335,of,0,0
214336,2,0,0
214337,opiodes,0,0
214338,",",0,0
214339,peridural,1,1
214340,morphine,1,1
214341,hydrochloride,1,1
214342,(,1,0
214343,0.5,1,1
214344,mg/kg,1,1
214345,),1,0
214346,administered,0,0
214347,to,0,0
214348,group,0,0
214349,A,0,0
214350,patients,0,0
214351,",",0,0
214352,and,0,0
214353,sublingual,1,1
214354,buprenorphine,1,1
214355,(,1,0
214356,0.4,1,0
214357,mg,1,1
214358,),1,0
214359,administered,0,0
214360,to,0,0
214361,group,0,0
214362,B,0,0
214363,patients,0,0
214364,in,0,0
214365,the,0,0
214366,management,0,0
214367,of,0,0
214368,post-operative,0,0
214369,pain,0,0
214370,in,0,0
214371,major,0,0
214372,abdominal,0,0
214373,surgery,0,0
214374,.,0,0
214375,The,0,0
214376,study,0,0
214377,was,0,0
214378,conducted,0,0
214379,on,0,0
214380,44,0,0
214381,patients,0,0
214382,",",0,0
214383,both,0,0
214384,male,0,0
214385,and,0,0
214386,female,0,0
214387,",",0,0
214388,classified,0,0
214389,as,0,0
214390,ASA,0,1
214391,II,0,0
214392,and,0,0
214393,III,0,0
214394,.,0,0
214395,Statistical,0,0
214396,analysis,0,0
214397,of,0,0
214398,cardiovascular,0,0
214399,parameters,0,0
214400,(,0,0
214401,BP,0,0
214402,and,0,0
214403,cardiac,0,0
214404,frequency,0,0
214405,),0,0
214406,",",0,0
214407,respiratory,0,0
214408,frequency,0,0
214409,and,0,0
214410,pain,0,0
214411,score,0,0
214412,showed,0,0
214413,an,0,0
214414,overlapping,0,0
214415,progression,0,0
214416,among,0,0
214417,the,0,0
214418,two,0,0
214419,groups,0,0
214420,.,0,0
214421,Spontaneous,0,0
214422,pain,0,0
214423,decreased,0,0
214424,significantly,0,0
214425,to,0,0
214426,zero,0,0
214427,at,0,0
214428,T6,0,0
214429,(,0,0
214430,p,0,0
214431,<,0,0
214432,0.001,0,0
214433,),0,0
214434,.,0,0
214435,However,0,0
214436,",",0,0
214437,the,0,0
214438,necessity,0,0
214439,to,0,0
214440,administer,0,0
214441,buprenorphine,1,1
214442,more,0,0
214443,frequently,0,0
214444,after,0,0
214445,the,0,0
214446,sixth,0,0
214447,hour,0,0
214448,and,0,0
214449,the,0,0
214450,consequent,0,0
214451,increase,0,0
214452,in,0,0
214453,side,0,0
214454,effects,0,0
214455,",",0,0
214456,lead,0,0
214457,us,0,0
214458,to,0,0
214459,believe,0,0
214460,that,0,0
214461,the,0,0
214462,method,0,0
214463,used,0,0
214464,for,0,0
214465,group,0,0
214466,A,0,0
214467,patients,0,0
214468,is,0,0
214469,more,0,0
214470,advantageous,0,0
214471,.,0,0
214472,Lipoprotein,0,0
214473,(,0,0
214474,a,0,0
214475,),0,0
214476,serum,0,0
214477,levels,0,0
214478,in,0,0
214479,post-menopausal,0,0
214480,women,0,0
214481,treated,0,0
214482,with,0,0
214483,oral,1,0
214484,estrogens,1,1
214485,administered,0,0
214486,at,0,0
214487,different,0,0
214488,times,0,0
214489,.,0,0
214490,The,0,0
214491,different,0,0
214492,effects,0,0
214493,on,0,0
214494,serum,0,0
214495,lipoprotein,0,0
214496,(,0,0
214497,a,0,0
214498,),0,0
214499,[,0,0
214500,Lp,0,1
214501,(,0,0
214502,a,0,0
214503,),0,0
214504,],0,0
214505,levels,0,0
214506,by,0,0
214507,administering,0,0
214508,estrogens,1,1
214509,at,1,0
214510,different,1,0
214511,times,1,0
214512,of,1,0
214513,the,1,0
214514,day,1,0
214515,(,0,0
214516,8,0,0
214517,a.m.,0,0
214518,and,0,0
214519,8,0,0
214520,p.m.,0,0
214521,),0,0
214522,were,0,0
214523,evaluated,0,0
214524,in,0,0
214525,twenty-four,0,0
214526,post-menopausal,0,0
214527,women,0,0
214528,.,0,0
214529,Patients,0,0
214530,were,0,0
214531,assigned,0,0
214532,to,0,0
214533,one,0,0
214534,of,0,0
214535,the,0,0
214536,two,0,0
214537,treatment,0,0
214538,groups,0,0
214539,by,0,0
214540,random,0,0
214541,sampling,0,0
214542,numbers,0,0
214543,.,0,0
214544,Patients,0,0
214545,of,0,0
214546,both,0,0
214547,groups,0,0
214548,received,0,0
214549,0.625,0,0
214550,mg,0,0
214551,conjugated,1,0
214552,equine,1,1
214553,estrogens,1,1
214554,daily,0,0
214555,per,0,0
214556,os,0,0
214557,for,0,0
214558,21,0,0
214559,days,0,0
214560,.,0,0
214561,Group,0,0
214562,A,0,0
214563,patients,0,0
214564,(,0,0
214565,n,0,0
214566,:,0,0
214567,9,0,0
214568,),0,0
214569,received,0,0
214570,the,0,0
214571,pill,0,1
214572,at,0,0
214573,8,0,0
214574,a.m.,0,0
214575,",",0,0
214576,and,0,0
214577,group,0,0
214578,B,0,0
214579,patients,0,0
214580,(,0,0
214581,n,0,0
214582,:,0,0
214583,12,0,0
214584,),0,0
214585,received,0,0
214586,the,0,0
214587,pill,0,1
214588,at,0,0
214589,8,0,0
214590,p.m,0,0
214591,.,0,0
214592,There,0,0
214593,were,0,0
214594,no,0,0
214595,statistically,0,0
214596,significant,0,0
214597,differences,0,0
214598,between,0,0
214599,the,0,0
214600,two,0,0
214601,treatment,0,0
214602,groups,0,0
214603,as,0,0
214604,regards,0,0
214605,the,0,0
214606,anthropometric,0,0
214607,characteristics,0,0
214608,",",0,0
214609,the,0,0
214610,basal,0,0
214611,values,0,0
214612,of,0,0
214613,the,0,0
214614,Lp,0,1
214615,(,0,0
214616,a,0,0
214617,),0,0
214618,",",0,0
214619,the,0,0
214620,sex,0,0
214621,steroid,0,1
214622,and,0,0
214623,pituitary,0,0
214624,hormone,0,0
214625,levels,0,0
214626,.,0,0
214627,Administration,0,0
214628,of,0,0
214629,conjugated,1,1
214630,equine,1,1
214631,estrogens,1,1
214632,resulted,0,0
214633,in,0,0
214634,decreased,0,0
214635,levels,0,0
214636,of,0,0
214637,Lp,0,1
214638,(,0,0
214639,a,0,0
214640,),0,0
214641,only,0,0
214642,in,0,0
214643,group,0,0
214644,B,0,0
214645,after,0,0
214646,treatment,0,0
214647,.,0,0
214648,The,0,0
214649,different,0,0
214650,Lp,0,1
214651,(,0,0
214652,a,0,0
214653,),0,0
214654,behaviour,0,0
214655,in,0,0
214656,the,0,0
214657,two,0,0
214658,groups,0,0
214659,and,0,0
214660,in,0,0
214661,the,0,0
214662,presence,0,0
214663,of,0,0
214664,the,0,0
214665,same,0,0
214666,serum,0,0
214667,hormonal,0,0
214668,levels,0,0
214669,",",0,0
214670,seems,0,0
214671,to,0,0
214672,be,0,0
214673,dependent,0,0
214674,on,0,0
214675,the,0,0
214676,existence,0,0
214677,of,0,0
214678,a,0,0
214679,circadian,0,0
214680,rhythm,0,1
214681,of,0,0
214682,the,0,0
214683,hepatic,0,0
214684,responsiveness,0,0
214685,to,0,0
214686,estrogens,0,1
214687,",",0,0
214688,whose,0,0
214689,expression,0,0
214690,is,0,0
214691,higher,0,0
214692,during,0,0
214693,evening,0,0
214694,hours,0,0
214695,.,0,0
214696,[,0,0
214697,New,0,0
214698,approaches,0,0
214699,to,0,0
214700,evaluation,0,0
214701,of,0,0
214702,nonspecific,1,0
214703,inhalation,1,1
214704,provocation,1,0
214705,(,0,0
214706,dose-response,0,0
214707,relationship,0,0
214708,),0,0
214709,in,0,0
214710,the,0,0
214711,comparative,0,0
214712,evaluation,0,0
214713,of,0,0
214714,bronchial,0,0
214715,hyperreactivity,0,0
214716,within,0,0
214717,the,0,0
214718,scope,0,0
214719,of,0,0
214720,clinical,0,0
214721,trials,0,0
214722,],0,0
214723,.,0,0
214724,For,0,0
214725,the,0,0
214726,performance,0,0
214727,of,0,0
214728,clinical,0,0
214729,drug,0,0
214730,trials,0,0
214731,in,0,0
214732,the,0,0
214733,therapy,0,1
214734,for,0,0
214735,bronchial,0,0
214736,hyperresponsiveness,0,0
214737,",",0,0
214738,unspecific,0,0
214739,inhalatory,0,0
214740,provocation,0,0
214741,tests,0,0
214742,are,0,0
214743,generally,0,0
214744,employed,0,0
214745,to,0,0
214746,judge,0,0
214747,therapeutic,0,0
214748,success,0,0
214749,.,0,0
214750,In,0,0
214751,particular,0,0
214752,",",0,0
214753,the,0,0
214754,parameter-specific,0,0
214755,provocation,0,0
214756,doses,0,0
214757,are,0,0
214758,considered,0,0
214759,to,0,0
214760,be,0,0
214761,the,0,0
214762,main,0,0
214763,target,0,0
214764,values,0,0
214765,.,0,0
214766,However,0,0
214767,",",0,0
214768,it,0,0
214769,must,0,0
214770,be,0,0
214771,considered,0,0
214772,that,0,0
214773,these,0,0
214774,provocation,0,0
214775,doses,0,0
214776,are,0,0
214777,not,0,0
214778,equally,0,0
214779,calculable,0,0
214780,for,0,0
214781,every,0,0
214782,patient,0,0
214783,in,0,0
214784,the,0,0
214785,same,0,0
214786,way,0,0
214787,and,0,0
214788,at,0,0
214789,any,0,0
214790,examination,0,0
214791,time,0,0
214792,.,0,0
214793,This,0,0
214794,leads,0,0
214795,to,0,0
214796,the,0,0
214797,fact,0,0
214798,that,0,0
214799,the,0,0
214800,number,0,0
214801,of,0,0
214802,evaluable,0,0
214803,case,0,0
214804,studies,0,0
214805,is,0,0
214806,often,0,0
214807,appreciably,0,0
214808,lower,0,0
214809,than,0,0
214810,the,0,0
214811,number,0,0
214812,of,0,0
214813,test,0,0
214814,participants,0,0
214815,and,0,0
214816,that,0,0
214817,a,0,0
214818,meaningful,0,0
214819,therapy,0,1
214820,group,0,0
214821,comparison,0,0
214822,may,0,0
214823,even,0,0
214824,not,0,0
214825,be,0,0
214826,possible,0,0
214827,under,0,0
214828,certain,0,0
214829,circumstances,0,0
214830,.,0,0
214831,An,0,0
214832,evaluation,0,0
214833,model,0,0
214834,is,0,0
214835,presented,0,0
214836,here,0,0
214837,in,0,0
214838,order,0,0
214839,to,0,0
214840,fully,0,0
214841,exploit,0,0
214842,the,0,0
214843,obtained,0,0
214844,data,0,0
214845,;,0,0
214846,in,0,0
214847,this,0,0
214848,the,0,0
214849,percentile,0,0
214850,changes,0,0
214851,of,0,0
214852,the,0,0
214853,function,0,0
214854,parameters,0,0
214855,(,0,0
214856,estimated,0,0
214857,by,0,0
214858,linear,0,0
214859,regression,0,0
214860,),0,0
214861,at,0,0
214862,a,0,0
214863,defined,0,0
214864,dose,0,0
214865,of,0,0
214866,the,0,0
214867,provocation,0,0
214868,substance,0,0
214869,are,0,0
214870,analyzed,0,0
214871,.,0,0
214872,In,0,0
214873,analogy,0,0
214874,",",0,0
214875,a,0,0
214876,survival,0,0
214877,time,0,0
214878,model,0,0
214879,and,0,0
214880,",",0,0
214881,as,0,0
214882,a,0,0
214883,supplement,0,1
214884,",",0,0
214885,a,0,0
214886,best,0,0
214887,case/worst,0,0
214888,case,0,0
214889,analysis,0,0
214890,are,0,0
214891,performed,0,0
214892,for,0,0
214893,further,0,0
214894,statistical,0,0
214895,evaluation,0,0
214896,.,0,0
214897,With,0,0
214898,the,0,0
214899,present,0,0
214900,procedure,0,0
214901,",",0,0
214902,an,0,0
214903,evaluation,0,0
214904,with,0,0
214905,inclusion,0,0
214906,of,0,0
214907,all,0,0
214908,test,0,0
214909,participants,0,0
214910,is,0,0
214911,possible,0,0
214912,.,0,0
214913,In,0,0
214914,contrast,0,0
214915,to,0,0
214916,the,0,0
214917,previously,0,0
214918,used,0,0
214919,evaluation,0,0
214920,procedures,0,0
214921,",",0,0
214922,this,0,0
214923,allows,0,0
214924,a,0,0
214925,reliable,0,0
214926,statistical,0,0
214927,confirmation,0,0
214928,of,0,0
214929,the,0,0
214930,results,0,0
214931,of,0,0
214932,clinical,0,0
214933,tests,0,0
214934,in,0,0
214935,the,0,0
214936,therapy,0,1
214937,for,0,0
214938,bronchial,0,0
214939,hyperresponsiveness,0,0
214940,.,0,0
214941,Effect,0,0
214942,of,0,0
214943,flurbiprofen,1,1
214944,sodium,1,1
214945,on,0,0
214946,pupillary,0,0
214947,dilatation,0,0
214948,during,0,0
214949,scleral,0,1
214950,buckling,0,0
214951,surgery,0,0
214952,.,0,0
214953,Maintenance,0,0
214954,of,0,0
214955,pupillary,0,0
214956,dilatation,0,1
214957,is,0,0
214958,necessary,0,0
214959,for,0,0
214960,success,0,0
214961,of,0,0
214962,scleral,0,1
214963,buckling,0,0
214964,procedures,0,0
214965,.,0,0
214966,The,0,0
214967,efficacy,0,0
214968,of,0,0
214969,0.03,1,0
214970,%,1,0
214971,flurbiprofen,1,1
214972,in,0,0
214973,preventing,0,0
214974,intraoperative,0,1
214975,miosis,0,0
214976,was,0,0
214977,evaluated,0,0
214978,by,0,0
214979,a,0,0
214980,prospective,0,0
214981,randomized,0,0
214982,",",0,0
214983,double-masked,0,0
214984,controlled,0,0
214985,trial,0,0
214986,of,0,0
214987,60,0,0
214988,patients,0,0
214989,.,0,0
214990,Thirty,0,0
214991,patients,0,0
214992,received,0,0
214993,0.03,0,0
214994,%,0,0
214995,flurbiprofen,1,1
214996,6,0,0
214997,times,0,0
214998,at,0,0
214999,15,0,0
215000,minute,0,0
215001,intervals,0,0
215002,90,0,0
215003,minutes,0,0
215004,preoperatively,0,0
215005,in,0,0
215006,addition,0,0
215007,to,0,0
215008,the,0,0
215009,routine,0,0
215010,dilation,0,0
215011,regimen,0,1
215012,.,0,0
215013,The,0,0
215014,treated,0,0
215015,group,0,0
215016,had,0,0
215017,a,0,0
215018,mean,0,0
215019,pupillary,0,0
215020,decrease,0,0
215021,of,0,0
215022,1.88,0,0
215023,mm,0,0
215024,and,0,0
215025,the,0,0
215026,control,0,1
215027,group,0,0
215028,had,0,0
215029,a,0,0
215030,decrease,0,0
215031,of,0,0
215032,1.57,0,0
215033,mm,0,0
215034,(,0,0
215035,p,0,0
215036,>,0,0
215037,0.05,0,0
215038,),0,0
215039,.,0,0
215040,Flurbiprofen,1,1
215041,did,0,0
215042,not,0,0
215043,affect,0,0
215044,the,0,0
215045,pupillary,0,0
215046,size,0,0
215047,at,0,0
215048,any,0,0
215049,step,0,0
215050,of,0,0
215051,the,0,0
215052,surgery,0,0
215053,.,0,0
215054,Factors,0,0
215055,such,0,0
215056,as,0,0
215057,age,0,0
215058,of,0,0
215059,the,0,0
215060,patient,0,0
215061,",",0,0
215062,lens,0,1
215063,status,0,0
215064,",",0,0
215065,number,0,0
215066,of,0,0
215067,cryo,0,0
215068,applications,0,0
215069,",",0,0
215070,duration,0,0
215071,of,0,0
215072,surgery,0,0
215073,",",0,0
215074,and,0,0
215075,the,0,0
215076,size,0,0
215077,and,0,0
215078,extent,0,0
215079,of,0,0
215080,buckle,0,1
215081,were,0,0
215082,assessed,0,0
215083,.,0,0
215084,The,0,0
215085,use,0,0
215086,of,0,0
215087,flurbiprofen,1,1
215088,did,0,0
215089,not,0,0
215090,affect,0,0
215091,the,0,0
215092,mean,0,0
215093,pupillary,0,0
215094,change,0,0
215095,for,0,0
215096,any,0,0
215097,of,0,0
215098,these,0,0
215099,groups,0,0
215100,.,0,0
215101,Preoperative,0,0
215102,use,0,0
215103,of,0,0
215104,flurbiprofen,1,1
215105,does,0,0
215106,not,0,0
215107,significantly,0,0
215108,decrease,0,0
215109,intraoperative,0,1
215110,miosis,0,0
215111,during,0,0
215112,scleral,0,1
215113,buckling,0,0
215114,procedures,0,0
215115,.,0,0
215116,Measurement,0,0
215117,of,0,0
215118,transfer,0,1
215119,factor,0,0
215120,during,0,0
215121,constant,1,0
215122,exhalation,1,0
215123,.,1,0
215124,BACKGROUND,0,0
215125,Transfer,0,0
215126,factor,0,0
215127,of,0,0
215128,the,0,0
215129,lung,0,0
215130,for,0,0
215131,carbon,0,1
215132,monoxide,0,1
215133,(,0,0
215134,TLCO,0,1
215135,),0,0
215136,was,0,0
215137,measured,0,0
215138,by,0,0
215139,a,0,0
215140,new,0,0
215141,method,0,0
215142,based,0,0
215143,on,0,0
215144,analysis,0,0
215145,of,0,0
215146,the,0,0
215147,ratio,0,0
215148,of,0,0
215149,the,0,0
215150,concentrations,0,0
215151,of,0,0
215152,carbon,0,1
215153,monoxide,0,0
215154,to,0,0
215155,an,0,0
215156,inert,0,1
215157,gas,0,1
215158,(,0,0
215159,methane,0,1
215160,),0,1
215161,relative,0,0
215162,to,0,0
215163,lung,0,0
215164,volume,0,0
215165,during,0,0
215166,a,0,0
215167,constant,1,0
215168,exhalation,1,0
215169,.,1,0
215170,Since,0,0
215171,this,0,0
215172,new,0,0
215173,technique,0,1
215174,is,0,0
215175,based,0,0
215176,solely,0,0
215177,upon,0,0
215178,exhalation,0,0
215179,",",0,0
215180,anomalies,0,0
215181,associated,0,0
215182,with,0,0
215183,inspiration,0,0
215184,and,0,0
215185,breath,0,0
215186,holding,0,0
215187,do,0,0
215188,not,0,0
215189,affect,0,0
215190,results,0,0
215191,.,0,0
215192,Additionally,0,0
215193,",",0,0
215194,because,0,0
215195,prolonged,0,0
215196,breath,0,0
215197,holding,0,0
215198,is,0,0
215199,not,0,0
215200,required,0,0
215201,",",0,0
215202,measurements,0,0
215203,can,0,0
215204,readily,0,0
215205,be,0,0
215206,made,0,0
215207,in,0,0
215208,dyspnoeic,0,0
215209,patients,0,0
215210,.,0,0
215211,METHODS,0,0
215212,Exhalation,1,0
215213,TLCO,1,1
215214,(,1,0
215215,TLCO,1,1
215216,",",1,0
215217,ex,1,0
215218,),1,0
215219,was,0,0
215220,compared,0,0
215221,with,0,0
215222,the,0,0
215223,standard,1,1
215224,(,1,0
215225,Jones,1,0
215226,and,1,0
215227,Meade,1,1
215228,),1,0
215229,10,1,0
215230,second,1,0
215231,breath,1,0
215232,holding,1,0
215233,TLCO,1,1
215234,(,1,0
215235,TLCO,1,1
215236,",",1,0
215237,bh,1,1
215238,),1,0
215239,in,0,0
215240,100,0,0
215241,consecutive,0,0
215242,patients,0,0
215243,.,0,0
215244,Patients,0,0
215245,did,0,0
215246,not,0,0
215247,practise,0,0
215248,the,0,0
215249,exhalation,0,0
215250,manoeuvre,0,1
215251,prior,0,0
215252,to,0,0
215253,testing,0,0
215254,.,0,0
215255,RESULTS,0,0
215256,The,0,0
215257,comparative,0,0
215258,results,0,0
215259,were,0,0
215260,very,0,0
215261,close,0,0
215262,;,0,0
215263,mean,0,0
215264,difference,0,0
215265,(,0,0
215266,bias,0,0
215267,),0,0
215268,+/-,0,0
215269,standard,0,1
215270,deviation,0,0
215271,(,0,0
215272,precision,0,0
215273,),0,0
215274,was,0,0
215275,0.05,0,0
215276,(,0,0
215277,0.84,0,0
215278,),0,0
215279,mmol/min/kPa,0,0
215280,.,0,0
215281,The,0,0
215282,relation,0,0
215283,was,0,0
215284,equally,0,0
215285,strong,0,0
215286,in,0,0
215287,patients,0,0
215288,with,0,0
215289,severe,0,0
215290,pulmonary,0,0
215291,disease,0,0
215292,;,0,0
215293,for,0,0
215294,patients,0,0
215295,with,0,0
215296,FEV1,0,0
215297,<,0,0
215298,1.51,0,0
215299,the,0,0
215300,mean,0,0
215301,difference,0,0
215302,was,0,0
215303,0.21,0,0
215304,(,0,0
215305,0.80,0,0
215306,),0,0
215307,mmol/min/kPa,0,0
215308,.,0,0
215309,CONCLUSIONS,0,0
215310,Since,0,0
215311,the,0,0
215312,results,0,0
215313,were,0,0
215314,essentially,0,0
215315,identical,0,0
215316,between,0,0
215317,the,0,0
215318,techniques,0,1
215319,",",0,0
215320,it,0,0
215321,seems,0,0
215322,that,0,0
215323,comparable,0,0
215324,pathophysiological,0,0
215325,factors,0,0
215326,affect,0,0
215327,TLCO,0,1
215328,during,0,0
215329,breath,1,0
215330,holding,1,0
215331,and,0,0
215332,constant,1,0
215333,exhalation,1,0
215334,.,1,0
215335,Constant,1,0
215336,exhalation,1,0
215337,may,0,0
215338,therefore,0,0
215339,be,0,0
215340,a,0,0
215341,useful,0,0
215342,alternative,0,0
215343,to,0,0
215344,the,0,0
215345,breath,1,0
215346,holding,1,0
215347,technique,0,1
215348,for,0,0
215349,clinical,0,0
215350,measurement,0,0
215351,of,0,0
215352,TLCO,0,1
215353,.,0,0
215354,Profound,0,0
215355,luteinizing,0,0
215356,hormone,0,1
215357,suppression,0,0
215358,after,0,0
215359,stopping,0,0
215360,the,0,0
215361,gonadotropin-releasing,1,1
215362,hormone-agonist,1,1
215363,leuprolide,1,1
215364,acetate,1,1
215365,.,1,0
215366,OBJECTIVE,0,0
215367,To,0,0
215368,compare,0,0
215369,levels,0,0
215370,of,0,0
215371,serum,0,0
215372,LH,0,0
215373,during,0,0
215374,continued,0,0
215375,use,0,0
215376,of,0,0
215377,leuprolide,1,1
215378,acetate,1,1
215379,(,1,0
215380,LA,1,1
215381,),1,0
215382,with,0,0
215383,levels,0,0
215384,during,0,0
215385,the,0,0
215386,first,0,0
215387,week,0,0
215388,after,0,0
215389,discontinuing,0,0
215390,LA,0,0
215391,.,0,0
215392,DESIGN,0,0
215393,Prospective,0,0
215394,controlled,0,0
215395,study,0,0
215396,.,0,0
215397,SETTING,0,0
215398,Clinical,0,0
215399,assisted,0,1
215400,conception,0,0
215401,program,0,1
215402,.,0,0
215403,PATIENTS,0,0
215404,Women,0,0
215405,undergoing,0,0
215406,controlled,0,0
215407,ovarian,0,0
215408,stimulation,0,1
215409,for,0,0
215410,assisted,0,1
215411,conception,0,0
215412,were,0,0
215413,randomized,0,0
215414,to,0,0
215415,receive,0,0
215416,LA,1,1
215417,according,1,0
215418,to,1,0
215419,short,1,0
215420,or,1,1
215421,ultrashort,1,0
215422,protocols,1,0
215423,.,1,0
215424,The,0,0
215425,alternative,0,0
215426,protocol,0,0
215427,was,0,0
215428,used,0,0
215429,then,0,0
215430,in,0,0
215431,a,0,0
215432,second,0,0
215433,cycle,0,0
215434,.,0,0
215435,Each,0,0
215436,patient,0,0
215437,was,0,0
215438,thus,0,0
215439,her,0,0
215440,own,0,0
215441,control,0,0
215442,.,0,0
215443,MAIN,0,0
215444,OUTCOME,0,0
215445,MEASURES,0,0
215446,Serum,0,0
215447,LH,0,1
215448,over,0,0
215449,time,0,0
215450,.,0,0
215451,RESULTS,0,0
215452,When,0,0
215453,LA,1,0
215454,was,0,0
215455,stopped,0,0
215456,after,0,0
215457,5,0,0
215458,days,0,0
215459,of,0,0
215460,administration,0,0
215461,",",0,0
215462,LH,0,0
215463,levels,0,0
215464,fell,0,0
215465,profoundly,0,0
215466,when,0,0
215467,compared,0,0
215468,with,0,0
215469,levels,0,0
215470,when,0,0
215471,LA,1,0
215472,was,0,0
215473,continued,0,0
215474,.,0,0
215475,CONCLUSION,0,0
215476,Loss,0,0
215477,of,0,0
215478,LH,0,0
215479,after,0,0
215480,stopping,0,0
215481,LA,1,1
215482,is,0,0
215483,likely,0,0
215484,to,0,0
215485,be,0,0
215486,clinically,0,0
215487,important,0,0
215488,in,0,0
215489,ovarian,0,0
215490,stimulation,0,0
215491,regimens,0,0
215492,that,0,0
215493,use,0,0
215494,pure,0,0
215495,FSH,0,0
215496,with,0,0
215497,LA,1,0
215498,in,0,0
215499,ultrashort,0,0
215500,protocols,0,0
215501,.,0,0
215502,The,0,0
215503,fall,0,0
215504,in,0,0
215505,LH,0,0
215506,lasts,0,0
215507,at,0,0
215508,least,0,0
215509,1,0,0
215510,week,0,0
215511,and,0,0
215512,may,0,0
215513,be,0,0
215514,explainable,0,0
215515,by,0,0
215516,persistent,0,0
215517,suppression,0,0
215518,of,0,0
215519,endogenous,0,0
215520,GnRH,0,1
215521,by,0,0
215522,LA,0,0
215523,during,0,0
215524,this,0,0
215525,time,0,0
215526,.,0,0
215527,Hypericum,1,1
215528,treatment,1,0
215529,of,0,0
215530,mild,0,0
215531,depressions,0,0
215532,with,0,0
215533,somatic,0,0
215534,symptoms,0,0
215535,.,0,0
215536,In,0,0
215537,a,0,0
215538,randomized,0,0
215539,",",0,0
215540,placebo-controlled,1,1
215541,",",0,0
215542,double-blind,0,0
215543,study,0,0
215544,",",0,0
215545,39,0,0
215546,patients,0,0
215547,with,0,0
215548,depression,0,0
215549,with,0,0
215550,somatic,0,0
215551,symptoms,0,0
215552,were,0,0
215553,treated,0,0
215554,with,0,0
215555,hypericum,1,1
215556,extract,1,1
215557,LI,1,1
215558,160,1,0
215559,.,1,0
215560,The,0,0
215561,therapy,0,0
215562,lasted,0,0
215563,for,0,0
215564,4,0,0
215565,weeks,0,0
215566,;,0,0
215567,the,0,0
215568,dosage,0,0
215569,was,0,0
215570,300,0,1
215571,mg,0,0
215572,three,0,0
215573,times,0,0
215574,daily,0,0
215575,.,0,0
215576,At,0,0
215577,the,0,0
215578,onset,0,0
215579,of,0,0
215580,the,0,0
215581,study,0,0
215582,as,0,0
215583,well,0,0
215584,as,0,0
215585,after,0,0
215586,2,0,0
215587,and,0,0
215588,4,0,0
215589,weeks,0,0
215590,",",0,0
215591,the,0,0
215592,following,0,0
215593,criteria,0,0
215594,were,0,0
215595,analyzed,0,0
215596,:,0,0
215597,HAMD,0,0
215598,",",0,0
215599,B-L,0,0
215600,",",0,0
215601,CGI,0,0
215602,",",0,0
215603,and,0,0
215604,vegetative,0,0
215605,symptoms,0,0
215606,.,0,0
215607,The,0,0
215608,results,0,0
215609,show,0,0
215610,a,0,0
215611,significant,0,0
215612,improvement,0,0
215613,in,0,0
215614,the,0,0
215615,active,0,0
215616,treatment,0,0
215617,group,0,0
215618,at,0,0
215619,the,0,0
215620,5,0,0
215621,%,0,0
215622,level,0,0
215623,as,0,0
215624,compared,0,0
215625,to,0,0
215626,placebo,0,1
215627,.,0,0
215628,Seventy,0,0
215629,percent,0,0
215630,of,0,0
215631,the,0,0
215632,patients,0,0
215633,treated,0,0
215634,with,0,0
215635,LI,0,1
215636,160,0,0
215637,were,0,0
215638,free,0,0
215639,of,0,0
215640,symptoms,0,0
215641,after,0,0
215642,4,0,0
215643,weeks,0,0
215644,.,0,0
215645,Typical,0,0
215646,symptoms,0,0
215647,of,0,0
215648,the,0,0
215649,depression,0,0
215650,such,0,0
215651,as,0,0
215652,lack,0,0
215653,of,0,0
215654,activity,0,0
215655,",",0,0
215656,tiredness,0,0
215657,",",0,0
215658,fatigue,0,0
215659,",",0,0
215660,and,0,0
215661,disturbed,0,0
215662,sleep,0,0
215663,",",0,0
215664,were,0,0
215665,especially,0,0
215666,responsive,0,0
215667,.,0,0
215668,In,0,0
215669,no,0,0
215670,case,0,0
215671,were,0,0
215672,any,0,0
215673,undesirable,0,0
215674,side,0,0
215675,effects,0,0
215676,observed,0,0
215677,.,0,0
215678,Angiotensin,0,1
215679,converting,0,0
215680,enzyme,0,0
215681,inhibition,0,1
215682,does,0,0
215683,not,0,0
215684,affect,0,0
215685,the,0,0
215686,response,0,0
215687,to,0,0
215688,exogenous,0,0
215689,angiotensin,0,1
215690,II,0,0
215691,in,0,0
215692,the,0,0
215693,human,0,0
215694,forearm,0,0
215695,.,0,0
215696,Suppression,0,0
215697,of,0,0
215698,endogenous,0,0
215699,levels,0,0
215700,of,0,0
215701,angiotensin,0,1
215702,II,0,0
215703,by,0,0
215704,angiotensin,0,1
215705,converting,0,0
215706,enzyme,0,0
215707,inhibition,0,0
215708,",",0,0
215709,may,0,0
215710,result,0,0
215711,in,0,0
215712,up-regulation,0,0
215713,of,0,0
215714,vascular,0,0
215715,AT1,0,0
215716,receptors,0,0
215717,.,0,0
215718,We,0,0
215719,have,0,0
215720,evaluated,0,0
215721,the,0,0
215722,effects,0,0
215723,of,0,0
215724,orally,0,1
215725,administered,0,0
215726,enalapril,1,1
215727,on,0,0
215728,angiotensin,0,1
215729,II,0,0
215730,induced,0,0
215731,vasoconstriction,0,0
215732,in,0,0
215733,the,0,0
215734,human,0,0
215735,forearm,0,0
215736,.,0,0
215737,Subjects,0,0
215738,received,0,0
215739,in,0,0
215740,random,0,0
215741,order,0,0
215742,",",0,0
215743,enalapril,1,1
215744,(,0,0
215745,20,0,1
215746,mg,0,1
215747,),0,0
215748,or,1,1
215749,matched,1,0
215750,placebo,1,1
215751,daily,0,0
215752,for,0,0
215753,2,0,0
215754,weeks,0,0
215755,.,0,0
215756,Forearm,0,0
215757,blood,0,0
215758,flow,0,0
215759,response,0,0
215760,to,0,0
215761,increasing,0,0
215762,doses,0,0
215763,of,0,0
215764,angiotensin,0,1
215765,II,0,0
215766,was,0,0
215767,measured,0,0
215768,using,0,0
215769,venous,0,0
215770,occlusion,0,0
215771,plethysmography,0,1
215772,at,0,0
215773,the,0,0
215774,beginning,0,0
215775,of,0,0
215776,the,0,0
215777,study,0,0
215778,and,0,0
215779,at,0,0
215780,the,0,0
215781,end,0,0
215782,of,0,0
215783,each,0,0
215784,2,0,0
215785,week,0,0
215786,treatment,0,0
215787,period,0,0
215788,.,0,0
215789,Treatment,0,0
215790,with,0,0
215791,enalapril,0,1
215792,significantly,0,0
215793,reduced,0,0
215794,plasma,0,0
215795,angiotensin,0,1
215796,II,0,0
215797,levels,0,0
215798,and,0,0
215799,supine,0,1
215800,blood,0,0
215801,pressure,0,0
215802,compared,0,0
215803,with,0,0
215804,placebo,0,1
215805,.,0,0
215806,The,0,0
215807,percentage,0,0
215808,reductions,0,0
215809,in,0,0
215810,forearm,0,1
215811,blood,0,0
215812,flow,0,0
215813,in,0,0
215814,the,0,0
215815,infused,0,0
215816,arm,0,0
215817,",",0,0
215818,in,0,0
215819,response,0,0
215820,to,0,0
215821,the,0,0
215822,maximum,0,0
215823,dose,0,0
215824,of,0,0
215825,angiotensin,0,1
215826,II,0,0
215827,(,0,0
215828,"50,000",0,1
215829,fmol,0,0
215830,min-1,0,0
215831,),0,0
215832,were,0,0
215833,48.1,0,0
215834,+/-,0,0
215835,3.6,0,0
215836,%,0,0
215837,at,0,0
215838,baseline,0,0
215839,",",0,0
215840,57.5,0,0
215841,+/-,0,0
215842,3.6,0,0
215843,%,0,0
215844,on,0,0
215845,placebo,0,1
215846,and,0,0
215847,54.5,0,0
215848,+/-,0,0
215849,4.2,0,0
215850,%,0,0
215851,on,0,0
215852,enalapril,0,1
215853,.,0,0
215854,The,0,0
215855,differences,0,0
215856,were,0,0
215857,not,0,0
215858,significantly,0,0
215859,different,0,0
215860,.,0,0
215861,This,0,0
215862,demonstrates,0,0
215863,that,0,0
215864,suppression,0,0
215865,of,0,0
215866,plasma,0,0
215867,angiotensin,0,1
215868,II,0,0
215869,for,0,0
215870,a,0,0
215871,14,0,0
215872,day,0,0
215873,period,0,0
215874,does,0,0
215875,not,0,0
215876,enhance,0,0
215877,the,0,0
215878,response,0,0
215879,to,0,0
215880,exogenous,0,0
215881,intra-arterial,0,1
215882,angiotensin,0,1
215883,II,0,0
215884,in,0,0
215885,the,0,0
215886,human,0,0
215887,forearm,0,0
215888,of,0,0
215889,healthy,0,0
215890,salt,0,1
215891,replete,0,0
215892,subjects,0,0
215893,.,0,0
215894,Aspirin,1,1
215895,in,0,0
215896,coronary,0,0
215897,heart,0,0
215898,disease,0,0
215899,.,0,0
215900,The,0,0
215901,Coronary,0,0
215902,Drug,0,0
215903,Project,0,0
215904,Research,0,0
215905,Group,0,0
215906,.,0,0
215907,Treatment,0,0
215908,of,0,0
215909,acute,0,0
215910,asthma,0,0
215911,.,0,0
215912,Lack,0,0
215913,of,0,0
215914,therapeutic,0,0
215915,benefit,0,0
215916,and,0,0
215917,increase,0,0
215918,of,0,0
215919,the,0,0
215920,toxicity,0,0
215921,from,0,0
215922,aminophylline,1,1
215923,given,0,0
215924,in,0,0
215925,addition,0,0
215926,to,0,0
215927,high,0,0
215928,doses,0,0
215929,of,0,0
215930,salbutamol,1,1
215931,delivered,0,0
215932,by,0,0
215933,metered-dose,0,1
215934,inhaler,0,1
215935,with,0,0
215936,a,0,0
215937,spacer,0,0
215938,.,0,0
215939,We,0,0
215940,conducted,0,0
215941,a,0,0
215942,randomized,0,0
215943,",",0,0
215944,double-blind,0,0
215945,",",0,0
215946,placebo-controlled,1,1
215947,study,0,0
215948,to,0,0
215949,determine,0,0
215950,if,0,0
215951,intravenous,0,1
215952,aminophylline,1,1
215953,adds,0,0
215954,any,0,0
215955,benefit,0,0
215956,to,0,0
215957,high,0,0
215958,doses,0,0
215959,of,0,0
215960,inhaled,0,1
215961,salbutamol,1,1
215962,in,0,0
215963,patients,0,0
215964,who,0,0
215965,presented,0,0
215966,for,0,0
215967,treatment,0,0
215968,of,0,0
215969,acute,0,0
215970,asthma,0,0
215971,.,0,0
215972,We,0,0
215973,studied,0,0
215974,94,0,0
215975,patients,0,0
215976,(,0,0
215977,mean,0,0
215978,age,0,0
215979,",",0,0
215980,35.6,0,0
215981,+/-,0,0
215982,11.2,0,0
215983,years,0,0
215984,),0,0
215985,with,0,0
215986,moderate,0,0
215987,to,0,0
215988,severe,0,0
215989,acute,0,0
215990,asthma,0,0
215991,.,0,0
215992,All,0,0
215993,patients,0,0
215994,received,0,0
215995,therapy,0,1
215996,with,0,0
215997,salbutamol,1,1
215998,delivered,0,0
215999,with,0,0
216000,metered-dose,1,1
216001,inhaler,1,1
216002,(,1,0
216003,MDI,1,0
216004,),1,0
216005,into,1,0
216006,a,1,0
216007,spacer,1,1
216008,device,1,1
216009,(,0,0
216010,Volumatic,0,1
216011,),0,0
216012,in,0,0
216013,four,0,0
216014,puffs,0,1
216015,(,0,0
216016,400,0,0
216017,micrograms,0,1
216018,),0,0
216019,at,0,0
216020,10-min,0,1
216021,interval,0,0
216022,",",0,0
216023,and,0,0
216024,intravenous,1,1
216025,hydrocortisone,1,1
216026,(,0,0
216027,500,0,0
216028,mg,0,1
216029,),0,0
216030,.,0,0
216031,Patients,0,0
216032,were,0,0
216033,randomly,0,0
216034,assigned,0,0
216035,to,0,0
216036,receive,0,0
216037,either,0,0
216038,a,0,0
216039,loading,0,1
216040,dose,0,0
216041,of,0,0
216042,intravenous,0,1
216043,aminophylline,1,1
216044,followed,0,0
216045,by,0,0
216046,a,0,0
216047,routine,0,0
216048,infusion,0,1
216049,(,0,0
216050,n,0,0
216051,=,0,0
216052,45,0,0
216053,),0,0
216054,or,0,0
216055,an,0,0
216056,equal,0,0
216057,volume,0,0
216058,of,0,0
216059,placebo,1,1
216060,as,0,0
216061,a,0,0
216062,loading,0,1
216063,dose,0,0
216064,and,0,0
216065,infusion,0,1
216066,(,0,0
216067,n,0,0
216068,=,0,0
216069,49,0,0
216070,),0,0
216071,.,0,0
216072,The,0,0
216073,two,0,0
216074,groups,0,0
216075,showed,0,0
216076,no,0,0
216077,differences,0,0
216078,in,0,0
216079,measurements,0,0
216080,of,0,0
216081,peak,0,0
216082,expiratory,0,0
216083,flow,0,0
216084,",",0,0
216085,FEV1,0,0
216086,",",0,0
216087,and,0,0
216088,FVC,0,0
216089,at,0,0
216090,baseline,0,0
216091,and,0,0
216092,at,0,0
216093,the,0,0
216094,end,0,0
216095,of,0,0
216096,treatment,0,0
216097,.,0,0
216098,However,0,0
216099,",",0,0
216100,the,0,0
216101,patients,0,0
216102,treated,0,0
216103,with,0,0
216104,aminophylline,1,1
216105,had,0,0
216106,significantly,0,0
216107,more,0,0
216108,adverse,0,0
216109,effects,0,0
216110,(,0,0
216111,p,0,0
216112,<,0,0
216113,0.05,0,0
216114,),0,0
216115,.,0,0
216116,There,0,0
216117,were,0,0
216118,no,0,0
216119,differences,0,0
216120,in,0,0
216121,the,0,0
216122,final,0,0
216123,mean,0,0
216124,dose,0,0
216125,of,0,0
216126,salbutamol,0,1
216127,(,0,0
216128,6.3,0,0
216129,+/-,0,0
216130,44.5,0,0
216131,mg,0,0
216132,for,0,0
216133,the,0,0
216134,placebo,1,1
216135,group,0,0
216136,and,0,0
216137,5.8,0,0
216138,+/-,0,0
216139,4.2,0,0
216140,mg,0,0
216141,for,0,0
216142,the,0,0
216143,aminophylline,0,1
216144,group,0,0
216145,),0,0
216146,",",0,0
216147,hospital,0,0
216148,admission,0,0
216149,rate,0,0
216150,(,0,0
216151,10.2,0,0
216152,percent,0,0
216153,for,0,0
216154,the,0,0
216155,placebo,0,1
216156,group,0,0
216157,and,0,0
216158,9.0,0,0
216159,percent,0,0
216160,for,0,0
216161,the,0,0
216162,aminophylline,1,1
216163,group,0,0
216164,),0,0
216165,",",0,0
216166,and,0,0
216167,mean,0,0
216168,duration,0,0
216169,of,0,0
216170,Emergency,0,1
216171,Department,0,1
216172,treatment,0,0
216173,(,0,0
216174,2.5,0,0
216175,+/-,0,0
216176,1.83,0,0
216177,h,0,0
216178,for,0,0
216179,the,0,0
216180,placebo,1,1
216181,group,0,0
216182,and,0,0
216183,2.37,0,0
216184,+/-,0,0
216185,1.75,0,0
216186,h,0,0
216187,for,0,0
216188,the,0,0
216189,aminophylline,1,1
216190,group,0,0
216191,),0,0
216192,.,0,0
216193,The,0,0
216194,results,0,0
216195,were,0,0
216196,similar,0,0
216197,when,0,0
216198,the,0,0
216199,patients,0,0
216200,were,0,0
216201,divided,0,0
216202,in,0,0
216203,accord,0,0
216204,with,0,0
216205,the,0,0
216206,degree,0,0
216207,of,0,0
216208,respiratory,0,0
216209,obstruction,0,0
216210,(,0,0
216211,baseline,0,0
216212,FEV1,0,0
216213,<,0,0
216214,30,0,0
216215,percent,0,0
216216,of,0,0
216217,predicted,0,0
216218,),0,0
216219,and,0,0
216220,theophylline,1,1
216221,level,0,0
216222,at,0,0
216223,30,0,0
216224,min,0,0
216225,of,0,0
216226,treatment,0,0
216227,(,0,0
216228,placebo,0,1
216229,group,0,0
216230,patients,0,0
216231,with,0,0
216232,theophylline,1,1
216233,level,0,0
216234,<,0,0
216235,10,0,0
216236,mg/L,0,1
216237,vs,0,0
216238,aminophylline,1,1
216239,group,0,0
216240,patients,0,0
216241,with,0,0
216242,theophylline,0,1
216243,level,0,0
216244,>,0,0
216245,or,0,0
216246,=,0,0
216247,10,0,0
216248,mg/L,0,1
216249,),0,0
216250,.,0,0
216251,We,0,0
216252,conclude,0,0
216253,that,0,0
216254,intravenous,0,1
216255,aminophylline,0,1
216256,adds,0,0
216257,to,0,0
216258,the,0,0
216259,toxicity,0,0
216260,but,0,0
216261,not,0,0
216262,the,0,0
216263,efficacy,0,0
216264,of,0,0
216265,inhaled,0,1
216266,salbutamol,1,1
216267,in,0,0
216268,the,0,0
216269,treatment,0,0
216270,of,0,0
216271,acute,0,0
216272,exacerbations,0,0
216273,of,0,0
216274,asthma,0,0
216275,.,0,0
216276,Aerosolized,1,1
216277,pentamidine,1,1
216278,as,0,0
216279,primary,0,0
216280,prophylaxis,0,0
216281,for,0,0
216282,Pneumocystis,0,0
216283,carinii,0,0
216284,pneumonia,0,0
216285,:,0,0
216286,efficacy,0,0
216287,",",0,0
216288,mortality,0,0
216289,and,0,0
216290,morbidity,0,0
216291,.,0,0
216292,OBJECTIVE,0,0
216293,Primary,0,0
216294,prophylaxis,0,0
216295,against,0,0
216296,Pneumocystis,0,0
216297,carinii,0,0
216298,pneumonia,0,0
216299,(,0,0
216300,PCP,0,1
216301,),0,0
216302,for,0,0
216303,patients,0,0
216304,with,0,0
216305,HIV,0,0
216306,infection,0,0
216307,has,0,0
216308,been,0,0
216309,recommended,0,0
216310,by,0,0
216311,the,0,0
216312,Centers,0,0
216313,for,0,0
216314,Disease,0,0
216315,Control,0,1
216316,and,0,0
216317,Prevention,0,1
216318,.,0,0
216319,We,0,0
216320,evaluated,0,0
216321,alternatives,0,0
216322,to,0,0
216323,routine,0,0
216324,primary,0,0
216325,PCP,0,1
216326,prophylaxis,0,0
216327,with,0,0
216328,aerosolized,1,0
216329,pentamidine,1,1
216330,.,1,0
216331,METHODS,0,0
216332,A,0,0
216333,total,0,0
216334,of,0,0
216335,121,0,0
216336,HIV-infected,0,0
216337,patients,0,0
216338,with,0,0
216339,CD4+,0,0
216340,cell,0,0
216341,counts,0,0
216342,<,0,0
216343,or,0,0
216344,=,0,0
216345,200,0,0
216346,x,0,0
216347,10,0,0
216348,(,0,0
216349,6,0,0
216350,),0,0
216351,/l,0,0
216352,or,0,1
216353,an,0,0
216354,AIDS,0,0
216355,diagnosis,0,0
216356,were,0,0
216357,enrolled,0,0
216358,in,0,0
216359,a,0,0
216360,controlled,0,0
216361,study,0,0
216362,of,0,0
216363,aerosolized,1,0
216364,pentamidine,1,1
216365,as,0,0
216366,primary,0,0
216367,PCP,0,1
216368,prophylaxis,0,0
216369,.,0,0
216370,Patients,0,0
216371,were,0,0
216372,randomly,0,0
216373,assigned,0,0
216374,to,0,0
216375,treatment,0,0
216376,(,0,0
216377,n,0,0
216378,=,0,0
216379,61,0,0
216380,),0,0
216381,with,0,0
216382,aerosolized,1,0
216383,pentamidine,1,1
216384,once,0,1
216385,every,0,1
216386,month,0,0
216387,or,0,0
216388,to,0,0
216389,no,1,0
216390,treatment,1,0
216391,(,0,0
216392,n,0,0
216393,=,0,0
216394,60,0,0
216395,),0,0
216396,.,0,0
216397,Patients,0,0
216398,were,0,0
216399,evaluated,0,0
216400,for,0,0
216401,PCP,0,1
216402,",",0,0
216403,mortality,0,0
216404,",",0,0
216405,morbidity,0,0
216406,and,0,0
216407,progression,0,0
216408,of,0,0
216409,HIV,0,0
216410,disease,0,0
216411,.,0,0
216412,Morbidity,0,0
216413,was,0,0
216414,estimated,0,0
216415,from,0,0
216416,the,0,0
216417,number,0,0
216418,of,0,0
216419,days,0,0
216420,patients,0,0
216421,were,0,0
216422,unable,0,0
216423,to,0,0
216424,work,0,0
216425,due,0,0
216426,to,0,0
216427,illness,0,0
216428,",",0,0
216429,number,0,0
216430,of,0,0
216431,days,0,0
216432,hospitalized,0,0
216433,and,0,0
216434,AIDS,0,0
216435,events,0,0
216436,.,0,0
216437,RESULTS,0,0
216438,Baseline,0,0
216439,characteristics,0,0
216440,were,0,0
216441,similar,0,0
216442,in,0,0
216443,the,0,0
216444,treatment,0,0
216445,and,0,0
216446,control,0,1
216447,groups,0,0
216448,and,0,0
216449,mean,0,0
216450,CD4+,0,0
216451,cell,0,0
216452,counts,0,0
216453,were,0,0
216454,116,0,0
216455,and,0,0
216456,107,0,0
216457,x,0,0
216458,10,0,0
216459,(,0,0
216460,6,0,0
216461,),0,0
216462,/l,0,0
216463,",",0,0
216464,respectively,0,0
216465,.,0,0
216466,Eight,0,0
216467,incidents,0,0
216468,of,0,0
216469,PCP,0,1
216470,and,0,0
216471,19,0,0
216472,deaths,0,0
216473,were,0,0
216474,observed,0,0
216475,in,0,0
216476,the,0,0
216477,treatment,0,0
216478,group,0,0
216479,during,0,0
216480,a,0,0
216481,median,0,0
216482,follow-up,0,0
216483,of,0,0
216484,16.4,0,0
216485,months,0,0
216486,(,0,0
216487,range,0,0
216488,",",0,0
216489,2.3-32.4,0,0
216490,months,0,0
216491,),0,0
216492,.,0,0
216493,Nineteen,0,0
216494,incidents,0,0
216495,of,0,0
216496,PCP,0,1
216497,and,0,0
216498,13,0,0
216499,deaths,0,0
216500,",",0,0
216501,of,0,0
216502,which,0,0
216503,one,0,0
216504,was,0,0
216505,related,0,0
216506,to,0,0
216507,an,0,0
216508,acute,0,0
216509,episode,0,0
216510,of,0,0
216511,PCP,0,1
216512,",",0,0
216513,were,0,0
216514,noted,0,0
216515,in,0,0
216516,the,0,0
216517,control,0,0
216518,group,0,0
216519,.,0,0
216520,Median,0,0
216521,follow-up,0,0
216522,of,0,0
216523,controls,0,0
216524,was,0,0
216525,18.5,0,0
216526,months,0,0
216527,(,0,0
216528,range,0,0
216529,",",0,0
216530,3.1-32.9,0,0
216531,months,0,0
216532,),0,0
216533,.,0,0
216534,Patients,0,0
216535,in,0,0
216536,the,0,0
216537,treatment,0,0
216538,group,0,0
216539,were,0,0
216540,unable,0,0
216541,to,0,0
216542,work,0,0
216543,19,0,0
216544,%,0,0
216545,of,0,0
216546,the,0,0
216547,observation,0,0
216548,time,0,0
216549,and,0,0
216550,were,0,0
216551,hospitalized,0,0
216552,for,0,0
216553,4.3,0,0
216554,%,0,0
216555,of,0,0
216556,that,0,0
216557,time,0,0
216558,.,0,0
216559,Corresponding,0,0
216560,figures,0,0
216561,were,0,0
216562,20,0,0
216563,and,0,0
216564,3.0,0,0
216565,%,0,0
216566,",",0,0
216567,respectively,0,0
216568,",",0,0
216569,in,0,0
216570,the,0,0
216571,control,0,0
216572,group,0,0
216573,.,0,0
216574,CONCLUSIONS,0,0
216575,Aerosolized,1,0
216576,pentamidine,1,1
216577,had,0,0
216578,significant,0,0
216579,prophylactic,0,1
216580,efficacy,0,0
216581,",",0,0
216582,but,0,0
216583,we,0,0
216584,could,0,0
216585,not,0,0
216586,detect,0,0
216587,any,0,0
216588,major,0,0
216589,effect,0,0
216590,on,0,0
216591,mortality,0,0
216592,and,0,0
216593,morbidity,0,0
216594,.,0,0
216595,The,0,0
216596,overall,0,0
216597,mortality,0,0
216598,and,0,0
216599,morbidity,0,0
216600,were,0,0
216601,not,0,0
216602,markedly,0,0
216603,influenced,0,0
216604,by,0,0
216605,PCP,0,1
216606,.,0,0
216607,Clinical,0,0
216608,check-ups,0,0
216609,and,0,0
216610,treatment,0,0
216611,of,0,0
216612,acute,0,0
216613,PCP,0,1
216614,could,0,0
216615,be,0,0
216616,a,0,0
216617,justifiable,0,0
216618,alternative,0,0
216619,to,0,0
216620,drug,0,0
216621,prophylaxis,0,1
216622,with,0,0
216623,aerosolized,1,0
216624,pentamidine,1,1
216625,in,0,0
216626,selected,0,0
216627,patients,0,0
216628,.,0,0
216629,Preventing,0,1
216630,disability,0,0
216631,and,0,0
216632,falls,0,0
216633,in,0,0
216634,older,0,0
216635,adults,0,0
216636,:,0,0
216637,a,0,0
216638,population-based,0,0
216639,randomized,0,0
216640,trial,0,0
216641,.,0,0
216642,OBJECTIVES,0,0
216643,Because,0,0
216644,preventing,0,0
216645,disability,0,0
216646,and,0,0
216647,falls,0,0
216648,in,0,0
216649,older,0,0
216650,adults,0,0
216651,is,0,0
216652,a,0,0
216653,national,0,0
216654,priority,0,0
216655,",",0,0
216656,a,0,0
216657,randomized,0,0
216658,controlled,0,0
216659,trial,0,0
216660,was,0,0
216661,conducted,0,0
216662,to,0,0
216663,test,0,0
216664,a,0,0
216665,multicomponent,0,1
216666,intervention,0,1
216667,program,0,1
216668,.,0,0
216669,METHODS,0,0
216670,From,0,0
216671,a,0,0
216672,random,0,0
216673,sample,0,0
216674,of,0,0
216675,health,0,0
216676,maintenance,0,0
216677,organization,0,0
216678,(,0,0
216679,HMO,0,1
216680,),0,1
216681,enrollees,0,0
216682,65,0,0
216683,years,0,0
216684,and,0,0
216685,older,0,0
216686,",",0,0
216687,1559,0,0
216688,ambulatory,0,0
216689,seniors,0,0
216690,were,0,0
216691,randomized,0,0
216692,to,0,0
216693,one,0,0
216694,of,0,0
216695,three,0,0
216696,groups,0,0
216697,:,0,0
216698,a,1,0
216699,nurse,1,1
216700,assessment,1,0
216701,visit,1,0
216702,and,1,0
216703,follow-up,1,0
216704,interventions,1,1
216705,targeting,1,0
216706,risk,1,0
216707,factors,1,0
216708,for,1,0
216709,disability,1,0
216710,and,1,0
216711,falls,1,0
216712,(,0,0
216713,group,0,0
216714,1,0,0
216715,",",0,0
216716,n,0,0
216717,=,0,0
216718,635,0,0
216719,),0,0
216720,;,0,0
216721,a,1,0
216722,general,1,0
216723,health,1,0
216724,promotion,1,0
216725,nurse,1,1
216726,visit,1,0
216727,(,0,0
216728,group,0,0
216729,2,0,0
216730,",",0,0
216731,n,0,0
216732,=,0,0
216733,317,0,0
216734,),0,0
216735,;,0,0
216736,and,0,0
216737,usual,1,1
216738,care,1,1
216739,(,0,0
216740,group,0,0
216741,3,0,0
216742,",",0,0
216743,n,0,0
216744,=,0,0
216745,607,0,0
216746,),0,0
216747,.,0,0
216748,Data,0,0
216749,collection,0,0
216750,consisted,0,0
216751,of,0,0
216752,a,0,0
216753,baseline,0,0
216754,and,0,0
216755,two,0,0
216756,annual,0,0
216757,follow-up,0,0
216758,surveys,0,0
216759,.,0,0
216760,RESULTS,0,0
216761,After,0,0
216762,1,0,0
216763,year,0,0
216764,",",0,0
216765,group,0,0
216766,1,0,0
216767,subjects,0,0
216768,reported,0,0
216769,a,0,0
216770,significantly,0,0
216771,lower,0,0
216772,incidence,0,0
216773,of,0,0
216774,declining,0,0
216775,functional,0,0
216776,status,0,0
216777,and,0,0
216778,a,0,0
216779,significantly,0,0
216780,lower,0,0
216781,incidence,0,0
216782,of,0,0
216783,falls,0,0
216784,than,0,0
216785,group,0,0
216786,3,0,0
216787,subjects,0,0
216788,.,0,0
216789,Group,0,0
216790,2,0,0
216791,subjects,0,0
216792,had,0,0
216793,intermediate,0,0
216794,levels,0,0
216795,of,0,0
216796,most,0,0
216797,outcomes,0,0
216798,.,0,0
216799,After,0,0
216800,2,0,0
216801,years,0,0
216802,of,0,0
216803,follow-up,0,0
216804,",",0,0
216805,the,0,0
216806,differences,0,0
216807,narrowed,0,0
216808,.,0,0
216809,CONCLUSIONS,0,0
216810,The,0,0
216811,results,0,0
216812,suggest,0,0
216813,that,0,0
216814,a,0,0
216815,modest,0,0
216816,",",0,0
216817,one-time,0,0
216818,prevention,0,0
216819,program,0,1
216820,appeared,0,0
216821,to,0,0
216822,confer,0,0
216823,short-term,0,0
216824,health,0,0
216825,benefits,0,0
216826,on,0,0
216827,ambulatory,0,0
216828,HMO,0,0
216829,enrollees,0,0
216830,",",0,0
216831,although,0,0
216832,benefits,0,0
216833,diminished,0,0
216834,by,0,0
216835,the,0,0
216836,second,0,0
216837,year,0,0
216838,of,0,0
216839,follow-up,0,0
216840,.,0,0
216841,The,0,0
216842,mechanisms,0,0
216843,by,0,0
216844,which,0,0
216845,the,0,0
216846,intervention,0,1
216847,may,0,0
216848,have,0,0
216849,improved,0,0
216850,outcomes,0,0
216851,require,0,0
216852,further,0,0
216853,investigation,0,0
216854,.,0,0
216855,Treatment,0,0
216856,of,0,0
216857,multiple,0,0
216858,myeloma,0,0
216859,according,0,0
216860,to,0,0
216861,the,0,0
216862,extension,0,0
216863,of,0,0
216864,the,0,0
216865,disease,0,0
216866,:,0,0
216867,a,0,0
216868,prospective,0,0
216869,",",0,0
216870,randomised,0,0
216871,study,0,0
216872,comparing,0,0
216873,a,0,0
216874,less,0,0
216875,with,0,0
216876,a,0,0
216877,more,0,0
216878,aggressive,1,0
216879,cystostatic,1,1
216880,policy,0,0
216881,.,0,0
216882,Cooperative,0,0
216883,Group,0,0
216884,of,0,0
216885,Study,0,0
216886,and,0,0
216887,Treatment,0,0
216888,of,0,0
216889,Multiple,0,0
216890,Myeloma,0,0
216891,.,0,0
216892,The,0,0
216893,purpose,0,0
216894,of,0,0
216895,the,0,0
216896,study,0,0
216897,was,0,0
216898,to,0,0
216899,ascertain,0,0
216900,whether,0,0
216901,the,0,0
216902,prognostic,0,0
216903,significance,0,0
216904,of,0,0
216905,staging,0,0
216906,in,0,0
216907,multiple,0,0
216908,myeloma,0,0
216909,(,0,0
216910,MM,0,1
216911,),0,1
216912,is,0,0
216913,influenced,0,0
216914,by,0,0
216915,the,0,0
216916,aggressiveness,1,0
216917,of,1,0
216918,effective,1,0
216919,induction,1,0
216920,treatment,1,0
216921,and/or,0,0
216922,by,0,0
216923,continuing,0,0
216924,or,0,1
216925,discontinuing,0,0
216926,maintenance,1,0
216927,chemotherapy,1,1
216928,.,1,0
216929,Patients,0,0
216930,with,0,0
216931,untreated,0,0
216932,stage,0,0
216933,I,0,0
216934,MM,0,1
216935,(,0,0
216936,defined,0,0
216937,according,0,0
216938,to,0,0
216939,Durie,0,0
216940,and,0,0
216941,Salmon,0,1
216942,),0,0
216943,were,0,0
216944,randomised,0,0
216945,between,0,0
216946,being,0,0
216947,followed,1,0
216948,without,1,0
216949,cytostatics,1,1
216950,until,0,0
216951,the,0,0
216952,disease,0,0
216953,progressed,0,0
216954,and,0,0
216955,receiving,1,0
216956,six,1,0
216957,courses,1,0
216958,of,1,0
216959,melphalan,1,1
216960,and,1,0
216961,prednisone,1,1
216962,(,1,1
216963,MP-P,1,0
216964,),1,0
216965,just,0,0
216966,after,0,0
216967,diagnosis,0,0
216968,;,0,0
216969,stage,0,0
216970,II,0,0
216971,patients,0,0
216972,were,0,0
216973,uniformly,0,0
216974,treated,0,0
216975,with,0,0
216976,MPH-P,1,1
216977,and,0,0
216978,stage,0,0
216979,III,0,0
216980,patients,0,0
216981,were,0,0
216982,randomised,0,0
216983,between,0,0
216984,MPH-P,1,0
216985,and,1,0
216986,four,1,0
216987,courses,1,0
216988,of,1,0
216989,combination,1,1
216990,chemotherapy,1,1
216991,with,1,0
216992,Peptichemio,1,1
216993,",",1,0
216994,vincristine,1,1
216995,and,1,0
216996,prednisone,1,1
216997,(,1,1
216998,PTC-VCR-P,1,0
216999,),1,0
217000,.,1,0
217001,Within,0,0
217002,each,0,0
217003,stage,0,0
217004,",",0,0
217005,responsive,0,0
217006,patients,0,0
217007,were,0,0
217008,randomised,0,0
217009,between,0,0
217010,receiving,0,0
217011,additional,0,0
217012,therapy,0,1
217013,only,0,0
217014,until,0,0
217015,maximal,0,0
217016,tumour,0,0
217017,reduction,0,0
217018,was,0,0
217019,reached,0,0
217020,(,0,0
217021,plateau,0,0
217022,phase,0,0
217023,),0,0
217024,and,0,0
217025,continuing,0,1
217026,induction,0,0
217027,therapy,0,1
217028,indefinitely,0,0
217029,until,0,0
217030,relapse,0,0
217031,.,0,0
217032,With,0,0
217033,resistant,0,0
217034,",",0,0
217035,progressive,0,0
217036,or,0,1
217037,relapsing,0,0
217038,disease,0,0
217039,",",0,0
217040,patients,0,0
217041,originally,0,0
217042,treated,0,0
217043,with,0,0
217044,MPH-P,1,0
217045,for,0,0
217046,induction,0,0
217047,received,0,0
217048,combination,0,1
217049,chemotherapy,0,1
217050,and,0,0
217051,vice,0,0
217052,versa,0,0
217053,.,0,0
217054,The,0,0
217055,overall,0,0
217056,first,0,0
217057,response,0,0
217058,rate,0,0
217059,was,0,0
217060,43.8,0,0
217061,%,0,0
217062,(,0,0
217063,42.2,0,0
217064,%,0,0
217065,in,0,0
217066,206,0,0
217067,stage,0,0
217068,I,0,0
217069,",",0,0
217070,II,0,0
217071,and,0,0
217072,III,0,0
217073,patients,0,0
217074,treated,0,0
217075,with,0,0
217076,MPH-P,1,0
217077,and,0,0
217078,48.0,0,0
217079,%,0,0
217080,in,0,0
217081,75,0,0
217082,stage,0,0
217083,III,0,0
217084,patients,0,0
217085,treated,0,0
217086,with,0,0
217087,combination,1,1
217088,chemotherapy,1,1
217089,",",0,0
217090,P,0,0
217091,=,0,0
217092,NS,0,0
217093,),0,0
217094,.,0,0
217095,Combination,1,0
217096,chemotherapy,1,1
217097,was,0,0
217098,more,0,0
217099,myelotoxic,0,0
217100,than,0,0
217101,MPH-P,1,0
217102,and,0,0
217103,",",0,0
217104,in,0,0
217105,particular,0,0
217106,",",0,0
217107,caused,0,0
217108,more,0,0
217109,non-haematological,0,0
217110,side-effects,0,0
217111,.,0,0
217112,Both,0,0
217113,the,0,0
217114,less,0,0
217115,and,0,0
217116,the,0,0
217117,more,0,0
217118,aggressive,0,0
217119,induction,0,0
217120,policies,0,0
217121,gave,0,0
217122,the,0,0
217123,same,0,0
217124,disease,0,0
217125,control,0,1
217126,.,0,0
217127,Progression,0,0
217128,of,0,0
217129,disease,0,0
217130,was,0,0
217131,statistically,0,0
217132,similar,0,0
217133,in,0,0
217134,stage,0,0
217135,I,0,0
217136,patients,0,0
217137,who,0,0
217138,were,0,0
217139,initially,0,0
217140,left,0,0
217141,untreated,0,0
217142,and,0,0
217143,in,0,0
217144,t,0,0
217145,hose,0,0
217146,who,0,0
217147,received,0,0
217148,MPH-P,1,0
217149,just,0,0
217150,after,0,0
217151,diagnosis,0,0
217152,;,0,0
217153,median,0,0
217154,duration,0,0
217155,of,0,0
217156,first,0,0
217157,response,0,0
217158,was,0,0
217159,similar,0,0
217160,in,0,0
217161,stage,0,0
217162,III,0,0
217163,patients,0,0
217164,receiving,0,0
217165,MPH-P,1,0
217166,and,0,0
217167,in,0,0
217168,those,0,0
217169,on,0,0
217170,combination,1,1
217171,chemotherapy,1,1
217172,.,1,0
217173,In,0,0
217174,all,0,0
217175,stages,0,0
217176,",",0,0
217177,discontinuing,0,0
217178,or,0,1
217179,continuing,0,0
217180,maintenance,0,0
217181,did,0,0
217182,not,0,0
217183,alter,0,0
217184,the,0,0
217185,median,0,0
217186,duration,0,0
217187,of,0,0
217188,first,0,0
217189,response,0,0
217190,.,0,0
217191,The,0,0
217192,overall,0,0
217193,second,0,0
217194,response,0,0
217195,rate,0,0
217196,was,0,0
217197,28.5,0,0
217198,%,0,0
217199,(,0,0
217200,34.0,0,0
217201,%,0,0
217202,to,0,0
217203,MPH-P,0,0
217204,and,0,0
217205,25.3,0,0
217206,%,0,0
217207,to,0,0
217208,combination,0,1
217209,chemotherapy,1,1
217210,",",0,0
217211,P,0,0
217212,=,0,0
217213,NS,0,0
217214,),0,0
217215,.,0,0
217216,Median,0,0
217217,survival,0,0
217218,was,0,0
217219,greater,0,0
217220,than,0,0
217221,78,0,0
217222,months,0,0
217223,in,0,0
217224,stage,0,0
217225,I,0,0
217226,",",0,0
217227,was,0,0
217228,46.3,0,0
217229,months,0,0
217230,in,0,0
217231,stage,0,0
217232,II,0,0
217233,and,0,0
217234,was,0,0
217235,24.3,0,0
217236,months,0,0
217237,in,0,0
217238,stage,0,0
217239,III,0,0
217240,patients,0,0
217241,",",0,0
217242,still,0,0
217243,independent,0,0
217244,of,0,0
217245,both,0,0
217246,induction,0,0
217247,and,0,0
217248,post-induction,0,0
217249,policies,0,0
217250,.,0,0
217251,In,0,0
217252,MM,0,1
217253,",",0,0
217254,the,0,0
217255,significance,0,0
217256,of,0,0
217257,staging,0,0
217258,for,0,0
217259,survival,0,0
217260,is,0,0
217261,independent,0,0
217262,of,0,0
217263,both,0,0
217264,the,0,0
217265,aggressiveness,0,0
217266,of,0,0
217267,induction,0,0
217268,and,0,0
217269,of,0,0
217270,continuing,0,0
217271,or,0,1
217272,discontinuing,0,0
217273,maintenance,0,0
217274,chemotherapy,0,1
217275,after,0,0
217276,the,0,0
217277,maximal,0,0
217278,tumor,0,0
217279,reduction,0,0
217280,has,0,0
217281,been,0,0
217282,achieved,0,0
217283,.,0,0
217284,Both,0,0
217285,MPH-P,1,0
217286,and,0,0
217287,and,0,0
217288,the,0,0
217289,association,0,0
217290,of,0,0
217291,PTC,1,1
217292,",",1,0
217293,VCR,1,0
217294,and,1,0
217295,P,1,0
217296,are,0,0
217297,effective,0,0
217298,in,0,0
217299,inducing,0,0
217300,first,0,0
217301,response,0,0
217302,and,0,0
217303,also,0,0
217304,second,0,0
217305,response,0,0
217306,in,0,0
217307,patients,0,0
217308,failing,0,0
217309,on,0,0
217310,the,0,0
217311,alternative,0,0
217312,regimen,0,0
217313,",",0,0
217314,but,0,0
217315,PTC-VCR-P,1,0
217316,causes,0,0
217317,more,0,0
217318,side,0,0
217319,effects,0,0
217320,.,0,0
217321,Thus,0,0
217322,",",0,0
217323,the,0,0
217324,overwhelming,0,0
217325,majority,0,0
217326,of,0,0
217327,patients,0,0
217328,with,0,0
217329,MM,0,1
217330,can,0,0
217331,safely,0,0
217332,be,0,0
217333,given,0,0
217334,MPH-P,1,0
217335,as,0,0
217336,first,0,0
217337,therapy,0,1
217338,",",0,0
217339,and,0,0
217340,this,0,0
217341,treatment,0,0
217342,may,0,0
217343,be,0,0
217344,delayed,0,0
217345,in,0,0
217346,early,0,0
217347,diseases,0,0
217348,.,0,0
217349,Effect,0,0
217350,of,0,0
217351,intravenous,1,1
217352,"fructose-1,6-diphosphate",1,1
217353,on,0,0
217354,myocardial,0,0
217355,contractility,0,0
217356,in,0,0
217357,patients,0,0
217358,with,0,0
217359,left,0,0
217360,ventricular,0,0
217361,dysfunction,0,0
217362,.,0,0
217363,STUDY,0,0
217364,OBJECTIVE,0,0
217365,To,0,0
217366,examine,0,0
217367,the,0,0
217368,effects,0,0
217369,of,0,0
217370,"fructose-1,6-diphosphate",1,0
217371,on,0,0
217372,myocardial,0,0
217373,performance,0,0
217374,using,0,0
217375,nuclear,0,0
217376,scintigraphy,0,1
217377,.,0,0
217378,DESIGN,0,0
217379,Prospective,0,0
217380,",",0,0
217381,randomized,0,0
217382,",",0,0
217383,single-blind,0,0
217384,",",0,0
217385,parallel,0,0
217386,study,0,0
217387,.,0,0
217388,SETTING,0,0
217389,Urban,0,0
217390,teaching,0,1
217391,hospital,0,0
217392,clinical,0,0
217393,research,0,0
217394,center,0,0
217395,.,0,0
217396,PATIENTS,0,0
217397,Individuals,0,0
217398,with,0,0
217399,New,0,0
217400,York,0,0
217401,Heart,0,1
217402,Association,0,0
217403,functional,0,0
217404,class,0,0
217405,II-III,0,1
217406,heart,0,0
217407,failure,0,0
217408,(,0,0
217409,mild,0,0
217410,to,0,0
217411,moderate,0,0
217412,),0,0
217413,.,0,0
217414,INTERVENTIONS,0,0
217415,Subjects,0,0
217416,received,0,0
217417,either,0,0
217418,intravenous,1,1
217419,"fructose-1,6-diphosphate",1,1
217420,125,1,0
217421,mg/kg,1,1
217422,or,1,0
217423,normal,1,0
217424,saline,1,1
217425,1.3,0,0
217426,ml/kg,0,0
217427,every,0,0
217428,12,0,0
217429,hours,0,0
217430,over,0,0
217431,10,0,0
217432,minutes,0,0
217433,for,0,0
217434,four,0,0
217435,consecutive,0,0
217436,doses,0,0
217437,.,0,0
217438,Left,0,1
217439,ventricular,0,0
217440,performance,0,0
217441,was,0,0
217442,assessed,0,0
217443,by,0,0
217444,radionuclide,1,1
217445,ventriculography,1,0
217446,at,0,0
217447,baseline,0,0
217448,and,0,0
217449,within,0,0
217450,60,0,0
217451,minutes,0,0
217452,after,0,0
217453,the,0,0
217454,fourth,0,0
217455,infusion,0,1
217456,.,0,0
217457,Vital,0,0
217458,signs,0,0
217459,were,0,0
217460,monitored,0,0
217461,throughout,0,0
217462,the,0,0
217463,study,0,0
217464,period,0,0
217465,.,0,0
217466,MEASUREMENTS,0,0
217467,AND,0,0
217468,MAIN,0,0
217469,RESULTS,0,0
217470,"Fructose-1,6-diphosphate",1,1
217471,resulted,0,0
217472,in,0,0
217473,a,0,0
217474,modest,0,0
217475,7,0,0
217476,%,0,0
217477,increase,0,0
217478,in,0,0
217479,left,0,0
217480,ventricular,0,0
217481,ejection,0,1
217482,fraction,0,0
217483,(,0,0
217484,p,0,0
217485,<,0,0
217486,0.05,0,0
217487,),0,0
217488,.,0,0
217489,Peak,0,0
217490,ejection,0,0
217491,rate,0,0
217492,and,0,0
217493,peak,0,0
217494,diastolic,0,0
217495,filling,0,1
217496,rate,0,0
217497,did,0,0
217498,not,0,0
217499,change,0,0
217500,significantly,0,0
217501,.,0,0
217502,There,0,0
217503,were,0,0
217504,no,0,0
217505,changes,0,0
217506,in,0,0
217507,blood,0,0
217508,pressure,0,0
217509,or,0,1
217510,heart,0,0
217511,rate,0,0
217512,with,0,0
217513,either,0,0
217514,"fructose-1,6-diphosphate",1,1
217515,or,0,0
217516,placebo,1,1
217517,.,1,0
217518,CONCLUSIONS,0,0
217519,"Fructose-1,6-diphosphate",1,1
217520,produces,0,0
217521,a,0,0
217522,modest,0,0
217523,but,0,0
217524,significant,0,0
217525,increase,0,0
217526,in,0,0
217527,left,0,0
217528,ventricular,0,0
217529,ejection,0,0
217530,fraction,0,0
217531,in,0,0
217532,patients,0,0
217533,with,0,0
217534,mild,0,0
217535,to,0,0
217536,moderate,0,0
217537,heart,0,0
217538,failure,0,0
217539,.,0,0
217540,Anaphylactoid,1,0
217541,reactions,0,0
217542,and,0,0
217543,histamine,0,1
217544,release,0,1
217545,by,0,0
217546,plasma,1,0
217547,substitutes,1,0
217548,:,1,0
217549,a,0,0
217550,randomized,0,0
217551,controlled,0,0
217552,trial,0,0
217553,in,0,0
217554,human,0,0
217555,subjects,0,0
217556,and,0,0
217557,in,0,0
217558,dogs,0,0
217559,[,0,0
217560,proceedings,0,0
217561,],0,0
217562,.,0,0
217563,Laser-aided,1,1
217564,external,1,1
217565,drainage,1,1
217566,of,0,0
217567,subretinal,0,0
217568,fluid,0,0
217569,:,0,0
217570,prospective,0,0
217571,randomized,0,0
217572,comparison,0,0
217573,with,0,0
217574,needle,0,1
217575,drainage,0,1
217576,.,0,0
217577,In,0,0
217578,a,0,0
217579,prospective,0,0
217580,randomized,0,0
217581,study,0,0
217582,of,0,0
217583,50,0,0
217584,consecutive,0,0
217585,eyes,0,0
217586,",",0,0
217587,we,0,0
217588,compared,0,0
217589,the,0,0
217590,safety,0,0
217591,and,0,0
217592,efficacy,0,0
217593,of,0,0
217594,draining,0,0
217595,subretinal,1,0
217596,fluid,1,0
217597,transchoroidally,1,0
217598,in,0,0
217599,primary,0,0
217600,scleral,0,1
217601,buckling,0,0
217602,for,0,0
217603,rhegmatogenous,0,0
217604,retinal,0,0
217605,detachment,0,0
217606,using,0,0
217607,a,0,0
217608,needle,1,1
217609,",",0,0
217610,with,0,0
217611,the,0,0
217612,safety,0,0
217613,and,0,0
217614,efficacy,0,0
217615,of,0,0
217616,the,0,0
217617,same,0,0
217618,procedure,0,0
217619,using,0,0
217620,an,0,0
217621,angulated,1,0
217622,endolaser,1,1
217623,probe,1,1
217624,set,0,0
217625,at,0,0
217626,1,0,0
217627,W,0,0
217628,for,0,0
217629,0.2,0,0
217630,seconds,0,0
217631,",",0,0
217632,using,0,0
217633,an,0,0
217634,average,0,0
217635,of,0,0
217636,2.4,0,0
217637,laser,0,1
217638,burns,0,0
217639,.,0,0
217640,There,0,0
217641,were,0,0
217642,no,0,0
217643,significant,0,0
217644,complications,0,0
217645,associated,0,0
217646,with,0,0
217647,the,0,0
217648,laser-aided,1,0
217649,drainage,1,1
217650,procedures,0,0
217651,(,0,0
217652,25,0,0
217653,eyes,0,0
217654,),0,0
217655,.,0,0
217656,In,0,0
217657,the,0,0
217658,transchoroidal,1,0
217659,needle,1,1
217660,drainage,1,1
217661,procedures,0,0
217662,(,0,0
217663,25,0,0
217664,eyes,0,0
217665,),0,0
217666,",",0,0
217667,subretinal,0,0
217668,hemorrhage,0,0
217669,occurred,0,0
217670,in,0,0
217671,three,0,0
217672,eyes,0,0
217673,and,0,0
217674,retinal,0,0
217675,incarceration,0,0
217676,in,0,0
217677,one,0,0
217678,.,0,0
217679,Thus,0,0
217680,",",0,0
217681,though,0,0
217682,our,0,0
217683,numbers,0,0
217684,are,0,0
217685,small,0,0
217686,",",0,0
217687,there,0,0
217688,appears,0,0
217689,to,0,0
217690,be,0,0
217691,some,0,0
217692,advantage,0,0
217693,of,0,0
217694,laser-assisted,0,1
217695,drainage,0,1
217696,in,0,0
217697,terms,0,0
217698,of,0,0
217699,a,0,0
217700,lower,0,0
217701,incidence,0,0
217702,of,0,0
217703,complications,0,0
217704,.,0,0
217705,[,0,0
217706,The,0,0
217707,anti-ischemic,0,1
217708,effect,0,0
217709,of,0,0
217710,phosphodiesterase,0,1
217711,III,0,0
217712,inhibitors,0,1
217713,],0,0
217714,.,0,0
217715,When,0,0
217716,enoximone,1,1
217717,is,0,0
217718,acutely,0,0
217719,administered,0,0
217720,to,0,0
217721,patients,0,0
217722,with,0,0
217723,stable,0,0
217724,angina,0,0
217725,and,0,0
217726,angiographically,0,0
217727,proven,0,0
217728,relevant,0,0
217729,coronary,0,0
217730,stenosis,0,0
217731,i.v,0,1
217732,.,0,0
217733,application,0,0
217734,of,0,0
217735,0.75,0,0
217736,mg/kg,0,0
217737,exhibits,0,0
217738,pronounced,0,0
217739,antiischemic,0,0
217740,effects,0,0
217741,.,0,0
217742,This,0,0
217743,could,0,0
217744,be,0,0
217745,observed,0,0
217746,in,0,0
217747,patients,0,0
217748,during,0,0
217749,exercise,0,1
217750,and,0,0
217751,in,0,0
217752,those,0,0
217753,in,0,0
217754,whom,0,0
217755,the,0,0
217756,ischemia,0,0
217757,was,0,0
217758,provoked,0,0
217759,by,0,0
217760,rapid,0,0
217761,cardiac,0,0
217762,stimulation,0,1
217763,.,0,0
217764,The,0,0
217765,antiischemic,0,0
217766,effects,0,0
217767,were,0,0
217768,documented,0,0
217769,by,0,0
217770,relief,0,0
217771,of,0,0
217772,symptoms,0,0
217773,",",0,0
217774,reduction,0,0
217775,of,0,0
217776,ST-depression,0,0
217777,",",0,0
217778,improvement,0,0
217779,of,0,0
217780,impaired,0,0
217781,myocardial,0,0
217782,wall,0,0
217783,motion,0,0
217784,",",0,0
217785,decrease,0,0
217786,to,0,0
217787,normalization,0,0
217788,of,0,0
217789,pathologically,0,0
217790,elevated,0,0
217791,filling,0,1
217792,pressure,0,0
217793,",",0,0
217794,amelioration,0,0
217795,of,0,0
217796,coronary,0,0
217797,blood,0,0
217798,flow,0,0
217799,as,0,0
217800,evidenced,0,0
217801,by,0,0
217802,myocard,0,0
217803,scintigraphy,0,1
217804,and,0,0
217805,washout,0,0
217806,time,0,0
217807,of,0,0
217808,an,0,0
217809,intracoronarily,0,1
217810,injected,0,1
217811,echo-contrast,0,1
217812,medium,0,0
217813,.,0,0
217814,There,0,0
217815,was,0,0
217816,also,0,0
217817,a,0,0
217818,definite,0,0
217819,improvement,0,0
217820,of,0,0
217821,ischemia-caused,0,0
217822,mitral,0,0
217823,regurgitation,0,0
217824,.,0,0
217825,Similar,0,0
217826,observations,0,0
217827,were,0,0
217828,found,0,0
217829,when,0,0
217830,the,0,0
217831,drug,0,0
217832,was,0,0
217833,injected,0,1
217834,in,0,0
217835,the,0,0
217836,diseased,0,0
217837,coronary,0,0
217838,arteries,0,0
217839,in,0,0
217840,a,0,0
217841,small,0,0
217842,dose,0,0
217843,(,0,0
217844,0.075,0,0
217845,mg/kg,0,1
217846,),0,0
217847,so,0,0
217848,that,0,0
217849,peripheral,0,0
217850,effects,0,0
217851,were,0,0
217852,not,0,0
217853,present,0,0
217854,.,0,0
217855,In,0,0
217856,comparison,0,0
217857,to,0,0
217858,the,0,0
217859,Ca,0,0
217860,(,0,0
217861,++,0,1
217862,),0,0
217863,-blocker,0,1
217864,Gallopamil,1,1
217865,the,0,0
217866,antiischemic,0,1
217867,effects,0,0
217868,of,0,0
217869,Enoximone,1,1
217870,were,0,0
217871,more,0,0
217872,pronounced,0,0
217873,",",0,0
217874,a,0,0
217875,synergistic,0,0
217876,action,0,0
217877,was,0,0
217878,",",0,0
217879,however,0,0
217880,",",0,0
217881,observed,0,0
217882,.,0,0
217883,Negative,0,0
217884,dromotropic,0,0
217885,effects,0,0
217886,of,0,0
217887,Gallopamil,1,1
217888,could,0,0
217889,be,0,0
217890,abolished,0,0
217891,by,0,0
217892,Enoximone,1,1
217893,.,1,0
217894,With,0,0
217895,oral,0,0
217896,administration,0,0
217897,of,0,0
217898,the,0,0
217899,drug,0,0
217900,over,0,0
217901,a,0,0
217902,period,0,0
217903,of,0,0
217904,one,0,0
217905,week,0,0
217906,antiischemic,0,1
217907,effects,0,0
217908,could,0,0
217909,also,0,0
217910,be,0,0
217911,documented,0,0
217912,with,0,0
217913,Holter,0,0
217914,monitoring,0,0
217915,as,0,0
217916,well,0,0
217917,as,0,0
217918,during,0,0
217919,exercise,0,1
217920,.,0,0
217921,There,0,0
217922,was,0,0
217923,a,0,0
217924,reduction,0,0
217925,of,0,0
217926,ST-depression,0,0
217927,both,0,0
217928,at,0,0
217929,spontaneously,0,0
217930,occurring,0,0
217931,ischemic,0,0
217932,episodes,0,0
217933,and,0,0
217934,during,0,0
217935,exercise,0,1
217936,",",0,0
217937,in,0,0
217938,the,0,0
217939,number,0,0
217940,and,0,0
217941,duration,0,0
217942,of,0,0
217943,episodes,0,0
217944,of,0,0
217945,silent,0,0
217946,ischemia,0,0
217947,",",0,0
217948,particularly,0,0
217949,",",0,0
217950,however,0,0
217951,",",0,0
217952,a,0,0
217953,decrease,0,0
217954,in,0,0
217955,symptomatic,0,0
217956,episodes,0,0
217957,.,0,0
217958,In,0,0
217959,none,0,0
217960,of,0,0
217961,the,0,0
217962,patients,0,0
217963,under,0,0
217964,study,0,0
217965,proarrhythmic,0,0
217966,effects,0,0
217967,were,0,0
217968,observed,0,0
217969,.,0,0
217970,Modest,0,0
217971,antihypertensive,0,1
217972,effect,0,0
217973,of,0,0
217974,epanolol,1,1
217975,",",0,0
217976,a,0,0
217977,beta,0,1
217978,1-selective,0,1
217979,receptor,0,0
217980,blocker,0,1
217981,with,0,0
217982,beta,0,1
217983,1,0,0
217984,agonist,0,1
217985,activity,0,0
217986,:,0,0
217987,an,0,0
217988,acute,0,0
217989,and,0,0
217990,long-term,0,0
217991,hemodynamic,0,0
217992,study,0,0
217993,at,0,0
217994,rest,0,0
217995,and,0,0
217996,during,0,0
217997,exercise,0,1
217998,and,0,0
217999,double,0,1
218000,crossover,0,0
218001,comparison,0,0
218002,with,0,0
218003,atenolol,0,1
218004,on,0,0
218005,ambulatory,0,0
218006,blood,0,0
218007,pressure,0,0
218008,.,0,0
218009,Beta-blockers,0,0
218010,with,0,0
218011,less,0,0
218012,cardiodepressive,0,0
218013,effect,0,0
218014,than,0,0
218015,traditional,0,1
218016,nonselective,0,1
218017,beta,0,1
218018,(,0,0
218019,1+2,0,0
218020,),0,0
218021,-blocking,0,0
218022,agents,0,0
218023,could,0,0
218024,be,0,0
218025,useful,0,0
218026,in,0,0
218027,the,0,0
218028,treatment,0,0
218029,of,0,0
218030,hypertension,0,0
218031,",",0,0
218032,provided,0,0
218033,the,0,0
218034,reduction,0,0
218035,in,0,0
218036,blood,0,0
218037,pressure,0,0
218038,was,0,0
218039,satisfactory,0,0
218040,.,0,0
218041,Epanolol,1,1
218042,",",0,0
218043,a,0,0
218044,selective,0,0
218045,beta,0,1
218046,1-receptor,0,1
218047,blocker,0,1
218048,with,0,0
218049,intrinsic,0,0
218050,sympathomimetic,0,1
218051,activity,0,0
218052,",",0,0
218053,induced,0,0
218054,a,0,0
218055,fall,0,0
218056,in,0,0
218057,intraarterial,0,1
218058,pressure,0,0
218059,of,0,0
218060,8,0,0
218061,%,0,0
218062,at,0,0
218063,rest,0,0
218064,sitting,0,0
218065,and,0,0
218066,11,0,0
218067,%,0,0
218068,during,0,0
218069,100,0,0
218070,W,0,0
218071,bicycle,0,1
218072,exercise,0,1
218073,after,0,0
218074,the,0,0
218075,first,0,0
218076,dose,0,0
218077,of,0,0
218078,200,0,0
218079,mg,0,0
218080,in,0,0
218081,12,0,0
218082,patients,0,0
218083,with,0,0
218084,essential,0,0
218085,hypertension,0,0
218086,.,0,0
218087,Heart,0,0
218088,rate,0,0
218089,",",0,0
218090,stroke,0,0
218091,index,0,0
218092,",",0,0
218093,and,0,0
218094,cardiac,0,0
218095,index,0,0
218096,initially,0,0
218097,fell,0,0
218098,by,0,0
218099,14,0,0
218100,%,0,0
218101,",",0,0
218102,11,0,0
218103,%,0,0
218104,",",0,0
218105,and,0,0
218106,23,0,0
218107,%,0,0
218108,",",0,0
218109,respectively,0,0
218110,.,0,0
218111,The,0,0
218112,total,0,0
218113,peripheral,0,0
218114,resistance,0,0
218115,index,0,0
218116,increased,0,0
218117,by,0,0
218118,21,0,0
218119,%,0,0
218120,after,0,0
218121,2,0,0
218122,hours,0,0
218123,",",0,0
218124,and,0,0
218125,then,0,0
218126,reverted,0,0
218127,towards,0,0
218128,the,0,0
218129,pretreatment,0,0
218130,level,0,0
218131,.,0,0
218132,After,0,0
218133,10,0,0
218134,months,0,0
218135,of,0,0
218136,epanolol,1,1
218137,treatment,0,0
218138,(,0,0
218139,mean,0,0
218140,300,0,1
218141,mg/day,0,0
218142,),0,0
218143,",",0,0
218144,the,0,0
218145,reduction,0,0
218146,in,0,0
218147,arterial,0,0
218148,pressure,0,0
218149,was,0,0
218150,5,0,0
218151,%,0,0
218152,at,0,0
218153,rest,0,0
218154,and,0,0
218155,10,0,0
218156,%,0,0
218157,during,0,0
218158,exercise,0,1
218159,.,0,0
218160,Cardiac,0,0
218161,index,0,0
218162,and,0,0
218163,heart,0,0
218164,rate,0,0
218165,were,0,0
218166,still,0,0
218167,reduced,0,0
218168,14-21,0,0
218169,%,0,0
218170,",",0,0
218171,while,0,0
218172,total,0,0
218173,peripheral,0,0
218174,resistance,0,0
218175,was,0,0
218176,unchanged,0,0
218177,or,0,0
218178,slightly,0,0
218179,increased,0,0
218180,(,0,0
218181,2-10,0,1
218182,%,0,0
218183,),0,0
218184,.,0,0
218185,Twenty-four,0,0
218186,hour,0,0
218187,ambulatory,0,0
218188,blood,0,0
218189,pressure,0,0
218190,was,0,0
218191,higher,0,0
218192,on,0,0
218193,epanolol,1,1
218194,(,0,0
218195,300,0,1
218196,mg/day,0,0
218197,),0,0
218198,than,0,0
218199,on,0,0
218200,atenolol,1,1
218201,(,0,0
218202,150,0,0
218203,mg/day,0,1
218204,),0,0
218205,treatment,0,0
218206,(,0,0
218207,137/97,0,0
218208,vs.,0,0
218209,128/91,0,0
218210,mmHg,0,0
218211,),0,0
218212,.,0,0
218213,Thus,0,0
218214,",",0,0
218215,the,0,0
218216,achieved,0,0
218217,blood,0,0
218218,pressure,0,0
218219,reduction,0,0
218220,induced,0,0
218221,by,0,0
218222,epanolol,1,1
218223,was,0,0
218224,moderate,0,0
218225,",",0,0
218226,while,0,0
218227,other,0,0
218228,characteristics,0,0
218229,of,0,0
218230,beta-receptor,0,1
218231,blockade,0,0
218232,",",0,0
218233,in,0,0
218234,particular,0,0
218235,",",0,0
218236,the,0,0
218237,reduction,0,0
218238,of,0,0
218239,heart,0,0
218240,rate,0,0
218241,and,0,0
218242,cardiac,0,0
218243,output,0,0
218244,",",0,0
218245,were,0,0
218246,maintained,0,0
218247,.,0,0
218248,This,0,0
218249,suggests,0,0
218250,that,0,0
218251,the,0,0
218252,compound,0,1
218253,may,0,0
218254,be,0,0
218255,useful,0,0
218256,for,0,0
218257,other,0,0
218258,cardiovascular,0,0
218259,disorders,0,0
218260,",",0,0
218261,e.g.,0,0
218262,",",0,0
218263,angina,0,0
218264,pectoris,0,0
218265,in,0,0
218266,patients,0,0
218267,without,0,0
218268,hypertension,0,0
218269,or,0,1
218270,cardiac,0,0
218271,arrhythmia,0,0
218272,.,0,0
218273,Short-term,0,0
218274,effects,0,0
218275,of,0,0
218276,denopamine,1,1
218277,on,0,0
218278,anaerobic,0,1
218279,threshold,0,0
218280,and,0,0
218281,related,0,0
218282,parameters,0,0
218283,in,0,0
218284,patients,0,0
218285,with,0,0
218286,chronic,0,0
218287,heart,0,0
218288,failure,0,0
218289,:,0,0
218290,a,0,0
218291,double-blind,0,0
218292,crossover,0,0
218293,study,0,0
218294,.,0,0
218295,BACKGROUND,0,0
218296,The,0,0
218297,short-term,0,0
218298,effects,0,0
218299,of,0,0
218300,denopamine,1,1
218301,",",0,0
218302,an,0,0
218303,orally,0,1
218304,available,0,0
218305,beta-stimulant,0,0
218306,",",0,0
218307,on,0,0
218308,exercise,0,1
218309,capacity,0,0
218310,were,0,0
218311,studied,0,0
218312,in,0,0
218313,patients,0,0
218314,with,0,0
218315,chronic,0,0
218316,heart,0,0
218317,failure,0,0
218318,.,0,0
218319,METHODS,0,0
218320,AND,0,0
218321,RESULTS,0,0
218322,Nineteen,0,1
218323,patients,0,0
218324,entered,0,0
218325,the,0,0
218326,study,0,0
218327,.,0,0
218328,Three,0,0
218329,patients,0,0
218330,had,0,0
218331,ischemic,0,0
218332,heart,0,0
218333,disease,0,0
218334,",",0,0
218335,13,0,0
218336,had,0,0
218337,dilated,0,0
218338,cardiomyopathy,0,0
218339,",",0,0
218340,and,0,0
218341,three,0,0
218342,had,0,0
218343,valvular,0,0
218344,disease,0,0
218345,;,0,0
218346,16,0,0
218347,patients,0,0
218348,were,0,0
218349,in,0,0
218350,New,0,0
218351,York,0,0
218352,Heart,0,1
218353,Association,0,0
218354,class,0,0
218355,II,0,0
218356,",",0,0
218357,and,0,0
218358,three,0,0
218359,patients,0,0
218360,were,0,0
218361,in,0,0
218362,New,0,0
218363,York,0,0
218364,Heart,0,1
218365,Association,0,0
218366,class,0,0
218367,III,0,0
218368,.,0,0
218369,Symptom-limited,0,0
218370,exercise,0,1
218371,testing,0,0
218372,(,0,0
218373,ramp,0,0
218374,protocol,0,0
218375,),0,0
218376,on,0,0
218377,a,0,0
218378,bicycle,0,1
218379,ergometer,1,1
218380,with,0,0
218381,gas,0,1
218382,exchange,0,1
218383,analysis,0,0
218384,was,0,0
218385,conducted,0,0
218386,1,0,0
218387,hour,0,0
218388,after,0,0
218389,oral,0,1
218390,administration,0,0
218391,of,0,0
218392,either,0,0
218393,20,1,0
218394,mg,1,1
218395,denopamine,1,1
218396,or,1,1
218397,placebo,1,1
218398,.,1,0
218399,Drug,0,0
218400,administration,0,0
218401,sequence,0,0
218402,was,0,0
218403,randomly,0,0
218404,assigned,0,0
218405,in,0,0
218406,a,0,0
218407,double-blind,0,0
218408,crossover,0,0
218409,method,0,0
218410,",",0,0
218411,with,0,0
218412,1,0,0
218413,week,0,0
218414,between,0,0
218415,drugs,0,0
218416,.,0,0
218417,Peak,0,0
218418,VO2,0,0
218419,was,0,0
218420,20.4,0,0
218421,+/-,0,0
218422,3.2,0,0
218423,and,0,0
218424,21.2,0,0
218425,+/-,0,0
218426,3.1,0,0
218427,ml/min/kg,0,0
218428,",",0,0
218429,respectively,0,0
218430,",",0,0
218431,for,0,0
218432,those,0,0
218433,administered,0,0
218434,the,0,0
218435,placebo,1,1
218436,and,0,0
218437,the,0,0
218438,drug,0,0
218439,",",0,0
218440,and,0,0
218441,anaerobic,0,1
218442,threshold,0,0
218443,was,0,0
218444,13.1,0,0
218445,+/-,0,0
218446,2.1,0,0
218447,and,0,0
218448,14.0,0,0
218449,+/-,0,0
218450,2.0,0,0
218451,ml/min/kg,0,0
218452,.,0,0
218453,There,0,0
218454,was,0,0
218455,a,0,0
218456,significant,0,0
218457,increase,0,0
218458,in,0,0
218459,peak,0,0
218460,VO2,0,1
218461,(,0,0
218462,p,0,0
218463,<,0,0
218464,0.05,0,0
218465,),0,0
218466,and,0,0
218467,anaerobic,0,1
218468,threshold,0,0
218469,(,0,0
218470,p,0,0
218471,<,0,0
218472,0.01,0,0
218473,),0,0
218474,with,0,0
218475,denopamine,1,1
218476,",",0,0
218477,whereas,0,0
218478,no,0,0
218479,significant,0,0
218480,change,0,0
218481,was,0,0
218482,observed,0,0
218483,in,0,0
218484,peak,0,0
218485,work,0,0
218486,rate,0,0
218487,or,0,1
218488,exercise,0,1
218489,time,0,0
218490,.,0,0
218491,Denopamine,1,1
218492,increased,0,0
218493,heart,0,0
218494,rate,0,0
218495,in,0,0
218496,patients,0,0
218497,with,0,0
218498,atrial,0,0
218499,fibrillation,0,0
218500,but,0,0
218501,had,0,0
218502,little,0,0
218503,effect,0,0
218504,on,0,0
218505,heart,0,0
218506,rate,0,0
218507,in,0,0
218508,patients,0,0
218509,with,0,0
218510,sinus,0,0
218511,rhythm,0,1
218512,.,0,0
218513,CONCLUSION,0,0
218514,Data,0,0
218515,obtained,0,0
218516,from,0,0
218517,gas,0,1
218518,exchange,0,1
218519,analysis,0,0
218520,are,0,0
218521,more,0,0
218522,sensitive,0,0
218523,and,0,0
218524,potentially,0,0
218525,more,0,0
218526,useful,0,0
218527,in,0,0
218528,the,0,0
218529,detection,0,0
218530,of,0,0
218531,short-term,0,0
218532,changes,0,0
218533,in,0,0
218534,exercise,0,1
218535,capacity,0,0
218536,than,0,0
218537,data,0,0
218538,obtained,0,0
218539,from,0,0
218540,either,0,0
218541,exercise,0,1
218542,time,0,0
218543,or,0,1
218544,peak,0,0
218545,work,0,0
218546,rate,0,0
218547,",",0,0
218548,indexes,0,0
218549,that,0,0
218550,are,0,0
218551,commonly,0,0
218552,used,0,0
218553,to,0,0
218554,assess,0,0
218555,drug,0,0
218556,therapy,0,1
218557,.,0,0
218558,Patients,0,0
218559,with,0,0
218560,mild-to-moderate,0,0
218561,heart,0,0
218562,failure,0,0
218563,with,0,0
218564,sinus,0,0
218565,rhythm,0,1
218566,",",0,0
218567,but,0,0
218568,not,0,0
218569,those,0,0
218570,with,0,0
218571,atrial,0,0
218572,fibrillation,0,0
218573,because,0,0
218574,of,0,0
218575,its,0,0
218576,frequent,0,0
218577,induction,0,0
218578,of,0,0
218579,tachycardia,0,0
218580,",",0,0
218581,may,0,0
218582,be,0,0
218583,good,0,0
218584,candidates,0,0
218585,for,0,0
218586,denopamine,1,1
218587,therapy,0,1
218588,.,0,0
218589,Citalopram,1,1
218590,for,0,0
218591,post-stroke,0,0
218592,pathological,0,0
218593,crying,0,0
218594,.,0,0
218595,Post-stroke,0,0
218596,pathological,0,0
218597,crying,0,0
218598,is,0,0
218599,a,0,0
218600,distressing,0,0
218601,condition,0,0
218602,in,0,0
218603,which,0,0
218604,episodes,0,0
218605,occur,0,0
218606,in,0,0
218607,response,0,0
218608,to,0,0
218609,minor,0,0
218610,stimuli,0,1
218611,without,0,0
218612,associated,0,0
218613,mood,0,0
218614,changes,0,0
218615,.,0,0
218616,There,0,0
218617,is,0,0
218618,preliminary,0,0
218619,evidence,0,0
218620,of,0,0
218621,disturbed,0,0
218622,serotoninergic,0,1
218623,neurotransmission,0,0
218624,in,0,0
218625,such,0,0
218626,cases,0,0
218627,.,0,0
218628,We,0,0
218629,investigated,0,0
218630,the,0,0
218631,effect,0,0
218632,of,0,0
218633,the,0,0
218634,selective,0,0
218635,serotonin,0,1
218636,reuptake,0,1
218637,inhibitor,0,1
218638,citalopram,1,1
218639,on,0,0
218640,uncontrolled,0,0
218641,crying,0,0
218642,in,0,0
218643,stroke,0,0
218644,patients,0,0
218645,in,0,0
218646,a,0,0
218647,double-blind,0,0
218648,placebo-controlled,0,1
218649,crossover,0,0
218650,study,0,0
218651,.,0,0
218652,16,0,0
218653,consecutive,0,0
218654,patients,0,0
218655,(,0,0
218656,median,0,0
218657,age,0,0
218658,58.5,0,0
218659,years,0,0
218660,",",0,0
218661,range,0,0
218662,40-83,0,0
218663,),0,0
218664,entered,0,0
218665,the,0,0
218666,9-week,1,0
218667,study,1,0
218668,a,1,0
218669,median,1,0
218670,of,1,0
218671,168,1,0
218672,days,1,0
218673,(,1,0
218674,range,1,0
218675,6-913,1,1
218676,),1,0
218677,post,1,0
218678,stroke,1,0
218679,and,1,0
218680,were,1,0
218681,treated,1,0
218682,with,1,0
218683,citalopram,1,1
218684,10-20,1,0
218685,mg,1,1
218686,daily,1,0
218687,for,1,0
218688,3,1,0
218689,weeks,1,0
218690,.,1,0
218691,Crying,1,0
218692,history,1,0
218693,was,1,0
218694,determined,1,0
218695,from,1,0
218696,semistructured,1,1
218697,interviews,1,0
218698,and,1,0
218699,from,1,0
218700,diaries,1,1
218701,kept,1,0
218702,by,1,0
218703,the,1,0
218704,patients,1,0
218705,.,1,0
218706,Psychiatric,0,0
218707,assessment,0,0
218708,was,0,0
218709,made,0,0
218710,with,0,0
218711,the,0,0
218712,Hamilton,0,0
218713,depression,0,0
218714,scale,0,0
218715,(,0,0
218716,HDS,0,1
218717,),0,0
218718,",",0,0
218719,and,0,0
218720,unwanted,0,0
218721,effects,0,0
218722,were,0,0
218723,measured,0,0
218724,with,0,0
218725,the,0,0
218726,UKU,0,0
218727,side-effect,0,0
218728,scale,0,0
218729,.,0,0
218730,In,0,0
218731,13,0,0
218732,patients,0,0
218733,in,0,0
218734,whom,0,0
218735,frequency,0,0
218736,of,0,0
218737,crying,0,0
218738,could,0,0
218739,be,0,0
218740,assessed,0,0
218741,",",0,0
218742,the,0,0
218743,number,0,0
218744,of,0,0
218745,daily,0,0
218746,crying,0,0
218747,episodes,0,0
218748,decreased,0,0
218749,by,0,0
218750,at,0,0
218751,least,0,0
218752,50,0,0
218753,%,0,0
218754,in,0,0
218755,all,0,0
218756,cases,0,0
218757,during,0,0
218758,citalopram,0,1
218759,treatment,0,0
218760,vs,0,0
218761,2,0,0
218762,patients,0,0
218763,during,0,0
218764,placebo,0,1
218765,treatment,0,0
218766,(,0,0
218767,p,0,0
218768,<,0,0
218769,0.005,0,0
218770,",",0,0
218771,McNemar,0,0
218772,'s,0,0
218773,test,0,0
218774,),0,0
218775,",",0,0
218776,the,0,0
218777,effect,0,0
218778,being,0,0
218779,rapid,0,0
218780,(,0,0
218781,1-3,0,0
218782,days,0,0
218783,),0,0
218784,and,0,0
218785,pronounced,0,0
218786,in,0,0
218787,11,0,0
218788,(,0,0
218789,73,0,0
218790,%,0,0
218791,),0,0
218792,.,0,0
218793,There,0,0
218794,was,0,0
218795,a,0,0
218796,concomitant,0,0
218797,significant,0,0
218798,decrease,0,0
218799,in,0,0
218800,depression,0,0
218801,rating,0,0
218802,from,0,0
218803,HDS,0,1
218804,8.9,0,0
218805,to,0,0
218806,5.3,0,0
218807,(,0,0
218808,p,0,0
218809,<,0,0
218810,0.005,0,0
218811,",",0,0
218812,Wilcoxon,0,0
218813,'s,0,0
218814,test,0,0
218815,),0,0
218816,.,0,0
218817,Citalopram,0,1
218818,was,0,0
218819,well,0,0
218820,tolerated,0,0
218821,",",0,0
218822,the,0,0
218823,few,0,0
218824,side-effects,0,0
218825,being,0,0
218826,mild,0,0
218827,and,0,0
218828,transient,0,0
218829,.,0,0
218830,We,0,0
218831,conclude,0,0
218832,that,0,0
218833,serotoninergic,0,0
218834,neurotransmission,0,0
218835,plays,0,0
218836,an,0,0
218837,important,0,0
218838,part,0,0
218839,in,0,0
218840,post-stroke,0,0
218841,pathological,0,0
218842,crying,0,0
218843,and,0,0
218844,that,0,0
218845,citalopram,1,1
218846,is,0,0
218847,an,0,0
218848,effective,0,0
218849,and,0,0
218850,well-tolerated,0,0
218851,treatment,0,0
218852,.,0,0
218853,Recovery,0,0
218854,following,0,0
218855,outpatient,1,0
218856,anesthesia,1,1
218857,:,1,0
218858,use,0,0
218859,of,0,0
218860,enflurane,1,1
218861,versus,1,0
218862,propofol,1,1
218863,.,1,0
218864,STUDY,0,0
218865,OBJECTIVE,0,0
218866,To,0,0
218867,compare,0,0
218868,the,0,0
218869,intraoperative,0,1
218870,conditions,0,0
218871,and,0,0
218872,postoperative,0,0
218873,recovery,0,0
218874,of,0,0
218875,patients,0,0
218876,following,0,0
218877,the,0,0
218878,use,0,0
218879,of,0,0
218880,either,0,0
218881,propofol-nitrous,1,1
218882,oxide,1,1
218883,(,1,0
218884,N2O,1,1
218885,),1,1
218886,or,1,0
218887,enflurane-N2O,1,1
218888,for,1,0
218889,maintenance,0,0
218890,of,0,0
218891,outpatient,0,0
218892,anesthesia,0,1
218893,.,0,0
218894,DESIGN,0,0
218895,Randomized,0,0
218896,",",0,0
218897,single-blind,0,0
218898,study,0,0
218899,.,0,0
218900,SETTING,0,0
218901,University,0,0
218902,hospital,0,0
218903,outpatient,0,0
218904,surgery,0,0
218905,center,0,0
218906,.,0,0
218907,PATIENTS,0,0
218908,61,0,0
218909,ASA,0,0
218910,physical,0,0
218911,status,0,0
218912,I,0,0
218913,and,0,0
218914,II,0,0
218915,",",0,0
218916,healthy,0,0
218917,female,0,0
218918,outpatients,0,0
218919,undergoing,0,0
218920,laparoscopic,0,1
218921,surgery,0,1
218922,.,0,0
218923,INTERVENTIONS,0,0
218924,Patients,0,0
218925,were,0,0
218926,randomly,0,0
218927,assigned,0,0
218928,to,0,0
218929,one,0,0
218930,of,0,0
218931,three,0,0
218932,anesthetic,0,0
218933,regimens,0,0
218934,.,0,0
218935,Group,1,0
218936,1,1,0
218937,(,1,0
218938,control,1,0
218939,),1,0
218940,received,1,0
218941,thiopental,1,1
218942,sodium,1,1
218943,4,1,0
218944,mg/kg,1,1
218945,intravenously,1,1
218946,(,1,0
218947,i.v,1,1
218948,.,1,0
218949,),1,0
218950,",",1,0
218951,followed,1,0
218952,by,1,0
218953,0.5,1,0
218954,%,1,0
218955,to,1,0
218956,1.5,1,0
218957,%,1,0
218958,enflurane,1,1
218959,and,1,0
218960,67,1,0
218961,%,1,0
218962,N2O,1,0
218963,in,1,0
218964,oxygen,1,1
218965,(,1,0
218966,O2,1,0
218967,),1,0
218968,.,1,0
218969,Group,1,0
218970,2,1,0
218971,received,1,0
218972,propofol,1,1
218973,2,1,0
218974,mg/kg,1,1
218975,i.v.,1,1
218976,",",0,0
218977,followed,1,0
218978,by,1,0
218979,0.5,1,0
218980,%,1,0
218981,to,1,0
218982,1.5,1,0
218983,%,1,0
218984,enflurane,1,1
218985,and,1,0
218986,67,1,0
218987,%,1,0
218988,N2O,1,0
218989,in,1,0
218990,O2,1,0
218991,.,1,0
218992,Group,1,0
218993,3,1,0
218994,received,1,0
218995,propofol,1,1
218996,2,1,0
218997,mg/kg,1,1
218998,i.v.,1,1
218999,",",0,0
219000,followed,1,0
219001,by,1,0
219002,propofol,1,1
219003,50,1,0
219004,to,1,0
219005,160,1,0
219006,micrograms/kg/min,1,0
219007,i.v,1,1
219008,.,1,0
219009,and,1,0
219010,67,1,0
219011,%,1,0
219012,N2O,1,0
219013,in,1,0
219014,O2,1,0
219015,.,1,0
219016,All,0,0
219017,patients,0,0
219018,received,0,0
219019,succinylcholine,1,1
219020,1,0,0
219021,mg/kg,0,0
219022,i.v,0,0
219023,.,0,0
219024,to,0,0
219025,facilitate,0,0
219026,tracheal,0,1
219027,intubation,0,1
219028,and,0,0
219029,atracurium,1,1
219030,10,0,0
219031,to,0,0
219032,20,0,0
219033,mg,0,0
219034,i.v,0,0
219035,.,0,0
219036,to,0,0
219037,provide,0,0
219038,adequate,0,0
219039,relaxation,0,1
219040,during,0,0
219041,the,0,0
219042,maintenance,0,0
219043,period,0,0
219044,.,0,0
219045,MEASUREMENTS,0,0
219046,AND,0,0
219047,MAIN,0,0
219048,RESULTS,0,0
219049,Recovery,0,0
219050,from,0,0
219051,anesthesia,1,1
219052,was,0,0
219053,assessed,0,0
219054,by,0,0
219055,a,0,0
219056,research,0,0
219057,nurse,0,1
219058,who,0,0
219059,was,0,0
219060,unaware,0,0
219061,of,0,0
219062,the,0,0
219063,anesthetic,0,1
219064,technique,0,1
219065,used,0,0
219066,.,0,0
219067,The,0,0
219068,mean,0,0
219069,+/-,0,0
219070,SD,0,0
219071,time,0,0
219072,to,0,0
219073,eye,0,1
219074,opening,0,0
219075,was,0,0
219076,significantly,0,0
219077,longer,0,0
219078,in,0,0
219079,the,0,0
219080,thiopental-enflurane-N2O,1,1
219081,group,1,0
219082,(,1,0
219083,Group,1,0
219084,1,1,0
219085,),1,0
219086,than,0,0
219087,in,0,0
219088,the,0,0
219089,propofol-propofol-N2O,1,1
219090,group,1,0
219091,(,1,0
219092,Group,1,0
219093,3,1,1
219094,),1,0
219095,(,0,0
219096,6.1,0,0
219097,+/-,0,0
219098,2.5,0,0
219099,minutes,0,0
219100,vs.,0,0
219101,3.5,0,0
219102,+/-,0,0
219103,2.8,0,0
219104,minutes,0,0
219105,",",0,0
219106,respectively,0,0
219107,),0,0
219108,.,0,0
219109,In,0,0
219110,addition,0,0
219111,",",0,0
219112,the,0,0
219113,mean,0,0
219114,time,0,0
219115,to,0,0
219116,respond,0,0
219117,to,0,0
219118,verbal,0,0
219119,commands,0,0
219120,was,0,0
219121,significantly,0,0
219122,shorter,0,0
219123,in,0,0
219124,the,0,0
219125,propofol,1,1
219126,induction,0,0
219127,groups,0,0
219128,compared,0,0
219129,with,0,0
219130,the,0,0
219131,thiopental,1,1
219132,induction,0,0
219133,group,0,0
219134,.,0,0
219135,However,0,0
219136,",",0,0
219137,the,0,0
219138,use,0,0
219139,of,0,0
219140,enflurane,1,1
219141,versus,0,0
219142,propofol,1,1
219143,for,0,0
219144,maintenance,0,0
219145,of,0,0
219146,anesthesia,0,1
219147,did,0,0
219148,not,0,0
219149,significantly,0,0
219150,prolong,0,0
219151,the,0,0
219152,time,0,0
219153,from,0,0
219154,arrival,0,0
219155,in,0,0
219156,the,0,0
219157,recovery,0,0
219158,room,0,0
219159,to,0,0
219160,sitting,0,0
219161,",",0,0
219162,tolerating,0,0
219163,oral,0,1
219164,fluids,0,0
219165,",",0,0
219166,walking,0,0
219167,",",0,0
219168,or,0,1
219169,being,0,0
219170,judged,0,0
219171,fit,0,0
219172,for,0,0
219173,discharge,0,0
219174,.,0,0
219175,There,0,0
219176,were,0,0
219177,no,0,0
219178,differences,0,0
219179,among,0,0
219180,the,0,0
219181,three,0,0
219182,groups,0,0
219183,with,0,0
219184,respect,0,0
219185,to,0,0
219186,postoperative,0,0
219187,pain,0,0
219188,or,0,0
219189,analgesic,0,0
219190,requirements,0,0
219191,.,0,0
219192,Finally,0,0
219193,",",0,0
219194,patients,0,0
219195,who,0,0
219196,received,0,0
219197,enflurane,1,1
219198,for,0,0
219199,maintenance,0,0
219200,of,0,0
219201,anesthesia,0,1
219202,had,0,0
219203,a,0,0
219204,significantly,0,0
219205,higher,0,0
219206,frequency,0,0
219207,of,0,0
219208,nausea,0,0
219209,and,0,0
219210,vomiting,0,0
219211,than,0,0
219212,the,0,0
219213,propofol,0,1
219214,maintenance,0,0
219215,group,0,0
219216,.,0,0
219217,CONCLUSION,0,0
219218,Induction,0,1
219219,of,0,0
219220,anesthesia,0,1
219221,with,0,0
219222,propofol,1,1
219223,is,0,0
219224,associated,0,0
219225,with,0,0
219226,a,0,0
219227,more,0,0
219228,rapid,0,0
219229,emergence,0,0
219230,from,0,0
219231,anesthesia,0,1
219232,than,0,0
219233,induction,0,0
219234,with,0,0
219235,thiopental,1,1
219236,.,1,0
219237,Maintenance,0,0
219238,of,0,0
219239,anesthesia,0,1
219240,with,0,0
219241,enflurane,1,1
219242,did,0,0
219243,not,0,0
219244,prolong,0,0
219245,recovery,0,0
219246,compared,0,0
219247,with,0,0
219248,maintenance,0,0
219249,with,0,0
219250,propofol,1,1
219251,",",0,0
219252,but,0,0
219253,enflurane,1,1
219254,was,0,0
219255,associated,0,0
219256,with,0,0
219257,increased,0,0
219258,frequency,0,0
219259,of,0,0
219260,postoperative,0,0
219261,nausea,0,0
219262,and,0,0
219263,vomiting,0,0
219264,.,0,0
219265,Videofluoroscopic,1,1
219266,evidence,1,0
219267,of,1,0
219268,aspiration,1,0
219269,predicts,0,0
219270,pneumonia,0,0
219271,and,0,0
219272,death,0,0
219273,but,0,0
219274,not,0,0
219275,dehydration,0,0
219276,following,0,0
219277,stroke,0,0
219278,.,0,0
219279,In,0,0
219280,order,0,0
219281,to,0,0
219282,assess,0,0
219283,the,0,0
219284,risk,0,0
219285,of,0,0
219286,pneumonia,0,0
219287,",",0,0
219288,dehydration,0,0
219289,",",0,0
219290,and,0,0
219291,death,0,0
219292,associated,0,0
219293,with,0,0
219294,videofluoroscopic,1,1
219295,evidence,0,0
219296,of,0,0
219297,aspiration,0,0
219298,following,0,0
219299,stroke,0,0
219300,",",0,0
219301,the,0,0
219302,clinical,0,0
219303,records,0,0
219304,of,0,0
219305,26,0,0
219306,patients,0,0
219307,with,0,0
219308,aspiration,0,0
219309,and,0,0
219310,33,0,0
219311,randomly,0,0
219312,selected,0,0
219313,",",0,0
219314,case-matched,0,0
219315,",",0,0
219316,dysphagic,0,0
219317,controls,0,0
219318,without,0,0
219319,videofluoroscopic,0,1
219320,evidence,0,0
219321,of,0,0
219322,aspiration,0,0
219323,were,0,0
219324,reviewed,0,0
219325,.,0,0
219326,The,1,0
219327,videofluoroscopic,1,1
219328,modified,1,0
219329,barium,1,1
219330,swallow,1,1
219331,technique,1,1
219332,included,1,0
219333,5,1,0
219334,ml-thin,1,1
219335,and,1,0
219336,thick,1,1
219337,liquid,1,1
219338,barium,1,1
219339,",",1,0
219340,5,1,0
219341,ml,1,0
219342,barium,1,1
219343,pudding,1,1
219344,",",1,0
219345,and,1,0
219346,1/4,1,0
219347,cookie,1,1
219348,coated,1,1
219349,with,1,0
219350,barium,1,1
219351,",",1,0
219352,plus,1,1
219353,additional,1,0
219354,20,1,0
219355,and,1,0
219356,30,1,0
219357,ml,1,0
219358,of,1,0
219359,thin,1,1
219360,liquid,1,1
219361,barium,1,1
219362,.,1,0
219363,Patients,0,0
219364,were,0,0
219365,assessed,0,0
219366,a,0,0
219367,mean,0,0
219368,of,0,0
219369,2,0,0
219370,+/-,0,0
219371,1,0,0
219372,SD,0,0
219373,months,0,0
219374,poststroke,0,0
219375,and,0,0
219376,were,0,0
219377,followed,0,0
219378,for,0,0
219379,a,0,0
219380,mean,0,0
219381,of,0,0
219382,16,0,0
219383,+/-,0,0
219384,8,0,0
219385,SD,0,0
219386,months,0,0
219387,poststroke,0,0
219388,.,0,0
219389,The,0,0
219390,odds,0,0
219391,ratio,0,0
219392,for,0,0
219393,developing,0,0
219394,pneumonia,0,0
219395,was,0,0
219396,7.6,0,0
219397,times,0,0
219398,greater,0,0
219399,for,0,0
219400,those,0,0
219401,who,0,0
219402,aspirated,0,0
219403,any,0,0
219404,amount,0,0
219405,of,0,0
219406,barium,0,1
219407,irrespective,0,0
219408,of,0,0
219409,its,0,0
219410,consistency,0,0
219411,(,0,0
219412,p,0,0
219413,=,0,0
219414,0.05,0,0
219415,),0,0
219416,.,0,0
219417,The,0,0
219418,odds,0,0
219419,ratio,0,0
219420,for,0,0
219421,developing,0,0
219422,pneumonia,0,0
219423,was,0,0
219424,5.6,0,0
219425,times,0,0
219426,greater,0,0
219427,for,0,0
219428,those,0,0
219429,who,0,0
219430,aspirated,0,0
219431,thickened,0,0
219432,liquids,0,1
219433,or,0,0
219434,more,0,0
219435,solid,0,0
219436,consistencies,0,0
219437,compared,0,0
219438,with,0,0
219439,those,0,0
219440,who,0,0
219441,did,0,0
219442,not,0,0
219443,aspirate,0,0
219444,",",0,0
219445,or,0,0
219446,who,0,0
219447,aspirated,0,0
219448,thin,0,1
219449,liquids,0,1
219450,only,0,0
219451,(,0,0
219452,p,0,0
219453,=,0,0
219454,0.06,0,0
219455,),0,0
219456,.,0,0
219457,Dehydration,0,1
219458,was,0,0
219459,unrelated,0,0
219460,to,0,0
219461,the,0,0
219462,presence,0,0
219463,or,0,1
219464,absence,0,0
219465,of,0,0
219466,aspiration,0,0
219467,.,0,0
219468,The,0,0
219469,odds,0,0
219470,ratio,0,0
219471,for,0,0
219472,death,0,0
219473,was,0,0
219474,9.2,0,0
219475,times,0,0
219476,greater,0,0
219477,for,0,0
219478,those,0,0
219479,aspirating,0,0
219480,thickened,0,1
219481,liquids,0,1
219482,or,0,0
219483,more,0,0
219484,solid,0,0
219485,consistencies,0,0
219486,compared,0,0
219487,with,0,0
219488,those,0,0
219489,who,0,0
219490,did,0,0
219491,not,0,0
219492,aspirate,0,0
219493,or,0,0
219494,who,0,0
219495,aspirated,0,0
219496,thin,0,1
219497,liquids,0,1
219498,only,0,0
219499,(,0,0
219500,p,0,0
219501,=,0,0
219502,0.01,0,0
219503,),0,0
219504,.,0,0
219505,Aspiration,0,0
219506,documented,0,0
219507,by,0,0
219508,modified,1,0
219509,videofluoroscopic,1,1
219510,barium,1,1
219511,swallow,1,1
219512,technique,1,1
219513,is,0,0
219514,associated,0,0
219515,with,0,0
219516,a,0,0
219517,significant,0,0
219518,increase,0,0
219519,in,0,0
219520,risk,0,0
219521,of,0,0
219522,pneumonia,0,0
219523,and,0,0
219524,death,0,0
219525,but,0,0
219526,not,0,0
219527,dehydration,0,0
219528,following,0,0
219529,stroke,0,0
219530,.,0,0
219531,Maternal,0,0
219532,erythropoietin,0,1
219533,in,0,0
219534,singleton,0,0
219535,pregnancies,0,0
219536,:,0,0
219537,a,0,0
219538,randomized,0,0
219539,trial,0,0
219540,on,0,0
219541,the,0,0
219542,effect,0,0
219543,of,0,0
219544,oral,0,1
219545,hematinic,0,1
219546,supplementation,1,1
219547,.,1,0
219548,OBJECTIVE,0,0
219549,Our,0,0
219550,purpose,0,0
219551,was,0,0
219552,to,0,0
219553,study,0,0
219554,the,0,0
219555,effect,0,0
219556,of,0,0
219557,hematinic,0,1
219558,supplementation,0,1
219559,on,0,0
219560,the,0,0
219561,maternal,0,0
219562,erythropoietin,0,1
219563,response,0,0
219564,during,0,0
219565,singleton,0,0
219566,pregnancy,0,0
219567,.,0,0
219568,STUDY,0,0
219569,DESIGN,0,0
219570,In,0,0
219571,a,0,0
219572,randomized,0,0
219573,",",0,0
219574,double-blind,0,0
219575,trial,0,0
219576,97,0,0
219577,patients,0,0
219578,with,0,0
219579,a,0,0
219580,first-trimester,0,0
219581,hemoglobin,0,0
219582,level,0,0
219583,>,0,0
219584,or,0,0
219585,=,0,0
219586,14.0,0,0
219587,gm/dl,0,0
219588,received,0,0
219589,either,0,0
219590,iron,1,1
219591,and,1,0
219592,folic,1,1
219593,acid,1,1
219594,(,0,0
219595,hematinic,0,1
219596,group,0,0
219597,",",0,0
219598,n,0,0
219599,=,0,0
219600,53,0,0
219601,),0,0
219602,or,0,0
219603,a,0,0
219604,placebo,1,1
219605,(,0,0
219606,n,0,0
219607,=,0,0
219608,44,0,0
219609,),0,0
219610,.,0,0
219611,Serial,0,0
219612,hemoglobin,0,0
219613,",",0,0
219614,hematocrit,0,0
219615,",",0,0
219616,and,0,0
219617,serum,0,0
219618,erythropoietin,0,1
219619,were,0,0
219620,recorded,0,0
219621,from,0,0
219622,maternal,0,0
219623,blood,0,0
219624,and,0,0
219625,from,0,0
219626,cord,0,0
219627,blood,0,0
219628,on,0,0
219629,delivery,0,0
219630,.,0,0
219631,Serum,0,0
219632,ferritin,0,0
219633,was,0,0
219634,measured,0,0
219635,in,0,0
219636,the,0,0
219637,first,0,0
219638,trimester,0,0
219639,",",0,0
219640,at,0,0
219641,36,0,0
219642,weeks,0,0
219643,',0,0
219644,gestation,0,0
219645,",",0,0
219646,and,0,0
219647,in,0,0
219648,cord,0,0
219649,blood,0,0
219650,.,0,0
219651,RESULTS,0,0
219652,In,0,0
219653,both,0,0
219654,groups,0,0
219655,(,0,0
219656,1,0,0
219657,),0,0
219658,the,0,0
219659,mean,0,0
219660,hemoglobin,0,0
219661,was,0,0
219662,lower,0,0
219663,(,0,0
219664,p,0,0
219665,<,0,0
219666,0.01,0,0
219667,),0,0
219668,at,0,0
219669,40,0,0
219670,weeks,0,0
219671,',0,0
219672,gestation,0,0
219673,than,0,0
219674,when,0,0
219675,first,0,0
219676,examined,0,0
219677,and,0,0
219678,(,0,0
219679,2,0,0
219680,),0,0
219681,the,0,0
219682,mean,0,0
219683,serum,0,0
219684,erythropoietin,0,1
219685,was,0,0
219686,higher,0,0
219687,(,0,0
219688,p,0,0
219689,<,0,0
219690,0.01,0,0
219691,),0,0
219692,.,0,0
219693,The,0,0
219694,mean,0,0
219695,serum,0,0
219696,ferritin,0,0
219697,was,0,0
219698,lower,0,0
219699,(,0,0
219700,p,0,0
219701,<,0,0
219702,0.001,0,0
219703,),0,0
219704,in,0,0
219705,both,0,0
219706,groups,0,0
219707,at,0,0
219708,36,0,0
219709,weeks,0,0
219710,',0,0
219711,gestation,0,0
219712,than,0,0
219713,at,0,0
219714,presentation,0,0
219715,but,0,0
219716,higher,0,0
219717,(,0,0
219718,p,0,0
219719,=,0,0
219720,0.04,0,0
219721,),0,0
219722,in,0,0
219723,the,0,0
219724,hematinic,0,1
219725,group,0,0
219726,than,0,0
219727,in,0,0
219728,the,0,0
219729,placebo,0,1
219730,group,0,0
219731,.,0,0
219732,The,0,0
219733,mean,0,0
219734,hemoglobin,0,0
219735,and,0,0
219736,hematocrit,0,0
219737,were,0,0
219738,similar,0,0
219739,in,0,0
219740,the,0,0
219741,two,0,0
219742,groups,0,0
219743,until,0,0
219744,the,0,0
219745,third,0,0
219746,trimester,0,0
219747,but,0,0
219748,thereafter,0,0
219749,were,0,0
219750,higher,0,0
219751,(,0,0
219752,p,0,0
219753,<,0,0
219754,0.05,0,0
219755,),0,0
219756,in,0,0
219757,the,0,0
219758,hematinic,0,0
219759,group,0,0
219760,.,0,0
219761,The,0,0
219762,mean,0,0
219763,maternal,0,0
219764,serum,0,0
219765,erythropoietin,0,1
219766,was,0,0
219767,higher,0,0
219768,(,0,0
219769,p,0,0
219770,<,0,0
219771,0.05,0,0
219772,),0,0
219773,in,0,0
219774,the,0,0
219775,placebo,0,1
219776,group,0,0
219777,than,0,0
219778,in,0,0
219779,the,0,0
219780,hematinic,0,1
219781,group,0,0
219782,after,0,0
219783,24,0,0
219784,weeks,0,0
219785,',0,0
219786,gestation,0,0
219787,.,0,0
219788,The,0,0
219789,mean,0,0
219790,cord,0,0
219791,blood,0,0
219792,hematologic,0,0
219793,values,0,0
219794,were,0,0
219795,similar,0,0
219796,in,0,0
219797,the,0,0
219798,two,0,0
219799,groups,0,0
219800,.,0,0
219801,CONCLUSION,0,0
219802,Maternal,0,0
219803,serum,0,0
219804,erythropoietin,0,1
219805,increased,0,0
219806,during,0,0
219807,pregnancy,0,0
219808,",",0,0
219809,but,0,0
219810,this,0,0
219811,response,0,0
219812,was,0,0
219813,reduced,0,0
219814,in,0,0
219815,the,0,0
219816,third,0,0
219817,trimester,0,0
219818,in,0,0
219819,the,0,0
219820,hematinic-supplemented,0,1
219821,group,0,0
219822,.,0,0
219823,[,0,0
219824,Effects,0,0
219825,of,0,0
219826,an,0,0
219827,intensive,1,1
219828,therapy,1,1
219829,program,1,1
219830,for,0,0
219831,behaviorally,0,0
219832,disordered,0,0
219833,mentally,0,0
219834,handicapped,0,0
219835,patients,0,0
219836,on,0,0
219837,staff,0,0
219838,personnel,0,0
219839,in,0,0
219840,residential,0,1
219841,care,0,0
219842,],0,0
219843,.,0,0
219844,This,0,0
219845,study,0,0
219846,evaluates,0,0
219847,the,0,0
219848,effects,0,0
219849,of,0,0
219850,an,0,0
219851,intensive,1,1
219852,therapy,1,1
219853,program,1,1
219854,designed,0,0
219855,for,0,0
219856,mentally,0,0
219857,handicapped,0,0
219858,persons,0,0
219859,with,0,0
219860,severely,0,0
219861,disturbed,0,0
219862,or,0,0
219863,autistic,0,0
219864,behavior,0,0
219865,on,0,0
219866,their,0,0
219867,staff,0,0
219868,personal,0,1
219869,which,0,0
219870,had,0,0
219871,an,0,0
219872,active,0,0
219873,role,0,0
219874,in,0,0
219875,the,0,0
219876,program,0,1
219877,.,0,0
219878,The,0,0
219879,staff,0,0
219880,members,0,0
219881,rated,0,0
219882,their,0,0
219883,professional,0,0
219884,competence,0,0
219885,",",0,0
219886,quality,0,0
219887,of,0,0
219888,interaction,0,0
219889,with,0,0
219890,the,0,0
219891,client,0,0
219892,",",0,0
219893,team,0,0
219894,culture,0,0
219895,and,0,0
219896,work,0,0
219897,satisfaction,0,0
219898,before,0,0
219899,and,0,0
219900,after,0,0
219901,being,0,0
219902,engaged,0,0
219903,in,0,0
219904,the,0,0
219905,program,0,1
219906,",",0,0
219907,with,0,0
219908,additional,0,0
219909,ratings,0,0
219910,of,0,0
219911,their,0,0
219912,personal,0,1
219913,aims,0,0
219914,at,0,0
219915,the,0,0
219916,beginning,0,0
219917,of,0,0
219918,the,0,0
219919,program,0,1
219920,.,0,0
219921,Three,0,0
219922,sets,0,0
219923,of,0,0
219924,data,0,0
219925,were,0,0
219926,obtained,0,0
219927,with,0,0
219928,the,0,0
219929,program,0,1
219930,being,0,0
219931,conducted,0,0
219932,three,0,0
219933,times,0,0
219934,in,0,0
219935,a,0,0
219936,row,0,0
219937,.,0,0
219938,The,0,0
219939,testings,0,0
219940,of,0,0
219941,the,0,0
219942,related,0,0
219943,as,0,0
219944,well,0,0
219945,as,0,0
219946,the,0,0
219947,independent,0,0
219948,samples,0,0
219949,show,0,0
219950,differentiated,0,0
219951,program,0,1
219952,effects,0,0
219953,.,0,0
219954,The,0,0
219955,main,0,0
219956,effect,0,0
219957,is,0,0
219958,an,0,0
219959,increase,0,0
219960,of,0,0
219961,the,0,0
219962,professional,0,1
219963,competence,0,0
219964,and,0,0
219965,quality,0,0
219966,of,0,0
219967,interaction,0,0
219968,",",0,0
219969,especially,0,0
219970,by,0,0
219971,the,0,0
219972,qualified,0,0
219973,staff,0,0
219974,members,0,0
219975,.,0,0
219976,Trainees,0,0
219977,put,0,0
219978,emphasis,0,0
219979,on,0,0
219980,the,0,0
219981,development,0,0
219982,of,0,0
219983,their,0,0
219984,personal,0,1
219985,relationship,0,0
219986,with,0,0
219987,the,0,0
219988,client,0,0
219989,.,0,0
219990,The,0,0
219991,results,0,0
219992,are,0,0
219993,discussed,0,0
219994,in,0,0
219995,terms,0,0
219996,of,0,0
219997,the,0,0
219998,impact,0,0
219999,of,0,0
220000,learning,0,0
220001,processes,0,0
220002,specific,0,0
220003,to,0,0
220004,the,0,0
220005,roles,0,0
220006,of,0,0
220007,the,0,0
220008,staff,0,0
220009,members,0,0
220010,and,0,0
220011,motivational,0,0
220012,factors,0,0
220013,on,0,0
220014,learning,0,0
220015,and,0,0
220016,therapy,0,1
220017,outcome,0,0
220018,",",0,0
220019,along,0,0
220020,with,0,0
220021,institutional,0,0
220022,conditions,0,0
220023,influencing,0,0
220024,successful,0,0
220025,learning,0,0
220026,.,0,0
220027,Thus,0,0
220028,the,0,0
220029,program,0,1
220030,facilitates,0,0
220031,the,0,0
220032,professional,0,0
220033,and,0,0
220034,interpersonal,0,0
220035,learning,0,0
220036,process,0,0
220037,of,0,0
220038,staff,0,0
220039,members,0,0
220040,in,0,0
220041,a,0,0
220042,specific,0,0
220043,way,0,0
220044,with,0,0
220045,success,0,0
220046,as,0,0
220047,well,0,0
220048,as,0,0
220049,with,0,0
220050,limitations,0,0
220051,.,0,0
220052,A,0,0
220053,double-blind,0,0
220054,comparison,0,0
220055,of,0,0
220056,oral,1,1
220057,ketoprofen,1,1
220058,'controlled,1,1
220059,release,1,0
220060,',1,0
220061,and,0,0
220062,indomethacin,1,1
220063,suppository,1,1
220064,in,0,0
220065,the,0,0
220066,treatment,0,0
220067,of,0,0
220068,rheumatoid,0,0
220069,arthritis,0,0
220070,with,0,0
220071,special,0,0
220072,regard,0,0
220073,to,0,0
220074,morning,0,0
220075,stiffness,0,0
220076,and,0,0
220077,pain,0,0
220078,on,0,0
220079,awakening,0,0
220080,.,0,0
220081,A,0,0
220082,double-blind,0,0
220083,",",0,0
220084,double-dummy,0,0
220085,",",0,0
220086,crossover,0,0
220087,study,0,0
220088,was,0,0
220089,carried,0,0
220090,out,0,0
220091,in,0,0
220092,8,0,0
220093,centres,0,0
220094,to,0,0
220095,compare,0,0
220096,the,0,0
220097,efficacy,0,0
220098,and,0,0
220099,tolerability,0,0
220100,of,0,0
220101,'controlled-release,1,1
220102,',1,0
220103,ketoprofen,1,1
220104,tablets,1,1
220105,(,0,0
220106,200,0,1
220107,mg,0,1
220108,),0,0
220109,with,0,0
220110,that,0,0
220111,of,0,0
220112,indomethacin,1,1
220113,suppositories,1,1
220114,(,0,0
220115,100,0,1
220116,mg,0,1
220117,),0,0
220118,in,0,0
220119,out-patients,0,0
220120,with,0,0
220121,definite,0,0
220122,or,0,1
220123,classical,0,1
220124,rheumatoid,0,0
220125,arthritis,0,0
220126,.,0,0
220127,Patients,0,0
220128,were,0,0
220129,allocated,0,0
220130,at,0,0
220131,random,0,0
220132,to,0,0
220133,receive,0,0
220134,a,0,0
220135,daily,0,1
220136,bedtime,0,1
220137,dose,0,0
220138,of,0,0
220139,either,0,0
220140,1,0,0
220141,ketoprofen,1,1
220142,tablet,0,1
220143,or,0,1
220144,1,0,0
220145,indomethacin,1,1
220146,suppository,1,1
220147,plus,0,1
220148,the,0,0
220149,dummy,0,0
220150,of,0,0
220151,the,0,0
220152,other,0,0
220153,formulation,0,0
220154,for,0,0
220155,a,0,0
220156,period,0,0
220157,of,0,0
220158,3,0,0
220159,weeks,0,0
220160,.,0,0
220161,They,0,0
220162,were,0,0
220163,then,0,0
220164,crossed,0,0
220165,over,0,0
220166,to,0,0
220167,the,0,0
220168,alternative,0,0
220169,treatment,0,0
220170,for,0,0
220171,a,0,0
220172,further,0,0
220173,3,0,0
220174,weeks,0,0
220175,.,0,0
220176,Daily,0,0
220177,diary,0,0
220178,records,0,0
220179,were,0,0
220180,kept,0,0
220181,by,0,0
220182,patients,0,0
220183,of,0,0
220184,the,0,0
220185,number,0,0
220186,of,0,0
220187,night-time,0,0
220188,awakenings,0,0
220189,due,0,0
220190,to,0,0
220191,pain,0,0
220192,",",0,0
220193,pain,0,0
220194,severity,0,0
220195,at,0,0
220196,awakening,0,0
220197,in,0,0
220198,the,0,0
220199,morning,0,0
220200,and,0,0
220201,the,0,0
220202,duration,0,0
220203,of,0,0
220204,early,0,0
220205,morning,0,0
220206,stiffness,0,0
220207,.,0,0
220208,Treatment,0,0
220209,efficacy,0,0
220210,was,0,0
220211,also,0,0
220212,assessed,0,0
220213,at,0,0
220214,the,0,0
220215,end,0,0
220216,of,0,0
220217,each,0,0
220218,trial,0,0
220219,period,0,0
220220,by,0,0
220221,means,0,0
220222,of,0,0
220223,an,0,0
220224,articular,0,0
220225,index,0,0
220226,and,0,0
220227,by,0,0
220228,physician,0,0
220229,'s,0,0
220230,and,0,0
220231,patient,0,0
220232,'s,0,0
220233,overall,0,0
220234,evaluation,0,0
220235,of,0,0
220236,response,0,0
220237,.,0,0
220238,Adverse,0,0
220239,effects,0,0
220240,spontaneously,0,0
220241,mentioned,0,0
220242,by,0,0
220243,the,0,0
220244,patients,0,0
220245,or,0,0
220246,elicited,0,0
220247,by,0,0
220248,direct,0,0
220249,questioning,0,0
220250,using,0,0
220251,a,0,0
220252,symptom,0,0
220253,check-list,0,0
220254,were,0,0
220255,recorded,0,0
220256,.,0,0
220257,Statistical,0,0
220258,analysis,0,0
220259,of,0,0
220260,the,0,0
220261,results,0,0
220262,from,0,0
220263,83,0,0
220264,evaluable,0,0
220265,patients,0,0
220266,showed,0,0
220267,that,0,0
220268,the,0,0
220269,'controlled-release,0,1
220270,',0,0
220271,tablet,0,1
220272,formulation,0,0
220273,of,0,0
220274,200,0,0
220275,mg,0,0
220276,ketoprofen,1,1
220277,was,0,0
220278,equally,0,0
220279,as,0,0
220280,effective,0,0
220281,as,0,0
220282,the,0,0
220283,100,0,0
220284,mg,0,1
220285,indomethacin,1,1
220286,suppository,1,1
220287,in,0,0
220288,the,0,0
220289,treatment,0,0
220290,of,0,0
220291,rheumatoid,0,0
220292,arthritis,0,0
220293,",",0,0
220294,especially,0,0
220295,with,0,0
220296,regard,0,0
220297,to,0,0
220298,pain,0,0
220299,at,0,0
220300,awakening,0,0
220301,and,0,0
220302,morning,0,0
220303,stiffness,0,0
220304,.,0,0
220305,Side-effects,0,0
220306,in,0,0
220307,both,0,0
220308,groups,0,0
220309,were,0,0
220310,those,0,0
220311,commonly,0,0
220312,seen,0,0
220313,with,0,0
220314,non-steroidal,0,1
220315,anti-inflammatory,0,1
220316,drugs,0,1
220317,and,0,0
220318,",",0,0
220319,as,0,0
220320,expected,0,0
220321,",",0,0
220322,gastro-intestinal,0,0
220323,and,0,0
220324,CNS,0,1
220325,disturbances,0,0
220326,predominated,0,0
220327,.,0,0
220328,Overall,0,0
220329,",",0,0
220330,side-effects,0,0
220331,were,0,0
220332,fewer,0,0
220333,with,0,0
220334,ketoprofen,1,1
220335,than,0,0
220336,with,0,0
220337,indomethacin,1,1
220338,.,1,0
220339,Increased,0,0
220340,blood,0,0
220341,pressure,0,0
220342,and,0,0
220343,neural,0,0
220344,tone,0,1
220345,in,0,0
220346,the,0,0
220347,silent,0,0
220348,ischemia,0,0
220349,of,0,0
220350,hypertension,0,0
220351,:,0,0
220352,disparate,0,0
220353,effects,0,0
220354,of,0,0
220355,immediate,0,0
220356,release,0,0
220357,nifedipine,1,1
220358,.,1,0
220359,OBJECTIVES,0,0
220360,The,0,0
220361,aims,0,0
220362,of,0,0
220363,this,0,0
220364,study,0,0
220365,were,0,0
220366,1,0,0
220367,),0,0
220368,to,0,0
220369,evaluate,0,0
220370,the,0,0
220371,role,0,0
220372,of,0,0
220373,blood,0,0
220374,pressure,0,0
220375,and,0,0
220376,associated,0,0
220377,neural,0,0
220378,tonicity,0,0
220379,in,0,0
220380,ambient,0,1
220381,ischemia,0,0
220382,of,0,0
220383,a,0,0
220384,group,0,0
220385,of,0,0
220386,hypertensive,0,0
220387,patients,0,0
220388,with,0,0
220389,stable,0,0
220390,angina,0,0
220391,",",0,0
220392,and,0,0
220393,2,0,0
220394,),0,0
220395,to,0,0
220396,determine,0,0
220397,the,0,0
220398,efficacy,0,0
220399,of,0,0
220400,immediate,0,0
220401,release,0,0
220402,nifedipine,1,1
220403,therapy,0,1
220404,in,0,0
220405,controlling,0,0
220406,the,0,0
220407,total,0,0
220408,ischemic,0,0
220409,burden,0,0
220410,in,0,0
220411,both,0,0
220412,office-measured,0,0
220413,and,0,0
220414,ambulatory,0,0
220415,blood,0,0
220416,pressure,0,0
220417,.,0,0
220418,BACKGROUND,0,0
220419,Low,0,0
220420,heart,0,0
220421,rate,0,0
220422,ischemia,0,0
220423,",",0,0
220424,as,0,0
220425,detected,0,0
220426,by,0,0
220427,Holter,0,0
220428,ambulatory,0,0
220429,electrocardiographic,0,0
220430,monitoring,0,0
220431,",",0,0
220432,suggests,0,0
220433,that,0,0
220434,reduced,0,0
220435,coronary,0,0
220436,flow,0,0
220437,is,0,0
220438,the,0,0
220439,major,0,0
220440,factor,0,0
220441,leading,0,0
220442,to,0,0
220443,ischemia,0,0
220444,.,0,0
220445,We,0,0
220446,previously,0,0
220447,found,0,0
220448,that,0,0
220449,91,0,0
220450,%,0,0
220451,of,0,0
220452,the,0,0
220453,ischemic,0,0
220454,episodes,0,0
220455,in,0,0
220456,our,0,0
220457,hypertensive,0,0
220458,patients,0,0
220459,with,0,0
220460,stable,0,0
220461,angina,0,0
220462,were,0,0
220463,silent,0,0
220464,.,0,0
220465,METHODS,0,0
220466,We,0,0
220467,measured,0,0
220468,plasma,0,0
220469,norepinephrine,0,0
220470,content,0,0
220471,during,0,0
220472,ischemic,0,0
220473,events,0,0
220474,from,0,0
220475,blood,0,0
220476,obtained,0,0
220477,from,0,0
220478,automatic,0,0
220479,pump,0,1
220480,withdrawal,0,0
220481,with,0,0
220482,the,0,0
220483,assistance,0,0
220484,of,0,0
220485,a,0,0
220486,real-time,1,1
220487,ST,1,0
220488,segment,1,0
220489,depression,1,0
220490,monitor,1,0
220491,.,1,0
220492,We,0,0
220493,then,0,0
220494,related,0,0
220495,the,0,0
220496,norepinephrine,0,0
220497,content,0,0
220498,to,0,0
220499,ischemic,0,0
220500,episodes,0,0
220501,assessed,0,0
220502,by,0,0
220503,48-h,0,0
220504,Holter,0,0
220505,recording,0,0
220506,",",0,0
220507,blood,0,0
220508,pressure,0,0
220509,reading,0,1
220510,by,0,0
220511,ambulatory,0,0
220512,blood,0,0
220513,pressure,0,0
220514,monitoring,0,0
220515,and,0,0
220516,patients,0,0
220517,',0,0
220518,diaries,0,0
220519,.,0,0
220520,Measurements,0,0
220521,were,0,0
220522,taken,0,0
220523,during,0,0
220524,the,0,0
220525,placebo,1,1
220526,period,0,0
220527,and,0,0
220528,immediate-release,0,1
220529,nifedipine,1,1
220530,therapy,1,1
220531,in,0,0
220532,30,0,0
220533,hypertensive,0,0
220534,patients,0,0
220535,(,0,0
220536,20,0,0
220537,with,0,0
220538,and,0,0
220539,10,0,0
220540,without,0,0
220541,stable,0,0
220542,angina,0,0
220543,),0,0
220544,.,0,0
220545,RESULTS,0,0
220546,More,0,0
220547,than,0,0
220548,half,0,0
220549,of,0,0
220550,the,0,0
220551,patients,0,0
220552,had,0,0
220553,ischemic,0,0
220554,episodes,0,0
220555,;,0,0
220556,95,0,0
220557,%,0,0
220558,of,0,0
220559,these,0,0
220560,were,0,0
220561,silent,0,0
220562,.,0,0
220563,Ischemic,0,0
220564,episodes,0,0
220565,peaked,0,0
220566,in,0,0
220567,the,0,0
220568,early,0,0
220569,morning,0,0
220570,",",0,0
220571,and,0,0
220572,55,0,0
220573,%,0,0
220574,occurred,0,0
220575,during,0,0
220576,routine,0,0
220577,sedentary,0,0
220578,activities,0,0
220579,.,0,0
220580,There,0,0
220581,was,0,0
220582,a,0,0
220583,10,0,0
220584,%,0,0
220585,to,0,0
220586,15,0,0
220587,%,0,0
220588,increase,0,0
220589,in,0,0
220590,heart,0,0
220591,rate,0,0
220592,at,0,0
220593,the,0,0
220594,onset,0,0
220595,of,0,0
220596,ischemia,0,0
220597,associated,0,0
220598,with,0,0
220599,a,0,0
220600,30,0,0
220601,%,0,0
220602,higher,0,0
220603,plasma,0,0
220604,norepinephrine,0,0
220605,level,0,0
220606,.,0,0
220607,Seventy-five,0,0
220608,percent,0,0
220609,of,0,0
220610,patients,0,0
220611,had,0,0
220612,increased,0,0
220613,norepinephrine,0,0
220614,after,0,0
220615,nifedipine,1,1
220616,therapy,0,1
220617,.,0,0
220618,Nifedipine,0,1
220619,therapy,0,1
220620,controlled,0,0
220621,measured,0,0
220622,blood,0,0
220623,pressure,0,0
220624,but,0,0
220625,not,0,0
220626,24-h,0,1
220627,ambulatory,0,0
220628,blood,0,0
220629,pressure,0,0
220630,.,0,0
220631,Ischemic,0,0
220632,episodes,0,0
220633,were,0,0
220634,reduced,0,0
220635,only,0,0
220636,in,0,0
220637,patients,0,0
220638,whose,0,0
220639,ambulatory,0,0
220640,blood,0,0
220641,pressure,0,0
220642,was,0,0
220643,controlled,0,0
220644,.,0,0
220645,CONCLUSIONS,0,0
220646,The,0,0
220647,results,0,0
220648,suggest,0,0
220649,that,0,0
220650,increased,0,0
220651,neural,0,0
220652,tone,0,0
220653,at,0,0
220654,the,0,0
220655,time,0,0
220656,of,0,0
220657,the,0,0
220658,ischemic,0,0
220659,event,0,0
220660,may,0,0
220661,play,0,0
220662,a,0,0
220663,role,0,0
220664,in,0,0
220665,reducing,0,0
220666,coronary,0,0
220667,perfusion,0,0
220668,leading,0,0
220669,to,0,0
220670,silent,0,0
220671,ischemia,0,0
220672,.,0,0
220673,Nifedipine,1,1
220674,therapy,1,1
220675,(,1,0
220676,immediate,1,0
220677,release,1,1
220678,),1,0
220679,was,0,0
220680,effective,0,0
220681,in,0,0
220682,control,0,0
220683,of,0,0
220684,ischemia,0,0
220685,only,0,0
220686,when,0,0
220687,both,0,0
220688,ambulatory,0,0
220689,and,0,0
220690,office-measured,0,0
220691,blood,0,0
220692,pressure,0,0
220693,were,0,0
220694,controlled,0,0
220695,.,0,0
220696,Veterans,0,0
220697,Affairs,0,0
220698,congestive,0,0
220699,heart,0,0
220700,failure,0,0
220701,antiarrhythmic,0,0
220702,trial,0,0
220703,.,0,0
220704,CHF,0,0
220705,STAT,0,0
220706,Investigators,0,0
220707,.,0,0
220708,This,0,0
220709,is,0,0
220710,a,0,0
220711,prospective,0,0
220712,",",0,0
220713,double-blind,0,0
220714,",",0,0
220715,placebo-controlled,0,1
220716,trial,0,0
220717,to,0,0
220718,determine,0,0
220719,the,0,0
220720,effect,0,0
220721,of,0,0
220722,antiarrhythmic,0,1
220723,drug,0,0
220724,therapy,0,1
220725,on,0,0
220726,mortality,0,0
220727,in,0,0
220728,patients,0,0
220729,with,0,0
220730,congestive,0,0
220731,heart,0,0
220732,failure,0,0
220733,and,0,0
220734,ventricular,0,0
220735,arrhythmia,0,0
220736,.,0,0
220737,Patients,0,0
220738,will,0,0
220739,be,0,0
220740,assigned,0,0
220741,to,0,0
220742,receive,0,0
220743,either,0,0
220744,amiodarone,1,1
220745,or,1,0
220746,placebo,1,1
220747,.,1,0
220748,Eligible,0,0
220749,patients,0,0
220750,include,0,0
220751,those,0,0
220752,with,0,0
220753,ischemic,0,0
220754,and,0,0
220755,nonischemic,0,0
220756,congestive,0,0
220757,heart,0,0
220758,failure,0,0
220759,and,0,0
220760,with,0,0
220761,>,0,0
220762,or,0,0
220763,=,0,0
220764,10,0,0
220765,ventricular,0,0
220766,premature,0,0
220767,beats,0,0
220768,per,0,0
220769,hour,0,0
220770,.,0,0
220771,All,0,0
220772,patients,0,0
220773,must,0,0
220774,have,0,0
220775,shortness,0,0
220776,of,0,0
220777,breath,0,0
220778,with,0,0
220779,minimal,0,0
220780,exertion,0,0
220781,or,0,1
220782,paroxysmal,0,0
220783,nocturnal,0,0
220784,dyspnea,0,0
220785,",",0,0
220786,a,0,0
220787,left,0,0
220788,ventricular,0,0
220789,internal,0,1
220790,dimension,0,0
220791,(,0,0
220792,LVIDd,0,1
220793,),0,0
220794,by,0,0
220795,echocardiogram,0,0
220796,of,0,0
220797,>,0,0
220798,or,0,0
220799,=,0,0
220800,55,0,0
220801,mm,0,0
220802,or,0,0
220803,a,0,0
220804,cardiothoracic,0,0
220805,ratio,0,0
220806,of,0,0
220807,>,0,0
220808,0.5,0,0
220809,and,0,0
220810,an,0,0
220811,ejection,0,0
220812,fraction,0,0
220813,of,0,0
220814,<,0,0
220815,or,0,0
220816,=,0,0
220817,40,0,0
220818,%,0,0
220819,.,0,0
220820,All,0,0
220821,patients,0,0
220822,will,0,0
220823,receive,0,0
220824,vasodilator,0,0
220825,therapy,0,1
220826,",",0,0
220827,unless,0,0
220828,they,0,0
220829,find,0,0
220830,it,0,0
220831,intolerable,0,0
220832,.,0,0
220833,Patients,0,0
220834,will,0,0
220835,be,0,0
220836,entered,0,0
220837,into,0,0
220838,the,0,0
220839,study,0,0
220840,for,0,0
220841,2.5,0,0
220842,years,0,0
220843,and,0,0
220844,followed,0,0
220845,for,0,0
220846,an,0,0
220847,additional,0,0
220848,2,0,0
220849,years,0,0
220850,.,0,0
220851,Drug,0,0
220852,therapy,0,1
220853,will,0,0
220854,be,0,0
220855,continued,0,0
220856,for,0,0
220857,all,0,0
220858,patients,0,0
220859,throughout,0,0
220860,the,0,0
220861,entire,0,0
220862,study,0,0
220863,unless,0,0
220864,adverse,0,0
220865,reactions,0,0
220866,occur,0,0
220867,that,0,0
220868,necessitate,0,0
220869,individualized,0,0
220870,treatment,0,0
220871,.,0,0
220872,The,0,0
220873,expectation,0,0
220874,is,0,0
220875,that,0,0
220876,674,0,0
220877,patients,0,0
220878,will,0,0
220879,be,0,0
220880,entered,0,0
220881,into,0,0
220882,the,0,0
220883,study,0,0
220884,from,0,0
220885,25,0,0
220886,participating,0,0
220887,centers,0,0
220888,.,0,0
220889,This,0,0
220890,sample,0,0
220891,size,0,0
220892,will,0,0
220893,allow,0,0
220894,for,0,0
220895,the,0,0
220896,detection,0,0
220897,of,0,0
220898,a,0,0
220899,33,0,0
220900,%,0,0
220901,decrease,0,0
220902,in,0,0
220903,2-year,0,0
220904,mortality,0,0
220905,(,0,0
220906,20,0,0
220907,%,0,0
220908,vs,0,0
220909,30,0,0
220910,%,0,0
220911,),0,0
220912,in,0,0
220913,the,0,0
220914,treated,0,0
220915,patients,0,0
220916,compared,0,0
220917,with,0,0
220918,those,0,0
220919,in,0,0
220920,the,0,0
220921,placebo,0,1
220922,group,0,0
220923,",",0,0
220924,with,0,0
220925,a,0,0
220926,power,0,0
220927,of,0,0
220928,0.90,0,0
220929,and,0,0
220930,a,0,0
220931,2-sided,0,0
220932,alpha,0,1
220933,level,0,0
220934,of,0,0
220935,0.05,0,0
220936,.,0,0
220937,Intermittent,0,0
220938,Holter,0,0
220939,monitoring,0,0
220940,",",0,0
220941,radionuclide,0,1
220942,ventriculograms,0,0
220943,",",0,0
220944,pulmonary,0,0
220945,function,0,0
220946,tests,0,0
220947,",",0,0
220948,echocardiograms,0,0
220949,",",0,0
220950,and,0,0
220951,blood,0,0
220952,tests,0,0
220953,",",0,0
220954,including,0,0
220955,arterial,0,0
220956,blood,0,0
220957,gases,0,0
220958,",",0,0
220959,will,0,0
220960,be,0,0
220961,required,0,0
220962,for,0,0
220963,each,0,0
220964,patient,0,0
220965,.,0,0
220966,(,0,0
220967,ABSTRACT,0,0
220968,TRUNCATED,0,1
220969,AT,0,1
220970,250,0,1
220971,WORDS,0,0
220972,),0,0
220973,Relaxing,1,1
220974,retinotomy,1,1
220975,with,1,0
220976,silicone,1,1
220977,oil,1,1
220978,or,1,1
220979,long-acting,1,1
220980,gas,1,1
220981,in,0,0
220982,eyes,0,0
220983,with,0,0
220984,severe,0,0
220985,proliferative,0,0
220986,vitreoretinopathy,0,0
220987,.,0,0
220988,Silicone,0,1
220989,Study,0,0
220990,Report,0,0
220991,5,0,0
220992,.,0,0
220993,The,0,0
220994,Silicone,0,1
220995,Study,0,0
220996,Group,0,0
220997,.,0,0
220998,In,0,0
220999,the,0,0
221000,Silicone,0,1
221001,Study,0,0
221002,",",0,0
221003,117,0,0
221004,of,0,0
221005,404,0,0
221006,eyes,0,0
221007,(,0,0
221008,29,0,0
221009,%,0,0
221010,),0,0
221011,with,0,0
221012,severe,0,0
221013,proliferative,0,0
221014,vitreoretinopathy,0,0
221015,(,0,0
221016,>,0,0
221017,or,0,0
221018,=,0,0
221019,C-3,0,1
221020,",",0,0
221021,full-thickness,0,0
221022,retinal,0,0
221023,folds,0,0
221024,in,0,0
221025,three,0,0
221026,or,0,0
221027,more,0,0
221028,quadrants,0,0
221029,),0,0
221030,enrolled,0,0
221031,in,0,0
221032,the,0,0
221033,study,0,0
221034,were,0,0
221035,treated,0,0
221036,with,0,0
221037,vitrectomy,1,1
221038,",",0,0
221039,underwent,0,0
221040,a,0,0
221041,relaxing,1,1
221042,retinotomy,1,1
221043,",",0,0
221044,and,0,0
221045,were,0,0
221046,randomly,0,0
221047,assigned,0,0
221048,to,0,0
221049,treatment,1,0
221050,with,1,0
221051,long-acting,1,1
221052,gas,1,1
221053,or,1,1
221054,silicone,1,1
221055,oil,1,1
221056,.,1,0
221057,Forty-six,0,0
221058,eyes,0,0
221059,(,0,0
221060,20,0,0
221061,%,0,0
221062,),0,0
221063,had,0,0
221064,undergone,0,0
221065,no,0,0
221066,previous,0,0
221067,vitrectomy,0,1
221068,(,0,0
221069,group,0,0
221070,1,0,0
221071,),0,0
221072,;,0,0
221073,71,0,0
221074,eyes,0,0
221075,(,0,0
221076,42,0,0
221077,%,0,0
221078,),0,0
221079,had,0,0
221080,undergone,0,0
221081,previous,0,0
221082,vitrectomy,0,1
221083,(,0,0
221084,group,0,0
221085,2,0,0
221086,),0,0
221087,with,0,0
221088,intraocular,0,0
221089,gas,0,1
221090,tamponade,0,0
221091,(,0,0
221092,P,0,0
221093,<,0,0
221094,.001,0,0
221095,),0,0
221096,.,0,0
221097,Group,0,0
221098,1,0,0
221099,eyes,0,0
221100,not,0,0
221101,undergoing,0,0
221102,retinotomy,0,0
221103,had,0,0
221104,better,0,0
221105,anatomic,0,0
221106,(,0,0
221107,six,0,0
221108,months,0,0
221109,),0,0
221110,and,0,0
221111,visual,0,1
221112,(,0,0
221113,six,0,0
221114,and,0,0
221115,24,0,0
221116,months,0,0
221117,),0,0
221118,outcomes,0,0
221119,and,0,0
221120,less,0,0
221121,hypotony,0,0
221122,(,0,0
221123,six,0,0
221124,months,0,0
221125,),0,0
221126,than,0,0
221127,eyes,0,0
221128,that,0,0
221129,did,0,0
221130,regardless,0,0
221131,of,0,0
221132,tamponade,0,0
221133,(,0,0
221134,P,0,0
221135,<,0,0
221136,.05,0,0
221137,),0,0
221138,.,0,0
221139,For,0,0
221140,eyes,0,0
221141,undergoing,0,0
221142,retinotomy,0,1
221143,",",0,0
221144,silicone,0,1
221145,oil,0,1
221146,decreased,0,0
221147,the,0,0
221148,likelihood,0,0
221149,of,0,0
221150,hypotony,0,0
221151,(,0,0
221152,six,0,0
221153,months,0,0
221154,",",0,0
221155,P,0,0
221156,<,0,0
221157,.05,0,0
221158,),0,0
221159,.,0,0
221160,These,0,0
221161,differences,0,0
221162,were,0,0
221163,not,0,0
221164,found,0,0
221165,in,0,0
221166,group,0,0
221167,2,0,0
221168,eyes,0,0
221169,.,0,0
221170,We,0,0
221171,conclude,0,0
221172,that,0,0
221173,eyes,0,0
221174,undergoing,0,0
221175,a,0,0
221176,vitreous,0,1
221177,operation,0,0
221178,for,0,0
221179,the,0,0
221180,first,0,0
221181,time,0,0
221182,for,0,0
221183,the,0,0
221184,treatment,0,0
221185,of,0,0
221186,proliferative,0,0
221187,vitreoretinopathy,0,0
221188,can,0,0
221189,in,0,0
221190,most,0,0
221191,instances,0,0
221192,be,0,0
221193,successfully,0,0
221194,treated,0,0
221195,by,0,0
221196,conventional,0,1
221197,techniques,0,1
221198,without,0,0
221199,the,0,0
221200,need,0,0
221201,for,0,0
221202,relaxing,0,1
221203,retinotomy,0,1
221204,.,0,0
221205,Retinotomy,0,1
221206,may,0,0
221207,be,0,0
221208,required,0,0
221209,more,0,0
221210,often,0,0
221211,in,0,0
221212,patients,0,0
221213,undergoing,0,0
221214,repeat,0,0
221215,vitreous,0,1
221216,surgery,0,0
221217,for,0,0
221218,proliferative,0,0
221219,vitreoretinopathy,0,0
221220,",",0,0
221221,in,0,0
221222,which,0,0
221223,case,0,0
221224,both,0,0
221225,silicone,0,1
221226,oil,0,1
221227,and,0,0
221228,long-acting,0,1
221229,perflouropropane,1,1
221230,gas,0,1
221231,appear,0,0
221232,to,0,0
221233,be,0,0
221234,equally,0,0
221235,effective,0,0
221236,.,0,0
221237,[,0,0
221238,Opiate,0,0
221239,hypothesis,0,0
221240,in,0,0
221241,infantile,0,0
221242,autism,0,0
221243,?,0,0
221244,Therapeutic,0,0
221245,trials,0,0
221246,with,0,0
221247,naltrexone,1,1
221248,],1,0
221249,.,0,0
221250,The,0,0
221251,opioid,0,0
221252,hypothesis,0,0
221253,suggests,0,0
221254,that,0,0
221255,childhood,0,0
221256,autism,0,0
221257,may,0,0
221258,result,0,0
221259,from,0,0
221260,excessive,0,0
221261,brain,0,0
221262,opioid,0,1
221263,activity,0,0
221264,during,0,0
221265,neonatal,0,0
221266,period,0,0
221267,which,0,0
221268,may,0,0
221269,constitutionally,0,0
221270,inhibit,0,0
221271,social,0,0
221272,motivation,0,0
221273,",",0,0
221274,yielding,0,0
221275,autistic,0,0
221276,isolation,0,0
221277,and,0,0
221278,aloofness,0,0
221279,(,0,0
221280,Panksepp,0,0
221281,",",0,0
221282,1979,0,0
221283,),0,0
221284,.,0,0
221285,This,0,0
221286,hypothesis,0,0
221287,has,0,0
221288,now,0,0
221289,received,0,0
221290,strong,0,0
221291,support,0,0
221292,and,0,0
221293,is,0,0
221294,currently,0,0
221295,based,0,0
221296,on,0,0
221297,three,0,0
221298,types,0,0
221299,of,0,0
221300,arguments,0,0
221301,:,0,0
221302,(,0,0
221303,1,0,0
221304,),0,0
221305,similarity,0,0
221306,between,0,0
221307,autistic,0,0
221308,symptomatology,0,0
221309,and,0,0
221310,abnormal,0,0
221311,behaviors,0,0
221312,induced,0,0
221313,in,0,0
221314,young,0,0
221315,animals,0,0
221316,by,0,0
221317,injections,0,1
221318,of,0,0
221319,exogenous,0,0
221320,opioids,0,1
221321,",",0,0
221322,such,0,0
221323,as,0,0
221324,increasing,0,0
221325,social,0,1
221326,aloofness,0,0
221327,and,0,0
221328,decreasing,0,0
221329,social,0,1
221330,vocalization,0,0
221331,;,0,0
221332,(,0,0
221333,2,0,0
221334,),0,0
221335,direct,0,0
221336,biochemical,0,0
221337,evidence,0,0
221338,of,0,0
221339,abnormalities,0,0
221340,of,0,0
221341,peripheral,0,0
221342,endogenous,0,0
221343,opioids,0,1
221344,being,0,0
221345,reported,0,0
221346,in,0,0
221347,autism,0,0
221348,and,0,0
221349,(,0,0
221350,3,0,0
221351,),0,0
221352,therapeutic,0,0
221353,effects,0,0
221354,of,0,0
221355,the,0,0
221356,long,0,0
221357,lasting,0,0
221358,opioid,0,1
221359,receptor,0,0
221360,blocking,0,0
221361,agent,0,0
221362,naltrexone,0,1
221363,in,0,0
221364,autism,0,0
221365,.,0,0
221366,In,0,0
221367,this,0,0
221368,article,0,0
221369,",",0,0
221370,we,0,0
221371,give,0,0
221372,description,0,0
221373,of,0,0
221374,open,0,0
221375,and,0,0
221376,double-blind,0,0
221377,studies,0,0
221378,of,0,0
221379,naltrexone,1,1
221380,in,0,0
221381,autism,0,0
221382,.,0,0
221383,Naltrexone,1,1
221384,has,0,0
221385,been,0,0
221386,tested,0,0
221387,in,0,0
221388,several,0,0
221389,open,0,0
221390,studies,0,0
221391,.,0,0
221392,We,0,0
221393,performed,0,0
221394,an,0,0
221395,open,0,0
221396,trial,0,0
221397,with,0,0
221398,naltrexone,1,1
221399,in,0,0
221400,2,0,0
221401,autistic,0,0
221402,girls,0,0
221403,",",0,0
221404,displaying,0,0
221405,serious,0,0
221406,self-injurious,0,0
221407,behavior,0,0
221408,",",0,0
221409,reduced,0,0
221410,crying,0,0
221411,and,0,0
221412,a,0,0
221413,marked,0,0
221414,preference,0,0
221415,for,0,0
221416,salty,0,1
221417,and,0,0
221418,spicy,0,1
221419,foods,0,1
221420,",",0,0
221421,symptoms,0,0
221422,that,0,0
221423,could,0,0
221424,be,0,0
221425,related,0,0
221426,to,0,0
221427,a,0,0
221428,dysfunction,0,0
221429,of,0,0
221430,the,0,0
221431,opioid,0,1
221432,system,0,0
221433,.,0,0
221434,With,0,0
221435,dosages,0,0
221436,of,0,0
221437,1,0,0
221438,mg/kg/day,0,0
221439,",",0,0
221440,we,0,0
221441,observed,0,0
221442,an,0,0
221443,immediate,0,0
221444,reduction,0,0
221445,of,0,0
221446,hyperactivity,0,0
221447,",",0,0
221448,self-injurious,0,0
221449,behavior,0,0
221450,and,0,0
221451,aggressiveness,0,0
221452,",",0,0
221453,while,0,0
221454,attention,0,0
221455,improved,0,0
221456,.,0,0
221457,In,0,0
221458,addition,0,0
221459,",",0,0
221460,social,0,0
221461,behaviors,0,0
221462,",",0,0
221463,smiling,0,0
221464,",",0,0
221465,social,0,0
221466,seeking,0,0
221467,behaviors,0,0
221468,and,0,0
221469,play,0,0
221470,interactions,0,0
221471,increased,0,0
221472,(,0,0
221473,Leboyer,0,0
221474,",",0,0
221475,Bouvard,0,1
221476,et,0,0
221477,Dugas,0,0
221478,",",0,0
221479,1988,0,0
221480,),0,0
221481,.,0,0
221482,Campbell,0,1
221483,et,0,0
221484,al,0,0
221485,.,0,0
221486,(,0,0
221487,1988,0,0
221488,),0,0
221489,has,0,0
221490,also,0,0
221491,reported,0,0
221492,a,0,0
221493,tranquilizing,0,1
221494,and,0,0
221495,a,0,0
221496,stimulating,0,0
221497,effect,0,0
221498,in,0,0
221499,6,0,0
221500,out,0,0
221501,of,0,0
221502,8,0,0
221503,children,0,0
221504,with,0,0
221505,autism,0,0
221506,.,0,0
221507,We,0,0
221508,did,0,0
221509,confirm,0,0
221510,these,0,0
221511,preliminary,0,0
221512,results,0,0
221513,in,0,0
221514,a,0,0
221515,double-blind,0,0
221516,study,0,0
221517,performed,0,0
221518,on,0,0
221519,4,0,0
221520,children,0,0
221521,with,0,0
221522,autism,0,0
221523,.,0,0
221524,In,0,0
221525,a,0,0
221526,cross-over,0,0
221527,double-blind,0,0
221528,study,0,0
221529,",",0,0
221530,three,0,0
221531,dosages,0,0
221532,of,0,0
221533,naltrexone,0,1
221534,(,0,0
221535,0.5,0,0
221536,",",0,0
221537,1,0,0
221538,and,0,0
221539,2,0,0
221540,mg/kg/day,0,1
221541,),0,0
221542,and,0,0
221543,placebo,0,1
221544,were,0,0
221545,compared,0,0
221546,.,0,0
221547,(,0,0
221548,ABSTRACT,0,0
221549,TRUNCATED,0,1
221550,AT,0,1
221551,250,0,1
221552,WORDS,0,0
221553,),0,0
221554,The,0,0
221555,incidence,0,0
221556,of,0,0
221557,first-dose,0,0
221558,hypotension,0,0
221559,with,0,0
221560,quinapril,1,1
221561,in,0,0
221562,patients,0,0
221563,with,0,0
221564,mild,0,0
221565,to,0,0
221566,moderate,0,0
221567,hypertension,0,0
221568,.,0,0
221569,A,0,0
221570,total,0,0
221571,of,0,0
221572,2242,0,0
221573,patients,0,0
221574,with,0,0
221575,mild,0,0
221576,to,0,0
221577,moderate,0,0
221578,hypertension,0,0
221579,(,0,0
221580,diastolic,0,0
221581,pressure,0,0
221582,95-120,0,1
221583,mmHg,0,0
221584,),0,0
221585,were,0,0
221586,randomised,0,0
221587,on,0,0
221588,a,0,0
221589,double-blind,0,0
221590,basis,0,0
221591,to,0,0
221592,receive,0,0
221593,a,0,0
221594,single,0,0
221595,dose,0,0
221596,of,0,0
221597,placebo,1,1
221598,",",1,0
221599,5,1,0
221600,mg,1,1
221601,quinapril,1,1
221602,or,1,1
221603,10,1,0
221604,mg,1,1
221605,quinapril,1,1
221606,.,1,0
221607,Patients,0,0
221608,were,0,0
221609,identified,0,0
221610,who,0,0
221611,:,0,0
221612,(,0,0
221613,a,0,0
221614,),0,0
221615,met,0,0
221616,the,0,0
221617,blood,0,0
221618,pressure,0,0
221619,(,0,0
221620,BP,0,0
221621,),0,0
221622,criteria,0,0
221623,for,0,0
221624,first-dose,0,0
221625,hypotension,0,0
221626,(,0,0
221627,sitting,0,1
221628,or,0,1
221629,standing,0,0
221630,systolic,0,0
221631,BP,0,0
221632,<,0,0
221633,100,0,0
221634,mmHg,0,0
221635,",",0,0
221636,or,0,0
221637,a,0,0
221638,fall,0,0
221639,in,0,0
221640,systolic,0,0
221641,BP,0,0
221642,>,0,0
221643,or,0,0
221644,=,0,0
221645,20,0,0
221646,mmHg,0,0
221647,on,0,0
221648,standing,0,0
221649,),0,0
221650,;,0,0
221651,(,0,0
221652,b,0,0
221653,),0,0
221654,had,0,0
221655,symptoms,0,0
221656,suggestive,0,0
221657,of,0,0
221658,hypotension,0,0
221659,;,0,0
221660,and,0,0
221661,(,0,0
221662,c,0,1
221663,),0,0
221664,met,0,0
221665,the,0,0
221666,BP,0,0
221667,criteria,0,0
221668,and,0,0
221669,had,0,0
221670,symptoms,0,0
221671,.,0,0
221672,In,0,0
221673,all,0,0
221674,three,0,0
221675,classifications,0,0
221676,there,0,0
221677,were,0,0
221678,no,0,0
221679,statistically,0,0
221680,significant,0,0
221681,differences,0,0
221682,between,0,0
221683,the,0,0
221684,incidences,0,0
221685,in,0,0
221686,placebo,0,1
221687,and,0,0
221688,combined,0,1
221689,active,0,0
221690,treatment,0,0
221691,groups,0,0
221692,",",0,0
221693,or,0,0
221694,between,0,0
221695,those,0,0
221696,in,0,0
221697,the,0,0
221698,two,0,0
221699,quinapril,0,1
221700,groups,0,0
221701,.,0,0
221702,No,0,0
221703,associated,0,0
221704,serious,0,0
221705,adverse,0,0
221706,events,0,0
221707,were,0,0
221708,reported,0,0
221709,.,0,0
221710,In,0,0
221711,the,0,0
221712,low-risk,0,0
221713,population,0,0
221714,studied,0,0
221715,",",0,0
221716,it,0,0
221717,would,0,0
221718,appear,0,0
221719,that,0,0
221720,the,0,0
221721,incidence,0,0
221722,of,0,0
221723,first-dose,0,0
221724,hypotension,0,0
221725,with,0,0
221726,quinapril,0,1
221727,is,0,0
221728,similar,0,0
221729,to,0,0
221730,placebo,0,1
221731,and,0,0
221732,is,0,0
221733,not,0,0
221734,dose-related,0,0
221735,.,0,0
221736,MR,0,1
221737,imaging,0,0
221738,of,0,0
221739,pituitary,0,0
221740,region,0,0
221741,lesions,0,0
221742,with,0,0
221743,gadodiamide,1,1
221744,injection,0,0
221745,.,0,0
221746,Twelve,0,0
221747,patients,0,0
221748,with,0,0
221749,known,0,0
221750,or,0,0
221751,suspected,0,0
221752,pituitary,0,0
221753,lesions,0,0
221754,underwent,0,0
221755,MR,1,1
221756,imaging,1,0
221757,with,0,0
221758,gadodiamide,1,1
221759,injection,1,0
221760,at,0,0
221761,a,0,0
221762,dose,0,0
221763,of,0,0
221764,0.1,0,0
221765,(,0,0
221766,n,0,0
221767,=,0,0
221768,5,0,0
221769,),0,0
221770,or,0,1
221771,0.3,0,0
221772,(,0,0
221773,n,0,0
221774,=,0,0
221775,7,0,0
221776,),0,0
221777,mM/kg,0,0
221778,.,0,0
221779,Six,0,0
221780,of,0,0
221781,the,0,0
221782,patients,0,0
221783,were,0,0
221784,also,0,0
221785,studied,0,0
221786,with,0,0
221787,0.1,1,0
221788,mM/kg,1,0
221789,gadopentetate,1,1
221790,dimeglumine,1,1
221791,.,1,0
221792,Consistent,0,0
221793,with,0,0
221794,previous,0,0
221795,reports,0,0
221796,gadodiamide,1,1
221797,injection,0,0
221798,was,0,0
221799,found,0,0
221800,to,0,0
221801,be,0,0
221802,a,0,0
221803,safe,0,0
221804,and,0,0
221805,effective,0,0
221806,contrast,0,0
221807,medium,0,1
221808,for,0,0
221809,MR,0,1
221810,imaging,0,0
221811,of,0,0
221812,the,0,0
221813,pituitary,0,0
221814,region,0,0
221815,.,0,0
221816,No,0,0
221817,additional,0,0
221818,diagnostic,0,0
221819,information,0,0
221820,was,0,0
221821,obtained,0,0
221822,using,0,0
221823,0.3,0,0
221824,mM/kg,0,1
221825,gadodiamide,1,1
221826,injection,0,1
221827,compared,0,0
221828,to,0,0
221829,0.1,0,0
221830,mM/kg,0,0
221831,gadopentate,0,0
221832,dimeglumine,0,1
221833,in,0,0
221834,the,0,0
221835,same,0,0
221836,patients,0,0
221837,.,0,0
221838,The,0,0
221839,high,0,0
221840,dose,0,0
221841,(,0,0
221842,0.3,0,0
221843,mM/kg,0,1
221844,),0,0
221845,gadodiamide,1,1
221846,injection,0,1
221847,in,0,0
221848,7,0,0
221849,patients,0,0
221850,did,0,0
221851,not,0,0
221852,shorten,0,0
221853,the,0,0
221854,T2,0,0
221855,value,0,0
221856,sufficiently,0,0
221857,to,0,0
221858,overwhelm,0,0
221859,the,0,0
221860,T1,0,1
221861,shortening,0,0
221862,and,0,0
221863,leave,0,0
221864,pathologic,0,0
221865,lesions,0,0
221866,hypointense,0,0
221867,compared,0,0
221868,to,0,0
221869,precontrast,0,0
221870,studies,0,0
221871,.,0,0
221872,With,0,0
221873,the,0,0
221874,comparable,0,0
221875,relaxivities,0,0
221876,of,0,0
221877,gadodiamide,1,1
221878,injection,0,1
221879,and,0,0
221880,gadopentetate,1,1
221881,dimeglumine,1,1
221882,",",0,0
221883,similarities,0,0
221884,in,0,0
221885,results,0,0
221886,have,0,0
221887,to,0,0
221888,be,0,0
221889,expected,0,0
221890,when,0,0
221891,using,0,0
221892,these,0,0
221893,media,0,1
221894,for,0,0
221895,MR,0,1
221896,image,0,1
221897,enhancement,0,0
221898,.,0,0
221899,Torasemide,1,1
221900,versus,0,0
221901,furosemide,1,1
221902,in,0,0
221903,cirrhosis,0,0
221904,:,0,0
221905,a,0,0
221906,long-term,0,0
221907,",",0,0
221908,double-blind,0,0
221909,",",0,0
221910,randomized,0,0
221911,clinical,0,0
221912,study,0,0
221913,.,0,0
221914,The,0,0
221915,effects,0,0
221916,of,0,0
221917,long-term,0,0
221918,therapy,0,1
221919,(,0,0
221920,70,0,0
221921,days,0,0
221922,),0,0
221923,with,0,0
221924,torasemide,1,1
221925,(,0,0
221926,20,0,1
221927,mg/day,0,0
221928,),0,0
221929,",",0,0
221930,a,0,0
221931,new,0,0
221932,loop,0,0
221933,diuretic,0,1
221934,",",0,0
221935,were,0,0
221936,compared,0,0
221937,with,0,0
221938,those,0,0
221939,of,0,0
221940,furosemide,1,1
221941,(,0,0
221942,50,0,0
221943,mg/day,0,0
221944,),0,0
221945,in,0,0
221946,a,0,0
221947,randomized,0,0
221948,double-blind,0,0
221949,trial,0,0
221950,.,0,0
221951,Both,0,0
221952,drugs,0,0
221953,were,0,0
221954,administered,0,0
221955,in,0,0
221956,association,0,0
221957,with,0,0
221958,spironolactone,1,1
221959,(,0,0
221960,200,0,1
221961,mg/day,0,0
221962,),0,0
221963,in,0,0
221964,28,0,0
221965,nonazotemic,0,0
221966,cirrhotic,0,0
221967,patients,0,0
221968,with,0,0
221969,controlled,0,0
221970,ascites,0,0
221971,.,0,0
221972,The,0,0
221973,treatments,0,0
221974,did,0,0
221975,not,0,0
221976,modify,0,0
221977,creatinine,0,0
221978,clearance,0,0
221979,and,0,0
221980,exhibited,0,0
221981,a,0,0
221982,similar,0,0
221983,effect,0,0
221984,on,0,0
221985,body,0,0
221986,weight,0,0
221987,",",0,0
221988,urinary,0,0
221989,volume,0,0
221990,",",0,0
221991,and,0,0
221992,fractional,0,0
221993,excretion,0,0
221994,of,0,0
221995,uric,0,0
221996,acid,0,1
221997,",",0,0
221998,sodium,0,1
221999,",",0,0
222000,and,0,0
222001,chloride,0,1
222002,.,0,0
222003,The,0,0
222004,effect,0,0
222005,of,0,0
222006,torasemide,1,1
222007,on,0,0
222008,fractional,0,0
222009,potassium,0,1
222010,excretion,0,0
222011,was,0,0
222012,lower,0,0
222013,than,0,0
222014,that,0,0
222015,of,0,0
222016,furosemide,1,1
222017,.,1,0
222018,Torasemide,1,1
222019,showed,0,0
222020,higher,0,0
222021,sparing,0,0
222022,effect,0,0
222023,than,0,0
222024,furosemide,1,1
222025,on,0,0
222026,calcium,0,1
222027,",",0,0
222028,inorganic,0,1
222029,phosphate,0,1
222030,",",0,0
222031,and,0,0
222032,magnesium,0,1
222033,excretion,0,0
222034,and,0,0
222035,stronger,0,0
222036,action,0,0
222037,on,0,0
222038,free,0,0
222039,water,0,1
222040,clearance,0,0
222041,.,0,0
222042,No,0,0
222043,changes,0,0
222044,in,0,0
222045,serum,0,0
222046,parameters,0,0
222047,were,0,0
222048,induced,0,0
222049,by,0,0
222050,either,0,0
222051,treatment,0,0
222052,.,0,0
222053,Two,0,0
222054,episodes,0,0
222055,of,0,0
222056,hepatic,0,0
222057,encephalopathy,0,0
222058,occurred,0,0
222059,in,0,0
222060,the,0,0
222061,torasemide,1,1
222062,group,0,0
222063,.,0,0
222064,In,0,0
222065,view,0,0
222066,of,0,0
222067,its,0,0
222068,effects,0,0
222069,on,0,0
222070,sodium,0,1
222071,and,0,0
222072,water,0,1
222073,excretion,0,0
222074,and,0,0
222075,on,0,0
222076,other,0,0
222077,urinary,0,0
222078,parameters,0,0
222079,",",0,0
222080,torasemide,1,1
222081,can,0,0
222082,represent,0,0
222083,an,0,0
222084,alternative,0,0
222085,tool,0,0
222086,for,0,0
222087,the,0,0
222088,long-term,0,0
222089,treatment,0,0
222090,of,0,0
222091,ascites,0,0
222092,.,0,0
222093,Video,0,1
222094,rating,0,0
222095,analysis,0,0
222096,of,0,0
222097,effect,0,0
222098,of,0,0
222099,maprotiline,0,1
222100,in,0,0
222101,patients,0,0
222102,with,0,0
222103,dementia,0,0
222104,and,0,0
222105,depression,0,0
222106,.,0,0
222107,In,0,0
222108,patients,0,0
222109,with,0,0
222110,dementia,0,0
222111,and,0,0
222112,mild,0,0
222113,depression,0,0
222114,(,0,0
222115,DSM-III-R,0,0
222116,290.21,0,0
222117,),0,0
222118,",",0,0
222119,the,0,0
222120,effect,0,0
222121,of,0,0
222122,low,0,0
222123,doses,0,0
222124,of,0,0
222125,the,0,0
222126,antidepressant,0,1
222127,maprotiline,1,1
222128,(,0,0
222129,up,0,0
222130,to,0,0
222131,75,0,0
222132,mg/d,0,0
222133,),0,0
222134,was,0,0
222135,examined,0,0
222136,.,0,0
222137,The,0,0
222138,main,0,0
222139,parameter,0,0
222140,was,0,0
222141,a,0,0
222142,video,0,1
222143,rating,0,0
222144,of,0,0
222145,global,0,0
222146,impression,0,1
222147,.,0,0
222148,The,0,0
222149,Mini-Mental,1,0
222150,State,1,1
222151,Examination,1,1
222152,(,1,0
222153,MMS,1,1
222154,),1,0
222155,and,0,0
222156,the,0,0
222157,Geriatric,1,0
222158,Depression,1,0
222159,Scale,1,1
222160,(,1,0
222161,GDS,1,1
222162,),1,0
222163,were,0,0
222164,applied,0,0
222165,to,0,0
222166,evaluate,0,0
222167,the,0,0
222168,effect,0,0
222169,of,0,0
222170,maprotiline,0,1
222171,on,0,0
222172,cognitive,0,0
222173,and,0,0
222174,depressive,0,0
222175,symptoms,0,0
222176,.,0,0
222177,The,0,0
222178,double-blind,0,0
222179,",",0,0
222180,placebo-controlled,1,1
222181,trial,0,0
222182,was,0,0
222183,of,0,0
222184,eight,0,0
222185,weeks,0,0
222186,',0,0
222187,duration,0,0
222188,and,0,0
222189,included,0,0
222190,127,0,0
222191,patients,0,0
222192,",",0,0
222193,randomized,0,0
222194,in,0,0
222195,two,0,0
222196,groups,0,0
222197,.,0,0
222198,The,0,0
222199,antidepressant,0,1
222200,effect,0,0
222201,of,0,0
222202,maprotiline,1,1
222203,was,0,0
222204,reflected,0,0
222205,in,0,0
222206,the,0,0
222207,GDS,0,0
222208,.,0,0
222209,There,0,0
222210,was,0,0
222211,",",0,0
222212,however,0,0
222213,",",0,0
222214,no,0,0
222215,indication,0,0
222216,of,0,0
222217,an,0,0
222218,effect,0,0
222219,of,0,0
222220,maprotiline,0,1
222221,on,0,0
222222,cognitive,0,0
222223,performance,0,0
222224,.,0,0
222225,The,0,0
222226,global,0,0
222227,impression,0,0
222228,",",0,0
222229,evaluated,0,0
222230,by,0,0
222231,video,0,1
222232,rating,0,0
222233,",",0,0
222234,gave,0,0
222235,no,0,0
222236,indication,0,0
222237,as,0,0
222238,to,0,0
222239,a,0,0
222240,beneficial,0,0
222241,effect,0,0
222242,of,0,0
222243,the,0,0
222244,treatment,0,0
222245,.,0,0
222246,-,0,0
222247,The,0,0
222248,video,0,1
222249,analysis,0,0
222250,showed,0,0
222251,a,0,0
222252,significant,0,0
222253,interrater,0,0
222254,reliability,0,0
222255,.,0,0
222256,The,0,0
222257,discrepancy,0,0
222258,between,0,0
222259,the,0,0
222260,results,0,0
222261,of,0,0
222262,the,0,0
222263,video,0,1
222264,rating,0,0
222265,and,0,0
222266,the,0,0
222267,GDS,0,1
222268,is,0,0
222269,discussed,0,0
222270,.,0,0
222271,-,0,0
222272,The,0,0
222273,results,0,0
222274,confirm,0,0
222275,similar,0,0
222276,findings,0,0
222277,of,0,0
222278,other,0,0
222279,authors,0,0
222280,;,0,0
222281,i.e.,0,0
222282,",",0,0
222283,that,0,0
222284,a,0,0
222285,sedating,0,0
222286,antidepressant,0,1
222287,with,0,0
222288,some,0,0
222289,anticholinergic,0,1
222290,effects,0,0
222291,can,0,0
222292,not,0,0
222293,be,0,0
222294,expected,0,0
222295,to,0,0
222296,improve,0,0
222297,cognitive,0,0
222298,functions,0,0
222299,despite,0,0
222300,its,0,0
222301,antidepressant,0,1
222302,effect,0,0
222303,.,0,0
222304,The,0,0
222305,main,0,0
222306,interest,0,0
222307,of,0,0
222308,this,0,0
222309,study,0,0
222310,",",0,0
222311,however,0,0
222312,",",0,0
222313,lies,0,0
222314,in,0,0
222315,its,0,0
222316,methodology,0,0
222317,(,0,0
222318,video,0,1
222319,analysis,0,0
222320,),0,0
222321,.,0,0
222322,Subcutaneous,0,1
222323,low-molecular-weight,1,1
222324,heparin,1,1
222325,compared,0,0
222326,with,0,0
222327,continuous,0,1
222328,intravenous,0,1
222329,unfractionated,1,1
222330,heparin,1,1
222331,in,0,0
222332,the,0,0
222333,treatment,0,0
222334,of,0,0
222335,proximal,0,0
222336,deep,0,1
222337,vein,0,0
222338,thrombosis,0,0
222339,.,0,0
222340,BACKGROUND,0,0
222341,A,0,0
222342,low-molecular-weight,1,1
222343,heparin,1,1
222344,",",1,0
222345,enoxaparin,1,1
222346,sodium,1,1
222347,",",0,0
222348,has,0,0
222349,been,0,0
222350,shown,0,0
222351,to,0,0
222352,be,0,0
222353,effective,0,0
222354,and,0,0
222355,safe,0,0
222356,in,0,0
222357,preventing,0,0
222358,deep,0,1
222359,vein,0,0
222360,thrombosis,0,0
222361,both,0,0
222362,in,0,0
222363,general,0,0
222364,surgery,0,0
222365,and,0,0
222366,in,0,0
222367,high-risk,0,0
222368,orthopedic,0,0
222369,surgery,0,0
222370,.,0,0
222371,We,0,0
222372,conducted,0,0
222373,a,0,0
222374,controlled,0,0
222375,",",0,0
222376,randomized,0,0
222377,trial,0,0
222378,with,0,0
222379,enoxaparin,0,1
222380,in,0,0
222381,the,0,0
222382,treatment,0,0
222383,of,0,0
222384,established,0,0
222385,deep,0,1
222386,vein,0,0
222387,thrombosis,0,0
222388,.,0,0
222389,METHODS,0,0
222390,In,0,0
222391,a,0,0
222392,multicenter,0,0
222393,trial,0,0
222394,",",0,0
222395,we,0,0
222396,compared,0,0
222397,fixed-dose,0,1
222398,subcutaneous,0,0
222399,enoxaparin,1,1
222400,",",0,0
222401,given,0,0
222402,twice,0,0
222403,daily,0,0
222404,",",0,0
222405,with,0,0
222406,adjusted-dose,0,1
222407,intravenous,0,1
222408,unfractionated,1,1
222409,heparin,1,1
222410,(,1,0
222411,UFH,1,1
222412,),1,0
222413,given,0,0
222414,by,0,0
222415,continuous,0,1
222416,intravenous,0,1
222417,infusion,0,1
222418,for,0,0
222419,the,0,0
222420,initial,0,0
222421,10,0,0
222422,days,0,0
222423,of,0,0
222424,treatment,0,0
222425,of,0,0
222426,patients,0,0
222427,with,0,0
222428,proximal,0,0
222429,vein,0,0
222430,thrombosis,0,0
222431,.,0,0
222432,The,0,0
222433,primary,0,0
222434,efficacy,0,0
222435,outcome,0,0
222436,was,0,0
222437,the,0,0
222438,change,0,0
222439,of,0,0
222440,the,0,0
222441,size,0,0
222442,of,0,0
222443,the,0,0
222444,thrombus,0,0
222445,assessed,0,0
222446,by,0,0
222447,repeated,0,0
222448,venograms,0,0
222449,between,0,0
222450,day,0,0
222451,0,0,0
222452,and,0,0
222453,day,0,0
222454,10,0,0
222455,.,0,0
222456,The,0,0
222457,primary,0,0
222458,analysis,0,0
222459,of,0,0
222460,safety,0,0
222461,was,0,0
222462,based,0,0
222463,on,0,0
222464,the,0,0
222465,incidence,0,0
222466,of,0,0
222467,major,0,0
222468,bleeding,0,0
222469,during,0,0
222470,10,0,0
222471,days,0,0
222472,of,0,0
222473,treatment,0,0
222474,.,0,0
222475,RESULTS,0,0
222476,There,0,0
222477,were,0,0
222478,67,0,0
222479,patients,0,0
222480,in,0,0
222481,each,0,0
222482,group,0,0
222483,.,0,0
222484,Venographic,0,0
222485,assessment,0,0
222486,of,0,0
222487,clot,0,0
222488,size,0,0
222489,evolution,0,0
222490,between,0,0
222491,day,0,0
222492,0,0,0
222493,and,0,0
222494,day,0,0
222495,10,0,0
222496,showed,0,0
222497,a,0,0
222498,statistically,0,0
222499,significant,0,0
222500,superiority,0,0
222501,(,0,0
222502,P,0,0
222503,<,0,0
222504,.002,0,0
222505,),0,0
222506,of,0,0
222507,enoxaparin,1,1
222508,over,0,0
222509,the,0,0
222510,reference,0,0
222511,treatment,0,0
222512,with,0,0
222513,UFH,1,1
222514,.,1,0
222515,Moreover,0,0
222516,",",0,0
222517,the,0,0
222518,incidence,0,0
222519,of,0,0
222520,overall,0,0
222521,recurrent,0,0
222522,thromboembolic,0,0
222523,events,0,0
222524,during,0,0
222525,10,0,0
222526,days,0,0
222527,of,0,0
222528,treatment,0,0
222529,was,0,0
222530,significantly,0,0
222531,higher,0,0
222532,(,0,0
222533,P,0,0
222534,<,0,0
222535,.002,0,0
222536,),0,0
222537,in,0,0
222538,the,0,0
222539,UFH,1,1
222540,group,0,0
222541,(,0,0
222542,seven,0,0
222543,of,0,0
222544,67,0,0
222545,),0,0
222546,than,0,0
222547,in,0,0
222548,the,0,0
222549,enoxaparin,1,1
222550,group,0,0
222551,(,0,0
222552,one,0,0
222553,of,0,0
222554,67,0,0
222555,),0,0
222556,.,0,0
222557,There,0,0
222558,were,0,0
222559,no,0,0
222560,serious,0,0
222561,bleeding,0,0
222562,complications,0,0
222563,in,0,0
222564,either,0,0
222565,group,0,0
222566,.,0,0
222567,CONCLUSIONS,0,0
222568,Enoxaparin,1,1
222569,is,0,0
222570,at,0,0
222571,least,0,0
222572,as,0,0
222573,effective,0,0
222574,and,0,0
222575,safe,0,0
222576,as,0,0
222577,UFH,1,1
222578,under,0,0
222579,the,0,0
222580,conditions,0,0
222581,of,0,0
222582,this,0,0
222583,study,0,0
222584,.,0,0
222585,Moreover,0,0
222586,",",0,0
222587,it,0,0
222588,is,0,0
222589,more,0,0
222590,comfortable,0,0
222591,for,0,0
222592,patients,0,0
222593,and,0,0
222594,less,0,0
222595,time-consuming,0,0
222596,for,0,0
222597,nurses,0,0
222598,and,0,0
222599,laboratories,0,0
222600,.,0,0
222601,Thus,0,0
222602,",",0,0
222603,our,0,0
222604,study,0,0
222605,confirmed,0,0
222606,",",0,0
222607,with,0,0
222608,the,0,0
222609,use,0,0
222610,of,0,0
222611,enoxaparin,1,1
222612,",",0,0
222613,other,0,0
222614,observations,0,0
222615,that,0,0
222616,low-molecular-weight,1,1
222617,heparin,1,1
222618,provides,0,0
222619,a,0,0
222620,real,0,0
222621,therapeutic,0,0
222622,advance,0,0
222623,in,0,0
222624,the,0,0
222625,treatment,0,0
222626,of,0,0
222627,deep,0,1
222628,vein,0,0
222629,thrombosis,0,0
222630,.,0,0
222631,Effect,0,0
222632,of,0,0
222633,extradural,1,0
222634,analgesia,1,0
222635,on,0,0
222636,stress,0,0
222637,responses,0,0
222638,to,0,0
222639,abdominal,0,0
222640,surgery,0,0
222641,in,0,0
222642,infants,0,0
222643,.,0,0
222644,We,0,0
222645,studied,0,0
222646,40,0,0
222647,children,0,0
222648,younger,0,0
222649,than,0,0
222650,4,0,0
222651,yr,0,0
222652,having,0,0
222653,elective,0,0
222654,abdominal,0,0
222655,surgery,0,0
222656,under,0,0
222657,general,1,0
222658,anaesthesia,1,1
222659,supplemented,0,1
222660,with,0,0
222661,either,0,0
222662,systemic,1,0
222663,opioids,1,1
222664,or,1,0
222665,extradural,1,0
222666,bupivacaine,1,1
222667,.,1,0
222668,Venous,1,0
222669,blood,1,0
222670,samples,1,0
222671,were,0,0
222672,obtained,0,0
222673,before,0,0
222674,tracheal,0,0
222675,intubation,0,0
222676,to,0,0
222677,measure,0,0
222678,baseline,0,0
222679,concentrations,0,0
222680,of,0,0
222681,adrenaline,0,0
222682,",",0,0
222683,noradrenaline,0,0
222684,",",0,0
222685,glucose,0,0
222686,",",0,0
222687,ACTH,0,0
222688,and,0,0
222689,cortisol,0,0
222690,.,0,0
222691,Additional,0,0
222692,samples,0,0
222693,were,0,0
222694,obtained,0,0
222695,45,0,0
222696,min,0,0
222697,after,0,0
222698,the,0,0
222699,start,0,0
222700,of,0,0
222701,surgery,0,0
222702,",",0,0
222703,at,0,0
222704,the,0,0
222705,end,0,0
222706,of,0,0
222707,surgery,0,0
222708,",",0,0
222709,1,0,0
222710,h,0,0
222711,and,0,0
222712,24,0,0
222713,h,0,0
222714,after,0,0
222715,the,0,0
222716,end,0,0
222717,of,0,0
222718,surgery,0,0
222719,.,0,0
222720,Plasma,0,0
222721,concentrations,0,0
222722,of,0,0
222723,bupivacaine,1,1
222724,were,0,0
222725,measured,0,0
222726,also,0,0
222727,in,0,0
222728,the,0,0
222729,extradural,0,0
222730,group,0,0
222731,at,0,0
222732,each,0,0
222733,sampling,0,0
222734,time,0,0
222735,.,0,0
222736,Both,0,0
222737,techniques,0,0
222738,provided,0,0
222739,acceptable,0,0
222740,analgesia,0,0
222741,",",0,0
222742,but,0,0
222743,the,0,0
222744,perioperative,0,0
222745,increases,0,0
222746,in,0,0
222747,adrenaline,0,0
222748,",",0,0
222749,glucose,0,0
222750,and,0,0
222751,ACTH,0,0
222752,were,0,0
222753,significantly,0,0
222754,greater,0,0
222755,in,0,0
222756,the,0,0
222757,opioid,0,1
222758,group,0,0
222759,.,0,0
222760,Noradrenaline,0,1
222761,concentrations,0,0
222762,decreased,0,0
222763,to,0,0
222764,less,0,0
222765,than,0,0
222766,baseline,0,0
222767,values,0,0
222768,in,0,0
222769,the,0,0
222770,extradural,0,0
222771,group,0,0
222772,and,0,0
222773,were,0,0
222774,significantly,0,0
222775,less,0,0
222776,than,0,0
222777,in,0,0
222778,the,0,0
222779,opioid,0,1
222780,group,0,0
222781,.,0,0
222782,The,0,0
222783,perioperative,0,0
222784,increase,0,0
222785,in,0,0
222786,cortisol,0,0
222787,was,0,0
222788,similar,0,0
222789,in,0,0
222790,the,0,0
222791,two,0,0
222792,groups,0,0
222793,",",0,0
222794,despite,0,0
222795,the,0,0
222796,differences,0,0
222797,in,0,0
222798,ACTH,0,0
222799,responses,0,0
222800,.,0,0
222801,Most,0,0
222802,responses,0,0
222803,returned,0,0
222804,to,0,0
222805,the,0,0
222806,baseline,0,0
222807,values,0,0
222808,within,0,0
222809,24,0,0
222810,h.,0,0
222811,Plasma,0,0
222812,bupivacaine,1,1
222813,concentrations,0,0
222814,remained,0,0
222815,within,0,0
222816,safe,0,0
222817,limits,0,0
222818,during,0,0
222819,the,0,0
222820,study,0,0
222821,",",0,0
222822,but,0,0
222823,systemic,0,0
222824,concentrations,0,0
222825,increased,0,0
222826,in,0,0
222827,some,0,0
222828,of,0,0
222829,the,0,0
222830,patients,0,0
222831,during,0,0
222832,postoperative,0,0
222833,infusion,0,1
222834,with,0,0
222835,0.125,0,1
222836,%,0,0
222837,bupivacaine,0,1
222838,.,0,0
222839,Timing,0,0
222840,of,0,0
222841,antibiotic,1,1
222842,administration,1,0
222843,in,0,0
222844,knee,0,0
222845,replacement,0,1
222846,under,0,0
222847,tourniquet,0,1
222848,.,0,0
222849,Cephamandole,1,1
222850,levels,0,0
222851,in,0,0
222852,serum,0,0
222853,and,0,0
222854,drain,0,1
222855,fluid,0,0
222856,were,0,0
222857,measured,0,0
222858,in,0,0
222859,32,0,0
222860,knee,0,0
222861,replacement,0,0
222862,operations,0,0
222863,to,0,0
222864,determine,0,0
222865,the,0,0
222866,benefit,0,0
222867,of,0,0
222868,an,0,0
222869,intravenous,0,1
222870,dose,0,0
222871,of,0,0
222872,antibiotic,0,1
222873,at,0,0
222874,the,0,0
222875,time,0,0
222876,of,0,0
222877,tourniquet,0,1
222878,deflation,0,0
222879,.,0,0
222880,Concentrations,0,0
222881,of,0,0
222882,cephamandole,1,1
222883,in,0,0
222884,drain,0,0
222885,fluid,0,0
222886,were,0,0
222887,directly,0,0
222888,proportional,0,0
222889,to,0,0
222890,the,0,0
222891,serum,0,0
222892,concentration,0,0
222893,at,0,0
222894,the,0,0
222895,time,0,0
222896,of,0,0
222897,tourniquet,0,1
222898,release,0,0
222899,.,0,0
222900,A,0,0
222901,'tourniquet-release,1,1
222902,',1,0
222903,dose,1,0
222904,of,1,0
222905,antibiotic,1,1
222906,increased,0,0
222907,drain,0,1
222908,fluid,0,0
222909,concentration,0,0
222910,threefold,0,0
222911,.,0,0
222912,Treatment,0,0
222913,of,0,0
222914,vasculogenic,0,0
222915,sexual,0,0
222916,dysfunction,0,0
222917,with,0,0
222918,pentoxifylline,1,1
222919,.,1,0
222920,OBJECTIVE,0,0
222921,To,0,0
222922,evaluate,0,0
222923,the,0,0
222924,use,0,0
222925,of,0,0
222926,pentoxifylline,1,1
222927,to,0,0
222928,treat,0,0
222929,impotence,0,0
222930,in,0,0
222931,men,0,0
222932,with,0,0
222933,mild,0,0
222934,to,0,0
222935,moderate,0,0
222936,penile,0,0
222937,vascular,0,0
222938,insufficiency,0,0
222939,.,0,0
222940,DESIGN,0,0
222941,Double-blind,0,0
222942,randomized,0,0
222943,clinical,0,0
222944,trial,0,0
222945,.,0,0
222946,SETTING,0,0
222947,Sexual,0,0
222948,Dysfunction,0,0
222949,Clinic,0,1
222950,at,0,0
222951,VA,0,1
222952,Medical,0,1
222953,Center,0,0
222954,",",0,0
222955,Sepulveda,0,0
222956,",",0,0
222957,CA,0,0
222958,.,0,0
222959,PARTICIPANTS,0,0
222960,Convenience,0,0
222961,sample,0,0
222962,of,0,0
222963,couples,0,0
222964,.,0,0
222965,INTERVENTION,0,0
222966,Twelve,0,0
222967,weeks,0,0
222968,of,0,0
222969,treatment,0,0
222970,with,0,0
222971,placebo,1,1
222972,or,1,0
222973,400,1,0
222974,mg,1,1
222975,tid,1,0
222976,of,1,0
222977,pentoxifylline,1,1
222978,.,1,0
222979,MEASUREMENTS,0,0
222980,(,0,0
222981,1,0,0
222982,),0,0
222983,Report,0,0
222984,of,0,0
222985,patient,0,0
222986,verified,0,0
222987,by,0,0
222988,partner,0,0
222989,as,0,0
222990,to,0,0
222991,number,0,0
222992,of,0,0
222993,coital,0,0
222994,episodes,0,0
222995,per,0,0
222996,month,0,0
222997,;,0,0
222998,(,0,0
222999,2,0,0
223000,),0,0
223001,penile-brachial,0,0
223002,pressure,0,0
223003,index,0,0
223004,determinations,0,0
223005,.,0,0
223006,RESULTS,0,0
223007,Pentoxifylline,1,1
223008,therapy,1,1
223009,regularly,0,0
223010,increased,0,0
223011,the,0,0
223012,PBPI,0,0
223013,in,0,0
223014,impotent,0,0
223015,men,0,0
223016,in,0,0
223017,comparison,0,0
223018,with,0,0
223019,the,0,0
223020,placebo,0,1
223021,",",0,0
223022,frequently,0,0
223023,into,0,0
223024,the,0,0
223025,normal,0,0
223026,range,0,0
223027,.,0,0
223028,Pentoxifylline,0,1
223029,therapy,0,1
223030,was,0,0
223031,particularly,0,0
223032,useful,0,0
223033,in,0,0
223034,restoring,0,0
223035,the,0,0
223036,PBPI,0,0
223037,in,0,0
223038,men,0,0
223039,with,0,0
223040,the,0,0
223041,pelvic,0,0
223042,steal,0,0
223043,syndrome,0,0
223044,;,0,0
223045,six,0,0
223046,of,0,0
223047,seven,0,0
223048,such,0,0
223049,subjects,0,0
223050,improved,0,0
223051,into,0,0
223052,the,0,0
223053,normal,0,0
223054,range,0,0
223055,.,0,0
223056,During,0,0
223057,the,0,0
223058,pentoxifylline,0,1
223059,treatment,0,0
223060,period,0,0
223061,",",0,0
223062,in,0,0
223063,contrast,0,0
223064,with,0,0
223065,the,0,0
223066,control,0,0
223067,period,0,0
223068,",",0,0
223069,nine,0,0
223070,men,0,0
223071,were,0,0
223072,able,0,0
223073,to,0,0
223074,reestablish,0,0
223075,coital,0,0
223076,function,0,0
223077,and,0,0
223078,three,0,0
223079,had,0,0
223080,no,0,0
223081,improvement,0,0
223082,.,0,0
223083,Six,0,0
223084,couples,0,0
223085,did,0,0
223086,not,0,0
223087,attempt,0,0
223088,intercourse,0,0
223089,despite,0,0
223090,a,0,0
223091,professed,0,0
223092,interest,0,0
223093,in,0,0
223094,sexual,0,0
223095,activity,0,0
223096,;,0,0
223097,however,0,0
223098,five,0,0
223099,out,0,0
223100,of,0,0
223101,the,0,0
223102,six,0,0
223103,men,0,0
223104,experienced,0,0
223105,erections,0,0
223106,during,0,0
223107,episodes,0,0
223108,of,0,0
223109,fantasy,0,0
223110,or,0,0
223111,attempts,0,0
223112,at,0,0
223113,masturbation,0,1
223114,during,0,0
223115,treatment,0,0
223116,.,0,0
223117,There,0,0
223118,were,0,0
223119,no,0,0
223120,complications,0,0
223121,of,0,0
223122,therapy,0,1
223123,.,0,0
223124,CONCLUSIONS,0,0
223125,These,0,0
223126,promising,0,0
223127,preliminary,0,0
223128,results,0,0
223129,suggest,0,0
223130,a,0,0
223131,well,0,0
223132,tolerated,0,0
223133,alternative,0,0
223134,therapy,0,1
223135,for,0,0
223136,erectile,0,0
223137,dysfunction,0,0
223138,in,0,0
223139,patients,0,0
223140,with,0,0
223141,mild,0,0
223142,to,0,0
223143,moderate,0,0
223144,penile,0,0
223145,vascular,0,0
223146,disease,0,0
223147,.,0,0
223148,Recombinant,1,1
223149,human,1,1
223150,erythropoietin,1,1
223151,therapy,1,1
223152,for,0,0
223153,anemic,0,0
223154,cancer,0,0
223155,patients,0,0
223156,on,0,0
223157,combination,0,1
223158,chemotherapy,0,1
223159,.,0,0
223160,BACKGROUND,0,0
223161,Patients,0,0
223162,with,0,0
223163,advanced,0,0
223164,cancer,0,0
223165,frequently,0,0
223166,experience,0,0
223167,clinically,0,0
223168,significant,0,0
223169,anemia,0,0
223170,",",0,0
223171,which,0,0
223172,is,0,0
223173,often,0,0
223174,exacerbated,0,0
223175,by,0,0
223176,myelosuppressive,0,0
223177,chemotherapy,0,1
223178,.,0,0
223179,Consistent,0,0
223180,with,0,0
223181,the,0,0
223182,anemia,0,0
223183,of,0,0
223184,chronic,0,0
223185,disease,0,0
223186,",",0,0
223187,studies,0,0
223188,have,0,0
223189,documented,0,0
223190,serum,0,0
223191,erythropoietin,0,1
223192,levels,0,0
223193,that,0,0
223194,are,0,0
223195,inappropriately,0,0
223196,low,0,0
223197,for,0,0
223198,the,0,0
223199,degree,0,0
223200,of,0,0
223201,anemia,0,0
223202,in,0,0
223203,cancer,0,0
223204,patients,0,0
223205,.,0,0
223206,Myelosuppressive,0,0
223207,chemotherapy,0,1
223208,impairs,0,0
223209,erythropoiesis,0,0
223210,",",0,0
223211,which,0,0
223212,may,0,0
223213,not,0,0
223214,fully,0,0
223215,recover,0,0
223216,between,0,0
223217,treatment,0,0
223218,cycles,0,0
223219,.,0,0
223220,Recombinant,1,0
223221,human,1,0
223222,erythropoietin,1,1
223223,(,1,0
223224,rHuEPO,1,0
223225,),1,1
223226,has,0,0
223227,been,0,0
223228,used,0,0
223229,safely,0,0
223230,and,0,0
223231,effectively,0,0
223232,to,0,0
223233,treat,0,0
223234,anemia,0,0
223235,in,0,0
223236,AIDS,0,0
223237,patients,0,0
223238,receiving,0,0
223239,zidovudine,0,1
223240,(,0,1
223241,AZT,0,0
223242,),0,0
223243,and,0,0
223244,in,0,0
223245,patients,0,0
223246,with,0,0
223247,chronic,0,0
223248,renal,0,0
223249,failure,0,0
223250,.,0,0
223251,PURPOSE,0,0
223252,This,0,0
223253,study,0,0
223254,was,0,0
223255,designed,0,0
223256,to,0,0
223257,evaluate,0,0
223258,the,0,0
223259,clinical,0,0
223260,role,0,0
223261,of,0,0
223262,rHuEPO,0,0
223263,in,0,0
223264,reducing,0,0
223265,symptomatic,0,0
223266,anemia,0,0
223267,in,0,0
223268,patients,0,0
223269,with,0,0
223270,advanced,0,0
223271,cancer,0,0
223272,who,0,0
223273,were,0,0
223274,receiving,0,0
223275,myelosuppressive,0,1
223276,chemotherapy,0,1
223277,(,0,0
223278,excluding,0,0
223279,cisplatin,0,1
223280,),0,0
223281,.,0,0
223282,METHODS,0,0
223283,We,0,0
223284,studied,0,0
223285,153,0,0
223286,anemic,0,0
223287,cancer,0,0
223288,patients,0,0
223289,receiving,0,0
223290,cyclic,1,1
223291,combination,1,1
223292,chemotherapy,1,1
223293,in,0,0
223294,a,0,0
223295,prospective,0,0
223296,multicenter,0,0
223297,",",0,0
223298,double-blind,0,0
223299,",",0,0
223300,placebo-controlled,0,1
223301,trial,0,0
223302,.,0,0
223303,The,0,0
223304,patients,0,0
223305,were,0,0
223306,randomly,0,0
223307,assigned,0,0
223308,to,0,0
223309,receive,0,0
223310,either,0,1
223311,rHuEPO,1,0
223312,(,0,0
223313,150,0,0
223314,U/kg,0,1
223315,),0,0
223316,or,0,1
223317,placebo,1,1
223318,subcutaneously,0,0
223319,three,0,0
223320,times,0,0
223321,a,0,0
223322,week,0,0
223323,for,0,0
223324,a,0,0
223325,maximum,0,0
223326,of,0,0
223327,12,0,0
223328,weeks,0,0
223329,or,0,0
223330,until,0,0
223331,the,0,0
223332,hematocrit,0,0
223333,level,0,0
223334,increased,0,0
223335,to,0,0
223336,38,0,0
223337,%,0,0
223338,-40,0,0
223339,%,0,0
223340,.,0,0
223341,If,0,0
223342,the,0,0
223343,hematocrit,0,0
223344,reached,0,0
223345,this,0,0
223346,target,0,0
223347,level,0,0
223348,before,0,0
223349,12,0,0
223350,weeks,0,0
223351,",",0,0
223352,the,0,0
223353,rHuEPO,1,0
223354,dose,0,0
223355,could,0,0
223356,be,0,0
223357,reduced,0,0
223358,to,0,0
223359,maintain,0,0
223360,the,0,0
223361,hematocrit,0,0
223362,at,0,0
223363,that,0,0
223364,level,0,0
223365,for,0,0
223366,the,0,0
223367,duration,0,0
223368,of,0,0
223369,the,0,0
223370,study,0,0
223371,.,0,0
223372,Response,0,0
223373,to,0,0
223374,rHuEPO,1,0
223375,therapy,0,1
223376,was,0,0
223377,assessed,0,0
223378,by,0,0
223379,measuring,0,0
223380,changes,0,0
223381,in,0,0
223382,hematocrit,0,0
223383,level,0,0
223384,",",0,0
223385,transfusion,0,0
223386,requirements,0,0
223387,",",0,0
223388,and,0,0
223389,quality,0,0
223390,of,0,0
223391,life,0,0
223392,.,0,0
223393,Quality-of-life,0,0
223394,assessment,0,0
223395,was,0,0
223396,based,0,0
223397,on,0,0
223398,patients,0,0
223399,',0,0
223400,responses,0,0
223401,to,0,0
223402,questionnaires,0,1
223403,before,0,0
223404,and,0,0
223405,after,0,0
223406,the,0,0
223407,courses,0,0
223408,of,0,0
223409,therapy,0,1
223410,.,0,0
223411,RESULTS,0,0
223412,The,0,0
223413,increase,0,0
223414,in,0,0
223415,hematocrit,0,0
223416,in,0,0
223417,the,0,0
223418,rHuEPO-treated,1,0
223419,group,0,0
223420,compared,0,0
223421,with,0,0
223422,hematocrit,0,0
223423,in,0,0
223424,the,0,0
223425,placebo-treated,1,0
223426,group,0,0
223427,was,0,0
223428,statistically,0,0
223429,significant,0,0
223430,(,0,0
223431,P,0,0
223432,=,0,0
223433,.0001,0,0
223434,),0,0
223435,as,0,0
223436,measured,0,0
223437,by,0,0
223438,percentage,0,0
223439,point,0,0
223440,of,0,0
223441,change,0,0
223442,from,0,0
223443,baseline,0,0
223444,to,0,0
223445,final,0,0
223446,evaluation,0,0
223447,",",0,0
223448,by,0,0
223449,an,0,0
223450,increase,0,0
223451,in,0,0
223452,hematocrit,0,0
223453,level,0,0
223454,of,0,0
223455,six,0,0
223456,percentage,0,0
223457,points,0,0
223458,or,0,0
223459,more,0,0
223460,unrelated,0,0
223461,to,0,0
223462,transfusion,0,0
223463,",",0,0
223464,and,0,0
223465,by,0,0
223466,a,0,0
223467,rise,0,0
223468,in,0,0
223469,hematocrit,0,0
223470,level,0,0
223471,to,0,0
223472,38,0,0
223473,%,0,0
223474,or,0,0
223475,more,0,0
223476,unrelated,0,0
223477,to,0,0
223478,transfusion,0,0
223479,.,0,0
223480,There,0,0
223481,was,0,0
223482,a,0,0
223483,trend,0,0
223484,toward,0,0
223485,the,0,0
223486,reduction,0,0
223487,in,0,0
223488,mean,0,0
223489,units,0,1
223490,of,0,0
223491,blood,0,0
223492,transfused,0,0
223493,per,0,0
223494,patient,0,0
223495,during,0,0
223496,months,0,0
223497,2,0,0
223498,and,0,0
223499,3,0,0
223500,of,0,0
223501,therapy,0,1
223502,combined,0,0
223503,in,0,0
223504,rHuEPO-treated,1,0
223505,patients,0,0
223506,compared,0,0
223507,with,0,0
223508,placebo-treated,0,0
223509,patients,0,0
223510,(,0,0
223511,0.91,0,0
223512,U,0,1
223513,versus,0,0
223514,1.65,0,0
223515,U,0,1
223516,;,0,0
223517,P,0,0
223518,=,0,0
223519,.056,0,0
223520,),0,0
223521,.,0,0
223522,In,0,0
223523,addition,0,0
223524,",",0,0
223525,rHuEPO-treated,1,0
223526,patients,0,0
223527,experienced,0,0
223528,a,0,0
223529,statistically,0,0
223530,significant,0,0
223531,improvement,0,0
223532,in,0,0
223533,energy,0,0
223534,level,0,0
223535,and,0,0
223536,ability,0,0
223537,to,0,0
223538,perform,0,0
223539,daily,0,1
223540,activities,0,0
223541,(,0,0
223542,P,0,0
223543,<,0,0
223544,or,0,1
223545,=,0,0
223546,.05,0,0
223547,),0,0
223548,.,0,0
223549,The,0,0
223550,two,0,0
223551,treatment,0,0
223552,groups,0,0
223553,showed,0,0
223554,no,0,0
223555,statistically,0,0
223556,significant,0,0
223557,differences,0,0
223558,in,0,0
223559,toxic,0,0
223560,effects,0,0
223561,except,0,0
223562,for,0,0
223563,increased,0,0
223564,incidence,0,0
223565,of,0,0
223566,diaphoresis,0,0
223567,(,0,0
223568,P,0,0
223569,<,0,0
223570,.05,0,0
223571,),0,0
223572,and,0,0
223573,diarrhea,0,0
223574,(,0,0
223575,P,0,0
223576,=,0,0
223577,.05,0,0
223578,),0,0
223579,in,0,0
223580,the,0,0
223581,rHuEPO-treated,0,0
223582,group,0,0
223583,.,0,0
223584,CONCLUSIONS,0,0
223585,We,0,0
223586,conclude,0,0
223587,that,0,0
223588,rHuEPO,1,0
223589,is,0,0
223590,safe,0,0
223591,and,0,0
223592,effective,0,0
223593,for,0,0
223594,reversing,0,0
223595,anemia,0,0
223596,related,0,0
223597,to,0,0
223598,advanced,0,0
223599,cancer,0,0
223600,or,0,0
223601,to,0,0
223602,chemotherapy,0,1
223603,for,0,0
223604,cancer,0,0
223605,.,0,0
223606,Double-blind,0,0
223607,randomized,0,0
223608,evaluation,0,0
223609,of,0,0
223610,intercostal,1,0
223611,nerve,1,0
223612,blocks,1,0
223613,as,0,0
223614,an,0,0
223615,adjuvant,0,1
223616,to,0,0
223617,subarachnoid,0,0
223618,administered,0,0
223619,morphine,1,1
223620,for,0,0
223621,post-thoracotomy,0,1
223622,analgesia,0,0
223623,.,0,0
223624,BACKGROUND,0,0
223625,AND,0,0
223626,OBJECTIVES,0,1
223627,Thoracotomy,0,1
223628,is,0,0
223629,associated,0,0
223630,with,0,0
223631,pain,0,0
223632,and,0,0
223633,compromised,0,0
223634,pulmonary,0,0
223635,function,0,0
223636,.,0,0
223637,Intercostal,1,0
223638,nerve,1,0
223639,blocks,1,1
223640,(,1,0
223641,INB,1,0
223642,),1,1
223643,and,0,0
223644,subarachnoid,1,0
223645,morphine,1,1
223646,(,1,0
223647,SM,1,0
223648,),1,0
223649,act,0,0
223650,on,0,0
223651,different,0,0
223652,portions,0,0
223653,of,0,0
223654,the,0,0
223655,pain,0,0
223656,pathway,0,0
223657,.,0,0
223658,Each,0,0
223659,is,0,0
223660,effective,0,0
223661,for,0,0
223662,post-thoracotomy,0,1
223663,pain,0,0
223664,relief,0,0
223665,.,0,0
223666,The,0,0
223667,combination,0,0
223668,of,0,0
223669,these,0,0
223670,two,0,0
223671,modalities,0,0
223672,in,0,0
223673,relieving,0,0
223674,post-thoracotomy,0,1
223675,pain,0,0
223676,and,0,0
223677,improving,0,0
223678,postoperative,0,0
223679,pulmonary,0,0
223680,function,0,0
223681,has,0,0
223682,not,0,0
223683,been,0,0
223684,investigated,0,0
223685,.,0,0
223686,METHODS,0,0
223687,In,0,0
223688,a,0,0
223689,double-blind,0,0
223690,study,0,0
223691,",",0,0
223692,20,0,0
223693,patients,0,0
223694,undergoing,0,0
223695,lateral,0,0
223696,thoracotomy,1,0
223697,for,0,0
223698,lung,0,0
223699,resection,0,1
223700,were,0,0
223701,randomized,0,0
223702,to,0,0
223703,receive,0,0
223704,0.5,1,0
223705,mg,1,0
223706,SM,1,0
223707,preoperatively,1,0
223708,and,1,0
223709,INB,1,0
223710,with,1,0
223711,bupivacaine,1,1
223712,(,1,0
223713,INB+,1,0
223714,),1,0
223715,prior,1,0
223716,to,1,0
223717,wound,1,0
223718,closure,1,0
223719,or,1,0
223720,0.5,1,0
223721,mg,1,1
223722,SM,1,0
223723,with,1,0
223724,INB,1,0
223725,using,1,0
223726,saline,1,1
223727,(,1,1
223728,INB-,1,1
223729,),1,0
223730,.,1,0
223731,Visual,0,0
223732,analog,0,0
223733,scale,0,0
223734,pain,0,0
223735,scores,0,0
223736,at,0,0
223737,rest,0,0
223738,",",0,0
223739,with,0,0
223740,cough,0,0
223741,",",0,0
223742,and,0,0
223743,with,0,0
223744,movement,0,0
223745,of,0,0
223746,the,0,0
223747,ipsilateral,0,0
223748,arm,0,0
223749,",",0,0
223750,forced,0,0
223751,expiratory,0,0
223752,volume,0,0
223753,in,0,0
223754,1,0,0
223755,second,0,0
223756,(,0,0
223757,FEV1,0,0
223758,),0,0
223759,",",0,0
223760,and,0,0
223761,forced,0,0
223762,vital,0,0
223763,capacity,0,0
223764,(,0,0
223765,FVC,0,0
223766,),0,0
223767,were,0,0
223768,measured,0,0
223769,at,0,0
223770,4,0,0
223771,",",0,0
223772,24,0,0
223773,",",0,0
223774,48,0,0
223775,",",0,0
223776,and,0,0
223777,72,0,0
223778,hours,0,0
223779,after,0,0
223780,the,0,0
223781,operation,0,0
223782,.,0,0
223783,Opioid,0,0
223784,use,0,0
223785,was,0,0
223786,measured,0,0
223787,during,0,0
223788,the,0,0
223789,initial,0,0
223790,24,0,0
223791,hours,0,0
223792,after,0,0
223793,the,0,0
223794,operation,0,0
223795,.,0,0
223796,RESULTS,0,0
223797,At,0,0
223798,4,0,0
223799,hours,0,0
223800,",",0,0
223801,the,0,0
223802,INB+,1,0
223803,group,0,0
223804,demonstrated,0,0
223805,better,0,0
223806,FEV1,0,0
223807,(,0,0
223808,56.6,0,0
223809,%,0,0
223810,vs.,0,0
223811,40.4,0,0
223812,%,0,0
223813,of,0,0
223814,baseline,0,0
223815,",",0,0
223816,P,0,0
223817,<,0,0
223818,.05,0,0
223819,),0,0
223820,and,0,0
223821,FVC,0,1
223822,values,0,0
223823,(,0,0
223824,54.6,0,0
223825,%,0,0
223826,vs.,0,0
223827,39.6,0,0
223828,%,0,0
223829,of,0,0
223830,baseline,0,0
223831,",",0,0
223832,P,0,0
223833,<,0,0
223834,.05,0,0
223835,),0,0
223836,and,0,0
223837,less,0,0
223838,resting,0,0
223839,and,0,0
223840,cough,0,0
223841,pain,0,0
223842,(,0,0
223843,P,0,0
223844,<,0,0
223845,.05,0,0
223846,),0,0
223847,.,0,0
223848,However,0,0
223849,",",0,0
223850,FEV1,0,0
223851,continued,0,0
223852,to,0,0
223853,decline,0,0
223854,in,0,0
223855,the,0,0
223856,INB+,1,0
223857,group,0,0
223858,at,0,0
223859,24,0,0
223860,hours,0,0
223861,to,0,0
223862,lower,0,0
223863,than,0,0
223864,the,0,0
223865,INB-,1,1
223866,group,0,0
223867,although,0,0
223868,pain,0,0
223869,scores,0,0
223870,were,0,0
223871,similar,0,0
223872,beyond,0,0
223873,4,0,0
223874,hours,0,0
223875,.,0,0
223876,Opioid,0,0
223877,usage,0,0
223878,during,0,0
223879,the,0,0
223880,first,0,0
223881,24,0,0
223882,hours,0,0
223883,was,0,0
223884,similar,0,0
223885,(,1,0
223886,INB-,1,1
223887,",",0,0
223888,16.7,0,0
223889,mg,0,0
223890,vs.,0,0
223891,INB+,1,0
223892,",",0,0
223893,13.2,0,0
223894,mg,0,0
223895,",",0,0
223896,P,0,0
223897,=,0,0
223898,.7,0,0
223899,),0,0
223900,.,0,0
223901,CONCLUSIONS,0,0
223902,Although,0,0
223903,postoperative,0,0
223904,INB,1,0
223905,provided,0,0
223906,modest,0,0
223907,improvements,0,0
223908,in,0,0
223909,pain,0,0
223910,and,0,0
223911,pulmonary,0,0
223912,function,0,0
223913,when,0,0
223914,used,0,0
223915,as,0,0
223916,an,0,0
223917,adjuvant,0,1
223918,to,0,0
223919,0.5,0,0
223920,mg,0,1
223921,SM,1,0
223922,for,0,0
223923,post-thoracotomy,0,1
223924,analgesia,0,0
223925,",",0,0
223926,the,0,0
223927,benefits,0,0
223928,were,0,0
223929,transient,0,0
223930,.,0,0
223931,The,0,0
223932,authors,0,0
223933,do,0,0
223934,not,0,0
223935,recommend,0,0
223936,adding,0,0
223937,INB,1,0
223938,for,0,0
223939,patients,0,0
223940,undergoing,0,0
223941,lateral,0,0
223942,thoracotomy,0,0
223943,who,0,0
223944,receive,0,0
223945,0.5,0,0
223946,mg,0,0
223947,SM,1,0
223948,.,1,0
223949,0.1,0,0
223950,%,0,0
223951,bupivacaine,1,1
223952,does,0,0
223953,not,0,0
223954,reduce,0,0
223955,the,0,0
223956,requirement,0,0
223957,for,0,0
223958,epidural,0,1
223959,fentanyl,0,1
223960,infusion,0,1
223961,after,0,0
223962,major,0,0
223963,abdominal,0,0
223964,surgery,0,0
223965,.,0,0
223966,BACKGROUND,0,0
223967,AND,0,0
223968,OBJECTIVES,0,0
223969,Although,0,0
223970,local,0,0
223971,anesthesia,0,1
223972,has,0,0
223973,been,0,0
223974,demonstrated,0,0
223975,to,0,0
223976,potentiate,0,0
223977,spinal,0,0
223978,morphine,0,1
223979,analgesia,0,0
223980,in,0,0
223981,animal,0,0
223982,studies,0,0
223983,",",0,0
223984,results,0,0
223985,comparing,0,0
223986,epidural,0,1
223987,local,0,0
223988,anesthesia/opioid,0,1
223989,mixtures,0,1
223990,with,0,0
223991,opioid,0,1
223992,alone,0,0
223993,are,0,0
223994,contradictory,0,0
223995,in,0,0
223996,clinical,0,0
223997,studies,0,0
223998,.,0,0
223999,The,0,0
224000,hypothesis,0,0
224001,was,0,0
224002,that,0,0
224003,",",0,0
224004,although,0,0
224005,the,0,0
224006,concentration,0,0
224007,of,0,0
224008,bupivacaine,1,1
224009,(,0,0
224010,0.1,0,1
224011,%,0,0
224012,),0,0
224013,was,0,0
224014,low,0,0
224015,to,0,0
224016,minimize,0,0
224017,its,0,0
224018,adverse,0,0
224019,effects,0,0
224020,",",0,0
224021,if,0,0
224022,the,0,0
224023,infusion,0,1
224024,rate,0,0
224025,of,0,0
224026,a,0,0
224027,fentanyl/bupivacaine,1,1
224028,solution,0,1
224029,was,0,0
224030,closely,0,0
224031,adjusted,0,0
224032,according,0,0
224033,to,0,0
224034,need,0,0
224035,",",0,0
224036,the,0,0
224037,presence,0,0
224038,bupivacaine,0,1
224039,would,0,0
224040,reduce,0,0
224041,the,0,0
224042,requirement,0,0
224043,for,0,0
224044,epidural,0,1
224045,fentanyl,0,1
224046,.,0,0
224047,METHODS,0,0
224048,Forty,0,0
224049,patients,0,0
224050,were,0,0
224051,randomly,0,0
224052,assigned,1,0
224053,to,1,0
224054,receive,1,0
224055,either,1,1
224056,fentanyl,1,1
224057,(,1,0
224058,10,1,0
224059,micrograms/mL,1,1
224060,),1,0
224061,or,1,1
224062,a,1,0
224063,fentanyl/bupivacaine,1,1
224064,(,1,0
224065,0.1,1,1
224066,%,1,0
224067,),1,0
224068,mixture,1,1
224069,epidurally,1,1
224070,corresponding,1,0
224071,to,1,0
224072,the,1,0
224073,dermatome,1,0
224074,of,1,0
224075,the,1,0
224076,surgical,1,0
224077,incision,1,1
224078,in,1,0
224079,a,1,0
224080,double-blind,1,0
224081,fashion,1,0
224082,for,1,0
224083,the,1,0
224084,first,1,0
224085,18,1,0
224086,hours,1,0
224087,after,1,0
224088,major,1,0
224089,abdominal,1,0
224090,surgery,1,0
224091,.,1,0
224092,The,1,0
224093,infusion,1,0
224094,was,1,0
224095,titrated,1,0
224096,for,1,0
224097,each,1,0
224098,patient,1,0
224099,to,1,0
224100,the,1,0
224101,rate,1,0
224102,required,1,0
224103,for,1,0
224104,pain,1,0
224105,relief,1,0
224106,during,1,0
224107,forced,1,0
224108,inspiration,1,0
224109,(,1,0
224110,pain,1,0
224111,score,1,0
224112,<,1,0
224113,or,1,0
224114,=,1,0
224115,2,1,0
224116,",",1,0
224117,maximum,1,0
224118,10,1,0
224119,),1,0
224120,.,1,0
224121,Pain,0,0
224122,scores,0,0
224123,",",0,0
224124,the,0,0
224125,fentanyl,0,1
224126,doses,0,0
224127,required,0,0
224128,",",0,0
224129,plasma,0,0
224130,concentrations,0,0
224131,of,0,0
224132,fentanyl,0,1
224133,at,0,0
224134,18,0,0
224135,hours,0,0
224136,",",0,0
224137,and,0,0
224138,the,0,0
224139,incidence,0,0
224140,and,0,0
224141,severity,0,0
224142,of,0,0
224143,adverse,0,0
224144,effects,0,0
224145,were,0,0
224146,recorded,0,0
224147,.,0,0
224148,RESULTS,0,0
224149,Patients,0,0
224150,reported,0,0
224151,similar,0,0
224152,median,0,0
224153,pain,0,0
224154,scores,0,0
224155,and,0,0
224156,were,0,0
224157,equally,0,0
224158,satisfied,0,0
224159,with,0,0
224160,pain,0,0
224161,relief,0,0
224162,in,0,0
224163,both,0,0
224164,groups,0,0
224165,.,0,0
224166,The,0,0
224167,mean,0,0
224168,required,0,0
224169,post-operative,0,0
224170,fentanyl,0,1
224171,infusion,0,1
224172,rate,0,0
224173,(,0,0
224174,57.7,0,0
224175,+/-,0,0
224176,19.5,0,0
224177,micrograms/h,0,0
224178,),0,0
224179,and,0,0
224180,the,0,0
224181,plasma,0,0
224182,concentrations,0,0
224183,(,0,0
224184,0.84,0,0
224185,+/-,0,0
224186,0.36,0,0
224187,ng/mL,0,0
224188,),0,0
224189,in,0,0
224190,the,0,0
224191,fentanyl,0,1
224192,group,0,0
224193,were,0,0
224194,comparable,0,0
224195,to,0,0
224196,the,0,0
224197,infusion,0,1
224198,rate,0,0
224199,(,0,0
224200,54.4,0,0
224201,+/-,0,0
224202,19.2,0,0
224203,micrograms/h,0,0
224204,),0,0
224205,and,0,0
224206,the,0,0
224207,plasma,0,0
224208,concentrations,0,0
224209,(,0,0
224210,0.86,0,0
224211,+/-,0,0
224212,0.36,0,0
224213,ng/mL,0,0
224214,),0,0
224215,in,0,0
224216,the,0,0
224217,fentanyl/bupivacaine,0,1
224218,group,0,0
224219,.,0,0
224220,Respiratory,0,0
224221,and,0,0
224222,cardiovascular,0,0
224223,functions,0,0
224224,were,0,0
224225,preserved,0,0
224226,",",0,0
224227,and,0,0
224228,the,0,0
224229,incidence,0,0
224230,of,0,0
224231,nausea,0,0
224232,",",0,0
224233,pruritus,0,0
224234,",",0,0
224235,and,0,0
224236,periods,0,0
224237,of,0,0
224238,drowsiness,0,0
224239,or,0,1
224240,sleep,0,0
224241,were,0,0
224242,similar,0,0
224243,in,0,0
224244,both,0,0
224245,groups,0,0
224246,.,0,0
224247,CONCLUSIONS,0,0
224248,In,0,0
224249,low,0,0
224250,concentrations,0,0
224251,(,0,0
224252,0.1,0,0
224253,%,0,0
224254,),0,0
224255,",",0,0
224256,bupivacaine,1,1
224257,did,0,0
224258,not,0,0
224259,reduce,0,0
224260,the,0,0
224261,titrated,0,0
224262,dose,0,0
224263,of,0,0
224264,epidural,0,1
224265,fentanyl,0,1
224266,required,0,0
224267,for,0,0
224268,adequate,0,0
224269,pain,0,0
224270,relief,0,0
224271,during,0,0
224272,forced,0,0
224273,inspiration,0,0
224274,after,0,0
224275,major,0,0
224276,abdominal,0,0
224277,surgery,0,0
224278,.,0,0
224279,The,0,0
224280,incidence,0,0
224281,and,0,0
224282,severity,0,0
224283,of,0,0
224284,adverse,0,0
224285,effects,0,0
224286,were,0,0
224287,also,0,0
224288,comparable,0,0
224289,whether,0,0
224290,or,0,0
224291,not,0,0
224292,low-dose,0,1
224293,bupivacaine,1,1
224294,infusion,0,1
224295,was,0,0
224296,used,0,0
224297,.,0,0
224298,Laparoscopic,0,1
224299,hysterectomy,0,1
224300,:,0,0
224301,is,0,0
224302,dissecting,1,0
224303,the,1,0
224304,ureter,1,0
224305,necessary,0,0
224306,?,0,0
224307,Laparoscopic,1,1
224308,hysterectomy,1,1
224309,has,0,0
224310,been,0,0
224311,first,0,0
224312,reported,0,0
224313,by,0,0
224314,Reich,0,0
224315,et,0,0
224316,al,0,0
224317,.,0,0
224318,in,0,0
224319,1989,0,0
224320,",",0,0
224321,which,0,0
224322,confirmed,0,0
224323,the,0,0
224324,possibility,0,0
224325,of,0,0
224326,laparoscopic,0,1
224327,hysterectomy,0,1
224328,being,0,0
224329,employed,0,0
224330,as,0,0
224331,a,0,0
224332,replacement,0,0
224333,of,0,0
224334,the,0,0
224335,vast,0,0
224336,majority,0,0
224337,of,0,0
224338,traditional,0,1
224339,abdominal,0,0
224340,hysterectomies,0,0
224341,.,0,0
224342,There,0,0
224343,are,0,0
224344,three,0,0
224345,critical,0,0
224346,points,0,0
224347,in,0,0
224348,laparoscopic,0,1
224349,hysterectomy,0,1
224350,.,0,0
224351,The,0,0
224352,most,0,0
224353,important,0,0
224354,critical,0,0
224355,point,0,0
224356,is,0,0
224357,to,0,0
224358,identify,0,0
224359,uterine,0,0
224360,arteries,0,0
224361,from,0,0
224362,the,0,0
224363,ureter,0,0
224364,in,0,0
224365,the,0,0
224366,paracervical,0,1
224367,area,0,0
224368,.,0,0
224369,Several,0,0
224370,ureteral,0,0
224371,injuries,0,0
224372,at,0,0
224373,operative,0,0
224374,laparoscopy,0,1
224375,have,0,0
224376,been,0,0
224377,reported,0,0
224378,.,0,0
224379,We,0,0
224380,performed,0,0
224381,two,0,0
224382,hundred,0,0
224383,and,0,0
224384,thirty,0,0
224385,laparoscopic,1,1
224386,hysterectomies,1,0
224387,during,0,0
224388,the,0,0
224389,period,0,0
224390,from,0,0
224391,March,0,0
224392,1991,0,0
224393,to,0,0
224394,October,0,0
224395,1993,0,0
224396,.,0,0
224397,Sixty,0,0
224398,patients,0,0
224399,were,0,0
224400,later,0,0
224401,included,0,0
224402,in,0,0
224403,this,0,0
224404,study,0,0
224405,.,0,0
224406,Thirty,0,0
224407,of,0,0
224408,these,0,0
224409,applied,0,0
224410,the,0,0
224411,technique,0,1
224412,of,0,0
224413,dissecting,1,0
224414,the,1,0
224415,ureter,1,0
224416,at,0,0
224417,the,0,0
224418,initiation,0,0
224419,of,0,0
224420,laparoscopic,0,1
224421,hysterectomy,0,1
224422,.,0,0
224423,Most,0,0
224424,of,0,0
224425,the,0,0
224426,patients,0,0
224427,were,0,0
224428,discharged,0,0
224429,on,0,0
224430,the,0,0
224431,second,0,0
224432,postoperative,0,0
224433,day,0,0
224434,.,0,0
224435,Although,0,0
224436,dissecting,1,0
224437,the,1,0
224438,ureter,1,0
224439,at,0,0
224440,the,0,0
224441,beginning,0,0
224442,of,0,0
224443,the,0,0
224444,operation,0,0
224445,did,0,0
224446,not,0,0
224447,produce,0,0
224448,a,0,0
224449,significant,0,0
224450,discrepancy,0,0
224451,in,0,0
224452,operation,0,0
224453,time,0,0
224454,",",0,0
224455,blood,0,0
224456,loss,0,0
224457,",",0,0
224458,hospitalization,0,0
224459,day,0,0
224460,and,0,0
224461,ureter,0,0
224462,injury,0,0
224463,when,0,0
224464,compared,0,0
224465,with,0,0
224466,the,0,0
224467,control,0,0
224468,group,0,0
224469,",",0,0
224470,the,0,0
224471,uterine,0,0
224472,arteries,0,0
224473,",",0,0
224474,however,0,0
224475,",",0,0
224476,may,0,0
224477,be,0,0
224478,confidently,0,0
224479,desiccated,0,0
224480,once,0,0
224481,the,0,0
224482,path,0,0
224483,of,0,0
224484,the,0,0
224485,ureter,0,0
224486,near,0,0
224487,the,0,0
224488,uterosacral,0,0
224489,ligament,0,0
224490,is,0,0
224491,identified,0,0
224492,.,0,0
224493,No,0,0
224494,effect,0,0
224495,of,0,0
224496,beta-carotene,1,1
224497,supplementation,1,1
224498,on,0,0
224499,the,0,0
224500,susceptibility,0,0
224501,of,0,0
224502,low,0,0
224503,density,0,0
224504,lipoprotein,0,0
224505,to,0,0
224506,in,0,0
224507,vitro,0,0
224508,oxidation,0,0
224509,among,0,0
224510,hypercholesterolaemic,0,0
224511,",",0,0
224512,postmenopausal,0,0
224513,women,0,0
224514,.,0,0
224515,The,0,0
224516,effect,0,0
224517,of,0,0
224518,beta-carotene,1,1
224519,on,0,0
224520,the,0,0
224521,susceptibility,0,0
224522,of,0,0
224523,low,0,0
224524,density,0,0
224525,lipoprotein,0,0
224526,(,0,0
224527,LDL,0,0
224528,),0,0
224529,to,0,0
224530,oxidative,0,0
224531,modification,0,0
224532,was,0,0
224533,investigated,0,0
224534,in,0,0
224535,a,0,0
224536,double-blind,0,0
224537,",",0,0
224538,randomized,0,0
224539,placebo-controlled,0,1
224540,study,0,0
224541,.,0,0
224542,Hypercholesterolaemic,0,0
224543,",",0,0
224544,postmenopausal,0,0
224545,women,0,0
224546,were,0,0
224547,given,0,0
224548,30,1,0
224549,mg,1,0
224550,beta-carotene,1,1
224551,per,1,0
224552,day,1,1
224553,(,0,0
224554,n,0,0
224555,=,0,0
224556,15,0,0
224557,subjects,0,0
224558,),0,0
224559,or,0,0
224560,placebo,1,1
224561,capsules,1,1
224562,(,0,0
224563,n,0,0
224564,=,0,0
224565,15,0,0
224566,subjects,0,0
224567,),0,0
224568,for,0,0
224569,10,0,0
224570,weeks,0,0
224571,.,0,0
224572,They,0,0
224573,were,0,0
224574,instructed,0,0
224575,to,0,0
224576,follow,0,0
224577,the,0,0
224578,American,0,0
224579,Heart,0,0
224580,Association,0,0
224581,Step,0,1
224582,One,0,0
224583,diet,0,1
224584,.,0,0
224585,LDL,0,0
224586,",",0,0
224587,isolated,0,0
224588,before,0,0
224589,and,0,0
224590,after,0,0
224591,treatment,0,0
224592,was,0,0
224593,subjected,0,0
224594,to,0,0
224595,copper-catalysed,0,0
224596,lipid,0,0
224597,peroxidation,0,0
224598,.,0,0
224599,There,0,0
224600,were,0,0
224601,no,0,0
224602,significant,0,0
224603,differences,0,0
224604,between,0,0
224605,LDL,0,0
224606,from,0,0
224607,the,0,0
224608,beta-carotene,1,1
224609,and,0,0
224610,placebo,1,1
224611,groups,0,0
224612,",",0,0
224613,as,0,0
224614,assessed,0,0
224615,by,0,0
224616,measuring,0,0
224617,the,0,0
224618,lag,0,0
224619,time,0,0
224620,for,0,0
224621,formation,0,0
224622,of,0,0
224623,conjugated,0,1
224624,dienes,0,0
224625,;,0,0
224626,the,0,0
224627,rate,0,0
224628,of,0,0
224629,formation,0,0
224630,and,0,0
224631,the,0,0
224632,amount,0,0
224633,of,0,0
224634,conjugated,0,1
224635,dienes,0,0
224636,formed,0,0
224637,;,0,0
224638,the,0,0
224639,amount,0,0
224640,of,0,0
224641,lipid,0,0
224642,peroxides,0,0
224643,generated,0,0
224644,;,0,0
224645,and,0,0
224646,the,0,0
224647,relative,0,0
224648,electrophoretic,0,0
224649,mobility,0,0
224650,",",0,0
224651,at,0,0
224652,baseline,0,0
224653,and,0,0
224654,after,0,0
224655,treatment,0,0
224656,.,0,0
224657,Dietary,0,0
224658,records,0,0
224659,showed,0,0
224660,that,0,0
224661,the,0,0
224662,subjects,0,0
224663,were,0,0
224664,consuming,0,0
224665,similar,0,0
224666,amounts,0,0
224667,and,0,0
224668,types,0,0
224669,of,0,0
224670,fat,0,0
224671,.,0,0
224672,No,0,0
224673,significant,0,0
224674,differences,0,0
224675,were,0,0
224676,found,0,0
224677,in,0,0
224678,the,0,0
224679,lipid,0,0
224680,composition,0,0
224681,and,0,0
224682,fatty,0,1
224683,acid,0,1
224684,pattern,0,0
224685,of,0,0
224686,LDL,0,0
224687,from,0,0
224688,the,0,0
224689,two,0,0
224690,groups,0,0
224691,.,0,0
224692,In,0,0
224693,conclusion,0,0
224694,",",0,0
224695,the,0,0
224696,results,0,0
224697,indicated,0,0
224698,that,0,0
224699,supplementation,0,1
224700,with,0,0
224701,beta-carotene,1,1
224702,in,0,0
224703,non-smoking,0,0
224704,",",0,0
224705,hypercholesterolaemic,0,0
224706,",",0,0
224707,postmenopausal,0,0
224708,women,0,0
224709,had,0,0
224710,no,0,0
224711,protective,0,0
224712,effect,0,0
224713,on,0,0
224714,the,0,0
224715,susceptibility,0,0
224716,of,0,0
224717,LDL,0,0
224718,to,0,0
224719,copper-catalysed,0,0
224720,modification,0,0
224721,in,0,0
224722,vitro,0,0
224723,.,0,0
224724,[,0,0
224725,Evaluating,0,0
224726,an,0,0
224727,interactive,1,0
224728,",",1,0
224729,multi-media,1,1
224730,learning,1,0
224731,system,1,0
224732,for,0,0
224733,the,0,0
224734,study,0,0
224735,of,0,0
224736,primary,0,0
224737,open,0,1
224738,angle,0,0
224739,glaucoma,0,0
224740,],0,0
224741,.,0,0
224742,Using,0,0
224743,the,0,0
224744,interactive,1,1
224745,multimedia,1,1
224746,learning,1,0
224747,system,1,1
224748,for,0,0
224749,studying,0,0
224750,open-angle,0,0
224751,glaucoma,0,0
224752,[,0,0
224753,3,0,0
224754,],0,0
224755,a,0,0
224756,prospective,0,0
224757,",",0,0
224758,randomized,0,0
224759,",",0,0
224760,case-controlled,0,0
224761,study,0,0
224762,was,0,0
224763,carried,0,0
224764,out,0,0
224765,to,0,0
224766,determine,0,0
224767,the,0,0
224768,value,0,0
224769,of,0,0
224770,this,0,0
224771,new,0,0
224772,form,0,0
224773,of,0,0
224774,learning,0,0
224775,in,0,0
224776,terms,0,0
224777,of,0,0
224778,acceptance,0,0
224779,and,0,0
224780,the,0,0
224781,imparting,0,0
224782,of,0,0
224783,knowledge,0,0
224784,.,0,0
224785,This,0,0
224786,article,0,0
224787,describes,0,0
224788,details,0,0
224789,of,0,0
224790,the,0,0
224791,study,0,0
224792,and,0,0
224793,presents,0,0
224794,their,0,0
224795,results,0,0
224796,.,0,0
224797,Results,0,0
224798,were,0,0
224799,established,0,0
224800,on,0,0
224801,the,0,0
224802,basis,0,0
224803,of,0,0
224804,targeted,0,0
224805,questions,0,0
224806,asked,0,0
224807,prior,0,0
224808,to,0,0
224809,and,0,0
224810,after,0,0
224811,the,0,0
224812,learning,0,0
224813,phase,0,0
224814,",",0,0
224815,followed,0,0
224816,by,0,0
224817,an,0,0
224818,analysis,0,0
224819,of,0,0
224820,frequencies,0,0
224821,and,0,0
224822,significance,0,0
224823,testing,0,0
224824,by,0,0
224825,the,0,0
224826,Chi,0,0
224827,squared,0,0
224828,method,0,0
224829,.,0,0
224830,It,0,0
224831,was,0,0
224832,shown,0,0
224833,that,0,0
224834,the,0,0
224835,imparting,0,0
224836,of,0,0
224837,knowledge,0,0
224838,is,0,0
224839,significantly,0,0
224840,improved,0,0
224841,when,0,0
224842,this,0,0
224843,learning,1,0
224844,system,1,0
224845,is,0,0
224846,employed,0,0
224847,.,0,0
224848,In,0,0
224849,addition,0,0
224850,",",0,0
224851,after,0,0
224852,its,0,0
224853,first,0,0
224854,use,0,0
224855,",",0,0
224856,acceptance,0,0
224857,of,0,0
224858,this,0,0
224859,new,0,0
224860,medium,0,0
224861,rose,0,0
224862,dramatically,0,0
224863,.,0,0
224864,Chronopharmacology,0,0
224865,of,0,0
224866,enalapril,1,1
224867,in,0,0
224868,hypertensive,0,0
224869,patients,0,0
224870,.,0,0
224871,The,0,0
224872,pharmacokinetics,0,0
224873,and,0,0
224874,pharmacodynamics,0,0
224875,of,0,0
224876,enalapril,1,1
224877,",",0,0
224878,an,0,0
224879,angiotensin,0,1
224880,converting,0,0
224881,enzyme,0,0
224882,inhibitor,0,1
224883,",",0,0
224884,are,0,0
224885,reported,0,0
224886,to,0,0
224887,vary,0,0
224888,with,0,0
224889,the,0,0
224890,time,0,0
224891,of,0,0
224892,administration,0,0
224893,.,0,0
224894,The,0,0
224895,present,0,0
224896,study,0,0
224897,was,0,0
224898,undertaken,0,0
224899,to,0,0
224900,examine,0,0
224901,whether,0,0
224902,the,0,0
224903,effect,0,0
224904,of,0,0
224905,enalapril,1,1
224906,on,0,0
224907,plasma,0,0
224908,bradykinin,0,1
224909,(,0,0
224910,BK,0,0
224911,),0,0
224912,",",0,0
224913,substance,0,0
224914,P,0,0
224915,and,0,0
224916,prostaglandin,0,1
224917,E2,0,0
224918,(,0,0
224919,PGE2,0,0
224920,),0,0
224921,",",0,0
224922,which,0,0
224923,are,0,0
224924,likely,0,0
224925,to,0,0
224926,be,0,0
224927,involved,0,0
224928,in,0,0
224929,the,0,0
224930,mechanism,0,0
224931,of,0,0
224932,enalapril-induced,0,0
224933,cough,0,0
224934,",",0,0
224935,might,0,0
224936,also,0,0
224937,be,0,0
224938,affected,0,0
224939,by,0,0
224940,its,0,0
224941,time,0,0
224942,of,0,0
224943,administration,0,0
224944,.,0,0
224945,Enalapril,1,1
224946,5,0,0
224947,mg,0,1
224948,or,0,1
224949,placebo,1,1
224950,was,0,0
224951,given,0,0
224952,orally,0,0
224953,at,0,0
224954,10:00,0,0
224955,h,0,0
224956,(,0,0
224957,day,0,1
224958,trial,0,0
224959,),0,0
224960,or,0,1
224961,22:00,0,0
224962,h,0,1
224963,(,0,0
224964,night,0,0
224965,trial,0,0
224966,),0,0
224967,to,0,0
224968,12,0,0
224969,patients,0,0
224970,with,0,0
224971,essential,0,0
224972,hypertension,0,0
224973,.,0,0
224974,Serum,0,0
224975,concentrations,0,0
224976,of,0,0
224977,total,0,0
224978,drug,0,0
224979,(,1,0
224980,enalapril,1,1
224981,+,0,1
224982,enalaprilat,1,1
224983,",",0,0
224984,its,0,0
224985,active,0,0
224986,metabolite,0,0
224987,),0,0
224988,during,0,0
224989,the,0,0
224990,day,0,0
224991,and,0,0
224992,night,0,0
224993,trials,0,0
224994,did,0,0
224995,not,0,0
224996,differ,0,0
224997,significantly,0,0
224998,at,0,0
224999,any,0,0
225000,time,0,0
225001,.,0,0
225002,However,0,0
225003,",",0,0
225004,serum,1,0
225005,enalaprilat,1,1
225006,tended,0,0
225007,to,0,0
225008,be,0,0
225009,higher,0,0
225010,and,0,0
225011,its,0,0
225012,maximum,0,0
225013,concentration,0,0
225014,greater,0,0
225015,in,0,0
225016,the,0,0
225017,day,0,0
225018,trial,0,0
225019,than,0,0
225020,in,0,0
225021,the,0,0
225022,night,0,0
225023,trial,0,0
225024,.,0,0
225025,Blood,0,0
225026,pressure,0,0
225027,24,0,0
225028,h,0,0
225029,after,0,0
225030,administration,0,0
225031,of,0,0
225032,enalapril,1,1
225033,was,0,0
225034,reduced,0,0
225035,at,0,0
225036,22:00,0,0
225037,h,0,0
225038,",",0,0
225039,but,0,0
225040,not,0,0
225041,at,0,0
225042,10:00,0,0
225043,h.,0,0
225044,Plasma,0,0
225045,BK,0,0
225046,tended,0,0
225047,to,0,0
225048,increase,0,0
225049,following,0,0
225050,enalapril,1,1
225051,administration,0,0
225052,at,0,0
225053,10:00,0,0
225054,h,0,0
225055,",",0,0
225056,but,0,0
225057,not,0,0
225058,at,0,0
225059,22:00,0,0
225060,h.,0,0
225061,Remarkable,0,0
225062,increases,0,0
225063,in,0,0
225064,plasma,0,0
225065,BK,0,0
225066,were,0,0
225067,observed,0,0
225068,in,0,0
225069,two,0,0
225070,patients,0,0
225071,in,0,0
225072,the,0,0
225073,day,0,0
225074,trial,0,0
225075,and,0,0
225076,one,0,0
225077,of,0,0
225078,them,0,0
225079,also,0,0
225080,complained,0,0
225081,of,0,0
225082,cough,0,0
225083,.,0,0
225084,However,0,0
225085,",",0,0
225086,no,0,0
225087,such,0,0
225088,increase,0,0
225089,in,0,0
225090,plasma,0,0
225091,BK,0,0
225092,or,0,1
225093,subsequent,0,0
225094,adverse,0,0
225095,effect,0,0
225096,were,0,0
225097,recorded,0,0
225098,in,0,0
225099,the,0,0
225100,night,0,0
225101,trial,0,0
225102,.,0,0
225103,Plasma,0,0
225104,substance,0,0
225105,P,0,0
225106,and,0,0
225107,PGE2,0,0
225108,did,0,0
225109,not,0,0
225110,change,0,0
225111,significantly,0,0
225112,following,0,0
225113,enalapril,1,1
225114,administration,0,0
225115,either,0,0
225116,in,0,0
225117,the,0,0
225118,day,0,0
225119,or,0,1
225120,night,0,0
225121,trial,0,0
225122,.,0,0
225123,The,0,0
225124,results,0,0
225125,suggest,0,0
225126,that,0,0
225127,the,0,0
225128,response,0,0
225129,of,0,0
225130,BK,0,0
225131,to,0,0
225132,enalapril,1,1
225133,is,0,0
225134,affected,0,0
225135,by,0,0
225136,the,0,0
225137,time,0,0
225138,of,0,0
225139,administration,0,0
225140,.,0,0
225141,In,0,0
225142,patients,0,0
225143,who,0,0
225144,complain,0,0
225145,of,0,0
225146,cough,0,0
225147,during,0,0
225148,treatment,0,0
225149,with,0,0
225150,enalapril,1,1
225151,during,0,0
225152,the,0,0
225153,daytime,0,0
225154,",",0,0
225155,this,0,0
225156,adverse,0,0
225157,effect,0,0
225158,might,0,0
225159,be,0,0
225160,diminished,0,0
225161,or,0,0
225162,eliminated,0,0
225163,by,0,0
225164,a,0,0
225165,switch,0,0
225166,to,0,0
225167,night-time,0,0
225168,administration,0,0
225169,.,0,0
225170,Synthetic,1,0
225171,serum,1,0
225172,substitute,1,0
225173,(,1,0
225174,SSS,1,1
225175,),1,0
225176,:,1,0
225177,a,0,0
225178,globulin-enriched,0,1
225179,protein,0,0
225180,supplement,0,1
225181,for,0,0
225182,human,0,0
225183,embryo,0,0
225184,culture,0,0
225185,.,0,0
225186,OBJECTIVE,0,0
225187,The,0,0
225188,purpose,0,0
225189,of,0,0
225190,the,0,0
225191,present,0,0
225192,study,0,0
225193,was,0,0
225194,to,0,0
225195,evaluate,0,0
225196,whether,0,0
225197,an,0,0
225198,IVF,0,0
225199,protein,0,0
225200,supplement,0,1
225201,prepared,0,1
225202,from,0,0
225203,human,0,0
225204,serum,0,0
225205,albumin,0,1
225206,(,0,0
225207,HSA,0,1
225208,),0,1
225209,and,0,0
225210,human,0,0
225211,globulins,0,1
225212,would,0,0
225213,retain,0,0
225214,performance,0,0
225215,characteristics,0,0
225216,equivalent,0,0
225217,to,0,0
225218,those,0,0
225219,reported,0,0
225220,for,0,0
225221,the,0,0
225222,commercial,0,0
225223,plasma,0,0
225224,expanders,0,1
225225,",",0,0
225226,Plasmatein,1,0
225227,(,0,0
225228,Alpha,0,1
225229,Therapeutics,0,1
225230,",",0,0
225231,Los,0,0
225232,Angeles,0,0
225233,",",0,0
225234,California,0,0
225235,),0,0
225236,and,0,0
225237,Plasmanate,1,1
225238,(,0,0
225239,Cutter,0,1
225240,Biological,0,0
225241,",",0,0
225242,Miles,0,0
225243,Inc.,0,0
225244,",",0,0
225245,Elkhart,0,0
225246,",",0,0
225247,Indiana,0,0
225248,),0,0
225249,.,0,0
225250,METHODS,0,0
225251,Pronuclear-stage,0,0
225252,human,0,0
225253,embryos,0,0
225254,were,0,0
225255,randomly,0,0
225256,divided,1,0
225257,and,1,0
225258,cultured,1,0
225259,in,1,0
225260,human,1,0
225261,tubal,1,1
225262,fluid,1,1
225263,medium,1,1
225264,(,1,0
225265,HTF,1,1
225266,),1,0
225267,supplemented,1,1
225268,with,1,0
225269,either,1,0
225270,HSA,1,0
225271,(,1,0
225272,5,1,0
225273,mg/mL,1,1
225274,),1,0
225275,or,1,1
225276,Plasmatein,1,1
225277,(,1,0
225278,10,1,0
225279,%,1,0
225280,",",1,0
225281,v/v,1,1
225282,;,1,0
225283,5,1,0
225284,mg/ml,1,0
225285,),1,0
225286,as,1,0
225287,a,1,0
225288,means,1,0
225289,of,1,0
225290,indirectly,1,0
225291,assessing,1,0
225292,the,1,0
225293,effect,1,0
225294,alpha-,1,1
225295,and,1,0
225296,beta-globulins,1,1
225297,have,1,0
225298,on,1,0
225299,embryonic,1,0
225300,development,1,0
225301,.,1,0
225302,Those,0,0
225303,results,0,0
225304,coupled,0,0
225305,with,0,0
225306,the,0,0
225307,known,0,0
225308,composition,0,0
225309,characteristics,0,0
225310,of,0,0
225311,Plasmatein,1,0
225312,were,0,0
225313,used,0,0
225314,as,0,0
225315,the,0,0
225316,starting,0,0
225317,basis,0,0
225318,to,0,0
225319,formulate,0,0
225320,test,0,0
225321,lots,0,0
225322,of,0,0
225323,synthetic,0,0
225324,serum,0,0
225325,substitute,0,0
225326,(,0,0
225327,SSS,0,1
225328,),0,0
225329,.,0,0
225330,RESULTS,0,0
225331,Significantly,0,0
225332,(,0,0
225333,P,0,0
225334,<,0,0
225335,0.05,0,0
225336,),0,0
225337,more,0,0
225338,of,0,0
225339,the,0,0
225340,human,0,0
225341,embryos,0,0
225342,cultured,0,0
225343,in,0,0
225344,Plasmatein,1,0
225345,supplemented,0,1
225346,medium,0,0
225347,reached,0,0
225348,the,0,0
225349,four-cell,0,0
225350,or,0,0
225351,greater,0,0
225352,stage,0,0
225353,by,0,0
225354,40,0,0
225355,hr,0,0
225356,postinsemination,0,0
225357,than,0,0
225358,a,0,0
225359,comparable,0,0
225360,group,0,0
225361,cultured,0,0
225362,in,0,0
225363,HSA,1,0
225364,alone,0,0
225365,.,0,0
225366,Lot,0,0
225367,1,0,0
225368,of,0,0
225369,SSS,0,1
225370,",",0,0
225371,formulated,0,0
225372,with,0,0
225373,HSA,0,0
225374,(,0,0
225375,84,0,0
225376,%,0,0
225377,of,0,0
225378,total,0,0
225379,protein,0,1
225380,),0,0
225381,and,0,0
225382,human,0,1
225383,globulins,0,1
225384,(,0,0
225385,16,0,0
225386,%,0,0
225387,of,0,0
225388,total,0,0
225389,protein,0,1
225390,),0,0
225391,and,0,0
225392,an,0,0
225393,aqueous,0,1
225394,lipoprotein,0,0
225395,fraction,0,0
225396,derived,0,0
225397,from,0,0
225398,human,0,1
225399,plasma,0,0
225400,(,0,0
225401,Excyte,0,0
225402,IV,0,0
225403,;,0,0
225404,Miles,0,0
225405,Diagnostics,0,0
225406,",",0,0
225407,Kankakee,0,0
225408,",",0,0
225409,Illinois,0,0
225410,),0,0
225411,",",0,0
225412,produced,0,0
225413,accelerated,0,1
225414,early,0,0
225415,embryonic,0,0
225416,growth,0,0
225417,relative,0,0
225418,to,0,0
225419,control,0,0
225420,murine,0,0
225421,embryos,0,0
225422,grown,0,0
225423,in,0,0
225424,the,0,0
225425,presence,0,0
225426,of,0,0
225427,Plasmatein,0,0
225428,",",0,0
225429,however,0,0
225430,",",0,0
225431,the,0,0
225432,percentage,0,0
225433,of,0,0
225434,the,0,0
225435,embryos,0,0
225436,reaching,0,0
225437,the,0,0
225438,hatched,0,0
225439,blastocyst,0,0
225440,stage,0,0
225441,was,0,0
225442,decreased,0,0
225443,(,0,0
225444,45,0,0
225445,vs,0,0
225446,100,0,0
225447,%,0,0
225448,),0,0
225449,.,0,0
225450,Human,0,0
225451,embryos,0,0
225452,from,0,0
225453,seven,0,0
225454,patients,0,0
225455,",",0,0
225456,randomized,0,0
225457,to,0,0
225458,HTF,0,0
225459,medium,0,1
225460,supplemented,0,1
225461,with,0,0
225462,Plasmatein,1,0
225463,or,0,1
225464,lot,0,0
225465,1,0,0
225466,of,0,0
225467,SSS,1,1
225468,",",0,0
225469,showed,0,0
225470,equivalent,0,0
225471,growth,0,0
225472,at,0,0
225473,36-40,0,0
225474,hr,0,0
225475,postinsemination,0,0
225476,.,0,0
225477,A,0,0
225478,microprecipitate,0,0
225479,developed,0,0
225480,in,0,0
225481,media,0,1
225482,supplemented,0,1
225483,with,0,0
225484,lot,0,0
225485,1,0,0
225486,after,0,0
225487,several,0,0
225488,days,0,0
225489,of,0,0
225490,culture,0,0
225491,.,0,0
225492,The,0,0
225493,Excyte,0,0
225494,IV,0,0
225495,concentration,0,0
225496,was,0,0
225497,reduced,0,0
225498,and,0,0
225499,",",0,0
225500,ultimately,0,0
225501,",",0,0
225502,eliminated,0,0
225503,from,0,0
225504,the,0,0
225505,subsequent,0,0
225506,and,0,0
225507,final,0,0
225508,prototype,0,1
225509,lots,0,0
225510,of,0,0
225511,SSS,0,1
225512,.,0,0
225513,Murine,0,0
225514,embryos,0,0
225515,grown,0,0
225516,in,0,0
225517,the,0,0
225518,presence,0,0
225519,of,0,0
225520,lipoprotein,0,0
225521,free,0,0
225522,SSS,1,1
225523,showed,0,0
225524,significantly,0,0
225525,accelerated,0,1
225526,(,0,0
225527,P,0,0
225528,<,0,0
225529,0.01,0,0
225530,),0,0
225531,growth,0,0
225532,at,0,0
225533,17,0,0
225534,hr,0,0
225535,postthaw,0,0
225536,compared,0,0
225537,to,0,0
225538,Plasmatein,1,0
225539,and,0,0
225540,all,0,0
225541,embryos,0,0
225542,progressed,0,0
225543,to,0,0
225544,hatching,0,0
225545,by,0,0
225546,41,0,0
225547,hr,0,0
225548,.,0,0
225549,Human,0,0
225550,embryos,0,0
225551,",",0,0
225552,randomized,0,0
225553,to,0,0
225554,either,0,0
225555,Plasmatein,1,0
225556,or,0,1
225557,lot,0,0
225558,3,0,0
225559,of,0,0
225560,SSS,1,1
225561,",",0,0
225562,showed,0,0
225563,significantly,0,0
225564,accelerated,0,1
225565,growth,0,0
225566,(,0,0
225567,P,0,0
225568,<,0,0
225569,0.01,0,0
225570,),0,0
225571,when,0,0
225572,scored,0,0
225573,at,0,0
225574,38,0,0
225575,hr,0,0
225576,following,0,0
225577,insemination,0,1
225578,.,0,0
225579,CONCLUSION,0,0
225580,Synthetic,1,0
225581,serum,1,0
225582,substitute,1,0
225583,provides,0,0
225584,a,0,0
225585,convient,0,0
225586,",",0,0
225587,standardized,0,0
225588,means,0,0
225589,of,0,0
225590,adding,0,0
225591,protein,0,0
225592,to,0,0
225593,media,0,1
225594,used,0,0
225595,in,0,0
225596,assisted,0,0
225597,reproductive,0,0
225598,technology,0,1
225599,(,0,0
225600,ART,0,0
225601,),0,0
225602,procedures,0,0
225603,.,0,0
225604,Prevention,0,1
225605,of,0,0
225606,venous,0,0
225607,thromboembolism,0,0
225608,after,0,0
225609,knee,0,0
225610,arthroplasty,0,0
225611,.,0,0
225612,A,0,0
225613,randomized,0,0
225614,",",0,0
225615,double-blind,0,0
225616,trial,0,0
225617,comparing,0,0
225618,enoxaparin,1,1
225619,with,0,0
225620,warfarin,1,1
225621,.,1,0
225622,OBJECTIVE,0,0
225623,To,0,0
225624,compare,0,0
225625,the,0,0
225626,effectiveness,0,0
225627,and,0,0
225628,safety,0,0
225629,of,0,0
225630,fixed-dose,1,1
225631,enoxaparin,1,1
225632,and,0,0
225633,adjusted,1,0
225634,dose,1,0
225635,warfarin,1,1
225636,in,0,0
225637,preventing,0,0
225638,venous,0,0
225639,thromboembolism,0,0
225640,after,0,0
225641,knee,0,0
225642,arthroplasty,0,0
225643,.,0,0
225644,DESIGN,0,0
225645,A,0,0
225646,randomized,0,0
225647,",",0,0
225648,double-blind,0,0
225649,controlled,0,0
225650,trial,0,0
225651,.,0,0
225652,SETTING,0,0
225653,8,0,0
225654,university,0,0
225655,hospitals,0,0
225656,.,0,0
225657,PATIENTS,0,0
225658,670,0,0
225659,consecutive,0,0
225660,patients,0,0
225661,who,0,0
225662,had,0,0
225663,knee,0,0
225664,arthroplasty,0,0
225665,.,0,0
225666,INTERVENTION,0,0
225667,Patients,0,0
225668,were,0,0
225669,randomly,0,0
225670,assigned,0,0
225671,to,0,0
225672,receive,0,1
225673,enoxaparin,1,1
225674,(,1,0
225675,30,1,0
225676,mg,1,1
225677,subcutaneously,1,0
225678,every,1,0
225679,12,1,0
225680,hours,1,0
225681,),1,0
225682,or,1,0
225683,adjusted-dose,1,1
225684,warfarin,1,1
225685,(,1,0
225686,international,1,0
225687,normalized,1,0
225688,ratio,1,0
225689,",",1,0
225690,2.0,1,0
225691,to,1,0
225692,3.0,1,0
225693,),1,0
225694,.,0,0
225695,Both,0,0
225696,regimens,0,0
225697,were,0,0
225698,started,0,0
225699,after,0,0
225700,surgery,0,0
225701,.,0,0
225702,MEASUREMENTS,0,0
225703,The,0,0
225704,primary,0,0
225705,end,0,0
225706,point,0,0
225707,was,0,0
225708,the,0,0
225709,incidence,0,0
225710,of,0,0
225711,deep,0,1
225712,venous,0,0
225713,thrombosis,0,0
225714,in,0,0
225715,patients,0,0
225716,with,0,0
225717,adequate,0,0
225718,bilateral,0,0
225719,venograms,0,0
225720,;,0,0
225721,the,0,0
225722,secondary,0,0
225723,end,0,0
225724,point,0,0
225725,was,0,0
225726,hemorrhage,0,0
225727,.,0,0
225728,RESULTS,0,0
225729,Among,0,0
225730,the,0,0
225731,417,0,0
225732,patients,0,0
225733,with,0,0
225734,adequate,0,0
225735,venograms,0,0
225736,",",0,0
225737,109,0,0
225738,of,0,0
225739,211,0,0
225740,warfarin,1,1
225741,recipients,0,0
225742,(,0,0
225743,51.7,0,0
225744,%,0,0
225745,),0,0
225746,had,0,0
225747,deep,0,1
225748,venous,0,0
225749,thrombosis,0,0
225750,compared,0,0
225751,with,0,0
225752,76,0,0
225753,of,0,0
225754,206,0,0
225755,enoxaparin,1,1
225756,recipients,0,0
225757,(,0,0
225758,36.9,0,0
225759,%,0,0
225760,),0,0
225761,(,0,0
225762,P,0,0
225763,=,0,0
225764,0.003,0,0
225765,),0,0
225766,.,0,0
225767,The,0,0
225768,absolute,0,0
225769,risk,0,0
225770,difference,0,0
225771,was,0,0
225772,14.8,0,0
225773,%,0,0
225774,in,0,0
225775,favor,0,0
225776,of,0,0
225777,enoxaparin,1,1
225778,(,0,0
225779,95,0,0
225780,%,0,0
225781,Cl,0,1
225782,",",0,0
225783,5.3,0,0
225784,%,0,0
225785,to,0,0
225786,24.1,0,0
225787,%,0,0
225788,),0,0
225789,Twenty-two,0,0
225790,warfarin,1,1
225791,recipients,0,0
225792,(,0,0
225793,10.4,0,0
225794,%,0,0
225795,),0,0
225796,and,0,0
225797,24,0,0
225798,enoxaparin,1,1
225799,recipients,0,0
225800,(,0,0
225801,11.7,0,0
225802,%,0,0
225803,),0,0
225804,had,0,0
225805,proximal,0,0
225806,venous,0,0
225807,thrombosis,0,0
225808,(,0,0
225809,P,0,0
225810,>,0,0
225811,0.2,0,0
225812,),0,0
225813,.,0,0
225814,The,0,0
225815,absolute,0,0
225816,risk,0,0
225817,difference,0,0
225818,was,0,0
225819,1.2,0,0
225820,%,0,0
225821,in,0,0
225822,favor,0,0
225823,of,0,0
225824,warfarin,1,1
225825,(,0,0
225826,Cl,0,1
225827,",",0,0
225828,-7.2,0,0
225829,%,0,0
225830,to,0,0
225831,4.8,0,0
225832,%,0,0
225833,),0,0
225834,.,0,0
225835,The,0,0
225836,incidence,0,0
225837,of,0,0
225838,major,0,0
225839,bleeding,0,0
225840,was,0,0
225841,1.8,0,0
225842,%,0,0
225843,(,0,0
225844,6,0,0
225845,of,0,0
225846,334,0,0
225847,patients,0,0
225848,),0,0
225849,in,0,0
225850,the,0,0
225851,warfarin,0,1
225852,group,0,0
225853,and,0,0
225854,2.1,0,0
225855,%,0,0
225856,(,0,0
225857,7,0,0
225858,of,0,0
225859,336,0,0
225860,patients,0,0
225861,),0,0
225862,in,0,0
225863,the,0,0
225864,enoxaparin,0,1
225865,group,0,0
225866,(,0,0
225867,P,0,0
225868,>,0,0
225869,0.2,0,0
225870,),0,0
225871,.,0,0
225872,The,0,0
225873,absolute,0,0
225874,risk,0,0
225875,difference,0,0
225876,was,0,0
225877,0.3,0,0
225878,%,0,0
225879,in,0,0
225880,favor,0,0
225881,of,0,0
225882,warfarin,0,1
225883,(,0,0
225884,Cl,0,1
225885,",",0,0
225886,-2.4,0,0
225887,%,0,0
225888,to,0,0
225889,1.8,0,0
225890,%,0,0
225891,),0,0
225892,.,0,0
225893,CONCLUSIONS,0,0
225894,A,0,0
225895,postoperative,0,0
225896,",",0,0
225897,fixed-dose,0,1
225898,enoxaparin,1,1
225899,regimen,0,1
225900,is,0,0
225901,more,0,0
225902,effective,0,0
225903,than,0,0
225904,adjusted-dose,0,1
225905,warfarin,1,1
225906,in,0,0
225907,preventing,0,0
225908,deep,0,1
225909,venous,0,0
225910,thrombosis,0,0
225911,after,0,0
225912,knee,0,0
225913,arthroplasty,0,0
225914,.,0,0
225915,No,0,0
225916,differences,0,0
225917,were,0,0
225918,seen,0,0
225919,in,0,0
225920,the,0,0
225921,incidence,0,0
225922,of,0,0
225923,proximal,0,0
225924,venous,0,0
225925,thrombosis,0,0
225926,or,0,1
225927,clinically,0,0
225928,overt,0,0
225929,hemorrhage,0,0
225930,.,0,0
225931,Iobitridol,1,1
225932,300,1,1
225933,compared,0,0
225934,to,0,0
225935,iopromide,1,1
225936,300,1,0
225937,--,1,0
225938,a,1,0
225939,double-blind,0,0
225940,randomized,0,0
225941,phase-III,0,0
225942,study,0,0
225943,of,0,0
225944,clinical,0,0
225945,tolerance,0,0
225946,in,0,0
225947,total,0,0
225948,body,0,0
225949,CT.,0,1
225950,UNLABELLED,0,0
225951,PURPOSE,0,0
225952,",",0,0
225953,MATERIAL,0,0
225954,AND,0,0
225955,METHODS,0,0
225956,:,0,0
225957,The,0,0
225958,clinical,0,0
225959,safety,0,0
225960,of,0,0
225961,iobitriodol,1,1
225962,300,1,1
225963,mg,1,1
225964,I/ml,1,0
225965,and,1,0
225966,iopromide,1,1
225967,300,1,0
225968,mg,1,0
225969,I/ml,1,0
225970,were,0,0
225971,compared,0,0
225972,in,0,0
225973,a,0,0
225974,randomized,0,0
225975,double,0,0
225976,blind,0,0
225977,phase-III,0,0
225978,study,0,0
225979,conducted,0,0
225980,on,0,0
225981,60,0,0
225982,patients,0,0
225983,undergoing,0,0
225984,abdominal,0,0
225985,CT,0,0
225986,for,0,0
225987,a,0,0
225988,variety,0,0
225989,of,0,0
225990,indications,0,0
225991,.,0,0
225992,Each,0,0
225993,examination,0,0
225994,was,0,0
225995,rated,0,0
225996,as,0,0
225997,diagnostic,0,0
225998,or,0,1
225999,nondiagnostic,0,0
226000,and,0,0
226001,the,0,0
226002,image,0,1
226003,quality,0,0
226004,was,0,0
226005,noted,0,0
226006,.,0,0
226007,Nature,0,0
226008,",",0,0
226009,onset,0,0
226010,",",0,0
226011,intensity,0,0
226012,as,0,0
226013,well,0,0
226014,as,0,0
226015,outcome,0,0
226016,of,0,0
226017,each,0,0
226018,adverse,0,0
226019,reaction,0,0
226020,were,0,0
226021,recorded,0,0
226022,.,0,0
226023,RESULTS,0,0
226024,There,0,0
226025,was,0,0
226026,no,0,0
226027,significant,0,0
226028,difference,0,0
226029,in,0,0
226030,imaging,0,1
226031,quality,0,0
226032,and,0,0
226033,side,0,0
226034,effects,0,0
226035,between,0,0
226036,the,0,0
226037,contrast,0,0
226038,media,0,1
226039,.,0,0
226040,In,0,0
226041,this,0,0
226042,study,0,0
226043,",",0,0
226044,both,0,0
226045,iobitridol,1,1
226046,and,0,0
226047,iopromide,1,1
226048,provided,0,0
226049,excellent,0,0
226050,image,0,1
226051,quality,0,0
226052,and,0,0
226053,a,0,0
226054,low,0,0
226055,rate,0,0
226056,of,0,0
226057,side,0,0
226058,effects,0,0
226059,.,0,0
226060,CONCLUSION,0,0
226061,Iobitridol,1,1
226062,is,0,0
226063,a,0,0
226064,safe,0,0
226065,and,0,0
226066,effective,0,0
226067,nonionic,0,1
226068,contrast,0,0
226069,agent,0,0
226070,for,0,0
226071,contrast-enhanced,0,1
226072,body,0,0
226073,CT,0,0
226074,.,0,0
226075,Comparative,0,0
226076,efficacy,0,0
226077,of,0,0
226078,intravenous,0,1
226079,ibutilide,1,1
226080,versus,0,0
226081,procainamide,1,1
226082,for,0,0
226083,enhancing,0,0
226084,termination,0,0
226085,of,0,0
226086,atrial,0,0
226087,flutter,0,0
226088,by,0,0
226089,atrial,0,0
226090,overdrive,0,0
226091,pacing,0,1
226092,.,0,0
226093,This,0,0
226094,study,0,0
226095,compares,0,0
226096,the,0,0
226097,influence,0,0
226098,of,0,0
226099,intravenous,0,1
226100,ibutilide,1,1
226101,",",0,0
226102,a,0,0
226103,class,0,0
226104,III,0,0
226105,antiarrhythmic,0,1
226106,agent,0,0
226107,",",0,0
226108,with,0,0
226109,procainamide,1,1
226110,",",0,0
226111,a,0,0
226112,class,0,0
226113,IA,0,0
226114,antiarrhythmic,0,1
226115,agent,0,0
226116,",",0,0
226117,and,0,0
226118,with,0,0
226119,placebo,1,1
226120,on,0,0
226121,its,0,0
226122,ability,0,0
226123,to,0,0
226124,terminate,0,0
226125,atrial,0,0
226126,flutter,0,0
226127,using,0,0
226128,rapid,0,0
226129,atrial,0,0
226130,pacing,0,1
226131,.,0,0
226132,Fifty-nine,0,0
226133,episodes,0,0
226134,of,0,0
226135,atrial,0,0
226136,flutter,0,0
226137,in,0,0
226138,54,0,0
226139,patients,0,0
226140,who,0,0
226141,failed,0,0
226142,to,0,0
226143,terminate,0,0
226144,with,0,0
226145,an,0,0
226146,intravenous,0,1
226147,infusion,0,1
226148,of,0,0
226149,ibutilide,1,1
226150,",",1,0
226151,procainamide,1,1
226152,",",1,0
226153,or,1,0
226154,placebo,1,1
226155,alone,0,1
226156,underwent,0,0
226157,attempts,0,0
226158,at,0,0
226159,pacing,0,1
226160,termination,0,0
226161,using,0,0
226162,a,0,0
226163,standard,0,1
226164,protocol,0,0
226165,of,0,0
226166,burst,0,0
226167,atrial,0,0
226168,overdrive,0,1
226169,pacing,0,1
226170,.,0,0
226171,Atrial,0,0
226172,flutter,0,0
226173,cycle,0,0
226174,length,0,0
226175,and,0,0
226176,atrial,0,0
226177,monophasic,0,0
226178,action,0,0
226179,potential,0,0
226180,duration,0,0
226181,recorded,0,0
226182,from,0,0
226183,the,0,0
226184,right,0,0
226185,atrium,0,0
226186,during,0,0
226187,atrial,0,0
226188,flutter,0,0
226189,were,0,0
226190,measured,0,0
226191,at,0,0
226192,baseline,0,0
226193,and,0,0
226194,following,0,0
226195,infusion,0,1
226196,of,0,0
226197,ibutilide,1,1
226198,",",1,0
226199,procainamide,1,1
226200,",",0,0
226201,or,0,0
226202,placebo,1,1
226203,.,1,0
226204,Both,0,0
226205,ibutilide,1,1
226206,and,0,0
226207,procainamide,1,1
226208,significantly,0,0
226209,enhanced,0,0
226210,(,0,0
226211,p,0,0
226212,<,0,0
226213,0.001,0,0
226214,),0,0
226215,pacing-induced,0,0
226216,termination,0,0
226217,of,0,0
226218,atrial,0,0
226219,flutter,0,0
226220,compared,0,0
226221,with,0,0
226222,placebo,1,1
226223,.,1,0
226224,Pacing,0,0
226225,converted,0,0
226226,2,0,0
226227,of,0,0
226228,11,0,0
226229,patients,0,0
226230,(,0,0
226231,18,0,0
226232,%,0,0
226233,),0,0
226234,who,0,0
226235,received,0,0
226236,placebo,1,1
226237,",",0,0
226238,13,0,0
226239,of,0,0
226240,15,0,0
226241,patients,0,0
226242,(,0,0
226243,87,0,0
226244,%,0,0
226245,),0,0
226246,who,0,0
226247,received,0,0
226248,ibutilide,1,1
226249,",",0,0
226250,and,0,0
226251,29,0,0
226252,of,0,0
226253,33,0,0
226254,patients,0,0
226255,(,0,0
226256,88,0,0
226257,%,0,0
226258,),0,0
226259,who,0,0
226260,received,0,0
226261,procainamide,1,1
226262,to,0,0
226263,sinus,0,0
226264,rhythm,0,1
226265,.,0,0
226266,Ibutilide,1,1
226267,and,0,0
226268,procainamide,1,1
226269,compared,0,0
226270,with,0,0
226271,placebo,1,1
226272,markedly,0,0
226273,reduced,0,0
226274,(,0,0
226275,p,0,0
226276,<,0,0
226277,0.001,0,0
226278,),0,0
226279,the,0,0
226280,incidence,0,0
226281,of,0,0
226282,pacing-induced,0,0
226283,atrial,0,0
226284,fibrillation,0,0
226285,.,0,0
226286,The,0,0
226287,atrial,0,0
226288,flutter,0,0
226289,cycle,0,0
226290,length,0,0
226291,was,0,0
226292,prolonged,0,0
226293,significantly,0,0
226294,less,0,0
226295,(,0,0
226296,p,0,0
226297,<,0,0
226298,0.001,0,0
226299,),0,0
226300,",",0,0
226301,and,0,0
226302,the,0,0
226303,atrial,0,0
226304,monophasic,0,0
226305,action,0,0
226306,potential,0,0
226307,duration,0,0
226308,was,0,0
226309,increased,0,0
226310,significantly,0,0
226311,more,0,0
226312,(,0,0
226313,p,0,0
226314,<,0,0
226315,0.001,0,0
226316,),0,0
226317,by,0,0
226318,ibutilide,1,1
226319,than,0,0
226320,by,0,0
226321,procainamide,1,1
226322,.,1,0
226323,Although,0,0
226324,the,0,0
226325,electrophysiologic,0,0
226326,changes,0,0
226327,induced,0,0
226328,by,0,0
226329,these,0,0
226330,antiarrhythmic,0,0
226331,agents,0,0
226332,contributed,0,0
226333,to,0,0
226334,facilitating,0,0
226335,pacing-induced,0,0
226336,termination,0,0
226337,",",0,0
226338,neither,0,0
226339,tachycardia,0,0
226340,cycle,0,0
226341,length,0,0
226342,nor,0,0
226343,action,0,0
226344,potential,0,0
226345,duration,0,0
226346,were,0,0
226347,useful,0,0
226348,predictors,0,0
226349,of,0,0
226350,the,0,0
226351,ability,0,0
226352,of,0,0
226353,pacing,0,0
226354,to,0,0
226355,terminate,0,0
226356,atrial,0,0
226357,flutter,0,0
226358,.,0,0
226359,In,0,0
226360,conclusion,0,0
226361,",",0,0
226362,despite,0,0
226363,differing,0,0
226364,electrophysiologic,0,0
226365,effects,0,0
226366,",",0,0
226367,the,0,0
226368,use,0,0
226369,of,0,0
226370,intravenous,0,1
226371,ibutilide,1,1
226372,or,0,1
226373,procainamide,1,1
226374,enhances,0,0
226375,the,0,0
226376,termination,0,0
226377,of,0,0
226378,atrial,0,0
226379,flutter,0,0
226380,by,0,0
226381,atrial,0,0
226382,overdrive,0,0
226383,pacing,0,0
226384,.,0,0
226385,Tight-fitting,1,1
226386,underwear,1,1
226387,and,0,0
226388,sperm,0,1
226389,quality,0,0
226390,.,0,0
226391,A,0,0
226392,phase,0,0
226393,I,0,0
226394,study,0,0
226395,of,0,0
226396,recombinant,1,1
226397,human,1,0
226398,ciliary,1,1
226399,neurotrophic,1,1
226400,factor,1,1
226401,(,1,0
226402,rHCNTF,1,1
226403,),1,0
226404,in,0,0
226405,patients,0,0
226406,with,0,0
226407,amyotrophic,0,0
226408,lateral,0,0
226409,sclerosis,0,0
226410,.,0,0
226411,The,0,0
226412,ALS,0,0
226413,CNTF,0,0
226414,Treatment,0,1
226415,Study,0,0
226416,(,0,0
226417,ACTS,0,1
226418,),0,0
226419,Phase,0,0
226420,I-II,0,1
226421,Study,0,0
226422,Group,0,0
226423,.,0,0
226424,Fifty-seven,0,0
226425,patients,0,0
226426,with,0,0
226427,amyotrophic,0,0
226428,lateral,0,1
226429,sclerosis,0,0
226430,(,0,0
226431,ALS,0,1
226432,),0,0
226433,were,0,0
226434,randomly,0,0
226435,assigned,0,0
226436,to,0,0
226437,receive,0,0
226438,0.5,0,0
226439,",",0,0
226440,1,0,0
226441,",",0,0
226442,3,0,0
226443,",",0,0
226444,7,0,0
226445,",",0,0
226446,10,0,0
226447,",",0,0
226448,or,0,0
226449,30,0,0
226450,micrograms/kg,0,0
226451,recombinant,1,1
226452,human,1,0
226453,ciliary,1,1
226454,neurotrophic,1,1
226455,factor,1,1
226456,(,1,0
226457,rHCNTF,1,1
226458,),1,0
226459,or,0,0
226460,placebo,1,1
226461,subcutaneously,0,0
226462,3,0,0
226463,times,0,0
226464,a,0,0
226465,week,0,0
226466,for,0,0
226467,2,0,0
226468,weeks,0,0
226469,.,0,0
226470,Dose-limiting,0,0
226471,toxicity,0,0
226472,",",0,0
226473,consisting,0,0
226474,of,0,0
226475,febrile,0,0
226476,reactions,0,0
226477,in,0,0
226478,some,0,0
226479,patients,0,0
226480,",",0,0
226481,fatigue,0,0
226482,",",0,0
226483,and,0,0
226484,nonproductive,0,0
226485,cough,0,0
226486,",",0,0
226487,was,0,0
226488,observed,0,0
226489,at,0,0
226490,a,0,0
226491,dose,0,0
226492,level,0,0
226493,of,0,0
226494,30,0,0
226495,micrograms/kg,0,0
226496,.,0,0
226497,Dose-related,0,0
226498,changes,0,0
226499,in,0,0
226500,parameters,0,0
226501,of,0,0
226502,the,0,0
226503,acute-phase,0,0
226504,response,0,0
226505,were,0,0
226506,noted,0,0
226507,",",0,0
226508,consistent,0,0
226509,with,0,0
226510,the,0,0
226511,relationship,0,0
226512,of,0,0
226513,CNTF,1,0
226514,and,0,0
226515,its,0,0
226516,receptor,0,0
226517,system,0,0
226518,to,0,0
226519,the,0,0
226520,cytokine,0,0
226521,interleukin-6,0,0
226522,(,0,0
226523,IL-6,0,1
226524,),0,0
226525,and,0,0
226526,its,0,0
226527,receptor,0,0
226528,.,0,0
226529,No,0,0
226530,adverse,0,0
226531,neurologic,0,0
226532,consequences,0,0
226533,of,0,0
226534,rHCNTF,1,1
226535,administration,0,0
226536,were,0,0
226537,observed,0,0
226538,.,0,0
226539,Antibodies,0,0
226540,to,0,0
226541,rHCNTF,1,0
226542,were,0,0
226543,observed,0,0
226544,in,0,0
226545,sera,0,0
226546,of,0,0
226547,most,0,0
226548,patients,0,0
226549,tested,0,0
226550,after,0,0
226551,2,0,0
226552,weeks,0,0
226553,of,0,0
226554,continuous,0,1
226555,treatment,0,0
226556,and,0,0
226557,4,0,0
226558,weeks,0,0
226559,',0,0
226560,withdrawal,0,0
226561,period,0,0
226562,.,0,0
226563,rHCNTF,1,0
226564,was,0,0
226565,safe,0,0
226566,and,0,0
226567,tolerated,0,0
226568,within,0,0
226569,acceptable,0,0
226570,limits,0,0
226571,when,0,0
226572,administered,0,0
226573,to,0,0
226574,patients,0,0
226575,with,0,0
226576,ALS,0,0
226577,in,0,0
226578,this,0,0
226579,study,0,0
226580,at,0,0
226581,doses,0,0
226582,of,0,0
226583,up,0,0
226584,to,0,0
226585,30,0,0
226586,micrograms/kg,0,0
226587,3,0,0
226588,times,0,0
226589,a,0,0
226590,week,0,0
226591,for,0,0
226592,2,0,0
226593,weeks,0,0
226594,.,0,0
226595,Further,0,0
226596,studies,0,0
226597,to,0,0
226598,explore,0,0
226599,the,0,0
226600,efficacy,0,0
226601,of,0,0
226602,rHCNTF,1,0
226603,in,0,0
226604,the,0,0
226605,treatment,0,0
226606,of,0,0
226607,human,0,0
226608,motor,0,0
226609,neuron,0,0
226610,diseases,0,0
226611,are,0,0
226612,justified,0,0
226613,.,0,0
226614,Intra-articular,0,0
226615,hyaluronic,1,1
226616,acid,1,1
226617,compared,0,0
226618,to,0,0
226619,intra-articular,0,1
226620,triamcinolone,1,1
226621,hexacetonide,1,1
226622,in,0,0
226623,inflammatory,0,0
226624,knee,0,0
226625,osteoarthritis,0,0
226626,.,0,0
226627,The,0,0
226628,aim,0,0
226629,of,0,0
226630,this,0,0
226631,study,0,0
226632,was,0,0
226633,to,0,0
226634,determine,0,0
226635,the,0,0
226636,comparative,0,0
226637,efficacy,0,0
226638,and,0,0
226639,safety,0,0
226640,of,0,0
226641,intra-articular,1,1
226642,(,1,0
226643,i/a,1,1
226644,),1,0
226645,triamcinolone,1,1
226646,.,1,1
226647,hexacetonide,1,1
226648,(,1,0
226649,TH,1,0
226650,),1,1
226651,and,1,0
226652,i/a,1,1
226653,hyaluronic,1,1
226654,acid,1,1
226655,(,1,0
226656,HA,1,1
226657,),1,0
226658,in,0,0
226659,inflammatory,0,0
226660,knee,0,0
226661,osteoarthritis,0,0
226662,.,0,0
226663,A,0,0
226664,randomized,0,0
226665,double-blind,0,0
226666,comparative,0,0
226667,trail,0,1
226668,was,0,0
226669,carried,0,0
226670,out,0,0
226671,in,0,0
226672,a,0,0
226673,rheumatology,0,0
226674,outpatient,0,0
226675,department,0,0
226676,.,0,0
226677,There,0,0
226678,were,0,0
226679,63,0,0
226680,patients,0,0
226681,(,0,0
226682,24,0,0
226683,male,0,0
226684,",",0,0
226685,39,0,0
226686,female,0,0
226687,",",0,0
226688,mean,0,0
226689,age,0,0
226690,70.5,0,0
226691,years,0,0
226692,),0,0
226693,with,0,0
226694,bilateral,0,1
226695,symptomatic,0,0
226696,knee,0,0
226697,osteoarthritis,0,0
226698,with,0,0
226699,effusion,0,0
226700,.,0,0
226701,Each,0,0
226702,was,0,0
226703,given,0,0
226704,five,1,0
226705,HA,1,0
226706,injections,1,1
226707,at,1,0
226708,weekly,1,0
226709,intervals,1,0
226710,;,1,0
226711,or,1,0
226712,20,1,0
226713,mg,1,1
226714,TH,1,0
226715,followed,1,0
226716,by,1,0
226717,four,1,0
226718,placebo,1,1
226719,(,1,0
226720,saline,1,1
226721,),1,0
226722,injections,1,1
226723,.,1,0
226724,Patients,0,0
226725,were,0,0
226726,examined,0,0
226727,weekly,0,1
226728,during,0,0
226729,the,0,0
226730,treatment,0,0
226731,period,0,0
226732,and,0,0
226733,then,0,0
226734,at,0,0
226735,monthly,0,0
226736,intervals,0,0
226737,for,0,0
226738,a,0,0
226739,further,0,0
226740,6,0,0
226741,months,0,0
226742,.,0,0
226743,Assessment,0,0
226744,included,0,0
226745,recording,0,0
226746,of,0,0
226747,:,0,0
226748,visual,0,0
226749,analog,0,1
226750,scores,0,0
226751,(,0,0
226752,VAS,0,0
226753,),0,0
226754,for,0,0
226755,pain,0,0
226756,;,0,0
226757,duration,0,0
226758,of,0,0
226759,stiffness,0,0
226760,;,0,0
226761,range,0,0
226762,of,0,0
226763,movement,0,0
226764,;,0,0
226765,joint,0,0
226766,effusion,0,0
226767,;,0,0
226768,local,0,0
226769,heat,0,0
226770,;,0,0
226771,synovial,0,0
226772,thickening,0,0
226773,;,0,0
226774,joint-line,0,0
226775,and,0,0
226776,periarticular,0,1
226777,tenderness,0,0
226778,.,0,0
226779,The,0,0
226780,principal,0,0
226781,outcome,0,0
226782,measure,0,0
226783,was,0,0
226784,pain,0,0
226785,on,0,0
226786,a,0,0
226787,self-selected,0,0
226788,activity,0,0
226789,assessed,0,0
226790,by,0,0
226791,Vas,0,0
226792,.,0,0
226793,The,0,0
226794,two,0,0
226795,groups,0,0
226796,were,0,0
226797,comparable,0,0
226798,at,0,0
226799,entry,0,0
226800,and,0,0
226801,no,0,0
226802,significant,0,0
226803,differences,0,0
226804,between,0,0
226805,the,0,0
226806,groups,0,0
226807,developed,0,0
226808,at,0,0
226809,any,0,0
226810,time,0,0
226811,during,0,0
226812,the,0,0
226813,treatment,0,0
226814,period,0,0
226815,.,0,0
226816,However,0,0
226817,",",0,0
226818,there,0,0
226819,was,0,0
226820,a,0,0
226821,high,0,0
226822,drop-out,0,0
226823,rate,0,0
226824,and,0,0
226825,intention,0,0
226826,to,0,0
226827,treat,0,0
226828,analysis,0,0
226829,failed,0,0
226830,to,0,0
226831,demonstrate,0,0
226832,statistically,0,0
226833,significant,0,0
226834,differences,0,0
226835,between,0,0
226836,the,0,0
226837,groups,0,0
226838,.,0,0
226839,In,0,0
226840,patients,0,0
226841,remaining,0,0
226842,in,0,0
226843,the,0,0
226844,study,0,0
226845,",",0,0
226846,significantly,0,0
226847,less,0,0
226848,pain,0,0
226849,was,0,0
226850,experienced,0,0
226851,by,0,0
226852,the,0,0
226853,HA,1,0
226854,group,0,0
226855,during,0,0
226856,the,0,0
226857,6,0,0
226858,month,0,0
226859,follow-up,0,0
226860,period,0,0
226861,.,0,0
226862,Other,0,0
226863,parameters,0,0
226864,showed,0,0
226865,a,0,0
226866,similar,0,0
226867,trend,0,0
226868,in,0,0
226869,favor,0,0
226870,of,0,0
226871,experienced,0,0
226872,by,0,0
226873,the,0,0
226874,HA,1,0
226875,group,0,0
226876,during,0,0
226877,the,0,0
226878,6,0,0
226879,month,0,0
226880,follow-up,0,0
226881,period,0,0
226882,.,0,0
226883,Other,0,0
226884,parameters,0,0
226885,showed,0,0
226886,a,0,0
226887,similar,0,0
226888,trend,0,0
226889,in,0,0
226890,favor,0,0
226891,of,0,0
226892,HA,1,0
226893,.,1,0
226894,We,0,0
226895,could,0,0
226896,not,0,0
226897,",",0,0
226898,however,0,0
226899,",",0,0
226900,demonstrate,0,0
226901,significant,0,0
226902,differences,0,0
226903,between,0,0
226904,the,0,0
226905,placebo,0,1
226906,and,0,0
226907,active,0,0
226908,treatments,0,0
226909,.,0,0
226910,HA,1,0
226911,may,0,0
226912,therefore,0,0
226913,be,0,0
226914,a,0,0
226915,useful,0,0
226916,additional,0,0
226917,therapy,0,1
226918,for,0,0
226919,symptomatic,0,0
226920,knee,0,0
226921,osteoarthritis,0,0
226922,and,0,0
226923,may,0,0
226924,have,0,0
226925,a,0,0
226926,long,0,0
226927,duration,0,0
226928,of,0,0
226929,action,0,0
226930,.,0,0
226931,The,0,0
226932,effects,0,0
226933,of,0,0
226934,sevoflurane,1,1
226935,and,0,0
226936,isoflurane,1,1
226937,on,0,0
226938,recovery,0,0
226939,from,0,0
226940,outpatient,0,0
226941,surgery,0,0
226942,.,0,0
226943,This,0,0
226944,randomized,0,0
226945,",",0,0
226946,open-label,0,0
226947,study,0,0
226948,compared,0,0
226949,the,0,0
226950,investigational,0,0
226951,inhalational,0,1
226952,anesthetic,0,1
226953,sevoflurane,1,1
226954,with,0,0
226955,isoflurane,1,1
226956,in,0,0
226957,47,0,0
226958,healthy,0,0
226959,women,0,0
226960,undergoing,0,0
226961,elective,0,0
226962,ambulatory,0,0
226963,surgery,0,0
226964,.,0,0
226965,The,0,0
226966,women,0,0
226967,were,0,0
226968,randomized,0,0
226969,to,0,0
226970,receive,1,0
226971,either,1,0
226972,sevoflurane,1,1
226973,or,1,1
226974,isoflurane,1,1
226975,in,1,0
226976,60,1,0
226977,%,1,0
226978,nitrous,1,1
226979,oxide-oxygen,1,1
226980,.,1,0
226981,Induction,1,0
226982,with,1,0
226983,thiopental,1,1
226984,3-6,1,1
226985,mg/kg,1,1
226986,was,1,0
226987,followed,1,0
226988,by,1,0
226989,vecuronium,1,1
226990,0.1,1,0
226991,mg/kg,1,1
226992,and,1,0
226993,fentanyl,1,1
226994,0-200,1,0
226995,micrograms,1,1
226996,.,1,0
226997,Duration,0,0
226998,of,0,0
226999,anesthesia,0,1
227000,",",0,0
227001,time,0,0
227002,to,0,0
227003,emergence,0,0
227004,",",0,0
227005,orientation,0,0
227006,",",0,0
227007,length,0,0
227008,of,0,0
227009,stay,0,0
227010,in,0,0
227011,the,0,0
227012,surgical,0,0
227013,unit,0,0
227014,",",0,0
227015,and,0,0
227016,hospital,0,0
227017,discharge,0,0
227018,were,0,0
227019,recorded,0,0
227020,.,0,0
227021,The,0,0
227022,emergence,0,0
227023,",",0,0
227024,length,0,0
227025,of,0,0
227026,stay,0,0
227027,",",0,0
227028,and,0,0
227029,discharge,0,0
227030,times,0,0
227031,after,0,0
227032,discontinuation,0,0
227033,of,0,0
227034,sevoflurane,1,1
227035,were,0,0
227036,9.7,0,0
227037,+/-,0,0
227038,0.7,0,0
227039,",",0,0
227040,120.6,0,0
227041,+/-,0,0
227042,8.0,0,0
227043,",",0,0
227044,and,0,0
227045,244,0,0
227046,+/-,0,0
227047,15,0,0
227048,minutes,0,0
227049,",",0,0
227050,respectively,0,0
227051,",",0,0
227052,and,0,0
227053,for,0,0
227054,isoflurane,1,1
227055,were,0,0
227056,11.9,0,0
227057,+/-,0,0
227058,1.4,0,0
227059,",",0,0
227060,106.8,0,0
227061,+/-,0,0
227062,7.1,0,0
227063,",",0,0
227064,and,0,0
227065,282,0,0
227066,+/-,0,0
227067,24,0,0
227068,minutes,0,0
227069,",",0,0
227070,respectively,0,0
227071,(,0,0
227072,NS,0,0
227073,),0,0
227074,.,0,0
227075,The,0,0
227076,isoflurane,0,1
227077,group,0,0
227078,had,0,0
227079,a,0,0
227080,higher,0,0
227081,frequency,0,0
227082,of,0,0
227083,postoperative,0,0
227084,cough,0,0
227085,.,0,0
227086,At,0,0
227087,the,0,0
227088,end,0,0
227089,of,0,0
227090,surgery,0,0
227091,",",0,0
227092,the,0,0
227093,sevoflurane,0,1
227094,group,0,0
227095,received,0,0
227096,a,0,0
227097,deeper,0,0
227098,level,0,0
227099,of,0,0
227100,anesthesia,0,1
227101,(,0,0
227102,minimum,0,0
227103,alveolar,0,0
227104,concentration,0,0
227105,1.5,0,0
227106,vs,0,0
227107,1.3,0,0
227108,),0,0
227109,",",0,0
227110,however,0,0
227111,",",0,0
227112,these,0,0
227113,patients,0,0
227114,were,0,0
227115,oriented,0,0
227116,earlier,0,0
227117,(,0,0
227118,13.6,0,0
227119,+/-,0,0
227120,1.1,0,0
227121,min,0,0
227122,vs,0,0
227123,17.0,0,0
227124,+/-,0,0
227125,1.5,0,0
227126,min,0,0
227127,isoflurane,0,1
227128,;,0,0
227129,p,0,0
227130,=,0,0
227131,0.02,0,0
227132,),0,0
227133,after,0,0
227134,discontinuation,0,0
227135,of,0,0
227136,anesthesia,0,1
227137,",",0,0
227138,although,0,0
227139,this,0,0
227140,difference,0,0
227141,is,0,0
227142,of,0,0
227143,little,0,0
227144,clinical,0,0
227145,significance,0,0
227146,.,0,0
227147,Pharmacokinetics,0,0
227148,of,0,0
227149,adriamycin,1,1
227150,and,0,0
227151,adriamycin,1,1
227152,--,1,0
227153,DNA,1,0
227154,complex,1,0
227155,in,0,0
227156,L1210,0,0
227157,mice,0,0
227158,and,0,0
227159,men,0,0
227160,.,0,0
227161,Comparison,0,0
227162,of,0,0
227163,analgesic,0,0
227164,effect,0,0
227165,of,0,0
227166,locally,0,0
227167,and,0,0
227168,systemically,0,0
227169,administered,0,1
227170,ketorolac,1,1
227171,in,0,0
227172,mastectomy,0,0
227173,patients,0,0
227174,.,0,0
227175,BACKGROUND,0,0
227176,Ketorolac,1,0
227177,is,0,0
227178,a,0,0
227179,parenteral,0,0
227180,nonsteroidal,0,1
227181,antiinflammatory,0,1
227182,drug,0,1
227183,(,0,0
227184,NSAID,0,0
227185,),0,0
227186,.,0,0
227187,Two,0,0
227188,features,0,0
227189,have,0,0
227190,limited,0,0
227191,its,0,0
227192,clinical,0,0
227193,utility,0,0
227194,:,0,0
227195,tendency,0,0
227196,to,0,0
227197,elicit,0,0
227198,kidney,0,0
227199,failure,0,0
227200,and,0,0
227201,inability,0,0
227202,to,0,0
227203,produce,0,0
227204,complete,0,0
227205,analgesia,0,0
227206,.,0,0
227207,Because,0,0
227208,most,0,0
227209,NSAIDs,1,0
227210,are,0,0
227211,weak,0,0
227212,acids,0,1
227213,(,0,0
227214,pKa,0,0
227215,3-5,0,1
227216,),0,0
227217,and,0,0
227218,become,0,0
227219,concentrated,0,0
227220,in,0,0
227221,acidic,0,0
227222,tissues,0,0
227223,",",0,0
227224,such,0,0
227225,as,0,0
227226,injured,0,0
227227,and,0,0
227228,inflamed,0,0
227229,tissues,0,0
227230,",",0,0
227231,we,0,0
227232,hypothesized,0,0
227233,that,0,0
227234,local,0,0
227235,administration,0,0
227236,may,0,0
227237,enhance,0,0
227238,its,0,0
227239,analgesic,0,0
227240,efficacy,0,0
227241,while,0,0
227242,lowering,0,0
227243,the,0,0
227244,potential,0,0
227245,for,0,0
227246,systemic,0,0
227247,complications,0,0
227248,.,0,0
227249,METHODS,0,0
227250,We,0,0
227251,conducted,0,0
227252,a,0,0
227253,randomized,0,0
227254,",",0,0
227255,placebo-controlled,1,1
227256,study,0,0
227257,of,0,0
227258,60,0,0
227259,group,0,0
227260,I-II,0,1
227261,(,0,0
227262,American,0,0
227263,Society,0,0
227264,of,0,0
227265,Anesthesiology,0,0
227266,criteria,0,0
227267,),0,0
227268,mastectomy,0,1
227269,patients,0,0
227270,",",0,0
227271,20,0,0
227272,in,0,0
227273,each,0,0
227274,group,0,0
227275,.,0,0
227276,Near,0,0
227277,the,0,0
227278,end,0,0
227279,of,0,0
227280,surgery,0,0
227281,and,0,0
227282,every,0,1
227283,6,0,0
227284,h,0,0
227285,postoperatively,0,0
227286,",",0,0
227287,20,0,0
227288,ml,0,0
227289,of,0,0
227290,the,0,0
227291,study,0,0
227292,solution,0,1
227293,containing,0,1
227294,normal,1,0
227295,saline,1,1
227296,with,1,0
227297,or,1,0
227298,without,1,0
227299,30,1,0
227300,mg,1,0
227301,of,1,0
227302,ketorolac,1,1
227303,were,0,0
227304,administered,0,0
227305,simultaneously,0,0
227306,either,0,0
227307,via,0,0
227308,a,0,0
227309,Jackson-Pratt,0,0
227310,drain,0,0
227311,or,0,0
227312,intravenously,0,0
227313,in,0,0
227314,a,0,0
227315,double-blind,0,0
227316,fashion,0,0
227317,.,0,0
227318,The,0,0
227319,quality,0,0
227320,of,0,0
227321,pain,0,0
227322,control,0,0
227323,",",0,0
227324,the,0,0
227325,amount,0,0
227326,and,0,0
227327,character,0,0
227328,of,0,0
227329,the,0,0
227330,drain,0,0
227331,fluid,0,0
227332,",",0,0
227333,incidence,0,0
227334,of,0,0
227335,nausea,0,0
227336,and,0,0
227337,vomiting,0,0
227338,",",0,0
227339,length,0,0
227340,of,0,0
227341,stay,0,0
227342,in,0,0
227343,the,0,0
227344,postoperative,0,0
227345,care,0,1
227346,unit,0,0
227347,",",0,0
227348,and,0,0
227349,amount,0,0
227350,of,0,0
227351,morphine,0,1
227352,used,0,0
227353,for,0,0
227354,treatment,0,0
227355,of,0,0
227356,break-through,0,0
227357,pain,0,0
227358,were,0,0
227359,recorded,0,0
227360,.,0,0
227361,RESULTS,0,0
227362,Intraoperative,0,0
227363,administration,0,0
227364,of,0,0
227365,ketorolac,1,1
227366,resulted,0,0
227367,in,0,0
227368,better,0,0
227369,quality,0,0
227370,of,0,0
227371,pain,0,0
227372,control,0,0
227373,in,0,0
227374,the,0,0
227375,immediate,0,0
227376,postoperative,0,0
227377,period,0,0
227378,regardless,0,0
227379,of,0,0
227380,route,0,0
227381,of,0,0
227382,administration,0,0
227383,.,0,0
227384,The,0,0
227385,incidence,0,0
227386,of,0,0
227387,nausea,0,0
227388,was,0,0
227389,significantly,0,0
227390,higher,0,0
227391,in,0,0
227392,the,0,0
227393,placebo,0,1
227394,group,0,0
227395,",",0,0
227396,and,0,0
227397,drain,0,1
227398,output,0,0
227399,in,0,0
227400,the,0,0
227401,ketorolac,1,1
227402,groups,0,0
227403,did,0,0
227404,not,0,0
227405,exceed,0,0
227406,the,0,0
227407,output,0,0
227408,in,0,0
227409,the,0,0
227410,placebo,1,1
227411,group,0,0
227412,.,0,0
227413,CONCLUSION,0,0
227414,Analgesic,0,0
227415,of,0,0
227416,the,0,0
227417,locally,0,0
227418,administered,0,0
227419,ketorolac,1,1
227420,is,0,0
227421,equally,0,0
227422,effective,0,0
227423,to,0,0
227424,the,0,0
227425,efficacy,0,0
227426,of,0,0
227427,ketorolac,1,1
227428,administered,0,0
227429,intravenously,0,0
227430,.,0,0
227431,Deep,0,1
227432,vein,0,0
227433,thrombosis,0,0
227434,after,0,0
227435,major,0,0
227436,reconstructive,0,0
227437,spinal,0,0
227438,surgery,0,0
227439,.,0,0
227440,STUDY,0,0
227441,DESIGN,0,0
227442,A,0,0
227443,prospective,0,0
227444,study,0,0
227445,was,0,0
227446,performed,0,0
227447,.,0,0
227448,OBJECTIVES,0,0
227449,The,0,0
227450,goals,0,0
227451,of,0,0
227452,the,0,0
227453,study,0,0
227454,were,0,0
227455,to,0,0
227456,determine,0,0
227457,the,0,0
227458,incidence,0,0
227459,of,0,0
227460,deep,0,1
227461,vein,0,0
227462,thrombosis,0,0
227463,after,0,0
227464,major,0,0
227465,adult,0,0
227466,spinal,0,1
227467,surgery,0,0
227468,and,0,0
227469,the,0,0
227470,optimal,0,0
227471,mode,0,0
227472,of,0,0
227473,prophylaxis,0,0
227474,in,0,0
227475,this,0,0
227476,surgical,0,0
227477,population,0,0
227478,.,0,0
227479,SUMMARY,0,0
227480,OF,0,0
227481,BACKGROUND,0,0
227482,DATA,0,1
227483,Few,0,0
227484,studies,0,0
227485,have,0,0
227486,evaluated,0,0
227487,deep,0,1
227488,vein,0,0
227489,thrombosis,0,0
227490,incidence,0,0
227491,and,0,0
227492,prophylaxis,0,0
227493,after,0,0
227494,major,0,0
227495,adult,0,0
227496,spinal,0,0
227497,surgery,0,0
227498,.,0,0
227499,Incidence,0,0
227500,rates,0,0
227501,have,0,0
227502,ranged,0,0
227503,from,0,0
227504,0.9-14,0,0
227505,%,0,0
227506,.,0,0
227507,METHODS,0,0
227508,Three,0,0
227509,hundred,0,0
227510,twenty-nine,0,0
227511,patients,0,0
227512,were,0,0
227513,evaluated,0,0
227514,.,0,0
227515,One,0,0
227516,hundred,0,0
227517,ten,0,0
227518,patients,0,0
227519,were,0,0
227520,randomized,0,0
227521,to,0,0
227522,3,0,0
227523,different,0,0
227524,deep,0,1
227525,vein,0,0
227526,thrombosis,0,0
227527,prophylaxis,0,0
227528,groups,0,0
227529,.,0,0
227530,These,0,0
227531,patients,0,0
227532,had,0,0
227533,duplex,1,1
227534,doppler,1,0
227535,scans,1,0
227536,between,0,0
227537,the,0,0
227538,fifth,0,0
227539,and,0,0
227540,seventh,0,0
227541,postoperative,0,0
227542,days,0,0
227543,.,0,0
227544,The,0,0
227545,remaining,0,0
227546,219,0,0
227547,patients,0,0
227548,formed,0,0
227549,a,0,0
227550,nonrandomized,0,0
227551,group,0,0
227552,and,0,0
227553,received,0,0
227554,either,0,0
227555,thrombosis,1,0
227556,embolic,1,1
227557,deterrent,1,0
227558,stockings,1,1
227559,alone,1,0
227560,or,1,0
227561,thrombosis,1,0
227562,embolic,1,0
227563,deterrent,1,0
227564,stockings,1,1
227565,and,1,0
227566,pneumatic,1,1
227567,compression,1,1
227568,boots,1,1
227569,for,0,0
227570,deep,0,1
227571,vein,0,0
227572,thrombosis,0,0
227573,prophylaxis,0,0
227574,.,0,0
227575,The,0,0
227576,type,0,0
227577,of,0,0
227578,deep,0,1
227579,vein,0,0
227580,thrombosis,0,0
227581,prophylaxis,0,0
227582,in,0,0
227583,this,0,0
227584,group,0,0
227585,was,0,0
227586,based,0,0
227587,on,0,0
227588,surgeon,0,0
227589,preference,0,0
227590,.,0,0
227591,All,0,0
227592,329,0,0
227593,patients,0,0
227594,were,0,0
227595,followed,0,0
227596,for,0,0
227597,clinical,0,0
227598,signs,0,0
227599,and,0,0
227600,symptoms,0,0
227601,of,0,0
227602,thromboembolic,0,0
227603,disease,0,0
227604,.,0,0
227605,Patients,0,0
227606,were,0,0
227607,followed,0,0
227608,clinically,0,0
227609,for,0,0
227610,a,0,0
227611,minimum,0,0
227612,of,0,0
227613,1,0,0
227614,year,0,0
227615,.,0,0
227616,RESULTS,0,0
227617,All,0,0
227618,110,0,0
227619,prophylaxis,0,0
227620,study,0,0
227621,group,0,0
227622,patients,0,0
227623,were,0,0
227624,clinically,0,0
227625,asymptomatic,0,0
227626,and,0,0
227627,109,0,0
227628,duplex,0,1
227629,scans,0,0
227630,were,0,0
227631,normal,0,0
227632,.,0,0
227633,One,0,0
227634,scan,0,0
227635,was,0,0
227636,indeterminate,0,0
227637,and,0,0
227638,a,0,0
227639,follow-up,0,0
227640,venogram,0,1
227641,was,0,0
227642,negative,0,0
227643,.,0,0
227644,Two,0,0
227645,patients,0,0
227646,in,0,0
227647,the,0,0
227648,coumadin,0,1
227649,group,0,0
227650,(,0,0
227651,5.7,0,0
227652,%,0,0
227653,),0,0
227654,experienced,0,0
227655,excessive,0,0
227656,blood,0,0
227657,loss,0,0
227658,.,0,0
227659,One,0,0
227660,of,0,0
227661,the,0,0
227662,219,0,0
227663,patients,0,0
227664,from,0,0
227665,the,0,0
227666,nonrandomized,0,0
227667,group,0,0
227668,developed,0,0
227669,a,0,0
227670,clinically,0,0
227671,detectable,0,0
227672,proximal,0,0
227673,deep,0,1
227674,vein,0,0
227675,thrombosis,0,0
227676,which,0,0
227677,was,0,0
227678,confirmed,0,0
227679,by,0,0
227680,duplex,0,1
227681,ultra-sonography,0,0
227682,.,0,0
227683,The,0,0
227684,overall,0,0
227685,clinical,0,0
227686,incidence,0,0
227687,of,0,0
227688,deep,0,1
227689,vein,0,0
227690,thrombosis,0,0
227691,was,0,0
227692,0.3,0,0
227693,%,0,0
227694,(,0,0
227695,1,0,0
227696,in,0,0
227697,329,0,0
227698,patients,0,0
227699,),0,0
227700,.,0,0
227701,CONCLUSIONS,0,0
227702,This,0,0
227703,low,0,0
227704,0.3,0,0
227705,%,0,0
227706,rate,0,0
227707,is,0,0
227708,in,0,0
227709,agreement,0,0
227710,with,0,0
227711,recent,0,0
227712,studies,0,0
227713,that,0,0
227714,focus,0,0
227715,on,0,0
227716,thromboembolic,0,0
227717,disease,0,0
227718,.,0,0
227719,Given,0,0
227720,the,0,0
227721,low,0,0
227722,incidence,0,0
227723,",",0,0
227724,routine,0,0
227725,screening,0,0
227726,for,0,0
227727,asymptomatic,0,0
227728,thrombi,0,1
227729,appears,0,0
227730,unwarranted,0,0
227731,.,0,0
227732,In,0,0
227733,addition,0,0
227734,",",0,0
227735,mechanical,0,0
227736,prophylaxis,0,0
227737,with,0,0
227738,graduated,0,0
227739,compression,0,1
227740,stockings,0,1
227741,and,0,0
227742,pneumatic,0,1
227743,compression,0,1
227744,boots,0,1
227745,is,0,0
227746,preferable,0,0
227747,to,0,0
227748,anticoagulation,0,1
227749,therapy,0,1
227750,.,0,0
227751,The,0,0
227752,long-term,0,0
227753,effects,0,0
227754,of,0,0
227755,auditory,1,1
227756,training,1,1
227757,on,0,0
227758,children,0,0
227759,with,0,0
227760,autism,0,0
227761,.,0,0
227762,Eighty,0,0
227763,children,0,0
227764,",",0,0
227765,3-17,0,0
227766,years,0,0
227767,of,0,0
227768,age,0,0
227769,",",0,0
227770,with,0,0
227771,autism,0,0
227772,or,0,1
227773,Asperger,0,0
227774,syndrome,0,0
227775,and,0,0
227776,mild,0,0
227777,to,0,0
227778,severe,0,0
227779,distress,0,0
227780,in,0,0
227781,the,0,0
227782,presence,0,0
227783,of,0,0
227784,some,0,0
227785,sounds,0,0
227786,",",0,0
227787,were,0,0
227788,randomly,0,0
227789,allocated,0,0
227790,to,0,0
227791,two,0,0
227792,groups,0,0
227793,.,0,0
227794,The,0,0
227795,experimental,0,0
227796,group,0,0
227797,received,0,0
227798,auditory,1,1
227799,training,1,1
227800,and,1,0
227801,the,1,0
227802,control,1,1
227803,group,1,0
227804,listened,1,0
227805,to,1,0
227806,the,1,0
227807,same,1,0
227808,unmodified,1,1
227809,music,1,1
227810,under,1,0
227811,the,1,0
227812,same,1,0
227813,conditions,1,0
227814,.,1,0
227815,Significant,0,0
227816,improvements,0,0
227817,in,0,0
227818,behavior,0,0
227819,and,0,0
227820,severity,0,0
227821,of,0,0
227822,autism,0,0
227823,were,0,0
227824,maintained,0,0
227825,for,0,0
227826,12,0,0
227827,months,0,0
227828,by,0,0
227829,both,0,0
227830,groups,0,0
227831,.,0,0
227832,Informal,0,0
227833,data,0,0
227834,suggested,0,0
227835,that,0,0
227836,a,0,0
227837,range,0,0
227838,of,0,0
227839,abnormal,0,0
227840,responses,0,0
227841,to,0,0
227842,sound,0,0
227843,and,0,0
227844,other,0,0
227845,sensory,0,0
227846,abnormalities,0,0
227847,may,0,0
227848,also,0,0
227849,have,0,0
227850,improved,0,0
227851,.,0,0
227852,Verbal,0,1
227853,and,0,0
227854,performance,0,0
227855,IQ,0,0
227856,increased,0,0
227857,significantly,0,0
227858,3,0,0
227859,to,0,0
227860,12,0,0
227861,months,0,0
227862,after,0,0
227863,interventions,0,0
227864,.,0,0
227865,Findings,0,0
227866,suggest,0,0
227867,that,0,0
227868,some,0,0
227869,aspect,0,0
227870,of,0,0
227871,both,0,0
227872,auditory,1,1
227873,training,1,1
227874,and,1,0
227875,listening,1,1
227876,to,0,0
227877,selected,0,0
227878,unmodified,0,1
227879,music,0,1
227880,may,0,0
227881,have,0,0
227882,a,0,0
227883,beneficial,0,0
227884,effect,0,0
227885,on,0,0
227886,children,0,0
227887,with,0,0
227888,autism,0,0
227889,and,0,0
227890,sound,0,0
227891,sensitivity,0,0
227892,",",0,0
227893,and,0,0
227894,indicate,0,0
227895,a,0,0
227896,need,0,0
227897,for,0,0
227898,further,0,0
227899,research,0,0
227900,into,0,0
227901,the,0,0
227902,effects,0,0
227903,that,0,0
227904,led,0,0
227905,to,0,0
227906,these,0,0
227907,changes,0,0
227908,and,0,0
227909,the,0,0
227910,mechanisms,0,0
227911,involved,0,0
227912,in,0,0
227913,the,0,0
227914,sensory,0,0
227915,abnormalities,0,0
227916,commonly,0,0
227917,associated,0,0
227918,with,0,0
227919,autism,0,0
227920,.,0,0
227921,Secondary,0,0
227922,caries,0,0
227923,formation,0,0
227924,in,0,0
227925,vitro,0,0
227926,around,0,0
227927,glass,0,1
227928,ionomer-lined,0,1
227929,amalgam,0,1
227930,and,0,0
227931,composite,0,0
227932,restorations,0,1
227933,.,0,0
227934,The,0,0
227935,aim,0,0
227936,of,0,0
227937,this,0,0
227938,in,0,0
227939,vitro,0,0
227940,secondary,0,0
227941,caries,0,0
227942,study,0,0
227943,was,0,0
227944,to,0,0
227945,examine,0,0
227946,the,0,0
227947,glass-ionomer,1,1
227948,liner,1,1
227949,'s,1,0
227950,effect,0,0
227951,on,0,0
227952,wall-lesion,0,0
227953,inhibition,0,0
227954,when,0,0
227955,a,0,0
227956,conventional,0,1
227957,and,0,0
227958,a,0,0
227959,light-cured,0,1
227960,glass,1,1
227961,ionomer,1,1
227962,liner,1,1
227963,was,0,0
227964,placed,0,0
227965,under,0,0
227966,amalgam,1,1
227967,and,0,0
227968,composite,1,1
227969,resin,1,1
227970,restorations,0,1
227971,.,0,0
227972,Class,0,0
227973,V,0,0
227974,preparations,0,1
227975,in,0,0
227976,extracted,0,0
227977,upper,0,0
227978,premolars,0,0
227979,were,0,0
227980,used,0,0
227981,and,0,0
227982,ten,0,0
227983,restorations,0,1
227984,were,0,0
227985,used,0,0
227986,for,0,0
227987,each,0,0
227988,of,0,0
227989,the,0,0
227990,following,0,0
227991,groups,0,0
227992,:,0,0
227993,(,1,0
227994,i,1,0
227995,),1,0
227996,two,1,0
227997,layers,1,0
227998,of,1,0
227999,copal,1,0
228000,varnish,1,1
228001,and,1,0
228002,amalgam,1,1
228003,;,1,0
228004,(,1,0
228005,ii,1,0
228006,),1,0
228007,conventional,1,1
228008,glass-ionomer,1,1
228009,and,1,0
228010,amalgam,1,1
228011,;,1,0
228012,(,1,0
228013,iii,1,0
228014,),1,1
228015,light-cured,1,1
228016,glass-ionomer,1,1
228017,and,1,0
228018,amalgam,1,1
228019,;,1,0
228020,(,1,0
228021,iv,1,0
228022,),1,1
228023,bonding,1,1
228024,agent,1,0
228025,and,1,0
228026,light-cured,1,1
228027,composite,1,1
228028,resin,1,1
228029,;,1,0
228030,(,1,0
228031,v,1,1
228032,),1,0
228033,conventional,1,1
228034,glass-ionomer,1,1
228035,",",1,0
228036,bonding,1,0
228037,agent,1,0
228038,and,1,0
228039,light-cured,1,1
228040,composite,1,1
228041,resin,1,1
228042,;,1,0
228043,(,1,0
228044,vi,1,0
228045,),1,1
228046,light-cured,1,1
228047,glass-ionomer,1,1
228048,",",1,0
228049,extended,1,0
228050,0.3,1,0
228051,mm,1,0
228052,short,1,0
228053,of,1,0
228054,the,1,0
228055,enamel,1,0
228056,margin,1,0
228057,bonding,1,1
228058,agent,1,0
228059,and,1,0
228060,light-cured,1,1
228061,composite,1,1
228062,resin,1,1
228063,;,1,0
228064,and,1,0
228065,(,1,0
228066,vii,1,1
228067,),1,1
228068,light-cured,1,1
228069,glass-ionomer,1,1
228070,",",1,0
228071,extended,1,0
228072,1,1,0
228073,mm,1,0
228074,short,1,0
228075,of,1,0
228076,the,1,0
228077,enamel,1,0
228078,margin,1,0
228079,",",1,0
228080,bonding,1,0
228081,agent,1,0
228082,and,1,0
228083,light-cured,1,1
228084,composite,1,1
228085,resin,1,1
228086,.,1,0
228087,The,0,0
228088,teeth,0,0
228089,were,0,0
228090,thermocycled,0,1
228091,and,0,0
228092,artificial,1,0
228093,caries,1,0
228094,were,0,0
228095,created,0,0
228096,using,0,0
228097,an,0,0
228098,acid-gel,0,1
228099,.,0,0
228100,The,0,0
228101,results,0,0
228102,of,0,0
228103,this,0,0
228104,study,0,0
228105,showed,0,0
228106,that,0,0
228107,artificial,0,0
228108,recurrent,0,0
228109,caries,0,0
228110,can,0,0
228111,be,0,0
228112,reduced,0,0
228113,significantly,0,0
228114,(,0,0
228115,P,0,0
228116,<,0,0
228117,0.05,0,0
228118,),0,0
228119,with,0,0
228120,a,0,0
228121,glass-ionomer,1,1
228122,liner,1,1
228123,under,1,0
228124,amalgam,1,1
228125,restorations,1,1
228126,.,1,0
228127,The,0,0
228128,results,0,0
228129,also,0,0
228130,showed,0,0
228131,that,0,0
228132,when,0,0
228133,the,0,0
228134,light-cured,0,1
228135,glass-ionomer,1,1
228136,liner,0,1
228137,was,0,0
228138,placed,0,0
228139,0.3,0,0
228140,mm,0,0
228141,from,0,0
228142,the,0,0
228143,cavosurface,0,1
228144,margin,0,0
228145,under,0,0
228146,composite,0,1
228147,resin,0,1
228148,restoration,0,0
228149,",",0,0
228150,the,0,0
228151,artificial,0,0
228152,recurrent,0,0
228153,caries,0,0
228154,reduced,0,0
228155,significantly,0,0
228156,(,0,0
228157,P,0,0
228158,<,0,0
228159,0.05,0,0
228160,),0,0
228161,.,0,0
228162,Levosulpiride,1,1
228163,in,0,0
228164,functional,0,0
228165,dyspepsia,0,0
228166,:,0,0
228167,a,0,0
228168,multicentric,0,0
228169,",",0,0
228170,double-blind,0,0
228171,",",0,0
228172,controlled,0,0
228173,trial,0,0
228174,.,0,0
228175,Abnormalities,0,0
228176,in,0,0
228177,gastrointestinal,0,0
228178,motility,0,0
228179,have,0,0
228180,been,0,0
228181,reported,0,0
228182,in,0,0
228183,a,0,0
228184,substantial,0,0
228185,proportion,0,0
228186,of,0,0
228187,patients,0,0
228188,with,0,0
228189,functional,0,0
228190,dyspepsia,0,0
228191,",",0,0
228192,supporting,0,0
228193,the,0,0
228194,use,0,0
228195,of,0,0
228196,prokinetic,1,1
228197,drugs,1,0
228198,for,0,0
228199,treatment,0,0
228200,of,0,0
228201,dyspeptic,0,0
228202,symptoms,0,0
228203,.,0,0
228204,To,0,0
228205,evaluate,0,0
228206,efficacy,0,0
228207,and,0,0
228208,safety,0,0
228209,of,0,0
228210,levosulpiride,1,1
228211,in,0,0
228212,short-term,0,0
228213,treatment,0,0
228214,",",0,0
228215,1298,0,0
228216,patients,0,0
228217,were,0,0
228218,enrolled,0,0
228219,in,0,0
228220,a,0,0
228221,double-blind,0,0
228222,multicentric,0,0
228223,study,0,0
228224,carried,0,0
228225,out,0,0
228226,in,0,0
228227,45,0,0
228228,Italian,0,0
228229,Gastroenterology,0,0
228230,Departments,0,0
228231,.,0,0
228232,Patients,0,0
228233,were,0,0
228234,randomly,0,0
228235,assigned,0,0
228236,to,0,0
228237,either,0,0
228238,levosulpiride,1,1
228239,(,0,0
228240,25,0,0
228241,mg,0,1
228242,tid,0,0
228243,),0,0
228244,",",0,0
228245,domperidone,1,1
228246,(,0,0
228247,10,0,0
228248,mg,0,1
228249,tid,0,0
228250,),0,0
228251,",",0,0
228252,metoclopramide,1,1
228253,(,0,0
228254,10,0,0
228255,mg,0,1
228256,tid,0,1
228257,),0,0
228258,or,0,1
228259,placebo,1,1
228260,(,0,0
228261,1,0,0
228262,tablet,0,1
228263,tid,0,1
228264,),0,0
228265,for,0,0
228266,4,0,0
228267,weeks,0,0
228268,.,0,0
228269,Patients,0,0
228270,were,0,0
228271,selected,0,0
228272,on,0,0
228273,the,0,0
228274,basis,0,0
228275,of,0,0
228276,:,0,0
228277,a,0,0
228278,),0,0
228279,occurrence,0,0
228280,in,0,0
228281,the,0,0
228282,last,0,0
228283,4,0,0
228284,weeks,0,0
228285,of,0,0
228286,at,0,0
228287,least,0,0
228288,5/10,0,0
228289,selected,0,0
228290,symptoms,0,0
228291,(,0,0
228292,anorexia,0,0
228293,",",0,0
228294,nausea,0,0
228295,",",0,0
228296,vomiting,0,0
228297,",",0,0
228298,upper,0,0
228299,abdominal,0,0
228300,pain,0,0
228301,",",0,0
228302,postprandial,0,0
228303,bloating,0,0
228304,",",0,0
228305,abdominal,0,0
228306,fullness,0,0
228307,",",0,0
228308,early,0,0
228309,satiety,0,0
228310,",",0,0
228311,belching,0,0
228312,",",0,0
228313,heartburn,0,0
228314,",",0,0
228315,regurgitation,0,0
228316,),0,0
228317,",",0,0
228318,severity,0,0
228319,of,0,0
228320,which,0,0
228321,should,0,0
228322,reach/exceed,0,0
228323,a,0,0
228324,total,0,0
228325,score,0,0
228326,of,0,0
228327,8,0,0
228328,",",0,0
228329,as,0,0
228330,assessed,0,0
228331,by,0,0
228332,a,0,0
228333,specific,0,0
228334,scale,0,0
228335,ranging,0,0
228336,from,0,0
228337,0,0,0
228338,(,0,0
228339,absent,0,0
228340,),0,0
228341,to,0,0
228342,3,0,0
228343,(,0,0
228344,severe,0,0
228345,),0,0
228346,;,0,0
228347,b,0,0
228348,),0,0
228349,normal,0,0
228350,results,0,0
228351,of,0,0
228352,routine,0,0
228353,biochemical,0,0
228354,",",0,0
228355,ultrasound,0,1
228356,and,0,0
228357,endoscopic,0,1
228358,examinations,0,0
228359,.,0,0
228360,In,0,0
228361,addition,0,0
228362,",",0,0
228363,each,0,0
228364,patient,0,0
228365,subjectively,0,0
228366,evaluated,0,0
228367,efficacy,0,0
228368,of,0,0
228369,treatment,0,0
228370,by,0,0
228371,a,0,0
228372,visual,0,0
228373,analogue,0,0
228374,scale,0,0
228375,.,0,0
228376,Significant,0,0
228377,improvement,0,0
228378,was,0,0
228379,recorded,0,0
228380,for,0,0
228381,all,0,0
228382,symptoms,0,0
228383,at,0,0
228384,days,0,0
228385,10,0,0
228386,and,0,0
228387,28,0,0
228388,in,0,0
228389,all,0,0
228390,groups,0,0
228391,(,0,0
228392,p,0,0
228393,<,0,0
228394,0.001,0,0
228395,),0,0
228396,",",0,0
228397,but,0,0
228398,levosulpiride,1,1
228399,was,0,0
228400,significantly,0,0
228401,(,0,0
228402,p,0,0
228403,<,0,0
228404,0.01,0,0
228405,),0,0
228406,superior,0,0
228407,to,0,0
228408,domperidone,1,1
228409,",",1,0
228410,metoclopramide,1,1
228411,and,0,0
228412,placebo,1,1
228413,both,0,0
228414,in,0,0
228415,the,0,0
228416,overall,0,0
228417,clinical,0,0
228418,improvement,0,0
228419,scale,0,0
228420,as,0,0
228421,well,0,0
228422,as,0,0
228423,in,0,0
228424,a,0,0
228425,subgroup,0,0
228426,of,0,0
228427,symptoms,0,0
228428,(,0,0
228429,postprandial,0,0
228430,bloating,0,0
228431,",",0,0
228432,epigastric,0,0
228433,pain,0,0
228434,",",0,0
228435,heartburn,0,0
228436,),0,0
228437,.,0,0
228438,Active,1,0
228439,treatments,1,0
228440,and,0,0
228441,placebo,1,1
228442,were,0,0
228443,comparable,0,0
228444,as,0,0
228445,far,0,0
228446,as,0,0
228447,concerns,0,0
228448,occurrence,0,0
228449,of,0,0
228450,side-effects,0,0
228451,(,0,0
228452,12-20,0,0
228453,%,0,0
228454,),0,0
228455,including,0,0
228456,galactorrhoea,0,0
228457,",",0,0
228458,breast,0,0
228459,tenderness,0,0
228460,and,0,0
228461,menstrual,0,0
228462,changes,0,0
228463,.,0,0
228464,Ganciclovir,1,1
228465,use,0,0
228466,during,0,0
228467,mild,0,0
228468,renal,0,0
228469,failure,0,0
228470,in,0,0
228471,heart,1,0
228472,transplantation,1,0
228473,.,1,0
228474,Is,0,0
228475,there,0,0
228476,a,0,0
228477,difference,0,0
228478,?,0,0
228479,A,0,0
228480,prospective,0,0
228481,study,0,0
228482,comparing,0,0
228483,lateral,1,1
228484,and,1,0
228485,standard,1,1
228486,SMAS,1,1
228487,face,1,0
228488,lifts,1,1
228489,with,0,0
228490,extended,1,1
228491,SMAS,1,1
228492,and,0,0
228493,composite,1,0
228494,rhytidectomies,1,0
228495,.,1,0
228496,Presented,0,0
228497,is,0,0
228498,a,0,0
228499,prospective,0,0
228500,study,0,0
228501,comparing,0,0
228502,limited,1,0
228503,SMAS,1,1
228504,(,1,0
228505,lateral,1,1
228506,SMASectomy,1,1
228507,),1,0
228508,",",1,0
228509,conventional,1,1
228510,SMAS,1,1
228511,",",1,0
228512,extended,1,1
228513,SMAS,1,1
228514,",",0,0
228515,and,0,0
228516,composite,1,0
228517,rhytidectomies,1,0
228518,.,1,0
228519,Randomized,0,0
228520,patients,0,0
228521,received,0,0
228522,either,0,0
228523,a,0,0
228524,limited,1,0
228525,SMAS,1,1
228526,or,1,1
228527,conventional,1,1
228528,SMAS,1,1
228529,face,1,0
228530,lift,1,0
228531,on,1,0
228532,one,1,0
228533,side,1,0
228534,and,1,0
228535,an,1,0
228536,extended,1,1
228537,SMAS,1,1
228538,or,1,1
228539,composite,1,1
228540,rhytidectomy,1,1
228541,on,0,0
228542,the,0,0
228543,other,0,0
228544,.,0,0
228545,All,0,0
228546,procedures,0,0
228547,were,0,0
228548,performed,0,0
228549,at,0,0
228550,Manhattan,0,0
228551,Eye,0,1
228552,",",0,0
228553,Ear,0,0
228554,and,0,0
228555,Throat,0,0
228556,Hospital,0,0
228557,in,0,0
228558,accordance,0,0
228559,with,0,0
228560,their,0,0
228561,well-defined,0,0
228562,surgical,0,0
228563,descriptions,0,0
228564,.,0,0
228565,Postoperative,0,0
228566,courses,0,0
228567,were,0,0
228568,followed,0,0
228569,clinically,0,0
228570,for,0,0
228571,at,0,0
228572,least,0,0
228573,1,0,0
228574,year,0,0
228575,.,0,0
228576,Photographs,0,0
228577,were,0,0
228578,taken,0,0
228579,preoperatively,0,0
228580,and,0,0
228581,at,0,0
228582,6,0,0
228583,and,0,0
228584,12,0,0
228585,months,0,0
228586,postoperatively,0,0
228587,.,0,0
228588,Photographs,0,0
228589,were,0,0
228590,reviewed,0,0
228591,by,0,0
228592,three,0,0
228593,independent,0,0
228594,experienced,0,0
228595,face,0,0
228596,lift,0,0
228597,surgeons,0,0
228598,.,0,0
228599,The,0,0
228600,study,0,0
228601,comprises,0,0
228602,21,0,0
228603,patients,0,0
228604,",",0,0
228605,20,0,0
228606,women,0,0
228607,and,0,0
228608,1,0,0
228609,man,0,0
228610,",",0,0
228611,with,0,0
228612,a,0,0
228613,mean,0,0
228614,age,0,0
228615,of,0,0
228616,59,0,0
228617,years,0,0
228618,(,0,0
228619,range,0,0
228620,47,0,0
228621,to,0,0
228622,70,0,0
228623,years,0,0
228624,),0,0
228625,.,0,0
228626,Nineteen,0,0
228627,patients,0,0
228628,underwent,0,0
228629,primary,1,0
228630,rhytidectomies,1,0
228631,;,1,0
228632,two,0,0
228633,underwent,0,0
228634,secondary,1,0
228635,face,1,0
228636,lifts,1,1
228637,.,1,0
228638,For,0,0
228639,the,0,0
228640,first,0,0
228641,12,0,0
228642,patients,0,0
228643,",",0,0
228644,each,0,0
228645,had,0,0
228646,an,0,0
228647,extended,0,1
228648,SMAS,0,1
228649,procedure,0,0
228650,performed,0,0
228651,on,0,0
228652,one,0,0
228653,side,0,0
228654,;,0,0
228655,on,0,0
228656,the,0,0
228657,other,0,0
228658,",",0,0
228659,7,0,0
228660,had,0,0
228661,a,0,0
228662,conventional,1,1
228663,SMAS,1,1
228664,and,0,0
228665,5,0,0
228666,had,0,0
228667,a,0,0
228668,limited,1,0
228669,SMAS,1,1
228670,(,0,0
228671,lateral,0,1
228672,SMASectomy,0,1
228673,),0,0
228674,face,0,0
228675,lift,0,0
228676,.,0,0
228677,In,0,0
228678,the,0,0
228679,last,0,0
228680,9,0,0
228681,patients,0,0
228682,",",0,0
228683,a,0,0
228684,conventional,1,1
228685,SMAS,1,1
228686,was,0,0
228687,carried,0,0
228688,out,0,0
228689,on,0,0
228690,one,0,0
228691,side,0,0
228692,in,0,0
228693,8,0,0
228694,",",0,0
228695,a,0,0
228696,limited,1,0
228697,SMAS,1,1
228698,in,0,0
228699,1,0,0
228700,",",0,0
228701,and,0,0
228702,on,0,0
228703,the,0,0
228704,opposite,0,0
228705,side,0,0
228706,",",0,0
228707,a,0,0
228708,composite,1,0
228709,rhytidectomy,1,1
228710,was,0,0
228711,performed,0,0
228712,.,0,0
228713,Complications,0,0
228714,were,0,0
228715,few,0,0
228716,.,0,0
228717,Temporary,0,0
228718,weakness,0,0
228719,of,0,0
228720,the,0,0
228721,buccal,0,1
228722,branch,0,0
228723,of,0,0
228724,the,0,0
228725,facial,0,0
228726,nerve,0,0
228727,occurred,0,0
228728,in,0,0
228729,2,0,0
228730,patients,0,0
228731,on,0,0
228732,the,0,0
228733,side,0,0
228734,of,0,0
228735,the,0,0
228736,more,0,0
228737,extensive,0,0
228738,surgery,0,0
228739,.,0,0
228740,On,0,0
228741,the,0,0
228742,operating,0,0
228743,table,0,0
228744,at,0,0
228745,completion,0,0
228746,of,0,0
228747,the,0,0
228748,surgery,0,0
228749,",",0,0
228750,there,0,0
228751,was,0,0
228752,more,0,0
228753,improvement,0,0
228754,in,0,0
228755,reversal,0,0
228756,of,0,0
228757,midfacial,0,0
228758,ptosis,0,0
228759,and,0,0
228760,flattening,0,0
228761,of,0,0
228762,the,0,0
228763,nasolabial,0,0
228764,folds,0,0
228765,with,0,0
228766,both,0,0
228767,extended,1,1
228768,SMAS,1,1
228769,and,0,0
228770,composite,1,0
228771,rhytidectomies,1,0
228772,.,1,0
228773,The,0,0
228774,composite,0,0
228775,flap,0,1
228776,had,0,0
228777,the,0,0
228778,most,0,0
228779,dramatic,0,0
228780,effect,0,0
228781,on,0,0
228782,the,0,0
228783,nasolabial,0,0
228784,folds,0,0
228785,and,0,0
228786,oral,0,1
228787,commissure,0,0
228788,.,0,0
228789,After,0,0
228790,24,0,0
228791,hours,0,0
228792,",",0,0
228793,once,0,0
228794,swelling,0,0
228795,developed,0,0
228796,and,0,0
228797,facial,0,0
228798,motion,0,0
228799,became,0,0
228800,reactivated,0,0
228801,",",0,0
228802,the,0,0
228803,noticeable,0,0
228804,differences,0,0
228805,in,0,0
228806,the,0,0
228807,midface,0,0
228808,and,0,0
228809,nasolabial,0,0
228810,folds,0,0
228811,were,0,0
228812,lost,0,0
228813,.,0,0
228814,No,0,0
228815,discernible,0,0
228816,differences,0,0
228817,in,0,0
228818,facial,0,0
228819,halves,0,0
228820,were,0,0
228821,noted,0,0
228822,again,0,0
228823,.,0,0
228824,Differences,0,0
228825,between,0,0
228826,facial,0,0
228827,sides,0,0
228828,on,0,0
228829,the,0,0
228830,6-,0,1
228831,and,0,0
228832,12-month,0,0
228833,postoperative,0,0
228834,photographs,0,0
228835,were,0,0
228836,not,0,0
228837,detectable,0,0
228838,.,0,0
228839,We,0,0
228840,conclude,0,0
228841,that,0,0
228842,for,0,0
228843,routine,0,0
228844,facial,0,0
228845,plasty,0,1
228846,",",0,0
228847,comparable,0,0
228848,clinical,0,0
228849,outcomes,0,0
228850,are,0,0
228851,obtained,0,0
228852,at,0,0
228853,6,0,0
228854,months,0,0
228855,and,0,0
228856,1,0,0
228857,year,0,0
228858,with,0,0
228859,limited,1,0
228860,(,1,0
228861,lateral,1,1
228862,SMASectomy,1,1
228863,),1,0
228864,and,0,0
228865,conventional,1,1
228866,SMAS,1,1
228867,face,0,0
228868,lifts,0,1
228869,compared,0,0
228870,with,0,0
228871,extended,1,1
228872,SMAS,1,1
228873,and,0,0
228874,composite,1,0
228875,rhytidectomies,1,0
228876,.,1,0
228877,All,0,0
228878,procedures,0,0
228879,are,0,0
228880,lacking,0,0
228881,in,0,0
228882,their,0,0
228883,improvement,0,0
228884,of,0,0
228885,midface,0,0
228886,ptosis,0,0
228887,and,0,0
228888,the,0,0
228889,nasolabial,0,0
228890,folds,0,0
228891,.,0,0
228892,The,0,0
228893,increased,0,0
228894,surgical,0,0
228895,risks,0,0
228896,",",0,0
228897,morbidity,0,0
228898,",",0,0
228899,and,0,0
228900,convalescence,0,0
228901,associated,0,0
228902,with,0,0
228903,those,0,0
228904,more,0,0
228905,extensive,0,0
228906,procedures,0,0
228907,do,0,0
228908,not,0,0
228909,seem,0,0
228910,to,0,0
228911,be,0,0
228912,warranted,0,0
228913,in,0,0
228914,the,0,0
228915,average,0,0
228916,patient,0,0
228917,.,0,0
228918,Dental,0,1
228919,bacteremia,0,0
228920,in,0,0
228921,children,0,0
228922,.,0,0
228923,Bacteremia,0,0
228924,resulting,0,0
228925,from,0,0
228926,dental,1,1
228927,extraction,1,1
228928,is,1,0
228929,regarded,0,0
228930,as,0,0
228931,an,0,0
228932,important,0,0
228933,cause,0,0
228934,of,0,0
228935,bacterial,0,0
228936,endocarditis,0,0
228937,",",0,0
228938,and,0,0
228939,it,0,0
228940,is,0,0
228941,therefore,0,0
228942,recommended,0,0
228943,that,0,0
228944,patients,0,0
228945,undergoing,0,0
228946,tooth,0,0
228947,extraction,0,1
228948,be,0,0
228949,given,0,0
228950,prophylactic,1,0
228951,antibiotics,1,1
228952,.,1,0
228953,As,0,0
228954,dental,0,0
228955,procedures,0,0
228956,other,0,0
228957,than,0,0
228958,extractions,0,0
228959,may,0,0
228960,also,0,0
228961,cause,0,0
228962,bacteremias,0,0
228963,",",0,0
228964,we,0,0
228965,studied,0,0
228966,a,0,0
228967,variety,0,0
228968,of,0,0
228969,dental,0,0
228970,procedures,0,0
228971,routinely,0,0
228972,used,0,0
228973,in,0,0
228974,pediatric,0,0
228975,dentistry,0,0
228976,.,0,0
228977,Blood,0,0
228978,samples,0,0
228979,for,0,0
228980,cultures,0,0
228981,were,0,0
228982,obtained,0,0
228983,30,0,0
228984,s,0,0
228985,after,0,0
228986,each,0,0
228987,of,0,0
228988,13,0,0
228989,dental,0,0
228990,operative,0,0
228991,procedures,0,0
228992,in,0,0
228993,735,0,0
228994,anesthetized,0,0
228995,children,0,0
228996,aged,0,0
228997,2-16,0,0
228998,years,0,0
228999,.,0,0
229000,Four,0,0
229001,procedures,0,0
229002,used,0,0
229003,for,0,0
229004,conservative,0,1
229005,dentistry,0,0
229006,caused,0,0
229007,bacteremias,0,0
229008,significantly,0,0
229009,more,0,0
229010,often,0,0
229011,than,0,0
229012,the,0,0
229013,baseline,0,0
229014,value,0,0
229015,of,0,0
229016,9.4,0,0
229017,%,0,0
229018,:,0,0
229019,polishing,1,1
229020,teeth,1,0
229021,24.5,0,0
229022,%,0,0
229023,",",0,0
229024,intraligamental,1,0
229025,injection,1,1
229026,96.6,0,0
229027,%,0,0
229028,",",0,0
229029,rubber,1,1
229030,dam,1,1
229031,placement,1,1
229032,29.4,0,0
229033,%,0,0
229034,",",0,0
229035,and,0,0
229036,matrix,1,1
229037,band,1,0
229038,with,1,0
229039,wedge,1,1
229040,placement,1,1
229041,32.1,0,0
229042,%,0,0
229043,.,0,0
229044,In,0,0
229045,comparison,0,0
229046,",",0,0
229047,toothbrushing,0,1
229048,alone,0,0
229049,caused,0,0
229050,a,0,0
229051,bacteremia,0,0
229052,on,0,0
229053,38.5,0,0
229054,%,0,0
229055,of,0,0
229056,occasions,0,0
229057,.,0,0
229058,The,0,0
229059,organisms,0,0
229060,isolated,0,0
229061,were,0,0
229062,typical,0,0
229063,of,0,0
229064,odontogenic,0,0
229065,bacteremias,0,0
229066,in,0,0
229067,that,0,0
229068,50,0,0
229069,%,0,0
229070,of,0,0
229071,the,0,0
229072,isolates,0,0
229073,were,0,0
229074,identified,0,0
229075,as,0,0
229076,varieties,0,0
229077,of,0,0
229078,viridans,0,0
229079,streptococci,0,0
229080,.,0,0
229081,These,0,0
229082,data,0,0
229083,show,0,0
229084,that,0,0
229085,a,0,0
229086,wider,0,0
229087,variety,0,0
229088,of,0,0
229089,dental,0,0
229090,procedures,0,0
229091,than,0,0
229092,was,0,0
229093,previously,0,0
229094,documented,0,0
229095,cause,0,0
229096,bacteremia,0,0
229097,.,0,0
229098,[,1,0
229099,Therapy,1,1
229100,of,0,0
229101,metastatic,0,0
229102,endocrine,0,0
229103,tumors,0,0
229104,of,0,0
229105,the,0,0
229106,gastrointestinal,0,0
229107,tract,0,0
229108,],0,0
229109,.,0,0
229110,[,0,0
229111,Drug,0,1
229112,therapy,0,1
229113,of,0,0
229114,condylomata,0,0
229115,acuminata,0,0
229116,],0,0
229117,.,0,0
229118,This,0,0
229119,study,0,0
229120,seeks,0,0
229121,to,0,0
229122,evaluate,0,0
229123,two,0,0
229124,candidate,0,0
229125,regimens,0,1
229126,(,1,0
229127,5-fluorouracil,1,1
229128,and,0,0
229129,interferon,1,1
229130,),1,0
229131,as,0,0
229132,adjuvants,0,1
229133,to,0,0
229134,optimally,0,0
229135,performed,0,0
229136,laser,1,1
229137,surgery,1,0
229138,in,0,0
229139,the,0,0
229140,treatment,0,0
229141,of,0,0
229142,condylomata,0,0
229143,acuminata,0,0
229144,.,0,0
229145,Skillful,0,0
229146,laser,0,1
229147,ablation,0,1
229148,can,0,0
229149,remove,0,0
229150,any,0,0
229151,volume,0,0
229152,of,0,0
229153,human,0,0
229154,papillomavirus-associated,0,0
229155,vulvar,0,0
229156,disease,0,0
229157,but,0,0
229158,can,0,0
229159,not,0,0
229160,prevent,0,0
229161,reactivation,0,0
229162,of,0,0
229163,the,0,0
229164,surrounding,0,0
229165,latent,0,0
229166,viral,0,0
229167,reservoir,0,0
229168,during,0,0
229169,postoperative,0,0
229170,healing,0,0
229171,.,0,0
229172,Conversely,0,0
229173,",",0,0
229174,interferon,1,1
229175,and,0,0
229176,5-fluorouracil,1,1
229177,are,0,0
229178,relatively,0,0
229179,ineffective,0,0
229180,as,0,0
229181,primary,0,0
229182,therapies,0,0
229183,.,0,0
229184,This,0,0
229185,study,0,0
229186,involves,0,0
229187,118,0,0
229188,evaluable,0,0
229189,patients,0,0
229190,:,0,0
229191,32,0,0
229192,in,0,0
229193,the,0,0
229194,laser-CO2,1,1
229195,group,0,0
229196,",",0,0
229197,34,0,0
229198,in,0,0
229199,the,0,0
229200,5-fluorouracil,1,1
229201,group,1,0
229202,and,1,0
229203,52,1,0
229204,in,1,0
229205,the,1,0
229206,interferon,1,1
229207,group,1,0
229208,.,1,0
229209,At,0,0
229210,assessment,0,0
229211,of,0,0
229212,final,0,0
229213,outcome,0,0
229214,",",0,0
229215,it,0,0
229216,was,0,0
229217,found,0,0
229218,that,0,0
229219,43,0,0
229220,of,0,0
229221,52,0,0
229222,(,0,0
229223,82,0,0
229224,%,0,0
229225,),0,0
229226,assessable,0,0
229227,patients,0,0
229228,in,0,0
229229,the,0,0
229230,adjuvant,0,1
229231,interferon,1,1
229232,arm,0,0
229233,were,0,0
229234,controlled,0,0
229235,by,0,0
229236,a,0,0
229237,single,0,0
229238,laser,0,1
229239,ablation,0,1
229240,as,0,0
229241,compared,0,0
229242,with,0,0
229243,only,0,0
229244,17,0,0
229245,of,0,0
229246,34,0,0
229247,(,0,0
229248,50,0,0
229249,%,0,0
229250,),0,0
229251,in,0,0
229252,the,0,0
229253,5-fluorouracil,1,1
229254,group,0,0
229255,and,0,0
229256,13,0,0
229257,of,0,0
229258,32,0,0
229259,(,0,0
229260,40,0,0
229261,%,0,0
229262,),0,0
229263,in,0,0
229264,the,0,0
229265,laser,1,1
229266,alone,1,1
229267,group,0,0
229268,.,0,0
229269,There,0,0
229270,was,0,0
229271,no,0,0
229272,statistical,0,0
229273,difference,0,0
229274,in,0,0
229275,outcome,0,0
229276,within,0,0
229277,the,0,0
229278,5-fluorouracil,1,1
229279,and,0,0
229280,laser,0,1
229281,only,0,0
229282,arms,0,0
229283,.,0,0
229284,Conversely,0,0
229285,",",0,0
229286,a,0,0
229287,relatively,0,0
229288,low,0,0
229289,dose,0,0
229290,of,0,0
229291,recombinant,0,1
229292,interferon,1,1
229293,",",0,0
229294,used,0,0
229295,in,0,0
229296,combination,0,1
229297,with,0,0
229298,effective,0,0
229299,surgical,1,0
229300,deleulking,1,0
229301,",",0,0
229302,can,0,0
229303,markedly,0,0
229304,reduce,0,0
229305,the,0,0
229306,risk,0,0
229307,of,0,0
229308,postoperative,0,0
229309,recurrence,0,0
229310,.,0,0
229311,Feasibility,0,0
229312,and,0,0
229313,effects,0,0
229314,of,0,0
229315,nurse,1,1
229316,run,1,0
229317,clinics,1,0
229318,for,0,0
229319,patients,0,0
229320,with,0,0
229321,epilepsy,0,0
229322,in,0,0
229323,general,0,0
229324,practice,0,0
229325,:,0,0
229326,randomised,0,0
229327,controlled,0,0
229328,trial,0,0
229329,.,0,0
229330,Epilepsy,0,0
229331,Care,0,0
229332,Evaluation,0,0
229333,Group,0,0
229334,.,0,0
229335,OBJECTIVE,0,0
229336,To,0,0
229337,test,0,0
229338,the,0,0
229339,feasibility,0,0
229340,and,0,0
229341,effect,0,0
229342,of,0,0
229343,nurse,1,1
229344,run,1,0
229345,epilepsy,1,0
229346,clinics,1,0
229347,in,0,0
229348,primary,0,0
229349,care,0,0
229350,.,0,0
229351,DESIGN,0,0
229352,A,0,0
229353,randomised,0,0
229354,controlled,0,0
229355,trial,0,0
229356,of,0,0
229357,nurse,1,1
229358,run,1,0
229359,clinics,1,0
229360,versus,0,0
229361,usual,1,0
229362,care,1,1
229363,.,1,0
229364,SETTING,0,0
229365,Six,0,0
229366,general,0,0
229367,practices,0,0
229368,in,0,0
229369,the,0,0
229370,South,0,0
229371,Thames,0,0
229372,region,0,0
229373,.,0,0
229374,SUBJECTS,0,0
229375,251,0,0
229376,patients,0,0
229377,aged,0,0
229378,over,0,0
229379,15,0,0
229380,years,0,0
229381,who,0,0
229382,were,0,0
229383,taking,0,0
229384,anti-epileptic,0,1
229385,drugs,0,1
229386,or,0,0
229387,had,0,0
229388,a,0,0
229389,diagnosis,0,0
229390,of,0,0
229391,epilepsy,0,0
229392,and,0,0
229393,an,0,0
229394,attack,0,0
229395,in,0,0
229396,the,0,0
229397,past,0,0
229398,two,0,0
229399,years,0,0
229400,who,0,0
229401,met,0,0
229402,specified,0,0
229403,inclusion,0,0
229404,criteria,0,0
229405,and,0,0
229406,had,0,0
229407,responded,0,0
229408,to,0,0
229409,a,0,0
229410,questionnaire,0,0
229411,.,0,0
229412,MAIN,0,0
229413,OUTCOME,0,0
229414,MEASURES,0,0
229415,Questionnaire,1,0
229416,responses,1,0
229417,and,0,0
229418,recording,0,0
229419,of,0,0
229420,key,0,0
229421,variables,0,0
229422,extracted,0,0
229423,from,0,0
229424,the,0,0
229425,clinical,0,0
229426,records,0,0
229427,before,0,0
229428,and,0,0
229429,after,0,0
229430,the,0,0
229431,intervention,0,1
229432,.,0,0
229433,RESULTS,0,0
229434,127,0,0
229435,patients,0,0
229436,were,0,0
229437,randomised,0,0
229438,to,0,0
229439,a,0,0
229440,nurse,0,1
229441,run,0,0
229442,clinic,0,0
229443,",",0,0
229444,of,0,0
229445,whom,0,0
229446,106,0,0
229447,(,0,0
229448,83,0,0
229449,%,0,0
229450,),0,0
229451,attended,0,0
229452,.,0,0
229453,The,0,0
229454,nurse,0,0
229455,wrote,0,0
229456,28,0,0
229457,letters,0,0
229458,to,0,0
229459,the,0,0
229460,general,0,0
229461,practitioners,0,0
229462,suggesting,0,0
229463,changes,1,0
229464,in,1,0
229465,epilepsy,1,0
229466,management,1,0
229467,.,1,0
229468,For,0,0
229469,this,0,0
229470,intervention,0,1
229471,group,0,0
229472,compared,0,0
229473,with,0,0
229474,the,0,0
229475,usual,1,1
229476,care,1,1
229477,group,0,0
229478,there,0,0
229479,was,0,0
229480,a,0,0
229481,highly,0,0
229482,significant,0,0
229483,improvement,0,0
229484,in,0,0
229485,the,0,0
229486,level,0,0
229487,of,0,0
229488,advice,0,1
229489,recorded,0,0
229490,as,0,0
229491,having,0,0
229492,been,0,0
229493,given,0,0
229494,on,0,0
229495,drug,0,0
229496,compliance,0,0
229497,",",0,0
229498,adverse,0,0
229499,drug,0,0
229500,effects,0,0
229501,",",0,0
229502,driving,0,0
229503,",",0,0
229504,alcohol,0,1
229505,intake,0,0
229506,",",0,0
229507,and,0,0
229508,self,0,0
229509,help,0,0
229510,groups,0,0
229511,.,0,0
229512,CONCLUSIONS,0,0
229513,Nurse,1,0
229514,run,1,0
229515,clinics,1,0
229516,for,0,0
229517,patients,0,0
229518,with,0,0
229519,epilepsy,0,0
229520,were,0,0
229521,feasible,0,0
229522,and,0,0
229523,well,0,0
229524,attended,0,0
229525,.,0,0
229526,Such,0,0
229527,clinics,0,0
229528,can,0,0
229529,significantly,0,0
229530,improve,0,0
229531,the,0,0
229532,level,0,0
229533,of,0,0
229534,advice,0,1
229535,and,0,0
229536,drug,0,0
229537,management,0,0
229538,recorded,0,0
229539,.,0,0
229540,The,0,0
229541,management,0,0
229542,of,0,0
229543,dermoid,0,0
229544,cysts,0,0
229545,--,0,0
229546,a,0,0
229547,comparative,0,0
229548,study,0,0
229549,of,0,0
229550,laparoscopy,1,1
229551,and,0,0
229552,laparotomy,1,1
229553,.,1,0
229554,The,0,0
229555,aim,0,0
229556,of,0,0
229557,our,0,0
229558,study,0,0
229559,was,0,0
229560,to,0,0
229561,compare,0,0
229562,laparoscopy,1,1
229563,with,0,0
229564,laparotomy,1,1
229565,for,0,0
229566,the,0,0
229567,removal,0,0
229568,of,0,0
229569,ovarian,0,0
229570,dermoid,0,0
229571,cysts,0,0
229572,.,0,0
229573,Thirty-eight,0,0
229574,women,0,0
229575,with,0,0
229576,benign,0,0
229577,ovarian,0,0
229578,dermoid,0,0
229579,cyst,0,0
229580,were,0,0
229581,allocated,0,0
229582,for,0,0
229583,either,0,0
229584,laparoscopy,1,1
229585,(,0,0
229586,18,0,0
229587,patients,0,0
229588,),0,0
229589,or,0,1
229590,laparotomy,1,1
229591,(,0,0
229592,20,0,0
229593,patients,0,0
229594,),0,0
229595,.,0,0
229596,The,0,0
229597,two,0,0
229598,groups,0,0
229599,were,0,0
229600,compared,0,0
229601,for,0,0
229602,operative,0,0
229603,and,0,0
229604,hospitalization,0,0
229605,times,0,0
229606,and,0,0
229607,postoperative,0,0
229608,course,0,0
229609,.,0,0
229610,Operating,0,0
229611,time,0,0
229612,was,0,0
229613,longer,0,0
229614,(,0,0
229615,93.6,0,0
229616,+/-,0,0
229617,23.8,0,0
229618,min,0,0
229619,),0,0
229620,and,0,0
229621,hospitalization,0,0
229622,time,0,0
229623,significantly,0,0
229624,shorter,0,0
229625,(,0,0
229626,22.4,0,0
229627,+/-,0,0
229628,6.6,0,0
229629,h,0,0
229630,),0,0
229631,in,0,0
229632,the,0,0
229633,laparoscopy,0,1
229634,group,0,0
229635,.,0,0
229636,No,0,0
229637,complications,0,0
229638,were,0,0
229639,reported,0,0
229640,in,0,0
229641,either,0,0
229642,group,0,0
229643,.,0,0
229644,We,0,0
229645,conclude,0,0
229646,that,0,0
229647,operative,1,0
229648,laparoscopy,1,1
229649,is,0,0
229650,a,0,0
229651,safe,0,0
229652,procedure,0,0
229653,for,0,0
229654,the,0,0
229655,removal,0,0
229656,of,0,0
229657,dermoid,0,0
229658,ovarian,0,0
229659,cysts,0,0
229660,and,0,0
229661,is,0,0
229662,as,0,0
229663,effective,0,0
229664,as,0,0
229665,laparotomy,1,1
229666,.,1,0
229667,Opioid-immune,0,0
229668,interactions,0,0
229669,in,0,0
229670,autism,0,0
229671,:,0,0
229672,behavioural,0,0
229673,and,0,0
229674,immunological,0,0
229675,assessment,0,0
229676,during,0,0
229677,a,0,0
229678,double-blind,0,0
229679,treatment,0,0
229680,with,0,0
229681,naltrexone,1,1
229682,.,1,0
229683,The,0,0
229684,emerging,0,0
229685,concept,0,0
229686,of,0,0
229687,opioid,0,1
229688,peptides,0,0
229689,as,0,0
229690,a,0,0
229691,new,0,0
229692,class,0,0
229693,of,0,0
229694,chemical,0,0
229695,messengers,0,0
229696,of,0,0
229697,the,0,0
229698,neuroimmune,0,0
229699,axis,0,0
229700,and,0,0
229701,the,0,0
229702,presence,0,0
229703,of,0,0
229704,a,0,0
229705,number,0,0
229706,of,0,0
229707,immunological,0,0
229708,abnormalities,0,0
229709,in,0,0
229710,infantile,0,0
229711,autism,0,0
229712,prompted,0,0
229713,us,0,0
229714,to,0,0
229715,correlate,0,0
229716,biological,0,0
229717,(,0,0
229718,hormonal,0,0
229719,and,0,0
229720,immunological,0,0
229721,),0,0
229722,determinations,0,0
229723,and,0,0
229724,behavioural,0,0
229725,performances,0,0
229726,during,0,0
229727,treatment,0,0
229728,with,0,0
229729,the,0,0
229730,potent,0,0
229731,opiate,0,1
229732,antagonist,0,1
229733,",",0,0
229734,naltrexone,1,1
229735,(,1,0
229736,NAL,1,1
229737,),1,0
229738,.,1,0
229739,Twelve,0,0
229740,autistic,0,0
229741,patients,0,0
229742,ranging,0,0
229743,from,0,0
229744,7,0,0
229745,to,0,0
229746,15,0,0
229747,years,0,0
229748,",",0,0
229749,diagnosed,0,0
229750,according,0,0
229751,to,0,0
229752,DSM-III-R,0,0
229753,",",0,0
229754,entered,0,0
229755,a,0,0
229756,double-blind,1,0
229757,crossover,1,0
229758,study,1,0
229759,with,1,0
229760,NAL,1,0
229761,at,1,0
229762,the,1,0
229763,doses,1,0
229764,of,1,0
229765,0.5,1,0
229766,",",1,0
229767,1.0,1,0
229768,and,1,0
229769,1.5,1,0
229770,mg/kg,1,0
229771,every,1,0
229772,48,1,0
229773,hours,1,0
229774,.,1,0
229775,The,1,0
229776,behavioural,1,0
229777,evaluation,1,0
229778,was,1,0
229779,conducted,1,0
229780,using,1,0
229781,the,1,0
229782,specific,1,0
229783,BSE,1,0
229784,and,1,0
229785,CARS,1,1
229786,rating,1,0
229787,scales,1,0
229788,NAL,1,0
229789,treatment,1,0
229790,produced,1,0
229791,a,1,0
229792,significant,1,0
229793,reduction,1,0
229794,of,1,0
229795,the,1,0
229796,autistic,1,0
229797,symptomatology,1,0
229798,in,1,0
229799,seven,1,0
229800,(,1,0
229801,responders,1,0
229802,),1,0
229803,out,1,0
229804,of,1,0
229805,12,1,0
229806,children,1,0
229807,.,1,0
229808,The,0,0
229809,behavioural,0,0
229810,improvement,0,0
229811,was,0,0
229812,accompanied,0,0
229813,by,0,0
229814,alterations,0,0
229815,in,0,0
229816,the,0,0
229817,distribution,0,0
229818,of,0,0
229819,the,0,0
229820,major,0,0
229821,lymphocyte,0,0
229822,subsets,0,0
229823,",",0,0
229824,with,0,0
229825,a,0,0
229826,significant,0,0
229827,increase,0,0
229828,of,0,0
229829,the,0,0
229830,T-helper-inducers,0,0
229831,(,0,0
229832,CD4+CD8-,0,1
229833,),0,0
229834,and,0,0
229835,a,0,0
229836,significant,0,0
229837,reduction,0,0
229838,of,0,0
229839,the,0,0
229840,T-cytotoxic-suppressor,0,0
229841,(,0,0
229842,CD4-CD8+,0,0
229843,),0,0
229844,resulting,0,0
229845,in,0,0
229846,a,0,0
229847,normalization,0,0
229848,of,0,0
229849,the,0,0
229850,CD4/CD8,0,0
229851,ratio,0,0
229852,.,0,0
229853,Changes,0,0
229854,in,0,0
229855,natural,0,0
229856,killer,0,0
229857,cells,0,0
229858,and,0,0
229859,activity,0,0
229860,were,0,0
229861,inversely,0,0
229862,related,0,0
229863,to,0,0
229864,plasma,0,0
229865,beta-endorphin,0,0
229866,levels,0,0
229867,.,0,0
229868,It,0,0
229869,is,0,0
229870,suggested,0,0
229871,that,0,0
229872,the,0,0
229873,mechanisms,0,0
229874,underlying,0,0
229875,opioid-immune,0,1
229876,interactions,0,0
229877,are,0,0
229878,altered,0,0
229879,in,0,0
229880,this,0,0
229881,population,0,0
229882,of,0,0
229883,autistic,0,0
229884,children,0,0
229885,and,0,0
229886,that,0,0
229887,an,0,0
229888,immunological,0,0
229889,screening,0,0
229890,may,0,0
229891,have,0,0
229892,prognostic,0,0
229893,value,0,0
229894,for,0,0
229895,the,0,0
229896,pharmacological,1,0
229897,therapy,1,1
229898,with,1,0
229899,opiate,1,0
229900,antagonists,1,0
229901,.,1,0
229902,Marginal,0,0
229903,zone,0,0
229904,B,0,0
229905,cell,0,0
229906,lymphoma,0,0
229907,of,0,0
229908,the,0,0
229909,parotid,0,0
229910,glands,0,0
229911,:,0,0
229912,results,0,0
229913,of,0,0
229914,a,0,0
229915,randomised,0,0
229916,trial,0,0
229917,comparing,0,0
229918,radiotherapy,1,1
229919,to,0,0
229920,combined,1,0
229921,therapy,1,1
229922,.,1,0
229923,39,0,0
229924,patients,0,0
229925,with,0,0
229926,marginal,0,0
229927,zone,0,0
229928,B,0,0
229929,cell,0,0
229930,lymphoma,0,0
229931,(,0,0
229932,MZBCL,0,0
229933,),0,0
229934,of,0,0
229935,the,0,0
229936,parotid,0,0
229937,glands,0,0
229938,(,0,0
229939,stages,0,0
229940,I,0,0
229941,or,0,0
229942,II,0,0
229943,),0,0
229944,were,0,0
229945,studied,0,0
229946,.,0,0
229947,They,0,0
229948,were,0,0
229949,randomized,0,0
229950,to,0,0
229951,be,0,0
229952,treated,0,0
229953,with,0,0
229954,either,0,0
229955,radiotherapy,1,1
229956,alone,1,1
229957,(,0,0
229958,extended,0,0
229959,fields,0,0
229960,",",0,0
229961,4500,0,0
229962,cGy,0,0
229963,),0,0
229964,or,0,1
229965,radiotherapy,1,1
229966,(,1,0
229967,the,1,0
229968,same,1,0
229969,schedule,1,1
229970,),1,0
229971,plus,1,1
229972,adjuvant,1,1
229973,chemotherapy,1,1
229974,(,1,0
229975,cyclophosphamide,1,1
229976,",",1,0
229977,vincristine,1,1
229978,and,1,0
229979,prednisone,1,1
229980,),1,0
229981,.,1,0
229982,The,0,0
229983,end,0,0
229984,points,0,0
229985,were,0,0
229986,survival,0,0
229987,and,0,0
229988,time,0,0
229989,to,0,0
229990,treatment,0,0
229991,failure,0,0
229992,(,0,0
229993,TTF,0,0
229994,),0,0
229995,.,0,0
229996,Patients,0,0
229997,who,0,0
229998,received,0,0
229999,radiotherapy,1,1
230000,alone,0,0
230001,had,0,0
230002,a,0,0
230003,complete,0,0
230004,remission,0,0
230005,rate,0,0
230006,of,0,0
230007,100,0,0
230008,%,0,0
230009,",",0,0
230010,the,0,0
230011,TTF,0,0
230012,was,0,0
230013,90,0,0
230014,%,0,0
230015,at,0,0
230016,5,0,0
230017,years,0,0
230018,and,0,0
230019,overall,0,0
230020,survival,0,0
230021,at,0,0
230022,5,0,0
230023,years,0,0
230024,was,0,0
230025,90,0,0
230026,%,0,0
230027,with,0,0
230028,no,0,0
230029,statistical,0,0
230030,difference,0,0
230031,when,0,0
230032,compared,0,0
230033,with,0,0
230034,patients,0,0
230035,who,0,0
230036,received,0,0
230037,combined,1,1
230038,therapy,1,1
230039,[,0,0
230040,100,0,0
230041,",",0,0
230042,80,0,0
230043,and,0,0
230044,95,0,0
230045,%,0,0
230046,",",0,0
230047,respectively,0,0
230048,(,0,0
230049,P,0,0
230050,=,0,0
230051,0.5,0,1
230052,),0,0
230053,],0,0
230054,.,0,0
230055,Although,0,0
230056,adjuvant,1,1
230057,chemotherapy,1,1
230058,was,0,0
230059,well,0,0
230060,tolerated,0,0
230061,",",0,0
230062,the,0,0
230063,use,0,0
230064,of,0,0
230065,this,0,0
230066,therapeutic,0,0
230067,approach,0,1
230068,in,0,0
230069,patients,0,0
230070,with,0,0
230071,early,0,0
230072,stage,0,0
230073,MZBCL,0,0
230074,did,0,0
230075,not,0,0
230076,offer,0,0
230077,any,0,0
230078,advantage,0,0
230079,over,0,0
230080,radiotherapy,0,1
230081,alone,0,0
230082,as,0,0
230083,the,0,0
230084,initial,0,0
230085,treatment,0,0
230086,.,0,0
230087,Until,0,0
230088,now,0,0
230089,",",0,0
230090,radiotherapy,1,1
230091,was,0,0
230092,considered,0,0
230093,the,0,0
230094,treatment,0,0
230095,of,0,0
230096,choice,0,0
230097,in,0,0
230098,this,0,0
230099,clinical,0,0
230100,setting,0,0
230101,of,0,0
230102,patients,0,0
230103,.,0,0
230104,Temporal,0,0
230105,variation,0,0
230106,in,0,0
230107,the,0,0
230108,effects,0,0
230109,of,0,0
230110,ophthalmic,1,0
230111,timolol,1,1
230112,on,0,0
230113,cardiovascular,0,0
230114,and,0,0
230115,respiratory,0,0
230116,functions,0,0
230117,in,0,0
230118,healthy,0,0
230119,men,0,0
230120,.,0,0
230121,This,0,0
230122,study,0,0
230123,examined,0,0
230124,the,0,0
230125,effects,0,0
230126,of,0,0
230127,ophthalmic,1,0
230128,timolol,1,1
230129,and,0,0
230130,time,0,0
230131,of,0,0
230132,administration,0,0
230133,on,0,0
230134,cardiovascular,0,0
230135,and,0,0
230136,respiratory,0,0
230137,functions,0,0
230138,in,0,0
230139,healthy,0,0
230140,young,0,0
230141,male,0,0
230142,volunteers,0,0
230143,.,0,0
230144,Eight,0,0
230145,participants,0,0
230146,(,0,0
230147,mean,0,0
230148,age,0,0
230149,+/-,0,0
230150,standard,0,1
230151,deviation,0,0
230152,",",0,0
230153,22,0,0
230154,+/-,0,0
230155,0.9,0,0
230156,years,0,0
230157,),0,0
230158,received,0,0
230159,either,0,0
230160,50,0,0
230161,microL,0,0
230162,of,0,0
230163,0.5,0,1
230164,%,0,0
230165,timolol,1,1
230166,or,0,1
230167,placebo,1,1
230168,in,0,0
230169,the,0,0
230170,lower,0,0
230171,conjunctival,0,0
230172,sacs,0,0
230173,of,0,0
230174,both,0,0
230175,eyes,0,0
230176,in,0,0
230177,the,0,0
230178,morning,0,0
230179,or,0,0
230180,evening,0,0
230181,.,0,0
230182,Intraocular,0,0
230183,pressure,0,0
230184,",",0,0
230185,blood,0,0
230186,pressure,0,0
230187,",",0,0
230188,heart,0,0
230189,rate,0,0
230190,",",0,0
230191,and,0,0
230192,respiratory,0,0
230193,functions,0,0
230194,",",0,0
230195,including,0,0
230196,percent,0,0
230197,forced,0,0
230198,expiratory,0,0
230199,volume,0,0
230200,in,0,0
230201,1,0,0
230202,second,0,0
230203,and,0,0
230204,peak,0,0
230205,expiratory,0,0
230206,flow,0,0
230207,rate,0,0
230208,",",0,0
230209,were,0,0
230210,then,0,0
230211,measured,0,0
230212,for,0,0
230213,3,0,0
230214,hours,0,0
230215,after,0,0
230216,drug,0,0
230217,administration,0,0
230218,.,0,0
230219,Timolol,1,1
230220,reduced,0,0
230221,intraocular,0,0
230222,pressure,0,0
230223,and,0,0
230224,cardiovascular,0,0
230225,function,0,0
230226,at,0,0
230227,both,0,0
230228,administration,0,0
230229,times,0,0
230230,.,0,0
230231,However,0,0
230232,",",0,0
230233,a,0,0
230234,timolol-induced,1,0
230235,reduction,0,0
230236,in,0,0
230237,respiratory,0,0
230238,function,0,0
230239,was,0,0
230240,observed,0,0
230241,only,0,0
230242,in,0,0
230243,the,0,0
230244,evening,0,0
230245,:,0,0
230246,percent,0,0
230247,forced,0,0
230248,expiratory,0,0
230249,volume,0,0
230250,in,0,0
230251,1,0,0
230252,second,0,0
230253,",",0,0
230254,peak,0,0
230255,expiratory,0,0
230256,flow,0,0
230257,rate,0,0
230258,",",0,0
230259,and,0,0
230260,expiratory,0,0
230261,flow,0,0
230262,rate,0,0
230263,at,0,0
230264,75,0,0
230265,%,0,0
230266,vital,0,0
230267,capacity,0,0
230268,were,0,0
230269,reduced,0,0
230270,by,0,0
230271,3,0,0
230272,%,0,0
230273,",",0,0
230274,7,0,0
230275,%,0,0
230276,",",0,0
230277,and,0,0
230278,12,0,0
230279,%,0,0
230280,",",0,0
230281,respectively,0,0
230282,",",0,0
230283,3,0,0
230284,hours,0,0
230285,after,0,0
230286,administration,0,0
230287,.,0,0
230288,These,0,0
230289,results,0,0
230290,indicate,0,0
230291,that,0,0
230292,ophthalmic,1,0
230293,timolol,1,1
230294,reduces,0,0
230295,cardiovascular,0,0
230296,and,0,0
230297,respiratory,0,0
230298,functions,0,0
230299,in,0,0
230300,healthy,0,0
230301,young,0,0
230302,male,0,0
230303,subjects,0,0
230304,and,0,0
230305,that,0,0
230306,bronchial,0,0
230307,sensitivity,0,0
230308,to,0,0
230309,timolol,0,1
230310,differs,0,0
230311,between,0,0
230312,morning,0,0
230313,and,0,0
230314,evening,0,0
230315,.,0,0
230316,Comparison,0,0
230317,of,0,0
230318,cuffed,1,1
230319,and,1,0
230320,uncuffed,1,1
230321,endotracheal,1,1
230322,tubes,1,1
230323,in,0,0
230324,young,0,0
230325,children,0,0
230326,during,0,0
230327,general,0,0
230328,anesthesia,0,1
230329,.,0,0
230330,BACKGROUND,0,0
230331,Uncuffed,1,1
230332,endotracheal,1,1
230333,tubes,1,1
230334,are,0,0
230335,routinely,0,0
230336,used,0,0
230337,in,0,0
230338,young,0,0
230339,children,0,0
230340,.,0,0
230341,This,0,0
230342,study,0,0
230343,tests,0,0
230344,a,0,0
230345,formula,0,1
230346,for,0,0
230347,selecting,0,0
230348,appropriately,0,0
230349,sized,0,0
230350,cuffed,0,1
230351,endotracheal,0,1
230352,tubes,0,1
230353,and,0,0
230354,compares,0,0
230355,the,0,0
230356,use,0,0
230357,of,0,0
230358,cuffed,1,1
230359,versus,1,0
230360,uncuffed,1,1
230361,endotracheal,1,1
230362,tubes,1,1
230363,for,0,0
230364,patients,0,0
230365,whose,0,0
230366,lungs,0,0
230367,are,0,0
230368,mechanically,0,0
230369,ventilated,0,0
230370,during,0,0
230371,anesthesia,0,1
230372,.,0,0
230373,METHODS,0,0
230374,Full-term,0,0
230375,newborns,0,0
230376,and,0,0
230377,children,0,0
230378,(,0,0
230379,n,0,0
230380,=,0,0
230381,488,0,0
230382,),0,0
230383,through,0,0
230384,8,0,0
230385,yr,0,0
230386,of,0,0
230387,age,0,0
230388,who,0,0
230389,required,0,0
230390,general,0,0
230391,anesthesia,0,1
230392,and,0,0
230393,tracheal,0,0
230394,intubation,0,1
230395,were,0,0
230396,assigned,0,0
230397,randomly,0,0
230398,to,0,0
230399,receive,0,0
230400,either,0,0
230401,a,0,0
230402,cuffed,1,1
230403,tube,1,1
230404,sized,1,0
230405,by,1,0
230406,a,1,0
230407,new,1,0
230408,formula,1,1
230409,[,0,0
230410,size,0,0
230411,(,0,0
230412,mm,0,0
230413,internal,0,1
230414,diameter,0,0
230415,),0,1
230416,=,0,0
230417,(,0,1
230418,age/4,0,0
230419,),0,1
230420,+,0,1
230421,3,0,0
230422,],0,0
230423,",",0,0
230424,or,0,0
230425,an,0,0
230426,uncuffed,1,1
230427,tube,1,1
230428,sized,1,0
230429,by,1,0
230430,the,1,0
230431,modified,1,0
230432,Cole,1,0
230433,'s,1,0
230434,formula,1,1
230435,[,0,0
230436,size,0,0
230437,(,0,0
230438,mm,0,0
230439,internal,0,1
230440,diameter,0,0
230441,),0,1
230442,=,0,0
230443,(,0,1
230444,age/4,0,0
230445,),0,1
230446,+,0,1
230447,4,0,0
230448,],0,0
230449,.,0,0
230450,The,0,0
230451,number,0,0
230452,of,0,0
230453,intubations,0,0
230454,required,0,0
230455,to,0,0
230456,achieve,0,0
230457,an,0,0
230458,appropriately,0,0
230459,sized,0,0
230460,tube,0,1
230461,",",0,0
230462,the,0,0
230463,need,0,0
230464,to,0,0
230465,use,0,0
230466,more,0,0
230467,than,0,0
230468,21.min-1,0,0
230469,fresh,0,0
230470,gas,0,1
230471,flow,0,0
230472,",",0,0
230473,the,0,0
230474,concentration,0,0
230475,of,0,0
230476,nitrous,0,1
230477,oxide,0,0
230478,in,0,0
230479,the,0,0
230480,operating,0,0
230481,room,0,0
230482,",",0,0
230483,and,0,0
230484,the,0,0
230485,incidence,0,0
230486,of,0,0
230487,croup,0,0
230488,were,0,0
230489,compared,0,0
230490,.,0,0
230491,RESULTS,0,0
230492,Cuffed,1,1
230493,tubes,1,1
230494,selected,0,0
230495,by,0,0
230496,our,0,0
230497,formula,0,1
230498,were,0,0
230499,appropriate,0,0
230500,for,0,0
230501,99,0,0
230502,%,0,0
230503,of,0,0
230504,patients,0,0
230505,.,0,0
230506,Uncuffed,1,0
230507,tubes,1,1
230508,selected,0,0
230509,by,0,0
230510,Cole,0,0
230511,'s,0,0
230512,formula,0,1
230513,were,0,0
230514,appropriate,0,0
230515,for,0,0
230516,77,0,0
230517,%,0,0
230518,of,0,0
230519,patients,0,0
230520,(,0,0
230521,P,0,0
230522,<,0,0
230523,0.001,0,0
230524,),0,0
230525,.,0,0
230526,The,0,0
230527,lungs,0,0
230528,of,0,0
230529,patients,0,0
230530,with,0,0
230531,cuffed,0,1
230532,tubes,0,1
230533,were,0,0
230534,adequately,0,0
230535,ventilated,0,0
230536,with,0,0
230537,2,0,0
230538,1.min-1,0,0
230539,fresh,0,0
230540,gas,0,1
230541,flow,0,0
230542,",",0,0
230543,whereas,0,0
230544,11,0,0
230545,%,0,0
230546,of,0,0
230547,those,0,0
230548,with,0,0
230549,uncuffed,0,1
230550,tubes,0,1
230551,needed,0,0
230552,greater,0,0
230553,fresh,0,0
230554,gas,0,1
230555,flow,0,0
230556,(,0,0
230557,P,0,0
230558,<,0,0
230559,0.001,0,0
230560,),0,0
230561,.,0,0
230562,Ambient,0,1
230563,nitrous,0,1
230564,oxide,0,1
230565,concentration,0,0
230566,exceeded,0,0
230567,25,0,0
230568,parts,0,0
230569,per,0,0
230570,million,0,0
230571,in,0,0
230572,37,0,0
230573,%,0,0
230574,of,0,0
230575,cases,0,0
230576,with,0,0
230577,uncuffed,0,1
230578,tubes,0,1
230579,and,0,0
230580,in,0,0
230581,0,0,0
230582,%,0,0
230583,of,0,0
230584,cases,0,0
230585,with,0,0
230586,cuffed,0,1
230587,tubes,0,1
230588,(,0,0
230589,P,0,0
230590,<,0,0
230591,0.001,0,0
230592,),0,0
230593,.,0,0
230594,Three,0,0
230595,patients,0,0
230596,in,0,0
230597,each,0,0
230598,group,0,0
230599,were,0,0
230600,treated,0,0
230601,for,0,0
230602,croup,0,0
230603,symptoms,0,0
230604,(,0,0
230605,1.2,0,0
230606,%,0,0
230607,cuffed,0,1
230608,;,0,0
230609,1.3,0,0
230610,%,0,0
230611,uncuffed,0,1
230612,),0,0
230613,.,0,0
230614,CONCLUSIONS,0,0
230615,Our,0,0
230616,formula,0,1
230617,for,0,0
230618,cuffed,0,1
230619,tube,0,1
230620,selection,0,0
230621,is,0,0
230622,appropriate,0,0
230623,for,0,0
230624,young,0,0
230625,children,0,0
230626,.,0,0
230627,Advantages,0,0
230628,of,0,0
230629,cuffed,1,1
230630,endotracheal,1,0
230631,tubes,1,1
230632,include,0,0
230633,avoidance,0,0
230634,of,0,0
230635,repeated,0,0
230636,laryngoscopy,0,1
230637,",",0,0
230638,use,0,0
230639,of,0,0
230640,low,0,0
230641,fresh,0,0
230642,gas,0,1
230643,flow,0,0
230644,",",0,0
230645,and,0,0
230646,reduction,0,0
230647,of,0,0
230648,the,0,0
230649,concentration,0,0
230650,of,0,0
230651,anesthetics,0,1
230652,detectable,0,0
230653,in,0,0
230654,the,0,0
230655,operating,0,0
230656,room,0,0
230657,.,0,0
230658,We,0,0
230659,conclude,0,0
230660,that,0,0
230661,cuffed,1,1
230662,endotracheal,1,1
230663,tubes,1,1
230664,may,0,0
230665,be,0,0
230666,used,0,0
230667,routinely,0,0
230668,during,0,0
230669,controlled,0,0
230670,ventilation,0,1
230671,in,0,0
230672,full-term,0,0
230673,newborns,0,0
230674,and,0,0
230675,children,0,0
230676,during,0,0
230677,anesthesia,0,0
230678,.,0,0
230679,Comparison,0,0
230680,of,0,0
230681,arbutamine,1,1
230682,and,0,0
230683,exercise,1,1
230684,echocardiography,1,0
230685,in,0,0
230686,diagnosing,0,0
230687,myocardial,0,0
230688,ischemia,0,0
230689,.,0,0
230690,Arbutamine,1,1
230691,is,0,0
230692,a,0,0
230693,new,0,0
230694,catecholamine,0,0
230695,designed,0,0
230696,for,0,0
230697,use,0,0
230698,as,0,0
230699,a,0,0
230700,pharmacologic,0,0
230701,stress,0,0
230702,agent,0,0
230703,.,0,0
230704,This,0,0
230705,study,0,0
230706,compared,0,0
230707,the,0,0
230708,sensitivity,0,0
230709,of,0,0
230710,arbutamine,1,1
230711,with,0,0
230712,symptom-limited,1,0
230713,exercise,1,1
230714,to,0,0
230715,induce,0,0
230716,echocardiographic,0,0
230717,signs,0,0
230718,of,0,0
230719,ischemia,0,0
230720,.,0,0
230721,Arbutamine,1,1
230722,was,0,0
230723,administered,0,0
230724,by,0,0
230725,a,0,0
230726,computerized,0,1
230727,closed-loop,0,1
230728,delivery,0,0
230729,system,0,0
230730,that,0,0
230731,controls,0,0
230732,the,0,0
230733,infusion,0,0
230734,rate,0,0
230735,of,0,0
230736,arbutamine,1,1
230737,toward,0,0
230738,a,0,0
230739,predefined,0,0
230740,rate,0,0
230741,of,0,0
230742,heart,0,0
230743,rate,0,0
230744,increase,0,0
230745,and,0,0
230746,maximum,0,0
230747,heart,0,0
230748,rate,0,0
230749,limit,0,0
230750,.,0,0
230751,Beta,0,0
230752,blockers,0,0
230753,were,0,0
230754,stopped,0,0
230755,>,0,0
230756,or,0,0
230757,=,0,0
230758,48,0,0
230759,hours,0,0
230760,before,0,0
230761,both,0,0
230762,tests,0,0
230763,.,0,0
230764,Stress,0,0
230765,was,0,0
230766,stopped,0,0
230767,for,0,0
230768,intolerable,0,0
230769,symptoms,0,0
230770,",",0,0
230771,or,0,0
230772,clinical,0,0
230773,",",0,0
230774,electrocardiographic,0,0
230775,or,0,0
230776,echocardiographic,0,0
230777,signs,0,0
230778,of,0,0
230779,ischemia,0,0
230780,(,0,0
230781,new,0,0
230782,or,0,1
230783,worsening,0,0
230784,wall,0,0
230785,motion,0,1
230786,abnormality,0,0
230787,),0,0
230788,",",0,0
230789,target,0,0
230790,heart,0,0
230791,rate,0,0
230792,(,0,0
230793,>,0,0
230794,or,0,0
230795,=,0,0
230796,85,0,0
230797,%,0,0
230798,age,0,0
230799,predicted,0,0
230800,maximum,0,0
230801,heart,0,0
230802,rate,0,0
230803,),0,0
230804,",",0,0
230805,or,0,1
230806,plateau,0,0
230807,of,0,0
230808,heart,0,0
230809,rate,0,0
230810,response,0,0
230811,.,0,0
230812,Thirty-seven,0,0
230813,patients,0,0
230814,were,0,0
230815,entered,0,0
230816,into,0,0
230817,the,0,0
230818,study,0,0
230819,(,0,0
230820,35,0,0
230821,arbutamine,1,1
230822,and,0,0
230823,exercise,1,1
230824,",",0,0
230825,1,0,0
230826,arbutamine,1,0
230827,only,0,0
230828,",",0,0
230829,1,0,0
230830,exercise,1,1
230831,only,0,0
230832,),0,0
230833,",",0,0
230834,of,0,0
230835,which,0,0
230836,30,0,0
230837,had,0,0
230838,angiographic,0,0
230839,evidence,0,0
230840,of,0,0
230841,coronary,0,0
230842,artery,0,0
230843,disease,0,0
230844,(,0,0
230845,>,0,0
230846,or,0,0
230847,=,0,0
230848,50,0,0
230849,%,0,0
230850,lumen,0,0
230851,diameter,0,0
230852,narrowing,0,0
230853,),0,0
230854,.,0,0
230855,Rate-pressure,0,1
230856,product,0,0
230857,increased,0,0
230858,significantly,0,0
230859,in,0,0
230860,response,0,0
230861,to,0,0
230862,both,0,0
230863,stress,0,0
230864,modalities,0,0
230865,(,0,0
230866,p,0,0
230867,<,0,0
230868,0.001,0,0
230869,),0,0
230870,and,0,0
230871,was,0,0
230872,significantly,0,0
230873,greater,0,0
230874,with,0,0
230875,exercise,0,1
230876,(,0,0
230877,"11,308",0,0
230878,+/-,0,0
230879,"2,443",0,0
230880,),0,0
230881,than,0,0
230882,with,0,0
230883,arbutamine,0,1
230884,(,0,0
230885,"9,486",0,0
230886,+/-,0,0
230887,"2,479",0,0
230888,",",0,0
230889,p,0,0
230890,<,0,0
230891,0.001,0,0
230892,),0,0
230893,.,0,0
230894,The,0,0
230895,time,0,0
230896,to,0,0
230897,maximum,0,0
230898,heart,0,0
230899,rate,0,0
230900,was,0,0
230901,longer,0,0
230902,during,0,0
230903,arbutamine,1,1
230904,stress,0,0
230905,echocardiography,0,0
230906,than,0,0
230907,during,0,0
230908,exercise,1,1
230909,testing,0,0
230910,(,0,0
230911,17.3,0,0
230912,+/-,0,0
230913,9.4,0,0
230914,versus,0,0
230915,9.3,0,0
230916,+/-,0,0
230917,4.2,0,0
230918,minutes,0,0
230919,",",0,0
230920,respectively,0,0
230921,",",0,0
230922,p,0,0
230923,<,0,0
230924,0.001,0,0
230925,),0,0
230926,.,0,0
230927,There,0,0
230928,were,0,0
230929,more,0,0
230930,patients,0,0
230931,with,0,0
230932,interpretable,0,0
230933,echo,0,0
230934,data,0,0
230935,for,0,0
230936,arbutamine,1,1
230937,(,0,0
230938,82,0,0
230939,%,0,0
230940,),0,0
230941,than,0,0
230942,for,0,0
230943,exercise,1,1
230944,(,0,0
230945,67,0,0
230946,%,0,0
230947,),0,0
230948,.,0,0
230949,Sensitivity,0,0
230950,for,0,0
230951,recognition,0,0
230952,of,0,0
230953,myocardial,0,0
230954,ischemia,0,0
230955,was,0,0
230956,94,0,0
230957,%,0,0
230958,(,0,0
230959,95,0,0
230960,%,0,0
230961,confidence,0,0
230962,interval,0,0
230963,70,0,0
230964,%,0,0
230965,to,0,0
230966,100,0,1
230967,%,0,0
230968,),0,0
230969,and,0,0
230970,88,0,0
230971,%,0,0
230972,(,0,0
230973,95,0,0
230974,%,0,0
230975,confidence,0,0
230976,interval,0,0
230977,62,0,0
230978,%,0,0
230979,to,0,0
230980,98,0,0
230981,%,0,0
230982,),0,0
230983,",",0,0
230984,respectively,0,0
230985,.,0,0
230986,The,0,0
230987,most,0,0
230988,frequent,0,0
230989,adverse,0,0
230990,events,0,0
230991,during,0,0
230992,arbutamine,1,1
230993,(,0,0
230994,n,0,0
230995,=,0,0
230996,36,0,0
230997,),0,0
230998,were,0,0
230999,dyspnea,0,0
231000,(,0,0
231001,5.6,0,0
231002,%,0,0
231003,),0,0
231004,and,0,0
231005,tremor,0,0
231006,(,0,0
231007,5.6,0,0
231008,%,0,0
231009,),0,0
231010,.,0,0
231011,Two,0,0
231012,arbutamine,1,0
231013,stress,0,0
231014,tests,0,0
231015,were,0,0
231016,discontinued,0,0
231017,due,0,0
231018,to,0,0
231019,arrhythmias,0,0
231020,:,0,0
231021,1,0,0
231022,patient,0,0
231023,had,0,0
231024,premature,0,0
231025,atrial,0,0
231026,and,0,0
231027,ventricular,0,0
231028,beats,0,1
231029,",",0,0
231030,and,0,0
231031,the,0,0
231032,other,0,0
231033,had,0,0
231034,premature,0,0
231035,atrial,0,0
231036,contractions,0,0
231037,and,0,0
231038,atrial,0,0
231039,fibrillation,0,0
231040,.,0,0
231041,Arrhythmias,0,0
231042,were,0,0
231043,well,0,0
231044,tolerated,0,0
231045,and,0,0
231046,resolved,0,0
231047,without,0,0
231048,sequelae,0,0
231049,.,0,0
231050,In,0,0
231051,conclusion,0,0
231052,",",0,0
231053,the,0,0
231054,sensitivity,0,0
231055,of,0,0
231056,arbutamine,1,1
231057,to,0,0
231058,induce,0,0
231059,echocardiographic,0,0
231060,signs,0,0
231061,of,0,0
231062,ischemia,0,0
231063,was,0,0
231064,similar,0,0
231065,to,0,0
231066,that,0,0
231067,of,0,0
231068,exercise,1,1
231069,despite,0,0
231070,a,0,0
231071,lower,0,0
231072,rate-pressure,0,0
231073,product,0,0
231074,.,0,0
231075,Arbutamine,1,1
231076,was,0,0
231077,well,0,0
231078,tolerated,0,0
231079,and,0,0
231080,provides,0,0
231081,a,0,0
231082,reliable,0,0
231083,alternative,0,0
231084,to,0,0
231085,exercise,1,1
231086,echocardiography,1,0
231087,.,1,0
231088,Long-term,0,0
231089,follow-up,0,0
231090,of,0,0
231091,cytostatic,1,1
231092,intravesical,1,1
231093,instillation,1,0
231094,in,0,0
231095,patients,0,0
231096,with,0,0
231097,superficial,0,0
231098,bladder,0,0
231099,carcinoma,0,0
231100,.,0,0
231101,Is,0,0
231102,short-term,0,0
231103,",",0,0
231104,intensive,0,1
231105,instillation,0,0
231106,better,0,0
231107,than,0,0
231108,maintenance,0,0
231109,therapy,0,1
231110,?,0,0
231111,OBJECTIVES,0,0
231112,Comparisons,0,0
231113,of,0,0
231114,two,0,0
231115,3-year,0,0
231116,protocols,0,0
231117,",",0,0
231118,one,0,0
231119,20-week,0,0
231120,protocol,0,0
231121,of,0,0
231122,mitomycin,1,1
231123,C,1,1
231124,instillation,1,0
231125,and,0,0
231126,one,0,0
231127,3-year,0,0
231128,protocol,0,0
231129,of,0,0
231130,doxorubicin,1,1
231131,instillation,1,0
231132,for,0,0
231133,the,0,0
231134,prevention,0,0
231135,of,0,0
231136,recurrent,0,0
231137,tumors,0,0
231138,and,0,0
231139,progression,0,0
231140,in,0,0
231141,patients,0,0
231142,whose,0,0
231143,superficial,0,0
231144,bladder,0,0
231145,tumors,0,0
231146,had,0,0
231147,been,0,0
231148,removed,0,0
231149,by,0,0
231150,transurethral,0,1
231151,resection,0,1
231152,.,0,0
231153,METHODS,0,0
231154,A,0,0
231155,prospective,0,0
231156,",",0,0
231157,randomized,0,0
231158,parallel,0,0
231159,group,0,0
231160,multicenter,0,0
231161,trial,0,0
231162,was,0,0
231163,conducted,0,0
231164,.,0,0
231165,419,0,0
231166,patients,0,0
231167,were,0,0
231168,evaluated,0,0
231169,after,0,0
231170,a,0,0
231171,median,0,0
231172,follow-up,0,0
231173,of,0,0
231174,57,0,0
231175,months,0,0
231176,.,0,0
231177,Cox,0,0
231178,proportional,0,0
231179,hazards,0,0
231180,analysis,0,0
231181,was,0,0
231182,performed,0,0
231183,.,0,0
231184,RESULTS,0,0
231185,An,0,0
231186,overall,0,0
231187,recurrence,0,0
231188,rate,0,0
231189,of,0,0
231190,22.7,0,0
231191,%,0,0
231192,and,0,0
231193,an,0,0
231194,overall,0,0
231195,progression,0,0
231196,rate,0,0
231197,of,0,0
231198,9.8,0,0
231199,%,0,0
231200,was,0,0
231201,found,0,0
231202,.,0,0
231203,For,0,0
231204,time,0,0
231205,to,0,0
231206,progression,0,0
231207,a,0,0
231208,significant,0,0
231209,overall,0,0
231210,treatment,0,0
231211,effect,0,0
231212,was,0,0
231213,detected,0,0
231214,dependent,0,0
231215,on,0,0
231216,the,0,0
231217,recurrence,0,0
231218,status,0,0
231219,before,0,0
231220,entry,0,0
231221,into,0,0
231222,the,0,0
231223,study,0,0
231224,(,0,0
231225,p,0,0
231226,=,0,0
231227,0.0059,0,0
231228,),0,0
231229,.,0,0
231230,Pairwise,0,0
231231,comparisons,0,0
231232,showed,0,0
231233,the,0,0
231234,mitomycin,0,1
231235,protocol,0,0
231236,with,0,0
231237,short-term,0,0
231238,intensive,0,1
231239,(,0,0
231240,weekly,0,1
231241,),0,0
231242,combined,0,0
231243,with,0,0
231244,long-term,0,0
231245,maintenance,0,0
231246,instillation,0,0
231247,to,0,0
231248,have,0,0
231249,a,0,0
231250,highly,0,0
231251,beneficial,0,0
231252,effect,0,0
231253,compared,0,0
231254,to,0,0
231255,long-term,0,0
231256,maintenance,0,0
231257,instillation,0,0
231258,only,0,0
231259,especially,0,0
231260,for,0,0
231261,patients,0,0
231262,entering,0,0
231263,the,0,0
231264,study,0,0
231265,with,0,0
231266,recurrent,0,0
231267,tumors,0,0
231268,(,0,0
231269,RR,0,0
231270,=,0,0
231271,0.06,0,0
231272,",",0,0
231273,95,0,0
231274,%,0,0
231275,CI,0,0
231276,:,0,0
231277,[,0,0
231278,0.008,0,0
231279,",",0,0
231280,0.506,0,0
231281,],0,0
231282,.,0,0
231283,CONCLUSION,0,0
231284,These,0,0
231285,results,0,0
231286,show,0,0
231287,that,0,0
231288,intensive,0,1
231289,therapeutic,0,0
231290,instillation,0,0
231291,may,0,0
231292,have,0,0
231293,an,0,0
231294,advantage,0,0
231295,over,0,0
231296,less,0,0
231297,intensive,0,0
231298,",",0,0
231299,prophylactic,0,0
231300,regimens,0,0
231301,.,0,0
231302,Effects,0,0
231303,of,0,0
231304,frusemide,1,1
231305,and,0,0
231306,hypoxia,0,0
231307,on,0,0
231308,the,0,0
231309,pulmonary,0,0
231310,vascular,0,0
231311,bed,0,0
231312,in,0,0
231313,man,0,0
231314,.,0,0
231315,AIMS,0,0
231316,Diuretic,1,0
231317,therapy,0,1
231318,is,0,0
231319,conventionally,0,0
231320,used,0,0
231321,to,0,0
231322,treat,0,0
231323,oedema,0,0
231324,in,0,0
231325,patients,0,0
231326,with,0,0
231327,hypoxic,0,0
231328,cor,0,0
231329,pulmonale,0,0
231330,.,0,0
231331,This,0,0
231332,condition,0,0
231333,is,0,0
231334,associated,0,0
231335,with,0,0
231336,activation,0,0
231337,of,0,0
231338,the,0,0
231339,renin,0,1
231340,angiotensin,0,1
231341,system,0,1
231342,(,0,0
231343,RAS,0,0
231344,),0,0
231345,with,0,0
231346,elevated,0,0
231347,levels,0,0
231348,of,0,0
231349,angiotensin,0,1
231350,II,0,0
231351,(,0,0
231352,ANG,0,0
231353,II,0,0
231354,),0,0
231355,",",0,0
231356,a,0,0
231357,potent,0,0
231358,pulmonary,0,0
231359,pressor,0,1
231360,agent,0,0
231361,.,0,0
231362,We,0,0
231363,explored,0,0
231364,the,0,0
231365,hypothesis,0,0
231366,that,0,0
231367,RAS,0,0
231368,activation,0,0
231369,by,0,0
231370,diuretic,0,1
231371,therapy,0,1
231372,might,0,0
231373,therefore,0,0
231374,worsen,0,0
231375,hypoxic,0,1
231376,pulmonary,0,0
231377,vasoconstriction,0,0
231378,via,0,0
231379,the,0,0
231380,effects,0,0
231381,of,0,0
231382,ANG,0,0
231383,II,0,0
231384,on,0,0
231385,the,0,0
231386,pulmonary,0,0
231387,vascular,0,0
231388,bed,0,0
231389,.,0,0
231390,METHODS,0,0
231391,Eight,0,0
231392,normal,0,0
231393,volunteers,0,0
231394,were,0,0
231395,studied,0,0
231396,on,0,0
231397,2,0,0
231398,separate,0,0
231399,days,0,0
231400,.,0,0
231401,They,0,0
231402,either,0,0
231403,received,0,0
231404,40,1,0
231405,mg,1,0
231406,frusemide,1,1
231407,daily,1,0
231408,or,1,0
231409,placebo,1,1
231410,for,0,0
231411,4,0,0
231412,days,0,0
231413,and,0,0
231414,were,0,0
231415,then,0,0
231416,rendered,0,0
231417,hypoxaemic,0,0
231418,",",0,0
231419,by,0,0
231420,breathing,0,0
231421,an,0,0
231422,N2/O2,0,1
231423,mixture,0,1
231424,for,0,0
231425,20,0,0
231426,min,0,0
231427,to,0,0
231428,achieve,0,0
231429,an,0,0
231430,SaO2,0,1
231431,of,0,0
231432,85-90,0,0
231433,%,0,0
231434,adjusted,0,0
231435,for,0,0
231436,a,0,0
231437,further,0,0
231438,20,0,0
231439,min,0,0
231440,to,0,0
231441,achieve,0,0
231442,an,0,0
231443,SaO2,0,1
231444,of,0,0
231445,75-80,0,0
231446,%,0,0
231447,.,0,0
231448,Pulsed,0,0
231449,wave,0,0
231450,doppler,0,0
231451,echocardiography,0,0
231452,was,0,0
231453,used,0,0
231454,to,0,0
231455,measure,0,0
231456,mean,0,0
231457,pulmonary,0,0
231458,artery,0,0
231459,pressure,0,0
231460,",",0,0
231461,cardiac,0,0
231462,output,0,0
231463,and,0,0
231464,hence,0,0
231465,pulmonary,0,0
231466,vascular,0,0
231467,resistance,0,0
231468,(,0,0
231469,PVR,0,0
231470,),0,0
231471,.,0,0
231472,RESULTS,0,0
231473,Plasma,0,0
231474,renin,0,1
231475,activity,0,0
231476,(,0,0
231477,PRA,0,0
231478,),0,0
231479,was,0,0
231480,significantly,0,0
231481,(,0,0
231482,P,0,0
231483,<,0,0
231484,0.01,0,0
231485,),0,0
231486,increased,0,0
231487,after,0,0
231488,prior,0,0
231489,treatment,0,0
231490,with,0,0
231491,frusemide,1,1
231492,compared,0,0
231493,with,0,0
231494,placebo,1,1
231495,at,0,0
231496,all,0,0
231497,time,0,0
231498,points,0,0
231499,.,0,0
231500,Prior,0,0
231501,treatment,0,0
231502,with,0,0
231503,frusemide,1,1
231504,significantly,0,0
231505,(,0,0
231506,P,0,0
231507,<,0,0
231508,0.05,0,0
231509,),0,0
231510,increased,0,0
231511,PVR,0,0
231512,compared,0,0
231513,with,0,0
231514,placebo,1,1
231515,at,0,0
231516,baseline,0,0
231517,:,0,0
231518,185,0,0
231519,+/-,0,0
231520,17,0,0
231521,vs,0,0
231522,132,0,0
231523,+/-,0,0
231524,10,0,0
231525,dyn,0,1
231526,s,0,0
231527,cm-5,0,0
231528,at,0,0
231529,an,0,0
231530,SaO2,0,1
231531,of,0,0
231532,85-90,0,0
231533,%,0,0
231534,:,0,0
231535,291,0,0
231536,+/-,0,0
231537,18,0,0
231538,vs,0,0
231539,229,0,0
231540,+/-,0,0
231541,16,0,0
231542,dyn,0,1
231543,s,0,0
231544,cm-5,0,0
231545,and,0,0
231546,at,0,0
231547,SaO2,0,1
231548,of,0,0
231549,75-80,0,0
231550,%,0,0
231551,:,0,0
231552,356,0,0
231553,+/-,0,0
231554,12,0,0
231555,vs,0,0
231556,296,0,0
231557,+/-,0,0
231558,17,0,0
231559,dyn,0,1
231560,s,0,0
231561,cm-5,0,0
231562,respectively,0,0
231563,.,0,0
231564,However,0,0
231565,",",0,0
231566,the,0,0
231567,delta-PVR,0,0
231568,response,0,0
231569,to,0,0
231570,hypoxaemia,0,0
231571,was,0,0
231572,not,0,0
231573,significantly,0,0
231574,altered,0,0
231575,by,0,0
231576,frusemide,1,1
231577,compared,0,0
231578,with,0,0
231579,placebo,1,1
231580,.,1,0
231581,In,0,0
231582,contrast,0,0
231583,to,0,0
231584,its,0,0
231585,effect,0,0
231586,on,0,0
231587,the,0,0
231588,pulmonary,0,0
231589,vasculature,0,0
231590,prior,0,0
231591,treatment,0,0
231592,with,0,0
231593,frusemide,1,1
231594,did,0,0
231595,not,0,0
231596,significantly,0,0
231597,alter,0,0
231598,systemic,0,0
231599,haemodynamic,0,0
231600,parameters,0,0
231601,either,0,0
231602,at,0,0
231603,baseline,0,0
231604,or,0,1
231605,during,0,0
231606,hypoxia,0,0
231607,.,0,0
231608,CONCLUSIONS,0,0
231609,Thus,0,0
231610,",",0,0
231611,prior,0,0
231612,treatment,0,0
231613,with,0,0
231614,frusemide,1,1
231615,increased,0,0
231616,baseline,0,0
231617,pulmonary,0,0
231618,vascular,0,0
231619,resistance,0,0
231620,and,0,0
231621,significantly,0,0
231622,augmented,0,0
231623,the,0,0
231624,hypoxaemic,0,0
231625,pulmonary,0,0
231626,vascular,0,0
231627,response,0,0
231628,in,0,0
231629,additive,0,0
231630,fashion,0,0
231631,.,0,0
231632,It,0,0
231633,is,0,0
231634,hypothesised,0,0
231635,that,0,0
231636,this,0,0
231637,effect,0,0
231638,of,0,0
231639,frusemide,1,1
231640,may,0,0
231641,be,0,0
231642,due,0,0
231643,to,0,0
231644,RAS,0,0
231645,activation,0,0
231646,with,0,0
231647,ANG,0,0
231648,II,0,0
231649,mediated,0,0
231650,pulmonary,0,0
231651,vasoconstriction,0,0
231652,.,0,0
231653,A,0,0
231654,limited,0,0
231655,sampling,0,0
231656,method,0,0
231657,for,0,0
231658,the,0,0
231659,estimation,0,0
231660,of,0,0
231661,flunarizine,0,1
231662,area,0,0
231663,under,0,0
231664,the,0,0
231665,curve,0,0
231666,(,0,0
231667,AUC,0,0
231668,),0,1
231669,and,0,0
231670,maximum,0,0
231671,plasma,0,0
231672,concentration,0,0
231673,(,0,0
231674,Cmax,0,0
231675,),0,0
231676,.,0,0
231677,A,0,0
231678,limited,0,0
231679,sampling,0,0
231680,model,0,0
231681,has,0,0
231682,been,0,0
231683,developed,0,0
231684,for,0,0
231685,flunarizine,0,1
231686,following,0,0
231687,a,0,0
231688,30,0,0
231689,mg,0,0
231690,oral,0,1
231691,dose,0,0
231692,in,0,0
231693,epileptic,0,0
231694,patients,0,0
231695,who,0,0
231696,were,1,0
231697,receiving,1,0
231698,phenytoin,1,1
231699,or,1,1
231700,carbamazepine,1,1
231701,or,1,1
231702,both,1,0
231703,",",1,0
231704,to,1,0
231705,estimate,1,0
231706,the,1,0
231707,area,1,0
231708,under,1,0
231709,the,1,0
231710,curve,1,0
231711,(,1,0
231712,AUC,1,0
231713,),1,1
231714,and,1,0
231715,maximum,1,0
231716,plasma,1,0
231717,concentration,1,0
231718,(,1,0
231719,Cmax,1,0
231720,),1,0
231721,.,1,0
231722,The,0,0
231723,model,0,0
231724,was,0,0
231725,developed,0,0
231726,using,0,0
231727,training,0,1
231728,data,0,0
231729,sets,0,0
231730,from,0,0
231731,30,0,0
231732,",",0,0
231733,20,0,0
231734,",",0,0
231735,15,0,0
231736,",",0,0
231737,or,0,0
231738,10,0,0
231739,patients,0,0
231740,at,0,0
231741,one,0,0
231742,or,0,0
231743,two,0,0
231744,time,0,0
231745,points,0,0
231746,.,0,0
231747,The,0,0
231748,equations,0,0
231749,describing,0,0
231750,the,0,0
231751,models,0,0
231752,for,0,0
231753,AUC,0,0
231754,using,0,0
231755,two,0,0
231756,time,0,0
231757,points,0,0
231758,(,0,0
231759,3,0,0
231760,and,0,0
231761,24h,0,0
231762,),0,0
231763,and,0,0
231764,Cmax,0,0
231765,for,0,0
231766,the,0,0
231767,training,0,1
231768,data,0,0
231769,set,0,0
231770,of,0,0
231771,30,0,0
231772,subjects,0,0
231773,were,0,0
231774,AUCpredicted,0,0
231775,=,0,0
231776,11.1,0,0
231777,C3h,0,0
231778,+,0,0
231779,121.4,0,0
231780,C24h,0,0
231781,-,0,0
231782,157,0,0
231783,(,0,0
231784,r,0,0
231785,=,0,0
231786,0.80,0,0
231787,),0,0
231788,Cmax,0,0
231789,(,0,0
231790,predicted,0,0
231791,),0,0
231792,=,0,0
231793,0.036,0,0
231794,AUC,0,0
231795,+,0,1
231796,42.9,0,0
231797,(,0,0
231798,r,0,0
231799,=,0,0
231800,0.74,0,0
231801,),0,0
231802,The,0,0
231803,model,0,0
231804,was,0,0
231805,validated,0,0
231806,on,0,0
231807,64,0,0
231808,patients,0,0
231809,who,0,0
231810,received,0,0
231811,flunarizine,0,1
231812,orally,0,1
231813,.,0,0
231814,The,0,0
231815,model,0,0
231816,provided,0,0
231817,reasonably,0,0
231818,good,0,0
231819,estimates,0,0
231820,for,0,0
231821,both,0,0
231822,AUC,0,0
231823,and,0,0
231824,Cmax,0,0
231825,.,0,0
231826,The,0,0
231827,mean,0,0
231828,predicted,0,0
231829,AUC,0,0
231830,of,0,0
231831,flunarizine,0,1
231832,was,0,0
231833,1230,0,0
231834,+/-,0,0
231835,717,0,0
231836,ng,0,1
231837,h,0,0
231838,mL-1,0,0
231839,",",0,0
231840,whereas,0,0
231841,the,0,0
231842,observed,0,0
231843,AUC,0,0
231844,was,0,0
231845,1203,0,0
231846,+/-,0,0
231847,900,0,1
231848,ng,0,0
231849,h,0,0
231850,mL-1,0,0
231851,.,0,0
231852,The,0,0
231853,bias,0,0
231854,of,0,0
231855,the,0,0
231856,prediction,0,0
231857,was,0,0
231858,2,0,0
231859,%,0,0
231860,and,0,0
231861,precision,0,0
231862,was,0,0
231863,28,0,0
231864,%,0,0
231865,.,0,0
231866,The,0,0
231867,mean,0,0
231868,predicted,0,0
231869,Cmax,0,0
231870,of,0,0
231871,flunarizine,0,1
231872,was,0,0
231873,86,0,0
231874,+/-,0,0
231875,32,0,0
231876,ng,0,0
231877,mL-1,0,0
231878,as,0,0
231879,compared,0,0
231880,to,0,0
231881,an,0,0
231882,observed,0,0
231883,mean,0,0
231884,Cmax,0,0
231885,of,0,0
231886,90,0,0
231887,+/-,0,0
231888,42,0,0
231889,ng,0,0
231890,mL-1,0,0
231891,.,0,0
231892,The,0,0
231893,bias,0,0
231894,and,0,0
231895,precision,0,0
231896,of,0,0
231897,the,0,0
231898,prediction,0,0
231899,were,0,0
231900,4,0,0
231901,%,0,0
231902,and,0,0
231903,24,0,0
231904,%,0,0
231905,",",0,0
231906,respectively,0,0
231907,.,0,0
231908,The,0,0
231909,method,0,0
231910,described,0,0
231911,here,0,0
231912,may,0,0
231913,be,0,0
231914,used,0,0
231915,to,0,0
231916,estimate,0,0
231917,AUC,0,0
231918,and,0,0
231919,Cmax,0,0
231920,for,0,0
231921,flunarizine,0,1
231922,without,0,0
231923,detailed,0,0
231924,pharmacokinetic,0,0
231925,studies,0,0
231926,.,0,0
231927,[,0,0
231928,Restorative,0,1
231929,proctectomy,0,0
231930,",",0,0
231931,reconstruction,0,1
231932,of,0,0
231933,continuity,0,0
231934,with,0,0
231935,or,0,0
231936,without,0,0
231937,colon,0,0
231938,J,0,0
231939,pouch,0,0
231940,],0,0
231941,.,0,0
231942,Of,0,0
231943,63,0,0
231944,patients,0,0
231945,undergoing,0,0
231946,deep,0,1
231947,anterior,0,0
231948,resection,0,1
231949,of,0,0
231950,the,0,0
231951,rectum,0,0
231952,",",0,0
231953,39,0,0
231954,patients,0,0
231955,received,0,0
231956,a,0,0
231957,straight,1,0
231958,colo-anal,1,0
231959,anastomosis,1,0
231960,(,1,0
231961,CAA,1,1
231962,),1,0
231963,",",0,0
231964,24,0,0
231965,additionally,0,0
231966,had,0,0
231967,a,0,0
231968,colon-j-pouch,1,1
231969,(,1,0
231970,CPA,1,1
231971,),1,0
231972,constructed,1,0
231973,.,1,0
231974,Local,0,0
231975,septic,0,0
231976,complications,0,0
231977,occurred,0,0
231978,in,0,0
231979,12.5,0,0
231980,%,0,0
231981,of,0,0
231982,patients,0,0
231983,after,0,0
231984,pouch-anal,0,0
231985,anastomosis,0,0
231986,compared,0,0
231987,to,0,0
231988,20.5,0,0
231989,%,0,0
231990,after,0,0
231991,colo-anal,0,0
231992,anastomosis,0,0
231993,:,0,0
231994,stool,0,0
231995,frequency,0,0
231996,",",0,0
231997,after,0,0
231998,pouch-anal,0,0
231999,anastomosis,0,0
232000,was,0,0
232001,3.3,0,0
232002,per,0,0
232003,24,0,0
232004,h,0,0
232005,compared,0,0
232006,to,0,0
232007,5.2,0,0
232008,per,0,0
232009,24,0,0
232010,h,0,0
232011,after,0,0
232012,straight,0,0
232013,anastomosis,0,0
232014,within,0,0
232015,the,0,0
232016,first,0,0
232017,year,0,0
232018,after,0,0
232019,ileostomy,0,0
232020,closure,0,0
232021,(,0,0
232022,p,0,0
232023,=,0,0
232024,0.053,0,0
232025,),0,0
232026,;,0,0
232027,continence,0,0
232028,was,0,0
232029,slightly,0,0
232030,better,0,0
232031,in,0,0
232032,the,0,0
232033,pouch,0,1
232034,group,0,0
232035,(,0,0
232036,n.s,0,0
232037,.,0,0
232038,),0,0
232039,;,0,0
232040,and,0,0
232041,anal,0,0
232042,manometry,0,1
232043,showed,0,0
232044,a,0,0
232045,significant,0,0
232046,postoperative,0,0
232047,decrease,0,0
232048,only,0,0
232049,in,0,0
232050,resting,0,0
232051,pressure,0,0
232052,after,0,0
232053,straight,0,0
232054,colo-anal,0,0
232055,anastomosis,0,1
232056,(,0,0
232057,p,0,0
232058,<,0,0
232059,0.001,0,0
232060,),0,0
232061,.,0,0
232062,Pouch,0,0
232063,construction,0,0
232064,should,0,0
232065,be,0,0
232066,considered,0,0
232067,after,0,0
232068,deep,0,1
232069,rectal,0,0
232070,resection,0,1
232071,",",0,0
232072,as,0,0
232073,it,0,0
232074,seems,0,0
232075,to,0,0
232076,improve,0,0
232077,functional,0,0
232078,outcome,0,0
232079,and,0,0
232080,has,0,0
232081,fewer,0,0
232082,local,0,0
232083,septic,0,0
232084,complications,0,0
232085,than,0,0
232086,straight,0,0
232087,anastomosis,0,0
232088,.,0,0
232089,Effects,0,0
232090,of,0,0
232091,age,0,0
232092,at,0,0
232093,introduction,0,0
232094,of,0,0
232095,complementary,1,1
232096,foods,1,1
232097,to,0,0
232098,breast-fed,0,0
232099,infants,0,0
232100,on,0,0
232101,duration,0,0
232102,of,0,0
232103,lactational,0,0
232104,amenorrhea,0,0
232105,in,0,0
232106,Honduran,0,1
232107,women,0,0
232108,.,0,0
232109,Lactational,0,0
232110,amenorrhea,0,0
232111,(,0,0
232112,LA,0,1
232113,),0,1
232114,is,0,0
232115,associated,0,0
232116,with,0,0
232117,postpartum,0,0
232118,infertility,0,0
232119,and,0,0
232120,is,0,0
232121,known,0,0
232122,to,0,0
232123,be,0,0
232124,related,0,0
232125,to,0,0
232126,breast-feeding,0,1
232127,frequency,0,0
232128,and,0,0
232129,duration,0,0
232130,",",0,0
232131,but,0,0
232132,the,0,0
232133,exact,0,0
232134,role,0,0
232135,of,0,0
232136,complementary,1,1
232137,feeding,1,0
232138,of,0,0
232139,the,0,0
232140,infant,0,0
232141,has,0,0
232142,not,0,0
232143,been,0,0
232144,clearly,0,0
232145,defined,0,0
232146,.,0,0
232147,Data,0,0
232148,on,0,0
232149,LA,0,0
232150,were,0,0
232151,collected,0,0
232152,during,0,0
232153,and,0,0
232154,after,0,0
232155,a,0,0
232156,2-mo,0,0
232157,intervention,0,1
232158,trial,0,0
232159,in,0,0
232160,which,0,0
232161,low-income,0,0
232162,Honduran,0,1
232163,women,0,0
232164,who,0,0
232165,had,0,0
232166,breast-fed,0,0
232167,fully,0,0
232168,for,0,0
232169,4,0,0
232170,mo,0,0
232171,were,0,0
232172,randomly,0,0
232173,assigned,0,0
232174,to,0,0
232175,one,0,0
232176,of,0,0
232177,three,0,0
232178,groups,0,0
232179,:,0,0
232180,continued,1,0
232181,full,1,0
232182,breast-feeding,1,0
232183,until,1,0
232184,6,1,0
232185,mo,1,0
232186,(,0,0
232187,FBF,0,1
232188,",",0,0
232189,n,0,0
232190,=,0,0
232191,50,0,0
232192,),0,0
232193,",",0,0
232194,introduction,1,0
232195,of,1,0
232196,complementary,1,1
232197,foods,1,1
232198,at,1,0
232199,4,1,0
232200,mo,1,0
232201,with,1,0
232202,ad,1,0
232203,libitum,1,1
232204,breast-feeding,1,0
232205,from,1,0
232206,4,1,0
232207,to,1,0
232208,6,1,0
232209,mo,1,0
232210,(,0,0
232211,SF,0,0
232212,",",0,0
232213,n,0,0
232214,=,0,0
232215,47,0,0
232216,),0,0
232217,",",0,0
232218,or,0,1
232219,introduction,1,0
232220,of,1,0
232221,complementary,1,1
232222,foods,1,1
232223,at,1,0
232224,4,1,0
232225,mo,1,0
232226,with,1,0
232227,maintenance,1,0
232228,of,1,0
232229,baseline,1,0
232230,breast-feeding,1,1
232231,frequency,1,0
232232,from,1,0
232233,4,1,0
232234,to,1,0
232235,6,1,0
232236,mo,1,0
232237,(,0,0
232238,SF-M,0,0
232239,",",0,0
232240,n,0,0
232241,=,0,0
232242,44,0,0
232243,),0,0
232244,.,0,0
232245,Women,0,0
232246,were,0,0
232247,followed,0,0
232248,up,0,0
232249,until,0,0
232250,the,0,0
232251,infant,0,0
232252,was,0,0
232253,12,0,0
232254,mo,0,0
232255,of,0,0
232256,age,0,0
232257,",",0,0
232258,or,0,0
232259,later,0,0
232260,if,0,0
232261,menses,0,0
232262,had,0,0
232263,not,0,0
232264,occurred,0,0
232265,by,0,0
232266,then,0,0
232267,.,0,0
232268,All,0,0
232269,but,0,0
232270,six,0,0
232271,of,0,0
232272,the,0,0
232273,women,0,0
232274,continued,0,0
232275,to,0,0
232276,breast-feed,0,0
232277,for,0,0
232278,>,0,0
232279,or,0,0
232280,=,0,0
232281,12,0,0
232282,mo,0,0
232283,.,0,0
232284,With,0,0
232285,the,0,0
232286,exclusion,0,0
232287,of,0,0
232288,those,0,0
232289,whose,0,0
232290,menses,0,0
232291,returned,0,0
232292,before,0,0
232293,18,0,0
232294,wk,0,0
232295,postpartum,0,0
232296,(,0,0
232297,which,0,0
232298,could,0,0
232299,not,0,0
232300,have,0,0
232301,been,0,0
232302,due,0,0
232303,to,0,0
232304,the,0,0
232305,intervention,0,1
232306,),0,0
232307,",",0,0
232308,the,0,0
232309,proportion,0,0
232310,of,0,0
232311,women,0,0
232312,who,0,0
232313,were,0,0
232314,amenorrheic,0,0
232315,at,0,0
232316,6,0,0
232317,mo,0,0
232318,was,0,0
232319,64.5,0,0
232320,%,0,0
232321,in,0,0
232322,the,0,0
232323,SF,0,0
232324,group,0,0
232325,",",0,0
232326,80.0,0,0
232327,%,0,0
232328,in,0,0
232329,the,0,0
232330,FBF,0,1
232331,group,0,0
232332,",",0,0
232333,and,0,0
232334,85.7,0,0
232335,%,0,0
232336,in,0,0
232337,the,0,0
232338,SF-M,0,0
232339,group,0,0
232340,(,0,0
232341,chi-square,0,0
232342,test,0,0
232343,=,0,0
232344,4.13,0,0
232345,",",0,0
232346,P,0,0
232347,=,0,0
232348,0.02,0,0
232349,;,0,0
232350,one-tailed,0,0
232351,test,0,0
232352,with,0,0
232353,the,0,0
232354,latter,0,0
232355,two,0,0
232356,groups,0,0
232357,combined,0,0
232358,),0,0
232359,.,0,0
232360,The,0,0
232361,total,0,0
232362,duration,0,0
232363,of,0,0
232364,LA,0,0
232365,did,0,0
232366,not,0,0
232367,differ,0,0
232368,significantly,0,0
232369,among,0,0
232370,groups,0,0
232371,.,0,0
232372,The,0,0
232373,most,0,0
232374,significant,0,0
232375,determinant,0,0
232376,of,0,0
232377,LA,0,0
232378,was,0,0
232379,time,0,0
232380,spent,0,0
232381,breast-feeding,1,1
232382,(,0,0
232383,min/d,0,1
232384,),0,0
232385,",",0,0
232386,which,0,0
232387,was,0,0
232388,in,0,0
232389,turn,0,0
232390,negatively,0,0
232391,associated,0,0
232392,(,0,0
232393,P,0,0
232394,=,0,0
232395,0.06,0,0
232396,),0,0
232397,with,0,0
232398,the,0,0
232399,infant,0,0
232400,'s,0,0
232401,energy,0,0
232402,intake,0,0
232403,from,0,0
232404,complementary,1,1
232405,foods,1,1
232406,in,0,0
232407,regression,0,0
232408,analyses,0,0
232409,.,0,0
232410,These,0,0
232411,results,0,0
232412,indicate,0,0
232413,that,0,0
232414,there,0,0
232415,is,0,0
232416,a,0,0
232417,significant,0,0
232418,effect,0,0
232419,of,0,0
232420,introducing,0,0
232421,foods,0,1
232422,at,0,0
232423,4,0,0
232424,mo,0,0
232425,on,0,0
232426,the,0,0
232427,likelihood,0,0
232428,of,0,0
232429,amenorrhea,0,0
232430,at,0,0
232431,6,0,0
232432,mo,0,0
232433,postpartum,0,0
232434,",",0,0
232435,but,0,0
232436,not,0,0
232437,thereafter,0,0
232438,",",0,0
232439,and,0,0
232440,that,0,0
232441,this,0,0
232442,effect,0,0
232443,is,0,0
232444,not,0,0
232445,seen,0,0
232446,in,0,0
232447,mothers,0,0
232448,who,0,0
232449,maintain,0,0
232450,breast-feeding,0,0
232451,frequency,0,0
232452,.,0,0
232453,Effect,0,0
232454,of,0,0
232455,inhaled,0,1
232456,heparin,1,1
232457,on,0,0
232458,adenosine-induced,0,0
232459,bronchial,0,0
232460,hyperreactivity,0,0
232461,.,0,0
232462,Glycosaminoglycan,1,0
232463,heparin,1,1
232464,possesses,0,0
232465,multiple,0,0
232466,noncoagulant,0,1
232467,properties,0,0
232468,including,0,0
232469,antiinflammatory,0,0
232470,actions,0,0
232471,.,0,0
232472,We,0,0
232473,have,0,0
232474,previously,0,0
232475,shown,0,0
232476,that,0,0
232477,heparin,1,1
232478,attenuates,0,0
232479,the,0,0
232480,methacholine-induced,0,0
232481,bronchoconstriction,0,0
232482,in,0,0
232483,humans,0,0
232484,.,0,0
232485,In,0,0
232486,contrast,0,0
232487,to,0,0
232488,methacholine,0,0
232489,",",0,0
232490,a,0,0
232491,stimulus,0,0
232492,that,0,0
232493,induces,0,0
232494,airway,0,0
232495,constriction,0,0
232496,mainly,0,0
232497,by,0,0
232498,direct,0,0
232499,stimulation,0,1
232500,of,0,0
232501,airway,0,0
232502,smooth,0,0
232503,muscle,0,0
232504,cells,0,0
232505,",",0,0
232506,adenosine,0,0
232507,airway,0,0
232508,responsiveness,0,0
232509,reflects,0,0
232510,indirectly,0,0
232511,induced,0,0
232512,airway,0,0
232513,narrowing,0,0
232514,via,0,0
232515,inflammatory,0,0
232516,mediators,0,0
232517,or,0,0
232518,neural,0,0
232519,reflex,0,0
232520,mechanisms,0,0
232521,.,0,0
232522,Whether,0,0
232523,heparin,1,1
232524,modulates,0,0
232525,bronchial,0,0
232526,hyperreactivity,0,0
232527,induced,0,0
232528,by,0,0
232529,adenosine,0,0
232530,",",0,0
232531,is,0,0
232532,not,0,0
232533,well,0,0
232534,known,0,0
232535,.,0,0
232536,We,0,0
232537,investigated,0,0
232538,the,0,0
232539,effect,0,0
232540,of,0,0
232541,inhaled,1,1
232542,heparin,1,1
232543,on,0,0
232544,adenosine-induced,0,0
232545,bronchoconstriction,0,0
232546,and,0,0
232547,compared,0,0
232548,the,0,0
232549,inhibitory,0,0
232550,role,0,0
232551,of,0,0
232552,heparin,1,1
232553,on,0,0
232554,the,0,0
232555,adenosine,0,1
232556,challenge,0,0
232557,test,0,0
232558,with,0,0
232559,that,0,0
232560,on,0,0
232561,the,0,0
232562,methacholine,0,0
232563,challenge,0,0
232564,test,0,0
232565,.,0,0
232566,Fifteen,0,0
232567,subjects,0,0
232568,(,0,0
232569,7,0,0
232570,males,0,0
232571,",",0,0
232572,8,0,0
232573,females,0,0
232574,),0,0
232575,with,0,0
232576,mild,0,0
232577,asthma,0,0
232578,were,0,0
232579,included,0,0
232580,in,0,0
232581,the,0,0
232582,study,0,0
232583,.,0,0
232584,Bronchial,0,0
232585,provocation,0,0
232586,tests,0,0
232587,were,0,0
232588,performed,0,0
232589,in,0,0
232590,a,0,0
232591,single-blind,0,0
232592,",",0,0
232593,crossover,0,0
232594,",",0,0
232595,randomized,0,0
232596,order,0,0
232597,",",0,0
232598,and,0,0
232599,repeated,0,0
232600,45,0,0
232601,minutes,0,0
232602,after,0,0
232603,placebo,1,1
232604,or,0,1
232605,aerosolized,1,0
232606,heparin,1,1
232607,inhalation,1,1
232608,(,0,0
232609,"1,000",0,1
232610,U/kg,0,1
232611,),0,0
232612,.,0,0
232613,The,0,0
232614,heparin,1,1
232615,increased,0,0
232616,the,0,0
232617,geometric,0,0
232618,mean,0,0
232619,log,0,0
232620,methacholine,0,1
232621,PD20,0,1
232622,value,0,0
232623,from,0,0
232624,0.47,0,0
232625,+/-,0,0
232626,0.16,0,0
232627,(,0,0
232628,2.95,0,0
232629,mg/ml,0,0
232630,),0,0
232631,to,0,0
232632,0.96,0,0
232633,+/-,0,0
232634,0.10,0,0
232635,(,0,0
232636,8.91,0,0
232637,mg/ml,0,0
232638,),0,0
232639,",",0,0
232640,(,0,0
232641,P,0,0
232642,<,0,0
232643,0.0009,0,0
232644,),0,0
232645,in,0,0
232646,15,0,0
232647,patients,0,0
232648,and,0,0
232649,the,0,0
232650,geometric,0,0
232651,mean,0,0
232652,log,0,0
232653,adenosine,0,1
232654,PD20,0,1
232655,values,0,0
232656,from,0,0
232657,1.59,0,0
232658,+/-,0,0
232659,0.23,0,0
232660,(,0,0
232661,38.9,0,0
232662,mg/ml,0,0
232663,),0,0
232664,to,0,0
232665,1.98,0,0
232666,+/-,0,0
232667,0.14,0,0
232668,(,0,0
232669,97.7,0,0
232670,mg/ml,0,1
232671,),0,0
232672,(,0,0
232673,NS,0,0
232674,),0,0
232675,in,0,0
232676,7,0,0
232677,patients,0,0
232678,whose,0,0
232679,baseline,0,0
232680,adenosine,0,1
232681,PD20,0,1
232682,levels,0,0
232683,were,0,0
232684,less,0,0
232685,than,0,0
232686,200,0,0
232687,mg/ml,0,0
232688,.,0,0
232689,The,0,0
232690,degree,0,0
232691,of,0,0
232692,protection,0,0
232693,by,0,0
232694,heparin,1,1
232695,against,0,0
232696,adenosine-induced,0,0
232697,bronchoconstriction,0,0
232698,was,0,0
232699,not,0,0
232700,correlated,0,0
232701,with,0,0
232702,that,0,0
232703,against,0,0
232704,methacholine-induced,0,0
232705,bronchoconstriction,0,0
232706,(,0,0
232707,r,0,0
232708,=,0,0
232709,0.60,0,0
232710,",",0,0
232711,NS,0,0
232712,),0,0
232713,.,0,0
232714,The,0,0
232715,data,0,0
232716,suggest,0,0
232717,that,0,0
232718,inhaled,0,1
232719,heparin,1,1
232720,may,0,0
232721,have,0,0
232722,an,0,0
232723,inhibitory,0,0
232724,effect,0,0
232725,on,0,0
232726,the,0,0
232727,methacholine,0,0
232728,bronchial,0,0
232729,challenge,0,0
232730,",",0,0
232731,and,0,0
232732,thus,0,0
232733,",",0,0
232734,most,0,0
232735,likely,0,0
232736,directs,0,0
232737,its,0,0
232738,effect,0,0
232739,against,0,0
232740,smooth,0,0
232741,muscle,0,0
232742,.,0,0
232743,Heparin,1,0
232744,caused,0,0
232745,less,0,0
232746,attenuation,0,0
232747,of,0,0
232748,a,0,0
232749,challenge,0,0
232750,with,0,0
232751,adenosine,0,1
232752,and,0,0
232753,probably,0,0
232754,does,0,0
232755,not,0,0
232756,affect,0,0
232757,mast,0,0
232758,cell,0,0
232759,degranulation,0,0
232760,.,0,0
232761,[,1,0
232762,Antazoline/tetryzoline,1,1
232763,eyedrops,0,1
232764,in,0,0
232765,comparison,0,0
232766,with,0,0
232767,levocabastine,1,1
232768,eyedrops,0,1
232769,in,0,0
232770,acute,0,0
232771,allergic,0,0
232772,conjunctivitis,0,0
232773,],0,0
232774,.,0,0
232775,BACKGROUND,0,0
232776,Allergic,0,0
232777,conjunctivitis,0,0
232778,is,0,0
232779,one,0,0
232780,of,0,0
232781,the,0,0
232782,most,0,0
232783,frequent,0,0
232784,allergic,0,0
232785,diseases,0,0
232786,of,0,0
232787,the,0,0
232788,anterior,0,0
232789,eye,0,1
232790,segment,0,0
232791,.,0,0
232792,METHODS,0,0
232793,This,0,0
232794,multicentre,0,0
232795,",",0,0
232796,clinical,0,0
232797,trial,0,0
232798,was,0,0
232799,an,0,0
232800,investigation,0,0
232801,to,0,0
232802,compare,0,0
232803,the,0,0
232804,antiallergic,0,0
232805,efficacy,0,0
232806,",",0,0
232807,local,0,0
232808,tolerance,0,0
232809,and,0,0
232810,safety,0,0
232811,of,0,0
232812,Antazolin/Tetryzolin,1,1
232813,eye,1,1
232814,drops,1,1
232815,and,1,0
232816,Levocabastine,1,1
232817,eye,0,1
232818,drops,0,1
232819,.,0,0
232820,69,0,0
232821,patients,0,0
232822,were,0,0
232823,treated,0,0
232824,over,0,0
232825,a,0,0
232826,2,0,0
232827,weeks,0,0
232828,course,0,0
232829,of,0,0
232830,therapy,0,1
232831,.,0,0
232832,The,0,0
232833,subjective,0,0
232834,and,0,0
232835,objective,0,0
232836,ocular,0,0
232837,symptoms,0,0
232838,were,0,0
232839,documented,0,0
232840,over,0,0
232841,the,0,0
232842,treatment,0,0
232843,period,0,0
232844,.,0,0
232845,RESULTS,0,0
232846,Both,0,1
232847,eye,0,1
232848,drops,0,1
232849,reduced,0,0
232850,subjective,0,0
232851,and,0,0
232852,objective,0,0
232853,ocular,0,0
232854,symptoms,0,0
232855,effective,0,0
232856,.,0,0
232857,The,0,0
232858,difference,0,0
232859,between,0,0
232860,the,0,0
232861,treatments,0,0
232862,(,0,0
232863,p,0,0
232864,=,0,0
232865,0.0395,0,0
232866,),0,0
232867,was,0,0
232868,the,0,0
232869,faster,0,0
232870,onset,0,0
232871,of,0,0
232872,action,0,0
232873,of,0,0
232874,Antazolin/Tetryzolin,1,1
232875,30,0,0
232876,minutes,0,0
232877,after,0,0
232878,administration,0,0
232879,of,0,0
232880,the,0,0
232881,first,0,0
232882,drop,0,0
232883,of,0,0
232884,trial,0,0
232885,medication,0,0
232886,.,0,0
232887,CONCLUSION,0,0
232888,A,0,0
232889,fast,0,0
232890,and,0,0
232891,effective,0,0
232892,onset,0,0
232893,of,0,0
232894,action,0,0
232895,is,0,0
232896,of,0,0
232897,high,0,0
232898,clinical,0,0
232899,relevance,0,0
232900,.,0,0
232901,Therefore,0,0
232902,the,0,0
232903,benefits,0,0
232904,of,0,0
232905,using,0,0
232906,Antazolin/Tetryzolin,1,1
232907,eye,0,1
232908,drops,0,1
232909,was,0,0
232910,clearly,0,0
232911,outweigh,0,0
232912,.,0,0
232913,[,0,0
232914,Clinical,0,0
232915,diagnosis,0,0
232916,of,0,0
232917,deep,0,1
232918,venous,0,0
232919,thrombosis,0,0
232920,after,0,0
232921,hip,0,0
232922,replacement,0,1
232923,surgery,0,0
232924,],0,0
232925,.,0,0
232926,Hip,0,0
232927,replacement,0,1
232928,surgery,0,1
232929,is,0,0
232930,associated,0,0
232931,with,0,0
232932,a,0,0
232933,high,0,0
232934,frequency,0,0
232935,of,0,0
232936,postoperative,0,0
232937,deep,0,1
232938,vein,0,0
232939,thrombosis,0,0
232940,.,0,0
232941,This,0,0
232942,prospective,0,0
232943,study,0,0
232944,was,0,0
232945,performed,0,0
232946,in,0,0
232947,order,0,0
232948,to,0,0
232949,investigate,0,0
232950,if,0,0
232951,routine,1,0
232952,bedside,1,0
232953,questioning,1,0
232954,and,1,0
232955,examination,1,0
232956,by,1,0
232957,the,1,0
232958,visiting,1,0
232959,doctor,1,0
232960,could,0,0
232961,reveal,0,0
232962,deep,0,0
232963,vein,0,0
232964,thrombosis,0,0
232965,in,0,0
232966,the,0,0
232967,legs,0,0
232968,of,0,0
232969,patients,0,0
232970,who,0,0
232971,had,0,0
232972,received,0,0
232973,a,0,0
232974,hip,0,0
232975,replacement,0,1
232976,.,0,0
232977,258,0,0
232978,patients,0,0
232979,were,0,0
232980,evaluated,0,0
232981,.,0,0
232982,Thromboprophylaxis,1,1
232983,(,1,0
232984,dextran-70,1,0
232985,",",1,0
232986,low,1,0
232987,molecular,1,0
232988,weight,1,0
232989,heparin,1,1
232990,and,1,0
232991,graded,1,0
232992,elastic,1,1
232993,stockings,1,1
232994,),1,0
232995,was,0,0
232996,given,0,0
232997,during,0,0
232998,the,0,0
232999,first,0,0
233000,week,0,0
233001,after,0,0
233002,operation,0,0
233003,.,0,0
233004,Bilateral,1,0
233005,venography,1,1
233006,was,0,0
233007,performed,0,0
233008,in,0,0
233009,all,0,0
233010,patients,0,0
233011,on,0,0
233012,day,0,0
233013,seven,0,0
233014,after,0,0
233015,operation,0,0
233016,",",0,0
233017,and,0,0
233018,showed,0,0
233019,an,0,0
233020,overall,0,0
233021,deep,0,1
233022,vein,0,0
233023,thrombosis,0,0
233024,incidence,0,0
233025,of,0,0
233026,16,0,0
233027,%,0,0
233028,.,0,0
233029,The,0,0
233030,visiting,0,0
233031,doctors,0,0
233032,had,0,0
233033,not,0,0
233034,suspected,0,0
233035,deep,0,1
233036,vein,0,0
233037,thrombosis,0,0
233038,in,0,0
233039,any,0,0
233040,of,0,0
233041,the,0,0
233042,patients,0,0
233043,.,0,0
233044,This,0,0
233045,may,0,0
233046,have,0,0
233047,been,0,0
233048,because,0,0
233049,postoperative,0,0
233050,painful,0,0
233051,and,0,0
233052,swollen,0,0
233053,legs,0,0
233054,effectively,0,0
233055,masked,0,0
233056,any,0,0
233057,signs,0,0
233058,and,0,0
233059,symptoms,0,0
233060,of,0,0
233061,deep,0,1
233062,vein,0,0
233063,thrombosis,0,0
233064,.,0,0
233065,Our,0,0
233066,results,0,0
233067,show,0,0
233068,that,0,0
233069,deep,0,1
233070,vein,0,0
233071,thrombosis,0,0
233072,during,0,0
233073,the,0,0
233074,first,0,0
233075,week,0,0
233076,after,0,0
233077,hip,0,0
233078,replacement,0,1
233079,surgery,0,0
233080,can,0,0
233081,not,0,0
233082,be,0,0
233083,discovered,0,0
233084,by,0,0
233085,clinical,0,0
233086,diagnostics,0,0
233087,.,0,0
233088,The,0,0
233089,high,0,0
233090,subclinical,0,0
233091,frequency,0,0
233092,of,0,0
233093,deep,0,1
233094,vein,0,0
233095,thrombosis,0,0
233096,indicates,0,0
233097,the,0,0
233098,importance,0,0
233099,of,0,0
233100,improving,0,0
233101,thromboprophylaxis,0,1
233102,in,0,0
233103,order,0,0
233104,to,0,0
233105,further,0,0
233106,minimise,0,0
233107,the,0,0
233108,occurrence,0,0
233109,of,0,0
233110,deep,0,1
233111,vein,0,0
233112,thrombosis,0,0
233113,and,0,0
233114,the,0,0
233115,risk,0,0
233116,of,0,0
233117,thromboembolic,0,0
233118,complications,0,0
233119,.,0,0
233120,Association,0,0
233121,of,0,0
233122,PML-RAR,0,1
233123,alpha,0,1
233124,fusion,0,0
233125,mRNA,0,0
233126,type,0,0
233127,with,0,0
233128,pretreatment,0,0
233129,hematologic,0,0
233130,characteristics,0,0
233131,but,0,0
233132,not,0,0
233133,treatment,0,0
233134,outcome,0,0
233135,in,0,0
233136,acute,0,0
233137,promyelocytic,0,1
233138,leukemia,0,0
233139,:,0,0
233140,an,0,0
233141,intergroup,0,0
233142,molecular,0,0
233143,study,0,0
233144,.,0,0
233145,In,0,0
233146,each,0,0
233147,case,0,0
233148,of,0,0
233149,acute,0,0
233150,promyelocytic,0,1
233151,leukemia,0,0
233152,(,0,0
233153,APL,0,0
233154,),0,0
233155,one,0,0
233156,of,0,0
233157,three,0,0
233158,PML-RAR,0,0
233159,alpha,0,1
233160,mRNA,0,0
233161,types,0,0
233162,is,0,0
233163,produced,0,0
233164,",",0,0
233165,depending,0,0
233166,on,0,0
233167,the,0,0
233168,break/fusion,0,0
233169,site,0,0
233170,in,0,0
233171,the,0,0
233172,PML,0,0
233173,gene,0,0
233174,that,0,0
233175,is,0,0
233176,linked,0,0
233177,to,0,0
233178,a,0,0
233179,common,0,0
233180,RAR,0,0
233181,alpha,0,1
233182,gene,0,0
233183,segment,0,0
233184,:,0,0
233185,a,0,0
233186,short,0,0
233187,(,0,0
233188,S,0,1
233189,),0,1
233190,-form,0,1
233191,type,0,0
233192,",",0,0
233193,PML,0,0
233194,exon,0,1
233195,3,0,0
233196,RAR,0,0
233197,alpha,0,1
233198,exon,0,1
233199,3,0,0
233200,;,0,0
233201,a,0,0
233202,long,0,0
233203,(,0,0
233204,L,0,1
233205,),0,1
233206,-form,0,1
233207,type,0,0
233208,",",0,0
233209,PML,0,0
233210,exon,0,1
233211,6,0,0
233212,RAR,0,0
233213,alpha,0,1
233214,exon,0,1
233215,3,0,0
233216,;,0,0
233217,or,0,0
233218,a,0,0
233219,variable,0,0
233220,(,0,0
233221,V,0,1
233222,),0,1
233223,-form,0,1
233224,type,0,0
233225,",",0,0
233226,variably,0,0
233227,deleted,0,0
233228,PML,0,0
233229,exon,0,1
233230,6,0,0
233231,RAR,0,0
233232,alpha,0,1
233233,exon,0,1
233234,3,0,0
233235,.,0,0
233236,We,0,0
233237,evaluated,0,0
233238,whether,0,0
233239,PML-RAR,0,1
233240,alpha,0,1
233241,mRNA,0,0
233242,type,0,0
233243,is,0,0
233244,associated,0,0
233245,with,0,0
233246,distinct,0,0
233247,pretreatment,0,0
233248,clinical,0,0
233249,characteristics,0,0
233250,and,0,0
233251,therapeutic,0,0
233252,outcome,0,0
233253,in,0,0
233254,previously,0,0
233255,untreated,0,0
233256,adult,0,0
233257,APL,0,0
233258,patients,0,0
233259,registered,0,0
233260,to,0,0
233261,protocol,0,0
233262,INT,0,1
233263,0129,0,0
233264,by,0,0
233265,the,0,0
233266,Eastern,0,0
233267,Cooperative,0,0
233268,Oncology,0,0
233269,Group,0,0
233270,",",0,0
233271,the,0,0
233272,Southwest,0,0
233273,Oncology,0,0
233274,Group,0,0
233275,",",0,0
233276,and,0,0
233277,the,0,0
233278,Cancer,0,0
233279,and,0,0
233280,Leukemia,0,0
233281,Group,0,0
233282,B,0,0
233283,.,0,0
233284,Of,0,0
233285,279,0,0
233286,clinically,0,0
233287,eligible,0,0
233288,cases,0,0
233289,",",0,0
233290,230,0,0
233291,were,0,0
233292,molecularly,1,0
233293,evaluable,1,0
233294,",",0,0
233295,and,0,0
233296,of,0,0
233297,these,0,0
233298,",",0,0
233299,111,0,0
233300,were,0,0
233301,randomized,0,0
233302,to,0,0
233303,receive,1,1
233304,remission,1,0
233305,induction,1,0
233306,therapy,1,1
233307,with,1,0
233308,all-trans,1,1
233309,retinoic,1,1
233310,acid,1,1
233311,(,1,0
233312,ATRA,1,0
233313,),1,0
233314,and,0,0
233315,119,0,0
233316,with,0,0
233317,conventional,1,1
233318,chemotherapy,1,1
233319,.,1,0
233320,Nine,0,1
233321,cases,0,0
233322,not,0,0
233323,excluded,0,0
233324,by,0,0
233325,central,0,0
233326,pathology,0,0
233327,review,0,0
233328,were,0,0
233329,PML-RAR,0,0
233330,alpha,0,1
233331,negative,0,0
233332,",",0,0
233333,and,0,0
233334,notably,0,0
233335,",",0,0
233336,none,0,0
233337,of,0,0
233338,five,0,0
233339,of,0,0
233340,these,0,0
233341,cases,0,0
233342,treated,0,0
233343,with,0,0
233344,ATRA,0,0
233345,achieved,0,0
233346,complete,0,0
233347,remission,0,0
233348,(,0,0
233349,CR,0,1
233350,),0,0
233351,.,0,0
233352,Among,0,0
233353,221,0,0
233354,PML-RAR,0,0
233355,alpha-positive,0,0
233356,cases,0,0
233357,",",0,0
233358,there,0,0
233359,were,0,0
233360,82,0,0
233361,S-form,0,0
233362,cases,0,0
233363,(,0,0
233364,37,0,0
233365,%,0,0
233366,),0,0
233367,",",0,0
233368,121,0,0
233369,L-form,0,0
233370,cases,0,0
233371,(,0,0
233372,55,0,0
233373,%,0,0
233374,),0,0
233375,",",0,0
233376,and,0,0
233377,18,0,0
233378,V-form,0,0
233379,cases,0,0
233380,(,0,0
233381,8,0,0
233382,%,0,0
233383,),0,0
233384,.,0,0
233385,Before,0,0
233386,any,0,0
233387,antileukemic,0,1
233388,therapy,0,1
233389,",",0,0
233390,the,0,0
233391,S-form,0,0
233392,type,0,0
233393,",",0,0
233394,compared,0,0
233395,with,0,0
233396,the,0,0
233397,L-form,0,1
233398,type,0,0
233399,",",0,0
233400,was,0,0
233401,associated,0,0
233402,with,0,0
233403,higher,0,0
233404,values,0,0
233405,for,0,0
233406,the,0,0
233407,white,0,0
233408,blood,0,0
233409,cell,0,0
233410,(,0,0
233411,WBC,0,0
233412,),0,1
233413,count,0,0
233414,(,0,0
233415,median,0,0
233416,"2,500/microL",0,0
233417,v,0,0
233418,"1,600/microL",0,0
233419,;,0,0
233420,P,0,0
233421,=,0,0
233422,.009,0,0
233423,),0,0
233424,",",0,0
233425,the,0,0
233426,percentage,0,0
233427,of,0,0
233428,blood,0,0
233429,blasts,0,0
233430,plus,0,1
233431,promyelocytes,0,1
233432,(,0,0
233433,median,0,0
233434,29,0,0
233435,%,0,0
233436,v,0,0
233437,8.5,0,0
233438,%,0,0
233439,;,0,0
233440,P,0,0
233441,=,0,0
233442,.03,0,0
233443,),0,0
233444,",",0,0
233445,and,0,0
233446,the,0,0
233447,absolute,0,0
233448,blood,0,0
233449,blasts,0,0
233450,plus,0,1
233451,promyelocytes,0,1
233452,(,0,0
233453,884/microL,0,0
233454,v,0,0
233455,126/microL,0,0
233456,;,0,0
233457,P,0,0
233458,=,0,0
233459,.019,0,0
233460,),0,0
233461,.,0,0
233462,Also,0,0
233463,",",0,0
233464,an,0,0
233465,increased,0,0
233466,percentage,0,0
233467,of,0,0
233468,S-form,0,0
233469,versus,0,0
233470,L-form,0,0
233471,cases,0,0
233472,had,0,0
233473,the,0,0
233474,M3,0,0
233475,variant,0,0
233476,phenotype,0,0
233477,",",0,0
233478,24,0,0
233479,%,0,0
233480,v,0,0
233481,12,0,0
233482,%,0,0
233483,(,0,0
233484,P,0,0
233485,=,0,0
233486,.036,0,0
233487,),0,0
233488,.,0,0
233489,There,0,0
233490,were,0,0
233491,no,0,0
233492,differences,0,0
233493,between,0,0
233494,S-form,0,0
233495,and,0,0
233496,L-form,0,1
233497,cases,0,0
233498,in,0,0
233499,either,0,0
233500,CR,0,1
233501,rate,0,0
233502,(,0,0
233503,79,0,0
233504,%,0,0
233505,v,0,0
233506,69,0,0
233507,%,0,0
233508,;,0,0
233509,P,0,0
233510,=,0,0
233511,.14,0,0
233512,),0,0
233513,or,0,1
233514,disease,0,0
233515,free,0,0
233516,survival,0,0
233517,distribution,0,0
233518,(,0,0
233519,multivariate,0,0
233520,analysis,0,0
233521,adjusting,0,0
233522,for,0,0
233523,the,0,0
233524,association,0,0
233525,of,0,0
233526,S-form,0,1
233527,type,0,0
233528,and,0,0
233529,higher,0,0
233530,WBC,0,0
233531,count,0,0
233532,;,0,0
233533,P,0,0
233534,=,0,0
233535,.40,0,0
233536,),0,0
233537,.,0,0
233538,We,0,0
233539,conclude,0,0
233540,that,0,0
233541,the,0,0
233542,S-form,0,0
233543,type,0,0
233544,is,0,0
233545,associated,0,0
233546,with,0,0
233547,previously-identified,0,0
233548,adverse,0,0
233549,risk,0,0
233550,WBC,0,0
233551,parameters,0,0
233552,but,0,0
233553,that,0,0
233554,the,0,0
233555,identification,0,0
233556,of,0,0
233557,the,0,0
233558,S-form,0,0
233559,or,0,1
233560,L-form,0,1
233561,type,0,0
233562,of,0,0
233563,PML-RAR,0,1
233564,alpha,0,1
233565,mRNA,0,0
233566,",",0,0
233567,per,0,0
233568,se,0,0
233569,",",0,0
233570,does,0,0
233571,not,0,0
233572,predict,0,0
233573,clinical,0,0
233574,outcome,0,0
233575,or,0,0
233576,add,0,0
233577,to,0,0
233578,the,0,0
233579,value,0,0
233580,of,0,0
233581,an,0,0
233582,increased,0,0
233583,WBC,0,0
233584,count,0,0
233585,as,0,0
233586,a,0,0
233587,negative,0,0
233588,prognostic,0,0
233589,indicator,0,0
233590,in,0,0
233591,APL,0,0
233592,patients,0,0
233593,.,0,0
233594,Dose-response,0,0
233595,and,0,0
233596,concentration-response,0,0
233597,relation,0,0
233598,of,0,0
233599,rocuronium,1,1
233600,infusion,1,1
233601,during,0,0
233602,propofol-nitrous,1,1
233603,oxide,1,1
233604,and,0,0
233605,isoflurane-nitrous,1,1
233606,oxide,1,1
233607,anaesthesia,1,1
233608,.,1,0
233609,The,0,0
233610,dose-response,0,0
233611,and,0,0
233612,concentration-response,0,0
233613,relation,0,0
233614,of,0,0
233615,rocuronium,1,1
233616,infusion,1,1
233617,was,0,0
233618,studied,0,0
233619,in,0,0
233620,20,0,0
233621,adult,0,0
233622,surgical,0,0
233623,patients,0,0
233624,during,0,0
233625,propofol-nitrous,1,1
233626,oxide,1,1
233627,and,1,0
233628,isoflurane,1,1
233629,(,1,0
233630,1,1,0
233631,MAC,1,0
233632,),1,0
233633,-nitrous,1,1
233634,oxide,1,1
233635,anaesthesia,1,1
233636,.,1,0
233637,Neuromuscular,0,0
233638,block,0,0
233639,was,0,0
233640,kept,0,0
233641,constant,0,0
233642,",",0,0
233643,initially,0,0
233644,at,0,0
233645,90,0,0
233646,%,0,0
233647,and,0,0
233648,then,0,0
233649,at,0,0
233650,50,0,0
233651,%,0,0
233652,with,0,0
233653,a,0,0
233654,closed-loop,1,1
233655,feedback,1,1
233656,controller,1,0
233657,.,1,0
233658,At,0,0
233659,90,0,0
233660,%,0,0
233661,block,0,0
233662,the,0,0
233663,steady-state,1,0
233664,infusion,1,1
233665,of,1,0
233666,rocuronium,1,1
233667,was,0,0
233668,0.55,0,0
233669,+/-,0,0
233670,0.16,0,0
233671,mg,0,1
233672,kg-1,0,1
233673,h-1,0,0
233674,and,0,0
233675,the,0,0
233676,corresponding,1,0
233677,concentration,1,0
233678,1714,0,0
233679,+/-,0,0
233680,281,0,0
233681,ng,0,0
233682,mL-1,0,0
233683,in,0,0
233684,patients,0,0
233685,receiving,0,0
233686,propofol,1,1
233687,.,1,0
233688,At,0,0
233689,50,0,0
233690,%,0,0
233691,block,0,0
233692,the,0,0
233693,corresponding,1,0
233694,infusion,1,1
233695,rate,0,0
233696,was,0,0
233697,0.27,0,0
233698,+/-,0,0
233699,0.11,0,0
233700,mg,0,1
233701,kg-1,0,1
233702,h-1,0,0
233703,and,0,0
233704,the,0,0
233705,concentration,0,0
233706,1077,0,0
233707,+/-,0,0
233708,244,0,0
233709,ng,0,0
233710,mL-1,0,0
233711,",",0,0
233712,respectively,0,0
233713,.,0,0
233714,At,0,0
233715,50,0,0
233716,%,0,0
233717,block,0,0
233718,isoflurane,1,1
233719,reduced,0,0
233720,the,0,0
233721,rate,0,0
233722,of,0,0
233723,infusion,0,1
233724,by,0,0
233725,52,0,0
233726,%,0,0
233727,(,0,0
233728,P,0,0
233729,<,0,0
233730,0.005,0,0
233731,),0,0
233732,and,0,0
233733,the,0,0
233734,concentration,0,0
233735,by,0,0
233736,59,0,0
233737,%,0,0
233738,(,0,0
233739,P,0,0
233740,<,0,0
233741,0.001,0,0
233742,),0,0
233743,;,0,0
233744,at,0,0
233745,90,0,0
233746,%,0,0
233747,block,0,0
233748,both,0,0
233749,the,0,0
233750,mean,0,0
233751,infusion,0,1
233752,rate,0,0
233753,and,0,0
233754,the,0,0
233755,concentration,0,0
233756,of,0,0
233757,rocuronium,1,1
233758,were,0,0
233759,reduced,0,0
233760,by,0,0
233761,35,0,0
233762,%,0,0
233763,(,0,0
233764,P,0,0
233765,<,0,0
233766,0.005,0,0
233767,),0,0
233768,.,0,0
233769,The,0,0
233770,mean,0,0
233771,rocuronium,1,1
233772,clearance,0,0
233773,at,0,0
233774,50,0,0
233775,%,0,0
233776,block,0,0
233777,was,0,0
233778,unaffected,0,0
233779,by,0,0
233780,the,0,0
233781,type,0,0
233782,of,0,0
233783,anaesthesia,1,1
233784,;,1,0
233785,it,0,0
233786,was,0,0
233787,4.1,0,0
233788,+/-,0,0
233789,1.6,0,0
233790,and,0,0
233791,4.9,0,0
233792,+/-,0,0
233793,2.7,0,0
233794,mL,0,0
233795,kg-1,0,1
233796,min-1,0,0
233797,in,0,0
233798,the,0,0
233799,groups,0,0
233800,receiving,0,0
233801,propofol,1,1
233802,and,0,0
233803,isoflurane,1,1
233804,anaesthesia,1,1
233805,",",0,0
233806,respectively,0,0
233807,.,0,0
233808,We,0,0
233809,conclude,0,0
233810,that,0,0
233811,isoflurane,0,1
233812,reduces,0,0
233813,the,0,0
233814,infusion,0,0
233815,requirements,0,0
233816,of,0,0
233817,rocuronium,1,1
233818,by,0,0
233819,changing,0,0
233820,the,0,0
233821,pharmacodynamic,0,0
233822,behaviour,0,0
233823,.,0,0
233824,Intravenous,1,1
233825,magnesium,1,1
233826,sulfate,1,1
233827,in,0,0
233828,acute,0,0
233829,severe,0,0
233830,asthma,0,0
233831,not,0,0
233832,responding,0,0
233833,to,0,0
233834,conventional,1,1
233835,therapy,1,1
233836,.,1,0
233837,OBJECTIVE,0,0
233838,To,0,0
233839,evaluate,0,0
233840,the,0,0
233841,effectiveness,0,0
233842,of,0,0
233843,early,0,0
233844,administration,0,0
233845,of,0,0
233846,intravenous,1,1
233847,Magnesium,1,1
233848,sulfate,1,1
233849,(,1,0
233850,i.v,1,0
233851,.,1,0
233852,MgSO4,1,0
233853,),1,0
233854,in,0,0
233855,children,0,0
233856,with,0,0
233857,acute,0,0
233858,severe,0,0
233859,asthma,0,0
233860,not,0,0
233861,responding,0,0
233862,to,0,0
233863,conventional,1,1
233864,therapy,1,1
233865,.,1,0
233866,DESIGN,0,0
233867,Randomized,0,0
233868,double-blind,0,0
233869,",",0,0
233870,placebo-controlled,1,1
233871,trial,0,0
233872,.,0,0
233873,SETTING,0,0
233874,Pediatric,0,1
233875,emergency,0,0
233876,service,0,0
233877,of,0,0
233878,a,0,0
233879,large,0,0
233880,teaching,0,0
233881,hospital,0,0
233882,.,0,0
233883,SUBJECTS,0,0
233884,47,0,0
233885,children,0,0
233886,aged,0,0
233887,between,0,0
233888,1-12,0,0
233889,years,0,0
233890,with,0,0
233891,acute,0,0
233892,severe,0,0
233893,asthma,0,0
233894,showing,0,0
233895,inadequate,0,0
233896,or,0,1
233897,poor,0,0
233898,response,0,0
233899,to,0,0
233900,3,0,0
233901,doses,0,0
233902,of,0,0
233903,nebulized,1,1
233904,salbutamol,1,1
233905,given,0,0
233906,at,0,0
233907,an,0,0
233908,interval,0,0
233909,of,0,0
233910,20,0,0
233911,min,0,0
233912,each,0,0
233913,.,0,0
233914,INTERVENTION,0,0
233915,The,0,0
233916,MgSO4,1,0
233917,group,0,0
233918,received,1,0
233919,0.2,1,0
233920,ml/kg,1,0
233921,of,1,0
233922,50,1,0
233923,%,1,0
233924,MgSO4,1,0
233925,as,1,0
233926,intravenous,1,1
233927,(,1,0
233928,i.v,1,1
233929,.,1,0
233930,),1,0
233931,infusion,1,0
233932,over,0,0
233933,35,0,0
233934,minutes,0,0
233935,and,0,0
233936,the,0,0
233937,placebo,1,1
233938,group,0,0
233939,received,0,0
233940,normal,1,0
233941,saline,1,1
233942,infusion,1,1
233943,in,0,0
233944,the,0,0
233945,same,0,0
233946,dose,0,0
233947,and,0,0
233948,at,0,0
233949,the,0,0
233950,same,0,0
233951,rate,0,0
233952,.,0,0
233953,MgSO4,1,0
233954,solution,1,1
233955,and,0,0
233956,normal,1,0
233957,saline,1,1
233958,were,0,0
233959,coded,0,0
233960,and,0,0
233961,dispensed,0,1
233962,in,0,0
233963,identical,0,0
233964,containers,0,1
233965,.,0,0
233966,Decoding,0,0
233967,was,0,0
233968,done,0,0
233969,at,0,0
233970,the,0,0
233971,completion,0,0
233972,of,0,0
233973,the,0,0
233974,study,0,0
233975,.,0,0
233976,All,0,0
233977,the,0,0
233978,patients,0,0
233979,received,0,0
233980,oxygen,1,0
233981,",",1,0
233982,nebulized,1,1
233983,salbutamol,1,1
233984,",",1,0
233985,i.v,1,1
233986,.,1,0
233987,aminophylline,1,1
233988,and,0,0
233989,corticosteroids,1,1
233990,.,1,0
233991,RESULTS,0,0
233992,MgSO4,1,0
233993,group,0,0
233994,showed,0,0
233995,early,0,0
233996,and,0,0
233997,significant,0,0
233998,improvement,0,0
233999,as,0,0
234000,compared,0,0
234001,to,0,0
234002,placebo,1,1
234003,group,0,0
234004,in,0,0
234005,PEFR,0,0
234006,and,0,0
234007,SaO2,0,1
234008,at,0,0
234009,30,0,0
234010,min,0,0
234011,and,0,0
234012,1,0,0
234013,",",0,0
234014,2,0,0
234015,",",0,0
234016,3,0,0
234017,and,0,0
234018,7,0,0
234019,hours,0,0
234020,after,0,0
234021,stopping,0,0
234022,the,0,0
234023,infusion,0,1
234024,(,0,0
234025,p,0,0
234026,ranging,0,0
234027,from,0,0
234028,<,0,0
234029,0.05,0,0
234030,to,0,0
234031,<,0,0
234032,0.01,0,0
234033,),0,0
234034,.,0,0
234035,The,0,0
234036,clinical,0,0
234037,asthma,0,0
234038,score,0,0
234039,also,0,0
234040,showed,0,0
234041,significant,0,0
234042,improvement,0,0
234043,in,0,0
234044,the,0,0
234045,MgSO4,1,0
234046,group,0,0
234047,1,0,0
234048,",",0,0
234049,2,0,0
234050,",",0,0
234051,3,0,0
234052,and,0,0
234053,11,0,0
234054,hours,0,0
234055,after,0,0
234056,stopping,0,0
234057,the,0,0
234058,infusion,0,1
234059,(,0,0
234060,p,0,0
234061,<,0,0
234062,0.01,0,0
234063,),0,0
234064,.,0,0
234065,CONCLUSION,0,0
234066,Addition,0,0
234067,of,0,0
234068,MgSO4,1,0
234069,to,0,0
234070,conventional,1,1
234071,therapy,1,1
234072,helps,0,0
234073,in,0,0
234074,achieving,0,0
234075,earlier,0,0
234076,improvement,0,0
234077,in,0,0
234078,clinical,0,0
234079,signs,0,0
234080,and,0,0
234081,symptoms,0,0
234082,of,0,0
234083,asthma,0,0
234084,and,0,0
234085,PEFR,0,0
234086,in,0,0
234087,patients,0,0
234088,not,0,0
234089,responding,0,0
234090,to,0,0
234091,conventional,0,1
234092,therapy,0,1
234093,alone,0,0
234094,.,0,0
234095,A,0,0
234096,drug,0,0
234097,interaction,0,0
234098,study,0,0
234099,between,0,0
234100,ticlopidine,1,1
234101,and,0,0
234102,cyclosporin,1,1
234103,in,0,0
234104,heart,0,0
234105,transplant,0,0
234106,recipients,0,0
234107,.,0,0
234108,OBJECTIVES,0,0
234109,Previous,0,0
234110,uncontrolled,0,0
234111,studies,0,0
234112,have,0,0
234113,suggested,0,0
234114,an,0,0
234115,interaction,0,0
234116,between,0,0
234117,ticlopidine,1,1
234118,",",0,0
234119,a,0,0
234120,major,0,0
234121,antiplatelet,0,1
234122,agent,0,0
234123,",",0,0
234124,and,0,0
234125,cyclosporin,1,1
234126,in,0,0
234127,heart-,0,0
234128,and,0,0
234129,kidney-transplant,0,0
234130,recipients,0,0
234131,.,0,0
234132,The,0,0
234133,aims,0,0
234134,of,0,0
234135,this,0,0
234136,study,0,0
234137,were,0,0
234138,to,0,0
234139,examine,0,0
234140,in,0,0
234141,a,0,0
234142,randomised,0,0
234143,",",0,0
234144,double-blind,0,0
234145,fashion,0,0
234146,",",0,0
234147,the,0,0
234148,possible,0,0
234149,interaction,0,0
234150,between,0,0
234151,cyclosporin,1,1
234152,A,1,0
234153,and,1,0
234154,ticlopidine,1,1
234155,(,0,0
234156,250,0,0
234157,mg,0,1
234158,per,0,0
234159,day,0,0
234160,),0,0
234161,and,0,0
234162,the,0,0
234163,tolerability,0,0
234164,of,0,0
234165,this,0,0
234166,combination,0,1
234167,in,0,0
234168,heart-transplant,0,0
234169,recipients,0,0
234170,.,0,0
234171,METHODS,0,0
234172,Twenty,0,0
234173,heart-transplant,0,0
234174,recipients,0,0
234175,were,0,0
234176,randomised,0,0
234177,into,0,0
234178,either,0,0
234179,a,0,0
234180,treated,0,0
234181,or,0,0
234182,a,0,0
234183,placebo,1,1
234184,group,0,0
234185,.,0,0
234186,Blood,0,0
234187,samples,0,0
234188,were,0,0
234189,drawn,0,0
234190,for,0,0
234191,time-course,0,0
234192,evaluation,0,0
234193,of,0,0
234194,cyclosporin,0,1
234195,blood,0,0
234196,levels,0,0
234197,over,0,0
234198,a,0,0
234199,period,0,0
234200,of,0,0
234201,12,0,0
234202,h,0,0
234203,",",0,0
234204,following,0,0
234205,the,0,0
234206,morning,0,0
234207,intake,0,0
234208,of,0,0
234209,cyclosporin,1,1
234210,and,0,0
234211,",",0,0
234212,for,0,0
234213,platelet,0,0
234214,aggregation,0,0
234215,studies,0,0
234216,",",0,0
234217,before,0,0
234218,and,0,0
234219,after,0,0
234220,14,0,0
234221,days,0,0
234222,of,0,0
234223,ticlopidine,1,1
234224,administration,0,0
234225,.,0,0
234226,Twenty,0,0
234227,four-hour,0,0
234228,urine,0,0
234229,samples,0,0
234230,were,0,0
234231,collected,0,0
234232,for,0,0
234233,6-beta-hydroxycortisol,0,0
234234,measurements,0,0
234235,",",0,0
234236,before,0,0
234237,and,0,0
234238,after,0,0
234239,14,0,0
234240,days,0,0
234241,of,0,0
234242,ticlopidine,0,1
234243,.,0,0
234244,RESULTS,0,0
234245,Although,0,0
234246,given,0,0
234247,at,0,0
234248,half,0,0
234249,the,0,0
234250,recommended,0,0
234251,daily,0,0
234252,dosage,0,0
234253,",",0,0
234254,ticlopidine,0,1
234255,significantly,0,0
234256,reduced,0,0
234257,platelet,0,0
234258,aggregation,0,0
234259,.,0,0
234260,Pharmacokinetic,0,0
234261,parameters,0,0
234262,indicate,0,0
234263,that,0,0
234264,the,0,0
234265,bioavailability,0,0
234266,of,0,0
234267,cyclosporin,1,1
234268,A,1,0
234269,was,0,0
234270,not,0,0
234271,significantly,0,0
234272,modified,0,0
234273,by,0,0
234274,ticlopidine,1,1
234275,.,1,0
234276,However,0,0
234277,",",0,0
234278,one,0,0
234279,patient,0,0
234280,in,0,0
234281,the,0,0
234282,ticlopidine,0,1
234283,group,0,0
234284,was,0,0
234285,withdrawn,0,0
234286,because,0,0
234287,of,0,0
234288,a,0,0
234289,major,0,0
234290,fall,0,0
234291,in,0,0
234292,cyclosporin,0,1
234293,blood,0,0
234294,level,0,0
234295,within,0,0
234296,3,0,0
234297,days,0,0
234298,of,0,0
234299,treatment,0,0
234300,.,0,0
234301,Urinary,0,0
234302,excretion,0,0
234303,of,0,0
234304,6-beta-hydroxycortisol,0,0
234305,was,0,0
234306,augmented,0,0
234307,after,0,0
234308,treatment,0,0
234309,in,0,0
234310,the,0,0
234311,ticlopidine,1,1
234312,group,0,0
234313,compared,0,0
234314,with,0,0
234315,the,0,0
234316,placebo,1,1
234317,group,0,0
234318,",",0,0
234319,suggesting,0,0
234320,that,0,0
234321,induction,0,0
234322,of,0,0
234323,drug,0,0
234324,metabolism,0,0
234325,might,0,0
234326,have,0,0
234327,occurred,0,0
234328,.,0,0
234329,Data,0,0
234330,also,0,0
234331,show,0,0
234332,quite,0,0
234333,a,0,0
234334,large,0,0
234335,intra-individual,0,0
234336,variability,0,0
234337,in,0,0
234338,cyclosporin,1,1
234339,bioavailability,0,0
234340,in,0,0
234341,the,0,0
234342,placebo,1,1
234343,group,0,0
234344,",",0,0
234345,suggesting,0,0
234346,that,0,0
234347,poor,0,0
234348,absorption,0,0
234349,of,0,0
234350,the,0,0
234351,drug,0,0
234352,formulation,0,0
234353,and/or,0,0
234354,poor,0,0
234355,compliance,0,0
234356,might,0,0
234357,have,0,0
234358,contributed,0,0
234359,to,0,0
234360,the,0,0
234361,decreased,0,0
234362,cyclosporin,1,1
234363,blood,0,0
234364,levels,0,0
234365,in,0,0
234366,the,0,0
234367,patient,0,0
234368,withdrawn,0,0
234369,from,0,0
234370,this,0,0
234371,study,0,0
234372,and,0,0
234373,in,0,0
234374,previous,0,0
234375,uncontrolled,0,0
234376,studies,0,0
234377,.,0,0
234378,CONCLUSION,0,0
234379,Cyclosporin,0,1
234380,bioavailability,0,0
234381,was,0,0
234382,not,0,0
234383,clearly,0,0
234384,modified,0,0
234385,by,0,0
234386,a,0,0
234387,half,0,0
234388,dosage,0,0
234389,of,0,0
234390,ticlopidine,1,1
234391,in,0,0
234392,this,0,0
234393,study,0,0
234394,.,0,0
234395,We,0,0
234396,",",0,0
234397,however,0,0
234398,",",0,0
234399,recommend,0,0
234400,closely,0,0
234401,monitoring,0,0
234402,cyclosporin,0,1
234403,blood,0,0
234404,levels,0,0
234405,when,0,0
234406,prescribing,0,0
234407,ticlopidine,1,1
234408,.,1,0
234409,Further,0,0
234410,studies,0,0
234411,will,0,0
234412,be,0,0
234413,needed,0,0
234414,with,0,0
234415,new,0,0
234416,formulations,0,0
234417,of,0,0
234418,cyclosporin,1,1
234419,or,0,1
234420,when,0,0
234421,using,0,0
234422,the,0,0
234423,full,0,0
234424,dosage,0,0
234425,of,0,0
234426,ticlopidine,1,1
234427,.,1,0
234428,Effectiveness,0,0
234429,of,0,0
234430,norgestimate,1,1
234431,and,0,0
234432,ethinyl,1,1
234433,estradiol,1,1
234434,in,0,0
234435,treating,0,0
234436,moderate,0,0
234437,acne,0,0
234438,vulgaris,0,1
234439,.,0,0
234440,BACKGROUND,0,0
234441,An,0,0
234442,excess,0,0
234443,of,0,0
234444,androgen,0,0
234445,is,0,0
234446,believed,0,0
234447,to,0,0
234448,contribute,0,0
234449,to,0,0
234450,development,0,0
234451,of,0,0
234452,acne,0,0
234453,in,0,0
234454,some,0,0
234455,patients,0,0
234456,.,0,0
234457,Because,0,0
234458,oral,1,0
234459,contraceptives,1,1
234460,(,0,0
234461,OCs,0,1
234462,),0,0
234463,may,0,0
234464,reduce,0,0
234465,the,0,0
234466,active,0,0
234467,androgen,0,0
234468,level,0,0
234469,",",0,0
234470,hormonal,0,0
234471,therapy,0,1
234472,with,0,0
234473,OCs,0,1
234474,has,0,0
234475,been,0,0
234476,used,0,0
234477,successfully,0,0
234478,to,0,0
234479,treat,0,0
234480,patients,0,0
234481,with,0,0
234482,acne,0,0
234483,",",0,0
234484,although,0,0
234485,this,0,0
234486,treatment,0,0
234487,has,0,0
234488,previously,0,0
234489,not,0,0
234490,been,0,0
234491,studied,0,0
234492,in,0,0
234493,placebo-controlled,0,1
234494,trials,0,0
234495,.,0,0
234496,OBJECTIVE,0,0
234497,Our,0,0
234498,purpose,0,0
234499,was,0,0
234500,to,0,0
234501,evaluate,0,0
234502,the,0,0
234503,efficacy,0,0
234504,of,0,0
234505,a,0,0
234506,triphasic,1,0
234507,",",1,0
234508,combination,1,1
234509,OC,1,0
234510,(,1,0
234511,ORTHO,1,1
234512,TRI-CYCLEN,1,1
234513,[,1,0
234514,Ortho-McNeil,1,0
234515,Pharmaceutical,1,0
234516,",",1,0
234517,Raritan,1,0
234518,",",1,0
234519,N.J.,1,0
234520,],1,0
234521,",",1,0
234522,norgestimate/ethinyl,1,1
234523,estradiol,1,1
234524,),1,0
234525,compared,0,0
234526,with,0,0
234527,placebo,1,1
234528,in,0,0
234529,the,0,0
234530,treatment,0,0
234531,of,0,0
234532,moderate,0,0
234533,acne,0,0
234534,vulgaris,0,1
234535,.,0,0
234536,METHODS,0,0
234537,Two,0,0
234538,hundred,0,0
234539,fifty-seven,0,0
234540,healthy,0,0
234541,female,0,0
234542,subjects,0,0
234543,",",0,0
234544,15,0,0
234545,to,0,0
234546,49,0,0
234547,years,0,0
234548,of,0,0
234549,age,0,0
234550,with,0,0
234551,moderate,0,0
234552,acne,0,0
234553,vulgaris,0,0
234554,",",0,0
234555,were,0,0
234556,enrolled,0,0
234557,in,0,0
234558,a,0,0
234559,multicenter,0,0
234560,",",0,0
234561,randomized,0,0
234562,",",0,0
234563,double-blind,0,0
234564,",",0,0
234565,placebo-controlled,0,1
234566,clinical,0,0
234567,trial,0,0
234568,.,0,0
234569,Each,0,0
234570,month,0,0
234571,for,0,0
234572,6,0,0
234573,months,0,0
234574,",",0,0
234575,subjects,0,0
234576,received,0,0
234577,either,0,0
234578,3,0,0
234579,consecutive,0,0
234580,weeks,0,0
234581,of,0,0
234582,the,0,0
234583,OC,1,0
234584,(,0,0
234585,i.e.,0,0
234586,",",0,0
234587,tablets,0,1
234588,containing,0,0
234589,a,0,0
234590,fixed,0,0
234591,dose,0,0
234592,of,0,0
234593,ethinyl,1,1
234594,estradiol,1,1
234595,[,1,0
234596,0.035,1,0
234597,mg,1,1
234598,],1,0
234599,and,1,0
234600,increasing,1,0
234601,doses,1,0
234602,of,1,0
234603,norgestimate,1,1
234604,[,0,0
234605,0.180,0,0
234606,mg,0,0
234607,",",0,0
234608,0.215,0,0
234609,mg,0,0
234610,",",0,0
234611,0.250,0,0
234612,mg,0,1
234613,],0,0
234614,),0,0
234615,followed,0,0
234616,by,0,0
234617,7,0,0
234618,days,0,0
234619,of,0,0
234620,inactive,1,1
234621,drug,1,0
234622,or,1,1
234623,placebo,1,1
234624,(,0,0
234625,color-matched,0,0
234626,tablets,0,1
234627,),0,0
234628,.,0,0
234629,Efficacy,0,0
234630,was,0,0
234631,assessed,0,0
234632,by,0,0
234633,facial,0,0
234634,acne,0,0
234635,lesion,0,0
234636,counts,0,0
234637,",",0,0
234638,an,0,0
234639,investigator,0,0
234640,'s,0,0
234641,global,0,0
234642,assessment,0,0
234643,",",0,0
234644,a,0,0
234645,subject,0,0
234646,'s,0,0
234647,self-assessment,0,0
234648,",",0,0
234649,and,0,0
234650,an,0,0
234651,analysis,0,0
234652,of,0,0
234653,within-cycle,0,0
234654,variation,0,0
234655,(,0,0
234656,cycle,0,0
234657,6,0,0
234658,),0,0
234659,in,0,0
234660,lesion,0,0
234661,counts,0,0
234662,.,0,0
234663,RESULTS,0,0
234664,Of,0,0
234665,the,0,0
234666,160,0,0
234667,subjects,0,0
234668,in,0,0
234669,whom,0,0
234670,efficacy,0,0
234671,could,0,0
234672,be,0,0
234673,evaluated,0,0
234674,",",0,0
234675,the,0,0
234676,OC,0,0
234677,group,0,0
234678,showed,0,0
234679,a,0,0
234680,statistically,0,0
234681,significantly,0,0
234682,greater,0,0
234683,improvement,0,0
234684,than,0,0
234685,the,0,0
234686,placebo,0,1
234687,group,0,0
234688,for,0,0
234689,all,0,0
234690,primary,0,0
234691,efficacy,0,0
234692,measures,0,0
234693,.,0,0
234694,The,0,0
234695,mean,0,0
234696,decrease,0,0
234697,in,0,0
234698,inflammatory,0,0
234699,lesion,0,0
234700,count,0,0
234701,from,0,0
234702,baseline,0,0
234703,to,0,0
234704,cycle,0,0
234705,6,0,0
234706,was,0,0
234707,11.8,0,0
234708,(,0,0
234709,62.0,0,0
234710,%,0,0
234711,),0,0
234712,versus,0,0
234713,7.6,0,0
234714,(,0,0
234715,38.6,0,0
234716,%,0,0
234717,),0,0
234718,(,0,0
234719,p,0,0
234720,=,0,0
234721,0.0001,0,0
234722,),0,0
234723,",",0,0
234724,and,0,0
234725,the,0,0
234726,mean,0,0
234727,decrease,0,0
234728,in,0,0
234729,total,0,0
234730,lesion,0,0
234731,count,0,0
234732,was,0,0
234733,29.1,0,0
234734,(,0,0
234735,53.1,0,0
234736,%,0,0
234737,),0,0
234738,versus,0,0
234739,14.1,0,0
234740,(,0,0
234741,26.8,0,0
234742,%,0,0
234743,),0,0
234744,(,0,0
234745,p,0,0
234746,=,0,0
234747,0.0001,0,0
234748,),0,0
234749,in,0,0
234750,the,0,0
234751,OC,0,0
234752,and,0,0
234753,placebo,0,1
234754,groups,0,0
234755,",",0,0
234756,respectively,0,0
234757,.,0,0
234758,In,0,0
234759,the,0,0
234760,investigator,0,0
234761,'s,0,0
234762,global,0,0
234763,assessment,0,0
234764,",",0,0
234765,93.7,0,0
234766,%,0,0
234767,of,0,0
234768,the,0,0
234769,active,0,0
234770,treatment,0,0
234771,group,0,0
234772,versus,0,0
234773,65.4,0,0
234774,%,0,0
234775,of,0,0
234776,the,0,0
234777,placebo,0,1
234778,group,0,0
234779,were,0,0
234780,rated,0,0
234781,as,0,0
234782,improved,0,0
234783,at,0,0
234784,the,0,0
234785,end,0,0
234786,of,0,0
234787,the,0,0
234788,study,0,0
234789,(,0,0
234790,p,0,0
234791,<,0,0
234792,0.001,0,0
234793,),0,0
234794,.,0,0
234795,Six,0,0
234796,of,0,0
234797,the,0,0
234798,seven,0,0
234799,secondary,0,0
234800,efficacy,0,0
234801,measures,0,0
234802,(,0,0
234803,total,0,0
234804,comedones,0,1
234805,",",0,0
234806,open,0,0
234807,comedones,0,0
234808,",",0,0
234809,closed,0,0
234810,comedones,0,0
234811,",",0,0
234812,papules,0,0
234813,",",0,0
234814,pustules,0,0
234815,",",0,0
234816,and,0,0
234817,the,0,0
234818,subject,0,0
234819,'s,0,0
234820,self-assessment,0,0
234821,of,0,0
234822,study,0,0
234823,treatment,0,0
234824,),0,0
234825,were,0,0
234826,also,0,0
234827,significantly,0,0
234828,more,0,0
234829,favorable,0,0
234830,in,0,0
234831,the,0,0
234832,OC,0,0
234833,group,0,0
234834,compared,0,0
234835,with,0,0
234836,the,0,0
234837,placebo,0,1
234838,group,0,0
234839,.,0,0
234840,CONCLUSION,0,0
234841,An,0,0
234842,OC,0,0
234843,containing,0,1
234844,0.035,0,0
234845,mg,0,0
234846,of,0,0
234847,ethinyl,1,1
234848,estradiol,1,1
234849,combined,0,0
234850,with,0,0
234851,the,0,0
234852,triphasic,0,0
234853,regimen,0,0
234854,of,0,0
234855,norgestimate,0,1
234856,is,0,0
234857,a,0,0
234858,safe,0,0
234859,and,0,0
234860,effective,0,0
234861,treatment,0,0
234862,of,0,0
234863,moderate,0,0
234864,acne,0,0
234865,vulgaris,0,0
234866,in,0,0
234867,women,0,0
234868,with,0,0
234869,no,0,0
234870,known,0,0
234871,contraindication,0,0
234872,to,0,0
234873,OC,0,0
234874,therapy,0,1
234875,.,0,0
234876,Maximal,0,0
234877,bioavailability,0,0
234878,of,0,0
234879,digoxin,1,1
234880,from,0,0
234881,tablets,0,1
234882,and,0,0
234883,oral,0,1
234884,solution,0,1
234885,in,0,0
234886,steady,0,0
234887,state,0,0
234888,.,0,0
234889,Comparison,0,0
234890,has,0,0
234891,been,0,0
234892,made,0,0
234893,between,0,0
234894,the,0,0
234895,absorption,0,0
234896,of,0,0
234897,digoxin,1,1
234898,from,0,0
234899,Lanoxin,1,1
234900,tablets,0,1
234901,and,0,0
234902,the,0,0
234903,absorption,0,0
234904,of,0,0
234905,international,0,0
234906,chemical,0,1
234907,reference,0,0
234908,substance,0,0
234909,digoxin,1,1
234910,from,1,0
234911,an,1,0
234912,oral,1,0
234913,solution,1,1
234914,.,1,0
234915,Plasma,0,0
234916,levels,0,0
234917,",",0,0
234918,areas,0,0
234919,under,0,0
234920,24-hour,0,0
234921,plasma,0,0
234922,concentration,0,0
234923,curves,0,0
234924,and,0,0
234925,urinary,0,0
234926,excretion,0,0
234927,were,0,0
234928,similar,0,0
234929,by,0,0
234930,both,0,0
234931,formulations,0,0
234932,in,0,0
234933,steady,0,0
234934,state,0,0
234935,.,0,0
234936,78,0,0
234937,%,0,0
234938,of,0,0
234939,the,0,0
234940,digoxin,1,1
234941,administered,0,0
234942,was,0,0
234943,absorbed,0,0
234944,from,0,0
234945,the,0,0
234946,tablets,0,1
234947,and,0,0
234948,76,0,0
234949,%,0,0
234950,from,0,0
234951,the,0,0
234952,solution,0,1
234953,.,0,0
234954,Rapid,0,0
234955,dissolution,0,0
234956,in,0,0
234957,the,0,0
234958,intestinal,0,0
234959,fluids,0,0
234960,accounts,0,0
234961,for,0,0
234962,the,0,0
234963,high,0,0
234964,digoxin,1,1
234965,bioavailability,0,0
234966,of,0,0
234967,the,0,0
234968,tablets,0,1
234969,.,0,0
234970,The,0,0
234971,effects,0,0
234972,of,0,0
234973,the,0,0
234974,angiotensin-converting,1,1
234975,enzyme,1,0
234976,inhibitor,1,1
234977,imidapril,1,1
234978,on,0,0
234979,plasma,0,0
234980,plasminogen,0,1
234981,activator,0,0
234982,inhibitor,0,1
234983,activity,0,0
234984,in,0,0
234985,patients,0,0
234986,with,0,0
234987,acute,0,0
234988,myocardial,0,0
234989,infarction,0,0
234990,.,0,0
234991,This,0,0
234992,study,0,0
234993,sought,0,0
234994,to,0,0
234995,determine,0,0
234996,whether,0,0
234997,early,0,0
234998,treatment,0,0
234999,with,0,0
235000,angiotensin-converting,1,1
235001,enzyme,1,1
235002,(,1,0
235003,ACE,1,0
235004,),1,0
235005,inhibitors,1,1
235006,in,0,0
235007,patients,0,0
235008,with,0,0
235009,acute,0,0
235010,myocardial,0,0
235011,infarction,0,0
235012,(,0,0
235013,AMI,0,1
235014,),0,1
235015,is,0,0
235016,useful,0,0
235017,for,0,0
235018,the,0,0
235019,improvement,0,0
235020,of,0,0
235021,fibrinolytic,0,0
235022,function,0,0
235023,",",0,0
235024,as,0,0
235025,well,0,0
235026,as,0,0
235027,left,0,0
235028,ventricular,0,0
235029,function,0,0
235030,.,0,0
235031,This,0,0
235032,study,0,0
235033,was,0,0
235034,designed,0,0
235035,to,0,0
235036,examine,0,0
235037,the,0,0
235038,levels,0,0
235039,of,0,0
235040,plasma,0,0
235041,plasminogen,0,1
235042,activator,0,1
235043,inhibitor,0,1
235044,(,0,0
235045,PAI,0,1
235046,),0,1
235047,activity,0,0
235048,and,0,0
235049,serum,0,0
235050,ACE,0,0
235051,activity,0,0
235052,during,0,0
235053,the,0,0
235054,course,0,0
235055,of,0,0
235056,2,0,0
235057,weeks,0,0
235058,in,0,0
235059,40,0,0
235060,patients,0,0
235061,with,0,0
235062,AMI,0,0
235063,within,0,0
235064,12,0,0
235065,hours,0,0
235066,after,0,0
235067,the,0,0
235068,onset,0,0
235069,of,0,0
235070,the,0,0
235071,symptom,0,0
235072,and,0,0
235073,who,0,0
235074,randomly,0,0
235075,received,0,0
235076,early,0,0
235077,treatment,0,0
235078,with,0,0
235079,either,0,0
235080,the,0,0
235081,ACE,1,0
235082,inhibitor,1,1
235083,imidapril,1,1
235084,or,1,1
235085,a,1,0
235086,placebo,1,1
235087,(,0,0
235088,20,0,0
235089,patients,0,0
235090,in,0,0
235091,the,0,0
235092,imidapril,0,1
235093,group,0,0
235094,and,0,0
235095,20,0,0
235096,in,0,0
235097,the,0,0
235098,placebo,0,1
235099,group,0,0
235100,),0,0
235101,.,0,0
235102,The,0,0
235103,levels,0,0
235104,of,0,0
235105,serum,0,0
235106,ACE,0,0
235107,activity,0,0
235108,in,0,0
235109,the,0,0
235110,imidapril,1,1
235111,group,0,0
235112,decreased,0,0
235113,significantly,0,0
235114,(,0,0
235115,p,0,0
235116,<,0,0
235117,0.01,0,0
235118,),0,0
235119,8,0,0
235120,hours,0,0
235121,after,0,0
235122,the,0,0
235123,administration,0,0
235124,of,0,0
235125,imidapril,1,1
235126,",",0,0
235127,and,0,0
235128,the,0,0
235129,levels,0,0
235130,24,0,0
235131,hours,0,0
235132,after,0,0
235133,administration,0,0
235134,were,0,0
235135,significantly,0,0
235136,lower,0,0
235137,than,0,0
235138,those,0,0
235139,in,0,0
235140,the,0,0
235141,placebo,1,1
235142,group,0,0
235143,(,0,0
235144,3.6,0,0
235145,+/-,0,0
235146,0.6,0,0
235147,IU/L,0,0
235148,vs,0,0
235149,7.4,0,0
235150,+/-,0,0
235151,0.8,0,0
235152,IU/L,0,0
235153,;,0,0
235154,p,0,0
235155,<,0,0
235156,0.001,0,0
235157,),0,0
235158,.,0,0
235159,The,0,0
235160,plasma,0,0
235161,PAI,0,1
235162,activity,0,0
235163,increased,0,0
235164,gradually,0,0
235165,to,0,0
235166,peak,0,0
235167,levels,0,0
235168,16,0,0
235169,hours,0,0
235170,after,0,0
235171,the,0,0
235172,administration,0,0
235173,of,0,0
235174,imidapril,0,1
235175,and,0,0
235176,placebo,0,1
235177,.,0,0
235178,The,0,0
235179,levels,0,0
235180,in,0,0
235181,the,0,0
235182,placebo,0,1
235183,group,0,0
235184,decreased,0,0
235185,gradually,0,0
235186,but,0,0
235187,remained,0,0
235188,high,0,0
235189,during,0,0
235190,the,0,0
235191,study,0,0
235192,period,0,0
235193,.,0,0
235194,On,0,0
235195,the,0,0
235196,other,0,0
235197,hand,0,0
235198,",",0,0
235199,the,0,0
235200,levels,0,0
235201,of,0,0
235202,PAI,0,1
235203,activity,0,0
235204,in,0,0
235205,the,0,0
235206,imidapril,1,1
235207,group,0,0
235208,decreased,0,0
235209,rapidly,0,0
235210,and,0,0
235211,those,0,0
235212,48,0,0
235213,hours,0,0
235214,after,0,0
235215,administration,0,0
235216,were,0,0
235217,significantly,0,0
235218,lower,0,0
235219,than,0,0
235220,those,0,0
235221,in,0,0
235222,the,0,0
235223,placebo,1,1
235224,group,0,0
235225,(,0,0
235226,7.9,0,0
235227,+/-,0,0
235228,1.9,0,0
235229,IU/ml,0,0
235230,vs,0,0
235231,18.4,0,0
235232,+/-,0,0
235233,3.5,0,0
235234,IU/ml,0,0
235235,;,0,0
235236,p,0,0
235237,<,0,0
235238,0.01,0,0
235239,),0,0
235240,.,0,0
235241,The,0,0
235242,levels,0,0
235243,of,0,0
235244,left,0,0
235245,ventricular,0,0
235246,ejection,0,0
235247,fraction,0,0
235248,about,0,0
235249,2,0,0
235250,weeks,0,0
235251,after,0,0
235252,admission,0,0
235253,were,0,0
235254,significantly,0,0
235255,higher,0,0
235256,in,0,0
235257,the,0,0
235258,imidapril,0,1
235259,group,0,0
235260,than,0,0
235261,in,0,0
235262,the,0,0
235263,placebo,1,1
235264,group,0,0
235265,(,0,0
235266,65.9,0,0
235267,%,0,0
235268,+/-,0,0
235269,2.5,0,0
235270,%,0,0
235271,vs,0,0
235272,49.1,0,0
235273,%,0,0
235274,+/-,0,0
235275,4.4,0,0
235276,%,0,0
235277,;,0,0
235278,p,0,0
235279,<,0,0
235280,0.01,0,0
235281,),0,0
235282,.,0,0
235283,This,0,0
235284,study,0,0
235285,showed,0,0
235286,that,0,0
235287,imidapril,1,1
235288,",",0,0
235289,an,0,0
235290,ACE,0,0
235291,inhibitor,0,1
235292,",",0,0
235293,might,0,0
235294,be,0,0
235295,useful,0,0
235296,for,0,0
235297,the,0,0
235298,improvement,0,0
235299,of,0,0
235300,fibrinolytic,0,0
235301,function,0,0
235302,and,0,0
235303,left,0,0
235304,ventricular,0,0
235305,function,0,0
235306,in,0,0
235307,the,0,0
235308,acute,0,0
235309,phase,0,0
235310,of,0,0
235311,myocardial,0,0
235312,infarction,0,0
235313,.,0,0
235314,Safety,0,0
235315,and,0,0
235316,immunogenicity,0,0
235317,of,0,0
235318,a,0,0
235319,combined,0,1
235320,pentavalent,1,1
235321,diphtheria,1,1
235322,",",1,0
235323,tetanus,1,1
235324,",",1,0
235325,acellular,1,1
235326,pertussis,1,0
235327,",",1,0
235328,inactivated,1,1
235329,poliovirus,1,0
235330,and,1,0
235331,Haemophilus,1,1
235332,influenzae,1,1
235333,type,1,0
235334,b-tetanus,1,0
235335,conjugate,1,1
235336,vaccine,1,1
235337,in,0,0
235338,infants,0,0
235339,",",0,0
235340,compared,0,0
235341,with,0,0
235342,a,0,0
235343,whole,1,0
235344,cell,1,0
235345,pertussis,1,1
235346,pentavalent,1,1
235347,vaccine,1,1
235348,.,1,0
235349,BACKGROUND,0,0
235350,We,0,0
235351,compared,0,0
235352,the,0,0
235353,safety,0,0
235354,and,0,0
235355,immunogenicity,0,0
235356,of,0,0
235357,two,0,0
235358,combined,1,0
235359,diphtheria-tetanus-pertussis-inactivated,1,1
235360,poliovirus,1,0
235361,vaccines,1,1
235362,containing,1,1
235363,either,1,0
235364,acellular,1,1
235365,(,1,0
235366,Pa,1,0
235367,",",1,0
235368,SmithKline,1,0
235369,Beecham,1,0
235370,Biologicals,1,1
235371,),1,0
235372,or,1,1
235373,whole,1,1
235374,cell,1,0
235375,(,1,0
235376,Pw,1,1
235377,",",1,0
235378,Pasteur,1,0
235379,Merieux,1,1
235380,Connaught,1,1
235381,),1,0
235382,pertussis,1,0
235383,components,1,0
235384,",",1,0
235385,mixed,1,0
235386,with,1,0
235387,a,1,0
235388,Haemophilus,1,1
235389,influenzae,1,0
235390,type,1,0
235391,b,1,0
235392,polysaccharide,1,0
235393,polyribosylribitol,1,1
235394,phosphate-tetanus,1,1
235395,conjugate,1,1
235396,vaccine,1,1
235397,in,0,0
235398,an,0,0
235399,open,0,0
235400,",",0,0
235401,randomized,0,0
235402,study,0,0
235403,in,0,0
235404,healthy,0,0
235405,infants,0,0
235406,.,0,0
235407,DESIGN,0,0
235408,The,0,0
235409,combined,0,0
235410,vaccines,0,1
235411,were,0,0
235412,given,0,0
235413,at,0,0
235414,2,0,0
235415,",",0,0
235416,4,0,0
235417,",",0,0
235418,6,0,0
235419,and,0,0
235420,12,0,0
235421,months,0,0
235422,of,0,0
235423,age,0,0
235424,",",0,0
235425,and,0,0
235426,serum,0,0
235427,samples,0,0
235428,were,0,0
235429,obtained,0,0
235430,at,0,0
235431,ages,0,0
235432,2,0,0
235433,",",0,0
235434,6,0,0
235435,",",0,0
235436,7,0,0
235437,",",0,0
235438,12,0,0
235439,and,0,0
235440,13,0,0
235441,months,0,0
235442,.,0,0
235443,Adverse,0,0
235444,events,0,0
235445,were,0,0
235446,obtained,0,0
235447,by,0,0
235448,diary,0,0
235449,cards,0,0
235450,.,0,0
235451,RESULTS,0,0
235452,The,0,0
235453,Pa,0,0
235454,group,0,0
235455,(,0,0
235456,n,0,0
235457,=,0,0
235458,101,0,0
235459,),0,0
235460,had,0,0
235461,a,0,0
235462,clearly,0,0
235463,lower,0,0
235464,incidence,0,0
235465,of,0,0
235466,both,0,0
235467,local,0,0
235468,and,0,0
235469,systemic,0,0
235470,adverse,0,0
235471,events,0,0
235472,than,0,0
235473,the,0,0
235474,Pw,0,1
235475,group,0,0
235476,(,0,0
235477,n,0,0
235478,=,0,0
235479,100,0,0
235480,),0,0
235481,.,0,0
235482,Immunogenicity,0,0
235483,was,0,0
235484,comparable,0,0
235485,for,0,0
235486,the,0,0
235487,diphtheria,0,1
235488,and,0,0
235489,tetanus,0,1
235490,components,0,0
235491,",",0,0
235492,but,0,0
235493,significantly,0,0
235494,superior,0,0
235495,for,0,0
235496,pertussis,0,0
235497,toxin,0,1
235498,",",0,0
235499,filamentous,0,0
235500,hemagglutinin,0,0
235501,",",0,0
235502,pertactin,0,0
235503,and,0,0
235504,polioviruses,0,0
235505,1,0,0
235506,",",0,0
235507,2,0,0
235508,and,0,0
235509,3,0,0
235510,in,0,0
235511,the,0,0
235512,Pa,0,0
235513,group,0,0
235514,.,0,0
235515,Both,0,0
235516,groups,0,0
235517,had,0,0
235518,an,0,0
235519,appropriate,0,0
235520,response,0,0
235521,with,0,0
235522,regard,0,0
235523,to,0,0
235524,H.,0,0
235525,influenzae,0,1
235526,type,0,0
235527,b,0,1
235528,polysaccharide,0,1
235529,polyribosylribitol,0,1
235530,phosphate,0,1
235531,",",0,0
235532,but,0,0
235533,the,0,0
235534,dynamics,0,0
235535,of,0,0
235536,the,0,0
235537,response,0,0
235538,were,0,0
235539,significantly,0,0
235540,different,0,0
235541,:,0,0
235542,geometric,0,0
235543,mean,0,0
235544,concentrations,0,0
235545,(,0,0
235546,micrograms,0,1
235547,per,0,0
235548,ml,0,0
235549,),0,0
235550,after,0,0
235551,the,0,0
235552,second,0,0
235553,",",0,0
235554,third,0,0
235555,and,0,0
235556,booster,0,0
235557,doses,0,0
235558,were,0,0
235559,1.27,0,0
235560,",",0,0
235561,5.06,0,0
235562,and,0,0
235563,23.12,0,0
235564,in,0,0
235565,the,0,0
235566,Pa,0,0
235567,group,0,0
235568,and,0,0
235569,2.72,0,0
235570,",",0,0
235571,6.66,0,0
235572,and,0,0
235573,13.59,0,0
235574,in,0,0
235575,the,0,0
235576,Pw,0,1
235577,group,0,0
235578,",",0,0
235579,respectively,0,0
235580,(,0,0
235581,P,0,0
235582,=,0,0
235583,0.0002,0,0
235584,after,0,0
235585,second,0,0
235586,dose,0,0
235587,;,0,0
235588,P,0,0
235589,=,0,0
235590,0.0005,0,0
235591,after,0,0
235592,booster,0,0
235593,),0,0
235594,.,0,0
235595,CONCLUSION,0,0
235596,The,0,0
235597,presently,0,0
235598,studied,0,0
235599,diphtheria,0,1
235600,",",0,0
235601,tetanus,0,1
235602,",",0,0
235603,acellular,0,1
235604,pertussis-H.,0,1
235605,influenzae,0,1
235606,b,0,0
235607,vaccine,0,1
235608,conjugated,0,1
235609,to,0,0
235610,tetanus,1,1
235611,toxoid,1,1
235612,combination,1,1
235613,was,0,0
235614,at,0,0
235615,least,0,0
235616,as,0,0
235617,immunogenic,0,0
235618,as,0,0
235619,the,0,0
235620,diphtheria,1,1
235621,",",1,0
235622,tetanus,1,1
235623,",",1,0
235624,whole,1,0
235625,cell,1,0
235626,pertussis-H.,1,1
235627,influenzae,1,1
235628,b,1,0
235629,vaccine,1,1
235630,conjugated,1,1
235631,to,1,0
235632,tetanus,1,1
235633,toxoid,1,1
235634,combination,1,1
235635,",",0,0
235636,with,0,0
235637,a,0,0
235638,significantly,0,0
235639,better,0,0
235640,safety,0,0
235641,profile,0,0
235642,.,0,0
235643,This,0,0
235644,is,0,0
235645,of,0,0
235646,obvious,0,0
235647,importance,0,0
235648,in,0,0
235649,countries,0,0
235650,where,0,0
235651,inactivated,0,1
235652,poliovirus,0,0
235653,vaccine,0,1
235654,is,0,0
235655,part,0,0
235656,of,0,0
235657,the,0,0
235658,routine,0,0
235659,infant,0,0
235660,immunization,0,1
235661,programs,0,0
235662,.,0,0
235663,Randomised,0,0
235664,community-based,0,0
235665,trial,0,0
235666,of,0,0
235667,annual,0,0
235668,single-dose,0,1
235669,diethylcarbamazine,1,1
235670,with,0,0
235671,or,0,0
235672,without,0,0
235673,ivermectin,1,1
235674,against,0,0
235675,Wuchereria,0,0
235676,bancrofti,0,0
235677,infection,0,0
235678,in,0,0
235679,human,0,0
235680,beings,0,0
235681,and,0,0
235682,mosquitoes,0,0
235683,.,0,0
235684,BACKGROUND,0,0
235685,WHO,0,1
235686,has,0,0
235687,targeted,0,0
235688,lymphatic,0,0
235689,filariasis,0,0
235690,for,0,0
235691,elimination,0,0
235692,.,0,0
235693,Studies,0,0
235694,of,0,0
235695,vector-parasite,0,0
235696,relations,0,0
235697,of,0,0
235698,Wuchereria,0,0
235699,bancrofti,0,0
235700,suggest,0,0
235701,that,0,0
235702,a,0,0
235703,reduction,0,0
235704,in,0,0
235705,the,0,0
235706,microfilarial,0,0
235707,reservoir,0,0
235708,by,0,0
235709,mass,0,0
235710,chemotherapy,1,1
235711,may,0,0
235712,interrupt,0,0
235713,transmission,0,0
235714,and,0,0
235715,thereby,0,0
235716,eliminate,0,0
235717,infection,0,0
235718,.,0,0
235719,However,0,0
235720,",",0,0
235721,no,0,0
235722,field,0,0
235723,data,0,0
235724,exist,0,0
235725,on,0,0
235726,the,0,0
235727,impact,0,0
235728,of,0,0
235729,chemotherapy,0,1
235730,alone,0,1
235731,on,0,0
235732,vector,0,1
235733,efficiency,0,0
235734,and,0,0
235735,transmission,0,0
235736,intensity,0,0
235737,of,0,0
235738,W,0,0
235739,bancrofti,0,0
235740,.,0,0
235741,We,0,0
235742,compared,0,0
235743,the,0,0
235744,impact,0,0
235745,of,0,0
235746,an,0,0
235747,annual,1,0
235748,community-wide,1,0
235749,single-dose,1,1
235750,treatment,1,0
235751,with,1,0
235752,diethylcarbamazine,1,1
235753,alone,1,1
235754,or,1,1
235755,with,1,0
235756,ivermectin,1,1
235757,on,0,0
235758,rate,0,0
235759,and,0,0
235760,intensity,0,0
235761,of,0,0
235762,microfilaraemia,0,0
235763,",",0,0
235764,and,0,0
235765,transmission,0,0
235766,intensity,0,0
235767,in,0,0
235768,an,0,0
235769,area,0,0
235770,of,0,0
235771,Papua,0,0
235772,New,0,0
235773,Guinea,0,1
235774,endemic,0,0
235775,for,0,0
235776,intense,0,0
235777,W,0,1
235778,bancrofti,0,0
235779,transmission,0,0
235780,.,0,0
235781,METHODS,0,0
235782,We,0,0
235783,carried,0,0
235784,out,0,0
235785,clinical,0,0
235786,and,0,0
235787,parasitological,0,0
235788,surveys,0,0
235789,in,0,0
235790,14,0,0
235791,communities,0,0
235792,in,0,0
235793,matched,0,0
235794,pairs,0,0
235795,.,0,0
235796,People,0,0
235797,aged,0,0
235798,5,0,0
235799,years,0,0
235800,or,0,0
235801,older,0,0
235802,in,0,0
235803,seven,0,0
235804,communities,0,0
235805,received,0,0
235806,randomly,0,0
235807,assigned,0,0
235808,diethylcarbamazine,1,1
235809,6,0,0
235810,mg/kg,0,0
235811,and,0,0
235812,people,0,0
235813,in,0,0
235814,the,0,0
235815,other,0,0
235816,seven,0,0
235817,communities,0,0
235818,received,0,0
235819,diethylcarbamazine,1,1
235820,6,0,0
235821,mg/kg,0,1
235822,plus,0,1
235823,ivermectin,1,1
235824,400,0,0
235825,micrograms/kg,0,0
235826,.,0,0
235827,We,0,0
235828,made,0,0
235829,physical,0,0
235830,examinations,0,0
235831,for,0,0
235832,hydroceles,0,0
235833,and,0,0
235834,leg,0,0
235835,oedema,0,0
235836,and,0,0
235837,investigated,0,0
235838,microfilarial,0,0
235839,densities,0,0
235840,by,0,0
235841,membrane,0,0
235842,filtration,0,0
235843,before,0,0
235844,and,0,0
235845,after,0,0
235846,treatment,0,0
235847,.,0,0
235848,We,0,0
235849,selected,0,0
235850,five,0,0
235851,communities,0,0
235852,for,0,0
235853,monthly,0,0
235854,entomological,0,0
235855,surveys,0,0
235856,between,0,0
235857,September,0,0
235858,",",0,0
235859,1993,0,0
235860,",",0,0
235861,and,0,0
235862,September,0,0
235863,",",0,0
235864,1995,0,0
235865,.,0,0
235866,Mosquitoes,0,0
235867,were,0,0
235868,collected,0,0
235869,in,0,0
235870,these,0,0
235871,communities,0,0
235872,by,0,0
235873,the,0,0
235874,all-night,0,0
235875,landing,0,0
235876,catch,0,0
235877,method,0,0
235878,and,0,0
235879,were,0,0
235880,individually,0,0
235881,dissected,0,0
235882,to,0,0
235883,identify,0,0
235884,rates,0,0
235885,of,0,0
235886,infection,0,0
235887,and,0,0
235888,infectiveness,0,0
235889,.,0,0
235890,FINDINGS,0,0
235891,2219,0,0
235892,(,0,0
235893,87.6,0,0
235894,%,0,0
235895,),0,0
235896,of,0,0
235897,2534,0,0
235898,eligible,0,0
235899,people,0,0
235900,received,0,0
235901,treatment,0,0
235902,.,0,0
235903,Microfilarial,0,0
235904,rate,0,0
235905,and,0,0
235906,density,0,0
235907,had,0,0
235908,decreased,0,0
235909,1,0,0
235910,year,0,0
235911,after,0,0
235912,treatment,0,0
235913,in,0,0
235914,all,0,0
235915,14,0,0
235916,communities,0,0
235917,;,0,0
235918,this,0,0
235919,decrease,0,0
235920,was,0,0
235921,significantly,0,0
235922,higher,0,0
235923,in,0,0
235924,communities,0,0
235925,given,0,0
235926,combined,0,0
235927,therapy,0,1
235928,than,0,0
235929,in,0,0
235930,those,0,0
235931,given,0,0
235932,diethylcarbamazine,1,1
235933,alone,0,1
235934,(,0,0
235935,mean,0,0
235936,decreases,0,0
235937,57.5,0,0
235938,%,0,0
235939,and,0,0
235940,30.6,0,0
235941,%,0,0
235942,",",0,0
235943,respectively,0,0
235944,;,0,0
235945,p,0,0
235946,=,0,0
235947,0.0013,0,0
235948,),0,0
235949,.,0,0
235950,Greater,0,0
235951,decreases,0,0
235952,were,0,0
235953,also,0,0
235954,seen,0,0
235955,in,0,0
235956,community-specific,0,0
235957,microfilarial,0,0
235958,intensity,0,0
235959,with,0,0
235960,combined,0,1
235961,therapy,0,1
235962,(,0,0
235963,mean,0,0
235964,reductions,0,0
235965,91.1,0,0
235966,%,0,0
235967,and,0,0
235968,69.8,0,0
235969,%,0,0
235970,",",0,0
235971,respectively,0,0
235972,;,0,0
235973,p,0,0
235974,=,0,0
235975,0.0047,0,0
235976,),0,0
235977,.,0,0
235978,The,0,0
235979,rate,0,0
235980,of,0,0
235981,leg,0,0
235982,oedema,0,0
235983,was,0,0
235984,not,0,0
235985,altered,0,0
235986,",",0,0
235987,but,0,0
235988,the,0,0
235989,frequency,0,0
235990,of,0,0
235991,advanced,0,0
235992,hydroceles,0,0
235993,decreased,0,0
235994,by,0,0
235995,47,0,0
235996,%,0,0
235997,with,0,0
235998,combined,0,1
235999,therapy,0,1
236000,and,0,0
236001,56,0,0
236002,%,0,0
236003,with,0,0
236004,diethylcarbamazine,1,1
236005,alone,0,0
236006,.,0,0
236007,"26,641",0,0
236008,Anopheles,0,0
236009,punctulatus,0,0
236010,mosquitoes,0,0
236011,were,0,0
236012,caught,0,0
236013,during,0,0
236014,499,0,0
236015,person-nights,0,1
236016,of,0,0
236017,landing,0,0
236018,catches,0,0
236019,.,0,0
236020,Exposure,0,0
236021,to,0,0
236022,infective,0,0
236023,third-stage,0,0
236024,larvae,0,0
236025,decreased,0,0
236026,in,0,0
236027,all,0,0
236028,monitored,0,0
236029,five,0,0
236030,communities,0,0
236031,.,0,0
236032,Annual,0,0
236033,transmission,0,0
236034,potential,0,0
236035,decreased,0,0
236036,by,0,0
236037,between,0,0
236038,75.7,0,0
236039,%,0,0
236040,and,0,0
236041,98.8,0,0
236042,%,0,0
236043,in,0,0
236044,combined-therapy,0,1
236045,communities,0,0
236046,and,0,0
236047,between,0,0
236048,75.6,0,0
236049,%,0,0
236050,and,0,0
236051,79.4,0,0
236052,%,0,0
236053,in,0,0
236054,communities,0,0
236055,given,0,0
236056,diethylcarbamazine,0,1
236057,alone,0,1
236058,.,0,0
236059,Transmission,0,0
236060,was,0,0
236061,almost,0,0
236062,interrupted,0,0
236063,in,0,0
236064,two,0,0
236065,communities,0,0
236066,treated,0,0
236067,with,0,0
236068,combined,0,0
236069,therapy,0,1
236070,.,0,0
236071,INTERPRETATION,0,0
236072,Annual,1,0
236073,single-dose,1,1
236074,community-wide,1,1
236075,treatment,1,0
236076,with,1,0
236077,diethylcarbamazine,1,1
236078,alone,1,1
236079,or,1,1
236080,with,1,0
236081,ivermectin,1,1
236082,is,0,0
236083,effective,0,0
236084,for,0,0
236085,the,0,0
236086,control,0,0
236087,of,0,0
236088,lymphatic,0,0
236089,filariasis,0,0
236090,in,0,0
236091,highly,0,0
236092,endemic,0,0
236093,areas,0,0
236094,",",0,0
236095,but,0,0
236096,combination,0,1
236097,therapy,0,1
236098,brings,0,0
236099,about,0,0
236100,greater,0,0
236101,decreases,0,0
236102,in,0,0
236103,rates,0,0
236104,and,0,0
236105,intensity,0,0
236106,of,0,0
236107,microfilaraemia,0,0
236108,.,0,0
236109,Randomized,0,0
236110,controlled,0,0
236111,study,0,0
236112,of,0,0
236113,customized,0,1
236114,preventive,0,0
236115,medicine,0,1
236116,reminder,0,1
236117,letters,0,1
236118,in,0,0
236119,a,0,0
236120,community,0,0
236121,practice,0,0
236122,.,0,0
236123,OBJECTIVE,0,0
236124,To,0,0
236125,test,0,0
236126,the,0,0
236127,effectiveness,0,0
236128,of,0,0
236129,customized,0,0
236130,",",0,0
236131,family-oriented,0,1
236132,reminder,0,1
236133,letters,0,1
236134,in,0,0
236135,activating,0,0
236136,patients,0,0
236137,to,0,0
236138,seek,0,0
236139,appropriate,0,0
236140,preventive,0,0
236141,services,0,0
236142,.,0,0
236143,DESIGN,0,0
236144,Randomized,0,0
236145,clinical,0,0
236146,trial,0,0
236147,.,0,0
236148,One,1,0
236149,group,1,0
236150,received,1,0
236151,computer-generated,1,0
236152,",",1,0
236153,customized,1,1
236154,letters,1,1
236155,explaining,1,0
236156,recommended,1,0
236157,preventive,1,0
236158,procedures,1,0
236159,for,1,0
236160,each,1,0
236161,family,1,0
236162,member,1,0
236163,.,1,0
236164,A,1,0
236165,second,1,0
236166,group,1,0
236167,received,1,0
236168,a,1,0
236169,form,1,0
236170,letter,1,1
236171,listing,1,0
236172,recommendations,1,0
236173,for,1,0
236174,all,1,0
236175,preventive,1,0
236176,procedures,1,0
236177,for,1,0
236178,all,1,0
236179,age,1,0
236180,and,1,0
236181,sex,1,0
236182,groups,1,0
236183,.,1,0
236184,A,1,0
236185,third,1,0
236186,group,1,0
236187,(,1,0
236188,control,1,1
236189,group,1,0
236190,),1,0
236191,received,1,0
236192,no,1,0
236193,letters,1,1
236194,.,1,0
236195,SETTING,0,0
236196,A,0,0
236197,private,0,1
236198,medical,0,0
236199,centre,0,0
236200,",",0,0
236201,without,0,0
236202,university,0,0
236203,affiliation,0,0
236204,",",0,0
236205,in,0,0
236206,rural,0,0
236207,Quebec,0,0
236208,.,0,0
236209,PARTICIPANTS,0,0
236210,From,0,0
236211,8770,0,0
236212,patients,0,0
236213,who,0,0
236214,met,0,0
236215,study,0,0
236216,criteria,0,0
236217,",",0,0
236218,719,0,0
236219,families,0,0
236220,were,0,0
236221,randomly,0,0
236222,selected,0,0
236223,.,0,0
236224,Data,0,0
236225,were,0,0
236226,available,0,0
236227,for,0,0
236228,1971,0,0
236229,of,0,0
236230,1998,0,0
236231,patients,0,0
236232,in,0,0
236233,these,0,0
236234,families,0,0
236235,.,0,0
236236,MAIN,0,0
236237,OUTCOME,0,0
236238,MEASURES,0,0
236239,The,0,0
236240,Family,0,0
236241,Received,0,0
236242,Index,0,1
236243,is,0,0
236244,the,0,0
236245,proportion,0,0
236246,of,0,0
236247,all,0,0
236248,procedures,0,0
236249,for,0,0
236250,which,0,0
236251,a,0,0
236252,family,0,0
236253,was,0,0
236254,overdue,0,0
236255,that,0,0
236256,they,0,0
236257,received,0,0
236258,.,0,0
236259,The,0,0
236260,Family,0,0
236261,End-of-study,0,0
236262,Up-to-date,0,0
236263,Index,0,1
236264,is,0,0
236265,the,0,0
236266,proportion,0,0
236267,of,0,0
236268,procedures,0,0
236269,for,0,0
236270,which,0,0
236271,the,0,0
236272,family,0,0
236273,was,0,0
236274,eligible,0,0
236275,and,0,0
236276,for,0,0
236277,which,0,0
236278,they,0,0
236279,were,0,0
236280,up-to-date,0,0
236281,at,0,0
236282,the,0,0
236283,end,0,0
236284,of,0,0
236285,the,0,0
236286,study,0,0
236287,.,0,0
236288,RESULTS,0,0
236289,The,0,0
236290,Family,0,0
236291,Received,0,0
236292,Index,0,1
236293,for,0,0
236294,families,0,0
236295,mailed,0,0
236296,customized,1,0
236297,letters,1,1
236298,was,0,0
236299,more,0,0
236300,than,0,0
236301,double,0,0
236302,the,0,0
236303,index,0,0
236304,for,0,0
236305,patients,0,0
236306,not,0,0
236307,mailed,0,0
236308,letters,0,1
236309,(,0,0
236310,Kruskal-Wallis,0,0
236311,P,0,0
236312,=,0,0
236313,.0139,0,0
236314,),0,0
236315,.,0,0
236316,Comparison,0,0
236317,of,0,0
236318,the,0,0
236319,Family,0,0
236320,End-of-study,0,0
236321,Up-to-date,0,0
236322,indices,0,0
236323,also,0,0
236324,demonstrated,0,0
236325,that,0,0
236326,families,0,0
236327,of,0,0
236328,patients,0,0
236329,sent,0,0
236330,customized,1,0
236331,letters,1,1
236332,were,0,0
236333,more,0,0
236334,likely,0,0
236335,to,0,0
236336,be,0,0
236337,up-to-date,0,0
236338,than,0,0
236339,families,0,0
236340,not,0,0
236341,sent,0,0
236342,letters,0,1
236343,(,0,0
236344,Kruskal-Wallis,0,0
236345,P,0,0
236346,=,0,0
236347,.0054,0,0
236348,),0,0
236349,.,0,0
236350,No,0,0
236351,statistically,0,0
236352,significant,0,0
236353,difference,0,0
236354,appeared,0,0
236355,between,0,0
236356,the,0,0
236357,number,0,0
236358,of,0,0
236359,preventive,0,0
236360,measures,0,0
236361,received,0,0
236362,by,0,0
236363,the,0,0
236364,control,1,1
236365,group,0,0
236366,and,0,0
236367,the,0,0
236368,form-letter,1,1
236369,group,0,0
236370,.,0,0
236371,CONCLUSIONS,0,0
236372,This,0,0
236373,study,0,0
236374,demonstrates,0,0
236375,a,0,0
236376,clinically,0,0
236377,small,0,0
236378,but,0,0
236379,statistically,0,0
236380,significant,0,0
236381,value,0,0
236382,to,0,0
236383,customizing,1,1
236384,reminder,1,1
236385,letters,1,1
236386,.,1,0
236387,The,0,0
236388,importance,0,0
236389,of,0,0
236390,the,0,0
236391,dual-switch,1,1
236392,valve,1,0
236393,for,0,0
236394,the,0,0
236395,treatment,0,0
236396,of,0,0
236397,adult,0,0
236398,normotensive,0,0
236399,or,0,1
236400,hypertensive,0,0
236401,hydrocephalus,0,0
236402,.,0,0
236403,Since,0,0
236404,the,0,0
236405,beginning,0,0
236406,of,0,0
236407,1995,0,0
236408,the,0,0
236409,new,0,0
236410,hydrostatic,1,1
236411,dual-switch,1,1
236412,valve,1,1
236413,(,1,0
236414,DSV,1,0
236415,),1,0
236416,was,0,0
236417,implanted,0,1
236418,in,0,0
236419,35,0,0
236420,adult,0,0
236421,patients,0,0
236422,with,0,0
236423,hydrocephalus,0,0
236424,of,0,0
236425,different,0,0
236426,etiology,0,0
236427,.,0,0
236428,26,0,0
236429,patients,0,0
236430,suffered,0,0
236431,from,0,0
236432,normotensive,0,0
236433,hydrocephalus,0,0
236434,(,0,0
236435,10,0,0
236436,idiopathic,0,0
236437,and,0,0
236438,16,0,0
236439,symptomatic,0,0
236440,),0,0
236441,",",0,0
236442,and,0,0
236443,9,0,0
236444,patients,0,0
236445,from,0,0
236446,hypertensive,0,0
236447,hydrocephalus,0,0
236448,of,0,0
236449,various,0,0
236450,origin,0,0
236451,.,0,0
236452,The,0,0
236453,first,0,0
236454,21,0,0
236455,cases,0,0
236456,of,0,0
236457,this,0,0
236458,cohort,0,0
236459,were,0,0
236460,compared,0,0
236461,in,0,0
236462,a,0,0
236463,randomized,0,0
236464,study,0,0
236465,with,0,0
236466,a,0,0
236467,comparable,0,0
236468,group,0,0
236469,of,0,0
236470,21,0,0
236471,hydrocephalic,0,0
236472,patients,0,0
236473,who,0,0
236474,received,0,0
236475,a,0,0
236476,conventional,1,1
236477,differential-pressure,1,1
236478,(,1,0
236479,DP-,1,0
236480,),1,0
236481,valve,1,0
236482,.,1,0
236483,The,0,0
236484,clinical,0,0
236485,status,0,0
236486,and,0,0
236487,CT,0,0
236488,were,0,0
236489,assessed,0,0
236490,prior,0,0
236491,to,0,0
236492,shunting,0,0
236493,",",0,0
236494,14,0,0
236495,days,0,0
236496,and,0,0
236497,3,0,0
236498,and,0,0
236499,6,0,0
236500,months,0,0
236501,after,0,0
236502,the,0,0
236503,operation,0,0
236504,.,0,0
236505,The,0,0
236506,reduction,0,0
236507,of,0,0
236508,ventricular,0,0
236509,size,0,0
236510,was,0,0
236511,evaluated,0,0
236512,by,0,0
236513,the,0,0
236514,measurement,0,0
236515,of,0,0
236516,the,0,0
236517,Evans,0,0
236518,Index,0,0
236519,.,0,0
236520,The,0,0
236521,CT,0,0
236522,follow-up,0,0
236523,in,0,0
236524,the,0,0
236525,DSV,1,0
236526,group,0,0
236527,was,0,0
236528,characterized,0,0
236529,by,0,0
236530,an,0,0
236531,only,0,0
236532,minimal,0,0
236533,(,0,0
236534,14,0,0
236535,),0,0
236536,or,0,0
236537,only,0,0
236538,slight,0,0
236539,(,0,0
236540,16,0,0
236541,),0,0
236542,reduction,0,0
236543,of,0,0
236544,ventricular,0,0
236545,size,0,0
236546,in,0,0
236547,the,0,0
236548,vast,0,0
236549,majority,0,0
236550,of,0,0
236551,cases,0,0
236552,.,0,0
236553,A,0,0
236554,comparison,0,0
236555,of,0,0
236556,21,0,0
236557,patients,0,0
236558,with,0,0
236559,a,0,0
236560,DSV,1,0
236561,and,0,0
236562,the,0,0
236563,patients,0,0
236564,with,0,0
236565,DP,1,0
236566,valves,1,0
236567,",",0,0
236568,evaluated,0,0
236569,by,0,0
236570,measuring,0,0
236571,the,0,0
236572,reduction,0,0
236573,of,0,0
236574,the,0,0
236575,Evans,0,0
236576,Index,0,0
236577,",",0,0
236578,revealed,0,0
236579,a,0,0
236580,distinctly,0,0
236581,higher,0,0
236582,percentage,0,0
236583,of,0,0
236584,significant,0,0
236585,regressions,0,0
236586,in,0,0
236587,the,0,0
236588,DP,1,0
236589,valve,1,0
236590,collective,0,0
236591,",",0,0
236592,without,0,0
236593,doubt,0,0
236594,due,0,0
236595,to,0,0
236596,chronic,0,0
236597,overdrainage,0,1
236598,.,0,0
236599,The,0,0
236600,overall,0,0
236601,clinical,0,0
236602,result,0,0
236603,of,0,0
236604,our,0,0
236605,35,0,0
236606,patients,0,0
236607,with,0,0
236608,a,0,0
236609,DSV,1,0
236610,was,0,0
236611,excellent,0,0
236612,and,0,0
236613,good,0,0
236614,in,0,0
236615,31,0,0
236616,patients,0,0
236617,",",0,0
236618,but,0,0
236619,the,0,0
236620,outcome,0,0
236621,seems,0,0
236622,to,0,0
236623,be,0,0
236624,more,0,0
236625,dependent,0,0
236626,on,0,0
236627,the,0,0
236628,preshunt,0,0
236629,damage,0,0
236630,of,0,0
236631,the,0,0
236632,brain,0,0
236633,than,0,0
236634,on,0,0
236635,hydrocephalic,0,0
236636,aspects,0,0
236637,.,0,0
236638,A,0,0
236639,neglegible,0,0
236640,incidence,0,0
236641,of,0,0
236642,subdural,0,0
236643,effusions,0,0
236644,in,0,0
236645,the,0,0
236646,DSV,1,0
236647,group,0,0
236648,compared,0,0
236649,to,0,0
236650,11,0,0
236651,cases,0,0
236652,in,0,0
236653,the,0,0
236654,DP,1,0
236655,valve,1,0
236656,collective,0,0
236657,reflects,0,0
236658,the,0,0
236659,ability,0,0
236660,of,0,0
236661,the,0,0
236662,DSV,1,0
236663,to,0,0
236664,prevent,0,0
236665,overdrainage,0,0
236666,.,0,0
236667,The,0,0
236668,capability,0,0
236669,of,0,0
236670,the,0,0
236671,DSV,1,0
236672,to,0,0
236673,maintain,0,0
236674,the,0,0
236675,IVP,0,0
236676,within,0,0
236677,physiological,0,0
236678,limits,0,0
236679,after,0,0
236680,shunting,0,0
236681,",",0,0
236682,especially,0,0
236683,in,0,0
236684,the,0,0
236685,upright,0,1
236686,position,0,0
236687,",",0,0
236688,is,0,0
236689,documented,0,0
236690,by,0,0
236691,a,0,0
236692,comparison,0,0
236693,with,0,0
236694,possible,0,0
236695,unphysiological,0,0
236696,IVP,0,0
236697,variations,0,0
236698,in,0,0
236699,other,0,0
236700,valve,0,0
236701,constructions,0,0
236702,",",0,0
236703,which,0,0
236704,depend,0,0
236705,on,0,0
236706,the,0,0
236707,level,0,0
236708,of,0,0
236709,implantation,0,0
236710,",",0,0
236711,subcutaneous,0,0
236712,pressure,0,0
236713,or,0,1
236714,CSF,0,0
236715,flow,0,0
236716,through,0,0
236717,the,0,0
236718,valve,0,0
236719,.,0,0
236720,Incidence,0,0
236721,and,0,0
236722,clinical,0,0
236723,significance,0,0
236724,of,0,0
236725,false-negative,0,0
236726,sextant,0,1
236727,prostate,0,0
236728,biopsies,0,0
236729,.,0,0
236730,PURPOSE,0,0
236731,Since,0,0
236732,most,0,0
236733,patients,0,0
236734,do,0,0
236735,not,0,0
236736,undergo,0,0
236737,repeat,0,0
236738,sextant,0,1
236739,prostate,0,0
236740,biopsies,0,0
236741,after,0,0
236742,a,0,0
236743,biopsy,0,1
236744,is,0,0
236745,positive,0,0
236746,for,0,0
236747,prostate,0,0
236748,cancer,0,0
236749,",",0,0
236750,the,0,0
236751,true,0,0
236752,incidence,0,0
236753,of,0,0
236754,false-negative,0,0
236755,biopsies,0,0
236756,is,0,0
236757,not,0,0
236758,well,0,0
236759,defined,0,0
236760,.,0,0
236761,We,0,0
236762,assess,0,0
236763,the,0,0
236764,incidence,0,0
236765,and,0,0
236766,clinical,0,0
236767,significance,0,0
236768,of,0,0
236769,false-negative,0,0
236770,sextant,0,1
236771,prostate,0,0
236772,biopsies,0,0
236773,in,0,0
236774,patients,0,0
236775,undergoing,0,0
236776,radical,1,1
236777,prostatectomy,1,1
236778,.,1,0
236779,MATERIALS,0,0
236780,AND,0,0
236781,METHODS,0,0
236782,A,0,0
236783,total,0,0
236784,of,0,0
236785,118,0,0
236786,patients,0,0
236787,with,0,0
236788,biopsy,0,1
236789,proved,0,0
236790,prostate,0,0
236791,cancer,0,0
236792,underwent,0,0
236793,repeat,1,0
236794,sextant,1,1
236795,prostate,1,0
236796,biopsy,1,1
236797,before,0,0
236798,enrollment,0,0
236799,in,0,0
236800,a,0,0
236801,prospective,0,0
236802,randomized,0,0
236803,trial,0,0
236804,of,0,0
236805,radical,1,1
236806,prostatectomy,1,1
236807,with,1,0
236808,or,1,0
236809,without,1,0
236810,neoadjuvant,1,1
236811,hormonal,1,0
236812,therapy,1,1
236813,.,1,0
236814,Clinical,0,0
236815,parameters,0,0
236816,were,0,0
236817,assessed,0,0
236818,to,0,0
236819,determine,0,0
236820,potential,0,0
236821,sources,0,0
236822,of,0,0
236823,bias,0,0
236824,.,0,0
236825,Pathological,0,0
236826,parameters,0,0
236827,and,0,0
236828,prostate,0,0
236829,specific,0,0
236830,antigen,0,0
236831,relapse-free,0,0
236832,survival,0,0
236833,rates,0,0
236834,were,0,0
236835,compared,0,0
236836,to,0,0
236837,determine,0,0
236838,the,0,0
236839,clinical,0,0
236840,significance,0,0
236841,of,0,0
236842,false-negative,0,0
236843,biopsies,0,0
236844,.,0,0
236845,RESULTS,0,0
236846,Of,0,0
236847,the,0,0
236848,118,0,0
236849,patients,0,0
236850,27,0,0
236851,(,0,0
236852,23,0,0
236853,%,0,0
236854,),0,0
236855,had,0,0
236856,a,0,0
236857,negative,0,0
236858,repeat,0,0
236859,sextant,0,1
236860,biopsy,0,1
236861,.,0,0
236862,Except,0,0
236863,for,0,0
236864,initial,0,0
236865,clinical,0,0
236866,stage,0,0
236867,",",0,0
236868,no,0,0
236869,differences,0,0
236870,were,0,0
236871,noted,0,0
236872,in,0,0
236873,the,0,0
236874,clinical,0,0
236875,or,0,0
236876,pathological,0,0
236877,parameters,0,0
236878,",",0,0
236879,or,0,0
236880,prostate,0,0
236881,specific,0,0
236882,antigen,0,0
236883,relapse,0,0
236884,rates,0,0
236885,in,0,0
236886,patients,0,0
236887,with,0,0
236888,negative,0,0
236889,versus,0,0
236890,positive,0,0
236891,repeat,0,0
236892,biopsies,0,0
236893,.,0,0
236894,CONCLUSIONS,0,0
236895,Our,0,0
236896,findings,0,0
236897,suggest,0,0
236898,that,0,0
236899,this,0,0
236900,23,0,0
236901,%,0,0
236902,incidence,0,0
236903,of,0,0
236904,false-negative,0,0
236905,biopsies,0,0
236906,represents,0,0
236907,significant,0,0
236908,cancer,0,0
236909,.,0,0
236910,This,0,0
236911,relatively,0,0
236912,high,0,0
236913,incidence,0,0
236914,is,0,0
236915,important,0,0
236916,to,0,0
236917,consider,0,0
236918,in,0,0
236919,treatment,0,0
236920,modalities,0,0
236921,in,0,0
236922,which,0,0
236923,prostate,0,0
236924,biopsy,0,0
236925,may,0,0
236926,be,0,0
236927,performed,0,0
236928,to,0,0
236929,determine,0,0
236930,response,0,0
236931,to,0,0
236932,therapy,0,1
236933,.,0,0
236934,Long-term,0,0
236935,evaluation,0,0
236936,of,0,0
236937,tamsulosin,1,1
236938,in,0,0
236939,benign,0,0
236940,prostatic,0,0
236941,hyperplasia,0,0
236942,:,0,0
236943,placebo-controlled,1,1
236944,",",0,0
236945,double-blind,0,0
236946,extension,0,0
236947,of,0,0
236948,phase,0,0
236949,III,0,0
236950,trial,0,0
236951,.,0,0
236952,Tamsulosin,0,1
236953,Investigator,0,0
236954,Group,0,0
236955,.,0,0
236956,OBJECTIVES,0,0
236957,To,0,0
236958,evaluate,0,0
236959,the,0,0
236960,long-term,0,0
236961,efficacy,0,0
236962,and,0,0
236963,safety,0,0
236964,of,0,0
236965,once-daily,0,1
236966,tamsulosin,1,1
236967,(,0,0
236968,0.4,0,0
236969,and,0,0
236970,0.8,0,0
236971,mg,0,1
236972,),0,0
236973,",",0,0
236974,a,0,0
236975,unique,0,0
236976,selective,0,1
236977,alpha1A-adrenoceptor,0,1
236978,antagonist,0,1
236979,in,0,0
236980,patients,0,0
236981,with,0,0
236982,benign,0,0
236983,prostatic,0,1
236984,hyperplasia,0,0
236985,(,0,0
236986,BPH,0,0
236987,),0,0
236988,.,0,0
236989,METHODS,0,0
236990,This,0,0
236991,trial,0,0
236992,extended,0,0
236993,a,0,0
236994,13-week,0,0
236995,",",0,0
236996,Phase,0,0
236997,III,0,0
236998,multicenter,0,0
236999,placebo-controlled,0,1
237000,",",0,0
237001,double-blind,0,0
237002,outpatient,0,0
237003,trial,0,0
237004,for,0,0
237005,an,0,0
237006,additional,0,0
237007,40,0,0
237008,weeks,0,0
237009,.,0,0
237010,Of,0,0
237011,618,0,0
237012,patients,0,0
237013,",",0,0
237014,418,0,0
237015,(,0,0
237016,68,0,0
237017,%,0,0
237018,),0,0
237019,continued,0,0
237020,into,0,0
237021,the,0,0
237022,extension,0,0
237023,phase,0,0
237024,on,0,0
237025,the,0,0
237026,same,0,0
237027,double-blind,0,0
237028,medication,0,1
237029,and,0,0
237030,dose,0,0
237031,.,0,0
237032,The,0,0
237033,primary,0,0
237034,efficacy,0,0
237035,parameters,0,0
237036,were,0,0
237037,total,0,0
237038,American,0,0
237039,Urological,0,1
237040,Association,0,0
237041,(,0,0
237042,AUA,0,1
237043,),0,1
237044,symptom,0,0
237045,score,0,0
237046,and,0,0
237047,maximum,0,0
237048,urinary,0,0
237049,flow,0,0
237050,(,0,0
237051,Qmax,0,0
237052,),0,0
237053,.,0,0
237054,RESULTS,0,0
237055,The,0,0
237056,mean,0,0
237057,changes,0,0
237058,in,0,0
237059,AUA,0,1
237060,symptom,0,0
237061,score,0,0
237062,from,0,0
237063,baseline,0,0
237064,to,0,0
237065,end,0,0
237066,point,0,0
237067,were,0,0
237068,statistically,0,0
237069,significant,0,0
237070,in,0,0
237071,all,0,0
237072,groups,0,0
237073,(,0,0
237074,P,0,0
237075,<,0,0
237076,0.001,0,0
237077,),0,0
237078,.,0,0
237079,Significant,0,0
237080,improvements,0,0
237081,were,0,0
237082,observed,0,0
237083,in,0,0
237084,Qmax,0,0
237085,for,0,0
237086,both,0,0
237087,tamsulosin,1,1
237088,groups,0,0
237089,but,0,0
237090,not,0,0
237091,for,0,0
237092,the,0,0
237093,placebo,1,1
237094,group,0,0
237095,.,0,0
237096,The,0,0
237097,statistically,0,0
237098,significant,0,0
237099,improvements,0,0
237100,from,0,0
237101,baseline,0,0
237102,in,0,0
237103,efficacy,0,0
237104,parameters,0,0
237105,observed,0,0
237106,for,0,0
237107,each,0,0
237108,tamsulosin,1,1
237109,group,0,0
237110,at,0,0
237111,the,0,0
237112,end,0,0
237113,of,0,0
237114,the,0,0
237115,13-week,0,0
237116,Phase,0,0
237117,III,0,0
237118,trial,0,0
237119,were,0,0
237120,maintained,0,0
237121,during,0,0
237122,the,0,0
237123,long-term,0,0
237124,extension,0,0
237125,phase,0,0
237126,.,0,0
237127,Tamsulosin,0,1
237128,at,0,0
237129,both,0,0
237130,dosages,0,0
237131,was,0,0
237132,well,0,0
237133,tolerated,0,0
237134,as,0,0
237135,maintenance,0,0
237136,therapy,0,1
237137,.,0,0
237138,Clinically,0,0
237139,significant,0,0
237140,orthostatic,0,0
237141,hypotension,0,0
237142,was,0,0
237143,not,0,0
237144,observed,0,0
237145,.,0,0
237146,Vital,0,0
237147,sign,0,0
237148,changes,0,0
237149,in,0,0
237150,either,0,0
237151,hypertensive,0,0
237152,or,0,0
237153,normotensive,0,0
237154,patients,0,0
237155,were,0,0
237156,not,0,0
237157,clinically,0,0
237158,significantly,0,0
237159,different,0,0
237160,across,0,0
237161,the,0,0
237162,three,0,0
237163,groups,0,0
237164,.,0,0
237165,CONCLUSIONS,0,0
237166,Tamsulosin,1,1
237167,once-daily,0,1
237168,at,0,0
237169,0.4,0,0
237170,or,0,0
237171,0.8,0,0
237172,mg,0,0
237173,was,0,0
237174,shown,0,0
237175,to,0,0
237176,be,0,0
237177,effective,0,0
237178,",",0,0
237179,safe,0,0
237180,",",0,0
237181,and,0,0
237182,well,0,0
237183,tolerated,0,0
237184,in,0,0
237185,the,0,0
237186,target,0,0
237187,BPH,0,0
237188,population,0,0
237189,during,0,0
237190,long-term,0,0
237191,use,0,0
237192,.,0,0
237193,Proposed,0,0
237194,synergistic,0,0
237195,effect,0,0
237196,of,0,0
237197,calcium,1,1
237198,channel,1,0
237199,blockers,1,1
237200,with,0,0
237201,lipid-lowering,1,1
237202,therapy,1,1
237203,in,0,0
237204,retarding,0,0
237205,progression,0,0
237206,of,0,0
237207,coronary,0,0
237208,atherosclerosis,0,0
237209,.,0,0
237210,Lipid-lowering,1,0
237211,therapy,1,1
237212,now,0,0
237213,has,0,0
237214,undoubtedly,0,0
237215,proven,0,0
237216,to,0,0
237217,be,0,0
237218,an,0,0
237219,effective,0,0
237220,therapeutic,0,0
237221,modality,0,0
237222,to,0,0
237223,retard,0,0
237224,the,0,0
237225,progression,0,0
237226,of,0,0
237227,coronary,0,0
237228,atherosclerosis,0,0
237229,.,0,0
237230,An,0,0
237231,additional,0,0
237232,approach,0,1
237233,for,0,0
237234,prevention,0,0
237235,of,0,0
237236,the,0,0
237237,progression,0,0
237238,of,0,0
237239,atherosclerosis,0,0
237240,is,0,0
237241,calcium,1,1
237242,channel,1,0
237243,blocker,1,1
237244,(,1,0
237245,CCB,1,0
237246,),1,0
237247,treatment,0,0
237248,.,0,0
237249,Evidence,0,0
237250,indicating,0,0
237251,that,0,0
237252,CCBs,1,1
237253,inhibit,0,0
237254,atherosclerosis,0,0
237255,is,0,0
237256,less,0,0
237257,unequivocal,0,0
237258,than,0,0
237259,the,0,0
237260,clear,0,0
237261,evidence,0,0
237262,for,0,0
237263,lipid-lowering,1,1
237264,therapy,1,1
237265,.,1,0
237266,Many,0,0
237267,investigations,0,0
237268,support,0,0
237269,the,0,0
237270,view,0,0
237271,that,0,0
237272,a,0,0
237273,number,0,0
237274,of,0,0
237275,key,0,0
237276,processes,0,0
237277,in,0,0
237278,atherosclerosis,0,0
237279,may,0,0
237280,be,0,0
237281,influenced,0,0
237282,by,0,0
237283,CCBs,1,0
237284,.,0,0
237285,From,0,0
237286,the,0,0
237287,negative,0,0
237288,and,0,0
237289,positive,0,0
237290,studies,0,0
237291,with,0,0
237292,CCBs,1,0
237293,performed,0,0
237294,in,0,0
237295,animals,0,0
237296,and,0,0
237297,humans,0,0
237298,we,0,0
237299,must,0,0
237300,conclude,0,0
237301,that,0,0
237302,apparently,0,0
237303,some,0,0
237304,",",0,0
237305,but,0,0
237306,not,0,0
237307,all,0,0
237308,",",0,0
237309,types,0,0
237310,or,0,0
237311,stages,0,0
237312,of,0,0
237313,the,0,0
237314,atherosclerotic,0,0
237315,process,0,0
237316,are,0,0
237317,inhibited,0,0
237318,by,0,0
237319,CCBs,1,0
237320,.,0,0
237321,To,0,0
237322,assess,0,0
237323,whether,0,0
237324,lipid-lowering,1,1
237325,therapy,1,1
237326,and,0,0
237327,CCB,1,0
237328,treatment,0,0
237329,may,0,0
237330,have,0,0
237331,an,0,0
237332,additive,0,0
237333,or,0,0
237334,synergistic,0,1
237335,beneficial,0,0
237336,effect,0,0
237337,on,0,0
237338,human,0,0
237339,atherosclerosis,0,0
237340,",",0,0
237341,which,0,0
237342,is,0,0
237343,conceivable,0,0
237344,because,0,0
237345,their,0,0
237346,anti-atherosclerotic,0,0
237347,properties,0,0
237348,differ,0,0
237349,",",0,0
237350,data,0,0
237351,from,0,0
237352,the,0,0
237353,angiographic,0,0
237354,lipid-lowering,0,1
237355,trial,0,0
237356,REGRESS,0,1
237357,(,1,0
237358,pravastatin,1,1
237359,vs.,0,0
237360,placebo,1,1
237361,),1,0
237362,were,0,0
237363,reviewed,0,0
237364,.,0,0
237365,In,0,0
237366,REGRESS,0,0
237367,",",0,0
237368,patients,0,0
237369,in,0,0
237370,the,0,0
237371,pravastatin,1,1
237372,group,0,0
237373,had,0,0
237374,significantly,0,0
237375,less,0,0
237376,progression,0,0
237377,if,0,0
237378,cotreated,0,0
237379,with,0,0
237380,CCBs,1,0
237381,as,0,0
237382,compared,0,0
237383,with,0,0
237384,those,0,0
237385,with,0,0
237386,no,0,0
237387,CCB,1,0
237388,cotreatment,0,1
237389,",",0,0
237390,whereas,0,0
237391,in,0,0
237392,the,0,0
237393,placebo,1,1
237394,(,1,0
237395,no,1,0
237396,pravastatin,1,1
237397,),1,0
237398,group,0,0
237399,no,0,0
237400,effect,0,0
237401,of,0,0
237402,CCB,1,0
237403,treatment,0,0
237404,was,0,0
237405,observed,0,0
237406,.,0,0
237407,With,0,0
237408,respect,0,0
237409,to,0,0
237410,angiographic,0,0
237411,new,0,0
237412,lesion,0,0
237413,formation,0,0
237414,",",0,0
237415,in,0,0
237416,the,0,0
237417,pravastatin,1,1
237418,group,0,0
237419,there,0,0
237420,were,0,0
237421,50,0,0
237422,%,0,0
237423,less,0,0
237424,patients,0,0
237425,with,0,0
237426,new,0,0
237427,angiographic,0,0
237428,lesions,0,0
237429,if,0,0
237430,cotreated,0,0
237431,with,0,0
237432,CCBs,1,0
237433,as,0,0
237434,compared,0,0
237435,with,0,0
237436,no,0,0
237437,CCB,1,0
237438,cotreatment,0,1
237439,",",0,0
237440,whereas,0,0
237441,in,0,0
237442,the,0,0
237443,placebo,1,1
237444,(,1,0
237445,no,1,0
237446,pravastatin,1,1
237447,),1,0
237448,group,0,0
237449,",",0,0
237450,again,0,0
237451,",",0,0
237452,no,0,0
237453,significant,0,0
237454,effect,0,0
237455,of,0,0
237456,CCB,1,0
237457,treatment,0,0
237458,was,0,0
237459,observed,0,0
237460,.,0,0
237461,No,0,0
237462,beneficial,0,0
237463,effects,0,0
237464,of,0,0
237465,CCB,1,0
237466,treatment,0,0
237467,on,0,0
237468,clinical,0,0
237469,events,0,0
237470,were,0,0
237471,observed,0,0
237472,during,0,0
237473,the,0,0
237474,2-year,0,0
237475,study,0,0
237476,follow-up,0,0
237477,.,0,0
237478,In,0,0
237479,view,0,0
237480,of,0,0
237481,the,0,0
237482,correlation,0,0
237483,between,0,0
237484,angiographic,0,1
237485,progression,0,0
237486,and,0,0
237487,subsequent,0,0
237488,clinical,0,0
237489,events,0,0
237490,as,0,0
237491,demonstrated,0,0
237492,in,0,0
237493,several,0,0
237494,large,0,0
237495,trials,0,0
237496,",",0,0
237497,it,0,0
237498,is,0,0
237499,not,0,0
237500,unrealistic,0,0
237501,to,0,0
237502,also,0,0
237503,anticipate,0,0
237504,in,0,0
237505,this,0,0
237506,population,0,0
237507,",",0,0
237508,a,0,0
237509,beneficial,0,0
237510,effect,0,0
237511,on,0,0
237512,clinical,0,0
237513,events,0,0
237514,with,0,0
237515,longer,0,0
237516,follow-up,0,0
237517,.,0,0
237518,Although,0,0
237519,the,0,0
237520,REGRESS,0,0
237521,trial,0,0
237522,was,0,0
237523,not,0,0
237524,designed,0,0
237525,to,0,0
237526,evaluate,0,0
237527,combination,0,1
237528,therapy,0,1
237529,",",0,0
237530,the,0,0
237531,results,0,0
237532,suggest,0,0
237533,that,0,0
237534,addition,0,0
237535,of,0,0
237536,CCBs,1,0
237537,to,0,0
237538,HMG-CoA,0,0
237539,reductase,0,1
237540,inhibitor,0,1
237541,therapy,0,1
237542,(,1,0
237543,pravastatin,1,1
237544,),1,1
237545,acts,0,0
237546,synergistically,0,0
237547,in,0,0
237548,retarding,0,0
237549,the,0,0
237550,progression,0,0
237551,of,0,0
237552,established,0,0
237553,coronary,0,0
237554,atherosclerosis,0,0
237555,.,0,0
237556,These,0,0
237557,results,0,0
237558,appear,0,0
237559,to,0,0
237560,warrant,0,0
237561,prospective,0,0
237562,randomized,0,0
237563,trials,0,0
237564,to,0,0
237565,determine,0,0
237566,in,0,0
237567,a,0,0
237568,more,0,0
237569,definitive,0,0
237570,manner,0,0
237571,the,0,0
237572,merits,0,0
237573,of,0,0
237574,this,0,0
237575,combination,0,0
237576,in,0,0
237577,the,0,0
237578,prevention,0,0
237579,of,0,0
237580,progression,0,0
237581,of,0,0
237582,coronary,0,0
237583,atherosclerosis,0,0
237584,.,0,0
237585,Currently,0,0
237586,a,0,0
237587,number,0,0
237588,of,0,0
237589,studies,0,0
237590,in,0,0
237591,these,0,0
237592,fields,0,0
237593,are,0,0
237594,being,0,0
237595,designed,0,0
237596,or,0,0
237597,are,0,0
237598,already,0,0
237599,underway,0,0
237600,.,0,0
237601,Bronchodilator,0,1
237602,response,0,0
237603,to,0,0
237604,salbutamol,1,1
237605,after,0,0
237606,spontaneous,0,0
237607,recovery,0,0
237608,from,0,0
237609,nonspecific,0,0
237610,bronchial,0,0
237611,provocation,0,0
237612,tests,0,0
237613,in,0,0
237614,asthma,0,0
237615,.,0,0
237616,Assessment,0,0
237617,of,0,0
237618,airway,0,0
237619,responsiveness,0,0
237620,by,0,0
237621,bronchoprovocation,0,1
237622,and,0,0
237623,bronchodilatation,0,1
237624,tests,0,0
237625,is,0,0
237626,important,0,0
237627,in,0,0
237628,the,0,0
237629,diagnostic,0,0
237630,work-up,0,0
237631,protocol,0,0
237632,of,0,0
237633,bronchial,0,0
237634,asthma,0,0
237635,and,0,0
237636,it,0,0
237637,would,0,0
237638,be,0,0
237639,convenient,0,0
237640,to,0,0
237641,undertake,0,0
237642,both,0,0
237643,tests,0,0
237644,on,0,0
237645,the,0,0
237646,same,0,0
237647,occasion,0,0
237648,.,0,0
237649,However,0,0
237650,",",0,0
237651,it,0,0
237652,is,0,0
237653,not,0,0
237654,known,0,0
237655,whether,0,0
237656,this,0,0
237657,can,0,0
237658,be,0,0
237659,done,0,0
237660,accurately,0,0
237661,.,0,0
237662,Therefore,0,0
237663,",",0,0
237664,this,0,0
237665,study,0,0
237666,evaluated,0,0
237667,the,0,0
237668,effect,0,0
237669,of,0,0
237670,a,0,0
237671,prior,0,0
237672,bronchial,0,0
237673,provocation,0,0
237674,test,0,0
237675,on,0,0
237676,the,0,0
237677,bronchodilator,0,1
237678,response,0,0
237679,to,0,0
237680,salbutamol,1,1
237681,after,0,0
237682,spontaneous,0,0
237683,recovery,0,0
237684,of,0,0
237685,the,0,0
237686,forced,0,0
237687,expiratory,0,0
237688,volume,0,0
237689,in,0,0
237690,one,0,0
237691,second,0,0
237692,(,0,0
237693,FEV1,0,0
237694,),0,0
237695,in,0,0
237696,a,0,0
237697,group,0,0
237698,of,0,0
237699,asthmatic,0,0
237700,subjects,0,0
237701,.,0,0
237702,On,0,0
237703,two,0,0
237704,separate,0,0
237705,occasions,0,0
237706,at,0,0
237707,the,0,0
237708,same,0,0
237709,time,0,0
237710,of,0,0
237711,day,0,0
237712,",",0,0
237713,concentration-response,0,0
237714,studies,0,0
237715,with,0,0
237716,inhaled,0,1
237717,histamine,1,1
237718,or,1,1
237719,methacholine,1,0
237720,",",1,0
237721,or,1,0
237722,a,1,0
237723,sham,1,1
237724,challenge,1,0
237725,with,1,0
237726,normal,1,0
237727,saline,1,1
237728,were,0,0
237729,carried,0,0
237730,out,0,0
237731,in,0,0
237732,a,0,0
237733,blinded,0,0
237734,",",0,0
237735,randomized,0,0
237736,manner,0,0
237737,.,0,0
237738,Changes,0,0
237739,in,0,0
237740,airway,0,0
237741,calibre,0,0
237742,were,0,0
237743,followed,0,0
237744,as,0,0
237745,FEV1,0,0
237746,and,0,0
237747,agonist,0,1
237748,responsiveness,0,0
237749,expressed,0,0
237750,as,0,0
237751,the,0,0
237752,provocative,0,0
237753,concentration,0,0
237754,causing,0,0
237755,a,0,0
237756,20,0,0
237757,%,0,0
237758,fall,0,0
237759,in,0,0
237760,FEV1,0,0
237761,(,0,0
237762,PC20,0,0
237763,),0,0
237764,.,0,0
237765,After,0,0
237766,either,0,0
237767,spontaneous,0,0
237768,recovery,0,0
237769,or,0,1
237770,a,0,0
237771,fixed-duration,0,1
237772,wait,0,0
237773,of,0,0
237774,45,0,0
237775,min,0,0
237776,(,0,0
237777,when,0,0
237778,appropriate,0,0
237779,),0,0
237780,",",0,0
237781,the,0,0
237782,subjects,0,0
237783,received,0,0
237784,2x100,0,1
237785,microg,0,0
237786,of,0,0
237787,salbutamol,1,1
237788,from,0,0
237789,a,0,0
237790,metered,0,1
237791,dose,0,0
237792,inhaler,0,1
237793,with,0,0
237794,a,0,0
237795,spacer,0,0
237796,.,0,0
237797,The,0,0
237798,bronchodilator,0,0
237799,response,0,0
237800,to,0,0
237801,salbutamol,0,1
237802,was,0,0
237803,expressed,0,0
237804,as,0,0
237805,a,0,0
237806,percentage,0,0
237807,of,0,0
237808,initial,0,0
237809,FEV1,0,0
237810,(,0,0
237811,deltaFEV1,0,0
237812,%,0,0
237813,init,0,0
237814,),0,0
237815,.,0,0
237816,Bronchial,0,0
237817,challenge,0,0
237818,with,0,0
237819,both,0,0
237820,agonists,0,0
237821,failed,0,0
237822,to,0,0
237823,alter,0,0
237824,significantly,0,0
237825,the,0,0
237826,airway,0,0
237827,response,0,0
237828,to,0,0
237829,salbutamol,0,1
237830,",",0,0
237831,with,0,0
237832,the,0,0
237833,deltaFEV1,0,0
237834,%,0,0
237835,init,0,0
237836,mean,0,0
237837,value,0,0
237838,(,0,0
237839,range,0,0
237840,),0,0
237841,being,0,0
237842,16.9,0,0
237843,%,0,0
237844,(,0,0
237845,9.0-31.9,0,0
237846,),0,0
237847,and,0,0
237848,17.5,0,0
237849,%,0,0
237850,(,0,0
237851,11.6-31.2,0,0
237852,),0,0
237853,on,0,0
237854,the,0,0
237855,sham,0,1
237856,and,0,0
237857,histamine/methacholine,0,1
237858,challenge,0,0
237859,day,0,0
237860,respectively,0,0
237861,.,0,0
237862,It,0,0
237863,was,0,0
237864,shown,0,0
237865,that,0,0
237866,the,0,0
237867,degree,0,0
237868,of,0,0
237869,bronchodilatation,0,1
237870,achieved,0,0
237871,after,0,0
237872,salbutamol,0,1
237873,200,0,1
237874,microg,0,0
237875,is,0,0
237876,not,0,0
237877,affected,0,0
237878,by,0,0
237879,prior,0,0
237880,bronchoprovocation,0,1
237881,testing,0,0
237882,when,0,0
237883,enough,0,0
237884,time,0,0
237885,is,0,0
237886,allowed,0,0
237887,for,0,0
237888,the,0,0
237889,airways,0,0
237890,to,0,0
237891,recover,0,0
237892,spontaneously,0,0
237893,to,0,0
237894,baseline,0,0
237895,forced,0,0
237896,expiratory,0,0
237897,volume,0,0
237898,in,0,0
237899,one,0,0
237900,second,0,0
237901,.,0,0
237902,Thus,0,0
237903,evaluation,0,0
237904,of,0,0
237905,airway,0,0
237906,responsiveness,0,0
237907,by,0,0
237908,both,0,0
237909,bronchial,0,0
237910,provocation,0,0
237911,tests,0,0
237912,and,0,0
237913,bronchodilator,0,1
237914,testing,0,0
237915,can,0,0
237916,be,0,0
237917,assessed,0,0
237918,reliably,0,0
237919,within,0,0
237920,a,0,0
237921,few,0,0
237922,hours,0,0
237923,in,0,0
237924,asthmatic,0,0
237925,patients,0,0
237926,.,0,0
237927,The,0,0
237928,effect,0,0
237929,of,0,0
237930,quality,0,0
237931,and,0,0
237932,amount,0,0
237933,of,0,0
237934,dietary,0,0
237935,fat,0,0
237936,on,0,0
237937,the,0,0
237938,susceptibility,0,0
237939,of,0,0
237940,low,0,0
237941,density,0,0
237942,lipoprotein,0,0
237943,to,0,0
237944,oxidation,0,0
237945,in,0,0
237946,subjects,0,0
237947,with,0,0
237948,impaired,0,0
237949,glucose,0,0
237950,tolerance,0,0
237951,.,0,0
237952,OBJECTIVES,0,0
237953,We,0,0
237954,examined,0,0
237955,the,0,0
237956,effects,0,0
237957,of,0,0
237958,a,0,0
237959,high,1,0
237960,fat,1,0
237961,diet,1,1
237962,rich,1,1
237963,in,1,0
237964,monounsaturated,1,1
237965,fat,1,0
237966,(,1,0
237967,MUFA-diet,1,1
237968,),1,0
237969,and,0,0
237970,a,0,0
237971,moderate,1,0
237972,fat,1,0
237973,diet,1,1
237974,rich,1,1
237975,in,1,0
237976,polyunsaturated,1,1
237977,fat,1,0
237978,(,1,0
237979,PUFA-diet,1,1
237980,),1,0
237981,on,0,0
237982,the,0,0
237983,susceptibility,0,0
237984,of,0,0
237985,LDL,0,0
237986,to,0,0
237987,oxidation,0,0
237988,.,0,0
237989,SUBJECTS,0,0
237990,29,0,0
237991,subjects,0,0
237992,with,0,0
237993,impaired,0,0
237994,glucose,0,0
237995,tolerance,0,0
237996,.,0,0
237997,METHODS,0,0
237998,After,0,0
237999,consuming,0,0
238000,a,0,0
238001,run-in,0,0
238002,diet,0,1
238003,[,0,0
238004,37,0,0
238005,%,0,0
238006,of,0,0
238007,energy,0,0
238008,(,0,0
238009,E,0,1
238010,%,0,0
238011,),0,0
238012,fat,0,0
238013,",",0,0
238014,18,0,0
238015,E,0,0
238016,%,0,0
238017,saturated,0,0
238018,fat,0,0
238019,],0,0
238020,for,0,0
238021,three,0,0
238022,weeks,0,0
238023,",",0,0
238024,subjects,0,0
238025,were,0,0
238026,randomly,0,0
238027,assigned,0,0
238028,either,0,0
238029,to,0,0
238030,a,0,0
238031,MUFA-diet,0,1
238032,(,0,0
238033,40,0,0
238034,E,0,1
238035,%,0,0
238036,fat,0,0
238037,",",0,0
238038,19,0,0
238039,E,0,0
238040,%,0,0
238041,monounsaturated,0,1
238042,fatty,0,1
238043,acids,0,1
238044,),0,0
238045,or,0,0
238046,a,0,0
238047,PUFA-diet,0,1
238048,(,0,0
238049,34,0,0
238050,E,0,1
238051,%,0,0
238052,fat,0,0
238053,",",0,0
238054,10,0,0
238055,E,0,0
238056,%,0,0
238057,polyunsaturated,0,1
238058,fat,0,0
238059,),0,0
238060,for,0,0
238061,eight,0,0
238062,weeks,0,0
238063,.,0,0
238064,The,0,0
238065,susceptibility,0,0
238066,of,0,0
238067,LDL,0,0
238068,to,0,0
238069,oxidation,0,0
238070,was,0,0
238071,measured,0,0
238072,by,0,0
238073,challenging,0,0
238074,LDL,0,0
238075,with,0,0
238076,hemin,0,1
238077,and,0,0
238078,H2O2,0,1
238079,and,0,0
238080,measuring,0,0
238081,the,0,0
238082,time,0,0
238083,for,0,0
238084,the,0,0
238085,reaction,0,0
238086,to,0,0
238087,reach,0,0
238088,maximum,0,0
238089,velocity,0,0
238090,.,0,0
238091,Results,0,0
238092,are,0,0
238093,expressed,0,0
238094,as,0,0
238095,lag,0,0
238096,time,0,0
238097,to,0,0
238098,oxidation,0,0
238099,in,0,0
238100,minutes,0,0
238101,.,0,0
238102,RESULTS,0,0
238103,In,0,0
238104,the,0,0
238105,PUFA-diet,0,1
238106,group,0,0
238107,(,0,0
238108,n,0,0
238109,=,0,0
238110,15,0,0
238111,),0,0
238112,lag,0,0
238113,time,0,0
238114,tended,0,0
238115,to,0,0
238116,decrease,0,0
238117,during,0,0
238118,the,0,0
238119,experimental,0,0
238120,diet,0,1
238121,(,0,0
238122,97,0,0
238123,+/-,0,0
238124,28,0,0
238125,vs,0,0
238126,90,0,0
238127,+/-,0,0
238128,25,0,0
238129,min,0,0
238130,",",0,0
238131,mean,0,0
238132,+/-,0,0
238133,s.d.,0,0
238134,",",0,0
238135,P,0,0
238136,=,0,0
238137,0.073,0,0
238138,),0,0
238139,",",0,0
238140,whereas,0,0
238141,in,0,0
238142,the,0,0
238143,MUFA-diet,0,1
238144,group,0,0
238145,(,0,0
238146,n,0,0
238147,=,0,0
238148,14,0,0
238149,),0,0
238150,there,0,0
238151,was,0,0
238152,no,0,0
238153,significant,0,0
238154,change,0,0
238155,(,0,0
238156,lag,0,0
238157,time,0,0
238158,96,0,0
238159,+/-,0,0
238160,24,0,0
238161,vs,0,0
238162,100,0,0
238163,+/-,0,0
238164,16,0,0
238165,min,0,0
238166,",",0,0
238167,P,0,0
238168,=,0,0
238169,0.408,0,0
238170,),0,0
238171,.,0,0
238172,The,0,0
238173,mean,0,0
238174,change,0,0
238175,in,0,0
238176,lag,0,0
238177,time,0,0
238178,was,0,0
238179,-7,0,0
238180,+/-,0,0
238181,14,0,0
238182,min,0,0
238183,(,0,0
238184,-7.2,0,0
238185,%,0,0
238186,),0,0
238187,in,0,0
238188,the,0,0
238189,PUFA-diet,0,1
238190,group,0,0
238191,and,0,0
238192,+4,0,0
238193,+/-,0,0
238194,16,0,0
238195,min,0,0
238196,(,0,0
238197,+4.0,0,0
238198,%,0,0
238199,),0,0
238200,in,0,0
238201,the,0,0
238202,MUFA-diet,0,1
238203,group,0,0
238204,(,0,0
238205,P,0,0
238206,=,0,0
238207,0.029,0,0
238208,",",0,0
238209,PUFA-diet,0,1
238210,group,0,0
238211,vs,0,0
238212,MUFA-diet,0,1
238213,group,0,0
238214,),0,0
238215,.,0,0
238216,The,0,0
238217,alpha-tocopherol,0,1
238218,concentration,0,0
238219,in,0,0
238220,LDL,0,0
238221,increased,0,0
238222,significantly,0,0
238223,(,0,0
238224,P,0,0
238225,<,0,0
238226,0.01,0,0
238227,),0,0
238228,in,0,0
238229,both,0,0
238230,diet,0,1
238231,groups,0,0
238232,relative,0,0
238233,to,0,0
238234,the,0,0
238235,run-in,0,0
238236,diet,0,1
238237,period,0,0
238238,",",0,0
238239,but,0,0
238240,LDL,0,0
238241,particle,0,0
238242,score,0,0
238243,did,0,0
238244,not,0,0
238245,change,0,0
238246,in,0,0
238247,either,0,0
238248,of,0,0
238249,the,0,0
238250,diet,0,1
238251,groups,0,0
238252,during,0,0
238253,the,0,0
238254,dietary,0,0
238255,intervention,0,1
238256,.,0,0
238257,In,0,0
238258,subjects,0,0
238259,with,0,0
238260,impaired,0,0
238261,glucose,0,0
238262,tolerance,0,0
238263,a,0,0
238264,PUFA-rich,1,0
238265,diet,0,1
238266,with,0,0
238267,a,0,0
238268,moderate,0,0
238269,amount,0,0
238270,of,0,0
238271,fat,0,0
238272,tended,0,0
238273,to,0,0
238274,increase,0,0
238275,the,0,0
238276,susceptibility,0,0
238277,of,0,0
238278,LDL,0,0
238279,to,0,0
238280,oxidation,0,0
238281,as,0,0
238282,compared,0,0
238283,to,0,0
238284,a,0,0
238285,higher,0,0
238286,fat,0,0
238287,diet,0,1
238288,rich,0,0
238289,in,0,0
238290,MUFA,1,0
238291,.,1,0
238292,Furthermore,0,0
238293,",",0,0
238294,the,0,0
238295,negative,0,0
238296,mean,0,0
238297,change,0,0
238298,in,0,0
238299,lag,0,0
238300,time,0,0
238301,to,0,0
238302,oxidation,0,0
238303,found,0,0
238304,in,0,0
238305,the,0,0
238306,PUFA-diet,0,1
238307,group,0,0
238308,differed,0,0
238309,significantly,0,0
238310,from,0,0
238311,the,0,0
238312,slightly,0,0
238313,positive,0,0
238314,mean,0,0
238315,change,0,0
238316,found,0,0
238317,in,0,0
238318,the,0,0
238319,MUFA-diet,0,0
238320,group,0,0
238321,.,0,0
238322,Relationship,0,0
238323,between,0,0
238324,biliary,0,0
238325,and,0,0
238326,serum,0,0
238327,bile,0,0
238328,acids,0,1
238329,and,0,0
238330,response,0,0
238331,to,0,0
238332,ursodeoxycholic,1,1
238333,acid,1,1
238334,in,0,0
238335,patients,0,0
238336,with,0,0
238337,primary,0,0
238338,biliary,0,0
238339,cirrhosis,0,0
238340,.,0,0
238341,OBJECTIVE,0,0
238342,Ursodeoxycholic,1,1
238343,acid,1,1
238344,(,1,0
238345,UDCA,1,0
238346,),1,1
238347,improves,0,0
238348,liver,0,0
238349,biochemistries,0,0
238350,and,0,0
238351,enriches,0,0
238352,the,0,0
238353,bile,0,0
238354,with,0,0
238355,UDCA,1,0
238356,in,0,0
238357,patients,0,0
238358,with,0,0
238359,primary,0,0
238360,biliary,0,0
238361,cirrhosis,0,0
238362,.,0,0
238363,The,0,0
238364,aim,0,0
238365,of,0,0
238366,this,0,0
238367,study,0,0
238368,was,0,0
238369,to,0,0
238370,determine,0,0
238371,whether,0,0
238372,the,0,0
238373,degree,0,0
238374,of,0,0
238375,enrichment,0,1
238376,of,0,0
238377,bile,0,0
238378,correlated,0,0
238379,with,0,0
238380,that,0,0
238381,of,0,0
238382,serum,0,0
238383,and,0,0
238384,whether,0,0
238385,either,0,0
238386,of,0,0
238387,these,0,0
238388,measures,0,0
238389,correlated,0,0
238390,with,0,0
238391,improvement,0,0
238392,in,0,0
238393,measures,0,0
238394,of,0,0
238395,liver,0,0
238396,disease,0,0
238397,.,0,0
238398,METHODS,0,0
238399,In,0,0
238400,a,0,0
238401,randomized,0,0
238402,study,0,0
238403,",",0,0
238404,biliary,0,0
238405,and,0,0
238406,serum,0,0
238407,bile,0,0
238408,acid,0,1
238409,analyses,0,0
238410,were,0,0
238411,performed,0,0
238412,at,0,0
238413,entry,0,0
238414,and,0,0
238415,after,0,0
238416,2,0,0
238417,yr,0,0
238418,of,0,0
238419,UDCA,1,0
238420,or,0,0
238421,placebo,1,1
238422,.,1,0
238423,RESULTS,0,0
238424,The,0,0
238425,percentage,0,0
238426,of,0,0
238427,ursodeoxycholic,1,1
238428,acid,1,1
238429,in,0,0
238430,bile,0,0
238431,increased,0,0
238432,by,0,0
238433,42,0,0
238434,%,0,0
238435,in,0,0
238436,the,0,0
238437,UDCA,1,0
238438,group,0,0
238439,(,0,0
238440,n,0,0
238441,=,0,0
238442,61,0,0
238443,),0,0
238444,compared,0,0
238445,with,0,0
238446,8,0,0
238447,%,0,0
238448,in,0,0
238449,the,0,0
238450,placebo,1,1
238451,group,0,0
238452,(,0,0
238453,n,0,0
238454,=,0,0
238455,57,0,0
238456,),0,0
238457,(,0,0
238458,p,0,0
238459,<,0,0
238460,0.0001,0,0
238461,),0,0
238462,.,0,0
238463,Measurement,0,0
238464,of,0,0
238465,serum,0,0
238466,bile,0,0
238467,acids,0,1
238468,in,0,0
238469,32,0,0
238470,patients,0,0
238471,(,0,0
238472,18,0,0
238473,ursodeoxycholic,1,1
238474,acid,1,1
238475,",",0,0
238476,14,0,0
238477,placebo,1,1
238478,),1,0
238479,indicated,0,0
238480,that,0,0
238481,at,0,0
238482,2,0,0
238483,yr,0,0
238484,",",0,0
238485,ursodeoxycholic,1,1
238486,acid,1,1
238487,comprised,0,0
238488,65,0,0
238489,%,0,0
238490,of,0,0
238491,serum,0,0
238492,bile,0,0
238493,acids,0,1
238494,in,0,0
238495,the,0,0
238496,treated,0,0
238497,group,0,0
238498,and,0,0
238499,7,0,0
238500,%,0,0
238501,in,0,0
238502,the,0,0
238503,placebo,1,1
238504,group,0,0
238505,.,0,0
238506,Agreement,0,0
238507,between,0,0
238508,bile,0,0
238509,and,0,0
238510,serum,0,0
238511,was,0,0
238512,fair,0,0
238513,(,0,0
238514,r,0,0
238515,=,0,0
238516,0.75,0,0
238517,",",0,0
238518,p,0,0
238519,<,0,0
238520,or,0,0
238521,=,0,0
238522,0.00002,0,0
238523,),0,0
238524,because,0,0
238525,in,0,0
238526,some,0,0
238527,patients,0,0
238528,",",0,0
238529,plasma,0,0
238530,but,0,0
238531,not,0,0
238532,biliary,0,0
238533,bile,0,0
238534,acids,0,1
238535,were,0,0
238536,enriched,0,0
238537,with,0,0
238538,UDCA,1,0
238539,.,1,0
238540,Changes,0,0
238541,in,0,0
238542,biliary,0,0
238543,ursodeoxycholic,1,1
238544,acid,1,1
238545,correlated,0,0
238546,significantly,0,0
238547,but,0,0
238548,weakly,0,0
238549,with,0,0
238550,the,0,0
238551,changes,0,0
238552,in,0,0
238553,serum,0,0
238554,alkaline,0,0
238555,phosphatase,0,0
238556,",",0,0
238557,AST,0,0
238558,",",0,0
238559,bilirubin,0,0
238560,",",0,0
238561,and,0,0
238562,in,0,0
238563,Mayo,0,1
238564,risk,0,0
238565,score,0,0
238566,.,0,0
238567,Correlations,0,0
238568,between,0,0
238569,changes,0,0
238570,in,0,0
238571,serum,0,0
238572,bile,0,0
238573,acid,0,1
238574,composition,0,0
238575,and,0,0
238576,biochemical,0,0
238577,measures,0,0
238578,of,0,0
238579,disease,0,0
238580,activity,0,0
238581,were,0,0
238582,even,0,0
238583,weaker,0,0
238584,.,0,0
238585,CONCLUSION,0,0
238586,The,0,0
238587,measurement,0,0
238588,of,0,0
238589,biliary,0,0
238590,bile,0,0
238591,acids,0,1
238592,is,0,0
238593,superior,0,0
238594,to,0,0
238595,that,0,0
238596,of,0,0
238597,serum,0,0
238598,bile,0,0
238599,acids,0,1
238600,for,0,0
238601,assessing,0,0
238602,the,0,0
238603,compliance,0,0
238604,and,0,0
238605,changes,0,0
238606,in,0,0
238607,the,0,0
238608,circulating,0,0
238609,bile,0,0
238610,acids,0,1
238611,in,0,0
238612,patients,0,0
238613,receiving,0,0
238614,ursodeoxycholic,1,1
238615,acid,1,1
238616,for,0,0
238617,the,0,0
238618,treatment,0,0
238619,of,0,0
238620,primary,0,0
238621,biliary,0,0
238622,cirrhosis,0,0
238623,.,0,0
238624,Furthermore,0,0
238625,",",0,0
238626,measures,0,0
238627,to,0,0
238628,further,0,0
238629,increase,0,0
238630,the,0,0
238631,proportion,0,0
238632,of,0,0
238633,ursodeoxycholic,1,1
238634,acid,1,1
238635,in,0,0
238636,circulating,0,0
238637,bile,0,0
238638,acids,0,1
238639,should,0,0
238640,be,0,0
238641,explored,0,0
238642,.,0,0
238643,Evaluation,0,0
238644,of,0,0
238645,the,0,0
238646,safety,0,0
238647,",",0,0
238648,immunogenicity,0,0
238649,",",0,0
238650,and,0,0
238651,pharmacokinetic,0,0
238652,profile,0,0
238653,of,0,0
238654,a,0,0
238655,new,1,0
238656,",",1,0
238657,highly,1,0
238658,purified,1,0
238659,",",1,0
238660,heat-treated,1,1
238661,equine,1,1
238662,rabies,1,1
238663,immunoglobulin,1,1
238664,",",0,0
238665,administered,0,0
238666,either,0,0
238667,alone,0,1
238668,or,0,1
238669,in,0,0
238670,association,0,0
238671,with,0,0
238672,a,0,0
238673,purified,0,0
238674,",",0,0
238675,Vero-cell,1,1
238676,rabies,1,1
238677,vaccine,1,1
238678,.,1,0
238679,A,0,0
238680,clinical,0,0
238681,evaluation,0,0
238682,of,0,0
238683,a,0,0
238684,new,1,0
238685,",",1,0
238686,purified,1,0
238687,",",1,0
238688,heat-treated,1,1
238689,equine,1,1
238690,rabies,1,1
238691,immunoglobulin,1,1
238692,(,1,0
238693,PHT-Erig,1,1
238694,),1,0
238695,",",1,0
238696,F,1,0
238697,(,1,0
238698,ab,1,1
238699,',1,0
238700,),1,0
238701,2,1,0
238702,preparation,1,1
238703,",",0,0
238704,was,0,0
238705,carried,0,0
238706,out,0,0
238707,in,0,0
238708,Thailand,0,0
238709,and,0,0
238710,in,0,0
238711,the,0,0
238712,Philippines-two,0,0
238713,countries,0,0
238714,where,0,0
238715,rabies,0,1
238716,is,0,0
238717,endemic,0,0
238718,.,0,0
238719,An,0,0
238720,initial,0,0
238721,prospective,0,0
238722,",",0,0
238723,randomised,0,0
238724,",",0,0
238725,controlled,0,0
238726,trial,0,0
238727,(,0,0
238728,Study,0,0
238729,1,0,0
238730,),0,0
238731,",",0,0
238732,compared,0,0
238733,the,0,0
238734,safety,0,0
238735,and,0,0
238736,pharmacokinetics,0,0
238737,(,0,0
238738,serum,0,0
238739,concentrations,0,0
238740,of,0,0
238741,rabies,0,1
238742,antibodies,0,0
238743,),0,0
238744,after,0,0
238745,administration,0,0
238746,either,0,0
238747,of,0,0
238748,PHT-Erig,1,0
238749,or,0,0
238750,of,0,0
238751,a,1,0
238752,commercially-available,1,0
238753,",",1,0
238754,equine,1,1
238755,rabies,1,1
238756,immune,1,0
238757,globulin,1,1
238758,(,1,0
238759,Erig,1,1
238760,PMC,1,1
238761,),1,0
238762,.,1,0
238763,A,0,0
238764,second,0,0
238765,trial,0,0
238766,(,0,0
238767,Study,0,0
238768,2,0,0
238769,),0,0
238770,simulated,0,0
238771,post-exposure,0,1
238772,rabies,0,1
238773,prophylaxis,0,0
238774,by,0,0
238775,using,0,0
238776,a,0,0
238777,reference,0,0
238778,cell,0,0
238779,culture,0,0
238780,vaccine,0,1
238781,",",0,0
238782,the,1,0
238783,purified,1,0
238784,Vero-cell,1,1
238785,rabies,1,1
238786,vaccine,1,1
238787,(,1,0
238788,PVRV,1,0
238789,),1,0
238790,",",0,0
238791,administered,0,0
238792,in,0,0
238793,association,0,0
238794,with,0,0
238795,either,1,0
238796,Erig,1,1
238797,PMC,1,1
238798,or,1,0
238799,PHT-Erig,1,0
238800,.,1,0
238801,In,0,0
238802,Study,0,0
238803,1,0,0
238804,",",0,0
238805,27,0,0
238806,healthy,0,0
238807,",",0,0
238808,Thai,0,0
238809,adults,0,0
238810,received,0,0
238811,a,0,0
238812,40,0,0
238813,IU,0,1
238814,kg,0,1
238815,(,0,0
238816,-1,0,0
238817,),0,0
238818,dose,0,0
238819,of,0,0
238820,either,0,0
238821,Erig,1,1
238822,PMC,1,1
238823,(,0,0
238824,n,0,0
238825,=,0,0
238826,12,0,0
238827,),0,0
238828,or,0,1
238829,PHT-Erig,1,1
238830,(,0,0
238831,n,0,0
238832,=,0,0
238833,15,0,0
238834,),0,0
238835,via,0,0
238836,the,0,0
238837,intramuscular,0,1
238838,(,0,0
238839,i.m,0,1
238840,.,0,0
238841,),0,0
238842,route,0,0
238843,;,0,0
238844,half,0,0
238845,of,0,0
238846,the,0,0
238847,dose,0,0
238848,was,0,0
238849,injected,0,1
238850,into,0,0
238851,the,0,0
238852,deltoid,0,1
238853,area,0,0
238854,and,0,0
238855,the,0,0
238856,other,0,0
238857,half,0,0
238858,into,0,0
238859,the,0,0
238860,buttocks,0,0
238861,.,0,0
238862,Serum,0,0
238863,for,0,0
238864,rabies,0,1
238865,antibody,0,0
238866,determination,0,0
238867,and,0,0
238868,F,0,0
238869,(,0,0
238870,ab,0,1
238871,',0,0
238872,),0,0
238873,2,0,0
238874,concentration,0,0
238875,was,0,0
238876,collected,0,0
238877,at,0,0
238878,hours,0,0
238879,(,0,0
238880,H,0,0
238881,),0,0
238882,0,0,0
238883,",",0,0
238884,6,0,0
238885,and,0,0
238886,12,0,0
238887,",",0,0
238888,and,0,0
238889,on,0,0
238890,day,0,1
238891,(,0,0
238892,D,0,1
238893,),0,0
238894,2,0,0
238895,",",0,0
238896,3,0,0
238897,",",0,0
238898,4,0,0
238899,",",0,0
238900,6,0,0
238901,",",0,0
238902,8,0,0
238903,",",0,0
238904,10,0,0
238905,",",0,0
238906,12,0,0
238907,and,0,0
238908,15,0,0
238909,.,0,0
238910,Both,0,0
238911,products,0,0
238912,were,0,0
238913,safe,0,0
238914,",",0,0
238915,with,0,0
238916,no,0,0
238917,serious,0,0
238918,adverse,0,0
238919,events,0,0
238920,",",0,0
238921,and,0,0
238922,in,0,0
238923,particular,0,0
238924,",",0,0
238925,no,0,0
238926,anaphylactic,0,0
238927,reactions,0,0
238928,or,0,0
238929,serum,0,0
238930,sickness,0,0
238931,was,0,0
238932,reported,0,0
238933,.,0,0
238934,A,0,0
238935,statistical,0,0
238936,comparison,0,0
238937,of,0,0
238938,the,0,0
238939,pharmacokinetic,0,0
238940,parameters,0,0
238941,did,0,0
238942,not,0,0
238943,demonstrate,0,0
238944,bioequivalence,0,0
238945,of,0,0
238946,the,0,0
238947,two,0,0
238948,products,0,0
238949,.,0,0
238950,Nonetheless,0,0
238951,",",0,0
238952,the,0,0
238953,relative,0,0
238954,bioavailability,0,0
238955,of,0,0
238956,93,0,0
238957,%,0,0
238958,and,0,0
238959,the,0,0
238960,similar,0,0
238961,absorption,0,0
238962,rates,0,0
238963,suggest,0,0
238964,the,0,0
238965,pharmacokinetic,0,0
238966,profiles,0,0
238967,of,0,0
238968,Erig,0,1
238969,and,0,0
238970,PHT-Erig,0,1
238971,are,0,0
238972,similar,0,0
238973,.,0,0
238974,The,0,0
238975,antibody,0,0
238976,level,0,0
238977,in,0,0
238978,either,0,0
238979,group,0,0
238980,were,0,0
238981,low,0,0
238982,throughout,0,0
238983,the,0,0
238984,15-day,0,0
238985,study,0,0
238986,period,0,0
238987,.,0,0
238988,The,0,0
238989,geometric,0,0
238990,mean,0,0
238991,titer,0,0
238992,(,0,0
238993,GMT,0,0
238994,),0,0
238995,values,0,0
238996,ranged,0,0
238997,from,0,0
238998,group,0,0
238999,0.027-0.117,0,0
239000,IU,0,1
239001,ml,0,1
239002,(,0,0
239003,-1,0,0
239004,),0,0
239005,in,0,0
239006,the,0,0
239007,Erig,0,1
239008,group,0,0
239009,and,0,0
239010,from,0,0
239011,0.029,0,0
239012,to,0,0
239013,0.072,0,0
239014,IU,0,1
239015,ml,0,1
239016,(,0,0
239017,-1,0,0
239018,),0,0
239019,in,0,0
239020,the,0,0
239021,PHT-Erig,0,0
239022,.,0,0
239023,There,0,0
239024,was,0,0
239025,no,0,0
239026,significant,0,0
239027,difference,0,0
239028,between,0,0
239029,the,0,0
239030,evolution,0,0
239031,of,0,0
239032,GMT,0,0
239033,values,0,0
239034,for,0,0
239035,the,0,0
239036,two,0,0
239037,groups,0,0
239038,.,0,0
239039,In,0,0
239040,Study,0,0
239041,2,0,0
239042,",",0,0
239043,71,0,0
239044,healthy,0,0
239045,volunteers,0,0
239046,received,0,0
239047,40,0,0
239048,IU,0,1
239049,kg,0,1
239050,(,0,0
239051,-1,0,0
239052,),0,0
239053,via,0,0
239054,the,0,0
239055,intramuscular,0,1
239056,route,0,0
239057,of,0,0
239058,either,0,0
239059,Erig,0,1
239060,PMC,0,1
239061,(,0,0
239062,n,0,0
239063,=,0,0
239064,36,0,0
239065,),0,0
239066,or,0,1
239067,PHT-Erig,0,1
239068,(,0,0
239069,n,0,0
239070,=,0,0
239071,35,0,0
239072,),0,0
239073,on,0,0
239074,D0,0,1
239075,",",0,0
239076,in,0,0
239077,association,0,0
239078,with,0,0
239079,five,0,0
239080,doses,0,0
239081,of,0,0
239082,PVRV,0,0
239083,on,0,0
239084,D0,0,1
239085,",",0,0
239086,D3,0,0
239087,",",0,0
239088,D7,0,0
239089,",",0,0
239090,D14,0,0
239091,and,0,0
239092,D28,0,0
239093,.,0,0
239094,The,0,0
239095,safety,0,0
239096,evaluation,0,0
239097,was,0,0
239098,performed,0,0
239099,during,0,0
239100,the,0,0
239101,28-day,0,0
239102,follow-up,0,0
239103,and,0,0
239104,serum,0,0
239105,samples,0,0
239106,for,0,0
239107,anti-rabies,0,1
239108,antibody,0,0
239109,titration,0,0
239110,were,0,0
239111,collected,0,0
239112,on,0,0
239113,D0,0,1
239114,(,0,0
239115,before,0,0
239116,injection,0,1
239117,),0,0
239118,D3,0,1
239119,",",0,0
239120,D7,0,0
239121,",",0,0
239122,D14,0,0
239123,and,0,0
239124,D28,0,0
239125,.,0,0
239126,No,0,0
239127,serious,0,0
239128,reactions,0,0
239129,were,0,0
239130,reported,0,0
239131,in,0,0
239132,either,0,0
239133,group,0,0
239134,.,0,0
239135,In,0,0
239136,particular,0,0
239137,",",0,0
239138,no,0,0
239139,immediate,0,0
239140,(,0,0
239141,anaphylactic,0,0
239142,type,0,0
239143,),0,0
239144,or,0,1
239145,delayed,0,0
239146,(,0,0
239147,serum,0,0
239148,sickness,0,1
239149,),0,0
239150,allergic,0,0
239151,reactions,0,0
239152,were,0,0
239153,observed,0,0
239154,.,0,0
239155,Over,0,0
239156,the,0,0
239157,28-day,0,0
239158,follow-up,0,0
239159,period,0,0
239160,",",0,0
239161,GMT,0,0
239162,profiles,0,0
239163,of,0,0
239164,the,0,0
239165,two,0,0
239166,groups,0,0
239167,were,0,0
239168,statistically,0,0
239169,equivalent,0,0
239170,.,0,0
239171,On,0,0
239172,D14,0,0
239173,",",0,0
239174,100,0,0
239175,%,0,0
239176,of,0,0
239177,the,0,0
239178,subjects,0,0
239179,had,0,0
239180,protective,0,0
239181,antibody,0,0
239182,titers,0,0
239183,(,0,0
239184,anti-rabies,0,1
239185,antibodies,0,0
239186,>,0,0
239187,or,0,0
239188,=,0,0
239189,0.5,0,1
239190,IU,0,1
239191,ml,0,1
239192,(,0,0
239193,-1,0,0
239194,),0,0
239195,",",0,0
239196,which,0,0
239197,is,0,0
239198,the,0,0
239199,WHO-recommended,0,0
239200,level,0,0
239201,of,0,0
239202,seroconversion,0,0
239203,),0,0
239204,",",0,0
239205,and,0,0
239206,Erig,0,1
239207,PMC,0,1
239208,and,0,0
239209,PHT-Erig,0,1
239210,were,0,0
239211,indistinguishable,0,0
239212,according,0,0
239213,to,0,0
239214,the,0,0
239215,clinical,0,0
239216,definition,0,0
239217,chosen,0,0
239218,.,0,0
239219,On,0,0
239220,D28,0,0
239221,",",0,0
239222,the,0,0
239223,GMT,0,0
239224,values,0,0
239225,were,0,0
239226,33.2,0,0
239227,IU,0,1
239228,ml,0,1
239229,(,0,0
239230,-1,0,0
239231,),0,1
239232,(,0,0
239233,95,0,0
239234,%,0,0
239235,CI,0,0
239236,",",0,0
239237,23.8-46.1,0,0
239238,IU,0,1
239239,ml,0,1
239240,(,0,0
239241,-1,0,0
239242,),0,1
239243,),0,0
239244,in,0,0
239245,the,0,0
239246,Erig,0,1
239247,PMC/PVRV,0,1
239248,group,0,0
239249,and,0,0
239250,31.4,0,0
239251,IU,0,1
239252,ml,0,1
239253,(,0,0
239254,-1,0,0
239255,),0,1
239256,(,0,0
239257,95,0,0
239258,%,0,0
239259,confidence,0,0
239260,interval,0,0
239261,",",0,0
239262,CI,0,0
239263,",",0,0
239264,23.4-42.2,0,0
239265,IU,0,1
239266,ml,0,1
239267,(,0,0
239268,-1,0,0
239269,),0,1
239270,),0,0
239271,in,0,0
239272,the,0,0
239273,PHT-Erig/PVRV,0,0
239274,group,0,0
239275,",",0,0
239276,showing,0,0
239277,evidence,0,0
239278,of,0,0
239279,adequate,0,0
239280,vaccine-induced,0,0
239281,antibody,0,0
239282,responses,0,0
239283,in,0,0
239284,both,0,0
239285,groups,0,0
239286,.,0,0
239287,The,0,0
239288,increased,0,0
239289,purity,0,0
239290,",",0,0
239291,the,0,0
239292,heat-treatment,0,1
239293,step,0,0
239294,introduced,0,0
239295,in,0,0
239296,the,0,0
239297,manufacturing,0,0
239298,process,0,0
239299,of,0,0
239300,PHT-Erig,0,0
239301,",",0,0
239302,and,0,0
239303,the,0,0
239304,good,0,0
239305,clinical,0,0
239306,results,0,0
239307,substantiate,0,0
239308,the,0,0
239309,use,0,0
239310,of,0,0
239311,this,0,0
239312,new,0,0
239313,generation,0,0
239314,",",0,0
239315,purified,0,0
239316,equine,0,1
239317,F,0,0
239318,(,0,0
239319,ab,0,1
239320,',0,0
239321,),0,0
239322,2,0,0
239323,preparation,0,1
239324,in,0,0
239325,the,0,0
239326,post-exposure,0,1
239327,prophylaxis,0,0
239328,of,0,0
239329,rabies,0,0
239330,.,0,0
239331,Pharmacokinetics,0,0
239332,of,0,0
239333,cefuroxime,1,1
239334,in,0,0
239335,healthy,0,0
239336,volunteers,0,0
239337,:,0,0
239338,an,0,0
239339,update,0,0
239340,.,0,0
239341,Preoperative,0,1
239342,irradiation,0,1
239343,versus,0,0
239344,the,0,0
239345,use,0,0
239346,of,0,0
239347,nonsteroidal,0,1
239348,anti-inflammatory,0,0
239349,drugs,0,1
239350,for,0,0
239351,prevention,0,0
239352,of,0,0
239353,heterotopic,0,0
239354,ossification,0,0
239355,following,0,0
239356,total,0,0
239357,hip,0,0
239358,replacement,0,1
239359,:,0,0
239360,the,0,0
239361,results,0,0
239362,of,0,0
239363,a,0,0
239364,randomized,0,0
239365,trial,0,0
239366,.,0,0
239367,PURPOSE,0,0
239368,Previous,0,0
239369,studies,0,0
239370,showed,0,0
239371,the,0,0
239372,effectiveness,0,0
239373,of,0,0
239374,early,0,0
239375,preoperative,0,0
239376,(,0,0
239377,4,0,0
239378,h,0,0
239379,before,0,0
239380,operation,0,1
239381,),0,0
239382,irradiation,0,1
239383,for,0,0
239384,prevention,0,0
239385,of,0,0
239386,heterotopic,0,0
239387,ossification,0,0
239388,(,0,0
239389,HO,0,1
239390,),0,0
239391,after,0,0
239392,total,0,0
239393,hip,0,0
239394,replacement,0,1
239395,.,0,0
239396,This,0,0
239397,procedure,0,0
239398,can,0,0
239399,result,0,0
239400,in,0,0
239401,logistic,0,0
239402,problems,0,0
239403,",",0,0
239404,if,0,0
239405,there,0,0
239406,is,0,0
239407,a,0,0
239408,great,0,0
239409,distance,0,0
239410,between,0,0
239411,the,0,0
239412,department,0,0
239413,of,0,0
239414,radiotherapy,0,1
239415,and,0,0
239416,the,0,0
239417,orthopedic,0,0
239418,clinic,0,0
239419,.,0,0
239420,To,0,0
239421,avoid,0,0
239422,these,0,0
239423,organizational,0,0
239424,problems,0,0
239425,a,0,0
239426,prospective,0,0
239427,study,0,0
239428,was,0,0
239429,undertaken,0,0
239430,to,0,0
239431,analyze,0,0
239432,the,0,0
239433,effectiveness,0,0
239434,of,0,0
239435,preoperative,0,0
239436,irradiation,0,1
239437,on,0,0
239438,the,0,0
239439,day,0,0
239440,preceding,0,0
239441,surgery,0,1
239442,(,0,0
239443,16-20,0,0
239444,h,0,1
239445,before,0,0
239446,operation,0,0
239447,),0,0
239448,.,0,0
239449,METHODS,0,0
239450,AND,0,0
239451,MATERIALS,0,0
239452,Between,0,0
239453,1995,0,0
239454,and,0,0
239455,1996,0,0
239456,",",0,0
239457,100,0,0
239458,patients,0,0
239459,were,0,0
239460,randomized,1,0
239461,to,0,0
239462,receive,0,0
239463,a,0,0
239464,prophylactic,0,1
239465,therapy,0,1
239466,for,0,0
239467,prevention,0,0
239468,of,0,0
239469,heterotopic,0,0
239470,ossification,0,0
239471,.,0,0
239472,Forty-six,0,0
239473,patients,0,0
239474,were,0,0
239475,irradiated,1,0
239476,with,1,0
239477,7,1,0
239478,Gy,1,1
239479,single,1,0
239480,dose,1,0
239481,within,1,0
239482,16-20,1,0
239483,h,1,0
239484,before,1,0
239485,operation,1,0
239486,.,1,0
239487,Fifty-four,0,0
239488,patients,0,0
239489,were,0,0
239490,treated,1,0
239491,with,1,0
239492,nonsteroidal,1,1
239493,anti-inflammatory,1,1
239494,drugs,1,1
239495,(,1,0
239496,NSAID,1,0
239497,),1,1
239498,(,1,0
239499,Voltaren,1,1
239500,resinat,1,1
239501,2,1,0
239502,x,1,0
239503,75,1,0
239504,mg/day,1,0
239505,for,1,0
239506,2,1,0
239507,weeks,1,0
239508,),1,0
239509,.,1,0
239510,Heterotopic,0,0
239511,ossification,0,0
239512,was,0,0
239513,scored,0,0
239514,according,0,0
239515,to,0,0
239516,the,0,0
239517,Brooker,0,0
239518,Grading,0,0
239519,system,0,0
239520,.,0,0
239521,One,0,0
239522,hundred,0,0
239523,patients,0,0
239524,receiving,0,0
239525,no,0,0
239526,prophylactic,0,1
239527,therapy,0,1
239528,after,0,0
239529,total,0,0
239530,hip,0,0
239531,arthroplasty,0,0
239532,between,0,0
239533,1988,0,0
239534,and,0,0
239535,1992,0,0
239536,were,0,0
239537,analyzed,0,0
239538,and,0,0
239539,defined,0,0
239540,as,0,0
239541,the,0,0
239542,historical,0,0
239543,control,0,0
239544,group,0,0
239545,.,0,0
239546,RESULTS,0,0
239547,Incidence,0,0
239548,of,0,0
239549,heterotopic,0,0
239550,ossification,0,0
239551,was,0,0
239552,47.8,0,0
239553,%,0,0
239554,in,0,0
239555,the,0,0
239556,7,0,0
239557,Gy,0,1
239558,preoperative,0,0
239559,group,0,0
239560,(,0,0
239561,Brooker,0,0
239562,Score,0,0
239563,I,0,0
239564,:,0,0
239565,36.9,0,0
239566,%,0,0
239567,;,0,0
239568,II,0,0
239569,:,0,0
239570,8.7,0,0
239571,%,0,0
239572,;,0,0
239573,III,0,0
239574,:,0,0
239575,2.2,0,0
239576,%,0,0
239577,;,0,0
239578,IV,0,0
239579,:,0,0
239580,0,0,0
239581,%,0,0
239582,),0,0
239583,and,0,0
239584,11.1,0,0
239585,%,0,0
239586,in,0,0
239587,the,0,0
239588,NSAID,0,0
239589,group,0,0
239590,(,0,0
239591,Brooker,0,0
239592,Score,0,0
239593,I,0,0
239594,:,0,0
239595,9.3,0,0
239596,%,0,0
239597,;,0,0
239598,II,0,0
239599,:,0,0
239600,1.8,0,0
239601,%,0,0
239602,;,0,0
239603,III,0,0
239604,:,0,0
239605,0,0,0
239606,%,0,0
239607,;,0,0
239608,IV,0,0
239609,:,0,0
239610,0,0,0
239611,%,0,0
239612,),0,0
239613,.,0,0
239614,Regarding,0,0
239615,overall,0,0
239616,heterotopic,0,0
239617,ossification,0,0
239618,there,0,0
239619,was,0,0
239620,a,0,0
239621,significant,0,0
239622,difference,0,0
239623,between,0,0
239624,the,0,0
239625,NSAID,0,0
239626,group,0,0
239627,and,0,0
239628,the,0,0
239629,7,0,0
239630,Gy,0,1
239631,group,0,0
239632,(,0,0
239633,p,0,0
239634,<,0,0
239635,0.01,0,0
239636,),0,0
239637,.,0,0
239638,Analyzing,0,0
239639,the,0,0
239640,clinically,0,0
239641,significant,0,0
239642,heterotopic,0,0
239643,ossification,0,0
239644,(,0,0
239645,Brooker,0,0
239646,Score,0,1
239647,III,0,0
239648,and,0,0
239649,IV,0,0
239650,),0,0
239651,there,0,0
239652,was,0,0
239653,no,0,0
239654,significant,0,0
239655,difference,0,0
239656,between,0,0
239657,the,0,0
239658,two,0,0
239659,treatment,0,0
239660,arms,0,0
239661,(,0,0
239662,p,0,0
239663,>,0,0
239664,0.05,0,0
239665,),0,0
239666,.,0,0
239667,In,0,0
239668,the,0,0
239669,untreated,0,0
239670,historical,0,0
239671,control,0,1
239672,group,0,0
239673,the,0,0
239674,incidence,0,0
239675,of,0,0
239676,heterotopic,0,0
239677,ossification,0,0
239678,was,0,0
239679,65,0,0
239680,%,0,0
239681,(,0,0
239682,Brooker,0,0
239683,Score,0,0
239684,I,0,0
239685,:,0,0
239686,26,0,0
239687,%,0,0
239688,;,0,0
239689,II,0,0
239690,:,0,0
239691,15,0,0
239692,%,0,0
239693,;,0,0
239694,III,0,0
239695,:,0,0
239696,19,0,0
239697,%,0,0
239698,;,0,0
239699,IV,0,0
239700,:,0,0
239701,5,0,0
239702,%,0,0
239703,),0,0
239704,.,0,0
239705,Referring,0,0
239706,to,0,0
239707,overall,0,0
239708,and,0,0
239709,to,0,0
239710,clinically,0,0
239711,relevant,0,0
239712,heterotopic,0,0
239713,ossification,0,0
239714,the,0,0
239715,incidence,0,0
239716,of,0,0
239717,HO,0,0
239718,was,0,0
239719,greater,0,0
239720,in,0,0
239721,the,0,0
239722,control,0,0
239723,group,0,0
239724,than,0,0
239725,in,0,0
239726,the,0,0
239727,prophylactically,0,0
239728,treated,0,0
239729,groups,0,0
239730,(,0,0
239731,p,0,0
239732,<,0,0
239733,0.05,0,0
239734,),0,0
239735,.,0,0
239736,CONCLUSION,0,0
239737,Irradiation,0,0
239738,within,0,0
239739,16-20,0,0
239740,h,0,0
239741,before,0,0
239742,operation,0,0
239743,and,0,0
239744,use,0,0
239745,of,0,0
239746,NSAID,0,0
239747,(,0,0
239748,Voltaren,0,1
239749,resinat,0,1
239750,),0,0
239751,can,0,0
239752,reduce,0,0
239753,the,0,0
239754,incidence,0,0
239755,of,0,0
239756,clinically,0,0
239757,relevant,0,0
239758,heterotopic,0,0
239759,ossification,0,0
239760,after,0,0
239761,total,0,0
239762,hip,0,0
239763,replacement,0,1
239764,.,0,0
239765,Sunbathing,0,1
239766,and,0,0
239767,sunbed,0,0
239768,use,0,0
239769,related,0,0
239770,to,0,0
239771,self-image,0,0
239772,in,0,0
239773,a,0,0
239774,randomized,0,0
239775,sample,0,0
239776,of,0,0
239777,Swedish,0,0
239778,adolescents,0,0
239779,.,0,0
239780,In,0,0
239781,1996,0,0
239782,a,0,0
239783,randomized,0,0
239784,sample,0,0
239785,of,0,0
239786,"4,020",0,0
239787,Swedish,0,0
239788,adolescents,0,0
239789,from,0,0
239790,three,0,0
239791,birth,0,0
239792,cohorts,0,0
239793,were,0,0
239794,sent,0,0
239795,a,0,0
239796,questionnaire,1,0
239797,consisting,0,0
239798,of,0,0
239799,50,0,0
239800,items,0,0
239801,concerning,0,0
239802,habitual,0,0
239803,sun-related,0,0
239804,behaviours,0,0
239805,and,0,0
239806,attitudes,0,0
239807,",",0,0
239808,knowledge,0,0
239809,about,0,0
239810,melanoma,0,0
239811,",",0,0
239812,risk,0,0
239813,perception,0,0
239814,and,0,0
239815,self-image,0,0
239816,.,0,0
239817,A,0,0
239818,total,0,0
239819,of,0,0
239820,"2,615",0,0
239821,questionnaires,1,0
239822,were,0,0
239823,returned,0,0
239824,.,0,0
239825,Girls,0,0
239826,sunbathed,0,0
239827,and,0,0
239828,used,0,0
239829,sunbeds,0,0
239830,more,0,0
239831,than,0,0
239832,boys,0,0
239833,at,0,0
239834,all,0,0
239835,ages,0,0
239836,.,0,0
239837,Sunbathing,0,0
239838,and,0,0
239839,sunbed,0,0
239840,use,0,0
239841,increased,0,0
239842,with,0,0
239843,age,0,0
239844,.,0,0
239845,Boys,0,0
239846,who,0,0
239847,were,0,0
239848,most,0,0
239849,satisfied,0,0
239850,and,0,0
239851,girls,0,0
239852,least,0,0
239853,satisfied,0,0
239854,with,0,0
239855,themselves,0,0
239856,sunbathed,0,0
239857,most,0,0
239858,.,0,0
239859,Those,0,0
239860,who,0,0
239861,were,0,0
239862,least,0,0
239863,satisfied,0,0
239864,with,0,0
239865,themselves,0,0
239866,used,0,0
239867,sunbeds,0,0
239868,most,0,0
239869,frequently,0,0
239870,.,0,0
239871,Girls,0,0
239872,reported,0,0
239873,a,0,0
239874,higher,0,0
239875,perceived,0,0
239876,susceptibility,0,0
239877,to,0,0
239878,melanoma,0,0
239879,than,0,0
239880,did,0,0
239881,boys,0,0
239882,.,0,0
239883,The,0,0
239884,perception,0,0
239885,of,0,0
239886,susceptibility,0,0
239887,increased,0,0
239888,with,0,0
239889,age,0,0
239890,.,0,0
239891,Those,0,0
239892,who,0,0
239893,were,0,0
239894,least,0,0
239895,satisfied,0,0
239896,with,0,0
239897,themselves,0,0
239898,reported,0,0
239899,feeling,0,0
239900,most,0,0
239901,susceptible,0,0
239902,.,0,0
239903,The,0,0
239904,overall,0,0
239905,main,0,0
239906,reason,0,0
239907,for,0,0
239908,sunbathing,0,0
239909,was,0,0
239910,appearance,0,0
239911,",",0,0
239912,both,0,0
239913,for,0,0
239914,own,0,0
239915,sunbathing,0,1
239916,",",0,0
239917,and,0,0
239918,to,0,0
239919,an,0,0
239920,even,0,0
239921,higher,0,0
239922,degree,0,0
239923,",",0,0
239924,as,0,0
239925,a,0,0
239926,supposed,0,0
239927,reason,0,0
239928,for,0,0
239929,other,0,0
239930,adolescents,0,0
239931,',0,0
239932,behaviour,0,0
239933,",",0,0
239934,and,0,0
239935,was,0,0
239936,reported,0,0
239937,most,0,0
239938,frequently,0,0
239939,by,0,0
239940,girls,0,0
239941,and,0,0
239942,the,0,0
239943,older,0,0
239944,age,0,0
239945,groups,0,0
239946,.,0,0
239947,The,0,0
239948,second,0,0
239949,most,0,0
239950,'important,0,0
239951,',0,0
239952,reason,0,0
239953,for,0,0
239954,sunbathing,0,0
239955,was,0,0
239956,'feeling,0,0
239957,warm,0,0
239958,and,0,0
239959,comfortable,0,0
239960,',0,0
239961,.,0,0
239962,Preventive,0,0
239963,programmes,0,0
239964,aimed,0,0
239965,at,0,0
239966,a,0,0
239967,change,0,0
239968,of,0,0
239969,sun,0,0
239970,related,0,0
239971,behaviours,0,0
239972,among,0,0
239973,Swedish,0,0
239974,adolescents,0,0
239975,have,0,0
239976,to,0,0
239977,be,0,0
239978,tailored,0,1
239979,to,0,0
239980,the,0,0
239981,climate,0,0
239982,and,0,0
239983,cultural,0,0
239984,conditions,0,0
239985,and,0,0
239986,must,0,0
239987,take,0,0
239988,into,0,0
239989,account,0,0
239990,that,0,0
239991,having,0,0
239992,a,0,0
239993,tan,0,0
239994,",",0,0
239995,and,0,0
239996,the,0,0
239997,warmth,0,0
239998,of,0,0
239999,the,0,0
240000,sun,0,0
240001,",",0,0
240002,are,0,0
240003,highly,0,0
240004,valued,0,0
240005,by,0,0
240006,most,0,0
240007,adolescents,0,0
240008,.,0,0
240009,Treatment,0,0
240010,of,0,0
240011,children,0,0
240012,with,0,0
240013,autism,0,0
240014,:,0,0
240015,a,0,0
240016,randomized,0,0
240017,controlled,0,0
240018,trial,0,0
240019,to,0,0
240020,evaluate,0,0
240021,a,0,0
240022,caregiver-based,1,1
240023,intervention,1,1
240024,program,1,1
240025,in,0,0
240026,community,0,0
240027,day-care,0,0
240028,centers,0,0
240029,.,0,0
240030,This,0,0
240031,study,0,0
240032,reports,0,0
240033,on,0,0
240034,the,0,0
240035,results,0,0
240036,of,0,0
240037,a,0,0
240038,randomized,0,0
240039,controlled,0,0
240040,trial,0,0
240041,that,0,0
240042,evaluated,0,0
240043,a,0,0
240044,caregiver-based,1,1
240045,intervention,1,1
240046,program,1,1
240047,for,0,0
240048,children,0,0
240049,with,0,0
240050,autism,0,0
240051,in,0,0
240052,community,0,0
240053,day-care,0,0
240054,centers,0,0
240055,.,0,0
240056,Thirty-five,0,0
240057,preschool,0,0
240058,children,0,0
240059,with,0,0
240060,a,0,0
240061,DSM,0,0
240062,III-R,0,0
240063,diagnosis,0,0
240064,of,0,0
240065,autism,0,0
240066,or,0,1
240067,pervasive,0,0
240068,developmental,0,0
240069,disorder,0,0
240070,were,0,0
240071,randomized,0,0
240072,to,0,0
240073,an,0,0
240074,experimental,0,0
240075,or,0,1
240076,control,0,0
240077,group,0,0
240078,.,0,0
240079,Children,0,0
240080,in,0,0
240081,the,0,0
240082,experimental,0,0
240083,group,0,0
240084,were,0,0
240085,enrolled,0,0
240086,in,0,0
240087,day,0,0
240088,care,0,1
240089,and,0,0
240090,their,0,0
240091,parents,1,0
240092,and,1,0
240093,child,1,0
240094,care,1,1
240095,workers,1,0
240096,received,1,0
240097,a,1,0
240098,12-week,1,0
240099,intervention,1,1
240100,consisting,1,0
240101,of,1,0
240102,lectures,1,1
240103,and,1,0
240104,on-site,1,1
240105,consultations,1,1
240106,to,1,0
240107,day-care,1,0
240108,centers,1,0
240109,.,1,0
240110,In,0,0
240111,addition,0,0
240112,",",0,0
240113,supportive,0,1
240114,work,0,0
240115,was,0,0
240116,undertaken,0,0
240117,with,0,0
240118,families,0,0
240119,.,0,0
240120,Control,0,0
240121,subjects,0,0
240122,received,0,0
240123,day,1,0
240124,care,1,0
240125,alone,1,0
240126,.,1,0
240127,In,0,0
240128,the,0,0
240129,experimental,0,0
240130,group,0,0
240131,",",0,0
240132,there,0,0
240133,were,0,0
240134,greater,0,0
240135,gains,0,0
240136,in,0,0
240137,language,0,0
240138,abilities,0,0
240139,",",0,0
240140,significant,0,0
240141,increases,0,0
240142,in,0,0
240143,caregivers,0,0
240144,',0,0
240145,knowledge,0,0
240146,about,0,0
240147,autism,0,0
240148,",",0,0
240149,greater,0,0
240150,perception,0,0
240151,of,0,0
240152,control,0,0
240153,on,0,0
240154,the,0,0
240155,part,0,0
240156,of,0,0
240157,mothers,0,0
240158,",",0,0
240159,and,0,0
240160,greater,0,0
240161,parent,0,0
240162,satisfaction,0,0
240163,.,0,0
240164,We,0,0
240165,conclude,0,0
240166,that,0,0
240167,this,0,0
240168,research,0,0
240169,design,0,0
240170,demonstrated,0,0
240171,that,0,0
240172,the,0,0
240173,intervention,0,1
240174,was,0,0
240175,significantly,0,0
240176,superior,0,0
240177,to,0,0
240178,day,0,0
240179,care,0,0
240180,alone,0,0
240181,.,0,0
240182,Amonafide,1,1
240183,:,1,0
240184,An,0,0
240185,active,0,0
240186,agent,0,0
240187,in,0,0
240188,the,0,0
240189,treatment,0,0
240190,of,0,0
240191,previously,0,0
240192,untreated,0,0
240193,advanced,0,0
240194,breast,0,0
240195,cancer,0,0
240196,--,0,0
240197,a,0,0
240198,cancer,0,0
240199,and,0,0
240200,leukemia,0,0
240201,group,0,0
240202,B,0,1
240203,study,0,0
240204,(,0,0
240205,CALGB,0,0
240206,8642,0,1
240207,),0,0
240208,.,0,0
240209,Amonafide,1,1
240210,is,0,0
240211,a,0,0
240212,new,0,0
240213,imide,0,1
240214,derivative,0,1
240215,of,0,0
240216,naphthalic,0,0
240217,acid,0,1
240218,.,0,0
240219,The,0,0
240220,drug,0,0
240221,had,0,0
240222,demonstrated,0,0
240223,significant,0,0
240224,activity,0,0
240225,in,0,0
240226,preclinical,0,0
240227,studies,0,0
240228,and,0,0
240229,some,0,0
240230,activity,0,0
240231,in,0,0
240232,Phase,0,0
240233,I,0,0
240234,trials,0,0
240235,.,0,0
240236,The,0,0
240237,drug,0,0
240238,is,0,0
240239,extensively,0,0
240240,metabolized,0,0
240241,and,0,0
240242,detected,0,0
240243,in,0,0
240244,plasma,0,0
240245,and,0,0
240246,urine,0,0
240247,.,0,0
240248,Its,0,0
240249,toxicity,0,0
240250,has,0,0
240251,previously,0,0
240252,been,0,0
240253,correlated,0,0
240254,to,0,0
240255,the,0,0
240256,formation,0,0
240257,of,0,0
240258,an,0,0
240259,active,0,0
240260,metabolite,0,0
240261,",",0,0
240262,N-acetyl-amonafide,0,1
240263,.,0,0
240264,Amonafide,1,0
240265,was,0,0
240266,chosen,0,0
240267,for,0,0
240268,inclusion,0,0
240269,in,0,0
240270,the,0,0
240271,Cancer,0,0
240272,and,0,0
240273,Leukemia,0,0
240274,Group,0,0
240275,B,0,0
240276,(,0,0
240277,CALGB,0,0
240278,),0,1
240279,master,0,0
240280,metastatic,0,0
240281,breast,0,0
240282,cancer,0,0
240283,protocol,0,0
240284,.,0,0
240285,CALGB,0,0
240286,8642,0,0
240287,randomizes,0,0
240288,previously,0,0
240289,untreated,0,0
240290,metastatic,0,0
240291,breast,0,0
240292,cancer,0,0
240293,patients,0,0
240294,either,0,0
240295,to,0,0
240296,one,0,0
240297,of,0,0
240298,several,0,0
240299,Phase,0,0
240300,II,0,0
240301,agents,0,0
240302,given,0,0
240303,for,0,0
240304,up,0,0
240305,to,0,0
240306,four,0,0
240307,cycles,0,0
240308,and,0,0
240309,then,0,0
240310,followed,0,0
240311,by,0,0
240312,standard,1,1
240313,cyclophosphamide-doxorubicin-5-fluorouracil,1,1
240314,",",0,0
240315,or,0,0
240316,to,0,0
240317,immediate,1,0
240318,treatment,1,0
240319,with,1,0
240320,standard,1,1
240321,cyclophosphamide-doxorubicin-5-fluorouracil,1,1
240322,.,1,0
240323,The,0,0
240324,end,0,0
240325,point,0,0
240326,of,0,0
240327,CALGB,0,0
240328,8642,0,1
240329,is,0,0
240330,to,0,0
240331,assess,0,0
240332,the,0,0
240333,difference,0,0
240334,in,0,0
240335,survival,0,0
240336,",",0,0
240337,toxicity,0,0
240338,",",0,0
240339,and,0,0
240340,overall,0,0
240341,response,0,0
240342,when,0,0
240343,limited,0,0
240344,exposure,0,0
240345,to,0,0
240346,Phase,0,0
240347,II,0,0
240348,agents,0,1
240349,precedes,0,0
240350,standard,0,0
240351,chemotherapy,0,1
240352,.,0,0
240353,This,0,0
240354,report,0,0
240355,deals,0,0
240356,only,0,0
240357,with,0,0
240358,amonafide,1,1
240359,as,0,0
240360,a,0,0
240361,Phase,0,0
240362,II,0,0
240363,agent,0,0
240364,.,0,0
240365,Comparisons,0,0
240366,with,0,0
240367,the,0,0
240368,cyclophosphamide-doxorubicin-5-fluorouracil,1,1
240369,arm,0,0
240370,will,0,0
240371,not,0,0
240372,be,0,0
240373,addressed,0,0
240374,.,0,0
240375,Patients,0,0
240376,had,0,0
240377,to,0,0
240378,have,0,0
240379,histologically,0,0
240380,documented,0,0
240381,measurable,0,0
240382,breast,0,0
240383,cancer,0,0
240384,and,0,0
240385,a,0,0
240386,performance,0,0
240387,status,0,0
240388,of,0,0
240389,0-1,0,0
240390,.,0,0
240391,Patients,0,0
240392,could,0,0
240393,not,0,0
240394,have,0,0
240395,had,0,0
240396,prior,0,0
240397,chemotherapy,0,1
240398,for,0,0
240399,metastatic,0,0
240400,disease,0,0
240401,.,0,0
240402,Prior,0,0
240403,adjuvant,0,1
240404,chemotherapy,0,1
240405,was,0,0
240406,permitted,0,0
240407,.,0,0
240408,Patients,0,0
240409,could,0,0
240410,not,0,0
240411,have,0,0
240412,visceral,0,0
240413,crisis,0,0
240414,.,0,0
240415,Amonafide,1,0
240416,was,0,0
240417,given,0,0
240418,at,0,0
240419,300,0,0
240420,mg/m2/day,0,0
240421,i.v,0,0
240422,.,0,0
240423,for,0,0
240424,5,0,0
240425,days,0,0
240426,",",0,0
240427,and,0,0
240428,repeated,0,0
240429,at,0,0
240430,21-day,0,0
240431,intervals,0,0
240432,for,0,0
240433,a,0,0
240434,maximum,0,0
240435,of,0,0
240436,four,0,0
240437,cycles,0,0
240438,.,0,0
240439,Escalation,0,0
240440,and,0,0
240441,reduction,0,0
240442,in,0,0
240443,dose,0,0
240444,was,0,0
240445,mandated,0,0
240446,dependent,0,0
240447,on,0,0
240448,hematotoxicity,0,0
240449,or,0,1
240450,lack,0,0
240451,thereof,0,1
240452,.,0,0
240453,Toxicity,0,0
240454,was,0,0
240455,primarily,0,0
240456,hematological,0,0
240457,and,0,0
240458,bimodal,0,0
240459,:,0,0
240460,32,0,0
240461,%,0,0
240462,had,0,0
240463,grade,0,0
240464,3,0,0
240465,or,0,0
240466,4,0,0
240467,leukopenia,0,0
240468,and,0,0
240469,24,0,0
240470,%,0,0
240471,had,0,0
240472,grade,0,0
240473,3,0,0
240474,or,0,0
240475,4,0,0
240476,thrombocytopenia,0,0
240477,;,0,0
240478,22,0,0
240479,%,0,0
240480,had,0,0
240481,no,0,0
240482,leukopenia,0,0
240483,and,0,0
240484,44,0,0
240485,%,0,0
240486,had,0,0
240487,no,0,0
240488,thrombocytopenia,0,0
240489,.,0,0
240490,The,0,0
240491,response,0,0
240492,rate,0,0
240493,was,0,0
240494,18,0,0
240495,%,0,0
240496,",",0,0
240497,including,0,0
240498,one,0,0
240499,complete,0,0
240500,response,0,0
240501,.,0,0
240502,When,0,0
240503,response,0,0
240504,was,0,0
240505,analyzed,0,0
240506,by,0,0
240507,hematological,0,0
240508,toxicity,0,0
240509,",",0,0
240510,there,0,0
240511,was,0,0
240512,a,0,0
240513,35.7,0,0
240514,%,0,0
240515,response,0,0
240516,if,0,0
240517,patients,0,0
240518,had,0,0
240519,leukopenia,0,0
240520,grade,0,0
240521,3/4,0,0
240522,(,0,0
240523,versus,0,0
240524,8.3,0,0
240525,%,0,0
240526,",",0,0
240527,P,0,0
240528,=,0,0
240529,0.08,0,0
240530,),0,0
240531,.,0,0
240532,There,0,0
240533,was,0,0
240534,a,0,0
240535,50,0,0
240536,%,0,0
240537,response,0,0
240538,if,0,0
240539,patients,0,0
240540,had,0,0
240541,thrombocytopenia,0,0
240542,grade,0,0
240543,3/4,0,0
240544,(,0,0
240545,versus,0,0
240546,7.1,0,0
240547,%,0,0
240548,",",0,0
240549,P,0,0
240550,=,0,0
240551,<,0,0
240552,0.01,0,0
240553,),0,0
240554,.,0,0
240555,We,0,0
240556,conclude,0,0
240557,that,0,0
240558,amonafide,1,1
240559,is,0,0
240560,somewhat,0,0
240561,active,0,0
240562,in,0,0
240563,previously,0,0
240564,untreated,0,0
240565,breast,0,0
240566,cancer,0,0
240567,patients,0,0
240568,.,0,0
240569,There,0,0
240570,may,0,0
240571,be,0,0
240572,a,0,0
240573,steep,0,0
240574,dose-response,0,0
240575,curve,0,0
240576,",",0,0
240577,based,0,0
240578,on,0,0
240579,the,0,0
240580,significant,0,0
240581,correlation,0,0
240582,between,0,0
240583,myelosuppression,0,0
240584,and,0,0
240585,response,0,0
240586,.,0,0
240587,Rates,0,0
240588,of,0,0
240589,responses,0,0
240590,in,0,0
240591,patients,0,0
240592,adequately,0,0
240593,dosed,0,1
240594,(,0,0
240595,i.e.,0,0
240596,",",0,0
240597,with,0,0
240598,significant,0,0
240599,hematotoxicity,0,0
240600,),0,0
240601,with,0,0
240602,amonafide,0,1
240603,ranged,0,0
240604,from,0,0
240605,35,0,0
240606,to,0,0
240607,50,0,0
240608,%,0,0
240609,.,0,0
240610,Further,0,0
240611,studies,0,0
240612,will,0,0
240613,incorporate,0,0
240614,individualized,0,0
240615,dosing,0,0
240616,based,0,0
240617,on,0,0
240618,pretreatment,0,0
240619,acetylator,0,0
240620,phenotyping,0,0
240621,.,0,0
240622,[,1,0
240623,Radiotherapy,1,1
240624,for,0,0
240625,choroidal,0,0
240626,neovascularization,0,0
240627,in,0,0
240628,age-related,0,0
240629,macular,0,0
240630,degeneration,0,0
240631,.,0,0
240632,A,0,0
240633,pilot,0,0
240634,study,0,0
240635,using,0,0
240636,low-,1,1
240637,versus,1,1
240638,high-dose,1,1
240639,photon,1,1
240640,bean,1,1
240641,radiation,1,1
240642,],1,0
240643,.,0,0
240644,PURPOSE,0,0
240645,Several,0,0
240646,pilot,0,0
240647,studies,0,0
240648,have,0,0
240649,indicated,0,0
240650,that,0,0
240651,low-dose,1,1
240652,radiation,1,1
240653,therapy,1,1
240654,might,0,0
240655,have,0,0
240656,a,0,0
240657,beneficial,0,0
240658,effect,0,0
240659,on,0,0
240660,the,0,0
240661,course,0,0
240662,of,0,0
240663,choroidal,0,0
240664,neovascularization,0,0
240665,(,0,0
240666,CNV,0,1
240667,),0,0
240668,in,0,0
240669,age-related,0,0
240670,macular,0,0
240671,degeneration,0,0
240672,(,0,0
240673,AMD,0,0
240674,),0,0
240675,.,0,0
240676,This,0,0
240677,study,0,0
240678,aimed,0,0
240679,to,0,0
240680,ascertain,0,0
240681,whether,0,0
240682,such,0,0
240683,treatment,0,0
240684,might,0,0
240685,halt,0,0
240686,the,0,0
240687,progression,0,0
240688,of,0,0
240689,neovascular,0,0
240690,AMD,0,0
240691,and,0,0
240692,whether,0,0
240693,a,0,0
240694,low,0,0
240695,or,0,0
240696,a,0,0
240697,high,0,0
240698,radiation,0,1
240699,dose,0,0
240700,should,0,0
240701,be,0,0
240702,applied,0,0
240703,.,0,0
240704,PATIENTS,0,0
240705,The,0,0
240706,patients,0,0
240707,comprised,0,0
240708,some,0,0
240709,randomized,0,0
240710,to,0,0
240711,0,1,0
240712,vs,1,0
240713,10,1,0
240714,vs,1,0
240715,36,1,0
240716,Gy,1,1
240717,of,1,0
240718,radiation,1,1
240719,and,0,0
240720,(,0,0
240721,after,0,0
240722,a,0,0
240723,change,0,0
240724,of,0,0
240725,the,0,0
240726,study,0,0
240727,protocol,0,0
240728,became,0,0
240729,necessary,0,0
240730,),0,0
240731,others,0,0
240732,who,0,0
240733,participated,0,0
240734,in,0,0
240735,a,0,0
240736,prospective,0,0
240737,",",0,0
240738,controlled,0,0
240739,non-randomized,0,0
240740,pilot,0,0
240741,study,0,0
240742,.,0,0
240743,Enclosed,0,1
240744,were,0,0
240745,eyes,0,0
240746,with,0,0
240747,visual,0,0
240748,acuity,0,0
240749,of,0,0
240750,>,0,0
240751,or,0,0
240752,=,0,0
240753,0.1,0,0
240754,and,0,0
240755,<,0,0
240756,or,0,1
240757,=,0,0
240758,0.6,0,0
240759,revealing,0,0
240760,a,0,0
240761,juxta-subfoveal,0,0
240762,CNV,0,1
240763,either,0,0
240764,of,0,0
240765,the,0,0
240766,occult,0,0
240767,type,0,0
240768,(,0,0
240769,type,0,0
240770,1,0,0
240771,),0,0
240772,or,0,0
240773,the,0,0
240774,classic,0,0
240775,type,0,0
240776,(,0,0
240777,isolated,0,0
240778,or,0,1
240779,as,0,0
240780,part,0,0
240781,of,0,0
240782,a,0,0
240783,predominantly,0,0
240784,occult,0,0
240785,lesion,0,0
240786,),0,0
240787,.,0,0
240788,RESULTS,0,0
240789,Eyes,0,0
240790,treated,0,0
240791,with,0,0
240792,10,1,0
240793,Gy,1,1
240794,for,0,0
240795,occult,0,0
240796,CNV,0,1
240797,(,0,0
240798,n,0,0
240799,=,0,0
240800,12,0,0
240801,),0,0
240802,were,0,0
240803,subject,0,0
240804,to,0,0
240805,severe,0,0
240806,visual,0,0
240807,loss,0,0
240808,in,0,0
240809,41.6,0,0
240810,%,0,0
240811,of,0,0
240812,the,0,0
240813,cases,0,0
240814,compared,0,0
240815,to,0,0
240816,38.5,0,0
240817,%,0,0
240818,in,0,0
240819,the,0,0
240820,control,0,1
240821,group,0,0
240822,(,0,0
240823,n,0,0
240824,=,0,0
240825,13,0,0
240826,),0,0
240827,at,0,0
240828,12,0,0
240829,months,0,0
240830,of,0,0
240831,follow-up,0,0
240832,.,0,0
240833,For,0,0
240834,eyes,0,0
240835,treated,0,0
240836,with,0,0
240837,10,1,0
240838,Gy,1,1
240839,because,0,0
240840,of,0,0
240841,classic,0,0
240842,CNV,0,1
240843,",",0,0
240844,the,0,0
240845,corresponding,0,0
240846,figures,0,0
240847,were,0,0
240848,33,0,0
240849,%,0,0
240850,(,0,0
240851,n,0,0
240852,=,0,0
240853,18,0,0
240854,),0,0
240855,and,0,0
240856,57,0,0
240857,%,0,0
240858,(,0,0
240859,n,0,0
240860,=,0,0
240861,14,0,0
240862,),0,0
240863,respectively,0,0
240864,.,0,0
240865,At,0,0
240866,18,0,0
240867,months,0,0
240868,of,0,0
240869,follow-up,0,0
240870,",",0,0
240871,the,0,0
240872,percentages,0,0
240873,were,0,0
240874,63,0,0
240875,%,0,0
240876,and,0,0
240877,75,0,0
240878,%,0,0
240879,respectively,0,0
240880,.,0,0
240881,Fluorescein,0,0
240882,angiographic,0,0
240883,growth,0,0
240884,of,0,0
240885,classic,0,0
240886,and,0,0
240887,occult,0,0
240888,CNV,0,1
240889,could,0,0
240890,not,0,0
240891,be,0,0
240892,halted,0,0
240893,by,0,0
240894,10,0,0
240895,Gy,0,1
240896,",",0,0
240897,while,0,0
240898,a,0,0
240899,temporary,0,0
240900,growth,0,0
240901,retardation,0,0
240902,was,0,0
240903,observed,0,0
240904,in,0,0
240905,cases,0,0
240906,irradiated,0,0
240907,with,0,0
240908,36,1,0
240909,Gy,1,1
240910,.,1,0
240911,CONCLUSION,0,0
240912,In,0,0
240913,the,0,0
240914,study,0,0
240915,presented,0,0
240916,",",0,0
240917,the,0,0
240918,natural,0,0
240919,course,0,0
240920,of,0,0
240921,occult,0,0
240922,CNV,0,1
240923,could,0,0
240924,not,0,0
240925,be,0,0
240926,improved,0,0
240927,by,0,0
240928,irradiation,0,1
240929,with,0,0
240930,10,1,0
240931,or,1,0
240932,36,1,0
240933,Gy,1,1
240934,.,1,0
240935,In,0,0
240936,cases,0,0
240937,of,0,0
240938,classic,0,0
240939,CNV,0,1
240940,",",0,0
240941,low-dose,0,1
240942,irradiation,0,1
240943,with,0,0
240944,10,1,0
240945,Gy,1,1
240946,postponed,0,0
240947,severe,0,0
240948,visual,0,0
240949,loss,0,0
240950,by,0,0
240951,a,0,0
240952,maximum,0,0
240953,of,0,0
240954,18,0,0
240955,months,0,0
240956,.,0,0
240957,A,0,0
240958,positive,0,0
240959,treatment,0,0
240960,effect,0,0
240961,was,0,0
240962,also,0,0
240963,observed,0,0
240964,in,0,0
240965,cases,0,0
240966,irradiated,0,0
240967,with,0,0
240968,36,1,0
240969,Gy,1,1
240970,;,1,0
240971,however,0,0
240972,",",0,0
240973,a,0,0
240974,25,0,0
240975,%,0,0
240976,incidence,0,0
240977,of,0,0
240978,radiation,0,1
240979,retinopathy,0,0
240980,seems,0,0
240981,unacceptable,0,0
240982,.,0,0
240983,Ten-year,0,0
240984,results,0,0
240985,of,0,0
240986,a,0,0
240987,randomised,0,0
240988,trial,0,0
240989,comparing,0,0
240990,cisplatin,1,1
240991,with,1,0
240992,cisplatin,1,1
240993,and,1,0
240994,cyclophosphamide,1,1
240995,in,0,0
240996,advanced,0,0
240997,",",0,0
240998,suboptimally,0,0
240999,debulked,0,0
241000,ovarian,0,0
241001,cancer,0,0
241002,.,0,0
241003,176,0,0
241004,eligible,0,0
241005,patients,0,0
241006,with,0,0
241007,advanced,0,0
241008,suboptimally,0,0
241009,operated,0,0
241010,ovarian,0,0
241011,carcinoma,0,0
241012,were,0,0
241013,randomly,0,0
241014,allocated,0,0
241015,to,0,0
241016,receive,0,0
241017,either,0,0
241018,cisplatin,1,1
241019,75,1,0
241020,mg/m2,1,1
241021,or,1,1
241022,cisplatin,1,1
241023,50,1,1
241024,mg/m2,1,1
241025,and,1,0
241026,cyclophosphamide,1,1
241027,500,1,0
241028,mg/m2,1,1
241029,(,0,0
241030,CP,0,1
241031,),0,0
241032,every,0,0
241033,28,0,0
241034,days,0,0
241035,for,0,0
241036,six,0,0
241037,courses,0,0
241038,.,0,0
241039,The,0,0
241040,overall,0,0
241041,clinical,0,0
241042,response,0,0
241043,rates,0,0
241044,(,0,0
241045,complete,0,0
241046,response,0,0
241047,plus,0,1
241048,partial,0,0
241049,response,0,0
241050,),0,0
241051,were,0,0
241052,52,0,0
241053,and,0,0
241054,63,0,0
241055,%,0,0
241056,for,0,0
241057,CP,1,1
241058,and,1,0
241059,cisplatin,1,1
241060,",",0,0
241061,respectively,0,0
241062,(,0,0
241063,non-significant,0,0
241064,),0,0
241065,.,0,0
241066,Including,0,0
241067,results,0,0
241068,obtained,0,0
241069,by,0,0
241070,second-look,0,0
241071,laparotomy,0,1
241072,",",0,0
241073,we,0,0
241074,did,0,0
241075,not,0,0
241076,observe,0,0
241077,a,0,0
241078,statistically,0,0
241079,significant,0,0
241080,difference,0,0
241081,in,0,0
241082,response,0,0
241083,rates,0,0
241084,in,0,0
241085,the,0,0
241086,two,0,0
241087,treatment,0,0
241088,groups,0,0
241089,.,0,0
241090,Median,0,0
241091,progression-free,0,0
241092,survival,0,0
241093,was,0,0
241094,10,0,0
241095,and,0,0
241096,11.9,0,0
241097,months,0,0
241098,for,0,0
241099,CP,1,1
241100,and,1,0
241101,cisplatin,1,1
241102,",",0,0
241103,respectively,0,0
241104,(,0,0
241105,non-significant,0,0
241106,),0,0
241107,.,0,0
241108,No,0,0
241109,significant,0,0
241110,difference,0,0
241111,was,0,0
241112,observed,0,0
241113,in,0,0
241114,overall,0,0
241115,survival,0,0
241116,",",0,0
241117,with,0,0
241118,a,0,0
241119,median,0,0
241120,of,0,0
241121,19.4,0,0
241122,and,0,0
241123,21.5,0,0
241124,months,0,0
241125,for,0,0
241126,CP,1,1
241127,and,1,0
241128,cisplatin,1,1
241129,",",0,0
241130,respectively,0,0
241131,.,0,0
241132,Thirty-seven,0,0
241133,platinum-resistant,0,0
241134,and,0,0
241135,27,0,0
241136,platinum-sensitive,0,0
241137,tumours,0,0
241138,were,0,0
241139,treated,0,0
241140,with,0,0
241141,carboplatin,1,1
241142,or,1,1
241143,cisplatin,1,1
241144,as,0,0
241145,second-line,0,0
241146,therapy,0,1
241147,.,0,0
241148,Response,0,0
241149,rates,0,0
241150,to,0,0
241151,platinum,0,1
241152,second-line,0,1
241153,therapy,0,1
241154,were,0,0
241155,6,0,0
241156,and,0,0
241157,50,0,0
241158,%,0,0
241159,for,0,0
241160,resistant,0,0
241161,and,0,0
241162,sensitive,0,0
241163,tumours,0,0
241164,",",0,0
241165,respectively,0,0
241166,(,0,0
241167,P,0,0
241168,<,0,0
241169,0.001,0,0
241170,),0,0
241171,.,0,0
241172,This,0,0
241173,difference,0,0
241174,in,0,0
241175,response,0,0
241176,rate,0,0
241177,was,0,0
241178,also,0,0
241179,confirmed,0,0
241180,by,0,0
241181,survival,0,0
241182,analysis,0,0
241183,.,0,0
241184,Patients,0,0
241185,with,0,0
241186,platinum-sensitive,0,0
241187,tumours,0,0
241188,survived,0,0
241189,longer,0,0
241190,when,0,0
241191,they,0,0
241192,were,0,0
241193,treated,0,0
241194,with,0,0
241195,platinum-containing,1,1
241196,chemotherapy,1,1
241197,(,0,0
241198,P,0,0
241199,=,0,0
241200,0.005,0,0
241201,),0,0
241202,.,0,0
241203,Median,0,0
241204,survival,0,0
241205,was,0,0
241206,22.8,0,0
241207,and,0,0
241208,8.5,0,0
241209,months,0,0
241210,after,0,0
241211,initiation,0,0
241212,of,0,0
241213,second-line,0,0
241214,treatment,0,0
241215,for,0,0
241216,the,0,0
241217,platinum-containing,1,1
241218,and,0,0
241219,platinum-free,1,1
241220,regimens,0,0
241221,",",0,0
241222,respectively,0,0
241223,.,0,0
241224,In,0,0
241225,summary,0,0
241226,",",0,0
241227,we,0,0
241228,observed,0,0
241229,in,0,0
241230,suboptimally,0,0
241231,operated,0,0
241232,ovarian,0,0
241233,carcinoma,0,0
241234,patients,0,0
241235,similar,0,0
241236,response,0,0
241237,rates,0,0
241238,",",0,0
241239,progression-free,0,0
241240,interval,0,0
241241,",",0,0
241242,and,0,0
241243,overall,0,0
241244,survival,0,0
241245,for,0,0
241246,equitoxic,0,1
241247,cisplatin,1,1
241248,and,1,0
241249,CP,1,1
241250,.,1,0
241251,However,0,0
241252,",",0,0
241253,the,0,0
241254,doses,0,0
241255,of,0,0
241256,cisplatin,1,1
241257,and,1,0
241258,cyclophosphamide,1,1
241259,chosen,0,0
241260,were,0,0
241261,substantially,0,0
241262,lower,0,0
241263,than,0,0
241264,current,0,0
241265,standard,0,1
241266,doses,0,0
241267,of,0,0
241268,CP,1,1
241269,.,1,0
241270,Our,0,0
241271,study,0,0
241272,demonstrates,0,0
241273,",",0,0
241274,therefore,0,0
241275,",",0,0
241276,that,0,0
241277,a,0,0
241278,suboptimal,0,0
241279,dose,0,0
241280,of,0,0
241281,CP,1,1
241282,is,0,0
241283,as,0,0
241284,effective,0,0
241285,as,0,0
241286,optimal,0,0
241287,dose,0,0
241288,monotherapy,0,1
241289,cisplatin,1,1
241290,.,1,0
241291,Patients,0,0
241292,with,0,0
241293,recurrences,0,0
241294,considered,0,0
241295,as,0,0
241296,platinum-sensitive,0,0
241297,had,0,0
241298,a,0,0
241299,significantly,0,0
241300,higher,0,0
241301,response,0,0
241302,rate,0,0
241303,and,0,0
241304,improved,0,0
241305,survival,0,0
241306,when,0,0
241307,retreated,0,0
241308,with,0,0
241309,platinum-containing,1,1
241310,therapy,1,1
241311,.,1,0
241312,Comparative,0,0
241313,efficacy,0,0
241314,and,0,0
241315,safety,0,0
241316,of,0,0
241317,calcium,1,1
241318,carbasalate,1,1
241319,plus,1,1
241320,metoclopramide,1,1
241321,versus,1,1
241322,ergotamine,1,1
241323,tartrate,1,1
241324,plus,1,1
241325,caffeine,1,1
241326,in,0,0
241327,the,0,0
241328,treatment,0,0
241329,of,0,0
241330,acute,0,0
241331,migraine,0,0
241332,attacks,0,0
241333,.,0,0
241334,This,0,0
241335,randomized,0,0
241336,",",0,0
241337,double-blind,0,0
241338,",",0,0
241339,double-dummy,0,0
241340,",",0,0
241341,multicenter,0,0
241342,",",0,0
241343,parallel-group,0,0
241344,study,0,0
241345,aimed,0,0
241346,at,0,0
241347,comparing,0,0
241348,the,0,0
241349,efficacy,0,0
241350,and,0,0
241351,safety,0,0
241352,of,0,0
241353,calcium,1,1
241354,carbasalate,1,1
241355,(,1,0
241356,equivalent,1,0
241357,to,1,0
241358,900,1,1
241359,mg,1,1
241360,aspirin,1,1
241361,),1,0
241362,plus,1,1
241363,metoclopramide,1,1
241364,10,1,0
241365,mg,1,1
241366,(,1,0
241367,CM,1,0
241368,),1,0
241369,with,1,0
241370,ergotamine,1,1
241371,tartrate,1,1
241372,1,1,0
241373,mg,1,1
241374,plus,1,1
241375,caffeine,1,1
241376,100,1,1
241377,mg,1,1
241378,(,1,0
241379,EC,1,1
241380,),1,0
241381,administered,0,0
241382,in,0,0
241383,the,0,0
241384,treatment,0,0
241385,of,0,0
241386,2,0,0
241387,acute,0,0
241388,migraine,0,0
241389,attacks,0,0
241390,.,0,0
241391,A,0,0
241392,total,0,0
241393,of,0,0
241394,296,0,0
241395,patients,0,0
241396,fulfilling,0,0
241397,the,0,0
241398,International,0,0
241399,Headache,0,0
241400,Society,0,0
241401,diagnostic,0,0
241402,criteria,0,0
241403,for,0,0
241404,migraine,0,0
241405,were,0,0
241406,enrolled,0,0
241407,.,0,0
241408,In,0,0
241409,total,0,0
241410,",",0,0
241411,one,0,0
241412,or,0,0
241413,two,0,0
241414,migraine,0,0
241415,attacks,0,0
241416,were,0,0
241417,treated,0,0
241418,in,0,0
241419,268,0,0
241420,and,0,0
241421,235,0,0
241422,patients,0,0
241423,",",0,0
241424,respectively,0,0
241425,.,0,0
241426,The,0,0
241427,primary,0,0
241428,endpoint,0,0
241429,for,0,0
241430,the,0,0
241431,first,0,0
241432,treated,0,0
241433,attack,0,0
241434,was,0,0
241435,headache,0,0
241436,relief,0,0
241437,",",0,0
241438,with,0,0
241439,intensity,0,0
241440,decreasing,0,0
241441,from,0,0
241442,moderate,0,0
241443,or,0,0
241444,severe,0,0
241445,to,0,0
241446,mild,0,0
241447,or,0,0
241448,absent,0,0
241449,2,0,0
241450,h,0,0
241451,after,0,0
241452,drug,0,0
241453,intake,0,0
241454,.,0,0
241455,Usual,0,0
241456,secondary,0,0
241457,efficacy,0,0
241458,endpoints,0,0
241459,were,0,0
241460,assessed,0,0
241461,.,0,0
241462,A,0,0
241463,superiority,0,0
241464,of,0,0
241465,CM,1,0
241466,over,0,0
241467,EC,1,1
241468,was,0,0
241469,observed,0,0
241470,for,0,0
241471,both,0,0
241472,treated,0,0
241473,attacks,0,0
241474,for,0,0
241475,the,0,0
241476,main,0,0
241477,endpoint,0,0
241478,:,0,0
241479,success,0,0
241480,in,0,0
241481,54,0,0
241482,versus,0,0
241483,36,0,0
241484,%,0,0
241485,",",0,0
241486,p,0,0
241487,=,0,0
241488,0.003,0,0
241489,for,0,0
241490,the,0,0
241491,first,0,0
241492,attack,0,0
241493,and,0,0
241494,60,0,0
241495,versus,0,0
241496,44,0,0
241497,%,0,0
241498,",",0,0
241499,p,0,0
241500,=,0,0
241501,0.02,0,0
241502,for,0,0
241503,the,0,0
241504,second,0,0
241505,attack,0,0
241506,.,0,0
241507,CM,1,0
241508,was,0,0
241509,also,0,0
241510,significantly,0,0
241511,superior,0,0
241512,to,0,0
241513,EC,1,1
241514,during,0,0
241515,the,0,0
241516,first,0,0
241517,attack,0,0
241518,for,0,0
241519,complete,0,0
241520,headache,0,0
241521,relief,0,0
241522,(,0,0
241523,20,0,0
241524,vs.,0,0
241525,8,0,0
241526,%,0,0
241527,",",0,0
241528,p,0,0
241529,=,0,0
241530,0.006,0,0
241531,),0,0
241532,",",0,0
241533,nausea,0,0
241534,(,0,0
241535,42,0,0
241536,vs.,0,0
241537,63,0,0
241538,%,0,0
241539,",",0,0
241540,p,0,0
241541,=,0,0
241542,0,0,0
241543,.,0,0
241544,007,0,0
241545,),0,0
241546,and,0,0
241547,willingness,0,0
241548,to,0,0
241549,take,0,0
241550,the,0,0
241551,drug,0,0
241552,again,0,0
241553,(,0,0
241554,90,0,0
241555,vs.,0,0
241556,80,0,0
241557,%,0,0
241558,",",0,0
241559,p,0,0
241560,=,0,0
241561,0.043,0,0
241562,),0,0
241563,.,0,0
241564,The,0,0
241565,global,0,0
241566,efficacy,0,0
241567,evaluation,0,0
241568,",",0,0
241569,rated,0,0
241570,by,0,0
241571,the,0,0
241572,investigators,0,0
241573,",",0,0
241574,was,0,0
241575,significantly,0,0
241576,more,0,0
241577,favorable,0,0
241578,to,0,0
241579,CM,1,0
241580,for,0,0
241581,both,0,0
241582,attacks,0,0
241583,(,0,0
241584,p,0,0
241585,=,0,0
241586,0.001,0,0
241587,for,0,0
241588,the,0,0
241589,first,0,0
241590,attack,0,0
241591,and,0,0
241592,p,0,0
241593,=,0,0
241594,0.02,0,0
241595,for,0,0
241596,the,0,0
241597,second,0,0
241598,),0,0
241599,.,0,0
241600,The,0,0
241601,patients,0,0
241602,',0,0
241603,evaluation,0,0
241604,was,0,0
241605,significant,0,0
241606,for,0,0
241607,the,0,0
241608,first,0,0
241609,attack,0,0
241610,(,0,0
241611,p,0,0
241612,=,0,0
241613,0.002,0,0
241614,),0,0
241615,.,0,0
241616,The,0,0
241617,global,0,0
241618,incidence,0,0
241619,of,0,0
241620,adverse,0,0
241621,events,0,0
241622,was,0,0
241623,45,0,0
241624,%,0,0
241625,higher,0,0
241626,with,0,0
241627,EC,1,0
241628,",",0,0
241629,though,0,0
241630,not,0,0
241631,significant,0,0
241632,(,0,0
241633,32,0,0
241634,vs.,0,0
241635,22,0,0
241636,%,0,0
241637,",",0,0
241638,p,0,0
241639,=,0,0
241640,0.075,0,0
241641,),0,0
241642,.,0,0
241643,They,0,0
241644,were,0,0
241645,most,0,0
241646,often,0,0
241647,unspecific,0,0
241648,and,0,0
241649,mild,0,0
241650,to,0,0
241651,moderate,0,0
241652,in,0,0
241653,intensity,0,0
241654,.,0,0
241655,Gastrointestinal,0,0
241656,side,0,0
241657,effects,0,0
241658,were,0,0
241659,significantly,0,0
241660,less,0,0
241661,frequent,0,0
241662,with,0,0
241663,CM,1,0
241664,than,0,0
241665,EC,0,1
241666,(,0,0
241667,7,0,0
241668,vs.,0,0
241669,21,0,0
241670,%,0,0
241671,",",0,0
241672,p,0,0
241673,=,0,0
241674,0.001,0,0
241675,),0,0
241676,.,0,0
241677,Thus,0,0
241678,",",0,0
241679,CM,1,0
241680,is,0,0
241681,more,0,0
241682,effective,0,0
241683,and,0,0
241684,has,0,0
241685,a,0,0
241686,better,0,0
241687,gastrointestinal,0,0
241688,safety,0,0
241689,than,0,0
241690,EC,1,1
241691,in,0,0
241692,the,0,0
241693,acute,0,0
241694,treatment,0,0
241695,of,0,0
241696,migraine,0,0
241697,attacks,0,0
241698,.,0,0
241699,A,0,0
241700,placebo-controlled,1,1
241701,trial,0,0
241702,of,0,0
241703,D-cycloserine,1,1
241704,added,0,0
241705,to,0,0
241706,conventional,0,1
241707,neuroleptics,0,1
241708,in,0,0
241709,patients,0,0
241710,with,0,0
241711,schizophrenia,0,0
241712,.,0,0
241713,BACKGROUND,0,0
241714,In,0,0
241715,a,0,0
241716,preliminary,0,0
241717,dose-finding,0,0
241718,study,0,0
241719,",",0,0
241720,D-cycloserine,1,1
241721,",",0,0
241722,a,0,0
241723,partial,0,0
241724,agonist,0,1
241725,at,0,0
241726,the,0,0
241727,glycine,0,0
241728,modulatory,0,0
241729,site,0,0
241730,of,0,0
241731,the,0,0
241732,glutamatergic,0,0
241733,N-methyl-D-aspartate,0,1
241734,(,0,0
241735,NMDA,0,0
241736,),0,0
241737,receptor,0,0
241738,",",0,0
241739,improved,0,0
241740,negative,0,0
241741,symptoms,0,0
241742,and,0,0
241743,cognitive,0,0
241744,function,0,0
241745,when,0,0
241746,added,0,0
241747,to,0,0
241748,conventional,0,1
241749,neuroleptics,0,1
241750,at,0,0
241751,a,0,0
241752,dose,0,0
241753,of,0,0
241754,50,0,0
241755,mg/d,0,0
241756,.,0,0
241757,METHODS,0,0
241758,Forty-seven,0,0
241759,patients,0,0
241760,with,0,0
241761,schizophrenia,0,0
241762,meeting,0,0
241763,criteria,0,0
241764,for,0,0
241765,deficit,0,0
241766,syndrome,0,0
241767,were,0,0
241768,randomized,0,0
241769,to,0,0
241770,D-cycloserine,1,1
241771,",",0,0
241772,50,0,0
241773,mg/d,0,0
241774,(,0,0
241775,n=23,0,0
241776,),0,1
241777,or,0,1
241778,placebo,1,1
241779,(,0,0
241780,n=24,0,0
241781,),0,0
241782,added,0,0
241783,to,0,0
241784,their,0,0
241785,conventional,0,1
241786,neuroleptic,0,0
241787,for,0,0
241788,an,0,0
241789,8-week,0,0
241790,",",0,0
241791,double-blind,0,0
241792,trial,0,0
241793,.,0,0
241794,Clinical,0,0
241795,assessments,0,0
241796,were,0,0
241797,performed,0,0
241798,at,0,0
241799,baseline,0,0
241800,and,0,0
241801,at,0,0
241802,weeks,0,0
241803,1,0,0
241804,",",0,0
241805,2,0,0
241806,",",0,0
241807,4,0,0
241808,",",0,0
241809,6,0,0
241810,",",0,0
241811,and,0,0
241812,8,0,0
241813,.,0,0
241814,Serum,0,0
241815,concentrations,0,0
241816,of,0,0
241817,D-cycloserine,1,1
241818,",",0,0
241819,relevant,0,0
241820,amino,0,1
241821,acids,0,1
241822,",",0,0
241823,and,0,0
241824,homovanillic,0,0
241825,acid,0,1
241826,were,0,0
241827,assayed,0,0
241828,at,0,0
241829,baseline,0,0
241830,and,0,0
241831,at,0,0
241832,weeks,0,0
241833,4,0,0
241834,and,0,0
241835,8,0,0
241836,.,0,0
241837,A,0,0
241838,cognitive,0,0
241839,battery,0,1
241840,was,0,0
241841,performed,0,0
241842,at,0,0
241843,baseline,0,0
241844,and,0,0
241845,at,0,0
241846,week,0,0
241847,8,0,0
241848,.,0,0
241849,RESULTS,0,0
241850,Thirty-nine,0,0
241851,patients,0,0
241852,completed,0,0
241853,the,0,0
241854,8-week,0,0
241855,trial,0,0
241856,.,0,0
241857,Seven,0,0
241858,dropouts,0,0
241859,occurred,0,0
241860,in,0,0
241861,the,0,0
241862,D-cycloserine,1,1
241863,group,0,0
241864,and,0,0
241865,1,0,0
241866,in,0,0
241867,the,0,0
241868,placebo,1,1
241869,group,0,0
241870,.,0,0
241871,The,0,0
241872,mean,0,0
241873,reduction,0,0
241874,in,0,0
241875,negative,0,0
241876,symptoms,0,0
241877,with,0,0
241878,D-cycloserine,1,1
241879,(,0,0
241880,23,0,0
241881,%,0,0
241882,),0,0
241883,was,0,0
241884,significantly,0,0
241885,greater,0,0
241886,than,0,0
241887,with,0,0
241888,placebo,1,1
241889,(,0,0
241890,7,0,0
241891,%,0,0
241892,),0,0
241893,as,0,0
241894,calculated,0,0
241895,by,0,0
241896,slopes,0,0
241897,representing,0,0
241898,Scale,0,0
241899,for,0,0
241900,the,0,0
241901,Assessment,0,0
241902,of,0,0
241903,Negative,0,0
241904,Symptoms,0,0
241905,(,0,0
241906,SANS,0,1
241907,),0,0
241908,total,0,0
241909,scores,0,0
241910,.,0,0
241911,Improvement,0,0
241912,of,0,0
241913,negative,0,0
241914,symptoms,0,0
241915,was,0,0
241916,predicted,0,0
241917,by,0,0
241918,low,0,0
241919,neuroleptic,0,1
241920,dose,0,0
241921,and,0,0
241922,low,0,0
241923,baseline,0,0
241924,SANS,0,1
241925,total,0,0
241926,score,0,0
241927,.,0,0
241928,No,0,0
241929,differences,0,0
241930,were,0,0
241931,found,0,0
241932,in,0,0
241933,performance,0,0
241934,on,0,0
241935,any,0,0
241936,cognitive,0,0
241937,test,0,0
241938,between,0,0
241939,groups,0,0
241940,or,0,0
241941,in,0,0
241942,changes,0,0
241943,in,0,0
241944,any,0,0
241945,other,0,0
241946,clinical,0,0
241947,measure,0,0
241948,.,0,0
241949,Clinical,0,0
241950,response,0,0
241951,did,0,0
241952,not,0,0
241953,correlate,0,0
241954,significantly,0,0
241955,with,0,0
241956,serum,0,0
241957,amino,0,1
241958,acid,0,1
241959,concentrations,0,0
241960,at,0,0
241961,baseline,0,0
241962,or,0,0
241963,with,0,0
241964,concentrations,0,0
241965,of,0,0
241966,D-cycloserine,1,1
241967,at,0,0
241968,weeks,0,0
241969,4,0,0
241970,and,0,0
241971,8,0,0
241972,.,0,0
241973,CONCLUSION,0,0
241974,These,0,0
241975,results,0,0
241976,support,0,0
241977,the,0,0
241978,hypothesis,0,0
241979,that,0,0
241980,agents,0,0
241981,acting,0,0
241982,at,0,0
241983,the,0,0
241984,glycine,0,0
241985,modulatory,0,0
241986,site,0,0
241987,of,0,0
241988,the,0,0
241989,NMDA,0,0
241990,receptor,0,0
241991,improve,0,0
241992,primary,0,0
241993,negative,0,0
241994,symptoms,0,0
241995,.,0,0
241996,[,0,0
241997,Effect,0,0
241998,of,0,0
241999,alanyl-glutamine,1,1
242000,in,0,0
242001,postoperative,0,0
242002,total,0,0
242003,parenteral,0,1
242004,nutrition,0,1
242005,on,0,0
242006,postoperative,0,0
242007,immunosuppression,0,1
242008,and,0,0
242009,morbidity,0,0
242010,.,0,0
242011,Preliminary,0,0
242012,results,0,0
242013,of,0,0
242014,a,0,0
242015,prospective,0,0
242016,randomized,0,0
242017,study,0,0
242018,],0,0
242019,.,0,0
242020,The,0,0
242021,impact,0,0
242022,of,0,0
242023,glutamine,1,1
242024,substitution,1,0
242025,on,0,0
242026,postoperative,0,0
242027,immunosuppression,0,1
242028,and,0,0
242029,morbidity,0,0
242030,was,0,0
242031,investigated,0,0
242032,in,0,0
242033,patients,0,0
242034,with,0,0
242035,surgical,0,0
242036,interventions,0,0
242037,and,0,0
242038,total,0,0
242039,parenteral,0,1
242040,nutrition,0,1
242041,in,0,0
242042,a,0,0
242043,prospective,0,0
242044,randomized,0,0
242045,trial,0,0
242046,.,0,0
242047,To,0,0
242048,analyze,0,0
242049,immune,0,0
242050,competence,0,0
242051,",",0,0
242052,the,0,0
242053,expression,0,0
242054,of,0,0
242055,CD3,0,1
242056,",",0,0
242057,CD4,0,0
242058,",",0,0
242059,and,0,0
242060,CD8,0,0
242061,on,0,0
242062,lymphocytes,0,0
242063,and,0,0
242064,of,0,0
242065,HLA-DR,0,0
242066,and,0,0
242067,CD14,0,1
242068,on,0,0
242069,monocytes,0,0
242070,as,0,0
242071,well,0,0
242072,as,0,0
242073,the,0,0
242074,plasma,0,0
242075,levels,0,0
242076,of,0,0
242077,IL-6,0,0
242078,and,0,0
242079,IL-10,0,0
242080,was,0,0
242081,evaluated,0,0
242082,before,0,0
242083,",",0,0
242084,1,0,0
242085,",",0,0
242086,2,0,0
242087,",",0,0
242088,4,0,0
242089,",",0,0
242090,and,0,0
242091,7,0,0
242092,days,0,0
242093,after,0,0
242094,surgery,0,0
242095,.,0,0
242096,A,0,0
242097,total,0,0
242098,of,0,0
242099,34,0,0
242100,patients,0,0
242101,have,0,0
242102,been,0,0
242103,included,0,0
242104,(,1,0
242105,with,1,0
242106,glutamine,1,1
242107,:,1,0
242108,n,1,0
242109,=,1,0
242110,18,1,0
242111,;,1,0
242112,without,1,0
242113,glutamine,1,1
242114,:,1,0
242115,n,0,0
242116,=,0,0
242117,16,0,0
242118,),0,0
242119,.,0,0
242120,Patients,0,0
242121,with,0,0
242122,glutamine,1,1
242123,substitution,1,0
242124,showed,0,0
242125,decreased,0,0
242126,systemic,0,0
242127,inflammation,0,0
242128,",",0,0
242129,significant,0,0
242130,faster,0,0
242131,compensation,0,0
242132,for,0,0
242133,postoperative,0,0
242134,immunosuppression,0,1
242135,and,0,0
242136,a,0,0
242137,lower,0,0
242138,incidence,0,0
242139,of,0,0
242140,postoperative,0,0
242141,complications,0,0
242142,.,0,0
242143,Patients,0,0
242144,without,0,0
242145,postoperative,0,0
242146,complications,0,0
242147,showed,0,0
242148,no,0,0
242149,significant,0,0
242150,differences,0,0
242151,in,0,0
242152,postoperative,0,0
242153,immunosuppression,0,1
242154,.,0,0
242155,[,1,0
242156,Intra-arterial,1,1
242157,(,1,0
242158,5-FU/FA,1,0
242159,and,1,0
242160,FUDR,1,0
242161,),1,0
242162,versus,1,0
242163,systemic,1,0
242164,chemotherapy,1,1
242165,(,1,0
242166,5-FU/FA,1,0
242167,),1,0
242168,of,0,0
242169,non-resectable,0,0
242170,colorectal,0,0
242171,liver,0,0
242172,metastases,0,0
242173,],0,0
242174,.,0,0
242175,The,0,0
242176,relative,0,0
242177,efficacy,0,0
242178,of,0,0
242179,HAI,1,0
242180,FUDR,1,0
242181,",",1,0
242182,HAI,1,0
242183,5-FU/FA,1,0
242184,",",1,0
242185,and,1,0
242186,i.v,1,1
242187,.,1,0
242188,5-FU/FA,1,0
242189,chemotherapy,1,1
242190,for,0,0
242191,the,0,0
242192,treatment,0,0
242193,of,0,0
242194,unresectable,0,0
242195,colorectal,0,0
242196,liver,0,0
242197,metastases,0,0
242198,was,0,0
242199,compared,0,0
242200,in,0,0
242201,a,0,0
242202,prospective,0,0
242203,randomized,0,0
242204,clinical,0,0
242205,trial,0,0
242206,.,0,0
242207,The,0,0
242208,response,0,0
242209,rate,0,0
242210,after,0,0
242211,HAI,1,0
242212,treatment,0,0
242213,was,0,0
242214,significantly,0,0
242215,higher,0,0
242216,as,0,0
242217,compared,0,0
242218,to,0,0
242219,i.v,0,0
242220,.,0,0
242221,treatment,0,0
242222,with,0,0
242223,no,0,0
242224,statistical,0,0
242225,benefit,0,0
242226,regarding,0,0
242227,survival,0,0
242228,and,0,0
242229,time,0,0
242230,to,0,0
242231,progression,0,0
242232,.,0,0
242233,HAI,1,0
242234,FUDR,1,0
242235,treatment,0,0
242236,was,0,0
242237,inferior,0,0
242238,as,0,0
242239,compared,0,0
242240,to,0,0
242241,HAI,1,0
242242,or,0,1
242243,i.v,0,1
242244,.,0,0
242245,5-FU/FA,1,0
242246,.,1,0
242247,i.v,0,0
242248,.,0,0
242249,5-FU/FA-therapy,1,0
242250,is,0,0
242251,therefore,0,0
242252,the,0,0
242253,method,0,0
242254,of,0,0
242255,choice,0,0
242256,outside,0,0
242257,clinical,0,0
242258,trials,0,0
242259,.,0,0
242260,Erythropoiesis,0,0
242261,after,0,0
242262,therapy,0,1
242263,with,0,0
242264,recombinant,1,1
242265,human,1,0
242266,erythropoietin,1,1
242267,:,1,0
242268,a,0,0
242269,dose-response,0,0
242270,study,0,0
242271,in,0,0
242272,anemic,0,0
242273,cancer,0,0
242274,surgery,0,0
242275,patients,0,0
242276,.,0,0
242277,BACKGROUND,0,0
242278,AND,0,0
242279,OBJECTIVES,0,1
242280,Preoperative,0,1
242281,treatment,0,0
242282,with,0,0
242283,600,0,0
242284,U/kg,0,0
242285,of,0,0
242286,recombinant,1,1
242287,human,1,1
242288,erythropoietin,1,1
242289,(,1,0
242290,r-HuEPO,1,0
242291,),1,0
242292,effectively,0,0
242293,increases,0,0
242294,erythropoiesis,0,0
242295,in,0,0
242296,cancer,0,0
242297,patients,0,0
242298,.,0,0
242299,The,0,0
242300,aim,0,0
242301,of,0,0
242302,this,0,0
242303,study,0,0
242304,was,0,0
242305,to,0,0
242306,evaluate,0,0
242307,the,0,0
242308,erythropoietic,0,0
242309,response,0,0
242310,after,0,0
242311,different,0,0
242312,doses,0,0
242313,of,0,0
242314,r-HuEPO,1,0
242315,in,0,0
242316,order,0,0
242317,to,0,0
242318,find,0,0
242319,the,0,0
242320,minimum,0,0
242321,effective,0,0
242322,dose,0,0
242323,.,0,0
242324,MATERIALS,0,0
242325,AND,0,0
242326,METHODS,0,0
242327,Twenty,0,1
242328,anemic,0,0
242329,sideropenic,0,0
242330,patients,0,0
242331,(,0,0
242332,hemoglobin,0,0
242333,<,0,0
242334,/=110,0,0
242335,g/l,0,0
242336,;,0,0
242337,serum,0,0
242338,iron,0,1
242339,<,0,0
242340,600,0,1
242341,microg/l,0,0
242342,),0,0
242343,with,0,0
242344,cancer,0,0
242345,of,0,0
242346,the,0,0
242347,gastrointestinal,0,0
242348,tract,0,0
242349,were,0,0
242350,randomly,0,0
242351,allocated,0,0
242352,to,0,0
242353,two,0,0
242354,groups,0,0
242355,:,0,0
242356,the,0,0
242357,first,0,0
242358,(,0,0
242359,n,0,0
242360,=,0,0
242361,10,0,0
242362,),0,0
242363,received,0,0
242364,400,1,0
242365,U/kg,1,0
242366,of,1,0
242367,r-Hu,1,0
242368,EPO,1,1
242369,divided,1,0
242370,in,1,0
242371,4,1,0
242372,doses,1,0
242373,(,0,0
242374,100,0,0
242375,U/kg,0,0
242376,each,0,0
242377,",",0,0
242378,every,0,0
242379,4,0,0
242380,days,0,0
242381,),0,0
242382,;,0,0
242383,the,0,0
242384,second,0,0
242385,(,0,0
242386,n,0,0
242387,=,0,0
242388,10,0,0
242389,),0,0
242390,received,1,0
242391,200,1,0
242392,U/kg,1,0
242393,of,1,0
242394,r-HuEPO,1,0
242395,(,0,0
242396,50,0,0
242397,U/kg,0,0
242398,each,0,0
242399,",",0,0
242400,every,0,0
242401,4,0,0
242402,days,0,0
242403,),0,0
242404,.,0,0
242405,Both,0,0
242406,groups,0,0
242407,were,0,0
242408,given,0,0
242409,intravenous,1,1
242410,iron,1,1
242411,gluconate,1,1
242412,(,0,0
242413,125,0,0
242414,mg,0,1
242415,),0,0
242416,every,0,1
242417,day,0,0
242418,for,0,0
242419,15,0,0
242420,days,0,0
242421,.,0,0
242422,RESULTS,0,0
242423,After,0,0
242424,treatment,0,0
242425,",",0,0
242426,the,0,0
242427,serum,0,0
242428,iron,0,1
242429,level,0,0
242430,significantly,0,0
242431,rose,0,0
242432,in,0,0
242433,both,0,0
242434,groups,0,0
242435,.,0,0
242436,The,0,0
242437,production,0,0
242438,of,0,0
242439,new,0,0
242440,red,0,1
242441,blood,0,0
242442,cells,0,0
242443,was,0,0
242444,176.3+/-90.8,0,0
242445,ml,0,0
242446,in,0,0
242447,the,0,0
242448,200,0,0
242449,U/kg,0,1
242450,group,0,0
242451,and,0,0
242452,268.4+/-79.4,0,0
242453,ml,0,1
242454,in,0,0
242455,the,0,0
242456,400,0,0
242457,U/kg,0,1
242458,group,0,0
242459,(,0,0
242460,p,0,0
242461,=,0,0
242462,0.036,0,0
242463,),0,0
242464,.,0,0
242465,The,0,0
242466,increase,0,0
242467,of,0,0
242468,hemoglobin,0,0
242469,was,0,0
242470,significantly,0,0
242471,higher,0,0
242472,in,0,0
242473,the,0,0
242474,400,0,0
242475,U/kg,0,1
242476,group,0,0
242477,(,0,0
242478,22.3+/-2.0,0,0
242479,g/l,0,0
242480,),0,0
242481,than,0,0
242482,in,0,0
242483,the,0,0
242484,200,0,0
242485,U/kg,0,1
242486,group,0,0
242487,(,0,0
242488,14.1+/-2.7,0,0
242489,g/l,0,0
242490,),0,1
242491,(,0,0
242492,p,0,0
242493,=,0,0
242494,0.017,0,0
242495,),0,0
242496,.,0,0
242497,CONCLUSION,0,0
242498,The,0,0
242499,r-HuEPO,0,0
242500,dose,0,0
242501,of,0,0
242502,400,0,0
242503,U/kg,0,0
242504,appears,0,0
242505,significantly,0,0
242506,more,0,0
242507,effective,0,0
242508,than,0,0
242509,the,0,0
242510,200,0,0
242511,U/kg,0,0
242512,to,0,0
242513,stimulate,0,0
242514,erythropoiesis,0,0
242515,in,0,0
242516,anemic,0,0
242517,sideropenic,0,0
242518,cancer,0,0
242519,patients,0,0
242520,.,0,0
242521,Adequacy,0,0
242522,of,0,0
242523,vitamin,1,1
242524,B6,1,1
242525,supplementation,1,1
242526,during,0,0
242527,pregnancy,0,0
242528,:,0,0
242529,a,0,0
242530,prospective,0,0
242531,study,0,0
242532,.,0,0
242533,This,0,0
242534,prospective,0,0
242535,study,0,0
242536,assesses,0,0
242537,the,0,0
242538,effect,0,0
242539,of,0,0
242540,2.5,1,0
242541,",",1,0
242542,4,1,0
242543,",",1,0
242544,and,1,0
242545,10,1,0
242546,mg,1,0
242547,of,1,0
242548,pyridoxine,1,1
242549,supplementation,1,1
242550,during,1,0
242551,pregnancy,1,0
242552,on,1,0
242553,maternal,1,0
242554,and,1,0
242555,fetal,1,0
242556,plasma,1,0
242557,levels,1,0
242558,of,0,0
242559,pyridoxal,0,1
242560,5'-phosphate,0,1
242561,(,0,0
242562,PLP,0,1
242563,),0,0
242564,and,0,0
242565,on,0,0
242566,the,0,0
242567,degree,0,0
242568,of,0,0
242569,coenzyme,0,1
242570,saturation,0,0
242571,(,0,0
242572,activation,0,0
242573,factor,0,0
242574,),0,0
242575,of,0,0
242576,aspartate,0,1
242577,aminotransferase,0,0
242578,and,0,0
242579,alanine,0,0
242580,aminotransferase,0,0
242581,(,0,0
242582,alphaEGOT,0,1
242583,and,0,0
242584,alphaEGPT,0,0
242585,),0,0
242586,in,0,0
242587,maternal,0,0
242588,erythrocytes,0,0
242589,.,0,0
242590,More,0,0
242591,than,0,0
242592,4,1,0
242593,mg,1,0
242594,of,1,0
242595,pyridoxine,1,1
242596,supplementation,1,1
242597,daily,1,0
242598,was,0,0
242599,required,0,0
242600,for,0,0
242601,most,0,0
242602,pregnancies,0,0
242603,to,0,0
242604,maintain,0,0
242605,maternal,0,0
242606,plasma,0,0
242607,PLP,0,1
242608,levels,0,0
242609,within,0,0
242610,the,0,0
242611,range,0,0
242612,observed,0,0
242613,during,0,0
242614,the,0,0
242615,first,0,0
242616,trimester,0,0
242617,and,0,0
242618,in,0,0
242619,the,0,0
242620,nonpregnant,0,0
242621,state,0,0
242622,.,0,0
242623,The,0,0
242624,plasma,0,0
242625,PLP,0,1
242626,concentrations,0,0
242627,in,0,0
242628,maternal,0,0
242629,and,0,0
242630,cord,0,0
242631,blood,0,0
242632,were,0,0
242633,highly,0,0
242634,correlated,0,0
242635,and,0,0
242636,indicated,0,0
242637,a,0,0
242638,dependence,0,0
242639,of,0,0
242640,fetal,0,0
242641,vitamin,0,1
242642,B6,0,1
242643,nutrition,0,1
242644,on,0,0
242645,maternal,0,0
242646,circulating,0,0
242647,PLP,0,1
242648,.,0,0
242649,Measurements,0,0
242650,of,0,0
242651,alphaEGOT,0,1
242652,and,0,0
242653,alphaEGPT,0,0
242654,were,0,0
242655,not,0,0
242656,as,0,0
242657,reproducible,0,0
242658,as,0,0
242659,plasma,0,0
242660,PLP,0,1
242661,assays,0,0
242662,and,0,0
242663,were,0,0
242664,less,0,0
242665,sensitive,0,0
242666,and,0,0
242667,quantitative,0,0
242668,indicators,0,0
242669,.,0,0
242670,In,0,0
242671,the,0,0
242672,majority,0,0
242673,of,0,0
242674,subjects,0,0
242675,",",0,0
242676,the,0,0
242677,changes,0,0
242678,in,0,0
242679,alphaEGOT,0,1
242680,and,0,0
242681,alphaEGPT,0,0
242682,with,0,0
242683,time,0,0
242684,correlated,0,0
242685,poorly,0,0
242686,with,0,0
242687,the,0,0
242688,changes,0,0
242689,in,0,0
242690,plasma,0,0
242691,PLP,0,1
242692,.,0,0
242693,However,0,0
242694,",",0,0
242695,when,0,0
242696,the,0,0
242697,data,0,0
242698,were,0,0
242699,analyzed,0,0
242700,without,0,0
242701,regard,0,0
242702,for,0,0
242703,their,0,0
242704,dependence,0,0
242705,on,0,0
242706,time,0,0
242707,",",0,0
242708,they,0,0
242709,demonstrated,0,0
242710,a,0,0
242711,negative,0,0
242712,",",0,0
242713,linear,0,0
242714,correlation,0,0
242715,between,0,0
242716,alphaEGOT,0,1
242717,and,0,0
242718,log,0,0
242719,plasma,0,0
242720,PLP,0,1
242721,and,0,0
242722,between,0,0
242723,alphaEGPT,0,0
242724,and,0,0
242725,log,0,0
242726,plasma,0,0
242727,PLP,0,1
242728,for,0,0
242729,the,0,0
242730,group,0,0
242731,on,0,0
242732,2.5,0,0
242733,mg,0,0
242734,of,0,0
242735,pyridoxine,1,1
242736,and,0,0
242737,for,0,0
242738,all,0,0
242739,the,0,0
242740,subjects,0,0
242741,combined,0,0
242742,.,0,0
242743,Finally,0,0
242744,",",0,0
242745,the,0,0
242746,dietary,0,0
242747,records,0,0
242748,showed,0,0
242749,that,0,0
242750,most,0,0
242751,of,0,0
242752,the,0,0
242753,subjects,0,0
242754,consumed,0,0
242755,less,0,0
242756,than,0,0
242757,2,0,0
242758,mg,0,0
242759,of,0,0
242760,vitamin,1,1
242761,B6,1,0
242762,daily,0,0
242763,from,0,0
242764,their,0,0
242765,food,0,0
242766,.,0,0
242767,The,0,0
242768,results,0,0
242769,indicate,0,0
242770,that,0,0
242771,the,0,0
242772,current,0,0
242773,Recommended,0,0
242774,Dietary,0,1
242775,Allowance,0,0
242776,for,0,0
242777,vitamin,1,1
242778,B6,1,1
242779,during,0,0
242780,pregnancy,0,0
242781,(,0,0
242782,2.5,0,0
242783,mg,0,1
242784,),0,0
242785,is,0,0
242786,too,0,0
242787,low,0,0
242788,and,0,0
242789,that,0,0
242790,supplementation,0,1
242791,of,0,0
242792,this,0,0
242793,vitamin,0,1
242794,in,0,0
242795,an,0,0
242796,amount,0,0
242797,more,0,0
242798,than,0,0
242799,4,0,0
242800,mg,0,0
242801,daily,0,0
242802,is,0,0
242803,recommended,0,0
242804,.,0,0
242805,Effectiveness,0,0
242806,of,0,0
242807,active,1,0
242808,physical,1,1
242809,training,1,1
242810,as,0,0
242811,treatment,0,0
242812,for,0,0
242813,long-standing,0,0
242814,adductor-related,0,0
242815,groin,0,0
242816,pain,0,0
242817,in,0,0
242818,athletes,0,0
242819,:,0,0
242820,randomised,0,0
242821,trial,0,0
242822,.,0,0
242823,BACKGROUND,0,0
242824,Groin,0,0
242825,pain,0,0
242826,is,0,0
242827,common,0,0
242828,among,0,0
242829,athletes,0,0
242830,.,0,0
242831,A,0,0
242832,major,0,0
242833,cause,0,0
242834,of,0,0
242835,long-standing,0,0
242836,problems,0,0
242837,is,0,0
242838,adductor-related,0,0
242839,groin,0,0
242840,pain,0,0
242841,.,0,0
242842,The,0,0
242843,purpose,0,0
242844,of,0,0
242845,this,0,0
242846,randomised,0,0
242847,clinical,0,0
242848,trial,0,0
242849,was,0,0
242850,to,0,0
242851,compare,0,0
242852,an,0,0
242853,active,1,0
242854,training,1,1
242855,programme,1,1
242856,(,1,0
242857,AT,1,1
242858,),1,0
242859,with,1,0
242860,a,1,0
242861,physiotherapy,1,1
242862,treatment,1,0
242863,without,1,0
242864,active,1,1
242865,training,1,1
242866,(,1,0
242867,PT,1,1
242868,),1,0
242869,in,0,0
242870,the,0,0
242871,treatment,0,0
242872,of,0,0
242873,adductor-related,0,0
242874,groin,0,0
242875,pain,0,0
242876,in,0,0
242877,athletes,0,0
242878,.,0,0
242879,METHODS,0,0
242880,68,0,0
242881,athletes,0,0
242882,with,0,0
242883,long-standing,0,0
242884,(,0,0
242885,median,0,0
242886,40,0,0
242887,weeks,0,0
242888,),0,0
242889,adductor-related,0,0
242890,groin,0,0
242891,pain,0,0
242892,--,0,0
242893,after,0,0
242894,examination,0,0
242895,according,0,0
242896,to,0,0
242897,a,0,0
242898,standardised,0,1
242899,protocol,0,0
242900,--,0,0
242901,were,0,0
242902,randomly,0,0
242903,assigned,0,0
242904,to,0,0
242905,AT,1,0
242906,or,0,1
242907,PT,1,1
242908,.,1,0
242909,The,0,0
242910,treatment,0,0
242911,period,0,0
242912,was,0,0
242913,8-12,0,0
242914,weeks,0,0
242915,.,0,0
242916,4,0,0
242917,months,0,0
242918,after,0,0
242919,the,0,0
242920,end,0,0
242921,of,0,0
242922,treatment,0,0
242923,a,0,0
242924,standardised,0,0
242925,examination,0,0
242926,was,0,0
242927,done,0,0
242928,.,0,0
242929,The,0,0
242930,examining,0,0
242931,physician,0,0
242932,was,0,0
242933,unaware,0,0
242934,of,0,0
242935,the,0,0
242936,treatment,0,0
242937,allocation,0,0
242938,.,0,0
242939,The,0,0
242940,ultimate,0,0
242941,outcome,0,0
242942,measure,0,0
242943,was,0,0
242944,full,0,0
242945,return,0,0
242946,to,0,0
242947,sports,0,0
242948,at,0,0
242949,the,0,0
242950,same,0,0
242951,level,0,0
242952,without,0,0
242953,groin,0,0
242954,pain,0,0
242955,.,0,0
242956,Analyses,0,0
242957,were,0,0
242958,by,0,0
242959,intention,0,0
242960,to,0,0
242961,treat,0,0
242962,.,0,0
242963,FINDINGS,0,0
242964,23,0,0
242965,patients,0,0
242966,in,0,0
242967,the,0,0
242968,AT,0,1
242969,group,0,0
242970,and,0,0
242971,four,0,0
242972,in,0,0
242973,the,0,0
242974,PT,0,1
242975,group,0,0
242976,returned,0,0
242977,to,0,0
242978,sports,0,0
242979,without,0,0
242980,groin,0,0
242981,pain,0,0
242982,(,0,0
242983,odds,0,0
242984,ratio,0,0
242985,",",0,0
242986,multiple-logistic-regression,0,0
242987,analysis,0,0
242988,",",0,0
242989,12.7,0,0
242990,[,0,0
242991,95,0,0
242992,%,0,0
242993,CI,0,0
242994,3.4-47.2,0,0
242995,],0,0
242996,),0,0
242997,.,0,0
242998,The,0,0
242999,subjective,0,0
243000,global,0,0
243001,assessments,0,0
243002,of,0,0
243003,the,0,0
243004,effect,0,0
243005,of,0,0
243006,the,0,0
243007,treatments,0,0
243008,showed,0,0
243009,a,0,0
243010,significant,0,0
243011,(,0,0
243012,p=0.006,0,0
243013,),0,0
243014,linear,0,0
243015,trend,0,0
243016,towards,0,0
243017,a,0,0
243018,better,0,0
243019,effect,0,0
243020,in,0,0
243021,the,0,0
243022,AT,0,0
243023,group,0,0
243024,.,0,0
243025,A,0,0
243026,per-protocol,0,0
243027,analysis,0,0
243028,did,0,0
243029,not,0,0
243030,show,0,0
243031,appreciably,0,0
243032,different,0,0
243033,results,0,0
243034,.,0,0
243035,INTERPRETATION,0,0
243036,AT,0,0
243037,with,0,0
243038,a,0,0
243039,programme,0,1
243040,aimed,0,0
243041,at,0,0
243042,improving,0,0
243043,strength,0,0
243044,and,0,0
243045,coordination,0,1
243046,of,0,0
243047,the,0,0
243048,muscles,0,0
243049,acting,0,0
243050,on,0,0
243051,the,0,0
243052,pelvis,0,1
243053,",",0,0
243054,in,0,0
243055,particular,0,0
243056,the,0,0
243057,adductor,0,0
243058,muscles,0,0
243059,",",0,0
243060,is,0,0
243061,very,0,0
243062,effective,0,0
243063,in,0,0
243064,the,0,0
243065,treatment,0,0
243066,of,0,0
243067,athletes,0,0
243068,with,0,0
243069,long-standing,0,0
243070,adductor-related,0,0
243071,groin,0,0
243072,pain,0,0
243073,.,0,0
243074,The,0,0
243075,potential,0,0
243076,preventive,0,0
243077,value,0,0
243078,of,0,0
243079,a,0,0
243080,short,0,0
243081,programme,0,1
243082,based,0,0
243083,upon,0,0
243084,the,0,0
243085,principles,0,0
243086,of,0,0
243087,AT,0,0
243088,should,0,0
243089,be,0,0
243090,assessed,0,0
243091,in,0,0
243092,future,0,0
243093,",",0,0
243094,randomised,0,0
243095,",",0,0
243096,clinical,0,0
243097,trials,0,0
243098,.,0,0
